id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
1|NCT02987374|2|P1|NOT COMPLETED|Overall Study||0
2|NCT02987374|2|P1|COMPLETED|Overall Study||10
3|NCT02987374|2|P1|STARTED|Overall Study||10
4|NCT02958956|9|P2|NOT COMPLETED|Overall Study||0
5|NCT02958956|10|P1|NOT COMPLETED|Overall Study||0
6|NCT02958956|9|P2|COMPLETED|Overall Study||198317
7|NCT02958956|10|P1|COMPLETED|Overall Study||38190
8|NCT02958956|9|P2|STARTED|Overall Study||198317
9|NCT02958956|10|P1|STARTED|Overall Study||38190
10|NCT02920749|27|P4|NOT COMPLETED|Overall Study||0
11|NCT02920749|28|P3|NOT COMPLETED|Overall Study||0
12|NCT02920749|29|P2|NOT COMPLETED|Overall Study||0
13|NCT02920749|30|P1|NOT COMPLETED|Overall Study||0
14|NCT02920749|27|P4|COMPLETED|Overall Study||30
15|NCT02920749|28|P3|COMPLETED|Overall Study||30
16|NCT02920749|29|P2|COMPLETED|Overall Study||30
17|NCT02920749|30|P1|COMPLETED|Overall Study||30
18|NCT02920749|27|P4|STARTED|Overall Study||30
19|NCT02920749|28|P3|STARTED|Overall Study||30
20|NCT02920749|29|P2|STARTED|Overall Study||30
21|NCT02920749|30|P1|STARTED|Overall Study||30
22|NCT02919657|44|P2|NOT COMPLETED|Overall Study||0
23|NCT02919657|45|P1|NOT COMPLETED|Overall Study||0
24|NCT02919657|44|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
25|NCT02919657|45|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
26|NCT02919657|44|P2|STARTED|Overall Study|10 Participants|10
27|NCT02919657|45|P1|STARTED|Overall Study|10 Participants|10
28|NCT02882152|53|P2|NOT COMPLETED|Overall Study||0
29|NCT02882152|54|P1|NOT COMPLETED|Overall Study||1
30|NCT02882152|53|P2|COMPLETED|Overall Study||20
31|NCT02882152|54|P1|COMPLETED|Overall Study||19
32|NCT02882152|53|P2|STARTED|Overall Study||20
33|NCT02882152|54|P1|STARTED|Overall Study||20
34|NCT02862106|68|P2|NOT COMPLETED|Overall Study||6
35|NCT02862106|69|P1|NOT COMPLETED|Overall Study||38
36|NCT02862106|68|P2|COMPLETED|Overall Study||20
37|NCT02862106|69|P1|COMPLETED|Overall Study||145
38|NCT02862106|68|P2|STARTED|Overall Study||26
39|NCT02862106|69|P1|STARTED|Overall Study||183
40|NCT02840916|129|P2|NOT COMPLETED|Overall Study||3
41|NCT02840916|130|P1|NOT COMPLETED|Overall Study||1
42|NCT02840916|129|P2|COMPLETED|Overall Study||30
43|NCT02840916|130|P1|COMPLETED|Overall Study||32
44|NCT02840916|129|P2|STARTED|Overall Study||33
45|NCT02840916|130|P1|STARTED|Overall Study||33
46|NCT02839772|142|P2|NOT COMPLETED|Overall Study||0
47|NCT02839772|143|P1|NOT COMPLETED|Overall Study||1
48|NCT02839772|142|P2|COMPLETED|Overall Study||96
49|NCT02839772|143|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
50|NCT02839772|142|P2|STARTED|Overall Study||96
51|NCT02839772|143|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
52|NCT02829775|180|P1|NOT COMPLETED|Overall Study||5
53|NCT02829775|180|P1|COMPLETED|Overall Study||4
54|NCT02829775|180|P1|STARTED|Overall Study||9
55|NCT02829463|187|P2|NOT COMPLETED|Overall Study||0
56|NCT02829463|188|P1|NOT COMPLETED|Overall Study||0
57|NCT02829463|187|P2|COMPLETED|Overall Study||62
58|NCT02829463|188|P1|COMPLETED|Overall Study||59
59|NCT02829463|187|P2|STARTED|Overall Study||62
60|NCT02829463|188|P1|STARTED|Overall Study||59
61|NCT02828137|197|P3|NOT COMPLETED|Overall Study||0
62|NCT02828137|198|P2|NOT COMPLETED|Overall Study||0
63|NCT02828137|199|P1|NOT COMPLETED|Overall Study||0
64|NCT02828137|197|P3|COMPLETED|Overall Study||41
65|NCT02828137|198|P2|COMPLETED|Overall Study||41
66|NCT02828137|199|P1|COMPLETED|Overall Study||41
67|NCT02828137|197|P3|STARTED|Overall Study||41
68|NCT02828137|198|P2|STARTED|Overall Study||41
69|NCT02828137|199|P1|STARTED|Overall Study||41
70|NCT02823080|209|P2|NOT COMPLETED|Overall Study||0
71|NCT02823080|210|P1|NOT COMPLETED|Overall Study||0
72|NCT02823080|209|P2|COMPLETED|Overall Study||24
73|NCT02823080|210|P1|COMPLETED|Overall Study||24
74|NCT02823080|209|P2|STARTED|Overall Study||24
75|NCT02823080|210|P1|STARTED|Overall Study||24
76|NCT02822287|228|P1|NOT COMPLETED|Overall Study||0
77|NCT02822287|228|P1|COMPLETED|Overall Study||57
78|NCT02822287|228|P1|STARTED|Overall Study||57
79|NCT02809911|240|P2|NOT COMPLETED|Overall Study||0
80|NCT02809911|241|P1|NOT COMPLETED|Overall Study||0
81|NCT02809911|240|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
82|NCT02809911|241|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
83|NCT02809911|240|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
84|NCT02809911|241|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
85|NCT02809833|249|P1|NOT COMPLETED|Overall Study||300
86|NCT02809833|249|P1|COMPLETED|Overall Study||550
87|NCT02809833|249|P1|STARTED|Overall Study||850
88|NCT02808130|329|P6|NOT COMPLETED|Overall Study||0
89|NCT02808130|330|P5|NOT COMPLETED|Overall Study||0
90|NCT02808130|331|P4|NOT COMPLETED|Overall Study||0
91|NCT02808130|332|P3|NOT COMPLETED|Overall Study||0
92|NCT02808130|333|P2|NOT COMPLETED|Overall Study||0
93|NCT02808130|334|P1|NOT COMPLETED|Overall Study||0
94|NCT02808130|329|P6|COMPLETED|Overall Study||15
95|NCT02808130|330|P5|COMPLETED|Overall Study||15
96|NCT02808130|331|P4|COMPLETED|Overall Study||15
97|NCT02808130|332|P3|COMPLETED|Overall Study||15
98|NCT02808130|333|P2|COMPLETED|Overall Study||15
99|NCT02808130|334|P1|COMPLETED|Overall Study||15
100|NCT02808130|329|P6|STARTED|Overall Study||15
101|NCT02808130|330|P5|STARTED|Overall Study||15
102|NCT02808130|331|P4|STARTED|Overall Study||15
103|NCT02808130|332|P3|STARTED|Overall Study||15
104|NCT02808130|333|P2|STARTED|Overall Study||15
105|NCT02808130|334|P1|STARTED|Overall Study||15
106|NCT02806544|360|P1|NOT COMPLETED|Overall Study||4
107|NCT02806544|360|P1|COMPLETED|Overall Study||31
108|NCT02806544|360|P1|STARTED|Overall Study||35
109|NCT02806505|371|P2|NOT COMPLETED|Overall Study||11
110|NCT02806505|372|P1|NOT COMPLETED|Overall Study||10
111|NCT02806505|371|P2|COMPLETED|Overall Study||32
112|NCT02806505|372|P1|COMPLETED|Overall Study||28
113|NCT02806505|371|P2|STARTED|Overall Study||43
114|NCT02806505|372|P1|STARTED|Overall Study||38
115|NCT02796092|384|P2|NOT COMPLETED|Overall Study||0
116|NCT02796092|385|P1|NOT COMPLETED|Overall Study||0
117|NCT02796092|384|P2|COMPLETED|Overall Study||50
118|NCT02796092|385|P1|COMPLETED|Overall Study||50
119|NCT02796092|384|P2|STARTED|Overall Study||50
120|NCT02796092|385|P1|STARTED|Overall Study||50
121|NCT02792049|419|P2|NOT COMPLETED|Overall Study||0
122|NCT02792049|420|P1|NOT COMPLETED|Overall Study||0
123|NCT02792049|419|P2|COMPLETED|Overall Study||35
124|NCT02792049|420|P1|COMPLETED|Overall Study||35
125|NCT02792049|419|P2|STARTED|Overall Study||35
126|NCT02792049|420|P1|STARTED|Overall Study||35
127|NCT02791269|436|P2|NOT COMPLETED|Overall Study||1
128|NCT02791269|437|P1|NOT COMPLETED|Overall Study||0
129|NCT02791269|436|P2|COMPLETED|Overall Study||19
130|NCT02791269|437|P1|COMPLETED|Overall Study||4
131|NCT02791269|436|P2|STARTED|Overall Study||20
132|NCT02791269|437|P1|STARTED|Overall Study||4
133|NCT02788097|453|P2|NOT COMPLETED|Overall Study||0
134|NCT02788097|454|P1|NOT COMPLETED|Overall Study||0
135|NCT02788097|453|P2|COMPLETED|Overall Study||69
136|NCT02788097|454|P1|COMPLETED|Overall Study||61
137|NCT02788097|453|P2|STARTED|Overall Study||69
138|NCT02788097|454|P1|STARTED|Overall Study||61
139|NCT02780622|460|P2|NOT COMPLETED|Treatment Period 2||0
140|NCT02780622|461|P1|NOT COMPLETED|Treatment Period 2||0
141|NCT02780622|460|P2|COMPLETED|Treatment Period 2||10
142|NCT02780622|461|P1|COMPLETED|Treatment Period 2||10
143|NCT02780622|460|P2|STARTED|Treatment Period 2||10
144|NCT02780622|461|P1|STARTED|Treatment Period 2||10
145|NCT02780622|460|P2|NOT COMPLETED|Treatment Period 1||0
146|NCT02780622|461|P1|NOT COMPLETED|Treatment Period 1||0
147|NCT02780622|460|P2|COMPLETED|Treatment Period 1||10
148|NCT02780622|461|P1|COMPLETED|Treatment Period 1||10
149|NCT02780622|460|P2|STARTED|Treatment Period 1||10
150|NCT02780622|461|P1|STARTED|Treatment Period 1||10
151|NCT02774278|499|P1|NOT COMPLETED|Overall Study||264
152|NCT02774278|499|P1|COMPLETED|Overall Study||0
153|NCT02774278|499|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
154|NCT02774278|499|P1|STARTED|Overall Study||264
155|NCT02773758|509|P2|NOT COMPLETED|Overall Study||0
156|NCT02773758|510|P1|NOT COMPLETED|Overall Study||0
157|NCT02773758|509|P2|COMPLETED|Overall Study||70
158|NCT02773758|510|P1|COMPLETED|Overall Study||71
159|NCT02773758|509|P2|STARTED|Overall Study||70
160|NCT02773758|510|P1|STARTED|Overall Study||71
161|NCT02772666|520|P1|NOT COMPLETED|SFT Then O-Glass||0
162|NCT02772666|520|P1|COMPLETED|SFT Then O-Glass||44
163|NCT02772666|520|P1|STARTED|SFT Then O-Glass||44
164|NCT02772666|520|P1|NOT COMPLETED|O-Glas Then SFT||0
165|NCT02772666|520|P1|COMPLETED|O-Glas Then SFT||44
166|NCT02772666|520|P1|STARTED|O-Glas Then SFT||44
167|NCT02766400|527|P2|NOT COMPLETED|Overall Study||2
168|NCT02766400|528|P1|NOT COMPLETED|Overall Study||2
169|NCT02766400|527|P2|COMPLETED|Overall Study||20
170|NCT02766400|528|P1|COMPLETED|Overall Study||19
171|NCT02766400|527|P2|STARTED|Overall Study||22
172|NCT02766400|528|P1|STARTED|Overall Study||21
173|NCT02766244|534|P1|NOT COMPLETED|Overall Study||0
174|NCT02766244|534|P1|COMPLETED|Overall Study||3
175|NCT02766244|534|P1|STARTED|Overall Study||3
176|NCT02765269|545|P2|NOT COMPLETED|Overall Study||0
177|NCT02765269|546|P1|NOT COMPLETED|Overall Study||0
178|NCT02765269|545|P2|COMPLETED|Overall Study||21
179|NCT02765269|546|P1|COMPLETED|Overall Study||25
180|NCT02765269|545|P2|STARTED|Overall Study||21
181|NCT02765269|546|P1|STARTED|Overall Study||25
182|NCT02761629|560|P2|NOT COMPLETED|Overall Study||32
183|NCT02761629|561|P1|NOT COMPLETED|Overall Study||27
184|NCT02761629|560|P2|COMPLETED|Overall Study||58
185|NCT02761629|561|P1|COMPLETED|Overall Study||63
186|NCT02761629|560|P2|Treated|Overall Study||86
187|NCT02761629|561|P1|Treated|Overall Study||82
188|NCT02761629|560|P2|STARTED|Overall Study||90
189|NCT02761629|561|P1|STARTED|Overall Study||90
190|NCT02756351|583|P2|NOT COMPLETED|Overall Study||0
191|NCT02756351|584|P1|NOT COMPLETED|Overall Study||0
192|NCT02756351|583|P2|COMPLETED|Overall Study||24
193|NCT02756351|584|P1|COMPLETED|Overall Study||24
194|NCT02756351|583|P2|STARTED|Overall Study||24
195|NCT02756351|584|P1|STARTED|Overall Study||24
196|NCT02755805|594|P2|NOT COMPLETED|Overall Study||4
197|NCT02755805|595|P1|NOT COMPLETED|Overall Study||2
198|NCT02755805|594|P2|COMPLETED|Overall Study||11
199|NCT02755805|595|P1|COMPLETED|Overall Study||13
200|NCT02755805|594|P2|STARTED|Overall Study||15
201|NCT02755805|595|P1|STARTED|Overall Study||15
202|NCT02753699|610|P3|NOT COMPLETED|Overall Study||23
203|NCT02753699|611|P2|NOT COMPLETED|Overall Study||43
204|NCT02753699|612|P1|NOT COMPLETED|Overall Study||14
205|NCT02753699|610|P3|COMPLETED|Overall Study||139
206|NCT02753699|611|P2|COMPLETED|Overall Study||354
207|NCT02753699|612|P1|COMPLETED|Overall Study||150
208|NCT02753699|610|P3|STARTED|Overall Study||162
209|NCT02753699|611|P2|STARTED|Overall Study||397
210|NCT02753699|612|P1|STARTED|Overall Study||164
211|NCT02750943|628|P2|NOT COMPLETED|Overall Study||9
212|NCT02750943|629|P1|NOT COMPLETED|Overall Study||6
213|NCT02750943|628|P2|COMPLETED|Overall Study||119
214|NCT02750943|629|P1|COMPLETED|Overall Study||119
215|NCT02750943|628|P2|STARTED|Overall Study||128
216|NCT02750943|629|P1|STARTED|Overall Study||125
217|NCT02750709|643|P6|NOT COMPLETED|Treatment Period 3||0
218|NCT02750709|644|P5|NOT COMPLETED|Treatment Period 3||0
219|NCT02750709|645|P4|NOT COMPLETED|Treatment Period 3||0
220|NCT02750709|646|P3|NOT COMPLETED|Treatment Period 3||0
221|NCT02750709|647|P2|NOT COMPLETED|Treatment Period 3||0
222|NCT02750709|648|P1|NOT COMPLETED|Treatment Period 3||0
223|NCT02750709|643|P6|COMPLETED|Treatment Period 3||3
224|NCT02750709|644|P5|COMPLETED|Treatment Period 3||4
225|NCT02750709|645|P4|COMPLETED|Treatment Period 3||4
226|NCT02750709|646|P3|COMPLETED|Treatment Period 3||4
227|NCT02750709|647|P2|COMPLETED|Treatment Period 3||4
228|NCT02750709|648|P1|COMPLETED|Treatment Period 3||4
229|NCT02750709|643|P6|STARTED|Treatment Period 3||3
230|NCT02750709|644|P5|STARTED|Treatment Period 3||4
231|NCT02750709|645|P4|STARTED|Treatment Period 3||4
232|NCT02750709|646|P3|STARTED|Treatment Period 3||4
233|NCT02750709|647|P2|STARTED|Treatment Period 3||4
234|NCT02750709|648|P1|STARTED|Treatment Period 3||4
235|NCT02750709|643|P6|NOT COMPLETED|Treatment Period 2||0
236|NCT02750709|644|P5|NOT COMPLETED|Treatment Period 2||0
237|NCT02750709|645|P4|NOT COMPLETED|Treatment Period 2||0
238|NCT02750709|646|P3|NOT COMPLETED|Treatment Period 2||0
239|NCT02750709|647|P2|NOT COMPLETED|Treatment Period 2||0
240|NCT02750709|648|P1|NOT COMPLETED|Treatment Period 2||0
241|NCT02750709|643|P6|COMPLETED|Treatment Period 2||3
242|NCT02750709|644|P5|COMPLETED|Treatment Period 2||4
243|NCT02750709|645|P4|COMPLETED|Treatment Period 2||4
244|NCT02750709|646|P3|COMPLETED|Treatment Period 2||4
245|NCT02750709|647|P2|COMPLETED|Treatment Period 2||4
246|NCT02750709|648|P1|COMPLETED|Treatment Period 2||4
247|NCT02750709|643|P6|STARTED|Treatment Period 2||3
248|NCT02750709|644|P5|STARTED|Treatment Period 2||4
249|NCT02750709|645|P4|STARTED|Treatment Period 2||4
250|NCT02750709|646|P3|STARTED|Treatment Period 2||4
251|NCT02750709|647|P2|STARTED|Treatment Period 2||4
252|NCT02750709|648|P1|STARTED|Treatment Period 2||4
253|NCT02750709|643|P6|NOT COMPLETED|Treatment Period 1||1
254|NCT02750709|644|P5|NOT COMPLETED|Treatment Period 1||0
255|NCT02750709|645|P4|NOT COMPLETED|Treatment Period 1||0
256|NCT02750709|646|P3|NOT COMPLETED|Treatment Period 1||0
257|NCT02750709|647|P2|NOT COMPLETED|Treatment Period 1||0
258|NCT02750709|648|P1|NOT COMPLETED|Treatment Period 1||0
259|NCT02750709|643|P6|COMPLETED|Treatment Period 1||3
260|NCT02750709|644|P5|COMPLETED|Treatment Period 1||4
261|NCT02750709|645|P4|COMPLETED|Treatment Period 1||4
262|NCT02750709|646|P3|COMPLETED|Treatment Period 1||4
263|NCT02750709|647|P2|COMPLETED|Treatment Period 1||4
264|NCT02750709|648|P1|COMPLETED|Treatment Period 1||4
265|NCT02750709|643|P6|STARTED|Treatment Period 1||4
266|NCT02750709|644|P5|STARTED|Treatment Period 1||4
267|NCT02750709|645|P4|STARTED|Treatment Period 1||4
268|NCT02750709|646|P3|STARTED|Treatment Period 1||4
269|NCT02750709|647|P2|STARTED|Treatment Period 1||4
270|NCT02750709|648|P1|STARTED|Treatment Period 1||4
271|NCT02750345|674|P6|NOT COMPLETED|Intervention 3||0
272|NCT02750345|675|P5|NOT COMPLETED|Intervention 3||0
273|NCT02750345|676|P4|NOT COMPLETED|Intervention 3||0
274|NCT02750345|677|P3|NOT COMPLETED|Intervention 3||0
275|NCT02750345|678|P2|NOT COMPLETED|Intervention 3||0
276|NCT02750345|679|P1|NOT COMPLETED|Intervention 3||0
277|NCT02750345|674|P6|COMPLETED|Intervention 3||4
278|NCT02750345|675|P5|COMPLETED|Intervention 3||3
279|NCT02750345|676|P4|COMPLETED|Intervention 3||4
280|NCT02750345|677|P3|COMPLETED|Intervention 3||4
281|NCT02750345|678|P2|COMPLETED|Intervention 3||4
282|NCT02750345|679|P1|COMPLETED|Intervention 3||4
283|NCT02750345|674|P6|STARTED|Intervention 3||4
284|NCT02750345|675|P5|STARTED|Intervention 3||3
285|NCT02750345|676|P4|STARTED|Intervention 3||4
286|NCT02750345|677|P3|STARTED|Intervention 3||4
287|NCT02750345|678|P2|STARTED|Intervention 3||4
288|NCT02750345|679|P1|STARTED|Intervention 3||4
289|NCT02750345|674|P6|NOT COMPLETED|Intervention 2||0
290|NCT02750345|675|P5|NOT COMPLETED|Intervention 2||0
291|NCT02750345|676|P4|NOT COMPLETED|Intervention 2||0
292|NCT02750345|677|P3|NOT COMPLETED|Intervention 2||0
293|NCT02750345|678|P2|NOT COMPLETED|Intervention 2||0
294|NCT02750345|679|P1|NOT COMPLETED|Intervention 2||0
295|NCT02750345|674|P6|COMPLETED|Intervention 2||4
296|NCT02750345|675|P5|COMPLETED|Intervention 2||3
297|NCT02750345|676|P4|COMPLETED|Intervention 2||4
298|NCT02750345|677|P3|COMPLETED|Intervention 2||4
299|NCT02750345|678|P2|COMPLETED|Intervention 2||4
300|NCT02750345|679|P1|COMPLETED|Intervention 2||4
301|NCT02750345|674|P6|STARTED|Intervention 2||4
302|NCT02750345|675|P5|STARTED|Intervention 2||3
303|NCT02750345|676|P4|STARTED|Intervention 2||4
304|NCT02750345|677|P3|STARTED|Intervention 2||4
305|NCT02750345|678|P2|STARTED|Intervention 2||4
306|NCT02750345|679|P1|STARTED|Intervention 2||4
307|NCT02750345|674|P6|NOT COMPLETED|Intervention 1||0
308|NCT02750345|675|P5|NOT COMPLETED|Intervention 1||1
309|NCT02750345|676|P4|NOT COMPLETED|Intervention 1||0
310|NCT02750345|677|P3|NOT COMPLETED|Intervention 1||0
311|NCT02750345|678|P2|NOT COMPLETED|Intervention 1||0
312|NCT02750345|679|P1|NOT COMPLETED|Intervention 1||0
313|NCT02750345|674|P6|COMPLETED|Intervention 1||4
314|NCT02750345|675|P5|COMPLETED|Intervention 1||3
315|NCT02750345|676|P4|COMPLETED|Intervention 1||4
316|NCT02750345|677|P3|COMPLETED|Intervention 1||4
317|NCT02750345|678|P2|COMPLETED|Intervention 1||4
318|NCT02750345|679|P1|COMPLETED|Intervention 1||4
319|NCT02750345|674|P6|STARTED|Intervention 1||4
320|NCT02750345|675|P5|STARTED|Intervention 1||4
321|NCT02750345|676|P4|STARTED|Intervention 1||4
322|NCT02750345|677|P3|STARTED|Intervention 1||4
323|NCT02750345|678|P2|STARTED|Intervention 1||4
324|NCT02750345|679|P1|STARTED|Intervention 1||4
325|NCT02750332|705|P2|NOT COMPLETED|Treatment Period 2||0
326|NCT02750332|706|P1|NOT COMPLETED|Treatment Period 2||0
327|NCT02750332|705|P2|COMPLETED|Treatment Period 2||9
328|NCT02750332|706|P1|COMPLETED|Treatment Period 2||10
329|NCT02750332|705|P2|STARTED|Treatment Period 2||9
330|NCT02750332|706|P1|STARTED|Treatment Period 2||10
331|NCT02750332|705|P2|NOT COMPLETED|Treatment Period 1||1
332|NCT02750332|706|P1|NOT COMPLETED|Treatment Period 1||0
333|NCT02750332|705|P2|COMPLETED|Treatment Period 1||9
334|NCT02750332|706|P1|COMPLETED|Treatment Period 1||10
335|NCT02750332|705|P2|STARTED|Treatment Period 1||10
336|NCT02750332|706|P1|STARTED|Treatment Period 1||10
337|NCT02748213|726|P2|NOT COMPLETED|Overall Study||112
338|NCT02748213|727|P1|NOT COMPLETED|Overall Study||113
339|NCT02748213|726|P2|COMPLETED|Overall Study||0
340|NCT02748213|727|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
341|NCT02748213|726|P2|Treated|Overall Study||110
342|NCT02748213|727|P1|Treated|Overall Study||112
343|NCT02748213|726|P2|STARTED|Overall Study||112
344|NCT02748213|727|P1|STARTED|Overall Study||113
345|NCT02746679|745|P2|NOT COMPLETED|Overall Study||6
346|NCT02746679|746|P1|NOT COMPLETED|Overall Study||4
347|NCT02746679|745|P2|COMPLETED|Overall Study||75
348|NCT02746679|746|P1|COMPLETED|Overall Study||76
349|NCT02746679|745|P2|STARTED|Overall Study||81
350|NCT02746679|746|P1|STARTED|Overall Study||80
351|NCT02746406|776|P1|NOT COMPLETED|Overall Study||0
352|NCT02746406|776|P1|COMPLETED|Overall Study||5
353|NCT02746406|776|P1|STARTED|Overall Study||5
354|NCT02746107|780|P1|NOT COMPLETED|Overall Study||0
355|NCT02746107|780|P1|COMPLETED|Overall Study||968
356|NCT02746107|780|P1|CHA2DS2-VASC Score = 5|Overall Study||192
357|NCT02746107|780|P1|CHA2DS2-VASC Score = 4|Overall Study||197
358|NCT02746107|780|P1|CHA2DS2-VASC Score = 3|Overall Study||195
359|NCT02746107|780|P1|CHA2DS2-VASC Score = 2|Overall Study||189
360|NCT02746107|780|P1|CHA2DS2-VASC Score = 1|Overall Study||195
361|NCT02746107|780|P1|Target=Physician|Overall Study||482
362|NCT02746107|780|P1|Target=Patient|Overall Study||486
363|NCT02746107|780|P1|5year Risk Estimate|Overall Study||485
364|NCT02746107|780|P1|1year Risk Estimate|Overall Study||483
365|NCT02746107|780|P1|1 Diagram DA|Overall Study||486
366|NCT02746107|780|P1|2 Diagrams DA|Overall Study||482
367|NCT02746107|780|P1|STARTED|Overall Study||968
368|NCT02743936|797|P2|NOT COMPLETED|Overall Study||0
369|NCT02743936|798|P1|NOT COMPLETED|Overall Study||0
370|NCT02743936|797|P2|COMPLETED|Overall Study||32
371|NCT02743936|798|P1|COMPLETED|Overall Study||32
372|NCT02743936|797|P2|STARTED|Overall Study||32
373|NCT02743936|798|P1|STARTED|Overall Study||32
374|NCT02743702|808|P2|NOT COMPLETED|Overall Study||0
375|NCT02743702|809|P1|NOT COMPLETED|Overall Study||0
376|NCT02743702|808|P2|COMPLETED|Overall Study||10
377|NCT02743702|809|P1|COMPLETED|Overall Study||11
378|NCT02743702|808|P2|STARTED|Overall Study||10
379|NCT02743702|809|P1|STARTED|Overall Study||11
380|NCT02739594|817|P2|NOT COMPLETED|Overall Study||28
381|NCT02739594|818|P1|NOT COMPLETED|Overall Study||25
382|NCT02739594|817|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
383|NCT02739594|818|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
384|NCT02739594|817|P2|Completed at Week 96|Overall Study||10
385|NCT02739594|818|P1|Completed at Week 96|Overall Study||10
386|NCT02739594|817|P2|Completed at Week 44|Overall Study||5
387|NCT02739594|818|P1|Completed at Week 44|Overall Study||11
388|NCT02739594|817|P2|STARTED|Overall Study||43
389|NCT02739594|818|P1|STARTED|Overall Study||46
390|NCT02736721|848|P1|NOT COMPLETED|Overall Study||16
391|NCT02736721|848|P1|COMPLETED|Overall Study||25
392|NCT02736721|848|P1|STARTED|Overall Study||41
393|NCT02732639|857|P1|NOT COMPLETED|Overall Study||1
394|NCT02732639|857|P1|COMPLETED|Overall Study||30
395|NCT02732639|857|P1|STARTED|Overall Study||31
396|NCT02732210|870|P2|NOT COMPLETED|Overall Study||294
397|NCT02732210|871|P1|NOT COMPLETED|Overall Study||85
398|NCT02732210|870|P2|COMPLETED|Overall Study||338
399|NCT02732210|871|P1|COMPLETED|Overall Study||218
400|NCT02732210|870|P2|STARTED|Overall Study||632
401|NCT02732210|871|P1|STARTED|Overall Study||303
402|NCT02731313|887|P1|NOT COMPLETED|Overall Study||0
403|NCT02731313|887|P1|COMPLETED|Overall Study||367
404|NCT02731313|887|P1|STARTED|Overall Study||367
405|NCT02731300|897|P2|NOT COMPLETED|Overall Study||0
406|NCT02731300|898|P1|NOT COMPLETED|Overall Study||0
407|NCT02731300|897|P2|COMPLETED|Overall Study||7
408|NCT02731300|898|P1|COMPLETED|Overall Study||15
409|NCT02731300|897|P2|STARTED|Overall Study||7
410|NCT02731300|898|P1|STARTED|Overall Study||15
411|NCT02731131|908|P2|NOT COMPLETED|Overall Study||2
412|NCT02731131|909|P1|NOT COMPLETED|Overall Study||0
413|NCT02731131|908|P2|COMPLETED|Overall Study||4
414|NCT02731131|909|P1|COMPLETED|Overall Study||6
415|NCT02731131|908|P2|STARTED|Overall Study||6
416|NCT02731131|909|P1|STARTED|Overall Study||6
417|NCT02730260|927|P2|NOT COMPLETED|Overall Study||75
418|NCT02730260|928|P1|NOT COMPLETED|Overall Study||82
419|NCT02730260|927|P2|COMPLETED|Overall Study||185
420|NCT02730260|928|P1|COMPLETED|Overall Study||176
421|NCT02730260|927|P2|STARTED|Overall Study||260
422|NCT02730260|928|P1|STARTED|Overall Study||258
423|NCT02726022|934|P1|NOT COMPLETED|Overall Study||36
424|NCT02726022|934|P1|COMPLETED|Overall Study||78
425|NCT02726022|934|P1|STARTED|Overall Study||114
426|NCT02717754|949|P6|NOT COMPLETED|Overall Study||20
427|NCT02717754|950|P5|NOT COMPLETED|Overall Study||20
428|NCT02717754|951|P4|NOT COMPLETED|Overall Study||10
429|NCT02717754|952|P3|NOT COMPLETED|Overall Study||0
430|NCT02717754|953|P2|NOT COMPLETED|Overall Study||0
431|NCT02717754|954|P1|NOT COMPLETED|Overall Study||0
432|NCT02717754|949|P6|COMPLETED|Overall Study||0
433|NCT02717754|950|P5|COMPLETED|Overall Study||0
434|NCT02717754|951|P4|COMPLETED|Overall Study||0
435|NCT02717754|952|P3|COMPLETED|Overall Study||20
436|NCT02717754|953|P2|COMPLETED|Overall Study||19
437|NCT02717754|954|P1|COMPLETED|Overall Study||10
438|NCT02717754|949|P6|STARTED|Overall Study||20
439|NCT02717754|950|P5|STARTED|Overall Study||20
440|NCT02717754|951|P4|STARTED|Overall Study||10
441|NCT02717754|952|P3|STARTED|Overall Study||20
442|NCT02717754|953|P2|STARTED|Overall Study||19
443|NCT02717754|954|P1|STARTED|Overall Study||10
444|NCT02716779|985|P3|NOT COMPLETED|Combination Therapy||1
445|NCT02716779|986|P2|NOT COMPLETED|Combination Therapy||2
446|NCT02716779|987|P1|NOT COMPLETED|Combination Therapy||0
447|NCT02716779|985|P3|COMPLETED|Combination Therapy||25
448|NCT02716779|986|P2|COMPLETED|Combination Therapy||23
449|NCT02716779|987|P1|COMPLETED|Combination Therapy||14
450|NCT02716779|985|P3|STARTED|Combination Therapy||26
451|NCT02716779|986|P2|STARTED|Combination Therapy||25
452|NCT02716779|987|P1|STARTED|Combination Therapy||14
453|NCT02716779|985|P3|NOT COMPLETED|Monotherapy||1
454|NCT02716779|986|P2|NOT COMPLETED|Monotherapy||1
455|NCT02716779|987|P1|NOT COMPLETED|Monotherapy||0
456|NCT02716779|985|P3|COMPLETED|Monotherapy||26
457|NCT02716779|986|P2|COMPLETED|Monotherapy||25
458|NCT02716779|987|P1|COMPLETED|Monotherapy||14
459|NCT02716779|985|P3|STARTED|Monotherapy||27
460|NCT02716779|986|P2|STARTED|Monotherapy||26
461|NCT02716779|987|P1|STARTED|Monotherapy||14
462|NCT02709577|1033|P4|NOT COMPLETED|Overall Study||0
463|NCT02709577|1034|P3|NOT COMPLETED|Overall Study||2
464|NCT02709577|1035|P2|NOT COMPLETED|Overall Study||5
465|NCT02709577|1036|P1|NOT COMPLETED|Overall Study||2
466|NCT02709577|1033|P4|COMPLETED|Overall Study||5
467|NCT02709577|1034|P3|COMPLETED|Overall Study||4
468|NCT02709577|1035|P2|COMPLETED|Overall Study||8
469|NCT02709577|1036|P1|COMPLETED|Overall Study||10
470|NCT02709577|1033|P4|STARTED|Overall Study||5
471|NCT02709577|1034|P3|STARTED|Overall Study||6
472|NCT02709577|1035|P2|STARTED|Overall Study||13
473|NCT02709577|1036|P1|STARTED|Overall Study||12
474|NCT02708524|1052|P4|NOT COMPLETED|Overall Study||0
475|NCT02708524|1053|P3|NOT COMPLETED|Overall Study||3
476|NCT02708524|1054|P2|NOT COMPLETED|Overall Study||6
477|NCT02708524|1055|P1|NOT COMPLETED|Overall Study||4
478|NCT02708524|1052|P4|COMPLETED|Overall Study||136
479|NCT02708524|1053|P3|COMPLETED|Overall Study||134
480|NCT02708524|1054|P2|COMPLETED|Overall Study||130
481|NCT02708524|1055|P1|COMPLETED|Overall Study||135
482|NCT02708524|1052|P4|STARTED|Overall Study||136
483|NCT02708524|1053|P3|STARTED|Overall Study||137
484|NCT02708524|1054|P2|STARTED|Overall Study||136
485|NCT02708524|1055|P1|STARTED|Overall Study||139
486|NCT02708277|1103|P2|NOT COMPLETED|Overall Study||4
487|NCT02708277|1104|P1|NOT COMPLETED|Overall Study||7
488|NCT02708277|1103|P2|COMPLETED|Overall Study||39
489|NCT02708277|1104|P1|COMPLETED|Overall Study||43
490|NCT02708277|1103|P2|STARTED|Overall Study||43
491|NCT02708277|1104|P1|STARTED|Overall Study||50
492|NCT02708238|1119|P3|NOT COMPLETED|Overall Study||3
493|NCT02708238|1120|P2|NOT COMPLETED|Overall Study||1
494|NCT02708238|1121|P1|NOT COMPLETED|Overall Study||0
495|NCT02708238|1119|P3|COMPLETED|Overall Study||57
496|NCT02708238|1120|P2|COMPLETED|Overall Study||59
497|NCT02708238|1121|P1|COMPLETED|Overall Study||60
498|NCT02708238|1119|P3|STARTED|Overall Study||60
499|NCT02708238|1120|P2|STARTED|Overall Study||60
500|NCT02708238|1121|P1|STARTED|Overall Study||60
501|NCT02708212|1134|P2|NOT COMPLETED|Overall Study||0
502|NCT02708212|1135|P1|NOT COMPLETED|Overall Study||0
503|NCT02708212|1134|P2|COMPLETED|Overall Study||60
504|NCT02708212|1135|P1|COMPLETED|Overall Study||60
505|NCT02708212|1134|P2|STARTED|Overall Study||60
506|NCT02708212|1135|P1|STARTED|Overall Study||60
507|NCT02707640|1147|P2|NOT COMPLETED|Overall Study||7
508|NCT02707640|1148|P1|NOT COMPLETED|Overall Study||9
509|NCT02707640|1147|P2|COMPLETED|Overall Study||55
510|NCT02707640|1148|P1|COMPLETED|Overall Study||52
511|NCT02707640|1147|P2|STARTED|Overall Study||62
512|NCT02707640|1148|P1|STARTED|Overall Study||61
513|NCT02701387|1166|P1|NOT COMPLETED|Overall Study||0
514|NCT02701387|1166|P1|COMPLETED|Overall Study||7
515|NCT02701387|1166|P1|STARTED|Overall Study||7
516|NCT02701270|1171|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
517|NCT02701270|1172|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
518|NCT02701270|1173|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
519|NCT02701270|1174|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
520|NCT02701270|1171|P4|COMPLETED|Fourth Intervention at Visit 4||3
521|NCT02701270|1172|P3|COMPLETED|Fourth Intervention at Visit 4||3
522|NCT02701270|1173|P2|COMPLETED|Fourth Intervention at Visit 4||3
523|NCT02701270|1174|P1|COMPLETED|Fourth Intervention at Visit 4||2
524|NCT02701270|1171|P4|STARTED|Fourth Intervention at Visit 4||3
525|NCT02701270|1172|P3|STARTED|Fourth Intervention at Visit 4||3
526|NCT02701270|1173|P2|STARTED|Fourth Intervention at Visit 4||3
527|NCT02701270|1174|P1|STARTED|Fourth Intervention at Visit 4||2
528|NCT02701270|1171|P4|NOT COMPLETED|Third Intervention at Visit 3||0
529|NCT02701270|1172|P3|NOT COMPLETED|Third Intervention at Visit 3||0
530|NCT02701270|1173|P2|NOT COMPLETED|Third Intervention at Visit 3||0
531|NCT02701270|1174|P1|NOT COMPLETED|Third Intervention at Visit 3||0
532|NCT02701270|1171|P4|COMPLETED|Third Intervention at Visit 3||3
533|NCT02701270|1172|P3|COMPLETED|Third Intervention at Visit 3||3
534|NCT02701270|1173|P2|COMPLETED|Third Intervention at Visit 3||3
535|NCT02701270|1174|P1|COMPLETED|Third Intervention at Visit 3||2
536|NCT02701270|1171|P4|STARTED|Third Intervention at Visit 3||3
537|NCT02701270|1172|P3|STARTED|Third Intervention at Visit 3||3
538|NCT02701270|1173|P2|STARTED|Third Intervention at Visit 3||3
539|NCT02701270|1174|P1|STARTED|Third Intervention at Visit 3||2
540|NCT02701270|1171|P4|NOT COMPLETED|Second Intervention at Visit 2||0
541|NCT02701270|1172|P3|NOT COMPLETED|Second Intervention at Visit 2||0
542|NCT02701270|1173|P2|NOT COMPLETED|Second Intervention at Visit 2||0
543|NCT02701270|1174|P1|NOT COMPLETED|Second Intervention at Visit 2||0
544|NCT02701270|1171|P4|COMPLETED|Second Intervention at Visit 2||3
545|NCT02701270|1172|P3|COMPLETED|Second Intervention at Visit 2||3
546|NCT02701270|1173|P2|COMPLETED|Second Intervention at Visit 2||3
547|NCT02701270|1174|P1|COMPLETED|Second Intervention at Visit 2||2
548|NCT02701270|1171|P4|STARTED|Second Intervention at Visit 2||3
549|NCT02701270|1172|P3|STARTED|Second Intervention at Visit 2||3
550|NCT02701270|1173|P2|STARTED|Second Intervention at Visit 2||3
551|NCT02701270|1174|P1|STARTED|Second Intervention at Visit 2||2
552|NCT02701270|1171|P4|NOT COMPLETED|First Intervention at Visit 1||0
553|NCT02701270|1172|P3|NOT COMPLETED|First Intervention at Visit 1||0
554|NCT02701270|1173|P2|NOT COMPLETED|First Intervention at Visit 1||0
555|NCT02701270|1174|P1|NOT COMPLETED|First Intervention at Visit 1||0
556|NCT02701270|1171|P4|COMPLETED|First Intervention at Visit 1||3
557|NCT02701270|1172|P3|COMPLETED|First Intervention at Visit 1||3
558|NCT02701270|1173|P2|COMPLETED|First Intervention at Visit 1||3
559|NCT02701270|1174|P1|COMPLETED|First Intervention at Visit 1||2
560|NCT02701270|1171|P4|STARTED|First Intervention at Visit 1||3
561|NCT02701270|1172|P3|STARTED|First Intervention at Visit 1||3
562|NCT02701270|1173|P2|STARTED|First Intervention at Visit 1||3
563|NCT02701270|1174|P1|STARTED|First Intervention at Visit 1||2
564|NCT02699892|1188|P1|NOT COMPLETED|Overall Study||36
565|NCT02699892|1188|P1|COMPLETED|Overall Study||94
566|NCT02699892|1188|P1|STARTED|Overall Study||130
567|NCT02694718|1193|P1|NOT COMPLETED|Overall Study||2
568|NCT02694718|1193|P1|COMPLETED|Overall Study||58
569|NCT02694718|1193|P1|STARTED|Overall Study||60
570|NCT02694536|1203|P1|NOT COMPLETED|Overall Study||80
571|NCT02694536|1203|P1|COMPLETED|Overall Study||0
572|NCT02694536|1203|P1|STARTED|Overall Study||80
573|NCT02694315|1212|P1|NOT COMPLETED|Overall Study||0
574|NCT02694315|1212|P1|COMPLETED|Overall Study||200
575|NCT02694315|1212|P1|STARTED|Overall Study||200
576|NCT02694198|1217|P1|NOT COMPLETED|Overall Study||0
577|NCT02694198|1217|P1|COMPLETED|Overall Study||135
578|NCT02694198|1217|P1|STARTED|Overall Study||135
579|NCT02693704|1226|P4|NOT COMPLETED|Overall Study||0
580|NCT02693704|1227|P3|NOT COMPLETED|Overall Study||0
581|NCT02693704|1228|P2|NOT COMPLETED|Overall Study||0
582|NCT02693704|1229|P1|NOT COMPLETED|Overall Study||0
583|NCT02693704|1226|P4|COMPLETED|Overall Study||10
584|NCT02693704|1227|P3|COMPLETED|Overall Study||10
585|NCT02693704|1228|P2|COMPLETED|Overall Study||10
586|NCT02693704|1229|P1|COMPLETED|Overall Study||10
587|NCT02693704|1226|P4|STARTED|Overall Study||10
588|NCT02693704|1227|P3|STARTED|Overall Study||10
589|NCT02693704|1228|P2|STARTED|Overall Study||10
590|NCT02693704|1229|P1|STARTED|Overall Study||10
591|NCT02691416|1249|P2|NOT COMPLETED|Overall Study||0
592|NCT02691416|1250|P1|NOT COMPLETED|Overall Study||0
593|NCT02691416|1249|P2|COMPLETED|Overall Study||30
594|NCT02691416|1250|P1|COMPLETED|Overall Study||30
595|NCT02691416|1249|P2|STARTED|Overall Study||30
596|NCT02691416|1250|P1|STARTED|Overall Study||30
597|NCT02687217|1272|P2|NOT COMPLETED|Overall Study||0
598|NCT02687217|1273|P1|NOT COMPLETED|Overall Study||0
599|NCT02687217|1272|P2|COMPLETED|Overall Study||30
600|NCT02687217|1273|P1|COMPLETED|Overall Study||30
601|NCT02687217|1272|P2|STARTED|Overall Study||30
602|NCT02687217|1273|P1|STARTED|Overall Study||30
603|NCT02684604|1285|P2|NOT COMPLETED|Overall Study||0
604|NCT02684604|1286|P1|NOT COMPLETED|Overall Study||0
605|NCT02684604|1285|P2|COMPLETED|Overall Study||44
606|NCT02684604|1286|P1|COMPLETED|Overall Study||44
607|NCT02684604|1285|P2|STARTED|Overall Study||44
608|NCT02684604|1286|P1|STARTED|Overall Study||44
609|NCT02684396|1298|P6|NOT COMPLETED|Overall Study||0
610|NCT02684396|1299|P5|NOT COMPLETED|Overall Study||0
611|NCT02684396|1300|P4|NOT COMPLETED|Overall Study||0
612|NCT02684396|1301|P3|NOT COMPLETED|Overall Study||0
613|NCT02684396|1302|P2|NOT COMPLETED|Overall Study||0
614|NCT02684396|1303|P1|NOT COMPLETED|Overall Study||0
615|NCT02684396|1298|P6|COMPLETED|Overall Study||10
616|NCT02684396|1299|P5|COMPLETED|Overall Study||5
617|NCT02684396|1300|P4|COMPLETED|Overall Study||6
618|NCT02684396|1301|P3|COMPLETED|Overall Study||6
619|NCT02684396|1302|P2|COMPLETED|Overall Study||6
620|NCT02684396|1303|P1|COMPLETED|Overall Study||6
621|NCT02684396|1298|P6|STARTED|Overall Study||10
622|NCT02684396|1299|P5|STARTED|Overall Study||5
623|NCT02684396|1300|P4|STARTED|Overall Study||6
624|NCT02684396|1301|P3|STARTED|Overall Study||6
625|NCT02684396|1302|P2|STARTED|Overall Study||6
626|NCT02684396|1303|P1|STARTED|Overall Study||6
627|NCT02683954|1357|P2|NOT COMPLETED|Overall Study||0
628|NCT02683954|1358|P1|NOT COMPLETED|Overall Study||0
629|NCT02683954|1357|P2|COMPLETED|Overall Study||30
630|NCT02683954|1358|P1|COMPLETED|Overall Study||30
631|NCT02683954|1357|P2|STARTED|Overall Study||30
632|NCT02683954|1358|P1|STARTED|Overall Study||30
633|NCT02681458|1366|P2|NOT COMPLETED|Overall Study||656
634|NCT02681458|1367|P1|NOT COMPLETED|Overall Study||645
635|NCT02681458|1366|P2|COMPLETED|Overall Study||62
636|NCT02681458|1367|P1|COMPLETED|Overall Study||73
637|NCT02681458|1366|P2|STARTED|Overall Study||718
638|NCT02681458|1367|P1|STARTED|Overall Study||718
639|NCT02679976|1373|P1|NOT COMPLETED|Overall Study||0
640|NCT02679976|1373|P1|COMPLETED|Overall Study||30
641|NCT02679976|1373|P1|Myopes|Overall Study||14
642|NCT02679976|1373|P1|Hyperopes|Overall Study||16
643|NCT02679976|1373|P1|STARTED|Overall Study||30
644|NCT02678676|1384|P2|NOT COMPLETED|Overall Study||872
645|NCT02678676|1385|P1|NOT COMPLETED|Overall Study||888
646|NCT02678676|1384|P2|COMPLETED|Overall Study||907
647|NCT02678676|1385|P1|COMPLETED|Overall Study||932
648|NCT02678676|1384|P2|STARTED|Overall Study||1779
649|NCT02678676|1385|P1|STARTED|Overall Study||1820
650|NCT02677779|1395|P2|NOT COMPLETED|Overall Study||0
651|NCT02677779|1396|P1|NOT COMPLETED|Overall Study||0
652|NCT02677779|1395|P2|COMPLETED|Overall Study||10
653|NCT02677779|1396|P1|COMPLETED|Overall Study||10
654|NCT02677779|1395|P2|STARTED|Overall Study||10
655|NCT02677779|1396|P1|STARTED|Overall Study||10
656|NCT02677493|1413|P3|NOT COMPLETED|Overall Study||3
657|NCT02677493|1414|P2|NOT COMPLETED|Overall Study||2
658|NCT02677493|1415|P1|NOT COMPLETED|Overall Study||11
659|NCT02677493|1413|P3|COMPLETED|Overall Study||296
660|NCT02677493|1414|P2|COMPLETED|Overall Study||296
661|NCT02677493|1415|P1|COMPLETED|Overall Study||1186
662|NCT02677493|1413|P3|STARTED|Overall Study||299
663|NCT02677493|1414|P2|STARTED|Overall Study||298
664|NCT02677493|1415|P1|STARTED|Overall Study||1197
665|NCT02673944|1426|P1|NOT COMPLETED|Overall Study||0
666|NCT02673944|1426|P1|COMPLETED|Overall Study||10
667|NCT02673944|1426|P1|STARTED|Overall Study||10
668|NCT02670811|1433|P2|NOT COMPLETED|Overall Study||0
669|NCT02670811|1434|P1|NOT COMPLETED|Overall Study||1
670|NCT02670811|1433|P2|COMPLETED|Overall Study||18
671|NCT02670811|1434|P1|COMPLETED|Overall Study||17
672|NCT02670811|1433|P2|STARTED|Overall Study||18
673|NCT02670811|1434|P1|STARTED|Overall Study||18
674|NCT02666560|1450|P2|NOT COMPLETED|Condition 2 (1 Day)||0
675|NCT02666560|1451|P1|NOT COMPLETED|Condition 2 (1 Day)||0
676|NCT02666560|1450|P2|COMPLETED|Condition 2 (1 Day)||11
677|NCT02666560|1451|P1|COMPLETED|Condition 2 (1 Day)||8
678|NCT02666560|1450|P2|STARTED|Condition 2 (1 Day)||11
679|NCT02666560|1451|P1|STARTED|Condition 2 (1 Day)||8
680|NCT02666560|1450|P2|NOT COMPLETED|Condition 1 (1 Day)||0
681|NCT02666560|1451|P1|NOT COMPLETED|Condition 1 (1 Day)||0
682|NCT02666560|1450|P2|COMPLETED|Condition 1 (1 Day)||11
683|NCT02666560|1451|P1|COMPLETED|Condition 1 (1 Day)||8
684|NCT02666560|1450|P2|STARTED|Condition 1 (1 Day)||11
685|NCT02666560|1451|P1|STARTED|Condition 1 (1 Day)||8
686|NCT02666222|1467|P1|NOT COMPLETED|Overall Study||2
687|NCT02666222|1467|P1|COMPLETED|Overall Study||49
688|NCT02666222|1467|P1|STARTED|Overall Study||51
689|NCT02664987|1475|P1|NOT COMPLETED|Overall Study||0
690|NCT02664987|1475|P1|COMPLETED|Overall Study||462
691|NCT02664987|1475|P1|STARTED|Overall Study||462
692|NCT02664532|1486|P2|NOT COMPLETED|Overall Study||0
693|NCT02664532|1487|P1|NOT COMPLETED|Overall Study||0
694|NCT02664532|1486|P2|COMPLETED|Overall Study||75
695|NCT02664532|1487|P1|COMPLETED|Overall Study||75
696|NCT02664532|1486|P2|STARTED|Overall Study||75
697|NCT02664532|1487|P1|STARTED|Overall Study||75
698|NCT02663232|1499|P1|NOT COMPLETED|Overall Study||0
699|NCT02663232|1499|P1|COMPLETED|Overall Study||264
700|NCT02663232|1499|P1|STARTED|Overall Study||264
701|NCT02658461|1523|P3|NOT COMPLETED|Overall Study||0
702|NCT02658461|1524|P2|NOT COMPLETED|Overall Study||0
703|NCT02658461|1525|P1|NOT COMPLETED|Overall Study||0
704|NCT02658461|1523|P3|COMPLETED|Overall Study||12
705|NCT02658461|1524|P2|COMPLETED|Overall Study||12
706|NCT02658461|1525|P1|COMPLETED|Overall Study||12
707|NCT02658461|1523|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
708|NCT02658461|1524|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
709|NCT02658461|1525|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
710|NCT02657629|1553|P2|NOT COMPLETED|Overall Study||0
711|NCT02657629|1554|P1|NOT COMPLETED|Overall Study||2
712|NCT02657629|1553|P2|COMPLETED|Overall Study||14
713|NCT02657629|1554|P1|COMPLETED|Overall Study||12
714|NCT02657629|1553|P2|STARTED|Overall Study||14
715|NCT02657629|1554|P1|STARTED|Overall Study||14
716|NCT02657538|1560|P1|NOT COMPLETED|Overall Study||4
717|NCT02657538|1560|P1|COMPLETED|Overall Study||31
718|NCT02657538|1560|P1|Received Visual Caries Detection + Bite|Overall Study||35
719|NCT02657538|1560|P1|Received Near Infrared Transillumination|Overall Study||35
720|NCT02657538|1560|P1|STARTED|Overall Study||35
721|NCT02653560|1567|P4|NOT COMPLETED|Placebo Phase||0
722|NCT02653560|1568|P3|NOT COMPLETED|Placebo Phase||0
723|NCT02653560|1569|P2|NOT COMPLETED|Placebo Phase||0
724|NCT02653560|1570|P1|NOT COMPLETED|Placebo Phase||0
725|NCT02653560|1567|P4|COMPLETED|Placebo Phase||30
726|NCT02653560|1568|P3|COMPLETED|Placebo Phase||0
727|NCT02653560|1569|P2|COMPLETED|Placebo Phase||0
728|NCT02653560|1570|P1|COMPLETED|Placebo Phase||0
729|NCT02653560|1567|P4|STARTED|Placebo Phase||30
730|NCT02653560|1568|P3|STARTED|Placebo Phase||0
731|NCT02653560|1569|P2|STARTED|Placebo Phase||0
732|NCT02653560|1570|P1|STARTED|Placebo Phase||0
733|NCT02653560|1567|P4|NOT COMPLETED|KCl Phase||0
734|NCT02653560|1568|P3|NOT COMPLETED|KCl Phase||0
735|NCT02653560|1569|P2|NOT COMPLETED|KCl Phase||0
736|NCT02653560|1570|P1|NOT COMPLETED|KCl Phase||0
737|NCT02653560|1567|P4|COMPLETED|KCl Phase||0
738|NCT02653560|1568|P3|COMPLETED|KCl Phase||30
739|NCT02653560|1569|P2|COMPLETED|KCl Phase||0
740|NCT02653560|1570|P1|COMPLETED|KCl Phase||0
741|NCT02653560|1567|P4|STARTED|KCl Phase||0
742|NCT02653560|1568|P3|STARTED|KCl Phase||30
743|NCT02653560|1569|P2|STARTED|KCl Phase||0
744|NCT02653560|1570|P1|STARTED|KCl Phase||0
745|NCT02653560|1567|P4|NOT COMPLETED|K Citrate Phase||0
746|NCT02653560|1568|P3|NOT COMPLETED|K Citrate Phase||0
747|NCT02653560|1569|P2|NOT COMPLETED|K Citrate Phase||0
748|NCT02653560|1570|P1|NOT COMPLETED|K Citrate Phase||0
749|NCT02653560|1567|P4|COMPLETED|K Citrate Phase||0
750|NCT02653560|1568|P3|COMPLETED|K Citrate Phase||0
751|NCT02653560|1569|P2|COMPLETED|K Citrate Phase||30
752|NCT02653560|1570|P1|COMPLETED|K Citrate Phase||0
753|NCT02653560|1567|P4|STARTED|K Citrate Phase||0
754|NCT02653560|1568|P3|STARTED|K Citrate Phase||0
755|NCT02653560|1569|P2|STARTED|K Citrate Phase||30
756|NCT02653560|1570|P1|STARTED|K Citrate Phase||0
757|NCT02653560|1567|P4|NOT COMPLETED|KMgCit Phase||0
758|NCT02653560|1568|P3|NOT COMPLETED|KMgCit Phase||0
759|NCT02653560|1569|P2|NOT COMPLETED|KMgCit Phase||0
760|NCT02653560|1570|P1|NOT COMPLETED|KMgCit Phase||0
761|NCT02653560|1567|P4|COMPLETED|KMgCit Phase||0
762|NCT02653560|1568|P3|COMPLETED|KMgCit Phase||0
763|NCT02653560|1569|P2|COMPLETED|KMgCit Phase||0
764|NCT02653560|1570|P1|COMPLETED|KMgCit Phase||30
765|NCT02653560|1567|P4|STARTED|KMgCit Phase||0
766|NCT02653560|1568|P3|STARTED|KMgCit Phase||0
767|NCT02653560|1569|P2|STARTED|KMgCit Phase||0
768|NCT02653560|1570|P1|STARTED|KMgCit Phase||30
769|NCT02650219|1582|P2|NOT COMPLETED|Overall Study||0
770|NCT02650219|1583|P1|NOT COMPLETED|Overall Study||0
771|NCT02650219|1582|P2|COMPLETED|Overall Study||20
772|NCT02650219|1583|P1|COMPLETED|Overall Study||40
773|NCT02650219|1582|P2|STARTED|Overall Study||20
774|NCT02650219|1583|P1|STARTED|Overall Study||40
775|NCT02648022|1595|P2|NOT COMPLETED|Overall Study||0
776|NCT02648022|1596|P1|NOT COMPLETED|Overall Study||0
777|NCT02648022|1595|P2|COMPLETED|Overall Study||39
778|NCT02648022|1596|P1|COMPLETED|Overall Study||40
779|NCT02648022|1595|P2|STARTED|Overall Study||39
780|NCT02648022|1596|P1|STARTED|Overall Study||40
781|NCT02645760|1608|P2|NOT COMPLETED|Overall Study||0
782|NCT02645760|1609|P1|NOT COMPLETED|Overall Study||0
783|NCT02645760|1608|P2|COMPLETED|Overall Study||19
784|NCT02645760|1609|P1|COMPLETED|Overall Study||19
785|NCT02645760|1608|P2|STARTED|Overall Study||19
786|NCT02645760|1609|P1|STARTED|Overall Study||19
787|NCT02644109|1623|P2|NOT COMPLETED|Overall Study||4
788|NCT02644109|1624|P1|NOT COMPLETED|Overall Study||0
789|NCT02644109|1623|P2|COMPLETED|Overall Study||24
790|NCT02644109|1624|P1|COMPLETED|Overall Study||24
791|NCT02644109|1623|P2|STARTED|Overall Study||28
792|NCT02644109|1624|P1|STARTED|Overall Study||24
793|NCT02644096|1632|P2|NOT COMPLETED|Overall Study||25
794|NCT02644096|1633|P1|NOT COMPLETED|Overall Study||28
795|NCT02644096|1632|P2|COMPLETED|Overall Study||57
796|NCT02644096|1633|P1|COMPLETED|Overall Study||65
797|NCT02644096|1632|P2|9 Month SF-36 Questionnaire|Overall Study||57
798|NCT02644096|1633|P1|9 Month SF-36 Questionnaire|Overall Study||65
799|NCT02644096|1632|P2|12 Week SF-36 Questionnaire|Overall Study||59
800|NCT02644096|1633|P1|12 Week SF-36 Questionnaire|Overall Study||68
801|NCT02644096|1632|P2|10 Week Interview|Overall Study||59
802|NCT02644096|1633|P1|10 Week Interview|Overall Study|Not done in control group|0
803|NCT02644096|1632|P2|2 Week Interview|Overall Study||68
804|NCT02644096|1633|P1|2 Week Interview|Overall Study|Not done in control group|0
805|NCT02644096|1632|P2|STARTED|Overall Study||82
806|NCT02644096|1633|P1|STARTED|Overall Study||93
807|NCT02643225|1641|P2|NOT COMPLETED|Overall Study||0
808|NCT02643225|1642|P1|NOT COMPLETED|Overall Study||0
809|NCT02643225|1641|P2|COMPLETED|Overall Study||40
810|NCT02643225|1642|P1|COMPLETED|Overall Study||40
811|NCT02643225|1641|P2|STARTED|Overall Study||40
812|NCT02643225|1642|P1|STARTED|Overall Study||40
813|NCT02641912|1656|P2|NOT COMPLETED|Overall Study||0
814|NCT02641912|1657|P1|NOT COMPLETED|Overall Study||0
815|NCT02641912|1656|P2|COMPLETED|Overall Study||47
816|NCT02641912|1657|P1|COMPLETED|Overall Study||53
817|NCT02641912|1656|P2|STARTED|Overall Study||47
818|NCT02641912|1657|P1|STARTED|Overall Study||53
819|NCT02641379|1736|P11|NOT COMPLETED|Overall Study||8
820|NCT02641379|1737|P10|NOT COMPLETED|Overall Study||9
821|NCT02641379|1738|P9|NOT COMPLETED|Overall Study||6
822|NCT02641379|1739|P8|NOT COMPLETED|Overall Study||19
823|NCT02641379|1740|P7|NOT COMPLETED|Overall Study||13
824|NCT02641379|1741|P6|NOT COMPLETED|Overall Study||16
825|NCT02641379|1742|P5|NOT COMPLETED|Overall Study||17
826|NCT02641379|1743|P4|NOT COMPLETED|Overall Study||17
827|NCT02641379|1744|P3|NOT COMPLETED|Overall Study||71
828|NCT02641379|1745|P2|NOT COMPLETED|Overall Study||51
829|NCT02641379|1746|P1|NOT COMPLETED|Overall Study||35
830|NCT02641379|1736|P11|COMPLETED|Overall Study||0
831|NCT02641379|1737|P10|COMPLETED|Overall Study||36
832|NCT02641379|1738|P9|COMPLETED|Overall Study||36
833|NCT02641379|1739|P8|COMPLETED|Overall Study||1
834|NCT02641379|1740|P7|COMPLETED|Overall Study||12
835|NCT02641379|1741|P6|COMPLETED|Overall Study||20
836|NCT02641379|1742|P5|COMPLETED|Overall Study||0
837|NCT02641379|1743|P4|COMPLETED|Overall Study||139
838|NCT02641379|1744|P3|COMPLETED|Overall Study||7
839|NCT02641379|1745|P2|COMPLETED|Overall Study||101
840|NCT02641379|1746|P1|COMPLETED|Overall Study||107
841|NCT02641379|1736|P11|STARTED|Overall Study||8
842|NCT02641379|1737|P10|STARTED|Overall Study||45
843|NCT02641379|1738|P9|STARTED|Overall Study||42
844|NCT02641379|1739|P8|STARTED|Overall Study||20
845|NCT02641379|1740|P7|STARTED|Overall Study||25
846|NCT02641379|1741|P6|STARTED|Overall Study||36
847|NCT02641379|1742|P5|STARTED|Overall Study||17
848|NCT02641379|1743|P4|STARTED|Overall Study||156
849|NCT02641379|1744|P3|STARTED|Overall Study||78
850|NCT02641379|1745|P2|STARTED|Overall Study||152
851|NCT02641379|1746|P1|STARTED|Overall Study||142
852|NCT02638051|1813|P2|NOT COMPLETED|Overall Study||0
853|NCT02638051|1814|P1|NOT COMPLETED|Overall Study||0
854|NCT02638051|1813|P2|COMPLETED|Overall Study||130
855|NCT02638051|1814|P1|COMPLETED|Overall Study||130
856|NCT02638051|1813|P2|STARTED|Overall Study||130
857|NCT02638051|1814|P1|STARTED|Overall Study||130
858|NCT02635425|1826|P2|NOT COMPLETED|Overall Study||0
859|NCT02635425|1827|P1|NOT COMPLETED|Overall Study||0
860|NCT02635425|1826|P2|COMPLETED|Overall Study||15
861|NCT02635425|1827|P1|COMPLETED|Overall Study||15
862|NCT02635425|1826|P2|STARTED|Overall Study||15
863|NCT02635425|1827|P1|STARTED|Overall Study||15
864|NCT02633787|1833|P1|NOT COMPLETED|Overall Study||1
865|NCT02633787|1833|P1|COMPLETED|Overall Study||109
866|NCT02633787|1833|P1|STARTED|Overall Study||110
867|NCT02630563|1839|P1|NOT COMPLETED|Overall Study||1
868|NCT02630563|1839|P1|COMPLETED|Overall Study||8
869|NCT02630563|1839|P1|STARTED|Overall Study||9
870|NCT02628418|1850|P2|NOT COMPLETED|Overall Study||2
871|NCT02628418|1851|P1|NOT COMPLETED|Overall Study||1
872|NCT02628418|1850|P2|COMPLETED|Overall Study||13
873|NCT02628418|1851|P1|COMPLETED|Overall Study||14
874|NCT02628418|1850|P2|STARTED|Overall Study||15
875|NCT02628418|1851|P1|STARTED|Overall Study||15
876|NCT02628938|1875|P3|NOT COMPLETED|Overall Study||4
877|NCT02628938|1876|P2|NOT COMPLETED|Overall Study||2
878|NCT02628938|1877|P1|NOT COMPLETED|Overall Study||5
879|NCT02628938|1875|P3|COMPLETED|Overall Study||11
880|NCT02628938|1876|P2|COMPLETED|Overall Study||13
881|NCT02628938|1877|P1|COMPLETED|Overall Study||10
882|NCT02628938|1875|P3|STARTED|Overall Study||15
883|NCT02628938|1876|P2|STARTED|Overall Study||15
884|NCT02628938|1877|P1|STARTED|Overall Study||15
885|NCT02628106|1891|P1|NOT COMPLETED|Overall Study||0
886|NCT02628106|1891|P1|COMPLETED|Overall Study||21
887|NCT02628106|1891|P1|STARTED|Overall Study||21
888|NCT02627144|1895|P1|NOT COMPLETED|Overall Study||365
889|NCT02627144|1895|P1|COMPLETED|Overall Study||0
890|NCT02627144|1895|P1|Treated|Overall Study||359
891|NCT02627144|1895|P1|STARTED|Overall Study||365
892|NCT02627001|1905|P2|NOT COMPLETED|Overall Study||0
893|NCT02627001|1906|P1|NOT COMPLETED|Overall Study||0
894|NCT02627001|1905|P2|COMPLETED|Overall Study||14
895|NCT02627001|1906|P1|COMPLETED|Overall Study||13
896|NCT02627001|1905|P2|STARTED|Overall Study||14
897|NCT02627001|1906|P1|STARTED|Overall Study||13
898|NCT02625844|1912|P1|NOT COMPLETED|Overall Study||0
899|NCT02625844|1912|P1|COMPLETED|Overall Study||110
900|NCT02625844|1912|P1|STARTED|Overall Study||110
901|NCT02621034|1919|P3|NOT COMPLETED|Overall Study||5
902|NCT02621034|1920|P2|NOT COMPLETED|Overall Study||2
903|NCT02621034|1921|P1|NOT COMPLETED|Overall Study||3
904|NCT02621034|1919|P3|COMPLETED|Overall Study||50
905|NCT02621034|1920|P2|COMPLETED|Overall Study||50
906|NCT02621034|1921|P1|COMPLETED|Overall Study||50
907|NCT02621034|1919|P3|STARTED|Overall Study||55
908|NCT02621034|1920|P2|STARTED|Overall Study||52
909|NCT02621034|1921|P1|STARTED|Overall Study||53
910|NCT02619799|1936|P2|NOT COMPLETED|Overall Study||0
911|NCT02619799|1937|P1|NOT COMPLETED|Overall Study||0
912|NCT02619799|1936|P2|COMPLETED|Overall Study||25
913|NCT02619799|1937|P1|COMPLETED|Overall Study||25
914|NCT02619799|1936|P2|STARTED|Overall Study||25
915|NCT02619799|1937|P1|STARTED|Overall Study||25
916|NCT02619591|1955|P2|NOT COMPLETED|Overall Study||121
917|NCT02619591|1956|P1|NOT COMPLETED|Overall Study||139
918|NCT02619591|1955|P2|COMPLETED|Overall Study||0
919|NCT02619591|1956|P1|COMPLETED|Overall Study||0
920|NCT02619591|1955|P2|STARTED|Overall Study||121
921|NCT02619591|1956|P1|STARTED|Overall Study||139
922|NCT02618772|1964|P2|NOT COMPLETED|Overall Study||0
923|NCT02618772|1965|P1|NOT COMPLETED|Overall Study||1
924|NCT02618772|1964|P2|COMPLETED|Overall Study||40
925|NCT02618772|1965|P1|COMPLETED|Overall Study||38
926|NCT02618772|1964|P2|Withdrawal by Subject|Overall Study||0
1019|NCT02609178|2133|P2|STARTED|5-minute Washout Time||1
927|NCT02618772|1965|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
928|NCT02618772|1964|P2|STARTED|Overall Study||40
929|NCT02618772|1965|P1|STARTED|Overall Study||39
930|NCT02617888|1999|P2|NOT COMPLETED|Overall Study||0
931|NCT02617888|2000|P1|NOT COMPLETED|Overall Study||0
932|NCT02617888|1999|P2|COMPLETED|Overall Study||51
933|NCT02617888|2000|P1|COMPLETED|Overall Study||50
934|NCT02617888|1999|P2|STARTED|Overall Study||51
935|NCT02617888|2000|P1|STARTED|Overall Study||50
936|NCT02617784|2008|P2|NOT COMPLETED|Overall Study||0
937|NCT02617784|2009|P1|NOT COMPLETED|Overall Study||0
938|NCT02617784|2008|P2|COMPLETED|Overall Study||12
939|NCT02617784|2009|P1|COMPLETED|Overall Study||12
940|NCT02617784|2008|P2|Second Dose Assessment Period|Overall Study||12
941|NCT02617784|2009|P1|Second Dose Assessment Period|Overall Study||11
942|NCT02617784|2008|P2|First Dose Assessment Period|Overall Study||12
943|NCT02617784|2009|P1|First Dose Assessment Period|Overall Study||12
944|NCT02617784|2008|P2|STARTED|Overall Study||12
945|NCT02617784|2009|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
946|NCT02616523|2059|P3|NOT COMPLETED|Overall Study||0
947|NCT02616523|2060|P2|NOT COMPLETED|Overall Study||0
948|NCT02616523|2061|P1|NOT COMPLETED|Overall Study||1
949|NCT02616523|2059|P3|COMPLETED|Overall Study|April 2015|20
950|NCT02616523|2060|P2|COMPLETED|Overall Study|April 2015|20
951|NCT02616523|2061|P1|COMPLETED|Overall Study|April 2015|19
952|NCT02616523|2059|P3|STARTED|Overall Study|June 2014|20
953|NCT02616523|2060|P2|STARTED|Overall Study|June 2014|20
954|NCT02616523|2061|P1|STARTED|Overall Study|June 2014|20
955|NCT02615717|2077|P2|NOT COMPLETED|Overall Study||0
956|NCT02615717|2078|P1|NOT COMPLETED|Overall Study||0
957|NCT02615717|2077|P2|COMPLETED|Overall Study||3
958|NCT02615717|2078|P1|COMPLETED|Overall Study||3
959|NCT02615717|2077|P2|STARTED|Overall Study||3
960|NCT02615717|2078|P1|STARTED|Overall Study||3
961|NCT02614924|2092|P2|NOT COMPLETED|Overall Study||0
962|NCT02614924|2093|P1|NOT COMPLETED|Overall Study||0
963|NCT02614924|2092|P2|COMPLETED|Overall Study||20
964|NCT02614924|2093|P1|COMPLETED|Overall Study||20
965|NCT02614924|2092|P2|STARTED|Overall Study||20
966|NCT02614924|2093|P1|STARTED|Overall Study||20
967|NCT02612077|2101|P1|NOT COMPLETED|Overall Study||466
968|NCT02612077|2101|P1|COMPLETED|Overall Study||299
969|NCT02612077|2101|P1|Efficacy Analysis Set|Overall Study||737
970|NCT02612077|2101|P1|Safety Analysis Set|Overall Study||760
971|NCT02612077|2101|P1|Did Not Receive Study Product|Overall Study||5
972|NCT02612077|2101|P1|STARTED|Overall Study||765
973|NCT02611765|2113|P2|NOT COMPLETED|Overall Study||6
974|NCT02611765|2114|P1|NOT COMPLETED|Overall Study||2
975|NCT02611765|2113|P2|COMPLETED|Overall Study||29
976|NCT02611765|2114|P1|COMPLETED|Overall Study||27
977|NCT02611765|2113|P2|STARTED|Overall Study||35
978|NCT02611765|2114|P1|STARTED|Overall Study||29
979|NCT02610634|2122|P2|NOT COMPLETED|Overall Study||0
980|NCT02610634|2123|P1|NOT COMPLETED|Overall Study||0
981|NCT02610634|2122|P2|COMPLETED|Overall Study||40
982|NCT02610634|2123|P1|COMPLETED|Overall Study||60
983|NCT02610634|2122|P2|STARTED|Overall Study||40
984|NCT02610634|2123|P1|STARTED|Overall Study||60
985|NCT02609178|2129|P6|NOT COMPLETED|Third Crown||0
986|NCT02609178|2130|P5|NOT COMPLETED|Third Crown||0
987|NCT02609178|2131|P4|NOT COMPLETED|Third Crown||0
988|NCT02609178|2132|P3|NOT COMPLETED|Third Crown||0
989|NCT02609178|2133|P2|NOT COMPLETED|Third Crown||0
990|NCT02609178|2134|P1|NOT COMPLETED|Third Crown||0
991|NCT02609178|2129|P6|COMPLETED|Third Crown||2
992|NCT02609178|2130|P5|COMPLETED|Third Crown||0
993|NCT02609178|2131|P4|COMPLETED|Third Crown||2
994|NCT02609178|2132|P3|COMPLETED|Third Crown||5
995|NCT02609178|2133|P2|COMPLETED|Third Crown||1
996|NCT02609178|2134|P1|COMPLETED|Third Crown||0
997|NCT02609178|2129|P6|STARTED|Third Crown||2
998|NCT02609178|2130|P5|STARTED|Third Crown||0
999|NCT02609178|2131|P4|STARTED|Third Crown||2
1000|NCT02609178|2132|P3|STARTED|Third Crown||5
1001|NCT02609178|2133|P2|STARTED|Third Crown||1
1002|NCT02609178|2134|P1|STARTED|Third Crown||0
1003|NCT02609178|2129|P6|NOT COMPLETED|5-minute Washout Time||0
1004|NCT02609178|2130|P5|NOT COMPLETED|5-minute Washout Time||0
1005|NCT02609178|2131|P4|NOT COMPLETED|5-minute Washout Time||0
1006|NCT02609178|2132|P3|NOT COMPLETED|5-minute Washout Time||0
1007|NCT02609178|2133|P2|NOT COMPLETED|5-minute Washout Time||0
1008|NCT02609178|2134|P1|NOT COMPLETED|5-minute Washout Time||0
1009|NCT02609178|2129|P6|COMPLETED|5-minute Washout Time||2
1010|NCT02609178|2130|P5|COMPLETED|5-minute Washout Time||0
1011|NCT02609178|2131|P4|COMPLETED|5-minute Washout Time||2
1012|NCT02609178|2132|P3|COMPLETED|5-minute Washout Time||5
1013|NCT02609178|2133|P2|COMPLETED|5-minute Washout Time||1
1014|NCT02609178|2134|P1|COMPLETED|5-minute Washout Time||0
1015|NCT02609178|2129|P6|STARTED|5-minute Washout Time||2
1016|NCT02609178|2130|P5|STARTED|5-minute Washout Time||0
1017|NCT02609178|2131|P4|STARTED|5-minute Washout Time||2
1018|NCT02609178|2132|P3|STARTED|5-minute Washout Time||5
1020|NCT02609178|2134|P1|STARTED|5-minute Washout Time||0
1021|NCT02609178|2129|P6|NOT COMPLETED|Second Crown||0
1022|NCT02609178|2130|P5|NOT COMPLETED|Second Crown||0
1023|NCT02609178|2131|P4|NOT COMPLETED|Second Crown||0
1024|NCT02609178|2132|P3|NOT COMPLETED|Second Crown||0
1025|NCT02609178|2133|P2|NOT COMPLETED|Second Crown||0
1026|NCT02609178|2134|P1|NOT COMPLETED|Second Crown||0
1027|NCT02609178|2129|P6|COMPLETED|Second Crown||2
1028|NCT02609178|2130|P5|COMPLETED|Second Crown||0
1029|NCT02609178|2131|P4|COMPLETED|Second Crown||2
1030|NCT02609178|2132|P3|COMPLETED|Second Crown||5
1031|NCT02609178|2133|P2|COMPLETED|Second Crown||1
1032|NCT02609178|2134|P1|COMPLETED|Second Crown||0
1033|NCT02609178|2129|P6|STARTED|Second Crown||2
1034|NCT02609178|2130|P5|STARTED|Second Crown||0
1035|NCT02609178|2131|P4|STARTED|Second Crown||2
1036|NCT02609178|2132|P3|STARTED|Second Crown||5
1037|NCT02609178|2133|P2|STARTED|Second Crown||1
1038|NCT02609178|2134|P1|STARTED|Second Crown||0
1039|NCT02609178|2129|P6|NOT COMPLETED|5-minute Washout Time||0
1040|NCT02609178|2130|P5|NOT COMPLETED|5-minute Washout Time||0
1041|NCT02609178|2131|P4|NOT COMPLETED|5-minute Washout Time||0
1042|NCT02609178|2132|P3|NOT COMPLETED|5-minute Washout Time||0
1043|NCT02609178|2133|P2|NOT COMPLETED|5-minute Washout Time||0
1044|NCT02609178|2134|P1|NOT COMPLETED|5-minute Washout Time||0
1045|NCT02609178|2129|P6|COMPLETED|5-minute Washout Time||2
1046|NCT02609178|2130|P5|COMPLETED|5-minute Washout Time||0
1047|NCT02609178|2131|P4|COMPLETED|5-minute Washout Time||2
1048|NCT02609178|2132|P3|COMPLETED|5-minute Washout Time||5
1049|NCT02609178|2133|P2|COMPLETED|5-minute Washout Time||1
1050|NCT02609178|2134|P1|COMPLETED|5-minute Washout Time||0
1051|NCT02609178|2129|P6|STARTED|5-minute Washout Time||2
1052|NCT02609178|2130|P5|STARTED|5-minute Washout Time||0
1053|NCT02609178|2131|P4|STARTED|5-minute Washout Time||2
1054|NCT02609178|2132|P3|STARTED|5-minute Washout Time||5
1055|NCT02609178|2133|P2|STARTED|5-minute Washout Time||1
1056|NCT02609178|2134|P1|STARTED|5-minute Washout Time||0
1057|NCT02609178|2129|P6|NOT COMPLETED|First Crown||0
1058|NCT02609178|2130|P5|NOT COMPLETED|First Crown||0
1059|NCT02609178|2131|P4|NOT COMPLETED|First Crown||1
1060|NCT02609178|2132|P3|NOT COMPLETED|First Crown||1
1061|NCT02609178|2133|P2|NOT COMPLETED|First Crown||0
1062|NCT02609178|2134|P1|NOT COMPLETED|First Crown||0
1063|NCT02609178|2129|P6|COMPLETED|First Crown||2
1064|NCT02609178|2130|P5|COMPLETED|First Crown||0
1065|NCT02609178|2131|P4|COMPLETED|First Crown||2
1066|NCT02609178|2132|P3|COMPLETED|First Crown||5
1067|NCT02609178|2133|P2|COMPLETED|First Crown||1
1068|NCT02609178|2134|P1|COMPLETED|First Crown||0
1069|NCT02609178|2129|P6|STARTED|First Crown||2
1070|NCT02609178|2130|P5|STARTED|First Crown||0
1071|NCT02609178|2131|P4|STARTED|First Crown||3
1072|NCT02609178|2132|P3|STARTED|First Crown||6
1073|NCT02609178|2133|P2|STARTED|First Crown||1
1074|NCT02609178|2134|P1|STARTED|First Crown||0
1075|NCT02608489|2151|P2|NOT COMPLETED|Overall Study||10
1076|NCT02608489|2152|P1|NOT COMPLETED|Overall Study||13
1077|NCT02608489|2151|P2|COMPLETED|Overall Study||33
1078|NCT02608489|2152|P1|COMPLETED|Overall Study||30
1079|NCT02608489|2151|P2|STARTED|Overall Study||43
1080|NCT02608489|2152|P1|STARTED|Overall Study||43
1081|NCT02606734|2172|P1|NOT COMPLETED|Overall Study||0
1082|NCT02606734|2172|P1|COMPLETED|Overall Study||44
1083|NCT02606734|2172|P1|STARTED|Overall Study||44
1084|NCT02603666|2176|P1|NOT COMPLETED|Overall Study||0
1085|NCT02603666|2176|P1|COMPLETED|Overall Study||130
1086|NCT02603666|2176|P1|STARTED|Overall Study||130
1087|NCT02602223|2180|P1|NOT COMPLETED|Overall Study||0
1088|NCT02602223|2180|P1|COMPLETED|Overall Study||9
1089|NCT02602223|2180|P1|STARTED|Overall Study||9
1090|NCT02598934|2198|P2|NOT COMPLETED|Overall Study||22
1091|NCT02598934|2199|P1|NOT COMPLETED|Overall Study||19
1092|NCT02598934|2198|P2|COMPLETED|Overall Study||132
1093|NCT02598934|2199|P1|COMPLETED|Overall Study||135
1094|NCT02598934|2198|P2|STARTED|Overall Study||154
1095|NCT02598934|2199|P1|STARTED|Overall Study||154
1096|NCT02598622|2211|P2|NOT COMPLETED|Overall Study||0
1097|NCT02598622|2212|P1|NOT COMPLETED|Overall Study||6
1098|NCT02598622|2211|P2|COMPLETED|Overall Study||0
1099|NCT02598622|2212|P1|COMPLETED|Overall Study||2
1100|NCT02598622|2211|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
1101|NCT02598622|2212|P1|STARTED|Overall Study||8
1102|NCT02598128|2218|P4|NOT COMPLETED|Period C: Days 12 to 20||0
1103|NCT02598128|2219|P3|NOT COMPLETED|Period C: Days 12 to 20||0
1104|NCT02598128|2220|P2|NOT COMPLETED|Period C: Days 12 to 20||0
1105|NCT02598128|2221|P1|NOT COMPLETED|Period C: Days 12 to 20||0
1106|NCT02598128|2218|P4|COMPLETED|Period C: Days 12 to 20||33
1107|NCT02598128|2219|P3|COMPLETED|Period C: Days 12 to 20||0
1108|NCT02598128|2220|P2|COMPLETED|Period C: Days 12 to 20||0
1109|NCT02598128|2221|P1|COMPLETED|Period C: Days 12 to 20||0
1110|NCT02598128|2218|P4|STARTED|Period C: Days 12 to 20||33
1111|NCT02598128|2219|P3|STARTED|Period C: Days 12 to 20||0
1112|NCT02598128|2220|P2|STARTED|Period C: Days 12 to 20||0
1113|NCT02598128|2221|P1|STARTED|Period C: Days 12 to 20||0
1114|NCT02598128|2218|P4|NOT COMPLETED|Period B: Days 1 to 11||0
1115|NCT02598128|2219|P3|NOT COMPLETED|Period B: Days 1 to 11||0
1116|NCT02598128|2220|P2|NOT COMPLETED|Period B: Days 1 to 11||0
1117|NCT02598128|2221|P1|NOT COMPLETED|Period B: Days 1 to 11||0
1118|NCT02598128|2218|P4|COMPLETED|Period B: Days 1 to 11||0
1119|NCT02598128|2219|P3|COMPLETED|Period B: Days 1 to 11||16
1120|NCT02598128|2220|P2|COMPLETED|Period B: Days 1 to 11||17
1121|NCT02598128|2221|P1|COMPLETED|Period B: Days 1 to 11||0
1122|NCT02598128|2218|P4|STARTED|Period B: Days 1 to 11||0
1123|NCT02598128|2219|P3|STARTED|Period B: Days 1 to 11||16
1124|NCT02598128|2220|P2|STARTED|Period B: Days 1 to 11||17
1125|NCT02598128|2221|P1|STARTED|Period B: Days 1 to 11||0
1126|NCT02598128|2218|P4|NOT COMPLETED|Period A: Days -7 to -1||0
1127|NCT02598128|2219|P3|NOT COMPLETED|Period A: Days -7 to -1||0
1128|NCT02598128|2220|P2|NOT COMPLETED|Period A: Days -7 to -1||0
1129|NCT02598128|2221|P1|NOT COMPLETED|Period A: Days -7 to -1||1
1130|NCT02598128|2218|P4|COMPLETED|Period A: Days -7 to -1||0
1131|NCT02598128|2219|P3|COMPLETED|Period A: Days -7 to -1||0
1132|NCT02598128|2220|P2|COMPLETED|Period A: Days -7 to -1||0
1133|NCT02598128|2221|P1|COMPLETED|Period A: Days -7 to -1||33
1134|NCT02598128|2218|P4|STARTED|Period A: Days -7 to -1||0
1135|NCT02598128|2219|P3|STARTED|Period A: Days -7 to -1||0
1136|NCT02598128|2220|P2|STARTED|Period A: Days -7 to -1||0
1137|NCT02598128|2221|P1|STARTED|Period A: Days -7 to -1||34
1138|NCT02597855|2235|P2|NOT COMPLETED|Overall Study||1
1139|NCT02597855|2236|P1|NOT COMPLETED|Overall Study||2
1140|NCT02597855|2235|P2|COMPLETED|Overall Study||13
1141|NCT02597855|2236|P1|COMPLETED|Overall Study||16
1142|NCT02597855|2235|P2|STARTED|Overall Study||14
1143|NCT02597855|2236|P1|STARTED|Overall Study||18
1144|NCT02597582|2246|P2|NOT COMPLETED|Overall Study||0
1145|NCT02597582|2247|P1|NOT COMPLETED|Overall Study||0
1146|NCT02597582|2246|P2|COMPLETED|Overall Study||20
1147|NCT02597582|2247|P1|COMPLETED|Overall Study||21
1148|NCT02597582|2246|P2|STARTED|Overall Study||20
1149|NCT02597582|2247|P1|STARTED|Overall Study||21
1150|NCT02596958|2263|P1|NOT COMPLETED|Overall Study||996
1151|NCT02596958|2263|P1|COMPLETED|Overall Study||0
1152|NCT02596958|2263|P1|STARTED|Overall Study||996
1153|NCT02596945|2275|P1|NOT COMPLETED|Overall Study||56
1154|NCT02596945|2275|P1|COMPLETED|Overall Study||167
1155|NCT02596945|2275|P1|Treated|Overall Study||220
1156|NCT02596945|2275|P1|STARTED|Overall Study||223
1157|NCT02596620|2283|P2|NOT COMPLETED|Overall Study||1
1158|NCT02596620|2284|P1|NOT COMPLETED|Overall Study||1
1159|NCT02596620|2283|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
1160|NCT02596620|2284|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
1161|NCT02596620|2283|P2|STARTED|Overall Study|Started from 1st October 2013|82
1162|NCT02596620|2284|P1|STARTED|Overall Study|Started from 1st October 2013|82
1163|NCT02595502|2290|P2|NOT COMPLETED|Period 3||2
1164|NCT02595502|2291|P1|NOT COMPLETED|Period 3||1
1165|NCT02595502|2290|P2|COMPLETED|Period 3||136
1166|NCT02595502|2291|P1|COMPLETED|Period 3||140
1167|NCT02595502|2290|P2|STARTED|Period 3||138
1168|NCT02595502|2291|P1|STARTED|Period 3||141
1169|NCT02595502|2290|P2|NOT COMPLETED|Period 2||2
1170|NCT02595502|2291|P1|NOT COMPLETED|Period 2||1
1171|NCT02595502|2290|P2|COMPLETED|Period 2||138
1172|NCT02595502|2291|P1|COMPLETED|Period 2||141
1173|NCT02595502|2290|P2|STARTED|Period 2||140
1174|NCT02595502|2291|P1|STARTED|Period 2||142
1175|NCT02595502|2290|P2|NOT COMPLETED|Period 1||2
1176|NCT02595502|2291|P1|NOT COMPLETED|Period 1||1
1177|NCT02595502|2290|P2|COMPLETED|Period 1||140
1178|NCT02595502|2291|P1|COMPLETED|Period 1||142
1179|NCT02595502|2290|P2|STARTED|Period 1||142
1180|NCT02595502|2291|P1|STARTED|Period 1||143
1181|NCT02595450|2297|P1|NOT COMPLETED|Overall Study||81
1182|NCT02595450|2297|P1|COMPLETED|Overall Study||218
1183|NCT02595450|2297|P1|Treated|Overall Study||291
1184|NCT02595450|2297|P1|STARTED|Overall Study||299
1185|NCT02594826|2305|P2|NOT COMPLETED|Overall Study||60
1186|NCT02594826|2306|P1|NOT COMPLETED|Overall Study||57
1187|NCT02594826|2305|P2|COMPLETED|Overall Study||298
1188|NCT02594826|2306|P1|COMPLETED|Overall Study||290
1189|NCT02594826|2305|P2|STARTED|Overall Study||358
1190|NCT02594826|2306|P1|STARTED|Overall Study||347
1191|NCT02591238|2316|P4|NOT COMPLETED|Overall Study||3
1192|NCT02591238|2317|P3|NOT COMPLETED|Overall Study||0
1193|NCT02591238|2318|P2|NOT COMPLETED|Overall Study||1
1194|NCT02591238|2319|P1|NOT COMPLETED|Overall Study||1
1195|NCT02591238|2316|P4|COMPLETED|Overall Study||15
1196|NCT02591238|2317|P3|COMPLETED|Overall Study||17
1197|NCT02591238|2318|P2|COMPLETED|Overall Study||16
1198|NCT02591238|2319|P1|COMPLETED|Overall Study||15
1199|NCT02591238|2316|P4|STARTED|Overall Study||18
1200|NCT02591238|2317|P3|STARTED|Overall Study||17
1201|NCT02591238|2318|P2|STARTED|Overall Study||17
1202|NCT02591238|2319|P1|STARTED|Overall Study||16
1203|NCT02591056|2349|P1|NOT COMPLETED|Overall Study||0
1204|NCT02591056|2349|P1|COMPLETED|Overall Study||27
1205|NCT02591056|2349|P1|STARTED|Overall Study||27
1206|NCT02590562|2353|P1|NOT COMPLETED|Overall Study||6
1207|NCT02590562|2353|P1|COMPLETED|Overall Study||802
1208|NCT02590562|2353|P1|STARTED|Overall Study||808
1209|NCT02588599|2410|P1|NOT COMPLETED|Overall Study||0
1210|NCT02588599|2410|P1|COMPLETED|Overall Study||54
1211|NCT02588599|2410|P1|STARTED|Overall Study||54
1212|NCT02587819|2415|P1|NOT COMPLETED|Overall Study||2
1213|NCT02587819|2415|P1|COMPLETED|Overall Study||19
1214|NCT02587819|2415|P1|Exposed|Overall Study||21
1215|NCT02587819|2415|P1|STARTED|Overall Study||21
1216|NCT02587117|2424|P2|NOT COMPLETED|Overall Study||0
1217|NCT02587117|2425|P1|NOT COMPLETED|Overall Study||0
1218|NCT02587117|2424|P2|COMPLETED|Overall Study||15
1219|NCT02587117|2425|P1|COMPLETED|Overall Study||13
1220|NCT02587117|2424|P2|STARTED|Overall Study||15
1221|NCT02587117|2425|P1|STARTED|Overall Study||13
1222|NCT02586506|2433|P1|NOT COMPLETED|Overall Study||9
1223|NCT02586506|2433|P1|COMPLETED|Overall Study||250
1224|NCT02586506|2433|P1|STARTED|Overall Study||259
1225|NCT02586493|2439|P1|NOT COMPLETED|Overall Study||12
1226|NCT02586493|2439|P1|COMPLETED|Overall Study||266
1227|NCT02586493|2439|P1|STARTED|Overall Study||278
1228|NCT02584686|2447|P2|NOT COMPLETED|Overall Study||0
1229|NCT02584686|2448|P1|NOT COMPLETED|Overall Study||0
1230|NCT02584686|2447|P2|COMPLETED|Overall Study||12
1231|NCT02584686|2448|P1|COMPLETED|Overall Study||12
1232|NCT02584686|2447|P2|STARTED|Overall Study||12
1233|NCT02584686|2448|P1|STARTED|Overall Study||12
1234|NCT02582983|2474|P1|NOT COMPLETED|Overall Study||6
1235|NCT02582983|2474|P1|COMPLETED|Overall Study||17
1236|NCT02582983|2474|P1|STARTED|Overall Study||23
1237|NCT02581475|2481|P2|NOT COMPLETED|Overall Study||15
1238|NCT02581475|2482|P1|NOT COMPLETED|Overall Study||11
1239|NCT02581475|2481|P2|COMPLETED|Overall Study||178
1240|NCT02581475|2482|P1|COMPLETED|Overall Study||182
1241|NCT02581475|2481|P2|STARTED|Overall Study||193
1242|NCT02581475|2482|P1|STARTED|Overall Study||193
1243|NCT02580799|2494|P1|NOT COMPLETED|Overall Study||0
1244|NCT02580799|2494|P1|COMPLETED|Overall Study||30
1245|NCT02580799|2494|P1|STARTED|Overall Study||30
1246|NCT02578992|2518|P2|NOT COMPLETED|Overall Study||3
1247|NCT02578992|2519|P1|NOT COMPLETED|Overall Study||3
1248|NCT02578992|2518|P2|COMPLETED|Overall Study|October 2015|62
1249|NCT02578992|2519|P1|COMPLETED|Overall Study|October 2015|62
1250|NCT02578992|2518|P2|STARTED|Overall Study|November 2014|65
1251|NCT02578992|2519|P1|STARTED|Overall Study|November 2014|65
1252|NCT02577315|2533|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1253|NCT02577315|2534|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1254|NCT02577315|2533|P2|COMPLETED|Treatment Period 2 (4 Days)||12
1255|NCT02577315|2534|P1|COMPLETED|Treatment Period 2 (4 Days)||12
1256|NCT02577315|2533|P2|STARTED|Treatment Period 2 (4 Days)||12
1257|NCT02577315|2534|P1|STARTED|Treatment Period 2 (4 Days)||12
1258|NCT02577315|2533|P2|NOT COMPLETED|Washout Period (5 Days)||0
1259|NCT02577315|2534|P1|NOT COMPLETED|Washout Period (5 Days)||0
1260|NCT02577315|2533|P2|COMPLETED|Washout Period (5 Days)||12
1261|NCT02577315|2534|P1|COMPLETED|Washout Period (5 Days)||12
1262|NCT02577315|2533|P2|STARTED|Washout Period (5 Days)||12
1263|NCT02577315|2534|P1|STARTED|Washout Period (5 Days)||12
1264|NCT02577315|2533|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
1265|NCT02577315|2534|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1266|NCT02577315|2533|P2|COMPLETED|Treatment Period 1 (4 Days)||12
1267|NCT02577315|2534|P1|COMPLETED|Treatment Period 1 (4 Days)||12
1268|NCT02577315|2533|P2|STARTED|Treatment Period 1 (4 Days)||13
1269|NCT02577315|2534|P1|STARTED|Treatment Period 1 (4 Days)||12
1270|NCT02576535|2550|P1|NOT COMPLETED|Overall Study||2
1271|NCT02576535|2550|P1|COMPLETED|Overall Study||16
1272|NCT02576535|2550|P1|STARTED|Overall Study||18
1273|NCT02576145|2561|P2|NOT COMPLETED|Overall Study||1
1274|NCT02576145|2562|P1|NOT COMPLETED|Overall Study||3
1275|NCT02576145|2561|P2|COMPLETED|Overall Study||4
1276|NCT02576145|2562|P1|COMPLETED|Overall Study||3
1277|NCT02576145|2561|P2|STARTED|Overall Study||5
1278|NCT02576145|2562|P1|STARTED|Overall Study||6
1279|NCT02576041|2598|P1|NOT COMPLETED|Overall Study||0
1280|NCT02576041|2598|P1|COMPLETED|Overall Study||18
1281|NCT02576041|2598|P1|STARTED|Overall Study||18
1282|NCT02574845|2610|P6|NOT COMPLETED|Overall Study||1
1283|NCT02574845|2611|P5|NOT COMPLETED|Overall Study||1
1284|NCT02574845|2612|P4|NOT COMPLETED|Overall Study||0
1285|NCT02574845|2613|P3|NOT COMPLETED|Overall Study||0
1286|NCT02574845|2614|P2|NOT COMPLETED|Overall Study||1
1287|NCT02574845|2615|P1|NOT COMPLETED|Overall Study||0
1288|NCT02574845|2610|P6|COMPLETED|Overall Study||2
1289|NCT02574845|2611|P5|COMPLETED|Overall Study||2
1290|NCT02574845|2612|P4|COMPLETED|Overall Study||3
1291|NCT02574845|2613|P3|COMPLETED|Overall Study||3
1292|NCT02574845|2614|P2|COMPLETED|Overall Study||2
1293|NCT02574845|2615|P1|COMPLETED|Overall Study||3
1294|NCT02574845|2610|P6|Received R|Overall Study||3
1295|NCT02574845|2611|P5|Received R|Overall Study||2
1296|NCT02574845|2612|P4|Received R|Overall Study||3
1297|NCT02574845|2613|P3|Received R|Overall Study||3
1298|NCT02574845|2614|P2|Received R|Overall Study||2
1299|NCT02574845|2615|P1|Received R|Overall Study||3
1300|NCT02574845|2610|P6|Received T5|Overall Study||2
1301|NCT02574845|2611|P5|Received T5|Overall Study||3
1302|NCT02574845|2612|P4|Received T5|Overall Study||3
1303|NCT02574845|2613|P3|Received T5|Overall Study||3
1304|NCT02574845|2614|P2|Received T5|Overall Study||2
1305|NCT02574845|2615|P1|Received T5|Overall Study||3
1306|NCT02574845|2610|P6|Received T4|Overall Study||2
1307|NCT02574845|2611|P5|Received T4|Overall Study||2
1308|NCT02574845|2612|P4|Received T4|Overall Study||3
1309|NCT02574845|2613|P3|Received T4|Overall Study||3
1310|NCT02574845|2614|P2|Received T4|Overall Study||2
1311|NCT02574845|2615|P1|Received T4|Overall Study||3
1312|NCT02574845|2610|P6|Received T3|Overall Study||3
1313|NCT02574845|2611|P5|Received T3|Overall Study||2
1314|NCT02574845|2612|P4|Received T3|Overall Study||3
1315|NCT02574845|2613|P3|Received T3|Overall Study||3
1316|NCT02574845|2614|P2|Received T3|Overall Study||2
1317|NCT02574845|2615|P1|Received T3|Overall Study|one subject missed treatment period 2|2
1318|NCT02574845|2610|P6|Received T2|Overall Study||3
1319|NCT02574845|2611|P5|Received T2|Overall Study||2
1320|NCT02574845|2612|P4|Received T2|Overall Study||3
1321|NCT02574845|2613|P3|Received T2|Overall Study||3
1322|NCT02574845|2614|P2|Received T2|Overall Study||3
1323|NCT02574845|2615|P1|Received T2|Overall Study||3
1324|NCT02574845|2610|P6|Received T1|Overall Study|one subject missed treatment period 2|2
1325|NCT02574845|2611|P5|Received T1|Overall Study||2
1326|NCT02574845|2612|P4|Received T1|Overall Study||3
1327|NCT02574845|2613|P3|Received T1|Overall Study||3
1328|NCT02574845|2614|P2|Received T1|Overall Study||2
1329|NCT02574845|2615|P1|Received T1|Overall Study||3
1330|NCT02574845|2610|P6|STARTED|Overall Study||3
1331|NCT02574845|2611|P5|STARTED|Overall Study||3
1332|NCT02574845|2612|P4|STARTED|Overall Study||3
1333|NCT02574845|2613|P3|STARTED|Overall Study||3
1334|NCT02574845|2614|P2|STARTED|Overall Study||3
1335|NCT02574845|2615|P1|STARTED|Overall Study||3
1336|NCT02574260|2641|P1|NOT COMPLETED|Overall Study||1
1337|NCT02574260|2641|P1|COMPLETED|Overall Study||2
1338|NCT02574260|2641|P1|STARTED|Overall Study||3
1339|NCT02572752|2650|P3|NOT COMPLETED|Period 3 Including Washout||0
1340|NCT02572752|2651|P2|NOT COMPLETED|Period 3 Including Washout||0
1341|NCT02572752|2652|P1|NOT COMPLETED|Period 3 Including Washout||0
1342|NCT02572752|2650|P3|COMPLETED|Period 3 Including Washout||24
1343|NCT02572752|2651|P2|COMPLETED|Period 3 Including Washout||23
1344|NCT02572752|2652|P1|COMPLETED|Period 3 Including Washout||23
1345|NCT02572752|2650|P3|STARTED|Period 3 Including Washout||24
1346|NCT02572752|2651|P2|STARTED|Period 3 Including Washout||23
1347|NCT02572752|2652|P1|STARTED|Period 3 Including Washout||23
1348|NCT02572752|2650|P3|NOT COMPLETED|Period 2 Including Washout||0
1349|NCT02572752|2651|P2|NOT COMPLETED|Period 2 Including Washout||0
1350|NCT02572752|2652|P1|NOT COMPLETED|Period 2 Including Washout||0
1351|NCT02572752|2650|P3|COMPLETED|Period 2 Including Washout||24
1352|NCT02572752|2651|P2|COMPLETED|Period 2 Including Washout||23
1353|NCT02572752|2652|P1|COMPLETED|Period 2 Including Washout||23
1354|NCT02572752|2650|P3|STARTED|Period 2 Including Washout||24
1355|NCT02572752|2651|P2|STARTED|Period 2 Including Washout||23
1356|NCT02572752|2652|P1|STARTED|Period 2 Including Washout||23
1357|NCT02572752|2650|P3|NOT COMPLETED|Period 1 Including Washout||0
1358|NCT02572752|2651|P2|NOT COMPLETED|Period 1 Including Washout||0
1359|NCT02572752|2652|P1|NOT COMPLETED|Period 1 Including Washout||0
1360|NCT02572752|2650|P3|COMPLETED|Period 1 Including Washout||24
1361|NCT02572752|2651|P2|COMPLETED|Period 1 Including Washout||23
1362|NCT02572752|2652|P1|COMPLETED|Period 1 Including Washout||23
1363|NCT02572752|2650|P3|STARTED|Period 1 Including Washout||24
1364|NCT02572752|2651|P2|STARTED|Period 1 Including Washout||23
1365|NCT02572752|2652|P1|STARTED|Period 1 Including Washout||23
1366|NCT02572609|2667|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
1367|NCT02572609|2668|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
1368|NCT02572609|2667|P2|COMPLETED|Period 2: Treatment Period 2||18
1369|NCT02572609|2668|P1|COMPLETED|Period 2: Treatment Period 2||18
1370|NCT02572609|2667|P2|STARTED|Period 2: Treatment Period 2||18
1371|NCT02572609|2668|P1|STARTED|Period 2: Treatment Period 2||18
1372|NCT02572609|2667|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1373|NCT02572609|2668|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
1374|NCT02572609|2667|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1375|NCT02572609|2668|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
1376|NCT02572609|2667|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
1377|NCT02572609|2668|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
1378|NCT02572427|2678|P2|NOT COMPLETED|Overall Study||9
1379|NCT02572427|2679|P1|NOT COMPLETED|Overall Study||6
1380|NCT02572427|2678|P2|COMPLETED|Overall Study||36
1381|NCT02572427|2679|P1|COMPLETED|Overall Study||31
1382|NCT02572427|2678|P2|STARTED|Overall Study||45
1383|NCT02572427|2679|P1|STARTED|Overall Study||37
1384|NCT02571634|2687|P1|NOT COMPLETED|Overall Study||0
1385|NCT02571634|2687|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
1386|NCT02571634|2687|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
1387|NCT02570425|2697|P2|NOT COMPLETED|Visit 3||0
1388|NCT02570425|2698|P1|NOT COMPLETED|Visit 3||0
1389|NCT02570425|2697|P2|COMPLETED|Visit 3||231
1390|NCT02570425|2698|P1|COMPLETED|Visit 3||229
1391|NCT02570425|2697|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
1392|NCT02570425|2698|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
1393|NCT02570425|2697|P2|NOT COMPLETED|Visit 2||0
1394|NCT02570425|2698|P1|NOT COMPLETED|Visit 2||0
1395|NCT02570425|2697|P2|COMPLETED|Visit 2||247
1396|NCT02570425|2698|P1|COMPLETED|Visit 2||251
1397|NCT02570425|2697|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
1398|NCT02570425|2698|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
1399|NCT02570425|2697|P2|NOT COMPLETED|Visit 1||0
1400|NCT02570425|2698|P1|NOT COMPLETED|Visit 1||0
1401|NCT02570425|2697|P2|COMPLETED|Visit 1||242
1402|NCT02570425|2698|P1|COMPLETED|Visit 1||274
1403|NCT02570425|2697|P2|STARTED|Visit 1||242
1404|NCT02570425|2698|P1|STARTED|Visit 1||274
1405|NCT02570022|2747|P2|NOT COMPLETED|Overall Study||0
1406|NCT02570022|2748|P1|NOT COMPLETED|Overall Study||0
1407|NCT02570022|2747|P2|COMPLETED|Overall Study||31
1408|NCT02570022|2748|P1|COMPLETED|Overall Study||26
1409|NCT02570022|2747|P2|STARTED|Overall Study||31
1410|NCT02570022|2748|P1|STARTED|Overall Study||26
1411|NCT02569996|2756|P1|NOT COMPLETED|Overall Study||55
1412|NCT02569996|2756|P1|COMPLETED|Overall Study||69
1413|NCT02569996|2756|P1|STARTED|Overall Study||124
1414|NCT02568852|2768|P2|NOT COMPLETED|Overall Study||0
1415|NCT02568852|2769|P1|NOT COMPLETED|Overall Study||0
1416|NCT02568852|2768|P2|COMPLETED|Overall Study||25
1417|NCT02568852|2769|P1|COMPLETED|Overall Study||25
1418|NCT02568852|2768|P2|STARTED|Overall Study||25
1419|NCT02568852|2769|P1|STARTED|Overall Study||25
1420|NCT02568345|2805|P1|NOT COMPLETED|Overall Study||0
1421|NCT02568345|2805|P1|COMPLETED|Overall Study||31
1422|NCT02568345|2805|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
1423|NCT02568345|2805|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
1424|NCT02568345|2805|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
1425|NCT02568345|2805|P1|STARTED|Overall Study||31
1426|NCT02567188|2809|P1|NOT COMPLETED|Overall Study||35
1427|NCT02567188|2809|P1|COMPLETED|Overall Study||109
1428|NCT02567188|2809|P1|STARTED|Overall Study||144
1429|NCT02563834|2840|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1430|NCT02563834|2841|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
1431|NCT02563834|2840|P2|COMPLETED|Insulin Infusion (*Day 2)||8
1432|NCT02563834|2841|P1|COMPLETED|Insulin Infusion (*Day 2)||10
1433|NCT02563834|2840|P2|STARTED|Insulin Infusion (*Day 2)||8
1434|NCT02563834|2841|P1|STARTED|Insulin Infusion (*Day 2)||10
1435|NCT02563834|2840|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1436|NCT02563834|2841|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
1437|NCT02563834|2840|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
1438|NCT02563834|2841|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
1439|NCT02563834|2840|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
1440|NCT02563834|2841|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
1441|NCT02563093|2861|P4|NOT COMPLETED|Overall Study||0
1442|NCT02563093|2862|P3|NOT COMPLETED|Overall Study||0
1443|NCT02563093|2863|P2|NOT COMPLETED|Overall Study||0
1444|NCT02563093|2864|P1|NOT COMPLETED|Overall Study||0
1445|NCT02563093|2861|P4|COMPLETED|Overall Study||51
1446|NCT02563093|2862|P3|COMPLETED|Overall Study||53
1447|NCT02563093|2863|P2|COMPLETED|Overall Study||52
1448|NCT02563093|2864|P1|COMPLETED|Overall Study||52
1449|NCT02563093|2861|P4|STARTED|Overall Study||51
1450|NCT02563093|2862|P3|STARTED|Overall Study||53
1451|NCT02563093|2863|P2|STARTED|Overall Study||52
1452|NCT02563093|2864|P1|STARTED|Overall Study||52
1453|NCT02561572|2892|P2|NOT COMPLETED|Overall Study||2
1454|NCT02561572|2893|P1|NOT COMPLETED|Overall Study||2
1455|NCT02561572|2892|P2|COMPLETED|Overall Study||62
1456|NCT02561572|2893|P1|COMPLETED|Overall Study||62
1457|NCT02561572|2892|P2|STARTED|Overall Study||64
1458|NCT02561572|2893|P1|STARTED|Overall Study||64
1459|NCT02557646|2909|P1|NOT COMPLETED|Overall Study||276
1460|NCT02557646|2909|P1|COMPLETED|Overall Study||417
1461|NCT02557646|2909|P1|STARTED|Overall Study||693
1462|NCT02556307|2927|P1|NOT COMPLETED|Overall Study||53
1463|NCT02556307|2927|P1|COMPLETED|Overall Study||217
1464|NCT02556307|2927|P1|Treated|Overall Study||268
1465|NCT02556307|2927|P1|STARTED|Overall Study||270
1466|NCT02555618|2939|P2|NOT COMPLETED|Overall Study||0
1467|NCT02555618|2940|P1|NOT COMPLETED|Overall Study||1
1468|NCT02555618|2939|P2|COMPLETED|Overall Study||200
1469|NCT02555618|2940|P1|COMPLETED|Overall Study||199
1470|NCT02555618|2939|P2|STARTED|Overall Study||200
1471|NCT02555618|2940|P1|STARTED|Overall Study||200
1472|NCT02555228|2984|P2|NOT COMPLETED|Overall Study||0
1473|NCT02555228|2985|P1|NOT COMPLETED|Overall Study||0
1474|NCT02555228|2984|P2|COMPLETED|Overall Study|29th October 2015|27
1475|NCT02555228|2985|P1|COMPLETED|Overall Study|19th November 2015|27
1476|NCT02555228|2984|P2|STARTED|Overall Study|14th August 2015|27
1477|NCT02555228|2985|P1|STARTED|Overall Study|20th August 2015|27
1478|NCT02553629|2999|P2|NOT COMPLETED|Overall Study||6
1479|NCT02553629|3000|P1|NOT COMPLETED|Overall Study||3
1480|NCT02553629|2999|P2|COMPLETED|Overall Study||50
1481|NCT02553629|3000|P1|COMPLETED|Overall Study||50
1482|NCT02553629|2999|P2|STARTED|Overall Study||56
1483|NCT02553629|3000|P1|STARTED|Overall Study||53
1484|NCT02553421|3016|P2|NOT COMPLETED|Overall Study||1
1485|NCT02553421|3017|P1|NOT COMPLETED|Overall Study||29
1486|NCT02553421|3016|P2|COMPLETED|Overall Study||57
1487|NCT02553421|3017|P1|COMPLETED|Overall Study||156
1488|NCT02553421|3016|P2|STARTED|Overall Study||58
1489|NCT02553421|3017|P1|STARTED|Overall Study||185
1490|NCT02552810|3027|P2|NOT COMPLETED|Overall Study||0
1491|NCT02552810|3028|P1|NOT COMPLETED|Overall Study||0
1492|NCT02552810|3027|P2|COMPLETED|Overall Study||15
1493|NCT02552810|3028|P1|COMPLETED|Overall Study||15
1494|NCT02552810|3027|P2|STARTED|Overall Study||15
1495|NCT02552810|3028|P1|STARTED|Overall Study||15
1496|NCT02551887|3047|P3|NOT COMPLETED|Overall Study||0
1497|NCT02551887|3048|P2|NOT COMPLETED|Overall Study||0
1498|NCT02551887|3049|P1|NOT COMPLETED|Overall Study||0
1499|NCT02551887|3047|P3|COMPLETED|Overall Study||222
1500|NCT02551887|3048|P2|COMPLETED|Overall Study||124
1501|NCT02551887|3049|P1|COMPLETED|Overall Study||301
1502|NCT02551887|3047|P3|STARTED|Overall Study||222
1503|NCT02551887|3048|P2|STARTED|Overall Study||124
1504|NCT02551887|3049|P1|STARTED|Overall Study||301
1505|NCT02550197|3062|P2|NOT COMPLETED|Overall Study||0
1506|NCT02550197|3063|P1|NOT COMPLETED|Overall Study||0
1507|NCT02550197|3062|P2|COMPLETED|Overall Study||100
1508|NCT02550197|3063|P1|COMPLETED|Overall Study||200
1509|NCT02550197|3062|P2|STARTED|Overall Study||100
1510|NCT02550197|3063|P1|STARTED|Overall Study||200
1511|NCT02550132|3081|P1|NOT COMPLETED|Overall Study||0
1512|NCT02550132|3081|P1|COMPLETED|Overall Study||25
1513|NCT02550132|3081|P1|STARTED|Overall Study||25
1514|NCT02549027|3112|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1515|NCT02549027|3113|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
1516|NCT02549027|3114|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1517|NCT02549027|3115|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1518|NCT02549027|3116|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1519|NCT02549027|3117|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
1520|NCT02549027|3112|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
1521|NCT02549027|3113|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
1522|NCT02549027|3114|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
1523|NCT02549027|3115|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
1524|NCT02549027|3116|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
1525|NCT02549027|3117|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
1526|NCT02549027|3112|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
1527|NCT02549027|3113|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
1528|NCT02549027|3114|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1529|NCT02549027|3115|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1530|NCT02549027|3116|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
1531|NCT02549027|3117|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
1532|NCT02549027|3112|P6|NOT COMPLETED|Washout After Period 4||0
1533|NCT02549027|3113|P5|NOT COMPLETED|Washout After Period 4||0
1534|NCT02549027|3114|P4|NOT COMPLETED|Washout After Period 4||1
1535|NCT02549027|3115|P3|NOT COMPLETED|Washout After Period 4||1
1536|NCT02549027|3116|P2|NOT COMPLETED|Washout After Period 4||1
1537|NCT02549027|3117|P1|NOT COMPLETED|Washout After Period 4||0
1538|NCT02549027|3112|P6|COMPLETED|Washout After Period 4||0
1539|NCT02549027|3113|P5|COMPLETED|Washout After Period 4||0
1540|NCT02549027|3114|P4|COMPLETED|Washout After Period 4||4
1541|NCT02549027|3115|P3|COMPLETED|Washout After Period 4||4
1542|NCT02549027|3116|P2|COMPLETED|Washout After Period 4||4
1543|NCT02549027|3117|P1|COMPLETED|Washout After Period 4||5
1544|NCT02549027|3112|P6|STARTED|Washout After Period 4||0
1545|NCT02549027|3113|P5|STARTED|Washout After Period 4||0
1546|NCT02549027|3114|P4|STARTED|Washout After Period 4||5
1547|NCT02549027|3115|P3|STARTED|Washout After Period 4||5
1548|NCT02549027|3116|P2|STARTED|Washout After Period 4||5
1549|NCT02549027|3117|P1|STARTED|Washout After Period 4||5
1550|NCT02549027|3112|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1551|NCT02549027|3113|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1552|NCT02549027|3114|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1553|NCT02549027|3115|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1554|NCT02549027|3116|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1555|NCT02549027|3117|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
1556|NCT02549027|3112|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
1557|NCT02549027|3113|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
1558|NCT02549027|3114|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
1559|NCT02549027|3115|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
1560|NCT02549027|3116|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
1561|NCT02549027|3117|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
1562|NCT02549027|3112|P6|STARTED|Period 4 - MK-1064 or Placebo||0
1563|NCT02549027|3113|P5|STARTED|Period 4 - MK-1064 or Placebo||0
1564|NCT02549027|3114|P4|STARTED|Period 4 - MK-1064 or Placebo||5
1565|NCT02549027|3115|P3|STARTED|Period 4 - MK-1064 or Placebo||5
1566|NCT02549027|3116|P2|STARTED|Period 4 - MK-1064 or Placebo||5
1567|NCT02549027|3117|P1|STARTED|Period 4 - MK-1064 or Placebo||5
1568|NCT02549027|3112|P6|NOT COMPLETED|Washout After Period 3||0
1569|NCT02549027|3113|P5|NOT COMPLETED|Washout After Period 3||0
1570|NCT02549027|3114|P4|NOT COMPLETED|Washout After Period 3||0
1571|NCT02549027|3115|P3|NOT COMPLETED|Washout After Period 3||0
1572|NCT02549027|3116|P2|NOT COMPLETED|Washout After Period 3||0
1573|NCT02549027|3117|P1|NOT COMPLETED|Washout After Period 3||0
1574|NCT02549027|3112|P6|COMPLETED|Washout After Period 3||0
1575|NCT02549027|3113|P5|COMPLETED|Washout After Period 3||0
1576|NCT02549027|3114|P4|COMPLETED|Washout After Period 3||5
1577|NCT02549027|3115|P3|COMPLETED|Washout After Period 3||5
1578|NCT02549027|3116|P2|COMPLETED|Washout After Period 3||5
1579|NCT02549027|3117|P1|COMPLETED|Washout After Period 3||5
1580|NCT02549027|3112|P6|STARTED|Washout After Period 3||0
1581|NCT02549027|3113|P5|STARTED|Washout After Period 3||0
1582|NCT02549027|3114|P4|STARTED|Washout After Period 3||5
1583|NCT02549027|3115|P3|STARTED|Washout After Period 3||5
1584|NCT02549027|3116|P2|STARTED|Washout After Period 3||5
1585|NCT02549027|3117|P1|STARTED|Washout After Period 3||5
1586|NCT02549027|3112|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1587|NCT02549027|3113|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1588|NCT02549027|3114|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1589|NCT02549027|3115|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1590|NCT02549027|3116|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1591|NCT02549027|3117|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
1592|NCT02549027|3112|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
1593|NCT02549027|3113|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
1594|NCT02549027|3114|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
1595|NCT02549027|3115|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
1596|NCT02549027|3116|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
1597|NCT02549027|3117|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
1598|NCT02549027|3112|P6|STARTED|Period 3 - MK-1064 or Placebo||0
1599|NCT02549027|3113|P5|STARTED|Period 3 - MK-1064 or Placebo||0
1600|NCT02549027|3114|P4|STARTED|Period 3 - MK-1064 or Placebo||5
1601|NCT02549027|3115|P3|STARTED|Period 3 - MK-1064 or Placebo||5
1602|NCT02549027|3116|P2|STARTED|Period 3 - MK-1064 or Placebo||5
1603|NCT02549027|3117|P1|STARTED|Period 3 - MK-1064 or Placebo||5
1604|NCT02549027|3112|P6|NOT COMPLETED|Washout After Period 2||0
1605|NCT02549027|3113|P5|NOT COMPLETED|Washout After Period 2||0
1606|NCT02549027|3114|P4|NOT COMPLETED|Washout After Period 2||0
1607|NCT02549027|3115|P3|NOT COMPLETED|Washout After Period 2||0
1608|NCT02549027|3116|P2|NOT COMPLETED|Washout After Period 2||0
1609|NCT02549027|3117|P1|NOT COMPLETED|Washout After Period 2||0
1610|NCT02549027|3112|P6|COMPLETED|Washout After Period 2||0
1611|NCT02549027|3113|P5|COMPLETED|Washout After Period 2||0
1612|NCT02549027|3114|P4|COMPLETED|Washout After Period 2||5
1613|NCT02549027|3115|P3|COMPLETED|Washout After Period 2||5
1614|NCT02549027|3116|P2|COMPLETED|Washout After Period 2||5
1615|NCT02549027|3117|P1|COMPLETED|Washout After Period 2||5
1616|NCT02549027|3112|P6|STARTED|Washout After Period 2||0
1617|NCT02549027|3113|P5|STARTED|Washout After Period 2||0
1618|NCT02549027|3114|P4|STARTED|Washout After Period 2||5
1619|NCT02549027|3115|P3|STARTED|Washout After Period 2||5
1620|NCT02549027|3116|P2|STARTED|Washout After Period 2||5
1621|NCT02549027|3117|P1|STARTED|Washout After Period 2||5
1622|NCT02549027|3112|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1623|NCT02549027|3113|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1624|NCT02549027|3114|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1625|NCT02549027|3115|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1626|NCT02549027|3116|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1627|NCT02549027|3117|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
1628|NCT02549027|3112|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
1629|NCT02549027|3113|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
1630|NCT02549027|3114|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
1631|NCT02549027|3115|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
1632|NCT02549027|3116|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
1633|NCT02549027|3117|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
1634|NCT02549027|3112|P6|STARTED|Period 2 - MK-1064 or Placebo||0
1635|NCT02549027|3113|P5|STARTED|Period 2 - MK-1064 or Placebo||0
1636|NCT02549027|3114|P4|STARTED|Period 2 - MK-1064 or Placebo||5
1637|NCT02549027|3115|P3|STARTED|Period 2 - MK-1064 or Placebo||5
1638|NCT02549027|3116|P2|STARTED|Period 2 - MK-1064 or Placebo||5
1639|NCT02549027|3117|P1|STARTED|Period 2 - MK-1064 or Placebo||5
1640|NCT02549027|3112|P6|NOT COMPLETED|Washout After Period 1||0
1641|NCT02549027|3113|P5|NOT COMPLETED|Washout After Period 1||0
1642|NCT02549027|3114|P4|NOT COMPLETED|Washout After Period 1||0
1643|NCT02549027|3115|P3|NOT COMPLETED|Washout After Period 1||0
1644|NCT02549027|3116|P2|NOT COMPLETED|Washout After Period 1||0
1645|NCT02549027|3117|P1|NOT COMPLETED|Washout After Period 1||0
1646|NCT02549027|3112|P6|COMPLETED|Washout After Period 1||0
1647|NCT02549027|3113|P5|COMPLETED|Washout After Period 1||0
1648|NCT02549027|3114|P4|COMPLETED|Washout After Period 1||5
1649|NCT02549027|3115|P3|COMPLETED|Washout After Period 1||5
1650|NCT02549027|3116|P2|COMPLETED|Washout After Period 1||5
1651|NCT02549027|3117|P1|COMPLETED|Washout After Period 1||5
1652|NCT02549027|3112|P6|STARTED|Washout After Period 1||0
1653|NCT02549027|3113|P5|STARTED|Washout After Period 1||0
1654|NCT02549027|3114|P4|STARTED|Washout After Period 1||5
1655|NCT02549027|3115|P3|STARTED|Washout After Period 1||5
1656|NCT02549027|3116|P2|STARTED|Washout After Period 1||5
1657|NCT02549027|3117|P1|STARTED|Washout After Period 1||5
1658|NCT02549027|3112|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1659|NCT02549027|3113|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1660|NCT02549027|3114|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1661|NCT02549027|3115|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1662|NCT02549027|3116|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1663|NCT02549027|3117|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
1664|NCT02549027|3112|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
1665|NCT02549027|3113|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
1666|NCT02549027|3114|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
1667|NCT02549027|3115|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
1668|NCT02549027|3116|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
1669|NCT02549027|3117|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
1670|NCT02549027|3112|P6|STARTED|Period 1 - MK-1064 or Placebo||0
1671|NCT02549027|3113|P5|STARTED|Period 1 - MK-1064 or Placebo||0
1672|NCT02549027|3114|P4|STARTED|Period 1 - MK-1064 or Placebo||5
1673|NCT02549027|3115|P3|STARTED|Period 1 - MK-1064 or Placebo||5
1674|NCT02549027|3116|P2|STARTED|Period 1 - MK-1064 or Placebo||5
1675|NCT02549027|3117|P1|STARTED|Period 1 - MK-1064 or Placebo||5
1676|NCT02549014|3154|P2|NOT COMPLETED|Overall Study||0
1677|NCT02549014|3155|P1|NOT COMPLETED|Overall Study||0
1678|NCT02549014|3154|P2|COMPLETED|Overall Study||8
1679|NCT02549014|3155|P1|COMPLETED|Overall Study||8
1680|NCT02549014|3154|P2|STARTED|Overall Study||8
1681|NCT02549014|3155|P1|STARTED|Overall Study||8
1682|NCT02548156|3245|P6|NOT COMPLETED|Period 3||0
1683|NCT02548156|3246|P5|NOT COMPLETED|Period 3||0
1684|NCT02548156|3247|P4|NOT COMPLETED|Period 3||0
1685|NCT02548156|3248|P3|NOT COMPLETED|Period 3||0
1686|NCT02548156|3249|P2|NOT COMPLETED|Period 3||0
1687|NCT02548156|3250|P1|NOT COMPLETED|Period 3||0
1688|NCT02548156|3245|P6|COMPLETED|Period 3||5
1689|NCT02548156|3246|P5|COMPLETED|Period 3||4
1690|NCT02548156|3247|P4|COMPLETED|Period 3||5
1691|NCT02548156|3248|P3|COMPLETED|Period 3||4
1692|NCT02548156|3249|P2|COMPLETED|Period 3||5
1693|NCT02548156|3250|P1|COMPLETED|Period 3||5
1694|NCT02548156|3245|P6|STARTED|Period 3||5
1695|NCT02548156|3246|P5|STARTED|Period 3||4
1696|NCT02548156|3247|P4|STARTED|Period 3||5
1697|NCT02548156|3248|P3|STARTED|Period 3||4
1698|NCT02548156|3249|P2|STARTED|Period 3||5
1699|NCT02548156|3250|P1|STARTED|Period 3||5
1700|NCT02548156|3245|P6|NOT COMPLETED|Washout Period 2||0
1701|NCT02548156|3246|P5|NOT COMPLETED|Washout Period 2||0
1702|NCT02548156|3247|P4|NOT COMPLETED|Washout Period 2||0
1703|NCT02548156|3248|P3|NOT COMPLETED|Washout Period 2||0
1704|NCT02548156|3249|P2|NOT COMPLETED|Washout Period 2||0
1705|NCT02548156|3250|P1|NOT COMPLETED|Washout Period 2||0
1706|NCT02548156|3245|P6|COMPLETED|Washout Period 2||5
1707|NCT02548156|3246|P5|COMPLETED|Washout Period 2||4
1708|NCT02548156|3247|P4|COMPLETED|Washout Period 2||5
1709|NCT02548156|3248|P3|COMPLETED|Washout Period 2||4
1710|NCT02548156|3249|P2|COMPLETED|Washout Period 2||5
1711|NCT02548156|3250|P1|COMPLETED|Washout Period 2||5
1712|NCT02548156|3245|P6|STARTED|Washout Period 2||5
1713|NCT02548156|3246|P5|STARTED|Washout Period 2||4
1714|NCT02548156|3247|P4|STARTED|Washout Period 2||5
1715|NCT02548156|3248|P3|STARTED|Washout Period 2||4
1716|NCT02548156|3249|P2|STARTED|Washout Period 2||5
1717|NCT02548156|3250|P1|STARTED|Washout Period 2||5
1718|NCT02548156|3245|P6|NOT COMPLETED|Period 2||0
1719|NCT02548156|3246|P5|NOT COMPLETED|Period 2||0
1720|NCT02548156|3247|P4|NOT COMPLETED|Period 2||0
1721|NCT02548156|3248|P3|NOT COMPLETED|Period 2||0
1722|NCT02548156|3249|P2|NOT COMPLETED|Period 2||0
1723|NCT02548156|3250|P1|NOT COMPLETED|Period 2||0
1724|NCT02548156|3245|P6|COMPLETED|Period 2||5
1725|NCT02548156|3246|P5|COMPLETED|Period 2||4
1726|NCT02548156|3247|P4|COMPLETED|Period 2||5
1727|NCT02548156|3248|P3|COMPLETED|Period 2||4
1728|NCT02548156|3249|P2|COMPLETED|Period 2||5
1729|NCT02548156|3250|P1|COMPLETED|Period 2||5
1730|NCT02548156|3245|P6|STARTED|Period 2||5
1731|NCT02548156|3246|P5|STARTED|Period 2||4
1732|NCT02548156|3247|P4|STARTED|Period 2||5
1733|NCT02548156|3248|P3|STARTED|Period 2||4
1734|NCT02548156|3249|P2|STARTED|Period 2||5
1735|NCT02548156|3250|P1|STARTED|Period 2||5
1736|NCT02548156|3245|P6|NOT COMPLETED|Washout Period 1||0
1737|NCT02548156|3246|P5|NOT COMPLETED|Washout Period 1||1
1738|NCT02548156|3247|P4|NOT COMPLETED|Washout Period 1||0
1739|NCT02548156|3248|P3|NOT COMPLETED|Washout Period 1||0
1740|NCT02548156|3249|P2|NOT COMPLETED|Washout Period 1||0
1741|NCT02548156|3250|P1|NOT COMPLETED|Washout Period 1||0
1742|NCT02548156|3245|P6|COMPLETED|Washout Period 1||5
1743|NCT02548156|3246|P5|COMPLETED|Washout Period 1||4
1744|NCT02548156|3247|P4|COMPLETED|Washout Period 1||5
1745|NCT02548156|3248|P3|COMPLETED|Washout Period 1||4
1746|NCT02548156|3249|P2|COMPLETED|Washout Period 1||5
1747|NCT02548156|3250|P1|COMPLETED|Washout Period 1||5
1748|NCT02548156|3245|P6|STARTED|Washout Period 1||5
1749|NCT02548156|3246|P5|STARTED|Washout Period 1||5
1750|NCT02548156|3247|P4|STARTED|Washout Period 1||5
1751|NCT02548156|3248|P3|STARTED|Washout Period 1||4
1752|NCT02548156|3249|P2|STARTED|Washout Period 1||5
1753|NCT02548156|3250|P1|STARTED|Washout Period 1||5
1754|NCT02548156|3245|P6|NOT COMPLETED|Period 1||0
1755|NCT02548156|3246|P5|NOT COMPLETED|Period 1||0
1756|NCT02548156|3247|P4|NOT COMPLETED|Period 1||0
1757|NCT02548156|3248|P3|NOT COMPLETED|Period 1||0
1758|NCT02548156|3249|P2|NOT COMPLETED|Period 1||0
1759|NCT02548156|3250|P1|NOT COMPLETED|Period 1||0
1760|NCT02548156|3245|P6|COMPLETED|Period 1||5
1761|NCT02548156|3246|P5|COMPLETED|Period 1||5
1762|NCT02548156|3247|P4|COMPLETED|Period 1||5
1763|NCT02548156|3248|P3|COMPLETED|Period 1||4
1764|NCT02548156|3249|P2|COMPLETED|Period 1||5
1765|NCT02548156|3250|P1|COMPLETED|Period 1||5
1766|NCT02548156|3245|P6|STARTED|Period 1||5
1767|NCT02548156|3246|P5|STARTED|Period 1||5
1768|NCT02548156|3247|P4|STARTED|Period 1||5
1769|NCT02548156|3248|P3|STARTED|Period 1||4
1770|NCT02548156|3249|P2|STARTED|Period 1||5
1771|NCT02548156|3250|P1|STARTED|Period 1||5
1772|NCT02547454|3267|P1|NOT COMPLETED|Overall Study||172
1773|NCT02547454|3267|P1|COMPLETED|Overall Study||221
1774|NCT02547454|3267|P1|STARTED|Overall Study||393
1775|NCT02543918|3297|P2|NOT COMPLETED|Overall Study||4
1776|NCT02543918|3298|P1|NOT COMPLETED|Overall Study||3
1777|NCT02543918|3297|P2|COMPLETED|Overall Study||39
1778|NCT02543918|3298|P1|COMPLETED|Overall Study||38
1779|NCT02543918|3297|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
1780|NCT02543918|3298|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
1781|NCT02543918|3297|P2|STARTED|Overall Study||43
1782|NCT02543918|3298|P1|STARTED|Overall Study||41
1783|NCT02542280|3306|P2|NOT COMPLETED|Overall Study||8
1784|NCT02542280|3307|P1|NOT COMPLETED|Overall Study||12
1785|NCT02542280|3306|P2|COMPLETED|Overall Study||167
1786|NCT02542280|3307|P1|COMPLETED|Overall Study||162
1787|NCT02542280|3306|P2|STARTED|Overall Study||175
1788|NCT02542280|3307|P1|STARTED|Overall Study||174
1789|NCT02543437|3315|P1|NOT COMPLETED|Overall Study||0
1790|NCT02543437|3315|P1|COMPLETED|Overall Study||117
1791|NCT02543437|3315|P1|STARTED|Overall Study||117
1792|NCT02540850|3323|P3|NOT COMPLETED|Overall Study||34
1793|NCT02540850|3324|P2|NOT COMPLETED|Overall Study||66
1794|NCT02540850|3325|P1|NOT COMPLETED|Overall Study||69
1795|NCT02540850|3323|P3|COMPLETED|Overall Study||410
1796|NCT02540850|3324|P2|COMPLETED|Overall Study||330
1797|NCT02540850|3325|P1|COMPLETED|Overall Study||291
1798|NCT02540850|3323|P3|STARTED|Overall Study||444
1799|NCT02540850|3324|P2|STARTED|Overall Study||396
1800|NCT02540850|3325|P1|STARTED|Overall Study||360
1801|NCT02540772|3353|P2|NOT COMPLETED|Overall Study||0
1802|NCT02540772|3354|P1|NOT COMPLETED|Overall Study||0
1803|NCT02540772|3353|P2|COMPLETED|Overall Study||10
1804|NCT02540772|3354|P1|COMPLETED|Overall Study||10
1805|NCT02540772|3353|P2|STARTED|Overall Study||10
1806|NCT02540772|3354|P1|STARTED|Overall Study||10
1807|NCT02540447|3368|P2|NOT COMPLETED|Overall Study||0
1808|NCT02540447|3369|P1|NOT COMPLETED|Overall Study||0
1809|NCT02540447|3368|P2|COMPLETED|Overall Study||40
1810|NCT02540447|3369|P1|COMPLETED|Overall Study||40
1811|NCT02540447|3368|P2|STARTED|Overall Study||40
1812|NCT02540447|3369|P1|STARTED|Overall Study||40
1813|NCT02540213|3383|P1|NOT COMPLETED|Overall Study||39
1814|NCT02540213|3383|P1|COMPLETED|Overall Study||201
1815|NCT02540213|3383|P1|STARTED|Overall Study||240
1816|NCT02539992|3407|P3|NOT COMPLETED|Overall Study||4
1817|NCT02539992|3408|P2|NOT COMPLETED|Overall Study||4
1818|NCT02539992|3409|P1|NOT COMPLETED|Overall Study||0
1819|NCT02539992|3407|P3|COMPLETED|Overall Study||14
1820|NCT02539992|3408|P2|COMPLETED|Overall Study||7
1821|NCT02539992|3409|P1|COMPLETED|Overall Study||15
1822|NCT02539992|3407|P3|STARTED|Overall Study||18
1823|NCT02539992|3408|P2|STARTED|Overall Study||11
1824|NCT02539992|3409|P1|STARTED|Overall Study||15
1825|NCT02539108|3437|P2|NOT COMPLETED|Overall Study||0
1826|NCT02539108|3438|P1|NOT COMPLETED|Overall Study||0
1827|NCT02539108|3437|P2|COMPLETED|Overall Study||30
1828|NCT02539108|3438|P1|COMPLETED|Overall Study||30
1829|NCT02539108|3437|P2|STARTED|Overall Study||30
1830|NCT02539108|3438|P1|STARTED|Overall Study||30
1831|NCT02538107|3452|P1|NOT COMPLETED|Overall Study||110
1832|NCT02538107|3452|P1|COMPLETED|Overall Study||180
1833|NCT02538107|3452|P1|STARTED|Overall Study||290
1834|NCT02537730|3472|P2|NOT COMPLETED|Second Intervention (7 Days)||0
1835|NCT02537730|3473|P1|NOT COMPLETED|Second Intervention (7 Days)||0
1836|NCT02537730|3472|P2|COMPLETED|Second Intervention (7 Days)||16
1837|NCT02537730|3473|P1|COMPLETED|Second Intervention (7 Days)||17
1838|NCT02537730|3472|P2|STARTED|Second Intervention (7 Days)||16
1839|NCT02537730|3473|P1|STARTED|Second Intervention (7 Days)||17
1840|NCT02537730|3472|P2|NOT COMPLETED|First Intervention (7 Days)||0
1841|NCT02537730|3473|P1|NOT COMPLETED|First Intervention (7 Days)||0
1842|NCT02537730|3472|P2|COMPLETED|First Intervention (7 Days)||16
1843|NCT02537730|3473|P1|COMPLETED|First Intervention (7 Days)||17
1844|NCT02537730|3472|P2|STARTED|First Intervention (7 Days)||16
1845|NCT02537730|3473|P1|STARTED|First Intervention (7 Days)||17
1846|NCT02537522|3485|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1847|NCT02537522|3486|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1848|NCT02537522|3487|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1849|NCT02537522|3488|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1850|NCT02537522|3485|P4|COMPLETED|Phase II - Period 1 Bilateral||22
1851|NCT02537522|3486|P3|COMPLETED|Phase II - Period 1 Bilateral||23
1852|NCT02537522|3487|P2|COMPLETED|Phase II - Period 1 Bilateral||0
1853|NCT02537522|3488|P1|COMPLETED|Phase II - Period 1 Bilateral||0
1854|NCT02537522|3485|P4|STARTED|Phase II - Period 1 Bilateral||22
1855|NCT02537522|3486|P3|STARTED|Phase II - Period 1 Bilateral||23
1856|NCT02537522|3487|P2|STARTED|Phase II - Period 1 Bilateral||0
1857|NCT02537522|3488|P1|STARTED|Phase II - Period 1 Bilateral||0
1858|NCT02537522|3485|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
1859|NCT02537522|3486|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1860|NCT02537522|3487|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1861|NCT02537522|3488|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
1862|NCT02537522|3485|P4|COMPLETED|Phase II - Period 1 Bilateral||22
1863|NCT02537522|3486|P3|COMPLETED|Phase II - Period 1 Bilateral||23
1864|NCT02537522|3487|P2|COMPLETED|Phase II - Period 1 Bilateral||0
1865|NCT02537522|3488|P1|COMPLETED|Phase II - Period 1 Bilateral||0
1866|NCT02537522|3485|P4|STARTED|Phase II - Period 1 Bilateral||23
1867|NCT02537522|3486|P3|STARTED|Phase II - Period 1 Bilateral||23
1868|NCT02537522|3487|P2|STARTED|Phase II - Period 1 Bilateral||0
1869|NCT02537522|3488|P1|STARTED|Phase II - Period 1 Bilateral||0
1870|NCT02537522|3485|P4|NOT COMPLETED|Phase I - Contralateral||0
1871|NCT02537522|3486|P3|NOT COMPLETED|Phase I - Contralateral||0
1872|NCT02537522|3487|P2|NOT COMPLETED|Phase I - Contralateral||10
1873|NCT02537522|3488|P1|NOT COMPLETED|Phase I - Contralateral||15
1874|NCT02537522|3485|P4|COMPLETED|Phase I - Contralateral||0
1875|NCT02537522|3486|P3|COMPLETED|Phase I - Contralateral||0
1876|NCT02537522|3487|P2|COMPLETED|Phase I - Contralateral||27
1877|NCT02537522|3488|P1|COMPLETED|Phase I - Contralateral||19
1878|NCT02537522|3485|P4|STARTED|Phase I - Contralateral||0
1879|NCT02537522|3486|P3|STARTED|Phase I - Contralateral||0
1880|NCT02537522|3487|P2|STARTED|Phase I - Contralateral||37
1881|NCT02537522|3488|P1|STARTED|Phase I - Contralateral||34
1882|NCT02536664|3498|P2|NOT COMPLETED|Overall Study||80
1883|NCT02536664|3499|P1|NOT COMPLETED|Overall Study||107
1884|NCT02536664|3498|P2|COMPLETED|Overall Study||97
1885|NCT02536664|3499|P1|COMPLETED|Overall Study||205
1886|NCT02536664|3498|P2|STARTED|Overall Study||177
1887|NCT02536664|3499|P1|STARTED|Overall Study||312
1888|NCT02535741|3517|P1|NOT COMPLETED|Overall Study||32
1889|NCT02535741|3517|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
1890|NCT02535741|3517|P1|STARTED|Overall Study||168
1891|NCT02534324|3523|P2|NOT COMPLETED|Overall Study||8
1892|NCT02534324|3524|P1|NOT COMPLETED|Overall Study||25
1893|NCT02534324|3523|P2|COMPLETED|Overall Study||40
1894|NCT02534324|3524|P1|COMPLETED|Overall Study||73
1895|NCT02534324|3523|P2|STARTED|Overall Study||48
1896|NCT02534324|3524|P1|STARTED|Overall Study||98
1897|NCT02533401|3534|P1|NOT COMPLETED|Overall Study||11
1898|NCT02533401|3534|P1|COMPLETED|Overall Study||23
1899|NCT02533401|3534|P1|STARTED|Overall Study||34
1900|NCT02531646|3545|P3|NOT COMPLETED|Overall Study||0
1901|NCT02531646|3546|P2|NOT COMPLETED|Overall Study||1
1902|NCT02531646|3547|P1|NOT COMPLETED|Overall Study||5
1903|NCT02531646|3545|P3|COMPLETED|Overall Study||11
1904|NCT02531646|3546|P2|COMPLETED|Overall Study||17
1905|NCT02531646|3547|P1|COMPLETED|Overall Study||32
1906|NCT02531646|3545|P3|STARTED|Overall Study||11
1907|NCT02531646|3546|P2|STARTED|Overall Study||18
1908|NCT02531646|3547|P1|STARTED|Overall Study||37
1909|NCT02531308|3561|P1|NOT COMPLETED|Overall Study||3
1910|NCT02531308|3561|P1|COMPLETED|Overall Study||2
1911|NCT02531308|3561|P1|STARTED|Overall Study||5
1912|NCT02530671|3567|P2|NOT COMPLETED|Overall Study||0
1913|NCT02530671|3568|P1|NOT COMPLETED|Overall Study||3
1914|NCT02530671|3567|P2|COMPLETED|Overall Study||55
1915|NCT02530671|3568|P1|COMPLETED|Overall Study||52
1916|NCT02530671|3567|P2|STARTED|Overall Study||55
1917|NCT02530671|3568|P1|STARTED|Overall Study||55
1918|NCT02530450|3586|P2|NOT COMPLETED|Overall Study||5
1919|NCT02530450|3587|P1|NOT COMPLETED|Overall Study||6
1920|NCT02530450|3586|P2|COMPLETED|Overall Study||9
1921|NCT02530450|3587|P1|COMPLETED|Overall Study||10
1922|NCT02530450|3586|P2|STARTED|Overall Study||14
1923|NCT02530450|3587|P1|STARTED|Overall Study||16
1924|NCT02528331|3593|P1|NOT COMPLETED|Overall Study||2
1925|NCT02528331|3593|P1|COMPLETED|Overall Study||0
1926|NCT02528331|3593|P1|STARTED|Overall Study||2
1927|NCT02528097|3602|P2|NOT COMPLETED|Overall Study||0
1928|NCT02528097|3603|P1|NOT COMPLETED|Overall Study||0
1929|NCT02528097|3602|P2|COMPLETED|Overall Study||1
1930|NCT02528097|3603|P1|COMPLETED|Overall Study||1
1931|NCT02528097|3602|P2|STARTED|Overall Study||1
1932|NCT02528097|3603|P1|STARTED|Overall Study||1
1933|NCT02527161|3611|P1|NOT COMPLETED|Overall Study||62
1934|NCT02527161|3611|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
1935|NCT02527161|3611|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
1936|NCT02527148|3630|P2|NOT COMPLETED|Overall Study||0
1937|NCT02527148|3631|P1|NOT COMPLETED|Overall Study||1
1938|NCT02527148|3630|P2|COMPLETED|Overall Study||50
1939|NCT02527148|3631|P1|COMPLETED|Overall Study||49
1940|NCT02527148|3630|P2|STARTED|Overall Study||50
1941|NCT02527148|3631|P1|STARTED|Overall Study||50
1942|NCT02526550|3649|P1|NOT COMPLETED|Overall Study||1
1943|NCT02526550|3649|P1|COMPLETED|Overall Study||49
1944|NCT02526550|3649|P1|STARTED|Overall Study||50
1945|NCT02525536|3658|P3|NOT COMPLETED|Overall Study||0
1946|NCT02525536|3659|P2|NOT COMPLETED|Overall Study||0
1947|NCT02525536|3660|P1|NOT COMPLETED|Overall Study||0
1948|NCT02525536|3658|P3|COMPLETED|Overall Study||6
1949|NCT02525536|3659|P2|COMPLETED|Overall Study||6
1950|NCT02525536|3660|P1|COMPLETED|Overall Study||6
1951|NCT02525536|3658|P3|STARTED|Overall Study||6
1952|NCT02525536|3659|P2|STARTED|Overall Study||6
1953|NCT02525536|3660|P1|STARTED|Overall Study||6
1954|NCT02522624|3733|P2|NOT COMPLETED|Overall Study||0
1955|NCT02522624|3734|P1|NOT COMPLETED|Overall Study||1
1956|NCT02522624|3733|P2|COMPLETED|Overall Study||163
1957|NCT02522624|3734|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
1958|NCT02522624|3733|P2|STARTED|Overall Study||163
1959|NCT02522624|3734|P1|STARTED|Overall Study||165
1960|NCT02519855|3752|P2|NOT COMPLETED|Overall Study||4
1961|NCT02519855|3753|P1|NOT COMPLETED|Overall Study||3
1962|NCT02519855|3752|P2|COMPLETED|Overall Study||437
1963|NCT02519855|3753|P1|COMPLETED|Overall Study||438
1964|NCT02519855|3752|P2|Vaccinated at Week 4|Overall Study||424
1965|NCT02519855|3753|P1|Vaccinated at Week 4|Overall Study||432
1966|NCT02519855|3752|P2|Vaccinated on Day 1|Overall Study||441
1967|NCT02519855|3753|P1|Vaccinated on Day 1|Overall Study||440
1968|NCT02519855|3752|P2|STARTED|Overall Study|Participants are included as treated|441
1969|NCT02519855|3753|P1|STARTED|Overall Study|Participants are included as treated|441
1970|NCT02519595|3772|P3|NOT COMPLETED|Overall Study||16
1971|NCT02519595|3773|P2|NOT COMPLETED|Overall Study||22
1972|NCT02519595|3774|P1|NOT COMPLETED|Overall Study||8
1973|NCT02519595|3772|P3|COMPLETED|Overall Study||40
1974|NCT02519595|3773|P2|COMPLETED|Overall Study||35
1975|NCT02519595|3774|P1|COMPLETED|Overall Study||50
1976|NCT02519595|3772|P3|STARTED|Overall Study||56
1977|NCT02519595|3773|P2|STARTED|Overall Study||57
1978|NCT02519595|3774|P1|STARTED|Overall Study||58
1979|NCT02519387|3797|P1|NOT COMPLETED|Overall Study||22
1980|NCT02519387|3797|P1|COMPLETED|Overall Study||56
1981|NCT02519387|3797|P1|STARTED|Overall Study||78
1982|NCT02516163|3805|P1|NOT COMPLETED|Overall Study||28
1983|NCT02516163|3805|P1|COMPLETED|Overall Study||24
1984|NCT02516163|3805|P1|STARTED|Overall Study||52
1985|NCT02516098|3811|P2|NOT COMPLETED|Washout After Period 2||0
1986|NCT02516098|3812|P1|NOT COMPLETED|Washout After Period 2||0
1987|NCT02516098|3811|P2|COMPLETED|Washout After Period 2||26
1988|NCT02516098|3812|P1|COMPLETED|Washout After Period 2||27
1989|NCT02516098|3811|P2|STARTED|Washout After Period 2||26
1990|NCT02516098|3812|P1|STARTED|Washout After Period 2||27
1991|NCT02516098|3811|P2|NOT COMPLETED|Period 2||1
1992|NCT02516098|3812|P1|NOT COMPLETED|Period 2||0
1993|NCT02516098|3811|P2|COMPLETED|Period 2||26
1994|NCT02516098|3812|P1|COMPLETED|Period 2||27
1995|NCT02516098|3811|P2|STARTED|Period 2||27
1996|NCT02516098|3812|P1|STARTED|Period 2||27
1997|NCT02516098|3811|P2|NOT COMPLETED|Washout After Period 1||1
1998|NCT02516098|3812|P1|NOT COMPLETED|Washout After Period 1||0
1999|NCT02516098|3811|P2|COMPLETED|Washout After Period 1||27
2000|NCT02516098|3812|P1|COMPLETED|Washout After Period 1||27
2001|NCT02516098|3811|P2|STARTED|Washout After Period 1||28
2002|NCT02516098|3812|P1|STARTED|Washout After Period 1||27
2003|NCT02516098|3811|P2|NOT COMPLETED|Period 1||0
2004|NCT02516098|3812|P1|NOT COMPLETED|Period 1||1
2005|NCT02516098|3811|P2|COMPLETED|Period 1||28
2006|NCT02516098|3812|P1|COMPLETED|Period 1||27
2007|NCT02516098|3811|P2|STARTED|Period 1||28
2008|NCT02516098|3812|P1|STARTED|Period 1||28
2009|NCT02515994|3826|P2|NOT COMPLETED|Overall Study||7
2010|NCT02515994|3827|P1|NOT COMPLETED|Overall Study||10
2011|NCT02515994|3826|P2|COMPLETED|Overall Study||105
2012|NCT02515994|3827|P1|COMPLETED|Overall Study||99
2013|NCT02515994|3826|P2|STARTED|Overall Study||112
2014|NCT02515994|3827|P1|STARTED|Overall Study||109
2015|NCT02515279|3839|P1|NOT COMPLETED|Overall Study||104
2016|NCT02515279|3839|P1|COMPLETED|Overall Study||359
2017|NCT02515279|3839|P1|STARTED|Overall Study||463
2018|NCT02512783|3847|P2|NOT COMPLETED|Overall Study||0
2019|NCT02512783|3848|P1|NOT COMPLETED|Overall Study||0
2020|NCT02512783|3847|P2|COMPLETED|Overall Study||75
2021|NCT02512783|3848|P1|COMPLETED|Overall Study||96
2022|NCT02512783|3847|P2|STARTED|Overall Study||75
2023|NCT02512783|3848|P1|STARTED|Overall Study||96
2024|NCT02512679|3856|P2|NOT COMPLETED|Overall Study||0
2025|NCT02512679|3857|P1|NOT COMPLETED|Overall Study||0
2026|NCT02512679|3856|P2|COMPLETED|Overall Study||0
2027|NCT02512679|3857|P1|COMPLETED|Overall Study||20
2028|NCT02512679|3856|P2|STARTED|Overall Study||0
2029|NCT02512679|3857|P1|STARTED|Overall Study||20
2030|NCT02512224|3867|P2|NOT COMPLETED|Overall Study||0
2031|NCT02512224|3868|P1|NOT COMPLETED|Overall Study||0
2032|NCT02512224|3867|P2|COMPLETED|Overall Study||2912
2033|NCT02512224|3868|P1|COMPLETED|Overall Study||2912
2034|NCT02512224|3867|P2|STARTED|Overall Study||2912
2035|NCT02512224|3868|P1|STARTED|Overall Study||2912
2036|NCT02510820|3884|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
2037|NCT02510820|3885|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
2038|NCT02510820|3884|P2|COMPLETED|Second Intervention (4 Weeks)||26
2039|NCT02510820|3885|P1|COMPLETED|Second Intervention (4 Weeks)||20
2040|NCT02510820|3884|P2|STARTED|Second Intervention (4 Weeks)||26
2041|NCT02510820|3885|P1|STARTED|Second Intervention (4 Weeks)||21
2042|NCT02510820|3884|P2|NOT COMPLETED|Washout (1 Week)||0
2043|NCT02510820|3885|P1|NOT COMPLETED|Washout (1 Week)||0
2044|NCT02510820|3884|P2|COMPLETED|Washout (1 Week)||26
2045|NCT02510820|3885|P1|COMPLETED|Washout (1 Week)||21
2046|NCT02510820|3884|P2|STARTED|Washout (1 Week)||26
2047|NCT02510820|3885|P1|STARTED|Washout (1 Week)||21
2048|NCT02510820|3884|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
2049|NCT02510820|3885|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
2050|NCT02510820|3884|P2|COMPLETED|First Intervention (4 Weeks)||26
2051|NCT02510820|3885|P1|COMPLETED|First Intervention (4 Weeks)||21
2052|NCT02510820|3884|P2|STARTED|First Intervention (4 Weeks)||27
2053|NCT02510820|3885|P1|STARTED|First Intervention (4 Weeks)||21
2054|NCT02507752|3923|P1|NOT COMPLETED|Overall Study||17
2055|NCT02507752|3923|P1|COMPLETED|Overall Study||55
2056|NCT02507752|3923|P1|STARTED|Overall Study||72
2057|NCT02507375|3943|P2|NOT COMPLETED|Overall Study||8
2058|NCT02507375|3944|P1|NOT COMPLETED|Overall Study||4
2059|NCT02507375|3943|P2|COMPLETED|Overall Study||1
2060|NCT02507375|3944|P1|COMPLETED|Overall Study||2
2061|NCT02507375|3943|P2|Extension Period|Overall Study||1
2062|NCT02507375|3944|P1|Extension Period|Overall Study||2
2063|NCT02507375|3943|P2|Cycle 6|Overall Study||1
2064|NCT02507375|3944|P1|Cycle 6|Overall Study||3
2065|NCT02507375|3943|P2|Cycle 5|Overall Study||1
2066|NCT02507375|3944|P1|Cycle 5|Overall Study||3
2067|NCT02507375|3943|P2|Cycle 4|Overall Study||2
2068|NCT02507375|3944|P1|Cycle 4|Overall Study||4
2069|NCT02507375|3943|P2|Cycle 3|Overall Study||5
2070|NCT02507375|3944|P1|Cycle 3|Overall Study||4
2071|NCT02507375|3943|P2|Cycle 2|Overall Study||5
2072|NCT02507375|3944|P1|Cycle 2|Overall Study||5
2073|NCT02507375|3943|P2|Received Pertuzumab|Overall Study||6
2074|NCT02507375|3944|P1|Received Pertuzumab|Overall Study||6
2075|NCT02507375|3943|P2|Cycle 1|Overall Study||9
2076|NCT02507375|3944|P1|Cycle 1|Overall Study||6
2077|NCT02507375|3943|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
2078|NCT02507375|3944|P1|STARTED|Overall Study||6
2079|NCT02506881|3965|P4|NOT COMPLETED|Second Intervention (Day 1)||0
2080|NCT02506881|3966|P3|NOT COMPLETED|Second Intervention (Day 1)||0
2081|NCT02506881|3967|P2|NOT COMPLETED|Second Intervention (Day 1)||0
2082|NCT02506881|3968|P1|NOT COMPLETED|Second Intervention (Day 1)||0
2083|NCT02506881|3965|P4|COMPLETED|Second Intervention (Day 1)||12
2084|NCT02506881|3966|P3|COMPLETED|Second Intervention (Day 1)||12
2085|NCT02506881|3967|P2|COMPLETED|Second Intervention (Day 1)||12
2086|NCT02506881|3968|P1|COMPLETED|Second Intervention (Day 1)||12
2087|NCT02506881|3965|P4|STARTED|Second Intervention (Day 1)||12
2088|NCT02506881|3966|P3|STARTED|Second Intervention (Day 1)||12
2089|NCT02506881|3967|P2|STARTED|Second Intervention (Day 1)||12
2090|NCT02506881|3968|P1|STARTED|Second Intervention (Day 1)||12
2091|NCT02506881|3965|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
2092|NCT02506881|3966|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
2093|NCT02506881|3967|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
2094|NCT02506881|3968|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
2095|NCT02506881|3965|P4|COMPLETED|Washout (at Least 25 Days)||12
2096|NCT02506881|3966|P3|COMPLETED|Washout (at Least 25 Days)||12
2097|NCT02506881|3967|P2|COMPLETED|Washout (at Least 25 Days)||12
2098|NCT02506881|3968|P1|COMPLETED|Washout (at Least 25 Days)||12
2099|NCT02506881|3965|P4|STARTED|Washout (at Least 25 Days)||12
2100|NCT02506881|3966|P3|STARTED|Washout (at Least 25 Days)||12
2101|NCT02506881|3967|P2|STARTED|Washout (at Least 25 Days)||12
2102|NCT02506881|3968|P1|STARTED|Washout (at Least 25 Days)||12
2103|NCT02506881|3965|P4|NOT COMPLETED|First Intervention (Day 1)||12
2104|NCT02506881|3966|P3|NOT COMPLETED|First Intervention (Day 1)||13
2105|NCT02506881|3967|P2|NOT COMPLETED|First Intervention (Day 1)||0
2106|NCT02506881|3968|P1|NOT COMPLETED|First Intervention (Day 1)||1
2107|NCT02506881|3965|P4|COMPLETED|First Intervention (Day 1)||12
2108|NCT02506881|3966|P3|COMPLETED|First Intervention (Day 1)||12
2109|NCT02506881|3967|P2|COMPLETED|First Intervention (Day 1)||12
2110|NCT02506881|3968|P1|COMPLETED|First Intervention (Day 1)||12
2111|NCT02506881|3965|P4|STARTED|First Intervention (Day 1)||24
2112|NCT02506881|3966|P3|STARTED|First Intervention (Day 1)||25
2113|NCT02506881|3967|P2|STARTED|First Intervention (Day 1)||12
2114|NCT02506881|3968|P1|STARTED|First Intervention (Day 1)||13
2115|NCT02506257|4006|P4|NOT COMPLETED|Overall Study||0
2116|NCT02506257|4007|P3|NOT COMPLETED|Overall Study||4
2117|NCT02506257|4008|P2|NOT COMPLETED|Overall Study||2
2118|NCT02506257|4009|P1|NOT COMPLETED|Overall Study||0
2119|NCT02506257|4006|P4|COMPLETED|Overall Study||9
2120|NCT02506257|4007|P3|COMPLETED|Overall Study||23
2121|NCT02506257|4008|P2|COMPLETED|Overall Study||26
2122|NCT02506257|4009|P1|COMPLETED|Overall Study||26
2123|NCT02506257|4006|P4|STARTED|Overall Study||9
2124|NCT02506257|4007|P3|STARTED|Overall Study||27
2125|NCT02506257|4008|P2|STARTED|Overall Study||28
2126|NCT02506257|4009|P1|STARTED|Overall Study||26
2127|NCT02504775|4039|P2|NOT COMPLETED|Period 2||0
2128|NCT02504775|4040|P1|NOT COMPLETED|Period 2||0
2129|NCT02504775|4039|P2|COMPLETED|Period 2||14
2130|NCT02504775|4040|P1|COMPLETED|Period 2||14
2131|NCT02504775|4039|P2|STARTED|Period 2||14
2132|NCT02504775|4040|P1|STARTED|Period 2||14
2133|NCT02504775|4039|P2|NOT COMPLETED|Washout||0
2134|NCT02504775|4040|P1|NOT COMPLETED|Washout||0
2135|NCT02504775|4039|P2|COMPLETED|Washout||14
2136|NCT02504775|4040|P1|COMPLETED|Washout||14
2137|NCT02504775|4039|P2|STARTED|Washout||14
2138|NCT02504775|4040|P1|STARTED|Washout||14
2139|NCT02504775|4039|P2|NOT COMPLETED|Period 1||0
2140|NCT02504775|4040|P1|NOT COMPLETED|Period 1||0
2141|NCT02504775|4039|P2|COMPLETED|Period 1||14
2142|NCT02504775|4040|P1|COMPLETED|Period 1||14
2143|NCT02504775|4039|P2|STARTED|Period 1||14
2144|NCT02504775|4040|P1|STARTED|Period 1||14
2145|NCT02504320|4056|P4|NOT COMPLETED|Treatment Period 4||0
2146|NCT02504320|4057|P3|NOT COMPLETED|Treatment Period 4||0
2147|NCT02504320|4058|P2|NOT COMPLETED|Treatment Period 4||0
2148|NCT02504320|4059|P1|NOT COMPLETED|Treatment Period 4||0
2149|NCT02504320|4056|P4|COMPLETED|Treatment Period 4||19
2150|NCT02504320|4057|P3|COMPLETED|Treatment Period 4||18
2151|NCT02504320|4058|P2|COMPLETED|Treatment Period 4||18
2152|NCT02504320|4059|P1|COMPLETED|Treatment Period 4||19
2153|NCT02504320|4056|P4|STARTED|Treatment Period 4||19
2154|NCT02504320|4057|P3|STARTED|Treatment Period 4||18
2155|NCT02504320|4058|P2|STARTED|Treatment Period 4||18
2156|NCT02504320|4059|P1|STARTED|Treatment Period 4||19
2157|NCT02504320|4056|P4|NOT COMPLETED|Treatment Period 3||1
2158|NCT02504320|4057|P3|NOT COMPLETED|Treatment Period 3||1
2159|NCT02504320|4058|P2|NOT COMPLETED|Treatment Period 3||0
2160|NCT02504320|4059|P1|NOT COMPLETED|Treatment Period 3||0
2161|NCT02504320|4056|P4|COMPLETED|Treatment Period 3||19
2162|NCT02504320|4057|P3|COMPLETED|Treatment Period 3||18
2163|NCT02504320|4058|P2|COMPLETED|Treatment Period 3||18
2164|NCT02504320|4059|P1|COMPLETED|Treatment Period 3||19
2165|NCT02504320|4056|P4|STARTED|Treatment Period 3||20
2166|NCT02504320|4057|P3|STARTED|Treatment Period 3||19
2167|NCT02504320|4058|P2|STARTED|Treatment Period 3||18
2168|NCT02504320|4059|P1|STARTED|Treatment Period 3||19
2169|NCT02504320|4056|P4|NOT COMPLETED|Treatment Period 2||0
2170|NCT02504320|4057|P3|NOT COMPLETED|Treatment Period 2||0
2171|NCT02504320|4058|P2|NOT COMPLETED|Treatment Period 2||1
2172|NCT02504320|4059|P1|NOT COMPLETED|Treatment Period 2||0
2173|NCT02504320|4056|P4|COMPLETED|Treatment Period 2||20
2174|NCT02504320|4057|P3|COMPLETED|Treatment Period 2||19
2175|NCT02504320|4058|P2|COMPLETED|Treatment Period 2||18
2176|NCT02504320|4059|P1|COMPLETED|Treatment Period 2||19
2177|NCT02504320|4056|P4|STARTED|Treatment Period 2||20
2178|NCT02504320|4057|P3|STARTED|Treatment Period 2||19
2179|NCT02504320|4058|P2|STARTED|Treatment Period 2||19
2180|NCT02504320|4059|P1|STARTED|Treatment Period 2||19
2181|NCT02504320|4056|P4|NOT COMPLETED|Treatment Period 1||0
2182|NCT02504320|4057|P3|NOT COMPLETED|Treatment Period 1||1
2183|NCT02504320|4058|P2|NOT COMPLETED|Treatment Period 1||0
2184|NCT02504320|4059|P1|NOT COMPLETED|Treatment Period 1||0
2185|NCT02504320|4056|P4|COMPLETED|Treatment Period 1||20
2186|NCT02504320|4057|P3|COMPLETED|Treatment Period 1||19
2187|NCT02504320|4058|P2|COMPLETED|Treatment Period 1||19
2188|NCT02504320|4059|P1|COMPLETED|Treatment Period 1||19
2189|NCT02504320|4056|P4|STARTED|Treatment Period 1||20
2190|NCT02504320|4057|P3|STARTED|Treatment Period 1||20
2191|NCT02504320|4058|P2|STARTED|Treatment Period 1||19
2192|NCT02504320|4059|P1|STARTED|Treatment Period 1||19
2193|NCT02503982|4077|P1|NOT COMPLETED|Overall Study||0
2194|NCT02503982|4077|P1|COMPLETED|Overall Study||13
2195|NCT02503982|4077|P1|STARTED|Overall Study||13
2196|NCT02503865|4084|P3|NOT COMPLETED|Overall Study||2
2197|NCT02503865|4085|P2|NOT COMPLETED|Overall Study||47
2198|NCT02503865|4086|P1|NOT COMPLETED|Overall Study||5
2199|NCT02503865|4084|P3|COMPLETED|Overall Study||64
2200|NCT02503865|4085|P2|COMPLETED|Overall Study||222
2201|NCT02503865|4086|P1|COMPLETED|Overall Study||65
2202|NCT02503865|4084|P3|STARTED|Overall Study||66
2203|NCT02503865|4085|P2|STARTED|Overall Study||269
2204|NCT02503865|4086|P1|STARTED|Overall Study||70
2205|NCT02503215|4106|P1|NOT COMPLETED|Overall Study||3
2206|NCT02503215|4106|P1|COMPLETED|Overall Study||14
2207|NCT02503215|4106|P1|STARTED|Overall Study||17
2208|NCT02502487|4115|P3|NOT COMPLETED|Overall Study||0
2209|NCT02502487|4116|P2|NOT COMPLETED|Overall Study||0
2210|NCT02502487|4117|P1|NOT COMPLETED|Overall Study||0
2211|NCT02502487|4115|P3|COMPLETED|Overall Study||86
2212|NCT02502487|4116|P2|COMPLETED|Overall Study||86
2213|NCT02502487|4117|P1|COMPLETED|Overall Study||86
2214|NCT02502487|4115|P3|STARTED|Overall Study||86
2215|NCT02502487|4116|P2|STARTED|Overall Study||86
2216|NCT02502487|4117|P1|STARTED|Overall Study||86
2217|NCT02502734|4185|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
2218|NCT02502734|4186|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
2219|NCT02502734|4185|P2|COMPLETED|Double-blind Treatment Period 2||30
2220|NCT02502734|4186|P1|COMPLETED|Double-blind Treatment Period 2||28
2221|NCT02502734|4185|P2|STARTED|Double-blind Treatment Period 2||30
2222|NCT02502734|4186|P1|STARTED|Double-blind Treatment Period 2||28
2223|NCT02502734|4185|P2|NOT COMPLETED|Washout Period||0
2224|NCT02502734|4186|P1|NOT COMPLETED|Washout Period||1
2225|NCT02502734|4185|P2|COMPLETED|Washout Period||30
2226|NCT02502734|4186|P1|COMPLETED|Washout Period||28
2227|NCT02502734|4185|P2|STARTED|Washout Period||30
2228|NCT02502734|4186|P1|STARTED|Washout Period||29
2229|NCT02502734|4185|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
2230|NCT02502734|4186|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
2231|NCT02502734|4185|P2|COMPLETED|Double-blind Treatment Period 1||30
2232|NCT02502734|4186|P1|COMPLETED|Double-blind Treatment Period 1||29
2233|NCT02502734|4185|P2|STARTED|Double-blind Treatment Period 1||30
2234|NCT02502734|4186|P1|STARTED|Double-blind Treatment Period 1||30
2235|NCT02500368|4194|P2|NOT COMPLETED|Second Intervention (1 Week)||0
2236|NCT02500368|4195|P1|NOT COMPLETED|Second Intervention (1 Week)||0
2237|NCT02500368|4194|P2|COMPLETED|Second Intervention (1 Week)||20
2238|NCT02500368|4195|P1|COMPLETED|Second Intervention (1 Week)||20
2239|NCT02500368|4194|P2|STARTED|Second Intervention (1 Week)||20
2240|NCT02500368|4195|P1|STARTED|Second Intervention (1 Week)||20
2241|NCT02500368|4194|P2|NOT COMPLETED|First Intervention (1 Week)||0
2242|NCT02500368|4195|P1|NOT COMPLETED|First Intervention (1 Week)||0
2243|NCT02500368|4194|P2|COMPLETED|First Intervention (1 Week)||20
2244|NCT02500368|4195|P1|COMPLETED|First Intervention (1 Week)||20
2245|NCT02500368|4194|P2|STARTED|First Intervention (1 Week)||20
2246|NCT02500368|4195|P1|STARTED|First Intervention (1 Week)||20
2247|NCT02499692|4243|P1|NOT COMPLETED|Overall Study||0
2248|NCT02499692|4243|P1|COMPLETED|Overall Study||103
2249|NCT02499692|4243|P1|STARTED|Overall Study||103
2250|NCT02498678|4254|P2|NOT COMPLETED|Overall Study||2
2251|NCT02498678|4255|P1|NOT COMPLETED|Overall Study||0
2252|NCT02498678|4254|P2|COMPLETED|Overall Study||23
2253|NCT02498678|4255|P1|COMPLETED|Overall Study||25
2254|NCT02498678|4254|P2|STARTED|Overall Study||25
2255|NCT02498678|4255|P1|STARTED|Overall Study||25
2256|NCT02498522|4271|P2|NOT COMPLETED|Overall Study||2
2257|NCT02498522|4272|P1|NOT COMPLETED|Overall Study||2
2258|NCT02498522|4271|P2|COMPLETED|Overall Study||83
2259|NCT02498522|4272|P1|COMPLETED|Overall Study||83
2260|NCT02498522|4271|P2|STARTED|Overall Study||85
2261|NCT02498522|4272|P1|STARTED|Overall Study||85
2262|NCT02496533|4280|P2|NOT COMPLETED|Overall Study||6
2263|NCT02496533|4281|P1|NOT COMPLETED|Overall Study||3
2264|NCT02496533|4280|P2|COMPLETED|Overall Study||106
2265|NCT02496533|4281|P1|COMPLETED|Overall Study||102
2266|NCT02496533|4280|P2|STARTED|Overall Study||112
2267|NCT02496533|4281|P1|STARTED|Overall Study||105
2268|NCT02496221|4293|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
2269|NCT02496221|4294|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
2270|NCT02496221|4293|P2|COMPLETED|Treatment Period 2 - 4 Days||9
2271|NCT02496221|4294|P1|COMPLETED|Treatment Period 2 - 4 Days||8
2272|NCT02496221|4293|P2|STARTED|Treatment Period 2 - 4 Days||10
2273|NCT02496221|4294|P1|STARTED|Treatment Period 2 - 4 Days||10
2274|NCT02496221|4293|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
2275|NCT02496221|4294|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
2276|NCT02496221|4293|P2|COMPLETED|Treatment Period 1 - 4 Days||10
2277|NCT02496221|4294|P1|COMPLETED|Treatment Period 1 - 4 Days||10
2278|NCT02496221|4293|P2|STARTED|Treatment Period 1 - 4 Days||10
2279|NCT02496221|4294|P1|STARTED|Treatment Period 1 - 4 Days||10
2280|NCT02496000|4331|P3|NOT COMPLETED|Overall Study||2
2281|NCT02496000|4332|P2|NOT COMPLETED|Overall Study||5
2282|NCT02496000|4333|P1|NOT COMPLETED|Overall Study||2
2283|NCT02496000|4331|P3|COMPLETED|Overall Study||61
2284|NCT02496000|4332|P2|COMPLETED|Overall Study||56
2285|NCT02496000|4333|P1|COMPLETED|Overall Study||62
2286|NCT02496000|4331|P3|STARTED|Overall Study||63
2287|NCT02496000|4332|P2|STARTED|Overall Study||61
2288|NCT02496000|4333|P1|STARTED|Overall Study||64
2289|NCT02495948|4342|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2290|NCT02495948|4343|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
2291|NCT02495948|4342|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
2292|NCT02495948|4343|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
2293|NCT02495948|4342|P2|STARTED|Period 2, Second 30 Days of Wear||83
2294|NCT02495948|4343|P1|STARTED|Period 2, Second 30 Days of Wear||83
2295|NCT02495948|4342|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
2296|NCT02495948|4343|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
2297|NCT02495948|4342|P2|COMPLETED|Period 1, First 30 Days of Wear||83
2298|NCT02495948|4343|P1|COMPLETED|Period 1, First 30 Days of Wear||83
2299|NCT02495948|4342|P2|STARTED|Period 1, First 30 Days of Wear||84
2300|NCT02495948|4343|P1|STARTED|Period 1, First 30 Days of Wear||83
2301|NCT02495831|4350|P2|NOT COMPLETED|Second Intervention||0
2302|NCT02495831|4351|P1|NOT COMPLETED|Second Intervention||0
2303|NCT02495831|4350|P2|COMPLETED|Second Intervention||10
2304|NCT02495831|4351|P1|COMPLETED|Second Intervention||12
2305|NCT02495831|4350|P2|STARTED|Second Intervention||10
2306|NCT02495831|4351|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
2307|NCT02495831|4350|P2|NOT COMPLETED|First Intervention||0
2308|NCT02495831|4351|P1|NOT COMPLETED|First Intervention||0
2309|NCT02495831|4350|P2|COMPLETED|First Intervention||10
2310|NCT02495831|4351|P1|COMPLETED|First Intervention||13
2311|NCT02495831|4350|P2|STARTED|First Intervention||10
2312|NCT02495831|4351|P1|STARTED|First Intervention||13
2313|NCT02494596|4365|P3|NOT COMPLETED|Overall Study||1
2314|NCT02494596|4366|P2|NOT COMPLETED|Overall Study||5
2315|NCT02494596|4367|P1|NOT COMPLETED|Overall Study||3
2316|NCT02494596|4365|P3|COMPLETED|Overall Study||6
2317|NCT02494596|4366|P2|COMPLETED|Overall Study||2
2318|NCT02494596|4367|P1|COMPLETED|Overall Study||2
2319|NCT02494596|4365|P3|STARTED|Overall Study||7
2320|NCT02494596|4366|P2|STARTED|Overall Study||7
2321|NCT02494596|4367|P1|STARTED|Overall Study||5
2322|NCT02494440|4392|P1|NOT COMPLETED|Overall Study||0
2323|NCT02494440|4392|P1|COMPLETED|Overall Study||90
2324|NCT02494440|4392|P1|STARTED|Overall Study||90
2325|NCT02494323|4398|P1|NOT COMPLETED|Overall Study||0
2326|NCT02494323|4398|P1|COMPLETED|Overall Study||70
2327|NCT02494323|4398|P1|STARTED|Overall Study||70
2328|NCT02492451|4406|P3|NOT COMPLETED|Overall Study||0
2329|NCT02492451|4407|P2|NOT COMPLETED|Overall Study||0
2330|NCT02492451|4408|P1|NOT COMPLETED|Overall Study||0
2331|NCT02492451|4406|P3|COMPLETED|Overall Study||39
2332|NCT02492451|4407|P2|COMPLETED|Overall Study||39
2333|NCT02492451|4408|P1|COMPLETED|Overall Study||40
2334|NCT02492451|4406|P3|STARTED|Overall Study||39
2335|NCT02492451|4407|P2|STARTED|Overall Study||39
2336|NCT02492451|4408|P1|STARTED|Overall Study||40
2337|NCT02492165|4420|P4|NOT COMPLETED|Overall Study||0
2338|NCT02492165|4421|P3|NOT COMPLETED|Overall Study||0
2339|NCT02492165|4422|P2|NOT COMPLETED|Overall Study||1
2340|NCT02492165|4423|P1|NOT COMPLETED|Overall Study||0
2341|NCT02492165|4420|P4|COMPLETED|Overall Study||30
2342|NCT02492165|4421|P3|COMPLETED|Overall Study||60
2343|NCT02492165|4422|P2|COMPLETED|Overall Study||59
2344|NCT02492165|4423|P1|COMPLETED|Overall Study||100
2345|NCT02492165|4420|P4|STARTED|Overall Study||30
2346|NCT02492165|4421|P3|STARTED|Overall Study||60
2347|NCT02492165|4422|P2|STARTED|Overall Study||60
2348|NCT02492165|4423|P1|STARTED|Overall Study||100
2349|NCT02491944|4445|P1|NOT COMPLETED|Overall Study||0
2350|NCT02491944|4445|P1|COMPLETED|Overall Study||10
2351|NCT02491944|4445|P1|STARTED|Overall Study||10
2352|NCT02491892|4467|P2|NOT COMPLETED|Overall Study||38
2353|NCT02491892|4468|P1|NOT COMPLETED|Overall Study||41
2354|NCT02491892|4467|P2|COMPLETED|Overall Study||0
2355|NCT02491892|4468|P1|COMPLETED|Overall Study||0
2356|NCT02491892|4467|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
2357|NCT02491892|4468|P1|Treated|Overall Study||41
2358|NCT02491892|4467|P2|STARTED|Overall Study||38
2359|NCT02491892|4468|P1|STARTED|Overall Study||41
2360|NCT02490670|4514|P2|NOT COMPLETED|Period 2 (19 Days)||0
2361|NCT02490670|4515|P1|NOT COMPLETED|Period 2 (19 Days)||0
2362|NCT02490670|4514|P2|COMPLETED|Period 2 (19 Days)||14
2363|NCT02490670|4515|P1|COMPLETED|Period 2 (19 Days)||14
2364|NCT02490670|4514|P2|STARTED|Period 2 (19 Days)||14
2365|NCT02490670|4515|P1|STARTED|Period 2 (19 Days)||14
2366|NCT02490670|4514|P2|NOT COMPLETED|Washout Period (7 Days)||0
2367|NCT02490670|4515|P1|NOT COMPLETED|Washout Period (7 Days)||0
2368|NCT02490670|4514|P2|COMPLETED|Washout Period (7 Days)||14
2369|NCT02490670|4515|P1|COMPLETED|Washout Period (7 Days)||14
2370|NCT02490670|4514|P2|STARTED|Washout Period (7 Days)||14
2371|NCT02490670|4515|P1|STARTED|Washout Period (7 Days)||14
2372|NCT02490670|4514|P2|NOT COMPLETED|Period 1 (19 Days)||0
2373|NCT02490670|4515|P1|NOT COMPLETED|Period 1 (19 Days)||0
2374|NCT02490670|4514|P2|COMPLETED|Period 1 (19 Days)||14
2375|NCT02490670|4515|P1|COMPLETED|Period 1 (19 Days)||14
2376|NCT02490670|4514|P2|STARTED|Period 1 (19 Days)||14
2377|NCT02490670|4515|P1|STARTED|Period 1 (19 Days)||14
2378|NCT02490475|4527|P4|NOT COMPLETED|Period 2: Extension Phase||1
2379|NCT02490475|4528|P3|NOT COMPLETED|Period 2: Extension Phase||3
2380|NCT02490475|4529|P2|NOT COMPLETED|Period 2: Extension Phase||0
2381|NCT02490475|4530|P1|NOT COMPLETED|Period 2: Extension Phase||1
2382|NCT02490475|4527|P4|COMPLETED|Period 2: Extension Phase||0
2383|NCT02490475|4528|P3|COMPLETED|Period 2: Extension Phase||0
2384|NCT02490475|4529|P2|COMPLETED|Period 2: Extension Phase||0
2385|NCT02490475|4530|P1|COMPLETED|Period 2: Extension Phase||0
2386|NCT02490475|4527|P4|STARTED|Period 2: Extension Phase||1
2387|NCT02490475|4528|P3|STARTED|Period 2: Extension Phase||3
2388|NCT02490475|4529|P2|STARTED|Period 2: Extension Phase||0
2389|NCT02490475|4530|P1|STARTED|Period 2: Extension Phase||1
2390|NCT02490475|4527|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
2391|NCT02490475|4528|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
2392|NCT02490475|4529|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
2393|NCT02490475|4530|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
2394|NCT02490475|4527|P4|COMPLETED|Period 1: First 6 Cycles||0
2395|NCT02490475|4528|P3|COMPLETED|Period 1: First 6 Cycles||0
2396|NCT02490475|4529|P2|COMPLETED|Period 1: First 6 Cycles||0
2397|NCT02490475|4530|P1|COMPLETED|Period 1: First 6 Cycles||0
2398|NCT02490475|4527|P4|STARTED|Period 1: First 6 Cycles||5
2399|NCT02490475|4528|P3|STARTED|Period 1: First 6 Cycles||6
2400|NCT02490475|4529|P2|STARTED|Period 1: First 6 Cycles||2
2401|NCT02490475|4530|P1|STARTED|Period 1: First 6 Cycles||6
2402|NCT02488317|4608|P2|NOT COMPLETED|Overall Study||47
2403|NCT02488317|4609|P1|NOT COMPLETED|Overall Study||54
2404|NCT02488317|4608|P2|COMPLETED|Overall Study||70
2405|NCT02488317|4609|P1|COMPLETED|Overall Study||63
2406|NCT02488317|4608|P2|STARTED|Overall Study||117
2407|NCT02488317|4609|P1|STARTED|Overall Study||117
2408|NCT02488018|4623|P1|NOT COMPLETED|Overall Study||0
2409|NCT02488018|4623|P1|COMPLETED|Overall Study||10
2410|NCT02488018|4623|P1|STARTED|Overall Study||10
2411|NCT02486952|4627|P1|NOT COMPLETED|Overall Study||50
2412|NCT02486952|4627|P1|COMPLETED|Overall Study||104
2413|NCT02486952|4627|P1|Started Induction Therapy|Overall Study||151
2414|NCT02486952|4627|P1|STARTED|Overall Study||154
2415|NCT02485483|4634|P2|NOT COMPLETED|Overall Study||0
2416|NCT02485483|4635|P1|NOT COMPLETED|Overall Study||54
2417|NCT02485483|4634|P2|COMPLETED|Overall Study||1015
2418|NCT02485483|4635|P1|COMPLETED|Overall Study||223
2419|NCT02485483|4634|P2|STARTED|Overall Study||1015
2420|NCT02485483|4635|P1|STARTED|Overall Study||277
2421|NCT02485158|4650|P1|NOT COMPLETED|Overall Study||4
2422|NCT02485158|4650|P1|COMPLETED|Overall Study||24
2423|NCT02485158|4650|P1|STARTED|Overall Study||28
2424|NCT02484898|4737|P1|NOT COMPLETED|Overall Study||18
2425|NCT02484898|4737|P1|COMPLETED|Overall Study||182
2426|NCT02484898|4737|P1|STARTED|Overall Study||200
2427|NCT02483611|4744|P3|NOT COMPLETED|Overall Study||1
2428|NCT02483611|4745|P2|NOT COMPLETED|Overall Study||0
2429|NCT02483611|4746|P1|NOT COMPLETED|Overall Study||0
2430|NCT02483611|4744|P3|COMPLETED|Overall Study|One patient required decurarization|15
2431|NCT02483611|4745|P2|COMPLETED|Overall Study||16
2432|NCT02483611|4746|P1|COMPLETED|Overall Study||16
2433|NCT02483611|4744|P3|STARTED|Overall Study||16
2434|NCT02483611|4745|P2|STARTED|Overall Study||16
2435|NCT02483611|4746|P1|STARTED|Overall Study||16
2436|NCT02481934|4841|P1|NOT COMPLETED|Overall Study||2
2437|NCT02481934|4841|P1|COMPLETED|Overall Study||3
2438|NCT02481934|4841|P1|STARTED|Overall Study||5
2439|NCT02481219|4848|P2|NOT COMPLETED|Overall Study||1
2440|NCT02481219|4849|P1|NOT COMPLETED|Overall Study||2
2441|NCT02481219|4848|P2|COMPLETED|Overall Study||61
2442|NCT02481219|4849|P1|COMPLETED|Overall Study||58
2443|NCT02481219|4848|P2|STARTED|Overall Study||62
2444|NCT02481219|4849|P1|STARTED|Overall Study||60
2445|NCT02480439|4868|P3|NOT COMPLETED|Treatment Period 3||0
2446|NCT02480439|4869|P2|NOT COMPLETED|Treatment Period 3||0
2447|NCT02480439|4870|P1|NOT COMPLETED|Treatment Period 3||0
2448|NCT02480439|4868|P3|COMPLETED|Treatment Period 3||7
2449|NCT02480439|4869|P2|COMPLETED|Treatment Period 3||7
2450|NCT02480439|4870|P1|COMPLETED|Treatment Period 3||8
2451|NCT02480439|4868|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
2452|NCT02480439|4869|P2|STARTED|Treatment Period 3||7
2453|NCT02480439|4870|P1|STARTED|Treatment Period 3||8
2454|NCT02480439|4868|P3|NOT COMPLETED|Treatment Period 2||0
2455|NCT02480439|4869|P2|NOT COMPLETED|Treatment Period 2||0
2456|NCT02480439|4870|P1|NOT COMPLETED|Treatment Period 2||0
2457|NCT02480439|4868|P3|COMPLETED|Treatment Period 2||8
2458|NCT02480439|4869|P2|COMPLETED|Treatment Period 2||7
2459|NCT02480439|4870|P1|COMPLETED|Treatment Period 2||8
2460|NCT02480439|4868|P3|STARTED|Treatment Period 2||8
2461|NCT02480439|4869|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
2462|NCT02480439|4870|P1|STARTED|Treatment Period 2||8
2463|NCT02480439|4868|P3|NOT COMPLETED|Treatment Period 1||0
2464|NCT02480439|4869|P2|NOT COMPLETED|Treatment Period 1||0
2465|NCT02480439|4870|P1|NOT COMPLETED|Treatment Period 1||0
2466|NCT02480439|4868|P3|COMPLETED|Treatment Period 1||8
2467|NCT02480439|4869|P2|COMPLETED|Treatment Period 1||8
2468|NCT02480439|4870|P1|COMPLETED|Treatment Period 1||8
2469|NCT02480439|4868|P3|STARTED|Treatment Period 1||8
2470|NCT02480439|4869|P2|STARTED|Treatment Period 1||8
2471|NCT02480439|4870|P1|STARTED|Treatment Period 1||8
2472|NCT02480010|4895|P2|NOT COMPLETED|Overall Study||33
2473|NCT02480010|4896|P1|NOT COMPLETED|Overall Study||35
2474|NCT02480010|4895|P2|COMPLETED|Overall Study||0
2475|NCT02480010|4896|P1|COMPLETED|Overall Study||0
2476|NCT02480010|4895|P2|STARTED|Overall Study||33
2477|NCT02480010|4896|P1|STARTED|Overall Study||35
2478|NCT02479763|4942|P2|NOT COMPLETED|Overall Study||3
2479|NCT02479763|4943|P1|NOT COMPLETED|Overall Study||3
2480|NCT02479763|4942|P2|COMPLETED|Overall Study||50
2481|NCT02479763|4943|P1|COMPLETED|Overall Study||50
2482|NCT02479763|4942|P2|STARTED|Overall Study||53
2483|NCT02479763|4943|P1|STARTED|Overall Study||53
2484|NCT02478671|4949|P1|NOT COMPLETED|Overall Study||0
2485|NCT02478671|4949|P1|COMPLETED|Overall Study||4
2486|NCT02478671|4949|P1|STARTED|Overall Study||4
2487|NCT02478580|4956|P2|NOT COMPLETED|Overall Study||0
2488|NCT02478580|4957|P1|NOT COMPLETED|Overall Study||0
2489|NCT02478580|4956|P2|COMPLETED|Overall Study||33
2490|NCT02478580|4957|P1|COMPLETED|Overall Study||34
2491|NCT02478580|4956|P2|STARTED|Overall Study||33
2492|NCT02478580|4957|P1|STARTED|Overall Study||34
2493|NCT02478372|4965|P2|NOT COMPLETED|Overall Study||14
2494|NCT02478372|4966|P1|NOT COMPLETED|Overall Study||13
2495|NCT02478372|4965|P2|COMPLETED|Overall Study||107
2496|NCT02478372|4966|P1|COMPLETED|Overall Study||108
2497|NCT02478372|4965|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
2498|NCT02478372|4966|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
2499|NCT02478372|4965|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
2500|NCT02478372|4966|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
2501|NCT02478372|4965|P2|Recieved Allocation Intervention|Overall Study||113
2502|NCT02478372|4966|P1|Recieved Allocation Intervention|Overall Study||109
2503|NCT02478372|4965|P2|STARTED|Overall Study||121
2504|NCT02478372|4966|P1|STARTED|Overall Study||121
2505|NCT02476422|4990|P2|NOT COMPLETED|Overall Study||1
2506|NCT02476422|4991|P1|NOT COMPLETED|Overall Study||0
2507|NCT02476422|4990|P2|COMPLETED|Overall Study||161
2508|NCT02476422|4991|P1|COMPLETED|Overall Study||166
2509|NCT02476422|4990|P2|STARTED|Overall Study||162
2510|NCT02476422|4991|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
2511|NCT02475980|5021|P1|NOT COMPLETED|Overall Study||5
2512|NCT02475980|5021|P1|COMPLETED|Overall Study||8
2513|NCT02475980|5021|P1|STARTED|Overall Study||13
2514|NCT02475564|5032|P2|NOT COMPLETED|Overall Study||1
2515|NCT02475564|5033|P1|NOT COMPLETED|Overall Study||4
2516|NCT02475564|5032|P2|COMPLETED|Overall Study||21
2517|NCT02475564|5033|P1|COMPLETED|Overall Study||18
2518|NCT02475564|5032|P2|STARTED|Overall Study||22
2519|NCT02475564|5033|P1|STARTED|Overall Study||22
2520|NCT02475278|5043|P1|NOT COMPLETED|Overall Study||2
2521|NCT02475278|5043|P1|COMPLETED|Overall Study||48
2522|NCT02475278|5043|P1|STARTED|Overall Study||50
2523|NCT02473510|5056|P2|NOT COMPLETED|Overall Study||2
2524|NCT02473510|5057|P1|NOT COMPLETED|Overall Study||1
2525|NCT02473510|5056|P2|COMPLETED|Overall Study||238
2526|NCT02473510|5057|P1|COMPLETED|Overall Study||59
2527|NCT02473510|5056|P2|STARTED|Overall Study||240
2528|NCT02473510|5057|P1|STARTED|Overall Study||60
2529|NCT02473367|5071|P1|NOT COMPLETED|Period 4||1
2530|NCT02473367|5071|P1|COMPLETED|Period 4||18
2531|NCT02473367|5071|P1|STARTED|Period 4||19
2532|NCT02473367|5071|P1|NOT COMPLETED|Wait 3||0
2533|NCT02473367|5071|P1|COMPLETED|Wait 3||19
2534|NCT02473367|5071|P1|STARTED|Wait 3||19
2535|NCT02473367|5071|P1|NOT COMPLETED|Period 3||0
2536|NCT02473367|5071|P1|COMPLETED|Period 3||19
2537|NCT02473367|5071|P1|STARTED|Period 3||19
2538|NCT02473367|5071|P1|NOT COMPLETED|Wait 2||0
2539|NCT02473367|5071|P1|COMPLETED|Wait 2||19
2540|NCT02473367|5071|P1|STARTED|Wait 2||19
2541|NCT02473367|5071|P1|NOT COMPLETED|Period 2||0
2542|NCT02473367|5071|P1|COMPLETED|Period 2||19
2543|NCT02473367|5071|P1|STARTED|Period 2||19
2544|NCT02473367|5071|P1|NOT COMPLETED|Wait 1||1
2545|NCT02473367|5071|P1|COMPLETED|Wait 1||19
2546|NCT02473367|5071|P1|STARTED|Wait 1||20
2547|NCT02473367|5071|P1|NOT COMPLETED|Period 1||0
2548|NCT02473367|5071|P1|COMPLETED|Period 1||20
2549|NCT02473367|5071|P1|STARTED|Period 1||20
2550|NCT02472847|5091|P2|NOT COMPLETED|Overall Study||5
2551|NCT02472847|5092|P1|NOT COMPLETED|Overall Study||1
2552|NCT02472847|5091|P2|COMPLETED|Overall Study||21
2553|NCT02472847|5092|P1|COMPLETED|Overall Study||23
2554|NCT02472847|5091|P2|STARTED|Overall Study||26
2555|NCT02472847|5092|P1|STARTED|Overall Study||24
2556|NCT02472756|5098|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
2557|NCT02472756|5098|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
2558|NCT02472756|5098|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
2559|NCT02472756|5098|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
2560|NCT02472756|5098|P1|COMPLETED|Induction (Approximately 6 Months)||39
2561|NCT02472756|5098|P1|Treated|Induction (Approximately 6 Months)||40
2562|NCT02472756|5098|P1|STARTED|Induction (Approximately 6 Months)||41
2563|NCT02472522|5106|P2|NOT COMPLETED|Overall Study||0
2564|NCT02472522|5107|P1|NOT COMPLETED|Overall Study||0
2565|NCT02472522|5106|P2|COMPLETED|Overall Study||50
2566|NCT02472522|5107|P1|COMPLETED|Overall Study||50
2567|NCT02472522|5106|P2|STARTED|Overall Study||50
2568|NCT02472522|5107|P1|STARTED|Overall Study||50
2569|NCT02472366|5139|P2|NOT COMPLETED|Overall Study||0
2570|NCT02472366|5140|P1|NOT COMPLETED|Overall Study||1
2571|NCT02472366|5139|P2|COMPLETED|Overall Study||10
2572|NCT02472366|5140|P1|COMPLETED|Overall Study||5
2573|NCT02472366|5139|P2|STARTED|Overall Study||10
2574|NCT02472366|5140|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
2575|NCT02471755|5156|P2|NOT COMPLETED|Overall Study||1
2576|NCT02471755|5157|P1|NOT COMPLETED|Overall Study||1
2577|NCT02471755|5156|P2|COMPLETED|Overall Study||44
2578|NCT02471755|5157|P1|COMPLETED|Overall Study||44
2579|NCT02471755|5156|P2|STARTED|Overall Study||45
2580|NCT02471755|5157|P1|STARTED|Overall Study||45
2581|NCT02471612|5173|P1|NOT COMPLETED|Overall Study||2
2582|NCT02471612|5173|P1|COMPLETED|Overall Study||157
2583|NCT02471612|5173|P1|STARTED|Overall Study||159
2584|NCT02470949|5190|P2|NOT COMPLETED|Second Intervention||0
2585|NCT02470949|5191|P1|NOT COMPLETED|Second Intervention||0
2586|NCT02470949|5190|P2|COMPLETED|Second Intervention||2
2587|NCT02470949|5191|P1|COMPLETED|Second Intervention||4
2588|NCT02470949|5190|P2|STARTED|Second Intervention||2
2589|NCT02470949|5191|P1|STARTED|Second Intervention||4
2590|NCT02470949|5190|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
2591|NCT02470949|5191|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
2592|NCT02470949|5190|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
2593|NCT02470949|5191|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
2594|NCT02470949|5190|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
2595|NCT02470949|5191|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
2596|NCT02470949|5190|P2|NOT COMPLETED|First Intervention||0
2597|NCT02470949|5191|P1|NOT COMPLETED|First Intervention||0
2598|NCT02470949|5190|P2|COMPLETED|First Intervention||5
2599|NCT02470949|5191|P1|COMPLETED|First Intervention||4
2600|NCT02470949|5190|P2|STARTED|First Intervention||5
2601|NCT02470949|5191|P1|STARTED|First Intervention||4
2602|NCT02469961|5203|P2|NOT COMPLETED|Overall Study||1
2603|NCT02469961|5204|P1|NOT COMPLETED|Overall Study||4
2604|NCT02469961|5203|P2|COMPLETED|Overall Study||24
2605|NCT02469961|5204|P1|COMPLETED|Overall Study||21
2606|NCT02469961|5203|P2|STARTED|Overall Study||25
2607|NCT02469961|5204|P1|STARTED|Overall Study||25
2608|NCT02469597|5218|P2|NOT COMPLETED|Overall Study||0
2609|NCT02469597|5219|P1|NOT COMPLETED|Overall Study||0
2610|NCT02469597|5218|P2|COMPLETED|Overall Study||24
2611|NCT02469597|5219|P1|COMPLETED|Overall Study||22
2612|NCT02469597|5218|P2|STARTED|Overall Study||24
2613|NCT02469597|5219|P1|STARTED|Overall Study||22
2614|NCT02469116|5235|P1|NOT COMPLETED|Overall Study||0
2615|NCT02469116|5235|P1|COMPLETED|Overall Study||18
2616|NCT02469116|5235|P1|STARTED|Overall Study||18
2617|NCT02468154|5247|P2|NOT COMPLETED|Overall Study||0
2618|NCT02468154|5248|P1|NOT COMPLETED|Overall Study||0
2619|NCT02468154|5247|P2|COMPLETED|Overall Study||28
2620|NCT02468154|5248|P1|COMPLETED|Overall Study||29
2621|NCT02468154|5247|P2|STARTED|Overall Study||28
2622|NCT02468154|5248|P1|STARTED|Overall Study||29
2623|NCT02467491|5260|P1|NOT COMPLETED|Overall Study||0
2624|NCT02467491|5260|P1|COMPLETED|Overall Study||12
2625|NCT02467491|5260|P1|STARTED|Overall Study||12
2626|NCT02465489|5269|P1|NOT COMPLETED|Overall Study||5
2627|NCT02465489|5269|P1|COMPLETED|Overall Study||15
2628|NCT02465489|5269|P1|STARTED|Overall Study||20
2629|NCT02465073|5299|P3|NOT COMPLETED|Overall Study||1
2630|NCT02465073|5300|P2|NOT COMPLETED|Overall Study||1
2631|NCT02465073|5301|P1|NOT COMPLETED|Overall Study||2
2632|NCT02465073|5299|P3|COMPLETED|Overall Study||15
2633|NCT02465073|5300|P2|COMPLETED|Overall Study||15
2634|NCT02465073|5301|P1|COMPLETED|Overall Study||15
2635|NCT02465073|5299|P3|STARTED|Overall Study||16
2636|NCT02465073|5300|P2|STARTED|Overall Study||16
2637|NCT02465073|5301|P1|STARTED|Overall Study||17
2638|NCT02463331|5311|P2|NOT COMPLETED|Overall Study||6
2639|NCT02463331|5312|P1|NOT COMPLETED|Overall Study||16
2640|NCT02463331|5311|P2|COMPLETED|Overall Study||25
2641|NCT02463331|5312|P1|COMPLETED|Overall Study||10
2642|NCT02463331|5311|P2|STARTED|Overall Study||31
2643|NCT02463331|5312|P1|STARTED|Overall Study||26
2644|NCT02462291|5322|P2|NOT COMPLETED|Overall Study||6
2645|NCT02462291|5323|P1|NOT COMPLETED|Overall Study||5
2646|NCT02462291|5322|P2|COMPLETED|Overall Study||75
2647|NCT02462291|5323|P1|COMPLETED|Overall Study||77
2648|NCT02462291|5322|P2|STARTED|Overall Study||81
2649|NCT02462291|5323|P1|STARTED|Overall Study||82
2650|NCT02461992|5361|P1|NOT COMPLETED|Overall Study||0
2651|NCT02461992|5361|P1|COMPLETED|Overall Study||13
2652|NCT02461992|5361|P1|STARTED|Overall Study||13
2653|NCT02461290|5378|P1|NOT COMPLETED|Overall Study||10
2654|NCT02461290|5378|P1|COMPLETED|Overall Study||89
2655|NCT02461290|5378|P1|STARTED|Overall Study||99
2656|NCT02460458|5385|P1|NOT COMPLETED|Prospective Phase||0
2657|NCT02460458|5385|P1|COMPLETED|Prospective Phase|Information not yet available.|0
2658|NCT02460458|5385|P1|STARTED|Prospective Phase|Information not yet available.|0
2659|NCT02460458|5385|P1|NOT COMPLETED|Confirmatory Phase||266
2660|NCT02460458|5385|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
2661|NCT02460458|5385|P1|STARTED|Confirmatory Phase||266
2662|NCT02460458|5385|P1|NOT COMPLETED|Retrospective Phase||0
2663|NCT02460458|5385|P1|COMPLETED|Retrospective Phase||266
2664|NCT02460458|5385|P1|STARTED|Retrospective Phase||266
2665|NCT02458768|5393|P2|NOT COMPLETED|Overall Study||5
2666|NCT02458768|5394|P1|NOT COMPLETED|Overall Study||7
2667|NCT02458768|5393|P2|COMPLETED|Overall Study||50
2668|NCT02458768|5394|P1|COMPLETED|Overall Study||50
2669|NCT02458768|5393|P2|STARTED|Overall Study||55
2670|NCT02458768|5394|P1|STARTED|Overall Study||57
2671|NCT02458365|5402|P2|NOT COMPLETED|Overall Study||294
2672|NCT02458365|5403|P1|NOT COMPLETED|Overall Study||277
2673|NCT02458365|5402|P2|COMPLETED|Overall Study||1607
2674|NCT02458365|5403|P1|COMPLETED|Overall Study||1723
2675|NCT02458365|5402|P2|STARTED|Overall Study||1901
2676|NCT02458365|5403|P1|STARTED|Overall Study||2000
2677|NCT02457728|5423|P1|NOT COMPLETED|Overall Study||0
2678|NCT02457728|5423|P1|COMPLETED|Overall Study||34
2679|NCT02457728|5423|P1|STARTED|Overall Study||34
2680|NCT02457247|5431|P4|NOT COMPLETED|Period 2||0
2681|NCT02457247|5432|P3|NOT COMPLETED|Period 2||0
2682|NCT02457247|5433|P2|NOT COMPLETED|Period 2||3
2683|NCT02457247|5434|P1|NOT COMPLETED|Period 2||2
2684|NCT02457247|5431|P4|COMPLETED|Period 2||70
2685|NCT02457247|5432|P3|COMPLETED|Period 2||68
2686|NCT02457247|5433|P2|COMPLETED|Period 2||65
2687|NCT02457247|5434|P1|COMPLETED|Period 2||64
2688|NCT02457247|5431|P4|STARTED|Period 2||70
2689|NCT02457247|5432|P3|STARTED|Period 2||68
2690|NCT02457247|5433|P2|STARTED|Period 2||68
2691|NCT02457247|5434|P1|STARTED|Period 2||66
2692|NCT02457247|5431|P4|NOT COMPLETED|Period 1||0
2693|NCT02457247|5432|P3|NOT COMPLETED|Period 1||0
2694|NCT02457247|5433|P2|NOT COMPLETED|Period 1||2
2695|NCT02457247|5434|P1|NOT COMPLETED|Period 1||2
2696|NCT02457247|5431|P4|COMPLETED|Period 1||70
2697|NCT02457247|5432|P3|COMPLETED|Period 1||68
2698|NCT02457247|5433|P2|COMPLETED|Period 1||68
2699|NCT02457247|5434|P1|COMPLETED|Period 1||66
2700|NCT02457247|5431|P4|STARTED|Period 1||70
2701|NCT02457247|5432|P3|STARTED|Period 1||68
2702|NCT02457247|5433|P2|STARTED|Period 1||70
2703|NCT02457247|5434|P1|STARTED|Period 1||68
2704|NCT02455050|5458|P4|NOT COMPLETED|Treatment Period 2||1
2705|NCT02455050|5459|P3|NOT COMPLETED|Treatment Period 2||2
2706|NCT02455050|5460|P2|NOT COMPLETED|Treatment Period 2||0
2707|NCT02455050|5461|P1|NOT COMPLETED|Treatment Period 2||1
2708|NCT02455050|5458|P4|COMPLETED|Treatment Period 2||17
2709|NCT02455050|5459|P3|COMPLETED|Treatment Period 2||17
2710|NCT02455050|5460|P2|COMPLETED|Treatment Period 2||18
2711|NCT02455050|5461|P1|COMPLETED|Treatment Period 2||18
2712|NCT02455050|5458|P4|STARTED|Treatment Period 2||18
2713|NCT02455050|5459|P3|STARTED|Treatment Period 2||19
2714|NCT02455050|5460|P2|STARTED|Treatment Period 2||18
2715|NCT02455050|5461|P1|STARTED|Treatment Period 2||19
2716|NCT02455050|5458|P4|NOT COMPLETED|Treatment Period 1||2
2717|NCT02455050|5459|P3|NOT COMPLETED|Treatment Period 1||1
2718|NCT02455050|5460|P2|NOT COMPLETED|Treatment Period 1||1
2719|NCT02455050|5461|P1|NOT COMPLETED|Treatment Period 1||1
2720|NCT02455050|5458|P4|COMPLETED|Treatment Period 1||18
2721|NCT02455050|5459|P3|COMPLETED|Treatment Period 1||19
2722|NCT02455050|5460|P2|COMPLETED|Treatment Period 1||18
2723|NCT02455050|5461|P1|COMPLETED|Treatment Period 1||19
2724|NCT02455050|5458|P4|STARTED|Treatment Period 1||20
2725|NCT02455050|5459|P3|STARTED|Treatment Period 1||20
2726|NCT02455050|5460|P2|STARTED|Treatment Period 1||19
2727|NCT02455050|5461|P1|STARTED|Treatment Period 1||20
2728|NCT02454608|5527|P2|NOT COMPLETED|Overall Study||2
2729|NCT02454608|5528|P1|NOT COMPLETED|Overall Study||0
2730|NCT02454608|5527|P2|COMPLETED|Overall Study||8
2731|NCT02454608|5528|P1|COMPLETED|Overall Study||10
2732|NCT02454608|5527|P2|STARTED|Overall Study||10
2733|NCT02454608|5528|P1|STARTED|Overall Study||10
2734|NCT02454283|5548|P2|NOT COMPLETED|Overall Study||0
2735|NCT02454283|5549|P1|NOT COMPLETED|Overall Study||0
2736|NCT02454283|5548|P2|COMPLETED|Overall Study||15
2737|NCT02454283|5549|P1|COMPLETED|Overall Study||26
2738|NCT02454283|5548|P2|STARTED|Overall Study||15
2739|NCT02454283|5549|P1|STARTED|Overall Study||26
2740|NCT02454127|5561|P4|NOT COMPLETED|Overall Study||20
2741|NCT02454127|5562|P3|NOT COMPLETED|Overall Study||14
2742|NCT02454127|5563|P2|NOT COMPLETED|Overall Study||14
2743|NCT02454127|5564|P1|NOT COMPLETED|Overall Study||19
2744|NCT02454127|5561|P4|COMPLETED|Overall Study||20
2745|NCT02454127|5562|P3|COMPLETED|Overall Study||26
2746|NCT02454127|5563|P2|COMPLETED|Overall Study||26
2747|NCT02454127|5564|P1|COMPLETED|Overall Study||21
2748|NCT02454127|5561|P4|STARTED|Overall Study||40
2749|NCT02454127|5562|P3|STARTED|Overall Study||40
2750|NCT02454127|5563|P2|STARTED|Overall Study||40
2751|NCT02454127|5564|P1|STARTED|Overall Study||40
2752|NCT02454101|5604|P2|NOT COMPLETED|Overall Study||7
2753|NCT02454101|5605|P1|NOT COMPLETED|Overall Study||5
2754|NCT02454101|5604|P2|COMPLETED|Overall Study||143
2755|NCT02454101|5605|P1|COMPLETED|Overall Study||145
2756|NCT02454101|5604|P2|STARTED|Overall Study||150
2757|NCT02454101|5605|P1|STARTED|Overall Study||150
2758|NCT02453581|5627|P3|NOT COMPLETED|Overall Study||0
2759|NCT02453581|5628|P2|NOT COMPLETED|Overall Study||0
2760|NCT02453581|5629|P1|NOT COMPLETED|Overall Study||0
2761|NCT02453581|5627|P3|COMPLETED|Overall Study||8
2762|NCT02453581|5628|P2|COMPLETED|Overall Study||8
2763|NCT02453581|5629|P1|COMPLETED|Overall Study||8
2764|NCT02453581|5627|P3|STARTED|Overall Study||8
2765|NCT02453581|5628|P2|STARTED|Overall Study||8
2766|NCT02453581|5629|P1|STARTED|Overall Study||8
2767|NCT02452944|5651|P2|NOT COMPLETED|Overall Study||0
2768|NCT02452944|5652|P1|NOT COMPLETED|Overall Study||0
2769|NCT02452944|5651|P2|COMPLETED|Overall Study||31
2770|NCT02452944|5652|P1|COMPLETED|Overall Study||31
2771|NCT02452944|5651|P2|STARTED|Overall Study||31
2772|NCT02452944|5652|P1|STARTED|Overall Study||31
2773|NCT02451150|5662|P2|NOT COMPLETED|Overall Study||0
2774|NCT02451150|5663|P1|NOT COMPLETED|Overall Study||0
2775|NCT02451150|5662|P2|COMPLETED|Overall Study||3
2776|NCT02451150|5663|P1|COMPLETED|Overall Study||3
2777|NCT02451150|5662|P2|STARTED|Overall Study||3
2778|NCT02451150|5663|P1|STARTED|Overall Study||3
2779|NCT02450799|5716|P3|NOT COMPLETED|Overall Study||0
2780|NCT02450799|5717|P2|NOT COMPLETED|Overall Study||0
2781|NCT02450799|5718|P1|NOT COMPLETED|Overall Study||0
2782|NCT02450799|5716|P3|COMPLETED|Overall Study||30
2783|NCT02450799|5717|P2|COMPLETED|Overall Study||37
2784|NCT02450799|5718|P1|COMPLETED|Overall Study||31
2785|NCT02450799|5716|P3|STARTED|Overall Study||30
2786|NCT02450799|5717|P2|STARTED|Overall Study||37
2787|NCT02450799|5718|P1|STARTED|Overall Study||31
2788|NCT02450747|5729|P1|NOT COMPLETED|Overall Study||0
2789|NCT02450747|5729|P1|COMPLETED|Overall Study||39
2790|NCT02450747|5729|P1|STARTED|Overall Study||39
2791|NCT02449902|5740|P2|NOT COMPLETED|Overall Study||2
2792|NCT02449902|5741|P1|NOT COMPLETED|Overall Study||0
2793|NCT02449902|5740|P2|COMPLETED|Overall Study||24
2794|NCT02449902|5741|P1|COMPLETED|Overall Study||24
2795|NCT02449902|5740|P2|STARTED|Overall Study||26
2796|NCT02449902|5741|P1|STARTED|Overall Study||24
2797|NCT02449044|5765|P1|NOT COMPLETED|Overall Study||64
2798|NCT02449044|5765|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
2799|NCT02449044|5765|P1|STARTED|Overall Study||111
2800|NCT02448914|5784|P2|NOT COMPLETED|Second Intervention (1 Day)||0
2801|NCT02448914|5785|P1|NOT COMPLETED|Second Intervention (1 Day)||0
2802|NCT02448914|5784|P2|COMPLETED|Second Intervention (1 Day)||5
2803|NCT02448914|5785|P1|COMPLETED|Second Intervention (1 Day)||6
2804|NCT02448914|5784|P2|STARTED|Second Intervention (1 Day)||5
2805|NCT02448914|5785|P1|STARTED|Second Intervention (1 Day)||6
2806|NCT02448914|5784|P2|NOT COMPLETED|First Intervention (1 Day)||0
2807|NCT02448914|5785|P1|NOT COMPLETED|First Intervention (1 Day)||0
2808|NCT02448914|5784|P2|COMPLETED|First Intervention (1 Day)||5
2809|NCT02448914|5785|P1|COMPLETED|First Intervention (1 Day)||6
2810|NCT02448914|5784|P2|STARTED|First Intervention (1 Day)||5
2811|NCT02448914|5785|P1|STARTED|First Intervention (1 Day)||6
2812|NCT02448862|5803|P2|NOT COMPLETED|Overall Study||0
2813|NCT02448862|5804|P1|NOT COMPLETED|Overall Study||0
2814|NCT02448862|5803|P2|COMPLETED|Overall Study||6050
2815|NCT02448862|5804|P1|COMPLETED|Overall Study||4525
2816|NCT02448862|5803|P2|STARTED|Overall Study||6050
2817|NCT02448862|5804|P1|STARTED|Overall Study||4525
2818|NCT02447458|5824|P6|NOT COMPLETED|Overall Study||0
2819|NCT02447458|5825|P5|NOT COMPLETED|Overall Study||0
2820|NCT02447458|5826|P4|NOT COMPLETED|Overall Study||0
2821|NCT02447458|5827|P3|NOT COMPLETED|Overall Study||1
2822|NCT02447458|5828|P2|NOT COMPLETED|Overall Study||0
2823|NCT02447458|5829|P1|NOT COMPLETED|Overall Study||0
2824|NCT02447458|5824|P6|COMPLETED|Overall Study||10
2825|NCT02447458|5825|P5|COMPLETED|Overall Study||6
2826|NCT02447458|5826|P4|COMPLETED|Overall Study||6
2827|NCT02447458|5827|P3|COMPLETED|Overall Study||5
2828|NCT02447458|5828|P2|COMPLETED|Overall Study||6
2829|NCT02447458|5829|P1|COMPLETED|Overall Study||5
2830|NCT02447458|5824|P6|STARTED|Overall Study||10
2831|NCT02447458|5825|P5|STARTED|Overall Study||6
2832|NCT02447458|5826|P4|STARTED|Overall Study||6
2833|NCT02447458|5827|P3|STARTED|Overall Study||6
2834|NCT02447458|5828|P2|STARTED|Overall Study||6
2835|NCT02447458|5829|P1|STARTED|Overall Study||5
2836|NCT02447133|5925|P1|NOT COMPLETED|Overall Study||0
2837|NCT02447133|5925|P1|COMPLETED|Overall Study||12
2838|NCT02447133|5925|P1|STARTED|Overall Study||12
2839|NCT02446990|5933|P2|NOT COMPLETED|Overall Study||658
2840|NCT02446990|5934|P1|NOT COMPLETED|Overall Study||720
2841|NCT02446990|5933|P2|COMPLETED|Overall Study||8894
2842|NCT02446990|5934|P1|COMPLETED|Overall Study||8830
2843|NCT02446990|5933|P2|STARTED|Overall Study||9552
2844|NCT02446990|5934|P1|STARTED|Overall Study||9550
2845|NCT02446171|5970|P4|NOT COMPLETED|Overall Study||0
2846|NCT02446171|5971|P3|NOT COMPLETED|Overall Study||2
2847|NCT02446171|5972|P2|NOT COMPLETED|Overall Study||0
2848|NCT02446171|5973|P1|NOT COMPLETED|Overall Study||0
2849|NCT02446171|5970|P4|COMPLETED|Overall Study||11
2850|NCT02446171|5971|P3|COMPLETED|Overall Study||9
2851|NCT02446171|5972|P2|COMPLETED|Overall Study||11
2852|NCT02446171|5973|P1|COMPLETED|Overall Study||11
2853|NCT02446171|5970|P4|STARTED|Overall Study||11
2854|NCT02446171|5971|P3|STARTED|Overall Study||11
2855|NCT02446171|5972|P2|STARTED|Overall Study||11
2856|NCT02446171|5973|P1|STARTED|Overall Study||11
2857|NCT02445755|6042|P1|NOT COMPLETED|Overall Study||13
2858|NCT02445755|6042|P1|COMPLETED|Overall Study||100
2859|NCT02445755|6042|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
2860|NCT02445573|6051|P2|NOT COMPLETED|Overall Study||2
2861|NCT02445573|6052|P1|NOT COMPLETED|Overall Study||1
2862|NCT02445573|6051|P2|COMPLETED|Overall Study||38
2863|NCT02445573|6052|P1|COMPLETED|Overall Study||39
2864|NCT02445573|6051|P2|STARTED|Overall Study||40
2865|NCT02445573|6052|P1|STARTED|Overall Study||40
2866|NCT02445287|6068|P2|NOT COMPLETED|Overall Study||0
2867|NCT02445287|6069|P1|NOT COMPLETED|Overall Study||0
2868|NCT02445287|6068|P2|COMPLETED|Overall Study||13
2869|NCT02445287|6069|P1|COMPLETED|Overall Study||35
2870|NCT02445287|6068|P2|STARTED|Overall Study||13
2871|NCT02445287|6069|P1|STARTED|Overall Study||35
2872|NCT02444715|6084|P2|NOT COMPLETED|Overall Study||16
2873|NCT02444715|6085|P1|NOT COMPLETED|Overall Study||10
2874|NCT02444715|6084|P2|COMPLETED|Overall Study||32
2875|NCT02444715|6085|P1|COMPLETED|Overall Study||36
2876|NCT02444715|6084|P2|STARTED|Overall Study||48
2877|NCT02444715|6085|P1|STARTED|Overall Study||46
2878|NCT02444182|6116|P2|NOT COMPLETED|Overall Study||5
2879|NCT02444182|6117|P1|NOT COMPLETED|Overall Study||2
2880|NCT02444182|6116|P2|COMPLETED|Overall Study||49
2881|NCT02444182|6117|P1|COMPLETED|Overall Study||52
2882|NCT02444182|6116|P2|STARTED|Overall Study||54
2883|NCT02444182|6117|P1|STARTED|Overall Study||54
2884|NCT02443792|6127|P2|NOT COMPLETED|Overall Study||2
2885|NCT02443792|6128|P1|NOT COMPLETED|Overall Study||7
2886|NCT02443792|6127|P2|COMPLETED|Overall Study||23
2887|NCT02443792|6128|P1|COMPLETED|Overall Study||43
2888|NCT02443792|6127|P2|STARTED|Overall Study||25
2889|NCT02443792|6128|P1|STARTED|Overall Study||50
2890|NCT02442700|6144|P2|NOT COMPLETED|Later 12 Weeks||0
2891|NCT02442700|6145|P1|NOT COMPLETED|Later 12 Weeks||0
2892|NCT02442700|6144|P2|COMPLETED|Later 12 Weeks||12
2893|NCT02442700|6145|P1|COMPLETED|Later 12 Weeks||12
2894|NCT02442700|6144|P2|STARTED|Later 12 Weeks||12
2895|NCT02442700|6145|P1|STARTED|Later 12 Weeks||12
2896|NCT02442700|6144|P2|NOT COMPLETED|First 12 Weeks||0
2897|NCT02442700|6145|P1|NOT COMPLETED|First 12 Weeks||0
2898|NCT02442700|6144|P2|COMPLETED|First 12 Weeks||12
2899|NCT02442700|6145|P1|COMPLETED|First 12 Weeks||12
2900|NCT02442700|6144|P2|STARTED|First 12 Weeks||12
2901|NCT02442700|6145|P1|STARTED|First 12 Weeks||12
2902|NCT02442310|6153|P1|NOT COMPLETED|Overall Study||3
2903|NCT02442310|6153|P1|COMPLETED|Overall Study||17
2904|NCT02442310|6153|P1|STARTED|Overall Study||20
2905|NCT02441218|6177|P2|NOT COMPLETED|Overall Study||612
2906|NCT02441218|6178|P1|NOT COMPLETED|Overall Study||578
2907|NCT02441218|6177|P2|COMPLETED|Overall Study||2652
2908|NCT02441218|6178|P1|COMPLETED|Overall Study||2663
2909|NCT02441218|6177|P2|STARTED|Overall Study||3264
2910|NCT02441218|6178|P1|STARTED|Overall Study||3241
2911|NCT02441179|6204|P2|NOT COMPLETED|Overall Study||1
2912|NCT02441179|6205|P1|NOT COMPLETED|Overall Study||1
2913|NCT02441179|6204|P2|COMPLETED|Overall Study||16
2914|NCT02441179|6205|P1|COMPLETED|Overall Study||17
2915|NCT02441179|6204|P2|STARTED|Overall Study||17
2916|NCT02441179|6205|P1|STARTED|Overall Study||18
2917|NCT02441114|6223|P1|NOT COMPLETED|Period3||0
2918|NCT02441114|6223|P1|COMPLETED|Period3||6
2919|NCT02441114|6223|P1|STARTED|Period3||6
2920|NCT02441114|6223|P1|NOT COMPLETED|Washout2||4
2921|NCT02441114|6223|P1|COMPLETED|Washout2||6
2922|NCT02441114|6223|P1|STARTED|Washout2||10
2923|NCT02441114|6223|P1|NOT COMPLETED|Period2||0
2924|NCT02441114|6223|P1|COMPLETED|Period2||10
2925|NCT02441114|6223|P1|STARTED|Period2||10
2926|NCT02441114|6223|P1|NOT COMPLETED|Washout1||0
2927|NCT02441114|6223|P1|COMPLETED|Washout1||10
2928|NCT02441114|6223|P1|STARTED|Washout1||10
2929|NCT02441114|6223|P1|NOT COMPLETED|Period1||0
2930|NCT02441114|6223|P1|COMPLETED|Period1||10
2931|NCT02441114|6223|P1|STARTED|Period1||10
2932|NCT02440659|6231|P2|NOT COMPLETED|Overall Study||335
2933|NCT02440659|6232|P1|NOT COMPLETED|Overall Study||651
2934|NCT02440659|6231|P2|COMPLETED|Overall Study||614
2935|NCT02440659|6232|P1|COMPLETED|Overall Study||1346
2936|NCT02440659|6231|P2|STARTED|Overall Study||949
2937|NCT02440659|6232|P1|STARTED|Overall Study||1997
2938|NCT02440633|6238|P1|NOT COMPLETED|Overall Study||0
2939|NCT02440633|6238|P1|COMPLETED|Overall Study||8
2940|NCT02440633|6238|P1|STARTED|Overall Study||8
2941|NCT02439879|6249|P2|NOT COMPLETED|Overall Study||0
2942|NCT02439879|6250|P1|NOT COMPLETED|Overall Study||0
2943|NCT02439879|6249|P2|COMPLETED|Overall Study||17
2944|NCT02439879|6250|P1|COMPLETED|Overall Study||16
2945|NCT02439879|6249|P2|STARTED|Overall Study||17
2946|NCT02439879|6250|P1|STARTED|Overall Study||16
2947|NCT02439138|6256|P1|NOT COMPLETED|Overall Study||3
2948|NCT02439138|6256|P1|COMPLETED|Overall Study||2
2949|NCT02439138|6256|P1|STARTED|Overall Study||5
2950|NCT02438540|6269|P2|NOT COMPLETED|Overall Study||0
2951|NCT02438540|6270|P1|NOT COMPLETED|Overall Study||0
2952|NCT02438540|6269|P2|COMPLETED|Overall Study||20
2953|NCT02438540|6270|P1|COMPLETED|Overall Study||19
2954|NCT02438540|6269|P2|STARTED|Overall Study||20
2955|NCT02438540|6270|P1|STARTED|Overall Study||19
2956|NCT02437409|6310|P1|NOT COMPLETED|Overall Study||15
2957|NCT02437409|6310|P1|COMPLETED|Overall Study||100
2958|NCT02437409|6310|P1|STARTED|Overall Study|100 evaluable patients, attrition rate of 15%|115
2959|NCT02437305|6323|P2|NOT COMPLETED|Overall Study||12
2960|NCT02437305|6324|P1|NOT COMPLETED|Overall Study||18
2961|NCT02437305|6323|P2|COMPLETED|Overall Study||38
2962|NCT02437305|6324|P1|COMPLETED|Overall Study||32
2963|NCT02437305|6323|P2|STARTED|Overall Study||50
2964|NCT02437305|6324|P1|STARTED|Overall Study||50
2965|NCT02436811|6335|P3|NOT COMPLETED|Overall Study||7
2966|NCT02436811|6336|P2|NOT COMPLETED|Overall Study||9
2967|NCT02436811|6337|P1|NOT COMPLETED|Overall Study||2
2968|NCT02436811|6335|P3|COMPLETED|Overall Study||53
2969|NCT02436811|6336|P2|COMPLETED|Overall Study||51
2970|NCT02436811|6337|P1|COMPLETED|Overall Study||58
2971|NCT02436811|6335|P3|STARTED|Overall Study||60
2972|NCT02436811|6336|P2|STARTED|Overall Study||60
2973|NCT02436811|6337|P1|STARTED|Overall Study||60
2974|NCT02436577|6351|P6|NOT COMPLETED|Overall Study||0
2975|NCT02436577|6352|P5|NOT COMPLETED|Overall Study||0
2976|NCT02436577|6353|P4|NOT COMPLETED|Overall Study||0
2977|NCT02436577|6354|P3|NOT COMPLETED|Overall Study||0
2978|NCT02436577|6355|P2|NOT COMPLETED|Overall Study||1
2979|NCT02436577|6356|P1|NOT COMPLETED|Overall Study||0
2980|NCT02436577|6351|P6|COMPLETED|Overall Study||7
2981|NCT02436577|6352|P5|COMPLETED|Overall Study||7
2982|NCT02436577|6353|P4|COMPLETED|Overall Study||7
2983|NCT02436577|6354|P3|COMPLETED|Overall Study||7
2984|NCT02436577|6355|P2|COMPLETED|Overall Study||6
2985|NCT02436577|6356|P1|COMPLETED|Overall Study||7
2986|NCT02436577|6351|P6|STARTED|Overall Study||7
2987|NCT02436577|6352|P5|STARTED|Overall Study||7
2988|NCT02436577|6353|P4|STARTED|Overall Study||7
2989|NCT02436577|6354|P3|STARTED|Overall Study||7
2990|NCT02436577|6355|P2|STARTED|Overall Study||7
2991|NCT02436577|6356|P1|STARTED|Overall Study||7
2992|NCT02436330|6411|P2|NOT COMPLETED|Cohort 6||1
2993|NCT02436330|6412|P1|NOT COMPLETED|Cohort 6||3
2994|NCT02436330|6411|P2|COMPLETED|Cohort 6||4
2995|NCT02436330|6412|P1|COMPLETED|Cohort 6||1
2996|NCT02436330|6411|P2|STARTED|Cohort 6||5
2997|NCT02436330|6412|P1|STARTED|Cohort 6||4
2998|NCT02436330|6411|P2|NOT COMPLETED|Cohort 5||4
2999|NCT02436330|6412|P1|NOT COMPLETED|Cohort 5||6
3000|NCT02436330|6411|P2|COMPLETED|Cohort 5||1
3001|NCT02436330|6412|P1|COMPLETED|Cohort 5||4
3002|NCT02436330|6411|P2|STARTED|Cohort 5||5
3003|NCT02436330|6412|P1|STARTED|Cohort 5||10
3004|NCT02436330|6411|P2|NOT COMPLETED|Cohort 4||0
3005|NCT02436330|6412|P1|NOT COMPLETED|Cohort 4||2
3006|NCT02436330|6411|P2|COMPLETED|Cohort 4||0
3007|NCT02436330|6412|P1|COMPLETED|Cohort 4||4
3008|NCT02436330|6411|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
3009|NCT02436330|6412|P1|STARTED|Cohort 4||6
3010|NCT02436330|6411|P2|NOT COMPLETED|Cohort 3||0
3011|NCT02436330|6412|P1|NOT COMPLETED|Cohort 3||5
3012|NCT02436330|6411|P2|COMPLETED|Cohort 3||0
3013|NCT02436330|6412|P1|COMPLETED|Cohort 3||7
3014|NCT02436330|6411|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
3015|NCT02436330|6412|P1|STARTED|Cohort 3||12
3016|NCT02436330|6411|P2|NOT COMPLETED|Cohort 2||3
3017|NCT02436330|6412|P1|NOT COMPLETED|Cohort 2||4
3018|NCT02436330|6411|P2|COMPLETED|Cohort 2||7
3019|NCT02436330|6412|P1|COMPLETED|Cohort 2||10
3020|NCT02436330|6411|P2|STARTED|Cohort 2||10
3021|NCT02436330|6412|P1|STARTED|Cohort 2||14
3022|NCT02436330|6411|P2|NOT COMPLETED|Cohort 1||3
3023|NCT02436330|6412|P1|NOT COMPLETED|Cohort 1||5
3024|NCT02436330|6411|P2|COMPLETED|Cohort 1||1
3025|NCT02436330|6412|P1|COMPLETED|Cohort 1||9
3026|NCT02436330|6411|P2|STARTED|Cohort 1||4
3027|NCT02436330|6412|P1|STARTED|Cohort 1||14
3028|NCT02435966|6457|P3|NOT COMPLETED|Overall Study||0
3029|NCT02435966|6458|P2|NOT COMPLETED|Overall Study||1
3030|NCT02435966|6459|P1|NOT COMPLETED|Overall Study||0
3031|NCT02435966|6457|P3|COMPLETED|Overall Study||30
3032|NCT02435966|6458|P2|COMPLETED|Overall Study||53
3033|NCT02435966|6459|P1|COMPLETED|Overall Study||47
3034|NCT02435966|6457|P3|Follow-up|Overall Study||30
3035|NCT02435966|6458|P2|Follow-up|Overall Study||53
3036|NCT02435966|6459|P1|Follow-up|Overall Study||47
3037|NCT02435966|6457|P3|Second Intervention|Overall Study||30
3038|NCT02435966|6458|P2|Second Intervention|Overall Study||53
3039|NCT02435966|6459|P1|Second Intervention|Overall Study||47
3040|NCT02435966|6457|P3|First Intervention|Overall Study||30
3041|NCT02435966|6458|P2|First Intervention|Overall Study||54
3042|NCT02435966|6459|P1|First Intervention|Overall Study||47
3043|NCT02435966|6457|P3|STARTED|Overall Study||30
3044|NCT02435966|6458|P2|STARTED|Overall Study||54
3045|NCT02435966|6459|P1|STARTED|Overall Study||47
3046|NCT02435836|6467|P1|NOT COMPLETED|Overall Study||631
3047|NCT02435836|6467|P1|COMPLETED|Overall Study||0
3048|NCT02435836|6467|P1|STARTED|Overall Study||631
3049|NCT02434939|6485|P2|NOT COMPLETED|Overall Study||49
3050|NCT02434939|6486|P1|NOT COMPLETED|Overall Study||37
3051|NCT02434939|6485|P2|COMPLETED|Overall Study||71
3052|NCT02434939|6486|P1|COMPLETED|Overall Study||83
3053|NCT02434939|6485|P2|STARTED|Overall Study||120
3054|NCT02434939|6486|P1|STARTED|Overall Study||120
3055|NCT02434523|6500|P2|NOT COMPLETED|Overall Study||6
3056|NCT02434523|6501|P1|NOT COMPLETED|Overall Study||5
3057|NCT02434523|6500|P2|COMPLETED|Overall Study||9
3058|NCT02434523|6501|P1|COMPLETED|Overall Study||10
3059|NCT02434523|6500|P2|STARTED|Overall Study||15
3060|NCT02434523|6501|P1|STARTED|Overall Study||15
3061|NCT02433366|6515|P2|NOT COMPLETED|Overall Study||0
3062|NCT02433366|6516|P1|NOT COMPLETED|Overall Study||0
3063|NCT02433366|6515|P2|COMPLETED|Overall Study||802
3064|NCT02433366|6516|P1|COMPLETED|Overall Study||411
3065|NCT02433366|6515|P2|STARTED|Overall Study||802
3066|NCT02433366|6516|P1|STARTED|Overall Study||411
3067|NCT02432040|6526|P2|NOT COMPLETED|Overall Study||6
3068|NCT02432040|6527|P1|NOT COMPLETED|Overall Study||8
3069|NCT02432040|6526|P2|COMPLETED|Overall Study||8
3070|NCT02432040|6527|P1|COMPLETED|Overall Study||6
3071|NCT02432040|6526|P2|STARTED|Overall Study||14
3072|NCT02432040|6527|P1|STARTED|Overall Study||14
3073|NCT02431741|6547|P1|NOT COMPLETED|Overall Study||0
3074|NCT02431741|6547|P1|COMPLETED|Overall Study||14
3075|NCT02431741|6547|P1|STARTED|Overall Study||14
3076|NCT02431455|6553|P2|NOT COMPLETED|Overall Study||0
3077|NCT02431455|6554|P1|NOT COMPLETED|Overall Study||0
3078|NCT02431455|6553|P2|COMPLETED|Overall Study||112
3079|NCT02431455|6554|P1|COMPLETED|Overall Study||112
3080|NCT02431455|6553|P2|STARTED|Overall Study||112
3081|NCT02431455|6554|P1|STARTED|Overall Study||112
3082|NCT02431299|6568|P2|NOT COMPLETED|Overall Study||1
3083|NCT02431299|6569|P1|NOT COMPLETED|Overall Study||53
3084|NCT02431299|6568|P2|COMPLETED|Overall Study||62
3085|NCT02431299|6569|P1|COMPLETED|Overall Study||183
3086|NCT02431299|6568|P2|STARTED|Overall Study||63
3087|NCT02431299|6569|P1|STARTED|Overall Study||236
3088|NCT02430870|6590|P8|NOT COMPLETED|Part 2||1
3089|NCT02430870|6591|P7|NOT COMPLETED|Part 2||1
3090|NCT02430870|6592|P6|NOT COMPLETED|Part 2||0
3091|NCT02430870|6593|P5|NOT COMPLETED|Part 2||0
3092|NCT02430870|6594|P4|NOT COMPLETED|Part 2||0
3093|NCT02430870|6595|P3|NOT COMPLETED|Part 2||0
3094|NCT02430870|6596|P2|NOT COMPLETED|Part 2||0
3095|NCT02430870|6597|P1|NOT COMPLETED|Part 2||0
3096|NCT02430870|6590|P8|COMPLETED|Part 2||7
3097|NCT02430870|6591|P7|COMPLETED|Part 2||5
3098|NCT02430870|6592|P6|COMPLETED|Part 2||6
3099|NCT02430870|6593|P5|COMPLETED|Part 2||6
3100|NCT02430870|6594|P4|COMPLETED|Part 2||6
3101|NCT02430870|6595|P3|COMPLETED|Part 2||0
3102|NCT02430870|6596|P2|COMPLETED|Part 2||0
3103|NCT02430870|6597|P1|COMPLETED|Part 2||0
3104|NCT02430870|6590|P8|STARTED|Part 2||8
3105|NCT02430870|6591|P7|STARTED|Part 2||6
3106|NCT02430870|6592|P6|STARTED|Part 2||6
3107|NCT02430870|6593|P5|STARTED|Part 2||6
3108|NCT02430870|6594|P4|STARTED|Part 2||6
3109|NCT02430870|6595|P3|STARTED|Part 2||0
3110|NCT02430870|6596|P2|STARTED|Part 2||0
3111|NCT02430870|6597|P1|STARTED|Part 2||0
3112|NCT02430870|6590|P8|NOT COMPLETED|Part 1||0
3113|NCT02430870|6591|P7|NOT COMPLETED|Part 1||0
3114|NCT02430870|6592|P6|NOT COMPLETED|Part 1||0
3115|NCT02430870|6593|P5|NOT COMPLETED|Part 1||0
3116|NCT02430870|6594|P4|NOT COMPLETED|Part 1||0
3117|NCT02430870|6595|P3|NOT COMPLETED|Part 1||0
3118|NCT02430870|6596|P2|NOT COMPLETED|Part 1||0
3119|NCT02430870|6597|P1|NOT COMPLETED|Part 1||0
3120|NCT02430870|6590|P8|COMPLETED|Part 1||0
3121|NCT02430870|6591|P7|COMPLETED|Part 1||0
3122|NCT02430870|6592|P6|COMPLETED|Part 1||0
3123|NCT02430870|6593|P5|COMPLETED|Part 1||0
3124|NCT02430870|6594|P4|COMPLETED|Part 1||0
3125|NCT02430870|6595|P3|COMPLETED|Part 1||4
3126|NCT02430870|6596|P2|COMPLETED|Part 1||6
3127|NCT02430870|6597|P1|COMPLETED|Part 1||6
3128|NCT02430870|6590|P8|STARTED|Part 1||0
3129|NCT02430870|6591|P7|STARTED|Part 1||0
3130|NCT02430870|6592|P6|STARTED|Part 1||0
3131|NCT02430870|6593|P5|STARTED|Part 1||0
3132|NCT02430870|6594|P4|STARTED|Part 1||0
3133|NCT02430870|6595|P3|STARTED|Part 1||4
3134|NCT02430870|6596|P2|STARTED|Part 1||6
3135|NCT02430870|6597|P1|STARTED|Part 1||6
3136|NCT02430389|6671|P2|NOT COMPLETED|Overall Study||0
3137|NCT02430389|6672|P1|NOT COMPLETED|Overall Study||0
3138|NCT02430389|6671|P2|COMPLETED|Overall Study||10
3139|NCT02430389|6672|P1|COMPLETED|Overall Study||10
3140|NCT02430389|6671|P2|STARTED|Overall Study||10
3141|NCT02430389|6672|P1|STARTED|Overall Study||10
3142|NCT02430090|6683|P3|NOT COMPLETED|Overall Study||0
3143|NCT02430090|6684|P2|NOT COMPLETED|Overall Study||0
3144|NCT02430090|6685|P1|NOT COMPLETED|Overall Study||0
3145|NCT02430090|6683|P3|COMPLETED|Overall Study||15
3146|NCT02430090|6684|P2|COMPLETED|Overall Study||15
3147|NCT02430090|6685|P1|COMPLETED|Overall Study||15
3148|NCT02430090|6683|P3|STARTED|Overall Study||15
3149|NCT02430090|6684|P2|STARTED|Overall Study||15
3150|NCT02430090|6685|P1|STARTED|Overall Study||15
3151|NCT02428413|6695|P2|NOT COMPLETED|Overall Study||9
3152|NCT02428413|6696|P1|NOT COMPLETED|Overall Study||8
3153|NCT02428413|6695|P2|COMPLETED|Overall Study||52
3154|NCT02428413|6696|P1|COMPLETED|Overall Study||56
3155|NCT02428413|6695|P2|STARTED|Overall Study||61
3156|NCT02428413|6696|P1|STARTED|Overall Study||64
3157|NCT02427984|6711|P3|NOT COMPLETED|Overall Study||18
3158|NCT02427984|6712|P2|NOT COMPLETED|Overall Study||5
3159|NCT02427984|6713|P1|NOT COMPLETED|Overall Study||13
3160|NCT02427984|6711|P3|COMPLETED|Overall Study||32
3161|NCT02427984|6712|P2|COMPLETED|Overall Study||40
3162|NCT02427984|6713|P1|COMPLETED|Overall Study||40
3163|NCT02427984|6711|P3|STARTED|Overall Study||50
3164|NCT02427984|6712|P2|STARTED|Overall Study||45
3165|NCT02427984|6713|P1|STARTED|Overall Study||53
3166|NCT02427750|6729|P2|NOT COMPLETED|Overall Study||0
3167|NCT02427750|6730|P1|NOT COMPLETED|Overall Study||0
3168|NCT02427750|6729|P2|COMPLETED|Overall Study||63
3169|NCT02427750|6730|P1|COMPLETED|Overall Study||63
3170|NCT02427750|6729|P2|STARTED|Overall Study||63
3171|NCT02427750|6730|P1|STARTED|Overall Study||63
3172|NCT02427477|6755|P2|NOT COMPLETED|Period 3||0
3173|NCT02427477|6756|P1|NOT COMPLETED|Period 3||0
3174|NCT02427477|6755|P2|COMPLETED|Period 3||60
3175|NCT02427477|6756|P1|COMPLETED|Period 3||59
3176|NCT02427477|6755|P2|STARTED|Period 3||60
3177|NCT02427477|6756|P1|STARTED|Period 3||59
3178|NCT02427477|6755|P2|NOT COMPLETED|Period 2||0
3179|NCT02427477|6756|P1|NOT COMPLETED|Period 2||0
3180|NCT02427477|6755|P2|COMPLETED|Period 2||60
3181|NCT02427477|6756|P1|COMPLETED|Period 2||59
3182|NCT02427477|6755|P2|STARTED|Period 2||60
3183|NCT02427477|6756|P1|STARTED|Period 2||59
3184|NCT02427477|6755|P2|NOT COMPLETED|Period 1||0
3185|NCT02427477|6756|P1|NOT COMPLETED|Period 1||1
3186|NCT02427477|6755|P2|COMPLETED|Period 1||60
3187|NCT02427477|6756|P1|COMPLETED|Period 1||59
3188|NCT02427477|6755|P2|STARTED|Period 1||60
3189|NCT02427477|6756|P1|STARTED|Period 1||60
3190|NCT02424565|6764|P2|NOT COMPLETED|Period 2 (D3)||0
3191|NCT02424565|6765|P1|NOT COMPLETED|Period 2 (D3)||0
3192|NCT02424565|6764|P2|COMPLETED|Period 2 (D3)||6
3193|NCT02424565|6765|P1|COMPLETED|Period 2 (D3)||8
3194|NCT02424565|6764|P2|STARTED|Period 2 (D3)||6
3195|NCT02424565|6765|P1|STARTED|Period 2 (D3)||8
3196|NCT02424565|6764|P2|NOT COMPLETED|Washout Period||0
3197|NCT02424565|6765|P1|NOT COMPLETED|Washout Period||0
3198|NCT02424565|6764|P2|COMPLETED|Washout Period||6
3199|NCT02424565|6765|P1|COMPLETED|Washout Period||8
3200|NCT02424565|6764|P2|STARTED|Washout Period||6
3201|NCT02424565|6765|P1|STARTED|Washout Period||8
3202|NCT02424565|6764|P2|NOT COMPLETED|Period 1 (D0)||1
3203|NCT02424565|6765|P1|NOT COMPLETED|Period 1 (D0)||0
3204|NCT02424565|6764|P2|COMPLETED|Period 1 (D0)||6
3205|NCT02424565|6765|P1|COMPLETED|Period 1 (D0)||8
3206|NCT02424565|6764|P2|STARTED|Period 1 (D0)||7
3207|NCT02424565|6765|P1|STARTED|Period 1 (D0)||8
3208|NCT02424149|6773|P2|NOT COMPLETED|Overall Study||1
3209|NCT02424149|6774|P1|NOT COMPLETED|Overall Study||2
3210|NCT02424149|6773|P2|COMPLETED|Overall Study||52
3211|NCT02424149|6774|P1|COMPLETED|Overall Study||52
3212|NCT02424149|6773|P2|STARTED|Overall Study||53
3213|NCT02424149|6774|P1|STARTED|Overall Study||54
3214|NCT02423993|6792|P4|NOT COMPLETED|Overall Study||0
3215|NCT02423993|6793|P3|NOT COMPLETED|Overall Study||0
3216|NCT02423993|6794|P2|NOT COMPLETED|Overall Study||0
3217|NCT02423993|6795|P1|NOT COMPLETED|Overall Study||0
3218|NCT02423993|6792|P4|COMPLETED|Overall Study||19
3219|NCT02423993|6793|P3|COMPLETED|Overall Study||23
3220|NCT02423993|6794|P2|COMPLETED|Overall Study||16
3221|NCT02423993|6795|P1|COMPLETED|Overall Study||19
3222|NCT02423993|6792|P4|STARTED|Overall Study||19
3223|NCT02423993|6793|P3|STARTED|Overall Study||23
3224|NCT02423993|6794|P2|STARTED|Overall Study||16
3225|NCT02423993|6795|P1|STARTED|Overall Study||19
3226|NCT02423447|6825|P2|NOT COMPLETED|Overall Study||0
3227|NCT02423447|6826|P1|NOT COMPLETED|Overall Study||0
3228|NCT02423447|6825|P2|COMPLETED|Overall Study||12
3229|NCT02423447|6826|P1|COMPLETED|Overall Study||13
3230|NCT02423447|6825|P2|STARTED|Overall Study||12
3231|NCT02423447|6826|P1|STARTED|Overall Study||13
3232|NCT02423408|6842|P2|NOT COMPLETED|Overall Study||2
3233|NCT02423408|6843|P1|NOT COMPLETED|Overall Study||1
3234|NCT02423408|6842|P2|COMPLETED|Overall Study||80
3235|NCT02423408|6843|P1|COMPLETED|Overall Study||82
3236|NCT02423408|6842|P2|STARTED|Overall Study||82
3237|NCT02423408|6843|P1|STARTED|Overall Study||83
3238|NCT02423317|6857|P2|NOT COMPLETED|Overall Study||0
3239|NCT02423317|6858|P1|NOT COMPLETED|Overall Study||0
3240|NCT02423317|6857|P2|COMPLETED|Overall Study||30
3241|NCT02423317|6858|P1|COMPLETED|Overall Study||30
3242|NCT02423317|6857|P2|STARTED|Overall Study||30
3243|NCT02423317|6858|P1|STARTED|Overall Study||30
3244|NCT02421211|6878|P2|NOT COMPLETED|Overall Study||0
3245|NCT02421211|6879|P1|NOT COMPLETED|Overall Study||0
3246|NCT02421211|6878|P2|COMPLETED|Overall Study||20
3247|NCT02421211|6879|P1|COMPLETED|Overall Study||20
3248|NCT02421211|6878|P2|STARTED|Overall Study||20
3249|NCT02421211|6879|P1|STARTED|Overall Study||20
3250|NCT02420093|6925|P2|NOT COMPLETED|Overall Study||1
3251|NCT02420093|6926|P1|NOT COMPLETED|Overall Study||1
3252|NCT02420093|6925|P2|COMPLETED|Overall Study||7
3253|NCT02420093|6926|P1|COMPLETED|Overall Study||8
3254|NCT02420093|6925|P2|STARTED|Overall Study||8
3255|NCT02420093|6926|P1|STARTED|Overall Study||9
3256|NCT02420041|6942|P2|NOT COMPLETED|Overall Study||0
3257|NCT02420041|6943|P1|NOT COMPLETED|Overall Study||0
3258|NCT02420041|6942|P2|COMPLETED|Overall Study||14
3259|NCT02420041|6943|P1|COMPLETED|Overall Study||14
3260|NCT02420041|6942|P2|STARTED|Overall Study||14
3261|NCT02420041|6943|P1|STARTED|Overall Study||14
3262|NCT02419313|6967|P2|NOT COMPLETED|Second Intervention||0
3263|NCT02419313|6968|P1|NOT COMPLETED|Second Intervention||1
3264|NCT02419313|6967|P2|COMPLETED|Second Intervention||15
3265|NCT02419313|6968|P1|COMPLETED|Second Intervention||15
3266|NCT02419313|6967|P2|STARTED|Second Intervention||15
3267|NCT02419313|6968|P1|STARTED|Second Intervention||16
3268|NCT02419313|6967|P2|NOT COMPLETED|First Intervention||0
3269|NCT02419313|6968|P1|NOT COMPLETED|First Intervention||2
3270|NCT02419313|6967|P2|COMPLETED|First Intervention||15
3271|NCT02419313|6968|P1|COMPLETED|First Intervention||16
3272|NCT02419313|6967|P2|STARTED|First Intervention||15
3273|NCT02419313|6968|P1|STARTED|First Intervention||18
3274|NCT02419001|6980|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
3275|NCT02419001|6981|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
3276|NCT02419001|6980|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
3277|NCT02419001|6981|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
3278|NCT02419001|6980|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
3279|NCT02419001|6981|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
3280|NCT02419001|6980|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
3281|NCT02419001|6981|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
3282|NCT02419001|6980|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
3283|NCT02419001|6981|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
3284|NCT02419001|6980|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
3285|NCT02419001|6981|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
3286|NCT02418676|6994|P3|NOT COMPLETED|Overall Study||0
3287|NCT02418676|6995|P2|NOT COMPLETED|Overall Study||0
3288|NCT02418676|6996|P1|NOT COMPLETED|Overall Study||0
3289|NCT02418676|6994|P3|COMPLETED|Overall Study||5
3290|NCT02418676|6995|P2|COMPLETED|Overall Study||5
3291|NCT02418676|6996|P1|COMPLETED|Overall Study||5
3292|NCT02418676|6994|P3|STARTED|Overall Study||5
3293|NCT02418676|6995|P2|STARTED|Overall Study||5
3294|NCT02418676|6996|P1|STARTED|Overall Study||5
3295|NCT02418234|7007|P1|NOT COMPLETED|Overall Study||0
3296|NCT02418234|7007|P1|COMPLETED|Overall Study||314
3297|NCT02418234|7007|P1|STARTED|Overall Study||314
3298|NCT02417532|7018|P1|NOT COMPLETED|Overall Study||4
3299|NCT02417532|7018|P1|COMPLETED|Overall Study||52
3300|NCT02417532|7018|P1|STARTED|Overall Study||56
3301|NCT02417129|7029|P2|NOT COMPLETED|Overall Study||0
3302|NCT02417129|7030|P1|NOT COMPLETED|Overall Study||0
3303|NCT02417129|7029|P2|COMPLETED|Overall Study||0
3304|NCT02417129|7030|P1|COMPLETED|Overall Study||2
3305|NCT02417129|7029|P2|STARTED|Overall Study||0
3306|NCT02417129|7030|P1|STARTED|Overall Study||2
3307|NCT02416973|7043|P3|NOT COMPLETED|Overall Study||1
3308|NCT02416973|7044|P2|NOT COMPLETED|Overall Study||3
3309|NCT02416973|7045|P1|NOT COMPLETED|Overall Study||1
3310|NCT02416973|7043|P3|COMPLETED|Overall Study||13
3311|NCT02416973|7044|P2|COMPLETED|Overall Study||10
3312|NCT02416973|7045|P1|COMPLETED|Overall Study||13
3313|NCT02416973|7043|P3|STARTED|Overall Study||14
3314|NCT02416973|7044|P2|STARTED|Overall Study||13
3315|NCT02416973|7045|P1|STARTED|Overall Study||14
3316|NCT02416180|7053|P1|NOT COMPLETED|Overall Study||1
3317|NCT02416180|7053|P1|COMPLETED|Overall Study||110
3318|NCT02416180|7053|P1|STARTED|Overall Study||111
3319|NCT02415959|7065|P5|NOT COMPLETED|Overall Study||0
3320|NCT02415959|7066|P4|NOT COMPLETED|Overall Study||1
3321|NCT02415959|7067|P3|NOT COMPLETED|Overall Study||0
3322|NCT02415959|7068|P2|NOT COMPLETED|Overall Study||1
3323|NCT02415959|7069|P1|NOT COMPLETED|Overall Study||0
3324|NCT02415959|7065|P5|COMPLETED|Overall Study||14
3325|NCT02415959|7066|P4|COMPLETED|Overall Study||13
3326|NCT02415959|7067|P3|COMPLETED|Overall Study||14
3327|NCT02415959|7068|P2|COMPLETED|Overall Study||13
3328|NCT02415959|7069|P1|COMPLETED|Overall Study||14
3329|NCT02415959|7065|P5|STARTED|Overall Study||14
3330|NCT02415959|7066|P4|STARTED|Overall Study||14
3331|NCT02415959|7067|P3|STARTED|Overall Study||14
3332|NCT02415959|7068|P2|STARTED|Overall Study||14
3333|NCT02415959|7069|P1|STARTED|Overall Study||14
3334|NCT02415439|7114|P13|NOT COMPLETED|Overall Study||0
3335|NCT02415439|7115|P12|NOT COMPLETED|Overall Study||0
3336|NCT02415439|7116|P11|NOT COMPLETED|Overall Study||0
3337|NCT02415439|7117|P10|NOT COMPLETED|Overall Study||0
3338|NCT02415439|7118|P9|NOT COMPLETED|Overall Study||1
3339|NCT02415439|7119|P8|NOT COMPLETED|Overall Study||0
3340|NCT02415439|7120|P7|NOT COMPLETED|Overall Study||0
3341|NCT02415439|7121|P6|NOT COMPLETED|Overall Study||0
3342|NCT02415439|7122|P5|NOT COMPLETED|Overall Study||0
3343|NCT02415439|7123|P4|NOT COMPLETED|Overall Study||0
3344|NCT02415439|7124|P3|NOT COMPLETED|Overall Study||0
3345|NCT02415439|7125|P2|NOT COMPLETED|Overall Study||0
3346|NCT02415439|7126|P1|NOT COMPLETED|Overall Study||0
3347|NCT02415439|7114|P13|COMPLETED|Overall Study||8
3348|NCT02415439|7115|P12|COMPLETED|Overall Study||6
3349|NCT02415439|7116|P11|COMPLETED|Overall Study||6
3350|NCT02415439|7117|P10|COMPLETED|Overall Study||6
3351|NCT02415439|7118|P9|COMPLETED|Overall Study||5
3352|NCT02415439|7119|P8|COMPLETED|Overall Study||12
3353|NCT02415439|7120|P7|COMPLETED|Overall Study||6
3354|NCT02415439|7121|P6|COMPLETED|Overall Study||6
3355|NCT02415439|7122|P5|COMPLETED|Overall Study||6
3356|NCT02415439|7123|P4|COMPLETED|Overall Study||6
3357|NCT02415439|7124|P3|COMPLETED|Overall Study||6
3358|NCT02415439|7125|P2|COMPLETED|Overall Study||6
3359|NCT02415439|7126|P1|COMPLETED|Overall Study||6
3360|NCT02415439|7114|P13|STARTED|Overall Study||8
3361|NCT02415439|7115|P12|STARTED|Overall Study||6
3362|NCT02415439|7116|P11|STARTED|Overall Study||6
3363|NCT02415439|7117|P10|STARTED|Overall Study||6
3364|NCT02415439|7118|P9|STARTED|Overall Study||6
3365|NCT02415439|7119|P8|STARTED|Overall Study||12
3366|NCT02415439|7120|P7|STARTED|Overall Study||6
3367|NCT02415439|7121|P6|STARTED|Overall Study||6
3368|NCT02415439|7122|P5|STARTED|Overall Study||6
3369|NCT02415439|7123|P4|STARTED|Overall Study||6
3370|NCT02415439|7124|P3|STARTED|Overall Study||6
3371|NCT02415439|7125|P2|STARTED|Overall Study||6
3372|NCT02415439|7126|P1|STARTED|Overall Study||6
3373|NCT02414828|7184|P4|NOT COMPLETED|Overall Study||2
3374|NCT02414828|7185|P3|NOT COMPLETED|Overall Study||1
3375|NCT02414828|7186|P2|NOT COMPLETED|Overall Study||1
3376|NCT02414828|7187|P1|NOT COMPLETED|Overall Study||0
3377|NCT02414828|7184|P4|COMPLETED|Overall Study||29
3378|NCT02414828|7185|P3|COMPLETED|Overall Study||19
3379|NCT02414828|7186|P2|COMPLETED|Overall Study||9
3380|NCT02414828|7187|P1|COMPLETED|Overall Study||11
3381|NCT02414828|7184|P4|STARTED|Overall Study||31
3382|NCT02414828|7185|P3|STARTED|Overall Study||20
3383|NCT02414828|7186|P2|STARTED|Overall Study||10
3384|NCT02414828|7187|P1|STARTED|Overall Study||11
3385|NCT02414152|7225|P1|NOT COMPLETED|Overall Study||2
3386|NCT02414152|7225|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
3387|NCT02414152|7225|P1|STARTED|Overall Study||2
3388|NCT02413593|7229|P1|NOT COMPLETED|Overall Study||4
3389|NCT02413593|7229|P1|COMPLETED|Overall Study||107
3390|NCT02413593|7229|P1|STARTED|Overall Study||111
3391|NCT02413333|7242|P2|NOT COMPLETED|Period 2||0
3392|NCT02413333|7243|P1|NOT COMPLETED|Period 2||1
3393|NCT02413333|7242|P2|COMPLETED|Period 2||65
3394|NCT02413333|7243|P1|COMPLETED|Period 2||64
3395|NCT02413333|7242|P2|STARTED|Period 2||65
3396|NCT02413333|7243|P1|STARTED|Period 2||65
3397|NCT02413333|7242|P2|NOT COMPLETED|Period 1||1
3398|NCT02413333|7243|P1|NOT COMPLETED|Period 1||1
3399|NCT02413333|7242|P2|COMPLETED|Period 1||65
3400|NCT02413333|7243|P1|COMPLETED|Period 1||65
3401|NCT02413333|7242|P2|Randomized and Treated|Period 1||66
3402|NCT02413333|7243|P1|Randomized and Treated|Period 1||66
3403|NCT02413333|7242|P2|STARTED|Period 1||66
3404|NCT02413333|7243|P1|STARTED|Period 1||66
3405|NCT02413034|7253|P2|NOT COMPLETED|Overall Study||0
3406|NCT02413034|7254|P1|NOT COMPLETED|Overall Study||0
3407|NCT02413034|7253|P2|COMPLETED|Overall Study||14
3408|NCT02413034|7254|P1|COMPLETED|Overall Study||14
3409|NCT02413034|7253|P2|STARTED|Overall Study||14
3410|NCT02413034|7254|P1|STARTED|Overall Study||14
3411|NCT02412657|7265|P3|NOT COMPLETED|Overall Study||3
3412|NCT02412657|7266|P2|NOT COMPLETED|Overall Study||2
3413|NCT02412657|7267|P1|NOT COMPLETED|Overall Study||1
3414|NCT02412657|7265|P3|COMPLETED|Overall Study||22
3415|NCT02412657|7266|P2|COMPLETED|Overall Study||23
3416|NCT02412657|7267|P1|COMPLETED|Overall Study||24
3417|NCT02412657|7265|P3|STARTED|Overall Study||25
3418|NCT02412657|7266|P2|STARTED|Overall Study||25
3419|NCT02412657|7267|P1|STARTED|Overall Study||25
3420|NCT02411929|7275|P1|NOT COMPLETED|Period 2||0
3421|NCT02411929|7275|P1|COMPLETED|Period 2||8
3422|NCT02411929|7275|P1|STARTED|Period 2||8
3423|NCT02411929|7275|P1|NOT COMPLETED|Washout Period||0
3424|NCT02411929|7275|P1|COMPLETED|Washout Period||8
3425|NCT02411929|7275|P1|STARTED|Washout Period||8
3426|NCT02411929|7275|P1|NOT COMPLETED|Period 1||0
3427|NCT02411929|7275|P1|COMPLETED|Period 1||8
3428|NCT02411929|7275|P1|STARTED|Period 1||8
3429|NCT02411747|7307|P2|NOT COMPLETED|Overall Study||4
3430|NCT02411747|7308|P1|NOT COMPLETED|Overall Study||3
3431|NCT02411747|7307|P2|COMPLETED|Overall Study||12
3432|NCT02411747|7308|P1|COMPLETED|Overall Study||13
3433|NCT02411747|7307|P2|Simulation Training Completed|Overall Study||16
3434|NCT02411747|7308|P1|Simulation Training Completed|Overall Study||16
3435|NCT02411747|7307|P2|STARTED|Overall Study||16
3436|NCT02411747|7308|P1|STARTED|Overall Study||16
3437|NCT02406937|7317|P3|NOT COMPLETED|Overall Study||2
3438|NCT02406937|7318|P2|NOT COMPLETED|Overall Study||1
3439|NCT02406937|7319|P1|NOT COMPLETED|Overall Study||1
3440|NCT02406937|7317|P3|COMPLETED|Overall Study||58
3441|NCT02406937|7318|P2|COMPLETED|Overall Study||59
3442|NCT02406937|7319|P1|COMPLETED|Overall Study||59
3443|NCT02406937|7317|P3|STARTED|Overall Study||60
3444|NCT02406937|7318|P2|STARTED|Overall Study||60
3445|NCT02406937|7319|P1|STARTED|Overall Study||60
3446|NCT02406586|7378|P3|NOT COMPLETED|Overall Study||2
3447|NCT02406586|7379|P2|NOT COMPLETED|Overall Study||4
3448|NCT02406586|7380|P1|NOT COMPLETED|Overall Study||1
3449|NCT02406586|7378|P3|COMPLETED|Overall Study||10
3450|NCT02406586|7379|P2|COMPLETED|Overall Study||8
3451|NCT02406586|7380|P1|COMPLETED|Overall Study||11
3452|NCT02406586|7378|P3|STARTED|Overall Study||12
3453|NCT02406586|7379|P2|STARTED|Overall Study||12
3454|NCT02406586|7380|P1|STARTED|Overall Study||12
3455|NCT02406495|7433|P1|NOT COMPLETED|Overall Study||0
3456|NCT02406495|7433|P1|COMPLETED|Overall Study||40
3457|NCT02406495|7433|P1|STARTED|Overall Study||40
3458|NCT02404649|7474|P2|NOT COMPLETED|Overall Study||2
3459|NCT02404649|7475|P1|NOT COMPLETED|Overall Study||1
3460|NCT02404649|7474|P2|COMPLETED|Overall Study||14
3461|NCT02404649|7475|P1|COMPLETED|Overall Study||16
3462|NCT02404649|7474|P2|STARTED|Overall Study||16
3463|NCT02404649|7475|P1|STARTED|Overall Study||17
3464|NCT02403180|7483|P2|NOT COMPLETED|Period 2 (5 Days)||1
3465|NCT02403180|7484|P1|NOT COMPLETED|Period 2 (5 Days)||0
3466|NCT02403180|7483|P2|COMPLETED|Period 2 (5 Days)||32
3467|NCT02403180|7484|P1|COMPLETED|Period 2 (5 Days)||36
3468|NCT02403180|7483|P2|STARTED|Period 2 (5 Days)||33
3469|NCT02403180|7484|P1|STARTED|Period 2 (5 Days)||36
3470|NCT02403180|7483|P2|NOT COMPLETED|Period 1 (5 Days)||0
3471|NCT02403180|7484|P1|NOT COMPLETED|Period 1 (5 Days)||0
3472|NCT02403180|7483|P2|COMPLETED|Period 1 (5 Days)||33
3473|NCT02403180|7484|P1|COMPLETED|Period 1 (5 Days)||36
3474|NCT02403180|7483|P2|Randomized|Period 1 (5 Days)||33
3475|NCT02403180|7484|P1|Randomized|Period 1 (5 Days)||36
3476|NCT02403180|7483|P2|STARTED|Period 1 (5 Days)||33
3477|NCT02403180|7484|P1|STARTED|Period 1 (5 Days)||36
3478|NCT02403180|7483|P2|NOT COMPLETED|Pre-Treatment Period||1
3479|NCT02403180|7484|P1|NOT COMPLETED|Pre-Treatment Period||0
3480|NCT02403180|7483|P2|COMPLETED|Pre-Treatment Period||33
3481|NCT02403180|7484|P1|COMPLETED|Pre-Treatment Period||36
3482|NCT02403180|7483|P2|STARTED|Pre-Treatment Period||34
3483|NCT02403180|7484|P1|STARTED|Pre-Treatment Period||36
3484|NCT02402322|7495|P3|NOT COMPLETED|Follow-up||24
3485|NCT02402322|7496|P2|NOT COMPLETED|Follow-up||3
3486|NCT02402322|7497|P1|NOT COMPLETED|Follow-up||6
3487|NCT02402322|7495|P3|COMPLETED|Follow-up||0
3488|NCT02402322|7496|P2|COMPLETED|Follow-up||21
3489|NCT02402322|7497|P1|COMPLETED|Follow-up||18
3490|NCT02402322|7495|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
3491|NCT02402322|7496|P2|STARTED|Follow-up||24
3492|NCT02402322|7497|P1|STARTED|Follow-up||24
3493|NCT02402322|7495|P3|NOT COMPLETED|Pretreatment||1
3494|NCT02402322|7496|P2|NOT COMPLETED|Pretreatment||1
3495|NCT02402322|7497|P1|NOT COMPLETED|Pretreatment||3
3496|NCT02402322|7495|P3|COMPLETED|Pretreatment||24
3497|NCT02402322|7496|P2|COMPLETED|Pretreatment||24
3498|NCT02402322|7497|P1|COMPLETED|Pretreatment||24
3499|NCT02402322|7495|P3|Posttreatment Measures|Pretreatment||24
3500|NCT02402322|7496|P2|Posttreatment Measures|Pretreatment||24
3501|NCT02402322|7497|P1|Posttreatment Measures|Pretreatment||24
3502|NCT02402322|7495|P3|STARTED|Pretreatment||25
3503|NCT02402322|7496|P2|STARTED|Pretreatment||25
3504|NCT02402322|7497|P1|STARTED|Pretreatment||27
3505|NCT02402296|7531|P2|NOT COMPLETED|Overall Study||0
3506|NCT02402296|7532|P1|NOT COMPLETED|Overall Study||0
3507|NCT02402296|7531|P2|COMPLETED|Overall Study||15
3508|NCT02402296|7532|P1|COMPLETED|Overall Study||15
3509|NCT02402296|7531|P2|STARTED|Overall Study||15
3510|NCT02402296|7532|P1|STARTED|Overall Study||15
3511|NCT02402127|7550|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
3512|NCT02402127|7551|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
3513|NCT02402127|7552|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
3514|NCT02402127|7553|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
3515|NCT02402127|7554|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
3516|NCT02402127|7555|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
3517|NCT02402127|7550|P6|COMPLETED|Third Wear Period (1 Day)||4
3518|NCT02402127|7551|P5|COMPLETED|Third Wear Period (1 Day)||4
3519|NCT02402127|7552|P4|COMPLETED|Third Wear Period (1 Day)||4
3520|NCT02402127|7553|P3|COMPLETED|Third Wear Period (1 Day)||4
3521|NCT02402127|7554|P2|COMPLETED|Third Wear Period (1 Day)||4
3522|NCT02402127|7555|P1|COMPLETED|Third Wear Period (1 Day)||4
3523|NCT02402127|7550|P6|STARTED|Third Wear Period (1 Day)||4
3524|NCT02402127|7551|P5|STARTED|Third Wear Period (1 Day)||4
3525|NCT02402127|7552|P4|STARTED|Third Wear Period (1 Day)||4
3526|NCT02402127|7553|P3|STARTED|Third Wear Period (1 Day)||4
3527|NCT02402127|7554|P2|STARTED|Third Wear Period (1 Day)||4
3528|NCT02402127|7555|P1|STARTED|Third Wear Period (1 Day)||4
3529|NCT02402127|7550|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
3530|NCT02402127|7551|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
3531|NCT02402127|7552|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
3532|NCT02402127|7553|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
3533|NCT02402127|7554|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
3534|NCT02402127|7555|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
3535|NCT02402127|7550|P6|COMPLETED|Second Wear Period (1 Day)||4
3536|NCT02402127|7551|P5|COMPLETED|Second Wear Period (1 Day)||4
3537|NCT02402127|7552|P4|COMPLETED|Second Wear Period (1 Day)||4
3538|NCT02402127|7553|P3|COMPLETED|Second Wear Period (1 Day)||4
3539|NCT02402127|7554|P2|COMPLETED|Second Wear Period (1 Day)||4
3540|NCT02402127|7555|P1|COMPLETED|Second Wear Period (1 Day)||4
3541|NCT02402127|7550|P6|STARTED|Second Wear Period (1 Day)||4
3542|NCT02402127|7551|P5|STARTED|Second Wear Period (1 Day)||4
3543|NCT02402127|7552|P4|STARTED|Second Wear Period (1 Day)||4
3544|NCT02402127|7553|P3|STARTED|Second Wear Period (1 Day)||4
3545|NCT02402127|7554|P2|STARTED|Second Wear Period (1 Day)||4
3546|NCT02402127|7555|P1|STARTED|Second Wear Period (1 Day)||4
3547|NCT02402127|7550|P6|NOT COMPLETED|First Wear Period (1 Day)||0
3548|NCT02402127|7551|P5|NOT COMPLETED|First Wear Period (1 Day)||0
3549|NCT02402127|7552|P4|NOT COMPLETED|First Wear Period (1 Day)||0
3550|NCT02402127|7553|P3|NOT COMPLETED|First Wear Period (1 Day)||0
3551|NCT02402127|7554|P2|NOT COMPLETED|First Wear Period (1 Day)||0
3552|NCT02402127|7555|P1|NOT COMPLETED|First Wear Period (1 Day)||0
3553|NCT02402127|7550|P6|COMPLETED|First Wear Period (1 Day)||4
3554|NCT02402127|7551|P5|COMPLETED|First Wear Period (1 Day)||4
3555|NCT02402127|7552|P4|COMPLETED|First Wear Period (1 Day)||4
3556|NCT02402127|7553|P3|COMPLETED|First Wear Period (1 Day)||4
3557|NCT02402127|7554|P2|COMPLETED|First Wear Period (1 Day)||4
3558|NCT02402127|7555|P1|COMPLETED|First Wear Period (1 Day)||4
3559|NCT02402127|7550|P6|Randomized and Treated|First Wear Period (1 Day)||4
3560|NCT02402127|7551|P5|Randomized and Treated|First Wear Period (1 Day)||4
3561|NCT02402127|7552|P4|Randomized and Treated|First Wear Period (1 Day)||4
3562|NCT02402127|7553|P3|Randomized and Treated|First Wear Period (1 Day)||4
3563|NCT02402127|7554|P2|Randomized and Treated|First Wear Period (1 Day)||4
3564|NCT02402127|7555|P1|Randomized and Treated|First Wear Period (1 Day)||4
3565|NCT02402127|7550|P6|STARTED|First Wear Period (1 Day)||4
3566|NCT02402127|7551|P5|STARTED|First Wear Period (1 Day)||4
3567|NCT02402127|7552|P4|STARTED|First Wear Period (1 Day)||4
3568|NCT02402127|7553|P3|STARTED|First Wear Period (1 Day)||4
3569|NCT02402127|7554|P2|STARTED|First Wear Period (1 Day)||4
3570|NCT02402127|7555|P1|STARTED|First Wear Period (1 Day)||4
3571|NCT02401529|7568|P2|NOT COMPLETED|Overall Study||7
3572|NCT02401529|7569|P1|NOT COMPLETED|Overall Study||9
3573|NCT02401529|7568|P2|COMPLETED|Overall Study||50
3574|NCT02401529|7569|P1|COMPLETED|Overall Study||50
3575|NCT02401529|7568|P2|STARTED|Overall Study||57
3576|NCT02401529|7569|P1|STARTED|Overall Study||59
3577|NCT02401464|7597|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3578|NCT02401464|7598|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3579|NCT02401464|7599|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3580|NCT02401464|7600|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3581|NCT02401464|7597|P4|COMPLETED|Intervention Period 2 (6 Days)||13
3582|NCT02401464|7598|P3|COMPLETED|Intervention Period 2 (6 Days)||13
3583|NCT02401464|7599|P2|COMPLETED|Intervention Period 2 (6 Days)||13
3584|NCT02401464|7600|P1|COMPLETED|Intervention Period 2 (6 Days)||13
3585|NCT02401464|7597|P4|STARTED|Intervention Period 2 (6 Days)||13
3586|NCT02401464|7598|P3|STARTED|Intervention Period 2 (6 Days)||13
3587|NCT02401464|7599|P2|STARTED|Intervention Period 2 (6 Days)||13
3588|NCT02401464|7600|P1|STARTED|Intervention Period 2 (6 Days)||13
3589|NCT02401464|7597|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3590|NCT02401464|7598|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3591|NCT02401464|7599|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3592|NCT02401464|7600|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
3593|NCT02401464|7597|P4|COMPLETED|Washout Period (At Least 6 Days)||13
3594|NCT02401464|7598|P3|COMPLETED|Washout Period (At Least 6 Days)||13
3595|NCT02401464|7599|P2|COMPLETED|Washout Period (At Least 6 Days)||13
3596|NCT02401464|7600|P1|COMPLETED|Washout Period (At Least 6 Days)||13
3597|NCT02401464|7597|P4|STARTED|Washout Period (At Least 6 Days)||13
3598|NCT02401464|7598|P3|STARTED|Washout Period (At Least 6 Days)||13
3599|NCT02401464|7599|P2|STARTED|Washout Period (At Least 6 Days)||13
3600|NCT02401464|7600|P1|STARTED|Washout Period (At Least 6 Days)||13
3601|NCT02401464|7597|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3602|NCT02401464|7598|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3603|NCT02401464|7599|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3604|NCT02401464|7600|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3605|NCT02401464|7597|P4|COMPLETED|Intervention Period 1 (6 Days)||13
3606|NCT02401464|7598|P3|COMPLETED|Intervention Period 1 (6 Days)||13
3607|NCT02401464|7599|P2|COMPLETED|Intervention Period 1 (6 Days)||13
3608|NCT02401464|7600|P1|COMPLETED|Intervention Period 1 (6 Days)||13
3609|NCT02401464|7597|P4|STARTED|Intervention Period 1 (6 Days)||13
3610|NCT02401464|7598|P3|STARTED|Intervention Period 1 (6 Days)||13
3611|NCT02401464|7599|P2|STARTED|Intervention Period 1 (6 Days)||13
3612|NCT02401464|7600|P1|STARTED|Intervention Period 1 (6 Days)||13
3613|NCT02400996|7634|P1|NOT COMPLETED|Overall Study||0
3614|NCT02400996|7634|P1|COMPLETED|Overall Study||40
3615|NCT02400996|7634|P1|STARTED|Overall Study||40
3616|NCT02400710|7640|P2|NOT COMPLETED|Overall Study||0
3617|NCT02400710|7641|P1|NOT COMPLETED|Overall Study||0
3618|NCT02400710|7640|P2|COMPLETED|Overall Study||10
3619|NCT02400710|7641|P1|COMPLETED|Overall Study||10
3620|NCT02400710|7640|P2|STARTED|Overall Study||10
3621|NCT02400710|7641|P1|STARTED|Overall Study||10
3622|NCT02400333|7653|P4|NOT COMPLETED|Overall Study||2
3623|NCT02400333|7654|P3|NOT COMPLETED|Overall Study||2
3624|NCT02400333|7655|P2|NOT COMPLETED|Overall Study||1
3625|NCT02400333|7656|P1|NOT COMPLETED|Overall Study||1
3626|NCT02400333|7653|P4|COMPLETED|Overall Study||7
3627|NCT02400333|7654|P3|COMPLETED|Overall Study||7
3628|NCT02400333|7655|P2|COMPLETED|Overall Study||8
3629|NCT02400333|7656|P1|COMPLETED|Overall Study||8
3630|NCT02400333|7653|P4|STARTED|Overall Study||9
3631|NCT02400333|7654|P3|STARTED|Overall Study||9
3632|NCT02400333|7655|P2|STARTED|Overall Study||9
3633|NCT02400333|7656|P1|STARTED|Overall Study||9
3634|NCT02399345|7714|P1|NOT COMPLETED|Overall Study||0
3635|NCT02399345|7714|P1|COMPLETED|Overall Study||10
3636|NCT02399345|7714|P1|STARTED|Overall Study||10
3637|NCT02399163|7720|P1|NOT COMPLETED|Overall Study||9
3638|NCT02399163|7720|P1|COMPLETED|Overall Study||53
3639|NCT02399163|7720|P1|STARTED|Overall Study||62
3640|NCT02399111|7748|P4|NOT COMPLETED|Overall Study||0
3641|NCT02399111|7749|P3|NOT COMPLETED|Overall Study||0
3642|NCT02399111|7750|P2|NOT COMPLETED|Overall Study||0
3643|NCT02399111|7751|P1|NOT COMPLETED|Overall Study||0
3644|NCT02399111|7748|P4|COMPLETED|Overall Study||0
3645|NCT02399111|7749|P3|COMPLETED|Overall Study||4
3646|NCT02399111|7750|P2|COMPLETED|Overall Study||1
3647|NCT02399111|7751|P1|COMPLETED|Overall Study||4
3648|NCT02399111|7748|P4|STARTED|Overall Study||0
3649|NCT02399111|7749|P3|STARTED|Overall Study||4
3650|NCT02399111|7750|P2|STARTED|Overall Study||1
3651|NCT02399111|7751|P1|STARTED|Overall Study||4
3652|NCT02397915|7765|P4|NOT COMPLETED|Period 2||0
3653|NCT02397915|7766|P3|NOT COMPLETED|Period 2||0
3654|NCT02397915|7767|P2|NOT COMPLETED|Period 2||0
3655|NCT02397915|7768|P1|NOT COMPLETED|Period 2||0
3656|NCT02397915|7765|P4|COMPLETED|Period 2||149
3657|NCT02397915|7766|P3|COMPLETED|Period 2||149
3658|NCT02397915|7767|P2|COMPLETED|Period 2||0
3659|NCT02397915|7768|P1|COMPLETED|Period 2||0
3660|NCT02397915|7765|P4|STARTED|Period 2||149
3661|NCT02397915|7766|P3|STARTED|Period 2||149
3662|NCT02397915|7767|P2|STARTED|Period 2||0
3663|NCT02397915|7768|P1|STARTED|Period 2||0
3664|NCT02397915|7765|P4|NOT COMPLETED|Period 1||0
3665|NCT02397915|7766|P3|NOT COMPLETED|Period 1||0
3666|NCT02397915|7767|P2|NOT COMPLETED|Period 1||1
3667|NCT02397915|7768|P1|NOT COMPLETED|Period 1||1
3668|NCT02397915|7765|P4|COMPLETED|Period 1||0
3669|NCT02397915|7766|P3|COMPLETED|Period 1||0
3670|NCT02397915|7767|P2|COMPLETED|Period 1||149
3671|NCT02397915|7768|P1|COMPLETED|Period 1||149
3672|NCT02397915|7765|P4|STARTED|Period 1||0
3673|NCT02397915|7766|P3|STARTED|Period 1||0
3674|NCT02397915|7767|P2|STARTED|Period 1||150
3675|NCT02397915|7768|P1|STARTED|Period 1||150
3676|NCT02397655|7818|P1|NOT COMPLETED|Overall Study||1301
3677|NCT02397655|7818|P1|COMPLETED|Overall Study||10711
3678|NCT02397655|7818|P1|STARTED|Overall Study||12012
3679|NCT02396160|7824|P2|NOT COMPLETED|Overall Study||2
3680|NCT02396160|7825|P1|NOT COMPLETED|Overall Study||6
3681|NCT02396160|7824|P2|COMPLETED|Overall Study||73
3682|NCT02396160|7825|P1|COMPLETED|Overall Study||69
3683|NCT02396160|7824|P2|STARTED|Overall Study||75
3684|NCT02396160|7825|P1|STARTED|Overall Study||75
3685|NCT02396147|7841|P2|NOT COMPLETED|Period 3||0
3686|NCT02396147|7842|P1|NOT COMPLETED|Period 3||0
3687|NCT02396147|7841|P2|COMPLETED|Period 3||27
3688|NCT02396147|7842|P1|COMPLETED|Period 3||27
3689|NCT02396147|7841|P2|STARTED|Period 3||27
3690|NCT02396147|7842|P1|STARTED|Period 3||27
3691|NCT02396147|7841|P2|NOT COMPLETED|Period 2||0
3692|NCT02396147|7842|P1|NOT COMPLETED|Period 2||0
3693|NCT02396147|7841|P2|COMPLETED|Period 2||27
3694|NCT02396147|7842|P1|COMPLETED|Period 2||27
3695|NCT02396147|7841|P2|STARTED|Period 2||27
3696|NCT02396147|7842|P1|STARTED|Period 2||27
3697|NCT02396147|7841|P2|NOT COMPLETED|Period 1||0
3698|NCT02396147|7842|P1|NOT COMPLETED|Period 1||0
3699|NCT02396147|7841|P2|COMPLETED|Period 1||27
3700|NCT02396147|7842|P1|COMPLETED|Period 1||27
3701|NCT02396147|7841|P2|STARTED|Period 1||27
3702|NCT02396147|7842|P1|STARTED|Period 1||27
3703|NCT02395055|7912|P2|NOT COMPLETED|Overall Study||3
3704|NCT02395055|7913|P1|NOT COMPLETED|Overall Study||7
3705|NCT02395055|7912|P2|COMPLETED|Overall Study||44
3706|NCT02395055|7913|P1|COMPLETED|Overall Study||40
3707|NCT02395055|7912|P2|STARTED|Overall Study||47
3708|NCT02395055|7913|P1|STARTED|Overall Study||47
3709|NCT02394665|7926|P3|NOT COMPLETED|Overall Study||0
3710|NCT02394665|7927|P2|NOT COMPLETED|Overall Study||0
3711|NCT02394665|7928|P1|NOT COMPLETED|Overall Study||1
3712|NCT02394665|7926|P3|COMPLETED|Overall Study||0
3713|NCT02394665|7927|P2|COMPLETED|Overall Study||0
3714|NCT02394665|7928|P1|COMPLETED|Overall Study||0
3715|NCT02394665|7926|P3|STARTED|Overall Study||0
3716|NCT02394665|7927|P2|STARTED|Overall Study||0
3717|NCT02394665|7928|P1|STARTED|Overall Study||1
3718|NCT02394457|7950|P2|NOT COMPLETED|Overall Study||0
3719|NCT02394457|7951|P1|NOT COMPLETED|Overall Study||0
3720|NCT02394457|7950|P2|COMPLETED|Overall Study||13
3721|NCT02394457|7951|P1|COMPLETED|Overall Study||15
3722|NCT02394457|7950|P2|STARTED|Overall Study||13
3723|NCT02394457|7951|P1|STARTED|Overall Study||15
3724|NCT02393950|7969|P2|NOT COMPLETED|Overall Study||1
3725|NCT02393950|7970|P1|NOT COMPLETED|Overall Study||1
3726|NCT02393950|7969|P2|COMPLETED|Overall Study||8
3727|NCT02393950|7970|P1|COMPLETED|Overall Study||8
3728|NCT02393950|7969|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
3729|NCT02393950|7970|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
3730|NCT02393950|7969|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
3731|NCT02393950|7970|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
3732|NCT02393950|7969|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
3733|NCT02393950|7970|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
3734|NCT02393950|7969|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
3735|NCT02393950|7970|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
3736|NCT02393950|7969|P2|STARTED|Overall Study||9
3737|NCT02393950|7970|P1|STARTED|Overall Study||9
3738|NCT02393677|8037|P2|NOT COMPLETED|Overall Study||0
3739|NCT02393677|8038|P1|NOT COMPLETED|Overall Study||0
3740|NCT02393677|8037|P2|COMPLETED|Overall Study||40
3741|NCT02393677|8038|P1|COMPLETED|Overall Study||40
3742|NCT02393677|8037|P2|STARTED|Overall Study||40
3743|NCT02393677|8038|P1|STARTED|Overall Study||40
3744|NCT02392767|8046|P2|NOT COMPLETED|Overall Study||0
3745|NCT02392767|8047|P1|NOT COMPLETED|Overall Study||0
3746|NCT02392767|8046|P2|COMPLETED|Overall Study||13
3747|NCT02392767|8047|P1|COMPLETED|Overall Study||12
3748|NCT02392767|8046|P2|STARTED|Overall Study||13
3749|NCT02392767|8047|P1|STARTED|Overall Study||12
3750|NCT02392247|8063|P1|NOT COMPLETED|Overall Study||2
3751|NCT02392247|8063|P1|COMPLETED|Overall Study||50
3752|NCT02392247|8063|P1|STARTED|Overall Study||52
3753|NCT02391714|8070|P2|NOT COMPLETED|Overall Study||0
3754|NCT02391714|8071|P1|NOT COMPLETED|Overall Study||0
3755|NCT02391714|8070|P2|COMPLETED|Overall Study||40
3756|NCT02391714|8071|P1|COMPLETED|Overall Study||40
3757|NCT02391714|8070|P2|STARTED|Overall Study||40
3758|NCT02391714|8071|P1|STARTED|Overall Study||40
3759|NCT02389452|8081|P1|NOT COMPLETED|Overall Study||25
3760|NCT02389452|8081|P1|COMPLETED|Overall Study||369
3761|NCT02389452|8081|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
3762|NCT02389452|8081|P1|STARTED|Overall Study||394
3763|NCT02389361|8101|P2|NOT COMPLETED|Overall Study||0
3764|NCT02389361|8102|P1|NOT COMPLETED|Overall Study||0
3765|NCT02389361|8101|P2|COMPLETED|Overall Study||27
3766|NCT02389361|8102|P1|COMPLETED|Overall Study||24
3767|NCT02389361|8101|P2|STARTED|Overall Study||27
3768|NCT02389361|8102|P1|STARTED|Overall Study||24
3769|NCT02389088|8108|P1|NOT COMPLETED|Phase II - All Study Participants||0
3770|NCT02389088|8108|P1|COMPLETED|Phase II - All Study Participants||9
3771|NCT02389088|8108|P1|STARTED|Phase II - All Study Participants||9
3772|NCT02389088|8108|P1|NOT COMPLETED|Overall Study - Phase I||0
3773|NCT02389088|8108|P1|COMPLETED|Overall Study - Phase I||9
3774|NCT02389088|8108|P1|STARTED|Overall Study - Phase I||9
3775|NCT02388815|8152|P1|NOT COMPLETED|Overall Study||4
3776|NCT02388815|8152|P1|COMPLETED|Overall Study||85
3777|NCT02388815|8152|P1|STARTED|Overall Study||89
3778|NCT02388763|8156|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
3779|NCT02388763|8157|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
3780|NCT02388763|8156|P2|COMPLETED|Period 2, 10 Days of Wear||30
3781|NCT02388763|8157|P1|COMPLETED|Period 2, 10 Days of Wear||30
3782|NCT02388763|8156|P2|STARTED|Period 2, 10 Days of Wear||30
3783|NCT02388763|8157|P1|STARTED|Period 2, 10 Days of Wear||30
3784|NCT02388763|8156|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
3785|NCT02388763|8157|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
3786|NCT02388763|8156|P2|COMPLETED|Period 1, 10 Days of Wear||30
3787|NCT02388763|8157|P1|COMPLETED|Period 1, 10 Days of Wear||30
3788|NCT02388763|8156|P2|STARTED|Period 1, 10 Days of Wear||31
3789|NCT02388763|8157|P1|STARTED|Period 1, 10 Days of Wear||31
3790|NCT02388763|8156|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
3791|NCT02388763|8157|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
3792|NCT02388763|8156|P2|COMPLETED|Habitual, 10 Days of Wear||31
3793|NCT02388763|8157|P1|COMPLETED|Habitual, 10 Days of Wear||31
3794|NCT02388763|8156|P2|STARTED|Habitual, 10 Days of Wear||32
3795|NCT02388763|8157|P1|STARTED|Habitual, 10 Days of Wear||32
3796|NCT02388074|8168|P1|NOT COMPLETED|Overall Study||3
3797|NCT02388074|8168|P1|COMPLETED|Overall Study||22
3798|NCT02388074|8168|P1|STARTED|Overall Study||25
3799|NCT02387801|8174|P2|NOT COMPLETED|Overall Study||0
3800|NCT02387801|8175|P1|NOT COMPLETED|Overall Study||0
3801|NCT02387801|8174|P2|COMPLETED|Overall Study||6
3802|NCT02387801|8175|P1|COMPLETED|Overall Study||6
3803|NCT02387801|8174|P2|STARTED|Overall Study||6
3804|NCT02387801|8175|P1|STARTED|Overall Study||6
3805|NCT02387580|8197|P6|NOT COMPLETED|Overall Study||0
3806|NCT02387580|8198|P5|NOT COMPLETED|Overall Study||0
3807|NCT02387580|8199|P4|NOT COMPLETED|Overall Study||1
3808|NCT02387580|8200|P3|NOT COMPLETED|Overall Study||0
3809|NCT02387580|8201|P2|NOT COMPLETED|Overall Study||0
3810|NCT02387580|8202|P1|NOT COMPLETED|Overall Study||0
3811|NCT02387580|8197|P6|COMPLETED|Overall Study||8
3812|NCT02387580|8198|P5|COMPLETED|Overall Study||8
3813|NCT02387580|8199|P4|COMPLETED|Overall Study||7
3814|NCT02387580|8200|P3|COMPLETED|Overall Study||8
3815|NCT02387580|8201|P2|COMPLETED|Overall Study||8
3816|NCT02387580|8202|P1|COMPLETED|Overall Study||8
3817|NCT02387580|8197|P6|STARTED|Overall Study||8
3818|NCT02387580|8198|P5|STARTED|Overall Study||8
3819|NCT02387580|8199|P4|STARTED|Overall Study||8
3820|NCT02387580|8200|P3|STARTED|Overall Study||8
3821|NCT02387580|8201|P2|STARTED|Overall Study||8
3822|NCT02387580|8202|P1|STARTED|Overall Study||8
3823|NCT02387554|8238|P4|NOT COMPLETED|Overall Study||2
3824|NCT02387554|8239|P3|NOT COMPLETED|Overall Study||2
3825|NCT02387554|8240|P2|NOT COMPLETED|Overall Study||0
3826|NCT02387554|8241|P1|NOT COMPLETED|Overall Study||3
3827|NCT02387554|8238|P4|COMPLETED|Overall Study||6
3828|NCT02387554|8239|P3|COMPLETED|Overall Study||6
3829|NCT02387554|8240|P2|COMPLETED|Overall Study||7
3830|NCT02387554|8241|P1|COMPLETED|Overall Study||7
3831|NCT02387554|8238|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
3832|NCT02387554|8239|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
3833|NCT02387554|8240|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
3834|NCT02387554|8241|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
3835|NCT02387502|8254|P3|NOT COMPLETED|Overall Study||0
3836|NCT02387502|8255|P2|NOT COMPLETED|Overall Study||0
3837|NCT02387502|8256|P1|NOT COMPLETED|Overall Study||0
3838|NCT02387502|8254|P3|COMPLETED|Overall Study||40
3839|NCT02387502|8255|P2|COMPLETED|Overall Study||40
3840|NCT02387502|8256|P1|COMPLETED|Overall Study||40
3841|NCT02387502|8254|P3|STARTED|Overall Study||40
3842|NCT02387502|8255|P2|STARTED|Overall Study||40
3843|NCT02387502|8256|P1|STARTED|Overall Study||40
3844|NCT02387268|8264|P1|NOT COMPLETED|Overall Study||1
3845|NCT02387268|8264|P1|COMPLETED|Overall Study||9
3846|NCT02387268|8264|P1|STARTED|Overall Study||10
3847|NCT02384070|8272|P3|NOT COMPLETED|Overall Study||0
3848|NCT02384070|8273|P2|NOT COMPLETED|Overall Study||0
3849|NCT02384070|8274|P1|NOT COMPLETED|Overall Study||0
3850|NCT02384070|8272|P3|COMPLETED|Overall Study||100
3851|NCT02384070|8273|P2|COMPLETED|Overall Study||100
3852|NCT02384070|8274|P1|COMPLETED|Overall Study||100
3853|NCT02384070|8272|P3|STARTED|Overall Study||100
3854|NCT02384070|8273|P2|STARTED|Overall Study||100
3855|NCT02384070|8274|P1|STARTED|Overall Study||100
3856|NCT02383719|8288|P1|NOT COMPLETED|Overall Study||0
3857|NCT02383719|8288|P1|COMPLETED|Overall Study||18
3858|NCT02383719|8288|P1|STARTED|Overall Study||18
3859|NCT02383420|8295|P3|NOT COMPLETED|Overall Study||0
3860|NCT02383420|8296|P2|NOT COMPLETED|Overall Study||0
3861|NCT02383420|8297|P1|NOT COMPLETED|Overall Study||2
3862|NCT02383420|8295|P3|COMPLETED|Overall Study||3
3863|NCT02383420|8296|P2|COMPLETED|Overall Study||10
3864|NCT02383420|8297|P1|COMPLETED|Overall Study||8
3865|NCT02383420|8295|P3|STARTED|Overall Study||3
3866|NCT02383420|8296|P2|STARTED|Overall Study||10
3867|NCT02383420|8297|P1|STARTED|Overall Study||10
3868|NCT02382913|8315|P10|NOT COMPLETED|Overall Study||0
3869|NCT02382913|8316|P9|NOT COMPLETED|Overall Study||0
3870|NCT02382913|8317|P8|NOT COMPLETED|Overall Study||0
3871|NCT02382913|8318|P7|NOT COMPLETED|Overall Study||0
3872|NCT02382913|8319|P6|NOT COMPLETED|Overall Study||0
3873|NCT02382913|8320|P5|NOT COMPLETED|Overall Study||0
3874|NCT02382913|8321|P4|NOT COMPLETED|Overall Study||0
3875|NCT02382913|8322|P3|NOT COMPLETED|Overall Study||0
3876|NCT02382913|8323|P2|NOT COMPLETED|Overall Study||0
3877|NCT02382913|8324|P1|NOT COMPLETED|Overall Study||0
3878|NCT02382913|8315|P10|COMPLETED|Overall Study||33
3879|NCT02382913|8316|P9|COMPLETED|Overall Study||30
3880|NCT02382913|8317|P8|COMPLETED|Overall Study||30
3881|NCT02382913|8318|P7|COMPLETED|Overall Study||37
3882|NCT02382913|8319|P6|COMPLETED|Overall Study||30
3883|NCT02382913|8320|P5|COMPLETED|Overall Study||33
3884|NCT02382913|8321|P4|COMPLETED|Overall Study||27
3885|NCT02382913|8322|P3|COMPLETED|Overall Study||32
3886|NCT02382913|8323|P2|COMPLETED|Overall Study||36
3887|NCT02382913|8324|P1|COMPLETED|Overall Study||27
3888|NCT02382913|8315|P10|STARTED|Overall Study||33
3889|NCT02382913|8316|P9|STARTED|Overall Study||30
3890|NCT02382913|8317|P8|STARTED|Overall Study||30
3891|NCT02382913|8318|P7|STARTED|Overall Study||37
3892|NCT02382913|8319|P6|STARTED|Overall Study||30
3893|NCT02382913|8320|P5|STARTED|Overall Study||33
3894|NCT02382913|8321|P4|STARTED|Overall Study||27
3895|NCT02382913|8322|P3|STARTED|Overall Study||32
3896|NCT02382913|8323|P2|STARTED|Overall Study||36
3897|NCT02382913|8324|P1|STARTED|Overall Study||27
3898|NCT02382640|8364|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3899|NCT02382640|8365|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3900|NCT02382640|8366|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
3901|NCT02382640|8367|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
3902|NCT02382640|8364|P4|COMPLETED|Intervention Period 4 (3 Days)||9
3903|NCT02382640|8365|P3|COMPLETED|Intervention Period 4 (3 Days)||9
3904|NCT02382640|8366|P2|COMPLETED|Intervention Period 4 (3 Days)||9
3905|NCT02382640|8367|P1|COMPLETED|Intervention Period 4 (3 Days)||8
3906|NCT02382640|8364|P4|STARTED|Intervention Period 4 (3 Days)||9
3907|NCT02382640|8365|P3|STARTED|Intervention Period 4 (3 Days)||9
3908|NCT02382640|8366|P2|STARTED|Intervention Period 4 (3 Days)||9
3909|NCT02382640|8367|P1|STARTED|Intervention Period 4 (3 Days)||9
3910|NCT02382640|8364|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
3911|NCT02382640|8365|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
3912|NCT02382640|8366|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
3913|NCT02382640|8367|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
3914|NCT02382640|8364|P4|COMPLETED|Washout Period 3 (7 Days)||9
3915|NCT02382640|8365|P3|COMPLETED|Washout Period 3 (7 Days)||9
3916|NCT02382640|8366|P2|COMPLETED|Washout Period 3 (7 Days)||9
3917|NCT02382640|8367|P1|COMPLETED|Washout Period 3 (7 Days)||9
3918|NCT02382640|8364|P4|STARTED|Washout Period 3 (7 Days)||9
3919|NCT02382640|8365|P3|STARTED|Washout Period 3 (7 Days)||9
3920|NCT02382640|8366|P2|STARTED|Washout Period 3 (7 Days)||9
3921|NCT02382640|8367|P1|STARTED|Washout Period 3 (7 Days)||9
3922|NCT02382640|8364|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3923|NCT02382640|8365|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3924|NCT02382640|8366|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3925|NCT02382640|8367|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
3926|NCT02382640|8364|P4|COMPLETED|Intervention Period 3 (3 Days)||9
3927|NCT02382640|8365|P3|COMPLETED|Intervention Period 3 (3 Days)||9
3928|NCT02382640|8366|P2|COMPLETED|Intervention Period 3 (3 Days)||9
3929|NCT02382640|8367|P1|COMPLETED|Intervention Period 3 (3 Days)||9
3930|NCT02382640|8364|P4|STARTED|Intervention Period 3 (3 Days)||9
3931|NCT02382640|8365|P3|STARTED|Intervention Period 3 (3 Days)||9
3932|NCT02382640|8366|P2|STARTED|Intervention Period 3 (3 Days)||9
3933|NCT02382640|8367|P1|STARTED|Intervention Period 3 (3 Days)||9
3934|NCT02382640|8364|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
3935|NCT02382640|8365|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
3936|NCT02382640|8366|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
3937|NCT02382640|8367|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
3938|NCT02382640|8364|P4|COMPLETED|Washout Period 2 (7 Days)||9
3939|NCT02382640|8365|P3|COMPLETED|Washout Period 2 (7 Days)||9
3940|NCT02382640|8366|P2|COMPLETED|Washout Period 2 (7 Days)||9
3941|NCT02382640|8367|P1|COMPLETED|Washout Period 2 (7 Days)||9
3942|NCT02382640|8364|P4|STARTED|Washout Period 2 (7 Days)||9
3943|NCT02382640|8365|P3|STARTED|Washout Period 2 (7 Days)||9
3944|NCT02382640|8366|P2|STARTED|Washout Period 2 (7 Days)||9
3945|NCT02382640|8367|P1|STARTED|Washout Period 2 (7 Days)||9
3946|NCT02382640|8364|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3947|NCT02382640|8365|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3948|NCT02382640|8366|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3949|NCT02382640|8367|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
3950|NCT02382640|8364|P4|COMPLETED|Intervention Period 2 (3 Days)||9
3951|NCT02382640|8365|P3|COMPLETED|Intervention Period 2 (3 Days)||9
3952|NCT02382640|8366|P2|COMPLETED|Intervention Period 2 (3 Days)||9
3953|NCT02382640|8367|P1|COMPLETED|Intervention Period 2 (3 Days)||9
3954|NCT02382640|8364|P4|STARTED|Intervention Period 2 (3 Days)||9
3955|NCT02382640|8365|P3|STARTED|Intervention Period 2 (3 Days)||9
3956|NCT02382640|8366|P2|STARTED|Intervention Period 2 (3 Days)||9
3957|NCT02382640|8367|P1|STARTED|Intervention Period 2 (3 Days)||9
3958|NCT02382640|8364|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
3959|NCT02382640|8365|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
3960|NCT02382640|8366|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
3961|NCT02382640|8367|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
3962|NCT02382640|8364|P4|COMPLETED|Washout Period 1 (7 Days)||9
3963|NCT02382640|8365|P3|COMPLETED|Washout Period 1 (7 Days)||9
3964|NCT02382640|8366|P2|COMPLETED|Washout Period 1 (7 Days)||9
3965|NCT02382640|8367|P1|COMPLETED|Washout Period 1 (7 Days)||9
3966|NCT02382640|8364|P4|STARTED|Washout Period 1 (7 Days)||9
3967|NCT02382640|8365|P3|STARTED|Washout Period 1 (7 Days)||9
3968|NCT02382640|8366|P2|STARTED|Washout Period 1 (7 Days)||9
3969|NCT02382640|8367|P1|STARTED|Washout Period 1 (7 Days)||9
3970|NCT02382640|8364|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3971|NCT02382640|8365|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3972|NCT02382640|8366|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3973|NCT02382640|8367|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
3974|NCT02382640|8364|P4|COMPLETED|Intervention Period 1 (3 Days)||9
3975|NCT02382640|8365|P3|COMPLETED|Intervention Period 1 (3 Days)||9
3976|NCT02382640|8366|P2|COMPLETED|Intervention Period 1 (3 Days)||9
3977|NCT02382640|8367|P1|COMPLETED|Intervention Period 1 (3 Days)||9
3978|NCT02382640|8364|P4|STARTED|Intervention Period 1 (3 Days)||9
3979|NCT02382640|8365|P3|STARTED|Intervention Period 1 (3 Days)||9
3980|NCT02382640|8366|P2|STARTED|Intervention Period 1 (3 Days)||9
3981|NCT02382640|8367|P1|STARTED|Intervention Period 1 (3 Days)||9
3982|NCT02381678|8405|P3|NOT COMPLETED|Overall Study||0
3983|NCT02381678|8406|P2|NOT COMPLETED|Overall Study||0
3984|NCT02381678|8407|P1|NOT COMPLETED|Overall Study||0
3985|NCT02381678|8405|P3|COMPLETED|Overall Study||32
3986|NCT02381678|8406|P2|COMPLETED|Overall Study||139
3987|NCT02381678|8407|P1|COMPLETED|Overall Study||54
3988|NCT02381678|8405|P3|STARTED|Overall Study||32
3989|NCT02381678|8406|P2|STARTED|Overall Study||139
3990|NCT02381678|8407|P1|STARTED|Overall Study||54
3991|NCT02381418|8413|P1|NOT COMPLETED|Overall Study||0
3992|NCT02381418|8413|P1|COMPLETED|Overall Study||120
3993|NCT02381418|8413|P1|STARTED|Overall Study||120
3994|NCT02380287|8427|P8|NOT COMPLETED|Overall Study||0
3995|NCT02380287|8428|P7|NOT COMPLETED|Overall Study||0
3996|NCT02380287|8429|P6|NOT COMPLETED|Overall Study||0
3997|NCT02380287|8430|P5|NOT COMPLETED|Overall Study||0
3998|NCT02380287|8431|P4|NOT COMPLETED|Overall Study||0
3999|NCT02380287|8432|P3|NOT COMPLETED|Overall Study||1
4000|NCT02380287|8433|P2|NOT COMPLETED|Overall Study||0
4001|NCT02380287|8434|P1|NOT COMPLETED|Overall Study||0
4002|NCT02380287|8427|P8|COMPLETED|Overall Study||3
4003|NCT02380287|8428|P7|COMPLETED|Overall Study||3
4004|NCT02380287|8429|P6|COMPLETED|Overall Study||3
4005|NCT02380287|8430|P5|COMPLETED|Overall Study||3
4006|NCT02380287|8431|P4|COMPLETED|Overall Study||3
4007|NCT02380287|8432|P3|COMPLETED|Overall Study||2
4008|NCT02380287|8433|P2|COMPLETED|Overall Study||3
4009|NCT02380287|8434|P1|COMPLETED|Overall Study||1
4010|NCT02380287|8427|P8|STARTED|Overall Study||3
4011|NCT02380287|8428|P7|STARTED|Overall Study||3
4012|NCT02380287|8429|P6|STARTED|Overall Study||3
4013|NCT02380287|8430|P5|STARTED|Overall Study||3
4014|NCT02380287|8431|P4|STARTED|Overall Study||3
4015|NCT02380287|8432|P3|STARTED|Overall Study||3
4016|NCT02380287|8433|P2|STARTED|Overall Study||3
4017|NCT02380287|8434|P1|STARTED|Overall Study||1
4018|NCT02380261|8445|P1|NOT COMPLETED|Overall Study||0
4019|NCT02380261|8445|P1|COMPLETED|Overall Study||35
4020|NCT02380261|8445|P1|STARTED|Overall Study||35
4021|NCT02379637|8452|P2|NOT COMPLETED|Overall Study||1
4022|NCT02379637|8453|P1|NOT COMPLETED|Overall Study||2
4023|NCT02379637|8452|P2|COMPLETED|Overall Study||34
4024|NCT02379637|8453|P1|COMPLETED|Overall Study||33
4025|NCT02379637|8452|P2|STARTED|Overall Study||35
4026|NCT02379637|8453|P1|STARTED|Overall Study||35
4027|NCT02376998|8461|P1|NOT COMPLETED|Overall Study||9
4028|NCT02376998|8461|P1|COMPLETED|Overall Study||11
4029|NCT02376998|8461|P1|STARTED|Overall Study||20
4030|NCT02375373|8465|P1|NOT COMPLETED|Overall Study||11
4031|NCT02375373|8465|P1|COMPLETED|Overall Study||1
4032|NCT02375373|8465|P1|STARTED|Overall Study||12
4033|NCT02375347|8469|P1|NOT COMPLETED|Overall Study||1
4034|NCT02375347|8469|P1|COMPLETED|Overall Study||12
4035|NCT02375347|8469|P1|STARTED|Overall Study||13
4036|NCT02374398|8477|P4|NOT COMPLETED|Overall Study||0
4037|NCT02374398|8478|P3|NOT COMPLETED|Overall Study||3
4038|NCT02374398|8479|P2|NOT COMPLETED|Overall Study||1
4039|NCT02374398|8480|P1|NOT COMPLETED|Overall Study||2
4040|NCT02374398|8477|P4|COMPLETED|Overall Study||32
4041|NCT02374398|8478|P3|COMPLETED|Overall Study||29
4042|NCT02374398|8479|P2|COMPLETED|Overall Study||31
4043|NCT02374398|8480|P1|COMPLETED|Overall Study||29
4044|NCT02374398|8477|P4|STARTED|Overall Study||32
4045|NCT02374398|8478|P3|STARTED|Overall Study||32
4046|NCT02374398|8479|P2|STARTED|Overall Study||32
4047|NCT02374398|8480|P1|STARTED|Overall Study||31
4048|NCT02374346|8506|P1|NOT COMPLETED|Overall Study||48
4049|NCT02374346|8506|P1|COMPLETED|Overall Study||446
4050|NCT02374346|8506|P1|STARTED|Overall Study||494
4051|NCT02374164|8515|P3|NOT COMPLETED|Treatment Period 3||0
4052|NCT02374164|8516|P2|NOT COMPLETED|Treatment Period 3||0
4053|NCT02374164|8517|P1|NOT COMPLETED|Treatment Period 3||0
4054|NCT02374164|8515|P3|COMPLETED|Treatment Period 3||12
4055|NCT02374164|8516|P2|COMPLETED|Treatment Period 3||11
4056|NCT02374164|8517|P1|COMPLETED|Treatment Period 3||12
4057|NCT02374164|8515|P3|STARTED|Treatment Period 3||12
4058|NCT02374164|8516|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
4059|NCT02374164|8517|P1|STARTED|Treatment Period 3||12
4060|NCT02374164|8515|P3|NOT COMPLETED|Treatment Period 2||0
4061|NCT02374164|8516|P2|NOT COMPLETED|Treatment Period 2||0
4062|NCT02374164|8517|P1|NOT COMPLETED|Treatment Period 2||0
4063|NCT02374164|8515|P3|COMPLETED|Treatment Period 2||12
4064|NCT02374164|8516|P2|COMPLETED|Treatment Period 2||12
4065|NCT02374164|8517|P1|COMPLETED|Treatment Period 2||12
4066|NCT02374164|8515|P3|STARTED|Treatment Period 2||12
4067|NCT02374164|8516|P2|STARTED|Treatment Period 2||12
4068|NCT02374164|8517|P1|STARTED|Treatment Period 2||12
4069|NCT02374164|8515|P3|NOT COMPLETED|Treatment Period 1||0
4070|NCT02374164|8516|P2|NOT COMPLETED|Treatment Period 1||0
4071|NCT02374164|8517|P1|NOT COMPLETED|Treatment Period 1||0
4072|NCT02374164|8515|P3|COMPLETED|Treatment Period 1||12
4073|NCT02374164|8516|P2|COMPLETED|Treatment Period 1||12
4074|NCT02374164|8517|P1|COMPLETED|Treatment Period 1||12
4075|NCT02374164|8515|P3|STARTED|Treatment Period 1||12
4076|NCT02374164|8516|P2|STARTED|Treatment Period 1||12
4077|NCT02374164|8517|P1|STARTED|Treatment Period 1||12
4078|NCT02372344|8534|P3|NOT COMPLETED|Period 3 (Visit 4)||0
4079|NCT02372344|8535|P2|NOT COMPLETED|Period 3 (Visit 4)||0
4080|NCT02372344|8536|P1|NOT COMPLETED|Period 3 (Visit 4)||0
4081|NCT02372344|8534|P3|COMPLETED|Period 3 (Visit 4)||14
4082|NCT02372344|8535|P2|COMPLETED|Period 3 (Visit 4)||14
4083|NCT02372344|8536|P1|COMPLETED|Period 3 (Visit 4)||14
4084|NCT02372344|8534|P3|STARTED|Period 3 (Visit 4)||14
4085|NCT02372344|8535|P2|STARTED|Period 3 (Visit 4)||14
4086|NCT02372344|8536|P1|STARTED|Period 3 (Visit 4)||14
4087|NCT02372344|8534|P3|NOT COMPLETED|Period 2 (Visit 3)||0
4088|NCT02372344|8535|P2|NOT COMPLETED|Period 2 (Visit 3)||0
4089|NCT02372344|8536|P1|NOT COMPLETED|Period 2 (Visit 3)||0
4090|NCT02372344|8534|P3|COMPLETED|Period 2 (Visit 3)||14
4091|NCT02372344|8535|P2|COMPLETED|Period 2 (Visit 3)||14
4092|NCT02372344|8536|P1|COMPLETED|Period 2 (Visit 3)||14
4093|NCT02372344|8534|P3|STARTED|Period 2 (Visit 3)||14
4094|NCT02372344|8535|P2|STARTED|Period 2 (Visit 3)||14
4095|NCT02372344|8536|P1|STARTED|Period 2 (Visit 3)||14
4096|NCT02372344|8534|P3|NOT COMPLETED|Period 1 (Visit 2)||0
4097|NCT02372344|8535|P2|NOT COMPLETED|Period 1 (Visit 2)||0
4098|NCT02372344|8536|P1|NOT COMPLETED|Period 1 (Visit 2)||0
4099|NCT02372344|8534|P3|COMPLETED|Period 1 (Visit 2)||14
4100|NCT02372344|8535|P2|COMPLETED|Period 1 (Visit 2)||14
4101|NCT02372344|8536|P1|COMPLETED|Period 1 (Visit 2)||14
4102|NCT02372344|8534|P3|STARTED|Period 1 (Visit 2)||14
4103|NCT02372344|8535|P2|STARTED|Period 1 (Visit 2)||14
4104|NCT02372344|8536|P1|STARTED|Period 1 (Visit 2)||14
4105|NCT02372097|8552|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
4106|NCT02372097|8553|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
4107|NCT02372097|8552|P2|COMPLETED|Second Intervention Period (8 Days)||12
4108|NCT02372097|8553|P1|COMPLETED|Second Intervention Period (8 Days)||12
4109|NCT02372097|8552|P2|STARTED|Second Intervention Period (8 Days)||12
4110|NCT02372097|8553|P1|STARTED|Second Intervention Period (8 Days)||12
4111|NCT02372097|8552|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
4112|NCT02372097|8553|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
4113|NCT02372097|8552|P2|COMPLETED|Wash Out Period (13 Days)||12
4114|NCT02372097|8553|P1|COMPLETED|Wash Out Period (13 Days)||12
4115|NCT02372097|8552|P2|STARTED|Wash Out Period (13 Days)||12
4116|NCT02372097|8553|P1|STARTED|Wash Out Period (13 Days)||12
4117|NCT02372097|8552|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
4118|NCT02372097|8553|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
4119|NCT02372097|8552|P2|COMPLETED|First Intervention Period (8 Days)||12
4120|NCT02372097|8553|P1|COMPLETED|First Intervention Period (8 Days)||12
4121|NCT02372097|8552|P2|STARTED|First Intervention Period (8 Days)||12
4122|NCT02372097|8553|P1|STARTED|First Intervention Period (8 Days)||12
4123|NCT02372071|8579|P1|NOT COMPLETED|Overall Study||18
4124|NCT02372071|8579|P1|COMPLETED|Overall Study||93
4125|NCT02372071|8579|P1|STARTED|Overall Study||111
4126|NCT02372058|8584|P1|NOT COMPLETED|Overall Study||3
4127|NCT02372058|8584|P1|COMPLETED|Overall Study||100
4128|NCT02372058|8584|P1|STARTED|Overall Study||103
4129|NCT02371876|8590|P1|NOT COMPLETED|Overall Study||0
4130|NCT02371876|8590|P1|COMPLETED|Overall Study||134
4131|NCT02371876|8590|P1|STARTED|Overall Study||134
4132|NCT02370121|8602|P2|NOT COMPLETED|Overall Study||1
4133|NCT02370121|8603|P1|NOT COMPLETED|Overall Study||1
4228|NCT02367170|8997|P2|NOT COMPLETED|Overall Study||0
4134|NCT02370121|8602|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
4135|NCT02370121|8603|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
4136|NCT02370121|8602|P2|STARTED|Overall Study||12
4137|NCT02370121|8603|P1|STARTED|Overall Study||12
4138|NCT02370615|8643|P2|NOT COMPLETED|Overall Study||0
4139|NCT02370615|8644|P1|NOT COMPLETED|Overall Study||1
4140|NCT02370615|8643|P2|COMPLETED|Overall Study||18
4141|NCT02370615|8644|P1|COMPLETED|Overall Study||15
4142|NCT02370615|8643|P2|STARTED|Overall Study||18
4143|NCT02370615|8644|P1|STARTED|Overall Study||16
4144|NCT02370602|8687|P6|NOT COMPLETED|Overall Study||0
4145|NCT02370602|8688|P5|NOT COMPLETED|Overall Study||0
4146|NCT02370602|8689|P4|NOT COMPLETED|Overall Study||0
4147|NCT02370602|8690|P3|NOT COMPLETED|Overall Study||0
4148|NCT02370602|8691|P2|NOT COMPLETED|Overall Study||0
4149|NCT02370602|8692|P1|NOT COMPLETED|Overall Study||1
4150|NCT02370602|8687|P6|COMPLETED|Overall Study||2
4151|NCT02370602|8688|P5|COMPLETED|Overall Study||3
4152|NCT02370602|8689|P4|COMPLETED|Overall Study||3
4153|NCT02370602|8690|P3|COMPLETED|Overall Study||2
4154|NCT02370602|8691|P2|COMPLETED|Overall Study||2
4155|NCT02370602|8692|P1|COMPLETED|Overall Study||0
4156|NCT02370602|8687|P6|STARTED|Overall Study||2
4157|NCT02370602|8688|P5|STARTED|Overall Study||3
4158|NCT02370602|8689|P4|STARTED|Overall Study||3
4159|NCT02370602|8690|P3|STARTED|Overall Study||2
4160|NCT02370602|8691|P2|STARTED|Overall Study||2
4161|NCT02370602|8692|P1|STARTED|Overall Study||1
4162|NCT02370537|8786|P3|NOT COMPLETED|Part B||259
4163|NCT02370537|8787|P2|NOT COMPLETED|Part B||3
4164|NCT02370537|8788|P1|NOT COMPLETED|Part B||1
4165|NCT02370537|8786|P3|COMPLETED|Part B||23
4166|NCT02370537|8787|P2|COMPLETED|Part B||12
4167|NCT02370537|8788|P1|COMPLETED|Part B||15
4168|NCT02370537|8786|P3|Period 2 Sequence BA|Part B||12
4169|NCT02370537|8787|P2|Period 2 Sequence BA|Part B||7
4170|NCT02370537|8788|P1|Period 2 Sequence BA|Part B||7
4171|NCT02370537|8786|P3|Period 2 Sequence AB|Part B||11
4172|NCT02370537|8787|P2|Period 2 Sequence AB|Part B||5
4173|NCT02370537|8788|P1|Period 2 Sequence AB|Part B||8
4174|NCT02370537|8786|P3|Period 1 Sequence BA|Part B||12
4175|NCT02370537|8787|P2|Period 1 Sequence BA|Part B||7
4176|NCT02370537|8788|P1|Period 1 Sequence BA|Part B||7
4177|NCT02370537|8786|P3|Period 1 Sequence AB|Part B||11
4178|NCT02370537|8787|P2|Period 1 Sequence AB|Part B||6
4179|NCT02370537|8788|P1|Period 1 Sequence AB|Part B||8
4180|NCT02370537|8786|P3|Eligible for Randomisation|Part B||23
4181|NCT02370537|8787|P2|Eligible for Randomisation|Part B||13
4182|NCT02370537|8788|P1|Eligible for Randomisation|Part B||15
4183|NCT02370537|8786|P3|STARTED|Part B||282
4184|NCT02370537|8787|P2|STARTED|Part B||15
4185|NCT02370537|8788|P1|STARTED|Part B||16
4186|NCT02370537|8786|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
4187|NCT02370537|8787|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
4188|NCT02370537|8788|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
4189|NCT02370537|8786|P3|COMPLETED|Part A (Open-label Recruitment)||282
4190|NCT02370537|8787|P2|COMPLETED|Part A (Open-label Recruitment)||15
4191|NCT02370537|8788|P1|COMPLETED|Part A (Open-label Recruitment)||16
4192|NCT02370537|8786|P3|STARTED|Part A (Open-label Recruitment)||283
4193|NCT02370537|8787|P2|STARTED|Part A (Open-label Recruitment)||16
4194|NCT02370537|8788|P1|STARTED|Part A (Open-label Recruitment)||16
4195|NCT02369341|8837|P2|NOT COMPLETED|Overall Study||0
4196|NCT02369341|8838|P1|NOT COMPLETED|Overall Study||1
4197|NCT02369341|8837|P2|COMPLETED|Overall Study||57
4198|NCT02369341|8838|P1|COMPLETED|Overall Study||62
4199|NCT02369341|8837|P2|STARTED|Overall Study||57
4200|NCT02369341|8838|P1|STARTED|Overall Study||63
4201|NCT02368457|8894|P2|NOT COMPLETED|Overall Study||0
4202|NCT02368457|8895|P1|NOT COMPLETED|Overall Study||0
4203|NCT02368457|8894|P2|COMPLETED|Overall Study||12
4204|NCT02368457|8895|P1|COMPLETED|Overall Study||12
4205|NCT02368457|8894|P2|STARTED|Overall Study||12
4206|NCT02368457|8895|P1|STARTED|Overall Study||12
4207|NCT02368314|8905|P2|NOT COMPLETED|Overall Study||3
4208|NCT02368314|8906|P1|NOT COMPLETED|Overall Study||3
4209|NCT02368314|8905|P2|COMPLETED|Overall Study||57
4210|NCT02368314|8906|P1|COMPLETED|Overall Study||61
4211|NCT02368314|8905|P2|STARTED|Overall Study||60
4212|NCT02368314|8906|P1|STARTED|Overall Study||64
4213|NCT02368093|8918|P2|NOT COMPLETED|Overall Study||0
4214|NCT02368093|8919|P1|NOT COMPLETED|Overall Study||0
4215|NCT02368093|8918|P2|COMPLETED|Overall Study||24
4216|NCT02368093|8919|P1|COMPLETED|Overall Study||24
4217|NCT02368093|8918|P2|STARTED|Overall Study||24
4218|NCT02368093|8919|P1|STARTED|Overall Study||24
4219|NCT02367885|8928|P3|NOT COMPLETED|Overall Study||0
4220|NCT02367885|8929|P2|NOT COMPLETED|Overall Study||0
4221|NCT02367885|8930|P1|NOT COMPLETED|Overall Study||2
4222|NCT02367885|8928|P3|COMPLETED|Overall Study||33
4223|NCT02367885|8929|P2|COMPLETED|Overall Study||33
4224|NCT02367885|8930|P1|COMPLETED|Overall Study||31
4225|NCT02367885|8928|P3|STARTED|Overall Study||33
4226|NCT02367885|8929|P2|STARTED|Overall Study||33
4227|NCT02367885|8930|P1|STARTED|Overall Study||33
4229|NCT02367170|8998|P1|NOT COMPLETED|Overall Study||0
4230|NCT02367170|8997|P2|COMPLETED|Overall Study||0
4231|NCT02367170|8998|P1|COMPLETED|Overall Study||1
4232|NCT02367170|8997|P2|STARTED|Overall Study||0
4233|NCT02367170|8998|P1|STARTED|Overall Study||1
4234|NCT02367066|9010|P2|NOT COMPLETED|Overall Study||0
4235|NCT02367066|9011|P1|NOT COMPLETED|Overall Study||0
4236|NCT02367066|9010|P2|COMPLETED|Overall Study||10
4237|NCT02367066|9011|P1|COMPLETED|Overall Study||10
4238|NCT02367066|9010|P2|STARTED|Overall Study||10
4239|NCT02367066|9011|P1|STARTED|Overall Study||10
4240|NCT02366923|9069|P1|NOT COMPLETED|Overall Study||6
4241|NCT02366923|9069|P1|COMPLETED|Overall Study||22
4242|NCT02366923|9069|P1|STARTED|Overall Study||28
4243|NCT02366910|9082|P1|NOT COMPLETED|Overall Study||5
4244|NCT02366910|9082|P1|COMPLETED|Overall Study||21
4245|NCT02366910|9082|P1|STARTED|Overall Study||26
4246|NCT02366767|9096|P2|NOT COMPLETED|Overall Study||0
4247|NCT02366767|9097|P1|NOT COMPLETED|Overall Study||1
4248|NCT02366767|9096|P2|COMPLETED|Overall Study||10
4249|NCT02366767|9097|P1|COMPLETED|Overall Study||10
4250|NCT02366767|9096|P2|STARTED|Overall Study||10
4251|NCT02366767|9097|P1|STARTED|Overall Study||11
4252|NCT02366689|9110|P3|NOT COMPLETED|Overall Study||2
4253|NCT02366689|9111|P2|NOT COMPLETED|Overall Study||3
4254|NCT02366689|9112|P1|NOT COMPLETED|Overall Study||4
4255|NCT02366689|9110|P3|COMPLETED|Overall Study||59
4256|NCT02366689|9111|P2|COMPLETED|Overall Study||55
4257|NCT02366689|9112|P1|COMPLETED|Overall Study||56
4258|NCT02366689|9110|P3|STARTED|Overall Study||61
4259|NCT02366689|9111|P2|STARTED|Overall Study||58
4260|NCT02366689|9112|P1|STARTED|Overall Study||60
4261|NCT02366637|9135|P2|NOT COMPLETED|Second Intervention Period||1
4262|NCT02366637|9136|P1|NOT COMPLETED|Second Intervention Period||1
4263|NCT02366637|9135|P2|COMPLETED|Second Intervention Period||0
4264|NCT02366637|9136|P1|COMPLETED|Second Intervention Period||0
4265|NCT02366637|9135|P2|STARTED|Second Intervention Period||1
4266|NCT02366637|9136|P1|STARTED|Second Intervention Period||1
4267|NCT02366637|9135|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
4268|NCT02366637|9136|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
4269|NCT02366637|9135|P2|COMPLETED|Washout Period 28 to 49 Days||1
4270|NCT02366637|9136|P1|COMPLETED|Washout Period 28 to 49 Days||1
4271|NCT02366637|9135|P2|STARTED|Washout Period 28 to 49 Days||1
4272|NCT02366637|9136|P1|STARTED|Washout Period 28 to 49 Days||1
4273|NCT02366637|9135|P2|NOT COMPLETED|First Intervention Period||5
4274|NCT02366637|9136|P1|NOT COMPLETED|First Intervention Period||6
4275|NCT02366637|9135|P2|COMPLETED|First Intervention Period||1
4276|NCT02366637|9136|P1|COMPLETED|First Intervention Period||1
4277|NCT02366637|9135|P2|STARTED|First Intervention Period||6
4278|NCT02366637|9136|P1|STARTED|First Intervention Period||7
4279|NCT02366338|9163|P3|NOT COMPLETED|Overall Study||0
4280|NCT02366338|9164|P2|NOT COMPLETED|Overall Study||0
4281|NCT02366338|9165|P1|NOT COMPLETED|Overall Study||0
4282|NCT02366338|9163|P3|COMPLETED|Overall Study||36
4283|NCT02366338|9164|P2|COMPLETED|Overall Study||39
4284|NCT02366338|9165|P1|COMPLETED|Overall Study||73
4285|NCT02366338|9163|P3|STARTED|Overall Study||36
4286|NCT02366338|9164|P2|STARTED|Overall Study||39
4287|NCT02366338|9165|P1|STARTED|Overall Study||73
4288|NCT02365688|9173|P1|NOT COMPLETED|Overall Study||0
4289|NCT02365688|9173|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
4290|NCT02365688|9173|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
4291|NCT02364778|9179|P1|NOT COMPLETED|Overall Study||0
4292|NCT02364778|9179|P1|COMPLETED|Overall Study||30
4293|NCT02364778|9179|P1|STARTED|Overall Study||30
4294|NCT02363478|9191|P1|NOT COMPLETED|Overall Study||8
4295|NCT02363478|9191|P1|COMPLETED|Overall Study||22
4296|NCT02363478|9191|P1|STARTED|Overall Study||30
4297|NCT02362373|9198|P1|NOT COMPLETED|Overall Study||0
4298|NCT02362373|9198|P1|COMPLETED|Overall Study||20
4299|NCT02362373|9198|P1|STARTED|Overall Study||20
4300|NCT02362360|9206|P2|NOT COMPLETED|Period 2||0
4301|NCT02362360|9207|P1|NOT COMPLETED|Period 2||0
4302|NCT02362360|9206|P2|COMPLETED|Period 2||25
4303|NCT02362360|9207|P1|COMPLETED|Period 2||23
4304|NCT02362360|9206|P2|STARTED|Period 2||25
4305|NCT02362360|9207|P1|STARTED|Period 2||23
4306|NCT02362360|9206|P2|NOT COMPLETED|Period 1||1
4307|NCT02362360|9207|P1|NOT COMPLETED|Period 1||3
4308|NCT02362360|9206|P2|COMPLETED|Period 1||25
4309|NCT02362360|9207|P1|COMPLETED|Period 1||23
4310|NCT02362360|9206|P2|STARTED|Period 1||26
4311|NCT02362360|9207|P1|STARTED|Period 1||26
4312|NCT02362321|9215|P2|NOT COMPLETED|Overall Study||0
4313|NCT02362321|9216|P1|NOT COMPLETED|Overall Study||4
4314|NCT02362321|9215|P2|COMPLETED|Overall Study||10
4315|NCT02362321|9216|P1|COMPLETED|Overall Study||6
4316|NCT02362321|9215|P2|STARTED|Overall Study||10
4317|NCT02362321|9216|P1|STARTED|Overall Study||10
4318|NCT02361736|9224|P2|NOT COMPLETED|Overall Study||1
4319|NCT02361736|9225|P1|NOT COMPLETED|Overall Study||1
4320|NCT02361736|9224|P2|COMPLETED|Overall Study||59
4321|NCT02361736|9225|P1|COMPLETED|Overall Study||59
4322|NCT02361736|9224|P2|STARTED|Overall Study||60
4323|NCT02361736|9225|P1|STARTED|Overall Study||60
4324|NCT02360995|9246|P3|NOT COMPLETED|Overall Study||2
4325|NCT02360995|9247|P2|NOT COMPLETED|Overall Study||1
4326|NCT02360995|9248|P1|NOT COMPLETED|Overall Study||2
4327|NCT02360995|9246|P3|COMPLETED|Overall Study||41
4328|NCT02360995|9247|P2|COMPLETED|Overall Study||42
4329|NCT02360995|9248|P1|COMPLETED|Overall Study||41
4330|NCT02360995|9246|P3|STARTED|Overall Study||43
4331|NCT02360995|9247|P2|STARTED|Overall Study||43
4332|NCT02360995|9248|P1|STARTED|Overall Study||43
4333|NCT02360124|9274|P3|NOT COMPLETED|Overall Study||26
4334|NCT02360124|9275|P2|NOT COMPLETED|Overall Study||12
4335|NCT02360124|9276|P1|NOT COMPLETED|Overall Study||28
4336|NCT02360124|9274|P3|COMPLETED|Overall Study||82
4337|NCT02360124|9275|P2|COMPLETED|Overall Study||95
4338|NCT02360124|9276|P1|COMPLETED|Overall Study||80
4339|NCT02360124|9274|P3|STARTED|Overall Study||108
4340|NCT02360124|9275|P2|STARTED|Overall Study||107
4341|NCT02360124|9276|P1|STARTED|Overall Study||108
4342|NCT02359955|9289|P2|NOT COMPLETED|Overall Study||0
4343|NCT02359955|9290|P1|NOT COMPLETED|Overall Study||0
4344|NCT02359955|9289|P2|COMPLETED|Overall Study||10
4345|NCT02359955|9290|P1|COMPLETED|Overall Study||10
4346|NCT02359955|9289|P2|STARTED|Overall Study||10
4347|NCT02359955|9290|P1|STARTED|Overall Study||10
4348|NCT02359903|9308|P2|NOT COMPLETED|Overall Study||2
4349|NCT02359903|9309|P1|NOT COMPLETED|Overall Study||0
4350|NCT02359903|9308|P2|COMPLETED|Overall Study||43
4351|NCT02359903|9309|P1|COMPLETED|Overall Study||45
4352|NCT02359903|9308|P2|STARTED|Overall Study||45
4353|NCT02359903|9309|P1|STARTED|Overall Study||45
4354|NCT02359877|9320|P3|NOT COMPLETED|Stage 2||0
4355|NCT02359877|9321|P2|NOT COMPLETED|Stage 2||0
4356|NCT02359877|9322|P1|NOT COMPLETED|Stage 2||3
4357|NCT02359877|9320|P3|COMPLETED|Stage 2||0
4358|NCT02359877|9321|P2|COMPLETED|Stage 2||0
4359|NCT02359877|9322|P1|COMPLETED|Stage 2||11
4360|NCT02359877|9320|P3|STARTED|Stage 2||0
4361|NCT02359877|9321|P2|STARTED|Stage 2||0
4362|NCT02359877|9322|P1|STARTED|Stage 2||14
4363|NCT02359877|9320|P3|NOT COMPLETED|Stage 1||0
4364|NCT02359877|9321|P2|NOT COMPLETED|Stage 1||0
4365|NCT02359877|9322|P1|NOT COMPLETED|Stage 1||1
4366|NCT02359877|9320|P3|COMPLETED|Stage 1||6
4367|NCT02359877|9321|P2|COMPLETED|Stage 1||6
4368|NCT02359877|9322|P1|COMPLETED|Stage 1||33
4369|NCT02359877|9320|P3|STARTED|Stage 1||6
4370|NCT02359877|9321|P2|STARTED|Stage 1||6
4371|NCT02359877|9322|P1|STARTED|Stage 1||34
4372|NCT02359435|9374|P2|NOT COMPLETED|Overall Study||4
4373|NCT02359435|9375|P1|NOT COMPLETED|Overall Study||4
4374|NCT02359435|9374|P2|COMPLETED|Overall Study||216
4375|NCT02359435|9375|P1|COMPLETED|Overall Study||216
4376|NCT02359435|9374|P2|STARTED|Overall Study||220
4377|NCT02359435|9375|P1|STARTED|Overall Study||220
4378|NCT02358876|9381|P1|NOT COMPLETED|Overall Study||2
4379|NCT02358876|9381|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
4380|NCT02358876|9381|P1|STARTED|Overall Study||32
4381|NCT02358044|9387|P2|NOT COMPLETED|Overall Study||74
4382|NCT02358044|9388|P1|NOT COMPLETED|Overall Study||76
4383|NCT02358044|9387|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|54
4384|NCT02358044|9388|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|53
4385|NCT02358044|9387|P2|Ongoing in Study|Overall Study||69
4386|NCT02358044|9388|P1|Ongoing in Study|Overall Study||75
4387|NCT02358044|9387|P2|Completed Follow-up Week 12 Visit|Overall Study||125
4388|NCT02358044|9388|P1|Completed Follow-up Week 12 Visit|Overall Study||128
4389|NCT02358044|9387|P2|Completed 12 Weeks Treatment|Overall Study||124
4390|NCT02358044|9388|P1|Completed 12 Weeks Treatment|Overall Study||128
4391|NCT02358044|9387|P2|Treated|Overall Study||126
4392|NCT02358044|9388|P1|Treated|Overall Study||129
4393|NCT02358044|9387|P2|STARTED|Overall Study||128
4394|NCT02358044|9388|P1|STARTED|Overall Study||129
4395|NCT02357940|9404|P2|NOT COMPLETED|Overall Study||2
4396|NCT02357940|9405|P1|NOT COMPLETED|Overall Study||0
4397|NCT02357940|9404|P2|COMPLETED|Overall Study||30
4398|NCT02357940|9405|P1|COMPLETED|Overall Study||9
4399|NCT02357940|9404|P2|STARTED|Overall Study||32
4400|NCT02357940|9405|P1|STARTED|Overall Study||9
4401|NCT02357485|9529|P1|NOT COMPLETED|Overall Study||0
4402|NCT02357485|9529|P1|COMPLETED|Overall Study||6
4403|NCT02357485|9529|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
4404|NCT02356588|9539|P2|NOT COMPLETED|Overall Study||13
4405|NCT02356588|9540|P1|NOT COMPLETED|Overall Study||5
4406|NCT02356588|9539|P2|COMPLETED|Overall Study||41
4407|NCT02356588|9540|P1|COMPLETED|Overall Study||102
4408|NCT02356588|9539|P2|STARTED|Overall Study||54
4409|NCT02356588|9540|P1|STARTED|Overall Study||107
4410|NCT02355977|9575|P3|NOT COMPLETED|Overall Study||0
4411|NCT02355977|9576|P2|NOT COMPLETED|Overall Study||0
4412|NCT02355977|9577|P1|NOT COMPLETED|Overall Study||0
4413|NCT02355977|9575|P3|COMPLETED|Overall Study||23
4414|NCT02355977|9576|P2|COMPLETED|Overall Study||26
4415|NCT02355977|9577|P1|COMPLETED|Overall Study||21
4416|NCT02355977|9575|P3|STARTED|Overall Study||23
4417|NCT02355977|9576|P2|STARTED|Overall Study||26
4418|NCT02355977|9577|P1|STARTED|Overall Study||21
4419|NCT02355275|9591|P1|NOT COMPLETED|Overall Study||8
4420|NCT02355275|9591|P1|COMPLETED|Overall Study||14
4421|NCT02355275|9591|P1|STARTED|Overall Study||22
4422|NCT02354833|9598|P2|NOT COMPLETED|Overall Study||0
4423|NCT02354833|9599|P1|NOT COMPLETED|Overall Study||0
4424|NCT02354833|9598|P2|COMPLETED|Overall Study||43
4425|NCT02354833|9599|P1|COMPLETED|Overall Study||38
4426|NCT02354833|9598|P2|STARTED|Overall Study||43
4427|NCT02354833|9599|P1|STARTED|Overall Study||38
4428|NCT02354599|9617|P6|NOT COMPLETED|Overall Study||1
4429|NCT02354599|9618|P5|NOT COMPLETED|Overall Study||0
4430|NCT02354599|9619|P4|NOT COMPLETED|Overall Study||0
4431|NCT02354599|9620|P3|NOT COMPLETED|Overall Study||0
4432|NCT02354599|9621|P2|NOT COMPLETED|Overall Study||1
4433|NCT02354599|9622|P1|NOT COMPLETED|Overall Study||1
4434|NCT02354599|9617|P6|COMPLETED|Overall Study||5
4435|NCT02354599|9618|P5|COMPLETED|Overall Study||2
4436|NCT02354599|9619|P4|COMPLETED|Overall Study||6
4437|NCT02354599|9620|P3|COMPLETED|Overall Study||6
4438|NCT02354599|9621|P2|COMPLETED|Overall Study||5
4439|NCT02354599|9622|P1|COMPLETED|Overall Study||5
4440|NCT02354599|9617|P6|STARTED|Overall Study||6
4441|NCT02354599|9618|P5|STARTED|Overall Study||2
4442|NCT02354599|9619|P4|STARTED|Overall Study||6
4443|NCT02354599|9620|P3|STARTED|Overall Study||6
4444|NCT02354599|9621|P2|STARTED|Overall Study||6
4445|NCT02354599|9622|P1|STARTED|Overall Study||6
4446|NCT02353754|9694|P2|NOT COMPLETED|Overall Study||0
4447|NCT02353754|9695|P1|NOT COMPLETED|Overall Study||2
4448|NCT02353754|9694|P2|COMPLETED|Overall Study||0
4449|NCT02353754|9695|P1|COMPLETED|Overall Study||10
4450|NCT02353754|9694|P2|STARTED|Overall Study||0
4451|NCT02353754|9695|P1|STARTED|Overall Study||12
4452|NCT02353572|9705|P1|NOT COMPLETED|Overall Study||3
4453|NCT02353572|9705|P1|COMPLETED|Overall Study||0
4454|NCT02353572|9705|P1|STARTED|Overall Study||3
4455|NCT02353468|9709|P1|NOT COMPLETED|Overall Study||3
4456|NCT02353468|9709|P1|COMPLETED|Overall Study||0
4457|NCT02353468|9709|P1|STARTED|Overall Study||3
4458|NCT02353442|9715|P2|NOT COMPLETED|Overall Study||4
4459|NCT02353442|9716|P1|NOT COMPLETED|Overall Study||3
4460|NCT02353442|9715|P2|COMPLETED|Overall Study||27
4461|NCT02353442|9716|P1|COMPLETED|Overall Study||25
4462|NCT02353442|9715|P2|STARTED|Overall Study||31
4463|NCT02353442|9716|P1|STARTED|Overall Study||28
4464|NCT02351817|9730|P2|NOT COMPLETED|Period 2||2
4465|NCT02351817|9731|P1|NOT COMPLETED|Period 2||1
4466|NCT02351817|9730|P2|COMPLETED|Period 2||3
4467|NCT02351817|9731|P1|COMPLETED|Period 2||4
4468|NCT02351817|9730|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
4469|NCT02351817|9731|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
4470|NCT02351817|9730|P2|NOT COMPLETED|Period 1||3
4471|NCT02351817|9731|P1|NOT COMPLETED|Period 1||1
4472|NCT02351817|9730|P2|COMPLETED|Period 1||2
4473|NCT02351817|9731|P1|COMPLETED|Period 1||4
4474|NCT02351817|9730|P2|STARTED|Period 1||5
4475|NCT02351817|9731|P1|STARTED|Period 1||5
4476|NCT02351817|9730|P2|NOT COMPLETED|Baseline Period||0
4477|NCT02351817|9731|P1|NOT COMPLETED|Baseline Period||0
4478|NCT02351817|9730|P2|COMPLETED|Baseline Period||5
4479|NCT02351817|9731|P1|COMPLETED|Baseline Period||5
4480|NCT02351817|9730|P2|STARTED|Baseline Period||5
4481|NCT02351817|9731|P1|STARTED|Baseline Period||5
4482|NCT02351505|9738|P1|NOT COMPLETED|Overall Study||0
4483|NCT02351505|9738|P1|COMPLETED|Overall Study||1
4484|NCT02351505|9738|P1|STARTED|Overall Study||1
4485|NCT02350881|9749|P1|NOT COMPLETED|Overall Study||0
4486|NCT02350881|9749|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
4487|NCT02350881|9749|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
4488|NCT02349711|9779|P2|NOT COMPLETED|Overall Study||2
4489|NCT02349711|9780|P1|NOT COMPLETED|Overall Study||3
4490|NCT02349711|9779|P2|COMPLETED|Overall Study||84
4491|NCT02349711|9780|P1|COMPLETED|Overall Study||84
4492|NCT02349711|9779|P2|STARTED|Overall Study||86
4493|NCT02349711|9780|P1|STARTED|Overall Study||87
4494|NCT02349685|9795|P3|NOT COMPLETED|Overall Study||4
4495|NCT02349685|9796|P2|NOT COMPLETED|Overall Study||2
4496|NCT02349685|9797|P1|NOT COMPLETED|Overall Study||5
4497|NCT02349685|9795|P3|COMPLETED|Overall Study||37
4498|NCT02349685|9796|P2|COMPLETED|Overall Study||87
4499|NCT02349685|9797|P1|COMPLETED|Overall Study||84
4500|NCT02349685|9795|P3|STARTED|Overall Study||41
4501|NCT02349685|9796|P2|STARTED|Overall Study||89
4502|NCT02349685|9797|P1|STARTED|Overall Study||89
4503|NCT02349438|9808|P2|NOT COMPLETED|Period 2||0
4504|NCT02349438|9809|P1|NOT COMPLETED|Period 2||0
4505|NCT02349438|9808|P2|COMPLETED|Period 2||10
4506|NCT02349438|9809|P1|COMPLETED|Period 2||11
4507|NCT02349438|9808|P2|STARTED|Period 2||10
4508|NCT02349438|9809|P1|STARTED|Period 2||11
4509|NCT02349438|9808|P2|NOT COMPLETED|Period 1||0
4510|NCT02349438|9809|P1|NOT COMPLETED|Period 1||0
4511|NCT02349438|9808|P2|COMPLETED|Period 1||10
4512|NCT02349438|9809|P1|COMPLETED|Period 1||11
4513|NCT02349438|9808|P2|STARTED|Period 1||10
4514|NCT02349438|9809|P1|STARTED|Period 1||11
4515|NCT02348658|9819|P2|NOT COMPLETED|Period 2 (7 Days)||0
4516|NCT02348658|9820|P1|NOT COMPLETED|Period 2 (7 Days)||0
4517|NCT02348658|9819|P2|COMPLETED|Period 2 (7 Days)||6
4518|NCT02348658|9820|P1|COMPLETED|Period 2 (7 Days)||6
4519|NCT02348658|9819|P2|STARTED|Period 2 (7 Days)||6
4520|NCT02348658|9820|P1|STARTED|Period 2 (7 Days)||6
4521|NCT02348658|9819|P2|NOT COMPLETED|Washout Period (22 Days)||0
4522|NCT02348658|9820|P1|NOT COMPLETED|Washout Period (22 Days)||0
4523|NCT02348658|9819|P2|COMPLETED|Washout Period (22 Days)||6
4524|NCT02348658|9820|P1|COMPLETED|Washout Period (22 Days)||6
4525|NCT02348658|9819|P2|STARTED|Washout Period (22 Days)||6
4526|NCT02348658|9820|P1|STARTED|Washout Period (22 Days)||6
4527|NCT02348658|9819|P2|NOT COMPLETED|Period 1 (7 Days)||0
4528|NCT02348658|9820|P1|NOT COMPLETED|Period 1 (7 Days)||0
4529|NCT02348658|9819|P2|COMPLETED|Period 1 (7 Days)||6
4530|NCT02348658|9820|P1|COMPLETED|Period 1 (7 Days)||6
4531|NCT02348658|9819|P2|STARTED|Period 1 (7 Days)||6
4532|NCT02348658|9820|P1|STARTED|Period 1 (7 Days)||6
4533|NCT02347488|9854|P1|NOT COMPLETED|Overall Study||0
4534|NCT02347488|9854|P1|COMPLETED|Overall Study||30
4535|NCT02347488|9854|P1|STARTED|Overall Study||30
4536|NCT02345720|9864|P1|NOT COMPLETED|Overall Study||0
4537|NCT02345720|9864|P1|COMPLETED|Overall Study||20
4538|NCT02345720|9864|P1|STARTED|Overall Study||20
4539|NCT02344745|9872|P2|NOT COMPLETED|Overall Study||0
4540|NCT02344745|9873|P1|NOT COMPLETED|Overall Study||2
4541|NCT02344745|9872|P2|COMPLETED|Overall Study||40
4542|NCT02344745|9873|P1|COMPLETED|Overall Study||38
4543|NCT02344745|9872|P2|STARTED|Overall Study||40
4544|NCT02344745|9873|P1|STARTED|Overall Study||40
4545|NCT02343380|9887|P2|NOT COMPLETED|Overall Study||0
4546|NCT02343380|9888|P1|NOT COMPLETED|Overall Study||0
4547|NCT02343380|9887|P2|COMPLETED|Overall Study|Morning test (second week)|10
4548|NCT02343380|9888|P1|COMPLETED|Overall Study|Evening test (second week)|10
4549|NCT02343380|9887|P2|STARTED|Overall Study|Evening test (first week)|10
4550|NCT02343380|9888|P1|STARTED|Overall Study|Morning test (first week)|10
4551|NCT02343081|9900|P2|NOT COMPLETED|Second Intervention (Day 4)||0
4552|NCT02343081|9901|P1|NOT COMPLETED|Second Intervention (Day 4)||0
4553|NCT02343081|9900|P2|COMPLETED|Second Intervention (Day 4)||8
4554|NCT02343081|9901|P1|COMPLETED|Second Intervention (Day 4)||8
4555|NCT02343081|9900|P2|Received Intervention|Second Intervention (Day 4)||8
4556|NCT02343081|9901|P1|Received Intervention|Second Intervention (Day 4)||8
4557|NCT02343081|9900|P2|STARTED|Second Intervention (Day 4)||8
4558|NCT02343081|9901|P1|STARTED|Second Intervention (Day 4)||8
4559|NCT02343081|9900|P2|NOT COMPLETED|Washout (10 Hours)||0
4560|NCT02343081|9901|P1|NOT COMPLETED|Washout (10 Hours)||0
4561|NCT02343081|9900|P2|COMPLETED|Washout (10 Hours)||8
4562|NCT02343081|9901|P1|COMPLETED|Washout (10 Hours)||8
4563|NCT02343081|9900|P2|STARTED|Washout (10 Hours)||8
4564|NCT02343081|9901|P1|STARTED|Washout (10 Hours)||8
4565|NCT02343081|9900|P2|NOT COMPLETED|First Intervention (Day 3)||0
4566|NCT02343081|9901|P1|NOT COMPLETED|First Intervention (Day 3)||0
4567|NCT02343081|9900|P2|COMPLETED|First Intervention (Day 3)||8
4568|NCT02343081|9901|P1|COMPLETED|First Intervention (Day 3)||8
4569|NCT02343081|9900|P2|Received Intervention|First Intervention (Day 3)||8
4570|NCT02343081|9901|P1|Received Intervention|First Intervention (Day 3)||8
4571|NCT02343081|9900|P2|STARTED|First Intervention (Day 3)||8
4572|NCT02343081|9901|P1|STARTED|First Intervention (Day 3)||8
4573|NCT02342561|9915|P1|NOT COMPLETED|Overall Study||0
4574|NCT02342561|9915|P1|COMPLETED|Overall Study||20
4575|NCT02342561|9915|P1|STARTED|Overall Study||20
4576|NCT02342288|9925|P2|NOT COMPLETED|Overall Study||6
4577|NCT02342288|9926|P1|NOT COMPLETED|Overall Study||5
4578|NCT02342288|9925|P2|COMPLETED|Overall Study||27
4579|NCT02342288|9926|P1|COMPLETED|Overall Study||25
4580|NCT02342288|9925|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
4581|NCT02342288|9926|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
4582|NCT02342223|9932|P1|NOT COMPLETED|Overall Study||1
4583|NCT02342223|9932|P1|COMPLETED|Overall Study||19
4584|NCT02342223|9932|P1|STARTED|Overall Study||20
4585|NCT02342197|9943|P2|NOT COMPLETED|Overall Study||2
4586|NCT02342197|9944|P1|NOT COMPLETED|Overall Study||3
4587|NCT02342197|9943|P2|COMPLETED|Overall Study||28
4588|NCT02342197|9944|P1|COMPLETED|Overall Study||27
4589|NCT02342197|9943|P2|STARTED|Overall Study||30
4590|NCT02342197|9944|P1|STARTED|Overall Study||30
4591|NCT02341859|9950|P2|NOT COMPLETED|Second Intervention (1 Day)||0
4592|NCT02341859|9951|P1|NOT COMPLETED|Second Intervention (1 Day)||0
4593|NCT02341859|9950|P2|COMPLETED|Second Intervention (1 Day)||9
4594|NCT02341859|9951|P1|COMPLETED|Second Intervention (1 Day)||10
4595|NCT02341859|9950|P2|STARTED|Second Intervention (1 Day)||9
4596|NCT02341859|9951|P1|STARTED|Second Intervention (1 Day)||10
4597|NCT02341859|9950|P2|NOT COMPLETED|First Intervention (1 Day)||0
4598|NCT02341859|9951|P1|NOT COMPLETED|First Intervention (1 Day)||0
4599|NCT02341859|9950|P2|COMPLETED|First Intervention (1 Day)||9
4600|NCT02341859|9951|P1|COMPLETED|First Intervention (1 Day)||10
4601|NCT02341859|9950|P2|STARTED|First Intervention (1 Day)||9
4602|NCT02341859|9951|P1|STARTED|First Intervention (1 Day)||10
4603|NCT02341482|10104|P1|NOT COMPLETED|Overall Study||1
4604|NCT02341482|10104|P1|COMPLETED|Overall Study||12
4605|NCT02341482|10104|P1|STARTED|Overall Study||13
4606|NCT02340338|10137|P7|NOT COMPLETED|Overall Study||0
4607|NCT02340338|10138|P6|NOT COMPLETED|Overall Study||0
4608|NCT02340338|10139|P5|NOT COMPLETED|Overall Study||0
4609|NCT02340338|10140|P4|NOT COMPLETED|Overall Study||0
4610|NCT02340338|10141|P3|NOT COMPLETED|Overall Study||0
4611|NCT02340338|10142|P2|NOT COMPLETED|Overall Study||0
4612|NCT02340338|10143|P1|NOT COMPLETED|Overall Study||0
4613|NCT02340338|10137|P7|COMPLETED|Overall Study||12
4614|NCT02340338|10138|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
4615|NCT02340338|10139|P5|COMPLETED|Overall Study||9
4616|NCT02340338|10140|P4|COMPLETED|Overall Study||9
4617|NCT02340338|10141|P3|COMPLETED|Overall Study||3
4618|NCT02340338|10142|P2|COMPLETED|Overall Study||2
4619|NCT02340338|10143|P1|COMPLETED|Overall Study||2
4620|NCT02340338|10137|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
4621|NCT02340338|10138|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
4622|NCT02340338|10139|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
4623|NCT02340338|10140|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
4624|NCT02340338|10141|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
4625|NCT02340338|10142|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
4626|NCT02340338|10143|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
4627|NCT02339246|10168|P3|NOT COMPLETED|Third Period (7 Days)||0
4628|NCT02339246|10169|P2|NOT COMPLETED|Third Period (7 Days)||0
4629|NCT02339246|10170|P1|NOT COMPLETED|Third Period (7 Days)||0
4630|NCT02339246|10168|P3|COMPLETED|Third Period (7 Days)||0
4631|NCT02339246|10169|P2|COMPLETED|Third Period (7 Days)||16
4632|NCT02339246|10170|P1|COMPLETED|Third Period (7 Days)||15
4633|NCT02339246|10168|P3|STARTED|Third Period (7 Days)||0
4634|NCT02339246|10169|P2|STARTED|Third Period (7 Days)||16
4635|NCT02339246|10170|P1|STARTED|Third Period (7 Days)||15
4636|NCT02339246|10168|P3|NOT COMPLETED|Second Intervention (7 Days)||0
4637|NCT02339246|10169|P2|NOT COMPLETED|Second Intervention (7 Days)||0
4638|NCT02339246|10170|P1|NOT COMPLETED|Second Intervention (7 Days)||0
4639|NCT02339246|10168|P3|COMPLETED|Second Intervention (7 Days)||0
4640|NCT02339246|10169|P2|COMPLETED|Second Intervention (7 Days)||15
4641|NCT02339246|10170|P1|COMPLETED|Second Intervention (7 Days)||16
4642|NCT02339246|10168|P3|STARTED|Second Intervention (7 Days)||0
4643|NCT02339246|10169|P2|STARTED|Second Intervention (7 Days)||15
4644|NCT02339246|10170|P1|STARTED|Second Intervention (7 Days)||16
4645|NCT02339246|10168|P3|NOT COMPLETED|First Intervention (7 Days)||0
4646|NCT02339246|10169|P2|NOT COMPLETED|First Intervention (7 Days)||0
4647|NCT02339246|10170|P1|NOT COMPLETED|First Intervention (7 Days)||0
4648|NCT02339246|10168|P3|COMPLETED|First Intervention (7 Days)||31
4649|NCT02339246|10169|P2|COMPLETED|First Intervention (7 Days)||0
4650|NCT02339246|10170|P1|COMPLETED|First Intervention (7 Days)||0
4651|NCT02339246|10168|P3|STARTED|First Intervention (7 Days)||31
4652|NCT02339246|10169|P2|STARTED|First Intervention (7 Days)||0
4653|NCT02339246|10170|P1|STARTED|First Intervention (7 Days)||0
4654|NCT02338336|10186|P4|NOT COMPLETED|Overall Study||0
4655|NCT02338336|10187|P3|NOT COMPLETED|Overall Study||0
4656|NCT02338336|10188|P2|NOT COMPLETED|Overall Study||0
4657|NCT02338336|10189|P1|NOT COMPLETED|Overall Study||2
4658|NCT02338336|10186|P4|COMPLETED|Overall Study||4
4659|NCT02338336|10187|P3|COMPLETED|Overall Study||7
4660|NCT02338336|10188|P2|COMPLETED|Overall Study||17
4661|NCT02338336|10189|P1|COMPLETED|Overall Study||24
4662|NCT02338336|10186|P4|STARTED|Overall Study||4
4663|NCT02338336|10187|P3|STARTED|Overall Study||7
4664|NCT02338336|10188|P2|STARTED|Overall Study||17
4665|NCT02338336|10189|P1|STARTED|Overall Study||26
4666|NCT02337959|10200|P3|NOT COMPLETED|Overall Study||0
4667|NCT02337959|10201|P2|NOT COMPLETED|Overall Study||3
4668|NCT02337959|10202|P1|NOT COMPLETED|Overall Study||0
4669|NCT02337959|10200|P3|COMPLETED|Overall Study||7
4670|NCT02337959|10201|P2|COMPLETED|Overall Study||7
4671|NCT02337959|10202|P1|COMPLETED|Overall Study||10
4672|NCT02337959|10200|P3|STARTED|Overall Study||7
4673|NCT02337959|10201|P2|STARTED|Overall Study||10
4674|NCT02337959|10202|P1|STARTED|Overall Study||10
4675|NCT02336958|10212|P2|NOT COMPLETED|Overall Study||0
4676|NCT02336958|10213|P1|NOT COMPLETED|Overall Study||0
4677|NCT02336958|10212|P2|COMPLETED|Overall Study||20
4678|NCT02336958|10213|P1|COMPLETED|Overall Study||20
4679|NCT02336958|10212|P2|STARTED|Overall Study||20
4680|NCT02336958|10213|P1|STARTED|Overall Study||20
4681|NCT02336763|10221|P1|NOT COMPLETED|Overall Study||0
4682|NCT02336763|10221|P1|COMPLETED|Overall Study||2
4683|NCT02336763|10221|P1|STARTED|Overall Study||2
4684|NCT02336607|10235|P4|NOT COMPLETED|Overall Study||87
4685|NCT02336607|10236|P3|NOT COMPLETED|Overall Study||6
4686|NCT02336607|10237|P2|NOT COMPLETED|Overall Study||10
4687|NCT02336607|10238|P1|NOT COMPLETED|Overall Study||4
4688|NCT02336607|10235|P4|COMPLETED|Overall Study||180
4689|NCT02336607|10236|P3|COMPLETED|Overall Study||86
4690|NCT02336607|10237|P2|COMPLETED|Overall Study||75
4691|NCT02336607|10238|P1|COMPLETED|Overall Study||81
4692|NCT02336607|10235|P4|Patients Included in Safety Population|Overall Study||260
4693|NCT02336607|10236|P3|Patients Included in Safety Population|Overall Study||92
4694|NCT02336607|10237|P2|Patients Included in Safety Population|Overall Study||85
4695|NCT02336607|10238|P1|Patients Included in Safety Population|Overall Study||85
4696|NCT02336607|10235|P4|Patients Included in PP Population|Overall Study||162
4697|NCT02336607|10236|P3|Patients Included in PP Population|Overall Study||75
4698|NCT02336607|10237|P2|Patients Included in PP Population|Overall Study||75
4699|NCT02336607|10238|P1|Patients Included in PP Population|Overall Study||78
4700|NCT02336607|10235|P4|Patients Included in ITT Population|Overall Study||222
4701|NCT02336607|10236|P3|Patients Included in ITT Population|Overall Study||91
4702|NCT02336607|10237|P2|Patients Included in ITT Population|Overall Study||84
4703|NCT02336607|10238|P1|Patients Included in ITT Population|Overall Study||84
4704|NCT02336607|10235|P4|STARTED|Overall Study||267
4705|NCT02336607|10236|P3|STARTED|Overall Study||92
4706|NCT02336607|10237|P2|STARTED|Overall Study||85
4707|NCT02336607|10238|P1|STARTED|Overall Study||85
4708|NCT02336438|10292|P1|NOT COMPLETED|Overall Study||1
4709|NCT02336438|10292|P1|COMPLETED|Overall Study||10
4710|NCT02336438|10292|P1|STARTED|Overall Study||11
4711|NCT02335710|10303|P2|NOT COMPLETED|Overall Study||0
4712|NCT02335710|10304|P1|NOT COMPLETED|Overall Study||0
4713|NCT02335710|10303|P2|COMPLETED|Overall Study||10
4714|NCT02335710|10304|P1|COMPLETED|Overall Study||40
4715|NCT02335710|10303|P2|STARTED|Overall Study||10
4716|NCT02335710|10304|P1|STARTED|Overall Study||40
4717|NCT02334982|10331|P7|NOT COMPLETED|Overall Study||0
4718|NCT02334982|10332|P6|NOT COMPLETED|Overall Study||0
4719|NCT02334982|10333|P5|NOT COMPLETED|Overall Study||0
4720|NCT02334982|10334|P4|NOT COMPLETED|Overall Study||0
4721|NCT02334982|10335|P3|NOT COMPLETED|Overall Study||0
4722|NCT02334982|10336|P2|NOT COMPLETED|Overall Study||0
4723|NCT02334982|10337|P1|NOT COMPLETED|Overall Study||0
4724|NCT02334982|10331|P7|COMPLETED|Overall Study||12
4725|NCT02334982|10332|P6|COMPLETED|Overall Study||6
4726|NCT02334982|10333|P5|COMPLETED|Overall Study||6
4727|NCT02334982|10334|P4|COMPLETED|Overall Study||6
4728|NCT02334982|10335|P3|COMPLETED|Overall Study||6
4729|NCT02334982|10336|P2|COMPLETED|Overall Study||5
4730|NCT02334982|10337|P1|COMPLETED|Overall Study||6
4731|NCT02334982|10331|P7|STARTED|Overall Study||12
4732|NCT02334982|10332|P6|STARTED|Overall Study||6
4733|NCT02334982|10333|P5|STARTED|Overall Study||6
4734|NCT02334982|10334|P4|STARTED|Overall Study||6
4735|NCT02334982|10335|P3|STARTED|Overall Study||6
4736|NCT02334982|10336|P2|STARTED|Overall Study||5
4737|NCT02334982|10337|P1|STARTED|Overall Study||6
4738|NCT02334787|10445|P4|NOT COMPLETED|Overall Study||0
4739|NCT02334787|10446|P3|NOT COMPLETED|Overall Study||0
4740|NCT02334787|10447|P2|NOT COMPLETED|Overall Study||0
4741|NCT02334787|10448|P1|NOT COMPLETED|Overall Study||0
4742|NCT02334787|10445|P4|COMPLETED|Overall Study||8
4743|NCT02334787|10446|P3|COMPLETED|Overall Study||8
4744|NCT02334787|10447|P2|COMPLETED|Overall Study||8
4745|NCT02334787|10448|P1|COMPLETED|Overall Study||8
4746|NCT02334787|10445|P4|STARTED|Overall Study||8
4747|NCT02334787|10446|P3|STARTED|Overall Study||8
4748|NCT02334787|10447|P2|STARTED|Overall Study||8
4749|NCT02334787|10448|P1|STARTED|Overall Study||8
4750|NCT02332798|10473|P3|NOT COMPLETED|Overall Study||1
4751|NCT02332798|10474|P2|NOT COMPLETED|Overall Study||2
4752|NCT02332798|10475|P1|NOT COMPLETED|Overall Study||1
4753|NCT02332798|10473|P3|COMPLETED|Overall Study||11
4754|NCT02332798|10474|P2|COMPLETED|Overall Study||12
4755|NCT02332798|10475|P1|COMPLETED|Overall Study||12
4756|NCT02332798|10473|P3|STARTED|Overall Study||12
4757|NCT02332798|10474|P2|STARTED|Overall Study||14
4758|NCT02332798|10475|P1|STARTED|Overall Study||13
4759|NCT02331589|10527|P2|NOT COMPLETED|Overall Study||5
4760|NCT02331589|10528|P1|NOT COMPLETED|Overall Study||5
4761|NCT02331589|10527|P2|COMPLETED|Overall Study||31
4762|NCT02331589|10528|P1|COMPLETED|Overall Study||34
4763|NCT02331589|10527|P2|STARTED|Overall Study||36
4764|NCT02331589|10528|P1|STARTED|Overall Study||39
4765|NCT02331446|10544|P4|NOT COMPLETED|Overall Study||3
4766|NCT02331446|10545|P3|NOT COMPLETED|Overall Study||3
4767|NCT02331446|10546|P2|NOT COMPLETED|Overall Study||5
4768|NCT02331446|10547|P1|NOT COMPLETED|Overall Study||4
4769|NCT02331446|10544|P4|COMPLETED|Overall Study||8
4770|NCT02331446|10545|P3|COMPLETED|Overall Study||8
4771|NCT02331446|10546|P2|COMPLETED|Overall Study||6
4772|NCT02331446|10547|P1|COMPLETED|Overall Study||5
4773|NCT02331446|10544|P4|STARTED|Overall Study||11
4774|NCT02331446|10545|P3|STARTED|Overall Study||11
4775|NCT02331446|10546|P2|STARTED|Overall Study||11
4776|NCT02331446|10547|P1|STARTED|Overall Study||9
4777|NCT02330523|10619|P2|NOT COMPLETED|Overall Study||0
4778|NCT02330523|10620|P1|NOT COMPLETED|Overall Study||0
4779|NCT02330523|10619|P2|COMPLETED|Overall Study||19
4780|NCT02330523|10620|P1|COMPLETED|Overall Study||21
4781|NCT02330523|10619|P2|STARTED|Overall Study||19
4782|NCT02330523|10620|P1|STARTED|Overall Study||21
4783|NCT02329964|10632|P2|NOT COMPLETED|Overall Study||0
4784|NCT02329964|10633|P1|NOT COMPLETED|Overall Study||0
4785|NCT02329964|10632|P2|COMPLETED|Overall Study||40
4786|NCT02329964|10633|P1|COMPLETED|Overall Study||40
4787|NCT02329964|10632|P2|STARTED|Overall Study||40
4788|NCT02329964|10633|P1|STARTED|Overall Study||40
4789|NCT02329730|10659|P12|NOT COMPLETED|Overall Study||0
4790|NCT02329730|10660|P11|NOT COMPLETED|Overall Study||0
4791|NCT02329730|10661|P10|NOT COMPLETED|Overall Study||1
4792|NCT02329730|10662|P9|NOT COMPLETED|Overall Study||1
4793|NCT02329730|10663|P8|NOT COMPLETED|Overall Study||1
4794|NCT02329730|10664|P7|NOT COMPLETED|Overall Study||1
4795|NCT02329730|10665|P6|NOT COMPLETED|Overall Study||2
4796|NCT02329730|10666|P5|NOT COMPLETED|Overall Study||3
4797|NCT02329730|10667|P4|NOT COMPLETED|Overall Study||0
4798|NCT02329730|10668|P3|NOT COMPLETED|Overall Study||0
4799|NCT02329730|10669|P2|NOT COMPLETED|Overall Study||0
4800|NCT02329730|10670|P1|NOT COMPLETED|Overall Study||0
4801|NCT02329730|10659|P12|COMPLETED|Overall Study||8
4802|NCT02329730|10660|P11|COMPLETED|Overall Study||8
4803|NCT02329730|10661|P10|COMPLETED|Overall Study||7
4804|NCT02329730|10662|P9|COMPLETED|Overall Study||7
4805|NCT02329730|10663|P8|COMPLETED|Overall Study||13
4806|NCT02329730|10664|P7|COMPLETED|Overall Study||13
4807|NCT02329730|10665|P6|COMPLETED|Overall Study||12
4808|NCT02329730|10666|P5|COMPLETED|Overall Study||11
4809|NCT02329730|10667|P4|COMPLETED|Overall Study||14
4810|NCT02329730|10668|P3|COMPLETED|Overall Study||14
4811|NCT02329730|10669|P2|COMPLETED|Overall Study||14
4812|NCT02329730|10670|P1|COMPLETED|Overall Study||14
4813|NCT02329730|10659|P12|STARTED|Overall Study||8
4814|NCT02329730|10660|P11|STARTED|Overall Study||8
4815|NCT02329730|10661|P10|STARTED|Overall Study||8
4816|NCT02329730|10662|P9|STARTED|Overall Study||8
4817|NCT02329730|10663|P8|STARTED|Overall Study||14
4818|NCT02329730|10664|P7|STARTED|Overall Study||14
4819|NCT02329730|10665|P6|STARTED|Overall Study||14
4820|NCT02329730|10666|P5|STARTED|Overall Study||14
4821|NCT02329730|10667|P4|STARTED|Overall Study||14
4822|NCT02329730|10668|P3|STARTED|Overall Study||14
4823|NCT02329730|10669|P2|STARTED|Overall Study||14
4824|NCT02329730|10670|P1|STARTED|Overall Study||14
4825|NCT02329600|10747|P3|NOT COMPLETED|Overall Study||0
4826|NCT02329600|10748|P2|NOT COMPLETED|Overall Study||0
4827|NCT02329600|10749|P1|NOT COMPLETED|Overall Study||0
4828|NCT02329600|10747|P3|COMPLETED|Overall Study||15
4829|NCT02329600|10748|P2|COMPLETED|Overall Study||15
4830|NCT02329600|10749|P1|COMPLETED|Overall Study||10
4831|NCT02329600|10747|P3|STARTED|Overall Study||15
4832|NCT02329600|10748|P2|STARTED|Overall Study||15
4833|NCT02329600|10749|P1|STARTED|Overall Study||10
4834|NCT02329223|10763|P3|NOT COMPLETED|Overall Study||6
4835|NCT02329223|10764|P2|NOT COMPLETED|Overall Study||3
4836|NCT02329223|10765|P1|NOT COMPLETED|Overall Study||1
4837|NCT02329223|10763|P3|COMPLETED|Overall Study||68
4838|NCT02329223|10764|P2|COMPLETED|Overall Study||68
4839|NCT02329223|10765|P1|COMPLETED|Overall Study||72
4840|NCT02329223|10763|P3|Safety Set|Overall Study||74
4841|NCT02329223|10764|P2|Safety Set|Overall Study||71
4842|NCT02329223|10765|P1|Safety Set|Overall Study||73
4843|NCT02329223|10763|P3|Full Analysis Set|Overall Study||74
4844|NCT02329223|10764|P2|Full Analysis Set|Overall Study||70
4845|NCT02329223|10765|P1|Full Analysis Set|Overall Study||73
4846|NCT02329223|10763|P3|STARTED|Overall Study||74
4847|NCT02329223|10764|P2|STARTED|Overall Study||71
4848|NCT02329223|10765|P1|STARTED|Overall Study||73
4849|NCT02329015|10798|P2|NOT COMPLETED|Overall Study||0
4850|NCT02329015|10799|P1|NOT COMPLETED|Overall Study||0
4851|NCT02329015|10798|P2|COMPLETED|Overall Study||64
4852|NCT02329015|10799|P1|COMPLETED|Overall Study||48
4853|NCT02329015|10798|P2|STARTED|Overall Study||64
4854|NCT02329015|10799|P1|STARTED|Overall Study||48
4855|NCT02328937|10815|P6|NOT COMPLETED|Period 3||0
4856|NCT02328937|10816|P5|NOT COMPLETED|Period 3||0
4857|NCT02328937|10817|P4|NOT COMPLETED|Period 3||0
4858|NCT02328937|10818|P3|NOT COMPLETED|Period 3||0
4859|NCT02328937|10819|P2|NOT COMPLETED|Period 3||0
4860|NCT02328937|10820|P1|NOT COMPLETED|Period 3||0
4861|NCT02328937|10815|P6|COMPLETED|Period 3||6
4862|NCT02328937|10816|P5|COMPLETED|Period 3||6
4863|NCT02328937|10817|P4|COMPLETED|Period 3||5
4864|NCT02328937|10818|P3|COMPLETED|Period 3||6
4865|NCT02328937|10819|P2|COMPLETED|Period 3||6
4866|NCT02328937|10820|P1|COMPLETED|Period 3||7
4867|NCT02328937|10815|P6|STARTED|Period 3||6
4868|NCT02328937|10816|P5|STARTED|Period 3||6
4869|NCT02328937|10817|P4|STARTED|Period 3||5
4870|NCT02328937|10818|P3|STARTED|Period 3||6
4871|NCT02328937|10819|P2|STARTED|Period 3||6
4872|NCT02328937|10820|P1|STARTED|Period 3||7
4873|NCT02328937|10815|P6|NOT COMPLETED|Period 2||0
4874|NCT02328937|10816|P5|NOT COMPLETED|Period 2||0
4875|NCT02328937|10817|P4|NOT COMPLETED|Period 2||0
4876|NCT02328937|10818|P3|NOT COMPLETED|Period 2||1
4877|NCT02328937|10819|P2|NOT COMPLETED|Period 2||0
4878|NCT02328937|10820|P1|NOT COMPLETED|Period 2||0
4879|NCT02328937|10815|P6|COMPLETED|Period 2||6
4880|NCT02328937|10816|P5|COMPLETED|Period 2||6
4881|NCT02328937|10817|P4|COMPLETED|Period 2||5
4882|NCT02328937|10818|P3|COMPLETED|Period 2||6
4883|NCT02328937|10819|P2|COMPLETED|Period 2||6
4884|NCT02328937|10820|P1|COMPLETED|Period 2||7
4885|NCT02328937|10815|P6|STARTED|Period 2||6
4886|NCT02328937|10816|P5|STARTED|Period 2||6
4887|NCT02328937|10817|P4|STARTED|Period 2||5
4888|NCT02328937|10818|P3|STARTED|Period 2||7
4889|NCT02328937|10819|P2|STARTED|Period 2||6
4890|NCT02328937|10820|P1|STARTED|Period 2||7
4891|NCT02328937|10815|P6|NOT COMPLETED|Period 1||0
4892|NCT02328937|10816|P5|NOT COMPLETED|Period 1||0
4893|NCT02328937|10817|P4|NOT COMPLETED|Period 1||1
4894|NCT02328937|10818|P3|NOT COMPLETED|Period 1||0
4895|NCT02328937|10819|P2|NOT COMPLETED|Period 1||0
4896|NCT02328937|10820|P1|NOT COMPLETED|Period 1||0
4897|NCT02328937|10815|P6|COMPLETED|Period 1||6
4898|NCT02328937|10816|P5|COMPLETED|Period 1||6
4899|NCT02328937|10817|P4|COMPLETED|Period 1||5
4900|NCT02328937|10818|P3|COMPLETED|Period 1||7
4901|NCT02328937|10819|P2|COMPLETED|Period 1||6
4902|NCT02328937|10820|P1|COMPLETED|Period 1||7
4903|NCT02328937|10815|P6|STARTED|Period 1||6
4904|NCT02328937|10816|P5|STARTED|Period 1||6
4905|NCT02328937|10817|P4|STARTED|Period 1||6
4906|NCT02328937|10818|P3|STARTED|Period 1||7
4907|NCT02328937|10819|P2|STARTED|Period 1||6
4908|NCT02328937|10820|P1|STARTED|Period 1||7
4909|NCT02328404|10833|P2|NOT COMPLETED|Overall Study||1
4910|NCT02328404|10834|P1|NOT COMPLETED|Overall Study||1
4911|NCT02328404|10833|P2|COMPLETED|Overall Study||29
4912|NCT02328404|10834|P1|COMPLETED|Overall Study||29
4913|NCT02328404|10833|P2|STARTED|Overall Study||30
4914|NCT02328404|10834|P1|STARTED|Overall Study||30
4915|NCT02327117|10870|P2|NOT COMPLETED|Overall Study||0
4916|NCT02327117|10871|P1|NOT COMPLETED|Overall Study||0
4917|NCT02327117|10870|P2|COMPLETED|Overall Study||45
4918|NCT02327117|10871|P1|COMPLETED|Overall Study||45
4919|NCT02327117|10870|P2|STARTED|Overall Study||45
4920|NCT02327117|10871|P1|STARTED|Overall Study||45
4921|NCT02325856|10879|P2|NOT COMPLETED|Overall Study||27
4922|NCT02325856|10880|P1|NOT COMPLETED|Overall Study||20
4923|NCT02325856|10879|P2|COMPLETED|Overall Study||123
4924|NCT02325856|10880|P1|COMPLETED|Overall Study||128
4925|NCT02325856|10879|P2|STARTED|Overall Study||150
4926|NCT02325856|10880|P1|STARTED|Overall Study||148
4927|NCT02325518|10890|P2|NOT COMPLETED|Overall Study||3
4928|NCT02325518|10891|P1|NOT COMPLETED|Overall Study||4
4929|NCT02325518|10890|P2|COMPLETED|Overall Study||100
4930|NCT02325518|10891|P1|COMPLETED|Overall Study||94
4931|NCT02325518|10890|P2|Per Protocol Set (PPS)|Overall Study||97
4932|NCT02325518|10891|P1|Per Protocol Set (PPS)|Overall Study||92
4933|NCT02325518|10890|P2|Full Analysis Set (FAS)|Overall Study||101
4934|NCT02325518|10891|P1|Full Analysis Set (FAS)|Overall Study||98
4935|NCT02325518|10890|P2|Safety Set|Overall Study||103
4936|NCT02325518|10891|P1|Safety Set|Overall Study||98
4937|NCT02325518|10890|P2|STARTED|Overall Study||103
4938|NCT02325518|10891|P1|STARTED|Overall Study||98
4939|NCT02322788|10900|P4|NOT COMPLETED|Visit 6||0
4940|NCT02322788|10901|P3|NOT COMPLETED|Visit 6||0
4941|NCT02322788|10902|P2|NOT COMPLETED|Visit 6||0
4942|NCT02322788|10903|P1|NOT COMPLETED|Visit 6||0
4943|NCT02322788|10900|P4|COMPLETED|Visit 6||15
4944|NCT02322788|10901|P3|COMPLETED|Visit 6||15
4945|NCT02322788|10902|P2|COMPLETED|Visit 6||16
4946|NCT02322788|10903|P1|COMPLETED|Visit 6||14
4947|NCT02322788|10900|P4|STARTED|Visit 6||15
4948|NCT02322788|10901|P3|STARTED|Visit 6||15
4949|NCT02322788|10902|P2|STARTED|Visit 6||16
4950|NCT02322788|10903|P1|STARTED|Visit 6||14
4951|NCT02322788|10900|P4|NOT COMPLETED|Visit 5||0
4952|NCT02322788|10901|P3|NOT COMPLETED|Visit 5||0
4953|NCT02322788|10902|P2|NOT COMPLETED|Visit 5||0
4954|NCT02322788|10903|P1|NOT COMPLETED|Visit 5||0
4955|NCT02322788|10900|P4|COMPLETED|Visit 5||14
4956|NCT02322788|10901|P3|COMPLETED|Visit 5||15
4957|NCT02322788|10902|P2|COMPLETED|Visit 5||15
4958|NCT02322788|10903|P1|COMPLETED|Visit 5||16
4959|NCT02322788|10900|P4|STARTED|Visit 5||14
4960|NCT02322788|10901|P3|STARTED|Visit 5||15
4961|NCT02322788|10902|P2|STARTED|Visit 5||15
4962|NCT02322788|10903|P1|STARTED|Visit 5||16
4963|NCT02322788|10900|P4|NOT COMPLETED|Visit 4||0
4964|NCT02322788|10901|P3|NOT COMPLETED|Visit 4||0
4965|NCT02322788|10902|P2|NOT COMPLETED|Visit 4||0
4966|NCT02322788|10903|P1|NOT COMPLETED|Visit 4||0
4967|NCT02322788|10900|P4|COMPLETED|Visit 4||15
4968|NCT02322788|10901|P3|COMPLETED|Visit 4||16
4969|NCT02322788|10902|P2|COMPLETED|Visit 4||14
4970|NCT02322788|10903|P1|COMPLETED|Visit 4||15
4971|NCT02322788|10900|P4|STARTED|Visit 4||15
4972|NCT02322788|10901|P3|STARTED|Visit 4||16
4973|NCT02322788|10902|P2|STARTED|Visit 4||14
4974|NCT02322788|10903|P1|STARTED|Visit 4||15
4975|NCT02322788|10900|P4|NOT COMPLETED|Visit 3||0
4976|NCT02322788|10901|P3|NOT COMPLETED|Visit 3||0
4977|NCT02322788|10902|P2|NOT COMPLETED|Visit 3||0
4978|NCT02322788|10903|P1|NOT COMPLETED|Visit 3||0
4979|NCT02322788|10900|P4|COMPLETED|Visit 3||16
4980|NCT02322788|10901|P3|COMPLETED|Visit 3||14
4981|NCT02322788|10902|P2|COMPLETED|Visit 3||15
4982|NCT02322788|10903|P1|COMPLETED|Visit 3||15
4983|NCT02322788|10900|P4|STARTED|Visit 3||16
4984|NCT02322788|10901|P3|STARTED|Visit 3||14
4985|NCT02322788|10902|P2|STARTED|Visit 3||15
4986|NCT02322788|10903|P1|STARTED|Visit 3||15
4987|NCT02322775|10915|P2|NOT COMPLETED|Overall Study||6
4988|NCT02322775|10916|P1|NOT COMPLETED|Overall Study||5
4989|NCT02322775|10915|P2|COMPLETED|Overall Study||99
4990|NCT02322775|10916|P1|COMPLETED|Overall Study||101
4991|NCT02322775|10915|P2|STARTED|Overall Study||105
4992|NCT02322775|10916|P1|STARTED|Overall Study||106
4993|NCT02322749|10942|P6|NOT COMPLETED|Period 3||0
4994|NCT02322749|10943|P5|NOT COMPLETED|Period 3||0
4995|NCT02322749|10944|P4|NOT COMPLETED|Period 3||0
4996|NCT02322749|10945|P3|NOT COMPLETED|Period 3||1
4997|NCT02322749|10946|P2|NOT COMPLETED|Period 3||0
4998|NCT02322749|10947|P1|NOT COMPLETED|Period 3||0
4999|NCT02322749|10942|P6|COMPLETED|Period 3||8
5000|NCT02322749|10943|P5|COMPLETED|Period 3||8
5001|NCT02322749|10944|P4|COMPLETED|Period 3||6
5002|NCT02322749|10945|P3|COMPLETED|Period 3||7
5003|NCT02322749|10946|P2|COMPLETED|Period 3||8
5004|NCT02322749|10947|P1|COMPLETED|Period 3||8
5005|NCT02322749|10942|P6|STARTED|Period 3||8
5006|NCT02322749|10943|P5|STARTED|Period 3||8
5007|NCT02322749|10944|P4|STARTED|Period 3||6
5008|NCT02322749|10945|P3|STARTED|Period 3||8
5009|NCT02322749|10946|P2|STARTED|Period 3||8
5010|NCT02322749|10947|P1|STARTED|Period 3||8
5011|NCT02322749|10942|P6|NOT COMPLETED|Period 2||0
5012|NCT02322749|10943|P5|NOT COMPLETED|Period 2||0
5013|NCT02322749|10944|P4|NOT COMPLETED|Period 2||2
5014|NCT02322749|10945|P3|NOT COMPLETED|Period 2||0
5015|NCT02322749|10946|P2|NOT COMPLETED|Period 2||0
5016|NCT02322749|10947|P1|NOT COMPLETED|Period 2||0
5017|NCT02322749|10942|P6|COMPLETED|Period 2||8
5018|NCT02322749|10943|P5|COMPLETED|Period 2||8
5019|NCT02322749|10944|P4|COMPLETED|Period 2||6
5020|NCT02322749|10945|P3|COMPLETED|Period 2||8
5021|NCT02322749|10946|P2|COMPLETED|Period 2||8
5022|NCT02322749|10947|P1|COMPLETED|Period 2||8
5023|NCT02322749|10942|P6|STARTED|Period 2||8
5024|NCT02322749|10943|P5|STARTED|Period 2||8
5025|NCT02322749|10944|P4|STARTED|Period 2||8
5026|NCT02322749|10945|P3|STARTED|Period 2||8
5027|NCT02322749|10946|P2|STARTED|Period 2||8
5028|NCT02322749|10947|P1|STARTED|Period 2||8
5029|NCT02322749|10942|P6|NOT COMPLETED|Period 1||0
5030|NCT02322749|10943|P5|NOT COMPLETED|Period 1||0
5031|NCT02322749|10944|P4|NOT COMPLETED|Period 1||0
5032|NCT02322749|10945|P3|NOT COMPLETED|Period 1||0
5033|NCT02322749|10946|P2|NOT COMPLETED|Period 1||0
5034|NCT02322749|10947|P1|NOT COMPLETED|Period 1||0
5035|NCT02322749|10942|P6|COMPLETED|Period 1||8
5036|NCT02322749|10943|P5|COMPLETED|Period 1||8
5037|NCT02322749|10944|P4|COMPLETED|Period 1||8
5038|NCT02322749|10945|P3|COMPLETED|Period 1||8
5039|NCT02322749|10946|P2|COMPLETED|Period 1||8
5040|NCT02322749|10947|P1|COMPLETED|Period 1||8
5041|NCT02322749|10942|P6|STARTED|Period 1||8
5042|NCT02322749|10943|P5|STARTED|Period 1||8
5043|NCT02322749|10944|P4|STARTED|Period 1||8
5044|NCT02322749|10945|P3|STARTED|Period 1||8
5045|NCT02322749|10946|P2|STARTED|Period 1||8
5046|NCT02322749|10947|P1|STARTED|Period 1||8
5047|NCT02322528|10970|P1|NOT COMPLETED|Overall Study||0
5048|NCT02322528|10970|P1|COMPLETED|Overall Study||10
5049|NCT02322528|10970|P1|STARTED|Overall Study||10
5050|NCT02322216|10977|P2|NOT COMPLETED|Overall Study||4
5051|NCT02322216|10978|P1|NOT COMPLETED|Overall Study||2
5052|NCT02322216|10977|P2|COMPLETED|Overall Study||123
5053|NCT02322216|10978|P1|COMPLETED|Overall Study||124
5054|NCT02322216|10977|P2|Per Protocol Set (PPS)|Overall Study||122
5055|NCT02322216|10978|P1|Per Protocol Set (PPS)|Overall Study||123
5056|NCT02322216|10977|P2|Treated (Safety Set)|Overall Study||126
5057|NCT02322216|10978|P1|Treated (Safety Set)|Overall Study||126
5058|NCT02322216|10977|P2|STARTED|Overall Study||127
5059|NCT02322216|10978|P1|STARTED|Overall Study||126
5060|NCT02320695|10985|P1|NOT COMPLETED|Overall Study||0
5061|NCT02320695|10985|P1|COMPLETED|Overall Study||60
5062|NCT02320695|10985|P1|Pain Relief Ointment|Overall Study||60
5063|NCT02320695|10985|P1|Original Ointment|Overall Study||60
5064|NCT02320695|10985|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
5065|NCT02320695|10985|P1|Pain Relieving Cream|Overall Study||59
5066|NCT02320695|10985|P1|Alcohol|Overall Study||60
5067|NCT02320695|10985|P1|Saline|Overall Study||60
5068|NCT02320695|10985|P1|STARTED|Overall Study||60
5069|NCT02320396|11014|P2|NOT COMPLETED|Overall Study||4
5070|NCT02320396|11015|P1|NOT COMPLETED|Overall Study||4
5071|NCT02320396|11014|P2|COMPLETED|Overall Study||221
5072|NCT02320396|11015|P1|COMPLETED|Overall Study||220
5073|NCT02320396|11014|P2|Treated (Full Analysis Set)|Overall Study||225
5074|NCT02320396|11015|P1|Treated (Full Analysis Set)|Overall Study||223
5075|NCT02320396|11014|P2|STARTED|Overall Study||225
5076|NCT02320396|11015|P1|STARTED|Overall Study||224
5077|NCT02320227|11045|P1|NOT COMPLETED|Overall Study||0
5078|NCT02320227|11045|P1|COMPLETED|Overall Study||30
5079|NCT02320227|11045|P1|STARTED|Overall Study||30
5080|NCT02320214|11050|P1|NOT COMPLETED|Overall Study||0
5081|NCT02320214|11050|P1|COMPLETED|Overall Study||30
5082|NCT02320214|11050|P1|STARTED|Overall Study||30
5083|NCT02319525|11057|P2|NOT COMPLETED|Overall Study||1
5084|NCT02319525|11058|P1|NOT COMPLETED|Overall Study||2
5085|NCT02319525|11057|P2|COMPLETED|Overall Study||147
5086|NCT02319525|11058|P1|COMPLETED|Overall Study||151
5087|NCT02319525|11057|P2|Primary Research Completion|Overall Study||147
5088|NCT02319525|11058|P1|Primary Research Completion|Overall Study||151
5089|NCT02319525|11057|P2|STARTED|Overall Study||148
5090|NCT02319525|11058|P1|STARTED|Overall Study||153
5091|NCT02319486|11072|P1|NOT COMPLETED|Overall Study||0
5092|NCT02319486|11072|P1|COMPLETED|Overall Study||26
5093|NCT02319486|11072|P1|STARTED|Overall Study||26
5094|NCT02319148|11081|P4|NOT COMPLETED|Second Intervention Period||2
5095|NCT02319148|11082|P3|NOT COMPLETED|Second Intervention Period||1
5096|NCT02319148|11083|P2|NOT COMPLETED|Second Intervention Period||1
5097|NCT02319148|11084|P1|NOT COMPLETED|Second Intervention Period||0
5098|NCT02319148|11081|P4|COMPLETED|Second Intervention Period||6
5099|NCT02319148|11082|P3|COMPLETED|Second Intervention Period||6
5100|NCT02319148|11083|P2|COMPLETED|Second Intervention Period||6
5101|NCT02319148|11084|P1|COMPLETED|Second Intervention Period||0
5102|NCT02319148|11081|P4|STARTED|Second Intervention Period||8
5103|NCT02319148|11082|P3|STARTED|Second Intervention Period||7
5104|NCT02319148|11083|P2|STARTED|Second Intervention Period||7
5105|NCT02319148|11084|P1|STARTED|Second Intervention Period||0
5106|NCT02319148|11081|P4|NOT COMPLETED|Washout Period 4 Days||0
5107|NCT02319148|11082|P3|NOT COMPLETED|Washout Period 4 Days||0
5108|NCT02319148|11083|P2|NOT COMPLETED|Washout Period 4 Days||0
5109|NCT02319148|11084|P1|NOT COMPLETED|Washout Period 4 Days||0
5110|NCT02319148|11081|P4|COMPLETED|Washout Period 4 Days||0
5111|NCT02319148|11082|P3|COMPLETED|Washout Period 4 Days||0
5112|NCT02319148|11083|P2|COMPLETED|Washout Period 4 Days||0
5113|NCT02319148|11084|P1|COMPLETED|Washout Period 4 Days||22
5114|NCT02319148|11081|P4|STARTED|Washout Period 4 Days||0
5115|NCT02319148|11082|P3|STARTED|Washout Period 4 Days||0
5116|NCT02319148|11083|P2|STARTED|Washout Period 4 Days||0
5117|NCT02319148|11084|P1|STARTED|Washout Period 4 Days||22
5118|NCT02319148|11081|P4|NOT COMPLETED|First Intervention Period||0
5119|NCT02319148|11082|P3|NOT COMPLETED|First Intervention Period||0
5120|NCT02319148|11083|P2|NOT COMPLETED|First Intervention Period||0
5121|NCT02319148|11084|P1|NOT COMPLETED|First Intervention Period||0
5122|NCT02319148|11081|P4|COMPLETED|First Intervention Period||0
5123|NCT02319148|11082|P3|COMPLETED|First Intervention Period||0
5124|NCT02319148|11083|P2|COMPLETED|First Intervention Period||0
5125|NCT02319148|11084|P1|COMPLETED|First Intervention Period||22
5126|NCT02319148|11081|P4|STARTED|First Intervention Period||0
5127|NCT02319148|11082|P3|STARTED|First Intervention Period||0
5128|NCT02319148|11083|P2|STARTED|First Intervention Period||0
5129|NCT02319148|11084|P1|STARTED|First Intervention Period||22
5130|NCT02319031|11146|P2|NOT COMPLETED|Follow-Up Period||0
5131|NCT02319031|11147|P1|NOT COMPLETED|Follow-Up Period||0
5132|NCT02319031|11146|P2|COMPLETED|Follow-Up Period||26
5133|NCT02319031|11147|P1|COMPLETED|Follow-Up Period||23
5134|NCT02319031|11146|P2|STARTED|Follow-Up Period||26
5135|NCT02319031|11147|P1|STARTED|Follow-Up Period||23
5136|NCT02319031|11146|P2|NOT COMPLETED|Treatment Period||0
5137|NCT02319031|11147|P1|NOT COMPLETED|Treatment Period||1
5138|NCT02319031|11146|P2|COMPLETED|Treatment Period||26
5139|NCT02319031|11147|P1|COMPLETED|Treatment Period||23
5140|NCT02319031|11146|P2|STARTED|Treatment Period||26
5141|NCT02319031|11147|P1|STARTED|Treatment Period||24
5142|NCT02318940|11159|P2|NOT COMPLETED|Overall Study||0
5143|NCT02318940|11160|P1|NOT COMPLETED|Overall Study||0
5144|NCT02318940|11159|P2|COMPLETED|Overall Study||50
5145|NCT02318940|11160|P1|COMPLETED|Overall Study||49
5146|NCT02318940|11159|P2|STARTED|Overall Study||50
5147|NCT02318940|11160|P1|STARTED|Overall Study|in the last patient we lost the record.|49
5148|NCT02318693|11172|P2|NOT COMPLETED|Overall Study||1
5149|NCT02318693|11173|P1|NOT COMPLETED|Overall Study||0
5150|NCT02318693|11172|P2|COMPLETED|Overall Study||26
5151|NCT02318693|11173|P1|COMPLETED|Overall Study||26
5152|NCT02318693|11172|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
5153|NCT02318693|11173|P1|Treated|Overall Study||26
5154|NCT02318693|11172|P2|STARTED|Overall Study||27
5155|NCT02318693|11173|P1|STARTED|Overall Study||26
5156|NCT02317809|11187|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
5157|NCT02317809|11188|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
5158|NCT02317809|11187|P2|COMPLETED|Second Intervention Period (8 Days)||17
5159|NCT02317809|11188|P1|COMPLETED|Second Intervention Period (8 Days)||14
5160|NCT02317809|11187|P2|STARTED|Second Intervention Period (8 Days)||17
5161|NCT02317809|11188|P1|STARTED|Second Intervention Period (8 Days)||14
5162|NCT02317809|11187|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
5163|NCT02317809|11188|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
5164|NCT02317809|11187|P2|COMPLETED|First Intervention Period (8 Days)||17
5165|NCT02317809|11188|P1|COMPLETED|First Intervention Period (8 Days)||14
5166|NCT02317809|11187|P2|STARTED|First Intervention Period (8 Days)||17
5167|NCT02317809|11188|P1|STARTED|First Intervention Period (8 Days)||17
5168|NCT02317510|11232|P2|NOT COMPLETED|Overall Study||1
5169|NCT02317510|11233|P1|NOT COMPLETED|Overall Study||0
5170|NCT02317510|11232|P2|COMPLETED|Overall Study||24
5171|NCT02317510|11233|P1|COMPLETED|Overall Study||25
5172|NCT02317510|11232|P2|STARTED|Overall Study||25
5173|NCT02317510|11233|P1|STARTED|Overall Study||25
5174|NCT02317016|11261|P1|NOT COMPLETED|Period 3||2
5175|NCT02317016|11261|P1|COMPLETED|Period 3||41
5176|NCT02317016|11261|P1|STARTED|Period 3||43
5177|NCT02317016|11261|P1|NOT COMPLETED|Period 2||1
5178|NCT02317016|11261|P1|COMPLETED|Period 2||43
5179|NCT02317016|11261|P1|STARTED|Period 2||44
5180|NCT02317016|11261|P1|NOT COMPLETED|Period 1||0
5181|NCT02317016|11261|P1|COMPLETED|Period 1||44
5182|NCT02317016|11261|P1|STARTED|Period 1||44
5183|NCT02316769|11287|P2|NOT COMPLETED|Overall Study||0
5184|NCT02316769|11288|P1|NOT COMPLETED|Overall Study||2
5185|NCT02316769|11287|P2|COMPLETED|Overall Study||33
5186|NCT02316769|11288|P1|COMPLETED|Overall Study||31
5187|NCT02316769|11287|P2|STARTED|Overall Study||33
5188|NCT02316769|11288|P1|STARTED|Overall Study||33
5189|NCT02316613|11296|P1|NOT COMPLETED|Overall Study||104
5190|NCT02316613|11296|P1|COMPLETED|Overall Study||156
5191|NCT02316613|11296|P1|Overall Population|Overall Study||241
5192|NCT02316613|11296|P1|Safety Population|Overall Study||255
5193|NCT02316613|11296|P1|STARTED|Overall Study||260
5194|NCT02316366|11335|P2|NOT COMPLETED|Overall Study||0
5195|NCT02316366|11336|P1|NOT COMPLETED|Overall Study||0
5196|NCT02316366|11335|P2|COMPLETED|Overall Study||40
5197|NCT02316366|11336|P1|COMPLETED|Overall Study||40
5198|NCT02316366|11335|P2|STARTED|Overall Study||40
5199|NCT02316366|11336|P1|STARTED|Overall Study||40
5200|NCT02315989|11346|P1|NOT COMPLETED|Overall Study||0
5201|NCT02315989|11346|P1|COMPLETED|Overall Study||6
5202|NCT02315989|11346|P1|STARTED|Overall Study||6
5203|NCT02314689|11354|P1|NOT COMPLETED|Overall Study||0
5204|NCT02314689|11354|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
5205|NCT02314689|11354|P1|STARTED|Overall Study||4
5206|NCT02314637|11360|P2|NOT COMPLETED|Overall Study||14
5207|NCT02314637|11361|P1|NOT COMPLETED|Overall Study||16
5208|NCT02314637|11360|P2|COMPLETED|Overall Study||75
5209|NCT02314637|11361|P1|COMPLETED|Overall Study||135
5210|NCT02314637|11360|P2|STARTED|Overall Study||89
5211|NCT02314637|11361|P1|STARTED|Overall Study||151
5212|NCT02314546|11374|P3|NOT COMPLETED|Overall Study||0
5213|NCT02314546|11375|P2|NOT COMPLETED|Overall Study||0
5214|NCT02314546|11376|P1|NOT COMPLETED|Overall Study||0
5215|NCT02314546|11374|P3|COMPLETED|Overall Study||5
5216|NCT02314546|11375|P2|COMPLETED|Overall Study||5
5217|NCT02314546|11376|P1|COMPLETED|Overall Study||5
5218|NCT02314546|11374|P3|STARTED|Overall Study||5
5219|NCT02314546|11375|P2|STARTED|Overall Study||5
5220|NCT02314546|11376|P1|STARTED|Overall Study||5
5221|NCT02314260|11402|P1|NOT COMPLETED|Overall Study||0
5222|NCT02314260|11402|P1|COMPLETED|Overall Study||80
5223|NCT02314260|11402|P1|STARTED|Overall Study||80
5224|NCT02314104|11412|P3|NOT COMPLETED|Overall Study||18
5225|NCT02314104|11413|P2|NOT COMPLETED|Overall Study||20
5226|NCT02314104|11414|P1|NOT COMPLETED|Overall Study||14
5227|NCT02314104|11412|P3|COMPLETED|Overall Study||53
5228|NCT02314104|11413|P2|COMPLETED|Overall Study||58
5229|NCT02314104|11414|P1|COMPLETED|Overall Study||57
5230|NCT02314104|11412|P3|STARTED|Overall Study||71
5231|NCT02314104|11413|P2|STARTED|Overall Study||78
5232|NCT02314104|11414|P1|STARTED|Overall Study||71
5233|NCT02313766|11437|P3|NOT COMPLETED|Overall Study||0
5234|NCT02313766|11438|P2|NOT COMPLETED|Overall Study||3
5235|NCT02313766|11439|P1|NOT COMPLETED|Overall Study||1
5236|NCT02313766|11437|P3|COMPLETED|Overall Study||50
5237|NCT02313766|11438|P2|COMPLETED|Overall Study||47
5238|NCT02313766|11439|P1|COMPLETED|Overall Study||49
5239|NCT02313766|11437|P3|STARTED|Overall Study||50
5240|NCT02313766|11438|P2|STARTED|Overall Study||50
5241|NCT02313766|11439|P1|STARTED|Overall Study||50
5242|NCT02313558|11455|P2|NOT COMPLETED|Overall Study||4
5243|NCT02313558|11456|P1|NOT COMPLETED|Overall Study||6
5244|NCT02313558|11455|P2|COMPLETED|Overall Study||46
5245|NCT02313558|11456|P1|COMPLETED|Overall Study||44
5246|NCT02313558|11455|P2|STARTED|Overall Study||50
5247|NCT02313558|11456|P1|STARTED|Overall Study||50
5248|NCT02313233|11470|P2|NOT COMPLETED|Overall Study||3
5249|NCT02313233|11471|P1|NOT COMPLETED|Overall Study||2
5250|NCT02313233|11470|P2|COMPLETED|Overall Study||18
5251|NCT02313233|11471|P1|COMPLETED|Overall Study||18
5252|NCT02313233|11470|P2|STARTED|Overall Study||21
5253|NCT02313233|11471|P1|STARTED|Overall Study||20
5254|NCT02313155|11493|P2|NOT COMPLETED|Overall Study||1
5255|NCT02313155|11494|P1|NOT COMPLETED|Overall Study||0
5256|NCT02313155|11493|P2|COMPLETED|Overall Study||54
5257|NCT02313155|11494|P1|COMPLETED|Overall Study||55
5258|NCT02313155|11493|P2|STARTED|Overall Study||55
5259|NCT02313155|11494|P1|STARTED|Overall Study||55
5260|NCT02312739|11544|P2|NOT COMPLETED|Overall Study||2
5261|NCT02312739|11545|P1|NOT COMPLETED|Overall Study||6
5262|NCT02312739|11544|P2|COMPLETED|Overall Study||34
5263|NCT02312739|11545|P1|COMPLETED|Overall Study||30
5264|NCT02312739|11544|P2|Withdrawn Prior to Procedure|Overall Study||2
5265|NCT02312739|11545|P1|Withdrawn Prior to Procedure|Overall Study||6
5266|NCT02312739|11544|P2|STARTED|Overall Study||36
5267|NCT02312739|11545|P1|STARTED|Overall Study||36
5268|NCT02312726|11559|P3|NOT COMPLETED|Overall Study||67
5269|NCT02312726|11560|P2|NOT COMPLETED|Overall Study||0
5270|NCT02312726|11561|P1|NOT COMPLETED|Overall Study||0
5271|NCT02312726|11559|P3|COMPLETED|Overall Study||0
5272|NCT02312726|11560|P2|COMPLETED|Overall Study||30
5273|NCT02312726|11561|P1|COMPLETED|Overall Study||38
5274|NCT02312726|11559|P3|STARTED|Overall Study||67
5275|NCT02312726|11560|P2|STARTED|Overall Study||30
5276|NCT02312726|11561|P1|STARTED|Overall Study||38
5277|NCT02312154|11573|P1|NOT COMPLETED|Overall Study||1
5278|NCT02312154|11573|P1|COMPLETED|Overall Study||24
5279|NCT02312154|11573|P1|STARTED|Overall Study||25
5280|NCT02311309|11591|P3|NOT COMPLETED|Overall Study||0
5281|NCT02311309|11592|P2|NOT COMPLETED|Overall Study||0
5282|NCT02311309|11593|P1|NOT COMPLETED|Overall Study||0
5283|NCT02311309|11591|P3|COMPLETED|Overall Study||863
5284|NCT02311309|11592|P2|COMPLETED|Overall Study||35
5285|NCT02311309|11593|P1|COMPLETED|Overall Study||541
5286|NCT02311309|11591|P3|STARTED|Overall Study||863
5287|NCT02311309|11592|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
5288|NCT02311309|11593|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
5289|NCT02310776|11604|P1|NOT COMPLETED|Overall Study||0
5290|NCT02310776|11604|P1|COMPLETED|Overall Study||501
5291|NCT02310776|11604|P1|STARTED|Overall Study||501
5292|NCT02310646|11610|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
5293|NCT02310646|11611|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
5294|NCT02310646|11610|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
5295|NCT02310646|11611|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
5296|NCT02310646|11610|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
5297|NCT02310646|11611|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
5298|NCT02310646|11610|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
5299|NCT02310646|11611|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
5300|NCT02310646|11610|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
5301|NCT02310646|11611|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
5302|NCT02310646|11610|P2|STARTED|First Intervention (Day 1 - Day 7)||104
5303|NCT02310646|11611|P1|STARTED|First Intervention (Day 1 - Day 7)||109
5304|NCT02310568|11640|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
5305|NCT02310568|11641|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
5306|NCT02310568|11642|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
5307|NCT02310568|11643|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
5308|NCT02310568|11644|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
5309|NCT02310568|11640|P5|COMPLETED|Stage 2 (4 Weeks)||19
5310|NCT02310568|11641|P4|COMPLETED|Stage 2 (4 Weeks)||17
5311|NCT02310568|11642|P3|COMPLETED|Stage 2 (4 Weeks)||13
5312|NCT02310568|11643|P2|COMPLETED|Stage 2 (4 Weeks)||12
5313|NCT02310568|11644|P1|COMPLETED|Stage 2 (4 Weeks)||11
5314|NCT02310568|11640|P5|STARTED|Stage 2 (4 Weeks)||20
5315|NCT02310568|11641|P4|STARTED|Stage 2 (4 Weeks)||22
5316|NCT02310568|11642|P3|STARTED|Stage 2 (4 Weeks)||14
5317|NCT02310568|11643|P2|STARTED|Stage 2 (4 Weeks)||13
5318|NCT02310568|11644|P1|STARTED|Stage 2 (4 Weeks)||12
5319|NCT02310568|11640|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
5320|NCT02310568|11641|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
5321|NCT02310568|11642|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
5322|NCT02310568|11643|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
5323|NCT02310568|11644|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
5324|NCT02310568|11640|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
5325|NCT02310568|11641|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
5326|NCT02310568|11642|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
5327|NCT02310568|11643|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
5328|NCT02310568|11644|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
5329|NCT02310568|11640|P5|STARTED|Stage 1 ( 4 Weeks)||21
5330|NCT02310568|11641|P4|STARTED|Stage 1 ( 4 Weeks)||24
5331|NCT02310568|11642|P3|STARTED|Stage 1 ( 4 Weeks)||15
5332|NCT02310568|11643|P2|STARTED|Stage 1 ( 4 Weeks)||15
5333|NCT02310568|11644|P1|STARTED|Stage 1 ( 4 Weeks)||15
5334|NCT02310126|11724|P2|NOT COMPLETED|Period 2||0
5335|NCT02310126|11725|P1|NOT COMPLETED|Period 2||0
5336|NCT02310126|11724|P2|COMPLETED|Period 2||95
5337|NCT02310126|11725|P1|COMPLETED|Period 2||94
5338|NCT02310126|11724|P2|Myopes|Period 2||63
5339|NCT02310126|11725|P1|Myopes|Period 2||56
5340|NCT02310126|11724|P2|Hyperopes|Period 2||32
5341|NCT02310126|11725|P1|Hyperopes|Period 2||38
5342|NCT02310126|11724|P2|STARTED|Period 2||95
5343|NCT02310126|11725|P1|STARTED|Period 2||94
5344|NCT02310126|11724|P2|NOT COMPLETED|Period 1||2
5345|NCT02310126|11725|P1|NOT COMPLETED|Period 1||0
5346|NCT02310126|11724|P2|COMPLETED|Period 1||95
5347|NCT02310126|11725|P1|COMPLETED|Period 1||94
5348|NCT02310126|11724|P2|Myopes|Period 1||64
5349|NCT02310126|11725|P1|Myopes|Period 1||56
5350|NCT02310126|11724|P2|Hyperopes|Period 1||33
5351|NCT02310126|11725|P1|Hyperopes|Period 1||38
5352|NCT02310126|11724|P2|STARTED|Period 1||97
5353|NCT02310126|11725|P1|STARTED|Period 1||94
5354|NCT02309294|11731|P1|NOT COMPLETED|Overall Study||2
5355|NCT02309294|11731|P1|COMPLETED|Overall Study||41
5356|NCT02309294|11731|P1|STARTED|Overall Study||43
5357|NCT02309112|11738|P3|NOT COMPLETED|Overall Study||1
5358|NCT02309112|11739|P2|NOT COMPLETED|Overall Study||1
5359|NCT02309112|11740|P1|NOT COMPLETED|Overall Study||1
5360|NCT02309112|11738|P3|COMPLETED|Overall Study||4
5361|NCT02309112|11739|P2|COMPLETED|Overall Study||4
5362|NCT02309112|11740|P1|COMPLETED|Overall Study||4
5363|NCT02309112|11738|P3|Completed Yoga Intervention|Overall Study||4
5364|NCT02309112|11739|P2|Completed Yoga Intervention|Overall Study||5
5365|NCT02309112|11740|P1|Completed Yoga Intervention|Overall Study||4
5366|NCT02309112|11738|P3|STARTED|Overall Study||5
5367|NCT02309112|11739|P2|STARTED|Overall Study||5
5368|NCT02309112|11740|P1|STARTED|Overall Study||5
5369|NCT02308787|11761|P1|NOT COMPLETED|Overall Study||0
5370|NCT02308787|11761|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
5371|NCT02308787|11761|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
5372|NCT02308748|11776|P10|NOT COMPLETED|Period 5||0
5373|NCT02308748|11777|P9|NOT COMPLETED|Period 5||1
5374|NCT02308748|11778|P8|NOT COMPLETED|Period 5||0
5375|NCT02308748|11779|P7|NOT COMPLETED|Period 5||0
5376|NCT02308748|11780|P6|NOT COMPLETED|Period 5||0
5377|NCT02308748|11781|P5|NOT COMPLETED|Period 5||0
5378|NCT02308748|11782|P4|NOT COMPLETED|Period 5||0
5379|NCT02308748|11783|P3|NOT COMPLETED|Period 5||0
5380|NCT02308748|11784|P2|NOT COMPLETED|Period 5||0
5381|NCT02308748|11785|P1|NOT COMPLETED|Period 5||1
5382|NCT02308748|11776|P10|COMPLETED|Period 5||2
5383|NCT02308748|11777|P9|COMPLETED|Period 5||1
5384|NCT02308748|11778|P8|COMPLETED|Period 5||1
5385|NCT02308748|11779|P7|COMPLETED|Period 5||2
5386|NCT02308748|11780|P6|COMPLETED|Period 5||3
5387|NCT02308748|11781|P5|COMPLETED|Period 5||2
5388|NCT02308748|11782|P4|COMPLETED|Period 5||2
5389|NCT02308748|11783|P3|COMPLETED|Period 5||1
5390|NCT02308748|11784|P2|COMPLETED|Period 5||2
5391|NCT02308748|11785|P1|COMPLETED|Period 5||1
5392|NCT02308748|11776|P10|STARTED|Period 5||2
5393|NCT02308748|11777|P9|STARTED|Period 5||2
5394|NCT02308748|11778|P8|STARTED|Period 5||1
5395|NCT02308748|11779|P7|STARTED|Period 5||2
5396|NCT02308748|11780|P6|STARTED|Period 5||3
5397|NCT02308748|11781|P5|STARTED|Period 5||2
5398|NCT02308748|11782|P4|STARTED|Period 5||2
5399|NCT02308748|11783|P3|STARTED|Period 5||1
5400|NCT02308748|11784|P2|STARTED|Period 5||2
5401|NCT02308748|11785|P1|STARTED|Period 5||2
5402|NCT02308748|11776|P10|NOT COMPLETED|Period 4||0
5403|NCT02308748|11777|P9|NOT COMPLETED|Period 4||0
5404|NCT02308748|11778|P8|NOT COMPLETED|Period 4||0
5405|NCT02308748|11779|P7|NOT COMPLETED|Period 4||0
5406|NCT02308748|11780|P6|NOT COMPLETED|Period 4||0
5407|NCT02308748|11781|P5|NOT COMPLETED|Period 4||0
5408|NCT02308748|11782|P4|NOT COMPLETED|Period 4||0
5409|NCT02308748|11783|P3|NOT COMPLETED|Period 4||0
5410|NCT02308748|11784|P2|NOT COMPLETED|Period 4||0
5411|NCT02308748|11785|P1|NOT COMPLETED|Period 4||0
5412|NCT02308748|11776|P10|COMPLETED|Period 4||2
5413|NCT02308748|11777|P9|COMPLETED|Period 4||2
5414|NCT02308748|11778|P8|COMPLETED|Period 4||1
5415|NCT02308748|11779|P7|COMPLETED|Period 4||2
5416|NCT02308748|11780|P6|COMPLETED|Period 4||3
5417|NCT02308748|11781|P5|COMPLETED|Period 4||2
5418|NCT02308748|11782|P4|COMPLETED|Period 4||2
5419|NCT02308748|11783|P3|COMPLETED|Period 4||1
5420|NCT02308748|11784|P2|COMPLETED|Period 4||2
5421|NCT02308748|11785|P1|COMPLETED|Period 4||2
5422|NCT02308748|11776|P10|STARTED|Period 4||2
5423|NCT02308748|11777|P9|STARTED|Period 4||2
5424|NCT02308748|11778|P8|STARTED|Period 4||1
5425|NCT02308748|11779|P7|STARTED|Period 4||2
5426|NCT02308748|11780|P6|STARTED|Period 4||3
5427|NCT02308748|11781|P5|STARTED|Period 4||2
5428|NCT02308748|11782|P4|STARTED|Period 4||2
5429|NCT02308748|11783|P3|STARTED|Period 4||1
5430|NCT02308748|11784|P2|STARTED|Period 4||2
5431|NCT02308748|11785|P1|STARTED|Period 4||2
5432|NCT02308748|11776|P10|NOT COMPLETED|Period 3||1
5433|NCT02308748|11777|P9|NOT COMPLETED|Period 3||0
5434|NCT02308748|11778|P8|NOT COMPLETED|Period 3||0
5435|NCT02308748|11779|P7|NOT COMPLETED|Period 3||0
5436|NCT02308748|11780|P6|NOT COMPLETED|Period 3||0
5437|NCT02308748|11781|P5|NOT COMPLETED|Period 3||0
5438|NCT02308748|11782|P4|NOT COMPLETED|Period 3||0
5439|NCT02308748|11783|P3|NOT COMPLETED|Period 3||0
5440|NCT02308748|11784|P2|NOT COMPLETED|Period 3||0
5441|NCT02308748|11785|P1|NOT COMPLETED|Period 3||0
5442|NCT02308748|11776|P10|COMPLETED|Period 3||2
5443|NCT02308748|11777|P9|COMPLETED|Period 3||2
5444|NCT02308748|11778|P8|COMPLETED|Period 3||1
5445|NCT02308748|11779|P7|COMPLETED|Period 3||2
5446|NCT02308748|11780|P6|COMPLETED|Period 3||3
5447|NCT02308748|11781|P5|COMPLETED|Period 3||2
5448|NCT02308748|11782|P4|COMPLETED|Period 3||2
5449|NCT02308748|11783|P3|COMPLETED|Period 3||1
5450|NCT02308748|11784|P2|COMPLETED|Period 3||2
5451|NCT02308748|11785|P1|COMPLETED|Period 3||2
5452|NCT02308748|11776|P10|STARTED|Period 3||3
5453|NCT02308748|11777|P9|STARTED|Period 3||2
5454|NCT02308748|11778|P8|STARTED|Period 3||1
5455|NCT02308748|11779|P7|STARTED|Period 3||2
5456|NCT02308748|11780|P6|STARTED|Period 3||3
5457|NCT02308748|11781|P5|STARTED|Period 3||2
5458|NCT02308748|11782|P4|STARTED|Period 3||2
5459|NCT02308748|11783|P3|STARTED|Period 3||1
5460|NCT02308748|11784|P2|STARTED|Period 3||2
5461|NCT02308748|11785|P1|STARTED|Period 3||2
5462|NCT02308748|11776|P10|NOT COMPLETED|Period 2||0
5463|NCT02308748|11777|P9|NOT COMPLETED|Period 2||0
5464|NCT02308748|11778|P8|NOT COMPLETED|Period 2||1
5465|NCT02308748|11779|P7|NOT COMPLETED|Period 2||0
5466|NCT02308748|11780|P6|NOT COMPLETED|Period 2||0
5467|NCT02308748|11781|P5|NOT COMPLETED|Period 2||0
5468|NCT02308748|11782|P4|NOT COMPLETED|Period 2||0
5469|NCT02308748|11783|P3|NOT COMPLETED|Period 2||0
5470|NCT02308748|11784|P2|NOT COMPLETED|Period 2||0
5471|NCT02308748|11785|P1|NOT COMPLETED|Period 2||0
5472|NCT02308748|11776|P10|COMPLETED|Period 2||3
5473|NCT02308748|11777|P9|COMPLETED|Period 2||2
5474|NCT02308748|11778|P8|COMPLETED|Period 2||1
5475|NCT02308748|11779|P7|COMPLETED|Period 2||2
5476|NCT02308748|11780|P6|COMPLETED|Period 2||3
5477|NCT02308748|11781|P5|COMPLETED|Period 2||2
5478|NCT02308748|11782|P4|COMPLETED|Period 2||2
5479|NCT02308748|11783|P3|COMPLETED|Period 2||1
5480|NCT02308748|11784|P2|COMPLETED|Period 2||2
5481|NCT02308748|11785|P1|COMPLETED|Period 2||2
5482|NCT02308748|11776|P10|STARTED|Period 2||3
5483|NCT02308748|11777|P9|STARTED|Period 2||2
5484|NCT02308748|11778|P8|STARTED|Period 2||2
5485|NCT02308748|11779|P7|STARTED|Period 2||2
5486|NCT02308748|11780|P6|STARTED|Period 2||3
5487|NCT02308748|11781|P5|STARTED|Period 2||2
5488|NCT02308748|11782|P4|STARTED|Period 2||2
5489|NCT02308748|11783|P3|STARTED|Period 2||1
5490|NCT02308748|11784|P2|STARTED|Period 2||2
5491|NCT02308748|11785|P1|STARTED|Period 2||2
5492|NCT02308748|11776|P10|NOT COMPLETED|Period 1||0
5493|NCT02308748|11777|P9|NOT COMPLETED|Period 1||0
5494|NCT02308748|11778|P8|NOT COMPLETED|Period 1||0
5495|NCT02308748|11779|P7|NOT COMPLETED|Period 1||0
5496|NCT02308748|11780|P6|NOT COMPLETED|Period 1||0
5497|NCT02308748|11781|P5|NOT COMPLETED|Period 1||0
5498|NCT02308748|11782|P4|NOT COMPLETED|Period 1||0
5499|NCT02308748|11783|P3|NOT COMPLETED|Period 1||1
5500|NCT02308748|11784|P2|NOT COMPLETED|Period 1||0
5501|NCT02308748|11785|P1|NOT COMPLETED|Period 1||0
5502|NCT02308748|11776|P10|COMPLETED|Period 1||3
5503|NCT02308748|11777|P9|COMPLETED|Period 1||2
5504|NCT02308748|11778|P8|COMPLETED|Period 1||2
5505|NCT02308748|11779|P7|COMPLETED|Period 1||2
5506|NCT02308748|11780|P6|COMPLETED|Period 1||3
5507|NCT02308748|11781|P5|COMPLETED|Period 1||2
5508|NCT02308748|11782|P4|COMPLETED|Period 1||2
5509|NCT02308748|11783|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
5510|NCT02308748|11784|P2|COMPLETED|Period 1||2
5511|NCT02308748|11785|P1|COMPLETED|Period 1||2
5512|NCT02308748|11776|P10|STARTED|Period 1||3
5513|NCT02308748|11777|P9|STARTED|Period 1||2
5514|NCT02308748|11778|P8|STARTED|Period 1||2
5515|NCT02308748|11779|P7|STARTED|Period 1||2
5516|NCT02308748|11780|P6|STARTED|Period 1||3
5517|NCT02308748|11781|P5|STARTED|Period 1||2
5518|NCT02308748|11782|P4|STARTED|Period 1||2
5519|NCT02308748|11783|P3|STARTED|Period 1||2
5520|NCT02308748|11784|P2|STARTED|Period 1||2
5521|NCT02308748|11785|P1|STARTED|Period 1||2
5522|NCT02308371|11799|P2|NOT COMPLETED|Overall Study||0
5523|NCT02308371|11800|P1|NOT COMPLETED|Overall Study||0
5524|NCT02308371|11799|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
5525|NCT02308371|11800|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
5526|NCT02308371|11799|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
5527|NCT02308371|11800|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
5528|NCT02307318|11814|P1|NOT COMPLETED|Overall Study||0
5529|NCT02307318|11814|P1|COMPLETED|Overall Study||51
5530|NCT02307318|11814|P1|STARTED|Overall Study||51
5531|NCT02307266|11824|P3|NOT COMPLETED|Overall Study||6
5532|NCT02307266|11825|P2|NOT COMPLETED|Overall Study||1
5533|NCT02307266|11826|P1|NOT COMPLETED|Overall Study||8
5534|NCT02307266|11824|P3|COMPLETED|Overall Study||25
5535|NCT02307266|11825|P2|COMPLETED|Overall Study||32
5536|NCT02307266|11826|P1|COMPLETED|Overall Study||25
5537|NCT02307266|11824|P3|STARTED|Overall Study||31
5538|NCT02307266|11825|P2|STARTED|Overall Study||33
5539|NCT02307266|11826|P1|STARTED|Overall Study||33
5540|NCT02307188|11834|P1|NOT COMPLETED|Overall Study||4
5541|NCT02307188|11834|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
5542|NCT02307188|11834|P1|STARTED|Overall Study||5
5543|NCT02307123|11838|P1|NOT COMPLETED|Overall Study||0
5544|NCT02307123|11838|P1|COMPLETED|Overall Study||483
5545|NCT02307123|11838|P1|STARTED|Overall Study||483
5546|NCT02306928|11843|P1|NOT COMPLETED|Overall Study||0
5547|NCT02306928|11843|P1|COMPLETED|Overall Study||15
5548|NCT02306928|11843|P1|STARTED|Overall Study||15
5549|NCT02305446|11851|P1|NOT COMPLETED|Overall Study||1
5550|NCT02305446|11851|P1|COMPLETED|Overall Study||54
5551|NCT02305446|11851|P1|STARTED|Overall Study||55
5552|NCT02305329|11860|P4|NOT COMPLETED|Overall Study||0
5553|NCT02305329|11861|P3|NOT COMPLETED|Overall Study||0
5554|NCT02305329|11862|P2|NOT COMPLETED|Overall Study||1
5555|NCT02305329|11863|P1|NOT COMPLETED|Overall Study||0
5556|NCT02305329|11860|P4|COMPLETED|Overall Study||14
5557|NCT02305329|11861|P3|COMPLETED|Overall Study||14
5558|NCT02305329|11862|P2|COMPLETED|Overall Study||13
5559|NCT02305329|11863|P1|COMPLETED|Overall Study||14
5560|NCT02305329|11860|P4|Period 2|Overall Study||14
5561|NCT02305329|11861|P3|Period 2|Overall Study||14
5562|NCT02305329|11862|P2|Period 2|Overall Study||13
5563|NCT02305329|11863|P1|Period 2|Overall Study||14
5564|NCT02305329|11860|P4|Period 1|Overall Study||14
5565|NCT02305329|11861|P3|Period 1|Overall Study||14
5566|NCT02305329|11862|P2|Period 1|Overall Study||14
5567|NCT02305329|11863|P1|Period 1|Overall Study||14
5568|NCT02305329|11860|P4|STARTED|Overall Study||14
5569|NCT02305329|11861|P3|STARTED|Overall Study||14
5570|NCT02305329|11862|P2|STARTED|Overall Study||14
5571|NCT02305329|11863|P1|STARTED|Overall Study||14
5572|NCT02305316|11887|P2|NOT COMPLETED|Overall Study||0
5573|NCT02305316|11888|P1|NOT COMPLETED|Overall Study||0
5574|NCT02305316|11887|P2|COMPLETED|Overall Study||14
5575|NCT02305316|11888|P1|COMPLETED|Overall Study||14
5576|NCT02305316|11887|P2|STARTED|Overall Study||14
5577|NCT02305316|11888|P1|STARTED|Overall Study||14
5578|NCT02305277|11906|P6|NOT COMPLETED|Overall Study||0
5579|NCT02305277|11907|P5|NOT COMPLETED|Overall Study||1
5580|NCT02305277|11908|P4|NOT COMPLETED|Overall Study||0
5581|NCT02305277|11909|P3|NOT COMPLETED|Overall Study||0
5582|NCT02305277|11910|P2|NOT COMPLETED|Overall Study||0
5583|NCT02305277|11911|P1|NOT COMPLETED|Overall Study||1
5584|NCT02305277|11906|P6|COMPLETED|Overall Study||14
5585|NCT02305277|11907|P5|COMPLETED|Overall Study||13
5586|NCT02305277|11908|P4|COMPLETED|Overall Study||14
5587|NCT02305277|11909|P3|COMPLETED|Overall Study||14
5588|NCT02305277|11910|P2|COMPLETED|Overall Study||14
5589|NCT02305277|11911|P1|COMPLETED|Overall Study||14
5590|NCT02305277|11906|P6|Received TBM|Overall Study||14
5591|NCT02305277|11907|P5|Received TBM|Overall Study||14
5592|NCT02305277|11908|P4|Received TBM|Overall Study||14
5593|NCT02305277|11909|P3|Received TBM|Overall Study||14
5594|NCT02305277|11910|P2|Received TBM|Overall Study||14
5595|NCT02305277|11911|P1|Received TBM|Overall Study||15
5596|NCT02305277|11906|P6|Received CM|Overall Study||14
5597|NCT02305277|11907|P5|Received CM|Overall Study||14
5598|NCT02305277|11908|P4|Received CM|Overall Study||14
5599|NCT02305277|11909|P3|Received CM|Overall Study||14
5600|NCT02305277|11910|P2|Received CM|Overall Study||14
5601|NCT02305277|11911|P1|Received CM|Overall Study||15
5602|NCT02305277|11906|P6|STARTED|Overall Study||14
5603|NCT02305277|11907|P5|STARTED|Overall Study||14
5604|NCT02305277|11908|P4|STARTED|Overall Study||14
5605|NCT02305277|11909|P3|STARTED|Overall Study||14
5606|NCT02305277|11910|P2|STARTED|Overall Study||14
5607|NCT02305277|11911|P1|STARTED|Overall Study||15
5608|NCT02305017|11939|P2|NOT COMPLETED|Overall Study||0
5609|NCT02305017|11940|P1|NOT COMPLETED|Overall Study||0
5610|NCT02305017|11939|P2|COMPLETED|Overall Study||14
5611|NCT02305017|11940|P1|COMPLETED|Overall Study||14
5612|NCT02305017|11939|P2|STARTED|Overall Study||14
5613|NCT02305017|11940|P1|STARTED|Overall Study||14
5614|NCT02304926|11954|P2|NOT COMPLETED|Overall Study||1
5615|NCT02304926|11955|P1|NOT COMPLETED|Overall Study||2
5616|NCT02304926|11954|P2|COMPLETED|Overall Study||19
5617|NCT02304926|11955|P1|COMPLETED|Overall Study||20
5618|NCT02304926|11954|P2|STARTED|Overall Study||20
5619|NCT02304926|11955|P1|STARTED|Overall Study||22
5620|NCT02303743|12001|P2|NOT COMPLETED|Overall Study||0
5621|NCT02303743|12002|P1|NOT COMPLETED|Overall Study||0
5622|NCT02303743|12001|P2|COMPLETED|Overall Study||152
5623|NCT02303743|12002|P1|COMPLETED|Overall Study||108
5624|NCT02303743|12001|P2|STARTED|Overall Study||152
5625|NCT02303743|12002|P1|STARTED|Overall Study||108
5626|NCT02303704|12012|P2|NOT COMPLETED|Overall Study||9
5627|NCT02303704|12013|P1|NOT COMPLETED|Overall Study||5
5628|NCT02303704|12012|P2|COMPLETED|Overall Study||219
5629|NCT02303704|12013|P1|COMPLETED|Overall Study||215
5630|NCT02303704|12012|P2|STARTED|Overall Study||228
5631|NCT02303704|12013|P1|STARTED|Overall Study||220
5632|NCT02302365|12029|P1|NOT COMPLETED|Overall Study||2
5633|NCT02302365|12029|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
5634|NCT02302365|12029|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
5635|NCT02301429|12045|P1|NOT COMPLETED|Overall Study||3
5636|NCT02301429|12045|P1|COMPLETED|Overall Study||13
5637|NCT02301429|12045|P1|STARTED|Overall Study||16
5638|NCT02301377|12051|P2|NOT COMPLETED|Overall Study||0
5639|NCT02301377|12052|P1|NOT COMPLETED|Overall Study||0
5640|NCT02301377|12051|P2|COMPLETED|Overall Study||2
5641|NCT02301377|12052|P1|COMPLETED|Overall Study||3
5642|NCT02301377|12051|P2|STARTED|Overall Study||2
5643|NCT02301377|12052|P1|STARTED|Overall Study||3
5644|NCT02301169|12064|P2|NOT COMPLETED|Overall Study||0
5645|NCT02301169|12065|P1|NOT COMPLETED|Overall Study||1
5646|NCT02301169|12064|P2|COMPLETED|Overall Study||21
5647|NCT02301169|12065|P1|COMPLETED|Overall Study||20
5648|NCT02301169|12064|P2|STARTED|Overall Study||21
5649|NCT02301169|12065|P1|STARTED|Overall Study||21
5650|NCT02300311|12081|P2|NOT COMPLETED|Overall Study||0
5651|NCT02300311|12082|P1|NOT COMPLETED|Overall Study||19
5652|NCT02300311|12081|P2|COMPLETED|Overall Study||69
5653|NCT02300311|12082|P1|COMPLETED|Overall Study||50
5654|NCT02300311|12081|P2|STARTED|Overall Study||69
5655|NCT02300311|12082|P1|STARTED|Overall Study||69
5656|NCT02300129|12094|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5657|NCT02300129|12095|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5658|NCT02300129|12096|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5659|NCT02300129|12097|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
5660|NCT02300129|12094|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
5661|NCT02300129|12095|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
5662|NCT02300129|12096|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
5663|NCT02300129|12097|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
5664|NCT02300129|12094|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
5665|NCT02300129|12095|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
5666|NCT02300129|12096|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
5667|NCT02300129|12097|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
5668|NCT02300129|12094|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
5669|NCT02300129|12095|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
5670|NCT02300129|12096|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
5671|NCT02300129|12097|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
5672|NCT02300129|12094|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
5673|NCT02300129|12095|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
5674|NCT02300129|12096|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
5675|NCT02300129|12097|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
5676|NCT02300129|12094|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
5677|NCT02300129|12095|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
5678|NCT02300129|12096|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
5679|NCT02300129|12097|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
5680|NCT02300129|12094|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5681|NCT02300129|12095|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5682|NCT02300129|12096|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5683|NCT02300129|12097|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
5684|NCT02300129|12094|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
5685|NCT02300129|12095|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
5686|NCT02300129|12096|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
5687|NCT02300129|12097|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
5688|NCT02300129|12094|P4|STARTED|Period 1 Session 3 (Day 5)||11
5689|NCT02300129|12095|P3|STARTED|Period 1 Session 3 (Day 5)||7
5690|NCT02300129|12096|P2|STARTED|Period 1 Session 3 (Day 5)||4
5691|NCT02300129|12097|P1|STARTED|Period 1 Session 3 (Day 5)||11
5692|NCT02300129|12094|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5693|NCT02300129|12095|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5694|NCT02300129|12096|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
5695|NCT02300129|12097|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
5696|NCT02300129|12094|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
5697|NCT02300129|12095|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
5698|NCT02300129|12096|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
5699|NCT02300129|12097|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
5700|NCT02300129|12094|P4|STARTED|Period 1 Session 2 (Day 3)||11
5701|NCT02300129|12095|P3|STARTED|Period 1 Session 2 (Day 3)||7
5702|NCT02300129|12096|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
5703|NCT02300129|12097|P1|STARTED|Period 1 Session 2 (Day 3)||11
5704|NCT02300129|12094|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5705|NCT02300129|12095|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5706|NCT02300129|12096|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5707|NCT02300129|12097|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
5708|NCT02300129|12094|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
5709|NCT02300129|12095|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
5710|NCT02300129|12096|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
5711|NCT02300129|12097|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
5712|NCT02300129|12094|P4|STARTED|Period 1 Session 1 (Day 1)||11
5713|NCT02300129|12095|P3|STARTED|Period 1 Session 1 (Day 1)||7
5714|NCT02300129|12096|P2|STARTED|Period 1 Session 1 (Day 1)||5
5715|NCT02300129|12097|P1|STARTED|Period 1 Session 1 (Day 1)||11
5716|NCT02300025|12111|P4|NOT COMPLETED|Overall Study||0
5717|NCT02300025|12112|P3|NOT COMPLETED|Overall Study||0
5718|NCT02300025|12113|P2|NOT COMPLETED|Overall Study||0
5719|NCT02300025|12114|P1|NOT COMPLETED|Overall Study||0
5720|NCT02300025|12111|P4|COMPLETED|Overall Study||6
5721|NCT02300025|12112|P3|COMPLETED|Overall Study||6
5722|NCT02300025|12113|P2|COMPLETED|Overall Study||6
5723|NCT02300025|12114|P1|COMPLETED|Overall Study||10
5724|NCT02300025|12111|P4|STARTED|Overall Study||6
5725|NCT02300025|12112|P3|STARTED|Overall Study||6
5726|NCT02300025|12113|P2|STARTED|Overall Study||6
5727|NCT02300025|12114|P1|STARTED|Overall Study||10
5728|NCT02299869|12160|P4|NOT COMPLETED|Overall Study||0
5729|NCT02299869|12161|P3|NOT COMPLETED|Overall Study||0
5730|NCT02299869|12162|P2|NOT COMPLETED|Overall Study||0
5731|NCT02299869|12163|P1|NOT COMPLETED|Overall Study||0
5732|NCT02299869|12160|P4|COMPLETED|Overall Study||10
5733|NCT02299869|12161|P3|COMPLETED|Overall Study||10
5734|NCT02299869|12162|P2|COMPLETED|Overall Study||10
5735|NCT02299869|12163|P1|COMPLETED|Overall Study||10
5736|NCT02299869|12160|P4|STARTED|Overall Study||10
5737|NCT02299869|12161|P3|STARTED|Overall Study||10
5738|NCT02299869|12162|P2|STARTED|Overall Study||10
5739|NCT02299869|12163|P1|STARTED|Overall Study||10
5740|NCT02299635|12186|P1|NOT COMPLETED|Overall Study||19
5741|NCT02299635|12186|P1|COMPLETED|Overall Study||0
5742|NCT02299635|12186|P1|STARTED|Overall Study||19
5743|NCT02299427|12207|P2|NOT COMPLETED|Overall Study||3
5744|NCT02299427|12208|P1|NOT COMPLETED|Overall Study||23
5745|NCT02299427|12207|P2|COMPLETED|Overall Study||31
5746|NCT02299427|12208|P1|COMPLETED|Overall Study||12
5747|NCT02299427|12207|P2|STARTED|Overall Study||34
5748|NCT02299427|12208|P1|STARTED|Overall Study||35
5749|NCT02299349|12218|P2|NOT COMPLETED|Overall Study||0
5750|NCT02299349|12219|P1|NOT COMPLETED|Overall Study||0
5751|NCT02299349|12218|P2|COMPLETED|Overall Study||35
5752|NCT02299349|12219|P1|COMPLETED|Overall Study||35
5753|NCT02299349|12218|P2|STARTED|Overall Study||35
5754|NCT02299349|12219|P1|STARTED|Overall Study||35
5755|NCT02299258|12229|P2|NOT COMPLETED|Overall Study||1
5756|NCT02299258|12230|P1|NOT COMPLETED|Overall Study||1
5757|NCT02299258|12229|P2|COMPLETED|Overall Study||30
5758|NCT02299258|12230|P1|COMPLETED|Overall Study||31
5759|NCT02299258|12229|P2|STARTED|Overall Study||31
5760|NCT02299258|12230|P1|STARTED|Overall Study||32
5761|NCT02298868|12238|P1|NOT COMPLETED|Overall Study||3
5762|NCT02298868|12238|P1|COMPLETED|Overall Study||7
5763|NCT02298868|12238|P1|STARTED|Overall Study||10
5764|NCT02298361|12253|P3|NOT COMPLETED|Overall Study||0
5765|NCT02298361|12254|P2|NOT COMPLETED|Overall Study||0
5766|NCT02298361|12255|P1|NOT COMPLETED|Overall Study||0
5767|NCT02298361|12253|P3|COMPLETED|Overall Study||12227
5768|NCT02298361|12254|P2|COMPLETED|Overall Study||12784
5769|NCT02298361|12255|P1|COMPLETED|Overall Study||2240
5770|NCT02298361|12253|P3|STARTED|Overall Study||12227
5771|NCT02298361|12254|P2|STARTED|Overall Study||12784
5772|NCT02298361|12255|P1|STARTED|Overall Study||2240
5773|NCT02297841|12269|P1|NOT COMPLETED|Overall Study||8
5774|NCT02297841|12269|P1|COMPLETED|Overall Study||201
5775|NCT02297841|12269|P1|Challenge Phase|Overall Study||201
5776|NCT02297841|12269|P1|Induction Phase|Overall Study||209
5777|NCT02297841|12269|P1|STARTED|Overall Study||209
5778|NCT02297308|12273|P1|NOT COMPLETED|Overall Study||0
5779|NCT02297308|12273|P1|COMPLETED|Overall Study||90
5780|NCT02297308|12273|P1|STARTED|Overall Study||90
5781|NCT02296931|12280|P2|NOT COMPLETED|Overall Study||2
5782|NCT02296931|12281|P1|NOT COMPLETED|Overall Study||0
5783|NCT02296931|12280|P2|COMPLETED|Overall Study||22
5784|NCT02296931|12281|P1|COMPLETED|Overall Study||10
5785|NCT02296931|12280|P2|STARTED|Overall Study||24
5786|NCT02296931|12281|P1|STARTED|Overall Study||10
5787|NCT02295774|12287|P1|NOT COMPLETED|Overall Study||3
5788|NCT02295774|12287|P1|COMPLETED|Overall Study||10
5789|NCT02295774|12287|P1|STARTED|Overall Study||13
5790|NCT02295644|12295|P4|NOT COMPLETED|Overall Study||0
5791|NCT02295644|12296|P3|NOT COMPLETED|Overall Study||0
5792|NCT02295644|12297|P2|NOT COMPLETED|Overall Study||0
5793|NCT02295644|12298|P1|NOT COMPLETED|Overall Study||0
5794|NCT02295644|12295|P4|COMPLETED|Overall Study||7
5795|NCT02295644|12296|P3|COMPLETED|Overall Study||7
5796|NCT02295644|12297|P2|COMPLETED|Overall Study||7
5797|NCT02295644|12298|P1|COMPLETED|Overall Study||7
5798|NCT02295644|12295|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5799|NCT02295644|12296|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5800|NCT02295644|12297|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5801|NCT02295644|12298|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
5802|NCT02295020|12318|P2|NOT COMPLETED|Overall Study||3
5803|NCT02295020|12319|P1|NOT COMPLETED|Overall Study||3
5804|NCT02295020|12318|P2|COMPLETED|Overall Study||17
5805|NCT02295020|12319|P1|COMPLETED|Overall Study||17
5806|NCT02295020|12318|P2|STARTED|Overall Study||20
5807|NCT02295020|12319|P1|STARTED|Overall Study||20
5808|NCT02294773|12351|P2|NOT COMPLETED|Overall Study||2
5809|NCT02294773|12352|P1|NOT COMPLETED|Overall Study||0
5810|NCT02294773|12351|P2|COMPLETED|Overall Study||4
5811|NCT02294773|12352|P1|COMPLETED|Overall Study||7
5812|NCT02294773|12351|P2|STARTED|Overall Study||6
5813|NCT02294773|12352|P1|STARTED|Overall Study||7
5814|NCT02294604|12369|P3|NOT COMPLETED|Overall Study||3
5815|NCT02294604|12370|P2|NOT COMPLETED|Overall Study||0
5816|NCT02294604|12371|P1|NOT COMPLETED|Overall Study||1
5817|NCT02294604|12369|P3|COMPLETED|Overall Study||77
5818|NCT02294604|12370|P2|COMPLETED|Overall Study||80
5819|NCT02294604|12371|P1|COMPLETED|Overall Study||79
5820|NCT02294604|12369|P3|STARTED|Overall Study||80
5821|NCT02294604|12370|P2|STARTED|Overall Study||80
5822|NCT02294604|12371|P1|STARTED|Overall Study||80
5823|NCT02294019|12388|P1|NOT COMPLETED|Overall Study||103
5824|NCT02294019|12388|P1|COMPLETED|Overall Study||635
5825|NCT02294019|12388|P1|STARTED|Overall Study||738
5826|NCT02293538|12395|P2|NOT COMPLETED|Overall Study||2
5827|NCT02293538|12396|P1|NOT COMPLETED|Overall Study||1
5828|NCT02293538|12395|P2|COMPLETED|Overall Study||69
5829|NCT02293538|12396|P1|COMPLETED|Overall Study||72
5830|NCT02293538|12395|P2|STARTED|Overall Study||71
5831|NCT02293538|12396|P1|STARTED|Overall Study||73
5832|NCT02292433|12412|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
5833|NCT02292433|12413|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
5834|NCT02292433|12414|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
5835|NCT02292433|12412|P3|COMPLETED|Third Intervention Period (7 Days)||4
5836|NCT02292433|12413|P2|COMPLETED|Third Intervention Period (7 Days)||4
5837|NCT02292433|12414|P1|COMPLETED|Third Intervention Period (7 Days)||4
5838|NCT02292433|12412|P3|STARTED|Third Intervention Period (7 Days)||4
5839|NCT02292433|12413|P2|STARTED|Third Intervention Period (7 Days)||4
5840|NCT02292433|12414|P1|STARTED|Third Intervention Period (7 Days)||4
5841|NCT02292433|12412|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5842|NCT02292433|12413|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5843|NCT02292433|12414|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
5844|NCT02292433|12412|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
5845|NCT02292433|12413|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
5846|NCT02292433|12414|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
5847|NCT02292433|12412|P3|STARTED|Second Washout Period (7 to 14 Days)||4
5848|NCT02292433|12413|P2|STARTED|Second Washout Period (7 to 14 Days)||4
5849|NCT02292433|12414|P1|STARTED|Second Washout Period (7 to 14 Days)||4
5850|NCT02292433|12412|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
5851|NCT02292433|12413|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
5852|NCT02292433|12414|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
5853|NCT02292433|12412|P3|COMPLETED|Second Intervention Period (7 Days)||4
5854|NCT02292433|12413|P2|COMPLETED|Second Intervention Period (7 Days)||4
5855|NCT02292433|12414|P1|COMPLETED|Second Intervention Period (7 Days)||4
5856|NCT02292433|12412|P3|STARTED|Second Intervention Period (7 Days)||4
5857|NCT02292433|12413|P2|STARTED|Second Intervention Period (7 Days)||4
5858|NCT02292433|12414|P1|STARTED|Second Intervention Period (7 Days)||4
5859|NCT02292433|12412|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5860|NCT02292433|12413|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5861|NCT02292433|12414|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
5862|NCT02292433|12412|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
5863|NCT02292433|12413|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
5864|NCT02292433|12414|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
5865|NCT02292433|12412|P3|STARTED|First Washout Period (7 to 14 Days)||4
5866|NCT02292433|12413|P2|STARTED|First Washout Period (7 to 14 Days)||4
5867|NCT02292433|12414|P1|STARTED|First Washout Period (7 to 14 Days)||4
5868|NCT02292433|12412|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
5869|NCT02292433|12413|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
5870|NCT02292433|12414|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
5871|NCT02292433|12412|P3|COMPLETED|First Intervention Period (7 Days)||4
5872|NCT02292433|12413|P2|COMPLETED|First Intervention Period (7 Days)||4
5873|NCT02292433|12414|P1|COMPLETED|First Intervention Period (7 Days)||4
5874|NCT02292433|12412|P3|STARTED|First Intervention Period (7 Days)||4
5875|NCT02292433|12413|P2|STARTED|First Intervention Period (7 Days)||4
5876|NCT02292433|12414|P1|STARTED|First Intervention Period (7 Days)||4
5877|NCT02291510|12489|P4|NOT COMPLETED|Overall Study||1
5878|NCT02291510|12490|P3|NOT COMPLETED|Overall Study||0
5879|NCT02291510|12491|P2|NOT COMPLETED|Overall Study||0
5880|NCT02291510|12492|P1|NOT COMPLETED|Overall Study||0
5881|NCT02291510|12489|P4|COMPLETED|Overall Study||4
5882|NCT02291510|12490|P3|COMPLETED|Overall Study||5
5883|NCT02291510|12491|P2|COMPLETED|Overall Study||5
5884|NCT02291510|12492|P1|COMPLETED|Overall Study||5
5885|NCT02291510|12489|P4|Completed Treatment D|Overall Study||5
5886|NCT02291510|12490|P3|Completed Treatment D|Overall Study||5
5887|NCT02291510|12491|P2|Completed Treatment D|Overall Study||5
5888|NCT02291510|12492|P1|Completed Treatment D|Overall Study||5
5889|NCT02291510|12489|P4|Completed Treatment C|Overall Study||4
5890|NCT02291510|12490|P3|Completed Treatment C|Overall Study||5
5891|NCT02291510|12491|P2|Completed Treatment C|Overall Study||5
5892|NCT02291510|12492|P1|Completed Treatment C|Overall Study||5
5893|NCT02291510|12489|P4|Completed Treatment B|Overall Study||4
5894|NCT02291510|12490|P3|Completed Treatment B|Overall Study||5
5895|NCT02291510|12491|P2|Completed Treatment B|Overall Study||5
5896|NCT02291510|12492|P1|Completed Treatment B|Overall Study||5
5897|NCT02291510|12489|P4|Completed Treatment A|Overall Study||5
5898|NCT02291510|12490|P3|Completed Treatment A|Overall Study||5
5899|NCT02291510|12491|P2|Completed Treatment A|Overall Study||5
5900|NCT02291510|12492|P1|Completed Treatment A|Overall Study||5
5901|NCT02291510|12489|P4|STARTED|Overall Study||5
5902|NCT02291510|12490|P3|STARTED|Overall Study||5
5903|NCT02291510|12491|P2|STARTED|Overall Study||5
5904|NCT02291510|12492|P1|STARTED|Overall Study||5
5905|NCT02291419|12508|P2|NOT COMPLETED|Overall Study||5
5906|NCT02291419|12509|P1|NOT COMPLETED|Overall Study||1
5907|NCT02291419|12508|P2|COMPLETED|Overall Study||0
5908|NCT02291419|12509|P1|COMPLETED|Overall Study||0
5909|NCT02291419|12508|P2|STARTED|Overall Study||5
5910|NCT02291419|12509|P1|STARTED|Overall Study||1
5911|NCT02290509|12527|P2|NOT COMPLETED|Overall Study||14
5912|NCT02290509|12528|P1|NOT COMPLETED|Overall Study||49
5913|NCT02290509|12527|P2|COMPLETED|Overall Study||325
5914|NCT02290509|12528|P1|COMPLETED|Overall Study||962
5915|NCT02290509|12527|P2|STARTED|Overall Study||339
5916|NCT02290509|12528|P1|STARTED|Overall Study||1011
5917|NCT02289755|12540|P1|NOT COMPLETED|Follow up Period [4 Days]||0
5918|NCT02289755|12540|P1|COMPLETED|Follow up Period [4 Days]||16
5919|NCT02289755|12540|P1|STARTED|Follow up Period [4 Days]||16
5920|NCT02289755|12540|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
5921|NCT02289755|12540|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
5922|NCT02289755|12540|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
5923|NCT02289755|12540|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
5924|NCT02289755|12540|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
5925|NCT02289755|12540|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
5926|NCT02289742|12547|P4|NOT COMPLETED|Third Wear Period||1
5927|NCT02289742|12548|P3|NOT COMPLETED|Third Wear Period||0
5928|NCT02289742|12549|P2|NOT COMPLETED|Third Wear Period||1
5929|NCT02289742|12550|P1|NOT COMPLETED|Third Wear Period||0
5930|NCT02289742|12547|P4|COMPLETED|Third Wear Period||8
5931|NCT02289742|12548|P3|COMPLETED|Third Wear Period||11
5932|NCT02289742|12549|P2|COMPLETED|Third Wear Period||10
5933|NCT02289742|12550|P1|COMPLETED|Third Wear Period||11
5934|NCT02289742|12547|P4|STARTED|Third Wear Period||9
5935|NCT02289742|12548|P3|STARTED|Third Wear Period||11
5936|NCT02289742|12549|P2|STARTED|Third Wear Period||11
5937|NCT02289742|12550|P1|STARTED|Third Wear Period||11
5938|NCT02289742|12547|P4|NOT COMPLETED|Second Wear Period||0
5939|NCT02289742|12548|P3|NOT COMPLETED|Second Wear Period||0
5940|NCT02289742|12549|P2|NOT COMPLETED|Second Wear Period||0
5941|NCT02289742|12550|P1|NOT COMPLETED|Second Wear Period||0
5942|NCT02289742|12547|P4|COMPLETED|Second Wear Period||9
5943|NCT02289742|12548|P3|COMPLETED|Second Wear Period||11
5944|NCT02289742|12549|P2|COMPLETED|Second Wear Period||11
5945|NCT02289742|12550|P1|COMPLETED|Second Wear Period||11
5946|NCT02289742|12547|P4|STARTED|Second Wear Period||9
5947|NCT02289742|12548|P3|STARTED|Second Wear Period||11
5948|NCT02289742|12549|P2|STARTED|Second Wear Period||11
5949|NCT02289742|12550|P1|STARTED|Second Wear Period||11
5950|NCT02289742|12547|P4|NOT COMPLETED|First Wear Period||1
5951|NCT02289742|12548|P3|NOT COMPLETED|First Wear Period||1
5952|NCT02289742|12549|P2|NOT COMPLETED|First Wear Period||1
5953|NCT02289742|12550|P1|NOT COMPLETED|First Wear Period||0
5954|NCT02289742|12547|P4|COMPLETED|First Wear Period||9
5955|NCT02289742|12548|P3|COMPLETED|First Wear Period||11
5956|NCT02289742|12549|P2|COMPLETED|First Wear Period||11
5957|NCT02289742|12550|P1|COMPLETED|First Wear Period||11
5958|NCT02289742|12547|P4|Treated|First Wear Period||9
5959|NCT02289742|12548|P3|Treated|First Wear Period||12
5960|NCT02289742|12549|P2|Treated|First Wear Period||11
5961|NCT02289742|12550|P1|Treated|First Wear Period||11
5962|NCT02289742|12547|P4|STARTED|First Wear Period||10
5963|NCT02289742|12548|P3|STARTED|First Wear Period||12
5964|NCT02289742|12549|P2|STARTED|First Wear Period||12
5965|NCT02289742|12550|P1|STARTED|First Wear Period||11
5966|NCT02289105|12569|P2|NOT COMPLETED|Overall Study||0
5967|NCT02289105|12570|P1|NOT COMPLETED|Overall Study||0
5968|NCT02289105|12569|P2|COMPLETED|Overall Study||637
5969|NCT02289105|12570|P1|COMPLETED|Overall Study||642
5970|NCT02289105|12569|P2|STARTED|Overall Study||637
5971|NCT02289105|12570|P1|STARTED|Overall Study||642
5972|NCT02289079|12582|P2|NOT COMPLETED|Overall Study||1
5973|NCT02289079|12583|P1|NOT COMPLETED|Overall Study||2
5974|NCT02289079|12582|P2|COMPLETED|Overall Study||29
5975|NCT02289079|12583|P1|COMPLETED|Overall Study||28
5976|NCT02289079|12582|P2|STARTED|Overall Study||30
5977|NCT02289079|12583|P1|STARTED|Overall Study||30
5978|NCT02288364|12597|P2|NOT COMPLETED|Overall Study||0
5979|NCT02288364|12598|P1|NOT COMPLETED|Overall Study||0
5980|NCT02288364|12597|P2|COMPLETED|Overall Study||44
5981|NCT02288364|12598|P1|COMPLETED|Overall Study||42
5982|NCT02288364|12597|P2|STARTED|Overall Study||44
5983|NCT02288364|12598|P1|STARTED|Overall Study||42
5984|NCT02288312|12625|P3|NOT COMPLETED|Overall Study||0
5985|NCT02288312|12626|P2|NOT COMPLETED|Overall Study||0
5986|NCT02288312|12627|P1|NOT COMPLETED|Overall Study||1
5987|NCT02288312|12625|P3|COMPLETED|Overall Study||6
5988|NCT02288312|12626|P2|COMPLETED|Overall Study||6
5989|NCT02288312|12627|P1|COMPLETED|Overall Study||5
5990|NCT02288312|12625|P3|STARTED|Overall Study||6
5991|NCT02288312|12626|P2|STARTED|Overall Study||6
5992|NCT02288312|12627|P1|STARTED|Overall Study||6
5993|NCT02288273|12646|P2|NOT COMPLETED|Overall Study||8
5994|NCT02288273|12647|P1|NOT COMPLETED|Overall Study||8
5995|NCT02288273|12646|P2|COMPLETED|Overall Study||48
5996|NCT02288273|12647|P1|COMPLETED|Overall Study||53
5997|NCT02288273|12646|P2|STARTED|Overall Study||56
5998|NCT02288273|12647|P1|STARTED|Overall Study||61
5999|NCT02287779|12673|P8|NOT COMPLETED|Overall Study||0
6000|NCT02287779|12674|P7|NOT COMPLETED|Overall Study||0
6001|NCT02287779|12675|P6|NOT COMPLETED|Overall Study||0
6002|NCT02287779|12676|P5|NOT COMPLETED|Overall Study||0
6003|NCT02287779|12677|P4|NOT COMPLETED|Overall Study||0
6004|NCT02287779|12678|P3|NOT COMPLETED|Overall Study||0
6005|NCT02287779|12679|P2|NOT COMPLETED|Overall Study||0
6006|NCT02287779|12680|P1|NOT COMPLETED|Overall Study||0
6007|NCT02287779|12673|P8|COMPLETED|Overall Study||9
6008|NCT02287779|12674|P7|COMPLETED|Overall Study||9
6009|NCT02287779|12675|P6|COMPLETED|Overall Study||9
6010|NCT02287779|12676|P5|COMPLETED|Overall Study||9
6011|NCT02287779|12677|P4|COMPLETED|Overall Study||9
6012|NCT02287779|12678|P3|COMPLETED|Overall Study||9
6013|NCT02287779|12679|P2|COMPLETED|Overall Study||9
6014|NCT02287779|12680|P1|COMPLETED|Overall Study||21
6015|NCT02287779|12673|P8|STARTED|Overall Study||9
6016|NCT02287779|12674|P7|STARTED|Overall Study||9
6017|NCT02287779|12675|P6|STARTED|Overall Study||9
6018|NCT02287779|12676|P5|STARTED|Overall Study||9
6019|NCT02287779|12677|P4|STARTED|Overall Study||9
6020|NCT02287779|12678|P3|STARTED|Overall Study||9
6021|NCT02287779|12679|P2|STARTED|Overall Study||9
6022|NCT02287779|12680|P1|STARTED|Overall Study||21
6023|NCT02287623|12820|P2|NOT COMPLETED|Overall Study||1
6024|NCT02287623|12821|P1|NOT COMPLETED|Overall Study||0
6025|NCT02287623|12820|P2|COMPLETED|Overall Study||29
6026|NCT02287623|12821|P1|COMPLETED|Overall Study||30
6027|NCT02287623|12820|P2|STARTED|Overall Study||30
6028|NCT02287623|12821|P1|STARTED|Overall Study||30
6029|NCT02287610|12837|P1|NOT COMPLETED|Overall Study||16
6030|NCT02287610|12837|P1|COMPLETED|Overall Study||48
6031|NCT02287610|12837|P1|Per Protocol Follow-Up|Overall Study||56
6032|NCT02287610|12837|P1|STARTED|Overall Study||64
6033|NCT02287415|12870|P1|NOT COMPLETED|Overall Study||0
6034|NCT02287415|12870|P1|COMPLETED|Overall Study||13
6035|NCT02287415|12870|P1|STARTED|Overall Study||13
6036|NCT02287402|12876|P1|NOT COMPLETED|Follow-up||3
6037|NCT02287402|12876|P1|COMPLETED|Follow-up||103
6038|NCT02287402|12876|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
6039|NCT02287402|12876|P1|NOT COMPLETED|Treatment Period||27
6040|NCT02287402|12876|P1|COMPLETED|Treatment Period||170
6041|NCT02287402|12876|P1|STARTED|Treatment Period||197
6042|NCT02286518|12905|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6043|NCT02286518|12906|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6044|NCT02286518|12907|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6045|NCT02286518|12908|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6046|NCT02286518|12909|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6047|NCT02286518|12910|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6048|NCT02286518|12911|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6049|NCT02286518|12912|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6050|NCT02286518|12913|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6051|NCT02286518|12914|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6052|NCT02286518|12915|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6053|NCT02286518|12916|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6054|NCT02286518|12917|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6055|NCT02286518|12918|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6056|NCT02286518|12905|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6057|NCT02286518|12906|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6058|NCT02286518|12907|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6059|NCT02286518|12908|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6060|NCT02286518|12909|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6061|NCT02286518|12910|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6062|NCT02286518|12911|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6063|NCT02286518|12912|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6064|NCT02286518|12913|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6065|NCT02286518|12914|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6066|NCT02286518|12915|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6067|NCT02286518|12916|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6068|NCT02286518|12917|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6069|NCT02286518|12918|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6070|NCT02286518|12905|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6071|NCT02286518|12906|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6072|NCT02286518|12907|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6073|NCT02286518|12908|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6074|NCT02286518|12909|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6075|NCT02286518|12910|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6076|NCT02286518|12911|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6077|NCT02286518|12912|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6078|NCT02286518|12913|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6079|NCT02286518|12914|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6080|NCT02286518|12915|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6081|NCT02286518|12916|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6082|NCT02286518|12917|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6083|NCT02286518|12918|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6084|NCT02286518|12905|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6085|NCT02286518|12906|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6086|NCT02286518|12907|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6087|NCT02286518|12908|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6088|NCT02286518|12909|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6089|NCT02286518|12910|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6090|NCT02286518|12911|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6091|NCT02286518|12912|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6092|NCT02286518|12913|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6093|NCT02286518|12914|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6094|NCT02286518|12915|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6095|NCT02286518|12916|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6096|NCT02286518|12917|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6097|NCT02286518|12918|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6098|NCT02286518|12905|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6099|NCT02286518|12906|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6100|NCT02286518|12907|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6101|NCT02286518|12908|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6102|NCT02286518|12909|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6103|NCT02286518|12910|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6104|NCT02286518|12911|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6105|NCT02286518|12912|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6106|NCT02286518|12913|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6107|NCT02286518|12914|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6108|NCT02286518|12915|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6109|NCT02286518|12916|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6110|NCT02286518|12917|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6111|NCT02286518|12918|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6112|NCT02286518|12905|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6113|NCT02286518|12906|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6114|NCT02286518|12907|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6115|NCT02286518|12908|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6116|NCT02286518|12909|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6117|NCT02286518|12910|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6118|NCT02286518|12911|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6119|NCT02286518|12912|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6120|NCT02286518|12913|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6121|NCT02286518|12914|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6122|NCT02286518|12915|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6123|NCT02286518|12916|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6124|NCT02286518|12917|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6125|NCT02286518|12918|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6126|NCT02286518|12905|P14|NOT COMPLETED|All Parts (16 Days)||0
6127|NCT02286518|12906|P13|NOT COMPLETED|All Parts (16 Days)||0
6128|NCT02286518|12907|P12|NOT COMPLETED|All Parts (16 Days)||0
6129|NCT02286518|12908|P11|NOT COMPLETED|All Parts (16 Days)||0
6130|NCT02286518|12909|P10|NOT COMPLETED|All Parts (16 Days)||0
6131|NCT02286518|12910|P9|NOT COMPLETED|All Parts (16 Days)||0
6132|NCT02286518|12911|P8|NOT COMPLETED|All Parts (16 Days)||0
6133|NCT02286518|12912|P7|NOT COMPLETED|All Parts (16 Days)||0
6134|NCT02286518|12913|P6|NOT COMPLETED|All Parts (16 Days)||0
6135|NCT02286518|12914|P5|NOT COMPLETED|All Parts (16 Days)||0
6136|NCT02286518|12915|P4|NOT COMPLETED|All Parts (16 Days)||0
6137|NCT02286518|12916|P3|NOT COMPLETED|All Parts (16 Days)||0
6138|NCT02286518|12917|P2|NOT COMPLETED|All Parts (16 Days)||0
6139|NCT02286518|12918|P1|NOT COMPLETED|All Parts (16 Days)||0
6140|NCT02286518|12905|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6141|NCT02286518|12906|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6142|NCT02286518|12907|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6143|NCT02286518|12908|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6144|NCT02286518|12909|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
6145|NCT02286518|12910|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
6146|NCT02286518|12911|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
6147|NCT02286518|12912|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6148|NCT02286518|12913|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6149|NCT02286518|12914|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6150|NCT02286518|12915|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6242|NCT02283840|13204|P1|COMPLETED|Overall Study||20
6151|NCT02286518|12916|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6152|NCT02286518|12917|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6153|NCT02286518|12918|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6154|NCT02286518|12905|P14|STARTED|All Parts (16 Days)||6
6155|NCT02286518|12906|P13|STARTED|All Parts (16 Days)||6
6156|NCT02286518|12907|P12|STARTED|All Parts (16 Days)||6
6157|NCT02286518|12908|P11|STARTED|All Parts (16 Days)||6
6158|NCT02286518|12909|P10|STARTED|All Parts (16 Days)||4
6159|NCT02286518|12910|P9|STARTED|All Parts (16 Days)||6
6160|NCT02286518|12911|P8|STARTED|All Parts (16 Days)||6
6161|NCT02286518|12912|P7|STARTED|All Parts (16 Days)||6
6162|NCT02286518|12913|P6|STARTED|All Parts (16 Days)||6
6163|NCT02286518|12914|P5|STARTED|All Parts (16 Days)||6
6164|NCT02286518|12915|P4|STARTED|All Parts (16 Days)||6
6165|NCT02286518|12916|P3|STARTED|All Parts (16 Days)||6
6166|NCT02286518|12917|P2|STARTED|All Parts (16 Days)||6
6167|NCT02286518|12918|P1|STARTED|All Parts (16 Days)||6
6168|NCT02286193|13058|P1|NOT COMPLETED|Overall Study||204
6169|NCT02286193|13058|P1|COMPLETED|Overall Study||418
6170|NCT02286193|13058|P1|STARTED|Overall Study||622
6171|NCT02285998|13065|P2|NOT COMPLETED|Overall Study||253
6172|NCT02285998|13066|P1|NOT COMPLETED|Overall Study||246
6173|NCT02285998|13065|P2|COMPLETED|Overall Study||4236
6174|NCT02285998|13066|P1|COMPLETED|Overall Study||4228
6175|NCT02285998|13065|P2|STARTED|Overall Study||4489
6176|NCT02285998|13066|P1|STARTED|Overall Study||4474
6177|NCT02285270|13090|P1|NOT COMPLETED|Overall Study||5
6178|NCT02285270|13090|P1|COMPLETED|Overall Study||5
6179|NCT02285270|13090|P1|STARTED|Overall Study||10
6180|NCT02284880|13098|P4|NOT COMPLETED|Overall Study||0
6181|NCT02284880|13099|P3|NOT COMPLETED|Overall Study||2
6182|NCT02284880|13100|P2|NOT COMPLETED|Overall Study||0
6183|NCT02284880|13101|P1|NOT COMPLETED|Overall Study||0
6184|NCT02284880|13098|P4|COMPLETED|Overall Study||10
6185|NCT02284880|13099|P3|COMPLETED|Overall Study||8
6186|NCT02284880|13100|P2|COMPLETED|Overall Study||9
6187|NCT02284880|13101|P1|COMPLETED|Overall Study||11
6188|NCT02284880|13098|P4|Second Period (4 Days)|Overall Study||10
6189|NCT02284880|13099|P3|Second Period (4 Days)|Overall Study||8
6190|NCT02284880|13100|P2|Second Period (4 Days)|Overall Study||9
6191|NCT02284880|13101|P1|Second Period (4 Days)|Overall Study||11
6192|NCT02284880|13098|P4|Wash-out Period (7 Days)|Overall Study||10
6193|NCT02284880|13099|P3|Wash-out Period (7 Days)|Overall Study||10
6194|NCT02284880|13100|P2|Wash-out Period (7 Days)|Overall Study||9
6195|NCT02284880|13101|P1|Wash-out Period (7 Days)|Overall Study||11
6196|NCT02284880|13098|P4|First Period (4 Days)|Overall Study||10
6197|NCT02284880|13099|P3|First Period (4 Days)|Overall Study||10
6198|NCT02284880|13100|P2|First Period (4 Days)|Overall Study||9
6199|NCT02284880|13101|P1|First Period (4 Days)|Overall Study||11
6200|NCT02284880|13098|P4|STARTED|Overall Study||10
6201|NCT02284880|13099|P3|STARTED|Overall Study||10
6202|NCT02284880|13100|P2|STARTED|Overall Study||9
6203|NCT02284880|13101|P1|STARTED|Overall Study||11
6204|NCT02284867|13117|P2|NOT COMPLETED|Overall Study||0
6205|NCT02284867|13118|P1|NOT COMPLETED|Overall Study||0
6206|NCT02284867|13117|P2|COMPLETED|Overall Study||30
6207|NCT02284867|13118|P1|COMPLETED|Overall Study||30
6208|NCT02284867|13117|P2|STARTED|Overall Study||30
6209|NCT02284867|13118|P1|STARTED|Overall Study||30
6210|NCT02284854|13128|P2|NOT COMPLETED|Overall Study||0
6211|NCT02284854|13129|P1|NOT COMPLETED|Overall Study||5
6212|NCT02284854|13128|P2|COMPLETED|Overall Study||20
6213|NCT02284854|13129|P1|COMPLETED|Overall Study||18
6214|NCT02284854|13128|P2|STARTED|Overall Study||20
6215|NCT02284854|13129|P1|STARTED|Overall Study||23
6216|NCT02284828|13146|P1|NOT COMPLETED|Overall Study||4
6217|NCT02284828|13146|P1|COMPLETED|Overall Study||22
6218|NCT02284828|13146|P1|STARTED|Overall Study||26
6219|NCT02284555|13158|P1|NOT COMPLETED|Overall Study||0
6220|NCT02284555|13158|P1|COMPLETED|Overall Study||12
6221|NCT02284555|13158|P1|STARTED|Overall Study||12
6222|NCT02284386|13163|P1|NOT COMPLETED|Overall Study||0
6223|NCT02284386|13163|P1|COMPLETED|Overall Study||15
6224|NCT02284386|13163|P1|STARTED|Overall Study||15
6225|NCT02284347|13172|P1|NOT COMPLETED|Overall Study||3
6226|NCT02284347|13172|P1|COMPLETED|Overall Study||48
6227|NCT02284347|13172|P1|STARTED|Overall Study||51
6228|NCT02284165|13181|P3|NOT COMPLETED|Overall Study||0
6229|NCT02284165|13182|P2|NOT COMPLETED|Overall Study||0
6230|NCT02284165|13183|P1|NOT COMPLETED|Overall Study||0
6231|NCT02284165|13181|P3|COMPLETED|Overall Study||70996
6232|NCT02284165|13182|P2|COMPLETED|Overall Study||40272
6233|NCT02284165|13183|P1|COMPLETED|Overall Study||36448
6234|NCT02284165|13181|P3|STARTED|Overall Study||70996
6235|NCT02284165|13182|P2|STARTED|Overall Study||40272
6236|NCT02284165|13183|P1|STARTED|Overall Study||36448
6237|NCT02283840|13202|P3|NOT COMPLETED|Overall Study||0
6238|NCT02283840|13203|P2|NOT COMPLETED|Overall Study||1
6239|NCT02283840|13204|P1|NOT COMPLETED|Overall Study||0
6240|NCT02283840|13202|P3|COMPLETED|Overall Study||20
6241|NCT02283840|13203|P2|COMPLETED|Overall Study||19
6243|NCT02283840|13202|P3|STARTED|Overall Study||20
6244|NCT02283840|13203|P2|STARTED|Overall Study||20
6245|NCT02283840|13204|P1|STARTED|Overall Study||20
6246|NCT02283827|13223|P2|NOT COMPLETED|Overall Study||3
6247|NCT02283827|13224|P1|NOT COMPLETED|Overall Study||1
6248|NCT02283827|13223|P2|COMPLETED|Overall Study||13
6249|NCT02283827|13224|P1|COMPLETED|Overall Study||15
6250|NCT02283827|13223|P2|STARTED|Overall Study||16
6251|NCT02283827|13224|P1|STARTED|Overall Study||16
6252|NCT02283814|13241|P2|NOT COMPLETED|Overall Study||2
6253|NCT02283814|13242|P1|NOT COMPLETED|Overall Study||3
6254|NCT02283814|13241|P2|COMPLETED|Overall Study||14
6255|NCT02283814|13242|P1|COMPLETED|Overall Study||13
6256|NCT02283814|13241|P2|STARTED|Overall Study||16
6257|NCT02283814|13242|P1|STARTED|Overall Study||16
6258|NCT02283788|13256|P4|NOT COMPLETED|Overall Study||2
6259|NCT02283788|13257|P3|NOT COMPLETED|Overall Study||5
6260|NCT02283788|13258|P2|NOT COMPLETED|Overall Study||4
6261|NCT02283788|13259|P1|NOT COMPLETED|Overall Study||1
6262|NCT02283788|13256|P4|COMPLETED|Overall Study||14
6263|NCT02283788|13257|P3|COMPLETED|Overall Study||12
6264|NCT02283788|13258|P2|COMPLETED|Overall Study||13
6265|NCT02283788|13259|P1|COMPLETED|Overall Study||16
6266|NCT02283788|13256|P4|STARTED|Overall Study||16
6267|NCT02283788|13257|P3|STARTED|Overall Study||17
6268|NCT02283788|13258|P2|STARTED|Overall Study||17
6269|NCT02283788|13259|P1|STARTED|Overall Study||17
6270|NCT02282982|13269|P1|NOT COMPLETED|Overall Study||206
6271|NCT02282982|13269|P1|COMPLETED|Overall Study||153
6272|NCT02282982|13269|P1|Attended Follow-up Visit|Overall Study||349
6273|NCT02282982|13269|P1|Attended Visit 5|Overall Study||83
6274|NCT02282982|13269|P1|Attended Visit 4|Overall Study||194
6275|NCT02282982|13269|P1|Attended Visit 3|Overall Study||298
6276|NCT02282982|13269|P1|Attended Visit 2|Overall Study||341
6277|NCT02282982|13269|P1|Attended Visit 1|Overall Study||359
6278|NCT02282982|13269|P1|STARTED|Overall Study||359
6279|NCT02282813|13287|P3|NOT COMPLETED|Overall Study||3
6280|NCT02282813|13288|P2|NOT COMPLETED|Overall Study||23
6281|NCT02282813|13289|P1|NOT COMPLETED|Overall Study||12
6282|NCT02282813|13287|P3|COMPLETED|Overall Study||39
6283|NCT02282813|13288|P2|COMPLETED|Overall Study||130
6284|NCT02282813|13289|P1|COMPLETED|Overall Study||91
6285|NCT02282813|13287|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
6286|NCT02282813|13288|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
6287|NCT02282813|13289|P1|STARTED|Overall Study|ITT Population|103
6288|NCT02282605|13309|P3|NOT COMPLETED|Overall Study||0
6289|NCT02282605|13310|P2|NOT COMPLETED|Overall Study||0
6290|NCT02282605|13311|P1|NOT COMPLETED|Overall Study||3
6291|NCT02282605|13309|P3|COMPLETED|Overall Study||24
6292|NCT02282605|13310|P2|COMPLETED|Overall Study||12
6293|NCT02282605|13311|P1|COMPLETED|Overall Study||24
6294|NCT02282605|13309|P3|STARTED|Overall Study||24
6295|NCT02282605|13310|P2|STARTED|Overall Study||12
6296|NCT02282605|13311|P1|STARTED|Overall Study||27
6297|NCT02281591|13335|P4|NOT COMPLETED|Overall Study||0
6298|NCT02281591|13336|P3|NOT COMPLETED|Overall Study||0
6299|NCT02281591|13337|P2|NOT COMPLETED|Overall Study||0
6300|NCT02281591|13338|P1|NOT COMPLETED|Overall Study||0
6301|NCT02281591|13335|P4|COMPLETED|Overall Study||8
6302|NCT02281591|13336|P3|COMPLETED|Overall Study||8
6303|NCT02281591|13337|P2|COMPLETED|Overall Study||8
6304|NCT02281591|13338|P1|COMPLETED|Overall Study||8
6305|NCT02281591|13335|P4|STARTED|Overall Study||8
6306|NCT02281591|13336|P3|STARTED|Overall Study||8
6307|NCT02281591|13337|P2|STARTED|Overall Study||8
6308|NCT02281591|13338|P1|STARTED|Overall Study||8
6309|NCT02281526|13362|P2|NOT COMPLETED|Overall Study||0
6310|NCT02281526|13363|P1|NOT COMPLETED|Overall Study||1
6311|NCT02281526|13362|P2|COMPLETED|Overall Study||8
6312|NCT02281526|13363|P1|COMPLETED|Overall Study||8
6313|NCT02281526|13362|P2|STARTED|Overall Study||8
6314|NCT02281526|13363|P1|STARTED|Overall Study||9
6315|NCT02281448|13373|P2|NOT COMPLETED|Overall Study||1
6316|NCT02281448|13374|P1|NOT COMPLETED|Overall Study||2
6317|NCT02281448|13373|P2|COMPLETED|Overall Study||9
6318|NCT02281448|13374|P1|COMPLETED|Overall Study||8
6319|NCT02281448|13373|P2|STARTED|Overall Study||10
6320|NCT02281448|13374|P1|STARTED|Overall Study||10
6321|NCT02281422|13387|P5|NOT COMPLETED|Overall Study||0
6322|NCT02281422|13388|P4|NOT COMPLETED|Overall Study||0
6323|NCT02281422|13389|P3|NOT COMPLETED|Overall Study||0
6324|NCT02281422|13390|P2|NOT COMPLETED|Overall Study||0
6325|NCT02281422|13391|P1|NOT COMPLETED|Overall Study||0
6326|NCT02281422|13387|P5|COMPLETED|Overall Study||8
6327|NCT02281422|13388|P4|COMPLETED|Overall Study||8
6328|NCT02281422|13389|P3|COMPLETED|Overall Study||8
6329|NCT02281422|13390|P2|COMPLETED|Overall Study||8
6330|NCT02281422|13391|P1|COMPLETED|Overall Study||8
6331|NCT02281422|13387|P5|STARTED|Overall Study||8
6332|NCT02281422|13388|P4|STARTED|Overall Study||8
6333|NCT02281422|13389|P3|STARTED|Overall Study||8
6334|NCT02281422|13390|P2|STARTED|Overall Study||8
6335|NCT02281422|13391|P1|STARTED|Overall Study||8
6336|NCT02281136|13413|P1|NOT COMPLETED|Overall Study||0
6337|NCT02281136|13413|P1|COMPLETED|Overall Study||29
6338|NCT02281136|13413|P1|STARTED|Overall Study||29
6339|NCT02280655|13447|P2|NOT COMPLETED|Overall Study||0
6340|NCT02280655|13448|P1|NOT COMPLETED|Overall Study||0
6341|NCT02280655|13447|P2|COMPLETED|Overall Study||18
6342|NCT02280655|13448|P1|COMPLETED|Overall Study||25
6343|NCT02280655|13447|P2|STARTED|Overall Study||18
6344|NCT02280655|13448|P1|STARTED|Overall Study||25
6345|NCT02280499|13456|P1|NOT COMPLETED|Overall Study||61
6346|NCT02280499|13456|P1|COMPLETED|Overall Study||26
6347|NCT02280499|13456|P1|STARTED|Overall Study||87
6348|NCT02280187|13462|P1|NOT COMPLETED|Overall Study||218
6349|NCT02280187|13462|P1|COMPLETED|Overall Study||182
6350|NCT02280187|13462|P1|STARTED|Overall Study||400
6351|NCT02280122|13480|P3|NOT COMPLETED|Overall Study||0
6352|NCT02280122|13481|P2|NOT COMPLETED|Overall Study||0
6353|NCT02280122|13482|P1|NOT COMPLETED|Overall Study||0
6354|NCT02280122|13480|P3|COMPLETED|Overall Study||30
6355|NCT02280122|13481|P2|COMPLETED|Overall Study||15
6356|NCT02280122|13482|P1|COMPLETED|Overall Study||15
6357|NCT02280122|13480|P3|STARTED|Overall Study||30
6358|NCT02280122|13481|P2|STARTED|Overall Study||15
6359|NCT02280122|13482|P1|STARTED|Overall Study||15
6360|NCT02279667|13491|P3|NOT COMPLETED|Overall Study||0
6361|NCT02279667|13492|P2|NOT COMPLETED|Overall Study||0
6362|NCT02279667|13493|P1|NOT COMPLETED|Overall Study||0
6363|NCT02279667|13491|P3|COMPLETED|Overall Study||6
6364|NCT02279667|13492|P2|COMPLETED|Overall Study||6
6365|NCT02279667|13493|P1|COMPLETED|Overall Study||6
6366|NCT02279667|13491|P3|STARTED|Overall Study||6
6367|NCT02279667|13492|P2|STARTED|Overall Study||6
6368|NCT02279667|13493|P1|STARTED|Overall Study||6
6369|NCT02279407|13515|P4|NOT COMPLETED|Overall Study||1
6370|NCT02279407|13516|P3|NOT COMPLETED|Overall Study||5
6371|NCT02279407|13517|P2|NOT COMPLETED|Overall Study||1
6372|NCT02279407|13518|P1|NOT COMPLETED|Overall Study||2
6373|NCT02279407|13515|P4|COMPLETED|Overall Study||20
6374|NCT02279407|13516|P3|COMPLETED|Overall Study||15
6375|NCT02279407|13517|P2|COMPLETED|Overall Study||20
6376|NCT02279407|13518|P1|COMPLETED|Overall Study||20
6377|NCT02279407|13515|P4|STARTED|Overall Study||21
6378|NCT02279407|13516|P3|STARTED|Overall Study||20
6379|NCT02279407|13517|P2|STARTED|Overall Study||21
6380|NCT02279407|13518|P1|STARTED|Overall Study||22
6381|NCT02278783|13529|P1|NOT COMPLETED|Overall Study||0
6382|NCT02278783|13529|P1|COMPLETED|Overall Study||1
6383|NCT02278783|13529|P1|STARTED|Overall Study||1
6384|NCT02278640|13536|P1|NOT COMPLETED|Overall Study||0
6385|NCT02278640|13536|P1|COMPLETED|Overall Study||40
6386|NCT02278640|13536|P1|STARTED|Overall Study||40
6387|NCT02278614|13545|P2|NOT COMPLETED|Overall Study||5
6388|NCT02278614|13546|P1|NOT COMPLETED|Overall Study||5
6389|NCT02278614|13545|P2|COMPLETED|Overall Study||110
6390|NCT02278614|13546|P1|COMPLETED|Overall Study||122
6391|NCT02278614|13545|P2|STARTED|Overall Study||115
6392|NCT02278614|13546|P1|STARTED|Overall Study||127
6393|NCT02278484|13552|P1|NOT COMPLETED|Overall Study||0
6394|NCT02278484|13552|P1|COMPLETED|Overall Study||50
6395|NCT02278484|13552|P1|STARTED|Overall Study||50
6396|NCT02278146|13561|P2|NOT COMPLETED|Overall Study||2
6397|NCT02278146|13562|P1|NOT COMPLETED|Overall Study||0
6398|NCT02278146|13561|P2|COMPLETED|Overall Study||8
6399|NCT02278146|13562|P1|COMPLETED|Overall Study||6
6400|NCT02278146|13561|P2|STARTED|Overall Study||10
6401|NCT02278146|13562|P1|STARTED|Overall Study||6
6402|NCT02277626|13572|P2|NOT COMPLETED|Overall Study||0
6403|NCT02277626|13573|P1|NOT COMPLETED|Overall Study||0
6404|NCT02277626|13572|P2|COMPLETED|Overall Study||9
6405|NCT02277626|13573|P1|COMPLETED|Overall Study||6
6406|NCT02277626|13572|P2|STARTED|Overall Study||9
6407|NCT02277626|13573|P1|STARTED|Overall Study||6
6408|NCT02277249|13589|P2|NOT COMPLETED|Overall Study||0
6409|NCT02277249|13590|P1|NOT COMPLETED|Overall Study||0
6410|NCT02277249|13589|P2|COMPLETED|Overall Study||30
6411|NCT02277249|13590|P1|COMPLETED|Overall Study||30
6412|NCT02277249|13589|P2|STARTED|Overall Study||30
6413|NCT02277249|13590|P1|STARTED|Overall Study||30
6414|NCT02277119|13599|P3|NOT COMPLETED|Overall Study||8
6415|NCT02277119|13600|P2|NOT COMPLETED|Overall Study||4
6416|NCT02277119|13601|P1|NOT COMPLETED|Overall Study||3
6417|NCT02277119|13599|P3|COMPLETED|Overall Study||19
6418|NCT02277119|13600|P2|COMPLETED|Overall Study||20
6419|NCT02277119|13601|P1|COMPLETED|Overall Study||55
6420|NCT02277119|13599|P3|STARTED|Overall Study||27
6421|NCT02277119|13600|P2|STARTED|Overall Study||24
6422|NCT02277119|13601|P1|STARTED|Overall Study||58
6423|NCT02276274|13620|P2|NOT COMPLETED|Second Intervention Period||0
6424|NCT02276274|13621|P1|NOT COMPLETED|Second Intervention Period||0
6425|NCT02276274|13620|P2|COMPLETED|Second Intervention Period||6
6426|NCT02276274|13621|P1|COMPLETED|Second Intervention Period||6
6427|NCT02276274|13620|P2|STARTED|Second Intervention Period||6
6428|NCT02276274|13621|P1|STARTED|Second Intervention Period||6
6429|NCT02276274|13620|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6430|NCT02276274|13621|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6431|NCT02276274|13620|P2|COMPLETED|Washout Period (at Least 15 Days)||6
6432|NCT02276274|13621|P1|COMPLETED|Washout Period (at Least 15 Days)||6
6433|NCT02276274|13620|P2|STARTED|Washout Period (at Least 15 Days)||6
6434|NCT02276274|13621|P1|STARTED|Washout Period (at Least 15 Days)||6
6435|NCT02276274|13620|P2|NOT COMPLETED|First Intervention Period||0
6436|NCT02276274|13621|P1|NOT COMPLETED|First Intervention Period||0
6437|NCT02276274|13620|P2|COMPLETED|First Intervention Period||6
6438|NCT02276274|13621|P1|COMPLETED|First Intervention Period||6
6439|NCT02276274|13620|P2|STARTED|First Intervention Period||6
6440|NCT02276274|13621|P1|STARTED|First Intervention Period||6
6441|NCT02275767|13732|P3|NOT COMPLETED|Overall Study||3
6442|NCT02275767|13733|P2|NOT COMPLETED|Overall Study||4
6443|NCT02275767|13734|P1|NOT COMPLETED|Overall Study||2
6444|NCT02275767|13732|P3|COMPLETED|Overall Study||19
6445|NCT02275767|13733|P2|COMPLETED|Overall Study||18
6446|NCT02275767|13734|P1|COMPLETED|Overall Study||20
6447|NCT02275767|13732|P3|STARTED|Overall Study||22
6448|NCT02275767|13733|P2|STARTED|Overall Study||22
6449|NCT02275767|13734|P1|STARTED|Overall Study||22
6450|NCT02275546|13745|P2|NOT COMPLETED|Treatment Period 2||2
6451|NCT02275546|13746|P1|NOT COMPLETED|Treatment Period 2||2
6452|NCT02275546|13745|P2|COMPLETED|Treatment Period 2||81
6453|NCT02275546|13746|P1|COMPLETED|Treatment Period 2||79
6454|NCT02275546|13745|P2|STARTED|Treatment Period 2||83
6455|NCT02275546|13746|P1|STARTED|Treatment Period 2||81
6456|NCT02275546|13745|P2|NOT COMPLETED|Treatment Period 1||0
6457|NCT02275546|13746|P1|NOT COMPLETED|Treatment Period 1||0
6458|NCT02275546|13745|P2|COMPLETED|Treatment Period 1||83
6459|NCT02275546|13746|P1|COMPLETED|Treatment Period 1||81
6460|NCT02275546|13745|P2|STARTED|Treatment Period 1||83
6461|NCT02275546|13746|P1|STARTED|Treatment Period 1||81
6462|NCT02275364|13754|P2|NOT COMPLETED|Period 4||0
6463|NCT02275364|13755|P1|NOT COMPLETED|Period 4||0
6464|NCT02275364|13754|P2|COMPLETED|Period 4||14
6465|NCT02275364|13755|P1|COMPLETED|Period 4||12
6466|NCT02275364|13754|P2|STARTED|Period 4||14
6467|NCT02275364|13755|P1|STARTED|Period 4||12
6468|NCT02275364|13754|P2|NOT COMPLETED|Period 3||0
6469|NCT02275364|13755|P1|NOT COMPLETED|Period 3||0
6470|NCT02275364|13754|P2|COMPLETED|Period 3||14
6471|NCT02275364|13755|P1|COMPLETED|Period 3||12
6472|NCT02275364|13754|P2|STARTED|Period 3||14
6473|NCT02275364|13755|P1|STARTED|Period 3||12
6474|NCT02275364|13754|P2|NOT COMPLETED|Washout Period 2||0
6475|NCT02275364|13755|P1|NOT COMPLETED|Washout Period 2||0
6476|NCT02275364|13754|P2|COMPLETED|Washout Period 2||14
6477|NCT02275364|13755|P1|COMPLETED|Washout Period 2||12
6478|NCT02275364|13754|P2|STARTED|Washout Period 2||14
6479|NCT02275364|13755|P1|STARTED|Washout Period 2||12
6480|NCT02275364|13754|P2|NOT COMPLETED|Period 2||0
6481|NCT02275364|13755|P1|NOT COMPLETED|Period 2||0
6482|NCT02275364|13754|P2|COMPLETED|Period 2||14
6483|NCT02275364|13755|P1|COMPLETED|Period 2||12
6484|NCT02275364|13754|P2|STARTED|Period 2||14
6485|NCT02275364|13755|P1|STARTED|Period 2||12
6486|NCT02275364|13754|P2|NOT COMPLETED|Washout Period 1||0
6487|NCT02275364|13755|P1|NOT COMPLETED|Washout Period 1||0
6488|NCT02275364|13754|P2|COMPLETED|Washout Period 1||14
6489|NCT02275364|13755|P1|COMPLETED|Washout Period 1||12
6490|NCT02275364|13754|P2|STARTED|Washout Period 1||14
6491|NCT02275364|13755|P1|STARTED|Washout Period 1||12
6492|NCT02275364|13754|P2|NOT COMPLETED|Period 1||0
6493|NCT02275364|13755|P1|NOT COMPLETED|Period 1||2
6494|NCT02275364|13754|P2|COMPLETED|Period 1||14
6495|NCT02275364|13755|P1|COMPLETED|Period 1||12
6496|NCT02275364|13754|P2|STARTED|Period 1||14
6497|NCT02275364|13755|P1|STARTED|Period 1||14
6498|NCT02275156|13787|P3|NOT COMPLETED|Overall Study||0
6499|NCT02275156|13788|P2|NOT COMPLETED|Overall Study||0
6500|NCT02275156|13789|P1|NOT COMPLETED|Overall Study||0
6501|NCT02275156|13787|P3|COMPLETED|Overall Study||6
6502|NCT02275156|13788|P2|COMPLETED|Overall Study||6
6503|NCT02275156|13789|P1|COMPLETED|Overall Study||6
6504|NCT02275156|13787|P3|STARTED|Overall Study||6
6505|NCT02275156|13788|P2|STARTED|Overall Study||6
6506|NCT02275156|13789|P1|STARTED|Overall Study||6
6507|NCT02274948|13818|P2|NOT COMPLETED|Overall Study||91
6508|NCT02274948|13819|P1|NOT COMPLETED|Overall Study||98
6509|NCT02274948|13818|P2|COMPLETED|Overall Study||82
6510|NCT02274948|13819|P1|COMPLETED|Overall Study||68
6511|NCT02274948|13818|P2|STARTED|Overall Study||173
6512|NCT02274948|13819|P1|STARTED|Overall Study||166
6513|NCT02274792|13833|P1|NOT COMPLETED|Overall Study||25
6514|NCT02274792|13833|P1|COMPLETED|Overall Study||107
6515|NCT02274792|13833|P1|Received Treatment|Overall Study||131
6516|NCT02274792|13833|P1|STARTED|Overall Study||132
6517|NCT02274675|13841|P1|NOT COMPLETED|Overall Study||0
6518|NCT02274675|13841|P1|COMPLETED|Overall Study||7
6519|NCT02274675|13841|P1|STARTED|Overall Study||7
6520|NCT02273908|13853|P2|NOT COMPLETED|Overall Study||5
6521|NCT02273908|13854|P1|NOT COMPLETED|Overall Study||33
6522|NCT02273908|13853|P2|COMPLETED|Overall Study||169
6523|NCT02273908|13854|P1|COMPLETED|Overall Study||124
6524|NCT02273908|13853|P2|STARTED|Overall Study||174
6525|NCT02273908|13854|P1|STARTED|Overall Study||157
6526|NCT02273752|13876|P1|NOT COMPLETED|Overall Study||2
6527|NCT02273752|13876|P1|COMPLETED|Overall Study||0
6528|NCT02273752|13876|P1|STARTED|Overall Study||2
6529|NCT02273323|13887|P2|NOT COMPLETED|Overall Study||0
6530|NCT02273323|13888|P1|NOT COMPLETED|Overall Study||0
6531|NCT02273323|13887|P2|COMPLETED|Overall Study||15
6532|NCT02273323|13888|P1|COMPLETED|Overall Study||15
6533|NCT02273323|13887|P2|STARTED|Overall Study||15
6534|NCT02273323|13888|P1|STARTED|Overall Study||15
6535|NCT02273310|13906|P2|NOT COMPLETED|Overall Study||3
6536|NCT02273310|13907|P1|NOT COMPLETED|Overall Study||18
6537|NCT02273310|13906|P2|COMPLETED|Overall Study||38
6538|NCT02273310|13907|P1|COMPLETED|Overall Study||24
6539|NCT02273310|13906|P2|STARTED|Overall Study||41
6540|NCT02273310|13907|P1|STARTED|Overall Study||42
6541|NCT02271854|13918|P1|NOT COMPLETED|Overall Study||4
6542|NCT02271854|13918|P1|COMPLETED|Overall Study||98
6543|NCT02271854|13918|P1|STARTED|Overall Study||102
6544|NCT02271529|13925|P1|NOT COMPLETED|Overall Study||1
6545|NCT02271529|13925|P1|COMPLETED|Overall Study||39
6546|NCT02271529|13925|P1|STARTED|Overall Study||40
6547|NCT02271477|13931|P2|NOT COMPLETED|Overall Study||0
6548|NCT02271477|13932|P1|NOT COMPLETED|Overall Study||0
6549|NCT02271477|13931|P2|COMPLETED|Overall Study||80
6550|NCT02271477|13932|P1|COMPLETED|Overall Study||80
6551|NCT02271477|13931|P2|STARTED|Overall Study||80
6552|NCT02271477|13932|P1|STARTED|Overall Study||80
6553|NCT02269657|13944|P1|NOT COMPLETED|Overall Study||3
6554|NCT02269657|13944|P1|COMPLETED|Overall Study||37
6555|NCT02269657|13944|P1|STARTED|Overall Study||40
6556|NCT02269488|13958|P1|NOT COMPLETED|Overall Study||0
6557|NCT02269488|13958|P1|COMPLETED|Overall Study||100
6558|NCT02269488|13958|P1|STARTED|Overall Study||100
6559|NCT02269475|13964|P2|NOT COMPLETED|Overall Study||1
6560|NCT02269475|13965|P1|NOT COMPLETED|Overall Study||3
6561|NCT02269475|13964|P2|COMPLETED|Overall Study||432
6562|NCT02269475|13965|P1|COMPLETED|Overall Study||865
6563|NCT02269475|13964|P2|Per Protocol Population|Overall Study||430
6564|NCT02269475|13965|P1|Per Protocol Population|Overall Study||849
6565|NCT02269475|13964|P2|Received IP (Safety Population)|Overall Study||433
6566|NCT02269475|13965|P1|Received IP (Safety Population)|Overall Study||868
6567|NCT02269475|13964|P2|STARTED|Overall Study||433
6568|NCT02269475|13965|P1|STARTED|Overall Study||868
6569|NCT02269098|13978|P2|NOT COMPLETED|Overall Study||9
6570|NCT02269098|13979|P1|NOT COMPLETED|Overall Study||14
6571|NCT02269098|13978|P2|COMPLETED|Overall Study||41
6572|NCT02269098|13979|P1|COMPLETED|Overall Study||37
6573|NCT02269098|13978|P2|STARTED|Overall Study||50
6574|NCT02269098|13979|P1|STARTED|Overall Study||51
6575|NCT02268864|13996|P3|NOT COMPLETED|Overall Study||0
6576|NCT02268864|13997|P2|NOT COMPLETED|Overall Study||1
6577|NCT02268864|13998|P1|NOT COMPLETED|Overall Study||2
6578|NCT02268864|13996|P3|COMPLETED|Overall Study||64
6579|NCT02268864|13997|P2|COMPLETED|Overall Study||24
6580|NCT02268864|13998|P1|COMPLETED|Overall Study||15
6581|NCT02268864|13996|P3|STARTED|Overall Study||64
6582|NCT02268864|13997|P2|STARTED|Overall Study||25
6583|NCT02268864|13998|P1|STARTED|Overall Study||17
6584|NCT02268396|14020|P1|NOT COMPLETED|Overall Study||12
6585|NCT02268396|14020|P1|COMPLETED|Overall Study||126
6586|NCT02268396|14020|P1|STARTED|Overall Study||138
6587|NCT02268058|14033|P4|NOT COMPLETED|Overall Study||0
6588|NCT02268058|14034|P3|NOT COMPLETED|Overall Study||0
6589|NCT02268058|14035|P2|NOT COMPLETED|Overall Study||0
6590|NCT02268058|14036|P1|NOT COMPLETED|Overall Study||1
6591|NCT02268058|14033|P4|COMPLETED|Overall Study||20
6592|NCT02268058|14034|P3|COMPLETED|Overall Study||20
6593|NCT02268058|14035|P2|COMPLETED|Overall Study||20
6594|NCT02268058|14036|P1|COMPLETED|Overall Study||19
6595|NCT02268058|14033|P4|STARTED|Overall Study||20
6596|NCT02268058|14034|P3|STARTED|Overall Study||20
6597|NCT02268058|14035|P2|STARTED|Overall Study||20
6598|NCT02268058|14036|P1|STARTED|Overall Study||20
6599|NCT02267837|14060|P2|NOT COMPLETED|Overall Study||0
6600|NCT02267837|14061|P1|NOT COMPLETED|Overall Study||0
6601|NCT02267837|14060|P2|COMPLETED|Overall Study||9
6602|NCT02267837|14061|P1|COMPLETED|Overall Study||11
6603|NCT02267837|14060|P2|STARTED|Overall Study||9
6604|NCT02267837|14061|P1|STARTED|Overall Study||11
6605|NCT02267824|14069|P2|NOT COMPLETED|Overall Study||1
6606|NCT02267824|14070|P1|NOT COMPLETED|Overall Study||10
6607|NCT02267824|14069|P2|COMPLETED|Overall Study||17
6608|NCT02267824|14070|P1|COMPLETED|Overall Study||73
6609|NCT02267824|14069|P2|STARTED|Overall Study||18
6610|NCT02267824|14070|P1|STARTED|Overall Study||83
6611|NCT02266797|14078|P2|NOT COMPLETED|Overall Study||1
6612|NCT02266797|14079|P1|NOT COMPLETED|Overall Study||0
6613|NCT02266797|14078|P2|COMPLETED|Overall Study||2
6614|NCT02266797|14079|P1|COMPLETED|Overall Study||1
6615|NCT02266797|14078|P2|STARTED|Overall Study||3
6616|NCT02266797|14079|P1|STARTED|Overall Study||1
6617|NCT02266381|14098|P3|NOT COMPLETED|Overall Study||4
6618|NCT02266381|14099|P2|NOT COMPLETED|Overall Study||5
6619|NCT02266381|14100|P1|NOT COMPLETED|Overall Study||3
6620|NCT02266381|14098|P3|COMPLETED|Overall Study||146
6621|NCT02266381|14099|P2|COMPLETED|Overall Study||145
6622|NCT02266381|14100|P1|COMPLETED|Overall Study||147
6623|NCT02266381|14098|P3|STARTED|Overall Study||150
6624|NCT02266381|14099|P2|STARTED|Overall Study||150
6625|NCT02266381|14100|P1|STARTED|Overall Study||150
6626|NCT02265848|14119|P2|NOT COMPLETED|Overall Study||0
6627|NCT02265848|14120|P1|NOT COMPLETED|Overall Study||0
6628|NCT02265848|14119|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
6629|NCT02265848|14120|P1|COMPLETED|Overall Study||11
6630|NCT02265848|14119|P2|STARTED|Overall Study||11
6631|NCT02265848|14120|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
6632|NCT02264821|14135|P3|NOT COMPLETED|Overall Study||6
6633|NCT02264821|14136|P2|NOT COMPLETED|Overall Study||3
6634|NCT02264821|14137|P1|NOT COMPLETED|Overall Study||1
6635|NCT02264821|14135|P3|COMPLETED|Overall Study||58
6636|NCT02264821|14136|P2|COMPLETED|Overall Study||61
6637|NCT02264821|14137|P1|COMPLETED|Overall Study||63
6638|NCT02264821|14135|P3|STARTED|Overall Study|Double Blind|64
6639|NCT02264821|14136|P2|STARTED|Overall Study|Double Blind|64
6640|NCT02264821|14137|P1|STARTED|Overall Study|Double Blind|64
6641|NCT02264249|14151|P3|NOT COMPLETED|Overall Study||0
6642|NCT02264249|14152|P2|NOT COMPLETED|Overall Study||0
6643|NCT02264249|14153|P1|NOT COMPLETED|Overall Study||0
6644|NCT02264249|14151|P3|COMPLETED|Overall Study||241
6645|NCT02264249|14152|P2|COMPLETED|Overall Study||187
6646|NCT02264249|14153|P1|COMPLETED|Overall Study||21
6647|NCT02264249|14151|P3|STARTED|Overall Study||241
6648|NCT02264249|14152|P2|STARTED|Overall Study||187
6649|NCT02264249|14153|P1|STARTED|Overall Study||21
6650|NCT02263833|14167|P1|NOT COMPLETED|Overall Study||0
6651|NCT02263833|14167|P1|COMPLETED|Overall Study||742
6652|NCT02263833|14167|P1|STARTED|Overall Study||742
6653|NCT02263131|14174|P2|NOT COMPLETED|Overall Study||1
6654|NCT02263131|14175|P1|NOT COMPLETED|Overall Study||10
6655|NCT02263131|14174|P2|COMPLETED|Overall Study||68
6656|NCT02263131|14175|P1|COMPLETED|Overall Study||337
6657|NCT02263131|14174|P2|STARTED|Overall Study||69
6658|NCT02263131|14175|P1|STARTED|Overall Study||347
6659|NCT02263118|14187|P4|NOT COMPLETED|Overall Study||2
6660|NCT02263118|14188|P3|NOT COMPLETED|Overall Study||8
6661|NCT02263118|14189|P2|NOT COMPLETED|Overall Study||8
6662|NCT02263118|14190|P1|NOT COMPLETED|Overall Study||4
6663|NCT02263118|14187|P4|COMPLETED|Overall Study||12
6664|NCT02263118|14188|P3|COMPLETED|Overall Study||22
6665|NCT02263118|14189|P2|COMPLETED|Overall Study||24
6666|NCT02263118|14190|P1|COMPLETED|Overall Study||20
6667|NCT02263118|14187|P4|STARTED|Overall Study||14
6668|NCT02263118|14188|P3|STARTED|Overall Study||30
6669|NCT02263118|14189|P2|STARTED|Overall Study||32
6670|NCT02263118|14190|P1|STARTED|Overall Study||24
6671|NCT02262754|14215|P3|NOT COMPLETED|Overall Study||9
6672|NCT02262754|14216|P2|NOT COMPLETED|Overall Study||9
6673|NCT02262754|14217|P1|NOT COMPLETED|Overall Study||16
6674|NCT02262754|14215|P3|COMPLETED|Overall Study||65
6675|NCT02262754|14216|P2|COMPLETED|Overall Study||65
6676|NCT02262754|14217|P1|COMPLETED|Overall Study||58
6677|NCT02262754|14215|P3|STARTED|Overall Study||74
6678|NCT02262754|14216|P2|STARTED|Overall Study||74
6679|NCT02262754|14217|P1|STARTED|Overall Study||74
6680|NCT02262728|14292|P2|NOT COMPLETED|Overall Study||0
6681|NCT02262728|14293|P1|NOT COMPLETED|Overall Study||0
6682|NCT02262728|14292|P2|COMPLETED|Overall Study||21
6683|NCT02262728|14293|P1|COMPLETED|Overall Study||19
6684|NCT02262728|14292|P2|STARTED|Overall Study||21
6685|NCT02262728|14293|P1|STARTED|Overall Study||19
6686|NCT02262078|14323|P2|NOT COMPLETED|Overall Study||0
6687|NCT02262078|14324|P1|NOT COMPLETED|Overall Study||0
6688|NCT02262078|14323|P2|COMPLETED|Overall Study||13
6689|NCT02262078|14324|P1|COMPLETED|Overall Study||13
6690|NCT02262078|14323|P2|STARTED|Overall Study||13
6691|NCT02262078|14324|P1|STARTED|Overall Study||13
6692|NCT02262039|14332|P2|NOT COMPLETED|Overall Study||0
6693|NCT02262039|14333|P1|NOT COMPLETED|Overall Study||0
6694|NCT02262039|14332|P2|COMPLETED|Overall Study||27
6695|NCT02262039|14333|P1|COMPLETED|Overall Study||14
6696|NCT02262039|14332|P2|STARTED|Overall Study||27
6697|NCT02262039|14333|P1|STARTED|Overall Study||14
6698|NCT02261948|14353|P2|NOT COMPLETED|Overall Study||0
6699|NCT02261948|14354|P1|NOT COMPLETED|Overall Study||0
6700|NCT02261948|14353|P2|COMPLETED|Overall Study||19
6701|NCT02261948|14354|P1|COMPLETED|Overall Study||23
6702|NCT02261948|14353|P2|STARTED|Overall Study||19
6703|NCT02261948|14354|P1|STARTED|Overall Study||23
6704|NCT02261428|14366|P2|NOT COMPLETED|Overall Study||0
6705|NCT02261428|14367|P1|NOT COMPLETED|Overall Study||0
6706|NCT02261428|14366|P2|COMPLETED|Overall Study||10
6707|NCT02261428|14367|P1|COMPLETED|Overall Study||10
6708|NCT02261428|14366|P2|STARTED|Overall Study|Washout (30 minutes)|10
6709|NCT02261428|14367|P1|STARTED|Overall Study|Washout (30 minutes)|10
6710|NCT02260882|14387|P2|NOT COMPLETED|Overall Study||1
6711|NCT02260882|14388|P1|NOT COMPLETED|Overall Study||0
6712|NCT02260882|14387|P2|COMPLETED|Overall Study||81
6713|NCT02260882|14388|P1|COMPLETED|Overall Study||161
6714|NCT02260882|14387|P2|STARTED|Overall Study||82
6715|NCT02260882|14388|P1|STARTED|Overall Study||161
6716|NCT02259608|14410|P1|NOT COMPLETED|Overall Study||0
6717|NCT02259608|14410|P1|COMPLETED|Overall Study||15
6718|NCT02259608|14410|P1|STARTED|Overall Study||15
6719|NCT02259400|14417|P2|NOT COMPLETED|Overall Study||2
6720|NCT02259400|14418|P1|NOT COMPLETED|Overall Study||0
6721|NCT02259400|14417|P2|COMPLETED|Overall Study||60
6722|NCT02259400|14418|P1|COMPLETED|Overall Study||62
6723|NCT02259400|14417|P2|STARTED|Overall Study||62
6724|NCT02259400|14418|P1|STARTED|Overall Study||62
6725|NCT02259348|14450|P1|NOT COMPLETED|Overall Study||10
6726|NCT02259348|14450|P1|COMPLETED|Overall Study||2
6727|NCT02259348|14450|P1|One Year Post-transplant|Overall Study||2
6728|NCT02259348|14450|P1|STARTED|Overall Study||12
6729|NCT02258477|14462|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
6730|NCT02258477|14463|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
6731|NCT02258477|14464|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
6732|NCT02258477|14465|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
6733|NCT02258477|14462|P4|COMPLETED|Fourth Intervention (1 Week)||8
6734|NCT02258477|14463|P3|COMPLETED|Fourth Intervention (1 Week)||8
6735|NCT02258477|14464|P2|COMPLETED|Fourth Intervention (1 Week)||8
6736|NCT02258477|14465|P1|COMPLETED|Fourth Intervention (1 Week)||9
6737|NCT02258477|14462|P4|STARTED|Fourth Intervention (1 Week)||8
6738|NCT02258477|14463|P3|STARTED|Fourth Intervention (1 Week)||8
6739|NCT02258477|14464|P2|STARTED|Fourth Intervention (1 Week)||8
6740|NCT02258477|14465|P1|STARTED|Fourth Intervention (1 Week)||9
6741|NCT02258477|14462|P4|NOT COMPLETED|Third Intervention (1 Week)||0
6742|NCT02258477|14463|P3|NOT COMPLETED|Third Intervention (1 Week)||0
6743|NCT02258477|14464|P2|NOT COMPLETED|Third Intervention (1 Week)||0
6744|NCT02258477|14465|P1|NOT COMPLETED|Third Intervention (1 Week)||0
6745|NCT02258477|14462|P4|COMPLETED|Third Intervention (1 Week)||8
6746|NCT02258477|14463|P3|COMPLETED|Third Intervention (1 Week)||8
6747|NCT02258477|14464|P2|COMPLETED|Third Intervention (1 Week)||8
6748|NCT02258477|14465|P1|COMPLETED|Third Intervention (1 Week)||9
6749|NCT02258477|14462|P4|STARTED|Third Intervention (1 Week)||8
6750|NCT02258477|14463|P3|STARTED|Third Intervention (1 Week)||8
6751|NCT02258477|14464|P2|STARTED|Third Intervention (1 Week)||8
6752|NCT02258477|14465|P1|STARTED|Third Intervention (1 Week)||9
6753|NCT02258477|14462|P4|NOT COMPLETED|Second Intervention (1 Week)||1
6754|NCT02258477|14463|P3|NOT COMPLETED|Second Intervention (1 Week)||1
6755|NCT02258477|14464|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6756|NCT02258477|14465|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6757|NCT02258477|14462|P4|COMPLETED|Second Intervention (1 Week)||8
6758|NCT02258477|14463|P3|COMPLETED|Second Intervention (1 Week)||8
6759|NCT02258477|14464|P2|COMPLETED|Second Intervention (1 Week)||8
6760|NCT02258477|14465|P1|COMPLETED|Second Intervention (1 Week)||9
6761|NCT02258477|14462|P4|STARTED|Second Intervention (1 Week)||9
6762|NCT02258477|14463|P3|STARTED|Second Intervention (1 Week)||9
6763|NCT02258477|14464|P2|STARTED|Second Intervention (1 Week)||8
6764|NCT02258477|14465|P1|STARTED|Second Intervention (1 Week)||9
6765|NCT02258477|14462|P4|NOT COMPLETED|First Intervention (1 Week)||0
6766|NCT02258477|14463|P3|NOT COMPLETED|First Intervention (1 Week)||0
6767|NCT02258477|14464|P2|NOT COMPLETED|First Intervention (1 Week)||1
6768|NCT02258477|14465|P1|NOT COMPLETED|First Intervention (1 Week)||1
6769|NCT02258477|14462|P4|COMPLETED|First Intervention (1 Week)||9
6770|NCT02258477|14463|P3|COMPLETED|First Intervention (1 Week)||9
6771|NCT02258477|14464|P2|COMPLETED|First Intervention (1 Week)||8
6772|NCT02258477|14465|P1|COMPLETED|First Intervention (1 Week)||9
6773|NCT02258477|14462|P4|STARTED|First Intervention (1 Week)||9
6774|NCT02258477|14463|P3|STARTED|First Intervention (1 Week)||9
6775|NCT02258477|14464|P2|STARTED|First Intervention (1 Week)||9
6776|NCT02258477|14465|P1|STARTED|First Intervention (1 Week)||10
6777|NCT02258334|14484|P4|NOT COMPLETED|Overall Study||0
6778|NCT02258334|14485|P3|NOT COMPLETED|Overall Study||0
6779|NCT02258334|14486|P2|NOT COMPLETED|Overall Study||0
6780|NCT02258334|14487|P1|NOT COMPLETED|Overall Study||1
6781|NCT02258334|14484|P4|COMPLETED|Overall Study||52
6782|NCT02258334|14485|P3|COMPLETED|Overall Study||52
6783|NCT02258334|14486|P2|COMPLETED|Overall Study||54
6784|NCT02258334|14487|P1|COMPLETED|Overall Study||49
6785|NCT02258334|14484|P4|STARTED|Overall Study||52
6786|NCT02258334|14485|P3|STARTED|Overall Study||52
6787|NCT02258334|14486|P2|STARTED|Overall Study||54
6788|NCT02258334|14487|P1|STARTED|Overall Study||50
6789|NCT02257918|14516|P3|NOT COMPLETED|Overall Study||2
6790|NCT02257918|14517|P2|NOT COMPLETED|Overall Study||1
6791|NCT02257918|14518|P1|NOT COMPLETED|Overall Study||4
6792|NCT02257918|14516|P3|COMPLETED|Overall Study||39
6793|NCT02257918|14517|P2|COMPLETED|Overall Study||66
6794|NCT02257918|14518|P1|COMPLETED|Overall Study||68
6795|NCT02257918|14516|P3|Test of Cure Visit|Overall Study||40
6796|NCT02257918|14517|P2|Test of Cure Visit|Overall Study||67
6797|NCT02257918|14518|P1|Test of Cure Visit|Overall Study||72
6798|NCT02257918|14516|P3|STARTED|Overall Study||41
6799|NCT02257918|14517|P2|STARTED|Overall Study||67
6800|NCT02257918|14518|P1|STARTED|Overall Study||72
6801|NCT02257385|14570|P2|NOT COMPLETED|Overall Study||22
6802|NCT02257385|14571|P1|NOT COMPLETED|Overall Study||22
6803|NCT02257385|14570|P2|COMPLETED|Overall Study||457
6804|NCT02257385|14571|P1|COMPLETED|Overall Study||460
6805|NCT02257385|14570|P2|STARTED|Overall Study||479
6806|NCT02257385|14571|P1|STARTED|Overall Study||482
6807|NCT02257372|14581|P2|NOT COMPLETED|Overall Study||10
6808|NCT02257372|14582|P1|NOT COMPLETED|Overall Study||7
6809|NCT02257372|14581|P2|COMPLETED|Overall Study||109
6810|NCT02257372|14582|P1|COMPLETED|Overall Study||110
6811|NCT02257372|14581|P2|STARTED|Overall Study||119
6812|NCT02257372|14582|P1|STARTED|Overall Study||117
6813|NCT02256982|14592|P2|NOT COMPLETED|Overall Study||1
6814|NCT02256982|14593|P1|NOT COMPLETED|Overall Study||0
6815|NCT02256982|14592|P2|COMPLETED|Overall Study||1
6816|NCT02256982|14593|P1|COMPLETED|Overall Study||1
6817|NCT02256982|14592|P2|STARTED|Overall Study||2
6818|NCT02256982|14593|P1|STARTED|Overall Study||1
6819|NCT02256553|14599|P1|NOT COMPLETED|Period III||3
6820|NCT02256553|14599|P1|COMPLETED|Period III||91
6821|NCT02256553|14599|P1|STARTED|Period III||94
6822|NCT02256553|14599|P1|NOT COMPLETED|Period II||2
6823|NCT02256553|14599|P1|COMPLETED|Period II||94
6824|NCT02256553|14599|P1|STARTED|Period II||96
6825|NCT02256553|14599|P1|NOT COMPLETED|Period I||6
6826|NCT02256553|14599|P1|COMPLETED|Period I||96
6827|NCT02256553|14599|P1|STARTED|Period I||102
6828|NCT02256488|14612|P4|NOT COMPLETED|Overall Study||6
6829|NCT02256488|14613|P3|NOT COMPLETED|Overall Study||10
6830|NCT02256488|14614|P2|NOT COMPLETED|Overall Study||6
6831|NCT02256488|14615|P1|NOT COMPLETED|Overall Study||8
6832|NCT02256488|14612|P4|COMPLETED|Overall Study||384
6833|NCT02256488|14613|P3|COMPLETED|Overall Study||382
6834|NCT02256488|14614|P2|COMPLETED|Overall Study||386
6835|NCT02256488|14615|P1|COMPLETED|Overall Study||379
6836|NCT02256488|14612|P4|STARTED|Overall Study||390
6837|NCT02256488|14613|P3|STARTED|Overall Study||392
6838|NCT02256488|14614|P2|STARTED|Overall Study||392
6839|NCT02256488|14615|P1|STARTED|Overall Study||387
6840|NCT02256358|14631|P2|NOT COMPLETED|Overall Study||1
6841|NCT02256358|14632|P1|NOT COMPLETED|Overall Study||0
6842|NCT02256358|14631|P2|COMPLETED|Overall Study||33
6843|NCT02256358|14632|P1|COMPLETED|Overall Study||34
6844|NCT02256358|14631|P2|STARTED|Overall Study||34
6845|NCT02256358|14632|P1|STARTED|Overall Study||34
6846|NCT02256072|14640|P2|NOT COMPLETED|Overall Study||29
6847|NCT02256072|14641|P1|NOT COMPLETED|Overall Study||42
6848|NCT02256072|14640|P2|COMPLETED|Overall Study||162
6849|NCT02256072|14641|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
6850|NCT02256072|14640|P2|Completed 1 Month Follow-Up|Overall Study||179
6851|NCT02256072|14641|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
6852|NCT02256072|14640|P2|STARTED|Overall Study||191
6853|NCT02256072|14641|P1|STARTED|Overall Study||194
6854|NCT02255279|14657|P2|NOT COMPLETED|Overall Study||9
6855|NCT02255279|14658|P1|NOT COMPLETED|Overall Study||5
6856|NCT02255279|14657|P2|COMPLETED|Overall Study||134
6857|NCT02255279|14658|P1|COMPLETED|Overall Study||139
6858|NCT02255279|14657|P2|STARTED|Overall Study||143
6859|NCT02255279|14658|P1|STARTED|Overall Study||144
6860|NCT02255149|14684|P1|NOT COMPLETED|Overall Study||5
6861|NCT02255149|14684|P1|COMPLETED|Overall Study||5
6862|NCT02255149|14684|P1|STARTED|Overall Study||10
6863|NCT02254551|14688|P1|NOT COMPLETED|Maintenance||0
6864|NCT02254551|14688|P1|COMPLETED|Maintenance||0
6865|NCT02254551|14688|P1|STARTED|Maintenance||0
6866|NCT02254551|14688|P1|NOT COMPLETED|Expansion||0
6867|NCT02254551|14688|P1|COMPLETED|Expansion||0
6868|NCT02254551|14688|P1|STARTED|Expansion||0
6869|NCT02254551|14688|P1|NOT COMPLETED|Dose Escalation||3
6870|NCT02254551|14688|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
6871|NCT02254551|14688|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
6872|NCT02254551|14688|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
6873|NCT02254551|14688|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
6874|NCT02254551|14688|P1|STARTED|Dose Escalation||7
6875|NCT02254252|14698|P2|NOT COMPLETED|Overall Study||2
6876|NCT02254252|14699|P1|NOT COMPLETED|Overall Study||3
6877|NCT02254252|14698|P2|COMPLETED|Overall Study||25
6878|NCT02254252|14699|P1|COMPLETED|Overall Study||24
6879|NCT02254252|14698|P2|STARTED|Overall Study||27
6880|NCT02254252|14699|P1|STARTED|Overall Study||27
6881|NCT02253160|14712|P3|NOT COMPLETED|Overall Study||0
6882|NCT02253160|14713|P2|NOT COMPLETED|Overall Study||0
6883|NCT02253160|14714|P1|NOT COMPLETED|Overall Study||0
6884|NCT02253160|14712|P3|COMPLETED|Overall Study||10
6885|NCT02253160|14713|P2|COMPLETED|Overall Study||12
6886|NCT02253160|14714|P1|COMPLETED|Overall Study||1
6887|NCT02253160|14712|P3|STARTED|Overall Study||10
6888|NCT02253160|14713|P2|STARTED|Overall Study||12
6889|NCT02253160|14714|P1|STARTED|Overall Study||1
6890|NCT02252965|14752|P2|NOT COMPLETED|Overall Study||43
6891|NCT02252965|14753|P1|NOT COMPLETED|Overall Study||40
6892|NCT02252965|14752|P2|COMPLETED|Overall Study||222
6893|NCT02252965|14753|P1|COMPLETED|Overall Study||227
6894|NCT02252965|14752|P2|Safety Population|Overall Study||264
6895|NCT02252965|14753|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
6896|NCT02252965|14752|P2|STARTED|Overall Study||265
6897|NCT02252965|14753|P1|STARTED|Overall Study||267
6898|NCT02252744|14780|P1|NOT COMPLETED|Overall Study||0
6899|NCT02252744|14780|P1|COMPLETED|Overall Study||286
6900|NCT02252744|14780|P1|STARTED|Overall Study||286
6901|NCT02252445|14786|P2|NOT COMPLETED|Overall Study||0
6902|NCT02252445|14787|P1|NOT COMPLETED|Overall Study||0
6903|NCT02252445|14786|P2|COMPLETED|Overall Study||41
6904|NCT02252445|14787|P1|COMPLETED|Overall Study||41
6905|NCT02252445|14786|P2|STARTED|Overall Study||41
6906|NCT02252445|14787|P1|STARTED|Overall Study||41
6907|NCT02252354|14813|P2|NOT COMPLETED|Overall Study||0
6908|NCT02252354|14814|P1|NOT COMPLETED|Overall Study||0
6909|NCT02252354|14813|P2|COMPLETED|Overall Study||6
6910|NCT02252354|14814|P1|COMPLETED|Overall Study||6
6911|NCT02252354|14813|P2|STARTED|Overall Study||6
6912|NCT02252354|14814|P1|STARTED|Overall Study||6
6913|NCT02252133|14859|P2|NOT COMPLETED|Period 2||0
6914|NCT02252133|14860|P1|NOT COMPLETED|Period 2||0
6915|NCT02252133|14859|P2|COMPLETED|Period 2||24
6916|NCT02252133|14860|P1|COMPLETED|Period 2||23
6917|NCT02252133|14859|P2|STARTED|Period 2||24
6918|NCT02252133|14860|P1|STARTED|Period 2||23
6919|NCT02252133|14859|P2|NOT COMPLETED|Period 1||0
6920|NCT02252133|14860|P1|NOT COMPLETED|Period 1||0
6921|NCT02252133|14859|P2|COMPLETED|Period 1||24
6922|NCT02252133|14860|P1|COMPLETED|Period 1||23
6923|NCT02252133|14859|P2|STARTED|Period 1||24
6924|NCT02252133|14860|P1|STARTED|Period 1||23
6925|NCT02252016|14868|P2|NOT COMPLETED|Safety Follow-Up||50
6926|NCT02252016|14869|P1|NOT COMPLETED|Safety Follow-Up||106
6927|NCT02252016|14868|P2|COMPLETED|Safety Follow-Up||0
6928|NCT02252016|14869|P1|COMPLETED|Safety Follow-Up||0
6929|NCT02252016|14868|P2|STARTED|Safety Follow-Up||50
6930|NCT02252016|14869|P1|STARTED|Safety Follow-Up||106
6931|NCT02252016|14868|P2|NOT COMPLETED|Treatment||2
6932|NCT02252016|14869|P1|NOT COMPLETED|Treatment||1
6933|NCT02252016|14868|P2|COMPLETED|Treatment||50
6934|NCT02252016|14869|P1|COMPLETED|Treatment||106
6935|NCT02252016|14868|P2|STARTED|Treatment||52
6936|NCT02252016|14869|P1|STARTED|Treatment||107
6937|NCT02251886|14885|P4|NOT COMPLETED|Overall Study||0
6938|NCT02251886|14886|P3|NOT COMPLETED|Overall Study||0
6939|NCT02251886|14887|P2|NOT COMPLETED|Overall Study||0
6940|NCT02251886|14888|P1|NOT COMPLETED|Overall Study||0
6941|NCT02251886|14885|P4|COMPLETED|Overall Study||54
6942|NCT02251886|14886|P3|COMPLETED|Overall Study||44
6943|NCT02251886|14887|P2|COMPLETED|Overall Study||54
6944|NCT02251886|14888|P1|COMPLETED|Overall Study||48
6945|NCT02251886|14885|P4|STARTED|Overall Study||54
6946|NCT02251886|14886|P3|STARTED|Overall Study||44
6947|NCT02251886|14887|P2|STARTED|Overall Study||54
6948|NCT02251886|14888|P1|STARTED|Overall Study||48
6949|NCT02251613|14898|P1|NOT COMPLETED|Overall Study||0
6950|NCT02251613|14898|P1|COMPLETED|Overall Study||50
6951|NCT02251613|14898|P1|STARTED|Overall Study||50
6952|NCT02251561|14906|P1|NOT COMPLETED|Overall Study||0
6953|NCT02251561|14906|P1|COMPLETED|Overall Study||28
6954|NCT02251561|14906|P1|STARTED|Overall Study||28
6955|NCT02250807|14914|P1|NOT COMPLETED|Overall Study||0
6956|NCT02250807|14914|P1|COMPLETED|Overall Study||40
6957|NCT02250807|14914|P1|STARTED|Overall Study||40
6958|NCT02250274|14926|P2|NOT COMPLETED|Overall Study||6
6959|NCT02250274|14927|P1|NOT COMPLETED|Overall Study||7
6960|NCT02250274|14926|P2|COMPLETED|Overall Study||40
6961|NCT02250274|14927|P1|COMPLETED|Overall Study||78
6962|NCT02250274|14926|P2|STARTED|Overall Study||46
6963|NCT02250274|14927|P1|STARTED|Overall Study||85
6964|NCT02249728|14937|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
6965|NCT02249728|14937|P1|COMPLETED|Part Two (up to 6 Days)||6
6966|NCT02249728|14937|P1|STARTED|Part Two (up to 6 Days)||6
6967|NCT02249728|14937|P1|NOT COMPLETED|Part One (4 Days)||0
6968|NCT02249728|14937|P1|COMPLETED|Part One (4 Days)||6
6969|NCT02249728|14937|P1|STARTED|Part One (4 Days)||6
6970|NCT02249104|14947|P1|NOT COMPLETED|Overall Study||3
6971|NCT02249104|14947|P1|COMPLETED|Overall Study||25
6972|NCT02249104|14947|P1|STARTED|Overall Study||28
6973|NCT02249052|14956|P1|NOT COMPLETED|Overall Study||0
6974|NCT02249052|14956|P1|COMPLETED|Overall Study||19
6975|NCT02249052|14956|P1|STARTED|Overall Study||19
6976|NCT02248818|14980|P9|NOT COMPLETED|Randomised Study||0
6977|NCT02248818|14981|P8|NOT COMPLETED|Randomised Study||0
6978|NCT02248818|14982|P7|NOT COMPLETED|Randomised Study||0
6979|NCT02248818|14983|P6|NOT COMPLETED|Randomised Study||8
6980|NCT02248818|14984|P5|NOT COMPLETED|Randomised Study||0
6981|NCT02248818|14985|P4|NOT COMPLETED|Randomised Study||0
6982|NCT02248818|14986|P3|NOT COMPLETED|Randomised Study||0
6983|NCT02248818|14987|P2|NOT COMPLETED|Randomised Study||0
6984|NCT02248818|14988|P1|NOT COMPLETED|Randomised Study||0
6985|NCT02248818|14980|P9|COMPLETED|Randomised Study||0
6986|NCT02248818|14981|P8|COMPLETED|Randomised Study||4
6987|NCT02248818|14982|P7|COMPLETED|Randomised Study||6
6988|NCT02248818|14983|P6|COMPLETED|Randomised Study||0
6989|NCT02248818|14984|P5|COMPLETED|Randomised Study||6
6990|NCT02248818|14985|P4|COMPLETED|Randomised Study||6
6991|NCT02248818|14986|P3|COMPLETED|Randomised Study||6
6992|NCT02248818|14987|P2|COMPLETED|Randomised Study||6
6993|NCT02248818|14988|P1|COMPLETED|Randomised Study||6
6994|NCT02248818|14980|P9|STARTED|Randomised Study||0
6995|NCT02248818|14981|P8|STARTED|Randomised Study||4
6996|NCT02248818|14982|P7|STARTED|Randomised Study||6
6997|NCT02248818|14983|P6|STARTED|Randomised Study||8
6998|NCT02248818|14984|P5|STARTED|Randomised Study||6
6999|NCT02248818|14985|P4|STARTED|Randomised Study||6
7000|NCT02248818|14986|P3|STARTED|Randomised Study||6
7001|NCT02248818|14987|P2|STARTED|Randomised Study||6
7002|NCT02248818|14988|P1|STARTED|Randomised Study||6
7003|NCT02248818|14980|P9|NOT COMPLETED|Screening||107
7004|NCT02248818|14981|P8|NOT COMPLETED|Screening||0
7005|NCT02248818|14982|P7|NOT COMPLETED|Screening||0
7006|NCT02248818|14983|P6|NOT COMPLETED|Screening||0
7007|NCT02248818|14984|P5|NOT COMPLETED|Screening||0
7008|NCT02248818|14985|P4|NOT COMPLETED|Screening||0
7009|NCT02248818|14986|P3|NOT COMPLETED|Screening||0
7010|NCT02248818|14987|P2|NOT COMPLETED|Screening||0
7011|NCT02248818|14988|P1|NOT COMPLETED|Screening||0
7012|NCT02248818|14980|P9|COMPLETED|Screening||48
7013|NCT02248818|14981|P8|COMPLETED|Screening||0
7014|NCT02248818|14982|P7|COMPLETED|Screening||0
7015|NCT02248818|14983|P6|COMPLETED|Screening||0
7016|NCT02248818|14984|P5|COMPLETED|Screening||0
7017|NCT02248818|14985|P4|COMPLETED|Screening||0
7018|NCT02248818|14986|P3|COMPLETED|Screening||0
7019|NCT02248818|14987|P2|COMPLETED|Screening||0
7020|NCT02248818|14988|P1|COMPLETED|Screening||0
7021|NCT02248818|14980|P9|STARTED|Screening||155
7022|NCT02248818|14981|P8|STARTED|Screening||0
7023|NCT02248818|14982|P7|STARTED|Screening||0
7024|NCT02248818|14983|P6|STARTED|Screening||0
7025|NCT02248818|14984|P5|STARTED|Screening||0
7026|NCT02248818|14985|P4|STARTED|Screening||0
7027|NCT02248818|14986|P3|STARTED|Screening||0
7028|NCT02248818|14987|P2|STARTED|Screening||0
7029|NCT02248818|14988|P1|STARTED|Screening||0
7030|NCT02248766|15126|P1|NOT COMPLETED|Overall Study||0
7031|NCT02248766|15126|P1|COMPLETED|Overall Study||30
7032|NCT02248766|15126|P1|STARTED|Overall Study||30
7033|NCT02248727|15138|P1|NOT COMPLETED|Overall Study||0
7034|NCT02248727|15138|P1|COMPLETED|Overall Study||30
7035|NCT02248727|15138|P1|STARTED|Overall Study||30
7036|NCT02248558|15151|P2|NOT COMPLETED|Overall Study||45
7037|NCT02248558|15152|P1|NOT COMPLETED|Overall Study||52
7038|NCT02248558|15151|P2|COMPLETED|Overall Study||307
7039|NCT02248558|15152|P1|COMPLETED|Overall Study||317
7040|NCT02248558|15151|P2|STARTED|Overall Study||352
7041|NCT02248558|15152|P1|STARTED|Overall Study||369
7042|NCT02248480|15164|P2|NOT COMPLETED|Overall Study||14
7043|NCT02248480|15165|P1|NOT COMPLETED|Overall Study||17
7044|NCT02248480|15164|P2|COMPLETED|Overall Study||162
7045|NCT02248480|15165|P1|COMPLETED|Overall Study||161
7046|NCT02248480|15164|P2|Efficacy Population|Overall Study||176
7047|NCT02248480|15165|P1|Efficacy Population|Overall Study||177
7048|NCT02248480|15164|P2|STARTED|Overall Study||176
7049|NCT02248480|15165|P1|STARTED|Overall Study||178
7050|NCT02248246|15203|P1|NOT COMPLETED|Overall Study||0
7051|NCT02248246|15203|P1|COMPLETED|Overall Study||40
7052|NCT02248246|15203|P1|STARTED|Overall Study||40
7053|NCT02248103|15210|P2|NOT COMPLETED|Overall Study||0
7054|NCT02248103|15211|P1|NOT COMPLETED|Overall Study||0
7055|NCT02248103|15210|P2|COMPLETED|Overall Study||10
7056|NCT02248103|15211|P1|COMPLETED|Overall Study||10
7057|NCT02248103|15210|P2|STARTED|Overall Study||10
7058|NCT02248103|15211|P1|STARTED|Overall Study||10
7059|NCT02247011|15223|P1|NOT COMPLETED|Overall Study||125
7060|NCT02247011|15223|P1|COMPLETED|Overall Study||975
7061|NCT02247011|15223|P1|STARTED|Overall Study||1100
7062|NCT02246582|15240|P2|NOT COMPLETED|Overall Study||4
7063|NCT02246582|15241|P1|NOT COMPLETED|Overall Study||3
7064|NCT02246582|15240|P2|COMPLETED|Overall Study||41
7065|NCT02246582|15241|P1|COMPLETED|Overall Study||41
7066|NCT02246582|15240|P2|STARTED|Overall Study||45
7067|NCT02246582|15241|P1|STARTED|Overall Study||44
7068|NCT02246166|15249|P2|NOT COMPLETED|Overall Study||0
7069|NCT02246166|15250|P1|NOT COMPLETED|Overall Study||1
7070|NCT02246166|15249|P2|COMPLETED|Overall Study||27
7071|NCT02246166|15250|P1|COMPLETED|Overall Study||25
7072|NCT02246166|15249|P2|STARTED|Overall Study||27
7073|NCT02246166|15250|P1|STARTED|Overall Study||26
7074|NCT02246114|15286|P2|NOT COMPLETED|Overall Study||0
7075|NCT02246114|15287|P1|NOT COMPLETED|Overall Study||1
7076|NCT02246114|15286|P2|COMPLETED|Overall Study||0
7077|NCT02246114|15287|P1|COMPLETED|Overall Study||0
7078|NCT02246114|15286|P2|STARTED|Overall Study||0
7079|NCT02246114|15287|P1|STARTED|Overall Study||1
7080|NCT02246062|15297|P4|NOT COMPLETED|Overall Study||0
7081|NCT02246062|15298|P3|NOT COMPLETED|Overall Study||0
7082|NCT02246062|15299|P2|NOT COMPLETED|Overall Study||0
7083|NCT02246062|15300|P1|NOT COMPLETED|Overall Study||0
7084|NCT02246062|15297|P4|COMPLETED|Overall Study||21
7085|NCT02246062|15298|P3|COMPLETED|Overall Study||21
7086|NCT02246062|15299|P2|COMPLETED|Overall Study||21
7087|NCT02246062|15300|P1|COMPLETED|Overall Study||21
7088|NCT02246062|15297|P4|STARTED|Overall Study||21
7089|NCT02246062|15298|P3|STARTED|Overall Study||21
7090|NCT02246062|15299|P2|STARTED|Overall Study||21
7091|NCT02246062|15300|P1|STARTED|Overall Study||21
7092|NCT02245360|15320|P2|NOT COMPLETED|Overall Study||2
7093|NCT02245360|15321|P1|NOT COMPLETED|Overall Study||5
7094|NCT02245360|15320|P2|COMPLETED|Overall Study||52
7095|NCT02245360|15321|P1|COMPLETED|Overall Study||48
7096|NCT02245360|15320|P2|STARTED|Overall Study||54
7097|NCT02245360|15321|P1|STARTED|Overall Study||53
7098|NCT02244840|15329|P1|NOT COMPLETED|Overall Study||0
7099|NCT02244840|15329|P1|COMPLETED|Overall Study||40
7100|NCT02244840|15329|P1|STARTED|Overall Study||40
7101|NCT02244580|15333|P1|NOT COMPLETED|Overall Study||241
7102|NCT02244580|15333|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
7103|NCT02244580|15333|P1|STARTED|Overall Study||1010
7104|NCT02243943|15343|P2|NOT COMPLETED|Overall Study||0
7105|NCT02243943|15344|P1|NOT COMPLETED|Overall Study||0
7106|NCT02243943|15343|P2|COMPLETED|Overall Study||50
7107|NCT02243943|15344|P1|COMPLETED|Overall Study||50
7108|NCT02243943|15343|P2|STARTED|Overall Study||50
7109|NCT02243943|15344|P1|STARTED|Overall Study||50
7110|NCT02243202|15358|P4|NOT COMPLETED|Overall Study||23
7111|NCT02243202|15359|P3|NOT COMPLETED|Overall Study||31
7112|NCT02243202|15360|P2|NOT COMPLETED|Overall Study||25
7113|NCT02243202|15361|P1|NOT COMPLETED|Overall Study||25
7114|NCT02243202|15358|P4|COMPLETED|Overall Study||61
7115|NCT02243202|15359|P3|COMPLETED|Overall Study||53
7116|NCT02243202|15360|P2|COMPLETED|Overall Study||60
7117|NCT02243202|15361|P1|COMPLETED|Overall Study||57
7118|NCT02243202|15358|P4|Treated|Overall Study||83
7119|NCT02243202|15359|P3|Treated|Overall Study||84
7120|NCT02243202|15360|P2|Treated|Overall Study||85
7121|NCT02243202|15361|P1|Treated|Overall Study||82
7122|NCT02243202|15358|P4|STARTED|Overall Study||84
7123|NCT02243202|15359|P3|STARTED|Overall Study||84
7124|NCT02243202|15360|P2|STARTED|Overall Study||85
7125|NCT02243202|15361|P1|STARTED|Overall Study||82
7126|NCT02243046|15398|P3|NOT COMPLETED|Overall Study||4
7127|NCT02243046|15399|P2|NOT COMPLETED|Overall Study||1
7128|NCT02243046|15400|P1|NOT COMPLETED|Overall Study||1
7129|NCT02243046|15398|P3|COMPLETED|Overall Study||49
7130|NCT02243046|15399|P2|COMPLETED|Overall Study||53
7131|NCT02243046|15400|P1|COMPLETED|Overall Study||54
7132|NCT02243046|15398|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
7133|NCT02243046|15399|P2|6 Month|Overall Study||53
7134|NCT02243046|15400|P1|6 Month|Overall Study||54
7135|NCT02243046|15398|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
7136|NCT02243046|15399|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
7137|NCT02243046|15400|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
7138|NCT02243046|15398|P3|STARTED|Overall Study||53
7139|NCT02243046|15399|P2|STARTED|Overall Study||54
7140|NCT02243046|15400|P1|STARTED|Overall Study||55
7141|NCT02242994|15423|P1|NOT COMPLETED|Overall Study||0
7142|NCT02242994|15423|P1|COMPLETED|Overall Study||5
7143|NCT02242994|15423|P1|STARTED|Overall Study||5
7144|NCT02242643|15430|P2|NOT COMPLETED|Overall Study||78
7145|NCT02242643|15431|P1|NOT COMPLETED|Overall Study||75
7146|NCT02242643|15430|P2|COMPLETED|Overall Study||1139
7147|NCT02242643|15431|P1|COMPLETED|Overall Study||1132
7148|NCT02242643|15430|P2|STARTED|Overall Study||1217
7149|NCT02242643|15431|P1|STARTED|Overall Study||1207
7150|NCT02242630|15467|P4|NOT COMPLETED|Overall Study||0
7151|NCT02242630|15468|P3|NOT COMPLETED|Overall Study||0
7152|NCT02242630|15469|P2|NOT COMPLETED|Overall Study||0
7153|NCT02242630|15470|P1|NOT COMPLETED|Overall Study||0
7154|NCT02242630|15467|P4|COMPLETED|Overall Study||16
7155|NCT02242630|15468|P3|COMPLETED|Overall Study||15
7156|NCT02242630|15469|P2|COMPLETED|Overall Study||15
7157|NCT02242630|15470|P1|COMPLETED|Overall Study||15
7158|NCT02242630|15467|P4|STARTED|Overall Study||16
7159|NCT02242630|15468|P3|STARTED|Overall Study||15
7160|NCT02242630|15469|P2|STARTED|Overall Study||15
7161|NCT02242630|15470|P1|STARTED|Overall Study||15
7162|NCT02242019|15484|P1|NOT COMPLETED|Overall Study||0
7163|NCT02242019|15484|P1|COMPLETED|Overall Study||109
7164|NCT02242019|15484|P1|STARTED|Overall Study||109
7165|NCT02240628|15492|P2|NOT COMPLETED|Overall Study||5
7166|NCT02240628|15493|P1|NOT COMPLETED|Overall Study||6
7167|NCT02240628|15492|P2|COMPLETED|Overall Study||33
7168|NCT02240628|15493|P1|COMPLETED|Overall Study||32
7169|NCT02240628|15492|P2|STARTED|Overall Study||38
7170|NCT02240628|15493|P1|STARTED|Overall Study||38
7171|NCT02240368|15504|P3|NOT COMPLETED|Overall Study||1
7172|NCT02240368|15505|P2|NOT COMPLETED|Overall Study||0
7173|NCT02240368|15506|P1|NOT COMPLETED|Overall Study||1
7174|NCT02240368|15504|P3|COMPLETED|Overall Study||18
7175|NCT02240368|15505|P2|COMPLETED|Overall Study||22
7176|NCT02240368|15506|P1|COMPLETED|Overall Study||8
7177|NCT02240368|15504|P3|STARTED|Overall Study||19
7178|NCT02240368|15505|P2|STARTED|Overall Study||22
7179|NCT02240368|15506|P1|STARTED|Overall Study||9
7180|NCT02240329|15523|P1|NOT COMPLETED|Overall Study||0
7181|NCT02240329|15523|P1|COMPLETED|Overall Study||4
7182|NCT02240329|15523|P1|Determination of Urge to Cough|Overall Study||4
7183|NCT02240329|15523|P1|STARTED|Overall Study||4
7184|NCT02239926|15530|P2|NOT COMPLETED|Overall Study||1
7185|NCT02239926|15531|P1|NOT COMPLETED|Overall Study||0
7186|NCT02239926|15530|P2|COMPLETED|Overall Study||1
7187|NCT02239926|15531|P1|COMPLETED|Overall Study||0
7188|NCT02239926|15530|P2|STARTED|Overall Study||2
7189|NCT02239926|15531|P1|STARTED|Overall Study||0
7190|NCT02239744|15541|P2|NOT COMPLETED|Period 2||0
7191|NCT02239744|15542|P1|NOT COMPLETED|Period 2||0
7192|NCT02239744|15541|P2|COMPLETED|Period 2||18
7193|NCT02239744|15542|P1|COMPLETED|Period 2||17
7194|NCT02239744|15541|P2|STARTED|Period 2||18
7195|NCT02239744|15542|P1|STARTED|Period 2||17
7196|NCT02239744|15541|P2|NOT COMPLETED|Period 1||0
7197|NCT02239744|15542|P1|NOT COMPLETED|Period 1||0
7198|NCT02239744|15541|P2|COMPLETED|Period 1||18
7199|NCT02239744|15542|P1|COMPLETED|Period 1||17
7200|NCT02239744|15541|P2|STARTED|Period 1||18
7201|NCT02239744|15542|P1|STARTED|Period 1||17
7202|NCT02239692|15556|P2|NOT COMPLETED|Overall Study||13
7203|NCT02239692|15557|P1|NOT COMPLETED|Overall Study||6
7204|NCT02239692|15556|P2|COMPLETED|Overall Study||118
7205|NCT02239692|15557|P1|COMPLETED|Overall Study||67
7206|NCT02239692|15556|P2|Safety Analysis Set|Overall Study||125
7207|NCT02239692|15557|P1|Safety Analysis Set|Overall Study||70
7208|NCT02239692|15556|P2|Per-protocol Analysis Set|Overall Study||120
7209|NCT02239692|15557|P1|Per-protocol Analysis Set|Overall Study||66
7210|NCT02239692|15556|P2|Intention-to-treat Analysis Set|Overall Study||131
7211|NCT02239692|15557|P1|Intention-to-treat Analysis Set|Overall Study||73
7212|NCT02239692|15556|P2|STARTED|Overall Study||131
7213|NCT02239692|15557|P1|STARTED|Overall Study||73
7214|NCT02239289|15573|P1|NOT COMPLETED|Overall Study||0
7215|NCT02239289|15573|P1|COMPLETED|Overall Study||21
7216|NCT02239289|15573|P1|STARTED|Overall Study||21
7217|NCT02238782|15592|P1|NOT COMPLETED|Overall Study||0
7218|NCT02238782|15592|P1|COMPLETED|Overall Study||12
7219|NCT02238782|15592|P1|Subjects Treated|Overall Study||12
7220|NCT02238782|15592|P1|STARTED|Overall Study||12
7221|NCT02238067|15596|P1|NOT COMPLETED|Overall Study||45
7222|NCT02238067|15596|P1|COMPLETED|Overall Study||151
7223|NCT02238067|15596|P1|STARTED|Overall Study||196
7224|NCT02238028|15619|P2|NOT COMPLETED|Overall Study||2
7225|NCT02238028|15620|P1|NOT COMPLETED|Overall Study||2
7226|NCT02238028|15619|P2|COMPLETED|Overall Study||12
7227|NCT02238028|15620|P1|COMPLETED|Overall Study||12
7228|NCT02238028|15619|P2|STARTED|Overall Study||14
7229|NCT02238028|15620|P1|STARTED|Overall Study||14
7230|NCT02237092|15639|P1|NOT COMPLETED|Overall Study||0
7231|NCT02237092|15639|P1|COMPLETED|Overall Study||196
7232|NCT02237092|15639|P1|STARTED|Overall Study||196
7233|NCT02236767|15656|P1|NOT COMPLETED|Overall Study||0
7234|NCT02236767|15656|P1|COMPLETED|Overall Study||1
7235|NCT02236767|15656|P1|STARTED|Overall Study||1
7236|NCT02236611|15662|P2|NOT COMPLETED|Overall Study||34
7237|NCT02236611|15663|P1|NOT COMPLETED|Overall Study||26
7238|NCT02236611|15662|P2|COMPLETED|Overall Study||484
7239|NCT02236611|15663|P1|COMPLETED|Overall Study||490
7240|NCT02236611|15662|P2|STARTED|Overall Study||518
7241|NCT02236611|15663|P1|STARTED|Overall Study||516
7242|NCT02236130|15671|P2|NOT COMPLETED|Overall Study||12
7243|NCT02236130|15672|P1|NOT COMPLETED|Overall Study||7
7244|NCT02236130|15671|P2|COMPLETED|Overall Study||15
7245|NCT02236130|15672|P1|COMPLETED|Overall Study||15
7246|NCT02236130|15671|P2|STARTED|Overall Study||27
7247|NCT02236130|15672|P1|STARTED|Overall Study||22
7248|NCT02235831|15680|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7249|NCT02235831|15681|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7250|NCT02235831|15682|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7251|NCT02235831|15683|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7252|NCT02235831|15684|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7253|NCT02235831|15685|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
7254|NCT02235831|15680|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
7255|NCT02235831|15681|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
7256|NCT02235831|15682|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
7257|NCT02235831|15683|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
7258|NCT02235831|15684|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
7259|NCT02235831|15685|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
7260|NCT02235831|15680|P6|STARTED|Period 3, Third 5 Days of Wear||4
7261|NCT02235831|15681|P5|STARTED|Period 3, Third 5 Days of Wear||4
7262|NCT02235831|15682|P4|STARTED|Period 3, Third 5 Days of Wear||4
7263|NCT02235831|15683|P3|STARTED|Period 3, Third 5 Days of Wear||4
7264|NCT02235831|15684|P2|STARTED|Period 3, Third 5 Days of Wear||4
7265|NCT02235831|15685|P1|STARTED|Period 3, Third 5 Days of Wear||4
7266|NCT02235831|15680|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7267|NCT02235831|15681|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7268|NCT02235831|15682|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7269|NCT02235831|15683|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7270|NCT02235831|15684|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7271|NCT02235831|15685|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
7272|NCT02235831|15680|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
7273|NCT02235831|15681|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
7274|NCT02235831|15682|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
7275|NCT02235831|15683|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
7276|NCT02235831|15684|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
7277|NCT02235831|15685|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
7278|NCT02235831|15680|P6|STARTED|Period 2, Second 5 Days of Wear||4
7279|NCT02235831|15681|P5|STARTED|Period 2, Second 5 Days of Wear||4
7280|NCT02235831|15682|P4|STARTED|Period 2, Second 5 Days of Wear||4
7281|NCT02235831|15683|P3|STARTED|Period 2, Second 5 Days of Wear||4
7282|NCT02235831|15684|P2|STARTED|Period 2, Second 5 Days of Wear||4
7283|NCT02235831|15685|P1|STARTED|Period 2, Second 5 Days of Wear||4
7284|NCT02235831|15680|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7285|NCT02235831|15681|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7286|NCT02235831|15682|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7287|NCT02235831|15683|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7288|NCT02235831|15684|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7289|NCT02235831|15685|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
7290|NCT02235831|15680|P6|COMPLETED|Period 1, First 5 Days of Wear||4
7291|NCT02235831|15681|P5|COMPLETED|Period 1, First 5 Days of Wear||4
7292|NCT02235831|15682|P4|COMPLETED|Period 1, First 5 Days of Wear||4
7293|NCT02235831|15683|P3|COMPLETED|Period 1, First 5 Days of Wear||4
7294|NCT02235831|15684|P2|COMPLETED|Period 1, First 5 Days of Wear||4
7295|NCT02235831|15685|P1|COMPLETED|Period 1, First 5 Days of Wear||4
7296|NCT02235831|15680|P6|STARTED|Period 1, First 5 Days of Wear||4
7297|NCT02235831|15681|P5|STARTED|Period 1, First 5 Days of Wear||4
7298|NCT02235831|15682|P4|STARTED|Period 1, First 5 Days of Wear||4
7299|NCT02235831|15683|P3|STARTED|Period 1, First 5 Days of Wear||4
7300|NCT02235831|15684|P2|STARTED|Period 1, First 5 Days of Wear||4
7301|NCT02235831|15685|P1|STARTED|Period 1, First 5 Days of Wear||4
7302|NCT02235493|15692|P1|NOT COMPLETED|Overall Study||0
7303|NCT02235493|15692|P1|COMPLETED|Overall Study||6
7304|NCT02235493|15692|P1|STARTED|Overall Study||6
7305|NCT02235285|15697|P1|NOT COMPLETED|Overall Study||13
7306|NCT02235285|15697|P1|COMPLETED|Overall Study||149
7307|NCT02235285|15697|P1|STARTED|Overall Study||162
7308|NCT02234479|15703|P2|NOT COMPLETED|Overall Study||3
7309|NCT02234479|15704|P1|NOT COMPLETED|Overall Study||1
7310|NCT02234479|15703|P2|COMPLETED|Overall Study||15
7311|NCT02234479|15704|P1|COMPLETED|Overall Study||15
7312|NCT02234479|15703|P2|STARTED|Overall Study||18
7313|NCT02234479|15704|P1|STARTED|Overall Study||16
7314|NCT02234427|15710|P1|NOT COMPLETED|Overall Study||1
7315|NCT02234427|15710|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
7316|NCT02234427|15710|P1|STARTED|Overall Study||34
7317|NCT02233998|15717|P3|NOT COMPLETED|Overall Study||0
7318|NCT02233998|15718|P2|NOT COMPLETED|Overall Study||0
7319|NCT02233998|15719|P1|NOT COMPLETED|Overall Study||0
7320|NCT02233998|15717|P3|COMPLETED|Overall Study||53
7321|NCT02233998|15718|P2|COMPLETED|Overall Study||52
7322|NCT02233998|15719|P1|COMPLETED|Overall Study||53
7323|NCT02233998|15717|P3|STARTED|Overall Study||53
7324|NCT02233998|15718|P2|STARTED|Overall Study||52
7325|NCT02233998|15719|P1|STARTED|Overall Study||53
7326|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
7327|NCT02233842|15751|P1|COMPLETED|Questionnaire 3 Version 2||5
7328|NCT02233842|15751|P1|STARTED|Questionnaire 3 Version 2||5
7329|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
7330|NCT02233842|15751|P1|COMPLETED|Questionnaire 3 Version 1||5
7331|NCT02233842|15751|P1|STARTED|Questionnaire 3 Version 1||5
7332|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
7333|NCT02233842|15751|P1|COMPLETED|Questionnaire 2 Version 2||5
7334|NCT02233842|15751|P1|STARTED|Questionnaire 2 Version 2||5
7335|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
7336|NCT02233842|15751|P1|COMPLETED|Questionnaire 2 Version 1||5
7337|NCT02233842|15751|P1|STARTED|Questionnaire 2 Version 1||5
7338|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
7339|NCT02233842|15751|P1|COMPLETED|Questionnaire 1 Version 2||5
7340|NCT02233842|15751|P1|STARTED|Questionnaire 1 Version 2||5
7341|NCT02233842|15751|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
7342|NCT02233842|15751|P1|COMPLETED|Questionnaire 1 Version 1||5
7343|NCT02233842|15751|P1|STARTED|Questionnaire 1 Version 1||5
7344|NCT02233647|15758|P1|NOT COMPLETED|Overall Study||1
7345|NCT02233647|15758|P1|COMPLETED|Overall Study||10
7346|NCT02233647|15758|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7347|NCT02233647|15758|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7348|NCT02233647|15758|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7349|NCT02233647|15758|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
7350|NCT02233647|15758|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
7351|NCT02233647|15758|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7352|NCT02233647|15758|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7353|NCT02233647|15758|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7354|NCT02233647|15758|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
7355|NCT02233647|15758|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
7356|NCT02233647|15758|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7357|NCT02233647|15758|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7358|NCT02233647|15758|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7359|NCT02233647|15758|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7360|NCT02233647|15758|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
7361|NCT02233647|15758|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7362|NCT02233647|15758|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7363|NCT02233647|15758|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
7364|NCT02233647|15758|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
7365|NCT02233647|15758|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
7366|NCT02233647|15758|P1|STARTED|Overall Study||11
7367|NCT02233309|15787|P1|NOT COMPLETED|Overall Study||5
7368|NCT02233309|15787|P1|COMPLETED|Overall Study||31
7369|NCT02233309|15787|P1|STARTED|Overall Study||36
7370|NCT02233296|15793|P2|NOT COMPLETED|Overall Study||0
7371|NCT02233296|15794|P1|NOT COMPLETED|Overall Study||0
7372|NCT02233296|15793|P2|COMPLETED|Overall Study||14
7373|NCT02233296|15794|P1|COMPLETED|Overall Study||16
7374|NCT02233296|15793|P2|STARTED|Overall Study||14
7375|NCT02233296|15794|P1|STARTED|Overall Study||16
7376|NCT02232880|15810|P1|NOT COMPLETED|Overall Study||1
7377|NCT02232880|15810|P1|COMPLETED|Overall Study||0
7378|NCT02232880|15810|P1|STARTED|Overall Study||1
7379|NCT02232126|15819|P2|NOT COMPLETED|Overall Study||0
7380|NCT02232126|15820|P1|NOT COMPLETED|Overall Study||0
7381|NCT02232126|15819|P2|COMPLETED|Overall Study||90
7382|NCT02232126|15820|P1|COMPLETED|Overall Study||91
7383|NCT02232126|15819|P2|STARTED|Overall Study||90
7384|NCT02232126|15820|P1|STARTED|Overall Study||91
7385|NCT02231918|15831|P3|NOT COMPLETED|Overall Study||1
7386|NCT02231918|15832|P2|NOT COMPLETED|Overall Study||1
7387|NCT02231918|15833|P1|NOT COMPLETED|Overall Study||0
7388|NCT02231918|15831|P3|COMPLETED|Overall Study||1
7389|NCT02231918|15832|P2|COMPLETED|Overall Study||14
7390|NCT02231918|15833|P1|COMPLETED|Overall Study||9
7391|NCT02231918|15831|P3|STARTED|Overall Study||2
7392|NCT02231918|15832|P2|STARTED|Overall Study||15
7393|NCT02231918|15833|P1|STARTED|Overall Study||9
7394|NCT02231177|15895|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7395|NCT02231177|15896|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7396|NCT02231177|15897|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7397|NCT02231177|15898|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7398|NCT02231177|15899|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7399|NCT02231177|15900|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
7400|NCT02231177|15895|P6|COMPLETED|Treatment Period 3 (21 Days)||9
7401|NCT02231177|15896|P5|COMPLETED|Treatment Period 3 (21 Days)||8
7402|NCT02231177|15897|P4|COMPLETED|Treatment Period 3 (21 Days)||7
7403|NCT02231177|15898|P3|COMPLETED|Treatment Period 3 (21 Days)||8
7404|NCT02231177|15899|P2|COMPLETED|Treatment Period 3 (21 Days)||7
7405|NCT02231177|15900|P1|COMPLETED|Treatment Period 3 (21 Days)||8
7406|NCT02231177|15895|P6|STARTED|Treatment Period 3 (21 Days)||9
7407|NCT02231177|15896|P5|STARTED|Treatment Period 3 (21 Days)||8
7408|NCT02231177|15897|P4|STARTED|Treatment Period 3 (21 Days)||7
7409|NCT02231177|15898|P3|STARTED|Treatment Period 3 (21 Days)||8
7410|NCT02231177|15899|P2|STARTED|Treatment Period 3 (21 Days)||7
7411|NCT02231177|15900|P1|STARTED|Treatment Period 3 (21 Days)||8
7412|NCT02231177|15895|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7413|NCT02231177|15896|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7414|NCT02231177|15897|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7415|NCT02231177|15898|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7416|NCT02231177|15899|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7417|NCT02231177|15900|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
7418|NCT02231177|15895|P6|COMPLETED|Treatment Period 2 (21 Days)||9
7419|NCT02231177|15896|P5|COMPLETED|Treatment Period 2 (21 Days)||8
7420|NCT02231177|15897|P4|COMPLETED|Treatment Period 2 (21 Days)||7
7421|NCT02231177|15898|P3|COMPLETED|Treatment Period 2 (21 Days)||8
7422|NCT02231177|15899|P2|COMPLETED|Treatment Period 2 (21 Days)||7
7423|NCT02231177|15900|P1|COMPLETED|Treatment Period 2 (21 Days)||8
7424|NCT02231177|15895|P6|STARTED|Treatment Period 2 (21 Days)||9
7425|NCT02231177|15896|P5|STARTED|Treatment Period 2 (21 Days)||8
7426|NCT02231177|15897|P4|STARTED|Treatment Period 2 (21 Days)||7
7427|NCT02231177|15898|P3|STARTED|Treatment Period 2 (21 Days)||8
7428|NCT02231177|15899|P2|STARTED|Treatment Period 2 (21 Days)||7
7429|NCT02231177|15900|P1|STARTED|Treatment Period 2 (21 Days)||8
7430|NCT02231177|15895|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7431|NCT02231177|15896|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7432|NCT02231177|15897|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7433|NCT02231177|15898|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7434|NCT02231177|15899|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7435|NCT02231177|15900|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
7436|NCT02231177|15895|P6|COMPLETED|Treatment Period 1 (21 Days)||9
7437|NCT02231177|15896|P5|COMPLETED|Treatment Period 1 (21 Days)||8
7438|NCT02231177|15897|P4|COMPLETED|Treatment Period 1 (21 Days)||7
7439|NCT02231177|15898|P3|COMPLETED|Treatment Period 1 (21 Days)||8
7440|NCT02231177|15899|P2|COMPLETED|Treatment Period 1 (21 Days)||7
7441|NCT02231177|15900|P1|COMPLETED|Treatment Period 1 (21 Days)||8
7442|NCT02231177|15895|P6|STARTED|Treatment Period 1 (21 Days)||9
7443|NCT02231177|15896|P5|STARTED|Treatment Period 1 (21 Days)||8
7444|NCT02231177|15897|P4|STARTED|Treatment Period 1 (21 Days)||7
7445|NCT02231177|15898|P3|STARTED|Treatment Period 1 (21 Days)||8
7446|NCT02231177|15899|P2|STARTED|Treatment Period 1 (21 Days)||7
7447|NCT02231177|15900|P1|STARTED|Treatment Period 1 (21 Days)||8
7448|NCT02231164|15956|P2|NOT COMPLETED|Overall Study||6
7449|NCT02231164|15957|P1|NOT COMPLETED|Overall Study||6
7450|NCT02231164|15956|P2|COMPLETED|Overall Study||0
7451|NCT02231164|15957|P1|COMPLETED|Overall Study||0
7452|NCT02231164|15956|P2|STARTED|Overall Study||6
7453|NCT02231164|15957|P1|STARTED|Overall Study||6
7454|NCT02230904|15965|P2|NOT COMPLETED|Overall Study||1
7455|NCT02230904|15966|P1|NOT COMPLETED|Overall Study||0
7456|NCT02230904|15965|P2|COMPLETED|Overall Study||27
7457|NCT02230904|15966|P1|COMPLETED|Overall Study||29
7458|NCT02230904|15965|P2|STARTED|Overall Study||28
7459|NCT02230904|15966|P1|STARTED|Overall Study||29
7460|NCT02230761|15988|P2|NOT COMPLETED|Overall Study||1
7461|NCT02230761|15989|P1|NOT COMPLETED|Overall Study||0
7462|NCT02230761|15988|P2|COMPLETED|Overall Study||29
7463|NCT02230761|15989|P1|COMPLETED|Overall Study||60
7464|NCT02230761|15988|P2|STARTED|Overall Study||30
7465|NCT02230761|15989|P1|STARTED|Overall Study||60
7466|NCT02230683|15999|P1|NOT COMPLETED|Overall Study||1
7467|NCT02230683|15999|P1|COMPLETED|Overall Study||22
7468|NCT02230683|15999|P1|STARTED|Overall Study||23
7469|NCT02230540|16014|P2|NOT COMPLETED|Overall Study||0
7470|NCT02230540|16015|P1|NOT COMPLETED|Overall Study||0
7471|NCT02230540|16014|P2|COMPLETED|Overall Study||0
7472|NCT02230540|16015|P1|COMPLETED|Overall Study||8
7473|NCT02230540|16014|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
7474|NCT02230540|16015|P1|STARTED|Overall Study||8
7475|NCT02230085|16019|P1|NOT COMPLETED|Overall Study||0
7476|NCT02230085|16019|P1|COMPLETED|Overall Study||103
7477|NCT02230085|16019|P1|STARTED|Overall Study||103
7478|NCT02229864|16023|P1|NOT COMPLETED|1 - Year Visit||1
7479|NCT02229864|16023|P1|COMPLETED|1 - Year Visit||11
7480|NCT02229864|16023|P1|STARTED|1 - Year Visit||12
7481|NCT02229864|16023|P1|NOT COMPLETED|6 - Month Visit||0
7482|NCT02229864|16023|P1|COMPLETED|6 - Month Visit||12
7483|NCT02229864|16023|P1|STARTED|6 - Month Visit||12
7484|NCT02229864|16023|P1|NOT COMPLETED|1 - Month Visit||0
7485|NCT02229864|16023|P1|COMPLETED|1 - Month Visit||12
7486|NCT02229864|16023|P1|STARTED|1 - Month Visit||12
7487|NCT02229513|16063|P2|NOT COMPLETED|Overall Study||0
7488|NCT02229513|16064|P1|NOT COMPLETED|Overall Study||0
7489|NCT02229513|16063|P2|COMPLETED|Overall Study||100
7490|NCT02229513|16064|P1|COMPLETED|Overall Study||100
7491|NCT02229513|16063|P2|STARTED|Overall Study||100
7492|NCT02229513|16064|P1|STARTED|Overall Study||100
7493|NCT02229461|16105|P6|NOT COMPLETED|Overall Study||0
7494|NCT02229461|16106|P5|NOT COMPLETED|Overall Study||0
7495|NCT02229461|16107|P4|NOT COMPLETED|Overall Study||0
7496|NCT02229461|16108|P3|NOT COMPLETED|Overall Study||0
7497|NCT02229461|16109|P2|NOT COMPLETED|Overall Study||0
7498|NCT02229461|16110|P1|NOT COMPLETED|Overall Study||0
7499|NCT02229461|16105|P6|COMPLETED|Overall Study||17
7500|NCT02229461|16106|P5|COMPLETED|Overall Study||17
7501|NCT02229461|16107|P4|COMPLETED|Overall Study||17
7502|NCT02229461|16108|P3|COMPLETED|Overall Study||17
7503|NCT02229461|16109|P2|COMPLETED|Overall Study||17
7504|NCT02229461|16110|P1|COMPLETED|Overall Study||17
7505|NCT02229461|16105|P6|STARTED|Overall Study|Randomized and received treatment|17
7506|NCT02229461|16106|P5|STARTED|Overall Study|Randomized and received treatment|17
7507|NCT02229461|16107|P4|STARTED|Overall Study|Randomized and received treatment|17
7508|NCT02229461|16108|P3|STARTED|Overall Study|Randomized and received treatment|17
7509|NCT02229461|16109|P2|STARTED|Overall Study|Randomized and received treatment|17
7510|NCT02229461|16110|P1|STARTED|Overall Study|Randomized and received treatment|17
7511|NCT02229318|16143|P1|NOT COMPLETED|Overall Study||0
7512|NCT02229318|16143|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
7513|NCT02229318|16143|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
7514|NCT02229214|16150|P2|NOT COMPLETED|Overall Study||0
7515|NCT02229214|16151|P1|NOT COMPLETED|Overall Study||6
7516|NCT02229214|16150|P2|COMPLETED|Overall Study||10
7517|NCT02229214|16151|P1|COMPLETED|Overall Study||35
7518|NCT02229214|16150|P2|STARTED|Overall Study||10
7519|NCT02229214|16151|P1|STARTED|Overall Study||41
7520|NCT02228980|16175|P4|NOT COMPLETED|Overall Study||3
7521|NCT02228980|16176|P3|NOT COMPLETED|Overall Study||2
7522|NCT02228980|16177|P2|NOT COMPLETED|Overall Study||3
7523|NCT02228980|16178|P1|NOT COMPLETED|Overall Study||24
7524|NCT02228980|16175|P4|COMPLETED|Overall Study||148
7525|NCT02228980|16176|P3|COMPLETED|Overall Study||149
7526|NCT02228980|16177|P2|COMPLETED|Overall Study||147
7527|NCT02228980|16178|P1|COMPLETED|Overall Study||126
7528|NCT02228980|16175|P4|STARTED|Overall Study||151
7529|NCT02228980|16176|P3|STARTED|Overall Study||151
7530|NCT02228980|16177|P2|STARTED|Overall Study||150
7531|NCT02228980|16178|P1|STARTED|Overall Study||150
7532|NCT02228395|16200|P3|NOT COMPLETED|Third Intervention Period||0
7533|NCT02228395|16201|P2|NOT COMPLETED|Third Intervention Period||0
7534|NCT02228395|16202|P1|NOT COMPLETED|Third Intervention Period||0
7535|NCT02228395|16200|P3|COMPLETED|Third Intervention Period||3
7536|NCT02228395|16201|P2|COMPLETED|Third Intervention Period||3
7537|NCT02228395|16202|P1|COMPLETED|Third Intervention Period||3
7538|NCT02228395|16200|P3|STARTED|Third Intervention Period||3
7539|NCT02228395|16201|P2|STARTED|Third Intervention Period||3
7540|NCT02228395|16202|P1|STARTED|Third Intervention Period||3
7541|NCT02228395|16200|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7542|NCT02228395|16201|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7543|NCT02228395|16202|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7544|NCT02228395|16200|P3|COMPLETED|Washout Period (at Least 10 Days)||3
7545|NCT02228395|16201|P2|COMPLETED|Washout Period (at Least 10 Days)||3
7546|NCT02228395|16202|P1|COMPLETED|Washout Period (at Least 10 Days)||3
7547|NCT02228395|16200|P3|STARTED|Washout Period (at Least 10 Days)||3
7548|NCT02228395|16201|P2|STARTED|Washout Period (at Least 10 Days)||3
7549|NCT02228395|16202|P1|STARTED|Washout Period (at Least 10 Days)||3
7550|NCT02228395|16200|P3|NOT COMPLETED|Second Intervention Period||0
7551|NCT02228395|16201|P2|NOT COMPLETED|Second Intervention Period||0
7552|NCT02228395|16202|P1|NOT COMPLETED|Second Intervention Period||0
7553|NCT02228395|16200|P3|COMPLETED|Second Intervention Period||3
7554|NCT02228395|16201|P2|COMPLETED|Second Intervention Period||3
7555|NCT02228395|16202|P1|COMPLETED|Second Intervention Period||3
7556|NCT02228395|16200|P3|STARTED|Second Intervention Period||3
7557|NCT02228395|16201|P2|STARTED|Second Intervention Period||3
7558|NCT02228395|16202|P1|STARTED|Second Intervention Period||3
7559|NCT02228395|16200|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7560|NCT02228395|16201|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7561|NCT02228395|16202|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
7562|NCT02228395|16200|P3|COMPLETED|Washout Period (at Least 10 Days)||3
7563|NCT02228395|16201|P2|COMPLETED|Washout Period (at Least 10 Days)||3
7564|NCT02228395|16202|P1|COMPLETED|Washout Period (at Least 10 Days)||3
7565|NCT02228395|16200|P3|STARTED|Washout Period (at Least 10 Days)||3
7566|NCT02228395|16201|P2|STARTED|Washout Period (at Least 10 Days)||3
7567|NCT02228395|16202|P1|STARTED|Washout Period (at Least 10 Days)||3
7568|NCT02228395|16200|P3|NOT COMPLETED|First Intervention Period||1
7569|NCT02228395|16201|P2|NOT COMPLETED|First Intervention Period||1
7570|NCT02228395|16202|P1|NOT COMPLETED|First Intervention Period||1
7571|NCT02228395|16200|P3|COMPLETED|First Intervention Period||2
7572|NCT02228395|16201|P2|COMPLETED|First Intervention Period||2
7573|NCT02228395|16202|P1|COMPLETED|First Intervention Period||2
7574|NCT02228395|16200|P3|STARTED|First Intervention Period||3
7575|NCT02228395|16201|P2|STARTED|First Intervention Period||3
7576|NCT02228395|16202|P1|STARTED|First Intervention Period||3
7577|NCT02227485|16268|P2|NOT COMPLETED|Second Follow-up||2
7578|NCT02227485|16269|P1|NOT COMPLETED|Second Follow-up||2
7579|NCT02227485|16268|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
7580|NCT02227485|16269|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
7581|NCT02227485|16268|P2|STARTED|Second Follow-up||38
7582|NCT02227485|16269|P1|STARTED|Second Follow-up||36
7583|NCT02227485|16268|P2|NOT COMPLETED|First Follow-up||2
7584|NCT02227485|16269|P1|NOT COMPLETED|First Follow-up||4
7585|NCT02227485|16268|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
7586|NCT02227485|16269|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
7587|NCT02227485|16268|P2|STARTED|First Follow-up||40
7588|NCT02227485|16269|P1|STARTED|First Follow-up||40
7589|NCT02227121|16285|P1|NOT COMPLETED|Overall Study||0
7590|NCT02227121|16285|P1|COMPLETED|Overall Study||16
7591|NCT02227121|16285|P1|STARTED|Overall Study||16
7592|NCT02226562|16291|P2|NOT COMPLETED|Overall Study||1
7593|NCT02226562|16292|P1|NOT COMPLETED|Overall Study||0
7594|NCT02226562|16291|P2|COMPLETED|Overall Study|Lost to follow up|95
7595|NCT02226562|16292|P1|COMPLETED|Overall Study||95
7596|NCT02226562|16291|P2|STARTED|Overall Study||96
7597|NCT02226562|16292|P1|STARTED|Overall Study||95
7598|NCT02226549|16310|P2|NOT COMPLETED|Overall Study||1
7599|NCT02226549|16311|P1|NOT COMPLETED|Overall Study||1
7600|NCT02226549|16310|P2|COMPLETED|Overall Study||23
7601|NCT02226549|16311|P1|COMPLETED|Overall Study||22
7602|NCT02226549|16310|P2|STARTED|Overall Study||24
7603|NCT02226549|16311|P1|STARTED|Overall Study||23
7604|NCT02226198|16321|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7605|NCT02226198|16322|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7606|NCT02226198|16323|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
7607|NCT02226198|16321|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
7608|NCT02226198|16322|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
7609|NCT02226198|16323|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
7610|NCT02226198|16321|P3|STARTED|Maintenance Phase (12 Weeks)||0
7611|NCT02226198|16322|P2|STARTED|Maintenance Phase (12 Weeks)||0
7612|NCT02226198|16323|P1|STARTED|Maintenance Phase (12 Weeks)||13
7613|NCT02226198|16321|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7614|NCT02226198|16322|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7615|NCT02226198|16323|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7616|NCT02226198|16321|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
7617|NCT02226198|16322|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
7618|NCT02226198|16323|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
7619|NCT02226198|16321|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
7620|NCT02226198|16322|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
7621|NCT02226198|16323|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
7622|NCT02226198|16321|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7623|NCT02226198|16322|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
7624|NCT02226198|16323|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7625|NCT02226198|16321|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
7626|NCT02226198|16322|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
7627|NCT02226198|16323|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
7628|NCT02226198|16321|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
7629|NCT02226198|16322|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
7630|NCT02226198|16323|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
7631|NCT02226198|16321|P3|NOT COMPLETED|Lead-in Phase||0
7632|NCT02226198|16322|P2|NOT COMPLETED|Lead-in Phase||0
7633|NCT02226198|16323|P1|NOT COMPLETED|Lead-in Phase||1
7634|NCT02226198|16321|P3|COMPLETED|Lead-in Phase||0
7635|NCT02226198|16322|P2|COMPLETED|Lead-in Phase||0
7636|NCT02226198|16323|P1|COMPLETED|Lead-in Phase||10
7637|NCT02226198|16321|P3|STARTED|Lead-in Phase||0
7638|NCT02226198|16322|P2|STARTED|Lead-in Phase||0
7639|NCT02226198|16323|P1|STARTED|Lead-in Phase||11
7640|NCT02224820|16396|P1|NOT COMPLETED|Overall Study||0
7641|NCT02224820|16396|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
7642|NCT02224820|16396|P1|STARTED|Overall Study||8
7643|NCT02224625|16404|P1|NOT COMPLETED|Sensitization||55
7644|NCT02224625|16404|P1|COMPLETED|Sensitization||194
7645|NCT02224625|16404|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
7646|NCT02224625|16404|P1|NOT COMPLETED|Irritation||6
7647|NCT02224625|16404|P1|COMPLETED|Irritation||33
7648|NCT02224625|16404|P1|STARTED|Irritation||39
7649|NCT02224404|16416|P1|NOT COMPLETED|Overall Study||0
7650|NCT02224404|16416|P1|COMPLETED|Overall Study||21
7651|NCT02224404|16416|P1|STARTED|Overall Study||21
7652|NCT02224053|16421|P1|NOT COMPLETED|AZD9291 Alone||0
7653|NCT02224053|16421|P1|COMPLETED|AZD9291 Alone||47
7654|NCT02224053|16421|P1|STARTED|AZD9291 Alone||47
7655|NCT02224053|16421|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
7656|NCT02224053|16421|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
7657|NCT02224053|16421|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
7658|NCT02223871|16453|P1|NOT COMPLETED|Overall Study||0
7659|NCT02223871|16453|P1|COMPLETED|Overall Study||8
7660|NCT02223871|16453|P1|STARTED|Overall Study||8
7661|NCT02223754|16467|P2|NOT COMPLETED|Period 2||3
7662|NCT02223754|16468|P1|NOT COMPLETED|Period 2||3
7663|NCT02223754|16467|P2|COMPLETED|Period 2||141
7664|NCT02223754|16468|P1|COMPLETED|Period 2||156
7665|NCT02223754|16467|P2|STARTED|Period 2||144
7666|NCT02223754|16468|P1|STARTED|Period 2||159
7667|NCT02223754|16467|P2|NOT COMPLETED|Period 1||15
7668|NCT02223754|16468|P1|NOT COMPLETED|Period 1||4
7669|NCT02223754|16467|P2|COMPLETED|Period 1||144
7670|NCT02223754|16468|P1|COMPLETED|Period 1||159
7671|NCT02223754|16467|P2|STARTED|Period 1||159
7672|NCT02223754|16468|P1|STARTED|Period 1||163
7673|NCT02223715|16488|P1|NOT COMPLETED|Overall Study||104
7674|NCT02223715|16488|P1|COMPLETED|Overall Study||496
7675|NCT02223715|16488|P1|STARTED|Overall Study||600
7676|NCT02223650|16497|P2|NOT COMPLETED|Overall Study||0
7677|NCT02223650|16498|P1|NOT COMPLETED|Overall Study||0
7678|NCT02223650|16497|P2|COMPLETED|Overall Study||31
7679|NCT02223650|16498|P1|COMPLETED|Overall Study||27
7680|NCT02223650|16497|P2|STARTED|Overall Study||31
7681|NCT02223650|16498|P1|STARTED|Overall Study||27
7682|NCT02223260|16528|P1|NOT COMPLETED|Overall Study||0
7683|NCT02223260|16528|P1|COMPLETED|Overall Study||8
7684|NCT02223260|16528|P1|STARTED|Overall Study||8
7685|NCT02223065|16546|P2|NOT COMPLETED|Overall Study||0
7686|NCT02223065|16547|P1|NOT COMPLETED|Overall Study||0
7687|NCT02223065|16546|P2|COMPLETED|Overall Study||18
7688|NCT02223065|16547|P1|COMPLETED|Overall Study||18
7689|NCT02223065|16546|P2|STARTED|Overall Study||18
7690|NCT02223065|16547|P1|STARTED|Overall Study||18
7691|NCT02222870|16565|P2|NOT COMPLETED|Overall Study||0
7692|NCT02222870|16566|P1|NOT COMPLETED|Overall Study||0
7693|NCT02222870|16565|P2|COMPLETED|Overall Study||30
7694|NCT02222870|16566|P1|COMPLETED|Overall Study||30
7695|NCT02222870|16565|P2|STARTED|Overall Study||30
7696|NCT02222870|16566|P1|STARTED|Overall Study||30
7697|NCT02222818|16582|P2|NOT COMPLETED|Period 2||0
7698|NCT02222818|16583|P1|NOT COMPLETED|Period 2||0
7699|NCT02222818|16582|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
7700|NCT02222818|16583|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
7701|NCT02222818|16582|P2|STARTED|Period 2|Start of CAFR evaluation period|30
7702|NCT02222818|16583|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
7703|NCT02222818|16582|P2|NOT COMPLETED|Period 1||3
7704|NCT02222818|16583|P1|NOT COMPLETED|Period 1||0
7705|NCT02222818|16582|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
7706|NCT02222818|16583|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
7707|NCT02222818|16582|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
7708|NCT02222818|16583|P1|STARTED|Period 1|Start of CAFR evaluation period|33
7709|NCT02222558|16590|P6|NOT COMPLETED|Period 3||1
7710|NCT02222558|16591|P5|NOT COMPLETED|Period 3||0
7711|NCT02222558|16592|P4|NOT COMPLETED|Period 3||0
7712|NCT02222558|16593|P3|NOT COMPLETED|Period 3||0
7713|NCT02222558|16594|P2|NOT COMPLETED|Period 3||0
7714|NCT02222558|16595|P1|NOT COMPLETED|Period 3||0
7715|NCT02222558|16590|P6|COMPLETED|Period 3||7
7716|NCT02222558|16591|P5|COMPLETED|Period 3||8
7717|NCT02222558|16592|P4|COMPLETED|Period 3||1
7718|NCT02222558|16593|P3|COMPLETED|Period 3||4
7719|NCT02222558|16594|P2|COMPLETED|Period 3||0
7720|NCT02222558|16595|P1|COMPLETED|Period 3||0
7721|NCT02222558|16590|P6|STARTED|Period 3||8
7722|NCT02222558|16591|P5|STARTED|Period 3||8
7723|NCT02222558|16592|P4|STARTED|Period 3||1
7724|NCT02222558|16593|P3|STARTED|Period 3||4
7725|NCT02222558|16594|P2|STARTED|Period 3||0
7726|NCT02222558|16595|P1|STARTED|Period 3||0
7727|NCT02222558|16590|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7728|NCT02222558|16591|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7729|NCT02222558|16592|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7730|NCT02222558|16593|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7731|NCT02222558|16594|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7732|NCT02222558|16595|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7733|NCT02222558|16590|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7734|NCT02222558|16591|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7735|NCT02222558|16592|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7736|NCT02222558|16593|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7737|NCT02222558|16594|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
7738|NCT02222558|16595|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
7739|NCT02222558|16590|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7740|NCT02222558|16591|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7741|NCT02222558|16592|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7742|NCT02222558|16593|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7743|NCT02222558|16594|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
7744|NCT02222558|16595|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
7745|NCT02222558|16590|P6|NOT COMPLETED|Period 1: Single Dose||0
7746|NCT02222558|16591|P5|NOT COMPLETED|Period 1: Single Dose||0
7747|NCT02222558|16592|P4|NOT COMPLETED|Period 1: Single Dose||0
7748|NCT02222558|16593|P3|NOT COMPLETED|Period 1: Single Dose||0
7749|NCT02222558|16594|P2|NOT COMPLETED|Period 1: Single Dose||0
7750|NCT02222558|16595|P1|NOT COMPLETED|Period 1: Single Dose||4
7751|NCT02222558|16590|P6|COMPLETED|Period 1: Single Dose||0
7752|NCT02222558|16591|P5|COMPLETED|Period 1: Single Dose||0
7753|NCT02222558|16592|P4|COMPLETED|Period 1: Single Dose||0
7754|NCT02222558|16593|P3|COMPLETED|Period 1: Single Dose||0
7755|NCT02222558|16594|P2|COMPLETED|Period 1: Single Dose||0
7756|NCT02222558|16595|P1|COMPLETED|Period 1: Single Dose||21
7757|NCT02222558|16590|P6|STARTED|Period 1: Single Dose||0
7758|NCT02222558|16591|P5|STARTED|Period 1: Single Dose||0
7759|NCT02222558|16592|P4|STARTED|Period 1: Single Dose||0
7760|NCT02222558|16593|P3|STARTED|Period 1: Single Dose||0
7761|NCT02222558|16594|P2|STARTED|Period 1: Single Dose||0
7762|NCT02222558|16595|P1|STARTED|Period 1: Single Dose||25
7763|NCT02222207|16609|P1|NOT COMPLETED|Overall Study||4
7764|NCT02222207|16609|P1|COMPLETED|Overall Study||48
7765|NCT02222207|16609|P1|Treated and Valid for Full Analysis Set|Overall Study||51
7766|NCT02222207|16609|P1|STARTED|Overall Study||52
7767|NCT02222181|16616|P1|NOT COMPLETED|Overall Study||108
7768|NCT02222181|16616|P1|COMPLETED|Overall Study||55
7769|NCT02222181|16616|P1|STARTED|Overall Study||163
7770|NCT02222129|16628|P2|NOT COMPLETED|Overall Study||0
7771|NCT02222129|16629|P1|NOT COMPLETED|Overall Study||0
7772|NCT02222129|16628|P2|COMPLETED|Overall Study||106
7773|NCT02222129|16629|P1|COMPLETED|Overall Study||100
7774|NCT02222129|16628|P2|STARTED|Overall Study||106
7775|NCT02222129|16629|P1|STARTED|Overall Study||100
7776|NCT02221947|16637|P2|NOT COMPLETED|Overall Study||0
7777|NCT02221947|16638|P1|NOT COMPLETED|Overall Study||0
7778|NCT02221947|16637|P2|COMPLETED|Overall Study||3
7779|NCT02221947|16638|P1|COMPLETED|Overall Study||6
7780|NCT02221947|16637|P2|STARTED|Overall Study||3
7781|NCT02221947|16638|P1|STARTED|Overall Study||6
7782|NCT02221648|16646|P2|NOT COMPLETED|Overall Study||3
7783|NCT02221648|16647|P1|NOT COMPLETED|Overall Study||3
7784|NCT02221648|16646|P2|COMPLETED|Overall Study||18
7785|NCT02221648|16647|P1|COMPLETED|Overall Study||19
7786|NCT02221648|16646|P2|STARTED|Overall Study||21
7787|NCT02221648|16647|P1|STARTED|Overall Study||22
7788|NCT02220998|16659|P2|NOT COMPLETED|Overall Study||11
7789|NCT02220998|16660|P1|NOT COMPLETED|Overall Study||7
7790|NCT02220998|16659|P2|COMPLETED|Overall Study||123
7791|NCT02220998|16660|P1|COMPLETED|Overall Study||128
7792|NCT02220998|16659|P2|STARTED|Overall Study||134
7793|NCT02220998|16660|P1|STARTED|Overall Study||135
7794|NCT02220920|16678|P2|NOT COMPLETED|Overall Study||3
7795|NCT02220920|16679|P1|NOT COMPLETED|Overall Study||3
7796|NCT02220920|16678|P2|COMPLETED|Overall Study||67
7797|NCT02220920|16679|P1|COMPLETED|Overall Study||73
7798|NCT02220920|16678|P2|STARTED|Overall Study||70
7799|NCT02220920|16679|P1|STARTED|Overall Study||76
7800|NCT02220764|16695|P2|NOT COMPLETED|Overall Study||1
7801|NCT02220764|16696|P1|NOT COMPLETED|Overall Study||4
7802|NCT02220764|16695|P2|COMPLETED|Overall Study||7
7803|NCT02220764|16696|P1|COMPLETED|Overall Study||20
7804|NCT02220764|16695|P2|STARTED|Overall Study||8
7805|NCT02220764|16696|P1|STARTED|Overall Study||24
7806|NCT02219997|16708|P3|NOT COMPLETED|Second Filter||0
7807|NCT02219997|16709|P2|NOT COMPLETED|Second Filter||0
7808|NCT02219997|16710|P1|NOT COMPLETED|Second Filter||0
7809|NCT02219997|16708|P3|COMPLETED|Second Filter||18
7810|NCT02219997|16709|P2|COMPLETED|Second Filter||17
7811|NCT02219997|16710|P1|COMPLETED|Second Filter||0
7812|NCT02219997|16708|P3|STARTED|Second Filter||18
7813|NCT02219997|16709|P2|STARTED|Second Filter||17
7814|NCT02219997|16710|P1|STARTED|Second Filter||0
7815|NCT02219997|16708|P3|NOT COMPLETED|First Filter||0
7816|NCT02219997|16709|P2|NOT COMPLETED|First Filter||0
7817|NCT02219997|16710|P1|NOT COMPLETED|First Filter||0
7818|NCT02219997|16708|P3|COMPLETED|First Filter||18
7819|NCT02219997|16709|P2|COMPLETED|First Filter||17
7820|NCT02219997|16710|P1|COMPLETED|First Filter||33
7821|NCT02219997|16708|P3|STARTED|First Filter||18
7822|NCT02219997|16709|P2|STARTED|First Filter||17
7823|NCT02219997|16710|P1|STARTED|First Filter||33
7824|NCT02219685|16723|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
7825|NCT02219685|16724|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
7826|NCT02219685|16723|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
7827|NCT02219685|16724|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
7828|NCT02219685|16723|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
7829|NCT02219685|16724|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
7830|NCT02219685|16723|P2|NOT COMPLETED|Blinded Treatment Phase||0
7831|NCT02219685|16724|P1|NOT COMPLETED|Blinded Treatment Phase||2
7832|NCT02219685|16723|P2|COMPLETED|Blinded Treatment Phase||14
7833|NCT02219685|16724|P1|COMPLETED|Blinded Treatment Phase||24
7834|NCT02219685|16723|P2|STARTED|Blinded Treatment Phase||14
7835|NCT02219685|16724|P1|STARTED|Blinded Treatment Phase||26
7836|NCT02219503|16768|P1|NOT COMPLETED|Overall Study||0
7837|NCT02219503|16768|P1|COMPLETED|Overall Study||60
7838|NCT02219503|16768|P1|STARTED|Overall Study||60
7839|NCT02218268|16774|P2|NOT COMPLETED|Final Phase (2 Hours)||0
7840|NCT02218268|16775|P1|NOT COMPLETED|Final Phase (2 Hours)||0
7841|NCT02218268|16774|P2|COMPLETED|Final Phase (2 Hours)||21
7842|NCT02218268|16775|P1|COMPLETED|Final Phase (2 Hours)||19
7843|NCT02218268|16774|P2|STARTED|Final Phase (2 Hours)||21
7844|NCT02218268|16775|P1|STARTED|Final Phase (2 Hours)||19
7845|NCT02218268|16774|P2|NOT COMPLETED|24 Hour Washout||9
7846|NCT02218268|16775|P1|NOT COMPLETED|24 Hour Washout||11
7847|NCT02218268|16774|P2|COMPLETED|24 Hour Washout||21
7848|NCT02218268|16775|P1|COMPLETED|24 Hour Washout||19
7849|NCT02218268|16774|P2|STARTED|24 Hour Washout||30
7850|NCT02218268|16775|P1|STARTED|24 Hour Washout||30
7851|NCT02218268|16774|P2|NOT COMPLETED|First Phase (2 Hours)||0
7852|NCT02218268|16775|P1|NOT COMPLETED|First Phase (2 Hours)||0
7853|NCT02218268|16774|P2|COMPLETED|First Phase (2 Hours)||30
7854|NCT02218268|16775|P1|COMPLETED|First Phase (2 Hours)||30
7855|NCT02218268|16774|P2|STARTED|First Phase (2 Hours)||30
7856|NCT02218268|16775|P1|STARTED|First Phase (2 Hours)||30
7857|NCT02217982|16783|P2|NOT COMPLETED|Overall Study||1
7858|NCT02217982|16784|P1|NOT COMPLETED|Overall Study||1
7859|NCT02217982|16783|P2|COMPLETED|Overall Study||3
7860|NCT02217982|16784|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
7861|NCT02217982|16783|P2|STARTED|Overall Study||4
7862|NCT02217982|16784|P1|STARTED|Overall Study||1
7863|NCT02217878|16792|P2|NOT COMPLETED|Overall Study||2
7864|NCT02217878|16793|P1|NOT COMPLETED|Overall Study||2
7865|NCT02217878|16792|P2|COMPLETED|Overall Study||35
7866|NCT02217878|16793|P1|COMPLETED|Overall Study||35
7867|NCT02217878|16792|P2|STARTED|Overall Study||37
7868|NCT02217878|16793|P1|STARTED|Overall Study||37
7869|NCT02216695|16799|P1|NOT COMPLETED|Overall Study||0
7870|NCT02216695|16799|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
7871|NCT02216695|16799|P1|STARTED|Overall Study||64882
7872|NCT02216422|16808|P1|NOT COMPLETED|Overall Study||0
7873|NCT02216422|16808|P1|COMPLETED|Overall Study||36
7874|NCT02216422|16808|P1|STARTED|Overall Study||36
7875|NCT02216097|16816|P2|NOT COMPLETED|Overall Study||0
7876|NCT02216097|16817|P1|NOT COMPLETED|Overall Study||0
7877|NCT02216097|16816|P2|COMPLETED|Overall Study||6
7878|NCT02216097|16817|P1|COMPLETED|Overall Study||8
7879|NCT02216097|16816|P2|STARTED|Overall Study||6
7880|NCT02216097|16817|P1|STARTED|Overall Study||8
7881|NCT02214225|16842|P3|NOT COMPLETED|Overall Study||22
7882|NCT02214225|16843|P2|NOT COMPLETED|Overall Study||19
7883|NCT02214225|16844|P1|NOT COMPLETED|Overall Study||55
7884|NCT02214225|16842|P3|COMPLETED|Overall Study||850
7885|NCT02214225|16843|P2|COMPLETED|Overall Study||852
7886|NCT02214225|16844|P1|COMPLETED|Overall Study||1686
7887|NCT02214225|16842|P3|STARTED|Overall Study||872
7888|NCT02214225|16843|P2|STARTED|Overall Study||871
7889|NCT02214225|16844|P1|STARTED|Overall Study||1741
7890|NCT02214186|16903|P2|NOT COMPLETED|Overall Study||2
7891|NCT02214186|16904|P1|NOT COMPLETED|Overall Study||2
7892|NCT02214186|16903|P2|COMPLETED|Overall Study||21
7893|NCT02214186|16904|P1|COMPLETED|Overall Study||21
7894|NCT02214186|16903|P2|STARTED|Overall Study||23
7895|NCT02214186|16904|P1|STARTED|Overall Study||23
7896|NCT02213510|16928|P2|NOT COMPLETED|Overall Study||1
7897|NCT02213510|16929|P1|NOT COMPLETED|Overall Study||1
7898|NCT02213510|16928|P2|COMPLETED|Overall Study||18
7899|NCT02213510|16929|P1|COMPLETED|Overall Study||20
7900|NCT02213510|16928|P2|STARTED|Overall Study||19
7901|NCT02213510|16929|P1|STARTED|Overall Study||21
7902|NCT02213250|16955|P2|NOT COMPLETED|Overall Study||0
7903|NCT02213250|16956|P1|NOT COMPLETED|Overall Study||0
7904|NCT02213250|16955|P2|COMPLETED|Overall Study||8
7905|NCT02213250|16956|P1|COMPLETED|Overall Study||4
7906|NCT02213250|16955|P2|STARTED|Overall Study||8
7907|NCT02213250|16956|P1|STARTED|Overall Study||4
7908|NCT02213055|16987|P2|NOT COMPLETED|Overall Study||0
7909|NCT02213055|16988|P1|NOT COMPLETED|Overall Study||39
7910|NCT02213055|16987|P2|COMPLETED|Overall Study||0
7911|NCT02213055|16988|P1|COMPLETED|Overall Study||58
7912|NCT02213055|16987|P2|STARTED|Overall Study||0
7913|NCT02213055|16988|P1|STARTED|Overall Study||97
7914|NCT02212977|16996|P2|NOT COMPLETED|Overall Study||6
7915|NCT02212977|16997|P1|NOT COMPLETED|Overall Study||5
7916|NCT02212977|16996|P2|COMPLETED|Overall Study||48
7917|NCT02212977|16997|P1|COMPLETED|Overall Study||50
7918|NCT02212977|16996|P2|STARTED|Overall Study||54
7919|NCT02212977|16997|P1|STARTED|Overall Study||55
7920|NCT02212834|17013|P2|NOT COMPLETED|Overall Study||0
7921|NCT02212834|17014|P1|NOT COMPLETED|Overall Study||0
7922|NCT02212834|17013|P2|COMPLETED|Overall Study||2506
7923|NCT02212834|17014|P1|COMPLETED|Overall Study||33938
7924|NCT02212834|17013|P2|STARTED|Overall Study||2506
7925|NCT02212834|17014|P1|STARTED|Overall Study||33938
7926|NCT02212301|17020|P2|NOT COMPLETED|Period 2||0
7927|NCT02212301|17021|P1|NOT COMPLETED|Period 2||0
7928|NCT02212301|17020|P2|COMPLETED|Period 2||21
7929|NCT02212301|17021|P1|COMPLETED|Period 2||21
7930|NCT02212301|17020|P2|STARTED|Period 2||21
7931|NCT02212301|17021|P1|STARTED|Period 2||21
7932|NCT02212301|17020|P2|NOT COMPLETED|Period 1||1
7933|NCT02212301|17021|P1|NOT COMPLETED|Period 1||0
7934|NCT02212301|17020|P2|COMPLETED|Period 1||21
7935|NCT02212301|17021|P1|COMPLETED|Period 1||21
7936|NCT02212301|17020|P2|STARTED|Period 1||22
7937|NCT02212301|17021|P1|STARTED|Period 1||21
7938|NCT02212197|17032|P3|NOT COMPLETED|Overall Study||0
7939|NCT02212197|17033|P2|NOT COMPLETED|Overall Study||0
7940|NCT02212197|17034|P1|NOT COMPLETED|Overall Study||1
7941|NCT02212197|17032|P3|COMPLETED|Overall Study||17
7942|NCT02212197|17033|P2|COMPLETED|Overall Study||15
7943|NCT02212197|17034|P1|COMPLETED|Overall Study||18
7944|NCT02212197|17032|P3|STARTED|Overall Study||17
7945|NCT02212197|17033|P2|STARTED|Overall Study||15
7946|NCT02212197|17034|P1|STARTED|Overall Study||19
7947|NCT02212106|17059|P2|NOT COMPLETED|Overall Study||4
7948|NCT02212106|17060|P1|NOT COMPLETED|Overall Study||10
7949|NCT02212106|17059|P2|COMPLETED|Overall Study||96
7950|NCT02212106|17060|P1|COMPLETED|Overall Study||292
7951|NCT02212106|17059|P2|STARTED|Overall Study||100
7952|NCT02212106|17060|P1|STARTED|Overall Study||302
7953|NCT02212028|17078|P2|NOT COMPLETED|Overall Study||0
7954|NCT02212028|17079|P1|NOT COMPLETED|Overall Study||0
7955|NCT02212028|17078|P2|COMPLETED|Overall Study||26
7956|NCT02212028|17079|P1|COMPLETED|Overall Study||26
7957|NCT02212028|17078|P2|STARTED|Overall Study||26
7958|NCT02212028|17079|P1|STARTED|Overall Study||26
7959|NCT02210091|17089|P2|NOT COMPLETED|Overall Study||2
7960|NCT02210091|17090|P1|NOT COMPLETED|Overall Study||0
7961|NCT02210091|17089|P2|COMPLETED|Overall Study||32
7962|NCT02210091|17090|P1|COMPLETED|Overall Study||32
7963|NCT02210091|17089|P2|STARTED|Overall Study||34
7964|NCT02210091|17090|P1|STARTED|Overall Study||32
7965|NCT02209766|17166|P5|NOT COMPLETED|Overall Study||0
7966|NCT02209766|17167|P4|NOT COMPLETED|Overall Study||1
7967|NCT02209766|17168|P3|NOT COMPLETED|Overall Study||0
7968|NCT02209766|17169|P2|NOT COMPLETED|Overall Study||0
7969|NCT02209766|17170|P1|NOT COMPLETED|Overall Study||0
7970|NCT02209766|17166|P5|COMPLETED|Overall Study||6
7971|NCT02209766|17167|P4|COMPLETED|Overall Study||2
7972|NCT02209766|17168|P3|COMPLETED|Overall Study||6
7973|NCT02209766|17169|P2|COMPLETED|Overall Study||3
7974|NCT02209766|17170|P1|COMPLETED|Overall Study||6
7975|NCT02209766|17166|P5|STARTED|Overall Study||6
7976|NCT02209766|17167|P4|STARTED|Overall Study||3
7977|NCT02209766|17168|P3|STARTED|Overall Study||6
7978|NCT02209766|17169|P2|STARTED|Overall Study||3
7979|NCT02209766|17170|P1|STARTED|Overall Study||6
7980|NCT02209506|17221|P5|NOT COMPLETED|Overall Study||1
7981|NCT02209506|17222|P4|NOT COMPLETED|Overall Study||0
7982|NCT02209506|17223|P3|NOT COMPLETED|Overall Study||0
7983|NCT02209506|17224|P2|NOT COMPLETED|Overall Study||0
7984|NCT02209506|17225|P1|NOT COMPLETED|Overall Study||0
7985|NCT02209506|17221|P5|COMPLETED|Overall Study||5
7986|NCT02209506|17222|P4|COMPLETED|Overall Study||2
7987|NCT02209506|17223|P3|COMPLETED|Overall Study||6
7988|NCT02209506|17224|P2|COMPLETED|Overall Study||6
7989|NCT02209506|17225|P1|COMPLETED|Overall Study||3
7990|NCT02209506|17221|P5|STARTED|Overall Study||6
7991|NCT02209506|17222|P4|STARTED|Overall Study||2
7992|NCT02209506|17223|P3|STARTED|Overall Study||6
7993|NCT02209506|17224|P2|STARTED|Overall Study||6
7994|NCT02209506|17225|P1|STARTED|Overall Study||3
7995|NCT02209454|17300|P2|NOT COMPLETED|Second Period||0
7996|NCT02209454|17301|P1|NOT COMPLETED|Second Period||1
7997|NCT02209454|17300|P2|COMPLETED|Second Period||13
7998|NCT02209454|17301|P1|COMPLETED|Second Period||12
7999|NCT02209454|17300|P2|STARTED|Second Period||13
8000|NCT02209454|17301|P1|STARTED|Second Period||13
8001|NCT02209454|17300|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8002|NCT02209454|17301|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8003|NCT02209454|17300|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
8004|NCT02209454|17301|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
8005|NCT02209454|17300|P2|STARTED|Washout Period a Minimum of a 7 Day||13
8006|NCT02209454|17301|P1|STARTED|Washout Period a Minimum of a 7 Day||13
8007|NCT02209454|17300|P2|NOT COMPLETED|First Period||0
8008|NCT02209454|17301|P1|NOT COMPLETED|First Period||0
8009|NCT02209454|17300|P2|COMPLETED|First Period||13
8010|NCT02209454|17301|P1|COMPLETED|First Period||13
8011|NCT02209454|17300|P2|STARTED|First Period||13
8012|NCT02209454|17301|P1|STARTED|First Period||13
8013|NCT02209181|17319|P4|NOT COMPLETED|Overall Study||0
8014|NCT02209181|17320|P3|NOT COMPLETED|Overall Study||1
8015|NCT02209181|17321|P2|NOT COMPLETED|Overall Study||1
8016|NCT02209181|17322|P1|NOT COMPLETED|Overall Study||1
8017|NCT02209181|17319|P4|COMPLETED|Overall Study||66
8018|NCT02209181|17320|P3|COMPLETED|Overall Study||68
8019|NCT02209181|17321|P2|COMPLETED|Overall Study||66
8020|NCT02209181|17322|P1|COMPLETED|Overall Study||66
8021|NCT02209181|17319|P4|STARTED|Overall Study||66
8022|NCT02209181|17320|P3|STARTED|Overall Study||69
8023|NCT02209181|17321|P2|STARTED|Overall Study||67
8024|NCT02209181|17322|P1|STARTED|Overall Study||67
8025|NCT02209064|17484|P1|NOT COMPLETED|Overall Study||0
8026|NCT02209064|17484|P1|COMPLETED|Overall Study||25
8027|NCT02209064|17484|P1|STARTED|Overall Study||25
8028|NCT02207907|17493|P2|NOT COMPLETED|Overall Study||8
8029|NCT02207907|17494|P1|NOT COMPLETED|Overall Study||11
8030|NCT02207907|17493|P2|COMPLETED|Overall Study||115
8031|NCT02207907|17494|P1|COMPLETED|Overall Study||113
8032|NCT02207907|17493|P2|STARTED|Overall Study||123
8033|NCT02207907|17494|P1|STARTED|Overall Study||124
8034|NCT02207829|17512|P2|NOT COMPLETED|Overall Study||34
8035|NCT02207829|17513|P1|NOT COMPLETED|Overall Study||42
8036|NCT02207829|17512|P2|COMPLETED|Overall Study||474
8037|NCT02207829|17513|P1|COMPLETED|Overall Study||467
8038|NCT02207829|17512|P2|STARTED|Overall Study||508
8039|NCT02207829|17513|P1|STARTED|Overall Study||509
8040|NCT02207608|17521|P2|NOT COMPLETED|Overall Study||0
8041|NCT02207608|17522|P1|NOT COMPLETED|Overall Study||1
8042|NCT02207608|17521|P2|COMPLETED|Overall Study||15
8043|NCT02207608|17522|P1|COMPLETED|Overall Study||14
8044|NCT02207608|17521|P2|STARTED|Overall Study||15
8045|NCT02207608|17522|P1|STARTED|Overall Study||15
8046|NCT02207478|17530|P2|NOT COMPLETED|Overall Study||0
8047|NCT02207478|17531|P1|NOT COMPLETED|Overall Study||0
8048|NCT02207478|17530|P2|COMPLETED|Overall Study||46
8049|NCT02207478|17531|P1|COMPLETED|Overall Study||40
8050|NCT02207478|17530|P2|STARTED|Overall Study||46
8051|NCT02207478|17531|P1|STARTED|Overall Study||40
8052|NCT02207413|17545|P6|NOT COMPLETED|Overall Study||13
8053|NCT02207413|17546|P5|NOT COMPLETED|Overall Study||7
8054|NCT02207413|17547|P4|NOT COMPLETED|Overall Study||1
8055|NCT02207413|17548|P3|NOT COMPLETED|Overall Study||0
8056|NCT02207413|17549|P2|NOT COMPLETED|Overall Study||0
8057|NCT02207413|17550|P1|NOT COMPLETED|Overall Study||1
8058|NCT02207413|17545|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
8059|NCT02207413|17546|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
8060|NCT02207413|17547|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
8061|NCT02207413|17548|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
8062|NCT02207413|17549|P2|COMPLETED|Overall Study||60
8063|NCT02207413|17550|P1|COMPLETED|Overall Study||59
8064|NCT02207413|17545|P6|STARTED|Overall Study||474
8065|NCT02207413|17546|P5|STARTED|Overall Study||466
8066|NCT02207413|17547|P4|STARTED|Overall Study||411
8067|NCT02207413|17548|P3|STARTED|Overall Study||410
8068|NCT02207413|17549|P2|STARTED|Overall Study||60
8069|NCT02207413|17550|P1|STARTED|Overall Study||60
8070|NCT02207400|17646|P2|NOT COMPLETED|Overall Study||14
8071|NCT02207400|17647|P1|NOT COMPLETED|Overall Study||16
8072|NCT02207400|17646|P2|COMPLETED|Overall Study||109
8073|NCT02207400|17647|P1|COMPLETED|Overall Study||107
8074|NCT02207400|17646|P2|STARTED|Overall Study||123
8075|NCT02207400|17647|P1|STARTED|Overall Study||123
8076|NCT02206607|17665|P5|NOT COMPLETED|Fourth Intervention Period||0
8077|NCT02206607|17666|P4|NOT COMPLETED|Fourth Intervention Period||0
8078|NCT02206607|17667|P3|NOT COMPLETED|Fourth Intervention Period||0
8079|NCT02206607|17668|P2|NOT COMPLETED|Fourth Intervention Period||0
8080|NCT02206607|17669|P1|NOT COMPLETED|Fourth Intervention Period||0
8081|NCT02206607|17665|P5|COMPLETED|Fourth Intervention Period||10
8082|NCT02206607|17666|P4|COMPLETED|Fourth Intervention Period||10
8083|NCT02206607|17667|P3|COMPLETED|Fourth Intervention Period||9
8084|NCT02206607|17668|P2|COMPLETED|Fourth Intervention Period||9
8085|NCT02206607|17669|P1|COMPLETED|Fourth Intervention Period||0
8086|NCT02206607|17665|P5|STARTED|Fourth Intervention Period||10
8087|NCT02206607|17666|P4|STARTED|Fourth Intervention Period||10
8088|NCT02206607|17667|P3|STARTED|Fourth Intervention Period||9
8089|NCT02206607|17668|P2|STARTED|Fourth Intervention Period||9
8090|NCT02206607|17669|P1|STARTED|Fourth Intervention Period||0
8091|NCT02206607|17665|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8092|NCT02206607|17666|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8093|NCT02206607|17667|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8094|NCT02206607|17668|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8095|NCT02206607|17669|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8096|NCT02206607|17665|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
8097|NCT02206607|17666|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
8098|NCT02206607|17667|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
8099|NCT02206607|17668|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
8100|NCT02206607|17669|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
8101|NCT02206607|17665|P5|STARTED|Third Washout Period 5 to 10 Days||10
8102|NCT02206607|17666|P4|STARTED|Third Washout Period 5 to 10 Days||10
8103|NCT02206607|17667|P3|STARTED|Third Washout Period 5 to 10 Days||9
8104|NCT02206607|17668|P2|STARTED|Third Washout Period 5 to 10 Days||9
8105|NCT02206607|17669|P1|STARTED|Third Washout Period 5 to 10 Days||0
8106|NCT02206607|17665|P5|NOT COMPLETED|Third Intervention Period||0
8107|NCT02206607|17666|P4|NOT COMPLETED|Third Intervention Period||0
8108|NCT02206607|17667|P3|NOT COMPLETED|Third Intervention Period||0
8109|NCT02206607|17668|P2|NOT COMPLETED|Third Intervention Period||0
8110|NCT02206607|17669|P1|NOT COMPLETED|Third Intervention Period||0
8111|NCT02206607|17665|P5|COMPLETED|Third Intervention Period||10
8112|NCT02206607|17666|P4|COMPLETED|Third Intervention Period||10
8113|NCT02206607|17667|P3|COMPLETED|Third Intervention Period||9
8114|NCT02206607|17668|P2|COMPLETED|Third Intervention Period||9
8115|NCT02206607|17669|P1|COMPLETED|Third Intervention Period||0
8116|NCT02206607|17665|P5|STARTED|Third Intervention Period||10
8117|NCT02206607|17666|P4|STARTED|Third Intervention Period||10
8118|NCT02206607|17667|P3|STARTED|Third Intervention Period||9
8119|NCT02206607|17668|P2|STARTED|Third Intervention Period||9
8120|NCT02206607|17669|P1|STARTED|Third Intervention Period||0
8121|NCT02206607|17665|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8122|NCT02206607|17666|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8123|NCT02206607|17667|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8124|NCT02206607|17668|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8125|NCT02206607|17669|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8126|NCT02206607|17665|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
8127|NCT02206607|17666|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
8128|NCT02206607|17667|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
8129|NCT02206607|17668|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
8130|NCT02206607|17669|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
8131|NCT02206607|17665|P5|STARTED|Second Washout Period 5 to 10 Days||10
8132|NCT02206607|17666|P4|STARTED|Second Washout Period 5 to 10 Days||10
8133|NCT02206607|17667|P3|STARTED|Second Washout Period 5 to 10 Days||9
8134|NCT02206607|17668|P2|STARTED|Second Washout Period 5 to 10 Days||9
8135|NCT02206607|17669|P1|STARTED|Second Washout Period 5 to 10 Days||0
8136|NCT02206607|17665|P5|NOT COMPLETED|Second Intervention Period||0
8137|NCT02206607|17666|P4|NOT COMPLETED|Second Intervention Period||1
8138|NCT02206607|17667|P3|NOT COMPLETED|Second Intervention Period||0
8139|NCT02206607|17668|P2|NOT COMPLETED|Second Intervention Period||0
8140|NCT02206607|17669|P1|NOT COMPLETED|Second Intervention Period||0
8141|NCT02206607|17665|P5|COMPLETED|Second Intervention Period||10
8142|NCT02206607|17666|P4|COMPLETED|Second Intervention Period||10
8143|NCT02206607|17667|P3|COMPLETED|Second Intervention Period||9
8144|NCT02206607|17668|P2|COMPLETED|Second Intervention Period||9
8145|NCT02206607|17669|P1|COMPLETED|Second Intervention Period||0
8146|NCT02206607|17665|P5|STARTED|Second Intervention Period||10
8147|NCT02206607|17666|P4|STARTED|Second Intervention Period||11
8148|NCT02206607|17667|P3|STARTED|Second Intervention Period||9
8149|NCT02206607|17668|P2|STARTED|Second Intervention Period||9
8150|NCT02206607|17669|P1|STARTED|Second Intervention Period||0
8151|NCT02206607|17665|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8152|NCT02206607|17666|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8153|NCT02206607|17667|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8154|NCT02206607|17668|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8155|NCT02206607|17669|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8156|NCT02206607|17665|P5|COMPLETED|First Washout Period 5 to 10 Days||10
8157|NCT02206607|17666|P4|COMPLETED|First Washout Period 5 to 10 Days||11
8158|NCT02206607|17667|P3|COMPLETED|First Washout Period 5 to 10 Days||9
8159|NCT02206607|17668|P2|COMPLETED|First Washout Period 5 to 10 Days||9
8160|NCT02206607|17669|P1|COMPLETED|First Washout Period 5 to 10 Days||0
8161|NCT02206607|17665|P5|STARTED|First Washout Period 5 to 10 Days||10
8162|NCT02206607|17666|P4|STARTED|First Washout Period 5 to 10 Days||11
8163|NCT02206607|17667|P3|STARTED|First Washout Period 5 to 10 Days||9
8164|NCT02206607|17668|P2|STARTED|First Washout Period 5 to 10 Days||9
8165|NCT02206607|17669|P1|STARTED|First Washout Period 5 to 10 Days||0
8166|NCT02206607|17665|P5|NOT COMPLETED|First Intervention Period||0
8167|NCT02206607|17666|P4|NOT COMPLETED|First Intervention Period||0
8168|NCT02206607|17667|P3|NOT COMPLETED|First Intervention Period||0
8169|NCT02206607|17668|P2|NOT COMPLETED|First Intervention Period||0
8170|NCT02206607|17669|P1|NOT COMPLETED|First Intervention Period||0
8171|NCT02206607|17665|P5|COMPLETED|First Intervention Period||10
8172|NCT02206607|17666|P4|COMPLETED|First Intervention Period||11
8173|NCT02206607|17667|P3|COMPLETED|First Intervention Period||9
8174|NCT02206607|17668|P2|COMPLETED|First Intervention Period||9
8175|NCT02206607|17669|P1|COMPLETED|First Intervention Period||0
8176|NCT02206607|17665|P5|STARTED|First Intervention Period||10
8177|NCT02206607|17666|P4|STARTED|First Intervention Period||11
8178|NCT02206607|17667|P3|STARTED|First Intervention Period||9
8179|NCT02206607|17668|P2|STARTED|First Intervention Period||9
8180|NCT02206607|17669|P1|STARTED|First Intervention Period||0
8181|NCT02206607|17665|P5|NOT COMPLETED|Open-Label Run-In||0
8182|NCT02206607|17666|P4|NOT COMPLETED|Open-Label Run-In||0
8183|NCT02206607|17667|P3|NOT COMPLETED|Open-Label Run-In||0
8184|NCT02206607|17668|P2|NOT COMPLETED|Open-Label Run-In||0
8185|NCT02206607|17669|P1|NOT COMPLETED|Open-Label Run-In||3
8186|NCT02206607|17665|P5|COMPLETED|Open-Label Run-In||0
8187|NCT02206607|17666|P4|COMPLETED|Open-Label Run-In||0
8188|NCT02206607|17667|P3|COMPLETED|Open-Label Run-In||0
8189|NCT02206607|17668|P2|COMPLETED|Open-Label Run-In||0
8190|NCT02206607|17669|P1|COMPLETED|Open-Label Run-In||39
8191|NCT02206607|17665|P5|STARTED|Open-Label Run-In||0
8192|NCT02206607|17666|P4|STARTED|Open-Label Run-In||0
8193|NCT02206607|17667|P3|STARTED|Open-Label Run-In||0
8194|NCT02206607|17668|P2|STARTED|Open-Label Run-In||0
8195|NCT02206607|17669|P1|STARTED|Open-Label Run-In||42
8196|NCT02205814|17725|P4|NOT COMPLETED|Overall Study||4
8197|NCT02205814|17726|P3|NOT COMPLETED|Overall Study||5
8198|NCT02205814|17727|P2|NOT COMPLETED|Overall Study||1
8199|NCT02205814|17728|P1|NOT COMPLETED|Overall Study||2
8200|NCT02205814|17725|P4|COMPLETED|Overall Study||104
8201|NCT02205814|17726|P3|COMPLETED|Overall Study||103
8202|NCT02205814|17727|P2|COMPLETED|Overall Study||109
8203|NCT02205814|17728|P1|COMPLETED|Overall Study||108
8204|NCT02205814|17725|P4|STARTED|Overall Study||108
8205|NCT02205814|17726|P3|STARTED|Overall Study||108
8206|NCT02205814|17727|P2|STARTED|Overall Study||110
8207|NCT02205814|17728|P1|STARTED|Overall Study||110
8208|NCT02205476|17752|P2|NOT COMPLETED|Overall Study||3
8209|NCT02205476|17753|P1|NOT COMPLETED|Overall Study||7
8210|NCT02205476|17752|P2|COMPLETED|Overall Study||0
8211|NCT02205476|17753|P1|COMPLETED|Overall Study||0
8212|NCT02205476|17752|P2|STARTED|Overall Study||3
8213|NCT02205476|17753|P1|STARTED|Overall Study||7
8214|NCT02204748|17783|P1|NOT COMPLETED|Overall Study||0
8215|NCT02204748|17783|P1|COMPLETED|Overall Study||5
8216|NCT02204748|17783|P1|STARTED|Overall Study||5
8217|NCT02204657|17797|P2|NOT COMPLETED|Overall Study||0
8218|NCT02204657|17798|P1|NOT COMPLETED|Overall Study||7
8219|NCT02204657|17797|P2|COMPLETED|Overall Study||25
8220|NCT02204657|17798|P1|COMPLETED|Overall Study||25
8221|NCT02204657|17797|P2|STARTED|Overall Study||25
8222|NCT02204657|17798|P1|STARTED|Overall Study||32
8223|NCT02204579|17806|P1|NOT COMPLETED|Overall Study||2
8224|NCT02204579|17806|P1|COMPLETED|Overall Study||5
8225|NCT02204579|17806|P1|Treated|Overall Study||5
8226|NCT02204579|17806|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
8227|NCT02204579|17806|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
8228|NCT02204579|17806|P1|STARTED|Overall Study||7
8229|NCT02204449|17860|P2|NOT COMPLETED|Overall Study||11
8230|NCT02204449|17861|P1|NOT COMPLETED|Overall Study||7
8231|NCT02204449|17860|P2|COMPLETED|Overall Study||37
8232|NCT02204449|17861|P1|COMPLETED|Overall Study||39
8233|NCT02204449|17860|P2|STARTED|Overall Study||48
8234|NCT02204449|17861|P1|STARTED|Overall Study||46
8235|NCT02203916|17874|P3|NOT COMPLETED|Overall Study||11
8236|NCT02203916|17875|P2|NOT COMPLETED|Overall Study||10
8237|NCT02203916|17876|P1|NOT COMPLETED|Overall Study||8
8238|NCT02203916|17874|P3|COMPLETED|Overall Study||120
8239|NCT02203916|17875|P2|COMPLETED|Overall Study||122
8240|NCT02203916|17876|P1|COMPLETED|Overall Study||57
8241|NCT02203916|17874|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
8242|NCT02203916|17875|P2|Safety Analysis Set (SAS)|Overall Study||132
8243|NCT02203916|17876|P1|Safety Analysis Set (SAS)|Overall Study||65
8244|NCT02203916|17874|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
8245|NCT02203916|17875|P2|Full Analysis Set (FAS)|Overall Study||132
8246|NCT02203916|17876|P1|Full Analysis Set (FAS)|Overall Study||65
8247|NCT02203916|17874|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
8248|NCT02203916|17875|P2|STARTED|Overall Study||132
8249|NCT02203916|17876|P1|STARTED|Overall Study||65
8250|NCT02203786|17900|P4|NOT COMPLETED|Overall Study||0
8251|NCT02203786|17901|P3|NOT COMPLETED|Overall Study||2
8252|NCT02203786|17902|P2|NOT COMPLETED|Overall Study||0
8253|NCT02203786|17903|P1|NOT COMPLETED|Overall Study||0
8254|NCT02203786|17900|P4|COMPLETED|Overall Study||15
8255|NCT02203786|17901|P3|COMPLETED|Overall Study||15
8256|NCT02203786|17902|P2|COMPLETED|Overall Study||15
8257|NCT02203786|17903|P1|COMPLETED|Overall Study||15
8258|NCT02203786|17900|P4|STARTED|Overall Study||15
8259|NCT02203786|17901|P3|STARTED|Overall Study||17
8260|NCT02203786|17902|P2|STARTED|Overall Study||15
8261|NCT02203786|17903|P1|STARTED|Overall Study||15
8262|NCT02203747|17935|P2|NOT COMPLETED|Overall Study||0
8263|NCT02203747|17936|P1|NOT COMPLETED|Overall Study||0
8264|NCT02203747|17935|P2|COMPLETED|Overall Study||34
8265|NCT02203747|17936|P1|COMPLETED|Overall Study||45
8266|NCT02203747|17935|P2|STARTED|Overall Study||34
8267|NCT02203747|17936|P1|STARTED|Overall Study||45
8268|NCT02203721|17946|P2|NOT COMPLETED|Overall Study||3
8269|NCT02203721|17947|P1|NOT COMPLETED|Overall Study||1
8270|NCT02203721|17946|P2|COMPLETED|Overall Study||148
8271|NCT02203721|17947|P1|COMPLETED|Overall Study||147
8272|NCT02203721|17946|P2|STARTED|Overall Study||151
8273|NCT02203721|17947|P1|STARTED|Overall Study||148
8274|NCT02203162|17955|P1|NOT COMPLETED|Overall Study||0
8275|NCT02203162|17955|P1|COMPLETED|Overall Study||30
8276|NCT02203162|17955|P1|STARTED|Overall Study||30
8277|NCT02203149|17964|P5|NOT COMPLETED|Part 2||1
8278|NCT02203149|17965|P4|NOT COMPLETED|Part 2||3
8279|NCT02203149|17966|P3|NOT COMPLETED|Part 2||1
8280|NCT02203149|17967|P2|NOT COMPLETED|Part 2||0
8281|NCT02203149|17968|P1|NOT COMPLETED|Part 2||0
8282|NCT02203149|17964|P5|COMPLETED|Part 2||34
8283|NCT02203149|17965|P4|COMPLETED|Part 2||71
8284|NCT02203149|17966|P3|COMPLETED|Part 2||226
8285|NCT02203149|17967|P2|COMPLETED|Part 2||0
8286|NCT02203149|17968|P1|COMPLETED|Part 2||0
8287|NCT02203149|17964|P5|Started Deferred Active Treatment|Part 2||0
8288|NCT02203149|17965|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
8289|NCT02203149|17966|P3|Started Deferred Active Treatment|Part 2||0
8290|NCT02203149|17967|P2|Started Deferred Active Treatment|Part 2||0
8291|NCT02203149|17968|P1|Started Deferred Active Treatment|Part 2||0
8292|NCT02203149|17964|P5|STARTED|Part 2||35
8293|NCT02203149|17965|P4|STARTED|Part 2||74
8294|NCT02203149|17966|P3|STARTED|Part 2||227
8295|NCT02203149|17967|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8296|NCT02203149|17968|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8297|NCT02203149|17964|P5|NOT COMPLETED|Part 1||0
8298|NCT02203149|17965|P4|NOT COMPLETED|Part 1||0
8299|NCT02203149|17966|P3|NOT COMPLETED|Part 1||0
8300|NCT02203149|17967|P2|NOT COMPLETED|Part 1||1
8301|NCT02203149|17968|P1|NOT COMPLETED|Part 1||0
8302|NCT02203149|17964|P5|COMPLETED|Part 1||0
8303|NCT02203149|17965|P4|COMPLETED|Part 1||0
8304|NCT02203149|17966|P3|COMPLETED|Part 1||0
8305|NCT02203149|17967|P2|COMPLETED|Part 1||31
8306|NCT02203149|17968|P1|COMPLETED|Part 1||31
8307|NCT02203149|17964|P5|STARTED|Part 1||0
8308|NCT02203149|17965|P4|STARTED|Part 1||0
8309|NCT02203149|17966|P3|STARTED|Part 1||0
8310|NCT02203149|17967|P2|STARTED|Part 1||32
8311|NCT02203149|17968|P1|STARTED|Part 1||31
8312|NCT02202538|18001|P1|NOT COMPLETED|Overall Study||8
8313|NCT02202538|18001|P1|COMPLETED|Overall Study||45
8314|NCT02202538|18001|P1|Screen Failure|Overall Study||2
8315|NCT02202538|18001|P1|STARTED|Overall Study||53
8316|NCT02202252|18014|P2|NOT COMPLETED|Overall Study||0
8317|NCT02202252|18015|P1|NOT COMPLETED|Overall Study||0
8318|NCT02202252|18014|P2|COMPLETED|Overall Study||30
8319|NCT02202252|18015|P1|COMPLETED|Overall Study||30
8320|NCT02202252|18014|P2|STARTED|Overall Study||30
8321|NCT02202252|18015|P1|STARTED|Overall Study||30
8322|NCT02202135|18025|P1|NOT COMPLETED|Overall Study||0
8323|NCT02202135|18025|P1|COMPLETED|Overall Study||4
8324|NCT02202135|18025|P1|STARTED|Overall Study||4
8325|NCT02201953|18031|P2|NOT COMPLETED|Overall Study||56
8326|NCT02201953|18032|P1|NOT COMPLETED|Overall Study||20
8327|NCT02201953|18031|P2|COMPLETED|Overall Study||224
8328|NCT02201953|18032|P1|COMPLETED|Overall Study||258
8329|NCT02201953|18031|P2|STARTED|Overall Study||280
8330|NCT02201953|18032|P1|STARTED|Overall Study||278
8331|NCT02201940|18050|P2|NOT COMPLETED|Overall Study||116
8332|NCT02201940|18051|P1|NOT COMPLETED|Overall Study||12
8333|NCT02201940|18050|P2|COMPLETED|Overall Study||0
8334|NCT02201940|18051|P1|COMPLETED|Overall Study||613
8335|NCT02201940|18050|P2|STARTED|Overall Study||116
8336|NCT02201940|18051|P1|STARTED|Overall Study||625
8337|NCT02201901|18070|P3|NOT COMPLETED|Overall Study||13
8338|NCT02201901|18071|P2|NOT COMPLETED|Overall Study||9
8339|NCT02201901|18072|P1|NOT COMPLETED|Overall Study||15
8340|NCT02201901|18070|P3|COMPLETED|Overall Study||77
8341|NCT02201901|18071|P2|COMPLETED|Overall Study||79
8342|NCT02201901|18072|P1|COMPLETED|Overall Study||75
8343|NCT02201901|18070|P3|STARTED|Overall Study||90
8344|NCT02201901|18071|P2|STARTED|Overall Study||88
8345|NCT02201901|18072|P1|STARTED|Overall Study||90
8346|NCT02201784|18103|P2|NOT COMPLETED|Overall Study||0
8347|NCT02201784|18104|P1|NOT COMPLETED|Overall Study||2
8348|NCT02201784|18103|P2|COMPLETED|Overall Study||30
8349|NCT02201784|18104|P1|COMPLETED|Overall Study||28
8350|NCT02201784|18103|P2|STARTED|Overall Study||30
8351|NCT02201784|18104|P1|STARTED|Overall Study||30
8352|NCT02201524|18122|P4|NOT COMPLETED|Overall Study||4
8353|NCT02201524|18123|P3|NOT COMPLETED|Overall Study||4
8354|NCT02201524|18124|P2|NOT COMPLETED|Overall Study||3
8355|NCT02201524|18125|P1|NOT COMPLETED|Overall Study||2
8356|NCT02201524|18122|P4|COMPLETED|Overall Study||10
8357|NCT02201524|18123|P3|COMPLETED|Overall Study||12
8358|NCT02201524|18124|P2|COMPLETED|Overall Study||12
8359|NCT02201524|18125|P1|COMPLETED|Overall Study||12
8360|NCT02201524|18122|P4|STARTED|Overall Study||14
8361|NCT02201524|18123|P3|STARTED|Overall Study||16
8362|NCT02201524|18124|P2|STARTED|Overall Study||15
8363|NCT02201524|18125|P1|STARTED|Overall Study||14
8364|NCT02201446|18209|P2|NOT COMPLETED|Overall Study||0
8365|NCT02201446|18210|P1|NOT COMPLETED|Overall Study||0
8366|NCT02201446|18209|P2|COMPLETED|Overall Study||58
8367|NCT02201446|18210|P1|COMPLETED|Overall Study||81
8368|NCT02201446|18209|P2|STARTED|Overall Study||58
8369|NCT02201446|18210|P1|STARTED|Overall Study||81
8370|NCT02201420|18238|P1|NOT COMPLETED|Overall Study||0
8371|NCT02201420|18238|P1|COMPLETED|Overall Study||5
8372|NCT02201420|18238|P1|STARTED|Overall Study||5
8373|NCT02201056|18250|P7|NOT COMPLETED|Overall Study||0
8374|NCT02201056|18251|P6|NOT COMPLETED|Overall Study||0
8375|NCT02201056|18252|P5|NOT COMPLETED|Overall Study||0
8376|NCT02201056|18253|P4|NOT COMPLETED|Overall Study||0
8377|NCT02201056|18254|P3|NOT COMPLETED|Overall Study||0
8378|NCT02201056|18255|P2|NOT COMPLETED|Overall Study||0
8379|NCT02201056|18256|P1|NOT COMPLETED|Overall Study||0
8380|NCT02201056|18250|P7|COMPLETED|Overall Study||6
8381|NCT02201056|18251|P6|COMPLETED|Overall Study||6
8382|NCT02201056|18252|P5|COMPLETED|Overall Study||6
8383|NCT02201056|18253|P4|COMPLETED|Overall Study||6
8384|NCT02201056|18254|P3|COMPLETED|Overall Study||6
8385|NCT02201056|18255|P2|COMPLETED|Overall Study||6
8386|NCT02201056|18256|P1|COMPLETED|Overall Study||12
8387|NCT02201056|18250|P7|STARTED|Overall Study||6
8388|NCT02201056|18251|P6|STARTED|Overall Study||6
8389|NCT02201056|18252|P5|STARTED|Overall Study||6
8390|NCT02201056|18253|P4|STARTED|Overall Study||6
8391|NCT02201056|18254|P3|STARTED|Overall Study||6
8392|NCT02201056|18255|P2|STARTED|Overall Study||6
8393|NCT02201056|18256|P1|STARTED|Overall Study||12
8394|NCT02200536|18314|P3|NOT COMPLETED|Overall Study||0
8395|NCT02200536|18315|P2|NOT COMPLETED|Overall Study||0
8396|NCT02200536|18316|P1|NOT COMPLETED|Overall Study||0
8397|NCT02200536|18314|P3|COMPLETED|Overall Study||30
8398|NCT02200536|18315|P2|COMPLETED|Overall Study||30
8399|NCT02200536|18316|P1|COMPLETED|Overall Study||32
8400|NCT02200536|18314|P3|STARTED|Overall Study||30
8401|NCT02200536|18315|P2|STARTED|Overall Study||30
8402|NCT02200536|18316|P1|STARTED|Overall Study||32
8403|NCT02200458|18327|P1|NOT COMPLETED|Overall Study||0
8404|NCT02200458|18327|P1|COMPLETED|Overall Study||62
8405|NCT02200458|18327|P1|STARTED|Overall Study||62
8406|NCT02200328|18333|P2|NOT COMPLETED|Overall Study||33
8407|NCT02200328|18334|P1|NOT COMPLETED|Overall Study||43
8408|NCT02200328|18333|P2|COMPLETED|Overall Study||0
8409|NCT02200328|18334|P1|COMPLETED|Overall Study||0
8410|NCT02200328|18333|P2|STARTED|Overall Study||33
8411|NCT02200328|18334|P1|STARTED|Overall Study||43
8412|NCT02199717|18342|P1|NOT COMPLETED|Overall Study||0
8413|NCT02199717|18342|P1|COMPLETED|Overall Study||66
8414|NCT02199717|18342|P1|STARTED|Overall Study||66
8415|NCT02199574|18349|P1|NOT COMPLETED|Overall Study||0
8416|NCT02199574|18349|P1|COMPLETED|Overall Study||12
8417|NCT02199574|18349|P1|STARTED|Overall Study||12
8418|NCT02198963|18358|P1|NOT COMPLETED|Overall Study||7
8419|NCT02198963|18358|P1|COMPLETED|Overall Study||36
8420|NCT02198963|18358|P1|STARTED|Overall Study||43
8421|NCT02198430|18369|P2|NOT COMPLETED|Overall Study||0
8422|NCT02198430|18370|P1|NOT COMPLETED|Overall Study||0
8423|NCT02198430|18369|P2|COMPLETED|Overall Study||51
8424|NCT02198430|18370|P1|COMPLETED|Overall Study||53
8425|NCT02198430|18369|P2|STARTED|Overall Study||51
8426|NCT02198430|18370|P1|STARTED|Overall Study||53
8427|NCT02198235|18385|P3|NOT COMPLETED|Overall Study||2
8428|NCT02198235|18386|P2|NOT COMPLETED|Overall Study||2
8429|NCT02198235|18387|P1|NOT COMPLETED|Overall Study||3
8430|NCT02198235|18385|P3|COMPLETED|Overall Study||28
8431|NCT02198235|18386|P2|COMPLETED|Overall Study||28
8432|NCT02198235|18387|P1|COMPLETED|Overall Study||27
8433|NCT02198235|18385|P3|STARTED|Overall Study||30
8434|NCT02198235|18386|P2|STARTED|Overall Study||30
8435|NCT02198235|18387|P1|STARTED|Overall Study||30
8436|NCT02197806|18408|P4|NOT COMPLETED|Overall Study||1
8437|NCT02197806|18409|P3|NOT COMPLETED|Overall Study||0
8438|NCT02197806|18410|P2|NOT COMPLETED|Overall Study||1
8439|NCT02197806|18411|P1|NOT COMPLETED|Overall Study||0
8440|NCT02197806|18408|P4|COMPLETED|Overall Study||16
8441|NCT02197806|18409|P3|COMPLETED|Overall Study||16
8442|NCT02197806|18410|P2|COMPLETED|Overall Study||16
8443|NCT02197806|18411|P1|COMPLETED|Overall Study||15
8444|NCT02197806|18408|P4|STARTED|Overall Study||17
8445|NCT02197806|18409|P3|STARTED|Overall Study||16
8446|NCT02197806|18410|P2|STARTED|Overall Study||17
8447|NCT02197806|18411|P1|STARTED|Overall Study||15
8448|NCT02197273|18423|P2|NOT COMPLETED|Overall Study||0
8449|NCT02197273|18424|P1|NOT COMPLETED|Overall Study||0
8450|NCT02197273|18423|P2|COMPLETED|Overall Study||104
8451|NCT02197273|18424|P1|COMPLETED|Overall Study||107
8452|NCT02197273|18423|P2|STARTED|Overall Study||104
8453|NCT02197273|18424|P1|STARTED|Overall Study||107
8454|NCT02197247|18434|P1|NOT COMPLETED|Period 3||5
8455|NCT02197247|18434|P1|COMPLETED|Period 3||32
8456|NCT02197247|18434|P1|STARTED|Period 3||37
8457|NCT02197247|18434|P1|NOT COMPLETED|Period 2||4
8458|NCT02197247|18434|P1|COMPLETED|Period 2||37
8459|NCT02197247|18434|P1|STARTED|Period 2||41
8460|NCT02197247|18434|P1|NOT COMPLETED|Period 1||0
8461|NCT02197247|18434|P1|COMPLETED|Period 1||41
8462|NCT02197247|18434|P1|STARTED|Period 1||41
8463|NCT02197234|18477|P1|NOT COMPLETED|Overall Study||3
8464|NCT02197234|18477|P1|COMPLETED|Overall Study||49
8465|NCT02197234|18477|P1|STARTED|Overall Study||52
8466|NCT02196766|18497|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8467|NCT02196766|18498|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8468|NCT02196766|18497|P2|COMPLETED|Second Intervention (7 Days)||15
8469|NCT02196766|18498|P1|COMPLETED|Second Intervention (7 Days)||15
8470|NCT02196766|18497|P2|STARTED|Second Intervention (7 Days)||15
8471|NCT02196766|18498|P1|STARTED|Second Intervention (7 Days)||15
8472|NCT02196766|18497|P2|NOT COMPLETED|First Intervention (7 Days)||0
8473|NCT02196766|18498|P1|NOT COMPLETED|First Intervention (7 Days)||0
8474|NCT02196766|18497|P2|COMPLETED|First Intervention (7 Days)||15
8475|NCT02196766|18498|P1|COMPLETED|First Intervention (7 Days)||15
8476|NCT02196766|18497|P2|STARTED|First Intervention (7 Days)||15
8477|NCT02196766|18498|P1|STARTED|First Intervention (7 Days)||15
8478|NCT02196675|18517|P3|NOT COMPLETED|Overall Study||1
8479|NCT02196675|18518|P2|NOT COMPLETED|Overall Study||2
8480|NCT02196675|18519|P1|NOT COMPLETED|Overall Study||2
8481|NCT02196675|18517|P3|COMPLETED|Overall Study||7
8482|NCT02196675|18518|P2|COMPLETED|Overall Study||68
8483|NCT02196675|18519|P1|COMPLETED|Overall Study||25
8484|NCT02196675|18517|P3|STARTED|Overall Study||8
8485|NCT02196675|18518|P2|STARTED|Overall Study||70
8486|NCT02196675|18519|P1|STARTED|Overall Study||27
8487|NCT02195713|18541|P2|NOT COMPLETED|Overall Study||0
8488|NCT02195713|18542|P1|NOT COMPLETED|Overall Study||0
8489|NCT02195713|18541|P2|COMPLETED|Overall Study||10
8490|NCT02195713|18542|P1|COMPLETED|Overall Study||10
8491|NCT02195713|18541|P2|STARTED|Overall Study||10
8492|NCT02195713|18542|P1|STARTED|Overall Study||10
8493|NCT02195687|18550|P2|NOT COMPLETED|Overall Study||2
8494|NCT02195687|18551|P1|NOT COMPLETED|Overall Study||5
8495|NCT02195687|18550|P2|COMPLETED|Overall Study||99
8496|NCT02195687|18551|P1|COMPLETED|Overall Study||311
8497|NCT02195687|18550|P2|STARTED|Overall Study||101
8498|NCT02195687|18551|P1|STARTED|Overall Study||316
8499|NCT02195583|18567|P1|NOT COMPLETED|Overall Study||9
8500|NCT02195583|18567|P1|COMPLETED|Overall Study||53
8501|NCT02195583|18567|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
8502|NCT02195583|18567|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
8503|NCT02195583|18567|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
8504|NCT02195583|18567|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
8505|NCT02195583|18567|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
8506|NCT02195583|18567|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
8507|NCT02195583|18567|P1|STARTED|Overall Study||62
8508|NCT02195414|18599|P1|NOT COMPLETED|Overall Study||0
8509|NCT02195414|18599|P1|COMPLETED|Overall Study||31
8510|NCT02195414|18599|P1|Primary Endpoint|Overall Study||31
8511|NCT02195414|18599|P1|STARTED|Overall Study||31
8512|NCT02194621|18609|P3|NOT COMPLETED|Overall Study||9
8513|NCT02194621|18610|P2|NOT COMPLETED|Overall Study||6
8514|NCT02194621|18611|P1|NOT COMPLETED|Overall Study||6
8515|NCT02194621|18609|P3|COMPLETED|Overall Study||34
8516|NCT02194621|18610|P2|COMPLETED|Overall Study||36
8517|NCT02194621|18611|P1|COMPLETED|Overall Study||37
8518|NCT02194621|18609|P3|STARTED|Overall Study||43
8519|NCT02194621|18610|P2|STARTED|Overall Study||42
8520|NCT02194621|18611|P1|STARTED|Overall Study||43
8521|NCT02193828|18632|P4|NOT COMPLETED|Overall Study||1
8522|NCT02193828|18633|P3|NOT COMPLETED|Overall Study||1
8523|NCT02193828|18634|P2|NOT COMPLETED|Overall Study||0
8524|NCT02193828|18635|P1|NOT COMPLETED|Overall Study||0
8525|NCT02193828|18632|P4|COMPLETED|Overall Study||16
8526|NCT02193828|18633|P3|COMPLETED|Overall Study||22
8527|NCT02193828|18634|P2|COMPLETED|Overall Study||18
8528|NCT02193828|18635|P1|COMPLETED|Overall Study||18
8529|NCT02193828|18632|P4|STARTED|Overall Study||17
8530|NCT02193828|18633|P3|STARTED|Overall Study||23
8531|NCT02193828|18634|P2|STARTED|Overall Study||18
8532|NCT02193828|18635|P1|STARTED|Overall Study||18
8533|NCT02193815|18673|P1|NOT COMPLETED|Overall Study||0
8534|NCT02193815|18673|P1|COMPLETED|Overall Study||15
8535|NCT02193815|18673|P1|STARTED|Overall Study||15
8536|NCT02193178|18708|P1|NOT COMPLETED|Overall Study||2
8537|NCT02193178|18708|P1|COMPLETED|Overall Study||13
8538|NCT02193178|18708|P1|STARTED|Overall Study||15
8539|NCT02193165|18758|P3|NOT COMPLETED|6 Week Product Use||0
8540|NCT02193165|18759|P2|NOT COMPLETED|6 Week Product Use||1
8541|NCT02193165|18760|P1|NOT COMPLETED|6 Week Product Use||0
8542|NCT02193165|18758|P3|COMPLETED|6 Week Product Use||39
8543|NCT02193165|18759|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
8544|NCT02193165|18760|P1|COMPLETED|6 Week Product Use||39
8545|NCT02193165|18758|P3|STARTED|6 Week Product Use||39
8546|NCT02193165|18759|P2|STARTED|6 Week Product Use||39
8547|NCT02193165|18760|P1|STARTED|6 Week Product Use||39
8548|NCT02193165|18758|P3|NOT COMPLETED|4 Week Product Use||1
8549|NCT02193165|18759|P2|NOT COMPLETED|4 Week Product Use||1
8550|NCT02193165|18760|P1|NOT COMPLETED|4 Week Product Use||1
8551|NCT02193165|18758|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8552|NCT02193165|18759|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8553|NCT02193165|18760|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8554|NCT02193165|18758|P3|STARTED|4 Week Product Use||40
8555|NCT02193165|18759|P2|STARTED|4 Week Product Use||40
8556|NCT02193165|18760|P1|STARTED|4 Week Product Use||40
8557|NCT02193087|18787|P4|NOT COMPLETED|Overall Study||79
8558|NCT02193087|18788|P3|NOT COMPLETED|Overall Study||7
8559|NCT02193087|18789|P2|NOT COMPLETED|Overall Study||14
8560|NCT02193087|18790|P1|NOT COMPLETED|Overall Study||37
8561|NCT02193087|18787|P4|COMPLETED|Overall Study||524
8562|NCT02193087|18788|P3|COMPLETED|Overall Study||93
8563|NCT02193087|18789|P2|COMPLETED|Overall Study||86
8564|NCT02193087|18790|P1|COMPLETED|Overall Study||162
8565|NCT02193087|18787|P4|Received Vaccination|Overall Study||602
8566|NCT02193087|18788|P3|Received Vaccination|Overall Study||100
8567|NCT02193087|18789|P2|Received Vaccination|Overall Study||97
8568|NCT02193087|18790|P1|Received Vaccination|Overall Study||197
8569|NCT02193087|18787|P4|STARTED|Overall Study||603
8570|NCT02193087|18788|P3|STARTED|Overall Study||100
8571|NCT02193087|18789|P2|STARTED|Overall Study||100
8572|NCT02193087|18790|P1|STARTED|Overall Study||199
8573|NCT02192879|18836|P3|NOT COMPLETED|Overall Study||0
8574|NCT02192879|18837|P2|NOT COMPLETED|Overall Study||0
8575|NCT02192879|18838|P1|NOT COMPLETED|Overall Study||0
8576|NCT02192879|18836|P3|COMPLETED|Overall Study||3
8577|NCT02192879|18837|P2|COMPLETED|Overall Study||4
8578|NCT02192879|18838|P1|COMPLETED|Overall Study||3
8579|NCT02192879|18836|P3|STARTED|Overall Study||3
8580|NCT02192879|18837|P2|STARTED|Overall Study||4
8581|NCT02192879|18838|P1|STARTED|Overall Study||3
8582|NCT02192814|18864|P1|NOT COMPLETED|Overall Study||0
8583|NCT02192814|18864|P1|COMPLETED|Overall Study||9
8584|NCT02192814|18864|P1|STARTED|Overall Study||9
8585|NCT02191865|18878|P3|NOT COMPLETED|Overall Study||0
8586|NCT02191865|18879|P2|NOT COMPLETED|Overall Study||0
8587|NCT02191865|18880|P1|NOT COMPLETED|Overall Study||0
8588|NCT02191865|18878|P3|COMPLETED|Overall Study||17
8589|NCT02191865|18879|P2|COMPLETED|Overall Study||8
8590|NCT02191865|18880|P1|COMPLETED|Overall Study||8
8591|NCT02191865|18878|P3|STARTED|Overall Study||17
8592|NCT02191865|18879|P2|STARTED|Overall Study||8
8593|NCT02191865|18880|P1|STARTED|Overall Study||8
8594|NCT02191046|18902|P2|NOT COMPLETED|Overall Study||1
8595|NCT02191046|18903|P1|NOT COMPLETED|Overall Study||5
8596|NCT02191046|18902|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
8597|NCT02191046|18903|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
8598|NCT02191046|18902|P2|STARTED|Overall Study||39
8599|NCT02191046|18903|P1|STARTED|Overall Study||41
8600|NCT02190591|18911|P2|NOT COMPLETED|Overall Study||0
8601|NCT02190591|18912|P1|NOT COMPLETED|Overall Study||0
8602|NCT02190591|18911|P2|COMPLETED|Overall Study||91
8603|NCT02190591|18912|P1|COMPLETED|Overall Study||100
8604|NCT02190591|18911|P2|STARTED|Overall Study||91
8605|NCT02190591|18912|P1|STARTED|Overall Study||100
8606|NCT02189954|18924|P2|NOT COMPLETED|Overall Study||0
8607|NCT02189954|18925|P1|NOT COMPLETED|Overall Study||0
8608|NCT02189954|18924|P2|COMPLETED|Overall Study||45
8609|NCT02189954|18925|P1|COMPLETED|Overall Study||45
8610|NCT02189954|18924|P2|STARTED|Overall Study||45
8611|NCT02189954|18925|P1|STARTED|Overall Study||45
8612|NCT02189941|18933|P3|NOT COMPLETED|Overall Study||1
8613|NCT02189941|18934|P2|NOT COMPLETED|Overall Study||0
8614|NCT02189941|18935|P1|NOT COMPLETED|Overall Study||0
8615|NCT02189941|18933|P3|COMPLETED|Overall Study||2
8616|NCT02189941|18934|P2|COMPLETED|Overall Study||4
8617|NCT02189941|18935|P1|COMPLETED|Overall Study||4
8618|NCT02189941|18933|P3|STARTED|Overall Study||3
8619|NCT02189941|18934|P2|STARTED|Overall Study||4
8620|NCT02189941|18935|P1|STARTED|Overall Study||4
8621|NCT02189915|18958|P1|NOT COMPLETED|Overall Study||3
8622|NCT02189915|18958|P1|COMPLETED|Overall Study||11
8623|NCT02189915|18958|P1|STARTED|Overall Study||14
8624|NCT02189863|18963|P2|NOT COMPLETED|Second 2 Weeks||0
8625|NCT02189863|18964|P1|NOT COMPLETED|Second 2 Weeks||0
8626|NCT02189863|18963|P2|COMPLETED|Second 2 Weeks||13
8627|NCT02189863|18964|P1|COMPLETED|Second 2 Weeks||8
8628|NCT02189863|18963|P2|STARTED|Second 2 Weeks||13
8629|NCT02189863|18964|P1|STARTED|Second 2 Weeks||8
8630|NCT02189863|18963|P2|NOT COMPLETED|First 2 Weeks||2
8631|NCT02189863|18964|P1|NOT COMPLETED|First 2 Weeks||4
8632|NCT02189863|18963|P2|COMPLETED|First 2 Weeks||13
8633|NCT02189863|18964|P1|COMPLETED|First 2 Weeks||8
8634|NCT02189863|18963|P2|STARTED|First 2 Weeks||15
8635|NCT02189863|18964|P1|STARTED|First 2 Weeks||12
8636|NCT02189837|18979|P4|NOT COMPLETED|Overall Study||2
8637|NCT02189837|18980|P3|NOT COMPLETED|Overall Study||3
8638|NCT02189837|18981|P2|NOT COMPLETED|Overall Study||1
8639|NCT02189837|18982|P1|NOT COMPLETED|Overall Study||2
8640|NCT02189837|18979|P4|COMPLETED|Overall Study||19
8641|NCT02189837|18980|P3|COMPLETED|Overall Study||20
8642|NCT02189837|18981|P2|COMPLETED|Overall Study||22
8643|NCT02189837|18982|P1|COMPLETED|Overall Study||20
8644|NCT02189837|18979|P4|Received Treatment|Overall Study||20
8645|NCT02189837|18980|P3|Received Treatment|Overall Study||22
8646|NCT02189837|18981|P2|Received Treatment|Overall Study||22
8647|NCT02189837|18982|P1|Received Treatment|Overall Study||21
8648|NCT02189837|18979|P4|STARTED|Overall Study||21
8649|NCT02189837|18980|P3|STARTED|Overall Study||23
8650|NCT02189837|18981|P2|STARTED|Overall Study||23
8651|NCT02189837|18982|P1|STARTED|Overall Study||22
8652|NCT02189317|19002|P2|NOT COMPLETED|Overall Study||0
8653|NCT02189317|19003|P1|NOT COMPLETED|Overall Study||0
8654|NCT02189317|19002|P2|COMPLETED|Overall Study||16
8655|NCT02189317|19003|P1|COMPLETED|Overall Study||16
8656|NCT02189317|19002|P2|STARTED|Overall Study||16
8657|NCT02189317|19003|P1|STARTED|Overall Study||16
8658|NCT02189252|19017|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8659|NCT02189252|19018|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8660|NCT02189252|19019|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8661|NCT02189252|19020|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8662|NCT02189252|19017|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
8663|NCT02189252|19018|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
8664|NCT02189252|19019|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
8665|NCT02189252|19020|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
8666|NCT02189252|19017|P4|STARTED|Period 2 (Visit6b, Week 12)||4
8667|NCT02189252|19018|P3|STARTED|Period 2 (Visit6b, Week 12)||3
8668|NCT02189252|19019|P2|STARTED|Period 2 (Visit6b, Week 12)||2
8669|NCT02189252|19020|P1|STARTED|Period 2 (Visit6b, Week 12)||4
8670|NCT02189252|19017|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8671|NCT02189252|19018|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8672|NCT02189252|19019|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
8673|NCT02189252|19020|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8674|NCT02189252|19017|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8675|NCT02189252|19018|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
8676|NCT02189252|19019|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
8677|NCT02189252|19020|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8678|NCT02189252|19017|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
8679|NCT02189252|19018|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
8680|NCT02189252|19019|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
8681|NCT02189252|19020|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
8682|NCT02189161|19052|P1|NOT COMPLETED|Overall Study||0
8683|NCT02189161|19052|P1|COMPLETED|Overall Study||10
8684|NCT02189161|19052|P1|STARTED|Overall Study||10
8685|NCT02189122|19060|P2|NOT COMPLETED|Overall Study||0
8686|NCT02189122|19061|P1|NOT COMPLETED|Overall Study||0
8687|NCT02189122|19060|P2|COMPLETED|Overall Study||18
8688|NCT02189122|19061|P1|COMPLETED|Overall Study||18
8689|NCT02189122|19060|P2|STARTED|Overall Study||18
8690|NCT02189122|19061|P1|STARTED|Overall Study||18
8691|NCT02188849|19079|P2|NOT COMPLETED|Overall Study||8
8692|NCT02188849|19080|P1|NOT COMPLETED|Overall Study||3
8693|NCT02188849|19079|P2|COMPLETED|Overall Study||17
8694|NCT02188849|19080|P1|COMPLETED|Overall Study||22
8695|NCT02188849|19079|P2|STARTED|Overall Study||25
8696|NCT02188849|19080|P1|STARTED|Overall Study||25
8697|NCT02188589|19092|P1|NOT COMPLETED|Overall Study||0
8698|NCT02188589|19092|P1|COMPLETED|Overall Study||30
8699|NCT02188589|19092|P1|STARTED|Overall Study||30
8700|NCT02187809|19097|P1|NOT COMPLETED|Overall Study||3
8701|NCT02187809|19097|P1|COMPLETED|Overall Study||0
8702|NCT02187809|19097|P1|Treated|Overall Study||1
8703|NCT02187809|19097|P1|STARTED|Overall Study||3
8704|NCT02187029|19111|P4|NOT COMPLETED|Overall Study||3
8705|NCT02187029|19112|P3|NOT COMPLETED|Overall Study||11
8706|NCT02187029|19113|P2|NOT COMPLETED|Overall Study||1
8707|NCT02187029|19114|P1|NOT COMPLETED|Overall Study||1
8708|NCT02187029|19111|P4|COMPLETED|Overall Study||6
8709|NCT02187029|19112|P3|COMPLETED|Overall Study||0
8710|NCT02187029|19113|P2|COMPLETED|Overall Study||2
8711|NCT02187029|19114|P1|COMPLETED|Overall Study||6
8712|NCT02187029|19111|P4|STARTED|Overall Study||9
8713|NCT02187029|19112|P3|STARTED|Overall Study||11
8714|NCT02187029|19113|P2|STARTED|Overall Study||3
8715|NCT02187029|19114|P1|STARTED|Overall Study||7
8716|NCT02187016|19190|P4|NOT COMPLETED|Overall Study||0
8717|NCT02187016|19191|P3|NOT COMPLETED|Overall Study||1
8718|NCT02187016|19192|P2|NOT COMPLETED|Overall Study||2
8719|NCT02187016|19193|P1|NOT COMPLETED|Overall Study||1
8720|NCT02187016|19190|P4|COMPLETED|Overall Study||51
8721|NCT02187016|19191|P3|COMPLETED|Overall Study||78
8722|NCT02187016|19192|P2|COMPLETED|Overall Study||78
8723|NCT02187016|19193|P1|COMPLETED|Overall Study||79
8724|NCT02187016|19190|P4|STARTED|Overall Study||51
8725|NCT02187016|19191|P3|STARTED|Overall Study||79
8726|NCT02187016|19192|P2|STARTED|Overall Study||80
8727|NCT02187016|19193|P1|STARTED|Overall Study||80
8728|NCT02186808|19223|P1|NOT COMPLETED|Overall Study||13
8729|NCT02186808|19223|P1|COMPLETED|Overall Study||67
8730|NCT02186808|19223|P1|STARTED|Overall Study||80
8731|NCT02186587|19230|P2|NOT COMPLETED|Overall Study||0
8732|NCT02186587|19231|P1|NOT COMPLETED|Overall Study||5
8733|NCT02186587|19230|P2|COMPLETED|Overall Study||0
8734|NCT02186587|19231|P1|COMPLETED|Overall Study||23
8735|NCT02186587|19230|P2|STARTED|Overall Study||0
8736|NCT02186587|19231|P1|STARTED|Overall Study||28
8737|NCT02185729|19236|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
8738|NCT02185729|19236|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
8739|NCT02185729|19236|P1|STARTED|24 Hours Into Dextrose Infusion||12
8740|NCT02185729|19236|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8741|NCT02185729|19236|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
8742|NCT02185729|19236|P1|STARTED|4 Hours Into Dextrose Infusion||12
8743|NCT02185729|19236|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8744|NCT02185729|19236|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8745|NCT02185729|19236|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8746|NCT02185729|19236|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
8747|NCT02185729|19236|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
8748|NCT02185729|19236|P1|STARTED|24 Hours Into ClinOleic Infusion||12
8749|NCT02185729|19236|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
8750|NCT02185729|19236|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
8751|NCT02185729|19236|P1|STARTED|4 Hours Into ClinOleic Infusion||12
8752|NCT02185729|19236|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
8753|NCT02185729|19236|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
8754|NCT02185729|19236|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
8755|NCT02185729|19236|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
8756|NCT02185729|19236|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
8757|NCT02185729|19236|P1|STARTED|24 Hours Into Intralipid Infusion||12
8758|NCT02185729|19236|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8759|NCT02185729|19236|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
8760|NCT02185729|19236|P1|STARTED|4 Hours Into Intralipid Infusion||12
8761|NCT02185729|19236|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8762|NCT02185729|19236|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8763|NCT02185729|19236|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8764|NCT02185729|19236|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
8765|NCT02185729|19236|P1|COMPLETED|24 Hours Into Saline Infusion||12
8766|NCT02185729|19236|P1|STARTED|24 Hours Into Saline Infusion||12
8767|NCT02185729|19236|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
8768|NCT02185729|19236|P1|COMPLETED|4 Hours Into Saline Infusion||12
8769|NCT02185729|19236|P1|STARTED|4 Hours Into Saline Infusion||12
8770|NCT02185729|19236|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8771|NCT02185729|19236|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8772|NCT02185729|19236|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
8773|NCT02185534|19257|P6|NOT COMPLETED|Third Period||0
8774|NCT02185534|19258|P5|NOT COMPLETED|Third Period||0
8775|NCT02185534|19259|P4|NOT COMPLETED|Third Period||0
8776|NCT02185534|19260|P3|NOT COMPLETED|Third Period||0
8777|NCT02185534|19261|P2|NOT COMPLETED|Third Period||0
8778|NCT02185534|19262|P1|NOT COMPLETED|Third Period||0
8779|NCT02185534|19257|P6|COMPLETED|Third Period||13
8780|NCT02185534|19258|P5|COMPLETED|Third Period||13
8781|NCT02185534|19259|P4|COMPLETED|Third Period||13
8782|NCT02185534|19260|P3|COMPLETED|Third Period||14
8783|NCT02185534|19261|P2|COMPLETED|Third Period||14
8784|NCT02185534|19262|P1|COMPLETED|Third Period||13
8785|NCT02185534|19257|P6|STARTED|Third Period||13
8786|NCT02185534|19258|P5|STARTED|Third Period||13
8787|NCT02185534|19259|P4|STARTED|Third Period||13
8788|NCT02185534|19260|P3|STARTED|Third Period||14
8789|NCT02185534|19261|P2|STARTED|Third Period||14
8790|NCT02185534|19262|P1|STARTED|Third Period||13
8791|NCT02185534|19257|P6|NOT COMPLETED|Second Washout Period||0
8792|NCT02185534|19258|P5|NOT COMPLETED|Second Washout Period||0
8793|NCT02185534|19259|P4|NOT COMPLETED|Second Washout Period||0
8794|NCT02185534|19260|P3|NOT COMPLETED|Second Washout Period||0
8795|NCT02185534|19261|P2|NOT COMPLETED|Second Washout Period||0
8796|NCT02185534|19262|P1|NOT COMPLETED|Second Washout Period||0
8797|NCT02185534|19257|P6|COMPLETED|Second Washout Period||13
8798|NCT02185534|19258|P5|COMPLETED|Second Washout Period||13
8799|NCT02185534|19259|P4|COMPLETED|Second Washout Period||13
8800|NCT02185534|19260|P3|COMPLETED|Second Washout Period||14
8801|NCT02185534|19261|P2|COMPLETED|Second Washout Period||14
8802|NCT02185534|19262|P1|COMPLETED|Second Washout Period||13
8803|NCT02185534|19257|P6|STARTED|Second Washout Period||13
8804|NCT02185534|19258|P5|STARTED|Second Washout Period||13
8805|NCT02185534|19259|P4|STARTED|Second Washout Period||13
8806|NCT02185534|19260|P3|STARTED|Second Washout Period||14
8807|NCT02185534|19261|P2|STARTED|Second Washout Period||14
8808|NCT02185534|19262|P1|STARTED|Second Washout Period||13
8809|NCT02185534|19257|P6|NOT COMPLETED|Second Period||0
8810|NCT02185534|19258|P5|NOT COMPLETED|Second Period||0
8811|NCT02185534|19259|P4|NOT COMPLETED|Second Period||0
8812|NCT02185534|19260|P3|NOT COMPLETED|Second Period||0
8813|NCT02185534|19261|P2|NOT COMPLETED|Second Period||0
8814|NCT02185534|19262|P1|NOT COMPLETED|Second Period||0
8815|NCT02185534|19257|P6|COMPLETED|Second Period||13
8816|NCT02185534|19258|P5|COMPLETED|Second Period||13
8817|NCT02185534|19259|P4|COMPLETED|Second Period||13
8818|NCT02185534|19260|P3|COMPLETED|Second Period||14
8819|NCT02185534|19261|P2|COMPLETED|Second Period||14
8820|NCT02185534|19262|P1|COMPLETED|Second Period||13
8821|NCT02185534|19257|P6|STARTED|Second Period||13
8822|NCT02185534|19258|P5|STARTED|Second Period||13
8823|NCT02185534|19259|P4|STARTED|Second Period||13
8824|NCT02185534|19260|P3|STARTED|Second Period||14
8825|NCT02185534|19261|P2|STARTED|Second Period||14
8826|NCT02185534|19262|P1|STARTED|Second Period||13
8827|NCT02185534|19257|P6|NOT COMPLETED|First Washout Period||1
8828|NCT02185534|19258|P5|NOT COMPLETED|First Washout Period||1
8829|NCT02185534|19259|P4|NOT COMPLETED|First Washout Period||0
8830|NCT02185534|19260|P3|NOT COMPLETED|First Washout Period||0
8831|NCT02185534|19261|P2|NOT COMPLETED|First Washout Period||0
8832|NCT02185534|19262|P1|NOT COMPLETED|First Washout Period||1
8833|NCT02185534|19257|P6|COMPLETED|First Washout Period||13
8834|NCT02185534|19258|P5|COMPLETED|First Washout Period||13
8835|NCT02185534|19259|P4|COMPLETED|First Washout Period||13
8836|NCT02185534|19260|P3|COMPLETED|First Washout Period||14
8837|NCT02185534|19261|P2|COMPLETED|First Washout Period||14
8838|NCT02185534|19262|P1|COMPLETED|First Washout Period||13
8839|NCT02185534|19257|P6|STARTED|First Washout Period||14
8840|NCT02185534|19258|P5|STARTED|First Washout Period||14
8841|NCT02185534|19259|P4|STARTED|First Washout Period||13
8842|NCT02185534|19260|P3|STARTED|First Washout Period||14
8843|NCT02185534|19261|P2|STARTED|First Washout Period||14
8844|NCT02185534|19262|P1|STARTED|First Washout Period||14
8845|NCT02185534|19257|P6|NOT COMPLETED|First Period||0
8846|NCT02185534|19258|P5|NOT COMPLETED|First Period||0
8847|NCT02185534|19259|P4|NOT COMPLETED|First Period||1
8848|NCT02185534|19260|P3|NOT COMPLETED|First Period||0
8849|NCT02185534|19261|P2|NOT COMPLETED|First Period||0
8850|NCT02185534|19262|P1|NOT COMPLETED|First Period||0
8851|NCT02185534|19257|P6|COMPLETED|First Period||14
8852|NCT02185534|19258|P5|COMPLETED|First Period||14
8853|NCT02185534|19259|P4|COMPLETED|First Period||13
8854|NCT02185534|19260|P3|COMPLETED|First Period||14
8855|NCT02185534|19261|P2|COMPLETED|First Period||14
8856|NCT02185534|19262|P1|COMPLETED|First Period||14
8857|NCT02185534|19257|P6|STARTED|First Period||14
8858|NCT02185534|19258|P5|STARTED|First Period||14
8859|NCT02185534|19259|P4|STARTED|First Period||14
8860|NCT02185534|19260|P3|STARTED|First Period||14
8861|NCT02185534|19261|P2|STARTED|First Period||14
8862|NCT02185534|19262|P1|STARTED|First Period||14
8863|NCT02185339|19279|P2|NOT COMPLETED|Overall Study||1
8864|NCT02185339|19280|P1|NOT COMPLETED|Overall Study||0
8865|NCT02185339|19279|P2|COMPLETED|Overall Study||30
8866|NCT02185339|19280|P1|COMPLETED|Overall Study||30
8867|NCT02185339|19279|P2|STARTED|Overall Study||31
8868|NCT02185339|19280|P1|STARTED|Overall Study||30
8869|NCT02185183|19302|P1|NOT COMPLETED|Overall Study||0
8870|NCT02185183|19302|P1|COMPLETED|Overall Study||14
8871|NCT02185183|19302|P1|STARTED|Overall Study||14
8872|NCT02185105|19306|P1|NOT COMPLETED|Overall Study||0
8873|NCT02185105|19306|P1|COMPLETED|Overall Study||30
8874|NCT02185105|19306|P1|STARTED|Overall Study||30
8875|NCT02184494|19348|P3|NOT COMPLETED|Overall Study||0
8876|NCT02184494|19349|P2|NOT COMPLETED|Overall Study||2
8877|NCT02184494|19350|P1|NOT COMPLETED|Overall Study||1
8878|NCT02184494|19348|P3|COMPLETED|Overall Study||8
8879|NCT02184494|19349|P2|COMPLETED|Overall Study||11
8880|NCT02184494|19350|P1|COMPLETED|Overall Study||12
8881|NCT02184494|19348|P3|STARTED|Overall Study||8
8882|NCT02184494|19349|P2|STARTED|Overall Study||13
8883|NCT02184494|19350|P1|STARTED|Overall Study||13
8884|NCT02183675|19376|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8885|NCT02183675|19377|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8886|NCT02183675|19378|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8887|NCT02183675|19379|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8888|NCT02183675|19380|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8889|NCT02183675|19381|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8890|NCT02183675|19376|P6|COMPLETED|Treatment Period 3 (10 Days)||4
8891|NCT02183675|19377|P5|COMPLETED|Treatment Period 3 (10 Days)||6
8892|NCT02183675|19378|P4|COMPLETED|Treatment Period 3 (10 Days)||6
8893|NCT02183675|19379|P3|COMPLETED|Treatment Period 3 (10 Days)||6
8894|NCT02183675|19380|P2|COMPLETED|Treatment Period 3 (10 Days)||6
8895|NCT02183675|19381|P1|COMPLETED|Treatment Period 3 (10 Days)||6
8896|NCT02183675|19376|P6|STARTED|Treatment Period 3 (10 Days)||4
8897|NCT02183675|19377|P5|STARTED|Treatment Period 3 (10 Days)||6
8898|NCT02183675|19378|P4|STARTED|Treatment Period 3 (10 Days)||6
8899|NCT02183675|19379|P3|STARTED|Treatment Period 3 (10 Days)||6
8900|NCT02183675|19380|P2|STARTED|Treatment Period 3 (10 Days)||6
8901|NCT02183675|19381|P1|STARTED|Treatment Period 3 (10 Days)||6
8902|NCT02183675|19376|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
8903|NCT02183675|19377|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8904|NCT02183675|19378|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8905|NCT02183675|19379|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8906|NCT02183675|19380|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8907|NCT02183675|19381|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8908|NCT02183675|19376|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
8909|NCT02183675|19377|P5|COMPLETED|Treatment Period 2 (10 Days)||6
8910|NCT02183675|19378|P4|COMPLETED|Treatment Period 2 (10 Days)||6
8911|NCT02183675|19379|P3|COMPLETED|Treatment Period 2 (10 Days)||6
8912|NCT02183675|19380|P2|COMPLETED|Treatment Period 2 (10 Days)||6
8913|NCT02183675|19381|P1|COMPLETED|Treatment Period 2 (10 Days)||6
8914|NCT02183675|19376|P6|STARTED|Treatment Period 2 (10 Days)||6
8915|NCT02183675|19377|P5|STARTED|Treatment Period 2 (10 Days)||6
8916|NCT02183675|19378|P4|STARTED|Treatment Period 2 (10 Days)||6
8917|NCT02183675|19379|P3|STARTED|Treatment Period 2 (10 Days)||6
8918|NCT02183675|19380|P2|STARTED|Treatment Period 2 (10 Days)||6
8919|NCT02183675|19381|P1|STARTED|Treatment Period 2 (10 Days)||6
8920|NCT02183675|19376|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8921|NCT02183675|19377|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8922|NCT02183675|19378|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8923|NCT02183675|19379|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8924|NCT02183675|19380|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8925|NCT02183675|19381|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8926|NCT02183675|19376|P6|COMPLETED|Treatment Period 1 (10 Days)||6
8927|NCT02183675|19377|P5|COMPLETED|Treatment Period 1 (10 Days)||6
8928|NCT02183675|19378|P4|COMPLETED|Treatment Period 1 (10 Days)||6
8929|NCT02183675|19379|P3|COMPLETED|Treatment Period 1 (10 Days)||6
8930|NCT02183675|19380|P2|COMPLETED|Treatment Period 1 (10 Days)||6
8931|NCT02183675|19381|P1|COMPLETED|Treatment Period 1 (10 Days)||6
8932|NCT02183675|19376|P6|STARTED|Treatment Period 1 (10 Days)||6
8933|NCT02183675|19377|P5|STARTED|Treatment Period 1 (10 Days)||6
8934|NCT02183675|19378|P4|STARTED|Treatment Period 1 (10 Days)||6
8935|NCT02183675|19379|P3|STARTED|Treatment Period 1 (10 Days)||6
8936|NCT02183675|19380|P2|STARTED|Treatment Period 1 (10 Days)||6
8937|NCT02183675|19381|P1|STARTED|Treatment Period 1 (10 Days)||6
8938|NCT02181530|19403|P1|NOT COMPLETED|Overall Study||0
8939|NCT02181530|19403|P1|COMPLETED|Overall Study||43
8940|NCT02181530|19403|P1|STARTED|Overall Study||43
8941|NCT02181517|19416|P3|NOT COMPLETED|Overall Study||0
8942|NCT02181517|19417|P2|NOT COMPLETED|Overall Study||0
8943|NCT02181517|19418|P1|NOT COMPLETED|Overall Study||0
8944|NCT02181517|19416|P3|COMPLETED|Overall Study||5
8945|NCT02181517|19417|P2|COMPLETED|Overall Study||10
8946|NCT02181517|19418|P1|COMPLETED|Overall Study||10
8947|NCT02181517|19416|P3|STARTED|Overall Study||5
8948|NCT02181517|19417|P2|STARTED|Overall Study||10
8949|NCT02181517|19418|P1|STARTED|Overall Study||10
8950|NCT02181140|19438|P1|NOT COMPLETED|Overall Study||0
8951|NCT02181140|19438|P1|COMPLETED|Overall Study||56
8952|NCT02181140|19438|P1|STARTED|Overall Study||56
8953|NCT02181127|19444|P1|NOT COMPLETED|Overall Study||0
8954|NCT02181127|19444|P1|COMPLETED|Overall Study||22
8955|NCT02181127|19444|P1|STARTED|Overall Study||22
8956|NCT02180893|19451|P2|NOT COMPLETED|Overall Study||7
8957|NCT02180893|19452|P1|NOT COMPLETED|Overall Study||3
8958|NCT02180893|19451|P2|COMPLETED|Overall Study||23
8959|NCT02180893|19452|P1|COMPLETED|Overall Study||27
8960|NCT02180893|19451|P2|STARTED|Overall Study||30
8961|NCT02180893|19452|P1|STARTED|Overall Study||30
8962|NCT02180828|19466|P2|NOT COMPLETED|Overall Study||7
8963|NCT02180828|19467|P1|NOT COMPLETED|Overall Study||5
8964|NCT02180828|19466|P2|COMPLETED|Overall Study||113
8965|NCT02180828|19467|P1|COMPLETED|Overall Study||115
8966|NCT02180828|19466|P2|STARTED|Overall Study||120
8967|NCT02180828|19467|P1|STARTED|Overall Study||120
8968|NCT02180646|19491|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8969|NCT02180646|19492|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8970|NCT02180646|19491|P2|COMPLETED|Second Intervention (7 Days)||6
8971|NCT02180646|19492|P1|COMPLETED|Second Intervention (7 Days)||6
8972|NCT02180646|19491|P2|STARTED|Second Intervention (7 Days)||6
8973|NCT02180646|19492|P1|STARTED|Second Intervention (7 Days)||6
8974|NCT02180646|19491|P2|NOT COMPLETED|Washout (7 Days)||0
8975|NCT02180646|19492|P1|NOT COMPLETED|Washout (7 Days)||0
8976|NCT02180646|19491|P2|COMPLETED|Washout (7 Days)||6
8977|NCT02180646|19492|P1|COMPLETED|Washout (7 Days)||6
8978|NCT02180646|19491|P2|STARTED|Washout (7 Days)||6
8979|NCT02180646|19492|P1|STARTED|Washout (7 Days)||6
8980|NCT02180646|19491|P2|NOT COMPLETED|First Intervention (7 Days)||0
8981|NCT02180646|19492|P1|NOT COMPLETED|First Intervention (7 Days)||0
8982|NCT02180646|19491|P2|COMPLETED|First Intervention (7 Days)||6
8983|NCT02180646|19492|P1|COMPLETED|First Intervention (7 Days)||6
8984|NCT02180646|19491|P2|STARTED|First Intervention (7 Days)||6
8985|NCT02180646|19492|P1|STARTED|First Intervention (7 Days)||6
8986|NCT02180230|19502|P1|NOT COMPLETED|Overall Study||7
8987|NCT02180230|19502|P1|COMPLETED|Overall Study||31
8988|NCT02180230|19502|P1|STARTED|Overall Study||38
8989|NCT02180061|19509|P2|NOT COMPLETED|Overall Study||8
8990|NCT02180061|19510|P1|NOT COMPLETED|Overall Study||34
8991|NCT02180061|19509|P2|COMPLETED|Overall Study||0
8992|NCT02180061|19510|P1|COMPLETED|Overall Study||0
8993|NCT02180061|19509|P2|STARTED|Overall Study||8
8994|NCT02180061|19510|P1|STARTED|Overall Study||34
8995|NCT02179424|19528|P4|NOT COMPLETED|Overall Study||0
8996|NCT02179424|19529|P3|NOT COMPLETED|Overall Study||0
8997|NCT02179424|19530|P2|NOT COMPLETED|Overall Study||0
8998|NCT02179424|19531|P1|NOT COMPLETED|Overall Study||0
8999|NCT02179424|19528|P4|COMPLETED|Overall Study||39
9000|NCT02179424|19529|P3|COMPLETED|Overall Study||516
9001|NCT02179424|19530|P2|COMPLETED|Overall Study||11
9002|NCT02179424|19531|P1|COMPLETED|Overall Study||76
9003|NCT02179424|19528|P4|STARTED|Overall Study||39
9004|NCT02179424|19529|P3|STARTED|Overall Study||516
9005|NCT02179424|19530|P2|STARTED|Overall Study||11
9006|NCT02179424|19531|P1|STARTED|Overall Study||76
9007|NCT02179398|19548|P2|NOT COMPLETED|Overall Study||4
9008|NCT02179398|19549|P1|NOT COMPLETED|Overall Study||3
9009|NCT02179398|19548|P2|COMPLETED|Overall Study||140
9010|NCT02179398|19549|P1|COMPLETED|Overall Study||131
9011|NCT02179398|19548|P2|STARTED|Overall Study||144
9012|NCT02179398|19549|P1|STARTED|Overall Study||134
9013|NCT02178995|19569|P9|NOT COMPLETED|Open Label||0
9014|NCT02178995|19570|P8|NOT COMPLETED|Open Label||0
9015|NCT02178995|19571|P7|NOT COMPLETED|Open Label||0
9016|NCT02178995|19572|P6|NOT COMPLETED|Open Label||0
9017|NCT02178995|19573|P5|NOT COMPLETED|Open Label||0
9018|NCT02178995|19574|P4|NOT COMPLETED|Open Label||0
9019|NCT02178995|19575|P3|NOT COMPLETED|Open Label||0
9020|NCT02178995|19576|P2|NOT COMPLETED|Open Label||0
9021|NCT02178995|19577|P1|NOT COMPLETED|Open Label||2
9022|NCT02178995|19569|P9|COMPLETED|Open Label||0
9023|NCT02178995|19570|P8|COMPLETED|Open Label||0
9024|NCT02178995|19571|P7|COMPLETED|Open Label||0
9025|NCT02178995|19572|P6|COMPLETED|Open Label||0
9026|NCT02178995|19573|P5|COMPLETED|Open Label||0
9027|NCT02178995|19574|P4|COMPLETED|Open Label||0
9028|NCT02178995|19575|P3|COMPLETED|Open Label||0
9029|NCT02178995|19576|P2|COMPLETED|Open Label||14
9030|NCT02178995|19577|P1|COMPLETED|Open Label||28
9031|NCT02178995|19569|P9|STARTED|Open Label||0
9032|NCT02178995|19570|P8|STARTED|Open Label||0
9033|NCT02178995|19571|P7|STARTED|Open Label||0
9034|NCT02178995|19572|P6|STARTED|Open Label||0
9035|NCT02178995|19573|P5|STARTED|Open Label||0
9036|NCT02178995|19574|P4|STARTED|Open Label||0
9037|NCT02178995|19575|P3|STARTED|Open Label||0
9038|NCT02178995|19576|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
9039|NCT02178995|19577|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
9040|NCT02178995|19569|P9|NOT COMPLETED|Double Blind||1
9041|NCT02178995|19570|P8|NOT COMPLETED|Double Blind||2
9042|NCT02178995|19571|P7|NOT COMPLETED|Double Blind||0
9043|NCT02178995|19572|P6|NOT COMPLETED|Double Blind||1
9044|NCT02178995|19573|P5|NOT COMPLETED|Double Blind||0
9045|NCT02178995|19574|P4|NOT COMPLETED|Double Blind||0
9046|NCT02178995|19575|P3|NOT COMPLETED|Double Blind||0
9047|NCT02178995|19576|P2|NOT COMPLETED|Double Blind||1
9048|NCT02178995|19577|P1|NOT COMPLETED|Double Blind||0
9049|NCT02178995|19569|P9|COMPLETED|Double Blind||0
9050|NCT02178995|19570|P8|COMPLETED|Double Blind||4
9051|NCT02178995|19571|P7|COMPLETED|Double Blind||5
9052|NCT02178995|19572|P6|COMPLETED|Double Blind||5
9053|NCT02178995|19573|P5|COMPLETED|Double Blind||6
9054|NCT02178995|19574|P4|COMPLETED|Double Blind||6
9055|NCT02178995|19575|P3|COMPLETED|Double Blind||5
9056|NCT02178995|19576|P2|COMPLETED|Double Blind||15
9057|NCT02178995|19577|P1|COMPLETED|Double Blind||0
9058|NCT02178995|19569|P9|STARTED|Double Blind||1
9059|NCT02178995|19570|P8|STARTED|Double Blind||6
9060|NCT02178995|19571|P7|STARTED|Double Blind||5
9061|NCT02178995|19572|P6|STARTED|Double Blind||6
9062|NCT02178995|19573|P5|STARTED|Double Blind||6
9063|NCT02178995|19574|P4|STARTED|Double Blind||6
9064|NCT02178995|19575|P3|STARTED|Double Blind||5
9065|NCT02178995|19576|P2|STARTED|Double Blind||16
9066|NCT02178995|19577|P1|STARTED|Double Blind||0
9067|NCT02178540|19641|P1|NOT COMPLETED|Overall Study||0
9068|NCT02178540|19641|P1|COMPLETED|Overall Study||45
9069|NCT02178540|19641|P1|STARTED|Overall Study||45
9070|NCT02178059|19648|P2|NOT COMPLETED|Second Intervention||0
9071|NCT02178059|19649|P1|NOT COMPLETED|Second Intervention||0
9072|NCT02178059|19648|P2|COMPLETED|Second Intervention||17
9073|NCT02178059|19649|P1|COMPLETED|Second Intervention||16
9074|NCT02178059|19648|P2|STARTED|Second Intervention||17
9075|NCT02178059|19649|P1|STARTED|Second Intervention||16
9076|NCT02178059|19648|P2|NOT COMPLETED|Washout||0
9077|NCT02178059|19649|P1|NOT COMPLETED|Washout||1
9078|NCT02178059|19648|P2|COMPLETED|Washout||17
9079|NCT02178059|19649|P1|COMPLETED|Washout||16
9080|NCT02178059|19648|P2|STARTED|Washout||17
9081|NCT02178059|19649|P1|STARTED|Washout||17
9082|NCT02178059|19648|P2|NOT COMPLETED|First Intervention||0
9083|NCT02178059|19649|P1|NOT COMPLETED|First Intervention||0
9084|NCT02178059|19648|P2|COMPLETED|First Intervention||17
9085|NCT02178059|19649|P1|COMPLETED|First Intervention||17
9086|NCT02178059|19648|P2|STARTED|First Intervention||17
9087|NCT02178059|19649|P1|STARTED|First Intervention||17
9088|NCT02177201|19667|P2|NOT COMPLETED|Overall Study||3
9089|NCT02177201|19668|P1|NOT COMPLETED|Overall Study||3
9090|NCT02177201|19667|P2|COMPLETED|Overall Study||77
9091|NCT02177201|19668|P1|COMPLETED|Overall Study||77
9092|NCT02177201|19667|P2|STARTED|Overall Study||80
9093|NCT02177201|19668|P1|STARTED|Overall Study||80
9094|NCT02176525|19682|P8|NOT COMPLETED|Overall Study||0
9095|NCT02176525|19683|P7|NOT COMPLETED|Overall Study||1
9096|NCT02176525|19684|P6|NOT COMPLETED|Overall Study||1
9097|NCT02176525|19685|P5|NOT COMPLETED|Overall Study||1
9098|NCT02176525|19686|P4|NOT COMPLETED|Overall Study||1
9099|NCT02176525|19687|P3|NOT COMPLETED|Overall Study||0
9100|NCT02176525|19688|P2|NOT COMPLETED|Overall Study||0
9101|NCT02176525|19689|P1|NOT COMPLETED|Overall Study||1
9102|NCT02176525|19682|P8|COMPLETED|Overall Study||10
9103|NCT02176525|19683|P7|COMPLETED|Overall Study||8
9104|NCT02176525|19684|P6|COMPLETED|Overall Study||5
9105|NCT02176525|19685|P5|COMPLETED|Overall Study||7
9106|NCT02176525|19686|P4|COMPLETED|Overall Study||8
9107|NCT02176525|19687|P3|COMPLETED|Overall Study||9
9108|NCT02176525|19688|P2|COMPLETED|Overall Study||9
9109|NCT02176525|19689|P1|COMPLETED|Overall Study||14
9110|NCT02176525|19682|P8|STARTED|Overall Study||10
9111|NCT02176525|19683|P7|STARTED|Overall Study||9
9112|NCT02176525|19684|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
9113|NCT02176525|19685|P5|STARTED|Overall Study||8
9114|NCT02176525|19686|P4|STARTED|Overall Study||9
9115|NCT02176525|19687|P3|STARTED|Overall Study||9
9116|NCT02176525|19688|P2|STARTED|Overall Study||9
9117|NCT02176525|19689|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
9118|NCT02176421|19866|P1|NOT COMPLETED|Overall Study||5
9119|NCT02176421|19866|P1|COMPLETED|Overall Study||75
9120|NCT02176421|19866|P1|STARTED|Overall Study||80
9121|NCT02176356|19875|P1|NOT COMPLETED|Overall Study||23
9122|NCT02176356|19875|P1|COMPLETED|Overall Study||93
9123|NCT02176356|19875|P1|Eligible and Received Treatment|Overall Study||100
9124|NCT02176356|19875|P1|STARTED|Overall Study||116
9125|NCT02175212|19894|P2|NOT COMPLETED|Overall Study||147
9126|NCT02175212|19895|P1|NOT COMPLETED|Overall Study||163
9127|NCT02175212|19894|P2|COMPLETED|Overall Study||31
9128|NCT02175212|19895|P1|COMPLETED|Overall Study||14
9129|NCT02175212|19894|P2|STARTED|Overall Study||178
9130|NCT02175212|19895|P1|STARTED|Overall Study||177
9131|NCT02175199|19911|P2|NOT COMPLETED|Overall Study||5
9132|NCT02175199|19912|P1|NOT COMPLETED|Overall Study||3
9133|NCT02175199|19911|P2|COMPLETED|Overall Study||71
9134|NCT02175199|19912|P1|COMPLETED|Overall Study||71
9135|NCT02175199|19911|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
9136|NCT02175199|19912|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
9137|NCT02175199|19911|P2|STARTED|Overall Study||76
9138|NCT02175199|19912|P1|STARTED|Overall Study||74
9139|NCT02175121|19926|P5|NOT COMPLETED|Overall Study||1
9140|NCT02175121|19927|P4|NOT COMPLETED|Overall Study||1
9141|NCT02175121|19928|P3|NOT COMPLETED|Overall Study||2
9142|NCT02175121|19929|P2|NOT COMPLETED|Overall Study||1
9143|NCT02175121|19930|P1|NOT COMPLETED|Overall Study||1
9144|NCT02175121|19926|P5|COMPLETED|Overall Study||33
9145|NCT02175121|19927|P4|COMPLETED|Overall Study||34
9146|NCT02175121|19928|P3|COMPLETED|Overall Study||32
9147|NCT02175121|19929|P2|COMPLETED|Overall Study||34
9148|NCT02175121|19930|P1|COMPLETED|Overall Study||33
9149|NCT02175121|19926|P5|STARTED|Overall Study||34
9150|NCT02175121|19927|P4|STARTED|Overall Study||35
9151|NCT02175121|19928|P3|STARTED|Overall Study||34
9152|NCT02175121|19929|P2|STARTED|Overall Study||35
9153|NCT02175121|19930|P1|STARTED|Overall Study||34
9154|NCT02173769|20057|P1|NOT COMPLETED|Overall Study||4
9155|NCT02173769|20057|P1|COMPLETED|Overall Study||1854
9156|NCT02173769|20057|P1|STARTED|Overall Study||1858
9157|NCT02173054|20071|P3|NOT COMPLETED|Overall Study||1
9158|NCT02173054|20072|P2|NOT COMPLETED|Overall Study||0
9159|NCT02173054|20073|P1|NOT COMPLETED|Overall Study||1
9160|NCT02173054|20071|P3|COMPLETED|Overall Study||39
9161|NCT02173054|20072|P2|COMPLETED|Overall Study||40
9162|NCT02173054|20073|P1|COMPLETED|Overall Study||39
9163|NCT02173054|20071|P3|STARTED|Overall Study||40
9164|NCT02173054|20072|P2|STARTED|Overall Study||40
9165|NCT02173054|20073|P1|STARTED|Overall Study||40
9166|NCT02172755|20095|P2|NOT COMPLETED|Overall Study||4
9167|NCT02172755|20096|P1|NOT COMPLETED|Overall Study||2
9168|NCT02172755|20095|P2|COMPLETED|Overall Study||12
9169|NCT02172755|20096|P1|COMPLETED|Overall Study||12
9170|NCT02172755|20095|P2|STARTED|Overall Study||16
9171|NCT02172755|20096|P1|STARTED|Overall Study||14
9172|NCT02172742|20108|P2|NOT COMPLETED|Overall Study||0
9173|NCT02172742|20109|P1|NOT COMPLETED|Overall Study||1
9174|NCT02172742|20108|P2|COMPLETED|Overall Study||6
9175|NCT02172742|20109|P1|COMPLETED|Overall Study||6
9176|NCT02172742|20108|P2|STARTED|Overall Study||6
9177|NCT02172742|20109|P1|STARTED|Overall Study||7
9178|NCT02172625|20118|P2|NOT COMPLETED|Overall Study||3
9179|NCT02172625|20119|P1|NOT COMPLETED|Overall Study||0
9180|NCT02172625|20118|P2|COMPLETED|Overall Study||16
9181|NCT02172625|20119|P1|COMPLETED|Overall Study||19
9182|NCT02172625|20118|P2|STARTED|Overall Study||19
9183|NCT02172625|20119|P1|STARTED|Overall Study||19
9184|NCT02171247|20139|P2|NOT COMPLETED|Overall Study||0
9185|NCT02171247|20140|P1|NOT COMPLETED|Overall Study||0
9186|NCT02171247|20139|P2|COMPLETED|Overall Study||17
9187|NCT02171247|20140|P1|COMPLETED|Overall Study||16
9188|NCT02171247|20139|P2|STARTED|Overall Study||17
9189|NCT02171247|20140|P1|STARTED|Overall Study||16
9190|NCT02171234|20157|P5|NOT COMPLETED|Overall Study||0
9191|NCT02171234|20158|P4|NOT COMPLETED|Overall Study||0
9192|NCT02171234|20159|P3|NOT COMPLETED|Overall Study||0
9193|NCT02171234|20160|P2|NOT COMPLETED|Overall Study||0
9194|NCT02171234|20161|P1|NOT COMPLETED|Overall Study||0
9195|NCT02171234|20157|P5|COMPLETED|Overall Study||6
9196|NCT02171234|20158|P4|COMPLETED|Overall Study||6
9197|NCT02171234|20159|P3|COMPLETED|Overall Study||6
9198|NCT02171234|20160|P2|COMPLETED|Overall Study||6
9199|NCT02171234|20161|P1|COMPLETED|Overall Study||8
9200|NCT02171234|20157|P5|STARTED|Overall Study||6
9201|NCT02171234|20158|P4|STARTED|Overall Study||6
9202|NCT02171234|20159|P3|STARTED|Overall Study||6
9203|NCT02171234|20160|P2|STARTED|Overall Study||6
9204|NCT02171234|20161|P1|STARTED|Overall Study||8
9205|NCT02171195|20190|P9|NOT COMPLETED|Overall Study||0
9206|NCT02171195|20191|P8|NOT COMPLETED|Overall Study||0
9207|NCT02171195|20192|P7|NOT COMPLETED|Overall Study||0
9208|NCT02171195|20193|P6|NOT COMPLETED|Overall Study||0
9209|NCT02171195|20194|P5|NOT COMPLETED|Overall Study||0
9210|NCT02171195|20195|P4|NOT COMPLETED|Overall Study||0
9211|NCT02171195|20196|P3|NOT COMPLETED|Overall Study||0
9212|NCT02171195|20197|P2|NOT COMPLETED|Overall Study||0
9213|NCT02171195|20198|P1|NOT COMPLETED|Overall Study||0
9214|NCT02171195|20190|P9|COMPLETED|Overall Study||6
9215|NCT02171195|20191|P8|COMPLETED|Overall Study||6
9216|NCT02171195|20192|P7|COMPLETED|Overall Study||6
9217|NCT02171195|20193|P6|COMPLETED|Overall Study||6
9218|NCT02171195|20194|P5|COMPLETED|Overall Study||6
9219|NCT02171195|20195|P4|COMPLETED|Overall Study||6
9220|NCT02171195|20196|P3|COMPLETED|Overall Study||6
9221|NCT02171195|20197|P2|COMPLETED|Overall Study||6
9222|NCT02171195|20198|P1|COMPLETED|Overall Study||16
9223|NCT02171195|20190|P9|STARTED|Overall Study||6
9224|NCT02171195|20191|P8|STARTED|Overall Study||6
9225|NCT02171195|20192|P7|STARTED|Overall Study||6
9226|NCT02171195|20193|P6|STARTED|Overall Study||6
9227|NCT02171195|20194|P5|STARTED|Overall Study||6
9228|NCT02171195|20195|P4|STARTED|Overall Study||6
9229|NCT02171195|20196|P3|STARTED|Overall Study||6
9230|NCT02171195|20197|P2|STARTED|Overall Study||6
9231|NCT02171195|20198|P1|STARTED|Overall Study||16
9232|NCT02170688|20223|P5|NOT COMPLETED|Overall Study||0
9233|NCT02170688|20224|P4|NOT COMPLETED|Overall Study||2
9234|NCT02170688|20225|P3|NOT COMPLETED|Overall Study||4
9235|NCT02170688|20226|P2|NOT COMPLETED|Overall Study||3
9236|NCT02170688|20227|P1|NOT COMPLETED|Overall Study||4
9237|NCT02170688|20223|P5|COMPLETED|Overall Study||25
9238|NCT02170688|20224|P4|COMPLETED|Overall Study||25
9239|NCT02170688|20225|P3|COMPLETED|Overall Study||25
9240|NCT02170688|20226|P2|COMPLETED|Overall Study||26
9241|NCT02170688|20227|P1|COMPLETED|Overall Study||25
9242|NCT02170688|20223|P5|STARTED|Overall Study||25
9243|NCT02170688|20224|P4|STARTED|Overall Study||27
9244|NCT02170688|20225|P3|STARTED|Overall Study||29
9245|NCT02170688|20226|P2|STARTED|Overall Study||29
9246|NCT02170688|20227|P1|STARTED|Overall Study||29
9247|NCT02170662|20246|P2|NOT COMPLETED|Overall Study||0
9248|NCT02170662|20247|P1|NOT COMPLETED|Overall Study||0
9249|NCT02170662|20246|P2|COMPLETED|Overall Study||6
9250|NCT02170662|20247|P1|COMPLETED|Overall Study||3
9251|NCT02170662|20246|P2|STARTED|Overall Study||6
9252|NCT02170662|20247|P1|STARTED|Overall Study||3
9253|NCT02170649|20259|P1|NOT COMPLETED|Fed Period||0
9254|NCT02170649|20259|P1|COMPLETED|Fed Period||12
9255|NCT02170649|20259|P1|STARTED|Fed Period||12
9256|NCT02170649|20259|P1|NOT COMPLETED|Fasting Period||0
9257|NCT02170649|20259|P1|COMPLETED|Fasting Period||12
9258|NCT02170649|20259|P1|STARTED|Fasting Period||12
9259|NCT02170532|20266|P1|NOT COMPLETED|Overall Study||0
9260|NCT02170532|20266|P1|COMPLETED|Overall Study||10
9261|NCT02170532|20266|P1|STARTED|Overall Study||10
9262|NCT02170519|20296|P2|NOT COMPLETED|Overall Study||0
9263|NCT02170519|20297|P1|NOT COMPLETED|Overall Study||0
9264|NCT02170519|20296|P2|COMPLETED|Overall Study||5
9265|NCT02170519|20297|P1|COMPLETED|Overall Study||22
9266|NCT02170519|20296|P2|STARTED|Overall Study||5
9267|NCT02170519|20297|P1|STARTED|Overall Study||22
9268|NCT02170376|20318|P5|NOT COMPLETED|Overall Study||0
9269|NCT02170376|20319|P4|NOT COMPLETED|Overall Study||0
9270|NCT02170376|20320|P3|NOT COMPLETED|Overall Study||0
9271|NCT02170376|20321|P2|NOT COMPLETED|Overall Study||1
9272|NCT02170376|20322|P1|NOT COMPLETED|Overall Study||0
9273|NCT02170376|20318|P5|COMPLETED|Overall Study||16
9274|NCT02170376|20319|P4|COMPLETED|Overall Study||16
9275|NCT02170376|20320|P3|COMPLETED|Overall Study||16
9276|NCT02170376|20321|P2|COMPLETED|Overall Study||15
9277|NCT02170376|20322|P1|COMPLETED|Overall Study||16
9278|NCT02170376|20318|P5|Pharmacokinetic Population|Overall Study||16
9279|NCT02170376|20319|P4|Pharmacokinetic Population|Overall Study||16
9280|NCT02170376|20320|P3|Pharmacokinetic Population|Overall Study||16
9281|NCT02170376|20321|P2|Pharmacokinetic Population|Overall Study||15
9282|NCT02170376|20322|P1|Pharmacokinetic Population|Overall Study||16
9283|NCT02170376|20318|P5|STARTED|Overall Study||16
9284|NCT02170376|20319|P4|STARTED|Overall Study||16
9285|NCT02170376|20320|P3|STARTED|Overall Study||16
9286|NCT02170376|20321|P2|STARTED|Overall Study||16
9287|NCT02170376|20322|P1|STARTED|Overall Study||16
9288|NCT02170220|20361|P2|NOT COMPLETED|Overall Study||0
9289|NCT02170220|20362|P1|NOT COMPLETED|Overall Study||0
9290|NCT02170220|20361|P2|COMPLETED|Overall Study||6
9291|NCT02170220|20362|P1|COMPLETED|Overall Study||6
9292|NCT02170220|20361|P2|STARTED|Overall Study||6
9293|NCT02170220|20362|P1|STARTED|Overall Study||6
9294|NCT02170207|20388|P1|NOT COMPLETED|Overall Study||5
9295|NCT02170207|20388|P1|COMPLETED|Overall Study||58
9296|NCT02170207|20388|P1|STARTED|Overall Study||63
9297|NCT02170077|20399|P3|NOT COMPLETED|Overall Study||12
9298|NCT02170077|20400|P2|NOT COMPLETED|Overall Study||13
9299|NCT02170077|20401|P1|NOT COMPLETED|Overall Study||9
9300|NCT02170077|20399|P3|COMPLETED|Overall Study||35
9301|NCT02170077|20400|P2|COMPLETED|Overall Study||34
9302|NCT02170077|20401|P1|COMPLETED|Overall Study||41
9303|NCT02170077|20399|P3|Intent to Treat (ITT) Population|Overall Study||47
9304|NCT02170077|20400|P2|Intent to Treat (ITT) Population|Overall Study||46
9305|NCT02170077|20401|P1|Intent to Treat (ITT) Population|Overall Study||50
9306|NCT02170077|20399|P3|STARTED|Overall Study||47
9307|NCT02170077|20400|P2|STARTED|Overall Study||47
9308|NCT02170077|20401|P1|STARTED|Overall Study||50
9309|NCT02170064|20412|P3|NOT COMPLETED|Overall Study||1
9310|NCT02170064|20413|P2|NOT COMPLETED|Overall Study||2
9311|NCT02170064|20414|P1|NOT COMPLETED|Overall Study||6
9312|NCT02170064|20412|P3|COMPLETED|Overall Study||10
9313|NCT02170064|20413|P2|COMPLETED|Overall Study||7
9314|NCT02170064|20414|P1|COMPLETED|Overall Study||9
9315|NCT02170064|20412|P3|Efficacy Population (EP)|Overall Study||10
9316|NCT02170064|20413|P2|Efficacy Population (EP)|Overall Study||8
9317|NCT02170064|20414|P1|Efficacy Population (EP)|Overall Study||11
9318|NCT02170064|20412|P3|Pharmacokinetic Population (PKP)|Overall Study||10
9319|NCT02170064|20413|P2|Pharmacokinetic Population (PKP)|Overall Study||8
9320|NCT02170064|20414|P1|Pharmacokinetic Population (PKP)|Overall Study||11
9321|NCT02170064|20412|P3|Safety Population (SP)|Overall Study||11
9322|NCT02170064|20413|P2|Safety Population (SP)|Overall Study||8
9323|NCT02170064|20414|P1|Safety Population (SP)|Overall Study||12
9324|NCT02170064|20412|P3|STARTED|Overall Study||11
9325|NCT02170064|20413|P2|STARTED|Overall Study||9
9326|NCT02170064|20414|P1|STARTED|Overall Study||15
9327|NCT02169895|20432|P4|NOT COMPLETED|Overall Study||2
9328|NCT02169895|20433|P3|NOT COMPLETED|Overall Study||0
9329|NCT02169895|20434|P2|NOT COMPLETED|Overall Study||0
9330|NCT02169895|20435|P1|NOT COMPLETED|Overall Study||0
9331|NCT02169895|20432|P4|COMPLETED|Overall Study||2
9332|NCT02169895|20433|P3|COMPLETED|Overall Study||4
9333|NCT02169895|20434|P2|COMPLETED|Overall Study||4
9334|NCT02169895|20435|P1|COMPLETED|Overall Study||4
9335|NCT02169895|20432|P4|Placebo|Overall Study||4
9336|NCT02169895|20433|P3|Placebo|Overall Study||4
9337|NCT02169895|20434|P2|Placebo|Overall Study||4
9338|NCT02169895|20435|P1|Placebo|Overall Study||4
9339|NCT02169895|20432|P4|100 mg BIA 9-1067|Overall Study||2
9340|NCT02169895|20433|P3|100 mg BIA 9-1067|Overall Study||4
9341|NCT02169895|20434|P2|100 mg BIA 9-1067|Overall Study||4
9342|NCT02169895|20435|P1|100 mg BIA 9-1067|Overall Study||4
9343|NCT02169895|20432|P4|50 mg BIA 9-1067|Overall Study||4
9344|NCT02169895|20433|P3|50 mg BIA 9-1067|Overall Study||4
9345|NCT02169895|20434|P2|50 mg BIA 9-1067|Overall Study||4
9346|NCT02169895|20435|P1|50 mg BIA 9-1067|Overall Study||4
9347|NCT02169895|20432|P4|25 mg BIA 9-1067|Overall Study||4
9348|NCT02169895|20433|P3|25 mg BIA 9-1067|Overall Study||4
9349|NCT02169895|20434|P2|25 mg BIA 9-1067|Overall Study||4
9350|NCT02169895|20435|P1|25 mg BIA 9-1067|Overall Study||4
9351|NCT02169895|20432|P4|STARTED|Overall Study||4
9352|NCT02169895|20433|P3|STARTED|Overall Study||4
9353|NCT02169895|20434|P2|STARTED|Overall Study||4
9354|NCT02169895|20435|P1|STARTED|Overall Study||4
9355|NCT02169479|20457|P4|NOT COMPLETED|Overall Study||0
9356|NCT02169479|20458|P3|NOT COMPLETED|Overall Study||0
9357|NCT02169479|20459|P2|NOT COMPLETED|Overall Study||1
9358|NCT02169479|20460|P1|NOT COMPLETED|Overall Study||1
9359|NCT02169479|20457|P4|COMPLETED|Overall Study||4
9360|NCT02169479|20458|P3|COMPLETED|Overall Study||4
9361|NCT02169479|20459|P2|COMPLETED|Overall Study||3
9362|NCT02169479|20460|P1|COMPLETED|Overall Study||3
9363|NCT02169479|20457|P4|Placebo|Overall Study||4
9364|NCT02169479|20458|P3|Placebo|Overall Study||4
9365|NCT02169479|20459|P2|Placebo|Overall Study||3
9366|NCT02169479|20460|P1|Placebo|Overall Study||3
9367|NCT02169479|20457|P4|100 mg BIA 9-1067|Overall Study||4
9368|NCT02169479|20458|P3|100 mg BIA 9-1067|Overall Study||4
9369|NCT02169479|20459|P2|100 mg BIA 9-1067|Overall Study||4
9370|NCT02169479|20460|P1|100 mg BIA 9-1067|Overall Study||3
9371|NCT02169479|20457|P4|50 mg BIA 9-1067|Overall Study||4
9372|NCT02169479|20458|P3|50 mg BIA 9-1067|Overall Study||4
9373|NCT02169479|20459|P2|50 mg BIA 9-1067|Overall Study||4
9374|NCT02169479|20460|P1|50 mg BIA 9-1067|Overall Study||4
9375|NCT02169479|20457|P4|25 mg BIA 9-1067|Overall Study||4
9376|NCT02169479|20458|P3|25 mg BIA 9-1067|Overall Study||4
9377|NCT02169479|20459|P2|25 mg BIA 9-1067|Overall Study||3
9378|NCT02169479|20460|P1|25 mg BIA 9-1067|Overall Study||4
9379|NCT02169479|20457|P4|STARTED|Overall Study||4
9380|NCT02169479|20458|P3|STARTED|Overall Study||4
9381|NCT02169479|20459|P2|STARTED|Overall Study||4
9382|NCT02169479|20460|P1|STARTED|Overall Study||4
9383|NCT02169466|20482|P4|NOT COMPLETED|Overall Study||0
9384|NCT02169466|20483|P3|NOT COMPLETED|Overall Study||0
9385|NCT02169466|20484|P2|NOT COMPLETED|Overall Study||1
9386|NCT02169466|20485|P1|NOT COMPLETED|Overall Study||1
9387|NCT02169466|20482|P4|COMPLETED|Overall Study||5
9388|NCT02169466|20483|P3|COMPLETED|Overall Study||5
9389|NCT02169466|20484|P2|COMPLETED|Overall Study||5
9390|NCT02169466|20485|P1|COMPLETED|Overall Study||5
9391|NCT02169466|20482|P4|Placebo|Overall Study||5
9392|NCT02169466|20483|P3|Placebo|Overall Study||5
9393|NCT02169466|20484|P2|Placebo|Overall Study||6
9394|NCT02169466|20485|P1|Placebo|Overall Study||5
9395|NCT02169466|20482|P4|100 mg BIA 9-1067|Overall Study||5
9396|NCT02169466|20483|P3|100 mg BIA 9-1067|Overall Study||5
9397|NCT02169466|20484|P2|100 mg BIA 9-1067|Overall Study||6
9398|NCT02169466|20485|P1|100 mg BIA 9-1067|Overall Study||6
9399|NCT02169466|20482|P4|50 mg BIA 9-1067|Overall Study||5
9400|NCT02169466|20483|P3|50 mg BIA 9-1067|Overall Study||5
9401|NCT02169466|20484|P2|50 mg BIA 9-1067|Overall Study||6
9402|NCT02169466|20485|P1|50 mg BIA 9-1067|Overall Study||6
9403|NCT02169466|20482|P4|25 mg BIA 9-1067|Overall Study||5
9404|NCT02169466|20483|P3|25 mg BIA 9-1067|Overall Study||5
9405|NCT02169466|20484|P2|25 mg BIA 9-1067|Overall Study||5
9406|NCT02169466|20485|P1|25 mg BIA 9-1067|Overall Study||6
9407|NCT02169466|20482|P4|STARTED|Overall Study||5
9408|NCT02169466|20483|P3|STARTED|Overall Study||5
9409|NCT02169466|20484|P2|STARTED|Overall Study||6
9410|NCT02169466|20485|P1|STARTED|Overall Study||6
9411|NCT02169453|20511|P4|NOT COMPLETED|Overall Study||0
9412|NCT02169453|20512|P3|NOT COMPLETED|Overall Study||1
9413|NCT02169453|20513|P2|NOT COMPLETED|Overall Study||0
9414|NCT02169453|20514|P1|NOT COMPLETED|Overall Study||0
9415|NCT02169453|20511|P4|COMPLETED|Overall Study||3
9416|NCT02169453|20512|P3|COMPLETED|Overall Study||2
9417|NCT02169453|20513|P2|COMPLETED|Overall Study||3
9418|NCT02169453|20514|P1|COMPLETED|Overall Study||3
9419|NCT02169453|20511|P4|Placebo|Overall Study||3
9420|NCT02169453|20512|P3|Placebo|Overall Study||3
9421|NCT02169453|20513|P2|Placebo|Overall Study||3
9422|NCT02169453|20514|P1|Placebo|Overall Study||3
9423|NCT02169453|20511|P4|100 mg BIA 9-1067|Overall Study||3
9424|NCT02169453|20512|P3|100 mg BIA 9-1067|Overall Study||3
9425|NCT02169453|20513|P2|100 mg BIA 9-1067|Overall Study||3
9426|NCT02169453|20514|P1|100 mg BIA 9-1067|Overall Study||3
9427|NCT02169453|20511|P4|50 mg BIA 9-1067|Overall Study||3
9428|NCT02169453|20512|P3|50 mg BIA 9-1067|Overall Study||2
9429|NCT02169453|20513|P2|50 mg BIA 9-1067|Overall Study||3
9430|NCT02169453|20514|P1|50 mg BIA 9-1067|Overall Study||3
9431|NCT02169453|20511|P4|25 mg BIA 9-1067|Overall Study||3
9432|NCT02169453|20512|P3|25 mg BIA 9-1067|Overall Study||3
9433|NCT02169453|20513|P2|25 mg BIA 9-1067|Overall Study||3
9434|NCT02169453|20514|P1|25 mg BIA 9-1067|Overall Study||3
9435|NCT02169453|20511|P4|STARTED|Overall Study||3
9436|NCT02169453|20512|P3|STARTED|Overall Study||3
9437|NCT02169453|20513|P2|STARTED|Overall Study||3
9438|NCT02169453|20514|P1|STARTED|Overall Study||3
9439|NCT02169440|20546|P2|NOT COMPLETED|Overall Study||0
9440|NCT02169440|20547|P1|NOT COMPLETED|Overall Study||0
9441|NCT02169440|20546|P2|COMPLETED|Overall Study||10
9442|NCT02169440|20547|P1|COMPLETED|Overall Study||10
9443|NCT02169440|20546|P2|STARTED|Overall Study||10
9444|NCT02169440|20547|P1|STARTED|Overall Study||10
9445|NCT02169427|20560|P1|NOT COMPLETED|Overall Study||0
9446|NCT02169427|20560|P1|COMPLETED|Overall Study||6
9447|NCT02169427|20560|P1|STARTED|Overall Study||6
9448|NCT02169414|20570|P4|NOT COMPLETED|Overall Study||0
9449|NCT02169414|20571|P3|NOT COMPLETED|Overall Study||0
9450|NCT02169414|20572|P2|NOT COMPLETED|Overall Study||1
9451|NCT02169414|20573|P1|NOT COMPLETED|Overall Study||1
9452|NCT02169414|20570|P4|COMPLETED|Overall Study||18
9453|NCT02169414|20571|P3|COMPLETED|Overall Study||18
9454|NCT02169414|20572|P2|COMPLETED|Overall Study||18
9455|NCT02169414|20573|P1|COMPLETED|Overall Study||18
9456|NCT02169414|20570|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
9457|NCT02169414|20571|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
9458|NCT02169414|20572|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
9459|NCT02169414|20573|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
9460|NCT02169414|20570|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
9461|NCT02169414|20571|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
9462|NCT02169414|20572|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
9463|NCT02169414|20573|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
9464|NCT02169414|20570|P4|STARTED|Overall Study||18
9465|NCT02169414|20571|P3|STARTED|Overall Study||18
9466|NCT02169414|20572|P2|STARTED|Overall Study||19
9467|NCT02169414|20573|P1|STARTED|Overall Study||19
9468|NCT02169336|20614|P3|NOT COMPLETED|Overall Study||3
9469|NCT02169336|20615|P2|NOT COMPLETED|Overall Study||4
9470|NCT02169336|20616|P1|NOT COMPLETED|Overall Study||4
9471|NCT02169336|20614|P3|COMPLETED|Overall Study||29
9472|NCT02169336|20615|P2|COMPLETED|Overall Study||28
9473|NCT02169336|20616|P1|COMPLETED|Overall Study||27
9474|NCT02169336|20614|P3|STARTED|Overall Study||32
9475|NCT02169336|20615|P2|STARTED|Overall Study||32
9476|NCT02169336|20616|P1|STARTED|Overall Study||31
9477|NCT02169115|20627|P3|NOT COMPLETED|Overall Study||0
9478|NCT02169115|20628|P2|NOT COMPLETED|Overall Study||0
9479|NCT02169115|20629|P1|NOT COMPLETED|Overall Study||0
9480|NCT02169115|20627|P3|COMPLETED|Overall Study||21
9481|NCT02169115|20628|P2|COMPLETED|Overall Study||21
9482|NCT02169115|20629|P1|COMPLETED|Overall Study||19
9483|NCT02169115|20627|P3|STARTED|Overall Study||21
9484|NCT02169115|20628|P2|STARTED|Overall Study||21
9485|NCT02169115|20629|P1|STARTED|Overall Study||19
9486|NCT02168478|20637|P1|NOT COMPLETED|Overall Study||4
9487|NCT02168478|20637|P1|COMPLETED|Overall Study||202
9488|NCT02168478|20637|P1|STARTED|Overall Study||206
9489|NCT02168387|20643|P2|NOT COMPLETED|Overall Study||3
9490|NCT02168387|20644|P1|NOT COMPLETED|Overall Study||7
9491|NCT02168387|20643|P2|COMPLETED|Overall Study||16
9492|NCT02168387|20644|P1|COMPLETED|Overall Study||13
9493|NCT02168387|20643|P2|STARTED|Overall Study||19
9494|NCT02168387|20644|P1|STARTED|Overall Study||20
9495|NCT02168361|20656|P2|NOT COMPLETED|Overall Study||10
9496|NCT02168361|20657|P1|NOT COMPLETED|Overall Study||5
9497|NCT02168361|20656|P2|COMPLETED|Overall Study||21
9498|NCT02168361|20657|P1|COMPLETED|Overall Study||57
9499|NCT02168361|20656|P2|STARTED|Overall Study||31
9500|NCT02168361|20657|P1|STARTED|Overall Study||62
9501|NCT02167867|20667|P2|NOT COMPLETED|Overall Study||0
9502|NCT02167867|20668|P1|NOT COMPLETED|Overall Study||0
9503|NCT02167867|20667|P2|COMPLETED|Overall Study||22
9504|NCT02167867|20668|P1|COMPLETED|Overall Study||22
9505|NCT02167867|20667|P2|STARTED|Overall Study||22
9506|NCT02167867|20668|P1|STARTED|Overall Study||22
9507|NCT02167815|20676|P2|NOT COMPLETED|Overall Study||0
9508|NCT02167815|20677|P1|NOT COMPLETED|Overall Study||0
9509|NCT02167815|20676|P2|COMPLETED|Overall Study||21
9510|NCT02167815|20677|P1|COMPLETED|Overall Study||9
9511|NCT02167815|20676|P2|STARTED|Overall Study||21
9512|NCT02167815|20677|P1|STARTED|Overall Study||9
9513|NCT02167139|20690|P4|NOT COMPLETED|Transition-extension||5
9514|NCT02167139|20691|P3|NOT COMPLETED|Transition-extension||8
9515|NCT02167139|20692|P2|NOT COMPLETED|Transition-extension||0
9516|NCT02167139|20693|P1|NOT COMPLETED|Transition-extension||6
9517|NCT02167139|20690|P4|COMPLETED|Transition-extension||124
9518|NCT02167139|20691|P3|COMPLETED|Transition-extension||117
9519|NCT02167139|20692|P2|COMPLETED|Transition-extension||0
9520|NCT02167139|20693|P1|COMPLETED|Transition-extension||248
9521|NCT02167139|20690|P4|STARTED|Transition-extension||129
9522|NCT02167139|20691|P3|STARTED|Transition-extension||125
9523|NCT02167139|20692|P2|STARTED|Transition-extension||0
9524|NCT02167139|20693|P1|STARTED|Transition-extension||254
9525|NCT02167139|20690|P4|NOT COMPLETED|Randomised, Double-blind||0
9526|NCT02167139|20691|P3|NOT COMPLETED|Randomised, Double-blind||0
9527|NCT02167139|20692|P2|NOT COMPLETED|Randomised, Double-blind||19
9528|NCT02167139|20693|P1|NOT COMPLETED|Randomised, Double-blind||17
9529|NCT02167139|20690|P4|COMPLETED|Randomised, Double-blind||0
9530|NCT02167139|20691|P3|COMPLETED|Randomised, Double-blind||0
9531|NCT02167139|20692|P2|COMPLETED|Randomised, Double-blind||254
9532|NCT02167139|20693|P1|COMPLETED|Randomised, Double-blind||254
9533|NCT02167139|20690|P4|STARTED|Randomised, Double-blind||0
9534|NCT02167139|20691|P3|STARTED|Randomised, Double-blind||0
9535|NCT02167139|20692|P2|STARTED|Randomised, Double-blind||273
9536|NCT02167139|20693|P1|STARTED|Randomised, Double-blind||271
9537|NCT02166697|20707|P1|NOT COMPLETED|Overall Study||347
9538|NCT02166697|20707|P1|COMPLETED|Overall Study||13804
9539|NCT02166697|20707|P1|STARTED|Overall Study||14151
9540|NCT02165462|20716|P1|NOT COMPLETED|Overall Study||0
9541|NCT02165462|20716|P1|COMPLETED|Overall Study||17
9542|NCT02165462|20716|P1|STARTED|Overall Study||17
9543|NCT02165111|20735|P2|NOT COMPLETED|Overall Study||0
9544|NCT02165111|20736|P1|NOT COMPLETED|Overall Study||0
9545|NCT02165111|20735|P2|COMPLETED|Overall Study||40
9546|NCT02165111|20736|P1|COMPLETED|Overall Study||40
9547|NCT02165111|20735|P2|STARTED|Overall Study||40
9548|NCT02165111|20736|P1|STARTED|Overall Study||40
9549|NCT02165072|20752|P1|NOT COMPLETED|Overall Study||0
9550|NCT02165072|20752|P1|COMPLETED|Overall Study||30
9551|NCT02165072|20752|P1|STARTED|Overall Study||30
9552|NCT02164539|20763|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
9553|NCT02164539|20764|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
9554|NCT02164539|20765|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
9555|NCT02164539|20766|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
9556|NCT02164539|20767|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
9557|NCT02164539|20768|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
9558|NCT02164539|20769|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
9559|NCT02164539|20763|P7|COMPLETED|Treatment Phase C (1 Week)||78
9560|NCT02164539|20764|P6|COMPLETED|Treatment Phase C (1 Week)||82
9561|NCT02164539|20765|P5|COMPLETED|Treatment Phase C (1 Week)||84
9562|NCT02164539|20766|P4|COMPLETED|Treatment Phase C (1 Week)||0
9563|NCT02164539|20767|P3|COMPLETED|Treatment Phase C (1 Week)||0
9564|NCT02164539|20768|P2|COMPLETED|Treatment Phase C (1 Week)||0
9565|NCT02164539|20769|P1|COMPLETED|Treatment Phase C (1 Week)||78
9566|NCT02164539|20763|P7|STARTED|Treatment Phase C (1 Week)||80
9567|NCT02164539|20764|P6|STARTED|Treatment Phase C (1 Week)||82
9568|NCT02164539|20765|P5|STARTED|Treatment Phase C (1 Week)||84
9569|NCT02164539|20766|P4|STARTED|Treatment Phase C (1 Week)||0
9570|NCT02164539|20767|P3|STARTED|Treatment Phase C (1 Week)||0
9571|NCT02164539|20768|P2|STARTED|Treatment Phase C (1 Week)||0
9572|NCT02164539|20769|P1|STARTED|Treatment Phase C (1 Week)||79
9573|NCT02164539|20763|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
9574|NCT02164539|20764|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
9575|NCT02164539|20765|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
9576|NCT02164539|20766|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
9577|NCT02164539|20767|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
9578|NCT02164539|20768|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
9579|NCT02164539|20769|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
9580|NCT02164539|20763|P7|COMPLETED|Treatment Phase B (1 Week)||162
9581|NCT02164539|20764|P6|COMPLETED|Treatment Phase B (1 Week)||0
9582|NCT02164539|20765|P5|COMPLETED|Treatment Phase B (1 Week)||163
9583|NCT02164539|20766|P4|COMPLETED|Treatment Phase B (1 Week)||0
9584|NCT02164539|20767|P3|COMPLETED|Treatment Phase B (1 Week)||0
9585|NCT02164539|20768|P2|COMPLETED|Treatment Phase B (1 Week)||0
9586|NCT02164539|20769|P1|COMPLETED|Treatment Phase B (1 Week)||0
9587|NCT02164539|20763|P7|STARTED|Treatment Phase B (1 Week)||163
9588|NCT02164539|20764|P6|STARTED|Treatment Phase B (1 Week)||0
9589|NCT02164539|20765|P5|STARTED|Treatment Phase B (1 Week)||166
9590|NCT02164539|20766|P4|STARTED|Treatment Phase B (1 Week)||0
9591|NCT02164539|20767|P3|STARTED|Treatment Phase B (1 Week)||0
9592|NCT02164539|20768|P2|STARTED|Treatment Phase B (1 Week)||0
9593|NCT02164539|20769|P1|STARTED|Treatment Phase B (1 Week)||0
9594|NCT02164539|20763|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
9595|NCT02164539|20764|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
9596|NCT02164539|20765|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
9597|NCT02164539|20766|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
9598|NCT02164539|20767|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
9599|NCT02164539|20768|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
9600|NCT02164539|20769|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
9601|NCT02164539|20763|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
9602|NCT02164539|20764|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
9603|NCT02164539|20765|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
9604|NCT02164539|20766|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
9605|NCT02164539|20767|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
9606|NCT02164539|20768|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
9607|NCT02164539|20769|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
9608|NCT02164539|20763|P7|STARTED|Treatment Phase A (4 Weeks)||0
9609|NCT02164539|20764|P6|STARTED|Treatment Phase A (4 Weeks)||84
9610|NCT02164539|20765|P5|STARTED|Treatment Phase A (4 Weeks)||85
9611|NCT02164539|20766|P4|STARTED|Treatment Phase A (4 Weeks)||46
9612|NCT02164539|20767|P3|STARTED|Treatment Phase A (4 Weeks)||40
9613|NCT02164539|20768|P2|STARTED|Treatment Phase A (4 Weeks)||42
9614|NCT02164539|20769|P1|STARTED|Treatment Phase A (4 Weeks)||41
9615|NCT02164396|20817|P3|NOT COMPLETED|Overall Study||0
9616|NCT02164396|20818|P2|NOT COMPLETED|Overall Study||0
9617|NCT02164396|20819|P1|NOT COMPLETED|Overall Study||0
9618|NCT02164396|20817|P3|COMPLETED|Overall Study||10
9619|NCT02164396|20818|P2|COMPLETED|Overall Study||10
9620|NCT02164396|20819|P1|COMPLETED|Overall Study||10
9621|NCT02164396|20817|P3|STARTED|Overall Study||10
9622|NCT02164396|20818|P2|STARTED|Overall Study||10
9623|NCT02164396|20819|P1|STARTED|Overall Study||10
9624|NCT02163915|20832|P5|NOT COMPLETED|Overall Study||4
9625|NCT02163915|20833|P4|NOT COMPLETED|Overall Study||3
9626|NCT02163915|20834|P3|NOT COMPLETED|Overall Study||2
9627|NCT02163915|20835|P2|NOT COMPLETED|Overall Study||0
9628|NCT02163915|20836|P1|NOT COMPLETED|Overall Study||3
9629|NCT02163915|20832|P5|COMPLETED|Overall Study||6
9630|NCT02163915|20833|P4|COMPLETED|Overall Study||6
9631|NCT02163915|20834|P3|COMPLETED|Overall Study||8
9632|NCT02163915|20835|P2|COMPLETED|Overall Study||8
9633|NCT02163915|20836|P1|COMPLETED|Overall Study||7
9634|NCT02163915|20832|P5|STARTED|Overall Study||10
9635|NCT02163915|20833|P4|STARTED|Overall Study||9
9636|NCT02163915|20834|P3|STARTED|Overall Study||10
9637|NCT02163915|20835|P2|STARTED|Overall Study||8
9638|NCT02163915|20836|P1|STARTED|Overall Study||10
9639|NCT02163733|20891|P2|NOT COMPLETED|2: Second Intervention (Day 10)||0
9640|NCT02163733|20892|P1|NOT COMPLETED|2: Second Intervention (Day 10)||0
9641|NCT02163733|20891|P2|COMPLETED|2: Second Intervention (Day 10)||20
9642|NCT02163733|20892|P1|COMPLETED|2: Second Intervention (Day 10)||18
9643|NCT02163733|20891|P2|STARTED|2: Second Intervention (Day 10)||20
9644|NCT02163733|20892|P1|STARTED|2: Second Intervention (Day 10)||18
9645|NCT02163733|20891|P2|NOT COMPLETED|1: First Intervention (Day 1)||0
9646|NCT02163733|20892|P1|NOT COMPLETED|1: First Intervention (Day 1)||0
9647|NCT02163733|20891|P2|COMPLETED|1: First Intervention (Day 1)||20
9648|NCT02163733|20892|P1|COMPLETED|1: First Intervention (Day 1)||18
9649|NCT02163733|20891|P2|STARTED|1: First Intervention (Day 1)||20
9650|NCT02163733|20892|P1|STARTED|1: First Intervention (Day 1)||18
9651|NCT02163421|20931|P4|NOT COMPLETED|Overall Study||0
9652|NCT02163421|20932|P3|NOT COMPLETED|Overall Study||0
9653|NCT02163421|20933|P2|NOT COMPLETED|Overall Study||0
9654|NCT02163421|20934|P1|NOT COMPLETED|Overall Study||0
9655|NCT02163421|20931|P4|COMPLETED|Overall Study||12
9656|NCT02163421|20932|P3|COMPLETED|Overall Study||12
9657|NCT02163421|20933|P2|COMPLETED|Overall Study||12
9658|NCT02163421|20934|P1|COMPLETED|Overall Study||12
9659|NCT02163421|20931|P4|STARTED|Overall Study||12
9660|NCT02163421|20932|P3|STARTED|Overall Study||12
9661|NCT02163421|20933|P2|STARTED|Overall Study||12
9662|NCT02163421|20934|P1|STARTED|Overall Study||12
9663|NCT02163395|20941|P1|NOT COMPLETED|Overall Study||5
9664|NCT02163395|20941|P1|COMPLETED|Overall Study||39
9665|NCT02163395|20941|P1|STARTED|Overall Study||44
9666|NCT02162979|20950|P2|NOT COMPLETED|Overall Study||0
9667|NCT02162979|20951|P1|NOT COMPLETED|Overall Study||0
9668|NCT02162979|20950|P2|COMPLETED|Overall Study||0
9669|NCT02162979|20951|P1|COMPLETED|Overall Study||0
9670|NCT02162979|20950|P2|STARTED|Overall Study||0
9671|NCT02162979|20951|P1|STARTED|Overall Study||0
9672|NCT02162680|20960|P3|NOT COMPLETED|Overall Study||0
9673|NCT02162680|20961|P2|NOT COMPLETED|Overall Study||0
9674|NCT02162680|20962|P1|NOT COMPLETED|Overall Study||0
9675|NCT02162680|20960|P3|COMPLETED|Overall Study||32
9676|NCT02162680|20961|P2|COMPLETED|Overall Study||33
9677|NCT02162680|20962|P1|COMPLETED|Overall Study||33
9678|NCT02162680|20960|P3|STARTED|Overall Study||32
9679|NCT02162680|20961|P2|STARTED|Overall Study||33
9680|NCT02162680|20962|P1|STARTED|Overall Study||33
9681|NCT02161146|20975|P5|NOT COMPLETED|Overall Study||1
9682|NCT02161146|20976|P4|NOT COMPLETED|Overall Study||3
9683|NCT02161146|20977|P3|NOT COMPLETED|Overall Study||0
9684|NCT02161146|20978|P2|NOT COMPLETED|Overall Study||4
9685|NCT02161146|20979|P1|NOT COMPLETED|Overall Study||1
9686|NCT02161146|20975|P5|COMPLETED|Overall Study||48
9687|NCT02161146|20976|P4|COMPLETED|Overall Study||45
9688|NCT02161146|20977|P3|COMPLETED|Overall Study||49
9689|NCT02161146|20978|P2|COMPLETED|Overall Study||43
9690|NCT02161146|20979|P1|COMPLETED|Overall Study||46
9691|NCT02161146|20975|P5|STARTED|Overall Study||49
9692|NCT02161146|20976|P4|STARTED|Overall Study||48
9693|NCT02161146|20977|P3|STARTED|Overall Study||49
9694|NCT02161146|20978|P2|STARTED|Overall Study||47
9695|NCT02161146|20979|P1|STARTED|Overall Study||47
9696|NCT02161016|20992|P1|NOT COMPLETED|Overall Study||1
9697|NCT02161016|20992|P1|COMPLETED|Overall Study||0
9698|NCT02161016|20992|P1|STARTED|Overall Study||1
9699|NCT02160990|21002|P2|NOT COMPLETED|Overall Study||0
9700|NCT02160990|21003|P1|NOT COMPLETED|Overall Study||0
9701|NCT02160990|21002|P2|COMPLETED|Overall Study||10
9702|NCT02160990|21003|P1|COMPLETED|Overall Study||10
9703|NCT02160990|21002|P2|STARTED|Overall Study||10
9704|NCT02160990|21003|P1|STARTED|Overall Study||10
9705|NCT02160977|21023|P2|NOT COMPLETED|Six Months After Surgery||1
9706|NCT02160977|21024|P1|NOT COMPLETED|Six Months After Surgery||2
9707|NCT02160977|21023|P2|COMPLETED|Six Months After Surgery||42
9708|NCT02160977|21024|P1|COMPLETED|Six Months After Surgery||42
9709|NCT02160977|21023|P2|STARTED|Six Months After Surgery||43
9710|NCT02160977|21024|P1|STARTED|Six Months After Surgery||44
9711|NCT02160977|21023|P2|NOT COMPLETED|Three Months After Surgery||2
9712|NCT02160977|21024|P1|NOT COMPLETED|Three Months After Surgery||0
9713|NCT02160977|21023|P2|COMPLETED|Three Months After Surgery||43
9714|NCT02160977|21024|P1|COMPLETED|Three Months After Surgery||44
9715|NCT02160977|21023|P2|STARTED|Three Months After Surgery||45
9716|NCT02160977|21024|P1|STARTED|Three Months After Surgery||44
9717|NCT02160977|21023|P2|NOT COMPLETED|Six Weeks After Surgery||0
9718|NCT02160977|21024|P1|NOT COMPLETED|Six Weeks After Surgery||1
9719|NCT02160977|21023|P2|COMPLETED|Six Weeks After Surgery||45
9720|NCT02160977|21024|P1|COMPLETED|Six Weeks After Surgery||44
9721|NCT02160977|21023|P2|STARTED|Six Weeks After Surgery||45
9722|NCT02160977|21024|P1|STARTED|Six Weeks After Surgery||45
9723|NCT02160977|21023|P2|NOT COMPLETED|One Week After Surgery||0
9724|NCT02160977|21024|P1|NOT COMPLETED|One Week After Surgery||0
9725|NCT02160977|21023|P2|COMPLETED|One Week After Surgery||45
9726|NCT02160977|21024|P1|COMPLETED|One Week After Surgery||45
9727|NCT02160977|21023|P2|STARTED|One Week After Surgery||45
9728|NCT02160977|21024|P1|STARTED|One Week After Surgery||45
9729|NCT02160314|21036|P2|NOT COMPLETED|Overall Study||13
9730|NCT02160314|21037|P1|NOT COMPLETED|Overall Study||1
9731|NCT02160314|21036|P2|COMPLETED|Overall Study||59
9732|NCT02160314|21037|P1|COMPLETED|Overall Study||72
9733|NCT02160314|21036|P2|STARTED|Overall Study||72
9734|NCT02160314|21037|P1|STARTED|Overall Study||73
9735|NCT02159950|21045|P2|NOT COMPLETED|Overall Study||2
9736|NCT02159950|21046|P1|NOT COMPLETED|Overall Study||0
9737|NCT02159950|21045|P2|COMPLETED|Overall Study||0
9738|NCT02159950|21046|P1|COMPLETED|Overall Study||0
9739|NCT02159950|21045|P2|STARTED|Overall Study||2
9740|NCT02159950|21046|P1|STARTED|Overall Study||0
9741|NCT02159768|21078|P1|NOT COMPLETED|Overall Study||0
9742|NCT02159768|21078|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
9743|NCT02159768|21078|P1|STARTED|Overall Study|Started 16 July 2014|30
9744|NCT02159547|21085|P2|NOT COMPLETED|Overall Study||0
9745|NCT02159547|21086|P1|NOT COMPLETED|Overall Study||0
9746|NCT02159547|21085|P2|COMPLETED|Overall Study||112
9747|NCT02159547|21086|P1|COMPLETED|Overall Study||112
9748|NCT02159547|21085|P2|STARTED|Overall Study||112
9749|NCT02159547|21086|P1|STARTED|Overall Study||112
9750|NCT02159482|21094|P1|NOT COMPLETED|Overall Study||5
9751|NCT02159482|21094|P1|COMPLETED|Overall Study||6
9752|NCT02159482|21094|P1|STARTED|Overall Study||11
9753|NCT02159365|21099|P1|NOT COMPLETED|Overall Study||22
9754|NCT02159365|21099|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
9755|NCT02159365|21099|P1|STARTED|Overall Study||70
9756|NCT02159352|21105|P2|NOT COMPLETED|Overall Study||2
9757|NCT02159352|21106|P1|NOT COMPLETED|Overall Study||3
9758|NCT02159352|21105|P2|COMPLETED|Overall Study||12
9759|NCT02159352|21106|P1|COMPLETED|Overall Study||11
9760|NCT02159352|21105|P2|Phase 2 (Day 5-14)|Overall Study||12
9761|NCT02159352|21106|P1|Phase 2 (Day 5-14)|Overall Study||11
9762|NCT02159352|21105|P2|Phase 1 (Day 1- 4)|Overall Study||14
9763|NCT02159352|21106|P1|Phase 1 (Day 1- 4)|Overall Study||14
9764|NCT02159352|21105|P2|STARTED|Overall Study||14
9765|NCT02159352|21106|P1|STARTED|Overall Study||14
9766|NCT02159118|21158|P2|NOT COMPLETED|Overall Study||0
9767|NCT02159118|21159|P1|NOT COMPLETED|Overall Study||0
9768|NCT02159118|21158|P2|COMPLETED|Overall Study||22
9769|NCT02159118|21159|P1|COMPLETED|Overall Study||22
9770|NCT02159118|21158|P2|STARTED|Overall Study||22
9771|NCT02159118|21159|P1|STARTED|Overall Study||22
9772|NCT02159040|21181|P1|NOT COMPLETED|Overall Study||1
9773|NCT02159040|21181|P1|COMPLETED|Overall Study||0
9774|NCT02159040|21181|P1|STARTED|Overall Study||1
9775|NCT02158442|21196|P2|NOT COMPLETED|Overall Study||0
9776|NCT02158442|21197|P1|NOT COMPLETED|Overall Study||2
9777|NCT02158442|21196|P2|COMPLETED|Overall Study||7
9778|NCT02158442|21197|P1|COMPLETED|Overall Study||6
9779|NCT02158442|21196|P2|STARTED|Overall Study||7
9780|NCT02158442|21197|P1|STARTED|Overall Study||8
9781|NCT02158247|21205|P1|NOT COMPLETED|Overall Study||5
9782|NCT02158247|21205|P1|COMPLETED|Overall Study||176
9783|NCT02158247|21205|P1|STARTED|Overall Study||181
9784|NCT02158039|21221|P1|NOT COMPLETED|Overall Study||10
9785|NCT02158039|21221|P1|COMPLETED|Overall Study||23
9786|NCT02158039|21221|P1|STARTED|Overall Study||33
9787|NCT02157909|21228|P2|NOT COMPLETED|Overall Study||0
9788|NCT02157909|21229|P1|NOT COMPLETED|Overall Study||0
9789|NCT02157909|21228|P2|COMPLETED|Overall Study||66
9790|NCT02157909|21229|P1|COMPLETED|Overall Study||66
9791|NCT02157909|21228|P2|STARTED|Overall Study||66
9792|NCT02157909|21229|P1|STARTED|Overall Study||66
9793|NCT02157883|21236|P1|NOT COMPLETED|2: AZD9291+Itraconozole||1
9794|NCT02157883|21236|P1|COMPLETED|2: AZD9291+Itraconozole||38
9795|NCT02157883|21236|P1|STARTED|2: AZD9291+Itraconozole||39
9796|NCT02157883|21236|P1|NOT COMPLETED|1: AZD9291 Alone||0
9797|NCT02157883|21236|P1|COMPLETED|1: AZD9291 Alone||39
9798|NCT02157883|21236|P1|STARTED|1: AZD9291 Alone||39
9799|NCT02157376|21267|P2|NOT COMPLETED|Overall Study||18
9800|NCT02157376|21268|P1|NOT COMPLETED|Overall Study||22
9801|NCT02157376|21267|P2|COMPLETED|Overall Study||138
9802|NCT02157376|21268|P1|COMPLETED|Overall Study||133
9803|NCT02157376|21267|P2|STARTED|Overall Study||156
9804|NCT02157376|21268|P1|STARTED|Overall Study||155
9805|NCT02157298|21278|P2|NOT COMPLETED|Overall Study||2
9806|NCT02157298|21279|P1|NOT COMPLETED|Overall Study||4
9807|NCT02157298|21278|P2|COMPLETED|Overall Study||58
9808|NCT02157298|21279|P1|COMPLETED|Overall Study||119
9809|NCT02157298|21278|P2|STARTED|Overall Study||60
9810|NCT02157298|21279|P1|STARTED|Overall Study||123
9811|NCT02157116|21293|P1|NOT COMPLETED|Overall Study||9
9812|NCT02157116|21293|P1|COMPLETED|Overall Study||4
9813|NCT02157116|21293|P1|STARTED|Overall Study|signed consent form|13
9814|NCT02156466|21307|P5|NOT COMPLETED|Overall Study||0
9815|NCT02156466|21308|P4|NOT COMPLETED|Overall Study||2
9816|NCT02156466|21309|P3|NOT COMPLETED|Overall Study||1
9817|NCT02156466|21310|P2|NOT COMPLETED|Overall Study||0
9818|NCT02156466|21311|P1|NOT COMPLETED|Overall Study||0
9819|NCT02156466|21307|P5|COMPLETED|Overall Study||8
9820|NCT02156466|21308|P4|COMPLETED|Overall Study||7
9821|NCT02156466|21309|P3|COMPLETED|Overall Study||7
9822|NCT02156466|21310|P2|COMPLETED|Overall Study||8
9823|NCT02156466|21311|P1|COMPLETED|Overall Study||8
9824|NCT02156466|21307|P5|STARTED|Overall Study||8
9825|NCT02156466|21308|P4|STARTED|Overall Study||9
9826|NCT02156466|21309|P3|STARTED|Overall Study||8
9827|NCT02156466|21310|P2|STARTED|Overall Study||8
9828|NCT02156466|21311|P1|STARTED|Overall Study||8
9829|NCT02156271|21492|P2|NOT COMPLETED|Overall Study||3
9830|NCT02156271|21493|P1|NOT COMPLETED|Overall Study||4
9831|NCT02156271|21492|P2|COMPLETED|Overall Study||10
9832|NCT02156271|21493|P1|COMPLETED|Overall Study||22
9833|NCT02156271|21492|P2|STARTED|Overall Study||13
9834|NCT02156271|21493|P1|STARTED|Overall Study||26
9835|NCT02156167|21525|P1|NOT COMPLETED|Overall Study||0
9836|NCT02156167|21525|P1|COMPLETED|Overall Study||15
9837|NCT02156167|21525|P1|STARTED|Overall Study||15
9838|NCT02155985|21532|P3|NOT COMPLETED|Overall Study||1
9839|NCT02155985|21533|P2|NOT COMPLETED|Overall Study||0
9840|NCT02155985|21534|P1|NOT COMPLETED|Overall Study||1
9841|NCT02155985|21532|P3|COMPLETED|Overall Study||39
9842|NCT02155985|21533|P2|COMPLETED|Overall Study||41
9843|NCT02155985|21534|P1|COMPLETED|Overall Study||39
9844|NCT02155985|21532|P3|STARTED|Overall Study||40
9845|NCT02155985|21533|P2|STARTED|Overall Study||41
9846|NCT02155985|21534|P1|STARTED|Overall Study||40
9847|NCT02155881|21544|P2|NOT COMPLETED|Overall Study||4
9848|NCT02155881|21545|P1|NOT COMPLETED|Overall Study||2
9849|NCT02155881|21544|P2|COMPLETED|Overall Study||36
9850|NCT02155881|21545|P1|COMPLETED|Overall Study||38
9851|NCT02155881|21544|P2|STARTED|Overall Study||40
9852|NCT02155881|21545|P1|STARTED|Overall Study||40
9853|NCT02155543|21572|P7|NOT COMPLETED|Overall Study||0
9854|NCT02155543|21573|P6|NOT COMPLETED|Overall Study||0
9855|NCT02155543|21574|P5|NOT COMPLETED|Overall Study||0
9856|NCT02155543|21575|P4|NOT COMPLETED|Overall Study||0
9857|NCT02155543|21576|P3|NOT COMPLETED|Overall Study||0
9858|NCT02155543|21577|P2|NOT COMPLETED|Overall Study||0
9859|NCT02155543|21578|P1|NOT COMPLETED|Overall Study||0
9860|NCT02155543|21572|P7|COMPLETED|Overall Study||9
9861|NCT02155543|21573|P6|COMPLETED|Overall Study||3
9862|NCT02155543|21574|P5|COMPLETED|Overall Study||3
9863|NCT02155543|21575|P4|COMPLETED|Overall Study||9
9864|NCT02155543|21576|P3|COMPLETED|Overall Study||9
9865|NCT02155543|21577|P2|COMPLETED|Overall Study||9
9866|NCT02155543|21578|P1|COMPLETED|Overall Study||9
9867|NCT02155543|21572|P7|STARTED|Overall Study||9
9868|NCT02155543|21573|P6|STARTED|Overall Study||3
9869|NCT02155543|21574|P5|STARTED|Overall Study||3
9870|NCT02155543|21575|P4|STARTED|Overall Study||9
9871|NCT02155543|21576|P3|STARTED|Overall Study||9
9872|NCT02155543|21577|P2|STARTED|Overall Study||9
9873|NCT02155543|21578|P1|STARTED|Overall Study||9
9874|NCT02155335|21591|P2|NOT COMPLETED|Period 2||0
9875|NCT02155335|21592|P1|NOT COMPLETED|Period 2||0
9876|NCT02155335|21591|P2|COMPLETED|Period 2||49
9877|NCT02155335|21592|P1|COMPLETED|Period 2||50
9878|NCT02155335|21591|P2|STARTED|Period 2||49
9879|NCT02155335|21592|P1|STARTED|Period 2||50
9880|NCT02155335|21591|P2|NOT COMPLETED|Period 1||1
9881|NCT02155335|21592|P1|NOT COMPLETED|Period 1||0
9882|NCT02155335|21591|P2|COMPLETED|Period 1||49
9883|NCT02155335|21592|P1|COMPLETED|Period 1||50
9884|NCT02155335|21591|P2|Treated|Period 1||49
9885|NCT02155335|21592|P1|Treated|Period 1||50
9886|NCT02155335|21591|P2|STARTED|Period 1||50
9887|NCT02155335|21592|P1|STARTED|Period 1||50
9888|NCT02155283|21597|P1|NOT COMPLETED|Overall Study||7
9889|NCT02155283|21597|P1|COMPLETED|Overall Study||9
9890|NCT02155283|21597|P1|STARTED|Overall Study||16
9891|NCT02155010|21604|P2|NOT COMPLETED|Overall Study||6
9892|NCT02155010|21605|P1|NOT COMPLETED|Overall Study||6
9893|NCT02155010|21604|P2|COMPLETED|Overall Study||31
9894|NCT02155010|21605|P1|COMPLETED|Overall Study||31
9895|NCT02155010|21604|P2|STARTED|Overall Study||37
9896|NCT02155010|21605|P1|STARTED|Overall Study||37
9897|NCT02154906|21615|P2|NOT COMPLETED|Overall Study||3
9898|NCT02154906|21616|P1|NOT COMPLETED|Overall Study||2
9899|NCT02154906|21615|P2|COMPLETED|Overall Study||17
9900|NCT02154906|21616|P1|COMPLETED|Overall Study||19
9901|NCT02154906|21615|P2|STARTED|Overall Study||20
9902|NCT02154906|21616|P1|STARTED|Overall Study||21
9903|NCT02154425|21624|P1|NOT COMPLETED|Sampling Period||0
9904|NCT02154425|21624|P1|COMPLETED|Sampling Period||17
9905|NCT02154425|21624|P1|STARTED|Sampling Period||17
9906|NCT02154425|21624|P1|NOT COMPLETED|Screening Period||1
9907|NCT02154425|21624|P1|COMPLETED|Screening Period||17
9908|NCT02154425|21624|P1|STARTED|Screening Period||18
9909|NCT02154386|21656|P2|NOT COMPLETED|Overall Study||2
9910|NCT02154386|21657|P1|NOT COMPLETED|Overall Study||1
9911|NCT02154386|21656|P2|COMPLETED|Overall Study||21
9912|NCT02154386|21657|P1|COMPLETED|Overall Study||22
9913|NCT02154386|21656|P2|STARTED|Overall Study||23
9914|NCT02154386|21657|P1|STARTED|Overall Study||23
9915|NCT02154139|21667|P1|NOT COMPLETED|Overall Study||7
9916|NCT02154139|21667|P1|COMPLETED|Overall Study||644
9917|NCT02154139|21667|P1|STARTED|Overall Study||651
9918|NCT02154087|21675|P1|NOT COMPLETED|Overall Study||1
9919|NCT02154087|21675|P1|COMPLETED|Overall Study||0
9920|NCT02154087|21675|P1|STARTED|Overall Study||1
9921|NCT02154048|21682|P3|NOT COMPLETED|Overall Study||0
9922|NCT02154048|21683|P2|NOT COMPLETED|Overall Study||0
9923|NCT02154048|21684|P1|NOT COMPLETED|Overall Study||0
9924|NCT02154048|21682|P3|COMPLETED|Overall Study||1
9925|NCT02154048|21683|P2|COMPLETED|Overall Study||2
9926|NCT02154048|21684|P1|COMPLETED|Overall Study||2
9927|NCT02154048|21682|P3|STARTED|Overall Study||1
9928|NCT02154048|21683|P2|STARTED|Overall Study||2
9929|NCT02154048|21684|P1|STARTED|Overall Study||2
9930|NCT02153827|21694|P2|NOT COMPLETED|Overall Study||9
9931|NCT02153827|21695|P1|NOT COMPLETED|Overall Study||3
9932|NCT02153827|21694|P2|COMPLETED|Overall Study||14
9933|NCT02153827|21695|P1|COMPLETED|Overall Study||22
9934|NCT02153827|21694|P2|STARTED|Overall Study||23
9935|NCT02153827|21695|P1|STARTED|Overall Study||25
9936|NCT02153788|21711|P2|NOT COMPLETED|Overall Study||1
9937|NCT02153788|21712|P1|NOT COMPLETED|Overall Study||2
9938|NCT02153788|21711|P2|COMPLETED|Overall Study||18
9939|NCT02153788|21712|P1|COMPLETED|Overall Study||23
9940|NCT02153788|21711|P2|STARTED|Overall Study||19
9941|NCT02153788|21712|P1|STARTED|Overall Study||25
9942|NCT02153489|21730|P2|NOT COMPLETED|Period 2||0
9943|NCT02153489|21731|P1|NOT COMPLETED|Period 2||0
9944|NCT02153489|21730|P2|COMPLETED|Period 2||15
9945|NCT02153489|21731|P1|COMPLETED|Period 2||15
9946|NCT02153489|21730|P2|STARTED|Period 2||15
9947|NCT02153489|21731|P1|STARTED|Period 2||15
9948|NCT02153489|21730|P2|NOT COMPLETED|Period 1||0
9949|NCT02153489|21731|P1|NOT COMPLETED|Period 1||0
9950|NCT02153489|21730|P2|COMPLETED|Period 1||15
9951|NCT02153489|21731|P1|COMPLETED|Period 1||15
9952|NCT02153489|21730|P2|STARTED|Period 1||15
9953|NCT02153489|21731|P1|STARTED|Period 1||15
9954|NCT02153398|21774|P5|NOT COMPLETED|Overall Study||0
9955|NCT02153398|21775|P4|NOT COMPLETED|Overall Study||1
9956|NCT02153398|21776|P3|NOT COMPLETED|Overall Study||1
9957|NCT02153398|21777|P2|NOT COMPLETED|Overall Study||0
9958|NCT02153398|21778|P1|NOT COMPLETED|Overall Study||1
9959|NCT02153398|21774|P5|COMPLETED|Overall Study||10
9960|NCT02153398|21775|P4|COMPLETED|Overall Study||9
9961|NCT02153398|21776|P3|COMPLETED|Overall Study||9
9962|NCT02153398|21777|P2|COMPLETED|Overall Study||10
9963|NCT02153398|21778|P1|COMPLETED|Overall Study||9
9964|NCT02153398|21774|P5|STARTED|Overall Study||10
9965|NCT02153398|21775|P4|STARTED|Overall Study||10
9966|NCT02153398|21776|P3|STARTED|Overall Study||10
9967|NCT02153398|21777|P2|STARTED|Overall Study||10
9968|NCT02153398|21778|P1|STARTED|Overall Study||10
9969|NCT02153099|21907|P7|NOT COMPLETED|Overall Study||0
9970|NCT02153099|21908|P6|NOT COMPLETED|Overall Study||0
9971|NCT02153099|21909|P5|NOT COMPLETED|Overall Study||0
9972|NCT02153099|21910|P4|NOT COMPLETED|Overall Study||0
9973|NCT02153099|21911|P3|NOT COMPLETED|Overall Study||0
9974|NCT02153099|21912|P2|NOT COMPLETED|Overall Study||0
9975|NCT02153099|21913|P1|NOT COMPLETED|Overall Study||0
9976|NCT02153099|21907|P7|COMPLETED|Overall Study||12
9977|NCT02153099|21908|P6|COMPLETED|Overall Study||6
9978|NCT02153099|21909|P5|COMPLETED|Overall Study||6
9979|NCT02153099|21910|P4|COMPLETED|Overall Study||6
9980|NCT02153099|21911|P3|COMPLETED|Overall Study||6
9981|NCT02153099|21912|P2|COMPLETED|Overall Study||6
9982|NCT02153099|21913|P1|COMPLETED|Overall Study||6
9983|NCT02153099|21907|P7|STARTED|Overall Study||12
9984|NCT02153099|21908|P6|STARTED|Overall Study||6
9985|NCT02153099|21909|P5|STARTED|Overall Study||6
9986|NCT02153099|21910|P4|STARTED|Overall Study||6
9987|NCT02153099|21911|P3|STARTED|Overall Study||6
9988|NCT02153099|21912|P2|STARTED|Overall Study||6
9989|NCT02153099|21913|P1|STARTED|Overall Study||6
9990|NCT02153086|21967|P1|NOT COMPLETED|Overall Study||4
9991|NCT02153086|21967|P1|COMPLETED|Overall Study||232
9992|NCT02153086|21967|P1|STARTED|Overall Study||236
9993|NCT02152605|21983|P2|NOT COMPLETED|Overall Study||18
9994|NCT02152605|21984|P1|NOT COMPLETED|Overall Study||19
9995|NCT02152605|21983|P2|COMPLETED|Overall Study||230
9996|NCT02152605|21984|P1|COMPLETED|Overall Study||229
9997|NCT02152605|21983|P2|STARTED|Overall Study||248
9998|NCT02152605|21984|P1|STARTED|Overall Study||248
9999|NCT02152566|21994|P1|NOT COMPLETED|Overall Study||3
10000|NCT02152566|21994|P1|COMPLETED|Overall Study||3
10001|NCT02152566|21994|P1|STARTED|Overall Study||6
10002|NCT02152371|22000|P2|NOT COMPLETED|Overall Study||16
10003|NCT02152371|22001|P1|NOT COMPLETED|Overall Study||12
10004|NCT02152371|22000|P2|COMPLETED|Overall Study||134
10005|NCT02152371|22001|P1|COMPLETED|Overall Study||138
10006|NCT02152371|22000|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
10007|NCT02152371|22001|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
10008|NCT02152371|22000|P2|STARTED|Overall Study||150
10009|NCT02152371|22001|P1|STARTED|Overall Study||150
10010|NCT02152007|22037|P1|NOT COMPLETED|Overall Study||1
10011|NCT02152007|22037|P1|COMPLETED|Overall Study||14
10012|NCT02152007|22037|P1|STARTED|Overall Study||15
10013|NCT02151994|22046|P13|NOT COMPLETED|Food Effect (FE): Fed||0
10014|NCT02151994|22047|P12|NOT COMPLETED|Food Effect (FE): Fed||0
10015|NCT02151994|22048|P11|NOT COMPLETED|Food Effect (FE): Fed||0
10016|NCT02151994|22049|P10|NOT COMPLETED|Food Effect (FE): Fed||0
10017|NCT02151994|22050|P9|NOT COMPLETED|Food Effect (FE): Fed||0
10018|NCT02151994|22051|P8|NOT COMPLETED|Food Effect (FE): Fed||0
10019|NCT02151994|22052|P7|NOT COMPLETED|Food Effect (FE): Fed||0
10020|NCT02151994|22053|P6|NOT COMPLETED|Food Effect (FE): Fed||0
10021|NCT02151994|22054|P5|NOT COMPLETED|Food Effect (FE): Fed||0
10022|NCT02151994|22055|P4|NOT COMPLETED|Food Effect (FE): Fed||0
10023|NCT02151994|22056|P3|NOT COMPLETED|Food Effect (FE): Fed||0
10024|NCT02151994|22057|P2|NOT COMPLETED|Food Effect (FE): Fed||0
10025|NCT02151994|22058|P1|NOT COMPLETED|Food Effect (FE): Fed||0
10026|NCT02151994|22046|P13|COMPLETED|Food Effect (FE): Fed||12
10027|NCT02151994|22047|P12|COMPLETED|Food Effect (FE): Fed||0
10028|NCT02151994|22048|P11|COMPLETED|Food Effect (FE): Fed||0
10029|NCT02151994|22049|P10|COMPLETED|Food Effect (FE): Fed||0
10030|NCT02151994|22050|P9|COMPLETED|Food Effect (FE): Fed||0
10031|NCT02151994|22051|P8|COMPLETED|Food Effect (FE): Fed||0
10032|NCT02151994|22052|P7|COMPLETED|Food Effect (FE): Fed||0
10033|NCT02151994|22053|P6|COMPLETED|Food Effect (FE): Fed||0
10034|NCT02151994|22054|P5|COMPLETED|Food Effect (FE): Fed||0
10035|NCT02151994|22055|P4|COMPLETED|Food Effect (FE): Fed||0
10036|NCT02151994|22056|P3|COMPLETED|Food Effect (FE): Fed||0
10037|NCT02151994|22057|P2|COMPLETED|Food Effect (FE): Fed||0
10038|NCT02151994|22058|P1|COMPLETED|Food Effect (FE): Fed||0
10039|NCT02151994|22046|P13|STARTED|Food Effect (FE): Fed||12
10040|NCT02151994|22047|P12|STARTED|Food Effect (FE): Fed||0
10041|NCT02151994|22048|P11|STARTED|Food Effect (FE): Fed||0
10042|NCT02151994|22049|P10|STARTED|Food Effect (FE): Fed||0
10043|NCT02151994|22050|P9|STARTED|Food Effect (FE): Fed||0
10044|NCT02151994|22051|P8|STARTED|Food Effect (FE): Fed||0
10045|NCT02151994|22052|P7|STARTED|Food Effect (FE): Fed||0
10046|NCT02151994|22053|P6|STARTED|Food Effect (FE): Fed||0
10047|NCT02151994|22054|P5|STARTED|Food Effect (FE): Fed||0
10048|NCT02151994|22055|P4|STARTED|Food Effect (FE): Fed||0
10049|NCT02151994|22056|P3|STARTED|Food Effect (FE): Fed||0
10050|NCT02151994|22057|P2|STARTED|Food Effect (FE): Fed||0
10051|NCT02151994|22058|P1|STARTED|Food Effect (FE): Fed||0
10052|NCT02151994|22046|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
10053|NCT02151994|22047|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
10054|NCT02151994|22048|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
10055|NCT02151994|22049|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
10056|NCT02151994|22050|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
10057|NCT02151994|22051|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
10058|NCT02151994|22052|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
10059|NCT02151994|22053|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
10060|NCT02151994|22054|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
10061|NCT02151994|22055|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
10062|NCT02151994|22056|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
10063|NCT02151994|22057|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
10064|NCT02151994|22058|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
10065|NCT02151994|22046|P13|COMPLETED|Food Effect (FE): Fasted||0
10066|NCT02151994|22047|P12|COMPLETED|Food Effect (FE): Fasted||12
10067|NCT02151994|22048|P11|COMPLETED|Food Effect (FE): Fasted||0
10068|NCT02151994|22049|P10|COMPLETED|Food Effect (FE): Fasted||0
10069|NCT02151994|22050|P9|COMPLETED|Food Effect (FE): Fasted||0
10070|NCT02151994|22051|P8|COMPLETED|Food Effect (FE): Fasted||0
10071|NCT02151994|22052|P7|COMPLETED|Food Effect (FE): Fasted||0
10072|NCT02151994|22053|P6|COMPLETED|Food Effect (FE): Fasted||0
10073|NCT02151994|22054|P5|COMPLETED|Food Effect (FE): Fasted||0
10074|NCT02151994|22055|P4|COMPLETED|Food Effect (FE): Fasted||0
10075|NCT02151994|22056|P3|COMPLETED|Food Effect (FE): Fasted||0
10076|NCT02151994|22057|P2|COMPLETED|Food Effect (FE): Fasted||0
10077|NCT02151994|22058|P1|COMPLETED|Food Effect (FE): Fasted||0
10078|NCT02151994|22046|P13|STARTED|Food Effect (FE): Fasted||0
10079|NCT02151994|22047|P12|STARTED|Food Effect (FE): Fasted||12
10080|NCT02151994|22048|P11|STARTED|Food Effect (FE): Fasted||0
10081|NCT02151994|22049|P10|STARTED|Food Effect (FE): Fasted||0
10082|NCT02151994|22050|P9|STARTED|Food Effect (FE): Fasted||0
10083|NCT02151994|22051|P8|STARTED|Food Effect (FE): Fasted||0
10084|NCT02151994|22052|P7|STARTED|Food Effect (FE): Fasted||0
10085|NCT02151994|22053|P6|STARTED|Food Effect (FE): Fasted||0
10086|NCT02151994|22054|P5|STARTED|Food Effect (FE): Fasted||0
10087|NCT02151994|22055|P4|STARTED|Food Effect (FE): Fasted||0
10088|NCT02151994|22056|P3|STARTED|Food Effect (FE): Fasted||0
10089|NCT02151994|22057|P2|STARTED|Food Effect (FE): Fasted||0
10090|NCT02151994|22058|P1|STARTED|Food Effect (FE): Fasted||0
10091|NCT02151994|22046|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10092|NCT02151994|22047|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10093|NCT02151994|22048|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10094|NCT02151994|22049|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10095|NCT02151994|22050|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10096|NCT02151994|22051|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10097|NCT02151994|22052|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10098|NCT02151994|22053|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10099|NCT02151994|22054|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10100|NCT02151994|22055|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10101|NCT02151994|22056|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10102|NCT02151994|22057|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10103|NCT02151994|22058|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
10104|NCT02151994|22046|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
10105|NCT02151994|22047|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
10106|NCT02151994|22048|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
10107|NCT02151994|22049|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
10108|NCT02151994|22050|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
10109|NCT02151994|22051|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
10110|NCT02151994|22052|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
10111|NCT02151994|22053|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
10112|NCT02151994|22054|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
10113|NCT02151994|22055|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
10114|NCT02151994|22056|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
10115|NCT02151994|22057|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
10116|NCT02151994|22058|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
10117|NCT02151994|22046|P13|STARTED|Multiple Ascending Dose (MAD)||0
10118|NCT02151994|22047|P12|STARTED|Multiple Ascending Dose (MAD)||0
10119|NCT02151994|22048|P11|STARTED|Multiple Ascending Dose (MAD)||0
10120|NCT02151994|22049|P10|STARTED|Multiple Ascending Dose (MAD)||0
10121|NCT02151994|22050|P9|STARTED|Multiple Ascending Dose (MAD)||6
10122|NCT02151994|22051|P8|STARTED|Multiple Ascending Dose (MAD)||0
10123|NCT02151994|22052|P7|STARTED|Multiple Ascending Dose (MAD)||6
10124|NCT02151994|22053|P6|STARTED|Multiple Ascending Dose (MAD)||6
10125|NCT02151994|22054|P5|STARTED|Multiple Ascending Dose (MAD)||6
10126|NCT02151994|22055|P4|STARTED|Multiple Ascending Dose (MAD)||6
10127|NCT02151994|22056|P3|STARTED|Multiple Ascending Dose (MAD)||0
10128|NCT02151994|22057|P2|STARTED|Multiple Ascending Dose (MAD)||0
10129|NCT02151994|22058|P1|STARTED|Multiple Ascending Dose (MAD)||10
10130|NCT02151994|22046|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
10131|NCT02151994|22047|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
10132|NCT02151994|22048|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
10133|NCT02151994|22049|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
10134|NCT02151994|22050|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
10135|NCT02151994|22051|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
10136|NCT02151994|22052|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
10137|NCT02151994|22053|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
10138|NCT02151994|22054|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
10139|NCT02151994|22055|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
10140|NCT02151994|22056|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
10141|NCT02151994|22057|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
10142|NCT02151994|22058|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
10143|NCT02151994|22046|P13|COMPLETED|Single Ascending Dose (SAD)||0
10144|NCT02151994|22047|P12|COMPLETED|Single Ascending Dose (SAD)||0
10145|NCT02151994|22048|P11|COMPLETED|Single Ascending Dose (SAD)||6
10146|NCT02151994|22049|P10|COMPLETED|Single Ascending Dose (SAD)||6
10147|NCT02151994|22050|P9|COMPLETED|Single Ascending Dose (SAD)||0
10148|NCT02151994|22051|P8|COMPLETED|Single Ascending Dose (SAD)||6
10149|NCT02151994|22052|P7|COMPLETED|Single Ascending Dose (SAD)||6
10150|NCT02151994|22053|P6|COMPLETED|Single Ascending Dose (SAD)||6
10151|NCT02151994|22054|P5|COMPLETED|Single Ascending Dose (SAD)||6
10152|NCT02151994|22055|P4|COMPLETED|Single Ascending Dose (SAD)||6
10153|NCT02151994|22056|P3|COMPLETED|Single Ascending Dose (SAD)||6
10154|NCT02151994|22057|P2|COMPLETED|Single Ascending Dose (SAD)||6
10155|NCT02151994|22058|P1|COMPLETED|Single Ascending Dose (SAD)||18
10156|NCT02151994|22046|P13|STARTED|Single Ascending Dose (SAD)||0
10157|NCT02151994|22047|P12|STARTED|Single Ascending Dose (SAD)||0
10158|NCT02151994|22048|P11|STARTED|Single Ascending Dose (SAD)||6
10159|NCT02151994|22049|P10|STARTED|Single Ascending Dose (SAD)||6
10160|NCT02151994|22050|P9|STARTED|Single Ascending Dose (SAD)||0
10161|NCT02151994|22051|P8|STARTED|Single Ascending Dose (SAD)||6
10162|NCT02151994|22052|P7|STARTED|Single Ascending Dose (SAD)||6
10163|NCT02151994|22053|P6|STARTED|Single Ascending Dose (SAD)||6
10164|NCT02151994|22054|P5|STARTED|Single Ascending Dose (SAD)||6
10165|NCT02151994|22055|P4|STARTED|Single Ascending Dose (SAD)||6
10166|NCT02151994|22056|P3|STARTED|Single Ascending Dose (SAD)||6
10167|NCT02151994|22057|P2|STARTED|Single Ascending Dose (SAD)||6
10168|NCT02151994|22058|P1|STARTED|Single Ascending Dose (SAD)||18
10169|NCT02151786|22096|P1|NOT COMPLETED|Overall Study||36
10170|NCT02151786|22096|P1|COMPLETED|Overall Study||1084
10171|NCT02151786|22096|P1|STARTED|Overall Study||1120
10172|NCT02151773|22107|P1|NOT COMPLETED|Overall Study||64
10173|NCT02151773|22107|P1|COMPLETED|Overall Study||3429
10174|NCT02151773|22107|P1|STARTED|Overall Study||3493
10175|NCT02151058|22115|P3|NOT COMPLETED|Overall Study||5
10176|NCT02151058|22116|P2|NOT COMPLETED|Overall Study||1
10177|NCT02151058|22117|P1|NOT COMPLETED|Overall Study||2
10178|NCT02151058|22115|P3|COMPLETED|Overall Study||86
10179|NCT02151058|22116|P2|COMPLETED|Overall Study||90
10180|NCT02151058|22117|P1|COMPLETED|Overall Study||43
10181|NCT02151058|22115|P3|STARTED|Overall Study||91
10182|NCT02151058|22116|P2|STARTED|Overall Study||91
10183|NCT02151058|22117|P1|STARTED|Overall Study||45
10184|NCT02150954|22151|P2|NOT COMPLETED|Overall Study||0
10185|NCT02150954|22152|P1|NOT COMPLETED|Overall Study||1
10186|NCT02150954|22151|P2|COMPLETED|Overall Study||59
10187|NCT02150954|22152|P1|COMPLETED|Overall Study||57
10188|NCT02150954|22151|P2|STARTED|Overall Study||59
10189|NCT02150954|22152|P1|STARTED|Overall Study||58
10190|NCT02150499|22176|P2|NOT COMPLETED|Overall Study||0
10191|NCT02150499|22177|P1|NOT COMPLETED|Overall Study||0
10192|NCT02150499|22176|P2|COMPLETED|Overall Study||9
10193|NCT02150499|22177|P1|COMPLETED|Overall Study||9
10194|NCT02150499|22176|P2|STARTED|Overall Study||9
10195|NCT02150499|22177|P1|STARTED|Overall Study||9
10196|NCT02150460|22199|P2|NOT COMPLETED|Overall Study||0
10197|NCT02150460|22200|P1|NOT COMPLETED|Overall Study||0
10198|NCT02150460|22199|P2|COMPLETED|Overall Study||50
10199|NCT02150460|22200|P1|COMPLETED|Overall Study||50
10200|NCT02150460|22199|P2|STARTED|Overall Study||50
10201|NCT02150460|22200|P1|STARTED|Overall Study||50
10202|NCT02150213|22224|P1|NOT COMPLETED|Overall Study||2
10203|NCT02150213|22224|P1|COMPLETED|Overall Study||57
10204|NCT02150213|22224|P1|STARTED|Overall Study||59
10205|NCT02150109|22229|P1|NOT COMPLETED|Overall Study||0
10206|NCT02150109|22229|P1|COMPLETED|Overall Study||372
10207|NCT02150109|22229|P1|STARTED|Overall Study||372
10208|NCT02150044|22241|P1|NOT COMPLETED|Overall Study||0
10209|NCT02150044|22241|P1|COMPLETED|Overall Study||29
10210|NCT02150044|22241|P1|Study Cohort|Overall Study||13
10211|NCT02150044|22241|P1|Lead-In Subjects|Overall Study||16
10212|NCT02150044|22241|P1|STARTED|Overall Study||29
10213|NCT02149875|22250|P3|NOT COMPLETED|Overall Study||9
10214|NCT02149875|22251|P2|NOT COMPLETED|Overall Study||8
10215|NCT02149875|22252|P1|NOT COMPLETED|Overall Study||7
10216|NCT02149875|22250|P3|COMPLETED|Overall Study||20
10217|NCT02149875|22251|P2|COMPLETED|Overall Study||20
10218|NCT02149875|22252|P1|COMPLETED|Overall Study||20
10219|NCT02149875|22250|P3|STARTED|Overall Study||29
10220|NCT02149875|22251|P2|STARTED|Overall Study||28
10221|NCT02149875|22252|P1|STARTED|Overall Study||27
10222|NCT02149342|22263|P1|NOT COMPLETED|Overall Study||0
10223|NCT02149342|22263|P1|COMPLETED|Overall Study|14 patients|14
10224|NCT02149342|22263|P1|STARTED|Overall Study|14 patients|14
10225|NCT02149303|22275|P1|NOT COMPLETED|Overall Study||0
10226|NCT02149303|22275|P1|COMPLETED|Overall Study||191
10227|NCT02149303|22275|P1|STARTED|Overall Study||191
10228|NCT02148107|22284|P3|NOT COMPLETED|Overall Study||0
10229|NCT02148107|22285|P2|NOT COMPLETED|Overall Study||0
10230|NCT02148107|22286|P1|NOT COMPLETED|Overall Study||0
10231|NCT02148107|22284|P3|COMPLETED|Overall Study||3
10232|NCT02148107|22285|P2|COMPLETED|Overall Study||7
10233|NCT02148107|22286|P1|COMPLETED|Overall Study||8
10234|NCT02148107|22284|P3|STARTED|Overall Study||3
10235|NCT02148107|22285|P2|STARTED|Overall Study||7
10236|NCT02148107|22286|P1|STARTED|Overall Study||8
10237|NCT02147691|22304|P2|NOT COMPLETED|Overall Study||1
10238|NCT02147691|22305|P1|NOT COMPLETED|Overall Study||4
10239|NCT02147691|22304|P2|COMPLETED|Overall Study||11
10240|NCT02147691|22305|P1|COMPLETED|Overall Study||6
10241|NCT02147691|22304|P2|STARTED|Overall Study||12
10242|NCT02147691|22305|P1|STARTED|Overall Study||10
10243|NCT02147561|22349|P1|NOT COMPLETED|Overall Study||4
10244|NCT02147561|22349|P1|COMPLETED|Overall Study||276
10245|NCT02147561|22349|P1|STARTED|Overall Study||280
10246|NCT02147288|22357|P10|NOT COMPLETED|Overall Study||0
10247|NCT02147288|22358|P9|NOT COMPLETED|Overall Study||0
10248|NCT02147288|22359|P8|NOT COMPLETED|Overall Study||0
10249|NCT02147288|22360|P7|NOT COMPLETED|Overall Study||0
10250|NCT02147288|22361|P6|NOT COMPLETED|Overall Study||0
10251|NCT02147288|22362|P5|NOT COMPLETED|Overall Study||0
10252|NCT02147288|22363|P4|NOT COMPLETED|Overall Study||0
10253|NCT02147288|22364|P3|NOT COMPLETED|Overall Study||0
10254|NCT02147288|22365|P2|NOT COMPLETED|Overall Study||2
10255|NCT02147288|22366|P1|NOT COMPLETED|Overall Study||1
10256|NCT02147288|22357|P10|COMPLETED|Overall Study||0
10257|NCT02147288|22358|P9|COMPLETED|Overall Study||0
10258|NCT02147288|22359|P8|COMPLETED|Overall Study||0
10259|NCT02147288|22360|P7|COMPLETED|Overall Study||0
10260|NCT02147288|22361|P6|COMPLETED|Overall Study||0
10261|NCT02147288|22362|P5|COMPLETED|Overall Study||0
10262|NCT02147288|22363|P4|COMPLETED|Overall Study||0
10263|NCT02147288|22364|P3|COMPLETED|Overall Study||0
10264|NCT02147288|22365|P2|COMPLETED|Overall Study||22
10265|NCT02147288|22366|P1|COMPLETED|Overall Study||21
10266|NCT02147288|22357|P10|STARTED|Overall Study||0
10267|NCT02147288|22358|P9|STARTED|Overall Study||0
10268|NCT02147288|22359|P8|STARTED|Overall Study||0
10269|NCT02147288|22360|P7|STARTED|Overall Study||0
10270|NCT02147288|22361|P6|STARTED|Overall Study||0
10271|NCT02147288|22362|P5|STARTED|Overall Study||0
10272|NCT02147288|22363|P4|STARTED|Overall Study||0
10273|NCT02147288|22364|P3|STARTED|Overall Study||0
10274|NCT02147288|22365|P2|STARTED|Overall Study||24
10275|NCT02147288|22366|P1|STARTED|Overall Study||22
10276|NCT02147093|22374|P2|NOT COMPLETED|Period 2||0
10277|NCT02147093|22375|P1|NOT COMPLETED|Period 2||2
10278|NCT02147093|22374|P2|COMPLETED|Period 2||19
10279|NCT02147093|22375|P1|COMPLETED|Period 2||18
10280|NCT02147093|22374|P2|STARTED|Period 2||19
10281|NCT02147093|22375|P1|STARTED|Period 2||20
10282|NCT02147093|22374|P2|NOT COMPLETED|Period 1||1
10283|NCT02147093|22375|P1|NOT COMPLETED|Period 1||0
10284|NCT02147093|22374|P2|COMPLETED|Period 1||19
10285|NCT02147093|22375|P1|COMPLETED|Period 1||20
10286|NCT02147093|22374|P2|STARTED|Period 1||20
10287|NCT02147093|22375|P1|STARTED|Period 1||20
10288|NCT02146599|22383|P1|NOT COMPLETED|Overall Study||5
10289|NCT02146599|22383|P1|COMPLETED|Overall Study||296
10290|NCT02146599|22383|P1|STARTED|Overall Study||301
10291|NCT02146482|22389|P2|NOT COMPLETED|Overall Study||0
10292|NCT02146482|22390|P1|NOT COMPLETED|Overall Study||0
10293|NCT02146482|22389|P2|COMPLETED|Overall Study||25
10294|NCT02146482|22390|P1|COMPLETED|Overall Study||21
10295|NCT02146482|22389|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
10296|NCT02146482|22390|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
10297|NCT02146352|22396|P1|NOT COMPLETED|Overall Study||2
10298|NCT02146352|22396|P1|COMPLETED|Overall Study||28
10299|NCT02146352|22396|P1|7 Days Post-stent Removal|Overall Study||28
10300|NCT02146352|22396|P1|30 or 60 Days Post-procedure|Overall Study||30
10301|NCT02146352|22396|P1|STARTED|Overall Study||30
10302|NCT02146105|22410|P1|NOT COMPLETED|Overall Study||6
10303|NCT02146105|22410|P1|COMPLETED|Overall Study||39
10304|NCT02146105|22410|P1|STARTED|Overall Study||45
10305|NCT02146001|22416|P2|NOT COMPLETED|Overall Study||0
10306|NCT02146001|22417|P1|NOT COMPLETED|Overall Study||0
10307|NCT02146001|22416|P2|COMPLETED|Overall Study||19
10308|NCT02146001|22417|P1|COMPLETED|Overall Study||19
10309|NCT02146001|22416|P2|STARTED|Overall Study||19
10310|NCT02146001|22417|P1|STARTED|Overall Study||19
10311|NCT02145754|22427|P1|NOT COMPLETED|Overall Study||0
10312|NCT02145754|22427|P1|COMPLETED|Overall Study||235
10313|NCT02145754|22427|P1|STARTED|Overall Study||235
10314|NCT02145676|22434|P3|NOT COMPLETED|Overall Study||0
10315|NCT02145676|22435|P2|NOT COMPLETED|Overall Study||0
10316|NCT02145676|22436|P1|NOT COMPLETED|Overall Study||0
10317|NCT02145676|22434|P3|COMPLETED|Overall Study||18
10318|NCT02145676|22435|P2|COMPLETED|Overall Study||18
10319|NCT02145676|22436|P1|COMPLETED|Overall Study||17
10320|NCT02145676|22434|P3|STARTED|Overall Study||18
10321|NCT02145676|22435|P2|STARTED|Overall Study||18
10322|NCT02145676|22436|P1|STARTED|Overall Study||17
10323|NCT02145299|22461|P2|NOT COMPLETED|Overall Study||0
10324|NCT02145299|22462|P1|NOT COMPLETED|Overall Study||0
10325|NCT02145299|22461|P2|COMPLETED|Overall Study||2
10326|NCT02145299|22462|P1|COMPLETED|Overall Study||6
10327|NCT02145299|22461|P2|STARTED|Overall Study||2
10328|NCT02145299|22462|P1|STARTED|Overall Study||6
10329|NCT02145156|22491|P3|NOT COMPLETED|Overall Study||82
10330|NCT02145156|22492|P2|NOT COMPLETED|Overall Study||120
10331|NCT02145156|22493|P1|NOT COMPLETED|Overall Study||93
10332|NCT02145156|22491|P3|COMPLETED|Overall Study||267
10333|NCT02145156|22492|P2|COMPLETED|Overall Study||259
10334|NCT02145156|22493|P1|COMPLETED|Overall Study||280
10335|NCT02145156|22491|P3|STARTED|Overall Study||349
10336|NCT02145156|22492|P2|STARTED|Overall Study||379
10337|NCT02145156|22493|P1|STARTED|Overall Study||373
10338|NCT02144337|22536|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
10339|NCT02144337|22537|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
10340|NCT02144337|22536|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10341|NCT02144337|22537|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
10342|NCT02144337|22536|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
10343|NCT02144337|22537|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
10344|NCT02144337|22536|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
10345|NCT02144337|22537|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
10346|NCT02144337|22536|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
10347|NCT02144337|22537|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
10348|NCT02144337|22536|P2|STARTED|T2 Follow-up (Post-intervention)||5
10349|NCT02144337|22537|P1|STARTED|T2 Follow-up (Post-intervention)||8
10350|NCT02144337|22536|P2|NOT COMPLETED|Baseline 0 Months||0
10351|NCT02144337|22537|P1|NOT COMPLETED|Baseline 0 Months||0
10352|NCT02144337|22536|P2|COMPLETED|Baseline 0 Months||5
10353|NCT02144337|22537|P1|COMPLETED|Baseline 0 Months||8
10354|NCT02144337|22536|P2|STARTED|Baseline 0 Months||5
10355|NCT02144337|22537|P1|STARTED|Baseline 0 Months||8
10356|NCT02144259|22550|P3|NOT COMPLETED|Overall Study||18
10357|NCT02144259|22551|P2|NOT COMPLETED|Overall Study||5
10358|NCT02144259|22552|P1|NOT COMPLETED|Overall Study||10
10359|NCT02144259|22550|P3|COMPLETED|Overall Study||16
10360|NCT02144259|22551|P2|COMPLETED|Overall Study||28
10361|NCT02144259|22552|P1|COMPLETED|Overall Study||23
10362|NCT02144259|22550|P3|STARTED|Overall Study||34
10363|NCT02144259|22551|P2|STARTED|Overall Study||33
10364|NCT02144259|22552|P1|STARTED|Overall Study||33
10365|NCT02144220|22566|P1|NOT COMPLETED|Overall Study||19
10366|NCT02144220|22566|P1|COMPLETED|Overall Study||258
10367|NCT02144220|22566|P1|STARTED|Overall Study||277
10368|NCT02143947|22576|P2|NOT COMPLETED|Overall Study||2
10369|NCT02143947|22577|P1|NOT COMPLETED|Overall Study||4
10370|NCT02143947|22576|P2|COMPLETED|Overall Study||42
10371|NCT02143947|22577|P1|COMPLETED|Overall Study||32
10372|NCT02143947|22576|P2|STARTED|Overall Study||44
10373|NCT02143947|22577|P1|STARTED|Overall Study||36
10374|NCT02143583|22592|P3|NOT COMPLETED|Overall Study||2
10375|NCT02143583|22593|P2|NOT COMPLETED|Overall Study||0
10376|NCT02143583|22594|P1|NOT COMPLETED|Overall Study||1
10377|NCT02143583|22592|P3|COMPLETED|Overall Study||66
10378|NCT02143583|22593|P2|COMPLETED|Overall Study||66
10379|NCT02143583|22594|P1|COMPLETED|Overall Study||61
10380|NCT02143583|22592|P3|STARTED|Overall Study||68
10381|NCT02143583|22593|P2|STARTED|Overall Study||66
10382|NCT02143583|22594|P1|STARTED|Overall Study||62
10383|NCT02142712|22608|P4|NOT COMPLETED|Overall Study||0
10384|NCT02142712|22609|P3|NOT COMPLETED|Overall Study||1
10385|NCT02142712|22610|P2|NOT COMPLETED|Overall Study||1
10386|NCT02142712|22611|P1|NOT COMPLETED|Overall Study||1
10387|NCT02142712|22608|P4|COMPLETED|Overall Study||0
10388|NCT02142712|22609|P3|COMPLETED|Overall Study||0
10389|NCT02142712|22610|P2|COMPLETED|Overall Study||0
10390|NCT02142712|22611|P1|COMPLETED|Overall Study||0
10391|NCT02142712|22608|P4|STARTED|Overall Study||0
10392|NCT02142712|22609|P3|STARTED|Overall Study||1
10393|NCT02142712|22610|P2|STARTED|Overall Study||1
10394|NCT02142712|22611|P1|STARTED|Overall Study||1
10395|NCT02141867|22631|P1|NOT COMPLETED|Overall Study||94
10396|NCT02141867|22631|P1|COMPLETED|Overall Study||3927
10397|NCT02141867|22631|P1|STARTED|Overall Study||4021
10398|NCT02142361|22638|P3|NOT COMPLETED|Overall Study||0
10399|NCT02142361|22639|P2|NOT COMPLETED|Overall Study||0
10400|NCT02142361|22640|P1|NOT COMPLETED|Overall Study||0
10401|NCT02142361|22638|P3|COMPLETED|Overall Study||20
10402|NCT02142361|22639|P2|COMPLETED|Overall Study||20
10403|NCT02142361|22640|P1|COMPLETED|Overall Study||20
10404|NCT02142361|22638|P3|STARTED|Overall Study||20
10405|NCT02142361|22639|P2|STARTED|Overall Study||20
10406|NCT02142361|22640|P1|STARTED|Overall Study||20
10407|NCT02142153|22749|P10|NOT COMPLETED|Overall Study||0
10408|NCT02142153|22750|P9|NOT COMPLETED|Overall Study||0
10409|NCT02142153|22751|P8|NOT COMPLETED|Overall Study||0
10410|NCT02142153|22752|P7|NOT COMPLETED|Overall Study||0
10411|NCT02142153|22753|P6|NOT COMPLETED|Overall Study||0
10412|NCT02142153|22754|P5|NOT COMPLETED|Overall Study||0
10413|NCT02142153|22755|P4|NOT COMPLETED|Overall Study||0
10414|NCT02142153|22756|P3|NOT COMPLETED|Overall Study||0
10415|NCT02142153|22757|P2|NOT COMPLETED|Overall Study||0
10416|NCT02142153|22758|P1|NOT COMPLETED|Overall Study||0
10417|NCT02142153|22749|P10|COMPLETED|Overall Study||2
10418|NCT02142153|22750|P9|COMPLETED|Overall Study||6
10419|NCT02142153|22751|P8|COMPLETED|Overall Study||2
10420|NCT02142153|22752|P7|COMPLETED|Overall Study||6
10421|NCT02142153|22753|P6|COMPLETED|Overall Study||2
10422|NCT02142153|22754|P5|COMPLETED|Overall Study||6
10423|NCT02142153|22755|P4|COMPLETED|Overall Study||2
10424|NCT02142153|22756|P3|COMPLETED|Overall Study||6
10425|NCT02142153|22757|P2|COMPLETED|Overall Study||2
10426|NCT02142153|22758|P1|COMPLETED|Overall Study||6
10427|NCT02142153|22749|P10|STARTED|Overall Study||2
10428|NCT02142153|22750|P9|STARTED|Overall Study||6
10429|NCT02142153|22751|P8|STARTED|Overall Study||2
10430|NCT02142153|22752|P7|STARTED|Overall Study||6
10431|NCT02142153|22753|P6|STARTED|Overall Study||2
10432|NCT02142153|22754|P5|STARTED|Overall Study||6
10433|NCT02142153|22755|P4|STARTED|Overall Study||2
10434|NCT02142153|22756|P3|STARTED|Overall Study||6
10435|NCT02142153|22757|P2|STARTED|Overall Study||2
10436|NCT02142153|22758|P1|STARTED|Overall Study||6
10437|NCT02141997|22794|P4|NOT COMPLETED|Overall Study||1
10438|NCT02141997|22795|P3|NOT COMPLETED|Overall Study||3
10439|NCT02141997|22796|P2|NOT COMPLETED|Overall Study||6
10440|NCT02141997|22797|P1|NOT COMPLETED|Overall Study||3
10441|NCT02141997|22794|P4|COMPLETED|Overall Study||54
10442|NCT02141997|22795|P3|COMPLETED|Overall Study||53
10443|NCT02141997|22796|P2|COMPLETED|Overall Study||49
10444|NCT02141997|22797|P1|COMPLETED|Overall Study||53
10445|NCT02141997|22794|P4|STARTED|Overall Study||55
10446|NCT02141997|22795|P3|STARTED|Overall Study||56
10447|NCT02141997|22796|P2|STARTED|Overall Study||55
10448|NCT02141997|22797|P1|STARTED|Overall Study||56
10449|NCT02141633|22837|P2|NOT COMPLETED|Overall Study||0
10450|NCT02141633|22838|P1|NOT COMPLETED|Overall Study||1
10451|NCT02141633|22837|P2|COMPLETED|Overall Study||15
10452|NCT02141633|22838|P1|COMPLETED|Overall Study||15
10453|NCT02141633|22837|P2|STARTED|Overall Study||15
10454|NCT02141633|22838|P1|STARTED|Overall Study||16
10455|NCT02141620|22846|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10456|NCT02141620|22847|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
10457|NCT02141620|22846|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
10458|NCT02141620|22847|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
10459|NCT02141620|22846|P2|STARTED|Treatment Condition 2 (7 Days)||7
10460|NCT02141620|22847|P1|STARTED|Treatment Condition 2 (7 Days)||7
10461|NCT02141620|22846|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
10462|NCT02141620|22847|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
10463|NCT02141620|22846|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
10464|NCT02141620|22847|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
10465|NCT02141620|22846|P2|STARTED|Treatment Condition 1 (7 Days)||7
10466|NCT02141620|22847|P1|STARTED|Treatment Condition 1 (7 Days)||8
10467|NCT02141516|22908|P3|NOT COMPLETED|Overall Study||0
10468|NCT02141516|22909|P2|NOT COMPLETED|Overall Study||5
10469|NCT02141516|22910|P1|NOT COMPLETED|Overall Study||0
10470|NCT02141516|22908|P3|COMPLETED|Overall Study||87
10471|NCT02141516|22909|P2|COMPLETED|Overall Study||107
10472|NCT02141516|22910|P1|COMPLETED|Overall Study||40
10473|NCT02141516|22908|P3|STARTED|Overall Study||87
10474|NCT02141516|22909|P2|STARTED|Overall Study||112
10475|NCT02141516|22910|P1|STARTED|Overall Study||40
10476|NCT02141217|22960|P2|NOT COMPLETED|Overall Study||8
10477|NCT02141217|22961|P1|NOT COMPLETED|Overall Study||11
10478|NCT02141217|22960|P2|COMPLETED|Overall Study||229
10479|NCT02141217|22961|P1|COMPLETED|Overall Study||223
10480|NCT02141217|22960|P2|ITT Population-Actual Treatment Received|Overall Study||235
10481|NCT02141217|22961|P1|ITT Population-Actual Treatment Received|Overall Study||236
10482|NCT02141217|22960|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
10483|NCT02141217|22961|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
10484|NCT02141217|22960|P2|STARTED|Overall Study||237
10485|NCT02141217|22961|P1|STARTED|Overall Study||234
10486|NCT02140957|22981|P2|NOT COMPLETED|Overall Study||23
10487|NCT02140957|22982|P1|NOT COMPLETED|Overall Study||27
10488|NCT02140957|22981|P2|COMPLETED|Overall Study||99
10489|NCT02140957|22982|P1|COMPLETED|Overall Study||102
10490|NCT02140957|22981|P2|STARTED|Overall Study||122
10491|NCT02140957|22982|P1|STARTED|Overall Study||129
10492|NCT02140788|22992|P4|NOT COMPLETED|Overall Study||0
10493|NCT02140788|22993|P3|NOT COMPLETED|Overall Study||0
10494|NCT02140788|22994|P2|NOT COMPLETED|Overall Study||0
10495|NCT02140788|22995|P1|NOT COMPLETED|Overall Study||0
10496|NCT02140788|22992|P4|COMPLETED|Overall Study||0
10497|NCT02140788|22993|P3|COMPLETED|Overall Study||0
10498|NCT02140788|22994|P2|COMPLETED|Overall Study||0
10499|NCT02140788|22995|P1|COMPLETED|Overall Study||0
10500|NCT02140788|22992|P4|STARTED|Overall Study||0
10501|NCT02140788|22993|P3|STARTED|Overall Study||0
10502|NCT02140788|22994|P2|STARTED|Overall Study||0
10503|NCT02140788|22995|P1|STARTED|Overall Study||0
10504|NCT02140645|23027|P6|NOT COMPLETED|Overall Study||70896
10505|NCT02140645|23028|P5|NOT COMPLETED|Overall Study||3286
10506|NCT02140645|23029|P4|NOT COMPLETED|Overall Study||13833
10507|NCT02140645|23030|P3|NOT COMPLETED|Overall Study||4236
10508|NCT02140645|23031|P2|NOT COMPLETED|Overall Study||61654
10509|NCT02140645|23032|P1|NOT COMPLETED|Overall Study||5489
10510|NCT02140645|23027|P6|COMPLETED|Overall Study||3050
10511|NCT02140645|23028|P5|COMPLETED|Overall Study||150
10512|NCT02140645|23029|P4|COMPLETED|Overall Study||530
10513|NCT02140645|23030|P3|COMPLETED|Overall Study||205
10514|NCT02140645|23031|P2|COMPLETED|Overall Study||3041
10515|NCT02140645|23032|P1|COMPLETED|Overall Study||243
10516|NCT02140645|23027|P6|STARTED|Overall Study||73946
10517|NCT02140645|23028|P5|STARTED|Overall Study||3436
10518|NCT02140645|23029|P4|STARTED|Overall Study||14363
10519|NCT02140645|23030|P3|STARTED|Overall Study||4441
10520|NCT02140645|23031|P2|STARTED|Overall Study||64695
10521|NCT02140645|23032|P1|STARTED|Overall Study||5732
10522|NCT02140372|23119|P1|NOT COMPLETED|Overall Study||0
10523|NCT02140372|23119|P1|COMPLETED|Overall Study||10
10524|NCT02140372|23119|P1|STARTED|Overall Study||10
10525|NCT02140164|23130|P1|NOT COMPLETED|Overall Study||2
10526|NCT02140164|23130|P1|COMPLETED|Overall Study||5
10527|NCT02140164|23130|P1|STARTED|Overall Study||7
10528|NCT02140060|23145|P6|NOT COMPLETED|Overall Study||1
10529|NCT02140060|23146|P5|NOT COMPLETED|Overall Study||1
10530|NCT02140060|23147|P4|NOT COMPLETED|Overall Study||2
10531|NCT02140060|23148|P3|NOT COMPLETED|Overall Study||0
10532|NCT02140060|23149|P2|NOT COMPLETED|Overall Study||0
10533|NCT02140060|23150|P1|NOT COMPLETED|Overall Study||0
10534|NCT02140060|23145|P6|COMPLETED|Overall Study||43
10535|NCT02140060|23146|P5|COMPLETED|Overall Study||44
10536|NCT02140060|23147|P4|COMPLETED|Overall Study||43
10537|NCT02140060|23148|P3|COMPLETED|Overall Study||44
10538|NCT02140060|23149|P2|COMPLETED|Overall Study||44
10539|NCT02140060|23150|P1|COMPLETED|Overall Study||44
10540|NCT02140060|23145|P6|STARTED|Overall Study||44
10541|NCT02140060|23146|P5|STARTED|Overall Study||45
10542|NCT02140060|23147|P4|STARTED|Overall Study||45
10543|NCT02140060|23148|P3|STARTED|Overall Study||44
10544|NCT02140060|23149|P2|STARTED|Overall Study||44
10545|NCT02140060|23150|P1|STARTED|Overall Study||44
10546|NCT02139982|23175|P10|NOT COMPLETED|Overall Study||0
10547|NCT02139982|23176|P9|NOT COMPLETED|Overall Study||0
10548|NCT02139982|23177|P8|NOT COMPLETED|Overall Study||0
10549|NCT02139982|23178|P7|NOT COMPLETED|Overall Study||0
10550|NCT02139982|23179|P6|NOT COMPLETED|Overall Study||0
10551|NCT02139982|23180|P5|NOT COMPLETED|Overall Study||0
10552|NCT02139982|23181|P4|NOT COMPLETED|Overall Study||1
10553|NCT02139982|23182|P3|NOT COMPLETED|Overall Study||0
10554|NCT02139982|23183|P2|NOT COMPLETED|Overall Study||1
10555|NCT02139982|23184|P1|NOT COMPLETED|Overall Study||0
10556|NCT02139982|23175|P10|COMPLETED|Overall Study||13
10557|NCT02139982|23176|P9|COMPLETED|Overall Study||13
10558|NCT02139982|23177|P8|COMPLETED|Overall Study||13
10559|NCT02139982|23178|P7|COMPLETED|Overall Study||13
10560|NCT02139982|23179|P6|COMPLETED|Overall Study||13
10561|NCT02139982|23180|P5|COMPLETED|Overall Study||13
10562|NCT02139982|23181|P4|COMPLETED|Overall Study||7
10563|NCT02139982|23182|P3|COMPLETED|Overall Study||8
10564|NCT02139982|23183|P2|COMPLETED|Overall Study||7
10565|NCT02139982|23184|P1|COMPLETED|Overall Study||8
10566|NCT02139982|23175|P10|STARTED|Overall Study||13
10567|NCT02139982|23176|P9|STARTED|Overall Study||13
10568|NCT02139982|23177|P8|STARTED|Overall Study||13
10569|NCT02139982|23178|P7|STARTED|Overall Study||13
10570|NCT02139982|23179|P6|STARTED|Overall Study||13
10571|NCT02139982|23180|P5|STARTED|Overall Study||13
10572|NCT02139982|23181|P4|STARTED|Overall Study||8
10573|NCT02139982|23182|P3|STARTED|Overall Study||8
10574|NCT02139982|23183|P2|STARTED|Overall Study||8
10575|NCT02139982|23184|P1|STARTED|Overall Study||8
10576|NCT02139943|23229|P3|NOT COMPLETED|Overall Study||7
10577|NCT02139943|23230|P2|NOT COMPLETED|Overall Study||6
10578|NCT02139943|23231|P1|NOT COMPLETED|Overall Study||10
10579|NCT02139943|23229|P3|COMPLETED|Overall Study||110
10580|NCT02139943|23230|P2|COMPLETED|Overall Study||111
10581|NCT02139943|23231|P1|COMPLETED|Overall Study||107
10582|NCT02139943|23229|P3|STARTED|Overall Study||117
10583|NCT02139943|23230|P2|STARTED|Overall Study||117
10584|NCT02139943|23231|P1|STARTED|Overall Study||117
10585|NCT02139878|23242|P2|NOT COMPLETED|Second Intervention (7 Days)||0
10586|NCT02139878|23243|P1|NOT COMPLETED|Second Intervention (7 Days)||0
10587|NCT02139878|23242|P2|COMPLETED|Second Intervention (7 Days)||9
10588|NCT02139878|23243|P1|COMPLETED|Second Intervention (7 Days)||10
10589|NCT02139878|23242|P2|STARTED|Second Intervention (7 Days)||9
10590|NCT02139878|23243|P1|STARTED|Second Intervention (7 Days)||10
10591|NCT02139878|23242|P2|NOT COMPLETED|Washout Period (8 Days)||0
10592|NCT02139878|23243|P1|NOT COMPLETED|Washout Period (8 Days)||0
10593|NCT02139878|23242|P2|COMPLETED|Washout Period (8 Days)||10
10594|NCT02139878|23243|P1|COMPLETED|Washout Period (8 Days)||9
10595|NCT02139878|23242|P2|STARTED|Washout Period (8 Days)||10
10596|NCT02139878|23243|P1|STARTED|Washout Period (8 Days)||9
10597|NCT02139878|23242|P2|NOT COMPLETED|First Intervention (7 Days)||0
10598|NCT02139878|23243|P1|NOT COMPLETED|First Intervention (7 Days)||0
10599|NCT02139878|23242|P2|COMPLETED|First Intervention (7 Days)||10
10600|NCT02139878|23243|P1|COMPLETED|First Intervention (7 Days)||9
10601|NCT02139878|23242|P2|STARTED|First Intervention (7 Days)||10
10602|NCT02139878|23243|P1|STARTED|First Intervention (7 Days)||9
10603|NCT02139228|23253|P2|NOT COMPLETED|Overall Study||0
10604|NCT02139228|23254|P1|NOT COMPLETED|Overall Study||0
10605|NCT02139228|23253|P2|COMPLETED|Overall Study||211
10606|NCT02139228|23254|P1|COMPLETED|Overall Study||215
10607|NCT02139228|23253|P2|STARTED|Overall Study||211
10608|NCT02139228|23254|P1|STARTED|Overall Study||215
10609|NCT02139046|23267|P5|NOT COMPLETED|Overall Study||57
10610|NCT02139046|23268|P4|NOT COMPLETED|Overall Study||68
10611|NCT02139046|23269|P3|NOT COMPLETED|Overall Study||59
10612|NCT02139046|23270|P2|NOT COMPLETED|Overall Study||54
10613|NCT02139046|23271|P1|NOT COMPLETED|Overall Study||62
10614|NCT02139046|23267|P5|COMPLETED|Overall Study||301
10615|NCT02139046|23268|P4|COMPLETED|Overall Study||290
10616|NCT02139046|23269|P3|COMPLETED|Overall Study||298
10617|NCT02139046|23270|P2|COMPLETED|Overall Study||305
10618|NCT02139046|23271|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
10619|NCT02139046|23267|P5|Full Analysis Set|Overall Study||357
10620|NCT02139046|23268|P4|Full Analysis Set|Overall Study||357
10621|NCT02139046|23269|P3|Full Analysis Set|Overall Study||355
10622|NCT02139046|23270|P2|Full Analysis Set|Overall Study||357
10623|NCT02139046|23271|P1|Full Analysis Set|Overall Study||357
10624|NCT02139046|23267|P5|Safety Analysis Set|Overall Study||357
10625|NCT02139046|23268|P4|Safety Analysis Set|Overall Study||357
10626|NCT02139046|23269|P3|Safety Analysis Set|Overall Study||355
10627|NCT02139046|23270|P2|Safety Analysis Set|Overall Study||358
10628|NCT02139046|23271|P1|Safety Analysis Set|Overall Study||356
10629|NCT02139046|23267|P5|STARTED|Overall Study||358
10630|NCT02139046|23268|P4|STARTED|Overall Study||358
10631|NCT02139046|23269|P3|STARTED|Overall Study||357
10632|NCT02139046|23270|P2|STARTED|Overall Study||359
10633|NCT02139046|23271|P1|STARTED|Overall Study||358
10634|NCT02138747|23297|P4|NOT COMPLETED|Treatment Period 2||3
10635|NCT02138747|23298|P3|NOT COMPLETED|Treatment Period 2||2
10636|NCT02138747|23299|P2|NOT COMPLETED|Treatment Period 2||7
10637|NCT02138747|23300|P1|NOT COMPLETED|Treatment Period 2||17
10638|NCT02138747|23297|P4|COMPLETED|Treatment Period 2||24
10639|NCT02138747|23298|P3|COMPLETED|Treatment Period 2||24
10640|NCT02138747|23299|P2|COMPLETED|Treatment Period 2||125
10641|NCT02138747|23300|P1|COMPLETED|Treatment Period 2||121
10642|NCT02138747|23297|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
10643|NCT02138747|23298|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
10644|NCT02138747|23299|P2|STARTED|Treatment Period 2||132
10645|NCT02138747|23300|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
10646|NCT02138747|23297|P4|NOT COMPLETED|Treatment Period 1||4
10647|NCT02138747|23298|P3|NOT COMPLETED|Treatment Period 1||4
10648|NCT02138747|23299|P2|NOT COMPLETED|Treatment Period 1||25
10649|NCT02138747|23300|P1|NOT COMPLETED|Treatment Period 1||20
10650|NCT02138747|23297|P4|COMPLETED|Treatment Period 1||28
10651|NCT02138747|23298|P3|COMPLETED|Treatment Period 1||27
10652|NCT02138747|23299|P2|COMPLETED|Treatment Period 1||132
10653|NCT02138747|23300|P1|COMPLETED|Treatment Period 1||136
10654|NCT02138747|23297|P4|STARTED|Treatment Period 1||32
10655|NCT02138747|23298|P3|STARTED|Treatment Period 1||31
10656|NCT02138747|23299|P2|STARTED|Treatment Period 1||157
10657|NCT02138747|23300|P1|STARTED|Treatment Period 1||156
10658|NCT02138461|23334|P2|NOT COMPLETED|Overall Study||0
10659|NCT02138461|23335|P1|NOT COMPLETED|Overall Study||0
10660|NCT02138461|23334|P2|COMPLETED|Overall Study||110
10661|NCT02138461|23335|P1|COMPLETED|Overall Study||101
10662|NCT02138461|23334|P2|STARTED|Overall Study||110
10663|NCT02138461|23335|P1|STARTED|Overall Study||101
10664|NCT02138097|23359|P2|NOT COMPLETED|Overall Study||0
10665|NCT02138097|23360|P1|NOT COMPLETED|Overall Study||0
10666|NCT02138097|23359|P2|COMPLETED|Overall Study||459722
10667|NCT02138097|23360|P1|COMPLETED|Overall Study||155345
10668|NCT02138097|23359|P2|STARTED|Overall Study||459722
10669|NCT02138097|23360|P1|STARTED|Overall Study||155345
10670|NCT02138006|23552|P2|NOT COMPLETED|Overall Study||0
10671|NCT02138006|23553|P1|NOT COMPLETED|Overall Study||0
10672|NCT02138006|23552|P2|COMPLETED|Overall Study||54
10673|NCT02138006|23553|P1|COMPLETED|Overall Study||48
10674|NCT02138006|23552|P2|STARTED|Overall Study||54
10675|NCT02138006|23553|P1|STARTED|Overall Study||48
10676|NCT02137785|23563|P2|NOT COMPLETED|Overall Study||4
10677|NCT02137785|23564|P1|NOT COMPLETED|Overall Study||3
10678|NCT02137785|23563|P2|COMPLETED|Overall Study||130
10679|NCT02137785|23564|P1|COMPLETED|Overall Study||132
10680|NCT02137785|23563|P2|STARTED|Overall Study||134
10681|NCT02137785|23564|P1|STARTED|Overall Study||135
10682|NCT02137603|23672|P2|NOT COMPLETED|Overall Study||0
10683|NCT02137603|23673|P1|NOT COMPLETED|Overall Study||2
10684|NCT02137603|23672|P2|COMPLETED|Overall Study||18
10685|NCT02137603|23673|P1|COMPLETED|Overall Study||16
10686|NCT02137603|23672|P2|STARTED|Overall Study||18
10687|NCT02137603|23673|P1|STARTED|Overall Study||18
10688|NCT02137512|23681|P1|NOT COMPLETED|Overall Study||0
10689|NCT02137512|23681|P1|COMPLETED|Overall Study||30
10690|NCT02137512|23681|P1|STARTED|Overall Study||30
10691|NCT02137382|23697|P2|NOT COMPLETED|Cross-over Period 2||0
10692|NCT02137382|23698|P1|NOT COMPLETED|Cross-over Period 2||0
10693|NCT02137382|23697|P2|COMPLETED|Cross-over Period 2||21
10694|NCT02137382|23698|P1|COMPLETED|Cross-over Period 2||18
10695|NCT02137382|23697|P2|STARTED|Cross-over Period 2||21
10696|NCT02137382|23698|P1|STARTED|Cross-over Period 2||18
10697|NCT02137382|23697|P2|NOT COMPLETED|Wash Out||0
10698|NCT02137382|23698|P1|NOT COMPLETED|Wash Out||0
10699|NCT02137382|23697|P2|COMPLETED|Wash Out||21
10700|NCT02137382|23698|P1|COMPLETED|Wash Out||18
10701|NCT02137382|23697|P2|STARTED|Wash Out||21
10702|NCT02137382|23698|P1|STARTED|Wash Out||18
10703|NCT02137382|23697|P2|NOT COMPLETED|Cross-over Period 1||0
10704|NCT02137382|23698|P1|NOT COMPLETED|Cross-over Period 1||2
10705|NCT02137382|23697|P2|COMPLETED|Cross-over Period 1||21
10706|NCT02137382|23698|P1|COMPLETED|Cross-over Period 1||18
10707|NCT02137382|23697|P2|STARTED|Cross-over Period 1||21
10708|NCT02137382|23698|P1|STARTED|Cross-over Period 1||20
10709|NCT02136498|23718|P2|NOT COMPLETED|Overall Study||0
10710|NCT02136498|23719|P1|NOT COMPLETED|Overall Study||0
10711|NCT02136498|23718|P2|COMPLETED|Overall Study||33
10712|NCT02136498|23719|P1|COMPLETED|Overall Study||33
10713|NCT02136498|23718|P2|STARTED|Overall Study||33
10714|NCT02136498|23719|P1|STARTED|Overall Study||33
10715|NCT02136238|23729|P3|NOT COMPLETED|Overall Study||0
10716|NCT02136238|23730|P2|NOT COMPLETED|Overall Study||0
10717|NCT02136238|23731|P1|NOT COMPLETED|Overall Study||0
10718|NCT02136238|23729|P3|COMPLETED|Overall Study||10
10719|NCT02136238|23730|P2|COMPLETED|Overall Study||4
10720|NCT02136238|23731|P1|COMPLETED|Overall Study||4
10721|NCT02136238|23729|P3|STARTED|Overall Study||10
10722|NCT02136238|23730|P2|STARTED|Overall Study||4
10723|NCT02136238|23731|P1|STARTED|Overall Study||4
10724|NCT02136134|23744|P2|NOT COMPLETED|Overall Study||251
10725|NCT02136134|23745|P1|NOT COMPLETED|Overall Study||247
10726|NCT02136134|23744|P2|COMPLETED|Overall Study||0
10727|NCT02136134|23745|P1|COMPLETED|Overall Study||0
10728|NCT02136134|23744|P2|Treated|Overall Study||243
10729|NCT02136134|23745|P1|Treated|Overall Study||237
10730|NCT02136134|23744|P2|STARTED|Overall Study||251
10731|NCT02136134|23745|P1|STARTED|Overall Study||247
10732|NCT02136004|23763|P1|NOT COMPLETED|Overall Study||1
10733|NCT02136004|23763|P1|COMPLETED|Overall Study||219
10734|NCT02136004|23763|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
10735|NCT02135900|23774|P1|NOT COMPLETED|Overall Study||0
10736|NCT02135900|23774|P1|COMPLETED|Overall Study||32
10737|NCT02135900|23774|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
10738|NCT02135016|23784|P3|NOT COMPLETED|Overall Study||0
10739|NCT02135016|23785|P2|NOT COMPLETED|Overall Study||0
10740|NCT02135016|23786|P1|NOT COMPLETED|Overall Study||0
10741|NCT02135016|23784|P3|COMPLETED|Overall Study||15
10742|NCT02135016|23785|P2|COMPLETED|Overall Study||15
10743|NCT02135016|23786|P1|COMPLETED|Overall Study||15
10744|NCT02135016|23784|P3|STARTED|Overall Study||15
10745|NCT02135016|23785|P2|STARTED|Overall Study||15
10746|NCT02135016|23786|P1|STARTED|Overall Study||15
10747|NCT02134977|23806|P1|NOT COMPLETED|Overall Study||102
10748|NCT02134977|23806|P1|COMPLETED|Overall Study||2714
10749|NCT02134977|23806|P1|STARTED|Overall Study||2816
10750|NCT02134587|23827|P1|NOT COMPLETED|Overall Study||30
10751|NCT02134587|23827|P1|COMPLETED|Overall Study||173
10752|NCT02134587|23827|P1|STARTED|Overall Study||203
10753|NCT02134184|23839|P3|NOT COMPLETED|Overall Study||0
10754|NCT02134184|23840|P2|NOT COMPLETED|Overall Study||0
10755|NCT02134184|23841|P1|NOT COMPLETED|Overall Study||0
10756|NCT02134184|23839|P3|COMPLETED|Overall Study||8
10757|NCT02134184|23840|P2|COMPLETED|Overall Study||37
10758|NCT02134184|23841|P1|COMPLETED|Overall Study||33
10759|NCT02134184|23839|P3|STARTED|Overall Study||8
10760|NCT02134184|23840|P2|STARTED|Overall Study||37
10761|NCT02134184|23841|P1|STARTED|Overall Study||33
10762|NCT02134119|23854|P2|NOT COMPLETED|Overall Study||0
10763|NCT02134119|23855|P1|NOT COMPLETED|Overall Study||0
10764|NCT02134119|23854|P2|COMPLETED|Overall Study||15
10765|NCT02134119|23855|P1|COMPLETED|Overall Study||30
10766|NCT02134119|23854|P2|STARTED|Overall Study||15
10767|NCT02134119|23855|P1|STARTED|Overall Study||30
10768|NCT02133534|23893|P1|NOT COMPLETED|Overall Study||0
10769|NCT02133534|23893|P1|COMPLETED|Overall Study||1
10770|NCT02133534|23893|P1|STARTED|Overall Study||1
10771|NCT02133235|23899|P2|NOT COMPLETED|Overall Study||0
10772|NCT02133235|23900|P1|NOT COMPLETED|Overall Study||0
10773|NCT02133235|23899|P2|COMPLETED|Overall Study||57
10774|NCT02133235|23900|P1|COMPLETED|Overall Study||55
10775|NCT02133235|23899|P2|STARTED|Overall Study||57
10776|NCT02133235|23900|P1|STARTED|Overall Study||55
10777|NCT02133131|23919|P7|NOT COMPLETED|Overall Study||12
10778|NCT02133131|23920|P6|NOT COMPLETED|Overall Study||14
10779|NCT02133131|23921|P5|NOT COMPLETED|Overall Study||15
10780|NCT02133131|23922|P4|NOT COMPLETED|Overall Study||6
10781|NCT02133131|23923|P3|NOT COMPLETED|Overall Study||1
10782|NCT02133131|23924|P2|NOT COMPLETED|Overall Study||5
10783|NCT02133131|23925|P1|NOT COMPLETED|Overall Study||5
10784|NCT02133131|23919|P7|COMPLETED|Overall Study||0
10785|NCT02133131|23920|P6|COMPLETED|Overall Study||0
10786|NCT02133131|23921|P5|COMPLETED|Overall Study||0
10787|NCT02133131|23922|P4|COMPLETED|Overall Study||15
10788|NCT02133131|23923|P3|COMPLETED|Overall Study||19
10789|NCT02133131|23924|P2|COMPLETED|Overall Study||25
10790|NCT02133131|23925|P1|COMPLETED|Overall Study||26
10791|NCT02133131|23919|P7|STARTED|Overall Study||12
10792|NCT02133131|23920|P6|STARTED|Overall Study||14
10793|NCT02133131|23921|P5|STARTED|Overall Study||15
10794|NCT02133131|23922|P4|STARTED|Overall Study||21
10795|NCT02133131|23923|P3|STARTED|Overall Study||20
10796|NCT02133131|23924|P2|STARTED|Overall Study||30
10797|NCT02133131|23925|P1|STARTED|Overall Study||31
10798|NCT02132936|23966|P4|NOT COMPLETED|Overall Study||14
10799|NCT02132936|23967|P3|NOT COMPLETED|Overall Study||14
10800|NCT02132936|23968|P2|NOT COMPLETED|Overall Study||9
10801|NCT02132936|23969|P1|NOT COMPLETED|Overall Study||10
10802|NCT02132936|23966|P4|COMPLETED|Overall Study||29
10803|NCT02132936|23967|P3|COMPLETED|Overall Study||174
10804|NCT02132936|23968|P2|COMPLETED|Overall Study||38
10805|NCT02132936|23969|P1|COMPLETED|Overall Study||175
10806|NCT02132936|23966|P4|STARTED|Overall Study||43
10807|NCT02132936|23967|P3|STARTED|Overall Study||188
10808|NCT02132936|23968|P2|STARTED|Overall Study||47
10809|NCT02132936|23969|P1|STARTED|Overall Study||185
10810|NCT02132767|23987|P2|NOT COMPLETED|Overall Study||15
10811|NCT02132767|23988|P1|NOT COMPLETED|Overall Study||17
10812|NCT02132767|23987|P2|COMPLETED|Overall Study||246
10813|NCT02132767|23988|P1|COMPLETED|Overall Study||245
10814|NCT02132767|23987|P2|STARTED|Overall Study||261
10815|NCT02132767|23988|P1|STARTED|Overall Study||262
10816|NCT02132611|24008|P1|NOT COMPLETED|Overall Study||2
10817|NCT02132611|24008|P1|COMPLETED|Overall Study||98
10818|NCT02132611|24008|P1|STARTED|Overall Study||100
10819|NCT02132572|24013|P1|NOT COMPLETED|Overall Study||0
10820|NCT02132572|24013|P1|COMPLETED|Overall Study||201
10821|NCT02132572|24013|P1|STARTED|Overall Study||201
10822|NCT02132117|24019|P2|NOT COMPLETED|Overall Study||5
10823|NCT02132117|24020|P1|NOT COMPLETED|Overall Study||11
10824|NCT02132117|24019|P2|COMPLETED|Overall Study||216
10825|NCT02132117|24020|P1|COMPLETED|Overall Study||213
10826|NCT02132117|24019|P2|STARTED|Overall Study||221
10827|NCT02132117|24020|P1|STARTED|Overall Study||224
10828|NCT02131636|24038|P2|NOT COMPLETED|Overall Study||5
10829|NCT02131636|24039|P1|NOT COMPLETED|Overall Study||12
10830|NCT02131636|24038|P2|COMPLETED|Overall Study||213
10831|NCT02131636|24039|P1|COMPLETED|Overall Study||210
10832|NCT02131636|24038|P2|STARTED|Overall Study||218
10833|NCT02131636|24039|P1|STARTED|Overall Study||222
10834|NCT02131532|24055|P1|NOT COMPLETED|Overall Study||4
10835|NCT02131532|24055|P1|COMPLETED|Overall Study||8
10836|NCT02131532|24055|P1|STARTED|Overall Study||12
10837|NCT02131402|24074|P1|NOT COMPLETED|Overall Study||0
10838|NCT02131402|24074|P1|COMPLETED|Overall Study||60
10839|NCT02131402|24074|P1|STARTED|Overall Study||60
10840|NCT02131311|24145|P1|NOT COMPLETED|Overall Study||4
10841|NCT02131311|24145|P1|COMPLETED|Overall Study||86
10842|NCT02131311|24145|P1|STARTED|Overall Study||90
10843|NCT02131233|24157|P2|NOT COMPLETED|Overall Study||27
10844|NCT02131233|24158|P1|NOT COMPLETED|Overall Study||43
10845|NCT02131233|24157|P2|COMPLETED|Overall Study|Completed to Week 48|242
10846|NCT02131233|24158|P1|COMPLETED|Overall Study|Completed to Week 48|490
10847|NCT02131233|24157|P2|Treated|Overall Study||266
10848|NCT02131233|24158|P1|Treated|Overall Study||531
10849|NCT02131233|24157|P2|STARTED|Overall Study|Enrolled participants|269
10850|NCT02131233|24158|P1|STARTED|Overall Study|Enrolled participants|533
10851|NCT02130999|24176|P2|NOT COMPLETED|Overall Study||0
10852|NCT02130999|24177|P1|NOT COMPLETED|Overall Study||0
10853|NCT02130999|24176|P2|COMPLETED|Overall Study||8
10854|NCT02130999|24177|P1|COMPLETED|Overall Study||6
10855|NCT02130999|24176|P2|STARTED|Overall Study||8
10856|NCT02130999|24177|P1|STARTED|Overall Study||6
10857|NCT02129608|24206|P3|NOT COMPLETED|Overall Study||3
10858|NCT02129608|24207|P2|NOT COMPLETED|Overall Study||1
10859|NCT02129608|24208|P1|NOT COMPLETED|Overall Study||0
10860|NCT02129608|24206|P3|COMPLETED|Overall Study||12
10861|NCT02129608|24207|P2|COMPLETED|Overall Study||13
10862|NCT02129608|24208|P1|COMPLETED|Overall Study||15
10863|NCT02129608|24206|P3|End of Treatment|Overall Study||12
10864|NCT02129608|24207|P2|End of Treatment|Overall Study||13
10865|NCT02129608|24208|P1|End of Treatment|Overall Study||15
10866|NCT02129608|24206|P3|STARTED|Overall Study||15
10867|NCT02129608|24207|P2|STARTED|Overall Study||14
10868|NCT02129608|24208|P1|STARTED|Overall Study||15
10869|NCT02129062|24219|P1|NOT COMPLETED|Overall Study||3
10870|NCT02129062|24219|P1|COMPLETED|Overall Study||0
10871|NCT02129062|24219|P1|STARTED|Overall Study||3
10872|NCT02128867|24227|P3|NOT COMPLETED|Overall Study||4
10873|NCT02128867|24228|P2|NOT COMPLETED|Overall Study||2
10874|NCT02128867|24229|P1|NOT COMPLETED|Overall Study||3
10875|NCT02128867|24227|P3|COMPLETED|Overall Study||50
10876|NCT02128867|24228|P2|COMPLETED|Overall Study||50
10877|NCT02128867|24229|P1|COMPLETED|Overall Study||50
10878|NCT02128867|24227|P3|STARTED|Overall Study||54
10879|NCT02128867|24228|P2|STARTED|Overall Study||52
10880|NCT02128867|24229|P1|STARTED|Overall Study||53
10881|NCT02128542|24239|P2|NOT COMPLETED|Overall Study||0
10882|NCT02128542|24240|P1|NOT COMPLETED|Overall Study||4
10883|NCT02128542|24239|P2|COMPLETED|Overall Study||19
10884|NCT02128542|24240|P1|COMPLETED|Overall Study||43
10885|NCT02128542|24239|P2|STARTED|Overall Study||19
10886|NCT02128542|24240|P1|STARTED|Overall Study||47
10887|NCT02128490|24258|P5|NOT COMPLETED|Overall Study||7
10888|NCT02128490|24259|P4|NOT COMPLETED|Overall Study||6
10889|NCT02128490|24260|P3|NOT COMPLETED|Overall Study||5
10890|NCT02128490|24261|P2|NOT COMPLETED|Overall Study||6
10891|NCT02128490|24262|P1|NOT COMPLETED|Overall Study||5
10892|NCT02128490|24258|P5|COMPLETED|Overall Study||31
10893|NCT02128490|24259|P4|COMPLETED|Overall Study||31
10894|NCT02128490|24260|P3|COMPLETED|Overall Study||34
10895|NCT02128490|24261|P2|COMPLETED|Overall Study||31
10896|NCT02128490|24262|P1|COMPLETED|Overall Study||33
10897|NCT02128490|24258|P5|STARTED|Overall Study||38
10898|NCT02128490|24259|P4|STARTED|Overall Study||37
10899|NCT02128490|24260|P3|STARTED|Overall Study||39
10900|NCT02128490|24261|P2|STARTED|Overall Study||37
10901|NCT02128490|24262|P1|STARTED|Overall Study||38
10902|NCT02127567|24284|P1|NOT COMPLETED|Overall Study||0
10903|NCT02127567|24284|P1|COMPLETED|Overall Study||41
10904|NCT02127567|24284|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
10905|NCT02127372|24306|P2|NOT COMPLETED|Overall Study||0
10906|NCT02127372|24307|P1|NOT COMPLETED|Overall Study||1
10907|NCT02127372|24306|P2|COMPLETED|Overall Study||28
10908|NCT02127372|24307|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
10909|NCT02127372|24306|P2|Started Study Treatment|Overall Study||28
10910|NCT02127372|24307|P1|Started Study Treatment|Overall Study||15
10911|NCT02127372|24306|P2|STARTED|Overall Study|Signed Consent|28
10912|NCT02127372|24307|P1|STARTED|Overall Study|Signed Consent|15
10913|NCT02126839|24319|P2|NOT COMPLETED|Overall Study||14
10914|NCT02126839|24320|P1|NOT COMPLETED|Overall Study||10
10915|NCT02126839|24319|P2|COMPLETED|Overall Study||80
10916|NCT02126839|24320|P1|COMPLETED|Overall Study||82
10917|NCT02126839|24319|P2|Full Analysis Set|Overall Study||92
10918|NCT02126839|24320|P1|Full Analysis Set|Overall Study||92
10919|NCT02126839|24319|P2|Safety Population|Overall Study||93
10920|NCT02126839|24320|P1|Safety Population|Overall Study||92
10921|NCT02126839|24319|P2|STARTED|Overall Study||94
10922|NCT02126839|24320|P1|STARTED|Overall Study||92
10923|NCT02126748|24333|P3|NOT COMPLETED|Overall Study||5
10924|NCT02126748|24334|P2|NOT COMPLETED|Overall Study||3
10925|NCT02126748|24335|P1|NOT COMPLETED|Overall Study||2
10926|NCT02126748|24333|P3|COMPLETED|Overall Study||31
10927|NCT02126748|24334|P2|COMPLETED|Overall Study||31
10928|NCT02126748|24335|P1|COMPLETED|Overall Study||31
10929|NCT02126748|24333|P3|STARTED|Overall Study||36
10930|NCT02126748|24334|P2|STARTED|Overall Study||34
10931|NCT02126748|24335|P1|STARTED|Overall Study||33
10932|NCT02126670|24347|P4|NOT COMPLETED|Overall Study||1
10933|NCT02126670|24348|P3|NOT COMPLETED|Overall Study||0
10934|NCT02126670|24349|P2|NOT COMPLETED|Overall Study||0
10935|NCT02126670|24350|P1|NOT COMPLETED|Overall Study||1
10936|NCT02126670|24347|P4|COMPLETED|Overall Study||24
10937|NCT02126670|24348|P3|COMPLETED|Overall Study||25
10938|NCT02126670|24349|P2|COMPLETED|Overall Study||24
10939|NCT02126670|24350|P1|COMPLETED|Overall Study||25
10940|NCT02126670|24347|P4|STARTED|Overall Study||25
10941|NCT02126670|24348|P3|STARTED|Overall Study||25
10942|NCT02126670|24349|P2|STARTED|Overall Study||24
10943|NCT02126670|24350|P1|STARTED|Overall Study||26
10944|NCT02126306|24366|P2|NOT COMPLETED|Overall Study||0
10945|NCT02126306|24367|P1|NOT COMPLETED|Overall Study||0
10946|NCT02126306|24366|P2|COMPLETED|Overall Study||13
10947|NCT02126306|24367|P1|COMPLETED|Overall Study||10
10948|NCT02126306|24366|P2|STARTED|Overall Study||13
10949|NCT02126306|24367|P1|STARTED|Overall Study||10
10950|NCT02125877|24375|P2|NOT COMPLETED|Overall Study||10
10951|NCT02125877|24376|P1|NOT COMPLETED|Overall Study||13
10952|NCT02125877|24375|P2|COMPLETED|Overall Study||77
10953|NCT02125877|24376|P1|COMPLETED|Overall Study||73
10954|NCT02125877|24375|P2|Safety Set|Overall Study||87
10955|NCT02125877|24376|P1|Safety Set|Overall Study||86
10956|NCT02125877|24375|P2|Pharmacokinetic Subset A|Overall Study||15
10957|NCT02125877|24376|P1|Pharmacokinetic Subset A|Overall Study||16
10958|NCT02125877|24375|P2|Pharmacokinetic Analysis Set|Overall Study||83
10959|NCT02125877|24376|P1|Pharmacokinetic Analysis Set|Overall Study||83
10960|NCT02125877|24375|P2|STARTED|Overall Study||87
10961|NCT02125877|24376|P1|STARTED|Overall Study||86
10962|NCT02125734|24406|P2|NOT COMPLETED|Overall Study||1
10963|NCT02125734|24407|P1|NOT COMPLETED|Overall Study||0
10964|NCT02125734|24406|P2|COMPLETED|Overall Study||47
10965|NCT02125734|24407|P1|COMPLETED|Overall Study||40
10966|NCT02125734|24406|P2|STARTED|Overall Study||48
10967|NCT02125734|24407|P1|STARTED|Overall Study||40
10968|NCT02125292|24417|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
10969|NCT02125292|24418|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
10970|NCT02125292|24419|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
10971|NCT02125292|24420|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
10972|NCT02125292|24421|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
10973|NCT02125292|24422|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
10974|NCT02125292|24417|P6|COMPLETED|Third Intervention (1 Hour)||3
10975|NCT02125292|24418|P5|COMPLETED|Third Intervention (1 Hour)||3
10976|NCT02125292|24419|P4|COMPLETED|Third Intervention (1 Hour)||3
10977|NCT02125292|24420|P3|COMPLETED|Third Intervention (1 Hour)||3
10978|NCT02125292|24421|P2|COMPLETED|Third Intervention (1 Hour)||3
10979|NCT02125292|24422|P1|COMPLETED|Third Intervention (1 Hour)||3
10980|NCT02125292|24417|P6|STARTED|Third Intervention (1 Hour)||3
10981|NCT02125292|24418|P5|STARTED|Third Intervention (1 Hour)||3
10982|NCT02125292|24419|P4|STARTED|Third Intervention (1 Hour)||3
10983|NCT02125292|24420|P3|STARTED|Third Intervention (1 Hour)||3
10984|NCT02125292|24421|P2|STARTED|Third Intervention (1 Hour)||3
10985|NCT02125292|24422|P1|STARTED|Third Intervention (1 Hour)||3
10986|NCT02125292|24417|P6|NOT COMPLETED|Washout (2 Hours)||0
10987|NCT02125292|24418|P5|NOT COMPLETED|Washout (2 Hours)||0
10988|NCT02125292|24419|P4|NOT COMPLETED|Washout (2 Hours)||0
10989|NCT02125292|24420|P3|NOT COMPLETED|Washout (2 Hours)||0
10990|NCT02125292|24421|P2|NOT COMPLETED|Washout (2 Hours)||0
10991|NCT02125292|24422|P1|NOT COMPLETED|Washout (2 Hours)||0
10992|NCT02125292|24417|P6|COMPLETED|Washout (2 Hours)||3
10993|NCT02125292|24418|P5|COMPLETED|Washout (2 Hours)||3
10994|NCT02125292|24419|P4|COMPLETED|Washout (2 Hours)||3
10995|NCT02125292|24420|P3|COMPLETED|Washout (2 Hours)||3
10996|NCT02125292|24421|P2|COMPLETED|Washout (2 Hours)||3
10997|NCT02125292|24422|P1|COMPLETED|Washout (2 Hours)||3
10998|NCT02125292|24417|P6|STARTED|Washout (2 Hours)||3
10999|NCT02125292|24418|P5|STARTED|Washout (2 Hours)||3
11000|NCT02125292|24419|P4|STARTED|Washout (2 Hours)||3
11001|NCT02125292|24420|P3|STARTED|Washout (2 Hours)||3
11002|NCT02125292|24421|P2|STARTED|Washout (2 Hours)||3
11003|NCT02125292|24422|P1|STARTED|Washout (2 Hours)||3
11004|NCT02125292|24417|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
11005|NCT02125292|24418|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
11006|NCT02125292|24419|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
11007|NCT02125292|24420|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
11008|NCT02125292|24421|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
11009|NCT02125292|24422|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
11010|NCT02125292|24417|P6|COMPLETED|Second Intervention (1 Hour)||3
11011|NCT02125292|24418|P5|COMPLETED|Second Intervention (1 Hour)||3
11012|NCT02125292|24419|P4|COMPLETED|Second Intervention (1 Hour)||3
11013|NCT02125292|24420|P3|COMPLETED|Second Intervention (1 Hour)||3
11014|NCT02125292|24421|P2|COMPLETED|Second Intervention (1 Hour)||3
11015|NCT02125292|24422|P1|COMPLETED|Second Intervention (1 Hour)||3
11016|NCT02125292|24417|P6|STARTED|Second Intervention (1 Hour)||3
11017|NCT02125292|24418|P5|STARTED|Second Intervention (1 Hour)||3
11018|NCT02125292|24419|P4|STARTED|Second Intervention (1 Hour)||3
11019|NCT02125292|24420|P3|STARTED|Second Intervention (1 Hour)||3
11020|NCT02125292|24421|P2|STARTED|Second Intervention (1 Hour)||3
11021|NCT02125292|24422|P1|STARTED|Second Intervention (1 Hour)||3
11022|NCT02125292|24417|P6|NOT COMPLETED|Washout (2 Hours)||0
11023|NCT02125292|24418|P5|NOT COMPLETED|Washout (2 Hours)||0
11024|NCT02125292|24419|P4|NOT COMPLETED|Washout (2 Hours)||0
11025|NCT02125292|24420|P3|NOT COMPLETED|Washout (2 Hours)||0
11026|NCT02125292|24421|P2|NOT COMPLETED|Washout (2 Hours)||0
11027|NCT02125292|24422|P1|NOT COMPLETED|Washout (2 Hours)||0
11028|NCT02125292|24417|P6|COMPLETED|Washout (2 Hours)||3
11029|NCT02125292|24418|P5|COMPLETED|Washout (2 Hours)||3
11030|NCT02125292|24419|P4|COMPLETED|Washout (2 Hours)||3
11031|NCT02125292|24420|P3|COMPLETED|Washout (2 Hours)||3
11032|NCT02125292|24421|P2|COMPLETED|Washout (2 Hours)||3
11033|NCT02125292|24422|P1|COMPLETED|Washout (2 Hours)||3
11034|NCT02125292|24417|P6|STARTED|Washout (2 Hours)||3
11035|NCT02125292|24418|P5|STARTED|Washout (2 Hours)||3
11036|NCT02125292|24419|P4|STARTED|Washout (2 Hours)||3
11037|NCT02125292|24420|P3|STARTED|Washout (2 Hours)||3
11038|NCT02125292|24421|P2|STARTED|Washout (2 Hours)||3
11039|NCT02125292|24422|P1|STARTED|Washout (2 Hours)||3
11040|NCT02125292|24417|P6|NOT COMPLETED|First Intervention (1 Hour)||0
11041|NCT02125292|24418|P5|NOT COMPLETED|First Intervention (1 Hour)||0
11042|NCT02125292|24419|P4|NOT COMPLETED|First Intervention (1 Hour)||0
11043|NCT02125292|24420|P3|NOT COMPLETED|First Intervention (1 Hour)||0
11044|NCT02125292|24421|P2|NOT COMPLETED|First Intervention (1 Hour)||0
11045|NCT02125292|24422|P1|NOT COMPLETED|First Intervention (1 Hour)||0
11046|NCT02125292|24417|P6|COMPLETED|First Intervention (1 Hour)||3
11047|NCT02125292|24418|P5|COMPLETED|First Intervention (1 Hour)||3
11048|NCT02125292|24419|P4|COMPLETED|First Intervention (1 Hour)||3
11049|NCT02125292|24420|P3|COMPLETED|First Intervention (1 Hour)||3
11050|NCT02125292|24421|P2|COMPLETED|First Intervention (1 Hour)||3
11051|NCT02125292|24422|P1|COMPLETED|First Intervention (1 Hour)||3
11052|NCT02125292|24417|P6|STARTED|First Intervention (1 Hour)||3
11053|NCT02125292|24418|P5|STARTED|First Intervention (1 Hour)||3
11054|NCT02125292|24419|P4|STARTED|First Intervention (1 Hour)||3
11055|NCT02125292|24420|P3|STARTED|First Intervention (1 Hour)||3
11056|NCT02125292|24421|P2|STARTED|First Intervention (1 Hour)||3
11057|NCT02125292|24422|P1|STARTED|First Intervention (1 Hour)||3
11058|NCT02124863|24443|P1|NOT COMPLETED|Overall Study||17
11059|NCT02124863|24443|P1|COMPLETED|Overall Study||50
11060|NCT02124863|24443|P1|STARTED|Overall Study||67
11061|NCT02124603|24449|P1|NOT COMPLETED|Overall Study||0
11062|NCT02124603|24449|P1|COMPLETED|Overall Study||120
11063|NCT02124603|24449|P1|STARTED|Overall Study||120
11064|NCT02123472|24455|P2|NOT COMPLETED|Period 2 (7 Days)||1
11065|NCT02123472|24456|P1|NOT COMPLETED|Period 2 (7 Days)||0
11066|NCT02123472|24455|P2|COMPLETED|Period 2 (7 Days)||13
11067|NCT02123472|24456|P1|COMPLETED|Period 2 (7 Days)||14
11068|NCT02123472|24455|P2|STARTED|Period 2 (7 Days)||14
11069|NCT02123472|24456|P1|STARTED|Period 2 (7 Days)||14
11070|NCT02123472|24455|P2|NOT COMPLETED|Washout Period (1 Day)||0
11071|NCT02123472|24456|P1|NOT COMPLETED|Washout Period (1 Day)||0
11072|NCT02123472|24455|P2|COMPLETED|Washout Period (1 Day)||14
11073|NCT02123472|24456|P1|COMPLETED|Washout Period (1 Day)||14
11074|NCT02123472|24455|P2|STARTED|Washout Period (1 Day)||14
11075|NCT02123472|24456|P1|STARTED|Washout Period (1 Day)||14
11076|NCT02123472|24455|P2|NOT COMPLETED|Period 1 (7 Days)||0
11077|NCT02123472|24456|P1|NOT COMPLETED|Period 1 (7 Days)||0
11078|NCT02123472|24455|P2|COMPLETED|Period 1 (7 Days)||14
11079|NCT02123472|24456|P1|COMPLETED|Period 1 (7 Days)||14
11080|NCT02123472|24455|P2|STARTED|Period 1 (7 Days)||14
11081|NCT02123472|24456|P1|STARTED|Period 1 (7 Days)||14
11082|NCT02123459|24466|P2|NOT COMPLETED|Period 2 (7 Days)||0
11083|NCT02123459|24467|P1|NOT COMPLETED|Period 2 (7 Days)||0
11084|NCT02123459|24466|P2|COMPLETED|Period 2 (7 Days)||14
11085|NCT02123459|24467|P1|COMPLETED|Period 2 (7 Days)||13
11086|NCT02123459|24466|P2|STARTED|Period 2 (7 Days)||14
11087|NCT02123459|24467|P1|STARTED|Period 2 (7 Days)||13
11088|NCT02123459|24466|P2|NOT COMPLETED|Washout Period (1 Day)||0
11089|NCT02123459|24467|P1|NOT COMPLETED|Washout Period (1 Day)||1
11090|NCT02123459|24466|P2|COMPLETED|Washout Period (1 Day)||14
11091|NCT02123459|24467|P1|COMPLETED|Washout Period (1 Day)||13
11092|NCT02123459|24466|P2|STARTED|Washout Period (1 Day)||14
11093|NCT02123459|24467|P1|STARTED|Washout Period (1 Day)||14
11094|NCT02123459|24466|P2|NOT COMPLETED|Period 1 (7 Days)||0
11095|NCT02123459|24467|P1|NOT COMPLETED|Period 1 (7 Days)||0
11096|NCT02123459|24466|P2|COMPLETED|Period 1 (7 Days)||14
11097|NCT02123459|24467|P1|COMPLETED|Period 1 (7 Days)||14
11098|NCT02123459|24466|P2|STARTED|Period 1 (7 Days)||14
11099|NCT02123459|24467|P1|STARTED|Period 1 (7 Days)||14
11100|NCT02123446|24477|P2|NOT COMPLETED|Period 2 (7 Days)||0
11101|NCT02123446|24478|P1|NOT COMPLETED|Period 2 (7 Days)||0
11102|NCT02123446|24477|P2|COMPLETED|Period 2 (7 Days)||14
11103|NCT02123446|24478|P1|COMPLETED|Period 2 (7 Days)||13
11104|NCT02123446|24477|P2|STARTED|Period 2 (7 Days)||14
11105|NCT02123446|24478|P1|STARTED|Period 2 (7 Days)||13
11106|NCT02123446|24477|P2|NOT COMPLETED|Washout Period (1 Day)||0
11107|NCT02123446|24478|P1|NOT COMPLETED|Washout Period (1 Day)||1
11108|NCT02123446|24477|P2|COMPLETED|Washout Period (1 Day)||14
11109|NCT02123446|24478|P1|COMPLETED|Washout Period (1 Day)||13
11110|NCT02123446|24477|P2|STARTED|Washout Period (1 Day)||14
11111|NCT02123446|24478|P1|STARTED|Washout Period (1 Day)||14
11112|NCT02123446|24477|P2|NOT COMPLETED|Period 1 (7 Days)||0
11113|NCT02123446|24478|P1|NOT COMPLETED|Period 1 (7 Days)||0
11114|NCT02123446|24477|P2|COMPLETED|Period 1 (7 Days)||14
11115|NCT02123446|24478|P1|COMPLETED|Period 1 (7 Days)||14
11116|NCT02123446|24477|P2|STARTED|Period 1 (7 Days)||14
11117|NCT02123446|24478|P1|STARTED|Period 1 (7 Days)||14
11118|NCT02124304|24490|P2|NOT COMPLETED|Overall Study||0
11119|NCT02124304|24491|P1|NOT COMPLETED|Overall Study||0
11120|NCT02124304|24490|P2|COMPLETED|Overall Study||15
11121|NCT02124304|24491|P1|COMPLETED|Overall Study||15
11122|NCT02124304|24490|P2|STARTED|Overall Study||15
11123|NCT02124304|24491|P1|STARTED|Overall Study||15
11124|NCT02124161|24501|P2|NOT COMPLETED|Overall Study||15
11125|NCT02124161|24502|P1|NOT COMPLETED|Overall Study||16
11126|NCT02124161|24501|P2|COMPLETED|Overall Study||426
11127|NCT02124161|24502|P1|COMPLETED|Overall Study||425
11128|NCT02124161|24501|P2|Vaccination 2|Overall Study||432
11129|NCT02124161|24502|P1|Vaccination 2|Overall Study||431
11130|NCT02124161|24501|P2|Vaccination 1|Overall Study||437
11131|NCT02124161|24502|P1|Vaccination 1|Overall Study||439
11132|NCT02124161|24501|P2|STARTED|Overall Study||441
11133|NCT02124161|24502|P1|STARTED|Overall Study||441
11134|NCT02123745|24532|P1|NOT COMPLETED|Overall Study||0
11135|NCT02123745|24532|P1|COMPLETED|Overall Study||71
11136|NCT02123745|24532|P1|STARTED|Overall Study||71
11137|NCT02123017|24543|P3|NOT COMPLETED|Overall Study||0
11138|NCT02123017|24544|P2|NOT COMPLETED|Overall Study||0
11139|NCT02123017|24545|P1|NOT COMPLETED|Overall Study||0
11140|NCT02123017|24543|P3|COMPLETED|Overall Study||12
11141|NCT02123017|24544|P2|COMPLETED|Overall Study||12
11142|NCT02123017|24545|P1|COMPLETED|Overall Study||8
11143|NCT02123017|24543|P3|STARTED|Overall Study||12
11144|NCT02123017|24544|P2|STARTED|Overall Study||12
11145|NCT02123017|24545|P1|STARTED|Overall Study||8
11146|NCT02122445|24562|P1|NOT COMPLETED|Overall Study||0
11147|NCT02122445|24562|P1|COMPLETED|Overall Study||20
11148|NCT02122445|24562|P1|STARTED|Overall Study||20
11149|NCT02122406|24567|P1|NOT COMPLETED|Overall Study||0
11150|NCT02122406|24567|P1|COMPLETED|Overall Study||200
11151|NCT02122406|24567|P1|STARTED|Overall Study||200
11152|NCT02121860|24575|P4|NOT COMPLETED|Overall Study||0
11153|NCT02121860|24576|P3|NOT COMPLETED|Overall Study||0
11154|NCT02121860|24577|P2|NOT COMPLETED|Overall Study||0
11155|NCT02121860|24578|P1|NOT COMPLETED|Overall Study||0
11156|NCT02121860|24575|P4|COMPLETED|Overall Study||8
11157|NCT02121860|24576|P3|COMPLETED|Overall Study||8
11158|NCT02121860|24577|P2|COMPLETED|Overall Study||12
11159|NCT02121860|24578|P1|COMPLETED|Overall Study||8
11160|NCT02121860|24575|P4|STARTED|Overall Study||8
11161|NCT02121860|24576|P3|STARTED|Overall Study||8
11162|NCT02121860|24577|P2|STARTED|Overall Study||12
11163|NCT02121860|24578|P1|STARTED|Overall Study||8
11164|NCT02121847|24597|P1|NOT COMPLETED|Overall Study||3
11165|NCT02121847|24597|P1|COMPLETED|Overall Study||37
11166|NCT02121847|24597|P1|STARTED|Overall Study||40
11167|NCT02121795|24618|P2|NOT COMPLETED|Overall Study||334
11168|NCT02121795|24619|P1|NOT COMPLETED|Overall Study||334
11169|NCT02121795|24618|P2|COMPLETED|Overall Study||0
11170|NCT02121795|24619|P1|COMPLETED|Overall Study||0
11171|NCT02121795|24618|P2|STARTED|Overall Study||334
11172|NCT02121795|24619|P1|STARTED|Overall Study||334
11173|NCT02121522|24633|P1|NOT COMPLETED|Overall Study||1
11174|NCT02121522|24633|P1|COMPLETED|Overall Study||13
11175|NCT02121522|24633|P1|STARTED|Overall Study||14
11176|NCT02121509|24640|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11177|NCT02121509|24641|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11178|NCT02121509|24642|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11179|NCT02121509|24643|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11180|NCT02121509|24640|P4|COMPLETED|Treatment Period-2 (4 Days)||8
11181|NCT02121509|24641|P3|COMPLETED|Treatment Period-2 (4 Days)||8
11182|NCT02121509|24642|P2|COMPLETED|Treatment Period-2 (4 Days)||24
11183|NCT02121509|24643|P1|COMPLETED|Treatment Period-2 (4 Days)||28
11184|NCT02121509|24640|P4|STARTED|Treatment Period-2 (4 Days)||8
11185|NCT02121509|24641|P3|STARTED|Treatment Period-2 (4 Days)||8
11186|NCT02121509|24642|P2|STARTED|Treatment Period-2 (4 Days)||24
11187|NCT02121509|24643|P1|STARTED|Treatment Period-2 (4 Days)||28
11188|NCT02121509|24640|P4|NOT COMPLETED|Washout Period (35 Days)||0
11189|NCT02121509|24641|P3|NOT COMPLETED|Washout Period (35 Days)||0
11190|NCT02121509|24642|P2|NOT COMPLETED|Washout Period (35 Days)||4
11191|NCT02121509|24643|P1|NOT COMPLETED|Washout Period (35 Days)||2
11192|NCT02121509|24640|P4|COMPLETED|Washout Period (35 Days)||8
11193|NCT02121509|24641|P3|COMPLETED|Washout Period (35 Days)||8
11194|NCT02121509|24642|P2|COMPLETED|Washout Period (35 Days)||24
11195|NCT02121509|24643|P1|COMPLETED|Washout Period (35 Days)||28
11196|NCT02121509|24640|P4|STARTED|Washout Period (35 Days)||8
11197|NCT02121509|24641|P3|STARTED|Washout Period (35 Days)||8
11198|NCT02121509|24642|P2|STARTED|Washout Period (35 Days)||28
11199|NCT02121509|24643|P1|STARTED|Washout Period (35 Days)||30
11200|NCT02121509|24640|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11201|NCT02121509|24641|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11202|NCT02121509|24642|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11203|NCT02121509|24643|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11204|NCT02121509|24640|P4|COMPLETED|Treatment Period-1 (4 Days)||8
11205|NCT02121509|24641|P3|COMPLETED|Treatment Period-1 (4 Days)||8
11206|NCT02121509|24642|P2|COMPLETED|Treatment Period-1 (4 Days)||28
11207|NCT02121509|24643|P1|COMPLETED|Treatment Period-1 (4 Days)||30
11208|NCT02121509|24640|P4|STARTED|Treatment Period-1 (4 Days)||8
11209|NCT02121509|24641|P3|STARTED|Treatment Period-1 (4 Days)||8
11210|NCT02121509|24642|P2|STARTED|Treatment Period-1 (4 Days)||28
11211|NCT02121509|24643|P1|STARTED|Treatment Period-1 (4 Days)||30
11212|NCT02121483|24676|P3|NOT COMPLETED|Overall Study||0
11213|NCT02121483|24677|P2|NOT COMPLETED|Overall Study||0
11214|NCT02121483|24678|P1|NOT COMPLETED|Overall Study||0
11215|NCT02121483|24676|P3|COMPLETED|Overall Study||10
11216|NCT02121483|24677|P2|COMPLETED|Overall Study||8
11217|NCT02121483|24678|P1|COMPLETED|Overall Study||9
11218|NCT02121483|24676|P3|STARTED|Overall Study||10
11219|NCT02121483|24677|P2|STARTED|Overall Study||8
11220|NCT02121483|24678|P1|STARTED|Overall Study||9
11221|NCT02121041|24709|P2|NOT COMPLETED|Overall Study||6
11222|NCT02121041|24710|P1|NOT COMPLETED|Overall Study||1
11223|NCT02121041|24709|P2|COMPLETED|Overall Study||8
11224|NCT02121041|24710|P1|COMPLETED|Overall Study||13
11225|NCT02121041|24709|P2|STARTED|Overall Study||14
11226|NCT02121041|24710|P1|STARTED|Overall Study||14
11227|NCT02120833|24718|P2|NOT COMPLETED|Overall Study||1
11228|NCT02120833|24719|P1|NOT COMPLETED|Overall Study||4
11229|NCT02120833|24718|P2|COMPLETED|Overall Study||11
11230|NCT02120833|24719|P1|COMPLETED|Overall Study||35
11231|NCT02120833|24718|P2|STARTED|Overall Study||12
11232|NCT02120833|24719|P1|STARTED|Overall Study||39
11233|NCT02120443|24873|P1|NOT COMPLETED|Overall Study||0
11234|NCT02120443|24873|P1|COMPLETED|Overall Study||43
11235|NCT02120443|24873|P1|STARTED|Overall Study||43
11236|NCT02120300|24883|P4|NOT COMPLETED|Overall Study||1
11237|NCT02120300|24884|P3|NOT COMPLETED|Overall Study||0
11238|NCT02120300|24885|P2|NOT COMPLETED|Overall Study||0
11239|NCT02120300|24886|P1|NOT COMPLETED|Overall Study||3
11240|NCT02120300|24883|P4|COMPLETED|Overall Study||5
11241|NCT02120300|24884|P3|COMPLETED|Overall Study||10
11242|NCT02120300|24885|P2|COMPLETED|Overall Study||5
11243|NCT02120300|24886|P1|COMPLETED|Overall Study||98
11244|NCT02120300|24883|P4|STARTED|Overall Study||6
11245|NCT02120300|24884|P3|STARTED|Overall Study||10
11246|NCT02120300|24885|P2|STARTED|Overall Study||5
11247|NCT02120300|24886|P1|STARTED|Overall Study||101
11248|NCT02120027|24924|P2|NOT COMPLETED|Overall Study||119
11249|NCT02120027|24925|P1|NOT COMPLETED|Overall Study||116
11250|NCT02120027|24924|P2|COMPLETED|Overall Study||160
11251|NCT02120027|24925|P1|COMPLETED|Overall Study||161
11252|NCT02120027|24924|P2|STARTED|Overall Study||279
11253|NCT02120027|24925|P1|STARTED|Overall Study||277
11254|NCT02119325|24939|P2|NOT COMPLETED|Period 2||0
11255|NCT02119325|24940|P1|NOT COMPLETED|Period 2||0
11256|NCT02119325|24939|P2|COMPLETED|Period 2||47
11257|NCT02119325|24940|P1|COMPLETED|Period 2||48
11258|NCT02119325|24939|P2|STARTED|Period 2||47
11259|NCT02119325|24940|P1|STARTED|Period 2||48
11260|NCT02119325|24939|P2|NOT COMPLETED|Washout Period 1||1
11261|NCT02119325|24940|P1|NOT COMPLETED|Washout Period 1||0
11262|NCT02119325|24939|P2|COMPLETED|Washout Period 1||47
11263|NCT02119325|24940|P1|COMPLETED|Washout Period 1||48
11264|NCT02119325|24939|P2|STARTED|Washout Period 1||48
11265|NCT02119325|24940|P1|STARTED|Washout Period 1||48
11266|NCT02119325|24939|P2|NOT COMPLETED|Period 1||0
11267|NCT02119325|24940|P1|NOT COMPLETED|Period 1||0
11268|NCT02119325|24939|P2|COMPLETED|Period 1||48
11269|NCT02119325|24940|P1|COMPLETED|Period 1||48
11270|NCT02119325|24939|P2|STARTED|Period 1||48
11271|NCT02119325|24940|P1|STARTED|Period 1||48
11272|NCT02119286|24987|P3|NOT COMPLETED|Overall Study||7
11273|NCT02119286|24988|P2|NOT COMPLETED|Overall Study||11
11274|NCT02119286|24989|P1|NOT COMPLETED|Overall Study||26
11275|NCT02119286|24987|P3|COMPLETED|Overall Study||200
11276|NCT02119286|24988|P2|COMPLETED|Overall Study||195
11277|NCT02119286|24989|P1|COMPLETED|Overall Study||180
11278|NCT02119286|24987|P3|STARTED|Overall Study||207
11279|NCT02119286|24988|P2|STARTED|Overall Study||206
11280|NCT02119286|24989|P1|STARTED|Overall Study||206
11281|NCT02118961|25002|P2|NOT COMPLETED|Overall Study||0
11282|NCT02118961|25003|P1|NOT COMPLETED|Overall Study||1
11283|NCT02118961|25002|P2|COMPLETED|Overall Study||222
11284|NCT02118961|25003|P1|COMPLETED|Overall Study||223
11285|NCT02118961|25002|P2|STARTED|Overall Study||222
11286|NCT02118961|25003|P1|STARTED|Overall Study||224
11287|NCT02118896|25031|P10|NOT COMPLETED|Overall Study||2
11288|NCT02118896|25032|P9|NOT COMPLETED|Overall Study||4
11289|NCT02118896|25033|P8|NOT COMPLETED|Overall Study||2
11290|NCT02118896|25034|P7|NOT COMPLETED|Overall Study||2
11291|NCT02118896|25035|P6|NOT COMPLETED|Overall Study||28
11292|NCT02118896|25036|P5|NOT COMPLETED|Overall Study||17
11293|NCT02118896|25037|P4|NOT COMPLETED|Overall Study||24
11294|NCT02118896|25038|P3|NOT COMPLETED|Overall Study||14
11295|NCT02118896|25039|P2|NOT COMPLETED|Overall Study||15
11296|NCT02118896|25040|P1|NOT COMPLETED|Overall Study||17
11297|NCT02118896|25031|P10|COMPLETED|Overall Study||7
11298|NCT02118896|25032|P9|COMPLETED|Overall Study||84
11299|NCT02118896|25033|P8|COMPLETED|Overall Study||105
11300|NCT02118896|25034|P7|COMPLETED|Overall Study||83
11301|NCT02118896|25035|P6|COMPLETED|Overall Study||163
11302|NCT02118896|25036|P5|COMPLETED|Overall Study||113
11303|NCT02118896|25037|P4|COMPLETED|Overall Study||55
11304|NCT02118896|25038|P3|COMPLETED|Overall Study||53
11305|NCT02118896|25039|P2|COMPLETED|Overall Study||32
11306|NCT02118896|25040|P1|COMPLETED|Overall Study||30
11307|NCT02118896|25031|P10|STARTED|Overall Study||9
11308|NCT02118896|25032|P9|STARTED|Overall Study||88
11309|NCT02118896|25033|P8|STARTED|Overall Study||107
11310|NCT02118896|25034|P7|STARTED|Overall Study||85
11311|NCT02118896|25035|P6|STARTED|Overall Study||191
11312|NCT02118896|25036|P5|STARTED|Overall Study||130
11313|NCT02118896|25037|P4|STARTED|Overall Study||79
11314|NCT02118896|25038|P3|STARTED|Overall Study||67
11315|NCT02118896|25039|P2|STARTED|Overall Study||47
11316|NCT02118896|25040|P1|STARTED|Overall Study||47
11317|NCT02118831|25115|P3|NOT COMPLETED|Overall Study||0
11318|NCT02118831|25116|P2|NOT COMPLETED|Overall Study||0
11319|NCT02118831|25117|P1|NOT COMPLETED|Overall Study||0
11320|NCT02118831|25115|P3|COMPLETED|Overall Study||20
11321|NCT02118831|25116|P2|COMPLETED|Overall Study||15
11322|NCT02118831|25117|P1|COMPLETED|Overall Study||21
11323|NCT02118831|25115|P3|STARTED|Overall Study||20
11324|NCT02118831|25116|P2|STARTED|Overall Study||15
11325|NCT02118831|25117|P1|STARTED|Overall Study||21
11326|NCT02118597|25128|P1|NOT COMPLETED|Overall Study||16
11327|NCT02118597|25128|P1|COMPLETED|Overall Study||3
11328|NCT02118597|25128|P1|STARTED|Overall Study||19
11329|NCT02118441|25144|P2|NOT COMPLETED|Overall Study||1
11330|NCT02118441|25145|P1|NOT COMPLETED|Overall Study||3
11331|NCT02118441|25144|P2|COMPLETED|Overall Study||63
11332|NCT02118441|25145|P1|COMPLETED|Overall Study||62
11333|NCT02118441|25144|P2|STARTED|Overall Study||64
11334|NCT02118441|25145|P1|STARTED|Overall Study||65
11335|NCT02117687|25159|P2|NOT COMPLETED|Overall Study||4
11336|NCT02117687|25160|P1|NOT COMPLETED|Overall Study||1
11337|NCT02117687|25159|P2|COMPLETED|Overall Study||36
11338|NCT02117687|25160|P1|COMPLETED|Overall Study||39
11339|NCT02117687|25159|P2|STARTED|Overall Study||40
11340|NCT02117687|25160|P1|STARTED|Overall Study||40
11341|NCT02117570|25195|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
11342|NCT02117570|25196|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
11343|NCT02117570|25197|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
11344|NCT02117570|25195|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
11345|NCT02117570|25196|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
11346|NCT02117570|25197|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
11347|NCT02117570|25195|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
11348|NCT02117570|25196|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
11349|NCT02117570|25197|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
11350|NCT02117570|25195|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
11351|NCT02117570|25196|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
11352|NCT02117570|25197|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
11353|NCT02117570|25195|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
11354|NCT02117570|25196|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
11355|NCT02117570|25197|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
11356|NCT02117570|25195|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
11357|NCT02117570|25196|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
11358|NCT02117570|25197|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
11359|NCT02117570|25195|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
11360|NCT02117570|25196|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
11361|NCT02117570|25197|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
11362|NCT02117570|25195|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
11363|NCT02117570|25196|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
11364|NCT02117570|25197|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
11365|NCT02117570|25195|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
11366|NCT02117570|25196|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
11367|NCT02117570|25197|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
11368|NCT02117570|25195|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
11369|NCT02117570|25196|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
11370|NCT02117570|25197|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
11371|NCT02117570|25195|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
11372|NCT02117570|25196|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
11373|NCT02117570|25197|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
11465|NCT02114268|25511|P5|STARTED|Overall Study||6
11374|NCT02117570|25195|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
11375|NCT02117570|25196|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
11376|NCT02117570|25197|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
11377|NCT02117544|25247|P2|NOT COMPLETED|Period 2||0
11378|NCT02117544|25248|P1|NOT COMPLETED|Period 2||0
11379|NCT02117544|25247|P2|COMPLETED|Period 2||55
11380|NCT02117544|25248|P1|COMPLETED|Period 2||52
11381|NCT02117544|25247|P2|STARTED|Period 2||55
11382|NCT02117544|25248|P1|STARTED|Period 2||52
11383|NCT02117544|25247|P2|NOT COMPLETED|Period 1||0
11384|NCT02117544|25248|P1|NOT COMPLETED|Period 1||2
11385|NCT02117544|25247|P2|COMPLETED|Period 1||55
11386|NCT02117544|25248|P1|COMPLETED|Period 1||52
11387|NCT02117544|25247|P2|Treated|Period 1||55
11388|NCT02117544|25248|P1|Treated|Period 1||52
11389|NCT02117544|25247|P2|STARTED|Period 1||55
11390|NCT02117544|25248|P1|STARTED|Period 1||54
11391|NCT02117414|25263|P2|NOT COMPLETED|Overall Study||6
11392|NCT02117414|25264|P1|NOT COMPLETED|Overall Study||15
11393|NCT02117414|25263|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
11394|NCT02117414|25264|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
11395|NCT02117414|25263|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
11396|NCT02117414|25264|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
11397|NCT02117193|25282|P1|NOT COMPLETED|Overall Study||0
11398|NCT02117193|25282|P1|COMPLETED|Overall Study||10
11399|NCT02117193|25282|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
11400|NCT02117193|25282|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
11401|NCT02117193|25282|P1|Placebo Intake + Normal Sleep|Overall Study||10
11402|NCT02117193|25282|P1|Alcohol Intake + Normal Sleep|Overall Study||10
11403|NCT02117193|25282|P1|STARTED|Overall Study||10
11404|NCT02117050|25304|P1|NOT COMPLETED|Overall Study||1
11405|NCT02117050|25304|P1|COMPLETED|Overall Study||0
11406|NCT02117050|25304|P1|STARTED|Overall Study||1
11407|NCT02115984|25318|P2|NOT COMPLETED|Overall Study||7
11408|NCT02115984|25319|P1|NOT COMPLETED|Overall Study||6
11409|NCT02115984|25318|P2|COMPLETED|Overall Study||16
11410|NCT02115984|25319|P1|COMPLETED|Overall Study||51
11411|NCT02115984|25318|P2|STARTED|Overall Study||23
11412|NCT02115984|25319|P1|STARTED|Overall Study||57
11413|NCT02115815|25332|P7|NOT COMPLETED|Overall Study||0
11414|NCT02115815|25333|P6|NOT COMPLETED|Overall Study||2
11415|NCT02115815|25334|P5|NOT COMPLETED|Overall Study||0
11416|NCT02115815|25335|P4|NOT COMPLETED|Overall Study||0
11417|NCT02115815|25336|P3|NOT COMPLETED|Overall Study||0
11418|NCT02115815|25337|P2|NOT COMPLETED|Overall Study||0
11419|NCT02115815|25338|P1|NOT COMPLETED|Overall Study||2
11420|NCT02115815|25332|P7|COMPLETED|Overall Study||20
11421|NCT02115815|25333|P6|COMPLETED|Overall Study||20
11422|NCT02115815|25334|P5|COMPLETED|Overall Study||20
11423|NCT02115815|25335|P4|COMPLETED|Overall Study||20
11424|NCT02115815|25336|P3|COMPLETED|Overall Study||20
11425|NCT02115815|25337|P2|COMPLETED|Overall Study||20
11426|NCT02115815|25338|P1|COMPLETED|Overall Study||22
11427|NCT02115815|25332|P7|STARTED|Overall Study||20
11428|NCT02115815|25333|P6|STARTED|Overall Study||22
11429|NCT02115815|25334|P5|STARTED|Overall Study||20
11430|NCT02115815|25335|P4|STARTED|Overall Study||20
11431|NCT02115815|25336|P3|STARTED|Overall Study||20
11432|NCT02115815|25337|P2|STARTED|Overall Study||20
11433|NCT02115815|25338|P1|STARTED|Overall Study||24
11434|NCT02115581|25433|P2|NOT COMPLETED|Overall Study||0
11435|NCT02115581|25434|P1|NOT COMPLETED|Overall Study||0
11436|NCT02115581|25433|P2|COMPLETED|Overall Study||21
11437|NCT02115581|25434|P1|COMPLETED|Overall Study||17
11438|NCT02115581|25433|P2|STARTED|Overall Study||21
11439|NCT02115581|25434|P1|STARTED|Overall Study||17
11440|NCT02115321|25446|P2|NOT COMPLETED|Overall Study||0
11441|NCT02115321|25447|P1|NOT COMPLETED|Overall Study||1
11442|NCT02115321|25446|P2|COMPLETED|Overall Study||10
11443|NCT02115321|25447|P1|COMPLETED|Overall Study||29
11444|NCT02115321|25446|P2|STARTED|Overall Study||10
11445|NCT02115321|25447|P1|STARTED|Overall Study||30
11446|NCT02114892|25469|P2|NOT COMPLETED|Overall Study||2
11447|NCT02114892|25470|P1|NOT COMPLETED|Overall Study||1
11448|NCT02114892|25469|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
11449|NCT02114892|25470|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
11450|NCT02114892|25469|P2|STARTED|Overall Study||12
11451|NCT02114892|25470|P1|STARTED|Overall Study||12
11452|NCT02114268|25510|P6|NOT COMPLETED|Overall Study||3
11453|NCT02114268|25511|P5|NOT COMPLETED|Overall Study||0
11454|NCT02114268|25512|P4|NOT COMPLETED|Overall Study||0
11455|NCT02114268|25513|P3|NOT COMPLETED|Overall Study||1
11456|NCT02114268|25514|P2|NOT COMPLETED|Overall Study||1
11457|NCT02114268|25515|P1|NOT COMPLETED|Overall Study||6
11458|NCT02114268|25510|P6|COMPLETED|Overall Study||75
11459|NCT02114268|25511|P5|COMPLETED|Overall Study||6
11460|NCT02114268|25512|P4|COMPLETED|Overall Study||6
11461|NCT02114268|25513|P3|COMPLETED|Overall Study||5
11462|NCT02114268|25514|P2|COMPLETED|Overall Study||5
11463|NCT02114268|25515|P1|COMPLETED|Overall Study||28
11464|NCT02114268|25510|P6|STARTED|Overall Study||78
11466|NCT02114268|25512|P4|STARTED|Overall Study||6
11467|NCT02114268|25513|P3|STARTED|Overall Study||6
11468|NCT02114268|25514|P2|STARTED|Overall Study||6
11469|NCT02114268|25515|P1|STARTED|Overall Study||34
11470|NCT02114216|25568|P3|NOT COMPLETED|Overall Study||0
11471|NCT02114216|25569|P2|NOT COMPLETED|Overall Study||0
11472|NCT02114216|25570|P1|NOT COMPLETED|Overall Study||0
11473|NCT02114216|25568|P3|COMPLETED|Overall Study||14
11474|NCT02114216|25569|P2|COMPLETED|Overall Study||45
11475|NCT02114216|25570|P1|COMPLETED|Overall Study||16
11476|NCT02114216|25568|P3|STARTED|Overall Study||14
11477|NCT02114216|25569|P2|STARTED|Overall Study||45
11478|NCT02114216|25570|P1|STARTED|Overall Study||16
11479|NCT02114177|25583|P2|NOT COMPLETED|Overall Study||4
11480|NCT02114177|25584|P1|NOT COMPLETED|Overall Study||9
11481|NCT02114177|25583|P2|COMPLETED|Overall Study||151
11482|NCT02114177|25584|P1|COMPLETED|Overall Study||146
11483|NCT02114177|25583|P2|STARTED|Overall Study||155
11484|NCT02114177|25584|P1|STARTED|Overall Study||155
11485|NCT02114151|25608|P1|NOT COMPLETED|Overall Study||7
11486|NCT02114151|25608|P1|COMPLETED|Overall Study||96
11487|NCT02114151|25608|P1|STARTED|Overall Study||103
11488|NCT02113579|25625|P2|NOT COMPLETED|Overall Study||4
11489|NCT02113579|25626|P1|NOT COMPLETED|Overall Study||10
11490|NCT02113579|25625|P2|COMPLETED|Overall Study||185
11491|NCT02113579|25626|P1|COMPLETED|Overall Study||176
11492|NCT02113579|25625|P2|STARTED|Overall Study||189
11493|NCT02113579|25626|P1|STARTED|Overall Study||186
11494|NCT02113449|25650|P1|NOT COMPLETED|Overall Study||4
11495|NCT02113449|25650|P1|COMPLETED|Overall Study||143
11496|NCT02113449|25650|P1|STARTED|Overall Study||147
11497|NCT02113124|25666|P2|NOT COMPLETED|Overall Study||1
11498|NCT02113124|25667|P1|NOT COMPLETED|Overall Study||1
11499|NCT02113124|25666|P2|COMPLETED|Overall Study||24
11500|NCT02113124|25667|P1|COMPLETED|Overall Study||17
11501|NCT02113124|25666|P2|STARTED|Overall Study||25
11502|NCT02113124|25667|P1|STARTED|Overall Study||18
11503|NCT02113007|25673|P1|NOT COMPLETED|Overall Study||2
11504|NCT02113007|25673|P1|COMPLETED|Overall Study||0
11505|NCT02113007|25673|P1|STARTED|Overall Study||2
11506|NCT02111603|25679|P1|NOT COMPLETED|Overall Study||1
11507|NCT02111603|25679|P1|COMPLETED|Overall Study||12
11508|NCT02111603|25679|P1|STARTED|Overall Study||13
11509|NCT02111369|25688|P1|NOT COMPLETED|Overall Study||3
11510|NCT02111369|25688|P1|COMPLETED|Overall Study||15
11511|NCT02111369|25688|P1|STARTED|Overall Study||18
11512|NCT02111252|25696|P1|NOT COMPLETED|Overall Study||0
11513|NCT02111252|25696|P1|COMPLETED|Overall Study||55
11514|NCT02111252|25696|P1|STARTED|Overall Study||55
11515|NCT02111083|25712|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
11516|NCT02111083|25713|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
11517|NCT02111083|25712|P2|COMPLETED|Fourth Intervention (1 Day)||18
11518|NCT02111083|25713|P1|COMPLETED|Fourth Intervention (1 Day)||18
11519|NCT02111083|25712|P2|STARTED|Fourth Intervention (1 Day)||18
11520|NCT02111083|25713|P1|STARTED|Fourth Intervention (1 Day)||18
11521|NCT02111083|25712|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
11522|NCT02111083|25713|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
11523|NCT02111083|25712|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
11524|NCT02111083|25713|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
11525|NCT02111083|25712|P2|STARTED|Interval Between Dosing (7-8 Days)||19
11526|NCT02111083|25713|P1|STARTED|Interval Between Dosing (7-8 Days)||19
11527|NCT02111083|25712|P2|NOT COMPLETED|Third Intervention (1 Day)||0
11528|NCT02111083|25713|P1|NOT COMPLETED|Third Intervention (1 Day)||0
11529|NCT02111083|25712|P2|COMPLETED|Third Intervention (1 Day)||19
11530|NCT02111083|25713|P1|COMPLETED|Third Intervention (1 Day)||19
11531|NCT02111083|25712|P2|STARTED|Third Intervention (1 Day)||19
11532|NCT02111083|25713|P1|STARTED|Third Intervention (1 Day)||19
11533|NCT02111083|25712|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11534|NCT02111083|25713|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11535|NCT02111083|25712|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
11536|NCT02111083|25713|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
11537|NCT02111083|25712|P2|STARTED|Interval Between Dosing (7-8 Days)||19
11538|NCT02111083|25713|P1|STARTED|Interval Between Dosing (7-8 Days)||19
11539|NCT02111083|25712|P2|NOT COMPLETED|Second Intervention (1 Day)||0
11540|NCT02111083|25713|P1|NOT COMPLETED|Second Intervention (1 Day)||0
11541|NCT02111083|25712|P2|COMPLETED|Second Intervention (1 Day)||19
11542|NCT02111083|25713|P1|COMPLETED|Second Intervention (1 Day)||19
11543|NCT02111083|25712|P2|STARTED|Second Intervention (1 Day)||19
11544|NCT02111083|25713|P1|STARTED|Second Intervention (1 Day)||19
11545|NCT02111083|25712|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11546|NCT02111083|25713|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11547|NCT02111083|25712|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
11548|NCT02111083|25713|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
11549|NCT02111083|25712|P2|STARTED|Interval Between Dosing (7-8 Days)||19
11550|NCT02111083|25713|P1|STARTED|Interval Between Dosing (7-8 Days)||19
11551|NCT02111083|25712|P2|NOT COMPLETED|First Intervention (1 Day)||0
11552|NCT02111083|25713|P1|NOT COMPLETED|First Intervention (1 Day)||0
11553|NCT02111083|25712|P2|COMPLETED|First Intervention (1 Day)||19
11554|NCT02111083|25713|P1|COMPLETED|First Intervention (1 Day)||19
11555|NCT02111083|25712|P2|STARTED|First Intervention (1 Day)||19
11556|NCT02111083|25713|P1|STARTED|First Intervention (1 Day)||19
11557|NCT02110238|25733|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
11558|NCT02110238|25734|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
11559|NCT02110238|25733|P2|COMPLETED|14 Week Blinded Extension Phase||188
11560|NCT02110238|25734|P1|COMPLETED|14 Week Blinded Extension Phase||190
11561|NCT02110238|25733|P2|STARTED|14 Week Blinded Extension Phase||200
11562|NCT02110238|25734|P1|STARTED|14 Week Blinded Extension Phase||202
11563|NCT02110238|25733|P2|NOT COMPLETED|12 Week Pivotal Phase||9
11564|NCT02110238|25734|P1|NOT COMPLETED|12 Week Pivotal Phase||10
11565|NCT02110238|25733|P2|COMPLETED|12 Week Pivotal Phase||200
11566|NCT02110238|25734|P1|COMPLETED|12 Week Pivotal Phase||202
11567|NCT02110238|25733|P2|STARTED|12 Week Pivotal Phase||209
11568|NCT02110238|25734|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
11569|NCT02109731|25740|P1|NOT COMPLETED|Overall Study||0
11570|NCT02109731|25740|P1|COMPLETED|Overall Study||15
11571|NCT02109731|25740|P1|STARTED|Overall Study||15
11572|NCT02109497|25744|P1|NOT COMPLETED|Overall Study||1
11573|NCT02109497|25744|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
11574|NCT02109497|25744|P1|STARTED|Overall Study||18
11575|NCT02109172|25749|P6|NOT COMPLETED|Overall Study||1
11576|NCT02109172|25750|P5|NOT COMPLETED|Overall Study||1
11577|NCT02109172|25751|P4|NOT COMPLETED|Overall Study||1
11578|NCT02109172|25752|P3|NOT COMPLETED|Overall Study||1
11579|NCT02109172|25753|P2|NOT COMPLETED|Overall Study||0
11580|NCT02109172|25754|P1|NOT COMPLETED|Overall Study||1
11581|NCT02109172|25749|P6|COMPLETED|Overall Study||10
11582|NCT02109172|25750|P5|COMPLETED|Overall Study||9
11583|NCT02109172|25751|P4|COMPLETED|Overall Study||10
11584|NCT02109172|25752|P3|COMPLETED|Overall Study||9
11585|NCT02109172|25753|P2|COMPLETED|Overall Study||11
11586|NCT02109172|25754|P1|COMPLETED|Overall Study||10
11587|NCT02109172|25749|P6|STARTED|Overall Study||11
11588|NCT02109172|25750|P5|STARTED|Overall Study||10
11589|NCT02109172|25751|P4|STARTED|Overall Study||11
11590|NCT02109172|25752|P3|STARTED|Overall Study||10
11591|NCT02109172|25753|P2|STARTED|Overall Study||11
11592|NCT02109172|25754|P1|STARTED|Overall Study||11
11593|NCT02109159|25764|P2|NOT COMPLETED|Overall Study||0
11594|NCT02109159|25765|P1|NOT COMPLETED|Overall Study||0
11595|NCT02109159|25764|P2|COMPLETED|Overall Study||4175
11596|NCT02109159|25765|P1|COMPLETED|Overall Study||4178
11597|NCT02109159|25764|P2|STARTED|Overall Study||4175
11598|NCT02109159|25765|P1|STARTED|Overall Study||4178
11599|NCT02109133|25775|P2|NOT COMPLETED|Overall Study||0
11600|NCT02109133|25776|P1|NOT COMPLETED|Overall Study||1
11601|NCT02109133|25775|P2|COMPLETED|Overall Study||34
11602|NCT02109133|25776|P1|COMPLETED|Overall Study||32
11603|NCT02109133|25775|P2|STARTED|Overall Study||34
11604|NCT02109133|25776|P1|STARTED|Overall Study||33
11605|NCT02109107|25788|P1|NOT COMPLETED|Overall Study||2
11606|NCT02109107|25788|P1|COMPLETED|Overall Study||52
11607|NCT02109107|25788|P1|STARTED|Overall Study||54
11608|NCT02108977|25797|P2|NOT COMPLETED|Overall Study||1
11609|NCT02108977|25798|P1|NOT COMPLETED|Overall Study||10
11610|NCT02108977|25797|P2|COMPLETED|Overall Study||19
11611|NCT02108977|25798|P1|COMPLETED|Overall Study||8
11612|NCT02108977|25797|P2|STARTED|Overall Study||20
11613|NCT02108977|25798|P1|STARTED|Overall Study||18
11614|NCT02108691|25812|P2|NOT COMPLETED|Overall Study||9
11615|NCT02108691|25813|P1|NOT COMPLETED|Overall Study||8
11616|NCT02108691|25812|P2|COMPLETED|Overall Study||31
11617|NCT02108691|25813|P1|COMPLETED|Overall Study||32
11618|NCT02108691|25812|P2|STARTED|Overall Study||40
11619|NCT02108691|25813|P1|STARTED|Overall Study||40
11620|NCT02108652|25831|P1|NOT COMPLETED|Overall Study||310
11621|NCT02108652|25831|P1|COMPLETED|Overall Study||0
11622|NCT02108652|25831|P1|STARTED|Overall Study||310
11623|NCT02108288|25855|P3|NOT COMPLETED|Overall Study||0
11624|NCT02108288|25856|P2|NOT COMPLETED|Overall Study||0
11625|NCT02108288|25857|P1|NOT COMPLETED|Overall Study||0
11626|NCT02108288|25855|P3|COMPLETED|Overall Study||10
11627|NCT02108288|25856|P2|COMPLETED|Overall Study||10
11628|NCT02108288|25857|P1|COMPLETED|Overall Study||10
11629|NCT02108288|25855|P3|STARTED|Overall Study||10
11630|NCT02108288|25856|P2|STARTED|Overall Study||10
11631|NCT02108288|25857|P1|STARTED|Overall Study||10
11632|NCT02108223|25873|P3|NOT COMPLETED|Overall Study||0
11633|NCT02108223|25874|P2|NOT COMPLETED|Overall Study||0
11634|NCT02108223|25875|P1|NOT COMPLETED|Overall Study||0
11635|NCT02108223|25873|P3|COMPLETED|Overall Study||35
11636|NCT02108223|25874|P2|COMPLETED|Overall Study||50
11637|NCT02108223|25875|P1|COMPLETED|Overall Study||52
11638|NCT02108223|25873|P3|STARTED|Overall Study||35
11639|NCT02108223|25874|P2|STARTED|Overall Study||50
11640|NCT02108223|25875|P1|STARTED|Overall Study||52
11641|NCT02108171|25897|P2|NOT COMPLETED|Overall Study||0
11642|NCT02108171|25898|P1|NOT COMPLETED|Overall Study||0
11643|NCT02108171|25897|P2|COMPLETED|Overall Study||41
11644|NCT02108171|25898|P1|COMPLETED|Overall Study||40
11645|NCT02108171|25897|P2|STARTED|Overall Study||41
11646|NCT02108171|25898|P1|STARTED|Overall Study||40
11647|NCT02107898|26000|P2|NOT COMPLETED|Overall Study||12
11648|NCT02107898|26001|P1|NOT COMPLETED|Overall Study||6
11649|NCT02107898|26000|P2|COMPLETED|Overall Study||132
11650|NCT02107898|26001|P1|COMPLETED|Overall Study||66
11651|NCT02107898|26000|P2|Treated|Overall Study||143
11652|NCT02107898|26001|P1|Treated|Overall Study||72
11653|NCT02107898|26000|P2|STARTED|Overall Study|Randomized|144
11654|NCT02107898|26001|P1|STARTED|Overall Study|Randomized|72
11655|NCT02107599|26053|P1|NOT COMPLETED|Overall Study||0
11656|NCT02107599|26053|P1|COMPLETED|Overall Study||96
11657|NCT02107599|26053|P1|STARTED|Overall Study||96
11658|NCT02107339|26062|P2|NOT COMPLETED|Overall Study||4
11659|NCT02107339|26063|P1|NOT COMPLETED|Overall Study||1
11660|NCT02107339|26062|P2|COMPLETED|Overall Study||53
11661|NCT02107339|26063|P1|COMPLETED|Overall Study||62
11662|NCT02107339|26062|P2|STARTED|Overall Study||57
11663|NCT02107339|26063|P1|STARTED|Overall Study||63
11664|NCT02107313|26091|P2|NOT COMPLETED|Overall Study||1
11665|NCT02107313|26092|P1|NOT COMPLETED|Overall Study||0
11666|NCT02107313|26091|P2|COMPLETED|Overall Study||8
11667|NCT02107313|26092|P1|COMPLETED|Overall Study||9
11668|NCT02107313|26091|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
11669|NCT02107313|26092|P1|STARTED|Overall Study||9
11670|NCT02107274|26102|P2|NOT COMPLETED|Control Phase||2
11671|NCT02107274|26103|P1|NOT COMPLETED|Control Phase||3
11672|NCT02107274|26102|P2|COMPLETED|Control Phase||35
11673|NCT02107274|26103|P1|COMPLETED|Control Phase||33
11674|NCT02107274|26102|P2|STARTED|Control Phase||37
11675|NCT02107274|26103|P1|STARTED|Control Phase||36
11676|NCT02107274|26102|P2|NOT COMPLETED|Treatment vs. Placebo||2
11677|NCT02107274|26103|P1|NOT COMPLETED|Treatment vs. Placebo||3
11678|NCT02107274|26102|P2|COMPLETED|Treatment vs. Placebo||37
11679|NCT02107274|26103|P1|COMPLETED|Treatment vs. Placebo||36
11680|NCT02107274|26102|P2|STARTED|Treatment vs. Placebo||39
11681|NCT02107274|26103|P1|STARTED|Treatment vs. Placebo||39
11682|NCT02107196|26117|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
11683|NCT02107196|26118|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
11684|NCT02107196|26117|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
11685|NCT02107196|26118|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
11686|NCT02107196|26117|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
11687|NCT02107196|26118|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
11688|NCT02107196|26117|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
11689|NCT02107196|26118|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
11690|NCT02107196|26117|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
11691|NCT02107196|26118|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
11692|NCT02107196|26117|P2|NOT COMPLETED|12-week Treatment Period||39
11693|NCT02107196|26118|P1|NOT COMPLETED|12-week Treatment Period||44
11694|NCT02107196|26117|P2|COMPLETED|12-week Treatment Period||225
11695|NCT02107196|26118|P1|COMPLETED|12-week Treatment Period||227
11696|NCT02107196|26117|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
11697|NCT02107196|26118|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
11698|NCT02107196|26117|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
11699|NCT02107196|26118|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
11700|NCT02107196|26117|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
11701|NCT02107196|26118|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
11702|NCT02106728|26133|P2|NOT COMPLETED|Overall Study||0
11703|NCT02106728|26134|P1|NOT COMPLETED|Overall Study||0
11704|NCT02106728|26133|P2|COMPLETED|Overall Study||47
11705|NCT02106728|26134|P1|COMPLETED|Overall Study||70
11706|NCT02106728|26133|P2|STARTED|Overall Study||47
11707|NCT02106728|26134|P1|STARTED|Overall Study||70
11708|NCT02106494|26150|P2|NOT COMPLETED|Overall Study||25
11709|NCT02106494|26151|P1|NOT COMPLETED|Overall Study||26
11710|NCT02106494|26150|P2|COMPLETED|Overall Study||446
11711|NCT02106494|26151|P1|COMPLETED|Overall Study||445
11712|NCT02106494|26150|P2|Efficacy Population|Overall Study||452
11713|NCT02106494|26151|P1|Efficacy Population|Overall Study||450
11714|NCT02106494|26150|P2|Safety Population|Overall Study||459
11715|NCT02106494|26151|P1|Safety Population|Overall Study||456
11716|NCT02106494|26150|P2|STARTED|Overall Study||471
11717|NCT02106494|26151|P1|STARTED|Overall Study||471
11718|NCT02106403|26165|P6|NOT COMPLETED|Follow-Up Visit 3||1
11719|NCT02106403|26166|P5|NOT COMPLETED|Follow-Up Visit 3||0
11720|NCT02106403|26167|P4|NOT COMPLETED|Follow-Up Visit 3||0
11721|NCT02106403|26168|P3|NOT COMPLETED|Follow-Up Visit 3||0
11722|NCT02106403|26169|P2|NOT COMPLETED|Follow-Up Visit 3||0
11723|NCT02106403|26170|P1|NOT COMPLETED|Follow-Up Visit 3||0
11724|NCT02106403|26165|P6|COMPLETED|Follow-Up Visit 3||8
11725|NCT02106403|26166|P5|COMPLETED|Follow-Up Visit 3||8
11726|NCT02106403|26167|P4|COMPLETED|Follow-Up Visit 3||8
11727|NCT02106403|26168|P3|COMPLETED|Follow-Up Visit 3||9
11728|NCT02106403|26169|P2|COMPLETED|Follow-Up Visit 3||8
11729|NCT02106403|26170|P1|COMPLETED|Follow-Up Visit 3||8
11730|NCT02106403|26165|P6|STARTED|Follow-Up Visit 3||9
11731|NCT02106403|26166|P5|STARTED|Follow-Up Visit 3||8
11732|NCT02106403|26167|P4|STARTED|Follow-Up Visit 3||8
11733|NCT02106403|26168|P3|STARTED|Follow-Up Visit 3||9
11734|NCT02106403|26169|P2|STARTED|Follow-Up Visit 3||8
11735|NCT02106403|26170|P1|STARTED|Follow-Up Visit 3||8
11736|NCT02106403|26165|P6|NOT COMPLETED|Follow-Up Visit 2||0
11737|NCT02106403|26166|P5|NOT COMPLETED|Follow-Up Visit 2||0
11738|NCT02106403|26167|P4|NOT COMPLETED|Follow-Up Visit 2||0
11739|NCT02106403|26168|P3|NOT COMPLETED|Follow-Up Visit 2||0
11740|NCT02106403|26169|P2|NOT COMPLETED|Follow-Up Visit 2||0
11741|NCT02106403|26170|P1|NOT COMPLETED|Follow-Up Visit 2||0
11742|NCT02106403|26165|P6|COMPLETED|Follow-Up Visit 2||9
11743|NCT02106403|26166|P5|COMPLETED|Follow-Up Visit 2||8
11744|NCT02106403|26167|P4|COMPLETED|Follow-Up Visit 2||8
11745|NCT02106403|26168|P3|COMPLETED|Follow-Up Visit 2||9
11746|NCT02106403|26169|P2|COMPLETED|Follow-Up Visit 2||8
11747|NCT02106403|26170|P1|COMPLETED|Follow-Up Visit 2||8
11748|NCT02106403|26165|P6|STARTED|Follow-Up Visit 2||9
11749|NCT02106403|26166|P5|STARTED|Follow-Up Visit 2||8
11750|NCT02106403|26167|P4|STARTED|Follow-Up Visit 2||8
11751|NCT02106403|26168|P3|STARTED|Follow-Up Visit 2||9
11752|NCT02106403|26169|P2|STARTED|Follow-Up Visit 2||8
11753|NCT02106403|26170|P1|STARTED|Follow-Up Visit 2||8
11754|NCT02106403|26165|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
11755|NCT02106403|26166|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
11756|NCT02106403|26167|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
11757|NCT02106403|26168|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
11758|NCT02106403|26169|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
11759|NCT02106403|26170|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
11760|NCT02106403|26165|P6|COMPLETED|Visit 1, Treatment Period 3||9
11761|NCT02106403|26166|P5|COMPLETED|Visit 1, Treatment Period 3||8
11762|NCT02106403|26167|P4|COMPLETED|Visit 1, Treatment Period 3||8
11763|NCT02106403|26168|P3|COMPLETED|Visit 1, Treatment Period 3||9
11764|NCT02106403|26169|P2|COMPLETED|Visit 1, Treatment Period 3||8
11765|NCT02106403|26170|P1|COMPLETED|Visit 1, Treatment Period 3||8
11766|NCT02106403|26165|P6|STARTED|Visit 1, Treatment Period 3||9
11767|NCT02106403|26166|P5|STARTED|Visit 1, Treatment Period 3||8
11768|NCT02106403|26167|P4|STARTED|Visit 1, Treatment Period 3||8
11769|NCT02106403|26168|P3|STARTED|Visit 1, Treatment Period 3||9
11770|NCT02106403|26169|P2|STARTED|Visit 1, Treatment Period 3||8
11771|NCT02106403|26170|P1|STARTED|Visit 1, Treatment Period 3||8
11772|NCT02106403|26165|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
11773|NCT02106403|26166|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
11774|NCT02106403|26167|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
11775|NCT02106403|26168|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
11776|NCT02106403|26169|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
11777|NCT02106403|26170|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
11778|NCT02106403|26165|P6|COMPLETED|Visit 1, Treatment Period 2||9
11779|NCT02106403|26166|P5|COMPLETED|Visit 1, Treatment Period 2||8
11780|NCT02106403|26167|P4|COMPLETED|Visit 1, Treatment Period 2||8
11781|NCT02106403|26168|P3|COMPLETED|Visit 1, Treatment Period 2||9
11782|NCT02106403|26169|P2|COMPLETED|Visit 1, Treatment Period 2||8
11783|NCT02106403|26170|P1|COMPLETED|Visit 1, Treatment Period 2||8
11784|NCT02106403|26165|P6|STARTED|Visit 1, Treatment Period 2||9
11785|NCT02106403|26166|P5|STARTED|Visit 1, Treatment Period 2||8
11786|NCT02106403|26167|P4|STARTED|Visit 1, Treatment Period 2||8
11787|NCT02106403|26168|P3|STARTED|Visit 1, Treatment Period 2||9
11788|NCT02106403|26169|P2|STARTED|Visit 1, Treatment Period 2||8
11789|NCT02106403|26170|P1|STARTED|Visit 1, Treatment Period 2||8
11790|NCT02106403|26165|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
11791|NCT02106403|26166|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
11792|NCT02106403|26167|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
11793|NCT02106403|26168|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
11794|NCT02106403|26169|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
11795|NCT02106403|26170|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
11796|NCT02106403|26165|P6|COMPLETED|Visit 1, Treatment Period 1||9
11797|NCT02106403|26166|P5|COMPLETED|Visit 1, Treatment Period 1||8
11798|NCT02106403|26167|P4|COMPLETED|Visit 1, Treatment Period 1||8
11799|NCT02106403|26168|P3|COMPLETED|Visit 1, Treatment Period 1||9
11800|NCT02106403|26169|P2|COMPLETED|Visit 1, Treatment Period 1||8
11801|NCT02106403|26170|P1|COMPLETED|Visit 1, Treatment Period 1||8
11802|NCT02106403|26165|P6|STARTED|Visit 1, Treatment Period 1||9
11803|NCT02106403|26166|P5|STARTED|Visit 1, Treatment Period 1||8
11804|NCT02106403|26167|P4|STARTED|Visit 1, Treatment Period 1||8
11805|NCT02106403|26168|P3|STARTED|Visit 1, Treatment Period 1||9
11806|NCT02106403|26169|P2|STARTED|Visit 1, Treatment Period 1||8
11807|NCT02106403|26170|P1|STARTED|Visit 1, Treatment Period 1||8
11808|NCT02106156|26193|P3|NOT COMPLETED|Overall Study||0
11809|NCT02106156|26194|P2|NOT COMPLETED|Overall Study||40
11810|NCT02106156|26195|P1|NOT COMPLETED|Overall Study||2549
11811|NCT02106156|26193|P3|COMPLETED|Overall Study||518
11812|NCT02106156|26194|P2|COMPLETED|Overall Study||50
11813|NCT02106156|26195|P1|COMPLETED|Overall Study||7071
11814|NCT02106156|26193|P3|STARTED|Overall Study||518
11815|NCT02106156|26194|P2|STARTED|Overall Study||90
11816|NCT02106156|26195|P1|STARTED|Overall Study||9620
11817|NCT02105987|26219|P6|NOT COMPLETED|Continuation Phase||0
11818|NCT02105987|26220|P5|NOT COMPLETED|Continuation Phase||1
11819|NCT02105987|26221|P4|NOT COMPLETED|Continuation Phase||0
11820|NCT02105987|26222|P3|NOT COMPLETED|Continuation Phase||0
11821|NCT02105987|26223|P2|NOT COMPLETED|Continuation Phase||0
11822|NCT02105987|26224|P1|NOT COMPLETED|Continuation Phase||0
11823|NCT02105987|26219|P6|COMPLETED|Continuation Phase||23
11824|NCT02105987|26220|P5|COMPLETED|Continuation Phase||13
11825|NCT02105987|26221|P4|COMPLETED|Continuation Phase||0
11826|NCT02105987|26222|P3|COMPLETED|Continuation Phase||0
11827|NCT02105987|26223|P2|COMPLETED|Continuation Phase||0
11828|NCT02105987|26224|P1|COMPLETED|Continuation Phase||0
11829|NCT02105987|26219|P6|STARTED|Continuation Phase||23
11830|NCT02105987|26220|P5|STARTED|Continuation Phase||14
11831|NCT02105987|26221|P4|STARTED|Continuation Phase||0
11832|NCT02105987|26222|P3|STARTED|Continuation Phase||0
11833|NCT02105987|26223|P2|STARTED|Continuation Phase||0
11834|NCT02105987|26224|P1|STARTED|Continuation Phase||0
11835|NCT02105987|26219|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11836|NCT02105987|26220|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11837|NCT02105987|26221|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
11838|NCT02105987|26222|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
11839|NCT02105987|26223|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11840|NCT02105987|26224|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11841|NCT02105987|26219|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
11842|NCT02105987|26220|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
11843|NCT02105987|26221|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
11844|NCT02105987|26222|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
11845|NCT02105987|26223|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
11846|NCT02105987|26224|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
11847|NCT02105987|26219|P6|STARTED|Late Switch Phase (24 Weeks)||0
11848|NCT02105987|26220|P5|STARTED|Late Switch Phase (24 Weeks)||0
11849|NCT02105987|26221|P4|STARTED|Late Switch Phase (24 Weeks)||244
11850|NCT02105987|26222|P3|STARTED|Late Switch Phase (24 Weeks)||275
11851|NCT02105987|26223|P2|STARTED|Late Switch Phase (24 Weeks)||0
11852|NCT02105987|26224|P1|STARTED|Late Switch Phase (24 Weeks)||0
11853|NCT02105987|26219|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11854|NCT02105987|26220|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11855|NCT02105987|26221|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11856|NCT02105987|26222|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11857|NCT02105987|26223|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
11858|NCT02105987|26224|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
11859|NCT02105987|26219|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
11860|NCT02105987|26220|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
11861|NCT02105987|26221|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
11862|NCT02105987|26222|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
11863|NCT02105987|26223|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
11864|NCT02105987|26224|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
11865|NCT02105987|26219|P6|STARTED|Early Switch Phase (24 Weeks)||0
11866|NCT02105987|26220|P5|STARTED|Early Switch Phase (24 Weeks)||0
11867|NCT02105987|26221|P4|STARTED|Early Switch Phase (24 Weeks)||0
11868|NCT02105987|26222|P3|STARTED|Early Switch Phase (24 Weeks)||0
11869|NCT02105987|26223|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
11870|NCT02105987|26224|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
11871|NCT02105974|26278|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
11872|NCT02105974|26279|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
11873|NCT02105974|26280|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
11874|NCT02105974|26278|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
11875|NCT02105974|26279|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
11876|NCT02105974|26280|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
11877|NCT02105974|26278|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
11878|NCT02105974|26279|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
11879|NCT02105974|26280|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
11880|NCT02105974|26278|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
11881|NCT02105974|26279|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
11882|NCT02105974|26280|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
11883|NCT02105974|26278|P3|NOT COMPLETED|2 Week Run-in Period||0
11884|NCT02105974|26279|P2|NOT COMPLETED|2 Week Run-in Period||0
11885|NCT02105974|26280|P1|NOT COMPLETED|2 Week Run-in Period||801
11886|NCT02105974|26278|P3|COMPLETED|2 Week Run-in Period||0
11887|NCT02105974|26279|P2|COMPLETED|2 Week Run-in Period||0
11888|NCT02105974|26280|P1|COMPLETED|2 Week Run-in Period||1622
11889|NCT02105974|26278|P3|STARTED|2 Week Run-in Period||0
11890|NCT02105974|26279|P2|STARTED|2 Week Run-in Period||0
11891|NCT02105974|26280|P1|STARTED|2 Week Run-in Period||2423
11892|NCT02105701|26294|P4|NOT COMPLETED|Overall Study||2
11893|NCT02105701|26295|P3|NOT COMPLETED|Overall Study||3
11894|NCT02105701|26296|P2|NOT COMPLETED|Overall Study||1
11895|NCT02105701|26297|P1|NOT COMPLETED|Overall Study||4
11896|NCT02105701|26294|P4|COMPLETED|Overall Study||104
11897|NCT02105701|26295|P3|COMPLETED|Overall Study||102
11898|NCT02105701|26296|P2|COMPLETED|Overall Study||103
11899|NCT02105701|26297|P1|COMPLETED|Overall Study||101
11900|NCT02105701|26294|P4|STARTED|Overall Study||106
11901|NCT02105701|26295|P3|STARTED|Overall Study||105
11902|NCT02105701|26296|P2|STARTED|Overall Study||104
11903|NCT02105701|26297|P1|STARTED|Overall Study||105
11904|NCT02105688|26321|P2|NOT COMPLETED|Overall Study||99
11905|NCT02105688|26322|P1|NOT COMPLETED|Overall Study||26
11906|NCT02105688|26321|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
11907|NCT02105688|26322|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
11908|NCT02105688|26321|P2|Not Reached FU Week 12 Visit|Overall Study||15
11909|NCT02105688|26322|P1|Not Reached FU Week 12 Visit|Overall Study||2
11910|NCT02105688|26321|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
11911|NCT02105688|26322|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
11912|NCT02105688|26321|P2|STARTED|Overall Study||100
11913|NCT02105688|26322|P1|STARTED|Overall Study||201
11914|NCT02105662|26332|P1|NOT COMPLETED|Overall Study||6
11915|NCT02105662|26332|P1|COMPLETED|Overall Study||212
11916|NCT02105662|26332|P1|STARTED|Overall Study||218
11917|NCT02105636|26341|P2|NOT COMPLETED|Overall Study||108
11918|NCT02105636|26342|P1|NOT COMPLETED|Overall Study||195
11919|NCT02105636|26341|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
11920|NCT02105636|26342|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
11921|NCT02105636|26341|P2|STARTED|Overall Study||111
11922|NCT02105636|26342|P1|STARTED|Overall Study||236
11923|NCT02105467|26354|P2|NOT COMPLETED|Period 3||1
11924|NCT02105467|26355|P1|NOT COMPLETED|Period 3||0
11925|NCT02105467|26354|P2|COMPLETED|Period 3||102
11926|NCT02105467|26355|P1|COMPLETED|Period 3||0
11927|NCT02105467|26354|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
11928|NCT02105467|26355|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
11929|NCT02105467|26354|P2|NOT COMPLETED|Period 2||2
11930|NCT02105467|26355|P1|NOT COMPLETED|Period 2||2
11931|NCT02105467|26354|P2|COMPLETED|Period 2||102
11932|NCT02105467|26355|P1|COMPLETED|Period 2||312
11933|NCT02105467|26354|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
11934|NCT02105467|26355|P1|STARTED|Period 2||314
11935|NCT02105467|26354|P2|NOT COMPLETED|Period 1||0
11936|NCT02105467|26355|P1|NOT COMPLETED|Period 1||2
11937|NCT02105467|26354|P2|COMPLETED|Period 1||105
11938|NCT02105467|26355|P1|COMPLETED|Period 1||314
11939|NCT02105467|26354|P2|STARTED|Period 1||105
11940|NCT02105467|26355|P1|STARTED|Period 1||316
11941|NCT02105454|26367|P1|NOT COMPLETED|Overall Study||1
11942|NCT02105454|26367|P1|COMPLETED|Overall Study||78
11943|NCT02105454|26367|P1|STARTED|Overall Study||79
11944|NCT02105285|26377|P3|NOT COMPLETED|Overall Study||0
11945|NCT02105285|26378|P2|NOT COMPLETED|Overall Study||2
11946|NCT02105285|26379|P1|NOT COMPLETED|Overall Study||2
11947|NCT02105285|26377|P3|COMPLETED|Overall Study||37
11948|NCT02105285|26378|P2|COMPLETED|Overall Study||76
11949|NCT02105285|26379|P1|COMPLETED|Overall Study||76
11950|NCT02105285|26377|P3|STARTED|Overall Study||37
11951|NCT02105285|26378|P2|STARTED|Overall Study||78
11952|NCT02105285|26379|P1|STARTED|Overall Study||78
11953|NCT02105272|26398|P2|NOT COMPLETED|Overall Study||3
11954|NCT02105272|26399|P1|NOT COMPLETED|Overall Study||5
11955|NCT02105272|26398|P2|COMPLETED|Overall Study||116
11956|NCT02105272|26399|P1|COMPLETED|Overall Study||113
11957|NCT02105272|26398|P2|STARTED|Overall Study||119
11958|NCT02105272|26399|P1|STARTED|Overall Study||118
11959|NCT02104895|26417|P2|NOT COMPLETED|Overall Study||14
11960|NCT02104895|26418|P1|NOT COMPLETED|Overall Study||0
11961|NCT02104895|26417|P2|COMPLETED|Overall Study||246
11962|NCT02104895|26418|P1|COMPLETED|Overall Study||260
11963|NCT02104895|26417|P2|STARTED|Overall Study||260
11964|NCT02104895|26418|P1|STARTED|Overall Study||260
11965|NCT02104830|26431|P3|NOT COMPLETED|Overall Study||7
11966|NCT02104830|26432|P2|NOT COMPLETED|Overall Study||7
11967|NCT02104830|26433|P1|NOT COMPLETED|Overall Study||4
11968|NCT02104830|26431|P3|COMPLETED|Overall Study||36
11969|NCT02104830|26432|P2|COMPLETED|Overall Study||36
11970|NCT02104830|26433|P1|COMPLETED|Overall Study||38
11971|NCT02104830|26431|P3|STARTED|Overall Study||43
11972|NCT02104830|26432|P2|STARTED|Overall Study||43
11973|NCT02104830|26433|P1|STARTED|Overall Study||42
11974|NCT02104219|26456|P1|NOT COMPLETED|Overall Study||0
11975|NCT02104219|26456|P1|COMPLETED|Overall Study||32
11976|NCT02104219|26456|P1|STARTED|Overall Study||32
11977|NCT02103439|26465|P2|NOT COMPLETED|Overall Study||3
11978|NCT02103439|26466|P1|NOT COMPLETED|Overall Study||3
11979|NCT02103439|26465|P2|COMPLETED|Overall Study||67
11980|NCT02103439|26466|P1|COMPLETED|Overall Study||67
11981|NCT02103439|26465|P2|STARTED|Overall Study||70
11982|NCT02103439|26466|P1|STARTED|Overall Study||70
11983|NCT02103309|26486|P2|NOT COMPLETED|Overall Study||0
11984|NCT02103309|26487|P1|NOT COMPLETED|Overall Study||0
11985|NCT02103309|26486|P2|COMPLETED|Overall Study||22
11986|NCT02103309|26487|P1|COMPLETED|Overall Study||20
11987|NCT02103309|26486|P2|STARTED|Overall Study||22
11988|NCT02103309|26487|P1|STARTED|Overall Study||20
11989|NCT02103062|26501|P2|NOT COMPLETED|Overall Study||23
11990|NCT02103062|26502|P1|NOT COMPLETED|Overall Study||18
11991|NCT02103062|26501|P2|COMPLETED|Overall Study||0
11992|NCT02103062|26502|P1|COMPLETED|Overall Study||0
11993|NCT02103062|26501|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
11994|NCT02103062|26502|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
11995|NCT02103062|26501|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
11996|NCT02103062|26502|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
11997|NCT02103062|26501|P2|STARTED|Overall Study||23
11998|NCT02103062|26502|P1|STARTED|Overall Study||18
11999|NCT02102932|26528|P8|NOT COMPLETED|Overall Study||0
12000|NCT02102932|26529|P7|NOT COMPLETED|Overall Study||0
12001|NCT02102932|26530|P6|NOT COMPLETED|Overall Study||0
12002|NCT02102932|26531|P5|NOT COMPLETED|Overall Study||0
12003|NCT02102932|26532|P4|NOT COMPLETED|Overall Study||0
12004|NCT02102932|26533|P3|NOT COMPLETED|Overall Study||0
12005|NCT02102932|26534|P2|NOT COMPLETED|Overall Study||0
12006|NCT02102932|26535|P1|NOT COMPLETED|Overall Study||0
12007|NCT02102932|26528|P8|COMPLETED|Overall Study||12
12008|NCT02102932|26529|P7|COMPLETED|Overall Study||12
12009|NCT02102932|26530|P6|COMPLETED|Overall Study||12
12010|NCT02102932|26531|P5|COMPLETED|Overall Study||12
12011|NCT02102932|26532|P4|COMPLETED|Overall Study||12
12012|NCT02102932|26533|P3|COMPLETED|Overall Study||12
12013|NCT02102932|26534|P2|COMPLETED|Overall Study||12
12014|NCT02102932|26535|P1|COMPLETED|Overall Study||12
12015|NCT02102932|26528|P8|STARTED|Overall Study||12
12016|NCT02102932|26529|P7|STARTED|Overall Study||12
12017|NCT02102932|26530|P6|STARTED|Overall Study||12
12018|NCT02102932|26531|P5|STARTED|Overall Study||12
12019|NCT02102932|26532|P4|STARTED|Overall Study||12
12020|NCT02102932|26533|P3|STARTED|Overall Study||12
12021|NCT02102932|26534|P2|STARTED|Overall Study||12
12022|NCT02102932|26535|P1|STARTED|Overall Study||12
12023|NCT02102399|26595|P2|NOT COMPLETED|Overall Study||4
12024|NCT02102399|26596|P1|NOT COMPLETED|Overall Study||6
12025|NCT02102399|26595|P2|COMPLETED|Overall Study||17
12026|NCT02102399|26596|P1|COMPLETED|Overall Study||14
12027|NCT02102399|26595|P2|STARTED|Overall Study||21
12028|NCT02102399|26596|P1|STARTED|Overall Study||20
12029|NCT02101359|26646|P2|NOT COMPLETED|Overall Study||19
12030|NCT02101359|26647|P1|NOT COMPLETED|Overall Study||29
12031|NCT02101359|26646|P2|COMPLETED|Overall Study||277
12032|NCT02101359|26647|P1|COMPLETED|Overall Study||266
12033|NCT02101359|26646|P2|STARTED|Overall Study||296
12034|NCT02101359|26647|P1|STARTED|Overall Study||295
12035|NCT02101294|26653|P1|NOT COMPLETED|Overall Study||11
12036|NCT02101294|26653|P1|COMPLETED|Overall Study||20
12037|NCT02101294|26653|P1|STARTED|Overall Study||31
12038|NCT02101190|26662|P2|NOT COMPLETED|Overall Study||0
12039|NCT02101190|26663|P1|NOT COMPLETED|Overall Study||0
12040|NCT02101190|26662|P2|COMPLETED|Overall Study||8
12041|NCT02101190|26663|P1|COMPLETED|Overall Study||8
12042|NCT02101190|26662|P2|STARTED|Overall Study||8
12043|NCT02101190|26663|P1|STARTED|Overall Study||8
12044|NCT02101112|26673|P6|NOT COMPLETED|Overall Study||0
12045|NCT02101112|26674|P5|NOT COMPLETED|Overall Study||1
12046|NCT02101112|26675|P4|NOT COMPLETED|Overall Study||0
12047|NCT02101112|26676|P3|NOT COMPLETED|Overall Study||1
12048|NCT02101112|26677|P2|NOT COMPLETED|Overall Study||0
12049|NCT02101112|26678|P1|NOT COMPLETED|Overall Study||0
12050|NCT02101112|26673|P6|COMPLETED|Overall Study||5
12051|NCT02101112|26674|P5|COMPLETED|Overall Study||5
12052|NCT02101112|26675|P4|COMPLETED|Overall Study||5
12053|NCT02101112|26676|P3|COMPLETED|Overall Study||5
12054|NCT02101112|26677|P2|COMPLETED|Overall Study||5
12055|NCT02101112|26678|P1|COMPLETED|Overall Study||6
12056|NCT02101112|26673|P6|STARTED|Overall Study||5
12057|NCT02101112|26674|P5|STARTED|Overall Study||6
12058|NCT02101112|26675|P4|STARTED|Overall Study||5
12059|NCT02101112|26676|P3|STARTED|Overall Study||6
12060|NCT02101112|26677|P2|STARTED|Overall Study||5
12061|NCT02101112|26678|P1|STARTED|Overall Study||6
12062|NCT02101008|26703|P1|NOT COMPLETED|Overall Study||0
12063|NCT02101008|26703|P1|COMPLETED|Overall Study||12
12064|NCT02101008|26703|P1|STARTED|Overall Study||12
12065|NCT02100839|26710|P2|NOT COMPLETED|Multiple Ascending Dose||0
12066|NCT02100839|26711|P1|NOT COMPLETED|Multiple Ascending Dose||4
12067|NCT02100839|26710|P2|COMPLETED|Multiple Ascending Dose||3
12068|NCT02100839|26711|P1|COMPLETED|Multiple Ascending Dose||9
12069|NCT02100839|26710|P2|STARTED|Multiple Ascending Dose||3
12070|NCT02100839|26711|P1|STARTED|Multiple Ascending Dose||13
12071|NCT02100839|26710|P2|NOT COMPLETED|Single Ascending Dose||0
12072|NCT02100839|26711|P1|NOT COMPLETED|Single Ascending Dose||0
12073|NCT02100839|26710|P2|COMPLETED|Single Ascending Dose||12
12074|NCT02100839|26711|P1|COMPLETED|Single Ascending Dose||24
12075|NCT02100839|26710|P2|STARTED|Single Ascending Dose||12
12076|NCT02100839|26711|P1|STARTED|Single Ascending Dose||24
12077|NCT02100826|26723|P2|NOT COMPLETED|Period 2 (7 Days)||0
12078|NCT02100826|26724|P1|NOT COMPLETED|Period 2 (7 Days)||0
12079|NCT02100826|26723|P2|COMPLETED|Period 2 (7 Days)||14
12080|NCT02100826|26724|P1|COMPLETED|Period 2 (7 Days)||14
12081|NCT02100826|26723|P2|STARTED|Period 2 (7 Days)||14
12082|NCT02100826|26724|P1|STARTED|Period 2 (7 Days)||14
12083|NCT02100826|26723|P2|NOT COMPLETED|Washout Period (1 Day)||0
12084|NCT02100826|26724|P1|NOT COMPLETED|Washout Period (1 Day)||0
12085|NCT02100826|26723|P2|COMPLETED|Washout Period (1 Day)||14
12086|NCT02100826|26724|P1|COMPLETED|Washout Period (1 Day)||14
12087|NCT02100826|26723|P2|STARTED|Washout Period (1 Day)||14
12088|NCT02100826|26724|P1|STARTED|Washout Period (1 Day)||14
12089|NCT02100826|26723|P2|NOT COMPLETED|Period 1 (7 Days)||0
12090|NCT02100826|26724|P1|NOT COMPLETED|Period 1 (7 Days)||0
12091|NCT02100826|26723|P2|COMPLETED|Period 1 (7 Days)||14
12092|NCT02100826|26724|P1|COMPLETED|Period 1 (7 Days)||14
12093|NCT02100826|26723|P2|STARTED|Period 1 (7 Days)||14
12094|NCT02100826|26724|P1|STARTED|Period 1 (7 Days)||14
12095|NCT02100644|26734|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
12096|NCT02100644|26735|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
12097|NCT02100644|26736|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
12098|NCT02100644|26734|P3|COMPLETED|LTG and VPA Maintenance Phase||20
12099|NCT02100644|26735|P2|COMPLETED|LTG and VPA Maintenance Phase||0
12100|NCT02100644|26736|P1|COMPLETED|LTG and VPA Maintenance Phase||0
12101|NCT02100644|26734|P3|STARTED|LTG and VPA Maintenance Phase||20
12102|NCT02100644|26735|P2|STARTED|LTG and VPA Maintenance Phase||0
12103|NCT02100644|26736|P1|STARTED|LTG and VPA Maintenance Phase||0
12104|NCT02100644|26734|P3|NOT COMPLETED|VPA Reduction Phase||0
12105|NCT02100644|26735|P2|NOT COMPLETED|VPA Reduction Phase||0
12106|NCT02100644|26736|P1|NOT COMPLETED|VPA Reduction Phase||0
12107|NCT02100644|26734|P3|COMPLETED|VPA Reduction Phase||0
12108|NCT02100644|26735|P2|COMPLETED|VPA Reduction Phase||20
12109|NCT02100644|26736|P1|COMPLETED|VPA Reduction Phase||0
12110|NCT02100644|26734|P3|STARTED|VPA Reduction Phase||0
12111|NCT02100644|26735|P2|STARTED|VPA Reduction Phase||20
12112|NCT02100644|26736|P1|STARTED|VPA Reduction Phase||0
12113|NCT02100644|26734|P3|NOT COMPLETED|LTG Escalation Phase||0
12114|NCT02100644|26735|P2|NOT COMPLETED|LTG Escalation Phase||0
12115|NCT02100644|26736|P1|NOT COMPLETED|LTG Escalation Phase||13
12116|NCT02100644|26734|P3|COMPLETED|LTG Escalation Phase||0
12117|NCT02100644|26735|P2|COMPLETED|LTG Escalation Phase||0
12118|NCT02100644|26736|P1|COMPLETED|LTG Escalation Phase||20
12119|NCT02100644|26734|P3|STARTED|LTG Escalation Phase||0
12120|NCT02100644|26735|P2|STARTED|LTG Escalation Phase||0
12121|NCT02100644|26736|P1|STARTED|LTG Escalation Phase||33
12122|NCT02100579|26748|P2|NOT COMPLETED|Overall Study||0
12123|NCT02100579|26749|P1|NOT COMPLETED|Overall Study||0
12124|NCT02100579|26748|P2|COMPLETED|Overall Study||20
12125|NCT02100579|26749|P1|COMPLETED|Overall Study||20
12126|NCT02100579|26748|P2|STARTED|Overall Study||20
12127|NCT02100579|26749|P1|STARTED|Overall Study||20
12128|NCT02100475|26761|P2|NOT COMPLETED|Overall Study||2
12129|NCT02100475|26762|P1|NOT COMPLETED|Overall Study||2
12130|NCT02100475|26761|P2|COMPLETED|Overall Study||13
12131|NCT02100475|26762|P1|COMPLETED|Overall Study||14
12132|NCT02100475|26761|P2|STARTED|Overall Study||15
12133|NCT02100475|26762|P1|STARTED|Overall Study||16
12134|NCT02100410|26772|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12135|NCT02100410|26773|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12136|NCT02100410|26774|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12137|NCT02100410|26775|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12138|NCT02100410|26776|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12139|NCT02100410|26777|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
12140|NCT02100410|26772|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
12141|NCT02100410|26773|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
12142|NCT02100410|26774|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
12143|NCT02100410|26775|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
12144|NCT02100410|26776|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
12145|NCT02100410|26777|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
12146|NCT02100410|26772|P6|STARTED|Exposure Pair 3, 30 Minutes||9
12147|NCT02100410|26773|P5|STARTED|Exposure Pair 3, 30 Minutes||8
12148|NCT02100410|26774|P4|STARTED|Exposure Pair 3, 30 Minutes||8
12149|NCT02100410|26775|P3|STARTED|Exposure Pair 3, 30 Minutes||8
12150|NCT02100410|26776|P2|STARTED|Exposure Pair 3, 30 Minutes||8
12151|NCT02100410|26777|P1|STARTED|Exposure Pair 3, 30 Minutes||8
12152|NCT02100410|26772|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12153|NCT02100410|26773|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12154|NCT02100410|26774|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12155|NCT02100410|26775|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12156|NCT02100410|26776|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12157|NCT02100410|26777|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
12158|NCT02100410|26772|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
12159|NCT02100410|26773|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
12160|NCT02100410|26774|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
12161|NCT02100410|26775|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
12162|NCT02100410|26776|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
12163|NCT02100410|26777|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
12164|NCT02100410|26772|P6|STARTED|Exposure Pair 2, 30 Minutes||9
12165|NCT02100410|26773|P5|STARTED|Exposure Pair 2, 30 Minutes||8
12166|NCT02100410|26774|P4|STARTED|Exposure Pair 2, 30 Minutes||8
12167|NCT02100410|26775|P3|STARTED|Exposure Pair 2, 30 Minutes||8
12168|NCT02100410|26776|P2|STARTED|Exposure Pair 2, 30 Minutes||8
12169|NCT02100410|26777|P1|STARTED|Exposure Pair 2, 30 Minutes||8
12170|NCT02100410|26772|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12171|NCT02100410|26773|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12172|NCT02100410|26774|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12173|NCT02100410|26775|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12174|NCT02100410|26776|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12175|NCT02100410|26777|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
12176|NCT02100410|26772|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
12177|NCT02100410|26773|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
12178|NCT02100410|26774|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
12179|NCT02100410|26775|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
12180|NCT02100410|26776|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
12181|NCT02100410|26777|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
12182|NCT02100410|26772|P6|STARTED|Exposure Pair 1, 30 Minutes||9
12183|NCT02100410|26773|P5|STARTED|Exposure Pair 1, 30 Minutes||8
12184|NCT02100410|26774|P4|STARTED|Exposure Pair 1, 30 Minutes||8
12185|NCT02100410|26775|P3|STARTED|Exposure Pair 1, 30 Minutes||8
12186|NCT02100410|26776|P2|STARTED|Exposure Pair 1, 30 Minutes||8
12187|NCT02100410|26777|P1|STARTED|Exposure Pair 1, 30 Minutes||8
12188|NCT02099838|26795|P2|NOT COMPLETED|Overall Study||2
12189|NCT02099838|26796|P1|NOT COMPLETED|Overall Study||4
12190|NCT02099838|26795|P2|COMPLETED|Overall Study||49
12191|NCT02099838|26796|P1|COMPLETED|Overall Study||43
12192|NCT02099838|26795|P2|STARTED|Overall Study||51
12193|NCT02099838|26796|P1|STARTED|Overall Study||47
12194|NCT02099708|26826|P1|NOT COMPLETED|Overall Study||200
12195|NCT02099708|26826|P1|COMPLETED|Overall Study||3302
12196|NCT02099708|26826|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
12197|NCT02099708|26826|P1|STARTED|Overall Study|Number of cases.|3502
12198|NCT02099682|26837|P1|NOT COMPLETED|Overall Study||111
12199|NCT02099682|26837|P1|COMPLETED|Overall Study||3255
12200|NCT02099682|26837|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
12201|NCT02099682|26837|P1|STARTED|Overall Study|Number of cases.|3366
12202|NCT02099461|26851|P3|NOT COMPLETED|Overall Study||0
12203|NCT02099461|26852|P2|NOT COMPLETED|Overall Study||0
12204|NCT02099461|26853|P1|NOT COMPLETED|Overall Study||0
12205|NCT02099461|26851|P3|COMPLETED|Overall Study||28
12206|NCT02099461|26852|P2|COMPLETED|Overall Study||27
12207|NCT02099461|26853|P1|COMPLETED|Overall Study||27
12208|NCT02099461|26851|P3|STARTED|Overall Study||28
12209|NCT02099461|26852|P2|STARTED|Overall Study||27
12210|NCT02099461|26853|P1|STARTED|Overall Study||27
12211|NCT02099344|26863|P2|NOT COMPLETED|Overall Study||0
12212|NCT02099344|26864|P1|NOT COMPLETED|Overall Study||1
12213|NCT02099344|26863|P2|COMPLETED|Overall Study||0
12214|NCT02099344|26864|P1|COMPLETED|Overall Study||0
12215|NCT02099344|26863|P2|STARTED|Overall Study||0
12216|NCT02099344|26864|P1|STARTED|Overall Study||1
12217|NCT02099084|26870|P2|NOT COMPLETED|Second Intervention||0
12218|NCT02099084|26871|P1|NOT COMPLETED|Second Intervention||0
12219|NCT02099084|26870|P2|COMPLETED|Second Intervention||4
12220|NCT02099084|26871|P1|COMPLETED|Second Intervention||4
12221|NCT02099084|26870|P2|STARTED|Second Intervention||4
12222|NCT02099084|26871|P1|STARTED|Second Intervention||4
12223|NCT02099084|26870|P2|NOT COMPLETED|Washout Period of 14 Days||0
12224|NCT02099084|26871|P1|NOT COMPLETED|Washout Period of 14 Days||0
12225|NCT02099084|26870|P2|COMPLETED|Washout Period of 14 Days||4
12226|NCT02099084|26871|P1|COMPLETED|Washout Period of 14 Days||4
12227|NCT02099084|26870|P2|STARTED|Washout Period of 14 Days||4
12228|NCT02099084|26871|P1|STARTED|Washout Period of 14 Days||4
12229|NCT02099084|26870|P2|NOT COMPLETED|First Intervention||0
12230|NCT02099084|26871|P1|NOT COMPLETED|First Intervention||0
12231|NCT02099084|26870|P2|COMPLETED|First Intervention||4
12232|NCT02099084|26871|P1|COMPLETED|First Intervention||4
12233|NCT02099084|26870|P2|STARTED|First Intervention||4
12234|NCT02099084|26871|P1|STARTED|First Intervention||4
12235|NCT02099006|26889|P1|NOT COMPLETED|Overall Study||1
12236|NCT02099006|26889|P1|COMPLETED|Overall Study||8
12237|NCT02099006|26889|P1|Received Gabapentin|Overall Study||8
12238|NCT02099006|26889|P1|Received Ketamine|Overall Study||6
12239|NCT02099006|26889|P1|Received Loperamide|Overall Study||7
12240|NCT02099006|26889|P1|Received Ketoprofen|Overall Study||3
12241|NCT02099006|26889|P1|Received Amitriptyline/ Baclofen|Overall Study||7
12242|NCT02099006|26889|P1|Received Placebo|Overall Study||9
12243|NCT02099006|26889|P1|STARTED|Overall Study||9
12244|NCT02098746|26897|P1|NOT COMPLETED|Overall Study||5
12245|NCT02098746|26897|P1|COMPLETED|Overall Study||289
12246|NCT02098746|26897|P1|STARTED|Overall Study||294
12247|NCT02098733|26905|P1|NOT COMPLETED|Overall Study||10
12248|NCT02098733|26905|P1|COMPLETED|Overall Study||1158
12249|NCT02098733|26905|P1|STARTED|Overall Study||1168
12250|NCT02098395|26919|P4|NOT COMPLETED|Overall Study||27
12251|NCT02098395|26920|P3|NOT COMPLETED|Overall Study||42
12252|NCT02098395|26921|P2|NOT COMPLETED|Overall Study||32
12253|NCT02098395|26922|P1|NOT COMPLETED|Overall Study||26
12254|NCT02098395|26919|P4|COMPLETED|Overall Study||180
12255|NCT02098395|26920|P3|COMPLETED|Overall Study||165
12256|NCT02098395|26921|P2|COMPLETED|Overall Study||177
12257|NCT02098395|26922|P1|COMPLETED|Overall Study||186
12258|NCT02098395|26919|P4|Exposed|Overall Study||206
12259|NCT02098395|26920|P3|Exposed|Overall Study||206
12260|NCT02098395|26921|P2|Exposed|Overall Study||209
12261|NCT02098395|26922|P1|Exposed|Overall Study||211
12262|NCT02098395|26919|P4|STARTED|Overall Study||207
12263|NCT02098395|26920|P3|STARTED|Overall Study||207
12264|NCT02098395|26921|P2|STARTED|Overall Study||209
12265|NCT02098395|26922|P1|STARTED|Overall Study||212
12266|NCT02098304|26940|P1|NOT COMPLETED|Overall Study||0
12267|NCT02098304|26940|P1|COMPLETED|Overall Study||42
12268|NCT02098304|26940|P1|STARTED|Overall Study||42
12269|NCT02097745|26947|P1|NOT COMPLETED|Overall Study||178
12270|NCT02097745|26947|P1|COMPLETED|Overall Study||157
12271|NCT02097745|26947|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
12272|NCT02097719|26971|P2|NOT COMPLETED|Overall Study||1
12273|NCT02097719|26972|P1|NOT COMPLETED|Overall Study||3
12274|NCT02097719|26971|P2|COMPLETED|Overall Study||50
12275|NCT02097719|26972|P1|COMPLETED|Overall Study||46
12276|NCT02097719|26971|P2|STARTED|Overall Study||51
12277|NCT02097719|26972|P1|STARTED|Overall Study||49
12278|NCT02097537|26978|P1|NOT COMPLETED|Overall Study||0
12279|NCT02097537|26978|P1|COMPLETED|Overall Study||10
12280|NCT02097537|26978|P1|Follow-Up|Overall Study||10
12281|NCT02097537|26978|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
12282|NCT02097537|26978|P1|STARTED|Overall Study||10
12283|NCT02097108|26984|P1|NOT COMPLETED|Overall Study||2
12284|NCT02097108|26984|P1|COMPLETED|Overall Study||9
12285|NCT02097108|26984|P1|STARTED|Overall Study||11
12286|NCT02097056|26991|P1|NOT COMPLETED|Overall Study||58
12287|NCT02097056|26991|P1|COMPLETED|Overall Study||113
12288|NCT02097056|26991|P1|ParticipantsTreated|Overall Study||170
12289|NCT02097056|26991|P1|STARTED|Overall Study||171
12290|NCT02097030|26999|P2|NOT COMPLETED|Second Intervention (3 Days)||0
12291|NCT02097030|27000|P1|NOT COMPLETED|Second Intervention (3 Days)||0
12292|NCT02097030|26999|P2|COMPLETED|Second Intervention (3 Days)||16
12293|NCT02097030|27000|P1|COMPLETED|Second Intervention (3 Days)||14
12294|NCT02097030|26999|P2|STARTED|Second Intervention (3 Days)||16
12295|NCT02097030|27000|P1|STARTED|Second Intervention (3 Days)||14
12296|NCT02097030|26999|P2|NOT COMPLETED|First Intervention (3 Days)||1
12297|NCT02097030|27000|P1|NOT COMPLETED|First Intervention (3 Days)||1
12298|NCT02097030|26999|P2|COMPLETED|First Intervention (3 Days)||16
12299|NCT02097030|27000|P1|COMPLETED|First Intervention (3 Days)||14
12300|NCT02097030|26999|P2|STARTED|First Intervention (3 Days)||17
12301|NCT02097030|27000|P1|STARTED|First Intervention (3 Days)||15
12302|NCT02096835|27064|P3|NOT COMPLETED|Overall Study||1
12303|NCT02096835|27065|P2|NOT COMPLETED|Overall Study||0
12304|NCT02096835|27066|P1|NOT COMPLETED|Overall Study||3
12305|NCT02096835|27064|P3|COMPLETED|Overall Study||50
12306|NCT02096835|27065|P2|COMPLETED|Overall Study||53
12307|NCT02096835|27066|P1|COMPLETED|Overall Study||50
12308|NCT02096835|27064|P3|STARTED|Overall Study||51
12309|NCT02096835|27065|P2|STARTED|Overall Study||53
12310|NCT02096835|27066|P1|STARTED|Overall Study||53
12311|NCT02096744|27083|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
12312|NCT02096744|27084|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
12313|NCT02096744|27083|P2|COMPLETED|Treatment Period 3 (7 Days)||27
12314|NCT02096744|27084|P1|COMPLETED|Treatment Period 3 (7 Days)||28
12315|NCT02096744|27083|P2|STARTED|Treatment Period 3 (7 Days)||28
12316|NCT02096744|27084|P1|STARTED|Treatment Period 3 (7 Days)||28
12317|NCT02096744|27083|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
12318|NCT02096744|27084|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
12319|NCT02096744|27083|P2|COMPLETED|Washout Period 2 (3 Days)||28
12320|NCT02096744|27084|P1|COMPLETED|Washout Period 2 (3 Days)||28
12321|NCT02096744|27083|P2|STARTED|Washout Period 2 (3 Days)||28
12322|NCT02096744|27084|P1|STARTED|Washout Period 2 (3 Days)||28
12323|NCT02096744|27083|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
12324|NCT02096744|27084|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
12325|NCT02096744|27083|P2|COMPLETED|Treatment Period 2 (7 Days)||28
12326|NCT02096744|27084|P1|COMPLETED|Treatment Period 2 (7 Days)||28
12327|NCT02096744|27083|P2|STARTED|Treatment Period 2 (7 Days)||28
12328|NCT02096744|27084|P1|STARTED|Treatment Period 2 (7 Days)||28
12329|NCT02096744|27083|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
12330|NCT02096744|27084|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
12331|NCT02096744|27083|P2|COMPLETED|Washout Period 1(7 Days)||28
12332|NCT02096744|27084|P1|COMPLETED|Washout Period 1(7 Days)||28
12333|NCT02096744|27083|P2|STARTED|Washout Period 1(7 Days)||28
12334|NCT02096744|27084|P1|STARTED|Washout Period 1(7 Days)||28
12335|NCT02096744|27083|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
12336|NCT02096744|27084|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
12337|NCT02096744|27083|P2|COMPLETED|Treatment Period 1(7 Days)||28
12338|NCT02096744|27084|P1|COMPLETED|Treatment Period 1(7 Days)||28
12339|NCT02096744|27083|P2|STARTED|Treatment Period 1(7 Days)||29
12340|NCT02096744|27084|P1|STARTED|Treatment Period 1(7 Days)||29
12341|NCT02096731|27099|P2|NOT COMPLETED|Overall Study||0
12342|NCT02096731|27100|P1|NOT COMPLETED|Overall Study||0
12343|NCT02096731|27099|P2|COMPLETED|Overall Study||88955
12344|NCT02096731|27100|P1|COMPLETED|Overall Study||26442
12345|NCT02096731|27099|P2|STARTED|Overall Study||88955
12346|NCT02096731|27100|P1|STARTED|Overall Study||26442
12347|NCT02096718|27117|P3|NOT COMPLETED|Overall Study||0
12348|NCT02096718|27118|P2|NOT COMPLETED|Overall Study||0
12349|NCT02096718|27119|P1|NOT COMPLETED|Overall Study||0
12350|NCT02096718|27117|P3|COMPLETED|Overall Study||14
12351|NCT02096718|27118|P2|COMPLETED|Overall Study||8
12352|NCT02096718|27119|P1|COMPLETED|Overall Study||8
12353|NCT02096718|27117|P3|STARTED|Overall Study||14
12354|NCT02096718|27118|P2|STARTED|Overall Study||8
12355|NCT02096718|27119|P1|STARTED|Overall Study||8
12356|NCT02096692|27136|P1|NOT COMPLETED|Overall Study||4
12357|NCT02096692|27136|P1|COMPLETED|Overall Study||150
12358|NCT02096692|27136|P1|STARTED|Overall Study||154
12359|NCT02096679|27142|P1|NOT COMPLETED|Overall Study||0
12360|NCT02096679|27142|P1|COMPLETED|Overall Study||8
12361|NCT02096679|27142|P1|STARTED|Overall Study||8
12362|NCT02096575|27167|P3|NOT COMPLETED|Overall Study||5
12363|NCT02096575|27168|P2|NOT COMPLETED|Overall Study||0
12364|NCT02096575|27169|P1|NOT COMPLETED|Overall Study||0
12365|NCT02096575|27167|P3|COMPLETED|Overall Study||0
12366|NCT02096575|27168|P2|COMPLETED|Overall Study||67
12367|NCT02096575|27169|P1|COMPLETED|Overall Study||68
12368|NCT02096575|27167|P3|STARTED|Overall Study||5
12369|NCT02096575|27168|P2|STARTED|Overall Study||67
12370|NCT02096575|27169|P1|STARTED|Overall Study||68
12371|NCT02096458|27183|P1|NOT COMPLETED|Overall Study||0
12372|NCT02096458|27183|P1|COMPLETED|Overall Study||8
12373|NCT02096458|27183|P1|STARTED|Overall Study||8
12374|NCT02095691|27187|P1|NOT COMPLETED|Overall Study||1
12375|NCT02095691|27187|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
12376|NCT02095691|27187|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
12377|NCT02095561|27206|P2|NOT COMPLETED|Overall Study||0
12378|NCT02095561|27207|P1|NOT COMPLETED|Overall Study||0
12379|NCT02095561|27206|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
12380|NCT02095561|27207|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
12381|NCT02095561|27206|P2|HPV Tested at Health Centers|Overall Study||599
12382|NCT02095561|27207|P1|HPV Tested at Health Centers|Overall Study||99
12383|NCT02095561|27206|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
12384|NCT02095561|27207|P1|HPV Self-tested Women|Overall Study||2519
12385|NCT02095561|27206|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
12386|NCT02095561|27207|P1|Self-testing Acceptability|Overall Study||2616
12387|NCT02095561|27206|P2|STARTED|Overall Study||2964
12388|NCT02095561|27207|P1|STARTED|Overall Study||3049
12389|NCT02095223|27221|P2|NOT COMPLETED|Overall Study||0
12390|NCT02095223|27222|P1|NOT COMPLETED|Overall Study||1
12391|NCT02095223|27221|P2|COMPLETED|Overall Study||2
12392|NCT02095223|27222|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
12393|NCT02095223|27221|P2|STARTED|Overall Study||2
12394|NCT02095223|27222|P1|STARTED|Overall Study||2
12395|NCT02095158|27230|P1|NOT COMPLETED|Overall Study||75
12396|NCT02095158|27230|P1|COMPLETED|Overall Study||365
12397|NCT02095158|27230|P1|STARTED|Overall Study||440
12398|NCT02094937|27235|P4|NOT COMPLETED|12 Weeks in Period 2||12
12399|NCT02094937|27236|P3|NOT COMPLETED|12 Weeks in Period 2||12
12400|NCT02094937|27237|P2|NOT COMPLETED|12 Weeks in Period 2||11
12401|NCT02094937|27238|P1|NOT COMPLETED|12 Weeks in Period 2||0
12402|NCT02094937|27235|P4|COMPLETED|12 Weeks in Period 2||112
12403|NCT02094937|27236|P3|COMPLETED|12 Weeks in Period 2||112
12404|NCT02094937|27237|P2|COMPLETED|12 Weeks in Period 2||112
12405|NCT02094937|27238|P1|COMPLETED|12 Weeks in Period 2||0
12406|NCT02094937|27235|P4|STARTED|12 Weeks in Period 2||124
12407|NCT02094937|27236|P3|STARTED|12 Weeks in Period 2||124
12408|NCT02094937|27237|P2|STARTED|12 Weeks in Period 2||123
12409|NCT02094937|27238|P1|STARTED|12 Weeks in Period 2||0
12410|NCT02094937|27235|P4|NOT COMPLETED|8 Weeks in Period 1||0
12411|NCT02094937|27236|P3|NOT COMPLETED|8 Weeks in Period 1||0
12412|NCT02094937|27237|P2|NOT COMPLETED|8 Weeks in Period 1||0
12413|NCT02094937|27238|P1|NOT COMPLETED|8 Weeks in Period 1||60
12414|NCT02094937|27235|P4|COMPLETED|8 Weeks in Period 1||0
12415|NCT02094937|27236|P3|COMPLETED|8 Weeks in Period 1||0
12416|NCT02094937|27237|P2|COMPLETED|8 Weeks in Period 1||0
12417|NCT02094937|27238|P1|COMPLETED|8 Weeks in Period 1||370
12418|NCT02094937|27235|P4|STARTED|8 Weeks in Period 1||0
12419|NCT02094937|27236|P3|STARTED|8 Weeks in Period 1||0
12420|NCT02094937|27237|P2|STARTED|8 Weeks in Period 1||0
12421|NCT02094937|27238|P1|STARTED|8 Weeks in Period 1||430
12422|NCT02094885|27270|P2|NOT COMPLETED|Overall Study||5
12423|NCT02094885|27271|P1|NOT COMPLETED|Overall Study||2
12424|NCT02094885|27270|P2|COMPLETED|Overall Study||122
12425|NCT02094885|27271|P1|COMPLETED|Overall Study||123
12426|NCT02094885|27270|P2|STARTED|Overall Study||127
12427|NCT02094885|27271|P1|STARTED|Overall Study||125
12428|NCT02094677|27285|P2|NOT COMPLETED|Overall Study||1
12429|NCT02094677|27286|P1|NOT COMPLETED|Overall Study||3
12430|NCT02094677|27285|P2|COMPLETED|Overall Study||30
12431|NCT02094677|27286|P1|COMPLETED|Overall Study||40
12432|NCT02094677|27285|P2|STARTED|Overall Study||31
12433|NCT02094677|27286|P1|STARTED|Overall Study||43
12434|NCT02094443|27350|P2|NOT COMPLETED|Overall Study||17
12435|NCT02094443|27351|P1|NOT COMPLETED|Overall Study||15
12436|NCT02094443|27350|P2|COMPLETED|Overall Study||9
12437|NCT02094443|27351|P1|COMPLETED|Overall Study||11
12438|NCT02094443|27350|P2|Completed at Week 24|Overall Study||8
12439|NCT02094443|27351|P1|Completed at Week 24|Overall Study||11
12440|NCT02094443|27350|P2|Completed at Week 12|Overall Study||1
12441|NCT02094443|27351|P1|Completed at Week 12|Overall Study||0
12442|NCT02094443|27350|P2|STARTED|Overall Study||26
12443|NCT02094443|27351|P1|STARTED|Overall Study||26
12444|NCT02094326|27369|P1|NOT COMPLETED|Overall Study||0
12445|NCT02094326|27369|P1|COMPLETED|Overall Study||301
12446|NCT02094326|27369|P1|STARTED|Overall Study||301
12447|NCT02094300|27378|P1|NOT COMPLETED|Overall Study||20
12448|NCT02094300|27378|P1|COMPLETED|Overall Study||6
12449|NCT02094300|27378|P1|30 Days|Overall Study||24
12450|NCT02094300|27378|P1|STARTED|Overall Study||26
12451|NCT02094261|27382|P1|NOT COMPLETED|Overall Study||210
12452|NCT02094261|27382|P1|COMPLETED|Overall Study||0
12453|NCT02094261|27382|P1|STARTED|Overall Study||210
12454|NCT02093923|27394|P5|NOT COMPLETED|Overall Study||0
12455|NCT02093923|27395|P4|NOT COMPLETED|Overall Study||2
12456|NCT02093923|27396|P3|NOT COMPLETED|Overall Study||0
12457|NCT02093923|27397|P2|NOT COMPLETED|Overall Study||0
12458|NCT02093923|27398|P1|NOT COMPLETED|Overall Study||0
12459|NCT02093923|27394|P5|COMPLETED|Overall Study||13
12460|NCT02093923|27395|P4|COMPLETED|Overall Study||10
12461|NCT02093923|27396|P3|COMPLETED|Overall Study||5
12462|NCT02093923|27397|P2|COMPLETED|Overall Study||4
12463|NCT02093923|27398|P1|COMPLETED|Overall Study||4
12464|NCT02093923|27394|P5|Treated - 2 Doses:|Overall Study||13
12465|NCT02093923|27395|P4|Treated - 2 Doses:|Overall Study||10
12466|NCT02093923|27396|P3|Treated - 2 Doses:|Overall Study||5
12467|NCT02093923|27397|P2|Treated - 2 Doses:|Overall Study||4
12468|NCT02093923|27398|P1|Treated - 2 Doses:|Overall Study||4
12469|NCT02093923|27394|P5|Treated - 1 Dose Only:|Overall Study||0
12470|NCT02093923|27395|P4|Treated - 1 Dose Only:|Overall Study||1
12471|NCT02093923|27396|P3|Treated - 1 Dose Only:|Overall Study||0
12472|NCT02093923|27397|P2|Treated - 1 Dose Only:|Overall Study||0
12473|NCT02093923|27398|P1|Treated - 1 Dose Only:|Overall Study||0
12474|NCT02093923|27394|P5|Total Treated|Overall Study||13
12475|NCT02093923|27395|P4|Total Treated|Overall Study||11
12476|NCT02093923|27396|P3|Total Treated|Overall Study||5
12477|NCT02093923|27397|P2|Total Treated|Overall Study||4
12478|NCT02093923|27398|P1|Total Treated|Overall Study||4
12479|NCT02093923|27394|P5|STARTED|Overall Study||13
12480|NCT02093923|27395|P4|STARTED|Overall Study||12
12481|NCT02093923|27396|P3|STARTED|Overall Study||5
12482|NCT02093923|27397|P2|STARTED|Overall Study||4
12483|NCT02093923|27398|P1|STARTED|Overall Study||4
12484|NCT02093897|27453|P1|NOT COMPLETED|Overall Study||19
12485|NCT02093897|27453|P1|COMPLETED|Overall Study||65
12486|NCT02093897|27453|P1|STARTED|Overall Study||84
12487|NCT02093819|27481|P8|NOT COMPLETED|Overall Study||0
12488|NCT02093819|27482|P7|NOT COMPLETED|Overall Study||0
12489|NCT02093819|27483|P6|NOT COMPLETED|Overall Study||0
12490|NCT02093819|27484|P5|NOT COMPLETED|Overall Study||0
12491|NCT02093819|27485|P4|NOT COMPLETED|Overall Study||0
12492|NCT02093819|27486|P3|NOT COMPLETED|Overall Study||0
12493|NCT02093819|27487|P2|NOT COMPLETED|Overall Study||0
12494|NCT02093819|27488|P1|NOT COMPLETED|Overall Study||0
12495|NCT02093819|27481|P8|COMPLETED|Overall Study||6
12496|NCT02093819|27482|P7|COMPLETED|Overall Study||5
12497|NCT02093819|27483|P6|COMPLETED|Overall Study||6
12498|NCT02093819|27484|P5|COMPLETED|Overall Study||6
12499|NCT02093819|27485|P4|COMPLETED|Overall Study||6
12500|NCT02093819|27486|P3|COMPLETED|Overall Study||10
12501|NCT02093819|27487|P2|COMPLETED|Overall Study||6
12502|NCT02093819|27488|P1|COMPLETED|Overall Study||15
12503|NCT02093819|27481|P8|STARTED|Overall Study||6
12504|NCT02093819|27482|P7|STARTED|Overall Study||5
12505|NCT02093819|27483|P6|STARTED|Overall Study||6
12506|NCT02093819|27484|P5|STARTED|Overall Study||6
12507|NCT02093819|27485|P4|STARTED|Overall Study||6
12508|NCT02093819|27486|P3|STARTED|Overall Study||10
12509|NCT02093819|27487|P2|STARTED|Overall Study||6
12510|NCT02093819|27488|P1|STARTED|Overall Study||15
12511|NCT02093702|27524|P2|NOT COMPLETED|Overall Study||0
12512|NCT02093702|27525|P1|NOT COMPLETED|Overall Study||0
12513|NCT02093702|27524|P2|COMPLETED|Overall Study||3
12514|NCT02093702|27525|P1|COMPLETED|Overall Study||2
12515|NCT02093702|27524|P2|STARTED|Overall Study||3
12516|NCT02093702|27525|P1|STARTED|Overall Study||2
12517|NCT02093390|27555|P2|NOT COMPLETED|Overall Study||1
12518|NCT02093390|27556|P1|NOT COMPLETED|Overall Study||0
12519|NCT02093390|27555|P2|COMPLETED|Overall Study||19
12520|NCT02093390|27556|P1|COMPLETED|Overall Study||20
12521|NCT02093390|27555|P2|STARTED|Overall Study||20
12522|NCT02093390|27556|P1|STARTED|Overall Study||20
12523|NCT02093351|27595|P3|NOT COMPLETED|Overall Study||3
12524|NCT02093351|27596|P2|NOT COMPLETED|Overall Study||2
12525|NCT02093351|27597|P1|NOT COMPLETED|Overall Study||2
12526|NCT02093351|27595|P3|COMPLETED|Overall Study||23
12527|NCT02093351|27596|P2|COMPLETED|Overall Study||21
12528|NCT02093351|27597|P1|COMPLETED|Overall Study||28
12529|NCT02093351|27595|P3|Completing Treatment Period 3|Overall Study||23
12530|NCT02093351|27596|P2|Completing Treatment Period 3|Overall Study||21
12531|NCT02093351|27597|P1|Completing Treatment Period 3|Overall Study||28
12532|NCT02093351|27595|P3|Completing Treatment Period 2|Overall Study||23
12533|NCT02093351|27596|P2|Completing Treatment Period 2|Overall Study||21
12534|NCT02093351|27597|P1|Completing Treatment Period 2|Overall Study||29
12535|NCT02093351|27595|P3|Completing Treatment Period 1|Overall Study||23
12536|NCT02093351|27596|P2|Completing Treatment Period 1|Overall Study||22
12537|NCT02093351|27597|P1|Completing Treatment Period 1|Overall Study||29
12538|NCT02093351|27595|P3|STARTED|Overall Study||26
12539|NCT02093351|27596|P2|STARTED|Overall Study||23
12540|NCT02093351|27597|P1|STARTED|Overall Study||30
12541|NCT02092961|27629|P3|NOT COMPLETED|Overall Study||16
12542|NCT02092961|27630|P2|NOT COMPLETED|Overall Study||14
12543|NCT02092961|27631|P1|NOT COMPLETED|Overall Study||21
12544|NCT02092961|27629|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
12545|NCT02092961|27630|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
12546|NCT02092961|27631|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
12547|NCT02092961|27629|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
12548|NCT02092961|27630|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
12549|NCT02092961|27631|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
12550|NCT02092961|27629|P3|STARTED|Overall Study|Patients who received treatment|29
12551|NCT02092961|27630|P2|STARTED|Overall Study|Patients who received treatment|28
12552|NCT02092961|27631|P1|STARTED|Overall Study|Patients who received treatment|33
12553|NCT02092857|27655|P3|NOT COMPLETED|Overall Study||13
12554|NCT02092857|27656|P2|NOT COMPLETED|Overall Study||12
12555|NCT02092857|27657|P1|NOT COMPLETED|Overall Study||10
12556|NCT02092857|27655|P3|COMPLETED|Overall Study||16
12557|NCT02092857|27656|P2|COMPLETED|Overall Study||18
12558|NCT02092857|27657|P1|COMPLETED|Overall Study||20
12559|NCT02092857|27655|P3|STARTED|Overall Study||29
12560|NCT02092857|27656|P2|STARTED|Overall Study||30
12561|NCT02092857|27657|P1|STARTED|Overall Study||30
12562|NCT02092662|27667|P2|NOT COMPLETED|Overall Study||0
12563|NCT02092662|27668|P1|NOT COMPLETED|Overall Study||13
12564|NCT02092662|27667|P2|COMPLETED|Overall Study||19
12565|NCT02092662|27668|P1|COMPLETED|Overall Study||25
12566|NCT02092662|27667|P2|Recruited|Overall Study||19
12567|NCT02092662|27668|P1|Recruited|Overall Study||38
12568|NCT02092662|27667|P2|STARTED|Overall Study||19
12569|NCT02092662|27668|P1|STARTED|Overall Study||38
12570|NCT02092649|27677|P2|NOT COMPLETED|Overall Study||0
12571|NCT02092649|27678|P1|NOT COMPLETED|Overall Study||0
12572|NCT02092649|27677|P2|COMPLETED|Overall Study|13 participants finished study|13
12573|NCT02092649|27678|P1|COMPLETED|Overall Study|13 participants finished study|13
12574|NCT02092649|27677|P2|STARTED|Overall Study|13 participants recruited|13
12575|NCT02092649|27678|P1|STARTED|Overall Study|13 participants recruited|13
12576|NCT02092610|27696|P2|NOT COMPLETED|Overall Study||12
12577|NCT02092610|27697|P1|NOT COMPLETED|Overall Study||8
12578|NCT02092610|27696|P2|COMPLETED|Overall Study||40
12579|NCT02092610|27697|P1|COMPLETED|Overall Study||17
12580|NCT02092610|27696|P2|STARTED|Overall Study||52
12581|NCT02092610|27697|P1|STARTED|Overall Study||25
12582|NCT02092441|27711|P2|NOT COMPLETED|Overall Study||0
12583|NCT02092441|27712|P1|NOT COMPLETED|Overall Study||0
12584|NCT02092441|27711|P2|COMPLETED|Overall Study||43
12585|NCT02092441|27712|P1|COMPLETED|Overall Study||37
12586|NCT02092441|27711|P2|STARTED|Overall Study||43
12587|NCT02092441|27712|P1|STARTED|Overall Study||37
12588|NCT02092415|27722|P1|NOT COMPLETED|Overall Study||0
12589|NCT02092415|27722|P1|COMPLETED|Overall Study||10
12590|NCT02092415|27722|P1|STARTED|Overall Study||10
12591|NCT02092350|27729|P2|NOT COMPLETED|Overall Study||12
12592|NCT02092350|27730|P1|NOT COMPLETED|Overall Study||10
12593|NCT02092350|27729|P2|COMPLETED|Overall Study||102
12594|NCT02092350|27730|P1|COMPLETED|Overall Study||113
12595|NCT02092350|27729|P2|STARTED|Overall Study||114
12596|NCT02092350|27730|P1|STARTED|Overall Study||123
12597|NCT02092311|27747|P2|NOT COMPLETED|Overall Study||0
12598|NCT02092311|27748|P1|NOT COMPLETED|Overall Study||0
12599|NCT02092311|27747|P2|COMPLETED|Overall Study||285
12600|NCT02092311|27748|P1|COMPLETED|Overall Study||285
12601|NCT02092311|27747|P2|STARTED|Overall Study||285
12602|NCT02092311|27748|P1|STARTED|Overall Study||285
12603|NCT02092168|27760|P2|NOT COMPLETED|Overall Study||0
12604|NCT02092168|27761|P1|NOT COMPLETED|Overall Study||0
12605|NCT02092168|27760|P2|COMPLETED|Overall Study||12
12606|NCT02092168|27761|P1|COMPLETED|Overall Study||12
12607|NCT02092168|27760|P2|STARTED|Overall Study||12
12608|NCT02092168|27761|P1|STARTED|Overall Study||12
12609|NCT02091856|27774|P3|NOT COMPLETED|Follow-up Assessment||0
12610|NCT02091856|27775|P2|NOT COMPLETED|Follow-up Assessment||3
12611|NCT02091856|27776|P1|NOT COMPLETED|Follow-up Assessment||5
12612|NCT02091856|27774|P3|COMPLETED|Follow-up Assessment||0
12613|NCT02091856|27775|P2|COMPLETED|Follow-up Assessment||9
12614|NCT02091856|27776|P1|COMPLETED|Follow-up Assessment||10
12615|NCT02091856|27774|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
12616|NCT02091856|27775|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
12617|NCT02091856|27776|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
12618|NCT02091856|27774|P3|NOT COMPLETED|Active Intervention Interval||7
12619|NCT02091856|27775|P2|NOT COMPLETED|Active Intervention Interval||7
12620|NCT02091856|27776|P1|NOT COMPLETED|Active Intervention Interval||19
12621|NCT02091856|27774|P3|COMPLETED|Active Intervention Interval||19
12622|NCT02091856|27775|P2|COMPLETED|Active Intervention Interval||12
12623|NCT02091856|27776|P1|COMPLETED|Active Intervention Interval||15
12624|NCT02091856|27774|P3|STARTED|Active Intervention Interval||26
12625|NCT02091856|27775|P2|STARTED|Active Intervention Interval||19
12626|NCT02091856|27776|P1|STARTED|Active Intervention Interval||34
12627|NCT02091778|27796|P1|NOT COMPLETED|Overall Study||1
12628|NCT02091778|27796|P1|COMPLETED|Overall Study||20
12629|NCT02091778|27796|P1|STARTED|Overall Study||21
12630|NCT02091752|27800|P1|NOT COMPLETED|Overall Study||3
12631|NCT02091752|27800|P1|COMPLETED|Overall Study||0
12632|NCT02091752|27800|P1|STARTED|Overall Study||3
12633|NCT02091726|27811|P1|NOT COMPLETED|Overall Study||6
12634|NCT02091726|27811|P1|COMPLETED|Overall Study||104
12635|NCT02091726|27811|P1|4 Week Followup|Overall Study||104
12636|NCT02091726|27811|P1|1 Week Followup|Overall Study||110
12637|NCT02091726|27811|P1|STARTED|Overall Study||110
12638|NCT02091466|27821|P2|NOT COMPLETED|Overall Study||0
12639|NCT02091466|27822|P1|NOT COMPLETED|Overall Study||0
12640|NCT02091466|27821|P2|COMPLETED|Overall Study||20
12641|NCT02091466|27822|P1|COMPLETED|Overall Study||20
12642|NCT02091466|27821|P2|STARTED|Overall Study||20
12643|NCT02091466|27822|P1|STARTED|Overall Study||20
12644|NCT02091414|27828|P1|NOT COMPLETED|Overall Study||4
12645|NCT02091414|27828|P1|COMPLETED|Overall Study||32
12646|NCT02091414|27828|P1|STARTED|Overall Study||36
12647|NCT02090855|27840|P1|NOT COMPLETED|Overall Study||2
12648|NCT02090855|27840|P1|COMPLETED|Overall Study||106
12649|NCT02090855|27840|P1|STARTED|Overall Study||108
12650|NCT02090777|27847|P1|NOT COMPLETED|Overall Study||0
12651|NCT02090777|27847|P1|COMPLETED|Overall Study||4
12652|NCT02090777|27847|P1|STARTED|Overall Study||4
12653|NCT02090764|27853|P2|NOT COMPLETED|Overall Study||20
12654|NCT02090764|27854|P1|NOT COMPLETED|Overall Study||6
12655|NCT02090764|27853|P2|COMPLETED|Overall Study||186
12656|NCT02090764|27854|P1|COMPLETED|Overall Study||200
12657|NCT02090764|27853|P2|STARTED|Overall Study||206
12658|NCT02090764|27854|P1|STARTED|Overall Study||206
12659|NCT02090413|27863|P3|NOT COMPLETED|Overall Study||23
12660|NCT02090413|27864|P2|NOT COMPLETED|Overall Study||20
12661|NCT02090413|27865|P1|NOT COMPLETED|Overall Study||19
12662|NCT02090413|27863|P3|COMPLETED|Overall Study||57
12663|NCT02090413|27864|P2|COMPLETED|Overall Study||60
12664|NCT02090413|27865|P1|COMPLETED|Overall Study||62
12665|NCT02090413|27863|P3|STARTED|Overall Study||80
12666|NCT02090413|27864|P2|STARTED|Overall Study||80
12667|NCT02090413|27865|P1|STARTED|Overall Study||81
12668|NCT02090088|27939|P1|NOT COMPLETED|Overall Study||0
12669|NCT02090088|27939|P1|COMPLETED|Overall Study||4
12670|NCT02090088|27939|P1|Gave Birth|Overall Study||4
12671|NCT02090088|27939|P1|STARTED|Overall Study||4
12672|NCT02089347|27953|P2|NOT COMPLETED|Overall Study||0
12673|NCT02089347|27954|P1|NOT COMPLETED|Overall Study||1
12674|NCT02089347|27953|P2|COMPLETED|Overall Study||178
12675|NCT02089347|27954|P1|COMPLETED|Overall Study||355
12676|NCT02089347|27953|P2|STARTED|Overall Study||178
12677|NCT02089347|27954|P1|STARTED|Overall Study||356
12678|NCT02089191|27976|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
12679|NCT02089191|27977|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
12680|NCT02089191|27976|P2|COMPLETED|Period 2, Second 12 Hours||15
12681|NCT02089191|27977|P1|COMPLETED|Period 2, Second 12 Hours||15
12682|NCT02089191|27976|P2|STARTED|Period 2, Second 12 Hours||15
12683|NCT02089191|27977|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
12684|NCT02089191|27976|P2|NOT COMPLETED|Period 1, First 12 Hours||0
12685|NCT02089191|27977|P1|NOT COMPLETED|Period 1, First 12 Hours||0
12686|NCT02089191|27976|P2|COMPLETED|Period 1, First 12 Hours||15
12687|NCT02089191|27977|P1|COMPLETED|Period 1, First 12 Hours||16
12688|NCT02089191|27976|P2|STARTED|Period 1, First 12 Hours||15
12689|NCT02089191|27977|P1|STARTED|Period 1, First 12 Hours||16
12690|NCT02089113|27987|P2|NOT COMPLETED|Overall Study||0
12691|NCT02089113|27988|P1|NOT COMPLETED|Overall Study||1
12692|NCT02089113|27987|P2|COMPLETED|Overall Study||80
12693|NCT02089113|27988|P1|COMPLETED|Overall Study||160
12694|NCT02089113|27987|P2|STARTED|Overall Study||80
12695|NCT02089113|27988|P1|STARTED|Overall Study||161
12696|NCT02088957|27994|P2|NOT COMPLETED|Overall Study||0
12697|NCT02088957|27995|P1|NOT COMPLETED|Overall Study||1
12698|NCT02088957|27994|P2|COMPLETED|Overall Study||0
12699|NCT02088957|27995|P1|COMPLETED|Overall Study||0
12700|NCT02088957|27994|P2|STARTED|Overall Study||0
12701|NCT02088957|27995|P1|STARTED|Overall Study||1
12702|NCT02087943|28014|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
12703|NCT02087943|28015|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
12704|NCT02087943|28016|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
12705|NCT02087943|28017|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
12706|NCT02087943|28018|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
12707|NCT02087943|28014|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
12708|NCT02087943|28015|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
12709|NCT02087943|28016|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
12710|NCT02087943|28017|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
12711|NCT02087943|28018|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
12712|NCT02087943|28014|P5|STARTED|Observational Follow-up Phase Week 24-30||23
12713|NCT02087943|28015|P4|STARTED|Observational Follow-up Phase Week 24-30||24
12714|NCT02087943|28016|P3|STARTED|Observational Follow-up Phase Week 24-30||48
12715|NCT02087943|28017|P2|STARTED|Observational Follow-up Phase Week 24-30||46
12716|NCT02087943|28018|P1|STARTED|Observational Follow-up Phase Week 24-30||0
12717|NCT02087943|28014|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
12718|NCT02087943|28015|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
12719|NCT02087943|28016|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
12720|NCT02087943|28017|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
12721|NCT02087943|28018|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
12722|NCT02087943|28014|P5|COMPLETED|Active Treatment Phase Week 12-24||21
12723|NCT02087943|28015|P4|COMPLETED|Active Treatment Phase Week 12-24||22
12724|NCT02087943|28016|P3|COMPLETED|Active Treatment Phase Week 12-24||44
12725|NCT02087943|28017|P2|COMPLETED|Active Treatment Phase Week 12-24||42
12726|NCT02087943|28018|P1|COMPLETED|Active Treatment Phase Week 12-24||0
12727|NCT02087943|28014|P5|STARTED|Active Treatment Phase Week 12-24||23
12728|NCT02087943|28015|P4|STARTED|Active Treatment Phase Week 12-24||24
12729|NCT02087943|28016|P3|STARTED|Active Treatment Phase Week 12-24||49
12730|NCT02087943|28017|P2|STARTED|Active Treatment Phase Week 12-24||46
12731|NCT02087943|28018|P1|STARTED|Active Treatment Phase Week 12-24||0
12732|NCT02087943|28014|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
12733|NCT02087943|28015|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
12734|NCT02087943|28016|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
12735|NCT02087943|28017|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
12736|NCT02087943|28018|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
12737|NCT02087943|28014|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
12738|NCT02087943|28015|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
12739|NCT02087943|28016|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
12740|NCT02087943|28017|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
12741|NCT02087943|28018|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
12742|NCT02087943|28014|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
12743|NCT02087943|28015|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
12744|NCT02087943|28016|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
12745|NCT02087943|28017|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
12746|NCT02087943|28018|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
12747|NCT02087943|28014|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
12748|NCT02087943|28015|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
12749|NCT02087943|28016|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
12750|NCT02087943|28017|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
12751|NCT02087943|28018|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
12752|NCT02087774|28044|P2|NOT COMPLETED|Overall Study||20
12753|NCT02087774|28045|P1|NOT COMPLETED|Overall Study||8
12754|NCT02087774|28044|P2|COMPLETED|Overall Study||130
12755|NCT02087774|28045|P1|COMPLETED|Overall Study||142
12756|NCT02087774|28044|P2|STARTED|Overall Study||150
12757|NCT02087774|28045|P1|STARTED|Overall Study||150
12758|NCT02087748|28053|P1|NOT COMPLETED|Overall Study||0
12759|NCT02087748|28053|P1|COMPLETED|Overall Study||24
12760|NCT02087748|28053|P1|STARTED|Overall Study||24
12761|NCT02087670|28065|P2|NOT COMPLETED|Overall Study||2
12762|NCT02087670|28066|P1|NOT COMPLETED|Overall Study||3
12763|NCT02087670|28065|P2|COMPLETED|Overall Study||20
12764|NCT02087670|28066|P1|COMPLETED|Overall Study||17
12765|NCT02087670|28065|P2|STARTED|Overall Study||22
12766|NCT02087670|28066|P1|STARTED|Overall Study||20
12767|NCT02087176|28074|P1|NOT COMPLETED|Overall Study||32
12768|NCT02087176|28074|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
12769|NCT02087176|28074|P1|STARTED|Overall Study||32
12770|NCT02087059|28079|P1|NOT COMPLETED|Overall Study||7
12771|NCT02087059|28079|P1|COMPLETED|Overall Study||44
12772|NCT02087059|28079|P1|STARTED|Overall Study||51
12773|NCT02086708|28087|P1|NOT COMPLETED|Overall Study||0
12774|NCT02086708|28087|P1|COMPLETED|Overall Study||24
12775|NCT02086708|28087|P1|STARTED|Overall Study||24
12776|NCT02086591|28099|P1|NOT COMPLETED|Overall Study||5
12777|NCT02086591|28099|P1|COMPLETED|Overall Study||2
12778|NCT02086591|28099|P1|STARTED|Overall Study||7
12779|NCT02085720|28105|P1|NOT COMPLETED|Overall Study||0
12780|NCT02085720|28105|P1|COMPLETED|Overall Study||819
12781|NCT02085720|28105|P1|STARTED|Overall Study||819
12782|NCT02085161|28117|P4|NOT COMPLETED|Overall Study||10
12783|NCT02085161|28118|P3|NOT COMPLETED|Overall Study||5
12784|NCT02085161|28119|P2|NOT COMPLETED|Overall Study||10
12785|NCT02085161|28120|P1|NOT COMPLETED|Overall Study||12
12786|NCT02085161|28117|P4|COMPLETED|Overall Study||66
12787|NCT02085161|28118|P3|COMPLETED|Overall Study||71
12788|NCT02085161|28119|P2|COMPLETED|Overall Study||66
12789|NCT02085161|28120|P1|COMPLETED|Overall Study||64
12790|NCT02085161|28117|P4|STARTED|Overall Study||76
12791|NCT02085161|28118|P3|STARTED|Overall Study||76
12792|NCT02085161|28119|P2|STARTED|Overall Study||76
12793|NCT02085161|28120|P1|STARTED|Overall Study||76
12794|NCT02084797|28159|P1|NOT COMPLETED|Overall Study||0
12795|NCT02084797|28159|P1|COMPLETED|Overall Study||10
12796|NCT02084797|28159|P1|STARTED|Overall Study||10
12797|NCT02084706|28168|P2|NOT COMPLETED|Overall Study||0
12798|NCT02084706|28169|P1|NOT COMPLETED|Overall Study||0
12799|NCT02084706|28168|P2|COMPLETED|Overall Study||31
12800|NCT02084706|28169|P1|COMPLETED|Overall Study||29
12801|NCT02084706|28168|P2|STARTED|Overall Study||31
12802|NCT02084706|28169|P1|STARTED|Overall Study||29
12803|NCT02084628|28175|P1|NOT COMPLETED|Overall Study||0
12804|NCT02084628|28175|P1|COMPLETED|Overall Study||1
12805|NCT02084628|28175|P1|STARTED|Overall Study||1
12806|NCT02084238|28188|P1|NOT COMPLETED|Overall Study||2
12807|NCT02084238|28188|P1|COMPLETED|Overall Study||38
12808|NCT02084238|28188|P1|STARTED|Overall Study||40
12809|NCT02084082|28201|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12810|NCT02084082|28202|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12811|NCT02084082|28203|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12812|NCT02084082|28204|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12813|NCT02084082|28201|P4|COMPLETED|Treatment Period 2 (4 Days)||6
12814|NCT02084082|28202|P3|COMPLETED|Treatment Period 2 (4 Days)||7
12815|NCT02084082|28203|P2|COMPLETED|Treatment Period 2 (4 Days)||26
12816|NCT02084082|28204|P1|COMPLETED|Treatment Period 2 (4 Days)||26
12817|NCT02084082|28201|P4|STARTED|Treatment Period 2 (4 Days)||6
12818|NCT02084082|28202|P3|STARTED|Treatment Period 2 (4 Days)||7
12819|NCT02084082|28203|P2|STARTED|Treatment Period 2 (4 Days)||26
12820|NCT02084082|28204|P1|STARTED|Treatment Period 2 (4 Days)||26
12821|NCT02084082|28201|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
12822|NCT02084082|28202|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
12823|NCT02084082|28203|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
12824|NCT02084082|28204|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
12825|NCT02084082|28201|P4|COMPLETED|Washout Period 1 (35 Days)||6
12826|NCT02084082|28202|P3|COMPLETED|Washout Period 1 (35 Days)||7
12827|NCT02084082|28203|P2|COMPLETED|Washout Period 1 (35 Days)||26
12828|NCT02084082|28204|P1|COMPLETED|Washout Period 1 (35 Days)||26
12829|NCT02084082|28201|P4|STARTED|Washout Period 1 (35 Days)||8
12830|NCT02084082|28202|P3|STARTED|Washout Period 1 (35 Days)||8
12831|NCT02084082|28203|P2|STARTED|Washout Period 1 (35 Days)||26
12832|NCT02084082|28204|P1|STARTED|Washout Period 1 (35 Days)||26
12833|NCT02084082|28201|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12834|NCT02084082|28202|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12835|NCT02084082|28203|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12836|NCT02084082|28204|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12837|NCT02084082|28201|P4|COMPLETED|Treatment Period 1 (4 Days)||8
12838|NCT02084082|28202|P3|COMPLETED|Treatment Period 1 (4 Days)||8
12839|NCT02084082|28203|P2|COMPLETED|Treatment Period 1 (4 Days)||26
12840|NCT02084082|28204|P1|COMPLETED|Treatment Period 1 (4 Days)||26
12841|NCT02084082|28201|P4|STARTED|Treatment Period 1 (4 Days)||8
12842|NCT02084082|28202|P3|STARTED|Treatment Period 1 (4 Days)||8
12843|NCT02084082|28203|P2|STARTED|Treatment Period 1 (4 Days)||26
12844|NCT02084082|28204|P1|STARTED|Treatment Period 1 (4 Days)||26
12845|NCT02084069|28236|P2|NOT COMPLETED|Overall Study||0
12846|NCT02084069|28237|P1|NOT COMPLETED|Overall Study||0
12847|NCT02084069|28236|P2|COMPLETED|Overall Study||29
12848|NCT02084069|28237|P1|COMPLETED|Overall Study||29
12849|NCT02084069|28236|P2|STARTED|Overall Study||29
12850|NCT02084069|28237|P1|STARTED|Overall Study||29
12851|NCT02084056|28245|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12852|NCT02084056|28246|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12853|NCT02084056|28247|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12854|NCT02084056|28248|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
12855|NCT02084056|28245|P4|COMPLETED|Treatment Period 2 (4 Days)||8
12856|NCT02084056|28246|P3|COMPLETED|Treatment Period 2 (4 Days)||8
12857|NCT02084056|28247|P2|COMPLETED|Treatment Period 2 (4 Days)||30
12858|NCT02084056|28248|P1|COMPLETED|Treatment Period 2 (4 Days)||26
12859|NCT02084056|28245|P4|STARTED|Treatment Period 2 (4 Days)||8
12860|NCT02084056|28246|P3|STARTED|Treatment Period 2 (4 Days)||8
12861|NCT02084056|28247|P2|STARTED|Treatment Period 2 (4 Days)||30
12862|NCT02084056|28248|P1|STARTED|Treatment Period 2 (4 Days)||26
12863|NCT02084056|28245|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
12864|NCT02084056|28246|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
12865|NCT02084056|28247|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
12866|NCT02084056|28248|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
12867|NCT02084056|28245|P4|COMPLETED|Washout Period 1 (35 Days)||8
12868|NCT02084056|28246|P3|COMPLETED|Washout Period 1 (35 Days)||8
12869|NCT02084056|28247|P2|COMPLETED|Washout Period 1 (35 Days)||30
12870|NCT02084056|28248|P1|COMPLETED|Washout Period 1 (35 Days)||26
12871|NCT02084056|28245|P4|STARTED|Washout Period 1 (35 Days)||8
12872|NCT02084056|28246|P3|STARTED|Washout Period 1 (35 Days)||8
12873|NCT02084056|28247|P2|STARTED|Washout Period 1 (35 Days)||30
12874|NCT02084056|28248|P1|STARTED|Washout Period 1 (35 Days)||27
12875|NCT02084056|28245|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12876|NCT02084056|28246|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12877|NCT02084056|28247|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
12878|NCT02084056|28248|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
12879|NCT02084056|28245|P4|COMPLETED|Treatment Period 1 (4 Days)||8
12880|NCT02084056|28246|P3|COMPLETED|Treatment Period 1 (4 Days)||8
12881|NCT02084056|28247|P2|COMPLETED|Treatment Period 1 (4 Days)||30
12882|NCT02084056|28248|P1|COMPLETED|Treatment Period 1 (4 Days)||27
12883|NCT02084056|28245|P4|STARTED|Treatment Period 1 (4 Days)||8
12884|NCT02084056|28246|P3|STARTED|Treatment Period 1 (4 Days)||8
12885|NCT02084056|28247|P2|STARTED|Treatment Period 1 (4 Days)||30
12886|NCT02084056|28248|P1|STARTED|Treatment Period 1 (4 Days)||28
12887|NCT02083965|28280|P2|NOT COMPLETED|Overall Study||1
12888|NCT02083965|28281|P1|NOT COMPLETED|Overall Study||1
12889|NCT02083965|28280|P2|COMPLETED|Overall Study||8
12890|NCT02083965|28281|P1|COMPLETED|Overall Study||9
12891|NCT02083965|28280|P2|STARTED|Overall Study||9
12892|NCT02083965|28281|P1|STARTED|Overall Study||10
12893|NCT02083679|28341|P4|NOT COMPLETED|Overall Study||0
12894|NCT02083679|28342|P3|NOT COMPLETED|Overall Study||0
12895|NCT02083679|28343|P2|NOT COMPLETED|Overall Study||0
12896|NCT02083679|28344|P1|NOT COMPLETED|Overall Study||0
12897|NCT02083679|28341|P4|COMPLETED|Overall Study||3
12898|NCT02083679|28342|P3|COMPLETED|Overall Study||3
12899|NCT02083679|28343|P2|COMPLETED|Overall Study||6
12900|NCT02083679|28344|P1|COMPLETED|Overall Study||3
12901|NCT02083679|28341|P4|STARTED|Overall Study||3
12902|NCT02083679|28342|P3|STARTED|Overall Study||3
12903|NCT02083679|28343|P2|STARTED|Overall Study||6
12904|NCT02083679|28344|P1|STARTED|Overall Study||3
12905|NCT02083406|28361|P3|NOT COMPLETED|Overall Study||0
12906|NCT02083406|28362|P2|NOT COMPLETED|Overall Study||0
12907|NCT02083406|28363|P1|NOT COMPLETED|Overall Study||0
12908|NCT02083406|28361|P3|COMPLETED|Overall Study||7
12909|NCT02083406|28362|P2|COMPLETED|Overall Study||8
12910|NCT02083406|28363|P1|COMPLETED|Overall Study||7
12911|NCT02083406|28361|P3|STARTED|Overall Study||7
12912|NCT02083406|28362|P2|STARTED|Overall Study||8
12913|NCT02083406|28363|P1|STARTED|Overall Study||7
12914|NCT02083380|28383|P3|NOT COMPLETED|Overall Study||84
12915|NCT02083380|28384|P2|NOT COMPLETED|Overall Study||95
12916|NCT02083380|28385|P1|NOT COMPLETED|Overall Study||91
12917|NCT02083380|28383|P3|COMPLETED|Overall Study||65
12918|NCT02083380|28384|P2|COMPLETED|Overall Study||56
12919|NCT02083380|28385|P1|COMPLETED|Overall Study||57
12920|NCT02083380|28383|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
12921|NCT02083380|28384|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
12922|NCT02083380|28385|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
12923|NCT02083263|28480|P2|NOT COMPLETED|Overall Study||0
12924|NCT02083263|28481|P1|NOT COMPLETED|Overall Study||0
12925|NCT02083263|28480|P2|COMPLETED|Overall Study||16
12926|NCT02083263|28481|P1|COMPLETED|Overall Study||16
12927|NCT02083263|28480|P2|STARTED|Overall Study||16
12928|NCT02083263|28481|P1|STARTED|Overall Study||16
12929|NCT02083107|28490|P3|NOT COMPLETED|Overall Study||0
12930|NCT02083107|28491|P2|NOT COMPLETED|Overall Study||0
12931|NCT02083107|28492|P1|NOT COMPLETED|Overall Study||0
12932|NCT02083107|28490|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
12933|NCT02083107|28491|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
12934|NCT02083107|28492|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
12935|NCT02083107|28490|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
12936|NCT02083107|28491|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
12937|NCT02083107|28492|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
12938|NCT02082912|28529|P2|NOT COMPLETED|Overall Study||1
12939|NCT02082912|28530|P1|NOT COMPLETED|Overall Study||0
12940|NCT02082912|28529|P2|COMPLETED|Overall Study||6
12941|NCT02082912|28530|P1|COMPLETED|Overall Study||7
12942|NCT02082912|28529|P2|STARTED|Overall Study||7
12943|NCT02082912|28530|P1|STARTED|Overall Study||7
12944|NCT02082769|28539|P3|NOT COMPLETED|Overall Study||36
12945|NCT02082769|28540|P2|NOT COMPLETED|Overall Study||27
12946|NCT02082769|28541|P1|NOT COMPLETED|Overall Study||24
12947|NCT02082769|28539|P3|COMPLETED|Overall Study||132
12948|NCT02082769|28540|P2|COMPLETED|Overall Study||141
12949|NCT02082769|28541|P1|COMPLETED|Overall Study||144
12950|NCT02082769|28539|P3|STARTED|Overall Study||168
12951|NCT02082769|28540|P2|STARTED|Overall Study||168
12952|NCT02082769|28541|P1|STARTED|Overall Study||168
12953|NCT02082288|28555|P1|NOT COMPLETED|Overall Study||0
12954|NCT02082288|28555|P1|COMPLETED|Overall Study||243
12955|NCT02082288|28555|P1|STARTED|Overall Study||243
12956|NCT02082262|28559|P1|NOT COMPLETED|Overall Study||51
12957|NCT02082262|28559|P1|COMPLETED|Overall Study||89
12958|NCT02082262|28559|P1|STARTED|Overall Study||140
12959|NCT02082158|28569|P6|NOT COMPLETED|Overall Study||7
12960|NCT02082158|28570|P5|NOT COMPLETED|Overall Study||4
12961|NCT02082158|28571|P4|NOT COMPLETED|Overall Study||4
12962|NCT02082158|28572|P3|NOT COMPLETED|Overall Study||14
12963|NCT02082158|28573|P2|NOT COMPLETED|Overall Study||8
12964|NCT02082158|28574|P1|NOT COMPLETED|Overall Study||8
12965|NCT02082158|28569|P6|COMPLETED|Overall Study||56
12966|NCT02082158|28570|P5|COMPLETED|Overall Study||64
12967|NCT02082158|28571|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
12968|NCT02082158|28572|P3|COMPLETED|Overall Study||38
12969|NCT02082158|28573|P2|COMPLETED|Overall Study||53
12970|NCT02082158|28574|P1|COMPLETED|Overall Study||58
12971|NCT02082158|28569|P6|STARTED|Overall Study||63
12972|NCT02082158|28570|P5|STARTED|Overall Study||68
12973|NCT02082158|28571|P4|STARTED|Overall Study||72
12974|NCT02082158|28572|P3|STARTED|Overall Study||52
12975|NCT02082158|28573|P2|STARTED|Overall Study||61
12976|NCT02082158|28574|P1|STARTED|Overall Study||66
12977|NCT02081599|28596|P2|NOT COMPLETED|Period 2：Open-label Period||4
12978|NCT02081599|28597|P1|NOT COMPLETED|Period 2：Open-label Period||6
12979|NCT02081599|28596|P2|COMPLETED|Period 2：Open-label Period||71
12980|NCT02081599|28597|P1|COMPLETED|Period 2：Open-label Period||57
12981|NCT02081599|28596|P2|STARTED|Period 2：Open-label Period||75
12982|NCT02081599|28597|P1|STARTED|Period 2：Open-label Period||63
12983|NCT02081599|28596|P2|NOT COMPLETED|Period 1：Double-blind Period||2
12984|NCT02081599|28597|P1|NOT COMPLETED|Period 1：Double-blind Period||8
12985|NCT02081599|28596|P2|COMPLETED|Period 1：Double-blind Period||75
12986|NCT02081599|28597|P1|COMPLETED|Period 1：Double-blind Period||63
12987|NCT02081599|28596|P2|STARTED|Period 1：Double-blind Period||77
12988|NCT02081599|28597|P1|STARTED|Period 1：Double-blind Period||71
12989|NCT02081365|28613|P2|NOT COMPLETED|Overall Study||23
12990|NCT02081365|28614|P1|NOT COMPLETED|Overall Study||30
12991|NCT02081365|28613|P2|COMPLETED|Overall Study||54
12992|NCT02081365|28614|P1|COMPLETED|Overall Study||44
12993|NCT02081365|28613|P2|Received Allocated Intervention|Overall Study||59
12994|NCT02081365|28614|P1|Received Allocated Intervention|Overall Study||46
12995|NCT02081365|28613|P2|STARTED|Overall Study||77
12996|NCT02081365|28614|P1|STARTED|Overall Study||74
12997|NCT02081183|28628|P2|NOT COMPLETED|Overall Study||4
12998|NCT02081183|28629|P1|NOT COMPLETED|Overall Study||4
12999|NCT02081183|28628|P2|COMPLETED|Overall Study||2
13000|NCT02081183|28629|P1|COMPLETED|Overall Study||1
13001|NCT02081183|28628|P2|STARTED|Overall Study||6
13002|NCT02081183|28629|P1|STARTED|Overall Study||5
13003|NCT02081079|28645|P2|NOT COMPLETED|Overall Study||2
13004|NCT02081079|28646|P1|NOT COMPLETED|Overall Study||4
13005|NCT02081079|28645|P2|COMPLETED|Overall Study||39
13006|NCT02081079|28646|P1|COMPLETED|Overall Study||40
13007|NCT02081079|28645|P2|STARTED|Overall Study||41
13008|NCT02081079|28646|P1|STARTED|Overall Study||44
13009|NCT02081014|28668|P6|NOT COMPLETED|Overall Study||0
13010|NCT02081014|28669|P5|NOT COMPLETED|Overall Study||0
13011|NCT02081014|28670|P4|NOT COMPLETED|Overall Study||0
13012|NCT02081014|28671|P3|NOT COMPLETED|Overall Study||0
13013|NCT02081014|28672|P2|NOT COMPLETED|Overall Study||0
13014|NCT02081014|28673|P1|NOT COMPLETED|Overall Study||0
13015|NCT02081014|28668|P6|COMPLETED|Overall Study||2
13016|NCT02081014|28669|P5|COMPLETED|Overall Study||2
13017|NCT02081014|28670|P4|COMPLETED|Overall Study||2
13018|NCT02081014|28671|P3|COMPLETED|Overall Study||2
13019|NCT02081014|28672|P2|COMPLETED|Overall Study||2
13020|NCT02081014|28673|P1|COMPLETED|Overall Study||2
13021|NCT02081014|28668|P6|STARTED|Overall Study||2
13022|NCT02081014|28669|P5|STARTED|Overall Study||2
13023|NCT02081014|28670|P4|STARTED|Overall Study||2
13024|NCT02081014|28671|P3|STARTED|Overall Study||2
13025|NCT02081014|28672|P2|STARTED|Overall Study||2
13026|NCT02081014|28673|P1|STARTED|Overall Study||2
13027|NCT02081001|28719|P12|NOT COMPLETED|Overall Study||0
13028|NCT02081001|28720|P11|NOT COMPLETED|Overall Study||0
13029|NCT02081001|28721|P10|NOT COMPLETED|Overall Study||0
13030|NCT02081001|28722|P9|NOT COMPLETED|Overall Study||0
13031|NCT02081001|28723|P8|NOT COMPLETED|Overall Study||0
13032|NCT02081001|28724|P7|NOT COMPLETED|Overall Study||0
13033|NCT02081001|28725|P6|NOT COMPLETED|Overall Study||0
13034|NCT02081001|28726|P5|NOT COMPLETED|Overall Study||1
13035|NCT02081001|28727|P4|NOT COMPLETED|Overall Study||0
13036|NCT02081001|28728|P3|NOT COMPLETED|Overall Study||0
13037|NCT02081001|28729|P2|NOT COMPLETED|Overall Study||0
13038|NCT02081001|28730|P1|NOT COMPLETED|Overall Study||0
13039|NCT02081001|28719|P12|COMPLETED|Overall Study||1
13040|NCT02081001|28720|P11|COMPLETED|Overall Study||2
13041|NCT02081001|28721|P10|COMPLETED|Overall Study||1
13042|NCT02081001|28722|P9|COMPLETED|Overall Study||2
13043|NCT02081001|28723|P8|COMPLETED|Overall Study||1
13044|NCT02081001|28724|P7|COMPLETED|Overall Study||2
13045|NCT02081001|28725|P6|COMPLETED|Overall Study||1
13046|NCT02081001|28726|P5|COMPLETED|Overall Study||2
13047|NCT02081001|28727|P4|COMPLETED|Overall Study||1
13048|NCT02081001|28728|P3|COMPLETED|Overall Study||2
13049|NCT02081001|28729|P2|COMPLETED|Overall Study||1
13050|NCT02081001|28730|P1|COMPLETED|Overall Study||2
13051|NCT02081001|28719|P12|STARTED|Overall Study||1
13052|NCT02081001|28720|P11|STARTED|Overall Study||2
13053|NCT02081001|28721|P10|STARTED|Overall Study||1
13054|NCT02081001|28722|P9|STARTED|Overall Study||2
13055|NCT02081001|28723|P8|STARTED|Overall Study||1
13056|NCT02081001|28724|P7|STARTED|Overall Study||2
13057|NCT02081001|28725|P6|STARTED|Overall Study||1
13058|NCT02081001|28726|P5|STARTED|Overall Study||3
13059|NCT02081001|28727|P4|STARTED|Overall Study||1
13060|NCT02081001|28728|P3|STARTED|Overall Study||2
13061|NCT02081001|28729|P2|STARTED|Overall Study||1
13062|NCT02081001|28730|P1|STARTED|Overall Study||2
13063|NCT02080780|28794|P1|NOT COMPLETED|Overall Study||0
13064|NCT02080780|28794|P1|COMPLETED|Overall Study||24
13065|NCT02080780|28794|P1|STARTED|Overall Study||24
13066|NCT02080546|28803|P2|NOT COMPLETED|Overall Study||11
13067|NCT02080546|28804|P1|NOT COMPLETED|Overall Study||8
13068|NCT02080546|28803|P2|COMPLETED|Overall Study||52
13069|NCT02080546|28804|P1|COMPLETED|Overall Study||49
13070|NCT02080546|28803|P2|STARTED|Overall Study||63
13071|NCT02080546|28804|P1|STARTED|Overall Study||57
13072|NCT02080312|28812|P1|NOT COMPLETED|Overall Study||0
13073|NCT02080312|28812|P1|COMPLETED|Overall Study||6
13074|NCT02080312|28812|P1|STARTED|Overall Study||6
13075|NCT02080091|28818|P1|NOT COMPLETED|Overall Study||25
13076|NCT02080091|28818|P1|COMPLETED|Overall Study||0
13077|NCT02080091|28818|P1|STARTED|Overall Study||25
13078|NCT02079844|28827|P3|NOT COMPLETED|Treatment Period 3||0
13079|NCT02079844|28828|P2|NOT COMPLETED|Treatment Period 3||0
13080|NCT02079844|28829|P1|NOT COMPLETED|Treatment Period 3||0
13081|NCT02079844|28827|P3|COMPLETED|Treatment Period 3||5
13082|NCT02079844|28828|P2|COMPLETED|Treatment Period 3||5
13083|NCT02079844|28829|P1|COMPLETED|Treatment Period 3||5
13084|NCT02079844|28827|P3|STARTED|Treatment Period 3||5
13085|NCT02079844|28828|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
13086|NCT02079844|28829|P1|STARTED|Treatment Period 3||5
13087|NCT02079844|28827|P3|NOT COMPLETED|Treatment Period 2||0
13088|NCT02079844|28828|P2|NOT COMPLETED|Treatment Period 2||1
13089|NCT02079844|28829|P1|NOT COMPLETED|Treatment Period 2||0
13090|NCT02079844|28827|P3|COMPLETED|Treatment Period 2||5
13091|NCT02079844|28828|P2|COMPLETED|Treatment Period 2||6
13092|NCT02079844|28829|P1|COMPLETED|Treatment Period 2||5
13093|NCT02079844|28827|P3|STARTED|Treatment Period 2||5
13094|NCT02079844|28828|P2|STARTED|Treatment Period 2||7
13095|NCT02079844|28829|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
13096|NCT02079844|28827|P3|NOT COMPLETED|Treatment Period 1||2
13097|NCT02079844|28828|P2|NOT COMPLETED|Treatment Period 1||0
13098|NCT02079844|28829|P1|NOT COMPLETED|Treatment Period 1||0
13099|NCT02079844|28827|P3|COMPLETED|Treatment Period 1||5
13100|NCT02079844|28828|P2|COMPLETED|Treatment Period 1||7
13101|NCT02079844|28829|P1|COMPLETED|Treatment Period 1||6
13102|NCT02079844|28827|P3|STARTED|Treatment Period 1||7
13103|NCT02079844|28828|P2|STARTED|Treatment Period 1||7
13104|NCT02079844|28829|P1|STARTED|Treatment Period 1||6
13105|NCT02079649|28889|P4|NOT COMPLETED|Overall Study||2
13106|NCT02079649|28890|P3|NOT COMPLETED|Overall Study||1
13107|NCT02079649|28891|P2|NOT COMPLETED|Overall Study||0
13108|NCT02079649|28892|P1|NOT COMPLETED|Overall Study||1
13109|NCT02079649|28889|P4|COMPLETED|Overall Study||38
13110|NCT02079649|28890|P3|COMPLETED|Overall Study||40
13111|NCT02079649|28891|P2|COMPLETED|Overall Study||41
13112|NCT02079649|28892|P1|COMPLETED|Overall Study||41
13113|NCT02079649|28889|P4|Treated|Overall Study||40
13114|NCT02079649|28890|P3|Treated|Overall Study||40
13115|NCT02079649|28891|P2|Treated|Overall Study||41
13116|NCT02079649|28892|P1|Treated|Overall Study||41
13117|NCT02079649|28889|P4|STARTED|Overall Study||40
13118|NCT02079649|28890|P3|STARTED|Overall Study||41
13119|NCT02079649|28891|P2|STARTED|Overall Study||41
13120|NCT02079649|28892|P1|STARTED|Overall Study||42
13121|NCT02079532|28907|P1|NOT COMPLETED|Overall Study||29
13122|NCT02079532|28907|P1|COMPLETED|Overall Study||273
13123|NCT02079532|28907|P1|STARTED|Overall Study||302
13124|NCT02079519|28929|P1|NOT COMPLETED|Overall Study||10
13125|NCT02079519|28929|P1|COMPLETED|Overall Study||0
13126|NCT02079519|28929|P1|STARTED|Overall Study||10
13127|NCT02079311|28935|P2|NOT COMPLETED|Overall Study||1
13128|NCT02079311|28936|P1|NOT COMPLETED|Overall Study||0
13129|NCT02079311|28935|P2|COMPLETED|Overall Study||26
13130|NCT02079311|28936|P1|COMPLETED|Overall Study||28
13131|NCT02079311|28935|P2|STARTED|Overall Study||27
13132|NCT02079311|28936|P1|STARTED|Overall Study||28
13133|NCT02077374|28944|P2|NOT COMPLETED|Overall Study||2
13134|NCT02077374|28945|P1|NOT COMPLETED|Overall Study||0
13135|NCT02077374|28944|P2|COMPLETED|Overall Study||17
13136|NCT02077374|28945|P1|COMPLETED|Overall Study||19
13137|NCT02077374|28944|P2|STARTED|Overall Study||19
13138|NCT02077374|28945|P1|STARTED|Overall Study||19
13139|NCT02076919|28973|P4|NOT COMPLETED|Overall Study||0
13140|NCT02076919|28974|P3|NOT COMPLETED|Overall Study||0
13141|NCT02076919|28975|P2|NOT COMPLETED|Overall Study||0
13142|NCT02076919|28976|P1|NOT COMPLETED|Overall Study||0
13143|NCT02076919|28973|P4|COMPLETED|Overall Study||12
13144|NCT02076919|28974|P3|COMPLETED|Overall Study||36
13145|NCT02076919|28975|P2|COMPLETED|Overall Study||8
13146|NCT02076919|28976|P1|COMPLETED|Overall Study||24
13147|NCT02076919|28973|P4|STARTED|Overall Study||12
13148|NCT02076919|28974|P3|STARTED|Overall Study||36
13149|NCT02076919|28975|P2|STARTED|Overall Study||8
13150|NCT02076919|28976|P1|STARTED|Overall Study||24
13151|NCT02076009|29076|P2|NOT COMPLETED|Overall Study||286
13152|NCT02076009|29077|P1|NOT COMPLETED|Overall Study||283
13153|NCT02076009|29076|P2|COMPLETED|Overall Study||0
13154|NCT02076009|29077|P1|COMPLETED|Overall Study||0
13155|NCT02076009|29076|P2|Treated|Overall Study||283
13156|NCT02076009|29077|P1|Treated|Overall Study||281
13157|NCT02076009|29076|P2|STARTED|Overall Study||286
13158|NCT02076009|29077|P1|STARTED|Overall Study||283
13159|NCT02075632|29099|P2|NOT COMPLETED|Overall Study||5
13160|NCT02075632|29100|P1|NOT COMPLETED|Overall Study||1
13161|NCT02075632|29099|P2|COMPLETED|Overall Study||143
13162|NCT02075632|29100|P1|COMPLETED|Overall Study||161
13163|NCT02075632|29099|P2|STARTED|Overall Study||148
13164|NCT02075632|29100|P1|STARTED|Overall Study||162
13165|NCT02075411|29114|P4|NOT COMPLETED|Overall Study||0
13166|NCT02075411|29115|P3|NOT COMPLETED|Overall Study||0
13167|NCT02075411|29116|P2|NOT COMPLETED|Overall Study||0
13168|NCT02075411|29117|P1|NOT COMPLETED|Overall Study||0
13169|NCT02075411|29114|P4|COMPLETED|Overall Study||1
13170|NCT02075411|29115|P3|COMPLETED|Overall Study||0
13171|NCT02075411|29116|P2|COMPLETED|Overall Study||0
13172|NCT02075411|29117|P1|COMPLETED|Overall Study||0
13173|NCT02075411|29114|P4|STARTED|Overall Study||1
13174|NCT02075411|29115|P3|STARTED|Overall Study||0
13175|NCT02075411|29116|P2|STARTED|Overall Study||0
13176|NCT02075411|29117|P1|STARTED|Overall Study||0
13177|NCT02075125|29137|P2|NOT COMPLETED|Overall Study||1
13178|NCT02075125|29138|P1|NOT COMPLETED|Overall Study||0
13179|NCT02075125|29137|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
13180|NCT02075125|29138|P1|COMPLETED|Overall Study||19
13181|NCT02075125|29137|P2|STARTED|Overall Study||20
13182|NCT02075125|29138|P1|STARTED|Overall Study||19
13183|NCT02075073|29159|P3|NOT COMPLETED|Overall Study||0
13184|NCT02075073|29160|P2|NOT COMPLETED|Overall Study||1
13185|NCT02075073|29161|P1|NOT COMPLETED|Overall Study||0
13186|NCT02075073|29159|P3|COMPLETED|Overall Study||36
13187|NCT02075073|29160|P2|COMPLETED|Overall Study||36
13188|NCT02075073|29161|P1|COMPLETED|Overall Study||36
13189|NCT02075073|29159|P3|STARTED|Overall Study||36
13190|NCT02075073|29160|P2|STARTED|Overall Study||37
13191|NCT02075073|29161|P1|STARTED|Overall Study||36
13192|NCT02074995|29178|P3|NOT COMPLETED|Overall Study||0
13193|NCT02074995|29179|P2|NOT COMPLETED|Overall Study||0
13194|NCT02074995|29180|P1|NOT COMPLETED|Overall Study||0
13195|NCT02074995|29178|P3|COMPLETED|Overall Study||0
13196|NCT02074995|29179|P2|COMPLETED|Overall Study||0
13197|NCT02074995|29180|P1|COMPLETED|Overall Study||1
13198|NCT02074995|29178|P3|STARTED|Overall Study||0
13199|NCT02074995|29179|P2|STARTED|Overall Study||0
13200|NCT02074995|29180|P1|STARTED|Overall Study||1
13201|NCT02074709|29197|P2|NOT COMPLETED|Overall Study||1
13202|NCT02074709|29198|P1|NOT COMPLETED|Overall Study||1
13203|NCT02074709|29197|P2|COMPLETED|Overall Study||29
13204|NCT02074709|29198|P1|COMPLETED|Overall Study||29
13205|NCT02074709|29197|P2|STARTED|Overall Study||30
13206|NCT02074709|29198|P1|STARTED|Overall Study||30
13207|NCT02074553|29206|P8|NOT COMPLETED|Intervention Period 4||0
13208|NCT02074553|29207|P7|NOT COMPLETED|Intervention Period 4||0
13209|NCT02074553|29208|P6|NOT COMPLETED|Intervention Period 4||0
13210|NCT02074553|29209|P5|NOT COMPLETED|Intervention Period 4||0
13211|NCT02074553|29210|P4|NOT COMPLETED|Intervention Period 4||0
13212|NCT02074553|29211|P3|NOT COMPLETED|Intervention Period 4||0
13213|NCT02074553|29212|P2|NOT COMPLETED|Intervention Period 4||0
13214|NCT02074553|29213|P1|NOT COMPLETED|Intervention Period 4||0
13215|NCT02074553|29206|P8|COMPLETED|Intervention Period 4||11
13216|NCT02074553|29207|P7|COMPLETED|Intervention Period 4||11
13217|NCT02074553|29208|P6|COMPLETED|Intervention Period 4||10
13218|NCT02074553|29209|P5|COMPLETED|Intervention Period 4||12
13219|NCT02074553|29210|P4|COMPLETED|Intervention Period 4||11
13220|NCT02074553|29211|P3|COMPLETED|Intervention Period 4||11
13221|NCT02074553|29212|P2|COMPLETED|Intervention Period 4||12
13222|NCT02074553|29213|P1|COMPLETED|Intervention Period 4||11
13223|NCT02074553|29206|P8|STARTED|Intervention Period 4||11
13224|NCT02074553|29207|P7|STARTED|Intervention Period 4||11
13225|NCT02074553|29208|P6|STARTED|Intervention Period 4||10
13226|NCT02074553|29209|P5|STARTED|Intervention Period 4||12
13227|NCT02074553|29210|P4|STARTED|Intervention Period 4||11
13228|NCT02074553|29211|P3|STARTED|Intervention Period 4||11
13229|NCT02074553|29212|P2|STARTED|Intervention Period 4||12
13230|NCT02074553|29213|P1|STARTED|Intervention Period 4||11
13231|NCT02074553|29206|P8|NOT COMPLETED|Washout Period 3||1
13232|NCT02074553|29207|P7|NOT COMPLETED|Washout Period 3||0
13233|NCT02074553|29208|P6|NOT COMPLETED|Washout Period 3||0
13234|NCT02074553|29209|P5|NOT COMPLETED|Washout Period 3||0
13235|NCT02074553|29210|P4|NOT COMPLETED|Washout Period 3||0
13236|NCT02074553|29211|P3|NOT COMPLETED|Washout Period 3||0
13237|NCT02074553|29212|P2|NOT COMPLETED|Washout Period 3||0
13238|NCT02074553|29213|P1|NOT COMPLETED|Washout Period 3||0
13239|NCT02074553|29206|P8|COMPLETED|Washout Period 3||11
13240|NCT02074553|29207|P7|COMPLETED|Washout Period 3||11
13241|NCT02074553|29208|P6|COMPLETED|Washout Period 3||10
13242|NCT02074553|29209|P5|COMPLETED|Washout Period 3||12
13243|NCT02074553|29210|P4|COMPLETED|Washout Period 3||11
13244|NCT02074553|29211|P3|COMPLETED|Washout Period 3||11
13245|NCT02074553|29212|P2|COMPLETED|Washout Period 3||12
13246|NCT02074553|29213|P1|COMPLETED|Washout Period 3||11
13247|NCT02074553|29206|P8|STARTED|Washout Period 3||12
13248|NCT02074553|29207|P7|STARTED|Washout Period 3||11
13249|NCT02074553|29208|P6|STARTED|Washout Period 3||10
13250|NCT02074553|29209|P5|STARTED|Washout Period 3||12
13251|NCT02074553|29210|P4|STARTED|Washout Period 3||11
13252|NCT02074553|29211|P3|STARTED|Washout Period 3||11
13253|NCT02074553|29212|P2|STARTED|Washout Period 3||12
13254|NCT02074553|29213|P1|STARTED|Washout Period 3||11
13255|NCT02074553|29206|P8|NOT COMPLETED|Intervention Period 3||0
13256|NCT02074553|29207|P7|NOT COMPLETED|Intervention Period 3||0
13257|NCT02074553|29208|P6|NOT COMPLETED|Intervention Period 3||0
13258|NCT02074553|29209|P5|NOT COMPLETED|Intervention Period 3||0
13259|NCT02074553|29210|P4|NOT COMPLETED|Intervention Period 3||0
13260|NCT02074553|29211|P3|NOT COMPLETED|Intervention Period 3||0
13261|NCT02074553|29212|P2|NOT COMPLETED|Intervention Period 3||0
13262|NCT02074553|29213|P1|NOT COMPLETED|Intervention Period 3||0
13263|NCT02074553|29206|P8|COMPLETED|Intervention Period 3||12
13264|NCT02074553|29207|P7|COMPLETED|Intervention Period 3||11
13265|NCT02074553|29208|P6|COMPLETED|Intervention Period 3||10
13266|NCT02074553|29209|P5|COMPLETED|Intervention Period 3||12
13267|NCT02074553|29210|P4|COMPLETED|Intervention Period 3||11
13268|NCT02074553|29211|P3|COMPLETED|Intervention Period 3||11
13269|NCT02074553|29212|P2|COMPLETED|Intervention Period 3||12
13270|NCT02074553|29213|P1|COMPLETED|Intervention Period 3||11
13271|NCT02074553|29206|P8|STARTED|Intervention Period 3||12
13272|NCT02074553|29207|P7|STARTED|Intervention Period 3||11
13273|NCT02074553|29208|P6|STARTED|Intervention Period 3||10
13274|NCT02074553|29209|P5|STARTED|Intervention Period 3||12
13275|NCT02074553|29210|P4|STARTED|Intervention Period 3||11
13276|NCT02074553|29211|P3|STARTED|Intervention Period 3||11
13277|NCT02074553|29212|P2|STARTED|Intervention Period 3||12
13278|NCT02074553|29213|P1|STARTED|Intervention Period 3||11
13279|NCT02074553|29206|P8|NOT COMPLETED|Washout Period 2||0
13280|NCT02074553|29207|P7|NOT COMPLETED|Washout Period 2||1
13281|NCT02074553|29208|P6|NOT COMPLETED|Washout Period 2||1
13282|NCT02074553|29209|P5|NOT COMPLETED|Washout Period 2||0
13283|NCT02074553|29210|P4|NOT COMPLETED|Washout Period 2||0
13284|NCT02074553|29211|P3|NOT COMPLETED|Washout Period 2||1
13285|NCT02074553|29212|P2|NOT COMPLETED|Washout Period 2||0
13286|NCT02074553|29213|P1|NOT COMPLETED|Washout Period 2||0
13287|NCT02074553|29206|P8|COMPLETED|Washout Period 2||12
13288|NCT02074553|29207|P7|COMPLETED|Washout Period 2||11
13289|NCT02074553|29208|P6|COMPLETED|Washout Period 2||10
13290|NCT02074553|29209|P5|COMPLETED|Washout Period 2||12
13291|NCT02074553|29210|P4|COMPLETED|Washout Period 2||11
13292|NCT02074553|29211|P3|COMPLETED|Washout Period 2||11
13293|NCT02074553|29212|P2|COMPLETED|Washout Period 2||12
13294|NCT02074553|29213|P1|COMPLETED|Washout Period 2||11
13295|NCT02074553|29206|P8|STARTED|Washout Period 2||12
13296|NCT02074553|29207|P7|STARTED|Washout Period 2||12
13297|NCT02074553|29208|P6|STARTED|Washout Period 2||11
13298|NCT02074553|29209|P5|STARTED|Washout Period 2||12
13299|NCT02074553|29210|P4|STARTED|Washout Period 2||11
13300|NCT02074553|29211|P3|STARTED|Washout Period 2||12
13301|NCT02074553|29212|P2|STARTED|Washout Period 2||12
13302|NCT02074553|29213|P1|STARTED|Washout Period 2||11
13303|NCT02074553|29206|P8|NOT COMPLETED|Intervention Period 2||0
13304|NCT02074553|29207|P7|NOT COMPLETED|Intervention Period 2||0
13305|NCT02074553|29208|P6|NOT COMPLETED|Intervention Period 2||0
13306|NCT02074553|29209|P5|NOT COMPLETED|Intervention Period 2||0
13307|NCT02074553|29210|P4|NOT COMPLETED|Intervention Period 2||0
13308|NCT02074553|29211|P3|NOT COMPLETED|Intervention Period 2||0
13309|NCT02074553|29212|P2|NOT COMPLETED|Intervention Period 2||0
13310|NCT02074553|29213|P1|NOT COMPLETED|Intervention Period 2||0
13311|NCT02074553|29206|P8|COMPLETED|Intervention Period 2||12
13312|NCT02074553|29207|P7|COMPLETED|Intervention Period 2||12
13313|NCT02074553|29208|P6|COMPLETED|Intervention Period 2||11
13314|NCT02074553|29209|P5|COMPLETED|Intervention Period 2||12
13315|NCT02074553|29210|P4|COMPLETED|Intervention Period 2||11
13316|NCT02074553|29211|P3|COMPLETED|Intervention Period 2||12
13317|NCT02074553|29212|P2|COMPLETED|Intervention Period 2||12
13318|NCT02074553|29213|P1|COMPLETED|Intervention Period 2||11
13319|NCT02074553|29206|P8|STARTED|Intervention Period 2||12
13320|NCT02074553|29207|P7|STARTED|Intervention Period 2||12
13321|NCT02074553|29208|P6|STARTED|Intervention Period 2||11
13322|NCT02074553|29209|P5|STARTED|Intervention Period 2||12
13323|NCT02074553|29210|P4|STARTED|Intervention Period 2||11
13324|NCT02074553|29211|P3|STARTED|Intervention Period 2||12
13325|NCT02074553|29212|P2|STARTED|Intervention Period 2||12
13326|NCT02074553|29213|P1|STARTED|Intervention Period 2||11
13327|NCT02074553|29206|P8|NOT COMPLETED|Washout Period 1||0
13328|NCT02074553|29207|P7|NOT COMPLETED|Washout Period 1||0
13329|NCT02074553|29208|P6|NOT COMPLETED|Washout Period 1||1
13330|NCT02074553|29209|P5|NOT COMPLETED|Washout Period 1||0
13331|NCT02074553|29210|P4|NOT COMPLETED|Washout Period 1||1
13332|NCT02074553|29211|P3|NOT COMPLETED|Washout Period 1||0
13333|NCT02074553|29212|P2|NOT COMPLETED|Washout Period 1||0
13334|NCT02074553|29213|P1|NOT COMPLETED|Washout Period 1||1
13335|NCT02074553|29206|P8|COMPLETED|Washout Period 1||12
13336|NCT02074553|29207|P7|COMPLETED|Washout Period 1||12
13337|NCT02074553|29208|P6|COMPLETED|Washout Period 1||11
13338|NCT02074553|29209|P5|COMPLETED|Washout Period 1||12
13339|NCT02074553|29210|P4|COMPLETED|Washout Period 1||11
13340|NCT02074553|29211|P3|COMPLETED|Washout Period 1||12
13341|NCT02074553|29212|P2|COMPLETED|Washout Period 1||12
13342|NCT02074553|29213|P1|COMPLETED|Washout Period 1||11
13343|NCT02074553|29206|P8|STARTED|Washout Period 1||12
13344|NCT02074553|29207|P7|STARTED|Washout Period 1||12
13345|NCT02074553|29208|P6|STARTED|Washout Period 1||12
13346|NCT02074553|29209|P5|STARTED|Washout Period 1||12
13347|NCT02074553|29210|P4|STARTED|Washout Period 1||12
13348|NCT02074553|29211|P3|STARTED|Washout Period 1||12
13349|NCT02074553|29212|P2|STARTED|Washout Period 1||12
13350|NCT02074553|29213|P1|STARTED|Washout Period 1||12
13351|NCT02074553|29206|P8|NOT COMPLETED|Intervention Period 1||0
13352|NCT02074553|29207|P7|NOT COMPLETED|Intervention Period 1||0
13353|NCT02074553|29208|P6|NOT COMPLETED|Intervention Period 1||0
13354|NCT02074553|29209|P5|NOT COMPLETED|Intervention Period 1||0
13355|NCT02074553|29210|P4|NOT COMPLETED|Intervention Period 1||1
13356|NCT02074553|29211|P3|NOT COMPLETED|Intervention Period 1||0
13357|NCT02074553|29212|P2|NOT COMPLETED|Intervention Period 1||0
13358|NCT02074553|29213|P1|NOT COMPLETED|Intervention Period 1||0
13359|NCT02074553|29206|P8|COMPLETED|Intervention Period 1||12
13360|NCT02074553|29207|P7|COMPLETED|Intervention Period 1||12
13361|NCT02074553|29208|P6|COMPLETED|Intervention Period 1||12
13362|NCT02074553|29209|P5|COMPLETED|Intervention Period 1||12
13363|NCT02074553|29210|P4|COMPLETED|Intervention Period 1||12
13364|NCT02074553|29211|P3|COMPLETED|Intervention Period 1||12
13365|NCT02074553|29212|P2|COMPLETED|Intervention Period 1||12
13366|NCT02074553|29213|P1|COMPLETED|Intervention Period 1||12
13367|NCT02074553|29206|P8|STARTED|Intervention Period 1||12
13368|NCT02074553|29207|P7|STARTED|Intervention Period 1||12
13369|NCT02074553|29208|P6|STARTED|Intervention Period 1||12
13370|NCT02074553|29209|P5|STARTED|Intervention Period 1||12
13371|NCT02074553|29210|P4|STARTED|Intervention Period 1||13
13372|NCT02074553|29211|P3|STARTED|Intervention Period 1||12
13373|NCT02074553|29212|P2|STARTED|Intervention Period 1||12
13374|NCT02074553|29213|P1|STARTED|Intervention Period 1||12
13375|NCT02074514|29395|P2|NOT COMPLETED|Overall Study||4
13376|NCT02074514|29396|P1|NOT COMPLETED|Overall Study||3
13377|NCT02074514|29395|P2|COMPLETED|Overall Study||54
13378|NCT02074514|29396|P1|COMPLETED|Overall Study||56
13379|NCT02074514|29395|P2|STARTED|Overall Study||58
13380|NCT02074514|29396|P1|STARTED|Overall Study||59
13381|NCT02074384|29417|P3|NOT COMPLETED|Overall Study||0
13382|NCT02074384|29418|P2|NOT COMPLETED|Overall Study||0
13383|NCT02074384|29419|P1|NOT COMPLETED|Overall Study||0
13384|NCT02074384|29417|P3|COMPLETED|Overall Study||17
13385|NCT02074384|29418|P2|COMPLETED|Overall Study||70
13386|NCT02074384|29419|P1|COMPLETED|Overall Study||74
13387|NCT02074384|29417|P3|STARTED|Overall Study||17
13388|NCT02074384|29418|P2|STARTED|Overall Study||70
13389|NCT02074384|29419|P1|STARTED|Overall Study||74
13390|NCT02074358|29427|P6|NOT COMPLETED|Overall Study||0
13391|NCT02074358|29428|P5|NOT COMPLETED|Overall Study||0
13392|NCT02074358|29429|P4|NOT COMPLETED|Overall Study||0
13393|NCT02074358|29430|P3|NOT COMPLETED|Overall Study||0
13394|NCT02074358|29431|P2|NOT COMPLETED|Overall Study||0
13395|NCT02074358|29432|P1|NOT COMPLETED|Overall Study||0
13396|NCT02074358|29427|P6|COMPLETED|Overall Study||2
13397|NCT02074358|29428|P5|COMPLETED|Overall Study||3
13398|NCT02074358|29429|P4|COMPLETED|Overall Study||2
13399|NCT02074358|29430|P3|COMPLETED|Overall Study||2
13400|NCT02074358|29431|P2|COMPLETED|Overall Study||3
13401|NCT02074358|29432|P1|COMPLETED|Overall Study||3
13402|NCT02074358|29427|P6|STARTED|Overall Study||2
13403|NCT02074358|29428|P5|STARTED|Overall Study||3
13404|NCT02074358|29429|P4|STARTED|Overall Study||2
13405|NCT02074358|29430|P3|STARTED|Overall Study||2
13406|NCT02074358|29431|P2|STARTED|Overall Study||3
13407|NCT02074358|29432|P1|STARTED|Overall Study||3
13408|NCT02074345|29521|P1|NOT COMPLETED|Overall Study||0
13409|NCT02074345|29521|P1|COMPLETED|Overall Study||31
13410|NCT02074345|29521|P1|STARTED|Overall Study||31
13411|NCT02073656|29531|P1|NOT COMPLETED|Retreatment Substudy||0
13412|NCT02073656|29531|P1|COMPLETED|Retreatment Substudy||9
13413|NCT02073656|29531|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
13414|NCT02073656|29531|P1|NOT COMPLETED|Primary Study||8
13415|NCT02073656|29531|P1|COMPLETED|Primary Study||327
13416|NCT02073656|29531|P1|STARTED|Primary Study||335
13417|NCT02073461|29550|P3|NOT COMPLETED|Overall Study||1
13418|NCT02073461|29551|P2|NOT COMPLETED|Overall Study||1
13419|NCT02073461|29552|P1|NOT COMPLETED|Overall Study||4
13420|NCT02073461|29550|P3|COMPLETED|Overall Study||78
13421|NCT02073461|29551|P2|COMPLETED|Overall Study||77
13422|NCT02073461|29552|P1|COMPLETED|Overall Study||75
13423|NCT02073461|29550|P3|STARTED|Overall Study||79
13424|NCT02073461|29551|P2|STARTED|Overall Study||78
13425|NCT02073461|29552|P1|STARTED|Overall Study||79
13426|NCT02073448|29581|P3|NOT COMPLETED|Overall Study||5
13427|NCT02073448|29582|P2|NOT COMPLETED|Overall Study||12
13428|NCT02073448|29583|P1|NOT COMPLETED|Overall Study||2
13429|NCT02073448|29581|P3|COMPLETED|Overall Study||99
13430|NCT02073448|29582|P2|COMPLETED|Overall Study||200
13431|NCT02073448|29583|P1|COMPLETED|Overall Study||99
13432|NCT02073448|29581|P3|STARTED|Overall Study||104
13433|NCT02073448|29582|P2|STARTED|Overall Study||212
13434|NCT02073448|29583|P1|STARTED|Overall Study||101
13435|NCT02072980|29609|P2|NOT COMPLETED|Period 2, Second Wear||1
13436|NCT02072980|29610|P1|NOT COMPLETED|Period 2, Second Wear||0
13437|NCT02072980|29609|P2|COMPLETED|Period 2, Second Wear||7
13438|NCT02072980|29610|P1|COMPLETED|Period 2, Second Wear||7
13439|NCT02072980|29609|P2|STARTED|Period 2, Second Wear||8
13440|NCT02072980|29610|P1|STARTED|Period 2, Second Wear||7
13441|NCT02072980|29609|P2|NOT COMPLETED|Period 1, First Wear||0
13442|NCT02072980|29610|P1|NOT COMPLETED|Period 1, First Wear||0
13443|NCT02072980|29609|P2|COMPLETED|Period 1, First Wear||8
13444|NCT02072980|29610|P1|COMPLETED|Period 1, First Wear||7
13445|NCT02072980|29609|P2|STARTED|Period 1, First Wear||8
13446|NCT02072980|29610|P1|STARTED|Period 1, First Wear||7
13447|NCT02072421|29616|P1|NOT COMPLETED|Overall Study||390
13448|NCT02072421|29616|P1|COMPLETED|Overall Study||2489
13449|NCT02072421|29616|P1|STARTED|Overall Study||2879
13450|NCT02072200|29624|P1|NOT COMPLETED|Overall Study||2
13451|NCT02072200|29624|P1|COMPLETED|Overall Study||145
13452|NCT02072200|29624|P1|STARTED|Overall Study||147
13453|NCT02072096|29632|P2|NOT COMPLETED|Overall Study||78
13454|NCT02072096|29633|P1|NOT COMPLETED|Overall Study||85
13455|NCT02072096|29632|P2|COMPLETED|Overall Study||15
13456|NCT02072096|29633|P1|COMPLETED|Overall Study||14
13457|NCT02072096|29632|P2|Received at Least One Dose of Study Drug|Overall Study||93
13458|NCT02072096|29633|P1|Received at Least One Dose of Study Drug|Overall Study||98
13459|NCT02072096|29632|P2|STARTED|Overall Study||93
13460|NCT02072096|29633|P1|STARTED|Overall Study||99
13461|NCT02071823|29657|P2|NOT COMPLETED|Overall Study||0
13462|NCT02071823|29658|P1|NOT COMPLETED|Overall Study||1
13463|NCT02071823|29657|P2|COMPLETED|Overall Study||6
13464|NCT02071823|29658|P1|COMPLETED|Overall Study||5
13465|NCT02071823|29657|P2|STARTED|Overall Study||6
13466|NCT02071823|29658|P1|STARTED|Overall Study||6
13467|NCT02071810|29673|P5|NOT COMPLETED|Overall Study||1
13468|NCT02071810|29674|P4|NOT COMPLETED|Overall Study||1
13469|NCT02071810|29675|P3|NOT COMPLETED|Overall Study||0
13470|NCT02071810|29676|P2|NOT COMPLETED|Overall Study||0
13471|NCT02071810|29677|P1|NOT COMPLETED|Overall Study||0
13472|NCT02071810|29673|P5|COMPLETED|Overall Study||8
13473|NCT02071810|29674|P4|COMPLETED|Overall Study||6
13474|NCT02071810|29675|P3|COMPLETED|Overall Study||6
13475|NCT02071810|29676|P2|COMPLETED|Overall Study||6
13476|NCT02071810|29677|P1|COMPLETED|Overall Study||6
13477|NCT02071810|29673|P5|STARTED|Overall Study||9
13478|NCT02071810|29674|P4|STARTED|Overall Study||7
13479|NCT02071810|29675|P3|STARTED|Overall Study||6
13480|NCT02071810|29676|P2|STARTED|Overall Study||6
13481|NCT02071810|29677|P1|STARTED|Overall Study||6
13482|NCT02071771|29689|P2|NOT COMPLETED|Period 2: Second 10 Days||0
13483|NCT02071771|29690|P1|NOT COMPLETED|Period 2: Second 10 Days||0
13484|NCT02071771|29689|P2|COMPLETED|Period 2: Second 10 Days||38
13485|NCT02071771|29690|P1|COMPLETED|Period 2: Second 10 Days||39
13486|NCT02071771|29689|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
13487|NCT02071771|29690|P1|STARTED|Period 2: Second 10 Days||39
13488|NCT02071771|29689|P2|NOT COMPLETED|Period 1: First 10 Days||0
13489|NCT02071771|29690|P1|NOT COMPLETED|Period 1: First 10 Days||2
13490|NCT02071771|29689|P2|COMPLETED|Period 1: First 10 Days||39
13491|NCT02071771|29690|P1|COMPLETED|Period 1: First 10 Days||39
13492|NCT02071771|29689|P2|Dispensed|Period 1: First 10 Days||39
13493|NCT02071771|29690|P1|Dispensed|Period 1: First 10 Days||39
13494|NCT02071771|29689|P2|STARTED|Period 1: First 10 Days||39
13495|NCT02071771|29690|P1|STARTED|Period 1: First 10 Days||41
13496|NCT02071108|29698|P1|NOT COMPLETED|Overall Study||0
13497|NCT02071108|29698|P1|COMPLETED|Overall Study||35
13498|NCT02071108|29698|P1|STARTED|Overall Study||35
13499|NCT02071082|29719|P2|NOT COMPLETED|Overall Study||75
13500|NCT02071082|29720|P1|NOT COMPLETED|Overall Study||4
13501|NCT02071082|29719|P2|COMPLETED|Overall Study||0
13502|NCT02071082|29720|P1|COMPLETED|Overall Study||0
13503|NCT02071082|29719|P2|STARTED|Overall Study||75
13504|NCT02071082|29720|P1|STARTED|Overall Study||4
13505|NCT02070640|29750|P2|NOT COMPLETED|Overall Study||0
13506|NCT02070640|29751|P1|NOT COMPLETED|Overall Study||11
13507|NCT02070640|29750|P2|COMPLETED|Overall Study||6
13508|NCT02070640|29751|P1|COMPLETED|Overall Study||82
13509|NCT02070640|29750|P2|STARTED|Overall Study||6
13510|NCT02070640|29751|P1|STARTED|Overall Study||93
13511|NCT02070380|29765|P4|NOT COMPLETED|Second Injection||5
13512|NCT02070380|29766|P3|NOT COMPLETED|Second Injection||1
13513|NCT02070380|29767|P2|NOT COMPLETED|Second Injection||2
13514|NCT02070380|29768|P1|NOT COMPLETED|Second Injection||0
13515|NCT02070380|29765|P4|COMPLETED|Second Injection||46
13516|NCT02070380|29766|P3|COMPLETED|Second Injection||50
13517|NCT02070380|29767|P2|COMPLETED|Second Injection||32
13518|NCT02070380|29768|P1|COMPLETED|Second Injection||31
13519|NCT02070380|29765|P4|STARTED|Second Injection||51
13520|NCT02070380|29766|P3|STARTED|Second Injection||51
13521|NCT02070380|29767|P2|STARTED|Second Injection||34
13522|NCT02070380|29768|P1|STARTED|Second Injection||31
13523|NCT02070380|29765|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
13524|NCT02070380|29766|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
13525|NCT02070380|29767|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
13526|NCT02070380|29768|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
13527|NCT02070380|29765|P4|COMPLETED|Washout (no Second Injection/MRI)||51
13528|NCT02070380|29766|P3|COMPLETED|Washout (no Second Injection/MRI)||51
13529|NCT02070380|29767|P2|COMPLETED|Washout (no Second Injection/MRI)||34
13530|NCT02070380|29768|P1|COMPLETED|Washout (no Second Injection/MRI)||31
13531|NCT02070380|29765|P4|STARTED|Washout (no Second Injection/MRI)||54
13532|NCT02070380|29766|P3|STARTED|Washout (no Second Injection/MRI)||53
13533|NCT02070380|29767|P2|STARTED|Washout (no Second Injection/MRI)||39
13534|NCT02070380|29768|P1|STARTED|Washout (no Second Injection/MRI)||31
13535|NCT02070380|29765|P4|NOT COMPLETED|First Injection||0
13536|NCT02070380|29766|P3|NOT COMPLETED|First Injection||0
13537|NCT02070380|29767|P2|NOT COMPLETED|First Injection||0
13538|NCT02070380|29768|P1|NOT COMPLETED|First Injection||0
13539|NCT02070380|29765|P4|COMPLETED|First Injection||54
13540|NCT02070380|29766|P3|COMPLETED|First Injection||53
13541|NCT02070380|29767|P2|COMPLETED|First Injection||39
13542|NCT02070380|29768|P1|COMPLETED|First Injection||31
13543|NCT02070380|29765|P4|STARTED|First Injection||54
13544|NCT02070380|29766|P3|STARTED|First Injection||53
13545|NCT02070380|29767|P2|STARTED|First Injection||39
13546|NCT02070380|29768|P1|STARTED|First Injection||31
13547|NCT02070237|29818|P2|NOT COMPLETED|Overall Study||3
13548|NCT02070237|29819|P1|NOT COMPLETED|Overall Study||3
13549|NCT02070237|29818|P2|COMPLETED|Overall Study||42
13550|NCT02070237|29819|P1|COMPLETED|Overall Study||42
13551|NCT02070237|29818|P2|STARTED|Overall Study||45
13552|NCT02070237|29819|P1|STARTED|Overall Study||45
13553|NCT02069093|29827|P1|NOT COMPLETED|Overall Study||30
13554|NCT02069093|29827|P1|COMPLETED|Overall Study||56
13555|NCT02069093|29827|P1|Pharmacokinetic Analysis Set|Overall Study||50
13556|NCT02069093|29827|P1|STARTED|Overall Study||86
13557|NCT02068443|29839|P3|NOT COMPLETED|Overall Study||3
13558|NCT02068443|29840|P2|NOT COMPLETED|Overall Study||6
13559|NCT02068443|29841|P1|NOT COMPLETED|Overall Study||7
13560|NCT02068443|29839|P3|COMPLETED|Overall Study||148
13561|NCT02068443|29840|P2|COMPLETED|Overall Study||146
13562|NCT02068443|29841|P1|COMPLETED|Overall Study||64
13563|NCT02068443|29839|P3|STARTED|Overall Study||151
13564|NCT02068443|29840|P2|STARTED|Overall Study||152
13565|NCT02068443|29841|P1|STARTED|Overall Study||71
13566|NCT02068222|29876|P1|NOT COMPLETED|Overall Study||1
13567|NCT02068222|29876|P1|COMPLETED|Overall Study||9
13568|NCT02068222|29876|P1|STARTED|Overall Study||10
13569|NCT02067728|29885|P2|NOT COMPLETED|6 Month Measurements||97
13570|NCT02067728|29886|P1|NOT COMPLETED|6 Month Measurements||114
13571|NCT02067728|29885|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
13572|NCT02067728|29886|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
13573|NCT02067728|29885|P2|STARTED|6 Month Measurements||210
13574|NCT02067728|29886|P1|STARTED|6 Month Measurements||220
13575|NCT02067728|29885|P2|NOT COMPLETED|6 Month Follow up Survey||60
13576|NCT02067728|29886|P1|NOT COMPLETED|6 Month Follow up Survey||48
13577|NCT02067728|29885|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
13578|NCT02067728|29886|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
13579|NCT02067728|29885|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
13580|NCT02067728|29886|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
13581|NCT02067728|29885|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
13582|NCT02067728|29886|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
13583|NCT02067728|29885|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
13584|NCT02067728|29886|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
13585|NCT02067728|29885|P2|STARTED|Baseline - 1 Month Follow up Survey||210
13586|NCT02067728|29886|P1|STARTED|Baseline - 1 Month Follow up Survey||220
13587|NCT02067533|29916|P2|NOT COMPLETED|Overall Study||2
13588|NCT02067533|29917|P1|NOT COMPLETED|Overall Study||4
13589|NCT02067533|29916|P2|COMPLETED|Overall Study||44
13590|NCT02067533|29917|P1|COMPLETED|Overall Study||41
13591|NCT02067533|29916|P2|STARTED|Overall Study||46
13592|NCT02067533|29917|P1|STARTED|Overall Study||45
13593|NCT02066922|29923|P1|NOT COMPLETED|Overall Study||1
13594|NCT02066922|29923|P1|COMPLETED|Overall Study||14
13595|NCT02066922|29923|P1|STARTED|Overall Study||15
13596|NCT02066740|29931|P1|NOT COMPLETED|Overall Study||2
13597|NCT02066740|29931|P1|COMPLETED|Overall Study||32
13598|NCT02066740|29931|P1|STARTED|Overall Study||34
13599|NCT02066727|29938|P2|NOT COMPLETED|Overall Study||0
13600|NCT02066727|29939|P1|NOT COMPLETED|Overall Study||0
13601|NCT02066727|29938|P2|COMPLETED|Overall Study||30
13602|NCT02066727|29939|P1|COMPLETED|Overall Study||30
13603|NCT02066727|29938|P2|STARTED|Overall Study||30
13604|NCT02066727|29939|P1|STARTED|Overall Study||30
13605|NCT02066051|29945|P1|NOT COMPLETED|Overall Study||1
13606|NCT02066051|29945|P1|COMPLETED|Overall Study||7
13607|NCT02066051|29945|P1|STARTED|Overall Study||8
13608|NCT02064985|29953|P3|NOT COMPLETED|Overall Study||0
13609|NCT02064985|29954|P2|NOT COMPLETED|Overall Study||0
13610|NCT02064985|29955|P1|NOT COMPLETED|Overall Study||0
13611|NCT02064985|29953|P3|COMPLETED|Overall Study||12
13612|NCT02064985|29954|P2|COMPLETED|Overall Study||12
13613|NCT02064985|29955|P1|COMPLETED|Overall Study||12
13614|NCT02064985|29953|P3|STARTED|Overall Study||12
13615|NCT02064985|29954|P2|STARTED|Overall Study||12
13616|NCT02064985|29955|P1|STARTED|Overall Study||12
13617|NCT02064907|30118|P2|NOT COMPLETED|Period 2||0
13618|NCT02064907|30119|P1|NOT COMPLETED|Period 2||0
13619|NCT02064907|30118|P2|COMPLETED|Period 2||26
13620|NCT02064907|30119|P1|COMPLETED|Period 2||26
13621|NCT02064907|30118|P2|STARTED|Period 2||26
13622|NCT02064907|30119|P1|STARTED|Period 2||26
13623|NCT02064907|30118|P2|NOT COMPLETED|Period 1||0
13624|NCT02064907|30119|P1|NOT COMPLETED|Period 1||0
13625|NCT02064907|30118|P2|COMPLETED|Period 1||26
13626|NCT02064907|30119|P1|COMPLETED|Period 1||26
13627|NCT02064907|30118|P2|STARTED|Period 1||26
13628|NCT02064907|30119|P1|STARTED|Period 1||26
13629|NCT02064231|30135|P2|NOT COMPLETED|Third Test Period (Own Product)||0
13630|NCT02064231|30136|P1|NOT COMPLETED|Third Test Period (Own Product)||0
13631|NCT02064231|30135|P2|COMPLETED|Third Test Period (Own Product)||8
13632|NCT02064231|30136|P1|COMPLETED|Third Test Period (Own Product)||8
13633|NCT02064231|30135|P2|STARTED|Third Test Period (Own Product)||8
13634|NCT02064231|30136|P1|STARTED|Third Test Period (Own Product)||8
13635|NCT02064231|30135|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||2
13636|NCT02064231|30136|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||2
13637|NCT02064231|30135|P2|COMPLETED|Second Test Period (Test B or Test D)||8
13638|NCT02064231|30136|P1|COMPLETED|Second Test Period (Test B or Test D)||6
13639|NCT02064231|30135|P2|STARTED|Second Test Period (Test B or Test D)||10
13640|NCT02064231|30136|P1|STARTED|Second Test Period (Test B or Test D)||8
13641|NCT02064231|30135|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
13642|NCT02064231|30136|P1|NOT COMPLETED|First Test Period (Test A or Test C)||6
13643|NCT02064231|30135|P2|COMPLETED|First Test Period (Test A or Test C)||8
13644|NCT02064231|30136|P1|COMPLETED|First Test Period (Test A or Test C)||9
13645|NCT02064231|30135|P2|STARTED|First Test Period (Test A or Test C)||12
13646|NCT02064231|30136|P1|STARTED|First Test Period (Test A or Test C)||15
13647|NCT02064205|30148|P1|NOT COMPLETED|Overall Study||1
13648|NCT02064205|30148|P1|COMPLETED|Overall Study||31
13649|NCT02064205|30148|P1|Condition D|Overall Study||32
13650|NCT02064205|30148|P1|Condition C|Overall Study||31
13651|NCT02064205|30148|P1|Condition B|Overall Study||32
13652|NCT02064205|30148|P1|Condition A|Overall Study||32
13653|NCT02064205|30148|P1|STARTED|Overall Study||32
13654|NCT02063737|30166|P2|NOT COMPLETED|Overall Study||4
13655|NCT02063737|30167|P1|NOT COMPLETED|Overall Study||11
13656|NCT02063737|30166|P2|COMPLETED|Overall Study||44
13657|NCT02063737|30167|P1|COMPLETED|Overall Study||41
13658|NCT02063737|30166|P2|STARTED|Overall Study||48
13659|NCT02063737|30167|P1|STARTED|Overall Study||52
13660|NCT02063516|30201|P2|NOT COMPLETED|Overall Study||0
13661|NCT02063516|30202|P1|NOT COMPLETED|Overall Study||0
13662|NCT02063516|30201|P2|COMPLETED|Overall Study||40
13663|NCT02063516|30202|P1|COMPLETED|Overall Study||40
13664|NCT02063516|30201|P2|STARTED|Overall Study||40
13665|NCT02063516|30202|P1|STARTED|Overall Study||40
13666|NCT02063230|30216|P4|NOT COMPLETED|Overall Study||0
13667|NCT02063230|30217|P3|NOT COMPLETED|Overall Study||0
13668|NCT02063230|30218|P2|NOT COMPLETED|Overall Study||0
13669|NCT02063230|30219|P1|NOT COMPLETED|Overall Study||0
13670|NCT02063230|30216|P4|COMPLETED|Overall Study||8
13671|NCT02063230|30217|P3|COMPLETED|Overall Study||8
13672|NCT02063230|30218|P2|COMPLETED|Overall Study||8
13673|NCT02063230|30219|P1|COMPLETED|Overall Study||8
13674|NCT02063230|30216|P4|Received Treatment|Overall Study||8
13675|NCT02063230|30217|P3|Received Treatment|Overall Study||8
13676|NCT02063230|30218|P2|Received Treatment|Overall Study||8
13677|NCT02063230|30219|P1|Received Treatment|Overall Study||8
13678|NCT02063230|30216|P4|STARTED|Overall Study||8
13679|NCT02063230|30217|P3|STARTED|Overall Study||8
13680|NCT02063230|30218|P2|STARTED|Overall Study||8
13681|NCT02063230|30219|P1|STARTED|Overall Study||8
13682|NCT02062905|30251|P2|NOT COMPLETED|Overall Study||2
13683|NCT02062905|30252|P1|NOT COMPLETED|Overall Study||7
13684|NCT02062905|30251|P2|COMPLETED|Overall Study||31
13685|NCT02062905|30252|P1|COMPLETED|Overall Study||28
13686|NCT02062905|30251|P2|STARTED|Overall Study||33
13687|NCT02062905|30252|P1|STARTED|Overall Study||35
13688|NCT02062801|30262|P2|NOT COMPLETED|Overall Study||4
13689|NCT02062801|30263|P1|NOT COMPLETED|Overall Study||2
13690|NCT02062801|30262|P2|COMPLETED|Overall Study||297
13691|NCT02062801|30263|P1|COMPLETED|Overall Study||299
13692|NCT02062801|30262|P2|STARTED|Overall Study||301
13693|NCT02062801|30263|P1|STARTED|Overall Study||301
13694|NCT02062710|30273|P6|NOT COMPLETED|Overall Study||0
13695|NCT02062710|30274|P5|NOT COMPLETED|Overall Study||0
13696|NCT02062710|30275|P4|NOT COMPLETED|Overall Study||0
13697|NCT02062710|30276|P3|NOT COMPLETED|Overall Study||0
13698|NCT02062710|30277|P2|NOT COMPLETED|Overall Study||0
13699|NCT02062710|30278|P1|NOT COMPLETED|Overall Study||0
13700|NCT02062710|30273|P6|COMPLETED|Overall Study||4
13701|NCT02062710|30274|P5|COMPLETED|Overall Study||3
13702|NCT02062710|30275|P4|COMPLETED|Overall Study||3
13703|NCT02062710|30276|P3|COMPLETED|Overall Study||5
13704|NCT02062710|30277|P2|COMPLETED|Overall Study||4
13705|NCT02062710|30278|P1|COMPLETED|Overall Study||3
13706|NCT02062710|30273|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
13707|NCT02062710|30274|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
13708|NCT02062710|30275|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
13709|NCT02062710|30276|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
13710|NCT02062710|30277|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
13711|NCT02062710|30278|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
13712|NCT02062658|30286|P1|NOT COMPLETED|Overall Study||2
13713|NCT02062658|30286|P1|COMPLETED|Overall Study||8
13714|NCT02062658|30286|P1|STARTED|Overall Study||10
13715|NCT02062502|30292|P2|NOT COMPLETED|Overall Study||35
13716|NCT02062502|30293|P1|NOT COMPLETED|Overall Study||43
13717|NCT02062502|30292|P2|COMPLETED|Overall Study||270
13718|NCT02062502|30293|P1|COMPLETED|Overall Study||263
13719|NCT02062502|30292|P2|Vaccinated Dose 1|Overall Study||305
13720|NCT02062502|30293|P1|Vaccinated Dose 1|Overall Study||306
13721|NCT02062502|30292|P2|STARTED|Overall Study||305
13722|NCT02062502|30293|P1|STARTED|Overall Study||306
13723|NCT02062450|30313|P1|NOT COMPLETED|Overall Study||124
13724|NCT02062450|30313|P1|COMPLETED|Overall Study||255
13725|NCT02062450|30313|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
13726|NCT02062450|30313|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
13727|NCT02062437|30327|P1|NOT COMPLETED|Overall Study||52
13728|NCT02062437|30327|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
13729|NCT02062437|30327|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
13730|NCT02062385|30340|P4|NOT COMPLETED|Overall Study||9
13731|NCT02062385|30341|P3|NOT COMPLETED|Overall Study||12
13732|NCT02062385|30342|P2|NOT COMPLETED|Overall Study||65
13733|NCT02062385|30343|P1|NOT COMPLETED|Overall Study||78
13734|NCT02062385|30340|P4|COMPLETED|Overall Study||391
13735|NCT02062385|30341|P3|COMPLETED|Overall Study||388
13736|NCT02062385|30342|P2|COMPLETED|Overall Study||1555
13737|NCT02062385|30343|P1|COMPLETED|Overall Study||1542
13738|NCT02062385|30340|P4|Received Vaccination 3|Overall Study||392
13739|NCT02062385|30341|P3|Received Vaccination 3|Overall Study||389
13740|NCT02062385|30342|P2|Received Vaccination 3|Overall Study||1554
13741|NCT02062385|30343|P1|Received Vaccination 3|Overall Study||1543
13742|NCT02062385|30340|P4|Received Vaccination 2|Overall Study||393
13743|NCT02062385|30341|P3|Received Vaccination 2|Overall Study||392
13744|NCT02062385|30342|P2|Received Vaccination 2|Overall Study||1566
13745|NCT02062385|30343|P1|Received Vaccination 2|Overall Study||1554
13746|NCT02062385|30340|P4|Received Vaccination 1|Overall Study||400
13747|NCT02062385|30341|P3|Received Vaccination 1|Overall Study||400
13748|NCT02062385|30342|P2|Received Vaccination 1|Overall Study||1619
13749|NCT02062385|30343|P1|Received Vaccination 1|Overall Study||1618
13750|NCT02062385|30340|P4|STARTED|Overall Study||400
13751|NCT02062385|30341|P3|STARTED|Overall Study||400
13752|NCT02062385|30342|P2|STARTED|Overall Study||1620
13753|NCT02062385|30343|P1|STARTED|Overall Study||1620
13754|NCT02062359|30363|P1|NOT COMPLETED|Overall Study||0
13755|NCT02062359|30363|P1|COMPLETED|Overall Study||2
13756|NCT02062359|30363|P1|STARTED|Overall Study||2
13757|NCT02062294|30369|P1|NOT COMPLETED|Overall Study||0
13758|NCT02062294|30369|P1|COMPLETED|Overall Study||14
13759|NCT02062294|30369|P1|STARTED|Overall Study||14
13760|NCT02062177|30376|P2|NOT COMPLETED|Overall Study||0
13761|NCT02062177|30377|P1|NOT COMPLETED|Overall Study||0
13762|NCT02062177|30376|P2|COMPLETED|Overall Study||70
13763|NCT02062177|30377|P1|COMPLETED|Overall Study||70
13764|NCT02062177|30376|P2|STARTED|Overall Study||70
13765|NCT02062177|30377|P1|STARTED|Overall Study||70
13766|NCT02061683|30387|P1|NOT COMPLETED|Overall Study||60
13767|NCT02061683|30387|P1|COMPLETED|Overall Study||203
13768|NCT02061683|30387|P1|STARTED|Overall Study||263
13769|NCT02061592|30394|P2|NOT COMPLETED|Period 2||1
13770|NCT02061592|30395|P1|NOT COMPLETED|Period 2||0
13771|NCT02061592|30394|P2|COMPLETED|Period 2||61
13772|NCT02061592|30395|P1|COMPLETED|Period 2||64
13773|NCT02061592|30394|P2|STARTED|Period 2||62
13774|NCT02061592|30395|P1|STARTED|Period 2||64
13775|NCT02061592|30394|P2|NOT COMPLETED|Period 1||0
13776|NCT02061592|30395|P1|NOT COMPLETED|Period 1||2
13777|NCT02061592|30394|P2|COMPLETED|Period 1||62
13778|NCT02061592|30395|P1|COMPLETED|Period 1||64
13779|NCT02061592|30394|P2|STARTED|Period 1||62
13780|NCT02061592|30395|P1|STARTED|Period 1||66
13781|NCT02061358|30416|P9|NOT COMPLETED|Overall Study||0
13782|NCT02061358|30417|P8|NOT COMPLETED|Overall Study||0
13783|NCT02061358|30418|P7|NOT COMPLETED|Overall Study||0
13784|NCT02061358|30419|P6|NOT COMPLETED|Overall Study||0
13785|NCT02061358|30420|P5|NOT COMPLETED|Overall Study||0
13786|NCT02061358|30421|P4|NOT COMPLETED|Overall Study||0
13787|NCT02061358|30422|P3|NOT COMPLETED|Overall Study||0
13788|NCT02061358|30423|P2|NOT COMPLETED|Overall Study||0
13789|NCT02061358|30424|P1|NOT COMPLETED|Overall Study||0
13790|NCT02061358|30416|P9|COMPLETED|Overall Study||16
13791|NCT02061358|30417|P8|COMPLETED|Overall Study||6
13792|NCT02061358|30418|P7|COMPLETED|Overall Study||6
13793|NCT02061358|30419|P6|COMPLETED|Overall Study||6
13794|NCT02061358|30420|P5|COMPLETED|Overall Study||6
13795|NCT02061358|30421|P4|COMPLETED|Overall Study||6
13796|NCT02061358|30422|P3|COMPLETED|Overall Study||6
13797|NCT02061358|30423|P2|COMPLETED|Overall Study||6
13798|NCT02061358|30424|P1|COMPLETED|Overall Study||6
13799|NCT02061358|30416|P9|STARTED|Overall Study||16
13800|NCT02061358|30417|P8|STARTED|Overall Study||6
13801|NCT02061358|30418|P7|STARTED|Overall Study||6
13802|NCT02061358|30419|P6|STARTED|Overall Study||6
13803|NCT02061358|30420|P5|STARTED|Overall Study||6
13804|NCT02061358|30421|P4|STARTED|Overall Study||6
13805|NCT02061358|30422|P3|STARTED|Overall Study||6
13806|NCT02061358|30423|P2|STARTED|Overall Study||6
13807|NCT02061358|30424|P1|STARTED|Overall Study||6
13808|NCT02060539|30560|P1|NOT COMPLETED|Overall Study||0
13809|NCT02060539|30560|P1|COMPLETED|Overall Study||19
13810|NCT02060539|30560|P1|STARTED|Overall Study||19
13811|NCT02059993|30607|P2|NOT COMPLETED|Overall Study||4
13812|NCT02059993|30608|P1|NOT COMPLETED|Overall Study||2
13813|NCT02059993|30607|P2|COMPLETED|Overall Study||37
13814|NCT02059993|30608|P1|COMPLETED|Overall Study||40
13815|NCT02059993|30607|P2|STARTED|Overall Study||41
13816|NCT02059993|30608|P1|STARTED|Overall Study||42
13817|NCT02059070|30616|P2|NOT COMPLETED|Overall Study||4
13818|NCT02059070|30617|P1|NOT COMPLETED|Overall Study||5
13819|NCT02059070|30616|P2|COMPLETED|Overall Study||16
13820|NCT02059070|30617|P1|COMPLETED|Overall Study||14
13821|NCT02059070|30616|P2|STARTED|Overall Study||20
13822|NCT02059070|30617|P1|STARTED|Overall Study||19
13823|NCT02058992|30629|P1|NOT COMPLETED|Overall Study||116
13824|NCT02058992|30629|P1|COMPLETED|Overall Study||3223
13825|NCT02058992|30629|P1|STARTED|Overall Study||3339
13826|NCT02058537|30638|P1|NOT COMPLETED|Overall Study||1
13827|NCT02058537|30638|P1|COMPLETED|Overall Study||2
13828|NCT02058537|30638|P1|STARTED|Overall Study||3
13829|NCT02058498|30644|P1|NOT COMPLETED|Overall Study||4
13830|NCT02058498|30644|P1|COMPLETED|Overall Study||8
13831|NCT02058498|30644|P1|6 Weeks|Overall Study||8
13832|NCT02058498|30644|P1|STARTED|Overall Study||12
13833|NCT02058290|30652|P2|NOT COMPLETED|Overall Study||9
13834|NCT02058290|30653|P1|NOT COMPLETED|Overall Study||11
13835|NCT02058290|30652|P2|COMPLETED|Overall Study||36
13836|NCT02058290|30653|P1|COMPLETED|Overall Study||66
13837|NCT02058290|30652|P2|STARTED|Overall Study||45
13838|NCT02058290|30653|P1|STARTED|Overall Study||77
13839|NCT02058160|30669|P2|NOT COMPLETED|Overall Study||14
13840|NCT02058160|30670|P1|NOT COMPLETED|Overall Study||31
13841|NCT02058160|30669|P2|COMPLETED|Overall Study||355
13842|NCT02058160|30670|P1|COMPLETED|Overall Study||336
13843|NCT02058160|30669|P2|Treated|Overall Study||365
13844|NCT02058160|30670|P1|Treated|Overall Study||365
13845|NCT02058160|30669|P2|STARTED|Overall Study||369
13846|NCT02058160|30670|P1|STARTED|Overall Study||367
13847|NCT02058147|30707|P3|NOT COMPLETED|Overall Study||29
13848|NCT02058147|30708|P2|NOT COMPLETED|Overall Study||27
13849|NCT02058147|30709|P1|NOT COMPLETED|Overall Study||29
13850|NCT02058147|30707|P3|COMPLETED|Overall Study||205
13851|NCT02058147|30708|P2|COMPLETED|Overall Study||440
13852|NCT02058147|30709|P1|COMPLETED|Overall Study||440
13853|NCT02058147|30707|P3|Treated|Overall Study||233
13854|NCT02058147|30708|P2|Treated|Overall Study||467
13855|NCT02058147|30709|P1|Treated|Overall Study||469
13856|NCT02058147|30707|P3|STARTED|Overall Study||234
13857|NCT02058147|30708|P2|STARTED|Overall Study||467
13858|NCT02058147|30709|P1|STARTED|Overall Study||469
13859|NCT02058069|30758|P1|NOT COMPLETED|Overall Study||11
13860|NCT02058069|30758|P1|COMPLETED|Overall Study||89
13861|NCT02058069|30758|P1|STARTED|Overall Study||100
13862|NCT02057835|30776|P10|NOT COMPLETED|Overall Study||0
13863|NCT02057835|30777|P9|NOT COMPLETED|Overall Study||0
13864|NCT02057835|30778|P8|NOT COMPLETED|Overall Study||0
13865|NCT02057835|30779|P7|NOT COMPLETED|Overall Study||0
13866|NCT02057835|30780|P6|NOT COMPLETED|Overall Study||0
13867|NCT02057835|30781|P5|NOT COMPLETED|Overall Study||0
13868|NCT02057835|30782|P4|NOT COMPLETED|Overall Study||0
13869|NCT02057835|30783|P3|NOT COMPLETED|Overall Study||0
13870|NCT02057835|30784|P2|NOT COMPLETED|Overall Study||2
13871|NCT02057835|30785|P1|NOT COMPLETED|Overall Study||0
13872|NCT02057835|30776|P10|COMPLETED|Overall Study||6
13873|NCT02057835|30777|P9|COMPLETED|Overall Study||6
13874|NCT02057835|30778|P8|COMPLETED|Overall Study||6
13875|NCT02057835|30779|P7|COMPLETED|Overall Study||6
13876|NCT02057835|30780|P6|COMPLETED|Overall Study||8
13877|NCT02057835|30781|P5|COMPLETED|Overall Study||6
13878|NCT02057835|30782|P4|COMPLETED|Overall Study||6
13879|NCT02057835|30783|P3|COMPLETED|Overall Study||6
13880|NCT02057835|30784|P2|COMPLETED|Overall Study||4
13881|NCT02057835|30785|P1|COMPLETED|Overall Study||8
13882|NCT02057835|30776|P10|STARTED|Overall Study||6
13883|NCT02057835|30777|P9|STARTED|Overall Study||6
13884|NCT02057835|30778|P8|STARTED|Overall Study||6
13885|NCT02057835|30779|P7|STARTED|Overall Study||6
13886|NCT02057835|30780|P6|STARTED|Overall Study||8
13887|NCT02057835|30781|P5|STARTED|Overall Study||6
13888|NCT02057835|30782|P4|STARTED|Overall Study||6
13889|NCT02057835|30783|P3|STARTED|Overall Study||6
13890|NCT02057835|30784|P2|STARTED|Overall Study||6
13891|NCT02057835|30785|P1|STARTED|Overall Study||8
13892|NCT02057276|30864|P2|NOT COMPLETED|Overall Study||0
13893|NCT02057276|30865|P1|NOT COMPLETED|Overall Study||0
13894|NCT02057276|30864|P2|COMPLETED|Overall Study||0
13895|NCT02057276|30865|P1|COMPLETED|Overall Study||0
13896|NCT02057276|30864|P2|STARTED|Overall Study||0
13897|NCT02057276|30865|P1|STARTED|Overall Study||0
13898|NCT02057237|30875|P1|NOT COMPLETED|Overall Study||0
13899|NCT02057237|30875|P1|COMPLETED|Overall Study||1
13900|NCT02057237|30875|P1|STARTED|Overall Study||1
13901|NCT02056834|30880|P1|NOT COMPLETED|Overall Study||7
13902|NCT02056834|30880|P1|COMPLETED|Overall Study||29
13903|NCT02056834|30880|P1|6 Months|Overall Study||31
13904|NCT02056834|30880|P1|6 Weeks|Overall Study||34
13905|NCT02056834|30880|P1|STARTED|Overall Study||36
13906|NCT02056392|30905|P6|NOT COMPLETED|Overall Study||0
13907|NCT02056392|30906|P5|NOT COMPLETED|Overall Study||1
13908|NCT02056392|30907|P4|NOT COMPLETED|Overall Study||0
13909|NCT02056392|30908|P3|NOT COMPLETED|Overall Study||3
13910|NCT02056392|30909|P2|NOT COMPLETED|Overall Study||1
13911|NCT02056392|30910|P1|NOT COMPLETED|Overall Study||2
13912|NCT02056392|30905|P6|COMPLETED|Overall Study||9
13913|NCT02056392|30906|P5|COMPLETED|Overall Study||7
13914|NCT02056392|30907|P4|COMPLETED|Overall Study||9
13915|NCT02056392|30908|P3|COMPLETED|Overall Study||6
13916|NCT02056392|30909|P2|COMPLETED|Overall Study||8
13917|NCT02056392|30910|P1|COMPLETED|Overall Study||8
13918|NCT02056392|30905|P6|STARTED|Overall Study||9
13919|NCT02056392|30906|P5|STARTED|Overall Study||8
13920|NCT02056392|30907|P4|STARTED|Overall Study||9
13921|NCT02056392|30908|P3|STARTED|Overall Study||9
13922|NCT02056392|30909|P2|STARTED|Overall Study||9
13923|NCT02056392|30910|P1|STARTED|Overall Study||10
13924|NCT02055430|30947|P2|NOT COMPLETED|Overall Study||0
13925|NCT02055430|30948|P1|NOT COMPLETED|Overall Study||0
13926|NCT02055430|30947|P2|COMPLETED|Overall Study||45
13927|NCT02055430|30948|P1|COMPLETED|Overall Study||45
13928|NCT02055430|30947|P2|STARTED|Overall Study||45
13929|NCT02055430|30948|P1|STARTED|Overall Study||45
13930|NCT02055404|30954|P1|NOT COMPLETED|Overall Study||0
13931|NCT02055404|30954|P1|COMPLETED|Overall Study||3
13932|NCT02055404|30954|P1|STARTED|Overall Study||3
13933|NCT02054754|30969|P6|NOT COMPLETED|Overall Study||0
13934|NCT02054754|30970|P5|NOT COMPLETED|Overall Study||0
13935|NCT02054754|30971|P4|NOT COMPLETED|Overall Study||0
13936|NCT02054754|30972|P3|NOT COMPLETED|Overall Study||0
13937|NCT02054754|30973|P2|NOT COMPLETED|Overall Study||0
13938|NCT02054754|30974|P1|NOT COMPLETED|Overall Study||0
13939|NCT02054754|30969|P6|COMPLETED|Overall Study||10
13940|NCT02054754|30970|P5|COMPLETED|Overall Study||6
13941|NCT02054754|30971|P4|COMPLETED|Overall Study||6
13942|NCT02054754|30972|P3|COMPLETED|Overall Study||6
13943|NCT02054754|30973|P2|COMPLETED|Overall Study||6
13944|NCT02054754|30974|P1|COMPLETED|Overall Study||6
13945|NCT02054754|30969|P6|STARTED|Overall Study||10
13946|NCT02054754|30970|P5|STARTED|Overall Study||6
13947|NCT02054754|30971|P4|STARTED|Overall Study||6
13948|NCT02054754|30972|P3|STARTED|Overall Study||6
13949|NCT02054754|30973|P2|STARTED|Overall Study||6
13950|NCT02054754|30974|P1|STARTED|Overall Study||6
13951|NCT02054702|30991|P2|NOT COMPLETED|Overall Study||12
13952|NCT02054702|30992|P1|NOT COMPLETED|Overall Study||24
13953|NCT02054702|30991|P2|COMPLETED|Overall Study||21
13954|NCT02054702|30992|P1|COMPLETED|Overall Study||40
13955|NCT02054702|30991|P2|STARTED|Overall Study||33
13956|NCT02054702|30992|P1|STARTED|Overall Study||64
13957|NCT02054481|31024|P4|NOT COMPLETED|Overall Study||1
13958|NCT02054481|31025|P3|NOT COMPLETED|Overall Study||2
13959|NCT02054481|31026|P2|NOT COMPLETED|Overall Study||2
13960|NCT02054481|31027|P1|NOT COMPLETED|Overall Study||4
13961|NCT02054481|31024|P4|COMPLETED|Overall Study||39
13962|NCT02054481|31025|P3|COMPLETED|Overall Study||40
13963|NCT02054481|31026|P2|COMPLETED|Overall Study||39
13964|NCT02054481|31027|P1|COMPLETED|Overall Study||39
13965|NCT02054481|31024|P4|STARTED|Overall Study||40
13966|NCT02054481|31025|P3|STARTED|Overall Study||42
13967|NCT02054481|31026|P2|STARTED|Overall Study||41
13968|NCT02054481|31027|P1|STARTED|Overall Study||43
13969|NCT02054325|31075|P2|NOT COMPLETED|Overall Study||5
13970|NCT02054325|31076|P1|NOT COMPLETED|Overall Study||8
13971|NCT02054325|31075|P2|COMPLETED|Overall Study||50
13972|NCT02054325|31076|P1|COMPLETED|Overall Study||43
13973|NCT02054325|31075|P2|STARTED|Overall Study||55
13974|NCT02054325|31076|P1|STARTED|Overall Study||51
13975|NCT02053610|31086|P2|NOT COMPLETED|Overall Study||174
13976|NCT02053610|31087|P1|NOT COMPLETED|Overall Study||235
13977|NCT02053610|31086|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
13978|NCT02053610|31087|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
13979|NCT02053610|31086|P2|Received Study Drug|Overall Study||331
13980|NCT02053610|31087|P1|Received Study Drug|Overall Study||326
13981|NCT02053610|31086|P2|STARTED|Overall Study||333
13982|NCT02053610|31087|P1|STARTED|Overall Study||330
13983|NCT02053493|31119|P2|NOT COMPLETED|Overall Study||1
13984|NCT02053493|31120|P1|NOT COMPLETED|Overall Study||1
13985|NCT02053493|31119|P2|COMPLETED|Overall Study||58
13986|NCT02053493|31120|P1|COMPLETED|Overall Study||50
13987|NCT02053493|31119|P2|STARTED|Overall Study||59
13988|NCT02053493|31120|P1|STARTED|Overall Study||51
13989|NCT02052895|31161|P3|NOT COMPLETED|Overall Study||0
13990|NCT02052895|31162|P2|NOT COMPLETED|Overall Study||0
13991|NCT02052895|31163|P1|NOT COMPLETED|Overall Study||0
13992|NCT02052895|31161|P3|COMPLETED|Overall Study||15
13993|NCT02052895|31162|P2|COMPLETED|Overall Study||15
13994|NCT02052895|31163|P1|COMPLETED|Overall Study||196
13995|NCT02052895|31161|P3|STARTED|Overall Study||15
13996|NCT02052895|31162|P2|STARTED|Overall Study||15
13997|NCT02052895|31163|P1|STARTED|Overall Study||196
13998|NCT02052752|31173|P3|NOT COMPLETED|Overall Study||0
13999|NCT02052752|31174|P2|NOT COMPLETED|Overall Study||0
14000|NCT02052752|31175|P1|NOT COMPLETED|Overall Study||0
14001|NCT02052752|31173|P3|COMPLETED|Overall Study||30
14002|NCT02052752|31174|P2|COMPLETED|Overall Study||30
14003|NCT02052752|31175|P1|COMPLETED|Overall Study||30
14004|NCT02052752|31173|P3|STARTED|Overall Study||30
14005|NCT02052752|31174|P2|STARTED|Overall Study||30
14006|NCT02052752|31175|P1|STARTED|Overall Study||30
14007|NCT02052661|31198|P1|NOT COMPLETED|Overall Study||0
14008|NCT02052661|31198|P1|COMPLETED|Overall Study||300
14009|NCT02052661|31198|P1|STARTED|Overall Study||300
14010|NCT02052635|31212|P2|NOT COMPLETED|Overall Study||0
14011|NCT02052635|31213|P1|NOT COMPLETED|Overall Study||0
14012|NCT02052635|31212|P2|COMPLETED|Overall Study||6
14013|NCT02052635|31213|P1|COMPLETED|Overall Study||7
14014|NCT02052635|31212|P2|STARTED|Overall Study||6
14015|NCT02052635|31213|P1|STARTED|Overall Study||7
14016|NCT02052544|31221|P1|NOT COMPLETED|Overall Study||0
14017|NCT02052544|31221|P1|COMPLETED|Overall Study|Last Subject Out|123
14018|NCT02052544|31221|P1|STARTED|Overall Study|First Subject In|123
14019|NCT02052414|31226|P1|NOT COMPLETED|Overall Study||17
14020|NCT02052414|31226|P1|COMPLETED|Overall Study||17
14021|NCT02052414|31226|P1|STARTED|Overall Study||34
14022|NCT02051790|31234|P1|NOT COMPLETED|Overall Study||0
14023|NCT02051790|31234|P1|COMPLETED|Overall Study||241
14024|NCT02051790|31234|P1|STARTED|Overall Study||241
14025|NCT02051595|31238|P1|NOT COMPLETED|Overall Study||0
14026|NCT02051595|31238|P1|COMPLETED|Overall Study||25
14027|NCT02051595|31238|P1|STARTED|Overall Study||25
14028|NCT02051426|31244|P2|NOT COMPLETED|Second Intervention||0
14029|NCT02051426|31245|P1|NOT COMPLETED|Second Intervention||0
14030|NCT02051426|31244|P2|COMPLETED|Second Intervention||19
14031|NCT02051426|31245|P1|COMPLETED|Second Intervention||16
14032|NCT02051426|31244|P2|STARTED|Second Intervention||19
14033|NCT02051426|31245|P1|STARTED|Second Intervention||16
14034|NCT02051426|31244|P2|NOT COMPLETED|Washout Period of 1 Month||0
14035|NCT02051426|31245|P1|NOT COMPLETED|Washout Period of 1 Month||0
14036|NCT02051426|31244|P2|COMPLETED|Washout Period of 1 Month||19
14037|NCT02051426|31245|P1|COMPLETED|Washout Period of 1 Month||16
14038|NCT02051426|31244|P2|STARTED|Washout Period of 1 Month||19
14039|NCT02051426|31245|P1|STARTED|Washout Period of 1 Month||16
14040|NCT02051426|31244|P2|NOT COMPLETED|First Intervention||0
14041|NCT02051426|31245|P1|NOT COMPLETED|First Intervention||0
14042|NCT02051426|31244|P2|COMPLETED|First Intervention||19
14043|NCT02051426|31245|P1|COMPLETED|First Intervention||16
14044|NCT02051426|31244|P2|STARTED|First Intervention||19
14045|NCT02051426|31245|P1|STARTED|First Intervention||16
14046|NCT02051335|31259|P4|NOT COMPLETED|Period 4||0
14047|NCT02051335|31260|P3|NOT COMPLETED|Period 4||0
14048|NCT02051335|31261|P2|NOT COMPLETED|Period 4||0
14049|NCT02051335|31262|P1|NOT COMPLETED|Period 4||0
14050|NCT02051335|31259|P4|COMPLETED|Period 4||4
14051|NCT02051335|31260|P3|COMPLETED|Period 4||5
14052|NCT02051335|31261|P2|COMPLETED|Period 4||7
14053|NCT02051335|31262|P1|COMPLETED|Period 4||7
14054|NCT02051335|31259|P4|STARTED|Period 4||4
14055|NCT02051335|31260|P3|STARTED|Period 4||5
14056|NCT02051335|31261|P2|STARTED|Period 4||7
14057|NCT02051335|31262|P1|STARTED|Period 4||7
14058|NCT02051335|31259|P4|NOT COMPLETED|Period 3||0
14059|NCT02051335|31260|P3|NOT COMPLETED|Period 3||0
14060|NCT02051335|31261|P2|NOT COMPLETED|Period 3||0
14061|NCT02051335|31262|P1|NOT COMPLETED|Period 3||0
14062|NCT02051335|31259|P4|COMPLETED|Period 3||4
14063|NCT02051335|31260|P3|COMPLETED|Period 3||5
14064|NCT02051335|31261|P2|COMPLETED|Period 3||7
14065|NCT02051335|31262|P1|COMPLETED|Period 3||7
14066|NCT02051335|31259|P4|STARTED|Period 3||4
14067|NCT02051335|31260|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
14068|NCT02051335|31261|P2|STARTED|Period 3||7
14069|NCT02051335|31262|P1|STARTED|Period 3||7
14070|NCT02051335|31259|P4|NOT COMPLETED|Period 2||0
14071|NCT02051335|31260|P3|NOT COMPLETED|Period 2||0
14072|NCT02051335|31261|P2|NOT COMPLETED|Period 2||0
14073|NCT02051335|31262|P1|NOT COMPLETED|Period 2||0
14074|NCT02051335|31259|P4|COMPLETED|Period 2||4
14075|NCT02051335|31260|P3|COMPLETED|Period 2||7
14076|NCT02051335|31261|P2|COMPLETED|Period 2||7
14077|NCT02051335|31262|P1|COMPLETED|Period 2||7
14078|NCT02051335|31259|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
14079|NCT02051335|31260|P3|STARTED|Period 2||7
14080|NCT02051335|31261|P2|STARTED|Period 2||7
14081|NCT02051335|31262|P1|STARTED|Period 2||7
14082|NCT02051335|31259|P4|NOT COMPLETED|Period 1||0
14083|NCT02051335|31260|P3|NOT COMPLETED|Period 1||0
14084|NCT02051335|31261|P2|NOT COMPLETED|Period 1||0
14085|NCT02051335|31262|P1|NOT COMPLETED|Period 1||0
14086|NCT02051335|31259|P4|COMPLETED|Period 1||6
14087|NCT02051335|31260|P3|COMPLETED|Period 1||7
14088|NCT02051335|31261|P2|COMPLETED|Period 1||7
14089|NCT02051335|31262|P1|COMPLETED|Period 1||7
14090|NCT02051335|31259|P4|STARTED|Period 1||6
14091|NCT02051335|31260|P3|STARTED|Period 1||7
14092|NCT02051335|31261|P2|STARTED|Period 1||7
14093|NCT02051335|31262|P1|STARTED|Period 1||7
14094|NCT02050334|31314|P2|NOT COMPLETED|Overall Study||0
14095|NCT02050334|31315|P1|NOT COMPLETED|Overall Study||0
14096|NCT02050334|31314|P2|COMPLETED|Overall Study||9
14097|NCT02050334|31315|P1|COMPLETED|Overall Study||9
14098|NCT02050334|31314|P2|STARTED|Overall Study||9
14099|NCT02050334|31315|P1|STARTED|Overall Study||9
14100|NCT02050048|31325|P2|NOT COMPLETED|Overall Study||2
14101|NCT02050048|31326|P1|NOT COMPLETED|Overall Study||5
14102|NCT02050048|31325|P2|COMPLETED|Overall Study||10
14103|NCT02050048|31326|P1|COMPLETED|Overall Study||9
14104|NCT02050048|31325|P2|STARTED|Overall Study||12
14105|NCT02050048|31326|P1|STARTED|Overall Study||14
14106|NCT02049931|31335|P3|NOT COMPLETED|Overall Study||3
14107|NCT02049931|31336|P2|NOT COMPLETED|Overall Study||5
14108|NCT02049931|31337|P1|NOT COMPLETED|Overall Study||3
14109|NCT02049931|31335|P3|COMPLETED|Overall Study||17
14110|NCT02049931|31336|P2|COMPLETED|Overall Study||15
14111|NCT02049931|31337|P1|COMPLETED|Overall Study||17
14112|NCT02049931|31335|P3|STARTED|Overall Study||20
14113|NCT02049931|31336|P2|STARTED|Overall Study||20
14114|NCT02049931|31337|P1|STARTED|Overall Study||20
14115|NCT02048891|31347|P2|NOT COMPLETED|Overall Study||0
14116|NCT02048891|31348|P1|NOT COMPLETED|Overall Study||0
14117|NCT02048891|31347|P2|COMPLETED|Overall Study||1
14118|NCT02048891|31348|P1|COMPLETED|Overall Study||2
14119|NCT02048891|31347|P2|STARTED|Overall Study||1
14120|NCT02048891|31348|P1|STARTED|Overall Study||2
14121|NCT02048072|31354|P1|NOT COMPLETED|Overall Study||4
14122|NCT02048072|31354|P1|COMPLETED|Overall Study||29
14123|NCT02048072|31354|P1|STARTED|Overall Study||33
14124|NCT02047747|31358|P1|NOT COMPLETED|Overall Study||3
14125|NCT02047747|31358|P1|COMPLETED|Overall Study||1
14126|NCT02047747|31358|P1|STARTED|Overall Study||4
14127|NCT02047227|31365|P2|NOT COMPLETED|Overall Study||130
14128|NCT02047227|31366|P1|NOT COMPLETED|Overall Study||144
14129|NCT02047227|31365|P2|COMPLETED|Overall Study||347
14130|NCT02047227|31366|P1|COMPLETED|Overall Study||318
14131|NCT02047227|31365|P2|Completed Ovarian Stimulation Phase|Overall Study||440
14132|NCT02047227|31366|P1|Completed Ovarian Stimulation Phase|Overall Study||424
14133|NCT02047227|31365|P2|STARTED|Overall Study||477
14134|NCT02047227|31366|P1|STARTED|Overall Study||462
14135|NCT02046993|31384|P2|NOT COMPLETED|Overall Study||11
14136|NCT02046993|31385|P1|NOT COMPLETED|Overall Study||3
14137|NCT02046993|31384|P2|COMPLETED|Overall Study||94
14138|NCT02046993|31385|P1|COMPLETED|Overall Study||102
14139|NCT02046993|31384|P2|6th Month|Overall Study||94
14140|NCT02046993|31385|P1|6th Month|Overall Study||102
14141|NCT02046993|31384|P2|3rd Month|Overall Study||97
14142|NCT02046993|31385|P1|3rd Month|Overall Study||104
14143|NCT02046993|31384|P2|STARTED|Overall Study||105
14144|NCT02046993|31385|P1|STARTED|Overall Study||105
14145|NCT02046980|31404|P3|NOT COMPLETED|Overall Study||1
14146|NCT02046980|31405|P2|NOT COMPLETED|Overall Study||5
14147|NCT02046980|31406|P1|NOT COMPLETED|Overall Study||2
14148|NCT02046980|31404|P3|COMPLETED|Overall Study||72
14149|NCT02046980|31405|P2|COMPLETED|Overall Study||67
14150|NCT02046980|31406|P1|COMPLETED|Overall Study||70
14151|NCT02046980|31404|P3|STARTED|Overall Study||73
14152|NCT02046980|31405|P2|STARTED|Overall Study||72
14153|NCT02046980|31406|P1|STARTED|Overall Study||72
14154|NCT02046863|31414|P1|NOT COMPLETED|Overall Study||0
14155|NCT02046863|31414|P1|COMPLETED|Overall Study||7
14156|NCT02046863|31414|P1|STARTED|Overall Study||7
14157|NCT02046772|31420|P2|NOT COMPLETED|Overall Study||0
14158|NCT02046772|31421|P1|NOT COMPLETED|Overall Study||0
14159|NCT02046772|31420|P2|COMPLETED|Overall Study||33
14160|NCT02046772|31421|P1|COMPLETED|Overall Study||30
14161|NCT02046772|31420|P2|STARTED|Overall Study||33
14162|NCT02046772|31421|P1|STARTED|Overall Study||30
14163|NCT02046226|31435|P1|NOT COMPLETED|Overall Study||7
14164|NCT02046226|31435|P1|COMPLETED|Overall Study||0
14165|NCT02046226|31435|P1|STARTED|Overall Study||7
14166|NCT02045732|31444|P2|NOT COMPLETED|Overall Study||1
14167|NCT02045732|31445|P1|NOT COMPLETED|Overall Study||1
14168|NCT02045732|31444|P2|COMPLETED|Overall Study||2
14169|NCT02045732|31445|P1|COMPLETED|Overall Study||0
14170|NCT02045732|31444|P2|STARTED|Overall Study||3
14171|NCT02045732|31445|P1|STARTED|Overall Study||1
14172|NCT02045264|31463|P1|NOT COMPLETED|Overall Study||0
14173|NCT02045264|31463|P1|COMPLETED|Overall Study||12
14174|NCT02045264|31463|P1|STARTED|Overall Study||12
14175|NCT02045238|31480|P2|NOT COMPLETED|Overall Study||1
14176|NCT02045238|31481|P1|NOT COMPLETED|Overall Study||7
14177|NCT02045238|31480|P2|COMPLETED|Overall Study||14
14178|NCT02045238|31481|P1|COMPLETED|Overall Study||9
14179|NCT02045238|31480|P2|STARTED|Overall Study||15
14180|NCT02045238|31481|P1|STARTED|Overall Study||16
14181|NCT02044848|31491|P2|NOT COMPLETED|Overall Study||3
14182|NCT02044848|31492|P1|NOT COMPLETED|Overall Study||2
14183|NCT02044848|31491|P2|COMPLETED|Overall Study||0
14184|NCT02044848|31492|P1|COMPLETED|Overall Study||0
14185|NCT02044848|31491|P2|STARTED|Overall Study||3
14186|NCT02044848|31492|P1|STARTED|Overall Study||2
14187|NCT02044458|31500|P2|NOT COMPLETED|Overall Study||8
14188|NCT02044458|31501|P1|NOT COMPLETED|Overall Study||3
14189|NCT02044458|31500|P2|COMPLETED|Overall Study||61
14190|NCT02044458|31501|P1|COMPLETED|Overall Study||62
14191|NCT02044458|31500|P2|STARTED|Overall Study||69
14192|NCT02044458|31501|P1|STARTED|Overall Study||65
14193|NCT02044393|31513|P2|NOT COMPLETED|Period 2||0
14194|NCT02044393|31514|P1|NOT COMPLETED|Period 2||0
14195|NCT02044393|31513|P2|COMPLETED|Period 2||10
14196|NCT02044393|31514|P1|COMPLETED|Period 2||10
14197|NCT02044393|31513|P2|STARTED|Period 2||10
14198|NCT02044393|31514|P1|STARTED|Period 2||10
14199|NCT02044393|31513|P2|NOT COMPLETED|Period 1||0
14200|NCT02044393|31514|P1|NOT COMPLETED|Period 1||0
14201|NCT02044393|31513|P2|COMPLETED|Period 1||10
14202|NCT02044393|31514|P1|COMPLETED|Period 1||10
14203|NCT02044393|31513|P2|STARTED|Period 1||10
14204|NCT02044393|31514|P1|STARTED|Period 1||10
14205|NCT02044367|31527|P6|NOT COMPLETED|Overall Study||0
14206|NCT02044367|31528|P5|NOT COMPLETED|Overall Study||0
14207|NCT02044367|31529|P4|NOT COMPLETED|Overall Study||0
14208|NCT02044367|31530|P3|NOT COMPLETED|Overall Study||0
14209|NCT02044367|31531|P2|NOT COMPLETED|Overall Study||0
14210|NCT02044367|31532|P1|NOT COMPLETED|Overall Study||0
14211|NCT02044367|31527|P6|COMPLETED|Overall Study||9
14212|NCT02044367|31528|P5|COMPLETED|Overall Study||9
14213|NCT02044367|31529|P4|COMPLETED|Overall Study||9
14214|NCT02044367|31530|P3|COMPLETED|Overall Study||9
14215|NCT02044367|31531|P2|COMPLETED|Overall Study||9
14216|NCT02044367|31532|P1|COMPLETED|Overall Study||9
14217|NCT02044367|31527|P6|STARTED|Overall Study||9
14218|NCT02044367|31528|P5|STARTED|Overall Study||9
14219|NCT02044367|31529|P4|STARTED|Overall Study||9
14220|NCT02044367|31530|P3|STARTED|Overall Study||9
14221|NCT02044367|31531|P2|STARTED|Overall Study||9
14222|NCT02044367|31532|P1|STARTED|Overall Study||9
14223|NCT02043808|31555|P2|NOT COMPLETED|Overall Study||0
14224|NCT02043808|31556|P1|NOT COMPLETED|Overall Study||0
14225|NCT02043808|31555|P2|COMPLETED|Overall Study||12793
14226|NCT02043808|31556|P1|COMPLETED|Overall Study||12793
14227|NCT02043808|31555|P2|STARTED|Overall Study||12793
14228|NCT02043808|31556|P1|STARTED|Overall Study||12793
14229|NCT02043782|31594|P6|NOT COMPLETED|Period 3||0
14230|NCT02043782|31595|P5|NOT COMPLETED|Period 3||0
14231|NCT02043782|31596|P4|NOT COMPLETED|Period 3||0
14232|NCT02043782|31597|P3|NOT COMPLETED|Period 3||0
14233|NCT02043782|31598|P2|NOT COMPLETED|Period 3||0
14234|NCT02043782|31599|P1|NOT COMPLETED|Period 3||0
14235|NCT02043782|31594|P6|COMPLETED|Period 3||6
14236|NCT02043782|31595|P5|COMPLETED|Period 3||6
14237|NCT02043782|31596|P4|COMPLETED|Period 3||6
14238|NCT02043782|31597|P3|COMPLETED|Period 3||6
14239|NCT02043782|31598|P2|COMPLETED|Period 3||6
14240|NCT02043782|31599|P1|COMPLETED|Period 3||7
14241|NCT02043782|31594|P6|STARTED|Period 3||6
14242|NCT02043782|31595|P5|STARTED|Period 3||6
14243|NCT02043782|31596|P4|STARTED|Period 3||6
14244|NCT02043782|31597|P3|STARTED|Period 3||6
14245|NCT02043782|31598|P2|STARTED|Period 3||6
14246|NCT02043782|31599|P1|STARTED|Period 3||7
14247|NCT02043782|31594|P6|NOT COMPLETED|Period 2||0
14248|NCT02043782|31595|P5|NOT COMPLETED|Period 2||0
14249|NCT02043782|31596|P4|NOT COMPLETED|Period 2||0
14250|NCT02043782|31597|P3|NOT COMPLETED|Period 2||0
14251|NCT02043782|31598|P2|NOT COMPLETED|Period 2||0
14252|NCT02043782|31599|P1|NOT COMPLETED|Period 2||0
14253|NCT02043782|31594|P6|COMPLETED|Period 2||6
14254|NCT02043782|31595|P5|COMPLETED|Period 2||6
14255|NCT02043782|31596|P4|COMPLETED|Period 2||6
14256|NCT02043782|31597|P3|COMPLETED|Period 2||6
14257|NCT02043782|31598|P2|COMPLETED|Period 2||6
14258|NCT02043782|31599|P1|COMPLETED|Period 2||7
14259|NCT02043782|31594|P6|STARTED|Period 2||6
14260|NCT02043782|31595|P5|STARTED|Period 2||6
14261|NCT02043782|31596|P4|STARTED|Period 2||6
14262|NCT02043782|31597|P3|STARTED|Period 2||6
14263|NCT02043782|31598|P2|STARTED|Period 2||6
14264|NCT02043782|31599|P1|STARTED|Period 2||7
14265|NCT02043782|31594|P6|NOT COMPLETED|Period 1||0
14266|NCT02043782|31595|P5|NOT COMPLETED|Period 1||0
14267|NCT02043782|31596|P4|NOT COMPLETED|Period 1||0
14268|NCT02043782|31597|P3|NOT COMPLETED|Period 1||1
14269|NCT02043782|31598|P2|NOT COMPLETED|Period 1||0
14270|NCT02043782|31599|P1|NOT COMPLETED|Period 1||0
14271|NCT02043782|31594|P6|COMPLETED|Period 1||6
14272|NCT02043782|31595|P5|COMPLETED|Period 1||6
14273|NCT02043782|31596|P4|COMPLETED|Period 1||6
14274|NCT02043782|31597|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
14275|NCT02043782|31598|P2|COMPLETED|Period 1||6
14276|NCT02043782|31599|P1|COMPLETED|Period 1||7
14277|NCT02043782|31594|P6|STARTED|Period 1||6
14278|NCT02043782|31595|P5|STARTED|Period 1||6
14279|NCT02043782|31596|P4|STARTED|Period 1||6
14280|NCT02043782|31597|P3|STARTED|Period 1||7
14281|NCT02043782|31598|P2|STARTED|Period 1||6
14282|NCT02043782|31599|P1|STARTED|Period 1||7
14283|NCT02043366|31613|P6|NOT COMPLETED|Overall Study||2
14284|NCT02043366|31614|P5|NOT COMPLETED|Overall Study||2
14285|NCT02043366|31615|P4|NOT COMPLETED|Overall Study||2
14286|NCT02043366|31616|P3|NOT COMPLETED|Overall Study||2
14287|NCT02043366|31617|P2|NOT COMPLETED|Overall Study||2
14288|NCT02043366|31618|P1|NOT COMPLETED|Overall Study||2
14289|NCT02043366|31613|P6|COMPLETED|Overall Study||28
14290|NCT02043366|31614|P5|COMPLETED|Overall Study||28
14291|NCT02043366|31615|P4|COMPLETED|Overall Study||28
14292|NCT02043366|31616|P3|COMPLETED|Overall Study||28
14293|NCT02043366|31617|P2|COMPLETED|Overall Study||28
14294|NCT02043366|31618|P1|COMPLETED|Overall Study||28
14295|NCT02043366|31613|P6|STARTED|Overall Study||30
14296|NCT02043366|31614|P5|STARTED|Overall Study||30
14297|NCT02043366|31615|P4|STARTED|Overall Study||30
14298|NCT02043366|31616|P3|STARTED|Overall Study||30
14299|NCT02043366|31617|P2|STARTED|Overall Study||30
14300|NCT02043366|31618|P1|STARTED|Overall Study||30
14301|NCT02043145|31641|P3|NOT COMPLETED|Overall Study||0
14302|NCT02043145|31642|P2|NOT COMPLETED|Overall Study||0
14303|NCT02043145|31643|P1|NOT COMPLETED|Overall Study||0
14304|NCT02043145|31641|P3|COMPLETED|Overall Study||425
14305|NCT02043145|31642|P2|COMPLETED|Overall Study||247
14306|NCT02043145|31643|P1|COMPLETED|Overall Study||55
14307|NCT02043145|31641|P3|STARTED|Overall Study||425
14308|NCT02043145|31642|P2|STARTED|Overall Study||247
14309|NCT02043145|31643|P1|STARTED|Overall Study||55
14310|NCT02042911|31654|P1|NOT COMPLETED|Overall Study||1
14311|NCT02042911|31654|P1|COMPLETED|Overall Study||9
14312|NCT02042911|31654|P1|STARTED|Overall Study||10
14313|NCT02042872|31668|P2|NOT COMPLETED|Overall Study||5
14314|NCT02042872|31669|P1|NOT COMPLETED|Overall Study||0
14315|NCT02042872|31668|P2|COMPLETED|Overall Study||8
14316|NCT02042872|31669|P1|COMPLETED|Overall Study||8
14317|NCT02042872|31668|P2|STARTED|Overall Study||13
14318|NCT02042872|31669|P1|STARTED|Overall Study||8
14319|NCT02042534|31679|P2|NOT COMPLETED|Overall Study||0
14320|NCT02042534|31680|P1|NOT COMPLETED|Overall Study||0
14321|NCT02042534|31679|P2|COMPLETED|Overall Study||94
14322|NCT02042534|31680|P1|COMPLETED|Overall Study||101
14323|NCT02042534|31679|P2|STARTED|Overall Study||94
14324|NCT02042534|31680|P1|STARTED|Overall Study||101
14325|NCT02042404|31694|P2|NOT COMPLETED|Overall Study||0
14326|NCT02042404|31695|P1|NOT COMPLETED|Overall Study||5
14327|NCT02042404|31694|P2|COMPLETED|Overall Study||5
14328|NCT02042404|31695|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
14329|NCT02042404|31694|P2|STARTED|Overall Study||5
14330|NCT02042404|31695|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
14331|NCT02041520|31708|P2|NOT COMPLETED|Overall Study||7
14332|NCT02041520|31709|P1|NOT COMPLETED|Overall Study||6
14333|NCT02041520|31708|P2|COMPLETED|Overall Study||28
14334|NCT02041520|31709|P1|COMPLETED|Overall Study||29
14335|NCT02041520|31708|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
14336|NCT02041520|31709|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
14337|NCT02041377|31729|P1|NOT COMPLETED|Overall Study||0
14338|NCT02041377|31729|P1|COMPLETED|Overall Study||134
14339|NCT02041377|31729|P1|STARTED|Overall Study||134
14340|NCT02041325|31739|P2|NOT COMPLETED|Overall Study||3
14341|NCT02041325|31740|P1|NOT COMPLETED|Overall Study||3
14342|NCT02041325|31739|P2|COMPLETED|Overall Study||13
14343|NCT02041325|31740|P1|COMPLETED|Overall Study||19
14344|NCT02041325|31739|P2|STARTED|Overall Study||16
14345|NCT02041325|31740|P1|STARTED|Overall Study||22
14346|NCT02041286|31752|P1|NOT COMPLETED|Overall Study||1
14347|NCT02041286|31752|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
14348|NCT02041286|31752|P1|STARTED|Overall Study||136
14349|NCT02041221|31766|P6|NOT COMPLETED|Part 2||0
14350|NCT02041221|31767|P5|NOT COMPLETED|Part 2||0
14351|NCT02041221|31768|P4|NOT COMPLETED|Part 2||0
14352|NCT02041221|31769|P3|NOT COMPLETED|Part 2||1
14353|NCT02041221|31770|P2|NOT COMPLETED|Part 2||0
14354|NCT02041221|31771|P1|NOT COMPLETED|Part 2||0
14355|NCT02041221|31766|P6|COMPLETED|Part 2||6
14356|NCT02041221|31767|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
14357|NCT02041221|31768|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
14358|NCT02041221|31769|P3|COMPLETED|Part 2||5
14359|NCT02041221|31770|P2|COMPLETED|Part 2||6
14360|NCT02041221|31771|P1|COMPLETED|Part 2||6
14361|NCT02041221|31766|P6|STARTED|Part 2||6
14362|NCT02041221|31767|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
14363|NCT02041221|31768|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
14364|NCT02041221|31769|P3|STARTED|Part 2||6
14365|NCT02041221|31770|P2|STARTED|Part 2||6
14366|NCT02041221|31771|P1|STARTED|Part 2||6
14367|NCT02041221|31766|P6|NOT COMPLETED|Part 1||0
14368|NCT02041221|31767|P5|NOT COMPLETED|Part 1||0
14369|NCT02041221|31768|P4|NOT COMPLETED|Part 1||0
14370|NCT02041221|31769|P3|NOT COMPLETED|Part 1||0
14371|NCT02041221|31770|P2|NOT COMPLETED|Part 1||0
14372|NCT02041221|31771|P1|NOT COMPLETED|Part 1||0
14373|NCT02041221|31766|P6|COMPLETED|Part 1||10
14374|NCT02041221|31767|P5|COMPLETED|Part 1||6
14375|NCT02041221|31768|P4|COMPLETED|Part 1||6
14376|NCT02041221|31769|P3|COMPLETED|Part 1||6
14377|NCT02041221|31770|P2|COMPLETED|Part 1||6
14378|NCT02041221|31771|P1|COMPLETED|Part 1||6
14379|NCT02041221|31766|P6|STARTED|Part 1||10
14380|NCT02041221|31767|P5|STARTED|Part 1||6
14381|NCT02041221|31768|P4|STARTED|Part 1||6
14382|NCT02041221|31769|P3|STARTED|Part 1||6
14383|NCT02041221|31770|P2|STARTED|Part 1||6
14384|NCT02041221|31771|P1|STARTED|Part 1||6
14385|NCT02040792|31790|P5|NOT COMPLETED|Overall Study||7
14386|NCT02040792|31791|P4|NOT COMPLETED|Overall Study||7
14387|NCT02040792|31792|P3|NOT COMPLETED|Overall Study||3
14388|NCT02040792|31793|P2|NOT COMPLETED|Overall Study||3
14389|NCT02040792|31794|P1|NOT COMPLETED|Overall Study||6
14390|NCT02040792|31790|P5|COMPLETED|Overall Study||67
14391|NCT02040792|31791|P4|COMPLETED|Overall Study||64
14392|NCT02040792|31792|P3|COMPLETED|Overall Study||68
14393|NCT02040792|31793|P2|COMPLETED|Overall Study||65
14394|NCT02040792|31794|P1|COMPLETED|Overall Study||64
14395|NCT02040792|31790|P5|STARTED|Overall Study||74
14396|NCT02040792|31791|P4|STARTED|Overall Study||71
14397|NCT02040792|31792|P3|STARTED|Overall Study||71
14398|NCT02040792|31793|P2|STARTED|Overall Study||68
14399|NCT02040792|31794|P1|STARTED|Overall Study||70
14400|NCT02040623|31809|P3|NOT COMPLETED|Overall Study||2
14401|NCT02040623|31810|P2|NOT COMPLETED|Overall Study||6
14402|NCT02040623|31811|P1|NOT COMPLETED|Overall Study||4
14403|NCT02040623|31809|P3|COMPLETED|Overall Study||10
14404|NCT02040623|31810|P2|COMPLETED|Overall Study||6
14405|NCT02040623|31811|P1|COMPLETED|Overall Study||7
14406|NCT02040623|31809|P3|STARTED|Overall Study||12
14407|NCT02040623|31810|P2|STARTED|Overall Study||12
14408|NCT02040623|31811|P1|STARTED|Overall Study||11
14409|NCT02039817|31821|P2|NOT COMPLETED|Overall Study||0
14410|NCT02039817|31822|P1|NOT COMPLETED|Overall Study||0
14411|NCT02039817|31821|P2|COMPLETED|Overall Study||8
14412|NCT02039817|31822|P1|COMPLETED|Overall Study||8
14413|NCT02039817|31821|P2|STARTED|Overall Study||8
14414|NCT02039817|31822|P1|STARTED|Overall Study||8
14415|NCT02039687|31835|P4|NOT COMPLETED|Overall Study||0
14416|NCT02039687|31836|P3|NOT COMPLETED|Overall Study||1
14417|NCT02039687|31837|P2|NOT COMPLETED|Overall Study||1
14418|NCT02039687|31838|P1|NOT COMPLETED|Overall Study||0
14419|NCT02039687|31835|P4|COMPLETED|Overall Study||16
14420|NCT02039687|31836|P3|COMPLETED|Overall Study||13
14421|NCT02039687|31837|P2|COMPLETED|Overall Study||15
14422|NCT02039687|31838|P1|COMPLETED|Overall Study||16
14423|NCT02039687|31835|P4|STARTED|Overall Study||16
14424|NCT02039687|31836|P3|STARTED|Overall Study||14
14425|NCT02039687|31837|P2|STARTED|Overall Study||16
14426|NCT02039687|31838|P1|STARTED|Overall Study||16
14427|NCT02039414|31858|P2|NOT COMPLETED|Overall Study||2
14428|NCT02039414|31859|P1|NOT COMPLETED|Overall Study||6
14429|NCT02039414|31858|P2|COMPLETED|Overall Study||16
14430|NCT02039414|31859|P1|COMPLETED|Overall Study||16
14431|NCT02039414|31858|P2|STARTED|Overall Study||18
14432|NCT02039414|31859|P1|STARTED|Overall Study||22
14433|NCT02038959|31873|P2|NOT COMPLETED|Overall Study||8
14434|NCT02038959|31874|P1|NOT COMPLETED|Overall Study||6
14435|NCT02038959|31873|P2|COMPLETED|Overall Study||89
14436|NCT02038959|31874|P1|COMPLETED|Overall Study||92
14437|NCT02038959|31873|P2|STARTED|Overall Study||97
14438|NCT02038959|31874|P1|STARTED|Overall Study||98
14439|NCT02038907|31914|P14|NOT COMPLETED|Overall Study||0
14440|NCT02038907|31915|P13|NOT COMPLETED|Overall Study||0
14441|NCT02038907|31916|P12|NOT COMPLETED|Overall Study||0
14442|NCT02038907|31917|P11|NOT COMPLETED|Overall Study||2
14443|NCT02038907|31918|P10|NOT COMPLETED|Overall Study||0
14444|NCT02038907|31919|P9|NOT COMPLETED|Overall Study||0
14445|NCT02038907|31920|P8|NOT COMPLETED|Overall Study||0
14446|NCT02038907|31921|P7|NOT COMPLETED|Overall Study||0
14447|NCT02038907|31922|P6|NOT COMPLETED|Overall Study||0
14448|NCT02038907|31923|P5|NOT COMPLETED|Overall Study||0
14449|NCT02038907|31924|P4|NOT COMPLETED|Overall Study||0
14450|NCT02038907|31925|P3|NOT COMPLETED|Overall Study||0
14451|NCT02038907|31926|P2|NOT COMPLETED|Overall Study||0
14452|NCT02038907|31927|P1|NOT COMPLETED|Overall Study||0
14453|NCT02038907|31914|P14|COMPLETED|Overall Study||31
14454|NCT02038907|31915|P13|COMPLETED|Overall Study||29
14455|NCT02038907|31916|P12|COMPLETED|Overall Study||28
14456|NCT02038907|31917|P11|COMPLETED|Overall Study||27
14457|NCT02038907|31918|P10|COMPLETED|Overall Study||30
14458|NCT02038907|31919|P9|COMPLETED|Overall Study||29
14459|NCT02038907|31920|P8|COMPLETED|Overall Study||32
14460|NCT02038907|31921|P7|COMPLETED|Overall Study||30
14461|NCT02038907|31922|P6|COMPLETED|Overall Study||31
14462|NCT02038907|31923|P5|COMPLETED|Overall Study||30
14463|NCT02038907|31924|P4|COMPLETED|Overall Study||31
14464|NCT02038907|31925|P3|COMPLETED|Overall Study||30
14465|NCT02038907|31926|P2|COMPLETED|Overall Study||30
14466|NCT02038907|31927|P1|COMPLETED|Overall Study||30
14467|NCT02038907|31914|P14|STARTED|Overall Study||31
14468|NCT02038907|31915|P13|STARTED|Overall Study||29
14469|NCT02038907|31916|P12|STARTED|Overall Study||28
14470|NCT02038907|31917|P11|STARTED|Overall Study||29
14471|NCT02038907|31918|P10|STARTED|Overall Study||30
14472|NCT02038907|31919|P9|STARTED|Overall Study||29
14473|NCT02038907|31920|P8|STARTED|Overall Study||32
14474|NCT02038907|31921|P7|STARTED|Overall Study||30
14475|NCT02038907|31922|P6|STARTED|Overall Study||31
14476|NCT02038907|31923|P5|STARTED|Overall Study||30
14477|NCT02038907|31924|P4|STARTED|Overall Study||31
14478|NCT02038907|31925|P3|STARTED|Overall Study||30
14479|NCT02038907|31926|P2|STARTED|Overall Study||30
14480|NCT02038907|31927|P1|STARTED|Overall Study||30
14481|NCT02038075|32457|P2|NOT COMPLETED|Overall Study||0
14482|NCT02038075|32458|P1|NOT COMPLETED|Overall Study||3
14483|NCT02038075|32457|P2|COMPLETED|Overall Study||76
14484|NCT02038075|32458|P1|COMPLETED|Overall Study||73
14485|NCT02038075|32457|P2|STARTED|Overall Study||76
14486|NCT02038075|32458|P1|STARTED|Overall Study||76
14487|NCT02037477|32468|P4|NOT COMPLETED|Treatment Period 2||0
14488|NCT02037477|32469|P3|NOT COMPLETED|Treatment Period 2||0
14489|NCT02037477|32470|P2|NOT COMPLETED|Treatment Period 2||0
14490|NCT02037477|32471|P1|NOT COMPLETED|Treatment Period 2||0
14491|NCT02037477|32468|P4|COMPLETED|Treatment Period 2||5
14492|NCT02037477|32469|P3|COMPLETED|Treatment Period 2||4
14493|NCT02037477|32470|P2|COMPLETED|Treatment Period 2||5
14494|NCT02037477|32471|P1|COMPLETED|Treatment Period 2||5
14495|NCT02037477|32468|P4|STARTED|Treatment Period 2||5
14496|NCT02037477|32469|P3|STARTED|Treatment Period 2||4
14497|NCT02037477|32470|P2|STARTED|Treatment Period 2||5
14498|NCT02037477|32471|P1|STARTED|Treatment Period 2||5
14499|NCT02037477|32468|P4|NOT COMPLETED|Treatment Period 1||0
14500|NCT02037477|32469|P3|NOT COMPLETED|Treatment Period 1||1
14501|NCT02037477|32470|P2|NOT COMPLETED|Treatment Period 1||0
14502|NCT02037477|32471|P1|NOT COMPLETED|Treatment Period 1||0
14503|NCT02037477|32468|P4|COMPLETED|Treatment Period 1||5
14504|NCT02037477|32469|P3|COMPLETED|Treatment Period 1||4
14505|NCT02037477|32470|P2|COMPLETED|Treatment Period 1||5
14506|NCT02037477|32471|P1|COMPLETED|Treatment Period 1||5
14507|NCT02037477|32468|P4|STARTED|Treatment Period 1||5
14508|NCT02037477|32469|P3|STARTED|Treatment Period 1||5
14509|NCT02037477|32470|P2|STARTED|Treatment Period 1||5
14510|NCT02037477|32471|P1|STARTED|Treatment Period 1||5
14511|NCT02037425|32497|P1|NOT COMPLETED|Overall Study||26
14512|NCT02037425|32497|P1|COMPLETED|Overall Study||18
14513|NCT02037425|32497|P1|Randomized to Treatment|Overall Study||32
14514|NCT02037425|32497|P1|STARTED|Overall Study||44
14515|NCT02037347|32539|P1|NOT COMPLETED|Overall Study||0
14516|NCT02037347|32539|P1|COMPLETED|Overall Study||1
14517|NCT02037347|32539|P1|STARTED|Overall Study||1
14518|NCT02036840|32545|P1|NOT COMPLETED|Overall Study||0
14519|NCT02036840|32545|P1|COMPLETED|Overall Study||513
14520|NCT02036840|32545|P1|STARTED|Overall Study||513
14521|NCT02036775|32549|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14522|NCT02036775|32550|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14523|NCT02036775|32551|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14524|NCT02036775|32552|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14525|NCT02036775|32553|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14526|NCT02036775|32554|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
14527|NCT02036775|32549|P6|COMPLETED|Treatment Period 3 (6 Days)||3
14528|NCT02036775|32550|P5|COMPLETED|Treatment Period 3 (6 Days)||4
14529|NCT02036775|32551|P4|COMPLETED|Treatment Period 3 (6 Days)||4
14530|NCT02036775|32552|P3|COMPLETED|Treatment Period 3 (6 Days)||4
14531|NCT02036775|32553|P2|COMPLETED|Treatment Period 3 (6 Days)||4
14532|NCT02036775|32554|P1|COMPLETED|Treatment Period 3 (6 Days)||4
14533|NCT02036775|32549|P6|STARTED|Treatment Period 3 (6 Days)||3
14534|NCT02036775|32550|P5|STARTED|Treatment Period 3 (6 Days)||4
14535|NCT02036775|32551|P4|STARTED|Treatment Period 3 (6 Days)||4
14536|NCT02036775|32552|P3|STARTED|Treatment Period 3 (6 Days)||4
14537|NCT02036775|32553|P2|STARTED|Treatment Period 3 (6 Days)||4
14538|NCT02036775|32554|P1|STARTED|Treatment Period 3 (6 Days)||4
14539|NCT02036775|32549|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
14540|NCT02036775|32550|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
14541|NCT02036775|32551|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
14542|NCT02036775|32552|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
14543|NCT02036775|32553|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
14544|NCT02036775|32554|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
14545|NCT02036775|32549|P6|COMPLETED|Treatment Period 2 (6 Days)||3
14546|NCT02036775|32550|P5|COMPLETED|Treatment Period 2 (6 Days)||4
14547|NCT02036775|32551|P4|COMPLETED|Treatment Period 2 (6 Days)||4
14548|NCT02036775|32552|P3|COMPLETED|Treatment Period 2 (6 Days)||4
14549|NCT02036775|32553|P2|COMPLETED|Treatment Period 2 (6 Days)||4
14550|NCT02036775|32554|P1|COMPLETED|Treatment Period 2 (6 Days)||4
14551|NCT02036775|32549|P6|STARTED|Treatment Period 2 (6 Days)||4
14552|NCT02036775|32550|P5|STARTED|Treatment Period 2 (6 Days)||4
14553|NCT02036775|32551|P4|STARTED|Treatment Period 2 (6 Days)||4
14554|NCT02036775|32552|P3|STARTED|Treatment Period 2 (6 Days)||4
14555|NCT02036775|32553|P2|STARTED|Treatment Period 2 (6 Days)||4
14556|NCT02036775|32554|P1|STARTED|Treatment Period 2 (6 Days)||4
14557|NCT02036775|32549|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14558|NCT02036775|32550|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14559|NCT02036775|32551|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14560|NCT02036775|32552|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14561|NCT02036775|32553|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14562|NCT02036775|32554|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
14563|NCT02036775|32549|P6|COMPLETED|Treatment Period 1 (6 Days)||4
14564|NCT02036775|32550|P5|COMPLETED|Treatment Period 1 (6 Days)||4
14565|NCT02036775|32551|P4|COMPLETED|Treatment Period 1 (6 Days)||4
14566|NCT02036775|32552|P3|COMPLETED|Treatment Period 1 (6 Days)||4
14567|NCT02036775|32553|P2|COMPLETED|Treatment Period 1 (6 Days)||4
14568|NCT02036775|32554|P1|COMPLETED|Treatment Period 1 (6 Days)||4
14569|NCT02036775|32549|P6|STARTED|Treatment Period 1 (6 Days)||4
14570|NCT02036775|32550|P5|STARTED|Treatment Period 1 (6 Days)||4
14571|NCT02036775|32551|P4|STARTED|Treatment Period 1 (6 Days)||4
14572|NCT02036775|32552|P3|STARTED|Treatment Period 1 (6 Days)||4
14573|NCT02036775|32553|P2|STARTED|Treatment Period 1 (6 Days)||4
14574|NCT02036775|32554|P1|STARTED|Treatment Period 1 (6 Days)||4
14575|NCT02036424|32594|P2|NOT COMPLETED|Overall Study||0
14576|NCT02036424|32595|P1|NOT COMPLETED|Overall Study||0
14577|NCT02036424|32594|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
14578|NCT02036424|32595|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
14579|NCT02036424|32594|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
14580|NCT02036424|32595|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
14581|NCT02035332|32603|P1|NOT COMPLETED|Overall Study||1
14582|NCT02035332|32603|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
14583|NCT02035332|32603|P1|Treated|Overall Study|Treatment Completed|20
14584|NCT02035332|32603|P1|STARTED|Overall Study|Treatment Attempted|21
14585|NCT02036320|32609|P2|NOT COMPLETED|Period 2||0
14586|NCT02036320|32610|P1|NOT COMPLETED|Period 2||0
14587|NCT02036320|32609|P2|COMPLETED|Period 2||95
14588|NCT02036320|32610|P1|COMPLETED|Period 2||95
14589|NCT02036320|32609|P2|STARTED|Period 2||95
14590|NCT02036320|32610|P1|STARTED|Period 2||95
14591|NCT02036320|32609|P2|NOT COMPLETED|Period 1||0
14592|NCT02036320|32610|P1|NOT COMPLETED|Period 1||0
14593|NCT02036320|32609|P2|COMPLETED|Period 1||95
14594|NCT02036320|32610|P1|COMPLETED|Period 1||95
14595|NCT02036320|32609|P2|STARTED|Period 1||95
14596|NCT02036320|32610|P1|STARTED|Period 1||95
14597|NCT02035748|32620|P1|NOT COMPLETED|Overall Study||20
14598|NCT02035748|32620|P1|COMPLETED|Overall Study||448
14599|NCT02035748|32620|P1|STARTED|Overall Study||468
14600|NCT02035475|32630|P1|NOT COMPLETED|Overall Study||6
14601|NCT02035475|32630|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
14602|NCT02035475|32630|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
14603|NCT02035345|32636|P1|NOT COMPLETED|Overall Study||0
14604|NCT02035345|32636|P1|COMPLETED|Overall Study||15
14605|NCT02035345|32636|P1|STARTED|Overall Study||15
14606|NCT02034877|32643|P2|NOT COMPLETED|Overall Study||6
14607|NCT02034877|32644|P1|NOT COMPLETED|Overall Study||0
14608|NCT02034877|32643|P2|COMPLETED|Overall Study||993
14609|NCT02034877|32644|P1|COMPLETED|Overall Study||200
14610|NCT02034877|32643|P2|STARTED|Overall Study||999
14611|NCT02034877|32644|P1|STARTED|Overall Study||200
14612|NCT02034708|32662|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
14613|NCT02034708|32663|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
14614|NCT02034708|32662|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
14615|NCT02034708|32663|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
14616|NCT02034708|32662|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
14617|NCT02034708|32663|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
14618|NCT02034708|32662|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
14619|NCT02034708|32663|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
14620|NCT02034708|32662|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
14621|NCT02034708|32663|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
14622|NCT02034708|32662|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
14623|NCT02034708|32663|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
14624|NCT02034708|32662|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
14625|NCT02034708|32663|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
14626|NCT02034708|32662|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
14627|NCT02034708|32663|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
14628|NCT02034708|32662|P2|STARTED|First Contrast Agent Injection (1 Day)||130
14629|NCT02034708|32663|P1|STARTED|First Contrast Agent Injection (1 Day)||138
14630|NCT02034591|32674|P6|NOT COMPLETED|Overall Study||0
14631|NCT02034591|32675|P5|NOT COMPLETED|Overall Study||1
14632|NCT02034591|32676|P4|NOT COMPLETED|Overall Study||0
14633|NCT02034591|32677|P3|NOT COMPLETED|Overall Study||0
14634|NCT02034591|32678|P2|NOT COMPLETED|Overall Study||0
14635|NCT02034591|32679|P1|NOT COMPLETED|Overall Study||0
14636|NCT02034591|32674|P6|COMPLETED|Overall Study||3
14637|NCT02034591|32675|P5|COMPLETED|Overall Study||3
14638|NCT02034591|32676|P4|COMPLETED|Overall Study||3
14639|NCT02034591|32677|P3|COMPLETED|Overall Study||4
14640|NCT02034591|32678|P2|COMPLETED|Overall Study||3
14641|NCT02034591|32679|P1|COMPLETED|Overall Study||4
14642|NCT02034591|32674|P6|STARTED|Overall Study||3
14643|NCT02034591|32675|P5|STARTED|Overall Study||4
14644|NCT02034591|32676|P4|STARTED|Overall Study||3
14645|NCT02034591|32677|P3|STARTED|Overall Study||4
14646|NCT02034591|32678|P2|STARTED|Overall Study||3
14647|NCT02034591|32679|P1|STARTED|Overall Study||4
14648|NCT02034578|32702|P6|NOT COMPLETED|Overall Study||0
14649|NCT02034578|32703|P5|NOT COMPLETED|Overall Study||0
14650|NCT02034578|32704|P4|NOT COMPLETED|Overall Study||0
14651|NCT02034578|32705|P3|NOT COMPLETED|Overall Study||0
14652|NCT02034578|32706|P2|NOT COMPLETED|Overall Study||0
14653|NCT02034578|32707|P1|NOT COMPLETED|Overall Study||0
14654|NCT02034578|32702|P6|COMPLETED|Overall Study||3
14655|NCT02034578|32703|P5|COMPLETED|Overall Study||4
14656|NCT02034578|32704|P4|COMPLETED|Overall Study||3
14657|NCT02034578|32705|P3|COMPLETED|Overall Study||4
14658|NCT02034578|32706|P2|COMPLETED|Overall Study||3
14659|NCT02034578|32707|P1|COMPLETED|Overall Study||4
14660|NCT02034578|32702|P6|STARTED|Overall Study||3
14661|NCT02034578|32703|P5|STARTED|Overall Study||4
14662|NCT02034578|32704|P4|STARTED|Overall Study||3
14663|NCT02034578|32705|P3|STARTED|Overall Study||4
14664|NCT02034578|32706|P2|STARTED|Overall Study||3
14665|NCT02034578|32707|P1|STARTED|Overall Study||4
14666|NCT02034565|32734|P2|NOT COMPLETED|Overall Study||0
14667|NCT02034565|32735|P1|NOT COMPLETED|Overall Study||1
14668|NCT02034565|32734|P2|COMPLETED|Overall Study||7
14669|NCT02034565|32735|P1|COMPLETED|Overall Study||6
14670|NCT02034565|32734|P2|STARTED|Overall Study||7
14671|NCT02034565|32735|P1|STARTED|Overall Study||7
14672|NCT02034162|32751|P3|NOT COMPLETED|Open-label||0
14673|NCT02034162|32752|P2|NOT COMPLETED|Open-label||0
14674|NCT02034162|32753|P1|NOT COMPLETED|Open-label||0
14675|NCT02034162|32751|P3|COMPLETED|Open-label||278
14676|NCT02034162|32752|P2|COMPLETED|Open-label||0
14677|NCT02034162|32753|P1|COMPLETED|Open-label||0
14678|NCT02034162|32751|P3|STARTED|Open-label||278
14679|NCT02034162|32752|P2|STARTED|Open-label||0
14680|NCT02034162|32753|P1|STARTED|Open-label||0
14681|NCT02034162|32751|P3|NOT COMPLETED|Double-blind||0
14682|NCT02034162|32752|P2|NOT COMPLETED|Double-blind||8
14683|NCT02034162|32753|P1|NOT COMPLETED|Double-blind||9
14684|NCT02034162|32751|P3|COMPLETED|Double-blind||0
14685|NCT02034162|32752|P2|COMPLETED|Double-blind||141
14686|NCT02034162|32753|P1|COMPLETED|Double-blind||137
14687|NCT02034162|32751|P3|STARTED|Double-blind||0
14688|NCT02034162|32752|P2|STARTED|Double-blind||149
14689|NCT02034162|32753|P1|STARTED|Double-blind||146
14690|NCT02033317|32781|P1|NOT COMPLETED|Overall Study||0
14691|NCT02033317|32781|P1|COMPLETED|Overall Study||6
14692|NCT02033317|32781|P1|STARTED|Overall Study||6
14693|NCT02033213|32788|P2|NOT COMPLETED|Overall Study||0
14694|NCT02033213|32789|P1|NOT COMPLETED|Overall Study||0
14695|NCT02033213|32788|P2|COMPLETED|Overall Study||8
14696|NCT02033213|32789|P1|COMPLETED|Overall Study||8
14697|NCT02033213|32788|P2|STARTED|Overall Study||8
14698|NCT02033213|32789|P1|STARTED|Overall Study||8
14699|NCT02033200|32807|P2|NOT COMPLETED|Overall Study||0
14700|NCT02033200|32808|P1|NOT COMPLETED|Overall Study||0
14701|NCT02033200|32807|P2|COMPLETED|Overall Study||40
14702|NCT02033200|32808|P1|COMPLETED|Overall Study||40
14703|NCT02033200|32807|P2|STARTED|Overall Study||40
14704|NCT02033200|32808|P1|STARTED|Overall Study||40
14705|NCT02033174|32828|P1|NOT COMPLETED|Second Intervention||0
14706|NCT02033174|32828|P1|COMPLETED|Second Intervention||16
14707|NCT02033174|32828|P1|STARTED|Second Intervention||16
14708|NCT02033174|32828|P1|NOT COMPLETED|First Intervention||0
14709|NCT02033174|32828|P1|COMPLETED|First Intervention||16
14710|NCT02033174|32828|P1|STARTED|First Intervention||16
14711|NCT02032901|32836|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
14712|NCT02032901|32837|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
14713|NCT02032901|32836|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
14714|NCT02032901|32837|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
14715|NCT02032901|32836|P2|STARTED|Follow-Up Period (24 Weeks)||51
14716|NCT02032901|32837|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
14717|NCT02032901|32836|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
14718|NCT02032901|32837|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
14719|NCT02032901|32836|P2|COMPLETED|Treatment Period (12 Weeks)||51
14720|NCT02032901|32837|P1|COMPLETED|Treatment Period (12 Weeks)||100
14721|NCT02032901|32836|P2|STARTED|Treatment Period (12 Weeks)||51
14722|NCT02032901|32837|P1|STARTED|Treatment Period (12 Weeks)||101
14723|NCT02032888|32861|P3|NOT COMPLETED|Follow-up Period||0
14724|NCT02032888|32862|P2|NOT COMPLETED|Follow-up Period||2
14725|NCT02032888|32863|P1|NOT COMPLETED|Follow-up Period||3
14726|NCT02032888|32861|P3|COMPLETED|Follow-up Period||52
14727|NCT02032888|32862|P2|COMPLETED|Follow-up Period||47
14728|NCT02032888|32863|P1|COMPLETED|Follow-up Period||97
14729|NCT02032888|32861|P3|STARTED|Follow-up Period||52
14730|NCT02032888|32862|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
14731|NCT02032888|32863|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
14732|NCT02032888|32861|P3|NOT COMPLETED|Treatment Period||0
14733|NCT02032888|32862|P2|NOT COMPLETED|Treatment Period||2
14734|NCT02032888|32863|P1|NOT COMPLETED|Treatment Period||2
14735|NCT02032888|32861|P3|COMPLETED|Treatment Period||52
14736|NCT02032888|32862|P2|COMPLETED|Treatment Period||48
14737|NCT02032888|32863|P1|COMPLETED|Treatment Period||99
14738|NCT02032888|32861|P3|STARTED|Treatment Period||52
14739|NCT02032888|32862|P2|STARTED|Treatment Period||50
14740|NCT02032888|32863|P1|STARTED|Treatment Period||101
14741|NCT02032875|32894|P2|NOT COMPLETED|Follow-up Period||11
14742|NCT02032875|32895|P1|NOT COMPLETED|Follow-up Period||3
14743|NCT02032875|32894|P2|COMPLETED|Follow-up Period||46
14744|NCT02032875|32895|P1|COMPLETED|Follow-up Period||50
14745|NCT02032875|32894|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
14746|NCT02032875|32895|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
14747|NCT02032875|32894|P2|NOT COMPLETED|Treatment Period||4
14748|NCT02032875|32895|P1|NOT COMPLETED|Treatment Period||1
14749|NCT02032875|32894|P2|COMPLETED|Treatment Period||56
14750|NCT02032875|32895|P1|COMPLETED|Treatment Period||52
14751|NCT02032875|32894|P2|STARTED|Treatment Period||60
14752|NCT02032875|32895|P1|STARTED|Treatment Period||53
14753|NCT02032758|32915|P2|NOT COMPLETED|Overall Study||0
14754|NCT02032758|32916|P1|NOT COMPLETED|Overall Study||0
14755|NCT02032758|32915|P2|COMPLETED|Overall Study||11
14756|NCT02032758|32916|P1|COMPLETED|Overall Study||27
14757|NCT02032758|32915|P2|STARTED|Overall Study||11
14758|NCT02032758|32916|P1|STARTED|Overall Study||27
14759|NCT02032706|32924|P1|NOT COMPLETED|Overall Study||6
14760|NCT02032706|32924|P1|COMPLETED|Overall Study||30
14761|NCT02032706|32924|P1|STARTED|Overall Study||36
14762|NCT02032641|32937|P1|NOT COMPLETED|Overall Study||1
14763|NCT02032641|32937|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
14764|NCT02032641|32937|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
14765|NCT02032420|32949|P2|NOT COMPLETED|Overall Study||0
14766|NCT02032420|32950|P1|NOT COMPLETED|Overall Study||0
14767|NCT02032420|32949|P2|COMPLETED|Overall Study||17
14768|NCT02032420|32950|P1|COMPLETED|Overall Study||18
14769|NCT02032420|32949|P2|STARTED|Overall Study||17
14770|NCT02032420|32950|P1|STARTED|Overall Study||18
14771|NCT02032407|32962|P1|NOT COMPLETED|Overall Study||5
14772|NCT02032407|32962|P1|COMPLETED|Overall Study||63
14773|NCT02032407|32962|P1|STARTED|Overall Study||68
14774|NCT02032212|32977|P4|NOT COMPLETED|Overall Study||0
14775|NCT02032212|32978|P3|NOT COMPLETED|Overall Study||0
14776|NCT02032212|32979|P2|NOT COMPLETED|Overall Study||0
14777|NCT02032212|32980|P1|NOT COMPLETED|Overall Study||0
14778|NCT02032212|32977|P4|COMPLETED|Overall Study||3
14779|NCT02032212|32978|P3|COMPLETED|Overall Study||3
14780|NCT02032212|32979|P2|COMPLETED|Overall Study||3
14781|NCT02032212|32980|P1|COMPLETED|Overall Study||3
14782|NCT02032212|32977|P4|STARTED|Overall Study||3
14783|NCT02032212|32978|P3|STARTED|Overall Study||3
14784|NCT02032212|32979|P2|STARTED|Overall Study||3
14785|NCT02032212|32980|P1|STARTED|Overall Study||3
14786|NCT02031471|33006|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
14787|NCT02031471|33006|P1|COMPLETED|Long Term Extension (LTE) Period||37
14788|NCT02031471|33006|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
14789|NCT02031471|33006|P1|NOT COMPLETED|24 Week Treatment Period||11
14790|NCT02031471|33006|P1|COMPLETED|24 Week Treatment Period||46
14791|NCT02031471|33006|P1|STARTED|24 Week Treatment Period||57
14792|NCT02030600|33038|P2|NOT COMPLETED|Overall Study||63
14793|NCT02030600|33039|P1|NOT COMPLETED|Overall Study||78
14794|NCT02030600|33038|P2|COMPLETED|Overall Study||297
14795|NCT02030600|33039|P1|COMPLETED|Overall Study||283
14796|NCT02030600|33038|P2|Exposed|Overall Study||357
14797|NCT02030600|33039|P1|Exposed|Overall Study||356
14798|NCT02030600|33038|P2|STARTED|Overall Study||360
14799|NCT02030600|33039|P1|STARTED|Overall Study||361
14800|NCT02030574|33055|P1|NOT COMPLETED|Overall Study||0
14801|NCT02030574|33055|P1|COMPLETED|Overall Study||2
14802|NCT02030574|33055|P1|STARTED|Overall Study||2
14803|NCT02030535|33060|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
14804|NCT02030535|33060|P1|COMPLETED|Treatment Period 3 (1 Day)||52
14805|NCT02030535|33060|P1|STARTED|Treatment Period 3 (1 Day)||52
14806|NCT02030535|33060|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
14807|NCT02030535|33060|P1|COMPLETED|Washout Period 2 (21 Days)||52
14808|NCT02030535|33060|P1|STARTED|Washout Period 2 (21 Days)||52
14809|NCT02030535|33060|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
14810|NCT02030535|33060|P1|COMPLETED|Treatment Period 2 (1 Day)||52
14811|NCT02030535|33060|P1|STARTED|Treatment Period 2 (1 Day)||52
14812|NCT02030535|33060|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
14813|NCT02030535|33060|P1|COMPLETED|Washout Period 1 (21 Days)||52
14814|NCT02030535|33060|P1|STARTED|Washout Period 1 (21 Days)||53
14815|NCT02030535|33060|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
14816|NCT02030535|33060|P1|COMPLETED|Treatment Period 1 (1 Day)||53
14817|NCT02030535|33060|P1|STARTED|Treatment Period 1 (1 Day)||53
14818|NCT02029989|33130|P2|NOT COMPLETED|Overall Study||11
14819|NCT02029989|33131|P1|NOT COMPLETED|Overall Study||16
14820|NCT02029989|33130|P2|COMPLETED|Overall Study||49
14821|NCT02029989|33131|P1|COMPLETED|Overall Study||45
14822|NCT02029989|33130|P2|STARTED|Overall Study||60
14823|NCT02029989|33131|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
14824|NCT02029911|33137|P1|NOT COMPLETED|Overall Study||0
14825|NCT02029911|33137|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
14826|NCT02029911|33137|P1|Treated|Overall Study|Treatment Completed|60
14827|NCT02029911|33137|P1|STARTED|Overall Study|Treatment Attempted|60
14828|NCT02029755|33146|P3|NOT COMPLETED|Overall Study||0
14829|NCT02029755|33147|P2|NOT COMPLETED|Overall Study||0
14830|NCT02029755|33148|P1|NOT COMPLETED|Overall Study||0
14831|NCT02029755|33146|P3|COMPLETED|Overall Study||36
14832|NCT02029755|33147|P2|COMPLETED|Overall Study||36
14833|NCT02029755|33148|P1|COMPLETED|Overall Study||36
14834|NCT02029755|33146|P3|STARTED|Overall Study||36
14835|NCT02029755|33147|P2|STARTED|Overall Study||36
14836|NCT02029755|33148|P1|STARTED|Overall Study||36
14837|NCT02029521|33161|P2|NOT COMPLETED|Overall Study||1
14838|NCT02029521|33162|P1|NOT COMPLETED|Overall Study||2
14839|NCT02029521|33161|P2|COMPLETED|Overall Study||22
14840|NCT02029521|33162|P1|COMPLETED|Overall Study||22
14841|NCT02029521|33161|P2|STARTED|Overall Study||23
14842|NCT02029521|33162|P1|STARTED|Overall Study||24
14843|NCT02029417|33244|P1|NOT COMPLETED|Overall Study||2
14844|NCT02029417|33244|P1|COMPLETED|Overall Study||0
14845|NCT02029417|33244|P1|STARTED|Overall Study||2
14846|NCT02028780|33261|P12|NOT COMPLETED|Follow up Phase||0
14847|NCT02028780|33262|P11|NOT COMPLETED|Follow up Phase||0
14848|NCT02028780|33263|P10|NOT COMPLETED|Follow up Phase||0
14849|NCT02028780|33264|P9|NOT COMPLETED|Follow up Phase||0
14850|NCT02028780|33265|P8|NOT COMPLETED|Follow up Phase||0
14851|NCT02028780|33266|P7|NOT COMPLETED|Follow up Phase||0
14852|NCT02028780|33267|P6|NOT COMPLETED|Follow up Phase||0
14853|NCT02028780|33268|P5|NOT COMPLETED|Follow up Phase||0
14854|NCT02028780|33269|P4|NOT COMPLETED|Follow up Phase||0
14855|NCT02028780|33270|P3|NOT COMPLETED|Follow up Phase||0
14856|NCT02028780|33271|P2|NOT COMPLETED|Follow up Phase||0
14857|NCT02028780|33272|P1|NOT COMPLETED|Follow up Phase||0
14858|NCT02028780|33261|P12|COMPLETED|Follow up Phase||9
14859|NCT02028780|33262|P11|COMPLETED|Follow up Phase||9
14860|NCT02028780|33263|P10|COMPLETED|Follow up Phase||9
14861|NCT02028780|33264|P9|COMPLETED|Follow up Phase||9
14862|NCT02028780|33265|P8|COMPLETED|Follow up Phase||3
14863|NCT02028780|33266|P7|COMPLETED|Follow up Phase||9
14864|NCT02028780|33267|P6|COMPLETED|Follow up Phase||6
14865|NCT02028780|33268|P5|COMPLETED|Follow up Phase||6
14866|NCT02028780|33269|P4|COMPLETED|Follow up Phase||6
14867|NCT02028780|33270|P3|COMPLETED|Follow up Phase||6
14868|NCT02028780|33271|P2|COMPLETED|Follow up Phase||2
14869|NCT02028780|33272|P1|COMPLETED|Follow up Phase||6
14870|NCT02028780|33261|P12|STARTED|Follow up Phase||9
14871|NCT02028780|33262|P11|STARTED|Follow up Phase||9
14872|NCT02028780|33263|P10|STARTED|Follow up Phase||9
14873|NCT02028780|33264|P9|STARTED|Follow up Phase||9
14874|NCT02028780|33265|P8|STARTED|Follow up Phase||3
14875|NCT02028780|33266|P7|STARTED|Follow up Phase||9
14876|NCT02028780|33267|P6|STARTED|Follow up Phase||6
14877|NCT02028780|33268|P5|STARTED|Follow up Phase||6
14878|NCT02028780|33269|P4|STARTED|Follow up Phase||6
14879|NCT02028780|33270|P3|STARTED|Follow up Phase||6
14880|NCT02028780|33271|P2|STARTED|Follow up Phase||2
14881|NCT02028780|33272|P1|STARTED|Follow up Phase||6
14882|NCT02028780|33261|P12|NOT COMPLETED|Observation Phase||0
14883|NCT02028780|33262|P11|NOT COMPLETED|Observation Phase||0
14884|NCT02028780|33263|P10|NOT COMPLETED|Observation Phase||0
14885|NCT02028780|33264|P9|NOT COMPLETED|Observation Phase||0
14886|NCT02028780|33265|P8|NOT COMPLETED|Observation Phase||0
14887|NCT02028780|33266|P7|NOT COMPLETED|Observation Phase||0
14888|NCT02028780|33267|P6|NOT COMPLETED|Observation Phase||0
14889|NCT02028780|33268|P5|NOT COMPLETED|Observation Phase||0
14890|NCT02028780|33269|P4|NOT COMPLETED|Observation Phase||0
14891|NCT02028780|33270|P3|NOT COMPLETED|Observation Phase||0
14892|NCT02028780|33271|P2|NOT COMPLETED|Observation Phase||0
14893|NCT02028780|33272|P1|NOT COMPLETED|Observation Phase||0
14894|NCT02028780|33261|P12|COMPLETED|Observation Phase||9
14895|NCT02028780|33262|P11|COMPLETED|Observation Phase||9
14896|NCT02028780|33263|P10|COMPLETED|Observation Phase||9
14897|NCT02028780|33264|P9|COMPLETED|Observation Phase||9
14898|NCT02028780|33265|P8|COMPLETED|Observation Phase||3
14899|NCT02028780|33266|P7|COMPLETED|Observation Phase||9
14900|NCT02028780|33267|P6|COMPLETED|Observation Phase||6
14901|NCT02028780|33268|P5|COMPLETED|Observation Phase||6
14902|NCT02028780|33269|P4|COMPLETED|Observation Phase||6
14903|NCT02028780|33270|P3|COMPLETED|Observation Phase||6
14904|NCT02028780|33271|P2|COMPLETED|Observation Phase||2
14905|NCT02028780|33272|P1|COMPLETED|Observation Phase||6
14906|NCT02028780|33261|P12|STARTED|Observation Phase||9
14907|NCT02028780|33262|P11|STARTED|Observation Phase||9
14908|NCT02028780|33263|P10|STARTED|Observation Phase||9
14909|NCT02028780|33264|P9|STARTED|Observation Phase||9
14910|NCT02028780|33265|P8|STARTED|Observation Phase||3
14911|NCT02028780|33266|P7|STARTED|Observation Phase||9
14912|NCT02028780|33267|P6|STARTED|Observation Phase||6
14913|NCT02028780|33268|P5|STARTED|Observation Phase||6
14914|NCT02028780|33269|P4|STARTED|Observation Phase||6
14915|NCT02028780|33270|P3|STARTED|Observation Phase||6
14916|NCT02028780|33271|P2|STARTED|Observation Phase||2
14917|NCT02028780|33272|P1|STARTED|Observation Phase||6
14918|NCT02028767|33337|P2|NOT COMPLETED|Treatment Period 2||0
14919|NCT02028767|33338|P1|NOT COMPLETED|Treatment Period 2||2
14920|NCT02028767|33337|P2|COMPLETED|Treatment Period 2||16
14921|NCT02028767|33338|P1|COMPLETED|Treatment Period 2||14
14922|NCT02028767|33337|P2|STARTED|Treatment Period 2||16
14923|NCT02028767|33338|P1|STARTED|Treatment Period 2||16
14924|NCT02028767|33337|P2|NOT COMPLETED|Treatment Period 1||0
14925|NCT02028767|33338|P1|NOT COMPLETED|Treatment Period 1||0
14926|NCT02028767|33337|P2|COMPLETED|Treatment Period 1||16
14927|NCT02028767|33338|P1|COMPLETED|Treatment Period 1||16
14928|NCT02028767|33337|P2|STARTED|Treatment Period 1||16
14929|NCT02028767|33338|P1|STARTED|Treatment Period 1||16
14930|NCT02028754|33350|P2|NOT COMPLETED|Overall Study||8
14931|NCT02028754|33351|P1|NOT COMPLETED|Overall Study||7
14932|NCT02028754|33350|P2|COMPLETED|Overall Study||82
14933|NCT02028754|33351|P1|COMPLETED|Overall Study||83
14934|NCT02028754|33350|P2|STARTED|Overall Study||90
14935|NCT02028754|33351|P1|STARTED|Overall Study||90
14936|NCT02028676|33378|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14937|NCT02028676|33379|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14938|NCT02028676|33380|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14939|NCT02028676|33381|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14940|NCT02028676|33382|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14941|NCT02028676|33383|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14942|NCT02028676|33384|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14943|NCT02028676|33385|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14944|NCT02028676|33386|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
14945|NCT02028676|33378|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
14946|NCT02028676|33379|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
14947|NCT02028676|33380|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14948|NCT02028676|33381|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14949|NCT02028676|33382|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14950|NCT02028676|33383|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14951|NCT02028676|33384|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14952|NCT02028676|33385|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14953|NCT02028676|33386|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
14954|NCT02028676|33378|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
14955|NCT02028676|33379|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
14956|NCT02028676|33380|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
14957|NCT02028676|33381|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
14958|NCT02028676|33382|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
14959|NCT02028676|33383|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
14960|NCT02028676|33384|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
14961|NCT02028676|33385|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
14962|NCT02028676|33386|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
14963|NCT02028676|33378|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14964|NCT02028676|33379|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14965|NCT02028676|33380|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
15119|NCT02026141|33671|P2|NOT COMPLETED|Overall Study||1
14966|NCT02028676|33381|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14967|NCT02028676|33382|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14968|NCT02028676|33383|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14969|NCT02028676|33384|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14970|NCT02028676|33385|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14971|NCT02028676|33386|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14972|NCT02028676|33378|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14973|NCT02028676|33379|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14974|NCT02028676|33380|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
14975|NCT02028676|33381|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
14976|NCT02028676|33382|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14977|NCT02028676|33383|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14978|NCT02028676|33384|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14979|NCT02028676|33385|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14980|NCT02028676|33386|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
14981|NCT02028676|33378|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14982|NCT02028676|33379|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14983|NCT02028676|33380|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
14984|NCT02028676|33381|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
14985|NCT02028676|33382|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14986|NCT02028676|33383|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14987|NCT02028676|33384|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14988|NCT02028676|33385|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14989|NCT02028676|33386|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
14990|NCT02028676|33378|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
14991|NCT02028676|33379|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
14992|NCT02028676|33380|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
14993|NCT02028676|33381|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
14994|NCT02028676|33382|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
14995|NCT02028676|33383|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
14996|NCT02028676|33384|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
14997|NCT02028676|33385|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
14998|NCT02028676|33386|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
14999|NCT02028676|33378|P9|COMPLETED|Initial Enrolment: Induction ART||0
15000|NCT02028676|33379|P8|COMPLETED|Initial Enrolment: Induction ART||0
15001|NCT02028676|33380|P7|COMPLETED|Initial Enrolment: Induction ART||0
15002|NCT02028676|33381|P6|COMPLETED|Initial Enrolment: Induction ART||0
15003|NCT02028676|33382|P5|COMPLETED|Initial Enrolment: Induction ART||405
15004|NCT02028676|33383|P4|COMPLETED|Initial Enrolment: Induction ART||404
15005|NCT02028676|33384|P3|COMPLETED|Initial Enrolment: Induction ART||397
15006|NCT02028676|33385|P2|COMPLETED|Initial Enrolment: Induction ART||0
15007|NCT02028676|33386|P1|COMPLETED|Initial Enrolment: Induction ART||0
15008|NCT02028676|33378|P9|STARTED|Initial Enrolment: Induction ART||0
15009|NCT02028676|33379|P8|STARTED|Initial Enrolment: Induction ART||0
15010|NCT02028676|33380|P7|STARTED|Initial Enrolment: Induction ART||0
15011|NCT02028676|33381|P6|STARTED|Initial Enrolment: Induction ART||0
15012|NCT02028676|33382|P5|STARTED|Initial Enrolment: Induction ART||405
15013|NCT02028676|33383|P4|STARTED|Initial Enrolment: Induction ART||404
15014|NCT02028676|33384|P3|STARTED|Initial Enrolment: Induction ART||397
15015|NCT02028676|33385|P2|STARTED|Initial Enrolment: Induction ART||0
15016|NCT02028676|33386|P1|STARTED|Initial Enrolment: Induction ART||0
15017|NCT02028676|33378|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15018|NCT02028676|33379|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15019|NCT02028676|33380|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15020|NCT02028676|33381|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15021|NCT02028676|33382|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15022|NCT02028676|33383|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15023|NCT02028676|33384|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15024|NCT02028676|33385|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15025|NCT02028676|33386|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
15026|NCT02028676|33378|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
15027|NCT02028676|33379|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
15028|NCT02028676|33380|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
15029|NCT02028676|33381|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
15030|NCT02028676|33382|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
15031|NCT02028676|33383|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
15032|NCT02028676|33384|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
15033|NCT02028676|33385|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
15034|NCT02028676|33386|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
15035|NCT02028676|33378|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
15036|NCT02028676|33379|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
15037|NCT02028676|33380|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
15038|NCT02028676|33381|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
15039|NCT02028676|33382|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
15040|NCT02028676|33383|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
15041|NCT02028676|33384|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
15042|NCT02028676|33385|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
15043|NCT02028676|33386|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
15044|NCT02028325|33559|P1|NOT COMPLETED|Overall Study||10
15045|NCT02028325|33559|P1|COMPLETED|Overall Study||126
15046|NCT02028325|33559|P1|STARTED|Overall Study||136
15047|NCT02028065|33566|P3|NOT COMPLETED|Treatment Through Study Completion||14
15048|NCT02028065|33567|P2|NOT COMPLETED|Treatment Through Study Completion||15
15049|NCT02028065|33568|P1|NOT COMPLETED|Treatment Through Study Completion||12
15050|NCT02028065|33566|P3|COMPLETED|Treatment Through Study Completion||134
15051|NCT02028065|33567|P2|COMPLETED|Treatment Through Study Completion||136
15052|NCT02028065|33568|P1|COMPLETED|Treatment Through Study Completion||64
15053|NCT02028065|33566|P3|Received Third Dose|Treatment Through Study Completion||134
15054|NCT02028065|33567|P2|Received Third Dose|Treatment Through Study Completion||136
15055|NCT02028065|33568|P1|Received Third Dose|Treatment Through Study Completion||64
15056|NCT02028065|33566|P3|Received Second Dose|Treatment Through Study Completion||138
15057|NCT02028065|33567|P2|Received Second Dose|Treatment Through Study Completion||140
15058|NCT02028065|33568|P1|Received Second Dose|Treatment Through Study Completion||69
15059|NCT02028065|33566|P3|Received First Dose|Treatment Through Study Completion||148
15060|NCT02028065|33567|P2|Received First Dose|Treatment Through Study Completion||151
15061|NCT02028065|33568|P1|Received First Dose|Treatment Through Study Completion||76
15062|NCT02028065|33566|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
15063|NCT02028065|33567|P2|STARTED|Treatment Through Study Completion||151
15064|NCT02028065|33568|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
15065|NCT02028065|33566|P3|NOT COMPLETED|Randomization Through Start Treatment||3
15066|NCT02028065|33567|P2|NOT COMPLETED|Randomization Through Start Treatment||3
15067|NCT02028065|33568|P1|NOT COMPLETED|Randomization Through Start Treatment||1
15068|NCT02028065|33566|P3|COMPLETED|Randomization Through Start Treatment||149
15069|NCT02028065|33567|P2|COMPLETED|Randomization Through Start Treatment||151
15070|NCT02028065|33568|P1|COMPLETED|Randomization Through Start Treatment||75
15071|NCT02028065|33566|P3|STARTED|Randomization Through Start Treatment|Randomized|152
15072|NCT02028065|33567|P2|STARTED|Randomization Through Start Treatment|Randomized|154
15073|NCT02028065|33568|P1|STARTED|Randomization Through Start Treatment|Randomized|76
15074|NCT02027883|33581|P2|NOT COMPLETED|Overall Study||0
15075|NCT02027883|33582|P1|NOT COMPLETED|Overall Study||0
15076|NCT02027883|33581|P2|COMPLETED|Overall Study||50
15077|NCT02027883|33582|P1|COMPLETED|Overall Study||50
15078|NCT02027883|33581|P2|STARTED|Overall Study||50
15079|NCT02027883|33582|P1|STARTED|Overall Study||50
15080|NCT02027844|33595|P3|NOT COMPLETED|Overall Study||2
15081|NCT02027844|33596|P2|NOT COMPLETED|Overall Study||6
15082|NCT02027844|33597|P1|NOT COMPLETED|Overall Study||5
15083|NCT02027844|33595|P3|COMPLETED|Overall Study||37
15084|NCT02027844|33596|P2|COMPLETED|Overall Study||33
15085|NCT02027844|33597|P1|COMPLETED|Overall Study||34
15086|NCT02027844|33595|P3|STARTED|Overall Study||39
15087|NCT02027844|33596|P2|STARTED|Overall Study||39
15088|NCT02027844|33597|P1|STARTED|Overall Study||39
15089|NCT02027402|33616|P2|NOT COMPLETED|Overall Study||1
15090|NCT02027402|33617|P1|NOT COMPLETED|Overall Study||4
15091|NCT02027402|33616|P2|COMPLETED|Overall Study||99
15092|NCT02027402|33617|P1|COMPLETED|Overall Study||94
15093|NCT02027402|33616|P2|STARTED|Overall Study||100
15094|NCT02027402|33617|P1|STARTED|Overall Study||98
15095|NCT02027311|33631|P2|NOT COMPLETED|Overall Study||2
15096|NCT02027311|33632|P1|NOT COMPLETED|Overall Study||3
15097|NCT02027311|33631|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
15098|NCT02027311|33632|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
15099|NCT02027311|33631|P2|STARTED|Overall Study||35
15100|NCT02027311|33632|P1|STARTED|Overall Study||33
15101|NCT02027272|33642|P2|NOT COMPLETED|Overall Study||1
15102|NCT02027272|33643|P1|NOT COMPLETED|Overall Study||0
15103|NCT02027272|33642|P2|COMPLETED|Overall Study||0
15104|NCT02027272|33643|P1|COMPLETED|Overall Study||0
15105|NCT02027272|33642|P2|STARTED|Overall Study||1
15106|NCT02027272|33643|P1|STARTED|Overall Study||0
15107|NCT02026206|33651|P2|NOT COMPLETED|Overall Study||8
15108|NCT02026206|33652|P1|NOT COMPLETED|Overall Study||4
15109|NCT02026206|33651|P2|COMPLETED|Overall Study||36
15110|NCT02026206|33652|P1|COMPLETED|Overall Study||40
15111|NCT02026206|33651|P2|STARTED|Overall Study||44
15112|NCT02026206|33652|P1|STARTED|Overall Study||44
15113|NCT02026193|33662|P2|NOT COMPLETED|Overall Study||0
15114|NCT02026193|33663|P1|NOT COMPLETED|Overall Study||0
15115|NCT02026193|33662|P2|COMPLETED|Overall Study||8
15116|NCT02026193|33663|P1|COMPLETED|Overall Study||3
15117|NCT02026193|33662|P2|STARTED|Overall Study||8
15118|NCT02026193|33663|P1|STARTED|Overall Study||3
15120|NCT02026141|33672|P1|NOT COMPLETED|Overall Study||0
15121|NCT02026141|33671|P2|COMPLETED|Overall Study||19
15122|NCT02026141|33672|P1|COMPLETED|Overall Study||20
15123|NCT02026141|33671|P2|STARTED|Overall Study||20
15124|NCT02026141|33672|P1|STARTED|Overall Study||20
15125|NCT02025907|33680|P2|NOT COMPLETED|Overall Study||12
15126|NCT02025907|33681|P1|NOT COMPLETED|Overall Study||27
15127|NCT02025907|33680|P2|COMPLETED|Overall Study||96
15128|NCT02025907|33681|P1|COMPLETED|Overall Study||81
15129|NCT02025907|33680|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
15130|NCT02025907|33681|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
15131|NCT02025647|33695|P1|NOT COMPLETED|Overall Study||0
15132|NCT02025647|33695|P1|COMPLETED|Overall Study||139
15133|NCT02025647|33695|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
15134|NCT02025647|33695|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
15135|NCT02025647|33695|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
15136|NCT02025647|33695|P1|Session 1 (Narrative Module)|Overall Study||139
15137|NCT02025647|33695|P1|STARTED|Overall Study||139
15138|NCT02024971|33724|P1|NOT COMPLETED|Overall Study||36
15139|NCT02024971|33724|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
15140|NCT02024971|33724|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
15141|NCT02024971|33724|P1|STARTED|Overall Study||1103
15142|NCT02024867|33733|P2|NOT COMPLETED|Overall Study||7
15143|NCT02024867|33734|P1|NOT COMPLETED|Overall Study||9
15144|NCT02024867|33733|P2|COMPLETED|Overall Study||124
15145|NCT02024867|33734|P1|COMPLETED|Overall Study||125
15146|NCT02024867|33733|P2|STARTED|Overall Study||131
15147|NCT02024867|33734|P1|STARTED|Overall Study||134
15148|NCT02024698|33750|P2|NOT COMPLETED|Second Intervention (7 Days)||0
15149|NCT02024698|33751|P1|NOT COMPLETED|Second Intervention (7 Days)||0
15150|NCT02024698|33750|P2|COMPLETED|Second Intervention (7 Days)||26
15151|NCT02024698|33751|P1|COMPLETED|Second Intervention (7 Days)||16
15152|NCT02024698|33750|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
15153|NCT02024698|33751|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
15154|NCT02024698|33750|P2|STARTED|Second Intervention (7 Days)||26
15155|NCT02024698|33751|P1|STARTED|Second Intervention (7 Days)||16
15156|NCT02024698|33750|P2|NOT COMPLETED|First Intervention (7 Days)||1
15157|NCT02024698|33751|P1|NOT COMPLETED|First Intervention (7 Days)||0
15158|NCT02024698|33750|P2|COMPLETED|First Intervention (7 Days)||26
15159|NCT02024698|33751|P1|COMPLETED|First Intervention (7 Days)||16
15160|NCT02024698|33750|P2|STARTED|First Intervention (7 Days)||27
15161|NCT02024698|33751|P1|STARTED|First Intervention (7 Days)||16
15162|NCT02024165|33777|P1|NOT COMPLETED|Overall Study||0
15163|NCT02024165|33777|P1|COMPLETED|Overall Study||71
15164|NCT02024165|33777|P1|STARTED|Overall Study||71
15165|NCT02023801|33782|P1|NOT COMPLETED|Overall Study||0
15166|NCT02023801|33782|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
15167|NCT02023801|33782|P1|Treated|Overall Study|Treatment Completed|24
15168|NCT02023801|33782|P1|STARTED|Overall Study|Treatment Attempted|24
15169|NCT02023268|33790|P2|NOT COMPLETED|Overall Study||4
15170|NCT02023268|33791|P1|NOT COMPLETED|Overall Study||0
15171|NCT02023268|33790|P2|COMPLETED|Overall Study||49
15172|NCT02023268|33791|P1|COMPLETED|Overall Study||52
15173|NCT02023268|33790|P2|STARTED|Overall Study||53
15174|NCT02023268|33791|P1|STARTED|Overall Study||52
15175|NCT02023125|33799|P3|NOT COMPLETED|Period 2||0
15176|NCT02023125|33800|P2|NOT COMPLETED|Period 2||0
15177|NCT02023125|33801|P1|NOT COMPLETED|Period 2||0
15178|NCT02023125|33799|P3|COMPLETED|Period 2||24
15179|NCT02023125|33800|P2|COMPLETED|Period 2||9
15180|NCT02023125|33801|P1|COMPLETED|Period 2||9
15181|NCT02023125|33799|P3|STARTED|Period 2||24
15182|NCT02023125|33800|P2|STARTED|Period 2||9
15183|NCT02023125|33801|P1|STARTED|Period 2||9
15184|NCT02023125|33799|P3|NOT COMPLETED|Washout Period||0
15185|NCT02023125|33800|P2|NOT COMPLETED|Washout Period||0
15186|NCT02023125|33801|P1|NOT COMPLETED|Washout Period||0
15187|NCT02023125|33799|P3|COMPLETED|Washout Period||24
15188|NCT02023125|33800|P2|COMPLETED|Washout Period||9
15189|NCT02023125|33801|P1|COMPLETED|Washout Period||9
15190|NCT02023125|33799|P3|STARTED|Washout Period||24
15191|NCT02023125|33800|P2|STARTED|Washout Period||9
15192|NCT02023125|33801|P1|STARTED|Washout Period||9
15193|NCT02023125|33799|P3|NOT COMPLETED|Period 1||0
15194|NCT02023125|33800|P2|NOT COMPLETED|Period 1||0
15195|NCT02023125|33801|P1|NOT COMPLETED|Period 1||0
15196|NCT02023125|33799|P3|COMPLETED|Period 1||24
15197|NCT02023125|33800|P2|COMPLETED|Period 1||9
15198|NCT02023125|33801|P1|COMPLETED|Period 1||9
15199|NCT02023125|33799|P3|STARTED|Period 1||24
15200|NCT02023125|33800|P2|STARTED|Period 1||9
15201|NCT02023125|33801|P1|STARTED|Period 1||9
15202|NCT02023112|33862|P2|NOT COMPLETED|Overall Study||1
15203|NCT02023112|33863|P1|NOT COMPLETED|Overall Study||2
15204|NCT02023112|33862|P2|COMPLETED|Overall Study||85
15205|NCT02023112|33863|P1|COMPLETED|Overall Study||83
15206|NCT02023112|33862|P2|STARTED|Overall Study||86
15207|NCT02023112|33863|P1|STARTED|Overall Study||85
15208|NCT02023099|33884|P3|NOT COMPLETED|Overall Study||3
15209|NCT02023099|33885|P2|NOT COMPLETED|Overall Study||0
15210|NCT02023099|33886|P1|NOT COMPLETED|Overall Study||3
15211|NCT02023099|33884|P3|COMPLETED|Overall Study||39
15212|NCT02023099|33885|P2|COMPLETED|Overall Study||106
15213|NCT02023099|33886|P1|COMPLETED|Overall Study||212
15214|NCT02023099|33884|P3|STARTED|Overall Study||42
15215|NCT02023099|33885|P2|STARTED|Overall Study||106
15216|NCT02023099|33886|P1|STARTED|Overall Study||215
15217|NCT02022670|33905|P3|NOT COMPLETED|Overall Study||1
15218|NCT02022670|33906|P2|NOT COMPLETED|Overall Study||0
15219|NCT02022670|33907|P1|NOT COMPLETED|Overall Study||1
15220|NCT02022670|33905|P3|COMPLETED|Overall Study||11
15221|NCT02022670|33906|P2|COMPLETED|Overall Study||10
15222|NCT02022670|33907|P1|COMPLETED|Overall Study||10
15223|NCT02022670|33905|P3|STARTED|Overall Study||12
15224|NCT02022670|33906|P2|STARTED|Overall Study||10
15225|NCT02022670|33907|P1|STARTED|Overall Study||11
15226|NCT02022085|33921|P1|NOT COMPLETED|Overall Study||1
15227|NCT02022085|33921|P1|COMPLETED|Overall Study||53
15228|NCT02022085|33921|P1|STARTED|Overall Study||54
15229|NCT02022020|33942|P1|NOT COMPLETED|Overall Study||0
15230|NCT02022020|33942|P1|COMPLETED|Overall Study||220
15231|NCT02022020|33942|P1|STARTED|Overall Study||220
15232|NCT02021461|33948|P1|NOT COMPLETED|Overall Study||0
15233|NCT02021461|33948|P1|COMPLETED|Overall Study||38
15234|NCT02021461|33948|P1|STARTED|Overall Study||38
15235|NCT02021071|33956|P2|NOT COMPLETED|Overall Study||0
15236|NCT02021071|33957|P1|NOT COMPLETED|Overall Study||0
15237|NCT02021071|33956|P2|COMPLETED|Overall Study||12
15238|NCT02021071|33957|P1|COMPLETED|Overall Study||12
15239|NCT02021071|33956|P2|STARTED|Overall Study||12
15240|NCT02021071|33957|P1|STARTED|Overall Study||12
15241|NCT02020941|33964|P1|NOT COMPLETED|Overall Study||8
15242|NCT02020941|33964|P1|COMPLETED|Overall Study||2
15243|NCT02020941|33964|P1|STARTED|Overall Study||10
15244|NCT02020863|33973|P1|NOT COMPLETED|Overall Study||5
15245|NCT02020863|33973|P1|COMPLETED|Overall Study||35
15246|NCT02020863|33973|P1|STARTED|Overall Study||40
15247|NCT02020577|33979|P2|NOT COMPLETED|Overall Study||52
15248|NCT02020577|33980|P1|NOT COMPLETED|Overall Study||3
15249|NCT02020577|33979|P2|COMPLETED|Overall Study|3 patients on treatment at cut-off date of 18Nov2015|3
15250|NCT02020577|33980|P1|COMPLETED|Overall Study||0
15251|NCT02020577|33979|P2|STARTED|Overall Study||55
15252|NCT02020577|33980|P1|STARTED|Overall Study||3
15253|NCT02020512|33990|P1|NOT COMPLETED|Overall Study||8
15254|NCT02020512|33990|P1|COMPLETED|Overall Study||79
15255|NCT02020512|33990|P1|STARTED|Overall Study||87
15256|NCT02020031|33996|P2|NOT COMPLETED|Overall Study||1
15257|NCT02020031|33997|P1|NOT COMPLETED|Overall Study||1
15258|NCT02020031|33996|P2|COMPLETED|Overall Study||10
15259|NCT02020031|33997|P1|COMPLETED|Overall Study||10
15260|NCT02020031|33996|P2|STARTED|Overall Study||11
15261|NCT02020031|33997|P1|STARTED|Overall Study||11
15262|NCT02019563|34007|P2|NOT COMPLETED|Overall Study||0
15263|NCT02019563|34008|P1|NOT COMPLETED|Overall Study||0
15264|NCT02019563|34007|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
15265|NCT02019563|34008|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
15266|NCT02019563|34007|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
15267|NCT02019563|34008|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
15268|NCT02017574|34024|P2|NOT COMPLETED|Overall Study||0
15269|NCT02017574|34025|P1|NOT COMPLETED|Overall Study||0
15270|NCT02017574|34024|P2|COMPLETED|Overall Study||12
15271|NCT02017574|34025|P1|COMPLETED|Overall Study||12
15272|NCT02017574|34024|P2|STARTED|Overall Study||12
15273|NCT02017574|34025|P1|STARTED|Overall Study||12
15274|NCT02017093|34035|P2|NOT COMPLETED|Overall Study||0
15275|NCT02017093|34036|P1|NOT COMPLETED|Overall Study||0
15276|NCT02017093|34035|P2|COMPLETED|Overall Study||3
15277|NCT02017093|34036|P1|COMPLETED|Overall Study||4
15278|NCT02017093|34035|P2|STARTED|Overall Study||3
15279|NCT02017093|34036|P1|STARTED|Overall Study||4
15280|NCT02017015|34044|P1|NOT COMPLETED|Overall Study||69
15281|NCT02017015|34044|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
15282|NCT02017015|34044|P1|Safety Population|Overall Study||83
15283|NCT02017015|34044|P1|STARTED|Overall Study||83
15284|NCT02016963|34051|P1|NOT COMPLETED|Overall Study||0
15285|NCT02016963|34051|P1|COMPLETED|Overall Study||20
15286|NCT02016963|34051|P1|STARTED|Overall Study||20
15287|NCT02016690|34067|P1|NOT COMPLETED|Overall Study||24
15288|NCT02016690|34067|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
15289|NCT02016690|34067|P1|Safety Analysis Set (SAS)|Overall Study||304
15290|NCT02016690|34067|P1|Treated|Overall Study||312
15291|NCT02016690|34067|P1|STARTED|Overall Study||312
15292|NCT02016625|34080|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
15293|NCT02016625|34081|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
15294|NCT02016625|34080|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
15295|NCT02016625|34081|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
15296|NCT02016625|34080|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
15297|NCT02016625|34081|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
15298|NCT02016625|34080|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
15299|NCT02016625|34081|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
15300|NCT02016625|34080|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
15301|NCT02016625|34081|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
15302|NCT02016625|34080|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
15303|NCT02016625|34081|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
15304|NCT02016482|34115|P2|NOT COMPLETED|Period B||7
15305|NCT02016482|34116|P1|NOT COMPLETED|Period B||9
15306|NCT02016482|34115|P2|COMPLETED|Period B|Participants who completed or are ongoing in Period B.|87
15307|NCT02016482|34116|P1|COMPLETED|Period B|Participants who completed or are ongoing in Period B.|85
15308|NCT02016482|34115|P2|STARTED|Period B||94
15309|NCT02016482|34116|P1|STARTED|Period B||94
15310|NCT02016482|34115|P2|NOT COMPLETED|Period A||15
15311|NCT02016482|34116|P1|NOT COMPLETED|Period A||14
15312|NCT02016482|34115|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
15313|NCT02016482|34116|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
15314|NCT02016482|34115|P2|STARTED|Period A||109
15315|NCT02016482|34116|P1|STARTED|Period A||108
15316|NCT02016170|34207|P3|NOT COMPLETED|Overall Study||0
15317|NCT02016170|34208|P2|NOT COMPLETED|Overall Study||1
15318|NCT02016170|34209|P1|NOT COMPLETED|Overall Study||2
15319|NCT02016170|34207|P3|COMPLETED|Overall Study||27
15320|NCT02016170|34208|P2|COMPLETED|Overall Study||27
15321|NCT02016170|34209|P1|COMPLETED|Overall Study||25
15322|NCT02016170|34207|P3|STARTED|Overall Study||27
15323|NCT02016170|34208|P2|STARTED|Overall Study||28
15324|NCT02016170|34209|P1|STARTED|Overall Study||27
15325|NCT02015910|34220|P2|NOT COMPLETED|Overall Study||0
15326|NCT02015910|34221|P1|NOT COMPLETED|Overall Study||0
15327|NCT02015910|34220|P2|COMPLETED|Overall Study||1
15328|NCT02015910|34221|P1|COMPLETED|Overall Study||0
15329|NCT02015910|34220|P2|STARTED|Overall Study||1
15330|NCT02015910|34221|P1|STARTED|Overall Study||0
15331|NCT02015793|34229|P2|NOT COMPLETED|Overall Study||4
15332|NCT02015793|34230|P1|NOT COMPLETED|Overall Study||4
15333|NCT02015793|34229|P2|COMPLETED|Overall Study||11
15334|NCT02015793|34230|P1|COMPLETED|Overall Study||11
15335|NCT02015793|34229|P2|Entered Open-label Extension Period|Overall Study||14
15336|NCT02015793|34230|P1|Entered Open-label Extension Period|Overall Study||13
15337|NCT02015793|34229|P2|Completed Double-Blind Period|Overall Study||14
15338|NCT02015793|34230|P1|Completed Double-Blind Period|Overall Study||14
15339|NCT02015793|34229|P2|STARTED|Overall Study||15
15340|NCT02015793|34230|P1|STARTED|Overall Study||15
15341|NCT02015676|34263|P3|NOT COMPLETED|Overall Study||3
15342|NCT02015676|34264|P2|NOT COMPLETED|Overall Study||34
15343|NCT02015676|34265|P1|NOT COMPLETED|Overall Study||9
15344|NCT02015676|34263|P3|COMPLETED|Overall Study||3
15345|NCT02015676|34264|P2|COMPLETED|Overall Study||14
15346|NCT02015676|34265|P1|COMPLETED|Overall Study||6
15347|NCT02015676|34263|P3|STARTED|Overall Study||6
15348|NCT02015676|34264|P2|STARTED|Overall Study||48
15349|NCT02015676|34265|P1|STARTED|Overall Study||15
15350|NCT02015546|34282|P3|NOT COMPLETED|Overall Study||4
15351|NCT02015546|34283|P2|NOT COMPLETED|Overall Study||2
15352|NCT02015546|34284|P1|NOT COMPLETED|Overall Study||3
15353|NCT02015546|34282|P3|COMPLETED|Overall Study||22
15354|NCT02015546|34283|P2|COMPLETED|Overall Study||19
15355|NCT02015546|34284|P1|COMPLETED|Overall Study||20
15356|NCT02015546|34282|P3|STARTED|Overall Study||26
15357|NCT02015546|34283|P2|STARTED|Overall Study||21
15358|NCT02015546|34284|P1|STARTED|Overall Study||23
15359|NCT02015221|34318|P2|NOT COMPLETED|Overall Study||6
15360|NCT02015221|34319|P1|NOT COMPLETED|Overall Study||9
15361|NCT02015221|34318|P2|COMPLETED|Overall Study||34
15362|NCT02015221|34319|P1|COMPLETED|Overall Study||32
15363|NCT02015221|34318|P2|STARTED|Overall Study||40
15364|NCT02015221|34319|P1|STARTED|Overall Study||41
15365|NCT02015195|34332|P7|NOT COMPLETED|Overall Study||0
15366|NCT02015195|34333|P6|NOT COMPLETED|Overall Study||0
15367|NCT02015195|34334|P5|NOT COMPLETED|Overall Study||0
15368|NCT02015195|34335|P4|NOT COMPLETED|Overall Study||1
15369|NCT02015195|34336|P3|NOT COMPLETED|Overall Study||0
15370|NCT02015195|34337|P2|NOT COMPLETED|Overall Study||0
15371|NCT02015195|34338|P1|NOT COMPLETED|Overall Study||0
15372|NCT02015195|34332|P7|COMPLETED|Overall Study||16
15373|NCT02015195|34333|P6|COMPLETED|Overall Study||16
15374|NCT02015195|34334|P5|COMPLETED|Overall Study||16
15375|NCT02015195|34335|P4|COMPLETED|Overall Study||0
15376|NCT02015195|34336|P3|COMPLETED|Overall Study||16
15377|NCT02015195|34337|P2|COMPLETED|Overall Study||16
15378|NCT02015195|34338|P1|COMPLETED|Overall Study||16
15379|NCT02015195|34332|P7|STARTED|Overall Study||16
15380|NCT02015195|34333|P6|STARTED|Overall Study||16
15381|NCT02015195|34334|P5|STARTED|Overall Study||16
15382|NCT02015195|34335|P4|STARTED|Overall Study||1
15383|NCT02015195|34336|P3|STARTED|Overall Study||16
15384|NCT02015195|34337|P2|STARTED|Overall Study||16
15385|NCT02015195|34338|P1|STARTED|Overall Study||16
15386|NCT02014480|34359|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
15387|NCT02014480|34360|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
15388|NCT02014480|34361|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
15389|NCT02014480|34362|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
15390|NCT02014480|34363|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
15391|NCT02014480|34364|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
15392|NCT02014480|34359|P6|COMPLETED|Treatment Period 3 (14 Days)||32
15393|NCT02014480|34360|P5|COMPLETED|Treatment Period 3 (14 Days)||34
15394|NCT02014480|34361|P4|COMPLETED|Treatment Period 3 (14 Days)||31
15395|NCT02014480|34362|P3|COMPLETED|Treatment Period 3 (14 Days)||29
15396|NCT02014480|34363|P2|COMPLETED|Treatment Period 3 (14 Days)||32
15397|NCT02014480|34364|P1|COMPLETED|Treatment Period 3 (14 Days)||34
15398|NCT02014480|34359|P6|STARTED|Treatment Period 3 (14 Days)||34
15399|NCT02014480|34360|P5|STARTED|Treatment Period 3 (14 Days)||34
15400|NCT02014480|34361|P4|STARTED|Treatment Period 3 (14 Days)||31
15401|NCT02014480|34362|P3|STARTED|Treatment Period 3 (14 Days)||30
15402|NCT02014480|34363|P2|STARTED|Treatment Period 3 (14 Days)||33
15403|NCT02014480|34364|P1|STARTED|Treatment Period 3 (14 Days)||34
15404|NCT02014480|34359|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15405|NCT02014480|34360|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15406|NCT02014480|34361|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15407|NCT02014480|34362|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15408|NCT02014480|34363|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15409|NCT02014480|34364|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
15410|NCT02014480|34359|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
15411|NCT02014480|34360|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
15412|NCT02014480|34361|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
15413|NCT02014480|34362|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
15414|NCT02014480|34363|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
15415|NCT02014480|34364|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
15416|NCT02014480|34359|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
15417|NCT02014480|34360|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
15418|NCT02014480|34361|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
15419|NCT02014480|34362|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
15420|NCT02014480|34363|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
15421|NCT02014480|34364|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
15422|NCT02014480|34359|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
15423|NCT02014480|34360|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
15424|NCT02014480|34361|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
15425|NCT02014480|34362|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
15426|NCT02014480|34363|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
15427|NCT02014480|34364|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
15428|NCT02014480|34359|P6|COMPLETED|Treatment Period 2 (14 Days)||34
15429|NCT02014480|34360|P5|COMPLETED|Treatment Period 2 (14 Days)||34
15430|NCT02014480|34361|P4|COMPLETED|Treatment Period 2 (14 Days)||31
15431|NCT02014480|34362|P3|COMPLETED|Treatment Period 2 (14 Days)||30
15432|NCT02014480|34363|P2|COMPLETED|Treatment Period 2 (14 Days)||33
15433|NCT02014480|34364|P1|COMPLETED|Treatment Period 2 (14 Days)||34
15434|NCT02014480|34359|P6|STARTED|Treatment Period 2 (14 Days)||34
15435|NCT02014480|34360|P5|STARTED|Treatment Period 2 (14 Days)||34
15436|NCT02014480|34361|P4|STARTED|Treatment Period 2 (14 Days)||32
15437|NCT02014480|34362|P3|STARTED|Treatment Period 2 (14 Days)||32
15438|NCT02014480|34363|P2|STARTED|Treatment Period 2 (14 Days)||34
15439|NCT02014480|34364|P1|STARTED|Treatment Period 2 (14 Days)||35
15440|NCT02014480|34359|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
15441|NCT02014480|34360|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
15442|NCT02014480|34361|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
15443|NCT02014480|34362|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
15444|NCT02014480|34363|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
15445|NCT02014480|34364|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
15446|NCT02014480|34359|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
15447|NCT02014480|34360|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
15448|NCT02014480|34361|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
15449|NCT02014480|34362|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
15450|NCT02014480|34363|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
15451|NCT02014480|34364|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
15452|NCT02014480|34359|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
15453|NCT02014480|34360|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
15454|NCT02014480|34361|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
15455|NCT02014480|34362|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
15456|NCT02014480|34363|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
15457|NCT02014480|34364|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
15458|NCT02014480|34359|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
15459|NCT02014480|34360|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
15460|NCT02014480|34361|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
15461|NCT02014480|34362|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
15462|NCT02014480|34363|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
15463|NCT02014480|34364|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
15464|NCT02014480|34359|P6|COMPLETED|Treatment Period 1 (14 Days)||34
15465|NCT02014480|34360|P5|COMPLETED|Treatment Period 1 (14 Days)||34
15466|NCT02014480|34361|P4|COMPLETED|Treatment Period 1 (14 Days)||32
15467|NCT02014480|34362|P3|COMPLETED|Treatment Period 1 (14 Days)||33
15468|NCT02014480|34363|P2|COMPLETED|Treatment Period 1 (14 Days)||34
15469|NCT02014480|34364|P1|COMPLETED|Treatment Period 1 (14 Days)||35
15470|NCT02014480|34359|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
15471|NCT02014480|34360|P5|STARTED|Treatment Period 1 (14 Days)||35
15472|NCT02014480|34361|P4|STARTED|Treatment Period 1 (14 Days)||34
15473|NCT02014480|34362|P3|STARTED|Treatment Period 1 (14 Days)||34
15474|NCT02014480|34363|P2|STARTED|Treatment Period 1 (14 Days)||35
15475|NCT02014480|34364|P1|STARTED|Treatment Period 1 (14 Days)||35
15476|NCT02014467|34383|P2|NOT COMPLETED|Overall Study||7
15477|NCT02014467|34384|P1|NOT COMPLETED|Overall Study||25
15478|NCT02014467|34383|P2|COMPLETED|Overall Study||112
15479|NCT02014467|34384|P1|COMPLETED|Overall Study||340
15480|NCT02014467|34383|P2|STARTED|Overall Study||119
15481|NCT02014467|34384|P1|STARTED|Overall Study||365
15482|NCT02014441|34444|P1|NOT COMPLETED|Overall Study||30
15483|NCT02014441|34444|P1|COMPLETED|Overall Study||31
15484|NCT02014441|34444|P1|Received Treatment|Overall Study||60
15485|NCT02014441|34444|P1|STARTED|Overall Study||61
15486|NCT02014363|34539|P3|NOT COMPLETED|Overall Study||24
15487|NCT02014363|34540|P2|NOT COMPLETED|Overall Study||19
15488|NCT02014363|34541|P1|NOT COMPLETED|Overall Study||17
15489|NCT02014363|34539|P3|COMPLETED|Overall Study||31
15490|NCT02014363|34540|P2|COMPLETED|Overall Study||35
15491|NCT02014363|34541|P1|COMPLETED|Overall Study||38
15492|NCT02014363|34539|P3|STARTED|Overall Study||55
15493|NCT02014363|34540|P2|STARTED|Overall Study||54
15494|NCT02014363|34541|P1|STARTED|Overall Study||55
15495|NCT02014272|34549|P2|NOT COMPLETED|Intervention Period 2||0
15496|NCT02014272|34550|P1|NOT COMPLETED|Intervention Period 2||0
15497|NCT02014272|34549|P2|COMPLETED|Intervention Period 2||13
15498|NCT02014272|34550|P1|COMPLETED|Intervention Period 2||13
15499|NCT02014272|34549|P2|STARTED|Intervention Period 2||13
15500|NCT02014272|34550|P1|STARTED|Intervention Period 2||13
15501|NCT02014272|34549|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
15502|NCT02014272|34550|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
15503|NCT02014272|34549|P2|COMPLETED|Washout Period 1 (7 Days)||13
15504|NCT02014272|34550|P1|COMPLETED|Washout Period 1 (7 Days)||13
15505|NCT02014272|34549|P2|STARTED|Washout Period 1 (7 Days)||13
15506|NCT02014272|34550|P1|STARTED|Washout Period 1 (7 Days)||13
15507|NCT02014272|34549|P2|NOT COMPLETED|Intervention Period 1||1
15508|NCT02014272|34550|P1|NOT COMPLETED|Intervention Period 1||1
15509|NCT02014272|34549|P2|COMPLETED|Intervention Period 1||13
15510|NCT02014272|34550|P1|COMPLETED|Intervention Period 1||13
15511|NCT02014272|34549|P2|STARTED|Intervention Period 1||14
15512|NCT02014272|34550|P1|STARTED|Intervention Period 1||14
15513|NCT02014051|34568|P2|NOT COMPLETED|Overall Study||1
15514|NCT02014051|34569|P1|NOT COMPLETED|Overall Study||1
15515|NCT02014051|34568|P2|COMPLETED|Overall Study||5
15516|NCT02014051|34569|P1|COMPLETED|Overall Study||2
15517|NCT02014051|34568|P2|STARTED|Overall Study||6
15518|NCT02014051|34569|P1|STARTED|Overall Study||3
15519|NCT02013830|34582|P1|NOT COMPLETED|Overall Study||30
15520|NCT02013830|34582|P1|COMPLETED|Overall Study||15
15521|NCT02013830|34582|P1|STARTED|Overall Study||45
15522|NCT02013817|34593|P1|NOT COMPLETED|Overall Study||27
15523|NCT02013817|34593|P1|COMPLETED|Overall Study||16
15524|NCT02013817|34593|P1|STARTED|Overall Study||43
15525|NCT02013765|34602|P1|NOT COMPLETED|Overall Study||1
15526|NCT02013765|34602|P1|COMPLETED|Overall Study||4
15527|NCT02013765|34602|P1|STARTED|Overall Study||5
15528|NCT02013687|34616|P4|NOT COMPLETED|Overall Study||2
15529|NCT02013687|34617|P3|NOT COMPLETED|Overall Study||2
15530|NCT02013687|34618|P2|NOT COMPLETED|Overall Study||0
15531|NCT02013687|34619|P1|NOT COMPLETED|Overall Study||0
15532|NCT02013687|34616|P4|COMPLETED|Overall Study||14
15533|NCT02013687|34617|P3|COMPLETED|Overall Study||14
15534|NCT02013687|34618|P2|COMPLETED|Overall Study||6
15535|NCT02013687|34619|P1|COMPLETED|Overall Study||6
15536|NCT02013687|34616|P4|STARTED|Overall Study||16
15537|NCT02013687|34617|P3|STARTED|Overall Study||16
15538|NCT02013687|34618|P2|STARTED|Overall Study||6
15539|NCT02013687|34619|P1|STARTED|Overall Study||6
15540|NCT02013622|34649|P1|NOT COMPLETED|Overall Study||24
15541|NCT02013622|34649|P1|COMPLETED|Overall Study||25
15542|NCT02013622|34649|P1|STARTED|Overall Study||49
15543|NCT02013609|34669|P1|NOT COMPLETED|Overall Study||18
15544|NCT02013609|34669|P1|COMPLETED|Overall Study||29
15545|NCT02013609|34669|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
15546|NCT02013531|34692|P1|NOT COMPLETED|Overall Study||5
15547|NCT02013531|34692|P1|COMPLETED|Overall Study||32
15548|NCT02013531|34692|P1|STARTED|Overall Study||37
15549|NCT02013388|34722|P8|NOT COMPLETED|Overall Study||0
15550|NCT02013388|34723|P7|NOT COMPLETED|Overall Study||0
15551|NCT02013388|34724|P6|NOT COMPLETED|Overall Study||0
15552|NCT02013388|34725|P5|NOT COMPLETED|Overall Study||1
15553|NCT02013388|34726|P4|NOT COMPLETED|Overall Study||0
15554|NCT02013388|34727|P3|NOT COMPLETED|Overall Study||0
15555|NCT02013388|34728|P2|NOT COMPLETED|Overall Study||0
15556|NCT02013388|34729|P1|NOT COMPLETED|Overall Study||1
15557|NCT02013388|34722|P8|COMPLETED|Overall Study||4
15558|NCT02013388|34723|P7|COMPLETED|Overall Study||6
15559|NCT02013388|34724|P6|COMPLETED|Overall Study||6
15560|NCT02013388|34725|P5|COMPLETED|Overall Study||5
15561|NCT02013388|34726|P4|COMPLETED|Overall Study||6
15562|NCT02013388|34727|P3|COMPLETED|Overall Study||6
15563|NCT02013388|34728|P2|COMPLETED|Overall Study||6
15564|NCT02013388|34729|P1|COMPLETED|Overall Study||8
15565|NCT02013388|34722|P8|STARTED|Overall Study||4
15566|NCT02013388|34723|P7|STARTED|Overall Study||6
15567|NCT02013388|34724|P6|STARTED|Overall Study||6
15568|NCT02013388|34725|P5|STARTED|Overall Study||6
15569|NCT02013388|34726|P4|STARTED|Overall Study||6
15570|NCT02013388|34727|P3|STARTED|Overall Study||6
15571|NCT02013388|34728|P2|STARTED|Overall Study||6
15572|NCT02013388|34729|P1|STARTED|Overall Study||9
15573|NCT02013206|34765|P2|NOT COMPLETED|Overall Study||22
15574|NCT02013206|34766|P1|NOT COMPLETED|Overall Study||27
15575|NCT02013206|34765|P2|COMPLETED|Overall Study||1
15576|NCT02013206|34766|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
15577|NCT02013206|34765|P2|Received Study Drug|Overall Study||23
15578|NCT02013206|34766|P1|Received Study Drug|Overall Study||26
15579|NCT02013206|34765|P2|STARTED|Overall Study||23
15580|NCT02013206|34766|P1|STARTED|Overall Study||29
15581|NCT02012686|34788|P2|NOT COMPLETED|Overall Study||2
15582|NCT02012686|34789|P1|NOT COMPLETED|Overall Study||0
15583|NCT02012686|34788|P2|COMPLETED|Overall Study||48
15584|NCT02012686|34789|P1|COMPLETED|Overall Study||50
15585|NCT02012686|34788|P2|STARTED|Overall Study||50
15586|NCT02012686|34789|P1|STARTED|Overall Study||50
15587|NCT02012582|34805|P4|NOT COMPLETED|Overall Study||1
15588|NCT02012582|34806|P3|NOT COMPLETED|Overall Study||0
15589|NCT02012582|34807|P2|NOT COMPLETED|Overall Study||0
15590|NCT02012582|34808|P1|NOT COMPLETED|Overall Study||0
15591|NCT02012582|34805|P4|COMPLETED|Overall Study||7
15592|NCT02012582|34806|P3|COMPLETED|Overall Study||8
15593|NCT02012582|34807|P2|COMPLETED|Overall Study||8
15594|NCT02012582|34808|P1|COMPLETED|Overall Study||8
15595|NCT02012582|34805|P4|STARTED|Overall Study||8
15596|NCT02012582|34806|P3|STARTED|Overall Study||8
15597|NCT02012582|34807|P2|STARTED|Overall Study||8
15598|NCT02012582|34808|P1|STARTED|Overall Study||8
15599|NCT02012452|34836|P2|NOT COMPLETED|Overall Study||1
15600|NCT02012452|34837|P1|NOT COMPLETED|Overall Study||6
15601|NCT02012452|34836|P2|COMPLETED|Overall Study||1
15602|NCT02012452|34837|P1|COMPLETED|Overall Study||1
15603|NCT02012452|34836|P2|STARTED|Overall Study||2
15604|NCT02012452|34837|P1|STARTED|Overall Study||7
15605|NCT02012218|34850|P5|NOT COMPLETED|Overall Study||1
15606|NCT02012218|34851|P4|NOT COMPLETED|Overall Study||2
15607|NCT02012218|34852|P3|NOT COMPLETED|Overall Study||2
15608|NCT02012218|34853|P2|NOT COMPLETED|Overall Study||1
15609|NCT02012218|34854|P1|NOT COMPLETED|Overall Study||4
15610|NCT02012218|34850|P5|COMPLETED|Overall Study||5
15611|NCT02012218|34851|P4|COMPLETED|Overall Study||17
15612|NCT02012218|34852|P3|COMPLETED|Overall Study||11
15613|NCT02012218|34853|P2|COMPLETED|Overall Study||10
15614|NCT02012218|34854|P1|COMPLETED|Overall Study||8
15615|NCT02012218|34850|P5|STARTED|Overall Study||6
15616|NCT02012218|34851|P4|STARTED|Overall Study||19
15617|NCT02012218|34852|P3|STARTED|Overall Study||13
15618|NCT02012218|34853|P2|STARTED|Overall Study||11
15619|NCT02012218|34854|P1|STARTED|Overall Study||12
15620|NCT02011490|34869|P6|NOT COMPLETED|Part 2||0
15621|NCT02011490|34870|P5|NOT COMPLETED|Part 2||0
15622|NCT02011490|34871|P4|NOT COMPLETED|Part 2||0
15623|NCT02011490|34872|P3|NOT COMPLETED|Part 2||0
15624|NCT02011490|34873|P2|NOT COMPLETED|Part 2||0
15625|NCT02011490|34874|P1|NOT COMPLETED|Part 2||0
15626|NCT02011490|34869|P6|COMPLETED|Part 2||6
15627|NCT02011490|34870|P5|COMPLETED|Part 2||6
15628|NCT02011490|34871|P4|COMPLETED|Part 2||6
15629|NCT02011490|34872|P3|COMPLETED|Part 2||0
15630|NCT02011490|34873|P2|COMPLETED|Part 2||0
15631|NCT02011490|34874|P1|COMPLETED|Part 2||0
15632|NCT02011490|34869|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
15633|NCT02011490|34870|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
15634|NCT02011490|34871|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
15635|NCT02011490|34872|P3|STARTED|Part 2||0
15636|NCT02011490|34873|P2|STARTED|Part 2||0
15637|NCT02011490|34874|P1|STARTED|Part 2||0
15638|NCT02011490|34869|P6|NOT COMPLETED|Part 1||0
15639|NCT02011490|34870|P5|NOT COMPLETED|Part 1||0
15640|NCT02011490|34871|P4|NOT COMPLETED|Part 1||0
15641|NCT02011490|34872|P3|NOT COMPLETED|Part 1||0
15642|NCT02011490|34873|P2|NOT COMPLETED|Part 1||0
15643|NCT02011490|34874|P1|NOT COMPLETED|Part 1||0
15644|NCT02011490|34869|P6|COMPLETED|Part 1||0
15645|NCT02011490|34870|P5|COMPLETED|Part 1||0
15646|NCT02011490|34871|P4|COMPLETED|Part 1||0
15647|NCT02011490|34872|P3|COMPLETED|Part 1||8
15648|NCT02011490|34873|P2|COMPLETED|Part 1||8
15649|NCT02011490|34874|P1|COMPLETED|Part 1||8
15650|NCT02011490|34869|P6|STARTED|Part 1||0
15651|NCT02011490|34870|P5|STARTED|Part 1||0
15652|NCT02011490|34871|P4|STARTED|Part 1||0
15653|NCT02011490|34872|P3|STARTED|Part 1||8
15654|NCT02011490|34873|P2|STARTED|Part 1||8
15655|NCT02011490|34874|P1|STARTED|Part 1||8
15656|NCT02011113|34960|P1|NOT COMPLETED|Overall Study||36
15657|NCT02011113|34960|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
15658|NCT02011113|34960|P1|STARTED|Overall Study||36
15659|NCT02010996|34976|P2|NOT COMPLETED|Overall Study||0
15660|NCT02010996|34977|P1|NOT COMPLETED|Overall Study||0
15661|NCT02010996|34976|P2|COMPLETED|Overall Study||36
15662|NCT02010996|34977|P1|COMPLETED|Overall Study||36
15663|NCT02010996|34976|P2|STARTED|Overall Study||36
15664|NCT02010996|34977|P1|STARTED|Overall Study||36
15665|NCT02010684|34989|P2|NOT COMPLETED|Overall Study||23
15666|NCT02010684|34990|P1|NOT COMPLETED|Overall Study||12
15667|NCT02010684|34989|P2|COMPLETED|Overall Study||59
15668|NCT02010684|34990|P1|COMPLETED|Overall Study||27
15669|NCT02010684|34989|P2|STARTED|Overall Study||82
15670|NCT02010684|34990|P1|STARTED|Overall Study||39
15671|NCT02010632|35008|P2|NOT COMPLETED|Second Intervention (7 Days)||0
15672|NCT02010632|35009|P1|NOT COMPLETED|Second Intervention (7 Days)||1
15673|NCT02010632|35008|P2|COMPLETED|Second Intervention (7 Days)||16
15674|NCT02010632|35009|P1|COMPLETED|Second Intervention (7 Days)||15
15675|NCT02010632|35008|P2|STARTED|Second Intervention (7 Days)||16
15676|NCT02010632|35009|P1|STARTED|Second Intervention (7 Days)||16
15677|NCT02010632|35008|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
15678|NCT02010632|35009|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
15679|NCT02010632|35008|P2|COMPLETED|Wash Out Period (14 Days)||16
15680|NCT02010632|35009|P1|COMPLETED|Wash Out Period (14 Days)||16
15681|NCT02010632|35008|P2|STARTED|Wash Out Period (14 Days)||16
15682|NCT02010632|35009|P1|STARTED|Wash Out Period (14 Days)||16
15683|NCT02010632|35008|P2|NOT COMPLETED|First Intervention (7 Days)||0
15684|NCT02010632|35009|P1|NOT COMPLETED|First Intervention (7 Days)||0
15685|NCT02010632|35008|P2|COMPLETED|First Intervention (7 Days)||16
15686|NCT02010632|35009|P1|COMPLETED|First Intervention (7 Days)||16
15687|NCT02010632|35008|P2|STARTED|First Intervention (7 Days)||16
15688|NCT02010632|35009|P1|STARTED|First Intervention (7 Days)||16
15689|NCT02010255|35029|P14|NOT COMPLETED|Overall Study||1
15690|NCT02010255|35030|P13|NOT COMPLETED|Overall Study||0
15691|NCT02010255|35031|P12|NOT COMPLETED|Overall Study||1
15692|NCT02010255|35032|P11|NOT COMPLETED|Overall Study||2
15693|NCT02010255|35033|P10|NOT COMPLETED|Overall Study||0
15694|NCT02010255|35034|P9|NOT COMPLETED|Overall Study||1
15695|NCT02010255|35035|P8|NOT COMPLETED|Overall Study||1
15696|NCT02010255|35036|P7|NOT COMPLETED|Overall Study||1
15697|NCT02010255|35037|P6|NOT COMPLETED|Overall Study||0
15698|NCT02010255|35038|P5|NOT COMPLETED|Overall Study||4
15699|NCT02010255|35039|P4|NOT COMPLETED|Overall Study||6
15700|NCT02010255|35040|P3|NOT COMPLETED|Overall Study||7
15701|NCT02010255|35041|P2|NOT COMPLETED|Overall Study||2
15702|NCT02010255|35042|P1|NOT COMPLETED|Overall Study||6
15703|NCT02010255|35029|P14|COMPLETED|Overall Study||2
15704|NCT02010255|35030|P13|COMPLETED|Overall Study||3
15705|NCT02010255|35031|P12|COMPLETED|Overall Study||4
15706|NCT02010255|35032|P11|COMPLETED|Overall Study||1
15707|NCT02010255|35033|P10|COMPLETED|Overall Study||23
15708|NCT02010255|35034|P9|COMPLETED|Overall Study||21
15709|NCT02010255|35035|P8|COMPLETED|Overall Study||32
15710|NCT02010255|35036|P7|COMPLETED|Overall Study||33
15711|NCT02010255|35037|P6|COMPLETED|Overall Study||49
15712|NCT02010255|35038|P5|COMPLETED|Overall Study||48
15713|NCT02010255|35039|P4|COMPLETED|Overall Study||20
15714|NCT02010255|35040|P3|COMPLETED|Overall Study||18
15715|NCT02010255|35041|P2|COMPLETED|Overall Study||26
15716|NCT02010255|35042|P1|COMPLETED|Overall Study||22
15717|NCT02010255|35029|P14|STARTED|Overall Study||3
15718|NCT02010255|35030|P13|STARTED|Overall Study||3
15719|NCT02010255|35031|P12|STARTED|Overall Study||5
15720|NCT02010255|35032|P11|STARTED|Overall Study||3
15721|NCT02010255|35033|P10|STARTED|Overall Study||23
15722|NCT02010255|35034|P9|STARTED|Overall Study||22
15723|NCT02010255|35035|P8|STARTED|Overall Study||33
15724|NCT02010255|35036|P7|STARTED|Overall Study||34
15725|NCT02010255|35037|P6|STARTED|Overall Study||49
15726|NCT02010255|35038|P5|STARTED|Overall Study||52
15727|NCT02010255|35039|P4|STARTED|Overall Study||26
15728|NCT02010255|35040|P3|STARTED|Overall Study||25
15729|NCT02010255|35041|P2|STARTED|Overall Study||28
15730|NCT02010255|35042|P1|STARTED|Overall Study||28
15731|NCT02010216|35366|P1|NOT COMPLETED|Overall Study||0
15732|NCT02010216|35366|P1|COMPLETED|Overall Study||23
15733|NCT02010216|35366|P1|STARTED|Overall Study||23
15734|NCT02009982|35374|P2|NOT COMPLETED|Overall Study||0
15735|NCT02009982|35375|P1|NOT COMPLETED|Overall Study||0
15736|NCT02009982|35374|P2|COMPLETED|Overall Study||2
15737|NCT02009982|35375|P1|COMPLETED|Overall Study||1
15738|NCT02009982|35374|P2|STARTED|Overall Study||2
15739|NCT02009982|35375|P1|STARTED|Overall Study||1
15740|NCT02009878|35386|P3|NOT COMPLETED|Overall Study||0
15741|NCT02009878|35387|P2|NOT COMPLETED|Overall Study||1
15742|NCT02009878|35388|P1|NOT COMPLETED|Overall Study||0
15743|NCT02009878|35386|P3|COMPLETED|Overall Study||9
15744|NCT02009878|35387|P2|COMPLETED|Overall Study||10
15745|NCT02009878|35388|P1|COMPLETED|Overall Study||10
15746|NCT02009878|35386|P3|STARTED|Overall Study||9
15747|NCT02009878|35387|P2|STARTED|Overall Study||11
15748|NCT02009878|35388|P1|STARTED|Overall Study||10
15749|NCT02009865|35422|P2|NOT COMPLETED|Overall Study||5
15750|NCT02009865|35423|P1|NOT COMPLETED|Overall Study||1
15751|NCT02009865|35422|P2|COMPLETED|Overall Study||76
15752|NCT02009865|35423|P1|COMPLETED|Overall Study||80
15753|NCT02009865|35422|P2|STARTED|Overall Study||81
15754|NCT02009865|35423|P1|STARTED|Overall Study||81
15755|NCT02009722|35439|P2|NOT COMPLETED|Overall Study||3
15756|NCT02009722|35440|P1|NOT COMPLETED|Overall Study||1
15757|NCT02009722|35439|P2|COMPLETED|Overall Study||40
15758|NCT02009722|35440|P1|COMPLETED|Overall Study||40
15759|NCT02009722|35439|P2|Received Intervention|Overall Study||42
15760|NCT02009722|35440|P1|Received Intervention|Overall Study||41
15761|NCT02009722|35439|P2|STARTED|Overall Study||43
15762|NCT02009722|35440|P1|STARTED|Overall Study||41
15763|NCT02009696|35464|P1|NOT COMPLETED|Overall Study||2
15764|NCT02009696|35464|P1|COMPLETED|Overall Study||219
15765|NCT02009696|35464|P1|STARTED|Overall Study||221
15766|NCT02009163|35472|P3|NOT COMPLETED|Randomized-withdrawal Period||35
15767|NCT02009163|35473|P2|NOT COMPLETED|Randomized-withdrawal Period||88
15768|NCT02009163|35474|P1|NOT COMPLETED|Randomized-withdrawal Period||0
15769|NCT02009163|35472|P3|COMPLETED|Randomized-withdrawal Period||102
15770|NCT02009163|35473|P2|COMPLETED|Randomized-withdrawal Period||50
15771|NCT02009163|35474|P1|COMPLETED|Randomized-withdrawal Period||0
15772|NCT02009163|35472|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
15773|NCT02009163|35473|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
15774|NCT02009163|35474|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
15775|NCT02009163|35472|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
15776|NCT02009163|35473|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
15777|NCT02009163|35474|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
15778|NCT02009163|35472|P3|COMPLETED|Open-label Period (Non-randomized)||0
15779|NCT02009163|35473|P2|COMPLETED|Open-label Period (Non-randomized)||0
15780|NCT02009163|35474|P1|COMPLETED|Open-label Period (Non-randomized)||275
15781|NCT02009163|35472|P3|STARTED|Open-label Period (Non-randomized)||0
15782|NCT02009163|35473|P2|STARTED|Open-label Period (Non-randomized)||0
15783|NCT02009163|35474|P1|STARTED|Open-label Period (Non-randomized)||418
15784|NCT02008942|35507|P2|NOT COMPLETED|Second Intervention||0
15785|NCT02008942|35508|P1|NOT COMPLETED|Second Intervention||1
15786|NCT02008942|35507|P2|COMPLETED|Second Intervention||30
15787|NCT02008942|35508|P1|COMPLETED|Second Intervention||25
15788|NCT02008942|35507|P2|STARTED|Second Intervention||30
15789|NCT02008942|35508|P1|STARTED|Second Intervention||26
15790|NCT02008942|35507|P2|NOT COMPLETED|First Intervention||0
15791|NCT02008942|35508|P1|NOT COMPLETED|First Intervention||0
15792|NCT02008942|35507|P2|COMPLETED|First Intervention||30
15793|NCT02008942|35508|P1|COMPLETED|First Intervention||27
15794|NCT02008942|35507|P2|STARTED|First Intervention||30
15795|NCT02008942|35508|P1|STARTED|First Intervention||27
15796|NCT02008682|35516|P2|NOT COMPLETED|Overall Study||14
15797|NCT02008682|35517|P1|NOT COMPLETED|Overall Study||27
15798|NCT02008682|35516|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
15799|NCT02008682|35517|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
15800|NCT02008682|35516|P2|Exposed|Overall Study||184
15801|NCT02008682|35517|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
15802|NCT02008682|35516|P2|STARTED|Overall Study||184
15803|NCT02008682|35517|P1|STARTED|Overall Study||184
15804|NCT02007863|35533|P1|NOT COMPLETED|Overall Study||0
15805|NCT02007863|35533|P1|COMPLETED|Overall Study||2
15806|NCT02007863|35533|P1|STARTED|Overall Study||2
15807|NCT02007577|35539|P2|NOT COMPLETED|Overall Study||1
15808|NCT02007577|35540|P1|NOT COMPLETED|Overall Study||1
15809|NCT02007577|35539|P2|COMPLETED|Overall Study||13
15810|NCT02007577|35540|P1|COMPLETED|Overall Study||26
15811|NCT02007577|35539|P2|STARTED|Overall Study||14
15812|NCT02007577|35540|P1|STARTED|Overall Study||27
15813|NCT02007434|35556|P8|NOT COMPLETED|Overall Study||0
15814|NCT02007434|35557|P7|NOT COMPLETED|Overall Study||0
15815|NCT02007434|35558|P6|NOT COMPLETED|Overall Study||0
15816|NCT02007434|35559|P5|NOT COMPLETED|Overall Study||0
15817|NCT02007434|35560|P4|NOT COMPLETED|Overall Study||0
15818|NCT02007434|35561|P3|NOT COMPLETED|Overall Study||1
15819|NCT02007434|35562|P2|NOT COMPLETED|Overall Study||1
15820|NCT02007434|35563|P1|NOT COMPLETED|Overall Study||1
15821|NCT02007434|35556|P8|COMPLETED|Overall Study||4
15822|NCT02007434|35557|P7|COMPLETED|Overall Study||18
15823|NCT02007434|35558|P6|COMPLETED|Overall Study||4
15824|NCT02007434|35559|P5|COMPLETED|Overall Study||16
15825|NCT02007434|35560|P4|COMPLETED|Overall Study||4
15826|NCT02007434|35561|P3|COMPLETED|Overall Study||16
15827|NCT02007434|35562|P2|COMPLETED|Overall Study||3
15828|NCT02007434|35563|P1|COMPLETED|Overall Study||16
15829|NCT02007434|35556|P8|Received Treatment|Overall Study||4
15830|NCT02007434|35557|P7|Received Treatment|Overall Study||18
15831|NCT02007434|35558|P6|Received Treatment|Overall Study||4
15832|NCT02007434|35559|P5|Received Treatment|Overall Study||16
15833|NCT02007434|35560|P4|Received Treatment|Overall Study||4
15834|NCT02007434|35561|P3|Received Treatment|Overall Study||17
15835|NCT02007434|35562|P2|Received Treatment|Overall Study||3
15836|NCT02007434|35563|P1|Received Treatment|Overall Study||17
15837|NCT02007434|35556|P8|STARTED|Overall Study||4
15838|NCT02007434|35557|P7|STARTED|Overall Study||18
15839|NCT02007434|35558|P6|STARTED|Overall Study||4
15840|NCT02007434|35559|P5|STARTED|Overall Study||16
15841|NCT02007434|35560|P4|STARTED|Overall Study||4
15842|NCT02007434|35561|P3|STARTED|Overall Study||17
15843|NCT02007434|35562|P2|STARTED|Overall Study||4
15844|NCT02007434|35563|P1|STARTED|Overall Study||17
15845|NCT02007369|35664|P3|NOT COMPLETED|Overall Study||0
15846|NCT02007369|35665|P2|NOT COMPLETED|Overall Study||0
15847|NCT02007369|35666|P1|NOT COMPLETED|Overall Study||0
15848|NCT02007369|35664|P3|COMPLETED|Overall Study||54
15849|NCT02007369|35665|P2|COMPLETED|Overall Study||40
15850|NCT02007369|35666|P1|COMPLETED|Overall Study||42
15851|NCT02007369|35664|P3|STARTED|Overall Study||54
15852|NCT02007369|35665|P2|STARTED|Overall Study||40
15853|NCT02007369|35666|P1|STARTED|Overall Study||42
15854|NCT02007252|35685|P2|NOT COMPLETED|Overall Study||11
15855|NCT02007252|35686|P1|NOT COMPLETED|Overall Study||11
15856|NCT02007252|35685|P2|COMPLETED|Overall Study||22
15857|NCT02007252|35686|P1|COMPLETED|Overall Study||20
15858|NCT02007252|35685|P2|Pharmacodynamic Analysis Set|Overall Study||33
15859|NCT02007252|35686|P1|Pharmacodynamic Analysis Set|Overall Study||31
15860|NCT02007252|35685|P2|Safety Analysis Set|Overall Study||33
15861|NCT02007252|35686|P1|Safety Analysis Set|Overall Study||31
15862|NCT02007252|35685|P2|STARTED|Overall Study||33
15863|NCT02007252|35686|P1|STARTED|Overall Study||31
15864|NCT02007200|35692|P1|NOT COMPLETED|Overall Study||0
15865|NCT02007200|35692|P1|COMPLETED|Overall Study||55
15866|NCT02007200|35692|P1|STARTED|Overall Study||55
15867|NCT02007070|35699|P1|NOT COMPLETED|Overall Study||38
15868|NCT02007070|35699|P1|COMPLETED|Overall Study||0
15869|NCT02007070|35699|P1|STARTED|Overall Study||38
15870|NCT02006836|35711|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
15871|NCT02006836|35712|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
15872|NCT02006836|35713|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
15873|NCT02006836|35711|P3|COMPLETED|Self-control Period: Month 7-month 12||19
15874|NCT02006836|35712|P2|COMPLETED|Self-control Period: Month 7-month 12||0
15875|NCT02006836|35713|P1|COMPLETED|Self-control Period: Month 7-month 12||0
15876|NCT02006836|35711|P3|STARTED|Self-control Period: Month 7-month 12||19
15877|NCT02006836|35712|P2|STARTED|Self-control Period: Month 7-month 12||0
15878|NCT02006836|35713|P1|STARTED|Self-control Period: Month 7-month 12||0
15879|NCT02006836|35711|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
15880|NCT02006836|35712|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
15881|NCT02006836|35713|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
15882|NCT02006836|35711|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
15883|NCT02006836|35712|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
15884|NCT02006836|35713|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
15885|NCT02006836|35711|P3|STARTED|Case-control Period: Month 1- Month 6||0
15886|NCT02006836|35712|P2|STARTED|Case-control Period: Month 1- Month 6||20
15887|NCT02006836|35713|P1|STARTED|Case-control Period: Month 1- Month 6||20
15888|NCT02006732|35733|P4|NOT COMPLETED|Overall Study||4
15889|NCT02006732|35734|P3|NOT COMPLETED|Overall Study||9
15890|NCT02006732|35735|P2|NOT COMPLETED|Overall Study||12
15891|NCT02006732|35736|P1|NOT COMPLETED|Overall Study||20
15892|NCT02006732|35733|P4|COMPLETED|Overall Study||198
15893|NCT02006732|35734|P3|COMPLETED|Overall Study||193
15894|NCT02006732|35735|P2|COMPLETED|Overall Study||191
15895|NCT02006732|35736|P1|COMPLETED|Overall Study||182
15896|NCT02006732|35733|P4|STARTED|Overall Study||202
15897|NCT02006732|35734|P3|STARTED|Overall Study||202
15898|NCT02006732|35735|P2|STARTED|Overall Study||203
15899|NCT02006732|35736|P1|STARTED|Overall Study||202
15900|NCT02006706|35774|P1|NOT COMPLETED|Overall Study||1
15901|NCT02006706|35774|P1|COMPLETED|Overall Study||14
15902|NCT02006706|35774|P1|STARTED|Overall Study||15
15903|NCT02006667|35779|P1|NOT COMPLETED|Overall Study||6
15904|NCT02006667|35779|P1|COMPLETED|Overall Study||7
15905|NCT02006667|35779|P1|STARTED|Overall Study||13
15906|NCT02006407|35789|P1|NOT COMPLETED|Overall Study||0
15907|NCT02006407|35789|P1|COMPLETED|Overall Study||5
15908|NCT02006407|35789|P1|STARTED|Overall Study||5
15909|NCT02005692|35795|P1|NOT COMPLETED|Overall Study||7
15910|NCT02005692|35795|P1|COMPLETED|Overall Study||63
15911|NCT02005692|35795|P1|STARTED|Overall Study||70
15912|NCT02005562|35802|P2|NOT COMPLETED|Overall Study||15
15913|NCT02005562|35803|P1|NOT COMPLETED|Overall Study||12
15914|NCT02005562|35802|P2|COMPLETED|Overall Study||110
15915|NCT02005562|35803|P1|COMPLETED|Overall Study||115
15916|NCT02005562|35802|P2|Transplanted|Overall Study||121
15917|NCT02005562|35803|P1|Transplanted|Overall Study||126
15918|NCT02005562|35802|P2|STARTED|Overall Study||125
15919|NCT02005562|35803|P1|STARTED|Overall Study||127
15920|NCT02005549|35831|P1|NOT COMPLETED|Overall Study||0
15921|NCT02005549|35831|P1|COMPLETED|Overall Study||18
15922|NCT02005549|35831|P1|STARTED|Overall Study||18
15923|NCT02005536|35837|P1|NOT COMPLETED|Overall Study||0
15924|NCT02005536|35837|P1|COMPLETED|Overall Study||60
15925|NCT02005536|35837|P1|STARTED|Overall Study||60
15926|NCT02005484|35845|P1|NOT COMPLETED|Overall Study||4
15927|NCT02005484|35845|P1|COMPLETED|Overall Study||2
15928|NCT02005484|35845|P1|STARTED|Overall Study||6
15929|NCT02005211|35862|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15930|NCT02005211|35863|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15931|NCT02005211|35864|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
15932|NCT02005211|35865|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15933|NCT02005211|35866|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15934|NCT02005211|35867|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15935|NCT02005211|35868|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15936|NCT02005211|35862|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
15937|NCT02005211|35863|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
15938|NCT02005211|35864|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
15939|NCT02005211|35865|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15940|NCT02005211|35866|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15941|NCT02005211|35867|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15942|NCT02005211|35868|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15943|NCT02005211|35862|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
15944|NCT02005211|35863|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
15945|NCT02005211|35864|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
15946|NCT02005211|35865|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15947|NCT02005211|35866|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15948|NCT02005211|35867|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15949|NCT02005211|35868|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
15950|NCT02005211|35862|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15951|NCT02005211|35863|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15952|NCT02005211|35864|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15953|NCT02005211|35865|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15954|NCT02005211|35866|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15955|NCT02005211|35867|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15956|NCT02005211|35868|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15957|NCT02005211|35862|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15958|NCT02005211|35863|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15959|NCT02005211|35864|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
15960|NCT02005211|35865|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
15961|NCT02005211|35866|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
15962|NCT02005211|35867|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
15963|NCT02005211|35868|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
15964|NCT02005211|35862|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
15965|NCT02005211|35863|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
15966|NCT02005211|35864|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
15967|NCT02005211|35865|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
15968|NCT02005211|35866|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
15969|NCT02005211|35867|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
15970|NCT02005211|35868|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
15971|NCT02005029|35903|P2|NOT COMPLETED|Second Intervention (1 Day)||0
15972|NCT02005029|35904|P1|NOT COMPLETED|Second Intervention (1 Day)||0
15973|NCT02005029|35903|P2|COMPLETED|Second Intervention (1 Day)||5
15974|NCT02005029|35904|P1|COMPLETED|Second Intervention (1 Day)||4
15975|NCT02005029|35903|P2|STARTED|Second Intervention (1 Day)||5
15976|NCT02005029|35904|P1|STARTED|Second Intervention (1 Day)||4
15977|NCT02005029|35903|P2|NOT COMPLETED|Washout (2 Weeks)||0
15978|NCT02005029|35904|P1|NOT COMPLETED|Washout (2 Weeks)||0
15979|NCT02005029|35903|P2|COMPLETED|Washout (2 Weeks)||5
15980|NCT02005029|35904|P1|COMPLETED|Washout (2 Weeks)||4
15981|NCT02005029|35903|P2|STARTED|Washout (2 Weeks)||5
15982|NCT02005029|35904|P1|STARTED|Washout (2 Weeks)||4
15983|NCT02005029|35903|P2|NOT COMPLETED|First Intervention (1 Day)||0
15984|NCT02005029|35904|P1|NOT COMPLETED|First Intervention (1 Day)||1
15985|NCT02005029|35903|P2|COMPLETED|First Intervention (1 Day)||5
15986|NCT02005029|35904|P1|COMPLETED|First Intervention (1 Day)||4
15987|NCT02005029|35903|P2|STARTED|First Intervention (1 Day)||5
15988|NCT02005029|35904|P1|STARTED|First Intervention (1 Day)||5
15989|NCT02004990|35930|P1|NOT COMPLETED|Overall Study||0
15990|NCT02004990|35930|P1|COMPLETED|Overall Study||12
15991|NCT02004990|35930|P1|STARTED|Overall Study||12
15992|NCT02004886|35939|P4|NOT COMPLETED|Overall Study||0
15993|NCT02004886|35940|P3|NOT COMPLETED|Overall Study||0
15994|NCT02004886|35941|P2|NOT COMPLETED|Overall Study||1
15995|NCT02004886|35942|P1|NOT COMPLETED|Overall Study||1
15996|NCT02004886|35939|P4|COMPLETED|Overall Study||19
15997|NCT02004886|35940|P3|COMPLETED|Overall Study||18
15998|NCT02004886|35941|P2|COMPLETED|Overall Study||17
15999|NCT02004886|35942|P1|COMPLETED|Overall Study||18
16000|NCT02004886|35939|P4|STARTED|Overall Study||19
16001|NCT02004886|35940|P3|STARTED|Overall Study||18
16002|NCT02004886|35941|P2|STARTED|Overall Study||18
16003|NCT02004886|35942|P1|STARTED|Overall Study||19
16004|NCT02004873|35992|P1|NOT COMPLETED|Overall Study||424
16005|NCT02004873|35992|P1|COMPLETED|Overall Study|6-Month Follow-up|301
16006|NCT02004873|35992|P1|Micra Implant Success|Overall Study||719
16007|NCT02004873|35992|P1|STARTED|Overall Study|Micra Implant Attempt|725
16008|NCT02004847|36001|P2|NOT COMPLETED|Overall Study||1
16009|NCT02004847|36002|P1|NOT COMPLETED|Overall Study||1
16010|NCT02004847|36001|P2|COMPLETED|Overall Study||22
16011|NCT02004847|36002|P1|COMPLETED|Overall Study||23
16012|NCT02004847|36001|P2|STARTED|Overall Study||23
16013|NCT02004847|36002|P1|STARTED|Overall Study||24
16014|NCT02004236|36049|P3|NOT COMPLETED|Overall Study||16
16015|NCT02004236|36050|P2|NOT COMPLETED|Overall Study||0
16016|NCT02004236|36051|P1|NOT COMPLETED|Overall Study||0
16017|NCT02004236|36049|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
16018|NCT02004236|36050|P2|COMPLETED|Overall Study||75
16019|NCT02004236|36051|P1|COMPLETED|Overall Study||75
16020|NCT02004236|36049|P3|STARTED|Overall Study||75
16021|NCT02004236|36050|P2|STARTED|Overall Study||75
16022|NCT02004236|36051|P1|STARTED|Overall Study||75
16023|NCT02004132|36095|P1|NOT COMPLETED|Overall Study||0
16024|NCT02004132|36095|P1|COMPLETED|Overall Study||12
16025|NCT02004132|36095|P1|Received Study Drug|Overall Study||12
16026|NCT02004132|36095|P1|STARTED|Overall Study||12
16027|NCT02004093|36103|P2|NOT COMPLETED|Overall Study||73
16028|NCT02004093|36104|P1|NOT COMPLETED|Overall Study||74
16029|NCT02004093|36103|P2|COMPLETED|Overall Study||1
16030|NCT02004093|36104|P1|COMPLETED|Overall Study||1
16031|NCT02004093|36103|P2|STARTED|Overall Study||74
16032|NCT02004093|36104|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
16033|NCT02003638|36136|P2|NOT COMPLETED|Overall Study||0
16034|NCT02003638|36137|P1|NOT COMPLETED|Overall Study||1
16035|NCT02003638|36136|P2|COMPLETED|Overall Study||3
16036|NCT02003638|36137|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
16037|NCT02003638|36136|P2|STARTED|Overall Study||3
16038|NCT02003638|36137|P1|STARTED|Overall Study||6
16039|NCT02003534|36143|P1|NOT COMPLETED|Overall Study||47
16040|NCT02003534|36143|P1|COMPLETED|Overall Study||329
16041|NCT02003534|36143|P1|STARTED|Overall Study||376
16042|NCT02003404|36147|P1|NOT COMPLETED|Overall Study||0
16043|NCT02003404|36147|P1|COMPLETED|Overall Study||17
16044|NCT02003404|36147|P1|STARTED|Overall Study||17
16045|NCT02003391|36155|P2|NOT COMPLETED|Overall Study||2
16046|NCT02003391|36156|P1|NOT COMPLETED|Overall Study||3
16047|NCT02003391|36155|P2|COMPLETED|Overall Study||73
16048|NCT02003391|36156|P1|COMPLETED|Overall Study||78
16049|NCT02003391|36155|P2|Intent to Treat Population|Overall Study||73
16050|NCT02003391|36156|P1|Intent to Treat Population|Overall Study||78
16051|NCT02003391|36155|P2|Safety Population|Overall Study||75
16052|NCT02003391|36156|P1|Safety Population|Overall Study||81
16053|NCT02003391|36155|P2|STARTED|Overall Study||75
16054|NCT02003391|36156|P1|STARTED|Overall Study||81
16055|NCT02003014|36166|P1|NOT COMPLETED|Overall Study||19
16056|NCT02003014|36166|P1|COMPLETED|Overall Study||880
16057|NCT02003014|36166|P1|STARTED|Overall Study||899
16058|NCT02002936|36176|P1|NOT COMPLETED|Overall Study||0
16059|NCT02002936|36176|P1|COMPLETED|Overall Study||1
16060|NCT02002936|36176|P1|STARTED|Overall Study||1
16061|NCT02002871|36183|P1|NOT COMPLETED|Overall Study||1
16062|NCT02002871|36183|P1|COMPLETED|Overall Study||20
16063|NCT02002871|36183|P1|STARTED|Overall Study||21
16064|NCT02002702|36212|P3|NOT COMPLETED|Overall Study||0
16065|NCT02002702|36213|P2|NOT COMPLETED|Overall Study||0
16066|NCT02002702|36214|P1|NOT COMPLETED|Overall Study||0
16067|NCT02002702|36212|P3|COMPLETED|Overall Study||15
16068|NCT02002702|36213|P2|COMPLETED|Overall Study||15
16069|NCT02002702|36214|P1|COMPLETED|Overall Study||16
16070|NCT02002702|36212|P3|STARTED|Overall Study||15
16071|NCT02002702|36213|P2|STARTED|Overall Study||15
16072|NCT02002702|36214|P1|STARTED|Overall Study||16
16073|NCT02002689|36246|P1|NOT COMPLETED|Overall Study||10
16074|NCT02002689|36246|P1|COMPLETED|Overall Study||0
16075|NCT02002689|36246|P1|STARTED|Overall Study||10
16076|NCT02002650|36254|P2|NOT COMPLETED|Overall Study||0
16077|NCT02002650|36255|P1|NOT COMPLETED|Overall Study||0
16078|NCT02002650|36254|P2|COMPLETED|Overall Study||1303
16079|NCT02002650|36255|P1|COMPLETED|Overall Study||1297
16080|NCT02002650|36254|P2|STARTED|Overall Study||1303
16081|NCT02002650|36255|P1|STARTED|Overall Study||1297
16082|NCT02002221|36265|P2|NOT COMPLETED|Overall Study||3
16083|NCT02002221|36266|P1|NOT COMPLETED|Overall Study||2
16084|NCT02002221|36265|P2|COMPLETED|Overall Study||75
16085|NCT02002221|36266|P1|COMPLETED|Overall Study||76
16086|NCT02002221|36265|P2|STARTED|Overall Study||78
16087|NCT02002221|36266|P1|STARTED|Overall Study||78
16088|NCT02002208|36282|P2|NOT COMPLETED|Overall Study||40
16089|NCT02002208|36283|P1|NOT COMPLETED|Overall Study||37
16090|NCT02002208|36282|P2|COMPLETED|Overall Study||30
16091|NCT02002208|36283|P1|COMPLETED|Overall Study||32
16092|NCT02002208|36282|P2|STARTED|Overall Study||70
16093|NCT02002208|36283|P1|STARTED|Overall Study||69
16094|NCT02001181|36293|P2|NOT COMPLETED|Overall Study||3
16095|NCT02001181|36294|P1|NOT COMPLETED|Overall Study||1
16096|NCT02001181|36293|P2|COMPLETED|Overall Study||31
16097|NCT02001181|36294|P1|COMPLETED|Overall Study||34
16098|NCT02001181|36293|P2|STARTED|Overall Study||34
16099|NCT02001181|36294|P1|STARTED|Overall Study||35
16100|NCT02000973|36312|P4|NOT COMPLETED|Overall Study||0
16101|NCT02000973|36313|P3|NOT COMPLETED|Overall Study||0
16102|NCT02000973|36314|P2|NOT COMPLETED|Overall Study||0
16103|NCT02000973|36315|P1|NOT COMPLETED|Overall Study||0
16104|NCT02000973|36312|P4|COMPLETED|Overall Study||20
16105|NCT02000973|36313|P3|COMPLETED|Overall Study||20
16106|NCT02000973|36314|P2|COMPLETED|Overall Study||20
16107|NCT02000973|36315|P1|COMPLETED|Overall Study||20
16108|NCT02000973|36312|P4|STARTED|Overall Study||20
16109|NCT02000973|36313|P3|STARTED|Overall Study||20
16110|NCT02000973|36314|P2|STARTED|Overall Study||20
16111|NCT02000973|36315|P1|STARTED|Overall Study||20
16112|NCT02000752|36339|P2|NOT COMPLETED|Overall Study||13
16113|NCT02000752|36340|P1|NOT COMPLETED|Overall Study||31
16114|NCT02000752|36339|P2|COMPLETED|Overall Study||47
16115|NCT02000752|36340|P1|COMPLETED|Overall Study||29
16116|NCT02000752|36339|P2|STARTED|Overall Study||60
16117|NCT02000752|36340|P1|STARTED|Overall Study||60
16118|NCT02000531|36354|P2|NOT COMPLETED|Overall Study||8
16119|NCT02000531|36355|P1|NOT COMPLETED|Overall Study||4
16120|NCT02000531|36354|P2|COMPLETED|Overall Study||16
16121|NCT02000531|36355|P1|COMPLETED|Overall Study||17
16122|NCT02000531|36354|P2|Safety Population|Overall Study||24
16123|NCT02000531|36355|P1|Safety Population|Overall Study||21
16124|NCT02000531|36354|P2|STARTED|Overall Study||24
16125|NCT02000531|36355|P1|STARTED|Overall Study||21
16126|NCT01999894|36363|P1|NOT COMPLETED|Overall Study||36
16127|NCT01999894|36363|P1|COMPLETED|Overall Study||66
16128|NCT01999894|36363|P1|STARTED|Overall Study||102
16129|NCT01999348|36368|P1|NOT COMPLETED|Overall Study||120
16130|NCT01999348|36368|P1|COMPLETED|Overall Study||1433
16131|NCT01999348|36368|P1|STARTED|Overall Study||1553
16132|NCT01999231|36382|P4|NOT COMPLETED|Overall Study||0
16133|NCT01999231|36383|P3|NOT COMPLETED|Overall Study||0
16134|NCT01999231|36384|P2|NOT COMPLETED|Overall Study||0
16135|NCT01999231|36385|P1|NOT COMPLETED|Overall Study||0
16136|NCT01999231|36382|P4|COMPLETED|Overall Study||6
16137|NCT01999231|36383|P3|COMPLETED|Overall Study||6
16138|NCT01999231|36384|P2|COMPLETED|Overall Study||6
16139|NCT01999231|36385|P1|COMPLETED|Overall Study||6
16140|NCT01999231|36382|P4|STARTED|Overall Study||6
16141|NCT01999231|36383|P3|STARTED|Overall Study||6
16142|NCT01999231|36384|P2|STARTED|Overall Study||6
16143|NCT01999231|36385|P1|STARTED|Overall Study||6
16144|NCT01998919|36417|P2|NOT COMPLETED|Overall Study||35
16145|NCT01998919|36418|P1|NOT COMPLETED|Overall Study||42
16146|NCT01998919|36417|P2|COMPLETED|Overall Study||39
16147|NCT01998919|36418|P1|COMPLETED|Overall Study||37
16148|NCT01998919|36417|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
16149|NCT01998919|36418|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
16150|NCT01998919|36417|P2|STARTED|Overall Study||74
16151|NCT01998919|36418|P1|STARTED|Overall Study||79
16152|NCT01998906|36439|P3|NOT COMPLETED|Overall Study||98
16153|NCT01998906|36440|P2|NOT COMPLETED|Overall Study||114
16154|NCT01998906|36441|P1|NOT COMPLETED|Overall Study||114
16155|NCT01998906|36439|P3|COMPLETED|Overall Study||1
16156|NCT01998906|36440|P2|COMPLETED|Overall Study||2
16157|NCT01998906|36441|P1|COMPLETED|Overall Study||1
16158|NCT01998906|36439|P3|STARTED|Overall Study||99
16159|NCT01998906|36440|P2|STARTED|Overall Study||116
16160|NCT01998906|36441|P1|STARTED|Overall Study||115
16161|NCT01998893|36485|P1|NOT COMPLETED|Overall Study||17
16162|NCT01998893|36485|P1|COMPLETED|Overall Study||21
16163|NCT01998893|36485|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
16164|NCT01998893|36485|P1|2nd Treatment Cycle Started|Overall Study||5
16165|NCT01998893|36485|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
16166|NCT01998893|36485|P1|STARTED|Overall Study||38
16167|NCT01998880|36497|P2|NOT COMPLETED|Overall Study||40
16168|NCT01998880|36498|P1|NOT COMPLETED|Overall Study||29
16169|NCT01998880|36497|P2|COMPLETED|Overall Study||78
16170|NCT01998880|36498|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
16171|NCT01998880|36497|P2|Received Study Drug|Overall Study||116
16172|NCT01998880|36498|P1|Received Study Drug|Overall Study||230
16173|NCT01998880|36497|P2|STARTED|Overall Study||118
16174|NCT01998880|36498|P1|STARTED|Overall Study||233
16175|NCT01998581|36516|P2|NOT COMPLETED|Overall Study||12
16176|NCT01998581|36517|P1|NOT COMPLETED|Overall Study||46
16177|NCT01998581|36516|P2|COMPLETED|Overall Study||44
16178|NCT01998581|36517|P1|COMPLETED|Overall Study||123
16179|NCT01998581|36516|P2|STARTED|Overall Study||56
16180|NCT01998581|36517|P1|STARTED|Overall Study||169
16181|NCT01998438|36530|P3|NOT COMPLETED|Overall Study||0
16182|NCT01998438|36531|P2|NOT COMPLETED|Overall Study||0
16183|NCT01998438|36532|P1|NOT COMPLETED|Overall Study||0
16184|NCT01998438|36530|P3|COMPLETED|Overall Study||318
16185|NCT01998438|36531|P2|COMPLETED|Overall Study||318
16186|NCT01998438|36532|P1|COMPLETED|Overall Study||319
16187|NCT01998438|36530|P3|STARTED|Overall Study||318
16188|NCT01998438|36531|P2|STARTED|Overall Study||318
16189|NCT01998438|36532|P1|STARTED|Overall Study||319
16190|NCT01998399|36542|P2|NOT COMPLETED|Overall Study||9
16191|NCT01998399|36543|P1|NOT COMPLETED|Overall Study||8
16192|NCT01998399|36542|P2|COMPLETED|Overall Study||4
16193|NCT01998399|36543|P1|COMPLETED|Overall Study||4
16194|NCT01998399|36542|P2|STARTED|Overall Study||13
16195|NCT01998399|36543|P1|STARTED|Overall Study||12
16196|NCT01998360|36551|P2|NOT COMPLETED|Overall Study||0
16197|NCT01998360|36552|P1|NOT COMPLETED|Overall Study||0
16198|NCT01998360|36551|P2|COMPLETED|Overall Study||50
16199|NCT01998360|36552|P1|COMPLETED|Overall Study||50
16200|NCT01998360|36551|P2|STARTED|Overall Study||50
16201|NCT01998360|36552|P1|STARTED|Overall Study||50
16202|NCT01998269|36566|P1|NOT COMPLETED|Overall Study||0
16203|NCT01998269|36566|P1|COMPLETED|Overall Study||193
16204|NCT01998269|36566|P1|STARTED|Overall Study||193
16205|NCT01997905|36570|P1|NOT COMPLETED|Overall Study||3
16206|NCT01997905|36570|P1|COMPLETED|Overall Study||10
16207|NCT01997905|36570|P1|Baseline Completed|Overall Study||11
16208|NCT01997905|36570|P1|STARTED|Overall Study||13
16209|NCT01997892|36579|P1|NOT COMPLETED|Overall Study||68
16210|NCT01997892|36579|P1|COMPLETED|Overall Study||959
16211|NCT01997892|36579|P1|Received Darbepoetin Alfa|Overall Study||987
16212|NCT01997892|36579|P1|STARTED|Overall Study||1027
16213|NCT01997723|36591|P1|NOT COMPLETED|Overall Study||0
16214|NCT01997723|36591|P1|COMPLETED|Overall Study||75
16215|NCT01997723|36591|P1|STARTED|Overall Study||75
16216|NCT01997567|36599|P2|NOT COMPLETED|Overall Study||0
16217|NCT01997567|36600|P1|NOT COMPLETED|Overall Study||0
16218|NCT01997567|36599|P2|COMPLETED|Overall Study||0
16219|NCT01997567|36600|P1|COMPLETED|Overall Study||0
16220|NCT01997567|36599|P2|STARTED|Overall Study||0
16221|NCT01997567|36600|P1|STARTED|Overall Study||0
16222|NCT01997437|36606|P1|NOT COMPLETED|Overall Study||0
16223|NCT01997437|36606|P1|COMPLETED|Overall Study||6
16224|NCT01997437|36606|P1|STARTED|Overall Study||6
16225|NCT01997398|36613|P1|NOT COMPLETED|Overall Study||1
16226|NCT01997398|36613|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
16227|NCT01997398|36613|P1|STARTED|Overall Study||35
16228|NCT01997216|36622|P2|NOT COMPLETED|Second 9 Hours||0
16229|NCT01997216|36623|P1|NOT COMPLETED|Second 9 Hours||0
16230|NCT01997216|36622|P2|COMPLETED|Second 9 Hours||21
16231|NCT01997216|36623|P1|COMPLETED|Second 9 Hours||19
16232|NCT01997216|36622|P2|STARTED|Second 9 Hours||21
16233|NCT01997216|36623|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
16234|NCT01997216|36622|P2|NOT COMPLETED|First 9 Hours||0
16235|NCT01997216|36623|P1|NOT COMPLETED|First 9 Hours||0
16236|NCT01997216|36622|P2|COMPLETED|First 9 Hours||21
16237|NCT01997216|36623|P1|COMPLETED|First 9 Hours||18
16238|NCT01997216|36622|P2|STARTED|First 9 Hours||21
16239|NCT01997216|36623|P1|STARTED|First 9 Hours||18
16240|NCT01996904|36635|P2|NOT COMPLETED|Overall Study||27
16241|NCT01996904|36636|P1|NOT COMPLETED|Overall Study||38
16242|NCT01996904|36635|P2|COMPLETED|Overall Study||90
16243|NCT01996904|36636|P1|COMPLETED|Overall Study||101
16244|NCT01996904|36635|P2|STARTED|Overall Study||117
16245|NCT01996904|36636|P1|STARTED|Overall Study||139
16246|NCT01996813|36642|P1|NOT COMPLETED|Overall Study||0
16247|NCT01996813|36642|P1|COMPLETED|Overall Study||23
16248|NCT01996813|36642|P1|STARTED|Overall Study||23
16249|NCT01996709|36649|P2|NOT COMPLETED|Overall Study||1
16250|NCT01996709|36650|P1|NOT COMPLETED|Overall Study||5
16251|NCT01996709|36649|P2|COMPLETED|Overall Study||67
16252|NCT01996709|36650|P1|COMPLETED|Overall Study||61
16253|NCT01996709|36649|P2|STARTED|Overall Study||68
16254|NCT01996709|36650|P1|STARTED|Overall Study||66
16255|NCT01996410|36672|P8|NOT COMPLETED|Overall Study||0
16256|NCT01996410|36673|P7|NOT COMPLETED|Overall Study||0
16257|NCT01996410|36674|P6|NOT COMPLETED|Overall Study||0
16258|NCT01996410|36675|P5|NOT COMPLETED|Overall Study||0
16259|NCT01996410|36676|P4|NOT COMPLETED|Overall Study||0
16260|NCT01996410|36677|P3|NOT COMPLETED|Overall Study||0
16261|NCT01996410|36678|P2|NOT COMPLETED|Overall Study||0
16262|NCT01996410|36679|P1|NOT COMPLETED|Overall Study||0
16263|NCT01996410|36672|P8|COMPLETED|Overall Study||0
16264|NCT01996410|36673|P7|COMPLETED|Overall Study||0
16265|NCT01996410|36674|P6|COMPLETED|Overall Study||2
16266|NCT01996410|36675|P5|COMPLETED|Overall Study||2
16267|NCT01996410|36676|P4|COMPLETED|Overall Study||0
16268|NCT01996410|36677|P3|COMPLETED|Overall Study||0
16269|NCT01996410|36678|P2|COMPLETED|Overall Study||3
16270|NCT01996410|36679|P1|COMPLETED|Overall Study||3
16271|NCT01996410|36672|P8|STARTED|Overall Study||0
16272|NCT01996410|36673|P7|STARTED|Overall Study||0
16273|NCT01996410|36674|P6|STARTED|Overall Study||2
16274|NCT01996410|36675|P5|STARTED|Overall Study||2
16275|NCT01996410|36676|P4|STARTED|Overall Study||0
16276|NCT01996410|36677|P3|STARTED|Overall Study||0
16277|NCT01996410|36678|P2|STARTED|Overall Study||3
16278|NCT01996410|36679|P1|STARTED|Overall Study||3
16279|NCT01996332|36691|P1|NOT COMPLETED|Overall Study||1805
16280|NCT01996332|36691|P1|COMPLETED|Overall Study||0
16281|NCT01996332|36691|P1|STARTED|Overall Study||1805
16282|NCT01996319|36699|P2|NOT COMPLETED|Overall Study||3
16283|NCT01996319|36700|P1|NOT COMPLETED|Overall Study||8
16284|NCT01996319|36699|P2|COMPLETED|Overall Study||95
16285|NCT01996319|36700|P1|COMPLETED|Overall Study||88
16286|NCT01996319|36699|P2|STARTED|Overall Study||98
16287|NCT01996319|36700|P1|STARTED|Overall Study||96
16288|NCT01995461|36720|P1|NOT COMPLETED|Overall Study||5
16289|NCT01995461|36720|P1|COMPLETED|Overall Study||21
16290|NCT01995461|36720|P1|STARTED|Overall Study||26
16291|NCT01995357|36726|P6|NOT COMPLETED|Period 5||0
16292|NCT01995357|36727|P5|NOT COMPLETED|Period 5||0
16293|NCT01995357|36728|P4|NOT COMPLETED|Period 5||0
16294|NCT01995357|36729|P3|NOT COMPLETED|Period 5||1
16295|NCT01995357|36730|P2|NOT COMPLETED|Period 5||0
16296|NCT01995357|36731|P1|NOT COMPLETED|Period 5||2
16297|NCT01995357|36726|P6|COMPLETED|Period 5||4
16298|NCT01995357|36727|P5|COMPLETED|Period 5||4
16299|NCT01995357|36728|P4|COMPLETED|Period 5||3
16300|NCT01995357|36729|P3|COMPLETED|Period 5||3
16301|NCT01995357|36730|P2|COMPLETED|Period 5||3
16302|NCT01995357|36731|P1|COMPLETED|Period 5||2
16303|NCT01995357|36726|P6|STARTED|Period 5||4
16304|NCT01995357|36727|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
16305|NCT01995357|36728|P4|STARTED|Period 5||3
16306|NCT01995357|36729|P3|STARTED|Period 5||4
16307|NCT01995357|36730|P2|STARTED|Period 5||3
16308|NCT01995357|36731|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
16309|NCT01995357|36726|P6|NOT COMPLETED|Period 4||0
16310|NCT01995357|36727|P5|NOT COMPLETED|Period 4||0
16311|NCT01995357|36728|P4|NOT COMPLETED|Period 4||0
16312|NCT01995357|36729|P3|NOT COMPLETED|Period 4||0
16313|NCT01995357|36730|P2|NOT COMPLETED|Period 4||0
16314|NCT01995357|36731|P1|NOT COMPLETED|Period 4||0
16315|NCT01995357|36726|P6|COMPLETED|Period 4||4
16316|NCT01995357|36727|P5|COMPLETED|Period 4||4
16317|NCT01995357|36728|P4|COMPLETED|Period 4||3
16318|NCT01995357|36729|P3|COMPLETED|Period 4||4
16319|NCT01995357|36730|P2|COMPLETED|Period 4||3
16320|NCT01995357|36731|P1|COMPLETED|Period 4||4
16321|NCT01995357|36726|P6|STARTED|Period 4||4
16322|NCT01995357|36727|P5|STARTED|Period 4||4
16323|NCT01995357|36728|P4|STARTED|Period 4||3
16324|NCT01995357|36729|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
16325|NCT01995357|36730|P2|STARTED|Period 4||3
16326|NCT01995357|36731|P1|STARTED|Period 4||4
16327|NCT01995357|36726|P6|NOT COMPLETED|Period 3||0
16328|NCT01995357|36727|P5|NOT COMPLETED|Period 3||0
16329|NCT01995357|36728|P4|NOT COMPLETED|Period 3||0
16330|NCT01995357|36729|P3|NOT COMPLETED|Period 3||0
16331|NCT01995357|36730|P2|NOT COMPLETED|Period 3||0
16332|NCT01995357|36731|P1|NOT COMPLETED|Period 3||0
16333|NCT01995357|36726|P6|COMPLETED|Period 3||4
16334|NCT01995357|36727|P5|COMPLETED|Period 3||4
16335|NCT01995357|36728|P4|COMPLETED|Period 3||3
16336|NCT01995357|36729|P3|COMPLETED|Period 3||4
16337|NCT01995357|36730|P2|COMPLETED|Period 3||3
16338|NCT01995357|36731|P1|COMPLETED|Period 3||4
16339|NCT01995357|36726|P6|STARTED|Period 3||4
16340|NCT01995357|36727|P5|STARTED|Period 3||4
16341|NCT01995357|36728|P4|STARTED|Period 3||3
16342|NCT01995357|36729|P3|STARTED|Period 3||4
16343|NCT01995357|36730|P2|STARTED|Period 3||3
16344|NCT01995357|36731|P1|STARTED|Period 3||4
16345|NCT01995357|36726|P6|NOT COMPLETED|Period 2||0
16346|NCT01995357|36727|P5|NOT COMPLETED|Period 2||0
16347|NCT01995357|36728|P4|NOT COMPLETED|Period 2||0
16348|NCT01995357|36729|P3|NOT COMPLETED|Period 2||0
16349|NCT01995357|36730|P2|NOT COMPLETED|Period 2||0
16350|NCT01995357|36731|P1|NOT COMPLETED|Period 2||0
16351|NCT01995357|36726|P6|COMPLETED|Period 2||4
16352|NCT01995357|36727|P5|COMPLETED|Period 2||4
16353|NCT01995357|36728|P4|COMPLETED|Period 2||3
16354|NCT01995357|36729|P3|COMPLETED|Period 2||4
16355|NCT01995357|36730|P2|COMPLETED|Period 2||3
16356|NCT01995357|36731|P1|COMPLETED|Period 2||4
16357|NCT01995357|36726|P6|STARTED|Period 2||4
16358|NCT01995357|36727|P5|STARTED|Period 2||4
16359|NCT01995357|36728|P4|STARTED|Period 2||3
16360|NCT01995357|36729|P3|STARTED|Period 2||4
16361|NCT01995357|36730|P2|STARTED|Period 2||3
16362|NCT01995357|36731|P1|STARTED|Period 2||4
16363|NCT01995357|36726|P6|NOT COMPLETED|Period 1||0
16364|NCT01995357|36727|P5|NOT COMPLETED|Period 1||0
16365|NCT01995357|36728|P4|NOT COMPLETED|Period 1||0
16366|NCT01995357|36729|P3|NOT COMPLETED|Period 1||0
16367|NCT01995357|36730|P2|NOT COMPLETED|Period 1||0
16368|NCT01995357|36731|P1|NOT COMPLETED|Period 1||0
16369|NCT01995357|36726|P6|COMPLETED|Period 1||4
16370|NCT01995357|36727|P5|COMPLETED|Period 1||4
16371|NCT01995357|36728|P4|COMPLETED|Period 1||3
16372|NCT01995357|36729|P3|COMPLETED|Period 1||4
16373|NCT01995357|36730|P2|COMPLETED|Period 1||3
16374|NCT01995357|36731|P1|COMPLETED|Period 1||4
16375|NCT01995357|36726|P6|STARTED|Period 1||4
16376|NCT01995357|36727|P5|STARTED|Period 1||4
16377|NCT01995357|36728|P4|STARTED|Period 1||3
16378|NCT01995357|36729|P3|STARTED|Period 1||4
16379|NCT01995357|36730|P2|STARTED|Period 1||3
16380|NCT01995357|36731|P1|STARTED|Period 1||4
16381|NCT01995136|36747|P1|NOT COMPLETED|Overall Study||1
16382|NCT01995136|36747|P1|COMPLETED|Overall Study||31
16383|NCT01995136|36747|P1|STARTED|Overall Study||32
16384|NCT01995045|36753|P2|NOT COMPLETED|Overall Study||0
16385|NCT01995045|36754|P1|NOT COMPLETED|Overall Study||0
16386|NCT01995045|36753|P2|COMPLETED|Overall Study||28
16387|NCT01995045|36754|P1|COMPLETED|Overall Study||29
16388|NCT01995045|36753|P2|STARTED|Overall Study||28
16389|NCT01995045|36754|P1|STARTED|Overall Study||29
16390|NCT01994902|36766|P2|NOT COMPLETED|Test Period 2||6
16391|NCT01994902|36767|P1|NOT COMPLETED|Test Period 2||0
16392|NCT01994902|36766|P2|COMPLETED|Test Period 2||55
16393|NCT01994902|36767|P1|COMPLETED|Test Period 2||57
16394|NCT01994902|36766|P2|STARTED|Test Period 2||61
16395|NCT01994902|36767|P1|STARTED|Test Period 2||57
16396|NCT01994902|36766|P2|NOT COMPLETED|Test Period 1||3
16397|NCT01994902|36767|P1|NOT COMPLETED|Test Period 1||6
16398|NCT01994902|36766|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
16399|NCT01994902|36767|P1|COMPLETED|Test Period 1||57
16400|NCT01994902|36766|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
16401|NCT01994902|36767|P1|STARTED|Test Period 1||63
16402|NCT01994876|36773|P2|NOT COMPLETED|Test Period 2||1
16403|NCT01994876|36774|P1|NOT COMPLETED|Test Period 2||1
16404|NCT01994876|36773|P2|COMPLETED|Test Period 2||6
16405|NCT01994876|36774|P1|COMPLETED|Test Period 2||8
16406|NCT01994876|36773|P2|STARTED|Test Period 2||7
16407|NCT01994876|36774|P1|STARTED|Test Period 2||9
16408|NCT01994876|36773|P2|NOT COMPLETED|Test Period 1||2
16409|NCT01994876|36774|P1|NOT COMPLETED|Test Period 1||0
16410|NCT01994876|36773|P2|COMPLETED|Test Period 1||7
16411|NCT01994876|36774|P1|COMPLETED|Test Period 1||9
16412|NCT01994876|36773|P2|STARTED|Test Period 1||9
16413|NCT01994876|36774|P1|STARTED|Test Period 1||9
16414|NCT01994876|36773|P2|NOT COMPLETED|Baseline - Own Product||0
16415|NCT01994876|36774|P1|NOT COMPLETED|Baseline - Own Product||0
16416|NCT01994876|36773|P2|COMPLETED|Baseline - Own Product||9
16417|NCT01994876|36774|P1|COMPLETED|Baseline - Own Product||9
16418|NCT01994876|36773|P2|STARTED|Baseline - Own Product||9
16419|NCT01994876|36774|P1|STARTED|Baseline - Own Product||9
16420|NCT01994863|36782|P2|NOT COMPLETED|Period 2||4
16421|NCT01994863|36783|P1|NOT COMPLETED|Period 2||1
16422|NCT01994863|36782|P2|COMPLETED|Period 2||5
16423|NCT01994863|36783|P1|COMPLETED|Period 2||7
16424|NCT01994863|36782|P2|STARTED|Period 2||9
16425|NCT01994863|36783|P1|STARTED|Period 2||8
16426|NCT01994863|36782|P2|NOT COMPLETED|Period 1||3
16427|NCT01994863|36783|P1|NOT COMPLETED|Period 1||7
16428|NCT01994863|36782|P2|COMPLETED|Period 1||9
16429|NCT01994863|36783|P1|COMPLETED|Period 1||4
16430|NCT01994863|36782|P2|STARTED|Period 1||12
16431|NCT01994863|36783|P1|STARTED|Period 1||11
16432|NCT01994746|36789|P2|NOT COMPLETED|Second Visit||0
16433|NCT01994746|36790|P1|NOT COMPLETED|Second Visit||0
16434|NCT01994746|36789|P2|COMPLETED|Second Visit||38
16435|NCT01994746|36790|P1|COMPLETED|Second Visit|Safety population|38
16436|NCT01994746|36789|P2|Efficacy|Second Visit||38
16437|NCT01994746|36790|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
16438|NCT01994746|36789|P2|STARTED|Second Visit||38
16439|NCT01994746|36790|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
16440|NCT01994746|36789|P2|NOT COMPLETED|First Visit||0
16441|NCT01994746|36790|P1|NOT COMPLETED|First Visit||0
16442|NCT01994746|36789|P2|COMPLETED|First Visit||38
16443|NCT01994746|36790|P1|COMPLETED|First Visit|Safety population|39
16444|NCT01994746|36789|P2|Efficacy|First Visit||38
16445|NCT01994746|36790|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
16446|NCT01994746|36789|P2|STARTED|First Visit||38
16447|NCT01994746|36790|P1|STARTED|First Visit||39
16448|NCT01994629|36798|P2|NOT COMPLETED|Overall Study||3
16449|NCT01994629|36799|P1|NOT COMPLETED|Overall Study||1
16450|NCT01994629|36798|P2|COMPLETED|Overall Study||99
16451|NCT01994629|36799|P1|COMPLETED|Overall Study||99
16452|NCT01994629|36798|P2|STARTED|Overall Study||102
16453|NCT01994629|36799|P1|STARTED|Overall Study||100
16454|NCT01994486|36823|P1|NOT COMPLETED|Overall Study||0
16455|NCT01994486|36823|P1|COMPLETED|Overall Study||20
16456|NCT01994486|36823|P1|STARTED|Overall Study||20
16457|NCT01994291|36835|P3|NOT COMPLETED|Overall Study||9
16458|NCT01994291|36836|P2|NOT COMPLETED|Overall Study||7
16459|NCT01994291|36837|P1|NOT COMPLETED|Overall Study||15
16460|NCT01994291|36835|P3|COMPLETED|Overall Study||47
16461|NCT01994291|36836|P2|COMPLETED|Overall Study||36
16462|NCT01994291|36837|P1|COMPLETED|Overall Study||84
16463|NCT01994291|36835|P3|Received Treatment|Overall Study||56
16464|NCT01994291|36836|P2|Received Treatment|Overall Study||43
16465|NCT01994291|36837|P1|Received Treatment|Overall Study||99
16466|NCT01994291|36835|P3|STARTED|Overall Study||56
16467|NCT01994291|36836|P2|STARTED|Overall Study||43
16468|NCT01994291|36837|P1|STARTED|Overall Study||99
16469|NCT01993888|36893|P2|NOT COMPLETED|Overall Study||3
16470|NCT01993888|36894|P1|NOT COMPLETED|Overall Study||2
16471|NCT01993888|36893|P2|COMPLETED|Overall Study||49
16472|NCT01993888|36894|P1|COMPLETED|Overall Study||48
16473|NCT01993888|36893|P2|STARTED|Overall Study||52
16474|NCT01993888|36894|P1|STARTED|Overall Study||50
16475|NCT01993823|36912|P2|NOT COMPLETED|Overall Study||16
16476|NCT01993823|36913|P1|NOT COMPLETED|Overall Study||7
16477|NCT01993823|36912|P2|COMPLETED|Overall Study||79
16478|NCT01993823|36913|P1|COMPLETED|Overall Study||88
16479|NCT01993823|36912|P2|STARTED|Overall Study||95
16480|NCT01993823|36913|P1|STARTED|Overall Study||95
16481|NCT01993238|36921|P1|NOT COMPLETED|Overall Study||0
16482|NCT01993238|36921|P1|COMPLETED|Overall Study||11
16483|NCT01993238|36921|P1|STARTED|Overall Study||11
16484|NCT01993030|36928|P2|NOT COMPLETED|Overall Study||4
16485|NCT01993030|36929|P1|NOT COMPLETED|Overall Study||0
16486|NCT01993030|36928|P2|COMPLETED|Overall Study||31
16487|NCT01993030|36929|P1|COMPLETED|Overall Study||36
16488|NCT01993030|36928|P2|STARTED|Overall Study||35
16489|NCT01993030|36929|P1|STARTED|Overall Study||36
16490|NCT01992874|36943|P3|NOT COMPLETED|Part B||0
16491|NCT01992874|36944|P2|NOT COMPLETED|Part B||0
16492|NCT01992874|36945|P1|NOT COMPLETED|Part B||0
16493|NCT01992874|36943|P3|COMPLETED|Part B||38
16494|NCT01992874|36944|P2|COMPLETED|Part B||0
16495|NCT01992874|36945|P1|COMPLETED|Part B||0
16496|NCT01992874|36943|P3|STARTED|Part B||38
16497|NCT01992874|36944|P2|STARTED|Part B||0
16498|NCT01992874|36945|P1|STARTED|Part B||0
16499|NCT01992874|36943|P3|NOT COMPLETED|Part A||0
16500|NCT01992874|36944|P2|NOT COMPLETED|Part A||0
16501|NCT01992874|36945|P1|NOT COMPLETED|Part A||0
16502|NCT01992874|36943|P3|COMPLETED|Part A||0
16503|NCT01992874|36944|P2|COMPLETED|Part A||17
16504|NCT01992874|36945|P1|COMPLETED|Part A||21
16505|NCT01992874|36943|P3|STARTED|Part A||0
16506|NCT01992874|36944|P2|STARTED|Part A||17
16507|NCT01992874|36945|P1|STARTED|Part A||21
16508|NCT01992536|36983|P10|NOT COMPLETED|Overall Study||1
16509|NCT01992536|36984|P9|NOT COMPLETED|Overall Study||1
16510|NCT01992536|36985|P8|NOT COMPLETED|Overall Study||0
16511|NCT01992536|36986|P7|NOT COMPLETED|Overall Study||7
16512|NCT01992536|36987|P6|NOT COMPLETED|Overall Study||1
16513|NCT01992536|36988|P5|NOT COMPLETED|Overall Study||0
16514|NCT01992536|36989|P4|NOT COMPLETED|Overall Study||2
16515|NCT01992536|36990|P3|NOT COMPLETED|Overall Study||1
16516|NCT01992536|36991|P2|NOT COMPLETED|Overall Study||3
16517|NCT01992536|36992|P1|NOT COMPLETED|Overall Study||4
16518|NCT01992536|36983|P10|COMPLETED|Overall Study||18
16519|NCT01992536|36984|P9|COMPLETED|Overall Study||18
16520|NCT01992536|36985|P8|COMPLETED|Overall Study||21
16521|NCT01992536|36986|P7|COMPLETED|Overall Study||0
16522|NCT01992536|36987|P6|COMPLETED|Overall Study||20
16523|NCT01992536|36988|P5|COMPLETED|Overall Study||11
16524|NCT01992536|36989|P4|COMPLETED|Overall Study||22
16525|NCT01992536|36990|P3|COMPLETED|Overall Study||16
16526|NCT01992536|36991|P2|COMPLETED|Overall Study||22
16527|NCT01992536|36992|P1|COMPLETED|Overall Study||22
16528|NCT01992536|36983|P10|STARTED|Overall Study||19
16529|NCT01992536|36984|P9|STARTED|Overall Study||19
16530|NCT01992536|36985|P8|STARTED|Overall Study||21
16531|NCT01992536|36986|P7|STARTED|Overall Study||7
16532|NCT01992536|36987|P6|STARTED|Overall Study||21
16533|NCT01992536|36988|P5|STARTED|Overall Study||11
16534|NCT01992536|36989|P4|STARTED|Overall Study||24
16535|NCT01992536|36990|P3|STARTED|Overall Study||17
16536|NCT01992536|36991|P2|STARTED|Overall Study||25
16537|NCT01992536|36992|P1|STARTED|Overall Study||26
16538|NCT01992523|37209|P2|NOT COMPLETED|Overall Study||0
16539|NCT01992523|37210|P1|NOT COMPLETED|Overall Study||0
16540|NCT01992523|37209|P2|COMPLETED|Overall Study||41
16541|NCT01992523|37210|P1|COMPLETED|Overall Study||41
16542|NCT01992523|37209|P2|STARTED|Overall Study||41
16543|NCT01992523|37210|P1|STARTED|Overall Study||41
16544|NCT01992185|37224|P2|NOT COMPLETED|Overall Study||0
16545|NCT01992185|37225|P1|NOT COMPLETED|Overall Study||0
16546|NCT01992185|37224|P2|COMPLETED|Overall Study||8
16547|NCT01992185|37225|P1|COMPLETED|Overall Study||7
16548|NCT01992185|37224|P2|STARTED|Overall Study||8
16549|NCT01992185|37225|P1|STARTED|Overall Study||7
16550|NCT01992172|37233|P2|NOT COMPLETED|Overall Study||0
16551|NCT01992172|37234|P1|NOT COMPLETED|Overall Study||0
16552|NCT01992172|37233|P2|COMPLETED|Overall Study||0
16553|NCT01992172|37234|P1|COMPLETED|Overall Study||7
16554|NCT01992172|37233|P2|STARTED|Overall Study||0
16555|NCT01992172|37234|P1|STARTED|Overall Study||7
16556|NCT01992107|37243|P3|NOT COMPLETED|Overall Study||36
16557|NCT01992107|37244|P2|NOT COMPLETED|Overall Study||33
16558|NCT01992107|37245|P1|NOT COMPLETED|Overall Study||68
16559|NCT01992107|37243|P3|COMPLETED|Overall Study||545
16560|NCT01992107|37244|P2|COMPLETED|Overall Study||560
16561|NCT01992107|37245|P1|COMPLETED|Overall Study||1091
16562|NCT01992107|37243|P3|STARTED|Overall Study||581
16563|NCT01992107|37244|P2|STARTED|Overall Study||593
16564|NCT01992107|37245|P1|STARTED|Overall Study||1159
16565|NCT01992094|37301|P3|NOT COMPLETED|Overall Study||21
16566|NCT01992094|37302|P2|NOT COMPLETED|Overall Study||24
16567|NCT01992094|37303|P1|NOT COMPLETED|Overall Study||50
16568|NCT01992094|37301|P3|COMPLETED|Overall Study||648
16569|NCT01992094|37302|P2|COMPLETED|Overall Study||652
16570|NCT01992094|37303|P1|COMPLETED|Overall Study||1285
16571|NCT01992094|37301|P3|STARTED|Overall Study||669
16572|NCT01992094|37302|P2|STARTED|Overall Study||676
16573|NCT01992094|37303|P1|STARTED|Overall Study||1335
16574|NCT01991990|37361|P2|NOT COMPLETED|Overall Study||0
16575|NCT01991990|37362|P1|NOT COMPLETED|Overall Study||0
16576|NCT01991990|37361|P2|COMPLETED|Overall Study||12
16577|NCT01991990|37362|P1|COMPLETED|Overall Study||6
16578|NCT01991990|37361|P2|STARTED|Overall Study||12
16579|NCT01991990|37362|P1|STARTED|Overall Study||6
16580|NCT01990859|37402|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
16581|NCT01990859|37402|P1|COMPLETED|90 Day Follow Up for All Participants||20
16582|NCT01990859|37402|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
16583|NCT01990859|37402|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
16584|NCT01990859|37402|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
16585|NCT01990859|37402|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
16586|NCT01990859|37402|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
16587|NCT01990859|37402|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
16588|NCT01990859|37402|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
16589|NCT01990794|37413|P1|NOT COMPLETED|Overall Study||3
16590|NCT01990794|37413|P1|COMPLETED|Overall Study||10
16591|NCT01990794|37413|P1|One Month Into Study|Overall Study||10
16592|NCT01990794|37413|P1|STARTED|Overall Study||13
16593|NCT01990664|37527|P2|NOT COMPLETED|Overall Study||11
16594|NCT01990664|37528|P1|NOT COMPLETED|Overall Study||7
16595|NCT01990664|37527|P2|COMPLETED|Overall Study||79
16596|NCT01990664|37528|P1|COMPLETED|Overall Study||95
16597|NCT01990664|37527|P2|STARTED|Overall Study||90
16598|NCT01990664|37528|P1|STARTED|Overall Study||102
16599|NCT01990339|37534|P1|NOT COMPLETED|Overall Study||2312
16600|NCT01990339|37534|P1|COMPLETED|Overall Study||12653
16601|NCT01990339|37534|P1|STARTED|Overall Study||14965
16602|NCT01990261|37539|P1|NOT COMPLETED|Overall Study||25
16603|NCT01990261|37539|P1|COMPLETED|Overall Study||8
16604|NCT01990261|37539|P1|Treated|Overall Study||29
16605|NCT01990261|37539|P1|STARTED|Overall Study||33
16606|NCT01989689|37551|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
16607|NCT01989689|37552|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
16608|NCT01989689|37551|P2|COMPLETED|Treatment Period ( 3 Months)||10
16609|NCT01989689|37552|P1|COMPLETED|Treatment Period ( 3 Months)||11
16610|NCT01989689|37551|P2|STARTED|Treatment Period ( 3 Months)||10
16611|NCT01989689|37552|P1|STARTED|Treatment Period ( 3 Months)||11
16612|NCT01989689|37551|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
16613|NCT01989689|37552|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
16614|NCT01989689|37551|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
16615|NCT01989689|37552|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
16616|NCT01989689|37551|P2|STARTED|Treatment Period 1 ( 3 Months)||13
16617|NCT01989689|37552|P1|STARTED|Treatment Period 1 ( 3 Months)||11
16618|NCT01989689|37551|P2|NOT COMPLETED|Baseline||0
16619|NCT01989689|37552|P1|NOT COMPLETED|Baseline||0
16620|NCT01989689|37551|P2|COMPLETED|Baseline||13
16621|NCT01989689|37552|P1|COMPLETED|Baseline||11
16622|NCT01989689|37551|P2|STARTED|Baseline||13
16623|NCT01989689|37552|P1|STARTED|Baseline||11
16624|NCT01989572|37568|P6|NOT COMPLETED|Overall Study||110
16625|NCT01989572|37569|P5|NOT COMPLETED|Overall Study||98
16626|NCT01989572|37570|P4|NOT COMPLETED|Overall Study||51
16627|NCT01989572|37571|P3|NOT COMPLETED|Overall Study||62
16628|NCT01989572|37572|P2|NOT COMPLETED|Overall Study||58
16629|NCT01989572|37573|P1|NOT COMPLETED|Overall Study||55
16630|NCT01989572|37568|P6|COMPLETED|Overall Study||79
16631|NCT01989572|37569|P5|COMPLETED|Overall Study||92
16632|NCT01989572|37570|P4|COMPLETED|Overall Study||56
16633|NCT01989572|37571|P3|COMPLETED|Overall Study||47
16634|NCT01989572|37572|P2|COMPLETED|Overall Study||53
16635|NCT01989572|37573|P1|COMPLETED|Overall Study||54
16636|NCT01989572|37568|P6|Treated|Overall Study||171
16637|NCT01989572|37569|P5|Treated|Overall Study||186
16638|NCT01989572|37570|P4|Treated|Overall Study||104
16639|NCT01989572|37571|P3|Treated|Overall Study||107
16640|NCT01989572|37572|P2|Treated|Overall Study||110
16641|NCT01989572|37573|P1|Treated|Overall Study||104
16642|NCT01989572|37568|P6|STARTED|Overall Study||189
16643|NCT01989572|37569|P5|STARTED|Overall Study||190
16644|NCT01989572|37570|P4|STARTED|Overall Study||107
16645|NCT01989572|37571|P3|STARTED|Overall Study||109
16646|NCT01989572|37572|P2|STARTED|Overall Study||111
16647|NCT01989572|37573|P1|STARTED|Overall Study||109
16648|NCT01989455|37606|P5|NOT COMPLETED|Overall Study||1
16649|NCT01989455|37607|P4|NOT COMPLETED|Overall Study||0
16650|NCT01989455|37608|P3|NOT COMPLETED|Overall Study||1
16651|NCT01989455|37609|P2|NOT COMPLETED|Overall Study||2
16652|NCT01989455|37610|P1|NOT COMPLETED|Overall Study||0
16653|NCT01989455|37606|P5|COMPLETED|Overall Study||7
16654|NCT01989455|37607|P4|COMPLETED|Overall Study||14
16655|NCT01989455|37608|P3|COMPLETED|Overall Study||13
16656|NCT01989455|37609|P2|COMPLETED|Overall Study||12
16657|NCT01989455|37610|P1|COMPLETED|Overall Study||14
16658|NCT01989455|37606|P5|STARTED|Overall Study||8
16659|NCT01989455|37607|P4|STARTED|Overall Study||14
16660|NCT01989455|37608|P3|STARTED|Overall Study||14
16661|NCT01989455|37609|P2|STARTED|Overall Study||14
16662|NCT01989455|37610|P1|STARTED|Overall Study||14
16663|NCT01989195|37644|P1|NOT COMPLETED|Overall Study||0
16664|NCT01989195|37644|P1|COMPLETED|Overall Study||6
16665|NCT01989195|37644|P1|STARTED|Overall Study||6
16666|NCT01989169|37654|P2|NOT COMPLETED|Period 2||1
16667|NCT01989169|37655|P1|NOT COMPLETED|Period 2||0
16668|NCT01989169|37654|P2|COMPLETED|Period 2||14
16669|NCT01989169|37655|P1|COMPLETED|Period 2||15
16670|NCT01989169|37654|P2|STARTED|Period 2||15
16671|NCT01989169|37655|P1|STARTED|Period 2||15
16672|NCT01989169|37654|P2|NOT COMPLETED|Period 1||0
16673|NCT01989169|37655|P1|NOT COMPLETED|Period 1||0
16674|NCT01989169|37654|P2|COMPLETED|Period 1||15
16675|NCT01989169|37655|P1|COMPLETED|Period 1||15
16676|NCT01989169|37654|P2|STARTED|Period 1||15
16677|NCT01989169|37655|P1|STARTED|Period 1||15
16678|NCT01988857|37665|P1|NOT COMPLETED|Overall Study||0
16679|NCT01988857|37665|P1|COMPLETED|Overall Study||300
16680|NCT01988857|37665|P1|STARTED|Overall Study||300
16681|NCT01988415|37672|P1|NOT COMPLETED|Overall Study||0
16682|NCT01988415|37672|P1|COMPLETED|Overall Study||26
16683|NCT01988415|37672|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
16684|NCT01988402|37682|P2|NOT COMPLETED|Overall Study||2
16685|NCT01988402|37683|P1|NOT COMPLETED|Overall Study||2
16686|NCT01988402|37682|P2|COMPLETED|Overall Study||17
16687|NCT01988402|37683|P1|COMPLETED|Overall Study||14
16688|NCT01988402|37682|P2|STARTED|Overall Study||19
16689|NCT01988402|37683|P1|STARTED|Overall Study||16
16690|NCT01988129|37693|P2|NOT COMPLETED|Overall Study||0
16691|NCT01988129|37694|P1|NOT COMPLETED|Overall Study||0
16692|NCT01988129|37693|P2|COMPLETED|Overall Study||588
16693|NCT01988129|37694|P1|COMPLETED|Overall Study||601
16694|NCT01988129|37693|P2|Completed 1-year Follow-up Survey|Overall Study||4
16695|NCT01988129|37694|P1|Completed 1-year Follow-up Survey|Overall Study||100
16696|NCT01988129|37693|P2|Screened for Sleep Disorders|Overall Study||15
16697|NCT01988129|37694|P1|Screened for Sleep Disorders|Overall Study||416
16698|NCT01988129|37693|P2|Attended Education Session|Overall Study||18
16699|NCT01988129|37694|P1|Attended Education Session|Overall Study||542
16700|NCT01988129|37693|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
16701|NCT01988129|37694|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
16702|NCT01987765|37721|P1|NOT COMPLETED|Overall Study||102
16703|NCT01987765|37721|P1|COMPLETED|Overall Study||745
16704|NCT01987765|37721|P1|STARTED|Overall Study||847
16705|NCT01987752|37726|P1|NOT COMPLETED|Overall Study||0
16706|NCT01987752|37726|P1|COMPLETED|Overall Study||732
16707|NCT01987752|37726|P1|STARTED|Overall Study||732
16708|NCT01987583|37733|P2|NOT COMPLETED|Overall Study||2
16709|NCT01987583|37734|P1|NOT COMPLETED|Overall Study||3
16710|NCT01987583|37733|P2|COMPLETED|Overall Study||38
16711|NCT01987583|37734|P1|COMPLETED|Overall Study||37
16712|NCT01987583|37733|P2|STARTED|Overall Study||40
16713|NCT01987583|37734|P1|STARTED|Overall Study||40
16714|NCT01987557|37745|P3|NOT COMPLETED|Overall Study||3
16715|NCT01987557|37746|P2|NOT COMPLETED|Overall Study||3
16716|NCT01987557|37747|P1|NOT COMPLETED|Overall Study||3
16717|NCT01987557|37745|P3|COMPLETED|Overall Study||13
16718|NCT01987557|37746|P2|COMPLETED|Overall Study||13
16719|NCT01987557|37747|P1|COMPLETED|Overall Study||13
16720|NCT01987557|37745|P3|STARTED|Overall Study||16
16721|NCT01987557|37746|P2|STARTED|Overall Study||16
16722|NCT01987557|37747|P1|STARTED|Overall Study||16
16723|NCT01987453|37758|P3|NOT COMPLETED|Overall Study||1
16724|NCT01987453|37759|P2|NOT COMPLETED|Overall Study||12
16725|NCT01987453|37760|P1|NOT COMPLETED|Overall Study||1
16726|NCT01987453|37758|P3|COMPLETED|Overall Study||7
16727|NCT01987453|37759|P2|COMPLETED|Overall Study||29
16728|NCT01987453|37760|P1|COMPLETED|Overall Study||50
16729|NCT01987453|37758|P3|STARTED|Overall Study||8
16730|NCT01987453|37759|P2|STARTED|Overall Study||41
16731|NCT01987453|37760|P1|STARTED|Overall Study||51
16732|NCT01987219|37789|P6|NOT COMPLETED|Overall Study||0
16733|NCT01987219|37790|P5|NOT COMPLETED|Overall Study||0
16734|NCT01987219|37791|P4|NOT COMPLETED|Overall Study||0
16735|NCT01987219|37792|P3|NOT COMPLETED|Overall Study||1
16736|NCT01987219|37793|P2|NOT COMPLETED|Overall Study||0
16737|NCT01987219|37794|P1|NOT COMPLETED|Overall Study||0
16738|NCT01987219|37789|P6|COMPLETED|Overall Study||1
16739|NCT01987219|37790|P5|COMPLETED|Overall Study||1
16740|NCT01987219|37791|P4|COMPLETED|Overall Study||2
16741|NCT01987219|37792|P3|COMPLETED|Overall Study||6
16742|NCT01987219|37793|P2|COMPLETED|Overall Study||2
16743|NCT01987219|37794|P1|COMPLETED|Overall Study||2
16744|NCT01987219|37789|P6|STARTED|Overall Study||1
16745|NCT01987219|37790|P5|STARTED|Overall Study||1
16746|NCT01987219|37791|P4|STARTED|Overall Study||2
16747|NCT01987219|37792|P3|STARTED|Overall Study||7
16748|NCT01987219|37793|P2|STARTED|Overall Study||2
16749|NCT01987219|37794|P1|STARTED|Overall Study||2
16750|NCT01986985|37811|P1|NOT COMPLETED|Overall Study||7
16751|NCT01986985|37811|P1|COMPLETED|Overall Study||51
16752|NCT01986985|37811|P1|STARTED|Overall Study||58
16753|NCT01986946|37817|P2|NOT COMPLETED|Overall Study||0
16754|NCT01986946|37818|P1|NOT COMPLETED|Overall Study||0
16755|NCT01986946|37817|P2|COMPLETED|Overall Study||9
16756|NCT01986946|37818|P1|COMPLETED|Overall Study||5
16757|NCT01986946|37817|P2|STARTED|Overall Study||9
16758|NCT01986946|37818|P1|STARTED|Overall Study||5
16759|NCT01986790|37851|P3|NOT COMPLETED|Overall Study||0
16760|NCT01986790|37852|P2|NOT COMPLETED|Overall Study||0
16761|NCT01986790|37853|P1|NOT COMPLETED|Overall Study||0
16762|NCT01986790|37851|P3|COMPLETED|Overall Study||98
16763|NCT01986790|37852|P2|COMPLETED|Overall Study||154
16764|NCT01986790|37853|P1|COMPLETED|Overall Study||91
16765|NCT01986790|37851|P3|STARTED|Overall Study||98
16766|NCT01986790|37852|P2|STARTED|Overall Study||154
16767|NCT01986790|37853|P1|STARTED|Overall Study||91
16768|NCT01986751|37869|P2|NOT COMPLETED|Overall Study||2
16769|NCT01986751|37870|P1|NOT COMPLETED|Overall Study||10
16770|NCT01986751|37869|P2|COMPLETED|Overall Study||2
16771|NCT01986751|37870|P1|COMPLETED|Overall Study||0
16772|NCT01986751|37869|P2|STARTED|Overall Study||4
16773|NCT01986751|37870|P1|STARTED|Overall Study||10
16774|NCT01986231|37890|P1|NOT COMPLETED|Overall Study||1
16775|NCT01986231|37890|P1|COMPLETED|Overall Study||11
16776|NCT01986231|37890|P1|STARTED|Overall Study||12
16777|NCT01986062|37897|P2|NOT COMPLETED|Overall Study||1
16778|NCT01986062|37898|P1|NOT COMPLETED|Overall Study||1
16779|NCT01986062|37897|P2|COMPLETED|Overall Study||49
16780|NCT01986062|37898|P1|COMPLETED|Overall Study||46
16781|NCT01986062|37897|P2|STARTED|Overall Study||50
16782|NCT01986062|37898|P1|STARTED|Overall Study||47
16783|NCT01985581|37916|P2|NOT COMPLETED|Second Intervention||4
16784|NCT01985581|37917|P1|NOT COMPLETED|Second Intervention||2
16785|NCT01985581|37916|P2|COMPLETED|Second Intervention||19
16786|NCT01985581|37917|P1|COMPLETED|Second Intervention||20
16787|NCT01985581|37916|P2|STARTED|Second Intervention||23
16788|NCT01985581|37917|P1|STARTED|Second Intervention||22
16789|NCT01985581|37916|P2|NOT COMPLETED|First Intervention||2
16790|NCT01985581|37917|P1|NOT COMPLETED|First Intervention||3
16791|NCT01985581|37916|P2|COMPLETED|First Intervention||23
16792|NCT01985581|37917|P1|COMPLETED|First Intervention||22
16793|NCT01985581|37916|P2|STARTED|First Intervention||25
16794|NCT01985581|37917|P1|STARTED|First Intervention||25
16795|NCT01985425|37937|P2|NOT COMPLETED|Overall Study||0
16796|NCT01985425|37938|P1|NOT COMPLETED|Overall Study||0
16797|NCT01985425|37937|P2|COMPLETED|Overall Study||51
16798|NCT01985425|37938|P1|COMPLETED|Overall Study||49
16799|NCT01985425|37937|P2|STARTED|Overall Study||51
16800|NCT01985425|37938|P1|STARTED|Overall Study||49
16801|NCT01985321|37958|P2|NOT COMPLETED|Overall Study||5
16802|NCT01985321|37959|P1|NOT COMPLETED|Overall Study||11
16803|NCT01985321|37958|P2|COMPLETED|Overall Study||78
16804|NCT01985321|37959|P1|COMPLETED|Overall Study||79
16805|NCT01985321|37958|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
16806|NCT01985321|37959|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
16807|NCT01985126|37969|P2|NOT COMPLETED|Overall Study||106
16808|NCT01985126|37970|P1|NOT COMPLETED|Overall Study||18
16809|NCT01985126|37969|P2|COMPLETED|Overall Study||0
16810|NCT01985126|37970|P1|COMPLETED|Overall Study||0
16811|NCT01985126|37969|P2|STARTED|Overall Study||106
16812|NCT01985126|37970|P1|STARTED|Overall Study||18
16813|NCT01984697|37993|P5|NOT COMPLETED|Overall Study||314
16814|NCT01984697|37994|P4|NOT COMPLETED|Overall Study||301
16815|NCT01984697|37995|P3|NOT COMPLETED|Overall Study||301
16816|NCT01984697|37996|P2|NOT COMPLETED|Overall Study||301
16817|NCT01984697|37997|P1|NOT COMPLETED|Overall Study||301
16818|NCT01984697|37993|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
16819|NCT01984697|37994|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
16820|NCT01984697|37995|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
16821|NCT01984697|37996|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
16822|NCT01984697|37997|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
16823|NCT01984697|37993|P5|Vaccination 3|Overall Study||311
16824|NCT01984697|37994|P4|Vaccination 3|Overall Study||293
16825|NCT01984697|37995|P3|Vaccination 3|Overall Study||0
16826|NCT01984697|37996|P2|Vaccination 3|Overall Study||0
16827|NCT01984697|37997|P1|Vaccination 3|Overall Study||0
16828|NCT01984697|37993|P5|Vaccination 2|Overall Study||313
16829|NCT01984697|37994|P4|Vaccination 2|Overall Study||298
16830|NCT01984697|37995|P3|Vaccination 2|Overall Study||291
16831|NCT01984697|37996|P2|Vaccination 2|Overall Study||296
16832|NCT01984697|37997|P1|Vaccination 2|Overall Study||293
16833|NCT01984697|37993|P5|Vaccination 1|Overall Study||314
16834|NCT01984697|37994|P4|Vaccination 1|Overall Study||300
16835|NCT01984697|37995|P3|Vaccination 1|Overall Study||300
16836|NCT01984697|37996|P2|Vaccination 1|Overall Study||301
16837|NCT01984697|37997|P1|Vaccination 1|Overall Study||301
16838|NCT01984697|37993|P5|STARTED|Overall Study||314
16839|NCT01984697|37994|P4|STARTED|Overall Study||301
16840|NCT01984697|37995|P3|STARTED|Overall Study||301
16841|NCT01984697|37996|P2|STARTED|Overall Study||301
16842|NCT01984697|37997|P1|STARTED|Overall Study||301
16843|NCT01984515|38094|P1|NOT COMPLETED|Overall Study||19
16844|NCT01984515|38094|P1|COMPLETED|Overall Study||40
16845|NCT01984515|38094|P1|Received CBT Session|Overall Study||40
16846|NCT01984515|38094|P1|STARTED|Overall Study||59
16847|NCT01984294|38103|P3|NOT COMPLETED|Overall Study||7
16848|NCT01984294|38104|P2|NOT COMPLETED|Overall Study||3
16849|NCT01984294|38105|P1|NOT COMPLETED|Overall Study||4
16850|NCT01984294|38103|P3|COMPLETED|Overall Study||27
16851|NCT01984294|38104|P2|COMPLETED|Overall Study||29
16852|NCT01984294|38105|P1|COMPLETED|Overall Study||31
16853|NCT01984294|38103|P3|STARTED|Overall Study||34
16854|NCT01984294|38104|P2|STARTED|Overall Study||32
16855|NCT01984294|38105|P1|STARTED|Overall Study||35
16856|NCT01984229|38127|P2|NOT COMPLETED|Safety Follow-up Period||1
16857|NCT01984229|38128|P1|NOT COMPLETED|Safety Follow-up Period||2
16858|NCT01984229|38127|P2|COMPLETED|Safety Follow-up Period||16
16859|NCT01984229|38128|P1|COMPLETED|Safety Follow-up Period||4
16860|NCT01984229|38127|P2|STARTED|Safety Follow-up Period||17
16861|NCT01984229|38128|P1|STARTED|Safety Follow-up Period||6
16862|NCT01984229|38127|P2|NOT COMPLETED|Period 3||0
16863|NCT01984229|38128|P1|NOT COMPLETED|Period 3||0
16864|NCT01984229|38127|P2|COMPLETED|Period 3||17
16865|NCT01984229|38128|P1|COMPLETED|Period 3||6
16866|NCT01984229|38127|P2|STARTED|Period 3||17
16867|NCT01984229|38128|P1|STARTED|Period 3||6
16868|NCT01984229|38127|P2|NOT COMPLETED|Period 2||0
16869|NCT01984229|38128|P1|NOT COMPLETED|Period 2||0
16870|NCT01984229|38127|P2|COMPLETED|Period 2||17
16871|NCT01984229|38128|P1|COMPLETED|Period 2||6
16872|NCT01984229|38127|P2|STARTED|Period 2||17
16873|NCT01984229|38128|P1|STARTED|Period 2||6
16874|NCT01984229|38127|P2|NOT COMPLETED|Period 1||0
16875|NCT01984229|38128|P1|NOT COMPLETED|Period 1||0
16876|NCT01984229|38127|P2|COMPLETED|Period 1||17
16877|NCT01984229|38128|P1|COMPLETED|Period 1||6
16878|NCT01984229|38127|P2|STARTED|Period 1||17
16879|NCT01984229|38128|P1|STARTED|Period 1||6
16880|NCT01983878|38178|P1|NOT COMPLETED|Overall Study||3
16881|NCT01983878|38178|P1|COMPLETED|Overall Study||33
16882|NCT01983878|38178|P1|Received At Least One Dose of Study Drug|Overall Study||36
16883|NCT01983878|38178|P1|STARTED|Overall Study||36
16884|NCT01983839|38188|P1|NOT COMPLETED|Overall Study||0
16885|NCT01983839|38188|P1|COMPLETED|Overall Study||18
16886|NCT01983839|38188|P1|STARTED|Overall Study||18
16887|NCT01983787|38193|P1|NOT COMPLETED|Overall Study||0
16888|NCT01983787|38193|P1|COMPLETED|Overall Study||10
16889|NCT01983787|38193|P1|STARTED|Overall Study||10
16890|NCT01983566|38220|P4|NOT COMPLETED|Test Period 4||0
16891|NCT01983566|38221|P3|NOT COMPLETED|Test Period 4||0
16892|NCT01983566|38222|P2|NOT COMPLETED|Test Period 4||0
16893|NCT01983566|38223|P1|NOT COMPLETED|Test Period 4||0
16894|NCT01983566|38220|P4|COMPLETED|Test Period 4||0
16895|NCT01983566|38221|P3|COMPLETED|Test Period 4||0
16896|NCT01983566|38222|P2|COMPLETED|Test Period 4||0
16897|NCT01983566|38223|P1|COMPLETED|Test Period 4||0
16898|NCT01983566|38220|P4|STARTED|Test Period 4||0
16899|NCT01983566|38221|P3|STARTED|Test Period 4||0
16900|NCT01983566|38222|P2|STARTED|Test Period 4||0
16901|NCT01983566|38223|P1|STARTED|Test Period 4||0
16902|NCT01983566|38220|P4|NOT COMPLETED|Wash-Out 3||0
16903|NCT01983566|38221|P3|NOT COMPLETED|Wash-Out 3||0
16904|NCT01983566|38222|P2|NOT COMPLETED|Wash-Out 3||0
16905|NCT01983566|38223|P1|NOT COMPLETED|Wash-Out 3||0
16906|NCT01983566|38220|P4|COMPLETED|Wash-Out 3||0
16907|NCT01983566|38221|P3|COMPLETED|Wash-Out 3||0
16908|NCT01983566|38222|P2|COMPLETED|Wash-Out 3||0
16909|NCT01983566|38223|P1|COMPLETED|Wash-Out 3||0
16910|NCT01983566|38220|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
16911|NCT01983566|38221|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
16912|NCT01983566|38222|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
16913|NCT01983566|38223|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
16914|NCT01983566|38220|P4|NOT COMPLETED|Test Period 3||0
16915|NCT01983566|38221|P3|NOT COMPLETED|Test Period 3||0
16916|NCT01983566|38222|P2|NOT COMPLETED|Test Period 3||0
16917|NCT01983566|38223|P1|NOT COMPLETED|Test Period 3||0
16918|NCT01983566|38220|P4|COMPLETED|Test Period 3||4
16919|NCT01983566|38221|P3|COMPLETED|Test Period 3||2
16920|NCT01983566|38222|P2|COMPLETED|Test Period 3||3
16921|NCT01983566|38223|P1|COMPLETED|Test Period 3||2
16922|NCT01983566|38220|P4|STARTED|Test Period 3||4
16923|NCT01983566|38221|P3|STARTED|Test Period 3||2
16924|NCT01983566|38222|P2|STARTED|Test Period 3||3
16925|NCT01983566|38223|P1|STARTED|Test Period 3||2
16926|NCT01983566|38220|P4|NOT COMPLETED|Wash-Out 2||0
16927|NCT01983566|38221|P3|NOT COMPLETED|Wash-Out 2||0
16928|NCT01983566|38222|P2|NOT COMPLETED|Wash-Out 2||0
16929|NCT01983566|38223|P1|NOT COMPLETED|Wash-Out 2||0
16930|NCT01983566|38220|P4|COMPLETED|Wash-Out 2||4
16931|NCT01983566|38221|P3|COMPLETED|Wash-Out 2||2
16932|NCT01983566|38222|P2|COMPLETED|Wash-Out 2||3
16933|NCT01983566|38223|P1|COMPLETED|Wash-Out 2||2
16934|NCT01983566|38220|P4|STARTED|Wash-Out 2||4
16935|NCT01983566|38221|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
16936|NCT01983566|38222|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
16937|NCT01983566|38223|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
16938|NCT01983566|38220|P4|NOT COMPLETED|Test Period 2||0
16939|NCT01983566|38221|P3|NOT COMPLETED|Test Period 2||0
16940|NCT01983566|38222|P2|NOT COMPLETED|Test Period 2||0
16941|NCT01983566|38223|P1|NOT COMPLETED|Test Period 2||0
16942|NCT01983566|38220|P4|COMPLETED|Test Period 2||4
16943|NCT01983566|38221|P3|COMPLETED|Test Period 2||4
16944|NCT01983566|38222|P2|COMPLETED|Test Period 2||4
16945|NCT01983566|38223|P1|COMPLETED|Test Period 2||4
16946|NCT01983566|38220|P4|STARTED|Test Period 2||4
16947|NCT01983566|38221|P3|STARTED|Test Period 2||4
16948|NCT01983566|38222|P2|STARTED|Test Period 2||4
16949|NCT01983566|38223|P1|STARTED|Test Period 2||4
16950|NCT01983566|38220|P4|NOT COMPLETED|Wash-Out 1||0
16951|NCT01983566|38221|P3|NOT COMPLETED|Wash-Out 1||0
16952|NCT01983566|38222|P2|NOT COMPLETED|Wash-Out 1||0
16953|NCT01983566|38223|P1|NOT COMPLETED|Wash-Out 1||0
16954|NCT01983566|38220|P4|COMPLETED|Wash-Out 1||4
16955|NCT01983566|38221|P3|COMPLETED|Wash-Out 1||4
16956|NCT01983566|38222|P2|COMPLETED|Wash-Out 1||4
16957|NCT01983566|38223|P1|COMPLETED|Wash-Out 1||4
16958|NCT01983566|38220|P4|STARTED|Wash-Out 1||4
16959|NCT01983566|38221|P3|STARTED|Wash-Out 1||4
16960|NCT01983566|38222|P2|STARTED|Wash-Out 1||4
16961|NCT01983566|38223|P1|STARTED|Wash-Out 1||4
16962|NCT01983566|38220|P4|NOT COMPLETED|Test Period 1||0
16963|NCT01983566|38221|P3|NOT COMPLETED|Test Period 1||0
16964|NCT01983566|38222|P2|NOT COMPLETED|Test Period 1||0
16965|NCT01983566|38223|P1|NOT COMPLETED|Test Period 1||0
16966|NCT01983566|38220|P4|COMPLETED|Test Period 1||4
16967|NCT01983566|38221|P3|COMPLETED|Test Period 1||4
16968|NCT01983566|38222|P2|COMPLETED|Test Period 1||4
16969|NCT01983566|38223|P1|COMPLETED|Test Period 1||4
16970|NCT01983566|38220|P4|STARTED|Test Period 1||4
16971|NCT01983566|38221|P3|STARTED|Test Period 1||4
16972|NCT01983566|38222|P2|STARTED|Test Period 1||4
16973|NCT01983566|38223|P1|STARTED|Test Period 1||4
16974|NCT01983111|38244|P2|NOT COMPLETED|Overall Study||7
16975|NCT01983111|38245|P1|NOT COMPLETED|Overall Study||12
16976|NCT01983111|38244|P2|COMPLETED|Overall Study||59
16977|NCT01983111|38245|P1|COMPLETED|Overall Study||58
16978|NCT01983111|38244|P2|STARTED|Overall Study||66
16979|NCT01983111|38245|P1|STARTED|Overall Study||70
16980|NCT01982812|38263|P2|NOT COMPLETED|Overall Study||10
16981|NCT01982812|38264|P1|NOT COMPLETED|Overall Study||1
16982|NCT01982812|38263|P2|COMPLETED|Overall Study||11
16983|NCT01982812|38264|P1|COMPLETED|Overall Study||22
16984|NCT01982812|38263|P2|STARTED|Overall Study||21
16985|NCT01982812|38264|P1|STARTED|Overall Study||23
16986|NCT01982539|38276|P1|NOT COMPLETED|Overall Study||0
16987|NCT01982539|38276|P1|COMPLETED|Overall Study||25
16988|NCT01982539|38276|P1|STARTED|Overall Study||25
16989|NCT01982292|38282|P2|NOT COMPLETED|Overall Study||1
16990|NCT01982292|38283|P1|NOT COMPLETED|Overall Study||12
16991|NCT01982292|38282|P2|COMPLETED|Overall Study||107
16992|NCT01982292|38283|P1|COMPLETED|Overall Study||203
16993|NCT01982292|38282|P2|Safety Set|Overall Study||108
16994|NCT01982292|38283|P1|Safety Set|Overall Study||212
16995|NCT01982292|38282|P2|Full Analaysis Set (FAS)|Overall Study||108
16996|NCT01982292|38283|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
16997|NCT01982292|38282|P2|STARTED|Overall Study||108
16998|NCT01982292|38283|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
16999|NCT01982253|38304|P3|NOT COMPLETED|Overall Study||4
17000|NCT01982253|38305|P2|NOT COMPLETED|Overall Study||4
17001|NCT01982253|38306|P1|NOT COMPLETED|Overall Study||2
17002|NCT01982253|38304|P3|COMPLETED|Overall Study||0
17003|NCT01982253|38305|P2|COMPLETED|Overall Study||0
17004|NCT01982253|38306|P1|COMPLETED|Overall Study||0
17005|NCT01982253|38304|P3|STARTED|Overall Study||4
17006|NCT01982253|38305|P2|STARTED|Overall Study||4
17007|NCT01982253|38306|P1|STARTED|Overall Study||2
17008|NCT01981967|38319|P2|NOT COMPLETED|Overall Study||0
17009|NCT01981967|38320|P1|NOT COMPLETED|Overall Study||0
17010|NCT01981967|38319|P2|COMPLETED|Overall Study||3149
17011|NCT01981967|38320|P1|COMPLETED|Overall Study||6851
17012|NCT01981967|38319|P2|STARTED|Overall Study||3149
17013|NCT01981967|38320|P1|STARTED|Overall Study||6851
17014|NCT01981863|38332|P2|NOT COMPLETED|Overall Study||0
17015|NCT01981863|38333|P1|NOT COMPLETED|Overall Study||0
17016|NCT01981863|38332|P2|COMPLETED|Overall Study||20
17017|NCT01981863|38333|P1|COMPLETED|Overall Study||20
17018|NCT01981863|38332|P2|STARTED|Overall Study||20
17019|NCT01981863|38333|P1|STARTED|Overall Study||20
17020|NCT01981616|38345|P2|NOT COMPLETED|Overall Study||1
17021|NCT01981616|38346|P1|NOT COMPLETED|Overall Study||1
17022|NCT01981616|38345|P2|COMPLETED|Overall Study||62
17023|NCT01981616|38346|P1|COMPLETED|Overall Study||63
17024|NCT01981616|38345|P2|STARTED|Overall Study||63
17025|NCT01981616|38346|P1|STARTED|Overall Study||64
17026|NCT01981473|38361|P3|NOT COMPLETED|Overall Study||8
17027|NCT01981473|38362|P2|NOT COMPLETED|Overall Study||0
17028|NCT01981473|38363|P1|NOT COMPLETED|Overall Study||2
17029|NCT01981473|38361|P3|COMPLETED|Overall Study||196
17030|NCT01981473|38362|P2|COMPLETED|Overall Study||199
17031|NCT01981473|38363|P1|COMPLETED|Overall Study||200
17032|NCT01981473|38361|P3|STARTED|Overall Study||204
17033|NCT01981473|38362|P2|STARTED|Overall Study||199
17034|NCT01981473|38363|P1|STARTED|Overall Study||202
17035|NCT01981356|38404|P2|NOT COMPLETED|Overall Study||2
17036|NCT01981356|38405|P1|NOT COMPLETED|Overall Study||7
17037|NCT01981356|38404|P2|COMPLETED|Overall Study||4
17038|NCT01981356|38405|P1|COMPLETED|Overall Study||5
17039|NCT01981356|38404|P2|STARTED|Overall Study||6
17040|NCT01981356|38405|P1|STARTED|Overall Study||12
17041|NCT01981057|38432|P2|NOT COMPLETED|Overall Study||0
17042|NCT01981057|38433|P1|NOT COMPLETED|Overall Study||0
17043|NCT01981057|38432|P2|COMPLETED|Overall Study||50
17044|NCT01981057|38433|P1|COMPLETED|Overall Study||50
17045|NCT01981057|38432|P2|STARTED|Overall Study||50
17046|NCT01981057|38433|P1|STARTED|Overall Study||50
17047|NCT01980940|38447|P8|NOT COMPLETED|Overall Study||0
17048|NCT01980940|38448|P7|NOT COMPLETED|Overall Study||0
17049|NCT01980940|38449|P6|NOT COMPLETED|Overall Study||2
17050|NCT01980940|38450|P5|NOT COMPLETED|Overall Study||0
17051|NCT01980940|38451|P4|NOT COMPLETED|Overall Study||0
17052|NCT01980940|38452|P3|NOT COMPLETED|Overall Study||0
17053|NCT01980940|38453|P2|NOT COMPLETED|Overall Study||0
17054|NCT01980940|38454|P1|NOT COMPLETED|Overall Study||0
17055|NCT01980940|38447|P8|COMPLETED|Overall Study||24
17056|NCT01980940|38448|P7|COMPLETED|Overall Study||24
17057|NCT01980940|38449|P6|COMPLETED|Overall Study||0
17058|NCT01980940|38450|P5|COMPLETED|Overall Study||2
17059|NCT01980940|38451|P4|COMPLETED|Overall Study||3
17060|NCT01980940|38452|P3|COMPLETED|Overall Study||5
17061|NCT01980940|38453|P2|COMPLETED|Overall Study||5
17062|NCT01980940|38454|P1|COMPLETED|Overall Study||5
17063|NCT01980940|38447|P8|Treated|Overall Study||24
17064|NCT01980940|38448|P7|Treated|Overall Study||24
17065|NCT01980940|38449|P6|Treated|Overall Study||2
17066|NCT01980940|38450|P5|Treated|Overall Study||2
17067|NCT01980940|38451|P4|Treated|Overall Study||3
17068|NCT01980940|38452|P3|Treated|Overall Study||5
17069|NCT01980940|38453|P2|Treated|Overall Study||5
17070|NCT01980940|38454|P1|Treated|Overall Study||5
17071|NCT01980940|38447|P8|STARTED|Overall Study||24
17072|NCT01980940|38448|P7|STARTED|Overall Study||24
17073|NCT01980940|38449|P6|STARTED|Overall Study||2
17074|NCT01980940|38450|P5|STARTED|Overall Study||2
17075|NCT01980940|38451|P4|STARTED|Overall Study||3
17076|NCT01980940|38452|P3|STARTED|Overall Study||5
17077|NCT01980940|38453|P2|STARTED|Overall Study||5
17078|NCT01980940|38454|P1|STARTED|Overall Study||5
17079|NCT01980628|38506|P1|NOT COMPLETED|Overall Study||39
17080|NCT01980628|38506|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
17081|NCT01980628|38506|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
17082|NCT01980589|38514|P3|NOT COMPLETED|Overall Study||0
17083|NCT01980589|38515|P2|NOT COMPLETED|Overall Study||0
17084|NCT01980589|38516|P1|NOT COMPLETED|Overall Study||0
17085|NCT01980589|38514|P3|COMPLETED|Overall Study||16
17086|NCT01980589|38515|P2|COMPLETED|Overall Study||3
17087|NCT01980589|38516|P1|COMPLETED|Overall Study||3
17088|NCT01980589|38514|P3|STARTED|Overall Study||16
17089|NCT01980589|38515|P2|STARTED|Overall Study||3
17090|NCT01980589|38516|P1|STARTED|Overall Study||3
17091|NCT01980095|38535|P2|NOT COMPLETED|Overall Study||11
17092|NCT01980095|38536|P1|NOT COMPLETED|Overall Study||14
17093|NCT01980095|38535|P2|COMPLETED|Overall Study||30
17094|NCT01980095|38536|P1|COMPLETED|Overall Study||63
17095|NCT01980095|38535|P2|Treated|Overall Study||41
17096|NCT01980095|38536|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
17097|NCT01980095|38535|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
17098|NCT01980095|38536|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
17099|NCT01979185|38546|P2|NOT COMPLETED|Period 2||1
17100|NCT01979185|38547|P1|NOT COMPLETED|Period 2||0
17101|NCT01979185|38546|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
17102|NCT01979185|38547|P1|COMPLETED|Period 2||15
17103|NCT01979185|38546|P2|STARTED|Period 2||15
17104|NCT01979185|38547|P1|STARTED|Period 2||15
17105|NCT01979185|38546|P2|NOT COMPLETED|Period 1||0
17106|NCT01979185|38547|P1|NOT COMPLETED|Period 1||0
17107|NCT01979185|38546|P2|COMPLETED|Period 1||15
17108|NCT01979185|38547|P1|COMPLETED|Period 1||15
17109|NCT01979185|38546|P2|STARTED|Period 1||15
17110|NCT01979185|38547|P1|STARTED|Period 1||15
17111|NCT01979029|38559|P2|NOT COMPLETED|Overall Study||0
17112|NCT01979029|38560|P1|NOT COMPLETED|Overall Study||0
17113|NCT01979029|38559|P2|COMPLETED|Overall Study||28
17114|NCT01979029|38560|P1|COMPLETED|Overall Study||29
17115|NCT01979029|38559|P2|STARTED|Overall Study||28
17116|NCT01979029|38560|P1|STARTED|Overall Study||29
17117|NCT01978600|38572|P2|NOT COMPLETED|Overall Study||0
17118|NCT01978600|38573|P1|NOT COMPLETED|Overall Study||0
17119|NCT01978600|38572|P2|COMPLETED|Overall Study||42
17120|NCT01978600|38573|P1|COMPLETED|Overall Study||44
17121|NCT01978600|38572|P2|STARTED|Overall Study||42
17122|NCT01978600|38573|P1|STARTED|Overall Study||44
17123|NCT01978145|38583|P2|NOT COMPLETED|Treatment Period 2||14
17124|NCT01978145|38584|P1|NOT COMPLETED|Treatment Period 2||19
17125|NCT01978145|38583|P2|COMPLETED|Treatment Period 2||179
17126|NCT01978145|38584|P1|COMPLETED|Treatment Period 2||185
17127|NCT01978145|38583|P2|STARTED|Treatment Period 2||193
17128|NCT01978145|38584|P1|STARTED|Treatment Period 2||204
17129|NCT01978145|38583|P2|NOT COMPLETED|Washout Period 1||3
17130|NCT01978145|38584|P1|NOT COMPLETED|Washout Period 1||1
17131|NCT01978145|38583|P2|COMPLETED|Washout Period 1||193
17132|NCT01978145|38584|P1|COMPLETED|Washout Period 1||204
17133|NCT01978145|38583|P2|STARTED|Washout Period 1||196
17134|NCT01978145|38584|P1|STARTED|Washout Period 1||205
17135|NCT01978145|38583|P2|NOT COMPLETED|Treatment Period 1||16
17136|NCT01978145|38584|P1|NOT COMPLETED|Treatment Period 1||9
17137|NCT01978145|38583|P2|COMPLETED|Treatment Period 1||196
17138|NCT01978145|38584|P1|COMPLETED|Treatment Period 1||205
17139|NCT01978145|38583|P2|STARTED|Treatment Period 1||212
17140|NCT01978145|38584|P1|STARTED|Treatment Period 1||214
17141|NCT01978119|38600|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
17142|NCT01978119|38601|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
17143|NCT01978119|38600|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
17144|NCT01978119|38601|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
17145|NCT01978119|38600|P2|STARTED|Treatment Period 2 (12 Weeks)||42
17146|NCT01978119|38601|P1|STARTED|Treatment Period 2 (12 Weeks)||38
17147|NCT01978119|38600|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
17148|NCT01978119|38601|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
17149|NCT01978119|38600|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
17150|NCT01978119|38601|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
17151|NCT01978119|38600|P2|STARTED|Washout Period 1 (3 Weeks)||42
17152|NCT01978119|38601|P1|STARTED|Washout Period 1 (3 Weeks)||38
17153|NCT01978119|38600|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
17154|NCT01978119|38601|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
17155|NCT01978119|38600|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
17156|NCT01978119|38601|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
17157|NCT01978119|38600|P2|STARTED|Treatment Period 1 (12 Weeks)||42
17158|NCT01978119|38601|P1|STARTED|Treatment Period 1 (12 Weeks)||40
17159|NCT01977820|38627|P2|NOT COMPLETED|Overall Study||1
17160|NCT01977820|38628|P1|NOT COMPLETED|Overall Study||1
17161|NCT01977820|38627|P2|COMPLETED|Overall Study||0
17162|NCT01977820|38628|P1|COMPLETED|Overall Study||0
17163|NCT01977820|38627|P2|STARTED|Overall Study||1
17164|NCT01977820|38628|P1|STARTED|Overall Study||1
17165|NCT01977794|38636|P2|NOT COMPLETED|Overall Study||6
17166|NCT01977794|38637|P1|NOT COMPLETED|Overall Study||8
17167|NCT01977794|38636|P2|COMPLETED|Overall Study||94
17168|NCT01977794|38637|P1|COMPLETED|Overall Study||92
17169|NCT01977794|38636|P2|STARTED|Overall Study||100
17170|NCT01977794|38637|P1|STARTED|Overall Study||100
17171|NCT01977729|38651|P1|NOT COMPLETED|Overall Study||1
17172|NCT01977729|38651|P1|COMPLETED|Overall Study||0
17173|NCT01977729|38651|P1|STARTED|Overall Study||1
17174|NCT01977573|38665|P4|NOT COMPLETED|Overall Study||3
17175|NCT01977573|38666|P3|NOT COMPLETED|Overall Study||4
17176|NCT01977573|38667|P2|NOT COMPLETED|Overall Study||3
17177|NCT01977573|38668|P1|NOT COMPLETED|Overall Study||20
17178|NCT01977573|38665|P4|COMPLETED|Overall Study||33
17179|NCT01977573|38666|P3|COMPLETED|Overall Study||32
17180|NCT01977573|38667|P2|COMPLETED|Overall Study||41
17181|NCT01977573|38668|P1|COMPLETED|Overall Study||116
17182|NCT01977573|38665|P4|STARTED|Overall Study||36
17183|NCT01977573|38666|P3|STARTED|Overall Study||36
17184|NCT01977573|38667|P2|STARTED|Overall Study||44
17185|NCT01977573|38668|P1|STARTED|Overall Study||136
17186|NCT01977482|38782|P6|NOT COMPLETED|Overall Study||5
17187|NCT01977482|38783|P5|NOT COMPLETED|Overall Study||3
17188|NCT01977482|38784|P4|NOT COMPLETED|Overall Study||4
17189|NCT01977482|38785|P3|NOT COMPLETED|Overall Study||5
17190|NCT01977482|38786|P2|NOT COMPLETED|Overall Study||9
17191|NCT01977482|38787|P1|NOT COMPLETED|Overall Study||3
17192|NCT01977482|38782|P6|COMPLETED|Overall Study||14
17193|NCT01977482|38783|P5|COMPLETED|Overall Study||37
17194|NCT01977482|38784|P4|COMPLETED|Overall Study||35
17195|NCT01977482|38785|P3|COMPLETED|Overall Study||35
17196|NCT01977482|38786|P2|COMPLETED|Overall Study||30
17197|NCT01977482|38787|P1|COMPLETED|Overall Study||36
17198|NCT01977482|38782|P6|STARTED|Overall Study||19
17199|NCT01977482|38783|P5|STARTED|Overall Study||40
17200|NCT01977482|38784|P4|STARTED|Overall Study||39
17201|NCT01977482|38785|P3|STARTED|Overall Study||40
17202|NCT01977482|38786|P2|STARTED|Overall Study||39
17203|NCT01977482|38787|P1|STARTED|Overall Study||39
17204|NCT01977456|38902|P1|NOT COMPLETED|Overall Study||5
17205|NCT01977456|38902|P1|COMPLETED|Overall Study||22
17206|NCT01977456|38902|P1|STARTED|Overall Study||27
17207|NCT01976988|38911|P2|NOT COMPLETED|Overall Study||18
17208|NCT01976988|38912|P1|NOT COMPLETED|Overall Study||16
17209|NCT01976988|38911|P2|COMPLETED|Overall Study||184
17210|NCT01976988|38912|P1|COMPLETED|Overall Study||192
17211|NCT01976988|38911|P2|STARTED|Overall Study||202
17212|NCT01976988|38912|P1|STARTED|Overall Study||208
17213|NCT01976871|38928|P1|NOT COMPLETED|Overall Study||1
17214|NCT01976871|38928|P1|COMPLETED|Overall Study||20
17215|NCT01976871|38928|P1|STARTED|Overall Study||21
17216|NCT01976845|38940|P3|NOT COMPLETED|Overall Study||3
17217|NCT01976845|38941|P2|NOT COMPLETED|Overall Study||8
17218|NCT01976845|38942|P1|NOT COMPLETED|Overall Study||8
17219|NCT01976845|38940|P3|COMPLETED|Overall Study||40
17220|NCT01976845|38941|P2|COMPLETED|Overall Study||40
17221|NCT01976845|38942|P1|COMPLETED|Overall Study||40
17222|NCT01976845|38940|P3|STARTED|Overall Study||43
17223|NCT01976845|38941|P2|STARTED|Overall Study||48
17224|NCT01976845|38942|P1|STARTED|Overall Study||48
17225|NCT01976806|38958|P2|NOT COMPLETED|Overall Study||6
17226|NCT01976806|38959|P1|NOT COMPLETED|Overall Study||3
17227|NCT01976806|38958|P2|COMPLETED|Overall Study||22
17228|NCT01976806|38959|P1|COMPLETED|Overall Study||24
17229|NCT01976806|38958|P2|STARTED|Overall Study||28
17230|NCT01976806|38959|P1|STARTED|Overall Study||27
17231|NCT01976650|38965|P1|NOT COMPLETED|Overall Study||6
17232|NCT01976650|38965|P1|COMPLETED|Overall Study||718
17233|NCT01976650|38965|P1|STARTED|Overall Study||724
17234|NCT01976624|38970|P1|NOT COMPLETED|Overall Study||14
17235|NCT01976624|38970|P1|COMPLETED|Overall Study||742
17236|NCT01976624|38970|P1|STARTED|Overall Study||756
17237|NCT01976572|38975|P3|NOT COMPLETED|Overall Study||0
17238|NCT01976572|38976|P2|NOT COMPLETED|Overall Study||0
17239|NCT01976572|38977|P1|NOT COMPLETED|Overall Study||0
17240|NCT01976572|38975|P3|COMPLETED|Overall Study||6
17241|NCT01976572|38976|P2|COMPLETED|Overall Study||6
17242|NCT01976572|38977|P1|COMPLETED|Overall Study||6
17243|NCT01976572|38975|P3|STARTED|Overall Study||6
17244|NCT01976572|38976|P2|STARTED|Overall Study||6
17245|NCT01976572|38977|P1|STARTED|Overall Study||6
17246|NCT01976299|38992|P2|NOT COMPLETED|Overall Study||6
17247|NCT01976299|38993|P1|NOT COMPLETED|Overall Study||23
17248|NCT01976299|38992|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
17249|NCT01976299|38993|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
17250|NCT01976299|38992|P2|Completed Procedure|Overall Study||284
17251|NCT01976299|38993|P1|Completed Procedure|Overall Study||283
17252|NCT01976299|38992|P2|STARTED|Overall Study||286
17253|NCT01976299|38993|P1|STARTED|Overall Study||292
17254|NCT01975974|39007|P1|NOT COMPLETED|Overall Study||0
17255|NCT01975974|39007|P1|COMPLETED|Overall Study||100
17256|NCT01975974|39007|P1|STARTED|Overall Study||100
17257|NCT01975675|39015|P4|NOT COMPLETED|Overall Study||0
17258|NCT01975675|39016|P3|NOT COMPLETED|Overall Study||0
17259|NCT01975675|39017|P2|NOT COMPLETED|Overall Study||1
17260|NCT01975675|39018|P1|NOT COMPLETED|Overall Study||0
17261|NCT01975675|39015|P4|COMPLETED|Overall Study||87
17262|NCT01975675|39016|P3|COMPLETED|Overall Study||88
17263|NCT01975675|39017|P2|COMPLETED|Overall Study||82
17264|NCT01975675|39018|P1|COMPLETED|Overall Study||83
17265|NCT01975675|39015|P4|STARTED|Overall Study||87
17266|NCT01975675|39016|P3|STARTED|Overall Study||88
17267|NCT01975675|39017|P2|STARTED|Overall Study||83
17268|NCT01975675|39018|P1|STARTED|Overall Study||83
17269|NCT01975467|39040|P2|NOT COMPLETED|Overall Study||0
17270|NCT01975467|39041|P1|NOT COMPLETED|Overall Study||0
17271|NCT01975467|39040|P2|COMPLETED|Overall Study||0
17272|NCT01975467|39041|P1|COMPLETED|Overall Study||0
17273|NCT01975467|39040|P2|STARTED|Overall Study|Study terminated before enrollment|0
17274|NCT01975467|39041|P1|STARTED|Overall Study|Study terminated before enrollment|0
17275|NCT01975285|39051|P2|NOT COMPLETED|Overall Study||2
17276|NCT01975285|39052|P1|NOT COMPLETED|Overall Study||2
17277|NCT01975285|39051|P2|COMPLETED|Overall Study||28
17278|NCT01975285|39052|P1|COMPLETED|Overall Study||28
17279|NCT01975285|39051|P2|STARTED|Overall Study||30
17280|NCT01975285|39052|P1|STARTED|Overall Study||30
17281|NCT01975246|39068|P2|NOT COMPLETED|Overall Study||2
17282|NCT01975246|39069|P1|NOT COMPLETED|Overall Study||4
17283|NCT01975246|39068|P2|COMPLETED|Overall Study||158
17284|NCT01975246|39069|P1|COMPLETED|Overall Study||145
17285|NCT01975246|39068|P2|STARTED|Overall Study||160
17286|NCT01975246|39069|P1|STARTED|Overall Study||149
17287|NCT01974895|39081|P2|NOT COMPLETED|Overall Study||15
17288|NCT01974895|39082|P1|NOT COMPLETED|Overall Study||15
17289|NCT01974895|39081|P2|COMPLETED|Overall Study||141
17290|NCT01974895|39082|P1|COMPLETED|Overall Study||143
17291|NCT01974895|39081|P2|STARTED|Overall Study||156
17292|NCT01974895|39082|P1|STARTED|Overall Study||158
17293|NCT01974817|39112|P1|NOT COMPLETED|Overall Study||8
17294|NCT01974817|39112|P1|COMPLETED|Overall Study||17
17295|NCT01974817|39112|P1|STARTED|Overall Study||25
17296|NCT01974752|39118|P2|NOT COMPLETED|Overall Study||15
17297|NCT01974752|39119|P1|NOT COMPLETED|Overall Study||37
17298|NCT01974752|39118|P2|COMPLETED|Overall Study||17
17299|NCT01974752|39119|P1|COMPLETED|Overall Study||60
17300|NCT01974752|39118|P2|STARTED|Overall Study||32
17301|NCT01974752|39119|P1|STARTED|Overall Study||97
17302|NCT01974700|39133|P2|NOT COMPLETED|Overall Study||0
17303|NCT01974700|39134|P1|NOT COMPLETED|Overall Study||0
17304|NCT01974700|39133|P2|COMPLETED|Overall Study||3
17305|NCT01974700|39134|P1|COMPLETED|Overall Study||5
17306|NCT01974700|39133|P2|STARTED|Overall Study||3
17307|NCT01974700|39134|P1|STARTED|Overall Study||5
17308|NCT01974323|39146|P2|NOT COMPLETED|Overall Study||93
17309|NCT01974323|39147|P1|NOT COMPLETED|Overall Study||92
17310|NCT01974323|39146|P2|COMPLETED|Overall Study||1027
17311|NCT01974323|39147|P1|COMPLETED|Overall Study||1026
17312|NCT01974323|39146|P2|STARTED|Overall Study||1120
17313|NCT01974323|39147|P1|STARTED|Overall Study||1118
17314|NCT01974245|39171|P2|NOT COMPLETED|Overall Study||8
17315|NCT01974245|39172|P1|NOT COMPLETED|Overall Study||9
17316|NCT01974245|39171|P2|COMPLETED|Overall Study||20
17317|NCT01974245|39172|P1|COMPLETED|Overall Study||18
17318|NCT01974245|39171|P2|STARTED|Overall Study||28
17319|NCT01974245|39172|P1|STARTED|Overall Study||27
17320|NCT01974141|39180|P2|NOT COMPLETED|Overall Study||82
17321|NCT01974141|39181|P1|NOT COMPLETED|Overall Study||96
17322|NCT01974141|39180|P2|COMPLETED|Overall Study||976
17323|NCT01974141|39181|P1|COMPLETED|Overall Study||948
17324|NCT01974141|39180|P2|STARTED|Overall Study||1058
17325|NCT01974141|39181|P1|STARTED|Overall Study||1044
17326|NCT01973777|39203|P1|NOT COMPLETED|Overall Study||7
17327|NCT01973777|39203|P1|COMPLETED|Overall Study||44
17328|NCT01973777|39203|P1|One Year Follow-up|Overall Study||44
17329|NCT01973777|39203|P1|STARTED|Overall Study|January 2014|51
17330|NCT01973608|39213|P4|NOT COMPLETED|Overall Study||0
17331|NCT01973608|39214|P3|NOT COMPLETED|Overall Study||0
17332|NCT01973608|39215|P2|NOT COMPLETED|Overall Study||0
17333|NCT01973608|39216|P1|NOT COMPLETED|Overall Study||0
17334|NCT01973608|39213|P4|COMPLETED|Overall Study||2
17335|NCT01973608|39214|P3|COMPLETED|Overall Study||6
17336|NCT01973608|39215|P2|COMPLETED|Overall Study||2
17337|NCT01973608|39216|P1|COMPLETED|Overall Study||2
17338|NCT01973608|39213|P4|STARTED|Overall Study||2
17339|NCT01973608|39214|P3|STARTED|Overall Study||6
17340|NCT01973608|39215|P2|STARTED|Overall Study||2
17341|NCT01973608|39216|P1|STARTED|Overall Study||2
17342|NCT01973595|39238|P4|NOT COMPLETED|Intervention Phase 2||0
17343|NCT01973595|39239|P3|NOT COMPLETED|Intervention Phase 2||0
17344|NCT01973595|39240|P2|NOT COMPLETED|Intervention Phase 2||0
17345|NCT01973595|39241|P1|NOT COMPLETED|Intervention Phase 2||0
17346|NCT01973595|39238|P4|COMPLETED|Intervention Phase 2||14
17347|NCT01973595|39239|P3|COMPLETED|Intervention Phase 2||14
17348|NCT01973595|39240|P2|COMPLETED|Intervention Phase 2||14
17349|NCT01973595|39241|P1|COMPLETED|Intervention Phase 2||14
17350|NCT01973595|39238|P4|STARTED|Intervention Phase 2||14
17351|NCT01973595|39239|P3|STARTED|Intervention Phase 2||14
17352|NCT01973595|39240|P2|STARTED|Intervention Phase 2||14
17353|NCT01973595|39241|P1|STARTED|Intervention Phase 2||14
17354|NCT01973595|39238|P4|NOT COMPLETED|Washout||0
17355|NCT01973595|39239|P3|NOT COMPLETED|Washout||1
17356|NCT01973595|39240|P2|NOT COMPLETED|Washout||0
17357|NCT01973595|39241|P1|NOT COMPLETED|Washout||1
17358|NCT01973595|39238|P4|COMPLETED|Washout||14
17359|NCT01973595|39239|P3|COMPLETED|Washout||14
17360|NCT01973595|39240|P2|COMPLETED|Washout||14
17361|NCT01973595|39241|P1|COMPLETED|Washout||14
17362|NCT01973595|39238|P4|STARTED|Washout||14
17363|NCT01973595|39239|P3|STARTED|Washout||15
17364|NCT01973595|39240|P2|STARTED|Washout||14
17365|NCT01973595|39241|P1|STARTED|Washout||15
17366|NCT01973595|39238|P4|NOT COMPLETED|Intervention Phase 1||0
17367|NCT01973595|39239|P3|NOT COMPLETED|Intervention Phase 1||0
17368|NCT01973595|39240|P2|NOT COMPLETED|Intervention Phase 1||0
17369|NCT01973595|39241|P1|NOT COMPLETED|Intervention Phase 1||0
17370|NCT01973595|39238|P4|COMPLETED|Intervention Phase 1||14
17371|NCT01973595|39239|P3|COMPLETED|Intervention Phase 1||15
17372|NCT01973595|39240|P2|COMPLETED|Intervention Phase 1||14
17373|NCT01973595|39241|P1|COMPLETED|Intervention Phase 1||15
17374|NCT01973595|39238|P4|STARTED|Intervention Phase 1||14
17375|NCT01973595|39239|P3|STARTED|Intervention Phase 1||15
17376|NCT01973595|39240|P2|STARTED|Intervention Phase 1||14
17377|NCT01973595|39241|P1|STARTED|Intervention Phase 1||15
17378|NCT01973439|39255|P1|NOT COMPLETED|Overall Study||5
17379|NCT01973439|39255|P1|COMPLETED|Overall Study||18
17380|NCT01973439|39255|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
17381|NCT01973439|39255|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
17382|NCT01973439|39255|P1|STARTED|Overall Study||23
17383|NCT01973413|39264|P2|NOT COMPLETED|Overall Study||0
17384|NCT01973413|39265|P1|NOT COMPLETED|Overall Study||1
17385|NCT01973413|39264|P2|COMPLETED|Overall Study||20
17386|NCT01973413|39265|P1|COMPLETED|Overall Study||11
17387|NCT01973413|39264|P2|STARTED|Overall Study||20
17388|NCT01973413|39265|P1|STARTED|Overall Study||12
17389|NCT01973231|39277|P2|NOT COMPLETED|Overall Study||12
17390|NCT01973231|39278|P1|NOT COMPLETED|Overall Study||11
17391|NCT01973231|39277|P2|COMPLETED|Overall Study||190
17392|NCT01973231|39278|P1|COMPLETED|Overall Study||191
17393|NCT01973231|39277|P2|STARTED|Overall Study||202
17394|NCT01973231|39278|P1|STARTED|Overall Study||202
17395|NCT01973218|39298|P2|NOT COMPLETED|Overall Study||0
17396|NCT01973218|39299|P1|NOT COMPLETED|Overall Study||2
17397|NCT01973218|39298|P2|COMPLETED|Overall Study||88
17398|NCT01973218|39299|P1|COMPLETED|Overall Study||174
17399|NCT01973218|39298|P2|STARTED|Overall Study||88
17400|NCT01973218|39299|P1|STARTED|Overall Study||176
17401|NCT01973205|39322|P2|NOT COMPLETED|Overall Study||22
17402|NCT01973205|39323|P1|NOT COMPLETED|Overall Study||30
17403|NCT01973205|39322|P2|COMPLETED|Overall Study||425
17404|NCT01973205|39323|P1|COMPLETED|Overall Study||423
17405|NCT01973205|39322|P2|STARTED|Overall Study||447
17406|NCT01973205|39323|P1|STARTED|Overall Study||453
17407|NCT01972776|39341|P6|NOT COMPLETED|Part 2||7
17408|NCT01972776|39342|P5|NOT COMPLETED|Part 2||13
17409|NCT01972776|39343|P4|NOT COMPLETED|Part 2||0
17410|NCT01972776|39344|P3|NOT COMPLETED|Part 2||0
17411|NCT01972776|39345|P2|NOT COMPLETED|Part 2||0
17412|NCT01972776|39346|P1|NOT COMPLETED|Part 2||0
17413|NCT01972776|39341|P6|COMPLETED|Part 2||0
17414|NCT01972776|39342|P5|COMPLETED|Part 2||1
17415|NCT01972776|39343|P4|COMPLETED|Part 2||0
17416|NCT01972776|39344|P3|COMPLETED|Part 2||0
17417|NCT01972776|39345|P2|COMPLETED|Part 2||0
17418|NCT01972776|39346|P1|COMPLETED|Part 2||0
17419|NCT01972776|39341|P6|STARTED|Part 2||7
17420|NCT01972776|39342|P5|STARTED|Part 2||14
17421|NCT01972776|39343|P4|STARTED|Part 2||0
17422|NCT01972776|39344|P3|STARTED|Part 2||0
17423|NCT01972776|39345|P2|STARTED|Part 2||0
17424|NCT01972776|39346|P1|STARTED|Part 2||0
17425|NCT01972776|39341|P6|NOT COMPLETED|Part 1||0
17426|NCT01972776|39342|P5|NOT COMPLETED|Part 1||0
17427|NCT01972776|39343|P4|NOT COMPLETED|Part 1||1
17428|NCT01972776|39344|P3|NOT COMPLETED|Part 1||2
17429|NCT01972776|39345|P2|NOT COMPLETED|Part 1||0
17430|NCT01972776|39346|P1|NOT COMPLETED|Part 1||0
17431|NCT01972776|39341|P6|COMPLETED|Part 1||0
17432|NCT01972776|39342|P5|COMPLETED|Part 1||0
17433|NCT01972776|39343|P4|COMPLETED|Part 1||6
17434|NCT01972776|39344|P3|COMPLETED|Part 1||6
17435|NCT01972776|39345|P2|COMPLETED|Part 1||6
17436|NCT01972776|39346|P1|COMPLETED|Part 1||6
17437|NCT01972776|39341|P6|STARTED|Part 1||0
17438|NCT01972776|39342|P5|STARTED|Part 1||0
17439|NCT01972776|39343|P4|STARTED|Part 1||7
17440|NCT01972776|39344|P3|STARTED|Part 1||8
17441|NCT01972776|39345|P2|STARTED|Part 1||6
17442|NCT01972776|39346|P1|STARTED|Part 1||6
17443|NCT01972659|39416|P2|NOT COMPLETED|Overall Study||3
17444|NCT01972659|39417|P1|NOT COMPLETED|Overall Study||4
17445|NCT01972659|39416|P2|COMPLETED|Overall Study||37
17446|NCT01972659|39417|P1|COMPLETED|Overall Study||36
17447|NCT01972659|39416|P2|STARTED|Overall Study||40
17448|NCT01972659|39417|P1|STARTED|Overall Study||40
17449|NCT01972516|39425|P2|NOT COMPLETED|Overall Study||0
17450|NCT01972516|39426|P1|NOT COMPLETED|Overall Study||0
17451|NCT01972516|39425|P2|COMPLETED|Overall Study||1
17452|NCT01972516|39426|P1|COMPLETED|Overall Study||3
17453|NCT01972516|39425|P2|STARTED|Overall Study||1
17454|NCT01972516|39426|P1|STARTED|Overall Study||3
17455|NCT01972438|39442|P2|NOT COMPLETED|Post Month 12 Study Period||4
17456|NCT01972438|39443|P1|NOT COMPLETED|Post Month 12 Study Period||3
17457|NCT01972438|39442|P2|COMPLETED|Post Month 12 Study Period||0
17458|NCT01972438|39443|P1|COMPLETED|Post Month 12 Study Period||0
17459|NCT01972438|39442|P2|STARTED|Post Month 12 Study Period||4
17460|NCT01972438|39443|P1|STARTED|Post Month 12 Study Period||3
17461|NCT01972438|39442|P2|NOT COMPLETED|Months 6-12 Study Period||2
17462|NCT01972438|39443|P1|NOT COMPLETED|Months 6-12 Study Period||3
17463|NCT01972438|39442|P2|COMPLETED|Months 6-12 Study Period||4
17464|NCT01972438|39443|P1|COMPLETED|Months 6-12 Study Period||3
17465|NCT01972438|39442|P2|STARTED|Months 6-12 Study Period||6
17466|NCT01972438|39443|P1|STARTED|Months 6-12 Study Period||6
17467|NCT01972438|39442|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
17468|NCT01972438|39443|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
17469|NCT01972438|39442|P2|COMPLETED|Months 3-6 Crossover Period||6
17470|NCT01972438|39443|P1|COMPLETED|Months 3-6 Crossover Period||6
17471|NCT01972438|39442|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
17472|NCT01972438|39443|P1|STARTED|Months 3-6 Crossover Period||6
17473|NCT01972438|39442|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
17474|NCT01972438|39443|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
17475|NCT01972438|39442|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
17476|NCT01972438|39443|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
17477|NCT01972438|39442|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
17478|NCT01972438|39443|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
17479|NCT01972152|39495|P6|NOT COMPLETED|Third Treatment Visit||0
17480|NCT01972152|39496|P5|NOT COMPLETED|Third Treatment Visit||0
17481|NCT01972152|39497|P4|NOT COMPLETED|Third Treatment Visit||0
17482|NCT01972152|39498|P3|NOT COMPLETED|Third Treatment Visit||0
17483|NCT01972152|39499|P2|NOT COMPLETED|Third Treatment Visit||0
17484|NCT01972152|39500|P1|NOT COMPLETED|Third Treatment Visit||0
17485|NCT01972152|39495|P6|COMPLETED|Third Treatment Visit||5
17486|NCT01972152|39496|P5|COMPLETED|Third Treatment Visit||5
17487|NCT01972152|39497|P4|COMPLETED|Third Treatment Visit||5
17488|NCT01972152|39498|P3|COMPLETED|Third Treatment Visit||5
17489|NCT01972152|39499|P2|COMPLETED|Third Treatment Visit||3
17490|NCT01972152|39500|P1|COMPLETED|Third Treatment Visit||5
17491|NCT01972152|39495|P6|STARTED|Third Treatment Visit||5
17492|NCT01972152|39496|P5|STARTED|Third Treatment Visit||5
17493|NCT01972152|39497|P4|STARTED|Third Treatment Visit||5
17494|NCT01972152|39498|P3|STARTED|Third Treatment Visit||5
17495|NCT01972152|39499|P2|STARTED|Third Treatment Visit||3
17496|NCT01972152|39500|P1|STARTED|Third Treatment Visit||5
17497|NCT01972152|39495|P6|NOT COMPLETED|Second Treatment Visit||0
17498|NCT01972152|39496|P5|NOT COMPLETED|Second Treatment Visit||0
17499|NCT01972152|39497|P4|NOT COMPLETED|Second Treatment Visit||0
17500|NCT01972152|39498|P3|NOT COMPLETED|Second Treatment Visit||0
17501|NCT01972152|39499|P2|NOT COMPLETED|Second Treatment Visit||1
17502|NCT01972152|39500|P1|NOT COMPLETED|Second Treatment Visit||0
17503|NCT01972152|39495|P6|COMPLETED|Second Treatment Visit||5
17504|NCT01972152|39496|P5|COMPLETED|Second Treatment Visit||5
17505|NCT01972152|39497|P4|COMPLETED|Second Treatment Visit||5
17506|NCT01972152|39498|P3|COMPLETED|Second Treatment Visit||5
17507|NCT01972152|39499|P2|COMPLETED|Second Treatment Visit||3
17508|NCT01972152|39500|P1|COMPLETED|Second Treatment Visit||5
17509|NCT01972152|39495|P6|STARTED|Second Treatment Visit||5
17510|NCT01972152|39496|P5|STARTED|Second Treatment Visit||5
17511|NCT01972152|39497|P4|STARTED|Second Treatment Visit||5
17512|NCT01972152|39498|P3|STARTED|Second Treatment Visit||5
17513|NCT01972152|39499|P2|STARTED|Second Treatment Visit||4
17514|NCT01972152|39500|P1|STARTED|Second Treatment Visit||5
17515|NCT01972152|39495|P6|NOT COMPLETED|First Treatment Visit||0
17516|NCT01972152|39496|P5|NOT COMPLETED|First Treatment Visit||0
17517|NCT01972152|39497|P4|NOT COMPLETED|First Treatment Visit||0
17518|NCT01972152|39498|P3|NOT COMPLETED|First Treatment Visit||0
17519|NCT01972152|39499|P2|NOT COMPLETED|First Treatment Visit||1
17520|NCT01972152|39500|P1|NOT COMPLETED|First Treatment Visit||0
17521|NCT01972152|39495|P6|COMPLETED|First Treatment Visit||5
17522|NCT01972152|39496|P5|COMPLETED|First Treatment Visit||5
17523|NCT01972152|39497|P4|COMPLETED|First Treatment Visit||5
17524|NCT01972152|39498|P3|COMPLETED|First Treatment Visit||5
17525|NCT01972152|39499|P2|COMPLETED|First Treatment Visit||4
17526|NCT01972152|39500|P1|COMPLETED|First Treatment Visit||5
17527|NCT01972152|39495|P6|STARTED|First Treatment Visit||5
17528|NCT01972152|39496|P5|STARTED|First Treatment Visit||5
17529|NCT01972152|39497|P4|STARTED|First Treatment Visit||5
17530|NCT01972152|39498|P3|STARTED|First Treatment Visit||5
17531|NCT01972152|39499|P2|STARTED|First Treatment Visit||5
17532|NCT01972152|39500|P1|STARTED|First Treatment Visit||5
17533|NCT01971723|39537|P2|NOT COMPLETED|Overall Study||3
17534|NCT01971723|39538|P1|NOT COMPLETED|Overall Study||2
17535|NCT01971723|39537|P2|COMPLETED|Overall Study||13
17536|NCT01971723|39538|P1|COMPLETED|Overall Study||14
17537|NCT01971723|39537|P2|STARTED|Overall Study||16
17538|NCT01971723|39538|P1|STARTED|Overall Study||16
17539|NCT01971554|39572|P4|NOT COMPLETED|Overall Study||0
17540|NCT01971554|39573|P3|NOT COMPLETED|Overall Study||0
17541|NCT01971554|39574|P2|NOT COMPLETED|Overall Study||0
17542|NCT01971554|39575|P1|NOT COMPLETED|Overall Study||1
17543|NCT01971554|39572|P4|COMPLETED|Overall Study||18
17544|NCT01971554|39573|P3|COMPLETED|Overall Study||18
17545|NCT01971554|39574|P2|COMPLETED|Overall Study||18
17546|NCT01971554|39575|P1|COMPLETED|Overall Study||8
17547|NCT01971554|39572|P4|STARTED|Overall Study||18
17548|NCT01971554|39573|P3|STARTED|Overall Study||18
17549|NCT01971554|39574|P2|STARTED|Overall Study||18
17550|NCT01971554|39575|P1|STARTED|Overall Study||9
17551|NCT01971086|39609|P1|NOT COMPLETED|Overall Study||0
17552|NCT01971086|39609|P1|COMPLETED|Overall Study||300
17553|NCT01971086|39609|P1|STARTED|Overall Study||300
17554|NCT01970995|39624|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
17555|NCT01970995|39625|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
17556|NCT01970995|39626|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
17557|NCT01970995|39624|P3|COMPLETED|End of Study (Population at Day 90)||38
17558|NCT01970995|39625|P2|COMPLETED|End of Study (Population at Day 90)||41
17559|NCT01970995|39626|P1|COMPLETED|End of Study (Population at Day 90)||76
17560|NCT01970995|39624|P3|STARTED|End of Study (Population at Day 90)||39
17561|NCT01970995|39625|P2|STARTED|End of Study (Population at Day 90)||41
17562|NCT01970995|39626|P1|STARTED|End of Study (Population at Day 90)||77
17563|NCT01970995|39624|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
17564|NCT01970995|39625|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
17565|NCT01970995|39626|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
17566|NCT01970995|39624|P3|COMPLETED|Confinement Period (Population at Day 5)||39
17567|NCT01970995|39625|P2|COMPLETED|Confinement Period (Population at Day 5)||41
17568|NCT01970995|39626|P1|COMPLETED|Confinement Period (Population at Day 5)||77
17569|NCT01970995|39624|P3|STARTED|Confinement Period (Population at Day 5)||40
17570|NCT01970995|39625|P2|STARTED|Confinement Period (Population at Day 5)||42
17571|NCT01970995|39626|P1|STARTED|Confinement Period (Population at Day 5)||78
17572|NCT01970982|39649|P3|NOT COMPLETED|Overall Study||2
17573|NCT01970982|39650|P2|NOT COMPLETED|Overall Study||0
17574|NCT01970982|39651|P1|NOT COMPLETED|Overall Study||0
17575|NCT01970982|39649|P3|COMPLETED|Overall Study||38
17576|NCT01970982|39650|P2|COMPLETED|Overall Study||40
17577|NCT01970982|39651|P1|COMPLETED|Overall Study||80
17578|NCT01970982|39649|P3|STARTED|Overall Study||40
17579|NCT01970982|39650|P2|STARTED|Overall Study||40
17580|NCT01970982|39651|P1|STARTED|Overall Study||80
17581|NCT01970878|39673|P4|NOT COMPLETED|Overall Study||24
17582|NCT01970878|39674|P3|NOT COMPLETED|Overall Study||26
17583|NCT01970878|39675|P2|NOT COMPLETED|Overall Study||27
17584|NCT01970878|39676|P1|NOT COMPLETED|Overall Study||37
17585|NCT01970878|39673|P4|COMPLETED|Overall Study||147
17586|NCT01970878|39674|P3|COMPLETED|Overall Study||187
17587|NCT01970878|39675|P2|COMPLETED|Overall Study||191
17588|NCT01970878|39676|P1|COMPLETED|Overall Study||253
17589|NCT01970878|39673|P4|STARTED|Overall Study||171
17590|NCT01970878|39674|P3|STARTED|Overall Study||213
17591|NCT01970878|39675|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
17592|NCT01970878|39676|P1|STARTED|Overall Study||290
17593|NCT01970787|39702|P1|NOT COMPLETED|Overall Study||1
17594|NCT01970787|39702|P1|COMPLETED|Overall Study||21
17595|NCT01970787|39702|P1|STARTED|Overall Study||22
17596|NCT01970488|39712|P5|NOT COMPLETED|Part 2: Post Week 16||8
17597|NCT01970488|39713|P4|NOT COMPLETED|Part 2: Post Week 16||8
17598|NCT01970488|39714|P3|NOT COMPLETED|Part 2: Post Week 16||17
17599|NCT01970488|39715|P2|NOT COMPLETED|Part 2: Post Week 16||0
17600|NCT01970488|39716|P1|NOT COMPLETED|Part 2: Post Week 16||0
17601|NCT01970488|39712|P5|COMPLETED|Part 2: Post Week 16||69
17602|NCT01970488|39713|P4|COMPLETED|Part 2: Post Week 16||71
17603|NCT01970488|39714|P3|COMPLETED|Part 2: Post Week 16||135
17604|NCT01970488|39715|P2|COMPLETED|Part 2: Post Week 16||0
17605|NCT01970488|39716|P1|COMPLETED|Part 2: Post Week 16||0
17606|NCT01970488|39712|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
17607|NCT01970488|39713|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
17608|NCT01970488|39714|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
17609|NCT01970488|39715|P2|STARTED|Part 2: Post Week 16||0
17610|NCT01970488|39716|P1|STARTED|Part 2: Post Week 16||0
17611|NCT01970488|39712|P5|NOT COMPLETED|Part 1: Through Week 16||0
17612|NCT01970488|39713|P4|NOT COMPLETED|Part 1: Through Week 16||0
17613|NCT01970488|39714|P3|NOT COMPLETED|Part 1: Through Week 16||0
17614|NCT01970488|39715|P2|NOT COMPLETED|Part 1: Through Week 16||13
17615|NCT01970488|39716|P1|NOT COMPLETED|Part 1: Through Week 16||11
17616|NCT01970488|39712|P5|COMPLETED|Part 1: Through Week 16||0
17617|NCT01970488|39713|P4|COMPLETED|Part 1: Through Week 16||0
17618|NCT01970488|39714|P3|COMPLETED|Part 1: Through Week 16||0
17619|NCT01970488|39715|P2|COMPLETED|Part 1: Through Week 16||162
17620|NCT01970488|39716|P1|COMPLETED|Part 1: Through Week 16||164
17621|NCT01970488|39712|P5|Received Treatment|Part 1: Through Week 16||0
17622|NCT01970488|39713|P4|Received Treatment|Part 1: Through Week 16||0
17623|NCT01970488|39714|P3|Received Treatment|Part 1: Through Week 16||0
17624|NCT01970488|39715|P2|Received Treatment|Part 1: Through Week 16||173
17625|NCT01970488|39716|P1|Received Treatment|Part 1: Through Week 16||174
17626|NCT01970488|39712|P5|STARTED|Part 1: Through Week 16||0
17627|NCT01970488|39713|P4|STARTED|Part 1: Through Week 16||0
17628|NCT01970488|39714|P3|STARTED|Part 1: Through Week 16||0
17629|NCT01970488|39715|P2|STARTED|Part 1: Through Week 16||175
17630|NCT01970488|39716|P1|STARTED|Part 1: Through Week 16||175
17631|NCT01970475|39783|P2|NOT COMPLETED|Overall Study||11
17632|NCT01970475|39784|P1|NOT COMPLETED|Overall Study||21
17633|NCT01970475|39783|P2|COMPLETED|Overall Study||251
17634|NCT01970475|39784|P1|COMPLETED|Overall Study||243
17635|NCT01970475|39783|P2|STARTED|Overall Study||262
17636|NCT01970475|39784|P1|STARTED|Overall Study||264
17637|NCT01970397|39804|P2|NOT COMPLETED|Overall Study||5
17638|NCT01970397|39805|P1|NOT COMPLETED|Overall Study||2
17639|NCT01970397|39804|P2|COMPLETED|Overall Study||64
17640|NCT01970397|39805|P1|COMPLETED|Overall Study||67
17641|NCT01970397|39804|P2|STARTED|Overall Study||69
17642|NCT01970397|39805|P1|STARTED|Overall Study||69
17643|NCT01969747|39819|P4|NOT COMPLETED|Overall Study||0
17644|NCT01969747|39820|P3|NOT COMPLETED|Overall Study||0
17645|NCT01969747|39821|P2|NOT COMPLETED|Overall Study||0
17646|NCT01969747|39822|P1|NOT COMPLETED|Overall Study||0
17647|NCT01969747|39819|P4|COMPLETED|Overall Study||18
17648|NCT01969747|39820|P3|COMPLETED|Overall Study||19
17649|NCT01969747|39821|P2|COMPLETED|Overall Study||19
17650|NCT01969747|39822|P1|COMPLETED|Overall Study||19
17651|NCT01969747|39819|P4|STARTED|Overall Study||18
17652|NCT01969747|39820|P3|STARTED|Overall Study||19
17653|NCT01969747|39821|P2|STARTED|Overall Study||19
17654|NCT01969747|39822|P1|STARTED|Overall Study||19
17655|NCT01969721|39832|P4|NOT COMPLETED|Overall Study||6
17656|NCT01969721|39833|P3|NOT COMPLETED|Overall Study||5
17657|NCT01969721|39834|P2|NOT COMPLETED|Overall Study||12
17658|NCT01969721|39835|P1|NOT COMPLETED|Overall Study||4
17659|NCT01969721|39832|P4|COMPLETED|Overall Study||46
17660|NCT01969721|39833|P3|COMPLETED|Overall Study||45
17661|NCT01969721|39834|P2|COMPLETED|Overall Study||57
17662|NCT01969721|39835|P1|COMPLETED|Overall Study||54
17663|NCT01969721|39832|P4|STARTED|Overall Study||52
17664|NCT01969721|39833|P3|STARTED|Overall Study||50
17665|NCT01969721|39834|P2|STARTED|Overall Study||69
17666|NCT01969721|39835|P1|STARTED|Overall Study||58
17667|NCT01969565|39861|P1|NOT COMPLETED|Overall Study||1
17668|NCT01969565|39861|P1|COMPLETED|Overall Study||0
17669|NCT01969565|39861|P1|STARTED|Overall Study||1
17670|NCT01969539|39865|P1|NOT COMPLETED|Overall Study||0
17671|NCT01969539|39865|P1|COMPLETED|Overall Study||11
17672|NCT01969539|39865|P1|STARTED|Overall Study||11
17673|NCT01969435|39871|P1|NOT COMPLETED|Overall Study||0
17674|NCT01969435|39871|P1|COMPLETED|Overall Study||50
17675|NCT01969435|39871|P1|STARTED|Overall Study||50
17676|NCT01969162|39884|P1|NOT COMPLETED|Overall Study||0
17677|NCT01969162|39884|P1|COMPLETED|Overall Study||35
17678|NCT01969162|39884|P1|STARTED|Overall Study||35
17679|NCT01969084|39890|P2|NOT COMPLETED|Overall Study||1
17680|NCT01969084|39891|P1|NOT COMPLETED|Overall Study||0
17681|NCT01969084|39890|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
17682|NCT01969084|39891|P1|COMPLETED|Overall Study||19
17683|NCT01969084|39890|P2|STARTED|Overall Study||22
17684|NCT01969084|39891|P1|STARTED|Overall Study||19
17685|NCT01968811|39905|P1|NOT COMPLETED|Overall Study||5
17686|NCT01968811|39905|P1|COMPLETED|Overall Study||5
17687|NCT01968811|39905|P1|STARTED|Overall Study||10
17688|NCT01968551|39913|P3|NOT COMPLETED|Extension Phase||34
17689|NCT01968551|39914|P2|NOT COMPLETED|Extension Phase||87
17690|NCT01968551|39915|P1|NOT COMPLETED|Extension Phase||20
17691|NCT01968551|39913|P3|COMPLETED|Extension Phase||0
17692|NCT01968551|39914|P2|COMPLETED|Extension Phase||0
17693|NCT01968551|39915|P1|COMPLETED|Extension Phase||0
17694|NCT01968551|39913|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
17695|NCT01968551|39914|P2|STARTED|Extension Phase||87
17696|NCT01968551|39915|P1|STARTED|Extension Phase||20
17697|NCT01968551|39913|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
17698|NCT01968551|39914|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
17699|NCT01968551|39915|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
17700|NCT01968551|39913|P3|COMPLETED|Open Label Phase (48 Weeks)||41
17701|NCT01968551|39914|P2|COMPLETED|Open Label Phase (48 Weeks)||87
17702|NCT01968551|39915|P1|COMPLETED|Open Label Phase (48 Weeks)||20
17703|NCT01968551|39913|P3|STARTED|Open Label Phase (48 Weeks)||46
17704|NCT01968551|39914|P2|STARTED|Open Label Phase (48 Weeks)||90
17705|NCT01968551|39915|P1|STARTED|Open Label Phase (48 Weeks)||22
17706|NCT01968434|39931|P2|NOT COMPLETED|Overall Study||6
17707|NCT01968434|39932|P1|NOT COMPLETED|Overall Study||3
17708|NCT01968434|39931|P2|COMPLETED|Overall Study||66
17709|NCT01968434|39932|P1|COMPLETED|Overall Study||75
17710|NCT01968434|39931|P2|STARTED|Overall Study||72
17711|NCT01968434|39932|P1|STARTED|Overall Study||78
17712|NCT01968135|39944|P2|NOT COMPLETED|Overall Study||0
17713|NCT01968135|39945|P1|NOT COMPLETED|Overall Study||0
17714|NCT01968135|39944|P2|COMPLETED|Overall Study||16
17715|NCT01968135|39945|P1|COMPLETED|Overall Study||16
17716|NCT01968135|39944|P2|STARTED|Overall Study||16
17717|NCT01968135|39945|P1|STARTED|Overall Study||16
17718|NCT01967784|39957|P1|NOT COMPLETED|Overall Study||0
17719|NCT01967784|39957|P1|COMPLETED|Overall Study||100
17720|NCT01967784|39957|P1|STARTED|Overall Study||100
17721|NCT01967732|39967|P4|NOT COMPLETED|Second Intervention (Day 3)||0
17722|NCT01967732|39968|P3|NOT COMPLETED|Second Intervention (Day 3)||0
17723|NCT01967732|39969|P2|NOT COMPLETED|Second Intervention (Day 3)||0
17724|NCT01967732|39970|P1|NOT COMPLETED|Second Intervention (Day 3)||0
17725|NCT01967732|39967|P4|COMPLETED|Second Intervention (Day 3)||9
17726|NCT01967732|39968|P3|COMPLETED|Second Intervention (Day 3)||9
17727|NCT01967732|39969|P2|COMPLETED|Second Intervention (Day 3)||20
17728|NCT01967732|39970|P1|COMPLETED|Second Intervention (Day 3)||22
17729|NCT01967732|39967|P4|STARTED|Second Intervention (Day 3)||9
17730|NCT01967732|39968|P3|STARTED|Second Intervention (Day 3)||9
17731|NCT01967732|39969|P2|STARTED|Second Intervention (Day 3)||20
17732|NCT01967732|39970|P1|STARTED|Second Intervention (Day 3)||22
17733|NCT01967732|39967|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17734|NCT01967732|39968|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17735|NCT01967732|39969|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17736|NCT01967732|39970|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17737|NCT01967732|39967|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
17738|NCT01967732|39968|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
17739|NCT01967732|39969|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
17740|NCT01967732|39970|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
17741|NCT01967732|39967|P4|STARTED|Washout Period of 1 Day (Day 2)||9
17742|NCT01967732|39968|P3|STARTED|Washout Period of 1 Day (Day 2)||9
17743|NCT01967732|39969|P2|STARTED|Washout Period of 1 Day (Day 2)||20
17744|NCT01967732|39970|P1|STARTED|Washout Period of 1 Day (Day 2)||22
17745|NCT01967732|39967|P4|NOT COMPLETED|First Intervention (Day 1)||0
17746|NCT01967732|39968|P3|NOT COMPLETED|First Intervention (Day 1)||0
17747|NCT01967732|39969|P2|NOT COMPLETED|First Intervention (Day 1)||1
17748|NCT01967732|39970|P1|NOT COMPLETED|First Intervention (Day 1)||0
17749|NCT01967732|39967|P4|COMPLETED|First Intervention (Day 1)||9
17750|NCT01967732|39968|P3|COMPLETED|First Intervention (Day 1)||9
17751|NCT01967732|39969|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
17752|NCT01967732|39970|P1|COMPLETED|First Intervention (Day 1)||22
17753|NCT01967732|39967|P4|STARTED|First Intervention (Day 1)||9
17754|NCT01967732|39968|P3|STARTED|First Intervention (Day 1)||9
17755|NCT01967732|39969|P2|STARTED|First Intervention (Day 1)||21
17756|NCT01967732|39970|P1|STARTED|First Intervention (Day 1)||22
17757|NCT01967732|39967|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17758|NCT01967732|39968|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17759|NCT01967732|39969|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
17760|NCT01967732|39970|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17761|NCT01967732|39967|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
17762|NCT01967732|39968|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
17763|NCT01967732|39969|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
17764|NCT01967732|39970|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
17765|NCT01967732|39967|P4|STARTED|Washout Period of 1 Day (Day 0)||9
17766|NCT01967732|39968|P3|STARTED|Washout Period of 1 Day (Day 0)||9
17767|NCT01967732|39969|P2|STARTED|Washout Period of 1 Day (Day 0)||22
17768|NCT01967732|39970|P1|STARTED|Washout Period of 1 Day (Day 0)||22
17769|NCT01967719|39984|P4|NOT COMPLETED|Second Intervention (Day 3)||0
17770|NCT01967719|39985|P3|NOT COMPLETED|Second Intervention (Day 3)||0
17771|NCT01967719|39986|P2|NOT COMPLETED|Second Intervention (Day 3)||1
17772|NCT01967719|39987|P1|NOT COMPLETED|Second Intervention (Day 3)||0
17773|NCT01967719|39984|P4|COMPLETED|Second Intervention (Day 3)||8
17774|NCT01967719|39985|P3|COMPLETED|Second Intervention (Day 3)||9
17775|NCT01967719|39986|P2|COMPLETED|Second Intervention (Day 3)||20
17776|NCT01967719|39987|P1|COMPLETED|Second Intervention (Day 3)||22
17777|NCT01967719|39984|P4|STARTED|Second Intervention (Day 3)||8
17778|NCT01967719|39985|P3|STARTED|Second Intervention (Day 3)||9
17779|NCT01967719|39986|P2|STARTED|Second Intervention (Day 3)||21
17780|NCT01967719|39987|P1|STARTED|Second Intervention (Day 3)||22
17781|NCT01967719|39984|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17782|NCT01967719|39985|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17783|NCT01967719|39986|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17784|NCT01967719|39987|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17785|NCT01967719|39984|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
17786|NCT01967719|39985|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
17787|NCT01967719|39986|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
17788|NCT01967719|39987|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
17789|NCT01967719|39984|P4|STARTED|Washout Period of 1 Day (Day 2)||8
17790|NCT01967719|39985|P3|STARTED|Washout Period of 1 Day (Day 2)||9
17791|NCT01967719|39986|P2|STARTED|Washout Period of 1 Day (Day 2)||21
17792|NCT01967719|39987|P1|STARTED|Washout Period of 1 Day (Day 2)||22
17793|NCT01967719|39984|P4|NOT COMPLETED|First Intervention (Day 1)||1
17794|NCT01967719|39985|P3|NOT COMPLETED|First Intervention (Day 1)||0
17795|NCT01967719|39986|P2|NOT COMPLETED|First Intervention (Day 1)||1
17796|NCT01967719|39987|P1|NOT COMPLETED|First Intervention (Day 1)||0
17797|NCT01967719|39984|P4|COMPLETED|First Intervention (Day 1)||8
17798|NCT01967719|39985|P3|COMPLETED|First Intervention (Day 1)||9
17799|NCT01967719|39986|P2|COMPLETED|First Intervention (Day 1)||21
17800|NCT01967719|39987|P1|COMPLETED|First Intervention (Day 1)||22
17801|NCT01967719|39984|P4|STARTED|First Intervention (Day 1)||9
17802|NCT01967719|39985|P3|STARTED|First Intervention (Day 1)||9
17803|NCT01967719|39986|P2|STARTED|First Intervention (Day 1)||22
17804|NCT01967719|39987|P1|STARTED|First Intervention (Day 1)||22
17805|NCT01967719|39984|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17806|NCT01967719|39985|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17807|NCT01967719|39986|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17808|NCT01967719|39987|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17809|NCT01967719|39984|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
17810|NCT01967719|39985|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
17811|NCT01967719|39986|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
17812|NCT01967719|39987|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
17813|NCT01967719|39984|P4|STARTED|Washout Period of 1 Day (Day 0)||9
17814|NCT01967719|39985|P3|STARTED|Washout Period of 1 Day (Day 0)||9
17815|NCT01967719|39986|P2|STARTED|Washout Period of 1 Day (Day 0)||22
17816|NCT01967719|39987|P1|STARTED|Washout Period of 1 Day (Day 0)||22
17817|NCT01967706|40002|P4|NOT COMPLETED|Second Intervention (Day 3)||0
17818|NCT01967706|40003|P3|NOT COMPLETED|Second Intervention (Day 3)||0
17819|NCT01967706|40004|P2|NOT COMPLETED|Second Intervention (Day 3)||0
17820|NCT01967706|40005|P1|NOT COMPLETED|Second Intervention (Day 3)||0
17821|NCT01967706|40002|P4|COMPLETED|Second Intervention (Day 3)||9
17822|NCT01967706|40003|P3|COMPLETED|Second Intervention (Day 3)||9
17823|NCT01967706|40004|P2|COMPLETED|Second Intervention (Day 3)||22
17824|NCT01967706|40005|P1|COMPLETED|Second Intervention (Day 3)||21
17825|NCT01967706|40002|P4|STARTED|Second Intervention (Day 3)||9
17826|NCT01967706|40003|P3|STARTED|Second Intervention (Day 3)||9
17827|NCT01967706|40004|P2|STARTED|Second Intervention (Day 3)||22
17828|NCT01967706|40005|P1|STARTED|Second Intervention (Day 3)||21
17829|NCT01967706|40002|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17830|NCT01967706|40003|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17831|NCT01967706|40004|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17832|NCT01967706|40005|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
17833|NCT01967706|40002|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
17834|NCT01967706|40003|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
17835|NCT01967706|40004|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
17836|NCT01967706|40005|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
17837|NCT01967706|40002|P4|STARTED|Washout Period of 1 Day (Day 2)||9
17838|NCT01967706|40003|P3|STARTED|Washout Period of 1 Day (Day 2)||9
17839|NCT01967706|40004|P2|STARTED|Washout Period of 1 Day (Day 2)||22
17840|NCT01967706|40005|P1|STARTED|Washout Period of 1 Day (Day 2)||21
17841|NCT01967706|40002|P4|NOT COMPLETED|First Intervention (Day 1)||0
17842|NCT01967706|40003|P3|NOT COMPLETED|First Intervention (Day 1)||0
17843|NCT01967706|40004|P2|NOT COMPLETED|First Intervention (Day 1)||0
17844|NCT01967706|40005|P1|NOT COMPLETED|First Intervention (Day 1)||1
17845|NCT01967706|40002|P4|COMPLETED|First Intervention (Day 1)||9
17846|NCT01967706|40003|P3|COMPLETED|First Intervention (Day 1)||9
17847|NCT01967706|40004|P2|COMPLETED|First Intervention (Day 1)||22
17848|NCT01967706|40005|P1|COMPLETED|First Intervention (Day 1)||21
17849|NCT01967706|40002|P4|STARTED|First Intervention (Day 1)||9
17850|NCT01967706|40003|P3|STARTED|First Intervention (Day 1)||9
17851|NCT01967706|40004|P2|STARTED|First Intervention (Day 1)||22
17852|NCT01967706|40005|P1|STARTED|First Intervention (Day 1)||22
17853|NCT01967706|40002|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17854|NCT01967706|40003|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17855|NCT01967706|40004|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17856|NCT01967706|40005|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
17857|NCT01967706|40002|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
17858|NCT01967706|40003|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
17859|NCT01967706|40004|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
17860|NCT01967706|40005|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
17861|NCT01967706|40002|P4|STARTED|Washout Period of 1 Day (Day 0)||9
17862|NCT01967706|40003|P3|STARTED|Washout Period of 1 Day (Day 0)||9
17863|NCT01967706|40004|P2|STARTED|Washout Period of 1 Day (Day 0)||22
17864|NCT01967706|40005|P1|STARTED|Washout Period of 1 Day (Day 0)||22
17865|NCT01967550|40016|P2|NOT COMPLETED|Overall Study||2
17866|NCT01967550|40017|P1|NOT COMPLETED|Overall Study||5
17867|NCT01967550|40016|P2|COMPLETED|Overall Study||149
17868|NCT01967550|40017|P1|COMPLETED|Overall Study||148
17869|NCT01967550|40016|P2|STARTED|Overall Study||151
17870|NCT01967550|40017|P1|STARTED|Overall Study||153
17871|NCT01967277|40025|P2|NOT COMPLETED|Overall Study||3
17872|NCT01967277|40026|P1|NOT COMPLETED|Overall Study||1
17873|NCT01967277|40025|P2|COMPLETED|Overall Study||19
17874|NCT01967277|40026|P1|COMPLETED|Overall Study||21
17875|NCT01967277|40025|P2|STARTED|Overall Study||22
17876|NCT01967277|40026|P1|STARTED|Overall Study||22
17877|NCT01967147|40036|P2|NOT COMPLETED|Overall Study||20
17878|NCT01967147|40037|P1|NOT COMPLETED|Overall Study||13
17879|NCT01967147|40036|P2|COMPLETED|Overall Study||82
17880|NCT01967147|40037|P1|COMPLETED|Overall Study||99
17881|NCT01967147|40036|P2|STARTED|Overall Study||102
17882|NCT01967147|40037|P1|STARTED|Overall Study||112
17883|NCT01967121|40055|P3|NOT COMPLETED|Overall Study||0
17884|NCT01967121|40056|P2|NOT COMPLETED|Overall Study||0
17885|NCT01967121|40057|P1|NOT COMPLETED|Overall Study||0
17886|NCT01967121|40055|P3|COMPLETED|Overall Study||25
17887|NCT01967121|40056|P2|COMPLETED|Overall Study||25
17888|NCT01967121|40057|P1|COMPLETED|Overall Study||25
17889|NCT01967121|40055|P3|STARTED|Overall Study||25
17890|NCT01967121|40056|P2|STARTED|Overall Study||25
17891|NCT01967121|40057|P1|STARTED|Overall Study||25
17892|NCT01966926|40067|P2|NOT COMPLETED|Overall Study||0
17893|NCT01966926|40068|P1|NOT COMPLETED|Overall Study||0
17894|NCT01966926|40067|P2|COMPLETED|Overall Study||15
17895|NCT01966926|40068|P1|COMPLETED|Overall Study||15
17896|NCT01966926|40067|P2|STARTED|Overall Study||15
17897|NCT01966926|40068|P1|STARTED|Overall Study||15
17898|NCT01966770|40084|P1|NOT COMPLETED|Overall Study||0
17899|NCT01966770|40084|P1|COMPLETED|Overall Study||20
17900|NCT01966770|40084|P1|STARTED|Overall Study||20
17901|NCT01966718|40193|P1|NOT COMPLETED|Overall Study||0
17902|NCT01966718|40193|P1|COMPLETED|Overall Study||8
17903|NCT01966718|40193|P1|STARTED|Overall Study||8
17904|NCT01966380|40201|P2|NOT COMPLETED|Overall Study||1
17905|NCT01966380|40202|P1|NOT COMPLETED|Overall Study||0
17906|NCT01966380|40201|P2|COMPLETED|Overall Study||2
17907|NCT01966380|40202|P1|COMPLETED|Overall Study||3
17908|NCT01966380|40201|P2|STARTED|Overall Study||3
17909|NCT01966380|40202|P1|STARTED|Overall Study||3
17910|NCT01966354|40211|P3|NOT COMPLETED|Overall Study||0
17911|NCT01966354|40212|P2|NOT COMPLETED|Overall Study||0
17912|NCT01966354|40213|P1|NOT COMPLETED|Overall Study||0
17913|NCT01966354|40211|P3|COMPLETED|Overall Study||72
17914|NCT01966354|40212|P2|COMPLETED|Overall Study||73
17915|NCT01966354|40213|P1|COMPLETED|Overall Study||75
17916|NCT01966354|40211|P3|STARTED|Overall Study||72
17917|NCT01966354|40212|P2|STARTED|Overall Study||73
17918|NCT01966354|40213|P1|STARTED|Overall Study||75
17919|NCT01966159|40238|P2|NOT COMPLETED|Overall Study||0
17920|NCT01966159|40239|P1|NOT COMPLETED|Overall Study||0
17921|NCT01966159|40238|P2|COMPLETED|Overall Study||207
17922|NCT01966159|40239|P1|COMPLETED|Overall Study||205
17923|NCT01966159|40238|P2|STARTED|Overall Study||207
17924|NCT01966159|40239|P1|STARTED|Overall Study||205
17925|NCT01966120|40251|P2|NOT COMPLETED|Overall Study||6
17926|NCT01966120|40252|P1|NOT COMPLETED|Overall Study||1
17927|NCT01966120|40251|P2|COMPLETED|Overall Study||26
17928|NCT01966120|40252|P1|COMPLETED|Overall Study||54
17929|NCT01966120|40251|P2|STARTED|Overall Study||32
17930|NCT01966120|40252|P1|STARTED|Overall Study||55
17931|NCT01966068|40276|P1|NOT COMPLETED|Overall Study||138
17932|NCT01966068|40276|P1|COMPLETED|Overall Study||156
17933|NCT01966068|40276|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
17934|NCT01966068|40276|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
17935|NCT01966068|40276|P1|STARTED|Overall Study||294
17936|NCT01966042|40281|P1|NOT COMPLETED|Overall Study||2
17937|NCT01966042|40281|P1|COMPLETED|Overall Study||11
17938|NCT01966042|40281|P1|STARTED|Overall Study||13
17939|NCT01965938|40290|P2|NOT COMPLETED|Overall Study||0
17940|NCT01965938|40291|P1|NOT COMPLETED|Overall Study||1
17941|NCT01965938|40290|P2|COMPLETED|Overall Study||20
17942|NCT01965938|40291|P1|COMPLETED|Overall Study||20
17943|NCT01965938|40290|P2|STARTED|Overall Study||20
17944|NCT01965938|40291|P1|STARTED|Overall Study||21
17945|NCT01965899|40311|P1|NOT COMPLETED|Overall Study||6
17946|NCT01965899|40311|P1|COMPLETED|Overall Study||145
17947|NCT01965899|40311|P1|STARTED|Overall Study||151
17948|NCT01965665|40322|P1|NOT COMPLETED|Overall Study||1
17949|NCT01965665|40322|P1|COMPLETED|Overall Study||19
17950|NCT01965665|40322|P1|STARTED|Overall Study||20
17951|NCT01965600|40328|P4|NOT COMPLETED|Second Intervention||2
17952|NCT01965600|40329|P3|NOT COMPLETED|Second Intervention||2
17953|NCT01965600|40330|P2|NOT COMPLETED|Second Intervention||0
17954|NCT01965600|40331|P1|NOT COMPLETED|Second Intervention||0
17955|NCT01965600|40328|P4|COMPLETED|Second Intervention||0
17956|NCT01965600|40329|P3|COMPLETED|Second Intervention||1
17957|NCT01965600|40330|P2|COMPLETED|Second Intervention||4
17958|NCT01965600|40331|P1|COMPLETED|Second Intervention||4
17959|NCT01965600|40328|P4|STARTED|Second Intervention||2
17960|NCT01965600|40329|P3|STARTED|Second Intervention||3
17961|NCT01965600|40330|P2|STARTED|Second Intervention||4
17962|NCT01965600|40331|P1|STARTED|Second Intervention||4
17963|NCT01965600|40328|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
17964|NCT01965600|40329|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
17965|NCT01965600|40330|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
17966|NCT01965600|40331|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
17967|NCT01965600|40328|P4|COMPLETED|Washout Period of Approximately 15 Days||2
17968|NCT01965600|40329|P3|COMPLETED|Washout Period of Approximately 15 Days||3
17969|NCT01965600|40330|P2|COMPLETED|Washout Period of Approximately 15 Days||4
17970|NCT01965600|40331|P1|COMPLETED|Washout Period of Approximately 15 Days||4
17971|NCT01965600|40328|P4|STARTED|Washout Period of Approximately 15 Days||4
17972|NCT01965600|40329|P3|STARTED|Washout Period of Approximately 15 Days||5
17973|NCT01965600|40330|P2|STARTED|Washout Period of Approximately 15 Days||8
17974|NCT01965600|40331|P1|STARTED|Washout Period of Approximately 15 Days||6
17975|NCT01965600|40328|P4|NOT COMPLETED|First Intervention||0
17976|NCT01965600|40329|P3|NOT COMPLETED|First Intervention||0
17977|NCT01965600|40330|P2|NOT COMPLETED|First Intervention||0
17978|NCT01965600|40331|P1|NOT COMPLETED|First Intervention||0
17979|NCT01965600|40328|P4|COMPLETED|First Intervention||4
17980|NCT01965600|40329|P3|COMPLETED|First Intervention||5
17981|NCT01965600|40330|P2|COMPLETED|First Intervention||8
17982|NCT01965600|40331|P1|COMPLETED|First Intervention||6
17983|NCT01965600|40328|P4|Received at Least One Dose of Drug|First Intervention||4
17984|NCT01965600|40329|P3|Received at Least One Dose of Drug|First Intervention||5
17985|NCT01965600|40330|P2|Received at Least One Dose of Drug|First Intervention||8
17986|NCT01965600|40331|P1|Received at Least One Dose of Drug|First Intervention||6
17987|NCT01965600|40328|P4|STARTED|First Intervention||4
17988|NCT01965600|40329|P3|STARTED|First Intervention||5
17989|NCT01965600|40330|P2|STARTED|First Intervention||8
17990|NCT01965600|40331|P1|STARTED|First Intervention||6
17991|NCT01965561|40375|P1|NOT COMPLETED|Overall Study||0
17992|NCT01965561|40375|P1|COMPLETED|Overall Study||10
17993|NCT01965561|40375|P1|STARTED|Overall Study||10
17994|NCT01965535|40388|P2|NOT COMPLETED|Overall Study||1
17995|NCT01965535|40389|P1|NOT COMPLETED|Overall Study||2
17996|NCT01965535|40388|P2|COMPLETED|Overall Study||76
17997|NCT01965535|40389|P1|COMPLETED|Overall Study||76
17998|NCT01965535|40388|P2|STARTED|Overall Study||77
17999|NCT01965535|40389|P1|STARTED|Overall Study||78
18000|NCT01965431|40403|P6|NOT COMPLETED|Overall Study||6
18001|NCT01965431|40404|P5|NOT COMPLETED|Overall Study||6
18002|NCT01965431|40405|P4|NOT COMPLETED|Overall Study||6
18003|NCT01965431|40406|P3|NOT COMPLETED|Overall Study||6
18004|NCT01965431|40407|P2|NOT COMPLETED|Overall Study||6
18005|NCT01965431|40408|P1|NOT COMPLETED|Overall Study||6
18006|NCT01965431|40403|P6|COMPLETED|Overall Study||2
18007|NCT01965431|40404|P5|COMPLETED|Overall Study||2
18008|NCT01965431|40405|P4|COMPLETED|Overall Study||2
18009|NCT01965431|40406|P3|COMPLETED|Overall Study||2
18010|NCT01965431|40407|P2|COMPLETED|Overall Study||2
18011|NCT01965431|40408|P1|COMPLETED|Overall Study||2
18012|NCT01965431|40403|P6|STARTED|Overall Study||8
18013|NCT01965431|40404|P5|STARTED|Overall Study||8
18014|NCT01965431|40405|P4|STARTED|Overall Study||8
18015|NCT01965431|40406|P3|STARTED|Overall Study||8
18016|NCT01965431|40407|P2|STARTED|Overall Study||8
18017|NCT01965431|40408|P1|STARTED|Overall Study|Started are actually Treated subjects|8
18018|NCT01965327|40421|P1|NOT COMPLETED|Overall Study||2
18019|NCT01965327|40421|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
18020|NCT01965327|40421|P1|STARTED|Overall Study||12
18021|NCT01965288|40428|P2|NOT COMPLETED|Overall Study||0
18022|NCT01965288|40429|P1|NOT COMPLETED|Overall Study||0
18023|NCT01965288|40428|P2|COMPLETED|Overall Study||30
18024|NCT01965288|40429|P1|COMPLETED|Overall Study||30
18025|NCT01965288|40428|P2|STARTED|Overall Study||30
18026|NCT01965288|40429|P1|STARTED|Overall Study||30
18027|NCT01965262|40635|P2|NOT COMPLETED|Second Intervention (7 Days)||10
18028|NCT01965262|40636|P1|NOT COMPLETED|Second Intervention (7 Days)||1
18029|NCT01965262|40635|P2|COMPLETED|Second Intervention (7 Days)||5
18030|NCT01965262|40636|P1|COMPLETED|Second Intervention (7 Days)||14
18031|NCT01965262|40635|P2|STARTED|Second Intervention (7 Days)||15
18032|NCT01965262|40636|P1|STARTED|Second Intervention (7 Days)||15
18033|NCT01965262|40635|P2|NOT COMPLETED|First Intervention (7 Days)||0
18034|NCT01965262|40636|P1|NOT COMPLETED|First Intervention (7 Days)||0
18035|NCT01965262|40635|P2|COMPLETED|First Intervention (7 Days)||15
18036|NCT01965262|40636|P1|COMPLETED|First Intervention (7 Days)||15
18037|NCT01965262|40635|P2|STARTED|First Intervention (7 Days)||15
18038|NCT01965262|40636|P1|STARTED|First Intervention (7 Days)||15
18039|NCT01965067|40700|P2|NOT COMPLETED|Overall Study||0
18040|NCT01965067|40701|P1|NOT COMPLETED|Overall Study||0
18041|NCT01965067|40700|P2|COMPLETED|Overall Study||30
18042|NCT01965067|40701|P1|COMPLETED|Overall Study||30
18043|NCT01965067|40700|P2|STARTED|Overall Study||30
18044|NCT01965067|40701|P1|STARTED|Overall Study||30
18045|NCT01964898|40719|P2|NOT COMPLETED|Overall Study||7
18046|NCT01964898|40720|P1|NOT COMPLETED|Overall Study||7
18047|NCT01964898|40719|P2|COMPLETED|Overall Study||26
18048|NCT01964898|40720|P1|COMPLETED|Overall Study||24
18049|NCT01964898|40719|P2|12 Week Assessment|Overall Study||30
18050|NCT01964898|40720|P1|12 Week Assessment|Overall Study||25
18051|NCT01964898|40719|P2|STARTED|Overall Study||33
18052|NCT01964898|40720|P1|STARTED|Overall Study||31
18053|NCT01964716|40742|P2|NOT COMPLETED|Overall Study||6
18054|NCT01964716|40743|P1|NOT COMPLETED|Overall Study||5
18055|NCT01964716|40742|P2|COMPLETED|Overall Study||244
18056|NCT01964716|40743|P1|COMPLETED|Overall Study||245
18057|NCT01964716|40742|P2|Vaccinated Dose 3|Overall Study||244
18058|NCT01964716|40743|P1|Vaccinated Dose 3|Overall Study||247
18059|NCT01964716|40742|P2|Vaccinated Dose 2|Overall Study||248
18060|NCT01964716|40743|P1|Vaccinated Dose 2|Overall Study||249
18061|NCT01964716|40742|P2|Vaccinated Dose 1|Overall Study||250
18062|NCT01964716|40743|P1|Vaccinated Dose 1|Overall Study||250
18063|NCT01964716|40742|P2|STARTED|Overall Study||250
18064|NCT01964716|40743|P1|STARTED|Overall Study||250
18065|NCT01964547|40781|P2|NOT COMPLETED|Overall Study||11
18066|NCT01964547|40782|P1|NOT COMPLETED|Overall Study||12
18067|NCT01964547|40781|P2|COMPLETED|Overall Study||48
18068|NCT01964547|40782|P1|COMPLETED|Overall Study||50
18069|NCT01964547|40781|P2|STARTED|Overall Study||59
18070|NCT01964547|40782|P1|STARTED|Overall Study||62
18071|NCT01964352|40810|P4|NOT COMPLETED|Overall Study||8
18072|NCT01964352|40811|P3|NOT COMPLETED|Overall Study||6
18073|NCT01964352|40812|P2|NOT COMPLETED|Overall Study||11
18074|NCT01964352|40813|P1|NOT COMPLETED|Overall Study||26
18075|NCT01964352|40810|P4|COMPLETED|Overall Study||195
18076|NCT01964352|40811|P3|COMPLETED|Overall Study||196
18077|NCT01964352|40812|P2|COMPLETED|Overall Study||192
18078|NCT01964352|40813|P1|COMPLETED|Overall Study||178
18079|NCT01964352|40810|P4|STARTED|Overall Study||203
18080|NCT01964352|40811|P3|STARTED|Overall Study||202
18081|NCT01964352|40812|P2|STARTED|Overall Study||203
18082|NCT01964352|40813|P1|STARTED|Overall Study||204
18083|NCT01964326|40843|P1|NOT COMPLETED|Overall Study||297
18084|NCT01964326|40843|P1|COMPLETED|Overall Study||1014
18085|NCT01964326|40843|P1|STARTED|Overall Study||1311
18086|NCT01964222|40852|P2|NOT COMPLETED|Overall Study||11
18087|NCT01964222|40853|P1|NOT COMPLETED|Overall Study||15
18088|NCT01964222|40852|P2|COMPLETED|Overall Study||89
18089|NCT01964222|40853|P1|COMPLETED|Overall Study||86
18090|NCT01964222|40852|P2|STARTED|Overall Study||100
18091|NCT01964222|40853|P1|STARTED|Overall Study||101
18092|NCT01963845|40869|P2|NOT COMPLETED|Overall Study||0
18093|NCT01963845|40870|P1|NOT COMPLETED|Overall Study||0
18094|NCT01963845|40869|P2|COMPLETED|Overall Study||25
18095|NCT01963845|40870|P1|COMPLETED|Overall Study||25
18096|NCT01963845|40869|P2|STARTED|Overall Study||25
18097|NCT01963845|40870|P1|STARTED|Overall Study||25
18098|NCT01963767|40886|P2|NOT COMPLETED|Overall Study||2
18099|NCT01963767|40887|P1|NOT COMPLETED|Overall Study||6
18100|NCT01963767|40886|P2|COMPLETED|Overall Study||53
18101|NCT01963767|40887|P1|COMPLETED|Overall Study||52
18102|NCT01963767|40886|P2|STARTED|Overall Study||55
18103|NCT01963767|40887|P1|STARTED|Overall Study||58
18104|NCT01963676|40897|P2|NOT COMPLETED|Overall Study||0
18105|NCT01963676|40898|P1|NOT COMPLETED|Overall Study||1
18106|NCT01963676|40897|P2|COMPLETED|Overall Study||13
18107|NCT01963676|40898|P1|COMPLETED|Overall Study||13
18108|NCT01963676|40897|P2|STARTED|Overall Study||13
18109|NCT01963676|40898|P1|STARTED|Overall Study||14
18110|NCT01963611|40911|P5|NOT COMPLETED|Overall Study||51
18111|NCT01963611|40912|P4|NOT COMPLETED|Overall Study||52
18112|NCT01963611|40913|P3|NOT COMPLETED|Overall Study||52
18113|NCT01963611|40914|P2|NOT COMPLETED|Overall Study||49
18114|NCT01963611|40915|P1|NOT COMPLETED|Overall Study||51
18115|NCT01963611|40911|P5|COMPLETED|Overall Study||0
18116|NCT01963611|40912|P4|COMPLETED|Overall Study||0
18117|NCT01963611|40913|P3|COMPLETED|Overall Study||0
18118|NCT01963611|40914|P2|COMPLETED|Overall Study||0
18119|NCT01963611|40915|P1|COMPLETED|Overall Study||0
18120|NCT01963611|40911|P5|Safety Analysis Set|Overall Study||50
18121|NCT01963611|40912|P4|Safety Analysis Set|Overall Study||52
18122|NCT01963611|40913|P3|Safety Analysis Set|Overall Study||52
18123|NCT01963611|40914|P2|Safety Analysis Set|Overall Study||49
18124|NCT01963611|40915|P1|Safety Analysis Set|Overall Study||51
18125|NCT01963611|40911|P5|STARTED|Overall Study||51
18126|NCT01963611|40912|P4|STARTED|Overall Study||52
18127|NCT01963611|40913|P3|STARTED|Overall Study||52
18128|NCT01963611|40914|P2|STARTED|Overall Study||49
18129|NCT01963611|40915|P1|STARTED|Overall Study||51
18130|NCT01963091|40974|P2|NOT COMPLETED|Overall Study||0
18131|NCT01963091|40975|P1|NOT COMPLETED|Overall Study||0
18132|NCT01963091|40974|P2|COMPLETED|Overall Study||16
18133|NCT01963091|40975|P1|COMPLETED|Overall Study||17
18134|NCT01963091|40974|P2|STARTED|Overall Study||16
18135|NCT01963091|40975|P1|STARTED|Overall Study||17
18136|NCT01962961|40988|P3|NOT COMPLETED|Overall Study||1
18137|NCT01962961|40989|P2|NOT COMPLETED|Overall Study||1
18138|NCT01962961|40990|P1|NOT COMPLETED|Overall Study||0
18139|NCT01962961|40988|P3|COMPLETED|Overall Study||6
18140|NCT01962961|40989|P2|COMPLETED|Overall Study||7
18141|NCT01962961|40990|P1|COMPLETED|Overall Study||9
18142|NCT01962961|40988|P3|STARTED|Overall Study||7
18143|NCT01962961|40989|P2|STARTED|Overall Study||8
18144|NCT01962961|40990|P1|STARTED|Overall Study||9
18145|NCT01962922|41006|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
18146|NCT01962922|41007|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
18147|NCT01962922|41006|P2|COMPLETED|Extendion Portion (up to Month 6)||20
18148|NCT01962922|41007|P1|COMPLETED|Extendion Portion (up to Month 6)||18
18149|NCT01962922|41006|P2|STARTED|Extendion Portion (up to Month 6)||23
18150|NCT01962922|41007|P1|STARTED|Extendion Portion (up to Month 6)||23
18151|NCT01962922|41006|P2|NOT COMPLETED|PK Portion Day 21||0
18152|NCT01962922|41007|P1|NOT COMPLETED|PK Portion Day 21||0
18153|NCT01962922|41006|P2|COMPLETED|PK Portion Day 21||23
18154|NCT01962922|41007|P1|COMPLETED|PK Portion Day 21||23
18155|NCT01962922|41006|P2|STARTED|PK Portion Day 21||23
18156|NCT01962922|41007|P1|STARTED|PK Portion Day 21||23
18157|NCT01962922|41006|P2|NOT COMPLETED|PK Portion Day 14||0
18158|NCT01962922|41007|P1|NOT COMPLETED|PK Portion Day 14||0
18159|NCT01962922|41006|P2|COMPLETED|PK Portion Day 14||23
18160|NCT01962922|41007|P1|COMPLETED|PK Portion Day 14||23
18161|NCT01962922|41006|P2|STARTED|PK Portion Day 14||23
18162|NCT01962922|41007|P1|STARTED|PK Portion Day 14||23
18163|NCT01962922|41006|P2|NOT COMPLETED|PK Portion Day 7||0
18164|NCT01962922|41007|P1|NOT COMPLETED|PK Portion Day 7||4
18165|NCT01962922|41006|P2|COMPLETED|PK Portion Day 7||23
18166|NCT01962922|41007|P1|COMPLETED|PK Portion Day 7||23
18167|NCT01962922|41006|P2|STARTED|PK Portion Day 7||23
18168|NCT01962922|41007|P1|STARTED|PK Portion Day 7||27
18169|NCT01962675|41031|P2|NOT COMPLETED|Overall Study||0
18170|NCT01962675|41032|P1|NOT COMPLETED|Overall Study||0
18171|NCT01962675|41031|P2|COMPLETED|Overall Study||7
18172|NCT01962675|41032|P1|COMPLETED|Overall Study||7
18173|NCT01962675|41031|P2|STARTED|Overall Study||7
18174|NCT01962675|41032|P1|STARTED|Overall Study||7
18175|NCT01962493|41046|P2|NOT COMPLETED|Overall Study||5
18176|NCT01962493|41047|P1|NOT COMPLETED|Overall Study||5
18177|NCT01962493|41046|P2|COMPLETED|Overall Study||77
18178|NCT01962493|41047|P1|COMPLETED|Overall Study||73
18179|NCT01962493|41046|P2|STARTED|Overall Study||82
18180|NCT01962493|41047|P1|STARTED|Overall Study||78
18181|NCT01962441|41070|P3|NOT COMPLETED|Retreatment Substudy||0
18182|NCT01962441|41071|P2|NOT COMPLETED|Retreatment Substudy||10
18183|NCT01962441|41072|P1|NOT COMPLETED|Retreatment Substudy||20
18184|NCT01962441|41070|P3|COMPLETED|Retreatment Substudy||0
18185|NCT01962441|41071|P2|COMPLETED|Retreatment Substudy||0
18186|NCT01962441|41072|P1|COMPLETED|Retreatment Substudy||0
18187|NCT01962441|41070|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
18188|NCT01962441|41071|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
18189|NCT01962441|41072|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
18190|NCT01962441|41070|P3|NOT COMPLETED|Randomized Period||11
18191|NCT01962441|41071|P2|NOT COMPLETED|Randomized Period||11
18192|NCT01962441|41072|P1|NOT COMPLETED|Randomized Period||10
18193|NCT01962441|41070|P3|COMPLETED|Randomized Period||189
18194|NCT01962441|41071|P2|COMPLETED|Randomized Period||190
18195|NCT01962441|41072|P1|COMPLETED|Randomized Period||190
18196|NCT01962441|41070|P3|STARTED|Randomized Period||200
18197|NCT01962441|41071|P2|STARTED|Randomized Period||201
18198|NCT01962441|41072|P1|STARTED|Randomized Period||200
18199|NCT01962428|41103|P2|NOT COMPLETED|Overall Study||6
18200|NCT01962428|41104|P1|NOT COMPLETED|Overall Study||10
18201|NCT01962428|41103|P2|COMPLETED|Overall Study||133
18202|NCT01962428|41104|P1|COMPLETED|Overall Study||129
18203|NCT01962428|41103|P2|STARTED|Overall Study||139
18204|NCT01962428|41104|P1|STARTED|Overall Study||139
18205|NCT01961544|41110|P1|NOT COMPLETED|Overall Study||13
18206|NCT01961544|41110|P1|COMPLETED|Overall Study||88
18207|NCT01961544|41110|P1|STARTED|Overall Study||101
18208|NCT01961349|41118|P3|NOT COMPLETED|Overall Study||2
18209|NCT01961349|41119|P2|NOT COMPLETED|Overall Study||6
18210|NCT01961349|41120|P1|NOT COMPLETED|Overall Study||3
18211|NCT01961349|41118|P3|COMPLETED|Overall Study||109
18212|NCT01961349|41119|P2|COMPLETED|Overall Study||101
18213|NCT01961349|41120|P1|COMPLETED|Overall Study||51
18214|NCT01961349|41118|P3|STARTED|Overall Study||111
18215|NCT01961349|41119|P2|STARTED|Overall Study||107
18216|NCT01961349|41120|P1|STARTED|Overall Study||54
18217|NCT01961271|41131|P1|NOT COMPLETED|Overall Study||50
18218|NCT01961271|41131|P1|COMPLETED|Overall Study||64
18219|NCT01961271|41131|P1|STARTED|Overall Study||114
18220|NCT01960907|41142|P2|NOT COMPLETED|Overall Study||45
18221|NCT01960907|41143|P1|NOT COMPLETED|Overall Study||36
18222|NCT01960907|41142|P2|COMPLETED|Overall Study||109
18223|NCT01960907|41143|P1|COMPLETED|Overall Study||122
18224|NCT01960907|41142|P2|STARTED|Overall Study||154
18225|NCT01960907|41143|P1|STARTED|Overall Study||158
18226|NCT01960842|41153|P1|NOT COMPLETED|Overall Study||3
18227|NCT01960842|41153|P1|COMPLETED|Overall Study||28
18228|NCT01960842|41153|P1|STARTED|Overall Study||31
18229|NCT01960816|41176|P1|NOT COMPLETED|Overall Study||1
18230|NCT01960816|41176|P1|COMPLETED|Overall Study||32
18231|NCT01960816|41176|P1|STARTED|Overall Study||33
18232|NCT01960400|41184|P2|NOT COMPLETED|Overall Study||0
18233|NCT01960400|41185|P1|NOT COMPLETED|Overall Study||0
18234|NCT01960400|41184|P2|COMPLETED|Overall Study||11
18235|NCT01960400|41185|P1|COMPLETED|Overall Study||11
18236|NCT01960400|41184|P2|STARTED|Overall Study||11
18237|NCT01960400|41185|P1|STARTED|Overall Study||11
18238|NCT01960387|41197|P1|NOT COMPLETED|Overall Study||0
18239|NCT01960387|41197|P1|COMPLETED|Overall Study||2
18240|NCT01960387|41197|P1|STARTED|Overall Study||2
18241|NCT01960114|41206|P2|NOT COMPLETED|Overall Study||1
18242|NCT01960114|41207|P1|NOT COMPLETED|Overall Study||1
18243|NCT01960114|41206|P2|COMPLETED|Overall Study||268
18244|NCT01960114|41207|P1|COMPLETED|Overall Study||133
18245|NCT01960114|41206|P2|STARTED|Overall Study||269
18246|NCT01960114|41207|P1|STARTED|Overall Study||134
18247|NCT01959945|41225|P4|NOT COMPLETED|Overall Study||16
18248|NCT01959945|41226|P3|NOT COMPLETED|Overall Study||19
18249|NCT01959945|41227|P2|NOT COMPLETED|Overall Study||3
18250|NCT01959945|41228|P1|NOT COMPLETED|Overall Study||4
18251|NCT01959945|41225|P4|COMPLETED|Overall Study||15
18252|NCT01959945|41226|P3|COMPLETED|Overall Study||9
18253|NCT01959945|41227|P2|COMPLETED|Overall Study||75
18254|NCT01959945|41228|P1|COMPLETED|Overall Study||76
18255|NCT01959945|41225|P4|STARTED|Overall Study||31
18256|NCT01959945|41226|P3|STARTED|Overall Study||28
18257|NCT01959945|41227|P2|STARTED|Overall Study||78
18258|NCT01959945|41228|P1|STARTED|Overall Study||80
18259|NCT01959932|41253|P3|NOT COMPLETED|Overall Study||0
18260|NCT01959932|41254|P2|NOT COMPLETED|Overall Study||0
18261|NCT01959932|41255|P1|NOT COMPLETED|Overall Study||1
18262|NCT01959932|41253|P3|COMPLETED|Overall Study||39
18263|NCT01959932|41254|P2|COMPLETED|Overall Study||41
18264|NCT01959932|41255|P1|COMPLETED|Overall Study||79
18265|NCT01959932|41253|P3|STARTED|Overall Study||39
18266|NCT01959932|41254|P2|STARTED|Overall Study||41
18267|NCT01959932|41255|P1|STARTED|Overall Study||80
18268|NCT01959880|41277|P4|NOT COMPLETED|Overall Study||181
18269|NCT01959880|41278|P3|NOT COMPLETED|Overall Study||208
18270|NCT01959880|41279|P2|NOT COMPLETED|Overall Study||369
18271|NCT01959880|41280|P1|NOT COMPLETED|Overall Study||1132
18272|NCT01959880|41277|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
18273|NCT01959880|41278|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
18274|NCT01959880|41279|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
18275|NCT01959880|41280|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
18276|NCT01959880|41277|P4|STARTED|Overall Study||181
18277|NCT01959880|41278|P3|STARTED|Overall Study||209
18278|NCT01959880|41279|P2|STARTED|Overall Study||369
18279|NCT01959880|41280|P1|STARTED|Overall Study||1132
18280|NCT01959685|41302|P1|NOT COMPLETED|Overall Study||0
18281|NCT01959685|41302|P1|COMPLETED|Overall Study||9
18282|NCT01959685|41302|P1|STARTED|Overall Study||9
18283|NCT01959607|41309|P4|NOT COMPLETED|Second Intervention (Day 3)||0
18284|NCT01959607|41310|P3|NOT COMPLETED|Second Intervention (Day 3)||0
18285|NCT01959607|41311|P2|NOT COMPLETED|Second Intervention (Day 3)||0
18286|NCT01959607|41312|P1|NOT COMPLETED|Second Intervention (Day 3)||0
18287|NCT01959607|41309|P4|COMPLETED|Second Intervention (Day 3)||9
18288|NCT01959607|41310|P3|COMPLETED|Second Intervention (Day 3)||9
18289|NCT01959607|41311|P2|COMPLETED|Second Intervention (Day 3)||21
18290|NCT01959607|41312|P1|COMPLETED|Second Intervention (Day 3)||21
18291|NCT01959607|41309|P4|STARTED|Second Intervention (Day 3)||9
18292|NCT01959607|41310|P3|STARTED|Second Intervention (Day 3)||9
18293|NCT01959607|41311|P2|STARTED|Second Intervention (Day 3)||21
18294|NCT01959607|41312|P1|STARTED|Second Intervention (Day 3)||21
18295|NCT01959607|41309|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
18296|NCT01959607|41310|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
18297|NCT01959607|41311|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
18298|NCT01959607|41312|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
18299|NCT01959607|41309|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
18300|NCT01959607|41310|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
18301|NCT01959607|41311|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
18302|NCT01959607|41312|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
18303|NCT01959607|41309|P4|STARTED|Washout Period of 1 Day (Day 2)||9
18304|NCT01959607|41310|P3|STARTED|Washout Period of 1 Day (Day 2)||9
18305|NCT01959607|41311|P2|STARTED|Washout Period of 1 Day (Day 2)||21
18306|NCT01959607|41312|P1|STARTED|Washout Period of 1 Day (Day 2)||21
18307|NCT01959607|41309|P4|NOT COMPLETED|First Intervention (Day 1)||0
18308|NCT01959607|41310|P3|NOT COMPLETED|First Intervention (Day 1)||0
18309|NCT01959607|41311|P2|NOT COMPLETED|First Intervention (Day 1)||1
18310|NCT01959607|41312|P1|NOT COMPLETED|First Intervention (Day 1)||1
18311|NCT01959607|41309|P4|COMPLETED|First Intervention (Day 1)||9
18312|NCT01959607|41310|P3|COMPLETED|First Intervention (Day 1)||9
18313|NCT01959607|41311|P2|COMPLETED|First Intervention (Day 1)||21
18314|NCT01959607|41312|P1|COMPLETED|First Intervention (Day 1)||21
18315|NCT01959607|41309|P4|STARTED|First Intervention (Day 1)||9
18316|NCT01959607|41310|P3|STARTED|First Intervention (Day 1)||9
18317|NCT01959607|41311|P2|STARTED|First Intervention (Day 1)||22
18318|NCT01959607|41312|P1|STARTED|First Intervention (Day 1)||22
18319|NCT01959607|41309|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
18320|NCT01959607|41310|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
18321|NCT01959607|41311|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
18322|NCT01959607|41312|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
18323|NCT01959607|41309|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
18324|NCT01959607|41310|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
18325|NCT01959607|41311|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
18326|NCT01959607|41312|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
18327|NCT01959607|41309|P4|STARTED|Washout Period of 1 Day (Day 0)||9
18328|NCT01959607|41310|P3|STARTED|Washout Period of 1 Day (Day 0)||9
18329|NCT01959607|41311|P2|STARTED|Washout Period of 1 Day (Day 0)||22
18330|NCT01959607|41312|P1|STARTED|Washout Period of 1 Day (Day 0)||22
18331|NCT01959516|41319|P2|NOT COMPLETED|Epoch 2||1
18332|NCT01959516|41320|P1|NOT COMPLETED|Epoch 2||2
18333|NCT01959516|41319|P2|COMPLETED|Epoch 2||62
18334|NCT01959516|41320|P1|COMPLETED|Epoch 2||61
18335|NCT01959516|41319|P2|STARTED|Epoch 2||63
18336|NCT01959516|41320|P1|STARTED|Epoch 2||63
18337|NCT01959516|41319|P2|NOT COMPLETED|Epoch 1||5
18338|NCT01959516|41320|P1|NOT COMPLETED|Epoch 1||10
18339|NCT01959516|41319|P2|COMPLETED|Epoch 1||58
18340|NCT01959516|41320|P1|COMPLETED|Epoch 1||53
18341|NCT01959516|41319|P2|ITT Population|Epoch 1||62
18342|NCT01959516|41320|P1|ITT Population|Epoch 1||62
18343|NCT01959516|41319|P2|Safety Population|Epoch 1||62
18344|NCT01959516|41320|P1|Safety Population|Epoch 1||62
18345|NCT01959516|41319|P2|STARTED|Epoch 1||63
18346|NCT01959516|41320|P1|STARTED|Epoch 1||63
18347|NCT01959503|41330|P2|NOT COMPLETED|Overall Study||2
18348|NCT01959503|41331|P1|NOT COMPLETED|Overall Study||3
18349|NCT01959503|41330|P2|COMPLETED|Overall Study||49
18350|NCT01959503|41331|P1|COMPLETED|Overall Study||104
18351|NCT01959503|41330|P2|STARTED|Overall Study||51
18352|NCT01959503|41331|P1|STARTED|Overall Study||107
18353|NCT01959412|41351|P6|NOT COMPLETED|Overall Study||0
18354|NCT01959412|41352|P5|NOT COMPLETED|Overall Study||3
18355|NCT01959412|41353|P4|NOT COMPLETED|Overall Study||2
18356|NCT01959412|41354|P3|NOT COMPLETED|Overall Study||0
18357|NCT01959412|41355|P2|NOT COMPLETED|Overall Study||1
18358|NCT01959412|41356|P1|NOT COMPLETED|Overall Study||1
18359|NCT01959412|41351|P6|COMPLETED|Overall Study||15
18360|NCT01959412|41352|P5|COMPLETED|Overall Study||13
18361|NCT01959412|41353|P4|COMPLETED|Overall Study||13
18362|NCT01959412|41354|P3|COMPLETED|Overall Study||15
18363|NCT01959412|41355|P2|COMPLETED|Overall Study||14
18364|NCT01959412|41356|P1|COMPLETED|Overall Study||14
18365|NCT01959412|41351|P6|STARTED|Overall Study||15
18366|NCT01959412|41352|P5|STARTED|Overall Study||16
18367|NCT01959412|41353|P4|STARTED|Overall Study||15
18368|NCT01959412|41354|P3|STARTED|Overall Study||15
18369|NCT01959412|41355|P2|STARTED|Overall Study||15
18370|NCT01959412|41356|P1|STARTED|Overall Study||15
18371|NCT01959035|41394|P1|NOT COMPLETED|Overall Study||11
18372|NCT01959035|41394|P1|COMPLETED|Overall Study||77
18373|NCT01959035|41394|P1|STARTED|Overall Study||88
18374|NCT01958827|41420|P1|NOT COMPLETED|Overall Study||10
18375|NCT01958827|41420|P1|COMPLETED|Overall Study||18
18376|NCT01958827|41420|P1|STARTED|Overall Study||28
18377|NCT01958788|41438|P1|NOT COMPLETED|Overall Study||0
18378|NCT01958788|41438|P1|COMPLETED|Overall Study||7
18379|NCT01958788|41438|P1|STARTED|Overall Study||7
18380|NCT01958645|41451|P3|NOT COMPLETED|Overall Study||0
18381|NCT01958645|41452|P2|NOT COMPLETED|Overall Study||0
18382|NCT01958645|41453|P1|NOT COMPLETED|Overall Study||0
18383|NCT01958645|41451|P3|COMPLETED|Overall Study||4
18384|NCT01958645|41452|P2|COMPLETED|Overall Study||4
18385|NCT01958645|41453|P1|COMPLETED|Overall Study||4
18386|NCT01958645|41451|P3|STARTED|Overall Study||4
18387|NCT01958645|41452|P2|STARTED|Overall Study||4
18388|NCT01958645|41453|P1|STARTED|Overall Study||4
18389|NCT01958619|41481|P4|NOT COMPLETED|Overall Study||0
18390|NCT01958619|41482|P3|NOT COMPLETED|Overall Study||1
18391|NCT01958619|41483|P2|NOT COMPLETED|Overall Study||0
18392|NCT01958619|41484|P1|NOT COMPLETED|Overall Study||2
18393|NCT01958619|41481|P4|COMPLETED|Overall Study||12
18394|NCT01958619|41482|P3|COMPLETED|Overall Study||13
18395|NCT01958619|41483|P2|COMPLETED|Overall Study||14
18396|NCT01958619|41484|P1|COMPLETED|Overall Study||13
18397|NCT01958619|41481|P4|STARTED|Overall Study||12
18398|NCT01958619|41482|P3|STARTED|Overall Study||14
18399|NCT01958619|41483|P2|STARTED|Overall Study||14
18400|NCT01958619|41484|P1|STARTED|Overall Study||15
18401|NCT01958346|41506|P2|NOT COMPLETED|Overall Study||0
18402|NCT01958346|41507|P1|NOT COMPLETED|Overall Study||0
18403|NCT01958346|41506|P2|COMPLETED|Overall Study||39
18404|NCT01958346|41507|P1|COMPLETED|Overall Study||39
18405|NCT01958346|41506|P2|STARTED|Overall Study||39
18406|NCT01958346|41507|P1|STARTED|Overall Study||39
18407|NCT01958164|41517|P2|NOT COMPLETED|Overall Study||5
18408|NCT01958164|41518|P1|NOT COMPLETED|Overall Study||2
18409|NCT01958164|41517|P2|COMPLETED|Overall Study||5
18410|NCT01958164|41518|P1|COMPLETED|Overall Study||4
18411|NCT01958164|41517|P2|STARTED|Overall Study|Randomised and treated|10
18412|NCT01958164|41518|P1|STARTED|Overall Study|Randomised and treated|6
18413|NCT01958060|41537|P6|NOT COMPLETED|Overall Study||0
18414|NCT01958060|41538|P5|NOT COMPLETED|Overall Study||1
18415|NCT01958060|41539|P4|NOT COMPLETED|Overall Study||0
18416|NCT01958060|41540|P3|NOT COMPLETED|Overall Study||0
18417|NCT01958060|41541|P2|NOT COMPLETED|Overall Study||0
18418|NCT01958060|41542|P1|NOT COMPLETED|Overall Study||2
18419|NCT01958060|41537|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
18420|NCT01958060|41538|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
18421|NCT01958060|41539|P4|COMPLETED|Overall Study||5
18422|NCT01958060|41540|P3|COMPLETED|Overall Study||6
18423|NCT01958060|41541|P2|COMPLETED|Overall Study||6
18424|NCT01958060|41542|P1|COMPLETED|Overall Study||8
18425|NCT01958060|41537|P6|STARTED|Overall Study||1
18426|NCT01958060|41538|P5|STARTED|Overall Study||7
18427|NCT01958060|41539|P4|STARTED|Overall Study||5
18428|NCT01958060|41540|P3|STARTED|Overall Study||6
18429|NCT01958060|41541|P2|STARTED|Overall Study||6
18430|NCT01958060|41542|P1|STARTED|Overall Study||10
18431|NCT01958008|41569|P4|NOT COMPLETED|Overall Study||0
18432|NCT01958008|41570|P3|NOT COMPLETED|Overall Study||1
18433|NCT01958008|41571|P2|NOT COMPLETED|Overall Study||0
18434|NCT01958008|41572|P1|NOT COMPLETED|Overall Study||1
18435|NCT01958008|41569|P4|COMPLETED|Overall Study||21
18436|NCT01958008|41570|P3|COMPLETED|Overall Study||20
18437|NCT01958008|41571|P2|COMPLETED|Overall Study||21
18438|NCT01958008|41572|P1|COMPLETED|Overall Study||20
18439|NCT01958008|41569|P4|STARTED|Overall Study||21
18440|NCT01958008|41570|P3|STARTED|Overall Study||21
18441|NCT01958008|41571|P2|STARTED|Overall Study||21
18442|NCT01958008|41572|P1|STARTED|Overall Study||21
18443|NCT01957930|41602|P2|NOT COMPLETED|Overall Study||0
18444|NCT01957930|41603|P1|NOT COMPLETED|Overall Study||0
18445|NCT01957930|41602|P2|COMPLETED|Overall Study||37
18446|NCT01957930|41603|P1|COMPLETED|Overall Study||35
18447|NCT01957930|41602|P2|STARTED|Overall Study||37
18448|NCT01957930|41603|P1|STARTED|Overall Study||35
18449|NCT01957865|41612|P3|NOT COMPLETED|Overall Study||3
18450|NCT01957865|41613|P2|NOT COMPLETED|Overall Study||2
18451|NCT01957865|41614|P1|NOT COMPLETED|Overall Study||0
18452|NCT01957865|41612|P3|COMPLETED|Overall Study||19
18453|NCT01957865|41613|P2|COMPLETED|Overall Study||18
18454|NCT01957865|41614|P1|COMPLETED|Overall Study||21
18455|NCT01957865|41612|P3|STARTED|Overall Study||22
18456|NCT01957865|41613|P2|STARTED|Overall Study||20
18457|NCT01957865|41614|P1|STARTED|Overall Study||21
18458|NCT01957761|41625|P1|NOT COMPLETED|Overall Study||0
18459|NCT01957761|41625|P1|COMPLETED|Overall Study||189
18460|NCT01957761|41625|P1|STARTED|Overall Study||189
18461|NCT01957657|41629|P1|NOT COMPLETED|Overall Study||0
18462|NCT01957657|41629|P1|COMPLETED|Overall Study||4
18463|NCT01957657|41629|P1|STARTED|Overall Study||4
18464|NCT01957553|41643|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
18465|NCT01957553|41644|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
18466|NCT01957553|41643|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
18467|NCT01957553|41644|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
18468|NCT01957553|41643|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
18469|NCT01957553|41644|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
18470|NCT01957553|41643|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
18471|NCT01957553|41644|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
18472|NCT01957553|41643|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
18473|NCT01957553|41644|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
18474|NCT01957553|41643|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
18475|NCT01957553|41644|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
18476|NCT01957488|41650|P6|NOT COMPLETED|Test Period 3||0
18477|NCT01957488|41651|P5|NOT COMPLETED|Test Period 3||0
18478|NCT01957488|41652|P4|NOT COMPLETED|Test Period 3||0
18479|NCT01957488|41653|P3|NOT COMPLETED|Test Period 3||0
18480|NCT01957488|41654|P2|NOT COMPLETED|Test Period 3||1
18481|NCT01957488|41655|P1|NOT COMPLETED|Test Period 3||1
18482|NCT01957488|41650|P6|COMPLETED|Test Period 3||23
18483|NCT01957488|41651|P5|COMPLETED|Test Period 3||25
18484|NCT01957488|41652|P4|COMPLETED|Test Period 3||28
18485|NCT01957488|41653|P3|COMPLETED|Test Period 3||25
18486|NCT01957488|41654|P2|COMPLETED|Test Period 3||26
18487|NCT01957488|41655|P1|COMPLETED|Test Period 3||23
18488|NCT01957488|41650|P6|STARTED|Test Period 3||23
18489|NCT01957488|41651|P5|STARTED|Test Period 3||25
18490|NCT01957488|41652|P4|STARTED|Test Period 3||28
18491|NCT01957488|41653|P3|STARTED|Test Period 3||25
18492|NCT01957488|41654|P2|STARTED|Test Period 3||27
18493|NCT01957488|41655|P1|STARTED|Test Period 3||24
18494|NCT01957488|41650|P6|NOT COMPLETED|Test Period 2||1
18495|NCT01957488|41651|P5|NOT COMPLETED|Test Period 2||2
18496|NCT01957488|41652|P4|NOT COMPLETED|Test Period 2||1
18497|NCT01957488|41653|P3|NOT COMPLETED|Test Period 2||1
18498|NCT01957488|41654|P2|NOT COMPLETED|Test Period 2||1
18499|NCT01957488|41655|P1|NOT COMPLETED|Test Period 2||3
18500|NCT01957488|41650|P6|COMPLETED|Test Period 2||23
18501|NCT01957488|41651|P5|COMPLETED|Test Period 2||25
18502|NCT01957488|41652|P4|COMPLETED|Test Period 2||28
18503|NCT01957488|41653|P3|COMPLETED|Test Period 2||25
18504|NCT01957488|41654|P2|COMPLETED|Test Period 2||27
18505|NCT01957488|41655|P1|COMPLETED|Test Period 2||24
18506|NCT01957488|41650|P6|STARTED|Test Period 2||24
18507|NCT01957488|41651|P5|STARTED|Test Period 2||27
18508|NCT01957488|41652|P4|STARTED|Test Period 2||29
18509|NCT01957488|41653|P3|STARTED|Test Period 2||26
18510|NCT01957488|41654|P2|STARTED|Test Period 2||28
18511|NCT01957488|41655|P1|STARTED|Test Period 2||27
18512|NCT01957488|41650|P6|NOT COMPLETED|Test Period 1||6
18513|NCT01957488|41651|P5|NOT COMPLETED|Test Period 1||3
18514|NCT01957488|41652|P4|NOT COMPLETED|Test Period 1||3
18515|NCT01957488|41653|P3|NOT COMPLETED|Test Period 1||4
18516|NCT01957488|41654|P2|NOT COMPLETED|Test Period 1||3
18517|NCT01957488|41655|P1|NOT COMPLETED|Test Period 1||3
18518|NCT01957488|41650|P6|COMPLETED|Test Period 1||24
18519|NCT01957488|41651|P5|COMPLETED|Test Period 1||27
18520|NCT01957488|41652|P4|COMPLETED|Test Period 1||29
18521|NCT01957488|41653|P3|COMPLETED|Test Period 1||26
18522|NCT01957488|41654|P2|COMPLETED|Test Period 1||28
18523|NCT01957488|41655|P1|COMPLETED|Test Period 1||27
18524|NCT01957488|41650|P6|STARTED|Test Period 1||30
18525|NCT01957488|41651|P5|STARTED|Test Period 1||30
18526|NCT01957488|41652|P4|STARTED|Test Period 1||32
18527|NCT01957488|41653|P3|STARTED|Test Period 1||30
18528|NCT01957488|41654|P2|STARTED|Test Period 1||31
18529|NCT01957488|41655|P1|STARTED|Test Period 1||30
18530|NCT01957475|41663|P2|NOT COMPLETED|Test Period 2||0
18531|NCT01957475|41664|P1|NOT COMPLETED|Test Period 2||1
18532|NCT01957475|41663|P2|COMPLETED|Test Period 2||8
18533|NCT01957475|41664|P1|COMPLETED|Test Period 2||8
18534|NCT01957475|41663|P2|STARTED|Test Period 2||8
18535|NCT01957475|41664|P1|STARTED|Test Period 2||9
18536|NCT01957475|41663|P2|NOT COMPLETED|Test Period 1||1
18537|NCT01957475|41664|P1|NOT COMPLETED|Test Period 1||2
18538|NCT01957475|41663|P2|COMPLETED|Test Period 1||9
18539|NCT01957475|41664|P1|COMPLETED|Test Period 1||8
18540|NCT01957475|41663|P2|STARTED|Test Period 1||10
18541|NCT01957475|41664|P1|STARTED|Test Period 1||10
18542|NCT01957462|41670|P2|NOT COMPLETED|Test Period 2||0
18543|NCT01957462|41671|P1|NOT COMPLETED|Test Period 2||0
18544|NCT01957462|41670|P2|COMPLETED|Test Period 2||15
18545|NCT01957462|41671|P1|COMPLETED|Test Period 2||14
18546|NCT01957462|41670|P2|STARTED|Test Period 2||15
18547|NCT01957462|41671|P1|STARTED|Test Period 2||14
18548|NCT01957462|41670|P2|NOT COMPLETED|Test Period 1||0
18549|NCT01957462|41671|P1|NOT COMPLETED|Test Period 1||2
18550|NCT01957462|41670|P2|COMPLETED|Test Period 1||15
18551|NCT01957462|41671|P1|COMPLETED|Test Period 1||14
18552|NCT01957462|41670|P2|STARTED|Test Period 1||15
18553|NCT01957462|41671|P1|STARTED|Test Period 1||16
18554|NCT01957410|41677|P1|NOT COMPLETED|Optional Open Label||0
18555|NCT01957410|41677|P1|COMPLETED|Optional Open Label||13
18556|NCT01957410|41677|P1|STARTED|Optional Open Label||13
18557|NCT01957410|41677|P1|NOT COMPLETED|Open Label||0
18558|NCT01957410|41677|P1|COMPLETED|Open Label||13
18559|NCT01957410|41677|P1|STARTED|Open Label||13
18560|NCT01957397|41682|P2|NOT COMPLETED|Test Period 3||2
18561|NCT01957397|41683|P1|NOT COMPLETED|Test Period 3||2
18562|NCT01957397|41682|P2|COMPLETED|Test Period 3||9
18563|NCT01957397|41683|P1|COMPLETED|Test Period 3||9
18564|NCT01957397|41682|P2|STARTED|Test Period 3||11
18565|NCT01957397|41683|P1|STARTED|Test Period 3||11
18566|NCT01957397|41682|P2|NOT COMPLETED|Test Period 2||1
18567|NCT01957397|41683|P1|NOT COMPLETED|Test Period 2||0
18568|NCT01957397|41682|P2|COMPLETED|Test Period 2||11
18569|NCT01957397|41683|P1|COMPLETED|Test Period 2||11
18570|NCT01957397|41682|P2|STARTED|Test Period 2||12
18571|NCT01957397|41683|P1|STARTED|Test Period 2||11
18572|NCT01957397|41682|P2|NOT COMPLETED|Test Period 1||1
18573|NCT01957397|41683|P1|NOT COMPLETED|Test Period 1||2
18574|NCT01957397|41682|P2|COMPLETED|Test Period 1||12
18575|NCT01957397|41683|P1|COMPLETED|Test Period 1||11
18576|NCT01957397|41682|P2|STARTED|Test Period 1||13
18577|NCT01957397|41683|P1|STARTED|Test Period 1||13
18578|NCT01957397|41682|P2|NOT COMPLETED|Baseline Own Product||0
18579|NCT01957397|41683|P1|NOT COMPLETED|Baseline Own Product||0
18580|NCT01957397|41682|P2|COMPLETED|Baseline Own Product||13
18581|NCT01957397|41683|P1|COMPLETED|Baseline Own Product||13
18582|NCT01957397|41682|P2|STARTED|Baseline Own Product||13
18583|NCT01957397|41683|P1|STARTED|Baseline Own Product||13
18584|NCT01957384|41693|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
18585|NCT01957384|41694|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
18586|NCT01957384|41695|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
18587|NCT01957384|41696|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
18588|NCT01957384|41697|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
18589|NCT01957384|41698|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
18590|NCT01957384|41693|P6|COMPLETED|Test Period 3 (14 Days)||3
18591|NCT01957384|41694|P5|COMPLETED|Test Period 3 (14 Days)||3
18592|NCT01957384|41695|P4|COMPLETED|Test Period 3 (14 Days)||4
18593|NCT01957384|41696|P3|COMPLETED|Test Period 3 (14 Days)||4
18594|NCT01957384|41697|P2|COMPLETED|Test Period 3 (14 Days)||4
18595|NCT01957384|41698|P1|COMPLETED|Test Period 3 (14 Days)||4
18596|NCT01957384|41693|P6|STARTED|Test Period 3 (14 Days)||3
18597|NCT01957384|41694|P5|STARTED|Test Period 3 (14 Days)||3
18598|NCT01957384|41695|P4|STARTED|Test Period 3 (14 Days)||4
18599|NCT01957384|41696|P3|STARTED|Test Period 3 (14 Days)||4
18600|NCT01957384|41697|P2|STARTED|Test Period 3 (14 Days)||4
18601|NCT01957384|41698|P1|STARTED|Test Period 3 (14 Days)||4
18602|NCT01957384|41693|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
18603|NCT01957384|41694|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
18604|NCT01957384|41695|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
18605|NCT01957384|41696|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
18606|NCT01957384|41697|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
18607|NCT01957384|41698|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
18608|NCT01957384|41693|P6|COMPLETED|Test Period 2 (14 Days)||3
18609|NCT01957384|41694|P5|COMPLETED|Test Period 2 (14 Days)||3
18610|NCT01957384|41695|P4|COMPLETED|Test Period 2 (14 Days)||4
18611|NCT01957384|41696|P3|COMPLETED|Test Period 2 (14 Days)||4
18612|NCT01957384|41697|P2|COMPLETED|Test Period 2 (14 Days)||4
18613|NCT01957384|41698|P1|COMPLETED|Test Period 2 (14 Days)||4
18614|NCT01957384|41693|P6|STARTED|Test Period 2 (14 Days)||3
18615|NCT01957384|41694|P5|STARTED|Test Period 2 (14 Days)||3
18616|NCT01957384|41695|P4|STARTED|Test Period 2 (14 Days)||4
18617|NCT01957384|41696|P3|STARTED|Test Period 2 (14 Days)||4
18618|NCT01957384|41697|P2|STARTED|Test Period 2 (14 Days)||4
18619|NCT01957384|41698|P1|STARTED|Test Period 2 (14 Days)||4
18620|NCT01957384|41693|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
18621|NCT01957384|41694|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
18622|NCT01957384|41695|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
18623|NCT01957384|41696|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
18624|NCT01957384|41697|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
18625|NCT01957384|41698|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
18626|NCT01957384|41693|P6|COMPLETED|Test Period 1 (14 Days)||3
18627|NCT01957384|41694|P5|COMPLETED|Test Period 1 (14 Days)||3
18628|NCT01957384|41695|P4|COMPLETED|Test Period 1 (14 Days)||4
18629|NCT01957384|41696|P3|COMPLETED|Test Period 1 (14 Days)||4
18630|NCT01957384|41697|P2|COMPLETED|Test Period 1 (14 Days)||4
18631|NCT01957384|41698|P1|COMPLETED|Test Period 1 (14 Days)||4
18632|NCT01957384|41693|P6|STARTED|Test Period 1 (14 Days)||3
18633|NCT01957384|41694|P5|STARTED|Test Period 1 (14 Days)||3
18634|NCT01957384|41695|P4|STARTED|Test Period 1 (14 Days)||4
18635|NCT01957384|41696|P3|STARTED|Test Period 1 (14 Days)||4
18636|NCT01957384|41697|P2|STARTED|Test Period 1 (14 Days)||4
18637|NCT01957384|41698|P1|STARTED|Test Period 1 (14 Days)||4
18638|NCT01957215|41708|P2|NOT COMPLETED|Overall Study||12
18639|NCT01957215|41709|P1|NOT COMPLETED|Overall Study||13
18640|NCT01957215|41708|P2|COMPLETED|Overall Study||123
18641|NCT01957215|41709|P1|COMPLETED|Overall Study||122
18642|NCT01957215|41708|P2|STARTED|Overall Study||135
18643|NCT01957215|41709|P1|STARTED|Overall Study||135
18644|NCT01957202|41737|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18645|NCT01957202|41738|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
18646|NCT01957202|41739|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18647|NCT01957202|41740|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18648|NCT01957202|41741|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18649|NCT01957202|41742|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18650|NCT01957202|41743|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18651|NCT01957202|41744|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18652|NCT01957202|41745|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18653|NCT01957202|41746|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18654|NCT01957202|41747|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18655|NCT01957202|41748|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18656|NCT01957202|41749|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18657|NCT01957202|41750|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18658|NCT01957202|41751|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18659|NCT01957202|41752|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18660|NCT01957202|41753|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18661|NCT01957202|41754|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
18662|NCT01957202|41737|P18|COMPLETED|Treatment Period 3 (8 Days)||3
18663|NCT01957202|41738|P17|COMPLETED|Treatment Period 3 (8 Days)||4
18664|NCT01957202|41739|P16|COMPLETED|Treatment Period 3 (8 Days)||3
18665|NCT01957202|41740|P15|COMPLETED|Treatment Period 3 (8 Days)||6
18666|NCT01957202|41741|P14|COMPLETED|Treatment Period 3 (8 Days)||3
18667|NCT01957202|41742|P13|COMPLETED|Treatment Period 3 (8 Days)||3
18668|NCT01957202|41743|P12|COMPLETED|Treatment Period 3 (8 Days)||6
18669|NCT01957202|41744|P11|COMPLETED|Treatment Period 3 (8 Days)||3
18670|NCT01957202|41745|P10|COMPLETED|Treatment Period 3 (8 Days)||6
18671|NCT01957202|41746|P9|COMPLETED|Treatment Period 3 (8 Days)||3
18672|NCT01957202|41747|P8|COMPLETED|Treatment Period 3 (8 Days)||3
18673|NCT01957202|41748|P7|COMPLETED|Treatment Period 3 (8 Days)||3
18674|NCT01957202|41749|P6|COMPLETED|Treatment Period 3 (8 Days)||2
18675|NCT01957202|41750|P5|COMPLETED|Treatment Period 3 (8 Days)||3
18676|NCT01957202|41751|P4|COMPLETED|Treatment Period 3 (8 Days)||3
18677|NCT01957202|41752|P3|COMPLETED|Treatment Period 3 (8 Days)||6
18678|NCT01957202|41753|P2|COMPLETED|Treatment Period 3 (8 Days)||5
18679|NCT01957202|41754|P1|COMPLETED|Treatment Period 3 (8 Days)||3
18680|NCT01957202|41737|P18|STARTED|Treatment Period 3 (8 Days)||3
18681|NCT01957202|41738|P17|STARTED|Treatment Period 3 (8 Days)||5
18682|NCT01957202|41739|P16|STARTED|Treatment Period 3 (8 Days)||3
18683|NCT01957202|41740|P15|STARTED|Treatment Period 3 (8 Days)||6
18684|NCT01957202|41741|P14|STARTED|Treatment Period 3 (8 Days)||3
18685|NCT01957202|41742|P13|STARTED|Treatment Period 3 (8 Days)||3
18686|NCT01957202|41743|P12|STARTED|Treatment Period 3 (8 Days)||6
18687|NCT01957202|41744|P11|STARTED|Treatment Period 3 (8 Days)||3
18688|NCT01957202|41745|P10|STARTED|Treatment Period 3 (8 Days)||6
18689|NCT01957202|41746|P9|STARTED|Treatment Period 3 (8 Days)||3
18690|NCT01957202|41747|P8|STARTED|Treatment Period 3 (8 Days)||3
18691|NCT01957202|41748|P7|STARTED|Treatment Period 3 (8 Days)||3
18692|NCT01957202|41749|P6|STARTED|Treatment Period 3 (8 Days)||2
18693|NCT01957202|41750|P5|STARTED|Treatment Period 3 (8 Days)||3
18694|NCT01957202|41751|P4|STARTED|Treatment Period 3 (8 Days)||3
18695|NCT01957202|41752|P3|STARTED|Treatment Period 3 (8 Days)||6
18696|NCT01957202|41753|P2|STARTED|Treatment Period 3 (8 Days)||5
18697|NCT01957202|41754|P1|STARTED|Treatment Period 3 (8 Days)||3
18698|NCT01957202|41737|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18699|NCT01957202|41738|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18700|NCT01957202|41739|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18701|NCT01957202|41740|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18702|NCT01957202|41741|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18703|NCT01957202|41742|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18704|NCT01957202|41743|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18705|NCT01957202|41744|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18706|NCT01957202|41745|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18707|NCT01957202|41746|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18708|NCT01957202|41747|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18709|NCT01957202|41748|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18710|NCT01957202|41749|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18711|NCT01957202|41750|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18712|NCT01957202|41751|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18713|NCT01957202|41752|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18714|NCT01957202|41753|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18715|NCT01957202|41754|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
18716|NCT01957202|41737|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18717|NCT01957202|41738|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
18718|NCT01957202|41739|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18719|NCT01957202|41740|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
18720|NCT01957202|41741|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18721|NCT01957202|41742|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18722|NCT01957202|41743|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
18723|NCT01957202|41744|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18724|NCT01957202|41745|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
18725|NCT01957202|41746|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18726|NCT01957202|41747|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18727|NCT01957202|41748|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18728|NCT01957202|41749|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
18729|NCT01957202|41750|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18730|NCT01957202|41751|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18731|NCT01957202|41752|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
18732|NCT01957202|41753|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
18733|NCT01957202|41754|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
18734|NCT01957202|41737|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
18735|NCT01957202|41738|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
18736|NCT01957202|41739|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
18737|NCT01957202|41740|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
18738|NCT01957202|41741|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
18739|NCT01957202|41742|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
18740|NCT01957202|41743|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
18741|NCT01957202|41744|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
18742|NCT01957202|41745|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
18743|NCT01957202|41746|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
18744|NCT01957202|41747|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
18745|NCT01957202|41748|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
18746|NCT01957202|41749|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
18747|NCT01957202|41750|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
18748|NCT01957202|41751|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
18749|NCT01957202|41752|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
18750|NCT01957202|41753|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
18751|NCT01957202|41754|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
18752|NCT01957202|41737|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18753|NCT01957202|41738|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
18754|NCT01957202|41739|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18755|NCT01957202|41740|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18756|NCT01957202|41741|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18757|NCT01957202|41742|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18758|NCT01957202|41743|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18759|NCT01957202|41744|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18760|NCT01957202|41745|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18761|NCT01957202|41746|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18762|NCT01957202|41747|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18763|NCT01957202|41748|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18764|NCT01957202|41749|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18765|NCT01957202|41750|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18766|NCT01957202|41751|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18767|NCT01957202|41752|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18768|NCT01957202|41753|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
18769|NCT01957202|41754|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
18770|NCT01957202|41737|P18|COMPLETED|Treatment Period 2 (8 Days)||3
18771|NCT01957202|41738|P17|COMPLETED|Treatment Period 2 (8 Days)||5
18772|NCT01957202|41739|P16|COMPLETED|Treatment Period 2 (8 Days)||3
18773|NCT01957202|41740|P15|COMPLETED|Treatment Period 2 (8 Days)||6
18774|NCT01957202|41741|P14|COMPLETED|Treatment Period 2 (8 Days)||3
18775|NCT01957202|41742|P13|COMPLETED|Treatment Period 2 (8 Days)||3
18776|NCT01957202|41743|P12|COMPLETED|Treatment Period 2 (8 Days)||6
18777|NCT01957202|41744|P11|COMPLETED|Treatment Period 2 (8 Days)||3
18778|NCT01957202|41745|P10|COMPLETED|Treatment Period 2 (8 Days)||6
18779|NCT01957202|41746|P9|COMPLETED|Treatment Period 2 (8 Days)||3
18780|NCT01957202|41747|P8|COMPLETED|Treatment Period 2 (8 Days)||3
18781|NCT01957202|41748|P7|COMPLETED|Treatment Period 2 (8 Days)||3
18782|NCT01957202|41749|P6|COMPLETED|Treatment Period 2 (8 Days)||2
18783|NCT01957202|41750|P5|COMPLETED|Treatment Period 2 (8 Days)||3
18784|NCT01957202|41751|P4|COMPLETED|Treatment Period 2 (8 Days)||3
18785|NCT01957202|41752|P3|COMPLETED|Treatment Period 2 (8 Days)||6
18786|NCT01957202|41753|P2|COMPLETED|Treatment Period 2 (8 Days)||5
18787|NCT01957202|41754|P1|COMPLETED|Treatment Period 2 (8 Days)||3
18788|NCT01957202|41737|P18|STARTED|Treatment Period 2 (8 Days)||3
18789|NCT01957202|41738|P17|STARTED|Treatment Period 2 (8 Days)||6
18790|NCT01957202|41739|P16|STARTED|Treatment Period 2 (8 Days)||3
18791|NCT01957202|41740|P15|STARTED|Treatment Period 2 (8 Days)||6
18792|NCT01957202|41741|P14|STARTED|Treatment Period 2 (8 Days)||3
18793|NCT01957202|41742|P13|STARTED|Treatment Period 2 (8 Days)||3
18794|NCT01957202|41743|P12|STARTED|Treatment Period 2 (8 Days)||6
18795|NCT01957202|41744|P11|STARTED|Treatment Period 2 (8 Days)||3
18796|NCT01957202|41745|P10|STARTED|Treatment Period 2 (8 Days)||6
18797|NCT01957202|41746|P9|STARTED|Treatment Period 2 (8 Days)||3
18798|NCT01957202|41747|P8|STARTED|Treatment Period 2 (8 Days)||3
18799|NCT01957202|41748|P7|STARTED|Treatment Period 2 (8 Days)||3
18800|NCT01957202|41749|P6|STARTED|Treatment Period 2 (8 Days)||2
18801|NCT01957202|41750|P5|STARTED|Treatment Period 2 (8 Days)||3
18802|NCT01957202|41751|P4|STARTED|Treatment Period 2 (8 Days)||3
18803|NCT01957202|41752|P3|STARTED|Treatment Period 2 (8 Days)||6
18804|NCT01957202|41753|P2|STARTED|Treatment Period 2 (8 Days)||6
18805|NCT01957202|41754|P1|STARTED|Treatment Period 2 (8 Days)||3
18806|NCT01957202|41737|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18807|NCT01957202|41738|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18808|NCT01957202|41739|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18809|NCT01957202|41740|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18810|NCT01957202|41741|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18811|NCT01957202|41742|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18812|NCT01957202|41743|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18813|NCT01957202|41744|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18814|NCT01957202|41745|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18815|NCT01957202|41746|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18816|NCT01957202|41747|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18817|NCT01957202|41748|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18818|NCT01957202|41749|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18819|NCT01957202|41750|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18820|NCT01957202|41751|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18821|NCT01957202|41752|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18822|NCT01957202|41753|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18823|NCT01957202|41754|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
18824|NCT01957202|41737|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18825|NCT01957202|41738|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18826|NCT01957202|41739|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18827|NCT01957202|41740|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18828|NCT01957202|41741|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18829|NCT01957202|41742|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18830|NCT01957202|41743|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18831|NCT01957202|41744|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18832|NCT01957202|41745|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18833|NCT01957202|41746|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18834|NCT01957202|41747|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18835|NCT01957202|41748|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18836|NCT01957202|41749|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
18837|NCT01957202|41750|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18838|NCT01957202|41751|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18839|NCT01957202|41752|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18840|NCT01957202|41753|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
18841|NCT01957202|41754|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
18842|NCT01957202|41737|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
18843|NCT01957202|41738|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
18844|NCT01957202|41739|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
18845|NCT01957202|41740|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
18846|NCT01957202|41741|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
18847|NCT01957202|41742|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
18848|NCT01957202|41743|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
18849|NCT01957202|41744|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
18850|NCT01957202|41745|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
18851|NCT01957202|41746|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
18852|NCT01957202|41747|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
18853|NCT01957202|41748|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
18854|NCT01957202|41749|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
18855|NCT01957202|41750|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
18856|NCT01957202|41751|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
18857|NCT01957202|41752|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
18858|NCT01957202|41753|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
18859|NCT01957202|41754|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
18860|NCT01957202|41737|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18861|NCT01957202|41738|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18862|NCT01957202|41739|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18863|NCT01957202|41740|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18864|NCT01957202|41741|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18865|NCT01957202|41742|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18866|NCT01957202|41743|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18867|NCT01957202|41744|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18868|NCT01957202|41745|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18869|NCT01957202|41746|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18870|NCT01957202|41747|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18871|NCT01957202|41748|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18872|NCT01957202|41749|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18873|NCT01957202|41750|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18874|NCT01957202|41751|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18875|NCT01957202|41752|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18876|NCT01957202|41753|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18877|NCT01957202|41754|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
18878|NCT01957202|41737|P18|COMPLETED|Treatment Period 1 (8 Days)||3
18879|NCT01957202|41738|P17|COMPLETED|Treatment Period 1 (8 Days)||6
18880|NCT01957202|41739|P16|COMPLETED|Treatment Period 1 (8 Days)||3
18881|NCT01957202|41740|P15|COMPLETED|Treatment Period 1 (8 Days)||6
18882|NCT01957202|41741|P14|COMPLETED|Treatment Period 1 (8 Days)||3
18883|NCT01957202|41742|P13|COMPLETED|Treatment Period 1 (8 Days)||3
18884|NCT01957202|41743|P12|COMPLETED|Treatment Period 1 (8 Days)||6
18885|NCT01957202|41744|P11|COMPLETED|Treatment Period 1 (8 Days)||3
18886|NCT01957202|41745|P10|COMPLETED|Treatment Period 1 (8 Days)||6
18887|NCT01957202|41746|P9|COMPLETED|Treatment Period 1 (8 Days)||3
18888|NCT01957202|41747|P8|COMPLETED|Treatment Period 1 (8 Days)||3
18889|NCT01957202|41748|P7|COMPLETED|Treatment Period 1 (8 Days)||3
18890|NCT01957202|41749|P6|COMPLETED|Treatment Period 1 (8 Days)||2
18891|NCT01957202|41750|P5|COMPLETED|Treatment Period 1 (8 Days)||3
18892|NCT01957202|41751|P4|COMPLETED|Treatment Period 1 (8 Days)||3
18893|NCT01957202|41752|P3|COMPLETED|Treatment Period 1 (8 Days)||6
18894|NCT01957202|41753|P2|COMPLETED|Treatment Period 1 (8 Days)||6
18895|NCT01957202|41754|P1|COMPLETED|Treatment Period 1 (8 Days)||3
18896|NCT01957202|41737|P18|STARTED|Treatment Period 1 (8 Days)||3
18897|NCT01957202|41738|P17|STARTED|Treatment Period 1 (8 Days)||6
18898|NCT01957202|41739|P16|STARTED|Treatment Period 1 (8 Days)||3
18899|NCT01957202|41740|P15|STARTED|Treatment Period 1 (8 Days)||6
18900|NCT01957202|41741|P14|STARTED|Treatment Period 1 (8 Days)||3
18901|NCT01957202|41742|P13|STARTED|Treatment Period 1 (8 Days)||3
18902|NCT01957202|41743|P12|STARTED|Treatment Period 1 (8 Days)||6
18903|NCT01957202|41744|P11|STARTED|Treatment Period 1 (8 Days)||3
18904|NCT01957202|41745|P10|STARTED|Treatment Period 1 (8 Days)||6
18905|NCT01957202|41746|P9|STARTED|Treatment Period 1 (8 Days)||3
18906|NCT01957202|41747|P8|STARTED|Treatment Period 1 (8 Days)||3
18907|NCT01957202|41748|P7|STARTED|Treatment Period 1 (8 Days)||3
18908|NCT01957202|41749|P6|STARTED|Treatment Period 1 (8 Days)||2
18909|NCT01957202|41750|P5|STARTED|Treatment Period 1 (8 Days)||3
18910|NCT01957202|41751|P4|STARTED|Treatment Period 1 (8 Days)||3
18911|NCT01957202|41752|P3|STARTED|Treatment Period 1 (8 Days)||6
18912|NCT01957202|41753|P2|STARTED|Treatment Period 1 (8 Days)||6
18913|NCT01957202|41754|P1|STARTED|Treatment Period 1 (8 Days)||3
18914|NCT01957163|41779|P3|NOT COMPLETED|Overall Study||18
18915|NCT01957163|41780|P2|NOT COMPLETED|Overall Study||11
18916|NCT01957163|41781|P1|NOT COMPLETED|Overall Study||15
18917|NCT01957163|41779|P3|COMPLETED|Overall Study||189
18918|NCT01957163|41780|P2|COMPLETED|Overall Study||195
18919|NCT01957163|41781|P1|COMPLETED|Overall Study||191
18920|NCT01957163|41779|P3|STARTED|Overall Study||207
18921|NCT01957163|41780|P2|STARTED|Overall Study||206
18922|NCT01957163|41781|P1|STARTED|Overall Study||206
18923|NCT01957111|41794|P2|NOT COMPLETED|Overall Study||1
18924|NCT01957111|41795|P1|NOT COMPLETED|Overall Study||1
18925|NCT01957111|41794|P2|COMPLETED|Overall Study||15
18926|NCT01957111|41795|P1|COMPLETED|Overall Study||15
18927|NCT01957111|41794|P2|STARTED|Overall Study||16
18928|NCT01957111|41795|P1|STARTED|Overall Study||16
18929|NCT01956240|41805|P2|NOT COMPLETED|Overall Study||24
18930|NCT01956240|41806|P1|NOT COMPLETED|Overall Study||23
18931|NCT01956240|41805|P2|COMPLETED|Overall Study||25
18932|NCT01956240|41806|P1|COMPLETED|Overall Study||25
18933|NCT01956240|41805|P2|STARTED|Overall Study||49
18934|NCT01956240|41806|P1|STARTED|Overall Study||48
18935|NCT01956097|41817|P3|NOT COMPLETED|Overall Study||0
18936|NCT01956097|41818|P2|NOT COMPLETED|Overall Study||2
18937|NCT01956097|41819|P1|NOT COMPLETED|Overall Study||6
18938|NCT01956097|41817|P3|COMPLETED|Overall Study||15
18939|NCT01956097|41818|P2|COMPLETED|Overall Study||28
18940|NCT01956097|41819|P1|COMPLETED|Overall Study||24
18941|NCT01956097|41817|P3|STARTED|Overall Study||15
18942|NCT01956097|41818|P2|STARTED|Overall Study||30
18943|NCT01956097|41819|P1|STARTED|Overall Study||30
18944|NCT01956032|41836|P1|NOT COMPLETED|Overall Study||0
18945|NCT01956032|41836|P1|COMPLETED|Overall Study||15
18946|NCT01956032|41836|P1|STARTED|Overall Study||15
18947|NCT01955720|41883|P6|NOT COMPLETED|Overall Study||0
18948|NCT01955720|41884|P5|NOT COMPLETED|Overall Study||0
18949|NCT01955720|41885|P4|NOT COMPLETED|Overall Study||0
18950|NCT01955720|41886|P3|NOT COMPLETED|Overall Study||0
18951|NCT01955720|41887|P2|NOT COMPLETED|Overall Study||0
18952|NCT01955720|41888|P1|NOT COMPLETED|Overall Study||0
18953|NCT01955720|41883|P6|COMPLETED|Overall Study||7
18954|NCT01955720|41884|P5|COMPLETED|Overall Study||7
18955|NCT01955720|41885|P4|COMPLETED|Overall Study||3
18956|NCT01955720|41886|P3|COMPLETED|Overall Study||3
18957|NCT01955720|41887|P2|COMPLETED|Overall Study||13
18958|NCT01955720|41888|P1|COMPLETED|Overall Study||13
18959|NCT01955720|41883|P6|Subjects With Moderate Renal Impairment|Overall Study||0
18960|NCT01955720|41884|P5|Subjects With Moderate Renal Impairment|Overall Study||0
18961|NCT01955720|41885|P4|Subjects With Moderate Renal Impairment|Overall Study||0
18962|NCT01955720|41886|P3|Subjects With Moderate Renal Impairment|Overall Study||0
18963|NCT01955720|41887|P2|Subjects With Moderate Renal Impairment|Overall Study||3
18964|NCT01955720|41888|P1|Subjects With Moderate Renal Impairment|Overall Study||3
18965|NCT01955720|41883|P6|Subjects With Mild Renal Impairment|Overall Study||3
18966|NCT01955720|41884|P5|Subjects With Mild Renal Impairment|Overall Study||3
18967|NCT01955720|41885|P4|Subjects With Mild Renal Impairment|Overall Study||0
18968|NCT01955720|41886|P3|Subjects With Mild Renal Impairment|Overall Study||0
18969|NCT01955720|41887|P2|Subjects With Mild Renal Impairment|Overall Study||3
18970|NCT01955720|41888|P1|Subjects With Mild Renal Impairment|Overall Study||3
18971|NCT01955720|41883|P6|Healthy Subjects Aged 65-80|Overall Study||4
18972|NCT01955720|41884|P5|Healthy Subjects Aged 65-80|Overall Study||4
18973|NCT01955720|41885|P4|Healthy Subjects Aged 65-80|Overall Study||0
18974|NCT01955720|41886|P3|Healthy Subjects Aged 65-80|Overall Study||0
18975|NCT01955720|41887|P2|Healthy Subjects Aged 65-80|Overall Study||4
18976|NCT01955720|41888|P1|Healthy Subjects Aged 65-80|Overall Study||4
18977|NCT01955720|41883|P6|Healthy Subjects Aged 45-64|Overall Study||0
18978|NCT01955720|41884|P5|Healthy Subjects Aged 45-64|Overall Study||0
18979|NCT01955720|41885|P4|Healthy Subjects Aged 45-64|Overall Study||3
18980|NCT01955720|41886|P3|Healthy Subjects Aged 45-64|Overall Study||3
18981|NCT01955720|41887|P2|Healthy Subjects Aged 45-64|Overall Study||3
18982|NCT01955720|41888|P1|Healthy Subjects Aged 45-64|Overall Study||3
18983|NCT01955720|41883|P6|STARTED|Overall Study||7
18984|NCT01955720|41884|P5|STARTED|Overall Study||7
18985|NCT01955720|41885|P4|STARTED|Overall Study||3
18986|NCT01955720|41886|P3|STARTED|Overall Study||3
18987|NCT01955720|41887|P2|STARTED|Overall Study||13
18988|NCT01955720|41888|P1|STARTED|Overall Study||13
18989|NCT01955707|41956|P2|NOT COMPLETED|Overall Study||22
18990|NCT01955707|41957|P1|NOT COMPLETED|Overall Study||20
18991|NCT01955707|41956|P2|COMPLETED|Overall Study||57
18992|NCT01955707|41957|P1|COMPLETED|Overall Study||62
18993|NCT01955707|41956|P2|Received Total Volume of Study Drug|Overall Study||77
18994|NCT01955707|41957|P1|Received Total Volume of Study Drug|Overall Study||82
18995|NCT01955707|41956|P2|Dosed|Overall Study||78
18996|NCT01955707|41957|P1|Dosed|Overall Study||82
18997|NCT01955707|41956|P2|Withdrew Prior to Dosing|Overall Study||1
18998|NCT01955707|41957|P1|Withdrew Prior to Dosing|Overall Study||0
18999|NCT01955707|41956|P2|STARTED|Overall Study||79
19000|NCT01955707|41957|P1|STARTED|Overall Study||82
19001|NCT01955629|41981|P1|NOT COMPLETED|Overall Study||0
19002|NCT01955629|41981|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
19003|NCT01955629|41981|P1|STARTED|Overall Study||4
19004|NCT01955369|41993|P1|NOT COMPLETED|Overall Study||0
19005|NCT01955369|41993|P1|COMPLETED|Overall Study||200
19006|NCT01955369|41993|P1|STARTED|Overall Study||200
19007|NCT01955083|42001|P2|NOT COMPLETED|Overall Study||1
19008|NCT01955083|42002|P1|NOT COMPLETED|Overall Study||1
19009|NCT01955083|42001|P2|COMPLETED|Overall Study||14
19010|NCT01955083|42002|P1|COMPLETED|Overall Study||14
19011|NCT01955083|42001|P2|STARTED|Overall Study||15
19012|NCT01955083|42002|P1|STARTED|Overall Study||15
19013|NCT01955044|42035|P3|NOT COMPLETED|Overall Study||0
19014|NCT01955044|42036|P2|NOT COMPLETED|Overall Study||1
19015|NCT01955044|42037|P1|NOT COMPLETED|Overall Study||1
19016|NCT01955044|42035|P3|COMPLETED|Overall Study||10
19017|NCT01955044|42036|P2|COMPLETED|Overall Study||9
19018|NCT01955044|42037|P1|COMPLETED|Overall Study||9
19019|NCT01955044|42035|P3|STARTED|Overall Study||10
19020|NCT01955044|42036|P2|STARTED|Overall Study||10
19021|NCT01955044|42037|P1|STARTED|Overall Study||10
19022|NCT01955005|42050|P2|NOT COMPLETED|Overall Study||5
19023|NCT01955005|42051|P1|NOT COMPLETED|Overall Study||3
19024|NCT01955005|42050|P2|COMPLETED|Overall Study||25
19025|NCT01955005|42051|P1|COMPLETED|Overall Study||27
19026|NCT01955005|42050|P2|STARTED|Overall Study||30
19027|NCT01955005|42051|P1|STARTED|Overall Study||30
19028|NCT01954745|42061|P1|NOT COMPLETED|Overall Study||19
19029|NCT01954745|42061|P1|COMPLETED|Overall Study||0
19030|NCT01954745|42061|P1|STARTED|Overall Study||19
19031|NCT01954251|42070|P2|NOT COMPLETED|Overall Study||19
19032|NCT01954251|42071|P1|NOT COMPLETED|Overall Study||13
19033|NCT01954251|42070|P2|COMPLETED|Overall Study||396
19034|NCT01954251|42071|P1|COMPLETED|Overall Study||400
19035|NCT01954251|42070|P2|STARTED|Overall Study||415
19036|NCT01954251|42071|P1|STARTED|Overall Study||413
19037|NCT01954160|42107|P2|NOT COMPLETED|Overall Study||0
19038|NCT01954160|42108|P1|NOT COMPLETED|Overall Study||5
19039|NCT01954160|42107|P2|COMPLETED|Overall Study||0
19040|NCT01954160|42108|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
19041|NCT01954160|42107|P2|STARTED|Overall Study|Not started|0
19042|NCT01954160|42108|P1|STARTED|Overall Study||5
19043|NCT01954121|42168|P2|NOT COMPLETED|Overall Study||91
19044|NCT01954121|42169|P1|NOT COMPLETED|Overall Study||127
19045|NCT01954121|42168|P2|COMPLETED|Overall Study||125
19046|NCT01954121|42169|P1|COMPLETED|Overall Study||93
19047|NCT01954121|42168|P2|STARTED|Overall Study||216
19048|NCT01954121|42169|P1|STARTED|Overall Study||220
19049|NCT01953354|42185|P2|NOT COMPLETED|Overall Study||2
19050|NCT01953354|42186|P1|NOT COMPLETED|Overall Study||1
19051|NCT01953354|42185|P2|COMPLETED|Overall Study||5
19052|NCT01953354|42186|P1|COMPLETED|Overall Study||8
19053|NCT01953354|42185|P2|STARTED|Overall Study||7
19054|NCT01953354|42186|P1|STARTED|Overall Study||9
19055|NCT01953328|42214|P8|NOT COMPLETED|Overall Study||0
19056|NCT01953328|42215|P7|NOT COMPLETED|Overall Study||0
19057|NCT01953328|42216|P6|NOT COMPLETED|Overall Study||0
19058|NCT01953328|42217|P5|NOT COMPLETED|Overall Study||2
19059|NCT01953328|42218|P4|NOT COMPLETED|Overall Study||0
19060|NCT01953328|42219|P3|NOT COMPLETED|Overall Study||0
19061|NCT01953328|42220|P2|NOT COMPLETED|Overall Study||0
19062|NCT01953328|42221|P1|NOT COMPLETED|Overall Study||0
19063|NCT01953328|42214|P8|COMPLETED|Overall Study||51
19064|NCT01953328|42215|P7|COMPLETED|Overall Study||51
19065|NCT01953328|42216|P6|COMPLETED|Overall Study||51
19066|NCT01953328|42217|P5|COMPLETED|Overall Study||50
19067|NCT01953328|42218|P4|COMPLETED|Overall Study||50
19068|NCT01953328|42219|P3|COMPLETED|Overall Study||50
19069|NCT01953328|42220|P2|COMPLETED|Overall Study||50
19070|NCT01953328|42221|P1|COMPLETED|Overall Study||49
19071|NCT01953328|42214|P8|Received Treatment|Overall Study||51
19072|NCT01953328|42215|P7|Received Treatment|Overall Study||51
19073|NCT01953328|42216|P6|Received Treatment|Overall Study||51
19074|NCT01953328|42217|P5|Received Treatment|Overall Study||52
19075|NCT01953328|42218|P4|Received Treatment|Overall Study||50
19076|NCT01953328|42219|P3|Received Treatment|Overall Study||50
19077|NCT01953328|42220|P2|Received Treatment|Overall Study||50
19078|NCT01953328|42221|P1|Received Treatment|Overall Study||49
19079|NCT01953328|42214|P8|STARTED|Overall Study||51
19080|NCT01953328|42215|P7|STARTED|Overall Study||51
19081|NCT01953328|42216|P6|STARTED|Overall Study||51
19082|NCT01953328|42217|P5|STARTED|Overall Study||52
19083|NCT01953328|42218|P4|STARTED|Overall Study||50
19084|NCT01953328|42219|P3|STARTED|Overall Study||50
19085|NCT01953328|42220|P2|STARTED|Overall Study||50
19086|NCT01953328|42221|P1|STARTED|Overall Study||49
19087|NCT01953237|42425|P2|NOT COMPLETED|Overall Study||0
19088|NCT01953237|42426|P1|NOT COMPLETED|Overall Study||0
19089|NCT01953237|42425|P2|COMPLETED|Overall Study||21
19090|NCT01953237|42426|P1|COMPLETED|Overall Study||10
19091|NCT01953237|42425|P2|STARTED|Overall Study||21
19092|NCT01953237|42426|P1|STARTED|Overall Study||10
19093|NCT01952834|42432|P1|NOT COMPLETED|Overall Study||1
19094|NCT01952834|42432|P1|COMPLETED|Overall Study||20
19095|NCT01952834|42432|P1|STARTED|Overall Study||21
19096|NCT01952691|42439|P1|NOT COMPLETED|Overall Study||2
19097|NCT01952691|42439|P1|COMPLETED|Overall Study||20
19098|NCT01952691|42439|P1|STARTED|Overall Study||22
19099|NCT01952665|42447|P2|NOT COMPLETED|Overall Study||6
19100|NCT01952665|42448|P1|NOT COMPLETED|Overall Study||6
19101|NCT01952665|42447|P2|COMPLETED|Overall Study||20
19102|NCT01952665|42448|P1|COMPLETED|Overall Study||31
19103|NCT01952665|42447|P2|STARTED|Overall Study||26
19104|NCT01952665|42448|P1|STARTED|Overall Study||37
19105|NCT01952600|42589|P3|NOT COMPLETED|Overall Study||7
19106|NCT01952600|42590|P2|NOT COMPLETED|Overall Study||13
19107|NCT01952600|42591|P1|NOT COMPLETED|Overall Study||15
19108|NCT01952600|42589|P3|COMPLETED|Overall Study||38
19109|NCT01952600|42590|P2|COMPLETED|Overall Study||77
19110|NCT01952600|42591|P1|COMPLETED|Overall Study||65
19111|NCT01952600|42589|P3|STARTED|Overall Study||45
19112|NCT01952600|42590|P2|STARTED|Overall Study||90
19113|NCT01952600|42591|P1|STARTED|Overall Study||80
19114|NCT01952366|42599|P1|NOT COMPLETED|Overall Study||31
19115|NCT01952366|42599|P1|COMPLETED|Overall Study||138
19116|NCT01952366|42599|P1|STARTED|Overall Study||169
19117|NCT01952301|42605|P1|NOT COMPLETED|Overall Study||0
19118|NCT01952301|42605|P1|COMPLETED|Overall Study||30
19119|NCT01952301|42605|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
19120|NCT01952145|42613|P2|NOT COMPLETED|Overall Study||14
19121|NCT01952145|42614|P1|NOT COMPLETED|Overall Study||28
19122|NCT01952145|42613|P2|COMPLETED|Overall Study||265
19123|NCT01952145|42614|P1|COMPLETED|Overall Study||250
19124|NCT01952145|42613|P2|STARTED|Overall Study||279
19125|NCT01952145|42614|P1|STARTED|Overall Study||278
19126|NCT01952080|42628|P4|NOT COMPLETED|Overall Study||1
19127|NCT01952080|42629|P3|NOT COMPLETED|Overall Study||0
19128|NCT01952080|42630|P2|NOT COMPLETED|Overall Study||1
19129|NCT01952080|42631|P1|NOT COMPLETED|Overall Study||0
19130|NCT01952080|42628|P4|COMPLETED|Overall Study||14
19131|NCT01952080|42629|P3|COMPLETED|Overall Study||14
19132|NCT01952080|42630|P2|COMPLETED|Overall Study||7
19133|NCT01952080|42631|P1|COMPLETED|Overall Study||5
19134|NCT01952080|42628|P4|Treated|Overall Study||15
19135|NCT01952080|42629|P3|Treated|Overall Study||14
19136|NCT01952080|42630|P2|Treated|Overall Study||8
19137|NCT01952080|42631|P1|Treated|Overall Study||5
19138|NCT01952080|42628|P4|STARTED|Overall Study||15
19139|NCT01952080|42629|P3|STARTED|Overall Study||14
19140|NCT01952080|42630|P2|STARTED|Overall Study||8
19141|NCT01952080|42631|P1|STARTED|Overall Study||5
19142|NCT01951950|42679|P2|NOT COMPLETED|Overall Study||6
19143|NCT01951950|42680|P1|NOT COMPLETED|Overall Study||6
19144|NCT01951950|42679|P2|COMPLETED|Overall Study||20
19145|NCT01951950|42680|P1|COMPLETED|Overall Study||20
19146|NCT01951950|42679|P2|STARTED|Overall Study||26
19147|NCT01951950|42680|P1|STARTED|Overall Study||26
19148|NCT01951820|42688|P2|NOT COMPLETED|Overall Study||0
19149|NCT01951820|42689|P1|NOT COMPLETED|Overall Study||0
19150|NCT01951820|42688|P2|COMPLETED|Overall Study||30
19151|NCT01951820|42689|P1|COMPLETED|Overall Study||34
19152|NCT01951820|42688|P2|STARTED|Overall Study||30
19153|NCT01951820|42689|P1|STARTED|Overall Study||34
19154|NCT01951703|42697|P2|NOT COMPLETED|Second Intervention||2
19155|NCT01951703|42698|P1|NOT COMPLETED|Second Intervention||0
19156|NCT01951703|42697|P2|COMPLETED|Second Intervention||60
19157|NCT01951703|42698|P1|COMPLETED|Second Intervention||61
19158|NCT01951703|42697|P2|STARTED|Second Intervention||62
19159|NCT01951703|42698|P1|STARTED|Second Intervention||61
19160|NCT01951703|42697|P2|NOT COMPLETED|First Intervention||1
19161|NCT01951703|42698|P1|NOT COMPLETED|First Intervention||3
19162|NCT01951703|42697|P2|COMPLETED|First Intervention||62
19163|NCT01951703|42698|P1|COMPLETED|First Intervention||61
19164|NCT01951703|42697|P2|STARTED|First Intervention||63
19165|NCT01951703|42698|P1|STARTED|First Intervention||64
19166|NCT01951651|42708|P2|NOT COMPLETED|Overall Study||2
19167|NCT01951651|42709|P1|NOT COMPLETED|Overall Study||4
19168|NCT01951651|42708|P2|COMPLETED|Overall Study||10
19169|NCT01951651|42709|P1|COMPLETED|Overall Study||8
19170|NCT01951651|42708|P2|STARTED|Overall Study||12
19171|NCT01951651|42709|P1|STARTED|Overall Study||12
19172|NCT01951573|42721|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
19173|NCT01951573|42722|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
19174|NCT01951573|42721|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
19175|NCT01951573|42722|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
19176|NCT01951573|42721|P2|STARTED|Period 2, Second 9 Hours of Wear||16
19177|NCT01951573|42722|P1|STARTED|Period 2, Second 9 Hours of Wear||17
19178|NCT01951573|42721|P2|NOT COMPLETED|Washout Period||1
19179|NCT01951573|42722|P1|NOT COMPLETED|Washout Period||0
19180|NCT01951573|42721|P2|COMPLETED|Washout Period||16
19181|NCT01951573|42722|P1|COMPLETED|Washout Period||17
19182|NCT01951573|42721|P2|STARTED|Washout Period||17
19183|NCT01951573|42722|P1|STARTED|Washout Period||17
19184|NCT01951573|42721|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
19185|NCT01951573|42722|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
19186|NCT01951573|42721|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
19187|NCT01951573|42722|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
19188|NCT01951573|42721|P2|STARTED|Period 1, First 9 Hours of Wear||17
19189|NCT01951573|42722|P1|STARTED|Period 1, First 9 Hours of Wear||17
19190|NCT01951417|42732|P1|NOT COMPLETED|Overall Study||9
19191|NCT01951417|42732|P1|COMPLETED|Overall Study||72
19192|NCT01951417|42732|P1|STARTED|Overall Study||81
19193|NCT01951170|42755|P1|NOT COMPLETED|Overall Study||1
19194|NCT01951170|42755|P1|COMPLETED|Overall Study||51
19195|NCT01951170|42755|P1|STARTED|Overall Study||52
19196|NCT01951092|42778|P1|NOT COMPLETED|Overall Study||12
19197|NCT01951092|42778|P1|COMPLETED|Overall Study||20
19198|NCT01951092|42778|P1|STARTED|Overall Study||32
19199|NCT01951066|42783|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
19200|NCT01951066|42784|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
19201|NCT01951066|42783|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
19202|NCT01951066|42784|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
19203|NCT01951066|42783|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
19204|NCT01951066|42784|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
19205|NCT01951066|42783|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
19206|NCT01951066|42784|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
19207|NCT01951066|42783|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
19208|NCT01951066|42784|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
19209|NCT01951066|42783|P2|STARTED|First Intervention (Baseline to Week 16)||10
19210|NCT01951066|42784|P1|STARTED|First Intervention (Baseline to Week 16)||10
19211|NCT01950741|42789|P1|NOT COMPLETED|Overall Study||3
19212|NCT01950741|42789|P1|COMPLETED|Overall Study||45
19213|NCT01950741|42789|P1|STARTED|Overall Study||48
19214|NCT01950364|42800|P2|NOT COMPLETED|Overall Study||10
19215|NCT01950364|42801|P1|NOT COMPLETED|Overall Study||10
19216|NCT01950364|42800|P2|COMPLETED|Overall Study||0
19217|NCT01950364|42801|P1|COMPLETED|Overall Study||0
19218|NCT01950364|42800|P2|STARTED|Overall Study||10
19219|NCT01950364|42801|P1|STARTED|Overall Study||10
19220|NCT01950078|42901|P2|NOT COMPLETED|Overall Study||12
19221|NCT01950078|42902|P1|NOT COMPLETED|Overall Study||20
19222|NCT01950078|42901|P2|COMPLETED|Overall Study||496
19223|NCT01950078|42902|P1|COMPLETED|Overall Study||1005
19224|NCT01950078|42901|P2|STARTED|Overall Study||508
19225|NCT01950078|42902|P1|STARTED|Overall Study||1025
19226|NCT01949870|42910|P1|NOT COMPLETED|Overall Study||6
19227|NCT01949870|42910|P1|COMPLETED|Overall Study||0
19228|NCT01949870|42910|P1|Received Treatment|Overall Study||4
19229|NCT01949870|42910|P1|STARTED|Overall Study||6
19230|NCT01949545|42918|P4|NOT COMPLETED|Overall Study||0
19231|NCT01949545|42919|P3|NOT COMPLETED|Overall Study||0
19232|NCT01949545|42920|P2|NOT COMPLETED|Overall Study||0
19233|NCT01949545|42921|P1|NOT COMPLETED|Overall Study||0
19234|NCT01949545|42918|P4|COMPLETED|Overall Study||4
19235|NCT01949545|42919|P3|COMPLETED|Overall Study||14
19236|NCT01949545|42920|P2|COMPLETED|Overall Study||17
19237|NCT01949545|42921|P1|COMPLETED|Overall Study||11
19238|NCT01949545|42918|P4|STARTED|Overall Study||4
19239|NCT01949545|42919|P3|STARTED|Overall Study||14
19240|NCT01949545|42920|P2|STARTED|Overall Study||17
19241|NCT01949545|42921|P1|STARTED|Overall Study||11
19242|NCT01949532|43069|P2|NOT COMPLETED|Overall Study||3
19243|NCT01949532|43070|P1|NOT COMPLETED|Overall Study||3
19244|NCT01949532|43069|P2|COMPLETED|Overall Study||8
19245|NCT01949532|43070|P1|COMPLETED|Overall Study||12
19246|NCT01949532|43069|P2|STARTED|Overall Study||11
19247|NCT01949532|43070|P1|STARTED|Overall Study||15
19248|NCT01949389|43138|P1|NOT COMPLETED|Overall Study||0
19249|NCT01949389|43138|P1|COMPLETED|Overall Study||51
19250|NCT01949389|43138|P1|STARTED|Overall Study||51
19251|NCT01949155|43145|P2|NOT COMPLETED|Overall Study||0
19252|NCT01949155|43146|P1|NOT COMPLETED|Overall Study||2
19253|NCT01949155|43145|P2|COMPLETED|Overall Study||88
19254|NCT01949155|43146|P1|COMPLETED|Overall Study||176
19255|NCT01949155|43145|P2|STARTED|Overall Study||88
19256|NCT01949155|43146|P1|STARTED|Overall Study||178
19257|NCT01949142|43158|P2|NOT COMPLETED|Overall Study||1
19258|NCT01949142|43159|P1|NOT COMPLETED|Overall Study||3
19259|NCT01949142|43158|P2|COMPLETED|Overall Study||86
19260|NCT01949142|43159|P1|COMPLETED|Overall Study||176
19261|NCT01949142|43158|P2|STARTED|Overall Study||87
19262|NCT01949142|43159|P1|STARTED|Overall Study||179
19263|NCT01949051|43169|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19264|NCT01949051|43170|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19265|NCT01949051|43171|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19266|NCT01949051|43172|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19267|NCT01949051|43173|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19268|NCT01949051|43174|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
19269|NCT01949051|43169|P6|COMPLETED|Treatment Period 3 (7 Days)||12
19270|NCT01949051|43170|P5|COMPLETED|Treatment Period 3 (7 Days)||13
19271|NCT01949051|43171|P4|COMPLETED|Treatment Period 3 (7 Days)||12
19272|NCT01949051|43172|P3|COMPLETED|Treatment Period 3 (7 Days)||12
19273|NCT01949051|43173|P2|COMPLETED|Treatment Period 3 (7 Days)||12
19274|NCT01949051|43174|P1|COMPLETED|Treatment Period 3 (7 Days)||11
19275|NCT01949051|43169|P6|STARTED|Treatment Period 3 (7 Days)||12
19276|NCT01949051|43170|P5|STARTED|Treatment Period 3 (7 Days)||13
19277|NCT01949051|43171|P4|STARTED|Treatment Period 3 (7 Days)||12
19278|NCT01949051|43172|P3|STARTED|Treatment Period 3 (7 Days)||12
19279|NCT01949051|43173|P2|STARTED|Treatment Period 3 (7 Days)||12
19280|NCT01949051|43174|P1|STARTED|Treatment Period 3 (7 Days)||11
19281|NCT01949051|43169|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19282|NCT01949051|43170|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19283|NCT01949051|43171|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19284|NCT01949051|43172|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19285|NCT01949051|43173|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19286|NCT01949051|43174|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
19287|NCT01949051|43169|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
19288|NCT01949051|43170|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
19289|NCT01949051|43171|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
19290|NCT01949051|43172|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
19291|NCT01949051|43173|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
19292|NCT01949051|43174|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
19293|NCT01949051|43169|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
19294|NCT01949051|43170|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
19295|NCT01949051|43171|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
19296|NCT01949051|43172|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
19297|NCT01949051|43173|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
19298|NCT01949051|43174|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
19299|NCT01949051|43169|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
19300|NCT01949051|43170|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
19301|NCT01949051|43171|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
19302|NCT01949051|43172|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
19303|NCT01949051|43173|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
19304|NCT01949051|43174|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
19305|NCT01949051|43169|P6|COMPLETED|Treatment Period 2 (7 Days)||12
19306|NCT01949051|43170|P5|COMPLETED|Treatment Period 2 (7 Days)||13
19307|NCT01949051|43171|P4|COMPLETED|Treatment Period 2 (7 Days)||12
19308|NCT01949051|43172|P3|COMPLETED|Treatment Period 2 (7 Days)||12
19309|NCT01949051|43173|P2|COMPLETED|Treatment Period 2 (7 Days)||12
19310|NCT01949051|43174|P1|COMPLETED|Treatment Period 2 (7 Days)||11
19311|NCT01949051|43169|P6|STARTED|Treatment Period 2 (7 Days)||13
19312|NCT01949051|43170|P5|STARTED|Treatment Period 2 (7 Days)||13
19313|NCT01949051|43171|P4|STARTED|Treatment Period 2 (7 Days)||12
19314|NCT01949051|43172|P3|STARTED|Treatment Period 2 (7 Days)||13
19315|NCT01949051|43173|P2|STARTED|Treatment Period 2 (7 Days)||13
19316|NCT01949051|43174|P1|STARTED|Treatment Period 2 (7 Days)||11
19317|NCT01949051|43169|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19318|NCT01949051|43170|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19319|NCT01949051|43171|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19320|NCT01949051|43172|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19321|NCT01949051|43173|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19322|NCT01949051|43174|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
19323|NCT01949051|43169|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
19324|NCT01949051|43170|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
19325|NCT01949051|43171|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
19326|NCT01949051|43172|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
19327|NCT01949051|43173|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
19328|NCT01949051|43174|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
19329|NCT01949051|43169|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
19330|NCT01949051|43170|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
19331|NCT01949051|43171|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
19332|NCT01949051|43172|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
19333|NCT01949051|43173|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
19334|NCT01949051|43174|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
19335|NCT01949051|43169|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
19336|NCT01949051|43170|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
19337|NCT01949051|43171|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
19338|NCT01949051|43172|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
19339|NCT01949051|43173|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
19340|NCT01949051|43174|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
19341|NCT01949051|43169|P6|COMPLETED|Treatment Period 1 (7 Days)||13
19342|NCT01949051|43170|P5|COMPLETED|Treatment Period 1 (7 Days)||13
19343|NCT01949051|43171|P4|COMPLETED|Treatment Period 1 (7 Days)||12
19344|NCT01949051|43172|P3|COMPLETED|Treatment Period 1 (7 Days)||13
19345|NCT01949051|43173|P2|COMPLETED|Treatment Period 1 (7 Days)||13
19346|NCT01949051|43174|P1|COMPLETED|Treatment Period 1 (7 Days)||11
19347|NCT01949051|43169|P6|STARTED|Treatment Period 1 (7 Days)||13
19348|NCT01949051|43170|P5|STARTED|Treatment Period 1 (7 Days)||13
19349|NCT01949051|43171|P4|STARTED|Treatment Period 1 (7 Days)||13
19350|NCT01949051|43172|P3|STARTED|Treatment Period 1 (7 Days)||13
19351|NCT01949051|43173|P2|STARTED|Treatment Period 1 (7 Days)||13
19352|NCT01949051|43174|P1|STARTED|Treatment Period 1 (7 Days)||13
19353|NCT01948908|43188|P3|NOT COMPLETED|Overall Study||2
19354|NCT01948908|43189|P2|NOT COMPLETED|Overall Study||0
19355|NCT01948908|43190|P1|NOT COMPLETED|Overall Study||1
19356|NCT01948908|43188|P3|COMPLETED|Overall Study||31
19357|NCT01948908|43189|P2|COMPLETED|Overall Study||33
19358|NCT01948908|43190|P1|COMPLETED|Overall Study||32
19359|NCT01948908|43188|P3|STARTED|Overall Study||33
19360|NCT01948908|43189|P2|STARTED|Overall Study||33
19361|NCT01948908|43190|P1|STARTED|Overall Study||33
19362|NCT01948830|43206|P2|NOT COMPLETED|Overall Study||32
19363|NCT01948830|43207|P1|NOT COMPLETED|Overall Study||33
19364|NCT01948830|43206|P2|COMPLETED|Overall Study||295
19365|NCT01948830|43207|P1|COMPLETED|Overall Study||290
19366|NCT01948830|43206|P2|Safety Set|Overall Study||326
19367|NCT01948830|43207|P1|Safety Set|Overall Study||323
19368|NCT01948830|43206|P2|STARTED|Overall Study||327
19369|NCT01948830|43207|P1|STARTED|Overall Study||323
19370|NCT01948791|43239|P1|NOT COMPLETED|Overall Study||71
19371|NCT01948791|43239|P1|COMPLETED|Overall Study||151
19372|NCT01948791|43239|P1|STARTED|Overall Study||222
19373|NCT01948518|43247|P1|NOT COMPLETED|Overall Study||0
19374|NCT01948518|43247|P1|COMPLETED|Overall Study||15
19375|NCT01948518|43247|P1|STARTED|Overall Study||15
19376|NCT01948375|43254|P2|NOT COMPLETED|Overall Study||0
19377|NCT01948375|43255|P1|NOT COMPLETED|Overall Study||0
19378|NCT01948375|43254|P2|COMPLETED|Overall Study||30
19379|NCT01948375|43255|P1|COMPLETED|Overall Study||30
19380|NCT01948375|43254|P2|STARTED|Overall Study||30
19381|NCT01948375|43255|P1|STARTED|Overall Study||30
19382|NCT01948193|43269|P1|NOT COMPLETED|Overall Study||9
19383|NCT01948193|43269|P1|COMPLETED|Overall Study||168
19384|NCT01948193|43269|P1|STARTED|Overall Study||177
19385|NCT01948076|43280|P2|NOT COMPLETED|Overall Study||1
19386|NCT01948076|43281|P1|NOT COMPLETED|Overall Study||0
19387|NCT01948076|43280|P2|COMPLETED|Overall Study||19
19388|NCT01948076|43281|P1|COMPLETED|Overall Study||20
19389|NCT01948076|43280|P2|STARTED|Overall Study||20
19390|NCT01948076|43281|P1|STARTED|Overall Study||20
19391|NCT01948050|43291|P2|NOT COMPLETED|Overall Study||1
19392|NCT01948050|43292|P1|NOT COMPLETED|Overall Study||0
19393|NCT01948050|43291|P2|COMPLETED|Overall Study||7
19394|NCT01948050|43292|P1|COMPLETED|Overall Study||16
19395|NCT01948050|43291|P2|STARTED|Overall Study||8
19396|NCT01948050|43292|P1|STARTED|Overall Study||16
19397|NCT01947946|43301|P3|NOT COMPLETED|Overall Study||5
19398|NCT01947946|43302|P2|NOT COMPLETED|Overall Study||5
19399|NCT01947946|43303|P1|NOT COMPLETED|Overall Study||3
19400|NCT01947946|43301|P3|COMPLETED|Overall Study||0
19401|NCT01947946|43302|P2|COMPLETED|Overall Study||0
19402|NCT01947946|43303|P1|COMPLETED|Overall Study|Study Stopped|0
19403|NCT01947946|43301|P3|STARTED|Overall Study||5
19404|NCT01947946|43302|P2|STARTED|Overall Study||5
19405|NCT01947946|43303|P1|STARTED|Overall Study||3
19406|NCT01947907|43315|P4|NOT COMPLETED|Overall Study||0
19407|NCT01947907|43316|P3|NOT COMPLETED|Overall Study||0
19408|NCT01947907|43317|P2|NOT COMPLETED|Overall Study||0
19409|NCT01947907|43318|P1|NOT COMPLETED|Overall Study||0
19410|NCT01947907|43315|P4|COMPLETED|Overall Study||13
19411|NCT01947907|43316|P3|COMPLETED|Overall Study||14
19412|NCT01947907|43317|P2|COMPLETED|Overall Study||14
19413|NCT01947907|43318|P1|COMPLETED|Overall Study||12
19414|NCT01947907|43315|P4|STARTED|Overall Study||13
19415|NCT01947907|43316|P3|STARTED|Overall Study||14
19416|NCT01947907|43317|P2|STARTED|Overall Study||14
19417|NCT01947907|43318|P1|STARTED|Overall Study||12
19418|NCT01947855|43360|P3|NOT COMPLETED|Overall Study||0
19419|NCT01947855|43361|P2|NOT COMPLETED|Overall Study||0
19420|NCT01947855|43362|P1|NOT COMPLETED|Overall Study||1
19421|NCT01947855|43360|P3|COMPLETED|Overall Study||19
19422|NCT01947855|43361|P2|COMPLETED|Overall Study||20
19423|NCT01947855|43362|P1|COMPLETED|Overall Study||20
19424|NCT01947855|43360|P3|STARTED|Overall Study||19
19425|NCT01947855|43361|P2|STARTED|Overall Study||20
19426|NCT01947855|43362|P1|STARTED|Overall Study||21
19427|NCT01947582|43370|P1|NOT COMPLETED|Overall Study||1
19428|NCT01947582|43370|P1|COMPLETED|Overall Study||1
19429|NCT01947582|43370|P1|STARTED|Overall Study||2
19430|NCT01947491|43381|P4|NOT COMPLETED|Overall Study||5
19431|NCT01947491|43382|P3|NOT COMPLETED|Overall Study||2
19432|NCT01947491|43383|P2|NOT COMPLETED|Overall Study||6
19433|NCT01947491|43384|P1|NOT COMPLETED|Overall Study||8
19434|NCT01947491|43381|P4|COMPLETED|Overall Study||38
19435|NCT01947491|43382|P3|COMPLETED|Overall Study||88
19436|NCT01947491|43383|P2|COMPLETED|Overall Study||81
19437|NCT01947491|43384|P1|COMPLETED|Overall Study||166
19438|NCT01947491|43381|P4|STARTED|Overall Study||43
19439|NCT01947491|43382|P3|STARTED|Overall Study||90
19440|NCT01947491|43383|P2|STARTED|Overall Study||87
19441|NCT01947491|43384|P1|STARTED|Overall Study||174
19442|NCT01947335|43396|P2|NOT COMPLETED|Overall Study||0
19443|NCT01947335|43397|P1|NOT COMPLETED|Overall Study||0
19444|NCT01947335|43396|P2|COMPLETED|Overall Study||41
19445|NCT01947335|43397|P1|COMPLETED|Overall Study||42
19446|NCT01947335|43396|P2|STARTED|Overall Study||41
19447|NCT01947335|43397|P1|STARTED|Overall Study||42
19448|NCT01947153|43407|P2|NOT COMPLETED|Test Period 2||0
19449|NCT01947153|43408|P1|NOT COMPLETED|Test Period 2||0
19450|NCT01947153|43407|P2|COMPLETED|Test Period 2||18
19451|NCT01947153|43408|P1|COMPLETED|Test Period 2||18
19452|NCT01947153|43407|P2|STARTED|Test Period 2||18
19453|NCT01947153|43408|P1|STARTED|Test Period 2||18
19454|NCT01947153|43407|P2|NOT COMPLETED|Test Period 1||0
19455|NCT01947153|43408|P1|NOT COMPLETED|Test Period 1||0
19456|NCT01947153|43407|P2|COMPLETED|Test Period 1||18
19457|NCT01947153|43408|P1|COMPLETED|Test Period 1||18
19458|NCT01947153|43407|P2|STARTED|Test Period 1||18
19459|NCT01947153|43408|P1|STARTED|Test Period 1||18
19460|NCT01947127|43428|P2|NOT COMPLETED|Overall Study||43
19461|NCT01947127|43429|P1|NOT COMPLETED|Overall Study||23
19462|NCT01947127|43428|P2|COMPLETED|Overall Study||249
19463|NCT01947127|43429|P1|COMPLETED|Overall Study||143
19464|NCT01947127|43428|P2|STARTED|Overall Study||292
19465|NCT01947127|43429|P1|STARTED|Overall Study||166
19466|NCT01946542|43441|P2|NOT COMPLETED|Testing Visit 2||0
19467|NCT01946542|43442|P1|NOT COMPLETED|Testing Visit 2||0
19468|NCT01946542|43441|P2|COMPLETED|Testing Visit 2||1
19469|NCT01946542|43442|P1|COMPLETED|Testing Visit 2||1
19470|NCT01946542|43441|P2|STARTED|Testing Visit 2||1
19471|NCT01946542|43442|P1|STARTED|Testing Visit 2||1
19472|NCT01946542|43441|P2|NOT COMPLETED|Testing Visit 1||0
19473|NCT01946542|43442|P1|NOT COMPLETED|Testing Visit 1||0
19474|NCT01946542|43441|P2|COMPLETED|Testing Visit 1||1
19475|NCT01946542|43442|P1|COMPLETED|Testing Visit 1||1
19476|NCT01946542|43441|P2|STARTED|Testing Visit 1||1
19477|NCT01946542|43442|P1|STARTED|Testing Visit 1||1
19478|NCT01946529|43453|P3|NOT COMPLETED|Completion of All Therapy||6
19479|NCT01946529|43454|P2|NOT COMPLETED|Completion of All Therapy||16
19480|NCT01946529|43455|P1|NOT COMPLETED|Completion of All Therapy||1
19481|NCT01946529|43453|P3|COMPLETED|Completion of All Therapy||0
19482|NCT01946529|43454|P2|COMPLETED|Completion of All Therapy||0
19483|NCT01946529|43455|P1|COMPLETED|Completion of All Therapy||0
19484|NCT01946529|43453|P3|STARTED|Completion of All Therapy||6
19485|NCT01946529|43454|P2|STARTED|Completion of All Therapy||16
19486|NCT01946529|43455|P1|STARTED|Completion of All Therapy||1
19487|NCT01946529|43453|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
19488|NCT01946529|43454|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
19489|NCT01946529|43455|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
19490|NCT01946529|43453|P3|COMPLETED|End of Window Therapy (2 Courses)||6
19491|NCT01946529|43454|P2|COMPLETED|End of Window Therapy (2 Courses)||16
19492|NCT01946529|43455|P1|COMPLETED|End of Window Therapy (2 Courses)||1
19493|NCT01946529|43453|P3|STARTED|End of Window Therapy (2 Courses)||6
19494|NCT01946529|43454|P2|STARTED|End of Window Therapy (2 Courses)||17
19495|NCT01946529|43455|P1|STARTED|End of Window Therapy (2 Courses)||1
19496|NCT01946438|43466|P4|NOT COMPLETED|Overall Study||1
19497|NCT01946438|43467|P3|NOT COMPLETED|Overall Study||1
19498|NCT01946438|43468|P2|NOT COMPLETED|Overall Study||0
19499|NCT01946438|43469|P1|NOT COMPLETED|Overall Study||2
19500|NCT01946438|43466|P4|COMPLETED|Overall Study||51
19501|NCT01946438|43467|P3|COMPLETED|Overall Study||51
19502|NCT01946438|43468|P2|COMPLETED|Overall Study||52
19503|NCT01946438|43469|P1|COMPLETED|Overall Study||50
19504|NCT01946438|43466|P4|STARTED|Overall Study||52
19505|NCT01946438|43467|P3|STARTED|Overall Study||52
19506|NCT01946438|43468|P2|STARTED|Overall Study||52
19507|NCT01946438|43469|P1|STARTED|Overall Study||52
19508|NCT01946425|43497|P2|NOT COMPLETED|Overall Study||0
19509|NCT01946425|43498|P1|NOT COMPLETED|Overall Study||2
19510|NCT01946425|43497|P2|COMPLETED|Overall Study||30
19511|NCT01946425|43498|P1|COMPLETED|Overall Study||28
19512|NCT01946425|43497|P2|STARTED|Overall Study||30
19513|NCT01946425|43498|P1|STARTED|Overall Study||30
19514|NCT01946412|43512|P1|NOT COMPLETED|Overall Study||5
19515|NCT01946412|43512|P1|COMPLETED|Overall Study||28
19516|NCT01946412|43512|P1|STARTED|Overall Study||33
19517|NCT01946243|43534|P1|NOT COMPLETED|Overall Study||0
19518|NCT01946243|43534|P1|COMPLETED|Overall Study||96
19519|NCT01946243|43534|P1|STARTED|Overall Study||96
19520|NCT01946178|43555|P1|NOT COMPLETED|Overall Study||2
19521|NCT01946178|43555|P1|COMPLETED|Overall Study||71
19522|NCT01946178|43555|P1|STARTED|Overall Study||73
19523|NCT01946126|43565|P2|NOT COMPLETED|Overall Study||0
19524|NCT01946126|43566|P1|NOT COMPLETED|Overall Study||0
19525|NCT01946126|43565|P2|COMPLETED|Overall Study||275
19526|NCT01946126|43566|P1|COMPLETED|Overall Study||184
19527|NCT01946126|43565|P2|STARTED|Overall Study||275
19528|NCT01946126|43566|P1|STARTED|Overall Study||184
19529|NCT01945970|43580|P6|NOT COMPLETED|Overall Study||0
19530|NCT01945970|43581|P5|NOT COMPLETED|Overall Study||0
19531|NCT01945970|43582|P4|NOT COMPLETED|Overall Study||0
19532|NCT01945970|43583|P3|NOT COMPLETED|Overall Study||0
19533|NCT01945970|43584|P2|NOT COMPLETED|Overall Study||0
19534|NCT01945970|43585|P1|NOT COMPLETED|Overall Study||0
19535|NCT01945970|43580|P6|COMPLETED|Overall Study||5
19536|NCT01945970|43581|P5|COMPLETED|Overall Study||5
19537|NCT01945970|43582|P4|COMPLETED|Overall Study||5
19538|NCT01945970|43583|P3|COMPLETED|Overall Study||5
19539|NCT01945970|43584|P2|COMPLETED|Overall Study||5
19540|NCT01945970|43585|P1|COMPLETED|Overall Study||5
19541|NCT01945970|43580|P6|STARTED|Overall Study||5
19542|NCT01945970|43581|P5|STARTED|Overall Study||5
19543|NCT01945970|43582|P4|STARTED|Overall Study||5
19544|NCT01945970|43583|P3|STARTED|Overall Study||5
19545|NCT01945970|43584|P2|STARTED|Overall Study||5
19546|NCT01945970|43585|P1|STARTED|Overall Study||5
19547|NCT01945944|43624|P2|NOT COMPLETED|Overall Study||3
19548|NCT01945944|43625|P1|NOT COMPLETED|Overall Study||1
19549|NCT01945944|43624|P2|COMPLETED|Overall Study||6
19550|NCT01945944|43625|P1|COMPLETED|Overall Study||8
19551|NCT01945944|43624|P2|STARTED|Overall Study||9
19552|NCT01945944|43625|P1|STARTED|Overall Study||9
19553|NCT01945294|43650|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
19554|NCT01945294|43651|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
19555|NCT01945294|43652|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
19556|NCT01945294|43653|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
19557|NCT01945294|43650|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
19558|NCT01945294|43651|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
19559|NCT01945294|43652|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
19560|NCT01945294|43653|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
19561|NCT01945294|43650|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
19562|NCT01945294|43651|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
19563|NCT01945294|43652|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
19564|NCT01945294|43653|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
19565|NCT01945294|43650|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19566|NCT01945294|43651|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19567|NCT01945294|43652|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19568|NCT01945294|43653|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
19569|NCT01945294|43650|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19570|NCT01945294|43651|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19571|NCT01945294|43652|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
19572|NCT01945294|43653|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
19573|NCT01945294|43650|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
19574|NCT01945294|43651|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
19575|NCT01945294|43652|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
19576|NCT01945294|43653|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
19577|NCT01945242|43684|P2|NOT COMPLETED|Overall Study||3
19578|NCT01945242|43685|P1|NOT COMPLETED|Overall Study||3
19579|NCT01945242|43684|P2|COMPLETED|Overall Study||120
19580|NCT01945242|43685|P1|COMPLETED|Overall Study||1248
19581|NCT01945242|43684|P2|STARTED|Overall Study||123
19582|NCT01945242|43685|P1|STARTED|Overall Study||1251
19583|NCT01945138|43699|P2|NOT COMPLETED|Overall Study||0
19584|NCT01945138|43700|P1|NOT COMPLETED|Overall Study||0
19585|NCT01945138|43699|P2|COMPLETED|Overall Study||7
19586|NCT01945138|43700|P1|COMPLETED|Overall Study||7
19587|NCT01945138|43699|P2|STARTED|Overall Study||7
19588|NCT01945138|43700|P1|STARTED|Overall Study||7
19589|NCT01945086|43737|P3|NOT COMPLETED|Overall Study||2
19590|NCT01945086|43738|P2|NOT COMPLETED|Overall Study||0
19591|NCT01945086|43739|P1|NOT COMPLETED|Overall Study||1
19592|NCT01945086|43737|P3|COMPLETED|Overall Study||26
19593|NCT01945086|43738|P2|COMPLETED|Overall Study||24
19594|NCT01945086|43739|P1|COMPLETED|Overall Study||26
19595|NCT01945086|43737|P3|STARTED|Overall Study||28
19596|NCT01945086|43738|P2|STARTED|Overall Study||24
19597|NCT01945086|43739|P1|STARTED|Overall Study||27
19598|NCT01945034|43783|P3|NOT COMPLETED|Overall Study||7
19599|NCT01945034|43784|P2|NOT COMPLETED|Overall Study||5
19600|NCT01945034|43785|P1|NOT COMPLETED|Overall Study||1
19601|NCT01945034|43783|P3|COMPLETED|Overall Study||145
19602|NCT01945034|43784|P2|COMPLETED|Overall Study||80
19603|NCT01945034|43785|P1|COMPLETED|Overall Study||66
19604|NCT01945034|43783|P3|STARTED|Overall Study||152
19605|NCT01945034|43784|P2|STARTED|Overall Study||85
19606|NCT01945034|43785|P1|STARTED|Overall Study||67
19607|NCT01945021|43835|P1|NOT COMPLETED|Overall Study||47
19608|NCT01945021|43835|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
19609|NCT01945021|43835|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
19610|NCT01945021|43835|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
19611|NCT01945021|43835|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
19612|NCT01945021|43835|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
19613|NCT01944969|43849|P1|NOT COMPLETED|Overall Study||26
19614|NCT01944969|43849|P1|COMPLETED|Overall Study||0
19615|NCT01944969|43849|P1|STARTED|Overall Study||26
19616|NCT01944878|43862|P2|NOT COMPLETED|Overall Study||0
19617|NCT01944878|43863|P1|NOT COMPLETED|Overall Study||0
19618|NCT01944878|43862|P2|COMPLETED|Overall Study||328
19619|NCT01944878|43863|P1|COMPLETED|Overall Study||127
19620|NCT01944878|43862|P2|STARTED|Overall Study||328
19621|NCT01944878|43863|P1|STARTED|Overall Study||127
19622|NCT01944774|43874|P3|NOT COMPLETED|Overall Study||8
19623|NCT01944774|43875|P2|NOT COMPLETED|Overall Study||8
19624|NCT01944774|43876|P1|NOT COMPLETED|Overall Study||6
19625|NCT01944774|43874|P3|COMPLETED|Overall Study||62
19626|NCT01944774|43875|P2|COMPLETED|Overall Study||60
19627|NCT01944774|43876|P1|COMPLETED|Overall Study||63
19628|NCT01944774|43874|P3|Received Treatment|Overall Study||70
19629|NCT01944774|43875|P2|Received Treatment|Overall Study||67
19630|NCT01944774|43876|P1|Received Treatment|Overall Study||68
19631|NCT01944774|43874|P3|STARTED|Overall Study||70
19632|NCT01944774|43875|P2|STARTED|Overall Study||68
19633|NCT01944774|43876|P1|STARTED|Overall Study||69
19634|NCT01944631|43919|P2|NOT COMPLETED|Overall Study||2
19635|NCT01944631|43920|P1|NOT COMPLETED|Overall Study||4
19636|NCT01944631|43919|P2|COMPLETED|Overall Study||98
19637|NCT01944631|43920|P1|COMPLETED|Overall Study||96
19638|NCT01944631|43919|P2|STARTED|Overall Study||100
19639|NCT01944631|43920|P1|STARTED|Overall Study||100
19640|NCT01944345|43936|P1|NOT COMPLETED|Overall Study||0
19641|NCT01944345|43936|P1|COMPLETED|Overall Study||69
19642|NCT01944345|43936|P1|STARTED|Overall Study||69
19643|NCT01944319|43944|P2|NOT COMPLETED|Overall Study||0
19644|NCT01944319|43945|P1|NOT COMPLETED|Overall Study||0
19645|NCT01944319|43944|P2|COMPLETED|Overall Study||39
19646|NCT01944319|43945|P1|COMPLETED|Overall Study||40
19647|NCT01944319|43944|P2|STARTED|Overall Study||39
19648|NCT01944319|43945|P1|STARTED|Overall Study||40
19649|NCT01944059|43955|P1|NOT COMPLETED|Overall Study||7
19650|NCT01944059|43955|P1|COMPLETED|Overall Study||24
19651|NCT01944059|43955|P1|STARTED|Overall Study||31
19652|NCT01943864|43964|P1|NOT COMPLETED|Overall Study||0
19653|NCT01943864|43964|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
19654|NCT01943864|43964|P1|STARTED|Overall Study||20
19655|NCT01943552|43994|P2|NOT COMPLETED|Overall Study||25
19656|NCT01943552|43995|P1|NOT COMPLETED|Overall Study||25
19657|NCT01943552|43994|P2|COMPLETED|Overall Study||69
19658|NCT01943552|43995|P1|COMPLETED|Overall Study||71
19659|NCT01943552|43994|P2|STARTED|Overall Study||94
19660|NCT01943552|43995|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
19661|NCT01943344|44011|P1|NOT COMPLETED|Overall Study||3
19662|NCT01943344|44011|P1|COMPLETED|Overall Study||9
19663|NCT01943344|44011|P1|STARTED|Overall Study||12
19664|NCT01943292|44018|P3|NOT COMPLETED|Overall Study||0
19665|NCT01943292|44019|P2|NOT COMPLETED|Overall Study||0
19666|NCT01943292|44020|P1|NOT COMPLETED|Overall Study||1
19667|NCT01943292|44018|P3|COMPLETED|Overall Study||3
19668|NCT01943292|44019|P2|COMPLETED|Overall Study||3
19669|NCT01943292|44020|P1|COMPLETED|Overall Study||2
19670|NCT01943292|44018|P3|Completed Follow-Up|Overall Study||3
19671|NCT01943292|44019|P2|Completed Follow-Up|Overall Study||3
19672|NCT01943292|44020|P1|Completed Follow-Up|Overall Study||2
19673|NCT01943292|44018|P3|Completed Treatment|Overall Study||3
19674|NCT01943292|44019|P2|Completed Treatment|Overall Study||3
19675|NCT01943292|44020|P1|Completed Treatment|Overall Study||3
19676|NCT01943292|44018|P3|Completed Cycle 1|Overall Study||3
19677|NCT01943292|44019|P2|Completed Cycle 1|Overall Study||3
19678|NCT01943292|44020|P1|Completed Cycle 1|Overall Study||3
19679|NCT01943292|44018|P3|STARTED|Overall Study||3
19680|NCT01943292|44019|P2|STARTED|Overall Study||3
19681|NCT01943292|44020|P1|STARTED|Overall Study||3
19682|NCT01943110|44031|P1|NOT COMPLETED|Overall Study||0
19683|NCT01943110|44031|P1|COMPLETED|Overall Study||30
19684|NCT01943110|44031|P1|STARTED|Overall Study||30
19685|NCT01942785|44047|P1|NOT COMPLETED|Overall Study||4
19686|NCT01942785|44047|P1|COMPLETED|Overall Study||50
19687|NCT01942785|44047|P1|STARTED|Overall Study||54
19688|NCT01942733|44076|P1|NOT COMPLETED|Overall Study||3
19689|NCT01942733|44076|P1|COMPLETED|Overall Study||41
19690|NCT01942733|44076|P1|STARTED|Overall Study||44
19691|NCT01942135|44107|P2|NOT COMPLETED|Overall Study||174
19692|NCT01942135|44108|P1|NOT COMPLETED|Overall Study||347
19693|NCT01942135|44107|P2|COMPLETED|Overall Study||0
19694|NCT01942135|44108|P1|COMPLETED|Overall Study||0
19695|NCT01942135|44107|P2|STARTED|Overall Study||174
19696|NCT01942135|44108|P1|STARTED|Overall Study||347
19697|NCT01941940|44145|P1|NOT COMPLETED|Overall Study||50
19698|NCT01941940|44145|P1|COMPLETED|Overall Study||177
19699|NCT01941940|44145|P1|STARTED|Overall Study||227
19700|NCT01941615|44155|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
19701|NCT01941615|44155|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
19702|NCT01941615|44155|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
19703|NCT01941615|44155|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
19704|NCT01941615|44155|P1|COMPLETED|Reference Treatment: Microgynon®||0
19705|NCT01941615|44155|P1|STARTED|Reference Treatment: Microgynon®||0
19706|NCT01941615|44155|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
19707|NCT01941615|44155|P1|COMPLETED|Run in Treatment: Microgynon®||16
19708|NCT01941615|44155|P1|STARTED|Run in Treatment: Microgynon®||16
19709|NCT01941498|44164|P1|NOT COMPLETED|Overall Study||1
19710|NCT01941498|44164|P1|COMPLETED|Overall Study||96
19711|NCT01941498|44164|P1|STARTED|Overall Study||97
19712|NCT01941485|44210|P1|NOT COMPLETED|Overall Study||0
19713|NCT01941485|44210|P1|COMPLETED|Overall Study||59
19714|NCT01941485|44210|P1|STARTED|Overall Study||59
19715|NCT01941186|44278|P2|NOT COMPLETED|Follow-up||0
19716|NCT01941186|44279|P1|NOT COMPLETED|Follow-up||1
19717|NCT01941186|44278|P2|COMPLETED|Follow-up||33
19718|NCT01941186|44279|P1|COMPLETED|Follow-up||30
19719|NCT01941186|44278|P2|STARTED|Follow-up||33
19720|NCT01941186|44279|P1|STARTED|Follow-up||31
19721|NCT01941186|44278|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
19722|NCT01941186|44279|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
19723|NCT01941186|44278|P2|COMPLETED|Randomization/Allocation to Study Group||33
19724|NCT01941186|44279|P1|COMPLETED|Randomization/Allocation to Study Group||31
19725|NCT01941186|44278|P2|STARTED|Randomization/Allocation to Study Group||33
19726|NCT01941186|44279|P1|STARTED|Randomization/Allocation to Study Group||31
19727|NCT01940510|44305|P1|NOT COMPLETED|Overall Study||0
19728|NCT01940510|44305|P1|COMPLETED|Overall Study||24
19729|NCT01940510|44305|P1|STARTED|Overall Study||24
19730|NCT01940484|44336|P1|NOT COMPLETED|Overall Study||10
19731|NCT01940484|44336|P1|COMPLETED|Overall Study||88
19732|NCT01940484|44336|P1|STARTED|Overall Study||98
19733|NCT01940146|44358|P4|NOT COMPLETED|Overall Study||2
19734|NCT01940146|44359|P3|NOT COMPLETED|Overall Study||1
19735|NCT01940146|44360|P2|NOT COMPLETED|Overall Study||0
19736|NCT01940146|44361|P1|NOT COMPLETED|Overall Study||1
19737|NCT01940146|44358|P4|COMPLETED|Overall Study||53
19738|NCT01940146|44359|P3|COMPLETED|Overall Study||55
19739|NCT01940146|44360|P2|COMPLETED|Overall Study||55
19740|NCT01940146|44361|P1|COMPLETED|Overall Study||55
19741|NCT01940146|44358|P4|STARTED|Overall Study||55
19742|NCT01940146|44359|P3|STARTED|Overall Study||56
19743|NCT01940146|44360|P2|STARTED|Overall Study||55
19744|NCT01940146|44361|P1|STARTED|Overall Study||56
19745|NCT01940120|44371|P1|NOT COMPLETED|Overall Study||44
19746|NCT01940120|44371|P1|COMPLETED|Overall Study||34
19747|NCT01940120|44371|P1|STARTED|Overall Study||78
19748|NCT01939548|44495|P3|NOT COMPLETED|Overall Study||30
19749|NCT01939548|44496|P2|NOT COMPLETED|Overall Study||49
19750|NCT01939548|44497|P1|NOT COMPLETED|Overall Study||37
19751|NCT01939548|44495|P3|COMPLETED|Overall Study||50
19752|NCT01939548|44496|P2|COMPLETED|Overall Study||33
19753|NCT01939548|44497|P1|COMPLETED|Overall Study||41
19754|NCT01939548|44495|P3|STARTED|Overall Study||80
19755|NCT01939548|44496|P2|STARTED|Overall Study||82
19756|NCT01939548|44497|P1|STARTED|Overall Study||78
19757|NCT01939496|44571|P3|NOT COMPLETED|Overall Study||2
19758|NCT01939496|44572|P2|NOT COMPLETED|Overall Study||3
19759|NCT01939496|44573|P1|NOT COMPLETED|Overall Study||9
19760|NCT01939496|44571|P3|COMPLETED|Overall Study||54
19761|NCT01939496|44572|P2|COMPLETED|Overall Study||54
19762|NCT01939496|44573|P1|COMPLETED|Overall Study||47
19763|NCT01939496|44571|P3|STARTED|Overall Study||56
19764|NCT01939496|44572|P2|STARTED|Overall Study||57
19765|NCT01939496|44573|P1|STARTED|Overall Study||56
19766|NCT01939314|44625|P2|NOT COMPLETED|Overall Study||8
19767|NCT01939314|44626|P1|NOT COMPLETED|Overall Study||9
19768|NCT01939314|44625|P2|COMPLETED|Overall Study||40
19769|NCT01939314|44626|P1|COMPLETED|Overall Study||36
19770|NCT01939314|44625|P2|24 Hour Endpoint|Overall Study||40
19771|NCT01939314|44626|P1|24 Hour Endpoint|Overall Study||36
19772|NCT01939314|44625|P2|15 Minute Endpoint|Overall Study||46
19773|NCT01939314|44626|P1|15 Minute Endpoint|Overall Study||41
19774|NCT01939314|44625|P2|STARTED|Overall Study||48
19775|NCT01939314|44626|P1|STARTED|Overall Study||45
19776|NCT01939145|44638|P2|NOT COMPLETED|Overall Study||7
19777|NCT01939145|44639|P1|NOT COMPLETED|Overall Study||2
19778|NCT01939145|44638|P2|COMPLETED|Overall Study||44
19779|NCT01939145|44639|P1|COMPLETED|Overall Study||47
19780|NCT01939145|44638|P2|STARTED|Overall Study||51
19781|NCT01939145|44639|P1|STARTED|Overall Study||49
19782|NCT01939002|44649|P2|NOT COMPLETED|Overall Study||18
19783|NCT01939002|44650|P1|NOT COMPLETED|Overall Study||19
19784|NCT01939002|44649|P2|COMPLETED|Overall Study||80
19785|NCT01939002|44650|P1|COMPLETED|Overall Study||84
19786|NCT01939002|44649|P2|STARTED|Overall Study||98
19787|NCT01939002|44650|P1|STARTED|Overall Study||103
19788|NCT01938989|44716|P2|NOT COMPLETED|Overall Study||0
19789|NCT01938989|44717|P1|NOT COMPLETED|Overall Study||0
19790|NCT01938989|44716|P2|COMPLETED|Overall Study||77
19791|NCT01938989|44717|P1|COMPLETED|Overall Study||77
19792|NCT01938989|44716|P2|STARTED|Overall Study||77
19793|NCT01938989|44717|P1|STARTED|Overall Study||77
19794|NCT01938430|44737|P14|NOT COMPLETED|Overall Study||1
19795|NCT01938430|44738|P13|NOT COMPLETED|Overall Study||0
19796|NCT01938430|44739|P12|NOT COMPLETED|Overall Study||1
19797|NCT01938430|44740|P11|NOT COMPLETED|Overall Study||3
19798|NCT01938430|44741|P10|NOT COMPLETED|Overall Study||3
19799|NCT01938430|44742|P9|NOT COMPLETED|Overall Study||4
19800|NCT01938430|44743|P8|NOT COMPLETED|Overall Study||1
19801|NCT01938430|44744|P7|NOT COMPLETED|Overall Study||2
19802|NCT01938430|44745|P6|NOT COMPLETED|Overall Study||1
19803|NCT01938430|44746|P5|NOT COMPLETED|Overall Study||0
19804|NCT01938430|44747|P4|NOT COMPLETED|Overall Study||2
19805|NCT01938430|44748|P3|NOT COMPLETED|Overall Study||5
19806|NCT01938430|44749|P2|NOT COMPLETED|Overall Study||3
19807|NCT01938430|44750|P1|NOT COMPLETED|Overall Study||4
19808|NCT01938430|44737|P14|COMPLETED|Overall Study||2
19809|NCT01938430|44738|P13|COMPLETED|Overall Study||4
19810|NCT01938430|44739|P12|COMPLETED|Overall Study||3
19811|NCT01938430|44740|P11|COMPLETED|Overall Study||3
19812|NCT01938430|44741|P10|COMPLETED|Overall Study||23
19813|NCT01938430|44742|P9|COMPLETED|Overall Study||22
19814|NCT01938430|44743|P8|COMPLETED|Overall Study||24
19815|NCT01938430|44744|P7|COMPLETED|Overall Study||24
19816|NCT01938430|44745|P6|COMPLETED|Overall Study||55
19817|NCT01938430|44746|P5|COMPLETED|Overall Study||55
19818|NCT01938430|44747|P4|COMPLETED|Overall Study||24
19819|NCT01938430|44748|P3|COMPLETED|Overall Study||18
19820|NCT01938430|44749|P2|COMPLETED|Overall Study||26
19821|NCT01938430|44750|P1|COMPLETED|Overall Study||26
19822|NCT01938430|44737|P14|STARTED|Overall Study||3
19823|NCT01938430|44738|P13|STARTED|Overall Study||4
19824|NCT01938430|44739|P12|STARTED|Overall Study||4
19825|NCT01938430|44740|P11|STARTED|Overall Study||6
19826|NCT01938430|44741|P10|STARTED|Overall Study||26
19827|NCT01938430|44742|P9|STARTED|Overall Study||26
19828|NCT01938430|44743|P8|STARTED|Overall Study||25
19829|NCT01938430|44744|P7|STARTED|Overall Study||26
19830|NCT01938430|44745|P6|STARTED|Overall Study||56
19831|NCT01938430|44746|P5|STARTED|Overall Study||55
19832|NCT01938430|44747|P4|STARTED|Overall Study||26
19833|NCT01938430|44748|P3|STARTED|Overall Study||23
19834|NCT01938430|44749|P2|STARTED|Overall Study||29
19835|NCT01938430|44750|P1|STARTED|Overall Study||30
19836|NCT01938170|45075|P1|NOT COMPLETED|Overall Study||0
19837|NCT01938170|45075|P1|COMPLETED|Overall Study||41
19838|NCT01938170|45075|P1|STARTED|Overall Study||41
19839|NCT01938079|45082|P2|NOT COMPLETED|Overall Study||0
19840|NCT01938079|45083|P1|NOT COMPLETED|Overall Study||0
19841|NCT01938079|45082|P2|COMPLETED|Overall Study||10
19842|NCT01938079|45083|P1|COMPLETED|Overall Study||10
19843|NCT01938079|45082|P2|STARTED|Overall Study||10
19844|NCT01938079|45083|P1|STARTED|Overall Study||10
19845|NCT01938066|45091|P2|NOT COMPLETED|Overall Study||2
19846|NCT01938066|45092|P1|NOT COMPLETED|Overall Study||1
19847|NCT01938066|45091|P2|COMPLETED|Overall Study||13
19848|NCT01938066|45092|P1|COMPLETED|Overall Study||14
19849|NCT01938066|45091|P2|STARTED|Overall Study||15
19850|NCT01938066|45092|P1|STARTED|Overall Study||15
19851|NCT01938040|45102|P2|NOT COMPLETED|Overall Study||0
19852|NCT01938040|45103|P1|NOT COMPLETED|Overall Study||0
19853|NCT01938040|45102|P2|COMPLETED|Overall Study||27
19854|NCT01938040|45103|P1|COMPLETED|Overall Study||28
19855|NCT01938040|45102|P2|Behavior Metrics|Overall Study||27
19856|NCT01938040|45103|P1|Behavior Metrics|Overall Study||28
19857|NCT01938040|45102|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
19858|NCT01938040|45103|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
19859|NCT01938040|45102|P2|STARTED|Overall Study||27
19860|NCT01938040|45103|P1|STARTED|Overall Study||28
19861|NCT01937975|45132|P3|NOT COMPLETED|Overall Study||0
19862|NCT01937975|45133|P2|NOT COMPLETED|Overall Study||0
19863|NCT01937975|45134|P1|NOT COMPLETED|Overall Study||0
19864|NCT01937975|45132|P3|COMPLETED|Overall Study||8
19865|NCT01937975|45133|P2|COMPLETED|Overall Study||8
19866|NCT01937975|45134|P1|COMPLETED|Overall Study||8
19867|NCT01937975|45132|P3|STARTED|Overall Study||8
19868|NCT01937975|45133|P2|STARTED|Overall Study||8
19869|NCT01937975|45134|P1|STARTED|Overall Study||8
19870|NCT01937871|45184|P3|NOT COMPLETED|Overall Study||11
19871|NCT01937871|45185|P2|NOT COMPLETED|Overall Study||17
19872|NCT01937871|45186|P1|NOT COMPLETED|Overall Study||24
19873|NCT01937871|45184|P3|COMPLETED|Overall Study||174
19874|NCT01937871|45185|P2|COMPLETED|Overall Study||346
19875|NCT01937871|45186|P1|COMPLETED|Overall Study||337
19876|NCT01937871|45184|P3|Received at Least One Dose of Study Drug|Overall Study||185
19877|NCT01937871|45185|P2|Received at Least One Dose of Study Drug|Overall Study||362
19878|NCT01937871|45186|P1|Received at Least One Dose of Study Drug|Overall Study||361
19879|NCT01937871|45184|P3|STARTED|Overall Study||185
19880|NCT01937871|45185|P2|STARTED|Overall Study||363
19881|NCT01937871|45186|P1|STARTED|Overall Study||361
19882|NCT01937715|45262|P5|NOT COMPLETED|Overall Study||2
19883|NCT01937715|45263|P4|NOT COMPLETED|Overall Study||4
19884|NCT01937715|45264|P3|NOT COMPLETED|Overall Study||0
19885|NCT01937715|45265|P2|NOT COMPLETED|Overall Study||1
19886|NCT01937715|45266|P1|NOT COMPLETED|Overall Study||0
19887|NCT01937715|45262|P5|COMPLETED|Overall Study||1
19888|NCT01937715|45263|P4|COMPLETED|Overall Study||1
19889|NCT01937715|45264|P3|COMPLETED|Overall Study||3
19890|NCT01937715|45265|P2|COMPLETED|Overall Study||3
19891|NCT01937715|45266|P1|COMPLETED|Overall Study||3
19892|NCT01937715|45262|P5|STARTED|Overall Study||3
19893|NCT01937715|45263|P4|STARTED|Overall Study||5
19894|NCT01937715|45264|P3|STARTED|Overall Study||3
19895|NCT01937715|45265|P2|STARTED|Overall Study||4
19896|NCT01937715|45266|P1|STARTED|Overall Study||3
19897|NCT01937598|45388|P2|NOT COMPLETED|Overall Study||0
19898|NCT01937598|45389|P1|NOT COMPLETED|Overall Study||0
19899|NCT01937598|45388|P2|COMPLETED|Overall Study||8
19900|NCT01937598|45389|P1|COMPLETED|Overall Study||8
19901|NCT01937598|45388|P2|STARTED|Overall Study||8
19902|NCT01937598|45389|P1|STARTED|Overall Study||8
19903|NCT01937520|45413|P2|NOT COMPLETED|Overall Study||0
19904|NCT01937520|45414|P1|NOT COMPLETED|Overall Study||0
19905|NCT01937520|45413|P2|COMPLETED|Overall Study||9
19906|NCT01937520|45414|P1|COMPLETED|Overall Study||11
19907|NCT01937520|45413|P2|STARTED|Overall Study||9
19908|NCT01937520|45414|P1|STARTED|Overall Study||11
19909|NCT01937312|45452|P2|NOT COMPLETED|Overall Study||3
19910|NCT01937312|45453|P1|NOT COMPLETED|Overall Study||11
19911|NCT01937312|45452|P2|COMPLETED|Overall Study||92
19912|NCT01937312|45453|P1|COMPLETED|Overall Study||83
19913|NCT01937312|45452|P2|Treated|Overall Study||95
19914|NCT01937312|45453|P1|Treated|Overall Study||93
19915|NCT01937312|45452|P2|STARTED|Overall Study||95
19916|NCT01937312|45453|P1|STARTED|Overall Study||94
19917|NCT01937299|45468|P2|NOT COMPLETED|Overall Study||4
19918|NCT01937299|45469|P1|NOT COMPLETED|Overall Study||14
19919|NCT01937299|45468|P2|COMPLETED|Overall Study||112
19920|NCT01937299|45469|P1|COMPLETED|Overall Study||103
19921|NCT01937299|45468|P2|STARTED|Overall Study||116
19922|NCT01937299|45469|P1|STARTED|Overall Study||117
19923|NCT01937130|45484|P4|NOT COMPLETED|Overall Study||2
19924|NCT01937130|45485|P3|NOT COMPLETED|Overall Study||3
19925|NCT01937130|45486|P2|NOT COMPLETED|Overall Study||4
19926|NCT01937130|45487|P1|NOT COMPLETED|Overall Study||5
19927|NCT01937130|45484|P4|COMPLETED|Overall Study||2
19928|NCT01937130|45485|P3|COMPLETED|Overall Study||2
19929|NCT01937130|45486|P2|COMPLETED|Overall Study||3
19930|NCT01937130|45487|P1|COMPLETED|Overall Study||0
19931|NCT01937130|45484|P4|STARTED|Overall Study||4
19932|NCT01937130|45485|P3|STARTED|Overall Study||5
19933|NCT01937130|45486|P2|STARTED|Overall Study||7
19934|NCT01937130|45487|P1|STARTED|Overall Study||5
19935|NCT01936181|45516|P4|NOT COMPLETED|Transition-extension||5
19936|NCT01936181|45517|P3|NOT COMPLETED|Transition-extension||6
19937|NCT01936181|45518|P2|NOT COMPLETED|Transition-extension||0
19938|NCT01936181|45519|P1|NOT COMPLETED|Transition-extension||15
19939|NCT01936181|45516|P4|COMPLETED|Transition-extension||96
19940|NCT01936181|45517|P3|COMPLETED|Transition-extension||88
19941|NCT01936181|45518|P2|COMPLETED|Transition-extension||0
19942|NCT01936181|45519|P1|COMPLETED|Transition-extension||186
19943|NCT01936181|45516|P4|STARTED|Transition-extension||101
19944|NCT01936181|45517|P3|STARTED|Transition-extension||94
19945|NCT01936181|45518|P2|STARTED|Transition-extension||0
19946|NCT01936181|45519|P1|STARTED|Transition-extension||201
19947|NCT01936181|45516|P4|NOT COMPLETED|Randomised, Double-blind||0
19948|NCT01936181|45517|P3|NOT COMPLETED|Randomised, Double-blind||0
19949|NCT01936181|45518|P2|NOT COMPLETED|Randomised, Double-blind||68
19950|NCT01936181|45519|P1|NOT COMPLETED|Randomised, Double-blind||64
19951|NCT01936181|45516|P4|COMPLETED|Randomised, Double-blind||0
19952|NCT01936181|45517|P3|COMPLETED|Randomised, Double-blind||0
19953|NCT01936181|45518|P2|COMPLETED|Randomised, Double-blind||225
19954|NCT01936181|45519|P1|COMPLETED|Randomised, Double-blind||227
19955|NCT01936181|45516|P4|STARTED|Randomised, Double-blind||0
19956|NCT01936181|45517|P3|STARTED|Randomised, Double-blind||0
19957|NCT01936181|45518|P2|STARTED|Randomised, Double-blind||293
19958|NCT01936181|45519|P1|STARTED|Randomised, Double-blind||291
19959|NCT01936896|45530|P1|NOT COMPLETED|Overall Study||0
19960|NCT01936896|45530|P1|COMPLETED|Overall Study||10
19961|NCT01936896|45530|P1|STARTED|Overall Study||10
19962|NCT01936844|45537|P2|NOT COMPLETED|Overall Study||7
19963|NCT01936844|45538|P1|NOT COMPLETED|Overall Study||6
19964|NCT01936844|45537|P2|COMPLETED|Overall Study||8
19965|NCT01936844|45538|P1|COMPLETED|Overall Study||9
19966|NCT01936844|45537|P2|STARTED|Overall Study||15
19967|NCT01936844|45538|P1|STARTED|Overall Study||15
19968|NCT01936662|45550|P2|NOT COMPLETED|Overall Study||0
19969|NCT01936662|45551|P1|NOT COMPLETED|Overall Study||0
19970|NCT01936662|45550|P2|COMPLETED|Overall Study||42
19971|NCT01936662|45551|P1|COMPLETED|Overall Study||42
19972|NCT01936662|45550|P2|STARTED|Overall Study||42
19973|NCT01936662|45551|P1|STARTED|Overall Study||42
19974|NCT01936649|45559|P1|NOT COMPLETED|Overall Study||13
19975|NCT01936649|45559|P1|COMPLETED|Overall Study||50
19976|NCT01936649|45559|P1|Treated|Overall Study||51
19977|NCT01936649|45559|P1|STARTED|Overall Study||63
19978|NCT01936389|45566|P2|NOT COMPLETED|Overall Study||0
19979|NCT01936389|45567|P1|NOT COMPLETED|Overall Study||1
19980|NCT01936389|45566|P2|COMPLETED|Overall Study||5
19981|NCT01936389|45567|P1|COMPLETED|Overall Study||4
19982|NCT01936389|45566|P2|STARTED|Overall Study||5
19983|NCT01936389|45567|P1|STARTED|Overall Study||5
19984|NCT01935622|45576|P3|NOT COMPLETED|Overall Study||0
19985|NCT01935622|45577|P2|NOT COMPLETED|Overall Study||2
19986|NCT01935622|45578|P1|NOT COMPLETED|Overall Study||2
19987|NCT01935622|45576|P3|COMPLETED|Overall Study||4
19988|NCT01935622|45577|P2|COMPLETED|Overall Study||1
19989|NCT01935622|45578|P1|COMPLETED|Overall Study||1
19990|NCT01935622|45576|P3|STARTED|Overall Study||4
19991|NCT01935622|45577|P2|STARTED|Overall Study||3
19992|NCT01935622|45578|P1|STARTED|Overall Study||3
19993|NCT01934790|45586|P1|NOT COMPLETED|Overall Study||16
19994|NCT01934790|45586|P1|COMPLETED|Overall Study||29
19995|NCT01934790|45586|P1|Participants Received Study Treatment|Overall Study||44
19996|NCT01934790|45586|P1|STARTED|Overall Study|Eligible for treatment|45
19997|NCT01934582|45606|P1|NOT COMPLETED|Overall Study||0
19998|NCT01934582|45606|P1|COMPLETED|Overall Study||13
19999|NCT01934582|45606|P1|STARTED|Overall Study||13
20000|NCT01934517|45620|P1|NOT COMPLETED|Overall Study||0
20001|NCT01934517|45620|P1|COMPLETED|Overall Study||25
20002|NCT01934517|45620|P1|STARTED|Overall Study||25
20003|NCT01934504|45632|P4|NOT COMPLETED|Overall Study||7
20004|NCT01934504|45633|P3|NOT COMPLETED|Overall Study||5
20005|NCT01934504|45634|P2|NOT COMPLETED|Overall Study||0
20006|NCT01934504|45635|P1|NOT COMPLETED|Overall Study||1
20007|NCT01934504|45632|P4|COMPLETED|Overall Study||1
20008|NCT01934504|45633|P3|COMPLETED|Overall Study||11
20009|NCT01934504|45634|P2|COMPLETED|Overall Study||3
20010|NCT01934504|45635|P1|COMPLETED|Overall Study||5
20011|NCT01934504|45632|P4|STARTED|Overall Study||8
20012|NCT01934504|45633|P3|STARTED|Overall Study||16
20013|NCT01934504|45634|P2|STARTED|Overall Study||3
20014|NCT01934504|45635|P1|STARTED|Overall Study||6
20015|NCT01934231|45657|P1|NOT COMPLETED|Overall Study||0
20016|NCT01934231|45657|P1|COMPLETED|Overall Study||27
20017|NCT01934231|45657|P1|STARTED|Overall Study||27
20018|NCT01933880|45668|P2|NOT COMPLETED|Overall Study||1
20019|NCT01933880|45669|P1|NOT COMPLETED|Overall Study||30
20020|NCT01933880|45668|P2|COMPLETED|Overall Study||40
20021|NCT01933880|45669|P1|COMPLETED|Overall Study||123
20022|NCT01933880|45668|P2|STARTED|Overall Study||41
20023|NCT01933880|45669|P1|STARTED|Overall Study||153
20024|NCT01933776|45736|P2|NOT COMPLETED|Overall Study||0
20025|NCT01933776|45737|P1|NOT COMPLETED|Overall Study||0
20026|NCT01933776|45736|P2|COMPLETED|Overall Study||20
20027|NCT01933776|45737|P1|COMPLETED|Overall Study||20
20028|NCT01933776|45736|P2|STARTED|Overall Study||20
20029|NCT01933776|45737|P1|STARTED|Overall Study||20
20030|NCT01933672|45745|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
20031|NCT01933672|45746|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
20032|NCT01933672|45747|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
20033|NCT01933672|45748|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
20034|NCT01933672|45749|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
20035|NCT01933672|45750|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
20036|NCT01933672|45751|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
20037|NCT01933672|45745|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
20038|NCT01933672|45746|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
20039|NCT01933672|45747|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
20040|NCT01933672|45748|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
20041|NCT01933672|45749|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
20042|NCT01933672|45750|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
20043|NCT01933672|45751|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
20044|NCT01933672|45745|P7|STARTED|Third Intervention Period (12-16 Days)||6
20045|NCT01933672|45746|P6|STARTED|Third Intervention Period (12-16 Days)||4
20046|NCT01933672|45747|P5|STARTED|Third Intervention Period (12-16 Days)||6
20047|NCT01933672|45748|P4|STARTED|Third Intervention Period (12-16 Days)||5
20048|NCT01933672|45749|P3|STARTED|Third Intervention Period (12-16 Days)||1
20049|NCT01933672|45750|P2|STARTED|Third Intervention Period (12-16 Days)||6
20050|NCT01933672|45751|P1|STARTED|Third Intervention Period (12-16 Days)||0
20051|NCT01933672|45745|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20052|NCT01933672|45746|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20053|NCT01933672|45747|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20054|NCT01933672|45748|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20055|NCT01933672|45749|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20056|NCT01933672|45750|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20057|NCT01933672|45751|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
20058|NCT01933672|45745|P7|COMPLETED|Second Washout Period (7-14 Days)||6
20059|NCT01933672|45746|P6|COMPLETED|Second Washout Period (7-14 Days)||4
20060|NCT01933672|45747|P5|COMPLETED|Second Washout Period (7-14 Days)||6
20061|NCT01933672|45748|P4|COMPLETED|Second Washout Period (7-14 Days)||5
20062|NCT01933672|45749|P3|COMPLETED|Second Washout Period (7-14 Days)||1
20063|NCT01933672|45750|P2|COMPLETED|Second Washout Period (7-14 Days)||6
20064|NCT01933672|45751|P1|COMPLETED|Second Washout Period (7-14 Days)||0
20065|NCT01933672|45745|P7|STARTED|Second Washout Period (7-14 Days)||6
20066|NCT01933672|45746|P6|STARTED|Second Washout Period (7-14 Days)||4
20067|NCT01933672|45747|P5|STARTED|Second Washout Period (7-14 Days)||6
20068|NCT01933672|45748|P4|STARTED|Second Washout Period (7-14 Days)||5
20069|NCT01933672|45749|P3|STARTED|Second Washout Period (7-14 Days)||1
20070|NCT01933672|45750|P2|STARTED|Second Washout Period (7-14 Days)||6
20071|NCT01933672|45751|P1|STARTED|Second Washout Period (7-14 Days)||0
20072|NCT01933672|45745|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
20073|NCT01933672|45746|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
20074|NCT01933672|45747|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
20075|NCT01933672|45748|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
20076|NCT01933672|45749|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
20077|NCT01933672|45750|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
20078|NCT01933672|45751|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
20079|NCT01933672|45745|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
20080|NCT01933672|45746|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
20081|NCT01933672|45747|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
20082|NCT01933672|45748|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
20083|NCT01933672|45749|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
20084|NCT01933672|45750|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
20085|NCT01933672|45751|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
20086|NCT01933672|45745|P7|STARTED|Second Intervention Period (12-16 Days)||6
20087|NCT01933672|45746|P6|STARTED|Second Intervention Period (12-16 Days)||4
20088|NCT01933672|45747|P5|STARTED|Second Intervention Period (12-16 Days)||6
20089|NCT01933672|45748|P4|STARTED|Second Intervention Period (12-16 Days)||5
20090|NCT01933672|45749|P3|STARTED|Second Intervention Period (12-16 Days)||2
20091|NCT01933672|45750|P2|STARTED|Second Intervention Period (12-16 Days)||7
20092|NCT01933672|45751|P1|STARTED|Second Intervention Period (12-16 Days)||0
20093|NCT01933672|45745|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
20094|NCT01933672|45746|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
20095|NCT01933672|45747|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
20096|NCT01933672|45748|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
20097|NCT01933672|45749|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
20098|NCT01933672|45750|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
20099|NCT01933672|45751|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
20100|NCT01933672|45745|P7|COMPLETED|First Washout Period (7-14 Days)||6
20101|NCT01933672|45746|P6|COMPLETED|First Washout Period (7-14 Days)||4
20102|NCT01933672|45747|P5|COMPLETED|First Washout Period (7-14 Days)||6
20103|NCT01933672|45748|P4|COMPLETED|First Washout Period (7-14 Days)||5
20104|NCT01933672|45749|P3|COMPLETED|First Washout Period (7-14 Days)||2
20105|NCT01933672|45750|P2|COMPLETED|First Washout Period (7-14 Days)||7
20106|NCT01933672|45751|P1|COMPLETED|First Washout Period (7-14 Days)||0
20107|NCT01933672|45745|P7|STARTED|First Washout Period (7-14 Days)||6
20108|NCT01933672|45746|P6|STARTED|First Washout Period (7-14 Days)||4
20109|NCT01933672|45747|P5|STARTED|First Washout Period (7-14 Days)||6
20110|NCT01933672|45748|P4|STARTED|First Washout Period (7-14 Days)||5
20111|NCT01933672|45749|P3|STARTED|First Washout Period (7-14 Days)||2
20112|NCT01933672|45750|P2|STARTED|First Washout Period (7-14 Days)||7
20113|NCT01933672|45751|P1|STARTED|First Washout Period (7-14 Days)||0
20114|NCT01933672|45745|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
20115|NCT01933672|45746|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
20116|NCT01933672|45747|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
20117|NCT01933672|45748|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
20118|NCT01933672|45749|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
20119|NCT01933672|45750|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
20120|NCT01933672|45751|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
20121|NCT01933672|45745|P7|COMPLETED|First Intervention Period (12-16 Days)||6
20122|NCT01933672|45746|P6|COMPLETED|First Intervention Period (12-16 Days)||4
20123|NCT01933672|45747|P5|COMPLETED|First Intervention Period (12-16 Days)||6
20124|NCT01933672|45748|P4|COMPLETED|First Intervention Period (12-16 Days)||5
20125|NCT01933672|45749|P3|COMPLETED|First Intervention Period (12-16 Days)||2
20126|NCT01933672|45750|P2|COMPLETED|First Intervention Period (12-16 Days)||7
20127|NCT01933672|45751|P1|COMPLETED|First Intervention Period (12-16 Days)||0
20128|NCT01933672|45745|P7|STARTED|First Intervention Period (12-16 Days)||6
20129|NCT01933672|45746|P6|STARTED|First Intervention Period (12-16 Days)||5
20130|NCT01933672|45747|P5|STARTED|First Intervention Period (12-16 Days)||7
20131|NCT01933672|45748|P4|STARTED|First Intervention Period (12-16 Days)||5
20132|NCT01933672|45749|P3|STARTED|First Intervention Period (12-16 Days)||3
20133|NCT01933672|45750|P2|STARTED|First Intervention Period (12-16 Days)||7
20134|NCT01933672|45751|P1|STARTED|First Intervention Period (12-16 Days)||0
20135|NCT01933672|45745|P7|NOT COMPLETED|Metformin Run-in Period||0
20136|NCT01933672|45746|P6|NOT COMPLETED|Metformin Run-in Period||0
20137|NCT01933672|45747|P5|NOT COMPLETED|Metformin Run-in Period||0
20138|NCT01933672|45748|P4|NOT COMPLETED|Metformin Run-in Period||0
20139|NCT01933672|45749|P3|NOT COMPLETED|Metformin Run-in Period||0
20140|NCT01933672|45750|P2|NOT COMPLETED|Metformin Run-in Period||0
20141|NCT01933672|45751|P1|NOT COMPLETED|Metformin Run-in Period||10
20142|NCT01933672|45745|P7|COMPLETED|Metformin Run-in Period||0
20143|NCT01933672|45746|P6|COMPLETED|Metformin Run-in Period||0
20144|NCT01933672|45747|P5|COMPLETED|Metformin Run-in Period||0
20145|NCT01933672|45748|P4|COMPLETED|Metformin Run-in Period||0
20146|NCT01933672|45749|P3|COMPLETED|Metformin Run-in Period||0
20147|NCT01933672|45750|P2|COMPLETED|Metformin Run-in Period||0
20148|NCT01933672|45751|P1|COMPLETED|Metformin Run-in Period||33
20149|NCT01933672|45745|P7|Received Treatment|Metformin Run-in Period||0
20150|NCT01933672|45746|P6|Received Treatment|Metformin Run-in Period||0
20151|NCT01933672|45747|P5|Received Treatment|Metformin Run-in Period||0
20152|NCT01933672|45748|P4|Received Treatment|Metformin Run-in Period||0
20153|NCT01933672|45749|P3|Received Treatment|Metformin Run-in Period||0
20154|NCT01933672|45750|P2|Received Treatment|Metformin Run-in Period||0
20155|NCT01933672|45751|P1|Received Treatment|Metformin Run-in Period||43
20156|NCT01933672|45745|P7|STARTED|Metformin Run-in Period||0
20157|NCT01933672|45746|P6|STARTED|Metformin Run-in Period||0
20158|NCT01933672|45747|P5|STARTED|Metformin Run-in Period||0
20159|NCT01933672|45748|P4|STARTED|Metformin Run-in Period||0
20160|NCT01933672|45749|P3|STARTED|Metformin Run-in Period||0
20161|NCT01933672|45750|P2|STARTED|Metformin Run-in Period||0
20162|NCT01933672|45751|P1|STARTED|Metformin Run-in Period||43
20163|NCT01933425|45797|P2|NOT COMPLETED|Overall Study||0
20164|NCT01933425|45798|P1|NOT COMPLETED|Overall Study||0
20165|NCT01933425|45797|P2|COMPLETED|Overall Study||7
20166|NCT01933425|45798|P1|COMPLETED|Overall Study||7
20167|NCT01933425|45797|P2|STARTED|Overall Study||7
20168|NCT01933425|45798|P1|STARTED|Overall Study||7
20169|NCT01933399|45811|P3|NOT COMPLETED|Overall Study||0
20170|NCT01933399|45812|P2|NOT COMPLETED|Overall Study||0
20171|NCT01933399|45813|P1|NOT COMPLETED|Overall Study||0
20172|NCT01933399|45811|P3|COMPLETED|Overall Study||37
20173|NCT01933399|45812|P2|COMPLETED|Overall Study||32
20174|NCT01933399|45813|P1|COMPLETED|Overall Study||29
20175|NCT01933399|45811|P3|STARTED|Overall Study||37
20176|NCT01933399|45812|P2|STARTED|Overall Study||32
20177|NCT01933399|45813|P1|STARTED|Overall Study||29
20178|NCT01933334|45826|P2|NOT COMPLETED|Overall Study||2
20179|NCT01933334|45827|P1|NOT COMPLETED|Overall Study||5
20180|NCT01933334|45826|P2|COMPLETED|Overall Study||29
20181|NCT01933334|45827|P1|COMPLETED|Overall Study||27
20182|NCT01933334|45826|P2|STARTED|Overall Study||31
20183|NCT01933334|45827|P1|STARTED|Overall Study||32
20184|NCT01933230|45837|P1|NOT COMPLETED|Overall Study||0
20185|NCT01933230|45837|P1|COMPLETED|Overall Study||2
20186|NCT01933230|45837|P1|STARTED|Overall Study||2
20187|NCT01932762|45845|P4|NOT COMPLETED|Overall Study||1
20188|NCT01932762|45846|P3|NOT COMPLETED|Overall Study||0
20189|NCT01932762|45847|P2|NOT COMPLETED|Overall Study||2
20190|NCT01932762|45848|P1|NOT COMPLETED|Overall Study||6
20191|NCT01932762|45845|P4|COMPLETED|Overall Study||18
20192|NCT01932762|45846|P3|COMPLETED|Overall Study||19
20193|NCT01932762|45847|P2|COMPLETED|Overall Study||28
20194|NCT01932762|45848|P1|COMPLETED|Overall Study||24
20195|NCT01932762|45845|P4|STARTED|Overall Study||19
20196|NCT01932762|45846|P3|STARTED|Overall Study||19
20197|NCT01932762|45847|P2|STARTED|Overall Study||30
20198|NCT01932762|45848|P1|STARTED|Overall Study||30
20199|NCT01932606|45884|P2|NOT COMPLETED|Overall Study||0
20200|NCT01932606|45885|P1|NOT COMPLETED|Overall Study||0
20201|NCT01932606|45884|P2|COMPLETED|Overall Study||14
20202|NCT01932606|45885|P1|COMPLETED|Overall Study||14
20203|NCT01932606|45884|P2|STARTED|Overall Study||14
20204|NCT01932606|45885|P1|STARTED|Overall Study||14
20205|NCT01932164|45935|P1|NOT COMPLETED|Overall Study||0
20206|NCT01932164|45935|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
20207|NCT01932164|45935|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
20208|NCT01932164|45935|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
20209|NCT01932164|45935|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
20210|NCT01932164|45935|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
20211|NCT01932164|45935|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
20212|NCT01932164|45935|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
20213|NCT01932112|45939|P1|NOT COMPLETED|Overall Study||0
20214|NCT01932112|45939|P1|COMPLETED|Overall Study||378
20215|NCT01932112|45939|P1|STARTED|Overall Study||378
20216|NCT01932060|45945|P2|NOT COMPLETED|Overall Study||0
20217|NCT01932060|45946|P1|NOT COMPLETED|Overall Study||0
20218|NCT01932060|45945|P2|COMPLETED|Overall Study||24
20219|NCT01932060|45946|P1|COMPLETED|Overall Study||27
20220|NCT01932060|45945|P2|STARTED|Overall Study||24
20221|NCT01932060|45946|P1|STARTED|Overall Study||27
20222|NCT01931878|45954|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
20223|NCT01931878|45955|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
20224|NCT01931878|45954|P2|COMPLETED|Second Intervention (After 3 Months)||12
20225|NCT01931878|45955|P1|COMPLETED|Second Intervention (After 3 Months)||9
20226|NCT01931878|45954|P2|STARTED|Second Intervention (After 3 Months)||14
20227|NCT01931878|45955|P1|STARTED|Second Intervention (After 3 Months)||9
20228|NCT01931878|45954|P2|NOT COMPLETED|First Intervention||0
20229|NCT01931878|45955|P1|NOT COMPLETED|First Intervention||1
20230|NCT01931878|45954|P2|COMPLETED|First Intervention||14
20231|NCT01931878|45955|P1|COMPLETED|First Intervention||9
20232|NCT01931878|45954|P2|STARTED|First Intervention||14
20233|NCT01931878|45955|P1|STARTED|First Intervention||10
20234|NCT01931865|45965|P1|NOT COMPLETED|Overall Study||4
20235|NCT01931865|45965|P1|COMPLETED|Overall Study||8
20236|NCT01931865|45965|P1|STARTED|Overall Study||12
20237|NCT01931527|45973|P2|NOT COMPLETED|Overall Study||0
20238|NCT01931527|45974|P1|NOT COMPLETED|Overall Study||0
20239|NCT01931527|45973|P2|COMPLETED|Overall Study||15
20240|NCT01931527|45974|P1|COMPLETED|Overall Study||16
20241|NCT01931527|45973|P2|STARTED|Overall Study||15
20242|NCT01931527|45974|P1|STARTED|Overall Study||16
20243|NCT01931475|45984|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
20244|NCT01931475|45985|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
20245|NCT01931475|45984|P2|COMPLETED|Period 2: Extension Treatment Phase||157
20246|NCT01931475|45985|P1|COMPLETED|Period 2: Extension Treatment Phase||162
20247|NCT01931475|45984|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
20248|NCT01931475|45985|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
20249|NCT01931475|45984|P2|STARTED|Period 2: Extension Treatment Phase||176
20250|NCT01931475|45985|P1|STARTED|Period 2: Extension Treatment Phase||166
20251|NCT01931475|45984|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
20252|NCT01931475|45985|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
20253|NCT01931475|45984|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
20254|NCT01931475|45985|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
20255|NCT01931475|45984|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
20256|NCT01931475|45985|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
20257|NCT01931475|45984|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
20258|NCT01931475|45985|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
20259|NCT01931150|46014|P2|NOT COMPLETED|Overall Study||2
20260|NCT01931150|46015|P1|NOT COMPLETED|Overall Study||1
20261|NCT01931150|46014|P2|COMPLETED|Overall Study||4
20262|NCT01931150|46015|P1|COMPLETED|Overall Study||4
20263|NCT01931150|46014|P2|STARTED|Overall Study||6
20264|NCT01931150|46015|P1|STARTED|Overall Study||5
20265|NCT01930890|46025|P4|NOT COMPLETED|Overall Study||27
20266|NCT01930890|46026|P3|NOT COMPLETED|Overall Study||13
20267|NCT01930890|46027|P2|NOT COMPLETED|Overall Study||33
20268|NCT01930890|46028|P1|NOT COMPLETED|Overall Study||14
20269|NCT01930890|46025|P4|COMPLETED|Overall Study||0
20270|NCT01930890|46026|P3|COMPLETED|Overall Study||0
20271|NCT01930890|46027|P2|COMPLETED|Overall Study||0
20272|NCT01930890|46028|P1|COMPLETED|Overall Study||0
20273|NCT01930890|46025|P4|STARTED|Overall Study||27
20274|NCT01930890|46026|P3|STARTED|Overall Study||13
20275|NCT01930890|46027|P2|STARTED|Overall Study||33
20276|NCT01930890|46028|P1|STARTED|Overall Study||14
20277|NCT01930799|46042|P1|NOT COMPLETED|Overall Study||8
20278|NCT01930799|46042|P1|COMPLETED|Overall Study||112
20279|NCT01930799|46042|P1|STARTED|Overall Study||120
20280|NCT01930487|46047|P2|NOT COMPLETED|Second Intervention (30 Days)||0
20281|NCT01930487|46048|P1|NOT COMPLETED|Second Intervention (30 Days)||0
20282|NCT01930487|46047|P2|COMPLETED|Second Intervention (30 Days)||23
20283|NCT01930487|46048|P1|COMPLETED|Second Intervention (30 Days)||19
20284|NCT01930487|46047|P2|STARTED|Second Intervention (30 Days)||23
20285|NCT01930487|46048|P1|STARTED|Second Intervention (30 Days)||19
20286|NCT01930487|46047|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
20287|NCT01930487|46048|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
20288|NCT01930487|46047|P2|COMPLETED|Washout Period (3 Weeks)||23
20289|NCT01930487|46048|P1|COMPLETED|Washout Period (3 Weeks)||19
20290|NCT01930487|46047|P2|STARTED|Washout Period (3 Weeks)||23
20291|NCT01930487|46048|P1|STARTED|Washout Period (3 Weeks)||19
20292|NCT01930487|46047|P2|NOT COMPLETED|First Intervention (30 Days)||2
20293|NCT01930487|46048|P1|NOT COMPLETED|First Intervention (30 Days)||2
20294|NCT01930487|46047|P2|COMPLETED|First Intervention (30 Days)||23
20295|NCT01930487|46048|P1|COMPLETED|First Intervention (30 Days)||19
20296|NCT01930487|46047|P2|STARTED|First Intervention (30 Days)||25
20297|NCT01930487|46048|P1|STARTED|First Intervention (30 Days)||21
20298|NCT01930435|46142|P1|NOT COMPLETED|Overall Study||0
20299|NCT01930435|46142|P1|COMPLETED|Overall Study||20
20300|NCT01930435|46142|P1|STARTED|Overall Study||20
20301|NCT01929031|46154|P6|NOT COMPLETED|Overall Study||1
20302|NCT01929031|46155|P5|NOT COMPLETED|Overall Study||1
20303|NCT01929031|46156|P4|NOT COMPLETED|Overall Study||0
20304|NCT01929031|46157|P3|NOT COMPLETED|Overall Study||1
20305|NCT01929031|46158|P2|NOT COMPLETED|Overall Study||2
20306|NCT01929031|46159|P1|NOT COMPLETED|Overall Study||4
20307|NCT01929031|46154|P6|COMPLETED|Overall Study||35
20308|NCT01929031|46155|P5|COMPLETED|Overall Study||33
20309|NCT01929031|46156|P4|COMPLETED|Overall Study||35
20310|NCT01929031|46157|P3|COMPLETED|Overall Study||34
20311|NCT01929031|46158|P2|COMPLETED|Overall Study||207
20312|NCT01929031|46159|P1|COMPLETED|Overall Study||209
20313|NCT01929031|46154|P6|STARTED|Overall Study||36
20314|NCT01929031|46155|P5|STARTED|Overall Study||34
20315|NCT01929031|46156|P4|STARTED|Overall Study||35
20316|NCT01929031|46157|P3|STARTED|Overall Study||35
20317|NCT01929031|46158|P2|STARTED|Overall Study||209
20318|NCT01929031|46159|P1|STARTED|Overall Study||213
20319|NCT01928940|46183|P2|NOT COMPLETED|Overall Study||6
20320|NCT01928940|46184|P1|NOT COMPLETED|Overall Study||4
20321|NCT01928940|46183|P2|COMPLETED|Overall Study||0
20322|NCT01928940|46184|P1|COMPLETED|Overall Study||2
20323|NCT01928940|46183|P2|Ongoing|Overall Study||5
20324|NCT01928940|46184|P1|Ongoing|Overall Study||4
20325|NCT01928940|46183|P2|STARTED|Overall Study||6
20326|NCT01928940|46184|P1|STARTED|Overall Study||6
20327|NCT01930058|46228|P3|NOT COMPLETED|Overall Study||0
20328|NCT01930058|46229|P2|NOT COMPLETED|Overall Study||0
20329|NCT01930058|46230|P1|NOT COMPLETED|Overall Study||0
20330|NCT01930058|46228|P3|COMPLETED|Overall Study||3
20331|NCT01930058|46229|P2|COMPLETED|Overall Study||3
20332|NCT01930058|46230|P1|COMPLETED|Overall Study||3
20333|NCT01930058|46228|P3|STARTED|Overall Study||3
20334|NCT01930058|46229|P2|STARTED|Overall Study||3
20335|NCT01930058|46230|P1|STARTED|Overall Study||3
20336|NCT01930045|46252|P6|NOT COMPLETED|Part 2 - Period 5||0
20337|NCT01930045|46253|P5|NOT COMPLETED|Part 2 - Period 5||0
20338|NCT01930045|46254|P4|NOT COMPLETED|Part 2 - Period 5||0
20339|NCT01930045|46255|P3|NOT COMPLETED|Part 2 - Period 5||0
20340|NCT01930045|46256|P2|NOT COMPLETED|Part 2 - Period 5||0
20341|NCT01930045|46257|P1|NOT COMPLETED|Part 2 - Period 5||0
20342|NCT01930045|46252|P6|COMPLETED|Part 2 - Period 5||1
20343|NCT01930045|46253|P5|COMPLETED|Part 2 - Period 5||3
20344|NCT01930045|46254|P4|COMPLETED|Part 2 - Period 5||3
20345|NCT01930045|46255|P3|COMPLETED|Part 2 - Period 5||3
20346|NCT01930045|46256|P2|COMPLETED|Part 2 - Period 5||3
20347|NCT01930045|46257|P1|COMPLETED|Part 2 - Period 5||3
20348|NCT01930045|46252|P6|STARTED|Part 2 - Period 5||1
20349|NCT01930045|46253|P5|STARTED|Part 2 - Period 5||3
20350|NCT01930045|46254|P4|STARTED|Part 2 - Period 5||3
20351|NCT01930045|46255|P3|STARTED|Part 2 - Period 5||3
20352|NCT01930045|46256|P2|STARTED|Part 2 - Period 5||3
20353|NCT01930045|46257|P1|STARTED|Part 2 - Period 5||3
20354|NCT01930045|46252|P6|NOT COMPLETED|Part 2 - Period 4||0
20355|NCT01930045|46253|P5|NOT COMPLETED|Part 2 - Period 4||0
20356|NCT01930045|46254|P4|NOT COMPLETED|Part 2 - Period 4||0
20357|NCT01930045|46255|P3|NOT COMPLETED|Part 2 - Period 4||0
20358|NCT01930045|46256|P2|NOT COMPLETED|Part 2 - Period 4||0
20359|NCT01930045|46257|P1|NOT COMPLETED|Part 2 - Period 4||0
20360|NCT01930045|46252|P6|COMPLETED|Part 2 - Period 4||1
20361|NCT01930045|46253|P5|COMPLETED|Part 2 - Period 4||3
20362|NCT01930045|46254|P4|COMPLETED|Part 2 - Period 4||3
20363|NCT01930045|46255|P3|COMPLETED|Part 2 - Period 4||3
20364|NCT01930045|46256|P2|COMPLETED|Part 2 - Period 4||3
20365|NCT01930045|46257|P1|COMPLETED|Part 2 - Period 4||3
20366|NCT01930045|46252|P6|STARTED|Part 2 - Period 4||1
20367|NCT01930045|46253|P5|STARTED|Part 2 - Period 4||3
20368|NCT01930045|46254|P4|STARTED|Part 2 - Period 4||3
20369|NCT01930045|46255|P3|STARTED|Part 2 - Period 4||3
20370|NCT01930045|46256|P2|STARTED|Part 2 - Period 4||3
20371|NCT01930045|46257|P1|STARTED|Part 2 - Period 4||3
20372|NCT01930045|46252|P6|NOT COMPLETED|Pause (up to 37 Days)||2
20373|NCT01930045|46253|P5|NOT COMPLETED|Pause (up to 37 Days)||0
20374|NCT01930045|46254|P4|NOT COMPLETED|Pause (up to 37 Days)||0
20375|NCT01930045|46255|P3|NOT COMPLETED|Pause (up to 37 Days)||0
20376|NCT01930045|46256|P2|NOT COMPLETED|Pause (up to 37 Days)||0
20377|NCT01930045|46257|P1|NOT COMPLETED|Pause (up to 37 Days)||0
20378|NCT01930045|46252|P6|COMPLETED|Pause (up to 37 Days)||1
20379|NCT01930045|46253|P5|COMPLETED|Pause (up to 37 Days)||3
20380|NCT01930045|46254|P4|COMPLETED|Pause (up to 37 Days)||3
20381|NCT01930045|46255|P3|COMPLETED|Pause (up to 37 Days)||3
20382|NCT01930045|46256|P2|COMPLETED|Pause (up to 37 Days)||3
20383|NCT01930045|46257|P1|COMPLETED|Pause (up to 37 Days)||3
20384|NCT01930045|46252|P6|STARTED|Pause (up to 37 Days)||3
20385|NCT01930045|46253|P5|STARTED|Pause (up to 37 Days)||3
20386|NCT01930045|46254|P4|STARTED|Pause (up to 37 Days)||3
20387|NCT01930045|46255|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
20388|NCT01930045|46256|P2|STARTED|Pause (up to 37 Days)||3
20389|NCT01930045|46257|P1|STARTED|Pause (up to 37 Days)||3
20390|NCT01930045|46252|P6|NOT COMPLETED|Part 1 - Period 3||0
20391|NCT01930045|46253|P5|NOT COMPLETED|Part 1 - Period 3||0
20392|NCT01930045|46254|P4|NOT COMPLETED|Part 1 - Period 3||0
20393|NCT01930045|46255|P3|NOT COMPLETED|Part 1 - Period 3||0
20394|NCT01930045|46256|P2|NOT COMPLETED|Part 1 - Period 3||0
20395|NCT01930045|46257|P1|NOT COMPLETED|Part 1 - Period 3||0
20396|NCT01930045|46252|P6|COMPLETED|Part 1 - Period 3||3
20397|NCT01930045|46253|P5|COMPLETED|Part 1 - Period 3||3
20398|NCT01930045|46254|P4|COMPLETED|Part 1 - Period 3||3
20399|NCT01930045|46255|P3|COMPLETED|Part 1 - Period 3||2
20400|NCT01930045|46256|P2|COMPLETED|Part 1 - Period 3||3
20401|NCT01930045|46257|P1|COMPLETED|Part 1 - Period 3||3
20402|NCT01930045|46252|P6|STARTED|Part 1 - Period 3||3
20403|NCT01930045|46253|P5|STARTED|Part 1 - Period 3||3
20404|NCT01930045|46254|P4|STARTED|Part 1 - Period 3||3
20405|NCT01930045|46255|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
20406|NCT01930045|46256|P2|STARTED|Part 1 - Period 3||3
20407|NCT01930045|46257|P1|STARTED|Part 1 - Period 3||3
20408|NCT01930045|46252|P6|NOT COMPLETED|Part 1 - Period 2||0
20409|NCT01930045|46253|P5|NOT COMPLETED|Part 1 - Period 2||0
20410|NCT01930045|46254|P4|NOT COMPLETED|Part 1 - Period 2||0
20411|NCT01930045|46255|P3|NOT COMPLETED|Part 1 - Period 2||0
20412|NCT01930045|46256|P2|NOT COMPLETED|Part 1 - Period 2||0
20413|NCT01930045|46257|P1|NOT COMPLETED|Part 1 - Period 2||0
20414|NCT01930045|46252|P6|COMPLETED|Part 1 - Period 2||3
20415|NCT01930045|46253|P5|COMPLETED|Part 1 - Period 2||3
20416|NCT01930045|46254|P4|COMPLETED|Part 1 - Period 2||3
20417|NCT01930045|46255|P3|COMPLETED|Part 1 - Period 2||3
20418|NCT01930045|46256|P2|COMPLETED|Part 1 - Period 2||3
20419|NCT01930045|46257|P1|COMPLETED|Part 1 - Period 2||3
20420|NCT01930045|46252|P6|STARTED|Part 1 - Period 2||3
20421|NCT01930045|46253|P5|STARTED|Part 1 - Period 2||3
20422|NCT01930045|46254|P4|STARTED|Part 1 - Period 2||3
20423|NCT01930045|46255|P3|STARTED|Part 1 - Period 2||3
20424|NCT01930045|46256|P2|STARTED|Part 1 - Period 2||3
20425|NCT01930045|46257|P1|STARTED|Part 1 - Period 2||3
20426|NCT01930045|46252|P6|NOT COMPLETED|Part 1 - Period 1||0
20427|NCT01930045|46253|P5|NOT COMPLETED|Part 1 - Period 1||0
20428|NCT01930045|46254|P4|NOT COMPLETED|Part 1 - Period 1||0
20429|NCT01930045|46255|P3|NOT COMPLETED|Part 1 - Period 1||0
20430|NCT01930045|46256|P2|NOT COMPLETED|Part 1 - Period 1||0
20431|NCT01930045|46257|P1|NOT COMPLETED|Part 1 - Period 1||0
20432|NCT01930045|46252|P6|COMPLETED|Part 1 - Period 1||3
20433|NCT01930045|46253|P5|COMPLETED|Part 1 - Period 1||3
20434|NCT01930045|46254|P4|COMPLETED|Part 1 - Period 1||3
20435|NCT01930045|46255|P3|COMPLETED|Part 1 - Period 1||3
20436|NCT01930045|46256|P2|COMPLETED|Part 1 - Period 1||3
20437|NCT01930045|46257|P1|COMPLETED|Part 1 - Period 1||3
20438|NCT01930045|46252|P6|STARTED|Part 1 - Period 1||3
20439|NCT01930045|46253|P5|STARTED|Part 1 - Period 1||3
20440|NCT01930045|46254|P4|STARTED|Part 1 - Period 1||3
20441|NCT01930045|46255|P3|STARTED|Part 1 - Period 1||3
20442|NCT01930045|46256|P2|STARTED|Part 1 - Period 1||3
20443|NCT01930045|46257|P1|STARTED|Part 1 - Period 1||3
20444|NCT01929993|46284|P2|NOT COMPLETED|Overall Study||28
20445|NCT01929993|46285|P1|NOT COMPLETED|Overall Study||30
20446|NCT01929993|46284|P2|COMPLETED|Overall Study||54
20447|NCT01929993|46285|P1|COMPLETED|Overall Study||52
20448|NCT01929993|46284|P2|STARTED|Overall Study||82
20449|NCT01929993|46285|P1|STARTED|Overall Study||82
20450|NCT01929980|46291|P1|NOT COMPLETED|Overall Study||1
20451|NCT01929980|46291|P1|COMPLETED|Overall Study||3
20452|NCT01929980|46291|P1|STARTED|Overall Study||4
20453|NCT01929889|46295|P1|NOT COMPLETED|Overall Study||5
20454|NCT01929889|46295|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
20455|NCT01929889|46295|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
20456|NCT01929876|46299|P1|NOT COMPLETED|Period 2||1
20457|NCT01929876|46299|P1|COMPLETED|Period 2||15
20458|NCT01929876|46299|P1|STARTED|Period 2||16
20459|NCT01929876|46299|P1|NOT COMPLETED|Period 1||0
20460|NCT01929876|46299|P1|COMPLETED|Period 1||16
20461|NCT01929876|46299|P1|STARTED|Period 1||16
20462|NCT01929473|46312|P1|NOT COMPLETED|Overall Study||587
20463|NCT01929473|46312|P1|COMPLETED|Overall Study||3243
20464|NCT01929473|46312|P1|365 Day|Overall Study||3589
20465|NCT01929473|46312|P1|STARTED|Overall Study|0 day|3830
20466|NCT01929460|46318|P2|NOT COMPLETED|Overall Study||0
20467|NCT01929460|46319|P1|NOT COMPLETED|Overall Study||0
20468|NCT01929460|46318|P2|COMPLETED|Overall Study||13
20469|NCT01929460|46319|P1|COMPLETED|Overall Study||13
20470|NCT01929460|46318|P2|STARTED|Overall Study||13
20471|NCT01929460|46319|P1|STARTED|Overall Study||13
20472|NCT01929317|46343|P2|NOT COMPLETED|Long-term Phase||4
20473|NCT01929317|46344|P1|NOT COMPLETED|Long-term Phase||19
20474|NCT01929317|46343|P2|COMPLETED|Long-term Phase||14
20475|NCT01929317|46344|P1|COMPLETED|Long-term Phase||25
20476|NCT01929317|46343|P2|STARTED|Long-term Phase||18
20477|NCT01929317|46344|P1|STARTED|Long-term Phase||44
20478|NCT01929317|46343|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
20479|NCT01929317|46344|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
20480|NCT01929317|46343|P2|COMPLETED|Dose Increase Effect Verification Phase||19
20481|NCT01929317|46344|P1|COMPLETED|Dose Increase Effect Verification Phase||52
20482|NCT01929317|46343|P2|STARTED|Dose Increase Effect Verification Phase||20
20483|NCT01929317|46344|P1|STARTED|Dose Increase Effect Verification Phase||61
20484|NCT01929135|46413|P2|NOT COMPLETED|Overall Study||1
20485|NCT01929135|46414|P1|NOT COMPLETED|Overall Study||1
20486|NCT01929135|46413|P2|COMPLETED|Overall Study||18
20487|NCT01929135|46414|P1|COMPLETED|Overall Study||18
20488|NCT01929135|46413|P2|STARTED|Overall Study||19
20489|NCT01929135|46414|P1|STARTED|Overall Study||19
20490|NCT01929083|46428|P2|NOT COMPLETED|Intervention 2||1
20491|NCT01929083|46429|P1|NOT COMPLETED|Intervention 2||0
20492|NCT01929083|46428|P2|COMPLETED|Intervention 2||8
20493|NCT01929083|46429|P1|COMPLETED|Intervention 2||7
20494|NCT01929083|46428|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
20495|NCT01929083|46429|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
20496|NCT01929083|46428|P2|STARTED|Intervention 2||9
20497|NCT01929083|46429|P1|STARTED|Intervention 2||7
20498|NCT01929083|46428|P2|NOT COMPLETED|Intervention 1||0
20499|NCT01929083|46429|P1|NOT COMPLETED|Intervention 1||3
20500|NCT01929083|46428|P2|COMPLETED|Intervention 1||9
20501|NCT01929083|46429|P1|COMPLETED|Intervention 1||7
20502|NCT01929083|46428|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
20503|NCT01929083|46429|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
20504|NCT01929083|46428|P2|STARTED|Intervention 1||9
20505|NCT01929083|46429|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
20506|NCT01929044|46455|P2|NOT COMPLETED|Overall Study||17
20507|NCT01929044|46456|P1|NOT COMPLETED|Overall Study||11
20508|NCT01929044|46455|P2|COMPLETED|Overall Study||129
20509|NCT01929044|46456|P1|COMPLETED|Overall Study||142
20510|NCT01929044|46455|P2|STARTED|Overall Study||146
20511|NCT01929044|46456|P1|STARTED|Overall Study||153
20512|NCT01928693|46477|P3|NOT COMPLETED|Overall Study||0
20513|NCT01928693|46478|P2|NOT COMPLETED|Overall Study||0
20514|NCT01928693|46479|P1|NOT COMPLETED|Overall Study||0
20515|NCT01928693|46477|P3|COMPLETED|Overall Study||1
20516|NCT01928693|46478|P2|COMPLETED|Overall Study||1
20517|NCT01928693|46479|P1|COMPLETED|Overall Study||0
20518|NCT01928693|46477|P3|STARTED|Overall Study||1
20519|NCT01928693|46478|P2|STARTED|Overall Study||1
20520|NCT01928693|46479|P1|STARTED|Overall Study||0
20521|NCT01928680|46505|P1|NOT COMPLETED|Overall Study||0
20522|NCT01928680|46505|P1|COMPLETED|Overall Study||33
20523|NCT01928680|46505|P1|STARTED|Overall Study||33
20524|NCT01928615|46509|P1|NOT COMPLETED|Overall Study||2
20525|NCT01928615|46509|P1|COMPLETED|Overall Study||0
20526|NCT01928615|46509|P1|STARTED|Overall Study||2
20527|NCT01928472|46528|P4|NOT COMPLETED|Overall Study||2
20528|NCT01928472|46529|P3|NOT COMPLETED|Overall Study||7
20529|NCT01928472|46530|P2|NOT COMPLETED|Overall Study||8
20530|NCT01928472|46531|P1|NOT COMPLETED|Overall Study||8
20531|NCT01928472|46528|P4|COMPLETED|Overall Study||100
20532|NCT01928472|46529|P3|COMPLETED|Overall Study||91
20533|NCT01928472|46530|P2|COMPLETED|Overall Study||96
20534|NCT01928472|46531|P1|COMPLETED|Overall Study||90
20535|NCT01928472|46528|P4|STARTED|Overall Study||102
20536|NCT01928472|46529|P3|STARTED|Overall Study||98
20537|NCT01928472|46530|P2|STARTED|Overall Study||104
20538|NCT01928472|46531|P1|STARTED|Overall Study||98
20539|NCT01928381|46598|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
20540|NCT01928381|46599|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
20541|NCT01928381|46600|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
20542|NCT01928381|46601|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
20543|NCT01928381|46602|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
20544|NCT01928381|46603|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
20545|NCT01928381|46604|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
20546|NCT01928381|46598|P7|COMPLETED|Part 2 - Post Third Intervention||5
20547|NCT01928381|46599|P6|COMPLETED|Part 2 - Post Third Intervention||5
20548|NCT01928381|46600|P5|COMPLETED|Part 2 - Post Third Intervention||3
20549|NCT01928381|46601|P4|COMPLETED|Part 2 - Post Third Intervention||4
20550|NCT01928381|46602|P3|COMPLETED|Part 2 - Post Third Intervention||3
20551|NCT01928381|46603|P2|COMPLETED|Part 2 - Post Third Intervention||5
20552|NCT01928381|46604|P1|COMPLETED|Part 2 - Post Third Intervention||0
20553|NCT01928381|46598|P7|STARTED|Part 2 - Post Third Intervention||5
20554|NCT01928381|46599|P6|STARTED|Part 2 - Post Third Intervention||5
20555|NCT01928381|46600|P5|STARTED|Part 2 - Post Third Intervention||3
20556|NCT01928381|46601|P4|STARTED|Part 2 - Post Third Intervention||4
20557|NCT01928381|46602|P3|STARTED|Part 2 - Post Third Intervention||4
20558|NCT01928381|46603|P2|STARTED|Part 2 - Post Third Intervention||5
20559|NCT01928381|46604|P1|STARTED|Part 2 - Post Third Intervention||0
20560|NCT01928381|46598|P7|NOT COMPLETED|Part 2 - Third Intervention||0
20561|NCT01928381|46599|P6|NOT COMPLETED|Part 2 - Third Intervention||0
20562|NCT01928381|46600|P5|NOT COMPLETED|Part 2 - Third Intervention||0
20563|NCT01928381|46601|P4|NOT COMPLETED|Part 2 - Third Intervention||0
20564|NCT01928381|46602|P3|NOT COMPLETED|Part 2 - Third Intervention||0
20565|NCT01928381|46603|P2|NOT COMPLETED|Part 2 - Third Intervention||0
20566|NCT01928381|46604|P1|NOT COMPLETED|Part 2 - Third Intervention||0
20567|NCT01928381|46598|P7|COMPLETED|Part 2 - Third Intervention||5
20568|NCT01928381|46599|P6|COMPLETED|Part 2 - Third Intervention||5
20569|NCT01928381|46600|P5|COMPLETED|Part 2 - Third Intervention||3
20570|NCT01928381|46601|P4|COMPLETED|Part 2 - Third Intervention||4
20571|NCT01928381|46602|P3|COMPLETED|Part 2 - Third Intervention||4
20572|NCT01928381|46603|P2|COMPLETED|Part 2 - Third Intervention||5
20573|NCT01928381|46604|P1|COMPLETED|Part 2 - Third Intervention||0
20574|NCT01928381|46598|P7|STARTED|Part 2 - Third Intervention||5
20575|NCT01928381|46599|P6|STARTED|Part 2 - Third Intervention||5
20576|NCT01928381|46600|P5|STARTED|Part 2 - Third Intervention||3
20577|NCT01928381|46601|P4|STARTED|Part 2 - Third Intervention||4
20578|NCT01928381|46602|P3|STARTED|Part 2 - Third Intervention||4
20579|NCT01928381|46603|P2|STARTED|Part 2 - Third Intervention||5
20580|NCT01928381|46604|P1|STARTED|Part 2 - Third Intervention||0
20581|NCT01928381|46598|P7|NOT COMPLETED|Washout Second Intervention||0
20582|NCT01928381|46599|P6|NOT COMPLETED|Washout Second Intervention||0
20583|NCT01928381|46600|P5|NOT COMPLETED|Washout Second Intervention||0
20584|NCT01928381|46601|P4|NOT COMPLETED|Washout Second Intervention||0
20585|NCT01928381|46602|P3|NOT COMPLETED|Washout Second Intervention||0
20586|NCT01928381|46603|P2|NOT COMPLETED|Washout Second Intervention||0
20587|NCT01928381|46604|P1|NOT COMPLETED|Washout Second Intervention||0
20588|NCT01928381|46598|P7|COMPLETED|Washout Second Intervention||5
20589|NCT01928381|46599|P6|COMPLETED|Washout Second Intervention||5
20590|NCT01928381|46600|P5|COMPLETED|Washout Second Intervention||3
20591|NCT01928381|46601|P4|COMPLETED|Washout Second Intervention||4
20592|NCT01928381|46602|P3|COMPLETED|Washout Second Intervention||4
20593|NCT01928381|46603|P2|COMPLETED|Washout Second Intervention||5
20594|NCT01928381|46604|P1|COMPLETED|Washout Second Intervention||0
20595|NCT01928381|46598|P7|STARTED|Washout Second Intervention||5
20596|NCT01928381|46599|P6|STARTED|Washout Second Intervention||5
20597|NCT01928381|46600|P5|STARTED|Washout Second Intervention||3
20598|NCT01928381|46601|P4|STARTED|Washout Second Intervention||4
20599|NCT01928381|46602|P3|STARTED|Washout Second Intervention||4
20600|NCT01928381|46603|P2|STARTED|Washout Second Intervention||5
20601|NCT01928381|46604|P1|STARTED|Washout Second Intervention||0
20602|NCT01928381|46598|P7|NOT COMPLETED|Part 2 - Second Intervention||0
20603|NCT01928381|46599|P6|NOT COMPLETED|Part 2 - Second Intervention||0
20604|NCT01928381|46600|P5|NOT COMPLETED|Part 2 - Second Intervention||0
20605|NCT01928381|46601|P4|NOT COMPLETED|Part 2 - Second Intervention||1
20606|NCT01928381|46602|P3|NOT COMPLETED|Part 2 - Second Intervention||0
20607|NCT01928381|46603|P2|NOT COMPLETED|Part 2 - Second Intervention||1
20608|NCT01928381|46604|P1|NOT COMPLETED|Part 2 - Second Intervention||0
20609|NCT01928381|46598|P7|COMPLETED|Part 2 - Second Intervention||5
20610|NCT01928381|46599|P6|COMPLETED|Part 2 - Second Intervention||5
20611|NCT01928381|46600|P5|COMPLETED|Part 2 - Second Intervention||3
20612|NCT01928381|46601|P4|COMPLETED|Part 2 - Second Intervention||4
20613|NCT01928381|46602|P3|COMPLETED|Part 2 - Second Intervention||4
20614|NCT01928381|46603|P2|COMPLETED|Part 2 - Second Intervention||5
20615|NCT01928381|46604|P1|COMPLETED|Part 2 - Second Intervention||0
20616|NCT01928381|46598|P7|STARTED|Part 2 - Second Intervention||5
20617|NCT01928381|46599|P6|STARTED|Part 2 - Second Intervention||5
20618|NCT01928381|46600|P5|STARTED|Part 2 - Second Intervention||3
20619|NCT01928381|46601|P4|STARTED|Part 2 - Second Intervention||5
20620|NCT01928381|46602|P3|STARTED|Part 2 - Second Intervention||4
20621|NCT01928381|46603|P2|STARTED|Part 2 - Second Intervention||6
20622|NCT01928381|46604|P1|STARTED|Part 2 - Second Intervention||0
20623|NCT01928381|46598|P7|NOT COMPLETED|Washout First Intervention||0
20624|NCT01928381|46599|P6|NOT COMPLETED|Washout First Intervention||0
20625|NCT01928381|46600|P5|NOT COMPLETED|Washout First Intervention||1
20626|NCT01928381|46601|P4|NOT COMPLETED|Washout First Intervention||0
20627|NCT01928381|46602|P3|NOT COMPLETED|Washout First Intervention||0
20628|NCT01928381|46603|P2|NOT COMPLETED|Washout First Intervention||0
20629|NCT01928381|46604|P1|NOT COMPLETED|Washout First Intervention||0
20630|NCT01928381|46598|P7|COMPLETED|Washout First Intervention||5
20631|NCT01928381|46599|P6|COMPLETED|Washout First Intervention||5
20632|NCT01928381|46600|P5|COMPLETED|Washout First Intervention||3
20633|NCT01928381|46601|P4|COMPLETED|Washout First Intervention||5
20634|NCT01928381|46602|P3|COMPLETED|Washout First Intervention||4
20635|NCT01928381|46603|P2|COMPLETED|Washout First Intervention||6
20636|NCT01928381|46604|P1|COMPLETED|Washout First Intervention||0
20637|NCT01928381|46598|P7|STARTED|Washout First Intervention||5
20638|NCT01928381|46599|P6|STARTED|Washout First Intervention||5
20639|NCT01928381|46600|P5|STARTED|Washout First Intervention||4
20640|NCT01928381|46601|P4|STARTED|Washout First Intervention||5
20641|NCT01928381|46602|P3|STARTED|Washout First Intervention||4
20642|NCT01928381|46603|P2|STARTED|Washout First Intervention||6
20643|NCT01928381|46604|P1|STARTED|Washout First Intervention||0
20644|NCT01928381|46598|P7|NOT COMPLETED|Part 2 - First Intervention||1
20645|NCT01928381|46599|P6|NOT COMPLETED|Part 2 - First Intervention||1
20646|NCT01928381|46600|P5|NOT COMPLETED|Part 2 - First Intervention||0
20647|NCT01928381|46601|P4|NOT COMPLETED|Part 2 - First Intervention||1
20648|NCT01928381|46602|P3|NOT COMPLETED|Part 2 - First Intervention||2
20649|NCT01928381|46603|P2|NOT COMPLETED|Part 2 - First Intervention||0
20650|NCT01928381|46604|P1|NOT COMPLETED|Part 2 - First Intervention||0
20651|NCT01928381|46598|P7|COMPLETED|Part 2 - First Intervention||5
20652|NCT01928381|46599|P6|COMPLETED|Part 2 - First Intervention||5
20653|NCT01928381|46600|P5|COMPLETED|Part 2 - First Intervention||4
20654|NCT01928381|46601|P4|COMPLETED|Part 2 - First Intervention||5
20655|NCT01928381|46602|P3|COMPLETED|Part 2 - First Intervention||4
20656|NCT01928381|46603|P2|COMPLETED|Part 2 - First Intervention||6
20657|NCT01928381|46604|P1|COMPLETED|Part 2 - First Intervention||0
20658|NCT01928381|46598|P7|STARTED|Part 2 - First Intervention||6
20659|NCT01928381|46599|P6|STARTED|Part 2 - First Intervention||6
20660|NCT01928381|46600|P5|STARTED|Part 2 - First Intervention||4
20661|NCT01928381|46601|P4|STARTED|Part 2 - First Intervention||6
20662|NCT01928381|46602|P3|STARTED|Part 2 - First Intervention||6
20663|NCT01928381|46603|P2|STARTED|Part 2 - First Intervention||6
20664|NCT01928381|46604|P1|STARTED|Part 2 - First Intervention||0
20665|NCT01928381|46598|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20666|NCT01928381|46599|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20667|NCT01928381|46600|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20668|NCT01928381|46601|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20669|NCT01928381|46602|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20670|NCT01928381|46603|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
20671|NCT01928381|46604|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
20672|NCT01928381|46598|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20673|NCT01928381|46599|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20674|NCT01928381|46600|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20675|NCT01928381|46601|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20676|NCT01928381|46602|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20677|NCT01928381|46603|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
20678|NCT01928381|46604|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
20679|NCT01928381|46598|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
20680|NCT01928381|46599|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
20681|NCT01928381|46600|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
20682|NCT01928381|46601|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
20683|NCT01928381|46602|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
20684|NCT01928381|46603|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
20685|NCT01928381|46604|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
20686|NCT01928381|46598|P7|NOT COMPLETED|Part 1 - Pain Training||0
20687|NCT01928381|46599|P6|NOT COMPLETED|Part 1 - Pain Training||0
20688|NCT01928381|46600|P5|NOT COMPLETED|Part 1 - Pain Training||0
20689|NCT01928381|46601|P4|NOT COMPLETED|Part 1 - Pain Training||0
20690|NCT01928381|46602|P3|NOT COMPLETED|Part 1 - Pain Training||0
20691|NCT01928381|46603|P2|NOT COMPLETED|Part 1 - Pain Training||0
20692|NCT01928381|46604|P1|NOT COMPLETED|Part 1 - Pain Training||35
20693|NCT01928381|46598|P7|COMPLETED|Part 1 - Pain Training||0
20694|NCT01928381|46599|P6|COMPLETED|Part 1 - Pain Training||0
20695|NCT01928381|46600|P5|COMPLETED|Part 1 - Pain Training||0
20696|NCT01928381|46601|P4|COMPLETED|Part 1 - Pain Training||0
20697|NCT01928381|46602|P3|COMPLETED|Part 1 - Pain Training||0
20698|NCT01928381|46603|P2|COMPLETED|Part 1 - Pain Training||0
20699|NCT01928381|46604|P1|COMPLETED|Part 1 - Pain Training||48
20700|NCT01928381|46598|P7|STARTED|Part 1 - Pain Training||0
20701|NCT01928381|46599|P6|STARTED|Part 1 - Pain Training||0
20702|NCT01928381|46600|P5|STARTED|Part 1 - Pain Training||0
20703|NCT01928381|46601|P4|STARTED|Part 1 - Pain Training||0
20704|NCT01928381|46602|P3|STARTED|Part 1 - Pain Training||0
20705|NCT01928381|46603|P2|STARTED|Part 1 - Pain Training||0
20706|NCT01928381|46604|P1|STARTED|Part 1 - Pain Training||83
20707|NCT01928381|46598|P7|NOT COMPLETED|Screening for Pain Training||0
20708|NCT01928381|46599|P6|NOT COMPLETED|Screening for Pain Training||0
20709|NCT01928381|46600|P5|NOT COMPLETED|Screening for Pain Training||0
20710|NCT01928381|46601|P4|NOT COMPLETED|Screening for Pain Training||0
20711|NCT01928381|46602|P3|NOT COMPLETED|Screening for Pain Training||0
20712|NCT01928381|46603|P2|NOT COMPLETED|Screening for Pain Training||0
20713|NCT01928381|46604|P1|NOT COMPLETED|Screening for Pain Training||60
20714|NCT01928381|46598|P7|COMPLETED|Screening for Pain Training||0
20715|NCT01928381|46599|P6|COMPLETED|Screening for Pain Training||0
20716|NCT01928381|46600|P5|COMPLETED|Screening for Pain Training||0
20717|NCT01928381|46601|P4|COMPLETED|Screening for Pain Training||0
20718|NCT01928381|46602|P3|COMPLETED|Screening for Pain Training||0
20719|NCT01928381|46603|P2|COMPLETED|Screening for Pain Training||0
20720|NCT01928381|46604|P1|COMPLETED|Screening for Pain Training||83
20721|NCT01928381|46598|P7|STARTED|Screening for Pain Training||0
20722|NCT01928381|46599|P6|STARTED|Screening for Pain Training||0
20723|NCT01928381|46600|P5|STARTED|Screening for Pain Training||0
20724|NCT01928381|46601|P4|STARTED|Screening for Pain Training||0
20725|NCT01928381|46602|P3|STARTED|Screening for Pain Training||0
20726|NCT01928381|46603|P2|STARTED|Screening for Pain Training||0
20727|NCT01928381|46604|P1|STARTED|Screening for Pain Training||143
20728|NCT01928030|46617|P3|NOT COMPLETED|Overall Study||0
20729|NCT01928030|46618|P2|NOT COMPLETED|Overall Study||0
20730|NCT01928030|46619|P1|NOT COMPLETED|Overall Study||0
20731|NCT01928030|46617|P3|COMPLETED|Overall Study||0
20732|NCT01928030|46618|P2|COMPLETED|Overall Study||0
20733|NCT01928030|46619|P1|COMPLETED|Overall Study||3
20734|NCT01928030|46617|P3|STARTED|Overall Study||0
20735|NCT01928030|46618|P2|STARTED|Overall Study||0
20736|NCT01928030|46619|P1|STARTED|Overall Study||3
20737|NCT01927757|46626|P1|NOT COMPLETED|Overall Study||23
20738|NCT01927757|46626|P1|COMPLETED|Overall Study||67
20739|NCT01927757|46626|P1|Received Etanercept|Overall Study||88
20740|NCT01927757|46626|P1|STARTED|Overall Study||90
20741|NCT01927419|46646|P2|NOT COMPLETED|Overall Study||28
20742|NCT01927419|46647|P1|NOT COMPLETED|Overall Study||70
20743|NCT01927419|46646|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
20744|NCT01927419|46647|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
20745|NCT01927419|46646|P2|Received Treatment|Overall Study||46
20746|NCT01927419|46647|P1|Received Treatment|Overall Study||94
20747|NCT01927419|46646|P2|STARTED|Overall Study||47
20748|NCT01927419|46647|P1|STARTED|Overall Study||95
20749|NCT01927055|46666|P3|NOT COMPLETED|Double-Blind||13
20750|NCT01927055|46667|P2|NOT COMPLETED|Double-Blind||11
20751|NCT01927055|46668|P1|NOT COMPLETED|Double-Blind||0
20752|NCT01927055|46666|P3|COMPLETED|Double-Blind||10
20753|NCT01927055|46667|P2|COMPLETED|Double-Blind||11
20754|NCT01927055|46668|P1|COMPLETED|Double-Blind||0
20755|NCT01927055|46666|P3|STARTED|Double-Blind||23
20756|NCT01927055|46667|P2|STARTED|Double-Blind||22
20757|NCT01927055|46668|P1|STARTED|Double-Blind||0
20758|NCT01927055|46666|P3|NOT COMPLETED|Open-label||0
20759|NCT01927055|46667|P2|NOT COMPLETED|Open-label||0
20760|NCT01927055|46668|P1|NOT COMPLETED|Open-label||16
20761|NCT01927055|46666|P3|COMPLETED|Open-label||0
20762|NCT01927055|46667|P2|COMPLETED|Open-label||0
20763|NCT01927055|46668|P1|COMPLETED|Open-label||45
20764|NCT01927055|46666|P3|STARTED|Open-label||0
20765|NCT01927055|46667|P2|STARTED|Open-label||0
20766|NCT01927055|46668|P1|STARTED|Open-label||61
20767|NCT01926977|46677|P2|NOT COMPLETED|Overall Study||0
20768|NCT01926977|46678|P1|NOT COMPLETED|Overall Study||0
20769|NCT01926977|46677|P2|COMPLETED|Overall Study||53
20770|NCT01926977|46678|P1|COMPLETED|Overall Study||47
20771|NCT01926977|46677|P2|STARTED|Overall Study||53
20772|NCT01926977|46678|P1|STARTED|Overall Study||47
20773|NCT01926626|46686|P1|NOT COMPLETED|Overall Study||22
20774|NCT01926626|46686|P1|COMPLETED|Overall Study||16
20775|NCT01926626|46686|P1|Received Moclobemide|Overall Study||37
20776|NCT01926626|46686|P1|STARTED|Overall Study||38
20777|NCT01926015|46698|P2|NOT COMPLETED|Overall Study||1
20778|NCT01926015|46699|P1|NOT COMPLETED|Overall Study||2
20779|NCT01926015|46698|P2|COMPLETED|Overall Study||95
20780|NCT01926015|46699|P1|COMPLETED|Overall Study||94
20781|NCT01926015|46698|P2|Received >=1 Vaccination|Overall Study||96
20782|NCT01926015|46699|P1|Received >=1 Vaccination|Overall Study||94
20783|NCT01926015|46698|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
20784|NCT01926015|46699|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
20785|NCT01925781|46731|P2|NOT COMPLETED|Overall Study||4
20786|NCT01925781|46732|P1|NOT COMPLETED|Overall Study||2
20787|NCT01925781|46731|P2|COMPLETED|Overall Study||1
20788|NCT01925781|46732|P1|COMPLETED|Overall Study||3
20789|NCT01925781|46731|P2|STARTED|Overall Study||5
20790|NCT01925781|46732|P1|STARTED|Overall Study||5
20791|NCT01925768|46742|P2|NOT COMPLETED|Overall Study||23
20792|NCT01925768|46743|P1|NOT COMPLETED|Overall Study||11
20793|NCT01925768|46742|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
20794|NCT01925768|46743|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
20795|NCT01925768|46742|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
20796|NCT01925768|46743|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
20797|NCT01925768|46742|P2|Completed Week 16|Overall Study||91
20798|NCT01925768|46743|P1|Completed Week 16|Overall Study||101
20799|NCT01925768|46742|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
20800|NCT01925768|46743|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
20801|NCT01925768|46742|P2|Received Treatment|Overall Study||109
20802|NCT01925768|46743|P1|Received Treatment|Overall Study||109
20803|NCT01925768|46742|P2|STARTED|Overall Study||110
20804|NCT01925768|46743|P1|STARTED|Overall Study||109
20805|NCT01925703|46751|P1|NOT COMPLETED|Overall Study||4
20806|NCT01925703|46751|P1|COMPLETED|Overall Study||9
20807|NCT01925703|46751|P1|Follow-up Completed|Overall Study||9
20808|NCT01925703|46751|P1|Full Iron Repletion Achieved|Overall Study||11
20809|NCT01925703|46751|P1|Dosing Regimen Completed|Overall Study||12
20810|NCT01925703|46751|P1|STARTED|Overall Study||13
20811|NCT01925417|46757|P1|NOT COMPLETED|Overall Study||3
20812|NCT01925417|46757|P1|COMPLETED|Overall Study||31
20813|NCT01925417|46757|P1|STARTED|Overall Study||34
20814|NCT01925183|46766|P2|NOT COMPLETED|Overall Study||0
20815|NCT01925183|46767|P1|NOT COMPLETED|Overall Study||1
20816|NCT01925183|46766|P2|COMPLETED|Overall Study||3
20817|NCT01925183|46767|P1|COMPLETED|Overall Study||2
20818|NCT01925183|46766|P2|STARTED|Overall Study||3
20819|NCT01925183|46767|P1|STARTED|Overall Study||3
20820|NCT01925170|46775|P1|NOT COMPLETED|Overall Study||53
20821|NCT01925170|46775|P1|COMPLETED|Overall Study||1585
20822|NCT01925170|46775|P1|STARTED|Overall Study||1638
20823|NCT01924975|46795|P2|NOT COMPLETED|Overall Study||0
20824|NCT01924975|46796|P1|NOT COMPLETED|Overall Study||0
20825|NCT01924975|46795|P2|COMPLETED|Overall Study||51
20826|NCT01924975|46796|P1|COMPLETED|Overall Study||51
20827|NCT01924975|46795|P2|STARTED|Overall Study||51
20828|NCT01924975|46796|P1|STARTED|Overall Study||51
20829|NCT01924949|46802|P1|NOT COMPLETED|Overall Study||0
20830|NCT01924949|46802|P1|COMPLETED|Overall Study||5
20831|NCT01924949|46802|P1|STARTED|Overall Study||5
20832|NCT01924871|46813|P2|NOT COMPLETED|Overall Study||2
20833|NCT01924871|46814|P1|NOT COMPLETED|Overall Study||6
20834|NCT01924871|46813|P2|COMPLETED|Overall Study||29
20835|NCT01924871|46814|P1|COMPLETED|Overall Study||25
20836|NCT01924871|46813|P2|STARTED|Overall Study||31
20837|NCT01924871|46814|P1|STARTED|Overall Study||31
20838|NCT01924767|46825|P5|NOT COMPLETED|Overall Study||0
20839|NCT01924767|46826|P4|NOT COMPLETED|Overall Study||0
20840|NCT01924767|46827|P3|NOT COMPLETED|Overall Study||1
20841|NCT01924767|46828|P2|NOT COMPLETED|Overall Study||0
20842|NCT01924767|46829|P1|NOT COMPLETED|Overall Study||1
20843|NCT01924767|46825|P5|COMPLETED|Overall Study||9
20844|NCT01924767|46826|P4|COMPLETED|Overall Study||9
20845|NCT01924767|46827|P3|COMPLETED|Overall Study||8
20846|NCT01924767|46828|P2|COMPLETED|Overall Study||9
20847|NCT01924767|46829|P1|COMPLETED|Overall Study||11
20848|NCT01924767|46825|P5|STARTED|Overall Study||9
20849|NCT01924767|46826|P4|STARTED|Overall Study||9
20850|NCT01924767|46827|P3|STARTED|Overall Study||9
20851|NCT01924767|46828|P2|STARTED|Overall Study||9
20852|NCT01924767|46829|P1|STARTED|Overall Study||12
20853|NCT01924559|46929|P1|NOT COMPLETED|Overall Study||0
20854|NCT01924559|46929|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
20855|NCT01924559|46929|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
20856|NCT01924390|46945|P2|NOT COMPLETED|Overall Study||1
20857|NCT01924390|46946|P1|NOT COMPLETED|Overall Study||1
20858|NCT01924390|46945|P2|COMPLETED|Overall Study||21
20859|NCT01924390|46946|P1|COMPLETED|Overall Study||21
20860|NCT01924390|46945|P2|STARTED|Overall Study||22
20861|NCT01924390|46946|P1|STARTED|Overall Study||22
20862|NCT01924182|46958|P2|NOT COMPLETED|Overall Study||0
20863|NCT01924182|46959|P1|NOT COMPLETED|Overall Study||1
20864|NCT01924182|46958|P2|COMPLETED|Overall Study||0
20865|NCT01924182|46959|P1|COMPLETED|Overall Study||2
20866|NCT01924182|46958|P2|STARTED|Overall Study||0
20867|NCT01924182|46959|P1|STARTED|Overall Study||3
20868|NCT01923896|46967|P2|NOT COMPLETED|Overall Study||0
20869|NCT01923896|46968|P1|NOT COMPLETED|Overall Study||1
20870|NCT01923896|46967|P2|COMPLETED|Overall Study||8
20871|NCT01923896|46968|P1|COMPLETED|Overall Study||7
20872|NCT01923896|46967|P2|STARTED|Overall Study||8
20873|NCT01923896|46968|P1|STARTED|Overall Study||8
20874|NCT01923467|46980|P1|NOT COMPLETED|Overall Study||541
20875|NCT01923467|46980|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
20876|NCT01923467|46980|P1|Baseline Completed, Enrolled|Overall Study||288
20877|NCT01923467|46980|P1|STARTED|Overall Study|Offered stop smoking program|767
20878|NCT01923389|46986|P2|NOT COMPLETED|Overall Study||0
20879|NCT01923389|46987|P1|NOT COMPLETED|Overall Study||1
20880|NCT01923389|46986|P2|COMPLETED|Overall Study||2
20881|NCT01923389|46987|P1|COMPLETED|Overall Study||1
20882|NCT01923389|46986|P2|STARTED|Overall Study||2
20883|NCT01923389|46987|P1|STARTED|Overall Study||2
20884|NCT01922349|47013|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
20885|NCT01922349|47014|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
20886|NCT01922349|47015|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
20887|NCT01922349|47016|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
20888|NCT01922349|47013|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
20889|NCT01922349|47014|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
20890|NCT01922349|47015|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
20891|NCT01922349|47016|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
20892|NCT01922349|47013|P4|STARTED|Multiple Rising Dose (MRD) Period||27
20893|NCT01922349|47014|P3|STARTED|Multiple Rising Dose (MRD) Period||18
20894|NCT01922349|47015|P2|STARTED|Multiple Rising Dose (MRD) Period||27
20895|NCT01922349|47016|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
20896|NCT01922349|47013|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
20897|NCT01922349|47014|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
20898|NCT01922349|47015|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
20899|NCT01922349|47016|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
20900|NCT01922349|47013|P4|COMPLETED|Single Rising Dose (SRD) Period||27
20901|NCT01922349|47014|P3|COMPLETED|Single Rising Dose (SRD) Period||18
20902|NCT01922349|47015|P2|COMPLETED|Single Rising Dose (SRD) Period||27
20903|NCT01922349|47016|P1|COMPLETED|Single Rising Dose (SRD) Period||25
20904|NCT01922349|47013|P4|STARTED|Single Rising Dose (SRD) Period||27
20905|NCT01922349|47014|P3|STARTED|Single Rising Dose (SRD) Period||18
20906|NCT01922349|47015|P2|STARTED|Single Rising Dose (SRD) Period||27
20907|NCT01922349|47016|P1|STARTED|Single Rising Dose (SRD) Period||25
20908|NCT01922271|47123|P2|NOT COMPLETED|PERIOD 2||0
20909|NCT01922271|47124|P1|NOT COMPLETED|PERIOD 2||0
20910|NCT01922271|47123|P2|COMPLETED|PERIOD 2||76
20911|NCT01922271|47124|P1|COMPLETED|PERIOD 2||75
20912|NCT01922271|47123|P2|STARTED|PERIOD 2||76
20913|NCT01922271|47124|P1|STARTED|PERIOD 2||75
20914|NCT01922271|47123|P2|NOT COMPLETED|WASHOUT Period||0
20915|NCT01922271|47124|P1|NOT COMPLETED|WASHOUT Period||1
20916|NCT01922271|47123|P2|COMPLETED|WASHOUT Period||76
20917|NCT01922271|47124|P1|COMPLETED|WASHOUT Period||75
20918|NCT01922271|47123|P2|STARTED|WASHOUT Period||76
20919|NCT01922271|47124|P1|STARTED|WASHOUT Period||76
20920|NCT01922271|47123|P2|NOT COMPLETED|PERIOD 1||0
20921|NCT01922271|47124|P1|NOT COMPLETED|PERIOD 1||0
20922|NCT01922271|47123|P2|COMPLETED|PERIOD 1||76
20923|NCT01922271|47124|P1|COMPLETED|PERIOD 1||76
20924|NCT01922271|47123|P2|STARTED|PERIOD 1||76
20925|NCT01922271|47124|P1|STARTED|PERIOD 1||76
20926|NCT01922115|47144|P2|NOT COMPLETED|Overall Study||7
20927|NCT01922115|47145|P1|NOT COMPLETED|Overall Study||7
20928|NCT01922115|47144|P2|COMPLETED|Overall Study||24
20929|NCT01922115|47145|P1|COMPLETED|Overall Study||21
20930|NCT01922115|47144|P2|STARTED|Overall Study||31
20931|NCT01922115|47145|P1|STARTED|Overall Study||28
20932|NCT01922089|47159|P2|NOT COMPLETED|Overall Study||30
20933|NCT01922089|47160|P1|NOT COMPLETED|Overall Study||39
20934|NCT01922089|47159|P2|COMPLETED|Overall Study||221
20935|NCT01922089|47160|P1|COMPLETED|Overall Study||208
20936|NCT01922089|47159|P2|Safety Set|Overall Study||251
20937|NCT01922089|47160|P1|Safety Set|Overall Study||246
20938|NCT01922089|47159|P2|STARTED|Overall Study||251
20939|NCT01922089|47160|P1|STARTED|Overall Study||247
20940|NCT01920568|47172|P2|NOT COMPLETED|Overall Study||84
20941|NCT01920568|47173|P1|NOT COMPLETED|Overall Study||151
20942|NCT01920568|47172|P2|COMPLETED|Overall Study||75
20943|NCT01920568|47173|P1|COMPLETED|Overall Study||175
20944|NCT01920568|47172|P2|STARTED|Overall Study||159
20945|NCT01920568|47173|P1|STARTED|Overall Study||326
20946|NCT01921452|47194|P1|NOT COMPLETED|Overall Study||0
20947|NCT01921452|47194|P1|COMPLETED|Overall Study||283
20948|NCT01921452|47194|P1|STARTED|Overall Study||283
20949|NCT01921296|47199|P1|NOT COMPLETED|Overall Study||0
20950|NCT01921296|47199|P1|COMPLETED|Overall Study||2
20951|NCT01921296|47199|P1|STARTED|Overall Study||2
20952|NCT01921101|47209|P2|NOT COMPLETED|Overall Study||6
20953|NCT01921101|47210|P1|NOT COMPLETED|Overall Study||16
20954|NCT01921101|47209|P2|COMPLETED|Overall Study||32
20955|NCT01921101|47210|P1|COMPLETED|Overall Study||24
20956|NCT01921101|47209|P2|STARTED|Overall Study||38
20957|NCT01921101|47210|P1|STARTED|Overall Study||40
20958|NCT01920958|47218|P1|NOT COMPLETED|Overall Study||5
20959|NCT01920958|47218|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
20960|NCT01920958|47218|P1|STARTED|Overall Study||233
20961|NCT01920854|47241|P7|NOT COMPLETED|Overall Study||1
20962|NCT01920854|47242|P6|NOT COMPLETED|Overall Study||0
20963|NCT01920854|47243|P5|NOT COMPLETED|Overall Study||1
20964|NCT01920854|47244|P4|NOT COMPLETED|Overall Study||0
20965|NCT01920854|47245|P3|NOT COMPLETED|Overall Study||0
20966|NCT01920854|47246|P2|NOT COMPLETED|Overall Study||0
20967|NCT01920854|47247|P1|NOT COMPLETED|Overall Study||1
20968|NCT01920854|47241|P7|COMPLETED|Overall Study||5
20969|NCT01920854|47242|P6|COMPLETED|Overall Study||6
20970|NCT01920854|47243|P5|COMPLETED|Overall Study||5
20971|NCT01920854|47244|P4|COMPLETED|Overall Study||6
20972|NCT01920854|47245|P3|COMPLETED|Overall Study||6
20973|NCT01920854|47246|P2|COMPLETED|Overall Study||6
20974|NCT01920854|47247|P1|COMPLETED|Overall Study||11
20975|NCT01920854|47241|P7|STARTED|Overall Study||6
20976|NCT01920854|47242|P6|STARTED|Overall Study||6
20977|NCT01920854|47243|P5|STARTED|Overall Study||6
20978|NCT01920854|47244|P4|STARTED|Overall Study||6
20979|NCT01920854|47245|P3|STARTED|Overall Study||6
20980|NCT01920854|47246|P2|STARTED|Overall Study||6
20981|NCT01920854|47247|P1|STARTED|Overall Study||12
20982|NCT01920282|47374|P3|NOT COMPLETED|Overall Study||0
20983|NCT01920282|47375|P2|NOT COMPLETED|Overall Study||0
20984|NCT01920282|47376|P1|NOT COMPLETED|Overall Study||0
20985|NCT01920282|47374|P3|COMPLETED|Overall Study||15
20986|NCT01920282|47375|P2|COMPLETED|Overall Study||15
20987|NCT01920282|47376|P1|COMPLETED|Overall Study||15
20988|NCT01920282|47374|P3|STARTED|Overall Study||15
20989|NCT01920282|47375|P2|STARTED|Overall Study||15
20990|NCT01920282|47376|P1|STARTED|Overall Study||15
20991|NCT01919996|47387|P1|NOT COMPLETED|Overall Study||0
20992|NCT01919996|47387|P1|COMPLETED|Overall Study||8
20993|NCT01919996|47387|P1|STARTED|Overall Study||8
20994|NCT01919801|47395|P2|NOT COMPLETED|Overall Study||3
20995|NCT01919801|47396|P1|NOT COMPLETED|Overall Study||1
20996|NCT01919801|47395|P2|COMPLETED|Overall Study||57
20997|NCT01919801|47396|P1|COMPLETED|Overall Study||60
20998|NCT01919801|47395|P2|STARTED|Overall Study||60
20999|NCT01919801|47396|P1|STARTED|Overall Study||61
21000|NCT01919606|47422|P2|NOT COMPLETED|Overall Study||0
21001|NCT01919606|47423|P1|NOT COMPLETED|Overall Study||0
21002|NCT01919606|47422|P2|COMPLETED|Overall Study||0
21003|NCT01919606|47423|P1|COMPLETED|Overall Study||1
21004|NCT01919606|47422|P2|STARTED|Overall Study||0
21005|NCT01919606|47423|P1|STARTED|Overall Study||1
21006|NCT01919229|47434|P3|NOT COMPLETED|Overall Study||1
21007|NCT01919229|47435|P2|NOT COMPLETED|Overall Study||0
21008|NCT01919229|47436|P1|NOT COMPLETED|Overall Study||0
21009|NCT01919229|47434|P3|COMPLETED|Overall Study||3
21010|NCT01919229|47435|P2|COMPLETED|Overall Study||6
21011|NCT01919229|47436|P1|COMPLETED|Overall Study||4
21012|NCT01919229|47434|P3|STARTED|Overall Study||4
21013|NCT01919229|47435|P2|STARTED|Overall Study||6
21014|NCT01919229|47436|P1|STARTED|Overall Study||4
21015|NCT01918371|47467|P2|NOT COMPLETED|Overall Study||1
21016|NCT01918371|47468|P1|NOT COMPLETED|Overall Study||1
21017|NCT01918371|47467|P2|COMPLETED|Overall Study||156
21018|NCT01918371|47468|P1|COMPLETED|Overall Study||165
21019|NCT01918371|47467|P2|Participants With Complete Data|Overall Study||156
21020|NCT01918371|47468|P1|Participants With Complete Data|Overall Study||165
21021|NCT01918371|47467|P2|STARTED|Overall Study||157
21022|NCT01918371|47468|P1|STARTED|Overall Study||166
21023|NCT01918332|47546|P4|NOT COMPLETED|Overall Study||7
21024|NCT01918332|47547|P3|NOT COMPLETED|Overall Study||9
21025|NCT01918332|47548|P2|NOT COMPLETED|Overall Study||5
21026|NCT01918332|47549|P1|NOT COMPLETED|Overall Study||8
21027|NCT01918332|47546|P4|COMPLETED|Overall Study||38
21028|NCT01918332|47547|P3|COMPLETED|Overall Study||30
21029|NCT01918332|47548|P2|COMPLETED|Overall Study||36
21030|NCT01918332|47549|P1|COMPLETED|Overall Study||35
21031|NCT01918332|47546|P4|STARTED|Overall Study||45
21032|NCT01918332|47547|P3|STARTED|Overall Study||39
21033|NCT01918332|47548|P2|STARTED|Overall Study||41
21034|NCT01918332|47549|P1|STARTED|Overall Study||43
21035|NCT01918085|47561|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
21036|NCT01918085|47562|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
21037|NCT01918085|47561|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
21038|NCT01918085|47562|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
21039|NCT01918085|47561|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
21040|NCT01918085|47562|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
21041|NCT01918085|47561|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
21042|NCT01918085|47562|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
21043|NCT01918085|47561|P2|COMPLETED|Test Period 2: Strata Strip||11
21044|NCT01918085|47562|P1|COMPLETED|Test Period 2: Strata Strip||10
21045|NCT01918085|47561|P2|STARTED|Test Period 2: Strata Strip||11
21046|NCT01918085|47562|P1|STARTED|Test Period 2: Strata Strip||10
21047|NCT01918085|47561|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
21048|NCT01918085|47562|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
21049|NCT01918085|47561|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
21050|NCT01918085|47562|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
21051|NCT01918085|47561|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
21052|NCT01918085|47562|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
21053|NCT01918085|47561|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
21054|NCT01918085|47562|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
21055|NCT01918085|47561|P2|COMPLETED|Test Period 1: Strata Strip||11
21056|NCT01918085|47562|P1|COMPLETED|Test Period 1: Strata Strip||10
21057|NCT01918085|47561|P2|STARTED|Test Period 1: Strata Strip||12
21058|NCT01918085|47562|P1|STARTED|Test Period 1: Strata Strip||10
21059|NCT01918033|47573|P3|NOT COMPLETED|Overall Study||3
21060|NCT01918033|47574|P2|NOT COMPLETED|Overall Study||2
21061|NCT01918033|47575|P1|NOT COMPLETED|Overall Study||5
21062|NCT01918033|47573|P3|COMPLETED|Overall Study||199
21063|NCT01918033|47574|P2|COMPLETED|Overall Study||201
21064|NCT01918033|47575|P1|COMPLETED|Overall Study||198
21065|NCT01918033|47573|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
21066|NCT01918033|47574|P2|Treated|Overall Study||203
21067|NCT01918033|47575|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
21068|NCT01918033|47573|P3|STARTED|Overall Study||202
21069|NCT01918033|47574|P2|STARTED|Overall Study||203
21070|NCT01918033|47575|P1|STARTED|Overall Study||203
21071|NCT01917812|47616|P3|NOT COMPLETED|Overall Study||0
21072|NCT01917812|47617|P2|NOT COMPLETED|Overall Study||0
21073|NCT01917812|47618|P1|NOT COMPLETED|Overall Study||1
21074|NCT01917812|47616|P3|COMPLETED|Overall Study||16
21075|NCT01917812|47617|P2|COMPLETED|Overall Study||16
21076|NCT01917812|47618|P1|COMPLETED|Overall Study||15
21077|NCT01917812|47616|P3|STARTED|Overall Study||16
21078|NCT01917812|47617|P2|STARTED|Overall Study||16
21079|NCT01917812|47618|P1|STARTED|Overall Study||16
21080|NCT01917773|47638|P1|NOT COMPLETED|Overall Study||0
21081|NCT01917773|47638|P1|COMPLETED|Overall Study||13
21082|NCT01917773|47638|P1|STARTED|Overall Study||13
21083|NCT01917656|47646|P2|NOT COMPLETED|Overall Study||24
21084|NCT01917656|47647|P1|NOT COMPLETED|Overall Study||26
21085|NCT01917656|47646|P2|COMPLETED|Overall Study||147
21086|NCT01917656|47647|P1|COMPLETED|Overall Study||146
21087|NCT01917656|47646|P2|Exposed During Ramadan (Fasting)|Overall Study||163
21088|NCT01917656|47647|P1|Exposed During Ramadan (Fasting)|Overall Study||152
21089|NCT01917656|47646|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
21090|NCT01917656|47647|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
21091|NCT01917656|47646|P2|STARTED|Overall Study||171
21092|NCT01917656|47647|P1|STARTED|Overall Study||172
21093|NCT01917526|47673|P2|NOT COMPLETED|Overall Study||1
21094|NCT01917526|47674|P1|NOT COMPLETED|Overall Study||1
21095|NCT01917526|47673|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
21096|NCT01917526|47674|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
21097|NCT01917526|47673|P2|STARTED|Overall Study||250
21098|NCT01917526|47674|P1|STARTED|Overall Study||250
21099|NCT01917344|47682|P1|NOT COMPLETED|Overall Study||1
21100|NCT01917344|47682|P1|COMPLETED|Overall Study||9
21101|NCT01917344|47682|P1|STARTED|Overall Study||10
21102|NCT01917214|47686|P1|NOT COMPLETED|Overall Study||0
21103|NCT01917214|47686|P1|COMPLETED|Overall Study||212
21104|NCT01917214|47686|P1|STARTED|Overall Study||212
21105|NCT01916980|47697|P2|NOT COMPLETED|Overall Study||4
21106|NCT01916980|47698|P1|NOT COMPLETED|Overall Study||7
21107|NCT01916980|47697|P2|COMPLETED|Overall Study||25
21108|NCT01916980|47698|P1|COMPLETED|Overall Study||58
21109|NCT01916980|47697|P2|STARTED|Overall Study||29
21110|NCT01916980|47698|P1|STARTED|Overall Study||65
21111|NCT01916967|47717|P3|NOT COMPLETED|Overall Study||9
21112|NCT01916967|47718|P2|NOT COMPLETED|Overall Study||1
21113|NCT01916967|47719|P1|NOT COMPLETED|Overall Study||0
21114|NCT01916967|47717|P3|COMPLETED|Overall Study||71
21115|NCT01916967|47718|P2|COMPLETED|Overall Study||78
21116|NCT01916967|47719|P1|COMPLETED|Overall Study||80
21117|NCT01916967|47717|P3|STARTED|Overall Study||80
21118|NCT01916967|47718|P2|STARTED|Overall Study||79
21119|NCT01916967|47719|P1|STARTED|Overall Study||80
21120|NCT01916928|47760|P1|NOT COMPLETED|Overall Study||0
21121|NCT01916928|47760|P1|COMPLETED|Overall Study||50
21122|NCT01916928|47760|P1|STARTED|Overall Study||50
21123|NCT01916681|47768|P4|NOT COMPLETED|Overall Study||0
21124|NCT01916681|47769|P3|NOT COMPLETED|Overall Study||0
21125|NCT01916681|47770|P2|NOT COMPLETED|Overall Study||0
21126|NCT01916681|47771|P1|NOT COMPLETED|Overall Study||0
21127|NCT01916681|47768|P4|COMPLETED|Overall Study||125
21128|NCT01916681|47769|P3|COMPLETED|Overall Study||123
21129|NCT01916681|47770|P2|COMPLETED|Overall Study||120
21130|NCT01916681|47771|P1|COMPLETED|Overall Study||123
21131|NCT01916681|47768|P4|STARTED|Overall Study||125
21132|NCT01916681|47769|P3|STARTED|Overall Study||123
21133|NCT01916681|47770|P2|STARTED|Overall Study||120
21134|NCT01916681|47771|P1|STARTED|Overall Study||123
21135|NCT01916629|47811|P2|NOT COMPLETED|Overall Study||0
21136|NCT01916629|47812|P1|NOT COMPLETED|Overall Study||0
21137|NCT01916629|47811|P2|COMPLETED|Overall Study||5
21138|NCT01916629|47812|P1|COMPLETED|Overall Study||7
21139|NCT01916629|47811|P2|STARTED|Overall Study||5
21140|NCT01916629|47812|P1|STARTED|Overall Study||7
21141|NCT01916590|47820|P2|NOT COMPLETED|Overall Study||0
21142|NCT01916590|47821|P1|NOT COMPLETED|Overall Study||0
21143|NCT01916590|47820|P2|COMPLETED|Overall Study||3
21144|NCT01916590|47821|P1|COMPLETED|Overall Study||4
21145|NCT01916590|47820|P2|STARTED|Overall Study||3
21146|NCT01916590|47821|P1|STARTED|Overall Study||4
21147|NCT01916304|47827|P1|NOT COMPLETED|Overall Study||17
21148|NCT01916304|47827|P1|COMPLETED|Overall Study||84
21149|NCT01916304|47827|P1|Intent-to-Treat Set|Overall Study||84
21150|NCT01916304|47827|P1|Safety Set|Overall Study||101
21151|NCT01916304|47827|P1|STARTED|Overall Study||101
21152|NCT01916226|47839|P4|NOT COMPLETED|Overall Study||4
21153|NCT01916226|47840|P3|NOT COMPLETED|Overall Study||3
21154|NCT01916226|47841|P2|NOT COMPLETED|Overall Study||1
21155|NCT01916226|47842|P1|NOT COMPLETED|Overall Study||1
21156|NCT01916226|47839|P4|COMPLETED|Overall Study||167
21157|NCT01916226|47840|P3|COMPLETED|Overall Study||168
21158|NCT01916226|47841|P2|COMPLETED|Overall Study||169
21159|NCT01916226|47842|P1|COMPLETED|Overall Study||169
21160|NCT01916226|47839|P4|STARTED|Overall Study||171
21161|NCT01916226|47840|P3|STARTED|Overall Study||171
21162|NCT01916226|47841|P2|STARTED|Overall Study||170
21163|NCT01916226|47842|P1|STARTED|Overall Study||170
21164|NCT01916109|47876|P1|NOT COMPLETED|Overall Study||1
21165|NCT01916109|47876|P1|COMPLETED|Overall Study||3
21166|NCT01916109|47876|P1|STARTED|Overall Study||4
21167|NCT01915914|47880|P4|NOT COMPLETED|Follow-up Phase||2
21168|NCT01915914|47881|P3|NOT COMPLETED|Follow-up Phase||0
21169|NCT01915914|47882|P2|NOT COMPLETED|Follow-up Phase||0
21170|NCT01915914|47883|P1|NOT COMPLETED|Follow-up Phase||0
21171|NCT01915914|47880|P4|COMPLETED|Follow-up Phase||64
21172|NCT01915914|47881|P3|COMPLETED|Follow-up Phase||0
21173|NCT01915914|47882|P2|COMPLETED|Follow-up Phase||0
21174|NCT01915914|47883|P1|COMPLETED|Follow-up Phase||0
21175|NCT01915914|47880|P4|STARTED|Follow-up Phase||66
21176|NCT01915914|47881|P3|STARTED|Follow-up Phase||0
21177|NCT01915914|47882|P2|STARTED|Follow-up Phase||0
21178|NCT01915914|47883|P1|STARTED|Follow-up Phase||0
21179|NCT01915914|47880|P4|NOT COMPLETED|Maintenance Phase||0
21180|NCT01915914|47881|P3|NOT COMPLETED|Maintenance Phase||2
21181|NCT01915914|47882|P2|NOT COMPLETED|Maintenance Phase||6
21182|NCT01915914|47883|P1|NOT COMPLETED|Maintenance Phase||0
21183|NCT01915914|47880|P4|COMPLETED|Maintenance Phase||0
21184|NCT01915914|47881|P3|COMPLETED|Maintenance Phase||51
21185|NCT01915914|47882|P2|COMPLETED|Maintenance Phase||48
21186|NCT01915914|47883|P1|COMPLETED|Maintenance Phase||0
21187|NCT01915914|47880|P4|STARTED|Maintenance Phase||0
21188|NCT01915914|47881|P3|STARTED|Maintenance Phase||53
21189|NCT01915914|47882|P2|STARTED|Maintenance Phase||54
21190|NCT01915914|47883|P1|STARTED|Maintenance Phase||0
21191|NCT01915914|47880|P4|NOT COMPLETED|Acute Phase||0
21192|NCT01915914|47881|P3|NOT COMPLETED|Acute Phase||0
21193|NCT01915914|47882|P2|NOT COMPLETED|Acute Phase||0
21194|NCT01915914|47883|P1|NOT COMPLETED|Acute Phase||12
21195|NCT01915914|47880|P4|COMPLETED|Acute Phase||0
21196|NCT01915914|47881|P3|COMPLETED|Acute Phase||0
21197|NCT01915914|47882|P2|COMPLETED|Acute Phase||0
21198|NCT01915914|47883|P1|COMPLETED|Acute Phase||111
21199|NCT01915914|47880|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
21200|NCT01915914|47881|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
21201|NCT01915914|47882|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
21202|NCT01915914|47883|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
21203|NCT01915914|47880|P4|STARTED|Acute Phase||0
21204|NCT01915914|47881|P3|STARTED|Acute Phase||0
21205|NCT01915914|47882|P2|STARTED|Acute Phase||0
21206|NCT01915914|47883|P1|STARTED|Acute Phase||123
21207|NCT01915849|47915|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
21208|NCT01915849|47916|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
21209|NCT01915849|47917|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
21210|NCT01915849|47918|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
21211|NCT01915849|47915|P4|COMPLETED|Treatment Period 4 (4 Days)||3
21212|NCT01915849|47916|P3|COMPLETED|Treatment Period 4 (4 Days)||3
21213|NCT01915849|47917|P2|COMPLETED|Treatment Period 4 (4 Days)||3
21214|NCT01915849|47918|P1|COMPLETED|Treatment Period 4 (4 Days)||3
21215|NCT01915849|47915|P4|STARTED|Treatment Period 4 (4 Days)||3
21216|NCT01915849|47916|P3|STARTED|Treatment Period 4 (4 Days)||3
21217|NCT01915849|47917|P2|STARTED|Treatment Period 4 (4 Days)||3
21218|NCT01915849|47918|P1|STARTED|Treatment Period 4 (4 Days)||3
21219|NCT01915849|47915|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
21220|NCT01915849|47916|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
21221|NCT01915849|47917|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
21222|NCT01915849|47918|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
21223|NCT01915849|47915|P4|COMPLETED|Treatment Period 3 (4 Days)||3
21224|NCT01915849|47916|P3|COMPLETED|Treatment Period 3 (4 Days)||3
21225|NCT01915849|47917|P2|COMPLETED|Treatment Period 3 (4 Days)||3
21226|NCT01915849|47918|P1|COMPLETED|Treatment Period 3 (4 Days)||3
21227|NCT01915849|47915|P4|STARTED|Treatment Period 3 (4 Days)||3
21228|NCT01915849|47916|P3|STARTED|Treatment Period 3 (4 Days)||3
21229|NCT01915849|47917|P2|STARTED|Treatment Period 3 (4 Days)||3
21230|NCT01915849|47918|P1|STARTED|Treatment Period 3 (4 Days)||3
21231|NCT01915849|47915|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21232|NCT01915849|47916|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21233|NCT01915849|47917|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21234|NCT01915849|47918|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21235|NCT01915849|47915|P4|COMPLETED|Treatment Period 2 (4 Days)||3
21236|NCT01915849|47916|P3|COMPLETED|Treatment Period 2 (4 Days)||3
21237|NCT01915849|47917|P2|COMPLETED|Treatment Period 2 (4 Days)||3
21238|NCT01915849|47918|P1|COMPLETED|Treatment Period 2 (4 Days)||3
21239|NCT01915849|47915|P4|STARTED|Treatment Period 2 (4 Days)||3
21240|NCT01915849|47916|P3|STARTED|Treatment Period 2 (4 Days)||3
21241|NCT01915849|47917|P2|STARTED|Treatment Period 2 (4 Days)||3
21242|NCT01915849|47918|P1|STARTED|Treatment Period 2 (4 Days)||3
21243|NCT01915849|47915|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21244|NCT01915849|47916|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21245|NCT01915849|47917|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21246|NCT01915849|47918|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
21247|NCT01915849|47915|P4|COMPLETED|Treatment Period 1 (4 Days)||3
21248|NCT01915849|47916|P3|COMPLETED|Treatment Period 1 (4 Days)||3
21249|NCT01915849|47917|P2|COMPLETED|Treatment Period 1 (4 Days)||3
21250|NCT01915849|47918|P1|COMPLETED|Treatment Period 1 (4 Days)||3
21251|NCT01915849|47915|P4|STARTED|Treatment Period 1 (4 Days)||3
21252|NCT01915849|47916|P3|STARTED|Treatment Period 1 (4 Days)||3
21253|NCT01915849|47917|P2|STARTED|Treatment Period 1 (4 Days)||3
21254|NCT01915849|47918|P1|STARTED|Treatment Period 1 (4 Days)||5
21255|NCT01915823|47930|P2|NOT COMPLETED|Overall Study||2
21256|NCT01915823|47931|P1|NOT COMPLETED|Overall Study||2
21257|NCT01915823|47930|P2|COMPLETED|Overall Study||173
21258|NCT01915823|47931|P1|COMPLETED|Overall Study||171
21259|NCT01915823|47930|P2|STARTED|Overall Study||175
21260|NCT01915823|47931|P1|STARTED|Overall Study||173
21261|NCT01915732|47943|P2|NOT COMPLETED|Overall Study||71
21262|NCT01915732|47944|P1|NOT COMPLETED|Overall Study||70
21263|NCT01915732|47943|P2|COMPLETED|Overall Study||445
21264|NCT01915732|47944|P1|COMPLETED|Overall Study||430
21265|NCT01915732|47943|P2|STARTED|Overall Study||516
21266|NCT01915732|47944|P1|STARTED|Overall Study||500
21267|NCT01915108|47972|P4|NOT COMPLETED|Overall Study||2
21268|NCT01915108|47973|P3|NOT COMPLETED|Overall Study||1
21269|NCT01915108|47974|P2|NOT COMPLETED|Overall Study||3
21270|NCT01915108|47975|P1|NOT COMPLETED|Overall Study||2
21271|NCT01915108|47972|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
21272|NCT01915108|47973|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
21273|NCT01915108|47974|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
21274|NCT01915108|47975|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
21275|NCT01915108|47972|P4|STARTED|Overall Study||32
21276|NCT01915108|47973|P3|STARTED|Overall Study||32
21277|NCT01915108|47974|P2|STARTED|Overall Study||32
21278|NCT01915108|47975|P1|STARTED|Overall Study||32
21279|NCT01914926|47987|P2|NOT COMPLETED|Overall Study||1
21280|NCT01914926|47988|P1|NOT COMPLETED|Overall Study||1
21281|NCT01914926|47987|P2|COMPLETED|Overall Study||24
21282|NCT01914926|47988|P1|COMPLETED|Overall Study||28
21283|NCT01914926|47987|P2|STARTED|Overall Study||25
21284|NCT01914926|47988|P1|STARTED|Overall Study||29
21285|NCT01914757|47997|P3|NOT COMPLETED|Overall Study||38
21286|NCT01914757|47998|P2|NOT COMPLETED|Overall Study||51
21287|NCT01914757|47999|P1|NOT COMPLETED|Overall Study||36
21288|NCT01914757|47997|P3|COMPLETED|Overall Study||402
21289|NCT01914757|47998|P2|COMPLETED|Overall Study||390
21290|NCT01914757|47999|P1|COMPLETED|Overall Study||389
21291|NCT01914757|47997|P3|STARTED|Overall Study||440
21292|NCT01914757|47998|P2|STARTED|Overall Study||441
21293|NCT01914757|47999|P1|STARTED|Overall Study||425
21294|NCT01914666|48076|P3|NOT COMPLETED|Tapering Period||0
21295|NCT01914666|48077|P2|NOT COMPLETED|Tapering Period||0
21296|NCT01914666|48078|P1|NOT COMPLETED|Tapering Period||0
21297|NCT01914666|48076|P3|COMPLETED|Tapering Period||40
21298|NCT01914666|48077|P2|COMPLETED|Tapering Period||39
21299|NCT01914666|48078|P1|COMPLETED|Tapering Period||59
21300|NCT01914666|48076|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
21301|NCT01914666|48077|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
21302|NCT01914666|48078|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
21303|NCT01914666|48076|P3|NOT COMPLETED|Treatment Period||8
21304|NCT01914666|48077|P2|NOT COMPLETED|Treatment Period||6
21305|NCT01914666|48078|P1|NOT COMPLETED|Treatment Period||13
21306|NCT01914666|48076|P3|COMPLETED|Treatment Period||33
21307|NCT01914666|48077|P2|COMPLETED|Treatment Period||36
21308|NCT01914666|48078|P1|COMPLETED|Treatment Period||55
21309|NCT01914666|48076|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
21310|NCT01914666|48077|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
21311|NCT01914666|48078|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
21312|NCT01914666|48076|P3|STARTED|Treatment Period||41
21313|NCT01914666|48077|P2|STARTED|Treatment Period||42
21314|NCT01914666|48078|P1|STARTED|Treatment Period||68
21315|NCT01914003|48113|P2|NOT COMPLETED|Overall Study||12
21316|NCT01914003|48114|P1|NOT COMPLETED|Overall Study||8
21317|NCT01914003|48113|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
21318|NCT01914003|48114|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
21319|NCT01914003|48113|P2|STARTED|Overall Study||26
21320|NCT01914003|48114|P1|STARTED|Overall Study||27
21321|NCT01913795|48124|P4|NOT COMPLETED|Overall Study||1
21322|NCT01913795|48125|P3|NOT COMPLETED|Overall Study||0
21323|NCT01913795|48126|P2|NOT COMPLETED|Overall Study||3
21324|NCT01913795|48127|P1|NOT COMPLETED|Overall Study||0
21325|NCT01913795|48124|P4|COMPLETED|Overall Study||5
21326|NCT01913795|48125|P3|COMPLETED|Overall Study||9
21327|NCT01913795|48126|P2|COMPLETED|Overall Study||7
21328|NCT01913795|48127|P1|COMPLETED|Overall Study||4
21329|NCT01913795|48124|P4|STARTED|Overall Study||6
21330|NCT01913795|48125|P3|STARTED|Overall Study||9
21331|NCT01913795|48126|P2|STARTED|Overall Study||10
21332|NCT01913795|48127|P1|STARTED|Overall Study||4
21333|NCT01913041|48141|P1|NOT COMPLETED|Overall Study||39
21334|NCT01913041|48141|P1|COMPLETED|Overall Study||830
21335|NCT01913041|48141|P1|STARTED|Overall Study||869
21336|NCT01912781|48147|P2|NOT COMPLETED|Overall Study||0
21337|NCT01912781|48148|P1|NOT COMPLETED|Overall Study||2
21338|NCT01912781|48147|P2|COMPLETED|Overall Study||35
21339|NCT01912781|48148|P1|COMPLETED|Overall Study||69
21340|NCT01912781|48147|P2|STARTED|Overall Study||35
21341|NCT01912781|48148|P1|STARTED|Overall Study||71
21342|NCT01912768|48179|P2|NOT COMPLETED|Overall Study||4
21343|NCT01912768|48180|P1|NOT COMPLETED|Overall Study||10
21344|NCT01912768|48179|P2|COMPLETED|Overall Study||109
21345|NCT01912768|48180|P1|COMPLETED|Overall Study||229
21346|NCT01912768|48179|P2|STARTED|Overall Study||113
21347|NCT01912768|48180|P1|STARTED|Overall Study||239
21348|NCT01912599|48211|P2|NOT COMPLETED|Overall Study||1
21349|NCT01912599|48212|P1|NOT COMPLETED|Overall Study||0
21350|NCT01912599|48211|P2|COMPLETED|Overall Study||15
21351|NCT01912599|48212|P1|COMPLETED|Overall Study||20
21352|NCT01912599|48211|P2|STARTED|Overall Study||16
21353|NCT01912599|48212|P1|STARTED|Overall Study||20
21354|NCT01912495|48226|P1|NOT COMPLETED|Overall Study||0
21355|NCT01912495|48226|P1|COMPLETED|Overall Study||57
21356|NCT01912495|48226|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
21357|NCT01912404|48237|P2|NOT COMPLETED|Overall Study||0
21358|NCT01912404|48238|P1|NOT COMPLETED|Overall Study||1
21359|NCT01912404|48237|P2|COMPLETED|Overall Study||2
21360|NCT01912404|48238|P1|COMPLETED|Overall Study||2
21361|NCT01912404|48237|P2|STARTED|Overall Study||2
21362|NCT01912404|48238|P1|STARTED|Overall Study||3
21363|NCT01912352|48244|P1|NOT COMPLETED|Overall Study||5
21364|NCT01912352|48244|P1|COMPLETED|Overall Study||78
21365|NCT01912352|48244|P1|STARTED|Overall Study||83
21366|NCT01912222|48252|P3|NOT COMPLETED|Part B: Treatment Period||20
21367|NCT01912222|48253|P2|NOT COMPLETED|Part B: Treatment Period||15
21368|NCT01912222|48254|P1|NOT COMPLETED|Part B: Treatment Period||13
21369|NCT01912222|48252|P3|COMPLETED|Part B: Treatment Period||0
21370|NCT01912222|48253|P2|COMPLETED|Part B: Treatment Period||0
21371|NCT01912222|48254|P1|COMPLETED|Part B: Treatment Period||0
21372|NCT01912222|48252|P3|STARTED|Part B: Treatment Period||20
21373|NCT01912222|48253|P2|STARTED|Part B: Treatment Period||15
21374|NCT01912222|48254|P1|STARTED|Part B: Treatment Period||13
21375|NCT01912222|48252|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
21376|NCT01912222|48253|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
21377|NCT01912222|48254|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
21378|NCT01912222|48252|P3|COMPLETED|Part A: Pharmacokinetic Period||18
21379|NCT01912222|48253|P2|COMPLETED|Part A: Pharmacokinetic Period||13
21380|NCT01912222|48254|P1|COMPLETED|Part A: Pharmacokinetic Period||12
21381|NCT01912222|48252|P3|STARTED|Part A: Pharmacokinetic Period||20
21382|NCT01912222|48253|P2|STARTED|Part A: Pharmacokinetic Period||15
21383|NCT01912222|48254|P1|STARTED|Part A: Pharmacokinetic Period||13
21384|NCT01911845|48277|P1|NOT COMPLETED|Overall Study||6
21385|NCT01911845|48277|P1|COMPLETED|Overall Study||32
21386|NCT01911845|48277|P1|Completed Study Drug|Overall Study||37
21387|NCT01911845|48277|P1|STARTED|Overall Study||38
21388|NCT01911780|48293|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
21389|NCT01911780|48294|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
21390|NCT01911780|48293|P2|COMPLETED|Extension Period (52 Weeks)||58
21391|NCT01911780|48294|P1|COMPLETED|Extension Period (52 Weeks)||61
21392|NCT01911780|48293|P2|STARTED|Extension Period (52 Weeks)||61
21393|NCT01911780|48294|P1|STARTED|Extension Period (52 Weeks)||65
21394|NCT01911780|48293|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
21395|NCT01911780|48294|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
21396|NCT01911780|48293|P2|COMPLETED|Double-blind Period (8 Weeks)||61
21397|NCT01911780|48294|P1|COMPLETED|Double-blind Period (8 Weeks)||65
21398|NCT01911780|48293|P2|STARTED|Double-blind Period (8 Weeks)||64
21399|NCT01911780|48294|P1|STARTED|Double-blind Period (8 Weeks)||68
21400|NCT01911689|48314|P2|NOT COMPLETED|Overall Study||0
21401|NCT01911689|48315|P1|NOT COMPLETED|Overall Study||0
21402|NCT01911689|48314|P2|COMPLETED|Overall Study||51
21403|NCT01911689|48315|P1|COMPLETED|Overall Study||117
21404|NCT01911689|48314|P2|STARTED|Overall Study||51
21405|NCT01911689|48315|P1|STARTED|Overall Study||117
21406|NCT01911442|48331|P3|NOT COMPLETED|Overall Study||12
21407|NCT01911442|48332|P2|NOT COMPLETED|Overall Study||4
21408|NCT01911442|48333|P1|NOT COMPLETED|Overall Study||6
21409|NCT01911442|48331|P3|COMPLETED|Overall Study||38
21410|NCT01911442|48332|P2|COMPLETED|Overall Study||47
21411|NCT01911442|48333|P1|COMPLETED|Overall Study||43
21412|NCT01911442|48331|P3|STARTED|Overall Study||50
21413|NCT01911442|48332|P2|STARTED|Overall Study||51
21414|NCT01911442|48333|P1|STARTED|Overall Study||49
21415|NCT01911403|48361|P2|NOT COMPLETED|Overall Study||3
21416|NCT01911403|48362|P1|NOT COMPLETED|Overall Study||9
21417|NCT01911403|48361|P2|COMPLETED|Overall Study||59
21418|NCT01911403|48362|P1|COMPLETED|Overall Study||52
21419|NCT01911403|48361|P2|STARTED|Overall Study||62
21420|NCT01911403|48362|P1|STARTED|Overall Study||61
21421|NCT01911351|48381|P2|NOT COMPLETED|Overall Study||0
21422|NCT01911351|48382|P1|NOT COMPLETED|Overall Study||0
21423|NCT01911351|48381|P2|COMPLETED|Overall Study||43
21424|NCT01911351|48382|P1|COMPLETED|Overall Study||39
21425|NCT01911351|48381|P2|STARTED|Overall Study||43
21426|NCT01911351|48382|P1|STARTED|Overall Study||39
21427|NCT01911273|48398|P2|NOT COMPLETED|Overall Study||2
21428|NCT01911273|48399|P1|NOT COMPLETED|Overall Study||1
21429|NCT01911273|48398|P2|COMPLETED|Overall Study||0
21430|NCT01911273|48399|P1|COMPLETED|Overall Study||0
21431|NCT01911273|48398|P2|STARTED|Overall Study||2
21432|NCT01911273|48399|P1|STARTED|Overall Study||1
21433|NCT01911260|48433|P4|NOT COMPLETED|Follow-up Period||12
21434|NCT01911260|48434|P3|NOT COMPLETED|Follow-up Period||15
21435|NCT01911260|48435|P2|NOT COMPLETED|Follow-up Period||20
21436|NCT01911260|48436|P1|NOT COMPLETED|Follow-up Period||13
21437|NCT01911260|48433|P4|COMPLETED|Follow-up Period||30
21438|NCT01911260|48434|P3|COMPLETED|Follow-up Period||24
21439|NCT01911260|48435|P2|COMPLETED|Follow-up Period||18
21440|NCT01911260|48436|P1|COMPLETED|Follow-up Period||27
21441|NCT01911260|48433|P4|STARTED|Follow-up Period||42
21442|NCT01911260|48434|P3|STARTED|Follow-up Period||39
21443|NCT01911260|48435|P2|STARTED|Follow-up Period||38
21444|NCT01911260|48436|P1|STARTED|Follow-up Period||40
21445|NCT01911260|48433|P4|NOT COMPLETED|Supplementation Period||8
21446|NCT01911260|48434|P3|NOT COMPLETED|Supplementation Period||10
21447|NCT01911260|48435|P2|NOT COMPLETED|Supplementation Period||12
21448|NCT01911260|48436|P1|NOT COMPLETED|Supplementation Period||10
21449|NCT01911260|48433|P4|COMPLETED|Supplementation Period||42
21450|NCT01911260|48434|P3|COMPLETED|Supplementation Period||39
21451|NCT01911260|48435|P2|COMPLETED|Supplementation Period||38
21452|NCT01911260|48436|P1|COMPLETED|Supplementation Period||40
21453|NCT01911260|48433|P4|STARTED|Supplementation Period||50
21454|NCT01911260|48434|P3|STARTED|Supplementation Period||49
21455|NCT01911260|48435|P2|STARTED|Supplementation Period||50
21456|NCT01911260|48436|P1|STARTED|Supplementation Period||50
21457|NCT01911221|48446|P1|NOT COMPLETED|Overall Study||0
21458|NCT01911221|48446|P1|COMPLETED|Overall Study||13
21459|NCT01911221|48446|P1|STARTED|Overall Study||13
21460|NCT01910831|48460|P1|NOT COMPLETED|Overall Study||1
21461|NCT01910831|48460|P1|COMPLETED|Overall Study||19
21462|NCT01910831|48460|P1|STARTED|Overall Study||20
21463|NCT01910688|48467|P1|NOT COMPLETED|Overall Study||5
21464|NCT01910688|48467|P1|COMPLETED|Overall Study||20
21465|NCT01910688|48467|P1|12months|Overall Study||22
21466|NCT01910688|48467|P1|3rd RFA Treatment|Overall Study||18
21467|NCT01910688|48467|P1|7.5months|Overall Study||24
21468|NCT01910688|48467|P1|2nd RFA Treatment|Overall Study||22
21469|NCT01910688|48467|P1|3.5month|Overall Study||25
21470|NCT01910688|48467|P1|STARTED|Overall Study||25
21471|NCT01910636|48476|P2|NOT COMPLETED|Overall Study||0
21472|NCT01910636|48477|P1|NOT COMPLETED|Overall Study||0
21473|NCT01910636|48476|P2|COMPLETED|Overall Study||63
21474|NCT01910636|48477|P1|COMPLETED|Overall Study||90
21475|NCT01910636|48476|P2|STARTED|Overall Study||63
21476|NCT01910636|48477|P1|STARTED|Overall Study||90
21477|NCT01910441|48491|P2|NOT COMPLETED|Overall Study||10
21478|NCT01910441|48492|P1|NOT COMPLETED|Overall Study||7
21479|NCT01910441|48491|P2|COMPLETED|Overall Study||37
21480|NCT01910441|48492|P1|COMPLETED|Overall Study||41
21481|NCT01910441|48491|P2|STARTED|Overall Study||47
21482|NCT01910441|48492|P1|STARTED|Overall Study||48
21483|NCT01910402|48500|P2|NOT COMPLETED|Continuation Phase||0
21484|NCT01910402|48501|P1|NOT COMPLETED|Continuation Phase||90
21485|NCT01910402|48500|P2|COMPLETED|Continuation Phase||0
21486|NCT01910402|48501|P1|COMPLETED|Continuation Phase||30
21487|NCT01910402|48500|P2|STARTED|Continuation Phase||0
21488|NCT01910402|48501|P1|STARTED|Continuation Phase||120
21489|NCT01910402|48500|P2|NOT COMPLETED|Randomized Phase||55
21490|NCT01910402|48501|P1|NOT COMPLETED|Randomized Phase||42
21491|NCT01910402|48500|P2|COMPLETED|Randomized Phase||192
21492|NCT01910402|48501|P1|COMPLETED|Randomized Phase||206
21493|NCT01910402|48500|P2|STARTED|Randomized Phase||247
21494|NCT01910402|48501|P1|STARTED|Randomized Phase||248
21495|NCT01910389|48571|P2|NOT COMPLETED|Overall Study||8
21496|NCT01910389|48572|P1|NOT COMPLETED|Overall Study||15
21497|NCT01910389|48571|P2|COMPLETED|Overall Study||0
21498|NCT01910389|48572|P1|COMPLETED|Overall Study||0
21499|NCT01910389|48571|P2|STARTED|Overall Study||8
21500|NCT01910389|48572|P1|STARTED|Overall Study||15
21501|NCT01910181|48602|P1|NOT COMPLETED|Overall Study||46
21502|NCT01910181|48602|P1|COMPLETED|Overall Study||0
21503|NCT01910181|48602|P1|Expansion Cohort|Overall Study||26
21504|NCT01910181|48602|P1|PK Cohort|Overall Study||20
21505|NCT01910181|48602|P1|STARTED|Overall Study||46
21506|NCT01910116|48629|P2|NOT COMPLETED|Overall Study||16
21507|NCT01910116|48630|P1|NOT COMPLETED|Overall Study||14
21508|NCT01910116|48629|P2|COMPLETED|Overall Study||94
21509|NCT01910116|48630|P1|COMPLETED|Overall Study||96
21510|NCT01910116|48629|P2|Week 16|Overall Study||94
21511|NCT01910116|48630|P1|Week 16|Overall Study||96
21512|NCT01910116|48629|P2|Week 12|Overall Study||96
21513|NCT01910116|48630|P1|Week 12|Overall Study||97
21514|NCT01910116|48629|P2|Week 8|Overall Study||99
21515|NCT01910116|48630|P1|Week 8|Overall Study||98
21516|NCT01910116|48629|P2|Week 4|Overall Study||102
21517|NCT01910116|48630|P1|Week 4|Overall Study||106
21518|NCT01910116|48629|P2|STARTED|Overall Study||110
21519|NCT01910116|48630|P1|STARTED|Overall Study||110
21520|NCT01910064|48706|P1|NOT COMPLETED|Overall Study||45
21521|NCT01910064|48706|P1|COMPLETED|Overall Study||391
21522|NCT01910064|48706|P1|STARTED|Overall Study||436
21523|NCT01909804|48727|P12|NOT COMPLETED|Overall Study||3
21524|NCT01909804|48728|P11|NOT COMPLETED|Overall Study||1
21525|NCT01909804|48729|P10|NOT COMPLETED|Overall Study||1
21526|NCT01909804|48730|P9|NOT COMPLETED|Overall Study||0
21527|NCT01909804|48731|P8|NOT COMPLETED|Overall Study||1
21528|NCT01909804|48732|P7|NOT COMPLETED|Overall Study||2
21529|NCT01909804|48733|P6|NOT COMPLETED|Overall Study||4
21530|NCT01909804|48734|P5|NOT COMPLETED|Overall Study||8
21531|NCT01909804|48735|P4|NOT COMPLETED|Overall Study||0
21532|NCT01909804|48736|P3|NOT COMPLETED|Overall Study||0
21533|NCT01909804|48737|P2|NOT COMPLETED|Overall Study||1
21534|NCT01909804|48738|P1|NOT COMPLETED|Overall Study||4
21535|NCT01909804|48727|P12|COMPLETED|Overall Study||26
21536|NCT01909804|48728|P11|COMPLETED|Overall Study||26
21537|NCT01909804|48729|P10|COMPLETED|Overall Study||28
21538|NCT01909804|48730|P9|COMPLETED|Overall Study||27
21539|NCT01909804|48731|P8|COMPLETED|Overall Study||25
21540|NCT01909804|48732|P7|COMPLETED|Overall Study||25
21541|NCT01909804|48733|P6|COMPLETED|Overall Study||21
21542|NCT01909804|48734|P5|COMPLETED|Overall Study||18
21543|NCT01909804|48735|P4|COMPLETED|Overall Study||26
21544|NCT01909804|48736|P3|COMPLETED|Overall Study||27
21545|NCT01909804|48737|P2|COMPLETED|Overall Study||27
21546|NCT01909804|48738|P1|COMPLETED|Overall Study||22
21547|NCT01909804|48727|P12|STARTED|Overall Study||29
21548|NCT01909804|48728|P11|STARTED|Overall Study||27
21549|NCT01909804|48729|P10|STARTED|Overall Study||29
21550|NCT01909804|48730|P9|STARTED|Overall Study||27
21551|NCT01909804|48731|P8|STARTED|Overall Study||26
21552|NCT01909804|48732|P7|STARTED|Overall Study||27
21553|NCT01909804|48733|P6|STARTED|Overall Study||25
21554|NCT01909804|48734|P5|STARTED|Overall Study||26
21555|NCT01909804|48735|P4|STARTED|Overall Study||26
21556|NCT01909804|48736|P3|STARTED|Overall Study||27
21557|NCT01909804|48737|P2|STARTED|Overall Study||28
21558|NCT01909804|48738|P1|STARTED|Overall Study||26
21559|NCT01909778|48784|P1|NOT COMPLETED|Overall Study||1
21560|NCT01909778|48784|P1|COMPLETED|Overall Study||1
21561|NCT01909778|48784|P1|STARTED|Overall Study||2
21562|NCT01909713|48808|P1|NOT COMPLETED|Overall Study||0
21563|NCT01909713|48808|P1|COMPLETED|Overall Study||35
21564|NCT01909713|48808|P1|STARTED|Overall Study||35
21565|NCT01909570|48863|P2|NOT COMPLETED|Overall Study||27
21566|NCT01909570|48864|P1|NOT COMPLETED|Overall Study||27
21567|NCT01909570|48863|P2|COMPLETED|Overall Study||64
21568|NCT01909570|48864|P1|COMPLETED|Overall Study||57
21569|NCT01909570|48863|P2|STARTED|Overall Study||91
21570|NCT01909570|48864|P1|STARTED|Overall Study||84
21571|NCT01909466|48874|P2|NOT COMPLETED|Overall Study||23
21572|NCT01909466|48875|P1|NOT COMPLETED|Overall Study||22
21573|NCT01909466|48874|P2|COMPLETED|Overall Study||50
21574|NCT01909466|48875|P1|COMPLETED|Overall Study||46
21575|NCT01909466|48874|P2|STARTED|Overall Study||73
21576|NCT01909466|48875|P1|STARTED|Overall Study||68
21577|NCT01909336|48898|P3|NOT COMPLETED|Overall Study||3
21578|NCT01909336|48899|P2|NOT COMPLETED|Overall Study||3
21579|NCT01909336|48900|P1|NOT COMPLETED|Overall Study||4
21580|NCT01909336|48898|P3|COMPLETED|Overall Study||52
21581|NCT01909336|48899|P2|COMPLETED|Overall Study||50
21582|NCT01909336|48900|P1|COMPLETED|Overall Study||49
21583|NCT01909336|48898|P3|STARTED|Overall Study||55
21584|NCT01909336|48899|P2|STARTED|Overall Study||53
21585|NCT01909336|48900|P1|STARTED|Overall Study||53
21586|NCT01909180|48914|P1|NOT COMPLETED|Overall Study||0
21587|NCT01909180|48914|P1|COMPLETED|Overall Study||49
21588|NCT01909180|48914|P1|STARTED|Overall Study||49
21589|NCT01909141|48922|P2|NOT COMPLETED|Overall Study||0
21590|NCT01909141|48923|P1|NOT COMPLETED|Overall Study||0
21591|NCT01909141|48922|P2|COMPLETED|Overall Study||50
21592|NCT01909141|48923|P1|COMPLETED|Overall Study||50
21593|NCT01909141|48922|P2|STARTED|Overall Study||50
21594|NCT01909141|48923|P1|STARTED|Overall Study||50
21595|NCT01909011|48939|P2|NOT COMPLETED|Overall Study||0
21596|NCT01909011|48940|P1|NOT COMPLETED|Overall Study||0
21597|NCT01909011|48939|P2|COMPLETED|Overall Study||9
21598|NCT01909011|48940|P1|COMPLETED|Overall Study||7
21599|NCT01909011|48939|P2|STARTED|Overall Study||9
21600|NCT01909011|48940|P1|STARTED|Overall Study||7
21601|NCT01908842|48952|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
21602|NCT01908842|48953|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
21603|NCT01908842|48952|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
21604|NCT01908842|48953|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
21605|NCT01908842|48952|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
21606|NCT01908842|48953|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
21607|NCT01908842|48952|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
21608|NCT01908842|48953|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
21609|NCT01908842|48952|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
21610|NCT01908842|48953|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
21611|NCT01908842|48952|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
21612|NCT01908842|48953|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
21613|NCT01908842|48952|P2|NOT COMPLETED|Induction||31
21614|NCT01908842|48953|P1|NOT COMPLETED|Induction||26
21615|NCT01908842|48952|P2|COMPLETED|Induction||344
21616|NCT01908842|48953|P1|COMPLETED|Induction||357
21617|NCT01908842|48952|P2|STARTED|Induction||375
21618|NCT01908842|48953|P1|STARTED|Induction||383
21619|NCT01908803|48973|P2|NOT COMPLETED|Overall Study||1
21620|NCT01908803|48974|P1|NOT COMPLETED|Overall Study||4
21621|NCT01908803|48973|P2|COMPLETED|Overall Study||23
21622|NCT01908803|48974|P1|COMPLETED|Overall Study||42
21623|NCT01908803|48973|P2|Treated|Overall Study||24
21624|NCT01908803|48974|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
21625|NCT01908803|48973|P2|STARTED|Overall Study||24
21626|NCT01908803|48974|P1|STARTED|Overall Study||46
21627|NCT01908140|48987|P2|NOT COMPLETED|Overall Study||79
21628|NCT01908140|48988|P1|NOT COMPLETED|Overall Study||66
21629|NCT01908140|48987|P2|COMPLETED|Overall Study||386
21630|NCT01908140|48988|P1|COMPLETED|Overall Study||402
21631|NCT01908140|48987|P2|STARTED|Overall Study||465
21632|NCT01908140|48988|P1|STARTED|Overall Study||468
21633|NCT01908127|48998|P2|NOT COMPLETED|Overall Study||0
21634|NCT01908127|48999|P1|NOT COMPLETED|Overall Study||1
21635|NCT01908127|48998|P2|COMPLETED|Overall Study||23
21636|NCT01908127|48999|P1|COMPLETED|Overall Study||22
21637|NCT01908127|48998|P2|STARTED|Overall Study||23
21638|NCT01908127|48999|P1|STARTED|Overall Study||23
21639|NCT01907906|49009|P2|NOT COMPLETED|Overall Study||1
21640|NCT01907906|49010|P1|NOT COMPLETED|Overall Study||4
21641|NCT01907906|49009|P2|COMPLETED|Overall Study||12
21642|NCT01907906|49010|P1|COMPLETED|Overall Study||12
21643|NCT01907906|49009|P2|STARTED|Overall Study||13
21644|NCT01907906|49010|P1|STARTED|Overall Study||16
21645|NCT01907854|49090|P2|NOT COMPLETED|Overall Study||13
21646|NCT01907854|49091|P1|NOT COMPLETED|Overall Study||16
21647|NCT01907854|49090|P2|COMPLETED|Overall Study||191
21648|NCT01907854|49091|P1|COMPLETED|Overall Study||187
21649|NCT01907854|49090|P2|Exposed|Overall Study||204
21650|NCT01907854|49091|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
21651|NCT01907854|49090|P2|STARTED|Overall Study||204
21652|NCT01907854|49091|P1|STARTED|Overall Study||203
21653|NCT01907516|49111|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
21654|NCT01907516|49112|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
21655|NCT01907516|49111|P2|COMPLETED|Second Intervention (3 Weeks)||34
21656|NCT01907516|49112|P1|COMPLETED|Second Intervention (3 Weeks)||40
21657|NCT01907516|49111|P2|STARTED|Second Intervention (3 Weeks)||34
21658|NCT01907516|49112|P1|STARTED|Second Intervention (3 Weeks)||40
21659|NCT01907516|49111|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
21660|NCT01907516|49112|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
21661|NCT01907516|49111|P2|COMPLETED|First Intervention (3 Weeks)||34
21662|NCT01907516|49112|P1|COMPLETED|First Intervention (3 Weeks)||40
21663|NCT01907516|49111|P2|STARTED|First Intervention (3 Weeks)||50
21664|NCT01907516|49112|P1|STARTED|First Intervention (3 Weeks)||50
21665|NCT01907490|49119|P1|NOT COMPLETED|Overall Study||0
21666|NCT01907490|49119|P1|COMPLETED|Overall Study||38
21667|NCT01907490|49119|P1|STARTED|Overall Study||38
21668|NCT01907334|49123|P2|NOT COMPLETED|Overall Study||0
21669|NCT01907334|49124|P1|NOT COMPLETED|Overall Study||0
21670|NCT01907334|49123|P2|COMPLETED|Overall Study||4
21671|NCT01907334|49124|P1|COMPLETED|Overall Study||6
21672|NCT01907334|49123|P2|STARTED|Overall Study||4
21673|NCT01907334|49124|P1|STARTED|Overall Study||6
21674|NCT01907321|49129|P1|NOT COMPLETED|Overall Study||2
21675|NCT01907321|49129|P1|COMPLETED|Overall Study||12
21676|NCT01907321|49129|P1|STARTED|Overall Study||14
21677|NCT01907113|49139|P5|NOT COMPLETED|Overall Study||0
21678|NCT01907113|49140|P4|NOT COMPLETED|Overall Study||0
21679|NCT01907113|49141|P3|NOT COMPLETED|Overall Study||0
21680|NCT01907113|49142|P2|NOT COMPLETED|Overall Study||0
21681|NCT01907113|49143|P1|NOT COMPLETED|Overall Study||0
21682|NCT01907113|49139|P5|COMPLETED|Overall Study||8
21683|NCT01907113|49140|P4|COMPLETED|Overall Study||8
21684|NCT01907113|49141|P3|COMPLETED|Overall Study||7
21685|NCT01907113|49142|P2|COMPLETED|Overall Study||9
21686|NCT01907113|49143|P1|COMPLETED|Overall Study||8
21687|NCT01907113|49139|P5|STARTED|Overall Study||8
21688|NCT01907113|49140|P4|STARTED|Overall Study||8
21689|NCT01907113|49141|P3|STARTED|Overall Study||7
21690|NCT01907113|49142|P2|STARTED|Overall Study||9
21691|NCT01907113|49143|P1|STARTED|Overall Study||8
21692|NCT01906658|49234|P4|NOT COMPLETED|Overall Study||0
21693|NCT01906658|49235|P3|NOT COMPLETED|Overall Study||3
21694|NCT01906658|49236|P2|NOT COMPLETED|Overall Study||1
21695|NCT01906658|49237|P1|NOT COMPLETED|Overall Study||2
21696|NCT01906658|49234|P4|COMPLETED|Overall Study||11
21697|NCT01906658|49235|P3|COMPLETED|Overall Study||7
21698|NCT01906658|49236|P2|COMPLETED|Overall Study||10
21699|NCT01906658|49237|P1|COMPLETED|Overall Study||9
21700|NCT01906658|49234|P4|STARTED|Overall Study||11
21701|NCT01906658|49235|P3|STARTED|Overall Study||10
21702|NCT01906658|49236|P2|STARTED|Overall Study||11
21703|NCT01906658|49237|P1|STARTED|Overall Study||11
21704|NCT01906515|49261|P2|NOT COMPLETED|Overall Study||0
21705|NCT01906515|49262|P1|NOT COMPLETED|Overall Study||0
21706|NCT01906515|49261|P2|COMPLETED|Overall Study||61
21707|NCT01906515|49262|P1|COMPLETED|Overall Study||45
21708|NCT01906515|49261|P2|STARTED|Overall Study||61
21709|NCT01906515|49262|P1|STARTED|Overall Study||45
21710|NCT01905956|49272|P2|NOT COMPLETED|Overall Study||11
21711|NCT01905956|49273|P1|NOT COMPLETED|Overall Study||6
21712|NCT01905956|49272|P2|COMPLETED|Overall Study|Per-protocol population|48
21713|NCT01905956|49273|P1|COMPLETED|Overall Study|Per-protocol population|54
21714|NCT01905956|49272|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
21715|NCT01905956|49273|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
21716|NCT01905956|49272|P2|STARTED|Overall Study|Randomized|59
21717|NCT01905956|49273|P1|STARTED|Overall Study|Randomized|60
21718|NCT01905657|49298|P3|NOT COMPLETED|Overall Study||328
21719|NCT01905657|49299|P2|NOT COMPLETED|Overall Study||346
21720|NCT01905657|49300|P1|NOT COMPLETED|Overall Study||345
21721|NCT01905657|49298|P3|COMPLETED|Overall Study||15
21722|NCT01905657|49299|P2|COMPLETED|Overall Study||0
21723|NCT01905657|49300|P1|COMPLETED|Overall Study||0
21724|NCT01905657|49298|P3|Treated|Overall Study||309
21725|NCT01905657|49299|P2|Treated|Overall Study||343
21726|NCT01905657|49300|P1|Treated|Overall Study||339
21727|NCT01905657|49298|P3|STARTED|Overall Study||343
21728|NCT01905657|49299|P2|STARTED|Overall Study||346
21729|NCT01905657|49300|P1|STARTED|Overall Study||345
21730|NCT01905553|49325|P2|NOT COMPLETED|Period 2||0
21731|NCT01905553|49326|P1|NOT COMPLETED|Period 2||1
21732|NCT01905553|49325|P2|COMPLETED|Period 2||4
21733|NCT01905553|49326|P1|COMPLETED|Period 2||4
21734|NCT01905553|49325|P2|STARTED|Period 2||4
21735|NCT01905553|49326|P1|STARTED|Period 2||5
21736|NCT01905553|49325|P2|NOT COMPLETED|Period 1||0
21737|NCT01905553|49326|P1|NOT COMPLETED|Period 1||0
21738|NCT01905553|49325|P2|COMPLETED|Period 1||4
21739|NCT01905553|49326|P1|COMPLETED|Period 1||5
21740|NCT01905553|49325|P2|STARTED|Period 1||4
21741|NCT01905553|49326|P1|STARTED|Period 1||5
21742|NCT01905540|49340|P4|NOT COMPLETED|Period 3||1
21743|NCT01905540|49341|P3|NOT COMPLETED|Period 3||1
21744|NCT01905540|49342|P2|NOT COMPLETED|Period 3||0
21745|NCT01905540|49343|P1|NOT COMPLETED|Period 3||1
21746|NCT01905540|49340|P4|COMPLETED|Period 3||6
21747|NCT01905540|49341|P3|COMPLETED|Period 3||6
21748|NCT01905540|49342|P2|COMPLETED|Period 3||7
21749|NCT01905540|49343|P1|COMPLETED|Period 3||6
21750|NCT01905540|49340|P4|STARTED|Period 3||7
21751|NCT01905540|49341|P3|STARTED|Period 3||7
21752|NCT01905540|49342|P2|STARTED|Period 3||7
21753|NCT01905540|49343|P1|STARTED|Period 3||7
21754|NCT01905540|49340|P4|NOT COMPLETED|Period 2||0
21755|NCT01905540|49341|P3|NOT COMPLETED|Period 2||0
21756|NCT01905540|49342|P2|NOT COMPLETED|Period 2||0
21757|NCT01905540|49343|P1|NOT COMPLETED|Period 2||0
21758|NCT01905540|49340|P4|COMPLETED|Period 2||7
21759|NCT01905540|49341|P3|COMPLETED|Period 2||7
21760|NCT01905540|49342|P2|COMPLETED|Period 2||7
21761|NCT01905540|49343|P1|COMPLETED|Period 2||7
21762|NCT01905540|49340|P4|STARTED|Period 2||7
21763|NCT01905540|49341|P3|STARTED|Period 2||7
21764|NCT01905540|49342|P2|STARTED|Period 2||7
21765|NCT01905540|49343|P1|STARTED|Period 2||7
21766|NCT01905540|49340|P4|NOT COMPLETED|Period 1||0
21767|NCT01905540|49341|P3|NOT COMPLETED|Period 1||0
21768|NCT01905540|49342|P2|NOT COMPLETED|Period 1||0
21769|NCT01905540|49343|P1|NOT COMPLETED|Period 1||0
21770|NCT01905540|49340|P4|COMPLETED|Period 1||7
21771|NCT01905540|49341|P3|COMPLETED|Period 1||7
21772|NCT01905540|49342|P2|COMPLETED|Period 1||7
21773|NCT01905540|49343|P1|COMPLETED|Period 1||7
21774|NCT01905540|49340|P4|STARTED|Period 1||7
21775|NCT01905540|49341|P3|STARTED|Period 1||7
21776|NCT01905540|49342|P2|STARTED|Period 1||7
21777|NCT01905540|49343|P1|STARTED|Period 1||7
21778|NCT01905254|49361|P1|NOT COMPLETED|Overall Study||0
21779|NCT01905254|49361|P1|COMPLETED|Overall Study||34
21780|NCT01905254|49361|P1|STARTED|Overall Study||34
21781|NCT01904773|49365|P9|NOT COMPLETED|Sixth Intervention||0
21782|NCT01904773|49366|P8|NOT COMPLETED|Sixth Intervention||0
21783|NCT01904773|49367|P7|NOT COMPLETED|Sixth Intervention||0
21784|NCT01904773|49368|P6|NOT COMPLETED|Sixth Intervention||0
21785|NCT01904773|49369|P5|NOT COMPLETED|Sixth Intervention||0
21786|NCT01904773|49370|P4|NOT COMPLETED|Sixth Intervention||0
21787|NCT01904773|49371|P3|NOT COMPLETED|Sixth Intervention||0
21788|NCT01904773|49372|P2|NOT COMPLETED|Sixth Intervention||0
21789|NCT01904773|49373|P1|NOT COMPLETED|Sixth Intervention||0
21790|NCT01904773|49365|P9|COMPLETED|Sixth Intervention||4
21791|NCT01904773|49366|P8|COMPLETED|Sixth Intervention||2
21792|NCT01904773|49367|P7|COMPLETED|Sixth Intervention||3
21793|NCT01904773|49368|P6|COMPLETED|Sixth Intervention||4
21794|NCT01904773|49369|P5|COMPLETED|Sixth Intervention||3
21795|NCT01904773|49370|P4|COMPLETED|Sixth Intervention||2
21796|NCT01904773|49371|P3|COMPLETED|Sixth Intervention||1
21797|NCT01904773|49372|P2|COMPLETED|Sixth Intervention||0
21798|NCT01904773|49373|P1|COMPLETED|Sixth Intervention||0
21799|NCT01904773|49365|P9|STARTED|Sixth Intervention||4
21800|NCT01904773|49366|P8|STARTED|Sixth Intervention||2
21801|NCT01904773|49367|P7|STARTED|Sixth Intervention||3
21802|NCT01904773|49368|P6|STARTED|Sixth Intervention||4
21803|NCT01904773|49369|P5|STARTED|Sixth Intervention||3
21804|NCT01904773|49370|P4|STARTED|Sixth Intervention||2
21805|NCT01904773|49371|P3|STARTED|Sixth Intervention||1
21806|NCT01904773|49372|P2|STARTED|Sixth Intervention||0
21807|NCT01904773|49373|P1|STARTED|Sixth Intervention||0
21808|NCT01904773|49365|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21809|NCT01904773|49366|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21810|NCT01904773|49367|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21811|NCT01904773|49368|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21812|NCT01904773|49369|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21813|NCT01904773|49370|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21814|NCT01904773|49371|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21815|NCT01904773|49372|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
21816|NCT01904773|49373|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
21817|NCT01904773|49365|P9|COMPLETED|Placebo Washout Fifth Intervention||4
21818|NCT01904773|49366|P8|COMPLETED|Placebo Washout Fifth Intervention||2
21819|NCT01904773|49367|P7|COMPLETED|Placebo Washout Fifth Intervention||3
21820|NCT01904773|49368|P6|COMPLETED|Placebo Washout Fifth Intervention||4
21821|NCT01904773|49369|P5|COMPLETED|Placebo Washout Fifth Intervention||3
21822|NCT01904773|49370|P4|COMPLETED|Placebo Washout Fifth Intervention||2
21823|NCT01904773|49371|P3|COMPLETED|Placebo Washout Fifth Intervention||1
21824|NCT01904773|49372|P2|COMPLETED|Placebo Washout Fifth Intervention||0
21825|NCT01904773|49373|P1|COMPLETED|Placebo Washout Fifth Intervention||0
21826|NCT01904773|49365|P9|STARTED|Placebo Washout Fifth Intervention||4
21827|NCT01904773|49366|P8|STARTED|Placebo Washout Fifth Intervention||2
21828|NCT01904773|49367|P7|STARTED|Placebo Washout Fifth Intervention||3
21829|NCT01904773|49368|P6|STARTED|Placebo Washout Fifth Intervention||4
21830|NCT01904773|49369|P5|STARTED|Placebo Washout Fifth Intervention||3
21831|NCT01904773|49370|P4|STARTED|Placebo Washout Fifth Intervention||2
21832|NCT01904773|49371|P3|STARTED|Placebo Washout Fifth Intervention||1
21833|NCT01904773|49372|P2|STARTED|Placebo Washout Fifth Intervention||1
21834|NCT01904773|49373|P1|STARTED|Placebo Washout Fifth Intervention||0
21835|NCT01904773|49365|P9|NOT COMPLETED|Fifth Intervention||0
21836|NCT01904773|49366|P8|NOT COMPLETED|Fifth Intervention||1
21837|NCT01904773|49367|P7|NOT COMPLETED|Fifth Intervention||0
21838|NCT01904773|49368|P6|NOT COMPLETED|Fifth Intervention||0
21839|NCT01904773|49369|P5|NOT COMPLETED|Fifth Intervention||0
21840|NCT01904773|49370|P4|NOT COMPLETED|Fifth Intervention||0
21841|NCT01904773|49371|P3|NOT COMPLETED|Fifth Intervention||0
21842|NCT01904773|49372|P2|NOT COMPLETED|Fifth Intervention||0
21843|NCT01904773|49373|P1|NOT COMPLETED|Fifth Intervention||0
21844|NCT01904773|49365|P9|COMPLETED|Fifth Intervention||4
21845|NCT01904773|49366|P8|COMPLETED|Fifth Intervention||2
21846|NCT01904773|49367|P7|COMPLETED|Fifth Intervention||3
21847|NCT01904773|49368|P6|COMPLETED|Fifth Intervention||4
21848|NCT01904773|49369|P5|COMPLETED|Fifth Intervention||3
21849|NCT01904773|49370|P4|COMPLETED|Fifth Intervention||2
21850|NCT01904773|49371|P3|COMPLETED|Fifth Intervention||1
21851|NCT01904773|49372|P2|COMPLETED|Fifth Intervention||1
21852|NCT01904773|49373|P1|COMPLETED|Fifth Intervention||0
21853|NCT01904773|49365|P9|STARTED|Fifth Intervention||4
21854|NCT01904773|49366|P8|STARTED|Fifth Intervention||3
21855|NCT01904773|49367|P7|STARTED|Fifth Intervention||3
21856|NCT01904773|49368|P6|STARTED|Fifth Intervention||4
21857|NCT01904773|49369|P5|STARTED|Fifth Intervention||3
21858|NCT01904773|49370|P4|STARTED|Fifth Intervention||2
21859|NCT01904773|49371|P3|STARTED|Fifth Intervention||1
21860|NCT01904773|49372|P2|STARTED|Fifth Intervention||1
21861|NCT01904773|49373|P1|STARTED|Fifth Intervention||0
21862|NCT01904773|49365|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21863|NCT01904773|49366|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21864|NCT01904773|49367|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21865|NCT01904773|49368|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21866|NCT01904773|49369|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21867|NCT01904773|49370|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21868|NCT01904773|49371|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21869|NCT01904773|49372|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21870|NCT01904773|49373|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
21871|NCT01904773|49365|P9|COMPLETED|Placebo Washout Fourth Intervention||4
21872|NCT01904773|49366|P8|COMPLETED|Placebo Washout Fourth Intervention||3
21873|NCT01904773|49367|P7|COMPLETED|Placebo Washout Fourth Intervention||3
21874|NCT01904773|49368|P6|COMPLETED|Placebo Washout Fourth Intervention||4
21875|NCT01904773|49369|P5|COMPLETED|Placebo Washout Fourth Intervention||3
21876|NCT01904773|49370|P4|COMPLETED|Placebo Washout Fourth Intervention||2
21877|NCT01904773|49371|P3|COMPLETED|Placebo Washout Fourth Intervention||1
21878|NCT01904773|49372|P2|COMPLETED|Placebo Washout Fourth Intervention||1
21879|NCT01904773|49373|P1|COMPLETED|Placebo Washout Fourth Intervention||0
21880|NCT01904773|49365|P9|STARTED|Placebo Washout Fourth Intervention||4
21881|NCT01904773|49366|P8|STARTED|Placebo Washout Fourth Intervention||3
21882|NCT01904773|49367|P7|STARTED|Placebo Washout Fourth Intervention||3
21883|NCT01904773|49368|P6|STARTED|Placebo Washout Fourth Intervention||4
21884|NCT01904773|49369|P5|STARTED|Placebo Washout Fourth Intervention||3
21885|NCT01904773|49370|P4|STARTED|Placebo Washout Fourth Intervention||2
21886|NCT01904773|49371|P3|STARTED|Placebo Washout Fourth Intervention||1
21887|NCT01904773|49372|P2|STARTED|Placebo Washout Fourth Intervention||1
21888|NCT01904773|49373|P1|STARTED|Placebo Washout Fourth Intervention||0
21889|NCT01904773|49365|P9|NOT COMPLETED|Fourth Intervention||0
21890|NCT01904773|49366|P8|NOT COMPLETED|Fourth Intervention||0
21891|NCT01904773|49367|P7|NOT COMPLETED|Fourth Intervention||0
21892|NCT01904773|49368|P6|NOT COMPLETED|Fourth Intervention||0
21893|NCT01904773|49369|P5|NOT COMPLETED|Fourth Intervention||0
21894|NCT01904773|49370|P4|NOT COMPLETED|Fourth Intervention||0
21895|NCT01904773|49371|P3|NOT COMPLETED|Fourth Intervention||0
21896|NCT01904773|49372|P2|NOT COMPLETED|Fourth Intervention||0
21897|NCT01904773|49373|P1|NOT COMPLETED|Fourth Intervention||0
21898|NCT01904773|49365|P9|COMPLETED|Fourth Intervention||4
21899|NCT01904773|49366|P8|COMPLETED|Fourth Intervention||3
21900|NCT01904773|49367|P7|COMPLETED|Fourth Intervention||3
21901|NCT01904773|49368|P6|COMPLETED|Fourth Intervention||4
21902|NCT01904773|49369|P5|COMPLETED|Fourth Intervention||3
21903|NCT01904773|49370|P4|COMPLETED|Fourth Intervention||2
21904|NCT01904773|49371|P3|COMPLETED|Fourth Intervention||1
21905|NCT01904773|49372|P2|COMPLETED|Fourth Intervention||1
21906|NCT01904773|49373|P1|COMPLETED|Fourth Intervention||0
21907|NCT01904773|49365|P9|STARTED|Fourth Intervention||4
21908|NCT01904773|49366|P8|STARTED|Fourth Intervention||3
21909|NCT01904773|49367|P7|STARTED|Fourth Intervention||3
21910|NCT01904773|49368|P6|STARTED|Fourth Intervention||4
21911|NCT01904773|49369|P5|STARTED|Fourth Intervention||3
21912|NCT01904773|49370|P4|STARTED|Fourth Intervention||2
21913|NCT01904773|49371|P3|STARTED|Fourth Intervention||1
21914|NCT01904773|49372|P2|STARTED|Fourth Intervention||1
21915|NCT01904773|49373|P1|STARTED|Fourth Intervention||0
21916|NCT01904773|49365|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
21917|NCT01904773|49366|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
21918|NCT01904773|49367|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
21919|NCT01904773|49368|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
21920|NCT01904773|49369|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
21921|NCT01904773|49370|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
21922|NCT01904773|49371|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
21923|NCT01904773|49372|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
21924|NCT01904773|49373|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
21925|NCT01904773|49365|P9|COMPLETED|Placebo Washout Third Intervention||4
21926|NCT01904773|49366|P8|COMPLETED|Placebo Washout Third Intervention||3
21927|NCT01904773|49367|P7|COMPLETED|Placebo Washout Third Intervention||3
21928|NCT01904773|49368|P6|COMPLETED|Placebo Washout Third Intervention||4
21929|NCT01904773|49369|P5|COMPLETED|Placebo Washout Third Intervention||3
21930|NCT01904773|49370|P4|COMPLETED|Placebo Washout Third Intervention||2
21931|NCT01904773|49371|P3|COMPLETED|Placebo Washout Third Intervention||1
21932|NCT01904773|49372|P2|COMPLETED|Placebo Washout Third Intervention||1
21933|NCT01904773|49373|P1|COMPLETED|Placebo Washout Third Intervention||0
21934|NCT01904773|49365|P9|STARTED|Placebo Washout Third Intervention||4
21935|NCT01904773|49366|P8|STARTED|Placebo Washout Third Intervention||3
21936|NCT01904773|49367|P7|STARTED|Placebo Washout Third Intervention||3
21937|NCT01904773|49368|P6|STARTED|Placebo Washout Third Intervention||4
21938|NCT01904773|49369|P5|STARTED|Placebo Washout Third Intervention||3
21939|NCT01904773|49370|P4|STARTED|Placebo Washout Third Intervention||2
21940|NCT01904773|49371|P3|STARTED|Placebo Washout Third Intervention||1
21941|NCT01904773|49372|P2|STARTED|Placebo Washout Third Intervention||1
21942|NCT01904773|49373|P1|STARTED|Placebo Washout Third Intervention||0
21943|NCT01904773|49365|P9|NOT COMPLETED|Third Intervention||0
21944|NCT01904773|49366|P8|NOT COMPLETED|Third Intervention||0
21945|NCT01904773|49367|P7|NOT COMPLETED|Third Intervention||0
21946|NCT01904773|49368|P6|NOT COMPLETED|Third Intervention||0
21947|NCT01904773|49369|P5|NOT COMPLETED|Third Intervention||0
21948|NCT01904773|49370|P4|NOT COMPLETED|Third Intervention||0
21949|NCT01904773|49371|P3|NOT COMPLETED|Third Intervention||0
21950|NCT01904773|49372|P2|NOT COMPLETED|Third Intervention||0
21951|NCT01904773|49373|P1|NOT COMPLETED|Third Intervention||0
21952|NCT01904773|49365|P9|COMPLETED|Third Intervention||4
21953|NCT01904773|49366|P8|COMPLETED|Third Intervention||3
21954|NCT01904773|49367|P7|COMPLETED|Third Intervention||3
21955|NCT01904773|49368|P6|COMPLETED|Third Intervention||4
21956|NCT01904773|49369|P5|COMPLETED|Third Intervention||3
21957|NCT01904773|49370|P4|COMPLETED|Third Intervention||2
21958|NCT01904773|49371|P3|COMPLETED|Third Intervention||1
21959|NCT01904773|49372|P2|COMPLETED|Third Intervention||1
21960|NCT01904773|49373|P1|COMPLETED|Third Intervention||0
21961|NCT01904773|49365|P9|STARTED|Third Intervention||4
21962|NCT01904773|49366|P8|STARTED|Third Intervention||3
21963|NCT01904773|49367|P7|STARTED|Third Intervention||3
21964|NCT01904773|49368|P6|STARTED|Third Intervention||4
21965|NCT01904773|49369|P5|STARTED|Third Intervention||3
21966|NCT01904773|49370|P4|STARTED|Third Intervention||2
21967|NCT01904773|49371|P3|STARTED|Third Intervention||1
21968|NCT01904773|49372|P2|STARTED|Third Intervention||1
21969|NCT01904773|49373|P1|STARTED|Third Intervention||0
21970|NCT01904773|49365|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
21971|NCT01904773|49366|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
21972|NCT01904773|49367|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
21973|NCT01904773|49368|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
21974|NCT01904773|49369|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
21975|NCT01904773|49370|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
21976|NCT01904773|49371|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
21977|NCT01904773|49372|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
21978|NCT01904773|49373|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
21979|NCT01904773|49365|P9|COMPLETED|Placebo Washout Second Intervention||4
21980|NCT01904773|49366|P8|COMPLETED|Placebo Washout Second Intervention||3
21981|NCT01904773|49367|P7|COMPLETED|Placebo Washout Second Intervention||3
21982|NCT01904773|49368|P6|COMPLETED|Placebo Washout Second Intervention||4
21983|NCT01904773|49369|P5|COMPLETED|Placebo Washout Second Intervention||3
21984|NCT01904773|49370|P4|COMPLETED|Placebo Washout Second Intervention||2
21985|NCT01904773|49371|P3|COMPLETED|Placebo Washout Second Intervention||1
21986|NCT01904773|49372|P2|COMPLETED|Placebo Washout Second Intervention||1
21987|NCT01904773|49373|P1|COMPLETED|Placebo Washout Second Intervention||0
21988|NCT01904773|49365|P9|STARTED|Placebo Washout Second Intervention||4
21989|NCT01904773|49366|P8|STARTED|Placebo Washout Second Intervention||3
21990|NCT01904773|49367|P7|STARTED|Placebo Washout Second Intervention||3
21991|NCT01904773|49368|P6|STARTED|Placebo Washout Second Intervention||4
21992|NCT01904773|49369|P5|STARTED|Placebo Washout Second Intervention||3
21993|NCT01904773|49370|P4|STARTED|Placebo Washout Second Intervention||2
21994|NCT01904773|49371|P3|STARTED|Placebo Washout Second Intervention||1
21995|NCT01904773|49372|P2|STARTED|Placebo Washout Second Intervention||1
21996|NCT01904773|49373|P1|STARTED|Placebo Washout Second Intervention||0
21997|NCT01904773|49365|P9|NOT COMPLETED|Second Intervention||0
21998|NCT01904773|49366|P8|NOT COMPLETED|Second Intervention||0
21999|NCT01904773|49367|P7|NOT COMPLETED|Second Intervention||0
22000|NCT01904773|49368|P6|NOT COMPLETED|Second Intervention||0
22001|NCT01904773|49369|P5|NOT COMPLETED|Second Intervention||0
22002|NCT01904773|49370|P4|NOT COMPLETED|Second Intervention||0
22003|NCT01904773|49371|P3|NOT COMPLETED|Second Intervention||0
22004|NCT01904773|49372|P2|NOT COMPLETED|Second Intervention||0
22005|NCT01904773|49373|P1|NOT COMPLETED|Second Intervention||0
22006|NCT01904773|49365|P9|COMPLETED|Second Intervention||4
22007|NCT01904773|49366|P8|COMPLETED|Second Intervention||3
22008|NCT01904773|49367|P7|COMPLETED|Second Intervention||3
22009|NCT01904773|49368|P6|COMPLETED|Second Intervention||4
22010|NCT01904773|49369|P5|COMPLETED|Second Intervention||3
22011|NCT01904773|49370|P4|COMPLETED|Second Intervention||2
22012|NCT01904773|49371|P3|COMPLETED|Second Intervention||1
22013|NCT01904773|49372|P2|COMPLETED|Second Intervention||1
22014|NCT01904773|49373|P1|COMPLETED|Second Intervention||0
22015|NCT01904773|49365|P9|STARTED|Second Intervention||4
22016|NCT01904773|49366|P8|STARTED|Second Intervention||3
22017|NCT01904773|49367|P7|STARTED|Second Intervention||3
22018|NCT01904773|49368|P6|STARTED|Second Intervention||4
22019|NCT01904773|49369|P5|STARTED|Second Intervention||3
22020|NCT01904773|49370|P4|STARTED|Second Intervention||2
22021|NCT01904773|49371|P3|STARTED|Second Intervention||1
22022|NCT01904773|49372|P2|STARTED|Second Intervention||1
22023|NCT01904773|49373|P1|STARTED|Second Intervention||0
22024|NCT01904773|49365|P9|NOT COMPLETED|Placebo Washout First Intervention||0
22025|NCT01904773|49366|P8|NOT COMPLETED|Placebo Washout First Intervention||0
22026|NCT01904773|49367|P7|NOT COMPLETED|Placebo Washout First Intervention||0
22027|NCT01904773|49368|P6|NOT COMPLETED|Placebo Washout First Intervention||0
22028|NCT01904773|49369|P5|NOT COMPLETED|Placebo Washout First Intervention||0
22029|NCT01904773|49370|P4|NOT COMPLETED|Placebo Washout First Intervention||0
22030|NCT01904773|49371|P3|NOT COMPLETED|Placebo Washout First Intervention||0
22031|NCT01904773|49372|P2|NOT COMPLETED|Placebo Washout First Intervention||1
22032|NCT01904773|49373|P1|NOT COMPLETED|Placebo Washout First Intervention||0
22033|NCT01904773|49365|P9|COMPLETED|Placebo Washout First Intervention||4
22034|NCT01904773|49366|P8|COMPLETED|Placebo Washout First Intervention||3
22035|NCT01904773|49367|P7|COMPLETED|Placebo Washout First Intervention||3
22036|NCT01904773|49368|P6|COMPLETED|Placebo Washout First Intervention||4
22037|NCT01904773|49369|P5|COMPLETED|Placebo Washout First Intervention||3
22038|NCT01904773|49370|P4|COMPLETED|Placebo Washout First Intervention||2
22039|NCT01904773|49371|P3|COMPLETED|Placebo Washout First Intervention||1
22040|NCT01904773|49372|P2|COMPLETED|Placebo Washout First Intervention||1
22041|NCT01904773|49373|P1|COMPLETED|Placebo Washout First Intervention||0
22042|NCT01904773|49365|P9|STARTED|Placebo Washout First Intervention||4
22043|NCT01904773|49366|P8|STARTED|Placebo Washout First Intervention||3
22044|NCT01904773|49367|P7|STARTED|Placebo Washout First Intervention||3
22045|NCT01904773|49368|P6|STARTED|Placebo Washout First Intervention||4
22046|NCT01904773|49369|P5|STARTED|Placebo Washout First Intervention||3
22047|NCT01904773|49370|P4|STARTED|Placebo Washout First Intervention||2
22048|NCT01904773|49371|P3|STARTED|Placebo Washout First Intervention||1
22049|NCT01904773|49372|P2|STARTED|Placebo Washout First Intervention||2
22050|NCT01904773|49373|P1|STARTED|Placebo Washout First Intervention||0
22051|NCT01904773|49365|P9|NOT COMPLETED|First Intervention||0
22052|NCT01904773|49366|P8|NOT COMPLETED|First Intervention||0
22053|NCT01904773|49367|P7|NOT COMPLETED|First Intervention||1
22054|NCT01904773|49368|P6|NOT COMPLETED|First Intervention||0
22055|NCT01904773|49369|P5|NOT COMPLETED|First Intervention||0
22056|NCT01904773|49370|P4|NOT COMPLETED|First Intervention||0
22057|NCT01904773|49371|P3|NOT COMPLETED|First Intervention||0
22058|NCT01904773|49372|P2|NOT COMPLETED|First Intervention||0
22059|NCT01904773|49373|P1|NOT COMPLETED|First Intervention||0
22060|NCT01904773|49365|P9|COMPLETED|First Intervention||4
22061|NCT01904773|49366|P8|COMPLETED|First Intervention||3
22062|NCT01904773|49367|P7|COMPLETED|First Intervention||3
22063|NCT01904773|49368|P6|COMPLETED|First Intervention||4
22064|NCT01904773|49369|P5|COMPLETED|First Intervention||3
22065|NCT01904773|49370|P4|COMPLETED|First Intervention||2
22066|NCT01904773|49371|P3|COMPLETED|First Intervention||1
22067|NCT01904773|49372|P2|COMPLETED|First Intervention||2
22068|NCT01904773|49373|P1|COMPLETED|First Intervention||0
22069|NCT01904773|49365|P9|STARTED|First Intervention||4
22070|NCT01904773|49366|P8|STARTED|First Intervention||3
22071|NCT01904773|49367|P7|STARTED|First Intervention||4
22072|NCT01904773|49368|P6|STARTED|First Intervention||4
22073|NCT01904773|49369|P5|STARTED|First Intervention||3
22074|NCT01904773|49370|P4|STARTED|First Intervention||2
22075|NCT01904773|49371|P3|STARTED|First Intervention||1
22076|NCT01904773|49372|P2|STARTED|First Intervention||2
22077|NCT01904773|49373|P1|STARTED|First Intervention||0
22078|NCT01904773|49365|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22079|NCT01904773|49366|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22080|NCT01904773|49367|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22081|NCT01904773|49368|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22082|NCT01904773|49369|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22083|NCT01904773|49370|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22084|NCT01904773|49371|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22085|NCT01904773|49372|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22086|NCT01904773|49373|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
22087|NCT01904773|49365|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22088|NCT01904773|49366|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22089|NCT01904773|49367|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22090|NCT01904773|49368|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22091|NCT01904773|49369|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22092|NCT01904773|49370|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22093|NCT01904773|49371|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22094|NCT01904773|49372|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22095|NCT01904773|49373|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
22096|NCT01904773|49365|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22097|NCT01904773|49366|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22098|NCT01904773|49367|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22099|NCT01904773|49368|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22181|NCT01904760|49390|P2|STARTED|Overall Study||40
22100|NCT01904773|49369|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22101|NCT01904773|49370|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22102|NCT01904773|49371|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22103|NCT01904773|49372|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22104|NCT01904773|49373|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
22105|NCT01904773|49365|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22106|NCT01904773|49366|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22107|NCT01904773|49367|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22108|NCT01904773|49368|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22109|NCT01904773|49369|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22110|NCT01904773|49370|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22111|NCT01904773|49371|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22112|NCT01904773|49372|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22113|NCT01904773|49373|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
22114|NCT01904773|49365|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22115|NCT01904773|49366|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22116|NCT01904773|49367|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22117|NCT01904773|49368|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22118|NCT01904773|49369|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22119|NCT01904773|49370|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22120|NCT01904773|49371|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22121|NCT01904773|49372|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
22122|NCT01904773|49373|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
22123|NCT01904773|49365|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22124|NCT01904773|49366|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22125|NCT01904773|49367|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22126|NCT01904773|49368|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22127|NCT01904773|49369|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22128|NCT01904773|49370|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22129|NCT01904773|49371|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22130|NCT01904773|49372|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22131|NCT01904773|49373|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22132|NCT01904773|49365|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22133|NCT01904773|49366|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22134|NCT01904773|49367|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22135|NCT01904773|49368|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22136|NCT01904773|49369|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22137|NCT01904773|49370|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22138|NCT01904773|49371|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22139|NCT01904773|49372|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22140|NCT01904773|49373|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
22141|NCT01904773|49365|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22142|NCT01904773|49366|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22143|NCT01904773|49367|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22144|NCT01904773|49368|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22145|NCT01904773|49369|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22146|NCT01904773|49370|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22147|NCT01904773|49371|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22148|NCT01904773|49372|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
22149|NCT01904773|49373|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
22150|NCT01904773|49365|P9|NOT COMPLETED|Screen||0
22151|NCT01904773|49366|P8|NOT COMPLETED|Screen||0
22152|NCT01904773|49367|P7|NOT COMPLETED|Screen||0
22153|NCT01904773|49368|P6|NOT COMPLETED|Screen||0
22154|NCT01904773|49369|P5|NOT COMPLETED|Screen||0
22155|NCT01904773|49370|P4|NOT COMPLETED|Screen||0
22156|NCT01904773|49371|P3|NOT COMPLETED|Screen||0
22157|NCT01904773|49372|P2|NOT COMPLETED|Screen||0
22158|NCT01904773|49373|P1|NOT COMPLETED|Screen||4
22159|NCT01904773|49365|P9|COMPLETED|Screen||0
22160|NCT01904773|49366|P8|COMPLETED|Screen||0
22161|NCT01904773|49367|P7|COMPLETED|Screen||0
22162|NCT01904773|49368|P6|COMPLETED|Screen||0
22163|NCT01904773|49369|P5|COMPLETED|Screen||0
22164|NCT01904773|49370|P4|COMPLETED|Screen||0
22165|NCT01904773|49371|P3|COMPLETED|Screen||0
22166|NCT01904773|49372|P2|COMPLETED|Screen||0
22167|NCT01904773|49373|P1|COMPLETED|Screen||24
22168|NCT01904773|49365|P9|STARTED|Screen||0
22169|NCT01904773|49366|P8|STARTED|Screen||0
22170|NCT01904773|49367|P7|STARTED|Screen||0
22171|NCT01904773|49368|P6|STARTED|Screen||0
22172|NCT01904773|49369|P5|STARTED|Screen||0
22173|NCT01904773|49370|P4|STARTED|Screen||0
22174|NCT01904773|49371|P3|STARTED|Screen||0
22175|NCT01904773|49372|P2|STARTED|Screen||0
22176|NCT01904773|49373|P1|STARTED|Screen||28
22177|NCT01904760|49390|P2|NOT COMPLETED|Overall Study||0
22178|NCT01904760|49391|P1|NOT COMPLETED|Overall Study||1
22179|NCT01904760|49390|P2|COMPLETED|Overall Study||40
22180|NCT01904760|49391|P1|COMPLETED|Overall Study||39
22182|NCT01904760|49391|P1|STARTED|Overall Study||40
22183|NCT01904721|49406|P7|NOT COMPLETED|Overall Study||7
22184|NCT01904721|49407|P6|NOT COMPLETED|Overall Study||9
22185|NCT01904721|49408|P5|NOT COMPLETED|Overall Study||8
22186|NCT01904721|49409|P4|NOT COMPLETED|Overall Study||1
22187|NCT01904721|49410|P3|NOT COMPLETED|Overall Study||1
22188|NCT01904721|49411|P2|NOT COMPLETED|Overall Study||0
22189|NCT01904721|49412|P1|NOT COMPLETED|Overall Study||0
22190|NCT01904721|49406|P7|COMPLETED|Overall Study||57
22191|NCT01904721|49407|P6|COMPLETED|Overall Study||56
22192|NCT01904721|49408|P5|COMPLETED|Overall Study||57
22193|NCT01904721|49409|P4|COMPLETED|Overall Study||11
22194|NCT01904721|49410|P3|COMPLETED|Overall Study||11
22195|NCT01904721|49411|P2|COMPLETED|Overall Study||13
22196|NCT01904721|49412|P1|COMPLETED|Overall Study||13
22197|NCT01904721|49406|P7|STARTED|Overall Study||64
22198|NCT01904721|49407|P6|STARTED|Overall Study||65
22199|NCT01904721|49408|P5|STARTED|Overall Study||65
22200|NCT01904721|49409|P4|STARTED|Overall Study||12
22201|NCT01904721|49410|P3|STARTED|Overall Study||12
22202|NCT01904721|49411|P2|STARTED|Overall Study||13
22203|NCT01904721|49412|P1|STARTED|Overall Study||13
22204|NCT01904604|49442|P3|NOT COMPLETED|Overall Study||0
22205|NCT01904604|49443|P2|NOT COMPLETED|Overall Study||4
22206|NCT01904604|49444|P1|NOT COMPLETED|Overall Study||3
22207|NCT01904604|49442|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
22208|NCT01904604|49443|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
22209|NCT01904604|49444|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
22210|NCT01904604|49442|P3|STARTED|Overall Study||25
22211|NCT01904604|49443|P2|STARTED|Overall Study||25
22212|NCT01904604|49444|P1|STARTED|Overall Study||25
22213|NCT01904149|49466|P6|NOT COMPLETED|Overall Study||3
22214|NCT01904149|49467|P5|NOT COMPLETED|Overall Study||5
22215|NCT01904149|49468|P4|NOT COMPLETED|Overall Study||4
22216|NCT01904149|49469|P3|NOT COMPLETED|Overall Study||2
22217|NCT01904149|49470|P2|NOT COMPLETED|Overall Study||11
22218|NCT01904149|49471|P1|NOT COMPLETED|Overall Study||5
22219|NCT01904149|49466|P6|COMPLETED|Overall Study||48
22220|NCT01904149|49467|P5|COMPLETED|Overall Study||46
22221|NCT01904149|49468|P4|COMPLETED|Overall Study||47
22222|NCT01904149|49469|P3|COMPLETED|Overall Study||148
22223|NCT01904149|49470|P2|COMPLETED|Overall Study||140
22224|NCT01904149|49471|P1|COMPLETED|Overall Study||147
22225|NCT01904149|49466|P6|Multiple-dose Phase|Overall Study||49
22226|NCT01904149|49467|P5|Multiple-dose Phase|Overall Study||48
22227|NCT01904149|49468|P4|Multiple-dose Phase|Overall Study||48
22228|NCT01904149|49469|P3|Multiple-dose Phase|Overall Study||149
22229|NCT01904149|49470|P2|Multiple-dose Phase|Overall Study||146
22230|NCT01904149|49471|P1|Multiple-dose Phase|Overall Study||150
22231|NCT01904149|49466|P6|Single-dose Phase|Overall Study||51
22232|NCT01904149|49467|P5|Single-dose Phase|Overall Study||51
22233|NCT01904149|49468|P4|Single-dose Phase|Overall Study||51
22234|NCT01904149|49469|P3|Single-dose Phase|Overall Study||150
22235|NCT01904149|49470|P2|Single-dose Phase|Overall Study||151
22236|NCT01904149|49471|P1|Single-dose Phase|Overall Study||152
22237|NCT01904149|49466|P6|STARTED|Overall Study||51
22238|NCT01904149|49467|P5|STARTED|Overall Study||51
22239|NCT01904149|49468|P4|STARTED|Overall Study||51
22240|NCT01904149|49469|P3|STARTED|Overall Study||150
22241|NCT01904149|49470|P2|STARTED|Overall Study||151
22242|NCT01904149|49471|P1|STARTED|Overall Study||152
22243|NCT01904071|49496|P3|NOT COMPLETED|Overall Study||0
22244|NCT01904071|49497|P2|NOT COMPLETED|Overall Study||0
22245|NCT01904071|49498|P1|NOT COMPLETED|Overall Study||0
22246|NCT01904071|49496|P3|COMPLETED|Overall Study||20
22247|NCT01904071|49497|P2|COMPLETED|Overall Study||20
22248|NCT01904071|49498|P1|COMPLETED|Overall Study||24
22249|NCT01904071|49496|P3|STARTED|Overall Study||20
22250|NCT01904071|49497|P2|STARTED|Overall Study||20
22251|NCT01904071|49498|P1|STARTED|Overall Study||24
22252|NCT01904058|49522|P4|NOT COMPLETED|Overall Study||1
22253|NCT01904058|49523|P3|NOT COMPLETED|Overall Study||1
22254|NCT01904058|49524|P2|NOT COMPLETED|Overall Study||0
22255|NCT01904058|49525|P1|NOT COMPLETED|Overall Study||3
22256|NCT01904058|49522|P4|COMPLETED|Overall Study||12
22257|NCT01904058|49523|P3|COMPLETED|Overall Study||10
22258|NCT01904058|49524|P2|COMPLETED|Overall Study||21
22259|NCT01904058|49525|P1|COMPLETED|Overall Study||18
22260|NCT01904058|49522|P4|STARTED|Overall Study||13
22261|NCT01904058|49523|P3|STARTED|Overall Study||11
22262|NCT01904058|49524|P2|STARTED|Overall Study||21
22263|NCT01904058|49525|P1|STARTED|Overall Study||21
22264|NCT01903876|49565|P2|NOT COMPLETED|Six-Month Follow-up Period||145
22265|NCT01903876|49566|P1|NOT COMPLETED|Six-Month Follow-up Period||91
22266|NCT01903876|49565|P2|COMPLETED|Six-Month Follow-up Period||123
22267|NCT01903876|49566|P1|COMPLETED|Six-Month Follow-up Period||92
22268|NCT01903876|49565|P2|STARTED|Six-Month Follow-up Period||268
22269|NCT01903876|49566|P1|STARTED|Six-Month Follow-up Period||183
22270|NCT01903876|49565|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
22271|NCT01903876|49566|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
22272|NCT01903876|49565|P2|COMPLETED|Baseline to Post-Intervention Period||268
22273|NCT01903876|49566|P1|COMPLETED|Baseline to Post-Intervention Period||183
22274|NCT01903876|49565|P2|STARTED|Baseline to Post-Intervention Period||376
22275|NCT01903876|49566|P1|STARTED|Baseline to Post-Intervention Period||367
22276|NCT01903720|49574|P1|NOT COMPLETED|Overall Study||12
22277|NCT01903720|49574|P1|COMPLETED|Overall Study||59
22278|NCT01903720|49574|P1|STARTED|Overall Study||71
22279|NCT01903460|49593|P4|NOT COMPLETED|Overall Study||1
22280|NCT01903460|49594|P3|NOT COMPLETED|Overall Study||0
22281|NCT01903460|49595|P2|NOT COMPLETED|Overall Study||0
22282|NCT01903460|49596|P1|NOT COMPLETED|Overall Study||0
22283|NCT01903460|49593|P4|COMPLETED|Overall Study||2
22284|NCT01903460|49594|P3|COMPLETED|Overall Study||3
22285|NCT01903460|49595|P2|COMPLETED|Overall Study||8
22286|NCT01903460|49596|P1|COMPLETED|Overall Study||6
22287|NCT01903460|49593|P4|STARTED|Overall Study||3
22288|NCT01903460|49594|P3|STARTED|Overall Study||3
22289|NCT01903460|49595|P2|STARTED|Overall Study||8
22290|NCT01903460|49596|P1|STARTED|Overall Study||6
22291|NCT01903265|49615|P2|NOT COMPLETED|Overall Study||17
22292|NCT01903265|49616|P1|NOT COMPLETED|Overall Study||14
22293|NCT01903265|49615|P2|COMPLETED|Overall Study||85
22294|NCT01903265|49616|P1|COMPLETED|Overall Study||89
22295|NCT01903265|49615|P2|STARTED|Overall Study||102
22296|NCT01903265|49616|P1|STARTED|Overall Study||103
22297|NCT01903187|49632|P2|NOT COMPLETED|12 Month||0
22298|NCT01903187|49633|P1|NOT COMPLETED|12 Month||0
22299|NCT01903187|49632|P2|COMPLETED|12 Month||0
22300|NCT01903187|49633|P1|COMPLETED|12 Month||2
22301|NCT01903187|49632|P2|STARTED|12 Month||0
22302|NCT01903187|49633|P1|STARTED|12 Month||2
22303|NCT01903187|49632|P2|NOT COMPLETED|6 Month||0
22304|NCT01903187|49633|P1|NOT COMPLETED|6 Month||0
22305|NCT01903187|49632|P2|COMPLETED|6 Month||0
22306|NCT01903187|49633|P1|COMPLETED|6 Month||2
22307|NCT01903187|49632|P2|STARTED|6 Month||0
22308|NCT01903187|49633|P1|STARTED|6 Month||2
22309|NCT01903187|49632|P2|NOT COMPLETED|3 Month||0
22310|NCT01903187|49633|P1|NOT COMPLETED|3 Month||0
22311|NCT01903187|49632|P2|COMPLETED|3 Month||0
22312|NCT01903187|49633|P1|COMPLETED|3 Month||2
22313|NCT01903187|49632|P2|STARTED|3 Month||0
22314|NCT01903187|49633|P1|STARTED|3 Month||2
22315|NCT01903187|49632|P2|NOT COMPLETED|1 Month||0
22316|NCT01903187|49633|P1|NOT COMPLETED|1 Month||0
22317|NCT01903187|49632|P2|COMPLETED|1 Month||2
22318|NCT01903187|49633|P1|COMPLETED|1 Month||2
22319|NCT01903187|49632|P2|STARTED|1 Month||2
22320|NCT01903187|49633|P1|STARTED|1 Month||2
22321|NCT01903187|49632|P2|NOT COMPLETED|Procedure||0
22322|NCT01903187|49633|P1|NOT COMPLETED|Procedure||0
22323|NCT01903187|49632|P2|COMPLETED|Procedure||2
22324|NCT01903187|49633|P1|COMPLETED|Procedure||2
22325|NCT01903187|49632|P2|STARTED|Procedure||2
22326|NCT01903187|49633|P1|STARTED|Procedure||2
22327|NCT01903148|49646|P1|NOT COMPLETED|Overall Study||0
22328|NCT01903148|49646|P1|COMPLETED|Overall Study||441
22329|NCT01903148|49646|P1|STARTED|Overall Study||441
22330|NCT01903005|49664|P1|NOT COMPLETED|Overall Study||373
22331|NCT01903005|49664|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
22332|NCT01903005|49664|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
22333|NCT01902888|49678|P1|NOT COMPLETED|Overall Study||3
22334|NCT01902888|49678|P1|COMPLETED|Overall Study||0
22335|NCT01902888|49678|P1|STARTED|Overall Study||3
22336|NCT01902758|49685|P2|NOT COMPLETED|Overall Study||0
22337|NCT01902758|49686|P1|NOT COMPLETED|Overall Study||0
22338|NCT01902758|49685|P2|COMPLETED|Overall Study||14
22339|NCT01902758|49686|P1|COMPLETED|Overall Study||14
22340|NCT01902758|49685|P2|STARTED|Overall Study||14
22341|NCT01902758|49686|P1|STARTED|Overall Study||14
22342|NCT01902303|49694|P2|NOT COMPLETED|Overall Study||24
22343|NCT01902303|49695|P1|NOT COMPLETED|Overall Study||23
22344|NCT01902303|49694|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
22345|NCT01902303|49695|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
22346|NCT01902303|49694|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
22347|NCT01902303|49695|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
22348|NCT01902303|49694|P2|STARTED|Overall Study|Allocated to active treatment|81
22349|NCT01902303|49695|P1|STARTED|Overall Study|Allocated to placebo|77
22350|NCT01902134|49709|P6|NOT COMPLETED|Overall Study||9
22351|NCT01902134|49710|P5|NOT COMPLETED|Overall Study||7
22352|NCT01902134|49711|P4|NOT COMPLETED|Overall Study||2
22353|NCT01902134|49712|P3|NOT COMPLETED|Overall Study||15
22354|NCT01902134|49713|P2|NOT COMPLETED|Overall Study||11
22355|NCT01902134|49714|P1|NOT COMPLETED|Overall Study||8
22356|NCT01902134|49709|P6|COMPLETED|Overall Study||45
22357|NCT01902134|49710|P5|COMPLETED|Overall Study||46
22358|NCT01902134|49711|P4|COMPLETED|Overall Study||52
22359|NCT01902134|49712|P3|COMPLETED|Overall Study||145
22360|NCT01902134|49713|P2|COMPLETED|Overall Study||150
22361|NCT01902134|49714|P1|COMPLETED|Overall Study||151
22362|NCT01902134|49709|P6|Multiple-dose Phase|Overall Study||52
22363|NCT01902134|49710|P5|Multiple-dose Phase|Overall Study||53
22364|NCT01902134|49711|P4|Multiple-dose Phase|Overall Study||54
22365|NCT01902134|49712|P3|Multiple-dose Phase|Overall Study||160
22366|NCT01902134|49713|P2|Multiple-dose Phase|Overall Study||160
22367|NCT01902134|49714|P1|Multiple-dose Phase|Overall Study||159
22368|NCT01902134|49709|P6|Single-dose Phase|Overall Study||54
22369|NCT01902134|49710|P5|Single-dose Phase|Overall Study||53
22370|NCT01902134|49711|P4|Single-dose Phase|Overall Study||54
22371|NCT01902134|49712|P3|Single-dose Phase|Overall Study||160
22372|NCT01902134|49713|P2|Single-dose Phase|Overall Study||161
22373|NCT01902134|49714|P1|Single-dose Phase|Overall Study||159
22374|NCT01902134|49709|P6|STARTED|Overall Study||54
22375|NCT01902134|49710|P5|STARTED|Overall Study||53
22376|NCT01902134|49711|P4|STARTED|Overall Study||54
22377|NCT01902134|49712|P3|STARTED|Overall Study||160
22378|NCT01902134|49713|P2|STARTED|Overall Study||161
22379|NCT01902134|49714|P1|STARTED|Overall Study||159
22380|NCT01901588|49738|P2|NOT COMPLETED|Overall Study||0
22381|NCT01901588|49739|P1|NOT COMPLETED|Overall Study||0
22382|NCT01901588|49738|P2|COMPLETED|Overall Study||31
22383|NCT01901588|49739|P1|COMPLETED|Overall Study||32
22384|NCT01901588|49738|P2|STARTED|Overall Study||31
22385|NCT01901588|49739|P1|STARTED|Overall Study||32
22386|NCT01901575|49755|P1|NOT COMPLETED|Overall Study||0
22387|NCT01901575|49755|P1|COMPLETED|Overall Study||16
22388|NCT01901575|49755|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
22389|NCT01901393|49761|P2|NOT COMPLETED|Overall Study||0
22390|NCT01901393|49762|P1|NOT COMPLETED|Overall Study||1
22391|NCT01901393|49761|P2|COMPLETED|Overall Study||49
22392|NCT01901393|49762|P1|COMPLETED|Overall Study||50
22393|NCT01901393|49761|P2|STARTED|Overall Study||49
22394|NCT01901393|49762|P1|STARTED|Overall Study||51
22395|NCT01901341|49780|P2|NOT COMPLETED|Overall Study||21
22396|NCT01901341|49781|P1|NOT COMPLETED|Overall Study||20
22397|NCT01901341|49780|P2|COMPLETED|Overall Study||1
22398|NCT01901341|49781|P1|COMPLETED|Overall Study||2
22399|NCT01901341|49780|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
22400|NCT01901341|49781|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
22401|NCT01901341|49780|P2|STARTED|Overall Study||22
22402|NCT01901341|49781|P1|STARTED|Overall Study||22
22403|NCT01901328|49795|P2|NOT COMPLETED|Overall Study||21
22404|NCT01901328|49796|P1|NOT COMPLETED|Overall Study||22
22405|NCT01901328|49795|P2|COMPLETED|Overall Study||2
22406|NCT01901328|49796|P1|COMPLETED|Overall Study||4
22407|NCT01901328|49795|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
22408|NCT01901328|49796|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
22409|NCT01901328|49795|P2|STARTED|Overall Study||23
22410|NCT01901328|49796|P1|STARTED|Overall Study||26
22411|NCT01901302|49810|P2|NOT COMPLETED|Overall Study||23
22412|NCT01901302|49811|P1|NOT COMPLETED|Overall Study||27
22413|NCT01901302|49810|P2|COMPLETED|Overall Study||7
22414|NCT01901302|49811|P1|COMPLETED|Overall Study||4
22415|NCT01901302|49810|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
22416|NCT01901302|49811|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
22417|NCT01901302|49810|P2|STARTED|Overall Study||30
22418|NCT01901302|49811|P1|STARTED|Overall Study||31
22419|NCT01901250|49825|P2|NOT COMPLETED|Overall Study||126
22420|NCT01901250|49826|P1|NOT COMPLETED|Overall Study||138
22421|NCT01901250|49825|P2|COMPLETED|Overall Study||139
22422|NCT01901250|49826|P1|COMPLETED|Overall Study||122
22423|NCT01901250|49825|P2|End of 1st Grade|Overall Study||151
22424|NCT01901250|49826|P1|End of 1st Grade|Overall Study||143
22425|NCT01901250|49825|P2|Start of 1st Grade|Overall Study||176
22426|NCT01901250|49826|P1|Start of 1st Grade|Overall Study||173
22427|NCT01901250|49825|P2|End of Kidergarten|Overall Study||212
22428|NCT01901250|49826|P1|End of Kidergarten|Overall Study||215
22429|NCT01901250|49825|P2|STARTED|Overall Study||265
22430|NCT01901250|49826|P1|STARTED|Overall Study||260
22431|NCT01901185|49832|P1|NOT COMPLETED|Overall Study||2
22432|NCT01901185|49832|P1|COMPLETED|Overall Study||75
22433|NCT01901185|49832|P1|Received Etanercept With Autoinjector A|Overall Study||75
22434|NCT01901185|49832|P1|STARTED|Overall Study||77
22435|NCT01900249|49842|P3|NOT COMPLETED|Overall Study||4
22436|NCT01900249|49843|P2|NOT COMPLETED|Overall Study||5
22437|NCT01900249|49844|P1|NOT COMPLETED|Overall Study||3
22438|NCT01900249|49842|P3|COMPLETED|Overall Study||65
22439|NCT01900249|49843|P2|COMPLETED|Overall Study||63
22440|NCT01900249|49844|P1|COMPLETED|Overall Study||64
22441|NCT01900249|49842|P3|STARTED|Overall Study||69
22442|NCT01900249|49843|P2|STARTED|Overall Study||68
22443|NCT01900249|49844|P1|STARTED|Overall Study||67
22444|NCT01900067|49854|P2|NOT COMPLETED|Overall Study||13
22445|NCT01900067|49855|P1|NOT COMPLETED|Overall Study||12
22446|NCT01900067|49854|P2|COMPLETED|Overall Study||124
22447|NCT01900067|49855|P1|COMPLETED|Overall Study||122
22448|NCT01900067|49854|P2|STARTED|Overall Study||137
22449|NCT01900067|49855|P1|STARTED|Overall Study||134
22450|NCT01900054|49861|P1|NOT COMPLETED|Overall Study||2
22451|NCT01900054|49861|P1|COMPLETED|Overall Study||56
22452|NCT01900054|49861|P1|STARTED|Overall Study||58
22453|NCT01899911|49866|P1|NOT COMPLETED|Overall Study||0
22454|NCT01899911|49866|P1|COMPLETED|Overall Study||12
22455|NCT01899911|49866|P1|STARTED|Overall Study||12
22456|NCT01899742|49872|P2|NOT COMPLETED|Overall Study||16
22457|NCT01899742|49873|P1|NOT COMPLETED|Overall Study||17
22458|NCT01899742|49872|P2|COMPLETED|Overall Study||231
22459|NCT01899742|49873|P1|COMPLETED|Overall Study||230
22460|NCT01899742|49872|P2|STARTED|Overall Study||247
22461|NCT01899742|49873|P1|STARTED|Overall Study||247
22462|NCT01899677|49883|P2|NOT COMPLETED|Overall Study||7
22463|NCT01899677|49884|P1|NOT COMPLETED|Overall Study||10
22464|NCT01899677|49883|P2|COMPLETED|Overall Study||28
22465|NCT01899677|49884|P1|COMPLETED|Overall Study||25
22466|NCT01899677|49883|P2|STARTED|Overall Study||35
22467|NCT01899677|49884|P1|STARTED|Overall Study||35
22468|NCT01899144|49912|P1|NOT COMPLETED|Treatment Period 5||1
22469|NCT01899144|49912|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
22470|NCT01899144|49912|P1|STARTED|Treatment Period 5||58
22471|NCT01899144|49912|P1|NOT COMPLETED|Treatment Period 4||0
22472|NCT01899144|49912|P1|COMPLETED|Treatment Period 4||58
22473|NCT01899144|49912|P1|STARTED|Treatment Period 4||58
22474|NCT01899144|49912|P1|NOT COMPLETED|Treatment Period 3||2
22475|NCT01899144|49912|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
22476|NCT01899144|49912|P1|STARTED|Treatment Period 3||60
22477|NCT01899144|49912|P1|NOT COMPLETED|Treatment Period 2||1
22478|NCT01899144|49912|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
22479|NCT01899144|49912|P1|STARTED|Treatment Period 2||61
22480|NCT01899144|49912|P1|NOT COMPLETED|Treatment Period 1||0
22481|NCT01899144|49912|P1|COMPLETED|Treatment Period 1||61
22482|NCT01899144|49912|P1|STARTED|Treatment Period 1||61
22483|NCT01898884|49939|P9|NOT COMPLETED|Multiple Dose Period||1
22484|NCT01898884|49940|P8|NOT COMPLETED|Multiple Dose Period||0
22485|NCT01898884|49941|P7|NOT COMPLETED|Multiple Dose Period||1
22486|NCT01898884|49942|P6|NOT COMPLETED|Multiple Dose Period||0
22487|NCT01898884|49943|P5|NOT COMPLETED|Multiple Dose Period||0
22488|NCT01898884|49944|P4|NOT COMPLETED|Multiple Dose Period||0
22489|NCT01898884|49945|P3|NOT COMPLETED|Multiple Dose Period||0
22490|NCT01898884|49946|P2|NOT COMPLETED|Multiple Dose Period||0
22491|NCT01898884|49947|P1|NOT COMPLETED|Multiple Dose Period||0
22492|NCT01898884|49939|P9|COMPLETED|Multiple Dose Period||5
22493|NCT01898884|49940|P8|COMPLETED|Multiple Dose Period||6
22494|NCT01898884|49941|P7|COMPLETED|Multiple Dose Period||5
22495|NCT01898884|49942|P6|COMPLETED|Multiple Dose Period||6
22496|NCT01898884|49943|P5|COMPLETED|Multiple Dose Period||0
22497|NCT01898884|49944|P4|COMPLETED|Multiple Dose Period||0
22498|NCT01898884|49945|P3|COMPLETED|Multiple Dose Period||0
22499|NCT01898884|49946|P2|COMPLETED|Multiple Dose Period||0
22500|NCT01898884|49947|P1|COMPLETED|Multiple Dose Period||0
22501|NCT01898884|49939|P9|Treated|Multiple Dose Period||5
22502|NCT01898884|49940|P8|Treated|Multiple Dose Period||6
22503|NCT01898884|49941|P7|Treated|Multiple Dose Period||6
22504|NCT01898884|49942|P6|Treated|Multiple Dose Period||6
22505|NCT01898884|49943|P5|Treated|Multiple Dose Period||0
22506|NCT01898884|49944|P4|Treated|Multiple Dose Period||0
22507|NCT01898884|49945|P3|Treated|Multiple Dose Period||0
22508|NCT01898884|49946|P2|Treated|Multiple Dose Period||0
22509|NCT01898884|49947|P1|Treated|Multiple Dose Period||0
22510|NCT01898884|49939|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
22511|NCT01898884|49940|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
22512|NCT01898884|49941|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
22513|NCT01898884|49942|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
22514|NCT01898884|49943|P5|STARTED|Multiple Dose Period||0
22515|NCT01898884|49944|P4|STARTED|Multiple Dose Period||0
22516|NCT01898884|49945|P3|STARTED|Multiple Dose Period||0
22517|NCT01898884|49946|P2|STARTED|Multiple Dose Period||0
22518|NCT01898884|49947|P1|STARTED|Multiple Dose Period||0
22519|NCT01898884|49939|P9|NOT COMPLETED|Single Dose Period||0
22520|NCT01898884|49940|P8|NOT COMPLETED|Single Dose Period||0
22521|NCT01898884|49941|P7|NOT COMPLETED|Single Dose Period||0
22522|NCT01898884|49942|P6|NOT COMPLETED|Single Dose Period||0
22523|NCT01898884|49943|P5|NOT COMPLETED|Single Dose Period||0
22524|NCT01898884|49944|P4|NOT COMPLETED|Single Dose Period||0
22525|NCT01898884|49945|P3|NOT COMPLETED|Single Dose Period||0
22526|NCT01898884|49946|P2|NOT COMPLETED|Single Dose Period||0
22527|NCT01898884|49947|P1|NOT COMPLETED|Single Dose Period||0
22528|NCT01898884|49939|P9|COMPLETED|Single Dose Period||0
22529|NCT01898884|49940|P8|COMPLETED|Single Dose Period||0
22530|NCT01898884|49941|P7|COMPLETED|Single Dose Period||0
22531|NCT01898884|49942|P6|COMPLETED|Single Dose Period||0
22532|NCT01898884|49943|P5|COMPLETED|Single Dose Period||6
22533|NCT01898884|49944|P4|COMPLETED|Single Dose Period||6
22534|NCT01898884|49945|P3|COMPLETED|Single Dose Period||6
22535|NCT01898884|49946|P2|COMPLETED|Single Dose Period||6
22536|NCT01898884|49947|P1|COMPLETED|Single Dose Period||8
22537|NCT01898884|49939|P9|STARTED|Single Dose Period||0
22538|NCT01898884|49940|P8|STARTED|Single Dose Period||0
22539|NCT01898884|49941|P7|STARTED|Single Dose Period||0
22540|NCT01898884|49942|P6|STARTED|Single Dose Period||0
22541|NCT01898884|49943|P5|STARTED|Single Dose Period||6
22542|NCT01898884|49944|P4|STARTED|Single Dose Period||6
22543|NCT01898884|49945|P3|STARTED|Single Dose Period||6
22544|NCT01898884|49946|P2|STARTED|Single Dose Period||6
22545|NCT01898884|49947|P1|STARTED|Single Dose Period||8
22546|NCT01898442|50100|P3|NOT COMPLETED|Overall Study||3
22547|NCT01898442|50101|P2|NOT COMPLETED|Overall Study||2
22548|NCT01898442|50102|P1|NOT COMPLETED|Overall Study||1
22549|NCT01898442|50100|P3|COMPLETED|Overall Study||15
22550|NCT01898442|50101|P2|COMPLETED|Overall Study||15
22551|NCT01898442|50102|P1|COMPLETED|Overall Study||16
22552|NCT01898442|50100|P3|STARTED|Overall Study||18
22553|NCT01898442|50101|P2|STARTED|Overall Study||17
22554|NCT01898442|50102|P1|STARTED|Overall Study||17
22555|NCT01898286|50125|P1|NOT COMPLETED|Overall Study||3
22556|NCT01898286|50125|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
22557|NCT01898286|50125|P1|STARTED|Overall Study||38
22558|NCT01898208|50135|P3|NOT COMPLETED|Overall Study||37
22559|NCT01898208|50136|P2|NOT COMPLETED|Overall Study||49
22560|NCT01898208|50137|P1|NOT COMPLETED|Overall Study||40
22561|NCT01898208|50135|P3|COMPLETED|Overall Study||212
22562|NCT01898208|50136|P2|COMPLETED|Overall Study||198
22563|NCT01898208|50137|P1|COMPLETED|Overall Study||207
22564|NCT01898208|50135|P3|STARTED|Overall Study||249
22565|NCT01898208|50136|P2|STARTED|Overall Study||247
22566|NCT01898208|50137|P1|STARTED|Overall Study||247
22567|NCT01897727|50183|P2|NOT COMPLETED|Overall Study||1
22568|NCT01897727|50184|P1|NOT COMPLETED|Overall Study||0
22569|NCT01897727|50183|P2|COMPLETED|Overall Study||8
22570|NCT01897727|50184|P1|COMPLETED|Overall Study||8
22571|NCT01897727|50183|P2|STARTED|Overall Study||9
22572|NCT01897727|50184|P1|STARTED|Overall Study||8
22573|NCT01897402|50192|P2|NOT COMPLETED|Overall Study||16
22574|NCT01897402|50193|P1|NOT COMPLETED|Overall Study||19
22575|NCT01897402|50192|P2|COMPLETED|Overall Study||244
22576|NCT01897402|50193|P1|COMPLETED|Overall Study||246
22577|NCT01897402|50192|P2|STARTED|Overall Study||260
22578|NCT01897402|50193|P1|STARTED|Overall Study||265
22579|NCT01897285|50205|P1|NOT COMPLETED|Overall Study||0
22580|NCT01897285|50205|P1|COMPLETED|Overall Study||20
22581|NCT01897285|50205|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
22582|NCT01897233|50213|P1|NOT COMPLETED|Part B (24 Weeks)||4
22583|NCT01897233|50213|P1|COMPLETED|Part B (24 Weeks)||54
22584|NCT01897233|50213|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
22585|NCT01897233|50213|P1|NOT COMPLETED|Part A (14 Days)||0
22586|NCT01897233|50213|P1|COMPLETED|Part A (14 Days)||10
22587|NCT01897233|50213|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
22588|NCT01897233|50213|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
22589|NCT01897233|50213|P1|STARTED|Part A (14 Days)||10
22590|NCT01897025|50237|P2|NOT COMPLETED|Overall Study||0
22591|NCT01897025|50238|P1|NOT COMPLETED|Overall Study||0
22592|NCT01897025|50237|P2|COMPLETED|Overall Study||9
22593|NCT01897025|50238|P1|COMPLETED|Overall Study||10
22594|NCT01897025|50237|P2|STARTED|Overall Study||9
22595|NCT01897025|50238|P1|STARTED|Overall Study||10
22596|NCT01896687|50246|P2|NOT COMPLETED|Overall Study||0
22597|NCT01896687|50247|P1|NOT COMPLETED|Overall Study||0
22598|NCT01896687|50246|P2|COMPLETED|Overall Study||15
22599|NCT01896687|50247|P1|COMPLETED|Overall Study||15
22600|NCT01896687|50246|P2|STARTED|Overall Study||15
22601|NCT01896687|50247|P1|STARTED|Overall Study||15
22602|NCT01896557|50255|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
22603|NCT01896557|50256|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
22604|NCT01896557|50255|P2|COMPLETED|Clopidogrel + GI Protector||44
22605|NCT01896557|50256|P1|COMPLETED|Clopidogrel + GI Protector||41
22606|NCT01896557|50255|P2|STARTED|Clopidogrel + GI Protector||48
22607|NCT01896557|50256|P1|STARTED|Clopidogrel + GI Protector||43
22608|NCT01896557|50255|P2|NOT COMPLETED|Clopidogrel Alone||0
22609|NCT01896557|50256|P1|NOT COMPLETED|Clopidogrel Alone||1
22610|NCT01896557|50255|P2|COMPLETED|Clopidogrel Alone||48
22611|NCT01896557|50256|P1|COMPLETED|Clopidogrel Alone||43
22612|NCT01896557|50255|P2|STARTED|Clopidogrel Alone||48
22613|NCT01896557|50256|P1|STARTED|Clopidogrel Alone||44
22614|NCT01896544|50267|P3|NOT COMPLETED|Overall Study||0
22615|NCT01896544|50268|P2|NOT COMPLETED|Overall Study||0
22616|NCT01896544|50269|P1|NOT COMPLETED|Overall Study||0
22617|NCT01896544|50267|P3|COMPLETED|Overall Study||10
22618|NCT01896544|50268|P2|COMPLETED|Overall Study||10
22619|NCT01896544|50269|P1|COMPLETED|Overall Study||10
22620|NCT01896544|50267|P3|STARTED|Overall Study||10
22621|NCT01896544|50268|P2|STARTED|Overall Study||10
22622|NCT01896544|50269|P1|STARTED|Overall Study||10
22623|NCT01896297|50289|P1|NOT COMPLETED|Overall Study||1
22624|NCT01896297|50289|P1|COMPLETED|Overall Study||59
22625|NCT01896297|50289|P1|STARTED|Overall Study||60
22626|NCT01896206|50294|P1|NOT COMPLETED|Overall Study||0
22627|NCT01896206|50294|P1|COMPLETED|Overall Study||21
22628|NCT01896206|50294|P1|STARTED|Overall Study||21
22629|NCT01896193|50302|P2|NOT COMPLETED|Overall Study||12
22630|NCT01896193|50303|P1|NOT COMPLETED|Overall Study||21
22631|NCT01896193|50302|P2|COMPLETED|Overall Study||53
22632|NCT01896193|50303|P1|COMPLETED|Overall Study||41
22633|NCT01896193|50302|P2|STARTED|Overall Study||65
22634|NCT01896193|50303|P1|STARTED|Overall Study||62
22635|NCT01895101|50330|P3|NOT COMPLETED|Overall Study||5
22636|NCT01895101|50331|P2|NOT COMPLETED|Overall Study||5
22637|NCT01895101|50332|P1|NOT COMPLETED|Overall Study||1
22638|NCT01895101|50330|P3|COMPLETED|Overall Study||245
22639|NCT01895101|50331|P2|COMPLETED|Overall Study||245
22640|NCT01895101|50332|P1|COMPLETED|Overall Study||249
22641|NCT01895101|50330|P3|STARTED|Overall Study||250
22642|NCT01895101|50331|P2|STARTED|Overall Study||250
22643|NCT01895101|50332|P1|STARTED|Overall Study||250
22644|NCT01895062|50348|P2|NOT COMPLETED|Overall Study||0
22645|NCT01895062|50349|P1|NOT COMPLETED|Overall Study||0
22646|NCT01895062|50348|P2|COMPLETED|Overall Study||24
22647|NCT01895062|50349|P1|COMPLETED|Overall Study||30
22648|NCT01895062|50348|P2|STARTED|Overall Study||24
22649|NCT01895062|50349|P1|STARTED|Overall Study||30
22650|NCT01894984|50359|P2|NOT COMPLETED|Overall Study||175
22651|NCT01894984|50360|P1|NOT COMPLETED|Overall Study||314
22652|NCT01894984|50359|P2|COMPLETED|Overall Study||69
22653|NCT01894984|50360|P1|COMPLETED|Overall Study||82
22654|NCT01894984|50359|P2|STARTED|Overall Study||244
22655|NCT01894984|50360|P1|STARTED|Overall Study||396
22656|NCT01894906|50378|P2|NOT COMPLETED|Overall Study||0
22657|NCT01894906|50379|P1|NOT COMPLETED|Overall Study||0
22658|NCT01894906|50378|P2|COMPLETED|Overall Study||6
22659|NCT01894906|50379|P1|COMPLETED|Overall Study||6
22660|NCT01894906|50378|P2|Treatment F|Overall Study||6
22661|NCT01894906|50379|P1|Treatment F|Overall Study||6
22662|NCT01894906|50378|P2|Treatment E|Overall Study||6
22663|NCT01894906|50379|P1|Treatment E|Overall Study||6
22664|NCT01894906|50378|P2|Treatment D|Overall Study||6
22665|NCT01894906|50379|P1|Treatment D|Overall Study||6
22666|NCT01894906|50378|P2|Treatment C|Overall Study||6
22667|NCT01894906|50379|P1|Treatment C|Overall Study||6
22668|NCT01894906|50378|P2|Treatment B|Overall Study||6
22669|NCT01894906|50379|P1|Treatment B|Overall Study||6
22670|NCT01894906|50378|P2|Treatment A|Overall Study||6
22671|NCT01894906|50379|P1|Treatment A|Overall Study||6
22672|NCT01894906|50378|P2|STARTED|Overall Study||6
22673|NCT01894906|50379|P1|STARTED|Overall Study||6
22674|NCT01896115|50409|P1|NOT COMPLETED|Overall Study||1
22675|NCT01896115|50409|P1|COMPLETED|Overall Study||15
22676|NCT01896115|50409|P1|Ventral Steering|Overall Study||15
22677|NCT01896115|50409|P1|Dorsal Steering|Overall Study||15
22678|NCT01896115|50409|P1|Conventional PW|Overall Study||15
22679|NCT01896115|50409|P1|Short PW|Overall Study||15
22680|NCT01896115|50409|P1|STARTED|Overall Study||16
22681|NCT01896050|50434|P2|NOT COMPLETED|Overall Study||2
22682|NCT01896050|50435|P1|NOT COMPLETED|Overall Study||38
22683|NCT01896050|50434|P2|COMPLETED|Overall Study||20
22684|NCT01896050|50435|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
22685|NCT01896050|50434|P2|STARTED|Overall Study||22
22686|NCT01896050|50435|P1|STARTED|Overall Study||93
22687|NCT01895946|50447|P2|NOT COMPLETED|Overall Study||0
22688|NCT01895946|50448|P1|NOT COMPLETED|Overall Study||0
22689|NCT01895946|50447|P2|COMPLETED|Overall Study||12
22690|NCT01895946|50448|P1|COMPLETED|Overall Study||18
22691|NCT01895946|50447|P2|STARTED|Overall Study||12
22692|NCT01895946|50448|P1|STARTED|Overall Study||18
22693|NCT01895634|50466|P1|NOT COMPLETED|Overall Study||3
22694|NCT01895634|50466|P1|COMPLETED|Overall Study||46
22695|NCT01895634|50466|P1|STARTED|Overall Study||49
22696|NCT01895543|50474|P1|NOT COMPLETED|Overall Study||129
22697|NCT01895543|50474|P1|COMPLETED|Overall Study||282
22698|NCT01895543|50474|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
22699|NCT01895543|50474|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
22700|NCT01895543|50474|P1|STARTED|Overall Study||411
22701|NCT01895335|50488|P1|NOT COMPLETED|Overall Study||215
22702|NCT01895335|50488|P1|COMPLETED|Overall Study||786
22703|NCT01895335|50488|P1|Treated|Overall Study||1000
22704|NCT01895335|50488|P1|STARTED|Overall Study||1001
22705|NCT01895322|50505|P1|NOT COMPLETED|Overall Study||13
22706|NCT01895322|50505|P1|COMPLETED|Overall Study||7
22707|NCT01895322|50505|P1|STARTED|Overall Study||20
22708|NCT01895309|50514|P2|NOT COMPLETED|Overall Study||51
22709|NCT01895309|50515|P1|NOT COMPLETED|Overall Study||40
22710|NCT01895309|50514|P2|COMPLETED|Overall Study||246
22711|NCT01895309|50515|P1|COMPLETED|Overall Study||259
22712|NCT01895309|50514|P2|STARTED|Overall Study||297
22713|NCT01895309|50515|P1|STARTED|Overall Study||299
22714|NCT01894607|50527|P1|NOT COMPLETED|Overall Study||1
22715|NCT01894607|50527|P1|COMPLETED|Overall Study||10
22716|NCT01894607|50527|P1|STARTED|Overall Study||11
22717|NCT01894581|50534|P2|NOT COMPLETED|Overall Study||7
22718|NCT01894581|50535|P1|NOT COMPLETED|Overall Study||5
22719|NCT01894581|50534|P2|COMPLETED|Overall Study||12
22720|NCT01894581|50535|P1|COMPLETED|Overall Study||15
22721|NCT01894581|50534|P2|STARTED|Overall Study||19
22722|NCT01894581|50535|P1|STARTED|Overall Study||20
22723|NCT01894555|50541|P1|NOT COMPLETED|Overall Study||0
22724|NCT01894555|50541|P1|COMPLETED|Overall Study||33
22725|NCT01894555|50541|P1|STARTED|Overall Study||33
22726|NCT01894256|50548|P3|NOT COMPLETED|Part B||14
22727|NCT01894256|50549|P2|NOT COMPLETED|Part B||14
22728|NCT01894256|50550|P1|NOT COMPLETED|Part B||15
22729|NCT01894256|50548|P3|COMPLETED|Part B||0
22730|NCT01894256|50549|P2|COMPLETED|Part B||0
22731|NCT01894256|50550|P1|COMPLETED|Part B||0
22732|NCT01894256|50548|P3|STARTED|Part B||14
22733|NCT01894256|50549|P2|STARTED|Part B||14
22734|NCT01894256|50550|P1|STARTED|Part B||15
22735|NCT01894256|50548|P3|NOT COMPLETED|Part A||0
22736|NCT01894256|50549|P2|NOT COMPLETED|Part A||1
22737|NCT01894256|50550|P1|NOT COMPLETED|Part A||0
22738|NCT01894256|50548|P3|COMPLETED|Part A||14
22739|NCT01894256|50549|P2|COMPLETED|Part A||14
22740|NCT01894256|50550|P1|COMPLETED|Part A||15
22741|NCT01894256|50548|P3|STARTED|Part A||14
22742|NCT01894256|50549|P2|STARTED|Part A||15
22743|NCT01894256|50550|P1|STARTED|Part A||15
22744|NCT01894100|50596|P2|NOT COMPLETED|Overall Study||1
22745|NCT01894100|50597|P1|NOT COMPLETED|Overall Study||3
22746|NCT01894100|50596|P2|COMPLETED|Overall Study||14
22747|NCT01894100|50597|P1|COMPLETED|Overall Study||12
22748|NCT01894100|50596|P2|STARTED|Overall Study||15
22749|NCT01894100|50597|P1|STARTED|Overall Study||15
22750|NCT01893567|50605|P1|NOT COMPLETED|Overall Study||0
22751|NCT01893567|50605|P1|COMPLETED|Overall Study||28
22752|NCT01893567|50605|P1|STARTED|Overall Study||28
22753|NCT01893359|50612|P3|NOT COMPLETED|Overall Study||0
22754|NCT01893359|50613|P2|NOT COMPLETED|Overall Study||0
22755|NCT01893359|50614|P1|NOT COMPLETED|Overall Study||0
22756|NCT01893359|50612|P3|COMPLETED|Overall Study||0
22757|NCT01893359|50613|P2|COMPLETED|Overall Study||2
22758|NCT01893359|50614|P1|COMPLETED|Overall Study||0
22759|NCT01893359|50612|P3|STARTED|Overall Study||0
22760|NCT01893359|50613|P2|STARTED|Overall Study||2
22761|NCT01893359|50614|P1|STARTED|Overall Study||0
22762|NCT01893346|50629|P4|NOT COMPLETED|Overall Study||0
22763|NCT01893346|50630|P3|NOT COMPLETED|Overall Study||0
22764|NCT01893346|50631|P2|NOT COMPLETED|Overall Study||1
22765|NCT01893346|50632|P1|NOT COMPLETED|Overall Study||3
22766|NCT01893346|50629|P4|COMPLETED|Overall Study||8
22767|NCT01893346|50630|P3|COMPLETED|Overall Study||8
22768|NCT01893346|50631|P2|COMPLETED|Overall Study||7
22769|NCT01893346|50632|P1|COMPLETED|Overall Study||8
22770|NCT01893346|50629|P4|Patients Who Received Full Infusion|Overall Study||8
22771|NCT01893346|50630|P3|Patients Who Received Full Infusion|Overall Study||8
22772|NCT01893346|50631|P2|Patients Who Received Full Infusion|Overall Study||8
22773|NCT01893346|50632|P1|Patients Who Received Full Infusion|Overall Study||8
22774|NCT01893346|50629|P4|STARTED|Overall Study||8
22775|NCT01893346|50630|P3|STARTED|Overall Study||8
22776|NCT01893346|50631|P2|STARTED|Overall Study||8
22777|NCT01893346|50632|P1|STARTED|Overall Study||11
22778|NCT01893281|50646|P1|NOT COMPLETED|Overall Study||3
22779|NCT01893281|50646|P1|COMPLETED|Overall Study||75
22780|NCT01893281|50646|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
22781|NCT01893281|50646|P1|STARTED|Overall Study||78
22782|NCT01893203|50653|P1|NOT COMPLETED|Overall Study||1
22783|NCT01893203|50653|P1|COMPLETED|Overall Study||13
22784|NCT01893203|50653|P1|STARTED|Overall Study||14
22785|NCT01892657|50660|P1|NOT COMPLETED|Overall Study||18
22786|NCT01892657|50660|P1|COMPLETED|Overall Study||110
22787|NCT01892657|50660|P1|STARTED|Overall Study||128
22788|NCT01892189|50685|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
22789|NCT01892189|50686|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
22790|NCT01892189|50687|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
22791|NCT01892189|50688|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
22792|NCT01892189|50689|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
22793|NCT01892189|50690|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
22794|NCT01892189|50691|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
22795|NCT01892189|50692|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
22796|NCT01892189|50693|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
22797|NCT01892189|50685|P9|COMPLETED|Third Intervention Period (1 Day)||1
22798|NCT01892189|50686|P8|COMPLETED|Third Intervention Period (1 Day)||3
22799|NCT01892189|50687|P7|COMPLETED|Third Intervention Period (1 Day)||2
22800|NCT01892189|50688|P6|COMPLETED|Third Intervention Period (1 Day)||2
22801|NCT01892189|50689|P5|COMPLETED|Third Intervention Period (1 Day)||3
22802|NCT01892189|50690|P4|COMPLETED|Third Intervention Period (1 Day)||2
22803|NCT01892189|50691|P3|COMPLETED|Third Intervention Period (1 Day)||1
22804|NCT01892189|50692|P2|COMPLETED|Third Intervention Period (1 Day)||3
22805|NCT01892189|50693|P1|COMPLETED|Third Intervention Period (1 Day)||3
22806|NCT01892189|50685|P9|STARTED|Third Intervention Period (1 Day)||1
22807|NCT01892189|50686|P8|STARTED|Third Intervention Period (1 Day)||3
22808|NCT01892189|50687|P7|STARTED|Third Intervention Period (1 Day)||2
22809|NCT01892189|50688|P6|STARTED|Third Intervention Period (1 Day)||2
22810|NCT01892189|50689|P5|STARTED|Third Intervention Period (1 Day)||3
22811|NCT01892189|50690|P4|STARTED|Third Intervention Period (1 Day)||2
22812|NCT01892189|50691|P3|STARTED|Third Intervention Period (1 Day)||1
22813|NCT01892189|50692|P2|STARTED|Third Intervention Period (1 Day)||3
22814|NCT01892189|50693|P1|STARTED|Third Intervention Period (1 Day)||3
22815|NCT01892189|50685|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
22816|NCT01892189|50686|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
22817|NCT01892189|50687|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
22818|NCT01892189|50688|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
22819|NCT01892189|50689|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
22820|NCT01892189|50690|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
22821|NCT01892189|50691|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
22822|NCT01892189|50692|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
22823|NCT01892189|50693|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
22824|NCT01892189|50685|P9|COMPLETED|Washout Period 2 (7 Days)||1
22825|NCT01892189|50686|P8|COMPLETED|Washout Period 2 (7 Days)||3
22826|NCT01892189|50687|P7|COMPLETED|Washout Period 2 (7 Days)||2
22827|NCT01892189|50688|P6|COMPLETED|Washout Period 2 (7 Days)||2
22828|NCT01892189|50689|P5|COMPLETED|Washout Period 2 (7 Days)||3
22829|NCT01892189|50690|P4|COMPLETED|Washout Period 2 (7 Days)||2
22830|NCT01892189|50691|P3|COMPLETED|Washout Period 2 (7 Days)||1
22831|NCT01892189|50692|P2|COMPLETED|Washout Period 2 (7 Days)||3
22832|NCT01892189|50693|P1|COMPLETED|Washout Period 2 (7 Days)||3
22833|NCT01892189|50685|P9|STARTED|Washout Period 2 (7 Days)||1
22834|NCT01892189|50686|P8|STARTED|Washout Period 2 (7 Days)||3
22835|NCT01892189|50687|P7|STARTED|Washout Period 2 (7 Days)||2
22836|NCT01892189|50688|P6|STARTED|Washout Period 2 (7 Days)||2
22837|NCT01892189|50689|P5|STARTED|Washout Period 2 (7 Days)||3
22838|NCT01892189|50690|P4|STARTED|Washout Period 2 (7 Days)||2
22839|NCT01892189|50691|P3|STARTED|Washout Period 2 (7 Days)||1
22840|NCT01892189|50692|P2|STARTED|Washout Period 2 (7 Days)||3
22841|NCT01892189|50693|P1|STARTED|Washout Period 2 (7 Days)||3
22842|NCT01892189|50685|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
22843|NCT01892189|50686|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
22844|NCT01892189|50687|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
22845|NCT01892189|50688|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
22846|NCT01892189|50689|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
22847|NCT01892189|50690|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
22848|NCT01892189|50691|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
22849|NCT01892189|50692|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
22850|NCT01892189|50693|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
22851|NCT01892189|50685|P9|COMPLETED|Second Intervention Period (1 Day)||1
22852|NCT01892189|50686|P8|COMPLETED|Second Intervention Period (1 Day)||3
22853|NCT01892189|50687|P7|COMPLETED|Second Intervention Period (1 Day)||2
22854|NCT01892189|50688|P6|COMPLETED|Second Intervention Period (1 Day)||2
22855|NCT01892189|50689|P5|COMPLETED|Second Intervention Period (1 Day)||3
22856|NCT01892189|50690|P4|COMPLETED|Second Intervention Period (1 Day)||2
22857|NCT01892189|50691|P3|COMPLETED|Second Intervention Period (1 Day)||1
22858|NCT01892189|50692|P2|COMPLETED|Second Intervention Period (1 Day)||3
22859|NCT01892189|50693|P1|COMPLETED|Second Intervention Period (1 Day)||3
22860|NCT01892189|50685|P9|STARTED|Second Intervention Period (1 Day)||1
22861|NCT01892189|50686|P8|STARTED|Second Intervention Period (1 Day)||3
22862|NCT01892189|50687|P7|STARTED|Second Intervention Period (1 Day)||2
22863|NCT01892189|50688|P6|STARTED|Second Intervention Period (1 Day)||2
22864|NCT01892189|50689|P5|STARTED|Second Intervention Period (1 Day)||3
22865|NCT01892189|50690|P4|STARTED|Second Intervention Period (1 Day)||2
22866|NCT01892189|50691|P3|STARTED|Second Intervention Period (1 Day)||1
22867|NCT01892189|50692|P2|STARTED|Second Intervention Period (1 Day)||3
22868|NCT01892189|50693|P1|STARTED|Second Intervention Period (1 Day)||3
22869|NCT01892189|50685|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
22870|NCT01892189|50686|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
22871|NCT01892189|50687|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
22872|NCT01892189|50688|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
22873|NCT01892189|50689|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
22874|NCT01892189|50690|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
22875|NCT01892189|50691|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
22876|NCT01892189|50692|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
22877|NCT01892189|50693|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
22878|NCT01892189|50685|P9|COMPLETED|Washout Period 1 (7 Days)||1
22879|NCT01892189|50686|P8|COMPLETED|Washout Period 1 (7 Days)||3
22880|NCT01892189|50687|P7|COMPLETED|Washout Period 1 (7 Days)||2
22881|NCT01892189|50688|P6|COMPLETED|Washout Period 1 (7 Days)||2
22882|NCT01892189|50689|P5|COMPLETED|Washout Period 1 (7 Days)||3
22883|NCT01892189|50690|P4|COMPLETED|Washout Period 1 (7 Days)||2
22884|NCT01892189|50691|P3|COMPLETED|Washout Period 1 (7 Days)||1
22885|NCT01892189|50692|P2|COMPLETED|Washout Period 1 (7 Days)||3
22886|NCT01892189|50693|P1|COMPLETED|Washout Period 1 (7 Days)||3
22887|NCT01892189|50685|P9|STARTED|Washout Period 1 (7 Days)||3
22888|NCT01892189|50686|P8|STARTED|Washout Period 1 (7 Days)||3
22889|NCT01892189|50687|P7|STARTED|Washout Period 1 (7 Days)||3
22890|NCT01892189|50688|P6|STARTED|Washout Period 1 (7 Days)||3
22891|NCT01892189|50689|P5|STARTED|Washout Period 1 (7 Days)||3
22892|NCT01892189|50690|P4|STARTED|Washout Period 1 (7 Days)||3
22893|NCT01892189|50691|P3|STARTED|Washout Period 1 (7 Days)||3
22894|NCT01892189|50692|P2|STARTED|Washout Period 1 (7 Days)||3
22895|NCT01892189|50693|P1|STARTED|Washout Period 1 (7 Days)||3
22896|NCT01892189|50685|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
22988|NCT01890785|50968|P1|NOT COMPLETED|Third Intervention||0
22897|NCT01892189|50686|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
22898|NCT01892189|50687|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
22899|NCT01892189|50688|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
22900|NCT01892189|50689|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
22901|NCT01892189|50690|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
22902|NCT01892189|50691|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
22903|NCT01892189|50692|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
22904|NCT01892189|50693|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
22905|NCT01892189|50685|P9|COMPLETED|First Intervention Period (1 Day)||3
22906|NCT01892189|50686|P8|COMPLETED|First Intervention Period (1 Day)||3
22907|NCT01892189|50687|P7|COMPLETED|First Intervention Period (1 Day)||3
22908|NCT01892189|50688|P6|COMPLETED|First Intervention Period (1 Day)||3
22909|NCT01892189|50689|P5|COMPLETED|First Intervention Period (1 Day)||3
22910|NCT01892189|50690|P4|COMPLETED|First Intervention Period (1 Day)||3
22911|NCT01892189|50691|P3|COMPLETED|First Intervention Period (1 Day)||3
22912|NCT01892189|50692|P2|COMPLETED|First Intervention Period (1 Day)||3
22913|NCT01892189|50693|P1|COMPLETED|First Intervention Period (1 Day)||3
22914|NCT01892189|50685|P9|STARTED|First Intervention Period (1 Day)||3
22915|NCT01892189|50686|P8|STARTED|First Intervention Period (1 Day)||3
22916|NCT01892189|50687|P7|STARTED|First Intervention Period (1 Day)||3
22917|NCT01892189|50688|P6|STARTED|First Intervention Period (1 Day)||3
22918|NCT01892189|50689|P5|STARTED|First Intervention Period (1 Day)||3
22919|NCT01892189|50690|P4|STARTED|First Intervention Period (1 Day)||3
22920|NCT01892189|50691|P3|STARTED|First Intervention Period (1 Day)||3
22921|NCT01892189|50692|P2|STARTED|First Intervention Period (1 Day)||3
22922|NCT01892189|50693|P1|STARTED|First Intervention Period (1 Day)||3
22923|NCT01892020|50733|P2|NOT COMPLETED|Period 2||0
22924|NCT01892020|50734|P1|NOT COMPLETED|Period 2||1
22925|NCT01892020|50733|P2|COMPLETED|Period 2||74
22926|NCT01892020|50734|P1|COMPLETED|Period 2||77
22927|NCT01892020|50733|P2|STARTED|Period 2||74
22928|NCT01892020|50734|P1|STARTED|Period 2||78
22929|NCT01892020|50733|P2|NOT COMPLETED|Period 1||6
22930|NCT01892020|50734|P1|NOT COMPLETED|Period 1||3
22931|NCT01892020|50733|P2|COMPLETED|Period 1||74
22932|NCT01892020|50734|P1|COMPLETED|Period 1||78
22933|NCT01892020|50733|P2|STARTED|Period 1||80
22934|NCT01892020|50734|P1|STARTED|Period 1||81
22935|NCT01891734|50754|P2|NOT COMPLETED|Overall Study||3
22936|NCT01891734|50755|P1|NOT COMPLETED|Overall Study||3
22937|NCT01891734|50754|P2|COMPLETED|Overall Study||13
22938|NCT01891734|50755|P1|COMPLETED|Overall Study||14
22939|NCT01891734|50754|P2|STARTED|Overall Study||16
22940|NCT01891734|50755|P1|STARTED|Overall Study||17
22941|NCT01891669|50775|P10|NOT COMPLETED|Overall Study||2
22942|NCT01891669|50776|P9|NOT COMPLETED|Overall Study||1
22943|NCT01891669|50777|P8|NOT COMPLETED|Overall Study||4
22944|NCT01891669|50778|P7|NOT COMPLETED|Overall Study||1
22945|NCT01891669|50779|P6|NOT COMPLETED|Overall Study||0
22946|NCT01891669|50780|P5|NOT COMPLETED|Overall Study||0
22947|NCT01891669|50781|P4|NOT COMPLETED|Overall Study||0
22948|NCT01891669|50782|P3|NOT COMPLETED|Overall Study||0
22949|NCT01891669|50783|P2|NOT COMPLETED|Overall Study||1
22950|NCT01891669|50784|P1|NOT COMPLETED|Overall Study||2
22951|NCT01891669|50775|P10|COMPLETED|Overall Study||1
22952|NCT01891669|50776|P9|COMPLETED|Overall Study||2
22953|NCT01891669|50777|P8|COMPLETED|Overall Study||2
22954|NCT01891669|50778|P7|COMPLETED|Overall Study||1
22955|NCT01891669|50779|P6|COMPLETED|Overall Study||2
22956|NCT01891669|50780|P5|COMPLETED|Overall Study||2
22957|NCT01891669|50781|P4|COMPLETED|Overall Study||2
22958|NCT01891669|50782|P3|COMPLETED|Overall Study||2
22959|NCT01891669|50783|P2|COMPLETED|Overall Study||1
22960|NCT01891669|50784|P1|COMPLETED|Overall Study||0
22961|NCT01891669|50775|P10|STARTED|Overall Study||3
22962|NCT01891669|50776|P9|STARTED|Overall Study||3
22963|NCT01891669|50777|P8|STARTED|Overall Study||6
22964|NCT01891669|50778|P7|STARTED|Overall Study||2
22965|NCT01891669|50779|P6|STARTED|Overall Study||2
22966|NCT01891669|50780|P5|STARTED|Overall Study||2
22967|NCT01891669|50781|P4|STARTED|Overall Study||2
22968|NCT01891669|50782|P3|STARTED|Overall Study||2
22969|NCT01891669|50783|P2|STARTED|Overall Study||2
22970|NCT01891669|50784|P1|STARTED|Overall Study||2
22971|NCT01890954|50937|P2|NOT COMPLETED|Overall Study||0
22972|NCT01890954|50938|P1|NOT COMPLETED|Overall Study||1
22973|NCT01890954|50937|P2|COMPLETED|Overall Study||8
22974|NCT01890954|50938|P1|COMPLETED|Overall Study||8
22975|NCT01890954|50937|P2|STARTED|Overall Study||8
22976|NCT01890954|50938|P1|STARTED|Overall Study||9
22977|NCT01890915|50946|P2|NOT COMPLETED|Overall Study||1
22978|NCT01890915|50947|P1|NOT COMPLETED|Overall Study||3
22979|NCT01890915|50946|P2|COMPLETED|Overall Study||9
22980|NCT01890915|50947|P1|COMPLETED|Overall Study||8
22981|NCT01890915|50946|P2|STARTED|Overall Study||10
22982|NCT01890915|50947|P1|STARTED|Overall Study||11
22983|NCT01890785|50963|P6|NOT COMPLETED|Third Intervention||0
22984|NCT01890785|50964|P5|NOT COMPLETED|Third Intervention||0
22985|NCT01890785|50965|P4|NOT COMPLETED|Third Intervention||0
22986|NCT01890785|50966|P3|NOT COMPLETED|Third Intervention||0
22987|NCT01890785|50967|P2|NOT COMPLETED|Third Intervention||1
22989|NCT01890785|50963|P6|COMPLETED|Third Intervention||5
22990|NCT01890785|50964|P5|COMPLETED|Third Intervention||5
22991|NCT01890785|50965|P4|COMPLETED|Third Intervention||5
22992|NCT01890785|50966|P3|COMPLETED|Third Intervention||5
22993|NCT01890785|50967|P2|COMPLETED|Third Intervention||4
22994|NCT01890785|50968|P1|COMPLETED|Third Intervention||5
22995|NCT01890785|50963|P6|STARTED|Third Intervention||5
22996|NCT01890785|50964|P5|STARTED|Third Intervention||5
22997|NCT01890785|50965|P4|STARTED|Third Intervention||5
22998|NCT01890785|50966|P3|STARTED|Third Intervention||5
22999|NCT01890785|50967|P2|STARTED|Third Intervention||5
23000|NCT01890785|50968|P1|STARTED|Third Intervention||5
23001|NCT01890785|50963|P6|NOT COMPLETED|Second Intervention||0
23002|NCT01890785|50964|P5|NOT COMPLETED|Second Intervention||0
23003|NCT01890785|50965|P4|NOT COMPLETED|Second Intervention||0
23004|NCT01890785|50966|P3|NOT COMPLETED|Second Intervention||0
23005|NCT01890785|50967|P2|NOT COMPLETED|Second Intervention||0
23006|NCT01890785|50968|P1|NOT COMPLETED|Second Intervention||0
23007|NCT01890785|50963|P6|COMPLETED|Second Intervention||5
23008|NCT01890785|50964|P5|COMPLETED|Second Intervention||5
23009|NCT01890785|50965|P4|COMPLETED|Second Intervention||5
23010|NCT01890785|50966|P3|COMPLETED|Second Intervention||5
23011|NCT01890785|50967|P2|COMPLETED|Second Intervention||5
23012|NCT01890785|50968|P1|COMPLETED|Second Intervention||5
23013|NCT01890785|50963|P6|STARTED|Second Intervention||5
23014|NCT01890785|50964|P5|STARTED|Second Intervention||5
23015|NCT01890785|50965|P4|STARTED|Second Intervention||5
23016|NCT01890785|50966|P3|STARTED|Second Intervention||5
23017|NCT01890785|50967|P2|STARTED|Second Intervention||5
23018|NCT01890785|50968|P1|STARTED|Second Intervention||5
23019|NCT01890785|50963|P6|NOT COMPLETED|First Intervention||0
23020|NCT01890785|50964|P5|NOT COMPLETED|First Intervention||0
23021|NCT01890785|50965|P4|NOT COMPLETED|First Intervention||0
23022|NCT01890785|50966|P3|NOT COMPLETED|First Intervention||0
23023|NCT01890785|50967|P2|NOT COMPLETED|First Intervention||0
23024|NCT01890785|50968|P1|NOT COMPLETED|First Intervention||0
23025|NCT01890785|50963|P6|COMPLETED|First Intervention||5
23026|NCT01890785|50964|P5|COMPLETED|First Intervention||5
23027|NCT01890785|50965|P4|COMPLETED|First Intervention||5
23028|NCT01890785|50966|P3|COMPLETED|First Intervention||5
23029|NCT01890785|50967|P2|COMPLETED|First Intervention||5
23030|NCT01890785|50968|P1|COMPLETED|First Intervention||5
23031|NCT01890785|50963|P6|STARTED|First Intervention||5
23032|NCT01890785|50964|P5|STARTED|First Intervention||5
23033|NCT01890785|50965|P4|STARTED|First Intervention||5
23034|NCT01890785|50966|P3|STARTED|First Intervention||5
23035|NCT01890785|50967|P2|STARTED|First Intervention||5
23036|NCT01890785|50968|P1|STARTED|First Intervention||5
23037|NCT01890746|50987|P2|NOT COMPLETED|Overall Study||74
23038|NCT01890746|50988|P1|NOT COMPLETED|Overall Study||74
23039|NCT01890746|50987|P2|COMPLETED|Overall Study||0
23040|NCT01890746|50988|P1|COMPLETED|Overall Study||0
23041|NCT01890746|50987|P2|STARTED|Overall Study||74
23042|NCT01890746|50988|P1|STARTED|Overall Study||74
23043|NCT01890694|51014|P2|NOT COMPLETED|Overall Study||1
23044|NCT01890694|51015|P1|NOT COMPLETED|Overall Study||1
23045|NCT01890694|51014|P2|COMPLETED|Overall Study||0
23046|NCT01890694|51015|P1|COMPLETED|Overall Study||0
23047|NCT01890694|51014|P2|STARTED|Overall Study||1
23048|NCT01890694|51015|P1|STARTED|Overall Study||1
23049|NCT01890642|51025|P3|NOT COMPLETED|Overall Study||0
23050|NCT01890642|51026|P2|NOT COMPLETED|Overall Study||0
23051|NCT01890642|51027|P1|NOT COMPLETED|Overall Study||0
23052|NCT01890642|51025|P3|COMPLETED|Overall Study||96
23053|NCT01890642|51026|P2|COMPLETED|Overall Study||53
23054|NCT01890642|51027|P1|COMPLETED|Overall Study||56
23055|NCT01890642|51025|P3|STARTED|Overall Study||96
23056|NCT01890642|51026|P2|STARTED|Overall Study||53
23057|NCT01890642|51027|P1|STARTED|Overall Study||56
23058|NCT01890577|51047|P1|NOT COMPLETED|Overall Study||28
23059|NCT01890577|51047|P1|COMPLETED|Overall Study||0
23060|NCT01890577|51047|P1|STARTED|Overall Study||28
23061|NCT01890512|51060|P1|NOT COMPLETED|Overall Study||3
23062|NCT01890512|51060|P1|COMPLETED|Overall Study||17
23063|NCT01890512|51060|P1|STARTED|Overall Study||20
23064|NCT01890473|51066|P2|NOT COMPLETED|Overall Study||0
23065|NCT01890473|51067|P1|NOT COMPLETED|Overall Study||2
23066|NCT01890473|51066|P2|COMPLETED|Overall Study||113
23067|NCT01890473|51067|P1|COMPLETED|Overall Study||109
23068|NCT01890473|51066|P2|STARTED|Overall Study||113
23069|NCT01890473|51067|P1|STARTED|Overall Study||111
23070|NCT01890343|51096|P3|NOT COMPLETED|Overall Study||0
23071|NCT01890343|51097|P2|NOT COMPLETED|Overall Study||0
23072|NCT01890343|51098|P1|NOT COMPLETED|Overall Study||0
23073|NCT01890343|51096|P3|COMPLETED|Overall Study||10
23074|NCT01890343|51097|P2|COMPLETED|Overall Study||10
23075|NCT01890343|51098|P1|COMPLETED|Overall Study||8
23076|NCT01890343|51096|P3|STARTED|Overall Study||10
23077|NCT01890343|51097|P2|STARTED|Overall Study||10
23078|NCT01890343|51098|P1|STARTED|Overall Study||8
23079|NCT01890148|51109|P1|NOT COMPLETED|Overall Study||1
23080|NCT01890148|51109|P1|COMPLETED|Overall Study||4
23081|NCT01890148|51109|P1|STARTED|Overall Study||5
23082|NCT01890122|51129|P4|NOT COMPLETED|Overall Study||59
23083|NCT01890122|51130|P3|NOT COMPLETED|Overall Study||13
23084|NCT01890122|51131|P2|NOT COMPLETED|Overall Study||37
23085|NCT01890122|51132|P1|NOT COMPLETED|Overall Study||27
23086|NCT01890122|51129|P4|COMPLETED|Overall Study||104
23087|NCT01890122|51130|P3|COMPLETED|Overall Study||146
23088|NCT01890122|51131|P2|COMPLETED|Overall Study||126
23089|NCT01890122|51132|P1|COMPLETED|Overall Study||135
23090|NCT01890122|51129|P4|Treated|Overall Study||163
23091|NCT01890122|51130|P3|Treated|Overall Study||159
23092|NCT01890122|51131|P2|Treated|Overall Study||162
23093|NCT01890122|51132|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
23094|NCT01890122|51129|P4|STARTED|Overall Study||163
23095|NCT01890122|51130|P3|STARTED|Overall Study||159
23096|NCT01890122|51131|P2|STARTED|Overall Study||163
23097|NCT01890122|51132|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
23098|NCT01890031|51199|P5|NOT COMPLETED|Overall Study||0
23099|NCT01890031|51200|P4|NOT COMPLETED|Overall Study||0
23100|NCT01890031|51201|P3|NOT COMPLETED|Overall Study||0
23101|NCT01890031|51202|P2|NOT COMPLETED|Overall Study||0
23102|NCT01890031|51203|P1|NOT COMPLETED|Overall Study||0
23103|NCT01890031|51199|P5|COMPLETED|Overall Study||8
23104|NCT01890031|51200|P4|COMPLETED|Overall Study||11
23105|NCT01890031|51201|P3|COMPLETED|Overall Study||12
23106|NCT01890031|51202|P2|COMPLETED|Overall Study||50
23107|NCT01890031|51203|P1|COMPLETED|Overall Study||50
23108|NCT01890031|51199|P5|STARTED|Overall Study||8
23109|NCT01890031|51200|P4|STARTED|Overall Study||11
23110|NCT01890031|51201|P3|STARTED|Overall Study||12
23111|NCT01890031|51202|P2|STARTED|Overall Study||50
23112|NCT01890031|51203|P1|STARTED|Overall Study||50
23113|NCT01889667|51223|P3|NOT COMPLETED|Overall Study||0
23114|NCT01889667|51224|P2|NOT COMPLETED|Overall Study||0
23115|NCT01889667|51225|P1|NOT COMPLETED|Overall Study||0
23116|NCT01889667|51223|P3|COMPLETED|Overall Study||10
23117|NCT01889667|51224|P2|COMPLETED|Overall Study||10
23118|NCT01889667|51225|P1|COMPLETED|Overall Study||10
23119|NCT01889667|51223|P3|STARTED|Overall Study||10
23120|NCT01889667|51224|P2|STARTED|Overall Study||10
23121|NCT01889667|51225|P1|STARTED|Overall Study||10
23122|NCT01889563|51247|P2|NOT COMPLETED|Overall Study||5
23123|NCT01889563|51248|P1|NOT COMPLETED|Overall Study||7
23124|NCT01889563|51247|P2|COMPLETED|Overall Study||10
23125|NCT01889563|51248|P1|COMPLETED|Overall Study||10
23126|NCT01889563|51247|P2|STARTED|Overall Study||15
23127|NCT01889563|51248|P1|STARTED|Overall Study||17
23128|NCT01889420|51256|P1|NOT COMPLETED|Overall Study||0
23129|NCT01889420|51256|P1|COMPLETED|Overall Study||1
23130|NCT01889420|51256|P1|STARTED|Overall Study||1
23131|NCT01889251|51264|P2|NOT COMPLETED|Overall Study||0
23132|NCT01889251|51265|P1|NOT COMPLETED|Overall Study||1
23133|NCT01889251|51264|P2|COMPLETED|Overall Study||57
23134|NCT01889251|51265|P1|COMPLETED|Overall Study||114
23135|NCT01889251|51264|P2|STARTED|Overall Study||57
23136|NCT01889251|51265|P1|STARTED|Overall Study||115
23137|NCT01888965|51271|P1|NOT COMPLETED|Overall Study||9
23138|NCT01888965|51271|P1|COMPLETED|Overall Study||0
23139|NCT01888965|51271|P1|STARTED|Overall Study||9
23140|NCT01888900|51279|P2|NOT COMPLETED|Overall Study||2
23141|NCT01888900|51280|P1|NOT COMPLETED|Overall Study||0
23142|NCT01888900|51279|P2|COMPLETED|Overall Study||11
23143|NCT01888900|51280|P1|COMPLETED|Overall Study||22
23144|NCT01888900|51279|P2|STARTED|Overall Study||13
23145|NCT01888900|51280|P1|STARTED|Overall Study||22
23146|NCT01888367|51303|P3|NOT COMPLETED|Overall Study||5
23147|NCT01888367|51304|P2|NOT COMPLETED|Overall Study||5
23148|NCT01888367|51305|P1|NOT COMPLETED|Overall Study||8
23149|NCT01888367|51303|P3|COMPLETED|Overall Study||73
23150|NCT01888367|51304|P2|COMPLETED|Overall Study||66
23151|NCT01888367|51305|P1|COMPLETED|Overall Study||288
23152|NCT01888367|51303|P3|STARTED|Overall Study||78
23153|NCT01888367|51304|P2|STARTED|Overall Study||71
23154|NCT01888367|51305|P1|STARTED|Overall Study||296
23155|NCT01888003|51325|P3|NOT COMPLETED|Overall Study||40
23156|NCT01888003|51326|P2|NOT COMPLETED|Overall Study||6
23157|NCT01888003|51327|P1|NOT COMPLETED|Overall Study||5
23158|NCT01888003|51325|P3|COMPLETED|Overall Study||0
23159|NCT01888003|51326|P2|COMPLETED|Overall Study||0
23160|NCT01888003|51327|P1|COMPLETED|Overall Study||0
23161|NCT01888003|51325|P3|STARTED|Overall Study||40
23162|NCT01888003|51326|P2|STARTED|Overall Study||6
23163|NCT01888003|51327|P1|STARTED|Overall Study||5
23164|NCT01887990|51348|P4|NOT COMPLETED|Overall Study||0
23165|NCT01887990|51349|P3|NOT COMPLETED|Overall Study||0
23166|NCT01887990|51350|P2|NOT COMPLETED|Overall Study||0
23167|NCT01887990|51351|P1|NOT COMPLETED|Overall Study||0
23168|NCT01887990|51348|P4|COMPLETED|Overall Study||2
23169|NCT01887990|51349|P3|COMPLETED|Overall Study||2
23170|NCT01887990|51350|P2|COMPLETED|Overall Study||7
23171|NCT01887990|51351|P1|COMPLETED|Overall Study||7
23172|NCT01887990|51348|P4|STARTED|Overall Study||2
23173|NCT01887990|51349|P3|STARTED|Overall Study||2
23174|NCT01887990|51350|P2|STARTED|Overall Study||7
23175|NCT01887990|51351|P1|STARTED|Overall Study||7
23176|NCT01887678|51367|P2|NOT COMPLETED|Overall Study||28
23177|NCT01887678|51368|P1|NOT COMPLETED|Overall Study||17
23178|NCT01887678|51367|P2|COMPLETED|Overall Study||85
23179|NCT01887678|51368|P1|COMPLETED|Overall Study||102
23180|NCT01887678|51367|P2|STARTED|Overall Study||113
23181|NCT01887678|51368|P1|STARTED|Overall Study||119
23182|NCT01887470|51414|P4|NOT COMPLETED|Overall Study||0
23183|NCT01887470|51415|P3|NOT COMPLETED|Overall Study||0
23184|NCT01887470|51416|P2|NOT COMPLETED|Overall Study||0
23185|NCT01887470|51417|P1|NOT COMPLETED|Overall Study||0
23186|NCT01887470|51414|P4|COMPLETED|Overall Study||10
23187|NCT01887470|51415|P3|COMPLETED|Overall Study||10
23188|NCT01887470|51416|P2|COMPLETED|Overall Study||10
23189|NCT01887470|51417|P1|COMPLETED|Overall Study||10
23190|NCT01887470|51414|P4|STARTED|Overall Study||10
23191|NCT01887470|51415|P3|STARTED|Overall Study||10
23192|NCT01887470|51416|P2|STARTED|Overall Study||10
23193|NCT01887470|51417|P1|STARTED|Overall Study||10
23194|NCT01887418|51436|P3|NOT COMPLETED|Overall Study||1
23195|NCT01887418|51437|P2|NOT COMPLETED|Overall Study||0
23196|NCT01887418|51438|P1|NOT COMPLETED|Overall Study||0
23197|NCT01887418|51436|P3|COMPLETED|Overall Study||9
23198|NCT01887418|51437|P2|COMPLETED|Overall Study||14
23199|NCT01887418|51438|P1|COMPLETED|Overall Study||15
23200|NCT01887418|51436|P3|STARTED|Overall Study||10
23201|NCT01887418|51437|P2|STARTED|Overall Study||14
23202|NCT01887418|51438|P1|STARTED|Overall Study||15
23203|NCT01887353|51457|P2|NOT COMPLETED|Overall Study||3
23204|NCT01887353|51458|P1|NOT COMPLETED|Overall Study||4
23205|NCT01887353|51457|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
23206|NCT01887353|51458|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
23207|NCT01887353|51457|P2|STARTED|Overall Study||4
23208|NCT01887353|51458|P1|STARTED|Overall Study||4
23209|NCT01886963|51466|P2|NOT COMPLETED|Overall Study||4
23210|NCT01886963|51467|P1|NOT COMPLETED|Overall Study||5
23211|NCT01886963|51466|P2|COMPLETED|Overall Study||49
23212|NCT01886963|51467|P1|COMPLETED|Overall Study||46
23213|NCT01886963|51466|P2|12 Week Follow Up|Overall Study||22
23214|NCT01886963|51467|P1|12 Week Follow Up|Overall Study||24
23215|NCT01886963|51466|P2|4 Week Follow Up|Overall Study||26
23216|NCT01886963|51467|P1|4 Week Follow Up|Overall Study||24
23217|NCT01886963|51466|P2|2 Week Follow Up|Overall Study||35
23218|NCT01886963|51467|P1|2 Week Follow Up|Overall Study||38
23219|NCT01886963|51466|P2|STARTED|Overall Study||53
23220|NCT01886963|51467|P1|STARTED|Overall Study||51
23221|NCT01886807|51476|P3|NOT COMPLETED|Overall Study||10
23222|NCT01886807|51477|P2|NOT COMPLETED|Overall Study||10
23223|NCT01886807|51478|P1|NOT COMPLETED|Overall Study||5
23224|NCT01886807|51476|P3|COMPLETED|Overall Study||153
23225|NCT01886807|51477|P2|COMPLETED|Overall Study||145
23226|NCT01886807|51478|P1|COMPLETED|Overall Study||159
23227|NCT01886807|51476|P3|STARTED|Overall Study||163
23228|NCT01886807|51477|P2|STARTED|Overall Study||155
23229|NCT01886807|51478|P1|STARTED|Overall Study||164
23230|NCT01886781|51488|P2|NOT COMPLETED|Overall Study||2
23231|NCT01886781|51489|P1|NOT COMPLETED|Overall Study||14
23232|NCT01886781|51488|P2|COMPLETED|Overall Study||25
23233|NCT01886781|51489|P1|COMPLETED|Overall Study||40
23234|NCT01886781|51488|P2|STARTED|Overall Study||27
23235|NCT01886781|51489|P1|STARTED|Overall Study||54
23236|NCT01886716|51499|P4|NOT COMPLETED|1-Month Post Follow-Up||0
23237|NCT01886716|51500|P3|NOT COMPLETED|1-Month Post Follow-Up||0
23238|NCT01886716|51501|P2|NOT COMPLETED|1-Month Post Follow-Up||0
23239|NCT01886716|51502|P1|NOT COMPLETED|1-Month Post Follow-Up||0
23240|NCT01886716|51499|P4|COMPLETED|1-Month Post Follow-Up||14
23241|NCT01886716|51500|P3|COMPLETED|1-Month Post Follow-Up||19
23242|NCT01886716|51501|P2|COMPLETED|1-Month Post Follow-Up||17
23243|NCT01886716|51502|P1|COMPLETED|1-Month Post Follow-Up||20
23244|NCT01886716|51499|P4|STARTED|1-Month Post Follow-Up||14
23245|NCT01886716|51500|P3|STARTED|1-Month Post Follow-Up||19
23246|NCT01886716|51501|P2|STARTED|1-Month Post Follow-Up||17
23247|NCT01886716|51502|P1|STARTED|1-Month Post Follow-Up||20
23248|NCT01886716|51499|P4|NOT COMPLETED|1-Week Post Follow-Up||0
23249|NCT01886716|51500|P3|NOT COMPLETED|1-Week Post Follow-Up||0
23250|NCT01886716|51501|P2|NOT COMPLETED|1-Week Post Follow-Up||0
23251|NCT01886716|51502|P1|NOT COMPLETED|1-Week Post Follow-Up||0
23252|NCT01886716|51499|P4|COMPLETED|1-Week Post Follow-Up||14
23253|NCT01886716|51500|P3|COMPLETED|1-Week Post Follow-Up||19
23254|NCT01886716|51501|P2|COMPLETED|1-Week Post Follow-Up||17
23255|NCT01886716|51502|P1|COMPLETED|1-Week Post Follow-Up||20
23256|NCT01886716|51499|P4|STARTED|1-Week Post Follow-Up||14
23257|NCT01886716|51500|P3|STARTED|1-Week Post Follow-Up||19
23258|NCT01886716|51501|P2|STARTED|1-Week Post Follow-Up||17
23259|NCT01886716|51502|P1|STARTED|1-Week Post Follow-Up||20
23260|NCT01886716|51499|P4|NOT COMPLETED|Week 4||0
23261|NCT01886716|51500|P3|NOT COMPLETED|Week 4||0
23262|NCT01886716|51501|P2|NOT COMPLETED|Week 4||0
23263|NCT01886716|51502|P1|NOT COMPLETED|Week 4||0
23264|NCT01886716|51499|P4|COMPLETED|Week 4||14
23265|NCT01886716|51500|P3|COMPLETED|Week 4||19
23266|NCT01886716|51501|P2|COMPLETED|Week 4||17
23267|NCT01886716|51502|P1|COMPLETED|Week 4||20
23268|NCT01886716|51499|P4|STARTED|Week 4||14
23269|NCT01886716|51500|P3|STARTED|Week 4||19
23270|NCT01886716|51501|P2|STARTED|Week 4||17
23271|NCT01886716|51502|P1|STARTED|Week 4||20
23272|NCT01886716|51499|P4|NOT COMPLETED|Week 3||1
23273|NCT01886716|51500|P3|NOT COMPLETED|Week 3||0
23274|NCT01886716|51501|P2|NOT COMPLETED|Week 3||1
23275|NCT01886716|51502|P1|NOT COMPLETED|Week 3||1
23276|NCT01886716|51499|P4|COMPLETED|Week 3||14
23277|NCT01886716|51500|P3|COMPLETED|Week 3||19
23278|NCT01886716|51501|P2|COMPLETED|Week 3||17
23279|NCT01886716|51502|P1|COMPLETED|Week 3||20
23280|NCT01886716|51499|P4|STARTED|Week 3||15
23281|NCT01886716|51500|P3|STARTED|Week 3||19
23282|NCT01886716|51501|P2|STARTED|Week 3||18
23283|NCT01886716|51502|P1|STARTED|Week 3||21
23284|NCT01886716|51499|P4|NOT COMPLETED|Week 2||3
23285|NCT01886716|51500|P3|NOT COMPLETED|Week 2||1
23286|NCT01886716|51501|P2|NOT COMPLETED|Week 2||2
23287|NCT01886716|51502|P1|NOT COMPLETED|Week 2||3
23288|NCT01886716|51499|P4|COMPLETED|Week 2||15
23289|NCT01886716|51500|P3|COMPLETED|Week 2||19
23290|NCT01886716|51501|P2|COMPLETED|Week 2||18
23291|NCT01886716|51502|P1|COMPLETED|Week 2||21
23292|NCT01886716|51499|P4|STARTED|Week 2||18
23293|NCT01886716|51500|P3|STARTED|Week 2||20
23294|NCT01886716|51501|P2|STARTED|Week 2||20
23295|NCT01886716|51502|P1|STARTED|Week 2||24
23296|NCT01886716|51499|P4|NOT COMPLETED|Week 1||2
23297|NCT01886716|51500|P3|NOT COMPLETED|Week 1||2
23298|NCT01886716|51501|P2|NOT COMPLETED|Week 1||0
23299|NCT01886716|51502|P1|NOT COMPLETED|Week 1||0
23300|NCT01886716|51499|P4|COMPLETED|Week 1||18
23301|NCT01886716|51500|P3|COMPLETED|Week 1||20
23302|NCT01886716|51501|P2|COMPLETED|Week 1||20
23303|NCT01886716|51502|P1|COMPLETED|Week 1||24
23304|NCT01886716|51499|P4|STARTED|Week 1||20
23305|NCT01886716|51500|P3|STARTED|Week 1||22
23306|NCT01886716|51501|P2|STARTED|Week 1||20
23307|NCT01886716|51502|P1|STARTED|Week 1||24
23308|NCT01886690|51518|P2|NOT COMPLETED|Overall Study||2
23309|NCT01886690|51519|P1|NOT COMPLETED|Overall Study||0
23310|NCT01886690|51518|P2|COMPLETED|Overall Study||71
23311|NCT01886690|51519|P1|COMPLETED|Overall Study||75
23312|NCT01886690|51518|P2|STARTED|Overall Study||73
23313|NCT01886690|51519|P1|STARTED|Overall Study||75
23314|NCT01886300|51533|P1|NOT COMPLETED|Overall Study||16
23315|NCT01886300|51533|P1|COMPLETED|Overall Study||0
23316|NCT01886300|51533|P1|STARTED|Overall Study||16
23317|NCT01886287|51544|P1|NOT COMPLETED|Overall Study||2
23318|NCT01886287|51544|P1|COMPLETED|Overall Study||0
23319|NCT01886287|51544|P1|STARTED|Overall Study||2
23320|NCT01885910|51549|P1|NOT COMPLETED|Overall Study||8
23321|NCT01885910|51549|P1|COMPLETED|Overall Study||24
23322|NCT01885910|51549|P1|STARTED|Overall Study||32
23323|NCT01885871|51563|P1|NOT COMPLETED|Overall Study||0
23324|NCT01885871|51563|P1|COMPLETED|Overall Study||20
23325|NCT01885871|51563|P1|STARTED|Overall Study||20
23326|NCT01885559|51573|P2|NOT COMPLETED|Overall Study||36
23327|NCT01885559|51574|P1|NOT COMPLETED|Overall Study||24
23328|NCT01885559|51573|P2|COMPLETED|Overall Study||208
23329|NCT01885559|51574|P1|COMPLETED|Overall Study||218
23330|NCT01885559|51573|P2|STARTED|Overall Study||244
23331|NCT01885559|51574|P1|STARTED|Overall Study||242
23332|NCT01885117|51596|P2|NOT COMPLETED|Overall Study||0
23333|NCT01885117|51597|P1|NOT COMPLETED|Overall Study||0
23334|NCT01885117|51596|P2|COMPLETED|Overall Study||64
23335|NCT01885117|51597|P1|COMPLETED|Overall Study||61
23336|NCT01885117|51596|P2|STARTED|Overall Study||64
23337|NCT01885117|51597|P1|STARTED|Overall Study||61
23338|NCT01885104|51619|P2|NOT COMPLETED|Overall Study||1
23339|NCT01885104|51620|P1|NOT COMPLETED|Overall Study||2
23340|NCT01885104|51619|P2|COMPLETED|Overall Study||33
23341|NCT01885104|51620|P1|COMPLETED|Overall Study||29
23342|NCT01885104|51619|P2|STARTED|Overall Study||34
23343|NCT01885104|51620|P1|STARTED|Overall Study||31
23344|NCT01885000|51630|P2|NOT COMPLETED|Overall Study||2
23345|NCT01885000|51631|P1|NOT COMPLETED|Overall Study||2
23346|NCT01885000|51630|P2|COMPLETED|Overall Study||42
23347|NCT01885000|51631|P1|COMPLETED|Overall Study||46
23348|NCT01885000|51630|P2|STARTED|Overall Study||44
23349|NCT01885000|51631|P1|STARTED|Overall Study||48
23350|NCT01884675|51645|P2|NOT COMPLETED|Overall Study||2
23351|NCT01884675|51646|P1|NOT COMPLETED|Overall Study||3
23352|NCT01884675|51645|P2|COMPLETED|Overall Study||15
23353|NCT01884675|51646|P1|COMPLETED|Overall Study||13
23354|NCT01884675|51645|P2|STARTED|Overall Study||17
23355|NCT01884675|51646|P1|STARTED|Overall Study||16
23356|NCT01884519|51688|P2|NOT COMPLETED|Overall Study||0
23357|NCT01884519|51689|P1|NOT COMPLETED|Overall Study||0
23358|NCT01884519|51688|P2|COMPLETED|Overall Study||60
23359|NCT01884519|51689|P1|COMPLETED|Overall Study||60
23360|NCT01884519|51688|P2|STARTED|Overall Study||60
23361|NCT01884519|51689|P1|STARTED|Overall Study||60
23362|NCT01884064|51733|P2|NOT COMPLETED|Overall Study||0
23363|NCT01884064|51734|P1|NOT COMPLETED|Overall Study||0
23364|NCT01884064|51733|P2|COMPLETED|Overall Study||5
23365|NCT01884064|51734|P1|COMPLETED|Overall Study||12
23366|NCT01884064|51733|P2|STARTED|Overall Study||5
23367|NCT01884064|51734|P1|STARTED|Overall Study||12
23368|NCT01883999|51740|P1|NOT COMPLETED|Overall Study||3
23369|NCT01883999|51740|P1|COMPLETED|Overall Study||61
23370|NCT01883999|51740|P1|STARTED|Overall Study||64
23371|NCT01883986|51748|P2|NOT COMPLETED|Overall Study||1
23372|NCT01883986|51749|P1|NOT COMPLETED|Overall Study||3
23373|NCT01883986|51748|P2|COMPLETED|Overall Study|Completed study|19
23374|NCT01883986|51749|P1|COMPLETED|Overall Study|Received allocated intervention|17
23375|NCT01883986|51748|P2|Did Not Complete Study|Overall Study|Did not completed study|1
23376|NCT01883986|51749|P1|Did Not Complete Study|Overall Study||3
23377|NCT01883986|51748|P2|STARTED|Overall Study|Allocated to usual care arm|20
23378|NCT01883986|51749|P1|STARTED|Overall Study|Allocated to intervention arm|20
23379|NCT01883908|51763|P2|NOT COMPLETED|Overall Study||0
23380|NCT01883908|51764|P1|NOT COMPLETED|Overall Study||0
23381|NCT01883908|51763|P2|COMPLETED|Overall Study||1
23382|NCT01883908|51764|P1|COMPLETED|Overall Study||3
23383|NCT01883908|51763|P2|STARTED|Overall Study||1
23384|NCT01883908|51764|P1|STARTED|Overall Study||3
23385|NCT01883635|51774|P2|NOT COMPLETED|Overall Study||0
23386|NCT01883635|51775|P1|NOT COMPLETED|Overall Study||4
23387|NCT01883635|51774|P2|COMPLETED|Overall Study||20
23388|NCT01883635|51775|P1|COMPLETED|Overall Study||20
23389|NCT01883635|51774|P2|STARTED|Overall Study||20
23390|NCT01883635|51775|P1|STARTED|Overall Study||24
23391|NCT01883453|51789|P2|NOT COMPLETED|Overall Study||23
23392|NCT01883453|51790|P1|NOT COMPLETED|Overall Study||25
23393|NCT01883453|51789|P2|COMPLETED|Overall Study||50
23394|NCT01883453|51790|P1|COMPLETED|Overall Study||48
23395|NCT01883453|51789|P2|STARTED|Overall Study||73
23396|NCT01883453|51790|P1|STARTED|Overall Study||73
23397|NCT01883440|51798|P2|NOT COMPLETED|Overall Study||0
23398|NCT01883440|51799|P1|NOT COMPLETED|Overall Study||3
23399|NCT01883440|51798|P2|COMPLETED|Overall Study||45
23400|NCT01883440|51799|P1|COMPLETED|Overall Study||42
23401|NCT01883440|51798|P2|STARTED|Overall Study||45
23402|NCT01883440|51799|P1|STARTED|Overall Study||45
23403|NCT01883427|51809|P2|NOT COMPLETED|Overall Study||0
23404|NCT01883427|51810|P1|NOT COMPLETED|Overall Study||0
23405|NCT01883427|51809|P2|COMPLETED|Overall Study||20
23406|NCT01883427|51810|P1|COMPLETED|Overall Study||20
23407|NCT01883427|51809|P2|STARTED|Overall Study||20
23408|NCT01883427|51810|P1|STARTED|Overall Study||20
23409|NCT01882907|51818|P2|NOT COMPLETED|Overall Study||28
23410|NCT01882907|51819|P1|NOT COMPLETED|Overall Study||14
23411|NCT01882907|51818|P2|COMPLETED|Overall Study||83
23412|NCT01882907|51819|P1|COMPLETED|Overall Study||103
23413|NCT01882907|51818|P2|STARTED|Overall Study||111
23414|NCT01882907|51819|P1|STARTED|Overall Study||117
23415|NCT01882725|51825|P1|NOT COMPLETED|Overall Study||0
23416|NCT01882725|51825|P1|COMPLETED|Overall Study||14
23417|NCT01882725|51825|P1|STARTED|Overall Study||14
23418|NCT01882647|51832|P2|NOT COMPLETED|Overall Study||6
23419|NCT01882647|51833|P1|NOT COMPLETED|Overall Study||2
23420|NCT01882647|51832|P2|COMPLETED|Overall Study||106
23421|NCT01882647|51833|P1|COMPLETED|Overall Study||108
23422|NCT01882647|51832|P2|STARTED|Overall Study||112
23423|NCT01882647|51833|P1|STARTED|Overall Study||110
23424|NCT01882465|51849|P7|NOT COMPLETED|Period 3||0
23425|NCT01882465|51850|P6|NOT COMPLETED|Period 3||0
23426|NCT01882465|51851|P5|NOT COMPLETED|Period 3||0
23427|NCT01882465|51852|P4|NOT COMPLETED|Period 3||0
23428|NCT01882465|51853|P3|NOT COMPLETED|Period 3||0
23429|NCT01882465|51854|P2|NOT COMPLETED|Period 3||0
23430|NCT01882465|51855|P1|NOT COMPLETED|Period 3||0
23431|NCT01882465|51849|P7|COMPLETED|Period 3||0
23432|NCT01882465|51850|P6|COMPLETED|Period 3||5
23433|NCT01882465|51851|P5|COMPLETED|Period 3||4
23434|NCT01882465|51852|P4|COMPLETED|Period 3||5
23435|NCT01882465|51853|P3|COMPLETED|Period 3||5
23436|NCT01882465|51854|P2|COMPLETED|Period 3||6
23437|NCT01882465|51855|P1|COMPLETED|Period 3||6
23438|NCT01882465|51849|P7|STARTED|Period 3||0
23439|NCT01882465|51850|P6|STARTED|Period 3||5
23440|NCT01882465|51851|P5|STARTED|Period 3||4
23441|NCT01882465|51852|P4|STARTED|Period 3||5
23442|NCT01882465|51853|P3|STARTED|Period 3||5
23443|NCT01882465|51854|P2|STARTED|Period 3||6
23444|NCT01882465|51855|P1|STARTED|Period 3||6
23445|NCT01882465|51849|P7|NOT COMPLETED|Period 2||0
23446|NCT01882465|51850|P6|NOT COMPLETED|Period 2||0
23447|NCT01882465|51851|P5|NOT COMPLETED|Period 2||1
23448|NCT01882465|51852|P4|NOT COMPLETED|Period 2||0
23449|NCT01882465|51853|P3|NOT COMPLETED|Period 2||0
23450|NCT01882465|51854|P2|NOT COMPLETED|Period 2||0
23451|NCT01882465|51855|P1|NOT COMPLETED|Period 2||0
23452|NCT01882465|51849|P7|COMPLETED|Period 2||0
23453|NCT01882465|51850|P6|COMPLETED|Period 2||5
23454|NCT01882465|51851|P5|COMPLETED|Period 2||4
23455|NCT01882465|51852|P4|COMPLETED|Period 2||5
23456|NCT01882465|51853|P3|COMPLETED|Period 2||5
23457|NCT01882465|51854|P2|COMPLETED|Period 2||6
23458|NCT01882465|51855|P1|COMPLETED|Period 2||6
23459|NCT01882465|51849|P7|STARTED|Period 2||0
23460|NCT01882465|51850|P6|STARTED|Period 2||5
23461|NCT01882465|51851|P5|STARTED|Period 2||5
23462|NCT01882465|51852|P4|STARTED|Period 2||5
23463|NCT01882465|51853|P3|STARTED|Period 2||5
23464|NCT01882465|51854|P2|STARTED|Period 2||6
23465|NCT01882465|51855|P1|STARTED|Period 2||6
23466|NCT01882465|51849|P7|NOT COMPLETED|Period 1||1
23467|NCT01882465|51850|P6|NOT COMPLETED|Period 1||0
23468|NCT01882465|51851|P5|NOT COMPLETED|Period 1||0
23469|NCT01882465|51852|P4|NOT COMPLETED|Period 1||1
23470|NCT01882465|51853|P3|NOT COMPLETED|Period 1||0
23471|NCT01882465|51854|P2|NOT COMPLETED|Period 1||0
23472|NCT01882465|51855|P1|NOT COMPLETED|Period 1||0
23473|NCT01882465|51849|P7|COMPLETED|Period 1||0
23474|NCT01882465|51850|P6|COMPLETED|Period 1||5
23475|NCT01882465|51851|P5|COMPLETED|Period 1||5
23476|NCT01882465|51852|P4|COMPLETED|Period 1||5
23477|NCT01882465|51853|P3|COMPLETED|Period 1||5
23478|NCT01882465|51854|P2|COMPLETED|Period 1||6
23479|NCT01882465|51855|P1|COMPLETED|Period 1||6
23480|NCT01882465|51849|P7|STARTED|Period 1||1
23481|NCT01882465|51850|P6|STARTED|Period 1||5
23482|NCT01882465|51851|P5|STARTED|Period 1||5
23483|NCT01882465|51852|P4|STARTED|Period 1||6
23484|NCT01882465|51853|P3|STARTED|Period 1||5
23485|NCT01882465|51854|P2|STARTED|Period 1||6
23486|NCT01882465|51855|P1|STARTED|Period 1||6
23487|NCT01882413|51863|P1|NOT COMPLETED|Overall Study||0
23488|NCT01882413|51863|P1|COMPLETED|Overall Study||204
23489|NCT01882413|51863|P1|STARTED|Overall Study||204
23490|NCT01882257|51880|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
23491|NCT01882257|51881|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
23492|NCT01882257|51882|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
23493|NCT01882257|51880|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
23494|NCT01882257|51881|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
23495|NCT01882257|51882|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
23496|NCT01882257|51880|P3|STARTED|Therapy Portion of Study (12 Months)||22
23497|NCT01882257|51881|P2|STARTED|Therapy Portion of Study (12 Months)||38
23498|NCT01882257|51882|P1|STARTED|Therapy Portion of Study (12 Months)||11
23499|NCT01882257|51880|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
23500|NCT01882257|51881|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
23501|NCT01882257|51882|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
23502|NCT01882257|51880|P3|COMPLETED|Study Origination to Beginning Therapy||22
23503|NCT01882257|51881|P2|COMPLETED|Study Origination to Beginning Therapy||38
23504|NCT01882257|51882|P1|COMPLETED|Study Origination to Beginning Therapy||11
23505|NCT01882257|51880|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
23506|NCT01882257|51881|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
23507|NCT01882257|51882|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
23508|NCT01882257|51880|P3|STARTED|Study Origination to Beginning Therapy||23
23509|NCT01882257|51881|P2|STARTED|Study Origination to Beginning Therapy||40
23510|NCT01882257|51882|P1|STARTED|Study Origination to Beginning Therapy||11
23511|NCT01882062|51889|P1|NOT COMPLETED|Overall Study||0
23512|NCT01882062|51889|P1|COMPLETED|Overall Study|18th of july 2013|10
23513|NCT01882062|51889|P1|STARTED|Overall Study|16th of may 2013|10
23514|NCT01881932|51896|P3|NOT COMPLETED|Overall Study||0
23515|NCT01881932|51897|P2|NOT COMPLETED|Overall Study||0
23516|NCT01881932|51898|P1|NOT COMPLETED|Overall Study||0
23517|NCT01881932|51896|P3|COMPLETED|Overall Study||13
23518|NCT01881932|51897|P2|COMPLETED|Overall Study||4
23519|NCT01881932|51898|P1|COMPLETED|Overall Study||2
23520|NCT01881932|51896|P3|STARTED|Overall Study||13
23521|NCT01881932|51897|P2|STARTED|Overall Study||4
23522|NCT01881932|51898|P1|STARTED|Overall Study||2
23523|NCT01881776|51909|P3|NOT COMPLETED|Overall Study||2
23524|NCT01881776|51910|P2|NOT COMPLETED|Overall Study||4
23525|NCT01881776|51911|P1|NOT COMPLETED|Overall Study||1
23526|NCT01881776|51909|P3|COMPLETED|Overall Study||20
23527|NCT01881776|51910|P2|COMPLETED|Overall Study||20
23528|NCT01881776|51911|P1|COMPLETED|Overall Study||23
23529|NCT01881776|51909|P3|STARTED|Overall Study||22
23530|NCT01881776|51910|P2|STARTED|Overall Study||24
23531|NCT01881776|51911|P1|STARTED|Overall Study||24
23532|NCT01881126|51939|P2|NOT COMPLETED|Overall Study||2
23533|NCT01881126|51940|P1|NOT COMPLETED|Overall Study||1
23534|NCT01881126|51939|P2|COMPLETED|Overall Study||44
23535|NCT01881126|51940|P1|COMPLETED|Overall Study||46
23536|NCT01881126|51939|P2|STARTED|Overall Study||46
23537|NCT01881126|51940|P1|STARTED|Overall Study||47
23538|NCT01880840|51948|P2|NOT COMPLETED|Overall Study||5
23539|NCT01880840|51949|P1|NOT COMPLETED|Overall Study||8
23540|NCT01880840|51948|P2|COMPLETED|Overall Study||91
23541|NCT01880840|51949|P1|COMPLETED|Overall Study||87
23542|NCT01880840|51948|P2|STARTED|Overall Study||96
23543|NCT01880840|51949|P1|STARTED|Overall Study||95
23544|NCT01880736|51959|P4|NOT COMPLETED|Overall Study||6
23545|NCT01880736|51960|P3|NOT COMPLETED|Overall Study||1
23546|NCT01880736|51961|P2|NOT COMPLETED|Overall Study||2
23547|NCT01880736|51962|P1|NOT COMPLETED|Overall Study||1
23548|NCT01880736|51959|P4|COMPLETED|Overall Study||108
23549|NCT01880736|51960|P3|COMPLETED|Overall Study||114
23550|NCT01880736|51961|P2|COMPLETED|Overall Study||113
23551|NCT01880736|51962|P1|COMPLETED|Overall Study||113
23552|NCT01880736|51959|P4|STARTED|Overall Study||114
23553|NCT01880736|51960|P3|STARTED|Overall Study||115
23554|NCT01880736|51961|P2|STARTED|Overall Study||115
23555|NCT01880736|51962|P1|STARTED|Overall Study||114
23556|NCT01880723|52006|P2|NOT COMPLETED|Overall Study||0
23557|NCT01880723|52007|P1|NOT COMPLETED|Overall Study||0
23558|NCT01880723|52006|P2|COMPLETED|Overall Study||16
23559|NCT01880723|52007|P1|COMPLETED|Overall Study||16
23560|NCT01880723|52006|P2|STARTED|Overall Study||16
23561|NCT01880723|52007|P1|STARTED|Overall Study||16
23562|NCT01880697|52023|P2|NOT COMPLETED|Overall Study||1
23563|NCT01880697|52024|P1|NOT COMPLETED|Overall Study||0
23564|NCT01880697|52023|P2|COMPLETED|Overall Study||62
23565|NCT01880697|52024|P1|COMPLETED|Overall Study||63
23566|NCT01880697|52023|P2|STARTED|Overall Study||63
23567|NCT01880697|52024|P1|STARTED|Overall Study||63
23568|NCT01880437|52047|P3|NOT COMPLETED|Overall Study||19
23569|NCT01880437|52048|P2|NOT COMPLETED|Overall Study||4
23570|NCT01880437|52049|P1|NOT COMPLETED|Overall Study||15
23571|NCT01880437|52047|P3|COMPLETED|Overall Study||0
23572|NCT01880437|52048|P2|COMPLETED|Overall Study||0
23573|NCT01880437|52049|P1|COMPLETED|Overall Study||0
23574|NCT01880437|52047|P3|STARTED|Overall Study||19
23575|NCT01880437|52048|P2|STARTED|Overall Study||4
23576|NCT01880437|52049|P1|STARTED|Overall Study||15
23577|NCT01880424|52075|P2|NOT COMPLETED|Overall Study||55
23578|NCT01880424|52076|P1|NOT COMPLETED|Overall Study||33
23579|NCT01880424|52075|P2|COMPLETED|Overall Study||367
23580|NCT01880424|52076|P1|COMPLETED|Overall Study||384
23581|NCT01880424|52075|P2|STARTED|Overall Study||422
23582|NCT01880424|52076|P1|STARTED|Overall Study||417
23583|NCT01880320|52101|P3|NOT COMPLETED|Overall Study||8
23584|NCT01880320|52102|P2|NOT COMPLETED|Overall Study||25
23585|NCT01880320|52103|P1|NOT COMPLETED|Overall Study||20
23586|NCT01880320|52101|P3|COMPLETED|Overall Study||61
23587|NCT01880320|52102|P2|COMPLETED|Overall Study||192
23588|NCT01880320|52103|P1|COMPLETED|Overall Study||197
23589|NCT01880320|52101|P3|STARTED|Overall Study||69
23590|NCT01880320|52102|P2|STARTED|Overall Study||217
23591|NCT01880320|52103|P1|STARTED|Overall Study||217
23592|NCT01879852|52119|P2|NOT COMPLETED|Overall Study||0
23593|NCT01879852|52120|P1|NOT COMPLETED|Overall Study||2
23594|NCT01879852|52119|P2|COMPLETED|Overall Study||13
23595|NCT01879852|52120|P1|COMPLETED|Overall Study||12
23596|NCT01879852|52119|P2|STARTED|Overall Study||13
23597|NCT01879852|52120|P1|STARTED|Overall Study||14
23598|NCT01879800|52134|P2|NOT COMPLETED|Overall Study||4
23599|NCT01879800|52135|P1|NOT COMPLETED|Overall Study||0
23600|NCT01879800|52134|P2|COMPLETED|Overall Study||26
23601|NCT01879800|52135|P1|COMPLETED|Overall Study||14
23602|NCT01879800|52134|P2|STARTED|Overall Study||30
23603|NCT01879800|52135|P1|STARTED|Overall Study||14
23604|NCT01879735|52147|P2|NOT COMPLETED|Overall Study||0
23605|NCT01879735|52148|P1|NOT COMPLETED|Overall Study||0
23606|NCT01879735|52147|P2|COMPLETED|Overall Study||16
23607|NCT01879735|52148|P1|COMPLETED|Overall Study||6
23608|NCT01879735|52147|P2|STARTED|Overall Study||16
23609|NCT01879735|52148|P1|STARTED|Overall Study||6
23610|NCT01879722|52164|P10|NOT COMPLETED|Overall Study||0
23611|NCT01879722|52165|P9|NOT COMPLETED|Overall Study||2
23612|NCT01879722|52166|P8|NOT COMPLETED|Overall Study||1
23613|NCT01879722|52167|P7|NOT COMPLETED|Overall Study||0
23614|NCT01879722|52168|P6|NOT COMPLETED|Overall Study||0
23615|NCT01879722|52169|P5|NOT COMPLETED|Overall Study||1
23616|NCT01879722|52170|P4|NOT COMPLETED|Overall Study||1
23617|NCT01879722|52171|P3|NOT COMPLETED|Overall Study||0
23618|NCT01879722|52172|P2|NOT COMPLETED|Overall Study||1
23619|NCT01879722|52173|P1|NOT COMPLETED|Overall Study||0
23620|NCT01879722|52164|P10|COMPLETED|Overall Study||6
23621|NCT01879722|52165|P9|COMPLETED|Overall Study||6
23622|NCT01879722|52166|P8|COMPLETED|Overall Study||7
23623|NCT01879722|52167|P7|COMPLETED|Overall Study||8
23624|NCT01879722|52168|P6|COMPLETED|Overall Study||9
23625|NCT01879722|52169|P5|COMPLETED|Overall Study||7
23626|NCT01879722|52170|P4|COMPLETED|Overall Study||7
23627|NCT01879722|52171|P3|COMPLETED|Overall Study||7
23628|NCT01879722|52172|P2|COMPLETED|Overall Study||7
23629|NCT01879722|52173|P1|COMPLETED|Overall Study||7
23630|NCT01879722|52164|P10|STARTED|Overall Study||6
23631|NCT01879722|52165|P9|STARTED|Overall Study||8
23632|NCT01879722|52166|P8|STARTED|Overall Study||8
23633|NCT01879722|52167|P7|STARTED|Overall Study||8
23634|NCT01879722|52168|P6|STARTED|Overall Study||9
23635|NCT01879722|52169|P5|STARTED|Overall Study||8
23636|NCT01879722|52170|P4|STARTED|Overall Study||8
23637|NCT01879722|52171|P3|STARTED|Overall Study||7
23638|NCT01879722|52172|P2|STARTED|Overall Study||8
23639|NCT01879722|52173|P1|STARTED|Overall Study||7
23640|NCT01879683|52321|P1|NOT COMPLETED|Overall Study||1
23641|NCT01879683|52321|P1|COMPLETED|Overall Study||9
23642|NCT01879683|52321|P1|STARTED|Overall Study||10
23643|NCT01879618|52328|P1|NOT COMPLETED|Overall Study||21
23644|NCT01879618|52328|P1|COMPLETED|Overall Study||131
23645|NCT01879618|52328|P1|STARTED|Overall Study||152
23646|NCT01879579|52335|P2|NOT COMPLETED|Overall Study||2
23647|NCT01879579|52336|P1|NOT COMPLETED|Overall Study||5
23648|NCT01879579|52335|P2|COMPLETED|Overall Study||26
23649|NCT01879579|52336|P1|COMPLETED|Overall Study||28
23650|NCT01879579|52335|P2|STARTED|Overall Study||28
23651|NCT01879579|52336|P1|STARTED|Overall Study||33
23652|NCT01879553|52366|P2|NOT COMPLETED|Overall Study||0
23653|NCT01879553|52367|P1|NOT COMPLETED|Overall Study||1
23654|NCT01879553|52366|P2|COMPLETED|Overall Study||63
23655|NCT01879553|52367|P1|COMPLETED|Overall Study||62
23656|NCT01879553|52366|P2|STARTED|Overall Study||63
23657|NCT01879553|52367|P1|STARTED|Overall Study||63
23658|NCT01879540|52388|P1|NOT COMPLETED|Overall Study||0
23659|NCT01879540|52388|P1|COMPLETED|Overall Study||63
23660|NCT01879540|52388|P1|STARTED|Overall Study||63
23661|NCT01879410|52401|P2|NOT COMPLETED|Overall Study||38
23662|NCT01879410|52402|P1|NOT COMPLETED|Overall Study||24
23663|NCT01879410|52401|P2|COMPLETED|Overall Study||312
23664|NCT01879410|52402|P1|COMPLETED|Overall Study||326
23665|NCT01879410|52401|P2|Intent-to-Treat Population|Overall Study||348
23666|NCT01879410|52402|P1|Intent-to-Treat Population|Overall Study||349
23667|NCT01879410|52401|P2|STARTED|Overall Study||350
23668|NCT01879410|52402|P1|STARTED|Overall Study||350
23669|NCT01879371|52416|P6|NOT COMPLETED|Overall Study||0
23670|NCT01879371|52417|P5|NOT COMPLETED|Overall Study||0
23671|NCT01879371|52418|P4|NOT COMPLETED|Overall Study||0
23672|NCT01879371|52419|P3|NOT COMPLETED|Overall Study||0
23673|NCT01879371|52420|P2|NOT COMPLETED|Overall Study||0
23674|NCT01879371|52421|P1|NOT COMPLETED|Overall Study||0
23675|NCT01879371|52416|P6|COMPLETED|Overall Study||6
23676|NCT01879371|52417|P5|COMPLETED|Overall Study||6
23677|NCT01879371|52418|P4|COMPLETED|Overall Study||6
23678|NCT01879371|52419|P3|COMPLETED|Overall Study||6
23679|NCT01879371|52420|P2|COMPLETED|Overall Study||6
23680|NCT01879371|52421|P1|COMPLETED|Overall Study||6
23681|NCT01879371|52416|P6|STARTED|Overall Study||6
23682|NCT01879371|52417|P5|STARTED|Overall Study||6
23683|NCT01879371|52418|P4|STARTED|Overall Study||6
23684|NCT01879371|52419|P3|STARTED|Overall Study||6
23685|NCT01879371|52420|P2|STARTED|Overall Study||6
23686|NCT01879371|52421|P1|STARTED|Overall Study||6
23687|NCT01879345|52438|P3|NOT COMPLETED|7-day Multiple-dose Period||0
23688|NCT01879345|52439|P2|NOT COMPLETED|7-day Multiple-dose Period||0
23689|NCT01879345|52440|P1|NOT COMPLETED|7-day Multiple-dose Period||0
23690|NCT01879345|52438|P3|COMPLETED|7-day Multiple-dose Period||6
23691|NCT01879345|52439|P2|COMPLETED|7-day Multiple-dose Period||6
23692|NCT01879345|52440|P1|COMPLETED|7-day Multiple-dose Period||6
23693|NCT01879345|52438|P3|STARTED|7-day Multiple-dose Period||6
23694|NCT01879345|52439|P2|STARTED|7-day Multiple-dose Period||6
23695|NCT01879345|52440|P1|STARTED|7-day Multiple-dose Period||6
23696|NCT01879345|52438|P3|NOT COMPLETED|Single-dose Period||0
23697|NCT01879345|52439|P2|NOT COMPLETED|Single-dose Period||0
23698|NCT01879345|52440|P1|NOT COMPLETED|Single-dose Period||0
23699|NCT01879345|52438|P3|COMPLETED|Single-dose Period||6
23700|NCT01879345|52439|P2|COMPLETED|Single-dose Period||6
23701|NCT01879345|52440|P1|COMPLETED|Single-dose Period||6
23702|NCT01879345|52438|P3|STARTED|Single-dose Period||6
23703|NCT01879345|52439|P2|STARTED|Single-dose Period||6
23704|NCT01879345|52440|P1|STARTED|Single-dose Period||6
23705|NCT01879332|52457|P3|NOT COMPLETED|Overall Study||4
23706|NCT01879332|52458|P2|NOT COMPLETED|Overall Study||6
23707|NCT01879332|52459|P1|NOT COMPLETED|Overall Study||6
23708|NCT01879332|52457|P3|COMPLETED|Overall Study||0
23709|NCT01879332|52458|P2|COMPLETED|Overall Study||0
23710|NCT01879332|52459|P1|COMPLETED|Overall Study||0
23711|NCT01879332|52457|P3|STARTED|Overall Study||4
23712|NCT01879332|52458|P2|STARTED|Overall Study||6
23713|NCT01879332|52459|P1|STARTED|Overall Study||6
23714|NCT01879319|52469|P2|NOT COMPLETED|Overall Study||5
23715|NCT01879319|52470|P1|NOT COMPLETED|Overall Study||2
23716|NCT01879319|52469|P2|COMPLETED|Overall Study||77
23717|NCT01879319|52470|P1|COMPLETED|Overall Study||80
23718|NCT01879319|52469|P2|Received Treatment|Overall Study||82
23719|NCT01879319|52470|P1|Received Treatment|Overall Study||82
23720|NCT01879319|52469|P2|STARTED|Overall Study||82
23721|NCT01879319|52470|P1|STARTED|Overall Study||82
23722|NCT01879176|52480|P2|NOT COMPLETED|Overall Study||6
23723|NCT01879176|52481|P1|NOT COMPLETED|Overall Study||8
23724|NCT01879176|52480|P2|COMPLETED|Overall Study||16
23725|NCT01879176|52481|P1|COMPLETED|Overall Study||16
23726|NCT01879176|52480|P2|STARTED|Overall Study||22
23727|NCT01879176|52481|P1|STARTED|Overall Study||24
23728|NCT01879059|52487|P1|NOT COMPLETED|Overall Study||0
23729|NCT01879059|52487|P1|COMPLETED|Overall Study||13
23730|NCT01879059|52487|P1|STARTED|Overall Study||13
23731|NCT01878825|52493|P2|NOT COMPLETED|Overall Study||0
23732|NCT01878825|52494|P1|NOT COMPLETED|Overall Study||0
23733|NCT01878825|52493|P2|COMPLETED|Overall Study||60
23734|NCT01878825|52494|P1|COMPLETED|Overall Study||60
23735|NCT01878825|52493|P2|STARTED|Overall Study||60
23736|NCT01878825|52494|P1|STARTED|Overall Study||60
23737|NCT01878812|52532|P2|NOT COMPLETED|Overall Study||0
23738|NCT01878812|52533|P1|NOT COMPLETED|Overall Study||0
23739|NCT01878812|52532|P2|COMPLETED|Overall Study||57
23740|NCT01878812|52533|P1|COMPLETED|Overall Study||60
23741|NCT01878812|52532|P2|STARTED|Overall Study||57
23742|NCT01878812|52533|P1|STARTED|Overall Study||60
23743|NCT01878799|52569|P2|NOT COMPLETED|Overall Study||0
23744|NCT01878799|52570|P1|NOT COMPLETED|Overall Study||1
23745|NCT01878799|52569|P2|COMPLETED|Overall Study||13
23746|NCT01878799|52570|P1|COMPLETED|Overall Study||36
23747|NCT01878799|52569|P2|STARTED|Overall Study||13
23748|NCT01878799|52570|P1|STARTED|Overall Study||37
23749|NCT01878656|52578|P2|NOT COMPLETED|Overall Study||0
23750|NCT01878656|52579|P1|NOT COMPLETED|Overall Study||0
23751|NCT01878656|52578|P2|COMPLETED|Overall Study||72
23752|NCT01878656|52579|P1|COMPLETED|Overall Study||72
23753|NCT01878656|52578|P2|STARTED|Overall Study||72
23754|NCT01878656|52579|P1|STARTED|Overall Study||72
23755|NCT01878214|52587|P2|NOT COMPLETED|Overall Study||44
23756|NCT01878214|52588|P1|NOT COMPLETED|Overall Study||53
23757|NCT01878214|52587|P2|COMPLETED|Overall Study||175
23758|NCT01878214|52588|P1|COMPLETED|Overall Study||170
23759|NCT01878214|52587|P2|STARTED|Overall Study||219
23760|NCT01878214|52588|P1|STARTED|Overall Study||223
23761|NCT01878149|52604|P2|NOT COMPLETED|Overall Study||2
23762|NCT01878149|52605|P1|NOT COMPLETED|Overall Study||2
23763|NCT01878149|52604|P2|COMPLETED|Overall Study||15
23764|NCT01878149|52605|P1|COMPLETED|Overall Study||19
23765|NCT01878149|52604|P2|STARTED|Overall Study||17
23766|NCT01878149|52605|P1|STARTED|Overall Study||21
23767|NCT01877941|52611|P1|NOT COMPLETED|Overall Study||0
23768|NCT01877941|52611|P1|COMPLETED|Overall Study||39
23769|NCT01877941|52611|P1|STARTED|Overall Study||39
23770|NCT01877720|52617|P2|NOT COMPLETED|Overall Study||0
23771|NCT01877720|52618|P1|NOT COMPLETED|Overall Study||1
23772|NCT01877720|52617|P2|COMPLETED|Overall Study||8
23773|NCT01877720|52618|P1|COMPLETED|Overall Study||7
23774|NCT01877720|52617|P2|2nd Intervention|Overall Study||8
23775|NCT01877720|52618|P1|2nd Intervention|Overall Study||7
23776|NCT01877720|52617|P2|1st Intervention|Overall Study||8
23777|NCT01877720|52618|P1|1st Intervention|Overall Study||7
23778|NCT01877720|52617|P2|STARTED|Overall Study||8
23779|NCT01877720|52618|P1|STARTED|Overall Study||8
23780|NCT01877538|52642|P1|NOT COMPLETED|Overall Study||0
23781|NCT01877538|52642|P1|COMPLETED|Overall Study||7
23782|NCT01877538|52642|P1|STARTED|Overall Study||7
23783|NCT01877408|52649|P2|NOT COMPLETED|Overall Study||2
23784|NCT01877408|52650|P1|NOT COMPLETED|Overall Study||0
23785|NCT01877408|52649|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
23786|NCT01877408|52650|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
23787|NCT01877408|52649|P2|STARTED|Overall Study||100
23788|NCT01877408|52650|P1|STARTED|Overall Study||50
23789|NCT01877343|52670|P7|NOT COMPLETED|Overall Study||0
23790|NCT01877343|52671|P6|NOT COMPLETED|Overall Study||0
23791|NCT01877343|52672|P5|NOT COMPLETED|Overall Study||0
23792|NCT01877343|52673|P4|NOT COMPLETED|Overall Study||0
23793|NCT01877343|52674|P3|NOT COMPLETED|Overall Study||0
23794|NCT01877343|52675|P2|NOT COMPLETED|Overall Study||0
23795|NCT01877343|52676|P1|NOT COMPLETED|Overall Study||0
23796|NCT01877343|52670|P7|COMPLETED|Overall Study||0
23797|NCT01877343|52671|P6|COMPLETED|Overall Study||5
23798|NCT01877343|52672|P5|COMPLETED|Overall Study||0
23799|NCT01877343|52673|P4|COMPLETED|Overall Study||0
23800|NCT01877343|52674|P3|COMPLETED|Overall Study||0
23801|NCT01877343|52675|P2|COMPLETED|Overall Study||3
23802|NCT01877343|52676|P1|COMPLETED|Overall Study||2
23803|NCT01877343|52670|P7|STARTED|Overall Study||0
23804|NCT01877343|52671|P6|STARTED|Overall Study||5
23805|NCT01877343|52672|P5|STARTED|Overall Study||0
23806|NCT01877343|52673|P4|STARTED|Overall Study||0
23807|NCT01877343|52674|P3|STARTED|Overall Study||0
23808|NCT01877343|52675|P2|STARTED|Overall Study||3
23809|NCT01877343|52676|P1|STARTED|Overall Study||2
23810|NCT01877278|52683|P2|NOT COMPLETED|Overall Study||3
23811|NCT01877278|52684|P1|NOT COMPLETED|Overall Study||3
23812|NCT01877278|52683|P2|COMPLETED|Overall Study||30
23813|NCT01877278|52684|P1|COMPLETED|Overall Study||30
23814|NCT01877278|52683|P2|STARTED|Overall Study||33
23815|NCT01877278|52684|P1|STARTED|Overall Study||33
23816|NCT01877161|52692|P1|NOT COMPLETED|Third Session of Stimulation||0
23817|NCT01877161|52692|P1|COMPLETED|Third Session of Stimulation||12
23818|NCT01877161|52692|P1|STARTED|Third Session of Stimulation||12
23819|NCT01877161|52692|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
23820|NCT01877161|52692|P1|COMPLETED|Washout (at Least 3 Days)||12
23821|NCT01877161|52692|P1|STARTED|Washout (at Least 3 Days)||12
23822|NCT01877161|52692|P1|NOT COMPLETED|Second Session of Stimulation||0
23823|NCT01877161|52692|P1|COMPLETED|Second Session of Stimulation||12
23824|NCT01877161|52692|P1|STARTED|Second Session of Stimulation||12
23825|NCT01877161|52692|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
23826|NCT01877161|52692|P1|COMPLETED|Washout (at Least 3 Days)||12
23827|NCT01877161|52692|P1|STARTED|Washout (at Least 3 Days)||12
23828|NCT01877161|52692|P1|NOT COMPLETED|First Session of Stimulation||0
23829|NCT01877161|52692|P1|COMPLETED|First Session of Stimulation||12
23830|NCT01877161|52692|P1|STARTED|First Session of Stimulation||12
23831|NCT01877148|52702|P2|NOT COMPLETED|Overall Study||1
23832|NCT01877148|52703|P1|NOT COMPLETED|Overall Study||1
23833|NCT01877148|52702|P2|COMPLETED|Overall Study||5
23834|NCT01877148|52703|P1|COMPLETED|Overall Study||5
23835|NCT01877148|52702|P2|STARTED|Overall Study||6
23836|NCT01877148|52703|P1|STARTED|Overall Study||6
23837|NCT01876823|52715|P1|NOT COMPLETED|Overall Study||9
23838|NCT01876823|52715|P1|COMPLETED|Overall Study||26
23839|NCT01876823|52715|P1|STARTED|Overall Study||35
23840|NCT01876732|52728|P1|NOT COMPLETED|Overall Study||75
23841|NCT01876732|52728|P1|COMPLETED|Overall Study||57
23842|NCT01876732|52728|P1|STARTED|Overall Study||132
23843|NCT01876706|52733|P1|NOT COMPLETED|Overall Study||4
23844|NCT01876706|52733|P1|COMPLETED|Overall Study||47
23845|NCT01876706|52733|P1|12 Months|Overall Study||41
23846|NCT01876706|52733|P1|1 Month|Overall Study||51
23847|NCT01876706|52733|P1|STARTED|Overall Study||51
23848|NCT01876368|52752|P2|NOT COMPLETED|Overall Study||13
23849|NCT01876368|52753|P1|NOT COMPLETED|Overall Study||9
23850|NCT01876368|52752|P2|COMPLETED|Overall Study||175
23851|NCT01876368|52753|P1|COMPLETED|Overall Study||179
23852|NCT01876368|52752|P2|Safety Set (SAF)|Overall Study||187
23853|NCT01876368|52753|P1|Safety Set (SAF)|Overall Study||188
23854|NCT01876368|52752|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
23855|NCT01876368|52753|P1|Full Analysis Set (FAS)|Overall Study||188
23856|NCT01876368|52752|P2|STARTED|Overall Study||188
23857|NCT01876368|52753|P1|STARTED|Overall Study||188
23858|NCT01876329|52782|P3|NOT COMPLETED|Overall Study||0
23859|NCT01876329|52783|P2|NOT COMPLETED|Overall Study||0
23860|NCT01876329|52784|P1|NOT COMPLETED|Overall Study||0
23861|NCT01876329|52782|P3|COMPLETED|Overall Study||44
23862|NCT01876329|52783|P2|COMPLETED|Overall Study||36
23863|NCT01876329|52784|P1|COMPLETED|Overall Study||45
23864|NCT01876329|52782|P3|STARTED|Overall Study||44
23865|NCT01876329|52783|P2|STARTED|Overall Study||36
23866|NCT01876329|52784|P1|STARTED|Overall Study||45
23867|NCT01875991|52797|P2|NOT COMPLETED|Overall Study||6
23868|NCT01875991|52798|P1|NOT COMPLETED|Overall Study||7
23869|NCT01875991|52797|P2|COMPLETED|Overall Study||103
23870|NCT01875991|52798|P1|COMPLETED|Overall Study||101
23871|NCT01875991|52797|P2|Received Etanercept in Period 2|Overall Study||103
23872|NCT01875991|52798|P1|Received Etanercept in Period 2|Overall Study||102
23873|NCT01875991|52797|P2|Received Etanercept in Period 1|Overall Study||108
23874|NCT01875991|52798|P1|Received Etanercept in Period 1|Overall Study||108
23875|NCT01875991|52797|P2|STARTED|Overall Study||109
23876|NCT01875991|52798|P1|STARTED|Overall Study||108
23877|NCT01875978|52821|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
23878|NCT01875978|52822|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
23879|NCT01875978|52821|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
23880|NCT01875978|52822|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
23881|NCT01875978|52821|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
23882|NCT01875978|52822|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
23883|NCT01875978|52821|P2|NOT COMPLETED|Study 4weeks||0
23884|NCT01875978|52822|P1|NOT COMPLETED|Study 4weeks||0
23885|NCT01875978|52821|P2|COMPLETED|Study 4weeks||20
23886|NCT01875978|52822|P1|COMPLETED|Study 4weeks||20
23887|NCT01875978|52821|P2|STARTED|Study 4weeks||20
23888|NCT01875978|52822|P1|STARTED|Study 4weeks||20
23889|NCT01875848|52836|P2|NOT COMPLETED|Overall Study||0
23890|NCT01875848|52837|P1|NOT COMPLETED|Overall Study||2
23891|NCT01875848|52836|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
23892|NCT01875848|52837|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
23893|NCT01875848|52836|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
23894|NCT01875848|52837|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
23895|NCT01875731|52847|P2|NOT COMPLETED|Overall Study||0
23896|NCT01875731|52848|P1|NOT COMPLETED|Overall Study||1
23897|NCT01875731|52847|P2|COMPLETED|Overall Study||32
23898|NCT01875731|52848|P1|COMPLETED|Overall Study||33
23899|NCT01875731|52847|P2|STARTED|Overall Study||32
23900|NCT01875731|52848|P1|STARTED|Overall Study||34
23901|NCT01874665|52858|P2|NOT COMPLETED|Overall Study||2
23902|NCT01874665|52859|P1|NOT COMPLETED|Overall Study||4
23903|NCT01874665|52858|P2|COMPLETED|Overall Study|Completed = off treatment|13
23904|NCT01874665|52859|P1|COMPLETED|Overall Study|Completed = off treatment|26
23905|NCT01874665|52858|P2|STARTED|Overall Study||15
23906|NCT01874665|52859|P1|STARTED|Overall Study||30
23907|NCT01875510|52866|P2|NOT COMPLETED|Overall Study||0
23908|NCT01875510|52867|P1|NOT COMPLETED|Overall Study||0
23909|NCT01875510|52866|P2|COMPLETED|Overall Study||40
23910|NCT01875510|52867|P1|COMPLETED|Overall Study||40
23911|NCT01875510|52866|P2|STARTED|Overall Study||40
23912|NCT01875510|52867|P1|STARTED|Overall Study||40
23913|NCT01875471|52875|P2|NOT COMPLETED|Overall Study||1
23914|NCT01875471|52876|P1|NOT COMPLETED|Overall Study||1
23915|NCT01875471|52875|P2|COMPLETED|Overall Study||137
23916|NCT01875471|52876|P1|COMPLETED|Overall Study||136
23917|NCT01875471|52875|P2|Completed Per Protocol|Overall Study||123
23918|NCT01875471|52876|P1|Completed Per Protocol|Overall Study||127
23919|NCT01875471|52875|P2|STARTED|Overall Study||138
23920|NCT01875471|52876|P1|STARTED|Overall Study||137
23921|NCT01875159|52884|P2|NOT COMPLETED|Overall Study||0
23922|NCT01875159|52885|P1|NOT COMPLETED|Overall Study||3
23923|NCT01875159|52884|P2|COMPLETED|Overall Study||53
23924|NCT01875159|52885|P1|COMPLETED|Overall Study||42
23925|NCT01875159|52884|P2|STARTED|Overall Study||53
23926|NCT01875159|52885|P1|STARTED|Overall Study||45
23927|NCT01874340|52897|P4|NOT COMPLETED|Overall Study||5
23928|NCT01874340|52898|P3|NOT COMPLETED|Overall Study||8
23929|NCT01874340|52899|P2|NOT COMPLETED|Overall Study||8
23930|NCT01874340|52900|P1|NOT COMPLETED|Overall Study||6
23931|NCT01874340|52897|P4|COMPLETED|Overall Study||1
23932|NCT01874340|52898|P3|COMPLETED|Overall Study||0
23933|NCT01874340|52899|P2|COMPLETED|Overall Study||0
23934|NCT01874340|52900|P1|COMPLETED|Overall Study||0
23935|NCT01874340|52897|P4|STARTED|Overall Study||6
23936|NCT01874340|52898|P3|STARTED|Overall Study||8
23937|NCT01874340|52899|P2|STARTED|Overall Study||8
23938|NCT01874340|52900|P1|STARTED|Overall Study||6
23939|NCT01874275|52928|P2|NOT COMPLETED|Overall Study||0
23940|NCT01874275|52929|P1|NOT COMPLETED|Overall Study||1
23941|NCT01874275|52928|P2|COMPLETED|Overall Study||2
23942|NCT01874275|52929|P1|COMPLETED|Overall Study||3
23943|NCT01874275|52928|P2|STARTED|Overall Study||2
23944|NCT01874275|52929|P1|STARTED|Overall Study||4
23945|NCT01874262|52943|P2|NOT COMPLETED|Overall Study||3
23946|NCT01874262|52944|P1|NOT COMPLETED|Overall Study||5
23947|NCT01874262|52943|P2|COMPLETED|Overall Study||80
23948|NCT01874262|52944|P1|COMPLETED|Overall Study||86
23949|NCT01874262|52943|P2|Not Included Due to Tehnical Issues|Overall Study||3
23950|NCT01874262|52944|P1|Not Included Due to Tehnical Issues|Overall Study||3
23951|NCT01874262|52943|P2|Not Correctly Randomised|Overall Study||0
23952|NCT01874262|52944|P1|Not Correctly Randomised|Overall Study||2
23953|NCT01874262|52943|P2|STARTED|Overall Study||83
23954|NCT01874262|52944|P1|STARTED|Overall Study||91
23955|NCT01874145|52952|P2|NOT COMPLETED|Extension Period||4
23956|NCT01874145|52953|P1|NOT COMPLETED|Extension Period||6
23957|NCT01874145|52952|P2|COMPLETED|Extension Period||97
23958|NCT01874145|52953|P1|COMPLETED|Extension Period||91
23959|NCT01874145|52952|P2|Full Analysis Set|Extension Period||101
23960|NCT01874145|52953|P1|Full Analysis Set|Extension Period||95
23961|NCT01874145|52952|P2|STARTED|Extension Period|Non-Switchers|101
23962|NCT01874145|52953|P1|STARTED|Extension Period|Switchers|97
23963|NCT01874145|52952|P2|NOT COMPLETED|Core Period||7
23964|NCT01874145|52953|P1|NOT COMPLETED|Core Period||3
23965|NCT01874145|52952|P2|COMPLETED|Core Period||101
23966|NCT01874145|52953|P1|COMPLETED|Core Period||98
23967|NCT01874145|52952|P2|Full Analysis Set|Core Period||108
23968|NCT01874145|52953|P1|Full Analysis Set|Core Period||100
23969|NCT01874145|52952|P2|STARTED|Core Period||108
23970|NCT01874145|52953|P1|STARTED|Core Period||101
23971|NCT01874132|52992|P3|NOT COMPLETED|Overall Study||3
23972|NCT01874132|52993|P2|NOT COMPLETED|Overall Study||4
23973|NCT01874132|52994|P1|NOT COMPLETED|Overall Study||4
23974|NCT01874132|52992|P3|COMPLETED|Overall Study||19
23975|NCT01874132|52993|P2|COMPLETED|Overall Study||18
23976|NCT01874132|52994|P1|COMPLETED|Overall Study||18
23977|NCT01874132|52992|P3|STARTED|Overall Study||22
23978|NCT01874132|52993|P2|STARTED|Overall Study||22
23979|NCT01874132|52994|P1|STARTED|Overall Study||22
23980|NCT01873950|53002|P5|NOT COMPLETED|Period 5||0
23981|NCT01873950|53003|P4|NOT COMPLETED|Period 5||1
23982|NCT01873950|53004|P3|NOT COMPLETED|Period 5||0
23983|NCT01873950|53005|P2|NOT COMPLETED|Period 5||0
23984|NCT01873950|53006|P1|NOT COMPLETED|Period 5||0
23985|NCT01873950|53002|P5|COMPLETED|Period 5||4
23986|NCT01873950|53003|P4|COMPLETED|Period 5||3
23987|NCT01873950|53004|P3|COMPLETED|Period 5||4
23988|NCT01873950|53005|P2|COMPLETED|Period 5||5
23989|NCT01873950|53006|P1|COMPLETED|Period 5||4
23990|NCT01873950|53002|P5|STARTED|Period 5||4
23991|NCT01873950|53003|P4|STARTED|Period 5||4
23992|NCT01873950|53004|P3|STARTED|Period 5||4
23993|NCT01873950|53005|P2|STARTED|Period 5||5
23994|NCT01873950|53006|P1|STARTED|Period 5||4
23995|NCT01873950|53002|P5|NOT COMPLETED|Period 4||0
23996|NCT01873950|53003|P4|NOT COMPLETED|Period 4||0
23997|NCT01873950|53004|P3|NOT COMPLETED|Period 4||0
23998|NCT01873950|53005|P2|NOT COMPLETED|Period 4||0
23999|NCT01873950|53006|P1|NOT COMPLETED|Period 4||0
24000|NCT01873950|53002|P5|COMPLETED|Period 4||5
24001|NCT01873950|53003|P4|COMPLETED|Period 4||4
24002|NCT01873950|53004|P3|COMPLETED|Period 4||4
24003|NCT01873950|53005|P2|COMPLETED|Period 4||5
24004|NCT01873950|53006|P1|COMPLETED|Period 4||4
24005|NCT01873950|53002|P5|STARTED|Period 4||5
24006|NCT01873950|53003|P4|STARTED|Period 4||4
24007|NCT01873950|53004|P3|STARTED|Period 4||4
24008|NCT01873950|53005|P2|STARTED|Period 4||5
24009|NCT01873950|53006|P1|STARTED|Period 4||4
24010|NCT01873950|53002|P5|NOT COMPLETED|Period 3||0
24011|NCT01873950|53003|P4|NOT COMPLETED|Period 3||0
24012|NCT01873950|53004|P3|NOT COMPLETED|Period 3||0
24013|NCT01873950|53005|P2|NOT COMPLETED|Period 3||0
24014|NCT01873950|53006|P1|NOT COMPLETED|Period 3||0
24015|NCT01873950|53002|P5|COMPLETED|Period 3||4
24016|NCT01873950|53003|P4|COMPLETED|Period 3||5
24017|NCT01873950|53004|P3|COMPLETED|Period 3||5
24018|NCT01873950|53005|P2|COMPLETED|Period 3||4
24019|NCT01873950|53006|P1|COMPLETED|Period 3||4
24020|NCT01873950|53002|P5|STARTED|Period 3||4
24021|NCT01873950|53003|P4|STARTED|Period 3||5
24022|NCT01873950|53004|P3|STARTED|Period 3||5
24023|NCT01873950|53005|P2|STARTED|Period 3||4
24024|NCT01873950|53006|P1|STARTED|Period 3||4
24025|NCT01873950|53002|P5|NOT COMPLETED|Period 2||0
24026|NCT01873950|53003|P4|NOT COMPLETED|Period 2||0
24027|NCT01873950|53004|P3|NOT COMPLETED|Period 2||0
24028|NCT01873950|53005|P2|NOT COMPLETED|Period 2||0
24029|NCT01873950|53006|P1|NOT COMPLETED|Period 2||0
24030|NCT01873950|53002|P5|COMPLETED|Period 2||5
24031|NCT01873950|53003|P4|COMPLETED|Period 2||4
24032|NCT01873950|53004|P3|COMPLETED|Period 2||4
24033|NCT01873950|53005|P2|COMPLETED|Period 2||4
24034|NCT01873950|53006|P1|COMPLETED|Period 2||5
24035|NCT01873950|53002|P5|STARTED|Period 2||5
24036|NCT01873950|53003|P4|STARTED|Period 2||4
24037|NCT01873950|53004|P3|STARTED|Period 2||4
24038|NCT01873950|53005|P2|STARTED|Period 2||4
24039|NCT01873950|53006|P1|STARTED|Period 2||5
24040|NCT01873950|53002|P5|NOT COMPLETED|Period 1||0
24041|NCT01873950|53003|P4|NOT COMPLETED|Period 1||0
24042|NCT01873950|53004|P3|NOT COMPLETED|Period 1||0
24043|NCT01873950|53005|P2|NOT COMPLETED|Period 1||0
24044|NCT01873950|53006|P1|NOT COMPLETED|Period 1||0
24045|NCT01873950|53002|P5|COMPLETED|Period 1||4
24046|NCT01873950|53003|P4|COMPLETED|Period 1||4
24047|NCT01873950|53004|P3|COMPLETED|Period 1||5
24048|NCT01873950|53005|P2|COMPLETED|Period 1||4
24049|NCT01873950|53006|P1|COMPLETED|Period 1||5
24050|NCT01873950|53002|P5|STARTED|Period 1||4
24051|NCT01873950|53003|P4|STARTED|Period 1||4
24052|NCT01873950|53004|P3|STARTED|Period 1||5
24053|NCT01873950|53005|P2|STARTED|Period 1||4
24054|NCT01873950|53006|P1|STARTED|Period 1||5
24055|NCT01873859|53027|P2|NOT COMPLETED|Overall Study||4
24056|NCT01873859|53028|P1|NOT COMPLETED|Overall Study||0
24057|NCT01873859|53027|P2|COMPLETED|Overall Study||79
24058|NCT01873859|53028|P1|COMPLETED|Overall Study||83
24059|NCT01873859|53027|P2|STARTED|Overall Study||83
24060|NCT01873859|53028|P1|STARTED|Overall Study||83
24061|NCT01873729|53036|P1|NOT COMPLETED|Overall Study||1
24062|NCT01873729|53036|P1|COMPLETED|Overall Study||2
24063|NCT01873729|53036|P1|STARTED|Overall Study||3
24064|NCT01873417|53041|P1|NOT COMPLETED|Overall Study||35
24065|NCT01873417|53041|P1|COMPLETED|Overall Study||202
24066|NCT01873417|53041|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
24067|NCT01873417|53041|P1|STARTED|Overall Study||237
24068|NCT01872715|53052|P1|NOT COMPLETED|Overall Study||4
24069|NCT01872715|53052|P1|COMPLETED|Overall Study||20
24070|NCT01872715|53052|P1|STARTED|Overall Study||24
24071|NCT01872611|53069|P2|NOT COMPLETED|Overall Study||12
24072|NCT01872611|53070|P1|NOT COMPLETED|Overall Study||24
24073|NCT01872611|53069|P2|COMPLETED|Overall Study||292
24074|NCT01872611|53070|P1|COMPLETED|Overall Study||277
24075|NCT01872611|53069|P2|Full Analysis Set|Overall Study||293
24076|NCT01872611|53070|P1|Full Analysis Set|Overall Study||289
24077|NCT01872611|53069|P2|Treated (Safety Analysis Set)|Overall Study||295
24078|NCT01872611|53070|P1|Treated (Safety Analysis Set)|Overall Study||293
24079|NCT01872611|53069|P2|Randomized|Overall Study||304
24080|NCT01872611|53070|P1|Randomized|Overall Study||301
24081|NCT01872611|53069|P2|STARTED|Overall Study||304
24082|NCT01872611|53070|P1|STARTED|Overall Study||301
24083|NCT01872078|53092|P4|NOT COMPLETED|Overall Study||2
24084|NCT01872078|53093|P3|NOT COMPLETED|Overall Study||3
24085|NCT01872078|53094|P2|NOT COMPLETED|Overall Study||0
24086|NCT01872078|53095|P1|NOT COMPLETED|Overall Study||0
24087|NCT01872078|53092|P4|COMPLETED|Overall Study||15
24088|NCT01872078|53093|P3|COMPLETED|Overall Study||14
24089|NCT01872078|53094|P2|COMPLETED|Overall Study||15
24090|NCT01872078|53095|P1|COMPLETED|Overall Study||16
24091|NCT01872078|53092|P4|STARTED|Overall Study||17
24092|NCT01872078|53093|P3|STARTED|Overall Study||17
24093|NCT01872078|53094|P2|STARTED|Overall Study||15
24094|NCT01872078|53095|P1|STARTED|Overall Study||16
24095|NCT01871870|53105|P1|NOT COMPLETED|Overall Study||9
24096|NCT01871870|53105|P1|COMPLETED|Overall Study||11
24097|NCT01871870|53105|P1|STARTED|Overall Study||20
24098|NCT01871805|53116|P6|NOT COMPLETED|Phase II||87
24099|NCT01871805|53117|P5|NOT COMPLETED|Phase II||0
24100|NCT01871805|53118|P4|NOT COMPLETED|Phase II||0
24101|NCT01871805|53119|P3|NOT COMPLETED|Phase II||0
24102|NCT01871805|53120|P2|NOT COMPLETED|Phase II||0
24103|NCT01871805|53121|P1|NOT COMPLETED|Phase II||0
24104|NCT01871805|53116|P6|COMPLETED|Phase II||0
24105|NCT01871805|53117|P5|COMPLETED|Phase II||0
24106|NCT01871805|53118|P4|COMPLETED|Phase II||0
24107|NCT01871805|53119|P3|COMPLETED|Phase II||0
24108|NCT01871805|53120|P2|COMPLETED|Phase II||0
24109|NCT01871805|53121|P1|COMPLETED|Phase II||0
24110|NCT01871805|53116|P6|STARTED|Phase II||87
24111|NCT01871805|53117|P5|STARTED|Phase II||0
24112|NCT01871805|53118|P4|STARTED|Phase II||0
24113|NCT01871805|53119|P3|STARTED|Phase II||0
24114|NCT01871805|53120|P2|STARTED|Phase II||0
24115|NCT01871805|53121|P1|STARTED|Phase II||0
24116|NCT01871805|53116|P6|NOT COMPLETED|Phase I||0
24117|NCT01871805|53117|P5|NOT COMPLETED|Phase I||13
24118|NCT01871805|53118|P4|NOT COMPLETED|Phase I||7
24119|NCT01871805|53119|P3|NOT COMPLETED|Phase I||13
24120|NCT01871805|53120|P2|NOT COMPLETED|Phase I||7
24121|NCT01871805|53121|P1|NOT COMPLETED|Phase I||7
24122|NCT01871805|53116|P6|COMPLETED|Phase I||0
24123|NCT01871805|53117|P5|COMPLETED|Phase I||0
24124|NCT01871805|53118|P4|COMPLETED|Phase I||0
24125|NCT01871805|53119|P3|COMPLETED|Phase I||0
24126|NCT01871805|53120|P2|COMPLETED|Phase I||0
24127|NCT01871805|53121|P1|COMPLETED|Phase I||0
24128|NCT01871805|53116|P6|STARTED|Phase I||0
24129|NCT01871805|53117|P5|STARTED|Phase I||13
24130|NCT01871805|53118|P4|STARTED|Phase I||7
24131|NCT01871805|53119|P3|STARTED|Phase I||13
24132|NCT01871805|53120|P2|STARTED|Phase I||7
24133|NCT01871805|53121|P1|STARTED|Phase I||7
24134|NCT01871558|53189|P2|NOT COMPLETED|Overall Study||2
24135|NCT01871558|53190|P1|NOT COMPLETED|Overall Study||3
24136|NCT01871558|53189|P2|COMPLETED|Overall Study||19
24137|NCT01871558|53190|P1|COMPLETED|Overall Study||18
24138|NCT01871558|53189|P2|STARTED|Overall Study||21
24139|NCT01871558|53190|P1|STARTED|Overall Study||21
24140|NCT01871532|53210|P2|NOT COMPLETED|Overall Study||2
24141|NCT01871532|53211|P1|NOT COMPLETED|Overall Study||1
24142|NCT01871532|53210|P2|COMPLETED|Overall Study||10
24143|NCT01871532|53211|P1|COMPLETED|Overall Study||11
24144|NCT01871532|53210|P2|Subjects Received hCG Treatment|Overall Study||9
24145|NCT01871532|53211|P1|Subjects Received hCG Treatment|Overall Study||11
24146|NCT01871532|53210|P2|STARTED|Overall Study||12
24147|NCT01871532|53211|P1|STARTED|Overall Study||12
24148|NCT01871519|53245|P1|NOT COMPLETED|Overall Study||90
24149|NCT01871519|53245|P1|COMPLETED|Overall Study||260
24150|NCT01871519|53245|P1|STARTED|Overall Study||350
24151|NCT01871402|53268|P2|NOT COMPLETED|Overall Study||3
24152|NCT01871402|53269|P1|NOT COMPLETED|Overall Study||1
24153|NCT01871402|53268|P2|COMPLETED|Overall Study||108
24154|NCT01871402|53269|P1|COMPLETED|Overall Study||109
24155|NCT01871402|53268|P2|STARTED|Overall Study||111
24156|NCT01871402|53269|P1|STARTED|Overall Study||110
24157|NCT01871285|53287|P4|NOT COMPLETED|Second Intervention (1 Day)||0
24158|NCT01871285|53288|P3|NOT COMPLETED|Second Intervention (1 Day)||0
24159|NCT01871285|53289|P2|NOT COMPLETED|Second Intervention (1 Day)||0
24160|NCT01871285|53290|P1|NOT COMPLETED|Second Intervention (1 Day)||0
24161|NCT01871285|53287|P4|COMPLETED|Second Intervention (1 Day)||2
24162|NCT01871285|53288|P3|COMPLETED|Second Intervention (1 Day)||3
24163|NCT01871285|53289|P2|COMPLETED|Second Intervention (1 Day)||14
24164|NCT01871285|53290|P1|COMPLETED|Second Intervention (1 Day)||17
24165|NCT01871285|53287|P4|STARTED|Second Intervention (1 Day)||2
24166|NCT01871285|53288|P3|STARTED|Second Intervention (1 Day)||3
24167|NCT01871285|53289|P2|STARTED|Second Intervention (1 Day)||14
24168|NCT01871285|53290|P1|STARTED|Second Intervention (1 Day)||17
24169|NCT01871285|53287|P4|NOT COMPLETED|First Intervention (1 Day)||0
24170|NCT01871285|53288|P3|NOT COMPLETED|First Intervention (1 Day)||1
24171|NCT01871285|53289|P2|NOT COMPLETED|First Intervention (1 Day)||1
24172|NCT01871285|53290|P1|NOT COMPLETED|First Intervention (1 Day)||1
24173|NCT01871285|53287|P4|COMPLETED|First Intervention (1 Day)||2
24174|NCT01871285|53288|P3|COMPLETED|First Intervention (1 Day)||3
24175|NCT01871285|53289|P2|COMPLETED|First Intervention (1 Day)||14
24176|NCT01871285|53290|P1|COMPLETED|First Intervention (1 Day)||17
24177|NCT01871285|53287|P4|STARTED|First Intervention (1 Day)||2
24178|NCT01871285|53288|P3|STARTED|First Intervention (1 Day)||4
24179|NCT01871285|53289|P2|STARTED|First Intervention (1 Day)||15
24180|NCT01871285|53290|P1|STARTED|First Intervention (1 Day)||18
24181|NCT01871142|53316|P1|NOT COMPLETED|Overall Study||1
24182|NCT01871142|53316|P1|COMPLETED|Overall Study||11
24183|NCT01871142|53316|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
24184|NCT01871142|53316|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
24185|NCT01871142|53316|P1|Received Placebo + Hypoxia|Overall Study||12
24186|NCT01871142|53316|P1|Received Placebo + Normoixa|Overall Study||11
24187|NCT01871142|53316|P1|STARTED|Overall Study||12
24188|NCT01871090|53332|P2|NOT COMPLETED|Overall Study||23
24189|NCT01871090|53333|P1|NOT COMPLETED|Overall Study||2
24190|NCT01871090|53332|P2|COMPLETED|Overall Study||25
24191|NCT01871090|53333|P1|COMPLETED|Overall Study||33
24192|NCT01871090|53332|P2|STARTED|Overall Study||48
24193|NCT01871090|53333|P1|STARTED|Overall Study||35
24194|NCT01870999|53346|P3|NOT COMPLETED|Overall Study||7
24195|NCT01870999|53347|P2|NOT COMPLETED|Overall Study||8
24196|NCT01870999|53348|P1|NOT COMPLETED|Overall Study||4
24197|NCT01870999|53346|P3|COMPLETED|Overall Study||4
24198|NCT01870999|53347|P2|COMPLETED|Overall Study||8
24199|NCT01870999|53348|P1|COMPLETED|Overall Study||10
24200|NCT01870999|53346|P3|Safety Population; Received Study Drug|Overall Study||10
24201|NCT01870999|53347|P2|Safety Population; Received Study Drug|Overall Study||15
24202|NCT01870999|53348|P1|Safety Population; Received Study Drug|Overall Study||14
24203|NCT01870999|53346|P3|STARTED|Overall Study||11
24204|NCT01870999|53347|P2|STARTED|Overall Study||16
24205|NCT01870999|53348|P1|STARTED|Overall Study||14
24206|NCT01870973|53406|P2|NOT COMPLETED|Overall Study||3
24207|NCT01870973|53407|P1|NOT COMPLETED|Overall Study||10
24208|NCT01870973|53406|P2|COMPLETED|Overall Study||49
24209|NCT01870973|53407|P1|COMPLETED|Overall Study||46
24210|NCT01870973|53406|P2|STARTED|Overall Study||52
24211|NCT01870973|53407|P1|STARTED|Overall Study||56
24212|NCT01870921|53413|P1|NOT COMPLETED|Overall Study||90
24213|NCT01870921|53413|P1|COMPLETED|Overall Study||1914
24214|NCT01870921|53413|P1|STARTED|Overall Study||2004
24215|NCT01870856|53421|P2|NOT COMPLETED|Overall Study||0
24216|NCT01870856|53422|P1|NOT COMPLETED|Overall Study||0
24217|NCT01870856|53421|P2|COMPLETED|Overall Study||27
24218|NCT01870856|53422|P1|COMPLETED|Overall Study||25
24219|NCT01870856|53421|P2|STARTED|Overall Study||27
24220|NCT01870856|53422|P1|STARTED|Overall Study||25
24221|NCT01870843|53432|P1|NOT COMPLETED|Overall Study||53
24222|NCT01870843|53432|P1|COMPLETED|Overall Study||208
24223|NCT01870843|53432|P1|STARTED|Overall Study||261
24224|NCT01870739|53447|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
24225|NCT01870739|53448|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
24226|NCT01870739|53447|P2|COMPLETED|Add-on Period (40 Weeks)||51
24227|NCT01870739|53448|P1|COMPLETED|Add-on Period (40 Weeks)||51
24228|NCT01870739|53447|P2|STARTED|Add-on Period (40 Weeks)||53
24229|NCT01870739|53448|P1|STARTED|Add-on Period (40 Weeks)||54
24230|NCT01870739|53447|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
24231|NCT01870739|53448|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
24232|NCT01870739|53447|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
24233|NCT01870739|53448|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
24234|NCT01870739|53447|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
24235|NCT01870739|53448|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
24236|NCT01870739|53447|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
24237|NCT01870739|53448|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
24238|NCT01870739|53447|P2|STARTED|Single Drug Treatment (12 Weeks)||57
24239|NCT01870739|53448|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
24240|NCT01870596|53482|P2|NOT COMPLETED|Overall Study||0
24241|NCT01870596|53483|P1|NOT COMPLETED|Overall Study||0
24242|NCT01870596|53482|P2|COMPLETED|Overall Study||18
24243|NCT01870596|53483|P1|COMPLETED|Overall Study||14
24244|NCT01870596|53482|P2|STARTED|Overall Study||18
24245|NCT01870596|53483|P1|STARTED|Overall Study||14
24246|NCT01869686|53489|P1|NOT COMPLETED|Overall Study||0
24247|NCT01869686|53489|P1|COMPLETED|Overall Study||12
24248|NCT01869686|53489|P1|STARTED|Overall Study||12
24249|NCT01869647|53504|P3|NOT COMPLETED|Overall Study||0
24250|NCT01869647|53505|P2|NOT COMPLETED|Overall Study||6
24251|NCT01869647|53506|P1|NOT COMPLETED|Overall Study||1
24252|NCT01869647|53504|P3|COMPLETED|Overall Study||62
24253|NCT01869647|53505|P2|COMPLETED|Overall Study||130
24254|NCT01869647|53506|P1|COMPLETED|Overall Study||65
24255|NCT01869647|53504|P3|STARTED|Overall Study||62
24256|NCT01869647|53505|P2|STARTED|Overall Study||136
24257|NCT01869647|53506|P1|STARTED|Overall Study||66
24258|NCT01869478|53519|P2|NOT COMPLETED|Overall Study||0
24259|NCT01869478|53520|P1|NOT COMPLETED|Overall Study||0
24260|NCT01869478|53519|P2|COMPLETED|Overall Study||1
24261|NCT01869478|53520|P1|COMPLETED|Overall Study||0
24262|NCT01869478|53519|P2|STARTED|Overall Study||1
24263|NCT01869478|53520|P1|STARTED|Overall Study||0
24264|NCT01869075|53534|P6|NOT COMPLETED|Phase 2||0
24265|NCT01869075|53535|P5|NOT COMPLETED|Phase 2||0
24266|NCT01869075|53536|P4|NOT COMPLETED|Phase 2||0
24267|NCT01869075|53537|P3|NOT COMPLETED|Phase 2||0
24268|NCT01869075|53538|P2|NOT COMPLETED|Phase 2||0
24269|NCT01869075|53539|P1|NOT COMPLETED|Phase 2||0
24270|NCT01869075|53534|P6|COMPLETED|Phase 2||45
24271|NCT01869075|53535|P5|COMPLETED|Phase 2||75
24272|NCT01869075|53536|P4|COMPLETED|Phase 2||45
24273|NCT01869075|53537|P3|COMPLETED|Phase 2||75
24274|NCT01869075|53538|P2|COMPLETED|Phase 2||30
24275|NCT01869075|53539|P1|COMPLETED|Phase 2||90
24276|NCT01869075|53534|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
24277|NCT01869075|53535|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
24278|NCT01869075|53536|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
24279|NCT01869075|53537|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
24280|NCT01869075|53538|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
24281|NCT01869075|53539|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
24282|NCT01869075|53534|P6|NOT COMPLETED|Phase 1||0
24283|NCT01869075|53535|P5|NOT COMPLETED|Phase 1||0
24284|NCT01869075|53536|P4|NOT COMPLETED|Phase 1||0
24285|NCT01869075|53537|P3|NOT COMPLETED|Phase 1||0
24286|NCT01869075|53538|P2|NOT COMPLETED|Phase 1||0
24287|NCT01869075|53539|P1|NOT COMPLETED|Phase 1||0
24288|NCT01869075|53534|P6|COMPLETED|Phase 1||90
24289|NCT01869075|53535|P5|COMPLETED|Phase 1||30
24290|NCT01869075|53536|P4|COMPLETED|Phase 1||75
24291|NCT01869075|53537|P3|COMPLETED|Phase 1||45
24292|NCT01869075|53538|P2|COMPLETED|Phase 1||75
24293|NCT01869075|53539|P1|COMPLETED|Phase 1||45
24294|NCT01869075|53534|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
24295|NCT01869075|53535|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
24296|NCT01869075|53536|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
24297|NCT01869075|53537|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
24298|NCT01869075|53538|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
24299|NCT01869075|53539|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
24300|NCT01869075|53534|P6|NOT COMPLETED|Phase 0 (Baseline)||0
24301|NCT01869075|53535|P5|NOT COMPLETED|Phase 0 (Baseline)||0
24302|NCT01869075|53536|P4|NOT COMPLETED|Phase 0 (Baseline)||0
24303|NCT01869075|53537|P3|NOT COMPLETED|Phase 0 (Baseline)||0
24304|NCT01869075|53538|P2|NOT COMPLETED|Phase 0 (Baseline)||0
24305|NCT01869075|53539|P1|NOT COMPLETED|Phase 0 (Baseline)||0
24306|NCT01869075|53534|P6|COMPLETED|Phase 0 (Baseline)||341
24307|NCT01869075|53535|P5|COMPLETED|Phase 0 (Baseline)||0
24308|NCT01869075|53536|P4|COMPLETED|Phase 0 (Baseline)||416
24309|NCT01869075|53537|P3|COMPLETED|Phase 0 (Baseline)||0
24310|NCT01869075|53538|P2|COMPLETED|Phase 0 (Baseline)||418
24311|NCT01869075|53539|P1|COMPLETED|Phase 0 (Baseline)||0
24312|NCT01869075|53534|P6|STARTED|Phase 0 (Baseline)||341
24313|NCT01869075|53535|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
24314|NCT01869075|53536|P4|STARTED|Phase 0 (Baseline)||416
24315|NCT01869075|53537|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
24316|NCT01869075|53538|P2|STARTED|Phase 0 (Baseline)||418
24317|NCT01869075|53539|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
24318|NCT01868893|53553|P1|NOT COMPLETED|Overall Study||20
24319|NCT01868893|53553|P1|COMPLETED|Overall Study||0
24320|NCT01868893|53553|P1|STARTED|Overall Study||20
24321|NCT01868776|53562|P2|NOT COMPLETED|Overall Study||0
24322|NCT01868776|53563|P1|NOT COMPLETED|Overall Study||0
24323|NCT01868776|53562|P2|COMPLETED|Overall Study||50
24324|NCT01868776|53563|P1|COMPLETED|Overall Study||50
24325|NCT01868776|53562|P2|STARTED|Overall Study||50
24326|NCT01868776|53563|P1|STARTED|Overall Study||50
24327|NCT01868542|53571|P2|NOT COMPLETED|Overall Study||2
24328|NCT01868542|53572|P1|NOT COMPLETED|Overall Study||0
24329|NCT01868542|53571|P2|COMPLETED|Overall Study||21
24330|NCT01868542|53572|P1|COMPLETED|Overall Study||23
24331|NCT01868542|53571|P2|STARTED|Overall Study||23
24332|NCT01868542|53572|P1|STARTED|Overall Study||23
24333|NCT01868503|53590|P1|NOT COMPLETED|Overall Study||2
24334|NCT01868503|53590|P1|COMPLETED|Overall Study||5
24335|NCT01868503|53590|P1|STARTED|Overall Study||7
24336|NCT01868243|53596|P2|NOT COMPLETED|Overall Study||1
24337|NCT01868243|53597|P1|NOT COMPLETED|Overall Study||0
24338|NCT01868243|53596|P2|COMPLETED|Overall Study||11
24339|NCT01868243|53597|P1|COMPLETED|Overall Study||15
24340|NCT01868243|53596|P2|STARTED|Overall Study||12
24341|NCT01868243|53597|P1|STARTED|Overall Study||15
24342|NCT01868074|53607|P2|NOT COMPLETED|Overall Study||4
24343|NCT01868074|53608|P1|NOT COMPLETED|Overall Study||7
24344|NCT01868074|53607|P2|COMPLETED|Overall Study||32
24345|NCT01868074|53608|P1|COMPLETED|Overall Study||29
24346|NCT01868074|53607|P2|STARTED|Overall Study||36
24347|NCT01868074|53608|P1|STARTED|Overall Study||36
24348|NCT01868035|53618|P1|NOT COMPLETED|Overall Study||7
24349|NCT01868035|53618|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
24350|NCT01868035|53618|P1|STARTED|Overall Study||15
24351|NCT01868009|53634|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
24352|NCT01868009|53635|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
24353|NCT01868009|53634|P2|COMPLETED|Period 2 (5-9 Days)||142
24354|NCT01868009|53635|P1|COMPLETED|Period 2 (5-9 Days)||141
24355|NCT01868009|53634|P2|STARTED|Period 2 (5-9 Days)||142
24356|NCT01868009|53635|P1|STARTED|Period 2 (5-9 Days)||143
24357|NCT01868009|53634|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
24358|NCT01868009|53635|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
24359|NCT01868009|53634|P2|COMPLETED|Period 1 (5-9 Days)||142
24360|NCT01868009|53635|P1|COMPLETED|Period 1 (5-9 Days)||143
24361|NCT01868009|53634|P2|STARTED|Period 1 (5-9 Days)||144
24362|NCT01868009|53635|P1|STARTED|Period 1 (5-9 Days)||143
24363|NCT01867710|53649|P4|NOT COMPLETED|Overall Study||7
24364|NCT01867710|53650|P3|NOT COMPLETED|Overall Study||9
24365|NCT01867710|53651|P2|NOT COMPLETED|Overall Study||7
24366|NCT01867710|53652|P1|NOT COMPLETED|Overall Study||8
24367|NCT01867710|53649|P4|COMPLETED|Overall Study||35
24368|NCT01867710|53650|P3|COMPLETED|Overall Study||31
24369|NCT01867710|53651|P2|COMPLETED|Overall Study||34
24370|NCT01867710|53652|P1|COMPLETED|Overall Study||33
24371|NCT01867710|53649|P4|Treated|Overall Study||42
24372|NCT01867710|53650|P3|Treated|Overall Study||39
24373|NCT01867710|53651|P2|Treated|Overall Study||41
24374|NCT01867710|53652|P1|Treated|Overall Study||41
24375|NCT01867710|53649|P4|STARTED|Overall Study||42
24376|NCT01867710|53650|P3|STARTED|Overall Study||40
24377|NCT01867710|53651|P2|STARTED|Overall Study||41
24378|NCT01867710|53652|P1|STARTED|Overall Study||41
24379|NCT01867658|53666|P1|NOT COMPLETED|Overall Study||9
24380|NCT01867658|53666|P1|COMPLETED|Overall Study||103
24381|NCT01867658|53666|P1|STARTED|Overall Study||112
24382|NCT01867164|53679|P2|NOT COMPLETED|Overall Study||0
24383|NCT01867164|53680|P1|NOT COMPLETED|Overall Study||0
24384|NCT01867164|53679|P2|COMPLETED|Overall Study||79
24385|NCT01867164|53680|P1|COMPLETED|Overall Study||81
24386|NCT01867164|53679|P2|STARTED|Overall Study||79
24387|NCT01867164|53680|P1|STARTED|Overall Study||81
24388|NCT01867021|53696|P2|NOT COMPLETED|Overall Study||10
24389|NCT01867021|53697|P1|NOT COMPLETED|Overall Study||2
24390|NCT01867021|53696|P2|COMPLETED|Overall Study||1440
24391|NCT01867021|53697|P1|COMPLETED|Overall Study||1450
24392|NCT01867021|53696|P2|STARTED|Overall Study||1450
24393|NCT01867021|53697|P1|STARTED|Overall Study||1452
24394|NCT01865812|53716|P1|NOT COMPLETED|Overall Study||2
24395|NCT01865812|53716|P1|COMPLETED|Overall Study||24
24396|NCT01865812|53716|P1|STARTED|Overall Study||26
24397|NCT01866709|53724|P2|NOT COMPLETED|Overall Study||0
24398|NCT01866709|53725|P1|NOT COMPLETED|Overall Study||1
24399|NCT01866709|53724|P2|COMPLETED|Overall Study||17
24400|NCT01866709|53725|P1|COMPLETED|Overall Study||14
24401|NCT01866709|53724|P2|STARTED|Overall Study||17
24402|NCT01866709|53725|P1|STARTED|Overall Study||15
24403|NCT01866319|53736|P3|NOT COMPLETED|Overall Study||277
24404|NCT01866319|53737|P2|NOT COMPLETED|Overall Study||279
24405|NCT01866319|53738|P1|NOT COMPLETED|Overall Study||277
24406|NCT01866319|53736|P3|COMPLETED|Overall Study||0
24407|NCT01866319|53737|P2|COMPLETED|Overall Study||0
24408|NCT01866319|53738|P1|COMPLETED|Overall Study||1
24409|NCT01866319|53736|P3|Treated|Overall Study||277
24410|NCT01866319|53737|P2|Treated|Overall Study||278
24411|NCT01866319|53738|P1|Treated|Overall Study||256
24412|NCT01866319|53736|P3|STARTED|Overall Study||277
24413|NCT01866319|53737|P2|STARTED|Overall Study||279
24414|NCT01866319|53738|P1|STARTED|Overall Study||278
24415|NCT01866163|53754|P2|NOT COMPLETED|Overall Study||4
24416|NCT01866163|53755|P1|NOT COMPLETED|Overall Study||10
24417|NCT01866163|53754|P2|COMPLETED|Overall Study||99
24418|NCT01866163|53755|P1|COMPLETED|Overall Study||313
24419|NCT01866163|53754|P2|STARTED|Overall Study||103
24420|NCT01866163|53755|P1|STARTED|Overall Study||323
24421|NCT01866150|53765|P1|NOT COMPLETED|Overall Study||0
24422|NCT01866150|53765|P1|COMPLETED|Overall Study||450
24423|NCT01866150|53765|P1|STARTED|Overall Study||450
24424|NCT01864434|53788|P2|NOT COMPLETED|Overall Study||0
24425|NCT01864434|53789|P1|NOT COMPLETED|Overall Study||0
24426|NCT01864434|53788|P2|COMPLETED|Overall Study||25
24427|NCT01864434|53789|P1|COMPLETED|Overall Study||25
24428|NCT01864434|53788|P2|STARTED|Overall Study||25
24429|NCT01864434|53789|P1|STARTED|Overall Study||25
24430|NCT01864005|53801|P2|NOT COMPLETED|Overall Study||6
24431|NCT01864005|53802|P1|NOT COMPLETED|Overall Study||3
24432|NCT01864005|53801|P2|COMPLETED|Overall Study||25
24433|NCT01864005|53802|P1|COMPLETED|Overall Study||26
24434|NCT01864005|53801|P2|STARTED|Overall Study||31
24435|NCT01864005|53802|P1|STARTED|Overall Study||29
24436|NCT01863953|53819|P3|NOT COMPLETED|Overall Study||1
24437|NCT01863953|53820|P2|NOT COMPLETED|Overall Study||0
24438|NCT01863953|53821|P1|NOT COMPLETED|Overall Study||0
24439|NCT01863953|53819|P3|COMPLETED|Overall Study||37
24440|NCT01863953|53820|P2|COMPLETED|Overall Study||36
24441|NCT01863953|53821|P1|COMPLETED|Overall Study||38
24442|NCT01863953|53819|P3|STARTED|Overall Study||38
24443|NCT01863953|53820|P2|STARTED|Overall Study||36
24444|NCT01863953|53821|P1|STARTED|Overall Study||38
24445|NCT01863771|53835|P4|NOT COMPLETED|Maintenance Phase||43
24446|NCT01863771|53836|P3|NOT COMPLETED|Maintenance Phase||12
24447|NCT01863771|53837|P2|NOT COMPLETED|Maintenance Phase||5
24448|NCT01863771|53838|P1|NOT COMPLETED|Maintenance Phase||0
24449|NCT01863771|53835|P4|COMPLETED|Maintenance Phase||17
24450|NCT01863771|53836|P3|COMPLETED|Maintenance Phase||19
24451|NCT01863771|53837|P2|COMPLETED|Maintenance Phase||27
24452|NCT01863771|53838|P1|COMPLETED|Maintenance Phase||0
24453|NCT01863771|53835|P4|STARTED|Maintenance Phase||60
24454|NCT01863771|53836|P3|STARTED|Maintenance Phase||31
24455|NCT01863771|53837|P2|STARTED|Maintenance Phase||32
24456|NCT01863771|53838|P1|STARTED|Maintenance Phase||0
24457|NCT01863771|53835|P4|NOT COMPLETED|Induction Phase||0
24458|NCT01863771|53836|P3|NOT COMPLETED|Induction Phase||0
24459|NCT01863771|53837|P2|NOT COMPLETED|Induction Phase||0
24460|NCT01863771|53838|P1|NOT COMPLETED|Induction Phase||21
24461|NCT01863771|53835|P4|COMPLETED|Induction Phase||0
24462|NCT01863771|53836|P3|COMPLETED|Induction Phase||0
24463|NCT01863771|53837|P2|COMPLETED|Induction Phase||0
24464|NCT01863771|53838|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
24465|NCT01863771|53835|P4|STARTED|Induction Phase||0
24466|NCT01863771|53836|P3|STARTED|Induction Phase||0
24467|NCT01863771|53837|P2|STARTED|Induction Phase||0
24468|NCT01863771|53838|P1|STARTED|Induction Phase||144
24469|NCT01863680|53850|P1|NOT COMPLETED|Overall Study||57
24470|NCT01863680|53850|P1|COMPLETED|Overall Study||121
24471|NCT01863680|53850|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
24472|NCT01863680|53850|P1|Subjects Received Study Drug|Overall Study||149
24473|NCT01863680|53850|P1|Subjects Received hCG Injection|Overall Study||162
24474|NCT01863680|53850|P1|Subjects Started COS Treatment|Overall Study||169
24475|NCT01863680|53850|P1|STARTED|Overall Study||178
24476|NCT01863667|53858|P2|NOT COMPLETED|Overall Study||32
24477|NCT01863667|53859|P1|NOT COMPLETED|Overall Study||33
24478|NCT01863667|53858|P2|COMPLETED|Overall Study||0
24479|NCT01863667|53859|P1|COMPLETED|Overall Study||0
24480|NCT01863667|53858|P2|STARTED|Overall Study||32
24481|NCT01863667|53859|P1|STARTED|Overall Study||33
24482|NCT01863433|53879|P1|NOT COMPLETED|Overall Study||1
24575|NCT01860534|54045|P1|STARTED|ROP #2||14
24483|NCT01863433|53879|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
24484|NCT01863433|53879|P1|STARTED|Overall Study||120
24485|NCT01863368|53889|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
24486|NCT01863368|53890|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
24487|NCT01863368|53889|P2|COMPLETED|Phase II, Day 35 to Day 90||41
24488|NCT01863368|53890|P1|COMPLETED|Phase II, Day 35 to Day 90||41
24489|NCT01863368|53889|P2|STARTED|Phase II, Day 35 to Day 90||41
24490|NCT01863368|53890|P1|STARTED|Phase II, Day 35 to Day 90||43
24491|NCT01863368|53889|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
24492|NCT01863368|53890|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
24493|NCT01863368|53889|P2|COMPLETED|Phase I, Day 0 to Day 35||41
24494|NCT01863368|53890|P1|COMPLETED|Phase I, Day 0 to Day 35||43
24495|NCT01863368|53889|P2|Treated|Phase I, Day 0 to Day 35||47
24496|NCT01863368|53890|P1|Treated|Phase I, Day 0 to Day 35||46
24497|NCT01863368|53889|P2|STARTED|Phase I, Day 0 to Day 35||48
24498|NCT01863368|53890|P1|STARTED|Phase I, Day 0 to Day 35||46
24499|NCT01863134|53905|P2|NOT COMPLETED|Overall Study||0
24500|NCT01863134|53906|P1|NOT COMPLETED|Overall Study||0
24501|NCT01863134|53905|P2|COMPLETED|Overall Study||68
24502|NCT01863134|53906|P1|COMPLETED|Overall Study||72
24503|NCT01863134|53905|P2|STARTED|Overall Study||68
24504|NCT01863134|53906|P1|STARTED|Overall Study||72
24505|NCT01862484|53914|P2|NOT COMPLETED|Overall Study||8
24506|NCT01862484|53915|P1|NOT COMPLETED|Overall Study||2
24507|NCT01862484|53914|P2|COMPLETED|Overall Study||6
24508|NCT01862484|53915|P1|COMPLETED|Overall Study||13
24509|NCT01862484|53914|P2|STARTED|Overall Study||14
24510|NCT01862484|53915|P1|STARTED|Overall Study||15
24511|NCT01862419|53923|P2|NOT COMPLETED|Overall Study||0
24512|NCT01862419|53924|P1|NOT COMPLETED|Overall Study||0
24513|NCT01862419|53923|P2|COMPLETED|Overall Study||1192
24514|NCT01862419|53924|P1|COMPLETED|Overall Study||1201
24515|NCT01862419|53923|P2|STARTED|Overall Study||1192
24516|NCT01862419|53924|P1|STARTED|Overall Study||1201
24517|NCT01862133|53934|P2|NOT COMPLETED|Overall Study||0
24518|NCT01862133|53935|P1|NOT COMPLETED|Overall Study||0
24519|NCT01862133|53934|P2|COMPLETED|Overall Study||31
24520|NCT01862133|53935|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
24521|NCT01862133|53934|P2|Returned During 6 mo Study|Overall Study||31
24522|NCT01862133|53935|P1|Returned During 6 mo Study|Overall Study||92
24523|NCT01862133|53934|P2|STARTED|Overall Study||31
24524|NCT01862133|53935|P1|STARTED|Overall Study||105
24525|NCT01861925|53944|P3|NOT COMPLETED|Overall Study||0
24526|NCT01861925|53945|P2|NOT COMPLETED|Overall Study||0
24527|NCT01861925|53946|P1|NOT COMPLETED|Overall Study||0
24528|NCT01861925|53944|P3|COMPLETED|Overall Study||8
24529|NCT01861925|53945|P2|COMPLETED|Overall Study||8
24530|NCT01861925|53946|P1|COMPLETED|Overall Study||34
24531|NCT01861925|53944|P3|STARTED|Overall Study||8
24532|NCT01861925|53945|P2|STARTED|Overall Study||8
24533|NCT01861925|53946|P1|STARTED|Overall Study||34
24534|NCT01861704|53969|P2|NOT COMPLETED|Overall Study||3
24535|NCT01861704|53970|P1|NOT COMPLETED|Overall Study||3
24536|NCT01861704|53969|P2|COMPLETED|Overall Study||104
24537|NCT01861704|53970|P1|COMPLETED|Overall Study||67
24538|NCT01861704|53969|P2|STARTED|Overall Study||107
24539|NCT01861704|53970|P1|STARTED|Overall Study||70
24540|NCT01861522|53978|P2|NOT COMPLETED|Overall Study||0
24541|NCT01861522|53979|P1|NOT COMPLETED|Overall Study||3
24542|NCT01861522|53978|P2|COMPLETED|Overall Study||232
24543|NCT01861522|53979|P1|COMPLETED|Overall Study||237
24544|NCT01861522|53978|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
24545|NCT01861522|53979|P1|STARTED|Overall Study||240
24546|NCT01861457|53987|P2|NOT COMPLETED|Overall Study||0
24547|NCT01861457|53988|P1|NOT COMPLETED|Overall Study||0
24548|NCT01861457|53987|P2|COMPLETED|Overall Study||19
24549|NCT01861457|53988|P1|COMPLETED|Overall Study||20
24550|NCT01861457|53987|P2|STARTED|Overall Study||19
24551|NCT01861457|53988|P1|STARTED|Overall Study||20
24552|NCT01861301|53996|P1|NOT COMPLETED|Overall Study||0
24553|NCT01861301|53996|P1|COMPLETED|Overall Study||18
24554|NCT01861301|53996|P1|STARTED|Overall Study||18
24555|NCT01860989|54003|P1|NOT COMPLETED|Overall Study||5
24556|NCT01860989|54003|P1|COMPLETED|Overall Study||6
24557|NCT01860989|54003|P1|STARTED|Overall Study||11
24558|NCT01860703|54007|P4|NOT COMPLETED|Overall Study||2
24559|NCT01860703|54008|P3|NOT COMPLETED|Overall Study||1
24560|NCT01860703|54009|P2|NOT COMPLETED|Overall Study||5
24561|NCT01860703|54010|P1|NOT COMPLETED|Overall Study||2
24562|NCT01860703|54007|P4|COMPLETED|Overall Study||10
24563|NCT01860703|54008|P3|COMPLETED|Overall Study||11
24564|NCT01860703|54009|P2|COMPLETED|Overall Study||8
24565|NCT01860703|54010|P1|COMPLETED|Overall Study||11
24566|NCT01860703|54007|P4|STARTED|Overall Study||12
24567|NCT01860703|54008|P3|STARTED|Overall Study||12
24568|NCT01860703|54009|P2|STARTED|Overall Study||13
24569|NCT01860703|54010|P1|STARTED|Overall Study||13
24570|NCT01860534|54044|P2|NOT COMPLETED|ROP #2||0
24571|NCT01860534|54045|P1|NOT COMPLETED|ROP #2||1
24572|NCT01860534|54044|P2|COMPLETED|ROP #2||13
24573|NCT01860534|54045|P1|COMPLETED|ROP #2||13
24574|NCT01860534|54044|P2|STARTED|ROP #2||13
24576|NCT01860534|54044|P2|NOT COMPLETED|ROP #1||1
24577|NCT01860534|54045|P1|NOT COMPLETED|ROP #1||0
24578|NCT01860534|54044|P2|COMPLETED|ROP #1||13
24579|NCT01860534|54045|P1|COMPLETED|ROP #1||14
24580|NCT01860534|54044|P2|STARTED|ROP #1||14
24581|NCT01860534|54045|P1|STARTED|ROP #1||14
24582|NCT01860521|54059|P2|NOT COMPLETED|Overall Study||0
24583|NCT01860521|54060|P1|NOT COMPLETED|Overall Study||0
24584|NCT01860521|54059|P2|COMPLETED|Overall Study|June 2013|52
24585|NCT01860521|54060|P1|COMPLETED|Overall Study|June 2013|52
24586|NCT01860521|54059|P2|STARTED|Overall Study|September 2011|52
24587|NCT01860521|54060|P1|STARTED|Overall Study|September 2011|52
24588|NCT01860079|54074|P2|NOT COMPLETED|Overall Study||22
24589|NCT01860079|54075|P1|NOT COMPLETED|Overall Study||14
24590|NCT01860079|54074|P2|COMPLETED|Overall Study||363
24591|NCT01860079|54075|P1|COMPLETED|Overall Study||370
24592|NCT01860079|54074|P2|STARTED|Overall Study||385
24593|NCT01860079|54075|P1|STARTED|Overall Study||384
24594|NCT01859949|54083|P2|NOT COMPLETED|Overall Study||17
24595|NCT01859949|54084|P1|NOT COMPLETED|Overall Study||14
24596|NCT01859949|54083|P2|COMPLETED|Overall Study||15
24597|NCT01859949|54084|P1|COMPLETED|Overall Study||15
24598|NCT01859949|54083|P2|STARTED|Overall Study|Treated participants|32
24599|NCT01859949|54084|P1|STARTED|Overall Study|Treated participants|29
24600|NCT01859793|54102|P2|NOT COMPLETED|2nd Intervention Period||0
24601|NCT01859793|54103|P1|NOT COMPLETED|2nd Intervention Period||0
24602|NCT01859793|54102|P2|COMPLETED|2nd Intervention Period||16
24603|NCT01859793|54103|P1|COMPLETED|2nd Intervention Period||14
24604|NCT01859793|54102|P2|STARTED|2nd Intervention Period||16
24605|NCT01859793|54103|P1|STARTED|2nd Intervention Period||14
24606|NCT01859793|54102|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
24607|NCT01859793|54103|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
24608|NCT01859793|54102|P2|COMPLETED|Washout Period (4 Weeks)||16
24609|NCT01859793|54103|P1|COMPLETED|Washout Period (4 Weeks)||14
24610|NCT01859793|54102|P2|STARTED|Washout Period (4 Weeks)||17
24611|NCT01859793|54103|P1|STARTED|Washout Period (4 Weeks)||15
24612|NCT01859793|54102|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
24613|NCT01859793|54103|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
24614|NCT01859793|54102|P2|COMPLETED|First Intervention (8 Weeks)||17
24615|NCT01859793|54103|P1|COMPLETED|First Intervention (8 Weeks)||15
24616|NCT01859793|54102|P2|STARTED|First Intervention (8 Weeks)||18
24617|NCT01859793|54103|P1|STARTED|First Intervention (8 Weeks)||20
24618|NCT01859715|54116|P3|NOT COMPLETED|Overall Study||23
24619|NCT01859715|54117|P2|NOT COMPLETED|Overall Study||8
24620|NCT01859715|54118|P1|NOT COMPLETED|Overall Study||16
24621|NCT01859715|54116|P3|COMPLETED|Overall Study||93
24622|NCT01859715|54117|P2|COMPLETED|Overall Study||83
24623|NCT01859715|54118|P1|COMPLETED|Overall Study||125
24624|NCT01859715|54116|P3|STARTED|Overall Study||116
24625|NCT01859715|54117|P2|STARTED|Overall Study||91
24626|NCT01859715|54118|P1|STARTED|Overall Study||141
24627|NCT01859702|54129|P1|NOT COMPLETED|Overall Study||5
24628|NCT01859702|54129|P1|COMPLETED|Overall Study||31
24629|NCT01859702|54129|P1|STARTED|Overall Study||36
24630|NCT01859637|54133|P1|NOT COMPLETED|Overall Study||0
24631|NCT01859637|54133|P1|COMPLETED|Overall Study||6
24632|NCT01859637|54133|P1|STARTED|Overall Study||6
24633|NCT01859611|54139|P1|NOT COMPLETED|Overall Study||8
24634|NCT01859611|54139|P1|COMPLETED|Overall Study||43
24635|NCT01859611|54139|P1|STARTED|Overall Study||51
24636|NCT01859598|54143|P1|NOT COMPLETED|Visit 3 at 6 Months||912
24637|NCT01859598|54143|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
24638|NCT01859598|54143|P1|STARTED|Visit 3 at 6 Months||17253
24639|NCT01859598|54143|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
24640|NCT01859598|54143|P1|COMPLETED|Visit 2 at 3 Months||17253
24641|NCT01859598|54143|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
24642|NCT01859507|54151|P1|NOT COMPLETED|Overall Study||4
24643|NCT01859507|54151|P1|COMPLETED|Overall Study||28
24644|NCT01859507|54151|P1|STARTED|Overall Study||32
24645|NCT01859494|54156|P1|NOT COMPLETED|Overall Study||1
24646|NCT01859494|54156|P1|COMPLETED|Overall Study||218
24647|NCT01859494|54156|P1|STARTED|Overall Study||219
24648|NCT01859247|54173|P8|NOT COMPLETED|Overall Study||0
24649|NCT01859247|54174|P7|NOT COMPLETED|Overall Study||0
24650|NCT01859247|54175|P6|NOT COMPLETED|Overall Study||0
24651|NCT01859247|54176|P5|NOT COMPLETED|Overall Study||0
24652|NCT01859247|54177|P4|NOT COMPLETED|Overall Study||0
24653|NCT01859247|54178|P3|NOT COMPLETED|Overall Study||0
24654|NCT01859247|54179|P2|NOT COMPLETED|Overall Study||0
24655|NCT01859247|54180|P1|NOT COMPLETED|Overall Study||0
24656|NCT01859247|54173|P8|COMPLETED|Overall Study||1
24657|NCT01859247|54174|P7|COMPLETED|Overall Study||1
24658|NCT01859247|54175|P6|COMPLETED|Overall Study||1
24659|NCT01859247|54176|P5|COMPLETED|Overall Study||1
24660|NCT01859247|54177|P4|COMPLETED|Overall Study||1
24661|NCT01859247|54178|P3|COMPLETED|Overall Study||1
24662|NCT01859247|54179|P2|COMPLETED|Overall Study||1
24663|NCT01859247|54180|P1|COMPLETED|Overall Study||1
24664|NCT01859247|54173|P8|STARTED|Overall Study||1
24665|NCT01859247|54174|P7|STARTED|Overall Study||1
24666|NCT01859247|54175|P6|STARTED|Overall Study||1
24667|NCT01859247|54176|P5|STARTED|Overall Study||1
24668|NCT01859247|54177|P4|STARTED|Overall Study||1
24669|NCT01859247|54178|P3|STARTED|Overall Study||1
24670|NCT01859247|54179|P2|STARTED|Overall Study||1
24671|NCT01859247|54180|P1|STARTED|Overall Study||1
24672|NCT01859143|54207|P2|NOT COMPLETED|Overall Study||0
24673|NCT01859143|54208|P1|NOT COMPLETED|Overall Study||2
24674|NCT01859143|54207|P2|COMPLETED|Overall Study||60
24675|NCT01859143|54208|P1|COMPLETED|Overall Study||238
24676|NCT01859143|54207|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
24677|NCT01859143|54208|P1|STARTED|Overall Study||240
24678|NCT01858766|54241|P19|NOT COMPLETED|Overall Study||4
24679|NCT01858766|54242|P18|NOT COMPLETED|Overall Study||4
24680|NCT01858766|54243|P17|NOT COMPLETED|Overall Study||3
24681|NCT01858766|54244|P16|NOT COMPLETED|Overall Study||6
24682|NCT01858766|54245|P15|NOT COMPLETED|Overall Study||8
24683|NCT01858766|54246|P14|NOT COMPLETED|Overall Study||3
24684|NCT01858766|54247|P13|NOT COMPLETED|Overall Study||5
24685|NCT01858766|54248|P12|NOT COMPLETED|Overall Study||5
24686|NCT01858766|54249|P11|NOT COMPLETED|Overall Study||0
24687|NCT01858766|54250|P10|NOT COMPLETED|Overall Study||0
24688|NCT01858766|54251|P9|NOT COMPLETED|Overall Study||0
24689|NCT01858766|54252|P8|NOT COMPLETED|Overall Study||2
24690|NCT01858766|54253|P7|NOT COMPLETED|Overall Study||0
24691|NCT01858766|54254|P6|NOT COMPLETED|Overall Study||4
24692|NCT01858766|54255|P5|NOT COMPLETED|Overall Study||1
24693|NCT01858766|54256|P4|NOT COMPLETED|Overall Study||0
24694|NCT01858766|54257|P3|NOT COMPLETED|Overall Study||1
24695|NCT01858766|54258|P2|NOT COMPLETED|Overall Study||0
24696|NCT01858766|54259|P1|NOT COMPLETED|Overall Study||1
24697|NCT01858766|54241|P19|COMPLETED|Overall Study||22
24698|NCT01858766|54242|P18|COMPLETED|Overall Study||23
24699|NCT01858766|54243|P17|COMPLETED|Overall Study||22
24700|NCT01858766|54244|P16|COMPLETED|Overall Study||20
24701|NCT01858766|54245|P15|COMPLETED|Overall Study||23
24702|NCT01858766|54246|P14|COMPLETED|Overall Study||26
24703|NCT01858766|54247|P13|COMPLETED|Overall Study||25
24704|NCT01858766|54248|P12|COMPLETED|Overall Study||25
24705|NCT01858766|54249|P11|COMPLETED|Overall Study||5
24706|NCT01858766|54250|P10|COMPLETED|Overall Study||4
24707|NCT01858766|54251|P9|COMPLETED|Overall Study||1
24708|NCT01858766|54252|P8|COMPLETED|Overall Study||5
24709|NCT01858766|54253|P7|COMPLETED|Overall Study||7
24710|NCT01858766|54254|P6|COMPLETED|Overall Study||24
24711|NCT01858766|54255|P5|COMPLETED|Overall Study||26
24712|NCT01858766|54256|P4|COMPLETED|Overall Study||10
24713|NCT01858766|54257|P3|COMPLETED|Overall Study||10
24714|NCT01858766|54258|P2|COMPLETED|Overall Study||28
24715|NCT01858766|54259|P1|COMPLETED|Overall Study||26
24716|NCT01858766|54241|P19|STARTED|Overall Study||26
24717|NCT01858766|54242|P18|STARTED|Overall Study||27
24718|NCT01858766|54243|P17|STARTED|Overall Study||25
24719|NCT01858766|54244|P16|STARTED|Overall Study||26
24720|NCT01858766|54245|P15|STARTED|Overall Study||31
24721|NCT01858766|54246|P14|STARTED|Overall Study||29
24722|NCT01858766|54247|P13|STARTED|Overall Study||30
24723|NCT01858766|54248|P12|STARTED|Overall Study||30
24724|NCT01858766|54249|P11|STARTED|Overall Study||5
24725|NCT01858766|54250|P10|STARTED|Overall Study||4
24726|NCT01858766|54251|P9|STARTED|Overall Study||1
24727|NCT01858766|54252|P8|STARTED|Overall Study||7
24728|NCT01858766|54253|P7|STARTED|Overall Study||7
24729|NCT01858766|54254|P6|STARTED|Overall Study||28
24730|NCT01858766|54255|P5|STARTED|Overall Study||27
24731|NCT01858766|54256|P4|STARTED|Overall Study||10
24732|NCT01858766|54257|P3|STARTED|Overall Study||11
24733|NCT01858766|54258|P2|STARTED|Overall Study||28
24734|NCT01858766|54259|P1|STARTED|Overall Study||27
24735|NCT01858701|54330|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
24736|NCT01858701|54331|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
24737|NCT01858701|54330|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
24738|NCT01858701|54331|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
24739|NCT01858701|54330|P2|STARTED|Period 2, Second 30 Days of Wear||17
24740|NCT01858701|54331|P1|STARTED|Period 2, Second 30 Days of Wear||18
24741|NCT01858701|54330|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
24742|NCT01858701|54331|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
24743|NCT01858701|54330|P2|COMPLETED|Washout Period, 1-13 Days||17
24744|NCT01858701|54331|P1|COMPLETED|Washout Period, 1-13 Days||18
24745|NCT01858701|54330|P2|STARTED|Washout Period, 1-13 Days||19
24746|NCT01858701|54331|P1|STARTED|Washout Period, 1-13 Days||20
24747|NCT01858701|54330|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
24748|NCT01858701|54331|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
24749|NCT01858701|54330|P2|COMPLETED|Period 1, First 30 Days of Wear||19
24750|NCT01858701|54331|P1|COMPLETED|Period 1, First 30 Days of Wear||20
24751|NCT01858701|54330|P2|STARTED|Period 1, First 30 Days of Wear||20
24752|NCT01858701|54331|P1|STARTED|Period 1, First 30 Days of Wear||20
24753|NCT01858636|54337|P1|NOT COMPLETED|Overall Study||28
24754|NCT01858636|54337|P1|COMPLETED|Overall Study||207
24755|NCT01858636|54337|P1|Device Deployment|Overall Study||211
24756|NCT01858636|54337|P1|STARTED|Overall Study|Subjects consented|235
24757|NCT01858376|54342|P1|NOT COMPLETED|Overall Study||4
24758|NCT01858376|54342|P1|COMPLETED|Overall Study||20
24759|NCT01858376|54342|P1|STARTED|Overall Study||24
24760|NCT01857882|54350|P2|NOT COMPLETED|Overall Study||0
24761|NCT01857882|54351|P1|NOT COMPLETED|Overall Study||0
24762|NCT01857882|54350|P2|COMPLETED|Overall Study||20
24763|NCT01857882|54351|P1|COMPLETED|Overall Study||21
24764|NCT01857882|54350|P2|STARTED|Overall Study||20
24765|NCT01857882|54351|P1|STARTED|Overall Study||21
24766|NCT01857713|54357|P1|NOT COMPLETED|Overall Study||6
24767|NCT01857713|54357|P1|COMPLETED|Overall Study||89
24768|NCT01857713|54357|P1|STARTED|Overall Study||95
24769|NCT01857622|54367|P3|NOT COMPLETED|Overall Study||2
24770|NCT01857622|54368|P2|NOT COMPLETED|Overall Study||1
24771|NCT01857622|54369|P1|NOT COMPLETED|Overall Study||11
24772|NCT01857622|54367|P3|COMPLETED|Overall Study||19
24773|NCT01857622|54368|P2|COMPLETED|Overall Study||21
24774|NCT01857622|54369|P1|COMPLETED|Overall Study||39
24775|NCT01857622|54367|P3|STARTED|Overall Study||21
24776|NCT01857622|54368|P2|STARTED|Overall Study||22
24777|NCT01857622|54369|P1|STARTED|Overall Study||50
24778|NCT01857583|54381|P4|NOT COMPLETED|Overall Study||4
24779|NCT01857583|54382|P3|NOT COMPLETED|Overall Study||3
24780|NCT01857583|54383|P2|NOT COMPLETED|Overall Study||1
24781|NCT01857583|54384|P1|NOT COMPLETED|Overall Study||1
24782|NCT01857583|54381|P4|COMPLETED|Overall Study||17
24783|NCT01857583|54382|P3|COMPLETED|Overall Study||19
24784|NCT01857583|54383|P2|COMPLETED|Overall Study||6
24785|NCT01857583|54384|P1|COMPLETED|Overall Study||29
24786|NCT01857583|54381|P4|Safety Analysis Population|Overall Study||20
24787|NCT01857583|54382|P3|Safety Analysis Population|Overall Study||22
24788|NCT01857583|54383|P2|Safety Analysis Population|Overall Study||7
24789|NCT01857583|54384|P1|Safety Analysis Population|Overall Study||30
24790|NCT01857583|54381|P4|STARTED|Overall Study||21
24791|NCT01857583|54382|P3|STARTED|Overall Study||22
24792|NCT01857583|54383|P2|STARTED|Overall Study||7
24793|NCT01857583|54384|P1|STARTED|Overall Study||30
24794|NCT01857531|54394|P1|NOT COMPLETED|Overall Study||4
24795|NCT01857531|54394|P1|COMPLETED|Overall Study||12
24796|NCT01857531|54394|P1|STARTED|Overall Study||16
24797|NCT01857362|54403|P2|NOT COMPLETED|Overall Study||0
24798|NCT01857362|54404|P1|NOT COMPLETED|Overall Study||0
24799|NCT01857362|54403|P2|COMPLETED|Overall Study||6
24800|NCT01857362|54404|P1|COMPLETED|Overall Study||6
24801|NCT01857362|54403|P2|STARTED|Overall Study||6
24802|NCT01857362|54404|P1|STARTED|Overall Study||6
24803|NCT01857323|54412|P1|NOT COMPLETED|Overall Study||64
24804|NCT01857323|54412|P1|COMPLETED|Overall Study||253
24805|NCT01857323|54412|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
24806|NCT01857323|54412|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
24807|NCT01857297|54423|P2|NOT COMPLETED|Overall Study||0
24808|NCT01857297|54424|P1|NOT COMPLETED|Overall Study||0
24809|NCT01857297|54423|P2|COMPLETED|Overall Study||60
24810|NCT01857297|54424|P1|COMPLETED|Overall Study||60
24811|NCT01857297|54423|P2|STARTED|Overall Study||60
24812|NCT01857297|54424|P1|STARTED|Overall Study||60
24813|NCT01857258|54438|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
24814|NCT01857258|54439|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
24815|NCT01857258|54438|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
24816|NCT01857258|54439|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
24817|NCT01857258|54438|P2|STARTED|Second Intervention (3 h Postprandially)||7
24818|NCT01857258|54439|P1|STARTED|Second Intervention (3 h Postprandially)||8
24819|NCT01857258|54438|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
24820|NCT01857258|54439|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
24821|NCT01857258|54438|P2|COMPLETED|Wash-out Period (7 Days)||7
24822|NCT01857258|54439|P1|COMPLETED|Wash-out Period (7 Days)||8
24823|NCT01857258|54438|P2|STARTED|Wash-out Period (7 Days)||7
24824|NCT01857258|54439|P1|STARTED|Wash-out Period (7 Days)||8
24825|NCT01857258|54438|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
24826|NCT01857258|54439|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
24827|NCT01857258|54438|P2|COMPLETED|First Intervention (3 h Postprandially)||7
24828|NCT01857258|54439|P1|COMPLETED|First Intervention (3 h Postprandially)||8
24829|NCT01857258|54438|P2|STARTED|First Intervention (3 h Postprandially)||7
24830|NCT01857258|54439|P1|STARTED|First Intervention (3 h Postprandially)||8
24831|NCT01857206|54461|P2|NOT COMPLETED|Overall Study||10
24832|NCT01857206|54462|P1|NOT COMPLETED|Overall Study||13
24833|NCT01857206|54461|P2|COMPLETED|Overall Study||673
24834|NCT01857206|54462|P1|COMPLETED|Overall Study||1359
24835|NCT01857206|54461|P2|STARTED|Overall Study||683
24836|NCT01857206|54462|P1|STARTED|Overall Study||1372
24837|NCT01857063|54482|P2|NOT COMPLETED|Period 2 (7 Days)||2
24838|NCT01857063|54483|P1|NOT COMPLETED|Period 2 (7 Days)||4
24839|NCT01857063|54482|P2|COMPLETED|Period 2 (7 Days)||104
24840|NCT01857063|54483|P1|COMPLETED|Period 2 (7 Days)||104
24841|NCT01857063|54482|P2|STARTED|Period 2 (7 Days)||106
24842|NCT01857063|54483|P1|STARTED|Period 2 (7 Days)||108
24843|NCT01857063|54482|P2|NOT COMPLETED|Period 1 (7 Days)||4
24844|NCT01857063|54483|P1|NOT COMPLETED|Period 1 (7 Days)||2
24845|NCT01857063|54482|P2|COMPLETED|Period 1 (7 Days)||106
24846|NCT01857063|54483|P1|COMPLETED|Period 1 (7 Days)||108
24847|NCT01857063|54482|P2|STARTED|Period 1 (7 Days)||110
24848|NCT01857063|54483|P1|STARTED|Period 1 (7 Days)||110
24849|NCT01856933|54509|P1|NOT COMPLETED|Overall Study||0
24850|NCT01856933|54509|P1|COMPLETED|Overall Study||6
24851|NCT01856933|54509|P1|STARTED|Overall Study||6
24852|NCT01856764|54515|P2|NOT COMPLETED|Overall Study||0
24853|NCT01856764|54516|P1|NOT COMPLETED|Overall Study||0
24854|NCT01856764|54515|P2|COMPLETED|Overall Study||20
24855|NCT01856764|54516|P1|COMPLETED|Overall Study||20
24856|NCT01856764|54515|P2|STARTED|Overall Study||20
24857|NCT01856764|54516|P1|STARTED|Overall Study||20
24858|NCT01856686|54528|P2|NOT COMPLETED|Overall Study||11
24859|NCT01856686|54529|P1|NOT COMPLETED|Overall Study||5
24860|NCT01856686|54528|P2|COMPLETED|Overall Study||22
24861|NCT01856686|54529|P1|COMPLETED|Overall Study||26
24862|NCT01856686|54528|P2|STARTED|Overall Study||33
24863|NCT01856686|54529|P1|STARTED|Overall Study||31
24864|NCT01856673|54572|P3|NOT COMPLETED|Overall Study||34
24865|NCT01856673|54573|P2|NOT COMPLETED|Overall Study||85
24866|NCT01856673|54574|P1|NOT COMPLETED|Overall Study||98
24867|NCT01856673|54572|P3|COMPLETED|Overall Study||137
24868|NCT01856673|54573|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
24869|NCT01856673|54574|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
24870|NCT01856673|54572|P3|Quibdó Participants|Overall Study||83
24871|NCT01856673|54573|P2|Quibdó Participants|Overall Study||86
24872|NCT01856673|54574|P1|Quibdó Participants|Overall Study||83
24873|NCT01856673|54572|P3|Buenaventura Participants|Overall Study||88
24874|NCT01856673|54573|P2|Buenaventura Participants|Overall Study||89
24875|NCT01856673|54574|P1|Buenaventura Participants|Overall Study||92
24876|NCT01856673|54572|P3|STARTED|Overall Study||171
24877|NCT01856673|54573|P2|STARTED|Overall Study||175
24878|NCT01856673|54574|P1|STARTED|Overall Study||175
24879|NCT01856530|54587|P2|NOT COMPLETED|Overall Study||0
24880|NCT01856530|54588|P1|NOT COMPLETED|Overall Study||0
24881|NCT01856530|54587|P2|COMPLETED|Overall Study||27
24882|NCT01856530|54588|P1|COMPLETED|Overall Study||27
24883|NCT01856530|54587|P2|STARTED|Overall Study||27
24884|NCT01856530|54588|P1|STARTED|Overall Study||27
24885|NCT01856322|54607|P3|NOT COMPLETED|Overall Study||3
24886|NCT01856322|54608|P2|NOT COMPLETED|Overall Study||0
24887|NCT01856322|54609|P1|NOT COMPLETED|Overall Study||0
24888|NCT01856322|54607|P3|COMPLETED|Overall Study||0
24889|NCT01856322|54608|P2|COMPLETED|Overall Study||0
24890|NCT01856322|54609|P1|COMPLETED|Overall Study||0
24891|NCT01856322|54607|P3|STARTED|Overall Study||3
24892|NCT01856322|54608|P2|STARTED|Overall Study||0
24893|NCT01856322|54609|P1|STARTED|Overall Study||0
24894|NCT01855997|54616|P1|NOT COMPLETED|Overall Study||0
24895|NCT01855997|54616|P1|COMPLETED|Overall Study||1669
24896|NCT01855997|54616|P1|STARTED|Overall Study||1669
24897|NCT01855958|54671|P2|NOT COMPLETED|Overall Study||0
24898|NCT01855958|54672|P1|NOT COMPLETED|Overall Study||1
24899|NCT01855958|54671|P2|COMPLETED|Overall Study||13
24900|NCT01855958|54672|P1|COMPLETED|Overall Study||12
24901|NCT01855958|54671|P2|STARTED|Overall Study||13
24902|NCT01855958|54672|P1|STARTED|Overall Study||13
24903|NCT01855945|54702|P12|NOT COMPLETED|Overall Study||3
24904|NCT01855945|54703|P11|NOT COMPLETED|Overall Study||5
24905|NCT01855945|54704|P10|NOT COMPLETED|Overall Study||2
24906|NCT01855945|54705|P9|NOT COMPLETED|Overall Study||2
24907|NCT01855945|54706|P8|NOT COMPLETED|Overall Study||8
24908|NCT01855945|54707|P7|NOT COMPLETED|Overall Study||10
24909|NCT01855945|54708|P6|NOT COMPLETED|Overall Study||3
24910|NCT01855945|54709|P5|NOT COMPLETED|Overall Study||1
24911|NCT01855945|54710|P4|NOT COMPLETED|Overall Study||4
24912|NCT01855945|54711|P3|NOT COMPLETED|Overall Study||12
24913|NCT01855945|54712|P2|NOT COMPLETED|Overall Study||11
24914|NCT01855945|54713|P1|NOT COMPLETED|Overall Study||16
24915|NCT01855945|54702|P12|COMPLETED|Overall Study||49
24916|NCT01855945|54703|P11|COMPLETED|Overall Study||46
24917|NCT01855945|54704|P10|COMPLETED|Overall Study||49
24918|NCT01855945|54705|P9|COMPLETED|Overall Study||46
24919|NCT01855945|54706|P8|COMPLETED|Overall Study||47
24920|NCT01855945|54707|P7|COMPLETED|Overall Study||43
24921|NCT01855945|54708|P6|COMPLETED|Overall Study||50
24922|NCT01855945|54709|P5|COMPLETED|Overall Study||50
24923|NCT01855945|54710|P4|COMPLETED|Overall Study||49
24924|NCT01855945|54711|P3|COMPLETED|Overall Study||39
24925|NCT01855945|54712|P2|COMPLETED|Overall Study||44
24926|NCT01855945|54713|P1|COMPLETED|Overall Study||38
24927|NCT01855945|54702|P12|STARTED|Overall Study||52
24928|NCT01855945|54703|P11|STARTED|Overall Study||51
24929|NCT01855945|54704|P10|STARTED|Overall Study||51
24930|NCT01855945|54705|P9|STARTED|Overall Study||48
24931|NCT01855945|54706|P8|STARTED|Overall Study||55
24932|NCT01855945|54707|P7|STARTED|Overall Study||53
24933|NCT01855945|54708|P6|STARTED|Overall Study||53
24934|NCT01855945|54709|P5|STARTED|Overall Study||51
24935|NCT01855945|54710|P4|STARTED|Overall Study||53
24936|NCT01855945|54711|P3|STARTED|Overall Study||51
24937|NCT01855945|54712|P2|STARTED|Overall Study||55
24938|NCT01855945|54713|P1|STARTED|Overall Study||54
24939|NCT01855919|54849|P2|NOT COMPLETED|Overall Study||26
24940|NCT01855919|54850|P1|NOT COMPLETED|Overall Study||23
24941|NCT01855919|54849|P2|COMPLETED|Overall Study||200
24942|NCT01855919|54850|P1|COMPLETED|Overall Study||209
24943|NCT01855919|54849|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
24944|NCT01855919|54850|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
24945|NCT01855919|54849|P2|STARTED|Overall Study||226
24946|NCT01855919|54850|P1|STARTED|Overall Study||232
24947|NCT01855074|54882|P1|NOT COMPLETED|Overall Study||14
24948|NCT01855074|54882|P1|COMPLETED|Overall Study||66
24949|NCT01855074|54882|P1|Treated|Overall Study||79
24950|NCT01855074|54882|P1|STARTED|Overall Study||80
24951|NCT01854944|54894|P3|NOT COMPLETED|Overall Study||1
24952|NCT01854944|54895|P2|NOT COMPLETED|Overall Study||0
24953|NCT01854944|54896|P1|NOT COMPLETED|Overall Study||0
24954|NCT01854944|54894|P3|COMPLETED|Overall Study||3
24955|NCT01854944|54895|P2|COMPLETED|Overall Study||4
24956|NCT01854944|54896|P1|COMPLETED|Overall Study||4
24957|NCT01854944|54894|P3|STARTED|Overall Study||4
24958|NCT01854944|54895|P2|STARTED|Overall Study||4
24959|NCT01854944|54896|P1|STARTED|Overall Study||4
24960|NCT01854905|54946|P1|NOT COMPLETED|Overall Study||0
24961|NCT01854905|54946|P1|COMPLETED|Overall Study||400
24962|NCT01854905|54946|P1|STARTED|Overall Study||400
24963|NCT01854697|54955|P5|NOT COMPLETED|Overall Study||2
24964|NCT01854697|54956|P4|NOT COMPLETED|Overall Study||3
24965|NCT01854697|54957|P3|NOT COMPLETED|Overall Study||2
24966|NCT01854697|54958|P2|NOT COMPLETED|Overall Study||3
24967|NCT01854697|54959|P1|NOT COMPLETED|Overall Study||6
24968|NCT01854697|54955|P5|COMPLETED|Overall Study||39
24969|NCT01854697|54956|P4|COMPLETED|Overall Study||80
24970|NCT01854697|54957|P3|COMPLETED|Overall Study||82
24971|NCT01854697|54958|P2|COMPLETED|Overall Study||31
24972|NCT01854697|54959|P1|COMPLETED|Overall Study||63
24973|NCT01854697|54955|P5|STARTED|Overall Study||41
24974|NCT01854697|54956|P4|STARTED|Overall Study||83
24975|NCT01854697|54957|P3|STARTED|Overall Study||84
24976|NCT01854697|54958|P2|STARTED|Overall Study||34
24977|NCT01854697|54959|P1|STARTED|Overall Study||69
24978|NCT01854632|55001|P2|NOT COMPLETED|Overall Study||13
24979|NCT01854632|55002|P1|NOT COMPLETED|Overall Study||26
24980|NCT01854632|55001|P2|COMPLETED|Overall Study||574
24981|NCT01854632|55002|P1|COMPLETED|Overall Study||1148
24982|NCT01854632|55001|P2|STARTED|Overall Study||587
24983|NCT01854632|55002|P1|STARTED|Overall Study||1174
24984|NCT01854593|55010|P2|NOT COMPLETED|Overall Study||1
24985|NCT01854593|55011|P1|NOT COMPLETED|Overall Study||2
24986|NCT01854593|55010|P2|COMPLETED|Overall Study||34
24987|NCT01854593|55011|P1|COMPLETED|Overall Study||32
24988|NCT01854593|55010|P2|STARTED|Overall Study||35
24989|NCT01854593|55011|P1|STARTED|Overall Study||34
24990|NCT01854528|55043|P2|NOT COMPLETED|Overall Study||15
24991|NCT01854528|55044|P1|NOT COMPLETED|Overall Study||0
24992|NCT01854528|55043|P2|COMPLETED|Overall Study||32
24993|NCT01854528|55044|P1|COMPLETED|Overall Study||101
24994|NCT01854528|55043|P2|STARTED|Overall Study||47
24995|NCT01854528|55044|P1|STARTED|Overall Study||101
24996|NCT01854281|55064|P4|NOT COMPLETED|Overall Study||0
24997|NCT01854281|55065|P3|NOT COMPLETED|Overall Study||0
24998|NCT01854281|55066|P2|NOT COMPLETED|Overall Study||0
24999|NCT01854281|55067|P1|NOT COMPLETED|Overall Study||0
25000|NCT01854281|55064|P4|COMPLETED|Overall Study||8
25001|NCT01854281|55065|P3|COMPLETED|Overall Study||5
25002|NCT01854281|55066|P2|COMPLETED|Overall Study||19
25003|NCT01854281|55067|P1|COMPLETED|Overall Study||15
25004|NCT01854281|55064|P4|STARTED|Overall Study||8
25005|NCT01854281|55065|P3|STARTED|Overall Study||5
25006|NCT01854281|55066|P2|STARTED|Overall Study||19
25007|NCT01854281|55067|P1|STARTED|Overall Study||15
25008|NCT01854268|55077|P1|NOT COMPLETED|Overall Study||0
25009|NCT01854268|55077|P1|COMPLETED|Overall Study||25
25010|NCT01854268|55077|P1|STARTED|Overall Study||25
25011|NCT01854242|55083|P1|NOT COMPLETED|Overall Study||0
25012|NCT01854242|55083|P1|COMPLETED|Overall Study||50
25013|NCT01854242|55083|P1|STARTED|Overall Study||50
25014|NCT01853982|55089|P2|NOT COMPLETED|Overall Study||1
25015|NCT01853982|55090|P1|NOT COMPLETED|Overall Study||2
25016|NCT01853982|55089|P2|COMPLETED|Overall Study||1
25017|NCT01853982|55090|P1|COMPLETED|Overall Study||0
25018|NCT01853982|55089|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
25019|NCT01853982|55090|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
25020|NCT01853982|55089|P2|STARTED|Overall Study||2
25021|NCT01853982|55090|P1|STARTED|Overall Study||2
25022|NCT01853839|55096|P1|NOT COMPLETED|Overall Study||429
25023|NCT01853839|55096|P1|COMPLETED|Overall Study||1663
25024|NCT01853839|55096|P1|STARTED|Overall Study||2092
25025|NCT01853696|55118|P2|NOT COMPLETED|Overall Study||5
25026|NCT01853696|55119|P1|NOT COMPLETED|Overall Study||6
25027|NCT01853696|55118|P2|COMPLETED|Overall Study||78
25028|NCT01853696|55119|P1|COMPLETED|Overall Study||78
25029|NCT01853696|55118|P2|STARTED|Overall Study||83
25030|NCT01853696|55119|P1|STARTED|Overall Study||84
25031|NCT01853605|55131|P4|NOT COMPLETED|Overall Study||0
25032|NCT01853605|55132|P3|NOT COMPLETED|Overall Study||0
25033|NCT01853605|55133|P2|NOT COMPLETED|Overall Study||0
25034|NCT01853605|55134|P1|NOT COMPLETED|Overall Study||0
25035|NCT01853605|55131|P4|COMPLETED|Overall Study||428
25036|NCT01853605|55132|P3|COMPLETED|Overall Study||751
25037|NCT01853605|55133|P2|COMPLETED|Overall Study||693
25038|NCT01853605|55134|P1|COMPLETED|Overall Study||1939
25039|NCT01853605|55131|P4|STARTED|Overall Study||428
25040|NCT01853605|55132|P3|STARTED|Overall Study||751
25041|NCT01853605|55133|P2|STARTED|Overall Study||693
25042|NCT01853605|55134|P1|STARTED|Overall Study||1939
25043|NCT01853475|55155|P3|NOT COMPLETED|Overall Study||0
25044|NCT01853475|55156|P2|NOT COMPLETED|Overall Study||1
25045|NCT01853475|55157|P1|NOT COMPLETED|Overall Study||0
25046|NCT01853475|55155|P3|COMPLETED|Overall Study||8
25047|NCT01853475|55156|P2|COMPLETED|Overall Study||7
25048|NCT01853475|55157|P1|COMPLETED|Overall Study||8
25049|NCT01853475|55155|P3|STARTED|Overall Study||8
25050|NCT01853475|55156|P2|STARTED|Overall Study||8
25051|NCT01853475|55157|P1|STARTED|Overall Study||8
25052|NCT01853397|55178|P4|NOT COMPLETED|Overall Study||2
25053|NCT01853397|55179|P3|NOT COMPLETED|Overall Study||0
25054|NCT01853397|55180|P2|NOT COMPLETED|Overall Study||0
25055|NCT01853397|55181|P1|NOT COMPLETED|Overall Study||0
25056|NCT01853397|55178|P4|COMPLETED|Overall Study||15
25057|NCT01853397|55179|P3|COMPLETED|Overall Study||17
25058|NCT01853397|55180|P2|COMPLETED|Overall Study||20
25059|NCT01853397|55181|P1|COMPLETED|Overall Study||18
25060|NCT01853397|55178|P4|STARTED|Overall Study||17
25061|NCT01853397|55179|P3|STARTED|Overall Study||17
25062|NCT01853397|55180|P2|STARTED|Overall Study||20
25063|NCT01853397|55181|P1|STARTED|Overall Study||18
25064|NCT01853384|55209|P2|NOT COMPLETED|Completed Follow up Visit 2||3
25065|NCT01853384|55210|P1|NOT COMPLETED|Completed Follow up Visit 2||3
25066|NCT01853384|55209|P2|COMPLETED|Completed Follow up Visit 2||91
25067|NCT01853384|55210|P1|COMPLETED|Completed Follow up Visit 2||93
25068|NCT01853384|55209|P2|STARTED|Completed Follow up Visit 2||94
25069|NCT01853384|55210|P1|STARTED|Completed Follow up Visit 2||96
25070|NCT01853384|55209|P2|NOT COMPLETED|Completed Follow up Visit 1||9
25071|NCT01853384|55210|P1|NOT COMPLETED|Completed Follow up Visit 1||14
25072|NCT01853384|55209|P2|COMPLETED|Completed Follow up Visit 1||85
25073|NCT01853384|55210|P1|COMPLETED|Completed Follow up Visit 1||82
25074|NCT01853384|55209|P2|STARTED|Completed Follow up Visit 1||94
25075|NCT01853384|55210|P1|STARTED|Completed Follow up Visit 1||96
25076|NCT01853384|55209|P2|NOT COMPLETED|Enrolled in Follow up Period||0
25077|NCT01853384|55210|P1|NOT COMPLETED|Enrolled in Follow up Period||0
25078|NCT01853384|55209|P2|COMPLETED|Enrolled in Follow up Period||94
25079|NCT01853384|55210|P1|COMPLETED|Enrolled in Follow up Period||96
25080|NCT01853384|55209|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
25081|NCT01853384|55210|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
25082|NCT01853384|55209|P2|STARTED|Enrolled in Follow up Period||94
25083|NCT01853384|55210|P1|STARTED|Enrolled in Follow up Period||96
25084|NCT01853384|55209|P2|NOT COMPLETED|Randomized||46
25085|NCT01853384|55210|P1|NOT COMPLETED|Randomized||62
25086|NCT01853384|55209|P2|COMPLETED|Randomized||75
25087|NCT01853384|55210|P1|COMPLETED|Randomized||69
25088|NCT01853384|55209|P2|STARTED|Randomized||121
25089|NCT01853384|55210|P1|STARTED|Randomized||131
25090|NCT01853371|55230|P2|NOT COMPLETED|Overall Study||2
25091|NCT01853371|55231|P1|NOT COMPLETED|Overall Study||0
25092|NCT01853371|55230|P2|COMPLETED|Overall Study||8
25093|NCT01853371|55231|P1|COMPLETED|Overall Study||10
25094|NCT01853371|55230|P2|STARTED|Overall Study||10
25095|NCT01853371|55231|P1|STARTED|Overall Study||10
25096|NCT01853254|55239|P1|NOT COMPLETED|Overall Study||104
25097|NCT01853254|55239|P1|COMPLETED|Overall Study||168
25098|NCT01853254|55239|P1|STARTED|Overall Study||272
25099|NCT01853215|55243|P1|NOT COMPLETED|Overall Study||0
25100|NCT01853215|55243|P1|COMPLETED|Overall Study||24
25101|NCT01853215|55243|P1|STARTED|Overall Study||24
25102|NCT01853176|55256|P2|NOT COMPLETED|Overall Study||0
25103|NCT01853176|55257|P1|NOT COMPLETED|Overall Study||4
25104|NCT01853176|55256|P2|COMPLETED|Overall Study||0
25105|NCT01853176|55257|P1|COMPLETED|Overall Study||0
25106|NCT01853176|55256|P2|STARTED|Overall Study||0
25107|NCT01853176|55257|P1|STARTED|Overall Study||4
25108|NCT01853085|55263|P1|NOT COMPLETED|Overall Study||235
25109|NCT01853085|55263|P1|COMPLETED|Overall Study||1595
25110|NCT01853085|55263|P1|STARTED|Overall Study||1830
25111|NCT01853072|55276|P2|NOT COMPLETED|Overall Study||21
25112|NCT01853072|55277|P1|NOT COMPLETED|Overall Study||12
25113|NCT01853072|55276|P2|COMPLETED|Overall Study||286
25114|NCT01853072|55277|P1|COMPLETED|Overall Study||296
25115|NCT01853072|55276|P2|Full Analysis Set|Overall Study||300
25116|NCT01853072|55277|P1|Full Analysis Set|Overall Study||298
25117|NCT01853072|55276|P2|Treated (Safety Analysis Set)|Overall Study||302
25118|NCT01853072|55277|P1|Treated (Safety Analysis Set)|Overall Study||301
25119|NCT01853072|55276|P2|Randomized|Overall Study||307
25120|NCT01853072|55277|P1|Randomized|Overall Study||308
25121|NCT01853072|55276|P2|STARTED|Overall Study||307
25122|NCT01853072|55277|P1|STARTED|Overall Study||308
25123|NCT01852955|55297|P2|NOT COMPLETED|Overall Study||3
25124|NCT01852955|55298|P1|NOT COMPLETED|Overall Study||2
25125|NCT01852955|55297|P2|COMPLETED|Overall Study||32
25126|NCT01852955|55298|P1|COMPLETED|Overall Study||33
25127|NCT01852955|55297|P2|STARTED|Overall Study||35
25128|NCT01852955|55298|P1|STARTED|Overall Study||35
25129|NCT01852825|55311|P3|NOT COMPLETED|Overall Study||0
25130|NCT01852825|55312|P2|NOT COMPLETED|Overall Study||0
25131|NCT01852825|55313|P1|NOT COMPLETED|Overall Study||2
25132|NCT01852825|55311|P3|COMPLETED|Overall Study||3
25133|NCT01852825|55312|P2|COMPLETED|Overall Study||7
25134|NCT01852825|55313|P1|COMPLETED|Overall Study||14
25135|NCT01852825|55311|P3|STARTED|Overall Study||3
25136|NCT01852825|55312|P2|STARTED|Overall Study||7
25137|NCT01852825|55313|P1|STARTED|Overall Study||16
25138|NCT01852812|55339|P3|NOT COMPLETED|Overall Study||1
25139|NCT01852812|55340|P2|NOT COMPLETED|Overall Study||1
25140|NCT01852812|55341|P1|NOT COMPLETED|Overall Study||0
25141|NCT01852812|55339|P3|COMPLETED|Overall Study||17
25142|NCT01852812|55340|P2|COMPLETED|Overall Study||17
25143|NCT01852812|55341|P1|COMPLETED|Overall Study||51
25144|NCT01852812|55339|P3|STARTED|Overall Study||18
25145|NCT01852812|55340|P2|STARTED|Overall Study||18
25146|NCT01852812|55341|P1|STARTED|Overall Study||51
25147|NCT01852669|55363|P2|NOT COMPLETED|Overall Study||1
25148|NCT01852669|55364|P1|NOT COMPLETED|Overall Study||0
25149|NCT01852669|55363|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
25150|NCT01852669|55364|P1|COMPLETED|Overall Study||71
25151|NCT01852669|55363|P2|STARTED|Overall Study||69
25152|NCT01852669|55364|P1|STARTED|Overall Study||71
25153|NCT01852591|55370|P1|NOT COMPLETED|Overall Study||3
25154|NCT01852591|55370|P1|COMPLETED|Overall Study||5
25155|NCT01852591|55370|P1|STARTED|Overall Study||8
25156|NCT01852383|55377|P1|NOT COMPLETED|Overall Study||11
25157|NCT01852383|55377|P1|COMPLETED|Overall Study||19
25158|NCT01852383|55377|P1|STARTED|Overall Study||30
25159|NCT01852214|55384|P2|NOT COMPLETED|Period 2||0
25160|NCT01852214|55385|P1|NOT COMPLETED|Period 2||0
25161|NCT01852214|55384|P2|COMPLETED|Period 2||20
25162|NCT01852214|55385|P1|COMPLETED|Period 2||25
25163|NCT01852214|55384|P2|STARTED|Period 2||20
25164|NCT01852214|55385|P1|STARTED|Period 2||25
25165|NCT01852214|55384|P2|NOT COMPLETED|Washout Period||1
25166|NCT01852214|55385|P1|NOT COMPLETED|Washout Period||0
25167|NCT01852214|55384|P2|COMPLETED|Washout Period||20
25168|NCT01852214|55385|P1|COMPLETED|Washout Period||25
25169|NCT01852214|55384|P2|STARTED|Washout Period||21
25170|NCT01852214|55385|P1|STARTED|Washout Period||25
25171|NCT01852214|55384|P2|NOT COMPLETED|Period 1||3
25172|NCT01852214|55385|P1|NOT COMPLETED|Period 1||1
25173|NCT01852214|55384|P2|COMPLETED|Period 1||21
25174|NCT01852214|55385|P1|COMPLETED|Period 1||25
25175|NCT01852214|55384|P2|STARTED|Period 1||24
25176|NCT01852214|55385|P1|STARTED|Period 1||26
25177|NCT01852175|55399|P2|NOT COMPLETED|Overall Study||0
25178|NCT01852175|55400|P1|NOT COMPLETED|Overall Study||0
25179|NCT01852175|55399|P2|COMPLETED|Overall Study||55
25180|NCT01852175|55400|P1|COMPLETED|Overall Study||55
25181|NCT01852175|55399|P2|STARTED|Overall Study||55
25182|NCT01852175|55400|P1|STARTED|Overall Study||55
25183|NCT01852162|55412|P2|NOT COMPLETED|Overall Study||1
25184|NCT01852162|55413|P1|NOT COMPLETED|Overall Study||4
25185|NCT01852162|55412|P2|COMPLETED|Overall Study||16
25186|NCT01852162|55413|P1|COMPLETED|Overall Study||14
25187|NCT01852162|55412|P2|STARTED|Overall Study||17
25188|NCT01852162|55413|P1|STARTED|Overall Study||18
25189|NCT01852019|55429|P5|NOT COMPLETED|Day 8||0
25190|NCT01852019|55430|P4|NOT COMPLETED|Day 8||0
25191|NCT01852019|55431|P3|NOT COMPLETED|Day 8||0
25192|NCT01852019|55432|P2|NOT COMPLETED|Day 8||0
25193|NCT01852019|55433|P1|NOT COMPLETED|Day 8||0
25194|NCT01852019|55429|P5|COMPLETED|Day 8||6
25195|NCT01852019|55430|P4|COMPLETED|Day 8||6
25196|NCT01852019|55431|P3|COMPLETED|Day 8||0
25197|NCT01852019|55432|P2|COMPLETED|Day 8||0
25198|NCT01852019|55433|P1|COMPLETED|Day 8||0
25199|NCT01852019|55429|P5|STARTED|Day 8||6
25200|NCT01852019|55430|P4|STARTED|Day 8||6
25201|NCT01852019|55431|P3|STARTED|Day 8||0
25202|NCT01852019|55432|P2|STARTED|Day 8||0
25203|NCT01852019|55433|P1|STARTED|Day 8||0
25204|NCT01852019|55429|P5|NOT COMPLETED|Day 1||0
25205|NCT01852019|55430|P4|NOT COMPLETED|Day 1||0
25206|NCT01852019|55431|P3|NOT COMPLETED|Day 1||0
25207|NCT01852019|55432|P2|NOT COMPLETED|Day 1||0
25208|NCT01852019|55433|P1|NOT COMPLETED|Day 1||0
25209|NCT01852019|55429|P5|COMPLETED|Day 1||0
25210|NCT01852019|55430|P4|COMPLETED|Day 1||0
25211|NCT01852019|55431|P3|COMPLETED|Day 1||6
25212|NCT01852019|55432|P2|COMPLETED|Day 1||3
25213|NCT01852019|55433|P1|COMPLETED|Day 1||3
25214|NCT01852019|55429|P5|STARTED|Day 1||0
25215|NCT01852019|55430|P4|STARTED|Day 1||0
25216|NCT01852019|55431|P3|STARTED|Day 1||6
25217|NCT01852019|55432|P2|STARTED|Day 1||3
25218|NCT01852019|55433|P1|STARTED|Day 1||3
25219|NCT01851876|55454|P2|NOT COMPLETED|Overall Study||0
25220|NCT01851876|55455|P1|NOT COMPLETED|Overall Study||0
25221|NCT01851876|55454|P2|COMPLETED|Overall Study||62
25222|NCT01851876|55455|P1|COMPLETED|Overall Study||56
25223|NCT01851876|55454|P2|STARTED|Overall Study||62
25224|NCT01851876|55455|P1|STARTED|Overall Study||56
25225|NCT01851863|55465|P4|NOT COMPLETED|Overall Study||3
25226|NCT01851863|55466|P3|NOT COMPLETED|Overall Study||5
25227|NCT01851863|55467|P2|NOT COMPLETED|Overall Study||9
25228|NCT01851863|55468|P1|NOT COMPLETED|Overall Study||5
25229|NCT01851863|55465|P4|COMPLETED|Overall Study||63
25230|NCT01851863|55466|P3|COMPLETED|Overall Study||60
25231|NCT01851863|55467|P2|COMPLETED|Overall Study||57
25232|NCT01851863|55468|P1|COMPLETED|Overall Study||60
25233|NCT01851863|55465|P4|STARTED|Overall Study||66
25234|NCT01851863|55466|P3|STARTED|Overall Study||65
25235|NCT01851863|55467|P2|STARTED|Overall Study||66
25236|NCT01851863|55468|P1|STARTED|Overall Study||65
25237|NCT01851772|55489|P1|NOT COMPLETED|Overall Study||0
25238|NCT01851772|55489|P1|COMPLETED|Overall Study||3
25239|NCT01851772|55489|P1|STARTED|Overall Study||3
25240|NCT01851655|55497|P2|NOT COMPLETED|Overall Study||0
25241|NCT01851655|55498|P1|NOT COMPLETED|Overall Study||0
25242|NCT01851655|55497|P2|COMPLETED|Overall Study||12
25243|NCT01851655|55498|P1|COMPLETED|Overall Study||12
25244|NCT01851655|55497|P2|STARTED|Overall Study||12
25245|NCT01851655|55498|P1|STARTED|Overall Study||12
25246|NCT01851590|55519|P3|NOT COMPLETED|Overall Study||3
25247|NCT01851590|55520|P2|NOT COMPLETED|Overall Study||1
25248|NCT01851590|55521|P1|NOT COMPLETED|Overall Study||0
25249|NCT01851590|55519|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
25250|NCT01851590|55520|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
25251|NCT01851590|55521|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
25252|NCT01851590|55519|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
25253|NCT01851590|55520|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
25254|NCT01851590|55521|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
25255|NCT01851590|55519|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
25256|NCT01851590|55520|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
25257|NCT01851590|55521|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
25258|NCT01851590|55519|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
25259|NCT01851590|55520|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
25260|NCT01851590|55521|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
25261|NCT01851590|55519|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
25262|NCT01851590|55520|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
25263|NCT01851590|55521|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
25264|NCT01851590|55519|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
25265|NCT01851590|55520|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
25266|NCT01851590|55521|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
25267|NCT01851330|55544|P3|NOT COMPLETED|Overall Study||12
25268|NCT01851330|55545|P2|NOT COMPLETED|Overall Study||16
25269|NCT01851330|55546|P1|NOT COMPLETED|Overall Study||13
25270|NCT01851330|55544|P3|COMPLETED|Overall Study||204
25271|NCT01851330|55545|P2|COMPLETED|Overall Study||200
25272|NCT01851330|55546|P1|COMPLETED|Overall Study||202
25273|NCT01851330|55544|P3|STARTED|Overall Study||216
25274|NCT01851330|55545|P2|STARTED|Overall Study||216
25275|NCT01851330|55546|P1|STARTED|Overall Study||215
25276|NCT01849562|55584|P3|NOT COMPLETED|Overall Study||0
25277|NCT01849562|55585|P2|NOT COMPLETED|Overall Study||0
25278|NCT01849562|55586|P1|NOT COMPLETED|Overall Study||2
25279|NCT01849562|55584|P3|COMPLETED|Overall Study||10
25280|NCT01849562|55585|P2|COMPLETED|Overall Study||10
25281|NCT01849562|55586|P1|COMPLETED|Overall Study||8
25282|NCT01849562|55584|P3|STARTED|Overall Study||10
25283|NCT01849562|55585|P2|STARTED|Overall Study||10
25284|NCT01849562|55586|P1|STARTED|Overall Study||10
25285|NCT01850589|55599|P2|NOT COMPLETED|Overall Study||0
25286|NCT01850589|55600|P1|NOT COMPLETED|Overall Study||8
25287|NCT01850589|55599|P2|COMPLETED|Overall Study||22
25288|NCT01850589|55600|P1|COMPLETED|Overall Study||14
25289|NCT01850589|55599|P2|STARTED|Overall Study||22
25290|NCT01850589|55600|P1|STARTED|Overall Study||22
25291|NCT01850550|55608|P2|NOT COMPLETED|Overall Study||3
25292|NCT01850550|55609|P1|NOT COMPLETED|Overall Study||0
25293|NCT01850550|55608|P2|COMPLETED|Overall Study||37
25294|NCT01850550|55609|P1|COMPLETED|Overall Study||40
25295|NCT01850550|55608|P2|STARTED|Overall Study||40
25296|NCT01850550|55609|P1|STARTED|Overall Study||40
25297|NCT01850485|55619|P2|NOT COMPLETED|Overall Study||0
25298|NCT01850485|55620|P1|NOT COMPLETED|Overall Study||0
25299|NCT01850485|55619|P2|COMPLETED|Overall Study||13
25300|NCT01850485|55620|P1|COMPLETED|Overall Study||9
25301|NCT01850485|55619|P2|STARTED|Overall Study||13
25302|NCT01850485|55620|P1|STARTED|Overall Study||9
25303|NCT01850394|55641|P3|NOT COMPLETED|Overall Study||0
25304|NCT01850394|55642|P2|NOT COMPLETED|Overall Study||0
25305|NCT01850394|55643|P1|NOT COMPLETED|Overall Study||0
25306|NCT01850394|55641|P3|COMPLETED|Overall Study||45
25307|NCT01850394|55642|P2|COMPLETED|Overall Study||45
25308|NCT01850394|55643|P1|COMPLETED|Overall Study||45
25309|NCT01850394|55641|P3|STARTED|Overall Study||45
25310|NCT01850394|55642|P2|STARTED|Overall Study||45
25311|NCT01850394|55643|P1|STARTED|Overall Study||45
25312|NCT01849848|55663|P1|NOT COMPLETED|Overall Study||4
25313|NCT01849848|55663|P1|COMPLETED|Overall Study||13
25314|NCT01849848|55663|P1|STARTED|Overall Study||17
25315|NCT01849770|55680|P3|NOT COMPLETED|Overall Study||1
25316|NCT01849770|55681|P2|NOT COMPLETED|Overall Study||4
25317|NCT01849770|55682|P1|NOT COMPLETED|Overall Study||0
25318|NCT01849770|55680|P3|COMPLETED|Overall Study||19
25319|NCT01849770|55681|P2|COMPLETED|Overall Study||15
25320|NCT01849770|55682|P1|COMPLETED|Overall Study||20
25321|NCT01849770|55680|P3|STARTED|Overall Study||20
25322|NCT01849770|55681|P2|STARTED|Overall Study||19
25323|NCT01849770|55682|P1|STARTED|Overall Study||20
25324|NCT01849692|55725|P8|NOT COMPLETED|Overall Study||0
25325|NCT01849692|55726|P7|NOT COMPLETED|Overall Study||0
25326|NCT01849692|55727|P6|NOT COMPLETED|Overall Study||0
25327|NCT01849692|55728|P5|NOT COMPLETED|Overall Study||0
25328|NCT01849692|55729|P4|NOT COMPLETED|Overall Study||0
25329|NCT01849692|55730|P3|NOT COMPLETED|Overall Study||0
25330|NCT01849692|55731|P2|NOT COMPLETED|Overall Study||0
25331|NCT01849692|55732|P1|NOT COMPLETED|Overall Study||0
25332|NCT01849692|55725|P8|COMPLETED|Overall Study||3
25333|NCT01849692|55726|P7|COMPLETED|Overall Study||10
25334|NCT01849692|55727|P6|COMPLETED|Overall Study||3
25335|NCT01849692|55728|P5|COMPLETED|Overall Study||10
25336|NCT01849692|55729|P4|COMPLETED|Overall Study||3
25337|NCT01849692|55730|P3|COMPLETED|Overall Study||10
25338|NCT01849692|55731|P2|COMPLETED|Overall Study||3
25339|NCT01849692|55732|P1|COMPLETED|Overall Study||10
25340|NCT01849692|55725|P8|STARTED|Overall Study||3
25341|NCT01849692|55726|P7|STARTED|Overall Study||10
25342|NCT01849692|55727|P6|STARTED|Overall Study||3
25343|NCT01849692|55728|P5|STARTED|Overall Study||10
25344|NCT01849692|55729|P4|STARTED|Overall Study||3
25345|NCT01849692|55730|P3|STARTED|Overall Study||10
25346|NCT01849692|55731|P2|STARTED|Overall Study||3
25347|NCT01849692|55732|P1|STARTED|Overall Study||10
25348|NCT01849497|55763|P2|NOT COMPLETED|Overall Study||4
25349|NCT01849497|55764|P1|NOT COMPLETED|Overall Study||1
25350|NCT01849497|55763|P2|COMPLETED|Overall Study||70
25351|NCT01849497|55764|P1|COMPLETED|Overall Study||74
25352|NCT01849497|55763|P2|Received Treatment|Overall Study||74
25353|NCT01849497|55764|P1|Received Treatment|Overall Study||75
25354|NCT01849497|55763|P2|STARTED|Overall Study||74
25355|NCT01849497|55764|P1|STARTED|Overall Study||75
25356|NCT01849419|55772|P1|NOT COMPLETED|Overall Study||0
25357|NCT01849419|55772|P1|COMPLETED|Overall Study||65
25358|NCT01849419|55772|P1|STARTED|Overall Study||65
25359|NCT01849289|55801|P2|NOT COMPLETED|Overall Study||24
25360|NCT01849289|55802|P1|NOT COMPLETED|Overall Study||32
25361|NCT01849289|55801|P2|COMPLETED|Overall Study||254
25362|NCT01849289|55802|P1|COMPLETED|Overall Study||523
25363|NCT01849289|55801|P2|Exposed|Overall Study||278
25364|NCT01849289|55802|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
25365|NCT01849289|55801|P2|STARTED|Overall Study||278
25366|NCT01849289|55802|P1|STARTED|Overall Study||555
25367|NCT01849068|55820|P2|NOT COMPLETED|Overall Study||0
25368|NCT01849068|55821|P1|NOT COMPLETED|Overall Study||0
25369|NCT01849068|55820|P2|COMPLETED|Overall Study||10
25370|NCT01849068|55821|P1|COMPLETED|Overall Study||10
25371|NCT01849068|55820|P2|STARTED|Overall Study||10
25372|NCT01849068|55821|P1|STARTED|Overall Study||10
25373|NCT01848990|55836|P3|NOT COMPLETED|Overall Study||11
25374|NCT01848990|55837|P2|NOT COMPLETED|Overall Study||9
25375|NCT01848990|55838|P1|NOT COMPLETED|Overall Study||33
25376|NCT01848990|55836|P3|COMPLETED|Overall Study||103
25377|NCT01848990|55837|P2|COMPLETED|Overall Study||106
25378|NCT01848990|55838|P1|COMPLETED|Overall Study||194
25379|NCT01848990|55836|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
25380|NCT01848990|55837|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
25381|NCT01848990|55838|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
25382|NCT01848990|55836|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
25383|NCT01848990|55837|P2|STARTED|Overall Study||115
25384|NCT01848990|55838|P1|STARTED|Overall Study||227
25385|NCT01848977|55853|P1|NOT COMPLETED|Overall Study||0
25386|NCT01848977|55853|P1|COMPLETED|Overall Study||20
25387|NCT01848977|55853|P1|STARTED|Overall Study||20
25388|NCT01848938|55864|P2|NOT COMPLETED|Overall Study||1
25389|NCT01848938|55865|P1|NOT COMPLETED|Overall Study||1
25390|NCT01848938|55864|P2|COMPLETED|Overall Study||60
25391|NCT01848938|55865|P1|COMPLETED|Overall Study||61
25392|NCT01848938|55864|P2|STARTED|Overall Study||61
25393|NCT01848938|55865|P1|STARTED|Overall Study||62
25394|NCT01848899|55883|P2|NOT COMPLETED|Overall Study||0
25395|NCT01848899|55884|P1|NOT COMPLETED|Overall Study||0
25396|NCT01848899|55883|P2|COMPLETED|Overall Study||50
25397|NCT01848899|55884|P1|COMPLETED|Overall Study||50
25398|NCT01848899|55883|P2|STARTED|Overall Study||50
25399|NCT01848899|55884|P1|STARTED|Overall Study||50
25400|NCT01848847|55900|P2|NOT COMPLETED|Overall Study||3
25401|NCT01848847|55901|P1|NOT COMPLETED|Overall Study||2
25402|NCT01848847|55900|P2|COMPLETED|Overall Study||48
25403|NCT01848847|55901|P1|COMPLETED|Overall Study||49
25404|NCT01848847|55900|P2|STARTED|Overall Study||51
25405|NCT01848847|55901|P1|STARTED|Overall Study||51
25406|NCT01848756|55909|P1|NOT COMPLETED|Overall Study||3
25407|NCT01848756|55909|P1|COMPLETED|Overall Study|Cycle 1|12
25408|NCT01848756|55909|P1|STARTED|Overall Study||15
25409|NCT01848366|55919|P1|NOT COMPLETED|Overall Study||0
25410|NCT01848366|55919|P1|COMPLETED|Overall Study||8
25411|NCT01848366|55919|P1|STARTED|Overall Study||8
25412|NCT01848288|55923|P1|NOT COMPLETED|Overall Study||3
25413|NCT01848288|55923|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
25414|NCT01848288|55923|P1|STARTED|Overall Study||100
25415|NCT01848210|55934|P2|NOT COMPLETED|Overall Study||78
25416|NCT01848210|55935|P1|NOT COMPLETED|Overall Study||88
25417|NCT01848210|55934|P2|COMPLETED|Overall Study||340
25418|NCT01848210|55935|P1|COMPLETED|Overall Study||323
25419|NCT01848210|55934|P2|Per Protocol Population|Overall Study||245
25420|NCT01848210|55935|P1|Per Protocol Population|Overall Study||222
25421|NCT01848210|55934|P2|Intent-to-Treat (ITT) Population|Overall Study||388
25422|NCT01848210|55935|P1|Intent-to-Treat (ITT) Population|Overall Study||383
25423|NCT01848210|55934|P2|Safety Population-Received Study Drug|Overall Study||398
25424|NCT01848210|55935|P1|Safety Population-Received Study Drug|Overall Study||394
25425|NCT01848210|55934|P2|STARTED|Overall Study||418
25426|NCT01848210|55935|P1|STARTED|Overall Study||411
25427|NCT01848054|55949|P2|NOT COMPLETED|Stabilization/Maintenance||40
25428|NCT01848054|55950|P1|NOT COMPLETED|Stabilization/Maintenance||40
25429|NCT01848054|55949|P2|COMPLETED|Stabilization/Maintenance||107
25430|NCT01848054|55950|P1|COMPLETED|Stabilization/Maintenance||92
25431|NCT01848054|55949|P2|STARTED|Stabilization/Maintenance||147
25432|NCT01848054|55950|P1|STARTED|Stabilization/Maintenance||132
25433|NCT01848054|55949|P2|NOT COMPLETED|Induction Phase||8
25434|NCT01848054|55950|P1|NOT COMPLETED|Induction Phase||23
25435|NCT01848054|55949|P2|COMPLETED|Induction Phase||147
25436|NCT01848054|55950|P1|COMPLETED|Induction Phase||132
25437|NCT01848054|55949|P2|STARTED|Induction Phase||155
25438|NCT01848054|55950|P1|STARTED|Induction Phase||155
25439|NCT01847547|55972|P2|NOT COMPLETED|Overall Study||0
25440|NCT01847547|55973|P1|NOT COMPLETED|Overall Study||0
25441|NCT01847547|55972|P2|COMPLETED|Overall Study||2991
25442|NCT01847547|55973|P1|COMPLETED|Overall Study||2991
25443|NCT01847547|55972|P2|STARTED|Overall Study||2991
25444|NCT01847547|55973|P1|STARTED|Overall Study||2991
25445|NCT01847443|56015|P4|NOT COMPLETED|Study Period 4||0
25446|NCT01847443|56016|P3|NOT COMPLETED|Study Period 4||0
25447|NCT01847443|56017|P2|NOT COMPLETED|Study Period 4||0
25448|NCT01847443|56018|P1|NOT COMPLETED|Study Period 4||0
25449|NCT01847443|56015|P4|COMPLETED|Study Period 4||21
25450|NCT01847443|56016|P3|COMPLETED|Study Period 4||21
25451|NCT01847443|56017|P2|COMPLETED|Study Period 4||19
25452|NCT01847443|56018|P1|COMPLETED|Study Period 4||16
25453|NCT01847443|56015|P4|STARTED|Study Period 4||21
25454|NCT01847443|56016|P3|STARTED|Study Period 4||21
25455|NCT01847443|56017|P2|STARTED|Study Period 4||19
25456|NCT01847443|56018|P1|STARTED|Study Period 4||16
25457|NCT01847443|56015|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
25458|NCT01847443|56016|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
25459|NCT01847443|56017|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
25460|NCT01847443|56018|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
25461|NCT01847443|56015|P4|COMPLETED|Washout Period Before Study Period 4||21
25462|NCT01847443|56016|P3|COMPLETED|Washout Period Before Study Period 4||21
25463|NCT01847443|56017|P2|COMPLETED|Washout Period Before Study Period 4||19
25464|NCT01847443|56018|P1|COMPLETED|Washout Period Before Study Period 4||16
25465|NCT01847443|56015|P4|STARTED|Washout Period Before Study Period 4||21
25466|NCT01847443|56016|P3|STARTED|Washout Period Before Study Period 4||21
25467|NCT01847443|56017|P2|STARTED|Washout Period Before Study Period 4||19
25468|NCT01847443|56018|P1|STARTED|Washout Period Before Study Period 4||18
25469|NCT01847443|56015|P4|NOT COMPLETED|Study Period 3||0
25470|NCT01847443|56016|P3|NOT COMPLETED|Study Period 3||0
25471|NCT01847443|56017|P2|NOT COMPLETED|Study Period 3||0
25472|NCT01847443|56018|P1|NOT COMPLETED|Study Period 3||0
25473|NCT01847443|56015|P4|COMPLETED|Study Period 3||21
25474|NCT01847443|56016|P3|COMPLETED|Study Period 3||21
25475|NCT01847443|56017|P2|COMPLETED|Study Period 3||19
25476|NCT01847443|56018|P1|COMPLETED|Study Period 3||18
25477|NCT01847443|56015|P4|STARTED|Study Period 3||21
25478|NCT01847443|56016|P3|STARTED|Study Period 3||21
25479|NCT01847443|56017|P2|STARTED|Study Period 3||19
25480|NCT01847443|56018|P1|STARTED|Study Period 3||18
25481|NCT01847443|56015|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
25482|NCT01847443|56016|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
25483|NCT01847443|56017|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
25484|NCT01847443|56018|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
25485|NCT01847443|56015|P4|COMPLETED|Washout Period Before Study Period 3||21
25486|NCT01847443|56016|P3|COMPLETED|Washout Period Before Study Period 3||21
25487|NCT01847443|56017|P2|COMPLETED|Washout Period Before Study Period 3||19
25488|NCT01847443|56018|P1|COMPLETED|Washout Period Before Study Period 3||18
25489|NCT01847443|56015|P4|STARTED|Washout Period Before Study Period 3||21
25490|NCT01847443|56016|P3|STARTED|Washout Period Before Study Period 3||21
25491|NCT01847443|56017|P2|STARTED|Washout Period Before Study Period 3||19
25492|NCT01847443|56018|P1|STARTED|Washout Period Before Study Period 3||19
25493|NCT01847443|56015|P4|NOT COMPLETED|Study Period 2||0
25494|NCT01847443|56016|P3|NOT COMPLETED|Study Period 2||0
25495|NCT01847443|56017|P2|NOT COMPLETED|Study Period 2||0
25496|NCT01847443|56018|P1|NOT COMPLETED|Study Period 2||0
25497|NCT01847443|56015|P4|COMPLETED|Study Period 2||21
25498|NCT01847443|56016|P3|COMPLETED|Study Period 2||21
25499|NCT01847443|56017|P2|COMPLETED|Study Period 2||19
25500|NCT01847443|56018|P1|COMPLETED|Study Period 2||19
25501|NCT01847443|56015|P4|STARTED|Study Period 2||21
25502|NCT01847443|56016|P3|STARTED|Study Period 2||21
25503|NCT01847443|56017|P2|STARTED|Study Period 2||19
25504|NCT01847443|56018|P1|STARTED|Study Period 2||19
25505|NCT01847443|56015|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
25506|NCT01847443|56016|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
25507|NCT01847443|56017|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
25508|NCT01847443|56018|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
25509|NCT01847443|56015|P4|COMPLETED|Washout Period Before Study Period 2||21
25510|NCT01847443|56016|P3|COMPLETED|Washout Period Before Study Period 2||21
25511|NCT01847443|56017|P2|COMPLETED|Washout Period Before Study Period 2||19
25512|NCT01847443|56018|P1|COMPLETED|Washout Period Before Study Period 2||19
25513|NCT01847443|56015|P4|STARTED|Washout Period Before Study Period 2||21
25514|NCT01847443|56016|P3|STARTED|Washout Period Before Study Period 2||21
25515|NCT01847443|56017|P2|STARTED|Washout Period Before Study Period 2||20
25516|NCT01847443|56018|P1|STARTED|Washout Period Before Study Period 2||21
25517|NCT01847443|56015|P4|NOT COMPLETED|Study Period 1||0
25518|NCT01847443|56016|P3|NOT COMPLETED|Study Period 1||0
25519|NCT01847443|56017|P2|NOT COMPLETED|Study Period 1||1
25520|NCT01847443|56018|P1|NOT COMPLETED|Study Period 1||0
25521|NCT01847443|56015|P4|COMPLETED|Study Period 1||21
25522|NCT01847443|56016|P3|COMPLETED|Study Period 1||21
25523|NCT01847443|56017|P2|COMPLETED|Study Period 1||20
25524|NCT01847443|56018|P1|COMPLETED|Study Period 1||21
25525|NCT01847443|56015|P4|STARTED|Study Period 1||21
25526|NCT01847443|56016|P3|STARTED|Study Period 1||21
25527|NCT01847443|56017|P2|STARTED|Study Period 1||21
25528|NCT01847443|56018|P1|STARTED|Study Period 1||21
25529|NCT01847430|56048|P1|NOT COMPLETED|Overall Study||0
25530|NCT01847430|56048|P1|COMPLETED|Overall Study||302
25531|NCT01847430|56048|P1|STARTED|Overall Study||302
25532|NCT01847196|56059|P1|NOT COMPLETED|Overall Study||0
25533|NCT01847196|56059|P1|COMPLETED|Overall Study||5
25534|NCT01847196|56059|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
25535|NCT01847131|56066|P2|NOT COMPLETED|Overall Study||0
25536|NCT01847131|56067|P1|NOT COMPLETED|Overall Study||0
25537|NCT01847131|56066|P2|COMPLETED|Overall Study||25
25538|NCT01847131|56067|P1|COMPLETED|Overall Study||25
25539|NCT01847131|56066|P2|STARTED|Overall Study||25
25540|NCT01847131|56067|P1|STARTED|Overall Study||25
25541|NCT01846741|56075|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
25542|NCT01846741|56075|P1|COMPLETED|Implantation to 18-Month/End of Study||20
25543|NCT01846741|56075|P1|STARTED|Implantation to 18-Month/End of Study||20
25544|NCT01846741|56075|P1|NOT COMPLETED|Baseline Visit||2
25545|NCT01846741|56075|P1|COMPLETED|Baseline Visit||20
25546|NCT01846741|56075|P1|STARTED|Baseline Visit||22
25547|NCT01846455|56136|P5|NOT COMPLETED|Overall Study||0
25548|NCT01846455|56137|P4|NOT COMPLETED|Overall Study||0
25549|NCT01846455|56138|P3|NOT COMPLETED|Overall Study||0
25550|NCT01846455|56139|P2|NOT COMPLETED|Overall Study||0
25551|NCT01846455|56140|P1|NOT COMPLETED|Overall Study||0
25552|NCT01846455|56136|P5|COMPLETED|Overall Study||8
25553|NCT01846455|56137|P4|COMPLETED|Overall Study||10
25554|NCT01846455|56138|P3|COMPLETED|Overall Study||8
25555|NCT01846455|56139|P2|COMPLETED|Overall Study||8
25556|NCT01846455|56140|P1|COMPLETED|Overall Study||9
25557|NCT01846455|56136|P5|PK Population|Overall Study||8
25558|NCT01846455|56137|P4|PK Population|Overall Study||6
25559|NCT01846455|56138|P3|PK Population|Overall Study||6
25560|NCT01846455|56139|P2|PK Population|Overall Study||7
25561|NCT01846455|56140|P1|PK Population|Overall Study||6
25562|NCT01846455|56136|P5|STARTED|Overall Study||8
25563|NCT01846455|56137|P4|STARTED|Overall Study||10
25564|NCT01846455|56138|P3|STARTED|Overall Study||8
25565|NCT01846455|56139|P2|STARTED|Overall Study||8
25566|NCT01846455|56140|P1|STARTED|Overall Study||9
25567|NCT01846416|56200|P3|NOT COMPLETED|Overall Study||13
25568|NCT01846416|56201|P2|NOT COMPLETED|Overall Study||93
25569|NCT01846416|56202|P1|NOT COMPLETED|Overall Study||31
25570|NCT01846416|56200|P3|COMPLETED|Overall Study||0
25571|NCT01846416|56201|P2|COMPLETED|Overall Study||0
25572|NCT01846416|56202|P1|COMPLETED|Overall Study||0
25573|NCT01846416|56200|P3|STARTED|Overall Study||13
25574|NCT01846416|56201|P2|STARTED|Overall Study||93
25575|NCT01846416|56202|P1|STARTED|Overall Study||31
25576|NCT01846299|56247|P2|NOT COMPLETED|Overall Study||10
25577|NCT01846299|56248|P1|NOT COMPLETED|Overall Study||12
25578|NCT01846299|56247|P2|COMPLETED|Overall Study||50
25579|NCT01846299|56248|P1|COMPLETED|Overall Study||106
25580|NCT01846299|56247|P2|Safety Set|Overall Study||58
25581|NCT01846299|56248|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
25582|NCT01846299|56247|P2|Full Analysis Set|Overall Study||60
25583|NCT01846299|56248|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
25584|NCT01846299|56247|P2|STARTED|Overall Study||60
25585|NCT01846299|56248|P1|STARTED|Overall Study||118
25586|NCT01846104|56284|P1|NOT COMPLETED|Overall Study||1
25587|NCT01846104|56284|P1|COMPLETED|Overall Study||3
25588|NCT01846104|56284|P1|STARTED|Overall Study||4
25589|NCT01846039|56290|P1|NOT COMPLETED|Overall Study||2
25590|NCT01846039|56290|P1|COMPLETED|Overall Study||27
25591|NCT01846039|56290|P1|STARTED|Overall Study||29
25592|NCT01845155|56302|P2|NOT COMPLETED|Overall Study||0
25593|NCT01845155|56303|P1|NOT COMPLETED|Overall Study||1
25594|NCT01845155|56302|P2|COMPLETED|Overall Study||144
25595|NCT01845155|56303|P1|COMPLETED|Overall Study||145
25596|NCT01845155|56302|P2|STARTED|Overall Study||144
25597|NCT01845155|56303|P1|STARTED|Overall Study||146
25598|NCT01845103|56311|P1|NOT COMPLETED|Overall Study||0
25599|NCT01845103|56311|P1|COMPLETED|Overall Study||1
25600|NCT01845103|56311|P1|STARTED|Overall Study||1
25601|NCT01845077|56319|P6|NOT COMPLETED|Treatment Period 2||0
25602|NCT01845077|56320|P5|NOT COMPLETED|Treatment Period 2||0
25603|NCT01845077|56321|P4|NOT COMPLETED|Treatment Period 2||0
25604|NCT01845077|56322|P3|NOT COMPLETED|Treatment Period 2||0
25605|NCT01845077|56323|P2|NOT COMPLETED|Treatment Period 2||0
25606|NCT01845077|56324|P1|NOT COMPLETED|Treatment Period 2||0
25607|NCT01845077|56319|P6|COMPLETED|Treatment Period 2||11
25608|NCT01845077|56320|P5|COMPLETED|Treatment Period 2||11
25609|NCT01845077|56321|P4|COMPLETED|Treatment Period 2||10
25610|NCT01845077|56322|P3|COMPLETED|Treatment Period 2||11
25611|NCT01845077|56323|P2|COMPLETED|Treatment Period 2||11
25612|NCT01845077|56324|P1|COMPLETED|Treatment Period 2||11
25613|NCT01845077|56319|P6|STARTED|Treatment Period 2||11
25614|NCT01845077|56320|P5|STARTED|Treatment Period 2||11
25615|NCT01845077|56321|P4|STARTED|Treatment Period 2||10
25616|NCT01845077|56322|P3|STARTED|Treatment Period 2||11
25617|NCT01845077|56323|P2|STARTED|Treatment Period 2||11
25618|NCT01845077|56324|P1|STARTED|Treatment Period 2||11
25619|NCT01845077|56319|P6|NOT COMPLETED|Washout Period||1
25620|NCT01845077|56320|P5|NOT COMPLETED|Washout Period||1
25621|NCT01845077|56321|P4|NOT COMPLETED|Washout Period||2
25622|NCT01845077|56322|P3|NOT COMPLETED|Washout Period||1
25623|NCT01845077|56323|P2|NOT COMPLETED|Washout Period||1
25624|NCT01845077|56324|P1|NOT COMPLETED|Washout Period||1
25625|NCT01845077|56319|P6|COMPLETED|Washout Period||11
25626|NCT01845077|56320|P5|COMPLETED|Washout Period||11
25627|NCT01845077|56321|P4|COMPLETED|Washout Period||10
25628|NCT01845077|56322|P3|COMPLETED|Washout Period||11
25629|NCT01845077|56323|P2|COMPLETED|Washout Period||11
25630|NCT01845077|56324|P1|COMPLETED|Washout Period||11
25631|NCT01845077|56319|P6|STARTED|Washout Period||12
25632|NCT01845077|56320|P5|STARTED|Washout Period||12
25633|NCT01845077|56321|P4|STARTED|Washout Period||12
25634|NCT01845077|56322|P3|STARTED|Washout Period||12
25635|NCT01845077|56323|P2|STARTED|Washout Period||12
25636|NCT01845077|56324|P1|STARTED|Washout Period||12
25637|NCT01845077|56319|P6|NOT COMPLETED|Treatment Period 1||0
25638|NCT01845077|56320|P5|NOT COMPLETED|Treatment Period 1||0
25639|NCT01845077|56321|P4|NOT COMPLETED|Treatment Period 1||0
25640|NCT01845077|56322|P3|NOT COMPLETED|Treatment Period 1||0
25641|NCT01845077|56323|P2|NOT COMPLETED|Treatment Period 1||0
25642|NCT01845077|56324|P1|NOT COMPLETED|Treatment Period 1||0
25643|NCT01845077|56319|P6|COMPLETED|Treatment Period 1||12
25644|NCT01845077|56320|P5|COMPLETED|Treatment Period 1||12
25645|NCT01845077|56321|P4|COMPLETED|Treatment Period 1||12
25646|NCT01845077|56322|P3|COMPLETED|Treatment Period 1||12
25647|NCT01845077|56323|P2|COMPLETED|Treatment Period 1||12
25648|NCT01845077|56324|P1|COMPLETED|Treatment Period 1||12
25649|NCT01845077|56319|P6|STARTED|Treatment Period 1||12
25650|NCT01845077|56320|P5|STARTED|Treatment Period 1||12
25651|NCT01845077|56321|P4|STARTED|Treatment Period 1||12
25652|NCT01845077|56322|P3|STARTED|Treatment Period 1||12
25653|NCT01845077|56323|P2|STARTED|Treatment Period 1||12
25654|NCT01845077|56324|P1|STARTED|Treatment Period 1||12
25655|NCT01844895|56368|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
25656|NCT01844895|56368|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
25657|NCT01844895|56368|P1|STARTED|Day 29 - Day113 - Autoinjector||117
25658|NCT01844895|56368|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
25659|NCT01844895|56368|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
25660|NCT01844895|56368|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
25661|NCT01844856|56386|P2|NOT COMPLETED|Overall Study||16
25662|NCT01844856|56387|P1|NOT COMPLETED|Overall Study||24
25663|NCT01844856|56386|P2|COMPLETED|Overall Study||255
25664|NCT01844856|56387|P1|COMPLETED|Overall Study||246
25665|NCT01844856|56386|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
25666|NCT01844856|56387|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
25667|NCT01844856|56386|P2|STARTED|Overall Study||271
25668|NCT01844856|56387|P1|STARTED|Overall Study||270
25669|NCT01844778|56400|P3|NOT COMPLETED|Overall Study||4
25670|NCT01844778|56401|P2|NOT COMPLETED|Overall Study||3
25671|NCT01844778|56402|P1|NOT COMPLETED|Overall Study||2
25672|NCT01844778|56400|P3|COMPLETED|Overall Study||14
25673|NCT01844778|56401|P2|COMPLETED|Overall Study||25
25674|NCT01844778|56402|P1|COMPLETED|Overall Study||12
25675|NCT01844778|56400|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
25676|NCT01844778|56401|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
25677|NCT01844778|56402|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
25678|NCT01844778|56400|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
25679|NCT01844778|56401|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
25680|NCT01844778|56402|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
25681|NCT01844778|56400|P3|STARTED|Overall Study||18
25682|NCT01844778|56401|P2|STARTED|Overall Study||28
25683|NCT01844778|56402|P1|STARTED|Overall Study||14
25684|NCT01844700|56428|P2|NOT COMPLETED|Overall Study||1
25685|NCT01844700|56429|P1|NOT COMPLETED|Overall Study||3
25686|NCT01844700|56428|P2|COMPLETED|Overall Study||2
25687|NCT01844700|56429|P1|COMPLETED|Overall Study||1
25688|NCT01844700|56428|P2|STARTED|Overall Study||3
25689|NCT01844700|56429|P1|STARTED|Overall Study||4
25690|NCT01844531|56445|P4|NOT COMPLETED|Overall Study||0
25691|NCT01844531|56446|P3|NOT COMPLETED|Overall Study||0
25692|NCT01844531|56447|P2|NOT COMPLETED|Overall Study||1
25693|NCT01844531|56448|P1|NOT COMPLETED|Overall Study||0
25694|NCT01844531|56445|P4|COMPLETED|Overall Study||6
25695|NCT01844531|56446|P3|COMPLETED|Overall Study||6
25696|NCT01844531|56447|P2|COMPLETED|Overall Study||5
25697|NCT01844531|56448|P1|COMPLETED|Overall Study||6
25698|NCT01844531|56445|P4|STARTED|Overall Study||6
25699|NCT01844531|56446|P3|STARTED|Overall Study||6
25700|NCT01844531|56447|P2|STARTED|Overall Study||6
25701|NCT01844531|56448|P1|STARTED|Overall Study||6
25702|NCT01844518|56478|P1|NOT COMPLETED|Long-Term Extension||157
25703|NCT01844518|56478|P1|COMPLETED|Long-Term Extension|Study is on-going|0
25704|NCT01844518|56478|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
25705|NCT01844518|56478|P1|NOT COMPLETED|Short-Term (ST) Period||9
25706|NCT01844518|56478|P1|COMPLETED|Short-Term (ST) Period||164
25707|NCT01844518|56478|P1|STARTED|Short-Term (ST) Period||173
25708|NCT01844479|56492|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
25709|NCT01844479|56493|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
25710|NCT01844479|56492|P2|COMPLETED|Second Intervention up to 30 Minutes||13
25711|NCT01844479|56493|P1|COMPLETED|Second Intervention up to 30 Minutes||14
25712|NCT01844479|56492|P2|STARTED|Second Intervention up to 30 Minutes||13
25713|NCT01844479|56493|P1|STARTED|Second Intervention up to 30 Minutes||14
25714|NCT01844479|56492|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
25715|NCT01844479|56493|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
25716|NCT01844479|56492|P2|COMPLETED|First Intervention up to 30 Minutes||13
25717|NCT01844479|56493|P1|COMPLETED|First Intervention up to 30 Minutes||14
25718|NCT01844479|56492|P2|STARTED|First Intervention up to 30 Minutes||13
25719|NCT01844479|56493|P1|STARTED|First Intervention up to 30 Minutes||14
25720|NCT01844388|56523|P2|NOT COMPLETED|Overall Study||7
25721|NCT01844388|56524|P1|NOT COMPLETED|Overall Study||8
25722|NCT01844388|56523|P2|COMPLETED|Overall Study||114
25723|NCT01844388|56524|P1|COMPLETED|Overall Study||236
25724|NCT01844388|56523|P2|STARTED|Overall Study||121
25725|NCT01844388|56524|P1|STARTED|Overall Study||244
25726|NCT01844206|56536|P2|NOT COMPLETED|Overall Study||1
25727|NCT01844206|56537|P1|NOT COMPLETED|Overall Study||0
25728|NCT01844206|56536|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
25729|NCT01844206|56537|P1|COMPLETED|Overall Study||2
25730|NCT01844206|56536|P2|STARTED|Overall Study||3
25731|NCT01844206|56537|P1|STARTED|Overall Study||2
25732|NCT01843972|56553|P10|NOT COMPLETED|Overall Study||0
25733|NCT01843972|56554|P9|NOT COMPLETED|Overall Study||0
25734|NCT01843972|56555|P8|NOT COMPLETED|Overall Study||0
25735|NCT01843972|56556|P7|NOT COMPLETED|Overall Study||0
25736|NCT01843972|56557|P6|NOT COMPLETED|Overall Study||0
25737|NCT01843972|56558|P5|NOT COMPLETED|Overall Study||1
25738|NCT01843972|56559|P4|NOT COMPLETED|Overall Study||0
25739|NCT01843972|56560|P3|NOT COMPLETED|Overall Study||0
25740|NCT01843972|56561|P2|NOT COMPLETED|Overall Study||0
25741|NCT01843972|56562|P1|NOT COMPLETED|Overall Study||0
25742|NCT01843972|56553|P10|COMPLETED|Overall Study||12
25743|NCT01843972|56554|P9|COMPLETED|Overall Study||17
25744|NCT01843972|56555|P8|COMPLETED|Overall Study||5
25745|NCT01843972|56556|P7|COMPLETED|Overall Study||5
25746|NCT01843972|56557|P6|COMPLETED|Overall Study||6
25747|NCT01843972|56558|P5|COMPLETED|Overall Study||5
25748|NCT01843972|56559|P4|COMPLETED|Overall Study||6
25749|NCT01843972|56560|P3|COMPLETED|Overall Study||5
25750|NCT01843972|56561|P2|COMPLETED|Overall Study||6
25751|NCT01843972|56562|P1|COMPLETED|Overall Study||13
25752|NCT01843972|56553|P10|STARTED|Overall Study||12
25753|NCT01843972|56554|P9|STARTED|Overall Study||17
25754|NCT01843972|56555|P8|STARTED|Overall Study||5
25755|NCT01843972|56556|P7|STARTED|Overall Study||5
25756|NCT01843972|56557|P6|STARTED|Overall Study||6
25757|NCT01843972|56558|P5|STARTED|Overall Study||6
25758|NCT01843972|56559|P4|STARTED|Overall Study||6
25759|NCT01843972|56560|P3|STARTED|Overall Study||5
25760|NCT01843972|56561|P2|STARTED|Overall Study||6
25761|NCT01843972|56562|P1|STARTED|Overall Study||13
25762|NCT01843933|56632|P2|NOT COMPLETED|Overall Study||4
25763|NCT01843933|56633|P1|NOT COMPLETED|Overall Study||6
25764|NCT01843933|56632|P2|COMPLETED|Overall Study||103
25765|NCT01843933|56633|P1|COMPLETED|Overall Study||98
25766|NCT01843933|56632|P2|STARTED|Overall Study||107
25767|NCT01843933|56633|P1|STARTED|Overall Study||104
25768|NCT01843920|56641|P2|NOT COMPLETED|Overall Study||0
25769|NCT01843920|56642|P1|NOT COMPLETED|Overall Study||0
25770|NCT01843920|56641|P2|COMPLETED|Overall Study||9
25771|NCT01843920|56642|P1|COMPLETED|Overall Study||12
25772|NCT01843920|56641|P2|STARTED|Overall Study||9
25773|NCT01843920|56642|P1|STARTED|Overall Study||12
25774|NCT01843777|56650|P2|NOT COMPLETED|Overall Study||0
25775|NCT01843777|56651|P1|NOT COMPLETED|Overall Study||1
25776|NCT01843777|56650|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
25777|NCT01843777|56651|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
25778|NCT01843777|56650|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
25779|NCT01843777|56651|P1|Per Protocol Population|Overall Study||11
25780|NCT01843777|56650|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
25781|NCT01843777|56651|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
25782|NCT01843673|56659|P1|NOT COMPLETED|Overall Study||6
25783|NCT01843673|56659|P1|COMPLETED|Overall Study||10
25784|NCT01843673|56659|P1|STARTED|Overall Study||16
25785|NCT01843660|56671|P1|NOT COMPLETED|Overall Study||30
25786|NCT01843660|56671|P1|COMPLETED|Overall Study||1029
25787|NCT01843660|56671|P1|STARTED|Overall Study||1059
25788|NCT01843465|56689|P1|NOT COMPLETED|Overall Study||0
25789|NCT01843465|56689|P1|COMPLETED|Overall Study||34
25790|NCT01843465|56689|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
25791|NCT01843192|56696|P3|NOT COMPLETED|Overall Study||2
25792|NCT01843192|56697|P2|NOT COMPLETED|Overall Study||6
25793|NCT01843192|56698|P1|NOT COMPLETED|Overall Study||2
25794|NCT01843192|56696|P3|COMPLETED|Overall Study||9
25795|NCT01843192|56697|P2|COMPLETED|Overall Study||28
25796|NCT01843192|56698|P1|COMPLETED|Overall Study||24
25797|NCT01843192|56696|P3|STARTED|Overall Study||11
25798|NCT01843192|56697|P2|STARTED|Overall Study||34
25799|NCT01843192|56698|P1|STARTED|Overall Study||26
25800|NCT01842841|56727|P1|NOT COMPLETED|Overall Study||0
25801|NCT01842841|56727|P1|COMPLETED|Overall Study||5
25802|NCT01842841|56727|P1|STARTED|Overall Study||5
25803|NCT01842607|56746|P1|NOT COMPLETED|Overall Study||66
25804|NCT01842607|56746|P1|COMPLETED|Overall Study||585
25805|NCT01842607|56746|P1|STARTED|Overall Study||651
25806|NCT01842594|56765|P1|NOT COMPLETED|Overall Study||3
25807|NCT01842594|56765|P1|COMPLETED|Overall Study||10
25808|NCT01842594|56765|P1|STARTED|Overall Study||13
25809|NCT01842464|56770|P1|NOT COMPLETED|Overall Study||0
25810|NCT01842464|56770|P1|COMPLETED|Overall Study||44
25811|NCT01842464|56770|P1|STARTED|Overall Study||44
25812|NCT01842438|56778|P2|NOT COMPLETED|T2: 6month Follow-up||4
25813|NCT01842438|56779|P1|NOT COMPLETED|T2: 6month Follow-up||4
25814|NCT01842438|56778|P2|COMPLETED|T2: 6month Follow-up||32
25815|NCT01842438|56779|P1|COMPLETED|T2: 6month Follow-up||32
25816|NCT01842438|56778|P2|STARTED|T2: 6month Follow-up||36
25817|NCT01842438|56779|P1|STARTED|T2: 6month Follow-up||36
25818|NCT01842438|56778|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
25819|NCT01842438|56779|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
25820|NCT01842438|56778|P2|COMPLETED|T1: Immediately After the Intervention||36
25821|NCT01842438|56779|P1|COMPLETED|T1: Immediately After the Intervention||36
25822|NCT01842438|56778|P2|STARTED|T1: Immediately After the Intervention||44
25823|NCT01842438|56779|P1|STARTED|T1: Immediately After the Intervention||42
25824|NCT01841970|56791|P1|NOT COMPLETED|Overall Study||11
25825|NCT01841970|56791|P1|COMPLETED|Overall Study||9
25826|NCT01841970|56791|P1|STARTED|Overall Study||20
25827|NCT01841697|56809|P2|NOT COMPLETED|Overall Study||18
25828|NCT01841697|56810|P1|NOT COMPLETED|Overall Study||20
25829|NCT01841697|56809|P2|COMPLETED|Overall Study||302
25830|NCT01841697|56810|P1|COMPLETED|Overall Study||302
25831|NCT01841697|56809|P2|STARTED|Overall Study||320
25832|NCT01841697|56810|P1|STARTED|Overall Study||322
25833|NCT01841619|56826|P1|NOT COMPLETED|Overall Study||0
25834|NCT01841619|56826|P1|COMPLETED|Overall Study||16
25835|NCT01841619|56826|P1|STARTED|Overall Study||16
25836|NCT01841593|56836|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
25837|NCT01841593|56837|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
25838|NCT01841593|56836|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
25839|NCT01841593|56837|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
25840|NCT01841593|56836|P2|STARTED|Third Intervention (Days 15 to 21)||6
25841|NCT01841593|56837|P1|STARTED|Third Intervention (Days 15 to 21)||11
25842|NCT01841593|56836|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
25843|NCT01841593|56837|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
25844|NCT01841593|56836|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
25845|NCT01841593|56837|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
25846|NCT01841593|56836|P2|STARTED|Second Intervention (Days 8 to 14)||6
25847|NCT01841593|56837|P1|STARTED|Second Intervention (Days 8 to 14)||12
25848|NCT01841593|56836|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
25849|NCT01841593|56837|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
25850|NCT01841593|56836|P2|COMPLETED|First Intervention (Days 1 to 7)||6
25851|NCT01841593|56837|P1|COMPLETED|First Intervention (Days 1 to 7)||12
25852|NCT01841593|56836|P2|STARTED|First Intervention (Days 1 to 7)||7
25853|NCT01841593|56837|P1|STARTED|First Intervention (Days 1 to 7)||12
25854|NCT01841567|56853|P1|NOT COMPLETED|Overall Study||3
25855|NCT01841567|56853|P1|COMPLETED|Overall Study||57
25856|NCT01841567|56853|P1|STARTED|Overall Study||60
25857|NCT01841216|56860|P2|NOT COMPLETED|Overall Study||0
25858|NCT01841216|56861|P1|NOT COMPLETED|Overall Study||0
25859|NCT01841216|56860|P2|COMPLETED|Overall Study||15
25860|NCT01841216|56861|P1|COMPLETED|Overall Study||15
25861|NCT01841216|56860|P2|STARTED|Overall Study||15
25862|NCT01841216|56861|P1|STARTED|Overall Study||15
25863|NCT01841021|56869|P1|NOT COMPLETED|Overall Study||0
25864|NCT01841021|56869|P1|COMPLETED|Overall Study||1
25865|NCT01841021|56869|P1|STARTED|Overall Study||1
25866|NCT01840943|56881|P2|NOT COMPLETED|Overall Study||12
25867|NCT01840943|56882|P1|NOT COMPLETED|Overall Study||13
25868|NCT01840943|56881|P2|COMPLETED|Overall Study||0
25869|NCT01840943|56882|P1|COMPLETED|Overall Study||1
25870|NCT01840943|56881|P2|STARTED|Overall Study||12
25871|NCT01840943|56882|P1|STARTED|Overall Study||14
25872|NCT01840605|56918|P2|NOT COMPLETED|Overall Study||2
25873|NCT01840605|56919|P1|NOT COMPLETED|Overall Study||2
25874|NCT01840605|56918|P2|COMPLETED|Overall Study||150
25875|NCT01840605|56919|P1|COMPLETED|Overall Study||149
25876|NCT01840605|56918|P2|STARTED|Overall Study||152
25877|NCT01840605|56919|P1|STARTED|Overall Study||151
25878|NCT01840410|56927|P2|NOT COMPLETED|Overall Study||4
25879|NCT01840410|56928|P1|NOT COMPLETED|Overall Study||7
25880|NCT01840410|56927|P2|COMPLETED|Overall Study||55
25881|NCT01840410|56928|P1|COMPLETED|Overall Study||112
25882|NCT01840410|56927|P2|Full Analysis Set|Overall Study||59
25883|NCT01840410|56928|P1|Full Analysis Set|Overall Study||119
25884|NCT01840410|56927|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
25885|NCT01840410|56928|P1|Safety Set|Overall Study||119
25886|NCT01840410|56927|P2|STARTED|Overall Study||59
25887|NCT01840410|56928|P1|STARTED|Overall Study||119
25888|NCT01840319|56964|P1|NOT COMPLETED|Overall Study||0
25889|NCT01840319|56964|P1|COMPLETED|Overall Study||156
25890|NCT01840319|56964|P1|STARTED|Overall Study||156
25891|NCT01840072|56970|P2|NOT COMPLETED|Overall Study||47
25892|NCT01840072|56971|P1|NOT COMPLETED|Overall Study||7
25893|NCT01840072|56970|P2|COMPLETED|Overall Study||1986
25894|NCT01840072|56971|P1|COMPLETED|Overall Study||2031
25895|NCT01840072|56970|P2|STARTED|Overall Study||2033
25896|NCT01840072|56971|P1|STARTED|Overall Study||2038
25897|NCT01839695|56983|P1|NOT COMPLETED|Overall Study||0
25898|NCT01839695|56983|P1|COMPLETED|Overall Study||9
25899|NCT01839695|56983|P1|STARTED|Overall Study||9
25900|NCT01839318|56988|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
25901|NCT01839318|56989|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
25902|NCT01839318|56990|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
25903|NCT01839318|56991|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
25904|NCT01839318|56992|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
25905|NCT01839318|56993|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
25906|NCT01839318|56988|P6|COMPLETED|Period 3, Third Day of Wear||2
25907|NCT01839318|56989|P5|COMPLETED|Period 3, Third Day of Wear||7
25908|NCT01839318|56990|P4|COMPLETED|Period 3, Third Day of Wear||6
25909|NCT01839318|56991|P3|COMPLETED|Period 3, Third Day of Wear||5
25910|NCT01839318|56992|P2|COMPLETED|Period 3, Third Day of Wear||4
25911|NCT01839318|56993|P1|COMPLETED|Period 3, Third Day of Wear||4
25912|NCT01839318|56988|P6|STARTED|Period 3, Third Day of Wear||2
25913|NCT01839318|56989|P5|STARTED|Period 3, Third Day of Wear||7
25914|NCT01839318|56990|P4|STARTED|Period 3, Third Day of Wear||6
25915|NCT01839318|56991|P3|STARTED|Period 3, Third Day of Wear||5
25916|NCT01839318|56992|P2|STARTED|Period 3, Third Day of Wear||4
25917|NCT01839318|56993|P1|STARTED|Period 3, Third Day of Wear||4
25918|NCT01839318|56988|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
25919|NCT01839318|56989|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
25920|NCT01839318|56990|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
25921|NCT01839318|56991|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
25922|NCT01839318|56992|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
25923|NCT01839318|56993|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
25924|NCT01839318|56988|P6|COMPLETED|Period 2, Second Day of Wear||2
25925|NCT01839318|56989|P5|COMPLETED|Period 2, Second Day of Wear||7
25926|NCT01839318|56990|P4|COMPLETED|Period 2, Second Day of Wear||6
25927|NCT01839318|56991|P3|COMPLETED|Period 2, Second Day of Wear||5
25928|NCT01839318|56992|P2|COMPLETED|Period 2, Second Day of Wear||4
25929|NCT01839318|56993|P1|COMPLETED|Period 2, Second Day of Wear||4
25930|NCT01839318|56988|P6|STARTED|Period 2, Second Day of Wear||2
25931|NCT01839318|56989|P5|STARTED|Period 2, Second Day of Wear||7
25932|NCT01839318|56990|P4|STARTED|Period 2, Second Day of Wear||6
25933|NCT01839318|56991|P3|STARTED|Period 2, Second Day of Wear||5
25934|NCT01839318|56992|P2|STARTED|Period 2, Second Day of Wear||4
25935|NCT01839318|56993|P1|STARTED|Period 2, Second Day of Wear||4
25936|NCT01839318|56988|P6|NOT COMPLETED|Period 1, First Day of Wear||0
25937|NCT01839318|56989|P5|NOT COMPLETED|Period 1, First Day of Wear||0
25938|NCT01839318|56990|P4|NOT COMPLETED|Period 1, First Day of Wear||0
25939|NCT01839318|56991|P3|NOT COMPLETED|Period 1, First Day of Wear||0
25940|NCT01839318|56992|P2|NOT COMPLETED|Period 1, First Day of Wear||0
25941|NCT01839318|56993|P1|NOT COMPLETED|Period 1, First Day of Wear||0
25942|NCT01839318|56988|P6|COMPLETED|Period 1, First Day of Wear||2
25943|NCT01839318|56989|P5|COMPLETED|Period 1, First Day of Wear||7
25944|NCT01839318|56990|P4|COMPLETED|Period 1, First Day of Wear||6
25945|NCT01839318|56991|P3|COMPLETED|Period 1, First Day of Wear||5
25946|NCT01839318|56992|P2|COMPLETED|Period 1, First Day of Wear||4
25947|NCT01839318|56993|P1|COMPLETED|Period 1, First Day of Wear||4
25948|NCT01839318|56988|P6|STARTED|Period 1, First Day of Wear||2
25949|NCT01839318|56989|P5|STARTED|Period 1, First Day of Wear||7
25950|NCT01839318|56990|P4|STARTED|Period 1, First Day of Wear||6
25951|NCT01839318|56991|P3|STARTED|Period 1, First Day of Wear||5
25952|NCT01839318|56992|P2|STARTED|Period 1, First Day of Wear||4
25953|NCT01839318|56993|P1|STARTED|Period 1, First Day of Wear||4
25954|NCT01839279|57007|P3|NOT COMPLETED|Overall Study||2
25955|NCT01839279|57008|P2|NOT COMPLETED|Overall Study||2
25956|NCT01839279|57009|P1|NOT COMPLETED|Overall Study||13
25957|NCT01839279|57007|P3|COMPLETED|Overall Study||30
25958|NCT01839279|57008|P2|COMPLETED|Overall Study||30
25959|NCT01839279|57009|P1|COMPLETED|Overall Study||59
25960|NCT01839279|57007|P3|PK/QTc Analysis Set|Overall Study||0
25961|NCT01839279|57008|P2|PK/QTc Analysis Set|Overall Study||0
25962|NCT01839279|57009|P1|PK/QTc Analysis Set|Overall Study||70
25963|NCT01839279|57007|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
25964|NCT01839279|57008|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
25965|NCT01839279|57009|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
25966|NCT01839279|57007|P3|PK Analysis Set|Overall Study||0
25967|NCT01839279|57008|P2|PK Analysis Set|Overall Study||0
25968|NCT01839279|57009|P1|PK Analysis Set|Overall Study||70
25969|NCT01839279|57007|P3|QT/QTc Analysis Set|Overall Study||32
25970|NCT01839279|57008|P2|QT/QTc Analysis Set|Overall Study||32
25971|NCT01839279|57009|P1|QT/QTc Analysis Set|Overall Study||72
25972|NCT01839279|57007|P3|STARTED|Overall Study||32
25973|NCT01839279|57008|P2|STARTED|Overall Study||32
25974|NCT01839279|57009|P1|STARTED|Overall Study||72
25975|NCT01838980|57028|P1|NOT COMPLETED|Overall Study||0
25976|NCT01838980|57028|P1|COMPLETED|Overall Study||15
25977|NCT01838980|57028|P1|STARTED|Overall Study||15
25978|NCT01838941|57032|P1|NOT COMPLETED|Overall Study||2
25979|NCT01838941|57032|P1|COMPLETED|Overall Study||10
25980|NCT01838941|57032|P1|STARTED|Overall Study||12
25981|NCT01838694|57039|P2|NOT COMPLETED|Overall Study||1
25982|NCT01838694|57040|P1|NOT COMPLETED|Overall Study||0
25983|NCT01838694|57039|P2|COMPLETED|Overall Study||21
25984|NCT01838694|57040|P1|COMPLETED|Overall Study||8
25985|NCT01838694|57039|P2|STARTED|Overall Study||22
25986|NCT01838694|57040|P1|STARTED|Overall Study||8
25987|NCT01838642|57049|P1|NOT COMPLETED|Overall Study||1
25988|NCT01838642|57049|P1|COMPLETED|Overall Study||2
25989|NCT01838642|57049|P1|STARTED|Overall Study||3
25990|NCT01838616|57062|P2|NOT COMPLETED|Pick-up Arm||0
25991|NCT01838616|57063|P1|NOT COMPLETED|Pick-up Arm||15
25992|NCT01838616|57062|P2|COMPLETED|Pick-up Arm||0
25993|NCT01838616|57063|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
25994|NCT01838616|57062|P2|Full Analysis Set|Pick-up Arm||0
25995|NCT01838616|57063|P1|Full Analysis Set|Pick-up Arm||49
25996|NCT01838616|57062|P2|STARTED|Pick-up Arm||0
25997|NCT01838616|57063|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
25998|NCT01838616|57062|P2|NOT COMPLETED|Continuation Period||14
25999|NCT01838616|57063|P1|NOT COMPLETED|Continuation Period||14
26000|NCT01838616|57062|P2|COMPLETED|Continuation Period||48
26001|NCT01838616|57063|P1|COMPLETED|Continuation Period||86
26002|NCT01838616|57062|P2|Switched to Pick-up Arm|Continuation Period||7
26003|NCT01838616|57063|P1|Switched to Pick-up Arm|Continuation Period||0
26004|NCT01838616|57062|P2|STARTED|Continuation Period||62
26005|NCT01838616|57063|P1|STARTED|Continuation Period||100
26006|NCT01838616|57062|P2|NOT COMPLETED|Titration Period||66
26007|NCT01838616|57063|P1|NOT COMPLETED|Titration Period||30
26008|NCT01838616|57062|P2|COMPLETED|Titration Period||62
26009|NCT01838616|57063|P1|COMPLETED|Titration Period||100
26010|NCT01838616|57062|P2|Per Protocol Set|Titration Period||112
26011|NCT01838616|57063|P1|Per Protocol Set|Titration Period||117
26012|NCT01838616|57062|P2|Full Analysis Set|Titration Period||128
26013|NCT01838616|57063|P1|Full Analysis Set|Titration Period||130
26014|NCT01838616|57062|P2|Switched to Pick-up Arm|Titration Period||43
26015|NCT01838616|57063|P1|Switched to Pick-up Arm|Titration Period||0
26016|NCT01838616|57062|P2|Major Protocol Deviations|Titration Period||16
26017|NCT01838616|57063|P1|Major Protocol Deviations|Titration Period||13
26018|NCT01838616|57062|P2|No Post Baseline Pain Intensity Values|Titration Period||2
26019|NCT01838616|57063|P1|No Post Baseline Pain Intensity Values|Titration Period||0
26020|NCT01838616|57062|P2|STARTED|Titration Period||128
26021|NCT01838616|57063|P1|STARTED|Titration Period||130
26022|NCT01838590|57134|P2|NOT COMPLETED|Overall Study||5
26023|NCT01838590|57135|P1|NOT COMPLETED|Overall Study||12
26024|NCT01838590|57134|P2|COMPLETED|Overall Study||46
26025|NCT01838590|57135|P1|COMPLETED|Overall Study||40
26026|NCT01838590|57134|P2|STARTED|Overall Study||51
26027|NCT01838590|57135|P1|STARTED|Overall Study||52
26028|NCT01838499|57159|P2|NOT COMPLETED|Overall Study||17
26029|NCT01838499|57160|P1|NOT COMPLETED|Overall Study||24
26030|NCT01838499|57159|P2|COMPLETED|Overall Study||37
26031|NCT01838499|57160|P1|COMPLETED|Overall Study||31
26032|NCT01838499|57159|P2|STARTED|Overall Study||54
26033|NCT01838499|57160|P1|STARTED|Overall Study||55
26034|NCT01838213|57172|P2|NOT COMPLETED|Overall Study||191
26035|NCT01838213|57173|P1|NOT COMPLETED|Overall Study||166
26036|NCT01838213|57172|P2|COMPLETED|Overall Study||262
26037|NCT01838213|57173|P1|COMPLETED|Overall Study||81
26038|NCT01838213|57172|P2|STARTED|Overall Study||453
26039|NCT01838213|57173|P1|STARTED|Overall Study||247
26040|NCT01838044|57181|P2|NOT COMPLETED|Overall Study||16
26041|NCT01838044|57182|P1|NOT COMPLETED|Overall Study||8
26042|NCT01838044|57181|P2|COMPLETED|Overall Study||75
26043|NCT01838044|57182|P1|COMPLETED|Overall Study||81
26044|NCT01838044|57181|P2|STARTED|Overall Study||91
26045|NCT01838044|57182|P1|STARTED|Overall Study||89
26046|NCT01837966|57215|P2|NOT COMPLETED|Overall Study||1
26047|NCT01837966|57216|P1|NOT COMPLETED|Overall Study||2
26048|NCT01837966|57215|P2|COMPLETED|Overall Study||45
26049|NCT01837966|57216|P1|COMPLETED|Overall Study||45
26050|NCT01837966|57215|P2|STARTED|Overall Study||46
26051|NCT01837966|57216|P1|STARTED|Overall Study||47
26052|NCT01837797|57225|P5|NOT COMPLETED|Period 3||23
26053|NCT01837797|57226|P4|NOT COMPLETED|Period 3||0
26054|NCT01837797|57227|P3|NOT COMPLETED|Period 3||0
26055|NCT01837797|57228|P2|NOT COMPLETED|Period 3||0
26056|NCT01837797|57229|P1|NOT COMPLETED|Period 3||0
26057|NCT01837797|57225|P5|COMPLETED|Period 3||24
26058|NCT01837797|57226|P4|COMPLETED|Period 3||0
26059|NCT01837797|57227|P3|COMPLETED|Period 3||0
26060|NCT01837797|57228|P2|COMPLETED|Period 3||0
26061|NCT01837797|57229|P1|COMPLETED|Period 3||0
26062|NCT01837797|57225|P5|STARTED|Period 3||47
26063|NCT01837797|57226|P4|STARTED|Period 3||0
26064|NCT01837797|57227|P3|STARTED|Period 3||0
26065|NCT01837797|57228|P2|STARTED|Period 3||0
26066|NCT01837797|57229|P1|STARTED|Period 3||0
26067|NCT01837797|57225|P5|NOT COMPLETED|Period 2||0
26068|NCT01837797|57226|P4|NOT COMPLETED|Period 2||5
26069|NCT01837797|57227|P3|NOT COMPLETED|Period 2||2
26070|NCT01837797|57228|P2|NOT COMPLETED|Period 2||5
26071|NCT01837797|57229|P1|NOT COMPLETED|Period 2||0
26072|NCT01837797|57225|P5|COMPLETED|Period 2||0
26073|NCT01837797|57226|P4|COMPLETED|Period 2||1
26074|NCT01837797|57227|P3|COMPLETED|Period 2||1
26075|NCT01837797|57228|P2|COMPLETED|Period 2||1
26076|NCT01837797|57229|P1|COMPLETED|Period 2||0
26077|NCT01837797|57225|P5|STARTED|Period 2||0
26078|NCT01837797|57226|P4|STARTED|Period 2||6
26079|NCT01837797|57227|P3|STARTED|Period 2||3
26080|NCT01837797|57228|P2|STARTED|Period 2||6
26081|NCT01837797|57229|P1|STARTED|Period 2||0
26082|NCT01837797|57225|P5|NOT COMPLETED|Period 1||0
26083|NCT01837797|57226|P4|NOT COMPLETED|Period 1||0
26084|NCT01837797|57227|P3|NOT COMPLETED|Period 1||0
26085|NCT01837797|57228|P2|NOT COMPLETED|Period 1||0
26086|NCT01837797|57229|P1|NOT COMPLETED|Period 1||102
26087|NCT01837797|57225|P5|COMPLETED|Period 1||0
26088|NCT01837797|57226|P4|COMPLETED|Period 1||0
26089|NCT01837797|57227|P3|COMPLETED|Period 1||0
26090|NCT01837797|57228|P2|COMPLETED|Period 1||0
26091|NCT01837797|57229|P1|COMPLETED|Period 1||27
26092|NCT01837797|57225|P5|STARTED|Period 1||0
26093|NCT01837797|57226|P4|STARTED|Period 1||0
26094|NCT01837797|57227|P3|STARTED|Period 1||0
26095|NCT01837797|57228|P2|STARTED|Period 1||0
26096|NCT01837797|57229|P1|STARTED|Period 1||129
26097|NCT01837719|57264|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
26098|NCT01837719|57264|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
26099|NCT01837719|57264|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
26100|NCT01837719|57264|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
26101|NCT01837719|57264|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
26102|NCT01837719|57264|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
26103|NCT01837719|57264|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
26104|NCT01837719|57264|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
26105|NCT01837719|57264|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
26106|NCT01837719|57264|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
26107|NCT01837719|57264|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
26108|NCT01837719|57264|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
26109|NCT01837719|57264|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
26110|NCT01837719|57264|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
26111|NCT01837719|57264|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
26112|NCT01837550|57333|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
26113|NCT01837550|57334|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
26114|NCT01837550|57333|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
26115|NCT01837550|57334|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
26116|NCT01837550|57333|P2|STARTED|T0-T2, 6 Months Follow-up||37
26117|NCT01837550|57334|P1|STARTED|T0-T2, 6 Months Follow-up||37
26118|NCT01837550|57333|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
26119|NCT01837550|57334|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
26120|NCT01837550|57333|P2|COMPLETED|T0-T1, 5 Weeks||37
26121|NCT01837550|57334|P1|COMPLETED|T0-T1, 5 Weeks||37
26122|NCT01837550|57333|P2|STARTED|T0-T1, 5 Weeks||37
26123|NCT01837550|57334|P1|STARTED|T0-T1, 5 Weeks||37
26124|NCT01837537|57346|P1|NOT COMPLETED|Overall Study||0
26125|NCT01837537|57346|P1|COMPLETED|Overall Study||90
26126|NCT01837537|57346|P1|STARTED|Overall Study||90
26127|NCT01836809|57355|P4|NOT COMPLETED|Overall Study||2
26128|NCT01836809|57356|P3|NOT COMPLETED|Overall Study||0
26129|NCT01836809|57357|P2|NOT COMPLETED|Overall Study||0
26130|NCT01836809|57358|P1|NOT COMPLETED|Overall Study||0
26131|NCT01836809|57355|P4|COMPLETED|Overall Study||0
26132|NCT01836809|57356|P3|COMPLETED|Overall Study||0
26133|NCT01836809|57357|P2|COMPLETED|Overall Study||0
26134|NCT01836809|57358|P1|COMPLETED|Overall Study||0
26135|NCT01836809|57355|P4|STARTED|Overall Study||2
26136|NCT01836809|57356|P3|STARTED|Overall Study||0
26137|NCT01836809|57357|P2|STARTED|Overall Study||0
26138|NCT01836809|57358|P1|STARTED|Overall Study||0
26139|NCT01836458|57392|P4|NOT COMPLETED|Overall Study||6
26140|NCT01836458|57393|P3|NOT COMPLETED|Overall Study||5
26141|NCT01836458|57394|P2|NOT COMPLETED|Overall Study||2
26142|NCT01836458|57395|P1|NOT COMPLETED|Overall Study||3
26143|NCT01836458|57392|P4|COMPLETED|Overall Study||1
26144|NCT01836458|57393|P3|COMPLETED|Overall Study||2
26145|NCT01836458|57394|P2|COMPLETED|Overall Study||2
26146|NCT01836458|57395|P1|COMPLETED|Overall Study||4
26147|NCT01836458|57392|P4|STARTED|Overall Study||7
26148|NCT01836458|57393|P3|STARTED|Overall Study||7
26149|NCT01836458|57394|P2|STARTED|Overall Study||4
26150|NCT01836458|57395|P1|STARTED|Overall Study||7
26151|NCT01836042|57420|P3|NOT COMPLETED|Overall Study||0
26152|NCT01836042|57421|P2|NOT COMPLETED|Overall Study||0
26153|NCT01836042|57422|P1|NOT COMPLETED|Overall Study||0
26154|NCT01836042|57420|P3|COMPLETED|Overall Study||22
26155|NCT01836042|57421|P2|COMPLETED|Overall Study||35
26156|NCT01836042|57422|P1|COMPLETED|Overall Study||51
26157|NCT01836042|57420|P3|STARTED|Overall Study||22
26158|NCT01836042|57421|P2|STARTED|Overall Study||35
26159|NCT01836042|57422|P1|STARTED|Overall Study||51
26160|NCT01835912|57430|P1|NOT COMPLETED|Overall Study||0
26161|NCT01835912|57430|P1|COMPLETED|Overall Study||10
26162|NCT01835912|57430|P1|Chronic Placebo|Overall Study||10
26163|NCT01835912|57430|P1|Chronic|Overall Study||10
26164|NCT01835912|57430|P1|Acute Placebo|Overall Study||10
26165|NCT01835912|57430|P1|Acute|Overall Study||10
26166|NCT01835912|57430|P1|STARTED|Overall Study||10
26167|NCT01835899|57451|P3|NOT COMPLETED|Overall Study||1
26168|NCT01835899|57452|P2|NOT COMPLETED|Overall Study||1
26169|NCT01835899|57453|P1|NOT COMPLETED|Overall Study||0
26170|NCT01835899|57451|P3|COMPLETED|Overall Study||8
26171|NCT01835899|57452|P2|COMPLETED|Overall Study||8
26172|NCT01835899|57453|P1|COMPLETED|Overall Study||6
26173|NCT01835899|57451|P3|STARTED|Overall Study||9
26174|NCT01835899|57452|P2|STARTED|Overall Study||9
26175|NCT01835899|57453|P1|STARTED|Overall Study||6
26176|NCT01835756|57473|P2|NOT COMPLETED|Overall Study||0
26177|NCT01835756|57474|P1|NOT COMPLETED|Overall Study||0
26178|NCT01835756|57473|P2|COMPLETED|Overall Study||31
26179|NCT01835756|57474|P1|COMPLETED|Overall Study||31
26180|NCT01835756|57473|P2|STARTED|Overall Study||31
26181|NCT01835756|57474|P1|STARTED|Overall Study||31
26182|NCT01835743|57486|P2|NOT COMPLETED|Overall Study||0
26183|NCT01835743|57487|P1|NOT COMPLETED|Overall Study||0
26184|NCT01835743|57486|P2|COMPLETED|Overall Study||32
26185|NCT01835743|57487|P1|COMPLETED|Overall Study||37
26186|NCT01835743|57486|P2|STARTED|Overall Study||32
26187|NCT01835743|57487|P1|STARTED|Overall Study||37
26188|NCT01835496|57495|P1|NOT COMPLETED|Overall Study||0
26189|NCT01835496|57495|P1|COMPLETED|Overall Study||8
26190|NCT01835496|57495|P1|STARTED|Overall Study||8
26191|NCT01835470|57504|P1|NOT COMPLETED|Long Term Treatment Period||2
26192|NCT01835470|57504|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
26193|NCT01835470|57504|P1|STARTED|Long Term Treatment Period||20
26194|NCT01835470|57504|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
26195|NCT01835470|57504|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
26196|NCT01835470|57504|P1|STARTED|Short Term Treatment Period (to Week 16)||20
26197|NCT01835431|57516|P2|NOT COMPLETED|Overall Study||12
26198|NCT01835431|57517|P1|NOT COMPLETED|Overall Study||8
26199|NCT01835431|57516|P2|COMPLETED|Overall Study||168
26200|NCT01835431|57517|P1|COMPLETED|Overall Study||174
26201|NCT01835431|57516|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
26202|NCT01835431|57517|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
26203|NCT01835431|57516|P2|STARTED|Overall Study||180
26204|NCT01835431|57517|P1|STARTED|Overall Study||182
26205|NCT01835379|57537|P2|NOT COMPLETED|Overall Study||0
26206|NCT01835379|57538|P1|NOT COMPLETED|Overall Study||0
26207|NCT01835379|57537|P2|COMPLETED|Overall Study||41
26208|NCT01835379|57538|P1|COMPLETED|Overall Study||41
26209|NCT01835379|57537|P2|STARTED|Overall Study||41
26210|NCT01835379|57538|P1|STARTED|Overall Study||41
26211|NCT01835262|57548|P2|NOT COMPLETED|Overall Study||0
26212|NCT01835262|57549|P1|NOT COMPLETED|Overall Study||0
26213|NCT01835262|57548|P2|COMPLETED|Overall Study||45
26214|NCT01835262|57549|P1|COMPLETED|Overall Study||45
26215|NCT01835262|57548|P2|STARTED|Overall Study||45
26216|NCT01835262|57549|P1|STARTED|Overall Study||45
26217|NCT01835132|57555|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
26218|NCT01835132|57555|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
26219|NCT01835132|57555|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
26220|NCT01835132|57555|P1|NOT COMPLETED|1st Extension Phase||0
26221|NCT01835132|57555|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
26222|NCT01835132|57555|P1|STARTED|1st Extension Phase||6
26223|NCT01835132|57555|P1|NOT COMPLETED|Initial Phase||2
26224|NCT01835132|57555|P1|COMPLETED|Initial Phase||6
26225|NCT01835132|57555|P1|STARTED|Initial Phase||8
26226|NCT01835015|57599|P5|NOT COMPLETED|Overall Study||0
26227|NCT01835015|57600|P4|NOT COMPLETED|Overall Study||0
26228|NCT01835015|57601|P3|NOT COMPLETED|Overall Study||1
26229|NCT01835015|57602|P2|NOT COMPLETED|Overall Study||0
26230|NCT01835015|57603|P1|NOT COMPLETED|Overall Study||0
26231|NCT01835015|57599|P5|COMPLETED|Overall Study||6
26232|NCT01835015|57600|P4|COMPLETED|Overall Study||6
26233|NCT01835015|57601|P3|COMPLETED|Overall Study||6
26234|NCT01835015|57602|P2|COMPLETED|Overall Study||6
26235|NCT01835015|57603|P1|COMPLETED|Overall Study||6
26236|NCT01835015|57599|P5|STARTED|Overall Study||6
26237|NCT01835015|57600|P4|STARTED|Overall Study||6
26238|NCT01835015|57601|P3|STARTED|Overall Study||7
26239|NCT01835015|57602|P2|STARTED|Overall Study||6
26240|NCT01835015|57603|P1|STARTED|Overall Study||6
26241|NCT01834404|57678|P2|NOT COMPLETED|Overall Study||0
26242|NCT01834404|57679|P1|NOT COMPLETED|Overall Study||0
26243|NCT01834404|57678|P2|COMPLETED|Overall Study||12
26244|NCT01834404|57679|P1|COMPLETED|Overall Study||12
26245|NCT01834404|57678|P2|STARTED|Overall Study||12
26246|NCT01834404|57679|P1|STARTED|Overall Study||12
26247|NCT01834274|57711|P2|NOT COMPLETED|Overall Study||41
26248|NCT01834274|57712|P1|NOT COMPLETED|Overall Study||47
26249|NCT01834274|57711|P2|COMPLETED|Overall Study||5
26250|NCT01834274|57712|P1|COMPLETED|Overall Study||3
26251|NCT01834274|57711|P2|STARTED|Overall Study||46
26252|NCT01834274|57712|P1|STARTED|Overall Study||50
26253|NCT01834027|57724|P2|NOT COMPLETED|Overall Study||0
26254|NCT01834027|57725|P1|NOT COMPLETED|Overall Study||0
26255|NCT01834027|57724|P2|COMPLETED|Overall Study||28
26256|NCT01834027|57725|P1|COMPLETED|Overall Study||28
26257|NCT01834027|57724|P2|STARTED|Overall Study||28
26258|NCT01834027|57725|P1|STARTED|Overall Study||28
26259|NCT01833897|57735|P1|NOT COMPLETED|Overall Study||1
26260|NCT01833897|57735|P1|COMPLETED|Overall Study||7
26261|NCT01833897|57735|P1|STARTED|Overall Study||8
26262|NCT01833845|57743|P1|NOT COMPLETED|Overall Study||0
26263|NCT01833845|57743|P1|COMPLETED|Overall Study||4
26264|NCT01833845|57743|P1|STARTED|Overall Study||4
26265|NCT01833741|57747|P1|NOT COMPLETED|Overall Study||140
26266|NCT01833741|57747|P1|COMPLETED|Overall Study||997
26267|NCT01833741|57747|P1|STARTED|Overall Study||1137
26268|NCT01833533|57762|P2|NOT COMPLETED|Overall Study||21
26269|NCT01833533|57763|P1|NOT COMPLETED|Overall Study||6
26270|NCT01833533|57762|P2|COMPLETED|Overall Study||184
26271|NCT01833533|57763|P1|COMPLETED|Overall Study||94
26272|NCT01833533|57762|P2|STARTED|Overall Study||205
26273|NCT01833533|57763|P1|STARTED|Overall Study||100
26274|NCT01833481|57780|P3|NOT COMPLETED|Overall Study||0
26275|NCT01833481|57781|P2|NOT COMPLETED|Overall Study||0
26276|NCT01833481|57782|P1|NOT COMPLETED|Overall Study||0
26277|NCT01833481|57780|P3|COMPLETED|Overall Study||10
26278|NCT01833481|57781|P2|COMPLETED|Overall Study||10
26279|NCT01833481|57782|P1|COMPLETED|Overall Study||10
26280|NCT01833481|57780|P3|STARTED|Overall Study||10
26281|NCT01833481|57781|P2|STARTED|Overall Study||10
26282|NCT01833481|57782|P1|STARTED|Overall Study||10
26283|NCT01833403|57796|P1|NOT COMPLETED|Overall Study||0
26284|NCT01833403|57796|P1|COMPLETED|Overall Study||4
26285|NCT01833403|57796|P1|STARTED|Overall Study||4
26286|NCT01833130|57802|P2|NOT COMPLETED|Overall Study||19
26287|NCT01833130|57803|P1|NOT COMPLETED|Overall Study||10
26288|NCT01833130|57802|P2|COMPLETED|Overall Study||8
26289|NCT01833130|57803|P1|COMPLETED|Overall Study||15
26290|NCT01833130|57802|P2|STARTED|Overall Study||27
26291|NCT01833130|57803|P1|STARTED|Overall Study||25
26292|NCT01833117|57841|P2|NOT COMPLETED|Overall Study||0
26293|NCT01833117|57842|P1|NOT COMPLETED|Overall Study||0
26294|NCT01833117|57841|P2|COMPLETED|Overall Study||19
26295|NCT01833117|57842|P1|COMPLETED|Overall Study||43
26296|NCT01833117|57841|P2|STARTED|Overall Study||19
26297|NCT01833117|57842|P1|STARTED|Overall Study||43
26298|NCT01833078|57850|P1|NOT COMPLETED|Overall Study||0
26299|NCT01833078|57850|P1|COMPLETED|Overall Study||5
26300|NCT01833078|57850|P1|STARTED|Overall Study||5
26301|NCT01833065|57858|P5|NOT COMPLETED|Overall Study||36
26302|NCT01833065|57859|P4|NOT COMPLETED|Overall Study||9
26303|NCT01833065|57860|P3|NOT COMPLETED|Overall Study||12
26304|NCT01833065|57861|P2|NOT COMPLETED|Overall Study||13
26305|NCT01833065|57862|P1|NOT COMPLETED|Overall Study||24
26306|NCT01833065|57858|P5|COMPLETED|Overall Study||74
26307|NCT01833065|57859|P4|COMPLETED|Overall Study||41
26308|NCT01833065|57860|P3|COMPLETED|Overall Study||23
26309|NCT01833065|57861|P2|COMPLETED|Overall Study||40
26310|NCT01833065|57862|P1|COMPLETED|Overall Study||41
26311|NCT01833065|57858|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
26312|NCT01833065|57859|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
26313|NCT01833065|57860|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
26314|NCT01833065|57861|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
26315|NCT01833065|57862|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
26316|NCT01833065|57858|P5|STARTED|Overall Study|Randomized patients - As treated|110
26317|NCT01833065|57859|P4|STARTED|Overall Study|Randomized patients - As treated|50
26318|NCT01833065|57860|P3|STARTED|Overall Study|Randomized patients - As treated|35
26319|NCT01833065|57861|P2|STARTED|Overall Study|Randomized patients - As treated|53
26320|NCT01833065|57862|P1|STARTED|Overall Study|Randomized patients - As treated|65
26321|NCT01832766|57893|P2|NOT COMPLETED|Second Intervention||0
26322|NCT01832766|57894|P1|NOT COMPLETED|Second Intervention||0
26323|NCT01832766|57893|P2|COMPLETED|Second Intervention||5
26324|NCT01832766|57894|P1|COMPLETED|Second Intervention||7
26325|NCT01832766|57893|P2|STARTED|Second Intervention||5
26326|NCT01832766|57894|P1|STARTED|Second Intervention||7
26327|NCT01832766|57893|P2|NOT COMPLETED|Washout||1
26328|NCT01832766|57894|P1|NOT COMPLETED|Washout||0
26329|NCT01832766|57893|P2|COMPLETED|Washout||5
26330|NCT01832766|57894|P1|COMPLETED|Washout||7
26331|NCT01832766|57893|P2|STARTED|Washout||6
26332|NCT01832766|57894|P1|STARTED|Washout||7
26333|NCT01832766|57893|P2|NOT COMPLETED|First Intervention||0
26334|NCT01832766|57894|P1|NOT COMPLETED|First Intervention||0
26335|NCT01832766|57893|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
26336|NCT01832766|57894|P1|COMPLETED|First Intervention||7
26337|NCT01832766|57893|P2|STARTED|First Intervention||6
26338|NCT01832766|57894|P1|STARTED|First Intervention||7
26339|NCT01832506|57907|P3|NOT COMPLETED|Overall Study||0
26340|NCT01832506|57908|P2|NOT COMPLETED|Overall Study||0
26341|NCT01832506|57909|P1|NOT COMPLETED|Overall Study||0
26342|NCT01832506|57907|P3|COMPLETED|Overall Study||6
26343|NCT01832506|57908|P2|COMPLETED|Overall Study||3
26344|NCT01832506|57909|P1|COMPLETED|Overall Study||3
26345|NCT01832506|57907|P3|STARTED|Overall Study||6
26346|NCT01832506|57908|P2|STARTED|Overall Study||3
26347|NCT01832506|57909|P1|STARTED|Overall Study||3
26348|NCT01832493|57960|P1|NOT COMPLETED|Overall Study||8
26349|NCT01832493|57960|P1|COMPLETED|Overall Study||42
26350|NCT01832493|57960|P1|STARTED|Overall Study||50
26351|NCT01832155|57969|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
26352|NCT01832155|57970|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
26353|NCT01832155|57969|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
26354|NCT01832155|57970|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
26355|NCT01832155|57969|P2|STARTED|End of Study: 4 - 8 Weeks||18
26356|NCT01832155|57970|P1|STARTED|End of Study: 4 - 8 Weeks||16
26357|NCT01832155|57969|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
26358|NCT01832155|57970|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
26359|NCT01832155|57969|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
26360|NCT01832155|57970|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
26361|NCT01832155|57969|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
26362|NCT01832155|57970|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
26363|NCT01832155|57969|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
26364|NCT01832155|57970|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
26365|NCT01832155|57969|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
26366|NCT01832155|57970|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
26367|NCT01832155|57969|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
26368|NCT01832155|57970|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
26369|NCT01831817|57995|P4|NOT COMPLETED|Overall Study||0
26370|NCT01831817|57996|P3|NOT COMPLETED|Overall Study||0
26371|NCT01831817|57997|P2|NOT COMPLETED|Overall Study||0
26372|NCT01831817|57998|P1|NOT COMPLETED|Overall Study||4
26373|NCT01831817|57995|P4|COMPLETED|Overall Study||36
26374|NCT01831817|57996|P3|COMPLETED|Overall Study||35
26375|NCT01831817|57997|P2|COMPLETED|Overall Study||34
26376|NCT01831817|57998|P1|COMPLETED|Overall Study||31
26377|NCT01831817|57995|P4|STARTED|Overall Study||36
26378|NCT01831817|57996|P3|STARTED|Overall Study||35
26379|NCT01831817|57997|P2|STARTED|Overall Study||34
26380|NCT01831817|57998|P1|STARTED|Overall Study||35
26381|NCT01831791|58036|P1|NOT COMPLETED|Overall Study||10
26382|NCT01831791|58036|P1|COMPLETED|Overall Study||110
26383|NCT01831791|58036|P1|STARTED|Overall Study||120
26384|NCT01831466|58074|P12|NOT COMPLETED|Overall Study||4
26385|NCT01831466|58075|P11|NOT COMPLETED|Overall Study||2
26386|NCT01831466|58076|P10|NOT COMPLETED|Overall Study||5
26387|NCT01831466|58077|P9|NOT COMPLETED|Overall Study||3
26388|NCT01831466|58078|P8|NOT COMPLETED|Overall Study||2
26389|NCT01831466|58079|P7|NOT COMPLETED|Overall Study||1
26390|NCT01831466|58080|P6|NOT COMPLETED|Overall Study||26
26391|NCT01831466|58081|P5|NOT COMPLETED|Overall Study||17
26392|NCT01831466|58082|P4|NOT COMPLETED|Overall Study||19
26393|NCT01831466|58083|P3|NOT COMPLETED|Overall Study||23
26394|NCT01831466|58084|P2|NOT COMPLETED|Overall Study||18
26395|NCT01831466|58085|P1|NOT COMPLETED|Overall Study||16
26396|NCT01831466|58074|P12|COMPLETED|Overall Study||3
26397|NCT01831466|58075|P11|COMPLETED|Overall Study||4
26398|NCT01831466|58076|P10|COMPLETED|Overall Study||2
26399|NCT01831466|58077|P9|COMPLETED|Overall Study||4
26400|NCT01831466|58078|P8|COMPLETED|Overall Study||5
26401|NCT01831466|58079|P7|COMPLETED|Overall Study||6
26402|NCT01831466|58080|P6|COMPLETED|Overall Study||48
26403|NCT01831466|58081|P5|COMPLETED|Overall Study||57
26404|NCT01831466|58082|P4|COMPLETED|Overall Study||51
26405|NCT01831466|58083|P3|COMPLETED|Overall Study||48
26406|NCT01831466|58084|P2|COMPLETED|Overall Study||52
26407|NCT01831466|58085|P1|COMPLETED|Overall Study||55
26408|NCT01831466|58074|P12|STARTED|Overall Study|Treated|7
26409|NCT01831466|58075|P11|STARTED|Overall Study|Treated|6
26410|NCT01831466|58076|P10|STARTED|Overall Study|Treated|7
26411|NCT01831466|58077|P9|STARTED|Overall Study|Treated|7
26412|NCT01831466|58078|P8|STARTED|Overall Study|Treated|7
26413|NCT01831466|58079|P7|STARTED|Overall Study|Treated|7
26414|NCT01831466|58080|P6|STARTED|Overall Study|Treated|74
26415|NCT01831466|58081|P5|STARTED|Overall Study|Treated|74
26416|NCT01831466|58082|P4|STARTED|Overall Study|Treated|70
26417|NCT01831466|58083|P3|STARTED|Overall Study|Treated|71
26418|NCT01831466|58084|P2|STARTED|Overall Study|Treated|70
26419|NCT01831466|58085|P1|STARTED|Overall Study|Treated|71
26420|NCT01831219|58209|P2|NOT COMPLETED|Overall Study||24
26421|NCT01831219|58210|P1|NOT COMPLETED|Overall Study||33
26422|NCT01831219|58209|P2|COMPLETED|Overall Study||21
26423|NCT01831219|58210|P1|COMPLETED|Overall Study||40
26424|NCT01831219|58209|P2|STARTED|Overall Study||45
26425|NCT01831219|58210|P1|STARTED|Overall Study||73
26426|NCT01830933|58230|P2|NOT COMPLETED|Overall Study||232
26427|NCT01830933|58231|P1|NOT COMPLETED|Overall Study||168
26428|NCT01830933|58230|P2|COMPLETED|Overall Study||580
26429|NCT01830933|58231|P1|COMPLETED|Overall Study||655
26430|NCT01830933|58230|P2|Completed Meet-up|Overall Study||603
26431|NCT01830933|58231|P1|Completed Meet-up|Overall Study||675
26432|NCT01830933|58230|P2|STARTED|Overall Study||812
26433|NCT01830933|58231|P1|STARTED|Overall Study||823
26434|NCT01830855|58247|P4|NOT COMPLETED|Overall Study||82
26435|NCT01830855|58248|P3|NOT COMPLETED|Overall Study||66
26436|NCT01830855|58249|P2|NOT COMPLETED|Overall Study||61
26437|NCT01830855|58250|P1|NOT COMPLETED|Overall Study||155
26438|NCT01830855|58247|P4|COMPLETED|Overall Study||815
26439|NCT01830855|58248|P3|COMPLETED|Overall Study||521
26440|NCT01830855|58249|P2|COMPLETED|Overall Study||537
26441|NCT01830855|58250|P1|COMPLETED|Overall Study||1353
26442|NCT01830855|58247|P4|STARTED|Overall Study||897
26443|NCT01830855|58248|P3|STARTED|Overall Study||587
26444|NCT01830855|58249|P2|STARTED|Overall Study||598
26445|NCT01830855|58250|P1|STARTED|Overall Study||1508
26446|NCT01830790|58356|P2|NOT COMPLETED|Overall Study||0
26447|NCT01830790|58357|P1|NOT COMPLETED|Overall Study||0
26448|NCT01830790|58356|P2|COMPLETED|Overall Study||10
26449|NCT01830790|58357|P1|COMPLETED|Overall Study||0
26450|NCT01830790|58356|P2|STARTED|Overall Study||10
26451|NCT01830790|58357|P1|STARTED|Overall Study||0
26452|NCT01830699|58367|P2|NOT COMPLETED|Overall Study||0
26453|NCT01830699|58368|P1|NOT COMPLETED|Overall Study||0
26454|NCT01830699|58367|P2|COMPLETED|Overall Study||20
26455|NCT01830699|58368|P1|COMPLETED|Overall Study||13
26456|NCT01830699|58367|P2|STARTED|Overall Study||20
26457|NCT01830699|58368|P1|STARTED|Overall Study||13
26458|NCT01830205|58382|P4|NOT COMPLETED|Overall Study||0
26459|NCT01830205|58383|P3|NOT COMPLETED|Overall Study||0
26460|NCT01830205|58384|P2|NOT COMPLETED|Overall Study||0
26461|NCT01830205|58385|P1|NOT COMPLETED|Overall Study||0
26462|NCT01830205|58382|P4|COMPLETED|Overall Study||12
26463|NCT01830205|58383|P3|COMPLETED|Overall Study||6
26464|NCT01830205|58384|P2|COMPLETED|Overall Study||6
26465|NCT01830205|58385|P1|COMPLETED|Overall Study||12
26466|NCT01830205|58382|P4|STARTED|Overall Study||12
26467|NCT01830205|58383|P3|STARTED|Overall Study||6
26468|NCT01830205|58384|P2|STARTED|Overall Study||6
26469|NCT01830205|58385|P1|STARTED|Overall Study||12
26470|NCT01830140|58469|P2|NOT COMPLETED|Overall Study||4
26471|NCT01830140|58470|P1|NOT COMPLETED|Overall Study||7
26472|NCT01830140|58469|P2|COMPLETED|Overall Study||229
26473|NCT01830140|58470|P1|COMPLETED|Overall Study||226
26474|NCT01830140|58469|P2|STARTED|Overall Study||233
26475|NCT01830140|58470|P1|STARTED|Overall Study||233
26476|NCT01830127|58478|P2|NOT COMPLETED|Overall Study||9
26477|NCT01830127|58479|P1|NOT COMPLETED|Overall Study||5
26478|NCT01830127|58478|P2|COMPLETED|Overall Study||8
26479|NCT01830127|58479|P1|COMPLETED|Overall Study||13
26480|NCT01830127|58478|P2|STARTED|Overall Study||17
26481|NCT01830127|58479|P1|STARTED|Overall Study||18
26482|NCT01829919|58487|P1|NOT COMPLETED|Overall Study||0
26483|NCT01829919|58487|P1|COMPLETED|Overall Study||24
26484|NCT01829919|58487|P1|STARTED|Overall Study||24
26485|NCT01829516|58503|P2|NOT COMPLETED|2nd Intervention||0
26486|NCT01829516|58504|P1|NOT COMPLETED|2nd Intervention||0
26487|NCT01829516|58503|P2|COMPLETED|2nd Intervention||14
26488|NCT01829516|58504|P1|COMPLETED|2nd Intervention||18
26489|NCT01829516|58503|P2|STARTED|2nd Intervention||14
26490|NCT01829516|58504|P1|STARTED|2nd Intervention||18
26491|NCT01829516|58503|P2|NOT COMPLETED|Washout Period - 1 Week||0
26492|NCT01829516|58504|P1|NOT COMPLETED|Washout Period - 1 Week||0
26493|NCT01829516|58503|P2|COMPLETED|Washout Period - 1 Week||14
26494|NCT01829516|58504|P1|COMPLETED|Washout Period - 1 Week||18
26495|NCT01829516|58503|P2|STARTED|Washout Period - 1 Week||14
26496|NCT01829516|58504|P1|STARTED|Washout Period - 1 Week||18
26497|NCT01829516|58503|P2|NOT COMPLETED|First Intervention||0
26498|NCT01829516|58504|P1|NOT COMPLETED|First Intervention||0
26499|NCT01829516|58503|P2|COMPLETED|First Intervention||14
26500|NCT01829516|58504|P1|COMPLETED|First Intervention||18
26501|NCT01829516|58503|P2|STARTED|First Intervention||14
26502|NCT01829516|58504|P1|STARTED|First Intervention||18
26503|NCT01829477|58514|P2|NOT COMPLETED|Overall Study||15
26504|NCT01829477|58515|P1|NOT COMPLETED|Overall Study||16
26505|NCT01829477|58514|P2|COMPLETED|Overall Study||1
26506|NCT01829477|58515|P1|COMPLETED|Overall Study||1
26507|NCT01829477|58514|P2|STARTED|Overall Study||16
26508|NCT01829477|58515|P1|STARTED|Overall Study||17
26509|NCT01829464|58528|P3|NOT COMPLETED|Overall Study||26
26510|NCT01829464|58529|P2|NOT COMPLETED|Overall Study||29
26511|NCT01829464|58530|P1|NOT COMPLETED|Overall Study||28
26512|NCT01829464|58528|P3|COMPLETED|Overall Study||3
26513|NCT01829464|58529|P2|COMPLETED|Overall Study||2
26514|NCT01829464|58530|P1|COMPLETED|Overall Study||2
26515|NCT01829464|58528|P3|STARTED|Overall Study||29
26516|NCT01829464|58529|P2|STARTED|Overall Study||31
26517|NCT01829464|58530|P1|STARTED|Overall Study||30
26518|NCT01829399|58546|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
26519|NCT01829399|58547|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
26520|NCT01829399|58546|P2|COMPLETED|Visit 2 (One Month Later)||12
26521|NCT01829399|58547|P1|COMPLETED|Visit 2 (One Month Later)||12
26522|NCT01829399|58546|P2|STARTED|Visit 2 (One Month Later)||12
26523|NCT01829399|58547|P1|STARTED|Visit 2 (One Month Later)||12
26524|NCT01829399|58546|P2|NOT COMPLETED|Visit 1||0
26525|NCT01829399|58547|P1|NOT COMPLETED|Visit 1||0
26526|NCT01829399|58546|P2|COMPLETED|Visit 1||12
26527|NCT01829399|58547|P1|COMPLETED|Visit 1||12
26528|NCT01829399|58546|P2|STARTED|Visit 1||12
26529|NCT01829399|58547|P1|STARTED|Visit 1||12
26530|NCT01829243|58555|P2|NOT COMPLETED|Second Intervention||0
26531|NCT01829243|58556|P1|NOT COMPLETED|Second Intervention||0
26532|NCT01829243|58555|P2|COMPLETED|Second Intervention||13
26533|NCT01829243|58556|P1|COMPLETED|Second Intervention||7
26534|NCT01829243|58555|P2|STARTED|Second Intervention||13
26535|NCT01829243|58556|P1|STARTED|Second Intervention||7
26536|NCT01829243|58555|P2|NOT COMPLETED|Washout Period of 1 Week||0
26537|NCT01829243|58556|P1|NOT COMPLETED|Washout Period of 1 Week||0
26538|NCT01829243|58555|P2|COMPLETED|Washout Period of 1 Week||13
26539|NCT01829243|58556|P1|COMPLETED|Washout Period of 1 Week||7
26540|NCT01829243|58555|P2|STARTED|Washout Period of 1 Week||13
26541|NCT01829243|58556|P1|STARTED|Washout Period of 1 Week||7
26542|NCT01829243|58555|P2|NOT COMPLETED|First Intervention||2
26543|NCT01829243|58556|P1|NOT COMPLETED|First Intervention||4
26544|NCT01829243|58555|P2|COMPLETED|First Intervention||13
26545|NCT01829243|58556|P1|COMPLETED|First Intervention||7
26546|NCT01829243|58555|P2|STARTED|First Intervention||15
26547|NCT01829243|58556|P1|STARTED|First Intervention||11
26548|NCT01829230|58570|P2|NOT COMPLETED|Overall Study||4
26549|NCT01829230|58571|P1|NOT COMPLETED|Overall Study||1
26550|NCT01829230|58570|P2|COMPLETED|Overall Study||38
26551|NCT01829230|58571|P1|COMPLETED|Overall Study||39
26552|NCT01829230|58570|P2|STARTED|Overall Study||42
26553|NCT01829230|58571|P1|STARTED|Overall Study||40
26554|NCT01829191|58581|P2|NOT COMPLETED|Overall Study||14
26555|NCT01829191|58582|P1|NOT COMPLETED|Overall Study||7
26556|NCT01829191|58581|P2|COMPLETED|Overall Study||50
26557|NCT01829191|58582|P1|COMPLETED|Overall Study||56
26558|NCT01829191|58581|P2|STARTED|Overall Study||64
26559|NCT01829191|58582|P1|STARTED|Overall Study||63
26560|NCT01828593|58592|P3|NOT COMPLETED|Placebo-Free Phase||6
26561|NCT01828593|58593|P2|NOT COMPLETED|Placebo-Free Phase||6
26562|NCT01828593|58594|P1|NOT COMPLETED|Placebo-Free Phase||0
26563|NCT01828593|58592|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
26564|NCT01828593|58593|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
26565|NCT01828593|58594|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
26566|NCT01828593|58592|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
26567|NCT01828593|58593|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
26568|NCT01828593|58594|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
26569|NCT01828593|58592|P3|NOT COMPLETED|Placebo-Controlled Phase||1
26570|NCT01828593|58593|P2|NOT COMPLETED|Placebo-Controlled Phase||0
26571|NCT01828593|58594|P1|NOT COMPLETED|Placebo-Controlled Phase||0
26572|NCT01828593|58592|P3|COMPLETED|Placebo-Controlled Phase||32
26573|NCT01828593|58593|P2|COMPLETED|Placebo-Controlled Phase||34
26574|NCT01828593|58594|P1|COMPLETED|Placebo-Controlled Phase||36
26575|NCT01828593|58592|P3|STARTED|Placebo-Controlled Phase||33
26576|NCT01828593|58593|P2|STARTED|Placebo-Controlled Phase||34
26577|NCT01828593|58594|P1|STARTED|Placebo-Controlled Phase||36
26578|NCT01828281|58606|P2|NOT COMPLETED|Overall Study||0
26579|NCT01828281|58607|P1|NOT COMPLETED|Overall Study||1
26580|NCT01828281|58606|P2|COMPLETED|Overall Study||45
26581|NCT01828281|58607|P1|COMPLETED|Overall Study||44
26582|NCT01828281|58606|P2|STARTED|Overall Study||45
26583|NCT01828281|58607|P1|STARTED|Overall Study||45
26584|NCT01828216|58619|P2|NOT COMPLETED|Overall Study||0
26585|NCT01828216|58620|P1|NOT COMPLETED|Overall Study||0
26586|NCT01828216|58619|P2|COMPLETED|Overall Study||157
26587|NCT01828216|58620|P1|COMPLETED|Overall Study||159
26588|NCT01828216|58619|P2|STARTED|Overall Study||157
26589|NCT01828216|58620|P1|STARTED|Overall Study||159
26590|NCT01827670|58630|P2|NOT COMPLETED|Overall Study||3
26591|NCT01827670|58631|P1|NOT COMPLETED|Overall Study||3
26592|NCT01827670|58630|P2|COMPLETED|Overall Study||56
26593|NCT01827670|58631|P1|COMPLETED|Overall Study||57
26594|NCT01827670|58630|P2|STARTED|Overall Study||59
26595|NCT01827670|58631|P1|STARTED|Overall Study||60
26596|NCT01827592|58650|P3|NOT COMPLETED|Overall Study||76
26597|NCT01827592|58651|P2|NOT COMPLETED|Overall Study||80
26598|NCT01827592|58652|P1|NOT COMPLETED|Overall Study||74
26599|NCT01827592|58650|P3|COMPLETED|Overall Study||48
26600|NCT01827592|58651|P2|COMPLETED|Overall Study||46
26601|NCT01827592|58652|P1|COMPLETED|Overall Study||52
26602|NCT01827592|58650|P3|Safety Analysis Set|Overall Study||124
26603|NCT01827592|58651|P2|Safety Analysis Set|Overall Study||126
26604|NCT01827592|58652|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
26605|NCT01827592|58650|P3|STARTED|Overall Study|Randomized patients.|124
26606|NCT01827592|58651|P2|STARTED|Overall Study|Randomized patients.|126
26607|NCT01827592|58652|P1|STARTED|Overall Study|Randomized patients.|126
26608|NCT01827475|58684|P3|NOT COMPLETED|Overall Study||0
26609|NCT01827475|58685|P2|NOT COMPLETED|Overall Study||0
26610|NCT01827475|58686|P1|NOT COMPLETED|Overall Study||0
26611|NCT01827475|58684|P3|COMPLETED|Overall Study||30
26612|NCT01827475|58685|P2|COMPLETED|Overall Study||30
26613|NCT01827475|58686|P1|COMPLETED|Overall Study||30
26614|NCT01827475|58684|P3|STARTED|Overall Study||30
26615|NCT01827475|58685|P2|STARTED|Overall Study||30
26616|NCT01827475|58686|P1|STARTED|Overall Study||30
26617|NCT01827371|58701|P4|NOT COMPLETED|Overall Study||23
26618|NCT01827371|58702|P3|NOT COMPLETED|Overall Study||11
26619|NCT01827371|58703|P2|NOT COMPLETED|Overall Study||7
26620|NCT01827371|58704|P1|NOT COMPLETED|Overall Study||13
26621|NCT01827371|58701|P4|COMPLETED|Overall Study||97
26622|NCT01827371|58702|P3|COMPLETED|Overall Study||93
26623|NCT01827371|58703|P2|COMPLETED|Overall Study||89
26624|NCT01827371|58704|P1|COMPLETED|Overall Study||102
26625|NCT01827371|58701|P4|STARTED|Overall Study||120
26626|NCT01827371|58702|P3|STARTED|Overall Study||104
26627|NCT01827371|58703|P2|STARTED|Overall Study||96
26628|NCT01827371|58704|P1|STARTED|Overall Study||115
26629|NCT01827332|58728|P2|NOT COMPLETED|Overall Study||1
26630|NCT01827332|58729|P1|NOT COMPLETED|Overall Study||2
26631|NCT01827332|58728|P2|COMPLETED|Overall Study||7
26632|NCT01827332|58729|P1|COMPLETED|Overall Study||6
26633|NCT01827332|58728|P2|STARTED|Overall Study||8
26634|NCT01827332|58729|P1|STARTED|Overall Study||8
26635|NCT01827319|58737|P1|NOT COMPLETED|Overall Study||3
26636|NCT01827319|58737|P1|COMPLETED|Overall Study||200
26637|NCT01827319|58737|P1|STARTED|Overall Study||203
26638|NCT01827306|58745|P2|NOT COMPLETED|Overall Study||5
26639|NCT01827306|58746|P1|NOT COMPLETED|Overall Study||11
26640|NCT01827306|58745|P2|COMPLETED|Overall Study||8
26641|NCT01827306|58746|P1|COMPLETED|Overall Study||10
26642|NCT01827306|58745|P2|STARTED|Overall Study||13
26643|NCT01827306|58746|P1|STARTED|Overall Study||21
26644|NCT01827254|58758|P1|NOT COMPLETED|Overall Study||59
26645|NCT01827254|58758|P1|COMPLETED|Overall Study||2
26646|NCT01827254|58758|P1|Evaluable Population|Overall Study||52
26647|NCT01827254|58758|P1|STARTED|Overall Study||61
26648|NCT01826981|58783|P15|NOT COMPLETED|Overall Study||0
26649|NCT01826981|58784|P14|NOT COMPLETED|Overall Study||5
26650|NCT01826981|58785|P13|NOT COMPLETED|Overall Study||1
26651|NCT01826981|58786|P12|NOT COMPLETED|Overall Study||2
26652|NCT01826981|58787|P11|NOT COMPLETED|Overall Study||2
26653|NCT01826981|58788|P10|NOT COMPLETED|Overall Study||1
26654|NCT01826981|58789|P9|NOT COMPLETED|Overall Study||7
26655|NCT01826981|58790|P8|NOT COMPLETED|Overall Study||11
26656|NCT01826981|58791|P7|NOT COMPLETED|Overall Study||1
26657|NCT01826981|58792|P6|NOT COMPLETED|Overall Study||1
26658|NCT01826981|58793|P5|NOT COMPLETED|Overall Study||7
26659|NCT01826981|58794|P4|NOT COMPLETED|Overall Study||0
26660|NCT01826981|58795|P3|NOT COMPLETED|Overall Study||0
26661|NCT01826981|58796|P2|NOT COMPLETED|Overall Study||1
26662|NCT01826981|58797|P1|NOT COMPLETED|Overall Study||0
26663|NCT01826981|58783|P15|COMPLETED|Overall Study||8
26664|NCT01826981|58784|P14|COMPLETED|Overall Study||15
26665|NCT01826981|58785|P13|COMPLETED|Overall Study||25
26666|NCT01826981|58786|P12|COMPLETED|Overall Study||25
26667|NCT01826981|58787|P11|COMPLETED|Overall Study||22
26668|NCT01826981|58788|P10|COMPLETED|Overall Study||26
26669|NCT01826981|58789|P9|COMPLETED|Overall Study||13
26670|NCT01826981|58790|P8|COMPLETED|Overall Study||40
26671|NCT01826981|58791|P7|COMPLETED|Overall Study||24
26672|NCT01826981|58792|P6|COMPLETED|Overall Study||25
26673|NCT01826981|58793|P5|COMPLETED|Overall Study||18
26674|NCT01826981|58794|P4|COMPLETED|Overall Study||26
26675|NCT01826981|58795|P3|COMPLETED|Overall Study||25
26676|NCT01826981|58796|P2|COMPLETED|Overall Study||9
26677|NCT01826981|58797|P1|COMPLETED|Overall Study||19
26678|NCT01826981|58783|P15|STARTED|Overall Study||8
26679|NCT01826981|58784|P14|STARTED|Overall Study||20
26680|NCT01826981|58785|P13|STARTED|Overall Study||26
26681|NCT01826981|58786|P12|STARTED|Overall Study||27
26682|NCT01826981|58787|P11|STARTED|Overall Study||24
26683|NCT01826981|58788|P10|STARTED|Overall Study||27
26684|NCT01826981|58789|P9|STARTED|Overall Study||20
26685|NCT01826981|58790|P8|STARTED|Overall Study||51
26686|NCT01826981|58791|P7|STARTED|Overall Study||25
26687|NCT01826981|58792|P6|STARTED|Overall Study||26
26688|NCT01826981|58793|P5|STARTED|Overall Study||25
26689|NCT01826981|58794|P4|STARTED|Overall Study||26
26690|NCT01826981|58795|P3|STARTED|Overall Study||25
26691|NCT01826981|58796|P2|STARTED|Overall Study||10
26692|NCT01826981|58797|P1|STARTED|Overall Study||19
26693|NCT01826812|58945|P2|NOT COMPLETED|Overall Study||1
26694|NCT01826812|58946|P1|NOT COMPLETED|Overall Study||0
26695|NCT01826812|58945|P2|COMPLETED|Overall Study||32
26696|NCT01826812|58946|P1|COMPLETED|Overall Study||167
26697|NCT01826812|58945|P2|STARTED|Overall Study||33
26698|NCT01826812|58946|P1|STARTED|Overall Study||167
26699|NCT01826604|58960|P2|NOT COMPLETED|Overall Study||9
26700|NCT01826604|58961|P1|NOT COMPLETED|Overall Study||8
26701|NCT01826604|58960|P2|COMPLETED|Overall Study||148
26702|NCT01826604|58961|P1|COMPLETED|Overall Study||136
26703|NCT01826604|58960|P2|STARTED|Overall Study||157
26704|NCT01826604|58961|P1|STARTED|Overall Study||144
26705|NCT01826370|58969|P1|NOT COMPLETED|Overall Study||20
26706|NCT01826370|58969|P1|COMPLETED|Overall Study||658
26707|NCT01826370|58969|P1|STARTED|Overall Study||678
26708|NCT01826214|58977|P2|NOT COMPLETED|Overall Study||34
26709|NCT01826214|58978|P1|NOT COMPLETED|Overall Study||35
26710|NCT01826214|58977|P2|COMPLETED|Overall Study||0
26711|NCT01826214|58978|P1|COMPLETED|Overall Study||0
26712|NCT01826214|58977|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
26713|NCT01826214|58978|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
26714|NCT01826214|58977|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
26715|NCT01826214|58978|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
26716|NCT01826214|58977|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
26717|NCT01826214|58978|P1|STARTED|Overall Study||35
26718|NCT01826201|58996|P1|NOT COMPLETED|Overall Study||4
26719|NCT01826201|58996|P1|COMPLETED|Overall Study||17
26720|NCT01826201|58996|P1|STARTED|Overall Study|Subjects in each arm are same|21
26721|NCT01825837|59006|P4|NOT COMPLETED|PART II||0
26722|NCT01825837|59007|P3|NOT COMPLETED|PART II||19
26723|NCT01825837|59008|P2|NOT COMPLETED|PART II||14
26724|NCT01825837|59009|P1|NOT COMPLETED|PART II||19
26725|NCT01825837|59006|P4|COMPLETED|PART II||0
26726|NCT01825837|59007|P3|COMPLETED|PART II||7
26727|NCT01825837|59008|P2|COMPLETED|PART II||12
26728|NCT01825837|59009|P1|COMPLETED|PART II||16
26729|NCT01825837|59006|P4|Per-Protocol Population|PART II||0
26730|NCT01825837|59007|P3|Per-Protocol Population|PART II||24
26731|NCT01825837|59008|P2|Per-Protocol Population|PART II||23
26732|NCT01825837|59009|P1|Per-Protocol Population|PART II||32
26733|NCT01825837|59006|P4|Intent-to-Treat Population|PART II||0
26734|NCT01825837|59007|P3|Intent-to-Treat Population|PART II||26
26735|NCT01825837|59008|P2|Intent-to-Treat Population|PART II||25
26736|NCT01825837|59009|P1|Intent-to-Treat Population|PART II||34
26737|NCT01825837|59006|P4|Safety Population (Double-Blind)|PART II||0
26738|NCT01825837|59007|P3|Safety Population (Double-Blind)|PART II||26
26739|NCT01825837|59008|P2|Safety Population (Double-Blind)|PART II||26
26740|NCT01825837|59009|P1|Safety Population (Double-Blind)|PART II||35
26741|NCT01825837|59006|P4|Randomized Patients|PART II||0
26742|NCT01825837|59007|P3|Randomized Patients|PART II||26
26743|NCT01825837|59008|P2|Randomized Patients|PART II||26
26744|NCT01825837|59009|P1|Randomized Patients|PART II||35
26745|NCT01825837|59006|P4|STARTED|PART II||0
26746|NCT01825837|59007|P3|STARTED|PART II||26
26747|NCT01825837|59008|P2|STARTED|PART II||26
26748|NCT01825837|59009|P1|STARTED|PART II||35
26749|NCT01825837|59006|P4|NOT COMPLETED|PART I||17
26750|NCT01825837|59007|P3|NOT COMPLETED|PART I||0
26751|NCT01825837|59008|P2|NOT COMPLETED|PART I||0
26752|NCT01825837|59009|P1|NOT COMPLETED|PART I||0
26753|NCT01825837|59006|P4|COMPLETED|PART I||87
26754|NCT01825837|59007|P3|COMPLETED|PART I||0
26755|NCT01825837|59008|P2|COMPLETED|PART I||0
26756|NCT01825837|59009|P1|COMPLETED|PART I||0
26757|NCT01825837|59006|P4|Safety Population (Open-Label)|PART I||104
26758|NCT01825837|59007|P3|Safety Population (Open-Label)|PART I||0
26759|NCT01825837|59008|P2|Safety Population (Open-Label)|PART I||0
26760|NCT01825837|59009|P1|Safety Population (Open-Label)|PART I||0
26761|NCT01825837|59006|P4|Enrolled|PART I||104
26762|NCT01825837|59007|P3|Enrolled|PART I||0
26763|NCT01825837|59008|P2|Enrolled|PART I||0
26764|NCT01825837|59009|P1|Enrolled|PART I||0
26765|NCT01825837|59006|P4|STARTED|PART I||104
26766|NCT01825837|59007|P3|STARTED|PART I||0
26767|NCT01825837|59008|P2|STARTED|PART I||0
26768|NCT01825837|59009|P1|STARTED|PART I||0
26769|NCT01825577|59017|P1|NOT COMPLETED|Overall Study||8
26770|NCT01825577|59017|P1|COMPLETED|Overall Study||6
26771|NCT01825577|59017|P1|STARTED|Overall Study||14
26772|NCT01825200|59024|P2|NOT COMPLETED|Overall Study||7
26773|NCT01825200|59025|P1|NOT COMPLETED|Overall Study||5
26774|NCT01825200|59024|P2|COMPLETED|Overall Study||1314
26775|NCT01825200|59025|P1|COMPLETED|Overall Study||1314
26776|NCT01825200|59024|P2|STARTED|Overall Study||1321
26777|NCT01825200|59025|P1|STARTED|Overall Study||1319
26778|NCT01825122|59039|P2|NOT COMPLETED|Overall Study||19
26779|NCT01825122|59040|P1|NOT COMPLETED|Overall Study||10
26780|NCT01825122|59039|P2|COMPLETED|Overall Study||59
26781|NCT01825122|59040|P1|COMPLETED|Overall Study||67
26782|NCT01825122|59039|P2|STARTED|Overall Study||78
26783|NCT01825122|59040|P1|STARTED|Overall Study||77
26784|NCT01824901|59046|P4|NOT COMPLETED|Overall Study||0
26785|NCT01824901|59047|P3|NOT COMPLETED|Overall Study||0
26786|NCT01824901|59048|P2|NOT COMPLETED|Overall Study||0
26787|NCT01824901|59049|P1|NOT COMPLETED|Overall Study||0
26788|NCT01824901|59046|P4|COMPLETED|Overall Study||0
26789|NCT01824901|59047|P3|COMPLETED|Overall Study||0
26790|NCT01824901|59048|P2|COMPLETED|Overall Study||0
26791|NCT01824901|59049|P1|COMPLETED|Overall Study||2
26792|NCT01824901|59046|P4|STARTED|Overall Study||0
26793|NCT01824901|59047|P3|STARTED|Overall Study||0
26794|NCT01824901|59048|P2|STARTED|Overall Study||0
26795|NCT01824901|59049|P1|STARTED|Overall Study||2
26796|NCT01824823|59055|P2|NOT COMPLETED|Overall Study||1
26797|NCT01824823|59056|P1|NOT COMPLETED|Overall Study||2
26798|NCT01824823|59055|P2|COMPLETED|Overall Study||0
26799|NCT01824823|59056|P1|COMPLETED|Overall Study||0
26800|NCT01824823|59055|P2|STARTED|Overall Study||1
26801|NCT01824823|59056|P1|STARTED|Overall Study||2
26802|NCT01823653|59062|P1|NOT COMPLETED|Overall Study||0
26803|NCT01823653|59062|P1|COMPLETED|Overall Study||60
26804|NCT01823653|59062|P1|STARTED|Overall Study||60
26805|NCT01823614|59076|P6|NOT COMPLETED|Overall Study||0
26806|NCT01823614|59077|P5|NOT COMPLETED|Overall Study||0
26807|NCT01823614|59078|P4|NOT COMPLETED|Overall Study||0
26808|NCT01823614|59079|P3|NOT COMPLETED|Overall Study||0
26809|NCT01823614|59080|P2|NOT COMPLETED|Overall Study||0
26810|NCT01823614|59081|P1|NOT COMPLETED|Overall Study||0
26811|NCT01823614|59076|P6|COMPLETED|Overall Study||154
26812|NCT01823614|59077|P5|COMPLETED|Overall Study||172
26813|NCT01823614|59078|P4|COMPLETED|Overall Study||122
26814|NCT01823614|59079|P3|COMPLETED|Overall Study||176
26815|NCT01823614|59080|P2|COMPLETED|Overall Study||140
26816|NCT01823614|59081|P1|COMPLETED|Overall Study||179
26817|NCT01823614|59076|P6|STARTED|Overall Study||154
26818|NCT01823614|59077|P5|STARTED|Overall Study||172
26819|NCT01823614|59078|P4|STARTED|Overall Study||122
26820|NCT01823614|59079|P3|STARTED|Overall Study||176
26821|NCT01823614|59080|P2|STARTED|Overall Study||140
26822|NCT01823614|59081|P1|STARTED|Overall Study||179
26823|NCT01824602|59105|P4|NOT COMPLETED|Overall Study||5
26824|NCT01824602|59106|P3|NOT COMPLETED|Overall Study||4
26825|NCT01824602|59107|P2|NOT COMPLETED|Overall Study||0
26826|NCT01824602|59108|P1|NOT COMPLETED|Overall Study||1
26827|NCT01824602|59105|P4|COMPLETED|Overall Study||5
26828|NCT01824602|59106|P3|COMPLETED|Overall Study||5
26829|NCT01824602|59107|P2|COMPLETED|Overall Study||8
26830|NCT01824602|59108|P1|COMPLETED|Overall Study||10
26831|NCT01824602|59105|P4|Intent-to-treat Population|Overall Study||9
26832|NCT01824602|59106|P3|Intent-to-treat Population|Overall Study||9
26833|NCT01824602|59107|P2|Intent-to-treat Population|Overall Study||8
26834|NCT01824602|59108|P1|Intent-to-treat Population|Overall Study||11
26835|NCT01824602|59105|P4|Safety Population|Overall Study||10
26836|NCT01824602|59106|P3|Safety Population|Overall Study||9
26837|NCT01824602|59107|P2|Safety Population|Overall Study||8
26838|NCT01824602|59108|P1|Safety Population|Overall Study||11
26839|NCT01824602|59105|P4|STARTED|Overall Study||10
26840|NCT01824602|59106|P3|STARTED|Overall Study||9
26841|NCT01824602|59107|P2|STARTED|Overall Study||8
26842|NCT01824602|59108|P1|STARTED|Overall Study||11
26843|NCT01824589|59122|P4|NOT COMPLETED|Overall Study||0
26844|NCT01824589|59123|P3|NOT COMPLETED|Overall Study||0
26845|NCT01824589|59124|P2|NOT COMPLETED|Overall Study||0
26846|NCT01824589|59125|P1|NOT COMPLETED|Overall Study||0
26847|NCT01824589|59122|P4|COMPLETED|Overall Study||0
26848|NCT01824589|59123|P3|COMPLETED|Overall Study||0
26849|NCT01824589|59124|P2|COMPLETED|Overall Study||0
26850|NCT01824589|59125|P1|COMPLETED|Overall Study||1
26851|NCT01824589|59122|P4|STARTED|Overall Study||0
26852|NCT01824589|59123|P3|STARTED|Overall Study||0
26853|NCT01824589|59124|P2|STARTED|Overall Study||0
26854|NCT01824589|59125|P1|STARTED|Overall Study||1
26855|NCT01824498|59153|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26856|NCT01824498|59154|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26857|NCT01824498|59155|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26858|NCT01824498|59156|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26859|NCT01824498|59157|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26860|NCT01824498|59158|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
26861|NCT01824498|59153|P6|COMPLETED|3rd Intervention (8 Weeks)||4
26862|NCT01824498|59154|P5|COMPLETED|3rd Intervention (8 Weeks)||3
26863|NCT01824498|59155|P4|COMPLETED|3rd Intervention (8 Weeks)||2
26864|NCT01824498|59156|P3|COMPLETED|3rd Intervention (8 Weeks)||4
26865|NCT01824498|59157|P2|COMPLETED|3rd Intervention (8 Weeks)||2
26866|NCT01824498|59158|P1|COMPLETED|3rd Intervention (8 Weeks)||3
26867|NCT01824498|59153|P6|STARTED|3rd Intervention (8 Weeks)||4
26868|NCT01824498|59154|P5|STARTED|3rd Intervention (8 Weeks)||3
26869|NCT01824498|59155|P4|STARTED|3rd Intervention (8 Weeks)||2
26870|NCT01824498|59156|P3|STARTED|3rd Intervention (8 Weeks)||4
26871|NCT01824498|59157|P2|STARTED|3rd Intervention (8 Weeks)||2
26872|NCT01824498|59158|P1|STARTED|3rd Intervention (8 Weeks)||3
26873|NCT01824498|59153|P6|NOT COMPLETED|Washout (8 Weeks)||0
26874|NCT01824498|59154|P5|NOT COMPLETED|Washout (8 Weeks)||0
26875|NCT01824498|59155|P4|NOT COMPLETED|Washout (8 Weeks)||0
26876|NCT01824498|59156|P3|NOT COMPLETED|Washout (8 Weeks)||0
26877|NCT01824498|59157|P2|NOT COMPLETED|Washout (8 Weeks)||0
26878|NCT01824498|59158|P1|NOT COMPLETED|Washout (8 Weeks)||0
26879|NCT01824498|59153|P6|COMPLETED|Washout (8 Weeks)||4
26880|NCT01824498|59154|P5|COMPLETED|Washout (8 Weeks)||3
26881|NCT01824498|59155|P4|COMPLETED|Washout (8 Weeks)||2
26882|NCT01824498|59156|P3|COMPLETED|Washout (8 Weeks)||4
26883|NCT01824498|59157|P2|COMPLETED|Washout (8 Weeks)||2
26884|NCT01824498|59158|P1|COMPLETED|Washout (8 Weeks)||3
26885|NCT01824498|59153|P6|STARTED|Washout (8 Weeks)||4
26886|NCT01824498|59154|P5|STARTED|Washout (8 Weeks)||3
26887|NCT01824498|59155|P4|STARTED|Washout (8 Weeks)||2
26888|NCT01824498|59156|P3|STARTED|Washout (8 Weeks)||4
26889|NCT01824498|59157|P2|STARTED|Washout (8 Weeks)||2
26890|NCT01824498|59158|P1|STARTED|Washout (8 Weeks)||3
26891|NCT01824498|59153|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26892|NCT01824498|59154|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26893|NCT01824498|59155|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26894|NCT01824498|59156|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26895|NCT01824498|59157|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26896|NCT01824498|59158|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
26897|NCT01824498|59153|P6|COMPLETED|2nd Intervention (8 Weeks)||4
26898|NCT01824498|59154|P5|COMPLETED|2nd Intervention (8 Weeks)||3
26899|NCT01824498|59155|P4|COMPLETED|2nd Intervention (8 Weeks)||2
26900|NCT01824498|59156|P3|COMPLETED|2nd Intervention (8 Weeks)||4
26901|NCT01824498|59157|P2|COMPLETED|2nd Intervention (8 Weeks)||2
26902|NCT01824498|59158|P1|COMPLETED|2nd Intervention (8 Weeks)||3
26903|NCT01824498|59153|P6|STARTED|2nd Intervention (8 Weeks)||4
26904|NCT01824498|59154|P5|STARTED|2nd Intervention (8 Weeks)||3
26905|NCT01824498|59155|P4|STARTED|2nd Intervention (8 Weeks)||2
26906|NCT01824498|59156|P3|STARTED|2nd Intervention (8 Weeks)||4
26907|NCT01824498|59157|P2|STARTED|2nd Intervention (8 Weeks)||2
26908|NCT01824498|59158|P1|STARTED|2nd Intervention (8 Weeks)||3
26909|NCT01824498|59153|P6|NOT COMPLETED|Washout (8 Weeks)||0
26910|NCT01824498|59154|P5|NOT COMPLETED|Washout (8 Weeks)||1
26911|NCT01824498|59155|P4|NOT COMPLETED|Washout (8 Weeks)||1
26912|NCT01824498|59156|P3|NOT COMPLETED|Washout (8 Weeks)||2
26913|NCT01824498|59157|P2|NOT COMPLETED|Washout (8 Weeks)||0
26914|NCT01824498|59158|P1|NOT COMPLETED|Washout (8 Weeks)||2
26915|NCT01824498|59153|P6|COMPLETED|Washout (8 Weeks)||4
26916|NCT01824498|59154|P5|COMPLETED|Washout (8 Weeks)||3
26917|NCT01824498|59155|P4|COMPLETED|Washout (8 Weeks)||2
26918|NCT01824498|59156|P3|COMPLETED|Washout (8 Weeks)||4
26919|NCT01824498|59157|P2|COMPLETED|Washout (8 Weeks)||2
26920|NCT01824498|59158|P1|COMPLETED|Washout (8 Weeks)||3
26921|NCT01824498|59153|P6|STARTED|Washout (8 Weeks)||4
26922|NCT01824498|59154|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
26923|NCT01824498|59155|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
26924|NCT01824498|59156|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
26925|NCT01824498|59157|P2|STARTED|Washout (8 Weeks)||2
26926|NCT01824498|59158|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
26927|NCT01824498|59153|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
26928|NCT01824498|59154|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
26929|NCT01824498|59155|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
26930|NCT01824498|59156|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
26931|NCT01824498|59157|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
26932|NCT01824498|59158|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
26933|NCT01824498|59153|P6|COMPLETED|1st Intervention (8 Weeks)||4
26934|NCT01824498|59154|P5|COMPLETED|1st Intervention (8 Weeks)||4
26935|NCT01824498|59155|P4|COMPLETED|1st Intervention (8 Weeks)||3
26936|NCT01824498|59156|P3|COMPLETED|1st Intervention (8 Weeks)||6
26937|NCT01824498|59157|P2|COMPLETED|1st Intervention (8 Weeks)||2
26938|NCT01824498|59158|P1|COMPLETED|1st Intervention (8 Weeks)||5
26939|NCT01824498|59153|P6|STARTED|1st Intervention (8 Weeks)||4
26940|NCT01824498|59154|P5|STARTED|1st Intervention (8 Weeks)||4
26941|NCT01824498|59155|P4|STARTED|1st Intervention (8 Weeks)||3
26942|NCT01824498|59156|P3|STARTED|1st Intervention (8 Weeks)||6
26943|NCT01824498|59157|P2|STARTED|1st Intervention (8 Weeks)||2
26944|NCT01824498|59158|P1|STARTED|1st Intervention (8 Weeks)||5
26945|NCT01824446|59166|P1|NOT COMPLETED|Overall Study||0
26946|NCT01824446|59166|P1|COMPLETED|Overall Study||6
26947|NCT01824446|59166|P1|STARTED|Overall Study||6
26948|NCT01824355|59189|P1|NOT COMPLETED|Overall Study||3
26949|NCT01824355|59189|P1|COMPLETED|Overall Study||110
26950|NCT01824355|59189|P1|STARTED|Overall Study||113
26951|NCT01824342|59200|P2|NOT COMPLETED|Overall Study||5
26952|NCT01824342|59201|P1|NOT COMPLETED|Overall Study||9
26953|NCT01824342|59200|P2|COMPLETED|Overall Study||2
26954|NCT01824342|59201|P1|COMPLETED|Overall Study||2
26955|NCT01824342|59200|P2|STARTED|Overall Study||7
26956|NCT01824342|59201|P1|STARTED|Overall Study||11
26957|NCT01824303|59215|P2|NOT COMPLETED|Open Label Extension||0
26958|NCT01824303|59216|P1|NOT COMPLETED|Open Label Extension||0
26959|NCT01824303|59215|P2|COMPLETED|Open Label Extension||11
26960|NCT01824303|59216|P1|COMPLETED|Open Label Extension||12
26961|NCT01824303|59215|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
26962|NCT01824303|59216|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
26963|NCT01824303|59215|P2|NOT COMPLETED|Randomized Study||1
26964|NCT01824303|59216|P1|NOT COMPLETED|Randomized Study||2
26965|NCT01824303|59215|P2|COMPLETED|Randomized Study||13
26966|NCT01824303|59216|P1|COMPLETED|Randomized Study||14
26967|NCT01824303|59215|P2|STARTED|Randomized Study||14
26968|NCT01824303|59216|P1|STARTED|Randomized Study||16
26969|NCT01824160|59240|P1|NOT COMPLETED|Overall Study||0
26970|NCT01824160|59240|P1|COMPLETED|Overall Study||50
26971|NCT01824160|59240|P1|STARTED|Overall Study||50
26972|NCT01823536|59250|P6|NOT COMPLETED|Overall Study||0
26973|NCT01823536|59251|P5|NOT COMPLETED|Overall Study||2
26974|NCT01823536|59252|P4|NOT COMPLETED|Overall Study||2
26975|NCT01823536|59253|P3|NOT COMPLETED|Overall Study||1
26976|NCT01823536|59254|P2|NOT COMPLETED|Overall Study||2
26977|NCT01823536|59255|P1|NOT COMPLETED|Overall Study||2
26978|NCT01823536|59250|P6|COMPLETED|Overall Study||2
26979|NCT01823536|59251|P5|COMPLETED|Overall Study||99
26980|NCT01823536|59252|P4|COMPLETED|Overall Study||64
26981|NCT01823536|59253|P3|COMPLETED|Overall Study||119
26982|NCT01823536|59254|P2|COMPLETED|Overall Study||101
26983|NCT01823536|59255|P1|COMPLETED|Overall Study||71
26984|NCT01823536|59250|P6|STARTED|Overall Study||2
26985|NCT01823536|59251|P5|STARTED|Overall Study||101
26986|NCT01823536|59252|P4|STARTED|Overall Study||66
26987|NCT01823536|59253|P3|STARTED|Overall Study||120
26988|NCT01823536|59254|P2|STARTED|Overall Study||103
26989|NCT01823536|59255|P1|STARTED|Overall Study||73
26990|NCT01823341|59293|P1|NOT COMPLETED|Overall Study||15
26991|NCT01823341|59293|P1|COMPLETED|Overall Study||82
26992|NCT01823341|59293|P1|STARTED|Overall Study||97
26993|NCT01823289|59336|P1|NOT COMPLETED|Overall Study||24
26994|NCT01823289|59336|P1|COMPLETED|Overall Study||47
26995|NCT01823289|59336|P1|STARTED|Overall Study||71
26996|NCT01823224|59344|P2|NOT COMPLETED|Overall Study||11
26997|NCT01823224|59345|P1|NOT COMPLETED|Overall Study||6
26998|NCT01823224|59344|P2|COMPLETED|Overall Study||22
26999|NCT01823224|59345|P1|COMPLETED|Overall Study||28
27000|NCT01823224|59344|P2|STARTED|Overall Study||33
27001|NCT01823224|59345|P1|STARTED|Overall Study||34
27002|NCT01823146|59355|P2|NOT COMPLETED|Overall Study||2
27003|NCT01823146|59356|P1|NOT COMPLETED|Overall Study||2
27004|NCT01823146|59355|P2|COMPLETED|Overall Study||49
27005|NCT01823146|59356|P1|COMPLETED|Overall Study||53
27006|NCT01823146|59355|P2|STARTED|Overall Study||51
27007|NCT01823146|59356|P1|STARTED|Overall Study||55
27008|NCT01822899|59368|P2|NOT COMPLETED|Overall Study||18
27009|NCT01822899|59369|P1|NOT COMPLETED|Overall Study||24
27010|NCT01822899|59368|P2|COMPLETED|Overall Study||340
27011|NCT01822899|59369|P1|COMPLETED|Overall Study||334
27012|NCT01822899|59368|P2|STARTED|Overall Study||358
27013|NCT01822899|59369|P1|STARTED|Overall Study||358
27014|NCT01822691|59377|P1|NOT COMPLETED|Overall Study||2
27015|NCT01822691|59377|P1|COMPLETED|Overall Study||13
27016|NCT01822691|59377|P1|STARTED|Overall Study||15
27017|NCT01822678|59388|P3|NOT COMPLETED|Overall Study||11
27018|NCT01822678|59389|P2|NOT COMPLETED|Overall Study||15
27019|NCT01822678|59390|P1|NOT COMPLETED|Overall Study||12
27020|NCT01822678|59388|P3|COMPLETED|Overall Study||29
27021|NCT01822678|59389|P2|COMPLETED|Overall Study||49
27022|NCT01822678|59390|P1|COMPLETED|Overall Study||45
27023|NCT01822678|59388|P3|Per Protocol Population|Overall Study||34
27024|NCT01822678|59389|P2|Per Protocol Population|Overall Study||52
27025|NCT01822678|59390|P1|Per Protocol Population|Overall Study||45
27026|NCT01822678|59388|P3|Intention-to-Treat Population (ITT)|Overall Study||40
27027|NCT01822678|59389|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
27028|NCT01822678|59390|P1|Intention-to-Treat Population (ITT)|Overall Study||57
27029|NCT01822678|59388|P3|Safety Population|Overall Study||40
27030|NCT01822678|59389|P2|Safety Population|Overall Study||64
27031|NCT01822678|59390|P1|Safety Population|Overall Study||57
27032|NCT01822678|59388|P3|Treated|Overall Study||40
27033|NCT01822678|59389|P2|Treated|Overall Study||64
27034|NCT01822678|59390|P1|Treated|Overall Study||57
27035|NCT01822678|59388|P3|STARTED|Overall Study||40
27036|NCT01822678|59389|P2|STARTED|Overall Study||64
27037|NCT01822678|59390|P1|STARTED|Overall Study||57
27038|NCT01822665|59398|P1|NOT COMPLETED|Overall Study||8
27039|NCT01822665|59398|P1|COMPLETED|Overall Study||20
27040|NCT01822665|59398|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
27041|NCT01822665|59398|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
27042|NCT01822665|59398|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
27043|NCT01822665|59398|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
27044|NCT01822665|59398|P1|STARTED|Overall Study||28
27045|NCT01822574|59425|P3|NOT COMPLETED|Overall Study||0
27046|NCT01822574|59426|P2|NOT COMPLETED|Overall Study||0
27047|NCT01822574|59427|P1|NOT COMPLETED|Overall Study||0
27048|NCT01822574|59425|P3|COMPLETED|Overall Study||30
27049|NCT01822574|59426|P2|COMPLETED|Overall Study||30
27050|NCT01822574|59427|P1|COMPLETED|Overall Study||30
27051|NCT01822574|59425|P3|STARTED|Overall Study||30
27052|NCT01822574|59426|P2|STARTED|Overall Study||30
27053|NCT01822574|59427|P1|STARTED|Overall Study||30
27054|NCT01822535|59443|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
27055|NCT01822535|59444|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
27056|NCT01822535|59443|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
27057|NCT01822535|59444|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
27058|NCT01822535|59443|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
27059|NCT01822535|59444|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
27060|NCT01822535|59443|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
27061|NCT01822535|59444|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
27062|NCT01822535|59443|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
27063|NCT01822535|59444|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
27064|NCT01822535|59443|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
27065|NCT01822535|59444|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
27066|NCT01822223|59458|P2|NOT COMPLETED|Overall Study||1
27067|NCT01822223|59459|P1|NOT COMPLETED|Overall Study||0
27068|NCT01822223|59458|P2|COMPLETED|Overall Study||9
27069|NCT01822223|59459|P1|COMPLETED|Overall Study||10
27070|NCT01822223|59458|P2|STARTED|Overall Study||10
27071|NCT01822223|59459|P1|STARTED|Overall Study||10
27072|NCT01822197|59475|P1|NOT COMPLETED|Overall Study||0
27073|NCT01822197|59475|P1|COMPLETED|Overall Study||30
27074|NCT01822197|59475|P1|STARTED|Overall Study||30
27075|NCT01822119|59481|P1|NOT COMPLETED|Overall Study||0
27076|NCT01822119|59481|P1|COMPLETED|Overall Study||27
27077|NCT01822119|59481|P1|STARTED|Overall Study||27
27078|NCT01821963|59504|P1|NOT COMPLETED|Overall Study||1
27079|NCT01821963|59504|P1|COMPLETED|Overall Study||0
27080|NCT01821963|59504|P1|STARTED|Overall Study||1
27081|NCT01821937|59510|P2|NOT COMPLETED|Overall Study||3
27082|NCT01821937|59511|P1|NOT COMPLETED|Overall Study||0
27083|NCT01821937|59510|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
27084|NCT01821937|59511|P1|COMPLETED|Overall Study||10
27085|NCT01821937|59510|P2|STARTED|Overall Study||15
27086|NCT01821937|59511|P1|STARTED|Overall Study||10
27087|NCT01821859|59529|P1|NOT COMPLETED|Overall Study||5
27088|NCT01821859|59529|P1|COMPLETED|Overall Study||0
27089|NCT01821859|59529|P1|STARTED|Overall Study||5
27090|NCT01821807|59535|P2|NOT COMPLETED|Overall Study||1
27091|NCT01821807|59536|P1|NOT COMPLETED|Overall Study||3
27092|NCT01821807|59535|P2|COMPLETED|Overall Study||109
27093|NCT01821807|59536|P1|COMPLETED|Overall Study||147
27094|NCT01821807|59535|P2|STARTED|Overall Study||110
27095|NCT01821807|59536|P1|STARTED|Overall Study||150
27096|NCT01821534|59544|P1|NOT COMPLETED|Overall Study||0
27097|NCT01821534|59544|P1|COMPLETED|Overall Study||201
27098|NCT01821534|59544|P1|STARTED|Overall Study||201
27099|NCT01821378|59554|P3|NOT COMPLETED|Overall Study||42
27100|NCT01821378|59555|P2|NOT COMPLETED|Overall Study||54
27101|NCT01821378|59556|P1|NOT COMPLETED|Overall Study||27
27102|NCT01821378|59554|P3|COMPLETED|Overall Study||70
27103|NCT01821378|59555|P2|COMPLETED|Overall Study||145
27104|NCT01821378|59556|P1|COMPLETED|Overall Study||74
27105|NCT01821378|59554|P3|STARTED|Overall Study||112
27106|NCT01821378|59555|P2|STARTED|Overall Study||199
27107|NCT01821378|59556|P1|STARTED|Overall Study||101
27108|NCT01821352|59594|P2|NOT COMPLETED|Overall Study||0
27109|NCT01821352|59595|P1|NOT COMPLETED|Overall Study||0
27110|NCT01821352|59594|P2|COMPLETED|Overall Study||25
27111|NCT01821352|59595|P1|COMPLETED|Overall Study||28
27112|NCT01821352|59594|P2|STARTED|Overall Study||25
27113|NCT01821352|59595|P1|STARTED|Overall Study||28
27114|NCT01821326|59605|P1|NOT COMPLETED|Overall Study||0
27115|NCT01821326|59605|P1|COMPLETED|Overall Study||339
27116|NCT01821326|59605|P1|STARTED|Overall Study||339
27117|NCT01820364|59609|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
27118|NCT01820364|59610|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
27119|NCT01820364|59609|P2|COMPLETED|Part II: LGX818 + MEK162||0
27120|NCT01820364|59610|P1|COMPLETED|Part II: LGX818 + MEK162||0
27121|NCT01820364|59609|P2|STARTED|Part II: LGX818 + MEK162||1
27122|NCT01820364|59610|P1|STARTED|Part II: LGX818 + MEK162||0
27123|NCT01820364|59609|P2|NOT COMPLETED|Part I: LGX818||0
27124|NCT01820364|59610|P1|NOT COMPLETED|Part I: LGX818||14
27125|NCT01820364|59609|P2|COMPLETED|Part I: LGX818||0
27126|NCT01820364|59610|P1|COMPLETED|Part I: LGX818||1
27127|NCT01820364|59609|P2|STARTED|Part I: LGX818||0
27128|NCT01820364|59610|P1|STARTED|Part I: LGX818||15
27129|NCT01821118|59624|P2|NOT COMPLETED|Overall Study||1
27130|NCT01821118|59625|P1|NOT COMPLETED|Overall Study||0
27131|NCT01821118|59624|P2|COMPLETED|Overall Study||11
27132|NCT01821118|59625|P1|COMPLETED|Overall Study||24
27133|NCT01821118|59624|P2|STARTED|Overall Study||12
27134|NCT01821118|59625|P1|STARTED|Overall Study||24
27135|NCT01821105|59658|P1|NOT COMPLETED|Overall Study||0
27136|NCT01821105|59658|P1|COMPLETED|Overall Study||21
27137|NCT01821105|59658|P1|STARTED|Overall Study||21
27138|NCT01820585|59668|P4|NOT COMPLETED|Overall Study||49
27139|NCT01820585|59669|P3|NOT COMPLETED|Overall Study||34
27140|NCT01820585|59670|P2|NOT COMPLETED|Overall Study||32
27141|NCT01820585|59671|P1|NOT COMPLETED|Overall Study||27
27142|NCT01820585|59668|P4|COMPLETED|Overall Study||83
27143|NCT01820585|59669|P3|COMPLETED|Overall Study||101
27144|NCT01820585|59670|P2|COMPLETED|Overall Study||98
27145|NCT01820585|59671|P1|COMPLETED|Overall Study||104
27146|NCT01820585|59668|P4|Completed Maintenance Period|Overall Study||84
27147|NCT01820585|59669|P3|Completed Maintenance Period|Overall Study||101
27148|NCT01820585|59670|P2|Completed Maintenance Period|Overall Study||98
27149|NCT01820585|59671|P1|Completed Maintenance Period|Overall Study||105
27150|NCT01820585|59668|P4|Entered Maintenance Period|Overall Study||123
27151|NCT01820585|59669|P3|Entered Maintenance Period|Overall Study||131
27152|NCT01820585|59670|P2|Entered Maintenance Period|Overall Study||124
27153|NCT01820585|59671|P1|Entered Maintenance Period|Overall Study||128
27154|NCT01820585|59668|P4|Completed Titration Period|Overall Study||126
27155|NCT01820585|59669|P3|Completed Titration Period|Overall Study||131
27156|NCT01820585|59670|P2|Completed Titration Period|Overall Study||125
27157|NCT01820585|59671|P1|Completed Titration Period|Overall Study||128
27158|NCT01820585|59668|P4|Full Analysis Set|Overall Study||129
27159|NCT01820585|59669|P3|Full Analysis Set|Overall Study||135
27160|NCT01820585|59670|P2|Full Analysis Set|Overall Study||130
27161|NCT01820585|59671|P1|Full Analysis Set|Overall Study||131
27162|NCT01820585|59668|P4|Randomized and Treated|Overall Study||132
27163|NCT01820585|59669|P3|Randomized and Treated|Overall Study||135
27164|NCT01820585|59670|P2|Randomized and Treated|Overall Study||130
27165|NCT01820585|59671|P1|Randomized and Treated|Overall Study||131
27166|NCT01820585|59668|P4|STARTED|Overall Study||132
27167|NCT01820585|59669|P3|STARTED|Overall Study||135
27168|NCT01820585|59670|P2|STARTED|Overall Study||130
27169|NCT01820585|59671|P1|STARTED|Overall Study||131
27170|NCT01820559|59684|P3|NOT COMPLETED|Overall Study||29
27171|NCT01820559|59685|P2|NOT COMPLETED|Overall Study||13
27172|NCT01820559|59686|P1|NOT COMPLETED|Overall Study||14
27173|NCT01820559|59684|P3|COMPLETED|Overall Study||110
27174|NCT01820559|59685|P2|COMPLETED|Overall Study||122
27175|NCT01820559|59686|P1|COMPLETED|Overall Study||122
27176|NCT01820559|59684|P3|Completed Maintenance Period|Overall Study||110
27177|NCT01820559|59685|P2|Completed Maintenance Period|Overall Study||123
27178|NCT01820559|59686|P1|Completed Maintenance Period|Overall Study||122
27179|NCT01820559|59684|P3|Entered Maintenance Period|Overall Study||129
27180|NCT01820559|59685|P2|Entered Maintenance Period|Overall Study||133
27181|NCT01820559|59686|P1|Entered Maintenance Period|Overall Study||129
27182|NCT01820559|59684|P3|Completed Tutration Period|Overall Study||131
27183|NCT01820559|59685|P2|Completed Tutration Period|Overall Study||134
27184|NCT01820559|59686|P1|Completed Tutration Period|Overall Study||130
27185|NCT01820559|59684|P3|Randomized and Treated|Overall Study||139
27186|NCT01820559|59685|P2|Randomized and Treated|Overall Study||135
27187|NCT01820559|59686|P1|Randomized and Treated|Overall Study||136
27188|NCT01820559|59684|P3|STARTED|Overall Study||139
27189|NCT01820559|59685|P2|STARTED|Overall Study||135
27190|NCT01820559|59686|P1|STARTED|Overall Study||136
27191|NCT01819935|59696|P2|NOT COMPLETED|Overall Study||0
27192|NCT01819935|59697|P1|NOT COMPLETED|Overall Study||0
27193|NCT01819935|59696|P2|COMPLETED|Overall Study||4943
27194|NCT01819935|59697|P1|COMPLETED|Overall Study||328
27195|NCT01819935|59696|P2|STARTED|Overall Study||4943
27196|NCT01819935|59697|P1|STARTED|Overall Study||328
27197|NCT01819922|59717|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
27198|NCT01819922|59718|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
27199|NCT01819922|59717|P2|COMPLETED|Second Intervention Period (1 Day)||6
27200|NCT01819922|59718|P1|COMPLETED|Second Intervention Period (1 Day)||6
27201|NCT01819922|59717|P2|STARTED|Second Intervention Period (1 Day)||6
27202|NCT01819922|59718|P1|STARTED|Second Intervention Period (1 Day)||6
27203|NCT01819922|59717|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
27204|NCT01819922|59718|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
27205|NCT01819922|59717|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
27206|NCT01819922|59718|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
27207|NCT01819922|59717|P2|STARTED|Washout Period (at Least 7-10 Days)||6
27208|NCT01819922|59718|P1|STARTED|Washout Period (at Least 7-10 Days)||6
27209|NCT01819922|59717|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
27210|NCT01819922|59718|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
27211|NCT01819922|59717|P2|COMPLETED|First Intervention Period (1 Day)||6
27212|NCT01819922|59718|P1|COMPLETED|First Intervention Period (1 Day)||6
27213|NCT01819922|59717|P2|STARTED|First Intervention Period (1 Day)||6
27214|NCT01819922|59718|P1|STARTED|First Intervention Period (1 Day)||6
27215|NCT01819415|59806|P4|NOT COMPLETED|Overall Study||2
27216|NCT01819415|59807|P3|NOT COMPLETED|Overall Study||1
27217|NCT01819415|59808|P2|NOT COMPLETED|Overall Study||4
27218|NCT01819415|59809|P1|NOT COMPLETED|Overall Study||3
27219|NCT01819415|59806|P4|COMPLETED|Overall Study||8
27220|NCT01819415|59807|P3|COMPLETED|Overall Study||9
27221|NCT01819415|59808|P2|COMPLETED|Overall Study||6
27222|NCT01819415|59809|P1|COMPLETED|Overall Study||7
27223|NCT01819415|59806|P4|STARTED|Overall Study||10
27224|NCT01819415|59807|P3|STARTED|Overall Study||10
27225|NCT01819415|59808|P2|STARTED|Overall Study||10
27226|NCT01819415|59809|P1|STARTED|Overall Study||10
27227|NCT01819272|59825|P6|NOT COMPLETED|Overall Study||7
27228|NCT01819272|59826|P5|NOT COMPLETED|Overall Study||4
27229|NCT01819272|59827|P4|NOT COMPLETED|Overall Study||5
27230|NCT01819272|59828|P3|NOT COMPLETED|Overall Study||3
27231|NCT01819272|59829|P2|NOT COMPLETED|Overall Study||3
27232|NCT01819272|59830|P1|NOT COMPLETED|Overall Study||6
27233|NCT01819272|59825|P6|COMPLETED|Overall Study||33
27234|NCT01819272|59826|P5|COMPLETED|Overall Study||36
27235|NCT01819272|59827|P4|COMPLETED|Overall Study||35
27236|NCT01819272|59828|P3|COMPLETED|Overall Study||37
27237|NCT01819272|59829|P2|COMPLETED|Overall Study||36
27238|NCT01819272|59830|P1|COMPLETED|Overall Study||35
27239|NCT01819272|59825|P6|STARTED|Overall Study||40
27240|NCT01819272|59826|P5|STARTED|Overall Study||40
27241|NCT01819272|59827|P4|STARTED|Overall Study||40
27242|NCT01819272|59828|P3|STARTED|Overall Study||40
27243|NCT01819272|59829|P2|STARTED|Overall Study||39
27244|NCT01819272|59830|P1|STARTED|Overall Study||41
27245|NCT01819194|59856|P1|NOT COMPLETED|Overall Study||2
27246|NCT01819194|59856|P1|COMPLETED|Overall Study||60
27247|NCT01819194|59856|P1|STARTED|Overall Study||62
27248|NCT01818700|59861|P1|NOT COMPLETED|Overall Study||104
27249|NCT01818700|59861|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
27250|NCT01818700|59861|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
27251|NCT01818700|59861|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
27252|NCT01818700|59861|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
27253|NCT01818700|59861|P1|STARTED|Overall Study|The No. of enrolled patients|245
27254|NCT01818596|59872|P2|NOT COMPLETED|Overall Study||6
27255|NCT01818596|59873|P1|NOT COMPLETED|Overall Study||246
27256|NCT01818596|59872|P2|COMPLETED|Overall Study||0
27257|NCT01818596|59873|P1|COMPLETED|Overall Study||0
27258|NCT01818596|59872|P2|STARTED|Overall Study||6
27259|NCT01818596|59873|P1|STARTED|Overall Study||246
27260|NCT01818414|59906|P2|NOT COMPLETED|Overall Study||0
27261|NCT01818414|59907|P1|NOT COMPLETED|Overall Study||0
27262|NCT01818414|59906|P2|COMPLETED|Overall Study||15
27263|NCT01818414|59907|P1|COMPLETED|Overall Study||14
27264|NCT01818414|59906|P2|STARTED|Overall Study||15
27265|NCT01818414|59907|P1|STARTED|Overall Study||14
27266|NCT01818336|59921|P2|NOT COMPLETED|Overall Study||12
27267|NCT01818336|59922|P1|NOT COMPLETED|Overall Study||0
27268|NCT01818336|59921|P2|COMPLETED|Overall Study||47
27269|NCT01818336|59922|P1|COMPLETED|Overall Study||391
27270|NCT01818336|59921|P2|STARTED|Overall Study||59
27271|NCT01818336|59922|P1|STARTED|Overall Study||391
27272|NCT01817855|59932|P4|NOT COMPLETED|Overall Study||0
27273|NCT01817855|59933|P3|NOT COMPLETED|Overall Study||2
27274|NCT01817855|59934|P2|NOT COMPLETED|Overall Study||2
27275|NCT01817855|59935|P1|NOT COMPLETED|Overall Study||0
27276|NCT01817855|59932|P4|COMPLETED|Overall Study||5
27277|NCT01817855|59933|P3|COMPLETED|Overall Study||9
27278|NCT01817855|59934|P2|COMPLETED|Overall Study||6
27279|NCT01817855|59935|P1|COMPLETED|Overall Study||23
27280|NCT01817855|59932|P4|STARTED|Overall Study||5
27281|NCT01817855|59933|P3|STARTED|Overall Study||11
27282|NCT01817855|59934|P2|STARTED|Overall Study||8
27283|NCT01817855|59935|P1|STARTED|Overall Study||23
27284|NCT01817790|59965|P2|NOT COMPLETED|Overall Study||8
27285|NCT01817790|59966|P1|NOT COMPLETED|Overall Study||4
27286|NCT01817790|59965|P2|COMPLETED|Overall Study||304
27287|NCT01817790|59966|P1|COMPLETED|Overall Study||310
27288|NCT01817790|59965|P2|STARTED|Overall Study||312
27289|NCT01817790|59966|P1|STARTED|Overall Study||314
27290|NCT01817777|60010|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
27291|NCT01817777|60011|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
27292|NCT01817777|60012|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
27293|NCT01817777|60010|P3|COMPLETED|Interventional Phase (20 Weeks)||10
27294|NCT01817777|60011|P2|COMPLETED|Interventional Phase (20 Weeks)||11
27295|NCT01817777|60012|P1|COMPLETED|Interventional Phase (20 Weeks)||0
27296|NCT01817777|60010|P3|STARTED|Interventional Phase (20 Weeks)||15
27297|NCT01817777|60011|P2|STARTED|Interventional Phase (20 Weeks)||16
27298|NCT01817777|60012|P1|STARTED|Interventional Phase (20 Weeks)||0
27299|NCT01817777|60010|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
27300|NCT01817777|60011|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
27301|NCT01817777|60012|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
27302|NCT01817777|60010|P3|COMPLETED|Observational Phase (8 Weeks)||0
27303|NCT01817777|60011|P2|COMPLETED|Observational Phase (8 Weeks)||0
27304|NCT01817777|60012|P1|COMPLETED|Observational Phase (8 Weeks)||31
27305|NCT01817777|60010|P3|STARTED|Observational Phase (8 Weeks)||0
27306|NCT01817777|60011|P2|STARTED|Observational Phase (8 Weeks)||0
27307|NCT01817777|60012|P1|STARTED|Observational Phase (8 Weeks)||36
27308|NCT01817764|60036|P2|NOT COMPLETED|Overall Study||38
27309|NCT01817764|60037|P1|NOT COMPLETED|Overall Study||34
27310|NCT01817764|60036|P2|COMPLETED|Overall Study||315
27311|NCT01817764|60037|P1|COMPLETED|Overall Study||319
27312|NCT01817764|60036|P2|STARTED|Overall Study||353
27313|NCT01817764|60037|P1|STARTED|Overall Study||353
27314|NCT01816685|60047|P2|NOT COMPLETED|Overall Study||11
27315|NCT01816685|60048|P1|NOT COMPLETED|Overall Study||10
27316|NCT01816685|60047|P2|COMPLETED|Overall Study||56
27317|NCT01816685|60048|P1|COMPLETED|Overall Study||58
27318|NCT01816685|60047|P2|STARTED|Overall Study||67
27319|NCT01816685|60048|P1|STARTED|Overall Study||68
27320|NCT01816451|60059|P3|NOT COMPLETED|Overall Study||0
27321|NCT01816451|60060|P2|NOT COMPLETED|Overall Study||0
27322|NCT01816451|60061|P1|NOT COMPLETED|Overall Study||0
27323|NCT01816451|60059|P3|COMPLETED|Overall Study||8
27324|NCT01816451|60060|P2|COMPLETED|Overall Study||11
27325|NCT01816451|60061|P1|COMPLETED|Overall Study||13
27326|NCT01816451|60059|P3|STARTED|Overall Study||8
27327|NCT01816451|60060|P2|STARTED|Overall Study||11
27328|NCT01816451|60061|P1|STARTED|Overall Study||13
27329|NCT01816295|60100|P2|NOT COMPLETED|OLE Phase||56
27330|NCT01816295|60101|P1|NOT COMPLETED|OLE Phase||53
27331|NCT01816295|60100|P2|COMPLETED|OLE Phase||227
27332|NCT01816295|60101|P1|COMPLETED|OLE Phase||222
27333|NCT01816295|60100|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
27334|NCT01816295|60101|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
27335|NCT01816295|60100|P2|NOT COMPLETED|Double Blind Phase||56
27336|NCT01816295|60101|P1|NOT COMPLETED|Double Blind Phase||63
27337|NCT01816295|60100|P2|COMPLETED|Double Blind Phase||302
27338|NCT01816295|60101|P1|COMPLETED|Double Blind Phase||294
27339|NCT01816295|60100|P2|Received Study Drug|Double Blind Phase||354
27340|NCT01816295|60101|P1|Received Study Drug|Double Blind Phase||356
27341|NCT01816295|60100|P2|STARTED|Double Blind Phase||358
27342|NCT01816295|60101|P1|STARTED|Double Blind Phase||357
27343|NCT01816243|60116|P1|NOT COMPLETED|Overall Study||12
27344|NCT01816243|60116|P1|COMPLETED|Overall Study||27
27345|NCT01816243|60116|P1|STARTED|Overall Study||39
27346|NCT01815840|60125|P2|NOT COMPLETED|Overall Study||113
27347|NCT01815840|60126|P1|NOT COMPLETED|Overall Study||116
27348|NCT01815840|60125|P2|COMPLETED|Overall Study||0
27349|NCT01815840|60126|P1|COMPLETED|Overall Study||0
27350|NCT01815840|60125|P2|STARTED|Overall Study||113
27351|NCT01815840|60126|P1|STARTED|Overall Study||116
27352|NCT01815736|60156|P2|NOT COMPLETED|Overall Study||478
27353|NCT01815736|60157|P1|NOT COMPLETED|Overall Study||961
27354|NCT01815736|60156|P2|COMPLETED|Overall Study||2
27355|NCT01815736|60157|P1|COMPLETED|Overall Study||2
27356|NCT01815736|60156|P2|STARTED|Overall Study||480
27357|NCT01815736|60157|P1|STARTED|Overall Study||963
27358|NCT01815671|60173|P2|NOT COMPLETED|Overall Study||0
27359|NCT01815671|60174|P1|NOT COMPLETED|Overall Study||0
27360|NCT01815671|60173|P2|COMPLETED|Overall Study||85
27361|NCT01815671|60174|P1|COMPLETED|Overall Study||88
27362|NCT01815671|60173|P2|STARTED|Overall Study||85
27363|NCT01815671|60174|P1|STARTED|Overall Study||88
27364|NCT01815008|60184|P1|NOT COMPLETED|Overall Study||4
27365|NCT01815008|60184|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
27366|NCT01815008|60184|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
27367|NCT01814878|60193|P2|NOT COMPLETED|Overall Study||30
27368|NCT01814878|60194|P1|NOT COMPLETED|Overall Study||46
27369|NCT01814878|60193|P2|COMPLETED|Overall Study||128
27370|NCT01814878|60194|P1|COMPLETED|Overall Study||116
27371|NCT01814878|60193|P2|STARTED|Overall Study||158
27372|NCT01814878|60194|P1|STARTED|Overall Study||162
27373|NCT01814800|60214|P1|NOT COMPLETED|Overall Study||5
27374|NCT01814800|60214|P1|COMPLETED|Overall Study||54
27375|NCT01814800|60214|P1|STARTED|Overall Study||59
27376|NCT01814774|60251|P1|NOT COMPLETED|Overall Study||0
27377|NCT01814774|60251|P1|COMPLETED|Overall Study||48
27378|NCT01814774|60251|P1|STARTED|Overall Study||48
27379|NCT01814761|60265|P2|NOT COMPLETED|Overall Study||30
27380|NCT01814761|60266|P1|NOT COMPLETED|Overall Study||8
27381|NCT01814761|60265|P2|COMPLETED|Overall Study||240
27382|NCT01814761|60266|P1|COMPLETED|Overall Study||34
27383|NCT01814761|60265|P2|STARTED|Overall Study||270
27384|NCT01814761|60266|P1|STARTED|Overall Study||42
27385|NCT01814748|60280|P2|NOT COMPLETED|Overall Study||7
27386|NCT01814748|60281|P1|NOT COMPLETED|Overall Study||8
27387|NCT01814748|60280|P2|COMPLETED|Overall Study||94
27388|NCT01814748|60281|P1|COMPLETED|Overall Study||94
27389|NCT01814748|60280|P2|STARTED|Overall Study||101
27390|NCT01814748|60281|P1|STARTED|Overall Study||102
27391|NCT01814722|60304|P3|NOT COMPLETED|Overall Study||0
27392|NCT01814722|60305|P2|NOT COMPLETED|Overall Study||0
27393|NCT01814722|60306|P1|NOT COMPLETED|Overall Study||0
27394|NCT01814722|60304|P3|COMPLETED|Overall Study||6
27395|NCT01814722|60305|P2|COMPLETED|Overall Study||21
27396|NCT01814722|60306|P1|COMPLETED|Overall Study||36
27397|NCT01814722|60304|P3|STARTED|Overall Study||6
27398|NCT01814722|60305|P2|STARTED|Overall Study||21
27399|NCT01814722|60306|P1|STARTED|Overall Study||36
27400|NCT01814696|60325|P2|NOT COMPLETED|Overall Study||0
27401|NCT01814696|60326|P1|NOT COMPLETED|Overall Study||2
27402|NCT01814696|60325|P2|COMPLETED|Overall Study||11
27403|NCT01814696|60326|P1|COMPLETED|Overall Study||13
27404|NCT01814696|60325|P2|STARTED|Overall Study||11
27405|NCT01814696|60326|P1|STARTED|Overall Study||15
27406|NCT01814670|60344|P1|NOT COMPLETED|Overall Study||12
27407|NCT01814670|60344|P1|COMPLETED|Overall Study||173
27408|NCT01814670|60344|P1|STARTED|Overall Study||185
27409|NCT01814553|60354|P2|NOT COMPLETED|Overall Study||22
27410|NCT01814553|60355|P1|NOT COMPLETED|Overall Study||18
27411|NCT01814553|60354|P2|COMPLETED|Overall Study||0
27412|NCT01814553|60355|P1|COMPLETED|Overall Study||0
27413|NCT01814553|60354|P2|STARTED|Overall Study||22
27414|NCT01814553|60355|P1|STARTED|Overall Study||18
27415|NCT01814397|60369|P1|NOT COMPLETED|Overall Study||14
27416|NCT01814397|60369|P1|COMPLETED|Overall Study||36
27417|NCT01814397|60369|P1|3 Month Evaluation|Overall Study||43
27418|NCT01814397|60369|P1|STARTED|Overall Study||50
27419|NCT01814332|60378|P2|NOT COMPLETED|Overall Study||16
27420|NCT01814332|60379|P1|NOT COMPLETED|Overall Study||16
27421|NCT01814332|60378|P2|COMPLETED|Overall Study||49
27422|NCT01814332|60379|P1|COMPLETED|Overall Study||47
27423|NCT01814332|60378|P2|STARTED|Overall Study||65
27424|NCT01814332|60379|P1|STARTED|Overall Study||63
27425|NCT01814137|60393|P2|NOT COMPLETED|Overall Study||5
27426|NCT01814137|60394|P1|NOT COMPLETED|Overall Study||5
27427|NCT01814137|60393|P2|COMPLETED|Overall Study||15
27428|NCT01814137|60394|P1|COMPLETED|Overall Study||15
27429|NCT01814137|60393|P2|STARTED|Overall Study||20
27430|NCT01814137|60394|P1|STARTED|Overall Study||20
27431|NCT01813890|60411|P3|NOT COMPLETED|Overall Study||6
27432|NCT01813890|60412|P2|NOT COMPLETED|Overall Study||4
27433|NCT01813890|60413|P1|NOT COMPLETED|Overall Study||9
27434|NCT01813890|60411|P3|COMPLETED|Overall Study||13
27435|NCT01813890|60412|P2|COMPLETED|Overall Study||17
27436|NCT01813890|60413|P1|COMPLETED|Overall Study||11
27437|NCT01813890|60411|P3|STARTED|Overall Study||19
27438|NCT01813890|60412|P2|STARTED|Overall Study||21
27439|NCT01813890|60413|P1|STARTED|Overall Study||20
27440|NCT01813721|60442|P1|NOT COMPLETED|Overall Study||64
27441|NCT01813721|60442|P1|COMPLETED|Overall Study||943
27442|NCT01813721|60442|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
27443|NCT01813019|60496|P2|NOT COMPLETED|Overall Study||6
27444|NCT01813019|60497|P1|NOT COMPLETED|Overall Study||7
27445|NCT01813019|60496|P2|COMPLETED|Overall Study||20
27446|NCT01813019|60497|P1|COMPLETED|Overall Study||17
27447|NCT01813019|60496|P2|STARTED|Overall Study||26
27448|NCT01813019|60497|P1|STARTED|Overall Study||24
27449|NCT01812837|60508|P3|NOT COMPLETED|Overall Study||0
27450|NCT01812837|60509|P2|NOT COMPLETED|Overall Study||1
27451|NCT01812837|60510|P1|NOT COMPLETED|Overall Study||2
27452|NCT01812837|60508|P3|COMPLETED|Overall Study||17
27453|NCT01812837|60509|P2|COMPLETED|Overall Study||16
27454|NCT01812837|60510|P1|COMPLETED|Overall Study||15
27455|NCT01812837|60508|P3|STARTED|Overall Study||17
27456|NCT01812837|60509|P2|STARTED|Overall Study||17
27457|NCT01812837|60510|P1|STARTED|Overall Study||17
27458|NCT01812707|60522|P4|NOT COMPLETED|Overall Study||2
27459|NCT01812707|60523|P3|NOT COMPLETED|Overall Study||0
27460|NCT01812707|60524|P2|NOT COMPLETED|Overall Study||0
27461|NCT01812707|60525|P1|NOT COMPLETED|Overall Study||2
27462|NCT01812707|60522|P4|COMPLETED|Overall Study||23
27463|NCT01812707|60523|P3|COMPLETED|Overall Study||25
27464|NCT01812707|60524|P2|COMPLETED|Overall Study||25
27465|NCT01812707|60525|P1|COMPLETED|Overall Study||23
27466|NCT01812707|60522|P4|Treated|Overall Study||25
27467|NCT01812707|60523|P3|Treated|Overall Study||25
27468|NCT01812707|60524|P2|Treated|Overall Study||25
27469|NCT01812707|60525|P1|Treated|Overall Study||25
27470|NCT01812707|60522|P4|STARTED|Overall Study||25
27471|NCT01812707|60523|P3|STARTED|Overall Study||25
27472|NCT01812707|60524|P2|STARTED|Overall Study||25
27473|NCT01812707|60525|P1|STARTED|Overall Study||25
27474|NCT01812681|60561|P2|NOT COMPLETED|Overall Study||0
27475|NCT01812681|60562|P1|NOT COMPLETED|Overall Study||3
27476|NCT01812681|60561|P2|COMPLETED|Overall Study||24
27477|NCT01812681|60562|P1|COMPLETED|Overall Study||57
27478|NCT01812681|60561|P2|STARTED|Overall Study||24
27479|NCT01812681|60562|P1|STARTED|Overall Study||60
27480|NCT01812655|60573|P3|NOT COMPLETED|Overall Study||0
27481|NCT01812655|60574|P2|NOT COMPLETED|Overall Study||1
27482|NCT01812655|60575|P1|NOT COMPLETED|Overall Study||1
27483|NCT01812655|60573|P3|COMPLETED|Overall Study||10
27484|NCT01812655|60574|P2|COMPLETED|Overall Study||10
27485|NCT01812655|60575|P1|COMPLETED|Overall Study||8
27486|NCT01812655|60573|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
27487|NCT01812655|60574|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
27488|NCT01812655|60575|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
27489|NCT01812473|60591|P2|NOT COMPLETED|Overall Study||0
27490|NCT01812473|60592|P1|NOT COMPLETED|Overall Study||0
27491|NCT01812473|60591|P2|COMPLETED|Overall Study||13
27492|NCT01812473|60592|P1|COMPLETED|Overall Study||22
27493|NCT01812473|60591|P2|STARTED|Overall Study||13
27494|NCT01812473|60592|P1|STARTED|Overall Study||22
27495|NCT01812044|60601|P3|NOT COMPLETED|Overall Study||0
27496|NCT01812044|60602|P2|NOT COMPLETED|Overall Study||0
27497|NCT01812044|60603|P1|NOT COMPLETED|Overall Study||0
27498|NCT01812044|60601|P3|COMPLETED|Overall Study||16
27499|NCT01812044|60602|P2|COMPLETED|Overall Study||17
27500|NCT01812044|60603|P1|COMPLETED|Overall Study||17
27501|NCT01812044|60601|P3|STARTED|Overall Study||16
27502|NCT01812044|60602|P2|STARTED|Overall Study||17
27503|NCT01812044|60603|P1|STARTED|Overall Study||17
27504|NCT01811953|60638|P6|NOT COMPLETED|Overall Study||1
27505|NCT01811953|60639|P5|NOT COMPLETED|Overall Study||1
27506|NCT01811953|60640|P4|NOT COMPLETED|Overall Study||1
27507|NCT01811953|60641|P3|NOT COMPLETED|Overall Study||0
27508|NCT01811953|60642|P2|NOT COMPLETED|Overall Study||0
27509|NCT01811953|60643|P1|NOT COMPLETED|Overall Study||0
27510|NCT01811953|60638|P6|COMPLETED|Overall Study||11
27511|NCT01811953|60639|P5|COMPLETED|Overall Study||11
27512|NCT01811953|60640|P4|COMPLETED|Overall Study||5
27513|NCT01811953|60641|P3|COMPLETED|Overall Study||6
27514|NCT01811953|60642|P2|COMPLETED|Overall Study||6
27515|NCT01811953|60643|P1|COMPLETED|Overall Study||6
27516|NCT01811953|60638|P6|STARTED|Overall Study||12
27517|NCT01811953|60639|P5|STARTED|Overall Study||12
27518|NCT01811953|60640|P4|STARTED|Overall Study||6
27519|NCT01811953|60641|P3|STARTED|Overall Study||6
27520|NCT01811953|60642|P2|STARTED|Overall Study||6
27521|NCT01811953|60643|P1|STARTED|Overall Study||6
27522|NCT01811706|60687|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
27523|NCT01811706|60688|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
27524|NCT01811706|60687|P2|COMPLETED|Second Intervention (4 Weeks)||10
27525|NCT01811706|60688|P1|COMPLETED|Second Intervention (4 Weeks)||9
27526|NCT01811706|60687|P2|STARTED|Second Intervention (4 Weeks)||10
27527|NCT01811706|60688|P1|STARTED|Second Intervention (4 Weeks)||9
27528|NCT01811706|60687|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
27529|NCT01811706|60688|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
27530|NCT01811706|60687|P2|COMPLETED|Washout ( 2 Weeks)||10
27531|NCT01811706|60688|P1|COMPLETED|Washout ( 2 Weeks)||9
27532|NCT01811706|60687|P2|STARTED|Washout ( 2 Weeks)||10
27533|NCT01811706|60688|P1|STARTED|Washout ( 2 Weeks)||9
27534|NCT01811706|60687|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
27535|NCT01811706|60688|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
27536|NCT01811706|60687|P2|COMPLETED|First Intervention ( 4 Weeks)||10
27537|NCT01811706|60688|P1|COMPLETED|First Intervention ( 4 Weeks)||9
27538|NCT01811706|60687|P2|STARTED|First Intervention ( 4 Weeks)||10
27539|NCT01811706|60688|P1|STARTED|First Intervention ( 4 Weeks)||10
27540|NCT01811680|60698|P1|NOT COMPLETED|Overall Study||0
27541|NCT01811680|60698|P1|COMPLETED|Overall Study||10
27542|NCT01811680|60698|P1|STARTED|Overall Study||10
27543|NCT01811485|60706|P3|NOT COMPLETED|Overall Study||5
27544|NCT01811485|60707|P2|NOT COMPLETED|Overall Study||4
27545|NCT01811485|60708|P1|NOT COMPLETED|Overall Study||2
27546|NCT01811485|60706|P3|COMPLETED|Overall Study||51
27547|NCT01811485|60707|P2|COMPLETED|Overall Study||55
27548|NCT01811485|60708|P1|COMPLETED|Overall Study||54
27549|NCT01811485|60706|P3|STARTED|Overall Study||56
27550|NCT01811485|60707|P2|STARTED|Overall Study||59
27551|NCT01811485|60708|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
27552|NCT01811472|60728|P3|NOT COMPLETED|Overall Study||5
27553|NCT01811472|60729|P2|NOT COMPLETED|Overall Study||0
27554|NCT01811472|60730|P1|NOT COMPLETED|Overall Study||2
27555|NCT01811472|60728|P3|COMPLETED|Overall Study||16
27556|NCT01811472|60729|P2|COMPLETED|Overall Study||11
27557|NCT01811472|60730|P1|COMPLETED|Overall Study||18
27558|NCT01811472|60728|P3|STARTED|Overall Study||21
27559|NCT01811472|60729|P2|STARTED|Overall Study||11
27560|NCT01811472|60730|P1|STARTED|Overall Study||20
27561|NCT01811303|60775|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
27562|NCT01811303|60776|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
27563|NCT01811303|60777|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
27564|NCT01811303|60778|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
27565|NCT01811303|60775|P4|COMPLETED|Fourth Intervention (1 Day)||2
27566|NCT01811303|60776|P3|COMPLETED|Fourth Intervention (1 Day)||4
27567|NCT01811303|60777|P2|COMPLETED|Fourth Intervention (1 Day)||4
27568|NCT01811303|60778|P1|COMPLETED|Fourth Intervention (1 Day)||4
27569|NCT01811303|60775|P4|STARTED|Fourth Intervention (1 Day)||2
27570|NCT01811303|60776|P3|STARTED|Fourth Intervention (1 Day)||4
27571|NCT01811303|60777|P2|STARTED|Fourth Intervention (1 Day)||4
27572|NCT01811303|60778|P1|STARTED|Fourth Intervention (1 Day)||4
27573|NCT01811303|60775|P4|NOT COMPLETED|Washout (2 Days or More)||0
27574|NCT01811303|60776|P3|NOT COMPLETED|Washout (2 Days or More)||0
27575|NCT01811303|60777|P2|NOT COMPLETED|Washout (2 Days or More)||0
27576|NCT01811303|60778|P1|NOT COMPLETED|Washout (2 Days or More)||0
27577|NCT01811303|60775|P4|COMPLETED|Washout (2 Days or More)||2
27578|NCT01811303|60776|P3|COMPLETED|Washout (2 Days or More)||4
27579|NCT01811303|60777|P2|COMPLETED|Washout (2 Days or More)||4
27580|NCT01811303|60778|P1|COMPLETED|Washout (2 Days or More)||4
27581|NCT01811303|60775|P4|STARTED|Washout (2 Days or More)||2
27582|NCT01811303|60776|P3|STARTED|Washout (2 Days or More)||4
27583|NCT01811303|60777|P2|STARTED|Washout (2 Days or More)||4
27584|NCT01811303|60778|P1|STARTED|Washout (2 Days or More)||4
27585|NCT01811303|60775|P4|NOT COMPLETED|Third Intervention (1 Day)||0
27586|NCT01811303|60776|P3|NOT COMPLETED|Third Intervention (1 Day)||0
27587|NCT01811303|60777|P2|NOT COMPLETED|Third Intervention (1 Day)||0
27588|NCT01811303|60778|P1|NOT COMPLETED|Third Intervention (1 Day)||0
27589|NCT01811303|60775|P4|COMPLETED|Third Intervention (1 Day)||2
27590|NCT01811303|60776|P3|COMPLETED|Third Intervention (1 Day)||4
27591|NCT01811303|60777|P2|COMPLETED|Third Intervention (1 Day)||4
27592|NCT01811303|60778|P1|COMPLETED|Third Intervention (1 Day)||4
27593|NCT01811303|60775|P4|STARTED|Third Intervention (1 Day)||2
27594|NCT01811303|60776|P3|STARTED|Third Intervention (1 Day)||4
27595|NCT01811303|60777|P2|STARTED|Third Intervention (1 Day)||4
27596|NCT01811303|60778|P1|STARTED|Third Intervention (1 Day)||4
27597|NCT01811303|60775|P4|NOT COMPLETED|Washout (2 Days or More)||0
27598|NCT01811303|60776|P3|NOT COMPLETED|Washout (2 Days or More)||0
27599|NCT01811303|60777|P2|NOT COMPLETED|Washout (2 Days or More)||0
27600|NCT01811303|60778|P1|NOT COMPLETED|Washout (2 Days or More)||0
27601|NCT01811303|60775|P4|COMPLETED|Washout (2 Days or More)||2
27602|NCT01811303|60776|P3|COMPLETED|Washout (2 Days or More)||4
27603|NCT01811303|60777|P2|COMPLETED|Washout (2 Days or More)||4
27604|NCT01811303|60778|P1|COMPLETED|Washout (2 Days or More)||4
27605|NCT01811303|60775|P4|STARTED|Washout (2 Days or More)||2
27606|NCT01811303|60776|P3|STARTED|Washout (2 Days or More)||4
27607|NCT01811303|60777|P2|STARTED|Washout (2 Days or More)||4
27608|NCT01811303|60778|P1|STARTED|Washout (2 Days or More)||4
27609|NCT01811303|60775|P4|NOT COMPLETED|Second Intervention (1 Day)||0
27610|NCT01811303|60776|P3|NOT COMPLETED|Second Intervention (1 Day)||0
27611|NCT01811303|60777|P2|NOT COMPLETED|Second Intervention (1 Day)||0
27612|NCT01811303|60778|P1|NOT COMPLETED|Second Intervention (1 Day)||0
27613|NCT01811303|60775|P4|COMPLETED|Second Intervention (1 Day)||2
27614|NCT01811303|60776|P3|COMPLETED|Second Intervention (1 Day)||4
27615|NCT01811303|60777|P2|COMPLETED|Second Intervention (1 Day)||4
27616|NCT01811303|60778|P1|COMPLETED|Second Intervention (1 Day)||4
27617|NCT01811303|60775|P4|STARTED|Second Intervention (1 Day)||2
27618|NCT01811303|60776|P3|STARTED|Second Intervention (1 Day)||4
27619|NCT01811303|60777|P2|STARTED|Second Intervention (1 Day)||4
27620|NCT01811303|60778|P1|STARTED|Second Intervention (1 Day)||4
27621|NCT01811303|60775|P4|NOT COMPLETED|Washout (2 Days or More)||0
27622|NCT01811303|60776|P3|NOT COMPLETED|Washout (2 Days or More)||0
27623|NCT01811303|60777|P2|NOT COMPLETED|Washout (2 Days or More)||0
27624|NCT01811303|60778|P1|NOT COMPLETED|Washout (2 Days or More)||0
27625|NCT01811303|60775|P4|COMPLETED|Washout (2 Days or More)||2
27626|NCT01811303|60776|P3|COMPLETED|Washout (2 Days or More)||4
27627|NCT01811303|60777|P2|COMPLETED|Washout (2 Days or More)||4
27628|NCT01811303|60778|P1|COMPLETED|Washout (2 Days or More)||4
27629|NCT01811303|60775|P4|STARTED|Washout (2 Days or More)||2
27630|NCT01811303|60776|P3|STARTED|Washout (2 Days or More)||4
27631|NCT01811303|60777|P2|STARTED|Washout (2 Days or More)||4
27632|NCT01811303|60778|P1|STARTED|Washout (2 Days or More)||4
27633|NCT01811303|60775|P4|NOT COMPLETED|First Intervention (1 Day)||0
27634|NCT01811303|60776|P3|NOT COMPLETED|First Intervention (1 Day)||0
27635|NCT01811303|60777|P2|NOT COMPLETED|First Intervention (1 Day)||0
27636|NCT01811303|60778|P1|NOT COMPLETED|First Intervention (1 Day)||0
27637|NCT01811303|60775|P4|COMPLETED|First Intervention (1 Day)||2
27638|NCT01811303|60776|P3|COMPLETED|First Intervention (1 Day)||4
27639|NCT01811303|60777|P2|COMPLETED|First Intervention (1 Day)||4
27640|NCT01811303|60778|P1|COMPLETED|First Intervention (1 Day)||4
27641|NCT01811303|60775|P4|STARTED|First Intervention (1 Day)||2
27642|NCT01811303|60776|P3|STARTED|First Intervention (1 Day)||4
27643|NCT01811303|60777|P2|STARTED|First Intervention (1 Day)||4
27644|NCT01811303|60778|P1|STARTED|First Intervention (1 Day)||4
27645|NCT01811238|60786|P1|NOT COMPLETED|Overall Study||81
27646|NCT01811238|60786|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
27647|NCT01811238|60786|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
27648|NCT01811238|60786|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
27734|NCT01809639|60975|P2|COMPLETED|Overall Study||7
27649|NCT01811238|60786|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
27650|NCT01811238|60786|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
27651|NCT01810952|60797|P2|NOT COMPLETED|Overall Study||0
27652|NCT01810952|60798|P1|NOT COMPLETED|Overall Study||0
27653|NCT01810952|60797|P2|COMPLETED|Overall Study||17
27654|NCT01810952|60798|P1|COMPLETED|Overall Study||20
27655|NCT01810952|60797|P2|STARTED|Overall Study||17
27656|NCT01810952|60798|P1|STARTED|Overall Study||20
27657|NCT01810939|60812|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
27658|NCT01810939|60813|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
27659|NCT01810939|60814|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
27660|NCT01810939|60812|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
27661|NCT01810939|60813|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
27662|NCT01810939|60814|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
27663|NCT01810939|60812|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
27664|NCT01810939|60813|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
27665|NCT01810939|60814|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
27666|NCT01810939|60812|P3|NOT COMPLETED|Part A Treatment Period||0
27667|NCT01810939|60813|P2|NOT COMPLETED|Part A Treatment Period||0
27668|NCT01810939|60814|P1|NOT COMPLETED|Part A Treatment Period||24
27669|NCT01810939|60812|P3|COMPLETED|Part A Treatment Period||0
27670|NCT01810939|60813|P2|COMPLETED|Part A Treatment Period||0
27671|NCT01810939|60814|P1|COMPLETED|Part A Treatment Period||219
27672|NCT01810939|60812|P3|STARTED|Part A Treatment Period||0
27673|NCT01810939|60813|P2|STARTED|Part A Treatment Period||0
27674|NCT01810939|60814|P1|STARTED|Part A Treatment Period||243
27675|NCT01810692|60829|P2|NOT COMPLETED|Overall Study||0
27676|NCT01810692|60830|P1|NOT COMPLETED|Overall Study||0
27677|NCT01810692|60829|P2|COMPLETED|Overall Study||77
27678|NCT01810692|60830|P1|COMPLETED|Overall Study||77
27679|NCT01810692|60829|P2|STARTED|Overall Study||77
27680|NCT01810692|60830|P1|STARTED|Overall Study||77
27681|NCT01810666|60842|P1|NOT COMPLETED|Overall Study||0
27682|NCT01810666|60842|P1|COMPLETED|Overall Study||30
27683|NCT01810666|60842|P1|STARTED|Overall Study||30
27684|NCT01810380|60851|P3|NOT COMPLETED|Overall Study||32
27685|NCT01810380|60852|P2|NOT COMPLETED|Overall Study||38
27686|NCT01810380|60853|P1|NOT COMPLETED|Overall Study||55
27687|NCT01810380|60851|P3|COMPLETED|Overall Study||122
27688|NCT01810380|60852|P2|COMPLETED|Overall Study||113
27689|NCT01810380|60853|P1|COMPLETED|Overall Study||108
27690|NCT01810380|60851|P3|Treated|Overall Study||153
27691|NCT01810380|60852|P2|Treated|Overall Study||150
27692|NCT01810380|60853|P1|Treated|Overall Study||161
27693|NCT01810380|60851|P3|STARTED|Overall Study||154
27694|NCT01810380|60852|P2|STARTED|Overall Study||151
27695|NCT01810380|60853|P1|STARTED|Overall Study||163
27696|NCT01810302|60914|P2|NOT COMPLETED|Overall Study||1
27697|NCT01810302|60915|P1|NOT COMPLETED|Overall Study||1
27698|NCT01810302|60914|P2|COMPLETED|Overall Study||0
27699|NCT01810302|60915|P1|COMPLETED|Overall Study||0
27700|NCT01810302|60914|P2|STARTED|Overall Study||1
27701|NCT01810302|60915|P1|STARTED|Overall Study||1
27702|NCT01810263|60925|P2|NOT COMPLETED|Overall Study||7
27703|NCT01810263|60926|P1|NOT COMPLETED|Overall Study||8
27704|NCT01810263|60925|P2|COMPLETED|Overall Study||11
27705|NCT01810263|60926|P1|COMPLETED|Overall Study|2014 July|8
27706|NCT01810263|60925|P2|STARTED|Overall Study||18
27707|NCT01810263|60926|P1|STARTED|Overall Study||16
27708|NCT01810042|60932|P1|NOT COMPLETED|Overall Study||10
27709|NCT01810042|60932|P1|COMPLETED|Overall Study||39
27710|NCT01810042|60932|P1|STARTED|Overall Study||49
27711|NCT01809938|60939|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
27712|NCT01809938|60940|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
27713|NCT01809938|60939|P2|COMPLETED|Second Intervention (170 Minutes)||5
27714|NCT01809938|60940|P1|COMPLETED|Second Intervention (170 Minutes)||5
27715|NCT01809938|60939|P2|STARTED|Second Intervention (170 Minutes)||5
27716|NCT01809938|60940|P1|STARTED|Second Intervention (170 Minutes)||5
27717|NCT01809938|60939|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
27718|NCT01809938|60940|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
27719|NCT01809938|60939|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
27720|NCT01809938|60940|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
27721|NCT01809938|60939|P2|STARTED|Washout (Not Less Than 24 Hours)||5
27722|NCT01809938|60940|P1|STARTED|Washout (Not Less Than 24 Hours)||5
27723|NCT01809938|60939|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
27724|NCT01809938|60940|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
27725|NCT01809938|60939|P2|COMPLETED|First Intervention (170 Minutes)||5
27726|NCT01809938|60940|P1|COMPLETED|First Intervention (170 Minutes)||5
27727|NCT01809938|60939|P2|STARTED|First Intervention (170 Minutes)||5
27728|NCT01809938|60940|P1|STARTED|First Intervention (170 Minutes)||5
27729|NCT01809834|60947|P1|NOT COMPLETED|Overall Study||0
27730|NCT01809834|60947|P1|COMPLETED|Overall Study||44
27731|NCT01809834|60947|P1|STARTED|Overall Study||44
27732|NCT01809639|60975|P2|NOT COMPLETED|Overall Study||0
27733|NCT01809639|60976|P1|NOT COMPLETED|Overall Study||0
27735|NCT01809639|60976|P1|COMPLETED|Overall Study||18
27736|NCT01809639|60975|P2|STARTED|Overall Study||7
27737|NCT01809639|60976|P1|STARTED|Overall Study||18
27738|NCT01808339|60982|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
27739|NCT01808339|60983|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
27740|NCT01808339|60984|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
27741|NCT01808339|60985|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
27742|NCT01808339|60986|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
27743|NCT01808339|60987|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
27744|NCT01808339|60982|P6|COMPLETED|Treatment Period 3 (14 Days)||5
27745|NCT01808339|60983|P5|COMPLETED|Treatment Period 3 (14 Days)||4
27746|NCT01808339|60984|P4|COMPLETED|Treatment Period 3 (14 Days)||2
27747|NCT01808339|60985|P3|COMPLETED|Treatment Period 3 (14 Days)||3
27748|NCT01808339|60986|P2|COMPLETED|Treatment Period 3 (14 Days)||3
27749|NCT01808339|60987|P1|COMPLETED|Treatment Period 3 (14 Days)||4
27750|NCT01808339|60982|P6|STARTED|Treatment Period 3 (14 Days)||5
27751|NCT01808339|60983|P5|STARTED|Treatment Period 3 (14 Days)||4
27752|NCT01808339|60984|P4|STARTED|Treatment Period 3 (14 Days)||2
27753|NCT01808339|60985|P3|STARTED|Treatment Period 3 (14 Days)||4
27754|NCT01808339|60986|P2|STARTED|Treatment Period 3 (14 Days)||3
27755|NCT01808339|60987|P1|STARTED|Treatment Period 3 (14 Days)||4
27756|NCT01808339|60982|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27757|NCT01808339|60983|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27758|NCT01808339|60984|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27759|NCT01808339|60985|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27760|NCT01808339|60986|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27761|NCT01808339|60987|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
27762|NCT01808339|60982|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
27763|NCT01808339|60983|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
27764|NCT01808339|60984|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
27765|NCT01808339|60985|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
27766|NCT01808339|60986|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
27767|NCT01808339|60987|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
27768|NCT01808339|60982|P6|STARTED|Washout Period 2 (14-21 Days)||5
27769|NCT01808339|60983|P5|STARTED|Washout Period 2 (14-21 Days)||4
27770|NCT01808339|60984|P4|STARTED|Washout Period 2 (14-21 Days)||2
27771|NCT01808339|60985|P3|STARTED|Washout Period 2 (14-21 Days)||4
27772|NCT01808339|60986|P2|STARTED|Washout Period 2 (14-21 Days)||3
27773|NCT01808339|60987|P1|STARTED|Washout Period 2 (14-21 Days)||4
27774|NCT01808339|60982|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27775|NCT01808339|60983|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27776|NCT01808339|60984|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27777|NCT01808339|60985|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27778|NCT01808339|60986|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27779|NCT01808339|60987|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
27780|NCT01808339|60982|P6|COMPLETED|Treatment Period 2 (14 Days)||5
27781|NCT01808339|60983|P5|COMPLETED|Treatment Period 2 (14 Days)||4
27782|NCT01808339|60984|P4|COMPLETED|Treatment Period 2 (14 Days)||2
27783|NCT01808339|60985|P3|COMPLETED|Treatment Period 2 (14 Days)||4
27784|NCT01808339|60986|P2|COMPLETED|Treatment Period 2 (14 Days)||3
27785|NCT01808339|60987|P1|COMPLETED|Treatment Period 2 (14 Days)||4
27786|NCT01808339|60982|P6|STARTED|Treatment Period 2 (14 Days)||5
27787|NCT01808339|60983|P5|STARTED|Treatment Period 2 (14 Days)||4
27788|NCT01808339|60984|P4|STARTED|Treatment Period 2 (14 Days)||2
27789|NCT01808339|60985|P3|STARTED|Treatment Period 2 (14 Days)||4
27790|NCT01808339|60986|P2|STARTED|Treatment Period 2 (14 Days)||3
27791|NCT01808339|60987|P1|STARTED|Treatment Period 2 (14 Days)||4
27792|NCT01808339|60982|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27793|NCT01808339|60983|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27794|NCT01808339|60984|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27795|NCT01808339|60985|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27796|NCT01808339|60986|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27797|NCT01808339|60987|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
27798|NCT01808339|60982|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
27799|NCT01808339|60983|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
27800|NCT01808339|60984|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
27801|NCT01808339|60985|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
27802|NCT01808339|60986|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
27803|NCT01808339|60987|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
27804|NCT01808339|60982|P6|STARTED|Washout Period 1 (14-21 Days)||5
27805|NCT01808339|60983|P5|STARTED|Washout Period 1 (14-21 Days)||4
27806|NCT01808339|60984|P4|STARTED|Washout Period 1 (14-21 Days)||2
27807|NCT01808339|60985|P3|STARTED|Washout Period 1 (14-21 Days)||4
27808|NCT01808339|60986|P2|STARTED|Washout Period 1 (14-21 Days)||3
27809|NCT01808339|60987|P1|STARTED|Washout Period 1 (14-21 Days)||4
27810|NCT01808339|60982|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
27811|NCT01808339|60983|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
27812|NCT01808339|60984|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
27813|NCT01808339|60985|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
27814|NCT01808339|60986|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
27815|NCT01808339|60987|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
27816|NCT01808339|60982|P6|COMPLETED|Treatment Period 1 (14 Days)||5
27817|NCT01808339|60983|P5|COMPLETED|Treatment Period 1 (14 Days)||4
27818|NCT01808339|60984|P4|COMPLETED|Treatment Period 1 (14 Days)||2
27819|NCT01808339|60985|P3|COMPLETED|Treatment Period 1 (14 Days)||4
27820|NCT01808339|60986|P2|COMPLETED|Treatment Period 1 (14 Days)||3
27821|NCT01808339|60987|P1|COMPLETED|Treatment Period 1 (14 Days)||4
27822|NCT01808339|60982|P6|STARTED|Treatment Period 1 (14 Days)||6
27823|NCT01808339|60983|P5|STARTED|Treatment Period 1 (14 Days)||6
27824|NCT01808339|60984|P4|STARTED|Treatment Period 1 (14 Days)||4
27825|NCT01808339|60985|P3|STARTED|Treatment Period 1 (14 Days)||4
27826|NCT01808339|60986|P2|STARTED|Treatment Period 1 (14 Days)||4
27827|NCT01808339|60987|P1|STARTED|Treatment Period 1 (14 Days)||4
27828|NCT01808326|61004|P1|NOT COMPLETED|Overall Study||0
27829|NCT01808326|61004|P1|COMPLETED|Overall Study||5
27830|NCT01808326|61004|P1|STARTED|Overall Study||5
27831|NCT01809327|61036|P5|NOT COMPLETED|Overall Study||25
27832|NCT01809327|61037|P4|NOT COMPLETED|Overall Study||12
27833|NCT01809327|61038|P3|NOT COMPLETED|Overall Study||22
27834|NCT01809327|61039|P2|NOT COMPLETED|Overall Study||26
27835|NCT01809327|61040|P1|NOT COMPLETED|Overall Study||32
27836|NCT01809327|61036|P5|COMPLETED|Overall Study||212
27837|NCT01809327|61037|P4|COMPLETED|Overall Study||225
27838|NCT01809327|61038|P3|COMPLETED|Overall Study||216
27839|NCT01809327|61039|P2|COMPLETED|Overall Study||211
27840|NCT01809327|61040|P1|COMPLETED|Overall Study||205
27841|NCT01809327|61036|P5|STARTED|Overall Study||237
27842|NCT01809327|61037|P4|STARTED|Overall Study||237
27843|NCT01809327|61038|P3|STARTED|Overall Study||238
27844|NCT01809327|61039|P2|STARTED|Overall Study||237
27845|NCT01809327|61040|P1|STARTED|Overall Study||237
27846|NCT01809314|61082|P1|NOT COMPLETED|Overall Study||745
27847|NCT01809314|61082|P1|COMPLETED|Overall Study||422
27848|NCT01809314|61082|P1|STARTED|Overall Study||1167
27849|NCT01809262|61088|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27850|NCT01809262|61089|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27851|NCT01809262|61090|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27852|NCT01809262|61091|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27853|NCT01809262|61092|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27854|NCT01809262|61093|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27855|NCT01809262|61094|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27856|NCT01809262|61095|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27857|NCT01809262|61096|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27858|NCT01809262|61097|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
27859|NCT01809262|61088|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
27860|NCT01809262|61089|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27861|NCT01809262|61090|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
27862|NCT01809262|61091|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27863|NCT01809262|61092|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27864|NCT01809262|61093|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27865|NCT01809262|61094|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27866|NCT01809262|61095|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
27867|NCT01809262|61096|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
27868|NCT01809262|61097|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
27869|NCT01809262|61088|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
27870|NCT01809262|61089|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
27871|NCT01809262|61090|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
27872|NCT01809262|61091|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
27873|NCT01809262|61092|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
27874|NCT01809262|61093|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
27875|NCT01809262|61094|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
27876|NCT01809262|61095|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
27877|NCT01809262|61096|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
27878|NCT01809262|61097|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
27879|NCT01809262|61088|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27880|NCT01809262|61089|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27881|NCT01809262|61090|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27882|NCT01809262|61091|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27883|NCT01809262|61092|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27884|NCT01809262|61093|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27885|NCT01809262|61094|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27886|NCT01809262|61095|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27887|NCT01809262|61096|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27888|NCT01809262|61097|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
27889|NCT01809262|61088|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
27890|NCT01809262|61089|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27891|NCT01809262|61090|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
27892|NCT01809262|61091|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27893|NCT01809262|61092|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27894|NCT01809262|61093|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27895|NCT01809262|61094|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27896|NCT01809262|61095|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
27897|NCT01809262|61096|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
27898|NCT01809262|61097|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
27899|NCT01809262|61088|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
27900|NCT01809262|61089|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
27901|NCT01809262|61090|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
27902|NCT01809262|61091|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
27903|NCT01809262|61092|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
27904|NCT01809262|61093|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
27905|NCT01809262|61094|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
27906|NCT01809262|61095|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
27907|NCT01809262|61096|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
27908|NCT01809262|61097|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
27909|NCT01809262|61088|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27910|NCT01809262|61089|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27911|NCT01809262|61090|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27912|NCT01809262|61091|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27913|NCT01809262|61092|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27914|NCT01809262|61093|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27915|NCT01809262|61094|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27916|NCT01809262|61095|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27917|NCT01809262|61096|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
27918|NCT01809262|61097|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
27919|NCT01809262|61088|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
27920|NCT01809262|61089|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
27921|NCT01809262|61090|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
27922|NCT01809262|61091|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
27923|NCT01809262|61092|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
27924|NCT01809262|61093|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
27925|NCT01809262|61094|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
27926|NCT01809262|61095|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
27927|NCT01809262|61096|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
27928|NCT01809262|61097|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
27929|NCT01809262|61088|P10|STARTED|Period 3 (Third Dose + Washout)||4
27930|NCT01809262|61089|P9|STARTED|Period 3 (Third Dose + Washout)||3
27931|NCT01809262|61090|P8|STARTED|Period 3 (Third Dose + Washout)||4
27932|NCT01809262|61091|P7|STARTED|Period 3 (Third Dose + Washout)||3
27933|NCT01809262|61092|P6|STARTED|Period 3 (Third Dose + Washout)||3
27934|NCT01809262|61093|P5|STARTED|Period 3 (Third Dose + Washout)||3
27935|NCT01809262|61094|P4|STARTED|Period 3 (Third Dose + Washout)||3
27936|NCT01809262|61095|P3|STARTED|Period 3 (Third Dose + Washout)||4
27937|NCT01809262|61096|P2|STARTED|Period 3 (Third Dose + Washout)||4
27938|NCT01809262|61097|P1|STARTED|Period 3 (Third Dose + Washout)||4
27939|NCT01809262|61088|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27940|NCT01809262|61089|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27941|NCT01809262|61090|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27942|NCT01809262|61091|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27943|NCT01809262|61092|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27944|NCT01809262|61093|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27945|NCT01809262|61094|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27946|NCT01809262|61095|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27947|NCT01809262|61096|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27948|NCT01809262|61097|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
27949|NCT01809262|61088|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
27950|NCT01809262|61089|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
27951|NCT01809262|61090|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
27952|NCT01809262|61091|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
27953|NCT01809262|61092|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
27954|NCT01809262|61093|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
27955|NCT01809262|61094|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
27956|NCT01809262|61095|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
27957|NCT01809262|61096|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
27958|NCT01809262|61097|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
27959|NCT01809262|61088|P10|STARTED|Period 2 (Second Dose + Washout)||4
27960|NCT01809262|61089|P9|STARTED|Period 2 (Second Dose + Washout)||3
27961|NCT01809262|61090|P8|STARTED|Period 2 (Second Dose + Washout)||4
27962|NCT01809262|61091|P7|STARTED|Period 2 (Second Dose + Washout)||3
27963|NCT01809262|61092|P6|STARTED|Period 2 (Second Dose + Washout)||3
27964|NCT01809262|61093|P5|STARTED|Period 2 (Second Dose + Washout)||3
27965|NCT01809262|61094|P4|STARTED|Period 2 (Second Dose + Washout)||3
27966|NCT01809262|61095|P3|STARTED|Period 2 (Second Dose + Washout)||4
27967|NCT01809262|61096|P2|STARTED|Period 2 (Second Dose + Washout)||4
27968|NCT01809262|61097|P1|STARTED|Period 2 (Second Dose + Washout)||4
27969|NCT01809262|61088|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27970|NCT01809262|61089|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27971|NCT01809262|61090|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27972|NCT01809262|61091|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27973|NCT01809262|61092|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27974|NCT01809262|61093|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
27975|NCT01809262|61094|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27976|NCT01809262|61095|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27977|NCT01809262|61096|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27978|NCT01809262|61097|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
27979|NCT01809262|61088|P10|COMPLETED|Period 1 (First Dose + Washout)||4
27980|NCT01809262|61089|P9|COMPLETED|Period 1 (First Dose + Washout)||3
27981|NCT01809262|61090|P8|COMPLETED|Period 1 (First Dose + Washout)||4
27982|NCT01809262|61091|P7|COMPLETED|Period 1 (First Dose + Washout)||3
27983|NCT01809262|61092|P6|COMPLETED|Period 1 (First Dose + Washout)||3
27984|NCT01809262|61093|P5|COMPLETED|Period 1 (First Dose + Washout)||3
27985|NCT01809262|61094|P4|COMPLETED|Period 1 (First Dose + Washout)||3
27986|NCT01809262|61095|P3|COMPLETED|Period 1 (First Dose + Washout)||4
27987|NCT01809262|61096|P2|COMPLETED|Period 1 (First Dose + Washout)||4
27988|NCT01809262|61097|P1|COMPLETED|Period 1 (First Dose + Washout)||4
27989|NCT01809262|61088|P10|STARTED|Period 1 (First Dose + Washout)||4
27990|NCT01809262|61089|P9|STARTED|Period 1 (First Dose + Washout)||3
27991|NCT01809262|61090|P8|STARTED|Period 1 (First Dose + Washout)||4
27992|NCT01809262|61091|P7|STARTED|Period 1 (First Dose + Washout)||3
27993|NCT01809262|61092|P6|STARTED|Period 1 (First Dose + Washout)||3
27994|NCT01809262|61093|P5|STARTED|Period 1 (First Dose + Washout)||4
27995|NCT01809262|61094|P4|STARTED|Period 1 (First Dose + Washout)||3
27996|NCT01809262|61095|P3|STARTED|Period 1 (First Dose + Washout)||4
27997|NCT01809262|61096|P2|STARTED|Period 1 (First Dose + Washout)||4
27998|NCT01809262|61097|P1|STARTED|Period 1 (First Dose + Washout)||4
27999|NCT01809197|61166|P2|NOT COMPLETED|Overall Study||8
28000|NCT01809197|61167|P1|NOT COMPLETED|Overall Study||10
28001|NCT01809197|61166|P2|COMPLETED|Overall Study||177
28002|NCT01809197|61167|P1|COMPLETED|Overall Study||177
28003|NCT01809197|61166|P2|STARTED|Overall Study||185
28004|NCT01809197|61167|P1|STARTED|Overall Study||187
28005|NCT01809106|61177|P4|NOT COMPLETED|Overall Study||4
28006|NCT01809106|61178|P3|NOT COMPLETED|Overall Study||3
28007|NCT01809106|61179|P2|NOT COMPLETED|Overall Study||5
28008|NCT01809106|61180|P1|NOT COMPLETED|Overall Study||8
28009|NCT01809106|61177|P4|COMPLETED|Overall Study||124
28010|NCT01809106|61178|P3|COMPLETED|Overall Study||127
28011|NCT01809106|61179|P2|COMPLETED|Overall Study||125
28012|NCT01809106|61180|P1|COMPLETED|Overall Study||122
28013|NCT01809106|61177|P4|STARTED|Overall Study||128
28014|NCT01809106|61178|P3|STARTED|Overall Study||130
28015|NCT01809106|61179|P2|STARTED|Overall Study||130
28016|NCT01809106|61180|P1|STARTED|Overall Study||130
28017|NCT01809054|61200|P2|NOT COMPLETED|Overall Study||0
28018|NCT01809054|61201|P1|NOT COMPLETED|Overall Study||0
28019|NCT01809054|61200|P2|COMPLETED|Overall Study||22
28020|NCT01809054|61201|P1|COMPLETED|Overall Study||27
28021|NCT01809054|61200|P2|STARTED|Overall Study||22
28022|NCT01809054|61201|P1|STARTED|Overall Study||27
28023|NCT01808963|61209|P1|NOT COMPLETED|Overall Study||0
28024|NCT01808963|61209|P1|COMPLETED|Overall Study||13
28025|NCT01808963|61209|P1|STARTED|Overall Study||13
28026|NCT01808950|61216|P3|NOT COMPLETED|Overall Study||0
28027|NCT01808950|61217|P2|NOT COMPLETED|Overall Study||0
28028|NCT01808950|61218|P1|NOT COMPLETED|Overall Study||0
28029|NCT01808950|61216|P3|COMPLETED|Overall Study||0
28030|NCT01808950|61217|P2|COMPLETED|Overall Study||3
28031|NCT01808950|61218|P1|COMPLETED|Overall Study||1
28032|NCT01808950|61216|P3|STARTED|Overall Study||0
28033|NCT01808950|61217|P2|STARTED|Overall Study||3
28034|NCT01808950|61218|P1|STARTED|Overall Study||1
28035|NCT01808755|61229|P2|NOT COMPLETED|Overall Study||0
28036|NCT01808755|61230|P1|NOT COMPLETED|Overall Study||0
28037|NCT01808755|61229|P2|COMPLETED|Overall Study||30
28038|NCT01808755|61230|P1|COMPLETED|Overall Study||30
28039|NCT01808755|61229|P2|STARTED|Overall Study||30
28040|NCT01808755|61230|P1|STARTED|Overall Study||30
28041|NCT01808651|61238|P3|NOT COMPLETED|Study Period 2||0
28042|NCT01808651|61239|P2|NOT COMPLETED|Study Period 2||0
28043|NCT01808651|61240|P1|NOT COMPLETED|Study Period 2||0
28044|NCT01808651|61238|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
28045|NCT01808651|61239|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
28046|NCT01808651|61240|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
28047|NCT01808651|61238|P3|STARTED|Study Period 2||33
28048|NCT01808651|61239|P2|STARTED|Study Period 2||52
28049|NCT01808651|61240|P1|STARTED|Study Period 2||77
28050|NCT01808651|61238|P3|NOT COMPLETED|Study Period 1||5
28051|NCT01808651|61239|P2|NOT COMPLETED|Study Period 1||17
28052|NCT01808651|61240|P1|NOT COMPLETED|Study Period 1||26
28053|NCT01808651|61238|P3|COMPLETED|Study Period 1||31
28054|NCT01808651|61239|P2|COMPLETED|Study Period 1||48
28055|NCT01808651|61240|P1|COMPLETED|Study Period 1||73
28056|NCT01808651|61238|P3|Received at Least One Dose of Study Drug|Study Period 1||36
28057|NCT01808651|61239|P2|Received at Least One Dose of Study Drug|Study Period 1||65
28058|NCT01808651|61240|P1|Received at Least One Dose of Study Drug|Study Period 1||98
28059|NCT01808651|61238|P3|STARTED|Study Period 1||36
28060|NCT01808651|61239|P2|STARTED|Study Period 1||65
28061|NCT01808651|61240|P1|STARTED|Study Period 1||99
28062|NCT01808612|61275|P3|NOT COMPLETED|Discontinuation Period||0
28063|NCT01808612|61276|P2|NOT COMPLETED|Discontinuation Period||1
28064|NCT01808612|61277|P1|NOT COMPLETED|Discontinuation Period||2
28065|NCT01808612|61275|P3|COMPLETED|Discontinuation Period||145
28066|NCT01808612|61276|P2|COMPLETED|Discontinuation Period||37
28067|NCT01808612|61277|P1|COMPLETED|Discontinuation Period||85
28068|NCT01808612|61275|P3|STARTED|Discontinuation Period||145
28069|NCT01808612|61276|P2|STARTED|Discontinuation Period||38
28070|NCT01808612|61277|P1|STARTED|Discontinuation Period||87
28071|NCT01808612|61275|P3|NOT COMPLETED|Treatment Period||14
28072|NCT01808612|61276|P2|NOT COMPLETED|Treatment Period||7
28073|NCT01808612|61277|P1|NOT COMPLETED|Treatment Period||15
28074|NCT01808612|61275|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
28075|NCT01808612|61276|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
28076|NCT01808612|61277|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
28077|NCT01808612|61275|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
28078|NCT01808612|61276|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
28079|NCT01808612|61277|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
28080|NCT01808612|61275|P3|STARTED|Treatment Period||260
28081|NCT01808612|61276|P2|STARTED|Treatment Period||84
28082|NCT01808612|61277|P1|STARTED|Treatment Period||169
28083|NCT01808547|61308|P2|NOT COMPLETED|Overall Study||46
28084|NCT01808547|61309|P1|NOT COMPLETED|Overall Study||37
28085|NCT01808547|61308|P2|COMPLETED|Overall Study||48
28086|NCT01808547|61309|P1|COMPLETED|Overall Study||137
28087|NCT01808547|61308|P2|mITT Population|Overall Study||85
28088|NCT01808547|61309|P1|mITT Population|Overall Study||168
28089|NCT01808547|61308|P2|Safety Population|Overall Study||85
28090|NCT01808547|61309|P1|Safety Population|Overall Study||170
28091|NCT01808547|61308|P2|STARTED|Overall Study||94
28092|NCT01808547|61309|P1|STARTED|Overall Study||174
28093|NCT01808534|61315|P1|NOT COMPLETED|Overall Study||4
28094|NCT01808534|61315|P1|COMPLETED|Overall Study||1
28095|NCT01808534|61315|P1|STARTED|Overall Study||5
28096|NCT01808508|61326|P3|NOT COMPLETED|Overall Study||0
28097|NCT01808508|61327|P2|NOT COMPLETED|Overall Study||0
28098|NCT01808508|61328|P1|NOT COMPLETED|Overall Study||1
28099|NCT01808508|61326|P3|COMPLETED|Overall Study||3
28100|NCT01808508|61327|P2|COMPLETED|Overall Study||9
28101|NCT01808508|61328|P1|COMPLETED|Overall Study||10
28102|NCT01808508|61326|P3|STARTED|Overall Study||3
28103|NCT01808508|61327|P2|STARTED|Overall Study||9
28104|NCT01808508|61328|P1|STARTED|Overall Study||11
28105|NCT01808313|61345|P1|NOT COMPLETED|Overall Study||10
28106|NCT01808313|61345|P1|COMPLETED|Overall Study||123
28107|NCT01808313|61345|P1|STARTED|Overall Study||133
28108|NCT01808248|61375|P1|NOT COMPLETED|Overall Study||5
28109|NCT01808248|61375|P1|COMPLETED|Overall Study||42
28110|NCT01808248|61375|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
28111|NCT01808248|61375|P1|STARTED|Overall Study||47
28112|NCT01808209|61389|P2|NOT COMPLETED|Overall Study||1
28113|NCT01808209|61390|P1|NOT COMPLETED|Overall Study||0
28114|NCT01808209|61389|P2|COMPLETED|Overall Study||26
28115|NCT01808209|61390|P1|COMPLETED|Overall Study||33
28116|NCT01808209|61389|P2|STARTED|Overall Study||27
28117|NCT01808209|61390|P1|STARTED|Overall Study||33
28118|NCT01808092|61434|P2|NOT COMPLETED|Overall Study||45
28119|NCT01808092|61435|P1|NOT COMPLETED|Overall Study||54
28120|NCT01808092|61434|P2|COMPLETED|Overall Study||363
28121|NCT01808092|61435|P1|COMPLETED|Overall Study||355
28122|NCT01808092|61434|P2|STARTED|Overall Study||408
28123|NCT01808092|61435|P1|STARTED|Overall Study||409
28124|NCT01808066|61537|P1|NOT COMPLETED|Overall Study||15
28125|NCT01808066|61537|P1|COMPLETED|Overall Study||6
28126|NCT01808066|61537|P1|STARTED|Overall Study||21
28127|NCT01807949|61544|P3|NOT COMPLETED|Overall Study||9
28128|NCT01807949|61545|P2|NOT COMPLETED|Overall Study||7
28129|NCT01807949|61546|P1|NOT COMPLETED|Overall Study||2
28130|NCT01807949|61544|P3|COMPLETED|Overall Study||180
28131|NCT01807949|61545|P2|COMPLETED|Overall Study||180
28132|NCT01807949|61546|P1|COMPLETED|Overall Study||185
28133|NCT01807949|61544|P3|STARTED|Overall Study||189
28134|NCT01807949|61545|P2|STARTED|Overall Study||187
28135|NCT01807949|61546|P1|STARTED|Overall Study||187
28136|NCT01807923|61598|P3|NOT COMPLETED|Overall Study||11
28137|NCT01807923|61599|P2|NOT COMPLETED|Overall Study||6
28138|NCT01807923|61600|P1|NOT COMPLETED|Overall Study||5
28139|NCT01807923|61598|P3|COMPLETED|Overall Study||176
28140|NCT01807923|61599|P2|COMPLETED|Overall Study||179
28141|NCT01807923|61600|P1|COMPLETED|Overall Study||182
28142|NCT01807923|61598|P3|STARTED|Overall Study||187
28143|NCT01807923|61599|P2|STARTED|Overall Study||185
28144|NCT01807923|61600|P1|STARTED|Overall Study||187
28145|NCT01807624|61649|P1|NOT COMPLETED|Overall Study||16
28146|NCT01807624|61649|P1|COMPLETED|Overall Study||24
28147|NCT01807624|61649|P1|STARTED|Overall Study||40
28148|NCT01807455|61665|P1|NOT COMPLETED|Overall Study||0
28149|NCT01807455|61665|P1|COMPLETED|Overall Study||12
28150|NCT01807455|61665|P1|STARTED|Overall Study||12
28151|NCT01807156|61673|P1|NOT COMPLETED|Overall Study||1
28152|NCT01807156|61673|P1|COMPLETED|Overall Study||6
28153|NCT01807156|61673|P1|STARTED|Overall Study||7
28154|NCT01807000|61678|P1|NOT COMPLETED|Overall Study||0
28155|NCT01807000|61678|P1|COMPLETED|Overall Study||6
28156|NCT01807000|61678|P1|STARTED|Overall Study||6
28157|NCT01806961|61697|P1|NOT COMPLETED|Overall Study||16
28158|NCT01806961|61697|P1|COMPLETED|Overall Study||0
28159|NCT01806961|61697|P1|STARTED|Overall Study||16
28160|NCT01806779|61703|P3|NOT COMPLETED|Overall Study||23
28161|NCT01806779|61704|P2|NOT COMPLETED|Overall Study||44
28162|NCT01806779|61705|P1|NOT COMPLETED|Overall Study||42
28163|NCT01806779|61703|P3|COMPLETED|Overall Study||0
28164|NCT01806779|61704|P2|COMPLETED|Overall Study||40
28165|NCT01806779|61705|P1|COMPLETED|Overall Study||48
28166|NCT01806779|61703|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
28167|NCT01806779|61704|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
28168|NCT01806779|61705|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
28169|NCT01806779|61703|P3|Randomized at Visit 2|Overall Study||0
28170|NCT01806779|61704|P2|Randomized at Visit 2|Overall Study||84
28171|NCT01806779|61705|P1|Randomized at Visit 2|Overall Study||90
28172|NCT01806779|61703|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
28173|NCT01806779|61704|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
28174|NCT01806779|61705|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
28175|NCT01806779|61703|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
28176|NCT01806779|61704|P2|STARTED|Overall Study||84
28177|NCT01806779|61705|P1|STARTED|Overall Study||90
28178|NCT01806623|61718|P1|NOT COMPLETED|Overall Study||58
28179|NCT01806623|61718|P1|COMPLETED|Overall Study||99
28180|NCT01806623|61718|P1|STARTED|Overall Study||157
28181|NCT01806584|61737|P2|NOT COMPLETED|Overall Study||18
28182|NCT01806584|61738|P1|NOT COMPLETED|Overall Study||14
28183|NCT01806584|61737|P2|COMPLETED|Overall Study||0
28184|NCT01806584|61738|P1|COMPLETED|Overall Study||0
28185|NCT01806584|61737|P2|STARTED|Overall Study||18
28186|NCT01806584|61738|P1|STARTED|Overall Study||14
28187|NCT01806545|61752|P2|NOT COMPLETED|Overall Study||5
28188|NCT01806545|61753|P1|NOT COMPLETED|Overall Study||6
28189|NCT01806545|61752|P2|COMPLETED|Overall Study||30
28190|NCT01806545|61753|P1|COMPLETED|Overall Study||23
28191|NCT01806545|61752|P2|STARTED|Overall Study||35
28192|NCT01806545|61753|P1|STARTED|Overall Study||29
28193|NCT01806051|61775|P1|NOT COMPLETED|Overall Study||6
28194|NCT01806051|61775|P1|COMPLETED|Overall Study||0
28195|NCT01806051|61775|P1|STARTED|Overall Study||6
28196|NCT01805687|61781|P1|NOT COMPLETED|Overall Study||0
28197|NCT01805687|61781|P1|COMPLETED|Overall Study||25
28198|NCT01805687|61781|P1|STARTED|Overall Study||25
28199|NCT01805323|61785|P1|NOT COMPLETED|Overall Study||0
28200|NCT01805323|61785|P1|COMPLETED|Overall Study||101
28201|NCT01805323|61785|P1|STARTED|Overall Study||101
28202|NCT01805180|61792|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
28203|NCT01805180|61793|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
28204|NCT01805180|61794|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
28205|NCT01805180|61792|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
28206|NCT01805180|61793|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
28207|NCT01805180|61794|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
28208|NCT01805180|61792|P3|STARTED|Pivotal Randomization Through Study Exit||20
28209|NCT01805180|61793|P2|STARTED|Pivotal Randomization Through Study Exit||22
28210|NCT01805180|61794|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
28211|NCT01805180|61792|P3|NOT COMPLETED|Lead-in Donor Phase||0
28212|NCT01805180|61793|P2|NOT COMPLETED|Lead-in Donor Phase||0
28213|NCT01805180|61794|P1|NOT COMPLETED|Lead-in Donor Phase||1
28214|NCT01805180|61792|P3|COMPLETED|Lead-in Donor Phase||0
28215|NCT01805180|61793|P2|COMPLETED|Lead-in Donor Phase||0
28216|NCT01805180|61794|P1|COMPLETED|Lead-in Donor Phase||6
28217|NCT01805180|61792|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
28218|NCT01805180|61793|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
28219|NCT01805180|61794|P1|STARTED|Lead-in Donor Phase||7
28220|NCT01805089|61819|P2|NOT COMPLETED|Overall Study||4
28221|NCT01805089|61820|P1|NOT COMPLETED|Overall Study||5
28222|NCT01805089|61819|P2|COMPLETED|Overall Study||43
28223|NCT01805089|61820|P1|COMPLETED|Overall Study||43
28224|NCT01805089|61819|P2|STARTED|Overall Study||47
28225|NCT01805089|61820|P1|STARTED|Overall Study||48
28226|NCT01804946|61832|P2|NOT COMPLETED|Overall Study||4
28227|NCT01804946|61833|P1|NOT COMPLETED|Overall Study||2
28228|NCT01804946|61832|P2|COMPLETED|Overall Study||76
28229|NCT01804946|61833|P1|COMPLETED|Overall Study||79
28230|NCT01804946|61832|P2|STARTED|Overall Study||80
28231|NCT01804946|61833|P1|STARTED|Overall Study||81
28232|NCT01804881|61857|P2|NOT COMPLETED|Overall Study||4
28233|NCT01804881|61858|P1|NOT COMPLETED|Overall Study||5
28234|NCT01804881|61857|P2|COMPLETED|Overall Study||10
28235|NCT01804881|61858|P1|COMPLETED|Overall Study||11
28236|NCT01804881|61857|P2|STARTED|Overall Study||14
28237|NCT01804881|61858|P1|STARTED|Overall Study||16
28238|NCT01804842|61871|P3|NOT COMPLETED|Overall Study||1
28239|NCT01804842|61872|P2|NOT COMPLETED|Overall Study||2
28240|NCT01804842|61873|P1|NOT COMPLETED|Overall Study||3
28241|NCT01804842|61871|P3|COMPLETED|Overall Study||8
28242|NCT01804842|61872|P2|COMPLETED|Overall Study||6
28243|NCT01804842|61873|P1|COMPLETED|Overall Study||6
28244|NCT01804842|61871|P3|Completed Treatment C|Overall Study||9
28245|NCT01804842|61872|P2|Completed Treatment C|Overall Study||7
28246|NCT01804842|61873|P1|Completed Treatment C|Overall Study||7
28247|NCT01804842|61871|P3|Completed Treatment B|Overall Study||8
28248|NCT01804842|61872|P2|Completed Treatment B|Overall Study||8
28249|NCT01804842|61873|P1|Completed Treatment B|Overall Study||8
28250|NCT01804842|61871|P3|Completed Treatment A|Overall Study||8
28251|NCT01804842|61872|P2|Completed Treatment A|Overall Study||6
28252|NCT01804842|61873|P1|Completed Treatment A|Overall Study||9
28253|NCT01804842|61871|P3|STARTED|Overall Study||9
28254|NCT01804842|61872|P2|STARTED|Overall Study||8
28255|NCT01804842|61873|P1|STARTED|Overall Study||9
28256|NCT01804673|61890|P1|NOT COMPLETED|Overall Study||140
28257|NCT01804673|61890|P1|COMPLETED|Overall Study||34
28258|NCT01804673|61890|P1|Completed Hour 72|Overall Study||36
28259|NCT01804673|61890|P1|Completed Hour 48|Overall Study||79
28260|NCT01804673|61890|P1|Completed Hour 24|Overall Study||170
28261|NCT01804673|61890|P1|STARTED|Overall Study||174
28262|NCT01804140|61906|P1|NOT COMPLETED|Overall Study||114
28263|NCT01804140|61906|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
28264|NCT01804140|61906|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
28265|NCT01804062|61911|P1|NOT COMPLETED|Overall Study||0
28266|NCT01804062|61911|P1|COMPLETED|Overall Study||30
28267|NCT01804062|61911|P1|STARTED|Overall Study||30
28268|NCT01803737|61918|P2|NOT COMPLETED|Overall Study||3
28269|NCT01803737|61919|P1|NOT COMPLETED|Overall Study||1
28270|NCT01803737|61918|P2|COMPLETED|Overall Study||10
28271|NCT01803737|61919|P1|COMPLETED|Overall Study||12
28272|NCT01803737|61918|P2|STARTED|Overall Study||13
28273|NCT01803737|61919|P1|STARTED|Overall Study||13
28274|NCT01802632|61947|P6|NOT COMPLETED|Overall Study||28
28275|NCT01802632|61948|P5|NOT COMPLETED|Overall Study||12
28276|NCT01802632|61949|P4|NOT COMPLETED|Overall Study||60
28277|NCT01802632|61950|P3|NOT COMPLETED|Overall Study||271
28278|NCT01802632|61951|P2|NOT COMPLETED|Overall Study||31
28279|NCT01802632|61952|P1|NOT COMPLETED|Overall Study||201
28280|NCT01802632|61947|P6|COMPLETED|Overall Study||0
28281|NCT01802632|61948|P5|COMPLETED|Overall Study||0
28282|NCT01802632|61949|P4|COMPLETED|Overall Study||0
28283|NCT01802632|61950|P3|COMPLETED|Overall Study||0
28284|NCT01802632|61951|P2|COMPLETED|Overall Study||0
28285|NCT01802632|61952|P1|COMPLETED|Overall Study||0
28286|NCT01802632|61947|P6|STARTED|Overall Study||28
28287|NCT01802632|61948|P5|STARTED|Overall Study||12
28288|NCT01802632|61949|P4|STARTED|Overall Study||60
28289|NCT01802632|61950|P3|STARTED|Overall Study||271
28290|NCT01802632|61951|P2|STARTED|Overall Study||31
28291|NCT01802632|61952|P1|STARTED|Overall Study||201
28292|NCT01802554|61968|P2|NOT COMPLETED|Overall Study||6
28293|NCT01802554|61969|P1|NOT COMPLETED|Overall Study||8
28294|NCT01802554|61968|P2|COMPLETED|Overall Study||43
28295|NCT01802554|61969|P1|COMPLETED|Overall Study||43
28296|NCT01802554|61968|P2|STARTED|Overall Study||49
28297|NCT01802554|61969|P1|STARTED|Overall Study||51
28298|NCT01802515|61986|P3|NOT COMPLETED|Overall Study||0
28299|NCT01802515|61987|P2|NOT COMPLETED|Overall Study||0
28300|NCT01802515|61988|P1|NOT COMPLETED|Overall Study||3
28301|NCT01802515|61986|P3|COMPLETED|Overall Study||4
28302|NCT01802515|61987|P2|COMPLETED|Overall Study||5
28303|NCT01802515|61988|P1|COMPLETED|Overall Study||2
28304|NCT01802515|61986|P3|STARTED|Overall Study||4
28305|NCT01802515|61987|P2|STARTED|Overall Study||5
28306|NCT01802515|61988|P1|STARTED|Overall Study||5
28307|NCT01802151|62003|P4|NOT COMPLETED|Overall Study||0
28308|NCT01802151|62004|P3|NOT COMPLETED|Overall Study||2
28309|NCT01802151|62005|P2|NOT COMPLETED|Overall Study||0
28310|NCT01802151|62006|P1|NOT COMPLETED|Overall Study||0
28311|NCT01802151|62003|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
28312|NCT01802151|62004|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
28313|NCT01802151|62005|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
28314|NCT01802151|62006|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
28315|NCT01802151|62003|P4|STARTED|Overall Study||20
28316|NCT01802151|62004|P3|STARTED|Overall Study||22
28317|NCT01802151|62005|P2|STARTED|Overall Study||21
28318|NCT01802151|62006|P1|STARTED|Overall Study||20
28319|NCT01801982|62068|P1|NOT COMPLETED|Overall Study||1
28320|NCT01801982|62068|P1|COMPLETED|Overall Study||0
28321|NCT01801982|62068|P1|STARTED|Overall Study||1
28322|NCT01801735|62078|P1|NOT COMPLETED|Overall Study||210
28323|NCT01801735|62078|P1|COMPLETED|Overall Study||390
28324|NCT01801735|62078|P1|STARTED|Overall Study||600
28325|NCT01801475|62085|P5|NOT COMPLETED|Overall Study||1
28326|NCT01801475|62086|P4|NOT COMPLETED|Overall Study||0
28327|NCT01801475|62087|P3|NOT COMPLETED|Overall Study||0
28328|NCT01801475|62088|P2|NOT COMPLETED|Overall Study||0
28329|NCT01801475|62089|P1|NOT COMPLETED|Overall Study||0
28330|NCT01801475|62085|P5|COMPLETED|Overall Study||39
28331|NCT01801475|62086|P4|COMPLETED|Overall Study||10
28332|NCT01801475|62087|P3|COMPLETED|Overall Study||10
28333|NCT01801475|62088|P2|COMPLETED|Overall Study||30
28334|NCT01801475|62089|P1|COMPLETED|Overall Study||10
28335|NCT01801475|62085|P5|STARTED|Overall Study||40
28336|NCT01801475|62086|P4|STARTED|Overall Study||10
28337|NCT01801475|62087|P3|STARTED|Overall Study||10
28338|NCT01801475|62088|P2|STARTED|Overall Study||30
28339|NCT01801475|62089|P1|STARTED|Overall Study||10
28340|NCT01801436|62100|P1|NOT COMPLETED|Overall Study||9
28341|NCT01801436|62100|P1|COMPLETED|Overall Study||5
28342|NCT01801436|62100|P1|STARTED|Overall Study||14
28343|NCT01801358|62138|P6|NOT COMPLETED|Overall Study||8
28344|NCT01801358|62139|P5|NOT COMPLETED|Overall Study||6
28345|NCT01801358|62140|P4|NOT COMPLETED|Overall Study||6
28346|NCT01801358|62141|P3|NOT COMPLETED|Overall Study||6
28347|NCT01801358|62142|P2|NOT COMPLETED|Overall Study||6
28348|NCT01801358|62143|P1|NOT COMPLETED|Overall Study||6
28349|NCT01801358|62138|P6|COMPLETED|Overall Study||0
28350|NCT01801358|62139|P5|COMPLETED|Overall Study||0
28351|NCT01801358|62140|P4|COMPLETED|Overall Study||0
28352|NCT01801358|62141|P3|COMPLETED|Overall Study||0
28353|NCT01801358|62142|P2|COMPLETED|Overall Study||0
28354|NCT01801358|62143|P1|COMPLETED|Overall Study||0
28355|NCT01801358|62138|P6|STARTED|Overall Study||8
28356|NCT01801358|62139|P5|STARTED|Overall Study||6
28357|NCT01801358|62140|P4|STARTED|Overall Study||6
28358|NCT01801358|62141|P3|STARTED|Overall Study||6
28359|NCT01801358|62142|P2|STARTED|Overall Study||6
28360|NCT01801358|62143|P1|STARTED|Overall Study||6
28361|NCT01801280|62265|P4|NOT COMPLETED|Period 4||0
28362|NCT01801280|62266|P3|NOT COMPLETED|Period 4||1
28363|NCT01801280|62267|P2|NOT COMPLETED|Period 4||0
28364|NCT01801280|62268|P1|NOT COMPLETED|Period 4||0
28365|NCT01801280|62265|P4|COMPLETED|Period 4||5
28366|NCT01801280|62266|P3|COMPLETED|Period 4||4
28367|NCT01801280|62267|P2|COMPLETED|Period 4||4
28368|NCT01801280|62268|P1|COMPLETED|Period 4||4
28369|NCT01801280|62265|P4|STARTED|Period 4||5
28370|NCT01801280|62266|P3|STARTED|Period 4||5
28371|NCT01801280|62267|P2|STARTED|Period 4||4
28372|NCT01801280|62268|P1|STARTED|Period 4||4
28373|NCT01801280|62265|P4|NOT COMPLETED|Period 3||0
28374|NCT01801280|62266|P3|NOT COMPLETED|Period 3||0
28375|NCT01801280|62267|P2|NOT COMPLETED|Period 3||0
28376|NCT01801280|62268|P1|NOT COMPLETED|Period 3||0
28377|NCT01801280|62265|P4|COMPLETED|Period 3||5
28378|NCT01801280|62266|P3|COMPLETED|Period 3||5
28379|NCT01801280|62267|P2|COMPLETED|Period 3||4
28380|NCT01801280|62268|P1|COMPLETED|Period 3||4
28381|NCT01801280|62265|P4|STARTED|Period 3||5
28382|NCT01801280|62266|P3|STARTED|Period 3||5
28383|NCT01801280|62267|P2|STARTED|Period 3||4
28384|NCT01801280|62268|P1|STARTED|Period 3||4
28385|NCT01801280|62265|P4|NOT COMPLETED|Period 2||0
28386|NCT01801280|62266|P3|NOT COMPLETED|Period 2||0
28387|NCT01801280|62267|P2|NOT COMPLETED|Period 2||0
28388|NCT01801280|62268|P1|NOT COMPLETED|Period 2||1
28389|NCT01801280|62265|P4|COMPLETED|Period 2||5
28390|NCT01801280|62266|P3|COMPLETED|Period 2||5
28391|NCT01801280|62267|P2|COMPLETED|Period 2||4
28392|NCT01801280|62268|P1|COMPLETED|Period 2||4
28393|NCT01801280|62265|P4|STARTED|Period 2||5
28394|NCT01801280|62266|P3|STARTED|Period 2||5
28395|NCT01801280|62267|P2|STARTED|Period 2||4
28396|NCT01801280|62268|P1|STARTED|Period 2||5
28397|NCT01801280|62265|P4|NOT COMPLETED|Period 1||0
28398|NCT01801280|62266|P3|NOT COMPLETED|Period 1||0
28399|NCT01801280|62267|P2|NOT COMPLETED|Period 1||1
28400|NCT01801280|62268|P1|NOT COMPLETED|Period 1||0
28401|NCT01801280|62265|P4|COMPLETED|Period 1||5
28402|NCT01801280|62266|P3|COMPLETED|Period 1||5
28403|NCT01801280|62267|P2|COMPLETED|Period 1||4
28404|NCT01801280|62268|P1|COMPLETED|Period 1||5
28405|NCT01801280|62265|P4|STARTED|Period 1||5
28406|NCT01801280|62266|P3|STARTED|Period 1||5
28407|NCT01801280|62267|P2|STARTED|Period 1||5
28408|NCT01801280|62268|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
28409|NCT01801124|62278|P1|NOT COMPLETED|Overall Study||0
28410|NCT01801124|62278|P1|COMPLETED|Overall Study||13
28411|NCT01801124|62278|P1|STARTED|Overall Study||13
28412|NCT01801111|62283|P1|NOT COMPLETED|Overall Study||138
28413|NCT01801111|62283|P1|COMPLETED|Overall Study||0
28414|NCT01801111|62283|P1|STARTED|Overall Study||138
28415|NCT01800968|62308|P2|NOT COMPLETED|Overall Study||32
28416|NCT01800968|62309|P1|NOT COMPLETED|Overall Study||36
28417|NCT01800968|62308|P2|COMPLETED|Overall Study||114
28418|NCT01800968|62309|P1|COMPLETED|Overall Study||118
28419|NCT01800968|62308|P2|STARTED|Overall Study||146
28420|NCT01800968|62309|P1|STARTED|Overall Study||154
28421|NCT01800916|62351|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
28422|NCT01800916|62352|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
28423|NCT01800916|62353|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
28424|NCT01800916|62354|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
28425|NCT01800916|62355|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
28426|NCT01800916|62356|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
28427|NCT01800916|62357|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
28428|NCT01800916|62358|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
28429|NCT01800916|62359|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
28430|NCT01800916|62351|P9|COMPLETED|Test Period 3 (1 Week)||7
28431|NCT01800916|62352|P8|COMPLETED|Test Period 3 (1 Week)||7
28432|NCT01800916|62353|P7|COMPLETED|Test Period 3 (1 Week)||7
28433|NCT01800916|62354|P6|COMPLETED|Test Period 3 (1 Week)||7
28434|NCT01800916|62355|P5|COMPLETED|Test Period 3 (1 Week)||7
28435|NCT01800916|62356|P4|COMPLETED|Test Period 3 (1 Week)||6
28436|NCT01800916|62357|P3|COMPLETED|Test Period 3 (1 Week)||7
28437|NCT01800916|62358|P2|COMPLETED|Test Period 3 (1 Week)||7
28438|NCT01800916|62359|P1|COMPLETED|Test Period 3 (1 Week)||7
28439|NCT01800916|62351|P9|STARTED|Test Period 3 (1 Week)||7
28440|NCT01800916|62352|P8|STARTED|Test Period 3 (1 Week)||7
28441|NCT01800916|62353|P7|STARTED|Test Period 3 (1 Week)||7
28442|NCT01800916|62354|P6|STARTED|Test Period 3 (1 Week)||7
28443|NCT01800916|62355|P5|STARTED|Test Period 3 (1 Week)||7
28444|NCT01800916|62356|P4|STARTED|Test Period 3 (1 Week)||6
28445|NCT01800916|62357|P3|STARTED|Test Period 3 (1 Week)||7
28446|NCT01800916|62358|P2|STARTED|Test Period 3 (1 Week)||7
28447|NCT01800916|62359|P1|STARTED|Test Period 3 (1 Week)||7
28448|NCT01800916|62351|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
28449|NCT01800916|62352|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
28450|NCT01800916|62353|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
28451|NCT01800916|62354|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
28452|NCT01800916|62355|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
28453|NCT01800916|62356|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
28454|NCT01800916|62357|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
28455|NCT01800916|62358|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
28456|NCT01800916|62359|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
28457|NCT01800916|62351|P9|COMPLETED|Test Period 2 (1 Week)||7
28458|NCT01800916|62352|P8|COMPLETED|Test Period 2 (1 Week)||7
28459|NCT01800916|62353|P7|COMPLETED|Test Period 2 (1 Week)||7
28460|NCT01800916|62354|P6|COMPLETED|Test Period 2 (1 Week)||7
28461|NCT01800916|62355|P5|COMPLETED|Test Period 2 (1 Week)||7
28462|NCT01800916|62356|P4|COMPLETED|Test Period 2 (1 Week)||6
28463|NCT01800916|62357|P3|COMPLETED|Test Period 2 (1 Week)||7
28464|NCT01800916|62358|P2|COMPLETED|Test Period 2 (1 Week)||7
28465|NCT01800916|62359|P1|COMPLETED|Test Period 2 (1 Week)||7
28466|NCT01800916|62351|P9|STARTED|Test Period 2 (1 Week)||7
28467|NCT01800916|62352|P8|STARTED|Test Period 2 (1 Week)||7
28468|NCT01800916|62353|P7|STARTED|Test Period 2 (1 Week)||7
28469|NCT01800916|62354|P6|STARTED|Test Period 2 (1 Week)||7
28470|NCT01800916|62355|P5|STARTED|Test Period 2 (1 Week)||7
28471|NCT01800916|62356|P4|STARTED|Test Period 2 (1 Week)||6
28472|NCT01800916|62357|P3|STARTED|Test Period 2 (1 Week)||7
28473|NCT01800916|62358|P2|STARTED|Test Period 2 (1 Week)||7
28474|NCT01800916|62359|P1|STARTED|Test Period 2 (1 Week)||7
28475|NCT01800916|62351|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
28476|NCT01800916|62352|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
28477|NCT01800916|62353|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
28478|NCT01800916|62354|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
28479|NCT01800916|62355|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
28480|NCT01800916|62356|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
28481|NCT01800916|62357|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
28482|NCT01800916|62358|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
28483|NCT01800916|62359|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
28484|NCT01800916|62351|P9|COMPLETED|Test Period 1 (1 Week)||7
28485|NCT01800916|62352|P8|COMPLETED|Test Period 1 (1 Week)||7
28486|NCT01800916|62353|P7|COMPLETED|Test Period 1 (1 Week)||7
28487|NCT01800916|62354|P6|COMPLETED|Test Period 1 (1 Week)||7
28488|NCT01800916|62355|P5|COMPLETED|Test Period 1 (1 Week)||7
28489|NCT01800916|62356|P4|COMPLETED|Test Period 1 (1 Week)||6
28490|NCT01800916|62357|P3|COMPLETED|Test Period 1 (1 Week)||7
28491|NCT01800916|62358|P2|COMPLETED|Test Period 1 (1 Week)||7
28492|NCT01800916|62359|P1|COMPLETED|Test Period 1 (1 Week)||7
28493|NCT01800916|62351|P9|STARTED|Test Period 1 (1 Week)||7
28494|NCT01800916|62352|P8|STARTED|Test Period 1 (1 Week)||7
28495|NCT01800916|62353|P7|STARTED|Test Period 1 (1 Week)||7
28496|NCT01800916|62354|P6|STARTED|Test Period 1 (1 Week)||7
28497|NCT01800916|62355|P5|STARTED|Test Period 1 (1 Week)||8
28498|NCT01800916|62356|P4|STARTED|Test Period 1 (1 Week)||7
28499|NCT01800916|62357|P3|STARTED|Test Period 1 (1 Week)||7
28500|NCT01800916|62358|P2|STARTED|Test Period 1 (1 Week)||7
28501|NCT01800916|62359|P1|STARTED|Test Period 1 (1 Week)||7
28502|NCT01800903|62369|P6|NOT COMPLETED|Third Test Period||0
28503|NCT01800903|62370|P5|NOT COMPLETED|Third Test Period||0
28504|NCT01800903|62371|P4|NOT COMPLETED|Third Test Period||0
28505|NCT01800903|62372|P3|NOT COMPLETED|Third Test Period||0
28506|NCT01800903|62373|P2|NOT COMPLETED|Third Test Period||0
28507|NCT01800903|62374|P1|NOT COMPLETED|Third Test Period||0
28508|NCT01800903|62369|P6|COMPLETED|Third Test Period||6
28509|NCT01800903|62370|P5|COMPLETED|Third Test Period||6
28510|NCT01800903|62371|P4|COMPLETED|Third Test Period||7
28511|NCT01800903|62372|P3|COMPLETED|Third Test Period||4
28512|NCT01800903|62373|P2|COMPLETED|Third Test Period||6
28513|NCT01800903|62374|P1|COMPLETED|Third Test Period||6
28514|NCT01800903|62369|P6|STARTED|Third Test Period||6
28515|NCT01800903|62370|P5|STARTED|Third Test Period||6
28516|NCT01800903|62371|P4|STARTED|Third Test Period||7
28517|NCT01800903|62372|P3|STARTED|Third Test Period||4
28518|NCT01800903|62373|P2|STARTED|Third Test Period||6
28519|NCT01800903|62374|P1|STARTED|Third Test Period||6
28520|NCT01800903|62369|P6|NOT COMPLETED|Second Test Period||0
28521|NCT01800903|62370|P5|NOT COMPLETED|Second Test Period||0
28522|NCT01800903|62371|P4|NOT COMPLETED|Second Test Period||0
28523|NCT01800903|62372|P3|NOT COMPLETED|Second Test Period||0
28524|NCT01800903|62373|P2|NOT COMPLETED|Second Test Period||0
28525|NCT01800903|62374|P1|NOT COMPLETED|Second Test Period||1
28526|NCT01800903|62369|P6|COMPLETED|Second Test Period||6
28527|NCT01800903|62370|P5|COMPLETED|Second Test Period||6
28528|NCT01800903|62371|P4|COMPLETED|Second Test Period||7
28529|NCT01800903|62372|P3|COMPLETED|Second Test Period||4
28530|NCT01800903|62373|P2|COMPLETED|Second Test Period||6
28531|NCT01800903|62374|P1|COMPLETED|Second Test Period||6
28532|NCT01800903|62369|P6|STARTED|Second Test Period||6
28533|NCT01800903|62370|P5|STARTED|Second Test Period||6
28534|NCT01800903|62371|P4|STARTED|Second Test Period||7
28535|NCT01800903|62372|P3|STARTED|Second Test Period||4
28536|NCT01800903|62373|P2|STARTED|Second Test Period||6
28537|NCT01800903|62374|P1|STARTED|Second Test Period||7
28538|NCT01800903|62369|P6|NOT COMPLETED|First Test Period||0
28539|NCT01800903|62370|P5|NOT COMPLETED|First Test Period||0
28540|NCT01800903|62371|P4|NOT COMPLETED|First Test Period||0
28541|NCT01800903|62372|P3|NOT COMPLETED|First Test Period||0
28542|NCT01800903|62373|P2|NOT COMPLETED|First Test Period||0
28543|NCT01800903|62374|P1|NOT COMPLETED|First Test Period||0
28544|NCT01800903|62369|P6|COMPLETED|First Test Period||6
28545|NCT01800903|62370|P5|COMPLETED|First Test Period||6
28546|NCT01800903|62371|P4|COMPLETED|First Test Period||7
28547|NCT01800903|62372|P3|COMPLETED|First Test Period||4
28548|NCT01800903|62373|P2|COMPLETED|First Test Period||6
28549|NCT01800903|62374|P1|COMPLETED|First Test Period||7
28550|NCT01800903|62369|P6|STARTED|First Test Period||6
28551|NCT01800903|62370|P5|STARTED|First Test Period||6
28552|NCT01800903|62371|P4|STARTED|First Test Period||7
28553|NCT01800903|62372|P3|STARTED|First Test Period||4
28554|NCT01800903|62373|P2|STARTED|First Test Period||6
28555|NCT01800903|62374|P1|STARTED|First Test Period||7
28556|NCT01800890|62380|P9|NOT COMPLETED|Test Period 3||0
28557|NCT01800890|62381|P8|NOT COMPLETED|Test Period 3||0
28558|NCT01800890|62382|P7|NOT COMPLETED|Test Period 3||0
28559|NCT01800890|62383|P6|NOT COMPLETED|Test Period 3||0
28560|NCT01800890|62384|P5|NOT COMPLETED|Test Period 3||0
28561|NCT01800890|62385|P4|NOT COMPLETED|Test Period 3||0
28562|NCT01800890|62386|P3|NOT COMPLETED|Test Period 3||0
28563|NCT01800890|62387|P2|NOT COMPLETED|Test Period 3||0
28564|NCT01800890|62388|P1|NOT COMPLETED|Test Period 3||0
28565|NCT01800890|62380|P9|COMPLETED|Test Period 3||3
28566|NCT01800890|62381|P8|COMPLETED|Test Period 3||3
28567|NCT01800890|62382|P7|COMPLETED|Test Period 3||3
28568|NCT01800890|62383|P6|COMPLETED|Test Period 3||4
28569|NCT01800890|62384|P5|COMPLETED|Test Period 3||4
28570|NCT01800890|62385|P4|COMPLETED|Test Period 3||2
28571|NCT01800890|62386|P3|COMPLETED|Test Period 3||3
28572|NCT01800890|62387|P2|COMPLETED|Test Period 3||3
28573|NCT01800890|62388|P1|COMPLETED|Test Period 3||3
28574|NCT01800890|62380|P9|STARTED|Test Period 3||3
28575|NCT01800890|62381|P8|STARTED|Test Period 3||3
28576|NCT01800890|62382|P7|STARTED|Test Period 3||3
28577|NCT01800890|62383|P6|STARTED|Test Period 3||4
28578|NCT01800890|62384|P5|STARTED|Test Period 3||4
28579|NCT01800890|62385|P4|STARTED|Test Period 3||2
28580|NCT01800890|62386|P3|STARTED|Test Period 3||3
28581|NCT01800890|62387|P2|STARTED|Test Period 3||3
28582|NCT01800890|62388|P1|STARTED|Test Period 3||3
28583|NCT01800890|62380|P9|NOT COMPLETED|Test Period 2||0
28584|NCT01800890|62381|P8|NOT COMPLETED|Test Period 2||0
28585|NCT01800890|62382|P7|NOT COMPLETED|Test Period 2||0
28586|NCT01800890|62383|P6|NOT COMPLETED|Test Period 2||0
28587|NCT01800890|62384|P5|NOT COMPLETED|Test Period 2||0
28588|NCT01800890|62385|P4|NOT COMPLETED|Test Period 2||0
28589|NCT01800890|62386|P3|NOT COMPLETED|Test Period 2||0
28590|NCT01800890|62387|P2|NOT COMPLETED|Test Period 2||0
28591|NCT01800890|62388|P1|NOT COMPLETED|Test Period 2||0
28592|NCT01800890|62380|P9|COMPLETED|Test Period 2||3
28593|NCT01800890|62381|P8|COMPLETED|Test Period 2||3
28594|NCT01800890|62382|P7|COMPLETED|Test Period 2||3
28595|NCT01800890|62383|P6|COMPLETED|Test Period 2||4
28596|NCT01800890|62384|P5|COMPLETED|Test Period 2||4
28597|NCT01800890|62385|P4|COMPLETED|Test Period 2||2
28598|NCT01800890|62386|P3|COMPLETED|Test Period 2||3
28599|NCT01800890|62387|P2|COMPLETED|Test Period 2||3
28600|NCT01800890|62388|P1|COMPLETED|Test Period 2||3
28601|NCT01800890|62380|P9|STARTED|Test Period 2||3
28602|NCT01800890|62381|P8|STARTED|Test Period 2||3
28603|NCT01800890|62382|P7|STARTED|Test Period 2||3
28604|NCT01800890|62383|P6|STARTED|Test Period 2||4
28605|NCT01800890|62384|P5|STARTED|Test Period 2||4
28606|NCT01800890|62385|P4|STARTED|Test Period 2||2
28607|NCT01800890|62386|P3|STARTED|Test Period 2||3
28608|NCT01800890|62387|P2|STARTED|Test Period 2||3
28609|NCT01800890|62388|P1|STARTED|Test Period 2||3
28610|NCT01800890|62380|P9|NOT COMPLETED|Test Period 1||0
28611|NCT01800890|62381|P8|NOT COMPLETED|Test Period 1||0
28612|NCT01800890|62382|P7|NOT COMPLETED|Test Period 1||0
28613|NCT01800890|62383|P6|NOT COMPLETED|Test Period 1||0
28614|NCT01800890|62384|P5|NOT COMPLETED|Test Period 1||0
28615|NCT01800890|62385|P4|NOT COMPLETED|Test Period 1||1
28616|NCT01800890|62386|P3|NOT COMPLETED|Test Period 1||0
28617|NCT01800890|62387|P2|NOT COMPLETED|Test Period 1||0
28618|NCT01800890|62388|P1|NOT COMPLETED|Test Period 1||0
28619|NCT01800890|62380|P9|COMPLETED|Test Period 1||3
28620|NCT01800890|62381|P8|COMPLETED|Test Period 1||3
28621|NCT01800890|62382|P7|COMPLETED|Test Period 1||3
28622|NCT01800890|62383|P6|COMPLETED|Test Period 1||4
28623|NCT01800890|62384|P5|COMPLETED|Test Period 1||4
28624|NCT01800890|62385|P4|COMPLETED|Test Period 1||2
28625|NCT01800890|62386|P3|COMPLETED|Test Period 1||3
28626|NCT01800890|62387|P2|COMPLETED|Test Period 1||3
28627|NCT01800890|62388|P1|COMPLETED|Test Period 1||3
28628|NCT01800890|62380|P9|STARTED|Test Period 1||3
28629|NCT01800890|62381|P8|STARTED|Test Period 1||3
28630|NCT01800890|62382|P7|STARTED|Test Period 1||3
28631|NCT01800890|62383|P6|STARTED|Test Period 1||4
28632|NCT01800890|62384|P5|STARTED|Test Period 1||4
28633|NCT01800890|62385|P4|STARTED|Test Period 1||3
28634|NCT01800890|62386|P3|STARTED|Test Period 1||3
28635|NCT01800890|62387|P2|STARTED|Test Period 1||3
28636|NCT01800890|62388|P1|STARTED|Test Period 1||3
28637|NCT01800318|62402|P4|NOT COMPLETED|Overall Study||1
28638|NCT01800318|62403|P3|NOT COMPLETED|Overall Study||1
28639|NCT01800318|62404|P2|NOT COMPLETED|Overall Study||5
28640|NCT01800318|62405|P1|NOT COMPLETED|Overall Study||2
28641|NCT01800318|62402|P4|COMPLETED|Overall Study||39
28642|NCT01800318|62403|P3|COMPLETED|Overall Study||40
28643|NCT01800318|62404|P2|COMPLETED|Overall Study||37
28644|NCT01800318|62405|P1|COMPLETED|Overall Study||37
28645|NCT01800318|62402|P4|STARTED|Overall Study||40
28646|NCT01800318|62403|P3|STARTED|Overall Study||41
28647|NCT01800318|62404|P2|STARTED|Overall Study||42
28648|NCT01800318|62405|P1|STARTED|Overall Study||39
28649|NCT01799720|62434|P3|NOT COMPLETED|Overall Study||1
28650|NCT01799720|62435|P2|NOT COMPLETED|Overall Study||1
28651|NCT01799720|62436|P1|NOT COMPLETED|Overall Study||3
28652|NCT01799720|62434|P3|COMPLETED|Overall Study||18
28653|NCT01799720|62435|P2|COMPLETED|Overall Study||17
28654|NCT01799720|62436|P1|COMPLETED|Overall Study||17
28655|NCT01799720|62434|P3|Began the Treatment and Finished it|Overall Study||18
28656|NCT01799720|62435|P2|Began the Treatment and Finished it|Overall Study||17
28657|NCT01799720|62436|P1|Began the Treatment and Finished it|Overall Study||17
28658|NCT01799720|62434|P3|Began the Treatment|Overall Study||19
28659|NCT01799720|62435|P2|Began the Treatment|Overall Study||18
28660|NCT01799720|62436|P1|Began the Treatment|Overall Study||20
28661|NCT01799720|62434|P3|STARTED|Overall Study||19
28662|NCT01799720|62435|P2|STARTED|Overall Study||18
28663|NCT01799720|62436|P1|STARTED|Overall Study||20
28664|NCT01799590|62474|P3|NOT COMPLETED|Overall Study||14
28665|NCT01799590|62475|P2|NOT COMPLETED|Overall Study||16
28666|NCT01799590|62476|P1|NOT COMPLETED|Overall Study||26
28667|NCT01799590|62474|P3|COMPLETED|Overall Study||77
28668|NCT01799590|62475|P2|COMPLETED|Overall Study||78
28669|NCT01799590|62476|P1|COMPLETED|Overall Study||85
28670|NCT01799590|62474|P3|STARTED|Overall Study||91
28671|NCT01799590|62475|P2|STARTED|Overall Study||94
28672|NCT01799590|62476|P1|STARTED|Overall Study||111
28673|NCT01799239|62511|P2|NOT COMPLETED|Period 2 (7 Days)||1
28674|NCT01799239|62512|P1|NOT COMPLETED|Period 2 (7 Days)||2
28675|NCT01799239|62511|P2|COMPLETED|Period 2 (7 Days)||14
28676|NCT01799239|62512|P1|COMPLETED|Period 2 (7 Days)||11
28677|NCT01799239|62511|P2|STARTED|Period 2 (7 Days)||15
28678|NCT01799239|62512|P1|STARTED|Period 2 (7 Days)||13
28679|NCT01799239|62511|P2|NOT COMPLETED|Period 1 (7 Days)||1
28680|NCT01799239|62512|P1|NOT COMPLETED|Period 1 (7 Days)||3
28681|NCT01799239|62511|P2|COMPLETED|Period 1 (7 Days)||15
28682|NCT01799239|62512|P1|COMPLETED|Period 1 (7 Days)||12
28683|NCT01799239|62511|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
28684|NCT01799239|62512|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
28685|NCT01799226|62520|P2|NOT COMPLETED|Overall Study||0
28686|NCT01799226|62521|P1|NOT COMPLETED|Overall Study||2
28687|NCT01799226|62520|P2|COMPLETED|Overall Study||16
28688|NCT01799226|62521|P1|COMPLETED|Overall Study||14
28689|NCT01799226|62520|P2|Left Stent Side|Overall Study||8
28690|NCT01799226|62521|P1|Left Stent Side|Overall Study||8
28691|NCT01799226|62520|P2|Right Stent Side|Overall Study||8
28692|NCT01799226|62521|P1|Right Stent Side|Overall Study||8
28693|NCT01799226|62520|P2|STARTED|Overall Study||16
28694|NCT01799226|62521|P1|STARTED|Overall Study||16
28695|NCT01798966|62529|P1|NOT COMPLETED|Overall Study||0
28696|NCT01798966|62529|P1|COMPLETED|Overall Study||10
28697|NCT01798966|62529|P1|STARTED|Overall Study||10
28698|NCT01798927|62535|P1|NOT COMPLETED|Overall Study||1
28699|NCT01798927|62535|P1|COMPLETED|Overall Study||3
28700|NCT01798927|62535|P1|STARTED|Overall Study||4
28701|NCT01798706|62543|P2|NOT COMPLETED|Overall Study||21
28702|NCT01798706|62544|P1|NOT COMPLETED|Overall Study||21
28703|NCT01798706|62543|P2|COMPLETED|Overall Study||153
28704|NCT01798706|62544|P1|COMPLETED|Overall Study||155
28705|NCT01798706|62543|P2|STARTED|Overall Study||174
28706|NCT01798706|62544|P1|STARTED|Overall Study||176
28707|NCT01798485|62572|P2|NOT COMPLETED|Overall Study||290
28708|NCT01798485|62573|P1|NOT COMPLETED|Overall Study||346
28709|NCT01798485|62572|P2|COMPLETED|Overall Study||59
28710|NCT01798485|62573|P1|COMPLETED|Overall Study||1
28711|NCT01798485|62572|P2|Randomized as of 19 October 2015|Overall Study||337
28712|NCT01798485|62573|P1|Randomized as of 19 October 2015|Overall Study||335
28713|NCT01798485|62572|P2|Safety Population as of 23 Dec 2015|Overall Study||342
28714|NCT01798485|62573|P1|Safety Population as of 23 Dec 2015|Overall Study||338
28715|NCT01798485|62572|P2|STARTED|Overall Study||349
28716|NCT01798485|62573|P1|STARTED|Overall Study||347
28717|NCT01798394|62609|P2|NOT COMPLETED|Overall Study||3
28718|NCT01798394|62610|P1|NOT COMPLETED|Overall Study||3
28719|NCT01798394|62609|P2|COMPLETED|Overall Study||19
28720|NCT01798394|62610|P1|COMPLETED|Overall Study||21
28721|NCT01798394|62609|P2|STARTED|Overall Study||22
28722|NCT01798394|62610|P1|STARTED|Overall Study||24
28723|NCT01798264|62632|P4|NOT COMPLETED|Overall Study||4
28724|NCT01798264|62633|P3|NOT COMPLETED|Overall Study||0
28725|NCT01798264|62634|P2|NOT COMPLETED|Overall Study||0
28726|NCT01798264|62635|P1|NOT COMPLETED|Overall Study||1
28727|NCT01798264|62632|P4|COMPLETED|Overall Study||7
28728|NCT01798264|62633|P3|COMPLETED|Overall Study||10
28729|NCT01798264|62634|P2|COMPLETED|Overall Study||11
28730|NCT01798264|62635|P1|COMPLETED|Overall Study||11
28731|NCT01798264|62632|P4|STARTED|Overall Study||11
28732|NCT01798264|62633|P3|STARTED|Overall Study||10
28733|NCT01798264|62634|P2|STARTED|Overall Study||11
28734|NCT01798264|62635|P1|STARTED|Overall Study||12
28735|NCT01798134|62657|P1|NOT COMPLETED|Overall Study||16
28736|NCT01798134|62657|P1|COMPLETED|Overall Study||9
28737|NCT01798134|62657|P1|STARTED|Overall Study||25
28738|NCT01798004|62664|P1|NOT COMPLETED|Overall Study||87
28739|NCT01798004|62664|P1|COMPLETED|Overall Study||63
28740|NCT01798004|62664|P1|STARTED|Overall Study||150
28741|NCT01797783|62670|P2|NOT COMPLETED|Overall Study||1
28742|NCT01797783|62671|P1|NOT COMPLETED|Overall Study||2
28743|NCT01797783|62670|P2|COMPLETED|Overall Study||26
28744|NCT01797783|62671|P1|COMPLETED|Overall Study||50
28745|NCT01797783|62670|P2|STARTED|Overall Study||27
28746|NCT01797783|62671|P1|STARTED|Overall Study||52
28747|NCT01797705|62693|P1|NOT COMPLETED|Overall Study||5
28748|NCT01797705|62693|P1|COMPLETED|Overall Study||28
28749|NCT01797705|62693|P1|STARTED|Overall Study||33
28750|NCT01797536|62701|P4|NOT COMPLETED|Overall Study||0
28751|NCT01797536|62702|P3|NOT COMPLETED|Overall Study||0
28752|NCT01797536|62703|P2|NOT COMPLETED|Overall Study||1
28753|NCT01797536|62704|P1|NOT COMPLETED|Overall Study||0
28754|NCT01797536|62701|P4|COMPLETED|Overall Study||8
28755|NCT01797536|62702|P3|COMPLETED|Overall Study||7
28756|NCT01797536|62703|P2|COMPLETED|Overall Study||10
28757|NCT01797536|62704|P1|COMPLETED|Overall Study||8
28758|NCT01797536|62701|P4|STARTED|Overall Study||8
28759|NCT01797536|62702|P3|STARTED|Overall Study||7
28760|NCT01797536|62703|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
28761|NCT01797536|62704|P1|STARTED|Overall Study||8
28762|NCT01797445|62736|P2|NOT COMPLETED|Overall Study||437
28763|NCT01797445|62737|P1|NOT COMPLETED|Overall Study||435
28764|NCT01797445|62736|P2|COMPLETED|Overall Study||0
28765|NCT01797445|62737|P1|COMPLETED|Overall Study||0
28766|NCT01797445|62736|P2|STARTED|Overall Study||437
28767|NCT01797445|62737|P1|STARTED|Overall Study||435
28768|NCT01797380|62777|P2|NOT COMPLETED|Overall Study||2
28769|NCT01797380|62778|P1|NOT COMPLETED|Overall Study||3
28770|NCT01797380|62777|P2|COMPLETED|Overall Study||0
28771|NCT01797380|62778|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
28772|NCT01797380|62777|P2|STARTED|Overall Study||2
28773|NCT01797380|62778|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
28774|NCT01797094|62786|P2|NOT COMPLETED|Overall Study||2
28775|NCT01797094|62787|P1|NOT COMPLETED|Overall Study||6
28776|NCT01797094|62786|P2|COMPLETED|Overall Study||51
28777|NCT01797094|62787|P1|COMPLETED|Overall Study||42
28778|NCT01797094|62786|P2|STARTED|Overall Study||53
28779|NCT01797094|62787|P1|STARTED|Overall Study||48
28780|NCT01797081|62809|P4|NOT COMPLETED|Overall Study||9
28781|NCT01797081|62810|P3|NOT COMPLETED|Overall Study||5
28782|NCT01797081|62811|P2|NOT COMPLETED|Overall Study||4
28783|NCT01797081|62812|P1|NOT COMPLETED|Overall Study||14
28784|NCT01797081|62809|P4|COMPLETED|Overall Study||40
28785|NCT01797081|62810|P3|COMPLETED|Overall Study||43
28786|NCT01797081|62811|P2|COMPLETED|Overall Study||95
28787|NCT01797081|62812|P1|COMPLETED|Overall Study||90
28788|NCT01797081|62809|P4|STARTED|Overall Study||49
28789|NCT01797081|62810|P3|STARTED|Overall Study||48
28790|NCT01797081|62811|P2|STARTED|Overall Study||99
28791|NCT01797081|62812|P1|STARTED|Overall Study||104
28792|NCT01797029|62831|P2|NOT COMPLETED|Overall Study||61
28793|NCT01797029|62832|P1|NOT COMPLETED|Overall Study||159
28794|NCT01797029|62831|P2|COMPLETED|Overall Study||526
28795|NCT01797029|62832|P1|COMPLETED|Overall Study||1015
28796|NCT01797029|62831|P2|STARTED|Overall Study||587
28797|NCT01797029|62832|P1|STARTED|Overall Study||1174
28798|NCT01796977|62840|P1|NOT COMPLETED|Overall Study||0
28799|NCT01796977|62840|P1|COMPLETED|Overall Study||27
28800|NCT01796977|62840|P1|STARTED|Overall Study||27
28801|NCT01796964|62853|P2|NOT COMPLETED|Overall Study||3
28802|NCT01796964|62854|P1|NOT COMPLETED|Overall Study||3
28803|NCT01796964|62853|P2|COMPLETED|Overall Study||42
28804|NCT01796964|62854|P1|COMPLETED|Overall Study||41
28805|NCT01796964|62853|P2|STARTED|Overall Study||45
28806|NCT01796964|62854|P1|STARTED|Overall Study||44
28807|NCT01796860|62876|P1|NOT COMPLETED|Overall Study||3
28808|NCT01796860|62876|P1|COMPLETED|Overall Study||7
28809|NCT01796860|62876|P1|STARTED|Overall Study||10
28810|NCT01796548|62882|P1|NOT COMPLETED|Overall Study||3
28811|NCT01796548|62882|P1|COMPLETED|Overall Study||14
28812|NCT01796548|62882|P1|Treated|Overall Study||15
28813|NCT01796548|62882|P1|STARTED|Overall Study||17
28814|NCT01796236|62896|P2|NOT COMPLETED|Overall Study||2
28815|NCT01796236|62897|P1|NOT COMPLETED|Overall Study||2
28816|NCT01796236|62896|P2|COMPLETED|Overall Study||50
28817|NCT01796236|62897|P1|COMPLETED|Overall Study||49
28818|NCT01796236|62896|P2|STARTED|Overall Study||52
28819|NCT01796236|62897|P1|STARTED|Overall Study||51
28820|NCT01795937|62916|P3|NOT COMPLETED|Overall Study||0
28821|NCT01795937|62917|P2|NOT COMPLETED|Overall Study||1
28822|NCT01795937|62918|P1|NOT COMPLETED|Overall Study||1
28823|NCT01795937|62916|P3|COMPLETED|Overall Study||17
28824|NCT01795937|62917|P2|COMPLETED|Overall Study||15
28825|NCT01795937|62918|P1|COMPLETED|Overall Study||17
28826|NCT01795937|62916|P3|STARTED|Overall Study||17
28827|NCT01795937|62917|P2|STARTED|Overall Study||16
28828|NCT01795937|62918|P1|STARTED|Overall Study||18
28829|NCT01795898|62947|P1|NOT COMPLETED|Overall Study||60
28830|NCT01795898|62947|P1|COMPLETED|Overall Study||177
28831|NCT01795898|62947|P1|STARTED|Overall Study||237
28832|NCT01795716|62957|P2|NOT COMPLETED|Second Intervention (13 Days)||0
28833|NCT01795716|62958|P1|NOT COMPLETED|Second Intervention (13 Days)||0
28834|NCT01795716|62957|P2|COMPLETED|Second Intervention (13 Days)||11
28835|NCT01795716|62958|P1|COMPLETED|Second Intervention (13 Days)||10
28836|NCT01795716|62957|P2|STARTED|Second Intervention (13 Days)||11
28837|NCT01795716|62958|P1|STARTED|Second Intervention (13 Days)||10
28838|NCT01795716|62957|P2|NOT COMPLETED|Washout (10 Days)||0
28839|NCT01795716|62958|P1|NOT COMPLETED|Washout (10 Days)||0
28840|NCT01795716|62957|P2|COMPLETED|Washout (10 Days)||11
28841|NCT01795716|62958|P1|COMPLETED|Washout (10 Days)||10
28842|NCT01795716|62957|P2|STARTED|Washout (10 Days)||11
28843|NCT01795716|62958|P1|STARTED|Washout (10 Days)||10
28844|NCT01795716|62957|P2|NOT COMPLETED|First Intervention (13 Days)||0
28845|NCT01795716|62958|P1|NOT COMPLETED|First Intervention (13 Days)||0
28846|NCT01795716|62957|P2|COMPLETED|First Intervention (13 Days)||11
28847|NCT01795716|62958|P1|COMPLETED|First Intervention (13 Days)||10
28848|NCT01795716|62957|P2|STARTED|First Intervention (13 Days)||11
28849|NCT01795716|62958|P1|STARTED|First Intervention (13 Days)||10
28850|NCT01795547|62966|P2|NOT COMPLETED|Overall Study||64
28851|NCT01795547|62967|P1|NOT COMPLETED|Overall Study||48
28852|NCT01795547|62966|P2|COMPLETED|Overall Study||83
28853|NCT01795547|62967|P1|COMPLETED|Overall Study||100
28854|NCT01795547|62966|P2|STARTED|Overall Study||147
28855|NCT01795547|62967|P1|STARTED|Overall Study||148
28856|NCT01795534|62989|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
28857|NCT01795534|62990|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
28858|NCT01795534|62989|P2|COMPLETED|Second Intervention (Second Shot)||5
28859|NCT01795534|62990|P1|COMPLETED|Second Intervention (Second Shot)||5
28860|NCT01795534|62989|P2|STARTED|Second Intervention (Second Shot)||5
28861|NCT01795534|62990|P1|STARTED|Second Intervention (Second Shot)||5
28862|NCT01795534|62989|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
28863|NCT01795534|62990|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
28864|NCT01795534|62989|P2|COMPLETED|Wash Out Period (4 Days)||5
28865|NCT01795534|62990|P1|COMPLETED|Wash Out Period (4 Days)||5
28866|NCT01795534|62989|P2|STARTED|Wash Out Period (4 Days)||5
28867|NCT01795534|62990|P1|STARTED|Wash Out Period (4 Days)||5
28868|NCT01795534|62989|P2|NOT COMPLETED|First Intervention (First Shot)||0
28869|NCT01795534|62990|P1|NOT COMPLETED|First Intervention (First Shot)||0
28870|NCT01795534|62989|P2|COMPLETED|First Intervention (First Shot)||5
28871|NCT01795534|62990|P1|COMPLETED|First Intervention (First Shot)||5
28872|NCT01795534|62989|P2|STARTED|First Intervention (First Shot)||5
28873|NCT01795534|62990|P1|STARTED|First Intervention (First Shot)||5
28874|NCT01794936|62996|P1|NOT COMPLETED|Overall Study||0
28875|NCT01794936|62996|P1|COMPLETED|Overall Study||9
28876|NCT01794936|62996|P1|STARTED|Overall Study||9
28877|NCT01794741|63003|P2|NOT COMPLETED|Overall Study||9
28878|NCT01794741|63004|P1|NOT COMPLETED|Overall Study||19
28879|NCT01794741|63003|P2|COMPLETED|Overall Study||92
28880|NCT01794741|63004|P1|COMPLETED|Overall Study||285
28881|NCT01794741|63003|P2|STARTED|Overall Study||101
28882|NCT01794741|63004|P1|STARTED|Overall Study||304
28883|NCT01794455|63012|P2|NOT COMPLETED|Overall Study||0
28884|NCT01794455|63013|P1|NOT COMPLETED|Overall Study||0
28885|NCT01794455|63012|P2|COMPLETED|Overall Study||1
28886|NCT01794455|63013|P1|COMPLETED|Overall Study||0
28887|NCT01794455|63012|P2|STARTED|Overall Study||1
28888|NCT01794455|63013|P1|STARTED|Overall Study||0
28889|NCT01794000|63031|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
28890|NCT01794000|63032|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
28891|NCT01794000|63031|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
28892|NCT01794000|63032|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
28893|NCT01794000|63031|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
28894|NCT01794000|63032|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
28895|NCT01794000|63031|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
28896|NCT01794000|63032|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
28897|NCT01794000|63031|P2|COMPLETED|Double-Blind Phase (DBP)||4
28898|NCT01794000|63032|P1|COMPLETED|Double-Blind Phase (DBP)||2
28899|NCT01794000|63031|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
28900|NCT01794000|63032|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
28901|NCT01794000|63031|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
28902|NCT01794000|63032|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
28903|NCT01794000|63031|P2|STARTED|Double-Blind Phase (DBP)||170
28904|NCT01794000|63032|P1|STARTED|Double-Blind Phase (DBP)||171
28905|NCT01793285|63063|P1|NOT COMPLETED|Overall Study||0
28906|NCT01793285|63063|P1|COMPLETED|Overall Study||85
28907|NCT01793285|63063|P1|STARTED|Overall Study||85
28908|NCT01792986|63083|P1|NOT COMPLETED|Overall Study||0
28909|NCT01792986|63083|P1|COMPLETED|Overall Study||12
28910|NCT01792986|63083|P1|STARTED|Overall Study||12
28911|NCT01792830|63098|P7|NOT COMPLETED|Overall Study||3
28912|NCT01792830|63099|P6|NOT COMPLETED|Overall Study||0
28913|NCT01792830|63100|P5|NOT COMPLETED|Overall Study||12
28914|NCT01792830|63101|P4|NOT COMPLETED|Overall Study||5
28915|NCT01792830|63102|P3|NOT COMPLETED|Overall Study||0
28916|NCT01792830|63103|P2|NOT COMPLETED|Overall Study||0
28917|NCT01792830|63104|P1|NOT COMPLETED|Overall Study||25
28918|NCT01792830|63098|P7|COMPLETED|Overall Study||9
28919|NCT01792830|63099|P6|COMPLETED|Overall Study||4
28920|NCT01792830|63100|P5|COMPLETED|Overall Study||29
28921|NCT01792830|63101|P4|COMPLETED|Overall Study||22
28922|NCT01792830|63102|P3|COMPLETED|Overall Study||4
28923|NCT01792830|63103|P2|COMPLETED|Overall Study||3
28924|NCT01792830|63104|P1|COMPLETED|Overall Study||59
28925|NCT01792830|63098|P7|STARTED|Overall Study||12
28926|NCT01792830|63099|P6|STARTED|Overall Study||4
28927|NCT01792830|63100|P5|STARTED|Overall Study||41
28928|NCT01792830|63101|P4|STARTED|Overall Study||27
28929|NCT01792830|63102|P3|STARTED|Overall Study||4
28930|NCT01792830|63103|P2|STARTED|Overall Study||3
28931|NCT01792830|63104|P1|STARTED|Overall Study||84
28932|NCT01792635|63135|P3|NOT COMPLETED|Part B||4
28933|NCT01792635|63136|P2|NOT COMPLETED|Part B||4
28934|NCT01792635|63137|P1|NOT COMPLETED|Part B||0
28935|NCT01792635|63135|P3|COMPLETED|Part B||3
28936|NCT01792635|63136|P2|COMPLETED|Part B||2
28937|NCT01792635|63137|P1|COMPLETED|Part B||0
28938|NCT01792635|63135|P3|STARTED|Part B||7
28939|NCT01792635|63136|P2|STARTED|Part B||6
28940|NCT01792635|63137|P1|STARTED|Part B||0
28941|NCT01792635|63135|P3|NOT COMPLETED|Part A||0
28942|NCT01792635|63136|P2|NOT COMPLETED|Part A||0
28943|NCT01792635|63137|P1|NOT COMPLETED|Part A||0
28944|NCT01792635|63135|P3|COMPLETED|Part A||0
28945|NCT01792635|63136|P2|COMPLETED|Part A||0
28946|NCT01792635|63137|P1|COMPLETED|Part A||6
28947|NCT01792635|63135|P3|STARTED|Part A||0
28948|NCT01792635|63136|P2|STARTED|Part A||0
28949|NCT01792635|63137|P1|STARTED|Part A||6
28950|NCT01791972|63165|P2|NOT COMPLETED|Overall Study||0
28951|NCT01791972|63166|P1|NOT COMPLETED|Overall Study||0
28952|NCT01791972|63165|P2|COMPLETED|Overall Study||19
28953|NCT01791972|63166|P1|COMPLETED|Overall Study||19
28954|NCT01791972|63165|P2|STARTED|Overall Study||19
28955|NCT01791972|63166|P1|STARTED|Overall Study||19
28956|NCT01791894|63176|P1|NOT COMPLETED|Overall Study||1
28957|NCT01791894|63176|P1|COMPLETED|Overall Study||4
28958|NCT01791894|63176|P1|STARTED|Overall Study||5
28959|NCT01791725|63186|P3|NOT COMPLETED|Overall Study||0
28960|NCT01791725|63187|P2|NOT COMPLETED|Overall Study||1
28961|NCT01791725|63188|P1|NOT COMPLETED|Overall Study||0
28962|NCT01791725|63186|P3|COMPLETED|Overall Study||6
28963|NCT01791725|63187|P2|COMPLETED|Overall Study||4
28964|NCT01791725|63188|P1|COMPLETED|Overall Study||12
28965|NCT01791725|63186|P3|STARTED|Overall Study||6
28966|NCT01791725|63187|P2|STARTED|Overall Study||5
28967|NCT01791725|63188|P1|STARTED|Overall Study||12
28968|NCT01791413|63210|P2|NOT COMPLETED|Overall Study||1
28969|NCT01791413|63211|P1|NOT COMPLETED|Overall Study||5
28970|NCT01791413|63210|P2|COMPLETED|Overall Study||19
28971|NCT01791413|63211|P1|COMPLETED|Overall Study||15
28972|NCT01791413|63210|P2|STARTED|Overall Study||20
28973|NCT01791413|63211|P1|STARTED|Overall Study||20
28974|NCT01791205|63220|P2|NOT COMPLETED|Phase II||0
28975|NCT01791205|63221|P1|NOT COMPLETED|Phase II||12
28976|NCT01791205|63220|P2|COMPLETED|Phase II||0
28977|NCT01791205|63221|P1|COMPLETED|Phase II||92
28978|NCT01791205|63220|P2|STARTED|Phase II||0
28979|NCT01791205|63221|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
28980|NCT01791205|63220|P2|NOT COMPLETED|Phase I||0
28981|NCT01791205|63221|P1|NOT COMPLETED|Phase I||0
28982|NCT01791205|63220|P2|COMPLETED|Phase I||152
28983|NCT01791205|63221|P1|COMPLETED|Phase I||152
28984|NCT01791205|63220|P2|STARTED|Phase I||152
28985|NCT01791205|63221|P1|STARTED|Phase I||152
28986|NCT01791127|63301|P1|NOT COMPLETED|Overall Study||1758
28987|NCT01791127|63301|P1|COMPLETED|Overall Study||0
28988|NCT01791127|63301|P1|Pre-Market Analysis|Overall Study||820
28989|NCT01791127|63301|P1|STARTED|Overall Study||1758
28990|NCT01789775|63309|P2|NOT COMPLETED|Overall Study||7
28991|NCT01789775|63310|P1|NOT COMPLETED|Overall Study||2
28992|NCT01789775|63309|P2|COMPLETED|Overall Study||50
28993|NCT01789775|63310|P1|COMPLETED|Overall Study||53
28994|NCT01789775|63309|P2|STARTED|Overall Study||57
28995|NCT01789775|63310|P1|STARTED|Overall Study||55
28996|NCT01790828|63316|P1|NOT COMPLETED|Overall Study||34
28997|NCT01790828|63316|P1|COMPLETED|Overall Study||8
28998|NCT01790828|63316|P1|STARTED|Overall Study||42
28999|NCT01790750|63339|P1|NOT COMPLETED|Overall Study||0
29000|NCT01790750|63339|P1|COMPLETED|Overall Study||50
29001|NCT01790750|63339|P1|STARTED|Overall Study||50
29002|NCT01790685|63346|P2|NOT COMPLETED|Overall Study||0
29003|NCT01790685|63347|P1|NOT COMPLETED|Overall Study||0
29004|NCT01790685|63346|P2|COMPLETED|Overall Study||17
29005|NCT01790685|63347|P1|COMPLETED|Overall Study||23
29006|NCT01790685|63346|P2|STARTED|Overall Study||17
29007|NCT01790685|63347|P1|STARTED|Overall Study||23
29008|NCT01790633|63355|P2|NOT COMPLETED|Overall Study||5
29009|NCT01790633|63356|P1|NOT COMPLETED|Overall Study||48
29010|NCT01790633|63355|P2|COMPLETED|Overall Study||159
29011|NCT01790633|63356|P1|COMPLETED|Overall Study||115
29012|NCT01790633|63355|P2|STARTED|Overall Study||164
29013|NCT01790633|63356|P1|STARTED|Overall Study||163
29014|NCT01790581|63369|P2|NOT COMPLETED|Overall Study||0
29015|NCT01790581|63370|P1|NOT COMPLETED|Overall Study||0
29016|NCT01790581|63369|P2|COMPLETED|Overall Study||12
29017|NCT01790581|63370|P1|COMPLETED|Overall Study||12
29018|NCT01790581|63369|P2|STARTED|Overall Study||12
29019|NCT01790581|63370|P1|STARTED|Overall Study||12
29020|NCT01790516|63380|P2|NOT COMPLETED|Overall Study||0
29021|NCT01790516|63381|P1|NOT COMPLETED|Overall Study||1
29022|NCT01790516|63380|P2|COMPLETED|Overall Study||1
29023|NCT01790516|63381|P1|COMPLETED|Overall Study||0
29024|NCT01790516|63380|P2|STARTED|Overall Study||1
29025|NCT01790516|63381|P1|STARTED|Overall Study||1
29026|NCT01790490|63390|P3|NOT COMPLETED|Overall Study||0
29027|NCT01790490|63391|P2|NOT COMPLETED|Overall Study||0
29028|NCT01790490|63392|P1|NOT COMPLETED|Overall Study||0
29029|NCT01790490|63390|P3|COMPLETED|Overall Study||2
29030|NCT01790490|63391|P2|COMPLETED|Overall Study||3
29031|NCT01790490|63392|P1|COMPLETED|Overall Study||3
29032|NCT01790490|63390|P3|STARTED|Overall Study||2
29033|NCT01790490|63391|P2|STARTED|Overall Study||3
29034|NCT01790490|63392|P1|STARTED|Overall Study||3
29035|NCT01790178|63405|P2|NOT COMPLETED|Overall Study||0
29036|NCT01790178|63406|P1|NOT COMPLETED|Overall Study||0
29037|NCT01790178|63405|P2|COMPLETED|Overall Study||24
29038|NCT01790178|63406|P1|COMPLETED|Overall Study||16
29039|NCT01790178|63405|P2|STARTED|Overall Study||24
29040|NCT01790178|63406|P1|STARTED|Overall Study||16
29041|NCT01789476|63422|P2|NOT COMPLETED|Overall Study||2
29042|NCT01789476|63423|P1|NOT COMPLETED|Overall Study||8
29043|NCT01789476|63422|P2|COMPLETED|Overall Study||15
29044|NCT01789476|63423|P1|COMPLETED|Overall Study||26
29045|NCT01789476|63422|P2|STARTED|Overall Study||17
29046|NCT01789476|63423|P1|STARTED|Overall Study||34
29047|NCT01789255|63433|P1|NOT COMPLETED|Overall Study||0
29048|NCT01789255|63433|P1|COMPLETED|Overall Study||12
29049|NCT01789255|63433|P1|STARTED|Overall Study||12
29050|NCT01789138|63440|P2|NOT COMPLETED|Overall Study||52
29051|NCT01789138|63441|P1|NOT COMPLETED|Overall Study||41
29052|NCT01789138|63440|P2|COMPLETED|Overall Study||206
29053|NCT01789138|63441|P1|COMPLETED|Overall Study||213
29054|NCT01789138|63440|P2|STARTED|Overall Study||258
29055|NCT01789138|63441|P1|STARTED|Overall Study||254
29056|NCT01788566|63449|P1|NOT COMPLETED|Overall Study||8
29057|NCT01788566|63449|P1|COMPLETED|Overall Study||53
29058|NCT01788566|63449|P1|STARTED|Overall Study||61
29059|NCT01788358|63459|P1|NOT COMPLETED|Overall Study||98
29060|NCT01788358|63459|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
29061|NCT01788358|63459|P1|Completed Week 52|Overall Study||193
29062|NCT01788358|63459|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
29063|NCT01788358|63459|P1|Completed Week 28|Overall Study||417
29064|NCT01788358|63459|P1|Treated|Overall Study||508
29065|NCT01788358|63459|P1|STARTED|Overall Study||508
29066|NCT01788228|63473|P2|NOT COMPLETED|Overall Study||0
29067|NCT01788228|63474|P1|NOT COMPLETED|Overall Study||1
29068|NCT01788228|63473|P2|COMPLETED|Overall Study||1
29069|NCT01788228|63474|P1|COMPLETED|Overall Study||48
29070|NCT01788228|63473|P2|STARTED|Overall Study||1
29071|NCT01788228|63474|P1|STARTED|Overall Study||49
29072|NCT01788215|63493|P2|NOT COMPLETED|Overall Study||1
29073|NCT01788215|63494|P1|NOT COMPLETED|Overall Study||2
29074|NCT01788215|63493|P2|COMPLETED|Overall Study||4
29075|NCT01788215|63494|P1|COMPLETED|Overall Study||3
29076|NCT01788215|63493|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
29077|NCT01788215|63494|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
29078|NCT01788215|63493|P2|STARTED|Overall Study||5
29079|NCT01788215|63494|P1|STARTED|Overall Study||5
29080|NCT01788163|63523|P9|NOT COMPLETED|Overall Study||16
29081|NCT01788163|63524|P8|NOT COMPLETED|Overall Study||48
29082|NCT01788163|63525|P7|NOT COMPLETED|Overall Study||1
29083|NCT01788163|63526|P6|NOT COMPLETED|Overall Study||7
29084|NCT01788163|63527|P5|NOT COMPLETED|Overall Study||0
29085|NCT01788163|63528|P4|NOT COMPLETED|Overall Study||0
29086|NCT01788163|63529|P3|NOT COMPLETED|Overall Study||0
29087|NCT01788163|63530|P2|NOT COMPLETED|Overall Study||0
29088|NCT01788163|63531|P1|NOT COMPLETED|Overall Study||55
29089|NCT01788163|63523|P9|COMPLETED|Overall Study||956
29090|NCT01788163|63524|P8|COMPLETED|Overall Study||254
29091|NCT01788163|63525|P7|COMPLETED|Overall Study||49
29092|NCT01788163|63526|P6|COMPLETED|Overall Study||95
29093|NCT01788163|63527|P5|COMPLETED|Overall Study||94
29094|NCT01788163|63528|P4|COMPLETED|Overall Study||71
29095|NCT01788163|63529|P3|COMPLETED|Overall Study||62
29096|NCT01788163|63530|P2|COMPLETED|Overall Study||271
29097|NCT01788163|63531|P1|COMPLETED|Overall Study||1403
29098|NCT01788163|63523|P9|STARTED|Overall Study||972
29099|NCT01788163|63524|P8|STARTED|Overall Study||302
29100|NCT01788163|63525|P7|STARTED|Overall Study||50
29101|NCT01788163|63526|P6|STARTED|Overall Study||102
29102|NCT01788163|63527|P5|STARTED|Overall Study||94
29103|NCT01788163|63528|P4|STARTED|Overall Study||71
29104|NCT01788163|63529|P3|STARTED|Overall Study||62
29105|NCT01788163|63530|P2|STARTED|Overall Study||271
29106|NCT01788163|63531|P1|STARTED|Overall Study||1458
29107|NCT01787838|63692|P1|NOT COMPLETED|Overall Study||1413
29108|NCT01787838|63692|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
29109|NCT01787838|63692|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
29110|NCT01787799|63696|P1|NOT COMPLETED|Overall Study||0
29111|NCT01787799|63696|P1|COMPLETED|Overall Study||100
29112|NCT01787799|63696|P1|STARTED|Overall Study||100
29113|NCT01787760|63703|P3|NOT COMPLETED|Overall Study||5
29114|NCT01787760|63704|P2|NOT COMPLETED|Overall Study||16
29115|NCT01787760|63705|P1|NOT COMPLETED|Overall Study||26
29116|NCT01787760|63703|P3|COMPLETED|Overall Study||46
29117|NCT01787760|63704|P2|COMPLETED|Overall Study||34
29118|NCT01787760|63705|P1|COMPLETED|Overall Study||25
29119|NCT01787760|63703|P3|STARTED|Overall Study||51
29120|NCT01787760|63704|P2|STARTED|Overall Study||50
29121|NCT01787760|63705|P1|STARTED|Overall Study||51
29122|NCT01787591|63719|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
29123|NCT01787591|63720|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
29124|NCT01787591|63721|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
29125|NCT01787591|63722|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
29126|NCT01787591|63719|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
29127|NCT01787591|63720|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
29128|NCT01787591|63721|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
29129|NCT01787591|63722|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
29130|NCT01787591|63719|P4|STARTED|Period 4 (Cross-over Arm 4)||5
29131|NCT01787591|63720|P3|STARTED|Period 4 (Cross-over Arm 4)||5
29132|NCT01787591|63721|P2|STARTED|Period 4 (Cross-over Arm 4)||5
29133|NCT01787591|63722|P1|STARTED|Period 4 (Cross-over Arm 4)||5
29134|NCT01787591|63719|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
29135|NCT01787591|63720|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
29136|NCT01787591|63721|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
29137|NCT01787591|63722|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
29138|NCT01787591|63719|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
29139|NCT01787591|63720|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
29140|NCT01787591|63721|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
29141|NCT01787591|63722|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
29142|NCT01787591|63719|P4|STARTED|Period 3 (Cross-over Arm 3)||5
29143|NCT01787591|63720|P3|STARTED|Period 3 (Cross-over Arm 3)||5
29144|NCT01787591|63721|P2|STARTED|Period 3 (Cross-over Arm 3)||5
29145|NCT01787591|63722|P1|STARTED|Period 3 (Cross-over Arm 3)||5
29146|NCT01787591|63719|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
29147|NCT01787591|63720|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
29148|NCT01787591|63721|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
29149|NCT01787591|63722|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
29150|NCT01787591|63719|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
29151|NCT01787591|63720|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
29152|NCT01787591|63721|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
29153|NCT01787591|63722|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
29154|NCT01787591|63719|P4|STARTED|Period 2 (Cross-over Arm 2)||5
29155|NCT01787591|63720|P3|STARTED|Period 2 (Cross-over Arm 2)||5
29156|NCT01787591|63721|P2|STARTED|Period 2 (Cross-over Arm 2)||5
29157|NCT01787591|63722|P1|STARTED|Period 2 (Cross-over Arm 2)||5
29158|NCT01787591|63719|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
29159|NCT01787591|63720|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
29160|NCT01787591|63721|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
29161|NCT01787591|63722|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
29162|NCT01787591|63719|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
29163|NCT01787591|63720|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
29164|NCT01787591|63721|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
29165|NCT01787591|63722|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
29166|NCT01787591|63719|P4|STARTED|Period 1 (Cross-over Arm 1)||6
29167|NCT01787591|63720|P3|STARTED|Period 1 (Cross-over Arm 1)||5
29168|NCT01787591|63721|P2|STARTED|Period 1 (Cross-over Arm 1)||5
29169|NCT01787591|63722|P1|STARTED|Period 1 (Cross-over Arm 1)||5
29170|NCT01787461|63750|P2|NOT COMPLETED|Overall Study||9
29171|NCT01787461|63751|P1|NOT COMPLETED|Overall Study||14
29172|NCT01787461|63750|P2|COMPLETED|Overall Study||89
29173|NCT01787461|63751|P1|COMPLETED|Overall Study||82
29174|NCT01787461|63750|P2|STARTED|Overall Study||98
29175|NCT01787461|63751|P1|STARTED|Overall Study||96
29176|NCT01787383|63779|P2|NOT COMPLETED|Overall Study||22
29177|NCT01787383|63780|P1|NOT COMPLETED|Overall Study||9
29178|NCT01787383|63779|P2|COMPLETED|Overall Study||76
29179|NCT01787383|63780|P1|COMPLETED|Overall Study||92
29180|NCT01787383|63779|P2|STARTED|Overall Study||98
29181|NCT01787383|63780|P1|STARTED|Overall Study||101
29182|NCT01787279|63800|P1|NOT COMPLETED|Overall Study||3
29183|NCT01787279|63800|P1|COMPLETED|Overall Study||56
29184|NCT01787279|63800|P1|STARTED|Overall Study||59
29185|NCT01787188|63812|P3|NOT COMPLETED|Overall Study||18
29186|NCT01787188|63813|P2|NOT COMPLETED|Overall Study||18
29187|NCT01787188|63814|P1|NOT COMPLETED|Overall Study||17
29188|NCT01787188|63812|P3|COMPLETED|Overall Study||116
29189|NCT01787188|63813|P2|COMPLETED|Overall Study||112
29190|NCT01787188|63814|P1|COMPLETED|Overall Study||122
29191|NCT01787188|63812|P3|STARTED|Overall Study||134
29192|NCT01787188|63813|P2|STARTED|Overall Study||130
29193|NCT01787188|63814|P1|STARTED|Overall Study||139
29194|NCT01787175|63869|P2|NOT COMPLETED|Overall Study||0
29195|NCT01787175|63870|P1|NOT COMPLETED|Overall Study||0
29196|NCT01787175|63869|P2|COMPLETED|Overall Study||28
29197|NCT01787175|63870|P1|COMPLETED|Overall Study||30
29198|NCT01787175|63869|P2|STARTED|Overall Study||28
29199|NCT01787175|63870|P1|STARTED|Overall Study||30
29200|NCT01786993|63882|P2|NOT COMPLETED|Overall Study||10
29201|NCT01786993|63883|P1|NOT COMPLETED|Overall Study||12
29202|NCT01786993|63882|P2|COMPLETED|Overall Study||170
29203|NCT01786993|63883|P1|COMPLETED|Overall Study||189
29204|NCT01786993|63882|P2|Per Protocol Population at 9 Months|Overall Study||170
29205|NCT01786993|63883|P1|Per Protocol Population at 9 Months|Overall Study||189
29206|NCT01786993|63882|P2|STARTED|Overall Study||180
29207|NCT01786993|63883|P1|STARTED|Overall Study||201
29208|NCT01786954|63890|P2|NOT COMPLETED|Overall Study||0
29209|NCT01786954|63891|P1|NOT COMPLETED|Overall Study||0
29210|NCT01786954|63890|P2|COMPLETED|Overall Study||34
29211|NCT01786954|63891|P1|COMPLETED|Overall Study||34
29212|NCT01786954|63890|P2|STARTED|Overall Study||34
29213|NCT01786954|63891|P1|STARTED|Overall Study||34
29214|NCT01786902|63903|P2|NOT COMPLETED|Overall Study||3
29215|NCT01786902|63904|P1|NOT COMPLETED|Overall Study||4
29216|NCT01786902|63903|P2|COMPLETED|Overall Study||31
29217|NCT01786902|63904|P1|COMPLETED|Overall Study||32
29218|NCT01786902|63903|P2|STARTED|Overall Study||34
29219|NCT01786902|63904|P1|STARTED|Overall Study||36
29220|NCT01786876|63914|P1|NOT COMPLETED|Overall Study||0
29221|NCT01786876|63914|P1|COMPLETED|Overall Study||6
29222|NCT01786876|63914|P1|STARTED|Overall Study||6
29223|NCT01786707|63933|P2|NOT COMPLETED|Overall Study||1
29224|NCT01786707|63934|P1|NOT COMPLETED|Overall Study||1
29225|NCT01786707|63933|P2|COMPLETED|Overall Study||0
29226|NCT01786707|63934|P1|COMPLETED|Overall Study||0
29227|NCT01786707|63933|P2|STARTED|Overall Study||1
29228|NCT01786707|63934|P1|STARTED|Overall Study||1
29229|NCT01786668|63944|P4|NOT COMPLETED|Overall Study||4
29230|NCT01786668|63945|P3|NOT COMPLETED|Overall Study||5
29231|NCT01786668|63946|P2|NOT COMPLETED|Overall Study||1
29232|NCT01786668|63947|P1|NOT COMPLETED|Overall Study||1
29233|NCT01786668|63944|P4|COMPLETED|Overall Study||47
29234|NCT01786668|63945|P3|COMPLETED|Overall Study||47
29235|NCT01786668|63946|P2|COMPLETED|Overall Study||51
29236|NCT01786668|63947|P1|COMPLETED|Overall Study||51
29237|NCT01786668|63944|P4|STARTED|Overall Study||51
29238|NCT01786668|63945|P3|STARTED|Overall Study||52
29239|NCT01786668|63946|P2|STARTED|Overall Study||52
29240|NCT01786668|63947|P1|STARTED|Overall Study||52
29241|NCT01786629|64047|P2|NOT COMPLETED|Overall Study||5
29242|NCT01786629|64048|P1|NOT COMPLETED|Overall Study||0
29243|NCT01786629|64047|P2|COMPLETED|Overall Study||164
29244|NCT01786629|64048|P1|COMPLETED|Overall Study||169
29245|NCT01786629|64047|P2|STARTED|Overall Study||169
29246|NCT01786629|64048|P1|STARTED|Overall Study||169
29247|NCT01786330|64056|P2|NOT COMPLETED|Overall Study||3
29248|NCT01786330|64057|P1|NOT COMPLETED|Overall Study||1
29249|NCT01786330|64056|P2|COMPLETED|Overall Study||27
29250|NCT01786330|64057|P1|COMPLETED|Overall Study||29
29251|NCT01786330|64056|P2|STARTED|Overall Study||30
29252|NCT01786330|64057|P1|STARTED|Overall Study||30
29253|NCT01786252|64071|P2|NOT COMPLETED|Overall Study||0
29254|NCT01786252|64072|P1|NOT COMPLETED|Overall Study||0
29255|NCT01786252|64071|P2|COMPLETED|Overall Study||8
29256|NCT01786252|64072|P1|COMPLETED|Overall Study||7
29257|NCT01786252|64071|P2|STARTED|Overall Study||8
29258|NCT01786252|64072|P1|STARTED|Overall Study||7
29259|NCT01786239|64086|P2|NOT COMPLETED|Overall Study||11
29260|NCT01786239|64087|P1|NOT COMPLETED|Overall Study||11
29261|NCT01786239|64086|P2|COMPLETED|Overall Study||14
29262|NCT01786239|64087|P1|COMPLETED|Overall Study||14
29263|NCT01786239|64086|P2|STARTED|Overall Study||25
29264|NCT01786239|64087|P1|STARTED|Overall Study||25
29265|NCT01786174|64095|P2|NOT COMPLETED|Overall Study||0
29266|NCT01786174|64096|P1|NOT COMPLETED|Overall Study||2
29267|NCT01786174|64095|P2|COMPLETED|Overall Study||10
29268|NCT01786174|64096|P1|COMPLETED|Overall Study||16
29269|NCT01786174|64095|P2|Randomized|Overall Study||11
29270|NCT01786174|64096|P1|Randomized|Overall Study||19
29271|NCT01786174|64095|P2|STARTED|Overall Study||10
29272|NCT01786174|64096|P1|STARTED|Overall Study||18
29273|NCT01786109|64113|P3|NOT COMPLETED|Overall Study||2
29274|NCT01786109|64114|P2|NOT COMPLETED|Overall Study||0
29275|NCT01786109|64115|P1|NOT COMPLETED|Overall Study||1
29276|NCT01786109|64113|P3|COMPLETED|Overall Study||25
29277|NCT01786109|64114|P2|COMPLETED|Overall Study||24
29278|NCT01786109|64115|P1|COMPLETED|Overall Study||23
29279|NCT01786109|64113|P3|STARTED|Overall Study||27
29280|NCT01786109|64114|P2|STARTED|Overall Study||24
29281|NCT01786109|64115|P1|STARTED|Overall Study||24
29282|NCT01785628|64146|P2|NOT COMPLETED|Overall Study||3
29283|NCT01785628|64147|P1|NOT COMPLETED|Overall Study||2
29284|NCT01785628|64146|P2|COMPLETED|Overall Study||12
29285|NCT01785628|64147|P1|COMPLETED|Overall Study||13
29286|NCT01785628|64146|P2|STARTED|Overall Study||15
29287|NCT01785628|64147|P1|STARTED|Overall Study||15
29288|NCT01785602|64169|P2|NOT COMPLETED|Overall Study||9
29289|NCT01785602|64170|P1|NOT COMPLETED|Overall Study||13
29290|NCT01785602|64169|P2|COMPLETED|Overall Study||18
29291|NCT01785602|64170|P1|COMPLETED|Overall Study||63
29292|NCT01785602|64169|P2|STARTED|Overall Study||27
29293|NCT01785602|64170|P1|STARTED|Overall Study||76
29294|NCT01785524|64180|P2|NOT COMPLETED|Overall Study||2
29295|NCT01785524|64181|P1|NOT COMPLETED|Overall Study||2
29296|NCT01785524|64180|P2|COMPLETED|Overall Study||2
29297|NCT01785524|64181|P1|COMPLETED|Overall Study||5
29298|NCT01785524|64180|P2|STARTED|Overall Study||4
29299|NCT01785524|64181|P1|STARTED|Overall Study||7
29300|NCT01785472|64196|P3|NOT COMPLETED|Overall Study||22
29301|NCT01785472|64197|P2|NOT COMPLETED|Overall Study||19
29302|NCT01785472|64198|P1|NOT COMPLETED|Overall Study||24
29303|NCT01785472|64196|P3|COMPLETED|Overall Study||464
29304|NCT01785472|64197|P2|COMPLETED|Overall Study||454
29305|NCT01785472|64198|P1|COMPLETED|Overall Study||455
29306|NCT01785472|64196|P3|Safety Set (SAF)|Overall Study||484
29307|NCT01785472|64197|P2|Safety Set (SAF)|Overall Study||472
29308|NCT01785472|64198|P1|Safety Set (SAF)|Overall Study||478
29309|NCT01785472|64196|P3|Full Analysis Set (FAS)|Overall Study||484
29310|NCT01785472|64197|P2|Full Analysis Set (FAS)|Overall Study||472
29311|NCT01785472|64198|P1|Full Analysis Set (FAS)|Overall Study||479
29312|NCT01785472|64196|P3|STARTED|Overall Study||486
29313|NCT01785472|64197|P2|STARTED|Overall Study||473
29314|NCT01785472|64198|P1|STARTED|Overall Study||479
29315|NCT01785160|64240|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
29316|NCT01785160|64240|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
29317|NCT01785160|64240|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
29318|NCT01785160|64240|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
29319|NCT01785160|64240|P1|COMPLETED|Washout Period of at Least 7 Days||23
29320|NCT01785160|64240|P1|STARTED|Washout Period of at Least 7 Days||24
29321|NCT01785160|64240|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
29322|NCT01785160|64240|P1|COMPLETED|Treatment Period 1: Raltegravir||24
29323|NCT01785160|64240|P1|STARTED|Treatment Period 1: Raltegravir||25
29324|NCT01785134|64250|P2|NOT COMPLETED|Overall Study||7
29325|NCT01785134|64251|P1|NOT COMPLETED|Overall Study||12
29326|NCT01785134|64250|P2|COMPLETED|Overall Study||33
29327|NCT01785134|64251|P1|COMPLETED|Overall Study||29
29328|NCT01785134|64250|P2|STARTED|Overall Study||40
29329|NCT01785134|64251|P1|STARTED|Overall Study||41
29330|NCT01785095|64265|P1|NOT COMPLETED|Overall Study||3
29331|NCT01785095|64265|P1|COMPLETED|Overall Study||24
29332|NCT01785095|64265|P1|STARTED|Overall Study||27
29333|NCT01784614|64273|P8|NOT COMPLETED|Period 4||0
29334|NCT01784614|64274|P7|NOT COMPLETED|Period 4||0
29335|NCT01784614|64275|P6|NOT COMPLETED|Period 4||0
29336|NCT01784614|64276|P5|NOT COMPLETED|Period 4||0
29337|NCT01784614|64277|P4|NOT COMPLETED|Period 4||0
29338|NCT01784614|64278|P3|NOT COMPLETED|Period 4||0
29339|NCT01784614|64279|P2|NOT COMPLETED|Period 4||0
29340|NCT01784614|64280|P1|NOT COMPLETED|Period 4||0
29341|NCT01784614|64273|P8|COMPLETED|Period 4||2
29342|NCT01784614|64274|P7|COMPLETED|Period 4||3
29343|NCT01784614|64275|P6|COMPLETED|Period 4||3
29344|NCT01784614|64276|P5|COMPLETED|Period 4||3
29345|NCT01784614|64277|P4|COMPLETED|Period 4||3
29346|NCT01784614|64278|P3|COMPLETED|Period 4||3
29347|NCT01784614|64279|P2|COMPLETED|Period 4||2
29348|NCT01784614|64280|P1|COMPLETED|Period 4||3
29349|NCT01784614|64273|P8|STARTED|Period 4||2
29350|NCT01784614|64274|P7|STARTED|Period 4||3
29351|NCT01784614|64275|P6|STARTED|Period 4||3
29352|NCT01784614|64276|P5|STARTED|Period 4||3
29353|NCT01784614|64277|P4|STARTED|Period 4||3
29354|NCT01784614|64278|P3|STARTED|Period 4||3
29355|NCT01784614|64279|P2|STARTED|Period 4||2
29356|NCT01784614|64280|P1|STARTED|Period 4||3
29357|NCT01784614|64273|P8|NOT COMPLETED|Period 3||0
29358|NCT01784614|64274|P7|NOT COMPLETED|Period 3||0
29359|NCT01784614|64275|P6|NOT COMPLETED|Period 3||0
29360|NCT01784614|64276|P5|NOT COMPLETED|Period 3||0
29361|NCT01784614|64277|P4|NOT COMPLETED|Period 3||0
29362|NCT01784614|64278|P3|NOT COMPLETED|Period 3||0
29363|NCT01784614|64279|P2|NOT COMPLETED|Period 3||0
29364|NCT01784614|64280|P1|NOT COMPLETED|Period 3||0
29365|NCT01784614|64273|P8|COMPLETED|Period 3||2
29366|NCT01784614|64274|P7|COMPLETED|Period 3||3
29367|NCT01784614|64275|P6|COMPLETED|Period 3||3
29368|NCT01784614|64276|P5|COMPLETED|Period 3||3
29369|NCT01784614|64277|P4|COMPLETED|Period 3||3
29370|NCT01784614|64278|P3|COMPLETED|Period 3||3
29371|NCT01784614|64279|P2|COMPLETED|Period 3||2
29372|NCT01784614|64280|P1|COMPLETED|Period 3||3
29373|NCT01784614|64273|P8|STARTED|Period 3||2
29374|NCT01784614|64274|P7|STARTED|Period 3||3
29375|NCT01784614|64275|P6|STARTED|Period 3||3
29376|NCT01784614|64276|P5|STARTED|Period 3||3
29377|NCT01784614|64277|P4|STARTED|Period 3||3
29378|NCT01784614|64278|P3|STARTED|Period 3||3
29379|NCT01784614|64279|P2|STARTED|Period 3||2
29380|NCT01784614|64280|P1|STARTED|Period 3||3
29381|NCT01784614|64273|P8|NOT COMPLETED|Period 2||0
29382|NCT01784614|64274|P7|NOT COMPLETED|Period 2||0
29383|NCT01784614|64275|P6|NOT COMPLETED|Period 2||0
29384|NCT01784614|64276|P5|NOT COMPLETED|Period 2||0
29385|NCT01784614|64277|P4|NOT COMPLETED|Period 2||0
29386|NCT01784614|64278|P3|NOT COMPLETED|Period 2||0
29387|NCT01784614|64279|P2|NOT COMPLETED|Period 2||0
29388|NCT01784614|64280|P1|NOT COMPLETED|Period 2||0
29389|NCT01784614|64273|P8|COMPLETED|Period 2||2
29390|NCT01784614|64274|P7|COMPLETED|Period 2||3
29391|NCT01784614|64275|P6|COMPLETED|Period 2||3
29392|NCT01784614|64276|P5|COMPLETED|Period 2||3
29393|NCT01784614|64277|P4|COMPLETED|Period 2||3
29394|NCT01784614|64278|P3|COMPLETED|Period 2||3
29395|NCT01784614|64279|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
29396|NCT01784614|64280|P1|COMPLETED|Period 2||3
29397|NCT01784614|64273|P8|STARTED|Period 2||2
29398|NCT01784614|64274|P7|STARTED|Period 2||3
29399|NCT01784614|64275|P6|STARTED|Period 2||3
29400|NCT01784614|64276|P5|STARTED|Period 2||3
29401|NCT01784614|64277|P4|STARTED|Period 2||3
29402|NCT01784614|64278|P3|STARTED|Period 2||3
29403|NCT01784614|64279|P2|STARTED|Period 2||3
29404|NCT01784614|64280|P1|STARTED|Period 2||3
29405|NCT01784614|64273|P8|NOT COMPLETED|Period 1||0
29406|NCT01784614|64274|P7|NOT COMPLETED|Period 1||0
29407|NCT01784614|64275|P6|NOT COMPLETED|Period 1||0
29408|NCT01784614|64276|P5|NOT COMPLETED|Period 1||0
29409|NCT01784614|64277|P4|NOT COMPLETED|Period 1||0
29410|NCT01784614|64278|P3|NOT COMPLETED|Period 1||0
29411|NCT01784614|64279|P2|NOT COMPLETED|Period 1||0
29412|NCT01784614|64280|P1|NOT COMPLETED|Period 1||0
29413|NCT01784614|64273|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
29414|NCT01784614|64274|P7|COMPLETED|Period 1||3
29415|NCT01784614|64275|P6|COMPLETED|Period 1||3
29416|NCT01784614|64276|P5|COMPLETED|Period 1||3
29417|NCT01784614|64277|P4|COMPLETED|Period 1||3
29418|NCT01784614|64278|P3|COMPLETED|Period 1||3
29419|NCT01784614|64279|P2|COMPLETED|Period 1||3
29420|NCT01784614|64280|P1|COMPLETED|Period 1||3
29421|NCT01784614|64273|P8|Received at Least 1 Dose of Study Drug|Period 1||3
29422|NCT01784614|64274|P7|Received at Least 1 Dose of Study Drug|Period 1||3
29423|NCT01784614|64275|P6|Received at Least 1 Dose of Study Drug|Period 1||3
29424|NCT01784614|64276|P5|Received at Least 1 Dose of Study Drug|Period 1||3
29425|NCT01784614|64277|P4|Received at Least 1 Dose of Study Drug|Period 1||3
29426|NCT01784614|64278|P3|Received at Least 1 Dose of Study Drug|Period 1||3
29427|NCT01784614|64279|P2|Received at Least 1 Dose of Study Drug|Period 1||3
29428|NCT01784614|64280|P1|Received at Least 1 Dose of Study Drug|Period 1||3
29429|NCT01784614|64273|P8|STARTED|Period 1||3
29430|NCT01784614|64274|P7|STARTED|Period 1||3
29431|NCT01784614|64275|P6|STARTED|Period 1||3
29432|NCT01784614|64276|P5|STARTED|Period 1||3
29433|NCT01784614|64277|P4|STARTED|Period 1||3
29434|NCT01784614|64278|P3|STARTED|Period 1||3
29435|NCT01784614|64279|P2|STARTED|Period 1||3
29436|NCT01784614|64280|P1|STARTED|Period 1||3
29437|NCT01783938|64316|P2|NOT COMPLETED|Overall Study||53
29438|NCT01783938|64317|P1|NOT COMPLETED|Overall Study||47
29439|NCT01783938|64316|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
29440|NCT01783938|64317|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
29441|NCT01783938|64316|P2|STARTED|Overall Study||70
29442|NCT01783938|64317|P1|STARTED|Overall Study||68
29443|NCT01783912|64332|P3|NOT COMPLETED|Overall Study||23
29444|NCT01783912|64333|P2|NOT COMPLETED|Overall Study||46
29445|NCT01783912|64334|P1|NOT COMPLETED|Overall Study||30
29446|NCT01783912|64332|P3|COMPLETED|Overall Study||25
29447|NCT01783912|64333|P2|COMPLETED|Overall Study||58
29448|NCT01783912|64334|P1|COMPLETED|Overall Study||88
29449|NCT01783912|64332|P3|STARTED|Overall Study||48
29450|NCT01783912|64333|P2|STARTED|Overall Study||104
29451|NCT01783912|64334|P1|STARTED|Overall Study||118
29452|NCT01783886|64345|P3|NOT COMPLETED|Overall Study||10
29453|NCT01783886|64346|P2|NOT COMPLETED|Overall Study||11
29454|NCT01783886|64347|P1|NOT COMPLETED|Overall Study||5
29455|NCT01783886|64345|P3|COMPLETED|Overall Study||117
29456|NCT01783886|64346|P2|COMPLETED|Overall Study||116
29457|NCT01783886|64347|P1|COMPLETED|Overall Study||122
29458|NCT01783886|64345|P3|Participants Received Treatment|Overall Study||124
29459|NCT01783886|64346|P2|Participants Received Treatment|Overall Study||127
29460|NCT01783886|64347|P1|Participants Received Treatment|Overall Study||127
29461|NCT01783886|64345|P3|STARTED|Overall Study||127
29462|NCT01783886|64346|P2|STARTED|Overall Study||127
29463|NCT01783886|64347|P1|STARTED|Overall Study||127
29464|NCT01783860|64375|P2|NOT COMPLETED|Overall Study||0
29465|NCT01783860|64376|P1|NOT COMPLETED|Overall Study||0
29466|NCT01783860|64375|P2|COMPLETED|Overall Study||50
29467|NCT01783860|64376|P1|COMPLETED|Overall Study||50
29468|NCT01783860|64375|P2|STARTED|Overall Study||50
29469|NCT01783860|64376|P1|STARTED|Overall Study||50
29470|NCT01783821|64394|P2|NOT COMPLETED|Overall Study||1
29471|NCT01783821|64395|P1|NOT COMPLETED|Overall Study||1
29472|NCT01783821|64394|P2|COMPLETED|Overall Study||30
29473|NCT01783821|64395|P1|COMPLETED|Overall Study||29
29474|NCT01783821|64394|P2|STARTED|Overall Study||31
29475|NCT01783821|64395|P1|STARTED|Overall Study||30
29476|NCT01783730|64411|P1|NOT COMPLETED|Overall Study||6
29477|NCT01783730|64411|P1|COMPLETED|Overall Study||157
29478|NCT01783730|64411|P1|STARTED|Overall Study||163
29479|NCT01783678|64436|P6|NOT COMPLETED|Overall Study||5
29480|NCT01783678|64437|P5|NOT COMPLETED|Overall Study||7
29481|NCT01783678|64438|P4|NOT COMPLETED|Overall Study||8
29482|NCT01783678|64439|P3|NOT COMPLETED|Overall Study||1
29483|NCT01783678|64440|P2|NOT COMPLETED|Overall Study||18
29484|NCT01783678|64441|P1|NOT COMPLETED|Overall Study||2
29485|NCT01783678|64436|P6|COMPLETED|Overall Study||26
29486|NCT01783678|64437|P5|COMPLETED|Overall Study||42
29487|NCT01783678|64438|P4|COMPLETED|Overall Study||50
29488|NCT01783678|64439|P3|COMPLETED|Overall Study||5
29489|NCT01783678|64440|P2|COMPLETED|Overall Study||94
29490|NCT01783678|64441|P1|COMPLETED|Overall Study||17
29491|NCT01783678|64436|P6|STARTED|Overall Study||31
29492|NCT01783678|64437|P5|STARTED|Overall Study||49
29493|NCT01783678|64438|P4|STARTED|Overall Study||58
29494|NCT01783678|64439|P3|STARTED|Overall Study||6
29495|NCT01783678|64440|P2|STARTED|Overall Study||112
29496|NCT01783678|64441|P1|STARTED|Overall Study||19
29497|NCT01783639|64513|P1|NOT COMPLETED|Overall Study||22
29498|NCT01783639|64513|P1|COMPLETED|Overall Study||120
29499|NCT01783639|64513|P1|STARTED|Overall Study||142
29500|NCT01783548|64519|P2|NOT COMPLETED|Overall Study||18
29501|NCT01783548|64520|P1|NOT COMPLETED|Overall Study||34
29502|NCT01783548|64519|P2|COMPLETED|Overall Study||167
29503|NCT01783548|64520|P1|COMPLETED|Overall Study||328
29504|NCT01783548|64519|P2|Full Analysis Set (FAS)|Overall Study||184
29505|NCT01783548|64520|P1|Full Analysis Set (FAS)|Overall Study||358
29506|NCT01783548|64519|P2|STARTED|Overall Study|Randomized|185
29507|NCT01783548|64520|P1|STARTED|Overall Study|Randomized|362
29508|NCT01783496|64538|P6|NOT COMPLETED|Overall Study||1
29509|NCT01783496|64539|P5|NOT COMPLETED|Overall Study||0
29510|NCT01783496|64540|P4|NOT COMPLETED|Overall Study||2
29511|NCT01783496|64541|P3|NOT COMPLETED|Overall Study||0
29512|NCT01783496|64542|P2|NOT COMPLETED|Overall Study||0
29513|NCT01783496|64543|P1|NOT COMPLETED|Overall Study||1
29514|NCT01783496|64538|P6|COMPLETED|Overall Study||4
29515|NCT01783496|64539|P5|COMPLETED|Overall Study||5
29516|NCT01783496|64540|P4|COMPLETED|Overall Study||8
29517|NCT01783496|64541|P3|COMPLETED|Overall Study||10
29518|NCT01783496|64542|P2|COMPLETED|Overall Study||10
29519|NCT01783496|64543|P1|COMPLETED|Overall Study||9
29520|NCT01783496|64538|P6|STARTED|Overall Study||5
29521|NCT01783496|64539|P5|STARTED|Overall Study||5
29522|NCT01783496|64540|P4|STARTED|Overall Study||10
29523|NCT01783496|64541|P3|STARTED|Overall Study||10
29524|NCT01783496|64542|P2|STARTED|Overall Study||10
29525|NCT01783496|64543|P1|STARTED|Overall Study||10
29526|NCT01783418|64571|P2|NOT COMPLETED|Overall Study||0
29527|NCT01783418|64572|P1|NOT COMPLETED|Overall Study||1
29528|NCT01783418|64571|P2|COMPLETED|Overall Study||6
29529|NCT01783418|64572|P1|COMPLETED|Overall Study||7
29530|NCT01783418|64571|P2|STARTED|Overall Study||6
29531|NCT01783418|64572|P1|STARTED|Overall Study||8
29532|NCT01783054|64590|P1|NOT COMPLETED|Overall Study||0
29533|NCT01783054|64590|P1|COMPLETED|Overall Study||2
29534|NCT01783054|64590|P1|STARTED|Overall Study||2
29535|NCT01783015|64601|P3|NOT COMPLETED|Open Label Treatment||6
29536|NCT01783015|64602|P2|NOT COMPLETED|Open Label Treatment||0
29537|NCT01783015|64603|P1|NOT COMPLETED|Open Label Treatment||0
29538|NCT01783015|64601|P3|COMPLETED|Open Label Treatment||5
29539|NCT01783015|64602|P2|COMPLETED|Open Label Treatment||0
29540|NCT01783015|64603|P1|COMPLETED|Open Label Treatment||0
29541|NCT01783015|64601|P3|STARTED|Open Label Treatment||11
29542|NCT01783015|64602|P2|STARTED|Open Label Treatment||0
29543|NCT01783015|64603|P1|STARTED|Open Label Treatment||0
29544|NCT01783015|64601|P3|NOT COMPLETED|Blinded Treatment||0
29545|NCT01783015|64602|P2|NOT COMPLETED|Blinded Treatment||3
29546|NCT01783015|64603|P1|NOT COMPLETED|Blinded Treatment||2
29547|NCT01783015|64601|P3|COMPLETED|Blinded Treatment||0
29548|NCT01783015|64602|P2|COMPLETED|Blinded Treatment||2
29549|NCT01783015|64603|P1|COMPLETED|Blinded Treatment||9
29550|NCT01783015|64601|P3|Treated|Blinded Treatment||0
29551|NCT01783015|64602|P2|Treated|Blinded Treatment||5
29552|NCT01783015|64603|P1|Treated|Blinded Treatment||11
29553|NCT01783015|64601|P3|STARTED|Blinded Treatment||0
29554|NCT01783015|64602|P2|STARTED|Blinded Treatment||5
29555|NCT01783015|64603|P1|STARTED|Blinded Treatment||11
29556|NCT01782898|64690|P2|NOT COMPLETED|Overall Study||6
29557|NCT01782898|64691|P1|NOT COMPLETED|Overall Study||6
29558|NCT01782898|64690|P2|COMPLETED|Overall Study||29
29559|NCT01782898|64691|P1|COMPLETED|Overall Study||29
29560|NCT01782898|64690|P2|STARTED|Overall Study||35
29561|NCT01782898|64691|P1|STARTED|Overall Study||35
29562|NCT01782885|64703|P2|NOT COMPLETED|Overall Study||6
29563|NCT01782885|64704|P1|NOT COMPLETED|Overall Study||4
29564|NCT01782885|64703|P2|COMPLETED|Overall Study||33
29565|NCT01782885|64704|P1|COMPLETED|Overall Study||32
29566|NCT01782885|64703|P2|STARTED|Overall Study||39
29567|NCT01782885|64704|P1|STARTED|Overall Study||36
29568|NCT01782872|64730|P4|NOT COMPLETED|Overall Study||1
29569|NCT01782872|64731|P3|NOT COMPLETED|Overall Study||0
29570|NCT01782872|64732|P2|NOT COMPLETED|Overall Study||1
29571|NCT01782872|64733|P1|NOT COMPLETED|Overall Study||0
29572|NCT01782872|64730|P4|COMPLETED|Overall Study||19
29573|NCT01782872|64731|P3|COMPLETED|Overall Study||20
29574|NCT01782872|64732|P2|COMPLETED|Overall Study||19
29575|NCT01782872|64733|P1|COMPLETED|Overall Study||20
29576|NCT01782872|64730|P4|STARTED|Overall Study||20
29577|NCT01782872|64731|P3|STARTED|Overall Study||20
29578|NCT01782872|64732|P2|STARTED|Overall Study||20
29579|NCT01782872|64733|P1|STARTED|Overall Study||20
29580|NCT01782859|64757|P2|NOT COMPLETED|Overall Study||7
29581|NCT01782859|64758|P1|NOT COMPLETED|Overall Study||6
29582|NCT01782859|64757|P2|COMPLETED|Overall Study||13
29583|NCT01782859|64758|P1|COMPLETED|Overall Study||14
29584|NCT01782859|64757|P2|STARTED|Overall Study||20
29585|NCT01782859|64758|P1|STARTED|Overall Study||20
29586|NCT01782742|64774|P2|NOT COMPLETED|Open Label Phase||0
29587|NCT01782742|64775|P1|NOT COMPLETED|Open Label Phase||0
29588|NCT01782742|64774|P2|COMPLETED|Open Label Phase||0
29589|NCT01782742|64775|P1|COMPLETED|Open Label Phase||19
29590|NCT01782742|64774|P2|STARTED|Open Label Phase||0
29591|NCT01782742|64775|P1|STARTED|Open Label Phase||19
29592|NCT01782742|64774|P2|NOT COMPLETED|Double-blind Treatment Phase||0
29593|NCT01782742|64775|P1|NOT COMPLETED|Double-blind Treatment Phase||1
29594|NCT01782742|64774|P2|COMPLETED|Double-blind Treatment Phase||4
29595|NCT01782742|64775|P1|COMPLETED|Double-blind Treatment Phase||15
29596|NCT01782742|64774|P2|STARTED|Double-blind Treatment Phase||4
29597|NCT01782742|64775|P1|STARTED|Double-blind Treatment Phase||16
29598|NCT01782482|64810|P2|NOT COMPLETED|Overall Study||10
29599|NCT01782482|64811|P1|NOT COMPLETED|Overall Study||10
29600|NCT01782482|64810|P2|COMPLETED|Overall Study||270
29601|NCT01782482|64811|P1|COMPLETED|Overall Study||271
29602|NCT01782482|64810|P2|STARTED|Overall Study||280
29603|NCT01782482|64811|P1|STARTED|Overall Study||281
29604|NCT01782469|64819|P1|NOT COMPLETED|Overall Study||1
29605|NCT01782469|64819|P1|COMPLETED|Overall Study||15
29606|NCT01782469|64819|P1|STARTED|Overall Study||16
29607|NCT01782326|64829|P2|NOT COMPLETED|Double-blind Treatment||320
29608|NCT01782326|64830|P1|NOT COMPLETED|Double-blind Treatment||278
29609|NCT01782326|64829|P2|COMPLETED|Double-blind Treatment||1360
29610|NCT01782326|64830|P1|COMPLETED|Double-blind Treatment||1400
29611|NCT01782326|64829|P2|STARTED|Double-blind Treatment||1680
29612|NCT01782326|64830|P1|STARTED|Double-blind Treatment||1678
29613|NCT01782326|64829|P2|NOT COMPLETED|Planned Treatment Epoch||208
29614|NCT01782326|64830|P1|NOT COMPLETED|Planned Treatment Epoch||202
29615|NCT01782326|64829|P2|COMPLETED|Planned Treatment Epoch||1474
29616|NCT01782326|64830|P1|COMPLETED|Planned Treatment Epoch||1478
29617|NCT01782326|64829|P2|Urine Cortisol Set|Planned Treatment Epoch||269
29618|NCT01782326|64830|P1|Urine Cortisol Set|Planned Treatment Epoch||266
29619|NCT01782326|64829|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
29620|NCT01782326|64830|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
29621|NCT01782326|64829|P2|Serial Spirometry Set|Planned Treatment Epoch||279
29622|NCT01782326|64830|P1|Serial Spirometry Set|Planned Treatment Epoch||280
29623|NCT01782326|64829|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
29624|NCT01782326|64830|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
29625|NCT01782326|64829|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
29626|NCT01782326|64830|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
29627|NCT01782326|64829|P2|STARTED|Planned Treatment Epoch||1682
29628|NCT01782326|64830|P1|STARTED|Planned Treatment Epoch||1680
29629|NCT01782222|64893|P3|NOT COMPLETED|Overall Study||4
29630|NCT01782222|64894|P2|NOT COMPLETED|Overall Study||11
29631|NCT01782222|64895|P1|NOT COMPLETED|Overall Study||8
29632|NCT01782222|64893|P3|COMPLETED|Overall Study||37
29633|NCT01782222|64894|P2|COMPLETED|Overall Study||30
29634|NCT01782222|64895|P1|COMPLETED|Overall Study||32
29635|NCT01782222|64893|P3|STARTED|Overall Study||41
29636|NCT01782222|64894|P2|STARTED|Overall Study||41
29637|NCT01782222|64895|P1|STARTED|Overall Study||40
29638|NCT01781962|64927|P1|NOT COMPLETED|Overall Study||5
29639|NCT01781962|64927|P1|COMPLETED|Overall Study||201
29640|NCT01781962|64927|P1|STARTED|Overall Study||206
29641|NCT01781481|64933|P1|NOT COMPLETED|Overall Study||0
29642|NCT01781481|64933|P1|COMPLETED|Overall Study||148
29643|NCT01781481|64933|P1|STARTED|Overall Study||148
29644|NCT01781403|64992|P3|NOT COMPLETED|Overall Study||0
29645|NCT01781403|64993|P2|NOT COMPLETED|Overall Study||0
29646|NCT01781403|64994|P1|NOT COMPLETED|Overall Study||0
29647|NCT01781403|64992|P3|COMPLETED|Overall Study||18
29648|NCT01781403|64993|P2|COMPLETED|Overall Study||2
29649|NCT01781403|64994|P1|COMPLETED|Overall Study||2
29650|NCT01781403|64992|P3|STARTED|Overall Study||18
29651|NCT01781403|64993|P2|STARTED|Overall Study||2
29652|NCT01781403|64994|P1|STARTED|Overall Study||2
29653|NCT01781208|65010|P1|NOT COMPLETED|Overall Study||0
29654|NCT01781208|65010|P1|COMPLETED|Overall Study||62
29655|NCT01781208|65010|P1|Overall Study|Overall Study||62
29656|NCT01781208|65010|P1|STARTED|Overall Study||62
29657|NCT01781169|65017|P2|NOT COMPLETED|Overall Study||0
29658|NCT01781169|65018|P1|NOT COMPLETED|Overall Study||1
29659|NCT01781169|65017|P2|COMPLETED|Overall Study||21
29660|NCT01781169|65018|P1|COMPLETED|Overall Study||21
29661|NCT01781169|65017|P2|STARTED|Overall Study||21
29662|NCT01781169|65018|P1|STARTED|Overall Study||22
29663|NCT01781026|65024|P1|NOT COMPLETED|Overall Study||2
29664|NCT01781026|65024|P1|COMPLETED|Overall Study||0
29665|NCT01781026|65024|P1|STARTED|Overall Study||2
29666|NCT01780987|65030|P2|NOT COMPLETED|Overall Study||6
29667|NCT01780987|65031|P1|NOT COMPLETED|Overall Study||3
29668|NCT01780987|65030|P2|COMPLETED|Overall Study||34
29669|NCT01780987|65031|P1|COMPLETED|Overall Study||37
29670|NCT01780987|65030|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
29671|NCT01780987|65031|P1|STARTED|Overall Study||40
29672|NCT01780935|65049|P2|NOT COMPLETED|Overall Study||336
29673|NCT01780935|65050|P1|NOT COMPLETED|Overall Study||335
29674|NCT01780935|65049|P2|COMPLETED|Overall Study||0
29675|NCT01780935|65050|P1|COMPLETED|Overall Study||0
29676|NCT01780935|65049|P2|Safety Set|Overall Study||336
29677|NCT01780935|65050|P1|Safety Set|Overall Study||334
29678|NCT01780935|65049|P2|STARTED|Overall Study||336
29679|NCT01780935|65050|P1|STARTED|Overall Study||335
29680|NCT01780922|65080|P6|NOT COMPLETED|Third Intervention (1 Day)||0
29681|NCT01780922|65081|P5|NOT COMPLETED|Third Intervention (1 Day)||0
29682|NCT01780922|65082|P4|NOT COMPLETED|Third Intervention (1 Day)||0
29683|NCT01780922|65083|P3|NOT COMPLETED|Third Intervention (1 Day)||0
29684|NCT01780922|65084|P2|NOT COMPLETED|Third Intervention (1 Day)||0
29685|NCT01780922|65085|P1|NOT COMPLETED|Third Intervention (1 Day)||0
29686|NCT01780922|65080|P6|COMPLETED|Third Intervention (1 Day)||2
29687|NCT01780922|65081|P5|COMPLETED|Third Intervention (1 Day)||2
29688|NCT01780922|65082|P4|COMPLETED|Third Intervention (1 Day)||2
29689|NCT01780922|65083|P3|COMPLETED|Third Intervention (1 Day)||2
29690|NCT01780922|65084|P2|COMPLETED|Third Intervention (1 Day)||2
29691|NCT01780922|65085|P1|COMPLETED|Third Intervention (1 Day)||2
29692|NCT01780922|65080|P6|STARTED|Third Intervention (1 Day)||2
29693|NCT01780922|65081|P5|STARTED|Third Intervention (1 Day)||2
29694|NCT01780922|65082|P4|STARTED|Third Intervention (1 Day)||2
29695|NCT01780922|65083|P3|STARTED|Third Intervention (1 Day)||2
29696|NCT01780922|65084|P2|STARTED|Third Intervention (1 Day)||2
29697|NCT01780922|65085|P1|STARTED|Third Intervention (1 Day)||2
29698|NCT01780922|65080|P6|NOT COMPLETED|Washout (7 Days)||0
29699|NCT01780922|65081|P5|NOT COMPLETED|Washout (7 Days)||0
29700|NCT01780922|65082|P4|NOT COMPLETED|Washout (7 Days)||0
29701|NCT01780922|65083|P3|NOT COMPLETED|Washout (7 Days)||0
29702|NCT01780922|65084|P2|NOT COMPLETED|Washout (7 Days)||0
29703|NCT01780922|65085|P1|NOT COMPLETED|Washout (7 Days)||0
29704|NCT01780922|65080|P6|COMPLETED|Washout (7 Days)||2
29705|NCT01780922|65081|P5|COMPLETED|Washout (7 Days)||2
29706|NCT01780922|65082|P4|COMPLETED|Washout (7 Days)||2
29707|NCT01780922|65083|P3|COMPLETED|Washout (7 Days)||2
29708|NCT01780922|65084|P2|COMPLETED|Washout (7 Days)||2
29709|NCT01780922|65085|P1|COMPLETED|Washout (7 Days)||2
29710|NCT01780922|65080|P6|STARTED|Washout (7 Days)||2
29711|NCT01780922|65081|P5|STARTED|Washout (7 Days)||2
29712|NCT01780922|65082|P4|STARTED|Washout (7 Days)||2
29713|NCT01780922|65083|P3|STARTED|Washout (7 Days)||2
29714|NCT01780922|65084|P2|STARTED|Washout (7 Days)||2
29715|NCT01780922|65085|P1|STARTED|Washout (7 Days)||2
29716|NCT01780922|65080|P6|NOT COMPLETED|Second Intervention (1 Day)||0
29717|NCT01780922|65081|P5|NOT COMPLETED|Second Intervention (1 Day)||0
29718|NCT01780922|65082|P4|NOT COMPLETED|Second Intervention (1 Day)||0
29719|NCT01780922|65083|P3|NOT COMPLETED|Second Intervention (1 Day)||0
29720|NCT01780922|65084|P2|NOT COMPLETED|Second Intervention (1 Day)||0
29721|NCT01780922|65085|P1|NOT COMPLETED|Second Intervention (1 Day)||0
29722|NCT01780922|65080|P6|COMPLETED|Second Intervention (1 Day)||2
29723|NCT01780922|65081|P5|COMPLETED|Second Intervention (1 Day)||2
29724|NCT01780922|65082|P4|COMPLETED|Second Intervention (1 Day)||2
29725|NCT01780922|65083|P3|COMPLETED|Second Intervention (1 Day)||2
29726|NCT01780922|65084|P2|COMPLETED|Second Intervention (1 Day)||2
29727|NCT01780922|65085|P1|COMPLETED|Second Intervention (1 Day)||2
29728|NCT01780922|65080|P6|STARTED|Second Intervention (1 Day)||2
29729|NCT01780922|65081|P5|STARTED|Second Intervention (1 Day)||2
29730|NCT01780922|65082|P4|STARTED|Second Intervention (1 Day)||2
29731|NCT01780922|65083|P3|STARTED|Second Intervention (1 Day)||2
29732|NCT01780922|65084|P2|STARTED|Second Intervention (1 Day)||2
29733|NCT01780922|65085|P1|STARTED|Second Intervention (1 Day)||2
29734|NCT01780922|65080|P6|NOT COMPLETED|Washout (7 Days)||0
29735|NCT01780922|65081|P5|NOT COMPLETED|Washout (7 Days)||0
29736|NCT01780922|65082|P4|NOT COMPLETED|Washout (7 Days)||0
29737|NCT01780922|65083|P3|NOT COMPLETED|Washout (7 Days)||0
29738|NCT01780922|65084|P2|NOT COMPLETED|Washout (7 Days)||0
29739|NCT01780922|65085|P1|NOT COMPLETED|Washout (7 Days)||0
29740|NCT01780922|65080|P6|COMPLETED|Washout (7 Days)||2
29741|NCT01780922|65081|P5|COMPLETED|Washout (7 Days)||2
29742|NCT01780922|65082|P4|COMPLETED|Washout (7 Days)||2
29743|NCT01780922|65083|P3|COMPLETED|Washout (7 Days)||2
29744|NCT01780922|65084|P2|COMPLETED|Washout (7 Days)||2
29745|NCT01780922|65085|P1|COMPLETED|Washout (7 Days)||2
29746|NCT01780922|65080|P6|STARTED|Washout (7 Days)||2
29747|NCT01780922|65081|P5|STARTED|Washout (7 Days)||2
29748|NCT01780922|65082|P4|STARTED|Washout (7 Days)||2
29749|NCT01780922|65083|P3|STARTED|Washout (7 Days)||2
29750|NCT01780922|65084|P2|STARTED|Washout (7 Days)||2
29751|NCT01780922|65085|P1|STARTED|Washout (7 Days)||2
29752|NCT01780922|65080|P6|NOT COMPLETED|First Intervention (1 Day)||0
29753|NCT01780922|65081|P5|NOT COMPLETED|First Intervention (1 Day)||0
29754|NCT01780922|65082|P4|NOT COMPLETED|First Intervention (1 Day)||0
29755|NCT01780922|65083|P3|NOT COMPLETED|First Intervention (1 Day)||0
29756|NCT01780922|65084|P2|NOT COMPLETED|First Intervention (1 Day)||0
29757|NCT01780922|65085|P1|NOT COMPLETED|First Intervention (1 Day)||0
29758|NCT01780922|65080|P6|COMPLETED|First Intervention (1 Day)||2
29759|NCT01780922|65081|P5|COMPLETED|First Intervention (1 Day)||2
29760|NCT01780922|65082|P4|COMPLETED|First Intervention (1 Day)||2
29761|NCT01780922|65083|P3|COMPLETED|First Intervention (1 Day)||2
29762|NCT01780922|65084|P2|COMPLETED|First Intervention (1 Day)||2
29763|NCT01780922|65085|P1|COMPLETED|First Intervention (1 Day)||2
29764|NCT01780922|65080|P6|STARTED|First Intervention (1 Day)||2
29765|NCT01780922|65081|P5|STARTED|First Intervention (1 Day)||2
29766|NCT01780922|65082|P4|STARTED|First Intervention (1 Day)||2
29767|NCT01780922|65083|P3|STARTED|First Intervention (1 Day)||2
29768|NCT01780922|65084|P2|STARTED|First Intervention (1 Day)||2
29769|NCT01780922|65085|P1|STARTED|First Intervention (1 Day)||2
29770|NCT01780584|65141|P3|NOT COMPLETED|Overall Study||2
29771|NCT01780584|65142|P2|NOT COMPLETED|Overall Study||1
29772|NCT01780584|65143|P1|NOT COMPLETED|Overall Study||1
29773|NCT01780584|65141|P3|COMPLETED|Overall Study||13
29774|NCT01780584|65142|P2|COMPLETED|Overall Study||14
29775|NCT01780584|65143|P1|COMPLETED|Overall Study||14
29776|NCT01780584|65141|P3|STARTED|Overall Study||15
29777|NCT01780584|65142|P2|STARTED|Overall Study||15
29778|NCT01780584|65143|P1|STARTED|Overall Study||15
29779|NCT01780506|65165|P2|NOT COMPLETED|Overall Study||434
29780|NCT01780506|65166|P1|NOT COMPLETED|Overall Study||438
29781|NCT01780506|65165|P2|COMPLETED|Overall Study||0
29782|NCT01780506|65166|P1|COMPLETED|Overall Study||0
29783|NCT01780506|65165|P2|STARTED|Overall Study||434
29784|NCT01780506|65166|P1|STARTED|Overall Study||438
29785|NCT01780389|65204|P1|NOT COMPLETED|Overall Study||1
29786|NCT01780389|65204|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
29787|NCT01780389|65204|P1|STARTED|Overall Study||5
29788|NCT01780350|65215|P1|NOT COMPLETED|Overall Study||0
29789|NCT01780350|65215|P1|COMPLETED|Overall Study||200
29790|NCT01780350|65215|P1|STARTED|Overall Study||200
29791|NCT01780337|65222|P2|NOT COMPLETED|Overall Study||0
29792|NCT01780337|65223|P1|NOT COMPLETED|Overall Study||0
29793|NCT01780337|65222|P2|COMPLETED|Overall Study||6
29794|NCT01780337|65223|P1|COMPLETED|Overall Study||6
29795|NCT01780337|65222|P2|STARTED|Overall Study||6
29796|NCT01780337|65223|P1|STARTED|Overall Study||6
29797|NCT01780324|65235|P2|NOT COMPLETED|Overall Study||6
29798|NCT01780324|65236|P1|NOT COMPLETED|Overall Study||1
29799|NCT01780324|65235|P2|COMPLETED|Overall Study||33
29800|NCT01780324|65236|P1|COMPLETED|Overall Study||40
29801|NCT01780324|65235|P2|STARTED|Overall Study||39
29802|NCT01780324|65236|P1|STARTED|Overall Study||41
29803|NCT01779648|65244|P2|NOT COMPLETED|Overall Study||0
29804|NCT01779648|65245|P1|NOT COMPLETED|Overall Study||1
29805|NCT01779648|65244|P2|COMPLETED|Overall Study||27
29806|NCT01779648|65245|P1|COMPLETED|Overall Study||27
29807|NCT01779648|65244|P2|STARTED|Overall Study||27
29808|NCT01779648|65245|P1|STARTED|Overall Study||28
29809|NCT01779219|65275|P2|NOT COMPLETED|Overall Study||0
29810|NCT01779219|65276|P1|NOT COMPLETED|Overall Study||0
29811|NCT01779219|65275|P2|COMPLETED|Overall Study|First interim analysis|21
29812|NCT01779219|65276|P1|COMPLETED|Overall Study|First interim analysis|21
29813|NCT01779219|65275|P2|STARTED|Overall Study|First interim analysis|21
29814|NCT01779219|65276|P1|STARTED|Overall Study|First interim analysis|21
29815|NCT01778985|65290|P2|NOT COMPLETED|Overall Study||3
29816|NCT01778985|65291|P1|NOT COMPLETED|Overall Study||7
29817|NCT01778985|65290|P2|COMPLETED|Overall Study||12
29818|NCT01778985|65291|P1|COMPLETED|Overall Study||8
29819|NCT01778985|65290|P2|STARTED|Overall Study||15
29820|NCT01778985|65291|P1|STARTED|Overall Study||15
29821|NCT01778751|65337|P2|NOT COMPLETED|Overall Study||2
29822|NCT01778751|65338|P1|NOT COMPLETED|Overall Study||2
29823|NCT01778751|65337|P2|COMPLETED|Overall Study||23
29824|NCT01778751|65338|P1|COMPLETED|Overall Study||23
29825|NCT01778751|65337|P2|STARTED|Overall Study||25
29826|NCT01778751|65338|P1|STARTED|Overall Study||25
29827|NCT01778530|65350|P1|NOT COMPLETED|Overall Study||2
29828|NCT01778530|65350|P1|COMPLETED|Overall Study||0
29829|NCT01778530|65350|P1|STARTED|Overall Study||2
29830|NCT01778296|65355|P1|NOT COMPLETED|Overall Study||0
29831|NCT01778296|65355|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
29832|NCT01778296|65355|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
29833|NCT01778127|65362|P3|NOT COMPLETED|Overall Study||6
29834|NCT01778127|65363|P2|NOT COMPLETED|Overall Study||2
29835|NCT01778127|65364|P1|NOT COMPLETED|Overall Study||8
29836|NCT01778127|65362|P3|COMPLETED|Overall Study||26
29837|NCT01778127|65363|P2|COMPLETED|Overall Study||31
29838|NCT01778127|65364|P1|COMPLETED|Overall Study||25
29839|NCT01778127|65362|P3|STARTED|Overall Study||32
29840|NCT01778127|65363|P2|STARTED|Overall Study||33
29841|NCT01778127|65364|P1|STARTED|Overall Study||33
29842|NCT01778062|65407|P2|NOT COMPLETED|Overall Study||11
29843|NCT01778062|65408|P1|NOT COMPLETED|Overall Study||6
29844|NCT01778062|65407|P2|COMPLETED|Overall Study||57
29845|NCT01778062|65408|P1|COMPLETED|Overall Study||62
29846|NCT01778062|65407|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
29847|NCT01778062|65408|P1|Intent to Treat (ITT)|Overall Study||68
29848|NCT01778062|65407|P2|Safety Set|Overall Study||68
29849|NCT01778062|65408|P1|Safety Set|Overall Study||68
29850|NCT01778062|65407|P2|STARTED|Overall Study||68
29851|NCT01778062|65408|P1|STARTED|Overall Study||68
29852|NCT01778049|65422|P6|NOT COMPLETED|Double Blind Treatment Period||7
29853|NCT01778049|65423|P5|NOT COMPLETED|Double Blind Treatment Period||12
29854|NCT01778049|65424|P4|NOT COMPLETED|Double Blind Treatment Period||12
29855|NCT01778049|65425|P3|NOT COMPLETED|Double Blind Treatment Period||15
29856|NCT01778049|65426|P2|NOT COMPLETED|Double Blind Treatment Period||0
29857|NCT01778049|65427|P1|NOT COMPLETED|Double Blind Treatment Period||0
29858|NCT01778049|65422|P6|COMPLETED|Double Blind Treatment Period||105
29859|NCT01778049|65423|P5|COMPLETED|Double Blind Treatment Period||102
29860|NCT01778049|65424|P4|COMPLETED|Double Blind Treatment Period||118
29861|NCT01778049|65425|P3|COMPLETED|Double Blind Treatment Period||111
29862|NCT01778049|65426|P2|COMPLETED|Double Blind Treatment Period||0
29863|NCT01778049|65427|P1|COMPLETED|Double Blind Treatment Period||0
29864|NCT01778049|65422|P6|STARTED|Double Blind Treatment Period||112
29865|NCT01778049|65423|P5|STARTED|Double Blind Treatment Period||114
29866|NCT01778049|65424|P4|STARTED|Double Blind Treatment Period||130
29867|NCT01778049|65425|P3|STARTED|Double Blind Treatment Period||126
29868|NCT01778049|65426|P2|STARTED|Double Blind Treatment Period||0
29869|NCT01778049|65427|P1|STARTED|Double Blind Treatment Period||0
29870|NCT01778049|65422|P6|NOT COMPLETED|Open Label Treatment Period||0
29871|NCT01778049|65423|P5|NOT COMPLETED|Open Label Treatment Period||0
29872|NCT01778049|65424|P4|NOT COMPLETED|Open Label Treatment Period||0
29873|NCT01778049|65425|P3|NOT COMPLETED|Open Label Treatment Period||0
29874|NCT01778049|65426|P2|NOT COMPLETED|Open Label Treatment Period||129
29875|NCT01778049|65427|P1|NOT COMPLETED|Open Label Treatment Period||98
29876|NCT01778049|65422|P6|COMPLETED|Open Label Treatment Period||0
29877|NCT01778049|65423|P5|COMPLETED|Open Label Treatment Period||0
29878|NCT01778049|65424|P4|COMPLETED|Open Label Treatment Period||0
29879|NCT01778049|65425|P3|COMPLETED|Open Label Treatment Period||0
29880|NCT01778049|65426|P2|COMPLETED|Open Label Treatment Period||226
29881|NCT01778049|65427|P1|COMPLETED|Open Label Treatment Period||256
29882|NCT01778049|65422|P6|STARTED|Open Label Treatment Period||0
29883|NCT01778049|65423|P5|STARTED|Open Label Treatment Period||0
29884|NCT01778049|65424|P4|STARTED|Open Label Treatment Period||0
29885|NCT01778049|65425|P3|STARTED|Open Label Treatment Period||0
29886|NCT01778049|65426|P2|STARTED|Open Label Treatment Period||355
29887|NCT01778049|65427|P1|STARTED|Open Label Treatment Period||354
29888|NCT01778023|65445|P2|NOT COMPLETED|Overall Study||3
29889|NCT01778023|65446|P1|NOT COMPLETED|Overall Study||0
29890|NCT01778023|65445|P2|COMPLETED|Overall Study||15
29891|NCT01778023|65446|P1|COMPLETED|Overall Study||36
29892|NCT01778023|65445|P2|Exposed|Overall Study||15
29893|NCT01778023|65446|P1|Exposed|Overall Study||36
29894|NCT01778023|65445|P2|STARTED|Overall Study||18
29895|NCT01778023|65446|P1|STARTED|Overall Study||36
29896|NCT01777945|65463|P1|NOT COMPLETED|Overall Study||0
29897|NCT01777945|65463|P1|COMPLETED|Overall Study||46
29898|NCT01777945|65463|P1|Evaluable Participants|Overall Study||45
29899|NCT01777945|65463|P1|STARTED|Overall Study||46
29900|NCT01777932|65473|P1|NOT COMPLETED|Overall Study||205
29901|NCT01777932|65473|P1|COMPLETED|Overall Study||15
29902|NCT01777932|65473|P1|STARTED|Overall Study||220
29903|NCT01777776|65491|P4|NOT COMPLETED|Overall Study||4
29904|NCT01777776|65492|P3|NOT COMPLETED|Overall Study||6
29905|NCT01777776|65493|P2|NOT COMPLETED|Overall Study||12
29906|NCT01777776|65494|P1|NOT COMPLETED|Overall Study||6
29907|NCT01777776|65491|P4|COMPLETED|Overall Study||0
29908|NCT01777776|65492|P3|COMPLETED|Overall Study||0
29909|NCT01777776|65493|P2|COMPLETED|Overall Study||0
29910|NCT01777776|65494|P1|COMPLETED|Overall Study||0
29911|NCT01777776|65491|P4|STARTED|Overall Study||4
29912|NCT01777776|65492|P3|STARTED|Overall Study||6
29913|NCT01777776|65493|P2|STARTED|Overall Study||12
29914|NCT01777776|65494|P1|STARTED|Overall Study||6
29915|NCT01777763|65553|P2|NOT COMPLETED|Overall Study||47
29916|NCT01777763|65554|P1|NOT COMPLETED|Overall Study||4
29917|NCT01777763|65553|P2|COMPLETED|Overall Study||163
29918|NCT01777763|65554|P1|COMPLETED|Overall Study||16
29919|NCT01777763|65553|P2|STARTED|Overall Study||210
29920|NCT01777763|65554|P1|STARTED|Overall Study||20
29921|NCT01777620|65578|P2|NOT COMPLETED|Overall Study||0
29922|NCT01777620|65579|P1|NOT COMPLETED|Overall Study||1
29923|NCT01777620|65578|P2|COMPLETED|Overall Study||62
29924|NCT01777620|65579|P1|COMPLETED|Overall Study||62
29925|NCT01777620|65578|P2|STARTED|Overall Study||62
29926|NCT01777620|65579|P1|STARTED|Overall Study||63
29927|NCT01777581|65605|P2|NOT COMPLETED|Overall Study||2
29928|NCT01777581|65606|P1|NOT COMPLETED|Overall Study||3
29929|NCT01777581|65605|P2|COMPLETED|Overall Study||3
29930|NCT01777581|65606|P1|COMPLETED|Overall Study||5
29931|NCT01777581|65605|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
29932|NCT01777581|65606|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
29933|NCT01777438|65626|P2|NOT COMPLETED|Overall Study||0
29934|NCT01777438|65627|P1|NOT COMPLETED|Overall Study||0
29935|NCT01777438|65626|P2|COMPLETED|Overall Study||82
29936|NCT01777438|65627|P1|COMPLETED|Overall Study||352
29937|NCT01777438|65626|P2|STARTED|Overall Study||82
29938|NCT01777438|65627|P1|STARTED|Overall Study||352
29939|NCT01777425|65639|P1|NOT COMPLETED|Overall Study||0
29940|NCT01777425|65639|P1|COMPLETED|Overall Study||389
29941|NCT01777425|65639|P1|STARTED|Overall Study||389
29942|NCT01777412|65645|P1|NOT COMPLETED|Overall Study||0
29943|NCT01777412|65645|P1|COMPLETED|Overall Study||10
29944|NCT01777412|65645|P1|STARTED|Overall Study||10
29945|NCT01777334|65653|P2|NOT COMPLETED|Overall Study||63
29946|NCT01777334|65654|P1|NOT COMPLETED|Overall Study||53
29947|NCT01777334|65653|P2|COMPLETED|Overall Study||388
29948|NCT01777334|65654|P1|COMPLETED|Overall Study||401
29949|NCT01777334|65653|P2|STARTED|Overall Study||451
29950|NCT01777334|65654|P1|STARTED|Overall Study||454
29951|NCT01777321|65664|P2|NOT COMPLETED|Overall Study||1
29952|NCT01777321|65665|P1|NOT COMPLETED|Overall Study||0
29953|NCT01777321|65664|P2|COMPLETED|Overall Study||29
29954|NCT01777321|65665|P1|COMPLETED|Overall Study||30
29955|NCT01777321|65664|P2|STARTED|Overall Study||30
29956|NCT01777321|65665|P1|STARTED|Overall Study||30
29957|NCT01777282|65706|P5|NOT COMPLETED|Overall Study||7
29958|NCT01777282|65707|P4|NOT COMPLETED|Overall Study||2
29959|NCT01777282|65708|P3|NOT COMPLETED|Overall Study||6
29960|NCT01777282|65709|P2|NOT COMPLETED|Overall Study||4
29961|NCT01777282|65710|P1|NOT COMPLETED|Overall Study||11
29962|NCT01777282|65706|P5|COMPLETED|Overall Study||54
29963|NCT01777282|65707|P4|COMPLETED|Overall Study||59
29964|NCT01777282|65708|P3|COMPLETED|Overall Study||59
29965|NCT01777282|65709|P2|COMPLETED|Overall Study||63
29966|NCT01777282|65710|P1|COMPLETED|Overall Study||109
29967|NCT01777282|65706|P5|Completing Follow-up Period|Overall Study||54
29968|NCT01777282|65707|P4|Completing Follow-up Period|Overall Study||59
29969|NCT01777282|65708|P3|Completing Follow-up Period|Overall Study||59
29970|NCT01777282|65709|P2|Completing Follow-up Period|Overall Study||63
29971|NCT01777282|65710|P1|Completing Follow-up Period|Overall Study||109
29972|NCT01777282|65706|P5|Completing Treatment Period|Overall Study||54
29973|NCT01777282|65707|P4|Completing Treatment Period|Overall Study||59
29974|NCT01777282|65708|P3|Completing Treatment Period|Overall Study||59
29975|NCT01777282|65709|P2|Completing Treatment Period|Overall Study||63
29976|NCT01777282|65710|P1|Completing Treatment Period|Overall Study||109
29977|NCT01777282|65706|P5|STARTED|Overall Study||61
29978|NCT01777282|65707|P4|STARTED|Overall Study||61
29979|NCT01777282|65708|P3|STARTED|Overall Study||65
29980|NCT01777282|65709|P2|STARTED|Overall Study||67
29981|NCT01777282|65710|P1|STARTED|Overall Study||120
29982|NCT01777217|65754|P2|NOT COMPLETED|Overall Study||0
29983|NCT01777217|65755|P1|NOT COMPLETED|Overall Study||0
29984|NCT01777217|65754|P2|COMPLETED|Overall Study||4
29985|NCT01777217|65755|P1|COMPLETED|Overall Study||4
29986|NCT01777217|65754|P2|STARTED|Overall Study||4
29987|NCT01777217|65755|P1|STARTED|Overall Study||4
29988|NCT01777191|65763|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
29989|NCT01777191|65764|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
29990|NCT01777191|65763|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
29991|NCT01777191|65764|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
29992|NCT01777191|65763|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
29993|NCT01777191|65764|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
29994|NCT01777191|65763|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
29995|NCT01777191|65764|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
29996|NCT01777191|65763|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
29997|NCT01777191|65764|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
29998|NCT01777191|65763|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
29999|NCT01777191|65764|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
30000|NCT01777126|65794|P2|NOT COMPLETED|Overall Study||0
30001|NCT01777126|65795|P1|NOT COMPLETED|Overall Study||0
30002|NCT01777126|65794|P2|COMPLETED|Overall Study||46
30003|NCT01777126|65795|P1|COMPLETED|Overall Study||48
30004|NCT01777126|65794|P2|STARTED|Overall Study||46
30005|NCT01777126|65795|P1|STARTED|Overall Study||48
30006|NCT01776645|65818|P2|NOT COMPLETED|Overall Study||14
30007|NCT01776645|65819|P1|NOT COMPLETED|Overall Study||14
30008|NCT01776645|65818|P2|COMPLETED|Overall Study||14
30009|NCT01776645|65819|P1|COMPLETED|Overall Study||14
30010|NCT01776645|65818|P2|STARTED|Overall Study||28
30011|NCT01776645|65819|P1|STARTED|Overall Study||28
30012|NCT01776554|65827|P2|NOT COMPLETED|Overall Study||23
30013|NCT01776554|65828|P1|NOT COMPLETED|Overall Study||17
30014|NCT01776554|65827|P2|COMPLETED|Overall Study||307
30015|NCT01776554|65828|P1|COMPLETED|Overall Study||315
30016|NCT01776554|65827|P2|STARTED|Overall Study||330
30017|NCT01776554|65828|P1|STARTED|Overall Study||332
30018|NCT01776541|65871|P2|NOT COMPLETED|Overall Study||75
30019|NCT01776541|65872|P1|NOT COMPLETED|Overall Study||56
30020|NCT01776541|65871|P2|COMPLETED|Overall Study||416
30021|NCT01776541|65872|P1|COMPLETED|Overall Study||432
30022|NCT01776541|65871|P2|STARTED|Overall Study||491
30023|NCT01776541|65872|P1|STARTED|Overall Study||488
30024|NCT01775995|65893|P2|NOT COMPLETED|Overall Study||1
30025|NCT01775995|65894|P1|NOT COMPLETED|Overall Study||1
30026|NCT01775995|65893|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
30027|NCT01775995|65894|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
30028|NCT01775995|65893|P2|STARTED|Overall Study||14
30029|NCT01775995|65894|P1|STARTED|Overall Study||21
30030|NCT01775852|65956|P2|NOT COMPLETED|Overall Study||1
30031|NCT01775852|65957|P1|NOT COMPLETED|Overall Study||0
30032|NCT01775852|65956|P2|COMPLETED|Overall Study||13
30033|NCT01775852|65957|P1|COMPLETED|Overall Study||31
30034|NCT01775852|65956|P2|STARTED|Overall Study||14
30035|NCT01775852|65957|P1|STARTED|Overall Study||31
30036|NCT01775137|65969|P1|NOT COMPLETED|Overall Study||11
30037|NCT01775137|65969|P1|COMPLETED|Overall Study||34
30038|NCT01775137|65969|P1|STARTED|Overall Study||45
30039|NCT01774968|65996|P2|NOT COMPLETED|Overall Study||35
30040|NCT01774968|65997|P1|NOT COMPLETED|Overall Study||30
30041|NCT01774968|65996|P2|COMPLETED|Overall Study||128
30042|NCT01774968|65997|P1|COMPLETED|Overall Study||132
30043|NCT01774968|65996|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
30044|NCT01774968|65997|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
30045|NCT01774968|65996|P2|STARTED|Overall Study||163
30046|NCT01774968|65997|P1|STARTED|Overall Study||162
30047|NCT01774929|66031|P1|NOT COMPLETED|Overall Study||3
30048|NCT01774929|66031|P1|COMPLETED|Overall Study||32
30049|NCT01774929|66031|P1|STARTED|Overall Study||35
30050|NCT01774903|66037|P1|NOT COMPLETED|Overall Study||11
30051|NCT01774903|66037|P1|COMPLETED|Overall Study||34
30052|NCT01774903|66037|P1|STARTED|Overall Study||45
30053|NCT01774604|66046|P2|NOT COMPLETED|Overall Study||0
30054|NCT01774604|66047|P1|NOT COMPLETED|Overall Study||0
30055|NCT01774604|66046|P2|COMPLETED|Overall Study||226
30056|NCT01774604|66047|P1|COMPLETED|Overall Study||223
30057|NCT01774604|66046|P2|STARTED|Overall Study||226
30058|NCT01774604|66047|P1|STARTED|Overall Study||223
30059|NCT01774305|66067|P2|NOT COMPLETED|Overall Study||0
30060|NCT01774305|66068|P1|NOT COMPLETED|Overall Study||1
30061|NCT01774305|66067|P2|COMPLETED|Overall Study||71
30062|NCT01774305|66068|P1|COMPLETED|Overall Study||70
30063|NCT01774305|66067|P2|STARTED|Overall Study||71
30064|NCT01774305|66068|P1|STARTED|Overall Study||71
30065|NCT01774253|66076|P1|NOT COMPLETED|Overall Study||9
30066|NCT01774253|66076|P1|COMPLETED|Overall Study||0
30067|NCT01774253|66076|P1|STARTED|Overall Study||9
30068|NCT01774149|66086|P2|NOT COMPLETED|Overall Study||3
30069|NCT01774149|66087|P1|NOT COMPLETED|Overall Study||1
30070|NCT01774149|66086|P2|COMPLETED|Overall Study||12
30071|NCT01774149|66087|P1|COMPLETED|Overall Study||14
30072|NCT01774149|66086|P2|STARTED|Overall Study||15
30073|NCT01774149|66087|P1|STARTED|Overall Study||15
30074|NCT01774110|66095|P1|NOT COMPLETED|Overall Study||7
30075|NCT01774110|66095|P1|COMPLETED|Overall Study||5
30076|NCT01774110|66095|P1|STARTED|Overall Study||12
30077|NCT01774084|66103|P2|NOT COMPLETED|Overall Study||0
30078|NCT01774084|66104|P1|NOT COMPLETED|Overall Study||1
30079|NCT01774084|66103|P2|COMPLETED|Overall Study||12
30080|NCT01774084|66104|P1|COMPLETED|Overall Study||10
30081|NCT01774084|66103|P2|STARTED|Overall Study||12
30082|NCT01774084|66104|P1|STARTED|Overall Study||11
30083|NCT01774045|66114|P2|NOT COMPLETED|Overall Study||0
30084|NCT01774045|66115|P1|NOT COMPLETED|Overall Study||0
30085|NCT01774045|66114|P2|COMPLETED|Overall Study||7
30086|NCT01774045|66115|P1|COMPLETED|Overall Study||23
30087|NCT01774045|66114|P2|STARTED|Overall Study||7
30088|NCT01774045|66115|P1|STARTED|Overall Study||23
30089|NCT01773135|66131|P1|NOT COMPLETED|Overall Study||0
30090|NCT01773135|66131|P1|COMPLETED|Overall Study||262
30091|NCT01773135|66131|P1|STARTED|Overall Study||262
30092|NCT01773122|66140|P4|NOT COMPLETED|Overall Study||1
30093|NCT01773122|66141|P3|NOT COMPLETED|Overall Study||0
30094|NCT01773122|66142|P2|NOT COMPLETED|Overall Study||1
30095|NCT01773122|66143|P1|NOT COMPLETED|Overall Study||3
30096|NCT01773122|66140|P4|COMPLETED|Overall Study||18
30097|NCT01773122|66141|P3|COMPLETED|Overall Study||19
30098|NCT01773122|66142|P2|COMPLETED|Overall Study||18
30099|NCT01773122|66143|P1|COMPLETED|Overall Study||17
30100|NCT01773122|66140|P4|STARTED|Overall Study||19
30101|NCT01773122|66141|P3|STARTED|Overall Study||19
30102|NCT01773122|66142|P2|STARTED|Overall Study||19
30103|NCT01773122|66143|P1|STARTED|Overall Study||20
30104|NCT01773889|66157|P1|NOT COMPLETED|Overall Study||2
30105|NCT01773889|66157|P1|COMPLETED|Overall Study||0
30106|NCT01773889|66157|P1|STARTED|Overall Study||2
30107|NCT01773473|66163|P2|NOT COMPLETED|Overall Study||19
30108|NCT01773473|66164|P1|NOT COMPLETED|Overall Study||16
30109|NCT01773473|66163|P2|COMPLETED|Overall Study||177
30110|NCT01773473|66164|P1|COMPLETED|Overall Study||191
30111|NCT01773473|66163|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
30112|NCT01773473|66164|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
30113|NCT01773473|66163|P2|STARTED|Overall Study||196
30114|NCT01773473|66164|P1|STARTED|Overall Study||207
30115|NCT01773291|66185|P3|NOT COMPLETED|Overall Study||1
30116|NCT01773291|66186|P2|NOT COMPLETED|Overall Study||0
30117|NCT01773291|66187|P1|NOT COMPLETED|Overall Study||1
30118|NCT01773291|66185|P3|COMPLETED|Overall Study||6
30119|NCT01773291|66186|P2|COMPLETED|Overall Study||9
30120|NCT01773291|66187|P1|COMPLETED|Overall Study||7
30121|NCT01773291|66185|P3|STARTED|Overall Study||7
30122|NCT01773291|66186|P2|STARTED|Overall Study||9
30123|NCT01773291|66187|P1|STARTED|Overall Study||8
30124|NCT01773226|66198|P1|NOT COMPLETED|Overall Study||1
30125|NCT01773226|66198|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
30126|NCT01773226|66198|P1|STARTED|Overall Study||11
30127|NCT01772654|66208|P2|NOT COMPLETED|Overall Study||0
30128|NCT01772654|66209|P1|NOT COMPLETED|Overall Study||0
30129|NCT01772654|66208|P2|COMPLETED|Overall Study||15
30130|NCT01772654|66209|P1|COMPLETED|Overall Study||2
30131|NCT01772654|66208|P2|STARTED|Overall Study||15
30132|NCT01772654|66209|P1|STARTED|Overall Study||2
30133|NCT01772550|66218|P3|NOT COMPLETED|Overall Study||6
30134|NCT01772550|66219|P2|NOT COMPLETED|Overall Study||1
30135|NCT01772550|66220|P1|NOT COMPLETED|Overall Study||1
30136|NCT01772550|66218|P3|COMPLETED|Overall Study||27
30137|NCT01772550|66219|P2|COMPLETED|Overall Study||102
30138|NCT01772550|66220|P1|COMPLETED|Overall Study||101
30139|NCT01772550|66218|P3|CT Cardiac|Overall Study||1
30140|NCT01772550|66219|P2|CT Cardiac|Overall Study||7
30141|NCT01772550|66220|P1|CT Cardiac|Overall Study||7
30142|NCT01772550|66218|P3|CT Kidney|Overall Study||6
30143|NCT01772550|66219|P2|CT Kidney|Overall Study||19
30144|NCT01772550|66220|P1|CT Kidney|Overall Study||12
30145|NCT01772550|66218|P3|CT Liver|Overall Study||8
30146|NCT01772550|66219|P2|CT Liver|Overall Study||14
30147|NCT01772550|66220|P1|CT Liver|Overall Study||18
30148|NCT01772550|66218|P3|CT Angiogram|Overall Study||4
30149|NCT01772550|66219|P2|CT Angiogram|Overall Study||25
30150|NCT01772550|66220|P1|CT Angiogram|Overall Study||24
30151|NCT01772550|66218|P3|CT Pancreas|Overall Study||8
30152|NCT01772550|66219|P2|CT Pancreas|Overall Study||36
30153|NCT01772550|66220|P1|CT Pancreas|Overall Study||40
30154|NCT01772550|66218|P3|STARTED|Overall Study||33
30155|NCT01772550|66219|P2|STARTED|Overall Study||103
30156|NCT01772550|66220|P1|STARTED|Overall Study||102
30157|NCT01772316|66258|P1|NOT COMPLETED|Overall Study||7
30158|NCT01772316|66258|P1|COMPLETED|Overall Study||40
30159|NCT01772316|66258|P1|STARTED|Overall Study||47
30160|NCT01772147|66279|P3|NOT COMPLETED|Overall Study||18
30161|NCT01772147|66280|P2|NOT COMPLETED|Overall Study||25
30162|NCT01772147|66281|P1|NOT COMPLETED|Overall Study||31
30163|NCT01772147|66279|P3|COMPLETED|Overall Study||184
30164|NCT01772147|66280|P2|COMPLETED|Overall Study||178
30165|NCT01772147|66281|P1|COMPLETED|Overall Study||170
30166|NCT01772147|66279|P3|STARTED|Overall Study||202
30167|NCT01772147|66280|P2|STARTED|Overall Study||203
30168|NCT01772147|66281|P1|STARTED|Overall Study||201
30169|NCT01772134|66301|P3|NOT COMPLETED|Overall Study||22
30170|NCT01772134|66302|P2|NOT COMPLETED|Overall Study||14
30171|NCT01772134|66303|P1|NOT COMPLETED|Overall Study||29
30172|NCT01772134|66301|P3|COMPLETED|Overall Study||184
30173|NCT01772134|66302|P2|COMPLETED|Overall Study||190
30174|NCT01772134|66303|P1|COMPLETED|Overall Study||178
30175|NCT01772134|66301|P3|Received Randomized Study Medication|Overall Study||205
30176|NCT01772134|66302|P2|Received Randomized Study Medication|Overall Study||204
30177|NCT01772134|66303|P1|Received Randomized Study Medication|Overall Study||205
30178|NCT01772134|66301|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
30179|NCT01772134|66302|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
30180|NCT01772134|66303|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
30181|NCT01771991|66322|P2|NOT COMPLETED|Overall Study||27
30182|NCT01771991|66323|P1|NOT COMPLETED|Overall Study||30
30183|NCT01771991|66322|P2|COMPLETED|Overall Study||9
30184|NCT01771991|66323|P1|COMPLETED|Overall Study||8
30185|NCT01771991|66322|P2|Completed Treatment|Overall Study||30
30186|NCT01771991|66323|P1|Completed Treatment|Overall Study||30
30187|NCT01771991|66322|P2|Started Treatment|Overall Study||34
30188|NCT01771991|66323|P1|Started Treatment|Overall Study||37
30189|NCT01771991|66322|P2|STARTED|Overall Study||36
30190|NCT01771991|66323|P1|STARTED|Overall Study||38
30191|NCT01771913|66331|P2|NOT COMPLETED|Overall Study||0
30192|NCT01771913|66332|P1|NOT COMPLETED|Overall Study||1
30193|NCT01771913|66331|P2|COMPLETED|Overall Study||11
30194|NCT01771913|66332|P1|COMPLETED|Overall Study||8
30195|NCT01771913|66331|P2|STARTED|Overall Study||11
30196|NCT01771913|66332|P1|STARTED|Overall Study||9
30197|NCT01771172|66342|P1|NOT COMPLETED|Overall Study||2
30198|NCT01771172|66342|P1|COMPLETED|Overall Study||46
30199|NCT01771172|66342|P1|STARTED|Overall Study||48
30200|NCT01770860|66346|P1|NOT COMPLETED|Overall Study||6
30201|NCT01770860|66346|P1|COMPLETED|Overall Study||40
30202|NCT01770860|66346|P1|Randomization|Overall Study|One participant withdrew before randomization|45
30203|NCT01770860|66346|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
30204|NCT01770743|66394|P5|NOT COMPLETED|Overall Study||2
30205|NCT01770743|66395|P4|NOT COMPLETED|Overall Study||2
30206|NCT01770743|66396|P3|NOT COMPLETED|Overall Study||1
30207|NCT01770743|66397|P2|NOT COMPLETED|Overall Study||3
30208|NCT01770743|66398|P1|NOT COMPLETED|Overall Study||2
30209|NCT01770743|66394|P5|COMPLETED|Overall Study||21
30210|NCT01770743|66395|P4|COMPLETED|Overall Study||42
30211|NCT01770743|66396|P3|COMPLETED|Overall Study||22
30212|NCT01770743|66397|P2|COMPLETED|Overall Study||31
30213|NCT01770743|66398|P1|COMPLETED|Overall Study||42
30214|NCT01770743|66394|P5|Treated|Overall Study||23
30215|NCT01770743|66395|P4|Treated|Overall Study||44
30216|NCT01770743|66396|P3|Treated|Overall Study||23
30217|NCT01770743|66397|P2|Treated|Overall Study||34
30218|NCT01770743|66398|P1|Treated|Overall Study||44
30219|NCT01770743|66394|P5|STARTED|Overall Study||23
30220|NCT01770743|66395|P4|STARTED|Overall Study||44
30221|NCT01770743|66396|P3|STARTED|Overall Study||23
30222|NCT01770743|66397|P2|STARTED|Overall Study||34
30223|NCT01770743|66398|P1|STARTED|Overall Study||44
30224|NCT01770691|66450|P1|NOT COMPLETED|Overall Study||0
30225|NCT01770691|66450|P1|COMPLETED|Overall Study||7
30226|NCT01770691|66450|P1|STARTED|Overall Study||7
30227|NCT01770652|66461|P4|NOT COMPLETED|Overall Study||0
30228|NCT01770652|66462|P3|NOT COMPLETED|Overall Study||0
30229|NCT01770652|66463|P2|NOT COMPLETED|Overall Study||0
30230|NCT01770652|66464|P1|NOT COMPLETED|Overall Study||0
30231|NCT01770652|66461|P4|COMPLETED|Overall Study||8
30232|NCT01770652|66462|P3|COMPLETED|Overall Study||8
30233|NCT01770652|66463|P2|COMPLETED|Overall Study||8
30234|NCT01770652|66464|P1|COMPLETED|Overall Study||8
30235|NCT01770652|66461|P4|STARTED|Overall Study||8
30236|NCT01770652|66462|P3|STARTED|Overall Study||8
30237|NCT01770652|66463|P2|STARTED|Overall Study||8
30238|NCT01770652|66464|P1|STARTED|Overall Study||8
30239|NCT01770509|66500|P2|NOT COMPLETED|Overall Study||3
30240|NCT01770509|66501|P1|NOT COMPLETED|Overall Study||1
30241|NCT01770509|66500|P2|COMPLETED|Overall Study||14
30242|NCT01770509|66501|P1|COMPLETED|Overall Study||11
30243|NCT01770509|66500|P2|STARTED|Overall Study||17
30244|NCT01770509|66501|P1|STARTED|Overall Study||12
30245|NCT01770483|66517|P2|NOT COMPLETED|Overall Study||0
30246|NCT01770483|66518|P1|NOT COMPLETED|Overall Study||0
30247|NCT01770483|66517|P2|COMPLETED|Overall Study||33
30248|NCT01770483|66518|P1|COMPLETED|Overall Study||33
30249|NCT01770483|66517|P2|STARTED|Overall Study||33
30250|NCT01770483|66518|P1|STARTED|Overall Study||33
30251|NCT01770392|66526|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
30252|NCT01770392|66526|P1|COMPLETED|Nintedanib+ Rifampicin||25
30253|NCT01770392|66526|P1|STARTED|Nintedanib+ Rifampicin||25
30254|NCT01770392|66526|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
30255|NCT01770392|66526|P1|COMPLETED|Washout Period of at Least 14 Days||25
30256|NCT01770392|66526|P1|STARTED|Washout Period of at Least 14 Days||26
30257|NCT01770392|66526|P1|NOT COMPLETED|Nintedanib||0
30258|NCT01770392|66526|P1|COMPLETED|Nintedanib||26
30259|NCT01770392|66526|P1|STARTED|Nintedanib||26
30260|NCT01770379|66541|P3|NOT COMPLETED|Overall Study||42
30261|NCT01770379|66542|P2|NOT COMPLETED|Overall Study||44
30262|NCT01770379|66543|P1|NOT COMPLETED|Overall Study||39
30263|NCT01770379|66541|P3|COMPLETED|Overall Study||39
30264|NCT01770379|66542|P2|COMPLETED|Overall Study||37
30265|NCT01770379|66543|P1|COMPLETED|Overall Study||41
30266|NCT01770379|66541|P3|STARTED|Overall Study||81
30267|NCT01770379|66542|P2|STARTED|Overall Study||81
30268|NCT01770379|66543|P1|STARTED|Overall Study||80
30269|NCT01770366|66562|P2|NOT COMPLETED|Overall Study||2
30270|NCT01770366|66563|P1|NOT COMPLETED|Overall Study||2
30271|NCT01770366|66562|P2|COMPLETED|Overall Study||4
30272|NCT01770366|66563|P1|COMPLETED|Overall Study||2
30273|NCT01770366|66562|P2|STARTED|Overall Study||6
30274|NCT01770366|66563|P1|STARTED|Overall Study||4
30275|NCT01770314|66571|P2|NOT COMPLETED|Overall Study||0
30276|NCT01770314|66572|P1|NOT COMPLETED|Overall Study||0
30277|NCT01770314|66571|P2|COMPLETED|Overall Study||90
30278|NCT01770314|66572|P1|COMPLETED|Overall Study||86
30279|NCT01770314|66571|P2|Contributed Data to One-month Follow-up|Overall Study||66
30280|NCT01770314|66572|P1|Contributed Data to One-month Follow-up|Overall Study||61
30281|NCT01770314|66571|P2|Contributed Data to Post-test|Overall Study||67
30282|NCT01770314|66572|P1|Contributed Data to Post-test|Overall Study||65
30283|NCT01770314|66571|P2|Contributed Data to Baseline|Overall Study||72
30284|NCT01770314|66572|P1|Contributed Data to Baseline|Overall Study||68
30285|NCT01770314|66571|P2|STARTED|Overall Study||90
30286|NCT01770314|66572|P1|STARTED|Overall Study||86
30287|NCT01770145|66580|P1|NOT COMPLETED|Treatment||4
30288|NCT01770145|66580|P1|COMPLETED|Treatment||97
30289|NCT01770145|66580|P1|STARTED|Treatment||101
30290|NCT01770145|66580|P1|NOT COMPLETED|Baseline||26
30291|NCT01770145|66580|P1|COMPLETED|Baseline||101
30292|NCT01770145|66580|P1|STARTED|Baseline||127
30293|NCT01769586|66587|P2|NOT COMPLETED|Overall Study||0
30294|NCT01769586|66588|P1|NOT COMPLETED|Overall Study||0
30295|NCT01769586|66587|P2|COMPLETED|Overall Study||100
30296|NCT01769586|66588|P1|COMPLETED|Overall Study||100
30297|NCT01769586|66587|P2|STARTED|Overall Study||100
30298|NCT01769586|66588|P1|STARTED|Overall Study||100
30299|NCT01769508|66594|P1|NOT COMPLETED|Overall Study||6
30300|NCT01769508|66594|P1|COMPLETED|Overall Study||6
30301|NCT01769508|66594|P1|STARTED|Overall Study||12
30302|NCT01769443|66605|P2|NOT COMPLETED|Overall Study||0
30303|NCT01769443|66606|P1|NOT COMPLETED|Overall Study||1
30304|NCT01769443|66605|P2|COMPLETED|Overall Study||1
30305|NCT01769443|66606|P1|COMPLETED|Overall Study||0
30306|NCT01769443|66605|P2|STARTED|Overall Study||1
30307|NCT01769443|66606|P1|STARTED|Overall Study||1
30308|NCT01769391|66650|P2|NOT COMPLETED|Overall Study||9
30309|NCT01769391|66651|P1|NOT COMPLETED|Overall Study||20
30310|NCT01769391|66650|P2|COMPLETED|Overall Study||48
30311|NCT01769391|66651|P1|COMPLETED|Overall Study||90
30312|NCT01769391|66650|P2|Received at Least One Dose of Study Drug|Overall Study||55
30313|NCT01769391|66651|P1|Received at Least One Dose of Study Drug|Overall Study||106
30314|NCT01769391|66650|P2|STARTED|Overall Study||57
30315|NCT01769391|66651|P1|STARTED|Overall Study||110
30316|NCT01769378|66670|P2|NOT COMPLETED|Overall Study||4
30317|NCT01769378|66671|P1|NOT COMPLETED|Overall Study||25
30318|NCT01769378|66670|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
30319|NCT01769378|66671|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
30320|NCT01769378|66670|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
30321|NCT01769378|66671|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
30322|NCT01769378|66670|P2|STARTED|Overall Study||60
30323|NCT01769378|66671|P1|STARTED|Overall Study||240
30324|NCT01769365|66709|P3|NOT COMPLETED|Overall Study||2
30325|NCT01769365|66710|P2|NOT COMPLETED|Overall Study||2
30326|NCT01769365|66711|P1|NOT COMPLETED|Overall Study||0
30327|NCT01769365|66709|P3|COMPLETED|Overall Study||101
30328|NCT01769365|66710|P2|COMPLETED|Overall Study||100
30329|NCT01769365|66711|P1|COMPLETED|Overall Study||102
30330|NCT01769365|66709|P3|STARTED|Overall Study||103
30331|NCT01769365|66710|P2|STARTED|Overall Study||102
30332|NCT01769365|66711|P1|STARTED|Overall Study||102
30333|NCT01769339|66719|P1|NOT COMPLETED|Overall Study||43
30334|NCT01769339|66719|P1|COMPLETED|Overall Study||72
30335|NCT01769339|66719|P1|STARTED|Overall Study||115
30336|NCT01769248|66728|P2|NOT COMPLETED|Overall Study||0
30337|NCT01769248|66729|P1|NOT COMPLETED|Overall Study||0
30338|NCT01769248|66728|P2|COMPLETED|Overall Study||70
30339|NCT01769248|66729|P1|COMPLETED|Overall Study||70
30340|NCT01769248|66728|P2|STARTED|Overall Study||70
30341|NCT01769248|66729|P1|STARTED|Overall Study||70
30342|NCT01769105|66737|P2|NOT COMPLETED|Cross-over||0
30343|NCT01769105|66738|P1|NOT COMPLETED|Cross-over||5
30344|NCT01769105|66737|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
30345|NCT01769105|66738|P1|COMPLETED|Cross-over||9
30346|NCT01769105|66737|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
30347|NCT01769105|66738|P1|STARTED|Cross-over||14
30348|NCT01769105|66737|P2|NOT COMPLETED|First Intervention||2
30349|NCT01769105|66738|P1|NOT COMPLETED|First Intervention||2
30350|NCT01769105|66737|P2|COMPLETED|First Intervention||17
30351|NCT01769105|66738|P1|COMPLETED|First Intervention||14
30352|NCT01769105|66737|P2|STARTED|First Intervention||19
30353|NCT01769105|66738|P1|STARTED|First Intervention||16
30354|NCT01768676|66759|P2|NOT COMPLETED|Overall Study||31
30355|NCT01768676|66760|P1|NOT COMPLETED|Overall Study||24
30356|NCT01768676|66759|P2|COMPLETED|Overall Study||60
30357|NCT01768676|66760|P1|COMPLETED|Overall Study||66
30358|NCT01768676|66759|P2|STARTED|Overall Study||91
30359|NCT01768676|66760|P1|STARTED|Overall Study||90
30360|NCT01768559|66777|P3|NOT COMPLETED|Overall Study||13
30361|NCT01768559|66778|P2|NOT COMPLETED|Overall Study||17
30362|NCT01768559|66779|P1|NOT COMPLETED|Overall Study||30
30363|NCT01768559|66777|P3|COMPLETED|Overall Study||285
30364|NCT01768559|66778|P2|COMPLETED|Overall Study||281
30365|NCT01768559|66779|P1|COMPLETED|Overall Study||268
30366|NCT01768559|66777|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
30367|NCT01768559|66778|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
30368|NCT01768559|66779|P1|Treated|Overall Study||298
30369|NCT01768559|66777|P3|STARTED|Overall Study||298
30370|NCT01768559|66778|P2|STARTED|Overall Study||298
30371|NCT01768559|66779|P1|STARTED|Overall Study||298
30372|NCT01768325|66829|P2|NOT COMPLETED|Overall Study||0
30373|NCT01768325|66830|P1|NOT COMPLETED|Overall Study||0
30374|NCT01768325|66829|P2|COMPLETED|Overall Study||41
30375|NCT01768325|66830|P1|COMPLETED|Overall Study||37
30376|NCT01768325|66829|P2|STARTED|Overall Study||41
30377|NCT01768325|66830|P1|STARTED|Overall Study||37
30378|NCT01768286|66844|P4|NOT COMPLETED|Overall Study||1
30379|NCT01768286|66845|P3|NOT COMPLETED|Overall Study||2
30380|NCT01768286|66846|P2|NOT COMPLETED|Overall Study||4
30381|NCT01768286|66847|P1|NOT COMPLETED|Overall Study||7
30382|NCT01768286|66844|P4|COMPLETED|Overall Study||110
30383|NCT01768286|66845|P3|COMPLETED|Overall Study||108
30384|NCT01768286|66846|P2|COMPLETED|Overall Study||107
30385|NCT01768286|66847|P1|COMPLETED|Overall Study||102
30386|NCT01768286|66844|P4|STARTED|Overall Study||111
30387|NCT01768286|66845|P3|STARTED|Overall Study||110
30388|NCT01768286|66846|P2|STARTED|Overall Study||111
30389|NCT01768286|66847|P1|STARTED|Overall Study||109
30390|NCT01768117|66909|P1|NOT COMPLETED|Overall Study||6
30391|NCT01768117|66909|P1|COMPLETED|Overall Study||7
30392|NCT01768117|66909|P1|STARTED|Overall Study||13
30393|NCT01768013|66917|P1|NOT COMPLETED|Overall Study||0
30394|NCT01768013|66917|P1|COMPLETED|Overall Study||13
30395|NCT01768013|66917|P1|STARTED|Overall Study||13
30396|NCT01768000|66950|P4|NOT COMPLETED|Overall Study||2
30397|NCT01768000|66951|P3|NOT COMPLETED|Overall Study||1
30398|NCT01768000|66952|P2|NOT COMPLETED|Overall Study||2
30399|NCT01768000|66953|P1|NOT COMPLETED|Overall Study||1
30400|NCT01768000|66950|P4|COMPLETED|Overall Study||8
30401|NCT01768000|66951|P3|COMPLETED|Overall Study||9
30402|NCT01768000|66952|P2|COMPLETED|Overall Study||8
30403|NCT01768000|66953|P1|COMPLETED|Overall Study||9
30404|NCT01768000|66950|P4|STARTED|Overall Study||10
30405|NCT01768000|66951|P3|STARTED|Overall Study||10
30406|NCT01768000|66952|P2|STARTED|Overall Study||10
30407|NCT01768000|66953|P1|STARTED|Overall Study||10
30408|NCT01767987|66973|P2|NOT COMPLETED|Overall Study||1
30409|NCT01767987|66974|P1|NOT COMPLETED|Overall Study||4
30410|NCT01767987|66973|P2|COMPLETED|Overall Study||1
30411|NCT01767987|66974|P1|COMPLETED|Overall Study||0
30412|NCT01767987|66973|P2|STARTED|Overall Study||2
30413|NCT01767987|66974|P1|STARTED|Overall Study||4
30414|NCT01767688|66998|P2|NOT COMPLETED|Overall Study||0
30415|NCT01767688|66999|P1|NOT COMPLETED|Overall Study||0
30416|NCT01767688|66998|P2|COMPLETED|Overall Study||8
30417|NCT01767688|66999|P1|COMPLETED|Overall Study||8
30418|NCT01767688|66998|P2|STARTED|Overall Study||8
30419|NCT01767688|66999|P1|STARTED|Overall Study||8
30420|NCT01767597|67021|P2|NOT COMPLETED|Overall Study||1
30421|NCT01767597|67022|P1|NOT COMPLETED|Overall Study||4
30422|NCT01767597|67021|P2|COMPLETED|Overall Study||499
30423|NCT01767597|67022|P1|COMPLETED|Overall Study||496
30424|NCT01767597|67021|P2|STARTED|Overall Study||500
30425|NCT01767597|67022|P1|STARTED|Overall Study||500
30426|NCT01767519|67031|P3|NOT COMPLETED|Overall Study||5
30427|NCT01767519|67032|P2|NOT COMPLETED|Overall Study||13
30428|NCT01767519|67033|P1|NOT COMPLETED|Overall Study||14
30429|NCT01767519|67031|P3|COMPLETED|Overall Study||55
30430|NCT01767519|67032|P2|COMPLETED|Overall Study||138
30431|NCT01767519|67033|P1|COMPLETED|Overall Study||131
30432|NCT01767519|67031|P3|STARTED|Overall Study||60
30433|NCT01767519|67032|P2|STARTED|Overall Study||151
30434|NCT01767519|67033|P1|STARTED|Overall Study||145
30435|NCT01767285|67061|P2|NOT COMPLETED|Overall Study||6
30436|NCT01767285|67062|P1|NOT COMPLETED|Overall Study||7
30437|NCT01767285|67061|P2|COMPLETED|Overall Study||24
30438|NCT01767285|67062|P1|COMPLETED|Overall Study||22
30439|NCT01767285|67061|P2|STARTED|Overall Study||30
30440|NCT01767285|67062|P1|STARTED|Overall Study||29
30441|NCT01767116|67080|P2|NOT COMPLETED|Overall Study||2
30442|NCT01767116|67081|P1|NOT COMPLETED|Overall Study||2
30443|NCT01767116|67080|P2|COMPLETED|Overall Study||207
30444|NCT01767116|67081|P1|COMPLETED|Overall Study||208
30445|NCT01767116|67080|P2|STARTED|Overall Study||209
30446|NCT01767116|67081|P1|STARTED|Overall Study||210
30447|NCT01767103|67100|P3|NOT COMPLETED|Overall Study||0
30448|NCT01767103|67101|P2|NOT COMPLETED|Overall Study||0
30449|NCT01767103|67102|P1|NOT COMPLETED|Overall Study||0
30450|NCT01767103|67100|P3|COMPLETED|Overall Study||7
30451|NCT01767103|67101|P2|COMPLETED|Overall Study||7
30452|NCT01767103|67102|P1|COMPLETED|Overall Study||7
30453|NCT01767103|67100|P3|STARTED|Overall Study||7
30454|NCT01767103|67101|P2|STARTED|Overall Study||7
30455|NCT01767103|67102|P1|STARTED|Overall Study||7
30456|NCT01766921|67130|P2|NOT COMPLETED|Overall Study||17
30457|NCT01766921|67131|P1|NOT COMPLETED|Overall Study||24
30458|NCT01766921|67130|P2|COMPLETED|Overall Study||676
30459|NCT01766921|67131|P1|COMPLETED|Overall Study||676
30460|NCT01766921|67130|P2|STARTED|Overall Study||693
30461|NCT01766921|67131|P1|STARTED|Overall Study||700
30462|NCT01766713|67152|P2|NOT COMPLETED|Overall Study||2
30463|NCT01766713|67153|P1|NOT COMPLETED|Overall Study||2
30464|NCT01766713|67152|P2|COMPLETED|Overall Study||23
30465|NCT01766713|67153|P1|COMPLETED|Overall Study||23
30466|NCT01766713|67152|P2|STARTED|Overall Study||25
30467|NCT01766713|67153|P1|STARTED|Overall Study||25
30468|NCT01766466|67161|P4|NOT COMPLETED|Day 5||0
30469|NCT01766466|67162|P3|NOT COMPLETED|Day 5||0
30470|NCT01766466|67163|P2|NOT COMPLETED|Day 5||0
30471|NCT01766466|67164|P1|NOT COMPLETED|Day 5||0
30472|NCT01766466|67161|P4|COMPLETED|Day 5||6
30473|NCT01766466|67162|P3|COMPLETED|Day 5||0
30474|NCT01766466|67163|P2|COMPLETED|Day 5||6
30475|NCT01766466|67164|P1|COMPLETED|Day 5||0
30476|NCT01766466|67161|P4|STARTED|Day 5||6
30477|NCT01766466|67162|P3|STARTED|Day 5||0
30478|NCT01766466|67163|P2|STARTED|Day 5||6
30479|NCT01766466|67164|P1|STARTED|Day 5||0
30480|NCT01766466|67161|P4|NOT COMPLETED|Day 1||0
30481|NCT01766466|67162|P3|NOT COMPLETED|Day 1||0
30482|NCT01766466|67163|P2|NOT COMPLETED|Day 1||0
30483|NCT01766466|67164|P1|NOT COMPLETED|Day 1||0
30484|NCT01766466|67161|P4|COMPLETED|Day 1||0
30485|NCT01766466|67162|P3|COMPLETED|Day 1||6
30486|NCT01766466|67163|P2|COMPLETED|Day 1||0
30487|NCT01766466|67164|P1|COMPLETED|Day 1||6
30488|NCT01766466|67161|P4|STARTED|Day 1||0
30489|NCT01766466|67162|P3|STARTED|Day 1||6
30490|NCT01766466|67163|P2|STARTED|Day 1||0
30491|NCT01766466|67164|P1|STARTED|Day 1||6
30492|NCT01766336|67179|P2|NOT COMPLETED|Overall Study||75
30493|NCT01766336|67180|P1|NOT COMPLETED|Overall Study||90
30494|NCT01766336|67179|P2|COMPLETED|Overall Study||71
30495|NCT01766336|67180|P1|COMPLETED|Overall Study||60
30496|NCT01766336|67179|P2|STARTED|Overall Study||146
30497|NCT01766336|67180|P1|STARTED|Overall Study||150
30498|NCT01766310|67188|P2|NOT COMPLETED|Overall Study||3
30499|NCT01766310|67189|P1|NOT COMPLETED|Overall Study||1
30500|NCT01766310|67188|P2|COMPLETED|Overall Study||23
30501|NCT01766310|67189|P1|COMPLETED|Overall Study||23
30502|NCT01766310|67188|P2|STARTED|Overall Study||26
30503|NCT01766310|67189|P1|STARTED|Overall Study||24
30504|NCT01766076|67199|P2|NOT COMPLETED|Overall Study||0
30505|NCT01766076|67200|P1|NOT COMPLETED|Overall Study||0
30506|NCT01766076|67199|P2|COMPLETED|Overall Study||15
30507|NCT01766076|67200|P1|COMPLETED|Overall Study||15
30508|NCT01766076|67199|P2|STARTED|Overall Study||15
30509|NCT01766076|67200|P1|STARTED|Overall Study||15
30510|NCT01766050|67206|P1|NOT COMPLETED|Overall Study||4
30511|NCT01766050|67206|P1|COMPLETED|Overall Study||18
30512|NCT01766050|67206|P1|STARTED|Overall Study||22
30513|NCT01766037|67341|P2|NOT COMPLETED|Overall Study||29
30514|NCT01766037|67342|P1|NOT COMPLETED|Overall Study||29
30515|NCT01766037|67341|P2|COMPLETED|Overall Study||31
30516|NCT01766037|67342|P1|COMPLETED|Overall Study||82
30517|NCT01766037|67341|P2|STARTED|Overall Study||60
30518|NCT01766037|67342|P1|STARTED|Overall Study||111
30519|NCT01766024|67379|P2|NOT COMPLETED|Overall Study||0
30520|NCT01766024|67380|P1|NOT COMPLETED|Overall Study||0
30521|NCT01766024|67379|P2|COMPLETED|Overall Study||16
30522|NCT01766024|67380|P1|COMPLETED|Overall Study||16
30523|NCT01766024|67379|P2|STARTED|Overall Study||16
30524|NCT01766024|67380|P1|STARTED|Overall Study||16
30525|NCT01765972|67390|P4|NOT COMPLETED|Overall Study||0
30526|NCT01765972|67391|P3|NOT COMPLETED|Overall Study||0
30527|NCT01765972|67392|P2|NOT COMPLETED|Overall Study||0
30528|NCT01765972|67393|P1|NOT COMPLETED|Overall Study||0
30529|NCT01765972|67390|P4|COMPLETED|Overall Study||6
30530|NCT01765972|67391|P3|COMPLETED|Overall Study||6
30531|NCT01765972|67392|P2|COMPLETED|Overall Study||6
30532|NCT01765972|67393|P1|COMPLETED|Overall Study||6
30533|NCT01765972|67390|P4|STARTED|Overall Study||6
30534|NCT01765972|67391|P3|STARTED|Overall Study||6
30535|NCT01765972|67392|P2|STARTED|Overall Study||6
30536|NCT01765972|67393|P1|STARTED|Overall Study||6
30537|NCT01765803|67403|P1|NOT COMPLETED|Overall Study||0
30538|NCT01765803|67403|P1|COMPLETED|Overall Study||6
30539|NCT01765803|67403|P1|STARTED|Overall Study||6
30540|NCT01765764|67411|P3|NOT COMPLETED|Post-treatment Period||0
30541|NCT01765764|67412|P2|NOT COMPLETED|Post-treatment Period||0
30542|NCT01765764|67413|P1|NOT COMPLETED|Post-treatment Period||0
30543|NCT01765764|67411|P3|COMPLETED|Post-treatment Period||112
30544|NCT01765764|67412|P2|COMPLETED|Post-treatment Period||107
30545|NCT01765764|67413|P1|COMPLETED|Post-treatment Period||114
30546|NCT01765764|67411|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
30547|NCT01765764|67412|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
30548|NCT01765764|67413|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
30549|NCT01765764|67411|P3|NOT COMPLETED|Treatment Period||6
30550|NCT01765764|67412|P2|NOT COMPLETED|Treatment Period||9
30551|NCT01765764|67413|P1|NOT COMPLETED|Treatment Period||3
30552|NCT01765764|67411|P3|COMPLETED|Treatment Period||115
30553|NCT01765764|67412|P2|COMPLETED|Treatment Period||109
30554|NCT01765764|67413|P1|COMPLETED|Treatment Period||115
30555|NCT01765764|67411|P3|STARTED|Treatment Period||121
30556|NCT01765764|67412|P2|STARTED|Treatment Period||118
30557|NCT01765764|67413|P1|STARTED|Treatment Period||118
30558|NCT01765569|67430|P1|NOT COMPLETED|Period C||1
30559|NCT01765569|67430|P1|COMPLETED|Period C||27
30560|NCT01765569|67430|P1|STARTED|Period C||28
30561|NCT01765569|67430|P1|NOT COMPLETED|Period B||1
30562|NCT01765569|67430|P1|COMPLETED|Period B||28
30563|NCT01765569|67430|P1|STARTED|Period B||29
30564|NCT01765569|67430|P1|NOT COMPLETED|Period A||0
30565|NCT01765569|67430|P1|COMPLETED|Period A||29
30566|NCT01765569|67430|P1|STARTED|Period A||29
30567|NCT01765543|67451|P1|NOT COMPLETED|Overall Study||3
30568|NCT01765543|67451|P1|COMPLETED|Overall Study||24
30569|NCT01765543|67451|P1|STARTED|Overall Study||27
30570|NCT01765465|67475|P2|NOT COMPLETED|Overall Study||4
30571|NCT01765465|67476|P1|NOT COMPLETED|Overall Study||7
30572|NCT01765465|67475|P2|COMPLETED|Overall Study||63
30573|NCT01765465|67476|P1|COMPLETED|Overall Study||64
30574|NCT01765465|67475|P2|STARTED|Overall Study||67
30575|NCT01765465|67476|P1|STARTED|Overall Study||71
30576|NCT01765426|67492|P4|NOT COMPLETED|Overall Study||0
30577|NCT01765426|67493|P3|NOT COMPLETED|Overall Study||0
30578|NCT01765426|67494|P2|NOT COMPLETED|Overall Study||1
30579|NCT01765426|67495|P1|NOT COMPLETED|Overall Study||0
30580|NCT01765426|67492|P4|COMPLETED|Overall Study||15
30581|NCT01765426|67493|P3|COMPLETED|Overall Study||17
30582|NCT01765426|67494|P2|COMPLETED|Overall Study||16
30583|NCT01765426|67495|P1|COMPLETED|Overall Study||18
30584|NCT01765426|67492|P4|Completed All Vaccinations|Overall Study||15
30585|NCT01765426|67493|P3|Completed All Vaccinations|Overall Study||17
30586|NCT01765426|67494|P2|Completed All Vaccinations|Overall Study||16
30587|NCT01765426|67495|P1|Completed All Vaccinations|Overall Study||17
30588|NCT01765426|67492|P4|STARTED|Overall Study||15
30589|NCT01765426|67493|P3|STARTED|Overall Study||17
30590|NCT01765426|67494|P2|STARTED|Overall Study||17
30591|NCT01765426|67495|P1|STARTED|Overall Study||18
30592|NCT01765270|67551|P2|NOT COMPLETED|Overall Study||1
30593|NCT01765270|67552|P1|NOT COMPLETED|Overall Study||1
30594|NCT01765270|67551|P2|COMPLETED|Overall Study||6
30595|NCT01765270|67552|P1|COMPLETED|Overall Study||4
30596|NCT01765270|67551|P2|STARTED|Overall Study||7
30597|NCT01765270|67552|P1|STARTED|Overall Study||5
30598|NCT01765192|67574|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
30599|NCT01765192|67575|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
30600|NCT01765192|67574|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
30601|NCT01765192|67575|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
30602|NCT01765192|67574|P2|STARTED|End of Treatment Period 2 to Final Visit||28
30603|NCT01765192|67575|P1|STARTED|End of Treatment Period 2 to Final Visit||30
30604|NCT01765192|67574|P2|NOT COMPLETED|Treatment Period 2||2
30605|NCT01765192|67575|P1|NOT COMPLETED|Treatment Period 2||0
30606|NCT01765192|67574|P2|COMPLETED|Treatment Period 2||28
30607|NCT01765192|67575|P1|COMPLETED|Treatment Period 2||30
30608|NCT01765192|67574|P2|STARTED|Treatment Period 2||30
30609|NCT01765192|67575|P1|STARTED|Treatment Period 2||30
30610|NCT01765192|67574|P2|NOT COMPLETED|Washout Period||1
30611|NCT01765192|67575|P1|NOT COMPLETED|Washout Period||2
30612|NCT01765192|67574|P2|COMPLETED|Washout Period||30
30613|NCT01765192|67575|P1|COMPLETED|Washout Period||30
30614|NCT01765192|67574|P2|STARTED|Washout Period||31
30615|NCT01765192|67575|P1|STARTED|Washout Period||32
30616|NCT01765192|67574|P2|NOT COMPLETED|Treatment Period 1||1
30617|NCT01765192|67575|P1|NOT COMPLETED|Treatment Period 1||0
30618|NCT01765192|67574|P2|COMPLETED|Treatment Period 1||31
30619|NCT01765192|67575|P1|COMPLETED|Treatment Period 1||32
30620|NCT01765192|67574|P2|STARTED|Treatment Period 1||32
30621|NCT01765192|67575|P1|STARTED|Treatment Period 1||32
30622|NCT01764945|67601|P8|NOT COMPLETED|Overall Study||0
30623|NCT01764945|67602|P7|NOT COMPLETED|Overall Study||1
30624|NCT01764945|67603|P6|NOT COMPLETED|Overall Study||0
30625|NCT01764945|67604|P5|NOT COMPLETED|Overall Study||0
30626|NCT01764945|67605|P4|NOT COMPLETED|Overall Study||0
30627|NCT01764945|67606|P3|NOT COMPLETED|Overall Study||0
30628|NCT01764945|67607|P2|NOT COMPLETED|Overall Study||1
30629|NCT01764945|67608|P1|NOT COMPLETED|Overall Study||0
30630|NCT01764945|67601|P8|COMPLETED|Overall Study||9
30631|NCT01764945|67602|P7|COMPLETED|Overall Study||8
30632|NCT01764945|67603|P6|COMPLETED|Overall Study||8
30633|NCT01764945|67604|P5|COMPLETED|Overall Study||10
30634|NCT01764945|67605|P4|COMPLETED|Overall Study||5
30635|NCT01764945|67606|P3|COMPLETED|Overall Study||5
30636|NCT01764945|67607|P2|COMPLETED|Overall Study||4
30637|NCT01764945|67608|P1|COMPLETED|Overall Study||5
30638|NCT01764945|67601|P8|STARTED|Overall Study||9
30639|NCT01764945|67602|P7|STARTED|Overall Study||9
30640|NCT01764945|67603|P6|STARTED|Overall Study||8
30641|NCT01764945|67604|P5|STARTED|Overall Study||10
30642|NCT01764945|67605|P4|STARTED|Overall Study||5
30643|NCT01764945|67606|P3|STARTED|Overall Study||5
30644|NCT01764945|67607|P2|STARTED|Overall Study||5
30645|NCT01764945|67608|P1|STARTED|Overall Study||5
30646|NCT01764919|67642|P1|NOT COMPLETED|Overall Study||0
30647|NCT01764919|67642|P1|COMPLETED|Overall Study||4
30648|NCT01764919|67642|P1|STARTED|Overall Study||4
30649|NCT01764685|67652|P2|NOT COMPLETED|Overall Study||1
30650|NCT01764685|67653|P1|NOT COMPLETED|Overall Study||0
30651|NCT01764685|67652|P2|COMPLETED|Overall Study||3
30652|NCT01764685|67653|P1|COMPLETED|Overall Study||0
30653|NCT01764685|67652|P2|STARTED|Overall Study||4
30654|NCT01764685|67653|P1|STARTED|Overall Study||0
30655|NCT01764607|67659|P1|NOT COMPLETED|Overall Study||0
30656|NCT01764607|67659|P1|COMPLETED|Overall Study||1
30657|NCT01764607|67659|P1|STARTED|Overall Study||1
30658|NCT01764386|67666|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
30659|NCT01764386|67667|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
30660|NCT01764386|67666|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
30661|NCT01764386|67667|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
30662|NCT01764386|67666|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
30663|NCT01764386|67667|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
30664|NCT01764386|67666|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
30665|NCT01764386|67667|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
30666|NCT01764386|67666|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
30667|NCT01764386|67667|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
30668|NCT01764386|67666|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
30669|NCT01764386|67667|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
30670|NCT01764386|67666|P2|STARTED|Controlled Treatment Period (CTP)||89
30671|NCT01764386|67667|P1|STARTED|Controlled Treatment Period (CTP)||153
30672|NCT01764022|67710|P2|NOT COMPLETED|Overall Study||12
30673|NCT01764022|67711|P1|NOT COMPLETED|Overall Study||21
30674|NCT01764022|67710|P2|COMPLETED|Overall Study||49
30675|NCT01764022|67711|P1|COMPLETED|Overall Study||44
30676|NCT01764022|67710|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
30677|NCT01764022|67711|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
30678|NCT01764022|67710|P2|STARTED|Overall Study||61
30679|NCT01764022|67711|P1|STARTED|Overall Study||65
30680|NCT01763996|67739|P2|NOT COMPLETED|Treatment Period 2||1
30681|NCT01763996|67740|P1|NOT COMPLETED|Treatment Period 2||0
30682|NCT01763996|67739|P2|COMPLETED|Treatment Period 2||14
30683|NCT01763996|67740|P1|COMPLETED|Treatment Period 2||15
30684|NCT01763996|67739|P2|STARTED|Treatment Period 2||15
30685|NCT01763996|67740|P1|STARTED|Treatment Period 2||15
30686|NCT01763996|67739|P2|NOT COMPLETED|Treatment Period 1||0
30687|NCT01763996|67740|P1|NOT COMPLETED|Treatment Period 1||0
30688|NCT01763996|67739|P2|COMPLETED|Treatment Period 1||15
30689|NCT01763996|67740|P1|COMPLETED|Treatment Period 1||15
30690|NCT01763996|67739|P2|STARTED|Treatment Period 1||15
30691|NCT01763996|67740|P1|STARTED|Treatment Period 1||15
30692|NCT01763918|67770|P4|NOT COMPLETED|Overall Study||2
30693|NCT01763918|67771|P3|NOT COMPLETED|Overall Study||10
30694|NCT01763918|67772|P2|NOT COMPLETED|Overall Study||1
30695|NCT01763918|67773|P1|NOT COMPLETED|Overall Study||6
30696|NCT01763918|67770|P4|COMPLETED|Overall Study||108
30697|NCT01763918|67771|P3|COMPLETED|Overall Study||101
30698|NCT01763918|67772|P2|COMPLETED|Overall Study||54
30699|NCT01763918|67773|P1|COMPLETED|Overall Study||49
30700|NCT01763918|67770|P4|Received Treatment|Overall Study||110
30701|NCT01763918|67771|P3|Received Treatment|Overall Study||110
30702|NCT01763918|67772|P2|Received Treatment|Overall Study||55
30703|NCT01763918|67773|P1|Received Treatment|Overall Study||54
30704|NCT01763918|67770|P4|STARTED|Overall Study||110
30705|NCT01763918|67771|P3|STARTED|Overall Study||111
30706|NCT01763918|67772|P2|STARTED|Overall Study||55
30707|NCT01763918|67773|P1|STARTED|Overall Study||55
30708|NCT01763905|67871|P4|NOT COMPLETED|Overall Study||1
30709|NCT01763905|67872|P3|NOT COMPLETED|Overall Study||9
30710|NCT01763905|67873|P2|NOT COMPLETED|Overall Study||1
30711|NCT01763905|67874|P1|NOT COMPLETED|Overall Study||6
30712|NCT01763905|67871|P4|COMPLETED|Overall Study||101
30713|NCT01763905|67872|P3|COMPLETED|Overall Study||94
30714|NCT01763905|67873|P2|COMPLETED|Overall Study||50
30715|NCT01763905|67874|P1|COMPLETED|Overall Study||45
30716|NCT01763905|67871|P4|STARTED|Overall Study||102
30717|NCT01763905|67872|P3|STARTED|Overall Study||103
30718|NCT01763905|67873|P2|STARTED|Overall Study||51
30719|NCT01763905|67874|P1|STARTED|Overall Study||51
30720|NCT01763866|67992|P24|NOT COMPLETED|Overall Study||2
30721|NCT01763866|67993|P23|NOT COMPLETED|Overall Study||3
30722|NCT01763866|67994|P22|NOT COMPLETED|Overall Study||1
30723|NCT01763866|67995|P21|NOT COMPLETED|Overall Study||4
30724|NCT01763866|67996|P20|NOT COMPLETED|Overall Study||2
30725|NCT01763866|67997|P19|NOT COMPLETED|Overall Study||6
30726|NCT01763866|67998|P18|NOT COMPLETED|Overall Study||1
30727|NCT01763866|67999|P17|NOT COMPLETED|Overall Study||1
30728|NCT01763866|68000|P16|NOT COMPLETED|Overall Study||3
30729|NCT01763866|68001|P15|NOT COMPLETED|Overall Study||12
30730|NCT01763866|68002|P14|NOT COMPLETED|Overall Study||0
30731|NCT01763866|68003|P13|NOT COMPLETED|Overall Study||4
30732|NCT01763866|68004|P12|NOT COMPLETED|Overall Study||2
30733|NCT01763866|68005|P11|NOT COMPLETED|Overall Study||8
30734|NCT01763866|68006|P10|NOT COMPLETED|Overall Study||1
30735|NCT01763866|68007|P9|NOT COMPLETED|Overall Study||3
30736|NCT01763866|68008|P8|NOT COMPLETED|Overall Study||0
30737|NCT01763866|68009|P7|NOT COMPLETED|Overall Study||7
30738|NCT01763866|68010|P6|NOT COMPLETED|Overall Study||3
30739|NCT01763866|68011|P5|NOT COMPLETED|Overall Study||2
30740|NCT01763866|68012|P4|NOT COMPLETED|Overall Study||0
30741|NCT01763866|68013|P3|NOT COMPLETED|Overall Study||5
30742|NCT01763866|68014|P2|NOT COMPLETED|Overall Study||1
30743|NCT01763866|68015|P1|NOT COMPLETED|Overall Study||2
30744|NCT01763866|67992|P24|COMPLETED|Overall Study||113
30745|NCT01763866|67993|P23|COMPLETED|Overall Study||109
30746|NCT01763866|67994|P22|COMPLETED|Overall Study||54
30747|NCT01763866|67995|P21|COMPLETED|Overall Study||52
30748|NCT01763866|67996|P20|COMPLETED|Overall Study||110
30749|NCT01763866|67997|P19|COMPLETED|Overall Study||105
30750|NCT01763866|67998|P18|COMPLETED|Overall Study||55
30751|NCT01763866|67999|P17|COMPLETED|Overall Study||55
30752|NCT01763866|68000|P16|COMPLETED|Overall Study||112
30753|NCT01763866|68001|P15|COMPLETED|Overall Study||102
30754|NCT01763866|68002|P14|COMPLETED|Overall Study||57
30755|NCT01763866|68003|P13|COMPLETED|Overall Study||54
30756|NCT01763866|68004|P12|COMPLETED|Overall Study||108
30757|NCT01763866|68005|P11|COMPLETED|Overall Study||102
30758|NCT01763866|68006|P10|COMPLETED|Overall Study||53
30759|NCT01763866|68007|P9|COMPLETED|Overall Study||53
30760|NCT01763866|68008|P8|COMPLETED|Overall Study||55
30761|NCT01763866|68009|P7|COMPLETED|Overall Study||48
30762|NCT01763866|68010|P6|COMPLETED|Overall Study||107
30763|NCT01763866|68011|P5|COMPLETED|Overall Study||108
30764|NCT01763866|68012|P4|COMPLETED|Overall Study||55
30765|NCT01763866|68013|P3|COMPLETED|Overall Study||51
30766|NCT01763866|68014|P2|COMPLETED|Overall Study||54
30767|NCT01763866|68015|P1|COMPLETED|Overall Study||54
30768|NCT01763866|67992|P24|Received Treatment|Overall Study||115
30769|NCT01763866|67993|P23|Received Treatment|Overall Study||112
30770|NCT01763866|67994|P22|Received Treatment|Overall Study||55
30771|NCT01763866|67995|P21|Received Treatment|Overall Study||56
30772|NCT01763866|67996|P20|Received Treatment|Overall Study||112
30773|NCT01763866|67997|P19|Received Treatment|Overall Study||111
30774|NCT01763866|67998|P18|Received Treatment|Overall Study||55
30775|NCT01763866|67999|P17|Received Treatment|Overall Study||56
30776|NCT01763866|68000|P16|Received Treatment|Overall Study||115
30777|NCT01763866|68001|P15|Received Treatment|Overall Study||113
30778|NCT01763866|68002|P14|Received Treatment|Overall Study||57
30779|NCT01763866|68003|P13|Received Treatment|Overall Study||58
30780|NCT01763866|68004|P12|Received Treatment|Overall Study||110
30781|NCT01763866|68005|P11|Received Treatment|Overall Study||109
30782|NCT01763866|68006|P10|Received Treatment|Overall Study||54
30783|NCT01763866|68007|P9|Received Treatment|Overall Study||56
30784|NCT01763866|68008|P8|Received Treatment|Overall Study||55
30785|NCT01763866|68009|P7|Received Treatment|Overall Study||55
30786|NCT01763866|68010|P6|Received Treatment|Overall Study||110
30787|NCT01763866|68011|P5|Received Treatment|Overall Study||110
30788|NCT01763866|68012|P4|Received Treatment|Overall Study||55
30789|NCT01763866|68013|P3|Received Treatment|Overall Study||56
30790|NCT01763866|68014|P2|Received Treatment|Overall Study||55
30791|NCT01763866|68015|P1|Received Treatment|Overall Study||56
30792|NCT01763866|67992|P24|STARTED|Overall Study||115
30793|NCT01763866|67993|P23|STARTED|Overall Study||112
30794|NCT01763866|67994|P22|STARTED|Overall Study||55
30795|NCT01763866|67995|P21|STARTED|Overall Study||56
30796|NCT01763866|67996|P20|STARTED|Overall Study||112
30797|NCT01763866|67997|P19|STARTED|Overall Study||111
30798|NCT01763866|67998|P18|STARTED|Overall Study||56
30799|NCT01763866|67999|P17|STARTED|Overall Study||56
30800|NCT01763866|68000|P16|STARTED|Overall Study||115
30801|NCT01763866|68001|P15|STARTED|Overall Study||114
30802|NCT01763866|68002|P14|STARTED|Overall Study||57
30803|NCT01763866|68003|P13|STARTED|Overall Study||58
30804|NCT01763866|68004|P12|STARTED|Overall Study||110
30805|NCT01763866|68005|P11|STARTED|Overall Study||110
30806|NCT01763866|68006|P10|STARTED|Overall Study||54
30807|NCT01763866|68007|P9|STARTED|Overall Study||56
30808|NCT01763866|68008|P8|STARTED|Overall Study||55
30809|NCT01763866|68009|P7|STARTED|Overall Study||55
30810|NCT01763866|68010|P6|STARTED|Overall Study||110
30811|NCT01763866|68011|P5|STARTED|Overall Study||110
30812|NCT01763866|68012|P4|STARTED|Overall Study||55
30813|NCT01763866|68013|P3|STARTED|Overall Study||56
30814|NCT01763866|68014|P2|STARTED|Overall Study||55
30815|NCT01763866|68015|P1|STARTED|Overall Study||56
30816|NCT01763827|68575|P6|NOT COMPLETED|Overall Study||2
30817|NCT01763827|68576|P5|NOT COMPLETED|Overall Study||6
30818|NCT01763827|68577|P4|NOT COMPLETED|Overall Study||1
30819|NCT01763827|68578|P3|NOT COMPLETED|Overall Study||4
30820|NCT01763827|68579|P2|NOT COMPLETED|Overall Study||1
30821|NCT01763827|68580|P1|NOT COMPLETED|Overall Study||3
30822|NCT01763827|68575|P6|COMPLETED|Overall Study||151
30823|NCT01763827|68576|P5|COMPLETED|Overall Study||147
30824|NCT01763827|68577|P4|COMPLETED|Overall Study||76
30825|NCT01763827|68578|P3|COMPLETED|Overall Study||73
30826|NCT01763827|68579|P2|COMPLETED|Overall Study||77
30827|NCT01763827|68580|P1|COMPLETED|Overall Study||74
30828|NCT01763827|68575|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
30829|NCT01763827|68576|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
30830|NCT01763827|68577|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
30831|NCT01763827|68578|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
30832|NCT01763827|68579|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
30833|NCT01763827|68580|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
30834|NCT01763827|68575|P6|STARTED|Overall Study||153
30835|NCT01763827|68576|P5|STARTED|Overall Study||153
30836|NCT01763827|68577|P4|STARTED|Overall Study||77
30837|NCT01763827|68578|P3|STARTED|Overall Study||77
30838|NCT01763827|68579|P2|STARTED|Overall Study||78
30839|NCT01763827|68580|P1|STARTED|Overall Study||77
30840|NCT01763645|68722|P2|NOT COMPLETED|Overall Study||24
30841|NCT01763645|68723|P1|NOT COMPLETED|Overall Study||26
30842|NCT01763645|68722|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
30843|NCT01763645|68723|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
30844|NCT01763645|68722|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
30845|NCT01763645|68723|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
30846|NCT01763645|68722|P2|STARTED|Overall Study||69
30847|NCT01763645|68723|P1|STARTED|Overall Study||69
30848|NCT01763567|68741|P1|NOT COMPLETED|Overall Study||0
30849|NCT01763567|68741|P1|COMPLETED|Overall Study||19
30850|NCT01763567|68741|P1|STARTED|Overall Study||19
30851|NCT01763047|68751|P2|NOT COMPLETED|Period 2||5
30852|NCT01763047|68752|P1|NOT COMPLETED|Period 2||4
30853|NCT01763047|68751|P2|COMPLETED|Period 2||121
30854|NCT01763047|68752|P1|COMPLETED|Period 2||126
30855|NCT01763047|68751|P2|Hyperopes|Period 2||54
30856|NCT01763047|68752|P1|Hyperopes|Period 2||56
30857|NCT01763047|68751|P2|Myopes|Period 2||72
30858|NCT01763047|68752|P1|Myopes|Period 2||74
30859|NCT01763047|68751|P2|STARTED|Period 2||126
30860|NCT01763047|68752|P1|STARTED|Period 2||130
30861|NCT01763047|68751|P2|NOT COMPLETED|Period 1||11
30862|NCT01763047|68752|P1|NOT COMPLETED|Period 1||9
30863|NCT01763047|68751|P2|COMPLETED|Period 1||126
30864|NCT01763047|68752|P1|COMPLETED|Period 1||130
30865|NCT01763047|68751|P2|Hyperopes|Period 1||61
30866|NCT01763047|68752|P1|Hyperopes|Period 1||62
30867|NCT01763047|68751|P2|Myopes|Period 1||76
30868|NCT01763047|68752|P1|Myopes|Period 1||77
30869|NCT01763047|68751|P2|STARTED|Period 1||137
30870|NCT01763047|68752|P1|STARTED|Period 1||139
30871|NCT01762982|68768|P1|NOT COMPLETED|Overall Study||0
30872|NCT01762982|68768|P1|COMPLETED|Overall Study||36
30873|NCT01762982|68768|P1|Received Empty Finn Chamber|Overall Study||36
30874|NCT01762982|68768|P1|Received SLS|Overall Study||36
30875|NCT01762982|68768|P1|Received Benzalkonium Chloride|Overall Study||36
30876|NCT01762982|68768|P1|Received Saline Water|Overall Study||36
30877|NCT01762982|68768|P1|STARTED|Overall Study||36
30878|NCT01762904|68789|P1|NOT COMPLETED|Overall Study||0
30879|NCT01762904|68789|P1|COMPLETED|Overall Study|October, 2013|135
30880|NCT01762904|68789|P1|STARTED|Overall Study|January, 2013|135
30881|NCT01762800|68798|P2|NOT COMPLETED|Overall Study||21
30882|NCT01762800|68799|P1|NOT COMPLETED|Overall Study||19
30883|NCT01762800|68798|P2|COMPLETED|Overall Study||183
30884|NCT01762800|68799|P1|COMPLETED|Overall Study||183
30885|NCT01762800|68798|P2|STARTED|Overall Study||204
30886|NCT01762800|68799|P1|STARTED|Overall Study||202
30887|NCT01762761|68873|P2|NOT COMPLETED|Overall Study||4
30888|NCT01762761|68874|P1|NOT COMPLETED|Overall Study||2
30889|NCT01762761|68873|P2|COMPLETED|Overall Study||100
30890|NCT01762761|68874|P1|COMPLETED|Overall Study||49
30891|NCT01762761|68873|P2|STARTED|Overall Study||104
30892|NCT01762761|68874|P1|STARTED|Overall Study||51
30893|NCT01762722|68928|P2|NOT COMPLETED|Overall Study||0
30894|NCT01762722|68929|P1|NOT COMPLETED|Overall Study||0
30895|NCT01762722|68928|P2|COMPLETED|Overall Study||11
30896|NCT01762722|68929|P1|COMPLETED|Overall Study||12
30897|NCT01762722|68928|P2|STARTED|Overall Study||11
30898|NCT01762722|68929|P1|STARTED|Overall Study||12
30899|NCT01762501|68937|P2|NOT COMPLETED|Overall Study||23
30900|NCT01762501|68938|P1|NOT COMPLETED|Overall Study||27
30901|NCT01762501|68937|P2|COMPLETED|Overall Study||336
30902|NCT01762501|68938|P1|COMPLETED|Overall Study||332
30903|NCT01762501|68937|P2|STARTED|Overall Study||359
30904|NCT01762501|68938|P1|STARTED|Overall Study||359
30905|NCT01762345|68952|P1|NOT COMPLETED|Overall Study||7
30906|NCT01762345|68952|P1|COMPLETED|Overall Study||76
30907|NCT01762345|68952|P1|STARTED|Overall Study||83
30908|NCT01761747|68962|P1|NOT COMPLETED|Overall Study||1
30909|NCT01761747|68962|P1|COMPLETED|Overall Study||2
30910|NCT01761747|68962|P1|STARTED|Overall Study||3
30911|NCT01761565|68973|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
30912|NCT01761565|68973|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
30913|NCT01761565|68973|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
30914|NCT01761565|68973|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
30915|NCT01761565|68973|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
30916|NCT01761565|68973|P1|STARTED|Single Dose of SUF NT 15 mcg||40
30917|NCT01761279|68982|P1|NOT COMPLETED|Overall Study||0
30918|NCT01761279|68982|P1|COMPLETED|Overall Study||84
30919|NCT01761279|68982|P1|STARTED|Overall Study||84
30920|NCT01761162|68995|P1|NOT COMPLETED|Overall Study||3
30921|NCT01761162|68995|P1|COMPLETED|Overall Study||226
30922|NCT01761162|68995|P1|STARTED|Overall Study||229
30923|NCT01761019|69003|P1|NOT COMPLETED|Overall Study||0
30924|NCT01761019|69003|P1|COMPLETED|Overall Study||8
30925|NCT01761019|69003|P1|STARTED|Overall Study||8
30926|NCT01760993|69011|P1|NOT COMPLETED|Overall Study||0
30927|NCT01760993|69011|P1|COMPLETED|Overall Study||0
30928|NCT01760993|69011|P1|STARTED|Overall Study||0
30929|NCT01760941|69028|P1|NOT COMPLETED|Overall Study||0
30930|NCT01760941|69028|P1|COMPLETED|Overall Study||1
30931|NCT01760941|69028|P1|STARTED|Overall Study||1
30932|NCT01760889|69038|P3|NOT COMPLETED|Overall Study||0
30933|NCT01760889|69039|P2|NOT COMPLETED|Overall Study||0
30934|NCT01760889|69040|P1|NOT COMPLETED|Overall Study||0
30935|NCT01760889|69038|P3|COMPLETED|Overall Study||0
30936|NCT01760889|69039|P2|COMPLETED|Overall Study||0
30937|NCT01760889|69040|P1|COMPLETED|Overall Study||0
30938|NCT01760889|69038|P3|STARTED|Overall Study||0
30939|NCT01760889|69039|P2|STARTED|Overall Study||0
30940|NCT01760889|69040|P1|STARTED|Overall Study||0
30941|NCT01760876|69087|P1|NOT COMPLETED|Overall Study||6
30942|NCT01760876|69087|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
30943|NCT01760876|69087|P1|STARTED|Overall Study||106
30944|NCT01760785|69093|P2|NOT COMPLETED|Overall Study||0
30945|NCT01760785|69094|P1|NOT COMPLETED|Overall Study||0
30946|NCT01760785|69093|P2|COMPLETED|Overall Study||27
30947|NCT01760785|69094|P1|COMPLETED|Overall Study||23
30948|NCT01760785|69093|P2|STARTED|Overall Study||27
30949|NCT01760785|69094|P1|STARTED|Overall Study||23
30950|NCT01759602|69100|P1|NOT COMPLETED|Overall Study||0
30951|NCT01759602|69100|P1|COMPLETED|Overall Study||10
30952|NCT01759602|69100|P1|STARTED|Overall Study||10
30953|NCT01759420|69108|P1|NOT COMPLETED|Overall Study||6
30954|NCT01759420|69108|P1|COMPLETED|Overall Study||22
30955|NCT01759420|69108|P1|STARTED|Overall Study||28
30956|NCT01759381|69115|P2|NOT COMPLETED|Overall Study||0
30957|NCT01759381|69116|P1|NOT COMPLETED|Overall Study||1
30958|NCT01759381|69115|P2|COMPLETED|Overall Study||11
30959|NCT01759381|69116|P1|COMPLETED|Overall Study||7
30960|NCT01759381|69115|P2|STARTED|Overall Study||11
30961|NCT01759381|69116|P1|STARTED|Overall Study||8
30962|NCT01759368|69124|P2|NOT COMPLETED|Overall Study||0
30963|NCT01759368|69125|P1|NOT COMPLETED|Overall Study||1
30964|NCT01759368|69124|P2|COMPLETED|Overall Study||47
30965|NCT01759368|69125|P1|COMPLETED|Overall Study||46
30966|NCT01759368|69124|P2|STARTED|Overall Study||47
30967|NCT01759368|69125|P1|STARTED|Overall Study||47
30968|NCT01759290|69143|P1|NOT COMPLETED|Overall Study||81
30969|NCT01759290|69143|P1|COMPLETED|Overall Study||1719
30970|NCT01759290|69143|P1|STARTED|Overall Study||1800
30971|NCT01759264|69203|P1|NOT COMPLETED|Overall Study||10
30972|NCT01759264|69203|P1|COMPLETED|Overall Study||91
30973|NCT01759264|69203|P1|STARTED|Overall Study||101
30974|NCT01759251|69216|P1|NOT COMPLETED|Follow-up Period||0
30975|NCT01759251|69216|P1|COMPLETED|Follow-up Period||305
30976|NCT01759251|69216|P1|STARTED|Follow-up Period||305
30977|NCT01759251|69216|P1|NOT COMPLETED|60 Days Treatment Period||0
30978|NCT01759251|69216|P1|COMPLETED|60 Days Treatment Period||305
30979|NCT01759251|69216|P1|STARTED|60 Days Treatment Period||305
30980|NCT01759251|69216|P1|NOT COMPLETED|30 Days Treatment Period||4
30981|NCT01759251|69216|P1|COMPLETED|30 Days Treatment Period||305
30982|NCT01759251|69216|P1|STARTED|30 Days Treatment Period||309
30983|NCT01759160|69222|P2|NOT COMPLETED|Overall Study||0
30984|NCT01759160|69223|P1|NOT COMPLETED|Overall Study||0
30985|NCT01759160|69222|P2|COMPLETED|Overall Study||30
30986|NCT01759160|69223|P1|COMPLETED|Overall Study||30
30987|NCT01759160|69222|P2|STARTED|Overall Study||30
30988|NCT01759160|69223|P1|STARTED|Overall Study||30
30989|NCT01758900|69231|P2|NOT COMPLETED|Overall Study||8
30990|NCT01758900|69232|P1|NOT COMPLETED|Overall Study||7
30991|NCT01758900|69231|P2|COMPLETED|Overall Study||100
30992|NCT01758900|69232|P1|COMPLETED|Overall Study||99
30993|NCT01758900|69231|P2|STARTED|Overall Study||108
30994|NCT01758900|69232|P1|STARTED|Overall Study||106
30995|NCT01758289|69250|P1|NOT COMPLETED|Overall Study||53
30996|NCT01758289|69250|P1|COMPLETED|Overall Study||52
30997|NCT01758289|69250|P1|STARTED|Overall Study||105
30998|NCT01757964|69269|P2|NOT COMPLETED|Overall Study||0
30999|NCT01757964|69270|P1|NOT COMPLETED|Overall Study||0
31000|NCT01757964|69269|P2|COMPLETED|Overall Study||4
31001|NCT01757964|69270|P1|COMPLETED|Overall Study||9
31002|NCT01757964|69269|P2|STARTED|Overall Study||4
31003|NCT01757964|69270|P1|STARTED|Overall Study||9
31004|NCT01757847|69276|P2|NOT COMPLETED|Overall Study||4
31005|NCT01757847|69277|P1|NOT COMPLETED|Overall Study||3
31006|NCT01757847|69276|P2|COMPLETED|Overall Study||42
31007|NCT01757847|69277|P1|COMPLETED|Overall Study||41
31008|NCT01757847|69276|P2|STARTED|Overall Study||46
31009|NCT01757847|69277|P1|STARTED|Overall Study||44
31010|NCT01757704|69287|P2|NOT COMPLETED|Overall Study||3
31011|NCT01757704|69288|P1|NOT COMPLETED|Overall Study||1
31012|NCT01757704|69287|P2|COMPLETED|Overall Study||10
31013|NCT01757704|69288|P1|COMPLETED|Overall Study||10
31014|NCT01757704|69287|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
31015|NCT01757704|69288|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
31016|NCT01757691|69306|P2|NOT COMPLETED|Overall Study||0
31017|NCT01757691|69307|P1|NOT COMPLETED|Overall Study||2
31018|NCT01757691|69306|P2|COMPLETED|Overall Study||0
31019|NCT01757691|69307|P1|COMPLETED|Overall Study||0
31020|NCT01757691|69306|P2|STARTED|Overall Study||0
31021|NCT01757691|69307|P1|STARTED|Overall Study||2
31022|NCT01757561|69324|P4|NOT COMPLETED|Overall Study||9
31023|NCT01757561|69325|P3|NOT COMPLETED|Overall Study||7
31024|NCT01757561|69326|P2|NOT COMPLETED|Overall Study||6
31025|NCT01757561|69327|P1|NOT COMPLETED|Overall Study||6
31026|NCT01757561|69324|P4|COMPLETED|Overall Study||25
31027|NCT01757561|69325|P3|COMPLETED|Overall Study||31
31028|NCT01757561|69326|P2|COMPLETED|Overall Study||28
31029|NCT01757561|69327|P1|COMPLETED|Overall Study||32
31030|NCT01757561|69324|P4|STARTED|Overall Study||34
31031|NCT01757561|69325|P3|STARTED|Overall Study||38
31032|NCT01757561|69326|P2|STARTED|Overall Study||34
31033|NCT01757561|69327|P1|STARTED|Overall Study||38
31034|NCT01757405|69343|P2|NOT COMPLETED|Overall Study||2
31035|NCT01757405|69344|P1|NOT COMPLETED|Overall Study||1
31036|NCT01757405|69343|P2|COMPLETED|Overall Study||18
31037|NCT01757405|69344|P1|COMPLETED|Overall Study||17
31038|NCT01757405|69343|P2|STARTED|Overall Study||20
31039|NCT01757405|69344|P1|STARTED|Overall Study||18
31040|NCT01757275|69362|P2|NOT COMPLETED|Overall Study||13
31041|NCT01757275|69363|P1|NOT COMPLETED|Overall Study||9
31042|NCT01757275|69362|P2|COMPLETED|Overall Study||98
31043|NCT01757275|69363|P1|COMPLETED|Overall Study||102
31044|NCT01757275|69362|P2|STARTED|Overall Study||111
31045|NCT01757275|69363|P1|STARTED|Overall Study||111
31046|NCT01757184|69387|P2|NOT COMPLETED|Open-Label Period||0
31047|NCT01757184|69388|P1|NOT COMPLETED|Open-Label Period||0
31048|NCT01757184|69387|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
31049|NCT01757184|69388|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
31050|NCT01757184|69387|P2|STARTED|Open-Label Period||30
31051|NCT01757184|69388|P1|STARTED|Open-Label Period||35
31052|NCT01757184|69387|P2|NOT COMPLETED|Double-Blind Period||0
31053|NCT01757184|69388|P1|NOT COMPLETED|Double-Blind Period||1
31054|NCT01757184|69387|P2|COMPLETED|Double-Blind Period||30
31055|NCT01757184|69388|P1|COMPLETED|Double-Blind Period||35
31056|NCT01757184|69387|P2|STARTED|Double-Blind Period||30
31057|NCT01757184|69388|P1|STARTED|Double-Blind Period||36
31058|NCT01756976|69412|P2|NOT COMPLETED|Overall Study||0
31059|NCT01756976|69413|P1|NOT COMPLETED|Overall Study||3
31060|NCT01756976|69412|P2|COMPLETED|Overall Study||8
31061|NCT01756976|69413|P1|COMPLETED|Overall Study||73
31062|NCT01756976|69412|P2|STARTED|Overall Study||8
31063|NCT01756976|69413|P1|STARTED|Overall Study||76
31064|NCT01756391|69419|P1|NOT COMPLETED|Overall Study||32
31065|NCT01756391|69419|P1|COMPLETED|Overall Study||319
31066|NCT01756391|69419|P1|STARTED|Overall Study||351
31067|NCT01756300|69423|P1|NOT COMPLETED|Overall Study||2
31068|NCT01756300|69423|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
31069|NCT01756300|69423|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
31070|NCT01756274|69445|P1|NOT COMPLETED|Overall Study||3
31071|NCT01756274|69445|P1|COMPLETED|Overall Study||159
31072|NCT01756274|69445|P1|STARTED|Overall Study||162
31073|NCT01756157|69452|P2|NOT COMPLETED|Second Intervention Period||0
31074|NCT01756157|69453|P1|NOT COMPLETED|Second Intervention Period||0
31075|NCT01756157|69452|P2|COMPLETED|Second Intervention Period||22
31076|NCT01756157|69453|P1|COMPLETED|Second Intervention Period||22
31077|NCT01756157|69452|P2|STARTED|Second Intervention Period||22
31078|NCT01756157|69453|P1|STARTED|Second Intervention Period||22
31079|NCT01756157|69452|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
31080|NCT01756157|69453|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
31081|NCT01756157|69452|P2|COMPLETED|Washout Period (at Least 7 Days)||22
31082|NCT01756157|69453|P1|COMPLETED|Washout Period (at Least 7 Days)||22
31083|NCT01756157|69452|P2|STARTED|Washout Period (at Least 7 Days)||22
31084|NCT01756157|69453|P1|STARTED|Washout Period (at Least 7 Days)||22
31085|NCT01756157|69452|P2|NOT COMPLETED|First Intervention Period||2
31086|NCT01756157|69453|P1|NOT COMPLETED|First Intervention Period||1
31087|NCT01756157|69452|P2|COMPLETED|First Intervention Period||22
31088|NCT01756157|69453|P1|COMPLETED|First Intervention Period||22
31089|NCT01756157|69452|P2|STARTED|First Intervention Period||24
31090|NCT01756157|69453|P1|STARTED|First Intervention Period||23
31091|NCT01756079|69467|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
31092|NCT01756079|69467|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
31093|NCT01756079|69467|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
31094|NCT01756079|69467|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
31095|NCT01756079|69467|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
31096|NCT01756079|69467|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
31097|NCT01756079|69467|P1|STARTED|Lead-in: Day 0 to Week 4||58
31098|NCT01756053|69473|P2|NOT COMPLETED|Period 2 (10 Days)||2
31099|NCT01756053|69474|P1|NOT COMPLETED|Period 2 (10 Days)||0
31100|NCT01756053|69473|P2|COMPLETED|Period 2 (10 Days)||6
31101|NCT01756053|69474|P1|COMPLETED|Period 2 (10 Days)||7
31102|NCT01756053|69473|P2|STARTED|Period 2 (10 Days)||8
31103|NCT01756053|69474|P1|STARTED|Period 2 (10 Days)||7
31104|NCT01756053|69473|P2|NOT COMPLETED|Washout Period (~21 Days)||0
31105|NCT01756053|69474|P1|NOT COMPLETED|Washout Period (~21 Days)||0
31106|NCT01756053|69473|P2|COMPLETED|Washout Period (~21 Days)||8
31107|NCT01756053|69474|P1|COMPLETED|Washout Period (~21 Days)||7
31108|NCT01756053|69473|P2|STARTED|Washout Period (~21 Days)||8
31109|NCT01756053|69474|P1|STARTED|Washout Period (~21 Days)||7
31110|NCT01756053|69473|P2|NOT COMPLETED|Period 1 (10 Days)||1
31111|NCT01756053|69474|P1|NOT COMPLETED|Period 1 (10 Days)||1
31112|NCT01756053|69473|P2|COMPLETED|Period 1 (10 Days)||8
31113|NCT01756053|69474|P1|COMPLETED|Period 1 (10 Days)||7
31114|NCT01756053|69473|P2|STARTED|Period 1 (10 Days)||9
31115|NCT01756053|69474|P1|STARTED|Period 1 (10 Days)||8
31116|NCT01755702|69494|P1|NOT COMPLETED|Period III||0
31117|NCT01755702|69494|P1|COMPLETED|Period III||58
31118|NCT01755702|69494|P1|Received Ibuprofen|Period III||18
31119|NCT01755702|69494|P1|Received Paracetamol/Caffeine|Period III||10
31120|NCT01755702|69494|P1|Received Placebo|Period III||13
31121|NCT01755702|69494|P1|Received Paracetamol|Period III||17
31122|NCT01755702|69494|P1|STARTED|Period III||58
31123|NCT01755702|69494|P1|NOT COMPLETED|Washout Period II||5
31124|NCT01755702|69494|P1|COMPLETED|Washout Period II||58
31125|NCT01755702|69494|P1|STARTED|Washout Period II||63
31126|NCT01755702|69494|P1|NOT COMPLETED|Period II||0
31127|NCT01755702|69494|P1|COMPLETED|Period II||63
31128|NCT01755702|69494|P1|Received Paracetamol|Period II||17
31129|NCT01755702|69494|P1|Received Paracetamol/Caffeine|Period II||20
31130|NCT01755702|69494|P1|Received Placebo|Period II||15
31131|NCT01755702|69494|P1|Received Ibuprofen|Period II||11
31132|NCT01755702|69494|P1|STARTED|Period II||63
31133|NCT01755702|69494|P1|NOT COMPLETED|Wash Out Period I||3
31134|NCT01755702|69494|P1|COMPLETED|Wash Out Period I||63
31135|NCT01755702|69494|P1|STARTED|Wash Out Period I||66
31136|NCT01755702|69494|P1|NOT COMPLETED|Period I||0
31137|NCT01755702|69494|P1|COMPLETED|Period I||66
31138|NCT01755702|69494|P1|Received Paracetamol/Caffeine|Period I||17
31139|NCT01755702|69494|P1|Received Ibuprofen|Period I||16
31140|NCT01755702|69494|P1|Received Placebo|Period I||17
31141|NCT01755702|69494|P1|Received Paracetamol|Period I||16
31142|NCT01755702|69494|P1|STARTED|Period I||66
31143|NCT01755637|69536|P2|NOT COMPLETED|Period 2||0
31144|NCT01755637|69537|P1|NOT COMPLETED|Period 2||0
31145|NCT01755637|69536|P2|COMPLETED|Period 2||27
31146|NCT01755637|69537|P1|COMPLETED|Period 2||28
31147|NCT01755637|69536|P2|STARTED|Period 2||27
31148|NCT01755637|69537|P1|STARTED|Period 2||28
31149|NCT01755637|69536|P2|NOT COMPLETED|Period 1||1
31150|NCT01755637|69537|P1|NOT COMPLETED|Period 1||0
31151|NCT01755637|69536|P2|COMPLETED|Period 1||27
31152|NCT01755637|69537|P1|COMPLETED|Period 1||28
31153|NCT01755637|69536|P2|STARTED|Period 1||28
31154|NCT01755637|69537|P1|STARTED|Period 1||28
31155|NCT01755455|69555|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
31156|NCT01755455|69556|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
31157|NCT01755455|69555|P2|COMPLETED|Second Intervention (6 Weeks)||11
31158|NCT01755455|69556|P1|COMPLETED|Second Intervention (6 Weeks)||11
31159|NCT01755455|69555|P2|STARTED|Second Intervention (6 Weeks)||11
31160|NCT01755455|69556|P1|STARTED|Second Intervention (6 Weeks)||11
31161|NCT01755455|69555|P2|NOT COMPLETED|Washout (4 Weeks)||0
31162|NCT01755455|69556|P1|NOT COMPLETED|Washout (4 Weeks)||0
31163|NCT01755455|69555|P2|COMPLETED|Washout (4 Weeks)||11
31164|NCT01755455|69556|P1|COMPLETED|Washout (4 Weeks)||11
31165|NCT01755455|69555|P2|STARTED|Washout (4 Weeks)||11
31166|NCT01755455|69556|P1|STARTED|Washout (4 Weeks)||11
31167|NCT01755455|69555|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
31168|NCT01755455|69556|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
31169|NCT01755455|69555|P2|COMPLETED|First Intervention (6 Weeks)||11
31170|NCT01755455|69556|P1|COMPLETED|First Intervention (6 Weeks)||11
31171|NCT01755455|69555|P2|STARTED|First Intervention (6 Weeks)||11
31172|NCT01755455|69556|P1|STARTED|First Intervention (6 Weeks)||11
31173|NCT01755234|69570|P2|NOT COMPLETED|Overall Study||8
31174|NCT01755234|69571|P1|NOT COMPLETED|Overall Study||15
31175|NCT01755234|69570|P2|COMPLETED|Overall Study||37
31176|NCT01755234|69571|P1|COMPLETED|Overall Study||30
31177|NCT01755234|69570|P2|STARTED|Overall Study||45
31178|NCT01755234|69571|P1|STARTED|Overall Study||45
31179|NCT01755169|69587|P4|NOT COMPLETED|Overall Study||0
31180|NCT01755169|69588|P3|NOT COMPLETED|Overall Study||0
31181|NCT01755169|69589|P2|NOT COMPLETED|Overall Study||0
31182|NCT01755169|69590|P1|NOT COMPLETED|Overall Study||0
31183|NCT01755169|69587|P4|COMPLETED|Overall Study||1
31184|NCT01755169|69588|P3|COMPLETED|Overall Study||0
31185|NCT01755169|69589|P2|COMPLETED|Overall Study||1
31186|NCT01755169|69590|P1|COMPLETED|Overall Study||2
31187|NCT01755169|69587|P4|STARTED|Overall Study||1
31188|NCT01755169|69588|P3|STARTED|Overall Study||0
31189|NCT01755169|69589|P2|STARTED|Overall Study||1
31190|NCT01755169|69590|P1|STARTED|Overall Study||2
31191|NCT01755143|69602|P2|NOT COMPLETED|Overall Study||3
31192|NCT01755143|69603|P1|NOT COMPLETED|Overall Study||11
31193|NCT01755143|69602|P2|COMPLETED|Overall Study||86
31194|NCT01755143|69603|P1|COMPLETED|Overall Study||166
31195|NCT01755143|69602|P2|STARTED|Overall Study||89
31196|NCT01755143|69603|P1|STARTED|Overall Study||177
31197|NCT01755026|69619|P2|NOT COMPLETED|Overall Study||1
31198|NCT01755026|69620|P1|NOT COMPLETED|Overall Study||2
31199|NCT01755026|69619|P2|COMPLETED|Overall Study||11
31200|NCT01755026|69620|P1|COMPLETED|Overall Study||9
31201|NCT01755026|69619|P2|STARTED|Overall Study||12
31202|NCT01755026|69620|P1|STARTED|Overall Study||11
31203|NCT01754922|69628|P2|NOT COMPLETED|Overall Study||1
31204|NCT01754922|69629|P1|NOT COMPLETED|Overall Study||0
31205|NCT01754922|69628|P2|COMPLETED|Overall Study||17
31206|NCT01754922|69629|P1|COMPLETED|Overall Study||32
31207|NCT01754922|69628|P2|STARTED|Overall Study||18
31208|NCT01754922|69629|P1|STARTED|Overall Study||32
31209|NCT01754766|69642|P3|NOT COMPLETED|Overall Study||0
31210|NCT01754766|69643|P2|NOT COMPLETED|Overall Study||1
31211|NCT01754766|69644|P1|NOT COMPLETED|Overall Study||1
31212|NCT01754766|69642|P3|COMPLETED|Overall Study||30
31213|NCT01754766|69643|P2|COMPLETED|Overall Study||28
31214|NCT01754766|69644|P1|COMPLETED|Overall Study||30
31215|NCT01754766|69642|P3|STARTED|Overall Study||30
31216|NCT01754766|69643|P2|STARTED|Overall Study||29
31217|NCT01754766|69644|P1|STARTED|Overall Study||31
31218|NCT01754714|69662|P4|NOT COMPLETED|Overall Study||1
31219|NCT01754714|69663|P3|NOT COMPLETED|Overall Study||2
31220|NCT01754714|69664|P2|NOT COMPLETED|Overall Study||1
31221|NCT01754714|69665|P1|NOT COMPLETED|Overall Study||0
31222|NCT01754714|69662|P4|COMPLETED|Overall Study||27
31223|NCT01754714|69663|P3|COMPLETED|Overall Study||24
31224|NCT01754714|69664|P2|COMPLETED|Overall Study||26
31225|NCT01754714|69665|P1|COMPLETED|Overall Study||27
31226|NCT01754714|69662|P4|STARTED|Overall Study||28
31227|NCT01754714|69663|P3|STARTED|Overall Study||26
31228|NCT01754714|69664|P2|STARTED|Overall Study||27
31229|NCT01754714|69665|P1|STARTED|Overall Study||27
31230|NCT01754623|69755|P1|NOT COMPLETED|Overall Study||0
31231|NCT01754623|69755|P1|COMPLETED|Overall Study||9
31232|NCT01754623|69755|P1|STARTED|Overall Study||9
31233|NCT01754493|69762|P1|NOT COMPLETED|Overall Study||7
31234|NCT01754493|69762|P1|COMPLETED|Overall Study||10
31235|NCT01754493|69762|P1|STARTED|Overall Study||17
31236|NCT01754480|69772|P2|NOT COMPLETED|Primary Part II||11
31237|NCT01754480|69773|P1|NOT COMPLETED|Primary Part II||15
31238|NCT01754480|69772|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
31239|NCT01754480|69773|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
31240|NCT01754480|69772|P2|Completed Study up to Week 6|Primary Part II||108
31241|NCT01754480|69773|P1|Completed Study up to Week 6|Primary Part II||100
31242|NCT01754480|69772|P2|STARTED|Primary Part II||113
31243|NCT01754480|69773|P1|STARTED|Primary Part II||111
31244|NCT01754480|69772|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
31245|NCT01754480|69773|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
31246|NCT01754480|69772|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
31247|NCT01754480|69773|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
31248|NCT01754480|69772|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
31249|NCT01754480|69773|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
31250|NCT01754480|69772|P2|STARTED|Part I + Part II (Overall Study)||162
31251|NCT01754480|69773|P1|STARTED|Part I + Part II (Overall Study)||163
31252|NCT01753856|69789|P2|NOT COMPLETED|Overall Study||2
31253|NCT01753856|69790|P1|NOT COMPLETED|Overall Study||3
31254|NCT01753856|69789|P2|COMPLETED|Overall Study||34
31255|NCT01753856|69790|P1|COMPLETED|Overall Study||30
31256|NCT01753856|69789|P2|Completed 3-Month Bone Biopsy|Overall Study||35
31257|NCT01753856|69790|P1|Completed 3-Month Bone Biopsy|Overall Study||31
31258|NCT01753856|69789|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
31259|NCT01753856|69790|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
31260|NCT01753856|69789|P2|STARTED|Overall Study||36
31261|NCT01753856|69790|P1|STARTED|Overall Study||33
31262|NCT01753557|69842|P2|NOT COMPLETED|Overall Study||0
31263|NCT01753557|69843|P1|NOT COMPLETED|Overall Study||0
31264|NCT01753557|69842|P2|COMPLETED|Overall Study||19
31265|NCT01753557|69843|P1|COMPLETED|Overall Study||35
31266|NCT01753557|69842|P2|STARTED|Overall Study||19
31267|NCT01753557|69843|P1|STARTED|Overall Study||35
31268|NCT01753518|69861|P2|NOT COMPLETED|Postpartum Follow-up||15
31269|NCT01753518|69862|P1|NOT COMPLETED|Postpartum Follow-up||22
31270|NCT01753518|69861|P2|COMPLETED|Postpartum Follow-up||88
31271|NCT01753518|69862|P1|COMPLETED|Postpartum Follow-up||81
31272|NCT01753518|69861|P2|STARTED|Postpartum Follow-up||103
31273|NCT01753518|69862|P1|STARTED|Postpartum Follow-up||103
31274|NCT01753518|69861|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
31275|NCT01753518|69862|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
31276|NCT01753518|69861|P2|COMPLETED|Intention-to-Treat Analysis||103
31277|NCT01753518|69862|P1|COMPLETED|Intention-to-Treat Analysis||103
31278|NCT01753518|69861|P2|STARTED|Intention-to-Treat Analysis||110
31279|NCT01753518|69862|P1|STARTED|Intention-to-Treat Analysis||110
31280|NCT01753323|69887|P3|NOT COMPLETED|Overall Study||9
31281|NCT01753323|69888|P2|NOT COMPLETED|Overall Study||0
31282|NCT01753323|69889|P1|NOT COMPLETED|Overall Study||1
31283|NCT01753323|69887|P3|COMPLETED|Overall Study||13
31284|NCT01753323|69888|P2|COMPLETED|Overall Study||10
31285|NCT01753323|69889|P1|COMPLETED|Overall Study||10
31286|NCT01753323|69887|P3|Intent-to-treat Analysis Set|Overall Study||22
31287|NCT01753323|69888|P2|Intent-to-treat Analysis Set|Overall Study||10
31288|NCT01753323|69889|P1|Intent-to-treat Analysis Set|Overall Study||11
31289|NCT01753323|69887|P3|Safety Set|Overall Study||22
31290|NCT01753323|69888|P2|Safety Set|Overall Study||10
31291|NCT01753323|69889|P1|Safety Set|Overall Study||11
31292|NCT01753323|69887|P3|Pharmacokinetic(PK) Set|Overall Study||21
31293|NCT01753323|69888|P2|Pharmacokinetic(PK) Set|Overall Study||10
31294|NCT01753323|69889|P1|Pharmacokinetic(PK) Set|Overall Study||10
31295|NCT01753323|69887|P3|Pharmacodynamic (PD) Set|Overall Study||21
31296|NCT01753323|69888|P2|Pharmacodynamic (PD) Set|Overall Study||10
31297|NCT01753323|69889|P1|Pharmacodynamic (PD) Set|Overall Study||10
31298|NCT01753323|69887|P3|STARTED|Overall Study||22
31299|NCT01753323|69888|P2|STARTED|Overall Study||10
31300|NCT01753323|69889|P1|STARTED|Overall Study||11
31301|NCT01753115|69928|P3|NOT COMPLETED|Overall Study||14
31302|NCT01753115|69929|P2|NOT COMPLETED|Overall Study||15
31303|NCT01753115|69930|P1|NOT COMPLETED|Overall Study||12
31304|NCT01753115|69928|P3|COMPLETED|Overall Study||56
31305|NCT01753115|69929|P2|COMPLETED|Overall Study||25
31306|NCT01753115|69930|P1|COMPLETED|Overall Study||32
31307|NCT01753115|69928|P3|Treated|Overall Study||67
31308|NCT01753115|69929|P2|Treated|Overall Study||39
31309|NCT01753115|69930|P1|Treated|Overall Study||38
31310|NCT01753115|69928|P3|STARTED|Overall Study||70
31311|NCT01753115|69929|P2|STARTED|Overall Study||40
31312|NCT01753115|69930|P1|STARTED|Overall Study||44
31313|NCT01752907|69940|P2|NOT COMPLETED|Overall Study||20
31314|NCT01752907|69941|P1|NOT COMPLETED|Overall Study||12
31315|NCT01752907|69940|P2|COMPLETED|Overall Study||133
31316|NCT01752907|69941|P1|COMPLETED|Overall Study||139
31317|NCT01752907|69940|P2|Received Pegfilgrastim|Overall Study||151
31318|NCT01752907|69941|P1|Received Pegfilgrastim|Overall Study||149
31319|NCT01752907|69940|P2|STARTED|Overall Study||153
31320|NCT01752907|69941|P1|STARTED|Overall Study||151
31321|NCT01752855|69961|P2|NOT COMPLETED|Overall Study||4
31322|NCT01752855|69962|P1|NOT COMPLETED|Overall Study||1
31323|NCT01752855|69961|P2|COMPLETED|Overall Study||40
31324|NCT01752855|69962|P1|COMPLETED|Overall Study||43
31325|NCT01752855|69961|P2|STARTED|Overall Study||44
31326|NCT01752855|69962|P1|STARTED|Overall Study||44
31327|NCT01751867|69978|P2|NOT COMPLETED|Overall Study||99
31328|NCT01751867|69979|P1|NOT COMPLETED|Overall Study||36
31329|NCT01751867|69978|P2|COMPLETED|Overall Study||0
31330|NCT01751867|69979|P1|COMPLETED|Overall Study||0
31331|NCT01751867|69978|P2|Treated|Overall Study||98
31332|NCT01751867|69979|P1|Treated|Overall Study||34
31333|NCT01751867|69978|P2|STARTED|Overall Study||99
31334|NCT01751867|69979|P1|STARTED|Overall Study||36
31335|NCT01751802|69999|P2|NOT COMPLETED|Overall Study||2
31336|NCT01751802|70000|P1|NOT COMPLETED|Overall Study||4
31337|NCT01751802|69999|P2|COMPLETED|Overall Study||2
31338|NCT01751802|70000|P1|COMPLETED|Overall Study||1
31339|NCT01751802|69999|P2|Completed Period 3|Overall Study||1
31340|NCT01751802|70000|P1|Completed Period 3|Overall Study||2
31341|NCT01751802|69999|P2|Completed Period 2|Overall Study||1
31342|NCT01751802|70000|P1|Completed Period 2|Overall Study||2
31343|NCT01751802|69999|P2|Completed Period 1|Overall Study||4
31344|NCT01751802|70000|P1|Completed Period 1|Overall Study||2
31345|NCT01751802|69999|P2|STARTED|Overall Study||4
31346|NCT01751802|70000|P1|STARTED|Overall Study||5
31347|NCT01751308|70017|P5|NOT COMPLETED|Phase 2||0
31348|NCT01751308|70018|P4|NOT COMPLETED|Phase 2||0
31349|NCT01751308|70019|P3|NOT COMPLETED|Phase 2||0
31350|NCT01751308|70020|P2|NOT COMPLETED|Phase 2||0
31351|NCT01751308|70021|P1|NOT COMPLETED|Phase 2||0
31352|NCT01751308|70017|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
31353|NCT01751308|70018|P4|COMPLETED|Phase 2||0
31354|NCT01751308|70019|P3|COMPLETED|Phase 2||0
31355|NCT01751308|70020|P2|COMPLETED|Phase 2||0
31356|NCT01751308|70021|P1|COMPLETED|Phase 2||0
31357|NCT01751308|70017|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
31358|NCT01751308|70018|P4|STARTED|Phase 2||0
31359|NCT01751308|70019|P3|STARTED|Phase 2||0
31360|NCT01751308|70020|P2|STARTED|Phase 2||0
31361|NCT01751308|70021|P1|STARTED|Phase 2||0
31362|NCT01751308|70017|P5|NOT COMPLETED|Phase 1||0
31363|NCT01751308|70018|P4|NOT COMPLETED|Phase 1||0
31364|NCT01751308|70019|P3|NOT COMPLETED|Phase 1||0
31365|NCT01751308|70020|P2|NOT COMPLETED|Phase 1||0
31366|NCT01751308|70021|P1|NOT COMPLETED|Phase 1||0
31367|NCT01751308|70017|P5|COMPLETED|Phase 1||0
31450|NCT01751113|70084|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
31368|NCT01751308|70018|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
31369|NCT01751308|70019|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
31370|NCT01751308|70020|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
31371|NCT01751308|70021|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
31372|NCT01751308|70017|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
31373|NCT01751308|70018|P4|STARTED|Phase 1||7
31374|NCT01751308|70019|P3|STARTED|Phase 1||7
31375|NCT01751308|70020|P2|STARTED|Phase 1||3
31376|NCT01751308|70021|P1|STARTED|Phase 1||6
31377|NCT01751178|70061|P3|NOT COMPLETED|Overall Study||2
31378|NCT01751178|70062|P2|NOT COMPLETED|Overall Study||0
31379|NCT01751178|70063|P1|NOT COMPLETED|Overall Study||3
31380|NCT01751178|70061|P3|COMPLETED|Overall Study||105
31381|NCT01751178|70062|P2|COMPLETED|Overall Study||109
31382|NCT01751178|70063|P1|COMPLETED|Overall Study||105
31383|NCT01751178|70061|P3|STARTED|Overall Study||107
31384|NCT01751178|70062|P2|STARTED|Overall Study||109
31385|NCT01751178|70063|P1|STARTED|Overall Study||108
31386|NCT01751113|70080|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
31387|NCT01751113|70081|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
31388|NCT01751113|70082|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
31389|NCT01751113|70083|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
31390|NCT01751113|70084|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
31391|NCT01751113|70085|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
31392|NCT01751113|70080|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
31393|NCT01751113|70081|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
31394|NCT01751113|70082|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
31395|NCT01751113|70083|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
31396|NCT01751113|70084|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
31397|NCT01751113|70085|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
31398|NCT01751113|70080|P6|STARTED|Treatment Period 3 (4 Weeks)||10
31399|NCT01751113|70081|P5|STARTED|Treatment Period 3 (4 Weeks)||8
31400|NCT01751113|70082|P4|STARTED|Treatment Period 3 (4 Weeks)||8
31401|NCT01751113|70083|P3|STARTED|Treatment Period 3 (4 Weeks)||9
31402|NCT01751113|70084|P2|STARTED|Treatment Period 3 (4 Weeks)||8
31403|NCT01751113|70085|P1|STARTED|Treatment Period 3 (4 Weeks)||8
31404|NCT01751113|70080|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31405|NCT01751113|70081|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31406|NCT01751113|70082|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31407|NCT01751113|70083|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31408|NCT01751113|70084|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31409|NCT01751113|70085|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
31410|NCT01751113|70080|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
31411|NCT01751113|70081|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
31412|NCT01751113|70082|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
31413|NCT01751113|70083|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
31414|NCT01751113|70084|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
31415|NCT01751113|70085|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
31416|NCT01751113|70080|P6|STARTED|Washout Period 2 (2 Weeks)||10
31417|NCT01751113|70081|P5|STARTED|Washout Period 2 (2 Weeks)||8
31418|NCT01751113|70082|P4|STARTED|Washout Period 2 (2 Weeks)||8
31419|NCT01751113|70083|P3|STARTED|Washout Period 2 (2 Weeks)||9
31420|NCT01751113|70084|P2|STARTED|Washout Period 2 (2 Weeks)||8
31421|NCT01751113|70085|P1|STARTED|Washout Period 2 (2 Weeks)||8
31422|NCT01751113|70080|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31423|NCT01751113|70081|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31424|NCT01751113|70082|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31425|NCT01751113|70083|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31426|NCT01751113|70084|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31427|NCT01751113|70085|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
31428|NCT01751113|70080|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
31429|NCT01751113|70081|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
31430|NCT01751113|70082|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
31431|NCT01751113|70083|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
31432|NCT01751113|70084|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
31433|NCT01751113|70085|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
31434|NCT01751113|70080|P6|STARTED|Treatment Period 2 (4 Weeks)||10
31435|NCT01751113|70081|P5|STARTED|Treatment Period 2 (4 Weeks)||8
31436|NCT01751113|70082|P4|STARTED|Treatment Period 2 (4 Weeks)||8
31437|NCT01751113|70083|P3|STARTED|Treatment Period 2 (4 Weeks)||9
31438|NCT01751113|70084|P2|STARTED|Treatment Period 2 (4 Weeks)||8
31439|NCT01751113|70085|P1|STARTED|Treatment Period 2 (4 Weeks)||8
31440|NCT01751113|70080|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31441|NCT01751113|70081|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31442|NCT01751113|70082|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31443|NCT01751113|70083|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31444|NCT01751113|70084|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31445|NCT01751113|70085|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
31446|NCT01751113|70080|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
31447|NCT01751113|70081|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
31448|NCT01751113|70082|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
31449|NCT01751113|70083|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
31451|NCT01751113|70085|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
31452|NCT01751113|70080|P6|STARTED|Washout Period 1 (2 Weeks)||10
31453|NCT01751113|70081|P5|STARTED|Washout Period 1 (2 Weeks)||8
31454|NCT01751113|70082|P4|STARTED|Washout Period 1 (2 Weeks)||8
31455|NCT01751113|70083|P3|STARTED|Washout Period 1 (2 Weeks)||9
31456|NCT01751113|70084|P2|STARTED|Washout Period 1 (2 Weeks)||8
31457|NCT01751113|70085|P1|STARTED|Washout Period 1 (2 Weeks)||8
31458|NCT01751113|70080|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
31459|NCT01751113|70081|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
31460|NCT01751113|70082|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
31461|NCT01751113|70083|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
31462|NCT01751113|70084|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
31463|NCT01751113|70085|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
31464|NCT01751113|70080|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
31465|NCT01751113|70081|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
31466|NCT01751113|70082|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
31467|NCT01751113|70083|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
31468|NCT01751113|70084|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
31469|NCT01751113|70085|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
31470|NCT01751113|70080|P6|STARTED|Treatment Period 1 (4 Weeks)||10
31471|NCT01751113|70081|P5|STARTED|Treatment Period 1 (4 Weeks)||9
31472|NCT01751113|70082|P4|STARTED|Treatment Period 1 (4 Weeks)||9
31473|NCT01751113|70083|P3|STARTED|Treatment Period 1 (4 Weeks)||9
31474|NCT01751113|70084|P2|STARTED|Treatment Period 1 (4 Weeks)||8
31475|NCT01751113|70085|P1|STARTED|Treatment Period 1 (4 Weeks)||8
31476|NCT01751087|70126|P3|NOT COMPLETED|Overall Study||1
31477|NCT01751087|70127|P2|NOT COMPLETED|Overall Study||0
31478|NCT01751087|70128|P1|NOT COMPLETED|Overall Study||1
31479|NCT01751087|70126|P3|COMPLETED|Overall Study||99
31480|NCT01751087|70127|P2|COMPLETED|Overall Study||100
31481|NCT01751087|70128|P1|COMPLETED|Overall Study||99
31482|NCT01751087|70126|P3|STARTED|Overall Study||100
31483|NCT01751087|70127|P2|STARTED|Overall Study||100
31484|NCT01751087|70128|P1|STARTED|Overall Study||100
31485|NCT01751022|70163|P3|NOT COMPLETED|Overall Study||27
31486|NCT01751022|70164|P2|NOT COMPLETED|Overall Study||44
31487|NCT01751022|70165|P1|NOT COMPLETED|Overall Study||56
31488|NCT01751022|70163|P3|COMPLETED|Overall Study|6 month visit|273
31489|NCT01751022|70164|P2|COMPLETED|Overall Study|6 month visit|282
31490|NCT01751022|70165|P1|COMPLETED|Overall Study|6 month visit|443
31491|NCT01751022|70163|P3|STARTED|Overall Study||300
31492|NCT01751022|70164|P2|STARTED|Overall Study||326
31493|NCT01751022|70165|P1|STARTED|Overall Study||499
31494|NCT01750840|70197|P1|NOT COMPLETED|Overall Study||4
31495|NCT01750840|70197|P1|COMPLETED|Overall Study||4
31496|NCT01750840|70197|P1|STARTED|Overall Study||8
31497|NCT01750684|70204|P2|NOT COMPLETED|Overall Study||2
31498|NCT01750684|70205|P1|NOT COMPLETED|Overall Study||2
31499|NCT01750684|70204|P2|COMPLETED|Overall Study||5
31500|NCT01750684|70205|P1|COMPLETED|Overall Study||4
31501|NCT01750684|70204|P2|STARTED|Overall Study||7
31502|NCT01750684|70205|P1|STARTED|Overall Study||6
31503|NCT01750502|70213|P2|NOT COMPLETED|Overall Study||0
31504|NCT01750502|70214|P1|NOT COMPLETED|Overall Study||0
31505|NCT01750502|70213|P2|COMPLETED|Overall Study||186
31506|NCT01750502|70214|P1|COMPLETED|Overall Study||70
31507|NCT01750502|70213|P2|STARTED|Overall Study||186
31508|NCT01750502|70214|P1|STARTED|Overall Study||70
31509|NCT01750398|70227|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
31510|NCT01750398|70227|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
31511|NCT01750398|70227|P1|STARTED|Bipolar Androgen Thearpy Phase||29
31512|NCT01750398|70227|P1|NOT COMPLETED|ADT Lead In Phase||4
31513|NCT01750398|70227|P1|COMPLETED|ADT Lead In Phase||29
31514|NCT01750398|70227|P1|STARTED|ADT Lead In Phase||33
31515|NCT01750346|70240|P3|NOT COMPLETED|Overall Study||0
31516|NCT01750346|70241|P2|NOT COMPLETED|Overall Study||0
31517|NCT01750346|70242|P1|NOT COMPLETED|Overall Study||1
31518|NCT01750346|70240|P3|COMPLETED|Overall Study||3
31519|NCT01750346|70241|P2|COMPLETED|Overall Study||2
31520|NCT01750346|70242|P1|COMPLETED|Overall Study||2
31521|NCT01750346|70240|P3|STARTED|Overall Study||3
31522|NCT01750346|70241|P2|STARTED|Overall Study||2
31523|NCT01750346|70242|P1|STARTED|Overall Study||3
31524|NCT01750294|70268|P1|NOT COMPLETED|Overall Study||2
31525|NCT01750294|70268|P1|COMPLETED|Overall Study||12
31526|NCT01750294|70268|P1|STARTED|Overall Study||14
31527|NCT01750255|70274|P2|NOT COMPLETED|Overall Study||5
31528|NCT01750255|70275|P1|NOT COMPLETED|Overall Study||6
31529|NCT01750255|70274|P2|COMPLETED|Overall Study||38
31530|NCT01750255|70275|P1|COMPLETED|Overall Study||43
31531|NCT01750255|70274|P2|STARTED|Overall Study||43
31532|NCT01750255|70275|P1|STARTED|Overall Study||49
31533|NCT01750242|70291|P1|NOT COMPLETED|Overall Study||3
31534|NCT01750242|70291|P1|COMPLETED|Overall Study||20
31535|NCT01750242|70291|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
31536|NCT01750242|70291|P1|STARTED|Overall Study||23
31537|NCT01750086|70298|P2|NOT COMPLETED|Overall Study||1
31538|NCT01750086|70299|P1|NOT COMPLETED|Overall Study||1
31539|NCT01750086|70298|P2|COMPLETED|Overall Study||13
31540|NCT01750086|70299|P1|COMPLETED|Overall Study||12
31541|NCT01750086|70298|P2|STARTED|Overall Study||14
31542|NCT01750086|70299|P1|STARTED|Overall Study||13
31543|NCT01749982|70309|P4|NOT COMPLETED|Overall Study||3
31544|NCT01749982|70310|P3|NOT COMPLETED|Overall Study||0
31545|NCT01749982|70311|P2|NOT COMPLETED|Overall Study||0
31546|NCT01749982|70312|P1|NOT COMPLETED|Overall Study||0
31547|NCT01749982|70309|P4|COMPLETED|Overall Study||12
31548|NCT01749982|70310|P3|COMPLETED|Overall Study||15
31549|NCT01749982|70311|P2|COMPLETED|Overall Study||15
31550|NCT01749982|70312|P1|COMPLETED|Overall Study||15
31551|NCT01749982|70309|P4|STARTED|Overall Study||15
31552|NCT01749982|70310|P3|STARTED|Overall Study||15
31553|NCT01749982|70311|P2|STARTED|Overall Study||15
31554|NCT01749982|70312|P1|STARTED|Overall Study||15
31555|NCT01749956|70330|P1|NOT COMPLETED|Overall Study||15
31556|NCT01749956|70330|P1|COMPLETED|Overall Study||24
31557|NCT01749956|70330|P1|STARTED|Overall Study||39
31558|NCT01748799|70348|P8|NOT COMPLETED|Overall Study||0
31559|NCT01748799|70349|P7|NOT COMPLETED|Overall Study||1
31560|NCT01748799|70350|P6|NOT COMPLETED|Overall Study||1
31561|NCT01748799|70351|P5|NOT COMPLETED|Overall Study||0
31562|NCT01748799|70352|P4|NOT COMPLETED|Overall Study||0
31563|NCT01748799|70353|P3|NOT COMPLETED|Overall Study||0
31564|NCT01748799|70354|P2|NOT COMPLETED|Overall Study||0
31565|NCT01748799|70355|P1|NOT COMPLETED|Overall Study||5
31566|NCT01748799|70348|P8|COMPLETED|Overall Study||1
31567|NCT01748799|70349|P7|COMPLETED|Overall Study||1
31568|NCT01748799|70350|P6|COMPLETED|Overall Study||1
31569|NCT01748799|70351|P5|COMPLETED|Overall Study||1
31570|NCT01748799|70352|P4|COMPLETED|Overall Study||2
31571|NCT01748799|70353|P3|COMPLETED|Overall Study||1
31572|NCT01748799|70354|P2|COMPLETED|Overall Study||1
31573|NCT01748799|70355|P1|COMPLETED|Overall Study||1
31574|NCT01748799|70348|P8|Completed Self-titrated Sativex|Overall Study||1
31575|NCT01748799|70349|P7|Completed Self-titrated Sativex|Overall Study||1
31576|NCT01748799|70350|P6|Completed Self-titrated Sativex|Overall Study||1
31577|NCT01748799|70351|P5|Completed Self-titrated Sativex|Overall Study||1
31578|NCT01748799|70352|P4|Completed Self-titrated Sativex|Overall Study||2
31579|NCT01748799|70353|P3|Completed Self-titrated Sativex|Overall Study||1
31580|NCT01748799|70354|P2|Completed Self-titrated Sativex|Overall Study||1
31581|NCT01748799|70355|P1|Completed Self-titrated Sativex|Overall Study||1
31582|NCT01748799|70348|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
31583|NCT01748799|70349|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
31584|NCT01748799|70350|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
31585|NCT01748799|70351|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
31586|NCT01748799|70352|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
31587|NCT01748799|70353|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
31588|NCT01748799|70354|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
31589|NCT01748799|70355|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
31590|NCT01748799|70348|P8|Completed Self-titrated Placebo|Overall Study||1
31591|NCT01748799|70349|P7|Completed Self-titrated Placebo|Overall Study||1
31592|NCT01748799|70350|P6|Completed Self-titrated Placebo|Overall Study||2
31593|NCT01748799|70351|P5|Completed Self-titrated Placebo|Overall Study||1
31594|NCT01748799|70352|P4|Completed Self-titrated Placebo|Overall Study||2
31595|NCT01748799|70353|P3|Completed Self-titrated Placebo|Overall Study||1
31596|NCT01748799|70354|P2|Completed Self-titrated Placebo|Overall Study||1
31597|NCT01748799|70355|P1|Completed Self-titrated Placebo|Overall Study||4
31598|NCT01748799|70348|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
31599|NCT01748799|70349|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
31600|NCT01748799|70350|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
31601|NCT01748799|70351|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
31602|NCT01748799|70352|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
31603|NCT01748799|70353|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
31604|NCT01748799|70354|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
31605|NCT01748799|70355|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
31606|NCT01748799|70348|P8|Completed Fixed Dose Sativex|Overall Study||1
31607|NCT01748799|70349|P7|Completed Fixed Dose Sativex|Overall Study||1
31608|NCT01748799|70350|P6|Completed Fixed Dose Sativex|Overall Study||1
31609|NCT01748799|70351|P5|Completed Fixed Dose Sativex|Overall Study||1
31610|NCT01748799|70352|P4|Completed Fixed Dose Sativex|Overall Study||2
31611|NCT01748799|70353|P3|Completed Fixed Dose Sativex|Overall Study||1
31612|NCT01748799|70354|P2|Completed Fixed Dose Sativex|Overall Study||1
31613|NCT01748799|70355|P1|Completed Fixed Dose Sativex|Overall Study||1
31614|NCT01748799|70348|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
31615|NCT01748799|70349|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
31616|NCT01748799|70350|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
31617|NCT01748799|70351|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
31618|NCT01748799|70352|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
31619|NCT01748799|70353|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
31620|NCT01748799|70354|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
31621|NCT01748799|70355|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
31622|NCT01748799|70348|P8|Completed Fixed Dose Placebo|Overall Study||1
31623|NCT01748799|70349|P7|Completed Fixed Dose Placebo|Overall Study||1
31624|NCT01748799|70350|P6|Completed Fixed Dose Placebo|Overall Study||1
31625|NCT01748799|70351|P5|Completed Fixed Dose Placebo|Overall Study||1
31626|NCT01748799|70352|P4|Completed Fixed Dose Placebo|Overall Study||2
31627|NCT01748799|70353|P3|Completed Fixed Dose Placebo|Overall Study||1
31628|NCT01748799|70354|P2|Completed Fixed Dose Placebo|Overall Study||1
31629|NCT01748799|70355|P1|Completed Fixed Dose Placebo|Overall Study||2
31630|NCT01748799|70348|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
31631|NCT01748799|70349|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
31632|NCT01748799|70350|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
31633|NCT01748799|70351|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
31634|NCT01748799|70352|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
31635|NCT01748799|70353|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
31636|NCT01748799|70354|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
31637|NCT01748799|70355|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
31638|NCT01748799|70348|P8|STARTED|Overall Study||1
31639|NCT01748799|70349|P7|STARTED|Overall Study||2
31640|NCT01748799|70350|P6|STARTED|Overall Study||2
31641|NCT01748799|70351|P5|STARTED|Overall Study||1
31642|NCT01748799|70352|P4|STARTED|Overall Study||2
31643|NCT01748799|70353|P3|STARTED|Overall Study||1
31644|NCT01748799|70354|P2|STARTED|Overall Study||1
31645|NCT01748799|70355|P1|STARTED|Overall Study||6
31646|NCT01748760|70391|P2|NOT COMPLETED|Overall Study||2
31647|NCT01748760|70392|P1|NOT COMPLETED|Overall Study||6
31648|NCT01748760|70391|P2|COMPLETED|Overall Study||23
31649|NCT01748760|70392|P1|COMPLETED|Overall Study||19
31650|NCT01748760|70391|P2|STARTED|Overall Study||25
31651|NCT01748760|70392|P1|STARTED|Overall Study||25
31652|NCT01749631|70398|P1|NOT COMPLETED|Overall Study||0
31653|NCT01749631|70398|P1|COMPLETED|Overall Study||97
31654|NCT01749631|70398|P1|STARTED|Overall Study||97
31655|NCT01749501|70410|P2|NOT COMPLETED|Overall Study||0
31656|NCT01749501|70411|P1|NOT COMPLETED|Overall Study||0
31657|NCT01749501|70410|P2|COMPLETED|Overall Study||23
31658|NCT01749501|70411|P1|COMPLETED|Overall Study||22
31659|NCT01749501|70410|P2|STARTED|Overall Study||23
31660|NCT01749501|70411|P1|STARTED|Overall Study||22
31661|NCT01749410|70419|P1|NOT COMPLETED|Overall Study||0
31662|NCT01749410|70419|P1|COMPLETED|Overall Study||33
31663|NCT01749410|70419|P1|STARTED|Overall Study||33
31664|NCT01748955|70425|P2|NOT COMPLETED|Overall Study||5
31665|NCT01748955|70426|P1|NOT COMPLETED|Overall Study||3
31666|NCT01748955|70425|P2|COMPLETED|Overall Study||4
31667|NCT01748955|70426|P1|COMPLETED|Overall Study||3
31668|NCT01748955|70425|P2|STARTED|Overall Study||9
31669|NCT01748955|70426|P1|STARTED|Overall Study||6
31670|NCT01748916|70434|P6|NOT COMPLETED|Overall Study||0
31671|NCT01748916|70435|P5|NOT COMPLETED|Overall Study||0
31672|NCT01748916|70436|P4|NOT COMPLETED|Overall Study||0
31673|NCT01748916|70437|P3|NOT COMPLETED|Overall Study||0
31674|NCT01748916|70438|P2|NOT COMPLETED|Overall Study||0
31675|NCT01748916|70439|P1|NOT COMPLETED|Overall Study||0
31676|NCT01748916|70434|P6|COMPLETED|Overall Study||3
31677|NCT01748916|70435|P5|COMPLETED|Overall Study||3
31678|NCT01748916|70436|P4|COMPLETED|Overall Study||3
31679|NCT01748916|70437|P3|COMPLETED|Overall Study||2
31680|NCT01748916|70438|P2|COMPLETED|Overall Study||3
31681|NCT01748916|70439|P1|COMPLETED|Overall Study||2
31682|NCT01748916|70434|P6|STARTED|Overall Study||3
31683|NCT01748916|70435|P5|STARTED|Overall Study||3
31684|NCT01748916|70436|P4|STARTED|Overall Study||3
31685|NCT01748916|70437|P3|STARTED|Overall Study||2
31686|NCT01748916|70438|P2|STARTED|Overall Study||3
31687|NCT01748916|70439|P1|STARTED|Overall Study||2
31688|NCT01748890|70447|P1|NOT COMPLETED|Overall Study||4
31689|NCT01748890|70447|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
31690|NCT01748890|70447|P1|STARTED|Overall Study||4
31691|NCT01748227|70451|P1|NOT COMPLETED|Overall Study||3
31692|NCT01748227|70451|P1|COMPLETED|Overall Study||17
31693|NCT01748227|70451|P1|STARTED|Overall Study||20
31694|NCT01748071|70462|P3|NOT COMPLETED|Overall Study||0
31695|NCT01748071|70463|P2|NOT COMPLETED|Overall Study||2
31696|NCT01748071|70464|P1|NOT COMPLETED|Overall Study||2
31697|NCT01748071|70462|P3|COMPLETED|Overall Study||40
31698|NCT01748071|70463|P2|COMPLETED|Overall Study||38
31699|NCT01748071|70464|P1|COMPLETED|Overall Study||38
31700|NCT01748071|70462|P3|STARTED|Overall Study||40
31701|NCT01748071|70463|P2|STARTED|Overall Study||40
31702|NCT01748071|70464|P1|STARTED|Overall Study||40
31703|NCT01747928|70492|P8|NOT COMPLETED|Overall Study||0
31704|NCT01747928|70493|P7|NOT COMPLETED|Overall Study||0
31705|NCT01747928|70494|P6|NOT COMPLETED|Overall Study||0
31706|NCT01747928|70495|P5|NOT COMPLETED|Overall Study||0
31707|NCT01747928|70496|P4|NOT COMPLETED|Overall Study||0
31708|NCT01747928|70497|P3|NOT COMPLETED|Overall Study||0
31709|NCT01747928|70498|P2|NOT COMPLETED|Overall Study||0
31710|NCT01747928|70499|P1|NOT COMPLETED|Overall Study||0
31711|NCT01747928|70492|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31712|NCT01747928|70493|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31713|NCT01747928|70494|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31714|NCT01747928|70495|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31715|NCT01747928|70496|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31716|NCT01747928|70497|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31717|NCT01747928|70498|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31718|NCT01747928|70499|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
31719|NCT01747928|70492|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31720|NCT01747928|70493|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31721|NCT01747928|70494|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31722|NCT01747928|70495|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31723|NCT01747928|70496|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31724|NCT01747928|70497|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31725|NCT01747928|70498|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31726|NCT01747928|70499|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
31727|NCT01747811|70705|P2|NOT COMPLETED|Overall Study||4
31728|NCT01747811|70706|P1|NOT COMPLETED|Overall Study||2
31729|NCT01747811|70705|P2|COMPLETED|Overall Study||12
31730|NCT01747811|70706|P1|COMPLETED|Overall Study||14
31731|NCT01747811|70705|P2|STARTED|Overall Study||16
31732|NCT01747811|70706|P1|STARTED|Overall Study||16
31733|NCT01747655|70722|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
31734|NCT01747655|70723|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
31735|NCT01747655|70722|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
31736|NCT01747655|70723|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
31737|NCT01747655|70722|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
31738|NCT01747655|70723|P1|STARTED|PEG-J Period (Continued Treatment)||41
31739|NCT01747655|70722|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
31740|NCT01747655|70723|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
31741|NCT01747655|70722|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
31742|NCT01747655|70723|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
31743|NCT01747655|70722|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
31744|NCT01747655|70723|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
31745|NCT01747655|70722|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
31746|NCT01747655|70723|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
31747|NCT01747655|70722|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
31748|NCT01747655|70723|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
31749|NCT01747655|70722|P2|STARTED|Temporary Naso-jejunal Tube Period||0
31750|NCT01747655|70723|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
31751|NCT01747629|70753|P2|NOT COMPLETED|Overall Study||6
31752|NCT01747629|70754|P1|NOT COMPLETED|Overall Study||8
31753|NCT01747629|70753|P2|COMPLETED|Overall Study||69
31754|NCT01747629|70754|P1|COMPLETED|Overall Study||77
31755|NCT01747629|70753|P2|Treated|Overall Study|Safety set and full analysis set|75
31756|NCT01747629|70754|P1|Treated|Overall Study|Safety set and full analysis set|84
31757|NCT01747629|70753|P2|STARTED|Overall Study||75
31758|NCT01747629|70754|P1|STARTED|Overall Study||85
31759|NCT01747343|70786|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
31760|NCT01747343|70786|P1|COMPLETED|Underwear/Differential Reinforcement||4
31761|NCT01747343|70786|P1|STARTED|Underwear/Differential Reinforcement||4
31762|NCT01747343|70786|P1|NOT COMPLETED|Underwear||0
31763|NCT01747343|70786|P1|COMPLETED|Underwear||4
31764|NCT01747343|70786|P1|STARTED|Underwear||4
31765|NCT01747343|70786|P1|NOT COMPLETED|Baseline||0
31766|NCT01747343|70786|P1|COMPLETED|Baseline||4
31767|NCT01747343|70786|P1|STARTED|Baseline||4
31768|NCT01747330|70792|P1|NOT COMPLETED|Overall Study||0
31769|NCT01747330|70792|P1|COMPLETED|Overall Study||40
31770|NCT01747330|70792|P1|STARTED|Overall Study||40
31771|NCT01746940|70808|P4|NOT COMPLETED|Safety Second Phase||0
31772|NCT01746940|70809|P3|NOT COMPLETED|Safety Second Phase||0
31773|NCT01746940|70810|P2|NOT COMPLETED|Safety Second Phase||0
31774|NCT01746940|70811|P1|NOT COMPLETED|Safety Second Phase||0
31775|NCT01746940|70808|P4|COMPLETED|Safety Second Phase||0
31776|NCT01746940|70809|P3|COMPLETED|Safety Second Phase||0
31777|NCT01746940|70810|P2|COMPLETED|Safety Second Phase||18
31778|NCT01746940|70811|P1|COMPLETED|Safety Second Phase||18
31779|NCT01746940|70808|P4|STARTED|Safety Second Phase||0
31780|NCT01746940|70809|P3|STARTED|Safety Second Phase||0
31781|NCT01746940|70810|P2|STARTED|Safety Second Phase||18
31782|NCT01746940|70811|P1|STARTED|Safety Second Phase||18
31783|NCT01746940|70808|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
31784|NCT01746940|70809|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
31785|NCT01746940|70810|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
31786|NCT01746940|70811|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
31787|NCT01746940|70808|P4|COMPLETED|Safety and Efficacy First Phase||0
31788|NCT01746940|70809|P3|COMPLETED|Safety and Efficacy First Phase||40
31789|NCT01746940|70810|P2|COMPLETED|Safety and Efficacy First Phase||41
31790|NCT01746940|70811|P1|COMPLETED|Safety and Efficacy First Phase||39
31791|NCT01746940|70808|P4|STARTED|Safety and Efficacy First Phase||3
31792|NCT01746940|70809|P3|STARTED|Safety and Efficacy First Phase||40
31793|NCT01746940|70810|P2|STARTED|Safety and Efficacy First Phase||41
31794|NCT01746940|70811|P1|STARTED|Safety and Efficacy First Phase||39
31795|NCT01746862|70821|P2|NOT COMPLETED|Overall Study||3
31796|NCT01746862|70822|P1|NOT COMPLETED|Overall Study||8
31797|NCT01746862|70821|P2|COMPLETED|Overall Study||27
31798|NCT01746862|70822|P1|COMPLETED|Overall Study||52
31799|NCT01746862|70821|P2|Treated|Overall Study||30
31800|NCT01746862|70822|P1|Treated|Overall Study||59
31801|NCT01746862|70821|P2|STARTED|Overall Study||30
31802|NCT01746862|70822|P1|STARTED|Overall Study||60
31803|NCT01746784|70847|P5|NOT COMPLETED|Overall Study||0
31804|NCT01746784|70848|P4|NOT COMPLETED|Overall Study||0
31805|NCT01746784|70849|P3|NOT COMPLETED|Overall Study||0
31806|NCT01746784|70850|P2|NOT COMPLETED|Overall Study||0
31807|NCT01746784|70851|P1|NOT COMPLETED|Overall Study||0
31808|NCT01746784|70847|P5|COMPLETED|Overall Study||19
31809|NCT01746784|70848|P4|COMPLETED|Overall Study||9
31810|NCT01746784|70849|P3|COMPLETED|Overall Study||9
31811|NCT01746784|70850|P2|COMPLETED|Overall Study||10
31812|NCT01746784|70851|P1|COMPLETED|Overall Study||19
31813|NCT01746784|70847|P5|Enrolled|Overall Study||19
31814|NCT01746784|70848|P4|Enrolled|Overall Study||9
31815|NCT01746784|70849|P3|Enrolled|Overall Study||9
31816|NCT01746784|70850|P2|Enrolled|Overall Study||10
31817|NCT01746784|70851|P1|Enrolled|Overall Study||19
31818|NCT01746784|70847|P5|STARTED|Overall Study||19
31819|NCT01746784|70848|P4|STARTED|Overall Study||9
31820|NCT01746784|70849|P3|STARTED|Overall Study||9
31821|NCT01746784|70850|P2|STARTED|Overall Study||10
31822|NCT01746784|70851|P1|STARTED|Overall Study||19
31823|NCT01746511|70875|P2|NOT COMPLETED|Overall Study||0
31824|NCT01746511|70876|P1|NOT COMPLETED|Overall Study||0
31825|NCT01746511|70875|P2|COMPLETED|Overall Study||39
31826|NCT01746511|70876|P1|COMPLETED|Overall Study||40
31827|NCT01746511|70875|P2|STARTED|Overall Study||39
31828|NCT01746511|70876|P1|STARTED|Overall Study||40
31829|NCT01746368|70892|P2|NOT COMPLETED|Overall Study||1
31830|NCT01746368|70893|P1|NOT COMPLETED|Overall Study||2
31831|NCT01746368|70892|P2|COMPLETED|Overall Study||16
31832|NCT01746368|70893|P1|COMPLETED|Overall Study||31
31833|NCT01746368|70892|P2|Analyzed for Satisfaction|Overall Study||16
31834|NCT01746368|70893|P1|Analyzed for Satisfaction|Overall Study||30
31835|NCT01746368|70892|P2|Analyzed for AD Completion Rate|Overall Study||17
31836|NCT01746368|70893|P1|Analyzed for AD Completion Rate|Overall Study||32
31837|NCT01746368|70892|P2|Assessment Completed|Overall Study||16
31838|NCT01746368|70893|P1|Assessment Completed|Overall Study||31
31839|NCT01746368|70892|P2|Recieved Allocated Intervention|Overall Study||8
31840|NCT01746368|70893|P1|Recieved Allocated Intervention|Overall Study||31
31841|NCT01746368|70892|P2|STARTED|Overall Study||17
31842|NCT01746368|70893|P1|STARTED|Overall Study||33
31843|NCT01746264|70901|P1|NOT COMPLETED|Overall Study||0
31844|NCT01746264|70901|P1|COMPLETED|Overall Study||19
31845|NCT01746264|70901|P1|STARTED|Overall Study||19
31846|NCT01746173|70920|P1|NOT COMPLETED|Overall Study||2
31847|NCT01746173|70920|P1|COMPLETED|Overall Study||3
31848|NCT01746173|70920|P1|STARTED|Overall Study||5
31849|NCT01746108|70928|P3|NOT COMPLETED|Overall Study||0
31850|NCT01746108|70929|P2|NOT COMPLETED|Overall Study||4
31851|NCT01746108|70930|P1|NOT COMPLETED|Overall Study||0
31852|NCT01746108|70928|P3|COMPLETED|Overall Study||6
31853|NCT01746108|70929|P2|COMPLETED|Overall Study||24
31854|NCT01746108|70930|P1|COMPLETED|Overall Study||18
31855|NCT01746108|70928|P3|STARTED|Overall Study||6
31856|NCT01746108|70929|P2|STARTED|Overall Study||28
31857|NCT01746108|70930|P1|STARTED|Overall Study||18
31858|NCT01745952|70966|P3|NOT COMPLETED|Overall Study||0
31859|NCT01745952|70967|P2|NOT COMPLETED|Overall Study||1
31860|NCT01745952|70968|P1|NOT COMPLETED|Overall Study||1
31861|NCT01745952|70966|P3|COMPLETED|Overall Study||3
31862|NCT01745952|70967|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
31863|NCT01745952|70968|P1|COMPLETED|Overall Study||3
31864|NCT01745952|70966|P3|STARTED|Overall Study||3
31865|NCT01745952|70967|P2|STARTED|Overall Study||4
31866|NCT01745952|70968|P1|STARTED|Overall Study||4
31867|NCT01745380|70994|P2|NOT COMPLETED|Overall Study||1
31868|NCT01745380|70995|P1|NOT COMPLETED|Overall Study||1
31869|NCT01745380|70994|P2|COMPLETED|Overall Study||49
31870|NCT01745380|70995|P1|COMPLETED|Overall Study||99
31871|NCT01745380|70994|P2|STARTED|Overall Study||50
31872|NCT01745380|70995|P1|STARTED|Overall Study||100
31873|NCT01745133|71034|P3|NOT COMPLETED|Overall Study||4
31874|NCT01745133|71035|P2|NOT COMPLETED|Overall Study||4
31875|NCT01745133|71036|P1|NOT COMPLETED|Overall Study||6
31876|NCT01745133|71034|P3|COMPLETED|Overall Study||15
31877|NCT01745133|71035|P2|COMPLETED|Overall Study||16
31878|NCT01745133|71036|P1|COMPLETED|Overall Study||13
31879|NCT01745133|71034|P3|STARTED|Overall Study||19
31880|NCT01745133|71035|P2|STARTED|Overall Study||20
31881|NCT01745133|71036|P1|STARTED|Overall Study||19
31882|NCT01745055|71044|P1|NOT COMPLETED|Overall Study||0
31883|NCT01745055|71044|P1|COMPLETED|Overall Study||12
31884|NCT01745055|71044|P1|STARTED|Overall Study||12
31885|NCT01744977|71079|P2|NOT COMPLETED|Overall Study||5
31886|NCT01744977|71080|P1|NOT COMPLETED|Overall Study||11
31887|NCT01744977|71079|P2|COMPLETED|Overall Study||115
31888|NCT01744977|71080|P1|COMPLETED|Overall Study||109
31889|NCT01744977|71079|P2|6 Month Completed|Overall Study||115
31890|NCT01744977|71080|P1|6 Month Completed|Overall Study||113
31891|NCT01744977|71079|P2|STARTED|Overall Study||120
31892|NCT01744977|71080|P1|STARTED|Overall Study||120
31893|NCT01744860|71088|P1|NOT COMPLETED|Overall Study||0
31894|NCT01744860|71088|P1|COMPLETED|Overall Study||420
31895|NCT01744860|71088|P1|STARTED|Overall Study||420
31896|NCT01744821|71126|P4|NOT COMPLETED|Overall Study||0
31897|NCT01744821|71127|P3|NOT COMPLETED|Overall Study||0
31898|NCT01744821|71128|P2|NOT COMPLETED|Overall Study||0
31899|NCT01744821|71129|P1|NOT COMPLETED|Overall Study||0
31900|NCT01744821|71126|P4|COMPLETED|Overall Study||1
31901|NCT01744821|71127|P3|COMPLETED|Overall Study||2
31902|NCT01744821|71128|P2|COMPLETED|Overall Study||3
31903|NCT01744821|71129|P1|COMPLETED|Overall Study||1
31904|NCT01744821|71126|P4|STARTED|Overall Study||1
31905|NCT01744821|71127|P3|STARTED|Overall Study||2
31906|NCT01744821|71128|P2|STARTED|Overall Study||3
31907|NCT01744821|71129|P1|STARTED|Overall Study||1
31908|NCT01744730|71156|P5|NOT COMPLETED|Overall Study||0
31909|NCT01744730|71157|P4|NOT COMPLETED|Overall Study||0
31910|NCT01744730|71158|P3|NOT COMPLETED|Overall Study||0
31911|NCT01744730|71159|P2|NOT COMPLETED|Overall Study||0
31912|NCT01744730|71160|P1|NOT COMPLETED|Overall Study||0
31913|NCT01744730|71156|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
31914|NCT01744730|71157|P4|COMPLETED|Overall Study||11
31915|NCT01744730|71158|P3|COMPLETED|Overall Study||4
31916|NCT01744730|71159|P2|COMPLETED|Overall Study||3
31917|NCT01744730|71160|P1|COMPLETED|Overall Study||4
31918|NCT01744730|71156|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
31919|NCT01744730|71157|P4|STARTED|Overall Study||11
31920|NCT01744730|71158|P3|STARTED|Overall Study||4
31921|NCT01744730|71159|P2|STARTED|Overall Study||3
31922|NCT01744730|71160|P1|STARTED|Overall Study||4
31923|NCT01744691|71203|P1|NOT COMPLETED|Overall Study||43
31924|NCT01744691|71203|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
31925|NCT01744691|71203|P1|STARTED|Overall Study|Participants who received study treatment|144
31926|NCT01744496|71210|P2|NOT COMPLETED|Maintenance Period||4
31927|NCT01744496|71211|P1|NOT COMPLETED|Maintenance Period||4
31928|NCT01744496|71210|P2|COMPLETED|Maintenance Period||29
31929|NCT01744496|71211|P1|COMPLETED|Maintenance Period||27
31930|NCT01744496|71210|P2|STARTED|Maintenance Period||33
31931|NCT01744496|71211|P1|STARTED|Maintenance Period||31
31932|NCT01744496|71210|P2|NOT COMPLETED|Titration Period||2
31933|NCT01744496|71211|P1|NOT COMPLETED|Titration Period||2
31934|NCT01744496|71210|P2|COMPLETED|Titration Period||33
31935|NCT01744496|71211|P1|COMPLETED|Titration Period||31
31936|NCT01744496|71210|P2|STARTED|Titration Period||35
31937|NCT01744496|71211|P1|STARTED|Titration Period||33
31938|NCT01744392|71229|P1|NOT COMPLETED|Overall Study||1
31939|NCT01744392|71229|P1|COMPLETED|Overall Study||22
31940|NCT01744392|71229|P1|STARTED|Overall Study||23
31941|NCT01744353|71245|P3|NOT COMPLETED|Overall Study||0
31942|NCT01744353|71246|P2|NOT COMPLETED|Overall Study||0
31943|NCT01744353|71247|P1|NOT COMPLETED|Overall Study||0
31944|NCT01744353|71245|P3|COMPLETED|Overall Study||3
31945|NCT01744353|71246|P2|COMPLETED|Overall Study||26
31946|NCT01744353|71247|P1|COMPLETED|Overall Study||6
31947|NCT01744353|71245|P3|STARTED|Overall Study||3
31948|NCT01744353|71246|P2|STARTED|Overall Study||26
31949|NCT01744353|71247|P1|STARTED|Overall Study||6
31950|NCT01744340|71258|P2|NOT COMPLETED|Overall Study||0
31951|NCT01744340|71259|P1|NOT COMPLETED|Overall Study||0
31952|NCT01744340|71258|P2|COMPLETED|Overall Study||15
31953|NCT01744340|71259|P1|COMPLETED|Overall Study||8
31954|NCT01744340|71258|P2|STARTED|Overall Study||15
31955|NCT01744340|71259|P1|STARTED|Overall Study||8
31956|NCT01744197|71269|P2|NOT COMPLETED|Overall Study||3
31957|NCT01744197|71270|P1|NOT COMPLETED|Overall Study||4
31958|NCT01744197|71269|P2|COMPLETED|Overall Study||26
31959|NCT01744197|71270|P1|COMPLETED|Overall Study||28
31960|NCT01744197|71269|P2|STARTED|Overall Study||29
31961|NCT01744197|71270|P1|STARTED|Overall Study||32
31962|NCT01743963|71282|P2|NOT COMPLETED|Overall Study||0
31963|NCT01743963|71283|P1|NOT COMPLETED|Overall Study||0
31964|NCT01743963|71282|P2|COMPLETED|Overall Study||17
31965|NCT01743963|71283|P1|COMPLETED|Overall Study||21
31966|NCT01743963|71282|P2|STARTED|Overall Study||17
31967|NCT01743963|71283|P1|STARTED|Overall Study||21
31968|NCT01743521|71293|P4|NOT COMPLETED|Overall Study||0
31969|NCT01743521|71294|P3|NOT COMPLETED|Overall Study||0
31970|NCT01743521|71295|P2|NOT COMPLETED|Overall Study||0
31971|NCT01743521|71296|P1|NOT COMPLETED|Overall Study||0
31972|NCT01743521|71293|P4|COMPLETED|Overall Study||2
31973|NCT01743521|71294|P3|COMPLETED|Overall Study||2
31974|NCT01743521|71295|P2|COMPLETED|Overall Study||3
31975|NCT01743521|71296|P1|COMPLETED|Overall Study||7
31976|NCT01743521|71293|P4|STARTED|Overall Study||2
31977|NCT01743521|71294|P3|STARTED|Overall Study||2
31978|NCT01743521|71295|P2|STARTED|Overall Study||3
31979|NCT01743521|71296|P1|STARTED|Overall Study||7
31980|NCT01743092|71333|P2|NOT COMPLETED|Overall Study||15
31981|NCT01743092|71334|P1|NOT COMPLETED|Overall Study||14
31982|NCT01743092|71333|P2|COMPLETED|Overall Study||11
31983|NCT01743092|71334|P1|COMPLETED|Overall Study||19
31984|NCT01743092|71333|P2|STARTED|Overall Study||26
31985|NCT01743092|71334|P1|STARTED|Overall Study||33
31986|NCT01743027|71346|P4|NOT COMPLETED|Overall Study||1
31987|NCT01743027|71347|P3|NOT COMPLETED|Overall Study||9
31988|NCT01743027|71348|P2|NOT COMPLETED|Overall Study||5
31989|NCT01743027|71349|P1|NOT COMPLETED|Overall Study||5
31990|NCT01743027|71346|P4|COMPLETED|Overall Study||48
31991|NCT01743027|71347|P3|COMPLETED|Overall Study||90
31992|NCT01743027|71348|P2|COMPLETED|Overall Study||94
31993|NCT01743027|71349|P1|COMPLETED|Overall Study||93
31994|NCT01743027|71346|P4|STARTED|Overall Study||49
31995|NCT01743027|71347|P3|STARTED|Overall Study||99
31996|NCT01743027|71348|P2|STARTED|Overall Study||99
31997|NCT01743027|71349|P1|STARTED|Overall Study||98
31998|NCT01742936|71389|P2|NOT COMPLETED|Overall Study||0
31999|NCT01742936|71390|P1|NOT COMPLETED|Overall Study||0
32000|NCT01742936|71389|P2|COMPLETED|Overall Study||50
32001|NCT01742936|71390|P1|COMPLETED|Overall Study||50
32002|NCT01742936|71389|P2|STARTED|Overall Study||50
32003|NCT01742936|71390|P1|STARTED|Overall Study||50
32004|NCT01742897|71398|P1|NOT COMPLETED|Overall Study||5
32005|NCT01742897|71398|P1|COMPLETED|Overall Study||30
32006|NCT01742897|71398|P1|Treated|Overall Study||33
32007|NCT01742897|71398|P1|STARTED|Overall Study||35
32008|NCT01742364|71406|P4|NOT COMPLETED|Overall Study||0
32009|NCT01742364|71407|P3|NOT COMPLETED|Overall Study||0
32010|NCT01742364|71408|P2|NOT COMPLETED|Overall Study||0
32011|NCT01742364|71409|P1|NOT COMPLETED|Overall Study||0
32012|NCT01742364|71406|P4|COMPLETED|Overall Study||15
32013|NCT01742364|71407|P3|COMPLETED|Overall Study||15
32014|NCT01742364|71408|P2|COMPLETED|Overall Study||33
32015|NCT01742364|71409|P1|COMPLETED|Overall Study||33
32016|NCT01742364|71406|P4|STARTED|Overall Study||15
32017|NCT01742364|71407|P3|STARTED|Overall Study||15
32018|NCT01742364|71408|P2|STARTED|Overall Study||33
32019|NCT01742364|71409|P1|STARTED|Overall Study||33
32020|NCT01741792|71438|P3|NOT COMPLETED|Overall Study||12
32021|NCT01741792|71439|P2|NOT COMPLETED|Overall Study||1
32022|NCT01741792|71440|P1|NOT COMPLETED|Overall Study||6
32023|NCT01741792|71438|P3|COMPLETED|Overall Study||2
32024|NCT01741792|71439|P2|COMPLETED|Overall Study||1
32025|NCT01741792|71440|P1|COMPLETED|Overall Study||3
32026|NCT01741792|71438|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
32027|NCT01741792|71439|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
32028|NCT01741792|71440|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
32029|NCT01741792|71438|P3|STARTED|Overall Study||14
32030|NCT01741792|71439|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
32031|NCT01741792|71440|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
32032|NCT01741701|71507|P2|NOT COMPLETED|Overall Study||2
32033|NCT01741701|71508|P1|NOT COMPLETED|Overall Study||5
32034|NCT01741701|71507|P2|COMPLETED|Overall Study||13
32035|NCT01741701|71508|P1|COMPLETED|Overall Study||13
32036|NCT01741701|71507|P2|STARTED|Overall Study||15
32037|NCT01741701|71508|P1|STARTED|Overall Study||18
32038|NCT01741688|71524|P1|NOT COMPLETED|Overall Study||3
32039|NCT01741688|71524|P1|COMPLETED|Overall Study||13
32040|NCT01741688|71524|P1|STARTED|Overall Study||16
32041|NCT01741350|71543|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
32042|NCT01741350|71544|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
32043|NCT01741350|71543|P2|COMPLETED|12-Month Follow-up Assessment||109
32044|NCT01741350|71544|P1|COMPLETED|12-Month Follow-up Assessment||111
32045|NCT01741350|71543|P2|STARTED|12-Month Follow-up Assessment||111
32046|NCT01741350|71544|P1|STARTED|12-Month Follow-up Assessment||114
32047|NCT01741350|71543|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
32048|NCT01741350|71544|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
32049|NCT01741350|71543|P2|COMPLETED|6-Month Follow-up Assessment||111
32050|NCT01741350|71544|P1|COMPLETED|6-Month Follow-up Assessment||114
32051|NCT01741350|71543|P2|STARTED|6-Month Follow-up Assessment||119
32052|NCT01741350|71544|P1|STARTED|6-Month Follow-up Assessment||129
32053|NCT01741350|71543|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
32054|NCT01741350|71544|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
32055|NCT01741350|71543|P2|COMPLETED|3-Month Follow-up Assessment||119
32056|NCT01741350|71544|P1|COMPLETED|3-Month Follow-up Assessment||129
32057|NCT01741350|71543|P2|STARTED|3-Month Follow-up Assessment||141
32058|NCT01741350|71544|P1|STARTED|3-Month Follow-up Assessment||135
32059|NCT01741350|71543|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
32060|NCT01741350|71544|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
32061|NCT01741350|71543|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
32062|NCT01741350|71544|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
32063|NCT01741350|71543|P2|STARTED|Post Intervention Assessment (at Week 4)||155
32064|NCT01741350|71544|P1|STARTED|Post Intervention Assessment (at Week 4)||149
32065|NCT01741350|71543|P2|NOT COMPLETED|Study Intervention||0
32066|NCT01741350|71544|P1|NOT COMPLETED|Study Intervention||0
32067|NCT01741350|71543|P2|COMPLETED|Study Intervention||155
32068|NCT01741350|71544|P1|COMPLETED|Study Intervention||149
32069|NCT01741350|71543|P2|STARTED|Study Intervention||155
32070|NCT01741350|71544|P1|STARTED|Study Intervention||149
32071|NCT01741272|71680|P2|NOT COMPLETED|Overall Study||0
32072|NCT01741272|71681|P1|NOT COMPLETED|Overall Study||0
32073|NCT01741272|71680|P2|COMPLETED|Overall Study||97
32074|NCT01741272|71681|P1|COMPLETED|Overall Study||92
32075|NCT01741272|71680|P2|STARTED|Overall Study||97
32076|NCT01741272|71681|P1|STARTED|Overall Study||92
32077|NCT01740817|71695|P2|NOT COMPLETED|Second Intervention (48 h)||0
32078|NCT01740817|71696|P1|NOT COMPLETED|Second Intervention (48 h)||0
32079|NCT01740817|71695|P2|COMPLETED|Second Intervention (48 h)||4
32080|NCT01740817|71696|P1|COMPLETED|Second Intervention (48 h)||8
32081|NCT01740817|71695|P2|STARTED|Second Intervention (48 h)||4
32082|NCT01740817|71696|P1|STARTED|Second Intervention (48 h)||8
32083|NCT01740817|71695|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
32084|NCT01740817|71696|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
32085|NCT01740817|71695|P2|COMPLETED|Washout (4-6 Weeks)||4
32086|NCT01740817|71696|P1|COMPLETED|Washout (4-6 Weeks)||8
32087|NCT01740817|71695|P2|STARTED|Washout (4-6 Weeks)||4
32088|NCT01740817|71696|P1|STARTED|Washout (4-6 Weeks)||8
32089|NCT01740817|71695|P2|NOT COMPLETED|First Intervention (48 h)||0
32090|NCT01740817|71696|P1|NOT COMPLETED|First Intervention (48 h)||0
32091|NCT01740817|71695|P2|COMPLETED|First Intervention (48 h)||4
32092|NCT01740817|71696|P1|COMPLETED|First Intervention (48 h)||8
32093|NCT01740817|71695|P2|STARTED|First Intervention (48 h)||4
32094|NCT01740817|71696|P1|STARTED|First Intervention (48 h)||8
32095|NCT01740726|71708|P2|NOT COMPLETED|Overall Study||0
32096|NCT01740726|71709|P1|NOT COMPLETED|Overall Study||0
32097|NCT01740726|71708|P2|COMPLETED|Overall Study||1
32098|NCT01740726|71709|P1|COMPLETED|Overall Study||0
32099|NCT01740726|71708|P2|STARTED|Overall Study||1
32100|NCT01740726|71709|P1|STARTED|Overall Study||0
32101|NCT01740713|71718|P3|NOT COMPLETED|Overall Study||1
32102|NCT01740713|71719|P2|NOT COMPLETED|Overall Study||2
32103|NCT01740713|71720|P1|NOT COMPLETED|Overall Study||0
32104|NCT01740713|71718|P3|COMPLETED|Overall Study||6
32105|NCT01740713|71719|P2|COMPLETED|Overall Study||6
32106|NCT01740713|71720|P1|COMPLETED|Overall Study||6
32107|NCT01740713|71718|P3|STARTED|Overall Study||7
32108|NCT01740713|71719|P2|STARTED|Overall Study||8
32109|NCT01740713|71720|P1|STARTED|Overall Study||6
32110|NCT01740440|71744|P1|NOT COMPLETED|Overall Study||3
32111|NCT01740440|71744|P1|COMPLETED|Overall Study||27
32112|NCT01740440|71744|P1|STARTED|Overall Study||30
32113|NCT01740388|71752|P2|NOT COMPLETED|Overall Study||44
32114|NCT01740388|71753|P1|NOT COMPLETED|Overall Study||46
32115|NCT01740388|71752|P2|COMPLETED|Overall Study||28
32116|NCT01740388|71753|P1|COMPLETED|Overall Study||18
32117|NCT01740388|71752|P2|STARTED|Overall Study||72
32118|NCT01740388|71753|P1|STARTED|Overall Study||64
32119|NCT01740362|71773|P4|NOT COMPLETED|Overall Study||0
32120|NCT01740362|71774|P3|NOT COMPLETED|Overall Study||0
32121|NCT01740362|71775|P2|NOT COMPLETED|Overall Study||0
32122|NCT01740362|71776|P1|NOT COMPLETED|Overall Study||0
32123|NCT01740362|71773|P4|COMPLETED|Overall Study||6
32124|NCT01740362|71774|P3|COMPLETED|Overall Study||6
32125|NCT01740362|71775|P2|COMPLETED|Overall Study||6
32126|NCT01740362|71776|P1|COMPLETED|Overall Study||6
32127|NCT01740362|71773|P4|STARTED|Overall Study||6
32128|NCT01740362|71774|P3|STARTED|Overall Study||6
32129|NCT01740362|71775|P2|STARTED|Overall Study||6
32130|NCT01740362|71776|P1|STARTED|Overall Study||6
32131|NCT01740089|71805|P3|NOT COMPLETED|After 12 Weeks||11
32132|NCT01740089|71806|P2|NOT COMPLETED|After 12 Weeks||3
32133|NCT01740089|71807|P1|NOT COMPLETED|After 12 Weeks||7
32134|NCT01740089|71805|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
32135|NCT01740089|71806|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
32136|NCT01740089|71807|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
32137|NCT01740089|71805|P3|STARTED|After 12 Weeks||48
32138|NCT01740089|71806|P2|STARTED|After 12 Weeks||48
32139|NCT01740089|71807|P1|STARTED|After 12 Weeks||50
32140|NCT01740089|71805|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
32141|NCT01740089|71806|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
32142|NCT01740089|71807|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
32143|NCT01740089|71805|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
32417|NCT01735201|72961|P1|COMPLETED|Overall Study||42
32144|NCT01740089|71806|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
32145|NCT01740089|71807|P1|COMPLETED|First 12 Weeks of Treatment||50
32146|NCT01740089|71805|P3|STARTED|First 12 Weeks of Treatment||50
32147|NCT01740089|71806|P2|STARTED|First 12 Weeks of Treatment||50
32148|NCT01740089|71807|P1|STARTED|First 12 Weeks of Treatment||50
32149|NCT01739803|71825|P2|NOT COMPLETED|Overall Study||6
32150|NCT01739803|71826|P1|NOT COMPLETED|Overall Study||9
32151|NCT01739803|71825|P2|COMPLETED|Overall Study||68
32152|NCT01739803|71826|P1|COMPLETED|Overall Study||67
32153|NCT01739803|71825|P2|STARTED|Overall Study||74
32154|NCT01739803|71826|P1|STARTED|Overall Study||76
32155|NCT01739595|71839|P3|NOT COMPLETED|Overall Study||2
32156|NCT01739595|71840|P2|NOT COMPLETED|Overall Study||1
32157|NCT01739595|71841|P1|NOT COMPLETED|Overall Study||13
32158|NCT01739595|71839|P3|COMPLETED|Overall Study||45
32159|NCT01739595|71840|P2|COMPLETED|Overall Study||21
32160|NCT01739595|71841|P1|COMPLETED|Overall Study||99
32161|NCT01739595|71839|P3|STARTED|Overall Study||47
32162|NCT01739595|71840|P2|STARTED|Overall Study||22
32163|NCT01739595|71841|P1|STARTED|Overall Study||112
32164|NCT01739361|71851|P2|NOT COMPLETED|Overall Study||1
32165|NCT01739361|71852|P1|NOT COMPLETED|Overall Study||3
32166|NCT01739361|71851|P2|COMPLETED|Overall Study||22
32167|NCT01739361|71852|P1|COMPLETED|Overall Study||18
32168|NCT01739361|71851|P2|STARTED|Overall Study||23
32169|NCT01739361|71852|P1|STARTED|Overall Study||21
32170|NCT01738984|71860|P2|NOT COMPLETED|Overall Study||39
32171|NCT01738984|71861|P1|NOT COMPLETED|Overall Study||64
32172|NCT01738984|71860|P2|COMPLETED|Overall Study||210
32173|NCT01738984|71861|P1|COMPLETED|Overall Study||186
32174|NCT01738984|71860|P2|STARTED|Overall Study||249
32175|NCT01738984|71861|P1|STARTED|Overall Study||250
32176|NCT01738971|71874|P3|NOT COMPLETED|Overall Study||17
32177|NCT01738971|71875|P2|NOT COMPLETED|Overall Study||30
32178|NCT01738971|71876|P1|NOT COMPLETED|Overall Study||19
32179|NCT01738971|71874|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
32180|NCT01738971|71875|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
32181|NCT01738971|71876|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
32182|NCT01738971|71874|P3|STARTED|Overall Study|56 participants recruited to this arm|56
32183|NCT01738971|71875|P2|STARTED|Overall Study|58 participants recruited to this arm|58
32184|NCT01738971|71876|P1|STARTED|Overall Study|54 participants recruited to this arm|54
32185|NCT01738919|71892|P2|NOT COMPLETED|Overall Study||3
32186|NCT01738919|71893|P1|NOT COMPLETED|Overall Study||1
32187|NCT01738919|71892|P2|COMPLETED|Overall Study||14
32188|NCT01738919|71893|P1|COMPLETED|Overall Study||14
32189|NCT01738919|71892|P2|STARTED|Overall Study||17
32190|NCT01738919|71893|P1|STARTED|Overall Study||15
32191|NCT01738750|71911|P2|NOT COMPLETED|Overall Study||0
32192|NCT01738750|71912|P1|NOT COMPLETED|Overall Study||0
32193|NCT01738750|71911|P2|COMPLETED|Overall Study||51
32194|NCT01738750|71912|P1|COMPLETED|Overall Study||49
32195|NCT01738750|71911|P2|STARTED|Overall Study||51
32196|NCT01738750|71912|P1|STARTED|Overall Study||49
32197|NCT01738737|71925|P5|NOT COMPLETED|Overall Study||4
32198|NCT01738737|71926|P4|NOT COMPLETED|Overall Study||4
32199|NCT01738737|71927|P3|NOT COMPLETED|Overall Study||4
32200|NCT01738737|71928|P2|NOT COMPLETED|Overall Study||4
32201|NCT01738737|71929|P1|NOT COMPLETED|Overall Study||4
32202|NCT01738737|71925|P5|COMPLETED|Overall Study||25
32203|NCT01738737|71926|P4|COMPLETED|Overall Study||25
32204|NCT01738737|71927|P3|COMPLETED|Overall Study||25
32205|NCT01738737|71928|P2|COMPLETED|Overall Study||25
32206|NCT01738737|71929|P1|COMPLETED|Overall Study||25
32207|NCT01738737|71925|P5|STARTED|Overall Study||29
32208|NCT01738737|71926|P4|STARTED|Overall Study||29
32209|NCT01738737|71927|P3|STARTED|Overall Study||29
32210|NCT01738737|71928|P2|STARTED|Overall Study||29
32211|NCT01738737|71929|P1|STARTED|Overall Study||29
32212|NCT01738698|71965|P4|NOT COMPLETED|Overall Study||0
32213|NCT01738698|71966|P3|NOT COMPLETED|Overall Study||0
32214|NCT01738698|71967|P2|NOT COMPLETED|Overall Study||0
32215|NCT01738698|71968|P1|NOT COMPLETED|Overall Study||0
32216|NCT01738698|71965|P4|COMPLETED|Overall Study||0
32217|NCT01738698|71966|P3|COMPLETED|Overall Study||0
32218|NCT01738698|71967|P2|COMPLETED|Overall Study||0
32219|NCT01738698|71968|P1|COMPLETED|Overall Study||0
32220|NCT01738698|71965|P4|STARTED|Overall Study||0
32221|NCT01738698|71966|P3|STARTED|Overall Study||0
32222|NCT01738698|71967|P2|STARTED|Overall Study||0
32223|NCT01738698|71968|P1|STARTED|Overall Study||0
32224|NCT01738646|72034|P1|NOT COMPLETED|Overall Study||2
32225|NCT01738646|72034|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
32226|NCT01738646|72034|P1|STARTED|Overall Study||40
32227|NCT01738581|72044|P2|NOT COMPLETED|Overall Study||0
32228|NCT01738581|72045|P1|NOT COMPLETED|Overall Study||1
32229|NCT01738581|72044|P2|COMPLETED|Overall Study||4
32230|NCT01738581|72045|P1|COMPLETED|Overall Study||4
32231|NCT01738581|72044|P2|STARTED|Overall Study||4
32232|NCT01738581|72045|P1|STARTED|Overall Study||5
32233|NCT01738438|72053|P1|NOT COMPLETED|Overall Study||35
32234|NCT01738438|72053|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
32235|NCT01738438|72053|P1|STARTED|Overall Study||35
32236|NCT01738321|72061|P2|NOT COMPLETED|Overall Study||0
32237|NCT01738321|72062|P1|NOT COMPLETED|Overall Study||0
32238|NCT01738321|72061|P2|COMPLETED|Overall Study||30
32239|NCT01738321|72062|P1|COMPLETED|Overall Study||33
32240|NCT01738321|72061|P2|STARTED|Overall Study||30
32241|NCT01738321|72062|P1|STARTED|Overall Study||33
32242|NCT01737996|72071|P3|NOT COMPLETED|Overall Study||2
32243|NCT01737996|72072|P2|NOT COMPLETED|Overall Study||1
32244|NCT01737996|72073|P1|NOT COMPLETED|Overall Study||0
32245|NCT01737996|72071|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
32246|NCT01737996|72072|P2|COMPLETED|Overall Study||7
32247|NCT01737996|72073|P1|COMPLETED|Overall Study||8
32248|NCT01737996|72071|P3|STARTED|Overall Study||16
32249|NCT01737996|72072|P2|STARTED|Overall Study||8
32250|NCT01737996|72073|P1|STARTED|Overall Study||8
32251|NCT01737944|72114|P4|NOT COMPLETED|Overall Study||0
32252|NCT01737944|72115|P3|NOT COMPLETED|Overall Study||0
32253|NCT01737944|72116|P2|NOT COMPLETED|Overall Study||0
32254|NCT01737944|72117|P1|NOT COMPLETED|Overall Study||0
32255|NCT01737944|72114|P4|COMPLETED|Overall Study||9
32256|NCT01737944|72115|P3|COMPLETED|Overall Study||9
32257|NCT01737944|72116|P2|COMPLETED|Overall Study||9
32258|NCT01737944|72117|P1|COMPLETED|Overall Study||9
32259|NCT01737944|72114|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
32260|NCT01737944|72115|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
32261|NCT01737944|72116|P2|STARTED|Overall Study||9
32262|NCT01737944|72117|P1|STARTED|Overall Study||9
32263|NCT01737931|72135|P3|NOT COMPLETED|Overall Study||1
32264|NCT01737931|72136|P2|NOT COMPLETED|Overall Study||2
32265|NCT01737931|72137|P1|NOT COMPLETED|Overall Study||0
32266|NCT01737931|72135|P3|COMPLETED|Overall Study||38
32267|NCT01737931|72136|P2|COMPLETED|Overall Study||38
32268|NCT01737931|72137|P1|COMPLETED|Overall Study||38
32269|NCT01737931|72135|P3|STARTED|Overall Study||39
32270|NCT01737931|72136|P2|STARTED|Overall Study||40
32271|NCT01737931|72137|P1|STARTED|Overall Study||38
32272|NCT01737879|72152|P1|NOT COMPLETED|Overall Study||41
32273|NCT01737879|72152|P1|COMPLETED|Overall Study||0
32274|NCT01737879|72152|P1|Transitioned to Epoetin Alfa|Overall Study||0
32275|NCT01737879|72152|P1|Received Peginesatide|Overall Study||34
32276|NCT01737879|72152|P1|STARTED|Overall Study||41
32277|NCT01737840|72161|P2|NOT COMPLETED|Overall Study||2
32278|NCT01737840|72162|P1|NOT COMPLETED|Overall Study||2
32279|NCT01737840|72161|P2|COMPLETED|Overall Study||33
32280|NCT01737840|72162|P1|COMPLETED|Overall Study||33
32281|NCT01737840|72161|P2|STARTED|Overall Study||35
32282|NCT01737840|72162|P1|STARTED|Overall Study||35
32283|NCT01737710|72175|P5|NOT COMPLETED|Overall Study||0
32284|NCT01737710|72176|P4|NOT COMPLETED|Overall Study||0
32285|NCT01737710|72177|P3|NOT COMPLETED|Overall Study||3
32286|NCT01737710|72178|P2|NOT COMPLETED|Overall Study||4
32287|NCT01737710|72179|P1|NOT COMPLETED|Overall Study||2
32288|NCT01737710|72175|P5|COMPLETED|Overall Study||21
32289|NCT01737710|72176|P4|COMPLETED|Overall Study||23
32290|NCT01737710|72177|P3|COMPLETED|Overall Study||102
32291|NCT01737710|72178|P2|COMPLETED|Overall Study||101
32292|NCT01737710|72179|P1|COMPLETED|Overall Study||112
32293|NCT01737710|72175|P5|STARTED|Overall Study||21
32294|NCT01737710|72176|P4|STARTED|Overall Study||23
32295|NCT01737710|72177|P3|STARTED|Overall Study||105
32296|NCT01737710|72178|P2|STARTED|Overall Study||105
32297|NCT01737710|72179|P1|STARTED|Overall Study||114
32298|NCT01737684|72218|P3|NOT COMPLETED|Overall Study||0
32299|NCT01737684|72219|P2|NOT COMPLETED|Overall Study||0
32300|NCT01737684|72220|P1|NOT COMPLETED|Overall Study||0
32301|NCT01737684|72218|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
32302|NCT01737684|72219|P2|COMPLETED|Overall Study||8
32303|NCT01737684|72220|P1|COMPLETED|Overall Study||8
32304|NCT01737684|72218|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
32305|NCT01737684|72219|P2|STARTED|Overall Study||8
32306|NCT01737684|72220|P1|STARTED|Overall Study||8
32307|NCT01737593|72239|P3|NOT COMPLETED|Overall Study||0
32308|NCT01737593|72240|P2|NOT COMPLETED|Overall Study||0
32309|NCT01737593|72241|P1|NOT COMPLETED|Overall Study||0
32310|NCT01737593|72239|P3|COMPLETED|Overall Study||39
32311|NCT01737593|72240|P2|COMPLETED|Overall Study||32
32312|NCT01737593|72241|P1|COMPLETED|Overall Study||37
32313|NCT01737593|72239|P3|STARTED|Overall Study||39
32314|NCT01737593|72240|P2|STARTED|Overall Study||32
32315|NCT01737593|72241|P1|STARTED|Overall Study||37
32316|NCT01737021|72272|P2|NOT COMPLETED|Overall Study||3
32317|NCT01737021|72273|P1|NOT COMPLETED|Overall Study||5
32318|NCT01737021|72272|P2|COMPLETED|Overall Study||6
32319|NCT01737021|72273|P1|COMPLETED|Overall Study||17
32320|NCT01737021|72272|P2|STARTED|Overall Study||9
32321|NCT01737021|72273|P1|STARTED|Overall Study||22
32322|NCT01736930|72279|P1|NOT COMPLETED|Overall Study||1
32323|NCT01736930|72279|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
32324|NCT01736930|72279|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
32325|NCT01736917|72319|P1|NOT COMPLETED|Overall Study||11
32326|NCT01736917|72319|P1|COMPLETED|Overall Study||54
32327|NCT01736917|72319|P1|STARTED|Overall Study||65
32328|NCT01736696|72333|P7|NOT COMPLETED|Overall Study||0
32329|NCT01736696|72334|P6|NOT COMPLETED|Overall Study||0
32330|NCT01736696|72335|P5|NOT COMPLETED|Overall Study||0
32331|NCT01736696|72336|P4|NOT COMPLETED|Overall Study||0
32332|NCT01736696|72337|P3|NOT COMPLETED|Overall Study||1
32333|NCT01736696|72338|P2|NOT COMPLETED|Overall Study||0
32334|NCT01736696|72339|P1|NOT COMPLETED|Overall Study||0
32335|NCT01736696|72333|P7|COMPLETED|Overall Study||13
32336|NCT01736696|72334|P6|COMPLETED|Overall Study||8
32337|NCT01736696|72335|P5|COMPLETED|Overall Study||9
32338|NCT01736696|72336|P4|COMPLETED|Overall Study||9
32339|NCT01736696|72337|P3|COMPLETED|Overall Study||9
32340|NCT01736696|72338|P2|COMPLETED|Overall Study||5
32341|NCT01736696|72339|P1|COMPLETED|Overall Study||5
32342|NCT01736696|72333|P7|STARTED|Overall Study||13
32343|NCT01736696|72334|P6|STARTED|Overall Study||8
32344|NCT01736696|72335|P5|STARTED|Overall Study||9
32345|NCT01736696|72336|P4|STARTED|Overall Study||9
32346|NCT01736696|72337|P3|STARTED|Overall Study||10
32347|NCT01736696|72338|P2|STARTED|Overall Study||5
32348|NCT01736696|72339|P1|STARTED|Overall Study||5
32349|NCT01736657|72656|P1|NOT COMPLETED|Overall Study||1
32350|NCT01736657|72656|P1|COMPLETED|Overall Study||72
32351|NCT01736657|72656|P1|STARTED|Overall Study||73
32352|NCT01736579|72665|P2|NOT COMPLETED|Overall Study||2
32353|NCT01736579|72666|P1|NOT COMPLETED|Overall Study||2
32354|NCT01736579|72665|P2|COMPLETED|Overall Study||0
32355|NCT01736579|72666|P1|COMPLETED|Overall Study||0
32356|NCT01736579|72665|P2|STARTED|Overall Study||2
32357|NCT01736579|72666|P1|STARTED|Overall Study||2
32358|NCT01736540|72700|P1|NOT COMPLETED|Overall Study||15
32359|NCT01736540|72700|P1|COMPLETED|Overall Study||228
32360|NCT01736540|72700|P1|STARTED|Overall Study||243
32361|NCT01736527|72757|P1|NOT COMPLETED|Overall Study||0
32362|NCT01736527|72757|P1|COMPLETED|Overall Study||12
32363|NCT01736527|72757|P1|STARTED|Overall Study||12
32364|NCT01736475|72766|P2|NOT COMPLETED|Overall Study||0
32365|NCT01736475|72767|P1|NOT COMPLETED|Overall Study||12
32366|NCT01736475|72766|P2|COMPLETED|Overall Study||17
32367|NCT01736475|72767|P1|COMPLETED|Overall Study||109
32368|NCT01736475|72766|P2|STARTED|Overall Study||17
32369|NCT01736475|72767|P1|STARTED|Overall Study||121
32370|NCT01736215|72820|P1|NOT COMPLETED|Overall Study||14
32371|NCT01736215|72820|P1|COMPLETED|Overall Study||19
32372|NCT01736215|72820|P1|Treated|Overall Study||25
32373|NCT01736215|72820|P1|STARTED|Overall Study||33
32374|NCT01736176|72832|P1|NOT COMPLETED|Overall Study||11
32375|NCT01736176|72832|P1|COMPLETED|Overall Study||28
32376|NCT01736176|72832|P1|Received LCIG|Overall Study||38
32377|NCT01736176|72832|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
32378|NCT01735916|72879|P3|NOT COMPLETED|Overall Study||7
32379|NCT01735916|72880|P2|NOT COMPLETED|Overall Study||19
32380|NCT01735916|72881|P1|NOT COMPLETED|Overall Study||18
32381|NCT01735916|72879|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
32382|NCT01735916|72880|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
32383|NCT01735916|72881|P1|COMPLETED|Overall Study||0
32384|NCT01735916|72879|P3|STARTED|Overall Study||7
32385|NCT01735916|72880|P2|STARTED|Overall Study||19
32386|NCT01735916|72881|P1|STARTED|Overall Study||18
32387|NCT01735877|72902|P2|NOT COMPLETED|Overall Study||0
32388|NCT01735877|72903|P1|NOT COMPLETED|Overall Study||1
32389|NCT01735877|72902|P2|COMPLETED|Overall Study||21
32390|NCT01735877|72903|P1|COMPLETED|Overall Study||26
32391|NCT01735877|72902|P2|STARTED|Overall Study||21
32392|NCT01735877|72903|P1|STARTED|Overall Study||27
32393|NCT01735630|72919|P2|NOT COMPLETED|Overall Study||18
32394|NCT01735630|72920|P1|NOT COMPLETED|Overall Study||18
32395|NCT01735630|72919|P2|COMPLETED|Overall Study||157
32396|NCT01735630|72920|P1|COMPLETED|Overall Study||157
32397|NCT01735630|72919|P2|STARTED|Overall Study||175
32398|NCT01735630|72920|P1|STARTED|Overall Study||175
32399|NCT01735214|72934|P1|NOT COMPLETED|Overall Study||0
32400|NCT01735214|72934|P1|COMPLETED|Overall Study||358
32401|NCT01735214|72934|P1|STARTED|Overall Study||358
32402|NCT01735201|72954|P8|NOT COMPLETED|Overall Study||2
32403|NCT01735201|72955|P7|NOT COMPLETED|Overall Study||3
32404|NCT01735201|72956|P6|NOT COMPLETED|Overall Study||5
32405|NCT01735201|72957|P5|NOT COMPLETED|Overall Study||1
32406|NCT01735201|72958|P4|NOT COMPLETED|Overall Study||2
32407|NCT01735201|72959|P3|NOT COMPLETED|Overall Study||0
32408|NCT01735201|72960|P2|NOT COMPLETED|Overall Study||1
32409|NCT01735201|72961|P1|NOT COMPLETED|Overall Study||3
32410|NCT01735201|72954|P8|COMPLETED|Overall Study||42
32411|NCT01735201|72955|P7|COMPLETED|Overall Study||42
32412|NCT01735201|72956|P6|COMPLETED|Overall Study||40
32413|NCT01735201|72957|P5|COMPLETED|Overall Study||44
32414|NCT01735201|72958|P4|COMPLETED|Overall Study||42
32415|NCT01735201|72959|P3|COMPLETED|Overall Study||44
32416|NCT01735201|72960|P2|COMPLETED|Overall Study||43
32418|NCT01735201|72954|P8|STARTED|Overall Study||44
32419|NCT01735201|72955|P7|STARTED|Overall Study||45
32420|NCT01735201|72956|P6|STARTED|Overall Study||45
32421|NCT01735201|72957|P5|STARTED|Overall Study||45
32422|NCT01735201|72958|P4|STARTED|Overall Study||44
32423|NCT01735201|72959|P3|STARTED|Overall Study||44
32424|NCT01735201|72960|P2|STARTED|Overall Study||44
32425|NCT01735201|72961|P1|STARTED|Overall Study||45
32426|NCT01734993|72995|P1|NOT COMPLETED|Overall Study||2
32427|NCT01734993|72995|P1|COMPLETED|Overall Study||9
32428|NCT01734993|72995|P1|STARTED|Overall Study||11
32429|NCT01734889|73021|P1|NOT COMPLETED|Overall Study||0
32430|NCT01734889|73021|P1|COMPLETED|Overall Study||18
32431|NCT01734889|73021|P1|STARTED|Overall Study||18
32432|NCT01734785|73032|P4|NOT COMPLETED|Double−Blind Period||0
32433|NCT01734785|73033|P3|NOT COMPLETED|Double−Blind Period||5
32434|NCT01734785|73034|P2|NOT COMPLETED|Double−Blind Period||9
32435|NCT01734785|73035|P1|NOT COMPLETED|Double−Blind Period||5
32436|NCT01734785|73032|P4|COMPLETED|Double−Blind Period||0
32437|NCT01734785|73033|P3|COMPLETED|Double−Blind Period||105
32438|NCT01734785|73034|P2|COMPLETED|Double−Blind Period||103
32439|NCT01734785|73035|P1|COMPLETED|Double−Blind Period||106
32440|NCT01734785|73032|P4|STARTED|Double−Blind Period||0
32441|NCT01734785|73033|P3|STARTED|Double−Blind Period||110
32442|NCT01734785|73034|P2|STARTED|Double−Blind Period||112
32443|NCT01734785|73035|P1|STARTED|Double−Blind Period||111
32444|NCT01734785|73032|P4|NOT COMPLETED|Open−Label Period||273
32445|NCT01734785|73033|P3|NOT COMPLETED|Open−Label Period||0
32446|NCT01734785|73034|P2|NOT COMPLETED|Open−Label Period||0
32447|NCT01734785|73035|P1|NOT COMPLETED|Open−Label Period||0
32448|NCT01734785|73032|P4|COMPLETED|Open−Label Period||333
32449|NCT01734785|73033|P3|COMPLETED|Open−Label Period||0
32450|NCT01734785|73034|P2|COMPLETED|Open−Label Period||0
32451|NCT01734785|73035|P1|COMPLETED|Open−Label Period||0
32452|NCT01734785|73032|P4|STARTED|Open−Label Period||606
32453|NCT01734785|73033|P3|STARTED|Open−Label Period||0
32454|NCT01734785|73034|P2|STARTED|Open−Label Period||0
32455|NCT01734785|73035|P1|STARTED|Open−Label Period||0
32456|NCT01734772|73052|P2|NOT COMPLETED|Overall Study||3
32457|NCT01734772|73053|P1|NOT COMPLETED|Overall Study||1
32458|NCT01734772|73052|P2|COMPLETED|Overall Study||21
32459|NCT01734772|73053|P1|COMPLETED|Overall Study||23
32460|NCT01734772|73052|P2|STARTED|Overall Study||24
32461|NCT01734772|73053|P1|STARTED|Overall Study||24
32462|NCT01734655|73070|P1|NOT COMPLETED|Overall Study||0
32463|NCT01734655|73070|P1|COMPLETED|Overall Study||40
32464|NCT01734655|73070|P1|STARTED|Overall Study||40
32465|NCT01734395|73079|P1|NOT COMPLETED|Overall Study||410
32466|NCT01734395|73079|P1|COMPLETED|Overall Study||1472
32467|NCT01734395|73079|P1|STARTED|Overall Study||1882
32468|NCT01734317|73085|P1|NOT COMPLETED|Overall Study||0
32469|NCT01734317|73085|P1|COMPLETED|Overall Study||10
32470|NCT01734317|73085|P1|STARTED|Overall Study||10
32471|NCT01734239|73091|P2|NOT COMPLETED|Overall Study||0
32472|NCT01734239|73092|P1|NOT COMPLETED|Overall Study||0
32473|NCT01734239|73091|P2|COMPLETED|Overall Study||50
32474|NCT01734239|73092|P1|COMPLETED|Overall Study||52
32475|NCT01734239|73091|P2|STARTED|Overall Study||50
32476|NCT01734239|73092|P1|STARTED|Overall Study||52
32477|NCT01733953|73107|P2|NOT COMPLETED|Overall Study||7
32478|NCT01733953|73108|P1|NOT COMPLETED|Overall Study||5
32479|NCT01733953|73107|P2|COMPLETED|Overall Study||6
32480|NCT01733953|73108|P1|COMPLETED|Overall Study||9
32481|NCT01733953|73107|P2|STARTED|Overall Study||13
32482|NCT01733953|73108|P1|STARTED|Overall Study||14
32483|NCT01733758|73128|P4|NOT COMPLETED|Overall Study||8
32484|NCT01733758|73129|P3|NOT COMPLETED|Overall Study||15
32485|NCT01733758|73130|P2|NOT COMPLETED|Overall Study||12
32486|NCT01733758|73131|P1|NOT COMPLETED|Overall Study||15
32487|NCT01733758|73128|P4|COMPLETED|Overall Study||95
32488|NCT01733758|73129|P3|COMPLETED|Overall Study||135
32489|NCT01733758|73130|P2|COMPLETED|Overall Study||148
32490|NCT01733758|73131|P1|COMPLETED|Overall Study||62
32491|NCT01733758|73128|P4|STARTED|Overall Study||103
32492|NCT01733758|73129|P3|STARTED|Overall Study||150
32493|NCT01733758|73130|P2|STARTED|Overall Study||160
32494|NCT01733758|73131|P1|STARTED|Overall Study||77
32495|NCT01733745|73184|P2|NOT COMPLETED|Overall Study||0
32496|NCT01733745|73185|P1|NOT COMPLETED|Overall Study||0
32497|NCT01733745|73184|P2|COMPLETED|Overall Study||13
32498|NCT01733745|73185|P1|COMPLETED|Overall Study||13
32499|NCT01733745|73184|P2|STARTED|Overall Study||13
32500|NCT01733745|73185|P1|STARTED|Overall Study||13
32501|NCT01733732|73197|P2|NOT COMPLETED|Overall Study||0
32502|NCT01733732|73198|P1|NOT COMPLETED|Overall Study||2
32503|NCT01733732|73197|P2|COMPLETED|Overall Study||27
32504|NCT01733732|73198|P1|COMPLETED|Overall Study||25
32505|NCT01733732|73197|P2|STARTED|Overall Study||27
32506|NCT01733732|73198|P1|STARTED|Overall Study||27
32507|NCT01733329|73234|P2|NOT COMPLETED|Overall Study||1
32508|NCT01733329|73235|P1|NOT COMPLETED|Overall Study||2
32509|NCT01733329|73234|P2|COMPLETED|Overall Study||60
32510|NCT01733329|73235|P1|COMPLETED|Overall Study||60
32511|NCT01733329|73234|P2|STARTED|Overall Study||61
32512|NCT01733329|73235|P1|STARTED|Overall Study||62
32513|NCT01733277|73249|P2|NOT COMPLETED|Overall Study||0
32514|NCT01733277|73250|P1|NOT COMPLETED|Overall Study||0
32515|NCT01733277|73249|P2|COMPLETED|Overall Study||25
32516|NCT01733277|73250|P1|COMPLETED|Overall Study||25
32517|NCT01733277|73249|P2|STARTED|Overall Study||25
32518|NCT01733277|73250|P1|STARTED|Overall Study||25
32519|NCT01733069|73262|P2|NOT COMPLETED|Overall Study||0
32520|NCT01733069|73263|P1|NOT COMPLETED|Overall Study||0
32521|NCT01733069|73262|P2|COMPLETED|Overall Study||1598
32522|NCT01733069|73263|P1|COMPLETED|Overall Study||264
32523|NCT01733069|73262|P2|STARTED|Overall Study||1598
32524|NCT01733069|73263|P1|STARTED|Overall Study||264
32525|NCT01733056|73272|P3|NOT COMPLETED|Overall Study||0
32526|NCT01733056|73273|P2|NOT COMPLETED|Overall Study||0
32527|NCT01733056|73274|P1|NOT COMPLETED|Overall Study||0
32528|NCT01733056|73272|P3|COMPLETED|Overall Study||12
32529|NCT01733056|73273|P2|COMPLETED|Overall Study||10
32530|NCT01733056|73274|P1|COMPLETED|Overall Study||21
32531|NCT01733056|73272|P3|STARTED|Overall Study||12
32532|NCT01733056|73273|P2|STARTED|Overall Study||10
32533|NCT01733056|73274|P1|STARTED|Overall Study||21
32534|NCT01732835|73288|P1|NOT COMPLETED|2-year Extended Follow-up||5
32535|NCT01732835|73288|P1|COMPLETED|2-year Extended Follow-up||39
32536|NCT01732835|73288|P1|STARTED|2-year Extended Follow-up||44
32537|NCT01732835|73288|P1|NOT COMPLETED|6-month Primary Endpoint||24
32538|NCT01732835|73288|P1|COMPLETED|6-month Primary Endpoint||44
32539|NCT01732835|73288|P1|STARTED|6-month Primary Endpoint|19 of the 68 consented participants did not receive the device|68
32540|NCT01732796|73322|P3|NOT COMPLETED|Overall Study||13
32541|NCT01732796|73323|P2|NOT COMPLETED|Overall Study||42
32542|NCT01732796|73324|P1|NOT COMPLETED|Overall Study||46
32543|NCT01732796|73322|P3|COMPLETED|Overall Study||38
32544|NCT01732796|73323|P2|COMPLETED|Overall Study||169
32545|NCT01732796|73324|P1|COMPLETED|Overall Study||162
32546|NCT01732796|73322|P3|STARTED|Overall Study||51
32547|NCT01732796|73323|P2|STARTED|Overall Study||211
32548|NCT01732796|73324|P1|STARTED|Overall Study||208
32549|NCT01732770|73342|P2|NOT COMPLETED|Overall Study||8
32550|NCT01732770|73343|P1|NOT COMPLETED|Overall Study||10
32551|NCT01732770|73342|P2|COMPLETED|Overall Study||313
32552|NCT01732770|73343|P1|COMPLETED|Overall Study||312
32553|NCT01732770|73342|P2|Received Study Treatment|Overall Study||320
32554|NCT01732770|73343|P1|Received Study Treatment|Overall Study||320
32555|NCT01732770|73342|P2|STARTED|Overall Study||321
32556|NCT01732770|73343|P1|STARTED|Overall Study||322
32557|NCT01732757|73358|P3|NOT COMPLETED|Overall Study||0
32558|NCT01732757|73359|P2|NOT COMPLETED|Overall Study||0
32559|NCT01732757|73360|P1|NOT COMPLETED|Overall Study||1
32560|NCT01732757|73358|P3|COMPLETED|Overall Study||52
32561|NCT01732757|73359|P2|COMPLETED|Overall Study||52
32562|NCT01732757|73360|P1|COMPLETED|Overall Study||52
32563|NCT01732757|73358|P3|STARTED|Overall Study||52
32564|NCT01732757|73359|P2|STARTED|Overall Study||52
32565|NCT01732757|73360|P1|STARTED|Overall Study||53
32566|NCT01732692|73400|P2|NOT COMPLETED|Overall Study||1
32567|NCT01732692|73401|P1|NOT COMPLETED|Overall Study||0
32568|NCT01732692|73400|P2|COMPLETED|Overall Study||69
32569|NCT01732692|73401|P1|COMPLETED|Overall Study||70
32570|NCT01732692|73400|P2|STARTED|Overall Study||70
32571|NCT01732692|73401|P1|STARTED|Overall Study||70
32572|NCT01732588|73418|P3|NOT COMPLETED|Third Intervention (7 Days)||0
32573|NCT01732588|73419|P2|NOT COMPLETED|Third Intervention (7 Days)||0
32574|NCT01732588|73420|P1|NOT COMPLETED|Third Intervention (7 Days)||0
32575|NCT01732588|73418|P3|COMPLETED|Third Intervention (7 Days)||4
32576|NCT01732588|73419|P2|COMPLETED|Third Intervention (7 Days)||2
32577|NCT01732588|73420|P1|COMPLETED|Third Intervention (7 Days)||4
32578|NCT01732588|73418|P3|STARTED|Third Intervention (7 Days)||4
32579|NCT01732588|73419|P2|STARTED|Third Intervention (7 Days)||2
32580|NCT01732588|73420|P1|STARTED|Third Intervention (7 Days)||4
32581|NCT01732588|73418|P3|NOT COMPLETED|Second Intervention (7 Days)||0
32582|NCT01732588|73419|P2|NOT COMPLETED|Second Intervention (7 Days)||0
32583|NCT01732588|73420|P1|NOT COMPLETED|Second Intervention (7 Days)||0
32584|NCT01732588|73418|P3|COMPLETED|Second Intervention (7 Days)||4
32585|NCT01732588|73419|P2|COMPLETED|Second Intervention (7 Days)||2
32586|NCT01732588|73420|P1|COMPLETED|Second Intervention (7 Days)||4
32587|NCT01732588|73418|P3|STARTED|Second Intervention (7 Days)||4
32588|NCT01732588|73419|P2|STARTED|Second Intervention (7 Days)||2
32589|NCT01732588|73420|P1|STARTED|Second Intervention (7 Days)||4
32590|NCT01732588|73418|P3|NOT COMPLETED|First Intervention (7 Days)||0
32591|NCT01732588|73419|P2|NOT COMPLETED|First Intervention (7 Days)||1
32592|NCT01732588|73420|P1|NOT COMPLETED|First Intervention (7 Days)||0
32593|NCT01732588|73418|P3|COMPLETED|First Intervention (7 Days)||4
32594|NCT01732588|73419|P2|COMPLETED|First Intervention (7 Days)||2
32595|NCT01732588|73420|P1|COMPLETED|First Intervention (7 Days)||4
32596|NCT01732588|73418|P3|STARTED|First Intervention (7 Days)||4
32597|NCT01732588|73419|P2|STARTED|First Intervention (7 Days)||3
32598|NCT01732588|73420|P1|STARTED|First Intervention (7 Days)||4
32599|NCT01732549|73436|P2|NOT COMPLETED|Overall Study||73
32600|NCT01732549|73437|P1|NOT COMPLETED|Overall Study||71
32601|NCT01732549|73436|P2|COMPLETED|Overall Study||0
32602|NCT01732549|73437|P1|COMPLETED|Overall Study||0
32603|NCT01732549|73436|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
32604|NCT01732549|73437|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
32605|NCT01732549|73436|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
32606|NCT01732549|73437|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
32607|NCT01732549|73436|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
32608|NCT01732549|73437|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
32609|NCT01732549|73436|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
32610|NCT01732549|73437|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
32611|NCT01732549|73436|P2|STARTED|Overall Study||73
32612|NCT01732549|73437|P1|STARTED|Overall Study||71
32613|NCT01732510|73464|P7|NOT COMPLETED|Overall Study||8
32614|NCT01732510|73465|P6|NOT COMPLETED|Overall Study||13
32615|NCT01732510|73466|P5|NOT COMPLETED|Overall Study||5
32616|NCT01732510|73467|P4|NOT COMPLETED|Overall Study||5
32617|NCT01732510|73468|P3|NOT COMPLETED|Overall Study||4
32618|NCT01732510|73469|P2|NOT COMPLETED|Overall Study||5
32619|NCT01732510|73470|P1|NOT COMPLETED|Overall Study||1
32620|NCT01732510|73464|P7|COMPLETED|Overall Study||0
32621|NCT01732510|73465|P6|COMPLETED|Overall Study||0
32622|NCT01732510|73466|P5|COMPLETED|Overall Study||3
32623|NCT01732510|73467|P4|COMPLETED|Overall Study||5
32624|NCT01732510|73468|P3|COMPLETED|Overall Study||4
32625|NCT01732510|73469|P2|COMPLETED|Overall Study||4
32626|NCT01732510|73470|P1|COMPLETED|Overall Study||8
32627|NCT01732510|73464|P7|STARTED|Overall Study||8
32628|NCT01732510|73465|P6|STARTED|Overall Study||13
32629|NCT01732510|73466|P5|STARTED|Overall Study||8
32630|NCT01732510|73467|P4|STARTED|Overall Study||10
32631|NCT01732510|73468|P3|STARTED|Overall Study||8
32632|NCT01732510|73469|P2|STARTED|Overall Study||9
32633|NCT01732510|73470|P1|STARTED|Overall Study||9
32634|NCT01732484|73549|P1|NOT COMPLETED|Overall Study||26
32635|NCT01732484|73549|P1|COMPLETED|Overall Study||74
32636|NCT01732484|73549|P1|Allocation|Overall Study||100
32637|NCT01732484|73549|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
32638|NCT01732484|73549|P1|STARTED|Overall Study||100
32639|NCT01732471|73557|P1|NOT COMPLETED|Overall Study||1
32640|NCT01732471|73557|P1|COMPLETED|Overall Study||89
32641|NCT01732471|73557|P1|STARTED|Overall Study||90
32642|NCT01732263|73566|P2|NOT COMPLETED|Overall Study||0
32643|NCT01732263|73567|P1|NOT COMPLETED|Overall Study||0
32644|NCT01732263|73566|P2|COMPLETED|Overall Study||20
32645|NCT01732263|73567|P1|COMPLETED|Overall Study||23
32646|NCT01732263|73566|P2|STARTED|Overall Study||20
32647|NCT01732263|73567|P1|STARTED|Overall Study||23
32648|NCT01731470|73607|P1|NOT COMPLETED|Overall Study||2
32649|NCT01731470|73607|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
32650|NCT01731470|73607|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
32651|NCT01731041|73614|P2|NOT COMPLETED|Overall Study||0
32652|NCT01731041|73615|P1|NOT COMPLETED|Overall Study||0
32653|NCT01731041|73614|P2|COMPLETED|Overall Study||30
32654|NCT01731041|73615|P1|COMPLETED|Overall Study||30
32655|NCT01731041|73614|P2|STARTED|Overall Study||30
32656|NCT01731041|73615|P1|STARTED|Overall Study||30
32657|NCT01730378|73625|P2|NOT COMPLETED|Overall Study||0
32658|NCT01730378|73626|P1|NOT COMPLETED|Overall Study||1
32659|NCT01730378|73625|P2|COMPLETED|Overall Study||47
32660|NCT01730378|73626|P1|COMPLETED|Overall Study||83
32661|NCT01730378|73625|P2|STARTED|Overall Study||47
32662|NCT01730378|73626|P1|STARTED|Overall Study||84
32663|NCT01730339|73657|P2|NOT COMPLETED|Overall Study||3
32664|NCT01730339|73658|P1|NOT COMPLETED|Overall Study||5
32665|NCT01730339|73657|P2|COMPLETED|Overall Study||52
32666|NCT01730339|73658|P1|COMPLETED|Overall Study||40
32667|NCT01730339|73657|P2|STARTED|Overall Study||55
32668|NCT01730339|73658|P1|STARTED|Overall Study||45
32669|NCT01730053|73698|P6|NOT COMPLETED|Overall Study||13
32670|NCT01730053|73699|P5|NOT COMPLETED|Overall Study||9
32671|NCT01730053|73700|P4|NOT COMPLETED|Overall Study||8
32672|NCT01730053|73701|P3|NOT COMPLETED|Overall Study||11
32673|NCT01730053|73702|P2|NOT COMPLETED|Overall Study||14
32674|NCT01730053|73703|P1|NOT COMPLETED|Overall Study||5
32675|NCT01730053|73698|P6|COMPLETED|Overall Study||41
32676|NCT01730053|73699|P5|COMPLETED|Overall Study||44
32677|NCT01730053|73700|P4|COMPLETED|Overall Study||45
32678|NCT01730053|73701|P3|COMPLETED|Overall Study||38
32679|NCT01730053|73702|P2|COMPLETED|Overall Study||34
32680|NCT01730053|73703|P1|COMPLETED|Overall Study||43
32681|NCT01730053|73698|P6|Treated|Overall Study||54
32682|NCT01730053|73699|P5|Treated|Overall Study||53
32683|NCT01730053|73700|P4|Treated|Overall Study||53
32684|NCT01730053|73701|P3|Treated|Overall Study||49
32685|NCT01730053|73702|P2|Treated|Overall Study||48
32686|NCT01730053|73703|P1|Treated|Overall Study||48
32687|NCT01730053|73698|P6|STARTED|Overall Study||54
32688|NCT01730053|73699|P5|STARTED|Overall Study||53
32689|NCT01730053|73700|P4|STARTED|Overall Study||53
32690|NCT01730053|73701|P3|STARTED|Overall Study||49
32691|NCT01730053|73702|P2|STARTED|Overall Study||48
32692|NCT01730053|73703|P1|STARTED|Overall Study||48
32693|NCT01730040|73862|P7|NOT COMPLETED|Overall Study||9
32694|NCT01730040|73863|P6|NOT COMPLETED|Overall Study||7
32695|NCT01730040|73864|P5|NOT COMPLETED|Overall Study||6
32696|NCT01730040|73865|P4|NOT COMPLETED|Overall Study||8
32697|NCT01730040|73866|P3|NOT COMPLETED|Overall Study||11
32698|NCT01730040|73867|P2|NOT COMPLETED|Overall Study||15
32699|NCT01730040|73868|P1|NOT COMPLETED|Overall Study||13
32700|NCT01730040|73862|P7|COMPLETED|Overall Study||38
32701|NCT01730040|73863|P6|COMPLETED|Overall Study||40
32702|NCT01730040|73864|P5|COMPLETED|Overall Study||39
32703|NCT01730040|73865|P4|COMPLETED|Overall Study||39
32704|NCT01730040|73866|P3|COMPLETED|Overall Study||46
32705|NCT01730040|73867|P2|COMPLETED|Overall Study||40
32706|NCT01730040|73868|P1|COMPLETED|Overall Study||44
32707|NCT01730040|73862|P7|Treated|Overall Study||47
32708|NCT01730040|73863|P6|Treated|Overall Study||46
32709|NCT01730040|73864|P5|Treated|Overall Study||45
32710|NCT01730040|73865|P4|Treated|Overall Study||47
32711|NCT01730040|73866|P3|Treated|Overall Study||57
32712|NCT01730040|73867|P2|Treated|Overall Study||55
32713|NCT01730040|73868|P1|Treated|Overall Study||57
32714|NCT01730040|73862|P7|STARTED|Overall Study||47
32715|NCT01730040|73863|P6|STARTED|Overall Study||47
32716|NCT01730040|73864|P5|STARTED|Overall Study||45
32717|NCT01730040|73865|P4|STARTED|Overall Study||47
32718|NCT01730040|73866|P3|STARTED|Overall Study||57
32719|NCT01730040|73867|P2|STARTED|Overall Study||55
32720|NCT01730040|73868|P1|STARTED|Overall Study||57
32721|NCT01729871|74047|P2|NOT COMPLETED|Overall Study||23
32722|NCT01729871|74048|P1|NOT COMPLETED|Overall Study||12
32723|NCT01729871|74047|P2|COMPLETED|Overall Study||101
32724|NCT01729871|74048|P1|COMPLETED|Overall Study||112
32725|NCT01729871|74047|P2|STARTED|Overall Study||124
32726|NCT01729871|74048|P1|STARTED|Overall Study||124
32727|NCT01729728|74067|P3|NOT COMPLETED|Overall Study||1
32728|NCT01729728|74068|P2|NOT COMPLETED|Overall Study||6
32729|NCT01729728|74069|P1|NOT COMPLETED|Overall Study||1
32730|NCT01729728|74067|P3|COMPLETED|Overall Study||16
32731|NCT01729728|74068|P2|COMPLETED|Overall Study||22
32732|NCT01729728|74069|P1|COMPLETED|Overall Study||20
32733|NCT01729728|74067|P3|STARTED|Overall Study||17
32734|NCT01729728|74068|P2|STARTED|Overall Study||28
32735|NCT01729728|74069|P1|STARTED|Overall Study||21
32736|NCT01729559|74202|P2|NOT COMPLETED|Overall Study||28
32737|NCT01729559|74203|P1|NOT COMPLETED|Overall Study||31
32738|NCT01729559|74202|P2|COMPLETED|Overall Study||216
32739|NCT01729559|74203|P1|COMPLETED|Overall Study||220
32740|NCT01729559|74202|P2|STARTED|Overall Study||244
32741|NCT01729559|74203|P1|STARTED|Overall Study||251
32742|NCT01729247|74215|P1|NOT COMPLETED|Overall Study||0
32743|NCT01729247|74215|P1|COMPLETED|Overall Study||50
32744|NCT01729247|74215|P1|STARTED|Overall Study||50
32745|NCT01729026|74231|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
32746|NCT01729026|74232|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
32747|NCT01729026|74231|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
32748|NCT01729026|74232|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
32749|NCT01729026|74231|P2|STARTED|3-month to 6-month (Final) Follow-up||8
32750|NCT01729026|74232|P1|STARTED|3-month to 6-month (Final) Follow-up||7
32751|NCT01729026|74231|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
32752|NCT01729026|74232|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
32753|NCT01729026|74231|P2|COMPLETED|Randomization to 3-month Follow-up||8
32754|NCT01729026|74232|P1|COMPLETED|Randomization to 3-month Follow-up||7
32755|NCT01729026|74231|P2|STARTED|Randomization to 3-month Follow-up||10
32756|NCT01729026|74232|P1|STARTED|Randomization to 3-month Follow-up||9
32757|NCT01728792|74243|P5|NOT COMPLETED|Overall Study||0
32758|NCT01728792|74244|P4|NOT COMPLETED|Overall Study||3
32759|NCT01728792|74245|P3|NOT COMPLETED|Overall Study||4
32760|NCT01728792|74246|P2|NOT COMPLETED|Overall Study||2
32761|NCT01728792|74247|P1|NOT COMPLETED|Overall Study||3
32762|NCT01728792|74243|P5|COMPLETED|Overall Study||16
32763|NCT01728792|74244|P4|COMPLETED|Overall Study||14
32764|NCT01728792|74245|P3|COMPLETED|Overall Study||13
32765|NCT01728792|74246|P2|COMPLETED|Overall Study||14
32766|NCT01728792|74247|P1|COMPLETED|Overall Study||11
32767|NCT01728792|74243|P5|STARTED|Overall Study||16
32768|NCT01728792|74244|P4|STARTED|Overall Study||17
32769|NCT01728792|74245|P3|STARTED|Overall Study||17
32770|NCT01728792|74246|P2|STARTED|Overall Study||16
32771|NCT01728792|74247|P1|STARTED|Overall Study||14
32772|NCT01728584|74298|P4|NOT COMPLETED|Overall Study||1
32773|NCT01728584|74299|P3|NOT COMPLETED|Overall Study||1
32774|NCT01728584|74300|P2|NOT COMPLETED|Overall Study||0
32775|NCT01728584|74301|P1|NOT COMPLETED|Overall Study||8
32776|NCT01728584|74298|P4|COMPLETED|Overall Study||29
32777|NCT01728584|74299|P3|COMPLETED|Overall Study||30
32778|NCT01728584|74300|P2|COMPLETED|Overall Study||30
32779|NCT01728584|74301|P1|COMPLETED|Overall Study||28
32780|NCT01728584|74298|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
32781|NCT01728584|74299|P3|STARTED|Overall Study|Randomized|31
32782|NCT01728584|74300|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
32783|NCT01728584|74301|P1|STARTED|Overall Study|Randomized|36
32784|NCT01728376|74359|P6|NOT COMPLETED|Overall Study||2
32785|NCT01728376|74360|P5|NOT COMPLETED|Overall Study||2
32786|NCT01728376|74361|P4|NOT COMPLETED|Overall Study||2
32787|NCT01728376|74362|P3|NOT COMPLETED|Overall Study||2
32788|NCT01728376|74363|P2|NOT COMPLETED|Overall Study||2
32789|NCT01728376|74364|P1|NOT COMPLETED|Overall Study||4
32790|NCT01728376|74359|P6|COMPLETED|Overall Study||5
32791|NCT01728376|74360|P5|COMPLETED|Overall Study||12
32792|NCT01728376|74361|P4|COMPLETED|Overall Study||7
32793|NCT01728376|74362|P3|COMPLETED|Overall Study||17
32794|NCT01728376|74363|P2|COMPLETED|Overall Study||9
32795|NCT01728376|74364|P1|COMPLETED|Overall Study||18
32796|NCT01728376|74359|P6|Treated|Overall Study||7
32797|NCT01728376|74360|P5|Treated|Overall Study||14
32798|NCT01728376|74361|P4|Treated|Overall Study||9
32799|NCT01728376|74362|P3|Treated|Overall Study||19
32800|NCT01728376|74363|P2|Treated|Overall Study||10
32801|NCT01728376|74364|P1|Treated|Overall Study||22
32802|NCT01728376|74359|P6|STARTED|Overall Study||7
32803|NCT01728376|74360|P5|STARTED|Overall Study||14
32804|NCT01728376|74361|P4|STARTED|Overall Study||9
32805|NCT01728376|74362|P3|STARTED|Overall Study||19
32806|NCT01728376|74363|P2|STARTED|Overall Study||11
32807|NCT01728376|74364|P1|STARTED|Overall Study||22
32808|NCT01728337|74426|P1|NOT COMPLETED|Overall Study||0
32809|NCT01728337|74426|P1|COMPLETED|Overall Study||80
32810|NCT01728337|74426|P1|STARTED|Overall Study||80
32811|NCT01728324|74437|P3|NOT COMPLETED|Termination of RBV||15
32812|NCT01728324|74438|P2|NOT COMPLETED|Termination of RBV||37
32813|NCT01728324|74439|P1|NOT COMPLETED|Termination of RBV||39
32814|NCT01728324|74437|P3|COMPLETED|Termination of RBV||57
32815|NCT01728324|74438|P2|COMPLETED|Termination of RBV||176
32816|NCT01728324|74439|P1|COMPLETED|Termination of RBV||172
32817|NCT01728324|74437|P3|STARTED|Termination of RBV||72
32818|NCT01728324|74438|P2|STARTED|Termination of RBV||213
32819|NCT01728324|74439|P1|STARTED|Termination of RBV||211
32820|NCT01728324|74437|P3|NOT COMPLETED|Termination of FDV||14
32821|NCT01728324|74438|P2|NOT COMPLETED|Termination of FDV||36
32822|NCT01728324|74439|P1|NOT COMPLETED|Termination of FDV||38
32823|NCT01728324|74437|P3|COMPLETED|Termination of FDV||58
32824|NCT01728324|74438|P2|COMPLETED|Termination of FDV||177
32825|NCT01728324|74439|P1|COMPLETED|Termination of FDV||173
32826|NCT01728324|74437|P3|STARTED|Termination of FDV||72
32827|NCT01728324|74438|P2|STARTED|Termination of FDV||213
32828|NCT01728324|74439|P1|STARTED|Termination of FDV||211
32829|NCT01728324|74437|P3|NOT COMPLETED|Termination of DBV||14
32830|NCT01728324|74438|P2|NOT COMPLETED|Termination of DBV||36
32831|NCT01728324|74439|P1|NOT COMPLETED|Termination of DBV||38
32832|NCT01728324|74437|P3|COMPLETED|Termination of DBV||58
32833|NCT01728324|74438|P2|COMPLETED|Termination of DBV||177
32834|NCT01728324|74439|P1|COMPLETED|Termination of DBV||173
32835|NCT01728324|74437|P3|STARTED|Termination of DBV||72
32836|NCT01728324|74438|P2|STARTED|Termination of DBV||213
32837|NCT01728324|74439|P1|STARTED|Termination of DBV||211
32838|NCT01728246|74460|P2|NOT COMPLETED|Overall Study||36
32839|NCT01728246|74461|P1|NOT COMPLETED|Overall Study||36
32840|NCT01728246|74460|P2|COMPLETED|Overall Study||195
32841|NCT01728246|74461|P1|COMPLETED|Overall Study||206
32842|NCT01728246|74460|P2|STARTED|Overall Study||231
32843|NCT01728246|74461|P1|STARTED|Overall Study||242
32844|NCT01728116|74479|P2|NOT COMPLETED|Overall Study||47
32845|NCT01728116|74480|P1|NOT COMPLETED|Overall Study||161
32846|NCT01728116|74479|P2|COMPLETED|Overall Study|Completed to Week 52|60
32847|NCT01728116|74480|P1|COMPLETED|Overall Study|Completed to Week 78|52
32848|NCT01728116|74479|P2|STARTED|Overall Study|Sham mITT subjects|107
32849|NCT01728116|74480|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
32850|NCT01727895|74505|P2|NOT COMPLETED|Overall Study||0
32851|NCT01727895|74506|P1|NOT COMPLETED|Overall Study||0
32852|NCT01727895|74505|P2|COMPLETED|Overall Study||5
32853|NCT01727895|74506|P1|COMPLETED|Overall Study||10
32854|NCT01727895|74505|P2|STARTED|Overall Study||5
32855|NCT01727895|74506|P1|STARTED|Overall Study||10
32856|NCT01727791|74512|P1|NOT COMPLETED|Overall Study||0
32857|NCT01727791|74512|P1|COMPLETED|Overall Study||10
32858|NCT01727791|74512|P1|STARTED|Overall Study||10
32859|NCT01727713|74542|P1|NOT COMPLETED|Overall Study||35
32860|NCT01727713|74542|P1|COMPLETED|Overall Study||75
32861|NCT01727713|74542|P1|STARTED|Overall Study||110
32862|NCT01727700|74569|P3|NOT COMPLETED|Overall Study||2
32863|NCT01727700|74570|P2|NOT COMPLETED|Overall Study||10
32864|NCT01727700|74571|P1|NOT COMPLETED|Overall Study||2
32865|NCT01727700|74569|P3|COMPLETED|Overall Study||42
32866|NCT01727700|74570|P2|COMPLETED|Overall Study||35
32867|NCT01727700|74571|P1|COMPLETED|Overall Study||42
32868|NCT01727700|74569|P3|STARTED|Overall Study||44
32869|NCT01727700|74570|P2|STARTED|Overall Study||45
32870|NCT01727700|74571|P1|STARTED|Overall Study||44
32871|NCT01727258|74597|P3|NOT COMPLETED|Overall Study||1
32872|NCT01727258|74598|P2|NOT COMPLETED|Overall Study||3
32873|NCT01727258|74599|P1|NOT COMPLETED|Overall Study||2
32874|NCT01727258|74597|P3|COMPLETED|Overall Study||50
32875|NCT01727258|74598|P2|COMPLETED|Overall Study||48
32876|NCT01727258|74599|P1|COMPLETED|Overall Study||49
32877|NCT01727258|74597|P3|STARTED|Overall Study||51
32878|NCT01727258|74598|P2|STARTED|Overall Study||51
32879|NCT01727258|74599|P1|STARTED|Overall Study||51
32880|NCT01727180|74622|P1|NOT COMPLETED|Overall Study||0
32881|NCT01727180|74622|P1|COMPLETED|Overall Study||108
32882|NCT01727180|74622|P1|STARTED|Overall Study||108
32883|NCT01727167|74628|P2|NOT COMPLETED|Overall Study||0
32884|NCT01727167|74629|P1|NOT COMPLETED|Overall Study||0
32885|NCT01727167|74628|P2|COMPLETED|Overall Study||0
32886|NCT01727167|74629|P1|COMPLETED|Overall Study||1
32887|NCT01727167|74628|P2|STARTED|Overall Study||0
32888|NCT01727167|74629|P1|STARTED|Overall Study||1
32889|NCT01727141|74641|P4|NOT COMPLETED|Overall Study||15
32890|NCT01727141|74642|P3|NOT COMPLETED|Overall Study||3
32891|NCT01727141|74643|P2|NOT COMPLETED|Overall Study||9
32892|NCT01727141|74644|P1|NOT COMPLETED|Overall Study||5
32893|NCT01727141|74641|P4|COMPLETED|Overall Study||246
32894|NCT01727141|74642|P3|COMPLETED|Overall Study||258
32895|NCT01727141|74643|P2|COMPLETED|Overall Study||251
32896|NCT01727141|74644|P1|COMPLETED|Overall Study||255
32897|NCT01727141|74641|P4|Full Analysis Set|Overall Study||261
32898|NCT01727141|74642|P3|Full Analysis Set|Overall Study||261
32899|NCT01727141|74643|P2|Full Analysis Set|Overall Study||260
32900|NCT01727141|74644|P1|Full Analysis Set|Overall Study||258
32901|NCT01727141|74641|P4|Safety Set|Overall Study||260
32902|NCT01727141|74642|P3|Safety Set|Overall Study||262
32903|NCT01727141|74643|P2|Safety Set|Overall Study||260
32904|NCT01727141|74644|P1|Safety Set|Overall Study||258
32905|NCT01727141|74641|P4|STARTED|Overall Study||261
32906|NCT01727141|74642|P3|STARTED|Overall Study||261
32907|NCT01727141|74643|P2|STARTED|Overall Study||260
32908|NCT01727141|74644|P1|STARTED|Overall Study||260
32909|NCT01727024|74694|P2|NOT COMPLETED|Period 2||0
32910|NCT01727024|74695|P1|NOT COMPLETED|Period 2||0
32911|NCT01727024|74694|P2|COMPLETED|Period 2||64
32912|NCT01727024|74695|P1|COMPLETED|Period 2||68
32913|NCT01727024|74694|P2|STARTED|Period 2||64
32914|NCT01727024|74695|P1|STARTED|Period 2||68
32915|NCT01727024|74694|P2|NOT COMPLETED|Period 1||4
32916|NCT01727024|74695|P1|NOT COMPLETED|Period 1||3
32917|NCT01727024|74694|P2|COMPLETED|Period 1||64
32918|NCT01727024|74695|P1|COMPLETED|Period 1||68
32919|NCT01727024|74694|P2|STARTED|Period 1||68
32920|NCT01727024|74695|P1|STARTED|Period 1||71
32921|NCT01726621|74708|P1|NOT COMPLETED|Overall Study||4
32922|NCT01726621|74708|P1|COMPLETED|Overall Study||51
32923|NCT01726621|74708|P1|STARTED|Overall Study||55
32924|NCT01726517|74717|P5|NOT COMPLETED|Overall Study||0
32925|NCT01726517|74718|P4|NOT COMPLETED|Overall Study||0
32926|NCT01726517|74719|P3|NOT COMPLETED|Overall Study||1
32927|NCT01726517|74720|P2|NOT COMPLETED|Overall Study||0
32928|NCT01726517|74721|P1|NOT COMPLETED|Overall Study||0
32929|NCT01726517|74717|P5|COMPLETED|Overall Study||21
32930|NCT01726517|74718|P4|COMPLETED|Overall Study||19
32931|NCT01726517|74719|P3|COMPLETED|Overall Study||18
32932|NCT01726517|74720|P2|COMPLETED|Overall Study||21
32933|NCT01726517|74721|P1|COMPLETED|Overall Study||20
32934|NCT01726517|74717|P5|STARTED|Overall Study||21
32935|NCT01726517|74718|P4|STARTED|Overall Study||19
32936|NCT01726517|74719|P3|STARTED|Overall Study||19
32937|NCT01726517|74720|P2|STARTED|Overall Study||21
32938|NCT01726517|74721|P1|STARTED|Overall Study||20
32939|NCT01726504|74750|P2|NOT COMPLETED|Overall Study||28
32940|NCT01726504|74751|P1|NOT COMPLETED|Overall Study||12
32941|NCT01726504|74750|P2|COMPLETED|Overall Study||511
32942|NCT01726504|74751|P1|COMPLETED|Overall Study||524
32943|NCT01726504|74750|P2|STARTED|Overall Study||539
32944|NCT01726504|74751|P1|STARTED|Overall Study||536
32945|NCT01726335|74777|P1|NOT COMPLETED|Overall Study||24
32946|NCT01726335|74777|P1|COMPLETED|Overall Study||29
32947|NCT01726335|74777|P1|STARTED|Overall Study||53
32948|NCT01726049|74795|P2|NOT COMPLETED|Overall Study||4
32949|NCT01726049|74796|P1|NOT COMPLETED|Overall Study||5
32950|NCT01726049|74795|P2|COMPLETED|Overall Study||22
32951|NCT01726049|74796|P1|COMPLETED|Overall Study||21
32952|NCT01726049|74795|P2|STARTED|Overall Study||26
32953|NCT01726049|74796|P1|STARTED|Overall Study||26
32954|NCT01726023|74810|P2|NOT COMPLETED|Overall Study||26
32955|NCT01726023|74811|P1|NOT COMPLETED|Overall Study||29
32956|NCT01726023|74810|P2|COMPLETED|Overall Study||196
32957|NCT01726023|74811|P1|COMPLETED|Overall Study||190
32958|NCT01726023|74810|P2|STARTED|Overall Study||222
32959|NCT01726023|74811|P1|STARTED|Overall Study||219
32960|NCT01725984|74903|P2|NOT COMPLETED|Overall Study||0
32961|NCT01725984|74904|P1|NOT COMPLETED|Overall Study||0
32962|NCT01725984|74903|P2|COMPLETED|Overall Study||41
32963|NCT01725984|74904|P1|COMPLETED|Overall Study||39
32964|NCT01725984|74903|P2|STARTED|Overall Study||41
32965|NCT01725984|74904|P1|STARTED|Overall Study||39
32966|NCT01725529|74931|P3|NOT COMPLETED|Overall Study||10
32967|NCT01725529|74932|P2|NOT COMPLETED|Overall Study||16
32968|NCT01725529|74933|P1|NOT COMPLETED|Overall Study||15
32969|NCT01725529|74931|P3|COMPLETED|Overall Study||142
32970|NCT01725529|74932|P2|COMPLETED|Overall Study||137
32971|NCT01725529|74933|P1|COMPLETED|Overall Study||137
32972|NCT01725529|74931|P3|STARTED|Overall Study||152
32973|NCT01725529|74932|P2|STARTED|Overall Study||153
32974|NCT01725529|74933|P1|STARTED|Overall Study||152
32975|NCT01725451|74959|P4|NOT COMPLETED|Period 6||0
32976|NCT01725451|74960|P3|NOT COMPLETED|Period 6||0
32977|NCT01725451|74961|P2|NOT COMPLETED|Period 6||0
32978|NCT01725451|74962|P1|NOT COMPLETED|Period 6||0
32979|NCT01725451|74959|P4|COMPLETED|Period 6||7
32980|NCT01725451|74960|P3|COMPLETED|Period 6||6
32981|NCT01725451|74961|P2|COMPLETED|Period 6||6
32982|NCT01725451|74962|P1|COMPLETED|Period 6||7
32983|NCT01725451|74959|P4|STARTED|Period 6||7
32984|NCT01725451|74960|P3|STARTED|Period 6||6
32985|NCT01725451|74961|P2|STARTED|Period 6||6
32986|NCT01725451|74962|P1|STARTED|Period 6||7
32987|NCT01725451|74959|P4|NOT COMPLETED|Washout From Period 5||0
32988|NCT01725451|74960|P3|NOT COMPLETED|Washout From Period 5||0
32989|NCT01725451|74961|P2|NOT COMPLETED|Washout From Period 5||0
32990|NCT01725451|74962|P1|NOT COMPLETED|Washout From Period 5||0
32991|NCT01725451|74959|P4|COMPLETED|Washout From Period 5||7
32992|NCT01725451|74960|P3|COMPLETED|Washout From Period 5||6
32993|NCT01725451|74961|P2|COMPLETED|Washout From Period 5||6
32994|NCT01725451|74962|P1|COMPLETED|Washout From Period 5||7
32995|NCT01725451|74959|P4|STARTED|Washout From Period 5||7
32996|NCT01725451|74960|P3|STARTED|Washout From Period 5||6
32997|NCT01725451|74961|P2|STARTED|Washout From Period 5||6
32998|NCT01725451|74962|P1|STARTED|Washout From Period 5||7
32999|NCT01725451|74959|P4|NOT COMPLETED|Period 5||0
33000|NCT01725451|74960|P3|NOT COMPLETED|Period 5||0
33001|NCT01725451|74961|P2|NOT COMPLETED|Period 5||0
33002|NCT01725451|74962|P1|NOT COMPLETED|Period 5||0
33003|NCT01725451|74959|P4|COMPLETED|Period 5||7
33004|NCT01725451|74960|P3|COMPLETED|Period 5||6
33005|NCT01725451|74961|P2|COMPLETED|Period 5||6
33006|NCT01725451|74962|P1|COMPLETED|Period 5||7
33007|NCT01725451|74959|P4|STARTED|Period 5||7
33008|NCT01725451|74960|P3|STARTED|Period 5||6
33009|NCT01725451|74961|P2|STARTED|Period 5||6
33010|NCT01725451|74962|P1|STARTED|Period 5||7
33011|NCT01725451|74959|P4|NOT COMPLETED|Washout From Period 4||0
33012|NCT01725451|74960|P3|NOT COMPLETED|Washout From Period 4||0
33013|NCT01725451|74961|P2|NOT COMPLETED|Washout From Period 4||0
33014|NCT01725451|74962|P1|NOT COMPLETED|Washout From Period 4||0
33015|NCT01725451|74959|P4|COMPLETED|Washout From Period 4||7
33016|NCT01725451|74960|P3|COMPLETED|Washout From Period 4||6
33017|NCT01725451|74961|P2|COMPLETED|Washout From Period 4||6
33018|NCT01725451|74962|P1|COMPLETED|Washout From Period 4||7
33019|NCT01725451|74959|P4|STARTED|Washout From Period 4||7
33020|NCT01725451|74960|P3|STARTED|Washout From Period 4||6
33021|NCT01725451|74961|P2|STARTED|Washout From Period 4||6
33022|NCT01725451|74962|P1|STARTED|Washout From Period 4||7
33023|NCT01725451|74959|P4|NOT COMPLETED|Period 4||0
33024|NCT01725451|74960|P3|NOT COMPLETED|Period 4||1
33025|NCT01725451|74961|P2|NOT COMPLETED|Period 4||0
33026|NCT01725451|74962|P1|NOT COMPLETED|Period 4||0
33027|NCT01725451|74959|P4|COMPLETED|Period 4||7
33028|NCT01725451|74960|P3|COMPLETED|Period 4||6
33029|NCT01725451|74961|P2|COMPLETED|Period 4||6
33030|NCT01725451|74962|P1|COMPLETED|Period 4||7
33031|NCT01725451|74959|P4|STARTED|Period 4||7
33032|NCT01725451|74960|P3|STARTED|Period 4||7
33033|NCT01725451|74961|P2|STARTED|Period 4||6
33034|NCT01725451|74962|P1|STARTED|Period 4||7
33035|NCT01725451|74959|P4|NOT COMPLETED|Washout From Period 3||0
33036|NCT01725451|74960|P3|NOT COMPLETED|Washout From Period 3||1
33037|NCT01725451|74961|P2|NOT COMPLETED|Washout From Period 3||1
33038|NCT01725451|74962|P1|NOT COMPLETED|Washout From Period 3||0
33039|NCT01725451|74959|P4|COMPLETED|Washout From Period 3||7
33040|NCT01725451|74960|P3|COMPLETED|Washout From Period 3||7
33041|NCT01725451|74961|P2|COMPLETED|Washout From Period 3||6
33042|NCT01725451|74962|P1|COMPLETED|Washout From Period 3||7
33043|NCT01725451|74959|P4|STARTED|Washout From Period 3||7
33044|NCT01725451|74960|P3|STARTED|Washout From Period 3||8
33045|NCT01725451|74961|P2|STARTED|Washout From Period 3||7
33046|NCT01725451|74962|P1|STARTED|Washout From Period 3||7
33047|NCT01725451|74959|P4|NOT COMPLETED|Period 3||0
33048|NCT01725451|74960|P3|NOT COMPLETED|Period 3||0
33049|NCT01725451|74961|P2|NOT COMPLETED|Period 3||0
33050|NCT01725451|74962|P1|NOT COMPLETED|Period 3||0
33051|NCT01725451|74959|P4|COMPLETED|Period 3||7
33052|NCT01725451|74960|P3|COMPLETED|Period 3||8
33053|NCT01725451|74961|P2|COMPLETED|Period 3||7
33054|NCT01725451|74962|P1|COMPLETED|Period 3||7
33055|NCT01725451|74959|P4|STARTED|Period 3||7
33056|NCT01725451|74960|P3|STARTED|Period 3||8
33057|NCT01725451|74961|P2|STARTED|Period 3||7
33058|NCT01725451|74962|P1|STARTED|Period 3||7
33059|NCT01725451|74959|P4|NOT COMPLETED|Washout From Period 2||0
33060|NCT01725451|74960|P3|NOT COMPLETED|Washout From Period 2||0
33061|NCT01725451|74961|P2|NOT COMPLETED|Washout From Period 2||0
33062|NCT01725451|74962|P1|NOT COMPLETED|Washout From Period 2||0
33063|NCT01725451|74959|P4|COMPLETED|Washout From Period 2||7
33064|NCT01725451|74960|P3|COMPLETED|Washout From Period 2||8
33065|NCT01725451|74961|P2|COMPLETED|Washout From Period 2||7
33066|NCT01725451|74962|P1|COMPLETED|Washout From Period 2||7
33067|NCT01725451|74959|P4|STARTED|Washout From Period 2||7
33068|NCT01725451|74960|P3|STARTED|Washout From Period 2||8
33069|NCT01725451|74961|P2|STARTED|Washout From Period 2||7
33070|NCT01725451|74962|P1|STARTED|Washout From Period 2||7
33071|NCT01725451|74959|P4|NOT COMPLETED|Period 2||0
33072|NCT01725451|74960|P3|NOT COMPLETED|Period 2||0
33073|NCT01725451|74961|P2|NOT COMPLETED|Period 2||0
33074|NCT01725451|74962|P1|NOT COMPLETED|Period 2||0
33075|NCT01725451|74959|P4|COMPLETED|Period 2||7
33076|NCT01725451|74960|P3|COMPLETED|Period 2||8
33077|NCT01725451|74961|P2|COMPLETED|Period 2||7
33078|NCT01725451|74962|P1|COMPLETED|Period 2||7
33079|NCT01725451|74959|P4|STARTED|Period 2||7
33080|NCT01725451|74960|P3|STARTED|Period 2||8
33081|NCT01725451|74961|P2|STARTED|Period 2||7
33082|NCT01725451|74962|P1|STARTED|Period 2||7
33083|NCT01725451|74959|P4|NOT COMPLETED|Washout From Period 1||0
33084|NCT01725451|74960|P3|NOT COMPLETED|Washout From Period 1||0
33085|NCT01725451|74961|P2|NOT COMPLETED|Washout From Period 1||0
33086|NCT01725451|74962|P1|NOT COMPLETED|Washout From Period 1||0
33087|NCT01725451|74959|P4|COMPLETED|Washout From Period 1||7
33088|NCT01725451|74960|P3|COMPLETED|Washout From Period 1||8
33089|NCT01725451|74961|P2|COMPLETED|Washout From Period 1||7
33090|NCT01725451|74962|P1|COMPLETED|Washout From Period 1||7
33091|NCT01725451|74959|P4|STARTED|Washout From Period 1||7
33092|NCT01725451|74960|P3|STARTED|Washout From Period 1||8
33093|NCT01725451|74961|P2|STARTED|Washout From Period 1||7
33094|NCT01725451|74962|P1|STARTED|Washout From Period 1||7
33095|NCT01725451|74959|P4|NOT COMPLETED|Period 1||0
33096|NCT01725451|74960|P3|NOT COMPLETED|Period 1||0
33097|NCT01725451|74961|P2|NOT COMPLETED|Period 1||0
33098|NCT01725451|74962|P1|NOT COMPLETED|Period 1||1
33099|NCT01725451|74959|P4|COMPLETED|Period 1||7
33100|NCT01725451|74960|P3|COMPLETED|Period 1||8
33101|NCT01725451|74961|P2|COMPLETED|Period 1||7
33102|NCT01725451|74962|P1|COMPLETED|Period 1||7
33103|NCT01725451|74959|P4|STARTED|Period 1||7
33104|NCT01725451|74960|P3|STARTED|Period 1||8
33105|NCT01725451|74961|P2|STARTED|Period 1||7
33106|NCT01725451|74962|P1|STARTED|Period 1||8
33107|NCT01725386|74984|P2|NOT COMPLETED|Overall Study||46
33108|NCT01725386|74985|P1|NOT COMPLETED|Overall Study||175
33109|NCT01725386|74984|P2|COMPLETED|Overall Study||17
33110|NCT01725386|74985|P1|COMPLETED|Overall Study||13
33111|NCT01725386|74984|P2|STARTED|Overall Study||63
33112|NCT01725386|74985|P1|STARTED|Overall Study||188
33113|NCT01725308|75004|P3|NOT COMPLETED|Overall Study||41
33114|NCT01725308|75005|P2|NOT COMPLETED|Overall Study||14
33115|NCT01725308|75006|P1|NOT COMPLETED|Overall Study||44
33116|NCT01725308|75004|P3|COMPLETED|Overall Study||138
33117|NCT01725308|75005|P2|COMPLETED|Overall Study||60
33118|NCT01725308|75006|P1|COMPLETED|Overall Study||134
33119|NCT01725308|75004|P3|Treated|Overall Study||179
33120|NCT01725308|75005|P2|Treated|Overall Study||74
33121|NCT01725308|75006|P1|Treated|Overall Study||177
33122|NCT01725308|75004|P3|STARTED|Overall Study||179
33123|NCT01725308|75005|P2|STARTED|Overall Study||74
33124|NCT01725308|75006|P1|STARTED|Overall Study||178
33125|NCT01725282|75060|P4|NOT COMPLETED|Overall Study||7
33126|NCT01725282|75061|P3|NOT COMPLETED|Overall Study||8
33127|NCT01725282|75062|P2|NOT COMPLETED|Overall Study||5
33128|NCT01725282|75063|P1|NOT COMPLETED|Overall Study||2
33129|NCT01725282|75060|P4|COMPLETED|Overall Study||36
33130|NCT01725282|75061|P3|COMPLETED|Overall Study||33
33131|NCT01725282|75062|P2|COMPLETED|Overall Study||39
33132|NCT01725282|75063|P1|COMPLETED|Overall Study||42
33133|NCT01725282|75060|P4|STARTED|Overall Study||43
33134|NCT01725282|75061|P3|STARTED|Overall Study||41
33135|NCT01725282|75062|P2|STARTED|Overall Study||44
33136|NCT01725282|75063|P1|STARTED|Overall Study||44
33137|NCT01725217|75096|P3|NOT COMPLETED|Overall Study||0
33138|NCT01725217|75097|P2|NOT COMPLETED|Overall Study||0
33139|NCT01725217|75098|P1|NOT COMPLETED|Overall Study||1
33140|NCT01725217|75096|P3|COMPLETED|Overall Study||66
33141|NCT01725217|75097|P2|COMPLETED|Overall Study||66
33142|NCT01725217|75098|P1|COMPLETED|Overall Study||65
33143|NCT01725217|75096|P3|STARTED|Overall Study||66
33144|NCT01725217|75097|P2|STARTED|Overall Study||66
33145|NCT01725217|75098|P1|STARTED|Overall Study||66
33146|NCT01724528|75128|P2|NOT COMPLETED|Overall Study||3
33147|NCT01724528|75129|P1|NOT COMPLETED|Overall Study||4
33148|NCT01724528|75128|P2|COMPLETED|Overall Study||170
33149|NCT01724528|75129|P1|COMPLETED|Overall Study||169
33150|NCT01724528|75128|P2|STARTED|Overall Study||173
33151|NCT01724528|75129|P1|STARTED|Overall Study||173
33152|NCT01724359|75143|P1|NOT COMPLETED|Overall Study||31
33153|NCT01724359|75143|P1|COMPLETED|Overall Study||64
33154|NCT01724359|75143|P1|STARTED|Overall Study||95
33155|NCT01724216|75156|P1|NOT COMPLETED|Overall Study||1
33156|NCT01724216|75156|P1|COMPLETED|Overall Study||10
33157|NCT01724216|75156|P1|STARTED|Overall Study||11
33158|NCT01724177|75160|P1|NOT COMPLETED|Overall Study||21
33159|NCT01724177|75160|P1|COMPLETED|Overall Study|Completed includes participants who continue receiving oral lenalidomide|5
33160|NCT01724177|75160|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
33161|NCT01724177|75160|P1|STARTED|Overall Study||26
33162|NCT01724021|75172|P2|NOT COMPLETED|Overall Study||60
33163|NCT01724021|75173|P1|NOT COMPLETED|Overall Study||48
33164|NCT01724021|75172|P2|COMPLETED|Overall Study||309
33165|NCT01724021|75173|P1|COMPLETED|Overall Study||323
33166|NCT01724021|75172|P2|STARTED|Overall Study||369
33167|NCT01724021|75173|P1|STARTED|Overall Study||371
33168|NCT01723904|75205|P1|NOT COMPLETED|Overall Study||11
33169|NCT01723904|75205|P1|COMPLETED|Overall Study||79
33170|NCT01723904|75205|P1|STARTED|Overall Study||90
33171|NCT01723722|75217|P2|NOT COMPLETED|Overall Study||0
33172|NCT01723722|75218|P1|NOT COMPLETED|Overall Study||0
33173|NCT01723722|75217|P2|COMPLETED|Overall Study||20
33174|NCT01723722|75218|P1|COMPLETED|Overall Study||20
33175|NCT01723722|75217|P2|STARTED|Overall Study||20
33176|NCT01723722|75218|P1|STARTED|Overall Study||20
33177|NCT01723397|75226|P2|NOT COMPLETED|Study Period 2||1
33178|NCT01723397|75227|P1|NOT COMPLETED|Study Period 2||0
33179|NCT01723397|75226|P2|COMPLETED|Study Period 2||5
33180|NCT01723397|75227|P1|COMPLETED|Study Period 2||7
33181|NCT01723397|75226|P2|STARTED|Study Period 2||6
33182|NCT01723397|75227|P1|STARTED|Study Period 2||7
33183|NCT01723397|75226|P2|NOT COMPLETED|Washout||0
33184|NCT01723397|75227|P1|NOT COMPLETED|Washout||0
33185|NCT01723397|75226|P2|COMPLETED|Washout||6
33186|NCT01723397|75227|P1|COMPLETED|Washout||7
33187|NCT01723397|75226|P2|STARTED|Washout||6
33188|NCT01723397|75227|P1|STARTED|Washout||7
33189|NCT01723397|75226|P2|NOT COMPLETED|Study Period 1||1
33190|NCT01723397|75227|P1|NOT COMPLETED|Study Period 1||0
33191|NCT01723397|75226|P2|COMPLETED|Study Period 1||6
33192|NCT01723397|75227|P1|COMPLETED|Study Period 1||7
33193|NCT01723397|75226|P2|STARTED|Study Period 1||7
33194|NCT01723397|75227|P1|STARTED|Study Period 1||7
33195|NCT01723254|75241|P8|NOT COMPLETED|Overall Study||3
33196|NCT01723254|75242|P7|NOT COMPLETED|Overall Study||1
33197|NCT01723254|75243|P6|NOT COMPLETED|Overall Study||2
33198|NCT01723254|75244|P5|NOT COMPLETED|Overall Study||2
33199|NCT01723254|75245|P4|NOT COMPLETED|Overall Study||2
33200|NCT01723254|75246|P3|NOT COMPLETED|Overall Study||3
33201|NCT01723254|75247|P2|NOT COMPLETED|Overall Study||3
33202|NCT01723254|75248|P1|NOT COMPLETED|Overall Study||1
33203|NCT01723254|75241|P8|COMPLETED|Overall Study||60
33204|NCT01723254|75242|P7|COMPLETED|Overall Study||19
33205|NCT01723254|75243|P6|COMPLETED|Overall Study||18
33206|NCT01723254|75244|P5|COMPLETED|Overall Study||18
33207|NCT01723254|75245|P4|COMPLETED|Overall Study||18
33208|NCT01723254|75246|P3|COMPLETED|Overall Study||17
33209|NCT01723254|75247|P2|COMPLETED|Overall Study||18
33210|NCT01723254|75248|P1|COMPLETED|Overall Study||5
33211|NCT01723254|75241|P8|STARTED|Overall Study||63
33212|NCT01723254|75242|P7|STARTED|Overall Study||20
33213|NCT01723254|75243|P6|STARTED|Overall Study||20
33214|NCT01723254|75244|P5|STARTED|Overall Study||20
33215|NCT01723254|75245|P4|STARTED|Overall Study||20
33216|NCT01723254|75246|P3|STARTED|Overall Study||20
33217|NCT01723254|75247|P2|STARTED|Overall Study||21
33218|NCT01723254|75248|P1|STARTED|Overall Study||6
33219|NCT01723228|75300|P2|NOT COMPLETED|Overall Study||11
33220|NCT01723228|75301|P1|NOT COMPLETED|Overall Study||8
33221|NCT01723228|75300|P2|COMPLETED|Overall Study||73
33222|NCT01723228|75301|P1|COMPLETED|Overall Study||78
33223|NCT01723228|75300|P2|STARTED|Overall Study||84
33224|NCT01723228|75301|P1|STARTED|Overall Study||86
33225|NCT01722994|75319|P2|NOT COMPLETED|Overall Study||17
33226|NCT01722994|75320|P1|NOT COMPLETED|Overall Study||25
33227|NCT01722994|75319|P2|COMPLETED|Overall Study||31
33228|NCT01722994|75320|P1|COMPLETED|Overall Study||24
33229|NCT01722994|75319|P2|STARTED|Overall Study||48
33230|NCT01722994|75320|P1|STARTED|Overall Study||49
33231|NCT01722734|75337|P3|NOT COMPLETED|Overall Study||2
33232|NCT01722734|75338|P2|NOT COMPLETED|Overall Study||1
33233|NCT01722734|75339|P1|NOT COMPLETED|Overall Study||2
33234|NCT01722734|75337|P3|COMPLETED|Overall Study||307
33235|NCT01722734|75338|P2|COMPLETED|Overall Study||276
33236|NCT01722734|75339|P1|COMPLETED|Overall Study||552
33237|NCT01722734|75337|P3|STARTED|Overall Study||309
33238|NCT01722734|75338|P2|STARTED|Overall Study||277
33239|NCT01722734|75339|P1|STARTED|Overall Study||554
33240|NCT01722487|75349|P2|NOT COMPLETED|Overall Study||7
33241|NCT01722487|75350|P1|NOT COMPLETED|Overall Study||2
33242|NCT01722487|75349|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
33243|NCT01722487|75350|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
33244|NCT01722487|75349|P2|STARTED|Overall Study||133
33245|NCT01722487|75350|P1|STARTED|Overall Study||136
33246|NCT01722435|75368|P1|NOT COMPLETED|Overall Study||0
33247|NCT01722435|75368|P1|COMPLETED|Overall Study||78
33248|NCT01722435|75368|P1|STARTED|Overall Study||78
33249|NCT01722266|75380|P4|NOT COMPLETED|Overall Study||0
33250|NCT01722266|75381|P3|NOT COMPLETED|Overall Study||5
33251|NCT01722266|75382|P2|NOT COMPLETED|Overall Study||3
33252|NCT01722266|75383|P1|NOT COMPLETED|Overall Study||1
33253|NCT01722266|75380|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
33254|NCT01722266|75381|P3|COMPLETED|Overall Study||13
33255|NCT01722266|75382|P2|COMPLETED|Overall Study||15
33256|NCT01722266|75383|P1|COMPLETED|Overall Study||17
33257|NCT01722266|75380|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
33258|NCT01722266|75381|P3|STARTED|Overall Study||18
33259|NCT01722266|75382|P2|STARTED|Overall Study||18
33260|NCT01722266|75383|P1|STARTED|Overall Study||18
33261|NCT01722162|75411|P2|NOT COMPLETED|Overall Study||6
33262|NCT01722162|75412|P1|NOT COMPLETED|Overall Study||5
33263|NCT01722162|75411|P2|COMPLETED|Overall Study||18
33264|NCT01722162|75412|P1|COMPLETED|Overall Study||18
33265|NCT01722162|75411|P2|STARTED|Overall Study||24
33266|NCT01722162|75412|P1|STARTED|Overall Study||23
33267|NCT01722097|75422|P2|NOT COMPLETED|Overall Study||5
33268|NCT01722097|75423|P1|NOT COMPLETED|Overall Study||6
33269|NCT01722097|75422|P2|COMPLETED|Overall Study||50
33270|NCT01722097|75423|P1|COMPLETED|Overall Study||49
33271|NCT01722097|75422|P2|STARTED|Overall Study||55
33272|NCT01722097|75423|P1|STARTED|Overall Study||55
33273|NCT01722071|75431|P2|NOT COMPLETED|Overall Study||0
33274|NCT01722071|75432|P1|NOT COMPLETED|Overall Study||1
33275|NCT01722071|75431|P2|COMPLETED|Overall Study||10
33276|NCT01722071|75432|P1|COMPLETED|Overall Study||9
33277|NCT01722071|75431|P2|STARTED|Overall Study||10
33278|NCT01722071|75432|P1|STARTED|Overall Study||10
33279|NCT01721967|75438|P1|NOT COMPLETED|Overall Study||3
33280|NCT01721967|75438|P1|COMPLETED|Overall Study||11
33281|NCT01721967|75438|P1|STARTED|Overall Study||14
33282|NCT01721837|75447|P1|NOT COMPLETED|Overall Study||0
33283|NCT01721837|75447|P1|COMPLETED|Overall Study||2120
33284|NCT01721837|75447|P1|STARTED|Overall Study||2120
33285|NCT01721772|75453|P2|NOT COMPLETED|Overall Study||192
33286|NCT01721772|75454|P1|NOT COMPLETED|Overall Study||111
33287|NCT01721772|75453|P2|COMPLETED|Overall Study|Continuing in treatment period|13
33288|NCT01721772|75454|P1|COMPLETED|Overall Study|Continuing in treatment period|95
33289|NCT01721772|75453|P2|STARTED|Overall Study||205
33290|NCT01721772|75454|P1|STARTED|Overall Study||206
33291|NCT01721759|75474|P1|NOT COMPLETED|Overall Study||102
33292|NCT01721759|75474|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
33293|NCT01721759|75474|P1|STARTED|Overall Study||117
33294|NCT01721564|75480|P1|NOT COMPLETED|Overall Study||0
33295|NCT01721564|75480|P1|COMPLETED|Overall Study||8
33296|NCT01721564|75480|P1|STARTED|Overall Study||8
33297|NCT01721330|75487|P2|NOT COMPLETED|Overall Study||1
33298|NCT01721330|75488|P1|NOT COMPLETED|Overall Study||0
33299|NCT01721330|75487|P2|COMPLETED|Overall Study||1
33300|NCT01721330|75488|P1|COMPLETED|Overall Study||1
33301|NCT01721330|75487|P2|STARTED|Overall Study||2
33302|NCT01721330|75488|P1|STARTED|Overall Study||1
33303|NCT01721317|75496|P2|NOT COMPLETED|Overall Study||4
33304|NCT01721317|75497|P1|NOT COMPLETED|Overall Study||2
33305|NCT01721317|75496|P2|COMPLETED|Overall Study||0
33306|NCT01721317|75497|P1|COMPLETED|Overall Study||0
33307|NCT01721317|75496|P2|STARTED|Overall Study||4
33308|NCT01721317|75497|P1|STARTED|Overall Study||2
33309|NCT01721226|75565|P2|NOT COMPLETED|Overall Study||7
33310|NCT01721226|75566|P1|NOT COMPLETED|Overall Study||5
33311|NCT01721226|75565|P2|COMPLETED|Overall Study||50
33312|NCT01721226|75566|P1|COMPLETED|Overall Study||50
33313|NCT01721226|75565|P2|Week 24|Overall Study||50
33314|NCT01721226|75566|P1|Week 24|Overall Study||50
33315|NCT01721226|75565|P2|Week 12|Overall Study||53
33316|NCT01721226|75566|P1|Week 12|Overall Study||48
33317|NCT01721226|75565|P2|Baseline|Overall Study||57
33318|NCT01721226|75566|P1|Baseline|Overall Study||53
33319|NCT01721226|75565|P2|STARTED|Overall Study||57
33320|NCT01721226|75566|P1|STARTED|Overall Study||55
33321|NCT01721161|75576|P2|NOT COMPLETED|Overall Study||7
33322|NCT01721161|75577|P1|NOT COMPLETED|Overall Study||4
33323|NCT01721161|75576|P2|COMPLETED|Overall Study||34
33324|NCT01721161|75577|P1|COMPLETED|Overall Study||37
33325|NCT01721161|75576|P2|STARTED|Overall Study||41
33326|NCT01721161|75577|P1|STARTED|Overall Study||41
33327|NCT01721096|75602|P2|NOT COMPLETED|Follow-up Completed at 3 Year||204
33328|NCT01721096|75603|P1|NOT COMPLETED|Follow-up Completed at 3 Year||302
33329|NCT01721096|75602|P2|COMPLETED|Follow-up Completed at 3 Year||2
33330|NCT01721096|75603|P1|COMPLETED|Follow-up Completed at 3 Year||5
33331|NCT01721096|75602|P2|STARTED|Follow-up Completed at 3 Year||206
33332|NCT01721096|75603|P1|STARTED|Follow-up Completed at 3 Year||307
33333|NCT01721096|75602|P2|NOT COMPLETED|Follow-up Completed at 2 Year||1
33334|NCT01721096|75603|P1|NOT COMPLETED|Follow-up Completed at 2 Year||8
33335|NCT01721096|75602|P2|COMPLETED|Follow-up Completed at 2 Year||206
33336|NCT01721096|75603|P1|COMPLETED|Follow-up Completed at 2 Year||307
33337|NCT01721096|75602|P2|STARTED|Follow-up Completed at 2 Year||207
33338|NCT01721096|75603|P1|STARTED|Follow-up Completed at 2 Year||315
33339|NCT01721096|75602|P2|NOT COMPLETED|Follow-up Completed at 1 Year||1
33340|NCT01721096|75603|P1|NOT COMPLETED|Follow-up Completed at 1 Year||4
33341|NCT01721096|75602|P2|COMPLETED|Follow-up Completed at 1 Year||207
33342|NCT01721096|75603|P1|COMPLETED|Follow-up Completed at 1 Year||315
33343|NCT01721096|75602|P2|STARTED|Follow-up Completed at 1 Year||208
33344|NCT01721096|75603|P1|STARTED|Follow-up Completed at 1 Year||319
33345|NCT01721096|75602|P2|NOT COMPLETED|Follow-up Completed at 8 Months||5
33346|NCT01721096|75603|P1|NOT COMPLETED|Follow-up Completed at 8 Months||4
33347|NCT01721096|75602|P2|COMPLETED|Follow-up Completed at 8 Months||208
33348|NCT01721096|75603|P1|COMPLETED|Follow-up Completed at 8 Months||319
33349|NCT01721096|75602|P2|STARTED|Follow-up Completed at 8 Months||213
33350|NCT01721096|75603|P1|STARTED|Follow-up Completed at 8 Months||323
33351|NCT01721070|75693|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
33352|NCT01721070|75693|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
33353|NCT01721070|75693|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
33354|NCT01721070|75693|P1|NOT COMPLETED|SUF NT 15 mcg||0
33355|NCT01721070|75693|P1|COMPLETED|SUF NT 15 mcg||19
33356|NCT01721070|75693|P1|STARTED|SUF NT 15 mcg||19
33357|NCT01720797|75703|P2|NOT COMPLETED|Overall Study||0
33358|NCT01720797|75704|P1|NOT COMPLETED|Overall Study||3
33359|NCT01720797|75703|P2|COMPLETED|Overall Study||9
33360|NCT01720797|75704|P1|COMPLETED|Overall Study||9
33361|NCT01720797|75703|P2|STARTED|Overall Study||9
33362|NCT01720797|75704|P1|STARTED|Overall Study||12
33363|NCT01720602|75710|P1|NOT COMPLETED|Overall Study||5
33364|NCT01720602|75710|P1|COMPLETED|Overall Study||10
33365|NCT01720602|75710|P1|STARTED|Overall Study||15
33366|NCT01720251|75719|P3|NOT COMPLETED|Overall Study||0
33367|NCT01720251|75720|P2|NOT COMPLETED|Overall Study||2
33368|NCT01720251|75721|P1|NOT COMPLETED|Overall Study||1
33369|NCT01720251|75719|P3|COMPLETED|Overall Study||82
33370|NCT01720251|75720|P2|COMPLETED|Overall Study||77
33371|NCT01720251|75721|P1|COMPLETED|Overall Study||78
33372|NCT01720251|75719|P3|STARTED|Overall Study||82
33373|NCT01720251|75720|P2|STARTED|Overall Study||79
33374|NCT01720251|75721|P1|STARTED|Overall Study||79
33375|NCT01719757|75729|P1|NOT COMPLETED|Overall Study||101
33376|NCT01719757|75729|P1|COMPLETED|Overall Study||258
33377|NCT01719757|75729|P1|STARTED|Overall Study||359
33378|NCT01719172|75737|P1|NOT COMPLETED|Overall Study||2
33379|NCT01719172|75737|P1|COMPLETED|Overall Study||28
33380|NCT01719172|75737|P1|STARTED|Overall Study||30
33381|NCT01719003|75751|P9|NOT COMPLETED|Overall Study||4
33382|NCT01719003|75752|P8|NOT COMPLETED|Overall Study||20
33383|NCT01719003|75753|P7|NOT COMPLETED|Overall Study||20
33384|NCT01719003|75754|P6|NOT COMPLETED|Overall Study||12
33385|NCT01719003|75755|P5|NOT COMPLETED|Overall Study||17
33386|NCT01719003|75756|P4|NOT COMPLETED|Overall Study||13
33387|NCT01719003|75757|P3|NOT COMPLETED|Overall Study||17
33388|NCT01719003|75758|P2|NOT COMPLETED|Overall Study||17
33389|NCT01719003|75759|P1|NOT COMPLETED|Overall Study||9
33390|NCT01719003|75751|P9|COMPLETED|Overall Study||49
33391|NCT01719003|75752|P8|COMPLETED|Overall Study||151
33392|NCT01719003|75753|P7|COMPLETED|Overall Study||150
33393|NCT01719003|75754|P6|COMPLETED|Overall Study||160
33394|NCT01719003|75755|P5|COMPLETED|Overall Study||150
33395|NCT01719003|75756|P4|COMPLETED|Overall Study||156
33396|NCT01719003|75757|P3|COMPLETED|Overall Study||154
33397|NCT01719003|75758|P2|COMPLETED|Overall Study||153
33398|NCT01719003|75759|P1|COMPLETED|Overall Study||161
33399|NCT01719003|75751|P9|STARTED|Overall Study||53
33400|NCT01719003|75752|P8|STARTED|Overall Study||171
33401|NCT01719003|75753|P7|STARTED|Overall Study||170
33402|NCT01719003|75754|P6|STARTED|Overall Study||172
33403|NCT01719003|75755|P5|STARTED|Overall Study||167
33404|NCT01719003|75756|P4|STARTED|Overall Study||169
33405|NCT01719003|75757|P3|STARTED|Overall Study||171
33406|NCT01719003|75758|P2|STARTED|Overall Study||170
33407|NCT01719003|75759|P1|STARTED|Overall Study||170
33408|NCT01718691|75796|P2|NOT COMPLETED|Overall Study||1
33409|NCT01718691|75797|P1|NOT COMPLETED|Overall Study||18
33410|NCT01718691|75796|P2|COMPLETED|Overall Study||9
33411|NCT01718691|75797|P1|COMPLETED|Overall Study||42
33412|NCT01718691|75796|P2|STARTED|Overall Study||10
33413|NCT01718691|75797|P1|STARTED|Overall Study||60
33414|NCT01718535|75840|P10|NOT COMPLETED|Overall Study||0
33415|NCT01718535|75841|P9|NOT COMPLETED|Overall Study||0
33416|NCT01718535|75842|P8|NOT COMPLETED|Overall Study||0
33417|NCT01718535|75843|P7|NOT COMPLETED|Overall Study||0
33418|NCT01718535|75844|P6|NOT COMPLETED|Overall Study||0
33419|NCT01718535|75845|P5|NOT COMPLETED|Overall Study||0
33420|NCT01718535|75846|P4|NOT COMPLETED|Overall Study||1
33421|NCT01718535|75847|P3|NOT COMPLETED|Overall Study||0
33422|NCT01718535|75848|P2|NOT COMPLETED|Overall Study||0
33423|NCT01718535|75849|P1|NOT COMPLETED|Overall Study||1
33424|NCT01718535|75840|P10|COMPLETED|Overall Study||1
33425|NCT01718535|75841|P9|COMPLETED|Overall Study||15
33426|NCT01718535|75842|P8|COMPLETED|Overall Study||6
33427|NCT01718535|75843|P7|COMPLETED|Overall Study||11
33428|NCT01718535|75844|P6|COMPLETED|Overall Study||40
33429|NCT01718535|75845|P5|COMPLETED|Overall Study||1
33430|NCT01718535|75846|P4|COMPLETED|Overall Study||7
33431|NCT01718535|75847|P3|COMPLETED|Overall Study||19
33432|NCT01718535|75848|P2|COMPLETED|Overall Study||95
33433|NCT01718535|75849|P1|COMPLETED|Overall Study||130
33434|NCT01718535|75840|P10|First Pass|Overall Study||1
33435|NCT01718535|75841|P9|First Pass|Overall Study||15
33436|NCT01718535|75842|P8|First Pass|Overall Study||6
33437|NCT01718535|75843|P7|First Pass|Overall Study||11
33438|NCT01718535|75844|P6|First Pass|Overall Study||39
33439|NCT01718535|75845|P5|First Pass|Overall Study||1
33440|NCT01718535|75846|P4|First Pass|Overall Study||7
33441|NCT01718535|75847|P3|First Pass|Overall Study||19
33442|NCT01718535|75848|P2|First Pass|Overall Study||94
33443|NCT01718535|75849|P1|First Pass|Overall Study||128
33444|NCT01718535|75840|P10|STARTED|Overall Study||1
33445|NCT01718535|75841|P9|STARTED|Overall Study||15
33446|NCT01718535|75842|P8|STARTED|Overall Study||6
33447|NCT01718535|75843|P7|STARTED|Overall Study||11
33448|NCT01718535|75844|P6|STARTED|Overall Study||40
33449|NCT01718535|75845|P5|STARTED|Overall Study||1
33450|NCT01718535|75846|P4|STARTED|Overall Study||8
33451|NCT01718535|75847|P3|STARTED|Overall Study||19
33452|NCT01718535|75848|P2|STARTED|Overall Study||95
33453|NCT01718535|75849|P1|STARTED|Overall Study||131
33454|NCT01718509|75873|P2|NOT COMPLETED|Overall Study||48
33455|NCT01718509|75874|P1|NOT COMPLETED|Overall Study||48
33456|NCT01718509|75873|P2|COMPLETED|Overall Study||147
33457|NCT01718509|75874|P1|COMPLETED|Overall Study||147
33458|NCT01718509|75873|P2|STARTED|Overall Study||195
33459|NCT01718509|75874|P1|STARTED|Overall Study||195
33460|NCT01718483|75920|P2|NOT COMPLETED|Overall Study||34
33461|NCT01718483|75921|P1|NOT COMPLETED|Overall Study||34
33462|NCT01718483|75920|P2|COMPLETED|Overall Study||158
33463|NCT01718483|75921|P1|COMPLETED|Overall Study||157
33464|NCT01718483|75920|P2|Treated|Overall Study||192
33465|NCT01718483|75921|P1|Treated|Overall Study||187
33466|NCT01718483|75920|P2|STARTED|Overall Study||192
33467|NCT01718483|75921|P1|STARTED|Overall Study||191
33468|NCT01718028|75967|P2|NOT COMPLETED|Overall Study||0
33469|NCT01718028|75968|P1|NOT COMPLETED|Overall Study||0
33470|NCT01718028|75967|P2|COMPLETED|Overall Study||24
33471|NCT01718028|75968|P1|COMPLETED|Overall Study||25
33472|NCT01718028|75967|P2|STARTED|Overall Study||24
33473|NCT01718028|75968|P1|STARTED|Overall Study||25
33474|NCT01717989|75980|P1|NOT COMPLETED|Overall Study||1066
33475|NCT01717989|75980|P1|COMPLETED|Overall Study||1182
33476|NCT01717989|75980|P1|STARTED|Overall Study||2248
33477|NCT01717872|76048|P2|NOT COMPLETED|Overall Study||0
33478|NCT01717872|76049|P1|NOT COMPLETED|Overall Study||0
33479|NCT01717872|76048|P2|COMPLETED|Overall Study||25
33480|NCT01717872|76049|P1|COMPLETED|Overall Study||25
33481|NCT01717872|76048|P2|STARTED|Overall Study||25
33482|NCT01717872|76049|P1|STARTED|Overall Study||25
33483|NCT01717768|76069|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33484|NCT01717768|76070|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33485|NCT01717768|76071|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
33486|NCT01717768|76072|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33487|NCT01717768|76073|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
33488|NCT01717768|76074|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33489|NCT01717768|76075|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33490|NCT01717768|76076|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33491|NCT01717768|76077|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33492|NCT01717768|76078|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33493|NCT01717768|76079|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33494|NCT01717768|76080|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33495|NCT01717768|76069|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33496|NCT01717768|76070|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33497|NCT01717768|76071|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
33498|NCT01717768|76072|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33499|NCT01717768|76073|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
33500|NCT01717768|76074|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33501|NCT01717768|76075|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33502|NCT01717768|76076|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33503|NCT01717768|76077|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33504|NCT01717768|76078|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33505|NCT01717768|76079|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33506|NCT01717768|76080|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
33507|NCT01717768|76069|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33508|NCT01717768|76070|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33509|NCT01717768|76071|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
33510|NCT01717768|76072|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33511|NCT01717768|76073|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
33512|NCT01717768|76074|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33513|NCT01717768|76075|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33514|NCT01717768|76076|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33515|NCT01717768|76077|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33516|NCT01717768|76078|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33517|NCT01717768|76079|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33518|NCT01717768|76080|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
33519|NCT01717768|76069|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
33520|NCT01717768|76070|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33521|NCT01717768|76071|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33522|NCT01717768|76072|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33523|NCT01717768|76073|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33524|NCT01717768|76074|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33525|NCT01717768|76075|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33526|NCT01717768|76076|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33527|NCT01717768|76077|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33528|NCT01717768|76078|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33529|NCT01717768|76079|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33530|NCT01717768|76080|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33531|NCT01717768|76069|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
33532|NCT01717768|76070|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
33533|NCT01717768|76071|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33534|NCT01717768|76072|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
33535|NCT01717768|76073|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33536|NCT01717768|76074|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
33537|NCT01717768|76075|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33538|NCT01717768|76076|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33539|NCT01717768|76077|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33540|NCT01717768|76078|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33541|NCT01717768|76079|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33542|NCT01717768|76080|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
33543|NCT01717768|76069|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
33544|NCT01717768|76070|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
33545|NCT01717768|76071|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33546|NCT01717768|76072|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
33547|NCT01717768|76073|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33548|NCT01717768|76074|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
33549|NCT01717768|76075|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33550|NCT01717768|76076|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33551|NCT01717768|76077|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33552|NCT01717768|76078|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33553|NCT01717768|76079|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33554|NCT01717768|76080|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
33555|NCT01717768|76069|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33556|NCT01717768|76070|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33557|NCT01717768|76071|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33558|NCT01717768|76072|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33559|NCT01717768|76073|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33560|NCT01717768|76074|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33561|NCT01717768|76075|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33562|NCT01717768|76076|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33563|NCT01717768|76077|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33564|NCT01717768|76078|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33565|NCT01717768|76079|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33566|NCT01717768|76080|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33567|NCT01717768|76069|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33568|NCT01717768|76070|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33569|NCT01717768|76071|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33570|NCT01717768|76072|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33571|NCT01717768|76073|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33572|NCT01717768|76074|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33573|NCT01717768|76075|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
33574|NCT01717768|76076|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
33575|NCT01717768|76077|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
33576|NCT01717768|76078|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33577|NCT01717768|76079|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33578|NCT01717768|76080|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33579|NCT01717768|76069|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33580|NCT01717768|76070|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33581|NCT01717768|76071|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33582|NCT01717768|76072|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33583|NCT01717768|76073|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33584|NCT01717768|76074|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33585|NCT01717768|76075|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
33586|NCT01717768|76076|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
33587|NCT01717768|76077|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
33588|NCT01717768|76078|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33589|NCT01717768|76079|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33590|NCT01717768|76080|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
33591|NCT01717768|76069|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33592|NCT01717768|76070|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33593|NCT01717768|76071|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33594|NCT01717768|76072|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33595|NCT01717768|76073|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33596|NCT01717768|76074|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33597|NCT01717768|76075|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33598|NCT01717768|76076|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33599|NCT01717768|76077|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33600|NCT01717768|76078|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33601|NCT01717768|76079|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33602|NCT01717768|76080|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33603|NCT01717768|76069|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33604|NCT01717768|76070|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33605|NCT01717768|76071|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33606|NCT01717768|76072|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33607|NCT01717768|76073|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33608|NCT01717768|76074|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33609|NCT01717768|76075|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
33610|NCT01717768|76076|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
33611|NCT01717768|76077|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
33612|NCT01717768|76078|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33613|NCT01717768|76079|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33614|NCT01717768|76080|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33615|NCT01717768|76069|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33616|NCT01717768|76070|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33617|NCT01717768|76071|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33618|NCT01717768|76072|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33619|NCT01717768|76073|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33620|NCT01717768|76074|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33621|NCT01717768|76075|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
33622|NCT01717768|76076|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
33623|NCT01717768|76077|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
33624|NCT01717768|76078|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33625|NCT01717768|76079|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33626|NCT01717768|76080|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
33627|NCT01717768|76069|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33628|NCT01717768|76070|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33629|NCT01717768|76071|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33630|NCT01717768|76072|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33631|NCT01717768|76073|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33632|NCT01717768|76074|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33633|NCT01717768|76075|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33634|NCT01717768|76076|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33635|NCT01717768|76077|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33636|NCT01717768|76078|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33637|NCT01717768|76079|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33638|NCT01717768|76080|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33639|NCT01717768|76069|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33640|NCT01717768|76070|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33641|NCT01717768|76071|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33642|NCT01717768|76072|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33643|NCT01717768|76073|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33644|NCT01717768|76074|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33645|NCT01717768|76075|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
33646|NCT01717768|76076|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
33647|NCT01717768|76077|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
33648|NCT01717768|76078|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33649|NCT01717768|76079|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33650|NCT01717768|76080|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33651|NCT01717768|76069|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33652|NCT01717768|76070|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33653|NCT01717768|76071|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33654|NCT01717768|76072|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33655|NCT01717768|76073|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33656|NCT01717768|76074|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33657|NCT01717768|76075|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
33658|NCT01717768|76076|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
33659|NCT01717768|76077|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
33660|NCT01717768|76078|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33661|NCT01717768|76079|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33662|NCT01717768|76080|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
33663|NCT01717768|76069|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33664|NCT01717768|76070|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33665|NCT01717768|76071|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33666|NCT01717768|76072|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33667|NCT01717768|76073|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33668|NCT01717768|76074|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33669|NCT01717768|76075|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33670|NCT01717768|76076|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33671|NCT01717768|76077|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33672|NCT01717768|76078|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33673|NCT01717768|76079|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33674|NCT01717768|76080|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
33675|NCT01717768|76069|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
33676|NCT01717768|76070|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
33677|NCT01717768|76071|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
33678|NCT01717768|76072|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
33679|NCT01717768|76073|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
33680|NCT01717768|76074|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
33681|NCT01717768|76075|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
33682|NCT01717768|76076|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
33683|NCT01717768|76077|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
33684|NCT01717768|76078|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
33685|NCT01717768|76079|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
33686|NCT01717768|76080|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
33687|NCT01717768|76069|P12|STARTED|Part 2 (Duration of 15 Days)||0
33688|NCT01717768|76070|P11|STARTED|Part 2 (Duration of 15 Days)||0
33689|NCT01717768|76071|P10|STARTED|Part 2 (Duration of 15 Days)||0
33690|NCT01717768|76072|P9|STARTED|Part 2 (Duration of 15 Days)||0
33691|NCT01717768|76073|P8|STARTED|Part 2 (Duration of 15 Days)||0
33692|NCT01717768|76074|P7|STARTED|Part 2 (Duration of 15 Days)||0
33693|NCT01717768|76075|P6|STARTED|Part 2 (Duration of 15 Days)||0
33694|NCT01717768|76076|P5|STARTED|Part 2 (Duration of 15 Days)||0
33695|NCT01717768|76077|P4|STARTED|Part 2 (Duration of 15 Days)||0
33696|NCT01717768|76078|P3|STARTED|Part 2 (Duration of 15 Days)||17
33697|NCT01717768|76079|P2|STARTED|Part 2 (Duration of 15 Days)||0
33698|NCT01717768|76080|P1|STARTED|Part 2 (Duration of 15 Days)||0
33699|NCT01717768|76069|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33700|NCT01717768|76070|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33701|NCT01717768|76071|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33702|NCT01717768|76072|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33703|NCT01717768|76073|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33704|NCT01717768|76074|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33705|NCT01717768|76075|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33706|NCT01717768|76076|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33707|NCT01717768|76077|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33708|NCT01717768|76078|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33709|NCT01717768|76079|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
33710|NCT01717768|76080|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
33711|NCT01717768|76069|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
33712|NCT01717768|76070|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
33713|NCT01717768|76071|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
33714|NCT01717768|76072|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
33715|NCT01717768|76073|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
33716|NCT01717768|76074|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
33717|NCT01717768|76075|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
33718|NCT01717768|76076|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
33719|NCT01717768|76077|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
33720|NCT01717768|76078|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
33721|NCT01717768|76079|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
33722|NCT01717768|76080|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
33723|NCT01717768|76069|P12|STARTED|Part 1 (Duration of 15 Days)||0
33724|NCT01717768|76070|P11|STARTED|Part 1 (Duration of 15 Days)||0
33725|NCT01717768|76071|P10|STARTED|Part 1 (Duration of 15 Days)||0
33726|NCT01717768|76072|P9|STARTED|Part 1 (Duration of 15 Days)||0
33727|NCT01717768|76073|P8|STARTED|Part 1 (Duration of 15 Days)||0
33728|NCT01717768|76074|P7|STARTED|Part 1 (Duration of 15 Days)||0
33729|NCT01717768|76075|P6|STARTED|Part 1 (Duration of 15 Days)||0
33730|NCT01717768|76076|P5|STARTED|Part 1 (Duration of 15 Days)||0
33731|NCT01717768|76077|P4|STARTED|Part 1 (Duration of 15 Days)||0
33732|NCT01717768|76078|P3|STARTED|Part 1 (Duration of 15 Days)||0
33733|NCT01717768|76079|P2|STARTED|Part 1 (Duration of 15 Days)||17
33734|NCT01717768|76080|P1|STARTED|Part 1 (Duration of 15 Days)||17
33735|NCT01717638|76131|P13|NOT COMPLETED|Overall Study||19
33736|NCT01717638|76132|P12|NOT COMPLETED|Overall Study||0
33737|NCT01717638|76133|P11|NOT COMPLETED|Overall Study||0
33738|NCT01717638|76134|P10|NOT COMPLETED|Overall Study||1
33739|NCT01717638|76135|P9|NOT COMPLETED|Overall Study||2
33740|NCT01717638|76136|P8|NOT COMPLETED|Overall Study||1
33741|NCT01717638|76137|P7|NOT COMPLETED|Overall Study||2
33742|NCT01717638|76138|P6|NOT COMPLETED|Overall Study||1
33743|NCT01717638|76139|P5|NOT COMPLETED|Overall Study||1
33744|NCT01717638|76140|P4|NOT COMPLETED|Overall Study||0
33745|NCT01717638|76141|P3|NOT COMPLETED|Overall Study||1
33746|NCT01717638|76142|P2|NOT COMPLETED|Overall Study||1
33747|NCT01717638|76143|P1|NOT COMPLETED|Overall Study||0
33748|NCT01717638|76131|P13|COMPLETED|Overall Study||190
33749|NCT01717638|76132|P12|COMPLETED|Overall Study||12
33750|NCT01717638|76133|P11|COMPLETED|Overall Study||11
33751|NCT01717638|76134|P10|COMPLETED|Overall Study||99
33752|NCT01717638|76135|P9|COMPLETED|Overall Study||26
33753|NCT01717638|76136|P8|COMPLETED|Overall Study||28
33754|NCT01717638|76137|P7|COMPLETED|Overall Study||41
33755|NCT01717638|76138|P6|COMPLETED|Overall Study||54
33756|NCT01717638|76139|P5|COMPLETED|Overall Study||63
33757|NCT01717638|76140|P4|COMPLETED|Overall Study||66
33758|NCT01717638|76141|P3|COMPLETED|Overall Study||59
33759|NCT01717638|76142|P2|COMPLETED|Overall Study||60
33760|NCT01717638|76143|P1|COMPLETED|Overall Study||67
33761|NCT01717638|76131|P13|STARTED|Overall Study||209
33762|NCT01717638|76132|P12|STARTED|Overall Study||12
33763|NCT01717638|76133|P11|STARTED|Overall Study||11
33764|NCT01717638|76134|P10|STARTED|Overall Study||100
33765|NCT01717638|76135|P9|STARTED|Overall Study||28
33766|NCT01717638|76136|P8|STARTED|Overall Study||29
33767|NCT01717638|76137|P7|STARTED|Overall Study||43
33768|NCT01717638|76138|P6|STARTED|Overall Study||55
33769|NCT01717638|76139|P5|STARTED|Overall Study||64
33770|NCT01717638|76140|P4|STARTED|Overall Study||66
33771|NCT01717638|76141|P3|STARTED|Overall Study||60
33772|NCT01717638|76142|P2|STARTED|Overall Study||61
33773|NCT01717638|76143|P1|STARTED|Overall Study||67
33774|NCT01717456|76287|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
33775|NCT01717456|76288|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
33776|NCT01717456|76287|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
33777|NCT01717456|76288|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
33778|NCT01717456|76287|P2|STARTED|Follow-Up 6 Months After End of Tx||6
33779|NCT01717456|76288|P1|STARTED|Follow-Up 6 Months After End of Tx||11
33780|NCT01717456|76287|P2|NOT COMPLETED|End of Treatment||2
33781|NCT01717456|76288|P1|NOT COMPLETED|End of Treatment||0
33782|NCT01717456|76287|P2|COMPLETED|End of Treatment||6
33783|NCT01717456|76288|P1|COMPLETED|End of Treatment||11
33784|NCT01717456|76287|P2|STARTED|End of Treatment||8
33785|NCT01717456|76288|P1|STARTED|End of Treatment||11
33786|NCT01717326|76376|P20|NOT COMPLETED|Overall Study||6
33787|NCT01717326|76377|P19|NOT COMPLETED|Overall Study||4
33788|NCT01717326|76378|P18|NOT COMPLETED|Overall Study||0
33789|NCT01717326|76379|P17|NOT COMPLETED|Overall Study||1
33790|NCT01717326|76380|P16|NOT COMPLETED|Overall Study||3
33791|NCT01717326|76381|P15|NOT COMPLETED|Overall Study||0
33792|NCT01717326|76382|P14|NOT COMPLETED|Overall Study||0
33793|NCT01717326|76383|P13|NOT COMPLETED|Overall Study||1
33794|NCT01717326|76384|P12|NOT COMPLETED|Overall Study||0
33795|NCT01717326|76385|P11|NOT COMPLETED|Overall Study||2
33796|NCT01717326|76386|P10|NOT COMPLETED|Overall Study||2
33797|NCT01717326|76387|P9|NOT COMPLETED|Overall Study||0
33798|NCT01717326|76388|P8|NOT COMPLETED|Overall Study||0
33799|NCT01717326|76389|P7|NOT COMPLETED|Overall Study||1
33800|NCT01717326|76390|P6|NOT COMPLETED|Overall Study||0
33801|NCT01717326|76391|P5|NOT COMPLETED|Overall Study||2
33802|NCT01717326|76392|P4|NOT COMPLETED|Overall Study||2
33803|NCT01717326|76393|P3|NOT COMPLETED|Overall Study||0
33804|NCT01717326|76394|P2|NOT COMPLETED|Overall Study||1
33805|NCT01717326|76395|P1|NOT COMPLETED|Overall Study||3
33806|NCT01717326|76376|P20|COMPLETED|Overall Study||15
33807|NCT01717326|76377|P19|COMPLETED|Overall Study||16
33808|NCT01717326|76378|P18|COMPLETED|Overall Study||31
33809|NCT01717326|76379|P17|COMPLETED|Overall Study||29
33810|NCT01717326|76380|P16|COMPLETED|Overall Study||27
33811|NCT01717326|76381|P15|COMPLETED|Overall Study||29
33812|NCT01717326|76382|P14|COMPLETED|Overall Study||32
33813|NCT01717326|76383|P13|COMPLETED|Overall Study||32
33814|NCT01717326|76384|P12|COMPLETED|Overall Study||33
33815|NCT01717326|76385|P11|COMPLETED|Overall Study||30
33816|NCT01717326|76386|P10|COMPLETED|Overall Study||29
33817|NCT01717326|76387|P9|COMPLETED|Overall Study||32
33818|NCT01717326|76388|P8|COMPLETED|Overall Study||29
33819|NCT01717326|76389|P7|COMPLETED|Overall Study||30
33820|NCT01717326|76390|P6|COMPLETED|Overall Study||31
33821|NCT01717326|76391|P5|COMPLETED|Overall Study||31
33822|NCT01717326|76392|P4|COMPLETED|Overall Study||28
33823|NCT01717326|76393|P3|COMPLETED|Overall Study||13
33824|NCT01717326|76394|P2|COMPLETED|Overall Study||26
33825|NCT01717326|76395|P1|COMPLETED|Overall Study||22
33826|NCT01717326|76376|P20|Treated|Overall Study||21
33827|NCT01717326|76377|P19|Treated|Overall Study||20
33828|NCT01717326|76378|P18|Treated|Overall Study||31
33829|NCT01717326|76379|P17|Treated|Overall Study||30
33830|NCT01717326|76380|P16|Treated|Overall Study||30
33831|NCT01717326|76381|P15|Treated|Overall Study||29
33832|NCT01717326|76382|P14|Treated|Overall Study||32
33833|NCT01717326|76383|P13|Treated|Overall Study||33
33834|NCT01717326|76384|P12|Treated|Overall Study||33
33835|NCT01717326|76385|P11|Treated|Overall Study||32
33836|NCT01717326|76386|P10|Treated|Overall Study||31
33837|NCT01717326|76387|P9|Treated|Overall Study||32
33838|NCT01717326|76388|P8|Treated|Overall Study||29
33839|NCT01717326|76389|P7|Treated|Overall Study||31
33840|NCT01717326|76390|P6|Treated|Overall Study||31
33841|NCT01717326|76391|P5|Treated|Overall Study||33
33842|NCT01717326|76392|P4|Treated|Overall Study||30
33843|NCT01717326|76393|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
33844|NCT01717326|76394|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
33845|NCT01717326|76395|P1|Treated|Overall Study||25
33846|NCT01717326|76376|P20|STARTED|Overall Study||21
33847|NCT01717326|76377|P19|STARTED|Overall Study||20
33848|NCT01717326|76378|P18|STARTED|Overall Study||31
33849|NCT01717326|76379|P17|STARTED|Overall Study||30
33850|NCT01717326|76380|P16|STARTED|Overall Study||30
33851|NCT01717326|76381|P15|STARTED|Overall Study||29
33852|NCT01717326|76382|P14|STARTED|Overall Study||32
33853|NCT01717326|76383|P13|STARTED|Overall Study||33
33854|NCT01717326|76384|P12|STARTED|Overall Study||33
33855|NCT01717326|76385|P11|STARTED|Overall Study||32
33856|NCT01717326|76386|P10|STARTED|Overall Study||31
33857|NCT01717326|76387|P9|STARTED|Overall Study||32
33858|NCT01717326|76388|P8|STARTED|Overall Study||29
33859|NCT01717326|76389|P7|STARTED|Overall Study||31
33860|NCT01717326|76390|P6|STARTED|Overall Study||31
33861|NCT01717326|76391|P5|STARTED|Overall Study||33
33862|NCT01717326|76392|P4|STARTED|Overall Study||30
33863|NCT01717326|76393|P3|STARTED|Overall Study||13
33864|NCT01717326|76394|P2|STARTED|Overall Study||27
33865|NCT01717326|76395|P1|STARTED|Overall Study||25
33866|NCT01717313|76659|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
33867|NCT01717313|76660|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
33868|NCT01717313|76659|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
33869|NCT01717313|76660|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
33870|NCT01717313|76659|P2|STARTED|Phase B (Weeks 24 to 54)||151
33871|NCT01717313|76660|P1|STARTED|Phase B (Weeks 24 to 54)||146
33872|NCT01717313|76659|P2|NOT COMPLETED|Interphase||0
33873|NCT01717313|76660|P1|NOT COMPLETED|Interphase||1
33874|NCT01717313|76659|P2|COMPLETED|Interphase||151
33875|NCT01717313|76660|P1|COMPLETED|Interphase||146
33876|NCT01717313|76659|P2|STARTED|Interphase||151
33877|NCT01717313|76660|P1|STARTED|Interphase||147
33878|NCT01717313|76659|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
33879|NCT01717313|76660|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
33880|NCT01717313|76659|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
33881|NCT01717313|76660|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
33882|NCT01717313|76659|P2|STARTED|Phase A (Weeks 0 to 24)||164
33883|NCT01717313|76660|P1|STARTED|Phase A (Weeks 0 to 24)||165
33884|NCT01717287|76698|P2|NOT COMPLETED|Overall Study||3
33885|NCT01717287|76699|P1|NOT COMPLETED|Overall Study||0
33886|NCT01717287|76698|P2|COMPLETED|Overall Study||25
33887|NCT01717287|76699|P1|COMPLETED|Overall Study||4
33888|NCT01717287|76698|P2|STARTED|Overall Study||28
33889|NCT01717287|76699|P1|STARTED|Overall Study||4
33890|NCT01717040|76723|P2|NOT COMPLETED|Overall Study||5
33891|NCT01717040|76724|P1|NOT COMPLETED|Overall Study||5
33892|NCT01717040|76723|P2|COMPLETED|Overall Study||15
33893|NCT01717040|76724|P1|COMPLETED|Overall Study||12
33894|NCT01717040|76723|P2|STARTED|Overall Study||20
33895|NCT01717040|76724|P1|STARTED|Overall Study||17
33896|NCT01717014|76730|P1|NOT COMPLETED|Overall Study||0
33897|NCT01717014|76730|P1|COMPLETED|Overall Study||8
33898|NCT01717014|76730|P1|STARTED|Overall Study||8
33899|NCT01716663|76738|P1|NOT COMPLETED|Overall Study||6
33900|NCT01716663|76738|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
33901|NCT01716663|76738|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
33902|NCT01716663|76738|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
33903|NCT01716585|76748|P2|NOT COMPLETED|Open-label Treatment||7
33904|NCT01716585|76749|P1|NOT COMPLETED|Open-label Treatment||0
33905|NCT01716585|76748|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
33906|NCT01716585|76749|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
33907|NCT01716585|76748|P2|STARTED|Open-label Treatment||157
33908|NCT01716585|76749|P1|STARTED|Open-label Treatment|not applicable to this arm|0
33909|NCT01716585|76748|P2|NOT COMPLETED|Double-blind Treatment||2
33910|NCT01716585|76749|P1|NOT COMPLETED|Double-blind Treatment||13
33911|NCT01716585|76748|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
33912|NCT01716585|76749|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
33913|NCT01716585|76748|P2|Randomized But Not Treated|Double-blind Treatment||1
33914|NCT01716585|76749|P1|Randomized But Not Treated|Double-blind Treatment||4
33915|NCT01716585|76748|P2|STARTED|Double-blind Treatment||159
33916|NCT01716585|76749|P1|STARTED|Double-blind Treatment||477
33917|NCT01716559|76761|P1|NOT COMPLETED|Overall Study||111
33918|NCT01716559|76761|P1|COMPLETED|Overall Study||49
33919|NCT01716559|76761|P1|STARTED|Overall Study||160
33920|NCT01716520|76769|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
33921|NCT01716520|76770|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
33922|NCT01716520|76771|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
33923|NCT01716520|76772|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
33924|NCT01716520|76773|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
33925|NCT01716520|76774|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
33926|NCT01716520|76769|P6|COMPLETED|Treatment Period 3 (14 Days)||23
33927|NCT01716520|76770|P5|COMPLETED|Treatment Period 3 (14 Days)||29
33928|NCT01716520|76771|P4|COMPLETED|Treatment Period 3 (14 Days)||28
33929|NCT01716520|76772|P3|COMPLETED|Treatment Period 3 (14 Days)||25
33930|NCT01716520|76773|P2|COMPLETED|Treatment Period 3 (14 Days)||27
33931|NCT01716520|76774|P1|COMPLETED|Treatment Period 3 (14 Days)||27
33932|NCT01716520|76769|P6|STARTED|Treatment Period 3 (14 Days)||25
33933|NCT01716520|76770|P5|STARTED|Treatment Period 3 (14 Days)||29
33934|NCT01716520|76771|P4|STARTED|Treatment Period 3 (14 Days)||28
33935|NCT01716520|76772|P3|STARTED|Treatment Period 3 (14 Days)||26
33936|NCT01716520|76773|P2|STARTED|Treatment Period 3 (14 Days)||27
33937|NCT01716520|76774|P1|STARTED|Treatment Period 3 (14 Days)||27
33938|NCT01716520|76769|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
33939|NCT01716520|76770|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
33940|NCT01716520|76771|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
33941|NCT01716520|76772|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
33942|NCT01716520|76773|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
33943|NCT01716520|76774|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
33944|NCT01716520|76769|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
33945|NCT01716520|76770|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
33946|NCT01716520|76771|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
33947|NCT01716520|76772|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
33948|NCT01716520|76773|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
33949|NCT01716520|76774|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
33950|NCT01716520|76769|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
33951|NCT01716520|76770|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
33952|NCT01716520|76771|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
33953|NCT01716520|76772|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
33954|NCT01716520|76773|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
33955|NCT01716520|76774|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
33956|NCT01716520|76769|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
33957|NCT01716520|76770|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
33958|NCT01716520|76771|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
33959|NCT01716520|76772|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
33960|NCT01716520|76773|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
33961|NCT01716520|76774|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
33962|NCT01716520|76769|P6|COMPLETED|Treatment Period 2 (14 Days)||27
33963|NCT01716520|76770|P5|COMPLETED|Treatment Period 2 (14 Days)||29
33964|NCT01716520|76771|P4|COMPLETED|Treatment Period 2 (14 Days)||28
33965|NCT01716520|76772|P3|COMPLETED|Treatment Period 2 (14 Days)||27
33966|NCT01716520|76773|P2|COMPLETED|Treatment Period 2 (14 Days)||28
33967|NCT01716520|76774|P1|COMPLETED|Treatment Period 2 (14 Days)||29
33968|NCT01716520|76769|P6|STARTED|Treatment Period 2 (14 Days)||27
33969|NCT01716520|76770|P5|STARTED|Treatment Period 2 (14 Days)||31
33970|NCT01716520|76771|P4|STARTED|Treatment Period 2 (14 Days)||29
33971|NCT01716520|76772|P3|STARTED|Treatment Period 2 (14 Days)||27
33972|NCT01716520|76773|P2|STARTED|Treatment Period 2 (14 Days)||28
33973|NCT01716520|76774|P1|STARTED|Treatment Period 2 (14 Days)||29
33974|NCT01716520|76769|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
33975|NCT01716520|76770|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
33976|NCT01716520|76771|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
33977|NCT01716520|76772|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
33978|NCT01716520|76773|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
33979|NCT01716520|76774|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
33980|NCT01716520|76769|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
33981|NCT01716520|76770|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
33982|NCT01716520|76771|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
33983|NCT01716520|76772|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
33984|NCT01716520|76773|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
33985|NCT01716520|76774|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
33986|NCT01716520|76769|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
33987|NCT01716520|76770|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
33988|NCT01716520|76771|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
33989|NCT01716520|76772|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
33990|NCT01716520|76773|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
33991|NCT01716520|76774|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
33992|NCT01716520|76769|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
33993|NCT01716520|76770|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
33994|NCT01716520|76771|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
33995|NCT01716520|76772|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
33996|NCT01716520|76773|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
33997|NCT01716520|76774|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
33998|NCT01716520|76769|P6|COMPLETED|Treatment Period 1 (14 Days)||29
33999|NCT01716520|76770|P5|COMPLETED|Treatment Period 1 (14 Days)||31
34000|NCT01716520|76771|P4|COMPLETED|Treatment Period 1 (14 Days)||29
34001|NCT01716520|76772|P3|COMPLETED|Treatment Period 1 (14 Days)||28
34002|NCT01716520|76773|P2|COMPLETED|Treatment Period 1 (14 Days)||29
34003|NCT01716520|76774|P1|COMPLETED|Treatment Period 1 (14 Days)||29
34004|NCT01716520|76769|P6|STARTED|Treatment Period 1 (14 Days)||30
34005|NCT01716520|76770|P5|STARTED|Treatment Period 1 (14 Days)||31
34006|NCT01716520|76771|P4|STARTED|Treatment Period 1 (14 Days)||30
34007|NCT01716520|76772|P3|STARTED|Treatment Period 1 (14 Days)||30
34008|NCT01716520|76773|P2|STARTED|Treatment Period 1 (14 Days)||30
34009|NCT01716520|76774|P1|STARTED|Treatment Period 1 (14 Days)||31
34010|NCT01716468|76790|P1|NOT COMPLETED|Overall Study||6
34011|NCT01716468|76790|P1|COMPLETED|Overall Study||11
34012|NCT01716468|76790|P1|STARTED|Overall Study||17
34013|NCT01716455|76800|P6|NOT COMPLETED|Overall Study||0
34014|NCT01716455|76801|P5|NOT COMPLETED|Overall Study||0
34015|NCT01716455|76802|P4|NOT COMPLETED|Overall Study||0
34016|NCT01716455|76803|P3|NOT COMPLETED|Overall Study||0
34017|NCT01716455|76804|P2|NOT COMPLETED|Overall Study||0
34018|NCT01716455|76805|P1|NOT COMPLETED|Overall Study||0
34019|NCT01716455|76800|P6|COMPLETED|Overall Study||8
34020|NCT01716455|76801|P5|COMPLETED|Overall Study||26
34021|NCT01716455|76802|P4|COMPLETED|Overall Study||8
34022|NCT01716455|76803|P3|COMPLETED|Overall Study||8
34023|NCT01716455|76804|P2|COMPLETED|Overall Study||8
34024|NCT01716455|76805|P1|COMPLETED|Overall Study||8
34025|NCT01716455|76800|P6|STARTED|Overall Study||8
34026|NCT01716455|76801|P5|STARTED|Overall Study||26
34027|NCT01716455|76802|P4|STARTED|Overall Study||8
34028|NCT01716455|76803|P3|STARTED|Overall Study||8
34029|NCT01716455|76804|P2|STARTED|Overall Study||8
34030|NCT01716455|76805|P1|STARTED|Overall Study||8
34031|NCT01716234|76829|P7|NOT COMPLETED|Overall Study||0
34032|NCT01716234|76830|P6|NOT COMPLETED|Overall Study||14
34033|NCT01716234|76831|P5|NOT COMPLETED|Overall Study||5
34034|NCT01716234|76832|P4|NOT COMPLETED|Overall Study||12
34035|NCT01716234|76833|P3|NOT COMPLETED|Overall Study||5
34036|NCT01716234|76834|P2|NOT COMPLETED|Overall Study||10
34037|NCT01716234|76835|P1|NOT COMPLETED|Overall Study||10
34038|NCT01716234|76829|P7|COMPLETED|Overall Study||1
34039|NCT01716234|76830|P6|COMPLETED|Overall Study||18
34040|NCT01716234|76831|P5|COMPLETED|Overall Study||10
34041|NCT01716234|76832|P4|COMPLETED|Overall Study||16
34042|NCT01716234|76833|P3|COMPLETED|Overall Study||15
34043|NCT01716234|76834|P2|COMPLETED|Overall Study||12
34044|NCT01716234|76835|P1|COMPLETED|Overall Study||14
34045|NCT01716234|76829|P7|Treated|Overall Study||1
34046|NCT01716234|76830|P6|Treated|Overall Study||30
34047|NCT01716234|76831|P5|Treated|Overall Study||15
34048|NCT01716234|76832|P4|Treated|Overall Study||28
34049|NCT01716234|76833|P3|Treated|Overall Study||19
34050|NCT01716234|76834|P2|Treated|Overall Study||21
34051|NCT01716234|76835|P1|Treated|Overall Study||22
34052|NCT01716234|76829|P7|STARTED|Overall Study||1
34053|NCT01716234|76830|P6|STARTED|Overall Study||32
34054|NCT01716234|76831|P5|STARTED|Overall Study||15
34055|NCT01716234|76832|P4|STARTED|Overall Study||28
34056|NCT01716234|76833|P3|STARTED|Overall Study||20
34057|NCT01716234|76834|P2|STARTED|Overall Study||22
34058|NCT01716234|76835|P1|STARTED|Overall Study||24
34059|NCT01716221|76872|P1|NOT COMPLETED|Overall Study||0
34060|NCT01716221|76872|P1|COMPLETED|Overall Study||1
34061|NCT01716221|76872|P1|STARTED|Overall Study||1
34062|NCT01716169|76898|P1|NOT COMPLETED|Overall Study||4
34063|NCT01716169|76898|P1|COMPLETED|Overall Study||6
34064|NCT01716169|76898|P1|Standard of Care Dressings Used|Overall Study||7
34065|NCT01716169|76898|P1|STARTED|Overall Study||10
34066|NCT01716156|76907|P3|NOT COMPLETED|Overall Study||2
34067|NCT01716156|76908|P2|NOT COMPLETED|Overall Study||1
34068|NCT01716156|76909|P1|NOT COMPLETED|Overall Study||2
34069|NCT01716156|76907|P3|COMPLETED|Overall Study||11
34070|NCT01716156|76908|P2|COMPLETED|Overall Study||3
34071|NCT01716156|76909|P1|COMPLETED|Overall Study||7
34072|NCT01716156|76907|P3|STARTED|Overall Study||13
34073|NCT01716156|76908|P2|STARTED|Overall Study||4
34074|NCT01716156|76909|P1|STARTED|Overall Study||9
34075|NCT01716052|76935|P2|NOT COMPLETED|Overall Study||1
34076|NCT01716052|76936|P1|NOT COMPLETED|Overall Study||1
34077|NCT01716052|76935|P2|COMPLETED|Overall Study||0
34078|NCT01716052|76936|P1|COMPLETED|Overall Study||0
34079|NCT01716052|76935|P2|STARTED|Overall Study||1
34080|NCT01716052|76936|P1|STARTED|Overall Study||1
34081|NCT01716013|76944|P2|NOT COMPLETED|Overall Study||0
34082|NCT01716013|76945|P1|NOT COMPLETED|Overall Study||3
34083|NCT01716013|76944|P2|COMPLETED|Overall Study||54
34084|NCT01716013|76945|P1|COMPLETED|Overall Study||105
34085|NCT01716013|76944|P2|STARTED|Overall Study||54
34086|NCT01716013|76945|P1|STARTED|Overall Study||108
34087|NCT01715948|76957|P1|NOT COMPLETED|Overall Study||1
34088|NCT01715948|76957|P1|COMPLETED|Overall Study||8
34089|NCT01715948|76957|P1|STARTED|Overall Study||9
34090|NCT01715896|76978|P2|NOT COMPLETED|Overall Study||11
34091|NCT01715896|76979|P1|NOT COMPLETED|Overall Study||3
34092|NCT01715896|76978|P2|COMPLETED|Overall Study||59
34093|NCT01715896|76979|P1|COMPLETED|Overall Study||65
34094|NCT01715896|76978|P2|STARTED|Overall Study||70
34095|NCT01715896|76979|P1|STARTED|Overall Study||68
34096|NCT01715857|77042|P1|NOT COMPLETED|Overall Study||96
34097|NCT01715857|77042|P1|COMPLETED|Overall Study||4004
34098|NCT01715857|77042|P1|STARTED|Overall Study||4100
34099|NCT01715415|77054|P2|NOT COMPLETED|Open-label Treatment||2
34100|NCT01715415|77055|P1|NOT COMPLETED|Open-label Treatment||0
34101|NCT01715415|77054|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
34102|NCT01715415|77055|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
34103|NCT01715415|77054|P2|STARTED|Open-label Treatment||96
34104|NCT01715415|77055|P1|STARTED|Open-label Treatment|not applicable to this arm|0
34105|NCT01715415|77054|P2|NOT COMPLETED|Double-blind Treatment||2
34106|NCT01715415|77055|P1|NOT COMPLETED|Double-blind Treatment||5
34107|NCT01715415|77054|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
34108|NCT01715415|77055|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
34109|NCT01715415|77054|P2|Randomized But Not Treated|Double-blind Treatment||1
34110|NCT01715415|77055|P1|Randomized But Not Treated|Double-blind Treatment||0
34111|NCT01715415|77054|P2|STARTED|Double-blind Treatment||98
34112|NCT01715415|77055|P1|STARTED|Double-blind Treatment||297
34113|NCT01715298|77069|P2|NOT COMPLETED|Overall Study||11
34114|NCT01715298|77070|P1|NOT COMPLETED|Overall Study||7
34115|NCT01715298|77069|P2|COMPLETED|Overall Study||205
34116|NCT01715298|77070|P1|COMPLETED|Overall Study||209
34117|NCT01715298|77069|P2|Full Analysis Set (FAS)|Overall Study||214
34118|NCT01715298|77070|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
34119|NCT01715298|77069|P2|STARTED|Overall Study||216
34120|NCT01715298|77070|P1|STARTED|Overall Study||216
34121|NCT01715129|77106|P1|NOT COMPLETED|Overall Study||9
34122|NCT01715129|77106|P1|COMPLETED|Overall Study||117
34123|NCT01715129|77106|P1|STARTED|Overall Study||126
34124|NCT01715064|77125|P2|NOT COMPLETED|Overall Study||0
34125|NCT01715064|77126|P1|NOT COMPLETED|Overall Study||0
34126|NCT01715064|77125|P2|COMPLETED|Overall Study||18
34127|NCT01715064|77126|P1|COMPLETED|Overall Study||18
34128|NCT01715064|77125|P2|STARTED|Overall Study||18
34129|NCT01715064|77126|P1|STARTED|Overall Study||18
34130|NCT01714635|77135|P3|NOT COMPLETED|Overall Study||2
34131|NCT01714635|77136|P2|NOT COMPLETED|Overall Study||0
34132|NCT01714635|77137|P1|NOT COMPLETED|Overall Study||2
34133|NCT01714635|77135|P3|COMPLETED|Overall Study||146
34134|NCT01714635|77136|P2|COMPLETED|Overall Study||150
34135|NCT01714635|77137|P1|COMPLETED|Overall Study||145
34136|NCT01714635|77135|P3|STARTED|Overall Study||148
34137|NCT01714635|77136|P2|STARTED|Overall Study||150
34138|NCT01714635|77137|P1|STARTED|Overall Study||147
34139|NCT01714609|77153|P2|NOT COMPLETED|Overall Study||0
34140|NCT01714609|77154|P1|NOT COMPLETED|Overall Study||1
34141|NCT01714609|77153|P2|COMPLETED|Overall Study||5
34142|NCT01714609|77154|P1|COMPLETED|Overall Study||4
34143|NCT01714609|77153|P2|STARTED|Overall Study||5
34144|NCT01714609|77154|P1|STARTED|Overall Study||5
34145|NCT01714544|77160|P1|NOT COMPLETED|Overall Study||3
34146|NCT01714544|77160|P1|COMPLETED|Overall Study||57
34147|NCT01714544|77160|P1|STARTED|Overall Study||60
34148|NCT01714505|77164|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
34149|NCT01714505|77165|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
34150|NCT01714505|77164|P2|COMPLETED|Admission 2 (40 Hours)||9
34151|NCT01714505|77165|P1|COMPLETED|Admission 2 (40 Hours)||9
34152|NCT01714505|77164|P2|STARTED|Admission 2 (40 Hours)||9
34153|NCT01714505|77165|P1|STARTED|Admission 2 (40 Hours)||9
34154|NCT01714505|77164|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
34155|NCT01714505|77165|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
34156|NCT01714505|77164|P2|COMPLETED|Admission 1 (40 Hours)||9
34157|NCT01714505|77165|P1|COMPLETED|Admission 1 (40 Hours)||9
34158|NCT01714505|77164|P2|STARTED|Admission 1 (40 Hours)||10
34159|NCT01714505|77165|P1|STARTED|Admission 1 (40 Hours)||10
34160|NCT01714492|77175|P1|NOT COMPLETED|Overall Study||0
34161|NCT01714492|77175|P1|COMPLETED|Overall Study||8
34162|NCT01714492|77175|P1|STARTED|Overall Study||8
34163|NCT01714336|77186|P2|NOT COMPLETED|Overall Study||0
34164|NCT01714336|77187|P1|NOT COMPLETED|Overall Study||0
34165|NCT01714336|77186|P2|COMPLETED|Overall Study||69
34166|NCT01714336|77187|P1|COMPLETED|Overall Study||69
34167|NCT01714336|77186|P2|STARTED|Overall Study||69
34168|NCT01714336|77187|P1|STARTED|Overall Study||69
34169|NCT01714232|77207|P1|NOT COMPLETED|Overall Study||0
34170|NCT01714232|77207|P1|COMPLETED|Overall Study||106
34171|NCT01714232|77207|P1|STARTED|Overall Study||106
34172|NCT01713998|77216|P3|NOT COMPLETED|Overall Study||2
34173|NCT01713998|77217|P2|NOT COMPLETED|Overall Study||0
34174|NCT01713998|77218|P1|NOT COMPLETED|Overall Study||3
34175|NCT01713998|77216|P3|COMPLETED|Overall Study||14
34176|NCT01713998|77217|P2|COMPLETED|Overall Study||15
34177|NCT01713998|77218|P1|COMPLETED|Overall Study||13
34178|NCT01713998|77216|P3|STARTED|Overall Study||16
34179|NCT01713998|77217|P2|STARTED|Overall Study||15
34180|NCT01713998|77218|P1|STARTED|Overall Study||16
34181|NCT01713933|77236|P1|NOT COMPLETED|Overall Study||6
34182|NCT01713933|77236|P1|COMPLETED|Overall Study||31
34183|NCT01713933|77236|P1|STARTED|Overall Study||37
34184|NCT01713686|77248|P1|NOT COMPLETED|Overall Study||15
34185|NCT01713686|77248|P1|COMPLETED|Overall Study||110
34186|NCT01713686|77248|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
34187|NCT01713660|77257|P1|NOT COMPLETED|Overall Study||0
34188|NCT01713660|77257|P1|COMPLETED|Overall Study||37
34189|NCT01713660|77257|P1|STARTED|Overall Study||37
34190|NCT01713621|77265|P2|NOT COMPLETED|Overall Study||16
34191|NCT01713621|77266|P1|NOT COMPLETED|Overall Study||7
34192|NCT01713621|77265|P2|COMPLETED|Overall Study||1
34193|NCT01713621|77266|P1|COMPLETED|Overall Study||1
34194|NCT01713621|77265|P2|STARTED|Overall Study||17
34195|NCT01713621|77266|P1|STARTED|Overall Study||8
34196|NCT01713608|77276|P4|NOT COMPLETED|Overall Study||0
34197|NCT01713608|77277|P3|NOT COMPLETED|Overall Study||0
34198|NCT01713608|77278|P2|NOT COMPLETED|Overall Study||0
34199|NCT01713608|77279|P1|NOT COMPLETED|Overall Study||0
34200|NCT01713608|77276|P4|COMPLETED|Overall Study||12
34201|NCT01713608|77277|P3|COMPLETED|Overall Study||8
34202|NCT01713608|77278|P2|COMPLETED|Overall Study||6
34203|NCT01713608|77279|P1|COMPLETED|Overall Study||8
34204|NCT01713608|77276|P4|STARTED|Overall Study||12
34205|NCT01713608|77277|P3|STARTED|Overall Study||8
34206|NCT01713608|77278|P2|STARTED|Overall Study||6
34207|NCT01713608|77279|P1|STARTED|Overall Study||8
34208|NCT01713530|77299|P2|NOT COMPLETED|Overall Study||19
34209|NCT01713530|77300|P1|NOT COMPLETED|Overall Study||25
34210|NCT01713530|77299|P2|COMPLETED|Overall Study||117
34211|NCT01713530|77300|P1|COMPLETED|Overall Study||113
34212|NCT01713530|77299|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
34213|NCT01713530|77300|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
34214|NCT01713530|77299|P2|STARTED|Overall Study||136
34215|NCT01713530|77300|P1|STARTED|Overall Study||138
34216|NCT01713400|77318|P2|NOT COMPLETED|Overall Study||0
34217|NCT01713400|77319|P1|NOT COMPLETED|Overall Study||0
34218|NCT01713400|77318|P2|COMPLETED|Overall Study||15
34219|NCT01713400|77319|P1|COMPLETED|Overall Study||15
34220|NCT01713400|77318|P2|STARTED|Overall Study||15
34221|NCT01713400|77319|P1|STARTED|Overall Study||15
34222|NCT01713348|77331|P4|NOT COMPLETED|Overall Study||0
34223|NCT01713348|77332|P3|NOT COMPLETED|Overall Study||2
34224|NCT01713348|77333|P2|NOT COMPLETED|Overall Study||2
34225|NCT01713348|77334|P1|NOT COMPLETED|Overall Study||4
34226|NCT01713348|77331|P4|COMPLETED|Overall Study||15
34227|NCT01713348|77332|P3|COMPLETED|Overall Study||28
34228|NCT01713348|77333|P2|COMPLETED|Overall Study||11
34229|NCT01713348|77334|P1|COMPLETED|Overall Study||25
34230|NCT01713348|77331|P4|STARTED|Overall Study||15
34231|NCT01713348|77332|P3|STARTED|Overall Study||30
34232|NCT01713348|77333|P2|STARTED|Overall Study||13
34233|NCT01713348|77334|P1|STARTED|Overall Study||29
34234|NCT01713283|77364|P2|NOT COMPLETED|Overall Study||3
34235|NCT01713283|77365|P1|NOT COMPLETED|Overall Study||11
34236|NCT01713283|77364|P2|COMPLETED|Overall Study||26
34237|NCT01713283|77365|P1|COMPLETED|Overall Study||20
34238|NCT01713283|77364|P2|STARTED|Overall Study||29
34239|NCT01713283|77365|P1|STARTED|Overall Study||31
34240|NCT01713036|77387|P1|NOT COMPLETED|Overall Study||1
34241|NCT01713036|77387|P1|COMPLETED|Overall Study||5
34242|NCT01713036|77387|P1|STARTED|Overall Study||6
34243|NCT01712984|77427|P3|NOT COMPLETED|Overall Study||10
34244|NCT01712984|77428|P2|NOT COMPLETED|Overall Study||16
34245|NCT01712984|77429|P1|NOT COMPLETED|Overall Study||16
34246|NCT01712984|77427|P3|COMPLETED|Overall Study||836
34247|NCT01712984|77428|P2|COMPLETED|Overall Study||821
34248|NCT01712984|77429|P1|COMPLETED|Overall Study||1656
34249|NCT01712984|77427|P3|STARTED|Overall Study||846
34250|NCT01712984|77428|P2|STARTED|Overall Study||837
34251|NCT01712984|77429|P1|STARTED|Overall Study||1672
34252|NCT01712854|77449|P1|NOT COMPLETED|Overall Study||1
34253|NCT01712854|77449|P1|COMPLETED|Overall Study||8
34254|NCT01712854|77449|P1|STARTED|Overall Study||9
34255|NCT01712776|77456|P2|NOT COMPLETED|Overall Study||0
34256|NCT01712776|77457|P1|NOT COMPLETED|Overall Study||0
34257|NCT01712776|77456|P2|COMPLETED|Overall Study||50
34258|NCT01712776|77457|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
34259|NCT01712776|77456|P2|STARTED|Overall Study||50
34260|NCT01712776|77457|P1|STARTED|Overall Study||50
34261|NCT01712711|77465|P2|NOT COMPLETED|Overall Study||0
34262|NCT01712711|77466|P1|NOT COMPLETED|Overall Study||0
34263|NCT01712711|77465|P2|COMPLETED|Overall Study||20
34264|NCT01712711|77466|P1|COMPLETED|Overall Study||20
34265|NCT01712711|77465|P2|STARTED|Overall Study||20
34266|NCT01712711|77466|P1|STARTED|Overall Study||20
34267|NCT01712685|77472|P1|NOT COMPLETED|Overall Study||1
34268|NCT01712685|77472|P1|COMPLETED|Overall Study||11
34269|NCT01712685|77472|P1|STARTED|Overall Study||12
34270|NCT01712516|77488|P4|NOT COMPLETED|Overall Study||13
34271|NCT01712516|77489|P3|NOT COMPLETED|Overall Study||6
34272|NCT01712516|77490|P2|NOT COMPLETED|Overall Study||10
34273|NCT01712516|77491|P1|NOT COMPLETED|Overall Study||6
34274|NCT01712516|77488|P4|COMPLETED|Overall Study||236
34275|NCT01712516|77489|P3|COMPLETED|Overall Study||245
34276|NCT01712516|77490|P2|COMPLETED|Overall Study||241
34277|NCT01712516|77491|P1|COMPLETED|Overall Study||244
34278|NCT01712516|77488|P4|Full Analysis Set|Overall Study||247
34279|NCT01712516|77489|P3|Full Analysis Set|Overall Study||250
34280|NCT01712516|77490|P2|Full Analysis Set|Overall Study||251
34281|NCT01712516|77491|P1|Full Analysis Set|Overall Study||250
34282|NCT01712516|77488|P4|Safety Set|Overall Study||248
34283|NCT01712516|77489|P3|Safety Set|Overall Study||251
34284|NCT01712516|77490|P2|Safety Set|Overall Study||251
34285|NCT01712516|77491|P1|Safety Set|Overall Study||250
34286|NCT01712516|77488|P4|STARTED|Overall Study||249
34287|NCT01712516|77489|P3|STARTED|Overall Study||251
34288|NCT01712516|77490|P2|STARTED|Overall Study||251
34289|NCT01712516|77491|P1|STARTED|Overall Study||250
34290|NCT01712360|77545|P4|NOT COMPLETED|Overall Study||2
34291|NCT01712360|77546|P3|NOT COMPLETED|Overall Study||0
34292|NCT01712360|77547|P2|NOT COMPLETED|Overall Study||1
34293|NCT01712360|77548|P1|NOT COMPLETED|Overall Study||0
34294|NCT01712360|77545|P4|COMPLETED|Overall Study||4
34295|NCT01712360|77546|P3|COMPLETED|Overall Study||6
34296|NCT01712360|77547|P2|COMPLETED|Overall Study||21
34297|NCT01712360|77548|P1|COMPLETED|Overall Study||22
34298|NCT01712360|77545|P4|STARTED|Overall Study||6
34299|NCT01712360|77546|P3|STARTED|Overall Study||6
34300|NCT01712360|77547|P2|STARTED|Overall Study||22
34301|NCT01712360|77548|P1|STARTED|Overall Study||22
34302|NCT01712334|77574|P2|NOT COMPLETED|Treatment Period 2||0
34303|NCT01712334|77575|P1|NOT COMPLETED|Treatment Period 2||0
34304|NCT01712334|77574|P2|COMPLETED|Treatment Period 2||41
34305|NCT01712334|77575|P1|COMPLETED|Treatment Period 2||44
34306|NCT01712334|77574|P2|STARTED|Treatment Period 2||41
34307|NCT01712334|77575|P1|STARTED|Treatment Period 2||44
34308|NCT01712334|77574|P2|NOT COMPLETED|Treatment Period 1||2
34309|NCT01712334|77575|P1|NOT COMPLETED|Treatment Period 1||0
34310|NCT01712334|77574|P2|COMPLETED|Treatment Period 1||41
34311|NCT01712334|77575|P1|COMPLETED|Treatment Period 1||44
34312|NCT01712334|77574|P2|Received Treatment|Treatment Period 1||41
34313|NCT01712334|77575|P1|Received Treatment|Treatment Period 1||44
34314|NCT01712334|77574|P2|STARTED|Treatment Period 1||43
34315|NCT01712334|77575|P1|STARTED|Treatment Period 1||44
34316|NCT01712204|77585|P2|NOT COMPLETED|Overall Study||5
34317|NCT01712204|77586|P1|NOT COMPLETED|Overall Study||8
34318|NCT01712204|77585|P2|COMPLETED|Overall Study||36
34319|NCT01712204|77586|P1|COMPLETED|Overall Study||33
34320|NCT01712204|77585|P2|STARTED|Overall Study||41
34321|NCT01712204|77586|P1|STARTED|Overall Study||41
34322|NCT01712178|77594|P2|NOT COMPLETED|Overall Study||3
34323|NCT01712178|77595|P1|NOT COMPLETED|Overall Study||1
34324|NCT01712178|77594|P2|COMPLETED|Overall Study||47
34325|NCT01712178|77595|P1|COMPLETED|Overall Study||49
34326|NCT01712178|77594|P2|STARTED|Overall Study||50
34327|NCT01712178|77595|P1|STARTED|Overall Study||50
34328|NCT01712061|77619|P3|NOT COMPLETED|Overall Study||11
34329|NCT01712061|77620|P2|NOT COMPLETED|Overall Study||26
34330|NCT01712061|77621|P1|NOT COMPLETED|Overall Study||10
34331|NCT01712061|77619|P3|COMPLETED|Overall Study||45
34332|NCT01712061|77620|P2|COMPLETED|Overall Study||114
34333|NCT01712061|77621|P1|COMPLETED|Overall Study||20
34334|NCT01712061|77619|P3|STARTED|Overall Study||56
34335|NCT01712061|77620|P2|STARTED|Overall Study||140
34336|NCT01712061|77621|P1|STARTED|Overall Study||30
34337|NCT01712009|77661|P3|NOT COMPLETED|Overall Study||21
34338|NCT01712009|77662|P2|NOT COMPLETED|Overall Study||29
34339|NCT01712009|77663|P1|NOT COMPLETED|Overall Study||38
34340|NCT01712009|77661|P3|COMPLETED|Overall Study||181
34341|NCT01712009|77662|P2|COMPLETED|Overall Study||171
34342|NCT01712009|77663|P1|COMPLETED|Overall Study||160
34343|NCT01712009|77661|P3|Received Naproxen / Loratadine|Overall Study||198
34344|NCT01712009|77662|P2|Received Naproxen / Loratadine|Overall Study||193
34345|NCT01712009|77663|P1|Received Naproxen / Loratadine|Overall Study||0
34346|NCT01712009|77661|P3|Received Pegfilgrastim|Overall Study||200
34347|NCT01712009|77662|P2|Received Pegfilgrastim|Overall Study||196
34348|NCT01712009|77663|P1|Received Pegfilgrastim|Overall Study||191
34349|NCT01712009|77661|P3|STARTED|Overall Study||202
34350|NCT01712009|77662|P2|STARTED|Overall Study||200
34351|NCT01712009|77663|P1|STARTED|Overall Study||198
34352|NCT01711918|77689|P1|NOT COMPLETED|Overall Study||2
34353|NCT01711918|77689|P1|COMPLETED|Overall Study||7
34354|NCT01711918|77689|P1|STARTED|Overall Study||9
34355|NCT01711866|77697|P1|NOT COMPLETED|Overall Study||8
34356|NCT01711866|77697|P1|COMPLETED|Overall Study||79
34357|NCT01711866|77697|P1|STARTED|Overall Study||87
34358|NCT01711853|77702|P1|NOT COMPLETED|Overall Study||3
34359|NCT01711853|77702|P1|COMPLETED|Overall Study||16
34360|NCT01711853|77702|P1|STARTED|Overall Study||19
34361|NCT01711736|77709|P2|NOT COMPLETED|Overall Study||8
34362|NCT01711736|77710|P1|NOT COMPLETED|Overall Study||12
34363|NCT01711736|77709|P2|COMPLETED|Overall Study|Up to Day 180|294
34364|NCT01711736|77710|P1|COMPLETED|Overall Study|Up to Day 180|287
34365|NCT01711736|77709|P2|STARTED|Overall Study||302
34366|NCT01711736|77710|P1|STARTED|Overall Study||299
34367|NCT01711424|77738|P1|NOT COMPLETED|Overall Study||0
34368|NCT01711424|77738|P1|COMPLETED|Overall Study||1209
34369|NCT01711424|77738|P1|STARTED|Overall Study||1209
34370|NCT01711216|77745|P1|NOT COMPLETED|Overall Study||217
34371|NCT01711216|77745|P1|COMPLETED|Overall Study||782
34372|NCT01711216|77745|P1|STARTED|Overall Study||999
34373|NCT01711177|77769|P3|NOT COMPLETED|Overall Study||0
34374|NCT01711177|77770|P2|NOT COMPLETED|Overall Study||0
34375|NCT01711177|77771|P1|NOT COMPLETED|Overall Study||0
34376|NCT01711177|77769|P3|COMPLETED|Overall Study||3
34377|NCT01711177|77770|P2|COMPLETED|Overall Study||3
34378|NCT01711177|77771|P1|COMPLETED|Overall Study||10
34379|NCT01711177|77769|P3|STARTED|Overall Study||3
34380|NCT01711177|77770|P2|STARTED|Overall Study||3
34381|NCT01711177|77771|P1|STARTED|Overall Study||10
34382|NCT01710800|77779|P1|NOT COMPLETED|Overall Study||22
34383|NCT01710800|77779|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
34384|NCT01710800|77779|P1|Received Placebo Intervention|Overall Study||45
34385|NCT01710800|77779|P1|Received PPI Intervention|Overall Study||44
34386|NCT01710800|77779|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
34387|NCT01710657|77788|P3|NOT COMPLETED|Overall Study||32
34388|NCT01710657|77789|P2|NOT COMPLETED|Overall Study||12
34389|NCT01710657|77790|P1|NOT COMPLETED|Overall Study||18
34390|NCT01710657|77788|P3|COMPLETED|Overall Study||148
34391|NCT01710657|77789|P2|COMPLETED|Overall Study||171
34392|NCT01710657|77790|P1|COMPLETED|Overall Study||166
34393|NCT01710657|77788|P3|Maintenance Period (12 Weeks)|Overall Study||168
34394|NCT01710657|77789|P2|Maintenance Period (12 Weeks)|Overall Study||175
34395|NCT01710657|77790|P1|Maintenance Period (12 Weeks)|Overall Study||176
34396|NCT01710657|77788|P3|Titration Period (4 Weeks)|Overall Study||180
34397|NCT01710657|77789|P2|Titration Period (4 Weeks)|Overall Study||183
34398|NCT01710657|77790|P1|Titration Period (4 Weeks)|Overall Study||184
34399|NCT01710657|77788|P3|STARTED|Overall Study||180
34400|NCT01710657|77789|P2|STARTED|Overall Study||183
34401|NCT01710657|77790|P1|STARTED|Overall Study||184
34402|NCT01710514|77809|P2|NOT COMPLETED|Overall Study||7
34403|NCT01710514|77810|P1|NOT COMPLETED|Overall Study||7
34404|NCT01710514|77809|P2|COMPLETED|Overall Study||47
34405|NCT01710514|77810|P1|COMPLETED|Overall Study||47
34406|NCT01710514|77809|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
34407|NCT01710514|77810|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
34408|NCT01710514|77809|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
34409|NCT01710514|77810|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
34410|NCT01710514|77809|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
34411|NCT01710514|77810|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
34412|NCT01710514|77809|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
34413|NCT01710514|77810|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
34414|NCT01710514|77809|P2|STARTED|Overall Study||54
34415|NCT01710514|77810|P1|STARTED|Overall Study||54
34416|NCT01710501|77831|P3|NOT COMPLETED|Overall Study||0
34417|NCT01710501|77832|P2|NOT COMPLETED|Overall Study||0
34418|NCT01710501|77833|P1|NOT COMPLETED|Overall Study||2
34419|NCT01710501|77831|P3|COMPLETED|Overall Study||30
34420|NCT01710501|77832|P2|COMPLETED|Overall Study||28
34421|NCT01710501|77833|P1|COMPLETED|Overall Study||27
34422|NCT01710501|77831|P3|STARTED|Overall Study||30
34423|NCT01710501|77832|P2|STARTED|Overall Study||28
34424|NCT01710501|77833|P1|STARTED|Overall Study||29
34425|NCT01710345|77865|P3|NOT COMPLETED|Overall Study||1
34426|NCT01710345|77866|P2|NOT COMPLETED|Overall Study||5
34427|NCT01710345|77867|P1|NOT COMPLETED|Overall Study||3
34428|NCT01710345|77865|P3|COMPLETED|Overall Study||19
34429|NCT01710345|77866|P2|COMPLETED|Overall Study||35
34430|NCT01710345|77867|P1|COMPLETED|Overall Study||37
34431|NCT01710345|77865|P3|STARTED|Overall Study||20
34432|NCT01710345|77866|P2|STARTED|Overall Study||40
34433|NCT01710345|77867|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
34434|NCT01710046|77877|P2|NOT COMPLETED|Overall Study||0
34435|NCT01710046|77878|P1|NOT COMPLETED|Overall Study||1
34436|NCT01710046|77877|P2|COMPLETED|Overall Study||3
34437|NCT01710046|77878|P1|COMPLETED|Overall Study||8
34438|NCT01710046|77877|P2|STARTED|Overall Study||3
34439|NCT01710046|77878|P1|STARTED|Overall Study||9
34440|NCT01710033|77918|P5|NOT COMPLETED|Stage 2||1
34441|NCT01710033|77919|P4|NOT COMPLETED|Stage 2||0
34442|NCT01710033|77920|P3|NOT COMPLETED|Stage 2||0
34443|NCT01710033|77921|P2|NOT COMPLETED|Stage 2||0
34444|NCT01710033|77922|P1|NOT COMPLETED|Stage 2||0
34445|NCT01710033|77918|P5|COMPLETED|Stage 2||3
34446|NCT01710033|77919|P4|COMPLETED|Stage 2||0
34447|NCT01710033|77920|P3|COMPLETED|Stage 2||0
34448|NCT01710033|77921|P2|COMPLETED|Stage 2||0
34449|NCT01710033|77922|P1|COMPLETED|Stage 2||0
34450|NCT01710033|77918|P5|STARTED|Stage 2||4
34451|NCT01710033|77919|P4|STARTED|Stage 2||0
34452|NCT01710033|77920|P3|STARTED|Stage 2||0
34453|NCT01710033|77921|P2|STARTED|Stage 2||0
34454|NCT01710033|77922|P1|STARTED|Stage 2||0
34455|NCT01710033|77918|P5|NOT COMPLETED|Stage 1||0
34456|NCT01710033|77919|P4|NOT COMPLETED|Stage 1||0
34457|NCT01710033|77920|P3|NOT COMPLETED|Stage 1||0
34458|NCT01710033|77921|P2|NOT COMPLETED|Stage 1||0
34459|NCT01710033|77922|P1|NOT COMPLETED|Stage 1||0
34460|NCT01710033|77918|P5|COMPLETED|Stage 1||0
34461|NCT01710033|77919|P4|COMPLETED|Stage 1||6
34462|NCT01710033|77920|P3|COMPLETED|Stage 1||6
34463|NCT01710033|77921|P2|COMPLETED|Stage 1||6
34464|NCT01710033|77922|P1|COMPLETED|Stage 1||6
34465|NCT01710033|77918|P5|STARTED|Stage 1||0
34466|NCT01710033|77919|P4|STARTED|Stage 1||6
34467|NCT01710033|77920|P3|STARTED|Stage 1||6
34468|NCT01710033|77921|P2|STARTED|Stage 1||6
34469|NCT01710033|77922|P1|STARTED|Stage 1||6
34470|NCT01710020|78003|P1|NOT COMPLETED|Period 2||0
34471|NCT01710020|78003|P1|COMPLETED|Period 2||11
34472|NCT01710020|78003|P1|STARTED|Period 2||11
34473|NCT01710020|78003|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
34474|NCT01710020|78003|P1|COMPLETED|Washout Period (at Least 14 Days)||11
34475|NCT01710020|78003|P1|STARTED|Washout Period (at Least 14 Days)||11
34476|NCT01710020|78003|P1|NOT COMPLETED|Period 1||1
34477|NCT01710020|78003|P1|COMPLETED|Period 1||11
34478|NCT01710020|78003|P1|STARTED|Period 1||12
34479|NCT01709903|78022|P2|NOT COMPLETED|Overall Study||39
34480|NCT01709903|78023|P1|NOT COMPLETED|Overall Study||29
34481|NCT01709903|78022|P2|COMPLETED|Overall Study||333
34482|NCT01709903|78023|P1|COMPLETED|Overall Study||343
34483|NCT01709903|78022|P2|STARTED|Overall Study|Randomized set|372
34484|NCT01709903|78023|P1|STARTED|Overall Study|Randomized set|372
34485|NCT01709864|78047|P2|NOT COMPLETED|Overall Study||11
34486|NCT01709864|78048|P1|NOT COMPLETED|Overall Study||7
34487|NCT01709864|78047|P2|COMPLETED|Overall Study||208
34488|NCT01709864|78048|P1|COMPLETED|Overall Study||215
34489|NCT01709864|78047|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
34490|NCT01709864|78048|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
34491|NCT01709864|78047|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
34492|NCT01709864|78048|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
34493|NCT01709864|78047|P2|STARTED|Overall Study||219
34494|NCT01709864|78048|P1|STARTED|Overall Study||222
34495|NCT01709799|78085|P3|NOT COMPLETED|Overall Study||3
34496|NCT01709799|78086|P2|NOT COMPLETED|Overall Study||3
34497|NCT01709799|78087|P1|NOT COMPLETED|Overall Study||3
34498|NCT01709799|78085|P3|COMPLETED|Overall Study||15
34499|NCT01709799|78086|P2|COMPLETED|Overall Study||18
34500|NCT01709799|78087|P1|COMPLETED|Overall Study||22
34501|NCT01709799|78085|P3|STARTED|Overall Study||18
34502|NCT01709799|78086|P2|STARTED|Overall Study||21
34503|NCT01709799|78087|P1|STARTED|Overall Study||25
34504|NCT01709786|78110|P1|NOT COMPLETED|Overall Study||0
34505|NCT01709786|78110|P1|COMPLETED|Overall Study||88
34506|NCT01709786|78110|P1|STARTED|Overall Study||88
34507|NCT01709708|78119|P2|NOT COMPLETED|Overall Study||2
34508|NCT01709708|78120|P1|NOT COMPLETED|Overall Study||1
34509|NCT01709708|78119|P2|COMPLETED|Overall Study||12
34510|NCT01709708|78120|P1|COMPLETED|Overall Study||26
34511|NCT01709708|78119|P2|STARTED|Overall Study||14
34512|NCT01709708|78120|P1|STARTED|Overall Study||27
34513|NCT01709513|78129|P3|NOT COMPLETED|Overall Study||30
34514|NCT01709513|78130|P2|NOT COMPLETED|Overall Study||43
34515|NCT01709513|78131|P1|NOT COMPLETED|Overall Study||21
34516|NCT01709513|78129|P3|COMPLETED|Overall Study||96
34517|NCT01709513|78130|P2|COMPLETED|Overall Study||82
34518|NCT01709513|78131|P1|COMPLETED|Overall Study||42
34519|NCT01709513|78129|P3|Treated|Overall Study||126
34520|NCT01709513|78130|P2|Treated|Overall Study||124
34521|NCT01709513|78131|P1|Treated|Overall Study||63
34522|NCT01709513|78129|P3|STARTED|Overall Study||126
34523|NCT01709513|78130|P2|STARTED|Overall Study||125
34524|NCT01709513|78131|P1|STARTED|Overall Study||63
34525|NCT01709500|78192|P2|NOT COMPLETED|Overall Study||82
34526|NCT01709500|78193|P1|NOT COMPLETED|Overall Study||167
34527|NCT01709500|78192|P2|COMPLETED|Overall Study||0
34528|NCT01709500|78193|P1|COMPLETED|Overall Study||0
34529|NCT01709500|78192|P2|Treated|Overall Study||81
34530|NCT01709500|78193|P1|Treated|Overall Study||167
34531|NCT01709500|78192|P2|STARTED|Overall Study||82
34532|NCT01709500|78193|P1|STARTED|Overall Study||167
34533|NCT01709474|78249|P2|NOT COMPLETED|Overall Study||0
34534|NCT01709474|78250|P1|NOT COMPLETED|Overall Study||0
34535|NCT01709474|78249|P2|COMPLETED|Overall Study||4
34536|NCT01709474|78250|P1|COMPLETED|Overall Study||3
34537|NCT01709474|78249|P2|STARTED|Overall Study||4
34538|NCT01709474|78250|P1|STARTED|Overall Study||3
34539|NCT01709422|78260|P2|NOT COMPLETED|Overall Study||0
34540|NCT01709422|78261|P1|NOT COMPLETED|Overall Study||0
34541|NCT01709422|78260|P2|COMPLETED|Overall Study||70
34542|NCT01709422|78261|P1|COMPLETED|Overall Study||70
34543|NCT01709422|78260|P2|STARTED|Overall Study||70
34544|NCT01709422|78261|P1|STARTED|Overall Study||70
34545|NCT01709331|78269|P1|NOT COMPLETED|Overall Study||1
34546|NCT01709331|78269|P1|COMPLETED|Overall Study||17
34547|NCT01709331|78269|P1|STARTED|Overall Study||18
34548|NCT01709305|78275|P5|NOT COMPLETED|Phase 2||47
34549|NCT01709305|78276|P4|NOT COMPLETED|Phase 2||48
34550|NCT01709305|78277|P3|NOT COMPLETED|Phase 2||45
34551|NCT01709305|78278|P2|NOT COMPLETED|Phase 2||52
34552|NCT01709305|78279|P1|NOT COMPLETED|Phase 2||0
34553|NCT01709305|78275|P5|COMPLETED|Phase 2||507
34554|NCT01709305|78276|P4|COMPLETED|Phase 2||508
34555|NCT01709305|78277|P3|COMPLETED|Phase 2||505
34556|NCT01709305|78278|P2|COMPLETED|Phase 2||500
34557|NCT01709305|78279|P1|COMPLETED|Phase 2||0
34558|NCT01709305|78275|P5|STARTED|Phase 2||554
34559|NCT01709305|78276|P4|STARTED|Phase 2||556
34560|NCT01709305|78277|P3|STARTED|Phase 2||550
34561|NCT01709305|78278|P2|STARTED|Phase 2||552
34562|NCT01709305|78279|P1|STARTED|Phase 2||0
34563|NCT01709305|78275|P5|NOT COMPLETED|Phase 1||0
34564|NCT01709305|78276|P4|NOT COMPLETED|Phase 1||0
34565|NCT01709305|78277|P3|NOT COMPLETED|Phase 1||0
34566|NCT01709305|78278|P2|NOT COMPLETED|Phase 1||0
34567|NCT01709305|78279|P1|NOT COMPLETED|Phase 1||637
34568|NCT01709305|78275|P5|COMPLETED|Phase 1||0
34569|NCT01709305|78276|P4|COMPLETED|Phase 1||0
34570|NCT01709305|78277|P3|COMPLETED|Phase 1||0
34571|NCT01709305|78278|P2|COMPLETED|Phase 1||0
34572|NCT01709305|78279|P1|COMPLETED|Phase 1||4933
34573|NCT01709305|78275|P5|STARTED|Phase 1||0
34574|NCT01709305|78276|P4|STARTED|Phase 1||0
34575|NCT01709305|78277|P3|STARTED|Phase 1||0
34576|NCT01709305|78278|P2|STARTED|Phase 1||0
34577|NCT01709305|78279|P1|STARTED|Phase 1||5570
34578|NCT01709162|78316|P2|NOT COMPLETED|Overall Study||5
34579|NCT01709162|78317|P1|NOT COMPLETED|Overall Study||6
34580|NCT01709162|78316|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
34581|NCT01709162|78317|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
34582|NCT01709162|78316|P2|Still Receiving Treatment|Overall Study||0
34583|NCT01709162|78317|P1|Still Receiving Treatment|Overall Study||0
34584|NCT01709162|78316|P2|Received Treatment|Overall Study||4
34585|NCT01709162|78317|P1|Received Treatment|Overall Study||18
34586|NCT01709162|78316|P2|STARTED|Overall Study|Randomized|5
34587|NCT01709162|78317|P1|STARTED|Overall Study|Randomized|18
34588|NCT01709136|78329|P1|NOT COMPLETED|Overall Study||0
34589|NCT01709136|78329|P1|COMPLETED|Overall Study||3
34590|NCT01709136|78329|P1|STARTED|Overall Study||3
34591|NCT01709084|78338|P2|NOT COMPLETED|Overall Study||15
34592|NCT01709084|78339|P1|NOT COMPLETED|Overall Study||16
34593|NCT01709084|78338|P2|COMPLETED|Overall Study||198
34594|NCT01709084|78339|P1|COMPLETED|Overall Study||197
34595|NCT01709084|78338|P2|Treated|Overall Study||211
34596|NCT01709084|78339|P1|Treated|Overall Study||213
34597|NCT01709084|78338|P2|STARTED|Overall Study||213
34598|NCT01709084|78339|P1|STARTED|Overall Study||213
34599|NCT01708967|78357|P2|NOT COMPLETED|Overall Study||7
34600|NCT01708967|78358|P1|NOT COMPLETED|Overall Study||0
34601|NCT01708967|78357|P2|COMPLETED|Overall Study||43
34602|NCT01708967|78358|P1|COMPLETED|Overall Study||50
34603|NCT01708967|78357|P2|STARTED|Overall Study||50
34604|NCT01708967|78358|P1|STARTED|Overall Study||50
34605|NCT01708954|78367|P3|NOT COMPLETED|Step 2||0
34606|NCT01708954|78368|P2|NOT COMPLETED|Step 2||7
34607|NCT01708954|78369|P1|NOT COMPLETED|Step 2||13
34608|NCT01708954|78367|P3|COMPLETED|Step 2||0
34609|NCT01708954|78368|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
34610|NCT01708954|78369|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
34611|NCT01708954|78367|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
34612|NCT01708954|78368|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
34613|NCT01708954|78369|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
34614|NCT01708954|78367|P3|NOT COMPLETED|Step 1||43
34615|NCT01708954|78368|P2|NOT COMPLETED|Step 1||40
34616|NCT01708954|78369|P1|NOT COMPLETED|Step 1||42
34617|NCT01708954|78367|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
34618|NCT01708954|78368|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
34619|NCT01708954|78369|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
34620|NCT01708954|78367|P3|Patients With MET Status Data Available|Step 1||24
34621|NCT01708954|78368|P2|Patients With MET Status Data Available|Step 1||32
34622|NCT01708954|78369|P1|Patients With MET Status Data Available|Step 1||30
34623|NCT01708954|78367|P3|Eligible and Treated|Step 1||35
34624|NCT01708954|78368|P2|Eligible and Treated|Step 1||38
34625|NCT01708954|78369|P1|Eligible and Treated|Step 1||38
34626|NCT01708954|78367|P3|Started Protocol Therapy|Step 1||39
34627|NCT01708954|78368|P2|Started Protocol Therapy|Step 1||40
34628|NCT01708954|78369|P1|Started Protocol Therapy|Step 1||40
34629|NCT01708954|78367|P3|STARTED|Step 1||43
34630|NCT01708954|78368|P2|STARTED|Step 1||40
34631|NCT01708954|78369|P1|STARTED|Step 1||42
34632|NCT01708915|78394|P4|NOT COMPLETED|Overall Study||33
34633|NCT01708915|78395|P3|NOT COMPLETED|Overall Study||46
34634|NCT01708915|78396|P2|NOT COMPLETED|Overall Study||62
34635|NCT01708915|78397|P1|NOT COMPLETED|Overall Study||86
34636|NCT01708915|78394|P4|COMPLETED|Overall Study||169
34637|NCT01708915|78395|P3|COMPLETED|Overall Study||152
34638|NCT01708915|78396|P2|COMPLETED|Overall Study||139
34639|NCT01708915|78397|P1|COMPLETED|Overall Study||118
34640|NCT01708915|78394|P4|STARTED|Overall Study||202
34641|NCT01708915|78395|P3|STARTED|Overall Study||198
34642|NCT01708915|78396|P2|STARTED|Overall Study||201
34643|NCT01708915|78397|P1|STARTED|Overall Study||204
34644|NCT01708902|78426|P7|NOT COMPLETED|Overall Study||7
34645|NCT01708902|78427|P6|NOT COMPLETED|Overall Study||7
34646|NCT01708902|78428|P5|NOT COMPLETED|Overall Study||16
34647|NCT01708902|78429|P4|NOT COMPLETED|Overall Study||10
34648|NCT01708902|78430|P3|NOT COMPLETED|Overall Study||17
34649|NCT01708902|78431|P2|NOT COMPLETED|Overall Study||8
34650|NCT01708902|78432|P1|NOT COMPLETED|Overall Study||17
34651|NCT01708902|78426|P7|COMPLETED|Overall Study||65
34652|NCT01708902|78427|P6|COMPLETED|Overall Study||64
34653|NCT01708902|78428|P5|COMPLETED|Overall Study||131
34654|NCT01708902|78429|P4|COMPLETED|Overall Study||137
34655|NCT01708902|78430|P3|COMPLETED|Overall Study||127
34656|NCT01708902|78431|P2|COMPLETED|Overall Study||137
34657|NCT01708902|78432|P1|COMPLETED|Overall Study||130
34658|NCT01708902|78426|P7|STARTED|Overall Study||72
34659|NCT01708902|78427|P6|STARTED|Overall Study||71
34660|NCT01708902|78428|P5|STARTED|Overall Study||147
34661|NCT01708902|78429|P4|STARTED|Overall Study||147
34662|NCT01708902|78430|P3|STARTED|Overall Study||144
34663|NCT01708902|78431|P2|STARTED|Overall Study||145
34664|NCT01708902|78432|P1|STARTED|Overall Study||147
34665|NCT01708525|78491|P1|NOT COMPLETED|Overall Study||0
34666|NCT01708525|78491|P1|COMPLETED|Overall Study||2
34667|NCT01708525|78491|P1|STARTED|Overall Study||2
34668|NCT01708317|78496|P1|NOT COMPLETED|Final Education Period||0
34669|NCT01708317|78496|P1|COMPLETED|Final Education Period||909
34670|NCT01708317|78496|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
34671|NCT01708317|78496|P1|NOT COMPLETED|ACASI + Education Period||0
34672|NCT01708317|78496|P1|COMPLETED|ACASI + Education Period||2601
34673|NCT01708317|78496|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
34674|NCT01708317|78496|P1|NOT COMPLETED|Initial Education Period||0
34675|NCT01708317|78496|P1|COMPLETED|Initial Education Period||982
34676|NCT01708317|78496|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
34677|NCT01708317|78496|P1|NOT COMPLETED|2010 Control Period||0
34678|NCT01708317|78496|P1|COMPLETED|2010 Control Period||3929
34679|NCT01708317|78496|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
34680|NCT01708291|78505|P2|NOT COMPLETED|Overall Study||1
34681|NCT01708291|78506|P1|NOT COMPLETED|Overall Study||2
34682|NCT01708291|78505|P2|COMPLETED|Overall Study||20
34683|NCT01708291|78506|P1|COMPLETED|Overall Study||19
34684|NCT01708291|78505|P2|STARTED|Overall Study||21
34685|NCT01708291|78506|P1|STARTED|Overall Study||21
34686|NCT01708278|78518|P6|NOT COMPLETED|Overall Study||0
34687|NCT01708278|78519|P5|NOT COMPLETED|Overall Study||0
34688|NCT01708278|78520|P4|NOT COMPLETED|Overall Study||0
34689|NCT01708278|78521|P3|NOT COMPLETED|Overall Study||0
34690|NCT01708278|78522|P2|NOT COMPLETED|Overall Study||0
34691|NCT01708278|78523|P1|NOT COMPLETED|Overall Study||0
34692|NCT01708278|78518|P6|COMPLETED|Overall Study||1
34693|NCT01708278|78519|P5|COMPLETED|Overall Study||1
34694|NCT01708278|78520|P4|COMPLETED|Overall Study||2
34695|NCT01708278|78521|P3|COMPLETED|Overall Study||2
34696|NCT01708278|78522|P2|COMPLETED|Overall Study||2
34697|NCT01708278|78523|P1|COMPLETED|Overall Study||1
34698|NCT01708278|78518|P6|STARTED|Overall Study||1
34699|NCT01708278|78519|P5|STARTED|Overall Study||1
34700|NCT01708278|78520|P4|STARTED|Overall Study||2
34701|NCT01708278|78521|P3|STARTED|Overall Study||2
34702|NCT01708278|78522|P2|STARTED|Overall Study||2
34703|NCT01708278|78523|P1|STARTED|Overall Study||1
34704|NCT01708213|78537|P1|NOT COMPLETED|Overall Study||1
34705|NCT01708213|78537|P1|COMPLETED|Overall Study||71
34706|NCT01708213|78537|P1|STARTED|Overall Study||72
34707|NCT01708187|78545|P2|NOT COMPLETED|Overall Study||1
34708|NCT01708187|78546|P1|NOT COMPLETED|Overall Study||0
34709|NCT01708187|78545|P2|COMPLETED|Overall Study||0
34710|NCT01708187|78546|P1|COMPLETED|Overall Study||1
34711|NCT01708187|78545|P2|STARTED|Overall Study||1
34712|NCT01708187|78546|P1|STARTED|Overall Study||1
34713|NCT01708122|78554|P2|NOT COMPLETED|Overall Study||0
34714|NCT01708122|78555|P1|NOT COMPLETED|Overall Study||0
34715|NCT01708122|78554|P2|COMPLETED|Overall Study||26
34716|NCT01708122|78555|P1|COMPLETED|Overall Study||27
34717|NCT01708122|78554|P2|STARTED|Overall Study||26
34718|NCT01708122|78555|P1|STARTED|Overall Study||27
34719|NCT01708057|78563|P3|NOT COMPLETED|Overall Study||1
34720|NCT01708057|78564|P2|NOT COMPLETED|Overall Study||1
34721|NCT01708057|78565|P1|NOT COMPLETED|Overall Study||1
34722|NCT01708057|78563|P3|COMPLETED|Overall Study||0
34723|NCT01708057|78564|P2|COMPLETED|Overall Study||0
34724|NCT01708057|78565|P1|COMPLETED|Overall Study||0
34725|NCT01708057|78563|P3|STARTED|Overall Study||1
34726|NCT01708057|78564|P2|STARTED|Overall Study||1
34727|NCT01708057|78565|P1|STARTED|Overall Study||1
34728|NCT01707667|78623|P2|NOT COMPLETED|Period 2||0
34729|NCT01707667|78624|P1|NOT COMPLETED|Period 2||0
34730|NCT01707667|78623|P2|COMPLETED|Period 2||6
34731|NCT01707667|78624|P1|COMPLETED|Period 2||6
34732|NCT01707667|78623|P2|STARTED|Period 2||6
34733|NCT01707667|78624|P1|STARTED|Period 2||6
34734|NCT01707667|78623|P2|NOT COMPLETED|Period 1||0
34735|NCT01707667|78624|P1|NOT COMPLETED|Period 1||1
34736|NCT01707667|78623|P2|COMPLETED|Period 1||6
34737|NCT01707667|78624|P1|COMPLETED|Period 1||6
34738|NCT01707667|78623|P2|STARTED|Period 1||6
34739|NCT01707667|78624|P1|STARTED|Period 1||7
34740|NCT01707654|78642|P1|NOT COMPLETED|Overall Study||0
34741|NCT01707654|78642|P1|COMPLETED|Overall Study||9
34742|NCT01707654|78642|P1|STARTED|Overall Study||9
34743|NCT01707238|78648|P2|NOT COMPLETED|Overall Study||0
34744|NCT01707238|78649|P1|NOT COMPLETED|Overall Study||0
34745|NCT01707238|78648|P2|COMPLETED|Overall Study||52
34746|NCT01707238|78649|P1|COMPLETED|Overall Study||48
34747|NCT01707238|78648|P2|STARTED|Overall Study||52
34748|NCT01707238|78649|P1|STARTED|Overall Study||48
34749|NCT01707225|78665|P1|NOT COMPLETED|Overall Study||0
34750|NCT01707225|78665|P1|COMPLETED|Overall Study||10
34751|NCT01707225|78665|P1|STARTED|Overall Study||10
34752|NCT01707095|78672|P2|NOT COMPLETED|Overall Study||0
34753|NCT01707095|78673|P1|NOT COMPLETED|Overall Study||0
34754|NCT01707095|78672|P2|COMPLETED|Overall Study||42
34755|NCT01707095|78673|P1|COMPLETED|Overall Study||42
34756|NCT01707095|78672|P2|STARTED|Overall Study||42
34757|NCT01707095|78673|P1|STARTED|Overall Study||42
34758|NCT01706926|78685|P4|NOT COMPLETED|Overall Study||5
34759|NCT01706926|78686|P3|NOT COMPLETED|Overall Study||6
34760|NCT01706926|78687|P2|NOT COMPLETED|Overall Study||4
34761|NCT01706926|78688|P1|NOT COMPLETED|Overall Study||6
34762|NCT01706926|78685|P4|COMPLETED|Overall Study||74
34763|NCT01706926|78686|P3|COMPLETED|Overall Study||79
34764|NCT01706926|78687|P2|COMPLETED|Overall Study||77
34765|NCT01706926|78688|P1|COMPLETED|Overall Study||75
34766|NCT01706926|78685|P4|STARTED|Overall Study||79
34767|NCT01706926|78686|P3|STARTED|Overall Study||85
34768|NCT01706926|78687|P2|STARTED|Overall Study||81
34769|NCT01706926|78688|P1|STARTED|Overall Study||81
34770|NCT01706822|78797|P1|NOT COMPLETED|Overall Study||0
34771|NCT01706822|78797|P1|COMPLETED|Overall Study||8
34772|NCT01706822|78797|P1|STARTED|Overall Study||8
34773|NCT01706770|78807|P2|NOT COMPLETED|Overall Study||0
34774|NCT01706770|78808|P1|NOT COMPLETED|Overall Study||2
34775|NCT01706770|78807|P2|COMPLETED|Overall Study||17
34776|NCT01706770|78808|P1|COMPLETED|Overall Study||31
34777|NCT01706770|78807|P2|STARTED|Overall Study||17
34778|NCT01706770|78808|P1|STARTED|Overall Study||33
34779|NCT01706666|78819|P3|NOT COMPLETED|Overall Study||0
34780|NCT01706666|78820|P2|NOT COMPLETED|Overall Study||0
34781|NCT01706666|78821|P1|NOT COMPLETED|Overall Study||0
34782|NCT01706666|78819|P3|COMPLETED|Overall Study||1
34783|NCT01706666|78820|P2|COMPLETED|Overall Study||1
34784|NCT01706666|78821|P1|COMPLETED|Overall Study||1
34785|NCT01706666|78819|P3|STARTED|Overall Study||1
34786|NCT01706666|78820|P2|STARTED|Overall Study||1
34787|NCT01706666|78821|P1|STARTED|Overall Study||1
34788|NCT01706588|78840|P5|NOT COMPLETED|Overall Study||0
34789|NCT01706588|78841|P4|NOT COMPLETED|Overall Study||0
34790|NCT01706588|78842|P3|NOT COMPLETED|Overall Study||0
34791|NCT01706588|78843|P2|NOT COMPLETED|Overall Study||0
34792|NCT01706588|78844|P1|NOT COMPLETED|Overall Study||0
34793|NCT01706588|78840|P5|COMPLETED|Overall Study||16
34794|NCT01706588|78841|P4|COMPLETED|Overall Study||14
34795|NCT01706588|78842|P3|COMPLETED|Overall Study||15
34796|NCT01706588|78843|P2|COMPLETED|Overall Study||15
34797|NCT01706588|78844|P1|COMPLETED|Overall Study||15
34798|NCT01706588|78840|P5|STARTED|Overall Study||16
34799|NCT01706588|78841|P4|STARTED|Overall Study||14
34800|NCT01706588|78842|P3|STARTED|Overall Study||15
34801|NCT01706588|78843|P2|STARTED|Overall Study||15
34802|NCT01706588|78844|P1|STARTED|Overall Study||15
34803|NCT01706575|78856|P1|NOT COMPLETED|Overall Study||30
34804|NCT01706575|78856|P1|COMPLETED|Overall Study||46
34805|NCT01706575|78856|P1|STARTED|Overall Study||76
34806|NCT01706549|78862|P1|NOT COMPLETED|Overall Study||0
34807|NCT01706549|78862|P1|COMPLETED|Overall Study||16
34808|NCT01706549|78862|P1|STARTED|Overall Study||16
34809|NCT01706328|78869|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
34810|NCT01706328|78870|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
34811|NCT01706328|78871|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
34812|NCT01706328|78869|P3|COMPLETED|12-week Double-blind Treatment Period||371
34813|NCT01706328|78870|P2|COMPLETED|12-week Double-blind Treatment Period||366
34814|NCT01706328|78871|P1|COMPLETED|12-week Double-blind Treatment Period||0
34815|NCT01706328|78869|P3|STARTED|12-week Double-blind Treatment Period||416
34816|NCT01706328|78870|P2|STARTED|12-week Double-blind Treatment Period||412
34817|NCT01706328|78871|P1|STARTED|12-week Double-blind Treatment Period||0
34818|NCT01706328|78869|P3|NOT COMPLETED|2-week Run-in Period||0
34819|NCT01706328|78870|P2|NOT COMPLETED|2-week Run-in Period||0
34820|NCT01706328|78871|P1|NOT COMPLETED|2-week Run-in Period||165
34821|NCT01706328|78869|P3|COMPLETED|2-week Run-in Period||0
34822|NCT01706328|78870|P2|COMPLETED|2-week Run-in Period||0
34823|NCT01706328|78871|P1|COMPLETED|2-week Run-in Period||828
34824|NCT01706328|78869|P3|STARTED|2-week Run-in Period||0
34825|NCT01706328|78870|P2|STARTED|2-week Run-in Period||0
34826|NCT01706328|78871|P1|STARTED|2-week Run-in Period||993
34827|NCT01706159|78883|P2|NOT COMPLETED|Overall Study||2
34828|NCT01706159|78884|P1|NOT COMPLETED|Overall Study||8
34829|NCT01706159|78883|P2|COMPLETED|Overall Study||4
34830|NCT01706159|78884|P1|COMPLETED|Overall Study||6
34831|NCT01706159|78883|P2|Completers (With Baron Score at Week 8)|Overall Study||3
34832|NCT01706159|78884|P1|Completers (With Baron Score at Week 8)|Overall Study||6
34833|NCT01706159|78883|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
34834|NCT01706159|78884|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
34835|NCT01706159|78883|P2|STARTED|Overall Study||6
34836|NCT01706159|78884|P1|STARTED|Overall Study||14
34837|NCT01706146|78898|P1|NOT COMPLETED|Overall Study||6
34838|NCT01706146|78898|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
34839|NCT01706146|78898|P1|STARTED|Overall Study||59
34840|NCT01705717|78905|P2|NOT COMPLETED|Overall Study||5
34841|NCT01705717|78906|P1|NOT COMPLETED|Overall Study||2
34842|NCT01705717|78905|P2|COMPLETED|Overall Study||7
34843|NCT01705717|78906|P1|COMPLETED|Overall Study||35
34844|NCT01705717|78905|P2|STARTED|Overall Study||12
34845|NCT01705717|78906|P1|STARTED|Overall Study||37
34846|NCT01705652|78923|P2|NOT COMPLETED|Overall Study||3
34847|NCT01705652|78924|P1|NOT COMPLETED|Overall Study||3
34848|NCT01705652|78923|P2|COMPLETED|Overall Study||9
34849|NCT01705652|78924|P1|COMPLETED|Overall Study||6
34850|NCT01705652|78923|P2|STARTED|Overall Study||12
34851|NCT01705652|78924|P1|STARTED|Overall Study||9
34852|NCT01705574|78932|P2|NOT COMPLETED|Overall Study||163
34853|NCT01705574|78933|P1|NOT COMPLETED|Overall Study||167
34854|NCT01705574|78932|P2|COMPLETED|Overall Study||127
34855|NCT01705574|78933|P1|COMPLETED|Overall Study||126
34856|NCT01705574|78932|P2|STARTED|Overall Study||290
34857|NCT01705574|78933|P1|STARTED|Overall Study||293
34858|NCT01705496|78941|P1|NOT COMPLETED|Overall Study||4
34859|NCT01705496|78941|P1|COMPLETED|Overall Study||19
34860|NCT01705496|78941|P1|STARTED|Overall Study||23
34861|NCT01705145|78951|P1|NOT COMPLETED|Part B||1
34862|NCT01705145|78951|P1|COMPLETED|Part B||33
34863|NCT01705145|78951|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
34864|NCT01705145|78951|P1|NOT COMPLETED|Part A||0
34865|NCT01705145|78951|P1|COMPLETED|Part A||9
34866|NCT01705145|78951|P1|STARTED|Part A||9
34867|NCT01704976|78981|P2|NOT COMPLETED|Overall Study||2
34868|NCT01704976|78982|P1|NOT COMPLETED|Overall Study||1
34869|NCT01704976|78981|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
34870|NCT01704976|78982|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
34871|NCT01704976|78981|P2|STARTED|Overall Study||13
34872|NCT01704976|78982|P1|STARTED|Overall Study||14
34873|NCT01704846|78998|P2|NOT COMPLETED|Treatment Period 4||0
34874|NCT01704846|78999|P1|NOT COMPLETED|Treatment Period 4||0
34875|NCT01704846|78998|P2|COMPLETED|Treatment Period 4||29
34876|NCT01704846|78999|P1|COMPLETED|Treatment Period 4||30
34877|NCT01704846|78998|P2|STARTED|Treatment Period 4||29
34878|NCT01704846|78999|P1|STARTED|Treatment Period 4||30
34879|NCT01704846|78998|P2|NOT COMPLETED|Treatment Period 3||0
34880|NCT01704846|78999|P1|NOT COMPLETED|Treatment Period 3||0
34881|NCT01704846|78998|P2|COMPLETED|Treatment Period 3||29
34882|NCT01704846|78999|P1|COMPLETED|Treatment Period 3||30
34883|NCT01704846|78998|P2|STARTED|Treatment Period 3||29
34884|NCT01704846|78999|P1|STARTED|Treatment Period 3||30
34885|NCT01704846|78998|P2|NOT COMPLETED|Treatment Period 2||1
34886|NCT01704846|78999|P1|NOT COMPLETED|Treatment Period 2||0
34887|NCT01704846|78998|P2|COMPLETED|Treatment Period 2||29
34888|NCT01704846|78999|P1|COMPLETED|Treatment Period 2||30
34889|NCT01704846|78998|P2|STARTED|Treatment Period 2||30
34890|NCT01704846|78999|P1|STARTED|Treatment Period 2||30
34891|NCT01704846|78998|P2|NOT COMPLETED|Treatment Period 1||0
34892|NCT01704846|78999|P1|NOT COMPLETED|Treatment Period 1||0
34893|NCT01704846|78998|P2|COMPLETED|Treatment Period 1||30
34894|NCT01704846|78999|P1|COMPLETED|Treatment Period 1||30
34895|NCT01704846|78998|P2|STARTED|Treatment Period 1||30
34896|NCT01704846|78999|P1|STARTED|Treatment Period 1||30
34897|NCT01704755|79019|P2|NOT COMPLETED|Overall Study||7
34898|NCT01704755|79020|P1|NOT COMPLETED|Overall Study||12
34899|NCT01704755|79019|P2|COMPLETED|Overall Study||165
34900|NCT01704755|79020|P1|COMPLETED|Overall Study||196
34901|NCT01704755|79019|P2|Completed Study Drug|Overall Study||163
34902|NCT01704755|79020|P1|Completed Study Drug|Overall Study||204
34903|NCT01704755|79019|P2|STARTED|Overall Study||172
34904|NCT01704755|79020|P1|STARTED|Overall Study||208
34905|NCT01704651|79034|P2|NOT COMPLETED|Overall Study||7
34906|NCT01704651|79035|P1|NOT COMPLETED|Overall Study||5
34907|NCT01704651|79034|P2|COMPLETED|Overall Study||68
34908|NCT01704651|79035|P1|COMPLETED|Overall Study||66
34909|NCT01704651|79034|P2|STARTED|Overall Study||75
34910|NCT01704651|79035|P1|STARTED|Overall Study||71
34911|NCT01704599|79043|P1|NOT COMPLETED|Overall Study||1
34912|NCT01704599|79043|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
34913|NCT01704599|79043|P1|STARTED|Overall Study|Study was started January 22, 2010|8
34914|NCT01704521|79072|P2|NOT COMPLETED|Overall Study||0
34915|NCT01704521|79073|P1|NOT COMPLETED|Overall Study||0
34916|NCT01704521|79072|P2|COMPLETED|Overall Study||2
34917|NCT01704521|79073|P1|COMPLETED|Overall Study||3
34918|NCT01704521|79072|P2|STARTED|Overall Study||2
34919|NCT01704521|79073|P1|STARTED|Overall Study||3
34920|NCT01704495|79083|P4|NOT COMPLETED|Optional Safety Extension||31
34921|NCT01704495|79084|P3|NOT COMPLETED|Optional Safety Extension||31
34922|NCT01704495|79085|P2|NOT COMPLETED|Optional Safety Extension||33
34923|NCT01704495|79086|P1|NOT COMPLETED|Optional Safety Extension||29
34924|NCT01704495|79083|P4|COMPLETED|Optional Safety Extension||85
34925|NCT01704495|79084|P3|COMPLETED|Optional Safety Extension||83
34926|NCT01704495|79085|P2|COMPLETED|Optional Safety Extension||88
34927|NCT01704495|79086|P1|COMPLETED|Optional Safety Extension||87
34928|NCT01704495|79083|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
35018|NCT01703286|79454|P3|STARTED|Period 3 Including Washout||7
34929|NCT01704495|79084|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
34930|NCT01704495|79085|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
34931|NCT01704495|79086|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
34932|NCT01704495|79083|P4|NOT COMPLETED|Subjects Randomized||17
34933|NCT01704495|79084|P3|NOT COMPLETED|Subjects Randomized||16
34934|NCT01704495|79085|P2|NOT COMPLETED|Subjects Randomized||15
34935|NCT01704495|79086|P1|NOT COMPLETED|Subjects Randomized||22
34936|NCT01704495|79083|P4|COMPLETED|Subjects Randomized||145
34937|NCT01704495|79084|P3|COMPLETED|Subjects Randomized||144
34938|NCT01704495|79085|P2|COMPLETED|Subjects Randomized||141
34939|NCT01704495|79086|P1|COMPLETED|Subjects Randomized||140
34940|NCT01704495|79083|P4|STARTED|Subjects Randomized||162
34941|NCT01704495|79084|P3|STARTED|Subjects Randomized||160
34942|NCT01704495|79085|P2|STARTED|Subjects Randomized||156
34943|NCT01704495|79086|P1|STARTED|Subjects Randomized||162
34944|NCT01704261|79262|P2|NOT COMPLETED|Overall Study||15
34945|NCT01704261|79263|P1|NOT COMPLETED|Overall Study||13
34946|NCT01704261|79262|P2|COMPLETED|Overall Study||138
34947|NCT01704261|79263|P1|COMPLETED|Overall Study||141
34948|NCT01704261|79262|P2|STARTED|Overall Study||153
34949|NCT01704261|79263|P1|STARTED|Overall Study||154
34950|NCT01704079|79279|P2|NOT COMPLETED|Overall Study||23
34951|NCT01704079|79280|P1|NOT COMPLETED|Overall Study||14
34952|NCT01704079|79279|P2|COMPLETED|Overall Study||121
34953|NCT01704079|79280|P1|COMPLETED|Overall Study||58
34954|NCT01704079|79279|P2|Entered Extension Study|Overall Study||102
34955|NCT01704079|79280|P1|Entered Extension Study|Overall Study||53
34956|NCT01704079|79279|P2|STARTED|Overall Study||144
34957|NCT01704079|79280|P1|STARTED|Overall Study||72
34958|NCT01703858|79295|P3|NOT COMPLETED|Overall Study||0
34959|NCT01703858|79296|P2|NOT COMPLETED|Overall Study||1
34960|NCT01703858|79297|P1|NOT COMPLETED|Overall Study||0
34961|NCT01703858|79295|P3|COMPLETED|Overall Study||5
34962|NCT01703858|79296|P2|COMPLETED|Overall Study||4
34963|NCT01703858|79297|P1|COMPLETED|Overall Study||5
34964|NCT01703858|79295|P3|STARTED|Overall Study||5
34965|NCT01703858|79296|P2|STARTED|Overall Study||5
34966|NCT01703858|79297|P1|STARTED|Overall Study||5
34967|NCT01703845|79322|P2|NOT COMPLETED|Overall Study||0
34968|NCT01703845|79323|P1|NOT COMPLETED|Overall Study||3
34969|NCT01703845|79322|P2|COMPLETED|Overall Study||16
34970|NCT01703845|79323|P1|COMPLETED|Overall Study||13
34971|NCT01703845|79322|P2|STARTED|Overall Study|started are actually the randomized|16
34972|NCT01703845|79323|P1|STARTED|Overall Study|started are actually the randomized|16
34973|NCT01703832|79360|P2|NOT COMPLETED|Overall Study||0
34974|NCT01703832|79361|P1|NOT COMPLETED|Overall Study||1
34975|NCT01703832|79360|P2|COMPLETED|Overall Study||32
34976|NCT01703832|79361|P1|COMPLETED|Overall Study||32
34977|NCT01703832|79360|P2|STARTED|Overall Study||32
34978|NCT01703832|79361|P1|STARTED|Overall Study||33
34979|NCT01703819|79393|P2|NOT COMPLETED|Overall Study||2
34980|NCT01703819|79394|P1|NOT COMPLETED|Overall Study||0
34981|NCT01703819|79393|P2|COMPLETED|Overall Study||30
34982|NCT01703819|79394|P1|COMPLETED|Overall Study||34
34983|NCT01703819|79393|P2|STARTED|Overall Study||32
34984|NCT01703819|79394|P1|STARTED|Overall Study||34
34985|NCT01703702|79426|P2|NOT COMPLETED|Overall Study||22
34986|NCT01703702|79427|P1|NOT COMPLETED|Overall Study||36
34987|NCT01703702|79426|P2|COMPLETED|Overall Study||288
34988|NCT01703702|79427|P1|COMPLETED|Overall Study||272
34989|NCT01703702|79426|P2|STARTED|Overall Study||310
34990|NCT01703702|79427|P1|STARTED|Overall Study||308
34991|NCT01703663|79444|P2|NOT COMPLETED|Second Treatment Period||0
34992|NCT01703663|79445|P1|NOT COMPLETED|Second Treatment Period||0
34993|NCT01703663|79444|P2|COMPLETED|Second Treatment Period||8
34994|NCT01703663|79445|P1|COMPLETED|Second Treatment Period||11
34995|NCT01703663|79444|P2|STARTED|Second Treatment Period||8
34996|NCT01703663|79445|P1|STARTED|Second Treatment Period||11
34997|NCT01703663|79444|P2|NOT COMPLETED|First Treatment Period||0
34998|NCT01703663|79445|P1|NOT COMPLETED|First Treatment Period||0
34999|NCT01703663|79444|P2|COMPLETED|First Treatment Period||20
35000|NCT01703663|79445|P1|COMPLETED|First Treatment Period||20
35001|NCT01703663|79444|P2|STARTED|First Treatment Period||20
35002|NCT01703663|79445|P1|STARTED|First Treatment Period||20
35003|NCT01703286|79451|P6|NOT COMPLETED|Period 3 Including Washout||0
35004|NCT01703286|79452|P5|NOT COMPLETED|Period 3 Including Washout||0
35005|NCT01703286|79453|P4|NOT COMPLETED|Period 3 Including Washout||0
35006|NCT01703286|79454|P3|NOT COMPLETED|Period 3 Including Washout||0
35007|NCT01703286|79455|P2|NOT COMPLETED|Period 3 Including Washout||0
35008|NCT01703286|79456|P1|NOT COMPLETED|Period 3 Including Washout||0
35009|NCT01703286|79451|P6|COMPLETED|Period 3 Including Washout||6
35010|NCT01703286|79452|P5|COMPLETED|Period 3 Including Washout||7
35011|NCT01703286|79453|P4|COMPLETED|Period 3 Including Washout||5
35012|NCT01703286|79454|P3|COMPLETED|Period 3 Including Washout||7
35013|NCT01703286|79455|P2|COMPLETED|Period 3 Including Washout||7
35014|NCT01703286|79456|P1|COMPLETED|Period 3 Including Washout||7
35015|NCT01703286|79451|P6|STARTED|Period 3 Including Washout||6
35016|NCT01703286|79452|P5|STARTED|Period 3 Including Washout||7
35017|NCT01703286|79453|P4|STARTED|Period 3 Including Washout||5
35019|NCT01703286|79455|P2|STARTED|Period 3 Including Washout||7
35020|NCT01703286|79456|P1|STARTED|Period 3 Including Washout||7
35021|NCT01703286|79451|P6|NOT COMPLETED|Period 2 Including Washout||0
35022|NCT01703286|79452|P5|NOT COMPLETED|Period 2 Including Washout||0
35023|NCT01703286|79453|P4|NOT COMPLETED|Period 2 Including Washout||1
35024|NCT01703286|79454|P3|NOT COMPLETED|Period 2 Including Washout||0
35025|NCT01703286|79455|P2|NOT COMPLETED|Period 2 Including Washout||0
35026|NCT01703286|79456|P1|NOT COMPLETED|Period 2 Including Washout||0
35027|NCT01703286|79451|P6|COMPLETED|Period 2 Including Washout||6
35028|NCT01703286|79452|P5|COMPLETED|Period 2 Including Washout||7
35029|NCT01703286|79453|P4|COMPLETED|Period 2 Including Washout||5
35030|NCT01703286|79454|P3|COMPLETED|Period 2 Including Washout||7
35031|NCT01703286|79455|P2|COMPLETED|Period 2 Including Washout||7
35032|NCT01703286|79456|P1|COMPLETED|Period 2 Including Washout||7
35033|NCT01703286|79451|P6|STARTED|Period 2 Including Washout||6
35034|NCT01703286|79452|P5|STARTED|Period 2 Including Washout||7
35035|NCT01703286|79453|P4|STARTED|Period 2 Including Washout||6
35036|NCT01703286|79454|P3|STARTED|Period 2 Including Washout||7
35037|NCT01703286|79455|P2|STARTED|Period 2 Including Washout||7
35038|NCT01703286|79456|P1|STARTED|Period 2 Including Washout||7
35039|NCT01703286|79451|P6|NOT COMPLETED|Period 1 Including Washout||1
35040|NCT01703286|79452|P5|NOT COMPLETED|Period 1 Including Washout||0
35041|NCT01703286|79453|P4|NOT COMPLETED|Period 1 Including Washout||1
35042|NCT01703286|79454|P3|NOT COMPLETED|Period 1 Including Washout||0
35043|NCT01703286|79455|P2|NOT COMPLETED|Period 1 Including Washout||0
35044|NCT01703286|79456|P1|NOT COMPLETED|Period 1 Including Washout||0
35045|NCT01703286|79451|P6|COMPLETED|Period 1 Including Washout||6
35046|NCT01703286|79452|P5|COMPLETED|Period 1 Including Washout||7
35047|NCT01703286|79453|P4|COMPLETED|Period 1 Including Washout||6
35048|NCT01703286|79454|P3|COMPLETED|Period 1 Including Washout||7
35049|NCT01703286|79455|P2|COMPLETED|Period 1 Including Washout||7
35050|NCT01703286|79456|P1|COMPLETED|Period 1 Including Washout||7
35051|NCT01703286|79451|P6|STARTED|Period 1 Including Washout||7
35052|NCT01703286|79452|P5|STARTED|Period 1 Including Washout||7
35053|NCT01703286|79453|P4|STARTED|Period 1 Including Washout||7
35054|NCT01703286|79454|P3|STARTED|Period 1 Including Washout||7
35055|NCT01703286|79455|P2|STARTED|Period 1 Including Washout||7
35056|NCT01703286|79456|P1|STARTED|Period 1 Including Washout||7
35057|NCT01703260|79479|P3|NOT COMPLETED|Overall Study||3
35058|NCT01703260|79480|P2|NOT COMPLETED|Overall Study||4
35059|NCT01703260|79481|P1|NOT COMPLETED|Overall Study||3
35060|NCT01703260|79479|P3|COMPLETED|Overall Study||3
35061|NCT01703260|79480|P2|COMPLETED|Overall Study||3
35062|NCT01703260|79481|P1|COMPLETED|Overall Study||4
35063|NCT01703260|79479|P3|STARTED|Overall Study||6
35064|NCT01703260|79480|P2|STARTED|Overall Study||7
35065|NCT01703260|79481|P1|STARTED|Overall Study||7
35066|NCT01703221|79507|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
35067|NCT01703221|79508|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
35068|NCT01703221|79509|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
35069|NCT01703221|79507|P3|COMPLETED|Phase B - (Week 25 to 52)||75
35070|NCT01703221|79508|P2|COMPLETED|Phase B - (Week 25 to 52)||147
35071|NCT01703221|79509|P1|COMPLETED|Phase B - (Week 25 to 52)||143
35072|NCT01703221|79507|P3|STARTED|Phase B - (Week 25 to 52)||80
35073|NCT01703221|79508|P2|STARTED|Phase B - (Week 25 to 52)||161
35074|NCT01703221|79509|P1|STARTED|Phase B - (Week 25 to 52)||159
35075|NCT01703221|79507|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
35076|NCT01703221|79508|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
35077|NCT01703221|79509|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
35078|NCT01703221|79507|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
35079|NCT01703221|79508|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
35080|NCT01703221|79509|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
35081|NCT01703221|79507|P3|STARTED|Phase A (Up to 24 Weeks)||83
35082|NCT01703221|79508|P2|STARTED|Phase A (Up to 24 Weeks)||165
35083|NCT01703221|79509|P1|STARTED|Phase A (Up to 24 Weeks)||166
35084|NCT01703091|79540|P2|NOT COMPLETED|Overall Study||4
35085|NCT01703091|79541|P1|NOT COMPLETED|Overall Study||9
35086|NCT01703091|79540|P2|COMPLETED|Overall Study||95
35087|NCT01703091|79541|P1|COMPLETED|Overall Study||89
35088|NCT01703091|79540|P2|Received at Least One Dose of Study Drug|Overall Study||98
35089|NCT01703091|79541|P1|Received at Least One Dose of Study Drug|Overall Study||94
35090|NCT01703091|79540|P2|STARTED|Overall Study||99
35091|NCT01703091|79541|P1|STARTED|Overall Study||98
35092|NCT01703000|79557|P1|NOT COMPLETED|Overall Study||1
35093|NCT01703000|79557|P1|COMPLETED|Overall Study||99
35094|NCT01703000|79557|P1|STARTED|Overall Study||100
35095|NCT01702961|79588|P1|NOT COMPLETED|Overall Study||47
35096|NCT01702961|79588|P1|COMPLETED|Overall Study||28
35097|NCT01702961|79588|P1|STARTED|Overall Study||75
35098|NCT01702532|79596|P2|NOT COMPLETED|Overall Study||1
35099|NCT01702532|79597|P1|NOT COMPLETED|Overall Study||0
35100|NCT01702532|79596|P2|COMPLETED|Overall Study||160
35101|NCT01702532|79597|P1|COMPLETED|Overall Study||161
35102|NCT01702532|79596|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
35103|NCT01702532|79597|P1|Safety Population|Overall Study||161
35104|NCT01702532|79596|P2|STARTED|Overall Study||161
35105|NCT01702532|79597|P1|STARTED|Overall Study||161
35106|NCT01702519|79607|P2|NOT COMPLETED|Period 2||0
35107|NCT01702519|79608|P1|NOT COMPLETED|Period 2||0
35108|NCT01702519|79607|P2|COMPLETED|Period 2||18
35109|NCT01702519|79608|P1|COMPLETED|Period 2||19
35110|NCT01702519|79607|P2|STARTED|Period 2||18
35111|NCT01702519|79608|P1|STARTED|Period 2||19
35112|NCT01702519|79607|P2|NOT COMPLETED|Washout Period||2
35113|NCT01702519|79608|P1|NOT COMPLETED|Washout Period||1
35114|NCT01702519|79607|P2|COMPLETED|Washout Period||18
35115|NCT01702519|79608|P1|COMPLETED|Washout Period||19
35116|NCT01702519|79607|P2|STARTED|Washout Period||20
35117|NCT01702519|79608|P1|STARTED|Washout Period||20
35118|NCT01702519|79607|P2|NOT COMPLETED|Period 1||0
35119|NCT01702519|79608|P1|NOT COMPLETED|Period 1||0
35120|NCT01702519|79607|P2|COMPLETED|Period 1||20
35121|NCT01702519|79608|P1|COMPLETED|Period 1||20
35122|NCT01702519|79607|P2|STARTED|Period 1||20
35123|NCT01702519|79608|P1|STARTED|Period 1||20
35124|NCT01702454|79626|P2|NOT COMPLETED|Overall Study||8
35125|NCT01702454|79627|P1|NOT COMPLETED|Overall Study||3
35126|NCT01702454|79626|P2|COMPLETED|Overall Study||221
35127|NCT01702454|79627|P1|COMPLETED|Overall Study||238
35128|NCT01702454|79626|P2|STARTED|Overall Study||229
35129|NCT01702454|79627|P1|STARTED|Overall Study||241
35130|NCT01702363|79669|P1|NOT COMPLETED|Overall Study||20
35131|NCT01702363|79669|P1|COMPLETED|Overall Study||111
35132|NCT01702363|79669|P1|STARTED|Overall Study||131
35133|NCT01702311|79686|P2|NOT COMPLETED|Overall Study||13
35134|NCT01702311|79687|P1|NOT COMPLETED|Overall Study||16
35135|NCT01702311|79686|P2|COMPLETED|Overall Study||100
35136|NCT01702311|79687|P1|COMPLETED|Overall Study||106
35137|NCT01702311|79686|P2|STARTED|Overall Study||113
35138|NCT01702311|79687|P1|STARTED|Overall Study||122
35139|NCT01702298|79693|P1|NOT COMPLETED|Overall Study||1
35140|NCT01702298|79693|P1|COMPLETED|Overall Study||41
35141|NCT01702298|79693|P1|STARTED|Overall Study||42
35142|NCT01702259|79706|P2|NOT COMPLETED|Overall Study||0
35143|NCT01702259|79707|P1|NOT COMPLETED|Overall Study||0
35144|NCT01702259|79706|P2|COMPLETED|Overall Study||34
35145|NCT01702259|79707|P1|COMPLETED|Overall Study||34
35146|NCT01702259|79706|P2|STARTED|Overall Study||34
35147|NCT01702259|79707|P1|STARTED|Overall Study||34
35148|NCT01702246|79721|P1|NOT COMPLETED|Overall Study||5
35149|NCT01702246|79721|P1|COMPLETED|Overall Study||19
35150|NCT01702246|79721|P1|STARTED|Overall Study||24
35151|NCT01702233|79733|P3|NOT COMPLETED|Overall Study||5
35152|NCT01702233|79734|P2|NOT COMPLETED|Overall Study||3
35153|NCT01702233|79735|P1|NOT COMPLETED|Overall Study||6
35154|NCT01702233|79733|P3|COMPLETED|Overall Study||31
35155|NCT01702233|79734|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
35156|NCT01702233|79735|P1|COMPLETED|Overall Study||66
35157|NCT01702233|79733|P3|Per Protocol Set|Overall Study||27
35158|NCT01702233|79734|P2|Per Protocol Set|Overall Study||58
35159|NCT01702233|79735|P1|Per Protocol Set|Overall Study||58
35160|NCT01702233|79733|P3|Full Analysis Set (ITT)|Overall Study||31
35161|NCT01702233|79734|P2|Full Analysis Set (ITT)|Overall Study||63
35162|NCT01702233|79735|P1|Full Analysis Set (ITT)|Overall Study||66
35163|NCT01702233|79733|P3|STARTED|Overall Study||36
35164|NCT01702233|79734|P2|STARTED|Overall Study||67
35165|NCT01702233|79735|P1|STARTED|Overall Study||72
35166|NCT01702025|79775|P4|NOT COMPLETED|Overall Study||0
35167|NCT01702025|79776|P3|NOT COMPLETED|Overall Study||1
35168|NCT01702025|79777|P2|NOT COMPLETED|Overall Study||1
35169|NCT01702025|79778|P1|NOT COMPLETED|Overall Study||2
35170|NCT01702025|79775|P4|COMPLETED|Overall Study||10
35171|NCT01702025|79776|P3|COMPLETED|Overall Study||9
35172|NCT01702025|79777|P2|COMPLETED|Overall Study||9
35173|NCT01702025|79778|P1|COMPLETED|Overall Study||9
35174|NCT01702025|79775|P4|STARTED|Overall Study||10
35175|NCT01702025|79776|P3|STARTED|Overall Study||10
35176|NCT01702025|79777|P2|STARTED|Overall Study||10
35177|NCT01702025|79778|P1|STARTED|Overall Study||11
35178|NCT01701999|79794|P2|NOT COMPLETED|Overall Study||0
35179|NCT01701999|79795|P1|NOT COMPLETED|Overall Study||0
35180|NCT01701999|79794|P2|COMPLETED|Overall Study||37
35181|NCT01701999|79795|P1|COMPLETED|Overall Study||8
35182|NCT01701999|79794|P2|STARTED|Overall Study||37
35183|NCT01701999|79795|P1|STARTED|Overall Study||8
35184|NCT01701622|79807|P1|NOT COMPLETED|Overall Study||0
35185|NCT01701622|79807|P1|COMPLETED|Overall Study||1
35186|NCT01701622|79807|P1|STARTED|Overall Study||1
35187|NCT01701414|79814|P2|NOT COMPLETED|Overall Study||1
35188|NCT01701414|79815|P1|NOT COMPLETED|Overall Study||1
35189|NCT01701414|79814|P2|COMPLETED|Overall Study||18
35190|NCT01701414|79815|P1|COMPLETED|Overall Study||18
35191|NCT01701414|79814|P2|STARTED|Overall Study||19
35192|NCT01701414|79815|P1|STARTED|Overall Study||19
35193|NCT01701401|79825|P4|NOT COMPLETED|Overall Study||6
35194|NCT01701401|79826|P3|NOT COMPLETED|Overall Study||5
35195|NCT01701401|79827|P2|NOT COMPLETED|Overall Study||9
35196|NCT01701401|79828|P1|NOT COMPLETED|Overall Study||10
35197|NCT01701401|79825|P4|COMPLETED|Overall Study||212
35198|NCT01701401|79826|P3|COMPLETED|Overall Study||212
35199|NCT01701401|79827|P2|COMPLETED|Overall Study||209
35200|NCT01701401|79828|P1|COMPLETED|Overall Study||207
35201|NCT01701401|79825|P4|STARTED|Overall Study||218
35202|NCT01701401|79826|P3|STARTED|Overall Study||217
35203|NCT01701401|79827|P2|STARTED|Overall Study||218
35204|NCT01701401|79828|P1|STARTED|Overall Study||217
35205|NCT01701375|79874|P1|NOT COMPLETED|Overall Study||0
35206|NCT01701375|79874|P1|COMPLETED|Overall Study||2
35207|NCT01701375|79874|P1|STARTED|Overall Study||2
35208|NCT01701271|79878|P1|NOT COMPLETED|Overall Study||0
35209|NCT01701271|79878|P1|COMPLETED|Overall Study||20
35210|NCT01701271|79878|P1|STARTED|Overall Study||20
35211|NCT01701245|79886|P2|NOT COMPLETED|Overall Study||15
35212|NCT01701245|79887|P1|NOT COMPLETED|Overall Study||12
35213|NCT01701245|79886|P2|COMPLETED|Overall Study||33
35214|NCT01701245|79887|P1|COMPLETED|Overall Study||37
35215|NCT01701245|79886|P2|FAS Matched Data|Overall Study||32
35216|NCT01701245|79887|P1|FAS Matched Data|Overall Study||42
35217|NCT01701245|79886|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
35218|NCT01701245|79887|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
35219|NCT01701245|79886|P2|STARTED|Overall Study||48
35220|NCT01701245|79887|P1|STARTED|Overall Study||49
35221|NCT01701102|79903|P4|NOT COMPLETED|Overall Study||0
35222|NCT01701102|79904|P3|NOT COMPLETED|Overall Study||0
35223|NCT01701102|79905|P2|NOT COMPLETED|Overall Study||0
35224|NCT01701102|79906|P1|NOT COMPLETED|Overall Study||0
35225|NCT01701102|79903|P4|COMPLETED|Overall Study||18
35226|NCT01701102|79904|P3|COMPLETED|Overall Study||10
35227|NCT01701102|79905|P2|COMPLETED|Overall Study||6
35228|NCT01701102|79906|P1|COMPLETED|Overall Study||22
35229|NCT01701102|79903|P4|STARTED|Overall Study||18
35230|NCT01701102|79904|P3|STARTED|Overall Study||10
35231|NCT01701102|79905|P2|STARTED|Overall Study||6
35232|NCT01701102|79906|P1|STARTED|Overall Study||22
35233|NCT01701063|79919|P3|NOT COMPLETED|Overall Study||2
35234|NCT01701063|79920|P2|NOT COMPLETED|Overall Study||1
35235|NCT01701063|79921|P1|NOT COMPLETED|Overall Study||0
35236|NCT01701063|79919|P3|COMPLETED|Overall Study||8
35237|NCT01701063|79920|P2|COMPLETED|Overall Study||18
35238|NCT01701063|79921|P1|COMPLETED|Overall Study||13
35239|NCT01701063|79919|P3|STARTED|Overall Study||10
35240|NCT01701063|79920|P2|STARTED|Overall Study||19
35241|NCT01701063|79921|P1|STARTED|Overall Study||13
35242|NCT01701024|79965|P2|NOT COMPLETED|Overall Study||9
35243|NCT01701024|79966|P1|NOT COMPLETED|Overall Study||10
35244|NCT01701024|79965|P2|COMPLETED|Overall Study||236
35245|NCT01701024|79966|P1|COMPLETED|Overall Study||243
35246|NCT01701024|79965|P2|STARTED|Overall Study||245
35247|NCT01701024|79966|P1|STARTED|Overall Study||253
35248|NCT01701011|79981|P3|NOT COMPLETED|Overall Study||34
35249|NCT01701011|79982|P2|NOT COMPLETED|Overall Study||24
35250|NCT01701011|79983|P1|NOT COMPLETED|Overall Study||35
35251|NCT01701011|79981|P3|COMPLETED|Overall Study||90
35252|NCT01701011|79982|P2|COMPLETED|Overall Study||102
35253|NCT01701011|79983|P1|COMPLETED|Overall Study||92
35254|NCT01701011|79981|P3|STARTED|Overall Study||124
35255|NCT01701011|79982|P2|STARTED|Overall Study||126
35256|NCT01701011|79983|P1|STARTED|Overall Study||127
35257|NCT01700907|79996|P2|NOT COMPLETED|Overall Study||0
35258|NCT01700907|79997|P1|NOT COMPLETED|Overall Study||0
35259|NCT01700907|79996|P2|COMPLETED|Overall Study||10
35260|NCT01700907|79997|P1|COMPLETED|Overall Study||10
35261|NCT01700907|79996|P2|STARTED|Overall Study||10
35262|NCT01700907|79997|P1|STARTED|Overall Study||10
35263|NCT01700530|80014|P3|NOT COMPLETED|Overall Study||1
35264|NCT01700530|80015|P2|NOT COMPLETED|Overall Study||3
35265|NCT01700530|80016|P1|NOT COMPLETED|Overall Study||0
35266|NCT01700530|80014|P3|COMPLETED|Overall Study||19
35267|NCT01700530|80015|P2|COMPLETED|Overall Study||18
35268|NCT01700530|80016|P1|COMPLETED|Overall Study||9
35269|NCT01700530|80014|P3|STARTED|Overall Study||20
35270|NCT01700530|80015|P2|STARTED|Overall Study||21
35271|NCT01700530|80016|P1|STARTED|Overall Study||9
35272|NCT01700517|80030|P3|NOT COMPLETED|Overall Study||0
35273|NCT01700517|80031|P2|NOT COMPLETED|Overall Study||0
35274|NCT01700517|80032|P1|NOT COMPLETED|Overall Study||0
35275|NCT01700517|80030|P3|COMPLETED|Overall Study||40
35276|NCT01700517|80031|P2|COMPLETED|Overall Study||40
35277|NCT01700517|80032|P1|COMPLETED|Overall Study||40
35278|NCT01700517|80030|P3|STARTED|Overall Study||40
35279|NCT01700517|80031|P2|STARTED|Overall Study||40
35280|NCT01700517|80032|P1|STARTED|Overall Study||40
35281|NCT01700387|80042|P2|NOT COMPLETED|Overall Study||4
35282|NCT01700387|80043|P1|NOT COMPLETED|Overall Study||4
35283|NCT01700387|80042|P2|COMPLETED|Overall Study||6
35284|NCT01700387|80043|P1|COMPLETED|Overall Study||6
35285|NCT01700387|80042|P2|STARTED|Overall Study||10
35286|NCT01700387|80043|P1|STARTED|Overall Study||10
35287|NCT01700348|80053|P1|NOT COMPLETED|Overall Study||23
35288|NCT01700348|80053|P1|COMPLETED|Overall Study||93
35289|NCT01700348|80053|P1|STARTED|Overall Study||116
35290|NCT01700335|80057|P2|NOT COMPLETED|Overall Study||4
35291|NCT01700335|80058|P1|NOT COMPLETED|Overall Study||1
35292|NCT01700335|80057|P2|COMPLETED|Overall Study||2
35293|NCT01700335|80058|P1|COMPLETED|Overall Study||2
35294|NCT01700335|80057|P2|STARTED|Overall Study||6
35295|NCT01700335|80058|P1|STARTED|Overall Study||3
35296|NCT01700179|80069|P1|NOT COMPLETED|Overall Study||2
35297|NCT01700179|80069|P1|COMPLETED|Overall Study||6
35298|NCT01700179|80069|P1|STARTED|Overall Study||8
35299|NCT01700140|80076|P3|NOT COMPLETED|Overall Study||1
35300|NCT01700140|80077|P2|NOT COMPLETED|Overall Study||9
35301|NCT01700140|80078|P1|NOT COMPLETED|Overall Study||6
35302|NCT01700140|80076|P3|COMPLETED|Overall Study||61
35303|NCT01700140|80077|P2|COMPLETED|Overall Study||57
35304|NCT01700140|80078|P1|COMPLETED|Overall Study||55
35305|NCT01700140|80076|P3|STARTED|Overall Study||62
35306|NCT01700140|80077|P2|STARTED|Overall Study||66
35307|NCT01700140|80078|P1|STARTED|Overall Study||61
35308|NCT01699867|80110|P1|NOT COMPLETED|Overall Study||3
35309|NCT01699867|80110|P1|COMPLETED|Overall Study||47
35310|NCT01699867|80110|P1|STARTED|Overall Study||50
35311|NCT01699815|80117|P2|NOT COMPLETED|Overall Study||8
35312|NCT01699815|80118|P1|NOT COMPLETED|Overall Study||5
35313|NCT01699815|80117|P2|COMPLETED|Overall Study||56
35314|NCT01699815|80118|P1|COMPLETED|Overall Study||57
35315|NCT01699815|80117|P2|STARTED|Overall Study||64
35316|NCT01699815|80118|P1|STARTED|Overall Study||62
35317|NCT01699789|80130|P2|NOT COMPLETED|Overall Study||126
35318|NCT01699789|80131|P1|NOT COMPLETED|Overall Study||102
35319|NCT01699789|80130|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
35320|NCT01699789|80131|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
35321|NCT01699789|80130|P2|12-Month Follow-Up|Overall Study||369
35322|NCT01699789|80131|P1|12-Month Follow-Up|Overall Study||364
35323|NCT01699789|80130|P2|6-Month Follow-Up|Overall Study||379
35324|NCT01699789|80131|P1|6-Month Follow-Up|Overall Study||380
35325|NCT01699789|80130|P2|Baseline|Overall Study||488
35326|NCT01699789|80131|P1|Baseline|Overall Study||492
35327|NCT01699789|80130|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
35328|NCT01699789|80131|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
35329|NCT01699763|80193|P1|NOT COMPLETED|Overall Study||0
35330|NCT01699763|80193|P1|COMPLETED|Overall Study||112
35331|NCT01699763|80193|P1|STARTED|Overall Study||112
35332|NCT01699750|80201|P2|NOT COMPLETED|Overall Study||3
35333|NCT01699750|80202|P1|NOT COMPLETED|Overall Study||0
35334|NCT01699750|80201|P2|COMPLETED|Overall Study||33
35335|NCT01699750|80202|P1|COMPLETED|Overall Study||34
35336|NCT01699750|80201|P2|STARTED|Overall Study||36
35337|NCT01699750|80202|P1|STARTED|Overall Study||34
35338|NCT01699698|80226|P2|NOT COMPLETED|Overall Study||5
35339|NCT01699698|80227|P1|NOT COMPLETED|Overall Study||2
35340|NCT01699698|80226|P2|COMPLETED|Overall Study||56
35341|NCT01699698|80227|P1|COMPLETED|Overall Study||42
35342|NCT01699698|80226|P2|STARTED|Overall Study||61
35343|NCT01699698|80227|P1|STARTED|Overall Study||44
35344|NCT01699685|80237|P2|NOT COMPLETED|Period 2||0
35345|NCT01699685|80238|P1|NOT COMPLETED|Period 2||1
35346|NCT01699685|80237|P2|COMPLETED|Period 2||36
35347|NCT01699685|80238|P1|COMPLETED|Period 2||35
35348|NCT01699685|80237|P2|STARTED|Period 2||36
35349|NCT01699685|80238|P1|STARTED|Period 2||36
35350|NCT01699685|80237|P2|NOT COMPLETED|Period 1||3
35351|NCT01699685|80238|P1|NOT COMPLETED|Period 1||3
35352|NCT01699685|80237|P2|COMPLETED|Period 1||36
35353|NCT01699685|80238|P1|COMPLETED|Period 1||36
35354|NCT01699685|80237|P2|Full Analysis Population (FAS)|Period 1||38
35355|NCT01699685|80238|P1|Full Analysis Population (FAS)|Period 1||38
35356|NCT01699685|80237|P2|Safety Population|Period 1||38
35357|NCT01699685|80238|P1|Safety Population|Period 1||39
35358|NCT01699685|80237|P2|STARTED|Period 1||39
35359|NCT01699685|80238|P1|STARTED|Period 1||39
35360|NCT01699607|80256|P2|NOT COMPLETED|Overall Study||0
35361|NCT01699607|80257|P1|NOT COMPLETED|Overall Study||0
35362|NCT01699607|80256|P2|COMPLETED|Overall Study||4
35363|NCT01699607|80257|P1|COMPLETED|Overall Study||6
35364|NCT01699607|80256|P2|STARTED|Overall Study||4
35365|NCT01699607|80257|P1|STARTED|Overall Study||6
35366|NCT01699373|80264|P2|NOT COMPLETED|Overall Study||0
35367|NCT01699373|80265|P1|NOT COMPLETED|Overall Study||0
35368|NCT01699373|80264|P2|COMPLETED|Overall Study||85
35369|NCT01699373|80265|P1|COMPLETED|Overall Study||85
35370|NCT01699373|80264|P2|STARTED|Overall Study||85
35371|NCT01699373|80265|P1|STARTED|Overall Study||85
35372|NCT01699022|80271|P1|NOT COMPLETED|Overall Study||3
35373|NCT01699022|80271|P1|COMPLETED|Overall Study||14
35374|NCT01699022|80271|P1|STARTED|Overall Study||17
35375|NCT01698814|80286|P2|NOT COMPLETED|Overall Study||3
35376|NCT01698814|80287|P1|NOT COMPLETED|Overall Study||2
35377|NCT01698814|80286|P2|COMPLETED|Overall Study||166
35378|NCT01698814|80287|P1|COMPLETED|Overall Study||329
35379|NCT01698814|80286|P2|STARTED|Overall Study||169
35380|NCT01698814|80287|P1|STARTED|Overall Study||331
35381|NCT01698801|80293|P1|NOT COMPLETED|Follow Up Phase||5
35382|NCT01698801|80293|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
35383|NCT01698801|80293|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
35384|NCT01698801|80293|P1|NOT COMPLETED|Treatment Phase||11
35471|NCT01697592|80452|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
35385|NCT01698801|80293|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
35386|NCT01698801|80293|P1|STARTED|Treatment Phase||26
35387|NCT01698684|80305|P3|NOT COMPLETED|Overall Study||21
35388|NCT01698684|80306|P2|NOT COMPLETED|Overall Study||23
35389|NCT01698684|80307|P1|NOT COMPLETED|Overall Study||29
35390|NCT01698684|80305|P3|COMPLETED|Overall Study||127
35391|NCT01698684|80306|P2|COMPLETED|Overall Study||124
35392|NCT01698684|80307|P1|COMPLETED|Overall Study||116
35393|NCT01698684|80305|P3|Safety Population|Overall Study||146
35394|NCT01698684|80306|P2|Safety Population|Overall Study||146
35395|NCT01698684|80307|P1|Safety Population|Overall Study||143
35396|NCT01698684|80305|P3|ITT Population|Overall Study||139
35397|NCT01698684|80306|P2|ITT Population|Overall Study||139
35398|NCT01698684|80307|P1|ITT Population|Overall Study||136
35399|NCT01698684|80305|P3|STARTED|Overall Study||148
35400|NCT01698684|80306|P2|STARTED|Overall Study||147
35401|NCT01698684|80307|P1|STARTED|Overall Study||145
35402|NCT01698554|80319|P4|NOT COMPLETED|Overall Study||2
35403|NCT01698554|80320|P3|NOT COMPLETED|Overall Study||2
35404|NCT01698554|80321|P2|NOT COMPLETED|Overall Study||10
35405|NCT01698554|80322|P1|NOT COMPLETED|Overall Study||6
35406|NCT01698554|80319|P4|COMPLETED|Overall Study||77
35407|NCT01698554|80320|P3|COMPLETED|Overall Study||73
35408|NCT01698554|80321|P2|COMPLETED|Overall Study||147
35409|NCT01698554|80322|P1|COMPLETED|Overall Study||147
35410|NCT01698554|80319|P4|STARTED|Overall Study||79
35411|NCT01698554|80320|P3|STARTED|Overall Study||75
35412|NCT01698554|80321|P2|STARTED|Overall Study||157
35413|NCT01698554|80322|P1|STARTED|Overall Study||153
35414|NCT01698502|80350|P2|NOT COMPLETED|Overall Study||0
35415|NCT01698502|80351|P1|NOT COMPLETED|Overall Study||0
35416|NCT01698502|80350|P2|COMPLETED|Overall Study||10
35417|NCT01698502|80351|P1|COMPLETED|Overall Study||11
35418|NCT01698502|80350|P2|STARTED|Overall Study||10
35419|NCT01698502|80351|P1|STARTED|Overall Study||11
35420|NCT01698320|80361|P3|NOT COMPLETED|40-Week Open-Label Period||10
35421|NCT01698320|80362|P2|NOT COMPLETED|40-Week Open-Label Period||19
35422|NCT01698320|80363|P1|NOT COMPLETED|40-Week Open-Label Period||0
35423|NCT01698320|80361|P3|COMPLETED|40-Week Open-Label Period||146
35424|NCT01698320|80362|P2|COMPLETED|40-Week Open-Label Period||146
35425|NCT01698320|80363|P1|COMPLETED|40-Week Open-Label Period||0
35426|NCT01698320|80361|P3|STARTED|40-Week Open-Label Period||156
35427|NCT01698320|80362|P2|STARTED|40-Week Open-Label Period||165
35428|NCT01698320|80363|P1|STARTED|40-Week Open-Label Period||0
35429|NCT01698320|80361|P3|NOT COMPLETED|12-Week Double-Blind Period||12
35430|NCT01698320|80362|P2|NOT COMPLETED|12-Week Double-Blind Period||4
35431|NCT01698320|80363|P1|NOT COMPLETED|12-Week Double-Blind Period||0
35432|NCT01698320|80361|P3|COMPLETED|12-Week Double-Blind Period||156
35433|NCT01698320|80362|P2|COMPLETED|12-Week Double-Blind Period||165
35434|NCT01698320|80363|P1|COMPLETED|12-Week Double-Blind Period||0
35435|NCT01698320|80361|P3|Safety Population|12-Week Double-Blind Period||168
35436|NCT01698320|80362|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
35437|NCT01698320|80363|P1|Safety Population|12-Week Double-Blind Period||0
35438|NCT01698320|80361|P3|STARTED|12-Week Double-Blind Period||168
35439|NCT01698320|80362|P2|STARTED|12-Week Double-Blind Period||169
35440|NCT01698320|80363|P1|STARTED|12-Week Double-Blind Period||0
35441|NCT01698320|80361|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
35442|NCT01698320|80362|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
35443|NCT01698320|80363|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
35444|NCT01698320|80361|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
35445|NCT01698320|80362|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
35446|NCT01698320|80363|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
35447|NCT01698320|80361|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
35448|NCT01698320|80362|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
35449|NCT01698320|80363|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
35450|NCT01697969|80381|P1|NOT COMPLETED|Overall Study||3
35451|NCT01697969|80381|P1|COMPLETED|Overall Study||10
35452|NCT01697969|80381|P1|STARTED|Overall Study||13
35453|NCT01697956|80388|P2|NOT COMPLETED|Overall Study||1
35454|NCT01697956|80389|P1|NOT COMPLETED|Overall Study||1
35455|NCT01697956|80388|P2|COMPLETED|Overall Study||31
35456|NCT01697956|80389|P1|COMPLETED|Overall Study||66
35457|NCT01697956|80388|P2|Per Protocol Population|Overall Study||31
35458|NCT01697956|80389|P1|Per Protocol Population|Overall Study||66
35459|NCT01697956|80388|P2|STARTED|Overall Study|enrolled and randomized|32
35460|NCT01697956|80389|P1|STARTED|Overall Study|enrolled and randomized|67
35461|NCT01697696|80419|P2|NOT COMPLETED|Overall Study||47
35462|NCT01697696|80420|P1|NOT COMPLETED|Overall Study||47
35463|NCT01697696|80419|P2|COMPLETED|Overall Study||210
35464|NCT01697696|80420|P1|COMPLETED|Overall Study||207
35465|NCT01697696|80419|P2|Full Analysis Set (FAS)|Overall Study||255
35466|NCT01697696|80420|P1|Full Analysis Set (FAS)|Overall Study||251
35467|NCT01697696|80419|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
35468|NCT01697696|80420|P1|Safety Set|Overall Study||251
35469|NCT01697696|80419|P2|STARTED|Overall Study||257
35470|NCT01697696|80420|P1|STARTED|Overall Study||254
35472|NCT01697592|80453|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
35473|NCT01697592|80454|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
35474|NCT01697592|80455|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
35475|NCT01697592|80456|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
35476|NCT01697592|80457|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
35477|NCT01697592|80458|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
35478|NCT01697592|80459|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
35479|NCT01697592|80460|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
35480|NCT01697592|80461|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
35481|NCT01697592|80452|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
35482|NCT01697592|80453|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
35483|NCT01697592|80454|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
35484|NCT01697592|80455|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
35485|NCT01697592|80456|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
35486|NCT01697592|80457|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
35487|NCT01697592|80458|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
35488|NCT01697592|80459|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
35489|NCT01697592|80460|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
35490|NCT01697592|80461|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
35491|NCT01697592|80452|P10|STARTED|Phase B (Week 25 to Week 52)||30
35492|NCT01697592|80453|P9|STARTED|Phase B (Week 25 to Week 52)||34
35493|NCT01697592|80454|P8|STARTED|Phase B (Week 25 to Week 52)||33
35494|NCT01697592|80455|P7|STARTED|Phase B (Week 25 to Week 52)||32
35495|NCT01697592|80456|P6|STARTED|Phase B (Week 25 to Week 52)||62
35496|NCT01697592|80457|P5|STARTED|Phase B (Week 25 to Week 52)||67
35497|NCT01697592|80458|P4|STARTED|Phase B (Week 25 to Week 52)||63
35498|NCT01697592|80459|P3|STARTED|Phase B (Week 25 to Week 52)||65
35499|NCT01697592|80460|P2|STARTED|Phase B (Week 25 to Week 52)||62
35500|NCT01697592|80461|P1|STARTED|Phase B (Week 25 to Week 52)||123
35501|NCT01697592|80452|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
35502|NCT01697592|80453|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
35503|NCT01697592|80454|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
35504|NCT01697592|80455|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
35505|NCT01697592|80456|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
35506|NCT01697592|80457|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
35507|NCT01697592|80458|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
35508|NCT01697592|80459|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
35509|NCT01697592|80460|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
35510|NCT01697592|80461|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
35511|NCT01697592|80452|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
35512|NCT01697592|80453|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
35513|NCT01697592|80454|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
35514|NCT01697592|80455|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
35515|NCT01697592|80456|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
35516|NCT01697592|80457|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
35517|NCT01697592|80458|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
35518|NCT01697592|80459|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
35519|NCT01697592|80460|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
35520|NCT01697592|80461|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
35521|NCT01697592|80452|P10|STARTED|Phase A (Up to 24 Weeks)||32
35522|NCT01697592|80453|P9|STARTED|Phase A (Up to 24 Weeks)||34
35523|NCT01697592|80454|P8|STARTED|Phase A (Up to 24 Weeks)||33
35524|NCT01697592|80455|P7|STARTED|Phase A (Up to 24 Weeks)||34
35525|NCT01697592|80456|P6|STARTED|Phase A (Up to 24 Weeks)||63
35526|NCT01697592|80457|P5|STARTED|Phase A (Up to 24 Weeks)||67
35527|NCT01697592|80458|P4|STARTED|Phase A (Up to 24 Weeks)||65
35528|NCT01697592|80459|P3|STARTED|Phase A (Up to 24 Weeks)||66
35529|NCT01697592|80460|P2|STARTED|Phase A (Up to 24 Weeks)||65
35530|NCT01697592|80461|P1|STARTED|Phase A (Up to 24 Weeks)||126
35531|NCT01697501|80525|P1|NOT COMPLETED|Overall Study||2
35532|NCT01697501|80525|P1|COMPLETED|Overall Study||86
35533|NCT01697501|80525|P1|STARTED|Overall Study||88
35534|NCT01697462|80568|P1|NOT COMPLETED|Overall Study||77
35535|NCT01697462|80568|P1|COMPLETED|Overall Study||181
35536|NCT01697462|80568|P1|STARTED|Overall Study||258
35537|NCT01697449|80575|P1|NOT COMPLETED|Overall Study||90
35538|NCT01697449|80575|P1|COMPLETED|Overall Study||101
35539|NCT01697449|80575|P1|STARTED|Overall Study||191
35540|NCT01697345|80584|P1|NOT COMPLETED|Overall Study||1
35541|NCT01697345|80584|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
35542|NCT01697345|80584|P1|STARTED|Overall Study||13
35543|NCT01697319|80603|P1|NOT COMPLETED|Extension Phase||15
35544|NCT01697319|80603|P1|COMPLETED|Extension Phase||0
35545|NCT01697319|80603|P1|STARTED|Extension Phase||15
35546|NCT01697319|80603|P1|NOT COMPLETED|Primary Phase||1
35547|NCT01697319|80603|P1|COMPLETED|Primary Phase||15
35548|NCT01697319|80603|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
35549|NCT01696994|80612|P2|NOT COMPLETED|Overall Study||8437
35550|NCT01696994|80613|P1|NOT COMPLETED|Overall Study||5192
35551|NCT01696994|80612|P2|COMPLETED|Overall Study||30668
35552|NCT01696994|80613|P1|COMPLETED|Overall Study||33919
35553|NCT01696994|80612|P2|STARTED|Overall Study||39105
35554|NCT01696994|80613|P1|STARTED|Overall Study||39111
35555|NCT01696981|80641|P2|NOT COMPLETED|Overall Study||10374
35556|NCT01696981|80642|P1|NOT COMPLETED|Overall Study||1201
35557|NCT01696981|80641|P2|COMPLETED|Overall Study||67071
35558|NCT01696981|80642|P1|COMPLETED|Overall Study||76254
35559|NCT01696981|80641|P2|STARTED|Overall Study||77445
35560|NCT01696981|80642|P1|STARTED|Overall Study||77455
35561|NCT01696968|80662|P2|NOT COMPLETED|Overall Study||6812
35562|NCT01696968|80663|P1|NOT COMPLETED|Overall Study||1201
35563|NCT01696968|80662|P2|COMPLETED|Overall Study||70633
35564|NCT01696968|80663|P1|COMPLETED|Overall Study||76255
35565|NCT01696968|80662|P2|STARTED|Overall Study||77445
35566|NCT01696968|80663|P1|STARTED|Overall Study||77456
35567|NCT01696929|80683|P1|NOT COMPLETED|Overall Study||1
35568|NCT01696929|80683|P1|COMPLETED|Overall Study||5
35569|NCT01696929|80683|P1|STARTED|Overall Study||6
35570|NCT01696773|80690|P2|NOT COMPLETED|Day 28, Second Intervention||0
35571|NCT01696773|80691|P1|NOT COMPLETED|Day 28, Second Intervention||0
35572|NCT01696773|80690|P2|COMPLETED|Day 28, Second Intervention||6
35573|NCT01696773|80691|P1|COMPLETED|Day 28, Second Intervention||5
35574|NCT01696773|80690|P2|STARTED|Day 28, Second Intervention||6
35575|NCT01696773|80691|P1|STARTED|Day 28, Second Intervention||5
35576|NCT01696773|80690|P2|NOT COMPLETED|Days 15-27, Washout||0
35577|NCT01696773|80691|P1|NOT COMPLETED|Days 15-27, Washout||1
35578|NCT01696773|80690|P2|COMPLETED|Days 15-27, Washout||6
35579|NCT01696773|80691|P1|COMPLETED|Days 15-27, Washout||5
35580|NCT01696773|80690|P2|STARTED|Days 15-27, Washout||6
35581|NCT01696773|80691|P1|STARTED|Days 15-27, Washout||6
35582|NCT01696773|80690|P2|NOT COMPLETED|Day 14, First Intervention||0
35583|NCT01696773|80691|P1|NOT COMPLETED|Day 14, First Intervention||0
35584|NCT01696773|80690|P2|COMPLETED|Day 14, First Intervention||6
35585|NCT01696773|80691|P1|COMPLETED|Day 14, First Intervention||6
35586|NCT01696773|80690|P2|STARTED|Day 14, First Intervention||6
35587|NCT01696773|80691|P1|STARTED|Day 14, First Intervention||6
35588|NCT01696773|80690|P2|NOT COMPLETED|Days 1-13, Washout||0
35589|NCT01696773|80691|P1|NOT COMPLETED|Days 1-13, Washout||0
35590|NCT01696773|80690|P2|COMPLETED|Days 1-13, Washout||6
35591|NCT01696773|80691|P1|COMPLETED|Days 1-13, Washout||6
35592|NCT01696773|80690|P2|STARTED|Days 1-13, Washout||6
35593|NCT01696773|80691|P1|STARTED|Days 1-13, Washout||6
35594|NCT01696760|80699|P2|NOT COMPLETED|Overall Study||0
35595|NCT01696760|80700|P1|NOT COMPLETED|Overall Study||0
35596|NCT01696760|80699|P2|COMPLETED|Overall Study||3
35597|NCT01696760|80700|P1|COMPLETED|Overall Study||9
35598|NCT01696760|80699|P2|STARTED|Overall Study||3
35599|NCT01696760|80700|P1|STARTED|Overall Study||9
35600|NCT01696695|80718|P1|NOT COMPLETED|Overall Study||882
35601|NCT01696695|80718|P1|COMPLETED|Overall Study||0
35602|NCT01696695|80718|P1|STARTED|Overall Study||882
35603|NCT01696643|80730|P2|NOT COMPLETED|Overall Study||535
35604|NCT01696643|80731|P1|NOT COMPLETED|Overall Study||529
35605|NCT01696643|80730|P2|COMPLETED|Overall Study||169
35606|NCT01696643|80731|P1|COMPLETED|Overall Study||174
35607|NCT01696643|80730|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
35608|NCT01696643|80731|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
35609|NCT01696643|80730|P2|STARTED|Overall Study||704
35610|NCT01696643|80731|P1|STARTED|Overall Study||703
35611|NCT01696357|80748|P2|NOT COMPLETED|Overall Study||1
35612|NCT01696357|80749|P1|NOT COMPLETED|Overall Study||2
35613|NCT01696357|80748|P2|COMPLETED|Overall Study||41
35614|NCT01696357|80749|P1|COMPLETED|Overall Study||40
35615|NCT01696357|80748|P2|STARTED|Overall Study||42
35616|NCT01696357|80749|P1|STARTED|Overall Study||42
35617|NCT01696214|80759|P4|NOT COMPLETED|Overall Study||0
35618|NCT01696214|80760|P3|NOT COMPLETED|Overall Study||0
35619|NCT01696214|80761|P2|NOT COMPLETED|Overall Study||1
35620|NCT01696214|80762|P1|NOT COMPLETED|Overall Study||0
35621|NCT01696214|80759|P4|COMPLETED|Overall Study||5
35622|NCT01696214|80760|P3|COMPLETED|Overall Study||5
35623|NCT01696214|80761|P2|COMPLETED|Overall Study||4
35624|NCT01696214|80762|P1|COMPLETED|Overall Study||5
35625|NCT01696214|80759|P4|STARTED|Overall Study||5
35626|NCT01696214|80760|P3|STARTED|Overall Study||5
35627|NCT01696214|80761|P2|STARTED|Overall Study||5
35628|NCT01696214|80762|P1|STARTED|Overall Study||5
35629|NCT01696188|80774|P2|NOT COMPLETED|Overall Study||1
35630|NCT01696188|80775|P1|NOT COMPLETED|Overall Study||1
35631|NCT01696188|80774|P2|COMPLETED|Overall Study||42
35632|NCT01696188|80775|P1|COMPLETED|Overall Study||40
35633|NCT01696188|80774|P2|STARTED|Overall Study||43
35634|NCT01696188|80775|P1|STARTED|Overall Study||41
35635|NCT01696071|80787|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
35636|NCT01696071|80788|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
35637|NCT01696071|80787|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
35638|NCT01696071|80788|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
35639|NCT01696071|80787|P2|STARTED|Treatment Period 2: 4 Weeks||47
35640|NCT01696071|80788|P1|STARTED|Treatment Period 2: 4 Weeks||51
35641|NCT01696071|80787|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
35642|NCT01696071|80788|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
35643|NCT01696071|80787|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
35644|NCT01696071|80788|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
35645|NCT01696071|80787|P2|STARTED|Treatment Period 1: 4 Weeks||47
35646|NCT01696071|80788|P1|STARTED|Treatment Period 1: 4 Weeks||51
35647|NCT01696058|80816|P2|NOT COMPLETED|Overall Study||31
35648|NCT01696058|80817|P1|NOT COMPLETED|Overall Study||43
35649|NCT01696058|80816|P2|COMPLETED|Overall Study||538
35650|NCT01696058|80817|P1|COMPLETED|Overall Study||523
35651|NCT01696058|80816|P2|STARTED|Overall Study||569
35652|NCT01696058|80817|P1|STARTED|Overall Study||566
35653|NCT01695772|80843|P1|NOT COMPLETED|Overall Study||38
35654|NCT01695772|80843|P1|COMPLETED|Overall Study||12
35655|NCT01695772|80843|P1|STARTED|Overall Study||50
35656|NCT01695746|80855|P1|NOT COMPLETED|Overall Study||12
35657|NCT01695746|80855|P1|COMPLETED|Overall Study||96
35658|NCT01695746|80855|P1|STARTED|Overall Study||108
35659|NCT01695668|80871|P2|NOT COMPLETED|Overall Study||17
35660|NCT01695668|80872|P1|NOT COMPLETED|Overall Study||15
35661|NCT01695668|80871|P2|COMPLETED|Overall Study||20
35662|NCT01695668|80872|P1|COMPLETED|Overall Study||23
35663|NCT01695668|80871|P2|STARTED|Overall Study||37
35664|NCT01695668|80872|P1|STARTED|Overall Study||38
35665|NCT01695369|80878|P1|NOT COMPLETED|Overall Study||0
35666|NCT01695369|80878|P1|COMPLETED|Overall Study||61
35667|NCT01695369|80878|P1|STARTED|Overall Study||61
35668|NCT01695330|80884|P2|NOT COMPLETED|Overall Study||0
35669|NCT01695330|80885|P1|NOT COMPLETED|Overall Study||47
35670|NCT01695330|80884|P2|COMPLETED|Overall Study||0
35671|NCT01695330|80885|P1|COMPLETED|Overall Study||5
35672|NCT01695330|80884|P2|STARTED|Overall Study||0
35673|NCT01695330|80885|P1|STARTED|Overall Study||52
35674|NCT01695239|80893|P4|NOT COMPLETED|Overall Study||6
35675|NCT01695239|80894|P3|NOT COMPLETED|Overall Study||10
35676|NCT01695239|80895|P2|NOT COMPLETED|Overall Study||4
35677|NCT01695239|80896|P1|NOT COMPLETED|Overall Study||15
35678|NCT01695239|80893|P4|COMPLETED|Overall Study||97
35679|NCT01695239|80894|P3|COMPLETED|Overall Study||97
35680|NCT01695239|80895|P2|COMPLETED|Overall Study||97
35681|NCT01695239|80896|P1|COMPLETED|Overall Study||91
35682|NCT01695239|80893|P4|Classified as Inadequate Responder (IR)|Overall Study||10
35683|NCT01695239|80894|P3|Classified as Inadequate Responder (IR)|Overall Study||11
35684|NCT01695239|80895|P2|Classified as Inadequate Responder (IR)|Overall Study||9
35685|NCT01695239|80896|P1|Classified as Inadequate Responder (IR)|Overall Study||27
35686|NCT01695239|80893|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
35687|NCT01695239|80894|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
35688|NCT01695239|80895|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
35689|NCT01695239|80896|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
35690|NCT01695239|80893|P4|STARTED|Overall Study||103
35691|NCT01695239|80894|P3|STARTED|Overall Study||107
35692|NCT01695239|80895|P2|STARTED|Overall Study||101
35693|NCT01695239|80896|P1|STARTED|Overall Study||106
35694|NCT01694771|80987|P2|NOT COMPLETED|Overall Study||40
35695|NCT01694771|80988|P1|NOT COMPLETED|Overall Study||40
35696|NCT01694771|80987|P2|COMPLETED|Overall Study||525
35697|NCT01694771|80988|P1|COMPLETED|Overall Study||527
35698|NCT01694771|80987|P2|STARTED|Overall Study||565
35699|NCT01694771|80988|P1|STARTED|Overall Study||567
35700|NCT01694706|81012|P3|NOT COMPLETED|Overall Study||0
35701|NCT01694706|81013|P2|NOT COMPLETED|Overall Study||1
35702|NCT01694706|81014|P1|NOT COMPLETED|Overall Study||1
35703|NCT01694706|81012|P3|COMPLETED|Overall Study||5
35704|NCT01694706|81013|P2|COMPLETED|Overall Study||4
35705|NCT01694706|81014|P1|COMPLETED|Overall Study||4
35706|NCT01694706|81012|P3|Received Faldaprevir Fed|Overall Study||5
35707|NCT01694706|81013|P2|Received Faldaprevir Fed|Overall Study||5
35708|NCT01694706|81014|P1|Received Faldaprevir Fed|Overall Study||4
35709|NCT01694706|81012|P3|Received Faldaprevir +OMP|Overall Study||5
35710|NCT01694706|81013|P2|Received Faldaprevir +OMP|Overall Study||5
35711|NCT01694706|81014|P1|Received Faldaprevir +OMP|Overall Study||5
35712|NCT01694706|81012|P3|Received Faldaprevir|Overall Study||5
35713|NCT01694706|81013|P2|Received Faldaprevir|Overall Study||5
35714|NCT01694706|81014|P1|Received Faldaprevir|Overall Study||5
35715|NCT01694706|81012|P3|STARTED|Overall Study||5
35716|NCT01694706|81013|P2|STARTED|Overall Study||5
35717|NCT01694706|81014|P1|STARTED|Overall Study||5
35718|NCT01694667|81031|P2|NOT COMPLETED|Overall Study||0
35719|NCT01694667|81032|P1|NOT COMPLETED|Overall Study||0
35720|NCT01694667|81031|P2|COMPLETED|Overall Study||28
35721|NCT01694667|81032|P1|COMPLETED|Overall Study||29
35722|NCT01694667|81031|P2|STARTED|Overall Study||28
35723|NCT01694667|81032|P1|STARTED|Overall Study||29
35724|NCT01694641|81050|P2|NOT COMPLETED|Overall Study||10
35725|NCT01694641|81051|P1|NOT COMPLETED|Overall Study||12
35726|NCT01694641|81050|P2|COMPLETED|Overall Study||71
35727|NCT01694641|81051|P1|COMPLETED|Overall Study||68
35728|NCT01694641|81050|P2|STARTED|Overall Study||81
35729|NCT01694641|81051|P1|STARTED|Overall Study||80
35730|NCT01694420|81057|P1|NOT COMPLETED|Overall Study||3
35731|NCT01694420|81057|P1|COMPLETED|Overall Study||30
35732|NCT01694420|81057|P1|STARTED|Overall Study||33
35733|NCT01694108|81068|P2|NOT COMPLETED|Overall Study||0
35734|NCT01694108|81069|P1|NOT COMPLETED|Overall Study||0
35735|NCT01694108|81068|P2|COMPLETED|Overall Study|100% follow-up|2133
35736|NCT01694108|81069|P1|COMPLETED|Overall Study|100% follow-up|2129
35737|NCT01694108|81068|P2|STARTED|Overall Study||2133
35738|NCT01694108|81069|P1|STARTED|Overall Study||2129
35739|NCT01693653|81125|P2|NOT COMPLETED|Overall Study||0
35740|NCT01693653|81126|P1|NOT COMPLETED|Overall Study||0
35741|NCT01693653|81125|P2|COMPLETED|Overall Study||0
35742|NCT01693653|81126|P1|COMPLETED|Overall Study||1
35743|NCT01693653|81125|P2|STARTED|Overall Study||0
35744|NCT01693653|81126|P1|STARTED|Overall Study||1
35745|NCT01693367|81134|P2|NOT COMPLETED|Overall Study||2
35746|NCT01693367|81135|P1|NOT COMPLETED|Overall Study||1
35747|NCT01693367|81134|P2|COMPLETED|Overall Study||1
35748|NCT01693367|81135|P1|COMPLETED|Overall Study||1
35749|NCT01693367|81134|P2|STARTED|Overall Study||3
35750|NCT01693367|81135|P1|STARTED|Overall Study||2
35751|NCT01693185|81153|P2|NOT COMPLETED|Overall Study||6
35752|NCT01693185|81154|P1|NOT COMPLETED|Overall Study||0
35753|NCT01693185|81153|P2|COMPLETED|Overall Study||27
35754|NCT01693185|81154|P1|COMPLETED|Overall Study||27
35755|NCT01693185|81153|P2|STARTED|Overall Study||33
35756|NCT01693185|81154|P1|STARTED|Overall Study||27
35757|NCT01692938|81172|P2|NOT COMPLETED|Overall Study||4
35758|NCT01692938|81173|P1|NOT COMPLETED|Overall Study||4
35759|NCT01692938|81172|P2|COMPLETED|Overall Study||12
35760|NCT01692938|81173|P1|COMPLETED|Overall Study||12
35761|NCT01692938|81172|P2|STARTED|Overall Study||16
35762|NCT01692938|81173|P1|STARTED|Overall Study||16
35763|NCT01692782|81184|P3|NOT COMPLETED|Overall Study||10
35764|NCT01692782|81185|P2|NOT COMPLETED|Overall Study||56
35765|NCT01692782|81186|P1|NOT COMPLETED|Overall Study||20
35766|NCT01692782|81184|P3|COMPLETED|Overall Study||100
35767|NCT01692782|81185|P2|COMPLETED|Overall Study||59
35768|NCT01692782|81186|P1|COMPLETED|Overall Study||96
35769|NCT01692782|81184|P3|STARTED|Overall Study||110
35770|NCT01692782|81185|P2|STARTED|Overall Study||115
35771|NCT01692782|81186|P1|STARTED|Overall Study||116
35772|NCT01692691|81209|P1|NOT COMPLETED|Overall Study||0
35773|NCT01692691|81209|P1|COMPLETED|Overall Study||1
35774|NCT01692691|81209|P1|STARTED|Overall Study||1
35775|NCT01692340|81217|P3|NOT COMPLETED|Overall Study||0
35776|NCT01692340|81218|P2|NOT COMPLETED|Overall Study||0
35777|NCT01692340|81219|P1|NOT COMPLETED|Overall Study||0
35778|NCT01692340|81217|P3|COMPLETED|Overall Study||0
35779|NCT01692340|81218|P2|COMPLETED|Overall Study||4
35780|NCT01692340|81219|P1|COMPLETED|Overall Study||8
35781|NCT01692340|81217|P3|STARTED|Overall Study||0
35782|NCT01692340|81218|P2|STARTED|Overall Study||4
35783|NCT01692340|81219|P1|STARTED|Overall Study||8
35784|NCT01692301|81238|P2|NOT COMPLETED|Overall Study||42
35785|NCT01692301|81239|P1|NOT COMPLETED|Overall Study||45
35786|NCT01692301|81238|P2|COMPLETED|Overall Study||183
35787|NCT01692301|81239|P1|COMPLETED|Overall Study||184
35788|NCT01692301|81238|P2|STARTED|Overall Study||225
35789|NCT01692301|81239|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
35790|NCT01691885|81265|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
35791|NCT01691885|81266|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
35792|NCT01691885|81265|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
35793|NCT01691885|81266|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
35794|NCT01691885|81265|P2|STARTED|Treatment Period 2 (7-14 Days)||21
35795|NCT01691885|81266|P1|STARTED|Treatment Period 2 (7-14 Days)||21
35796|NCT01691885|81265|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
35797|NCT01691885|81266|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
35798|NCT01691885|81265|P2|COMPLETED|Washout Period (7-9 Days)||21
35799|NCT01691885|81266|P1|COMPLETED|Washout Period (7-9 Days)||21
35800|NCT01691885|81265|P2|STARTED|Washout Period (7-9 Days)||22
35801|NCT01691885|81266|P1|STARTED|Washout Period (7-9 Days)||21
35802|NCT01691885|81265|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
35803|NCT01691885|81266|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
35804|NCT01691885|81265|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
35805|NCT01691885|81266|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
35806|NCT01691885|81265|P2|STARTED|Treatment Period 1(7-14 Days)||23
35807|NCT01691885|81266|P1|STARTED|Treatment Period 1(7-14 Days)||22
35808|NCT01691794|81275|P3|NOT COMPLETED|Overall Study||3
35809|NCT01691794|81276|P2|NOT COMPLETED|Overall Study||3
35810|NCT01691794|81277|P1|NOT COMPLETED|Overall Study||0
35811|NCT01691794|81275|P3|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|20
35812|NCT01691794|81276|P2|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|30
35813|NCT01691794|81277|P1|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|3
35814|NCT01691794|81275|P3|STARTED|Overall Study||23
35815|NCT01691794|81276|P2|STARTED|Overall Study||33
35816|NCT01691794|81277|P1|STARTED|Overall Study||3
35817|NCT01690546|81291|P1|NOT COMPLETED|Overall Study||9
35818|NCT01690546|81291|P1|COMPLETED|Overall Study||26
35819|NCT01690546|81291|P1|Extended Release Injectable NTX|Overall Study||27
35820|NCT01690546|81291|P1|STARTED|Overall Study||35
35821|NCT01691560|81308|P4|NOT COMPLETED|Overall Study||0
35822|NCT01691560|81309|P3|NOT COMPLETED|Overall Study||0
35823|NCT01691560|81310|P2|NOT COMPLETED|Overall Study||0
35824|NCT01691560|81311|P1|NOT COMPLETED|Overall Study||0
35825|NCT01691560|81308|P4|COMPLETED|Overall Study||33
35826|NCT01691560|81309|P3|COMPLETED|Overall Study||34
35827|NCT01691560|81310|P2|COMPLETED|Overall Study||33
35828|NCT01691560|81311|P1|COMPLETED|Overall Study||34
35829|NCT01691560|81308|P4|STARTED|Overall Study||33
35830|NCT01691560|81309|P3|STARTED|Overall Study||34
35831|NCT01691560|81310|P2|STARTED|Overall Study||33
35832|NCT01691560|81311|P1|STARTED|Overall Study||34
35833|NCT01691534|81348|P7|NOT COMPLETED|Overall Study||1
35834|NCT01691534|81349|P6|NOT COMPLETED|Overall Study||1
35835|NCT01691534|81350|P5|NOT COMPLETED|Overall Study||0
35836|NCT01691534|81351|P4|NOT COMPLETED|Overall Study||1
35837|NCT01691534|81352|P3|NOT COMPLETED|Overall Study||1
35838|NCT01691534|81353|P2|NOT COMPLETED|Overall Study||1
35839|NCT01691534|81354|P1|NOT COMPLETED|Overall Study||0
35840|NCT01691534|81348|P7|COMPLETED|Overall Study||14
35841|NCT01691534|81349|P6|COMPLETED|Overall Study||14
35842|NCT01691534|81350|P5|COMPLETED|Overall Study||15
35843|NCT01691534|81351|P4|COMPLETED|Overall Study||14
35844|NCT01691534|81352|P3|COMPLETED|Overall Study||14
35845|NCT01691534|81353|P2|COMPLETED|Overall Study||14
35846|NCT01691534|81354|P1|COMPLETED|Overall Study||15
35847|NCT01691534|81348|P7|STARTED|Overall Study||15
35848|NCT01691534|81349|P6|STARTED|Overall Study||15
35849|NCT01691534|81350|P5|STARTED|Overall Study||15
35850|NCT01691534|81351|P4|STARTED|Overall Study||15
35851|NCT01691534|81352|P3|STARTED|Overall Study||15
35852|NCT01691534|81353|P2|STARTED|Overall Study||15
35853|NCT01691534|81354|P1|STARTED|Overall Study||15
35854|NCT01691521|81408|P3|NOT COMPLETED|Overall Study||9
35855|NCT01691521|81409|P2|NOT COMPLETED|Overall Study||16
35856|NCT01691521|81410|P1|NOT COMPLETED|Overall Study||12
35857|NCT01691521|81408|P3|COMPLETED|Overall Study||185
35858|NCT01691521|81409|P2|COMPLETED|Overall Study||175
35859|NCT01691521|81410|P1|COMPLETED|Overall Study||179
35860|NCT01691521|81408|P3|STARTED|Overall Study||194
35861|NCT01691521|81409|P2|STARTED|Overall Study||191
35862|NCT01691521|81410|P1|STARTED|Overall Study||191
35863|NCT01691508|81432|P2|NOT COMPLETED|Overall Study||3
35864|NCT01691508|81433|P1|NOT COMPLETED|Overall Study||4
35865|NCT01691508|81432|P2|COMPLETED|Overall Study||66
35866|NCT01691508|81433|P1|COMPLETED|Overall Study||62
35867|NCT01691508|81432|P2|STARTED|Overall Study||69
35868|NCT01691508|81433|P1|STARTED|Overall Study||66
35869|NCT01691482|81447|P2|NOT COMPLETED|Treatment Period 2||2
35870|NCT01691482|81448|P1|NOT COMPLETED|Treatment Period 2||1
35871|NCT01691482|81447|P2|COMPLETED|Treatment Period 2||26
35872|NCT01691482|81448|P1|COMPLETED|Treatment Period 2||27
35873|NCT01691482|81447|P2|STARTED|Treatment Period 2||28
35874|NCT01691482|81448|P1|STARTED|Treatment Period 2||28
35875|NCT01691482|81447|P2|NOT COMPLETED|Treatment Period 1||0
35876|NCT01691482|81448|P1|NOT COMPLETED|Treatment Period 1||0
35877|NCT01691482|81447|P2|COMPLETED|Treatment Period 1||28
35878|NCT01691482|81448|P1|COMPLETED|Treatment Period 1||28
35879|NCT01691482|81447|P2|STARTED|Treatment Period 1||28
35880|NCT01691482|81448|P1|STARTED|Treatment Period 1||28
35881|NCT01691339|81468|P4|NOT COMPLETED|Overall Study||0
35882|NCT01691339|81469|P3|NOT COMPLETED|Overall Study||0
35883|NCT01691339|81470|P2|NOT COMPLETED|Overall Study||0
35884|NCT01691339|81471|P1|NOT COMPLETED|Overall Study||0
35885|NCT01691339|81468|P4|COMPLETED|Overall Study||49
35886|NCT01691339|81469|P3|COMPLETED|Overall Study||51
35887|NCT01691339|81470|P2|COMPLETED|Overall Study||50
35888|NCT01691339|81471|P1|COMPLETED|Overall Study||50
35889|NCT01691339|81468|P4|STARTED|Overall Study||49
35890|NCT01691339|81469|P3|STARTED|Overall Study||51
35891|NCT01691339|81470|P2|STARTED|Overall Study||50
35892|NCT01691339|81471|P1|STARTED|Overall Study||50
35893|NCT01691326|81499|P2|NOT COMPLETED|Overall Study||0
35894|NCT01691326|81500|P1|NOT COMPLETED|Overall Study||0
35895|NCT01691326|81499|P2|COMPLETED|Overall Study||30
35896|NCT01691326|81500|P1|COMPLETED|Overall Study||30
35897|NCT01691326|81499|P2|STARTED|Overall Study||30
35898|NCT01691326|81500|P1|STARTED|Overall Study||30
35899|NCT01691313|81518|P4|NOT COMPLETED|Overall Study||0
35900|NCT01691313|81519|P3|NOT COMPLETED|Overall Study||0
35901|NCT01691313|81520|P2|NOT COMPLETED|Overall Study||0
35902|NCT01691313|81521|P1|NOT COMPLETED|Overall Study||0
35903|NCT01691313|81518|P4|COMPLETED|Overall Study||25
35904|NCT01691313|81519|P3|COMPLETED|Overall Study||25
35905|NCT01691313|81520|P2|COMPLETED|Overall Study||32
35906|NCT01691313|81521|P1|COMPLETED|Overall Study||22
35907|NCT01691313|81518|P4|STARTED|Overall Study||25
35908|NCT01691313|81519|P3|STARTED|Overall Study||25
35909|NCT01691313|81520|P2|STARTED|Overall Study||32
35910|NCT01691313|81521|P1|STARTED|Overall Study||22
35911|NCT01691248|81537|P2|NOT COMPLETED|Overall Study||114
35912|NCT01691248|81538|P1|NOT COMPLETED|Overall Study||111
35913|NCT01691248|81537|P2|COMPLETED|Overall Study||192
35914|NCT01691248|81538|P1|COMPLETED|Overall Study||194
35915|NCT01691248|81537|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
35916|NCT01691248|81538|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
35917|NCT01691248|81537|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
35918|NCT01691248|81538|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
35919|NCT01691248|81537|P2|STARTED|Overall Study|Randomized|306
35920|NCT01691248|81538|P1|STARTED|Overall Study|Randomized|305
35921|NCT01691014|81552|P4|NOT COMPLETED|Overall Study||5
35922|NCT01691014|81553|P3|NOT COMPLETED|Overall Study||11
35923|NCT01691014|81554|P2|NOT COMPLETED|Overall Study||15
35924|NCT01691014|81555|P1|NOT COMPLETED|Overall Study||3
35925|NCT01691014|81552|P4|COMPLETED|Overall Study||4
35926|NCT01691014|81553|P3|COMPLETED|Overall Study||25
35927|NCT01691014|81554|P2|COMPLETED|Overall Study||11
35928|NCT01691014|81555|P1|COMPLETED|Overall Study||5
35929|NCT01691014|81552|P4|STARTED|Overall Study||9
35930|NCT01691014|81553|P3|STARTED|Overall Study||36
35931|NCT01691014|81554|P2|STARTED|Overall Study||26
35932|NCT01691014|81555|P1|STARTED|Overall Study||8
35933|NCT01690923|81597|P2|NOT COMPLETED|Overall Study||1
35934|NCT01690923|81598|P1|NOT COMPLETED|Overall Study||0
35935|NCT01690923|81597|P2|COMPLETED|Overall Study||10
35936|NCT01690923|81598|P1|COMPLETED|Overall Study||10
35937|NCT01690923|81597|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
35938|NCT01690923|81598|P1|STARTED|Overall Study||10
35939|NCT01690299|81606|P3|NOT COMPLETED|Overall Study||2
35940|NCT01690299|81607|P2|NOT COMPLETED|Overall Study||6
35941|NCT01690299|81608|P1|NOT COMPLETED|Overall Study||9
35942|NCT01690299|81606|P3|COMPLETED|Overall Study||81
35943|NCT01690299|81607|P2|COMPLETED|Overall Study||77
35944|NCT01690299|81608|P1|COMPLETED|Overall Study||75
35945|NCT01690299|81606|P3|STARTED|Overall Study||83
35946|NCT01690299|81607|P2|STARTED|Overall Study||83
35947|NCT01690299|81608|P1|STARTED|Overall Study||84
35948|NCT01690273|81624|P3|NOT COMPLETED|Overall Study||0
35949|NCT01690273|81625|P2|NOT COMPLETED|Overall Study||0
35950|NCT01690273|81626|P1|NOT COMPLETED|Overall Study||0
35951|NCT01690273|81624|P3|COMPLETED|Overall Study||20
35952|NCT01690273|81625|P2|COMPLETED|Overall Study||17
35953|NCT01690273|81626|P1|COMPLETED|Overall Study||18
35954|NCT01690273|81624|P3|STARTED|Overall Study||20
35955|NCT01690273|81625|P2|STARTED|Overall Study||17
35956|NCT01690273|81626|P1|STARTED|Overall Study||18
35957|NCT01690117|81678|P2|NOT COMPLETED|Overall Study||14
35958|NCT01690117|81679|P1|NOT COMPLETED|Overall Study||16
35959|NCT01690117|81678|P2|COMPLETED|Overall Study||31
35960|NCT01690117|81679|P1|COMPLETED|Overall Study||31
35961|NCT01690117|81678|P2|Post-Measurement|Overall Study||40
35962|NCT01690117|81679|P1|Post-Measurement|Overall Study||41
35963|NCT01690117|81678|P2|STARTED|Overall Study||45
35964|NCT01690117|81679|P1|STARTED|Overall Study||47
35965|NCT01690052|81715|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
35966|NCT01690052|81716|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
35967|NCT01690052|81715|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
35968|NCT01690052|81716|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
35969|NCT01690052|81715|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
35970|NCT01690052|81716|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
35971|NCT01690052|81715|P2|NOT COMPLETED|Washout Period of 1 Week||0
35972|NCT01690052|81716|P1|NOT COMPLETED|Washout Period of 1 Week||0
35973|NCT01690052|81715|P2|COMPLETED|Washout Period of 1 Week||6
35974|NCT01690052|81716|P1|COMPLETED|Washout Period of 1 Week||6
35975|NCT01690052|81715|P2|STARTED|Washout Period of 1 Week||6
35976|NCT01690052|81716|P1|STARTED|Washout Period of 1 Week||6
35977|NCT01690052|81715|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
35978|NCT01690052|81716|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
35979|NCT01690052|81715|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
35980|NCT01690052|81716|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
35981|NCT01690052|81715|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
35982|NCT01690052|81716|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
35983|NCT01690000|81724|P2|NOT COMPLETED|Overall Study||6
35984|NCT01690000|81725|P1|NOT COMPLETED|Overall Study||3
35985|NCT01690000|81724|P2|COMPLETED|Overall Study||35
35986|NCT01690000|81725|P1|COMPLETED|Overall Study||37
35987|NCT01690000|81724|P2|STARTED|Overall Study||41
35988|NCT01690000|81725|P1|STARTED|Overall Study||40
35989|NCT01689857|81733|P2|NOT COMPLETED|Overall Study||2
35990|NCT01689857|81734|P1|NOT COMPLETED|Overall Study||5
35991|NCT01689857|81733|P2|COMPLETED|Overall Study||18
35992|NCT01689857|81734|P1|COMPLETED|Overall Study||15
35993|NCT01689857|81733|P2|STARTED|Overall Study||20
35994|NCT01689857|81734|P1|STARTED|Overall Study||20
35995|NCT01689649|81740|P1|NOT COMPLETED|Overall Study||22
35996|NCT01689649|81740|P1|COMPLETED|Overall Study||117
35997|NCT01689649|81740|P1|STARTED|Overall Study||139
35998|NCT01689532|81752|P2|NOT COMPLETED|Overall Study||9
35999|NCT01689532|81753|P1|NOT COMPLETED|Overall Study||14
36000|NCT01689532|81752|P2|COMPLETED|Overall Study||52
36001|NCT01689532|81753|P1|COMPLETED|Overall Study||47
36002|NCT01689532|81752|P2|STARTED|Overall Study||61
36003|NCT01689532|81753|P1|STARTED|Overall Study||61
36004|NCT01689519|81817|P2|NOT COMPLETED|Overall Study||138
36005|NCT01689519|81818|P1|NOT COMPLETED|Overall Study||166
36006|NCT01689519|81817|P2|COMPLETED|Overall Study||109
36007|NCT01689519|81818|P1|COMPLETED|Overall Study||82
36008|NCT01689519|81817|P2|Received Treatment|Overall Study||246
36009|NCT01689519|81818|P1|Received Treatment|Overall Study||247
36010|NCT01689519|81817|P2|STARTED|Overall Study||247
36011|NCT01689519|81818|P1|STARTED|Overall Study||248
36012|NCT01689441|81834|P2|NOT COMPLETED|Overall Study||0
36013|NCT01689441|81835|P1|NOT COMPLETED|Overall Study||0
36014|NCT01689441|81834|P2|COMPLETED|Overall Study||31
36015|NCT01689441|81835|P1|COMPLETED|Overall Study||36
36016|NCT01689441|81834|P2|STARTED|Overall Study||31
36017|NCT01689441|81835|P1|STARTED|Overall Study||36
36018|NCT01689363|81845|P8|NOT COMPLETED|Overall Study||0
36019|NCT01689363|81846|P7|NOT COMPLETED|Overall Study||0
36020|NCT01689363|81847|P6|NOT COMPLETED|Overall Study||0
36021|NCT01689363|81848|P5|NOT COMPLETED|Overall Study||0
36022|NCT01689363|81849|P4|NOT COMPLETED|Overall Study||0
36023|NCT01689363|81850|P3|NOT COMPLETED|Overall Study||0
36024|NCT01689363|81851|P2|NOT COMPLETED|Overall Study||1
36025|NCT01689363|81852|P1|NOT COMPLETED|Overall Study||0
36026|NCT01689363|81845|P8|COMPLETED|Overall Study||32
36027|NCT01689363|81846|P7|COMPLETED|Overall Study||32
36028|NCT01689363|81847|P6|COMPLETED|Overall Study||31
36029|NCT01689363|81848|P5|COMPLETED|Overall Study||31
36030|NCT01689363|81849|P4|COMPLETED|Overall Study||31
36031|NCT01689363|81850|P3|COMPLETED|Overall Study||32
36032|NCT01689363|81851|P2|COMPLETED|Overall Study||31
36033|NCT01689363|81852|P1|COMPLETED|Overall Study||32
36034|NCT01689363|81845|P8|STARTED|Overall Study||32
36035|NCT01689363|81846|P7|STARTED|Overall Study||32
36036|NCT01689363|81847|P6|STARTED|Overall Study||31
36037|NCT01689363|81848|P5|STARTED|Overall Study||31
36038|NCT01689363|81849|P4|STARTED|Overall Study||31
36039|NCT01689363|81850|P3|STARTED|Overall Study||32
36040|NCT01689363|81851|P2|STARTED|Overall Study||32
36041|NCT01689363|81852|P1|STARTED|Overall Study||32
36042|NCT01689350|81898|P2|NOT COMPLETED|Overall Study||0
36043|NCT01689350|81899|P1|NOT COMPLETED|Overall Study||0
36044|NCT01689350|81898|P2|COMPLETED|Overall Study||45
36045|NCT01689350|81899|P1|COMPLETED|Overall Study||47
36046|NCT01689350|81898|P2|STARTED|Overall Study||45
36047|NCT01689350|81899|P1|STARTED|Overall Study||47
36048|NCT01689337|81907|P1|NOT COMPLETED|Overall Study||1
36049|NCT01689337|81907|P1|COMPLETED|Overall Study||0
36050|NCT01689337|81907|P1|STARTED|Overall Study||1
36051|NCT01689324|81922|P1|NOT COMPLETED|Overall Study||0
36052|NCT01689324|81922|P1|COMPLETED|Overall Study||43
36053|NCT01689324|81922|P1|STARTED|Overall Study||43
36054|NCT01689207|81946|P11|NOT COMPLETED|Overall Study||0
36055|NCT01689207|81947|P10|NOT COMPLETED|Overall Study||0
36056|NCT01689207|81948|P9|NOT COMPLETED|Overall Study||1
36057|NCT01689207|81949|P8|NOT COMPLETED|Overall Study||0
36058|NCT01689207|81950|P7|NOT COMPLETED|Overall Study||0
36059|NCT01689207|81951|P6|NOT COMPLETED|Overall Study||1
36060|NCT01689207|81952|P5|NOT COMPLETED|Overall Study||2
36061|NCT01689207|81953|P4|NOT COMPLETED|Overall Study||0
36062|NCT01689207|81954|P3|NOT COMPLETED|Overall Study||0
36063|NCT01689207|81955|P2|NOT COMPLETED|Overall Study||1
36064|NCT01689207|81956|P1|NOT COMPLETED|Overall Study||0
36065|NCT01689207|81946|P11|COMPLETED|Overall Study|Subjects completed study|8
36066|NCT01689207|81947|P10|COMPLETED|Overall Study|Subjects completed study|10
36067|NCT01689207|81948|P9|COMPLETED|Overall Study|Subjects completed study|5
36068|NCT01689207|81949|P8|COMPLETED|Overall Study|Subjects completed study|10
36069|NCT01689207|81950|P7|COMPLETED|Overall Study|Subjects completed study|10
36070|NCT01689207|81951|P6|COMPLETED|Overall Study|Subjects completed study|7
36071|NCT01689207|81952|P5|COMPLETED|Overall Study|Subjects completed study|2
36072|NCT01689207|81953|P4|COMPLETED|Overall Study|Subjects completed study|8
36073|NCT01689207|81954|P3|COMPLETED|Overall Study|Subjects completed study|16
36074|NCT01689207|81955|P2|COMPLETED|Overall Study|Subjects completed study|7
36075|NCT01689207|81956|P1|COMPLETED|Overall Study|Subjects completed study|4
36076|NCT01689207|81946|P11|STARTED|Overall Study|Subjects randomised|8
36077|NCT01689207|81947|P10|STARTED|Overall Study|Subjects randomised|10
36078|NCT01689207|81948|P9|STARTED|Overall Study|Subjects randomised|6
36079|NCT01689207|81949|P8|STARTED|Overall Study|Subjects randomised|10
36080|NCT01689207|81950|P7|STARTED|Overall Study|Subjects randomised|10
36081|NCT01689207|81951|P6|STARTED|Overall Study|Subjects randomised|8
36082|NCT01689207|81952|P5|STARTED|Overall Study|Subjects randomised|4
36083|NCT01689207|81953|P4|STARTED|Overall Study|Subjects randomised|8
36084|NCT01689207|81954|P3|STARTED|Overall Study|Subjects randomised|16
36085|NCT01689207|81955|P2|STARTED|Overall Study|Subjects randomised|8
36086|NCT01689207|81956|P1|STARTED|Overall Study|Subjects randomised|4
36087|NCT01689155|82052|P1|NOT COMPLETED|Overall Study||0
36088|NCT01689155|82052|P1|COMPLETED|Overall Study||116
36089|NCT01689155|82052|P1|STARTED|Overall Study||116
36090|NCT01688921|82063|P2|NOT COMPLETED|Overall Study||15
36091|NCT01688921|82064|P1|NOT COMPLETED|Overall Study||16
36092|NCT01688921|82063|P2|COMPLETED|Overall Study||608
36093|NCT01688921|82064|P1|COMPLETED|Overall Study||611
36094|NCT01688921|82063|P2|STARTED|Overall Study||623
36095|NCT01688921|82064|P1|STARTED|Overall Study||627
36096|NCT01688882|82089|P2|NOT COMPLETED|Overall Study||1
36097|NCT01688882|82090|P1|NOT COMPLETED|Overall Study||3
36098|NCT01688882|82089|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
36099|NCT01688882|82090|P1|COMPLETED|Overall Study||10
36100|NCT01688882|82089|P2|Safety Follow-up|Overall Study||5
36101|NCT01688882|82090|P1|Safety Follow-up|Overall Study||11
36102|NCT01688882|82089|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
36103|NCT01688882|82090|P1|STARTED|Overall Study||13
36104|NCT01688830|82125|P21|NOT COMPLETED|Overall Study||0
36105|NCT01688830|82126|P20|NOT COMPLETED|Overall Study||0
36106|NCT01688830|82127|P19|NOT COMPLETED|Overall Study||0
36107|NCT01688830|82128|P18|NOT COMPLETED|Overall Study||0
36108|NCT01688830|82129|P17|NOT COMPLETED|Overall Study||0
36109|NCT01688830|82130|P16|NOT COMPLETED|Overall Study||0
36110|NCT01688830|82131|P15|NOT COMPLETED|Overall Study||0
36111|NCT01688830|82132|P14|NOT COMPLETED|Overall Study||0
36112|NCT01688830|82133|P13|NOT COMPLETED|Overall Study||0
36113|NCT01688830|82134|P12|NOT COMPLETED|Overall Study||0
36114|NCT01688830|82135|P11|NOT COMPLETED|Overall Study||1
36115|NCT01688830|82136|P10|NOT COMPLETED|Overall Study||0
36116|NCT01688830|82137|P9|NOT COMPLETED|Overall Study||0
36117|NCT01688830|82138|P8|NOT COMPLETED|Overall Study||0
36118|NCT01688830|82139|P7|NOT COMPLETED|Overall Study||0
36119|NCT01688830|82140|P6|NOT COMPLETED|Overall Study||0
36120|NCT01688830|82141|P5|NOT COMPLETED|Overall Study||0
36121|NCT01688830|82142|P4|NOT COMPLETED|Overall Study||0
36122|NCT01688830|82143|P3|NOT COMPLETED|Overall Study||0
36123|NCT01688830|82144|P2|NOT COMPLETED|Overall Study||0
36124|NCT01688830|82145|P1|NOT COMPLETED|Overall Study||0
36125|NCT01688830|82125|P21|COMPLETED|Overall Study||9
36126|NCT01688830|82126|P20|COMPLETED|Overall Study||3
36127|NCT01688830|82127|P19|COMPLETED|Overall Study||8
36128|NCT01688830|82128|P18|COMPLETED|Overall Study||9
36129|NCT01688830|82129|P17|COMPLETED|Overall Study||9
36130|NCT01688830|82130|P16|COMPLETED|Overall Study||9
36131|NCT01688830|82131|P15|COMPLETED|Overall Study||6
36132|NCT01688830|82132|P14|COMPLETED|Overall Study||6
36133|NCT01688830|82133|P13|COMPLETED|Overall Study||6
36134|NCT01688830|82134|P12|COMPLETED|Overall Study||6
36135|NCT01688830|82135|P11|COMPLETED|Overall Study||5
36136|NCT01688830|82136|P10|COMPLETED|Overall Study||6
36137|NCT01688830|82137|P9|COMPLETED|Overall Study||6
36138|NCT01688830|82138|P8|COMPLETED|Overall Study||6
36139|NCT01688830|82139|P7|COMPLETED|Overall Study||12
36140|NCT01688830|82140|P6|COMPLETED|Overall Study||6
36141|NCT01688830|82141|P5|COMPLETED|Overall Study||5
36142|NCT01688830|82142|P4|COMPLETED|Overall Study||6
36143|NCT01688830|82143|P3|COMPLETED|Overall Study||6
36144|NCT01688830|82144|P2|COMPLETED|Overall Study||6
36145|NCT01688830|82145|P1|COMPLETED|Overall Study||21
36146|NCT01688830|82125|P21|STARTED|Overall Study||9
36147|NCT01688830|82126|P20|STARTED|Overall Study||3
36148|NCT01688830|82127|P19|STARTED|Overall Study||8
36149|NCT01688830|82128|P18|STARTED|Overall Study||9
36150|NCT01688830|82129|P17|STARTED|Overall Study||9
36151|NCT01688830|82130|P16|STARTED|Overall Study||9
36152|NCT01688830|82131|P15|STARTED|Overall Study||6
36153|NCT01688830|82132|P14|STARTED|Overall Study||6
36154|NCT01688830|82133|P13|STARTED|Overall Study||6
36155|NCT01688830|82134|P12|STARTED|Overall Study||6
36156|NCT01688830|82135|P11|STARTED|Overall Study||6
36157|NCT01688830|82136|P10|STARTED|Overall Study||6
36158|NCT01688830|82137|P9|STARTED|Overall Study||6
36159|NCT01688830|82138|P8|STARTED|Overall Study||6
36160|NCT01688830|82139|P7|STARTED|Overall Study||12
36161|NCT01688830|82140|P6|STARTED|Overall Study||6
36162|NCT01688830|82141|P5|STARTED|Overall Study||5
36163|NCT01688830|82142|P4|STARTED|Overall Study||6
36164|NCT01688830|82143|P3|STARTED|Overall Study||6
36165|NCT01688830|82144|P2|STARTED|Overall Study||6
36166|NCT01688830|82145|P1|STARTED|Overall Study||21
36167|NCT01688726|82291|P2|NOT COMPLETED|Overall Study||1
36168|NCT01688726|82292|P1|NOT COMPLETED|Overall Study||1
36169|NCT01688726|82291|P2|COMPLETED|Overall Study||44
36170|NCT01688726|82292|P1|COMPLETED|Overall Study||45
36171|NCT01688726|82291|P2|STARTED|Overall Study||45
36172|NCT01688726|82292|P1|STARTED|Overall Study||46
36173|NCT01688635|82304|P2|NOT COMPLETED|Period 4||0
36174|NCT01688635|82305|P1|NOT COMPLETED|Period 4||0
36175|NCT01688635|82304|P2|COMPLETED|Period 4||42
36176|NCT01688635|82305|P1|COMPLETED|Period 4||40
36177|NCT01688635|82304|P2|STARTED|Period 4||42
36178|NCT01688635|82305|P1|STARTED|Period 4||40
36179|NCT01688635|82304|P2|NOT COMPLETED|Washout 3||0
36180|NCT01688635|82305|P1|NOT COMPLETED|Washout 3||1
36181|NCT01688635|82304|P2|COMPLETED|Washout 3||42
36182|NCT01688635|82305|P1|COMPLETED|Washout 3||40
36183|NCT01688635|82304|P2|STARTED|Washout 3||42
36184|NCT01688635|82305|P1|STARTED|Washout 3||41
36185|NCT01688635|82304|P2|NOT COMPLETED|Period 3||0
36186|NCT01688635|82305|P1|NOT COMPLETED|Period 3||0
36187|NCT01688635|82304|P2|COMPLETED|Period 3||42
36188|NCT01688635|82305|P1|COMPLETED|Period 3||41
36189|NCT01688635|82304|P2|STARTED|Period 3||42
36190|NCT01688635|82305|P1|STARTED|Period 3||41
36191|NCT01688635|82304|P2|NOT COMPLETED|Washout 2||2
36192|NCT01688635|82305|P1|NOT COMPLETED|Washout 2||3
36193|NCT01688635|82304|P2|COMPLETED|Washout 2||42
36194|NCT01688635|82305|P1|COMPLETED|Washout 2||41
36195|NCT01688635|82304|P2|STARTED|Washout 2||44
36196|NCT01688635|82305|P1|STARTED|Washout 2||44
36197|NCT01688635|82304|P2|NOT COMPLETED|Period 2||0
36198|NCT01688635|82305|P1|NOT COMPLETED|Period 2||0
36199|NCT01688635|82304|P2|COMPLETED|Period 2||44
36200|NCT01688635|82305|P1|COMPLETED|Period 2||44
36201|NCT01688635|82304|P2|STARTED|Period 2||44
36202|NCT01688635|82305|P1|STARTED|Period 2||44
36203|NCT01688635|82304|P2|NOT COMPLETED|Washout 1||2
36204|NCT01688635|82305|P1|NOT COMPLETED|Washout 1||1
36205|NCT01688635|82304|P2|COMPLETED|Washout 1||44
36206|NCT01688635|82305|P1|COMPLETED|Washout 1||44
36207|NCT01688635|82304|P2|STARTED|Washout 1||46
36208|NCT01688635|82305|P1|STARTED|Washout 1||45
36209|NCT01688635|82304|P2|NOT COMPLETED|Period 1||0
36210|NCT01688635|82305|P1|NOT COMPLETED|Period 1||0
36211|NCT01688635|82304|P2|COMPLETED|Period 1||46
36212|NCT01688635|82305|P1|COMPLETED|Period 1||45
36213|NCT01688635|82304|P2|Received at Least 1 Dose of Study Drug|Period 1||46
36214|NCT01688635|82305|P1|Received at Least 1 Dose of Study Drug|Period 1||45
36215|NCT01688635|82304|P2|STARTED|Period 1||46
36216|NCT01688635|82305|P1|STARTED|Period 1||45
36217|NCT01688310|82319|P2|NOT COMPLETED|Overall Study||0
36218|NCT01688310|82320|P1|NOT COMPLETED|Overall Study||0
36219|NCT01688310|82319|P2|COMPLETED|Overall Study||100
36220|NCT01688310|82320|P1|COMPLETED|Overall Study||100
36221|NCT01688310|82319|P2|STARTED|Overall Study||100
36222|NCT01688310|82320|P1|STARTED|Overall Study||100
36223|NCT01688102|82340|P2|NOT COMPLETED|Overall Study||18
36224|NCT01688102|82341|P1|NOT COMPLETED|Overall Study||16
36225|NCT01688102|82340|P2|COMPLETED|Overall Study||40
36226|NCT01688102|82341|P1|COMPLETED|Overall Study||44
36227|NCT01688102|82340|P2|STARTED|Overall Study||58
36228|NCT01688102|82341|P1|STARTED|Overall Study||60
36229|NCT01688050|82347|P1|NOT COMPLETED|Overall Study||50
36230|NCT01688050|82347|P1|COMPLETED|Overall Study||0
36231|NCT01688050|82347|P1|30 Days|Overall Study||50
36232|NCT01688050|82347|P1|STARTED|Overall Study||50
36233|NCT01687790|82353|P1|NOT COMPLETED|Overall Study||0
36234|NCT01687790|82353|P1|COMPLETED|Overall Study||60
36235|NCT01687790|82353|P1|STARTED|Overall Study||60
36236|NCT01687270|82358|P1|NOT COMPLETED|Overall Study||12
36237|NCT01687270|82358|P1|COMPLETED|Overall Study||28
36238|NCT01687270|82358|P1|STARTED|Overall Study||40
36239|NCT01687257|82369|P3|NOT COMPLETED|Overall Study||6
36240|NCT01687257|82370|P2|NOT COMPLETED|Overall Study||4
36241|NCT01687257|82371|P1|NOT COMPLETED|Overall Study||8
36242|NCT01687257|82369|P3|COMPLETED|Overall Study||15
36243|NCT01687257|82370|P2|COMPLETED|Overall Study||0
36244|NCT01687257|82371|P1|COMPLETED|Overall Study||17
36245|NCT01687257|82369|P3|STARTED|Overall Study||21
36246|NCT01687257|82370|P2|STARTED|Overall Study||4
36247|NCT01687257|82371|P1|STARTED|Overall Study||25
36248|NCT01687218|82403|P6|NOT COMPLETED|Overall Study||0
36249|NCT01687218|82404|P5|NOT COMPLETED|Overall Study||1
36250|NCT01687218|82405|P4|NOT COMPLETED|Overall Study||2
36251|NCT01687218|82406|P3|NOT COMPLETED|Overall Study||1
36252|NCT01687218|82407|P2|NOT COMPLETED|Overall Study||3
36253|NCT01687218|82408|P1|NOT COMPLETED|Overall Study||3
36254|NCT01687218|82403|P6|COMPLETED|Overall Study||32
36255|NCT01687218|82404|P5|COMPLETED|Overall Study||32
36256|NCT01687218|82405|P4|COMPLETED|Overall Study||32
36257|NCT01687218|82406|P3|COMPLETED|Overall Study||30
36258|NCT01687218|82407|P2|COMPLETED|Overall Study||29
36259|NCT01687218|82408|P1|COMPLETED|Overall Study||30
36260|NCT01687218|82403|P6|STARTED|Overall Study||32
36261|NCT01687218|82404|P5|STARTED|Overall Study||33
36262|NCT01687218|82405|P4|STARTED|Overall Study||34
36263|NCT01687218|82406|P3|STARTED|Overall Study||31
36264|NCT01687218|82407|P2|STARTED|Overall Study||32
36265|NCT01687218|82408|P1|STARTED|Overall Study||33
36266|NCT01687114|82428|P1|NOT COMPLETED|Overall Study||0
36267|NCT01687114|82428|P1|COMPLETED|Overall Study||5
36268|NCT01687114|82428|P1|STARTED|Overall Study||5
36269|NCT01687101|82432|P1|NOT COMPLETED|Overall Study||7
36270|NCT01687101|82432|P1|COMPLETED|Overall Study||25
36271|NCT01687101|82432|P1|STARTED|Overall Study||32
36272|NCT01687088|82438|P2|NOT COMPLETED|Overall Study||0
36273|NCT01687088|82439|P1|NOT COMPLETED|Overall Study||0
36274|NCT01687088|82438|P2|COMPLETED|Overall Study||50
36275|NCT01687088|82439|P1|COMPLETED|Overall Study||50
36276|NCT01687088|82438|P2|STARTED|Overall Study||50
36277|NCT01687088|82439|P1|STARTED|Overall Study||50
36278|NCT01687036|82445|P1|NOT COMPLETED|Overall Study||0
36279|NCT01687036|82445|P1|COMPLETED|Overall Study||10
36280|NCT01687036|82445|P1|STARTED|Overall Study||10
36281|NCT01686932|82459|P2|NOT COMPLETED|Period 2||0
36282|NCT01686932|82460|P1|NOT COMPLETED|Period 2||0
36283|NCT01686932|82459|P2|COMPLETED|Period 2||25
36284|NCT01686932|82460|P1|COMPLETED|Period 2||24
36285|NCT01686932|82459|P2|STARTED|Period 2||25
36286|NCT01686932|82460|P1|STARTED|Period 2||24
36287|NCT01686932|82459|P2|NOT COMPLETED|Period 1||1
36288|NCT01686932|82460|P1|NOT COMPLETED|Period 1||1
36289|NCT01686932|82459|P2|COMPLETED|Period 1||25
36290|NCT01686932|82460|P1|COMPLETED|Period 1||24
36291|NCT01686932|82459|P2|STARTED|Period 1||26
36292|NCT01686932|82460|P1|STARTED|Period 1||25
36293|NCT01686646|82490|P4|NOT COMPLETED|Overall Study||0
36294|NCT01686646|82491|P3|NOT COMPLETED|Overall Study||0
36295|NCT01686646|82492|P2|NOT COMPLETED|Overall Study||0
36296|NCT01686646|82493|P1|NOT COMPLETED|Overall Study||0
36297|NCT01686646|82490|P4|COMPLETED|Overall Study||75
36298|NCT01686646|82491|P3|COMPLETED|Overall Study||75
36299|NCT01686646|82492|P2|COMPLETED|Overall Study||45
36300|NCT01686646|82493|P1|COMPLETED|Overall Study||45
36301|NCT01686646|82490|P4|Safety Population|Overall Study||75
36302|NCT01686646|82491|P3|Safety Population|Overall Study||74
36303|NCT01686646|82492|P2|Safety Population|Overall Study||45
36304|NCT01686646|82493|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
36305|NCT01686646|82490|P4|Intent to Treat Population|Overall Study||75
36306|NCT01686646|82491|P3|Intent to Treat Population|Overall Study||75
36307|NCT01686646|82492|P2|Intent to Treat Population|Overall Study||45
36308|NCT01686646|82493|P1|Intent to Treat Population|Overall Study||45
36309|NCT01686646|82490|P4|STARTED|Overall Study||75
36310|NCT01686646|82491|P3|STARTED|Overall Study||75
36311|NCT01686646|82492|P2|STARTED|Overall Study||45
36312|NCT01686646|82493|P1|STARTED|Overall Study||45
36313|NCT01686633|82542|P3|NOT COMPLETED|Overall Study||25
36314|NCT01686633|82543|P2|NOT COMPLETED|Overall Study||32
36315|NCT01686633|82544|P1|NOT COMPLETED|Overall Study||51
36316|NCT01686633|82542|P3|COMPLETED|Overall Study||321
36317|NCT01686633|82543|P2|COMPLETED|Overall Study||314
36318|NCT01686633|82544|P1|COMPLETED|Overall Study||296
36319|NCT01686633|82542|P3|STARTED|Overall Study||346
36320|NCT01686633|82543|P2|STARTED|Overall Study||346
36321|NCT01686633|82544|P1|STARTED|Overall Study||347
36322|NCT01686568|82569|P2|NOT COMPLETED|Overall Study||4
36323|NCT01686568|82570|P1|NOT COMPLETED|Overall Study||2
36324|NCT01686568|82569|P2|COMPLETED|Overall Study||11
36325|NCT01686568|82570|P1|COMPLETED|Overall Study||14
36326|NCT01686568|82569|P2|STARTED|Overall Study||15
36327|NCT01686568|82570|P1|STARTED|Overall Study||16
36328|NCT01686503|82584|P4|NOT COMPLETED|Overall Study||1
36329|NCT01686503|82585|P3|NOT COMPLETED|Overall Study||2
36330|NCT01686503|82586|P2|NOT COMPLETED|Overall Study||3
36331|NCT01686503|82587|P1|NOT COMPLETED|Overall Study||1
36332|NCT01686503|82584|P4|COMPLETED|Overall Study||32
36333|NCT01686503|82585|P3|COMPLETED|Overall Study||64
36334|NCT01686503|82586|P2|COMPLETED|Overall Study||63
36335|NCT01686503|82587|P1|COMPLETED|Overall Study||65
36336|NCT01686503|82584|P4|STARTED|Overall Study||33
36337|NCT01686503|82585|P3|STARTED|Overall Study||66
36338|NCT01686503|82586|P2|STARTED|Overall Study||66
36339|NCT01686503|82587|P1|STARTED|Overall Study||66
36340|NCT01686451|82603|P2|NOT COMPLETED|Overall Study||0
36341|NCT01686451|82604|P1|NOT COMPLETED|Overall Study||0
36342|NCT01686451|82603|P2|COMPLETED|Overall Study||27
36343|NCT01686451|82604|P1|COMPLETED|Overall Study||33
36344|NCT01686451|82603|P2|STARTED|Overall Study||27
36345|NCT01686451|82604|P1|STARTED|Overall Study||33
36346|NCT01685983|82632|P1|NOT COMPLETED|Overall Study||82
36347|NCT01685983|82632|P1|COMPLETED|Overall Study||0
36348|NCT01685983|82632|P1|STARTED|Overall Study||82
36349|NCT01685801|82646|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
36350|NCT01685801|82647|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
36351|NCT01685801|82648|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
36352|NCT01685801|82649|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
36353|NCT01685801|82646|P4|COMPLETED|Open-label Period (8 Weeks)||4
36354|NCT01685801|82647|P3|COMPLETED|Open-label Period (8 Weeks)||7
36355|NCT01685801|82648|P2|COMPLETED|Open-label Period (8 Weeks)||5
36356|NCT01685801|82649|P1|COMPLETED|Open-label Period (8 Weeks)||5
36357|NCT01685801|82646|P4|STARTED|Open-label Period (8 Weeks)||4
36358|NCT01685801|82647|P3|STARTED|Open-label Period (8 Weeks)||7
36359|NCT01685801|82648|P2|STARTED|Open-label Period (8 Weeks)||5
36360|NCT01685801|82649|P1|STARTED|Open-label Period (8 Weeks)||5
36361|NCT01685801|82646|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
36362|NCT01685801|82647|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
36363|NCT01685801|82648|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
36364|NCT01685801|82649|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
36365|NCT01685801|82646|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
36366|NCT01685801|82647|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
36367|NCT01685801|82648|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
36368|NCT01685801|82649|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
36369|NCT01685801|82646|P4|STARTED|Washout Period 2 (4 Weeks)||4
36370|NCT01685801|82647|P3|STARTED|Washout Period 2 (4 Weeks)||7
36371|NCT01685801|82648|P2|STARTED|Washout Period 2 (4 Weeks)||5
36372|NCT01685801|82649|P1|STARTED|Washout Period 2 (4 Weeks)||5
36373|NCT01685801|82646|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
36374|NCT01685801|82647|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
36375|NCT01685801|82648|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
36376|NCT01685801|82649|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
36377|NCT01685801|82646|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
36378|NCT01685801|82647|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
36379|NCT01685801|82648|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
36380|NCT01685801|82649|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
36381|NCT01685801|82646|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
36382|NCT01685801|82647|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
36383|NCT01685801|82648|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
36384|NCT01685801|82649|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
36385|NCT01685801|82646|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
36386|NCT01685801|82647|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
36387|NCT01685801|82648|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
36388|NCT01685801|82649|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
36389|NCT01685801|82646|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
36390|NCT01685801|82647|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
36391|NCT01685801|82648|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
36392|NCT01685801|82649|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
36393|NCT01685801|82646|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
36394|NCT01685801|82647|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
36395|NCT01685801|82648|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
36396|NCT01685801|82649|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
36397|NCT01685801|82646|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
36398|NCT01685801|82647|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
36399|NCT01685801|82648|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
36400|NCT01685801|82649|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
36401|NCT01685801|82646|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
36402|NCT01685801|82647|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
36403|NCT01685801|82648|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
36404|NCT01685801|82649|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
36405|NCT01685801|82646|P4|STARTED|Washout Period 1 (4 Weeks)||5
36406|NCT01685801|82647|P3|STARTED|Washout Period 1 (4 Weeks)||7
36407|NCT01685801|82648|P2|STARTED|Washout Period 1 (4 Weeks)||6
36408|NCT01685801|82649|P1|STARTED|Washout Period 1 (4 Weeks)||5
36409|NCT01685801|82646|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
36410|NCT01685801|82647|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
36411|NCT01685801|82648|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
36412|NCT01685801|82649|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
36413|NCT01685801|82646|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
36414|NCT01685801|82647|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
36415|NCT01685801|82648|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
36416|NCT01685801|82649|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
36417|NCT01685801|82646|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
36418|NCT01685801|82647|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
36419|NCT01685801|82648|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
36420|NCT01685801|82649|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
36421|NCT01685801|82646|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
36422|NCT01685801|82647|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
36423|NCT01685801|82648|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
36424|NCT01685801|82649|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
36425|NCT01685801|82646|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
36426|NCT01685801|82647|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
36427|NCT01685801|82648|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
36428|NCT01685801|82649|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
36429|NCT01685801|82646|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
36430|NCT01685801|82647|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
36431|NCT01685801|82648|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
36432|NCT01685801|82649|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
36433|NCT01685606|82669|P1|NOT COMPLETED|Overall Study||1
36434|NCT01685606|82669|P1|COMPLETED|Overall Study||5
36435|NCT01685606|82669|P1|STARTED|Overall Study||6
36436|NCT01685437|82674|P1|NOT COMPLETED|Overall Study||31
36437|NCT01685437|82674|P1|COMPLETED|Overall Study||158
36438|NCT01685437|82674|P1|STARTED|Overall Study||189
36439|NCT01685320|82688|P2|NOT COMPLETED|Overall Study||0
36440|NCT01685320|82689|P1|NOT COMPLETED|Overall Study||0
36441|NCT01685320|82688|P2|COMPLETED|Overall Study||15
36442|NCT01685320|82689|P1|COMPLETED|Overall Study||15
36443|NCT01685320|82688|P2|STARTED|Overall Study||15
36444|NCT01685320|82689|P1|STARTED|Overall Study||15
36445|NCT01685216|82697|P1|NOT COMPLETED|Overall Study||1
36446|NCT01685216|82697|P1|COMPLETED|Overall Study||6
36447|NCT01685216|82697|P1|STARTED|Overall Study||7
36448|NCT01685203|82714|P7|NOT COMPLETED|Overall Study||0
36449|NCT01685203|82715|P6|NOT COMPLETED|Overall Study||3
36450|NCT01685203|82716|P5|NOT COMPLETED|Overall Study||0
36451|NCT01685203|82717|P4|NOT COMPLETED|Overall Study||1
36452|NCT01685203|82718|P3|NOT COMPLETED|Overall Study||0
36453|NCT01685203|82719|P2|NOT COMPLETED|Overall Study||3
36454|NCT01685203|82720|P1|NOT COMPLETED|Overall Study||4
36455|NCT01685203|82714|P7|COMPLETED|Overall Study||52
36456|NCT01685203|82715|P6|COMPLETED|Overall Study||44
36457|NCT01685203|82716|P5|COMPLETED|Overall Study||49
36458|NCT01685203|82717|P4|COMPLETED|Overall Study||41
36459|NCT01685203|82718|P3|COMPLETED|Overall Study||40
36460|NCT01685203|82719|P2|COMPLETED|Overall Study||39
36461|NCT01685203|82720|P1|COMPLETED|Overall Study||40
36462|NCT01685203|82714|P7|Completed Study Drug|Overall Study||52
36463|NCT01685203|82715|P6|Completed Study Drug|Overall Study||43
36464|NCT01685203|82716|P5|Completed Study Drug|Overall Study||49
36465|NCT01685203|82717|P4|Completed Study Drug|Overall Study||42
36466|NCT01685203|82718|P3|Completed Study Drug|Overall Study||39
36467|NCT01685203|82719|P2|Completed Study Drug|Overall Study||40
36468|NCT01685203|82720|P1|Completed Study Drug|Overall Study||42
36469|NCT01685203|82714|P7|STARTED|Overall Study||52
36470|NCT01685203|82715|P6|STARTED|Overall Study||47
36471|NCT01685203|82716|P5|STARTED|Overall Study||49
36472|NCT01685203|82717|P4|STARTED|Overall Study||42
36473|NCT01685203|82718|P3|STARTED|Overall Study||40
36474|NCT01685203|82719|P2|STARTED|Overall Study||42
36475|NCT01685203|82720|P1|STARTED|Overall Study||44
36476|NCT01684930|82766|P2|NOT COMPLETED|Overall Study||1
36477|NCT01684930|82767|P1|NOT COMPLETED|Overall Study||3
36478|NCT01684930|82766|P2|COMPLETED|Overall Study||13
36479|NCT01684930|82767|P1|COMPLETED|Overall Study||9
36480|NCT01684930|82766|P2|STARTED|Overall Study||14
36481|NCT01684930|82767|P1|STARTED|Overall Study||12
36482|NCT01684878|82783|P4|NOT COMPLETED|Part 2: Randomized Phase||45
36483|NCT01684878|82784|P3|NOT COMPLETED|Part 2: Randomized Phase||43
36484|NCT01684878|82785|P2|NOT COMPLETED|Part 2: Randomized Phase||0
36485|NCT01684878|82786|P1|NOT COMPLETED|Part 2: Randomized Phase||0
36486|NCT01684878|82783|P4|COMPLETED|Part 2: Randomized Phase||33
36487|NCT01684878|82784|P3|COMPLETED|Part 2: Randomized Phase||35
36488|NCT01684878|82785|P2|COMPLETED|Part 2: Randomized Phase||0
36489|NCT01684878|82786|P1|COMPLETED|Part 2: Randomized Phase||0
36490|NCT01684878|82783|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
36491|NCT01684878|82784|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
36492|NCT01684878|82785|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
36493|NCT01684878|82786|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
36494|NCT01684878|82783|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
36495|NCT01684878|82784|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
36496|NCT01684878|82785|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
36497|NCT01684878|82786|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
36498|NCT01684878|82783|P4|STARTED|Part 2: Randomized Phase||78
36499|NCT01684878|82784|P3|STARTED|Part 2: Randomized Phase||78
36500|NCT01684878|82785|P2|STARTED|Part 2: Randomized Phase||0
36501|NCT01684878|82786|P1|STARTED|Part 2: Randomized Phase||0
36502|NCT01684878|82783|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
36503|NCT01684878|82784|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
36504|NCT01684878|82785|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
36505|NCT01684878|82786|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
36506|NCT01684878|82783|P4|COMPLETED|Part 1: Safety Run in Phase||0
36507|NCT01684878|82784|P3|COMPLETED|Part 1: Safety Run in Phase||0
36508|NCT01684878|82785|P2|COMPLETED|Part 1: Safety Run in Phase||5
36509|NCT01684878|82786|P1|COMPLETED|Part 1: Safety Run in Phase||6
36510|NCT01684878|82783|P4|STARTED|Part 1: Safety Run in Phase||0
36511|NCT01684878|82784|P3|STARTED|Part 1: Safety Run in Phase||0
36512|NCT01684878|82785|P2|STARTED|Part 1: Safety Run in Phase||28
36513|NCT01684878|82786|P1|STARTED|Part 1: Safety Run in Phase||22
36514|NCT01684839|82808|P1|NOT COMPLETED|Overall Study||0
36515|NCT01684839|82808|P1|COMPLETED|Overall Study||9
36516|NCT01684839|82808|P1|STARTED|Overall Study||9
36517|NCT01684826|82812|P1|NOT COMPLETED|Overall Study||10
36518|NCT01684826|82812|P1|COMPLETED|Overall Study||39
36519|NCT01684826|82812|P1|Collected Dose and Image Information|Overall Study||39
36520|NCT01684826|82812|P1|STARTED|Overall Study||49
36521|NCT01684748|82820|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
36522|NCT01684748|82821|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
36523|NCT01684748|82820|P2|COMPLETED|Second Intervention - 8 Weeks||8
36524|NCT01684748|82821|P1|COMPLETED|Second Intervention - 8 Weeks||8
36525|NCT01684748|82820|P2|STARTED|Second Intervention - 8 Weeks||8
36526|NCT01684748|82821|P1|STARTED|Second Intervention - 8 Weeks||8
36527|NCT01684748|82820|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
36528|NCT01684748|82821|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
36529|NCT01684748|82820|P2|COMPLETED|First Intervention - 8 Weeks||8
36530|NCT01684748|82821|P1|COMPLETED|First Intervention - 8 Weeks||8
36531|NCT01684748|82820|P2|STARTED|First Intervention - 8 Weeks||10
36532|NCT01684748|82821|P1|STARTED|First Intervention - 8 Weeks||10
36533|NCT01684566|82829|P2|NOT COMPLETED|Overall Study||7
36534|NCT01684566|82830|P1|NOT COMPLETED|Overall Study||16
36535|NCT01684566|82829|P2|COMPLETED|Overall Study||49
36536|NCT01684566|82830|P1|COMPLETED|Overall Study||44
36537|NCT01684566|82829|P2|Treated (ITT)|Overall Study||52
36538|NCT01684566|82830|P1|Treated (ITT)|Overall Study||57
36539|NCT01684566|82829|P2|STARTED|Overall Study||56
36540|NCT01684566|82830|P1|STARTED|Overall Study||60
36541|NCT01684436|82852|P1|NOT COMPLETED|Overall Study||1
36542|NCT01684436|82852|P1|COMPLETED|Overall Study||29
36543|NCT01684436|82852|P1|STARTED|Overall Study||30
36544|NCT01684410|82864|P3|NOT COMPLETED|Overall Study||0
36545|NCT01684410|82865|P2|NOT COMPLETED|Overall Study||0
36546|NCT01684410|82866|P1|NOT COMPLETED|Overall Study||0
36547|NCT01684410|82864|P3|COMPLETED|Overall Study||10
36548|NCT01684410|82865|P2|COMPLETED|Overall Study||10
36549|NCT01684410|82866|P1|COMPLETED|Overall Study||10
36550|NCT01684410|82864|P3|STARTED|Overall Study||10
36551|NCT01684410|82865|P2|STARTED|Overall Study||10
36552|NCT01684410|82866|P1|STARTED|Overall Study||10
36553|NCT01684046|82880|P2|NOT COMPLETED|Period 2, Second 30 Days||0
36554|NCT01684046|82881|P1|NOT COMPLETED|Period 2, Second 30 Days||0
36555|NCT01684046|82880|P2|COMPLETED|Period 2, Second 30 Days||93
36556|NCT01684046|82881|P1|COMPLETED|Period 2, Second 30 Days||97
36557|NCT01684046|82880|P2|STARTED|Period 2, Second 30 Days||93
36558|NCT01684046|82881|P1|STARTED|Period 2, Second 30 Days||97
36559|NCT01684046|82880|P2|NOT COMPLETED|Period 1, First 30 Days||2
36560|NCT01684046|82881|P1|NOT COMPLETED|Period 1, First 30 Days||0
36561|NCT01684046|82880|P2|COMPLETED|Period 1, First 30 Days||93
36562|NCT01684046|82881|P1|COMPLETED|Period 1, First 30 Days||97
36563|NCT01684046|82880|P2|STARTED|Period 1, First 30 Days||95
36564|NCT01684046|82881|P1|STARTED|Period 1, First 30 Days||97
36565|NCT01684033|82887|P2|NOT COMPLETED|Period 2, Second 30 Days||0
36566|NCT01684033|82888|P1|NOT COMPLETED|Period 2, Second 30 Days||1
36567|NCT01684033|82887|P2|COMPLETED|Period 2, Second 30 Days||98
36568|NCT01684033|82888|P1|COMPLETED|Period 2, Second 30 Days||94
36569|NCT01684033|82887|P2|STARTED|Period 2, Second 30 Days||98
36570|NCT01684033|82888|P1|STARTED|Period 2, Second 30 Days||95
36571|NCT01684033|82887|P2|NOT COMPLETED|Period 1, First 30 Days||1
36572|NCT01684033|82888|P1|NOT COMPLETED|Period 1, First 30 Days||4
36573|NCT01684033|82887|P2|COMPLETED|Period 1, First 30 Days||98
36574|NCT01684033|82888|P1|COMPLETED|Period 1, First 30 Days||95
36575|NCT01684033|82887|P2|STARTED|Period 1, First 30 Days||99
36576|NCT01684033|82888|P1|STARTED|Period 1, First 30 Days||99
36577|NCT01684007|82898|P2|NOT COMPLETED|Overall Study||0
36578|NCT01684007|82899|P1|NOT COMPLETED|Overall Study||0
36579|NCT01684007|82898|P2|COMPLETED|Overall Study||50
36580|NCT01684007|82899|P1|COMPLETED|Overall Study||53
36581|NCT01684007|82898|P2|STARTED|Overall Study||50
36582|NCT01684007|82899|P1|STARTED|Overall Study||53
36583|NCT01683838|82909|P2|NOT COMPLETED|Overall Study||12
36584|NCT01683838|82910|P1|NOT COMPLETED|Overall Study||26
36585|NCT01683838|82909|P2|COMPLETED|Overall Study||88
36586|NCT01683838|82910|P1|COMPLETED|Overall Study||78
36587|NCT01683838|82909|P2|Efficacy Population|Overall Study||93
36588|NCT01683838|82910|P1|Efficacy Population|Overall Study||89
36589|NCT01683838|82909|P2|Safety Population|Overall Study||100
36590|NCT01683838|82910|P1|Safety Population|Overall Study||103
36591|NCT01683838|82909|P2|Intent to Treat (ITT) Population|Overall Study||100
36592|NCT01683838|82910|P1|Intent to Treat (ITT) Population|Overall Study||103
36593|NCT01683838|82909|P2|STARTED|Overall Study||100
36594|NCT01683838|82910|P1|STARTED|Overall Study||104
36595|NCT01683630|82934|P2|NOT COMPLETED|Overall Study||0
36596|NCT01683630|82935|P1|NOT COMPLETED|Overall Study||0
36597|NCT01683630|82934|P2|COMPLETED|Overall Study||445
36598|NCT01683630|82935|P1|COMPLETED|Overall Study||1404
36599|NCT01683630|82934|P2|STARTED|Overall Study||445
36600|NCT01683630|82935|P1|STARTED|Overall Study||1404
36601|NCT01683604|82945|P1|NOT COMPLETED|Overall Study||5
36602|NCT01683604|82945|P1|COMPLETED|Overall Study||32
36603|NCT01683604|82945|P1|STARTED|Overall Study||37
36604|NCT01683526|83110|P2|NOT COMPLETED|Overall Study||0
36605|NCT01683526|83111|P1|NOT COMPLETED|Overall Study||0
36606|NCT01683526|83110|P2|COMPLETED|Overall Study||57
36607|NCT01683526|83111|P1|COMPLETED|Overall Study||60
36608|NCT01683526|83110|P2|STARTED|Overall Study||57
36609|NCT01683526|83111|P1|STARTED|Overall Study||60
36610|NCT01683383|83127|P2|NOT COMPLETED|Overall Study||0
36611|NCT01683383|83128|P1|NOT COMPLETED|Overall Study||1
36612|NCT01683383|83127|P2|COMPLETED|Overall Study||51
36613|NCT01683383|83128|P1|COMPLETED|Overall Study||49
36614|NCT01683383|83127|P2|Transported and Treated|Overall Study||51
36615|NCT01683383|83128|P1|Transported and Treated|Overall Study||49
36616|NCT01683383|83127|P2|STARTED|Overall Study||51
36617|NCT01683383|83128|P1|STARTED|Overall Study||50
36618|NCT01683266|83144|P2|NOT COMPLETED|Overall Study||50
36619|NCT01683266|83145|P1|NOT COMPLETED|Overall Study||55
36620|NCT01683266|83144|P2|COMPLETED|Overall Study||225
36621|NCT01683266|83145|P1|COMPLETED|Overall Study||219
36622|NCT01683266|83144|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
36623|NCT01683266|83145|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
36624|NCT01683266|83144|P2|STARTED|Overall Study||275
36625|NCT01683266|83145|P1|STARTED|Overall Study||274
36626|NCT01683058|83173|P1|NOT COMPLETED|Overall Study||29
36627|NCT01683058|83173|P1|COMPLETED|Overall Study||45
36628|NCT01683058|83173|P1|STARTED|Overall Study||74
36629|NCT01683019|83204|P3|NOT COMPLETED|Overall Study||4
36630|NCT01683019|83205|P2|NOT COMPLETED|Overall Study||1
36631|NCT01683019|83206|P1|NOT COMPLETED|Overall Study||2
36632|NCT01683019|83204|P3|COMPLETED|Overall Study||15
36633|NCT01683019|83205|P2|COMPLETED|Overall Study||14
36634|NCT01683019|83206|P1|COMPLETED|Overall Study||16
36635|NCT01683019|83204|P3|STARTED|Overall Study||19
36636|NCT01683019|83205|P2|STARTED|Overall Study||15
36637|NCT01683019|83206|P1|STARTED|Overall Study||18
36638|NCT01682954|83216|P2|NOT COMPLETED|Overall Study||5
36639|NCT01682954|83217|P1|NOT COMPLETED|Overall Study||5
36640|NCT01682954|83216|P2|COMPLETED|Overall Study||33
36641|NCT01682954|83217|P1|COMPLETED|Overall Study||35
36642|NCT01682954|83216|P2|STARTED|Overall Study||38
36643|NCT01682954|83217|P1|STARTED|Overall Study||40
36644|NCT01682876|83229|P4|NOT COMPLETED|Overall Study||19
36645|NCT01682876|83230|P3|NOT COMPLETED|Overall Study||11
36646|NCT01682876|83231|P2|NOT COMPLETED|Overall Study||20
36647|NCT01682876|83232|P1|NOT COMPLETED|Overall Study||21
36648|NCT01682876|83229|P4|COMPLETED|Overall Study||157
36649|NCT01682876|83230|P3|COMPLETED|Overall Study||169
36650|NCT01682876|83231|P2|COMPLETED|Overall Study||163
36651|NCT01682876|83232|P1|COMPLETED|Overall Study||155
36652|NCT01682876|83229|P4|STARTED|Overall Study||176
36653|NCT01682876|83230|P3|STARTED|Overall Study||180
36654|NCT01682876|83231|P2|STARTED|Overall Study||183
36655|NCT01682876|83232|P1|STARTED|Overall Study||176
36656|NCT01682863|83278|P3|NOT COMPLETED|Overall Study||24
36657|NCT01682863|83279|P2|NOT COMPLETED|Overall Study||17
36658|NCT01682863|83280|P1|NOT COMPLETED|Overall Study||27
36659|NCT01682863|83278|P3|COMPLETED|Overall Study||183
36660|NCT01682863|83279|P2|COMPLETED|Overall Study||187
36661|NCT01682863|83280|P1|COMPLETED|Overall Study||177
36662|NCT01682863|83278|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
36663|NCT01682863|83279|P2|Randomized Set|Overall Study||204
36664|NCT01682863|83280|P1|Randomized Set|Overall Study||204
36665|NCT01682863|83278|P3|Full Analysis Set (FAS)|Overall Study||206
36666|NCT01682863|83279|P2|Full Analysis Set (FAS)|Overall Study||204
36667|NCT01682863|83280|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
36668|NCT01682863|83278|P3|Safety Set|Overall Study||206
36669|NCT01682863|83279|P2|Safety Set|Overall Study||204
36670|NCT01682863|83280|P1|Safety Set|Overall Study||204
36671|NCT01682863|83278|P3|STARTED|Overall Study||207
36672|NCT01682863|83279|P2|STARTED|Overall Study||204
36673|NCT01682863|83280|P1|STARTED|Overall Study||204
36674|NCT01682759|83311|P2|NOT COMPLETED|Overall Study||70
36675|NCT01682759|83312|P1|NOT COMPLETED|Overall Study||69
36676|NCT01682759|83311|P2|COMPLETED|Overall Study||305
36677|NCT01682759|83312|P1|COMPLETED|Overall Study||307
36678|NCT01682759|83311|P2|Treated|Overall Study||375
36679|NCT01682759|83312|P1|Treated|Overall Study||375
36680|NCT01682759|83311|P2|STARTED|Overall Study||375
36681|NCT01682759|83312|P1|STARTED|Overall Study||376
36682|NCT01682720|83336|P4|NOT COMPLETED|Overall Study||39
36683|NCT01682720|83337|P3|NOT COMPLETED|Overall Study||7
36684|NCT01682720|83338|P2|NOT COMPLETED|Overall Study||5
36685|NCT01682720|83339|P1|NOT COMPLETED|Overall Study||85
36686|NCT01682720|83336|P4|COMPLETED|Overall Study||211
36687|NCT01682720|83337|P3|COMPLETED|Overall Study||5
36688|NCT01682720|83338|P2|COMPLETED|Overall Study||69
36689|NCT01682720|83339|P1|COMPLETED|Overall Study||0
36690|NCT01682720|83336|P4|Included in Full Analysis Set|Overall Study||250
36691|NCT01682720|83337|P3|Included in Full Analysis Set|Overall Study||11
36692|NCT01682720|83338|P2|Included in Full Analysis Set|Overall Study||73
36693|NCT01682720|83339|P1|Included in Full Analysis Set|Overall Study||0
36694|NCT01682720|83336|P4|STARTED|Overall Study||250
36695|NCT01682720|83337|P3|STARTED|Overall Study||12
36696|NCT01682720|83338|P2|STARTED|Overall Study||74
36697|NCT01682720|83339|P1|STARTED|Overall Study||85
36698|NCT01682681|83356|P1|NOT COMPLETED|Overall Study||332
36699|NCT01682681|83356|P1|COMPLETED|Overall Study||902
36700|NCT01682681|83356|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
36701|NCT01682681|83356|P1|STARTED|Overall Study||1234
36702|NCT01682642|83366|P2|NOT COMPLETED|Overall Study||1
36703|NCT01682642|83367|P1|NOT COMPLETED|Overall Study||0
36704|NCT01682642|83366|P2|COMPLETED|Overall Study||58
36705|NCT01682642|83367|P1|COMPLETED|Overall Study||61
36706|NCT01682642|83366|P2|STARTED|Overall Study||59
36707|NCT01682642|83367|P1|STARTED|Overall Study||61
36708|NCT01682603|83385|P1|NOT COMPLETED|Overall Study||3
36709|NCT01682603|83385|P1|COMPLETED|Overall Study||34
36710|NCT01682603|83385|P1|STARTED|Overall Study||37
36711|NCT01682538|83399|P1|NOT COMPLETED|Overall Study||0
36712|NCT01682538|83399|P1|COMPLETED|Overall Study||12
36713|NCT01682538|83399|P1|STARTED|Overall Study||12
36714|NCT01682460|83427|P1|NOT COMPLETED|Overall Study||4
36715|NCT01682460|83427|P1|COMPLETED|Overall Study||11
36716|NCT01682460|83427|P1|STARTED|Overall Study||15
36717|NCT01682135|83445|P3|NOT COMPLETED|Overall Study||0
36718|NCT01682135|83446|P2|NOT COMPLETED|Overall Study||0
36719|NCT01682135|83447|P1|NOT COMPLETED|Overall Study||0
36720|NCT01682135|83445|P3|COMPLETED|Overall Study||12
36721|NCT01682135|83446|P2|COMPLETED|Overall Study||10
36722|NCT01682135|83447|P1|COMPLETED|Overall Study||6
36723|NCT01682135|83445|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
36724|NCT01682135|83446|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
36725|NCT01682135|83447|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
36726|NCT01682135|83445|P3|STARTED|Overall Study||12
36727|NCT01682135|83446|P2|STARTED|Overall Study||10
36728|NCT01682135|83447|P1|STARTED|Overall Study||6
36729|NCT01682031|83481|P2|NOT COMPLETED|Overall Study||5
36730|NCT01682031|83482|P1|NOT COMPLETED|Overall Study||1
36731|NCT01682031|83481|P2|COMPLETED|Overall Study||5
36732|NCT01682031|83482|P1|COMPLETED|Overall Study||7
36733|NCT01682031|83481|P2|STARTED|Overall Study||10
36734|NCT01682031|83482|P1|STARTED|Overall Study||8
36735|NCT01681576|83504|P2|NOT COMPLETED|Period 2||1
36736|NCT01681576|83505|P1|NOT COMPLETED|Period 2||4
36737|NCT01681576|83504|P2|COMPLETED|Period 2||35
36738|NCT01681576|83505|P1|COMPLETED|Period 2||30
36739|NCT01681576|83504|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
36740|NCT01681576|83505|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
36741|NCT01681576|83504|P2|NOT COMPLETED|Period 1||0
36742|NCT01681576|83505|P1|NOT COMPLETED|Period 1||2
36743|NCT01681576|83504|P2|COMPLETED|Period 1||36
36744|NCT01681576|83505|P1|COMPLETED|Period 1||34
36745|NCT01681576|83504|P2|STARTED|Period 1||36
36746|NCT01681576|83505|P1|STARTED|Period 1||36
36747|NCT01681511|83521|P2|NOT COMPLETED|Overall Study||14
36748|NCT01681511|83522|P1|NOT COMPLETED|Overall Study||18
36749|NCT01681511|83521|P2|COMPLETED|Overall Study||35
36750|NCT01681511|83522|P1|COMPLETED|Overall Study||28
36751|NCT01681511|83521|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
36752|NCT01681511|83522|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
36753|NCT01681511|83521|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
36754|NCT01681511|83522|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
36755|NCT01681511|83521|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
36756|NCT01681511|83522|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
36757|NCT01681472|83540|P4|NOT COMPLETED|Overall Study||0
36758|NCT01681472|83541|P3|NOT COMPLETED|Overall Study||0
36759|NCT01681472|83542|P2|NOT COMPLETED|Overall Study||1
36760|NCT01681472|83543|P1|NOT COMPLETED|Overall Study||0
36761|NCT01681472|83540|P4|COMPLETED|Overall Study||8
36762|NCT01681472|83541|P3|COMPLETED|Overall Study||8
36763|NCT01681472|83542|P2|COMPLETED|Overall Study||7
36764|NCT01681472|83543|P1|COMPLETED|Overall Study||8
36765|NCT01681472|83540|P4|STARTED|Overall Study||8
36766|NCT01681472|83541|P3|STARTED|Overall Study||8
36767|NCT01681472|83542|P2|STARTED|Overall Study||8
36768|NCT01681472|83543|P1|STARTED|Overall Study||8
36769|NCT01681368|83553|P1|NOT COMPLETED|Overall Study||2
36770|NCT01681368|83553|P1|COMPLETED|Overall Study||9
36771|NCT01681368|83553|P1|STARTED|Overall Study||11
36772|NCT01681277|83563|P5|NOT COMPLETED|Overall Study||0
36773|NCT01681277|83564|P4|NOT COMPLETED|Overall Study||0
36774|NCT01681277|83565|P3|NOT COMPLETED|Overall Study||0
36775|NCT01681277|83566|P2|NOT COMPLETED|Overall Study||0
36776|NCT01681277|83567|P1|NOT COMPLETED|Overall Study||1
36777|NCT01681277|83563|P5|COMPLETED|Overall Study||9
36778|NCT01681277|83564|P4|COMPLETED|Overall Study||9
36779|NCT01681277|83565|P3|COMPLETED|Overall Study||9
36780|NCT01681277|83566|P2|COMPLETED|Overall Study||9
36781|NCT01681277|83567|P1|COMPLETED|Overall Study||11
36782|NCT01681277|83563|P5|STARTED|Overall Study||9
36783|NCT01681277|83564|P4|STARTED|Overall Study||9
36784|NCT01681277|83565|P3|STARTED|Overall Study||9
36785|NCT01681277|83566|P2|STARTED|Overall Study||9
36786|NCT01681277|83567|P1|STARTED|Overall Study||12
36787|NCT01681212|83608|P1|NOT COMPLETED|Overall Study||6
36788|NCT01681212|83608|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
36789|NCT01681212|83608|P1|Received Treatment|Overall Study||15
36790|NCT01681212|83608|P1|STARTED|Overall Study|Enrolled|21
36791|NCT01681121|83616|P2|NOT COMPLETED|Overall Study||11
36792|NCT01681121|83617|P1|NOT COMPLETED|Overall Study||8
36793|NCT01681121|83616|P2|COMPLETED|Overall Study||38
36794|NCT01681121|83617|P1|COMPLETED|Overall Study||36
36795|NCT01681121|83616|P2|STARTED|Overall Study||49
36796|NCT01681121|83617|P1|STARTED|Overall Study||44
36797|NCT01681069|83625|P2|NOT COMPLETED|Overall Study||7
36798|NCT01681069|83626|P1|NOT COMPLETED|Overall Study||5
36799|NCT01681069|83625|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
36800|NCT01681069|83626|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
36801|NCT01681069|83625|P2|Full Analysis Set (FAS)|Overall Study||60
36802|NCT01681069|83626|P1|Full Analysis Set (FAS)|Overall Study||57
36803|NCT01681069|83625|P2|STARTED|Overall Study||60
36804|NCT01681069|83626|P1|STARTED|Overall Study||60
36805|NCT01680991|83639|P3|NOT COMPLETED|Overall Study||4
36806|NCT01680991|83640|P2|NOT COMPLETED|Overall Study||19
36807|NCT01680991|83641|P1|NOT COMPLETED|Overall Study||8
36808|NCT01680991|83639|P3|COMPLETED|Overall Study||9
36809|NCT01680991|83640|P2|COMPLETED|Overall Study||4
36810|NCT01680991|83641|P1|COMPLETED|Overall Study||4
36811|NCT01680991|83639|P3|STARTED|Overall Study||13
36812|NCT01680991|83640|P2|STARTED|Overall Study||23
36813|NCT01680991|83641|P1|STARTED|Overall Study||12
36814|NCT01680900|83702|P2|NOT COMPLETED|Overall Study||1
36815|NCT01680900|83703|P1|NOT COMPLETED|Overall Study||4
36816|NCT01680900|83702|P2|COMPLETED|Overall Study||11
36817|NCT01680900|83703|P1|COMPLETED|Overall Study||20
36818|NCT01680900|83702|P2|STARTED|Overall Study||12
36819|NCT01680900|83703|P1|STARTED|Overall Study||24
36820|NCT01680861|83721|P2|NOT COMPLETED|First 12 Months Post-transplant||0
36821|NCT01680861|83722|P1|NOT COMPLETED|First 12 Months Post-transplant||0
36822|NCT01680861|83721|P2|COMPLETED|First 12 Months Post-transplant||15
36823|NCT01680861|83722|P1|COMPLETED|First 12 Months Post-transplant||15
36824|NCT01680861|83721|P2|STARTED|First 12 Months Post-transplant||15
36825|NCT01680861|83722|P1|STARTED|First 12 Months Post-transplant||15
36826|NCT01680861|83721|P2|NOT COMPLETED|Early Post-transplant Period||1
36827|NCT01680861|83722|P1|NOT COMPLETED|Early Post-transplant Period||1
36828|NCT01680861|83721|P2|COMPLETED|Early Post-transplant Period||15
36829|NCT01680861|83722|P1|COMPLETED|Early Post-transplant Period||15
36830|NCT01680861|83721|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
36831|NCT01680861|83722|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
36832|NCT01680848|83740|P1|NOT COMPLETED|Overall Study||93
36833|NCT01680848|83740|P1|COMPLETED|Overall Study||189
36834|NCT01680848|83740|P1|STARTED|Overall Study||282
36835|NCT01680666|83746|P2|NOT COMPLETED|Overall Study||0
36836|NCT01680666|83747|P1|NOT COMPLETED|Overall Study||0
36837|NCT01680666|83746|P2|COMPLETED|Overall Study||66
36838|NCT01680666|83747|P1|COMPLETED|Overall Study||84
36839|NCT01680666|83746|P2|STARTED|Overall Study||66
36840|NCT01680666|83747|P1|STARTED|Overall Study||84
36841|NCT01680497|83753|P1|NOT COMPLETED|Overall Study||2
36842|NCT01680497|83753|P1|COMPLETED|Overall Study||68
36843|NCT01680497|83753|P1|STARTED|Overall Study||70
36844|NCT01680458|83763|P1|NOT COMPLETED|Overall Study||3
36845|NCT01680458|83763|P1|COMPLETED|Overall Study||27
36846|NCT01680458|83763|P1|STARTED|Overall Study||30
36847|NCT01680341|83774|P2|NOT COMPLETED|Overall Study||17
36848|NCT01680341|83775|P1|NOT COMPLETED|Overall Study||21
36849|NCT01680341|83774|P2|COMPLETED|Overall Study||119
36850|NCT01680341|83775|P1|COMPLETED|Overall Study||115
36851|NCT01680341|83774|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
36852|NCT01680341|83775|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
36853|NCT01680341|83774|P2|STARTED|Overall Study||136
36854|NCT01680341|83775|P1|STARTED|Overall Study||136
36855|NCT01680328|83795|P1|NOT COMPLETED|Overall Study||2
36856|NCT01680328|83795|P1|COMPLETED|Overall Study||80
36857|NCT01680328|83795|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
36858|NCT01680328|83795|P1|STARTED|Overall Study||82
36859|NCT01680172|83833|P2|NOT COMPLETED|Overall Study||0
36860|NCT01680172|83834|P1|NOT COMPLETED|Overall Study||0
36861|NCT01680172|83833|P2|COMPLETED|Overall Study||2
36862|NCT01680172|83834|P1|COMPLETED|Overall Study||3
36863|NCT01680172|83833|P2|STARTED|Overall Study||2
36864|NCT01680172|83834|P1|STARTED|Overall Study||3
36865|NCT01680016|83844|P4|NOT COMPLETED|Overall Study||5
36866|NCT01680016|83845|P3|NOT COMPLETED|Overall Study||5
36867|NCT01680016|83846|P2|NOT COMPLETED|Overall Study||8
36868|NCT01680016|83847|P1|NOT COMPLETED|Overall Study||6
36869|NCT01680016|83844|P4|COMPLETED|Overall Study||195
36870|NCT01680016|83845|P3|COMPLETED|Overall Study||196
36871|NCT01680016|83846|P2|COMPLETED|Overall Study||114
36872|NCT01680016|83847|P1|COMPLETED|Overall Study||115
36873|NCT01680016|83844|P4|STARTED|Overall Study||200
36874|NCT01680016|83845|P3|STARTED|Overall Study||201
36875|NCT01680016|83846|P2|STARTED|Overall Study||122
36876|NCT01680016|83847|P1|STARTED|Overall Study||121
36877|NCT01679613|83909|P4|NOT COMPLETED|Overall Study||2
36878|NCT01679613|83910|P3|NOT COMPLETED|Overall Study||2
36879|NCT01679613|83911|P2|NOT COMPLETED|Overall Study||1
36880|NCT01679613|83912|P1|NOT COMPLETED|Overall Study||0
36881|NCT01679613|83909|P4|COMPLETED|Overall Study||11
36882|NCT01679613|83910|P3|COMPLETED|Overall Study||11
36883|NCT01679613|83911|P2|COMPLETED|Overall Study||3
36884|NCT01679613|83912|P1|COMPLETED|Overall Study||4
36885|NCT01679613|83909|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
36886|NCT01679613|83910|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
36887|NCT01679613|83911|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
36888|NCT01679613|83912|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
36889|NCT01679613|83909|P4|Received Nintedanib (Main)|Overall Study||11
36890|NCT01679613|83910|P3|Received Nintedanib (Main)|Overall Study||13
36891|NCT01679613|83911|P2|Received Nintedanib (Main)|Overall Study||0
36892|NCT01679613|83912|P1|Received Nintedanib (Main)|Overall Study||0
36893|NCT01679613|83909|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
36894|NCT01679613|83910|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
36895|NCT01679613|83911|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
36896|NCT01679613|83912|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
36897|NCT01679613|83909|P4|Received Nintedanib (Pilot)|Overall Study||0
36898|NCT01679613|83910|P3|Received Nintedanib (Pilot)|Overall Study||0
36899|NCT01679613|83911|P2|Received Nintedanib (Pilot)|Overall Study||3
36900|NCT01679613|83912|P1|Received Nintedanib (Pilot)|Overall Study||4
36901|NCT01679613|83909|P4|STARTED|Overall Study||13
36902|NCT01679613|83910|P3|STARTED|Overall Study||13
36903|NCT01679613|83911|P2|STARTED|Overall Study||4
36904|NCT01679613|83912|P1|STARTED|Overall Study||4
36905|NCT01679600|83925|P2|NOT COMPLETED|Overall Study||0
36906|NCT01679600|83926|P1|NOT COMPLETED|Overall Study||0
36907|NCT01679600|83925|P2|COMPLETED|Overall Study||7
36908|NCT01679600|83926|P1|COMPLETED|Overall Study||7
36909|NCT01679600|83925|P2|STARTED|Overall Study||7
36910|NCT01679600|83926|P1|STARTED|Overall Study||7
36911|NCT01679314|83934|P2|NOT COMPLETED|Overall Study||0
36912|NCT01679314|83935|P1|NOT COMPLETED|Overall Study||2
36913|NCT01679314|83934|P2|COMPLETED|Overall Study||28
36914|NCT01679314|83935|P1|COMPLETED|Overall Study||24
36915|NCT01679314|83934|P2|STARTED|Overall Study||28
36916|NCT01679314|83935|P1|STARTED|Overall Study||26
36917|NCT01679236|83955|P2|NOT COMPLETED|Overall Study||15
36918|NCT01679236|83956|P1|NOT COMPLETED|Overall Study||15
36919|NCT01679236|83955|P2|COMPLETED|Overall Study||10
36920|NCT01679236|83956|P1|COMPLETED|Overall Study||15
36921|NCT01679236|83955|P2|STARTED|Overall Study||25
36922|NCT01679236|83956|P1|STARTED|Overall Study||30
36923|NCT01679028|83968|P6|NOT COMPLETED|Overall Study||0
36924|NCT01679028|83969|P5|NOT COMPLETED|Overall Study||0
36925|NCT01679028|83970|P4|NOT COMPLETED|Overall Study||0
36926|NCT01679028|83971|P3|NOT COMPLETED|Overall Study||0
36927|NCT01679028|83972|P2|NOT COMPLETED|Overall Study||0
36928|NCT01679028|83973|P1|NOT COMPLETED|Overall Study||0
36929|NCT01679028|83968|P6|COMPLETED|Overall Study||6
36930|NCT01679028|83969|P5|COMPLETED|Overall Study||2
36931|NCT01679028|83970|P4|COMPLETED|Overall Study||4
36932|NCT01679028|83971|P3|COMPLETED|Overall Study||2
36933|NCT01679028|83972|P2|COMPLETED|Overall Study||4
36934|NCT01679028|83973|P1|COMPLETED|Overall Study||2
36935|NCT01679028|83968|P6|STARTED|Overall Study||6
36936|NCT01679028|83969|P5|STARTED|Overall Study||2
36937|NCT01679028|83970|P4|STARTED|Overall Study||4
36938|NCT01679028|83971|P3|STARTED|Overall Study||2
36939|NCT01679028|83972|P2|STARTED|Overall Study||4
36940|NCT01679028|83973|P1|STARTED|Overall Study||2
36941|NCT01679002|83990|P3|NOT COMPLETED|Overall Study||0
36942|NCT01679002|83991|P2|NOT COMPLETED|Overall Study||1
36943|NCT01679002|83992|P1|NOT COMPLETED|Overall Study||1
36944|NCT01679002|83990|P3|COMPLETED|Overall Study||4
36945|NCT01679002|83991|P2|COMPLETED|Overall Study||3
36946|NCT01679002|83992|P1|COMPLETED|Overall Study||3
36947|NCT01679002|83990|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
36948|NCT01679002|83991|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
36949|NCT01679002|83992|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
36950|NCT01679002|83990|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
36951|NCT01679002|83991|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
36952|NCT01679002|83992|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
36953|NCT01679002|83990|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
36954|NCT01679002|83991|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
36955|NCT01679002|83992|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
36956|NCT01679002|83990|P3|STARTED|Overall Study||4
36957|NCT01679002|83991|P2|STARTED|Overall Study||4
36958|NCT01679002|83992|P1|STARTED|Overall Study||4
36959|NCT01678976|84008|P2|NOT COMPLETED|Second Period||0
36960|NCT01678976|84009|P1|NOT COMPLETED|Second Period||0
36961|NCT01678976|84008|P2|COMPLETED|Second Period||6
36962|NCT01678976|84009|P1|COMPLETED|Second Period||6
36963|NCT01678976|84008|P2|STARTED|Second Period||6
36964|NCT01678976|84009|P1|STARTED|Second Period||6
36965|NCT01678976|84008|P2|NOT COMPLETED|First Period||1
36966|NCT01678976|84009|P1|NOT COMPLETED|First Period||0
36967|NCT01678976|84008|P2|COMPLETED|First Period||6
36968|NCT01678976|84009|P1|COMPLETED|First Period||6
36969|NCT01678976|84008|P2|STARTED|First Period||7
36970|NCT01678976|84009|P1|STARTED|First Period||6
36971|NCT01678911|84019|P2|NOT COMPLETED|Second Intervention||0
36972|NCT01678911|84020|P1|NOT COMPLETED|Second Intervention||2
36973|NCT01678911|84019|P2|COMPLETED|Second Intervention||1
36974|NCT01678911|84020|P1|COMPLETED|Second Intervention||2
36975|NCT01678911|84019|P2|STARTED|Second Intervention||1
36976|NCT01678911|84020|P1|STARTED|Second Intervention||4
36977|NCT01678911|84019|P2|NOT COMPLETED|First Intervention||0
36978|NCT01678911|84020|P1|NOT COMPLETED|First Intervention||0
36979|NCT01678911|84019|P2|COMPLETED|First Intervention||1
36980|NCT01678911|84020|P1|COMPLETED|First Intervention||4
36981|NCT01678911|84019|P2|Cross Over|First Intervention||1
36982|NCT01678911|84020|P1|Cross Over|First Intervention||4
36983|NCT01678911|84019|P2|STARTED|First Intervention||1
36984|NCT01678911|84020|P1|STARTED|First Intervention||4
36985|NCT01678885|84034|P3|NOT COMPLETED|Phase II||5
36986|NCT01678885|84035|P2|NOT COMPLETED|Phase II||0
36987|NCT01678885|84036|P1|NOT COMPLETED|Phase II||0
36988|NCT01678885|84034|P3|COMPLETED|Phase II||22
36989|NCT01678885|84035|P2|COMPLETED|Phase II||0
36990|NCT01678885|84036|P1|COMPLETED|Phase II||0
36991|NCT01678885|84034|P3|STARTED|Phase II||27
36992|NCT01678885|84035|P2|STARTED|Phase II||0
36993|NCT01678885|84036|P1|STARTED|Phase II||0
36994|NCT01678885|84034|P3|NOT COMPLETED|Phase 1||0
36995|NCT01678885|84035|P2|NOT COMPLETED|Phase 1||3
36996|NCT01678885|84036|P1|NOT COMPLETED|Phase 1||0
36997|NCT01678885|84034|P3|COMPLETED|Phase 1||0
36998|NCT01678885|84035|P2|COMPLETED|Phase 1||15
36999|NCT01678885|84036|P1|COMPLETED|Phase 1||22
37000|NCT01678885|84034|P3|STARTED|Phase 1||0
37001|NCT01678885|84035|P2|STARTED|Phase 1||18
37002|NCT01678885|84036|P1|STARTED|Phase 1||22
37003|NCT01678846|84043|P2|NOT COMPLETED|Overall Study||0
37004|NCT01678846|84044|P1|NOT COMPLETED|Overall Study||0
37005|NCT01678846|84043|P2|COMPLETED|Overall Study||1899
37006|NCT01678846|84044|P1|COMPLETED|Overall Study||1921
37007|NCT01678846|84043|P2|STARTED|Overall Study||1899
37008|NCT01678846|84044|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
37009|NCT01678820|84059|P3|NOT COMPLETED|Overall Study||57
37010|NCT01678820|84060|P2|NOT COMPLETED|Overall Study||63
37011|NCT01678820|84061|P1|NOT COMPLETED|Overall Study||62
37012|NCT01678820|84059|P3|COMPLETED|Overall Study||43
37013|NCT01678820|84060|P2|COMPLETED|Overall Study||36
37014|NCT01678820|84061|P1|COMPLETED|Overall Study||38
37015|NCT01678820|84059|P3|Treated With Double-blind Study Drug|Overall Study||98
37016|NCT01678820|84060|P2|Treated With Double-blind Study Drug|Overall Study||97
37017|NCT01678820|84061|P1|Treated With Double-blind Study Drug|Overall Study||100
37018|NCT01678820|84059|P3|STARTED|Overall Study||100
37019|NCT01678820|84060|P2|STARTED|Overall Study||99
37020|NCT01678820|84061|P1|STARTED|Overall Study||100
37021|NCT01678807|84106|P3|NOT COMPLETED|Overall Study||0
37022|NCT01678807|84107|P2|NOT COMPLETED|Overall Study||5
37023|NCT01678807|84108|P1|NOT COMPLETED|Overall Study||4
37024|NCT01678807|84106|P3|COMPLETED|Overall Study||65
37025|NCT01678807|84107|P2|COMPLETED|Overall Study||60
37026|NCT01678807|84108|P1|COMPLETED|Overall Study||61
37027|NCT01678807|84106|P3|STARTED|Overall Study||65
37028|NCT01678807|84107|P2|STARTED|Overall Study||65
37029|NCT01678807|84108|P1|STARTED|Overall Study||65
37030|NCT01678313|84121|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
37031|NCT01678313|84122|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
37032|NCT01678313|84121|P2|COMPLETED|Prostate Biopsy at 3 Months||37
37033|NCT01678313|84122|P1|COMPLETED|Prostate Biopsy at 3 Months||45
37034|NCT01678313|84121|P2|STARTED|Prostate Biopsy at 3 Months||49
37035|NCT01678313|84122|P1|STARTED|Prostate Biopsy at 3 Months||56
37036|NCT01678313|84121|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
37037|NCT01678313|84122|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
37038|NCT01678313|84121|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
37039|NCT01678313|84122|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
37040|NCT01678313|84121|P2|STARTED|PSA >4 ng/dL at 3 Months||58
37041|NCT01678313|84122|P1|STARTED|PSA >4 ng/dL at 3 Months||64
37042|NCT01678313|84121|P2|NOT COMPLETED|Completed the 3-month Therapy||12
37043|NCT01678313|84122|P1|NOT COMPLETED|Completed the 3-month Therapy||6
37044|NCT01678313|84121|P2|COMPLETED|Completed the 3-month Therapy||58
37045|NCT01678313|84122|P1|COMPLETED|Completed the 3-month Therapy||64
37046|NCT01678313|84121|P2|STARTED|Completed the 3-month Therapy||70
37047|NCT01678313|84122|P1|STARTED|Completed the 3-month Therapy||70
37048|NCT01678196|84140|P2|NOT COMPLETED|Overall Study||0
37049|NCT01678196|84141|P1|NOT COMPLETED|Overall Study||0
37050|NCT01678196|84140|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
37051|NCT01678196|84141|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
37052|NCT01678196|84140|P2|STARTED|Overall Study||32
37053|NCT01678196|84141|P1|STARTED|Overall Study||34
37054|NCT01678131|84156|P3|NOT COMPLETED|Overall Study||2
37055|NCT01678131|84157|P2|NOT COMPLETED|Overall Study||1
37056|NCT01678131|84158|P1|NOT COMPLETED|Overall Study||0
37057|NCT01678131|84156|P3|COMPLETED|Overall Study||9
37058|NCT01678131|84157|P2|COMPLETED|Overall Study||9
37059|NCT01678131|84158|P1|COMPLETED|Overall Study||10
37060|NCT01678131|84156|P3|STARTED|Overall Study||11
37061|NCT01678131|84157|P2|STARTED|Overall Study||10
37062|NCT01678131|84158|P1|STARTED|Overall Study||10
37063|NCT01677988|84166|P1|NOT COMPLETED|Overall Study||2
37064|NCT01677988|84166|P1|COMPLETED|Overall Study||1
37065|NCT01677988|84166|P1|STARTED|Overall Study||3
37066|NCT01677936|84179|P2|NOT COMPLETED|Overall Study||5
37067|NCT01677936|84180|P1|NOT COMPLETED|Overall Study||9
37068|NCT01677936|84179|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
37069|NCT01677936|84180|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
37070|NCT01677936|84179|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
37071|NCT01677936|84180|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
37072|NCT01677767|84188|P1|NOT COMPLETED|Overall Study||22
37073|NCT01677767|84188|P1|COMPLETED|Overall Study||102
37074|NCT01677767|84188|P1|STARTED|Overall Study||124
37075|NCT01677624|84202|P1|NOT COMPLETED|Overall Study||1
37076|NCT01677624|84202|P1|COMPLETED|Overall Study||27
37077|NCT01677624|84202|P1|STARTED|Overall Study||28
37078|NCT01677299|84211|P4|NOT COMPLETED|Overall Study||1
37079|NCT01677299|84212|P3|NOT COMPLETED|Overall Study||1
37080|NCT01677299|84213|P2|NOT COMPLETED|Overall Study||3
37081|NCT01677299|84214|P1|NOT COMPLETED|Overall Study||0
37082|NCT01677299|84211|P4|COMPLETED|Overall Study||5
37083|NCT01677299|84212|P3|COMPLETED|Overall Study||5
37084|NCT01677299|84213|P2|COMPLETED|Overall Study||3
37085|NCT01677299|84214|P1|COMPLETED|Overall Study||6
37086|NCT01677299|84211|P4|STARTED|Overall Study||6
37087|NCT01677299|84212|P3|STARTED|Overall Study||6
37088|NCT01677299|84213|P2|STARTED|Overall Study||6
37089|NCT01677299|84214|P1|STARTED|Overall Study||6
37090|NCT01677195|84239|P3|NOT COMPLETED|Overall Study||30
37091|NCT01677195|84240|P2|NOT COMPLETED|Overall Study||32
37092|NCT01677195|84241|P1|NOT COMPLETED|Overall Study||29
37093|NCT01677195|84239|P3|COMPLETED|Overall Study||50
37094|NCT01677195|84240|P2|COMPLETED|Overall Study||51
37095|NCT01677195|84241|P1|COMPLETED|Overall Study||42
37096|NCT01677195|84239|P3|STARTED|Overall Study||80
37097|NCT01677195|84240|P2|STARTED|Overall Study||83
37098|NCT01677195|84241|P1|STARTED|Overall Study||71
37099|NCT01677182|84252|P3|NOT COMPLETED|Overall Study||39
37100|NCT01677182|84253|P2|NOT COMPLETED|Overall Study||28
37101|NCT01677182|84254|P1|NOT COMPLETED|Overall Study||34
37102|NCT01677182|84252|P3|COMPLETED|Overall Study||143
37103|NCT01677182|84253|P2|COMPLETED|Overall Study||141
37104|NCT01677182|84254|P1|COMPLETED|Overall Study||150
37105|NCT01677182|84252|P3|STARTED|Overall Study||182
37106|NCT01677182|84253|P2|STARTED|Overall Study||169
37107|NCT01677182|84254|P1|STARTED|Overall Study||184
37108|NCT01676896|84289|P3|NOT COMPLETED|Overall Study||19
37109|NCT01676896|84290|P2|NOT COMPLETED|Overall Study||7
37110|NCT01676896|84291|P1|NOT COMPLETED|Overall Study||12
37111|NCT01676896|84289|P3|COMPLETED|Overall Study||81
37112|NCT01676896|84290|P2|COMPLETED|Overall Study||89
37113|NCT01676896|84291|P1|COMPLETED|Overall Study||84
37114|NCT01676896|84289|P3|STARTED|Overall Study||100
37115|NCT01676896|84290|P2|STARTED|Overall Study||96
37116|NCT01676896|84291|P1|STARTED|Overall Study||96
37117|NCT01676532|84386|P1|NOT COMPLETED|Overall Study||0
37118|NCT01676532|84386|P1|COMPLETED|Overall Study||127
37119|NCT01676532|84386|P1|STARTED|Overall Study||127
37120|NCT01676298|84403|P8|NOT COMPLETED|Overall Study||0
37121|NCT01676298|84404|P7|NOT COMPLETED|Overall Study||0
37122|NCT01676298|84405|P6|NOT COMPLETED|Overall Study||0
37123|NCT01676298|84406|P5|NOT COMPLETED|Overall Study||0
37124|NCT01676298|84407|P4|NOT COMPLETED|Overall Study||0
37125|NCT01676298|84408|P3|NOT COMPLETED|Overall Study||0
37126|NCT01676298|84409|P2|NOT COMPLETED|Overall Study||0
37127|NCT01676298|84410|P1|NOT COMPLETED|Overall Study||0
37128|NCT01676298|84403|P8|COMPLETED|Overall Study||1
37129|NCT01676298|84404|P7|COMPLETED|Overall Study||1
37130|NCT01676298|84405|P6|COMPLETED|Overall Study||1
37131|NCT01676298|84406|P5|COMPLETED|Overall Study||1
37132|NCT01676298|84407|P4|COMPLETED|Overall Study||1
37133|NCT01676298|84408|P3|COMPLETED|Overall Study||1
37134|NCT01676298|84409|P2|COMPLETED|Overall Study||1
37135|NCT01676298|84410|P1|COMPLETED|Overall Study||1
37136|NCT01676298|84403|P8|Participated in All Tests|Overall Study||1
37137|NCT01676298|84404|P7|Participated in All Tests|Overall Study||1
37138|NCT01676298|84405|P6|Participated in All Tests|Overall Study||1
37139|NCT01676298|84406|P5|Participated in All Tests|Overall Study||1
37140|NCT01676298|84407|P4|Participated in All Tests|Overall Study||1
37141|NCT01676298|84408|P3|Participated in All Tests|Overall Study||1
37142|NCT01676298|84409|P2|Participated in All Tests|Overall Study||1
37143|NCT01676298|84410|P1|Participated in All Tests|Overall Study||1
37144|NCT01676298|84403|P8|All Genotypes Confirmed With Reference|Overall Study||1
37145|NCT01676298|84404|P7|All Genotypes Confirmed With Reference|Overall Study||1
37146|NCT01676298|84405|P6|All Genotypes Confirmed With Reference|Overall Study||1
37147|NCT01676298|84406|P5|All Genotypes Confirmed With Reference|Overall Study||1
37148|NCT01676298|84407|P4|All Genotypes Confirmed With Reference|Overall Study||1
37149|NCT01676298|84408|P3|All Genotypes Confirmed With Reference|Overall Study||1
37150|NCT01676298|84409|P2|All Genotypes Confirmed With Reference|Overall Study||1
37151|NCT01676298|84410|P1|All Genotypes Confirmed With Reference|Overall Study||1
37152|NCT01676298|84403|P8|STARTED|Overall Study||1
37153|NCT01676298|84404|P7|STARTED|Overall Study||1
37154|NCT01676298|84405|P6|STARTED|Overall Study||1
37155|NCT01676298|84406|P5|STARTED|Overall Study||1
37156|NCT01676298|84407|P4|STARTED|Overall Study||1
37157|NCT01676298|84408|P3|STARTED|Overall Study||1
37158|NCT01676298|84409|P2|STARTED|Overall Study||1
37159|NCT01676298|84410|P1|STARTED|Overall Study||1
37160|NCT01676220|84430|P2|NOT COMPLETED|Overall Study||125
37161|NCT01676220|84431|P1|NOT COMPLETED|Overall Study||102
37162|NCT01676220|84430|P2|COMPLETED|Overall Study||314
37163|NCT01676220|84431|P1|COMPLETED|Overall Study||337
37164|NCT01676220|84430|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
37165|NCT01676220|84431|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
37166|NCT01676220|84430|P2|Treated|Overall Study||438
37167|NCT01676220|84431|P1|Treated|Overall Study||435
37168|NCT01676220|84430|P2|STARTED|Overall Study||439
37169|NCT01676220|84431|P1|STARTED|Overall Study||439
37170|NCT01676012|84461|P1|NOT COMPLETED|Overall Study||3
37171|NCT01676012|84461|P1|COMPLETED|Overall Study||29
37172|NCT01676012|84461|P1|STARTED|Overall Study||32
37173|NCT01675830|84465|P1|NOT COMPLETED|Overall Study||0
37174|NCT01675830|84465|P1|COMPLETED|Overall Study||10
37175|NCT01675830|84465|P1|STARTED|Overall Study||10
37176|NCT01675544|84470|P1|NOT COMPLETED|Overall Study||2
37177|NCT01675544|84470|P1|COMPLETED|Overall Study||44
37178|NCT01675544|84470|P1|STARTED|Overall Study||46
37179|NCT01675531|84475|P1|NOT COMPLETED|Overall Study||25
37180|NCT01675531|84475|P1|COMPLETED|Overall Study||41
37181|NCT01675531|84475|P1|STARTED|Overall Study||66
37182|NCT01675453|84484|P2|NOT COMPLETED|Overall Study||0
37183|NCT01675453|84485|P1|NOT COMPLETED|Overall Study||0
37184|NCT01675453|84484|P2|COMPLETED|Overall Study||20
37185|NCT01675453|84485|P1|COMPLETED|Overall Study||20
37186|NCT01675453|84484|P2|STARTED|Overall Study||20
37187|NCT01675453|84485|P1|STARTED|Overall Study||20
37188|NCT01675427|84491|P1|NOT COMPLETED|Overall Study||34
37189|NCT01675427|84491|P1|COMPLETED|Overall Study||4732
37190|NCT01675427|84491|P1|STARTED|Overall Study||4766
37191|NCT01675167|84778|P3|NOT COMPLETED|Double-blind Treatment Phase||110
37192|NCT01675167|84779|P2|NOT COMPLETED|Double-blind Treatment Phase||48
37193|NCT01675167|84780|P1|NOT COMPLETED|Double-blind Treatment Phase||0
37194|NCT01675167|84778|P3|COMPLETED|Double-blind Treatment Phase||147
37195|NCT01675167|84779|P2|COMPLETED|Double-blind Treatment Phase||206
37196|NCT01675167|84780|P1|COMPLETED|Double-blind Treatment Phase||0
37197|NCT01675167|84778|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
37198|NCT01675167|84779|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
37199|NCT01675167|84780|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
37200|NCT01675167|84778|P3|NOT COMPLETED|Open-label Titration Phase||0
37201|NCT01675167|84779|P2|NOT COMPLETED|Open-label Titration Phase||0
37202|NCT01675167|84780|P1|NOT COMPLETED|Open-label Titration Phase||304
37203|NCT01675167|84778|P3|COMPLETED|Open-label Titration Phase||0
37204|NCT01675167|84779|P2|COMPLETED|Open-label Titration Phase||0
37205|NCT01675167|84780|P1|COMPLETED|Open-label Titration Phase||511
37206|NCT01675167|84778|P3|STARTED|Open-label Titration Phase||0
37207|NCT01675167|84779|P2|STARTED|Open-label Titration Phase||0
37208|NCT01675167|84780|P1|STARTED|Open-label Titration Phase||815
37209|NCT01675128|84805|P3|NOT COMPLETED|Overall Study||1
37210|NCT01675128|84806|P2|NOT COMPLETED|Overall Study||2
37211|NCT01675128|84807|P1|NOT COMPLETED|Overall Study||2
37212|NCT01675128|84805|P3|COMPLETED|Overall Study||9
37213|NCT01675128|84806|P2|COMPLETED|Overall Study||8
37214|NCT01675128|84807|P1|COMPLETED|Overall Study||2
37215|NCT01675128|84805|P3|STARTED|Overall Study||10
37216|NCT01675128|84806|P2|STARTED|Overall Study||10
37217|NCT01675128|84807|P1|STARTED|Overall Study||4
37218|NCT01675011|84831|P2|NOT COMPLETED|Overall Study||1
37219|NCT01675011|84832|P1|NOT COMPLETED|Overall Study||3
37220|NCT01675011|84831|P2|COMPLETED|Overall Study||0
37221|NCT01675011|84832|P1|COMPLETED|Overall Study||0
37222|NCT01675011|84831|P2|STARTED|Overall Study||1
37223|NCT01675011|84832|P1|STARTED|Overall Study||3
37224|NCT01674725|84840|P2|NOT COMPLETED|Overall Study||1
37225|NCT01674725|84841|P1|NOT COMPLETED|Overall Study||3
37226|NCT01674725|84840|P2|COMPLETED|Overall Study||94
37227|NCT01674725|84841|P1|COMPLETED|Overall Study||89
37228|NCT01674725|84840|P2|STARTED|Overall Study||95
37229|NCT01674725|84841|P1|STARTED|Overall Study||92
37230|NCT01674712|84860|P5|NOT COMPLETED|Overall Study||11
37231|NCT01674712|84861|P4|NOT COMPLETED|Overall Study||8
37232|NCT01674712|84862|P3|NOT COMPLETED|Overall Study||9
37233|NCT01674712|84863|P2|NOT COMPLETED|Overall Study||9
37234|NCT01674712|84864|P1|NOT COMPLETED|Overall Study||10
37235|NCT01674712|84860|P5|COMPLETED|Overall Study||102
37236|NCT01674712|84861|P4|COMPLETED|Overall Study||108
37237|NCT01674712|84862|P3|COMPLETED|Overall Study||106
37238|NCT01674712|84863|P2|COMPLETED|Overall Study||108
37239|NCT01674712|84864|P1|COMPLETED|Overall Study||104
37240|NCT01674712|84860|P5|Safety Subject Sample|Overall Study||112
37241|NCT01674712|84861|P4|Safety Subject Sample|Overall Study||115
37242|NCT01674712|84862|P3|Safety Subject Sample|Overall Study||113
37243|NCT01674712|84863|P2|Safety Subject Sample|Overall Study||117
37244|NCT01674712|84864|P1|Safety Subject Sample|Overall Study||111
37245|NCT01674712|84860|P5|Full Analysis Subject Sample|Overall Study||111
37246|NCT01674712|84861|P4|Full Analysis Subject Sample|Overall Study||112
37247|NCT01674712|84862|P3|Full Analysis Subject Sample|Overall Study||110
37248|NCT01674712|84863|P2|Full Analysis Subject Sample|Overall Study||114
37249|NCT01674712|84864|P1|Full Analysis Subject Sample|Overall Study||109
37250|NCT01674712|84860|P5|STARTED|Overall Study||113
37251|NCT01674712|84861|P4|STARTED|Overall Study||116
37252|NCT01674712|84862|P3|STARTED|Overall Study||115
37253|NCT01674712|84863|P2|STARTED|Overall Study||117
37254|NCT01674712|84864|P1|STARTED|Overall Study||114
37255|NCT01674647|84888|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
37256|NCT01674647|84889|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
37257|NCT01674647|84888|P2|COMPLETED|30-day Safety Follow-up Period||446
37258|NCT01674647|84889|P1|COMPLETED|30-day Safety Follow-up Period||924
37259|NCT01674647|84888|P2|STARTED|30-day Safety Follow-up Period||487
37260|NCT01674647|84889|P1|STARTED|30-day Safety Follow-up Period||982
37261|NCT01674647|84888|P2|NOT COMPLETED|Treatment Period||102
37262|NCT01674647|84889|P1|NOT COMPLETED|Treatment Period||156
37263|NCT01674647|84888|P2|COMPLETED|Treatment Period||400
37264|NCT01674647|84889|P1|COMPLETED|Treatment Period||846
37265|NCT01674647|84888|P2|Subjects Received Treatment|Treatment Period||499
37266|NCT01674647|84889|P1|Subjects Received Treatment|Treatment Period||988
37267|NCT01674647|84888|P2|STARTED|Treatment Period||502
37268|NCT01674647|84889|P1|STARTED|Treatment Period||1002
37269|NCT01674634|84915|P1|NOT COMPLETED|Overall Study||6
37270|NCT01674634|84915|P1|COMPLETED|Overall Study||709
37271|NCT01674634|84915|P1|STARTED|Overall Study||715
37272|NCT01674621|84935|P5|NOT COMPLETED|Overall Study||6
37273|NCT01674621|84936|P4|NOT COMPLETED|Overall Study||7
37274|NCT01674621|84937|P3|NOT COMPLETED|Overall Study||8
37275|NCT01674621|84938|P2|NOT COMPLETED|Overall Study||5
37276|NCT01674621|84939|P1|NOT COMPLETED|Overall Study||6
37277|NCT01674621|84935|P5|COMPLETED|Overall Study||45
37278|NCT01674621|84936|P4|COMPLETED|Overall Study||41
37279|NCT01674621|84937|P3|COMPLETED|Overall Study||43
37280|NCT01674621|84938|P2|COMPLETED|Overall Study||45
37281|NCT01674621|84939|P1|COMPLETED|Overall Study||44
37282|NCT01674621|84935|P5|STARTED|Overall Study||51
37283|NCT01674621|84936|P4|STARTED|Overall Study||48
37284|NCT01674621|84937|P3|STARTED|Overall Study||51
37285|NCT01674621|84938|P2|STARTED|Overall Study||50
37286|NCT01674621|84939|P1|STARTED|Overall Study||50
37287|NCT01674062|84963|P2|NOT COMPLETED|Overall Study||29
37288|NCT01674062|84964|P1|NOT COMPLETED|Overall Study||66
37289|NCT01674062|84963|P2|COMPLETED|Overall Study||0
37290|NCT01674062|84964|P1|COMPLETED|Overall Study||0
37291|NCT01674062|84963|P2|STARTED|Overall Study||29
37292|NCT01674062|84964|P1|STARTED|Overall Study||66
37293|NCT01674010|84979|P3|NOT COMPLETED|Randomization Phase 2||61
37294|NCT01674010|84980|P2|NOT COMPLETED|Randomization Phase 2||62
37295|NCT01674010|84981|P1|NOT COMPLETED|Randomization Phase 2||0
37296|NCT01674010|84979|P3|COMPLETED|Randomization Phase 2||3
37297|NCT01674010|84980|P2|COMPLETED|Randomization Phase 2||3
37298|NCT01674010|84981|P1|COMPLETED|Randomization Phase 2||0
37299|NCT01674010|84979|P3|STARTED|Randomization Phase 2||64
37300|NCT01674010|84980|P2|STARTED|Randomization Phase 2||65
37301|NCT01674010|84981|P1|STARTED|Randomization Phase 2||0
37302|NCT01674010|84979|P3|NOT COMPLETED|Open Treatment Phase 1||0
37303|NCT01674010|84980|P2|NOT COMPLETED|Open Treatment Phase 1||0
37304|NCT01674010|84981|P1|NOT COMPLETED|Open Treatment Phase 1||180
37305|NCT01674010|84979|P3|COMPLETED|Open Treatment Phase 1||0
37306|NCT01674010|84980|P2|COMPLETED|Open Treatment Phase 1||0
37307|NCT01674010|84981|P1|COMPLETED|Open Treatment Phase 1||129
37308|NCT01674010|84979|P3|STARTED|Open Treatment Phase 1||0
37309|NCT01674010|84980|P2|STARTED|Open Treatment Phase 1||0
37310|NCT01674010|84981|P1|STARTED|Open Treatment Phase 1||309
37311|NCT01673984|85000|P2|NOT COMPLETED|Overall Study||6
37312|NCT01673984|85001|P1|NOT COMPLETED|Overall Study||10
37313|NCT01673984|85000|P2|COMPLETED|Overall Study||1
37314|NCT01673984|85001|P1|COMPLETED|Overall Study||4
37315|NCT01673984|85000|P2|STARTED|Overall Study||7
37316|NCT01673984|85001|P1|STARTED|Overall Study||14
37317|NCT01673919|85019|P1|NOT COMPLETED|Overall Study||0
37318|NCT01673919|85019|P1|COMPLETED|Overall Study||7
37319|NCT01673919|85019|P1|STARTED|Overall Study||7
37320|NCT01673867|85043|P2|NOT COMPLETED|Treatment||268
37321|NCT01673867|85044|P1|NOT COMPLETED|Treatment||244
37322|NCT01673867|85043|P2|COMPLETED|Treatment||0
37323|NCT01673867|85044|P1|COMPLETED|Treatment||43
37324|NCT01673867|85043|P2|STARTED|Treatment||268
37325|NCT01673867|85044|P1|STARTED|Treatment||287
37326|NCT01673867|85043|P2|NOT COMPLETED|Randomization||22
37327|NCT01673867|85044|P1|NOT COMPLETED|Randomization||5
37328|NCT01673867|85043|P2|COMPLETED|Randomization||268
37329|NCT01673867|85044|P1|COMPLETED|Randomization||287
37330|NCT01673867|85043|P2|STARTED|Randomization||290
37331|NCT01673867|85044|P1|STARTED|Randomization||292
37332|NCT01673854|85070|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
37333|NCT01673854|85070|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
37334|NCT01673854|85070|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
37335|NCT01673854|85070|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
37336|NCT01673854|85070|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
37337|NCT01673854|85070|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
37338|NCT01673854|85070|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
37339|NCT01673854|85070|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
37340|NCT01673854|85070|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
37341|NCT01673802|85080|P2|NOT COMPLETED|Overall Study||1
37342|NCT01673802|85081|P1|NOT COMPLETED|Overall Study||1
37343|NCT01673802|85080|P2|COMPLETED|Overall Study||9
37344|NCT01673802|85081|P1|COMPLETED|Overall Study||8
37345|NCT01673802|85080|P2|STARTED|Overall Study||10
37346|NCT01673802|85081|P1|STARTED|Overall Study||9
37347|NCT01673698|85089|P2|NOT COMPLETED|Overall Study||13
37348|NCT01673698|85090|P1|NOT COMPLETED|Overall Study||51
37349|NCT01673698|85089|P2|COMPLETED|Overall Study||126
37350|NCT01673698|85090|P1|COMPLETED|Overall Study||136
37351|NCT01673698|85089|P2|STARTED|Overall Study||139
37352|NCT01673698|85090|P1|STARTED|Overall Study||187
37353|NCT01673620|85100|P2|NOT COMPLETED|Overall Study||0
37354|NCT01673620|85101|P1|NOT COMPLETED|Overall Study||1
37355|NCT01673620|85100|P2|COMPLETED|Overall Study||22
37356|NCT01673620|85101|P1|COMPLETED|Overall Study||46
37357|NCT01673620|85100|P2|STARTED|Overall Study||22
37358|NCT01673620|85101|P1|STARTED|Overall Study||47
37359|NCT01673594|85111|P2|NOT COMPLETED|Overall Study||6
37360|NCT01673594|85112|P1|NOT COMPLETED|Overall Study||6
37361|NCT01673594|85111|P2|COMPLETED|Overall Study||13
37362|NCT01673594|85112|P1|COMPLETED|Overall Study||12
37363|NCT01673594|85111|P2|STARTED|Overall Study||19
37364|NCT01673594|85112|P1|STARTED|Overall Study||18
37365|NCT01673568|85122|P2|NOT COMPLETED|Overall Study||0
37366|NCT01673568|85123|P1|NOT COMPLETED|Overall Study||0
37367|NCT01673568|85122|P2|COMPLETED|Overall Study||28
37368|NCT01673568|85123|P1|COMPLETED|Overall Study||28
37369|NCT01673568|85122|P2|STARTED|Overall Study||28
37370|NCT01673568|85123|P1|STARTED|Overall Study||28
37371|NCT01673490|85131|P1|NOT COMPLETED|Overall Study||7
37372|NCT01673490|85131|P1|COMPLETED|Overall Study||52
37373|NCT01673490|85131|P1|STARTED|Overall Study||59
37374|NCT01673425|85144|P1|NOT COMPLETED|Overall Study||1
37375|NCT01673425|85144|P1|COMPLETED|Overall Study||4
37376|NCT01673425|85144|P1|STARTED|Overall Study||5
37377|NCT01673282|85150|P2|NOT COMPLETED|Overall Study||26
37378|NCT01673282|85151|P1|NOT COMPLETED|Overall Study||33
37379|NCT01673282|85150|P2|COMPLETED|Overall Study||132
37380|NCT01673282|85151|P1|COMPLETED|Overall Study||120
37381|NCT01673282|85150|P2|STARTED|Overall Study||158
37382|NCT01673282|85151|P1|STARTED|Overall Study||153
37383|NCT01673256|85157|P1|NOT COMPLETED|Overall Study||0
37384|NCT01673256|85157|P1|COMPLETED|Overall Study||90
37385|NCT01673256|85157|P1|STARTED|Overall Study||90
37386|NCT01673178|85166|P5|NOT COMPLETED|Overall Study||2
37387|NCT01673178|85167|P4|NOT COMPLETED|Overall Study||8
37388|NCT01673178|85168|P3|NOT COMPLETED|Overall Study||3
37389|NCT01673178|85169|P2|NOT COMPLETED|Overall Study||2
37390|NCT01673178|85170|P1|NOT COMPLETED|Overall Study||3
37391|NCT01673178|85166|P5|COMPLETED|Overall Study||19
37392|NCT01673178|85167|P4|COMPLETED|Overall Study||14
37393|NCT01673178|85168|P3|COMPLETED|Overall Study||18
37394|NCT01673178|85169|P2|COMPLETED|Overall Study||19
37395|NCT01673178|85170|P1|COMPLETED|Overall Study||19
37396|NCT01673178|85166|P5|STARTED|Overall Study||21
37397|NCT01673178|85167|P4|STARTED|Overall Study||22
37398|NCT01673178|85168|P3|STARTED|Overall Study||21
37399|NCT01673178|85169|P2|STARTED|Overall Study||21
37400|NCT01673178|85170|P1|STARTED|Overall Study||22
37401|NCT01673126|85409|P2|NOT COMPLETED|Overall Study||3
37402|NCT01673126|85410|P1|NOT COMPLETED|Overall Study||4
37403|NCT01673126|85409|P2|COMPLETED|Overall Study||23
37404|NCT01673126|85410|P1|COMPLETED|Overall Study||32
37405|NCT01673126|85409|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
37406|NCT01673126|85410|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
37407|NCT01673009|85416|P1|NOT COMPLETED|Overall Study||13
37408|NCT01673009|85416|P1|COMPLETED|Overall Study||23
37409|NCT01673009|85416|P1|STARTED|Overall Study||36
37410|NCT01672996|85428|P3|NOT COMPLETED|Overall Study||0
37411|NCT01672996|85429|P2|NOT COMPLETED|Overall Study||0
37412|NCT01672996|85430|P1|NOT COMPLETED|Overall Study||0
37413|NCT01672996|85428|P3|COMPLETED|Overall Study||6
37414|NCT01672996|85429|P2|COMPLETED|Overall Study||30
37415|NCT01672996|85430|P1|COMPLETED|Overall Study||30
37416|NCT01672996|85428|P3|STARTED|Overall Study||6
37417|NCT01672996|85429|P2|STARTED|Overall Study||30
37418|NCT01672996|85430|P1|STARTED|Overall Study||30
37419|NCT01672983|85466|P6|NOT COMPLETED|Overall Study||0
37420|NCT01672983|85467|P5|NOT COMPLETED|Overall Study||0
37421|NCT01672983|85468|P4|NOT COMPLETED|Overall Study||0
37422|NCT01672983|85469|P3|NOT COMPLETED|Overall Study||0
37423|NCT01672983|85470|P2|NOT COMPLETED|Overall Study||0
37424|NCT01672983|85471|P1|NOT COMPLETED|Overall Study||0
37425|NCT01672983|85466|P6|COMPLETED|Overall Study||18
37426|NCT01672983|85467|P5|COMPLETED|Overall Study||19
37427|NCT01672983|85468|P4|COMPLETED|Overall Study||18
37428|NCT01672983|85469|P3|COMPLETED|Overall Study||19
37429|NCT01672983|85470|P2|COMPLETED|Overall Study||18
37430|NCT01672983|85471|P1|COMPLETED|Overall Study||18
37431|NCT01672983|85466|P6|Completed Study Drug|Overall Study||17
37432|NCT01672983|85467|P5|Completed Study Drug|Overall Study||12
37433|NCT01672983|85468|P4|Completed Study Drug|Overall Study||18
37434|NCT01672983|85469|P3|Completed Study Drug|Overall Study||18
37435|NCT01672983|85470|P2|Completed Study Drug|Overall Study||17
37436|NCT01672983|85471|P1|Completed Study Drug|Overall Study||18
37437|NCT01672983|85466|P6|STARTED|Overall Study||18
37438|NCT01672983|85467|P5|STARTED|Overall Study||19
37439|NCT01672983|85468|P4|STARTED|Overall Study||18
37440|NCT01672983|85469|P3|STARTED|Overall Study||19
37441|NCT01672983|85470|P2|STARTED|Overall Study||18
37442|NCT01672983|85471|P1|STARTED|Overall Study||18
37443|NCT01672970|85501|P1|NOT COMPLETED|Overall Study||47
37444|NCT01672970|85501|P1|COMPLETED|Overall Study||244
37445|NCT01672970|85501|P1|Treated|Overall Study||290
37446|NCT01672970|85501|P1|STARTED|Overall Study||291
37447|NCT01672957|85537|P1|NOT COMPLETED|Overall Study||55
37448|NCT01672957|85537|P1|COMPLETED|Overall Study||73
37449|NCT01672957|85537|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
37450|NCT01672957|85537|P1|STARTED|Overall Study||128
37451|NCT01672827|85550|P1|NOT COMPLETED|Overall Study||0
37452|NCT01672827|85550|P1|COMPLETED|Overall Study||276
37453|NCT01672827|85550|P1|STARTED|Overall Study||276
37454|NCT01672788|85556|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
37455|NCT01672788|85557|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
37456|NCT01672788|85558|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
37457|NCT01672788|85559|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
37458|NCT01672788|85556|P4|COMPLETED|Treatment Period 4 (3 Days)||8
37459|NCT01672788|85557|P3|COMPLETED|Treatment Period 4 (3 Days)||9
37460|NCT01672788|85558|P2|COMPLETED|Treatment Period 4 (3 Days)||9
37461|NCT01672788|85559|P1|COMPLETED|Treatment Period 4 (3 Days)||9
37462|NCT01672788|85556|P4|STARTED|Treatment Period 4 (3 Days)||8
37463|NCT01672788|85557|P3|STARTED|Treatment Period 4 (3 Days)||9
37464|NCT01672788|85558|P2|STARTED|Treatment Period 4 (3 Days)||9
37465|NCT01672788|85559|P1|STARTED|Treatment Period 4 (3 Days)||9
37466|NCT01672788|85556|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
37467|NCT01672788|85557|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
37468|NCT01672788|85558|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
37469|NCT01672788|85559|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
37470|NCT01672788|85556|P4|COMPLETED|Washout Period 3 (7 Days)||8
37471|NCT01672788|85557|P3|COMPLETED|Washout Period 3 (7 Days)||9
37472|NCT01672788|85558|P2|COMPLETED|Washout Period 3 (7 Days)||9
37473|NCT01672788|85559|P1|COMPLETED|Washout Period 3 (7 Days)||9
37474|NCT01672788|85556|P4|STARTED|Washout Period 3 (7 Days)||8
37475|NCT01672788|85557|P3|STARTED|Washout Period 3 (7 Days)||9
37476|NCT01672788|85558|P2|STARTED|Washout Period 3 (7 Days)||9
37477|NCT01672788|85559|P1|STARTED|Washout Period 3 (7 Days)||9
37478|NCT01672788|85556|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
37479|NCT01672788|85557|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
37480|NCT01672788|85558|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
37481|NCT01672788|85559|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
37482|NCT01672788|85556|P4|COMPLETED|Treatment Period 3 (3 Days)||8
37483|NCT01672788|85557|P3|COMPLETED|Treatment Period 3 (3 Days)||9
37484|NCT01672788|85558|P2|COMPLETED|Treatment Period 3 (3 Days)||9
37485|NCT01672788|85559|P1|COMPLETED|Treatment Period 3 (3 Days)||9
37486|NCT01672788|85556|P4|STARTED|Treatment Period 3 (3 Days)||8
37487|NCT01672788|85557|P3|STARTED|Treatment Period 3 (3 Days)||9
37488|NCT01672788|85558|P2|STARTED|Treatment Period 3 (3 Days)||9
37489|NCT01672788|85559|P1|STARTED|Treatment Period 3 (3 Days)||9
37490|NCT01672788|85556|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
37491|NCT01672788|85557|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
37492|NCT01672788|85558|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
37493|NCT01672788|85559|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
37494|NCT01672788|85556|P4|COMPLETED|Washout Period 2 (7 Days)||8
37495|NCT01672788|85557|P3|COMPLETED|Washout Period 2 (7 Days)||9
37496|NCT01672788|85558|P2|COMPLETED|Washout Period 2 (7 Days)||9
37497|NCT01672788|85559|P1|COMPLETED|Washout Period 2 (7 Days)||9
37498|NCT01672788|85556|P4|STARTED|Washout Period 2 (7 Days)||9
37499|NCT01672788|85557|P3|STARTED|Washout Period 2 (7 Days)||9
37500|NCT01672788|85558|P2|STARTED|Washout Period 2 (7 Days)||9
37501|NCT01672788|85559|P1|STARTED|Washout Period 2 (7 Days)||9
37502|NCT01672788|85556|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
37503|NCT01672788|85557|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
37504|NCT01672788|85558|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
37505|NCT01672788|85559|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
37506|NCT01672788|85556|P4|COMPLETED|Treatment Period 2 (3 Days)||9
37507|NCT01672788|85557|P3|COMPLETED|Treatment Period 2 (3 Days)||9
37508|NCT01672788|85558|P2|COMPLETED|Treatment Period 2 (3 Days)||9
37509|NCT01672788|85559|P1|COMPLETED|Treatment Period 2 (3 Days)||9
37510|NCT01672788|85556|P4|STARTED|Treatment Period 2 (3 Days)||9
37511|NCT01672788|85557|P3|STARTED|Treatment Period 2 (3 Days)||9
37512|NCT01672788|85558|P2|STARTED|Treatment Period 2 (3 Days)||9
37513|NCT01672788|85559|P1|STARTED|Treatment Period 2 (3 Days)||9
37514|NCT01672788|85556|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
37515|NCT01672788|85557|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
37516|NCT01672788|85558|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
37517|NCT01672788|85559|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
37518|NCT01672788|85556|P4|COMPLETED|Washout Period 1 (7 Days)||9
37519|NCT01672788|85557|P3|COMPLETED|Washout Period 1 (7 Days)||9
37520|NCT01672788|85558|P2|COMPLETED|Washout Period 1 (7 Days)||9
37521|NCT01672788|85559|P1|COMPLETED|Washout Period 1 (7 Days)||9
37522|NCT01672788|85556|P4|STARTED|Washout Period 1 (7 Days)||9
37523|NCT01672788|85557|P3|STARTED|Washout Period 1 (7 Days)||9
37524|NCT01672788|85558|P2|STARTED|Washout Period 1 (7 Days)||9
37525|NCT01672788|85559|P1|STARTED|Washout Period 1 (7 Days)||9
37526|NCT01672788|85556|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
37527|NCT01672788|85557|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
37528|NCT01672788|85558|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
37529|NCT01672788|85559|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
37530|NCT01672788|85556|P4|COMPLETED|Treatment Period 1 (3 Days)||9
37531|NCT01672788|85557|P3|COMPLETED|Treatment Period 1 (3 Days)||9
37532|NCT01672788|85558|P2|COMPLETED|Treatment Period 1 (3 Days)||9
37533|NCT01672788|85559|P1|COMPLETED|Treatment Period 1 (3 Days)||9
37534|NCT01672788|85556|P4|STARTED|Treatment Period 1 (3 Days)||9
37535|NCT01672788|85557|P3|STARTED|Treatment Period 1 (3 Days)||9
37536|NCT01672788|85558|P2|STARTED|Treatment Period 1 (3 Days)||9
37537|NCT01672788|85559|P1|STARTED|Treatment Period 1 (3 Days)||9
37538|NCT01672723|85589|P2|NOT COMPLETED|Second Intervention||0
37539|NCT01672723|85590|P1|NOT COMPLETED|Second Intervention||0
37540|NCT01672723|85589|P2|COMPLETED|Second Intervention||15
37541|NCT01672723|85590|P1|COMPLETED|Second Intervention||16
37542|NCT01672723|85589|P2|STARTED|Second Intervention||15
37543|NCT01672723|85590|P1|STARTED|Second Intervention||16
37544|NCT01672723|85589|P2|NOT COMPLETED|Washout Period of 10 Days||0
37545|NCT01672723|85590|P1|NOT COMPLETED|Washout Period of 10 Days||0
37546|NCT01672723|85589|P2|COMPLETED|Washout Period of 10 Days||15
37547|NCT01672723|85590|P1|COMPLETED|Washout Period of 10 Days||16
37548|NCT01672723|85589|P2|STARTED|Washout Period of 10 Days||15
37549|NCT01672723|85590|P1|STARTED|Washout Period of 10 Days||16
37550|NCT01672723|85589|P2|NOT COMPLETED|First Intervention||0
37551|NCT01672723|85590|P1|NOT COMPLETED|First Intervention||3
37552|NCT01672723|85589|P2|COMPLETED|First Intervention||15
37553|NCT01672723|85590|P1|COMPLETED|First Intervention||16
37554|NCT01672723|85589|P2|STARTED|First Intervention||15
37555|NCT01672723|85590|P1|STARTED|First Intervention||19
37556|NCT01672658|85602|P2|NOT COMPLETED|Overall Study||1
37557|NCT01672658|85603|P1|NOT COMPLETED|Overall Study||0
37558|NCT01672658|85602|P2|COMPLETED|Overall Study||14
37559|NCT01672658|85603|P1|COMPLETED|Overall Study||16
37560|NCT01672658|85602|P2|STARTED|Overall Study||15
37561|NCT01672658|85603|P1|STARTED|Overall Study||16
37562|NCT01671839|85623|P1|NOT COMPLETED|Overall Study||5
37563|NCT01671839|85623|P1|COMPLETED|Overall Study||50
37564|NCT01671839|85623|P1|STARTED|Overall Study||55
37565|NCT01671748|85634|P2|NOT COMPLETED|12 Week Treatment Phase||0
37566|NCT01671748|85635|P1|NOT COMPLETED|12 Week Treatment Phase||0
37567|NCT01671748|85634|P2|COMPLETED|12 Week Treatment Phase||17
37568|NCT01671748|85635|P1|COMPLETED|12 Week Treatment Phase||19
37569|NCT01671748|85634|P2|STARTED|12 Week Treatment Phase||17
37570|NCT01671748|85635|P1|STARTED|12 Week Treatment Phase||19
37571|NCT01671748|85634|P2|NOT COMPLETED|4 Week run-in Phase||0
37572|NCT01671748|85635|P1|NOT COMPLETED|4 Week run-in Phase||11
37573|NCT01671748|85634|P2|COMPLETED|4 Week run-in Phase||0
37574|NCT01671748|85635|P1|COMPLETED|4 Week run-in Phase||36
37575|NCT01671748|85634|P2|STARTED|4 Week run-in Phase||0
37576|NCT01671748|85635|P1|STARTED|4 Week run-in Phase||47
37577|NCT01671293|85655|P2|NOT COMPLETED|Overall Study||2
37578|NCT01671293|85656|P1|NOT COMPLETED|Overall Study||3
37579|NCT01671293|85655|P2|COMPLETED|Overall Study||32
37580|NCT01671293|85656|P1|COMPLETED|Overall Study||33
37581|NCT01671293|85655|P2|STARTED|Overall Study||34
37582|NCT01671293|85656|P1|STARTED|Overall Study||36
37583|NCT01671111|85662|P1|NOT COMPLETED|Overall Study||30
37584|NCT01671111|85662|P1|COMPLETED|Overall Study||0
37585|NCT01671111|85662|P1|STARTED|Overall Study||30
37586|NCT01671059|85672|P1|NOT COMPLETED|Overall Study||5
37587|NCT01671059|85672|P1|COMPLETED|Overall Study||75
37588|NCT01671059|85672|P1|STARTED|Overall Study||80
37589|NCT01670721|85695|P1|NOT COMPLETED|Overall Study||53
37590|NCT01670721|85695|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
37591|NCT01670721|85695|P1|STARTED|Overall Study||175
37592|NCT01670487|85704|P2|NOT COMPLETED|Overall Study||0
37593|NCT01670487|85705|P1|NOT COMPLETED|Overall Study||0
37594|NCT01670487|85704|P2|COMPLETED|Overall Study||150
37595|NCT01670487|85705|P1|COMPLETED|Overall Study||150
37596|NCT01670487|85704|P2|STARTED|Overall Study||150
37597|NCT01670487|85705|P1|STARTED|Overall Study||150
37598|NCT01670279|85714|P4|NOT COMPLETED|Overall Study||1
37599|NCT01670279|85715|P3|NOT COMPLETED|Overall Study||0
37600|NCT01670279|85716|P2|NOT COMPLETED|Overall Study||2
37601|NCT01670279|85717|P1|NOT COMPLETED|Overall Study||0
37602|NCT01670279|85714|P4|COMPLETED|Overall Study||4
37603|NCT01670279|85715|P3|COMPLETED|Overall Study||0
37604|NCT01670279|85716|P2|COMPLETED|Overall Study||5
37605|NCT01670279|85717|P1|COMPLETED|Overall Study||6
37606|NCT01670279|85714|P4|STARTED|Overall Study||5
37607|NCT01670279|85715|P3|STARTED|Overall Study||0
37608|NCT01670279|85716|P2|STARTED|Overall Study||7
37609|NCT01670279|85717|P1|STARTED|Overall Study||6
37610|NCT01670201|85752|P1|NOT COMPLETED|Overall Study||0
37611|NCT01670201|85752|P1|COMPLETED|Overall Study||8
37612|NCT01670201|85752|P1|STARTED|Overall Study||8
37613|NCT01670045|85757|P1|NOT COMPLETED|Overall Study||16
37614|NCT01670045|85757|P1|COMPLETED|Overall Study||27
37615|NCT01670045|85757|P1|STARTED|Overall Study||43
37616|NCT01670019|85775|P2|NOT COMPLETED|Overall Study||0
37617|NCT01670019|85776|P1|NOT COMPLETED|Overall Study||9
37618|NCT01670019|85775|P2|COMPLETED|Overall Study||23
37619|NCT01670019|85776|P1|COMPLETED|Overall Study||14
37620|NCT01670019|85775|P2|STARTED|Overall Study||23
37621|NCT01670019|85776|P1|STARTED|Overall Study||23
37622|NCT01669902|85790|P1|NOT COMPLETED|Overall Study||29
37623|NCT01669902|85790|P1|COMPLETED|Overall Study||78
37624|NCT01669902|85790|P1|STARTED|Overall Study||107
37625|NCT01669863|85817|P1|NOT COMPLETED|Overall Study||0
37626|NCT01669863|85817|P1|COMPLETED|Overall Study||6
37627|NCT01669863|85817|P1|STARTED|Overall Study||6
37628|NCT01669811|85825|P2|NOT COMPLETED|Overall Study||11
37629|NCT01669811|85826|P1|NOT COMPLETED|Overall Study||3
37630|NCT01669811|85825|P2|COMPLETED|Overall Study||131
37631|NCT01669811|85826|P1|COMPLETED|Overall Study||142
37632|NCT01669811|85825|P2|STARTED|Overall Study||142
37633|NCT01669811|85826|P1|STARTED|Overall Study||145
37634|NCT01669785|85847|P3|NOT COMPLETED|Overall Study||0
37635|NCT01669785|85848|P2|NOT COMPLETED|Overall Study||0
37636|NCT01669785|85849|P1|NOT COMPLETED|Overall Study||0
37637|NCT01669785|85847|P3|COMPLETED|Overall Study||46
37638|NCT01669785|85848|P2|COMPLETED|Overall Study||48
37639|NCT01669785|85849|P1|COMPLETED|Overall Study||45
37640|NCT01669785|85847|P3|STARTED|Overall Study||46
37641|NCT01669785|85848|P2|STARTED|Overall Study||48
37642|NCT01669785|85849|P1|STARTED|Overall Study||45
37643|NCT01669720|85886|P2|NOT COMPLETED|Overall Study||0
37644|NCT01669720|85887|P1|NOT COMPLETED|Overall Study||0
37645|NCT01669720|85886|P2|COMPLETED|Overall Study||3
37646|NCT01669720|85887|P1|COMPLETED|Overall Study||7
37647|NCT01669720|85886|P2|STARTED|Overall Study||3
37648|NCT01669720|85887|P1|STARTED|Overall Study||7
37649|NCT01669629|85893|P2|NOT COMPLETED|Period 2||0
37650|NCT01669629|85894|P1|NOT COMPLETED|Period 2||0
37651|NCT01669629|85893|P2|COMPLETED|Period 2||89
37652|NCT01669629|85894|P1|COMPLETED|Period 2||91
37653|NCT01669629|85893|P2|STARTED|Period 2||89
37654|NCT01669629|85894|P1|STARTED|Period 2||91
37655|NCT01669629|85893|P2|NOT COMPLETED|Period 1||2
37656|NCT01669629|85894|P1|NOT COMPLETED|Period 1||1
37657|NCT01669629|85893|P2|COMPLETED|Period 1||89
37658|NCT01669629|85894|P1|COMPLETED|Period 1||91
37659|NCT01669629|85893|P2|STARTED|Period 1||91
37660|NCT01669629|85894|P1|STARTED|Period 1||92
37661|NCT01669577|85908|P1|NOT COMPLETED|Overall Study||134
37662|NCT01669577|85908|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
37663|NCT01669577|85908|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
37664|NCT01669174|85914|P2|NOT COMPLETED|Overall Study||6
37665|NCT01669174|85915|P1|NOT COMPLETED|Overall Study||6
37666|NCT01669174|85914|P2|COMPLETED|Overall Study||28
37667|NCT01669174|85915|P1|COMPLETED|Overall Study||27
37668|NCT01669174|85914|P2|STARTED|Overall Study||34
37669|NCT01669174|85915|P1|STARTED|Overall Study||33
37670|NCT01669122|85926|P1|NOT COMPLETED|Period IV||0
37671|NCT01669122|85926|P1|COMPLETED|Period IV||37
37672|NCT01669122|85926|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
37673|NCT01669122|85926|P1|NOT COMPLETED|Period III||0
37674|NCT01669122|85926|P1|COMPLETED|Period III||37
37675|NCT01669122|85926|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
37676|NCT01669122|85926|P1|NOT COMPLETED|Washout Period III||0
37677|NCT01669122|85926|P1|COMPLETED|Washout Period III||37
37678|NCT01669122|85926|P1|STARTED|Washout Period III||37
37679|NCT01669122|85926|P1|NOT COMPLETED|Washout Period II||2
37680|NCT01669122|85926|P1|COMPLETED|Washout Period II||37
37681|NCT01669122|85926|P1|STARTED|Washout Period II||39
37682|NCT01669122|85926|P1|NOT COMPLETED|Period II||0
37683|NCT01669122|85926|P1|COMPLETED|Period II||39
37684|NCT01669122|85926|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
37685|NCT01669122|85926|P1|NOT COMPLETED|Washout Period I||0
37686|NCT01669122|85926|P1|COMPLETED|Washout Period I||39
37687|NCT01669122|85926|P1|STARTED|Washout Period I||39
37688|NCT01669122|85926|P1|NOT COMPLETED|Period I||1
37689|NCT01669122|85926|P1|COMPLETED|Period I||39
37690|NCT01669122|85926|P1|Safety Population|Period I||39
37691|NCT01669122|85926|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
37692|NCT01668836|85960|P4|NOT COMPLETED|Overall Study||0
37693|NCT01668836|85961|P3|NOT COMPLETED|Overall Study||0
37694|NCT01668836|85962|P2|NOT COMPLETED|Overall Study||0
37695|NCT01668836|85963|P1|NOT COMPLETED|Overall Study||0
37696|NCT01668836|85960|P4|COMPLETED|Overall Study||12
37697|NCT01668836|85961|P3|COMPLETED|Overall Study||12
37698|NCT01668836|85962|P2|COMPLETED|Overall Study||12
37699|NCT01668836|85963|P1|COMPLETED|Overall Study||12
37700|NCT01668836|85960|P4|STARTED|Overall Study||12
37701|NCT01668836|85961|P3|STARTED|Overall Study||12
37702|NCT01668836|85962|P2|STARTED|Overall Study||12
37703|NCT01668836|85963|P1|STARTED|Overall Study||12
37704|NCT01668797|86019|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
37705|NCT01668797|86020|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
37706|NCT01668797|86021|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
37707|NCT01668797|86022|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
37708|NCT01668797|86019|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
37709|NCT01668797|86020|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
37710|NCT01668797|86021|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
37711|NCT01668797|86022|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
37712|NCT01668797|86019|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
37713|NCT01668797|86020|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
37714|NCT01668797|86021|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
37715|NCT01668797|86022|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
37716|NCT01668797|86019|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
37717|NCT01668797|86020|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
37718|NCT01668797|86021|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
37719|NCT01668797|86022|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
37720|NCT01668797|86019|P4|COMPLETED|Phase B (Stabilization Phase)||0
37721|NCT01668797|86020|P3|COMPLETED|Phase B (Stabilization Phase)||0
37722|NCT01668797|86021|P2|COMPLETED|Phase B (Stabilization Phase)||202
37723|NCT01668797|86022|P1|COMPLETED|Phase B (Stabilization Phase)||0
37724|NCT01668797|86019|P4|STARTED|Phase B (Stabilization Phase)||0
37725|NCT01668797|86020|P3|STARTED|Phase B (Stabilization Phase)||0
37816|NCT01667900|86283|P9|NOT COMPLETED|Part B||0
37726|NCT01668797|86021|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
37727|NCT01668797|86022|P1|STARTED|Phase B (Stabilization Phase)||0
37728|NCT01668797|86019|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
37729|NCT01668797|86020|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
37730|NCT01668797|86021|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
37731|NCT01668797|86022|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
37732|NCT01668797|86019|P4|COMPLETED|Phase A (Conversion Phase)||0
37733|NCT01668797|86020|P3|COMPLETED|Phase A (Conversion Phase)||0
37734|NCT01668797|86021|P2|COMPLETED|Phase A (Conversion Phase)||0
37735|NCT01668797|86022|P1|COMPLETED|Phase A (Conversion Phase)||346
37736|NCT01668797|86019|P4|STARTED|Phase A (Conversion Phase)||0
37737|NCT01668797|86020|P3|STARTED|Phase A (Conversion Phase)||0
37738|NCT01668797|86021|P2|STARTED|Phase A (Conversion Phase)||0
37739|NCT01668797|86022|P1|STARTED|Phase A (Conversion Phase)||406
37740|NCT01668784|86087|P2|NOT COMPLETED|Treated (Overall)||369
37741|NCT01668784|86088|P1|NOT COMPLETED|Treated (Overall)||339
37742|NCT01668784|86087|P2|COMPLETED|Treated (Overall)||28
37743|NCT01668784|86088|P1|COMPLETED|Treated (Overall)||67
37744|NCT01668784|86087|P2|STARTED|Treated (Overall)||397
37745|NCT01668784|86088|P1|STARTED|Treated (Overall)||406
37746|NCT01668784|86087|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
37747|NCT01668784|86088|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
37748|NCT01668784|86087|P2|COMPLETED|Randomized (Pre-treatment)||397
37749|NCT01668784|86088|P1|COMPLETED|Randomized (Pre-treatment)||406
37750|NCT01668784|86087|P2|STARTED|Randomized (Pre-treatment)||411
37751|NCT01668784|86088|P1|STARTED|Randomized (Pre-treatment)||410
37752|NCT01668667|86116|P4|NOT COMPLETED|Overall Study||23
37753|NCT01668667|86117|P3|NOT COMPLETED|Overall Study||31
37754|NCT01668667|86118|P2|NOT COMPLETED|Overall Study||26
37755|NCT01668667|86119|P1|NOT COMPLETED|Overall Study||31
37756|NCT01668667|86116|P4|COMPLETED|Overall Study||102
37757|NCT01668667|86117|P3|COMPLETED|Overall Study||94
37758|NCT01668667|86118|P2|COMPLETED|Overall Study||99
37759|NCT01668667|86119|P1|COMPLETED|Overall Study||95
37760|NCT01668667|86116|P4|STARTED|Overall Study||125
37761|NCT01668667|86117|P3|STARTED|Overall Study||125
37762|NCT01668667|86118|P2|STARTED|Overall Study||125
37763|NCT01668667|86119|P1|STARTED|Overall Study||126
37764|NCT01668654|86141|P1|NOT COMPLETED|Overall Study||4
37765|NCT01668654|86141|P1|COMPLETED|Overall Study||0
37766|NCT01668654|86141|P1|STARTED|Overall Study||4
37767|NCT01668628|86184|P3|NOT COMPLETED|Overall Study||0
37768|NCT01668628|86185|P2|NOT COMPLETED|Overall Study||0
37769|NCT01668628|86186|P1|NOT COMPLETED|Overall Study||2
37770|NCT01668628|86184|P3|COMPLETED|Overall Study||367
37771|NCT01668628|86185|P2|COMPLETED|Overall Study||359
37772|NCT01668628|86186|P1|COMPLETED|Overall Study||347
37773|NCT01668628|86184|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
37774|NCT01668628|86185|P2|STARTED|Overall Study||359
37775|NCT01668628|86186|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
37776|NCT01668589|86202|P4|NOT COMPLETED|Overall Study||35
37777|NCT01668589|86203|P3|NOT COMPLETED|Overall Study||35
37778|NCT01668589|86204|P2|NOT COMPLETED|Overall Study||58
37779|NCT01668589|86205|P1|NOT COMPLETED|Overall Study||139
37780|NCT01668589|86202|P4|COMPLETED|Overall Study||266
37781|NCT01668589|86203|P3|COMPLETED|Overall Study||265
37782|NCT01668589|86204|P2|COMPLETED|Overall Study||242
37783|NCT01668589|86205|P1|COMPLETED|Overall Study||461
37784|NCT01668589|86202|P4|Received Denosumab|Overall Study||301
37785|NCT01668589|86203|P3|Received Denosumab|Overall Study||300
37786|NCT01668589|86204|P2|Received Denosumab|Overall Study||300
37787|NCT01668589|86205|P1|Received Denosumab|Overall Study||599
37788|NCT01668589|86202|P4|STARTED|Overall Study||301
37789|NCT01668589|86203|P3|STARTED|Overall Study||300
37790|NCT01668589|86204|P2|STARTED|Overall Study||300
37791|NCT01668589|86205|P1|STARTED|Overall Study||600
37792|NCT01668173|86243|P1|NOT COMPLETED|Overall Study||7
37793|NCT01668173|86243|P1|COMPLETED|Overall Study||0
37794|NCT01668173|86243|P1|STARTED|Overall Study||7
37795|NCT01668004|86247|P1|NOT COMPLETED|Overall Study||25
37796|NCT01668004|86247|P1|COMPLETED|Overall Study||76
37797|NCT01668004|86247|P1|Treated|Overall Study||101
37798|NCT01668004|86247|P1|STARTED|Overall Study||101
37799|NCT01667978|86260|P2|NOT COMPLETED|Overall Study||0
37800|NCT01667978|86261|P1|NOT COMPLETED|Overall Study||2
37801|NCT01667978|86260|P2|COMPLETED|Overall Study||17
37802|NCT01667978|86261|P1|COMPLETED|Overall Study||16
37803|NCT01667978|86260|P2|STARTED|Overall Study||17
37804|NCT01667978|86261|P1|STARTED|Overall Study||18
37805|NCT01667900|86272|P20|NOT COMPLETED|Part B||0
37806|NCT01667900|86273|P19|NOT COMPLETED|Part B||0
37807|NCT01667900|86274|P18|NOT COMPLETED|Part B||0
37808|NCT01667900|86275|P17|NOT COMPLETED|Part B||1
37809|NCT01667900|86276|P16|NOT COMPLETED|Part B||0
37810|NCT01667900|86277|P15|NOT COMPLETED|Part B||0
37811|NCT01667900|86278|P14|NOT COMPLETED|Part B||0
37812|NCT01667900|86279|P13|NOT COMPLETED|Part B||0
37813|NCT01667900|86280|P12|NOT COMPLETED|Part B||0
37814|NCT01667900|86281|P11|NOT COMPLETED|Part B||0
37815|NCT01667900|86282|P10|NOT COMPLETED|Part B||0
37817|NCT01667900|86284|P8|NOT COMPLETED|Part B||0
37818|NCT01667900|86285|P7|NOT COMPLETED|Part B||0
37819|NCT01667900|86286|P6|NOT COMPLETED|Part B||0
37820|NCT01667900|86287|P5|NOT COMPLETED|Part B||0
37821|NCT01667900|86288|P4|NOT COMPLETED|Part B||0
37822|NCT01667900|86289|P3|NOT COMPLETED|Part B||0
37823|NCT01667900|86290|P2|NOT COMPLETED|Part B||0
37824|NCT01667900|86291|P1|NOT COMPLETED|Part B||0
37825|NCT01667900|86272|P20|COMPLETED|Part B||10
37826|NCT01667900|86273|P19|COMPLETED|Part B||10
37827|NCT01667900|86274|P18|COMPLETED|Part B||11
37828|NCT01667900|86275|P17|COMPLETED|Part B||10
37829|NCT01667900|86276|P16|COMPLETED|Part B||0
37830|NCT01667900|86277|P15|COMPLETED|Part B||0
37831|NCT01667900|86278|P14|COMPLETED|Part B||0
37832|NCT01667900|86279|P13|COMPLETED|Part B||0
37833|NCT01667900|86280|P12|COMPLETED|Part B||0
37834|NCT01667900|86281|P11|COMPLETED|Part B||0
37835|NCT01667900|86282|P10|COMPLETED|Part B||0
37836|NCT01667900|86283|P9|COMPLETED|Part B||0
37837|NCT01667900|86284|P8|COMPLETED|Part B||0
37838|NCT01667900|86285|P7|COMPLETED|Part B||0
37839|NCT01667900|86286|P6|COMPLETED|Part B||0
37840|NCT01667900|86287|P5|COMPLETED|Part B||0
37841|NCT01667900|86288|P4|COMPLETED|Part B||0
37842|NCT01667900|86289|P3|COMPLETED|Part B||0
37843|NCT01667900|86290|P2|COMPLETED|Part B||0
37844|NCT01667900|86291|P1|COMPLETED|Part B||0
37845|NCT01667900|86272|P20|STARTED|Part B||10
37846|NCT01667900|86273|P19|STARTED|Part B||10
37847|NCT01667900|86274|P18|STARTED|Part B||11
37848|NCT01667900|86275|P17|STARTED|Part B||11
37849|NCT01667900|86276|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
37850|NCT01667900|86277|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
37851|NCT01667900|86278|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
37852|NCT01667900|86279|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
37853|NCT01667900|86280|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
37854|NCT01667900|86281|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
37855|NCT01667900|86282|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
37856|NCT01667900|86283|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
37857|NCT01667900|86284|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
37858|NCT01667900|86285|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
37859|NCT01667900|86286|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
37860|NCT01667900|86287|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
37861|NCT01667900|86288|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
37862|NCT01667900|86289|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
37863|NCT01667900|86290|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
37864|NCT01667900|86291|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
37865|NCT01667900|86272|P20|NOT COMPLETED|Part A, Period 3||0
37866|NCT01667900|86273|P19|NOT COMPLETED|Part A, Period 3||0
37867|NCT01667900|86274|P18|NOT COMPLETED|Part A, Period 3||0
37868|NCT01667900|86275|P17|NOT COMPLETED|Part A, Period 3||0
37869|NCT01667900|86276|P16|NOT COMPLETED|Part A, Period 3||0
37870|NCT01667900|86277|P15|NOT COMPLETED|Part A, Period 3||0
37871|NCT01667900|86278|P14|NOT COMPLETED|Part A, Period 3||0
37872|NCT01667900|86279|P13|NOT COMPLETED|Part A, Period 3||0
37873|NCT01667900|86280|P12|NOT COMPLETED|Part A, Period 3||0
37874|NCT01667900|86281|P11|NOT COMPLETED|Part A, Period 3||0
37875|NCT01667900|86282|P10|NOT COMPLETED|Part A, Period 3||0
37876|NCT01667900|86283|P9|NOT COMPLETED|Part A, Period 3||0
37877|NCT01667900|86284|P8|NOT COMPLETED|Part A, Period 3||0
37878|NCT01667900|86285|P7|NOT COMPLETED|Part A, Period 3||0
37879|NCT01667900|86286|P6|NOT COMPLETED|Part A, Period 3||0
37880|NCT01667900|86287|P5|NOT COMPLETED|Part A, Period 3||0
37881|NCT01667900|86288|P4|NOT COMPLETED|Part A, Period 3||0
37882|NCT01667900|86289|P3|NOT COMPLETED|Part A, Period 3||0
37883|NCT01667900|86290|P2|NOT COMPLETED|Part A, Period 3||0
37884|NCT01667900|86291|P1|NOT COMPLETED|Part A, Period 3||0
37885|NCT01667900|86272|P20|COMPLETED|Part A, Period 3||0
37886|NCT01667900|86273|P19|COMPLETED|Part A, Period 3||0
37887|NCT01667900|86274|P18|COMPLETED|Part A, Period 3||0
37888|NCT01667900|86275|P17|COMPLETED|Part A, Period 3||0
37889|NCT01667900|86276|P16|COMPLETED|Part A, Period 3||1
37890|NCT01667900|86277|P15|COMPLETED|Part A, Period 3||1
37891|NCT01667900|86278|P14|COMPLETED|Part A, Period 3||1
37892|NCT01667900|86279|P13|COMPLETED|Part A, Period 3||1
37893|NCT01667900|86280|P12|COMPLETED|Part A, Period 3||1
37894|NCT01667900|86281|P11|COMPLETED|Part A, Period 3||1
37895|NCT01667900|86282|P10|COMPLETED|Part A, Period 3||1
37896|NCT01667900|86283|P9|COMPLETED|Part A, Period 3||1
37897|NCT01667900|86284|P8|COMPLETED|Part A, Period 3||1
37898|NCT01667900|86285|P7|COMPLETED|Part A, Period 3||1
37899|NCT01667900|86286|P6|COMPLETED|Part A, Period 3||1
37900|NCT01667900|86287|P5|COMPLETED|Part A, Period 3||1
37901|NCT01667900|86288|P4|COMPLETED|Part A, Period 3||1
37902|NCT01667900|86289|P3|COMPLETED|Part A, Period 3||1
37903|NCT01667900|86290|P2|COMPLETED|Part A, Period 3||1
37904|NCT01667900|86291|P1|COMPLETED|Part A, Period 3||1
37905|NCT01667900|86272|P20|STARTED|Part A, Period 3||0
37906|NCT01667900|86273|P19|STARTED|Part A, Period 3||0
37907|NCT01667900|86274|P18|STARTED|Part A, Period 3||0
37908|NCT01667900|86275|P17|STARTED|Part A, Period 3||0
37909|NCT01667900|86276|P16|STARTED|Part A, Period 3||1
37910|NCT01667900|86277|P15|STARTED|Part A, Period 3||1
37911|NCT01667900|86278|P14|STARTED|Part A, Period 3||1
37912|NCT01667900|86279|P13|STARTED|Part A, Period 3||1
37913|NCT01667900|86280|P12|STARTED|Part A, Period 3||1
37914|NCT01667900|86281|P11|STARTED|Part A, Period 3||1
37915|NCT01667900|86282|P10|STARTED|Part A, Period 3||1
37916|NCT01667900|86283|P9|STARTED|Part A, Period 3||1
37917|NCT01667900|86284|P8|STARTED|Part A, Period 3||1
37918|NCT01667900|86285|P7|STARTED|Part A, Period 3||1
37919|NCT01667900|86286|P6|STARTED|Part A, Period 3||1
37920|NCT01667900|86287|P5|STARTED|Part A, Period 3||1
37921|NCT01667900|86288|P4|STARTED|Part A, Period 3||1
37922|NCT01667900|86289|P3|STARTED|Part A, Period 3||1
37923|NCT01667900|86290|P2|STARTED|Part A, Period 3||1
37924|NCT01667900|86291|P1|STARTED|Part A, Period 3||1
37925|NCT01667900|86272|P20|NOT COMPLETED|Part A, Washout 2||0
37926|NCT01667900|86273|P19|NOT COMPLETED|Part A, Washout 2||0
37927|NCT01667900|86274|P18|NOT COMPLETED|Part A, Washout 2||0
37928|NCT01667900|86275|P17|NOT COMPLETED|Part A, Washout 2||0
37929|NCT01667900|86276|P16|NOT COMPLETED|Part A, Washout 2||0
37930|NCT01667900|86277|P15|NOT COMPLETED|Part A, Washout 2||0
37931|NCT01667900|86278|P14|NOT COMPLETED|Part A, Washout 2||0
37932|NCT01667900|86279|P13|NOT COMPLETED|Part A, Washout 2||0
37933|NCT01667900|86280|P12|NOT COMPLETED|Part A, Washout 2||0
37934|NCT01667900|86281|P11|NOT COMPLETED|Part A, Washout 2||0
37935|NCT01667900|86282|P10|NOT COMPLETED|Part A, Washout 2||0
37936|NCT01667900|86283|P9|NOT COMPLETED|Part A, Washout 2||0
37937|NCT01667900|86284|P8|NOT COMPLETED|Part A, Washout 2||0
37938|NCT01667900|86285|P7|NOT COMPLETED|Part A, Washout 2||0
37939|NCT01667900|86286|P6|NOT COMPLETED|Part A, Washout 2||0
37940|NCT01667900|86287|P5|NOT COMPLETED|Part A, Washout 2||0
37941|NCT01667900|86288|P4|NOT COMPLETED|Part A, Washout 2||0
37942|NCT01667900|86289|P3|NOT COMPLETED|Part A, Washout 2||0
37943|NCT01667900|86290|P2|NOT COMPLETED|Part A, Washout 2||0
37944|NCT01667900|86291|P1|NOT COMPLETED|Part A, Washout 2||0
37945|NCT01667900|86272|P20|COMPLETED|Part A, Washout 2||0
37946|NCT01667900|86273|P19|COMPLETED|Part A, Washout 2||0
37947|NCT01667900|86274|P18|COMPLETED|Part A, Washout 2||0
37948|NCT01667900|86275|P17|COMPLETED|Part A, Washout 2||0
37949|NCT01667900|86276|P16|COMPLETED|Part A, Washout 2||1
37950|NCT01667900|86277|P15|COMPLETED|Part A, Washout 2||1
37951|NCT01667900|86278|P14|COMPLETED|Part A, Washout 2||1
37952|NCT01667900|86279|P13|COMPLETED|Part A, Washout 2||1
37953|NCT01667900|86280|P12|COMPLETED|Part A, Washout 2||1
37954|NCT01667900|86281|P11|COMPLETED|Part A, Washout 2||1
37955|NCT01667900|86282|P10|COMPLETED|Part A, Washout 2||1
37956|NCT01667900|86283|P9|COMPLETED|Part A, Washout 2||1
37957|NCT01667900|86284|P8|COMPLETED|Part A, Washout 2||1
37958|NCT01667900|86285|P7|COMPLETED|Part A, Washout 2||1
37959|NCT01667900|86286|P6|COMPLETED|Part A, Washout 2||1
37960|NCT01667900|86287|P5|COMPLETED|Part A, Washout 2||1
37961|NCT01667900|86288|P4|COMPLETED|Part A, Washout 2||1
37962|NCT01667900|86289|P3|COMPLETED|Part A, Washout 2||1
37963|NCT01667900|86290|P2|COMPLETED|Part A, Washout 2||1
37964|NCT01667900|86291|P1|COMPLETED|Part A, Washout 2||1
37965|NCT01667900|86272|P20|STARTED|Part A, Washout 2||0
37966|NCT01667900|86273|P19|STARTED|Part A, Washout 2||0
37967|NCT01667900|86274|P18|STARTED|Part A, Washout 2||0
37968|NCT01667900|86275|P17|STARTED|Part A, Washout 2||0
37969|NCT01667900|86276|P16|STARTED|Part A, Washout 2||1
37970|NCT01667900|86277|P15|STARTED|Part A, Washout 2||1
37971|NCT01667900|86278|P14|STARTED|Part A, Washout 2||1
37972|NCT01667900|86279|P13|STARTED|Part A, Washout 2||1
37973|NCT01667900|86280|P12|STARTED|Part A, Washout 2||1
37974|NCT01667900|86281|P11|STARTED|Part A, Washout 2||1
37975|NCT01667900|86282|P10|STARTED|Part A, Washout 2||1
37976|NCT01667900|86283|P9|STARTED|Part A, Washout 2||1
37977|NCT01667900|86284|P8|STARTED|Part A, Washout 2||1
37978|NCT01667900|86285|P7|STARTED|Part A, Washout 2||1
37979|NCT01667900|86286|P6|STARTED|Part A, Washout 2||1
37980|NCT01667900|86287|P5|STARTED|Part A, Washout 2||1
37981|NCT01667900|86288|P4|STARTED|Part A, Washout 2||1
37982|NCT01667900|86289|P3|STARTED|Part A, Washout 2||1
37983|NCT01667900|86290|P2|STARTED|Part A, Washout 2||1
37984|NCT01667900|86291|P1|STARTED|Part A, Washout 2||1
37985|NCT01667900|86272|P20|NOT COMPLETED|Part A, Period 2||0
37986|NCT01667900|86273|P19|NOT COMPLETED|Part A, Period 2||0
37987|NCT01667900|86274|P18|NOT COMPLETED|Part A, Period 2||0
37988|NCT01667900|86275|P17|NOT COMPLETED|Part A, Period 2||0
37989|NCT01667900|86276|P16|NOT COMPLETED|Part A, Period 2||0
37990|NCT01667900|86277|P15|NOT COMPLETED|Part A, Period 2||0
37991|NCT01667900|86278|P14|NOT COMPLETED|Part A, Period 2||0
37992|NCT01667900|86279|P13|NOT COMPLETED|Part A, Period 2||0
37993|NCT01667900|86280|P12|NOT COMPLETED|Part A, Period 2||0
37994|NCT01667900|86281|P11|NOT COMPLETED|Part A, Period 2||0
37995|NCT01667900|86282|P10|NOT COMPLETED|Part A, Period 2||0
37996|NCT01667900|86283|P9|NOT COMPLETED|Part A, Period 2||0
37997|NCT01667900|86284|P8|NOT COMPLETED|Part A, Period 2||0
37998|NCT01667900|86285|P7|NOT COMPLETED|Part A, Period 2||0
37999|NCT01667900|86286|P6|NOT COMPLETED|Part A, Period 2||0
38000|NCT01667900|86287|P5|NOT COMPLETED|Part A, Period 2||0
38001|NCT01667900|86288|P4|NOT COMPLETED|Part A, Period 2||0
38002|NCT01667900|86289|P3|NOT COMPLETED|Part A, Period 2||0
38003|NCT01667900|86290|P2|NOT COMPLETED|Part A, Period 2||0
38004|NCT01667900|86291|P1|NOT COMPLETED|Part A, Period 2||0
38005|NCT01667900|86272|P20|COMPLETED|Part A, Period 2||0
38006|NCT01667900|86273|P19|COMPLETED|Part A, Period 2||0
38007|NCT01667900|86274|P18|COMPLETED|Part A, Period 2||0
38008|NCT01667900|86275|P17|COMPLETED|Part A, Period 2||0
38009|NCT01667900|86276|P16|COMPLETED|Part A, Period 2||1
38010|NCT01667900|86277|P15|COMPLETED|Part A, Period 2||1
38011|NCT01667900|86278|P14|COMPLETED|Part A, Period 2||1
38012|NCT01667900|86279|P13|COMPLETED|Part A, Period 2||1
38013|NCT01667900|86280|P12|COMPLETED|Part A, Period 2||1
38014|NCT01667900|86281|P11|COMPLETED|Part A, Period 2||1
38015|NCT01667900|86282|P10|COMPLETED|Part A, Period 2||1
38016|NCT01667900|86283|P9|COMPLETED|Part A, Period 2||1
38017|NCT01667900|86284|P8|COMPLETED|Part A, Period 2||1
38018|NCT01667900|86285|P7|COMPLETED|Part A, Period 2||1
38019|NCT01667900|86286|P6|COMPLETED|Part A, Period 2||1
38020|NCT01667900|86287|P5|COMPLETED|Part A, Period 2||1
38021|NCT01667900|86288|P4|COMPLETED|Part A, Period 2||1
38022|NCT01667900|86289|P3|COMPLETED|Part A, Period 2||1
38023|NCT01667900|86290|P2|COMPLETED|Part A, Period 2||1
38024|NCT01667900|86291|P1|COMPLETED|Part A, Period 2||1
38025|NCT01667900|86272|P20|STARTED|Part A, Period 2||0
38026|NCT01667900|86273|P19|STARTED|Part A, Period 2||0
38027|NCT01667900|86274|P18|STARTED|Part A, Period 2||0
38028|NCT01667900|86275|P17|STARTED|Part A, Period 2||0
38029|NCT01667900|86276|P16|STARTED|Part A, Period 2||1
38030|NCT01667900|86277|P15|STARTED|Part A, Period 2||1
38031|NCT01667900|86278|P14|STARTED|Part A, Period 2||1
38032|NCT01667900|86279|P13|STARTED|Part A, Period 2||1
38033|NCT01667900|86280|P12|STARTED|Part A, Period 2||1
38034|NCT01667900|86281|P11|STARTED|Part A, Period 2||1
38035|NCT01667900|86282|P10|STARTED|Part A, Period 2||1
38036|NCT01667900|86283|P9|STARTED|Part A, Period 2||1
38037|NCT01667900|86284|P8|STARTED|Part A, Period 2||1
38038|NCT01667900|86285|P7|STARTED|Part A, Period 2||1
38039|NCT01667900|86286|P6|STARTED|Part A, Period 2||1
38040|NCT01667900|86287|P5|STARTED|Part A, Period 2||1
38041|NCT01667900|86288|P4|STARTED|Part A, Period 2||1
38042|NCT01667900|86289|P3|STARTED|Part A, Period 2||1
38043|NCT01667900|86290|P2|STARTED|Part A, Period 2||1
38044|NCT01667900|86291|P1|STARTED|Part A, Period 2||1
38045|NCT01667900|86272|P20|NOT COMPLETED|Part A, Washout 1||0
38046|NCT01667900|86273|P19|NOT COMPLETED|Part A, Washout 1||0
38047|NCT01667900|86274|P18|NOT COMPLETED|Part A, Washout 1||0
38048|NCT01667900|86275|P17|NOT COMPLETED|Part A, Washout 1||0
38049|NCT01667900|86276|P16|NOT COMPLETED|Part A, Washout 1||0
38050|NCT01667900|86277|P15|NOT COMPLETED|Part A, Washout 1||0
38051|NCT01667900|86278|P14|NOT COMPLETED|Part A, Washout 1||0
38052|NCT01667900|86279|P13|NOT COMPLETED|Part A, Washout 1||0
38053|NCT01667900|86280|P12|NOT COMPLETED|Part A, Washout 1||0
38054|NCT01667900|86281|P11|NOT COMPLETED|Part A, Washout 1||0
38055|NCT01667900|86282|P10|NOT COMPLETED|Part A, Washout 1||0
38056|NCT01667900|86283|P9|NOT COMPLETED|Part A, Washout 1||0
38057|NCT01667900|86284|P8|NOT COMPLETED|Part A, Washout 1||0
38058|NCT01667900|86285|P7|NOT COMPLETED|Part A, Washout 1||0
38059|NCT01667900|86286|P6|NOT COMPLETED|Part A, Washout 1||0
38060|NCT01667900|86287|P5|NOT COMPLETED|Part A, Washout 1||0
38061|NCT01667900|86288|P4|NOT COMPLETED|Part A, Washout 1||0
38062|NCT01667900|86289|P3|NOT COMPLETED|Part A, Washout 1||0
38063|NCT01667900|86290|P2|NOT COMPLETED|Part A, Washout 1||0
38064|NCT01667900|86291|P1|NOT COMPLETED|Part A, Washout 1||0
38065|NCT01667900|86272|P20|COMPLETED|Part A, Washout 1||0
38066|NCT01667900|86273|P19|COMPLETED|Part A, Washout 1||0
38067|NCT01667900|86274|P18|COMPLETED|Part A, Washout 1||0
38068|NCT01667900|86275|P17|COMPLETED|Part A, Washout 1||0
38069|NCT01667900|86276|P16|COMPLETED|Part A, Washout 1||1
38070|NCT01667900|86277|P15|COMPLETED|Part A, Washout 1||1
38071|NCT01667900|86278|P14|COMPLETED|Part A, Washout 1||1
38072|NCT01667900|86279|P13|COMPLETED|Part A, Washout 1||1
38073|NCT01667900|86280|P12|COMPLETED|Part A, Washout 1||1
38074|NCT01667900|86281|P11|COMPLETED|Part A, Washout 1||1
38075|NCT01667900|86282|P10|COMPLETED|Part A, Washout 1||1
38076|NCT01667900|86283|P9|COMPLETED|Part A, Washout 1||1
38077|NCT01667900|86284|P8|COMPLETED|Part A, Washout 1||1
38078|NCT01667900|86285|P7|COMPLETED|Part A, Washout 1||1
38079|NCT01667900|86286|P6|COMPLETED|Part A, Washout 1||1
38080|NCT01667900|86287|P5|COMPLETED|Part A, Washout 1||1
38081|NCT01667900|86288|P4|COMPLETED|Part A, Washout 1||1
38082|NCT01667900|86289|P3|COMPLETED|Part A, Washout 1||1
38083|NCT01667900|86290|P2|COMPLETED|Part A, Washout 1||1
38084|NCT01667900|86291|P1|COMPLETED|Part A, Washout 1||1
38085|NCT01667900|86272|P20|STARTED|Part A, Washout 1||0
38086|NCT01667900|86273|P19|STARTED|Part A, Washout 1||0
38087|NCT01667900|86274|P18|STARTED|Part A, Washout 1||0
38088|NCT01667900|86275|P17|STARTED|Part A, Washout 1||0
38089|NCT01667900|86276|P16|STARTED|Part A, Washout 1||1
38090|NCT01667900|86277|P15|STARTED|Part A, Washout 1||1
38091|NCT01667900|86278|P14|STARTED|Part A, Washout 1||1
38092|NCT01667900|86279|P13|STARTED|Part A, Washout 1||1
38093|NCT01667900|86280|P12|STARTED|Part A, Washout 1||1
38094|NCT01667900|86281|P11|STARTED|Part A, Washout 1||1
38095|NCT01667900|86282|P10|STARTED|Part A, Washout 1||1
38096|NCT01667900|86283|P9|STARTED|Part A, Washout 1||1
38097|NCT01667900|86284|P8|STARTED|Part A, Washout 1||1
38098|NCT01667900|86285|P7|STARTED|Part A, Washout 1||1
38099|NCT01667900|86286|P6|STARTED|Part A, Washout 1||1
38100|NCT01667900|86287|P5|STARTED|Part A, Washout 1||1
38101|NCT01667900|86288|P4|STARTED|Part A, Washout 1||1
38102|NCT01667900|86289|P3|STARTED|Part A, Washout 1||1
38103|NCT01667900|86290|P2|STARTED|Part A, Washout 1||1
38104|NCT01667900|86291|P1|STARTED|Part A, Washout 1||1
38105|NCT01667900|86272|P20|NOT COMPLETED|Part A, Period 1||0
38106|NCT01667900|86273|P19|NOT COMPLETED|Part A, Period 1||0
38107|NCT01667900|86274|P18|NOT COMPLETED|Part A, Period 1||0
38108|NCT01667900|86275|P17|NOT COMPLETED|Part A, Period 1||0
38109|NCT01667900|86276|P16|NOT COMPLETED|Part A, Period 1||0
38110|NCT01667900|86277|P15|NOT COMPLETED|Part A, Period 1||0
38111|NCT01667900|86278|P14|NOT COMPLETED|Part A, Period 1||0
38112|NCT01667900|86279|P13|NOT COMPLETED|Part A, Period 1||0
38113|NCT01667900|86280|P12|NOT COMPLETED|Part A, Period 1||0
38114|NCT01667900|86281|P11|NOT COMPLETED|Part A, Period 1||0
38115|NCT01667900|86282|P10|NOT COMPLETED|Part A, Period 1||0
38116|NCT01667900|86283|P9|NOT COMPLETED|Part A, Period 1||0
38117|NCT01667900|86284|P8|NOT COMPLETED|Part A, Period 1||0
38118|NCT01667900|86285|P7|NOT COMPLETED|Part A, Period 1||0
38119|NCT01667900|86286|P6|NOT COMPLETED|Part A, Period 1||0
38120|NCT01667900|86287|P5|NOT COMPLETED|Part A, Period 1||0
38121|NCT01667900|86288|P4|NOT COMPLETED|Part A, Period 1||0
38122|NCT01667900|86289|P3|NOT COMPLETED|Part A, Period 1||0
38123|NCT01667900|86290|P2|NOT COMPLETED|Part A, Period 1||0
38124|NCT01667900|86291|P1|NOT COMPLETED|Part A, Period 1||0
38125|NCT01667900|86272|P20|COMPLETED|Part A, Period 1||0
38126|NCT01667900|86273|P19|COMPLETED|Part A, Period 1||0
38127|NCT01667900|86274|P18|COMPLETED|Part A, Period 1||0
38128|NCT01667900|86275|P17|COMPLETED|Part A, Period 1||0
38129|NCT01667900|86276|P16|COMPLETED|Part A, Period 1||1
38130|NCT01667900|86277|P15|COMPLETED|Part A, Period 1||1
38131|NCT01667900|86278|P14|COMPLETED|Part A, Period 1||1
38132|NCT01667900|86279|P13|COMPLETED|Part A, Period 1||1
38133|NCT01667900|86280|P12|COMPLETED|Part A, Period 1||1
38134|NCT01667900|86281|P11|COMPLETED|Part A, Period 1||1
38135|NCT01667900|86282|P10|COMPLETED|Part A, Period 1||1
38136|NCT01667900|86283|P9|COMPLETED|Part A, Period 1||1
38137|NCT01667900|86284|P8|COMPLETED|Part A, Period 1||1
38138|NCT01667900|86285|P7|COMPLETED|Part A, Period 1||1
38139|NCT01667900|86286|P6|COMPLETED|Part A, Period 1||1
38140|NCT01667900|86287|P5|COMPLETED|Part A, Period 1||1
38141|NCT01667900|86288|P4|COMPLETED|Part A, Period 1||1
38142|NCT01667900|86289|P3|COMPLETED|Part A, Period 1||1
38143|NCT01667900|86290|P2|COMPLETED|Part A, Period 1||1
38144|NCT01667900|86291|P1|COMPLETED|Part A, Period 1||1
38145|NCT01667900|86272|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
38146|NCT01667900|86273|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
38147|NCT01667900|86274|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
38148|NCT01667900|86275|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
38149|NCT01667900|86276|P16|STARTED|Part A, Period 1||1
38150|NCT01667900|86277|P15|STARTED|Part A, Period 1||1
38151|NCT01667900|86278|P14|STARTED|Part A, Period 1||1
38152|NCT01667900|86279|P13|STARTED|Part A, Period 1||1
38153|NCT01667900|86280|P12|STARTED|Part A, Period 1||1
38154|NCT01667900|86281|P11|STARTED|Part A, Period 1||1
38155|NCT01667900|86282|P10|STARTED|Part A, Period 1||1
38156|NCT01667900|86283|P9|STARTED|Part A, Period 1||1
38157|NCT01667900|86284|P8|STARTED|Part A, Period 1||1
38158|NCT01667900|86285|P7|STARTED|Part A, Period 1||1
38159|NCT01667900|86286|P6|STARTED|Part A, Period 1||1
38160|NCT01667900|86287|P5|STARTED|Part A, Period 1||1
38161|NCT01667900|86288|P4|STARTED|Part A, Period 1||1
38162|NCT01667900|86289|P3|STARTED|Part A, Period 1||1
38163|NCT01667900|86290|P2|STARTED|Part A, Period 1||1
38164|NCT01667900|86291|P1|STARTED|Part A, Period 1||1
38165|NCT01667848|86331|P2|NOT COMPLETED|Overall Study||0
38166|NCT01667848|86332|P1|NOT COMPLETED|Overall Study||0
38167|NCT01667848|86331|P2|COMPLETED|Overall Study||81
38168|NCT01667848|86332|P1|COMPLETED|Overall Study||67
38169|NCT01667848|86331|P2|STARTED|Overall Study||81
38170|NCT01667848|86332|P1|STARTED|Overall Study||67
38171|NCT01667796|86342|P2|NOT COMPLETED|Overall Study||1
38172|NCT01667796|86343|P1|NOT COMPLETED|Overall Study||3
38173|NCT01667796|86342|P2|COMPLETED|Overall Study||29
38174|NCT01667796|86343|P1|COMPLETED|Overall Study||24
38175|NCT01667796|86342|P2|STARTED|Overall Study||30
38176|NCT01667796|86343|P1|STARTED|Overall Study||27
38177|NCT01667731|86354|P5|NOT COMPLETED|Overall Study||28
38178|NCT01667731|86355|P4|NOT COMPLETED|Overall Study||2
38179|NCT01667731|86356|P3|NOT COMPLETED|Overall Study||2
38180|NCT01667731|86357|P2|NOT COMPLETED|Overall Study||16
38181|NCT01667731|86358|P1|NOT COMPLETED|Overall Study||5
38182|NCT01667731|86354|P5|COMPLETED|Overall Study||87
38183|NCT01667731|86355|P4|COMPLETED|Overall Study||15
38184|NCT01667731|86356|P3|COMPLETED|Overall Study||22
38185|NCT01667731|86357|P2|COMPLETED|Overall Study||26
38186|NCT01667731|86358|P1|COMPLETED|Overall Study||21
38187|NCT01667731|86354|P5|STARTED|Overall Study||115
38188|NCT01667731|86355|P4|STARTED|Overall Study||17
38189|NCT01667731|86356|P3|STARTED|Overall Study||24
38190|NCT01667731|86357|P2|STARTED|Overall Study||42
38191|NCT01667731|86358|P1|STARTED|Overall Study||26
38192|NCT01667536|86411|P1|NOT COMPLETED|Overall Study||0
38193|NCT01667536|86411|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
38194|NCT01667536|86411|P1|STARTED|Overall Study||105
38195|NCT01667471|86422|P1|NOT COMPLETED|Overall Study||0
38196|NCT01667471|86422|P1|COMPLETED|Overall Study||7
38197|NCT01667471|86422|P1|STARTED|Overall Study||7
38198|NCT01667432|86438|P1|NOT COMPLETED|Overall Study||57
38199|NCT01667432|86438|P1|COMPLETED|Overall Study||84
38200|NCT01667432|86438|P1|STARTED|Overall Study||141
38201|NCT01667224|86445|P2|NOT COMPLETED|Overall Study||2
38202|NCT01667224|86446|P1|NOT COMPLETED|Overall Study||4
38203|NCT01667224|86445|P2|COMPLETED|Overall Study||38
38204|NCT01667224|86446|P1|COMPLETED|Overall Study||36
38205|NCT01667224|86445|P2|STARTED|Overall Study||40
38206|NCT01667224|86446|P1|STARTED|Overall Study||40
38207|NCT01667107|86460|P2|NOT COMPLETED|Overall Study||7
38208|NCT01667107|86461|P1|NOT COMPLETED|Overall Study||4
38209|NCT01667107|86460|P2|COMPLETED|Overall Study||11
38210|NCT01667107|86461|P1|COMPLETED|Overall Study||4
38211|NCT01667107|86460|P2|STARTED|Overall Study||18
38212|NCT01667107|86461|P1|STARTED|Overall Study||8
38213|NCT01666951|86479|P2|NOT COMPLETED|Overall Study||1
38214|NCT01666951|86480|P1|NOT COMPLETED|Overall Study||1
38215|NCT01666951|86479|P2|COMPLETED|Overall Study||17
38216|NCT01666951|86480|P1|COMPLETED|Overall Study||17
38217|NCT01666951|86479|P2|STARTED|Overall Study||18
38218|NCT01666951|86480|P1|STARTED|Overall Study||18
38219|NCT01666782|86518|P2|NOT COMPLETED|Overall Study||1
38220|NCT01666782|86519|P1|NOT COMPLETED|Overall Study||4
38221|NCT01666782|86518|P2|COMPLETED|Overall Study||50
38222|NCT01666782|86519|P1|COMPLETED|Overall Study||50
38223|NCT01666782|86518|P2|STARTED|Overall Study||51
38224|NCT01666782|86519|P1|STARTED|Overall Study||54
38225|NCT01666197|86537|P2|NOT COMPLETED|Overall Study||0
38226|NCT01666197|86538|P1|NOT COMPLETED|Overall Study||0
38227|NCT01666197|86537|P2|COMPLETED|Overall Study||50
38228|NCT01666197|86538|P1|COMPLETED|Overall Study||50
38229|NCT01666197|86537|P2|STARTED|Overall Study||50
38230|NCT01666197|86538|P1|STARTED|Overall Study||50
38231|NCT01666002|86546|P2|NOT COMPLETED|Overall Study||0
38232|NCT01666002|86547|P1|NOT COMPLETED|Overall Study||5
38233|NCT01666002|86546|P2|COMPLETED|Overall Study||10
38234|NCT01666002|86547|P1|COMPLETED|Overall Study||12
38235|NCT01666002|86546|P2|STARTED|Overall Study||10
38236|NCT01666002|86547|P1|STARTED|Overall Study||17
38237|NCT01665911|86555|P1|NOT COMPLETED|Overall Study||6
38238|NCT01665911|86555|P1|COMPLETED|Overall Study||22
38239|NCT01665911|86555|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
38240|NCT01665911|86555|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
38241|NCT01665911|86555|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
38242|NCT01665911|86555|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
38243|NCT01665911|86555|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
38244|NCT01665911|86555|P1|STARTED|Overall Study||28
38245|NCT01665807|86564|P3|NOT COMPLETED|Overall Study||1
38246|NCT01665807|86565|P2|NOT COMPLETED|Overall Study||0
38247|NCT01665807|86566|P1|NOT COMPLETED|Overall Study||2
38248|NCT01665807|86564|P3|COMPLETED|Overall Study||401
38249|NCT01665807|86565|P2|COMPLETED|Overall Study||58
38250|NCT01665807|86566|P1|COMPLETED|Overall Study||409
38251|NCT01665807|86564|P3|STARTED|Overall Study||402
38252|NCT01665807|86565|P2|STARTED|Overall Study||58
38253|NCT01665807|86566|P1|STARTED|Overall Study||411
38254|NCT01665170|86579|P2|NOT COMPLETED|Overall Study||0
38255|NCT01665170|86580|P1|NOT COMPLETED|Overall Study||0
38256|NCT01665170|86579|P2|COMPLETED|Overall Study||30
38257|NCT01665170|86580|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
38258|NCT01665170|86579|P2|After TSST|Overall Study||30
38259|NCT01665170|86580|P1|After TSST|Overall Study||30
38260|NCT01665170|86579|P2|During TSST|Overall Study||30
38261|NCT01665170|86580|P1|During TSST|Overall Study||30
38262|NCT01665170|86579|P2|Bevore TSST|Overall Study||30
38263|NCT01665170|86580|P1|Bevore TSST|Overall Study||30
38264|NCT01665170|86579|P2|STARTED|Overall Study||30
38265|NCT01665170|86580|P1|STARTED|Overall Study|First patient in|30
38266|NCT01665157|86631|P3|NOT COMPLETED|Overall Study||0
38267|NCT01665157|86632|P2|NOT COMPLETED|Overall Study||0
38268|NCT01665157|86633|P1|NOT COMPLETED|Overall Study||0
38269|NCT01665157|86631|P3|COMPLETED|Overall Study||60
38270|NCT01665157|86632|P2|COMPLETED|Overall Study||60
38271|NCT01665157|86633|P1|COMPLETED|Overall Study||60
38272|NCT01665157|86631|P3|STARTED|Overall Study||60
38273|NCT01665157|86632|P2|STARTED|Overall Study||60
38274|NCT01665157|86633|P1|STARTED|Overall Study||60
38275|NCT01665053|86661|P2|NOT COMPLETED|Overall Study||15
38276|NCT01665053|86662|P1|NOT COMPLETED|Overall Study||32
38277|NCT01665053|86661|P2|COMPLETED|Overall Study||831
38278|NCT01665053|86662|P1|COMPLETED|Overall Study||806
38279|NCT01665053|86661|P2|Death With No 12-month Clinical FU|Overall Study||9
38280|NCT01665053|86662|P1|Death With No 12-month Clinical FU|Overall Study||9
38281|NCT01665053|86661|P2|No 12-Month F/U|Overall Study||15
38282|NCT01665053|86662|P1|No 12-Month F/U|Overall Study||32
38283|NCT01665053|86661|P2|Completed 12-Month Clinical F/U|Overall Study||822
38284|NCT01665053|86662|P1|Completed 12-Month Clinical F/U|Overall Study||797
38285|NCT01665053|86661|P2|STARTED|Overall Study||846
38286|NCT01665053|86662|P1|STARTED|Overall Study||838
38287|NCT01664975|86702|P2|NOT COMPLETED|Overall Study||3
38288|NCT01664975|86703|P1|NOT COMPLETED|Overall Study||5
38289|NCT01664975|86702|P2|COMPLETED|Overall Study||51
38290|NCT01664975|86703|P1|COMPLETED|Overall Study||52
38291|NCT01664975|86702|P2|STARTED|Overall Study||54
38292|NCT01664975|86703|P1|STARTED|Overall Study||57
38293|NCT01664949|86711|P2|NOT COMPLETED|Overall Study||25
38294|NCT01664949|86712|P1|NOT COMPLETED|Overall Study||24
38295|NCT01664949|86711|P2|COMPLETED|Overall Study||211
38296|NCT01664949|86712|P1|COMPLETED|Overall Study||200
38297|NCT01664949|86711|P2|STARTED|Overall Study||236
38298|NCT01664949|86712|P1|STARTED|Overall Study||224
38299|NCT01664923|86728|P2|NOT COMPLETED|Overall Study||158
38300|NCT01664923|86729|P1|NOT COMPLETED|Overall Study||93
38301|NCT01664923|86728|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
38302|NCT01664923|86729|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
38303|NCT01664923|86728|P2|Received Study Treatment|Overall Study||198
38304|NCT01664923|86729|P1|Received Study Treatment|Overall Study||197
38305|NCT01664923|86728|P2|STARTED|Overall Study||198
38306|NCT01664923|86729|P1|STARTED|Overall Study||198
38307|NCT01664806|86749|P2|NOT COMPLETED|Overall Study||0
38308|NCT01664806|86750|P1|NOT COMPLETED|Overall Study||0
38309|NCT01664806|86749|P2|COMPLETED|Overall Study||20
38310|NCT01664806|86750|P1|COMPLETED|Overall Study||20
38311|NCT01664806|86749|P2|STARTED|Overall Study||20
38312|NCT01664806|86750|P1|STARTED|Overall Study||20
38313|NCT01664793|86760|P2|NOT COMPLETED|Overall Study||0
38314|NCT01664793|86761|P1|NOT COMPLETED|Overall Study||0
38315|NCT01664793|86760|P2|COMPLETED|Overall Study||38626
38316|NCT01664793|86761|P1|COMPLETED|Overall Study||49039
38317|NCT01664793|86760|P2|STARTED|Overall Study||38626
38318|NCT01664793|86761|P1|STARTED|Overall Study||49039
38319|NCT01664624|86773|P4|NOT COMPLETED|Overall Study||0
38320|NCT01664624|86774|P3|NOT COMPLETED|Overall Study||0
38321|NCT01664624|86775|P2|NOT COMPLETED|Overall Study||1
38322|NCT01664624|86776|P1|NOT COMPLETED|Overall Study||0
38323|NCT01664624|86773|P4|COMPLETED|Overall Study||9
38324|NCT01664624|86774|P3|COMPLETED|Overall Study||10
38325|NCT01664624|86775|P2|COMPLETED|Overall Study||10
38326|NCT01664624|86776|P1|COMPLETED|Overall Study||10
38327|NCT01664624|86773|P4|STARTED|Overall Study||9
38328|NCT01664624|86774|P3|STARTED|Overall Study||10
38329|NCT01664624|86775|P2|STARTED|Overall Study||11
38330|NCT01664624|86776|P1|STARTED|Overall Study||10
38331|NCT01664559|86808|P2|NOT COMPLETED|Overall Study||0
38332|NCT01664559|86809|P1|NOT COMPLETED|Overall Study||0
38333|NCT01664559|86808|P2|COMPLETED|Overall Study||33
38334|NCT01664559|86809|P1|COMPLETED|Overall Study||34
38335|NCT01664559|86808|P2|STARTED|Overall Study||33
38336|NCT01664559|86809|P1|STARTED|Overall Study||34
38337|NCT01664533|86823|P1|NOT COMPLETED|Overall Study||57
38338|NCT01664533|86823|P1|COMPLETED|Overall Study||0
38339|NCT01664533|86823|P1|STARTED|Overall Study||57
38340|NCT01664494|86831|P1|NOT COMPLETED|Overall Study||193
38341|NCT01664494|86831|P1|COMPLETED|Overall Study||370
38342|NCT01664494|86831|P1|STARTED|Overall Study||563
38343|NCT01664247|86838|P2|NOT COMPLETED|Overall Study||41
38344|NCT01664247|86839|P1|NOT COMPLETED|Overall Study||14
38345|NCT01664247|86838|P2|COMPLETED|Overall Study||131
38346|NCT01664247|86839|P1|COMPLETED|Overall Study||160
38347|NCT01664247|86838|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
38348|NCT01664247|86839|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
38349|NCT01664247|86838|P2|STARTED|Overall Study||172
38350|NCT01664247|86839|P1|STARTED|Overall Study||174
38351|NCT01664117|86861|P1|NOT COMPLETED|Overall Study||0
38352|NCT01664117|86861|P1|COMPLETED|Overall Study||209
38353|NCT01664117|86861|P1|STARTED|Overall Study||209
38354|NCT01664052|86918|P2|NOT COMPLETED|Phase 2||4
38355|NCT01664052|86919|P1|NOT COMPLETED|Phase 2||0
38356|NCT01664052|86918|P2|COMPLETED|Phase 2||31
38357|NCT01664052|86919|P1|COMPLETED|Phase 2||0
38358|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
38359|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
38360|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
38361|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
38362|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
38363|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
38364|NCT01664052|86918|P2|HSG 1 Hour Post Placement|Phase 2||31
38365|NCT01664052|86919|P1|HSG 1 Hour Post Placement|Phase 2||0
38366|NCT01664052|86918|P2|Insert Placed|Phase 2||31
38367|NCT01664052|86919|P1|Insert Placed|Phase 2||0
38368|NCT01664052|86918|P2|STARTED|Phase 2||35
38369|NCT01664052|86919|P1|STARTED|Phase 2|Screened and enrolled|0
38370|NCT01664052|86918|P2|NOT COMPLETED|Phase 1||0
38371|NCT01664052|86919|P1|NOT COMPLETED|Phase 1||7
38372|NCT01664052|86918|P2|COMPLETED|Phase 1||0
38373|NCT01664052|86919|P1|COMPLETED|Phase 1||24
38374|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
38375|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
38376|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
38377|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
38378|NCT01664052|86918|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
38379|NCT01664052|86919|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
38380|NCT01664052|86918|P2|HSG 1 Hour Post Placement|Phase 1||0
38381|NCT01664052|86919|P1|HSG 1 Hour Post Placement|Phase 1||24
38382|NCT01664052|86918|P2|Insert Placed in at Least One Tube|Phase 1||0
38383|NCT01664052|86919|P1|Insert Placed in at Least One Tube|Phase 1||25
38384|NCT01664052|86918|P2|STARTED|Phase 1||0
38385|NCT01664052|86919|P1|STARTED|Phase 1|Screening and enrollment|31
38386|NCT01664039|86937|P2|NOT COMPLETED|Overall Study||9
38387|NCT01664039|86938|P1|NOT COMPLETED|Overall Study||6
38388|NCT01664039|86937|P2|COMPLETED|Overall Study||43
38389|NCT01664039|86938|P1|COMPLETED|Overall Study||46
38390|NCT01664039|86937|P2|STARTED|Overall Study||52
38391|NCT01664039|86938|P1|STARTED|Overall Study||52
38392|NCT01663987|86960|P2|NOT COMPLETED|Overall Study||6
38393|NCT01663987|86961|P1|NOT COMPLETED|Overall Study||13
38394|NCT01663987|86960|P2|COMPLETED|Overall Study||34
38395|NCT01663987|86961|P1|COMPLETED|Overall Study||26
38396|NCT01663987|86960|P2|STARTED|Overall Study||40
38397|NCT01663987|86961|P1|STARTED|Overall Study||39
38398|NCT01663922|86987|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
38399|NCT01663922|86988|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
38400|NCT01663922|86987|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
38401|NCT01663922|86988|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
38402|NCT01663922|86987|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
38403|NCT01663922|86988|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
38404|NCT01663922|86987|P2|NOT COMPLETED|Washout (7 Days)||0
38405|NCT01663922|86988|P1|NOT COMPLETED|Washout (7 Days)||0
38406|NCT01663922|86987|P2|COMPLETED|Washout (7 Days)||9
38407|NCT01663922|86988|P1|COMPLETED|Washout (7 Days)||8
38408|NCT01663922|86987|P2|STARTED|Washout (7 Days)||9
38409|NCT01663922|86988|P1|STARTED|Washout (7 Days)||8
38410|NCT01663922|86987|P2|NOT COMPLETED|Second Intervention (14 Days)||0
38411|NCT01663922|86988|P1|NOT COMPLETED|Second Intervention (14 Days)||0
38412|NCT01663922|86987|P2|COMPLETED|Second Intervention (14 Days)||9
38413|NCT01663922|86988|P1|COMPLETED|Second Intervention (14 Days)||8
38414|NCT01663922|86987|P2|STARTED|Second Intervention (14 Days)||9
38415|NCT01663922|86988|P1|STARTED|Second Intervention (14 Days)||8
38416|NCT01663922|86987|P2|NOT COMPLETED|Washout (7 Days)||0
38417|NCT01663922|86988|P1|NOT COMPLETED|Washout (7 Days)||0
38418|NCT01663922|86987|P2|COMPLETED|Washout (7 Days)||9
38419|NCT01663922|86988|P1|COMPLETED|Washout (7 Days)||8
38420|NCT01663922|86987|P2|STARTED|Washout (7 Days)||9
38421|NCT01663922|86988|P1|STARTED|Washout (7 Days)||8
38422|NCT01663922|86987|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
38423|NCT01663922|86988|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
38424|NCT01663922|86987|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
38425|NCT01663922|86988|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
38426|NCT01663922|86987|P2|STARTED|First Intervention (14 Days or 5 Days)||9
38427|NCT01663922|86988|P1|STARTED|First Intervention (14 Days or 5 Days)||8
38428|NCT01663779|86995|P2|NOT COMPLETED|Overall Study||0
38429|NCT01663779|86996|P1|NOT COMPLETED|Overall Study||0
38430|NCT01663779|86995|P2|COMPLETED|Overall Study||23
38431|NCT01663779|86996|P1|COMPLETED|Overall Study||27
38432|NCT01663779|86995|P2|STARTED|Overall Study||23
38433|NCT01663779|86996|P1|STARTED|Overall Study||27
38434|NCT01663727|87004|P2|NOT COMPLETED|Overall Study||239
38435|NCT01663727|87005|P1|NOT COMPLETED|Overall Study||242
38436|NCT01663727|87004|P2|COMPLETED|Overall Study||0
38437|NCT01663727|87005|P1|COMPLETED|Overall Study||0
38438|NCT01663727|87004|P2|STARTED|Overall Study||239
38439|NCT01663727|87005|P1|STARTED|Overall Study||242
38440|NCT01663714|87033|P1|NOT COMPLETED|Long-Term Follow-Up||6
38441|NCT01663714|87033|P1|COMPLETED|Long-Term Follow-Up||16
38442|NCT01663714|87033|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
38443|NCT01663714|87033|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
38444|NCT01663714|87033|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
38445|NCT01663714|87033|P1|STARTED|Dosimetric and Therapeutic Treatment||30
38446|NCT01663532|87062|P2|NOT COMPLETED|Overall Study||107
38447|NCT01663532|87063|P1|NOT COMPLETED|Overall Study||74
38448|NCT01663532|87062|P2|COMPLETED|Overall Study||65
38449|NCT01663532|87063|P1|COMPLETED|Overall Study||94
38450|NCT01663532|87062|P2|STARTED|Overall Study||172
38451|NCT01663532|87063|P1|STARTED|Overall Study||168
38452|NCT01663506|87081|P1|NOT COMPLETED|Overall Study||8
38453|NCT01663506|87081|P1|COMPLETED|Overall Study||15
38454|NCT01663506|87081|P1|STARTED|Overall Study||23
38455|NCT01663363|87110|P1|NOT COMPLETED|Overall Study||0
38456|NCT01663363|87110|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
38457|NCT01663363|87110|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
38458|NCT01663285|87115|P1|NOT COMPLETED|Overall Study||0
38459|NCT01663285|87115|P1|COMPLETED|Overall Study||1
38460|NCT01663285|87115|P1|STARTED|Overall Study||1
38461|NCT01663233|87123|P2|NOT COMPLETED|Overall Study||7
38462|NCT01663233|87124|P1|NOT COMPLETED|Overall Study||4
38463|NCT01663233|87123|P2|COMPLETED|Overall Study||129
38464|NCT01663233|87124|P1|COMPLETED|Overall Study||126
38465|NCT01663233|87123|P2|STARTED|Overall Study||136
38466|NCT01663233|87124|P1|STARTED|Overall Study||130
38467|NCT01663103|87148|P2|NOT COMPLETED|Overall Study||2
38468|NCT01663103|87149|P1|NOT COMPLETED|Overall Study||3
38469|NCT01663103|87148|P2|COMPLETED|Overall Study||19
38470|NCT01663103|87149|P1|COMPLETED|Overall Study||18
38471|NCT01663103|87148|P2|STARTED|Overall Study||21
38472|NCT01663103|87149|P1|STARTED|Overall Study||21
38473|NCT01663012|87165|P1|NOT COMPLETED|Overall Study||0
38474|NCT01663012|87165|P1|COMPLETED|Overall Study||20
38475|NCT01663012|87165|P1|STARTED|Overall Study||20
38476|NCT01662999|87177|P6|NOT COMPLETED|Period 3||0
38477|NCT01662999|87178|P5|NOT COMPLETED|Period 3||0
38478|NCT01662999|87179|P4|NOT COMPLETED|Period 3||0
38479|NCT01662999|87180|P3|NOT COMPLETED|Period 3||0
38480|NCT01662999|87181|P2|NOT COMPLETED|Period 3||1
38481|NCT01662999|87182|P1|NOT COMPLETED|Period 3||0
38482|NCT01662999|87177|P6|COMPLETED|Period 3||7
38483|NCT01662999|87178|P5|COMPLETED|Period 3||7
38484|NCT01662999|87179|P4|COMPLETED|Period 3||7
38485|NCT01662999|87180|P3|COMPLETED|Period 3||7
38486|NCT01662999|87181|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
38487|NCT01662999|87182|P1|COMPLETED|Period 3||7
38488|NCT01662999|87177|P6|STARTED|Period 3||7
38489|NCT01662999|87178|P5|STARTED|Period 3||7
38490|NCT01662999|87179|P4|STARTED|Period 3||7
38491|NCT01662999|87180|P3|STARTED|Period 3||7
38492|NCT01662999|87181|P2|STARTED|Period 3||7
38493|NCT01662999|87182|P1|STARTED|Period 3||7
38494|NCT01662999|87177|P6|NOT COMPLETED|Period 2||0
38495|NCT01662999|87178|P5|NOT COMPLETED|Period 2||0
38496|NCT01662999|87179|P4|NOT COMPLETED|Period 2||0
38497|NCT01662999|87180|P3|NOT COMPLETED|Period 2||0
38498|NCT01662999|87181|P2|NOT COMPLETED|Period 2||0
38499|NCT01662999|87182|P1|NOT COMPLETED|Period 2||0
38500|NCT01662999|87177|P6|COMPLETED|Period 2||7
38501|NCT01662999|87178|P5|COMPLETED|Period 2||7
38502|NCT01662999|87179|P4|COMPLETED|Period 2||7
38503|NCT01662999|87180|P3|COMPLETED|Period 2||7
38504|NCT01662999|87181|P2|COMPLETED|Period 2||7
38505|NCT01662999|87182|P1|COMPLETED|Period 2||7
38506|NCT01662999|87177|P6|STARTED|Period 2||7
38507|NCT01662999|87178|P5|STARTED|Period 2||7
38508|NCT01662999|87179|P4|STARTED|Period 2||7
38509|NCT01662999|87180|P3|STARTED|Period 2||7
38510|NCT01662999|87181|P2|STARTED|Period 2||7
38511|NCT01662999|87182|P1|STARTED|Period 2||7
38512|NCT01662999|87177|P6|NOT COMPLETED|Period 1||0
38513|NCT01662999|87178|P5|NOT COMPLETED|Period 1||0
38514|NCT01662999|87179|P4|NOT COMPLETED|Period 1||0
38515|NCT01662999|87180|P3|NOT COMPLETED|Period 1||0
38516|NCT01662999|87181|P2|NOT COMPLETED|Period 1||0
38517|NCT01662999|87182|P1|NOT COMPLETED|Period 1||0
38518|NCT01662999|87177|P6|COMPLETED|Period 1||7
38519|NCT01662999|87178|P5|COMPLETED|Period 1||7
38520|NCT01662999|87179|P4|COMPLETED|Period 1||7
38521|NCT01662999|87180|P3|COMPLETED|Period 1||7
38522|NCT01662999|87181|P2|COMPLETED|Period 1||7
38523|NCT01662999|87182|P1|COMPLETED|Period 1||7
38524|NCT01662999|87177|P6|STARTED|Period 1||7
38525|NCT01662999|87178|P5|STARTED|Period 1||7
38526|NCT01662999|87179|P4|STARTED|Period 1||7
38527|NCT01662999|87180|P3|STARTED|Period 1||7
38528|NCT01662999|87181|P2|STARTED|Period 1||7
38529|NCT01662999|87182|P1|STARTED|Period 1||7
38530|NCT01662986|87253|P2|NOT COMPLETED|Overall Study||13
38531|NCT01662986|87254|P1|NOT COMPLETED|Overall Study||18
38532|NCT01662986|87253|P2|COMPLETED|Overall Study||26
38533|NCT01662986|87254|P1|COMPLETED|Overall Study||22
38534|NCT01662986|87253|P2|STARTED|Overall Study||39
38535|NCT01662986|87254|P1|STARTED|Overall Study||40
38536|NCT01662882|87287|P3|NOT COMPLETED|Overall Study||0
38537|NCT01662882|87288|P2|NOT COMPLETED|Overall Study||0
38538|NCT01662882|87289|P1|NOT COMPLETED|Overall Study||0
38539|NCT01662882|87287|P3|COMPLETED|Overall Study||15
38540|NCT01662882|87288|P2|COMPLETED|Overall Study||18
38541|NCT01662882|87289|P1|COMPLETED|Overall Study||15
38542|NCT01662882|87287|P3|STARTED|Overall Study||15
38543|NCT01662882|87288|P2|STARTED|Overall Study||18
38544|NCT01662882|87289|P1|STARTED|Overall Study||15
38545|NCT01662791|87302|P2|NOT COMPLETED|Part 2 - Interventional||0
38546|NCT01662791|87303|P1|NOT COMPLETED|Part 2 - Interventional||0
38547|NCT01662791|87302|P2|COMPLETED|Part 2 - Interventional||0
38548|NCT01662791|87303|P1|COMPLETED|Part 2 - Interventional||8
38549|NCT01662791|87302|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
38550|NCT01662791|87303|P1|STARTED|Part 2 - Interventional||8
38551|NCT01662791|87302|P2|NOT COMPLETED|Part 1 - Observational||0
38552|NCT01662791|87303|P1|NOT COMPLETED|Part 1 - Observational||0
38553|NCT01662791|87302|P2|COMPLETED|Part 1 - Observational||41
38554|NCT01662791|87303|P1|COMPLETED|Part 1 - Observational||8
38555|NCT01662791|87302|P2|STARTED|Part 1 - Observational||41
38556|NCT01662791|87303|P1|STARTED|Part 1 - Observational||8
38557|NCT01662765|87327|P2|NOT COMPLETED|Overall Study||2
38558|NCT01662765|87328|P1|NOT COMPLETED|Overall Study||1
38559|NCT01662765|87327|P2|COMPLETED|Overall Study||40
38560|NCT01662765|87328|P1|COMPLETED|Overall Study||41
38561|NCT01662765|87327|P2|STARTED|Overall Study||42
38562|NCT01662765|87328|P1|STARTED|Overall Study||42
38563|NCT01662648|87342|P2|NOT COMPLETED|Overall Study||178
38564|NCT01662648|87343|P1|NOT COMPLETED|Overall Study||147
38565|NCT01662648|87342|P2|COMPLETED|Overall Study||419
38566|NCT01662648|87343|P1|COMPLETED|Overall Study||373
38567|NCT01662648|87342|P2|STARTED|Overall Study||597
38568|NCT01662648|87343|P1|STARTED|Overall Study||520
38569|NCT01662635|87365|P1|NOT COMPLETED|Overall Study||30
38570|NCT01662635|87365|P1|COMPLETED|Overall Study||200
38571|NCT01662635|87365|P1|STARTED|Overall Study||230
38572|NCT01662583|87374|P3|NOT COMPLETED|Overall Study||0
38573|NCT01662583|87375|P2|NOT COMPLETED|Overall Study||0
38574|NCT01662583|87376|P1|NOT COMPLETED|Overall Study||0
38575|NCT01662583|87374|P3|COMPLETED|Overall Study||219
38576|NCT01662583|87375|P2|COMPLETED|Overall Study||225
38577|NCT01662583|87376|P1|COMPLETED|Overall Study||216
38578|NCT01662583|87374|P3|STARTED|Overall Study||219
38579|NCT01662583|87375|P2|STARTED|Overall Study||225
38580|NCT01662583|87376|P1|STARTED|Overall Study||216
38581|NCT01662531|87389|P1|NOT COMPLETED|Overall Study||0
38582|NCT01662531|87389|P1|COMPLETED|Overall Study||27
38583|NCT01662531|87389|P1|STARTED|Overall Study||27
38584|NCT01662440|87417|P4|NOT COMPLETED|Overall Study||4
38585|NCT01662440|87418|P3|NOT COMPLETED|Overall Study||6
38586|NCT01662440|87419|P2|NOT COMPLETED|Overall Study||6
38587|NCT01662440|87420|P1|NOT COMPLETED|Overall Study||9
38588|NCT01662440|87417|P4|COMPLETED|Overall Study||52
38589|NCT01662440|87418|P3|COMPLETED|Overall Study||215
38590|NCT01662440|87419|P2|COMPLETED|Overall Study||211
38591|NCT01662440|87420|P1|COMPLETED|Overall Study||158
38592|NCT01662440|87417|P4|STARTED|Overall Study||56
38593|NCT01662440|87418|P3|STARTED|Overall Study||221
38594|NCT01662440|87419|P2|STARTED|Overall Study||217
38595|NCT01662440|87420|P1|STARTED|Overall Study||167
38596|NCT01662362|87468|P1|NOT COMPLETED|Overall Study||38
38597|NCT01662362|87468|P1|COMPLETED|Overall Study||25
38598|NCT01662362|87468|P1|STARTED|Overall Study||63
38599|NCT01662310|87473|P5|NOT COMPLETED|Open-Label Extension Phase||10
38600|NCT01662310|87474|P4|NOT COMPLETED|Open-Label Extension Phase||11
38601|NCT01662310|87475|P3|NOT COMPLETED|Open-Label Extension Phase||0
38602|NCT01662310|87476|P2|NOT COMPLETED|Open-Label Extension Phase||0
38603|NCT01662310|87477|P1|NOT COMPLETED|Open-Label Extension Phase||0
38604|NCT01662310|87473|P5|COMPLETED|Open-Label Extension Phase||49
38605|NCT01662310|87474|P4|COMPLETED|Open-Label Extension Phase||36
38606|NCT01662310|87475|P3|COMPLETED|Open-Label Extension Phase||0
38607|NCT01662310|87476|P2|COMPLETED|Open-Label Extension Phase||0
38608|NCT01662310|87477|P1|COMPLETED|Open-Label Extension Phase||0
38609|NCT01662310|87473|P5|STARTED|Open-Label Extension Phase||59
38610|NCT01662310|87474|P4|STARTED|Open-Label Extension Phase||47
38611|NCT01662310|87475|P3|STARTED|Open-Label Extension Phase||0
38612|NCT01662310|87476|P2|STARTED|Open-Label Extension Phase||0
38613|NCT01662310|87477|P1|STARTED|Open-Label Extension Phase||0
38614|NCT01662310|87473|P5|NOT COMPLETED|Double-Blind Phase||0
38615|NCT01662310|87474|P4|NOT COMPLETED|Double-Blind Phase||0
38616|NCT01662310|87475|P3|NOT COMPLETED|Double-Blind Phase||5
38617|NCT01662310|87476|P2|NOT COMPLETED|Double-Blind Phase||15
38618|NCT01662310|87477|P1|NOT COMPLETED|Double-Blind Phase||0
38619|NCT01662310|87473|P5|COMPLETED|Double-Blind Phase||0
38620|NCT01662310|87474|P4|COMPLETED|Double-Blind Phase||0
38621|NCT01662310|87475|P3|COMPLETED|Double-Blind Phase||66
38622|NCT01662310|87476|P2|COMPLETED|Double-Blind Phase||50
38623|NCT01662310|87477|P1|COMPLETED|Double-Blind Phase||0
38624|NCT01662310|87473|P5|Treated|Double-Blind Phase||0
38625|NCT01662310|87474|P4|Treated|Double-Blind Phase||0
38626|NCT01662310|87475|P3|Treated|Double-Blind Phase||71
38627|NCT01662310|87476|P2|Treated|Double-Blind Phase||64
38628|NCT01662310|87477|P1|Treated|Double-Blind Phase||0
38629|NCT01662310|87473|P5|STARTED|Double-Blind Phase||0
38630|NCT01662310|87474|P4|STARTED|Double-Blind Phase||0
38631|NCT01662310|87475|P3|STARTED|Double-Blind Phase||71
38632|NCT01662310|87476|P2|STARTED|Double-Blind Phase||65
38633|NCT01662310|87477|P1|STARTED|Double-Blind Phase||0
38634|NCT01662310|87473|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
38635|NCT01662310|87474|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
38636|NCT01662310|87475|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
38637|NCT01662310|87476|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
38638|NCT01662310|87477|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
38639|NCT01662310|87473|P5|COMPLETED|Run-In or Stabilization Phase||0
38640|NCT01662310|87474|P4|COMPLETED|Run-In or Stabilization Phase||0
38641|NCT01662310|87475|P3|COMPLETED|Run-In or Stabilization Phase||0
38642|NCT01662310|87476|P2|COMPLETED|Run-In or Stabilization Phase||0
38643|NCT01662310|87477|P1|COMPLETED|Run-In or Stabilization Phase||136
38644|NCT01662310|87473|P5|STARTED|Run-In or Stabilization Phase||0
38645|NCT01662310|87474|P4|STARTED|Run-In or Stabilization Phase||0
38646|NCT01662310|87475|P3|STARTED|Run-In or Stabilization Phase||0
38647|NCT01662310|87476|P2|STARTED|Run-In or Stabilization Phase||0
38648|NCT01662310|87477|P1|STARTED|Run-In or Stabilization Phase||201
38649|NCT01662102|87511|P2|NOT COMPLETED|Overall Study||0
38650|NCT01662102|87512|P1|NOT COMPLETED|Overall Study||1
38651|NCT01662102|87511|P2|COMPLETED|Overall Study||0
38652|NCT01662102|87512|P1|COMPLETED|Overall Study||0
38653|NCT01662102|87511|P2|STARTED|Overall Study||0
38654|NCT01662102|87512|P1|STARTED|Overall Study||1
38655|NCT01662063|87520|P3|NOT COMPLETED|Overall Study||1
38656|NCT01662063|87521|P2|NOT COMPLETED|Overall Study||29
38657|NCT01662063|87522|P1|NOT COMPLETED|Overall Study||5
38658|NCT01662063|87520|P3|COMPLETED|Overall Study||0
38659|NCT01662063|87521|P2|COMPLETED|Overall Study||144
38660|NCT01662063|87522|P1|COMPLETED|Overall Study||39
38661|NCT01662063|87520|P3|STARTED|Overall Study||1
38662|NCT01662063|87521|P2|STARTED|Overall Study||173
38663|NCT01662063|87522|P1|STARTED|Overall Study||44
38664|NCT01661933|87601|P1|NOT COMPLETED|High-dose Gluten Challenge||2
38665|NCT01661933|87601|P1|COMPLETED|High-dose Gluten Challenge||8
38666|NCT01661933|87601|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
38667|NCT01661933|87601|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
38668|NCT01661933|87601|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
38669|NCT01661933|87601|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
38670|NCT01661933|87601|P1|NOT COMPLETED|Gluten Micro-challenge||0
38671|NCT01661933|87601|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
38672|NCT01661933|87601|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
38673|NCT01661881|87608|P1|NOT COMPLETED|Overall Study||0
38674|NCT01661881|87608|P1|COMPLETED|Overall Study||23
38675|NCT01661881|87608|P1|STARTED|Overall Study||23
38676|NCT01661790|87616|P2|NOT COMPLETED|Overall Study||2
38677|NCT01661790|87617|P1|NOT COMPLETED|Overall Study||0
38678|NCT01661790|87616|P2|COMPLETED|Overall Study||34
38679|NCT01661790|87617|P1|COMPLETED|Overall Study||36
38680|NCT01661790|87616|P2|STARTED|Overall Study||36
38681|NCT01661790|87617|P1|STARTED|Overall Study||36
38682|NCT01661621|87625|P2|NOT COMPLETED|Overall Study||0
38683|NCT01661621|87626|P1|NOT COMPLETED|Overall Study||0
38684|NCT01661621|87625|P2|COMPLETED|Overall Study||279
38685|NCT01661621|87626|P1|COMPLETED|Overall Study||116
38686|NCT01661621|87625|P2|STARTED|Overall Study||279
38687|NCT01661621|87626|P1|STARTED|Overall Study||116
38688|NCT01661270|87648|P2|NOT COMPLETED|Overall Study||0
38689|NCT01661270|87649|P1|NOT COMPLETED|Overall Study||0
38690|NCT01661270|87648|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
38691|NCT01661270|87649|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
38692|NCT01661270|87648|P2|Other Reasons|Overall Study||2
38693|NCT01661270|87649|P1|Other Reasons|Overall Study||0
38694|NCT01661270|87648|P2|Participant’s Request|Overall Study|Met EOT criteria|48
38695|NCT01661270|87649|P1|Participant’s Request|Overall Study|Met EOT criteria|15
38696|NCT01661270|87648|P2|Physician Decision|Overall Study|Met EOT criteria|8
38697|NCT01661270|87649|P1|Physician Decision|Overall Study|Met EOT criteria|1
38698|NCT01661270|87648|P2|Disease Progression|Overall Study|Met EOT criteria|118
38699|NCT01661270|87649|P1|Disease Progression|Overall Study|Met EOT criteria|67
38700|NCT01661270|87648|P2|Adverse Event|Overall Study|Met EOT criteria|47
38701|NCT01661270|87649|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
38702|NCT01661270|87648|P2|STARTED|Overall Study||223
38703|NCT01661270|87649|P1|STARTED|Overall Study||109
38704|NCT01661179|87660|P1|NOT COMPLETED|Overall Study||6
38705|NCT01661179|87660|P1|COMPLETED|Overall Study||8
38706|NCT01661179|87660|P1|STARTED|Overall Study||14
38707|NCT01661140|87664|P3|NOT COMPLETED|Double-Blind Period||50
38708|NCT01661140|87665|P2|NOT COMPLETED|Double-Blind Period||41
38709|NCT01661140|87666|P1|NOT COMPLETED|Double-Blind Period||0
38710|NCT01661140|87664|P3|COMPLETED|Double-Blind Period||86
38711|NCT01661140|87665|P2|COMPLETED|Double-Blind Period||95
38712|NCT01661140|87666|P1|COMPLETED|Double-Blind Period||0
38713|NCT01661140|87664|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
38714|NCT01661140|87665|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
38715|NCT01661140|87666|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
38716|NCT01661140|87664|P3|NOT COMPLETED|Open-Label Period||0
38717|NCT01661140|87665|P2|NOT COMPLETED|Open-Label Period||0
38718|NCT01661140|87666|P1|NOT COMPLETED|Open-Label Period||76
38719|NCT01661140|87664|P3|COMPLETED|Open-Label Period||0
38720|NCT01661140|87665|P2|COMPLETED|Open-Label Period||0
38721|NCT01661140|87666|P1|COMPLETED|Open-Label Period||351
38722|NCT01661140|87664|P3|STARTED|Open-Label Period||0
38723|NCT01661140|87665|P2|STARTED|Open-Label Period||0
38724|NCT01661140|87666|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
38725|NCT01661114|87707|P1|NOT COMPLETED|Overall Study||0
38726|NCT01661114|87707|P1|COMPLETED|Overall Study||39
38727|NCT01661114|87707|P1|STARTED|Overall Study||39
38728|NCT01661062|87712|P1|NOT COMPLETED|Overall Study||5
38729|NCT01661062|87712|P1|COMPLETED|Overall Study||18
38730|NCT01661062|87712|P1|STARTED|Overall Study||23
38731|NCT01660906|87717|P1|NOT COMPLETED|Overall Study||3
38732|NCT01660906|87717|P1|COMPLETED|Overall Study||36
38733|NCT01660906|87717|P1|STARTED|Overall Study||39
38734|NCT01660815|87726|P1|NOT COMPLETED|Overall Study||0
38735|NCT01660815|87726|P1|COMPLETED|Overall Study||7
38736|NCT01660815|87726|P1|STARTED|Overall Study||7
38737|NCT01660802|87733|P2|NOT COMPLETED|Overall Study||11
38738|NCT01660802|87734|P1|NOT COMPLETED|Overall Study||4
38739|NCT01660802|87733|P2|COMPLETED|Overall Study||121
38740|NCT01660802|87734|P1|COMPLETED|Overall Study||126
38741|NCT01660802|87733|P2|STARTED|Overall Study||132
38742|NCT01660802|87734|P1|STARTED|Overall Study||130
38743|NCT01660763|87748|P2|NOT COMPLETED|Overall Study||61
38744|NCT01660763|87749|P1|NOT COMPLETED|Overall Study||100
38745|NCT01660763|87748|P2|COMPLETED|Overall Study||43
38746|NCT01660763|87749|P1|COMPLETED|Overall Study||215
38747|NCT01660763|87748|P2|STARTED|Overall Study||104
38748|NCT01660763|87749|P1|STARTED|Overall Study||315
38749|NCT01660698|87757|P2|NOT COMPLETED|Overall Study||0
38750|NCT01660698|87758|P1|NOT COMPLETED|Overall Study||0
38751|NCT01660698|87757|P2|COMPLETED|Overall Study||10
38752|NCT01660698|87758|P1|COMPLETED|Overall Study||10
38753|NCT01660698|87757|P2|STARTED|Overall Study||10
38754|NCT01660698|87758|P1|STARTED|Overall Study||10
38755|NCT01660672|87768|P1|NOT COMPLETED|Overall Study||0
38756|NCT01660672|87768|P1|COMPLETED|Overall Study||7
38757|NCT01660672|87768|P1|STARTED|Overall Study||7
38758|NCT01659736|87781|P2|NOT COMPLETED|3-month Follow-up||1
38759|NCT01659736|87782|P1|NOT COMPLETED|3-month Follow-up||0
38760|NCT01659736|87781|P2|COMPLETED|3-month Follow-up||9
38761|NCT01659736|87782|P1|COMPLETED|3-month Follow-up||9
38762|NCT01659736|87781|P2|STARTED|3-month Follow-up||10
38763|NCT01659736|87782|P1|STARTED|3-month Follow-up||9
38764|NCT01659736|87781|P2|NOT COMPLETED|Treatment Period||2
38765|NCT01659736|87782|P1|NOT COMPLETED|Treatment Period||5
38766|NCT01659736|87781|P2|COMPLETED|Treatment Period||10
38767|NCT01659736|87782|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
38768|NCT01659736|87781|P2|STARTED|Treatment Period||12
38769|NCT01659736|87782|P1|STARTED|Treatment Period||14
38770|NCT01659554|87796|P1|NOT COMPLETED|Overall Study||4
38771|NCT01659554|87796|P1|COMPLETED|Overall Study||0
38772|NCT01659554|87796|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
38773|NCT01660334|87803|P1|NOT COMPLETED|Overall Study||1
38774|NCT01660334|87803|P1|COMPLETED|Overall Study||12
38775|NCT01660334|87803|P1|STARTED|Overall Study||13
38776|NCT01660321|87808|P1|NOT COMPLETED|Overall Study||0
38777|NCT01660321|87808|P1|COMPLETED|Overall Study||26
38778|NCT01660321|87808|P1|STARTED|Overall Study||26
38779|NCT01660230|87832|P12|NOT COMPLETED|Overall Study||0
38780|NCT01660230|87833|P11|NOT COMPLETED|Overall Study||0
38781|NCT01660230|87834|P10|NOT COMPLETED|Overall Study||0
38782|NCT01660230|87835|P9|NOT COMPLETED|Overall Study||0
38783|NCT01660230|87836|P8|NOT COMPLETED|Overall Study||0
38784|NCT01660230|87837|P7|NOT COMPLETED|Overall Study||0
38785|NCT01660230|87838|P6|NOT COMPLETED|Overall Study||0
38786|NCT01660230|87839|P5|NOT COMPLETED|Overall Study||0
38787|NCT01660230|87840|P4|NOT COMPLETED|Overall Study||0
38788|NCT01660230|87841|P3|NOT COMPLETED|Overall Study||0
38789|NCT01660230|87842|P2|NOT COMPLETED|Overall Study||0
38790|NCT01660230|87843|P1|NOT COMPLETED|Overall Study||0
38791|NCT01660230|87832|P12|COMPLETED|Overall Study||14
38792|NCT01660230|87833|P11|COMPLETED|Overall Study||6
38793|NCT01660230|87834|P10|COMPLETED|Overall Study||6
38794|NCT01660230|87835|P9|COMPLETED|Overall Study||6
38795|NCT01660230|87836|P8|COMPLETED|Overall Study||6
38796|NCT01660230|87837|P7|COMPLETED|Overall Study||4
38797|NCT01660230|87838|P6|COMPLETED|Overall Study||2
38798|NCT01660230|87839|P5|COMPLETED|Overall Study||4
38799|NCT01660230|87840|P4|COMPLETED|Overall Study||4
38800|NCT01660230|87841|P3|COMPLETED|Overall Study||4
38801|NCT01660230|87842|P2|COMPLETED|Overall Study||4
38802|NCT01660230|87843|P1|COMPLETED|Overall Study||4
38803|NCT01660230|87832|P12|STARTED|Overall Study||14
38804|NCT01660230|87833|P11|STARTED|Overall Study||6
38805|NCT01660230|87834|P10|STARTED|Overall Study||6
38806|NCT01660230|87835|P9|STARTED|Overall Study||6
38807|NCT01660230|87836|P8|STARTED|Overall Study||6
38808|NCT01660230|87837|P7|STARTED|Overall Study||4
38809|NCT01660230|87838|P6|STARTED|Overall Study||2
38810|NCT01660230|87839|P5|STARTED|Overall Study||4
38811|NCT01660230|87840|P4|STARTED|Overall Study||4
38812|NCT01660230|87841|P3|STARTED|Overall Study||4
38813|NCT01660230|87842|P2|STARTED|Overall Study||4
38814|NCT01660230|87843|P1|STARTED|Overall Study||4
38815|NCT01660191|88015|P3|NOT COMPLETED|End of Treatment||1
38816|NCT01660191|88016|P2|NOT COMPLETED|End of Treatment||6
38817|NCT01660191|88017|P1|NOT COMPLETED|End of Treatment||1
38818|NCT01660191|88015|P3|COMPLETED|End of Treatment||43
38819|NCT01660191|88016|P2|COMPLETED|End of Treatment||39
38820|NCT01660191|88017|P1|COMPLETED|End of Treatment||44
38821|NCT01660191|88015|P3|STARTED|End of Treatment||44
38822|NCT01660191|88016|P2|STARTED|End of Treatment||45
38823|NCT01660191|88017|P1|STARTED|End of Treatment||45
38824|NCT01660191|88015|P3|NOT COMPLETED|Randomization||0
38825|NCT01660191|88016|P2|NOT COMPLETED|Randomization||0
38826|NCT01660191|88017|P1|NOT COMPLETED|Randomization||0
38827|NCT01660191|88015|P3|COMPLETED|Randomization||44
38828|NCT01660191|88016|P2|COMPLETED|Randomization||45
38829|NCT01660191|88017|P1|COMPLETED|Randomization||45
38830|NCT01660191|88015|P3|STARTED|Randomization||44
38831|NCT01660191|88016|P2|STARTED|Randomization||45
38832|NCT01660191|88017|P1|STARTED|Randomization||45
38833|NCT01660191|88015|P3|NOT COMPLETED|Enrollment and Washout||0
38834|NCT01660191|88016|P2|NOT COMPLETED|Enrollment and Washout||0
38835|NCT01660191|88017|P1|NOT COMPLETED|Enrollment and Washout||0
38836|NCT01660191|88015|P3|COMPLETED|Enrollment and Washout||44
38837|NCT01660191|88016|P2|COMPLETED|Enrollment and Washout||45
38838|NCT01660191|88017|P1|COMPLETED|Enrollment and Washout||45
38839|NCT01660191|88015|P3|STARTED|Enrollment and Washout||44
38840|NCT01660191|88016|P2|STARTED|Enrollment and Washout||45
38841|NCT01660191|88017|P1|STARTED|Enrollment and Washout||45
38842|NCT01660022|88046|P6|NOT COMPLETED|Second Sequence (42 Days)||0
38843|NCT01660022|88047|P5|NOT COMPLETED|Second Sequence (42 Days)||0
38844|NCT01660022|88048|P4|NOT COMPLETED|Second Sequence (42 Days)||0
38845|NCT01660022|88049|P3|NOT COMPLETED|Second Sequence (42 Days)||0
38846|NCT01660022|88050|P2|NOT COMPLETED|Second Sequence (42 Days)||0
38847|NCT01660022|88051|P1|NOT COMPLETED|Second Sequence (42 Days)||0
38848|NCT01660022|88046|P6|COMPLETED|Second Sequence (42 Days)||16
38849|NCT01660022|88047|P5|COMPLETED|Second Sequence (42 Days)||6
38850|NCT01660022|88048|P4|COMPLETED|Second Sequence (42 Days)||7
38851|NCT01660022|88049|P3|COMPLETED|Second Sequence (42 Days)||8
38852|NCT01660022|88050|P2|COMPLETED|Second Sequence (42 Days)||7
38853|NCT01660022|88051|P1|COMPLETED|Second Sequence (42 Days)||8
38854|NCT01660022|88046|P6|STARTED|Second Sequence (42 Days)||16
38855|NCT01660022|88047|P5|STARTED|Second Sequence (42 Days)||6
38856|NCT01660022|88048|P4|STARTED|Second Sequence (42 Days)||7
38857|NCT01660022|88049|P3|STARTED|Second Sequence (42 Days)||8
38858|NCT01660022|88050|P2|STARTED|Second Sequence (42 Days)||7
38859|NCT01660022|88051|P1|STARTED|Second Sequence (42 Days)||8
38860|NCT01660022|88046|P6|NOT COMPLETED|First Sequence (7 Days)||4
38861|NCT01660022|88047|P5|NOT COMPLETED|First Sequence (7 Days)||1
38862|NCT01660022|88048|P4|NOT COMPLETED|First Sequence (7 Days)||1
38863|NCT01660022|88049|P3|NOT COMPLETED|First Sequence (7 Days)||0
38864|NCT01660022|88050|P2|NOT COMPLETED|First Sequence (7 Days)||1
38865|NCT01660022|88051|P1|NOT COMPLETED|First Sequence (7 Days)||0
38866|NCT01660022|88046|P6|COMPLETED|First Sequence (7 Days)||16
38867|NCT01660022|88047|P5|COMPLETED|First Sequence (7 Days)||6
38868|NCT01660022|88048|P4|COMPLETED|First Sequence (7 Days)||7
38869|NCT01660022|88049|P3|COMPLETED|First Sequence (7 Days)||8
38870|NCT01660022|88050|P2|COMPLETED|First Sequence (7 Days)||7
38871|NCT01660022|88051|P1|COMPLETED|First Sequence (7 Days)||8
38872|NCT01660022|88046|P6|STARTED|First Sequence (7 Days)||20
38873|NCT01660022|88047|P5|STARTED|First Sequence (7 Days)||7
38874|NCT01660022|88048|P4|STARTED|First Sequence (7 Days)||8
38875|NCT01660022|88049|P3|STARTED|First Sequence (7 Days)||8
38876|NCT01660022|88050|P2|STARTED|First Sequence (7 Days)||8
38877|NCT01660022|88051|P1|STARTED|First Sequence (7 Days)||8
38878|NCT01659996|88110|P3|NOT COMPLETED|Overall Study||11
38879|NCT01659996|88111|P2|NOT COMPLETED|Overall Study||7
38880|NCT01659996|88112|P1|NOT COMPLETED|Overall Study||8
38881|NCT01659996|88110|P3|COMPLETED|Overall Study||461
38882|NCT01659996|88111|P2|COMPLETED|Overall Study||388
38883|NCT01659996|88112|P1|COMPLETED|Overall Study||413
38884|NCT01659996|88110|P3|STARTED|Overall Study||472
38885|NCT01659996|88111|P2|STARTED|Overall Study||395
38886|NCT01659996|88112|P1|STARTED|Overall Study||421
38887|NCT01659853|88144|P2|NOT COMPLETED|Treatment Period 2||0
38888|NCT01659853|88145|P1|NOT COMPLETED|Treatment Period 2||0
38889|NCT01659853|88144|P2|COMPLETED|Treatment Period 2||35
38890|NCT01659853|88145|P1|COMPLETED|Treatment Period 2||33
38891|NCT01659853|88144|P2|STARTED|Treatment Period 2||35
38892|NCT01659853|88145|P1|STARTED|Treatment Period 2||33
38893|NCT01659853|88144|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
38894|NCT01659853|88145|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
38895|NCT01659853|88144|P2|COMPLETED|Washout , 3 to 7 Days||35
38896|NCT01659853|88145|P1|COMPLETED|Washout , 3 to 7 Days||33
38897|NCT01659853|88144|P2|STARTED|Washout , 3 to 7 Days||35
38898|NCT01659853|88145|P1|STARTED|Washout , 3 to 7 Days||35
38899|NCT01659853|88144|P2|NOT COMPLETED|Treatment Period 1||0
38900|NCT01659853|88145|P1|NOT COMPLETED|Treatment Period 1||0
38901|NCT01659853|88144|P2|COMPLETED|Treatment Period 1||35
38902|NCT01659853|88145|P1|COMPLETED|Treatment Period 1||35
38903|NCT01659853|88144|P2|STARTED|Treatment Period 1||35
38904|NCT01659853|88145|P1|STARTED|Treatment Period 1||35
38905|NCT01659268|88155|P2|NOT COMPLETED|Overall Study||0
38906|NCT01659268|88156|P1|NOT COMPLETED|Overall Study||0
38907|NCT01659268|88155|P2|COMPLETED|Overall Study||8
38908|NCT01659268|88156|P1|COMPLETED|Overall Study||9
38909|NCT01659268|88155|P2|STARTED|Overall Study||8
38910|NCT01659268|88156|P1|STARTED|Overall Study||9
38911|NCT01659125|88168|P1|NOT COMPLETED|Overall Study||14
38912|NCT01659125|88168|P1|COMPLETED|Overall Study||12
38913|NCT01659125|88168|P1|Completed 6-month Follow-up|Overall Study||12
38914|NCT01659125|88168|P1|Completed 3-month Follow-up|Overall Study||16
38915|NCT01659125|88168|P1|Completed the Posttreatment Assessment|Overall Study||17
38916|NCT01659125|88168|P1|Initiated Treatment|Overall Study||24
38917|NCT01659125|88168|P1|STARTED|Overall Study||26
38918|NCT01658943|88175|P2|NOT COMPLETED|Overall Study||67
38919|NCT01658943|88176|P1|NOT COMPLETED|Overall Study||70
38920|NCT01658943|88175|P2|COMPLETED|Overall Study||0
38921|NCT01658943|88176|P1|COMPLETED|Overall Study||0
38922|NCT01658943|88175|P2|Eligible and Began Protocol Therapy|Overall Study||58
38923|NCT01658943|88176|P1|Eligible and Began Protocol Therapy|Overall Study||62
38924|NCT01658943|88175|P2|Eligible|Overall Study||58
38925|NCT01658943|88176|P1|Eligible|Overall Study||63
38926|NCT01658943|88175|P2|STARTED|Overall Study||67
38927|NCT01658943|88176|P1|STARTED|Overall Study||70
38928|NCT01658904|88191|P3|NOT COMPLETED|Overall Study||0
38929|NCT01658904|88192|P2|NOT COMPLETED|Overall Study||0
38930|NCT01658904|88193|P1|NOT COMPLETED|Overall Study||2
38931|NCT01658904|88191|P3|COMPLETED|Overall Study||0
38932|NCT01658904|88192|P2|COMPLETED|Overall Study||0
38933|NCT01658904|88193|P1|COMPLETED|Overall Study||1
38934|NCT01658904|88191|P3|STARTED|Overall Study||0
38935|NCT01658904|88192|P2|STARTED|Overall Study||0
38936|NCT01658904|88193|P1|STARTED|Overall Study||3
38937|NCT01658839|88210|P1|NOT COMPLETED|Overall Study||0
38938|NCT01658839|88210|P1|COMPLETED|Overall Study||25
38939|NCT01658839|88210|P1|STARTED|Overall Study||25
38940|NCT01658813|88219|P1|NOT COMPLETED|Overall Study||3
38941|NCT01658813|88219|P1|COMPLETED|Overall Study||15
38942|NCT01658813|88219|P1|Treated|Overall Study||18
38943|NCT01658813|88219|P1|Eligible|Overall Study||18
38944|NCT01658813|88219|P1|STARTED|Overall Study||18
38945|NCT01658735|88230|P3|NOT COMPLETED|Overall Study||4
38946|NCT01658735|88231|P2|NOT COMPLETED|Overall Study||7
38947|NCT01658735|88232|P1|NOT COMPLETED|Overall Study||5
38948|NCT01658735|88230|P3|COMPLETED|Overall Study||34
38949|NCT01658735|88231|P2|COMPLETED|Overall Study||29
38950|NCT01658735|88232|P1|COMPLETED|Overall Study||34
38951|NCT01658735|88230|P3|STARTED|Overall Study||38
38952|NCT01658735|88231|P2|STARTED|Overall Study||36
38953|NCT01658735|88232|P1|STARTED|Overall Study||39
38954|NCT01658657|88263|P2|NOT COMPLETED|Overall Study||3
38955|NCT01658657|88264|P1|NOT COMPLETED|Overall Study||3
38956|NCT01658657|88263|P2|COMPLETED|Overall Study||7
38957|NCT01658657|88264|P1|COMPLETED|Overall Study||4
38958|NCT01658657|88263|P2|STARTED|Overall Study||10
38959|NCT01658657|88264|P1|STARTED|Overall Study||7
38960|NCT01658579|88274|P4|NOT COMPLETED|Treatment Period B||1
38961|NCT01658579|88275|P3|NOT COMPLETED|Treatment Period B||0
38962|NCT01658579|88276|P2|NOT COMPLETED|Treatment Period B||0
38963|NCT01658579|88277|P1|NOT COMPLETED|Treatment Period B||0
38964|NCT01658579|88274|P4|COMPLETED|Treatment Period B||12
38965|NCT01658579|88275|P3|COMPLETED|Treatment Period B||14
38966|NCT01658579|88276|P2|COMPLETED|Treatment Period B||15
38967|NCT01658579|88277|P1|COMPLETED|Treatment Period B||14
38968|NCT01658579|88274|P4|STARTED|Treatment Period B||13
38969|NCT01658579|88275|P3|STARTED|Treatment Period B||14
38970|NCT01658579|88276|P2|STARTED|Treatment Period B||15
38971|NCT01658579|88277|P1|STARTED|Treatment Period B||14
38972|NCT01658579|88274|P4|NOT COMPLETED|Treatment Period A||1
38973|NCT01658579|88275|P3|NOT COMPLETED|Treatment Period A||1
38974|NCT01658579|88276|P2|NOT COMPLETED|Treatment Period A||0
38975|NCT01658579|88277|P1|NOT COMPLETED|Treatment Period A||1
38976|NCT01658579|88274|P4|COMPLETED|Treatment Period A||13
38977|NCT01658579|88275|P3|COMPLETED|Treatment Period A||14
38978|NCT01658579|88276|P2|COMPLETED|Treatment Period A||15
38979|NCT01658579|88277|P1|COMPLETED|Treatment Period A||14
38980|NCT01658579|88274|P4|STARTED|Treatment Period A||14
38981|NCT01658579|88275|P3|STARTED|Treatment Period A||15
38982|NCT01658579|88276|P2|STARTED|Treatment Period A||15
38983|NCT01658579|88277|P1|STARTED|Treatment Period A||15
38984|NCT01658514|88305|P3|NOT COMPLETED|Overall Study||2
38985|NCT01658514|88306|P2|NOT COMPLETED|Overall Study||0
38986|NCT01658514|88307|P1|NOT COMPLETED|Overall Study||1
38987|NCT01658514|88305|P3|COMPLETED|Overall Study||12
38988|NCT01658514|88306|P2|COMPLETED|Overall Study||11
38989|NCT01658514|88307|P1|COMPLETED|Overall Study||13
38990|NCT01658514|88305|P3|Completed - Severe RI Cohort Only|Overall Study||3
38991|NCT01658514|88306|P2|Completed - Severe RI Cohort Only|Overall Study||2
38992|NCT01658514|88307|P1|Completed - Severe RI Cohort Only|Overall Study||3
38993|NCT01658514|88305|P3|Started - Severe RI Cohort Only|Overall Study||3
38994|NCT01658514|88306|P2|Started - Severe RI Cohort Only|Overall Study||2
38995|NCT01658514|88307|P1|Started - Severe RI Cohort Only|Overall Study||3
38996|NCT01658514|88305|P3|Completed - Moderate RI Cohort Only|Overall Study||2
38997|NCT01658514|88306|P2|Completed - Moderate RI Cohort Only|Overall Study||4
38998|NCT01658514|88307|P1|Completed - Moderate RI Cohort Only|Overall Study||3
38999|NCT01658514|88305|P3|Started - Moderate RI Cohort Only|Overall Study||4
39000|NCT01658514|88306|P2|Started - Moderate RI Cohort Only|Overall Study||4
39001|NCT01658514|88307|P1|Started - Moderate RI Cohort Only|Overall Study||4
39002|NCT01658514|88305|P3|Completed - Mild RI Cohort Only|Overall Study||4
39003|NCT01658514|88306|P2|Completed - Mild RI Cohort Only|Overall Study||3
39004|NCT01658514|88307|P1|Completed - Mild RI Cohort Only|Overall Study||4
39005|NCT01658514|88305|P3|Started - Mild RI Cohort Only|Overall Study||4
39006|NCT01658514|88306|P2|Started - Mild RI Cohort Only|Overall Study||3
39007|NCT01658514|88307|P1|Started - Mild RI Cohort Only|Overall Study||4
39008|NCT01658514|88305|P3|Completed - Normal RF Cohort Only|Overall Study||3
39009|NCT01658514|88306|P2|Completed - Normal RF Cohort Only|Overall Study||2
39010|NCT01658514|88307|P1|Completed - Normal RF Cohort Only|Overall Study||3
39011|NCT01658514|88305|P3|Started - Normal RF Cohort Only|Overall Study||3
39012|NCT01658514|88306|P2|Started - Normal RF Cohort Only|Overall Study||2
39013|NCT01658514|88307|P1|Started - Normal RF Cohort Only|Overall Study||3
39014|NCT01658514|88305|P3|Completed Treatment C|Overall Study||12
39015|NCT01658514|88306|P2|Completed Treatment C|Overall Study||11
39016|NCT01658514|88307|P1|Completed Treatment C|Overall Study||13
39017|NCT01658514|88305|P3|Completed Treatment B|Overall Study||14
39018|NCT01658514|88306|P2|Completed Treatment B|Overall Study||11
39019|NCT01658514|88307|P1|Completed Treatment B|Overall Study||13
39020|NCT01658514|88305|P3|Completed Treatment A|Overall Study||12
39021|NCT01658514|88306|P2|Completed Treatment A|Overall Study||11
39022|NCT01658514|88307|P1|Completed Treatment A|Overall Study||14
39023|NCT01658514|88305|P3|STARTED|Overall Study||14
39024|NCT01658514|88306|P2|STARTED|Overall Study||11
39025|NCT01658514|88307|P1|STARTED|Overall Study||14
39026|NCT01658436|88318|P2|NOT COMPLETED|Overall Study||11
39027|NCT01658436|88319|P1|NOT COMPLETED|Overall Study||20
39028|NCT01658436|88318|P2|COMPLETED|Overall Study||0
39029|NCT01658436|88319|P1|COMPLETED|Overall Study||0
39030|NCT01658436|88318|P2|STARTED|Overall Study||11
39031|NCT01658436|88319|P1|STARTED|Overall Study||20
39032|NCT01658072|88328|P2|NOT COMPLETED|Overall Study||2
39033|NCT01658072|88329|P1|NOT COMPLETED|Overall Study||4
39034|NCT01658072|88328|P2|COMPLETED|Overall Study||43
39035|NCT01658072|88329|P1|COMPLETED|Overall Study||41
39036|NCT01658072|88328|P2|STARTED|Overall Study||45
39037|NCT01658072|88329|P1|STARTED|Overall Study||45
39038|NCT01658020|88337|P2|NOT COMPLETED|Overall Study||9
39039|NCT01658020|88338|P1|NOT COMPLETED|Overall Study||8
39040|NCT01658020|88337|P2|COMPLETED|Overall Study||158
39041|NCT01658020|88338|P1|COMPLETED|Overall Study||167
39042|NCT01658020|88337|P2|STARTED|Overall Study||167
39043|NCT01658020|88338|P1|STARTED|Overall Study||175
39044|NCT01657903|88354|P1|NOT COMPLETED|Overall Study||2
39045|NCT01657903|88354|P1|COMPLETED|Overall Study||54
39046|NCT01657903|88354|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
39047|NCT01657903|88354|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
39048|NCT01657903|88354|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
39049|NCT01657903|88354|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
39050|NCT01657903|88354|P1|STARTED|Overall Study||56
39051|NCT01657877|88376|P1|NOT COMPLETED|Overall Study||14
39052|NCT01657877|88376|P1|COMPLETED|Overall Study||65
39053|NCT01657877|88376|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
39054|NCT01657877|88376|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
39055|NCT01657877|88376|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
39056|NCT01657877|88376|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
39057|NCT01657877|88376|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
39058|NCT01657877|88376|P1|STARTED|Overall Study||79
39059|NCT01657370|88399|P6|NOT COMPLETED|Overall Study||4
39060|NCT01657370|88400|P5|NOT COMPLETED|Overall Study||7
39061|NCT01657370|88401|P4|NOT COMPLETED|Overall Study||5
39062|NCT01657370|88402|P3|NOT COMPLETED|Overall Study||7
39063|NCT01657370|88403|P2|NOT COMPLETED|Overall Study||4
39064|NCT01657370|88404|P1|NOT COMPLETED|Overall Study||6
39065|NCT01657370|88399|P6|COMPLETED|Overall Study||27
39066|NCT01657370|88400|P5|COMPLETED|Overall Study||27
39067|NCT01657370|88401|P4|COMPLETED|Overall Study||28
39068|NCT01657370|88402|P3|COMPLETED|Overall Study||25
39069|NCT01657370|88403|P2|COMPLETED|Overall Study||28
39070|NCT01657370|88404|P1|COMPLETED|Overall Study||27
39071|NCT01657370|88399|P6|STARTED|Overall Study||31
39072|NCT01657370|88400|P5|STARTED|Overall Study||34
39073|NCT01657370|88401|P4|STARTED|Overall Study||33
39074|NCT01657370|88402|P3|STARTED|Overall Study||32
39075|NCT01657370|88403|P2|STARTED|Overall Study||32
39076|NCT01657370|88404|P1|STARTED|Overall Study||33
39077|NCT01657292|88486|P1|NOT COMPLETED|Overall Study||10
39078|NCT01657292|88486|P1|COMPLETED|Overall Study||51
39079|NCT01657292|88486|P1|STARTED|Overall Study||61
39080|NCT01657032|88495|P2|NOT COMPLETED|Overall Study||7
39081|NCT01657032|88496|P1|NOT COMPLETED|Overall Study||0
39082|NCT01657032|88495|P2|COMPLETED|Overall Study||37
39083|NCT01657032|88496|P1|COMPLETED|Overall Study||44
39084|NCT01657032|88495|P2|STARTED|Overall Study||44
39085|NCT01657032|88496|P1|STARTED|Overall Study||44
39086|NCT01657019|88522|P1|NOT COMPLETED|Overall Study||235
39087|NCT01657019|88522|P1|COMPLETED|Overall Study||369
39088|NCT01657019|88522|P1|STARTED|Overall Study||604
39089|NCT01656967|88536|P2|NOT COMPLETED|Overall Study||2
39090|NCT01656967|88537|P1|NOT COMPLETED|Overall Study||4
39091|NCT01656967|88536|P2|COMPLETED|Overall Study||31
39092|NCT01656967|88537|P1|COMPLETED|Overall Study||29
39093|NCT01656967|88536|P2|ETT Insertion|Overall Study||31
39094|NCT01656967|88537|P1|ETT Insertion|Overall Study||29
39095|NCT01656967|88536|P2|SGA Placement|Overall Study||33
39096|NCT01656967|88537|P1|SGA Placement|Overall Study||32
39097|NCT01656967|88536|P2|STARTED|Overall Study||33
39098|NCT01656967|88537|P1|STARTED|Overall Study||33
39099|NCT01656889|88559|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
39100|NCT01656889|88560|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
39101|NCT01656889|88559|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
39102|NCT01656889|88560|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
39103|NCT01656889|88559|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
39104|NCT01656889|88560|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
39105|NCT01656889|88559|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
39106|NCT01656889|88560|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
39107|NCT01656889|88559|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
39108|NCT01656889|88560|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
39109|NCT01656889|88559|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
39110|NCT01656889|88560|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
39111|NCT01656850|88580|P2|NOT COMPLETED|Second Intervention (3 Months)||0
39112|NCT01656850|88581|P1|NOT COMPLETED|Second Intervention (3 Months)||0
39113|NCT01656850|88580|P2|COMPLETED|Second Intervention (3 Months)||16
39114|NCT01656850|88581|P1|COMPLETED|Second Intervention (3 Months)||17
39115|NCT01656850|88580|P2|STARTED|Second Intervention (3 Months)||16
39116|NCT01656850|88581|P1|STARTED|Second Intervention (3 Months)||17
39117|NCT01656850|88580|P2|NOT COMPLETED|Washout (2 Weeks)||0
39118|NCT01656850|88581|P1|NOT COMPLETED|Washout (2 Weeks)||0
39119|NCT01656850|88580|P2|COMPLETED|Washout (2 Weeks)||16
39120|NCT01656850|88581|P1|COMPLETED|Washout (2 Weeks)||17
39121|NCT01656850|88580|P2|STARTED|Washout (2 Weeks)||16
39122|NCT01656850|88581|P1|STARTED|Washout (2 Weeks)||17
39123|NCT01656850|88580|P2|NOT COMPLETED|First Intervention (3 Months)||4
39124|NCT01656850|88581|P1|NOT COMPLETED|First Intervention (3 Months)||3
39125|NCT01656850|88580|P2|COMPLETED|First Intervention (3 Months)||16
39126|NCT01656850|88581|P1|COMPLETED|First Intervention (3 Months)||17
39127|NCT01656850|88580|P2|STARTED|First Intervention (3 Months)||20
39128|NCT01656850|88581|P1|STARTED|First Intervention (3 Months)||20
39129|NCT01656772|88661|P2|NOT COMPLETED|Overall Study||0
39130|NCT01656772|88662|P1|NOT COMPLETED|Overall Study||0
39131|NCT01656772|88661|P2|COMPLETED|Overall Study||77
39132|NCT01656772|88662|P1|COMPLETED|Overall Study||43
39133|NCT01656772|88661|P2|STARTED|Overall Study||77
39134|NCT01656772|88662|P1|STARTED|Overall Study||43
39135|NCT01656759|88672|P2|NOT COMPLETED|Overall Study||3
39136|NCT01656759|88673|P1|NOT COMPLETED|Overall Study||2
39137|NCT01656759|88672|P2|COMPLETED|Overall Study||22
39138|NCT01656759|88673|P1|COMPLETED|Overall Study||25
39139|NCT01656759|88672|P2|STARTED|Overall Study||25
39140|NCT01656759|88673|P1|STARTED|Overall Study||27
39141|NCT01656486|88685|P1|NOT COMPLETED|Overall Study||0
39142|NCT01656486|88685|P1|COMPLETED|Overall Study||1
39143|NCT01656486|88685|P1|STARTED|Overall Study||1
39144|NCT01656460|88689|P4|NOT COMPLETED|Overall Study||0
39145|NCT01656460|88690|P3|NOT COMPLETED|Overall Study||0
39146|NCT01656460|88691|P2|NOT COMPLETED|Overall Study||0
39147|NCT01656460|88692|P1|NOT COMPLETED|Overall Study||0
39148|NCT01656460|88689|P4|COMPLETED|Overall Study||3
39149|NCT01656460|88690|P3|COMPLETED|Overall Study||3
39150|NCT01656460|88691|P2|COMPLETED|Overall Study||3
39151|NCT01656460|88692|P1|COMPLETED|Overall Study||3
39152|NCT01656460|88689|P4|STARTED|Overall Study||3
39153|NCT01656460|88690|P3|STARTED|Overall Study||3
39154|NCT01656460|88691|P2|STARTED|Overall Study||3
39155|NCT01656460|88692|P1|STARTED|Overall Study||3
39156|NCT01656434|88704|P2|NOT COMPLETED|Overall Study||580
39157|NCT01656434|88705|P1|NOT COMPLETED|Overall Study||2401
39158|NCT01656434|88704|P2|COMPLETED|Overall Study||40
39159|NCT01656434|88705|P1|COMPLETED|Overall Study||152
39160|NCT01656434|88704|P2|Treated|Overall Study||604
39161|NCT01656434|88705|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
39162|NCT01656434|88704|P2|STARTED|Overall Study||620
39163|NCT01656434|88705|P1|STARTED|Overall Study||2553
39164|NCT01656408|88731|P10|NOT COMPLETED|Overall Study||3
39165|NCT01656408|88732|P9|NOT COMPLETED|Overall Study||2
39166|NCT01656408|88733|P8|NOT COMPLETED|Overall Study||1
39167|NCT01656408|88734|P7|NOT COMPLETED|Overall Study||1
39168|NCT01656408|88735|P6|NOT COMPLETED|Overall Study||2
39169|NCT01656408|88736|P5|NOT COMPLETED|Overall Study||1
39170|NCT01656408|88737|P4|NOT COMPLETED|Overall Study||0
39171|NCT01656408|88738|P3|NOT COMPLETED|Overall Study||2
39172|NCT01656408|88739|P2|NOT COMPLETED|Overall Study||0
39173|NCT01656408|88740|P1|NOT COMPLETED|Overall Study||1
39174|NCT01656408|88731|P10|COMPLETED|Overall Study||15
39175|NCT01656408|88732|P9|COMPLETED|Overall Study||16
39176|NCT01656408|88733|P8|COMPLETED|Overall Study||7
39177|NCT01656408|88734|P7|COMPLETED|Overall Study||9
39178|NCT01656408|88735|P6|COMPLETED|Overall Study||7
39179|NCT01656408|88736|P5|COMPLETED|Overall Study||8
39180|NCT01656408|88737|P4|COMPLETED|Overall Study||7
39181|NCT01656408|88738|P3|COMPLETED|Overall Study||6
39182|NCT01656408|88739|P2|COMPLETED|Overall Study||8
39183|NCT01656408|88740|P1|COMPLETED|Overall Study||7
39184|NCT01656408|88731|P10|STARTED|Overall Study||18
39185|NCT01656408|88732|P9|STARTED|Overall Study||18
39186|NCT01656408|88733|P8|STARTED|Overall Study||8
39187|NCT01656408|88734|P7|STARTED|Overall Study||10
39188|NCT01656408|88735|P6|STARTED|Overall Study||9
39189|NCT01656408|88736|P5|STARTED|Overall Study||9
39190|NCT01656408|88737|P4|STARTED|Overall Study||7
39191|NCT01656408|88738|P3|STARTED|Overall Study||8
39192|NCT01656408|88739|P2|STARTED|Overall Study||8
39193|NCT01656408|88740|P1|STARTED|Overall Study||8
39194|NCT01656304|88929|P1|NOT COMPLETED|Overall Study||1
39195|NCT01656304|88929|P1|COMPLETED|Overall Study||15
39196|NCT01656304|88929|P1|STARTED|Overall Study||16
39197|NCT01656161|88935|P1|NOT COMPLETED|Overall Study||7
39198|NCT01656161|88935|P1|COMPLETED|Overall Study|Per protocol analysis set|113
39199|NCT01656161|88935|P1|Received Triptorelin at Day 169|Overall Study||115
39200|NCT01656161|88935|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
39201|NCT01656161|88935|P1|STARTED|Overall Study|Intention to treat analysis set|120
39202|NCT01656031|88949|P1|NOT COMPLETED|Overall Study||0
39203|NCT01656031|88949|P1|COMPLETED|Overall Study||39
39204|NCT01656031|88949|P1|STARTED|Overall Study||39
39205|NCT01655498|88953|P1|NOT COMPLETED|Overall Study||5
39206|NCT01655498|88953|P1|COMPLETED|Overall Study||56
39207|NCT01655498|88953|P1|STARTED|Overall Study||61
39208|NCT01655381|88960|P1|NOT COMPLETED|Overall Study||3
39209|NCT01655381|88960|P1|COMPLETED|Overall Study||12
39210|NCT01655381|88960|P1|STARTED|Overall Study||15
39211|NCT01655329|88980|P1|NOT COMPLETED|Overall Study||0
39212|NCT01655329|88980|P1|COMPLETED|Overall Study||10
39213|NCT01655329|88980|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
39214|NCT01655043|88996|P1|NOT COMPLETED|Overall Study||0
39215|NCT01655043|88996|P1|COMPLETED|Overall Study||20
39216|NCT01655043|88996|P1|STARTED|Overall Study||20
39217|NCT01654861|89000|P1|NOT COMPLETED|Overall Study||0
39218|NCT01654861|89000|P1|COMPLETED|Overall Study||3
39219|NCT01654861|89000|P1|STARTED|Overall Study||3
39220|NCT01654666|89008|P3|NOT COMPLETED|Overall Study||14
39221|NCT01654666|89009|P2|NOT COMPLETED|Overall Study||13
39222|NCT01654666|89010|P1|NOT COMPLETED|Overall Study||15
39223|NCT01654666|89008|P3|COMPLETED|Overall Study||49
39224|NCT01654666|89009|P2|COMPLETED|Overall Study||50
39225|NCT01654666|89010|P1|COMPLETED|Overall Study||48
39226|NCT01654666|89008|P3|Primary Analysis|Overall Study||54
39227|NCT01654666|89009|P2|Primary Analysis|Overall Study||56
39228|NCT01654666|89010|P1|Primary Analysis|Overall Study||52
39229|NCT01654666|89008|P3|STARTED|Overall Study||63
39230|NCT01654666|89009|P2|STARTED|Overall Study||63
39231|NCT01654666|89010|P1|STARTED|Overall Study||63
39232|NCT01654601|89035|P2|NOT COMPLETED|2nd Administration||1
39233|NCT01654601|89036|P1|NOT COMPLETED|2nd Administration||1
39234|NCT01654601|89035|P2|COMPLETED|2nd Administration||11
39235|NCT01654601|89036|P1|COMPLETED|2nd Administration||11
39236|NCT01654601|89035|P2|STARTED|2nd Administration||12
39237|NCT01654601|89036|P1|STARTED|2nd Administration||12
39238|NCT01654601|89035|P2|NOT COMPLETED|1st Administration||2
39239|NCT01654601|89036|P1|NOT COMPLETED|1st Administration||2
39240|NCT01654601|89035|P2|COMPLETED|1st Administration||12
39241|NCT01654601|89036|P1|COMPLETED|1st Administration||12
39242|NCT01654601|89035|P2|STARTED|1st Administration||14
39243|NCT01654601|89036|P1|STARTED|1st Administration||14
39244|NCT01654549|89050|P2|NOT COMPLETED|Overall Study||1
39245|NCT01654549|89051|P1|NOT COMPLETED|Overall Study||0
39246|NCT01654549|89050|P2|COMPLETED|Overall Study||19
39247|NCT01654549|89051|P1|COMPLETED|Overall Study||20
39248|NCT01654549|89050|P2|STARTED|Overall Study||20
39249|NCT01654549|89051|P1|STARTED|Overall Study||20
39250|NCT01654536|89063|P2|NOT COMPLETED|Overall Study||38
39251|NCT01654536|89064|P1|NOT COMPLETED|Overall Study||44
39252|NCT01654536|89063|P2|COMPLETED|Overall Study||331
39253|NCT01654536|89064|P1|COMPLETED|Overall Study||324
39254|NCT01654536|89063|P2|STARTED|Overall Study||369
39255|NCT01654536|89064|P1|STARTED|Overall Study||368
39256|NCT01654523|89100|P1|NOT COMPLETED|Overall Study||1
39257|NCT01654523|89100|P1|COMPLETED|Overall Study||19
39258|NCT01654523|89100|P1|STARTED|Overall Study||20
39259|NCT01654302|89106|P2|NOT COMPLETED|Second Intervention (Day 7)||1
39260|NCT01654302|89107|P1|NOT COMPLETED|Second Intervention (Day 7)||1
39261|NCT01654302|89106|P2|COMPLETED|Second Intervention (Day 7)||19
39262|NCT01654302|89107|P1|COMPLETED|Second Intervention (Day 7)||19
39263|NCT01654302|89106|P2|STARTED|Second Intervention (Day 7)||20
39264|NCT01654302|89107|P1|STARTED|Second Intervention (Day 7)||20
39265|NCT01654302|89106|P2|NOT COMPLETED|First Intervention (Day 1)||0
39266|NCT01654302|89107|P1|NOT COMPLETED|First Intervention (Day 1)||0
39267|NCT01654302|89106|P2|COMPLETED|First Intervention (Day 1)||20
39268|NCT01654302|89107|P1|COMPLETED|First Intervention (Day 1)||20
39269|NCT01654302|89106|P2|STARTED|First Intervention (Day 1)||20
39270|NCT01654302|89107|P1|STARTED|First Intervention (Day 1)||20
39271|NCT01654276|89113|P1|NOT COMPLETED|Overall Study||6
39272|NCT01654276|89113|P1|COMPLETED|Overall Study||18
39273|NCT01654276|89113|P1|Visit 4 (6months)|Overall Study||18
39274|NCT01654276|89113|P1|Visit 3 (4 Months)|Overall Study||18
39275|NCT01654276|89113|P1|Visit 2 (2 Months)|Overall Study||19
39276|NCT01654276|89113|P1|STARTED|Overall Study||24
39277|NCT01654263|89137|P6|NOT COMPLETED|Overall Study||1
39278|NCT01654263|89138|P5|NOT COMPLETED|Overall Study||1
39279|NCT01654263|89139|P4|NOT COMPLETED|Overall Study||1
39280|NCT01654263|89140|P3|NOT COMPLETED|Overall Study||2
39281|NCT01654263|89141|P2|NOT COMPLETED|Overall Study||0
39282|NCT01654263|89142|P1|NOT COMPLETED|Overall Study||0
39283|NCT01654263|89137|P6|COMPLETED|Overall Study||148
39284|NCT01654263|89138|P5|COMPLETED|Overall Study||139
39285|NCT01654263|89139|P4|COMPLETED|Overall Study||144
39286|NCT01654263|89140|P3|COMPLETED|Overall Study||137
39287|NCT01654263|89141|P2|COMPLETED|Overall Study||147
39288|NCT01654263|89142|P1|COMPLETED|Overall Study||164
39289|NCT01654263|89137|P6|STARTED|Overall Study||149
39290|NCT01654263|89138|P5|STARTED|Overall Study||140
39291|NCT01654263|89139|P4|STARTED|Overall Study||145
39292|NCT01654263|89140|P3|STARTED|Overall Study||139
39293|NCT01654263|89141|P2|STARTED|Overall Study||147
39294|NCT01654263|89142|P1|STARTED|Overall Study||164
39295|NCT01654250|89167|P2|NOT COMPLETED|Overall Study||0
39296|NCT01654250|89168|P1|NOT COMPLETED|Overall Study||1
39297|NCT01654250|89167|P2|COMPLETED|Overall Study||42
39298|NCT01654250|89168|P1|COMPLETED|Overall Study||43
39299|NCT01654250|89167|P2|STARTED|Overall Study||42
39300|NCT01654250|89168|P1|STARTED|Overall Study||44
39301|NCT01654224|89185|P2|NOT COMPLETED|Overall Study||12
39302|NCT01654224|89186|P1|NOT COMPLETED|Overall Study||6
39303|NCT01654224|89185|P2|COMPLETED|Overall Study||98
39304|NCT01654224|89186|P1|COMPLETED|Overall Study||89
39305|NCT01654224|89185|P2|STARTED|Overall Study||110
39306|NCT01654224|89186|P1|STARTED|Overall Study||95
39307|NCT01654107|89198|P2|NOT COMPLETED|Overall Study||8
39308|NCT01654107|89199|P1|NOT COMPLETED|Overall Study||3
39309|NCT01654107|89198|P2|COMPLETED|Overall Study||22
39310|NCT01654107|89199|P1|COMPLETED|Overall Study||25
39311|NCT01654107|89198|P2|STARTED|Overall Study||30
39312|NCT01654107|89199|P1|STARTED|Overall Study||28
39313|NCT01653782|89208|P3|NOT COMPLETED|Overall Study||6
39314|NCT01653782|89209|P2|NOT COMPLETED|Overall Study||18
39315|NCT01653782|89210|P1|NOT COMPLETED|Overall Study||16
39316|NCT01653782|89208|P3|COMPLETED|Overall Study||46
39317|NCT01653782|89209|P2|COMPLETED|Overall Study||37
39318|NCT01653782|89210|P1|COMPLETED|Overall Study||36
39319|NCT01653782|89208|P3|STARTED|Overall Study||52
39320|NCT01653782|89209|P2|STARTED|Overall Study||55
39321|NCT01653782|89210|P1|STARTED|Overall Study||52
39322|NCT01653743|89220|P2|NOT COMPLETED|Overall Study||0
39323|NCT01653743|89221|P1|NOT COMPLETED|Overall Study||4
39324|NCT01653743|89220|P2|COMPLETED|Overall Study||27
39325|NCT01653743|89221|P1|COMPLETED|Overall Study||50
39326|NCT01653743|89220|P2|STARTED|Overall Study||27
39327|NCT01653743|89221|P1|STARTED|Overall Study||54
39328|NCT01653509|89237|P2|NOT COMPLETED|Overall Study||0
39329|NCT01653509|89238|P1|NOT COMPLETED|Overall Study||0
39330|NCT01653509|89237|P2|COMPLETED|Overall Study||13
39331|NCT01653509|89238|P1|COMPLETED|Overall Study||12
39332|NCT01653509|89237|P2|STARTED|Overall Study||13
39333|NCT01653509|89238|P1|STARTED|Overall Study||12
39334|NCT01653418|89256|P1|NOT COMPLETED|Overall Study||0
39335|NCT01653418|89256|P1|COMPLETED|Overall Study||10
39336|NCT01653418|89256|P1|STARTED|Overall Study||10
39337|NCT01653262|89268|P1|NOT COMPLETED|Overall Study||3
39338|NCT01653262|89268|P1|COMPLETED|Overall Study||26
39339|NCT01653262|89268|P1|STARTED|Overall Study||29
39340|NCT01653158|89281|P8|NOT COMPLETED|Overall Study||15
39341|NCT01653158|89282|P7|NOT COMPLETED|Overall Study||2
39342|NCT01653158|89283|P6|NOT COMPLETED|Overall Study||1
39343|NCT01653158|89284|P5|NOT COMPLETED|Overall Study||1
39344|NCT01653158|89285|P4|NOT COMPLETED|Overall Study||2
39345|NCT01653158|89286|P3|NOT COMPLETED|Overall Study||0
39346|NCT01653158|89287|P2|NOT COMPLETED|Overall Study||0
39347|NCT01653158|89288|P1|NOT COMPLETED|Overall Study||1
39348|NCT01653158|89281|P8|COMPLETED|Overall Study||4
39349|NCT01653158|89282|P7|COMPLETED|Overall Study||7
39350|NCT01653158|89283|P6|COMPLETED|Overall Study||2
39351|NCT01653158|89284|P5|COMPLETED|Overall Study||2
39352|NCT01653158|89285|P4|COMPLETED|Overall Study||1
39353|NCT01653158|89286|P3|COMPLETED|Overall Study||3
39354|NCT01653158|89287|P2|COMPLETED|Overall Study||3
39355|NCT01653158|89288|P1|COMPLETED|Overall Study||2
39356|NCT01653158|89281|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
39357|NCT01653158|89282|P7|STARTED|Overall Study||9
39358|NCT01653158|89283|P6|STARTED|Overall Study||3
39359|NCT01653158|89284|P5|STARTED|Overall Study||3
39360|NCT01653158|89285|P4|STARTED|Overall Study||3
39361|NCT01653158|89286|P3|STARTED|Overall Study||3
39362|NCT01653158|89287|P2|STARTED|Overall Study||3
39363|NCT01653158|89288|P1|STARTED|Overall Study||3
39364|NCT01653132|89560|P2|NOT COMPLETED|Second Intervention||0
39365|NCT01653132|89561|P1|NOT COMPLETED|Second Intervention||0
39366|NCT01653132|89560|P2|COMPLETED|Second Intervention||5
39367|NCT01653132|89561|P1|COMPLETED|Second Intervention||4
39368|NCT01653132|89560|P2|STARTED|Second Intervention||5
39369|NCT01653132|89561|P1|STARTED|Second Intervention||4
39370|NCT01653132|89560|P2|NOT COMPLETED|Washout 1-2 Months||0
39371|NCT01653132|89561|P1|NOT COMPLETED|Washout 1-2 Months||0
39372|NCT01653132|89560|P2|COMPLETED|Washout 1-2 Months||5
39373|NCT01653132|89561|P1|COMPLETED|Washout 1-2 Months||4
39374|NCT01653132|89560|P2|STARTED|Washout 1-2 Months||5
39375|NCT01653132|89561|P1|STARTED|Washout 1-2 Months||4
39376|NCT01653132|89560|P2|NOT COMPLETED|First Intervention||0
39377|NCT01653132|89561|P1|NOT COMPLETED|First Intervention||1
39378|NCT01653132|89560|P2|COMPLETED|First Intervention||5
39379|NCT01653132|89561|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
39380|NCT01653132|89560|P2|STARTED|First Intervention||5
39381|NCT01653132|89561|P1|STARTED|First Intervention||5
39382|NCT01653028|89580|P5|NOT COMPLETED|Overall Study||0
39383|NCT01653028|89581|P4|NOT COMPLETED|Overall Study||0
39384|NCT01653028|89582|P3|NOT COMPLETED|Overall Study||0
39385|NCT01653028|89583|P2|NOT COMPLETED|Overall Study||0
39386|NCT01653028|89584|P1|NOT COMPLETED|Overall Study||0
39387|NCT01653028|89580|P5|COMPLETED|Overall Study||29
39388|NCT01653028|89581|P4|COMPLETED|Overall Study||10
39389|NCT01653028|89582|P3|COMPLETED|Overall Study||11
39390|NCT01653028|89583|P2|COMPLETED|Overall Study||10
39391|NCT01653028|89584|P1|COMPLETED|Overall Study||12
39392|NCT01653028|89580|P5|STARTED|Overall Study||29
39393|NCT01653028|89581|P4|STARTED|Overall Study||10
39394|NCT01653028|89582|P3|STARTED|Overall Study||11
39395|NCT01653028|89583|P2|STARTED|Overall Study||10
39396|NCT01653028|89584|P1|STARTED|Overall Study||12
39397|NCT01652729|89614|P3|NOT COMPLETED|Overall Study||14
39398|NCT01652729|89615|P2|NOT COMPLETED|Overall Study||13
39399|NCT01652729|89616|P1|NOT COMPLETED|Overall Study||27
39400|NCT01652729|89614|P3|COMPLETED|Overall Study||47
39401|NCT01652729|89615|P2|COMPLETED|Overall Study||109
39402|NCT01652729|89616|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
39403|NCT01652729|89614|P3|Meal Test Evaluable|Overall Study||15
39404|NCT01652729|89615|P2|Meal Test Evaluable|Overall Study||31
39405|NCT01652729|89616|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
39406|NCT01652729|89614|P3|Meal Test Subjects|Overall Study||20
39407|NCT01652729|89615|P2|Meal Test Subjects|Overall Study||41
39408|NCT01652729|89616|P1|Meal Test Subjects|Overall Study||60
39409|NCT01652729|89614|P3|Evaluable|Overall Study||43
39410|NCT01652729|89615|P2|Evaluable|Overall Study||91
39411|NCT01652729|89616|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
39412|NCT01652729|89614|P3|Treated|Overall Study||61
39413|NCT01652729|89615|P2|Treated|Overall Study||122
39414|NCT01652729|89616|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
39415|NCT01652729|89614|P3|Modified Intent-to-Treat|Overall Study||61
39416|NCT01652729|89615|P2|Modified Intent-to-Treat|Overall Study||122
39417|NCT01652729|89616|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
39418|NCT01652729|89614|P3|STARTED|Overall Study||61
39419|NCT01652729|89615|P2|STARTED|Overall Study||122
39420|NCT01652729|89616|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
39421|NCT01652716|89638|P2|NOT COMPLETED|Overall Study||46
39422|NCT01652716|89639|P1|NOT COMPLETED|Overall Study||56
39423|NCT01652716|89638|P2|COMPLETED|Overall Study|* completed study|102
39424|NCT01652716|89639|P1|COMPLETED|Overall Study|* completed study|173
39425|NCT01652716|89638|P2|Completed 28-week|Overall Study||118
39426|NCT01652716|89639|P1|Completed 28-week|Overall Study||197
39427|NCT01652716|89638|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
39428|NCT01652716|89639|P1|STARTED|Overall Study||229
39429|NCT01652703|89659|P6|NOT COMPLETED|Overall Study||2
39430|NCT01652703|89660|P5|NOT COMPLETED|Overall Study||1
39431|NCT01652703|89661|P4|NOT COMPLETED|Overall Study||2
39432|NCT01652703|89662|P3|NOT COMPLETED|Overall Study||3
39433|NCT01652703|89663|P2|NOT COMPLETED|Overall Study||1
39434|NCT01652703|89664|P1|NOT COMPLETED|Overall Study||0
39435|NCT01652703|89659|P6|COMPLETED|Overall Study||51
39436|NCT01652703|89660|P5|COMPLETED|Overall Study||51
39437|NCT01652703|89661|P4|COMPLETED|Overall Study||50
39438|NCT01652703|89662|P3|COMPLETED|Overall Study||47
39439|NCT01652703|89663|P2|COMPLETED|Overall Study||50
39440|NCT01652703|89664|P1|COMPLETED|Overall Study||52
39441|NCT01652703|89659|P6|Received Treatment|Overall Study||53
39442|NCT01652703|89660|P5|Received Treatment|Overall Study||51
39443|NCT01652703|89661|P4|Received Treatment|Overall Study||52
39444|NCT01652703|89662|P3|Received Treatment|Overall Study||49
39445|NCT01652703|89663|P2|Received Treatment|Overall Study||50
39446|NCT01652703|89664|P1|Received Treatment|Overall Study||52
39447|NCT01652703|89659|P6|STARTED|Overall Study||53
39448|NCT01652703|89660|P5|STARTED|Overall Study||52
39449|NCT01652703|89661|P4|STARTED|Overall Study||52
39450|NCT01652703|89662|P3|STARTED|Overall Study||50
39451|NCT01652703|89663|P2|STARTED|Overall Study||51
39452|NCT01652703|89664|P1|STARTED|Overall Study||52
39453|NCT01652690|89722|P2|NOT COMPLETED|Overall Study||21
39454|NCT01652690|89723|P1|NOT COMPLETED|Overall Study||35
39455|NCT01652690|89722|P2|COMPLETED|Overall Study||279
39456|NCT01652690|89723|P1|COMPLETED|Overall Study||265
39457|NCT01652690|89722|P2|STARTED|Overall Study||300
39458|NCT01652690|89723|P1|STARTED|Overall Study||300
39459|NCT01652664|89757|P2|NOT COMPLETED|Overall Study||1
39460|NCT01652664|89758|P1|NOT COMPLETED|Overall Study||6
39461|NCT01652664|89757|P2|COMPLETED|Overall Study||74
39462|NCT01652664|89758|P1|COMPLETED|Overall Study||71
39463|NCT01652664|89757|P2|STARTED|Overall Study||75
39464|NCT01652664|89758|P1|STARTED|Overall Study||77
39465|NCT01652495|89767|P2|NOT COMPLETED|Overall Study||2
39466|NCT01652495|89768|P1|NOT COMPLETED|Overall Study||2
39467|NCT01652495|89767|P2|COMPLETED|Overall Study||20
39468|NCT01652495|89768|P1|COMPLETED|Overall Study||20
39469|NCT01652495|89767|P2|STARTED|Overall Study||22
39470|NCT01652495|89768|P1|STARTED|Overall Study||22
39471|NCT01652001|89780|P2|NOT COMPLETED|Overall Study||6
39472|NCT01652001|89781|P1|NOT COMPLETED|Overall Study||9
39473|NCT01652001|89780|P2|COMPLETED|Overall Study||79
39474|NCT01652001|89781|P1|COMPLETED|Overall Study||91
39475|NCT01652001|89780|P2|STARTED|Overall Study||85
39476|NCT01652001|89781|P1|STARTED|Overall Study||100
39477|NCT01651949|89792|P3|NOT COMPLETED|Overall Study||31
39478|NCT01651949|89793|P2|NOT COMPLETED|Overall Study||86
39479|NCT01651949|89794|P1|NOT COMPLETED|Overall Study||53
39480|NCT01651949|89792|P3|COMPLETED|Overall Study||282
39481|NCT01651949|89793|P2|COMPLETED|Overall Study||1015
39482|NCT01651949|89794|P1|COMPLETED|Overall Study||1053
39483|NCT01651949|89792|P3|Vaccination 3|Overall Study||291
39484|NCT01651949|89793|P2|Vaccination 3|Overall Study||1037
39485|NCT01651949|89794|P1|Vaccination 3|Overall Study||1067
39486|NCT01651949|89792|P3|Vaccination 2|Overall Study||298
39487|NCT01651949|89793|P2|Vaccination 2|Overall Study||1069
39488|NCT01651949|89794|P1|Vaccination 2|Overall Study||1089
39489|NCT01651949|89792|P3|Vaccination 1|Overall Study||313
39490|NCT01651949|89793|P2|Vaccination 1|Overall Study||1099
39491|NCT01651949|89794|P1|Vaccination 1|Overall Study||1103
39492|NCT01651949|89792|P3|STARTED|Overall Study||313
39493|NCT01651949|89793|P2|STARTED|Overall Study||1101
39494|NCT01651949|89794|P1|STARTED|Overall Study||1106
39495|NCT01651351|89814|P2|NOT COMPLETED|Overall Study||0
39496|NCT01651351|89815|P1|NOT COMPLETED|Overall Study||0
39497|NCT01651351|89814|P2|COMPLETED|Overall Study||15
39498|NCT01651351|89815|P1|COMPLETED|Overall Study||15
39499|NCT01651351|89814|P2|STARTED|Overall Study||15
39500|NCT01651351|89815|P1|STARTED|Overall Study||15
39501|NCT01651260|89832|P1|NOT COMPLETED|Overall Study||3
39502|NCT01651260|89832|P1|COMPLETED|Overall Study||62
39503|NCT01651260|89832|P1|STARTED|Overall Study||65
39504|NCT01651208|89839|P2|NOT COMPLETED|Overall Study||16
39505|NCT01651208|89840|P1|NOT COMPLETED|Overall Study||14
39506|NCT01651208|89839|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
39507|NCT01651208|89840|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
39508|NCT01651208|89839|P2|STARTED|Overall Study||225
39509|NCT01651208|89840|P1|STARTED|Overall Study||227
39510|NCT01651104|89848|P1|NOT COMPLETED|Overall Study||0
39511|NCT01651104|89848|P1|COMPLETED|Overall Study||63
39512|NCT01651104|89848|P1|STARTED|Overall Study||63
39513|NCT01651000|89857|P2|NOT COMPLETED|Overall Study||28
39514|NCT01651000|89858|P1|NOT COMPLETED|Overall Study||10
39515|NCT01651000|89857|P2|COMPLETED|Overall Study||113
39516|NCT01651000|89858|P1|COMPLETED|Overall Study||62
39517|NCT01651000|89857|P2|Entered Extension Study|Overall Study||93
39518|NCT01651000|89858|P1|Entered Extension Study|Overall Study||50
39519|NCT01651000|89857|P2|STARTED|Overall Study||141
39520|NCT01651000|89858|P1|STARTED|Overall Study||72
39521|NCT01650831|89870|P1|NOT COMPLETED|Overall Study||1
39522|NCT01650831|89870|P1|COMPLETED|Overall Study||112
39523|NCT01650831|89870|P1|STARTED|Overall Study||113
39524|NCT01650805|89880|P2|NOT COMPLETED|Overall Study||0
39525|NCT01650805|89881|P1|NOT COMPLETED|Overall Study||1
39526|NCT01650805|89880|P2|COMPLETED|Overall Study||152
39527|NCT01650805|89881|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
39528|NCT01650805|89880|P2|STARTED|Overall Study||152
39529|NCT01650805|89881|P1|STARTED|Overall Study|Started means patient has been randomized.|155
39530|NCT01650779|89891|P1|NOT COMPLETED|Overall Study||1
39531|NCT01650779|89891|P1|COMPLETED|Overall Study||14
39532|NCT01650779|89891|P1|STARTED|Overall Study||15
39533|NCT01650519|89900|P2|NOT COMPLETED|Overall Study||0
39534|NCT01650519|89901|P1|NOT COMPLETED|Overall Study||1
39535|NCT01650519|89900|P2|COMPLETED|Overall Study||31
39536|NCT01650519|89901|P1|COMPLETED|Overall Study||19
39537|NCT01650519|89900|P2|STARTED|Overall Study||31
39538|NCT01650519|89901|P1|STARTED|Overall Study||20
39539|NCT01650350|89919|P1|NOT COMPLETED|Overall Study||0
39540|NCT01650350|89919|P1|COMPLETED|Overall Study||7
39541|NCT01650350|89919|P1|STARTED|Overall Study||7
39542|NCT01650324|89928|P5|NOT COMPLETED|Overall Study||0
39543|NCT01650324|89929|P4|NOT COMPLETED|Overall Study||0
39544|NCT01650324|89930|P3|NOT COMPLETED|Overall Study||0
39545|NCT01650324|89931|P2|NOT COMPLETED|Overall Study||0
39546|NCT01650324|89932|P1|NOT COMPLETED|Overall Study||0
39547|NCT01650324|89928|P5|COMPLETED|Overall Study||6
39548|NCT01650324|89929|P4|COMPLETED|Overall Study||6
39549|NCT01650324|89930|P3|COMPLETED|Overall Study||6
39550|NCT01650324|89931|P2|COMPLETED|Overall Study||6
39551|NCT01650324|89932|P1|COMPLETED|Overall Study||8
39552|NCT01650324|89928|P5|STARTED|Overall Study||6
39553|NCT01650324|89929|P4|STARTED|Overall Study||6
39554|NCT01650324|89930|P3|STARTED|Overall Study||6
39555|NCT01650324|89931|P2|STARTED|Overall Study||6
39556|NCT01650324|89932|P1|STARTED|Overall Study||8
39557|NCT01650285|89961|P1|NOT COMPLETED|Overall Study||1
39558|NCT01650285|89961|P1|COMPLETED|Overall Study||4
39559|NCT01650285|89961|P1|STARTED|Overall Study||5
39560|NCT01650246|89965|P1|NOT COMPLETED|Overall Study||143
39561|NCT01650246|89965|P1|COMPLETED|Overall Study||0
39562|NCT01650246|89965|P1|STARTED|Overall Study||143
39563|NCT01649856|89972|P2|NOT COMPLETED|Overall Study||203
39564|NCT01649856|89973|P1|NOT COMPLETED|Overall Study||369
39565|NCT01649856|89972|P2|COMPLETED|Overall Study||0
39566|NCT01649856|89973|P1|COMPLETED|Overall Study||0
39567|NCT01649856|89972|P2|STARTED|Overall Study||203
39568|NCT01649856|89973|P1|STARTED|Overall Study||369
39569|NCT01649804|90005|P1|NOT COMPLETED|Overall Study||8
39570|NCT01649804|90005|P1|COMPLETED|Overall Study||4
39571|NCT01649804|90005|P1|STARTED|Overall Study||12
39572|NCT01649791|90017|P1|NOT COMPLETED|Overall Study||3
39573|NCT01649791|90017|P1|COMPLETED|Overall Study||5
39574|NCT01649791|90017|P1|STARTED|Overall Study||8
39575|NCT01649557|90027|P3|NOT COMPLETED|Overall Study||9
39576|NCT01649557|90028|P2|NOT COMPLETED|Overall Study||14
39577|NCT01649557|90029|P1|NOT COMPLETED|Overall Study||44
39578|NCT01649557|90027|P3|COMPLETED|Overall Study||15
39579|NCT01649557|90028|P2|COMPLETED|Overall Study||27
39580|NCT01649557|90029|P1|COMPLETED|Overall Study||135
39581|NCT01649557|90027|P3|52-week Enrollers|Overall Study||2
39582|NCT01649557|90028|P2|52-week Enrollers|Overall Study||6
39583|NCT01649557|90029|P1|52-week Enrollers|Overall Study||20
39584|NCT01649557|90027|P3|6-week Enrollers|Overall Study||22
39585|NCT01649557|90028|P2|6-week Enrollers|Overall Study||35
39586|NCT01649557|90029|P1|6-week Enrollers|Overall Study||159
39587|NCT01649557|90027|P3|STARTED|Overall Study||24
39588|NCT01649557|90028|P2|STARTED|Overall Study||41
39589|NCT01649557|90029|P1|STARTED|Overall Study||179
39590|NCT01649505|90066|P2|NOT COMPLETED|Overall Study||1
39591|NCT01649505|90067|P1|NOT COMPLETED|Overall Study||1
39592|NCT01649505|90066|P2|COMPLETED|Overall Study||0
39593|NCT01649505|90067|P1|COMPLETED|Overall Study||0
39594|NCT01649505|90066|P2|STARTED|Overall Study||1
39595|NCT01649505|90067|P1|STARTED|Overall Study||1
39596|NCT01649362|90075|P2|NOT COMPLETED|Overall Study||14
39597|NCT01649362|90076|P1|NOT COMPLETED|Overall Study||1
39598|NCT01649362|90075|P2|COMPLETED|Overall Study||40
39599|NCT01649362|90076|P1|COMPLETED|Overall Study||46
39600|NCT01649362|90075|P2|STARTED|Overall Study||54
39601|NCT01649362|90076|P1|STARTED|Overall Study||47
39602|NCT01649297|90091|P5|NOT COMPLETED|Overall Study||4
39603|NCT01649297|90092|P4|NOT COMPLETED|Overall Study||19
39604|NCT01649297|90093|P3|NOT COMPLETED|Overall Study||17
39605|NCT01649297|90094|P2|NOT COMPLETED|Overall Study||13
39606|NCT01649297|90095|P1|NOT COMPLETED|Overall Study||14
39607|NCT01649297|90091|P5|COMPLETED|Overall Study||103
39608|NCT01649297|90092|P4|COMPLETED|Overall Study||201
39609|NCT01649297|90093|P3|COMPLETED|Overall Study||202
39610|NCT01649297|90094|P2|COMPLETED|Overall Study||205
39611|NCT01649297|90095|P1|COMPLETED|Overall Study||205
39612|NCT01649297|90091|P5|STARTED|Overall Study|randomised|107
39613|NCT01649297|90092|P4|STARTED|Overall Study|randomised|220
39614|NCT01649297|90093|P3|STARTED|Overall Study|randomised|219
39615|NCT01649297|90094|P2|STARTED|Overall Study|randomised|218
39616|NCT01649297|90095|P1|STARTED|Overall Study|randomised|219
39617|NCT01649232|90114|P2|NOT COMPLETED|Overall Study||0
39618|NCT01649232|90115|P1|NOT COMPLETED|Overall Study||2
39619|NCT01649232|90114|P2|COMPLETED|Overall Study||30
39620|NCT01649232|90115|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
39621|NCT01649232|90114|P2|STARTED|Overall Study||30
39622|NCT01649232|90115|P1|STARTED|Overall Study||30
39623|NCT01648920|90135|P1|NOT COMPLETED|Overall Study||0
39624|NCT01648920|90135|P1|COMPLETED|Overall Study||50
39625|NCT01648920|90135|P1|STARTED|Overall Study||50
39626|NCT01648790|90159|P5|NOT COMPLETED|Treatment 5||0
39627|NCT01648790|90160|P4|NOT COMPLETED|Treatment 5||0
39628|NCT01648790|90161|P3|NOT COMPLETED|Treatment 5||0
39629|NCT01648790|90162|P2|NOT COMPLETED|Treatment 5||0
39630|NCT01648790|90163|P1|NOT COMPLETED|Treatment 5||0
39631|NCT01648790|90159|P5|COMPLETED|Treatment 5||4
39632|NCT01648790|90160|P4|COMPLETED|Treatment 5||3
39633|NCT01648790|90161|P3|COMPLETED|Treatment 5||4
39634|NCT01648790|90162|P2|COMPLETED|Treatment 5||4
39635|NCT01648790|90163|P1|COMPLETED|Treatment 5||4
39636|NCT01648790|90159|P5|STARTED|Treatment 5||4
39637|NCT01648790|90160|P4|STARTED|Treatment 5||3
39638|NCT01648790|90161|P3|STARTED|Treatment 5||4
39639|NCT01648790|90162|P2|STARTED|Treatment 5||4
39640|NCT01648790|90163|P1|STARTED|Treatment 5||4
39641|NCT01648790|90159|P5|NOT COMPLETED|Treatment 4||0
39642|NCT01648790|90160|P4|NOT COMPLETED|Treatment 4||0
39643|NCT01648790|90161|P3|NOT COMPLETED|Treatment 4||0
39644|NCT01648790|90162|P2|NOT COMPLETED|Treatment 4||0
39645|NCT01648790|90163|P1|NOT COMPLETED|Treatment 4||0
39646|NCT01648790|90159|P5|COMPLETED|Treatment 4||4
39647|NCT01648790|90160|P4|COMPLETED|Treatment 4||3
39648|NCT01648790|90161|P3|COMPLETED|Treatment 4||4
39649|NCT01648790|90162|P2|COMPLETED|Treatment 4||4
39650|NCT01648790|90163|P1|COMPLETED|Treatment 4||4
39651|NCT01648790|90159|P5|STARTED|Treatment 4||4
39652|NCT01648790|90160|P4|STARTED|Treatment 4||3
39653|NCT01648790|90161|P3|STARTED|Treatment 4||4
39654|NCT01648790|90162|P2|STARTED|Treatment 4||4
39655|NCT01648790|90163|P1|STARTED|Treatment 4||4
39656|NCT01648790|90159|P5|NOT COMPLETED|Treatment 3||0
39657|NCT01648790|90160|P4|NOT COMPLETED|Treatment 3||1
39658|NCT01648790|90161|P3|NOT COMPLETED|Treatment 3||0
39659|NCT01648790|90162|P2|NOT COMPLETED|Treatment 3||0
39660|NCT01648790|90163|P1|NOT COMPLETED|Treatment 3||0
39661|NCT01648790|90159|P5|COMPLETED|Treatment 3||4
39662|NCT01648790|90160|P4|COMPLETED|Treatment 3||3
39663|NCT01648790|90161|P3|COMPLETED|Treatment 3||4
39664|NCT01648790|90162|P2|COMPLETED|Treatment 3||4
39665|NCT01648790|90163|P1|COMPLETED|Treatment 3||4
39666|NCT01648790|90159|P5|STARTED|Treatment 3||4
39667|NCT01648790|90160|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
39668|NCT01648790|90161|P3|STARTED|Treatment 3||4
39669|NCT01648790|90162|P2|STARTED|Treatment 3||4
39670|NCT01648790|90163|P1|STARTED|Treatment 3||4
39671|NCT01648790|90159|P5|NOT COMPLETED|Treatment 2||0
39672|NCT01648790|90160|P4|NOT COMPLETED|Treatment 2||0
39673|NCT01648790|90161|P3|NOT COMPLETED|Treatment 2||0
39674|NCT01648790|90162|P2|NOT COMPLETED|Treatment 2||0
39675|NCT01648790|90163|P1|NOT COMPLETED|Treatment 2||0
39676|NCT01648790|90159|P5|COMPLETED|Treatment 2||4
39677|NCT01648790|90160|P4|COMPLETED|Treatment 2||4
39678|NCT01648790|90161|P3|COMPLETED|Treatment 2||4
39679|NCT01648790|90162|P2|COMPLETED|Treatment 2||4
39680|NCT01648790|90163|P1|COMPLETED|Treatment 2||4
39681|NCT01648790|90159|P5|STARTED|Treatment 2||4
39682|NCT01648790|90160|P4|STARTED|Treatment 2||4
39683|NCT01648790|90161|P3|STARTED|Treatment 2||4
39684|NCT01648790|90162|P2|STARTED|Treatment 2||4
39685|NCT01648790|90163|P1|STARTED|Treatment 2||4
39686|NCT01648790|90159|P5|NOT COMPLETED|Treatment 1||0
39687|NCT01648790|90160|P4|NOT COMPLETED|Treatment 1||0
39688|NCT01648790|90161|P3|NOT COMPLETED|Treatment 1||0
39689|NCT01648790|90162|P2|NOT COMPLETED|Treatment 1||0
39690|NCT01648790|90163|P1|NOT COMPLETED|Treatment 1||0
39691|NCT01648790|90159|P5|COMPLETED|Treatment 1||4
39692|NCT01648790|90160|P4|COMPLETED|Treatment 1||4
39693|NCT01648790|90161|P3|COMPLETED|Treatment 1||4
39694|NCT01648790|90162|P2|COMPLETED|Treatment 1||4
39695|NCT01648790|90163|P1|COMPLETED|Treatment 1||4
39696|NCT01648790|90159|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
39697|NCT01648790|90160|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
39698|NCT01648790|90161|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
39699|NCT01648790|90162|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
39700|NCT01648790|90163|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
39701|NCT01648790|90159|P5|STARTED|Treatment 1||4
39702|NCT01648790|90160|P4|STARTED|Treatment 1||4
39703|NCT01648790|90161|P3|STARTED|Treatment 1||4
39704|NCT01648790|90162|P2|STARTED|Treatment 1||4
39705|NCT01648790|90163|P1|STARTED|Treatment 1||4
39706|NCT01648699|90184|P1|NOT COMPLETED|Overall Study||5
39707|NCT01648699|90184|P1|COMPLETED|Overall Study||15
39708|NCT01648699|90184|P1|STARTED|Overall Study||20
39709|NCT01648582|90213|P3|NOT COMPLETED|Overall Study||32
39710|NCT01648582|90214|P2|NOT COMPLETED|Overall Study||38
39711|NCT01648582|90215|P1|NOT COMPLETED|Overall Study||32
39712|NCT01648582|90213|P3|COMPLETED|Overall Study||231
39713|NCT01648582|90214|P2|COMPLETED|Overall Study||225
39714|NCT01648582|90215|P1|COMPLETED|Overall Study||231
39715|NCT01648582|90213|P3|Modified Intent-to-Treat Population|Overall Study||254
39716|NCT01648582|90214|P2|Modified Intent-to-Treat Population|Overall Study||258
39717|NCT01648582|90215|P1|Modified Intent-to-Treat Population|Overall Study||258
39718|NCT01648582|90213|P3|Received at Least One Dose of Study Drug|Overall Study||257
39719|NCT01648582|90214|P2|Received at Least One Dose of Study Drug|Overall Study||263
39720|NCT01648582|90215|P1|Received at Least One Dose of Study Drug|Overall Study||263
39721|NCT01648582|90213|P3|STARTED|Overall Study||263
39722|NCT01648582|90214|P2|STARTED|Overall Study||263
39723|NCT01648582|90215|P1|STARTED|Overall Study||263
39724|NCT01648530|90284|P1|NOT COMPLETED|Overall Study||10874
39725|NCT01648530|90284|P1|COMPLETED|Overall Study||5915
39726|NCT01648530|90284|P1|STARTED|Overall Study||16789
39727|NCT01648491|90290|P1|NOT COMPLETED|Overall Study||0
39728|NCT01648491|90290|P1|COMPLETED|Overall Study||1
39729|NCT01648491|90290|P1|STARTED|Overall Study||1
39730|NCT01648452|90297|P1|NOT COMPLETED|Overall Study||0
39731|NCT01648452|90297|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
39732|NCT01648452|90297|P1|STARTED|Overall Study||5
39733|NCT01648101|90318|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
39734|NCT01648101|90319|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
39735|NCT01648101|90320|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
39736|NCT01648101|90318|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
39737|NCT01648101|90319|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
39738|NCT01648101|90320|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
39739|NCT01648101|90318|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
39740|NCT01648101|90319|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
39741|NCT01648101|90320|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
39742|NCT01648101|90318|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
39743|NCT01648101|90319|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
39744|NCT01648101|90320|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
39745|NCT01648101|90318|P3|COMPLETED|Transition Phase (4 Weeks)||5
39746|NCT01648101|90319|P2|COMPLETED|Transition Phase (4 Weeks)||13
39747|NCT01648101|90320|P1|COMPLETED|Transition Phase (4 Weeks)||12
39748|NCT01648101|90318|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
39749|NCT01648101|90319|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
39750|NCT01648101|90320|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
39751|NCT01648101|90318|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
39752|NCT01648101|90319|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
39753|NCT01648101|90320|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
39754|NCT01648101|90318|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
39755|NCT01648101|90319|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
39756|NCT01648101|90320|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
39757|NCT01648101|90318|P3|STARTED|Maintenance Phase (12 Weeks)||18
39758|NCT01648101|90319|P2|STARTED|Maintenance Phase (12 Weeks)||23
39759|NCT01648101|90320|P1|STARTED|Maintenance Phase (12 Weeks)||23
39760|NCT01648101|90318|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
39761|NCT01648101|90319|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
39762|NCT01648101|90320|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
39763|NCT01648101|90318|P3|COMPLETED|Titration Phase (4 Weeks)||18
39764|NCT01648101|90319|P2|COMPLETED|Titration Phase (4 Weeks)||23
39765|NCT01648101|90320|P1|COMPLETED|Titration Phase (4 Weeks)||23
39766|NCT01648101|90318|P3|STARTED|Titration Phase (4 Weeks)||24
39767|NCT01648101|90319|P2|STARTED|Titration Phase (4 Weeks)||26
39768|NCT01648101|90320|P1|STARTED|Titration Phase (4 Weeks)||25
39769|NCT01647945|90372|P4|NOT COMPLETED|Overall Study||1
39770|NCT01647945|90373|P3|NOT COMPLETED|Overall Study||2
39771|NCT01647945|90374|P2|NOT COMPLETED|Overall Study||0
39772|NCT01647945|90375|P1|NOT COMPLETED|Overall Study||0
39773|NCT01647945|90372|P4|COMPLETED|Overall Study||5
39774|NCT01647945|90373|P3|COMPLETED|Overall Study||3
39775|NCT01647945|90374|P2|COMPLETED|Overall Study||6
39776|NCT01647945|90375|P1|COMPLETED|Overall Study||6
39777|NCT01647945|90372|P4|STARTED|Overall Study||6
39778|NCT01647945|90373|P3|STARTED|Overall Study||5
39779|NCT01647945|90374|P2|STARTED|Overall Study||6
39780|NCT01647945|90375|P1|STARTED|Overall Study||6
39781|NCT01647737|90395|P2|NOT COMPLETED|Overall Study||5
39782|NCT01647737|90396|P1|NOT COMPLETED|Overall Study||4
39783|NCT01647737|90395|P2|COMPLETED|Overall Study||25
39784|NCT01647737|90396|P1|COMPLETED|Overall Study||26
39785|NCT01647737|90395|P2|STARTED|Overall Study||30
39786|NCT01647737|90396|P1|STARTED|Overall Study||30
39787|NCT01647711|90407|P5|NOT COMPLETED|Overall Study||6
39788|NCT01647711|90408|P4|NOT COMPLETED|Overall Study||11
39789|NCT01647711|90409|P3|NOT COMPLETED|Overall Study||9
39790|NCT01647711|90410|P2|NOT COMPLETED|Overall Study||3
39791|NCT01647711|90411|P1|NOT COMPLETED|Overall Study||6
39792|NCT01647711|90407|P5|COMPLETED|Overall Study||0
39793|NCT01647711|90408|P4|COMPLETED|Overall Study||0
39794|NCT01647711|90409|P3|COMPLETED|Overall Study||0
39795|NCT01647711|90410|P2|COMPLETED|Overall Study||0
39796|NCT01647711|90411|P1|COMPLETED|Overall Study||0
39797|NCT01647711|90407|P5|STARTED|Overall Study||6
39798|NCT01647711|90408|P4|STARTED|Overall Study||11
39799|NCT01647711|90409|P3|STARTED|Overall Study||9
39800|NCT01647711|90410|P2|STARTED|Overall Study||3
39801|NCT01647711|90411|P1|STARTED|Overall Study||6
39802|NCT01647542|90439|P3|NOT COMPLETED|Overall Study||72
39803|NCT01647542|90440|P2|NOT COMPLETED|Overall Study||73
39804|NCT01647542|90441|P1|NOT COMPLETED|Overall Study||76
39805|NCT01647542|90439|P3|COMPLETED|Overall Study||59
39806|NCT01647542|90440|P2|COMPLETED|Overall Study||58
39807|NCT01647542|90441|P1|COMPLETED|Overall Study||55
39808|NCT01647542|90439|P3|STARTED|Overall Study||131
39809|NCT01647542|90440|P2|STARTED|Overall Study||131
39810|NCT01647542|90441|P1|STARTED|Overall Study||131
39811|NCT01647464|90458|P1|NOT COMPLETED|Overall Study||0
39812|NCT01647464|90458|P1|COMPLETED|Overall Study||10
39813|NCT01647464|90458|P1|STARTED|Overall Study||10
39814|NCT01647438|90464|P2|NOT COMPLETED|Overall Study||0
39815|NCT01647438|90465|P1|NOT COMPLETED|Overall Study||0
39816|NCT01647438|90464|P2|COMPLETED|Overall Study||31
39817|NCT01647438|90465|P1|COMPLETED|Overall Study||32
39818|NCT01647438|90464|P2|STARTED|Overall Study||31
39819|NCT01647438|90465|P1|STARTED|Overall Study||32
39820|NCT01646827|90475|P2|NOT COMPLETED|Overall Study||5
39821|NCT01646827|90476|P1|NOT COMPLETED|Overall Study||2
39822|NCT01646827|90475|P2|COMPLETED|Overall Study||14
39823|NCT01646827|90476|P1|COMPLETED|Overall Study||16
39824|NCT01646827|90475|P2|STARTED|Overall Study||19
39825|NCT01646827|90476|P1|STARTED|Overall Study||18
39826|NCT01646814|90506|P2|NOT COMPLETED|Overall Study||6
39827|NCT01646814|90507|P1|NOT COMPLETED|Overall Study||11
39828|NCT01646814|90506|P2|COMPLETED|Overall Study||120
39829|NCT01646814|90507|P1|COMPLETED|Overall Study||110
39830|NCT01646814|90506|P2|STARTED|Overall Study||126
39831|NCT01646814|90507|P1|STARTED|Overall Study||121
39832|NCT01646671|90516|P3|NOT COMPLETED|Overall Study||0
39833|NCT01646671|90517|P2|NOT COMPLETED|Overall Study||0
39834|NCT01646671|90518|P1|NOT COMPLETED|Overall Study||0
39835|NCT01646671|90516|P3|COMPLETED|Overall Study||21
39836|NCT01646671|90517|P2|COMPLETED|Overall Study||11
39837|NCT01646671|90518|P1|COMPLETED|Overall Study||3
39838|NCT01646671|90516|P3|STARTED|Overall Study||21
39839|NCT01646671|90517|P2|STARTED|Overall Study||11
39840|NCT01646671|90518|P1|STARTED|Overall Study||3
39841|NCT01646398|90554|P2|NOT COMPLETED|Overall Study||0
39842|NCT01646398|90555|P1|NOT COMPLETED|Overall Study||1
39843|NCT01646398|90554|P2|COMPLETED|Overall Study||382
39844|NCT01646398|90555|P1|COMPLETED|Overall Study||381
39845|NCT01646398|90554|P2|STARTED|Overall Study||382
39846|NCT01646398|90555|P1|STARTED|Overall Study||382
39847|NCT01646385|90571|P2|NOT COMPLETED|Overall Study||871
39848|NCT01646385|90572|P1|NOT COMPLETED|Overall Study||838
39849|NCT01646385|90571|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
39850|NCT01646385|90572|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
39851|NCT01646385|90571|P2|STARTED|Overall Study||2864
39852|NCT01646385|90572|P1|STARTED|Overall Study||3529
39853|NCT01646320|90605|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
39854|NCT01646320|90606|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
39855|NCT01646320|90605|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
39856|NCT01646320|90606|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
39857|NCT01646320|90605|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
39858|NCT01646320|90606|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
39859|NCT01646320|90605|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
39860|NCT01646320|90606|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
39861|NCT01646320|90605|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
39862|NCT01646320|90606|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
39863|NCT01646320|90605|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
39864|NCT01646320|90606|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
39865|NCT01646268|90622|P2|NOT COMPLETED|Overall Study||16
39866|NCT01646268|90623|P1|NOT COMPLETED|Overall Study||11
39867|NCT01646268|90622|P2|COMPLETED|Overall Study||107
39868|NCT01646268|90623|P1|COMPLETED|Overall Study||113
39869|NCT01646268|90622|P2|STARTED|Overall Study||123
39870|NCT01646268|90623|P1|STARTED|Overall Study||124
39871|NCT01646255|90637|P2|NOT COMPLETED|Overall Study||14
39872|NCT01646255|90638|P1|NOT COMPLETED|Overall Study||21
39873|NCT01646255|90637|P2|COMPLETED|Overall Study||160
39874|NCT01646255|90638|P1|COMPLETED|Overall Study||151
39875|NCT01646255|90637|P2|STARTED|Overall Study||174
39876|NCT01646255|90638|P1|STARTED|Overall Study||172
39877|NCT01646177|90672|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
39878|NCT01646177|90673|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
39879|NCT01646177|90674|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
39880|NCT01646177|90675|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
39881|NCT01646177|90672|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39882|NCT01646177|90673|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39883|NCT01646177|90674|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39884|NCT01646177|90675|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39885|NCT01646177|90672|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39886|NCT01646177|90673|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39887|NCT01646177|90674|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39888|NCT01646177|90675|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
39889|NCT01646177|90672|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
39890|NCT01646177|90673|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
39891|NCT01646177|90674|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
39892|NCT01646177|90675|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
39893|NCT01646177|90672|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
39894|NCT01646177|90673|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
39895|NCT01646177|90674|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
39896|NCT01646177|90675|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
39897|NCT01646177|90672|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
39898|NCT01646177|90673|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
39899|NCT01646177|90674|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
39900|NCT01646177|90675|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
39901|NCT01646151|90753|P1|NOT COMPLETED|Overall Study||170
39902|NCT01646151|90753|P1|COMPLETED|Overall Study||2410
39903|NCT01646151|90753|P1|STARTED|Overall Study||2580
39904|NCT01646138|90769|P5|NOT COMPLETED|Overall Study||2
39905|NCT01646138|90770|P4|NOT COMPLETED|Overall Study||0
39906|NCT01646138|90771|P3|NOT COMPLETED|Overall Study||0
39907|NCT01646138|90772|P2|NOT COMPLETED|Overall Study||0
39908|NCT01646138|90773|P1|NOT COMPLETED|Overall Study||0
39909|NCT01646138|90769|P5|COMPLETED|Overall Study||13
39910|NCT01646138|90770|P4|COMPLETED|Overall Study||19
39911|NCT01646138|90771|P3|COMPLETED|Overall Study||5
39912|NCT01646138|90772|P2|COMPLETED|Overall Study||4
39913|NCT01646138|90773|P1|COMPLETED|Overall Study||5
39914|NCT01646138|90769|P5|STARTED|Overall Study||15
39915|NCT01646138|90770|P4|STARTED|Overall Study||19
39916|NCT01646138|90771|P3|STARTED|Overall Study||5
39917|NCT01646138|90772|P2|STARTED|Overall Study||4
39918|NCT01646138|90773|P1|STARTED|Overall Study||5
39919|NCT01646073|90787|P2|NOT COMPLETED|Period B (12 Weeks)||13
39920|NCT01646073|90788|P1|NOT COMPLETED|Period B (12 Weeks)||1
39921|NCT01646073|90787|P2|COMPLETED|Period B (12 Weeks)||320
39922|NCT01646073|90788|P1|COMPLETED|Period B (12 Weeks)||84
39923|NCT01646073|90787|P2|STARTED|Period B (12 Weeks)||333
39924|NCT01646073|90788|P1|STARTED|Period B (12 Weeks)||85
39925|NCT01646073|90787|P2|NOT COMPLETED|Period A (12 Weeks)||5
39926|NCT01646073|90788|P1|NOT COMPLETED|Period A (12 Weeks)||2
39927|NCT01646073|90787|P2|COMPLETED|Period A (12 Weeks)||333
39928|NCT01646073|90788|P1|COMPLETED|Period A (12 Weeks)||85
39929|NCT01646073|90787|P2|STARTED|Period A (12 Weeks)||338
39930|NCT01646073|90788|P1|STARTED|Period A (12 Weeks)||87
39931|NCT01645735|90829|P2|NOT COMPLETED|Overall Study||1
39932|NCT01645735|90830|P1|NOT COMPLETED|Overall Study||4
39933|NCT01645735|90829|P2|COMPLETED|Overall Study||16
39934|NCT01645735|90830|P1|COMPLETED|Overall Study||28
39935|NCT01645735|90829|P2|STARTED|Overall Study||17
39936|NCT01645735|90830|P1|STARTED|Overall Study||32
39937|NCT01645709|90844|P2|NOT COMPLETED|Overall Study||0
39938|NCT01645709|90845|P1|NOT COMPLETED|Overall Study||0
39939|NCT01645709|90844|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
39940|NCT01645709|90845|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
39941|NCT01645709|90844|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
39942|NCT01645709|90845|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
39943|NCT01645280|90872|P5|NOT COMPLETED|Overall Study||8
39944|NCT01645280|90873|P4|NOT COMPLETED|Overall Study||6
39945|NCT01645280|90874|P3|NOT COMPLETED|Overall Study||6
39946|NCT01645280|90875|P2|NOT COMPLETED|Overall Study||3
39947|NCT01645280|90876|P1|NOT COMPLETED|Overall Study||6
39948|NCT01645280|90872|P5|COMPLETED|Overall Study||47
39949|NCT01645280|90873|P4|COMPLETED|Overall Study||48
39950|NCT01645280|90874|P3|COMPLETED|Overall Study||49
39951|NCT01645280|90875|P2|COMPLETED|Overall Study||51
39952|NCT01645280|90876|P1|COMPLETED|Overall Study||49
39953|NCT01645280|90872|P5|STARTED|Overall Study||55
39954|NCT01645280|90873|P4|STARTED|Overall Study||54
39955|NCT01645280|90874|P3|STARTED|Overall Study||55
39956|NCT01645280|90875|P2|STARTED|Overall Study||54
39957|NCT01645280|90876|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
39958|NCT01645111|90904|P1|NOT COMPLETED|Overall Study||15
39959|NCT01645111|90904|P1|COMPLETED|Overall Study||35
39960|NCT01645111|90904|P1|STARTED|Overall Study||50
39961|NCT01645098|90910|P2|NOT COMPLETED|Overall Study||0
39962|NCT01645098|90911|P1|NOT COMPLETED|Overall Study||0
39963|NCT01645098|90910|P2|COMPLETED|Overall Study||29
39964|NCT01645098|90911|P1|COMPLETED|Overall Study||24
39965|NCT01645098|90910|P2|STARTED|Overall Study||29
39966|NCT01645098|90911|P1|STARTED|Overall Study||24
39967|NCT01645059|90925|P1|NOT COMPLETED|Overall Study||0
39968|NCT01645059|90925|P1|COMPLETED|Overall Study||129
39969|NCT01645059|90925|P1|STARTED|Overall Study||129
39970|NCT01644734|90943|P1|NOT COMPLETED|Overall Study||266
39971|NCT01644734|90943|P1|COMPLETED|Overall Study||1016
39972|NCT01644734|90943|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
39973|NCT01644695|90948|P1|NOT COMPLETED|Overall Study||0
39974|NCT01644695|90948|P1|COMPLETED|Overall Study||85
39975|NCT01644695|90948|P1|STARTED|Overall Study||85
39976|NCT01644643|90957|P4|NOT COMPLETED|Overall Study||10
39977|NCT01644643|90958|P3|NOT COMPLETED|Overall Study||5
39978|NCT01644643|90959|P2|NOT COMPLETED|Overall Study||0
39979|NCT01644643|90960|P1|NOT COMPLETED|Overall Study||2
39980|NCT01644643|90957|P4|COMPLETED|Overall Study||143
39981|NCT01644643|90958|P3|COMPLETED|Overall Study||148
39982|NCT01644643|90959|P2|COMPLETED|Overall Study||12
39983|NCT01644643|90960|P1|COMPLETED|Overall Study||13
39984|NCT01644643|90957|P4|STARTED|Overall Study||153
39985|NCT01644643|90958|P3|STARTED|Overall Study||153
39986|NCT01644643|90959|P2|STARTED|Overall Study||12
39987|NCT01644643|90960|P1|STARTED|Overall Study||15
39988|NCT01644617|91125|P3|NOT COMPLETED|Overall Study||7
39989|NCT01644617|91126|P2|NOT COMPLETED|Overall Study||5
39990|NCT01644617|91127|P1|NOT COMPLETED|Overall Study||6
39991|NCT01644617|91125|P3|COMPLETED|Overall Study||34
39992|NCT01644617|91126|P2|COMPLETED|Overall Study||36
39993|NCT01644617|91127|P1|COMPLETED|Overall Study||36
39994|NCT01644617|91125|P3|STARTED|Overall Study||41
39995|NCT01644617|91126|P2|STARTED|Overall Study||41
39996|NCT01644617|91127|P1|STARTED|Overall Study||42
39997|NCT01644500|91180|P3|NOT COMPLETED|Overall Study||18
39998|NCT01644500|91181|P2|NOT COMPLETED|Overall Study||28
39999|NCT01644500|91182|P1|NOT COMPLETED|Overall Study||24
40000|NCT01644500|91180|P3|COMPLETED|Overall Study||253
40001|NCT01644500|91181|P2|COMPLETED|Overall Study||240
40002|NCT01644500|91182|P1|COMPLETED|Overall Study||244
40003|NCT01644500|91180|P3|Modified Intent-to-treat Population|Overall Study||268
40004|NCT01644500|91181|P2|Modified Intent-to-treat Population|Overall Study||259
40005|NCT01644500|91182|P1|Modified Intent-to-treat Population|Overall Study||263
40006|NCT01644500|91180|P3|Received at Least One Dose of Study Drug|Overall Study||269
40007|NCT01644500|91181|P2|Received at Least One Dose of Study Drug|Overall Study||268
40008|NCT01644500|91182|P1|Received at Least One Dose of Study Drug|Overall Study||268
40009|NCT01644500|91180|P3|STARTED|Overall Study||271
40010|NCT01644500|91181|P2|STARTED|Overall Study||268
40011|NCT01644500|91182|P1|STARTED|Overall Study||268
40012|NCT01644474|91252|P2|NOT COMPLETED|Overall Study||8
40013|NCT01644474|91253|P1|NOT COMPLETED|Overall Study||7
40014|NCT01644474|91252|P2|COMPLETED|Overall Study||44
40015|NCT01644474|91253|P1|COMPLETED|Overall Study||44
40016|NCT01644474|91252|P2|Treated|Overall Study||52
40017|NCT01644474|91253|P1|Treated|Overall Study||51
40018|NCT01644474|91252|P2|STARTED|Overall Study|Randomized|52
40019|NCT01644474|91253|P1|STARTED|Overall Study|Randomized|51
40020|NCT01644396|91293|P1|NOT COMPLETED|Overall Study||0
40021|NCT01644396|91293|P1|COMPLETED|Overall Study||50
40022|NCT01644396|91293|P1|STARTED|Overall Study||50
40023|NCT01644292|91335|P1|NOT COMPLETED|Overall Study||0
40024|NCT01644292|91335|P1|COMPLETED|Overall Study||2
40025|NCT01644292|91335|P1|STARTED|Overall Study||2
40026|NCT01644188|91341|P2|NOT COMPLETED|Overall Study||75
40027|NCT01644188|91342|P1|NOT COMPLETED|Overall Study||122
40028|NCT01644188|91341|P2|COMPLETED|Overall Study||166
40029|NCT01644188|91342|P1|COMPLETED|Overall Study||357
40030|NCT01644188|91341|P2|Treated|Overall Study||241
40031|NCT01644188|91342|P1|Treated|Overall Study||479
40032|NCT01644188|91341|P2|STARTED|Overall Study|Randomized|241
40033|NCT01644188|91342|P1|STARTED|Overall Study|Randomized|479
40034|NCT01644175|91400|P2|NOT COMPLETED|Overall Study||53
40035|NCT01644175|91401|P1|NOT COMPLETED|Overall Study||32
40036|NCT01644175|91400|P2|COMPLETED|Overall Study||156
40037|NCT01644175|91401|P1|COMPLETED|Overall Study||75
40038|NCT01644175|91400|P2|Treated|Overall Study||207
40039|NCT01644175|91401|P1|Treated|Overall Study||107
40040|NCT01644175|91400|P2|STARTED|Overall Study|Randomized|209
40041|NCT01644175|91401|P1|STARTED|Overall Study|Randomized|107
40042|NCT01644058|91451|P1|NOT COMPLETED|Overall Study||0
40043|NCT01644058|91451|P1|COMPLETED|Overall Study||18
40044|NCT01644058|91451|P1|STARTED|Overall Study||18
40045|NCT01643876|91456|P1|NOT COMPLETED|Overall Study||0
40046|NCT01643876|91456|P1|COMPLETED|Overall Study||48
40047|NCT01643876|91456|P1|STARTED|Overall Study||48
40048|NCT01643798|91461|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
40049|NCT01643798|91462|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
40050|NCT01643798|91461|P2|COMPLETED|Pretreatment 2 and Stimulation||8
40051|NCT01643798|91462|P1|COMPLETED|Pretreatment 2 and Stimulation||6
40052|NCT01643798|91461|P2|STARTED|Pretreatment 2 and Stimulation||8
40053|NCT01643798|91462|P1|STARTED|Pretreatment 2 and Stimulation||6
40054|NCT01643798|91461|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
40055|NCT01643798|91462|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
40056|NCT01643798|91461|P2|COMPLETED|Pretreatment 1 and Stimulation||8
40057|NCT01643798|91462|P1|COMPLETED|Pretreatment 1 and Stimulation||6
40058|NCT01643798|91461|P2|STARTED|Pretreatment 1 and Stimulation||8
40059|NCT01643798|91462|P1|STARTED|Pretreatment 1 and Stimulation||7
40060|NCT01643616|91475|P2|NOT COMPLETED|Overall Study||0
40061|NCT01643616|91476|P1|NOT COMPLETED|Overall Study||0
40062|NCT01643616|91475|P2|COMPLETED|Overall Study||125
40063|NCT01643616|91476|P1|COMPLETED|Overall Study||125
40064|NCT01643616|91475|P2|STARTED|Overall Study||125
40065|NCT01643616|91476|P1|STARTED|Overall Study||125
40066|NCT01643525|91486|P1|NOT COMPLETED|Overall Study||0
40067|NCT01643525|91486|P1|COMPLETED|Overall Study||29
40068|NCT01643525|91486|P1|STARTED|Overall Study||29
40069|NCT01643213|91492|P2|NOT COMPLETED|Overall Study||0
40070|NCT01643213|91493|P1|NOT COMPLETED|Overall Study||1
40071|NCT01643213|91492|P2|COMPLETED|Overall Study||14
40072|NCT01643213|91493|P1|COMPLETED|Overall Study||12
40073|NCT01643213|91492|P2|STARTED|Overall Study||14
40074|NCT01643213|91493|P1|STARTED|Overall Study||13
40075|NCT01643044|91501|P2|NOT COMPLETED|Overall Study||5
40076|NCT01643044|91502|P1|NOT COMPLETED|Overall Study||4
40077|NCT01643044|91501|P2|COMPLETED|Overall Study||19
40078|NCT01643044|91502|P1|COMPLETED|Overall Study||20
40079|NCT01643044|91501|P2|STARTED|Overall Study||24
40080|NCT01643044|91502|P1|STARTED|Overall Study||24
40081|NCT01642914|91511|P3|NOT COMPLETED|Overall Study||40
40082|NCT01642914|91512|P2|NOT COMPLETED|Overall Study||32
40083|NCT01642914|91513|P1|NOT COMPLETED|Overall Study||46
40084|NCT01642914|91511|P3|COMPLETED|Overall Study||120
40085|NCT01642914|91512|P2|COMPLETED|Overall Study||122
40086|NCT01642914|91513|P1|COMPLETED|Overall Study||127
40087|NCT01642914|91511|P3|STARTED|Overall Study||160
40088|NCT01642914|91512|P2|STARTED|Overall Study||154
40089|NCT01642914|91513|P1|STARTED|Overall Study||173
40090|NCT01642732|91588|P1|NOT COMPLETED|Overall Study||1
40091|NCT01642732|91588|P1|COMPLETED|Overall Study||0
40092|NCT01642732|91588|P1|STARTED|Overall Study||1
40093|NCT01642615|91593|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
40094|NCT01642615|91594|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
40095|NCT01642615|91595|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
40096|NCT01642615|91593|P3|COMPLETED|Double Blind Maintenance Phase||20
40097|NCT01642615|91594|P2|COMPLETED|Double Blind Maintenance Phase||18
40098|NCT01642615|91595|P1|COMPLETED|Double Blind Maintenance Phase||0
40099|NCT01642615|91593|P3|STARTED|Double Blind Maintenance Phase||26
40100|NCT01642615|91594|P2|STARTED|Double Blind Maintenance Phase||25
40101|NCT01642615|91595|P1|STARTED|Double Blind Maintenance Phase||0
40102|NCT01642615|91593|P3|NOT COMPLETED|Open Label Maintenance Phase||0
40103|NCT01642615|91594|P2|NOT COMPLETED|Open Label Maintenance Phase||0
40104|NCT01642615|91595|P1|NOT COMPLETED|Open Label Maintenance Phase||5
40105|NCT01642615|91593|P3|COMPLETED|Open Label Maintenance Phase||0
40106|NCT01642615|91594|P2|COMPLETED|Open Label Maintenance Phase||0
40107|NCT01642615|91595|P1|COMPLETED|Open Label Maintenance Phase||58
40108|NCT01642615|91593|P3|Safety Analysis Set|Open Label Maintenance Phase||0
40109|NCT01642615|91594|P2|Safety Analysis Set|Open Label Maintenance Phase||0
40110|NCT01642615|91595|P1|Safety Analysis Set|Open Label Maintenance Phase||62
40111|NCT01642615|91593|P3|STARTED|Open Label Maintenance Phase||0
40112|NCT01642615|91594|P2|STARTED|Open Label Maintenance Phase||0
40113|NCT01642615|91595|P1|STARTED|Open Label Maintenance Phase||63
40114|NCT01642602|91609|P1|NOT COMPLETED|Overall Study||2
40115|NCT01642602|91609|P1|COMPLETED|Overall Study||102
40116|NCT01642602|91609|P1|STARTED|Overall Study||104
40117|NCT01642589|91616|P2|NOT COMPLETED|Overall Study||1
40118|NCT01642589|91617|P1|NOT COMPLETED|Overall Study||1
40119|NCT01642589|91616|P2|COMPLETED|Overall Study||99
40120|NCT01642589|91617|P1|COMPLETED|Overall Study||199
40121|NCT01642589|91616|P2|STARTED|Overall Study||100
40122|NCT01642589|91617|P1|STARTED|Overall Study||200
40123|NCT01642485|91631|P8|NOT COMPLETED|Period 2, Day 3||0
40124|NCT01642485|91632|P7|NOT COMPLETED|Period 2, Day 3||0
40125|NCT01642485|91633|P6|NOT COMPLETED|Period 2, Day 3||0
40126|NCT01642485|91634|P5|NOT COMPLETED|Period 2, Day 3||0
40127|NCT01642485|91635|P4|NOT COMPLETED|Period 2, Day 3||0
40128|NCT01642485|91636|P3|NOT COMPLETED|Period 2, Day 3||0
40129|NCT01642485|91637|P2|NOT COMPLETED|Period 2, Day 3||0
40130|NCT01642485|91638|P1|NOT COMPLETED|Period 2, Day 3||0
40131|NCT01642485|91631|P8|COMPLETED|Period 2, Day 3||4
40132|NCT01642485|91632|P7|COMPLETED|Period 2, Day 3||4
40133|NCT01642485|91633|P6|COMPLETED|Period 2, Day 3||4
40134|NCT01642485|91634|P5|COMPLETED|Period 2, Day 3||4
40135|NCT01642485|91635|P4|COMPLETED|Period 2, Day 3||4
40136|NCT01642485|91636|P3|COMPLETED|Period 2, Day 3||4
40137|NCT01642485|91637|P2|COMPLETED|Period 2, Day 3||4
40138|NCT01642485|91638|P1|COMPLETED|Period 2, Day 3||4
40139|NCT01642485|91631|P8|STARTED|Period 2, Day 3||4
40140|NCT01642485|91632|P7|STARTED|Period 2, Day 3||4
40141|NCT01642485|91633|P6|STARTED|Period 2, Day 3||4
40142|NCT01642485|91634|P5|STARTED|Period 2, Day 3||4
40143|NCT01642485|91635|P4|STARTED|Period 2, Day 3||4
40144|NCT01642485|91636|P3|STARTED|Period 2, Day 3||4
40145|NCT01642485|91637|P2|STARTED|Period 2, Day 3||4
40146|NCT01642485|91638|P1|STARTED|Period 2, Day 3||4
40147|NCT01642485|91631|P8|NOT COMPLETED|Period 2, Day 2||0
40148|NCT01642485|91632|P7|NOT COMPLETED|Period 2, Day 2||0
40149|NCT01642485|91633|P6|NOT COMPLETED|Period 2, Day 2||0
40150|NCT01642485|91634|P5|NOT COMPLETED|Period 2, Day 2||0
40151|NCT01642485|91635|P4|NOT COMPLETED|Period 2, Day 2||0
40152|NCT01642485|91636|P3|NOT COMPLETED|Period 2, Day 2||0
40153|NCT01642485|91637|P2|NOT COMPLETED|Period 2, Day 2||0
40154|NCT01642485|91638|P1|NOT COMPLETED|Period 2, Day 2||0
40155|NCT01642485|91631|P8|COMPLETED|Period 2, Day 2||4
40156|NCT01642485|91632|P7|COMPLETED|Period 2, Day 2||4
40157|NCT01642485|91633|P6|COMPLETED|Period 2, Day 2||4
40158|NCT01642485|91634|P5|COMPLETED|Period 2, Day 2||4
40159|NCT01642485|91635|P4|COMPLETED|Period 2, Day 2||4
40160|NCT01642485|91636|P3|COMPLETED|Period 2, Day 2||4
40161|NCT01642485|91637|P2|COMPLETED|Period 2, Day 2||4
40162|NCT01642485|91638|P1|COMPLETED|Period 2, Day 2||4
40163|NCT01642485|91631|P8|STARTED|Period 2, Day 2||4
40164|NCT01642485|91632|P7|STARTED|Period 2, Day 2||4
40165|NCT01642485|91633|P6|STARTED|Period 2, Day 2||4
40166|NCT01642485|91634|P5|STARTED|Period 2, Day 2||4
40167|NCT01642485|91635|P4|STARTED|Period 2, Day 2||4
40168|NCT01642485|91636|P3|STARTED|Period 2, Day 2||4
40169|NCT01642485|91637|P2|STARTED|Period 2, Day 2||4
40170|NCT01642485|91638|P1|STARTED|Period 2, Day 2||4
40171|NCT01642485|91631|P8|NOT COMPLETED|Period 2, Day 1||0
40172|NCT01642485|91632|P7|NOT COMPLETED|Period 2, Day 1||0
40173|NCT01642485|91633|P6|NOT COMPLETED|Period 2, Day 1||0
40174|NCT01642485|91634|P5|NOT COMPLETED|Period 2, Day 1||0
40175|NCT01642485|91635|P4|NOT COMPLETED|Period 2, Day 1||0
40176|NCT01642485|91636|P3|NOT COMPLETED|Period 2, Day 1||0
40177|NCT01642485|91637|P2|NOT COMPLETED|Period 2, Day 1||0
40178|NCT01642485|91638|P1|NOT COMPLETED|Period 2, Day 1||0
40179|NCT01642485|91631|P8|COMPLETED|Period 2, Day 1||4
40180|NCT01642485|91632|P7|COMPLETED|Period 2, Day 1||4
40181|NCT01642485|91633|P6|COMPLETED|Period 2, Day 1||4
40182|NCT01642485|91634|P5|COMPLETED|Period 2, Day 1||4
40183|NCT01642485|91635|P4|COMPLETED|Period 2, Day 1||4
40184|NCT01642485|91636|P3|COMPLETED|Period 2, Day 1||4
40185|NCT01642485|91637|P2|COMPLETED|Period 2, Day 1||4
40186|NCT01642485|91638|P1|COMPLETED|Period 2, Day 1||4
40187|NCT01642485|91631|P8|STARTED|Period 2, Day 1||4
40188|NCT01642485|91632|P7|STARTED|Period 2, Day 1||4
40189|NCT01642485|91633|P6|STARTED|Period 2, Day 1||4
40190|NCT01642485|91634|P5|STARTED|Period 2, Day 1||4
40191|NCT01642485|91635|P4|STARTED|Period 2, Day 1||4
40192|NCT01642485|91636|P3|STARTED|Period 2, Day 1||4
40193|NCT01642485|91637|P2|STARTED|Period 2, Day 1||4
40194|NCT01642485|91638|P1|STARTED|Period 2, Day 1||4
40195|NCT01642485|91631|P8|NOT COMPLETED|Period 1, Day 3||0
40196|NCT01642485|91632|P7|NOT COMPLETED|Period 1, Day 3||0
40197|NCT01642485|91633|P6|NOT COMPLETED|Period 1, Day 3||0
40198|NCT01642485|91634|P5|NOT COMPLETED|Period 1, Day 3||0
40199|NCT01642485|91635|P4|NOT COMPLETED|Period 1, Day 3||0
40200|NCT01642485|91636|P3|NOT COMPLETED|Period 1, Day 3||0
40201|NCT01642485|91637|P2|NOT COMPLETED|Period 1, Day 3||0
40202|NCT01642485|91638|P1|NOT COMPLETED|Period 1, Day 3||0
40203|NCT01642485|91631|P8|COMPLETED|Period 1, Day 3||4
40204|NCT01642485|91632|P7|COMPLETED|Period 1, Day 3||4
40205|NCT01642485|91633|P6|COMPLETED|Period 1, Day 3||4
40206|NCT01642485|91634|P5|COMPLETED|Period 1, Day 3||4
40207|NCT01642485|91635|P4|COMPLETED|Period 1, Day 3||4
40208|NCT01642485|91636|P3|COMPLETED|Period 1, Day 3||4
40209|NCT01642485|91637|P2|COMPLETED|Period 1, Day 3||4
40210|NCT01642485|91638|P1|COMPLETED|Period 1, Day 3||4
40211|NCT01642485|91631|P8|STARTED|Period 1, Day 3||4
40212|NCT01642485|91632|P7|STARTED|Period 1, Day 3||4
40213|NCT01642485|91633|P6|STARTED|Period 1, Day 3||4
40214|NCT01642485|91634|P5|STARTED|Period 1, Day 3||4
40215|NCT01642485|91635|P4|STARTED|Period 1, Day 3||4
40216|NCT01642485|91636|P3|STARTED|Period 1, Day 3||4
40217|NCT01642485|91637|P2|STARTED|Period 1, Day 3||4
40218|NCT01642485|91638|P1|STARTED|Period 1, Day 3||4
40219|NCT01642485|91631|P8|NOT COMPLETED|Period 1, Day 2||0
40220|NCT01642485|91632|P7|NOT COMPLETED|Period 1, Day 2||0
40221|NCT01642485|91633|P6|NOT COMPLETED|Period 1, Day 2||0
40222|NCT01642485|91634|P5|NOT COMPLETED|Period 1, Day 2||0
40223|NCT01642485|91635|P4|NOT COMPLETED|Period 1, Day 2||0
40224|NCT01642485|91636|P3|NOT COMPLETED|Period 1, Day 2||0
40225|NCT01642485|91637|P2|NOT COMPLETED|Period 1, Day 2||0
40226|NCT01642485|91638|P1|NOT COMPLETED|Period 1, Day 2||0
40227|NCT01642485|91631|P8|COMPLETED|Period 1, Day 2||4
40228|NCT01642485|91632|P7|COMPLETED|Period 1, Day 2||4
40229|NCT01642485|91633|P6|COMPLETED|Period 1, Day 2||4
40230|NCT01642485|91634|P5|COMPLETED|Period 1, Day 2||4
40231|NCT01642485|91635|P4|COMPLETED|Period 1, Day 2||4
40232|NCT01642485|91636|P3|COMPLETED|Period 1, Day 2||4
40233|NCT01642485|91637|P2|COMPLETED|Period 1, Day 2||4
40234|NCT01642485|91638|P1|COMPLETED|Period 1, Day 2||4
40235|NCT01642485|91631|P8|STARTED|Period 1, Day 2||4
40236|NCT01642485|91632|P7|STARTED|Period 1, Day 2||4
40237|NCT01642485|91633|P6|STARTED|Period 1, Day 2||4
40238|NCT01642485|91634|P5|STARTED|Period 1, Day 2||4
40239|NCT01642485|91635|P4|STARTED|Period 1, Day 2||4
40240|NCT01642485|91636|P3|STARTED|Period 1, Day 2||4
40241|NCT01642485|91637|P2|STARTED|Period 1, Day 2||4
40242|NCT01642485|91638|P1|STARTED|Period 1, Day 2||4
40243|NCT01642485|91631|P8|NOT COMPLETED|Period 1, Day 1||0
40244|NCT01642485|91632|P7|NOT COMPLETED|Period 1, Day 1||0
40245|NCT01642485|91633|P6|NOT COMPLETED|Period 1, Day 1||0
40246|NCT01642485|91634|P5|NOT COMPLETED|Period 1, Day 1||0
40247|NCT01642485|91635|P4|NOT COMPLETED|Period 1, Day 1||0
40248|NCT01642485|91636|P3|NOT COMPLETED|Period 1, Day 1||0
40249|NCT01642485|91637|P2|NOT COMPLETED|Period 1, Day 1||0
40250|NCT01642485|91638|P1|NOT COMPLETED|Period 1, Day 1||0
40251|NCT01642485|91631|P8|COMPLETED|Period 1, Day 1||4
40252|NCT01642485|91632|P7|COMPLETED|Period 1, Day 1||4
40253|NCT01642485|91633|P6|COMPLETED|Period 1, Day 1||4
40254|NCT01642485|91634|P5|COMPLETED|Period 1, Day 1||4
40255|NCT01642485|91635|P4|COMPLETED|Period 1, Day 1||4
40256|NCT01642485|91636|P3|COMPLETED|Period 1, Day 1||4
40257|NCT01642485|91637|P2|COMPLETED|Period 1, Day 1||4
40258|NCT01642485|91638|P1|COMPLETED|Period 1, Day 1||4
40259|NCT01642485|91631|P8|STARTED|Period 1, Day 1||4
40260|NCT01642485|91632|P7|STARTED|Period 1, Day 1||4
40261|NCT01642485|91633|P6|STARTED|Period 1, Day 1||4
40262|NCT01642485|91634|P5|STARTED|Period 1, Day 1||4
40263|NCT01642485|91635|P4|STARTED|Period 1, Day 1||4
40264|NCT01642485|91636|P3|STARTED|Period 1, Day 1||4
40265|NCT01642485|91637|P2|STARTED|Period 1, Day 1||4
40266|NCT01642485|91638|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
40267|NCT01642277|91658|P2|NOT COMPLETED|Overall Study||0
40268|NCT01642277|91659|P1|NOT COMPLETED|Overall Study||24
40269|NCT01642277|91658|P2|COMPLETED|Overall Study||60
40270|NCT01642277|91659|P1|COMPLETED|Overall Study||50
40271|NCT01642277|91658|P2|STARTED|Overall Study||60
40272|NCT01642277|91659|P1|STARTED|Overall Study||74
40273|NCT01642238|91668|P2|NOT COMPLETED|Second Intervention (1 Day)||0
40274|NCT01642238|91669|P1|NOT COMPLETED|Second Intervention (1 Day)||0
40275|NCT01642238|91668|P2|COMPLETED|Second Intervention (1 Day)||8
40276|NCT01642238|91669|P1|COMPLETED|Second Intervention (1 Day)||7
40277|NCT01642238|91668|P2|STARTED|Second Intervention (1 Day)||8
40278|NCT01642238|91669|P1|STARTED|Second Intervention (1 Day)||7
40279|NCT01642238|91668|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
40280|NCT01642238|91669|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
40281|NCT01642238|91668|P2|COMPLETED|Washout (1-2 Weeks)||8
40282|NCT01642238|91669|P1|COMPLETED|Washout (1-2 Weeks)||7
40283|NCT01642238|91668|P2|STARTED|Washout (1-2 Weeks)||8
40284|NCT01642238|91669|P1|STARTED|Washout (1-2 Weeks)||7
40285|NCT01642238|91668|P2|NOT COMPLETED|First Intervention (1 Day)||0
40286|NCT01642238|91669|P1|NOT COMPLETED|First Intervention (1 Day)||0
40287|NCT01642238|91668|P2|COMPLETED|First Intervention (1 Day)||8
40288|NCT01642238|91669|P1|COMPLETED|First Intervention (1 Day)||7
40289|NCT01642238|91668|P2|STARTED|First Intervention (1 Day)||8
40290|NCT01642238|91669|P1|STARTED|First Intervention (1 Day)||7
40291|NCT01642212|91691|P5|NOT COMPLETED|Open-label Extension||8
40292|NCT01642212|91692|P4|NOT COMPLETED|Open-label Extension||10
40293|NCT01642212|91693|P3|NOT COMPLETED|Open-label Extension||0
40294|NCT01642212|91694|P2|NOT COMPLETED|Open-label Extension||0
40295|NCT01642212|91695|P1|NOT COMPLETED|Open-label Extension||0
40296|NCT01642212|91691|P5|COMPLETED|Open-label Extension||37
40297|NCT01642212|91692|P4|COMPLETED|Open-label Extension||27
40298|NCT01642212|91693|P3|COMPLETED|Open-label Extension||0
40299|NCT01642212|91694|P2|COMPLETED|Open-label Extension||0
40300|NCT01642212|91695|P1|COMPLETED|Open-label Extension||0
40301|NCT01642212|91691|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
40302|NCT01642212|91692|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
40303|NCT01642212|91693|P3|STARTED|Open-label Extension||0
40304|NCT01642212|91694|P2|STARTED|Open-label Extension||0
40305|NCT01642212|91695|P1|STARTED|Open-label Extension||0
40306|NCT01642212|91691|P5|NOT COMPLETED|Double-blind Treatment||0
40307|NCT01642212|91692|P4|NOT COMPLETED|Double-blind Treatment||0
40308|NCT01642212|91693|P3|NOT COMPLETED|Double-blind Treatment||2
40309|NCT01642212|91694|P2|NOT COMPLETED|Double-blind Treatment||3
40310|NCT01642212|91695|P1|NOT COMPLETED|Double-blind Treatment||0
40311|NCT01642212|91691|P5|COMPLETED|Double-blind Treatment||0
40312|NCT01642212|91692|P4|COMPLETED|Double-blind Treatment||0
40313|NCT01642212|91693|P3|COMPLETED|Double-blind Treatment||49
40314|NCT01642212|91694|P2|COMPLETED|Double-blind Treatment||39
40315|NCT01642212|91695|P1|COMPLETED|Double-blind Treatment||0
40316|NCT01642212|91691|P5|STARTED|Double-blind Treatment||0
40317|NCT01642212|91692|P4|STARTED|Double-blind Treatment||0
40318|NCT01642212|91693|P3|STARTED|Double-blind Treatment||51
40319|NCT01642212|91694|P2|STARTED|Double-blind Treatment||42
40320|NCT01642212|91695|P1|STARTED|Double-blind Treatment||0
40321|NCT01642212|91691|P5|NOT COMPLETED|Single-blind Baseline||0
40322|NCT01642212|91692|P4|NOT COMPLETED|Single-blind Baseline||0
40323|NCT01642212|91693|P3|NOT COMPLETED|Single-blind Baseline||0
40324|NCT01642212|91694|P2|NOT COMPLETED|Single-blind Baseline||0
40325|NCT01642212|91695|P1|NOT COMPLETED|Single-blind Baseline||26
40326|NCT01642212|91691|P5|COMPLETED|Single-blind Baseline||0
40327|NCT01642212|91692|P4|COMPLETED|Single-blind Baseline||0
40328|NCT01642212|91693|P3|COMPLETED|Single-blind Baseline||0
40329|NCT01642212|91694|P2|COMPLETED|Single-blind Baseline||0
40330|NCT01642212|91695|P1|COMPLETED|Single-blind Baseline||93
40331|NCT01642212|91691|P5|STARTED|Single-blind Baseline||0
40332|NCT01642212|91692|P4|STARTED|Single-blind Baseline||0
40333|NCT01642212|91693|P3|STARTED|Single-blind Baseline||0
40334|NCT01642212|91694|P2|STARTED|Single-blind Baseline||0
40335|NCT01642212|91695|P1|STARTED|Single-blind Baseline||119
40336|NCT01642147|91745|P2|NOT COMPLETED|Overall Study||0
40337|NCT01642147|91746|P1|NOT COMPLETED|Overall Study||0
40338|NCT01642147|91745|P2|COMPLETED|Overall Study||30
40339|NCT01642147|91746|P1|COMPLETED|Overall Study||30
40340|NCT01642147|91745|P2|STARTED|Overall Study||30
40341|NCT01642147|91746|P1|STARTED|Overall Study||30
40342|NCT01642082|91774|P1|NOT COMPLETED|Overall Study||0
40343|NCT01642082|91774|P1|COMPLETED|Overall Study||28
40344|NCT01642082|91774|P1|STARTED|Overall Study||28
40345|NCT01642004|91784|P2|NOT COMPLETED|Treatment||127
40346|NCT01642004|91785|P1|NOT COMPLETED|Treatment||110
40347|NCT01642004|91784|P2|COMPLETED|Treatment||2
40348|NCT01642004|91785|P1|COMPLETED|Treatment||21
40349|NCT01642004|91784|P2|STARTED|Treatment||129
40350|NCT01642004|91785|P1|STARTED|Treatment||131
40351|NCT01642004|91784|P2|NOT COMPLETED|Randomization||8
40352|NCT01642004|91785|P1|NOT COMPLETED|Randomization||4
40353|NCT01642004|91784|P2|COMPLETED|Randomization||129
40354|NCT01642004|91785|P1|COMPLETED|Randomization||131
40355|NCT01642004|91784|P2|STARTED|Randomization||137
40356|NCT01642004|91785|P1|STARTED|Randomization||135
40357|NCT01641991|91819|P4|NOT COMPLETED|Overall Study||16
40358|NCT01641991|91820|P3|NOT COMPLETED|Overall Study||17
40359|NCT01641991|91821|P2|NOT COMPLETED|Overall Study||8
40360|NCT01641991|91822|P1|NOT COMPLETED|Overall Study||9
40361|NCT01641991|91819|P4|COMPLETED|Overall Study||66
40362|NCT01641991|91820|P3|COMPLETED|Overall Study||65
40363|NCT01641991|91821|P2|COMPLETED|Overall Study||74
40364|NCT01641991|91822|P1|COMPLETED|Overall Study||73
40365|NCT01641991|91819|P4|STARTED|Overall Study||82
40366|NCT01641991|91820|P3|STARTED|Overall Study||82
40367|NCT01641991|91821|P2|STARTED|Overall Study||82
40368|NCT01641991|91822|P1|STARTED|Overall Study||82
40369|NCT01641978|91898|P1|NOT COMPLETED|Overall Study||0
40370|NCT01641978|91898|P1|COMPLETED|Overall Study||125
40371|NCT01641978|91898|P1|STARTED|Overall Study||125
40372|NCT01641952|91906|P1|NOT COMPLETED|Overall Study||34
40373|NCT01641952|91906|P1|COMPLETED|Overall Study||471
40374|NCT01641952|91906|P1|Treated|Overall Study||504
40375|NCT01641952|91906|P1|STARTED|Overall Study||505
40376|NCT01641939|91922|P3|NOT COMPLETED|Overall Study||70
40377|NCT01641939|91923|P2|NOT COMPLETED|Overall Study||228
40378|NCT01641939|91924|P1|NOT COMPLETED|Overall Study||117
40379|NCT01641939|91922|P3|COMPLETED|Overall Study||0
40380|NCT01641939|91923|P2|COMPLETED|Overall Study||0
40381|NCT01641939|91924|P1|COMPLETED|Overall Study||0
40382|NCT01641939|91922|P3|Phase 3|Overall Study||0
40383|NCT01641939|91923|P2|Phase 3|Overall Study||153
40384|NCT01641939|91924|P1|Phase 3|Overall Study||80
40385|NCT01641939|91922|P3|Phase 2|Overall Study||70
40386|NCT01641939|91923|P2|Phase 2|Overall Study||75
40387|NCT01641939|91924|P1|Phase 2|Overall Study||37
40388|NCT01641939|91922|P3|STARTED|Overall Study||70
40389|NCT01641939|91923|P2|STARTED|Overall Study||228
40390|NCT01641939|91924|P1|STARTED|Overall Study||117
40391|NCT01641926|91967|P4|NOT COMPLETED|Overall Study||4
40392|NCT01641926|91968|P3|NOT COMPLETED|Overall Study||11
40393|NCT01641926|91969|P2|NOT COMPLETED|Overall Study||15
40394|NCT01641926|91970|P1|NOT COMPLETED|Overall Study||28
40395|NCT01641926|91967|P4|COMPLETED|Overall Study||53
40396|NCT01641926|91968|P3|COMPLETED|Overall Study||46
40397|NCT01641926|91969|P2|COMPLETED|Overall Study||130
40398|NCT01641926|91970|P1|COMPLETED|Overall Study||115
40399|NCT01641926|91967|P4|Treated (All Participants as Treated)|Overall Study||57
40400|NCT01641926|91968|P3|Treated (All Participants as Treated)|Overall Study||56
40401|NCT01641926|91969|P2|Treated (All Participants as Treated)|Overall Study||144
40402|NCT01641926|91970|P1|Treated (All Participants as Treated)|Overall Study||142
40403|NCT01641926|91967|P4|STARTED|Overall Study||57
40404|NCT01641926|91968|P3|STARTED|Overall Study||57
40405|NCT01641926|91969|P2|STARTED|Overall Study||145
40406|NCT01641926|91970|P1|STARTED|Overall Study||143
40407|NCT01641861|91998|P2|NOT COMPLETED|Overall Study||25
40408|NCT01641861|91999|P1|NOT COMPLETED|Overall Study||35
40409|NCT01641861|91998|P2|COMPLETED|Overall Study||217
40410|NCT01641861|91999|P1|COMPLETED|Overall Study||211
40411|NCT01641861|91998|P2|STARTED|Overall Study||242
40412|NCT01641861|91999|P1|STARTED|Overall Study||246
40413|NCT01641835|92013|P1|NOT COMPLETED|Overall Study||0
40414|NCT01641835|92013|P1|COMPLETED|Overall Study||303
40415|NCT01641835|92013|P1|STARTED|Overall Study||303
40416|NCT01641822|92020|P3|NOT COMPLETED|Comparative Phase||10
40417|NCT01641822|92021|P2|NOT COMPLETED|Comparative Phase||6
40418|NCT01641822|92022|P1|NOT COMPLETED|Comparative Phase||0
40419|NCT01641822|92020|P3|COMPLETED|Comparative Phase||37
40420|NCT01641822|92021|P2|COMPLETED|Comparative Phase||37
40421|NCT01641822|92022|P1|COMPLETED|Comparative Phase||0
40422|NCT01641822|92020|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
40423|NCT01641822|92021|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
40424|NCT01641822|92022|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
40425|NCT01641822|92020|P3|STARTED|Comparative Phase||47
40426|NCT01641822|92021|P2|STARTED|Comparative Phase||43
40427|NCT01641822|92022|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
40428|NCT01641822|92020|P3|NOT COMPLETED|Run-in Phase||0
40429|NCT01641822|92021|P2|NOT COMPLETED|Run-in Phase||0
40430|NCT01641822|92022|P1|NOT COMPLETED|Run-in Phase||14
40431|NCT01641822|92020|P3|COMPLETED|Run-in Phase||0
40432|NCT01641822|92021|P2|COMPLETED|Run-in Phase||0
40433|NCT01641822|92022|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
40434|NCT01641822|92020|P3|STARTED|Run-in Phase||0
40435|NCT01641822|92021|P2|STARTED|Run-in Phase||0
40436|NCT01641822|92022|P1|STARTED|Run-in Phase||107
40437|NCT01641692|92039|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
40438|NCT01641692|92040|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
40439|NCT01641692|92041|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
40440|NCT01641692|92042|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
40441|NCT01641692|92043|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
40442|NCT01641692|92044|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
40443|NCT01641692|92045|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
40444|NCT01641692|92046|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
40445|NCT01641692|92039|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
40446|NCT01641692|92040|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
40447|NCT01641692|92041|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
40448|NCT01641692|92042|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
40449|NCT01641692|92043|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
40450|NCT01641692|92044|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
40451|NCT01641692|92045|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
40452|NCT01641692|92046|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
40453|NCT01641692|92039|P8|STARTED|Washout Period 3 or Follow-up||38
40454|NCT01641692|92040|P7|STARTED|Washout Period 3 or Follow-up||33
40455|NCT01641692|92041|P6|STARTED|Washout Period 3 or Follow-up||39
40456|NCT01641692|92042|P5|STARTED|Washout Period 3 or Follow-up||40
40457|NCT01641692|92043|P4|STARTED|Washout Period 3 or Follow-up||42
40458|NCT01641692|92044|P3|STARTED|Washout Period 3 or Follow-up||37
40459|NCT01641692|92045|P2|STARTED|Washout Period 3 or Follow-up||32
40460|NCT01641692|92046|P1|STARTED|Washout Period 3 or Follow-up||43
40461|NCT01641692|92039|P8|NOT COMPLETED|Treatment Period 3||0
40462|NCT01641692|92040|P7|NOT COMPLETED|Treatment Period 3||2
40463|NCT01641692|92041|P6|NOT COMPLETED|Treatment Period 3||0
40464|NCT01641692|92042|P5|NOT COMPLETED|Treatment Period 3||0
40465|NCT01641692|92043|P4|NOT COMPLETED|Treatment Period 3||0
40466|NCT01641692|92044|P3|NOT COMPLETED|Treatment Period 3||1
40467|NCT01641692|92045|P2|NOT COMPLETED|Treatment Period 3||1
40468|NCT01641692|92046|P1|NOT COMPLETED|Treatment Period 3||0
40469|NCT01641692|92039|P8|COMPLETED|Treatment Period 3||38
40470|NCT01641692|92040|P7|COMPLETED|Treatment Period 3||33
40471|NCT01641692|92041|P6|COMPLETED|Treatment Period 3||39
40472|NCT01641692|92042|P5|COMPLETED|Treatment Period 3||40
40473|NCT01641692|92043|P4|COMPLETED|Treatment Period 3||42
40474|NCT01641692|92044|P3|COMPLETED|Treatment Period 3||37
40475|NCT01641692|92045|P2|COMPLETED|Treatment Period 3||32
40476|NCT01641692|92046|P1|COMPLETED|Treatment Period 3||43
40477|NCT01641692|92039|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
40478|NCT01641692|92040|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
40479|NCT01641692|92041|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
40480|NCT01641692|92042|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
40481|NCT01641692|92043|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
40482|NCT01641692|92044|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
40483|NCT01641692|92045|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
40484|NCT01641692|92046|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
40485|NCT01641692|92039|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
40486|NCT01641692|92040|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
40487|NCT01641692|92041|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
40488|NCT01641692|92042|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
40489|NCT01641692|92043|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
40490|NCT01641692|92044|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
40491|NCT01641692|92045|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
40492|NCT01641692|92046|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
40493|NCT01641692|92039|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
40494|NCT01641692|92040|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
40495|NCT01641692|92041|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
40496|NCT01641692|92042|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
40497|NCT01641692|92043|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
40498|NCT01641692|92044|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
40499|NCT01641692|92045|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
40570|NCT01641692|92044|P3|COMPLETED|Treatment Period 1||50
40500|NCT01641692|92046|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
40501|NCT01641692|92039|P8|STARTED|Washout Period 2 (12-14 Days)||35
40502|NCT01641692|92040|P7|STARTED|Washout Period 2 (12-14 Days)||43
40503|NCT01641692|92041|P6|STARTED|Washout Period 2 (12-14 Days)||43
40504|NCT01641692|92042|P5|STARTED|Washout Period 2 (12-14 Days)||37
40505|NCT01641692|92043|P4|STARTED|Washout Period 2 (12-14 Days)||41
40506|NCT01641692|92044|P3|STARTED|Washout Period 2 (12-14 Days)||40
40507|NCT01641692|92045|P2|STARTED|Washout Period 2 (12-14 Days)||46
40508|NCT01641692|92046|P1|STARTED|Washout Period 2 (12-14 Days)||30
40509|NCT01641692|92039|P8|NOT COMPLETED|Treatment Period 2||1
40510|NCT01641692|92040|P7|NOT COMPLETED|Treatment Period 2||0
40511|NCT01641692|92041|P6|NOT COMPLETED|Treatment Period 2||2
40512|NCT01641692|92042|P5|NOT COMPLETED|Treatment Period 2||0
40513|NCT01641692|92043|P4|NOT COMPLETED|Treatment Period 2||0
40514|NCT01641692|92044|P3|NOT COMPLETED|Treatment Period 2||0
40515|NCT01641692|92045|P2|NOT COMPLETED|Treatment Period 2||0
40516|NCT01641692|92046|P1|NOT COMPLETED|Treatment Period 2||3
40517|NCT01641692|92039|P8|COMPLETED|Treatment Period 2||35
40518|NCT01641692|92040|P7|COMPLETED|Treatment Period 2||43
40519|NCT01641692|92041|P6|COMPLETED|Treatment Period 2||43
40520|NCT01641692|92042|P5|COMPLETED|Treatment Period 2||37
40521|NCT01641692|92043|P4|COMPLETED|Treatment Period 2||41
40522|NCT01641692|92044|P3|COMPLETED|Treatment Period 2||40
40523|NCT01641692|92045|P2|COMPLETED|Treatment Period 2||46
40524|NCT01641692|92046|P1|COMPLETED|Treatment Period 2||30
40525|NCT01641692|92039|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
40526|NCT01641692|92040|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
40527|NCT01641692|92041|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
40528|NCT01641692|92042|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
40529|NCT01641692|92043|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
40530|NCT01641692|92044|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
40531|NCT01641692|92045|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
40532|NCT01641692|92046|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
40533|NCT01641692|92039|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
40534|NCT01641692|92040|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
40535|NCT01641692|92041|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
40536|NCT01641692|92042|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
40537|NCT01641692|92043|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
40538|NCT01641692|92044|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
40539|NCT01641692|92045|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
40540|NCT01641692|92046|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
40541|NCT01641692|92039|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
40542|NCT01641692|92040|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
40543|NCT01641692|92041|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
40544|NCT01641692|92042|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
40545|NCT01641692|92043|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
40546|NCT01641692|92044|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
40547|NCT01641692|92045|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
40548|NCT01641692|92046|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
40549|NCT01641692|92039|P8|STARTED|Washout Period 1 (12-14 Days)||48
40550|NCT01641692|92040|P7|STARTED|Washout Period 1 (12-14 Days)||38
40551|NCT01641692|92041|P6|STARTED|Washout Period 1 (12-14 Days)||37
40552|NCT01641692|92042|P5|STARTED|Washout Period 1 (12-14 Days)||39
40553|NCT01641692|92043|P4|STARTED|Washout Period 1 (12-14 Days)||41
40554|NCT01641692|92044|P3|STARTED|Washout Period 1 (12-14 Days)||50
40555|NCT01641692|92045|P2|STARTED|Washout Period 1 (12-14 Days)||45
40556|NCT01641692|92046|P1|STARTED|Washout Period 1 (12-14 Days)||40
40557|NCT01641692|92039|P8|NOT COMPLETED|Treatment Period 1||3
40558|NCT01641692|92040|P7|NOT COMPLETED|Treatment Period 1||0
40559|NCT01641692|92041|P6|NOT COMPLETED|Treatment Period 1||2
40560|NCT01641692|92042|P5|NOT COMPLETED|Treatment Period 1||4
40561|NCT01641692|92043|P4|NOT COMPLETED|Treatment Period 1||0
40562|NCT01641692|92044|P3|NOT COMPLETED|Treatment Period 1||1
40563|NCT01641692|92045|P2|NOT COMPLETED|Treatment Period 1||0
40564|NCT01641692|92046|P1|NOT COMPLETED|Treatment Period 1||2
40565|NCT01641692|92039|P8|COMPLETED|Treatment Period 1||48
40566|NCT01641692|92040|P7|COMPLETED|Treatment Period 1||38
40567|NCT01641692|92041|P6|COMPLETED|Treatment Period 1||37
40568|NCT01641692|92042|P5|COMPLETED|Treatment Period 1||39
40569|NCT01641692|92043|P4|COMPLETED|Treatment Period 1||41
40571|NCT01641692|92045|P2|COMPLETED|Treatment Period 1||45
40572|NCT01641692|92046|P1|COMPLETED|Treatment Period 1||40
40573|NCT01641692|92039|P8|STARTED|Treatment Period 1||51
40574|NCT01641692|92040|P7|STARTED|Treatment Period 1||38
40575|NCT01641692|92041|P6|STARTED|Treatment Period 1||39
40576|NCT01641692|92042|P5|STARTED|Treatment Period 1||43
40577|NCT01641692|92043|P4|STARTED|Treatment Period 1||41
40578|NCT01641692|92044|P3|STARTED|Treatment Period 1||51
40579|NCT01641692|92045|P2|STARTED|Treatment Period 1||45
40580|NCT01641692|92046|P1|STARTED|Treatment Period 1||42
40581|NCT01641653|92235|P2|NOT COMPLETED|Overall Study||0
40582|NCT01641653|92236|P1|NOT COMPLETED|Overall Study||0
40583|NCT01641653|92235|P2|COMPLETED|Overall Study||30
40584|NCT01641653|92236|P1|COMPLETED|Overall Study||30
40585|NCT01641653|92235|P2|STARTED|Overall Study||30
40586|NCT01641653|92236|P1|STARTED|Overall Study||30
40587|NCT01641640|92246|P1|NOT COMPLETED|Overall Study||36
40588|NCT01641640|92246|P1|COMPLETED|Overall Study||292
40589|NCT01641640|92246|P1|Enrolled and Treated|Overall Study||327
40590|NCT01641640|92246|P1|STARTED|Overall Study||328
40591|NCT01641471|92257|P2|NOT COMPLETED|Overall Study||27
40592|NCT01641471|92258|P1|NOT COMPLETED|Overall Study||23
40593|NCT01641471|92257|P2|COMPLETED|Overall Study||31
40594|NCT01641471|92258|P1|COMPLETED|Overall Study||35
40595|NCT01641471|92257|P2|STARTED|Overall Study||58
40596|NCT01641471|92258|P1|STARTED|Overall Study||58
40597|NCT01641237|92264|P4|NOT COMPLETED|Period IV||0
40598|NCT01641237|92265|P3|NOT COMPLETED|Period IV||0
40599|NCT01641237|92266|P2|NOT COMPLETED|Period IV||0
40600|NCT01641237|92267|P1|NOT COMPLETED|Period IV||0
40601|NCT01641237|92264|P4|COMPLETED|Period IV||15
40602|NCT01641237|92265|P3|COMPLETED|Period IV||15
40603|NCT01641237|92266|P2|COMPLETED|Period IV||15
40604|NCT01641237|92267|P1|COMPLETED|Period IV||15
40605|NCT01641237|92264|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
40606|NCT01641237|92265|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
40607|NCT01641237|92266|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
40608|NCT01641237|92267|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
40609|NCT01641237|92264|P4|NOT COMPLETED|Period III||0
40610|NCT01641237|92265|P3|NOT COMPLETED|Period III||0
40611|NCT01641237|92266|P2|NOT COMPLETED|Period III||0
40612|NCT01641237|92267|P1|NOT COMPLETED|Period III||1
40613|NCT01641237|92264|P4|COMPLETED|Period III||16
40614|NCT01641237|92265|P3|COMPLETED|Period III||15
40615|NCT01641237|92266|P2|COMPLETED|Period III||14
40616|NCT01641237|92267|P1|COMPLETED|Period III||15
40617|NCT01641237|92264|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
40618|NCT01641237|92265|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
40619|NCT01641237|92266|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
40620|NCT01641237|92267|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
40621|NCT01641237|92264|P4|NOT COMPLETED|Period II||0
40622|NCT01641237|92265|P3|NOT COMPLETED|Period II||0
40623|NCT01641237|92266|P2|NOT COMPLETED|Period II||0
40624|NCT01641237|92267|P1|NOT COMPLETED|Period II||1
40625|NCT01641237|92264|P4|COMPLETED|Period II||15
40626|NCT01641237|92265|P3|COMPLETED|Period II||16
40627|NCT01641237|92266|P2|COMPLETED|Period II||16
40628|NCT01641237|92267|P1|COMPLETED|Period II||14
40629|NCT01641237|92264|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
40630|NCT01641237|92265|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
40631|NCT01641237|92266|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
40632|NCT01641237|92267|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
40633|NCT01641237|92264|P4|NOT COMPLETED|Period I||0
40634|NCT01641237|92265|P3|NOT COMPLETED|Period I||0
40635|NCT01641237|92266|P2|NOT COMPLETED|Period I||0
40636|NCT01641237|92267|P1|NOT COMPLETED|Period I||0
40637|NCT01641237|92264|P4|COMPLETED|Period I||15
40638|NCT01641237|92265|P3|COMPLETED|Period I||15
40639|NCT01641237|92266|P2|COMPLETED|Period I||16
40640|NCT01641237|92267|P1|COMPLETED|Period I||16
40641|NCT01641237|92264|P4|STARTED|Period I||15
40642|NCT01641237|92265|P3|STARTED|Period I||15
40643|NCT01641237|92266|P2|STARTED|Period I||16
40644|NCT01641237|92267|P1|STARTED|Period I||16
40645|NCT01641159|92291|P2|NOT COMPLETED|Overall Study||2
40646|NCT01641159|92292|P1|NOT COMPLETED|Overall Study||2
40647|NCT01641159|92291|P2|COMPLETED|Overall Study||25
40648|NCT01641159|92292|P1|COMPLETED|Overall Study||33
40649|NCT01641159|92291|P2|STARTED|Overall Study||27
40650|NCT01641159|92292|P1|STARTED|Overall Study||35
40651|NCT01641120|92300|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
40652|NCT01641120|92300|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
40653|NCT01641120|92300|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
40654|NCT01641120|92300|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
40655|NCT01641120|92300|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
40656|NCT01641120|92300|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
40657|NCT01641081|92312|P10|NOT COMPLETED|Period 5||0
40658|NCT01641081|92313|P9|NOT COMPLETED|Period 5||0
40659|NCT01641081|92314|P8|NOT COMPLETED|Period 5||0
40660|NCT01641081|92315|P7|NOT COMPLETED|Period 5||0
40661|NCT01641081|92316|P6|NOT COMPLETED|Period 5||0
40662|NCT01641081|92317|P5|NOT COMPLETED|Period 5||0
40663|NCT01641081|92318|P4|NOT COMPLETED|Period 5||0
40664|NCT01641081|92319|P3|NOT COMPLETED|Period 5||2
40665|NCT01641081|92320|P2|NOT COMPLETED|Period 5||0
40666|NCT01641081|92321|P1|NOT COMPLETED|Period 5||0
40667|NCT01641081|92312|P10|COMPLETED|Period 5||14
40668|NCT01641081|92313|P9|COMPLETED|Period 5||14
40669|NCT01641081|92314|P8|COMPLETED|Period 5||14
40670|NCT01641081|92315|P7|COMPLETED|Period 5||16
40671|NCT01641081|92316|P6|COMPLETED|Period 5||18
40672|NCT01641081|92317|P5|COMPLETED|Period 5||16
40673|NCT01641081|92318|P4|COMPLETED|Period 5||20
40674|NCT01641081|92319|P3|COMPLETED|Period 5||12
40675|NCT01641081|92320|P2|COMPLETED|Period 5||17
40676|NCT01641081|92321|P1|COMPLETED|Period 5||16
40677|NCT01641081|92312|P10|STARTED|Period 5||14
40678|NCT01641081|92313|P9|STARTED|Period 5||14
40679|NCT01641081|92314|P8|STARTED|Period 5||14
40680|NCT01641081|92315|P7|STARTED|Period 5||16
40681|NCT01641081|92316|P6|STARTED|Period 5||18
40682|NCT01641081|92317|P5|STARTED|Period 5||16
40683|NCT01641081|92318|P4|STARTED|Period 5||20
40684|NCT01641081|92319|P3|STARTED|Period 5||14
40685|NCT01641081|92320|P2|STARTED|Period 5||17
40686|NCT01641081|92321|P1|STARTED|Period 5||16
40687|NCT01641081|92312|P10|NOT COMPLETED|Period 4||0
40688|NCT01641081|92313|P9|NOT COMPLETED|Period 4||0
40689|NCT01641081|92314|P8|NOT COMPLETED|Period 4||0
40690|NCT01641081|92315|P7|NOT COMPLETED|Period 4||0
40691|NCT01641081|92316|P6|NOT COMPLETED|Period 4||0
40692|NCT01641081|92317|P5|NOT COMPLETED|Period 4||0
40693|NCT01641081|92318|P4|NOT COMPLETED|Period 4||1
40694|NCT01641081|92319|P3|NOT COMPLETED|Period 4||0
40695|NCT01641081|92320|P2|NOT COMPLETED|Period 4||1
40696|NCT01641081|92321|P1|NOT COMPLETED|Period 4||0
40697|NCT01641081|92312|P10|COMPLETED|Period 4||14
40698|NCT01641081|92313|P9|COMPLETED|Period 4||14
40699|NCT01641081|92314|P8|COMPLETED|Period 4||14
40700|NCT01641081|92315|P7|COMPLETED|Period 4||16
40701|NCT01641081|92316|P6|COMPLETED|Period 4||18
40702|NCT01641081|92317|P5|COMPLETED|Period 4||16
40703|NCT01641081|92318|P4|COMPLETED|Period 4||20
40704|NCT01641081|92319|P3|COMPLETED|Period 4||14
40705|NCT01641081|92320|P2|COMPLETED|Period 4||17
40706|NCT01641081|92321|P1|COMPLETED|Period 4||16
40707|NCT01641081|92312|P10|STARTED|Period 4||14
40708|NCT01641081|92313|P9|STARTED|Period 4||14
40709|NCT01641081|92314|P8|STARTED|Period 4||14
40710|NCT01641081|92315|P7|STARTED|Period 4||16
40711|NCT01641081|92316|P6|STARTED|Period 4||18
40712|NCT01641081|92317|P5|STARTED|Period 4||16
40713|NCT01641081|92318|P4|STARTED|Period 4||21
40714|NCT01641081|92319|P3|STARTED|Period 4||14
40715|NCT01641081|92320|P2|STARTED|Period 4||18
40716|NCT01641081|92321|P1|STARTED|Period 4||16
40717|NCT01641081|92312|P10|NOT COMPLETED|Period 3||0
40718|NCT01641081|92313|P9|NOT COMPLETED|Period 3||1
40719|NCT01641081|92314|P8|NOT COMPLETED|Period 3||0
40720|NCT01641081|92315|P7|NOT COMPLETED|Period 3||0
40721|NCT01641081|92316|P6|NOT COMPLETED|Period 3||0
40722|NCT01641081|92317|P5|NOT COMPLETED|Period 3||0
40723|NCT01641081|92318|P4|NOT COMPLETED|Period 3||0
40724|NCT01641081|92319|P3|NOT COMPLETED|Period 3||1
40725|NCT01641081|92320|P2|NOT COMPLETED|Period 3||0
40726|NCT01641081|92321|P1|NOT COMPLETED|Period 3||0
40727|NCT01641081|92312|P10|COMPLETED|Period 3||14
40728|NCT01641081|92313|P9|COMPLETED|Period 3||14
40729|NCT01641081|92314|P8|COMPLETED|Period 3||14
40730|NCT01641081|92315|P7|COMPLETED|Period 3||16
40731|NCT01641081|92316|P6|COMPLETED|Period 3||18
40732|NCT01641081|92317|P5|COMPLETED|Period 3||16
40733|NCT01641081|92318|P4|COMPLETED|Period 3||21
40734|NCT01641081|92319|P3|COMPLETED|Period 3||14
40735|NCT01641081|92320|P2|COMPLETED|Period 3||18
40736|NCT01641081|92321|P1|COMPLETED|Period 3||16
40737|NCT01641081|92312|P10|STARTED|Period 3||14
40738|NCT01641081|92313|P9|STARTED|Period 3||15
40739|NCT01641081|92314|P8|STARTED|Period 3||14
40740|NCT01641081|92315|P7|STARTED|Period 3||16
40741|NCT01641081|92316|P6|STARTED|Period 3||18
40742|NCT01641081|92317|P5|STARTED|Period 3||16
40743|NCT01641081|92318|P4|STARTED|Period 3||21
40744|NCT01641081|92319|P3|STARTED|Period 3||15
40745|NCT01641081|92320|P2|STARTED|Period 3||18
40746|NCT01641081|92321|P1|STARTED|Period 3||16
40747|NCT01641081|92312|P10|NOT COMPLETED|Period 2||0
40748|NCT01641081|92313|P9|NOT COMPLETED|Period 2||0
40749|NCT01641081|92314|P8|NOT COMPLETED|Period 2||0
40750|NCT01641081|92315|P7|NOT COMPLETED|Period 2||2
40751|NCT01641081|92316|P6|NOT COMPLETED|Period 2||1
40752|NCT01641081|92317|P5|NOT COMPLETED|Period 2||0
40753|NCT01641081|92318|P4|NOT COMPLETED|Period 2||1
40754|NCT01641081|92319|P3|NOT COMPLETED|Period 2||0
40755|NCT01641081|92320|P2|NOT COMPLETED|Period 2||0
40756|NCT01641081|92321|P1|NOT COMPLETED|Period 2||1
40757|NCT01641081|92312|P10|COMPLETED|Period 2||14
40758|NCT01641081|92313|P9|COMPLETED|Period 2||15
40759|NCT01641081|92314|P8|COMPLETED|Period 2||14
40760|NCT01641081|92315|P7|COMPLETED|Period 2||16
40761|NCT01641081|92316|P6|COMPLETED|Period 2||18
40762|NCT01641081|92317|P5|COMPLETED|Period 2||16
40763|NCT01641081|92318|P4|COMPLETED|Period 2||21
40764|NCT01641081|92319|P3|COMPLETED|Period 2||15
40765|NCT01641081|92320|P2|COMPLETED|Period 2||18
40766|NCT01641081|92321|P1|COMPLETED|Period 2||16
40767|NCT01641081|92312|P10|STARTED|Period 2||14
40768|NCT01641081|92313|P9|STARTED|Period 2||15
40769|NCT01641081|92314|P8|STARTED|Period 2||14
40770|NCT01641081|92315|P7|STARTED|Period 2||18
40771|NCT01641081|92316|P6|STARTED|Period 2||19
40772|NCT01641081|92317|P5|STARTED|Period 2||16
40773|NCT01641081|92318|P4|STARTED|Period 2||22
40774|NCT01641081|92319|P3|STARTED|Period 2||15
40775|NCT01641081|92320|P2|STARTED|Period 2||18
40776|NCT01641081|92321|P1|STARTED|Period 2||17
40777|NCT01641081|92312|P10|NOT COMPLETED|Period 1||0
40778|NCT01641081|92313|P9|NOT COMPLETED|Period 1||0
40779|NCT01641081|92314|P8|NOT COMPLETED|Period 1||3
40780|NCT01641081|92315|P7|NOT COMPLETED|Period 1||1
40781|NCT01641081|92316|P6|NOT COMPLETED|Period 1||0
40782|NCT01641081|92317|P5|NOT COMPLETED|Period 1||1
40783|NCT01641081|92318|P4|NOT COMPLETED|Period 1||0
40784|NCT01641081|92319|P3|NOT COMPLETED|Period 1||0
40785|NCT01641081|92320|P2|NOT COMPLETED|Period 1||0
40786|NCT01641081|92321|P1|NOT COMPLETED|Period 1||1
40787|NCT01641081|92312|P10|COMPLETED|Period 1||14
40788|NCT01641081|92313|P9|COMPLETED|Period 1||15
40789|NCT01641081|92314|P8|COMPLETED|Period 1||14
40790|NCT01641081|92315|P7|COMPLETED|Period 1||18
40791|NCT01641081|92316|P6|COMPLETED|Period 1||19
40792|NCT01641081|92317|P5|COMPLETED|Period 1||16
40793|NCT01641081|92318|P4|COMPLETED|Period 1||22
40794|NCT01641081|92319|P3|COMPLETED|Period 1||15
40795|NCT01641081|92320|P2|COMPLETED|Period 1||18
40796|NCT01641081|92321|P1|COMPLETED|Period 1||17
40797|NCT01641081|92312|P10|STARTED|Period 1||14
40798|NCT01641081|92313|P9|STARTED|Period 1||15
40799|NCT01641081|92314|P8|STARTED|Period 1||17
40800|NCT01641081|92315|P7|STARTED|Period 1||19
40801|NCT01641081|92316|P6|STARTED|Period 1||19
40802|NCT01641081|92317|P5|STARTED|Period 1||17
40803|NCT01641081|92318|P4|STARTED|Period 1||22
40804|NCT01641081|92319|P3|STARTED|Period 1||15
40805|NCT01641081|92320|P2|STARTED|Period 1||18
40806|NCT01641081|92321|P1|STARTED|Period 1||18
40807|NCT01640964|92341|P3|NOT COMPLETED|Overall Study||3
40808|NCT01640964|92342|P2|NOT COMPLETED|Overall Study||1
40809|NCT01640964|92343|P1|NOT COMPLETED|Overall Study||1
40810|NCT01640964|92341|P3|COMPLETED|Overall Study||3
40811|NCT01640964|92342|P2|COMPLETED|Overall Study||19
40812|NCT01640964|92343|P1|COMPLETED|Overall Study||19
40813|NCT01640964|92341|P3|STARTED|Overall Study||6
40814|NCT01640964|92342|P2|STARTED|Overall Study||20
40815|NCT01640964|92343|P1|STARTED|Overall Study||20
40816|NCT01640925|92360|P2|NOT COMPLETED|Overall Study||11
40817|NCT01640925|92361|P1|NOT COMPLETED|Overall Study||14
40818|NCT01640925|92360|P2|COMPLETED|Overall Study||164
40819|NCT01640925|92361|P1|COMPLETED|Overall Study||161
40820|NCT01640925|92360|P2|STARTED|Overall Study||175
40821|NCT01640925|92361|P1|STARTED|Overall Study||175
40822|NCT01640548|92367|P1|NOT COMPLETED|Overall Study||0
40823|NCT01640548|92367|P1|COMPLETED|Overall Study||309
40824|NCT01640548|92367|P1|STARTED|Overall Study||309
40825|NCT01640340|92383|P2|NOT COMPLETED|Overall Study||0
40826|NCT01640340|92384|P1|NOT COMPLETED|Overall Study||0
40827|NCT01640340|92383|P2|COMPLETED|Overall Study||20
40828|NCT01640340|92384|P1|COMPLETED|Overall Study||20
40829|NCT01640340|92383|P2|Overall Complete Response Rate|Overall Study||20
40830|NCT01640340|92384|P1|Overall Complete Response Rate|Overall Study||20
40831|NCT01640340|92383|P2|STARTED|Overall Study||20
40832|NCT01640340|92384|P1|STARTED|Overall Study||20
40833|NCT01640327|92404|P2|NOT COMPLETED|Overall Study||0
40834|NCT01640327|92405|P1|NOT COMPLETED|Overall Study||0
40835|NCT01640327|92404|P2|COMPLETED|Overall Study||63
40836|NCT01640327|92405|P1|COMPLETED|Overall Study||63
40837|NCT01640327|92404|P2|STARTED|Overall Study||63
40838|NCT01640327|92405|P1|STARTED|Overall Study||63
40839|NCT01640314|92419|P2|NOT COMPLETED|Overall Study||1
40840|NCT01640314|92420|P1|NOT COMPLETED|Overall Study||0
40841|NCT01640314|92419|P2|COMPLETED|Overall Study||62
40842|NCT01640314|92420|P1|COMPLETED|Overall Study||63
40843|NCT01640314|92419|P2|STARTED|Overall Study||63
40844|NCT01640314|92420|P1|STARTED|Overall Study||63
40845|NCT01640197|92436|P2|NOT COMPLETED|Overall Study||0
40846|NCT01640197|92437|P1|NOT COMPLETED|Overall Study||0
40847|NCT01640197|92436|P2|COMPLETED|Overall Study||30
40848|NCT01640197|92437|P1|COMPLETED|Overall Study||30
40849|NCT01640197|92436|P2|STARTED|Overall Study||30
40850|NCT01640197|92437|P1|STARTED|Overall Study||30
40851|NCT01640184|92458|P3|NOT COMPLETED|Overall Study||2
40852|NCT01640184|92459|P2|NOT COMPLETED|Overall Study||2
40853|NCT01640184|92460|P1|NOT COMPLETED|Overall Study||8
40854|NCT01640184|92458|P3|COMPLETED|Overall Study||20
40855|NCT01640184|92459|P2|COMPLETED|Overall Study||21
40856|NCT01640184|92460|P1|COMPLETED|Overall Study||26
40857|NCT01640184|92458|P3|STARTED|Overall Study||22
40858|NCT01640184|92459|P2|STARTED|Overall Study||23
40859|NCT01640184|92460|P1|STARTED|Overall Study||34
40860|NCT01640171|92482|P1|NOT COMPLETED|Overall Study||0
40861|NCT01640171|92482|P1|COMPLETED|Overall Study||57
40862|NCT01640171|92482|P1|STARTED|Overall Study||57
40863|NCT01640054|92489|P1|NOT COMPLETED|Overall Study||6
40864|NCT01640054|92489|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
40865|NCT01640054|92489|P1|Did Not Receive Treatment|Overall Study||0
40866|NCT01640054|92489|P1|STARTED|Overall Study|Patients who received treatment|115
40867|NCT01639833|92499|P2|NOT COMPLETED|Overall Study||4
40868|NCT01639833|92500|P1|NOT COMPLETED|Overall Study||6
40869|NCT01639833|92499|P2|COMPLETED|Overall Study||41
40870|NCT01639833|92500|P1|COMPLETED|Overall Study||39
40871|NCT01639833|92499|P2|STARTED|Overall Study||45
40872|NCT01639833|92500|P1|STARTED|Overall Study||45
40873|NCT01639755|92508|P1|NOT COMPLETED|Overall Study||19
40874|NCT01639755|92508|P1|COMPLETED|Overall Study||0
40875|NCT01639755|92508|P1|STARTED|Overall Study||19
40876|NCT01639742|92516|P1|NOT COMPLETED|Overall Study||18
40877|NCT01639742|92516|P1|COMPLETED|Overall Study||0
40878|NCT01639742|92516|P1|STARTED|Overall Study||18
40879|NCT01639729|92524|P6|NOT COMPLETED|Overall Study||0
40880|NCT01639729|92525|P5|NOT COMPLETED|Overall Study||0
40881|NCT01639729|92526|P4|NOT COMPLETED|Overall Study||1
40882|NCT01639729|92527|P3|NOT COMPLETED|Overall Study||1
40883|NCT01639729|92528|P2|NOT COMPLETED|Overall Study||0
40884|NCT01639729|92529|P1|NOT COMPLETED|Overall Study||1
40885|NCT01639729|92524|P6|COMPLETED|Overall Study||4
40886|NCT01639729|92525|P5|COMPLETED|Overall Study||4
40887|NCT01639729|92526|P4|COMPLETED|Overall Study||4
40888|NCT01639729|92527|P3|COMPLETED|Overall Study||3
40889|NCT01639729|92528|P2|COMPLETED|Overall Study||4
40890|NCT01639729|92529|P1|COMPLETED|Overall Study||3
40891|NCT01639729|92524|P6|STARTED|Overall Study||4
40892|NCT01639729|92525|P5|STARTED|Overall Study||4
40893|NCT01639729|92526|P4|STARTED|Overall Study||5
40894|NCT01639729|92527|P3|STARTED|Overall Study||4
40895|NCT01639729|92528|P2|STARTED|Overall Study||4
40896|NCT01639729|92529|P1|STARTED|Overall Study||4
40897|NCT01639560|92553|P2|NOT COMPLETED|Overall Study||29
40898|NCT01639560|92554|P1|NOT COMPLETED|Overall Study||19
40899|NCT01639560|92553|P2|COMPLETED|Overall Study||19
40900|NCT01639560|92554|P1|COMPLETED|Overall Study||26
40901|NCT01639560|92553|P2|End of Treatment|Overall Study||20
40902|NCT01639560|92554|P1|End of Treatment|Overall Study||28
40903|NCT01639560|92553|P2|STARTED|Overall Study||48
40904|NCT01639560|92554|P1|STARTED|Overall Study||45
40905|NCT01639443|92568|P2|NOT COMPLETED|Overall Study||0
40906|NCT01639443|92569|P1|NOT COMPLETED|Overall Study||0
40907|NCT01639443|92568|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
40908|NCT01639443|92569|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
40909|NCT01639443|92568|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
40910|NCT01639443|92569|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
40911|NCT01639222|92585|P1|NOT COMPLETED|Overall Study||0
40912|NCT01639222|92585|P1|COMPLETED|Overall Study||55
40913|NCT01639222|92585|P1|STARTED|Overall Study||55
40914|NCT01639157|92595|P2|NOT COMPLETED|Overall Study||0
40915|NCT01639157|92596|P1|NOT COMPLETED|Overall Study||0
40916|NCT01639157|92595|P2|COMPLETED|Overall Study||5
40917|NCT01639157|92596|P1|COMPLETED|Overall Study||4
40918|NCT01639157|92595|P2|STARTED|Overall Study||5
40919|NCT01639157|92596|P1|STARTED|Overall Study||4
40920|NCT01639144|92656|P2|NOT COMPLETED|Overall Study||5
40921|NCT01639144|92657|P1|NOT COMPLETED|Overall Study||10
40922|NCT01639144|92656|P2|COMPLETED|Overall Study||250
40923|NCT01639144|92657|P1|COMPLETED|Overall Study||250
40924|NCT01639144|92656|P2|STARTED|Overall Study||255
40925|NCT01639144|92657|P1|STARTED|Overall Study||260
40926|NCT01638507|92663|P1|NOT COMPLETED|Overall Study||6
40927|NCT01638507|92663|P1|COMPLETED|Overall Study||224
40928|NCT01638507|92663|P1|STARTED|Overall Study||230
40929|NCT01638468|92676|P1|NOT COMPLETED|Overall Study||0
40930|NCT01638468|92676|P1|COMPLETED|Overall Study||7
40931|NCT01638468|92676|P1|STARTED|Overall Study||7
40932|NCT01638312|92692|P2|NOT COMPLETED|Overall Study||0
40933|NCT01638312|92693|P1|NOT COMPLETED|Overall Study||0
40934|NCT01638312|92692|P2|COMPLETED|Overall Study||30
40935|NCT01638312|92693|P1|COMPLETED|Overall Study||20
40936|NCT01638312|92692|P2|STARTED|Overall Study||30
40937|NCT01638312|92693|P1|STARTED|Overall Study||20
40938|NCT01638000|92701|P2|NOT COMPLETED|Overall Study||71
40939|NCT01638000|92702|P1|NOT COMPLETED|Overall Study||60
40940|NCT01638000|92701|P2|COMPLETED|Overall Study||873
40941|NCT01638000|92702|P1|COMPLETED|Overall Study||883
40942|NCT01638000|92701|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
40943|NCT01638000|92702|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
40944|NCT01638000|92701|P2|STARTED|Overall Study||944
40945|NCT01638000|92702|P1|STARTED|Overall Study||943
40946|NCT01637961|92800|P1|NOT COMPLETED|Overall Study||2
40947|NCT01637961|92800|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
40948|NCT01637961|92800|P1|STARTED|Overall Study||23
40949|NCT01637935|92808|P2|NOT COMPLETED|Overall Study||0
40950|NCT01637935|92809|P1|NOT COMPLETED|Overall Study||0
40951|NCT01637935|92808|P2|COMPLETED|Overall Study||158918
40952|NCT01637935|92809|P1|COMPLETED|Overall Study||34181
40953|NCT01637935|92808|P2|STARTED|Overall Study||158918
40954|NCT01637935|92809|P1|STARTED|Overall Study||34181
40955|NCT01637922|92825|P2|NOT COMPLETED|Overall Study||5
40956|NCT01637922|92826|P1|NOT COMPLETED|Overall Study||2
40957|NCT01637922|92825|P2|COMPLETED|Overall Study||14
40958|NCT01637922|92826|P1|COMPLETED|Overall Study||13
40959|NCT01637922|92825|P2|STARTED|Overall Study||19
40960|NCT01637922|92826|P1|STARTED|Overall Study||15
40961|NCT01637246|92849|P1|NOT COMPLETED|Overall Study||2139
40962|NCT01637246|92849|P1|COMPLETED|Overall Study||2246
40963|NCT01637246|92849|P1|STARTED|Overall Study||4385
40964|NCT01637090|92857|P1|NOT COMPLETED|Overall Study||3
40965|NCT01637090|92857|P1|COMPLETED|Overall Study||0
40966|NCT01637090|92857|P1|STARTED|Overall Study||3
40967|NCT01636986|92867|P2|NOT COMPLETED|Overall Study||2
40968|NCT01636986|92868|P1|NOT COMPLETED|Overall Study||0
40969|NCT01636986|92867|P2|COMPLETED|Overall Study||30
40970|NCT01636986|92868|P1|COMPLETED|Overall Study||30
40971|NCT01636986|92867|P2|STARTED|Overall Study||32
40972|NCT01636986|92868|P1|STARTED|Overall Study||30
40973|NCT01636960|92874|P1|NOT COMPLETED|Maintenance Phase||7
40974|NCT01636960|92874|P1|COMPLETED|Maintenance Phase||0
40975|NCT01636960|92874|P1|STARTED|Maintenance Phase||7
40976|NCT01636960|92874|P1|NOT COMPLETED|Induction Phase||2
40977|NCT01636960|92874|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
40978|NCT01636960|92874|P1|STARTED|Induction Phase||9
40979|NCT01636947|92882|P2|NOT COMPLETED|Overall Study||11
40980|NCT01636947|92883|P1|NOT COMPLETED|Overall Study||12
40981|NCT01636947|92882|P2|COMPLETED|Overall Study||239
40982|NCT01636947|92883|P1|COMPLETED|Overall Study||232
40983|NCT01636947|92882|P2|Treated|Overall Study||248
40984|NCT01636947|92883|P1|Treated|Overall Study||242
40985|NCT01636947|92882|P2|STARTED|Overall Study||250
40986|NCT01636947|92883|P1|STARTED|Overall Study||244
40987|NCT01636778|92903|P3|NOT COMPLETED|Follow-up Period After Part 2||4
40988|NCT01636778|92904|P2|NOT COMPLETED|Follow-up Period After Part 2||0
40989|NCT01636778|92905|P1|NOT COMPLETED|Follow-up Period After Part 2||0
40990|NCT01636778|92903|P3|COMPLETED|Follow-up Period After Part 2||37
40991|NCT01636778|92904|P2|COMPLETED|Follow-up Period After Part 2||0
40992|NCT01636778|92905|P1|COMPLETED|Follow-up Period After Part 2||0
40993|NCT01636778|92903|P3|STARTED|Follow-up Period After Part 2||41
40994|NCT01636778|92904|P2|STARTED|Follow-up Period After Part 2||0
40995|NCT01636778|92905|P1|STARTED|Follow-up Period After Part 2||0
40996|NCT01636778|92903|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
40997|NCT01636778|92904|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
40998|NCT01636778|92905|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
40999|NCT01636778|92903|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
41000|NCT01636778|92904|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
41001|NCT01636778|92905|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
41002|NCT01636778|92903|P3|STARTED|Antiviral Treatment Period (Part 2)||0
41003|NCT01636778|92904|P2|STARTED|Antiviral Treatment Period (Part 2)||41
41004|NCT01636778|92905|P1|STARTED|Antiviral Treatment Period (Part 2)||0
41005|NCT01636778|92903|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
41006|NCT01636778|92904|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
41007|NCT01636778|92905|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
41008|NCT01636778|92903|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
41009|NCT01636778|92904|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
41010|NCT01636778|92905|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
41011|NCT01636778|92903|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
41012|NCT01636778|92904|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
41013|NCT01636778|92905|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
41014|NCT01636765|92968|P1|NOT COMPLETED|Overall Study||0
41015|NCT01636765|92968|P1|COMPLETED|Overall Study||104
41016|NCT01636765|92968|P1|STARTED|Overall Study||104
41017|NCT01636713|92976|P3|NOT COMPLETED|Overall Study||23
41018|NCT01636713|92977|P2|NOT COMPLETED|Overall Study||28
41019|NCT01636713|92978|P1|NOT COMPLETED|Overall Study||32
41020|NCT01636713|92976|P3|COMPLETED|Overall Study||170
41021|NCT01636713|92977|P2|COMPLETED|Overall Study||166
41022|NCT01636713|92978|P1|COMPLETED|Overall Study||161
41023|NCT01636713|92976|P3|STARTED|Overall Study||193
41024|NCT01636713|92977|P2|STARTED|Overall Study||194
41025|NCT01636713|92978|P1|STARTED|Overall Study||193
41026|NCT01636661|92994|P2|NOT COMPLETED|Overall Study||0
41027|NCT01636661|92995|P1|NOT COMPLETED|Overall Study||0
41028|NCT01636661|92994|P2|COMPLETED|Overall Study||6
41029|NCT01636661|92995|P1|COMPLETED|Overall Study||5
41030|NCT01636661|92994|P2|STARTED|Overall Study||6
41031|NCT01636661|92995|P1|STARTED|Overall Study||5
41032|NCT01636466|93005|P2|NOT COMPLETED|Overall Study||0
41033|NCT01636466|93006|P1|NOT COMPLETED|Overall Study||1
41034|NCT01636466|93005|P2|COMPLETED|Overall Study||0
41035|NCT01636466|93006|P1|COMPLETED|Overall Study||0
41036|NCT01636466|93005|P2|STARTED|Overall Study||0
41037|NCT01636466|93006|P1|STARTED|Overall Study||1
41038|NCT01636414|93015|P3|NOT COMPLETED|Overall Study||9
41039|NCT01636414|93016|P2|NOT COMPLETED|Overall Study||6
41040|NCT01636414|93017|P1|NOT COMPLETED|Overall Study||3
41041|NCT01636414|93015|P3|COMPLETED|Overall Study||65
41042|NCT01636414|93016|P2|COMPLETED|Overall Study||60
41043|NCT01636414|93017|P1|COMPLETED|Overall Study||61
41044|NCT01636414|93015|P3|STARTED|Overall Study||74
41045|NCT01636414|93016|P2|STARTED|Overall Study||66
41046|NCT01636414|93017|P1|STARTED|Overall Study||64
41047|NCT01636362|93028|P1|NOT COMPLETED|Overall Study||8
41048|NCT01636362|93028|P1|COMPLETED|Overall Study||37
41049|NCT01636362|93028|P1|STARTED|Overall Study||45
41050|NCT01636258|93036|P2|NOT COMPLETED|Overall Study||0
41051|NCT01636258|93037|P1|NOT COMPLETED|Overall Study||1
41052|NCT01636258|93036|P2|COMPLETED|Overall Study||14
41053|NCT01636258|93037|P1|COMPLETED|Overall Study||12
41054|NCT01636258|93036|P2|STARTED|Overall Study||14
41055|NCT01636258|93037|P1|STARTED|Overall Study||13
41056|NCT01636206|93053|P2|NOT COMPLETED|Overall Study||51
41057|NCT01636206|93054|P1|NOT COMPLETED|Overall Study||19
41058|NCT01636206|93053|P2|COMPLETED|Overall Study||170
41059|NCT01636206|93054|P1|COMPLETED|Overall Study||92
41060|NCT01636206|93053|P2|STARTED|Overall Study||221
41061|NCT01636206|93054|P1|STARTED|Overall Study||111
41062|NCT01636102|93062|P2|NOT COMPLETED|Overall Study||0
41063|NCT01636102|93063|P1|NOT COMPLETED|Overall Study||0
41064|NCT01636102|93062|P2|COMPLETED|Overall Study||63
41065|NCT01636102|93063|P1|COMPLETED|Overall Study||63
41066|NCT01636102|93062|P2|STARTED|Overall Study||63
41067|NCT01636102|93063|P1|STARTED|Overall Study||63
41068|NCT01636076|93077|P2|NOT COMPLETED|Overall Study||25
41069|NCT01636076|93078|P1|NOT COMPLETED|Overall Study||17
41070|NCT01636076|93077|P2|COMPLETED|Overall Study||288
41071|NCT01636076|93078|P1|COMPLETED|Overall Study||299
41072|NCT01636076|93077|P2|STARTED|Overall Study||313
41073|NCT01636076|93078|P1|STARTED|Overall Study||316
41074|NCT01635933|93140|P2|NOT COMPLETED|Overall Study||8
41075|NCT01635933|93141|P1|NOT COMPLETED|Overall Study||2
41076|NCT01635933|93140|P2|COMPLETED|Overall Study||177
41077|NCT01635933|93141|P1|COMPLETED|Overall Study||176
41078|NCT01635933|93140|P2|STARTED|Overall Study||185
41079|NCT01635933|93141|P1|STARTED|Overall Study||178
41080|NCT01635920|93153|P2|NOT COMPLETED|Overall Study||1
41081|NCT01635920|93154|P1|NOT COMPLETED|Overall Study||3
41082|NCT01635920|93153|P2|COMPLETED|Overall Study||125
41083|NCT01635920|93154|P1|COMPLETED|Overall Study||122
41084|NCT01635920|93153|P2|STARTED|Overall Study||126
41085|NCT01635920|93154|P1|STARTED|Overall Study||125
41086|NCT01635881|93162|P1|NOT COMPLETED|Overall Study||0
41087|NCT01635881|93162|P1|COMPLETED|Overall Study||60
41088|NCT01635881|93162|P1|STARTED|Overall Study||60
41089|NCT01635855|93167|P1|NOT COMPLETED|Overall Study||4
41090|NCT01635855|93167|P1|COMPLETED|Overall Study||113
41091|NCT01635855|93167|P1|STARTED|Overall Study||117
41092|NCT01635504|93171|P1|NOT COMPLETED|Overall Study||0
41093|NCT01635504|93171|P1|COMPLETED|Overall Study||5
41094|NCT01635504|93171|P1|STARTED|Overall Study||5
41095|NCT01635439|93178|P2|NOT COMPLETED|Overall Study||0
41096|NCT01635439|93179|P1|NOT COMPLETED|Overall Study||0
41097|NCT01635439|93178|P2|COMPLETED|Overall Study||100
41098|NCT01635439|93179|P1|COMPLETED|Overall Study||100
41099|NCT01635439|93178|P2|STARTED|Overall Study||100
41100|NCT01635439|93179|P1|STARTED|Overall Study||100
41101|NCT01635244|93196|P3|NOT COMPLETED|Overall Study||2
41102|NCT01635244|93197|P2|NOT COMPLETED|Overall Study||1
41103|NCT01635244|93198|P1|NOT COMPLETED|Overall Study||1
41104|NCT01635244|93196|P3|COMPLETED|Overall Study||18
41105|NCT01635244|93197|P2|COMPLETED|Overall Study||21
41106|NCT01635244|93198|P1|COMPLETED|Overall Study||17
41107|NCT01635244|93196|P3|STARTED|Overall Study||20
41108|NCT01635244|93197|P2|STARTED|Overall Study||22
41109|NCT01635244|93198|P1|STARTED|Overall Study||18
41110|NCT01635218|93209|P3|NOT COMPLETED|Overall Study||6
41111|NCT01635218|93210|P2|NOT COMPLETED|Overall Study||7
41112|NCT01635218|93211|P1|NOT COMPLETED|Overall Study||3
41113|NCT01635218|93209|P3|COMPLETED|Overall Study||37
41114|NCT01635218|93210|P2|COMPLETED|Overall Study||39
41115|NCT01635218|93211|P1|COMPLETED|Overall Study||41
41116|NCT01635218|93209|P3|STARTED|Overall Study||43
41117|NCT01635218|93210|P2|STARTED|Overall Study||46
41118|NCT01635218|93211|P1|STARTED|Overall Study||44
41119|NCT01634659|93233|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
41120|NCT01634659|93234|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
41121|NCT01634659|93233|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
41122|NCT01634659|93234|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
41123|NCT01634659|93233|P2|STARTED|Period 2 - Second 8 Days of Wear||158
41124|NCT01634659|93234|P1|STARTED|Period 2 - Second 8 Days of Wear||155
41125|NCT01634659|93233|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
41126|NCT01634659|93234|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
41127|NCT01634659|93233|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
41128|NCT01634659|93234|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
41129|NCT01634659|93233|P2|STARTED|Period 1 - First 8 Days of Wear||158
41130|NCT01634659|93234|P1|STARTED|Period 1 - First 8 Days of Wear||155
41131|NCT01634620|93244|P1|NOT COMPLETED|Overall Study||0
41132|NCT01634620|93244|P1|COMPLETED|Overall Study||200
41133|NCT01634620|93244|P1|STARTED|Overall Study||200
41134|NCT01634555|93264|P1|NOT COMPLETED|Overall Study||17
41135|NCT01634555|93264|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
41136|NCT01634555|93264|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
41137|NCT01634555|93264|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
41138|NCT01634555|93264|P1|STARTED|Overall Study||29
41139|NCT01634360|93274|P2|NOT COMPLETED|Overall Study||136
41140|NCT01634360|93275|P1|NOT COMPLETED|Overall Study||49
41141|NCT01634360|93274|P2|COMPLETED|Overall Study||0
41142|NCT01634360|93275|P1|COMPLETED|Overall Study||0
41143|NCT01634360|93274|P2|STARTED|Overall Study||136
41144|NCT01634360|93275|P1|STARTED|Overall Study||49
41145|NCT01634256|93287|P2|NOT COMPLETED|Overall Study||8
41146|NCT01634256|93288|P1|NOT COMPLETED|Overall Study||4
41147|NCT01634256|93287|P2|COMPLETED|Overall Study||22
41148|NCT01634256|93288|P1|COMPLETED|Overall Study||26
41149|NCT01634256|93287|P2|STARTED|Overall Study||30
41150|NCT01634256|93288|P1|STARTED|Overall Study||30
41151|NCT01634243|93304|P2|NOT COMPLETED|Overall Study||5
41152|NCT01634243|93305|P1|NOT COMPLETED|Overall Study||6
41153|NCT01634243|93304|P2|COMPLETED|Overall Study||38
41154|NCT01634243|93305|P1|COMPLETED|Overall Study||15
41155|NCT01634243|93304|P2|STARTED|Overall Study||43
41156|NCT01634243|93305|P1|STARTED|Overall Study||21
41157|NCT01634165|93331|P4|NOT COMPLETED|Period 4||0
41158|NCT01634165|93332|P3|NOT COMPLETED|Period 4||0
41159|NCT01634165|93333|P2|NOT COMPLETED|Period 4||0
41160|NCT01634165|93334|P1|NOT COMPLETED|Period 4||0
41161|NCT01634165|93331|P4|COMPLETED|Period 4||6
41162|NCT01634165|93332|P3|COMPLETED|Period 4||6
41163|NCT01634165|93333|P2|COMPLETED|Period 4||5
41164|NCT01634165|93334|P1|COMPLETED|Period 4||6
41165|NCT01634165|93331|P4|STARTED|Period 4||6
41166|NCT01634165|93332|P3|STARTED|Period 4||6
41167|NCT01634165|93333|P2|STARTED|Period 4||5
41168|NCT01634165|93334|P1|STARTED|Period 4||6
41169|NCT01634165|93331|P4|NOT COMPLETED|Period 3||0
41170|NCT01634165|93332|P3|NOT COMPLETED|Period 3||0
41171|NCT01634165|93333|P2|NOT COMPLETED|Period 3||0
41172|NCT01634165|93334|P1|NOT COMPLETED|Period 3||0
41173|NCT01634165|93331|P4|COMPLETED|Period 3||6
41174|NCT01634165|93332|P3|COMPLETED|Period 3||6
41175|NCT01634165|93333|P2|COMPLETED|Period 3||5
41176|NCT01634165|93334|P1|COMPLETED|Period 3||6
41177|NCT01634165|93331|P4|STARTED|Period 3||6
41178|NCT01634165|93332|P3|STARTED|Period 3||6
41179|NCT01634165|93333|P2|STARTED|Period 3||5
41180|NCT01634165|93334|P1|STARTED|Period 3||6
41181|NCT01634165|93331|P4|NOT COMPLETED|Period 2||0
41182|NCT01634165|93332|P3|NOT COMPLETED|Period 2||0
41183|NCT01634165|93333|P2|NOT COMPLETED|Period 2||1
41184|NCT01634165|93334|P1|NOT COMPLETED|Period 2||0
41185|NCT01634165|93331|P4|COMPLETED|Period 2||6
41186|NCT01634165|93332|P3|COMPLETED|Period 2||6
41187|NCT01634165|93333|P2|COMPLETED|Period 2||5
41188|NCT01634165|93334|P1|COMPLETED|Period 2||6
41189|NCT01634165|93331|P4|STARTED|Period 2||6
41190|NCT01634165|93332|P3|STARTED|Period 2||6
41191|NCT01634165|93333|P2|STARTED|Period 2||6
41192|NCT01634165|93334|P1|STARTED|Period 2||6
41193|NCT01634165|93331|P4|NOT COMPLETED|Period 1||0
41194|NCT01634165|93332|P3|NOT COMPLETED|Period 1||0
41195|NCT01634165|93333|P2|NOT COMPLETED|Period 1||0
41196|NCT01634165|93334|P1|NOT COMPLETED|Period 1||0
41197|NCT01634165|93331|P4|COMPLETED|Period 1||6
41198|NCT01634165|93332|P3|COMPLETED|Period 1||6
41199|NCT01634165|93333|P2|COMPLETED|Period 1||6
41200|NCT01634165|93334|P1|COMPLETED|Period 1||6
41201|NCT01634165|93331|P4|Received at Least 1 Dose of Study Drug|Period 1||6
41202|NCT01634165|93332|P3|Received at Least 1 Dose of Study Drug|Period 1||6
41203|NCT01634165|93333|P2|Received at Least 1 Dose of Study Drug|Period 1||6
41204|NCT01634165|93334|P1|Received at Least 1 Dose of Study Drug|Period 1||6
41205|NCT01634165|93331|P4|STARTED|Period 1||6
41206|NCT01634165|93332|P3|STARTED|Period 1||6
41207|NCT01634165|93333|P2|STARTED|Period 1||6
41208|NCT01634165|93334|P1|STARTED|Period 1||6
41209|NCT01634152|93367|P3|NOT COMPLETED|Overall Study||4
41210|NCT01634152|93368|P2|NOT COMPLETED|Overall Study||1
41211|NCT01634152|93369|P1|NOT COMPLETED|Overall Study||4
41212|NCT01634152|93367|P3|COMPLETED|Overall Study||126
41213|NCT01634152|93368|P2|COMPLETED|Overall Study||136
41214|NCT01634152|93369|P1|COMPLETED|Overall Study||130
41215|NCT01634152|93367|P3|STARTED|Overall Study||130
41216|NCT01634152|93368|P2|STARTED|Overall Study||137
41217|NCT01634152|93369|P1|STARTED|Overall Study||134
41218|NCT01634139|93452|P3|NOT COMPLETED|Overall Study||5
41219|NCT01634139|93453|P2|NOT COMPLETED|Overall Study||6
41220|NCT01634139|93454|P1|NOT COMPLETED|Overall Study||10
41221|NCT01634139|93452|P3|COMPLETED|Overall Study||130
41222|NCT01634139|93453|P2|COMPLETED|Overall Study||130
41223|NCT01634139|93454|P1|COMPLETED|Overall Study||122
41224|NCT01634139|93452|P3|STARTED|Overall Study||135
41225|NCT01634139|93453|P2|STARTED|Overall Study||136
41226|NCT01634139|93454|P1|STARTED|Overall Study||132
41227|NCT01634113|93555|P3|NOT COMPLETED|Overall Study||1
41228|NCT01634113|93556|P2|NOT COMPLETED|Overall Study||0
41229|NCT01634113|93557|P1|NOT COMPLETED|Overall Study||0
41230|NCT01634113|93555|P3|COMPLETED|Overall Study||31
41231|NCT01634113|93556|P2|COMPLETED|Overall Study||36
41232|NCT01634113|93557|P1|COMPLETED|Overall Study||34
41233|NCT01634113|93555|P3|STARTED|Overall Study||32
41234|NCT01634113|93556|P2|STARTED|Overall Study||36
41235|NCT01634113|93557|P1|STARTED|Overall Study||34
41236|NCT01634100|93601|P6|NOT COMPLETED|Overall Study||0
41237|NCT01634100|93602|P5|NOT COMPLETED|Overall Study||0
41238|NCT01634100|93603|P4|NOT COMPLETED|Overall Study||0
41239|NCT01634100|93604|P3|NOT COMPLETED|Overall Study||1
41240|NCT01634100|93605|P2|NOT COMPLETED|Overall Study||0
41241|NCT01634100|93606|P1|NOT COMPLETED|Overall Study||1
41242|NCT01634100|93601|P6|COMPLETED|Overall Study||3
41243|NCT01634100|93602|P5|COMPLETED|Overall Study||3
41244|NCT01634100|93603|P4|COMPLETED|Overall Study||3
41245|NCT01634100|93604|P3|COMPLETED|Overall Study||2
41246|NCT01634100|93605|P2|COMPLETED|Overall Study||3
41247|NCT01634100|93606|P1|COMPLETED|Overall Study||2
41248|NCT01634100|93601|P6|Received Empa + Probenecid|Overall Study||3
41249|NCT01634100|93602|P5|Received Empa + Probenecid|Overall Study||3
41250|NCT01634100|93603|P4|Received Empa + Probenecid|Overall Study||3
41251|NCT01634100|93604|P3|Received Empa + Probenecid|Overall Study||2
41252|NCT01634100|93605|P2|Received Empa + Probenecid|Overall Study||3
41253|NCT01634100|93606|P1|Received Empa + Probenecid|Overall Study||2
41254|NCT01634100|93601|P6|Received Empa + Rifampicin|Overall Study||3
41255|NCT01634100|93602|P5|Received Empa + Rifampicin|Overall Study||3
41256|NCT01634100|93603|P4|Received Empa + Rifampicin|Overall Study||3
41257|NCT01634100|93604|P3|Received Empa + Rifampicin|Overall Study||3
41258|NCT01634100|93605|P2|Received Empa + Rifampicin|Overall Study||3
41259|NCT01634100|93606|P1|Received Empa + Rifampicin|Overall Study||3
41260|NCT01634100|93601|P6|Received Empa Alone|Overall Study||3
41261|NCT01634100|93602|P5|Received Empa Alone|Overall Study||3
41262|NCT01634100|93603|P4|Received Empa Alone|Overall Study||3
41263|NCT01634100|93604|P3|Received Empa Alone|Overall Study||3
41264|NCT01634100|93605|P2|Received Empa Alone|Overall Study||3
41265|NCT01634100|93606|P1|Received Empa Alone|Overall Study||3
41266|NCT01634100|93601|P6|STARTED|Overall Study||3
41267|NCT01634100|93602|P5|STARTED|Overall Study||3
41268|NCT01634100|93603|P4|STARTED|Overall Study||3
41269|NCT01634100|93604|P3|STARTED|Overall Study||3
41270|NCT01634100|93605|P2|STARTED|Overall Study||3
41271|NCT01634100|93606|P1|STARTED|Overall Study||3
41272|NCT01633944|93622|P3|NOT COMPLETED|Double-blind Treatment Phase||58
41273|NCT01633944|93623|P2|NOT COMPLETED|Double-blind Treatment Phase||54
41274|NCT01633944|93624|P1|NOT COMPLETED|Double-blind Treatment Phase||0
41275|NCT01633944|93622|P3|COMPLETED|Double-blind Treatment Phase||174
41276|NCT01633944|93623|P2|COMPLETED|Double-blind Treatment Phase||176
41277|NCT01633944|93624|P1|COMPLETED|Double-blind Treatment Phase||0
41278|NCT01633944|93622|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
41279|NCT01633944|93623|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
41280|NCT01633944|93624|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
41281|NCT01633944|93622|P3|NOT COMPLETED|Open-label Titration Phase||0
41282|NCT01633944|93623|P2|NOT COMPLETED|Open-label Titration Phase||0
41283|NCT01633944|93624|P1|NOT COMPLETED|Open-label Titration Phase||290
41284|NCT01633944|93622|P3|COMPLETED|Open-label Titration Phase||0
41285|NCT01633944|93623|P2|COMPLETED|Open-label Titration Phase||0
41286|NCT01633944|93624|P1|COMPLETED|Open-label Titration Phase||462
41287|NCT01633944|93622|P3|STARTED|Open-label Titration Phase||0
41288|NCT01633944|93623|P2|STARTED|Open-label Titration Phase||0
41289|NCT01633944|93624|P1|STARTED|Open-label Titration Phase||752
41290|NCT01633853|93646|P2|NOT COMPLETED|Overall Study||0
41291|NCT01633853|93647|P1|NOT COMPLETED|Overall Study||0
41292|NCT01633853|93646|P2|COMPLETED|Overall Study||100
41293|NCT01633853|93647|P1|COMPLETED|Overall Study||104
41294|NCT01633853|93646|P2|STARTED|Overall Study||100
41295|NCT01633853|93647|P1|STARTED|Overall Study||104
41296|NCT01633320|93663|P2|NOT COMPLETED|Overall Study||0
41297|NCT01633320|93664|P1|NOT COMPLETED|Overall Study||0
41298|NCT01633320|93663|P2|COMPLETED|Overall Study||68
41299|NCT01633320|93664|P1|COMPLETED|Overall Study||132
41300|NCT01633320|93663|P2|STARTED|Overall Study||68
41301|NCT01633320|93664|P1|STARTED|Overall Study||132
41302|NCT01632904|93674|P2|NOT COMPLETED|Overall Study||6
41303|NCT01632904|93675|P1|NOT COMPLETED|Overall Study||7
41304|NCT01632904|93674|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
41305|NCT01632904|93675|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
41306|NCT01632904|93674|P2|STARTED|Overall Study||56
41307|NCT01632904|93675|P1|STARTED|Overall Study||54
41308|NCT01632878|93685|P1|NOT COMPLETED|Treatment||158
41309|NCT01632878|93685|P1|COMPLETED|Treatment||1105
41310|NCT01632878|93685|P1|STARTED|Treatment||1263
41311|NCT01632878|93685|P1|NOT COMPLETED|Screening||268
41312|NCT01632878|93685|P1|COMPLETED|Screening||1263
41313|NCT01632878|93685|P1|STARTED|Screening||1531
41314|NCT01632800|93689|P1|NOT COMPLETED|Overall Study||1
41315|NCT01632800|93689|P1|COMPLETED|Overall Study||25
41316|NCT01632800|93689|P1|STARTED|Overall Study||26
41317|NCT01632735|93695|P2|NOT COMPLETED|Overall Study||3
41318|NCT01632735|93696|P1|NOT COMPLETED|Overall Study||4
41319|NCT01632735|93695|P2|COMPLETED|Overall Study||37
41320|NCT01632735|93696|P1|COMPLETED|Overall Study||36
41321|NCT01632735|93695|P2|STARTED|Overall Study||40
41322|NCT01632735|93696|P1|STARTED|Overall Study||40
41323|NCT01632709|93712|P4|NOT COMPLETED|Overall Study||1
41324|NCT01632709|93713|P3|NOT COMPLETED|Overall Study||0
41325|NCT01632709|93714|P2|NOT COMPLETED|Overall Study||1
41326|NCT01632709|93715|P1|NOT COMPLETED|Overall Study||2
41327|NCT01632709|93712|P4|COMPLETED|Overall Study||3
41328|NCT01632709|93713|P3|COMPLETED|Overall Study||5
41329|NCT01632709|93714|P2|COMPLETED|Overall Study||2
41330|NCT01632709|93715|P1|COMPLETED|Overall Study||2
41331|NCT01632709|93712|P4|Completed Visit 2 (Received Injection)|Overall Study||3
41332|NCT01632709|93713|P3|Completed Visit 2 (Received Injection)|Overall Study||5
41333|NCT01632709|93714|P2|Completed Visit 2 (Received Injection)|Overall Study||2
41334|NCT01632709|93715|P1|Completed Visit 2 (Received Injection)|Overall Study||4
41335|NCT01632709|93712|P4|STARTED|Overall Study||4
41336|NCT01632709|93713|P3|STARTED|Overall Study||5
41337|NCT01632709|93714|P2|STARTED|Overall Study||3
41338|NCT01632709|93715|P1|STARTED|Overall Study||4
41339|NCT01632683|93741|P2|NOT COMPLETED|Overall Study||0
41340|NCT01632683|93742|P1|NOT COMPLETED|Overall Study||0
41341|NCT01632683|93741|P2|COMPLETED|Overall Study||552
41342|NCT01632683|93742|P1|COMPLETED|Overall Study||548
41343|NCT01632683|93741|P2|STARTED|Overall Study||552
41344|NCT01632683|93742|P1|STARTED|Overall Study||548
41345|NCT01632423|93748|P1|NOT COMPLETED|Overall Study||246
41346|NCT01632423|93748|P1|COMPLETED|Overall Study||10091
41347|NCT01632423|93748|P1|STARTED|Overall Study||10337
41348|NCT01632267|93756|P1|NOT COMPLETED|Overall Study||7
41349|NCT01632267|93756|P1|COMPLETED|Overall Study||97
41350|NCT01632267|93756|P1|STARTED|Overall Study||104
41351|NCT01632215|93762|P2|NOT COMPLETED|Overall Study||1
41352|NCT01632215|93763|P1|NOT COMPLETED|Overall Study||2
41353|NCT01632215|93762|P2|COMPLETED|Overall Study||19
41354|NCT01632215|93763|P1|COMPLETED|Overall Study||18
41355|NCT01632215|93762|P2|STARTED|Overall Study||20
41356|NCT01632215|93763|P1|STARTED|Overall Study||20
41357|NCT01632150|93769|P1|NOT COMPLETED|Overall Study||27
41358|NCT01632150|93769|P1|COMPLETED|Overall Study|Completed=still receiving treatment|13
41359|NCT01632150|93769|P1|Received Cyclophosphamide|Overall Study||11
41360|NCT01632150|93769|P1|STARTED|Overall Study||40
41361|NCT01632020|93778|P2|NOT COMPLETED|Overall Study||0
41362|NCT01632020|93779|P1|NOT COMPLETED|Overall Study||2
41363|NCT01632020|93778|P2|COMPLETED|Overall Study||3
41364|NCT01632020|93779|P1|COMPLETED|Overall Study||2
41365|NCT01632020|93778|P2|STARTED|Overall Study||3
41366|NCT01632020|93779|P1|STARTED|Overall Study||4
41367|NCT01631929|93789|P2|NOT COMPLETED|Overall Study||0
41368|NCT01631929|93790|P1|NOT COMPLETED|Overall Study||0
41369|NCT01631929|93789|P2|COMPLETED|Overall Study||6
41370|NCT01631929|93790|P1|COMPLETED|Overall Study||6
41371|NCT01631929|93789|P2|STARTED|Overall Study||6
41372|NCT01631929|93790|P1|STARTED|Overall Study||6
41373|NCT01631864|93798|P2|NOT COMPLETED|Overall Study||4
41374|NCT01631864|93799|P1|NOT COMPLETED|Overall Study||2
41375|NCT01631864|93798|P2|COMPLETED|Overall Study||44
41376|NCT01631864|93799|P1|COMPLETED|Overall Study||48
41377|NCT01631864|93798|P2|STARTED|Overall Study||48
41378|NCT01631864|93799|P1|STARTED|Overall Study||50
41379|NCT01631825|93811|P1|NOT COMPLETED|Overall Study||65
41380|NCT01631825|93811|P1|COMPLETED|Overall Study||256
41381|NCT01631825|93811|P1|STARTED|Overall Study||321
41382|NCT01631812|93831|P1|NOT COMPLETED|Overall Study||37
41383|NCT01631812|93831|P1|COMPLETED|Overall Study||93
41384|NCT01631812|93831|P1|STARTED|Overall Study||130
41385|NCT01631630|93841|P2|NOT COMPLETED|Overall Study||0
41386|NCT01631630|93842|P1|NOT COMPLETED|Overall Study||3
41387|NCT01631630|93841|P2|COMPLETED|Overall Study||8
41388|NCT01631630|93842|P1|COMPLETED|Overall Study||5
41389|NCT01631630|93841|P2|STARTED|Overall Study||8
41390|NCT01631630|93842|P1|STARTED|Overall Study||8
41391|NCT01631435|93952|P1|NOT COMPLETED|Overall Study||9
41392|NCT01631435|93952|P1|COMPLETED|Overall Study||66
41393|NCT01631435|93952|P1|STARTED|Overall Study||75
41394|NCT01631227|93959|P2|NOT COMPLETED|Overall Study||22
41395|NCT01631227|93960|P1|NOT COMPLETED|Overall Study||30
41396|NCT01631227|93959|P2|COMPLETED|Overall Study||310
41397|NCT01631227|93960|P1|COMPLETED|Overall Study||303
41398|NCT01631227|93959|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
41399|NCT01631227|93960|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
41400|NCT01631227|93959|P2|Safety Subject Sample|Overall Study||332
41401|NCT01631227|93960|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
41402|NCT01631227|93959|P2|STARTED|Overall Study||332
41403|NCT01631227|93960|P1|STARTED|Overall Study||333
41404|NCT01631149|93968|P2|NOT COMPLETED|Overall Study||0
41405|NCT01631149|93969|P1|NOT COMPLETED|Overall Study||0
41406|NCT01631149|93968|P2|COMPLETED|Overall Study||12
41407|NCT01631149|93969|P1|COMPLETED|Overall Study||12
41408|NCT01631149|93968|P2|STARTED|Overall Study||12
41409|NCT01631149|93969|P1|STARTED|Overall Study||12
41410|NCT01631110|93985|P2|NOT COMPLETED|Overall Study||0
41411|NCT01631110|93986|P1|NOT COMPLETED|Overall Study||0
41412|NCT01631110|93985|P2|COMPLETED|Overall Study||55
41413|NCT01631110|93986|P1|COMPLETED|Overall Study||55
41414|NCT01631110|93985|P2|STARTED|Overall Study||55
41415|NCT01631110|93986|P1|STARTED|Overall Study||55
41416|NCT01631071|94000|P2|NOT COMPLETED|Overall Study||0
41417|NCT01631071|94001|P1|NOT COMPLETED|Overall Study||0
41418|NCT01631071|94000|P2|COMPLETED|Overall Study||55
41419|NCT01631071|94001|P1|COMPLETED|Overall Study||55
41420|NCT01631071|94000|P2|STARTED|Overall Study||55
41421|NCT01631071|94001|P1|STARTED|Overall Study||55
41422|NCT01630694|94015|P2|NOT COMPLETED|Overall Study||0
41423|NCT01630694|94016|P1|NOT COMPLETED|Overall Study||0
41424|NCT01630694|94015|P2|COMPLETED|Overall Study||16
41425|NCT01630694|94016|P1|COMPLETED|Overall Study||12
41426|NCT01630694|94015|P2|STARTED|Overall Study||16
41427|NCT01630694|94016|P1|STARTED|Overall Study||12
41428|NCT01630135|94026|P2|NOT COMPLETED|Overall Study||2
41429|NCT01630135|94027|P1|NOT COMPLETED|Overall Study||0
41430|NCT01630135|94026|P2|COMPLETED|Overall Study||128
41431|NCT01630135|94027|P1|COMPLETED|Overall Study||131
41432|NCT01630135|94026|P2|STARTED|Overall Study||130
41433|NCT01630135|94027|P1|STARTED|Overall Study||131
41434|NCT01630109|94066|P3|NOT COMPLETED|Overall Study||0
41435|NCT01630109|94067|P2|NOT COMPLETED|Overall Study||0
41436|NCT01630109|94068|P1|NOT COMPLETED|Overall Study||0
41437|NCT01630109|94066|P3|COMPLETED|Overall Study||3
41438|NCT01630109|94067|P2|COMPLETED|Overall Study||1
41439|NCT01630109|94068|P1|COMPLETED|Overall Study||1
41440|NCT01630109|94066|P3|STARTED|Overall Study||3
41441|NCT01630109|94067|P2|STARTED|Overall Study||1
41442|NCT01630109|94068|P1|STARTED|Overall Study||1
41443|NCT01629797|94088|P1|NOT COMPLETED|Overall Study||18
41444|NCT01629797|94088|P1|COMPLETED|Overall Study||82
41445|NCT01629797|94088|P1|STARTED|Overall Study||100
41446|NCT01629784|94095|P1|NOT COMPLETED|Overall Study||6
41447|NCT01629784|94095|P1|COMPLETED|Overall Study||25
41448|NCT01629784|94095|P1|STARTED|Overall Study||31
41449|NCT01629771|94104|P2|NOT COMPLETED|Overall Study||0
41450|NCT01629771|94105|P1|NOT COMPLETED|Overall Study||0
41451|NCT01629771|94104|P2|COMPLETED|Overall Study||36
41452|NCT01629771|94105|P1|COMPLETED|Overall Study||36
41453|NCT01629771|94104|P2|STARTED|Overall Study||36
41454|NCT01629771|94105|P1|STARTED|Overall Study||36
41455|NCT01629706|94115|P1|NOT COMPLETED|Phase 2 Habitual||10
41456|NCT01629706|94115|P1|COMPLETED|Phase 2 Habitual||48
41457|NCT01629706|94115|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
41458|NCT01629706|94115|P1|NOT COMPLETED|Phase 1 PureVision||9
41459|NCT01629706|94115|P1|COMPLETED|Phase 1 PureVision||35
41460|NCT01629706|94115|P1|STARTED|Phase 1 PureVision||44
41461|NCT01629693|94143|P2|NOT COMPLETED|Overall Study||10
41462|NCT01629693|94144|P1|NOT COMPLETED|Overall Study||5
41463|NCT01629693|94143|P2|COMPLETED|Overall Study||178
41464|NCT01629693|94144|P1|COMPLETED|Overall Study||188
41465|NCT01629693|94143|P2|STARTED|Overall Study||188
41466|NCT01629693|94144|P1|STARTED|Overall Study||193
41467|NCT01629589|94152|P2|NOT COMPLETED|Overall Study||7
41468|NCT01629589|94153|P1|NOT COMPLETED|Overall Study||8
41469|NCT01629589|94152|P2|COMPLETED|Overall Study||204
41470|NCT01629589|94153|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
41471|NCT01629589|94152|P2|STARTED|Overall Study||211
41472|NCT01629589|94153|P1|STARTED|Overall Study||212
41473|NCT01629134|94169|P1|NOT COMPLETED|Overall Study||0
41474|NCT01629134|94169|P1|COMPLETED|Overall Study||62
41475|NCT01629134|94169|P1|STARTED|Overall Study||62
41476|NCT01628965|94182|P1|NOT COMPLETED|Overall Study||49
41477|NCT01628965|94182|P1|COMPLETED|Overall Study||94
41478|NCT01628965|94182|P1|STARTED|Overall Study||143
41479|NCT01628926|94191|P3|NOT COMPLETED|Overall Study||17
41480|NCT01628926|94192|P2|NOT COMPLETED|Overall Study||23
41481|NCT01628926|94193|P1|NOT COMPLETED|Overall Study||26
41482|NCT01628926|94191|P3|COMPLETED|Overall Study||68
41483|NCT01628926|94192|P2|COMPLETED|Overall Study||144
41484|NCT01628926|94193|P1|COMPLETED|Overall Study||142
41485|NCT01628926|94191|P3|STARTED|Overall Study||85
41486|NCT01628926|94192|P2|STARTED|Overall Study||167
41487|NCT01628926|94193|P1|STARTED|Overall Study||168
41488|NCT01628913|94242|P2|NOT COMPLETED|Overall Study||31
41489|NCT01628913|94243|P1|NOT COMPLETED|Overall Study||31
41490|NCT01628913|94242|P2|COMPLETED|Overall Study||0
41491|NCT01628913|94243|P1|COMPLETED|Overall Study||0
41492|NCT01628913|94242|P2|STARTED|Overall Study||31
41493|NCT01628913|94243|P1|STARTED|Overall Study||31
41494|NCT01628848|94257|P2|NOT COMPLETED|Overall Study||14
41495|NCT01628848|94258|P1|NOT COMPLETED|Overall Study||12
41496|NCT01628848|94257|P2|COMPLETED|Overall Study||73
41497|NCT01628848|94258|P1|COMPLETED|Overall Study||75
41498|NCT01628848|94257|P2|STARTED|Overall Study||87
41499|NCT01628848|94258|P1|STARTED|Overall Study||87
41500|NCT01628692|94292|P6|NOT COMPLETED|Overall Study||9
41501|NCT01628692|94293|P5|NOT COMPLETED|Overall Study||4
41502|NCT01628692|94294|P4|NOT COMPLETED|Overall Study||1
41503|NCT01628692|94295|P3|NOT COMPLETED|Overall Study||8
41504|NCT01628692|94296|P2|NOT COMPLETED|Overall Study||6
41505|NCT01628692|94297|P1|NOT COMPLETED|Overall Study||7
41506|NCT01628692|94292|P6|COMPLETED|Overall Study||0
41507|NCT01628692|94293|P5|COMPLETED|Overall Study||8
41508|NCT01628692|94294|P4|COMPLETED|Overall Study||19
41509|NCT01628692|94295|P3|COMPLETED|Overall Study||43
41510|NCT01628692|94296|P2|COMPLETED|Overall Study||17
41511|NCT01628692|94297|P1|COMPLETED|Overall Study||46
41512|NCT01628692|94292|P6|STARTED|Overall Study||9
41513|NCT01628692|94293|P5|STARTED|Overall Study||12
41514|NCT01628692|94294|P4|STARTED|Overall Study||20
41515|NCT01628692|94295|P3|STARTED|Overall Study||51
41516|NCT01628692|94296|P2|STARTED|Overall Study||23
41517|NCT01628692|94297|P1|STARTED|Overall Study||53
41518|NCT01628614|94341|P1|NOT COMPLETED|Overall Study||1775
41519|NCT01628614|94341|P1|COMPLETED|Overall Study||3037
41520|NCT01628614|94341|P1|STARTED|Overall Study||4812
41521|NCT01628601|94347|P1|NOT COMPLETED|Overall Study||41
41522|NCT01628601|94347|P1|COMPLETED|Overall Study||351
41523|NCT01628601|94347|P1|STARTED|Overall Study||392
41524|NCT01628588|94355|P1|NOT COMPLETED|Overall Study||16
41525|NCT01628588|94355|P1|COMPLETED|Overall Study||838
41526|NCT01628588|94355|P1|STARTED|Overall Study||854
41527|NCT01628510|94365|P2|NOT COMPLETED|Overall Study||5
41528|NCT01628510|94366|P1|NOT COMPLETED|Overall Study||3
41529|NCT01628510|94365|P2|COMPLETED|Overall Study||44
41530|NCT01628510|94366|P1|COMPLETED|Overall Study||48
41531|NCT01628510|94365|P2|STARTED|Overall Study||49
41532|NCT01628510|94366|P1|STARTED|Overall Study||51
41533|NCT01628367|94374|P2|NOT COMPLETED|Overall Study||0
41534|NCT01628367|94375|P1|NOT COMPLETED|Overall Study||1
41535|NCT01628367|94374|P2|COMPLETED|Overall Study||16
41536|NCT01628367|94375|P1|COMPLETED|Overall Study||15
41537|NCT01628367|94374|P2|STARTED|Overall Study||16
41538|NCT01628367|94375|P1|STARTED|Overall Study||16
41539|NCT01628250|94387|P2|NOT COMPLETED|Overall Study||0
41540|NCT01628250|94388|P1|NOT COMPLETED|Overall Study||0
41541|NCT01628250|94387|P2|COMPLETED|Overall Study||50
41542|NCT01628250|94388|P1|COMPLETED|Overall Study||49
41543|NCT01628250|94387|P2|STARTED|Overall Study||50
41544|NCT01628250|94388|P1|STARTED|Overall Study||49
41545|NCT01628042|94398|P4|NOT COMPLETED|Overall Study||0
41546|NCT01628042|94399|P3|NOT COMPLETED|Overall Study||0
41547|NCT01628042|94400|P2|NOT COMPLETED|Overall Study||0
41548|NCT01628042|94401|P1|NOT COMPLETED|Overall Study||0
41549|NCT01628042|94398|P4|COMPLETED|Overall Study||8
41550|NCT01628042|94399|P3|COMPLETED|Overall Study||8
41551|NCT01628042|94400|P2|COMPLETED|Overall Study||8
41552|NCT01628042|94401|P1|COMPLETED|Overall Study||8
41553|NCT01628042|94398|P4|STARTED|Overall Study||8
41554|NCT01628042|94399|P3|STARTED|Overall Study||8
41555|NCT01628042|94400|P2|STARTED|Overall Study||8
41556|NCT01628042|94401|P1|STARTED|Overall Study||8
41557|NCT01627860|94421|P2|NOT COMPLETED|Overall Study||6
41558|NCT01627860|94422|P1|NOT COMPLETED|Overall Study||12
41559|NCT01627860|94421|P2|COMPLETED|Overall Study||14
41560|NCT01627860|94422|P1|COMPLETED|Overall Study||23
41561|NCT01627860|94421|P2|STARTED|Overall Study||20
41562|NCT01627860|94422|P1|STARTED|Overall Study||35
41563|NCT01627782|94436|P4|NOT COMPLETED|Overall Study||6
41564|NCT01627782|94437|P3|NOT COMPLETED|Overall Study||15
41565|NCT01627782|94438|P2|NOT COMPLETED|Overall Study||6
41566|NCT01627782|94439|P1|NOT COMPLETED|Overall Study||16
41567|NCT01627782|94436|P4|COMPLETED|Overall Study||11
41568|NCT01627782|94437|P3|COMPLETED|Overall Study||1
41569|NCT01627782|94438|P2|COMPLETED|Overall Study||12
41570|NCT01627782|94439|P1|COMPLETED|Overall Study||1
41571|NCT01627782|94436|P4|Treated|Overall Study||17
41572|NCT01627782|94437|P3|Treated|Overall Study||16
41573|NCT01627782|94438|P2|Treated|Overall Study||18
41574|NCT01627782|94439|P1|Treated|Overall Study||16
41575|NCT01627782|94436|P4|STARTED|Overall Study||17
41576|NCT01627782|94437|P3|STARTED|Overall Study||16
41577|NCT01627782|94438|P2|STARTED|Overall Study||18
41578|NCT01627782|94439|P1|STARTED|Overall Study||17
41579|NCT01627561|94497|P2|NOT COMPLETED|Overall Study||2
41580|NCT01627561|94498|P1|NOT COMPLETED|Overall Study||0
41581|NCT01627561|94497|P2|COMPLETED|Overall Study||72
41582|NCT01627561|94498|P1|COMPLETED|Overall Study||74
41583|NCT01627561|94497|P2|STARTED|Overall Study||74
41584|NCT01627561|94498|P1|STARTED|Overall Study||74
41585|NCT01627340|94538|P2|NOT COMPLETED|Overall Study||4
41586|NCT01627340|94539|P1|NOT COMPLETED|Overall Study||12
41587|NCT01627340|94538|P2|COMPLETED|Overall Study||254
41588|NCT01627340|94539|P1|COMPLETED|Overall Study||404
41589|NCT01627340|94538|P2|STARTED|Overall Study||258
41590|NCT01627340|94539|P1|STARTED|Overall Study||416
41591|NCT01627327|94557|P2|NOT COMPLETED|Overall Study||39
41592|NCT01627327|94558|P1|NOT COMPLETED|Overall Study||19
41593|NCT01627327|94557|P2|COMPLETED|Overall Study||274
41594|NCT01627327|94558|P1|COMPLETED|Overall Study||291
41595|NCT01627327|94557|P2|STARTED|Overall Study||313
41596|NCT01627327|94558|P1|STARTED|Overall Study||310
41597|NCT01627249|94571|P3|NOT COMPLETED|Overall Study||12
41598|NCT01627249|94572|P2|NOT COMPLETED|Overall Study||12
41599|NCT01627249|94573|P1|NOT COMPLETED|Overall Study||16
41600|NCT01627249|94571|P3|COMPLETED|Overall Study||206
41601|NCT01627249|94572|P2|COMPLETED|Overall Study||206
41602|NCT01627249|94573|P1|COMPLETED|Overall Study||208
41603|NCT01627249|94571|P3|STARTED|Overall Study||218
41604|NCT01627249|94572|P2|STARTED|Overall Study||218
41605|NCT01627249|94573|P1|STARTED|Overall Study||224
41606|NCT01627002|94610|P9|NOT COMPLETED|Overall Study||0
41607|NCT01627002|94611|P8|NOT COMPLETED|Overall Study||0
41608|NCT01627002|94612|P7|NOT COMPLETED|Overall Study||0
41609|NCT01627002|94613|P6|NOT COMPLETED|Overall Study||0
41610|NCT01627002|94614|P5|NOT COMPLETED|Overall Study||0
41611|NCT01627002|94615|P4|NOT COMPLETED|Overall Study||0
41612|NCT01627002|94616|P3|NOT COMPLETED|Overall Study||0
41613|NCT01627002|94617|P2|NOT COMPLETED|Overall Study||0
41614|NCT01627002|94618|P1|NOT COMPLETED|Overall Study||0
41615|NCT01627002|94610|P9|COMPLETED|Overall Study||7
41616|NCT01627002|94611|P8|COMPLETED|Overall Study||5
41617|NCT01627002|94612|P7|COMPLETED|Overall Study||10
41618|NCT01627002|94613|P6|COMPLETED|Overall Study||9
41619|NCT01627002|94614|P5|COMPLETED|Overall Study||2
41620|NCT01627002|94615|P4|COMPLETED|Overall Study||4
41621|NCT01627002|94616|P3|COMPLETED|Overall Study||4
41622|NCT01627002|94617|P2|COMPLETED|Overall Study||4
41623|NCT01627002|94618|P1|COMPLETED|Overall Study||4
41624|NCT01627002|94610|P9|STARTED|Overall Study||7
41625|NCT01627002|94611|P8|STARTED|Overall Study||5
41626|NCT01627002|94612|P7|STARTED|Overall Study||10
41627|NCT01627002|94613|P6|STARTED|Overall Study||9
41628|NCT01627002|94614|P5|STARTED|Overall Study||2
41629|NCT01627002|94615|P4|STARTED|Overall Study||4
41630|NCT01627002|94616|P3|STARTED|Overall Study||4
41631|NCT01627002|94617|P2|STARTED|Overall Study||4
41632|NCT01627002|94618|P1|STARTED|Overall Study||4
41633|NCT01626820|94671|P2|NOT COMPLETED|Overall Study||0
41634|NCT01626820|94672|P1|NOT COMPLETED|Overall Study||0
41635|NCT01626820|94671|P2|COMPLETED|Overall Study||57
41636|NCT01626820|94672|P1|COMPLETED|Overall Study||56
41637|NCT01626820|94671|P2|STARTED|Overall Study||57
41638|NCT01626820|94672|P1|STARTED|Overall Study||56
41639|NCT01626690|94694|P2|NOT COMPLETED|Overall Study||0
41640|NCT01626690|94695|P1|NOT COMPLETED|Overall Study||2
41641|NCT01626690|94694|P2|COMPLETED|Overall Study||51
41642|NCT01626690|94695|P1|COMPLETED|Overall Study||47
41643|NCT01626690|94694|P2|STARTED|Overall Study||51
41644|NCT01626690|94695|P1|STARTED|Overall Study||49
41645|NCT01626456|94717|P2|NOT COMPLETED|Overall Study||117
41646|NCT01626456|94718|P1|NOT COMPLETED|Overall Study||35
41647|NCT01626456|94717|P2|COMPLETED|Overall Study||251
41648|NCT01626456|94718|P1|COMPLETED|Overall Study||75
41649|NCT01626456|94717|P2|STARTED|Overall Study||368
41650|NCT01626456|94718|P1|STARTED|Overall Study||110
41651|NCT01626391|94748|P2|NOT COMPLETED|Overall Study||0
41652|NCT01626391|94749|P1|NOT COMPLETED|Overall Study||2
41653|NCT01626391|94748|P2|COMPLETED|Overall Study||4
41654|NCT01626391|94749|P1|COMPLETED|Overall Study||3
41655|NCT01626391|94748|P2|STARTED|Overall Study||4
41656|NCT01626391|94749|P1|STARTED|Overall Study||5
41657|NCT01626118|94759|P4|NOT COMPLETED|Overall Study||3
41658|NCT01626118|94760|P3|NOT COMPLETED|Overall Study||2
41659|NCT01626118|94761|P2|NOT COMPLETED|Overall Study||2
41660|NCT01626118|94762|P1|NOT COMPLETED|Overall Study||2
41661|NCT01626118|94759|P4|COMPLETED|Overall Study||91
41662|NCT01626118|94760|P3|COMPLETED|Overall Study||90
41663|NCT01626118|94761|P2|COMPLETED|Overall Study||91
41664|NCT01626118|94762|P1|COMPLETED|Overall Study||92
41665|NCT01626118|94759|P4|STARTED|Overall Study||94
41666|NCT01626118|94760|P3|STARTED|Overall Study||92
41667|NCT01626118|94761|P2|STARTED|Overall Study||93
41668|NCT01626118|94762|P1|STARTED|Overall Study||94
41669|NCT01626092|94800|P1|NOT COMPLETED|Overall Study||0
41670|NCT01626092|94800|P1|COMPLETED|Overall Study||3
41671|NCT01626092|94800|P1|STARTED|Overall Study||3
41672|NCT01625910|94808|P2|NOT COMPLETED|Overall Study||4
41673|NCT01625910|94809|P1|NOT COMPLETED|Overall Study||3
41674|NCT01625910|94808|P2|COMPLETED|Overall Study||33
41675|NCT01625910|94809|P1|COMPLETED|Overall Study||32
41676|NCT01625910|94808|P2|STARTED|Overall Study||37
41677|NCT01625910|94809|P1|STARTED|Overall Study||35
41678|NCT01625845|94819|P2|NOT COMPLETED|Overall Study||3
41679|NCT01625845|94820|P1|NOT COMPLETED|Overall Study||5
41680|NCT01625845|94819|P2|COMPLETED|Overall Study||3
41681|NCT01625845|94820|P1|COMPLETED|Overall Study||5
41682|NCT01625845|94819|P2|STARTED|Overall Study||6
41683|NCT01625845|94820|P1|STARTED|Overall Study||10
41684|NCT01625689|94840|P2|NOT COMPLETED|Overall Study||1
41685|NCT01625689|94841|P1|NOT COMPLETED|Overall Study||2
41686|NCT01625689|94840|P2|COMPLETED|Overall Study||149
41687|NCT01625689|94841|P1|COMPLETED|Overall Study||148
41688|NCT01625689|94840|P2|STARTED|Overall Study||150
41689|NCT01625689|94841|P1|STARTED|Overall Study||150
41690|NCT01625507|94851|P1|NOT COMPLETED|Overall Study||10
41691|NCT01625507|94851|P1|COMPLETED|Overall Study||63
41692|NCT01625507|94851|P1|STARTED|Overall Study||73
41693|NCT01625377|94866|P2|NOT COMPLETED|Overall Study||22
41694|NCT01625377|94867|P1|NOT COMPLETED|Overall Study||7
41695|NCT01625377|94866|P2|COMPLETED|Overall Study||71
41696|NCT01625377|94867|P1|COMPLETED|Overall Study||88
41697|NCT01625377|94866|P2|Intent to Treat Population|Overall Study||90
41698|NCT01625377|94867|P1|Intent to Treat Population|Overall Study||93
41699|NCT01625377|94866|P2|Safety Set of Population|Overall Study||90
41700|NCT01625377|94867|P1|Safety Set of Population|Overall Study||94
41701|NCT01625377|94866|P2|STARTED|Overall Study||93
41702|NCT01625377|94867|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
41703|NCT01625338|94900|P3|NOT COMPLETED|Overall Study||39
41704|NCT01625338|94901|P2|NOT COMPLETED|Overall Study||44
41705|NCT01625338|94902|P1|NOT COMPLETED|Overall Study||32
41706|NCT01625338|94900|P3|COMPLETED|Overall Study||181
41707|NCT01625338|94901|P2|COMPLETED|Overall Study||156
41708|NCT01625338|94902|P1|COMPLETED|Overall Study||82
41709|NCT01625338|94900|P3|STARTED|Overall Study||220
41710|NCT01625338|94901|P2|STARTED|Overall Study||200
41711|NCT01625338|94902|P1|STARTED|Overall Study||114
41712|NCT01625221|94922|P1|NOT COMPLETED|Overall Study||7
41713|NCT01625221|94922|P1|COMPLETED|Overall Study||28
41714|NCT01625221|94922|P1|STARTED|Overall Study||35
41715|NCT01625169|94926|P1|NOT COMPLETED|Overall Study||0
41716|NCT01625169|94926|P1|COMPLETED|Overall Study||9
41717|NCT01625169|94926|P1|STARTED|Overall Study||9
41718|NCT01624948|94941|P2|NOT COMPLETED|Overall Study||0
41719|NCT01624948|94942|P1|NOT COMPLETED|Overall Study||0
41720|NCT01624948|94941|P2|COMPLETED|Overall Study||20
41721|NCT01624948|94942|P1|COMPLETED|Overall Study||20
41722|NCT01624948|94941|P2|STARTED|Overall Study||20
41723|NCT01624948|94942|P1|STARTED|Overall Study||20
41724|NCT01624740|94960|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
41725|NCT01624740|94961|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
41726|NCT01624740|94960|P2|COMPLETED|Second Intervention (3-4 Days)||9
41727|NCT01624740|94961|P1|COMPLETED|Second Intervention (3-4 Days)||8
41728|NCT01624740|94960|P2|STARTED|Second Intervention (3-4 Days)||9
41729|NCT01624740|94961|P1|STARTED|Second Intervention (3-4 Days)||9
41730|NCT01624740|94960|P2|NOT COMPLETED|Washout (1 Hour)||0
41731|NCT01624740|94961|P1|NOT COMPLETED|Washout (1 Hour)||0
41732|NCT01624740|94960|P2|COMPLETED|Washout (1 Hour)||9
41733|NCT01624740|94961|P1|COMPLETED|Washout (1 Hour)||9
41734|NCT01624740|94960|P2|STARTED|Washout (1 Hour)||9
41735|NCT01624740|94961|P1|STARTED|Washout (1 Hour)||9
41736|NCT01624740|94960|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
41737|NCT01624740|94961|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
41738|NCT01624740|94960|P2|COMPLETED|First Intervention (3-4 Days)||9
41739|NCT01624740|94961|P1|COMPLETED|First Intervention (3-4 Days)||9
41740|NCT01624740|94960|P2|STARTED|First Intervention (3-4 Days)||9
41741|NCT01624740|94961|P1|STARTED|First Intervention (3-4 Days)||9
41742|NCT01624467|94968|P1|NOT COMPLETED|Overall Study||31
41743|NCT01624467|94968|P1|COMPLETED|Overall Study||44
41744|NCT01624467|94968|P1|Received at Least One Dose of Study Drug|Overall Study||75
41745|NCT01624467|94968|P1|STARTED|Overall Study||75
41746|NCT01624350|94981|P1|NOT COMPLETED|Overall Study||25
41747|NCT01624350|94981|P1|COMPLETED|Overall Study||75
41748|NCT01624350|94981|P1|STARTED|Overall Study||100
41749|NCT01624259|95003|P2|NOT COMPLETED|Overall Study||31
41750|NCT01624259|95004|P1|NOT COMPLETED|Overall Study||30
41751|NCT01624259|95003|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
41752|NCT01624259|95004|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
41753|NCT01624259|95003|P2|Received at Least One Dose of Study Drug|Overall Study||300
41754|NCT01624259|95004|P1|Received at Least One Dose of Study Drug|Overall Study||299
41755|NCT01624259|95003|P2|STARTED|Overall Study||300
41756|NCT01624259|95004|P1|STARTED|Overall Study||299
41757|NCT01624233|95053|P1|NOT COMPLETED|Period 3 - Maintenance||7
41758|NCT01624233|95053|P1|COMPLETED|Period 3 - Maintenance||83
41759|NCT01624233|95053|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
41760|NCT01624233|95053|P1|STARTED|Period 3 - Maintenance||90
41761|NCT01624233|95053|P1|NOT COMPLETED|Period 2 - Induction||1
41762|NCT01624233|95053|P1|COMPLETED|Period 2 - Induction||90
41763|NCT01624233|95053|P1|Plaque Ps|Period 2 - Induction||78
41764|NCT01624233|95053|P1|Pustular Ps|Period 2 - Induction||5
41765|NCT01624233|95053|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
41766|NCT01624233|95053|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
41767|NCT01624233|95053|P1|STARTED|Period 2 - Induction||91
41768|NCT01624168|95073|P3|NOT COMPLETED|Overall Study||6
41769|NCT01624168|95074|P2|NOT COMPLETED|Overall Study||12
41770|NCT01624168|95075|P1|NOT COMPLETED|Overall Study||4
41771|NCT01624168|95073|P3|COMPLETED|Overall Study||22
41772|NCT01624168|95074|P2|COMPLETED|Overall Study||16
41773|NCT01624168|95075|P1|COMPLETED|Overall Study||15
41774|NCT01624168|95073|P3|STARTED|Overall Study||28
41775|NCT01624168|95074|P2|STARTED|Overall Study||28
41776|NCT01624168|95075|P1|STARTED|Overall Study||19
41777|NCT01623869|95098|P1|NOT COMPLETED|Overall Study||0
41778|NCT01623869|95098|P1|COMPLETED|Overall Study||16
41779|NCT01623869|95098|P1|STARTED|Overall Study||16
41780|NCT01623830|95106|P2|NOT COMPLETED|Overall Study||9
41781|NCT01623830|95107|P1|NOT COMPLETED|Overall Study||7
41782|NCT01623830|95106|P2|COMPLETED|Overall Study||35
41783|NCT01623830|95107|P1|COMPLETED|Overall Study||38
41784|NCT01623830|95106|P2|STARTED|Overall Study||44
41785|NCT01623830|95107|P1|STARTED|Overall Study||45
41786|NCT01623479|95121|P1|NOT COMPLETED|Overall Study||0
41787|NCT01623479|95121|P1|COMPLETED|Overall Study||585
41788|NCT01623479|95121|P1|STARTED|Overall Study||585
41789|NCT01623323|95127|P1|NOT COMPLETED|Overall Study||104
41790|NCT01623323|95127|P1|COMPLETED|Overall Study||601
41791|NCT01623323|95127|P1|STARTED|Overall Study||705
41792|NCT01623154|95131|P1|NOT COMPLETED|Overall Study||4
41793|NCT01623154|95131|P1|COMPLETED|Overall Study||95
41794|NCT01623154|95131|P1|Available for Analysis|Overall Study||95
41795|NCT01623154|95131|P1|STARTED|Overall Study||99
41796|NCT01623115|95139|P2|NOT COMPLETED|Overall Study||77
41797|NCT01623115|95140|P1|NOT COMPLETED|Overall Study||33
41798|NCT01623115|95139|P2|COMPLETED|Overall Study||246
41799|NCT01623115|95140|P1|COMPLETED|Overall Study||130
41800|NCT01623115|95139|P2|Treated|Overall Study||322
41801|NCT01623115|95140|P1|Treated|Overall Study||163
41802|NCT01623115|95139|P2|STARTED|Overall Study|Randomized|323
41803|NCT01623115|95140|P1|STARTED|Overall Study|Randomized|163
41804|NCT01623050|95200|P1|NOT COMPLETED|Overall Study||9
41805|NCT01623050|95200|P1|COMPLETED|Overall Study||27
41806|NCT01623050|95200|P1|Treated|Overall Study||34
41807|NCT01623050|95200|P1|STARTED|Overall Study||36
41808|NCT01622673|95214|P6|NOT COMPLETED|Treatment Period 5||0
41809|NCT01622673|95215|P5|NOT COMPLETED|Treatment Period 5||0
41810|NCT01622673|95216|P4|NOT COMPLETED|Treatment Period 5||0
41811|NCT01622673|95217|P3|NOT COMPLETED|Treatment Period 5||0
41812|NCT01622673|95218|P2|NOT COMPLETED|Treatment Period 5||0
41813|NCT01622673|95219|P1|NOT COMPLETED|Treatment Period 5||0
41814|NCT01622673|95214|P6|COMPLETED|Treatment Period 5||4
41815|NCT01622673|95215|P5|COMPLETED|Treatment Period 5||4
41816|NCT01622673|95216|P4|COMPLETED|Treatment Period 5||4
41817|NCT01622673|95217|P3|COMPLETED|Treatment Period 5||4
41818|NCT01622673|95218|P2|COMPLETED|Treatment Period 5||3
41819|NCT01622673|95219|P1|COMPLETED|Treatment Period 5||4
41820|NCT01622673|95214|P6|STARTED|Treatment Period 5||4
41821|NCT01622673|95215|P5|STARTED|Treatment Period 5||4
41822|NCT01622673|95216|P4|STARTED|Treatment Period 5||4
41823|NCT01622673|95217|P3|STARTED|Treatment Period 5||4
41824|NCT01622673|95218|P2|STARTED|Treatment Period 5||3
41825|NCT01622673|95219|P1|STARTED|Treatment Period 5||4
41826|NCT01622673|95214|P6|NOT COMPLETED|Treatment Period 4||0
41827|NCT01622673|95215|P5|NOT COMPLETED|Treatment Period 4||0
41828|NCT01622673|95216|P4|NOT COMPLETED|Treatment Period 4||0
41829|NCT01622673|95217|P3|NOT COMPLETED|Treatment Period 4||0
41830|NCT01622673|95218|P2|NOT COMPLETED|Treatment Period 4||0
41831|NCT01622673|95219|P1|NOT COMPLETED|Treatment Period 4||0
41832|NCT01622673|95214|P6|COMPLETED|Treatment Period 4||4
41833|NCT01622673|95215|P5|COMPLETED|Treatment Period 4||4
41834|NCT01622673|95216|P4|COMPLETED|Treatment Period 4||4
41835|NCT01622673|95217|P3|COMPLETED|Treatment Period 4||4
41836|NCT01622673|95218|P2|COMPLETED|Treatment Period 4||3
41837|NCT01622673|95219|P1|COMPLETED|Treatment Period 4||4
41838|NCT01622673|95214|P6|STARTED|Treatment Period 4||4
41839|NCT01622673|95215|P5|STARTED|Treatment Period 4||4
41840|NCT01622673|95216|P4|STARTED|Treatment Period 4||4
41841|NCT01622673|95217|P3|STARTED|Treatment Period 4||4
41842|NCT01622673|95218|P2|STARTED|Treatment Period 4||3
41843|NCT01622673|95219|P1|STARTED|Treatment Period 4||4
41844|NCT01622673|95214|P6|NOT COMPLETED|Treatment Period 3||0
41845|NCT01622673|95215|P5|NOT COMPLETED|Treatment Period 3||0
41846|NCT01622673|95216|P4|NOT COMPLETED|Treatment Period 3||0
41847|NCT01622673|95217|P3|NOT COMPLETED|Treatment Period 3||0
41848|NCT01622673|95218|P2|NOT COMPLETED|Treatment Period 3||1
41849|NCT01622673|95219|P1|NOT COMPLETED|Treatment Period 3||0
41850|NCT01622673|95214|P6|COMPLETED|Treatment Period 3||4
41851|NCT01622673|95215|P5|COMPLETED|Treatment Period 3||4
41852|NCT01622673|95216|P4|COMPLETED|Treatment Period 3||4
41853|NCT01622673|95217|P3|COMPLETED|Treatment Period 3||4
41854|NCT01622673|95218|P2|COMPLETED|Treatment Period 3||3
41855|NCT01622673|95219|P1|COMPLETED|Treatment Period 3||4
41856|NCT01622673|95214|P6|STARTED|Treatment Period 3||4
41857|NCT01622673|95215|P5|STARTED|Treatment Period 3||4
41858|NCT01622673|95216|P4|STARTED|Treatment Period 3||4
41859|NCT01622673|95217|P3|STARTED|Treatment Period 3||4
41860|NCT01622673|95218|P2|STARTED|Treatment Period 3||4
41861|NCT01622673|95219|P1|STARTED|Treatment Period 3||4
41862|NCT01622673|95214|P6|NOT COMPLETED|Treatment Period 2||0
41863|NCT01622673|95215|P5|NOT COMPLETED|Treatment Period 2||0
41864|NCT01622673|95216|P4|NOT COMPLETED|Treatment Period 2||1
41865|NCT01622673|95217|P3|NOT COMPLETED|Treatment Period 2||0
41866|NCT01622673|95218|P2|NOT COMPLETED|Treatment Period 2||0
41867|NCT01622673|95219|P1|NOT COMPLETED|Treatment Period 2||0
41868|NCT01622673|95214|P6|COMPLETED|Treatment Period 2||4
41869|NCT01622673|95215|P5|COMPLETED|Treatment Period 2||4
41870|NCT01622673|95216|P4|COMPLETED|Treatment Period 2||4
41871|NCT01622673|95217|P3|COMPLETED|Treatment Period 2||4
41872|NCT01622673|95218|P2|COMPLETED|Treatment Period 2||4
41873|NCT01622673|95219|P1|COMPLETED|Treatment Period 2||4
41874|NCT01622673|95214|P6|STARTED|Treatment Period 2||4
41875|NCT01622673|95215|P5|STARTED|Treatment Period 2||4
41876|NCT01622673|95216|P4|STARTED|Treatment Period 2||5
41877|NCT01622673|95217|P3|STARTED|Treatment Period 2||4
41878|NCT01622673|95218|P2|STARTED|Treatment Period 2||4
41879|NCT01622673|95219|P1|STARTED|Treatment Period 2||4
41880|NCT01622673|95214|P6|NOT COMPLETED|Treatment Period 1||0
41881|NCT01622673|95215|P5|NOT COMPLETED|Treatment Period 1||0
41882|NCT01622673|95216|P4|NOT COMPLETED|Treatment Period 1||1
41883|NCT01622673|95217|P3|NOT COMPLETED|Treatment Period 1||0
41884|NCT01622673|95218|P2|NOT COMPLETED|Treatment Period 1||1
41885|NCT01622673|95219|P1|NOT COMPLETED|Treatment Period 1||0
41886|NCT01622673|95214|P6|COMPLETED|Treatment Period 1||4
41887|NCT01622673|95215|P5|COMPLETED|Treatment Period 1||4
41888|NCT01622673|95216|P4|COMPLETED|Treatment Period 1||5
41889|NCT01622673|95217|P3|COMPLETED|Treatment Period 1||4
41890|NCT01622673|95218|P2|COMPLETED|Treatment Period 1||4
41891|NCT01622673|95219|P1|COMPLETED|Treatment Period 1||4
41892|NCT01622673|95214|P6|STARTED|Treatment Period 1||4
41893|NCT01622673|95215|P5|STARTED|Treatment Period 1||4
41894|NCT01622673|95216|P4|STARTED|Treatment Period 1||6
41895|NCT01622673|95217|P3|STARTED|Treatment Period 1||4
41896|NCT01622673|95218|P2|STARTED|Treatment Period 1||5
41897|NCT01622673|95219|P1|STARTED|Treatment Period 1||4
41898|NCT01622296|95254|P2|NOT COMPLETED|Second Intervention||0
41899|NCT01622296|95255|P1|NOT COMPLETED|Second Intervention||0
41900|NCT01622296|95254|P2|COMPLETED|Second Intervention||10
41901|NCT01622296|95255|P1|COMPLETED|Second Intervention||10
41902|NCT01622296|95254|P2|STARTED|Second Intervention||10
41903|NCT01622296|95255|P1|STARTED|Second Intervention||10
41904|NCT01622296|95254|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
41905|NCT01622296|95255|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
41906|NCT01622296|95254|P2|COMPLETED|Washout Period of at Least 1 Week||10
41907|NCT01622296|95255|P1|COMPLETED|Washout Period of at Least 1 Week||10
41908|NCT01622296|95254|P2|STARTED|Washout Period of at Least 1 Week||10
41909|NCT01622296|95255|P1|STARTED|Washout Period of at Least 1 Week||10
41910|NCT01622296|95254|P2|NOT COMPLETED|First Intervention||0
41911|NCT01622296|95255|P1|NOT COMPLETED|First Intervention||0
41912|NCT01622296|95254|P2|COMPLETED|First Intervention||10
41913|NCT01622296|95255|P1|COMPLETED|First Intervention||10
41914|NCT01622296|95254|P2|STARTED|First Intervention||10
41915|NCT01622296|95255|P1|STARTED|First Intervention||10
41916|NCT01622257|95263|P3|NOT COMPLETED|Overall Study||0
41917|NCT01622257|95264|P2|NOT COMPLETED|Overall Study||0
41918|NCT01622257|95265|P1|NOT COMPLETED|Overall Study||0
41919|NCT01622257|95263|P3|COMPLETED|Overall Study||66
41920|NCT01622257|95264|P2|COMPLETED|Overall Study||66
41921|NCT01622257|95265|P1|COMPLETED|Overall Study||66
41922|NCT01622257|95263|P3|STARTED|Overall Study||66
41923|NCT01622257|95264|P2|STARTED|Overall Study||66
41924|NCT01622257|95265|P1|STARTED|Overall Study||66
41925|NCT01622231|95285|P1|NOT COMPLETED|Overall Study||2
41926|NCT01622231|95285|P1|COMPLETED|Overall Study||59
41927|NCT01622231|95285|P1|STARTED|Overall Study||61
41928|NCT01621776|95316|P3|NOT COMPLETED|Overall Study||0
41929|NCT01621776|95317|P2|NOT COMPLETED|Overall Study||0
41930|NCT01621776|95318|P1|NOT COMPLETED|Overall Study||0
41931|NCT01621776|95316|P3|COMPLETED|Overall Study||18
41932|NCT01621776|95317|P2|COMPLETED|Overall Study||40
41933|NCT01621776|95318|P1|COMPLETED|Overall Study||41
41934|NCT01621776|95316|P3|STARTED|Overall Study||18
41935|NCT01621776|95317|P2|STARTED|Overall Study||40
41936|NCT01621776|95318|P1|STARTED|Overall Study||41
41937|NCT01621672|95334|P2|NOT COMPLETED|Overall Study||0
41938|NCT01621672|95335|P1|NOT COMPLETED|Overall Study||0
41939|NCT01621672|95334|P2|COMPLETED|Overall Study||17
41940|NCT01621672|95335|P1|COMPLETED|Overall Study||25
41941|NCT01621672|95334|P2|STARTED|Overall Study||17
41942|NCT01621672|95335|P1|STARTED|Overall Study||25
41943|NCT01621633|95345|P4|NOT COMPLETED|Overall Study||0
41944|NCT01621633|95346|P3|NOT COMPLETED|Overall Study||0
41945|NCT01621633|95347|P2|NOT COMPLETED|Overall Study||0
41946|NCT01621633|95348|P1|NOT COMPLETED|Overall Study||0
41947|NCT01621633|95345|P4|COMPLETED|Overall Study||8
41948|NCT01621633|95346|P3|COMPLETED|Overall Study||8
41949|NCT01621633|95347|P2|COMPLETED|Overall Study||8
41950|NCT01621633|95348|P1|COMPLETED|Overall Study||8
41951|NCT01621633|95345|P4|STARTED|Overall Study||8
41952|NCT01621633|95346|P3|STARTED|Overall Study||8
41953|NCT01621633|95347|P2|STARTED|Overall Study||8
41954|NCT01621633|95348|P1|STARTED|Overall Study||8
41955|NCT01621191|95370|P1|NOT COMPLETED|Overall Study||25
41956|NCT01621191|95370|P1|COMPLETED|Overall Study||124
41957|NCT01621191|95370|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
41958|NCT01621191|95370|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
41959|NCT01621191|95370|P1|STARTED|Overall Study||149
41960|NCT01621126|95381|P1|NOT COMPLETED|Overall Study||6
41961|NCT01621126|95381|P1|COMPLETED|Overall Study||34
41962|NCT01621126|95381|P1|STARTED|Overall Study||40
41963|NCT01621009|95389|P4|NOT COMPLETED|Overall Study||53
41964|NCT01621009|95390|P3|NOT COMPLETED|Overall Study||63
41965|NCT01621009|95391|P2|NOT COMPLETED|Overall Study||51
41966|NCT01621009|95392|P1|NOT COMPLETED|Overall Study||43
41967|NCT01621009|95389|P4|COMPLETED|Overall Study||60
41968|NCT01621009|95390|P3|COMPLETED|Overall Study||58
41969|NCT01621009|95391|P2|COMPLETED|Overall Study||65
41970|NCT01621009|95392|P1|COMPLETED|Overall Study||70
41971|NCT01621009|95389|P4|STARTED|Overall Study||113
41972|NCT01621009|95390|P3|STARTED|Overall Study||121
41973|NCT01621009|95391|P2|STARTED|Overall Study||116
41974|NCT01621009|95392|P1|STARTED|Overall Study||113
41975|NCT01620489|95402|P2|NOT COMPLETED|Overall Study||34
41976|NCT01620489|95403|P1|NOT COMPLETED|Overall Study||35
41977|NCT01620489|95402|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
41978|NCT01620489|95403|P1|COMPLETED|Overall Study||105
41979|NCT01620489|95402|P2|Exposed|Overall Study|2 subjects did not take trial product|137
41980|NCT01620489|95403|P1|Exposed|Overall Study||140
41981|NCT01620489|95402|P2|STARTED|Overall Study||139
41982|NCT01620489|95403|P1|STARTED|Overall Study||140
41983|NCT01620138|95421|P2|NOT COMPLETED|Overall Study||0
41984|NCT01620138|95422|P1|NOT COMPLETED|Overall Study||6
41985|NCT01620138|95421|P2|COMPLETED|Overall Study||9
41986|NCT01620138|95422|P1|COMPLETED|Overall Study||6
41987|NCT01620138|95421|P2|STARTED|Overall Study||9
41988|NCT01620138|95422|P1|STARTED|Overall Study||12
41989|NCT01620086|95430|P3|NOT COMPLETED|Overall Study||0
41990|NCT01620086|95431|P2|NOT COMPLETED|Overall Study||7
41991|NCT01620086|95432|P1|NOT COMPLETED|Overall Study||5
41992|NCT01620086|95430|P3|COMPLETED|Overall Study||2
41993|NCT01620086|95431|P2|COMPLETED|Overall Study||4
41994|NCT01620086|95432|P1|COMPLETED|Overall Study||8
41995|NCT01620086|95430|P3|STARTED|Overall Study||2
41996|NCT01620086|95431|P2|STARTED|Overall Study||11
41997|NCT01620086|95432|P1|STARTED|Overall Study||13
41998|NCT01620060|95451|P1|NOT COMPLETED|Overall Study||15
41999|NCT01620060|95451|P1|COMPLETED|Overall Study||90
42000|NCT01620060|95451|P1|STARTED|Overall Study||105
42001|NCT01620047|95460|P3|NOT COMPLETED|Overall Study||0
42002|NCT01620047|95461|P2|NOT COMPLETED|Overall Study||0
42003|NCT01620047|95462|P1|NOT COMPLETED|Overall Study||0
42004|NCT01620047|95460|P3|COMPLETED|Overall Study||20
42005|NCT01620047|95461|P2|COMPLETED|Overall Study||20
42006|NCT01620047|95462|P1|COMPLETED|Overall Study||20
42007|NCT01620047|95460|P3|STARTED|Overall Study||20
42008|NCT01620047|95461|P2|STARTED|Overall Study||20
42009|NCT01620047|95462|P1|STARTED|Overall Study||20
42010|NCT01619878|95470|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
42011|NCT01619878|95470|P1|COMPLETED|Follow-up at 12 Months of Age||17
42012|NCT01619878|95470|P1|STARTED|Follow-up at 12 Months of Age||20
42013|NCT01619878|95470|P1|NOT COMPLETED|6 Week Follow-up Phase||1
42014|NCT01619878|95470|P1|COMPLETED|6 Week Follow-up Phase||19
42015|NCT01619878|95470|P1|STARTED|6 Week Follow-up Phase||20
42016|NCT01619800|95484|P2|NOT COMPLETED|Overall Study||0
42017|NCT01619800|95485|P1|NOT COMPLETED|Overall Study||2
42018|NCT01619800|95484|P2|COMPLETED|Overall Study||0
42019|NCT01619800|95485|P1|COMPLETED|Overall Study||0
42020|NCT01619800|95484|P2|STARTED|Overall Study||0
42021|NCT01619800|95485|P1|STARTED|Overall Study||2
42022|NCT01619787|95493|P1|NOT COMPLETED|Overall Study||5
42023|NCT01619787|95493|P1|COMPLETED|Overall Study||212
42024|NCT01619787|95493|P1|STARTED|Overall Study||217
42025|NCT01619774|95502|P1|NOT COMPLETED|Overall Study||0
42026|NCT01619774|95502|P1|COMPLETED|Overall Study||23
42027|NCT01619774|95502|P1|STARTED|Overall Study||23
42028|NCT01619579|95510|P2|NOT COMPLETED|Overall Study||3
42029|NCT01619579|95511|P1|NOT COMPLETED|Overall Study||0
42030|NCT01619579|95510|P2|COMPLETED|Overall Study||14
42031|NCT01619579|95511|P1|COMPLETED|Overall Study||5
42032|NCT01619579|95510|P2|STARTED|Overall Study||17
42033|NCT01619579|95511|P1|STARTED|Overall Study||5
42034|NCT01619059|95523|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
42035|NCT01619059|95524|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
42036|NCT01619059|95523|P2|COMPLETED|Long-Term (LT) Treatment Period||133
42037|NCT01619059|95524|P1|COMPLETED|Long-Term (LT) Treatment Period||147
42038|NCT01619059|95523|P2|STARTED|Long-Term (LT) Treatment Period||142
42039|NCT01619059|95524|P1|STARTED|Long-Term (LT) Treatment Period||155
42040|NCT01619059|95523|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
42041|NCT01619059|95524|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
42042|NCT01619059|95523|P2|COMPLETED|Short-Term (ST) Treatment Period||142
42043|NCT01619059|95524|P1|COMPLETED|Short-Term (ST) Treatment Period||156
42044|NCT01619059|95523|P2|STARTED|Short-Term (ST) Treatment Period||153
42045|NCT01619059|95524|P1|STARTED|Short-Term (ST) Treatment Period||162
42046|NCT01618968|95540|P4|NOT COMPLETED|Overall Study||1
42047|NCT01618968|95541|P3|NOT COMPLETED|Overall Study||0
42048|NCT01618968|95542|P2|NOT COMPLETED|Overall Study||0
42049|NCT01618968|95543|P1|NOT COMPLETED|Overall Study||1
42050|NCT01618968|95540|P4|COMPLETED|Overall Study||11
42051|NCT01618968|95541|P3|COMPLETED|Overall Study||12
42052|NCT01618968|95542|P2|COMPLETED|Overall Study||12
42053|NCT01618968|95543|P1|COMPLETED|Overall Study||12
42054|NCT01618968|95540|P4|Received Treatment C|Overall Study||11
42055|NCT01618968|95541|P3|Received Treatment C|Overall Study||12
42056|NCT01618968|95542|P2|Received Treatment C|Overall Study||12
42057|NCT01618968|95543|P1|Received Treatment C|Overall Study||12
42058|NCT01618968|95540|P4|Received Treatment B|Overall Study||12
42059|NCT01618968|95541|P3|Received Treatment B|Overall Study||12
42060|NCT01618968|95542|P2|Received Treatment B|Overall Study||12
42061|NCT01618968|95543|P1|Received Treatment B|Overall Study||13
42062|NCT01618968|95540|P4|Received Treatment A|Overall Study||11
42063|NCT01618968|95541|P3|Received Treatment A|Overall Study||12
42064|NCT01618968|95542|P2|Received Treatment A|Overall Study||12
42065|NCT01618968|95543|P1|Received Treatment A|Overall Study||12
42066|NCT01618968|95540|P4|STARTED|Overall Study||12
42067|NCT01618968|95541|P3|STARTED|Overall Study||12
42068|NCT01618968|95542|P2|STARTED|Overall Study||12
42069|NCT01618968|95543|P1|STARTED|Overall Study||13
42070|NCT01618955|95562|P4|NOT COMPLETED|Overall Study||0
42071|NCT01618955|95563|P3|NOT COMPLETED|Overall Study||0
42072|NCT01618955|95564|P2|NOT COMPLETED|Overall Study||0
42073|NCT01618955|95565|P1|NOT COMPLETED|Overall Study||0
42074|NCT01618955|95562|P4|COMPLETED|Overall Study||20
42075|NCT01618955|95563|P3|COMPLETED|Overall Study||31
42076|NCT01618955|95564|P2|COMPLETED|Overall Study||30
42077|NCT01618955|95565|P1|COMPLETED|Overall Study||20
42078|NCT01618955|95562|P4|STARTED|Overall Study||20
42079|NCT01618955|95563|P3|STARTED|Overall Study||31
42080|NCT01618955|95564|P2|STARTED|Overall Study||30
42081|NCT01618955|95565|P1|STARTED|Overall Study||20
42082|NCT01618942|95589|P2|NOT COMPLETED|Overall Study||0
42083|NCT01618942|95590|P1|NOT COMPLETED|Overall Study||0
42084|NCT01618942|95589|P2|COMPLETED|Overall Study||50
42085|NCT01618942|95590|P1|COMPLETED|Overall Study||50
42086|NCT01618942|95589|P2|STARTED|Overall Study||50
42087|NCT01618942|95590|P1|STARTED|Overall Study||50
42088|NCT01618864|95610|P1|NOT COMPLETED|Overall Study||4
42089|NCT01618864|95610|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
42090|NCT01618864|95610|P1|Completed 2 Weeks|Overall Study||19
42091|NCT01618864|95610|P1|STARTED|Overall Study||23
42092|NCT01618838|95619|P1|NOT COMPLETED|Overall Study||4
42093|NCT01618838|95619|P1|COMPLETED|Overall Study||0
42094|NCT01618838|95619|P1|STARTED|Overall Study||4
42095|NCT01618708|95625|P2|NOT COMPLETED|Overall Study||46
42096|NCT01618708|95626|P1|NOT COMPLETED|Overall Study||44
42097|NCT01618708|95625|P2|COMPLETED|Overall Study||136
42098|NCT01618708|95626|P1|COMPLETED|Overall Study||131
42099|NCT01618708|95625|P2|Treated|Overall Study||180
42100|NCT01618708|95626|P1|Treated|Overall Study||172
42101|NCT01618708|95625|P2|STARTED|Overall Study||182
42102|NCT01618708|95626|P1|STARTED|Overall Study||175
42103|NCT01618669|95640|P2|NOT COMPLETED|Overall Study||23
42104|NCT01618669|95641|P1|NOT COMPLETED|Overall Study||34
42105|NCT01618669|95640|P2|COMPLETED|Overall Study||546
42106|NCT01618669|95641|P1|COMPLETED|Overall Study||544
42107|NCT01618669|95640|P2|Received Treatment|Overall Study||567
42108|NCT01618669|95641|P1|Received Treatment|Overall Study||575
42109|NCT01618669|95640|P2|STARTED|Overall Study||569
42110|NCT01618669|95641|P1|STARTED|Overall Study||578
42111|NCT01618422|95687|P2|NOT COMPLETED|Overall Study||0
42112|NCT01618422|95688|P1|NOT COMPLETED|Overall Study||0
42113|NCT01618422|95687|P2|COMPLETED|Overall Study||111
42114|NCT01618422|95688|P1|COMPLETED|Overall Study||114
42115|NCT01618422|95687|P2|STARTED|Overall Study||111
42116|NCT01618422|95688|P1|STARTED|Overall Study||114
42117|NCT01618266|95694|P1|NOT COMPLETED|Overall Study||96
42118|NCT01618266|95694|P1|COMPLETED|Overall Study||279
42119|NCT01618266|95694|P1|STARTED|Overall Study||375
42120|NCT01618240|95709|P1|NOT COMPLETED|Overall Study||0
42121|NCT01618240|95709|P1|COMPLETED|Overall Study||30
42122|NCT01618240|95709|P1|STARTED|Overall Study||30
42123|NCT01618214|95716|P2|NOT COMPLETED|Overall Study||13
42124|NCT01618214|95717|P1|NOT COMPLETED|Overall Study||10
42125|NCT01618214|95716|P2|COMPLETED|Overall Study||159
42126|NCT01618214|95717|P1|COMPLETED|Overall Study||162
42127|NCT01618214|95716|P2|Exposed|Overall Study||172
42128|NCT01618214|95717|P1|Exposed|Overall Study||172
42129|NCT01618214|95716|P2|STARTED|Overall Study||172
42130|NCT01618214|95717|P1|STARTED|Overall Study||172
42131|NCT01618162|95733|P2|NOT COMPLETED|Overall Study||35
42132|NCT01618162|95734|P1|NOT COMPLETED|Overall Study||38
42133|NCT01618162|95733|P2|COMPLETED|Overall Study||111
42134|NCT01618162|95734|P1|COMPLETED|Overall Study||251
42135|NCT01618162|95733|P2|Exposed|Overall Study||146
42136|NCT01618162|95734|P1|Exposed|Overall Study||288
42137|NCT01618162|95733|P2|STARTED|Overall Study||146
42138|NCT01618162|95734|P1|STARTED|Overall Study||289
42139|NCT01618019|95754|P2|NOT COMPLETED|Overall Study||14
42140|NCT01618019|95755|P1|NOT COMPLETED|Overall Study||14
42141|NCT01618019|95754|P2|COMPLETED|Overall Study||40
42142|NCT01618019|95755|P1|COMPLETED|Overall Study||41
42143|NCT01618019|95754|P2|STARTED|Overall Study||54
42144|NCT01618019|95755|P1|STARTED|Overall Study||55
42145|NCT01617668|95777|P4|NOT COMPLETED|Overall Study||15
42146|NCT01617668|95778|P3|NOT COMPLETED|Overall Study||23
42147|NCT01617668|95779|P2|NOT COMPLETED|Overall Study||9
42148|NCT01617668|95780|P1|NOT COMPLETED|Overall Study||13
42149|NCT01617668|95777|P4|COMPLETED|Overall Study||38
42150|NCT01617668|95778|P3|COMPLETED|Overall Study||32
42151|NCT01617668|95779|P2|COMPLETED|Overall Study||41
42152|NCT01617668|95780|P1|COMPLETED|Overall Study||38
42153|NCT01617668|95777|P4|Randomized Patients|Overall Study||55
42154|NCT01617668|95778|P3|Randomized Patients|Overall Study||55
42155|NCT01617668|95779|P2|Randomized Patients|Overall Study||54
42156|NCT01617668|95780|P1|Randomized Patients|Overall Study||51
42157|NCT01617668|95777|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
42158|NCT01617668|95778|P3|STARTED|Overall Study||55
42159|NCT01617668|95779|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
42160|NCT01617668|95780|P1|STARTED|Overall Study||51
42161|NCT01617655|95821|P2|NOT COMPLETED|Overall Study||29
42162|NCT01617655|95822|P1|NOT COMPLETED|Overall Study||9
42163|NCT01617655|95821|P2|COMPLETED|Overall Study||43
42164|NCT01617655|95822|P1|COMPLETED|Overall Study||26
42165|NCT01617655|95821|P2|Treated|Overall Study||72
42166|NCT01617655|95822|P1|Treated|Overall Study||35
42167|NCT01617655|95821|P2|STARTED|Overall Study|Randomized|72
42168|NCT01617655|95822|P1|STARTED|Overall Study|Randomized|35
42169|NCT01617603|95885|P3|NOT COMPLETED|Overall Study||1
42170|NCT01617603|95886|P2|NOT COMPLETED|Overall Study||2
42171|NCT01617603|95887|P1|NOT COMPLETED|Overall Study||3
42172|NCT01617603|95885|P3|COMPLETED|Overall Study||20
42173|NCT01617603|95886|P2|COMPLETED|Overall Study||19
42174|NCT01617603|95887|P1|COMPLETED|Overall Study||17
42175|NCT01617603|95885|P3|STARTED|Overall Study||21
42176|NCT01617603|95886|P2|STARTED|Overall Study||21
42177|NCT01617603|95887|P1|STARTED|Overall Study||20
42178|NCT01617577|95897|P2|NOT COMPLETED|Overall Study||0
42179|NCT01617577|95898|P1|NOT COMPLETED|Overall Study||0
42180|NCT01617577|95897|P2|COMPLETED|Overall Study||3
42181|NCT01617577|95898|P1|COMPLETED|Overall Study||5
42182|NCT01617577|95897|P2|STARTED|Overall Study||3
42183|NCT01617577|95898|P1|STARTED|Overall Study||5
42184|NCT01617434|95907|P2|NOT COMPLETED|Overall Study||51
42185|NCT01617434|95908|P1|NOT COMPLETED|Overall Study||35
42186|NCT01617434|95907|P2|COMPLETED|Overall Study||174
42187|NCT01617434|95908|P1|COMPLETED|Overall Study||191
42188|NCT01617434|95907|P2|Exposed|Overall Study||225
42189|NCT01617434|95908|P1|Exposed|Overall Study||225
42190|NCT01617434|95907|P2|STARTED|Overall Study||225
42191|NCT01617434|95908|P1|STARTED|Overall Study||226
42192|NCT01617187|95934|P4|NOT COMPLETED|Treatment Through Study Completion||10
42193|NCT01617187|95935|P3|NOT COMPLETED|Treatment Through Study Completion||5
42194|NCT01617187|95936|P2|NOT COMPLETED|Treatment Through Study Completion||11
42195|NCT01617187|95937|P1|NOT COMPLETED|Treatment Through Study Completion||11
42196|NCT01617187|95934|P4|COMPLETED|Treatment Through Study Completion||91
42197|NCT01617187|95935|P3|COMPLETED|Treatment Through Study Completion||41
42198|NCT01617187|95936|P2|COMPLETED|Treatment Through Study Completion||102
42199|NCT01617187|95937|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
42200|NCT01617187|95934|P4|STARTED|Treatment Through Study Completion|Treated|101
42201|NCT01617187|95935|P3|STARTED|Treatment Through Study Completion|Treated|46
42202|NCT01617187|95936|P2|STARTED|Treatment Through Study Completion|Treated|113
42203|NCT01617187|95937|P1|STARTED|Treatment Through Study Completion|Treated|97
42204|NCT01617187|95934|P4|NOT COMPLETED|Randomization Through Start Treatment||2
42205|NCT01617187|95935|P3|NOT COMPLETED|Randomization Through Start Treatment||0
42206|NCT01617187|95936|P2|NOT COMPLETED|Randomization Through Start Treatment||0
42207|NCT01617187|95937|P1|NOT COMPLETED|Randomization Through Start Treatment||1
42208|NCT01617187|95934|P4|COMPLETED|Randomization Through Start Treatment||101
42209|NCT01617187|95935|P3|COMPLETED|Randomization Through Start Treatment||46
42210|NCT01617187|95936|P2|COMPLETED|Randomization Through Start Treatment||113
42211|NCT01617187|95937|P1|COMPLETED|Randomization Through Start Treatment||97
42212|NCT01617187|95934|P4|STARTED|Randomization Through Start Treatment|Randomized|103
42213|NCT01617187|95935|P3|STARTED|Randomization Through Start Treatment|Randomized|46
42214|NCT01617187|95936|P2|STARTED|Randomization Through Start Treatment|Randomized|113
42215|NCT01617187|95937|P1|STARTED|Randomization Through Start Treatment|Randomized|98
42216|NCT01617070|96007|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
42217|NCT01617070|96007|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
42218|NCT01617070|96007|P1|STARTED|BH4 and LNAA (4 Weeks)||10
42219|NCT01617070|96007|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
42220|NCT01617070|96007|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
42221|NCT01617070|96007|P1|STARTED|BH4 Therapy (4 Weeks)||10
42222|NCT01617070|96007|P1|NOT COMPLETED|Washout (4 Weeks)||0
42223|NCT01617070|96007|P1|COMPLETED|Washout (4 Weeks)||10
42224|NCT01617070|96007|P1|STARTED|Washout (4 Weeks)||10
42225|NCT01617070|96007|P1|NOT COMPLETED|LNAA (4 Weeks)||0
42226|NCT01617070|96007|P1|COMPLETED|LNAA (4 Weeks)||10
42227|NCT01617070|96007|P1|STARTED|LNAA (4 Weeks)||10
42228|NCT01617005|96025|P1|NOT COMPLETED|Overall Study||2
42229|NCT01617005|96025|P1|COMPLETED|Overall Study||48
42230|NCT01617005|96025|P1|STARTED|Overall Study||50
42231|NCT01616771|96032|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
42232|NCT01616771|96032|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
42233|NCT01616771|96032|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
42234|NCT01616771|96032|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
42235|NCT01616771|96032|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
42236|NCT01616771|96032|P1|STARTED|GVL Selected by Weight for 5 Sec||23
42237|NCT01616771|96032|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
42238|NCT01616771|96032|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
42239|NCT01616771|96032|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
42240|NCT01616576|96043|P2|NOT COMPLETED|Overall Study||0
42241|NCT01616576|96044|P1|NOT COMPLETED|Overall Study||0
42242|NCT01616576|96043|P2|COMPLETED|Overall Study||18
42243|NCT01616576|96044|P1|COMPLETED|Overall Study||18
42244|NCT01616576|96043|P2|STARTED|Overall Study||18
42245|NCT01616576|96044|P1|STARTED|Overall Study||18
42246|NCT01616459|96057|P4|NOT COMPLETED|Overall Study||8
42247|NCT01616459|96058|P3|NOT COMPLETED|Overall Study||10
42248|NCT01616459|96059|P2|NOT COMPLETED|Overall Study||17
42249|NCT01616459|96060|P1|NOT COMPLETED|Overall Study||4
42250|NCT01616459|96057|P4|COMPLETED|Overall Study||233
42251|NCT01616459|96058|P3|COMPLETED|Overall Study||220
42252|NCT01616459|96059|P2|COMPLETED|Overall Study||223
42253|NCT01616459|96060|P1|COMPLETED|Overall Study||236
42254|NCT01616459|96057|P4|STARTED|Overall Study||241
42255|NCT01616459|96058|P3|STARTED|Overall Study||230
42256|NCT01616459|96059|P2|STARTED|Overall Study||240
42257|NCT01616459|96060|P1|STARTED|Overall Study||240
42258|NCT01616173|96109|P3|NOT COMPLETED|Overall Study||0
42259|NCT01616173|96110|P2|NOT COMPLETED|Overall Study||2
42260|NCT01616173|96111|P1|NOT COMPLETED|Overall Study||0
42261|NCT01616173|96109|P3|COMPLETED|Overall Study||27
42262|NCT01616173|96110|P2|COMPLETED|Overall Study||24
42263|NCT01616173|96111|P1|COMPLETED|Overall Study||27
42264|NCT01616173|96109|P3|STARTED|Overall Study||27
42265|NCT01616173|96110|P2|STARTED|Overall Study||26
42266|NCT01616173|96111|P1|STARTED|Overall Study||27
42267|NCT01615939|96127|P2|NOT COMPLETED|Overall Study||0
42268|NCT01615939|96128|P1|NOT COMPLETED|Overall Study||5
42269|NCT01615939|96127|P2|COMPLETED|Overall Study||4
42270|NCT01615939|96128|P1|COMPLETED|Overall Study||8
42271|NCT01615939|96127|P2|STARTED|Overall Study||4
42272|NCT01615939|96128|P1|STARTED|Overall Study||13
42273|NCT01615822|96141|P3|NOT COMPLETED|Period 2||2
42274|NCT01615822|96142|P2|NOT COMPLETED|Period 2||1
42275|NCT01615822|96143|P1|NOT COMPLETED|Period 2||0
42276|NCT01615822|96141|P3|COMPLETED|Period 2||4
42277|NCT01615822|96142|P2|COMPLETED|Period 2||8
42278|NCT01615822|96143|P1|COMPLETED|Period 2||7
42279|NCT01615822|96141|P3|STARTED|Period 2||6
42280|NCT01615822|96142|P2|STARTED|Period 2||9
42281|NCT01615822|96143|P1|STARTED|Period 2||7
42282|NCT01615822|96141|P3|NOT COMPLETED|Period 1||0
42283|NCT01615822|96142|P2|NOT COMPLETED|Period 1||2
42284|NCT01615822|96143|P1|NOT COMPLETED|Period 1||1
42285|NCT01615822|96141|P3|COMPLETED|Period 1||6
42286|NCT01615822|96142|P2|COMPLETED|Period 1||9
42287|NCT01615822|96143|P1|COMPLETED|Period 1||7
42288|NCT01615822|96141|P3|STARTED|Period 1||6
42289|NCT01615822|96142|P2|STARTED|Period 1||11
42290|NCT01615822|96143|P1|STARTED|Period 1||8
42291|NCT01615809|96160|P1|NOT COMPLETED|Overall Study||10
42292|NCT01615809|96160|P1|COMPLETED|Overall Study||22
42293|NCT01615809|96160|P1|STARTED|Overall Study|basal visit|32
42294|NCT01615731|96168|P2|NOT COMPLETED|Overall Study||2
42295|NCT01615731|96169|P1|NOT COMPLETED|Overall Study||3
42296|NCT01615731|96168|P2|COMPLETED|Overall Study||24
42297|NCT01615731|96169|P1|COMPLETED|Overall Study||21
42298|NCT01615731|96168|P2|STARTED|Overall Study||26
42299|NCT01615731|96169|P1|STARTED|Overall Study||24
42300|NCT01615328|96189|P2|NOT COMPLETED|Overall Study||5
42301|NCT01615328|96190|P1|NOT COMPLETED|Overall Study||3
42302|NCT01615328|96189|P2|COMPLETED|Overall Study||38
42303|NCT01615328|96190|P1|COMPLETED|Overall Study||39
42304|NCT01615328|96189|P2|STARTED|Overall Study||43
42305|NCT01615328|96190|P1|STARTED|Overall Study||42
42306|NCT01615263|96202|P2|NOT COMPLETED|Overall Study||2
42307|NCT01615263|96203|P1|NOT COMPLETED|Overall Study||0
42308|NCT01615263|96202|P2|COMPLETED|Overall Study||18
42309|NCT01615263|96203|P1|COMPLETED|Overall Study||20
42310|NCT01615263|96202|P2|STARTED|Overall Study||20
42311|NCT01615263|96203|P1|STARTED|Overall Study||20
42312|NCT01615198|96217|P2|NOT COMPLETED|Overall Study||19
42313|NCT01615198|96218|P1|NOT COMPLETED|Overall Study||24
42314|NCT01615198|96217|P2|COMPLETED|Overall Study||273
42315|NCT01615198|96218|P1|COMPLETED|Overall Study||272
42316|NCT01615198|96217|P2|ABPM Dipper Status Subset|Overall Study||84
42317|NCT01615198|96218|P1|ABPM Dipper Status Subset|Overall Study||82
42318|NCT01615198|96217|P2|Safety Set|Overall Study||292
42319|NCT01615198|96218|P1|Safety Set|Overall Study||296
42320|NCT01615198|96217|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
42321|NCT01615198|96218|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
42322|NCT01615198|96217|P2|Full Analysis Set|Overall Study||292
42323|NCT01615198|96218|P1|Full Analysis Set|Overall Study||296
42324|NCT01615198|96217|P2|STARTED|Overall Study||292
42325|NCT01615198|96218|P1|STARTED|Overall Study||296
42326|NCT01614886|96248|P2|NOT COMPLETED|Overall Study||26
42327|NCT01614886|96249|P1|NOT COMPLETED|Overall Study||20
42328|NCT01614886|96248|P2|COMPLETED|Overall Study||83
42329|NCT01614886|96249|P1|COMPLETED|Overall Study||87
42330|NCT01614886|96248|P2|Full Analysis Set (FAS)|Overall Study||105
42331|NCT01614886|96249|P1|Full Analysis Set (FAS)|Overall Study||104
42332|NCT01614886|96248|P2|Safety Population (SAF)|Overall Study||108
42333|NCT01614886|96249|P1|Safety Population (SAF)|Overall Study||107
42334|NCT01614886|96248|P2|STARTED|Overall Study||109
42335|NCT01614886|96249|P1|STARTED|Overall Study||107
42336|NCT01614795|96267|P4|NOT COMPLETED|Overall Study||12
42337|NCT01614795|96268|P3|NOT COMPLETED|Overall Study||11
42338|NCT01614795|96269|P2|NOT COMPLETED|Overall Study||12
42339|NCT01614795|96270|P1|NOT COMPLETED|Overall Study||11
42340|NCT01614795|96267|P4|COMPLETED|Overall Study||0
42341|NCT01614795|96268|P3|COMPLETED|Overall Study||0
42342|NCT01614795|96269|P2|COMPLETED|Overall Study||0
42343|NCT01614795|96270|P1|COMPLETED|Overall Study||0
42344|NCT01614795|96267|P4|STARTED|Overall Study||12
42345|NCT01614795|96268|P3|STARTED|Overall Study||11
42346|NCT01614795|96269|P2|STARTED|Overall Study||12
42347|NCT01614795|96270|P1|STARTED|Overall Study||11
42348|NCT01614769|96280|P6|NOT COMPLETED|Period 3||0
42349|NCT01614769|96281|P5|NOT COMPLETED|Period 3||0
42350|NCT01614769|96282|P4|NOT COMPLETED|Period 3||0
42351|NCT01614769|96283|P3|NOT COMPLETED|Period 3||1
42352|NCT01614769|96284|P2|NOT COMPLETED|Period 3||0
42353|NCT01614769|96285|P1|NOT COMPLETED|Period 3||0
42354|NCT01614769|96280|P6|COMPLETED|Period 3||1
42355|NCT01614769|96281|P5|COMPLETED|Period 3||1
42356|NCT01614769|96282|P4|COMPLETED|Period 3||0
42357|NCT01614769|96283|P3|COMPLETED|Period 3||1
42358|NCT01614769|96284|P2|COMPLETED|Period 3||1
42359|NCT01614769|96285|P1|COMPLETED|Period 3||1
42360|NCT01614769|96280|P6|STARTED|Period 3||1
42361|NCT01614769|96281|P5|STARTED|Period 3||1
42362|NCT01614769|96282|P4|STARTED|Period 3||0
42363|NCT01614769|96283|P3|STARTED|Period 3||2
42364|NCT01614769|96284|P2|STARTED|Period 3||1
42365|NCT01614769|96285|P1|STARTED|Period 3||1
42366|NCT01614769|96280|P6|NOT COMPLETED|7-Day Washout||0
42367|NCT01614769|96281|P5|NOT COMPLETED|7-Day Washout||0
42368|NCT01614769|96282|P4|NOT COMPLETED|7-Day Washout||0
42369|NCT01614769|96283|P3|NOT COMPLETED|7-Day Washout||0
42370|NCT01614769|96284|P2|NOT COMPLETED|7-Day Washout||0
42371|NCT01614769|96285|P1|NOT COMPLETED|7-Day Washout||0
42372|NCT01614769|96280|P6|COMPLETED|7-Day Washout||1
42373|NCT01614769|96281|P5|COMPLETED|7-Day Washout||1
42374|NCT01614769|96282|P4|COMPLETED|7-Day Washout||0
42375|NCT01614769|96283|P3|COMPLETED|7-Day Washout||2
42376|NCT01614769|96284|P2|COMPLETED|7-Day Washout||1
42377|NCT01614769|96285|P1|COMPLETED|7-Day Washout||1
42378|NCT01614769|96280|P6|STARTED|7-Day Washout||1
42379|NCT01614769|96281|P5|STARTED|7-Day Washout||1
42380|NCT01614769|96282|P4|STARTED|7-Day Washout||0
42381|NCT01614769|96283|P3|STARTED|7-Day Washout||2
42382|NCT01614769|96284|P2|STARTED|7-Day Washout||1
42383|NCT01614769|96285|P1|STARTED|7-Day Washout||1
42384|NCT01614769|96280|P6|NOT COMPLETED|Period 2||0
42385|NCT01614769|96281|P5|NOT COMPLETED|Period 2||0
42386|NCT01614769|96282|P4|NOT COMPLETED|Period 2||0
42387|NCT01614769|96283|P3|NOT COMPLETED|Period 2||0
42388|NCT01614769|96284|P2|NOT COMPLETED|Period 2||0
42389|NCT01614769|96285|P1|NOT COMPLETED|Period 2||0
42390|NCT01614769|96280|P6|COMPLETED|Period 2||1
42391|NCT01614769|96281|P5|COMPLETED|Period 2||1
42392|NCT01614769|96282|P4|COMPLETED|Period 2||0
42393|NCT01614769|96283|P3|COMPLETED|Period 2||2
42394|NCT01614769|96284|P2|COMPLETED|Period 2||1
42395|NCT01614769|96285|P1|COMPLETED|Period 2||1
42396|NCT01614769|96280|P6|STARTED|Period 2||1
42397|NCT01614769|96281|P5|STARTED|Period 2||1
42398|NCT01614769|96282|P4|STARTED|Period 2||0
42399|NCT01614769|96283|P3|STARTED|Period 2||2
42400|NCT01614769|96284|P2|STARTED|Period 2||1
42401|NCT01614769|96285|P1|STARTED|Period 2||1
42402|NCT01614769|96280|P6|NOT COMPLETED|7-Day Washout||0
42403|NCT01614769|96281|P5|NOT COMPLETED|7-Day Washout||0
42404|NCT01614769|96282|P4|NOT COMPLETED|7-Day Washout||0
42405|NCT01614769|96283|P3|NOT COMPLETED|7-Day Washout||0
42406|NCT01614769|96284|P2|NOT COMPLETED|7-Day Washout||0
42407|NCT01614769|96285|P1|NOT COMPLETED|7-Day Washout||0
42408|NCT01614769|96280|P6|COMPLETED|7-Day Washout||1
42409|NCT01614769|96281|P5|COMPLETED|7-Day Washout||1
42410|NCT01614769|96282|P4|COMPLETED|7-Day Washout||0
42411|NCT01614769|96283|P3|COMPLETED|7-Day Washout||2
42412|NCT01614769|96284|P2|COMPLETED|7-Day Washout||1
42413|NCT01614769|96285|P1|COMPLETED|7-Day Washout||1
42414|NCT01614769|96280|P6|STARTED|7-Day Washout||1
42415|NCT01614769|96281|P5|STARTED|7-Day Washout||1
42416|NCT01614769|96282|P4|STARTED|7-Day Washout||0
42417|NCT01614769|96283|P3|STARTED|7-Day Washout||2
42418|NCT01614769|96284|P2|STARTED|7-Day Washout||1
42419|NCT01614769|96285|P1|STARTED|7-Day Washout||1
42420|NCT01614769|96280|P6|NOT COMPLETED|Period 1||1
42421|NCT01614769|96281|P5|NOT COMPLETED|Period 1||0
42422|NCT01614769|96282|P4|NOT COMPLETED|Period 1||2
42423|NCT01614769|96283|P3|NOT COMPLETED|Period 1||0
42424|NCT01614769|96284|P2|NOT COMPLETED|Period 1||0
42425|NCT01614769|96285|P1|NOT COMPLETED|Period 1||1
42426|NCT01614769|96280|P6|COMPLETED|Period 1||1
42427|NCT01614769|96281|P5|COMPLETED|Period 1||1
42428|NCT01614769|96282|P4|COMPLETED|Period 1||0
42429|NCT01614769|96283|P3|COMPLETED|Period 1||2
42430|NCT01614769|96284|P2|COMPLETED|Period 1||1
42431|NCT01614769|96285|P1|COMPLETED|Period 1||1
42432|NCT01614769|96280|P6|STARTED|Period 1||2
42433|NCT01614769|96281|P5|STARTED|Period 1||1
42434|NCT01614769|96282|P4|STARTED|Period 1||2
42435|NCT01614769|96283|P3|STARTED|Period 1||2
42436|NCT01614769|96284|P2|STARTED|Period 1||1
42437|NCT01614769|96285|P1|STARTED|Period 1||2
42438|NCT01614613|96299|P1|NOT COMPLETED|Overall Study||0
42439|NCT01614613|96299|P1|COMPLETED|Overall Study||146
42440|NCT01614613|96299|P1|STARTED|Overall Study||146
42441|NCT01614600|96307|P1|NOT COMPLETED|Overall Study||4
42442|NCT01614600|96307|P1|COMPLETED|Overall Study||84
42443|NCT01614600|96307|P1|STARTED|Overall Study||88
42444|NCT01614574|96311|P1|NOT COMPLETED|Overall Study||0
42445|NCT01614574|96311|P1|COMPLETED|Overall Study||6
42446|NCT01614574|96311|P1|STARTED|Overall Study||6
42447|NCT01614509|96327|P2|NOT COMPLETED|Overall Study||3
42448|NCT01614509|96328|P1|NOT COMPLETED|Overall Study||1
42449|NCT01614509|96327|P2|COMPLETED|Overall Study||18
42450|NCT01614509|96328|P1|COMPLETED|Overall Study||23
42451|NCT01614509|96327|P2|STARTED|Overall Study||21
42452|NCT01614509|96328|P1|STARTED|Overall Study||24
42453|NCT01614470|96338|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
42454|NCT01614470|96339|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
42455|NCT01614470|96340|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
42456|NCT01614470|96338|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
42457|NCT01614470|96339|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
42458|NCT01614470|96340|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
42459|NCT01614470|96338|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
42460|NCT01614470|96339|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
42461|NCT01614470|96340|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
42462|NCT01614470|96338|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
42463|NCT01614470|96339|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
42464|NCT01614470|96340|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
42465|NCT01614470|96338|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
42466|NCT01614470|96339|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
42467|NCT01614470|96340|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
42468|NCT01614470|96338|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
42469|NCT01614470|96339|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
42470|NCT01614470|96340|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
42471|NCT01614470|96338|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
42472|NCT01614470|96339|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
42473|NCT01614470|96340|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
42474|NCT01614470|96338|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
42475|NCT01614470|96339|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
42476|NCT01614470|96340|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
42477|NCT01614470|96338|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
42478|NCT01614470|96339|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
42479|NCT01614470|96340|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
42480|NCT01614470|96338|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
42481|NCT01614470|96339|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
42482|NCT01614470|96340|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
42483|NCT01614470|96338|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
42484|NCT01614470|96339|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
42485|NCT01614470|96340|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
42486|NCT01614470|96338|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
42487|NCT01614470|96339|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
42488|NCT01614470|96340|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
42489|NCT01614457|96362|P2|NOT COMPLETED|Overall Study||0
42490|NCT01614457|96363|P1|NOT COMPLETED|Overall Study||2
42491|NCT01614457|96362|P2|COMPLETED|Overall Study||35
42492|NCT01614457|96363|P1|COMPLETED|Overall Study||32
42493|NCT01614457|96362|P2|STARTED|Overall Study||35
42494|NCT01614457|96363|P1|STARTED|Overall Study||34
42495|NCT01614249|96381|P2|NOT COMPLETED|Overall Study||23
42496|NCT01614249|96382|P1|NOT COMPLETED|Overall Study||11
42497|NCT01614249|96381|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
42498|NCT01614249|96382|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
42499|NCT01614249|96381|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
42500|NCT01614249|96382|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
42501|NCT01614249|96381|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
42502|NCT01614249|96382|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
42503|NCT01614249|96381|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
42504|NCT01614249|96382|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
42505|NCT01613599|96388|P1|NOT COMPLETED|Overall Study||97
42506|NCT01613599|96388|P1|COMPLETED|Overall Study||0
42507|NCT01613599|96388|P1|STARTED|Overall Study||97
42508|NCT01613417|96403|P2|NOT COMPLETED|Second Injection||0
42509|NCT01613417|96404|P1|NOT COMPLETED|Second Injection||0
42510|NCT01613417|96403|P2|COMPLETED|Second Injection||109
42511|NCT01613417|96404|P1|COMPLETED|Second Injection||100
42512|NCT01613417|96403|P2|STARTED|Second Injection||109
42513|NCT01613417|96404|P1|STARTED|Second Injection||100
42514|NCT01613417|96403|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
42515|NCT01613417|96404|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
42516|NCT01613417|96403|P2|COMPLETED|Washout (no Second Injection/MRI)||109
42517|NCT01613417|96404|P1|COMPLETED|Washout (no Second Injection/MRI)||100
42518|NCT01613417|96403|P2|STARTED|Washout (no Second Injection/MRI)||116
42519|NCT01613417|96404|P1|STARTED|Washout (no Second Injection/MRI)||113
42520|NCT01613417|96403|P2|NOT COMPLETED|First Injection||0
42521|NCT01613417|96404|P1|NOT COMPLETED|First Injection||0
42522|NCT01613417|96403|P2|COMPLETED|First Injection||116
42523|NCT01613417|96404|P1|COMPLETED|First Injection||113
42524|NCT01613417|96403|P2|STARTED|First Injection||116
42525|NCT01613417|96404|P1|STARTED|First Injection||113
42526|NCT01613378|96441|P1|NOT COMPLETED|Overall Study||39
42527|NCT01613378|96441|P1|COMPLETED|Overall Study||161
42528|NCT01613378|96441|P1|STARTED|Overall Study||200
42529|NCT01613339|96459|P2|NOT COMPLETED|Overall Study||1
42530|NCT01613339|96460|P1|NOT COMPLETED|Overall Study||3
42531|NCT01613339|96459|P2|COMPLETED|Overall Study||21
42532|NCT01613339|96460|P1|COMPLETED|Overall Study||21
42533|NCT01613339|96459|P2|STARTED|Overall Study||22
42534|NCT01613339|96460|P1|STARTED|Overall Study||24
42535|NCT01613326|96471|P2|NOT COMPLETED|Overall Study||14
42536|NCT01613326|96472|P1|NOT COMPLETED|Overall Study||13
42537|NCT01613326|96471|P2|COMPLETED|Overall Study||316
42538|NCT01613326|96472|P1|COMPLETED|Overall Study||314
42539|NCT01613326|96471|P2|STARTED|Overall Study||330
42540|NCT01613326|96472|P1|STARTED|Overall Study||327
42541|NCT01613313|96506|P4|NOT COMPLETED|Overall Study||0
42542|NCT01613313|96507|P3|NOT COMPLETED|Overall Study||0
42543|NCT01613313|96508|P2|NOT COMPLETED|Overall Study||0
42544|NCT01613313|96509|P1|NOT COMPLETED|Overall Study||0
42545|NCT01613313|96506|P4|COMPLETED|Overall Study||4
42546|NCT01613313|96507|P3|COMPLETED|Overall Study||4
42547|NCT01613313|96508|P2|COMPLETED|Overall Study||4
42548|NCT01613313|96509|P1|COMPLETED|Overall Study||2
42549|NCT01613313|96506|P4|STARTED|Overall Study||4
42550|NCT01613313|96507|P3|STARTED|Overall Study||4
42551|NCT01613313|96508|P2|STARTED|Overall Study||4
42552|NCT01613313|96509|P1|STARTED|Overall Study||2
42553|NCT01613248|96529|P6|NOT COMPLETED|Overall Study||38
42554|NCT01613248|96530|P5|NOT COMPLETED|Overall Study||35
42555|NCT01613248|96531|P4|NOT COMPLETED|Overall Study||38
42556|NCT01613248|96532|P3|NOT COMPLETED|Overall Study||33
42557|NCT01613248|96533|P2|NOT COMPLETED|Overall Study||34
42558|NCT01613248|96534|P1|NOT COMPLETED|Overall Study||29
42559|NCT01613248|96529|P6|COMPLETED|Overall Study||102
42560|NCT01613248|96530|P5|COMPLETED|Overall Study||104
42561|NCT01613248|96531|P4|COMPLETED|Overall Study||101
42562|NCT01613248|96532|P3|COMPLETED|Overall Study||106
42563|NCT01613248|96533|P2|COMPLETED|Overall Study||104
42564|NCT01613248|96534|P1|COMPLETED|Overall Study||110
42565|NCT01613248|96529|P6|STARTED|Overall Study||140
42566|NCT01613248|96530|P5|STARTED|Overall Study||139
42567|NCT01613248|96531|P4|STARTED|Overall Study||139
42568|NCT01613248|96532|P3|STARTED|Overall Study||139
42569|NCT01613248|96533|P2|STARTED|Overall Study||138
42570|NCT01613248|96534|P1|STARTED|Overall Study||139
42571|NCT01613131|96634|P2|NOT COMPLETED|Overall Study||5
42572|NCT01613131|96635|P1|NOT COMPLETED|Overall Study||3
42573|NCT01613131|96634|P2|COMPLETED|Overall Study||13
42574|NCT01613131|96635|P1|COMPLETED|Overall Study||17
42575|NCT01613131|96634|P2|STARTED|Overall Study||18
42576|NCT01613131|96635|P1|STARTED|Overall Study||20
42577|NCT01613027|96663|P1|NOT COMPLETED|Overall Study||8
42578|NCT01613027|96663|P1|COMPLETED|Overall Study||127
42579|NCT01613027|96663|P1|STARTED|Overall Study||135
42580|NCT01612858|96684|P2|NOT COMPLETED|Overall Study||1
42581|NCT01612858|96685|P1|NOT COMPLETED|Overall Study||5
42582|NCT01612858|96684|P2|COMPLETED|Overall Study||3
42583|NCT01612858|96685|P1|COMPLETED|Overall Study||11
42584|NCT01612858|96684|P2|STARTED|Overall Study||4
42585|NCT01612858|96685|P1|STARTED|Overall Study||16
42586|NCT01612702|96695|P2|NOT COMPLETED|Overall Study||11
42587|NCT01612702|96696|P1|NOT COMPLETED|Overall Study||11
42588|NCT01612702|96695|P2|COMPLETED|Overall Study||134
42589|NCT01612702|96696|P1|COMPLETED|Overall Study||135
42590|NCT01612702|96695|P2|STARTED|Overall Study||145
42591|NCT01612702|96696|P1|STARTED|Overall Study||146
42592|NCT01612676|96710|P4|NOT COMPLETED|Overall Study||3
42593|NCT01612676|96711|P3|NOT COMPLETED|Overall Study||1
42594|NCT01612676|96712|P2|NOT COMPLETED|Overall Study||4
42595|NCT01612676|96713|P1|NOT COMPLETED|Overall Study||2
42596|NCT01612676|96710|P4|COMPLETED|Overall Study||10
42597|NCT01612676|96711|P3|COMPLETED|Overall Study||4
42598|NCT01612676|96712|P2|COMPLETED|Overall Study||3
42599|NCT01612676|96713|P1|COMPLETED|Overall Study||4
42600|NCT01612676|96710|P4|Dosed|Overall Study||13
42601|NCT01612676|96711|P3|Dosed|Overall Study||5
42602|NCT01612676|96712|P2|Dosed|Overall Study||7
42603|NCT01612676|96713|P1|Dosed|Overall Study||5
42604|NCT01612676|96710|P4|STARTED|Overall Study||13
42605|NCT01612676|96711|P3|STARTED|Overall Study||5
42606|NCT01612676|96712|P2|STARTED|Overall Study||7
42607|NCT01612676|96713|P1|STARTED|Overall Study||6
42608|NCT01612494|96771|P2|NOT COMPLETED|Overall Study||0
42609|NCT01612494|96772|P1|NOT COMPLETED|Overall Study||0
42610|NCT01612494|96771|P2|COMPLETED|Overall Study||23
42611|NCT01612494|96772|P1|COMPLETED|Overall Study||21
42612|NCT01612494|96771|P2|STARTED|Overall Study||23
42613|NCT01612494|96772|P1|STARTED|Overall Study||21
42614|NCT01612156|96780|P2|NOT COMPLETED|Overall Study||0
42615|NCT01612156|96781|P1|NOT COMPLETED|Overall Study||2
42616|NCT01612156|96780|P2|COMPLETED|Overall Study||48
42617|NCT01612156|96781|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
42618|NCT01612156|96780|P2|STARTED|Overall Study||48
42619|NCT01612156|96781|P1|STARTED|Overall Study||42
42620|NCT01612000|96793|P4|NOT COMPLETED|Overall Study||10
42621|NCT01612000|96794|P3|NOT COMPLETED|Overall Study||7
42622|NCT01612000|96795|P2|NOT COMPLETED|Overall Study||5
42623|NCT01612000|96796|P1|NOT COMPLETED|Overall Study||9
42624|NCT01612000|96793|P4|COMPLETED|Overall Study||76
42625|NCT01612000|96794|P3|COMPLETED|Overall Study||78
42626|NCT01612000|96795|P2|COMPLETED|Overall Study||81
42627|NCT01612000|96796|P1|COMPLETED|Overall Study||75
42628|NCT01612000|96793|P4|STARTED|Overall Study||86
42629|NCT01612000|96794|P3|STARTED|Overall Study||85
42630|NCT01612000|96795|P2|STARTED|Overall Study||86
42631|NCT01612000|96796|P1|STARTED|Overall Study||84
42632|NCT01611974|96821|P3|NOT COMPLETED|Overall Study||16
42633|NCT01611974|96822|P2|NOT COMPLETED|Overall Study||15
42634|NCT01611974|96823|P1|NOT COMPLETED|Overall Study||15
42635|NCT01611974|96821|P3|COMPLETED|Overall Study||24
42636|NCT01611974|96822|P2|COMPLETED|Overall Study||25
42637|NCT01611974|96823|P1|COMPLETED|Overall Study||25
42638|NCT01611974|96821|P3|STARTED|Overall Study||40
42639|NCT01611974|96822|P2|STARTED|Overall Study||40
42640|NCT01611974|96823|P1|STARTED|Overall Study||40
42641|NCT01611883|96860|P2|NOT COMPLETED|Overall Study||1
42642|NCT01611883|96861|P1|NOT COMPLETED|Overall Study||1
42643|NCT01611883|96860|P2|COMPLETED|Overall Study||76
42644|NCT01611883|96861|P1|COMPLETED|Overall Study||74
42645|NCT01611883|96860|P2|STARTED|Overall Study||77
42646|NCT01611883|96861|P1|STARTED|Overall Study||75
42647|NCT01611857|96887|P2|NOT COMPLETED|Overall Study||2
42648|NCT01611857|96888|P1|NOT COMPLETED|Overall Study||0
42649|NCT01611857|96887|P2|COMPLETED|Overall Study||32
42650|NCT01611857|96888|P1|COMPLETED|Overall Study||15
42651|NCT01611857|96887|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
42652|NCT01611857|96888|P1|Tivantinib 360 mg|Overall Study||7
42653|NCT01611857|96887|P2|Tivantinib 240 mg|Overall Study||0
42654|NCT01611857|96888|P1|Tivantinib 240 mg|Overall Study||3
42655|NCT01611857|96887|P2|Tivantinib 120 mg|Overall Study||0
42656|NCT01611857|96888|P1|Tivantinib 120 mg|Overall Study||5
42657|NCT01611857|96887|P2|STARTED|Overall Study||34
42658|NCT01611857|96888|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
42659|NCT01611779|96898|P1|NOT COMPLETED|Overall Study||0
42660|NCT01611779|96898|P1|COMPLETED|Overall Study||5
42661|NCT01611779|96898|P1|STARTED|Overall Study||5
42662|NCT01611571|96910|P3|NOT COMPLETED|Overall Study||1
42663|NCT01611571|96911|P2|NOT COMPLETED|Overall Study||0
42664|NCT01611571|96912|P1|NOT COMPLETED|Overall Study||1
42665|NCT01611571|96910|P3|COMPLETED|Overall Study||9
42666|NCT01611571|96911|P2|COMPLETED|Overall Study||10
42667|NCT01611571|96912|P1|COMPLETED|Overall Study||10
42668|NCT01611571|96910|P3|STARTED|Overall Study||10
42669|NCT01611571|96911|P2|STARTED|Overall Study||10
42670|NCT01611571|96912|P1|STARTED|Overall Study||11
42671|NCT01611558|96932|P1|NOT COMPLETED|Maintenance Phase||2
42672|NCT01611558|96932|P1|COMPLETED|Maintenance Phase||0
42673|NCT01611558|96932|P1|STARTED|Maintenance Phase||2
42674|NCT01611558|96932|P1|NOT COMPLETED|Induction Phase||38
42675|NCT01611558|96932|P1|COMPLETED|Induction Phase||2
42676|NCT01611558|96932|P1|STARTED|Induction Phase||40
42677|NCT01610791|96938|P1|NOT COMPLETED|Overall Study||21
42678|NCT01610791|96938|P1|COMPLETED|Overall Study||100
42679|NCT01610791|96938|P1|STARTED|Overall Study||121
42680|NCT01610713|96961|P2|NOT COMPLETED|Overall Study||1
42681|NCT01610713|96962|P1|NOT COMPLETED|Overall Study||6
42682|NCT01610713|96961|P2|COMPLETED|Overall Study||76
42683|NCT01610713|96962|P1|COMPLETED|Overall Study||71
42684|NCT01610713|96961|P2|STARTED|Overall Study||77
42685|NCT01610713|96962|P1|STARTED|Overall Study||77
42686|NCT01610700|97020|P2|NOT COMPLETED|Overall Study||3
42687|NCT01610700|97021|P1|NOT COMPLETED|Overall Study||3
42688|NCT01610700|97020|P2|COMPLETED|Overall Study||77
42689|NCT01610700|97021|P1|COMPLETED|Overall Study||77
42690|NCT01610700|97020|P2|STARTED|Overall Study||80
42691|NCT01610700|97021|P1|STARTED|Overall Study||80
42692|NCT01610687|97075|P1|NOT COMPLETED|Overall Study||67
42693|NCT01610687|97075|P1|COMPLETED|Overall Study||70
42694|NCT01610687|97075|P1|STARTED|Overall Study||137
42695|NCT01610596|97088|P2|NOT COMPLETED|Overall Study||1
42696|NCT01610596|97089|P1|NOT COMPLETED|Overall Study||0
42697|NCT01610596|97088|P2|COMPLETED|Overall Study||35
42698|NCT01610596|97089|P1|COMPLETED|Overall Study||36
42699|NCT01610596|97088|P2|STARTED|Overall Study||36
42700|NCT01610596|97089|P1|STARTED|Overall Study||36
42701|NCT01610570|97105|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42702|NCT01610570|97106|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42703|NCT01610570|97107|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42704|NCT01610570|97108|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42705|NCT01610570|97105|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42706|NCT01610570|97106|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42707|NCT01610570|97107|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42708|NCT01610570|97108|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
42709|NCT01610570|97105|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
42710|NCT01610570|97106|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
42711|NCT01610570|97107|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
42712|NCT01610570|97108|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
42713|NCT01610570|97105|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42714|NCT01610570|97106|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42715|NCT01610570|97107|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42716|NCT01610570|97108|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42717|NCT01610570|97105|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
42718|NCT01610570|97106|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42719|NCT01610570|97107|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42720|NCT01610570|97108|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
42721|NCT01610570|97105|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
42722|NCT01610570|97106|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
42723|NCT01610570|97107|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
42724|NCT01610570|97108|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
42725|NCT01610570|97105|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42726|NCT01610570|97106|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42727|NCT01610570|97107|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42728|NCT01610570|97108|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42729|NCT01610570|97105|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42730|NCT01610570|97106|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42731|NCT01610570|97107|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
42732|NCT01610570|97108|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
42733|NCT01610570|97105|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
42734|NCT01610570|97106|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
42735|NCT01610570|97107|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
42736|NCT01610570|97108|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
42737|NCT01610557|97126|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
42738|NCT01610557|97127|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
42739|NCT01610557|97128|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
42740|NCT01610557|97129|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
42741|NCT01610557|97130|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
42742|NCT01610557|97126|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
42743|NCT01610557|97127|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42744|NCT01610557|97128|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42745|NCT01610557|97129|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42746|NCT01610557|97130|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42747|NCT01610557|97126|P5|STARTED|Post-36-Week Extension Phase||55
42748|NCT01610557|97127|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42749|NCT01610557|97128|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42750|NCT01610557|97129|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42751|NCT01610557|97130|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
42752|NCT01610557|97126|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
42753|NCT01610557|97127|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
42754|NCT01610557|97128|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
42755|NCT01610557|97129|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
42756|NCT01610557|97130|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
42757|NCT01610557|97126|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
42758|NCT01610557|97127|P4|COMPLETED|36-Week Randomized Crossover Phase||13
42759|NCT01610557|97128|P3|COMPLETED|36-Week Randomized Crossover Phase||14
42760|NCT01610557|97129|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
42761|NCT01610557|97130|P1|COMPLETED|36-Week Randomized Crossover Phase||16
42762|NCT01610557|97126|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
42763|NCT01610557|97127|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
42764|NCT01610557|97128|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
42765|NCT01610557|97129|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
42766|NCT01610557|97130|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
42767|NCT01610492|97143|P1|NOT COMPLETED|Overall Study||3
42768|NCT01610492|97143|P1|COMPLETED|Overall Study||11
42769|NCT01610492|97143|P1|STARTED|Overall Study||14
42770|NCT01610453|97150|P1|NOT COMPLETED|Overall Study||0
42771|NCT01610453|97150|P1|COMPLETED|Overall Study||150
42772|NCT01610453|97150|P1|STARTED|Overall Study||150
42773|NCT01610297|97155|P1|NOT COMPLETED|Overall Study||1
42774|NCT01610297|97155|P1|COMPLETED|Overall Study||26
42775|NCT01610297|97155|P1|STARTED|Overall Study||27
42776|NCT01610167|97166|P3|NOT COMPLETED|Overall Study||2
42777|NCT01610167|97167|P2|NOT COMPLETED|Overall Study||0
42778|NCT01610167|97168|P1|NOT COMPLETED|Overall Study||0
42779|NCT01610167|97166|P3|COMPLETED|Overall Study||48
42780|NCT01610167|97167|P2|COMPLETED|Overall Study||49
42781|NCT01610167|97168|P1|COMPLETED|Overall Study||52
42782|NCT01610167|97166|P3|STARTED|Overall Study||50
42783|NCT01610167|97167|P2|STARTED|Overall Study||49
42784|NCT01610167|97168|P1|STARTED|Overall Study||52
42785|NCT01610076|97190|P2|NOT COMPLETED|Overall Study||5
42786|NCT01610076|97191|P1|NOT COMPLETED|Overall Study||3
42787|NCT01610076|97190|P2|COMPLETED|Overall Study||100
42788|NCT01610076|97191|P1|COMPLETED|Overall Study||100
42789|NCT01610076|97190|P2|STARTED|Overall Study||105
42790|NCT01610076|97191|P1|STARTED|Overall Study||103
42791|NCT01610037|97203|P3|NOT COMPLETED|Treatment and Follow up Period||26
42792|NCT01610037|97204|P2|NOT COMPLETED|Treatment and Follow up Period||28
42793|NCT01610037|97205|P1|NOT COMPLETED|Treatment and Follow up Period||25
42794|NCT01610037|97203|P3|COMPLETED|Treatment and Follow up Period||378
42795|NCT01610037|97204|P2|COMPLETED|Treatment and Follow up Period||377
42796|NCT01610037|97205|P1|COMPLETED|Treatment and Follow up Period||382
42797|NCT01610037|97203|P3|STARTED|Treatment and Follow up Period||404
42798|NCT01610037|97204|P2|STARTED|Treatment and Follow up Period||405
42799|NCT01610037|97205|P1|STARTED|Treatment and Follow up Period||407
42800|NCT01610037|97203|P3|NOT COMPLETED|All Patients||84
42801|NCT01610037|97204|P2|NOT COMPLETED|All Patients||51
42802|NCT01610037|97205|P1|NOT COMPLETED|All Patients||59
42803|NCT01610037|97203|P3|COMPLETED|All Patients||320
42804|NCT01610037|97204|P2|COMPLETED|All Patients||354
42805|NCT01610037|97205|P1|COMPLETED|All Patients||348
42806|NCT01610037|97203|P3|Full Analysis Set (FAS)|All Patients||403
42807|NCT01610037|97204|P2|Full Analysis Set (FAS)|All Patients||405
42808|NCT01610037|97205|P1|Full Analysis Set (FAS)|All Patients||407
42809|NCT01610037|97203|P3|Randomized Set (RAN)|All Patients||404
42810|NCT01610037|97204|P2|Randomized Set (RAN)|All Patients||405
42811|NCT01610037|97205|P1|Randomized Set (RAN)|All Patients||407
42812|NCT01610037|97203|P3|STARTED|All Patients||404
42813|NCT01610037|97204|P2|STARTED|All Patients||405
42814|NCT01610037|97205|P1|STARTED|All Patients||407
42815|NCT01610011|97248|P2|NOT COMPLETED|Overall Study||0
42816|NCT01610011|97249|P1|NOT COMPLETED|Overall Study||10
42817|NCT01610011|97248|P2|COMPLETED|Overall Study||2
42818|NCT01610011|97249|P1|COMPLETED|Overall Study||9
42819|NCT01610011|97248|P2|STARTED|Overall Study||2
42820|NCT01610011|97249|P1|STARTED|Overall Study||19
42821|NCT01609582|97257|P2|NOT COMPLETED|Overall Study||1604
42822|NCT01609582|97258|P1|NOT COMPLETED|Overall Study||1603
42823|NCT01609582|97257|P2|COMPLETED|Overall Study||0
42824|NCT01609582|97258|P1|COMPLETED|Overall Study||0
42825|NCT01609582|97257|P2|Treated|Overall Study||1601
42826|NCT01609582|97258|P1|Treated|Overall Study||1603
42827|NCT01609582|97257|P2|STARTED|Overall Study||1604
42828|NCT01609582|97258|P1|STARTED|Overall Study||1603
42829|NCT01609543|97266|P1|NOT COMPLETED|Overall Study||42
42830|NCT01609543|97266|P1|COMPLETED|Overall Study||20
42831|NCT01609543|97266|P1|STARTED|Overall Study||62
42832|NCT01609478|97275|P3|NOT COMPLETED|Overall Study||9
42833|NCT01609478|97276|P2|NOT COMPLETED|Overall Study||2
42834|NCT01609478|97277|P1|NOT COMPLETED|Overall Study||7
42835|NCT01609478|97275|P3|COMPLETED|Overall Study||107
42836|NCT01609478|97276|P2|COMPLETED|Overall Study||106
42837|NCT01609478|97277|P1|COMPLETED|Overall Study||104
42838|NCT01609478|97275|P3|Full Analysis Set (FAS)|Overall Study||115
42839|NCT01609478|97276|P2|Full Analysis Set (FAS)|Overall Study||108
42840|NCT01609478|97277|P1|Full Analysis Set (FAS)|Overall Study||110
42841|NCT01609478|97275|P3|STARTED|Overall Study||116
42842|NCT01609478|97276|P2|STARTED|Overall Study||108
42843|NCT01609478|97277|P1|STARTED|Overall Study||111
42844|NCT01609257|97343|P2|NOT COMPLETED|Overall Study||8
42845|NCT01609257|97344|P1|NOT COMPLETED|Overall Study||6
42846|NCT01609257|97343|P2|COMPLETED|Overall Study||57
42847|NCT01609257|97344|P1|COMPLETED|Overall Study||61
42848|NCT01609257|97343|P2|Received Challenge Product|Overall Study||53
42849|NCT01609257|97344|P1|Received Challenge Product|Overall Study||56
42850|NCT01609257|97343|P2|Received 2 Doses|Overall Study||64
42851|NCT01609257|97344|P1|Received 2 Doses|Overall Study||63
42852|NCT01609257|97343|P2|STARTED|Overall Study||65
42853|NCT01609257|97344|P1|STARTED|Overall Study||67
42854|NCT01609062|97416|P2|NOT COMPLETED|Extension Phase||10
42855|NCT01609062|97417|P1|NOT COMPLETED|Extension Phase||15
42856|NCT01609062|97416|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
42857|NCT01609062|97417|P1|COMPLETED|Extension Phase||0
42858|NCT01609062|97416|P2|STARTED|Extension Phase||10
42859|NCT01609062|97417|P1|STARTED|Extension Phase||15
42860|NCT01609062|97416|P2|NOT COMPLETED|Primary Phase||0
42861|NCT01609062|97417|P1|NOT COMPLETED|Primary Phase||0
42862|NCT01609062|97416|P2|COMPLETED|Primary Phase||10
42863|NCT01609062|97417|P1|COMPLETED|Primary Phase||15
42864|NCT01609062|97416|P2|STARTED|Primary Phase||10
42865|NCT01609062|97417|P1|STARTED|Primary Phase||15
42866|NCT01609010|97462|P2|NOT COMPLETED|Overall Study||37
42867|NCT01609010|97463|P1|NOT COMPLETED|Overall Study||43
42868|NCT01609010|97462|P2|COMPLETED|Overall Study||120
42869|NCT01609010|97463|P1|COMPLETED|Overall Study||113
42870|NCT01609010|97462|P2|Entering Cycle 2|Overall Study||124
42871|NCT01609010|97463|P1|Entering Cycle 2|Overall Study||120
42872|NCT01609010|97462|P2|STARTED|Overall Study||157
42873|NCT01609010|97463|P1|STARTED|Overall Study||156
42874|NCT01608971|97489|P2|NOT COMPLETED|Overall Study||0
42875|NCT01608971|97490|P1|NOT COMPLETED|Overall Study||0
42876|NCT01608971|97489|P2|COMPLETED|Overall Study||15
42877|NCT01608971|97490|P1|COMPLETED|Overall Study||15
42878|NCT01608971|97489|P2|STARTED|Overall Study||15
42879|NCT01608971|97490|P1|STARTED|Overall Study||15
42880|NCT01608815|97505|P3|NOT COMPLETED|Overall Study||0
42881|NCT01608815|97506|P2|NOT COMPLETED|Overall Study||0
42882|NCT01608815|97507|P1|NOT COMPLETED|Overall Study||0
42883|NCT01608815|97505|P3|COMPLETED|Overall Study||5
42884|NCT01608815|97506|P2|COMPLETED|Overall Study||7
42885|NCT01608815|97507|P1|COMPLETED|Overall Study||188
42886|NCT01608815|97505|P3|STARTED|Overall Study||5
42887|NCT01608815|97506|P2|STARTED|Overall Study||7
42888|NCT01608815|97507|P1|STARTED|Overall Study||188
42889|NCT01608724|97524|P1|NOT COMPLETED|Overall Study||243
42890|NCT01608724|97524|P1|COMPLETED|Overall Study||1180
42891|NCT01608724|97524|P1|Treated|Overall Study||1361
42892|NCT01608724|97524|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
42893|NCT01608672|97531|P1|NOT COMPLETED|Overall Study||0
42894|NCT01608672|97531|P1|COMPLETED|Overall Study||207
42895|NCT01608672|97531|P1|STARTED|Overall Study||207
42896|NCT01608659|97537|P1|NOT COMPLETED|Overall Study||16
42897|NCT01608659|97537|P1|COMPLETED|Overall Study||94
42898|NCT01608659|97537|P1|STARTED|Overall Study||110
42899|NCT01608308|97545|P2|NOT COMPLETED|Overall Study||2
42900|NCT01608308|97546|P1|NOT COMPLETED|Overall Study||0
42901|NCT01608308|97545|P2|COMPLETED|Overall Study||29
42902|NCT01608308|97546|P1|COMPLETED|Overall Study||31
42903|NCT01608308|97545|P2|STARTED|Overall Study||31
42904|NCT01608308|97546|P1|STARTED|Overall Study||31
42905|NCT01608100|97568|P1|NOT COMPLETED|Overall Study||0
42906|NCT01608100|97568|P1|COMPLETED|Overall Study||1101
42907|NCT01608100|97568|P1|STARTED|Overall Study||1101
42908|NCT01607853|97592|P1|NOT COMPLETED|Overall Study||0
42909|NCT01607853|97592|P1|COMPLETED|Overall Study||24
42910|NCT01607853|97592|P1|STARTED|Overall Study||24
42911|NCT01607593|97699|P1|NOT COMPLETED|Overall Study||93
42912|NCT01607593|97699|P1|COMPLETED|Overall Study||29
42913|NCT01607593|97699|P1|STARTED|Overall Study||122
42914|NCT01607476|97708|P3|NOT COMPLETED|Overall Study||3
42915|NCT01607476|97709|P2|NOT COMPLETED|Overall Study||0
42916|NCT01607476|97710|P1|NOT COMPLETED|Overall Study||1
42917|NCT01607476|97708|P3|COMPLETED|Overall Study||30
42918|NCT01607476|97709|P2|COMPLETED|Overall Study||30
42919|NCT01607476|97710|P1|COMPLETED|Overall Study||24
42920|NCT01607476|97708|P3|STARTED|Overall Study||33
42921|NCT01607476|97709|P2|STARTED|Overall Study||30
42922|NCT01607476|97710|P1|STARTED|Overall Study||25
42923|NCT01607450|97728|P7|NOT COMPLETED|Overall Study||0
42924|NCT01607450|97729|P6|NOT COMPLETED|Overall Study||0
42925|NCT01607450|97730|P5|NOT COMPLETED|Overall Study||0
42926|NCT01607450|97731|P4|NOT COMPLETED|Overall Study||0
42927|NCT01607450|97732|P3|NOT COMPLETED|Overall Study||0
42928|NCT01607450|97733|P2|NOT COMPLETED|Overall Study||0
42929|NCT01607450|97734|P1|NOT COMPLETED|Overall Study||0
42930|NCT01607450|97728|P7|COMPLETED|Overall Study||0
42931|NCT01607450|97729|P6|COMPLETED|Overall Study||0
42932|NCT01607450|97730|P5|COMPLETED|Overall Study||1
42933|NCT01607450|97731|P4|COMPLETED|Overall Study||11
42934|NCT01607450|97732|P3|COMPLETED|Overall Study||7
42935|NCT01607450|97733|P2|COMPLETED|Overall Study||8
42936|NCT01607450|97734|P1|COMPLETED|Overall Study||6
42937|NCT01607450|97728|P7|STARTED|Overall Study||0
42938|NCT01607450|97729|P6|STARTED|Overall Study||0
42939|NCT01607450|97730|P5|STARTED|Overall Study||1
42940|NCT01607450|97731|P4|STARTED|Overall Study||11
42941|NCT01607450|97732|P3|STARTED|Overall Study||7
42942|NCT01607450|97733|P2|STARTED|Overall Study||8
42943|NCT01607450|97734|P1|STARTED|Overall Study||6
42944|NCT01607411|97778|P4|NOT COMPLETED|Period IV||0
42945|NCT01607411|97779|P3|NOT COMPLETED|Period IV||0
42946|NCT01607411|97780|P2|NOT COMPLETED|Period IV||0
42947|NCT01607411|97781|P1|NOT COMPLETED|Period IV||0
42948|NCT01607411|97778|P4|COMPLETED|Period IV||14
42949|NCT01607411|97779|P3|COMPLETED|Period IV||14
42950|NCT01607411|97780|P2|COMPLETED|Period IV||14
42951|NCT01607411|97781|P1|COMPLETED|Period IV||13
42952|NCT01607411|97778|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
42953|NCT01607411|97779|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
42954|NCT01607411|97780|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
42955|NCT01607411|97781|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
42956|NCT01607411|97778|P4|NOT COMPLETED|Period III||0
42957|NCT01607411|97779|P3|NOT COMPLETED|Period III||0
42958|NCT01607411|97780|P2|NOT COMPLETED|Period III||0
42959|NCT01607411|97781|P1|NOT COMPLETED|Period III||0
42960|NCT01607411|97778|P4|COMPLETED|Period III||13
42961|NCT01607411|97779|P3|COMPLETED|Period III||14
42962|NCT01607411|97780|P2|COMPLETED|Period III||14
42963|NCT01607411|97781|P1|COMPLETED|Period III||14
42964|NCT01607411|97778|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
42965|NCT01607411|97779|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
42966|NCT01607411|97780|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
42967|NCT01607411|97781|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
42968|NCT01607411|97778|P4|NOT COMPLETED|Period II||0
42969|NCT01607411|97779|P3|NOT COMPLETED|Period II||0
42970|NCT01607411|97780|P2|NOT COMPLETED|Period II||0
42971|NCT01607411|97781|P1|NOT COMPLETED|Period II||0
42972|NCT01607411|97778|P4|COMPLETED|Period II||14
42973|NCT01607411|97779|P3|COMPLETED|Period II||13
42974|NCT01607411|97780|P2|COMPLETED|Period II||14
42975|NCT01607411|97781|P1|COMPLETED|Period II||14
42976|NCT01607411|97778|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
42977|NCT01607411|97779|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
42978|NCT01607411|97780|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
42979|NCT01607411|97781|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
42980|NCT01607411|97778|P4|NOT COMPLETED|Period I||0
42981|NCT01607411|97779|P3|NOT COMPLETED|Period I||0
42982|NCT01607411|97780|P2|NOT COMPLETED|Period I||0
42983|NCT01607411|97781|P1|NOT COMPLETED|Period I||0
42984|NCT01607411|97778|P4|COMPLETED|Period I||14
42985|NCT01607411|97779|P3|COMPLETED|Period I||14
42986|NCT01607411|97780|P2|COMPLETED|Period I||13
42987|NCT01607411|97781|P1|COMPLETED|Period I||14
42988|NCT01607411|97778|P4|STARTED|Period I||14
42989|NCT01607411|97779|P3|STARTED|Period I||14
42990|NCT01607411|97780|P2|STARTED|Period I||13
42991|NCT01607411|97781|P1|STARTED|Period I||14
42992|NCT01607398|97804|P2|NOT COMPLETED|Overall Study||2
42993|NCT01607398|97805|P1|NOT COMPLETED|Overall Study||2
42994|NCT01607398|97804|P2|COMPLETED|Overall Study||26
42995|NCT01607398|97805|P1|COMPLETED|Overall Study||26
42996|NCT01607398|97804|P2|STARTED|Overall Study||28
42997|NCT01607398|97805|P1|STARTED|Overall Study||28
42998|NCT01607320|97849|P2|NOT COMPLETED|Overall Study||0
42999|NCT01607320|97850|P1|NOT COMPLETED|Overall Study||0
43000|NCT01607320|97849|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
43001|NCT01607320|97850|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
43002|NCT01607320|97849|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
43003|NCT01607320|97850|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
43004|NCT01607203|97856|P2|NOT COMPLETED|Overall Study||0
43005|NCT01607203|97857|P1|NOT COMPLETED|Overall Study||0
43006|NCT01607203|97856|P2|COMPLETED|Overall Study||61
43007|NCT01607203|97857|P1|COMPLETED|Overall Study||59
43008|NCT01607203|97856|P2|STARTED|Overall Study||61
43009|NCT01607203|97857|P1|STARTED|Overall Study||59
43010|NCT01607112|97869|P2|NOT COMPLETED|Overall Study||0
43011|NCT01607112|97870|P1|NOT COMPLETED|Overall Study||0
43012|NCT01607112|97869|P2|COMPLETED|Overall Study||59
43013|NCT01607112|97870|P1|COMPLETED|Overall Study||60
43014|NCT01607112|97869|P2|STARTED|Overall Study||59
43015|NCT01607112|97870|P1|STARTED|Overall Study||60
43016|NCT01606800|97906|P2|NOT COMPLETED|Overall Study||2
43017|NCT01606800|97907|P1|NOT COMPLETED|Overall Study||5
43018|NCT01606800|97906|P2|COMPLETED|Overall Study||21
43019|NCT01606800|97907|P1|COMPLETED|Overall Study||17
43020|NCT01606800|97906|P2|Treated|Overall Study||23
43021|NCT01606800|97907|P1|Treated|Overall Study||22
43022|NCT01606800|97906|P2|STARTED|Overall Study||23
43023|NCT01606800|97907|P1|STARTED|Overall Study||22
43024|NCT01606748|97915|P2|NOT COMPLETED|Overall Study||11
43025|NCT01606748|97916|P1|NOT COMPLETED|Overall Study||5
43026|NCT01606748|97915|P2|COMPLETED|Overall Study||6
43027|NCT01606748|97916|P1|COMPLETED|Overall Study||13
43028|NCT01606748|97915|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
43029|NCT01606748|97916|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
43030|NCT01606748|97915|P2|STARTED|Overall Study||17
43031|NCT01606748|97916|P1|STARTED|Overall Study||18
43032|NCT01606735|97947|P3|NOT COMPLETED|Overall Study||0
43033|NCT01606735|97948|P2|NOT COMPLETED|Overall Study||0
43034|NCT01606735|97949|P1|NOT COMPLETED|Overall Study||0
43035|NCT01606735|97947|P3|COMPLETED|Overall Study||58
43036|NCT01606735|97948|P2|COMPLETED|Overall Study||56
43037|NCT01606735|97949|P1|COMPLETED|Overall Study||58
43038|NCT01606735|97947|P3|STARTED|Overall Study||58
43039|NCT01606735|97948|P2|STARTED|Overall Study||56
43040|NCT01606735|97949|P1|STARTED|Overall Study||58
43041|NCT01606670|97957|P1|NOT COMPLETED|Overall Study||16
43042|NCT01606670|97957|P1|COMPLETED|Overall Study||77
43043|NCT01606670|97957|P1|Full Analysis Set|Overall Study||70
43044|NCT01606670|97957|P1|Safety Set|Overall Study||93
43045|NCT01606670|97957|P1|STARTED|Overall Study||93
43046|NCT01606319|97967|P2|NOT COMPLETED|Overall Study||40
43047|NCT01606319|97968|P1|NOT COMPLETED|Overall Study||34
43048|NCT01606319|97967|P2|COMPLETED|Overall Study||110
43049|NCT01606319|97968|P1|COMPLETED|Overall Study||116
43050|NCT01606319|97967|P2|STARTED|Overall Study||150
43051|NCT01606319|97968|P1|STARTED|Overall Study||150
43052|NCT01606254|97984|P4|NOT COMPLETED|Overall Study||3
43053|NCT01606254|97985|P3|NOT COMPLETED|Overall Study||0
43054|NCT01606254|97986|P2|NOT COMPLETED|Overall Study||4
43055|NCT01606254|97987|P1|NOT COMPLETED|Overall Study||2
43056|NCT01606254|97984|P4|COMPLETED|Overall Study||11
43057|NCT01606254|97985|P3|COMPLETED|Overall Study||14
43058|NCT01606254|97986|P2|COMPLETED|Overall Study||10
43059|NCT01606254|97987|P1|COMPLETED|Overall Study||12
43060|NCT01606254|97984|P4|STARTED|Overall Study||14
43061|NCT01606254|97985|P3|STARTED|Overall Study||14
43062|NCT01606254|97986|P2|STARTED|Overall Study||14
43063|NCT01606254|97987|P1|STARTED|Overall Study||14
43064|NCT01606228|98069|P1|NOT COMPLETED|Overall Study||29
43065|NCT01606228|98069|P1|COMPLETED|Overall Study||159
43066|NCT01606228|98069|P1|STARTED|Overall Study||188
43067|NCT01606202|98086|P2|NOT COMPLETED|Overall Study||3
43068|NCT01606202|98087|P1|NOT COMPLETED|Overall Study||7
43069|NCT01606202|98086|P2|COMPLETED|Overall Study||57
43070|NCT01606202|98087|P1|COMPLETED|Overall Study||49
43071|NCT01606202|98086|P2|STARTED|Overall Study||60
43072|NCT01606202|98087|P1|STARTED|Overall Study||56
43073|NCT01606189|98119|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
43074|NCT01606189|98120|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
43075|NCT01606189|98121|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
43076|NCT01606189|98122|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
43077|NCT01606189|98123|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
43078|NCT01606189|98124|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
43079|NCT01606189|98119|P6|COMPLETED|Third Intenvention (14-20 Days)||6
43080|NCT01606189|98120|P5|COMPLETED|Third Intenvention (14-20 Days)||8
43081|NCT01606189|98121|P4|COMPLETED|Third Intenvention (14-20 Days)||8
43082|NCT01606189|98122|P3|COMPLETED|Third Intenvention (14-20 Days)||8
43083|NCT01606189|98123|P2|COMPLETED|Third Intenvention (14-20 Days)||8
43084|NCT01606189|98124|P1|COMPLETED|Third Intenvention (14-20 Days)||8
43085|NCT01606189|98119|P6|STARTED|Third Intenvention (14-20 Days)||7
43086|NCT01606189|98120|P5|STARTED|Third Intenvention (14-20 Days)||8
43087|NCT01606189|98121|P4|STARTED|Third Intenvention (14-20 Days)||8
43088|NCT01606189|98122|P3|STARTED|Third Intenvention (14-20 Days)||8
43089|NCT01606189|98123|P2|STARTED|Third Intenvention (14-20 Days)||8
43090|NCT01606189|98124|P1|STARTED|Third Intenvention (14-20 Days)||8
43091|NCT01606189|98119|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
43092|NCT01606189|98120|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
43093|NCT01606189|98121|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
43094|NCT01606189|98122|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
43095|NCT01606189|98123|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
43096|NCT01606189|98124|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
43097|NCT01606189|98119|P6|COMPLETED|Second Intenvention (14-20 Days)||7
43098|NCT01606189|98120|P5|COMPLETED|Second Intenvention (14-20 Days)||8
43099|NCT01606189|98121|P4|COMPLETED|Second Intenvention (14-20 Days)||8
43100|NCT01606189|98122|P3|COMPLETED|Second Intenvention (14-20 Days)||8
43101|NCT01606189|98123|P2|COMPLETED|Second Intenvention (14-20 Days)||8
43102|NCT01606189|98124|P1|COMPLETED|Second Intenvention (14-20 Days)||8
43103|NCT01606189|98119|P6|STARTED|Second Intenvention (14-20 Days)||8
43104|NCT01606189|98120|P5|STARTED|Second Intenvention (14-20 Days)||8
43105|NCT01606189|98121|P4|STARTED|Second Intenvention (14-20 Days)||8
43106|NCT01606189|98122|P3|STARTED|Second Intenvention (14-20 Days)||8
43107|NCT01606189|98123|P2|STARTED|Second Intenvention (14-20 Days)||8
43108|NCT01606189|98124|P1|STARTED|Second Intenvention (14-20 Days)||8
43109|NCT01606189|98119|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
43110|NCT01606189|98120|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
43111|NCT01606189|98121|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
43112|NCT01606189|98122|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
43113|NCT01606189|98123|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
43114|NCT01606189|98124|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
43115|NCT01606189|98119|P6|COMPLETED|First Intenvention (14-20 Days)||8
43116|NCT01606189|98120|P5|COMPLETED|First Intenvention (14-20 Days)||8
43117|NCT01606189|98121|P4|COMPLETED|First Intenvention (14-20 Days)||8
43118|NCT01606189|98122|P3|COMPLETED|First Intenvention (14-20 Days)||8
43119|NCT01606189|98123|P2|COMPLETED|First Intenvention (14-20 Days)||8
43120|NCT01606189|98124|P1|COMPLETED|First Intenvention (14-20 Days)||8
43121|NCT01606189|98119|P6|STARTED|First Intenvention (14-20 Days)||8
43122|NCT01606189|98120|P5|STARTED|First Intenvention (14-20 Days)||8
43123|NCT01606189|98121|P4|STARTED|First Intenvention (14-20 Days)||8
43124|NCT01606189|98122|P3|STARTED|First Intenvention (14-20 Days)||8
43125|NCT01606189|98123|P2|STARTED|First Intenvention (14-20 Days)||8
43126|NCT01606189|98124|P1|STARTED|First Intenvention (14-20 Days)||8
43127|NCT01606176|98158|P2|NOT COMPLETED|Overall Study||3
43128|NCT01606176|98159|P1|NOT COMPLETED|Overall Study||4
43129|NCT01606176|98158|P2|COMPLETED|Overall Study||31
43130|NCT01606176|98159|P1|COMPLETED|Overall Study||32
43131|NCT01606176|98158|P2|STARTED|Overall Study||34
43132|NCT01606176|98159|P1|STARTED|Overall Study||36
43133|NCT01606150|98195|P2|NOT COMPLETED|Overall Study||0
43134|NCT01606150|98196|P1|NOT COMPLETED|Overall Study||0
43135|NCT01606150|98195|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
43136|NCT01606150|98196|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
43137|NCT01606150|98195|P2|STARTED|Overall Study||0
43138|NCT01606150|98196|P1|STARTED|Overall Study||0
43139|NCT01606137|98204|P1|NOT COMPLETED|Overall Study||262
43140|NCT01606137|98204|P1|COMPLETED|Overall Study||245
43141|NCT01606137|98204|P1|STARTED|Overall Study||507
43142|NCT01606007|98227|P3|NOT COMPLETED|Overall Study||10
43143|NCT01606007|98228|P2|NOT COMPLETED|Overall Study||19
43144|NCT01606007|98229|P1|NOT COMPLETED|Overall Study||15
43145|NCT01606007|98227|P3|COMPLETED|Overall Study||169
43146|NCT01606007|98228|P2|COMPLETED|Overall Study||160
43147|NCT01606007|98229|P1|COMPLETED|Overall Study||161
43148|NCT01606007|98227|P3|STARTED|Overall Study||179
43149|NCT01606007|98228|P2|STARTED|Overall Study||179
43150|NCT01606007|98229|P1|STARTED|Overall Study||176
43151|NCT01605942|98251|P2|NOT COMPLETED|Overall Study||0
43152|NCT01605942|98252|P1|NOT COMPLETED|Overall Study||0
43153|NCT01605942|98251|P2|COMPLETED|Overall Study||2
43154|NCT01605942|98252|P1|COMPLETED|Overall Study||6
43155|NCT01605942|98251|P2|STARTED|Overall Study||2
43156|NCT01605942|98252|P1|STARTED|Overall Study||6
43157|NCT01605916|98264|P5|NOT COMPLETED|Overall Study||6
43158|NCT01605916|98265|P4|NOT COMPLETED|Overall Study||6
43159|NCT01605916|98266|P3|NOT COMPLETED|Overall Study||3
43160|NCT01605916|98267|P2|NOT COMPLETED|Overall Study||4
43161|NCT01605916|98268|P1|NOT COMPLETED|Overall Study||4
43162|NCT01605916|98264|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
43163|NCT01605916|98265|P4|COMPLETED|Overall Study||0
43164|NCT01605916|98266|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
43165|NCT01605916|98267|P2|COMPLETED|Overall Study||0
43166|NCT01605916|98268|P1|COMPLETED|Overall Study||0
43167|NCT01605916|98264|P5|STARTED|Overall Study||7
43168|NCT01605916|98265|P4|STARTED|Overall Study||6
43169|NCT01605916|98266|P3|STARTED|Overall Study||4
43170|NCT01605916|98267|P2|STARTED|Overall Study||4
43171|NCT01605916|98268|P1|STARTED|Overall Study||4
43172|NCT01605877|98341|P1|NOT COMPLETED|Overall Study||1
43173|NCT01605877|98341|P1|COMPLETED|Overall Study||63
43174|NCT01605877|98341|P1|STARTED|Overall Study||64
43175|NCT01605825|98405|P2|NOT COMPLETED|Overall Study||3
43176|NCT01605825|98406|P1|NOT COMPLETED|Overall Study||10
43177|NCT01605825|98405|P2|COMPLETED|Overall Study||25
43178|NCT01605825|98406|P1|COMPLETED|Overall Study||45
43179|NCT01605825|98405|P2|STARTED|Overall Study||28
43180|NCT01605825|98406|P1|STARTED|Overall Study||55
43181|NCT01605799|98414|P2|NOT COMPLETED|Overall Study||1
43182|NCT01605799|98415|P1|NOT COMPLETED|Overall Study||2
43183|NCT01605799|98414|P2|COMPLETED|Overall Study||15
43184|NCT01605799|98415|P1|COMPLETED|Overall Study||15
43185|NCT01605799|98414|P2|STARTED|Overall Study||16
43186|NCT01605799|98415|P1|STARTED|Overall Study||17
43187|NCT01605669|98423|P1|NOT COMPLETED|Overall Study||0
43188|NCT01605669|98423|P1|COMPLETED|Overall Study||50
43189|NCT01605669|98423|P1|STARTED|Overall Study||50
43190|NCT01605617|98430|P2|NOT COMPLETED|Second Intervention||0
43191|NCT01605617|98431|P1|NOT COMPLETED|Second Intervention||0
43192|NCT01605617|98430|P2|COMPLETED|Second Intervention||0
43193|NCT01605617|98431|P1|COMPLETED|Second Intervention||0
43194|NCT01605617|98430|P2|STARTED|Second Intervention||0
43195|NCT01605617|98431|P1|STARTED|Second Intervention||0
43196|NCT01605617|98430|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
43197|NCT01605617|98431|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
43198|NCT01605617|98430|P2|COMPLETED|Washout Period of 4 Weeks||0
43199|NCT01605617|98431|P1|COMPLETED|Washout Period of 4 Weeks||0
43200|NCT01605617|98430|P2|STARTED|Washout Period of 4 Weeks||1
43201|NCT01605617|98431|P1|STARTED|Washout Period of 4 Weeks||2
43202|NCT01605617|98430|P2|NOT COMPLETED|First Intervention||1
43203|NCT01605617|98431|P1|NOT COMPLETED|First Intervention||0
43204|NCT01605617|98430|P2|COMPLETED|First Intervention||1
43205|NCT01605617|98431|P1|COMPLETED|First Intervention||2
43206|NCT01605617|98430|P2|STARTED|First Intervention||2
43207|NCT01605617|98431|P1|STARTED|First Intervention||2
43208|NCT01605552|98451|P2|NOT COMPLETED|Overall Study||2
43209|NCT01605552|98452|P1|NOT COMPLETED|Overall Study||6
43210|NCT01605552|98451|P2|COMPLETED|Overall Study||14
43211|NCT01605552|98452|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
43212|NCT01605552|98451|P2|STARTED|Overall Study||16
43213|NCT01605552|98452|P1|STARTED|Overall Study||13
43214|NCT01605539|98466|P3|NOT COMPLETED|Overall Study||0
43215|NCT01605539|98467|P2|NOT COMPLETED|Overall Study||1
43216|NCT01605539|98468|P1|NOT COMPLETED|Overall Study||0
43217|NCT01605539|98466|P3|COMPLETED|Overall Study||4
43218|NCT01605539|98467|P2|COMPLETED|Overall Study||2
43219|NCT01605539|98468|P1|COMPLETED|Overall Study||3
43220|NCT01605539|98466|P3|STARTED|Overall Study||4
43221|NCT01605539|98467|P2|STARTED|Overall Study||3
43222|NCT01605539|98468|P1|STARTED|Overall Study||3
43223|NCT01605461|98490|P1|NOT COMPLETED|Overall Study||4
43224|NCT01605461|98490|P1|COMPLETED|Overall Study||8
43225|NCT01605461|98490|P1|STARTED|Overall Study||12
43226|NCT01605370|98501|P2|NOT COMPLETED|Overall Study||0
43227|NCT01605370|98502|P1|NOT COMPLETED|Overall Study||1
43228|NCT01605370|98501|P2|COMPLETED|Overall Study||0
43229|NCT01605370|98502|P1|COMPLETED|Overall Study||0
43230|NCT01605370|98501|P2|STARTED|Overall Study||0
43231|NCT01605370|98502|P1|STARTED|Overall Study||1
43232|NCT01605292|98510|P2|NOT COMPLETED|Overall Study||0
43233|NCT01605292|98511|P1|NOT COMPLETED|Overall Study||0
43234|NCT01605292|98510|P2|COMPLETED|Overall Study||347
43235|NCT01605292|98511|P1|COMPLETED|Overall Study||351
43236|NCT01605292|98510|P2|STARTED|Overall Study||347
43237|NCT01605292|98511|P1|STARTED|Overall Study||351
43238|NCT01603875|98538|P3|NOT COMPLETED|Overall Study||9
43239|NCT01603875|98539|P2|NOT COMPLETED|Overall Study||8
43240|NCT01603875|98540|P1|NOT COMPLETED|Overall Study||7
43241|NCT01603875|98538|P3|COMPLETED|Overall Study||26
43242|NCT01603875|98539|P2|COMPLETED|Overall Study||27
43243|NCT01603875|98540|P1|COMPLETED|Overall Study||28
43244|NCT01603875|98538|P3|STARTED|Overall Study||35
43245|NCT01603875|98539|P2|STARTED|Overall Study||35
43246|NCT01603875|98540|P1|STARTED|Overall Study||35
43247|NCT01604941|98562|P6|NOT COMPLETED|Overall Study||7
43248|NCT01604941|98563|P5|NOT COMPLETED|Overall Study||1
43249|NCT01604941|98564|P4|NOT COMPLETED|Overall Study||3
43250|NCT01604941|98565|P3|NOT COMPLETED|Overall Study||3
43251|NCT01604941|98566|P2|NOT COMPLETED|Overall Study||4
43252|NCT01604941|98567|P1|NOT COMPLETED|Overall Study||11
43253|NCT01604941|98562|P6|COMPLETED|Overall Study||0
43254|NCT01604941|98563|P5|COMPLETED|Overall Study||3
43255|NCT01604941|98564|P4|COMPLETED|Overall Study||0
43256|NCT01604941|98565|P3|COMPLETED|Overall Study||0
43257|NCT01604941|98566|P2|COMPLETED|Overall Study||0
43258|NCT01604941|98567|P1|COMPLETED|Overall Study||0
43259|NCT01604941|98562|P6|STARTED|Overall Study||7
43260|NCT01604941|98563|P5|STARTED|Overall Study||4
43261|NCT01604941|98564|P4|STARTED|Overall Study||3
43262|NCT01604941|98565|P3|STARTED|Overall Study||3
43263|NCT01604941|98566|P2|STARTED|Overall Study||4
43264|NCT01604941|98567|P1|STARTED|Overall Study||11
43265|NCT01604850|98595|P2|NOT COMPLETED|Overall Study||30
43266|NCT01604850|98596|P1|NOT COMPLETED|Overall Study||52
43267|NCT01604850|98595|P2|COMPLETED|Overall Study||69
43268|NCT01604850|98596|P1|COMPLETED|Overall Study||51
43269|NCT01604850|98595|P2|Enrolled and Treated|Overall Study||98
43270|NCT01604850|98596|P1|Enrolled and Treated|Overall Study||103
43271|NCT01604850|98595|P2|STARTED|Overall Study||99
43272|NCT01604850|98596|P1|STARTED|Overall Study||103
43273|NCT01604772|98612|P1|NOT COMPLETED|Overall Study||0
43274|NCT01604772|98612|P1|COMPLETED|Overall Study||16
43275|NCT01604772|98612|P1|STARTED|Overall Study||16
43276|NCT01604278|98620|P2|NOT COMPLETED|Overall Study||13
43277|NCT01604278|98621|P1|NOT COMPLETED|Overall Study||14
43278|NCT01604278|98620|P2|COMPLETED|Overall Study||210
43279|NCT01604278|98621|P1|COMPLETED|Overall Study||212
43280|NCT01604278|98620|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
43281|NCT01604278|98621|P1|Full Analysis Set|Overall Study||226
43282|NCT01604278|98620|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
43283|NCT01604278|98621|P1|Safety Set|Overall Study||226
43284|NCT01604278|98620|P2|STARTED|Overall Study||223
43285|NCT01604278|98621|P1|STARTED|Overall Study||226
43286|NCT01604265|98647|P2|NOT COMPLETED|Overall Study||0
43287|NCT01604265|98648|P1|NOT COMPLETED|Overall Study||2
43288|NCT01604265|98647|P2|COMPLETED|Overall Study||32
43289|NCT01604265|98648|P1|COMPLETED|Overall Study||32
43290|NCT01604265|98647|P2|STARTED|Overall Study||32
43291|NCT01604265|98648|P1|STARTED|Overall Study||34
43292|NCT01604109|98684|P2|NOT COMPLETED|Overall Study||34
43293|NCT01604109|98685|P1|NOT COMPLETED|Overall Study||33
43294|NCT01604109|98684|P2|COMPLETED|Overall Study||112
43295|NCT01604109|98685|P1|COMPLETED|Overall Study||117
43296|NCT01604109|98684|P2|STARTED|Overall Study||146
43297|NCT01604109|98685|P1|STARTED|Overall Study||150
43298|NCT01603940|98693|P2|NOT COMPLETED|Overall Study||0
43299|NCT01603940|98694|P1|NOT COMPLETED|Overall Study||0
43300|NCT01603940|98693|P2|COMPLETED|Overall Study||14
43301|NCT01603940|98694|P1|COMPLETED|Overall Study||16
43302|NCT01603940|98693|P2|STARTED|Overall Study||14
43303|NCT01603940|98694|P1|STARTED|Overall Study||16
43304|NCT01603459|98708|P1|NOT COMPLETED|Overall Study||18
43305|NCT01603459|98708|P1|COMPLETED|Overall Study||137
43306|NCT01603459|98708|P1|STARTED|Overall Study||155
43307|NCT01603420|98830|P2|NOT COMPLETED|Overall Study||0
43308|NCT01603420|98831|P1|NOT COMPLETED|Overall Study||0
43309|NCT01603420|98830|P2|COMPLETED|Overall Study||1
43310|NCT01603420|98831|P1|COMPLETED|Overall Study||1
43311|NCT01603420|98830|P2|STARTED|Overall Study||1
43312|NCT01603420|98831|P1|STARTED|Overall Study||1
43313|NCT01603394|98859|P1|NOT COMPLETED|Overall Study||1
43314|NCT01603394|98859|P1|COMPLETED|Overall Study||8
43315|NCT01603394|98859|P1|STARTED|Overall Study||9
43316|NCT01603277|98876|P2|NOT COMPLETED|Overall Study||18
43317|NCT01603277|98877|P1|NOT COMPLETED|Overall Study||14
43318|NCT01603277|98876|P2|COMPLETED|Overall Study||64
43319|NCT01603277|98877|P1|COMPLETED|Overall Study||64
43320|NCT01603277|98876|P2|STARTED|Overall Study||82
43321|NCT01603277|98877|P1|STARTED|Overall Study||78
43322|NCT01603121|98883|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
43323|NCT01603121|98884|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
43324|NCT01603121|98883|P2|COMPLETED|Second Intervention, 10 Hours||0
43325|NCT01603121|98884|P1|COMPLETED|Second Intervention, 10 Hours||0
43326|NCT01603121|98883|P2|STARTED|Second Intervention, 10 Hours||0
43327|NCT01603121|98884|P1|STARTED|Second Intervention, 10 Hours||1
43328|NCT01603121|98883|P2|NOT COMPLETED|First Intervention, 10 Hours||0
43329|NCT01603121|98884|P1|NOT COMPLETED|First Intervention, 10 Hours||0
43330|NCT01603121|98883|P2|COMPLETED|First Intervention, 10 Hours||0
43331|NCT01603121|98884|P1|COMPLETED|First Intervention, 10 Hours||1
43332|NCT01603121|98883|P2|STARTED|First Intervention, 10 Hours||0
43333|NCT01603121|98884|P1|STARTED|First Intervention, 10 Hours||1
43334|NCT01603082|98896|P2|NOT COMPLETED|Overall Study||1
43335|NCT01603082|98897|P1|NOT COMPLETED|Overall Study||2
43336|NCT01603082|98896|P2|COMPLETED|Overall Study|Completed the study|48
43337|NCT01603082|98897|P1|COMPLETED|Overall Study|Completed the study.|49
43338|NCT01603082|98896|P2|STARTED|Overall Study|Randomized|49
43339|NCT01603082|98897|P1|STARTED|Overall Study|Randomized|51
43340|NCT01603056|98907|P2|NOT COMPLETED|Overall Study||14
43341|NCT01603056|98908|P1|NOT COMPLETED|Overall Study||34
43342|NCT01603056|98907|P2|COMPLETED|Overall Study||190
43343|NCT01603056|98908|P1|COMPLETED|Overall Study||379
43344|NCT01603056|98907|P2|STARTED|Overall Study||204
43345|NCT01603056|98908|P1|STARTED|Overall Study||413
43346|NCT01603043|98938|P2|NOT COMPLETED|Overall Study||3
43347|NCT01603043|98939|P1|NOT COMPLETED|Overall Study||7
43348|NCT01603043|98938|P2|COMPLETED|Overall Study||0
43349|NCT01603043|98939|P1|COMPLETED|Overall Study||0
43350|NCT01603043|98938|P2|STARTED|Overall Study||3
43351|NCT01603043|98939|P1|STARTED|Overall Study||7
43352|NCT01602744|98951|P2|NOT COMPLETED|Overall Study||23
43353|NCT01602744|98952|P1|NOT COMPLETED|Overall Study||30
43354|NCT01602744|98951|P2|COMPLETED|Overall Study||160
43355|NCT01602744|98952|P1|COMPLETED|Overall Study||146
43356|NCT01602744|98951|P2|STARTED|Overall Study||183
43357|NCT01602744|98952|P1|STARTED|Overall Study||176
43358|NCT01602731|98968|P1|NOT COMPLETED|Overall Study||30
43359|NCT01602731|98968|P1|COMPLETED|Overall Study||15
43360|NCT01602731|98968|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
43361|NCT01602731|98968|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
43362|NCT01602731|98968|P1|STARTED|Overall Study||45
43363|NCT01602562|98976|P2|NOT COMPLETED|Overall Study||3
43364|NCT01602562|98977|P1|NOT COMPLETED|Overall Study||5
43365|NCT01602562|98976|P2|COMPLETED|Overall Study||16
43366|NCT01602562|98977|P1|COMPLETED|Overall Study||16
43367|NCT01602562|98976|P2|STARTED|Overall Study||19
43368|NCT01602562|98977|P1|STARTED|Overall Study||21
43369|NCT01602549|99013|P2|NOT COMPLETED|Overall Study||1
43370|NCT01602549|99014|P1|NOT COMPLETED|Overall Study||1
43371|NCT01602549|99013|P2|COMPLETED|Overall Study||37
43372|NCT01602549|99014|P1|COMPLETED|Overall Study||18
43373|NCT01602549|99013|P2|STARTED|Overall Study||38
43374|NCT01602549|99014|P1|STARTED|Overall Study||19
43375|NCT01602510|99093|P3|NOT COMPLETED|Randomized Phase||73
43376|NCT01602510|99094|P2|NOT COMPLETED|Randomized Phase||74
43377|NCT01602510|99095|P1|NOT COMPLETED|Randomized Phase||0
43378|NCT01602510|99093|P3|COMPLETED|Randomized Phase||58
43379|NCT01602510|99094|P2|COMPLETED|Randomized Phase||59
43380|NCT01602510|99095|P1|COMPLETED|Randomized Phase||0
43381|NCT01602510|99093|P3|STARTED|Randomized Phase||131
43382|NCT01602510|99094|P2|STARTED|Randomized Phase||133
43383|NCT01602510|99095|P1|STARTED|Randomized Phase||0
43384|NCT01602510|99093|P3|NOT COMPLETED|Open Label Phase||0
43385|NCT01602510|99094|P2|NOT COMPLETED|Open Label Phase||0
43386|NCT01602510|99095|P1|NOT COMPLETED|Open Label Phase||303
43387|NCT01602510|99093|P3|COMPLETED|Open Label Phase||0
43388|NCT01602510|99094|P2|COMPLETED|Open Label Phase||0
43389|NCT01602510|99095|P1|COMPLETED|Open Label Phase||117
43390|NCT01602510|99093|P3|STARTED|Open Label Phase||0
43391|NCT01602510|99094|P2|STARTED|Open Label Phase||0
43392|NCT01602510|99095|P1|STARTED|Open Label Phase||420
43393|NCT01602471|99119|P1|NOT COMPLETED|Overall Study||0
43394|NCT01602471|99119|P1|COMPLETED|Overall Study||4
43395|NCT01602471|99119|P1|STARTED|Overall Study||4
43396|NCT01602016|99123|P1|NOT COMPLETED|Overall Study||0
43397|NCT01602016|99123|P1|COMPLETED|Overall Study||0
43398|NCT01602016|99123|P1|STARTED|Overall Study||0
43399|NCT01601977|99127|P1|NOT COMPLETED|Overall Study||0
43400|NCT01601977|99127|P1|COMPLETED|Overall Study||10
43401|NCT01601977|99127|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
43402|NCT01601821|99147|P2|NOT COMPLETED|Overall Study||29
43403|NCT01601821|99148|P1|NOT COMPLETED|Overall Study||29
43404|NCT01601821|99147|P2|COMPLETED|Overall Study||91
43405|NCT01601821|99148|P1|COMPLETED|Overall Study||96
43406|NCT01601821|99147|P2|STARTED|Overall Study||120
43407|NCT01601821|99148|P1|STARTED|Overall Study||125
43408|NCT01601782|99178|P1|NOT COMPLETED|Overall Study||0
43409|NCT01601782|99178|P1|COMPLETED|Overall Study||16
43410|NCT01601782|99178|P1|STARTED|Overall Study||16
43411|NCT01601691|99182|P1|NOT COMPLETED|Overall Study||0
43412|NCT01601691|99182|P1|COMPLETED|Overall Study||10
43413|NCT01601691|99182|P1|STARTED|Overall Study||10
43414|NCT01601470|99186|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
43415|NCT01601470|99186|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
43416|NCT01601470|99186|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
43417|NCT01601470|99186|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
43418|NCT01601470|99186|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
43419|NCT01601470|99186|P1|NOT COMPLETED|Period 2 - LCZ696||1
43420|NCT01601470|99186|P1|COMPLETED|Period 2 - LCZ696||27
43421|NCT01601470|99186|P1|Safety Set|Period 2 - LCZ696||27
43422|NCT01601470|99186|P1|PK Analysis Set|Period 2 - LCZ696||27
43423|NCT01601470|99186|P1|STARTED|Period 2 - LCZ696||28
43424|NCT01601470|99186|P1|NOT COMPLETED|Period 1 - Sildenafil||0
43425|NCT01601470|99186|P1|COMPLETED|Period 1 - Sildenafil||28
43426|NCT01601470|99186|P1|Safety Set|Period 1 - Sildenafil||28
43427|NCT01601470|99186|P1|PK Analysis Set|Period 1 - Sildenafil||28
43428|NCT01601470|99186|P1|STARTED|Period 1 - Sildenafil||28
43429|NCT01601132|99201|P1|NOT COMPLETED|Overall Study||2
43430|NCT01601132|99201|P1|COMPLETED|Overall Study||28
43431|NCT01601132|99201|P1|STARTED|Overall Study||30
43432|NCT01600950|99218|P2|NOT COMPLETED|Period 2||0
43433|NCT01600950|99219|P1|NOT COMPLETED|Period 2||0
43434|NCT01600950|99218|P2|COMPLETED|Period 2||10
43435|NCT01600950|99219|P1|COMPLETED|Period 2||10
43436|NCT01600950|99218|P2|STARTED|Period 2||10
43437|NCT01600950|99219|P1|STARTED|Period 2||10
43438|NCT01600950|99218|P2|NOT COMPLETED|Period 1||0
43439|NCT01600950|99219|P1|NOT COMPLETED|Period 1||0
43440|NCT01600950|99218|P2|COMPLETED|Period 1||10
43441|NCT01600950|99219|P1|COMPLETED|Period 1||10
43442|NCT01600950|99218|P2|STARTED|Period 1||10
43443|NCT01600950|99219|P1|STARTED|Period 1||10
43444|NCT01600885|99235|P2|NOT COMPLETED|Second Period||0
43445|NCT01600885|99236|P1|NOT COMPLETED|Second Period||0
43446|NCT01600885|99235|P2|COMPLETED|Second Period||8
43447|NCT01600885|99236|P1|COMPLETED|Second Period||8
43448|NCT01600885|99235|P2|STARTED|Second Period||8
43449|NCT01600885|99236|P1|STARTED|Second Period||8
43450|NCT01600885|99235|P2|NOT COMPLETED|Wash Out Period||0
43451|NCT01600885|99236|P1|NOT COMPLETED|Wash Out Period||0
43452|NCT01600885|99235|P2|COMPLETED|Wash Out Period||8
43453|NCT01600885|99236|P1|COMPLETED|Wash Out Period||8
43454|NCT01600885|99235|P2|STARTED|Wash Out Period||8
43455|NCT01600885|99236|P1|STARTED|Wash Out Period||8
43456|NCT01600885|99235|P2|NOT COMPLETED|First Period||1
43457|NCT01600885|99236|P1|NOT COMPLETED|First Period||2
43458|NCT01600885|99235|P2|COMPLETED|First Period||8
43459|NCT01600885|99236|P1|COMPLETED|First Period||8
43460|NCT01600885|99235|P2|STARTED|First Period||9
43461|NCT01600885|99236|P1|STARTED|First Period||10
43462|NCT01600729|99246|P1|NOT COMPLETED|Overall Study||1
43463|NCT01600729|99246|P1|COMPLETED|Overall Study||65
43464|NCT01600729|99246|P1|STARTED|Overall Study||66
43465|NCT01600716|99253|P2|NOT COMPLETED|Overall Study||7
43466|NCT01600716|99254|P1|NOT COMPLETED|Overall Study||7
43467|NCT01600716|99253|P2|COMPLETED|Overall Study||71
43468|NCT01600716|99254|P1|COMPLETED|Overall Study||59
43469|NCT01600716|99253|P2|STARTED|Overall Study||78
43470|NCT01600716|99254|P1|STARTED|Overall Study||66
43471|NCT01600703|99270|P2|NOT COMPLETED|Second Intervention||0
43472|NCT01600703|99271|P1|NOT COMPLETED|Second Intervention||0
43473|NCT01600703|99270|P2|COMPLETED|Second Intervention||8
43474|NCT01600703|99271|P1|COMPLETED|Second Intervention||7
43475|NCT01600703|99270|P2|STARTED|Second Intervention||8
43476|NCT01600703|99271|P1|STARTED|Second Intervention||7
43477|NCT01600703|99270|P2|NOT COMPLETED|First Intervention||0
43478|NCT01600703|99271|P1|NOT COMPLETED|First Intervention||0
43479|NCT01600703|99270|P2|COMPLETED|First Intervention||8
43480|NCT01600703|99271|P1|COMPLETED|First Intervention||7
43481|NCT01600703|99270|P2|STARTED|First Intervention||8
43482|NCT01600703|99271|P1|STARTED|First Intervention||7
43483|NCT01600677|99281|P2|NOT COMPLETED|Overall Study||0
43484|NCT01600677|99282|P1|NOT COMPLETED|Overall Study||0
43485|NCT01600677|99281|P2|COMPLETED|Overall Study||4
43486|NCT01600677|99282|P1|COMPLETED|Overall Study||7
43487|NCT01600677|99281|P2|STARTED|Overall Study||4
43488|NCT01600677|99282|P1|STARTED|Overall Study||7
43489|NCT01600495|99294|P2|NOT COMPLETED|Overall Study||0
43490|NCT01600495|99295|P1|NOT COMPLETED|Overall Study||0
43491|NCT01600495|99294|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
43492|NCT01600495|99295|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
43493|NCT01600495|99294|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
43494|NCT01600495|99295|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
43495|NCT01600287|99309|P2|NOT COMPLETED|Overall Study||0
43496|NCT01600287|99310|P1|NOT COMPLETED|Overall Study||0
43497|NCT01600287|99309|P2|COMPLETED|Overall Study||20
43498|NCT01600287|99310|P1|COMPLETED|Overall Study||20
43499|NCT01600287|99309|P2|STARTED|Overall Study||20
43500|NCT01600287|99310|P1|STARTED|Overall Study||20
43501|NCT01600222|99350|P1|NOT COMPLETED|Overall Study||2
43502|NCT01600222|99350|P1|COMPLETED|Overall Study||35
43503|NCT01600222|99350|P1|STARTED|Overall Study||37
43504|NCT01599104|99376|P3|NOT COMPLETED|Overall Study||26
43505|NCT01599104|99377|P2|NOT COMPLETED|Overall Study||14
43506|NCT01599104|99378|P1|NOT COMPLETED|Overall Study||16
43507|NCT01599104|99376|P3|COMPLETED|Overall Study||363
43508|NCT01599104|99377|P2|COMPLETED|Overall Study||371
43509|NCT01599104|99378|P1|COMPLETED|Overall Study||371
43510|NCT01599104|99376|P3|STARTED|Overall Study||389
43511|NCT01599104|99377|P2|STARTED|Overall Study||385
43512|NCT01599104|99378|P1|STARTED|Overall Study||387
43513|NCT01598987|99416|P1|NOT COMPLETED|Period up to 24 Month||8
43514|NCT01598987|99416|P1|COMPLETED|Period up to 24 Month||48
43515|NCT01598987|99416|P1|STARTED|Period up to 24 Month||56
43516|NCT01598987|99416|P1|NOT COMPLETED|Period up to Month 12||6
43517|NCT01598987|99416|P1|COMPLETED|Period up to Month 12||50
43518|NCT01598987|99416|P1|STARTED|Period up to Month 12||56
43519|NCT01600092|99452|P2|NOT COMPLETED|Overall Study||16
43520|NCT01600092|99453|P1|NOT COMPLETED|Overall Study||18
43521|NCT01600092|99452|P2|COMPLETED|Overall Study||491
43522|NCT01600092|99453|P1|COMPLETED|Overall Study||495
43523|NCT01600092|99452|P2|Received All 3 Vaccinations|Overall Study||494
43524|NCT01600092|99453|P1|Received All 3 Vaccinations|Overall Study||500
43525|NCT01600092|99452|P2|Received at Least 1 Vaccination|Overall Study||504
43526|NCT01600092|99453|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
43527|NCT01600092|99452|P2|STARTED|Overall Study||507
43528|NCT01600092|99453|P1|STARTED|Overall Study||513
43529|NCT01600053|99467|P1|NOT COMPLETED|Overall Study||11
43530|NCT01600053|99467|P1|COMPLETED|Overall Study||0
43531|NCT01600053|99467|P1|STARTED|Overall Study||11
43532|NCT01600014|99472|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
43533|NCT01600014|99473|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
43534|NCT01600014|99472|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
43535|NCT01600014|99473|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
43536|NCT01600014|99472|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
43537|NCT01600014|99473|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
43538|NCT01600014|99472|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
43539|NCT01600014|99473|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
43540|NCT01600014|99472|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
43541|NCT01600014|99473|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
43542|NCT01600014|99472|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
43543|NCT01600014|99473|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
43544|NCT01600014|99472|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
43545|NCT01600014|99473|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
43546|NCT01600014|99472|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
43547|NCT01600014|99473|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
43548|NCT01600014|99472|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
43549|NCT01600014|99473|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
43550|NCT01599806|99493|P2|NOT COMPLETED|Overall Study||41
43551|NCT01599806|99494|P1|NOT COMPLETED|Overall Study||43
43552|NCT01599806|99493|P2|COMPLETED|Overall Study||476
43553|NCT01599806|99494|P1|COMPLETED|Overall Study||473
43554|NCT01599806|99493|P2|STARTED|Overall Study||517
43555|NCT01599806|99494|P1|STARTED|Overall Study||516
43556|NCT01599741|99618|P1|NOT COMPLETED|Overall Study||3
43557|NCT01599741|99618|P1|COMPLETED|Overall Study||48
43558|NCT01599741|99618|P1|Collected Dose and Image Information|Overall Study||48
43559|NCT01599741|99618|P1|STARTED|Overall Study||51
43560|NCT01599650|99627|P3|NOT COMPLETED|Overall Study||27
43561|NCT01599650|99628|P2|NOT COMPLETED|Overall Study||26
43562|NCT01599650|99629|P1|NOT COMPLETED|Overall Study||22
43563|NCT01599650|99627|P3|COMPLETED|Overall Study||65
43564|NCT01599650|99628|P2|COMPLETED|Overall Study||154
43565|NCT01599650|99629|P1|COMPLETED|Overall Study||161
43566|NCT01599650|99627|P3|Completed 6 Mos|Overall Study||80
43567|NCT01599650|99628|P2|Completed 6 Mos|Overall Study||170
43568|NCT01599650|99629|P1|Completed 6 Mos|Overall Study||174
43569|NCT01599650|99627|P3|STARTED|Overall Study||92
43570|NCT01599650|99628|P2|STARTED|Overall Study||180
43571|NCT01599650|99629|P1|STARTED|Overall Study||183
43572|NCT01599637|99668|P3|NOT COMPLETED|Overall Study||0
43573|NCT01599637|99669|P2|NOT COMPLETED|Overall Study||2
43574|NCT01599637|99670|P1|NOT COMPLETED|Overall Study||1
43575|NCT01599637|99668|P3|COMPLETED|Overall Study||10
43576|NCT01599637|99669|P2|COMPLETED|Overall Study||8
43577|NCT01599637|99670|P1|COMPLETED|Overall Study||19
43578|NCT01599637|99668|P3|STARTED|Overall Study||10
43579|NCT01599637|99669|P2|STARTED|Overall Study||10
43580|NCT01599637|99670|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
43581|NCT01599325|99715|P1|NOT COMPLETED|Overall Study||57
43582|NCT01599325|99715|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
43583|NCT01599325|99715|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
43584|NCT01599325|99715|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
43585|NCT01599325|99715|P1|STARTED|Overall Study||72
43586|NCT01599234|99737|P2|NOT COMPLETED|Overall Study||15
43587|NCT01599234|99738|P1|NOT COMPLETED|Overall Study||17
43588|NCT01599234|99737|P2|COMPLETED|Overall Study||155
43589|NCT01599234|99738|P1|COMPLETED|Overall Study||150
43590|NCT01599234|99737|P2|STARTED|Overall Study||170
43591|NCT01599234|99738|P1|STARTED|Overall Study||167
43592|NCT01598779|99760|P1|NOT COMPLETED|Overall Study||0
43593|NCT01598779|99760|P1|COMPLETED|Overall Study||150
43594|NCT01598779|99760|P1|STARTED|Overall Study||150
43595|NCT01598740|99766|P2|NOT COMPLETED|Period 2||0
43596|NCT01598740|99767|P1|NOT COMPLETED|Period 2||1
43597|NCT01598740|99766|P2|COMPLETED|Period 2||9
43598|NCT01598740|99767|P1|COMPLETED|Period 2||7
43599|NCT01598740|99766|P2|STARTED|Period 2||9
43600|NCT01598740|99767|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
43601|NCT01598740|99766|P2|NOT COMPLETED|Period 1||0
43602|NCT01598740|99767|P1|NOT COMPLETED|Period 1||0
43603|NCT01598740|99766|P2|COMPLETED|Period 1||9
43604|NCT01598740|99767|P1|COMPLETED|Period 1||9
43605|NCT01598740|99766|P2|STARTED|Period 1||9
43606|NCT01598740|99767|P1|STARTED|Period 1||9
43607|NCT01598610|99775|P1|NOT COMPLETED|Overall Study||1
43608|NCT01598610|99775|P1|COMPLETED|Overall Study||219
43609|NCT01598610|99775|P1|STARTED|Overall Study||220
43610|NCT01598545|99784|P1|NOT COMPLETED|Overall Study||0
43611|NCT01598545|99784|P1|COMPLETED|Overall Study||20
43612|NCT01598545|99784|P1|STARTED|Overall Study||20
43613|NCT01598532|99792|P1|NOT COMPLETED|Overall Study||11
43614|NCT01598532|99792|P1|COMPLETED|Overall Study||11
43615|NCT01598532|99792|P1|STARTED|Overall Study||22
43616|NCT01598506|99801|P1|NOT COMPLETED|Overall Study||2
43617|NCT01598506|99801|P1|COMPLETED|Overall Study||20
43618|NCT01598506|99801|P1|STARTED|Overall Study||22
43619|NCT01598428|99807|P1|NOT COMPLETED|Overall Study||0
43620|NCT01598428|99807|P1|COMPLETED|Overall Study||20
43621|NCT01598428|99807|P1|STARTED|Overall Study||20
43622|NCT01598350|99816|P1|NOT COMPLETED|Overall Study||0
43623|NCT01598350|99816|P1|COMPLETED|Overall Study||6
43624|NCT01598350|99816|P1|STARTED|Overall Study||6
43625|NCT01598129|99820|P1|NOT COMPLETED|Overall Study||9
43626|NCT01598129|99820|P1|COMPLETED|Overall Study||3
43627|NCT01598129|99820|P1|STARTED|Overall Study||12
43628|NCT01598064|99831|P2|NOT COMPLETED|Overall Study||0
43629|NCT01598064|99832|P1|NOT COMPLETED|Overall Study||0
43630|NCT01598064|99831|P2|COMPLETED|Overall Study||24
43631|NCT01598064|99832|P1|COMPLETED|Overall Study||25
43632|NCT01598064|99831|P2|STARTED|Overall Study||24
43633|NCT01598064|99832|P1|STARTED|Overall Study||25
43634|NCT01597908|99842|P2|NOT COMPLETED|Overall Study||352
43635|NCT01597908|99843|P1|NOT COMPLETED|Overall Study||352
43636|NCT01597908|99842|P2|COMPLETED|Overall Study||0
43637|NCT01597908|99843|P1|COMPLETED|Overall Study||0
43638|NCT01597908|99842|P2|Ongoing|Overall Study||202
43639|NCT01597908|99843|P1|Ongoing|Overall Study||236
43640|NCT01597908|99842|P2|STARTED|Overall Study||352
43641|NCT01597908|99843|P1|STARTED|Overall Study||352
43642|NCT01597843|99858|P3|NOT COMPLETED|Overall Study||0
43643|NCT01597843|99859|P2|NOT COMPLETED|Overall Study||0
43644|NCT01597843|99860|P1|NOT COMPLETED|Overall Study||0
43645|NCT01597843|99858|P3|COMPLETED|Overall Study||81
43646|NCT01597843|99859|P2|COMPLETED|Overall Study||122
43647|NCT01597843|99860|P1|COMPLETED|Overall Study||79
43648|NCT01597843|99858|P3|Survey 3 Responses|Overall Study||76
43649|NCT01597843|99859|P2|Survey 3 Responses|Overall Study||56
43650|NCT01597843|99860|P1|Survey 3 Responses|Overall Study||65
43651|NCT01597843|99858|P3|Survey 2 Responses|Overall Study||58
43652|NCT01597843|99859|P2|Survey 2 Responses|Overall Study||42
43653|NCT01597843|99860|P1|Survey 2 Responses|Overall Study||52
43654|NCT01597843|99858|P3|Survey 1 Responses|Overall Study||59
43655|NCT01597843|99859|P2|Survey 1 Responses|Overall Study||71
43656|NCT01597843|99860|P1|Survey 1 Responses|Overall Study||45
43657|NCT01597843|99858|P3|STARTED|Overall Study||81
43658|NCT01597843|99859|P2|STARTED|Overall Study||122
43659|NCT01597843|99860|P1|STARTED|Overall Study||79
43660|NCT01597596|99870|P2|NOT COMPLETED|Overall Study||1
43661|NCT01597596|99871|P1|NOT COMPLETED|Overall Study||1
43662|NCT01597596|99870|P2|COMPLETED|Overall Study||2
43663|NCT01597596|99871|P1|COMPLETED|Overall Study||0
43664|NCT01597596|99870|P2|STARTED|Overall Study||3
43665|NCT01597596|99871|P1|STARTED|Overall Study||1
43666|NCT01597492|99885|P2|NOT COMPLETED|Overall Study||4
43667|NCT01597492|99886|P1|NOT COMPLETED|Overall Study||6
43668|NCT01597492|99885|P2|COMPLETED|Overall Study||41
43669|NCT01597492|99886|P1|COMPLETED|Overall Study||28
43670|NCT01597492|99885|P2|STARTED|Overall Study||45
43671|NCT01597492|99886|P1|STARTED|Overall Study||34
43672|NCT01597479|99894|P2|NOT COMPLETED|Overall Study||0
43673|NCT01597479|99895|P1|NOT COMPLETED|Overall Study||2
43674|NCT01597479|99894|P2|COMPLETED|Overall Study||26
43675|NCT01597479|99895|P1|COMPLETED|Overall Study||24
43676|NCT01597479|99894|P2|STARTED|Overall Study||26
43677|NCT01597479|99895|P1|STARTED|Overall Study||26
43678|NCT01597245|99906|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
43679|NCT01597245|99907|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
43680|NCT01597245|99908|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
43681|NCT01597245|99909|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
43682|NCT01597245|99910|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
43683|NCT01597245|99911|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
43684|NCT01597245|99912|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
43685|NCT01597245|99913|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
43686|NCT01597245|99914|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
43687|NCT01597245|99915|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43688|NCT01597245|99916|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43689|NCT01597245|99917|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43690|NCT01597245|99918|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43691|NCT01597245|99906|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
43692|NCT01597245|99907|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
43693|NCT01597245|99908|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
43694|NCT01597245|99909|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
43695|NCT01597245|99910|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
43696|NCT01597245|99911|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43697|NCT01597245|99912|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
43698|NCT01597245|99913|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
43699|NCT01597245|99914|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
43700|NCT01597245|99915|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43701|NCT01597245|99916|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43702|NCT01597245|99917|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43703|NCT01597245|99918|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
43704|NCT01597245|99906|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
43705|NCT01597245|99907|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
43706|NCT01597245|99908|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
43707|NCT01597245|99909|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
43708|NCT01597245|99910|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
43709|NCT01597245|99911|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
43710|NCT01597245|99912|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
43711|NCT01597245|99913|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
43712|NCT01597245|99914|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
43713|NCT01597245|99915|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
43714|NCT01597245|99916|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
43715|NCT01597245|99917|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
43716|NCT01597245|99918|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
43717|NCT01597245|99906|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
43718|NCT01597245|99907|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
43719|NCT01597245|99908|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
43720|NCT01597245|99909|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
43721|NCT01597245|99910|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
43722|NCT01597245|99911|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
43723|NCT01597245|99912|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
43724|NCT01597245|99913|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
43725|NCT01597245|99914|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
43726|NCT01597245|99915|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
43727|NCT01597245|99916|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
43728|NCT01597245|99917|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
43729|NCT01597245|99918|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
43730|NCT01597245|99906|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43731|NCT01597245|99907|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43732|NCT01597245|99908|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43733|NCT01597245|99909|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43734|NCT01597245|99910|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43735|NCT01597245|99911|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43736|NCT01597245|99912|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43737|NCT01597245|99913|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43738|NCT01597245|99914|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
43739|NCT01597245|99915|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
43740|NCT01597245|99916|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
43741|NCT01597245|99917|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
43742|NCT01597245|99918|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
43743|NCT01597245|99906|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
43744|NCT01597245|99907|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
43745|NCT01597245|99908|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
43746|NCT01597245|99909|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
43747|NCT01597245|99910|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
43748|NCT01597245|99911|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
43749|NCT01597245|99912|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
43750|NCT01597245|99913|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
43751|NCT01597245|99914|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
43752|NCT01597245|99915|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
43753|NCT01597245|99916|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
43754|NCT01597245|99917|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
43755|NCT01597245|99918|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
43756|NCT01597245|99906|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43757|NCT01597245|99907|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43758|NCT01597245|99908|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43759|NCT01597245|99909|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43760|NCT01597245|99910|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43761|NCT01597245|99911|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43762|NCT01597245|99912|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43763|NCT01597245|99913|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43764|NCT01597245|99914|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
43765|NCT01597245|99915|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
43766|NCT01597245|99916|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
43767|NCT01597245|99917|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
43768|NCT01597245|99918|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
43769|NCT01597245|99906|P13|STARTED|Induction Period (Week 0 - Week 12)||0
43770|NCT01597245|99907|P12|STARTED|Induction Period (Week 0 - Week 12)||0
43771|NCT01597245|99908|P11|STARTED|Induction Period (Week 0 - Week 12)||0
43772|NCT01597245|99909|P10|STARTED|Induction Period (Week 0 - Week 12)||0
43773|NCT01597245|99910|P9|STARTED|Induction Period (Week 0 - Week 12)||0
43774|NCT01597245|99911|P8|STARTED|Induction Period (Week 0 - Week 12)||0
43775|NCT01597245|99912|P7|STARTED|Induction Period (Week 0 - Week 12)||0
43776|NCT01597245|99913|P6|STARTED|Induction Period (Week 0 - Week 12)||0
43777|NCT01597245|99914|P5|STARTED|Induction Period (Week 0 - Week 12)||0
43778|NCT01597245|99915|P4|STARTED|Induction Period (Week 0 - Week 12)||351
43779|NCT01597245|99916|P3|STARTED|Induction Period (Week 0 - Week 12)||347
43780|NCT01597245|99917|P2|STARTED|Induction Period (Week 0 - Week 12)||358
43781|NCT01597245|99918|P1|STARTED|Induction Period (Week 0 - Week 12)||168
43782|NCT01597141|100003|P2|NOT COMPLETED|Overall Study||0
43783|NCT01597141|100004|P1|NOT COMPLETED|Overall Study||0
43784|NCT01597141|100003|P2|COMPLETED|Overall Study||50
43785|NCT01597141|100004|P1|COMPLETED|Overall Study||50
43786|NCT01597141|100003|P2|STARTED|Overall Study||50
43787|NCT01597141|100004|P1|STARTED|Overall Study||50
43788|NCT01597050|100014|P2|NOT COMPLETED|Overall Study||0
43789|NCT01597050|100015|P1|NOT COMPLETED|Overall Study||1
43790|NCT01597050|100014|P2|COMPLETED|Overall Study||18
43791|NCT01597050|100015|P1|COMPLETED|Overall Study||35
43792|NCT01597050|100014|P2|STARTED|Overall Study||18
43793|NCT01597050|100015|P1|STARTED|Overall Study||36
43794|NCT01596972|100023|P2|NOT COMPLETED|Overall Study||14
43795|NCT01596972|100024|P1|NOT COMPLETED|Overall Study||1
43796|NCT01596972|100023|P2|COMPLETED|Overall Study||12
43797|NCT01596972|100024|P1|COMPLETED|Overall Study||24
43798|NCT01596972|100023|P2|STARTED|Overall Study||26
43799|NCT01596972|100024|P1|STARTED|Overall Study||25
43800|NCT01596842|100036|P2|NOT COMPLETED|Overall Study||0
43801|NCT01596842|100037|P1|NOT COMPLETED|Overall Study||2
43802|NCT01596842|100036|P2|COMPLETED|Overall Study||7
43803|NCT01596842|100037|P1|COMPLETED|Overall Study||8
43804|NCT01596842|100036|P2|STARTED|Overall Study||7
43805|NCT01596842|100037|P1|STARTED|Overall Study||10
43806|NCT01596504|100048|P3|NOT COMPLETED|Overall Study||1
43807|NCT01596504|100049|P2|NOT COMPLETED|Overall Study||3
43808|NCT01596504|100050|P1|NOT COMPLETED|Overall Study||2
43809|NCT01596504|100048|P3|COMPLETED|Overall Study||46
43810|NCT01596504|100049|P2|COMPLETED|Overall Study||44
43811|NCT01596504|100050|P1|COMPLETED|Overall Study||46
43812|NCT01596504|100048|P3|STARTED|Overall Study||47
43813|NCT01596504|100049|P2|STARTED|Overall Study||47
43814|NCT01596504|100050|P1|STARTED|Overall Study||48
43815|NCT01596231|100108|P2|NOT COMPLETED|Overall Study||0
43816|NCT01596231|100109|P1|NOT COMPLETED|Overall Study||0
43817|NCT01596231|100108|P2|COMPLETED|Overall Study||10
43818|NCT01596231|100109|P1|COMPLETED|Overall Study||10
43819|NCT01596231|100108|P2|STARTED|Overall Study||10
43820|NCT01596231|100109|P1|STARTED|Overall Study||10
43821|NCT01596088|100115|P1|NOT COMPLETED|Overall Study||0
43822|NCT01596088|100115|P1|COMPLETED|Overall Study||2
43823|NCT01596088|100115|P1|STARTED|Overall Study||2
43824|NCT01596062|100122|P3|NOT COMPLETED|Overall Study||3
43825|NCT01596062|100123|P2|NOT COMPLETED|Overall Study||0
43826|NCT01596062|100124|P1|NOT COMPLETED|Overall Study||1
43827|NCT01596062|100122|P3|COMPLETED|Overall Study||4
43828|NCT01596062|100123|P2|COMPLETED|Overall Study||6
43829|NCT01596062|100124|P1|COMPLETED|Overall Study||2
43830|NCT01596062|100122|P3|STARTED|Overall Study||7
43831|NCT01596062|100123|P2|STARTED|Overall Study||6
43832|NCT01596062|100124|P1|STARTED|Overall Study||3
43833|NCT01595854|100161|P5|NOT COMPLETED|Overall Study||0
43834|NCT01595854|100162|P4|NOT COMPLETED|Overall Study||0
43835|NCT01595854|100163|P3|NOT COMPLETED|Overall Study||0
43836|NCT01595854|100164|P2|NOT COMPLETED|Overall Study||0
43837|NCT01595854|100165|P1|NOT COMPLETED|Overall Study||0
43838|NCT01595854|100161|P5|COMPLETED|Overall Study||12
43839|NCT01595854|100162|P4|COMPLETED|Overall Study||4
43840|NCT01595854|100163|P3|COMPLETED|Overall Study||8
43841|NCT01595854|100164|P2|COMPLETED|Overall Study||4
43842|NCT01595854|100165|P1|COMPLETED|Overall Study||8
43843|NCT01595854|100161|P5|STARTED|Overall Study||12
43844|NCT01595854|100162|P4|STARTED|Overall Study||4
43845|NCT01595854|100163|P3|STARTED|Overall Study||8
43846|NCT01595854|100164|P2|STARTED|Overall Study||4
43847|NCT01595854|100165|P1|STARTED|Overall Study||8
43848|NCT01595438|100187|P2|NOT COMPLETED|Overall Study||41
43849|NCT01595438|100188|P1|NOT COMPLETED|Overall Study||43
43850|NCT01595438|100187|P2|COMPLETED|Overall Study||476
43851|NCT01595438|100188|P1|COMPLETED|Overall Study||473
43852|NCT01595438|100187|P2|STARTED|Overall Study||517
43853|NCT01595438|100188|P1|STARTED|Overall Study||516
43854|NCT01595386|100314|P2|NOT COMPLETED|Overall Study||0
43855|NCT01595386|100315|P1|NOT COMPLETED|Overall Study||0
43856|NCT01595386|100314|P2|COMPLETED|Overall Study||19
43857|NCT01595386|100315|P1|COMPLETED|Overall Study||21
43858|NCT01595386|100314|P2|STARTED|Overall Study||19
43859|NCT01595386|100315|P1|STARTED|Overall Study||21
43860|NCT01595282|100343|P2|NOT COMPLETED|Overall Study||0
43861|NCT01595282|100344|P1|NOT COMPLETED|Overall Study||0
43862|NCT01595282|100343|P2|COMPLETED|Overall Study||47
43863|NCT01595282|100344|P1|COMPLETED|Overall Study||47
43864|NCT01595282|100343|P2|STARTED|Overall Study||47
43865|NCT01595282|100344|P1|STARTED|Overall Study||47
43866|NCT01594970|100357|P3|NOT COMPLETED|Overall Study||66
43867|NCT01594970|100358|P2|NOT COMPLETED|Overall Study||82
43868|NCT01594970|100359|P1|NOT COMPLETED|Overall Study||75
43869|NCT01594970|100357|P3|COMPLETED|Overall Study||191
43870|NCT01594970|100358|P2|COMPLETED|Overall Study||166
43871|NCT01594970|100359|P1|COMPLETED|Overall Study||220
43872|NCT01594970|100357|P3|STARTED|Overall Study||257
43873|NCT01594970|100358|P2|STARTED|Overall Study||248
43874|NCT01594970|100359|P1|STARTED|Overall Study||295
43875|NCT01594749|100378|P2|NOT COMPLETED|Overall Study||18
43876|NCT01594749|100379|P1|NOT COMPLETED|Overall Study||22
43877|NCT01594749|100378|P2|COMPLETED|Overall Study||490
43878|NCT01594749|100379|P1|COMPLETED|Overall Study||485
43879|NCT01594749|100378|P2|Treated|Overall Study||498
43880|NCT01594749|100379|P1|Treated|Overall Study||503
43881|NCT01594749|100378|P2|STARTED|Overall Study||508
43882|NCT01594749|100379|P1|STARTED|Overall Study||507
43883|NCT01594515|100405|P10|NOT COMPLETED|Overall Study||0
43884|NCT01594515|100406|P9|NOT COMPLETED|Overall Study||0
43885|NCT01594515|100407|P8|NOT COMPLETED|Overall Study||0
43886|NCT01594515|100408|P7|NOT COMPLETED|Overall Study||0
43887|NCT01594515|100409|P6|NOT COMPLETED|Overall Study||0
43888|NCT01594515|100410|P5|NOT COMPLETED|Overall Study||0
43889|NCT01594515|100411|P4|NOT COMPLETED|Overall Study||0
43890|NCT01594515|100412|P3|NOT COMPLETED|Overall Study||0
43891|NCT01594515|100413|P2|NOT COMPLETED|Overall Study||0
43892|NCT01594515|100414|P1|NOT COMPLETED|Overall Study||0
43893|NCT01594515|100405|P10|COMPLETED|Overall Study||16
43894|NCT01594515|100406|P9|COMPLETED|Overall Study||6
43895|NCT01594515|100407|P8|COMPLETED|Overall Study||6
43896|NCT01594515|100408|P7|COMPLETED|Overall Study||6
43897|NCT01594515|100409|P6|COMPLETED|Overall Study||6
43898|NCT01594515|100410|P5|COMPLETED|Overall Study||6
43899|NCT01594515|100411|P4|COMPLETED|Overall Study||6
43900|NCT01594515|100412|P3|COMPLETED|Overall Study||6
43901|NCT01594515|100413|P2|COMPLETED|Overall Study||6
43902|NCT01594515|100414|P1|COMPLETED|Overall Study||6
43903|NCT01594515|100405|P10|STARTED|Overall Study||16
43904|NCT01594515|100406|P9|STARTED|Overall Study||6
43905|NCT01594515|100407|P8|STARTED|Overall Study||6
43906|NCT01594515|100408|P7|STARTED|Overall Study||6
43907|NCT01594515|100409|P6|STARTED|Overall Study||6
43908|NCT01594515|100410|P5|STARTED|Overall Study||6
43909|NCT01594515|100411|P4|STARTED|Overall Study||6
43910|NCT01594515|100412|P3|STARTED|Overall Study||6
43911|NCT01594515|100413|P2|STARTED|Overall Study||6
43912|NCT01594515|100414|P1|STARTED|Overall Study||6
43913|NCT01594424|100504|P1|NOT COMPLETED|Overall Study||2
43914|NCT01594424|100504|P1|COMPLETED|Overall Study||8
43915|NCT01594424|100504|P1|STARTED|Overall Study||10
43916|NCT01594411|100508|P1|NOT COMPLETED|Overall Study||2
43917|NCT01594411|100508|P1|COMPLETED|Overall Study||249
43918|NCT01594411|100508|P1|STARTED|Overall Study||251
43919|NCT01594294|100517|P2|NOT COMPLETED|Overall Study||4
43920|NCT01594294|100518|P1|NOT COMPLETED|Overall Study||3
43921|NCT01594294|100517|P2|COMPLETED|Overall Study||36
43922|NCT01594294|100518|P1|COMPLETED|Overall Study||36
43923|NCT01594294|100517|P2|STARTED|Overall Study||40
43924|NCT01594294|100518|P1|STARTED|Overall Study||39
43925|NCT01594125|100537|P5|NOT COMPLETED|Overall Study||7
43926|NCT01594125|100538|P4|NOT COMPLETED|Overall Study||4
43927|NCT01594125|100539|P3|NOT COMPLETED|Overall Study||3
43928|NCT01594125|100540|P2|NOT COMPLETED|Overall Study||12
43929|NCT01594125|100541|P1|NOT COMPLETED|Overall Study||4
43930|NCT01594125|100537|P5|COMPLETED|Overall Study||0
43931|NCT01594125|100538|P4|COMPLETED|Overall Study||0
43932|NCT01594125|100539|P3|COMPLETED|Overall Study||0
43933|NCT01594125|100540|P2|COMPLETED|Overall Study||0
43934|NCT01594125|100541|P1|COMPLETED|Overall Study||0
43935|NCT01594125|100537|P5|STARTED|Overall Study||7
43936|NCT01594125|100538|P4|STARTED|Overall Study||4
43937|NCT01594125|100539|P3|STARTED|Overall Study||3
43938|NCT01594125|100540|P2|STARTED|Overall Study||12
43939|NCT01594125|100541|P1|STARTED|Overall Study||4
43940|NCT01593852|100575|P2|NOT COMPLETED|Overall Study||0
43941|NCT01593852|100576|P1|NOT COMPLETED|Overall Study||0
43942|NCT01593852|100575|P2|COMPLETED|Overall Study||68
43943|NCT01593852|100576|P1|COMPLETED|Overall Study||68
43944|NCT01593852|100575|P2|STARTED|Overall Study||68
43945|NCT01593852|100576|P1|STARTED|Overall Study||68
43946|NCT01593787|100601|P3|NOT COMPLETED|Overall Study||0
43947|NCT01593787|100602|P2|NOT COMPLETED|Overall Study||0
43948|NCT01593787|100603|P1|NOT COMPLETED|Overall Study||1
43949|NCT01593787|100601|P3|COMPLETED|Overall Study||18
43950|NCT01593787|100602|P2|COMPLETED|Overall Study||8
43951|NCT01593787|100603|P1|COMPLETED|Overall Study||5
43952|NCT01593787|100601|P3|STARTED|Overall Study||18
43953|NCT01593787|100602|P2|STARTED|Overall Study||8
43954|NCT01593787|100603|P1|STARTED|Overall Study||6
43955|NCT01593722|100643|P2|NOT COMPLETED|Overall Study||0
43956|NCT01593722|100644|P1|NOT COMPLETED|Overall Study||0
43957|NCT01593722|100643|P2|COMPLETED|Overall Study||6
43958|NCT01593722|100644|P1|COMPLETED|Overall Study||6
43959|NCT01593722|100643|P2|STARTED|Overall Study||6
43960|NCT01593722|100644|P1|STARTED|Overall Study||6
43961|NCT01593592|100660|P2|NOT COMPLETED|Overall Study||0
43962|NCT01593592|100661|P1|NOT COMPLETED|Overall Study||0
43963|NCT01593592|100660|P2|COMPLETED|Overall Study||35
43964|NCT01593592|100661|P1|COMPLETED|Overall Study||35
43965|NCT01593592|100660|P2|STARTED|Overall Study||35
43966|NCT01593592|100661|P1|STARTED|Overall Study||35
43967|NCT01593215|100673|P2|NOT COMPLETED|Overall Study||0
43968|NCT01593215|100674|P1|NOT COMPLETED|Overall Study||1
43969|NCT01593215|100673|P2|COMPLETED|Overall Study||25
43970|NCT01593215|100674|P1|COMPLETED|Overall Study||24
43971|NCT01593215|100673|P2|STARTED|Overall Study||25
43972|NCT01593215|100674|P1|STARTED|Overall Study||25
43973|NCT01592864|100682|P2|NOT COMPLETED|Overall Study||1
43974|NCT01592864|100683|P1|NOT COMPLETED|Overall Study||0
43975|NCT01592864|100682|P2|COMPLETED|Overall Study||57
43976|NCT01592864|100683|P1|COMPLETED|Overall Study||60
43977|NCT01592864|100682|P2|STARTED|Overall Study||58
43978|NCT01592864|100683|P1|STARTED|Overall Study||60
43979|NCT01592851|100697|P2|NOT COMPLETED|Overall Study||0
43980|NCT01592851|100698|P1|NOT COMPLETED|Overall Study||0
43981|NCT01592851|100697|P2|COMPLETED|Overall Study||57
43982|NCT01592851|100698|P1|COMPLETED|Overall Study||56
43983|NCT01592851|100697|P2|STARTED|Overall Study||57
43984|NCT01592851|100698|P1|STARTED|Overall Study||56
43985|NCT01592786|100714|P1|NOT COMPLETED|Overall Study||138
43986|NCT01592786|100714|P1|COMPLETED|Overall Study||765
43987|NCT01592786|100714|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
43988|NCT01592773|100718|P1|NOT COMPLETED|Overall Study||666
43989|NCT01592773|100718|P1|COMPLETED|Overall Study||81
43990|NCT01592773|100718|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
43991|NCT01592760|100725|P3|NOT COMPLETED|24-hour Follow-Up||2
43992|NCT01592760|100726|P2|NOT COMPLETED|24-hour Follow-Up||3
43993|NCT01592760|100727|P1|NOT COMPLETED|24-hour Follow-Up||4
43994|NCT01592760|100725|P3|COMPLETED|24-hour Follow-Up||43
43995|NCT01592760|100726|P2|COMPLETED|24-hour Follow-Up||87
43996|NCT01592760|100727|P1|COMPLETED|24-hour Follow-Up||86
43997|NCT01592760|100725|P3|STARTED|24-hour Follow-Up||45
43998|NCT01592760|100726|P2|STARTED|24-hour Follow-Up||90
43999|NCT01592760|100727|P1|STARTED|24-hour Follow-Up||90
44000|NCT01592760|100725|P3|NOT COMPLETED|Perioperative to Discharge||0
44001|NCT01592760|100726|P2|NOT COMPLETED|Perioperative to Discharge||0
44002|NCT01592760|100727|P1|NOT COMPLETED|Perioperative to Discharge||0
44003|NCT01592760|100725|P3|COMPLETED|Perioperative to Discharge||45
44004|NCT01592760|100726|P2|COMPLETED|Perioperative to Discharge||90
44005|NCT01592760|100727|P1|COMPLETED|Perioperative to Discharge||90
44006|NCT01592760|100725|P3|STARTED|Perioperative to Discharge||45
44007|NCT01592760|100726|P2|STARTED|Perioperative to Discharge||90
44008|NCT01592760|100727|P1|STARTED|Perioperative to Discharge||90
44009|NCT01592708|100770|P2|NOT COMPLETED|Overall Study||0
44010|NCT01592708|100771|P1|NOT COMPLETED|Overall Study||3
44011|NCT01592708|100770|P2|COMPLETED|Overall Study||137
44012|NCT01592708|100771|P1|COMPLETED|Overall Study||93
44013|NCT01592708|100770|P2|STARTED|Overall Study||137
44014|NCT01592708|100771|P1|STARTED|Overall Study||96
44015|NCT01592396|100787|P2|NOT COMPLETED|Overall Study||0
44016|NCT01592396|100788|P1|NOT COMPLETED|Overall Study||0
44017|NCT01592396|100787|P2|COMPLETED|Overall Study||10
44018|NCT01592396|100788|P1|COMPLETED|Overall Study||10
44019|NCT01592396|100787|P2|STARTED|Overall Study||10
44020|NCT01592396|100788|P1|STARTED|Overall Study||10
44021|NCT01592344|100805|P2|NOT COMPLETED|Overall Study||5
44022|NCT01592344|100806|P1|NOT COMPLETED|Overall Study||4
44023|NCT01592344|100805|P2|COMPLETED|Overall Study||44
44024|NCT01592344|100806|P1|COMPLETED|Overall Study||41
44025|NCT01592344|100805|P2|STARTED|Overall Study||49
44026|NCT01592344|100806|P1|STARTED|Overall Study||45
44027|NCT01592292|100820|P4|NOT COMPLETED|Overall Study||1
44028|NCT01592292|100821|P3|NOT COMPLETED|Overall Study||3
44029|NCT01592292|100822|P2|NOT COMPLETED|Overall Study||5
44030|NCT01592292|100823|P1|NOT COMPLETED|Overall Study||6
44031|NCT01592292|100820|P4|COMPLETED|Overall Study||10
44032|NCT01592292|100821|P3|COMPLETED|Overall Study||10
44033|NCT01592292|100822|P2|COMPLETED|Overall Study||15
44034|NCT01592292|100823|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
44035|NCT01592292|100820|P4|Standard Population Set (SPS)|Overall Study||7
44036|NCT01592292|100821|P3|Standard Population Set (SPS)|Overall Study||7
44037|NCT01592292|100822|P2|Standard Population Set (SPS)|Overall Study||10
44038|NCT01592292|100823|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
44039|NCT01592292|100820|P4|Intention to Treat (ITT) Set|Overall Study||8
44040|NCT01592292|100821|P3|Intention to Treat (ITT) Set|Overall Study||10
44041|NCT01592292|100822|P2|Intention to Treat (ITT) Set|Overall Study||13
44042|NCT01592292|100823|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
44043|NCT01592292|100820|P4|STARTED|Overall Study||11
44044|NCT01592292|100821|P3|STARTED|Overall Study||13
44045|NCT01592292|100822|P2|STARTED|Overall Study||20
44046|NCT01592292|100823|P1|STARTED|Overall Study||46
44047|NCT01592071|100855|P1|NOT COMPLETED|Overall Study||0
44048|NCT01592071|100855|P1|COMPLETED|Overall Study||120
44049|NCT01592071|100855|P1|STARTED|Overall Study||120
44050|NCT01592045|100868|P2|NOT COMPLETED|Overall Study||2
44051|NCT01592045|100869|P1|NOT COMPLETED|Overall Study||5
44052|NCT01592045|100868|P2|COMPLETED|Overall Study||12
44053|NCT01592045|100869|P1|COMPLETED|Overall Study||9
44054|NCT01592045|100868|P2|Completed Course 5|Overall Study||12
44055|NCT01592045|100869|P1|Completed Course 5|Overall Study||9
44056|NCT01592045|100868|P2|Completed Course 4|Overall Study||12
44057|NCT01592045|100869|P1|Completed Course 4|Overall Study||11
44058|NCT01592045|100868|P2|Completed Course 3|Overall Study||13
44059|NCT01592045|100869|P1|Completed Course 3|Overall Study||11
44060|NCT01592045|100868|P2|Completed Course 2|Overall Study||13
44061|NCT01592045|100869|P1|Completed Course 2|Overall Study||13
44062|NCT01592045|100868|P2|Completed Course 1|Overall Study||14
44063|NCT01592045|100869|P1|Completed Course 1|Overall Study||13
44064|NCT01592045|100868|P2|STARTED|Overall Study||14
44065|NCT01592045|100869|P1|STARTED|Overall Study||14
44066|NCT01592006|100877|P1|NOT COMPLETED|Overall Study||0
44067|NCT01592006|100877|P1|COMPLETED|Overall Study||3
44068|NCT01592006|100877|P1|STARTED|Overall Study||3
44069|NCT01591954|100882|P1|NOT COMPLETED|Overall Study||0
44070|NCT01591954|100882|P1|COMPLETED|Overall Study||1
44071|NCT01591954|100882|P1|STARTED|Overall Study||1
44072|NCT01591863|100887|P1|NOT COMPLETED|Overall Study||14
44073|NCT01591863|100887|P1|COMPLETED|Overall Study||24
44074|NCT01591863|100887|P1|STARTED|Overall Study||38
44075|NCT01591837|100899|P2|NOT COMPLETED|Overall Study||0
44076|NCT01591837|100900|P1|NOT COMPLETED|Overall Study||0
44077|NCT01591837|100899|P2|COMPLETED|Overall Study||60
44078|NCT01591837|100900|P1|COMPLETED|Overall Study||60
44079|NCT01591837|100899|P2|STARTED|Overall Study||60
44080|NCT01591837|100900|P1|STARTED|Overall Study||60
44081|NCT01591681|100914|P1|NOT COMPLETED|Overall Study||4
44082|NCT01591681|100914|P1|COMPLETED|Overall Study||45
44083|NCT01591681|100914|P1|STARTED|Overall Study||49
44084|NCT01591616|100940|P1|NOT COMPLETED|Overall Study||1
44085|NCT01591616|100940|P1|COMPLETED|Overall Study||15
44086|NCT01591616|100940|P1|STARTED|Overall Study||16
44087|NCT01591499|101081|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
44088|NCT01591499|101082|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
44089|NCT01591499|101083|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
44090|NCT01591499|101084|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
44091|NCT01591499|101081|P4|COMPLETED|Second Intervention (up to 24 Days)||34
44092|NCT01591499|101082|P3|COMPLETED|Second Intervention (up to 24 Days)||28
44093|NCT01591499|101083|P2|COMPLETED|Second Intervention (up to 24 Days)||34
44094|NCT01591499|101084|P1|COMPLETED|Second Intervention (up to 24 Days)||27
44095|NCT01591499|101081|P4|STARTED|Second Intervention (up to 24 Days)||37
44096|NCT01591499|101082|P3|STARTED|Second Intervention (up to 24 Days)||31
44097|NCT01591499|101083|P2|STARTED|Second Intervention (up to 24 Days)||37
44098|NCT01591499|101084|P1|STARTED|Second Intervention (up to 24 Days)||33
44099|NCT01591499|101081|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
44100|NCT01591499|101082|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
44101|NCT01591499|101083|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
44102|NCT01591499|101084|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
44103|NCT01591499|101081|P4|COMPLETED|First Intervention (up to 24 Days)||37
44104|NCT01591499|101082|P3|COMPLETED|First Intervention (up to 24 Days)||31
44105|NCT01591499|101083|P2|COMPLETED|First Intervention (up to 24 Days)||37
44106|NCT01591499|101084|P1|COMPLETED|First Intervention (up to 24 Days)||33
44107|NCT01591499|101081|P4|STARTED|First Intervention (up to 24 Days)||37
44108|NCT01591499|101082|P3|STARTED|First Intervention (up to 24 Days)||31
44109|NCT01591499|101083|P2|STARTED|First Intervention (up to 24 Days)||37
44110|NCT01591499|101084|P1|STARTED|First Intervention (up to 24 Days)||33
44111|NCT01591499|101081|P4|NOT COMPLETED|Baseline Visit||2
44112|NCT01591499|101082|P3|NOT COMPLETED|Baseline Visit||0
44113|NCT01591499|101083|P2|NOT COMPLETED|Baseline Visit||2
44114|NCT01591499|101084|P1|NOT COMPLETED|Baseline Visit||0
44115|NCT01591499|101081|P4|COMPLETED|Baseline Visit||37
44116|NCT01591499|101082|P3|COMPLETED|Baseline Visit||31
44117|NCT01591499|101083|P2|COMPLETED|Baseline Visit||37
44118|NCT01591499|101084|P1|COMPLETED|Baseline Visit||33
44119|NCT01591499|101081|P4|STARTED|Baseline Visit||39
44120|NCT01591499|101082|P3|STARTED|Baseline Visit||31
44121|NCT01591499|101083|P2|STARTED|Baseline Visit||39
44122|NCT01591499|101084|P1|STARTED|Baseline Visit||33
44123|NCT01591460|101150|P1|NOT COMPLETED|Overall Study||26
44124|NCT01591460|101150|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
44125|NCT01591460|101150|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
44126|NCT01591408|101232|P2|NOT COMPLETED|Overall Study||8
44127|NCT01591408|101233|P1|NOT COMPLETED|Overall Study||12
44128|NCT01591408|101232|P2|COMPLETED|Overall Study||24
44129|NCT01591408|101233|P1|COMPLETED|Overall Study||24
44130|NCT01591408|101232|P2|STARTED|Overall Study||32
44131|NCT01591408|101233|P1|STARTED|Overall Study||36
44132|NCT01591317|101242|P3|NOT COMPLETED|Overall Study||0
44133|NCT01591317|101243|P2|NOT COMPLETED|Overall Study||0
44134|NCT01591317|101244|P1|NOT COMPLETED|Overall Study||0
44135|NCT01591317|101242|P3|COMPLETED|Overall Study||10
44136|NCT01591317|101243|P2|COMPLETED|Overall Study||10
44137|NCT01591317|101244|P1|COMPLETED|Overall Study||10
44138|NCT01591317|101242|P3|STARTED|Overall Study||10
44139|NCT01591317|101243|P2|STARTED|Overall Study||10
44140|NCT01591317|101244|P1|STARTED|Overall Study||10
44141|NCT01591044|101273|P3|NOT COMPLETED|Overall Study||4
44142|NCT01591044|101274|P2|NOT COMPLETED|Overall Study||9
44143|NCT01591044|101275|P1|NOT COMPLETED|Overall Study||7
44144|NCT01591044|101273|P3|COMPLETED|Overall Study||96
44145|NCT01591044|101274|P2|COMPLETED|Overall Study||91
44146|NCT01591044|101275|P1|COMPLETED|Overall Study||94
44147|NCT01591044|101273|P3|STARTED|Overall Study||100
44148|NCT01591044|101274|P2|STARTED|Overall Study||100
44149|NCT01591044|101275|P1|STARTED|Overall Study||101
44150|NCT01591018|101285|P2|NOT COMPLETED|Overall Study||0
44151|NCT01591018|101286|P1|NOT COMPLETED|Overall Study||0
44152|NCT01591018|101285|P2|COMPLETED|Overall Study||60
44153|NCT01591018|101286|P1|COMPLETED|Overall Study||60
44154|NCT01591018|101285|P2|STARTED|Overall Study||60
44155|NCT01591018|101286|P1|STARTED|Overall Study||60
44156|NCT01591005|101300|P4|NOT COMPLETED|Overall Study||0
44157|NCT01591005|101301|P3|NOT COMPLETED|Overall Study||0
44158|NCT01591005|101302|P2|NOT COMPLETED|Overall Study||0
44159|NCT01591005|101303|P1|NOT COMPLETED|Overall Study||0
44160|NCT01591005|101300|P4|COMPLETED|Overall Study||68
44161|NCT01591005|101301|P3|COMPLETED|Overall Study||68
44162|NCT01591005|101302|P2|COMPLETED|Overall Study||53
44163|NCT01591005|101303|P1|COMPLETED|Overall Study||53
44164|NCT01591005|101300|P4|STARTED|Overall Study||68
44165|NCT01591005|101301|P3|STARTED|Overall Study||68
44166|NCT01591005|101302|P2|STARTED|Overall Study||53
44167|NCT01591005|101303|P1|STARTED|Overall Study||53
44168|NCT01590888|101340|P3|NOT COMPLETED|Overall Study||1
44169|NCT01590888|101341|P2|NOT COMPLETED|Overall Study||0
44170|NCT01590888|101342|P1|NOT COMPLETED|Overall Study||4
44171|NCT01590888|101340|P3|COMPLETED|Overall Study||34
44172|NCT01590888|101341|P2|COMPLETED|Overall Study||38
44173|NCT01590888|101342|P1|COMPLETED|Overall Study||32
44174|NCT01590888|101340|P3|STARTED|Overall Study||35
44175|NCT01590888|101341|P2|STARTED|Overall Study||38
44176|NCT01590888|101342|P1|STARTED|Overall Study||36
44177|NCT01590810|101391|P5|NOT COMPLETED|Overall Study||0
44178|NCT01590810|101392|P4|NOT COMPLETED|Overall Study||0
44179|NCT01590810|101393|P3|NOT COMPLETED|Overall Study||1
44180|NCT01590810|101394|P2|NOT COMPLETED|Overall Study||1
44181|NCT01590810|101395|P1|NOT COMPLETED|Overall Study||0
44182|NCT01590810|101391|P5|COMPLETED|Overall Study||2
44183|NCT01590810|101392|P4|COMPLETED|Overall Study||8
44184|NCT01590810|101393|P3|COMPLETED|Overall Study||7
44185|NCT01590810|101394|P2|COMPLETED|Overall Study||7
44186|NCT01590810|101395|P1|COMPLETED|Overall Study||8
44187|NCT01590810|101391|P5|STARTED|Overall Study||2
44188|NCT01590810|101392|P4|STARTED|Overall Study||8
44189|NCT01590810|101393|P3|STARTED|Overall Study||8
44190|NCT01590810|101394|P2|STARTED|Overall Study||8
44191|NCT01590810|101395|P1|STARTED|Overall Study||8
44192|NCT01590797|101540|P2|NOT COMPLETED|Overall Study||16
44193|NCT01590797|101541|P1|NOT COMPLETED|Overall Study||17
44194|NCT01590797|101540|P2|COMPLETED|Overall Study||217
44195|NCT01590797|101541|P1|COMPLETED|Overall Study||217
44196|NCT01590797|101540|P2|STARTED|Overall Study||233
44197|NCT01590797|101541|P1|STARTED|Overall Study||234
44198|NCT01590771|101557|P2|NOT COMPLETED|Overall Study||39
44199|NCT01590771|101558|P1|NOT COMPLETED|Overall Study||19
44200|NCT01590771|101557|P2|COMPLETED|Overall Study||210
44201|NCT01590771|101558|P1|COMPLETED|Overall Study||230
44202|NCT01590771|101557|P2|STARTED|Overall Study||249
44203|NCT01590771|101558|P1|STARTED|Overall Study||249
44204|NCT01590563|101584|P1|NOT COMPLETED|Overall Study||1
44205|NCT01590563|101584|P1|COMPLETED|Overall Study||14
44206|NCT01590563|101584|P1|STARTED|Overall Study||15
44207|NCT01590550|101590|P1|NOT COMPLETED|Overall Study||0
44208|NCT01590550|101590|P1|COMPLETED|Overall Study||18
44209|NCT01590550|101590|P1|STARTED|Overall Study||18
44210|NCT01590264|101596|P1|NOT COMPLETED|Overall Study||0
44211|NCT01590264|101596|P1|COMPLETED|Overall Study||5
44212|NCT01590264|101596|P1|STARTED|Overall Study||5
44213|NCT01590238|101601|P1|NOT COMPLETED|Overall Study||2
44214|NCT01590238|101601|P1|COMPLETED|Overall Study||13
44215|NCT01590238|101601|P1|STARTED|Overall Study||15
44216|NCT01590212|101608|P3|NOT COMPLETED|Overall Study||5
44217|NCT01590212|101609|P2|NOT COMPLETED|Overall Study||4
44218|NCT01590212|101610|P1|NOT COMPLETED|Overall Study||3
44219|NCT01590212|101608|P3|COMPLETED|Overall Study||9
44220|NCT01590212|101609|P2|COMPLETED|Overall Study||5
44221|NCT01590212|101610|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
44222|NCT01590212|101608|P3|Post-intervention|Overall Study|failed contact=1|10
44223|NCT01590212|101609|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
44224|NCT01590212|101610|P1|Post-intervention|Overall Study|failed contact=3|7
44225|NCT01590212|101608|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
44226|NCT01590212|101609|P2|Baseline (Pre-intervention)|Overall Study||9
44227|NCT01590212|101610|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
44228|NCT01590212|101608|P3|STARTED|Overall Study||14
44229|NCT01590212|101609|P2|STARTED|Overall Study||9
44230|NCT01590212|101610|P1|STARTED|Overall Study||12
44231|NCT01589978|101627|P1|NOT COMPLETED|Overall Study||0
44232|NCT01589978|101627|P1|COMPLETED|Overall Study||2681
44233|NCT01589978|101627|P1|STARTED|Overall Study||2681
44234|NCT01589822|101654|P3|NOT COMPLETED|Overall Study||1
44235|NCT01589822|101655|P2|NOT COMPLETED|Overall Study||3
44236|NCT01589822|101656|P1|NOT COMPLETED|Overall Study||4
44237|NCT01589822|101654|P3|COMPLETED|Overall Study||40
44238|NCT01589822|101655|P2|COMPLETED|Overall Study||86
44239|NCT01589822|101656|P1|COMPLETED|Overall Study||80
44240|NCT01589822|101654|P3|STARTED|Overall Study||41
44241|NCT01589822|101655|P2|STARTED|Overall Study||89
44242|NCT01589822|101656|P1|STARTED|Overall Study||84
44243|NCT01589653|101675|P2|NOT COMPLETED|Overall Study||11
44244|NCT01589653|101676|P1|NOT COMPLETED|Overall Study||7
44245|NCT01589653|101675|P2|COMPLETED|Overall Study||68
44246|NCT01589653|101676|P1|COMPLETED|Overall Study||69
44247|NCT01589653|101675|P2|Exposed|Overall Study||78
44248|NCT01589653|101676|P1|Exposed|Overall Study||76
44249|NCT01589653|101675|P2|STARTED|Overall Study||79
44250|NCT01589653|101676|P1|STARTED|Overall Study||76
44251|NCT01589510|101690|P1|NOT COMPLETED|Overall Study||33
44252|NCT01589510|101690|P1|COMPLETED|Overall Study||386
44253|NCT01589510|101690|P1|STARTED|Overall Study||419
44254|NCT01589484|101701|P1|NOT COMPLETED|Overall Study||4
44255|NCT01589484|101701|P1|COMPLETED|Overall Study||100
44256|NCT01589484|101701|P1|STARTED|Overall Study||104
44257|NCT01589445|101706|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
44258|NCT01589445|101706|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
44259|NCT01589445|101706|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
44260|NCT01589445|101706|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
44261|NCT01589445|101706|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
44262|NCT01589445|101706|P1|STARTED|001 (Pioglitazone) -3 Months||77
44263|NCT01589237|101726|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
44264|NCT01589237|101727|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
44265|NCT01589237|101728|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
44266|NCT01589237|101729|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
44267|NCT01589237|101726|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
44268|NCT01589237|101727|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
44269|NCT01589237|101728|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
44270|NCT01589237|101729|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
44271|NCT01589237|101726|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
44272|NCT01589237|101727|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
44273|NCT01589237|101728|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
44274|NCT01589237|101729|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
44275|NCT01589237|101726|P4|NOT COMPLETED|Part A (52 Weeks)||0
44276|NCT01589237|101727|P3|NOT COMPLETED|Part A (52 Weeks)||2
44277|NCT01589237|101728|P2|NOT COMPLETED|Part A (52 Weeks)||3
44278|NCT01589237|101729|P1|NOT COMPLETED|Part A (52 Weeks)||2
44279|NCT01589237|101726|P4|COMPLETED|Part A (52 Weeks)||5
44280|NCT01589237|101727|P3|COMPLETED|Part A (52 Weeks)||8
44281|NCT01589237|101728|P2|COMPLETED|Part A (52 Weeks)||9
44282|NCT01589237|101729|P1|COMPLETED|Part A (52 Weeks)||9
44283|NCT01589237|101726|P4|STARTED|Part A (52 Weeks)||5
44284|NCT01589237|101727|P3|STARTED|Part A (52 Weeks)||10
44285|NCT01589237|101728|P2|STARTED|Part A (52 Weeks)||12
44286|NCT01589237|101729|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
44287|NCT01588548|101781|P6|NOT COMPLETED|Overall Study||6
44288|NCT01588548|101782|P5|NOT COMPLETED|Overall Study||6
44289|NCT01588548|101783|P4|NOT COMPLETED|Overall Study||7
44290|NCT01588548|101784|P3|NOT COMPLETED|Overall Study||6
44291|NCT01588548|101785|P2|NOT COMPLETED|Overall Study||7
44292|NCT01588548|101786|P1|NOT COMPLETED|Overall Study||3
44293|NCT01588548|101781|P6|COMPLETED|Overall Study||0
44294|NCT01588548|101782|P5|COMPLETED|Overall Study||0
44295|NCT01588548|101783|P4|COMPLETED|Overall Study||0
44296|NCT01588548|101784|P3|COMPLETED|Overall Study||0
44297|NCT01588548|101785|P2|COMPLETED|Overall Study||0
44298|NCT01588548|101786|P1|COMPLETED|Overall Study||0
44299|NCT01588548|101781|P6|Cycle 1 Day 21|Overall Study||3
44300|NCT01588548|101782|P5|Cycle 1 Day 21|Overall Study||3
44301|NCT01588548|101783|P4|Cycle 1 Day 21|Overall Study||5
44302|NCT01588548|101784|P3|Cycle 1 Day 21|Overall Study||2
44303|NCT01588548|101785|P2|Cycle 1 Day 21|Overall Study||5
44304|NCT01588548|101786|P1|Cycle 1 Day 21|Overall Study||3
44305|NCT01588548|101781|P6|STARTED|Overall Study||6
44306|NCT01588548|101782|P5|STARTED|Overall Study||6
44307|NCT01588548|101783|P4|STARTED|Overall Study||7
44308|NCT01588548|101784|P3|STARTED|Overall Study||6
44309|NCT01588548|101785|P2|STARTED|Overall Study||7
44310|NCT01588548|101786|P1|STARTED|Overall Study||3
44311|NCT01588496|101803|P3|NOT COMPLETED|Overall Study||0
44312|NCT01588496|101804|P2|NOT COMPLETED|Overall Study||1
44313|NCT01588496|101805|P1|NOT COMPLETED|Overall Study||0
44314|NCT01588496|101803|P3|COMPLETED|Overall Study||33
44315|NCT01588496|101804|P2|COMPLETED|Overall Study||16
44316|NCT01588496|101805|P1|COMPLETED|Overall Study||8
44317|NCT01588496|101803|P3|Received Treatment|Overall Study||33
44318|NCT01588496|101804|P2|Received Treatment|Overall Study||16
44319|NCT01588496|101805|P1|Received Treatment|Overall Study||8
44320|NCT01588496|101803|P3|STARTED|Overall Study||33
44321|NCT01588496|101804|P2|STARTED|Overall Study||17
44322|NCT01588496|101805|P1|STARTED|Overall Study||8
44323|NCT01588444|101832|P2|NOT COMPLETED|Overall Study||0
44324|NCT01588444|101833|P1|NOT COMPLETED|Overall Study||0
44325|NCT01588444|101832|P2|COMPLETED|Overall Study||20
44326|NCT01588444|101833|P1|COMPLETED|Overall Study||20
44327|NCT01588444|101832|P2|STARTED|Overall Study||20
44328|NCT01588444|101833|P1|STARTED|Overall Study||20
44329|NCT01588405|101839|P1|NOT COMPLETED|Overall Study||2
44330|NCT01588405|101839|P1|COMPLETED|Overall Study||31
44331|NCT01588405|101839|P1|STARTED|Overall Study||33
44332|NCT01588353|101866|P3|NOT COMPLETED|Step3||2
44333|NCT01588353|101867|P2|NOT COMPLETED|Step3||0
44334|NCT01588353|101868|P1|NOT COMPLETED|Step3||0
44335|NCT01588353|101866|P3|COMPLETED|Step3||23
44336|NCT01588353|101867|P2|COMPLETED|Step3||0
44337|NCT01588353|101868|P1|COMPLETED|Step3||0
44338|NCT01588353|101866|P3|STARTED|Step3||25
44339|NCT01588353|101867|P2|STARTED|Step3||0
44340|NCT01588353|101868|P1|STARTED|Step3||0
44341|NCT01588353|101866|P3|NOT COMPLETED|Step2||0
44342|NCT01588353|101867|P2|NOT COMPLETED|Step2||1
44343|NCT01588353|101868|P1|NOT COMPLETED|Step2||0
44344|NCT01588353|101866|P3|COMPLETED|Step2||0
44345|NCT01588353|101867|P2|COMPLETED|Step2||70
44346|NCT01588353|101868|P1|COMPLETED|Step2||0
44347|NCT01588353|101866|P3|STARTED|Step2||0
44348|NCT01588353|101867|P2|STARTED|Step2||71
44349|NCT01588353|101868|P1|STARTED|Step2||0
44350|NCT01588353|101866|P3|NOT COMPLETED|Step1||0
44351|NCT01588353|101867|P2|NOT COMPLETED|Step1||0
44352|NCT01588353|101868|P1|NOT COMPLETED|Step1||0
44353|NCT01588353|101866|P3|COMPLETED|Step1||0
44354|NCT01588353|101867|P2|COMPLETED|Step1||0
44355|NCT01588353|101868|P1|COMPLETED|Step1||6
44356|NCT01588353|101866|P3|STARTED|Step1||0
44357|NCT01588353|101867|P2|STARTED|Step1||0
44358|NCT01588353|101868|P1|STARTED|Step1||6
44359|NCT01588158|101886|P2|NOT COMPLETED|Overall Study||0
44360|NCT01588158|101887|P1|NOT COMPLETED|Overall Study||0
44361|NCT01588158|101886|P2|COMPLETED|Overall Study||3
44362|NCT01588158|101887|P1|COMPLETED|Overall Study||4
44363|NCT01588158|101886|P2|STARTED|Overall Study||3
44364|NCT01588158|101887|P1|STARTED|Overall Study||4
44365|NCT01587989|101907|P3|NOT COMPLETED|Randomized Study Treatment||1
44366|NCT01587989|101908|P2|NOT COMPLETED|Randomized Study Treatment||2
44367|NCT01587989|101909|P1|NOT COMPLETED|Randomized Study Treatment||0
44368|NCT01587989|101907|P3|COMPLETED|Randomized Study Treatment||32
44369|NCT01587989|101908|P2|COMPLETED|Randomized Study Treatment||30
44370|NCT01587989|101909|P1|COMPLETED|Randomized Study Treatment||0
44371|NCT01587989|101907|P3|STARTED|Randomized Study Treatment||33
44372|NCT01587989|101908|P2|STARTED|Randomized Study Treatment||32
44373|NCT01587989|101909|P1|STARTED|Randomized Study Treatment||0
44374|NCT01587989|101907|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
44375|NCT01587989|101908|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
44376|NCT01587989|101909|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
44377|NCT01587989|101907|P3|COMPLETED|12-Week Open-Label Run-In Period||0
44378|NCT01587989|101908|P2|COMPLETED|12-Week Open-Label Run-In Period||0
44379|NCT01587989|101909|P1|COMPLETED|12-Week Open-Label Run-In Period||65
44380|NCT01587989|101907|P3|STARTED|12-Week Open-Label Run-In Period||0
44381|NCT01587989|101908|P2|STARTED|12-Week Open-Label Run-In Period||0
44382|NCT01587989|101909|P1|STARTED|12-Week Open-Label Run-In Period||77
44383|NCT01587950|101931|P1|NOT COMPLETED|Period 3||0
44384|NCT01587950|101931|P1|COMPLETED|Period 3||12
44385|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
44386|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
44387|NCT01587950|101931|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
44388|NCT01587950|101931|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
44389|NCT01587950|101931|P1|Received Sterile Water (5 Minutes)|Period 3||5
44390|NCT01587950|101931|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
44391|NCT01587950|101931|P1|Received Sterile Water (2 Minutes)|Period 3||2
44392|NCT01587950|101931|P1|Received Sterile Water (10 Minutes)|Period 3||5
44393|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
44394|NCT01587950|101931|P1|STARTED|Period 3||12
44395|NCT01587950|101931|P1|NOT COMPLETED|Washout 2||0
44396|NCT01587950|101931|P1|COMPLETED|Washout 2||12
44397|NCT01587950|101931|P1|STARTED|Washout 2||12
44398|NCT01587950|101931|P1|NOT COMPLETED|Period 2||0
44399|NCT01587950|101931|P1|COMPLETED|Period 2||12
44400|NCT01587950|101931|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
44401|NCT01587950|101931|P1|Received Sterile Water (10 Minutes)|Period 2||2
44402|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
44403|NCT01587950|101931|P1|Received Sterile Water (5 Minutes)|Period 2||2
44404|NCT01587950|101931|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
44405|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
44406|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
44407|NCT01587950|101931|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
44408|NCT01587950|101931|P1|Received Sterile Water (2 Minutes)|Period 2||8
44409|NCT01587950|101931|P1|STARTED|Period 2||12
44410|NCT01587950|101931|P1|NOT COMPLETED|Washout 1||0
44411|NCT01587950|101931|P1|COMPLETED|Washout 1||12
44412|NCT01587950|101931|P1|STARTED|Washout 1||12
44413|NCT01587950|101931|P1|NOT COMPLETED|Period 1||0
44414|NCT01587950|101931|P1|COMPLETED|Period 1||12
44415|NCT01587950|101931|P1|Received Sterile Water (5 Minutes)|Period 1||5
44416|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
44417|NCT01587950|101931|P1|Received Sterile Water (10 Minutes)|Period 1||5
44418|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
44419|NCT01587950|101931|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
44420|NCT01587950|101931|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
44421|NCT01587950|101931|P1|Received Sterile Water (2 Minutes)|Period 1||2
44422|NCT01587950|101931|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
44423|NCT01587950|101931|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
44424|NCT01587950|101931|P1|STARTED|Period 1||12
44425|NCT01587885|101961|P2|NOT COMPLETED|Treatment Period 2||0
44426|NCT01587885|101962|P1|NOT COMPLETED|Treatment Period 2||0
44427|NCT01587885|101961|P2|COMPLETED|Treatment Period 2||19
44428|NCT01587885|101962|P1|COMPLETED|Treatment Period 2||26
44429|NCT01587885|101961|P2|STARTED|Treatment Period 2||19
44430|NCT01587885|101962|P1|STARTED|Treatment Period 2||26
44431|NCT01587885|101961|P2|NOT COMPLETED|Treatment Period 1||3
44432|NCT01587885|101962|P1|NOT COMPLETED|Treatment Period 1||0
44433|NCT01587885|101961|P2|COMPLETED|Treatment Period 1||19
44434|NCT01587885|101962|P1|COMPLETED|Treatment Period 1||26
44435|NCT01587885|101961|P2|STARTED|Treatment Period 1||22
44436|NCT01587885|101962|P1|STARTED|Treatment Period 1||26
44437|NCT01587651|101978|P3|NOT COMPLETED|Overall Study||1
44438|NCT01587651|101979|P2|NOT COMPLETED|Overall Study||3
44439|NCT01587651|101980|P1|NOT COMPLETED|Overall Study||0
44440|NCT01587651|101978|P3|COMPLETED|Overall Study||34
44441|NCT01587651|101979|P2|COMPLETED|Overall Study||38
44442|NCT01587651|101980|P1|COMPLETED|Overall Study||34
44443|NCT01587651|101978|P3|STARTED|Overall Study||35
44444|NCT01587651|101979|P2|STARTED|Overall Study||41
44445|NCT01587651|101980|P1|STARTED|Overall Study||34
44446|NCT01587118|102007|P1|NOT COMPLETED|Overall Study||7
44447|NCT01587118|102007|P1|COMPLETED|Overall Study||11
44448|NCT01587118|102007|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
44449|NCT01587079|102012|P1|NOT COMPLETED|Overall Study||39
44450|NCT01587079|102012|P1|COMPLETED|Overall Study||120
44451|NCT01587079|102012|P1|STARTED|Overall Study||159
44452|NCT01587027|102136|P2|NOT COMPLETED|Discharge (1 Day)||0
44453|NCT01587027|102137|P1|NOT COMPLETED|Discharge (1 Day)||0
44454|NCT01587027|102136|P2|COMPLETED|Discharge (1 Day)||8
44455|NCT01587027|102137|P1|COMPLETED|Discharge (1 Day)||8
44456|NCT01587027|102136|P2|STARTED|Discharge (1 Day)||8
44457|NCT01587027|102137|P1|STARTED|Discharge (1 Day)||8
44458|NCT01587027|102136|P2|NOT COMPLETED|Third Intervention (1 Day)||0
44459|NCT01587027|102137|P1|NOT COMPLETED|Third Intervention (1 Day)||0
44460|NCT01587027|102136|P2|COMPLETED|Third Intervention (1 Day)||8
44461|NCT01587027|102137|P1|COMPLETED|Third Intervention (1 Day)||8
44462|NCT01587027|102136|P2|STARTED|Third Intervention (1 Day)||8
44463|NCT01587027|102137|P1|STARTED|Third Intervention (1 Day)||8
44464|NCT01587027|102136|P2|NOT COMPLETED|Washout (1 Day)||0
44465|NCT01587027|102137|P1|NOT COMPLETED|Washout (1 Day)||0
44466|NCT01587027|102136|P2|COMPLETED|Washout (1 Day)||8
44467|NCT01587027|102137|P1|COMPLETED|Washout (1 Day)||8
44468|NCT01587027|102136|P2|STARTED|Washout (1 Day)||8
44469|NCT01587027|102137|P1|STARTED|Washout (1 Day)||8
44470|NCT01587027|102136|P2|NOT COMPLETED|Second Intervention (1 Day)||0
44471|NCT01587027|102137|P1|NOT COMPLETED|Second Intervention (1 Day)||0
44472|NCT01587027|102136|P2|COMPLETED|Second Intervention (1 Day)||8
44473|NCT01587027|102137|P1|COMPLETED|Second Intervention (1 Day)||8
44474|NCT01587027|102136|P2|STARTED|Second Intervention (1 Day)||8
44475|NCT01587027|102137|P1|STARTED|Second Intervention (1 Day)||8
44476|NCT01587027|102136|P2|NOT COMPLETED|Washout (1 Day)||0
44477|NCT01587027|102137|P1|NOT COMPLETED|Washout (1 Day)||0
44478|NCT01587027|102136|P2|COMPLETED|Washout (1 Day)||8
44479|NCT01587027|102137|P1|COMPLETED|Washout (1 Day)||8
44480|NCT01587027|102136|P2|STARTED|Washout (1 Day)||8
44481|NCT01587027|102137|P1|STARTED|Washout (1 Day)||8
44482|NCT01587027|102136|P2|NOT COMPLETED|First Intervention (1 Day)||0
44483|NCT01587027|102137|P1|NOT COMPLETED|First Intervention (1 Day)||0
44484|NCT01587027|102136|P2|COMPLETED|First Intervention (1 Day)||8
44485|NCT01587027|102137|P1|COMPLETED|First Intervention (1 Day)||8
44486|NCT01587027|102136|P2|STARTED|First Intervention (1 Day)||8
44487|NCT01587027|102137|P1|STARTED|First Intervention (1 Day)||8
44488|NCT01587014|102143|P1|NOT COMPLETED|Overall Study||2
44489|NCT01587014|102143|P1|COMPLETED|Overall Study||24
44490|NCT01587014|102143|P1|STARTED|Overall Study||26
44491|NCT01587001|102150|P2|NOT COMPLETED|Overall Study||1
44492|NCT01587001|102151|P1|NOT COMPLETED|Overall Study||6
44493|NCT01587001|102150|P2|COMPLETED|Overall Study||2
44494|NCT01587001|102151|P1|COMPLETED|Overall Study||8
44495|NCT01587001|102150|P2|STARTED|Overall Study||3
44496|NCT01587001|102151|P1|STARTED|Overall Study||14
44497|NCT01586975|102162|P3|NOT COMPLETED|Overall Study||0
44498|NCT01586975|102163|P2|NOT COMPLETED|Overall Study||0
44499|NCT01586975|102164|P1|NOT COMPLETED|Overall Study||0
44500|NCT01586975|102162|P3|COMPLETED|Overall Study||46
44501|NCT01586975|102163|P2|COMPLETED|Overall Study||32
44502|NCT01586975|102164|P1|COMPLETED|Overall Study||15
44503|NCT01586975|102162|P3|STARTED|Overall Study||46
44504|NCT01586975|102163|P2|STARTED|Overall Study||32
44505|NCT01586975|102164|P1|STARTED|Overall Study||15
44506|NCT01586962|102172|P1|NOT COMPLETED|Overall Study||0
44507|NCT01586962|102172|P1|COMPLETED|Overall Study||56
44508|NCT01586962|102172|P1|STARTED|Overall Study||56
44509|NCT01586897|102180|P2|NOT COMPLETED|Overall Study||0
44510|NCT01586897|102181|P1|NOT COMPLETED|Overall Study||0
44511|NCT01586897|102180|P2|COMPLETED|Overall Study||26
44512|NCT01586897|102181|P1|COMPLETED|Overall Study||26
44513|NCT01586897|102180|P2|STARTED|Overall Study||26
44514|NCT01586897|102181|P1|STARTED|Overall Study||26
44515|NCT01586806|102200|P3|NOT COMPLETED|Overall Study||2
44516|NCT01586806|102201|P2|NOT COMPLETED|Overall Study||4
44517|NCT01586806|102202|P1|NOT COMPLETED|Overall Study||3
44518|NCT01586806|102200|P3|COMPLETED|Overall Study||63
44519|NCT01586806|102201|P2|COMPLETED|Overall Study||61
44520|NCT01586806|102202|P1|COMPLETED|Overall Study||62
44521|NCT01586806|102200|P3|STARTED|Overall Study||65
44522|NCT01586806|102201|P2|STARTED|Overall Study||65
44523|NCT01586806|102202|P1|STARTED|Overall Study||65
44524|NCT01586364|102222|P1|NOT COMPLETED|Overall Study||117
44525|NCT01586364|102222|P1|COMPLETED|Overall Study||184
44526|NCT01586364|102222|P1|STARTED|Overall Study||301
44527|NCT01586338|102275|P1|NOT COMPLETED|Overall Study||8
44528|NCT01586338|102275|P1|COMPLETED|Overall Study||229
44529|NCT01586338|102275|P1|STARTED|Overall Study||237
44530|NCT01586312|102287|P2|NOT COMPLETED|Overall Study||0
44531|NCT01586312|102288|P1|NOT COMPLETED|Overall Study||0
44532|NCT01586312|102287|P2|COMPLETED|Overall Study||15
44533|NCT01586312|102288|P1|COMPLETED|Overall Study||15
44534|NCT01586312|102287|P2|STARTED|Overall Study||15
44535|NCT01586312|102288|P1|STARTED|Overall Study||15
44536|NCT01586026|102298|P3|NOT COMPLETED|Overall Study||0
44537|NCT01586026|102299|P2|NOT COMPLETED|Overall Study||0
44538|NCT01586026|102300|P1|NOT COMPLETED|Overall Study||0
44539|NCT01586026|102298|P3|COMPLETED|Overall Study||271
44540|NCT01586026|102299|P2|COMPLETED|Overall Study||414
44541|NCT01586026|102300|P1|COMPLETED|Overall Study||350
44542|NCT01586026|102298|P3|STARTED|Overall Study||271
44543|NCT01586026|102299|P2|STARTED|Overall Study||414
44544|NCT01586026|102300|P1|STARTED|Overall Study||350
44545|NCT01585987|102310|P2|NOT COMPLETED|Treated||49
44546|NCT01585987|102311|P1|NOT COMPLETED|Treated||54
44547|NCT01585987|102310|P2|COMPLETED|Treated||2
44548|NCT01585987|102311|P1|COMPLETED|Treated||3
44549|NCT01585987|102310|P2|STARTED|Treated||51
44550|NCT01585987|102311|P1|STARTED|Treated||57
44551|NCT01585987|102310|P2|NOT COMPLETED|Randomized||6
44552|NCT01585987|102311|P1|NOT COMPLETED|Randomized||0
44553|NCT01585987|102310|P2|COMPLETED|Randomized||51
44554|NCT01585987|102311|P1|COMPLETED|Randomized||57
44555|NCT01585987|102310|P2|STARTED|Randomized||57
44556|NCT01585987|102311|P1|STARTED|Randomized||57
44557|NCT01585961|102326|P1|NOT COMPLETED|Overall Study||33
44558|NCT01585961|102326|P1|COMPLETED|Overall Study||478
44559|NCT01585961|102326|P1|Safety|Overall Study|Patients ablated with study catheter|508
44560|NCT01585961|102326|P1|STARTED|Overall Study||511
44561|NCT01585597|102341|P1|NOT COMPLETED|Overall Study||0
44562|NCT01585597|102341|P1|COMPLETED|Overall Study||20
44563|NCT01585597|102341|P1|STARTED|Overall Study||20
44564|NCT01585584|102346|P1|NOT COMPLETED|Overall Study||4
44565|NCT01585584|102346|P1|COMPLETED|Overall Study||6
44566|NCT01585584|102346|P1|STARTED|Overall Study||10
44567|NCT01585558|102353|P3|NOT COMPLETED|Overall Study||15
44568|NCT01585558|102354|P2|NOT COMPLETED|Overall Study||12
44569|NCT01585558|102355|P1|NOT COMPLETED|Overall Study||13
44570|NCT01585558|102353|P3|COMPLETED|Overall Study||34
44571|NCT01585558|102354|P2|COMPLETED|Overall Study||57
44572|NCT01585558|102355|P1|COMPLETED|Overall Study||49
44573|NCT01585558|102353|P3|STARTED|Overall Study||49
44574|NCT01585558|102354|P2|STARTED|Overall Study||69
44575|NCT01585558|102355|P1|STARTED|Overall Study||62
44576|NCT01585441|102536|P2|NOT COMPLETED|Overall Study||0
44577|NCT01585441|102537|P1|NOT COMPLETED|Overall Study||0
44578|NCT01585441|102536|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
44579|NCT01585441|102537|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
44580|NCT01585441|102536|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
44581|NCT01585441|102537|P1|Final Study Safety Visit|Overall Study||3
44582|NCT01585441|102536|P2|Received Finasteride at Month 3|Overall Study||2
44583|NCT01585441|102537|P1|Received Finasteride at Month 3|Overall Study||2
44584|NCT01585441|102536|P2|Month 3|Overall Study||3
44585|NCT01585441|102537|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
44586|NCT01585441|102536|P2|STARTED|Overall Study||3
44587|NCT01585441|102537|P1|STARTED|Overall Study||3
44588|NCT01585324|102587|P1|NOT COMPLETED|Overall Study||0
44589|NCT01585324|102587|P1|COMPLETED|Overall Study||30
44590|NCT01585324|102587|P1|STARTED|Overall Study||30
44591|NCT01585272|102603|P1|NOT COMPLETED|Overall Study||39
44592|NCT01585272|102603|P1|COMPLETED|Overall Study||82
44593|NCT01585272|102603|P1|Exelon Patch 10 cm2|Overall Study||96
44594|NCT01585272|102603|P1|Exelon Patch 5 cm2|Overall Study||114
44595|NCT01585272|102603|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
44596|NCT01585272|102603|P1|STARTED|Overall Study||121
44597|NCT01585038|102613|P2|NOT COMPLETED|Overall Study||2
44598|NCT01585038|102614|P1|NOT COMPLETED|Overall Study||2
44599|NCT01585038|102613|P2|COMPLETED|Overall Study||18
44600|NCT01585038|102614|P1|COMPLETED|Overall Study||18
44601|NCT01585038|102613|P2|STARTED|Overall Study||20
44602|NCT01585038|102614|P1|STARTED|Overall Study||20
44603|NCT01584843|102630|P6|NOT COMPLETED|Second Treatment Period||1
44604|NCT01584843|102631|P5|NOT COMPLETED|Second Treatment Period||0
44605|NCT01584843|102632|P4|NOT COMPLETED|Second Treatment Period||0
44606|NCT01584843|102633|P3|NOT COMPLETED|Second Treatment Period||0
44607|NCT01584843|102634|P2|NOT COMPLETED|Second Treatment Period||0
44608|NCT01584843|102635|P1|NOT COMPLETED|Second Treatment Period||0
44609|NCT01584843|102630|P6|COMPLETED|Second Treatment Period||0
44610|NCT01584843|102631|P5|COMPLETED|Second Treatment Period||3
44611|NCT01584843|102632|P4|COMPLETED|Second Treatment Period||6
44612|NCT01584843|102633|P3|COMPLETED|Second Treatment Period||2
44613|NCT01584843|102634|P2|COMPLETED|Second Treatment Period||1
44614|NCT01584843|102635|P1|COMPLETED|Second Treatment Period||2
44615|NCT01584843|102630|P6|STARTED|Second Treatment Period||1
44616|NCT01584843|102631|P5|STARTED|Second Treatment Period||3
44617|NCT01584843|102632|P4|STARTED|Second Treatment Period||6
44618|NCT01584843|102633|P3|STARTED|Second Treatment Period||2
44619|NCT01584843|102634|P2|STARTED|Second Treatment Period||1
44620|NCT01584843|102635|P1|STARTED|Second Treatment Period||2
44621|NCT01584843|102630|P6|NOT COMPLETED|First Treatment Period||2
44622|NCT01584843|102631|P5|NOT COMPLETED|First Treatment Period||0
44623|NCT01584843|102632|P4|NOT COMPLETED|First Treatment Period||0
44624|NCT01584843|102633|P3|NOT COMPLETED|First Treatment Period||1
44625|NCT01584843|102634|P2|NOT COMPLETED|First Treatment Period||0
44626|NCT01584843|102635|P1|NOT COMPLETED|First Treatment Period||0
44627|NCT01584843|102630|P6|COMPLETED|First Treatment Period||9
44628|NCT01584843|102631|P5|COMPLETED|First Treatment Period||10
44629|NCT01584843|102632|P4|COMPLETED|First Treatment Period||10
44630|NCT01584843|102633|P3|COMPLETED|First Treatment Period||2
44631|NCT01584843|102634|P2|COMPLETED|First Treatment Period||4
44632|NCT01584843|102635|P1|COMPLETED|First Treatment Period||3
44633|NCT01584843|102630|P6|STARTED|First Treatment Period||11
44634|NCT01584843|102631|P5|STARTED|First Treatment Period||10
44635|NCT01584843|102632|P4|STARTED|First Treatment Period||10
44636|NCT01584843|102633|P3|STARTED|First Treatment Period||3
44637|NCT01584843|102634|P2|STARTED|First Treatment Period||4
44638|NCT01584843|102635|P1|STARTED|First Treatment Period||3
44639|NCT01584648|102746|P2|NOT COMPLETED|Overall Study||212
44640|NCT01584648|102747|P1|NOT COMPLETED|Overall Study||211
44641|NCT01584648|102746|P2|COMPLETED|Overall Study||0
44642|NCT01584648|102747|P1|COMPLETED|Overall Study||0
44643|NCT01584648|102746|P2|Ongoing|Overall Study||147
44644|NCT01584648|102747|P1|Ongoing|Overall Study||154
44645|NCT01584648|102746|P2|STARTED|Overall Study||212
44646|NCT01584648|102747|P1|STARTED|Overall Study||211
44647|NCT01584544|102790|P5|NOT COMPLETED|Overall Study||0
44648|NCT01584544|102791|P4|NOT COMPLETED|Overall Study||0
44649|NCT01584544|102792|P3|NOT COMPLETED|Overall Study||0
44650|NCT01584544|102793|P2|NOT COMPLETED|Overall Study||0
44651|NCT01584544|102794|P1|NOT COMPLETED|Overall Study||0
44652|NCT01584544|102790|P5|COMPLETED|Overall Study||6
44653|NCT01584544|102791|P4|COMPLETED|Overall Study||3
44654|NCT01584544|102792|P3|COMPLETED|Overall Study||6
44655|NCT01584544|102793|P2|COMPLETED|Overall Study||6
44656|NCT01584544|102794|P1|COMPLETED|Overall Study||3
44657|NCT01584544|102790|P5|STARTED|Overall Study||6
44658|NCT01584544|102791|P4|STARTED|Overall Study||3
44659|NCT01584544|102792|P3|STARTED|Overall Study||6
44660|NCT01584544|102793|P2|STARTED|Overall Study||6
44661|NCT01584544|102794|P1|STARTED|Overall Study||3
44662|NCT01584518|102808|P2|NOT COMPLETED|Overall Study||0
44663|NCT01584518|102809|P1|NOT COMPLETED|Overall Study||0
44664|NCT01584518|102808|P2|COMPLETED|Overall Study||25
44665|NCT01584518|102809|P1|COMPLETED|Overall Study||25
44666|NCT01584518|102808|P2|STARTED|Overall Study||25
44667|NCT01584518|102809|P1|STARTED|Overall Study||25
44668|NCT01584479|102819|P4|NOT COMPLETED|Overall Study||0
44669|NCT01584479|102820|P3|NOT COMPLETED|Overall Study||0
44670|NCT01584479|102821|P2|NOT COMPLETED|Overall Study||0
44671|NCT01584479|102822|P1|NOT COMPLETED|Overall Study||0
44672|NCT01584479|102819|P4|COMPLETED|Overall Study||1847
44673|NCT01584479|102820|P3|COMPLETED|Overall Study||852
44674|NCT01584479|102821|P2|COMPLETED|Overall Study||1686
44675|NCT01584479|102822|P1|COMPLETED|Overall Study||732
44676|NCT01584479|102819|P4|STARTED|Overall Study||1847
44677|NCT01584479|102820|P3|STARTED|Overall Study||852
44678|NCT01584479|102821|P2|STARTED|Overall Study||1686
44679|NCT01584479|102822|P1|STARTED|Overall Study||732
44680|NCT01584232|102834|P2|NOT COMPLETED|Overall Study||3
44681|NCT01584232|102835|P1|NOT COMPLETED|Overall Study||8
44682|NCT01584232|102834|P2|COMPLETED|Overall Study||177
44683|NCT01584232|102835|P1|COMPLETED|Overall Study||173
44684|NCT01584232|102834|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
44685|NCT01584232|102835|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
44686|NCT01584232|102834|P2|STARTED|Overall Study||180
44687|NCT01584232|102835|P1|STARTED|Overall Study||181
44688|NCT01583894|102851|P1|NOT COMPLETED|Overall Study||15
44689|NCT01583894|102851|P1|COMPLETED|Overall Study||813
44690|NCT01583894|102851|P1|STARTED|Overall Study||828
44691|NCT01583647|102855|P2|NOT COMPLETED|Overall Study||0
44692|NCT01583647|102856|P1|NOT COMPLETED|Overall Study||0
44693|NCT01583647|102855|P2|COMPLETED|Overall Study||0
44694|NCT01583647|102856|P1|COMPLETED|Overall Study||10
44695|NCT01583647|102855|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
44696|NCT01583647|102856|P1|STARTED|Overall Study||10
44697|NCT01583530|102874|P6|NOT COMPLETED|Overall Study||3
44698|NCT01583530|102875|P5|NOT COMPLETED|Overall Study||5
44699|NCT01583530|102876|P4|NOT COMPLETED|Overall Study||1
44700|NCT01583530|102877|P3|NOT COMPLETED|Overall Study||0
44701|NCT01583530|102878|P2|NOT COMPLETED|Overall Study||3
44702|NCT01583530|102879|P1|NOT COMPLETED|Overall Study||0
44703|NCT01583530|102874|P6|COMPLETED|Overall Study||17
44704|NCT01583530|102875|P5|COMPLETED|Overall Study||15
44705|NCT01583530|102876|P4|COMPLETED|Overall Study||18
44706|NCT01583530|102877|P3|COMPLETED|Overall Study||20
44707|NCT01583530|102878|P2|COMPLETED|Overall Study||17
44708|NCT01583530|102879|P1|COMPLETED|Overall Study||19
44709|NCT01583530|102874|P6|STARTED|Overall Study||20
44710|NCT01583530|102875|P5|STARTED|Overall Study||20
44711|NCT01583530|102876|P4|STARTED|Overall Study||19
44712|NCT01583530|102877|P3|STARTED|Overall Study||20
44713|NCT01583530|102878|P2|STARTED|Overall Study||20
44714|NCT01583530|102879|P1|STARTED|Overall Study||19
44715|NCT01583452|102925|P2|NOT COMPLETED|Overall Study||0
44716|NCT01583452|102926|P1|NOT COMPLETED|Overall Study||0
44717|NCT01583452|102925|P2|COMPLETED|Overall Study||20
44718|NCT01583452|102926|P1|COMPLETED|Overall Study||21
44719|NCT01583452|102925|P2|STARTED|Overall Study||20
44720|NCT01583452|102926|P1|STARTED|Overall Study||21
44721|NCT01583374|102941|P3|NOT COMPLETED|Overall Study||25
44722|NCT01583374|102942|P2|NOT COMPLETED|Overall Study||16
44723|NCT01583374|102943|P1|NOT COMPLETED|Overall Study||19
44724|NCT01583374|102941|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
44725|NCT01583374|102942|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
44726|NCT01583374|102943|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
44727|NCT01583374|102941|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
44728|NCT01583374|102942|P2|Early Escape at Week 16|Overall Study||49
44729|NCT01583374|102943|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
44730|NCT01583374|102941|P3|Completed Week 16|Overall Study||144
44731|NCT01583374|102942|P2|Completed Week 16|Overall Study||151
44732|NCT01583374|102943|P1|Completed Week 16|Overall Study||150
44733|NCT01583374|102941|P3|Received Treatment|Overall Study||163
44734|NCT01583374|102942|P2|Received Treatment|Overall Study||163
44735|NCT01583374|102943|P1|Received Treatment|Overall Study||164
44736|NCT01583374|102941|P3|STARTED|Overall Study||163
44737|NCT01583374|102942|P2|STARTED|Overall Study||163
44738|NCT01583374|102943|P1|STARTED|Overall Study||164
44739|NCT01582854|102955|P2|NOT COMPLETED|Overall Study||34
44740|NCT01582854|102956|P1|NOT COMPLETED|Overall Study||36
44741|NCT01582854|102955|P2|COMPLETED|Overall Study||221
44742|NCT01582854|102956|P1|COMPLETED|Overall Study||212
44743|NCT01582854|102955|P2|STARTED|Overall Study||255
44744|NCT01582854|102956|P1|STARTED|Overall Study||248
44745|NCT01582789|102984|P2|NOT COMPLETED|Second Intervention (14 Days)||0
44746|NCT01582789|102985|P1|NOT COMPLETED|Second Intervention (14 Days)||1
44747|NCT01582789|102984|P2|COMPLETED|Second Intervention (14 Days)||27
44748|NCT01582789|102985|P1|COMPLETED|Second Intervention (14 Days)||33
44749|NCT01582789|102984|P2|STARTED|Second Intervention (14 Days)||27
44750|NCT01582789|102985|P1|STARTED|Second Intervention (14 Days)||34
44751|NCT01582789|102984|P2|NOT COMPLETED|First Intervention (14 Days)||0
44752|NCT01582789|102985|P1|NOT COMPLETED|First Intervention (14 Days)||0
44753|NCT01582789|102984|P2|COMPLETED|First Intervention (14 Days)||27
44754|NCT01582789|102985|P1|COMPLETED|First Intervention (14 Days)||34
44755|NCT01582789|102984|P2|STARTED|First Intervention (14 Days)||27
44756|NCT01582789|102985|P1|STARTED|First Intervention (14 Days)||34
44757|NCT01582490|103003|P2|NOT COMPLETED|Overall Study||1
44758|NCT01582490|103004|P1|NOT COMPLETED|Overall Study||1
44759|NCT01582490|103003|P2|COMPLETED|Overall Study||9
44760|NCT01582490|103004|P1|COMPLETED|Overall Study||8
44761|NCT01582490|103003|P2|STARTED|Overall Study||10
44762|NCT01582490|103004|P1|STARTED|Overall Study||9
44763|NCT01582477|103026|P2|NOT COMPLETED|Overall Study||0
44764|NCT01582477|103027|P1|NOT COMPLETED|Overall Study||0
44765|NCT01582477|103026|P2|COMPLETED|Overall Study||12
44766|NCT01582477|103027|P1|COMPLETED|Overall Study||12
44767|NCT01582477|103026|P2|STARTED|Overall Study||12
44768|NCT01582477|103027|P1|STARTED|Overall Study||12
44769|NCT01582308|103043|P10|NOT COMPLETED|Period 5||0
44770|NCT01582308|103044|P9|NOT COMPLETED|Period 5||0
44771|NCT01582308|103045|P8|NOT COMPLETED|Period 5||0
44772|NCT01582308|103046|P7|NOT COMPLETED|Period 5||0
44773|NCT01582308|103047|P6|NOT COMPLETED|Period 5||0
44774|NCT01582308|103048|P5|NOT COMPLETED|Period 5||0
44775|NCT01582308|103049|P4|NOT COMPLETED|Period 5||0
44776|NCT01582308|103050|P3|NOT COMPLETED|Period 5||0
44777|NCT01582308|103051|P2|NOT COMPLETED|Period 5||0
44778|NCT01582308|103052|P1|NOT COMPLETED|Period 5||0
44779|NCT01582308|103043|P10|COMPLETED|Period 5||1
44780|NCT01582308|103044|P9|COMPLETED|Period 5||2
44781|NCT01582308|103045|P8|COMPLETED|Period 5||2
44782|NCT01582308|103046|P7|COMPLETED|Period 5||2
44783|NCT01582308|103047|P6|COMPLETED|Period 5||1
44784|NCT01582308|103048|P5|COMPLETED|Period 5||2
44785|NCT01582308|103049|P4|COMPLETED|Period 5||2
44786|NCT01582308|103050|P3|COMPLETED|Period 5||2
44787|NCT01582308|103051|P2|COMPLETED|Period 5||2
44788|NCT01582308|103052|P1|COMPLETED|Period 5||1
44789|NCT01582308|103043|P10|STARTED|Period 5||1
44790|NCT01582308|103044|P9|STARTED|Period 5||2
44791|NCT01582308|103045|P8|STARTED|Period 5||2
44792|NCT01582308|103046|P7|STARTED|Period 5||2
44793|NCT01582308|103047|P6|STARTED|Period 5||1
44794|NCT01582308|103048|P5|STARTED|Period 5||2
44795|NCT01582308|103049|P4|STARTED|Period 5||2
44796|NCT01582308|103050|P3|STARTED|Period 5||2
44797|NCT01582308|103051|P2|STARTED|Period 5||2
44798|NCT01582308|103052|P1|STARTED|Period 5||1
44799|NCT01582308|103043|P10|NOT COMPLETED|10-day Washout Following Period 4||0
44800|NCT01582308|103044|P9|NOT COMPLETED|10-day Washout Following Period 4||0
44801|NCT01582308|103045|P8|NOT COMPLETED|10-day Washout Following Period 4||0
44802|NCT01582308|103046|P7|NOT COMPLETED|10-day Washout Following Period 4||0
44803|NCT01582308|103047|P6|NOT COMPLETED|10-day Washout Following Period 4||0
44804|NCT01582308|103048|P5|NOT COMPLETED|10-day Washout Following Period 4||0
44805|NCT01582308|103049|P4|NOT COMPLETED|10-day Washout Following Period 4||0
44806|NCT01582308|103050|P3|NOT COMPLETED|10-day Washout Following Period 4||0
44807|NCT01582308|103051|P2|NOT COMPLETED|10-day Washout Following Period 4||0
44808|NCT01582308|103052|P1|NOT COMPLETED|10-day Washout Following Period 4||0
44809|NCT01582308|103043|P10|COMPLETED|10-day Washout Following Period 4||1
44810|NCT01582308|103044|P9|COMPLETED|10-day Washout Following Period 4||2
44811|NCT01582308|103045|P8|COMPLETED|10-day Washout Following Period 4||2
44812|NCT01582308|103046|P7|COMPLETED|10-day Washout Following Period 4||2
44813|NCT01582308|103047|P6|COMPLETED|10-day Washout Following Period 4||1
44814|NCT01582308|103048|P5|COMPLETED|10-day Washout Following Period 4||2
44815|NCT01582308|103049|P4|COMPLETED|10-day Washout Following Period 4||2
44816|NCT01582308|103050|P3|COMPLETED|10-day Washout Following Period 4||2
44817|NCT01582308|103051|P2|COMPLETED|10-day Washout Following Period 4||2
44818|NCT01582308|103052|P1|COMPLETED|10-day Washout Following Period 4||1
44819|NCT01582308|103043|P10|STARTED|10-day Washout Following Period 4||1
44820|NCT01582308|103044|P9|STARTED|10-day Washout Following Period 4||2
44821|NCT01582308|103045|P8|STARTED|10-day Washout Following Period 4||2
44822|NCT01582308|103046|P7|STARTED|10-day Washout Following Period 4||2
44823|NCT01582308|103047|P6|STARTED|10-day Washout Following Period 4||1
44824|NCT01582308|103048|P5|STARTED|10-day Washout Following Period 4||2
44825|NCT01582308|103049|P4|STARTED|10-day Washout Following Period 4||2
44826|NCT01582308|103050|P3|STARTED|10-day Washout Following Period 4||2
44827|NCT01582308|103051|P2|STARTED|10-day Washout Following Period 4||2
44828|NCT01582308|103052|P1|STARTED|10-day Washout Following Period 4||1
44829|NCT01582308|103043|P10|NOT COMPLETED|Period 4||1
44830|NCT01582308|103044|P9|NOT COMPLETED|Period 4||0
44831|NCT01582308|103045|P8|NOT COMPLETED|Period 4||0
44832|NCT01582308|103046|P7|NOT COMPLETED|Period 4||0
44833|NCT01582308|103047|P6|NOT COMPLETED|Period 4||1
44834|NCT01582308|103048|P5|NOT COMPLETED|Period 4||0
44835|NCT01582308|103049|P4|NOT COMPLETED|Period 4||0
44836|NCT01582308|103050|P3|NOT COMPLETED|Period 4||0
44837|NCT01582308|103051|P2|NOT COMPLETED|Period 4||0
44838|NCT01582308|103052|P1|NOT COMPLETED|Period 4||1
44839|NCT01582308|103043|P10|COMPLETED|Period 4||1
44840|NCT01582308|103044|P9|COMPLETED|Period 4||2
44841|NCT01582308|103045|P8|COMPLETED|Period 4||2
44842|NCT01582308|103046|P7|COMPLETED|Period 4||2
44843|NCT01582308|103047|P6|COMPLETED|Period 4||1
44844|NCT01582308|103048|P5|COMPLETED|Period 4||2
44845|NCT01582308|103049|P4|COMPLETED|Period 4||2
44846|NCT01582308|103050|P3|COMPLETED|Period 4||2
44847|NCT01582308|103051|P2|COMPLETED|Period 4||2
44848|NCT01582308|103052|P1|COMPLETED|Period 4||1
44849|NCT01582308|103043|P10|STARTED|Period 4||2
44850|NCT01582308|103044|P9|STARTED|Period 4||2
44851|NCT01582308|103045|P8|STARTED|Period 4||2
44852|NCT01582308|103046|P7|STARTED|Period 4||2
44853|NCT01582308|103047|P6|STARTED|Period 4||2
44854|NCT01582308|103048|P5|STARTED|Period 4||2
44855|NCT01582308|103049|P4|STARTED|Period 4||2
44856|NCT01582308|103050|P3|STARTED|Period 4||2
44857|NCT01582308|103051|P2|STARTED|Period 4||2
44858|NCT01582308|103052|P1|STARTED|Period 4||2
44859|NCT01582308|103043|P10|NOT COMPLETED|10-day Washout Following Period 3||0
44860|NCT01582308|103044|P9|NOT COMPLETED|10-day Washout Following Period 3||0
44861|NCT01582308|103045|P8|NOT COMPLETED|10-day Washout Following Period 3||0
44862|NCT01582308|103046|P7|NOT COMPLETED|10-day Washout Following Period 3||0
44863|NCT01582308|103047|P6|NOT COMPLETED|10-day Washout Following Period 3||0
44864|NCT01582308|103048|P5|NOT COMPLETED|10-day Washout Following Period 3||0
44865|NCT01582308|103049|P4|NOT COMPLETED|10-day Washout Following Period 3||0
44866|NCT01582308|103050|P3|NOT COMPLETED|10-day Washout Following Period 3||0
44867|NCT01582308|103051|P2|NOT COMPLETED|10-day Washout Following Period 3||0
44868|NCT01582308|103052|P1|NOT COMPLETED|10-day Washout Following Period 3||0
44869|NCT01582308|103043|P10|COMPLETED|10-day Washout Following Period 3||2
44870|NCT01582308|103044|P9|COMPLETED|10-day Washout Following Period 3||2
44871|NCT01582308|103045|P8|COMPLETED|10-day Washout Following Period 3||2
44872|NCT01582308|103046|P7|COMPLETED|10-day Washout Following Period 3||2
44873|NCT01582308|103047|P6|COMPLETED|10-day Washout Following Period 3||2
44874|NCT01582308|103048|P5|COMPLETED|10-day Washout Following Period 3||2
44875|NCT01582308|103049|P4|COMPLETED|10-day Washout Following Period 3||2
44876|NCT01582308|103050|P3|COMPLETED|10-day Washout Following Period 3||2
44877|NCT01582308|103051|P2|COMPLETED|10-day Washout Following Period 3||2
44878|NCT01582308|103052|P1|COMPLETED|10-day Washout Following Period 3||2
44879|NCT01582308|103043|P10|STARTED|10-day Washout Following Period 3||2
44880|NCT01582308|103044|P9|STARTED|10-day Washout Following Period 3||2
44881|NCT01582308|103045|P8|STARTED|10-day Washout Following Period 3||2
44882|NCT01582308|103046|P7|STARTED|10-day Washout Following Period 3||2
44883|NCT01582308|103047|P6|STARTED|10-day Washout Following Period 3||2
44884|NCT01582308|103048|P5|STARTED|10-day Washout Following Period 3||2
44885|NCT01582308|103049|P4|STARTED|10-day Washout Following Period 3||2
44886|NCT01582308|103050|P3|STARTED|10-day Washout Following Period 3||2
44887|NCT01582308|103051|P2|STARTED|10-day Washout Following Period 3||2
44888|NCT01582308|103052|P1|STARTED|10-day Washout Following Period 3||2
44889|NCT01582308|103043|P10|NOT COMPLETED|Period 3||0
44890|NCT01582308|103044|P9|NOT COMPLETED|Period 3||0
44891|NCT01582308|103045|P8|NOT COMPLETED|Period 3||0
44892|NCT01582308|103046|P7|NOT COMPLETED|Period 3||0
44893|NCT01582308|103047|P6|NOT COMPLETED|Period 3||0
44894|NCT01582308|103048|P5|NOT COMPLETED|Period 3||0
44895|NCT01582308|103049|P4|NOT COMPLETED|Period 3||0
44896|NCT01582308|103050|P3|NOT COMPLETED|Period 3||0
44897|NCT01582308|103051|P2|NOT COMPLETED|Period 3||0
44898|NCT01582308|103052|P1|NOT COMPLETED|Period 3||0
44899|NCT01582308|103043|P10|COMPLETED|Period 3||2
44900|NCT01582308|103044|P9|COMPLETED|Period 3||2
44901|NCT01582308|103045|P8|COMPLETED|Period 3||2
44902|NCT01582308|103046|P7|COMPLETED|Period 3||2
44903|NCT01582308|103047|P6|COMPLETED|Period 3||2
44904|NCT01582308|103048|P5|COMPLETED|Period 3||2
44905|NCT01582308|103049|P4|COMPLETED|Period 3||2
44906|NCT01582308|103050|P3|COMPLETED|Period 3||2
44907|NCT01582308|103051|P2|COMPLETED|Period 3||2
44908|NCT01582308|103052|P1|COMPLETED|Period 3||2
44909|NCT01582308|103043|P10|STARTED|Period 3||2
44910|NCT01582308|103044|P9|STARTED|Period 3||2
44911|NCT01582308|103045|P8|STARTED|Period 3||2
44912|NCT01582308|103046|P7|STARTED|Period 3||2
44913|NCT01582308|103047|P6|STARTED|Period 3||2
44914|NCT01582308|103048|P5|STARTED|Period 3||2
44915|NCT01582308|103049|P4|STARTED|Period 3||2
44916|NCT01582308|103050|P3|STARTED|Period 3||2
44917|NCT01582308|103051|P2|STARTED|Period 3||2
44918|NCT01582308|103052|P1|STARTED|Period 3||2
44919|NCT01582308|103043|P10|NOT COMPLETED|10-day Washout Following Period 2||0
44920|NCT01582308|103044|P9|NOT COMPLETED|10-day Washout Following Period 2||0
44921|NCT01582308|103045|P8|NOT COMPLETED|10-day Washout Following Period 2||0
44922|NCT01582308|103046|P7|NOT COMPLETED|10-day Washout Following Period 2||0
44923|NCT01582308|103047|P6|NOT COMPLETED|10-day Washout Following Period 2||0
44924|NCT01582308|103048|P5|NOT COMPLETED|10-day Washout Following Period 2||0
44925|NCT01582308|103049|P4|NOT COMPLETED|10-day Washout Following Period 2||0
44926|NCT01582308|103050|P3|NOT COMPLETED|10-day Washout Following Period 2||0
44927|NCT01582308|103051|P2|NOT COMPLETED|10-day Washout Following Period 2||0
44928|NCT01582308|103052|P1|NOT COMPLETED|10-day Washout Following Period 2||0
44929|NCT01582308|103043|P10|COMPLETED|10-day Washout Following Period 2||2
44930|NCT01582308|103044|P9|COMPLETED|10-day Washout Following Period 2||2
44931|NCT01582308|103045|P8|COMPLETED|10-day Washout Following Period 2||2
44932|NCT01582308|103046|P7|COMPLETED|10-day Washout Following Period 2||2
44933|NCT01582308|103047|P6|COMPLETED|10-day Washout Following Period 2||2
44934|NCT01582308|103048|P5|COMPLETED|10-day Washout Following Period 2||2
44935|NCT01582308|103049|P4|COMPLETED|10-day Washout Following Period 2||2
44936|NCT01582308|103050|P3|COMPLETED|10-day Washout Following Period 2||2
44937|NCT01582308|103051|P2|COMPLETED|10-day Washout Following Period 2||2
44938|NCT01582308|103052|P1|COMPLETED|10-day Washout Following Period 2||2
44939|NCT01582308|103043|P10|STARTED|10-day Washout Following Period 2||2
44940|NCT01582308|103044|P9|STARTED|10-day Washout Following Period 2||2
44941|NCT01582308|103045|P8|STARTED|10-day Washout Following Period 2||2
44942|NCT01582308|103046|P7|STARTED|10-day Washout Following Period 2||2
44943|NCT01582308|103047|P6|STARTED|10-day Washout Following Period 2||2
44944|NCT01582308|103048|P5|STARTED|10-day Washout Following Period 2||2
44945|NCT01582308|103049|P4|STARTED|10-day Washout Following Period 2||2
44946|NCT01582308|103050|P3|STARTED|10-day Washout Following Period 2||2
44947|NCT01582308|103051|P2|STARTED|10-day Washout Following Period 2||2
44948|NCT01582308|103052|P1|STARTED|10-day Washout Following Period 2||2
44949|NCT01582308|103043|P10|NOT COMPLETED|Period 2||0
44950|NCT01582308|103044|P9|NOT COMPLETED|Period 2||0
44951|NCT01582308|103045|P8|NOT COMPLETED|Period 2||0
44952|NCT01582308|103046|P7|NOT COMPLETED|Period 2||0
44953|NCT01582308|103047|P6|NOT COMPLETED|Period 2||0
44954|NCT01582308|103048|P5|NOT COMPLETED|Period 2||0
44955|NCT01582308|103049|P4|NOT COMPLETED|Period 2||0
44956|NCT01582308|103050|P3|NOT COMPLETED|Period 2||0
44957|NCT01582308|103051|P2|NOT COMPLETED|Period 2||0
44958|NCT01582308|103052|P1|NOT COMPLETED|Period 2||0
44959|NCT01582308|103043|P10|COMPLETED|Period 2||2
44960|NCT01582308|103044|P9|COMPLETED|Period 2||2
44961|NCT01582308|103045|P8|COMPLETED|Period 2||2
44962|NCT01582308|103046|P7|COMPLETED|Period 2||2
44963|NCT01582308|103047|P6|COMPLETED|Period 2||2
44964|NCT01582308|103048|P5|COMPLETED|Period 2||2
44965|NCT01582308|103049|P4|COMPLETED|Period 2||2
44966|NCT01582308|103050|P3|COMPLETED|Period 2||2
44967|NCT01582308|103051|P2|COMPLETED|Period 2||2
44968|NCT01582308|103052|P1|COMPLETED|Period 2||2
44969|NCT01582308|103043|P10|STARTED|Period 2||2
44970|NCT01582308|103044|P9|STARTED|Period 2||2
44971|NCT01582308|103045|P8|STARTED|Period 2||2
44972|NCT01582308|103046|P7|STARTED|Period 2||2
44973|NCT01582308|103047|P6|STARTED|Period 2||2
44974|NCT01582308|103048|P5|STARTED|Period 2||2
44975|NCT01582308|103049|P4|STARTED|Period 2||2
44976|NCT01582308|103050|P3|STARTED|Period 2||2
44977|NCT01582308|103051|P2|STARTED|Period 2||2
44978|NCT01582308|103052|P1|STARTED|Period 2||2
44979|NCT01582308|103043|P10|NOT COMPLETED|10-day Washout Following Period 1||0
44980|NCT01582308|103044|P9|NOT COMPLETED|10-day Washout Following Period 1||0
44981|NCT01582308|103045|P8|NOT COMPLETED|10-day Washout Following Period 1||0
44982|NCT01582308|103046|P7|NOT COMPLETED|10-day Washout Following Period 1||0
44983|NCT01582308|103047|P6|NOT COMPLETED|10-day Washout Following Period 1||0
44984|NCT01582308|103048|P5|NOT COMPLETED|10-day Washout Following Period 1||1
44985|NCT01582308|103049|P4|NOT COMPLETED|10-day Washout Following Period 1||0
44986|NCT01582308|103050|P3|NOT COMPLETED|10-day Washout Following Period 1||0
44987|NCT01582308|103051|P2|NOT COMPLETED|10-day Washout Following Period 1||0
44988|NCT01582308|103052|P1|NOT COMPLETED|10-day Washout Following Period 1||0
44989|NCT01582308|103043|P10|COMPLETED|10-day Washout Following Period 1||2
44990|NCT01582308|103044|P9|COMPLETED|10-day Washout Following Period 1||2
44991|NCT01582308|103045|P8|COMPLETED|10-day Washout Following Period 1||2
44992|NCT01582308|103046|P7|COMPLETED|10-day Washout Following Period 1||2
44993|NCT01582308|103047|P6|COMPLETED|10-day Washout Following Period 1||2
44994|NCT01582308|103048|P5|COMPLETED|10-day Washout Following Period 1||2
44995|NCT01582308|103049|P4|COMPLETED|10-day Washout Following Period 1||2
44996|NCT01582308|103050|P3|COMPLETED|10-day Washout Following Period 1||2
44997|NCT01582308|103051|P2|COMPLETED|10-day Washout Following Period 1||2
44998|NCT01582308|103052|P1|COMPLETED|10-day Washout Following Period 1||2
44999|NCT01582308|103043|P10|STARTED|10-day Washout Following Period 1||2
45000|NCT01582308|103044|P9|STARTED|10-day Washout Following Period 1||2
45001|NCT01582308|103045|P8|STARTED|10-day Washout Following Period 1||2
45002|NCT01582308|103046|P7|STARTED|10-day Washout Following Period 1||2
45003|NCT01582308|103047|P6|STARTED|10-day Washout Following Period 1||2
45004|NCT01582308|103048|P5|STARTED|10-day Washout Following Period 1||3
45005|NCT01582308|103049|P4|STARTED|10-day Washout Following Period 1||2
45006|NCT01582308|103050|P3|STARTED|10-day Washout Following Period 1||2
45007|NCT01582308|103051|P2|STARTED|10-day Washout Following Period 1||2
45008|NCT01582308|103052|P1|STARTED|10-day Washout Following Period 1||2
45009|NCT01582308|103043|P10|NOT COMPLETED|Period 1||0
45010|NCT01582308|103044|P9|NOT COMPLETED|Period 1||0
45011|NCT01582308|103045|P8|NOT COMPLETED|Period 1||0
45012|NCT01582308|103046|P7|NOT COMPLETED|Period 1||1
45013|NCT01582308|103047|P6|NOT COMPLETED|Period 1||0
45014|NCT01582308|103048|P5|NOT COMPLETED|Period 1||0
45015|NCT01582308|103049|P4|NOT COMPLETED|Period 1||0
45016|NCT01582308|103050|P3|NOT COMPLETED|Period 1||0
45017|NCT01582308|103051|P2|NOT COMPLETED|Period 1||0
45018|NCT01582308|103052|P1|NOT COMPLETED|Period 1||0
45019|NCT01582308|103043|P10|COMPLETED|Period 1||2
45020|NCT01582308|103044|P9|COMPLETED|Period 1||2
45021|NCT01582308|103045|P8|COMPLETED|Period 1||2
45022|NCT01582308|103046|P7|COMPLETED|Period 1||2
45023|NCT01582308|103047|P6|COMPLETED|Period 1||2
45024|NCT01582308|103048|P5|COMPLETED|Period 1||3
45025|NCT01582308|103049|P4|COMPLETED|Period 1||2
45026|NCT01582308|103050|P3|COMPLETED|Period 1||2
45027|NCT01582308|103051|P2|COMPLETED|Period 1||2
45028|NCT01582308|103052|P1|COMPLETED|Period 1||2
45029|NCT01582308|103043|P10|STARTED|Period 1||2
45030|NCT01582308|103044|P9|STARTED|Period 1||2
45031|NCT01582308|103045|P8|STARTED|Period 1||2
45032|NCT01582308|103046|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
45033|NCT01582308|103047|P6|STARTED|Period 1||2
45034|NCT01582308|103048|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
45035|NCT01582308|103049|P4|STARTED|Period 1||2
45036|NCT01582308|103050|P3|STARTED|Period 1||2
45037|NCT01582308|103051|P2|STARTED|Period 1||2
45038|NCT01582308|103052|P1|STARTED|Period 1||2
45039|NCT01582282|103080|P3|NOT COMPLETED|Overall Study||0
45040|NCT01582282|103081|P2|NOT COMPLETED|Overall Study||2
45041|NCT01582282|103082|P1|NOT COMPLETED|Overall Study||2
45042|NCT01582282|103080|P3|COMPLETED|Overall Study||8
45043|NCT01582282|103081|P2|COMPLETED|Overall Study||12
45044|NCT01582282|103082|P1|COMPLETED|Overall Study||13
45045|NCT01582282|103080|P3|STARTED|Overall Study||8
45046|NCT01582282|103081|P2|STARTED|Overall Study||14
45047|NCT01582282|103082|P1|STARTED|Overall Study||15
45048|NCT01582243|103105|P1|NOT COMPLETED|Overall Study||3
45049|NCT01582243|103105|P1|COMPLETED|Overall Study||37
45050|NCT01582243|103105|P1|STARTED|Overall Study||40
45051|NCT01582178|103116|P2|NOT COMPLETED|Overall Study||5
45052|NCT01582178|103117|P1|NOT COMPLETED|Overall Study||6
45053|NCT01582178|103116|P2|COMPLETED|Overall Study||101
45054|NCT01582178|103117|P1|COMPLETED|Overall Study||100
45055|NCT01582178|103116|P2|STARTED|Overall Study||106
45056|NCT01582178|103117|P1|STARTED|Overall Study||106
45057|NCT01582139|103125|P2|NOT COMPLETED|Overall Study||0
45058|NCT01582139|103126|P1|NOT COMPLETED|Overall Study||0
45059|NCT01582139|103125|P2|COMPLETED|Overall Study||6
45060|NCT01582139|103126|P1|COMPLETED|Overall Study||6
45061|NCT01582139|103125|P2|STARTED|Overall Study||6
45062|NCT01582139|103126|P1|STARTED|Overall Study||6
45063|NCT01582100|103138|P1|NOT COMPLETED|Overall Study||2
45064|NCT01582100|103138|P1|COMPLETED|Overall Study||0
45065|NCT01582100|103138|P1|STARTED|Overall Study||2
45066|NCT01581931|103142|P2|NOT COMPLETED|Second Period||0
45067|NCT01581931|103143|P1|NOT COMPLETED|Second Period||0
45068|NCT01581931|103142|P2|COMPLETED|Second Period||15
45069|NCT01581931|103143|P1|COMPLETED|Second Period||16
45070|NCT01581931|103142|P2|STARTED|Second Period||15
45071|NCT01581931|103143|P1|STARTED|Second Period||16
45072|NCT01581931|103142|P2|NOT COMPLETED|Washout||1
45073|NCT01581931|103143|P1|NOT COMPLETED|Washout||0
45074|NCT01581931|103142|P2|COMPLETED|Washout||15
45075|NCT01581931|103143|P1|COMPLETED|Washout||16
45076|NCT01581931|103142|P2|STARTED|Washout||16
45077|NCT01581931|103143|P1|STARTED|Washout||16
45078|NCT01581931|103142|P2|NOT COMPLETED|First Period||0
45079|NCT01581931|103143|P1|NOT COMPLETED|First Period||0
45080|NCT01581931|103142|P2|COMPLETED|First Period||16
45081|NCT01581931|103143|P1|COMPLETED|First Period||16
45082|NCT01581931|103142|P2|STARTED|First Period||16
45083|NCT01581931|103143|P1|STARTED|First Period||16
45084|NCT01581684|103167|P10|NOT COMPLETED|Overall Study||0
45085|NCT01581684|103168|P9|NOT COMPLETED|Overall Study||1
45086|NCT01581684|103169|P8|NOT COMPLETED|Overall Study||0
45087|NCT01581684|103170|P7|NOT COMPLETED|Overall Study||0
45088|NCT01581684|103171|P6|NOT COMPLETED|Overall Study||0
45089|NCT01581684|103172|P5|NOT COMPLETED|Overall Study||0
45090|NCT01581684|103173|P4|NOT COMPLETED|Overall Study||0
45091|NCT01581684|103174|P3|NOT COMPLETED|Overall Study||0
45092|NCT01581684|103175|P2|NOT COMPLETED|Overall Study||0
45093|NCT01581684|103176|P1|NOT COMPLETED|Overall Study||0
45094|NCT01581684|103167|P10|COMPLETED|Overall Study||5
45095|NCT01581684|103168|P9|COMPLETED|Overall Study||0
45096|NCT01581684|103169|P8|COMPLETED|Overall Study||6
45097|NCT01581684|103170|P7|COMPLETED|Overall Study||6
45098|NCT01581684|103171|P6|COMPLETED|Overall Study||6
45099|NCT01581684|103172|P5|COMPLETED|Overall Study||6
45100|NCT01581684|103173|P4|COMPLETED|Overall Study||6
45101|NCT01581684|103174|P3|COMPLETED|Overall Study||6
45102|NCT01581684|103175|P2|COMPLETED|Overall Study||6
45103|NCT01581684|103176|P1|COMPLETED|Overall Study||14
45104|NCT01581684|103167|P10|STARTED|Overall Study||5
45105|NCT01581684|103168|P9|STARTED|Overall Study||1
45106|NCT01581684|103169|P8|STARTED|Overall Study||6
45107|NCT01581684|103170|P7|STARTED|Overall Study||6
45108|NCT01581684|103171|P6|STARTED|Overall Study||6
45109|NCT01581684|103172|P5|STARTED|Overall Study||6
45110|NCT01581684|103173|P4|STARTED|Overall Study||6
45111|NCT01581684|103174|P3|STARTED|Overall Study||6
45112|NCT01581684|103175|P2|STARTED|Overall Study||6
45113|NCT01581684|103176|P1|STARTED|Overall Study||14
45114|NCT01581658|103251|P4|NOT COMPLETED|Overall Study||0
45115|NCT01581658|103252|P3|NOT COMPLETED|Overall Study||0
45116|NCT01581658|103253|P2|NOT COMPLETED|Overall Study||0
45117|NCT01581658|103254|P1|NOT COMPLETED|Overall Study||0
45118|NCT01581658|103251|P4|COMPLETED|Overall Study||8
45119|NCT01581658|103252|P3|COMPLETED|Overall Study||8
45120|NCT01581658|103253|P2|COMPLETED|Overall Study||8
45121|NCT01581658|103254|P1|COMPLETED|Overall Study||8
45122|NCT01581658|103251|P4|STARTED|Overall Study||8
45123|NCT01581658|103252|P3|STARTED|Overall Study||8
45124|NCT01581658|103253|P2|STARTED|Overall Study||8
45125|NCT01581658|103254|P1|STARTED|Overall Study||8
45126|NCT01581437|103272|P1|NOT COMPLETED|Overall Study||0
45127|NCT01581437|103272|P1|COMPLETED|Overall Study||78
45128|NCT01581437|103272|P1|STARTED|Overall Study||78
45129|NCT01581307|103283|P1|NOT COMPLETED|Overall Study||1
45130|NCT01581307|103283|P1|COMPLETED|Overall Study||8
45131|NCT01581307|103283|P1|STARTED|Overall Study||9
45132|NCT01581021|103291|P2|NOT COMPLETED|Overall Study||11
45133|NCT01581021|103292|P1|NOT COMPLETED|Overall Study||10
45134|NCT01581021|103291|P2|COMPLETED|Overall Study||18
45135|NCT01581021|103292|P1|COMPLETED|Overall Study||19
45136|NCT01581021|103291|P2|STARTED|Overall Study||29
45137|NCT01581021|103292|P1|STARTED|Overall Study||29
45138|NCT01581008|103306|P2|NOT COMPLETED|Overall Study||6
45139|NCT01581008|103307|P1|NOT COMPLETED|Overall Study||1
45140|NCT01581008|103306|P2|COMPLETED|Overall Study||7
45141|NCT01581008|103307|P1|COMPLETED|Overall Study||16
45142|NCT01581008|103306|P2|STARTED|Overall Study||13
45143|NCT01581008|103307|P1|STARTED|Overall Study||17
45144|NCT01580995|103318|P2|NOT COMPLETED|Overall Study||2
45145|NCT01580995|103319|P1|NOT COMPLETED|Overall Study||2
45146|NCT01580995|103318|P2|COMPLETED|Overall Study||7
45147|NCT01580995|103319|P1|COMPLETED|Overall Study||8
45148|NCT01580995|103318|P2|STARTED|Overall Study||9
45149|NCT01580995|103319|P1|STARTED|Overall Study||10
45150|NCT01580904|103327|P2|NOT COMPLETED|Overall Study||7
45151|NCT01580904|103328|P1|NOT COMPLETED|Overall Study||4
45152|NCT01580904|103327|P2|COMPLETED|Overall Study||42
45153|NCT01580904|103328|P1|COMPLETED|Overall Study||47
45154|NCT01580904|103327|P2|STARTED|Overall Study||49
45155|NCT01580904|103328|P1|STARTED|Overall Study||51
45156|NCT01580618|103342|P2|NOT COMPLETED|Overall Study||0
45157|NCT01580618|103343|P1|NOT COMPLETED|Overall Study||1
45158|NCT01580618|103342|P2|COMPLETED|Overall Study||12
45159|NCT01580618|103343|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
45160|NCT01580618|103342|P2|STARTED|Overall Study||12
45161|NCT01580618|103343|P1|STARTED|Overall Study||8
45162|NCT01580592|103359|P3|NOT COMPLETED|Overall Study||0
45163|NCT01580592|103360|P2|NOT COMPLETED|Overall Study||0
45164|NCT01580592|103361|P1|NOT COMPLETED|Overall Study||0
45165|NCT01580592|103359|P3|COMPLETED|Overall Study||12
45166|NCT01580592|103360|P2|COMPLETED|Overall Study||9
45167|NCT01580592|103361|P1|COMPLETED|Overall Study||10
45168|NCT01580592|103359|P3|STARTED|Overall Study||12
45169|NCT01580592|103360|P2|STARTED|Overall Study||9
45170|NCT01580592|103361|P1|STARTED|Overall Study||10
45171|NCT01580488|103369|P1|NOT COMPLETED|Overall Study||1
45172|NCT01580488|103369|P1|COMPLETED|Overall Study||23
45173|NCT01580488|103369|P1|STARTED|Overall Study||24
45174|NCT01580423|103413|P2|NOT COMPLETED|Second Intervention||0
45175|NCT01580423|103414|P1|NOT COMPLETED|Second Intervention||0
45176|NCT01580423|103413|P2|COMPLETED|Second Intervention||8
45177|NCT01580423|103414|P1|COMPLETED|Second Intervention||8
45178|NCT01580423|103413|P2|STARTED|Second Intervention||8
45179|NCT01580423|103414|P1|STARTED|Second Intervention||8
45180|NCT01580423|103413|P2|NOT COMPLETED|First Intervention||0
45181|NCT01580423|103414|P1|NOT COMPLETED|First Intervention||0
45182|NCT01580423|103413|P2|COMPLETED|First Intervention||8
45183|NCT01580423|103414|P1|COMPLETED|First Intervention||8
45184|NCT01580423|103413|P2|STARTED|First Intervention||8
45185|NCT01580423|103414|P1|STARTED|First Intervention||8
45186|NCT01580306|103428|P4|NOT COMPLETED|Overall Study||0
45187|NCT01580306|103429|P3|NOT COMPLETED|Overall Study||0
45188|NCT01580306|103430|P2|NOT COMPLETED|Overall Study||0
45189|NCT01580306|103431|P1|NOT COMPLETED|Overall Study||0
45190|NCT01580306|103428|P4|COMPLETED|Overall Study||8
45191|NCT01580306|103429|P3|COMPLETED|Overall Study||8
45192|NCT01580306|103430|P2|COMPLETED|Overall Study||8
45193|NCT01580306|103431|P1|COMPLETED|Overall Study||8
45194|NCT01580306|103428|P4|STARTED|Overall Study||8
45195|NCT01580306|103429|P3|STARTED|Overall Study||8
45196|NCT01580306|103430|P2|STARTED|Overall Study||8
45197|NCT01580306|103431|P1|STARTED|Overall Study||8
45198|NCT01580098|103455|P3|NOT COMPLETED|Overall Study||3
45199|NCT01580098|103456|P2|NOT COMPLETED|Overall Study||13
45200|NCT01580098|103457|P1|NOT COMPLETED|Overall Study||15
45201|NCT01580098|103455|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
45202|NCT01580098|103456|P2|COMPLETED|Overall Study||101
45203|NCT01580098|103457|P1|COMPLETED|Overall Study||61
45204|NCT01580098|103455|P3|STARTED|Overall Study||3
45205|NCT01580098|103456|P2|STARTED|Overall Study||114
45206|NCT01580098|103457|P1|STARTED|Overall Study||76
45207|NCT01580072|103480|P3|NOT COMPLETED|Overall Study||0
45208|NCT01580072|103481|P2|NOT COMPLETED|Overall Study||9
45209|NCT01580072|103482|P1|NOT COMPLETED|Overall Study||12
45210|NCT01580072|103480|P3|COMPLETED|Overall Study||0
45211|NCT01580072|103481|P2|COMPLETED|Overall Study||28
45212|NCT01580072|103482|P1|COMPLETED|Overall Study||16
45213|NCT01580072|103480|P3|STARTED|Overall Study||0
45214|NCT01580072|103481|P2|STARTED|Overall Study||37
45215|NCT01580072|103482|P1|STARTED|Overall Study||28
45216|NCT01580020|103510|P4|NOT COMPLETED|Overall Study||2
45217|NCT01580020|103511|P3|NOT COMPLETED|Overall Study||4
45218|NCT01580020|103512|P2|NOT COMPLETED|Overall Study||7
45219|NCT01580020|103513|P1|NOT COMPLETED|Overall Study||1
45220|NCT01580020|103510|P4|COMPLETED|Overall Study||20
45221|NCT01580020|103511|P3|COMPLETED|Overall Study||57
45222|NCT01580020|103512|P2|COMPLETED|Overall Study||33
45223|NCT01580020|103513|P1|COMPLETED|Overall Study||51
45224|NCT01580020|103510|P4|STARTED|Overall Study||22
45225|NCT01580020|103511|P3|STARTED|Overall Study||61
45226|NCT01580020|103512|P2|STARTED|Overall Study||40
45227|NCT01580020|103513|P1|STARTED|Overall Study||52
45228|NCT01579916|103557|P2|NOT COMPLETED|Overall Study||2
45229|NCT01579916|103558|P1|NOT COMPLETED|Overall Study||8
45230|NCT01579916|103557|P2|COMPLETED|Overall Study||59
45231|NCT01579916|103558|P1|COMPLETED|Overall Study||234
45232|NCT01579916|103557|P2|STARTED|Overall Study||61
45233|NCT01579916|103558|P1|STARTED|Overall Study||242
45234|NCT01579747|103586|P2|NOT COMPLETED|Overall Study||0
45235|NCT01579747|103587|P1|NOT COMPLETED|Overall Study||0
45236|NCT01579747|103586|P2|COMPLETED|Overall Study||12
45237|NCT01579747|103587|P1|COMPLETED|Overall Study||12
45238|NCT01579747|103586|P2|STARTED|Overall Study||12
45239|NCT01579747|103587|P1|STARTED|Overall Study||12
45240|NCT01579669|103597|P2|NOT COMPLETED|Overall Study||0
45241|NCT01579669|103598|P1|NOT COMPLETED|Overall Study||36
45242|NCT01579669|103597|P2|COMPLETED|Overall Study||41
45243|NCT01579669|103598|P1|COMPLETED|Overall Study||134
45244|NCT01579669|103597|P2|STARTED|Overall Study||41
45245|NCT01579669|103598|P1|STARTED|Overall Study||170
45246|NCT01579578|103610|P2|NOT COMPLETED|Overall Study||12
45247|NCT01579578|103611|P1|NOT COMPLETED|Overall Study||13
45248|NCT01579578|103610|P2|COMPLETED|Overall Study||0
45249|NCT01579578|103611|P1|COMPLETED|Overall Study||0
45250|NCT01579578|103610|P2|Ongoing|Overall Study||0
45251|NCT01579578|103611|P1|Ongoing|Overall Study||3
45252|NCT01579578|103610|P2|STARTED|Overall Study||12
45253|NCT01579578|103611|P1|STARTED|Overall Study||13
45254|NCT01579565|103623|P2|NOT COMPLETED|Treated||3
45255|NCT01579565|103624|P1|NOT COMPLETED|Treated||2
45256|NCT01579565|103623|P2|COMPLETED|Treated||201
45257|NCT01579565|103624|P1|COMPLETED|Treated||200
45258|NCT01579565|103623|P2|STARTED|Treated||204
45259|NCT01579565|103624|P1|STARTED|Treated||202
45260|NCT01579565|103623|P2|NOT COMPLETED|Randomized||5
45261|NCT01579565|103624|P1|NOT COMPLETED|Randomized||5
45262|NCT01579565|103623|P2|COMPLETED|Randomized||204
45263|NCT01579565|103624|P1|COMPLETED|Randomized||202
45264|NCT01579565|103623|P2|STARTED|Randomized||209
45265|NCT01579565|103624|P1|STARTED|Randomized||207
45266|NCT01579474|103658|P6|NOT COMPLETED|Overall Study||1
45267|NCT01579474|103659|P5|NOT COMPLETED|Overall Study||1
45268|NCT01579474|103660|P4|NOT COMPLETED|Overall Study||0
45269|NCT01579474|103661|P3|NOT COMPLETED|Overall Study||2
45270|NCT01579474|103662|P2|NOT COMPLETED|Overall Study||13
45271|NCT01579474|103663|P1|NOT COMPLETED|Overall Study||3
45272|NCT01579474|103658|P6|COMPLETED|Overall Study||1
45273|NCT01579474|103659|P5|COMPLETED|Overall Study||9
45274|NCT01579474|103660|P4|COMPLETED|Overall Study||3
45275|NCT01579474|103661|P3|COMPLETED|Overall Study||27
45276|NCT01579474|103662|P2|COMPLETED|Overall Study||30
45277|NCT01579474|103663|P1|COMPLETED|Overall Study||41
45278|NCT01579474|103658|P6|STARTED|Overall Study||2
45279|NCT01579474|103659|P5|STARTED|Overall Study||10
45280|NCT01579474|103660|P4|STARTED|Overall Study||3
45281|NCT01579474|103661|P3|STARTED|Overall Study||29
45282|NCT01579474|103662|P2|STARTED|Overall Study||43
45283|NCT01579474|103663|P1|STARTED|Overall Study||44
45284|NCT01579305|103739|P2|NOT COMPLETED|Overall Study||27
45285|NCT01579305|103740|P1|NOT COMPLETED|Overall Study||21
45286|NCT01579305|103739|P2|COMPLETED|Overall Study||115
45287|NCT01579305|103740|P1|COMPLETED|Overall Study||118
45288|NCT01579305|103739|P2|Continued After Treatment|Overall Study||141
45289|NCT01579305|103740|P1|Continued After Treatment|Overall Study||139
45290|NCT01579305|103739|P2|Discontinued Before Treatment|Overall Study||1
45291|NCT01579305|103740|P1|Discontinued Before Treatment|Overall Study||0
45292|NCT01579305|103739|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
45293|NCT01579305|103740|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
45294|NCT01579084|103756|P10|NOT COMPLETED|Overall Study||0
45295|NCT01579084|103757|P9|NOT COMPLETED|Overall Study||0
45296|NCT01579084|103758|P8|NOT COMPLETED|Overall Study||0
45297|NCT01579084|103759|P7|NOT COMPLETED|Overall Study||0
45298|NCT01579084|103760|P6|NOT COMPLETED|Overall Study||0
45299|NCT01579084|103761|P5|NOT COMPLETED|Overall Study||0
45300|NCT01579084|103762|P4|NOT COMPLETED|Overall Study||0
45301|NCT01579084|103763|P3|NOT COMPLETED|Overall Study||0
45302|NCT01579084|103764|P2|NOT COMPLETED|Overall Study||0
45303|NCT01579084|103765|P1|NOT COMPLETED|Overall Study||0
45304|NCT01579084|103756|P10|COMPLETED|Overall Study||4
45305|NCT01579084|103757|P9|COMPLETED|Overall Study||4
45306|NCT01579084|103758|P8|COMPLETED|Overall Study||4
45307|NCT01579084|103759|P7|COMPLETED|Overall Study||4
45308|NCT01579084|103760|P6|COMPLETED|Overall Study||8
45309|NCT01579084|103761|P5|COMPLETED|Overall Study||8
45310|NCT01579084|103762|P4|COMPLETED|Overall Study||8
45311|NCT01579084|103763|P3|COMPLETED|Overall Study||8
45312|NCT01579084|103764|P2|COMPLETED|Overall Study||8
45313|NCT01579084|103765|P1|COMPLETED|Overall Study||8
45314|NCT01579084|103756|P10|STARTED|Overall Study||4
45315|NCT01579084|103757|P9|STARTED|Overall Study||4
45316|NCT01579084|103758|P8|STARTED|Overall Study||4
45317|NCT01579084|103759|P7|STARTED|Overall Study||4
45318|NCT01579084|103760|P6|STARTED|Overall Study||8
45319|NCT01579084|103761|P5|STARTED|Overall Study||8
45320|NCT01579084|103762|P4|STARTED|Overall Study||8
45321|NCT01579084|103763|P3|STARTED|Overall Study||8
45322|NCT01579084|103764|P2|STARTED|Overall Study||8
45323|NCT01579084|103765|P1|STARTED|Overall Study||8
45324|NCT01579045|103793|P1|NOT COMPLETED|Overall Study||0
45325|NCT01579045|103793|P1|COMPLETED|Overall Study||24
45326|NCT01579045|103793|P1|STARTED|Overall Study||24
45327|NCT01579006|103810|P1|NOT COMPLETED|Overall Study||33
45328|NCT01579006|103810|P1|COMPLETED|Overall Study||151
45329|NCT01579006|103810|P1|STARTED|Overall Study||184
45330|NCT01578993|103849|P1|NOT COMPLETED|Overall Study||0
45331|NCT01578993|103849|P1|COMPLETED|Overall Study||101
45332|NCT01578993|103849|P1|STARTED|Overall Study||101
45333|NCT01578980|103853|P1|NOT COMPLETED|Overall Study||0
45334|NCT01578980|103853|P1|COMPLETED|Overall Study||20
45335|NCT01578980|103853|P1|STARTED|Overall Study||20
45336|NCT01578850|103860|P3|NOT COMPLETED|Period 2||14
45337|NCT01578850|103861|P2|NOT COMPLETED|Period 2||13
45338|NCT01578850|103862|P1|NOT COMPLETED|Period 2||0
45339|NCT01578850|103860|P3|COMPLETED|Period 2||162
45340|NCT01578850|103861|P2|COMPLETED|Period 2||154
45341|NCT01578850|103862|P1|COMPLETED|Period 2||0
45342|NCT01578850|103860|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
45343|NCT01578850|103861|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
45344|NCT01578850|103862|P1|STARTED|Period 2||0
45345|NCT01578850|103860|P3|NOT COMPLETED|Period 1||0
45346|NCT01578850|103861|P2|NOT COMPLETED|Period 1||0
45347|NCT01578850|103862|P1|NOT COMPLETED|Period 1||37
45348|NCT01578850|103860|P3|COMPLETED|Period 1||0
45349|NCT01578850|103861|P2|COMPLETED|Period 1||0
45350|NCT01578850|103862|P1|COMPLETED|Period 1||452
45351|NCT01578850|103860|P3|STARTED|Period 1||0
45352|NCT01578850|103861|P2|STARTED|Period 1||0
45353|NCT01578850|103862|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
45354|NCT01578785|103914|P2|NOT COMPLETED|Overall Study||119
45355|NCT01578785|103915|P1|NOT COMPLETED|Overall Study||59
45356|NCT01578785|103914|P2|COMPLETED|Overall Study||0
45357|NCT01578785|103915|P1|COMPLETED|Overall Study||0
45358|NCT01578785|103914|P2|STARTED|Overall Study||119
45359|NCT01578785|103915|P1|STARTED|Overall Study||59
45360|NCT01578772|103927|P1|NOT COMPLETED|Overall Study||0
45361|NCT01578772|103927|P1|COMPLETED|Overall Study||17
45362|NCT01578772|103927|P1|STARTED|Overall Study||17
45363|NCT01578707|103936|P2|NOT COMPLETED|Overall Study||0
45364|NCT01578707|103937|P1|NOT COMPLETED|Overall Study||0
45365|NCT01578707|103936|P2|COMPLETED|Overall Study||195
45366|NCT01578707|103937|P1|COMPLETED|Overall Study||196
45367|NCT01578707|103936|P2|STARTED|Overall Study||195
45368|NCT01578707|103937|P1|STARTED|Overall Study||196
45369|NCT01578330|103945|P1|NOT COMPLETED|Overall Study||7
45370|NCT01578330|103945|P1|COMPLETED|Overall Study||35
45371|NCT01578330|103945|P1|Per Protocol Population|Overall Study||35
45372|NCT01578330|103945|P1|STARTED|Overall Study||42
45373|NCT01578187|103952|P1|NOT COMPLETED|Usability Phase||1
45374|NCT01578187|103952|P1|COMPLETED|Usability Phase||47
45375|NCT01578187|103952|P1|STARTED|Usability Phase||48
45376|NCT01578187|103952|P1|NOT COMPLETED|Label Comprehension Phase||0
45377|NCT01578187|103952|P1|COMPLETED|Label Comprehension Phase||63
45378|NCT01578187|103952|P1|STARTED|Label Comprehension Phase||63
45379|NCT01578044|103960|P2|NOT COMPLETED|Overall Study||0
45380|NCT01578044|103961|P1|NOT COMPLETED|Overall Study||0
45381|NCT01578044|103960|P2|COMPLETED|Overall Study||6
45382|NCT01578044|103961|P1|COMPLETED|Overall Study||6
45383|NCT01578044|103960|P2|STARTED|Overall Study||6
45384|NCT01578044|103961|P1|STARTED|Overall Study||6
45385|NCT01577966|103967|P1|NOT COMPLETED|Overall Study||0
45386|NCT01577966|103967|P1|COMPLETED|Overall Study||9
45387|NCT01577966|103967|P1|STARTED|Overall Study||9
45388|NCT01577758|103971|P8|NOT COMPLETED|mCRC Expansion Phase||25
45389|NCT01577758|103972|P7|NOT COMPLETED|mCRC Expansion Phase||0
45390|NCT01577758|103973|P6|NOT COMPLETED|mCRC Expansion Phase||0
45391|NCT01577758|103974|P5|NOT COMPLETED|mCRC Expansion Phase||0
45392|NCT01577758|103975|P4|NOT COMPLETED|mCRC Expansion Phase||0
45393|NCT01577758|103976|P3|NOT COMPLETED|mCRC Expansion Phase||0
45394|NCT01577758|103977|P2|NOT COMPLETED|mCRC Expansion Phase||0
45395|NCT01577758|103978|P1|NOT COMPLETED|mCRC Expansion Phase||0
45396|NCT01577758|103971|P8|COMPLETED|mCRC Expansion Phase||0
45397|NCT01577758|103972|P7|COMPLETED|mCRC Expansion Phase||0
45398|NCT01577758|103973|P6|COMPLETED|mCRC Expansion Phase||0
45399|NCT01577758|103974|P5|COMPLETED|mCRC Expansion Phase||0
45400|NCT01577758|103975|P4|COMPLETED|mCRC Expansion Phase||0
45401|NCT01577758|103976|P3|COMPLETED|mCRC Expansion Phase||0
45402|NCT01577758|103977|P2|COMPLETED|mCRC Expansion Phase||0
45403|NCT01577758|103978|P1|COMPLETED|mCRC Expansion Phase||0
45404|NCT01577758|103971|P8|STARTED|mCRC Expansion Phase||25
45405|NCT01577758|103972|P7|STARTED|mCRC Expansion Phase||0
45406|NCT01577758|103973|P6|STARTED|mCRC Expansion Phase||0
45407|NCT01577758|103974|P5|STARTED|mCRC Expansion Phase||0
45408|NCT01577758|103975|P4|STARTED|mCRC Expansion Phase||0
45409|NCT01577758|103976|P3|STARTED|mCRC Expansion Phase||0
45410|NCT01577758|103977|P2|STARTED|mCRC Expansion Phase||0
45411|NCT01577758|103978|P1|STARTED|mCRC Expansion Phase||0
45412|NCT01577758|103971|P8|NOT COMPLETED|Dose Escalation Phase||0
45413|NCT01577758|103972|P7|NOT COMPLETED|Dose Escalation Phase||1
45414|NCT01577758|103973|P6|NOT COMPLETED|Dose Escalation Phase||4
45415|NCT01577758|103974|P5|NOT COMPLETED|Dose Escalation Phase||6
45416|NCT01577758|103975|P4|NOT COMPLETED|Dose Escalation Phase||2
45417|NCT01577758|103976|P3|NOT COMPLETED|Dose Escalation Phase||2
45418|NCT01577758|103977|P2|NOT COMPLETED|Dose Escalation Phase||2
45419|NCT01577758|103978|P1|NOT COMPLETED|Dose Escalation Phase||2
45420|NCT01577758|103971|P8|COMPLETED|Dose Escalation Phase||0
45421|NCT01577758|103972|P7|COMPLETED|Dose Escalation Phase||0
45422|NCT01577758|103973|P6|COMPLETED|Dose Escalation Phase||0
45423|NCT01577758|103974|P5|COMPLETED|Dose Escalation Phase||0
45424|NCT01577758|103975|P4|COMPLETED|Dose Escalation Phase||0
45425|NCT01577758|103976|P3|COMPLETED|Dose Escalation Phase||0
45426|NCT01577758|103977|P2|COMPLETED|Dose Escalation Phase||0
45427|NCT01577758|103978|P1|COMPLETED|Dose Escalation Phase||0
45428|NCT01577758|103971|P8|STARTED|Dose Escalation Phase||0
45429|NCT01577758|103972|P7|STARTED|Dose Escalation Phase||1
45430|NCT01577758|103973|P6|STARTED|Dose Escalation Phase||4
45431|NCT01577758|103974|P5|STARTED|Dose Escalation Phase||6
45432|NCT01577758|103975|P4|STARTED|Dose Escalation Phase||2
45433|NCT01577758|103976|P3|STARTED|Dose Escalation Phase||2
45434|NCT01577758|103977|P2|STARTED|Dose Escalation Phase||2
45435|NCT01577758|103978|P1|STARTED|Dose Escalation Phase||2
45436|NCT01577732|104011|P1|NOT COMPLETED|Overall Study||0
45437|NCT01577732|104011|P1|COMPLETED|Overall Study||300
45438|NCT01577732|104011|P1|STARTED|Overall Study||300
45439|NCT01577628|104020|P3|NOT COMPLETED|Overall Study||2
45440|NCT01577628|104021|P2|NOT COMPLETED|Overall Study||0
45441|NCT01577628|104022|P1|NOT COMPLETED|Overall Study||0
45442|NCT01577628|104020|P3|COMPLETED|Overall Study||0
45443|NCT01577628|104021|P2|COMPLETED|Overall Study||0
45444|NCT01577628|104022|P1|COMPLETED|Overall Study||0
45445|NCT01577628|104020|P3|STARTED|Overall Study||2
45446|NCT01577628|104021|P2|STARTED|Overall Study||0
45447|NCT01577628|104022|P1|STARTED|Overall Study||0
45448|NCT01577381|104050|P4|NOT COMPLETED|Overall Study||2
45449|NCT01577381|104051|P3|NOT COMPLETED|Overall Study||3
45450|NCT01577381|104052|P2|NOT COMPLETED|Overall Study||3
45451|NCT01577381|104053|P1|NOT COMPLETED|Overall Study||2
45452|NCT01577381|104050|P4|COMPLETED|Overall Study||0
45453|NCT01577381|104051|P3|COMPLETED|Overall Study||0
45454|NCT01577381|104052|P2|COMPLETED|Overall Study||0
45455|NCT01577381|104053|P1|COMPLETED|Overall Study||0
45456|NCT01577381|104050|P4|STARTED|Overall Study||2
45457|NCT01577381|104051|P3|STARTED|Overall Study||3
45458|NCT01577381|104052|P2|STARTED|Overall Study||3
45459|NCT01577381|104053|P1|STARTED|Overall Study||2
45460|NCT01577186|104182|P1|NOT COMPLETED|Overall Study||130
45461|NCT01577186|104182|P1|COMPLETED|Overall Study||350
45462|NCT01577186|104182|P1|STARTED|Overall Study||480
45463|NCT01577160|104190|P1|NOT COMPLETED|Overall Study||98
45464|NCT01577160|104190|P1|COMPLETED|Overall Study||255
45465|NCT01577160|104190|P1|STARTED|Overall Study||353
45466|NCT01576952|104200|P2|NOT COMPLETED|Overall Study||55
45467|NCT01576952|104201|P1|NOT COMPLETED|Overall Study||41
45468|NCT01576952|104200|P2|COMPLETED|Overall Study||33
45469|NCT01576952|104201|P1|COMPLETED|Overall Study||139
45470|NCT01576952|104200|P2|mITT Population|Overall Study||85
45471|NCT01576952|104201|P1|mITT Population|Overall Study||168
45472|NCT01576952|104200|P2|Safety Population|Overall Study||85
45473|NCT01576952|104201|P1|Safety Population|Overall Study||169
45474|NCT01576952|104200|P2|STARTED|Overall Study||88
45475|NCT01576952|104201|P1|STARTED|Overall Study||180
45476|NCT01576809|104207|P1|NOT COMPLETED|Overall Study||0
45477|NCT01576809|104207|P1|COMPLETED|Overall Study||51
45478|NCT01576809|104207|P1|STARTED|Overall Study||51
45479|NCT01576367|104213|P1|NOT COMPLETED|Overall Study||3
45480|NCT01576367|104213|P1|COMPLETED|Overall Study||14
45481|NCT01576367|104213|P1|STARTED|Overall Study||17
45482|NCT01576159|104225|P4|NOT COMPLETED|Overall Study||1
45483|NCT01576159|104226|P3|NOT COMPLETED|Overall Study||1
45484|NCT01576159|104227|P2|NOT COMPLETED|Overall Study||1
45485|NCT01576159|104228|P1|NOT COMPLETED|Overall Study||1
45486|NCT01576159|104225|P4|COMPLETED|Overall Study||11
45487|NCT01576159|104226|P3|COMPLETED|Overall Study||11
45488|NCT01576159|104227|P2|COMPLETED|Overall Study||11
45489|NCT01576159|104228|P1|COMPLETED|Overall Study||11
45490|NCT01576159|104225|P4|STARTED|Overall Study||12
45491|NCT01576159|104226|P3|STARTED|Overall Study||12
45492|NCT01576159|104227|P2|STARTED|Overall Study||12
45493|NCT01576159|104228|P1|STARTED|Overall Study||12
45494|NCT01576120|104248|P2|NOT COMPLETED|Overall Study||0
45495|NCT01576120|104249|P1|NOT COMPLETED|Overall Study||0
45496|NCT01576120|104248|P2|COMPLETED|Overall Study||19
45497|NCT01576120|104249|P1|COMPLETED|Overall Study||21
45498|NCT01576120|104248|P2|STARTED|Overall Study||19
45499|NCT01576120|104249|P1|STARTED|Overall Study||21
45500|NCT01576055|104257|P2|NOT COMPLETED|Overall Study||6
45501|NCT01576055|104258|P1|NOT COMPLETED|Overall Study||19
45502|NCT01576055|104257|P2|COMPLETED|Overall Study||64
45503|NCT01576055|104258|P1|COMPLETED|Overall Study||178
45504|NCT01576055|104257|P2|STARTED|Overall Study||70
45505|NCT01576055|104258|P1|STARTED|Overall Study||197
45506|NCT01576042|104272|P2|NOT COMPLETED|Overall Study||0
45507|NCT01576042|104273|P1|NOT COMPLETED|Overall Study||2
45508|NCT01576042|104272|P2|COMPLETED|Overall Study||14
45509|NCT01576042|104273|P1|COMPLETED|Overall Study||11
45510|NCT01576042|104272|P2|Switched to the Other Arm|Overall Study||1
45511|NCT01576042|104273|P1|Switched to the Other Arm|Overall Study||5
45512|NCT01576042|104272|P2|STARTED|Overall Study||14
45513|NCT01576042|104273|P1|STARTED|Overall Study||13
45514|NCT01575899|104296|P3|NOT COMPLETED|Overall Study||2
45515|NCT01575899|104297|P2|NOT COMPLETED|Overall Study||5
45516|NCT01575899|104298|P1|NOT COMPLETED|Overall Study||5
45517|NCT01575899|104296|P3|COMPLETED|Overall Study||60
45518|NCT01575899|104297|P2|COMPLETED|Overall Study||68
45519|NCT01575899|104298|P1|COMPLETED|Overall Study||68
45520|NCT01575899|104296|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
45521|NCT01575899|104297|P2|STARTED|Overall Study||73
45522|NCT01575899|104298|P1|STARTED|Overall Study||73
45523|NCT01575769|104308|P1|NOT COMPLETED|Overall Study||41
45524|NCT01575769|104308|P1|COMPLETED|Overall Study||0
45525|NCT01575769|104308|P1|STARTED|Overall Study||41
45526|NCT01575756|104334|P2|NOT COMPLETED|Treatment Period 2||0
45527|NCT01575756|104335|P1|NOT COMPLETED|Treatment Period 2||0
45528|NCT01575756|104334|P2|COMPLETED|Treatment Period 2||11
45529|NCT01575756|104335|P1|COMPLETED|Treatment Period 2||11
45530|NCT01575756|104334|P2|STARTED|Treatment Period 2||11
45531|NCT01575756|104335|P1|STARTED|Treatment Period 2||11
45532|NCT01575756|104334|P2|NOT COMPLETED|Treatment Period 1||0
45533|NCT01575756|104335|P1|NOT COMPLETED|Treatment Period 1||0
45534|NCT01575756|104334|P2|COMPLETED|Treatment Period 1||11
45535|NCT01575756|104335|P1|COMPLETED|Treatment Period 1||11
45536|NCT01575756|104334|P2|STARTED|Treatment Period 1||11
45537|NCT01575756|104335|P1|STARTED|Treatment Period 1||11
45538|NCT01575561|104351|P1|NOT COMPLETED|Overall Study||39
45539|NCT01575561|104351|P1|COMPLETED|Overall Study||338
45540|NCT01575561|104351|P1|STARTED|Overall Study||377
45541|NCT01575522|104363|P1|NOT COMPLETED|Overall Study||0
45542|NCT01575522|104363|P1|COMPLETED|Overall Study||22
45543|NCT01575522|104363|P1|STARTED|Overall Study||22
45544|NCT01575197|104374|P3|NOT COMPLETED|Overall Study||6
45545|NCT01575197|104375|P2|NOT COMPLETED|Overall Study||9
45546|NCT01575197|104376|P1|NOT COMPLETED|Overall Study||3
45547|NCT01575197|104374|P3|COMPLETED|Overall Study||146
45548|NCT01575197|104375|P2|COMPLETED|Overall Study||143
45549|NCT01575197|104376|P1|COMPLETED|Overall Study||149
45550|NCT01575197|104374|P3|STARTED|Overall Study||152
45551|NCT01575197|104375|P2|STARTED|Overall Study||152
45552|NCT01575197|104376|P1|STARTED|Overall Study||152
45553|NCT01575080|104389|P1|NOT COMPLETED|Overall Study||0
45554|NCT01575080|104389|P1|COMPLETED|Overall Study||102
45555|NCT01575080|104389|P1|STARTED|Overall Study||102
45556|NCT01575054|104398|P2|NOT COMPLETED|Overall Study||26
45557|NCT01575054|104399|P1|NOT COMPLETED|Overall Study||29
45558|NCT01575054|104398|P2|COMPLETED|Overall Study||209
45559|NCT01575054|104399|P1|COMPLETED|Overall Study||204
45560|NCT01575054|104398|P2|STARTED|Overall Study||235
45561|NCT01575054|104399|P1|STARTED|Overall Study||233
45562|NCT01575028|104415|P2|NOT COMPLETED|Overall Study||1
45563|NCT01575028|104416|P1|NOT COMPLETED|Overall Study||0
45564|NCT01575028|104415|P2|COMPLETED|Overall Study||0
45565|NCT01575028|104416|P1|COMPLETED|Overall Study||2
45566|NCT01575028|104415|P2|STARTED|Overall Study||1
45567|NCT01575028|104416|P1|STARTED|Overall Study||2
45568|NCT01574703|104426|P4|NOT COMPLETED|Overall Study||114
45569|NCT01574703|104427|P3|NOT COMPLETED|Overall Study||105
45570|NCT01574703|104428|P2|NOT COMPLETED|Overall Study||112
45571|NCT01574703|104429|P1|NOT COMPLETED|Overall Study||125
45572|NCT01574703|104426|P4|COMPLETED|Overall Study||1007
45573|NCT01574703|104427|P3|COMPLETED|Overall Study||1011
45574|NCT01574703|104428|P2|COMPLETED|Overall Study||1054
45575|NCT01574703|104429|P1|COMPLETED|Overall Study||1067
45576|NCT01574703|104426|P4|STARTED|Overall Study||1121
45577|NCT01574703|104427|P3|STARTED|Overall Study||1116
45578|NCT01574703|104428|P2|STARTED|Overall Study||1166
45579|NCT01574703|104429|P1|STARTED|Overall Study||1192
45580|NCT01574651|104473|P2|NOT COMPLETED|Overall Study||52
45581|NCT01574651|104474|P1|NOT COMPLETED|Overall Study||61
45582|NCT01574651|104473|P2|COMPLETED|Overall Study||406
45583|NCT01574651|104474|P1|COMPLETED|Overall Study||415
45584|NCT01574651|104473|P2|Per Protocol Set (PPS)|Overall Study||374
45585|NCT01574651|104474|P1|Per Protocol Set (PPS)|Overall Study||373
45586|NCT01574651|104473|P2|Full Analysis Set (FAS)|Overall Study||458
45587|NCT01574651|104474|P1|Full Analysis Set (FAS)|Overall Study||476
45588|NCT01574651|104473|P2|STARTED|Overall Study||458
45589|NCT01574651|104474|P1|STARTED|Overall Study||476
45590|NCT01574612|104496|P1|NOT COMPLETED|Overall Study||8
45591|NCT01574612|104496|P1|COMPLETED|Overall Study||46
45592|NCT01574612|104496|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
45593|NCT01574326|104502|P2|NOT COMPLETED|Overall Study||19
45594|NCT01574326|104503|P1|NOT COMPLETED|Overall Study||16
45595|NCT01574326|104502|P2|COMPLETED|Overall Study||31
45596|NCT01574326|104503|P1|COMPLETED|Overall Study||35
45597|NCT01574326|104502|P2|Treated|Overall Study||49
45598|NCT01574326|104503|P1|Treated|Overall Study||51
45599|NCT01574326|104502|P2|STARTED|Overall Study||50
45600|NCT01574326|104503|P1|STARTED|Overall Study||51
45601|NCT01574248|104516|P2|NOT COMPLETED|Overall Study||0
45602|NCT01574248|104517|P1|NOT COMPLETED|Overall Study||3
45603|NCT01574248|104516|P2|COMPLETED|Overall Study||18
45604|NCT01574248|104517|P1|COMPLETED|Overall Study||12
45605|NCT01574248|104516|P2|STARTED|Overall Study||18
45606|NCT01574248|104517|P1|STARTED|Overall Study||15
45607|NCT01574183|104537|P2|NOT COMPLETED|Overall Study||18
45608|NCT01574183|104538|P1|NOT COMPLETED|Overall Study||27
45609|NCT01574183|104537|P2|COMPLETED|Overall Study||17
45610|NCT01574183|104538|P1|COMPLETED|Overall Study||14
45611|NCT01574183|104537|P2|STARTED|Overall Study||35
45612|NCT01574183|104538|P1|STARTED|Overall Study||41
45613|NCT01574105|104550|P2|NOT COMPLETED|Overall Study||0
45614|NCT01574105|104551|P1|NOT COMPLETED|Overall Study||0
45615|NCT01574105|104550|P2|COMPLETED|Overall Study||37
45616|NCT01574105|104551|P1|COMPLETED|Overall Study||29
45617|NCT01574105|104550|P2|STARTED|Overall Study||37
45618|NCT01574105|104551|P1|STARTED|Overall Study||29
45619|NCT01574079|104561|P2|NOT COMPLETED|Overall Study||2
45620|NCT01574079|104562|P1|NOT COMPLETED|Overall Study||1
45621|NCT01574079|104561|P2|COMPLETED|Overall Study||13
45622|NCT01574079|104562|P1|COMPLETED|Overall Study||17
45623|NCT01574079|104561|P2|STARTED|Overall Study||15
45624|NCT01574079|104562|P1|STARTED|Overall Study||18
45625|NCT01573910|104574|P2|NOT COMPLETED|Overall Study||17
45626|NCT01573910|104575|P1|NOT COMPLETED|Overall Study||20
45627|NCT01573910|104574|P2|COMPLETED|Overall Study||476
45628|NCT01573910|104575|P1|COMPLETED|Overall Study||469
45629|NCT01573910|104574|P2|STARTED|Overall Study||493
45630|NCT01573910|104575|P1|STARTED|Overall Study||489
45631|NCT01573767|104587|P4|NOT COMPLETED|Overall Study||24
45632|NCT01573767|104588|P3|NOT COMPLETED|Overall Study||14
45633|NCT01573767|104589|P2|NOT COMPLETED|Overall Study||21
45634|NCT01573767|104590|P1|NOT COMPLETED|Overall Study||22
45635|NCT01573767|104587|P4|COMPLETED|Overall Study||90
45636|NCT01573767|104588|P3|COMPLETED|Overall Study||99
45637|NCT01573767|104589|P2|COMPLETED|Overall Study||93
45638|NCT01573767|104590|P1|COMPLETED|Overall Study||93
45639|NCT01573767|104587|P4|STARTED|Overall Study||114
45640|NCT01573767|104588|P3|STARTED|Overall Study||113
45641|NCT01573767|104589|P2|STARTED|Overall Study||114
45642|NCT01573767|104590|P1|STARTED|Overall Study||115
45643|NCT01573325|104624|P1|NOT COMPLETED|Overall Study||0
45644|NCT01573325|104624|P1|COMPLETED|Overall Study||50
45645|NCT01573325|104624|P1|STARTED|Overall Study||50
45646|NCT01573260|104631|P2|NOT COMPLETED|Overall Study||0
45647|NCT01573260|104632|P1|NOT COMPLETED|Overall Study||0
45648|NCT01573260|104631|P2|COMPLETED|Overall Study||15
45649|NCT01573260|104632|P1|COMPLETED|Overall Study||18
45650|NCT01573260|104631|P2|STARTED|Overall Study||15
45651|NCT01573260|104632|P1|STARTED|Overall Study||18
45652|NCT01573000|104666|P2|NOT COMPLETED|Long-Term Follow-Up||1
45653|NCT01573000|104667|P1|NOT COMPLETED|Long-Term Follow-Up||3
45654|NCT01573000|104666|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
45655|NCT01573000|104667|P1|COMPLETED|Long-Term Follow-Up||11
45656|NCT01573000|104666|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
45657|NCT01573000|104667|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
45658|NCT01573000|104666|P2|NOT COMPLETED|Crossover Phase||18
45659|NCT01573000|104667|P1|NOT COMPLETED|Crossover Phase||0
45660|NCT01573000|104666|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
45661|NCT01573000|104667|P1|COMPLETED|Crossover Phase||0
45662|NCT01573000|104666|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
45663|NCT01573000|104667|P1|STARTED|Crossover Phase||0
45664|NCT01573000|104666|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
45665|NCT01573000|104667|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
45666|NCT01573000|104666|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
45667|NCT01573000|104667|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
45668|NCT01573000|104666|P2|STARTED|Dosimetric and Therapeutic Treatment||36
45669|NCT01573000|104667|P1|STARTED|Dosimetric and Therapeutic Treatment||42
45670|NCT01572948|104763|P2|NOT COMPLETED|Overall Study||1
45671|NCT01572948|104764|P1|NOT COMPLETED|Overall Study||1
45672|NCT01572948|104763|P2|COMPLETED|Overall Study||15
45673|NCT01572948|104764|P1|COMPLETED|Overall Study||10
45674|NCT01572948|104763|P2|STARTED|Overall Study||16
45675|NCT01572948|104764|P1|STARTED|Overall Study||11
45676|NCT01572740|104782|P2|NOT COMPLETED|Overall Study||5
45677|NCT01572740|104783|P1|NOT COMPLETED|Overall Study||6
45678|NCT01572740|104782|P2|COMPLETED|Overall Study||125
45679|NCT01572740|104783|P1|COMPLETED|Overall Study||121
45680|NCT01572740|104782|P2|STARTED|Overall Study||130
45681|NCT01572740|104783|P1|STARTED|Overall Study||127
45682|NCT01572727|104813|P2|NOT COMPLETED|Overall Study||209
45683|NCT01572727|104814|P1|NOT COMPLETED|Overall Study||207
45684|NCT01572727|104813|P2|COMPLETED|Overall Study||0
45685|NCT01572727|104814|P1|COMPLETED|Overall Study||0
45686|NCT01572727|104813|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
45687|NCT01572727|104814|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
45688|NCT01572727|104813|P2|STARTED|Overall Study||209
45689|NCT01572727|104814|P1|STARTED|Overall Study||207
45690|NCT01572675|104836|P2|NOT COMPLETED|Overall Study||223
45691|NCT01572675|104837|P1|NOT COMPLETED|Overall Study||237
45692|NCT01572675|104836|P2|COMPLETED|Overall Study||56
45693|NCT01572675|104837|P1|COMPLETED|Overall Study||31
45694|NCT01572675|104836|P2|STARTED|Overall Study||279
45695|NCT01572675|104837|P1|STARTED|Overall Study||268
45696|NCT01572298|104936|P2|NOT COMPLETED|Overall Study||1
45697|NCT01572298|104937|P1|NOT COMPLETED|Overall Study||2
45698|NCT01572298|104936|P2|COMPLETED|Overall Study||12
45699|NCT01572298|104937|P1|COMPLETED|Overall Study||12
45700|NCT01572298|104936|P2|STARTED|Overall Study||13
45701|NCT01572298|104937|P1|STARTED|Overall Study||14
45702|NCT01572207|104945|P2|NOT COMPLETED|Overall Study||3
45703|NCT01572207|104946|P1|NOT COMPLETED|Overall Study||2
45704|NCT01572207|104945|P2|COMPLETED|Overall Study||13
45705|NCT01572207|104946|P1|COMPLETED|Overall Study||12
45706|NCT01572207|104945|P2|STARTED|Overall Study||16
45707|NCT01572207|104946|P1|STARTED|Overall Study||14
45708|NCT01571557|104956|P1|NOT COMPLETED|Overall Study||0
45709|NCT01571557|104956|P1|COMPLETED|Overall Study||573
45710|NCT01571557|104956|P1|STARTED|Overall Study||573
45711|NCT01571453|104965|P2|NOT COMPLETED|Overall Study||62
45712|NCT01571453|104966|P1|NOT COMPLETED|Overall Study||38
45713|NCT01571453|104965|P2|COMPLETED|Overall Study||164
45714|NCT01571453|104966|P1|COMPLETED|Overall Study||173
45715|NCT01571453|104965|P2|STARTED|Overall Study||226
45716|NCT01571453|104966|P1|STARTED|Overall Study||211
45717|NCT01570751|104984|P2|NOT COMPLETED|Period B (16 Weeks)||1
45718|NCT01570751|104985|P1|NOT COMPLETED|Period B (16 Weeks)||1
45719|NCT01570751|104984|P2|COMPLETED|Period B (16 Weeks)||66
45720|NCT01570751|104985|P1|COMPLETED|Period B (16 Weeks)||69
45721|NCT01570751|104984|P2|Exposed|Period B (16 Weeks)||67
45722|NCT01570751|104985|P1|Exposed|Period B (16 Weeks)||70
45723|NCT01570751|104984|P2|STARTED|Period B (16 Weeks)||67
45724|NCT01570751|104985|P1|STARTED|Period B (16 Weeks)||70
45725|NCT01570751|104984|P2|NOT COMPLETED|Period A (16 Weeks)||5
45726|NCT01570751|104985|P1|NOT COMPLETED|Period A (16 Weeks)||3
45727|NCT01570751|104984|P2|COMPLETED|Period A (16 Weeks)||67
45728|NCT01570751|104985|P1|COMPLETED|Period A (16 Weeks)||70
45729|NCT01570751|104984|P2|Exposed|Period A (16 Weeks)||72
45730|NCT01570751|104985|P1|Exposed|Period A (16 Weeks)||73
45731|NCT01570751|104984|P2|STARTED|Period A (16 Weeks)||72
45732|NCT01570751|104985|P1|STARTED|Period A (16 Weeks)||73
45733|NCT01570686|105003|P2|NOT COMPLETED|Overall Study||16
45734|NCT01570686|105004|P1|NOT COMPLETED|Overall Study||22
45735|NCT01570686|105003|P2|COMPLETED|Overall Study||278
45736|NCT01570686|105004|P1|COMPLETED|Overall Study||274
45737|NCT01570686|105003|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
45738|NCT01570686|105004|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
45739|NCT01570686|105003|P2|STARTED|Overall Study||294
45740|NCT01570686|105004|P1|STARTED|Overall Study||296
45741|NCT01570634|105030|P1|NOT COMPLETED|Overall Study||0
45742|NCT01570634|105030|P1|COMPLETED|Overall Study||2
45743|NCT01570634|105030|P1|STARTED|Overall Study||2
45744|NCT01570309|105040|P2|NOT COMPLETED|Overall Study||3
45745|NCT01570309|105041|P1|NOT COMPLETED|Overall Study||3
45746|NCT01570309|105040|P2|COMPLETED|Overall Study||45
45747|NCT01570309|105041|P1|COMPLETED|Overall Study||45
45748|NCT01570309|105040|P2|STARTED|Overall Study||48
45749|NCT01570309|105041|P1|STARTED|Overall Study||48
45750|NCT01570244|105055|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
45751|NCT01570244|105055|P1|COMPLETED|Microgynon+Faldaprevir||15
45752|NCT01570244|105055|P1|STARTED|Microgynon+Faldaprevir||16
45753|NCT01570244|105055|P1|NOT COMPLETED|Microgynon||0
45754|NCT01570244|105055|P1|COMPLETED|Microgynon||16
45755|NCT01570244|105055|P1|STARTED|Microgynon||16
45756|NCT01569841|105075|P2|NOT COMPLETED|Period B (6 Weeks)||0
45757|NCT01569841|105076|P1|NOT COMPLETED|Period B (6 Weeks)||0
45758|NCT01569841|105075|P2|COMPLETED|Period B (6 Weeks)||11
45759|NCT01569841|105076|P1|COMPLETED|Period B (6 Weeks)||12
45760|NCT01569841|105075|P2|Exposed|Period B (6 Weeks)||11
45761|NCT01569841|105076|P1|Exposed|Period B (6 Weeks)||12
45762|NCT01569841|105075|P2|STARTED|Period B (6 Weeks)||11
45763|NCT01569841|105076|P1|STARTED|Period B (6 Weeks)||12
45764|NCT01569841|105075|P2|NOT COMPLETED|Period A (6 Weeks)||1
45765|NCT01569841|105076|P1|NOT COMPLETED|Period A (6 Weeks)||0
45766|NCT01569841|105075|P2|COMPLETED|Period A (6 Weeks)||11
45767|NCT01569841|105076|P1|COMPLETED|Period A (6 Weeks)||12
45768|NCT01569841|105075|P2|Exposed|Period A (6 Weeks)||12
45769|NCT01569841|105076|P1|Exposed|Period A (6 Weeks)||12
45770|NCT01569841|105075|P2|STARTED|Period A (6 Weeks)||12
45771|NCT01569841|105076|P1|STARTED|Period A (6 Weeks)||12
45772|NCT01569828|105094|P2|NOT COMPLETED|Overall Study||0
45773|NCT01569828|105095|P1|NOT COMPLETED|Overall Study||0
45774|NCT01569828|105094|P2|COMPLETED|Overall Study||6
45775|NCT01569828|105095|P1|COMPLETED|Overall Study||6
45776|NCT01569828|105094|P2|STARTED|Overall Study||6
45777|NCT01569828|105095|P1|STARTED|Overall Study||6
45778|NCT01569815|105117|P4|NOT COMPLETED|Overall Study||0
45779|NCT01569815|105118|P3|NOT COMPLETED|Overall Study||0
45780|NCT01569815|105119|P2|NOT COMPLETED|Overall Study||0
45781|NCT01569815|105120|P1|NOT COMPLETED|Overall Study||0
45782|NCT01569815|105117|P4|COMPLETED|Overall Study||8
45783|NCT01569815|105118|P3|COMPLETED|Overall Study||8
45784|NCT01569815|105119|P2|COMPLETED|Overall Study||8
45785|NCT01569815|105120|P1|COMPLETED|Overall Study||8
45786|NCT01569815|105117|P4|STARTED|Overall Study||8
45787|NCT01569815|105118|P3|STARTED|Overall Study||8
45788|NCT01569815|105119|P2|STARTED|Overall Study||8
45789|NCT01569815|105120|P1|STARTED|Overall Study||8
45790|NCT01569763|105165|P2|NOT COMPLETED|Overall Study||7
45791|NCT01569763|105166|P1|NOT COMPLETED|Overall Study||3
45792|NCT01569763|105165|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
45793|NCT01569763|105166|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
45794|NCT01569763|105165|P2|Treated|Overall Study||51
45795|NCT01569763|105166|P1|Treated|Overall Study||102
45796|NCT01569763|105165|P2|STARTED|Overall Study||51
45797|NCT01569763|105166|P1|STARTED|Overall Study||102
45798|NCT01569529|105178|P2|NOT COMPLETED|Overall Study||0
45799|NCT01569529|105179|P1|NOT COMPLETED|Overall Study||0
45800|NCT01569529|105178|P2|COMPLETED|Overall Study||394
45801|NCT01569529|105179|P1|COMPLETED|Overall Study||2676
45802|NCT01569529|105178|P2|STARTED|Overall Study||394
45803|NCT01569529|105179|P1|STARTED|Overall Study||2676
45804|NCT01569464|105187|P2|NOT COMPLETED|Overall Study||5
45805|NCT01569464|105188|P1|NOT COMPLETED|Overall Study||10
45806|NCT01569464|105187|P2|COMPLETED|Overall Study||44
45807|NCT01569464|105188|P1|COMPLETED|Overall Study||91
45808|NCT01569464|105187|P2|STARTED|Overall Study||49
45809|NCT01569464|105188|P1|STARTED|Overall Study||101
45810|NCT01569438|105226|P2|NOT COMPLETED|Overall Study||9
45811|NCT01569438|105227|P1|NOT COMPLETED|Overall Study||2
45812|NCT01569438|105226|P2|COMPLETED|Overall Study||27
45813|NCT01569438|105227|P1|COMPLETED|Overall Study||36
45814|NCT01569438|105226|P2|STARTED|Overall Study||36
45815|NCT01569438|105227|P1|STARTED|Overall Study||38
45816|NCT01569126|105245|P6|NOT COMPLETED|Overall Study||0
45817|NCT01569126|105246|P5|NOT COMPLETED|Overall Study||0
45818|NCT01569126|105247|P4|NOT COMPLETED|Overall Study||0
45819|NCT01569126|105248|P3|NOT COMPLETED|Overall Study||0
45820|NCT01569126|105249|P2|NOT COMPLETED|Overall Study||0
45821|NCT01569126|105250|P1|NOT COMPLETED|Overall Study||0
45822|NCT01569126|105245|P6|COMPLETED|Overall Study||12
45823|NCT01569126|105246|P5|COMPLETED|Overall Study||12
45824|NCT01569126|105247|P4|COMPLETED|Overall Study||8
45825|NCT01569126|105248|P3|COMPLETED|Overall Study||8
45826|NCT01569126|105249|P2|COMPLETED|Overall Study||8
45827|NCT01569126|105250|P1|COMPLETED|Overall Study||8
45828|NCT01569126|105245|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
45829|NCT01569126|105246|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
45830|NCT01569126|105247|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
45831|NCT01569126|105248|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
45832|NCT01569126|105249|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
45833|NCT01569126|105250|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
45834|NCT01569126|105245|P6|STARTED|Overall Study||12
45835|NCT01569126|105246|P5|STARTED|Overall Study||12
45836|NCT01569126|105247|P4|STARTED|Overall Study||8
45837|NCT01569126|105248|P3|STARTED|Overall Study||8
45838|NCT01569126|105249|P2|STARTED|Overall Study||8
45839|NCT01569126|105250|P1|STARTED|Overall Study||8
45840|NCT01569087|105288|P3|NOT COMPLETED|Overall Study||1
45841|NCT01569087|105289|P2|NOT COMPLETED|Overall Study||0
45842|NCT01569087|105290|P1|NOT COMPLETED|Overall Study||1
45843|NCT01569087|105288|P3|COMPLETED|Overall Study||18
45844|NCT01569087|105289|P2|COMPLETED|Overall Study||20
45845|NCT01569087|105290|P1|COMPLETED|Overall Study||20
45846|NCT01569087|105288|P3|STARTED|Overall Study||19
45847|NCT01569087|105289|P2|STARTED|Overall Study||20
45848|NCT01569087|105290|P1|STARTED|Overall Study||21
45849|NCT01569074|105318|P5|NOT COMPLETED|Overall Study||8
45850|NCT01569074|105319|P4|NOT COMPLETED|Overall Study||8
45851|NCT01569074|105320|P3|NOT COMPLETED|Overall Study||12
45852|NCT01569074|105321|P2|NOT COMPLETED|Overall Study||9
45853|NCT01569074|105322|P1|NOT COMPLETED|Overall Study||7
45854|NCT01569074|105318|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
45855|NCT01569074|105319|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
45856|NCT01569074|105320|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
45857|NCT01569074|105321|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
45858|NCT01569074|105322|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
45859|NCT01569074|105318|P5|Randomised But Did Not Receive Treatment|Overall Study||0
45860|NCT01569074|105319|P4|Randomised But Did Not Receive Treatment|Overall Study||0
45861|NCT01569074|105320|P3|Randomised But Did Not Receive Treatment|Overall Study||0
45862|NCT01569074|105321|P2|Randomised But Did Not Receive Treatment|Overall Study||0
45863|NCT01569074|105322|P1|Randomised But Did Not Receive Treatment|Overall Study||0
45864|NCT01569074|105318|P5|STARTED|Overall Study|Patients who received treatment|33
45865|NCT01569074|105319|P4|STARTED|Overall Study|Patients who received treatment|33
45866|NCT01569074|105320|P3|STARTED|Overall Study|Patients who received treatment|33
45867|NCT01569074|105321|P2|STARTED|Overall Study|Patients who received treatment|33
45868|NCT01569074|105322|P1|STARTED|Overall Study|Patients who received treatment|31
45869|NCT01568905|105381|P3|NOT COMPLETED|Overall Study||0
45870|NCT01568905|105382|P2|NOT COMPLETED|Overall Study||0
45871|NCT01568905|105383|P1|NOT COMPLETED|Overall Study||1
45872|NCT01568905|105381|P3|COMPLETED|Overall Study||12
45873|NCT01568905|105382|P2|COMPLETED|Overall Study||11
45874|NCT01568905|105383|P1|COMPLETED|Overall Study||12
45875|NCT01568905|105381|P3|STARTED|Overall Study||12
45876|NCT01568905|105382|P2|STARTED|Overall Study||11
45877|NCT01568905|105383|P1|STARTED|Overall Study||13
45878|NCT01568892|105402|P2|NOT COMPLETED|Open-label Phase||16
45879|NCT01568892|105403|P1|NOT COMPLETED|Open-label Phase||13
45880|NCT01568892|105402|P2|COMPLETED|Open-label Phase||0
45881|NCT01568892|105403|P1|COMPLETED|Open-label Phase||0
45882|NCT01568892|105402|P2|Ongoing|Open-label Phase||15
45883|NCT01568892|105403|P1|Ongoing|Open-label Phase||12
45884|NCT01568892|105402|P2|STARTED|Open-label Phase||16
45885|NCT01568892|105403|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
45886|NCT01568892|105402|P2|NOT COMPLETED|Double-blind Phase||0
45887|NCT01568892|105403|P1|NOT COMPLETED|Double-blind Phase||0
45888|NCT01568892|105402|P2|COMPLETED|Double-blind Phase||16
45889|NCT01568892|105403|P1|COMPLETED|Double-blind Phase||14
45890|NCT01568892|105402|P2|STARTED|Double-blind Phase||16
45891|NCT01568892|105403|P1|STARTED|Double-blind Phase||14
45892|NCT01568866|105441|P2|NOT COMPLETED|Overall Study||264
45893|NCT01568866|105442|P1|NOT COMPLETED|Overall Study||360
45894|NCT01568866|105441|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|200
45895|NCT01568866|105442|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|105
45896|NCT01568866|105441|P2|Received Treatment|Overall Study||463
45897|NCT01568866|105442|P1|Received Treatment|Overall Study||456
45898|NCT01568866|105441|P2|STARTED|Overall Study||464
45899|NCT01568866|105442|P1|STARTED|Overall Study||465
45900|NCT01568827|105464|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
45901|NCT01568827|105465|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
45902|NCT01568827|105464|P2|COMPLETED|Intervention 2 (5 Days)||5
45903|NCT01568827|105465|P1|COMPLETED|Intervention 2 (5 Days)||5
45904|NCT01568827|105464|P2|STARTED|Intervention 2 (5 Days)||5
45905|NCT01568827|105465|P1|STARTED|Intervention 2 (5 Days)||5
45906|NCT01568827|105464|P2|NOT COMPLETED|Washout (2 Days)||0
45907|NCT01568827|105465|P1|NOT COMPLETED|Washout (2 Days)||0
45908|NCT01568827|105464|P2|COMPLETED|Washout (2 Days)||5
45909|NCT01568827|105465|P1|COMPLETED|Washout (2 Days)||5
45910|NCT01568827|105464|P2|STARTED|Washout (2 Days)||5
45911|NCT01568827|105465|P1|STARTED|Washout (2 Days)||5
45912|NCT01568827|105464|P2|NOT COMPLETED|First Intervention (6 Days)||0
45913|NCT01568827|105465|P1|NOT COMPLETED|First Intervention (6 Days)||0
45914|NCT01568827|105464|P2|COMPLETED|First Intervention (6 Days)||5
45915|NCT01568827|105465|P1|COMPLETED|First Intervention (6 Days)||5
45916|NCT01568827|105464|P2|STARTED|First Intervention (6 Days)||5
45917|NCT01568827|105465|P1|STARTED|First Intervention (6 Days)||5
45918|NCT01568593|105473|P2|NOT COMPLETED|Overall Study||3
45919|NCT01568593|105474|P1|NOT COMPLETED|Overall Study||7
45920|NCT01568593|105473|P2|COMPLETED|Overall Study||42
45921|NCT01568593|105474|P1|COMPLETED|Overall Study||41
45922|NCT01568593|105473|P2|STARTED|Overall Study||45
45923|NCT01568593|105474|P1|STARTED|Overall Study||48
45924|NCT01568112|105484|P4|NOT COMPLETED|Overall Study||12
45925|NCT01568112|105485|P3|NOT COMPLETED|Overall Study||7
45926|NCT01568112|105486|P2|NOT COMPLETED|Overall Study||8
45927|NCT01568112|105487|P1|NOT COMPLETED|Overall Study||5
45928|NCT01568112|105484|P4|COMPLETED|Overall Study||30
45929|NCT01568112|105485|P3|COMPLETED|Overall Study||36
45930|NCT01568112|105486|P2|COMPLETED|Overall Study||36
45931|NCT01568112|105487|P1|COMPLETED|Overall Study||39
45932|NCT01568112|105484|P4|STARTED|Overall Study||42
45933|NCT01568112|105485|P3|STARTED|Overall Study||43
45934|NCT01568112|105486|P2|STARTED|Overall Study||44
45935|NCT01568112|105487|P1|STARTED|Overall Study||44
45936|NCT01568073|105610|P5|NOT COMPLETED|Overall Study||9
45937|NCT01568073|105611|P4|NOT COMPLETED|Overall Study||11
45938|NCT01568073|105612|P3|NOT COMPLETED|Overall Study||12
45939|NCT01568073|105613|P2|NOT COMPLETED|Overall Study||15
45940|NCT01568073|105614|P1|NOT COMPLETED|Overall Study||11
45941|NCT01568073|105610|P5|COMPLETED|Overall Study||107
45942|NCT01568073|105611|P4|COMPLETED|Overall Study||108
45943|NCT01568073|105612|P3|COMPLETED|Overall Study||110
45944|NCT01568073|105613|P2|COMPLETED|Overall Study||107
45945|NCT01568073|105614|P1|COMPLETED|Overall Study||110
45946|NCT01568073|105610|P5|STARTED|Overall Study||116
45947|NCT01568073|105611|P4|STARTED|Overall Study||119
45948|NCT01568073|105612|P3|STARTED|Overall Study||122
45949|NCT01568073|105613|P2|STARTED|Overall Study||122
45950|NCT01568073|105614|P1|STARTED|Overall Study||121
45951|NCT01568047|105645|P4|NOT COMPLETED|Overall Study||1
45952|NCT01568047|105646|P3|NOT COMPLETED|Overall Study||1
45953|NCT01568047|105647|P2|NOT COMPLETED|Overall Study||1
45954|NCT01568047|105648|P1|NOT COMPLETED|Overall Study||1
45955|NCT01568047|105645|P4|COMPLETED|Overall Study||9
45956|NCT01568047|105646|P3|COMPLETED|Overall Study||9
45957|NCT01568047|105647|P2|COMPLETED|Overall Study||9
45958|NCT01568047|105648|P1|COMPLETED|Overall Study||9
45959|NCT01568047|105645|P4|STARTED|Overall Study||10
45960|NCT01568047|105646|P3|STARTED|Overall Study||10
45961|NCT01568047|105647|P2|STARTED|Overall Study||10
45962|NCT01568047|105648|P1|STARTED|Overall Study||10
45963|NCT01568034|105666|P4|NOT COMPLETED|Overall Study||0
45964|NCT01568034|105667|P3|NOT COMPLETED|Overall Study||0
45965|NCT01568034|105668|P2|NOT COMPLETED|Overall Study||0
45966|NCT01568034|105669|P1|NOT COMPLETED|Overall Study||1
45967|NCT01568034|105666|P4|COMPLETED|Overall Study||3
45968|NCT01568034|105667|P3|COMPLETED|Overall Study||3
45969|NCT01568034|105668|P2|COMPLETED|Overall Study||2
45970|NCT01568034|105669|P1|COMPLETED|Overall Study||1
45971|NCT01568034|105666|P4|Placebo|Overall Study||3
45972|NCT01568034|105667|P3|Placebo|Overall Study||3
45973|NCT01568034|105668|P2|Placebo|Overall Study||2
45974|NCT01568034|105669|P1|Placebo|Overall Study||1
45975|NCT01568034|105666|P4|100 mg BIA 9-1067|Overall Study||3
45976|NCT01568034|105667|P3|100 mg BIA 9-1067|Overall Study||3
45977|NCT01568034|105668|P2|100 mg BIA 9-1067|Overall Study||2
45978|NCT01568034|105669|P1|100 mg BIA 9-1067|Overall Study||2
45979|NCT01568034|105666|P4|50 mg BIA 9-1067|Overall Study||3
45980|NCT01568034|105667|P3|50 mg BIA 9-1067|Overall Study||3
45981|NCT01568034|105668|P2|50 mg BIA 9-1067|Overall Study||2
45982|NCT01568034|105669|P1|50 mg BIA 9-1067|Overall Study||2
45983|NCT01568034|105666|P4|25 mg BIA 9-1067|Overall Study||3
45984|NCT01568034|105667|P3|25 mg BIA 9-1067|Overall Study||3
45985|NCT01568034|105668|P2|25 mg BIA 9-1067|Overall Study||2
45986|NCT01568034|105669|P1|25 mg BIA 9-1067|Overall Study||2
45987|NCT01568034|105666|P4|STARTED|Overall Study||3
45988|NCT01568034|105667|P3|STARTED|Overall Study||3
45989|NCT01568034|105668|P2|STARTED|Overall Study||2
45990|NCT01568034|105669|P1|STARTED|Overall Study||2
45991|NCT01568021|105687|P1|NOT COMPLETED|Overall Study||16
45992|NCT01568021|105687|P1|COMPLETED|Overall Study||83
45993|NCT01568021|105687|P1|STARTED|Overall Study||99
45994|NCT01568008|105693|P1|NOT COMPLETED|Overall Study||234
45995|NCT01568008|105693|P1|COMPLETED|Overall Study||699
45996|NCT01568008|105693|P1|STARTED|Overall Study||933
45997|NCT01567943|105704|P2|NOT COMPLETED|Overall Study||10
45998|NCT01567943|105705|P1|NOT COMPLETED|Overall Study||14
45999|NCT01567943|105704|P2|COMPLETED|Overall Study||29
46000|NCT01567943|105705|P1|COMPLETED|Overall Study||26
46001|NCT01567943|105704|P2|STARTED|Overall Study||39
46002|NCT01567943|105705|P1|STARTED|Overall Study||40
46003|NCT01567852|105713|P2|NOT COMPLETED|Overall Study||7
46004|NCT01567852|105714|P1|NOT COMPLETED|Overall Study||4
46005|NCT01567852|105713|P2|COMPLETED|Overall Study||5
46006|NCT01567852|105714|P1|COMPLETED|Overall Study||4
46007|NCT01567852|105713|P2|STARTED|Overall Study||12
46008|NCT01567852|105714|P1|STARTED|Overall Study||8
46009|NCT01567839|105722|P1|NOT COMPLETED|Overall Study||0
46010|NCT01567839|105722|P1|COMPLETED|Overall Study||60
46011|NCT01567839|105722|P1|STARTED|Overall Study||60
46012|NCT01567371|105730|P1|NOT COMPLETED|Overall Study||0
46013|NCT01567371|105730|P1|COMPLETED|Overall Study||30
46014|NCT01567371|105730|P1|STARTED|Overall Study||30
46015|NCT01567163|105735|P1|NOT COMPLETED|Overall Study||4
46016|NCT01567163|105735|P1|COMPLETED|Overall Study||18
46017|NCT01567163|105735|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
46018|NCT01567163|105735|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
46019|NCT01567163|105735|P1|STARTED|Overall Study||22
46020|NCT01567150|105747|P2|NOT COMPLETED|Overall Study||2
46021|NCT01567150|105748|P1|NOT COMPLETED|Overall Study||2
46022|NCT01567150|105747|P2|COMPLETED|Overall Study||16
46023|NCT01567150|105748|P1|COMPLETED|Overall Study||19
46024|NCT01567150|105747|P2|STARTED|Overall Study||18
46025|NCT01567150|105748|P1|STARTED|Overall Study||21
46026|NCT01567020|105760|P4|NOT COMPLETED|Overall Study||1
46027|NCT01567020|105761|P3|NOT COMPLETED|Overall Study||2
46028|NCT01567020|105762|P2|NOT COMPLETED|Overall Study||5
46029|NCT01567020|105763|P1|NOT COMPLETED|Overall Study||7
46030|NCT01567020|105760|P4|COMPLETED|Overall Study||10
46031|NCT01567020|105761|P3|COMPLETED|Overall Study||18
46032|NCT01567020|105762|P2|COMPLETED|Overall Study||41
46033|NCT01567020|105763|P1|COMPLETED|Overall Study||21
46034|NCT01567020|105760|P4|STARTED|Overall Study||11
46035|NCT01567020|105761|P3|STARTED|Overall Study||20
46036|NCT01567020|105762|P2|STARTED|Overall Study||46
46037|NCT01567020|105763|P1|STARTED|Overall Study||28
46038|NCT01566981|105775|P2|NOT COMPLETED|Overall Study||8
46039|NCT01566981|105776|P1|NOT COMPLETED|Overall Study||5
46040|NCT01566981|105775|P2|COMPLETED|Overall Study||54
46041|NCT01566981|105776|P1|COMPLETED|Overall Study||53
46042|NCT01566981|105775|P2|STARTED|Overall Study||62
46043|NCT01566981|105776|P1|STARTED|Overall Study||58
46044|NCT01566838|105788|P2|NOT COMPLETED|Overall Study||0
46045|NCT01566838|105789|P1|NOT COMPLETED|Overall Study||3
46046|NCT01566838|105788|P2|COMPLETED|Overall Study||42
46047|NCT01566838|105789|P1|COMPLETED|Overall Study||38
46048|NCT01566838|105788|P2|STARTED|Overall Study||42
46049|NCT01566838|105789|P1|STARTED|Overall Study||41
46050|NCT01566630|105807|P2|NOT COMPLETED|Overall Study||0
46051|NCT01566630|105808|P1|NOT COMPLETED|Overall Study||0
46052|NCT01566630|105807|P2|COMPLETED|Overall Study||1
46053|NCT01566630|105808|P1|COMPLETED|Overall Study||2
46054|NCT01566630|105807|P2|STARTED|Overall Study||1
46055|NCT01566630|105808|P1|STARTED|Overall Study||2
46056|NCT01566604|105864|P2|NOT COMPLETED|Overall Study||11
46057|NCT01566604|105865|P1|NOT COMPLETED|Overall Study||24
46058|NCT01566604|105864|P2|COMPLETED|Overall Study||143
46059|NCT01566604|105865|P1|COMPLETED|Overall Study||282
46060|NCT01566604|105864|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
46061|NCT01566604|105865|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
46062|NCT01566604|105864|P2|Full Analysis Set (FAS)|Overall Study||154
46063|NCT01566604|105865|P1|Full Analysis Set (FAS)|Overall Study||305
46064|NCT01566604|105864|P2|Safety Set|Overall Study||154
46065|NCT01566604|105865|P1|Safety Set|Overall Study||305
46066|NCT01566604|105864|P2|STARTED|Overall Study||154
46067|NCT01566604|105865|P1|STARTED|Overall Study||306
46068|NCT01566526|105891|P1|NOT COMPLETED|Overall Study||0
46069|NCT01566526|105891|P1|COMPLETED|Overall Study||26
46070|NCT01566526|105891|P1|STARTED|Overall Study||26
46071|NCT01566500|105901|P1|NOT COMPLETED|Overall Study||0
46072|NCT01566500|105901|P1|COMPLETED|Overall Study||140
46073|NCT01566500|105901|P1|STARTED|Overall Study||140
46074|NCT01566461|105907|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
46075|NCT01566461|105908|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
46076|NCT01566461|105907|P2|COMPLETED|IN.PACT SFA II Phase||55
46077|NCT01566461|105908|P1|COMPLETED|IN.PACT SFA II Phase||109
46078|NCT01566461|105907|P2|STARTED|IN.PACT SFA II Phase||60
46079|NCT01566461|105908|P1|STARTED|IN.PACT SFA II Phase||121
46080|NCT01566461|105907|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
46081|NCT01566461|105908|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
46082|NCT01566461|105907|P2|COMPLETED|IN.PACT SFA I Phase||49
46083|NCT01566461|105908|P1|COMPLETED|IN.PACT SFA I Phase||88
46084|NCT01566461|105907|P2|STARTED|IN.PACT SFA I Phase||51
46085|NCT01566461|105908|P1|STARTED|IN.PACT SFA I Phase||99
46086|NCT01566435|105952|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
46087|NCT01566435|105952|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
46088|NCT01566435|105952|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
46089|NCT01566435|105952|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
46090|NCT01566435|105952|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
46091|NCT01566435|105952|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
46092|NCT01566435|105952|P1|NOT COMPLETED|ACF Induction Therapy||0
46093|NCT01566435|105952|P1|COMPLETED|ACF Induction Therapy||30
46094|NCT01566435|105952|P1|STARTED|ACF Induction Therapy||30
46095|NCT01566409|105964|P2|NOT COMPLETED|Overall Study||5
46096|NCT01566409|105965|P1|NOT COMPLETED|Overall Study||2
46097|NCT01566409|105964|P2|COMPLETED|Overall Study||48
46098|NCT01566409|105965|P1|COMPLETED|Overall Study||47
46099|NCT01566409|105964|P2|STARTED|Overall Study||53
46100|NCT01566409|105965|P1|STARTED|Overall Study||49
46101|NCT01566370|105973|P2|NOT COMPLETED|Overall Study||1
46102|NCT01566370|105974|P1|NOT COMPLETED|Overall Study||2
46103|NCT01566370|105973|P2|COMPLETED|Overall Study||0
46104|NCT01566370|105974|P1|COMPLETED|Overall Study||0
46105|NCT01566370|105973|P2|STARTED|Overall Study||1
46106|NCT01566370|105974|P1|STARTED|Overall Study||2
46107|NCT01566331|106000|P2|NOT COMPLETED|Overall Study||0
46108|NCT01566331|106001|P1|NOT COMPLETED|Overall Study||0
46109|NCT01566331|106000|P2|COMPLETED|Overall Study||40
46110|NCT01566331|106001|P1|COMPLETED|Overall Study||40
46111|NCT01566331|106000|P2|STARTED|Overall Study||40
46112|NCT01566331|106001|P1|STARTED|Overall Study||40
46113|NCT01566162|106007|P1|NOT COMPLETED|Overall Study||36
46114|NCT01566162|106007|P1|COMPLETED|Overall Study||155
46115|NCT01566162|106007|P1|STARTED|Overall Study||191
46116|NCT01566149|106021|P2|NOT COMPLETED|Overall Study||2
46117|NCT01566149|106022|P1|NOT COMPLETED|Overall Study||3
46118|NCT01566149|106021|P2|COMPLETED|Overall Study||23
46119|NCT01566149|106022|P1|COMPLETED|Overall Study||21
46120|NCT01566149|106021|P2|STARTED|Overall Study||25
46121|NCT01566149|106022|P1|STARTED|Overall Study||24
46122|NCT01566084|106038|P2|NOT COMPLETED|Overall Study||0
46123|NCT01566084|106039|P1|NOT COMPLETED|Overall Study||0
46124|NCT01566084|106038|P2|COMPLETED|Overall Study||10
46125|NCT01566084|106039|P1|COMPLETED|Overall Study||7
46126|NCT01566084|106038|P2|STARTED|Overall Study||10
46127|NCT01566084|106039|P1|STARTED|Overall Study||7
46128|NCT01565993|106055|P2|NOT COMPLETED|Overall Study||3
46129|NCT01565993|106056|P1|NOT COMPLETED|Overall Study||0
46130|NCT01565993|106055|P2|COMPLETED|Overall Study||39
46131|NCT01565993|106056|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
46132|NCT01565993|106055|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
46133|NCT01565993|106056|P1|STARTED|Overall Study||66
46134|NCT01565980|106064|P2|NOT COMPLETED|Overall Study||4
46135|NCT01565980|106065|P1|NOT COMPLETED|Overall Study||4
46136|NCT01565980|106064|P2|COMPLETED|Overall Study||16
46137|NCT01565980|106065|P1|COMPLETED|Overall Study||16
46138|NCT01565980|106064|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
46139|NCT01565980|106065|P1|STARTED|Overall Study||20
46140|NCT01565902|106087|P4|NOT COMPLETED|Overall Study||0
46141|NCT01565902|106088|P3|NOT COMPLETED|Overall Study||0
46142|NCT01565902|106089|P2|NOT COMPLETED|Overall Study||0
46143|NCT01565902|106090|P1|NOT COMPLETED|Overall Study||0
46144|NCT01565902|106087|P4|COMPLETED|Overall Study||16
46145|NCT01565902|106088|P3|COMPLETED|Overall Study||8
46146|NCT01565902|106089|P2|COMPLETED|Overall Study||8
46147|NCT01565902|106090|P1|COMPLETED|Overall Study||8
46148|NCT01565902|106087|P4|STARTED|Overall Study||16
46149|NCT01565902|106088|P3|STARTED|Overall Study||8
46150|NCT01565902|106089|P2|STARTED|Overall Study||8
46151|NCT01565902|106090|P1|STARTED|Overall Study||8
46152|NCT01565889|106124|P6|NOT COMPLETED|Part B||4
46153|NCT01565889|106125|P5|NOT COMPLETED|Part B||0
46154|NCT01565889|106126|P4|NOT COMPLETED|Part B||0
46155|NCT01565889|106127|P3|NOT COMPLETED|Part B||0
46156|NCT01565889|106128|P2|NOT COMPLETED|Part B||0
46157|NCT01565889|106129|P1|NOT COMPLETED|Part B||0
46158|NCT01565889|106124|P6|COMPLETED|Part B||19
46159|NCT01565889|106125|P5|COMPLETED|Part B||0
46160|NCT01565889|106126|P4|COMPLETED|Part B||0
46161|NCT01565889|106127|P3|COMPLETED|Part B||0
46162|NCT01565889|106128|P2|COMPLETED|Part B||0
46163|NCT01565889|106129|P1|COMPLETED|Part B||0
46164|NCT01565889|106124|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
46165|NCT01565889|106125|P5|STARTED|Part B||0
46166|NCT01565889|106126|P4|STARTED|Part B||0
46167|NCT01565889|106127|P3|STARTED|Part B||0
46168|NCT01565889|106128|P2|STARTED|Part B||0
46169|NCT01565889|106129|P1|STARTED|Part B||0
46170|NCT01565889|106124|P6|NOT COMPLETED|Part A||0
46171|NCT01565889|106125|P5|NOT COMPLETED|Part A||0
46172|NCT01565889|106126|P4|NOT COMPLETED|Part A||0
46173|NCT01565889|106127|P3|NOT COMPLETED|Part A||0
46174|NCT01565889|106128|P2|NOT COMPLETED|Part A||0
46175|NCT01565889|106129|P1|NOT COMPLETED|Part A||1
46176|NCT01565889|106124|P6|COMPLETED|Part A||0
46177|NCT01565889|106125|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
46178|NCT01565889|106126|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
46179|NCT01565889|106127|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
46180|NCT01565889|106128|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
46181|NCT01565889|106129|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
46182|NCT01565889|106124|P6|STARTED|Part A||0
46183|NCT01565889|106125|P5|STARTED|Part A||7
46184|NCT01565889|106126|P4|STARTED|Part A||7
46185|NCT01565889|106127|P3|STARTED|Part A||8
46186|NCT01565889|106128|P2|STARTED|Part A||4
46187|NCT01565889|106129|P1|STARTED|Part A||12
46188|NCT01565850|106160|P2|NOT COMPLETED|Overall Study||8
46189|NCT01565850|106161|P1|NOT COMPLETED|Overall Study||20
46190|NCT01565850|106160|P2|COMPLETED|Overall Study||42
46191|NCT01565850|106161|P1|COMPLETED|Overall Study||83
46192|NCT01565850|106160|P2|STARTED|Overall Study||50
46193|NCT01565850|106161|P1|STARTED|Overall Study||103
46194|NCT01565707|106181|P4|NOT COMPLETED|Overall Study||5
46195|NCT01565707|106182|P3|NOT COMPLETED|Overall Study||3
46196|NCT01565707|106183|P2|NOT COMPLETED|Overall Study||8
46197|NCT01565707|106184|P1|NOT COMPLETED|Overall Study||9
46198|NCT01565707|106181|P4|COMPLETED|Overall Study||17
46199|NCT01565707|106182|P3|COMPLETED|Overall Study||16
46200|NCT01565707|106183|P2|COMPLETED|Overall Study||65
46201|NCT01565707|106184|P1|COMPLETED|Overall Study||66
46202|NCT01565707|106181|P4|Treated|Overall Study||22
46203|NCT01565707|106182|P3|Treated|Overall Study||19
46204|NCT01565707|106183|P2|Treated|Overall Study||73
46205|NCT01565707|106184|P1|Treated|Overall Study||73
46206|NCT01565707|106181|P4|STARTED|Overall Study||22
46207|NCT01565707|106182|P3|STARTED|Overall Study||19
46208|NCT01565707|106183|P2|STARTED|Overall Study||73
46209|NCT01565707|106184|P1|STARTED|Overall Study||75
46210|NCT01565564|106277|P2|NOT COMPLETED|Overall Study||1
46211|NCT01565564|106278|P1|NOT COMPLETED|Overall Study||5
46212|NCT01565564|106277|P2|COMPLETED|Overall Study||361
46213|NCT01565564|106278|P1|COMPLETED|Overall Study||339
46214|NCT01565564|106277|P2|STARTED|Overall Study||362
46215|NCT01565564|106278|P1|STARTED|Overall Study||344
46216|NCT01565551|106288|P2|NOT COMPLETED|Overall Study||0
46217|NCT01565551|106289|P1|NOT COMPLETED|Overall Study||0
46218|NCT01565551|106288|P2|COMPLETED|Overall Study||51
46219|NCT01565551|106289|P1|COMPLETED|Overall Study||586
46220|NCT01565551|106288|P2|6-Month Outcomes|Overall Study||30
46221|NCT01565551|106289|P1|6-Month Outcomes|Overall Study||412
46222|NCT01565551|106288|P2|Neuroimaging|Overall Study||25
46223|NCT01565551|106289|P1|Neuroimaging|Overall Study||233
46224|NCT01565551|106288|P2|Biospecimens/Biomarkers|Overall Study||22
46225|NCT01565551|106289|P1|Biospecimens/Biomarkers|Overall Study||479
46226|NCT01565551|106288|P2|Clinical/Demographics|Overall Study||51
46227|NCT01565551|106289|P1|Clinical/Demographics|Overall Study||586
46228|NCT01565551|106288|P2|STARTED|Overall Study||51
46229|NCT01565551|106289|P1|STARTED|Overall Study||586
46230|NCT01565538|106297|P2|NOT COMPLETED|Overall Study||0
46231|NCT01565538|106298|P1|NOT COMPLETED|Overall Study||0
46232|NCT01565538|106297|P2|COMPLETED|Overall Study||62
46233|NCT01565538|106298|P1|COMPLETED|Overall Study||61
46234|NCT01565538|106297|P2|STARTED|Overall Study||62
46235|NCT01565538|106298|P1|STARTED|Overall Study||61
46236|NCT01565382|106308|P2|NOT COMPLETED|Overall Study||0
46237|NCT01565382|106309|P1|NOT COMPLETED|Overall Study||0
46238|NCT01565382|106308|P2|COMPLETED|Overall Study||7
46239|NCT01565382|106309|P1|COMPLETED|Overall Study||40
46240|NCT01565382|106308|P2|STARTED|Overall Study||7
46241|NCT01565382|106309|P1|STARTED|Overall Study||40
46242|NCT01565369|106314|P1|NOT COMPLETED|Overall Study||0
46243|NCT01565369|106314|P1|COMPLETED|Overall Study||35
46244|NCT01565369|106314|P1|STARTED|Overall Study||35
46245|NCT01565356|106320|P1|NOT COMPLETED|Overall Study||0
46246|NCT01565356|106320|P1|COMPLETED|Overall Study||41
46247|NCT01565356|106320|P1|STARTED|Overall Study||41
46248|NCT01565343|106328|P3|NOT COMPLETED|Overall Study||0
46249|NCT01565343|106329|P2|NOT COMPLETED|Overall Study||0
46250|NCT01565343|106330|P1|NOT COMPLETED|Overall Study||1
46251|NCT01565343|106328|P3|COMPLETED|Overall Study||10
46252|NCT01565343|106329|P2|COMPLETED|Overall Study||4
46253|NCT01565343|106330|P1|COMPLETED|Overall Study||10
46254|NCT01565343|106328|P3|STARTED|Overall Study||10
46255|NCT01565343|106329|P2|STARTED|Overall Study||4
46256|NCT01565343|106330|P1|STARTED|Overall Study||11
46257|NCT01565330|106341|P4|NOT COMPLETED|Overall Study||0
46258|NCT01565330|106342|P3|NOT COMPLETED|Overall Study||0
46259|NCT01565330|106343|P2|NOT COMPLETED|Overall Study||0
46260|NCT01565330|106344|P1|NOT COMPLETED|Overall Study||0
46261|NCT01565330|106341|P4|COMPLETED|Overall Study||7
46262|NCT01565330|106342|P3|COMPLETED|Overall Study||4
46263|NCT01565330|106343|P2|COMPLETED|Overall Study||4
46264|NCT01565330|106344|P1|COMPLETED|Overall Study||5
46265|NCT01565330|106341|P4|STARTED|Overall Study||7
46266|NCT01565330|106342|P3|STARTED|Overall Study||4
46267|NCT01565330|106343|P2|STARTED|Overall Study||4
46268|NCT01565330|106344|P1|STARTED|Overall Study||5
46269|NCT01565291|106360|P2|NOT COMPLETED|Overall Study||0
46270|NCT01565291|106361|P1|NOT COMPLETED|Overall Study||1
46271|NCT01565291|106360|P2|COMPLETED|Overall Study||16
46272|NCT01565291|106361|P1|COMPLETED|Overall Study||15
46273|NCT01565291|106360|P2|STARTED|Overall Study||16
46274|NCT01565291|106361|P1|STARTED|Overall Study||16
46275|NCT01565083|106371|P2|NOT COMPLETED|Overall Study||39
46276|NCT01565083|106372|P1|NOT COMPLETED|Overall Study||33
46277|NCT01565083|106371|P2|COMPLETED|Overall Study||68
46278|NCT01565083|106372|P1|COMPLETED|Overall Study||73
46279|NCT01565083|106371|P2|STARTED|Overall Study||107
46280|NCT01565083|106372|P1|STARTED|Overall Study||106
46281|NCT01564862|106401|P3|NOT COMPLETED|Overall Study||30
46282|NCT01564862|106402|P2|NOT COMPLETED|Overall Study||34
46283|NCT01564862|106403|P1|NOT COMPLETED|Overall Study||30
46284|NCT01564862|106401|P3|COMPLETED|Overall Study||164
46285|NCT01564862|106402|P2|COMPLETED|Overall Study||176
46286|NCT01564862|106403|P1|COMPLETED|Overall Study||168
46287|NCT01564862|106401|P3|Received Treatment|Overall Study||191
46288|NCT01564862|106402|P2|Received Treatment|Overall Study||207
46289|NCT01564862|106403|P1|Received Treatment|Overall Study||196
46290|NCT01564862|106401|P3|STARTED|Overall Study||194
46291|NCT01564862|106402|P2|STARTED|Overall Study||210
46292|NCT01564862|106403|P1|STARTED|Overall Study||198
46293|NCT01564758|106452|P1|NOT COMPLETED|Overall Study||14
46294|NCT01564758|106452|P1|COMPLETED|Overall Study||85
46295|NCT01564758|106452|P1|STARTED|Overall Study||99
46296|NCT01564732|106459|P2|NOT COMPLETED|Overall Study||5
46297|NCT01564732|106460|P1|NOT COMPLETED|Overall Study||6
46298|NCT01564732|106459|P2|COMPLETED|Overall Study||0
46299|NCT01564732|106460|P1|COMPLETED|Overall Study||0
46300|NCT01564732|106459|P2|STARTED|Overall Study||5
46301|NCT01564732|106460|P1|STARTED|Overall Study||6
46302|NCT01564706|106476|P1|NOT COMPLETED|Overall Study||0
46303|NCT01564706|106476|P1|COMPLETED|Overall Study||9
46304|NCT01564706|106476|P1|STARTED|Overall Study||9
46305|NCT01564693|106483|P3|NOT COMPLETED|Overall Study||0
46306|NCT01564693|106484|P2|NOT COMPLETED|Overall Study||0
46307|NCT01564693|106485|P1|NOT COMPLETED|Overall Study||0
46308|NCT01564693|106483|P3|COMPLETED|Overall Study||2
46309|NCT01564693|106484|P2|COMPLETED|Overall Study||4
46310|NCT01564693|106485|P1|COMPLETED|Overall Study||9
46311|NCT01564693|106483|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
46312|NCT01564693|106484|P2|STARTED|Overall Study||4
46313|NCT01564693|106485|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
46314|NCT01563406|106497|P4|NOT COMPLETED|Overall Study||0
46315|NCT01563406|106498|P3|NOT COMPLETED|Overall Study||0
46316|NCT01563406|106499|P2|NOT COMPLETED|Overall Study||0
46317|NCT01563406|106500|P1|NOT COMPLETED|Overall Study||0
46318|NCT01563406|106497|P4|COMPLETED|Overall Study|112 hubs|29
46319|NCT01563406|106498|P3|COMPLETED|Overall Study|101 hubs|30
46320|NCT01563406|106499|P2|COMPLETED|Overall Study|102 hubs|30
46321|NCT01563406|106500|P1|COMPLETED|Overall Study|194 hubs|60
46322|NCT01563406|106497|P4|STARTED|Overall Study|112 hubs|29
46323|NCT01563406|106498|P3|STARTED|Overall Study|101 hubs|30
46324|NCT01563406|106499|P2|STARTED|Overall Study|102 hubs|30
46325|NCT01563406|106500|P1|STARTED|Overall Study|194 hubs|60
46326|NCT01564537|106520|P2|NOT COMPLETED|Overall Study||6
46327|NCT01564537|106521|P1|NOT COMPLETED|Overall Study||6
46328|NCT01564537|106520|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
46329|NCT01564537|106521|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
46330|NCT01564537|106520|P2|Safety Population: Received Study Drug|Overall Study||360
46331|NCT01564537|106521|P1|Safety Population: Received Study Drug|Overall Study||360
46332|NCT01564537|106520|P2|STARTED|Overall Study||362
46333|NCT01564537|106521|P1|STARTED|Overall Study||360
46334|NCT01564459|106544|P3|NOT COMPLETED|Double-blind Treatment||1
46335|NCT01564459|106545|P2|NOT COMPLETED|Double-blind Treatment||0
46336|NCT01564459|106546|P1|NOT COMPLETED|Double-blind Treatment||0
46337|NCT01564459|106544|P3|COMPLETED|Double-blind Treatment||82
46338|NCT01564459|106545|P2|COMPLETED|Double-blind Treatment||87
46339|NCT01564459|106546|P1|COMPLETED|Double-blind Treatment||0
46340|NCT01564459|106544|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
46341|NCT01564459|106545|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
46342|NCT01564459|106546|P1|STARTED|Double-blind Treatment||0
46343|NCT01564459|106544|P3|NOT COMPLETED|Run-In||0
46344|NCT01564459|106545|P2|NOT COMPLETED|Run-In||0
46345|NCT01564459|106546|P1|NOT COMPLETED|Run-In||12
46346|NCT01564459|106544|P3|COMPLETED|Run-In||83
46347|NCT01564459|106545|P2|COMPLETED|Run-In||87
46348|NCT01564459|106546|P1|COMPLETED|Run-In||0
46349|NCT01564459|106544|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
46350|NCT01564459|106545|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
46351|NCT01564459|106546|P1|STARTED|Run-In||12
46352|NCT01564394|106567|P2|NOT COMPLETED|Overall Study||10
46353|NCT01564394|106568|P1|NOT COMPLETED|Overall Study||6
46354|NCT01564394|106567|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
46355|NCT01564394|106568|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
46356|NCT01564394|106567|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
46357|NCT01564394|106568|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
46358|NCT01563978|106582|P2|NOT COMPLETED|Overall Study||2
46359|NCT01563978|106583|P1|NOT COMPLETED|Overall Study||4
46360|NCT01563978|106582|P2|COMPLETED|Overall Study||65
46361|NCT01563978|106583|P1|COMPLETED|Overall Study||64
46362|NCT01563978|106582|P2|Randomised But Did Not Receive Treatment|Overall Study||0
46363|NCT01563978|106583|P1|Randomised But Did Not Receive Treatment|Overall Study||0
46364|NCT01563978|106582|P2|STARTED|Overall Study|Patients who received treatment.|67
46365|NCT01563978|106583|P1|STARTED|Overall Study|Patients who received treatment.|68
46366|NCT01563536|106609|P2|NOT COMPLETED|Overall Study||2
46367|NCT01563536|106610|P1|NOT COMPLETED|Overall Study||1
46368|NCT01563536|106609|P2|COMPLETED|Overall Study||4
46369|NCT01563536|106610|P1|COMPLETED|Overall Study||5
46370|NCT01563536|106609|P2|STARTED|Overall Study||6
46371|NCT01563536|106610|P1|STARTED|Overall Study||6
46372|NCT01563185|106638|P1|NOT COMPLETED|Overall Study||2
46373|NCT01563185|106638|P1|COMPLETED|Overall Study||10
46374|NCT01563185|106638|P1|STARTED|Overall Study||12
46375|NCT01563081|106654|P2|NOT COMPLETED|Overall Study||0
46376|NCT01563081|106655|P1|NOT COMPLETED|Overall Study||0
46377|NCT01563081|106654|P2|COMPLETED|Overall Study||30
46378|NCT01563081|106655|P1|COMPLETED|Overall Study||30
46379|NCT01563081|106654|P2|STARTED|Overall Study||30
46380|NCT01563081|106655|P1|STARTED|Overall Study||30
46381|NCT01563055|106668|P1|NOT COMPLETED|Overall Study||0
46382|NCT01563055|106668|P1|COMPLETED|Overall Study||10
46383|NCT01563055|106668|P1|STARTED|Overall Study||10
46384|NCT01563029|106731|P5|NOT COMPLETED|Overall Study||29
46385|NCT01563029|106732|P4|NOT COMPLETED|Overall Study||33
46386|NCT01563029|106733|P3|NOT COMPLETED|Overall Study||33
46387|NCT01563029|106734|P2|NOT COMPLETED|Overall Study||24
46388|NCT01563029|106735|P1|NOT COMPLETED|Overall Study||53
46389|NCT01563029|106731|P5|COMPLETED|Overall Study||89
46390|NCT01563029|106732|P4|COMPLETED|Overall Study||85
46391|NCT01563029|106733|P3|COMPLETED|Overall Study||87
46392|NCT01563029|106734|P2|COMPLETED|Overall Study||94
46393|NCT01563029|106735|P1|COMPLETED|Overall Study||66
46394|NCT01563029|106731|P5|STARTED|Overall Study||118
46395|NCT01563029|106732|P4|STARTED|Overall Study||118
46396|NCT01563029|106733|P3|STARTED|Overall Study||120
46397|NCT01563029|106734|P2|STARTED|Overall Study||118
46398|NCT01563029|106735|P1|STARTED|Overall Study||119
46399|NCT01563003|106785|P2|NOT COMPLETED|Overall Study||0
46400|NCT01563003|106786|P1|NOT COMPLETED|Overall Study||0
46401|NCT01563003|106785|P2|COMPLETED|Overall Study||15
46402|NCT01563003|106786|P1|COMPLETED|Overall Study||16
46403|NCT01563003|106785|P2|STARTED|Overall Study||15
46404|NCT01563003|106786|P1|STARTED|Overall Study||16
46405|NCT01562886|106796|P1|NOT COMPLETED|Overall Study||1
46406|NCT01562886|106796|P1|COMPLETED|Overall Study||13
46407|NCT01562886|106796|P1|STARTED|Overall Study||14
46408|NCT01562743|106801|P1|NOT COMPLETED|Overall Study||52
46409|NCT01562743|106801|P1|COMPLETED|Overall Study||133
46410|NCT01562743|106801|P1|STARTED|Overall Study||185
46411|NCT01562613|106811|P1|NOT COMPLETED|Overall Study||4
46412|NCT01562613|106811|P1|COMPLETED|Overall Study||529
46413|NCT01562613|106811|P1|STARTED|Overall Study||533
46414|NCT01562548|106821|P4|NOT COMPLETED|Overall Study||0
46415|NCT01562548|106822|P3|NOT COMPLETED|Overall Study||1
46416|NCT01562548|106823|P2|NOT COMPLETED|Overall Study||0
46417|NCT01562548|106824|P1|NOT COMPLETED|Overall Study||0
46418|NCT01562548|106821|P4|COMPLETED|Overall Study||14
46419|NCT01562548|106822|P3|COMPLETED|Overall Study||24
46420|NCT01562548|106823|P2|COMPLETED|Overall Study||15
46421|NCT01562548|106824|P1|COMPLETED|Overall Study||25
46422|NCT01562548|106821|P4|STARTED|Overall Study||14
46423|NCT01562548|106822|P3|STARTED|Overall Study||25
46424|NCT01562548|106823|P2|STARTED|Overall Study||15
46425|NCT01562548|106824|P1|STARTED|Overall Study||25
46426|NCT01562327|106874|P1|NOT COMPLETED|Overall Study||8
46427|NCT01562327|106874|P1|COMPLETED|Overall Study||42
46428|NCT01562327|106874|P1|STARTED|Overall Study||50
46429|NCT01562314|106904|P2|NOT COMPLETED|Overall Study||8
46430|NCT01562314|106905|P1|NOT COMPLETED|Overall Study||13
46431|NCT01562314|106904|P2|COMPLETED|Overall Study||23
46432|NCT01562314|106905|P1|COMPLETED|Overall Study||16
46433|NCT01562314|106904|P2|STARTED|Overall Study||31
46434|NCT01562314|106905|P1|STARTED|Overall Study||29
46435|NCT01562275|106992|P13|NOT COMPLETED|Stage 2||5
46436|NCT01562275|106993|P12|NOT COMPLETED|Stage 2||14
46437|NCT01562275|106994|P11|NOT COMPLETED|Stage 2||0
46438|NCT01562275|106995|P10|NOT COMPLETED|Stage 2||0
46439|NCT01562275|106996|P9|NOT COMPLETED|Stage 2||0
46440|NCT01562275|106997|P8|NOT COMPLETED|Stage 2||0
46441|NCT01562275|106998|P7|NOT COMPLETED|Stage 2||0
46442|NCT01562275|106999|P6|NOT COMPLETED|Stage 2||0
46443|NCT01562275|107000|P5|NOT COMPLETED|Stage 2||0
46444|NCT01562275|107001|P4|NOT COMPLETED|Stage 2||0
46445|NCT01562275|107002|P3|NOT COMPLETED|Stage 2||0
46446|NCT01562275|107003|P2|NOT COMPLETED|Stage 2||0
46447|NCT01562275|107004|P1|NOT COMPLETED|Stage 2||0
46448|NCT01562275|106992|P13|COMPLETED|Stage 2||0
46449|NCT01562275|106993|P12|COMPLETED|Stage 2||0
46450|NCT01562275|106994|P11|COMPLETED|Stage 2||0
46451|NCT01562275|106995|P10|COMPLETED|Stage 2||0
46452|NCT01562275|106996|P9|COMPLETED|Stage 2||0
46453|NCT01562275|106997|P8|COMPLETED|Stage 2||0
46454|NCT01562275|106998|P7|COMPLETED|Stage 2||0
46455|NCT01562275|106999|P6|COMPLETED|Stage 2||0
46456|NCT01562275|107000|P5|COMPLETED|Stage 2||0
46457|NCT01562275|107001|P4|COMPLETED|Stage 2||0
46458|NCT01562275|107002|P3|COMPLETED|Stage 2||0
46459|NCT01562275|107003|P2|COMPLETED|Stage 2||0
46460|NCT01562275|107004|P1|COMPLETED|Stage 2||0
46461|NCT01562275|106992|P13|STARTED|Stage 2||5
46462|NCT01562275|106993|P12|STARTED|Stage 2||14
46463|NCT01562275|106994|P11|STARTED|Stage 2||0
46464|NCT01562275|106995|P10|STARTED|Stage 2||0
46465|NCT01562275|106996|P9|STARTED|Stage 2||0
46466|NCT01562275|106997|P8|STARTED|Stage 2||0
46467|NCT01562275|106998|P7|STARTED|Stage 2||0
46468|NCT01562275|106999|P6|STARTED|Stage 2||0
46469|NCT01562275|107000|P5|STARTED|Stage 2||0
46470|NCT01562275|107001|P4|STARTED|Stage 2||0
46471|NCT01562275|107002|P3|STARTED|Stage 2||0
46472|NCT01562275|107003|P2|STARTED|Stage 2||0
46473|NCT01562275|107004|P1|STARTED|Stage 2||0
46474|NCT01562275|106992|P13|NOT COMPLETED|Stage 1||0
46475|NCT01562275|106993|P12|NOT COMPLETED|Stage 1||0
46476|NCT01562275|106994|P11|NOT COMPLETED|Stage 1||3
46477|NCT01562275|106995|P10|NOT COMPLETED|Stage 1||7
46478|NCT01562275|106996|P9|NOT COMPLETED|Stage 1||3
46479|NCT01562275|106997|P8|NOT COMPLETED|Stage 1||7
46480|NCT01562275|106998|P7|NOT COMPLETED|Stage 1||3
46481|NCT01562275|106999|P6|NOT COMPLETED|Stage 1||4
46482|NCT01562275|107000|P5|NOT COMPLETED|Stage 1||4
46483|NCT01562275|107001|P4|NOT COMPLETED|Stage 1||4
46484|NCT01562275|107002|P3|NOT COMPLETED|Stage 1||3
46485|NCT01562275|107003|P2|NOT COMPLETED|Stage 1||7
46486|NCT01562275|107004|P1|NOT COMPLETED|Stage 1||3
46487|NCT01562275|106992|P13|COMPLETED|Stage 1||0
46488|NCT01562275|106993|P12|COMPLETED|Stage 1||0
46489|NCT01562275|106994|P11|COMPLETED|Stage 1||0
46490|NCT01562275|106995|P10|COMPLETED|Stage 1||0
46491|NCT01562275|106996|P9|COMPLETED|Stage 1||0
46492|NCT01562275|106997|P8|COMPLETED|Stage 1||0
46493|NCT01562275|106998|P7|COMPLETED|Stage 1||0
46494|NCT01562275|106999|P6|COMPLETED|Stage 1||0
46495|NCT01562275|107000|P5|COMPLETED|Stage 1||0
46496|NCT01562275|107001|P4|COMPLETED|Stage 1||0
46497|NCT01562275|107002|P3|COMPLETED|Stage 1||0
46498|NCT01562275|107003|P2|COMPLETED|Stage 1||0
46499|NCT01562275|107004|P1|COMPLETED|Stage 1||0
46500|NCT01562275|106992|P13|STARTED|Stage 1||0
46501|NCT01562275|106993|P12|STARTED|Stage 1||0
46502|NCT01562275|106994|P11|STARTED|Stage 1||3
46503|NCT01562275|106995|P10|STARTED|Stage 1||7
46504|NCT01562275|106996|P9|STARTED|Stage 1||3
46505|NCT01562275|106997|P8|STARTED|Stage 1||7
46506|NCT01562275|106998|P7|STARTED|Stage 1||3
46507|NCT01562275|106999|P6|STARTED|Stage 1||4
46508|NCT01562275|107000|P5|STARTED|Stage 1||4
46509|NCT01562275|107001|P4|STARTED|Stage 1||4
46510|NCT01562275|107002|P3|STARTED|Stage 1||3
46511|NCT01562275|107003|P2|STARTED|Stage 1||7
46512|NCT01562275|107004|P1|STARTED|Stage 1||3
46513|NCT01562132|107136|P2|NOT COMPLETED|Overall Study||0
46514|NCT01562132|107137|P1|NOT COMPLETED|Overall Study||0
46515|NCT01562132|107136|P2|COMPLETED|Overall Study||3
46516|NCT01562132|107137|P1|COMPLETED|Overall Study||3
46517|NCT01562132|107136|P2|STARTED|Overall Study||3
46518|NCT01562132|107137|P1|STARTED|Overall Study||3
46519|NCT01561898|107147|P4|NOT COMPLETED|Overall Study||20
46520|NCT01561898|107148|P3|NOT COMPLETED|Overall Study||44
46521|NCT01561898|107149|P2|NOT COMPLETED|Overall Study||41
46522|NCT01561898|107150|P1|NOT COMPLETED|Overall Study||2
46523|NCT01561898|107147|P4|COMPLETED|Overall Study||12
46524|NCT01561898|107148|P3|COMPLETED|Overall Study||53
46525|NCT01561898|107149|P2|COMPLETED|Overall Study||51
46526|NCT01561898|107150|P1|COMPLETED|Overall Study||5
46527|NCT01561898|107147|P4|STARTED|Overall Study||32
46528|NCT01561898|107148|P3|STARTED|Overall Study||97
46529|NCT01561898|107149|P2|STARTED|Overall Study||92
46530|NCT01561898|107150|P1|STARTED|Overall Study||7
46531|NCT01561716|107168|P6|NOT COMPLETED|Overall Study||0
46532|NCT01561716|107169|P5|NOT COMPLETED|Overall Study||0
46533|NCT01561716|107170|P4|NOT COMPLETED|Overall Study||0
46534|NCT01561716|107171|P3|NOT COMPLETED|Overall Study||0
46535|NCT01561716|107172|P2|NOT COMPLETED|Overall Study||0
46536|NCT01561716|107173|P1|NOT COMPLETED|Overall Study||0
46537|NCT01561716|107168|P6|COMPLETED|Overall Study||5
46538|NCT01561716|107169|P5|COMPLETED|Overall Study||5
46539|NCT01561716|107170|P4|COMPLETED|Overall Study||5
46540|NCT01561716|107171|P3|COMPLETED|Overall Study||5
46541|NCT01561716|107172|P2|COMPLETED|Overall Study||5
46542|NCT01561716|107173|P1|COMPLETED|Overall Study||5
46543|NCT01561716|107168|P6|STARTED|Overall Study||5
46544|NCT01561716|107169|P5|STARTED|Overall Study||5
46545|NCT01561716|107170|P4|STARTED|Overall Study||5
46546|NCT01561716|107171|P3|STARTED|Overall Study||5
46547|NCT01561716|107172|P2|STARTED|Overall Study||5
46548|NCT01561716|107173|P1|STARTED|Overall Study||5
46549|NCT01561703|107189|P2|NOT COMPLETED|Overall Study||6
46550|NCT01561703|107190|P1|NOT COMPLETED|Overall Study||8
46551|NCT01561703|107189|P2|COMPLETED|Overall Study||24
46552|NCT01561703|107190|P1|COMPLETED|Overall Study||20
46553|NCT01561703|107189|P2|STARTED|Overall Study||30
46554|NCT01561703|107190|P1|STARTED|Overall Study||28
46555|NCT01561560|107196|P2|NOT COMPLETED|Second Two Weeks of Wear||1
46556|NCT01561560|107197|P1|NOT COMPLETED|Second Two Weeks of Wear||0
46557|NCT01561560|107196|P2|COMPLETED|Second Two Weeks of Wear||58
46558|NCT01561560|107197|P1|COMPLETED|Second Two Weeks of Wear||60
46559|NCT01561560|107196|P2|STARTED|Second Two Weeks of Wear||59
46560|NCT01561560|107197|P1|STARTED|Second Two Weeks of Wear||60
46561|NCT01561560|107196|P2|NOT COMPLETED|First Two Weeks of Wear||2
46562|NCT01561560|107197|P1|NOT COMPLETED|First Two Weeks of Wear||0
46563|NCT01561560|107196|P2|COMPLETED|First Two Weeks of Wear||59
46564|NCT01561560|107197|P1|COMPLETED|First Two Weeks of Wear||60
46565|NCT01561560|107196|P2|STARTED|First Two Weeks of Wear||61
46566|NCT01561560|107197|P1|STARTED|First Two Weeks of Wear||60
46567|NCT01561469|107205|P2|NOT COMPLETED|Overall Study||0
46568|NCT01561469|107206|P1|NOT COMPLETED|Overall Study||0
46569|NCT01561469|107205|P2|COMPLETED|Overall Study||87
46570|NCT01561469|107206|P1|COMPLETED|Overall Study||101
46571|NCT01561469|107205|P2|STARTED|Overall Study||87
46572|NCT01561469|107206|P1|STARTED|Overall Study||101
46573|NCT01561313|107226|P2|NOT COMPLETED|Overall Study||0
46574|NCT01561313|107227|P1|NOT COMPLETED|Overall Study||2
46575|NCT01561313|107226|P2|COMPLETED|Overall Study||31
46576|NCT01561313|107227|P1|COMPLETED|Overall Study||31
46577|NCT01561313|107226|P2|STARTED|Overall Study||31
46578|NCT01561313|107227|P1|STARTED|Overall Study||33
46579|NCT01560975|107245|P1|NOT COMPLETED|Overall Study||0
46580|NCT01560975|107245|P1|COMPLETED|Overall Study||10
46581|NCT01560975|107245|P1|STARTED|Overall Study||10
46582|NCT01560819|107260|P2|NOT COMPLETED|Overall Study||0
46583|NCT01560819|107261|P1|NOT COMPLETED|Overall Study||1
46584|NCT01560819|107260|P2|COMPLETED|Overall Study||10
46585|NCT01560819|107261|P1|COMPLETED|Overall Study||9
46586|NCT01560819|107260|P2|STARTED|Overall Study||10
46587|NCT01560819|107261|P1|STARTED|Overall Study||10
46588|NCT01560507|107268|P3|NOT COMPLETED|Overall Study||2
46589|NCT01560507|107269|P2|NOT COMPLETED|Overall Study||2
46590|NCT01560507|107270|P1|NOT COMPLETED|Overall Study||4
46591|NCT01560507|107268|P3|COMPLETED|Overall Study||0
46592|NCT01560507|107269|P2|COMPLETED|Overall Study||0
46593|NCT01560507|107270|P1|COMPLETED|Overall Study||1
46594|NCT01560507|107268|P3|STARTED|Overall Study||2
46595|NCT01560507|107269|P2|STARTED|Overall Study||2
46596|NCT01560507|107270|P1|STARTED|Overall Study||5
46597|NCT01560429|107283|P2|NOT COMPLETED|Overall Study||6
46598|NCT01560429|107284|P1|NOT COMPLETED|Overall Study||3
46599|NCT01560429|107283|P2|COMPLETED|Overall Study||20
46600|NCT01560429|107284|P1|COMPLETED|Overall Study||23
46601|NCT01560429|107283|P2|STARTED|Overall Study||26
46602|NCT01560429|107284|P1|STARTED|Overall Study||26
46603|NCT01560403|107294|P2|NOT COMPLETED|Overall Study||1
46604|NCT01560403|107295|P1|NOT COMPLETED|Overall Study||0
46605|NCT01560403|107294|P2|COMPLETED|Overall Study||8
46606|NCT01560403|107295|P1|COMPLETED|Overall Study||5
46607|NCT01560403|107294|P2|STARTED|Overall Study||9
46608|NCT01560403|107295|P1|STARTED|Overall Study||5
46609|NCT01560260|107301|P1|NOT COMPLETED|Overall Study||0
46610|NCT01560260|107301|P1|COMPLETED|Overall Study||20
46611|NCT01560260|107301|P1|STARTED|Overall Study||20
46612|NCT01560234|107313|P8|NOT COMPLETED|Overall Study||2
46613|NCT01560234|107314|P7|NOT COMPLETED|Overall Study||0
46614|NCT01560234|107315|P6|NOT COMPLETED|Overall Study||2
46615|NCT01560234|107316|P5|NOT COMPLETED|Overall Study||0
46616|NCT01560234|107317|P4|NOT COMPLETED|Overall Study||0
46617|NCT01560234|107318|P3|NOT COMPLETED|Overall Study||1
46618|NCT01560234|107319|P2|NOT COMPLETED|Overall Study||0
46619|NCT01560234|107320|P1|NOT COMPLETED|Overall Study||3
46620|NCT01560234|107313|P8|COMPLETED|Overall Study||6
46621|NCT01560234|107314|P7|COMPLETED|Overall Study||4
46622|NCT01560234|107315|P6|COMPLETED|Overall Study||2
46623|NCT01560234|107316|P5|COMPLETED|Overall Study||4
46624|NCT01560234|107317|P4|COMPLETED|Overall Study||3
46625|NCT01560234|107318|P3|COMPLETED|Overall Study||3
46626|NCT01560234|107319|P2|COMPLETED|Overall Study||4
46627|NCT01560234|107320|P1|COMPLETED|Overall Study||13
46628|NCT01560234|107313|P8|STARTED|Overall Study||8
46629|NCT01560234|107314|P7|STARTED|Overall Study||4
46630|NCT01560234|107315|P6|STARTED|Overall Study||4
46631|NCT01560234|107316|P5|STARTED|Overall Study||4
46632|NCT01560234|107317|P4|STARTED|Overall Study||3
46633|NCT01560234|107318|P3|STARTED|Overall Study||4
46634|NCT01560234|107319|P2|STARTED|Overall Study||4
46635|NCT01560234|107320|P1|STARTED|Overall Study||16
46636|NCT01560143|107394|P1|NOT COMPLETED|Overall Study||0
46637|NCT01560143|107394|P1|COMPLETED|Overall Study||12
46638|NCT01560143|107394|P1|STARTED|Overall Study||12
46639|NCT01559922|107400|P2|NOT COMPLETED|Overall Study||10
46640|NCT01559922|107401|P1|NOT COMPLETED|Overall Study||4
46641|NCT01559922|107400|P2|COMPLETED|Overall Study||87
46642|NCT01559922|107401|P1|COMPLETED|Overall Study||46
46643|NCT01559922|107400|P2|STARTED|Overall Study||97
46644|NCT01559922|107401|P1|STARTED|Overall Study||50
46645|NCT01559844|107407|P1|NOT COMPLETED|Overall Study||25
46646|NCT01559844|107407|P1|COMPLETED|Overall Study||36
46647|NCT01559844|107407|P1|STARTED|Overall Study||61
46648|NCT01559675|107420|P2|NOT COMPLETED|Overall Study||14
46649|NCT01559675|107421|P1|NOT COMPLETED|Overall Study||15
46650|NCT01559675|107420|P2|COMPLETED|Overall Study||49
46651|NCT01559675|107421|P1|COMPLETED|Overall Study||43
46652|NCT01559675|107420|P2|STARTED|Overall Study||63
46653|NCT01559675|107421|P1|STARTED|Overall Study||58
46654|NCT01559649|107429|P2|NOT COMPLETED|Overall Study||6
46655|NCT01559649|107430|P1|NOT COMPLETED|Overall Study||19
46656|NCT01559649|107429|P2|COMPLETED|Overall Study||9
46657|NCT01559649|107430|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
46658|NCT01559649|107429|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
46659|NCT01559649|107430|P1|STARTED|Overall Study||269
46660|NCT01559506|107443|P2|NOT COMPLETED|Overall Study||3
46661|NCT01559506|107444|P1|NOT COMPLETED|Overall Study||0
46662|NCT01559506|107443|P2|COMPLETED|Overall Study||18
46663|NCT01559506|107444|P1|COMPLETED|Overall Study||20
46664|NCT01559506|107443|P2|STARTED|Overall Study||21
46665|NCT01559506|107444|P1|STARTED|Overall Study||20
46666|NCT01559311|107453|P3|NOT COMPLETED|Overall Study||8
46667|NCT01559311|107454|P2|NOT COMPLETED|Overall Study||6
46668|NCT01559311|107455|P1|NOT COMPLETED|Overall Study||3
46669|NCT01559311|107453|P3|COMPLETED|Overall Study|12-Month|26
46670|NCT01559311|107454|P2|COMPLETED|Overall Study|12-Month|28
46671|NCT01559311|107455|P1|COMPLETED|Overall Study|12-Month|27
46672|NCT01559311|107453|P3|6-Month|Overall Study||28
46673|NCT01559311|107454|P2|6-Month|Overall Study||33
46674|NCT01559311|107455|P1|6-Month|Overall Study||27
46675|NCT01559311|107453|P3|3-Month|Overall Study||29
46676|NCT01559311|107454|P2|3-Month|Overall Study||34
46677|NCT01559311|107455|P1|3-Month|Overall Study||27
46678|NCT01559311|107453|P3|1-Month|Overall Study||29
46679|NCT01559311|107454|P2|1-Month|Overall Study||34
46680|NCT01559311|107455|P1|1-Month|Overall Study||27
46681|NCT01559311|107453|P3|Implant|Overall Study||32
46682|NCT01559311|107454|P2|Implant|Overall Study||34
46683|NCT01559311|107455|P1|Implant|Overall Study||28
46684|NCT01559311|107453|P3|STARTED|Overall Study|Enrollment & Baseline|34
46685|NCT01559311|107454|P2|STARTED|Overall Study|Enrollment & Baseline|34
46686|NCT01559311|107455|P1|STARTED|Overall Study|Enrollment & Baseline|30
46687|NCT01559116|107466|P1|NOT COMPLETED|Overall Study||26
46688|NCT01559116|107466|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
46689|NCT01559116|107466|P1|STARTED|Overall Study|Randomised|219
46690|NCT01559064|107537|P3|NOT COMPLETED|Overall Study||2
46691|NCT01559064|107538|P2|NOT COMPLETED|Overall Study||1
46692|NCT01559064|107539|P1|NOT COMPLETED|Overall Study||1
46693|NCT01559064|107537|P3|COMPLETED|Overall Study||57
46694|NCT01559064|107538|P2|COMPLETED|Overall Study||39
46695|NCT01559064|107539|P1|COMPLETED|Overall Study||15
46696|NCT01559064|107537|P3|STARTED|Overall Study||59
46697|NCT01559064|107538|P2|STARTED|Overall Study||40
46698|NCT01559064|107539|P1|STARTED|Overall Study||16
46699|NCT01559012|107549|P2|NOT COMPLETED|Overall Study||1
46700|NCT01559012|107550|P1|NOT COMPLETED|Overall Study||0
46701|NCT01559012|107549|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
46702|NCT01559012|107550|P1|COMPLETED|Overall Study||6
46703|NCT01559012|107549|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
46704|NCT01559012|107550|P1|STARTED|Overall Study||6
46705|NCT01558791|107575|P2|NOT COMPLETED|Overall Study||0
46706|NCT01558791|107576|P1|NOT COMPLETED|Overall Study||0
46707|NCT01558791|107575|P2|COMPLETED|Overall Study||629
46708|NCT01558791|107576|P1|COMPLETED|Overall Study||607
46709|NCT01558791|107575|P2|STARTED|Overall Study||629
46710|NCT01558791|107576|P1|STARTED|Overall Study||607
46711|NCT01558739|107586|P1|NOT COMPLETED|Overall Study||17
46712|NCT01558739|107586|P1|COMPLETED|Overall Study||31
46713|NCT01558739|107586|P1|STARTED|Overall Study||48
46714|NCT01558700|107600|P2|NOT COMPLETED|Overall Study||0
46715|NCT01558700|107601|P1|NOT COMPLETED|Overall Study||0
46716|NCT01558700|107600|P2|COMPLETED|Overall Study||21
46717|NCT01558700|107601|P1|COMPLETED|Overall Study||19
46718|NCT01558700|107600|P2|STARTED|Overall Study||21
46719|NCT01558700|107601|P1|STARTED|Overall Study||19
46720|NCT01558596|107611|P2|NOT COMPLETED|Overall Study||1
46721|NCT01558596|107612|P1|NOT COMPLETED|Overall Study||3
46722|NCT01558596|107611|P2|COMPLETED|Overall Study||100
46723|NCT01558596|107612|P1|COMPLETED|Overall Study||101
46724|NCT01558596|107611|P2|STARTED|Overall Study||101
46725|NCT01558596|107612|P1|STARTED|Overall Study||104
46726|NCT01558297|107621|P3|NOT COMPLETED|Overall Study||1
46727|NCT01558297|107622|P2|NOT COMPLETED|Overall Study||2
46728|NCT01558297|107623|P1|NOT COMPLETED|Overall Study||2
46729|NCT01558297|107621|P3|COMPLETED|Overall Study||29
46730|NCT01558297|107622|P2|COMPLETED|Overall Study||27
46731|NCT01558297|107623|P1|COMPLETED|Overall Study||28
46732|NCT01558297|107621|P3|STARTED|Overall Study||30
46733|NCT01558297|107622|P2|STARTED|Overall Study||29
46734|NCT01558297|107623|P1|STARTED|Overall Study||30
46735|NCT01558271|107640|P3|NOT COMPLETED|Overall Study||17
46736|NCT01558271|107641|P2|NOT COMPLETED|Overall Study||11
46737|NCT01558271|107642|P1|NOT COMPLETED|Overall Study||18
46738|NCT01558271|107640|P3|COMPLETED|Overall Study||124
46739|NCT01558271|107641|P2|COMPLETED|Overall Study||59
46740|NCT01558271|107642|P1|COMPLETED|Overall Study||263
46741|NCT01558271|107640|P3|Completed 26 Weeks|Overall Study||128
46742|NCT01558271|107641|P2|Completed 26 Weeks|Overall Study||63
46743|NCT01558271|107642|P1|Completed 26 Weeks|Overall Study||271
46744|NCT01558271|107640|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
46745|NCT01558271|107641|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
46746|NCT01558271|107642|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
46747|NCT01558271|107640|P3|STARTED|Overall Study||141
46748|NCT01558271|107641|P2|STARTED|Overall Study||70
46749|NCT01558271|107642|P1|STARTED|Overall Study||281
46750|NCT01558089|107704|P1|NOT COMPLETED|Overall Study||13
46751|NCT01558089|107704|P1|COMPLETED|Overall Study||63
46752|NCT01558089|107704|P1|STARTED|Overall Study||76
46753|NCT01557959|107715|P1|NOT COMPLETED|Overall Study||0
46754|NCT01557959|107715|P1|COMPLETED|Overall Study||45
46755|NCT01557959|107715|P1|STARTED|Overall Study||45
46756|NCT01557920|107719|P2|NOT COMPLETED|Overall Study||3
46757|NCT01557920|107720|P1|NOT COMPLETED|Overall Study||3
46758|NCT01557920|107719|P2|COMPLETED|Overall Study||6
46759|NCT01557920|107720|P1|COMPLETED|Overall Study||6
46760|NCT01557920|107719|P2|STARTED|Overall Study||9
46761|NCT01557920|107720|P1|STARTED|Overall Study||9
46762|NCT01557894|107755|P2|NOT COMPLETED|Overall Study||5
46763|NCT01557894|107756|P1|NOT COMPLETED|Overall Study||3
46764|NCT01557894|107755|P2|COMPLETED|Overall Study||33
46765|NCT01557894|107756|P1|COMPLETED|Overall Study||35
46766|NCT01557894|107755|P2|STARTED|Overall Study||38
46767|NCT01557894|107756|P1|STARTED|Overall Study||38
46768|NCT01557868|107772|P2|NOT COMPLETED|Overall Study||30
46769|NCT01557868|107773|P1|NOT COMPLETED|Overall Study||27
46770|NCT01557868|107772|P2|COMPLETED|Overall Study||65
46771|NCT01557868|107773|P1|COMPLETED|Overall Study||76
46772|NCT01557868|107772|P2|STARTED|Overall Study||95
46773|NCT01557868|107773|P1|STARTED|Overall Study||103
46774|NCT01557842|107783|P2|NOT COMPLETED|Overall Study||6
46775|NCT01557842|107784|P1|NOT COMPLETED|Overall Study||9
46776|NCT01557842|107783|P2|COMPLETED|Overall Study||0
46777|NCT01557842|107784|P1|COMPLETED|Overall Study||0
46778|NCT01557842|107783|P2|STARTED|Overall Study||6
46779|NCT01557842|107784|P1|STARTED|Overall Study||9
46780|NCT01557699|107795|P3|NOT COMPLETED|Overall Study||0
46781|NCT01557699|107796|P2|NOT COMPLETED|Overall Study||0
46782|NCT01557699|107797|P1|NOT COMPLETED|Overall Study||0
46783|NCT01557699|107795|P3|COMPLETED|Overall Study||20
46784|NCT01557699|107796|P2|COMPLETED|Overall Study||20
46785|NCT01557699|107797|P1|COMPLETED|Overall Study||20
46786|NCT01557699|107795|P3|STARTED|Overall Study||20
46787|NCT01557699|107796|P2|STARTED|Overall Study||20
46788|NCT01557699|107797|P1|STARTED|Overall Study||20
46789|NCT01555567|107833|P4|NOT COMPLETED|Return to Activity||1
46790|NCT01555567|107834|P3|NOT COMPLETED|Return to Activity||0
46791|NCT01555567|107835|P2|NOT COMPLETED|Return to Activity||2
46792|NCT01555567|107836|P1|NOT COMPLETED|Return to Activity||1
46793|NCT01555567|107833|P4|COMPLETED|Return to Activity||8
46794|NCT01555567|107834|P3|COMPLETED|Return to Activity||8
46795|NCT01555567|107835|P2|COMPLETED|Return to Activity||10
46796|NCT01555567|107836|P1|COMPLETED|Return to Activity||10
46797|NCT01555567|107833|P4|STARTED|Return to Activity||9
46798|NCT01555567|107834|P3|STARTED|Return to Activity||8
46799|NCT01555567|107835|P2|STARTED|Return to Activity||12
46800|NCT01555567|107836|P1|STARTED|Return to Activity||11
46801|NCT01555567|107833|P4|NOT COMPLETED|12 Week||0
46802|NCT01555567|107834|P3|NOT COMPLETED|12 Week||1
46803|NCT01555567|107835|P2|NOT COMPLETED|12 Week||1
46804|NCT01555567|107836|P1|NOT COMPLETED|12 Week||1
46805|NCT01555567|107833|P4|COMPLETED|12 Week||9
46806|NCT01555567|107834|P3|COMPLETED|12 Week||8
46807|NCT01555567|107835|P2|COMPLETED|12 Week||12
46808|NCT01555567|107836|P1|COMPLETED|12 Week||11
46809|NCT01555567|107833|P4|STARTED|12 Week||9
46810|NCT01555567|107834|P3|STARTED|12 Week||9
46811|NCT01555567|107835|P2|STARTED|12 Week||13
46812|NCT01555567|107836|P1|STARTED|12 Week||12
46813|NCT01557595|107850|P1|NOT COMPLETED|Overall Study||8
46814|NCT01557595|107850|P1|COMPLETED|Overall Study||14
46815|NCT01557595|107850|P1|STARTED|Overall Study||22
46816|NCT01557582|107854|P1|NOT COMPLETED|Overall Study||6
46817|NCT01557582|107854|P1|COMPLETED|Overall Study||97
46818|NCT01557582|107854|P1|STARTED|Overall Study||103
46819|NCT01557569|107862|P2|NOT COMPLETED|Overall Study||7
46820|NCT01557569|107863|P1|NOT COMPLETED|Overall Study||5
46821|NCT01557569|107862|P2|COMPLETED|Overall Study||0
46822|NCT01557569|107863|P1|COMPLETED|Overall Study||1
46823|NCT01557569|107862|P2|Completed 2-wk Residential Stay|Overall Study||1
46824|NCT01557569|107863|P1|Completed 2-wk Residential Stay|Overall Study||3
46825|NCT01557569|107862|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
46826|NCT01557569|107863|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
46827|NCT01557504|107871|P2|NOT COMPLETED|Overall Study||0
46828|NCT01557504|107872|P1|NOT COMPLETED|Overall Study||1
46829|NCT01557504|107871|P2|COMPLETED|Overall Study||12
46830|NCT01557504|107872|P1|COMPLETED|Overall Study||12
46831|NCT01557504|107871|P2|STARTED|Overall Study||12
46832|NCT01557504|107872|P1|STARTED|Overall Study||13
46833|NCT01557348|107897|P2|NOT COMPLETED|Overall Study||90
46834|NCT01557348|107898|P1|NOT COMPLETED|Overall Study||80
46835|NCT01557348|107897|P2|COMPLETED|Overall Study||417
46836|NCT01557348|107898|P1|COMPLETED|Overall Study||524
46837|NCT01557348|107897|P2|Safety Population|Overall Study||507
46838|NCT01557348|107898|P1|Safety Population|Overall Study||604
46839|NCT01557348|107897|P2|STARTED|Overall Study||507
46840|NCT01557348|107898|P1|STARTED|Overall Study||604
46841|NCT01557322|107940|P2|NOT COMPLETED|Overall Study||0
46842|NCT01557322|107941|P1|NOT COMPLETED|Overall Study||0
46843|NCT01557322|107940|P2|COMPLETED|Overall Study||1543
46844|NCT01557322|107941|P1|COMPLETED|Overall Study||211
46845|NCT01557322|107940|P2|STARTED|Overall Study||1543
46846|NCT01557322|107941|P1|STARTED|Overall Study||211
46847|NCT01557283|108015|P1|NOT COMPLETED|Overall Study||44
46848|NCT01557283|108015|P1|COMPLETED|Overall Study||96
46849|NCT01557283|108015|P1|STARTED|Overall Study||140
46850|NCT01557166|108027|P2|NOT COMPLETED|Overall Study||37
46851|NCT01557166|108028|P1|NOT COMPLETED|Overall Study||46
46852|NCT01557166|108027|P2|COMPLETED|Overall Study||142
46853|NCT01557166|108028|P1|COMPLETED|Overall Study||134
46854|NCT01557166|108027|P2|Exposed|Overall Study||179
46855|NCT01557166|108028|P1|Exposed|Overall Study||176
46856|NCT01557166|108027|P2|STARTED|Overall Study||179
46857|NCT01557166|108028|P1|STARTED|Overall Study||180
46858|NCT01556997|108043|P3|NOT COMPLETED|Overall Study||32
46859|NCT01556997|108044|P2|NOT COMPLETED|Overall Study||28
46860|NCT01556997|108045|P1|NOT COMPLETED|Overall Study||26
46861|NCT01556997|108043|P3|COMPLETED|Overall Study||246
46862|NCT01556997|108044|P2|COMPLETED|Overall Study||252
46863|NCT01556997|108045|P1|COMPLETED|Overall Study||253
46864|NCT01556997|108043|P3|STARTED|Overall Study||278
46865|NCT01556997|108044|P2|STARTED|Overall Study||280
46866|NCT01556997|108045|P1|STARTED|Overall Study||279
46867|NCT01556932|108056|P2|NOT COMPLETED|Second Treament||0
46868|NCT01556932|108057|P1|NOT COMPLETED|Second Treament||0
46869|NCT01556932|108056|P2|COMPLETED|Second Treament||8
46870|NCT01556932|108057|P1|COMPLETED|Second Treament||12
46871|NCT01556932|108056|P2|Recieved|Second Treament||8
46872|NCT01556932|108057|P1|Recieved|Second Treament||12
46873|NCT01556932|108056|P2|STARTED|Second Treament||8
46874|NCT01556932|108057|P1|STARTED|Second Treament||12
46875|NCT01556932|108056|P2|NOT COMPLETED|Time Point 60 Minutes||1
46876|NCT01556932|108057|P1|NOT COMPLETED|Time Point 60 Minutes||1
46877|NCT01556932|108056|P2|COMPLETED|Time Point 60 Minutes||8
46878|NCT01556932|108057|P1|COMPLETED|Time Point 60 Minutes||12
46879|NCT01556932|108056|P2|Recieved|Time Point 60 Minutes||8
46880|NCT01556932|108057|P1|Recieved|Time Point 60 Minutes||12
46881|NCT01556932|108056|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
46882|NCT01556932|108057|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
46883|NCT01556932|108056|P2|NOT COMPLETED|Baseline First Treatment||0
46884|NCT01556932|108057|P1|NOT COMPLETED|Baseline First Treatment||0
46885|NCT01556932|108056|P2|COMPLETED|Baseline First Treatment||9
46886|NCT01556932|108057|P1|COMPLETED|Baseline First Treatment||13
46887|NCT01556932|108056|P2|Recieved|Baseline First Treatment||9
46888|NCT01556932|108057|P1|Recieved|Baseline First Treatment||13
46889|NCT01556932|108056|P2|STARTED|Baseline First Treatment||9
46890|NCT01556932|108057|P1|STARTED|Baseline First Treatment||13
46891|NCT01556906|108062|P1|NOT COMPLETED|Overall Study||0
46892|NCT01556906|108062|P1|COMPLETED|Overall Study||6
46893|NCT01556906|108062|P1|STARTED|Overall Study||6
46894|NCT01556763|108083|P3|NOT COMPLETED|Overall Study||0
46895|NCT01556763|108084|P2|NOT COMPLETED|Overall Study||1
46896|NCT01556763|108085|P1|NOT COMPLETED|Overall Study||0
46897|NCT01556763|108083|P3|COMPLETED|Overall Study||8
46898|NCT01556763|108084|P2|COMPLETED|Overall Study||8
46899|NCT01556763|108085|P1|COMPLETED|Overall Study||4
46900|NCT01556763|108083|P3|STARTED|Overall Study||8
46901|NCT01556763|108084|P2|STARTED|Overall Study||9
46902|NCT01556763|108085|P1|STARTED|Overall Study||4
46903|NCT01555463|108123|P2|NOT COMPLETED|Follow up||45
46904|NCT01555463|108124|P1|NOT COMPLETED|Follow up||38
46905|NCT01555463|108123|P2|COMPLETED|Follow up||394
46906|NCT01555463|108124|P1|COMPLETED|Follow up||409
46907|NCT01555463|108123|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
46908|NCT01555463|108124|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
46909|NCT01555463|108123|P2|NOT COMPLETED|Treatment||79
46910|NCT01555463|108124|P1|NOT COMPLETED|Treatment||64
46911|NCT01555463|108123|P2|COMPLETED|Treatment||399
46912|NCT01555463|108124|P1|COMPLETED|Treatment||419
46913|NCT01555463|108123|P2|STARTED|Treatment||478
46914|NCT01555463|108124|P1|STARTED|Treatment||483
46915|NCT01556724|108166|P2|NOT COMPLETED|Overall Study||0
46916|NCT01556724|108167|P1|NOT COMPLETED|Overall Study||0
46917|NCT01556724|108166|P2|COMPLETED|Overall Study||15
46918|NCT01556724|108167|P1|COMPLETED|Overall Study||15
46919|NCT01556724|108166|P2|STARTED|Overall Study||15
46920|NCT01556724|108167|P1|STARTED|Overall Study||15
46921|NCT01556633|108175|P2|NOT COMPLETED|Overall Study||0
46922|NCT01556633|108176|P1|NOT COMPLETED|Overall Study||0
46923|NCT01556633|108175|P2|COMPLETED|Overall Study||6
46924|NCT01556633|108176|P1|COMPLETED|Overall Study||10
46925|NCT01556633|108175|P2|STARTED|Overall Study||6
46926|NCT01556633|108176|P1|STARTED|Overall Study||10
46927|NCT01556594|108201|P3|NOT COMPLETED|Overall Study||0
46928|NCT01556594|108202|P2|NOT COMPLETED|Overall Study||0
46929|NCT01556594|108203|P1|NOT COMPLETED|Overall Study||0
46930|NCT01556594|108201|P3|COMPLETED|Overall Study||6
46931|NCT01556594|108202|P2|COMPLETED|Overall Study||2
46932|NCT01556594|108203|P1|COMPLETED|Overall Study||10
46933|NCT01556594|108201|P3|STARTED|Overall Study||6
46934|NCT01556594|108202|P2|STARTED|Overall Study||2
46935|NCT01556594|108203|P1|STARTED|Overall Study||10
46936|NCT01556451|108221|P1|NOT COMPLETED|Overall Study||0
46937|NCT01556451|108221|P1|COMPLETED|Overall Study||180
46938|NCT01556451|108221|P1|STARTED|Overall Study||180
46939|NCT01556204|108230|P2|NOT COMPLETED|Overall Study||0
46940|NCT01556204|108231|P1|NOT COMPLETED|Overall Study||0
46941|NCT01556204|108230|P2|COMPLETED|Overall Study||38
46942|NCT01556204|108231|P1|COMPLETED|Overall Study||35
46943|NCT01556204|108230|P2|STARTED|Overall Study||38
46944|NCT01556204|108231|P1|STARTED|Overall Study||35
46945|NCT01556165|108241|P2|NOT COMPLETED|Overall Study||7
46946|NCT01556165|108242|P1|NOT COMPLETED|Overall Study||12
46947|NCT01556165|108241|P2|COMPLETED|Overall Study||58
46948|NCT01556165|108242|P1|COMPLETED|Overall Study||53
46949|NCT01556165|108241|P2|STARTED|Overall Study||65
46950|NCT01556165|108242|P1|STARTED|Overall Study||65
46951|NCT01556061|108256|P2|NOT COMPLETED|Overall Study||0
46952|NCT01556061|108257|P1|NOT COMPLETED|Overall Study||0
46953|NCT01556061|108256|P2|COMPLETED|Overall Study||25
46954|NCT01556061|108257|P1|COMPLETED|Overall Study||25
46955|NCT01556061|108256|P2|STARTED|Overall Study||25
46956|NCT01556061|108257|P1|STARTED|Overall Study||25
46957|NCT01555983|108267|P6|NOT COMPLETED|Overall Study||1
46958|NCT01555983|108268|P5|NOT COMPLETED|Overall Study||1
46959|NCT01555983|108269|P4|NOT COMPLETED|Overall Study||0
46960|NCT01555983|108270|P3|NOT COMPLETED|Overall Study||0
46961|NCT01555983|108271|P2|NOT COMPLETED|Overall Study||0
46962|NCT01555983|108272|P1|NOT COMPLETED|Overall Study||1
46963|NCT01555983|108267|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
46964|NCT01555983|108268|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
46965|NCT01555983|108269|P4|COMPLETED|Overall Study||7
46966|NCT01555983|108270|P3|COMPLETED|Overall Study||7
46967|NCT01555983|108271|P2|COMPLETED|Overall Study||7
46968|NCT01555983|108272|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
46969|NCT01555983|108267|P6|STARTED|Overall Study||7
46970|NCT01555983|108268|P5|STARTED|Overall Study||5
46971|NCT01555983|108269|P4|STARTED|Overall Study||7
46972|NCT01555983|108270|P3|STARTED|Overall Study||7
46973|NCT01555983|108271|P2|STARTED|Overall Study||7
46974|NCT01555983|108272|P1|STARTED|Overall Study||9
46975|NCT01555931|108282|P2|NOT COMPLETED|Overall Study||5
46976|NCT01555931|108283|P1|NOT COMPLETED|Overall Study||2
46977|NCT01555931|108282|P2|COMPLETED|Overall Study||13
46978|NCT01555931|108283|P1|COMPLETED|Overall Study||15
46979|NCT01555931|108282|P2|STARTED|Overall Study||18
46980|NCT01555931|108283|P1|STARTED|Overall Study||17
46981|NCT01555164|108293|P2|NOT COMPLETED|Overall Study||35
46982|NCT01555164|108294|P1|NOT COMPLETED|Overall Study||40
46983|NCT01555164|108293|P2|COMPLETED|Overall Study||185
46984|NCT01555164|108294|P1|COMPLETED|Overall Study||182
46985|NCT01555164|108293|P2|STARTED|Overall Study||220
46986|NCT01555164|108294|P1|STARTED|Overall Study||222
46987|NCT01555151|108308|P4|NOT COMPLETED|Overall Study||10
46988|NCT01555151|108309|P3|NOT COMPLETED|Overall Study||6
46989|NCT01555151|108310|P2|NOT COMPLETED|Overall Study||8
46990|NCT01555151|108311|P1|NOT COMPLETED|Overall Study||13
46991|NCT01555151|108308|P4|COMPLETED|Overall Study||176
46992|NCT01555151|108309|P3|COMPLETED|Overall Study||178
46993|NCT01555151|108310|P2|COMPLETED|Overall Study||173
46994|NCT01555151|108311|P1|COMPLETED|Overall Study||175
46995|NCT01555151|108308|P4|Safety Set (SAF)|Overall Study||186
46996|NCT01555151|108309|P3|Safety Set (SAF)|Overall Study||183
46997|NCT01555151|108310|P2|Safety Set (SAF)|Overall Study||180
46998|NCT01555151|108311|P1|Safety Set (SAF)|Overall Study||186
46999|NCT01555151|108308|P4|STARTED|Overall Study||186
47000|NCT01555151|108309|P3|STARTED|Overall Study||184
47001|NCT01555151|108310|P2|STARTED|Overall Study||181
47002|NCT01555151|108311|P1|STARTED|Overall Study||188
47003|NCT01555138|108364|P2|NOT COMPLETED|Overall Study||38
47004|NCT01555138|108365|P1|NOT COMPLETED|Overall Study||47
47005|NCT01555138|108364|P2|COMPLETED|Overall Study||250
47006|NCT01555138|108365|P1|COMPLETED|Overall Study||246
47007|NCT01555138|108364|P2|STARTED|Overall Study||288
47008|NCT01555138|108365|P1|STARTED|Overall Study||293
47009|NCT01555073|108395|P4|NOT COMPLETED|Overall Study||5
47010|NCT01555073|108396|P3|NOT COMPLETED|Overall Study||0
47011|NCT01555073|108397|P2|NOT COMPLETED|Overall Study||2
47012|NCT01555073|108398|P1|NOT COMPLETED|Overall Study||1
47013|NCT01555073|108395|P4|COMPLETED|Overall Study||1
47014|NCT01555073|108396|P3|COMPLETED|Overall Study||7
47015|NCT01555073|108397|P2|COMPLETED|Overall Study||1
47016|NCT01555073|108398|P1|COMPLETED|Overall Study||6
47017|NCT01555073|108395|P4|STARTED|Overall Study||6
47018|NCT01555073|108396|P3|STARTED|Overall Study||7
47019|NCT01555073|108397|P2|STARTED|Overall Study||3
47020|NCT01555073|108398|P1|STARTED|Overall Study||7
47021|NCT01554982|108412|P1|NOT COMPLETED|Overall Study||43
47022|NCT01554982|108412|P1|COMPLETED|Overall Study||125
47023|NCT01554982|108412|P1|Received Drug|Overall Study||166
47024|NCT01554982|108412|P1|STARTED|Overall Study||168
47025|NCT01554904|108425|P1|NOT COMPLETED|Overall Study||4
47026|NCT01554904|108425|P1|COMPLETED|Overall Study||14
47027|NCT01554904|108425|P1|Home Sleep Study 2|Overall Study||14
47028|NCT01554904|108425|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
47029|NCT01554904|108425|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
47030|NCT01554904|108425|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
47031|NCT01554904|108425|P1|STARTED|Overall Study||18
47032|NCT01554891|108433|P3|NOT COMPLETED|Overall Study||2
47033|NCT01554891|108434|P2|NOT COMPLETED|Overall Study||5
47034|NCT01554891|108435|P1|NOT COMPLETED|Overall Study||7
47035|NCT01554891|108433|P3|COMPLETED|Overall Study||55
47036|NCT01554891|108434|P2|COMPLETED|Overall Study||115
47037|NCT01554891|108435|P1|COMPLETED|Overall Study||98
47038|NCT01554891|108433|P3|STARTED|Overall Study||57
47039|NCT01554891|108434|P2|STARTED|Overall Study||120
47040|NCT01554891|108435|P1|STARTED|Overall Study||105
47041|NCT01554241|108447|P4|NOT COMPLETED|Overall Study||1
47042|NCT01554241|108448|P3|NOT COMPLETED|Overall Study||4
47043|NCT01554241|108449|P2|NOT COMPLETED|Overall Study||1
47044|NCT01554241|108450|P1|NOT COMPLETED|Overall Study||3
47045|NCT01554241|108447|P4|COMPLETED|Overall Study||13
47046|NCT01554241|108448|P3|COMPLETED|Overall Study||20
47047|NCT01554241|108449|P2|COMPLETED|Overall Study||19
47048|NCT01554241|108450|P1|COMPLETED|Overall Study||20
47049|NCT01554241|108447|P4|STARTED|Overall Study||14
47050|NCT01554241|108448|P3|STARTED|Overall Study||24
47051|NCT01554241|108449|P2|STARTED|Overall Study||20
47052|NCT01554241|108450|P1|STARTED|Overall Study||23
47053|NCT01554176|108466|P5|NOT COMPLETED|Run-out Phase||0
47054|NCT01554176|108467|P4|NOT COMPLETED|Run-out Phase||1
47055|NCT01554176|108468|P3|NOT COMPLETED|Run-out Phase||0
47056|NCT01554176|108469|P2|NOT COMPLETED|Run-out Phase||0
47057|NCT01554176|108470|P1|NOT COMPLETED|Run-out Phase||0
47058|NCT01554176|108466|P5|COMPLETED|Run-out Phase||59
47059|NCT01554176|108467|P4|COMPLETED|Run-out Phase||27
47060|NCT01554176|108468|P3|COMPLETED|Run-out Phase||29
47061|NCT01554176|108469|P2|COMPLETED|Run-out Phase||0
47062|NCT01554176|108470|P1|COMPLETED|Run-out Phase||0
47063|NCT01554176|108466|P5|Treated|Run-out Phase||59
47064|NCT01554176|108467|P4|Treated|Run-out Phase||28
47065|NCT01554176|108468|P3|Treated|Run-out Phase||29
47066|NCT01554176|108469|P2|Treated|Run-out Phase||0
47067|NCT01554176|108470|P1|Treated|Run-out Phase||0
47068|NCT01554176|108466|P5|STARTED|Run-out Phase||59
47069|NCT01554176|108467|P4|STARTED|Run-out Phase||28
47070|NCT01554176|108468|P3|STARTED|Run-out Phase||29
47071|NCT01554176|108469|P2|STARTED|Run-out Phase||0
47072|NCT01554176|108470|P1|STARTED|Run-out Phase||0
47073|NCT01554176|108466|P5|NOT COMPLETED|Treatment Phase||0
47074|NCT01554176|108467|P4|NOT COMPLETED|Treatment Phase||0
47075|NCT01554176|108468|P3|NOT COMPLETED|Treatment Phase||0
47076|NCT01554176|108469|P2|NOT COMPLETED|Treatment Phase||5
47077|NCT01554176|108470|P1|NOT COMPLETED|Treatment Phase||8
47078|NCT01554176|108466|P5|COMPLETED|Treatment Phase||0
47079|NCT01554176|108467|P4|COMPLETED|Treatment Phase||0
47080|NCT01554176|108468|P3|COMPLETED|Treatment Phase||0
47081|NCT01554176|108469|P2|COMPLETED|Treatment Phase||59
47082|NCT01554176|108470|P1|COMPLETED|Treatment Phase||57
47083|NCT01554176|108466|P5|Treated|Treatment Phase||0
47084|NCT01554176|108467|P4|Treated|Treatment Phase||0
47085|NCT01554176|108468|P3|Treated|Treatment Phase||0
47086|NCT01554176|108469|P2|Treated|Treatment Phase||64
47087|NCT01554176|108470|P1|Treated|Treatment Phase||64
47088|NCT01554176|108466|P5|STARTED|Treatment Phase||0
47089|NCT01554176|108467|P4|STARTED|Treatment Phase||0
47090|NCT01554176|108468|P3|STARTED|Treatment Phase||0
47091|NCT01554176|108469|P2|STARTED|Treatment Phase||64
47092|NCT01554176|108470|P1|STARTED|Treatment Phase||65
47093|NCT01554163|108497|P2|NOT COMPLETED|Overall Study||10
47094|NCT01554163|108498|P1|NOT COMPLETED|Overall Study||8
47095|NCT01554163|108497|P2|COMPLETED|Overall Study||109
47096|NCT01554163|108498|P1|COMPLETED|Overall Study||112
47097|NCT01554163|108497|P2|Number Treated|Overall Study||119
47098|NCT01554163|108498|P1|Number Treated|Overall Study||119
47099|NCT01554163|108497|P2|STARTED|Overall Study||119
47100|NCT01554163|108498|P1|STARTED|Overall Study||120
47101|NCT01553851|108516|P1|NOT COMPLETED|Overall Study||3
47102|NCT01553851|108516|P1|COMPLETED|Overall Study||17
47103|NCT01553851|108516|P1|STARTED|Overall Study||20
47104|NCT01553708|108530|P2|NOT COMPLETED|Overall Study||0
47105|NCT01553708|108531|P1|NOT COMPLETED|Overall Study||0
47106|NCT01553708|108530|P2|COMPLETED|Overall Study||17
47107|NCT01553708|108531|P1|COMPLETED|Overall Study||17
47108|NCT01553708|108530|P2|STARTED|Overall Study||17
47109|NCT01553708|108531|P1|STARTED|Overall Study||17
47110|NCT01553539|108537|P1|NOT COMPLETED|Overall Study||0
47111|NCT01553539|108537|P1|COMPLETED|Overall Study||20
47112|NCT01553539|108537|P1|STARTED|Overall Study||20
47113|NCT01553318|108544|P2|NOT COMPLETED|Overall Study||2
47114|NCT01553318|108545|P1|NOT COMPLETED|Overall Study||3
47115|NCT01553318|108544|P2|COMPLETED|Overall Study||25
47116|NCT01553318|108545|P1|COMPLETED|Overall Study||21
47117|NCT01553318|108544|P2|STARTED|Overall Study||27
47118|NCT01553318|108545|P1|STARTED|Overall Study||24
47119|NCT01553292|108557|P1|NOT COMPLETED|Overall Study||0
47120|NCT01553292|108557|P1|COMPLETED|Overall Study||21
47121|NCT01553292|108557|P1|STARTED|Overall Study||21
47122|NCT01553240|108573|P1|NOT COMPLETED|Overall Study||0
47123|NCT01553240|108573|P1|COMPLETED|Overall Study||0
47124|NCT01553240|108573|P1|STARTED|Overall Study||0
47125|NCT01552954|108580|P2|NOT COMPLETED|Overall Study||6
47126|NCT01552954|108581|P1|NOT COMPLETED|Overall Study||5
47127|NCT01552954|108580|P2|COMPLETED|Overall Study||119
47128|NCT01552954|108581|P1|COMPLETED|Overall Study||126
47129|NCT01552954|108580|P2|STARTED|Overall Study||125
47130|NCT01552954|108581|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
47131|NCT01552928|108597|P4|NOT COMPLETED|Period 4||0
47132|NCT01552928|108598|P3|NOT COMPLETED|Period 4||0
47133|NCT01552928|108599|P2|NOT COMPLETED|Period 4||0
47134|NCT01552928|108600|P1|NOT COMPLETED|Period 4||0
47135|NCT01552928|108597|P4|COMPLETED|Period 4||16
47136|NCT01552928|108598|P3|COMPLETED|Period 4||14
47137|NCT01552928|108599|P2|COMPLETED|Period 4||15
47138|NCT01552928|108600|P1|COMPLETED|Period 4||14
47139|NCT01552928|108597|P4|STARTED|Period 4||16
47140|NCT01552928|108598|P3|STARTED|Period 4||14
47141|NCT01552928|108599|P2|STARTED|Period 4||15
47142|NCT01552928|108600|P1|STARTED|Period 4||14
47143|NCT01552928|108597|P4|NOT COMPLETED|Period 3||0
47144|NCT01552928|108598|P3|NOT COMPLETED|Period 3||1
47145|NCT01552928|108599|P2|NOT COMPLETED|Period 3||0
47146|NCT01552928|108600|P1|NOT COMPLETED|Period 3||0
47147|NCT01552928|108597|P4|COMPLETED|Period 3||16
47148|NCT01552928|108598|P3|COMPLETED|Period 3||14
47149|NCT01552928|108599|P2|COMPLETED|Period 3||15
47150|NCT01552928|108600|P1|COMPLETED|Period 3||14
47151|NCT01552928|108597|P4|STARTED|Period 3||16
47152|NCT01552928|108598|P3|STARTED|Period 3||15
47153|NCT01552928|108599|P2|STARTED|Period 3||15
47154|NCT01552928|108600|P1|STARTED|Period 3||14
47155|NCT01552928|108597|P4|NOT COMPLETED|Period 2||0
47156|NCT01552928|108598|P3|NOT COMPLETED|Period 2||0
47157|NCT01552928|108599|P2|NOT COMPLETED|Period 2||0
47158|NCT01552928|108600|P1|NOT COMPLETED|Period 2||0
47159|NCT01552928|108597|P4|COMPLETED|Period 2||16
47160|NCT01552928|108598|P3|COMPLETED|Period 2||15
47161|NCT01552928|108599|P2|COMPLETED|Period 2||15
47162|NCT01552928|108600|P1|COMPLETED|Period 2||14
47163|NCT01552928|108597|P4|STARTED|Period 2||16
47164|NCT01552928|108598|P3|STARTED|Period 2||15
47165|NCT01552928|108599|P2|STARTED|Period 2||15
47166|NCT01552928|108600|P1|STARTED|Period 2||14
47167|NCT01552928|108597|P4|NOT COMPLETED|Period 1||0
47168|NCT01552928|108598|P3|NOT COMPLETED|Period 1||0
47169|NCT01552928|108599|P2|NOT COMPLETED|Period 1||0
47170|NCT01552928|108600|P1|NOT COMPLETED|Period 1||0
47171|NCT01552928|108597|P4|COMPLETED|Period 1||16
47172|NCT01552928|108598|P3|COMPLETED|Period 1||15
47173|NCT01552928|108599|P2|COMPLETED|Period 1||15
47174|NCT01552928|108600|P1|COMPLETED|Period 1||14
47175|NCT01552928|108597|P4|STARTED|Period 1||16
47176|NCT01552928|108598|P3|STARTED|Period 1||15
47177|NCT01552928|108599|P2|STARTED|Period 1||15
47178|NCT01552928|108600|P1|STARTED|Period 1||14
47179|NCT01552915|108647|P3|NOT COMPLETED|Overall Study||27
47180|NCT01552915|108648|P2|NOT COMPLETED|Overall Study||29
47181|NCT01552915|108649|P1|NOT COMPLETED|Overall Study||23
47182|NCT01552915|108647|P3|COMPLETED|Overall Study||157
47183|NCT01552915|108648|P2|COMPLETED|Overall Study||155
47184|NCT01552915|108649|P1|COMPLETED|Overall Study||68
47185|NCT01552915|108647|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
47186|NCT01552915|108648|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
47187|NCT01552915|108649|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
47188|NCT01552902|108672|P3|NOT COMPLETED|Overall Study||33
47189|NCT01552902|108673|P2|NOT COMPLETED|Overall Study||37
47190|NCT01552902|108674|P1|NOT COMPLETED|Overall Study||13
47191|NCT01552902|108672|P3|COMPLETED|Overall Study||186
47192|NCT01552902|108673|P2|COMPLETED|Overall Study||181
47193|NCT01552902|108674|P1|COMPLETED|Overall Study||97
47194|NCT01552902|108672|P3|STARTED|Overall Study||219
47195|NCT01552902|108673|P2|STARTED|Overall Study||218
47196|NCT01552902|108674|P1|STARTED|Overall Study||110
47197|NCT01552876|108694|P2|NOT COMPLETED|Overall Study||0
47198|NCT01552876|108695|P1|NOT COMPLETED|Overall Study||0
47199|NCT01552876|108694|P2|COMPLETED|Overall Study||20
47200|NCT01552876|108695|P1|COMPLETED|Overall Study||20
47201|NCT01552876|108694|P2|STARTED|Overall Study||20
47202|NCT01552876|108695|P1|STARTED|Overall Study||20
47203|NCT01552772|108711|P1|NOT COMPLETED|Overall Study||4
47204|NCT01552772|108711|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
47205|NCT01552772|108711|P1|STARTED|Overall Study||60
47206|NCT01552694|108727|P2|NOT COMPLETED|Overall Study||2
47207|NCT01552694|108728|P1|NOT COMPLETED|Overall Study||0
47208|NCT01552694|108727|P2|COMPLETED|Overall Study||18
47209|NCT01552694|108728|P1|COMPLETED|Overall Study||18
47210|NCT01552694|108727|P2|STARTED|Overall Study||20
47211|NCT01552694|108728|P1|STARTED|Overall Study||18
47212|NCT01552681|108740|P2|NOT COMPLETED|Overall Study||1
47213|NCT01552681|108741|P1|NOT COMPLETED|Overall Study||5
47214|NCT01552681|108740|P2|COMPLETED|Overall Study||18
47215|NCT01552681|108741|P1|COMPLETED|Overall Study||28
47216|NCT01552681|108740|P2|STARTED|Overall Study||19
47217|NCT01552681|108741|P1|STARTED|Overall Study||33
47218|NCT01552603|108789|P1|NOT COMPLETED|Overall Study||1
47219|NCT01552603|108789|P1|COMPLETED|Overall Study||13
47220|NCT01552603|108789|P1|STARTED|Overall Study||14
47221|NCT01552057|108796|P2|NOT COMPLETED|Overall Study||48
47222|NCT01552057|108797|P1|NOT COMPLETED|Overall Study||30
47223|NCT01552057|108796|P2|COMPLETED|Overall Study||149
47224|NCT01552057|108797|P1|COMPLETED|Overall Study||166
47225|NCT01552057|108796|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
47226|NCT01552057|108797|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
47227|NCT01552057|108796|P2|STARTED|Overall Study||197
47228|NCT01552057|108797|P1|STARTED|Overall Study||196
47229|NCT01551888|108829|P2|NOT COMPLETED|Period 2||0
47230|NCT01551888|108830|P1|NOT COMPLETED|Period 2||0
47231|NCT01551888|108829|P2|COMPLETED|Period 2||12
47232|NCT01551888|108830|P1|COMPLETED|Period 2||12
47233|NCT01551888|108829|P2|STARTED|Period 2||12
47234|NCT01551888|108830|P1|STARTED|Period 2||12
47235|NCT01551888|108829|P2|NOT COMPLETED|Period 1||0
47236|NCT01551888|108830|P1|NOT COMPLETED|Period 1||0
47237|NCT01551888|108829|P2|COMPLETED|Period 1||12
47238|NCT01551888|108830|P1|COMPLETED|Period 1||12
47239|NCT01551888|108829|P2|STARTED|Period 1||12
47240|NCT01551888|108830|P1|STARTED|Period 1||12
47241|NCT01551355|108848|P6|NOT COMPLETED|Overall Study||6
47242|NCT01551355|108849|P5|NOT COMPLETED|Overall Study||9
47243|NCT01551355|108850|P4|NOT COMPLETED|Overall Study||24
47244|NCT01551355|108851|P3|NOT COMPLETED|Overall Study||34
47245|NCT01551355|108852|P2|NOT COMPLETED|Overall Study||49
47246|NCT01551355|108853|P1|NOT COMPLETED|Overall Study||51
47247|NCT01551355|108848|P6|COMPLETED|Overall Study||65
47248|NCT01551355|108849|P5|COMPLETED|Overall Study||55
47249|NCT01551355|108850|P4|COMPLETED|Overall Study||411
47250|NCT01551355|108851|P3|COMPLETED|Overall Study||459
47251|NCT01551355|108852|P2|COMPLETED|Overall Study||545
47252|NCT01551355|108853|P1|COMPLETED|Overall Study||571
47253|NCT01551355|108848|P6|STARTED|Overall Study||71
47254|NCT01551355|108849|P5|STARTED|Overall Study||64
47255|NCT01551355|108850|P4|STARTED|Overall Study||435
47256|NCT01551355|108851|P3|STARTED|Overall Study||493
47257|NCT01551355|108852|P2|STARTED|Overall Study||594
47258|NCT01551355|108853|P1|STARTED|Overall Study||622
47259|NCT01551303|108867|P2|NOT COMPLETED|Overall Study||7
47260|NCT01551303|108868|P1|NOT COMPLETED|Overall Study||4
47261|NCT01551303|108867|P2|COMPLETED|Overall Study||15
47262|NCT01551303|108868|P1|COMPLETED|Overall Study||21
47263|NCT01551303|108867|P2|STARTED|Overall Study||22
47264|NCT01551303|108868|P1|STARTED|Overall Study||25
47265|NCT01551199|108874|P1|NOT COMPLETED|Overall Study||5
47266|NCT01551199|108874|P1|COMPLETED|Overall Study||2
47267|NCT01551199|108874|P1|STARTED|Overall Study||7
47268|NCT01551173|108882|P2|NOT COMPLETED|Overall Study||32
47269|NCT01551173|108883|P1|NOT COMPLETED|Overall Study||28
47270|NCT01551173|108882|P2|COMPLETED|Overall Study||186
47271|NCT01551173|108883|P1|COMPLETED|Overall Study||190
47272|NCT01551173|108882|P2|Full Analysis Set (FAS)|Overall Study||214
47273|NCT01551173|108883|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
47274|NCT01551173|108882|P2|STARTED|Overall Study||218
47275|NCT01551173|108883|P1|STARTED|Overall Study|"Started indicates randomized"|218
47276|NCT01551095|108894|P1|NOT COMPLETED|Overall Study||0
47277|NCT01551095|108894|P1|COMPLETED|Overall Study||7
47278|NCT01551095|108894|P1|STARTED|Overall Study||7
47279|NCT01551082|108899|P1|NOT COMPLETED|Overall Study||0
47280|NCT01551082|108899|P1|COMPLETED|Overall Study||12
47281|NCT01551082|108899|P1|STARTED|Overall Study||12
47282|NCT01550965|108903|P1|NOT COMPLETED|Overall Study||110
47283|NCT01550965|108903|P1|COMPLETED|Overall Study||353
47284|NCT01550965|108903|P1|STARTED|Overall Study||463
47285|NCT01550952|108922|P1|NOT COMPLETED|Overall Study||0
47286|NCT01550952|108922|P1|COMPLETED|Overall Study||10
47287|NCT01550952|108922|P1|STARTED|Overall Study||10
47288|NCT01550809|108932|P2|NOT COMPLETED|Overall Study||0
47289|NCT01550809|108933|P1|NOT COMPLETED|Overall Study||0
47290|NCT01550809|108932|P2|COMPLETED|Overall Study||6
47291|NCT01550809|108933|P1|COMPLETED|Overall Study||6
47292|NCT01550809|108932|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
47293|NCT01550809|108933|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
47294|NCT01550744|108943|P3|NOT COMPLETED|Double-Blind||67
47295|NCT01550744|108944|P2|NOT COMPLETED|Double-Blind||17
47296|NCT01550744|108945|P1|NOT COMPLETED|Double-Blind||0
47297|NCT01550744|108943|P3|COMPLETED|Double-Blind||235
47298|NCT01550744|108944|P2|COMPLETED|Double-Blind||59
47299|NCT01550744|108945|P1|COMPLETED|Double-Blind||0
47300|NCT01550744|108943|P3|STARTED|Double-Blind||302
47301|NCT01550744|108944|P2|STARTED|Double-Blind||76
47302|NCT01550744|108945|P1|STARTED|Double-Blind||0
47303|NCT01550744|108943|P3|NOT COMPLETED|Open-Label||0
47304|NCT01550744|108944|P2|NOT COMPLETED|Open-Label||0
47305|NCT01550744|108945|P1|NOT COMPLETED|Open-Label||100
47306|NCT01550744|108943|P3|COMPLETED|Open-Label||0
47307|NCT01550744|108944|P2|COMPLETED|Open-Label||0
47308|NCT01550744|108945|P1|COMPLETED|Open-Label||378
47309|NCT01550744|108943|P3|STARTED|Open-Label||0
47310|NCT01550744|108944|P2|STARTED|Open-Label||0
47311|NCT01550744|108945|P1|STARTED|Open-Label||478
47312|NCT01550705|108958|P1|NOT COMPLETED|Overall Study||1
47313|NCT01550705|108958|P1|COMPLETED|Overall Study||10
47314|NCT01550705|108958|P1|STARTED|Overall Study||11
47315|NCT01550549|108963|P1|NOT COMPLETED|Overall Study||0
47316|NCT01550549|108963|P1|COMPLETED|Overall Study||151
47317|NCT01550549|108963|P1|STARTED|Overall Study||151
47318|NCT01550289|108977|P2|NOT COMPLETED|Overall Study||4
47319|NCT01550289|108978|P1|NOT COMPLETED|Overall Study||13
47320|NCT01550289|108977|P2|COMPLETED|Overall Study||57
47321|NCT01550289|108978|P1|COMPLETED|Overall Study||115
47322|NCT01550289|108977|P2|STARTED|Overall Study||61
47323|NCT01550289|108978|P1|STARTED|Overall Study||128
47324|NCT01549977|109010|P2|NOT COMPLETED|Overall Study||0
47325|NCT01549977|109011|P1|NOT COMPLETED|Overall Study||0
47326|NCT01549977|109010|P2|COMPLETED|Overall Study||0
47327|NCT01549977|109011|P1|COMPLETED|Overall Study||1
47328|NCT01549977|109010|P2|STARTED|Overall Study||0
47329|NCT01549977|109011|P1|STARTED|Overall Study||1
47330|NCT01549964|109029|P4|NOT COMPLETED|80-Week Extension Period||137
47331|NCT01549964|109030|P3|NOT COMPLETED|80-Week Extension Period||140
47332|NCT01549964|109031|P2|NOT COMPLETED|80-Week Extension Period||138
47333|NCT01549964|109032|P1|NOT COMPLETED|80-Week Extension Period||66
47334|NCT01549964|109029|P4|COMPLETED|80-Week Extension Period||0
47335|NCT01549964|109030|P3|COMPLETED|80-Week Extension Period||0
47336|NCT01549964|109031|P2|COMPLETED|80-Week Extension Period||0
47337|NCT01549964|109032|P1|COMPLETED|80-Week Extension Period||0
47338|NCT01549964|109029|P4|STARTED|80-Week Extension Period||137
47339|NCT01549964|109030|P3|STARTED|80-Week Extension Period||140
47340|NCT01549964|109031|P2|STARTED|80-Week Extension Period||138
47341|NCT01549964|109032|P1|STARTED|80-Week Extension Period||66
47342|NCT01549964|109029|P4|NOT COMPLETED|24-Week Treatment Period||121
47343|NCT01549964|109030|P3|NOT COMPLETED|24-Week Treatment Period||116
47344|NCT01549964|109031|P2|NOT COMPLETED|24-Week Treatment Period||111
47345|NCT01549964|109032|P1|NOT COMPLETED|24-Week Treatment Period||61
47346|NCT01549964|109029|P4|COMPLETED|24-Week Treatment Period||140
47347|NCT01549964|109030|P3|COMPLETED|24-Week Treatment Period||147
47348|NCT01549964|109031|P2|COMPLETED|24-Week Treatment Period||149
47349|NCT01549964|109032|P1|COMPLETED|24-Week Treatment Period||71
47350|NCT01549964|109029|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
47351|NCT01549964|109030|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
47352|NCT01549964|109031|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
47353|NCT01549964|109032|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
47354|NCT01549964|109029|P4|STARTED|24-Week Treatment Period||261
47355|NCT01549964|109030|P3|STARTED|24-Week Treatment Period||263
47356|NCT01549964|109031|P2|STARTED|24-Week Treatment Period||260
47357|NCT01549964|109032|P1|STARTED|24-Week Treatment Period||132
47358|NCT01549951|109050|P1|NOT COMPLETED|Overall Study||50
47359|NCT01549951|109050|P1|COMPLETED|Overall Study||0
47360|NCT01549951|109050|P1|Primary Reason Off Study Treatment|Overall Study||50
47361|NCT01549951|109050|P1|STARTED|Overall Study||50
47362|NCT01549925|109068|P2|NOT COMPLETED|Overall Study||0
47363|NCT01549925|109069|P1|NOT COMPLETED|Overall Study||0
47364|NCT01549925|109068|P2|COMPLETED|Overall Study||25
47365|NCT01549925|109069|P1|COMPLETED|Overall Study||25
47366|NCT01549925|109068|P2|STARTED|Overall Study||25
47367|NCT01549925|109069|P1|STARTED|Overall Study||25
47368|NCT01549873|109077|P2|NOT COMPLETED|Overall Study||1
47369|NCT01549873|109078|P1|NOT COMPLETED|Overall Study||0
47370|NCT01549873|109077|P2|COMPLETED|Overall Study||14
47371|NCT01549873|109078|P1|COMPLETED|Overall Study||15
47372|NCT01549873|109077|P2|STARTED|Overall Study||15
47373|NCT01549873|109078|P1|STARTED|Overall Study||15
47374|NCT01549860|109090|P2|NOT COMPLETED|Overall Study||1
47375|NCT01549860|109091|P1|NOT COMPLETED|Overall Study||2
47376|NCT01549860|109090|P2|COMPLETED|Overall Study||40
47377|NCT01549860|109091|P1|COMPLETED|Overall Study||38
47378|NCT01549860|109090|P2|STARTED|Overall Study||41
47379|NCT01549860|109091|P1|STARTED|Overall Study||40
47380|NCT01549613|109103|P2|NOT COMPLETED|Overall Study||11
47381|NCT01549613|109104|P1|NOT COMPLETED|Overall Study||11
47382|NCT01549613|109103|P2|COMPLETED|Overall Study||39
47383|NCT01549613|109104|P1|COMPLETED|Overall Study||39
47384|NCT01549613|109103|P2|STARTED|Overall Study||50
47385|NCT01549613|109104|P1|STARTED|Overall Study||50
47386|NCT01549405|109112|P2|NOT COMPLETED|Overall Study||0
47387|NCT01549405|109113|P1|NOT COMPLETED|Overall Study||0
47388|NCT01549405|109112|P2|COMPLETED|Overall Study||20
47389|NCT01549405|109113|P1|COMPLETED|Overall Study||20
47390|NCT01549405|109112|P2|STARTED|Overall Study||20
47391|NCT01549405|109113|P1|STARTED|Overall Study||20
47392|NCT01549392|109123|P2|NOT COMPLETED|Overall Study||0
47393|NCT01549392|109124|P1|NOT COMPLETED|Overall Study||1
47394|NCT01549392|109123|P2|COMPLETED|Overall Study||0
47395|NCT01549392|109124|P1|COMPLETED|Overall Study||2
47396|NCT01549392|109123|P2|STARTED|Overall Study||0
47397|NCT01549392|109124|P1|STARTED|Overall Study||3
47398|NCT01549340|109130|P1|NOT COMPLETED|Overall Study||8405
47399|NCT01549340|109130|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
47400|NCT01549340|109130|P1|Started AIT|Overall Study||3182
47401|NCT01549340|109130|P1|STARTED|Overall Study|Advised to receive AIT|8790
47402|NCT01549275|109143|P2|NOT COMPLETED|Overall Study||0
47403|NCT01549275|109144|P1|NOT COMPLETED|Overall Study||1
47404|NCT01549275|109143|P2|COMPLETED|Overall Study||29
47405|NCT01549275|109144|P1|COMPLETED|Overall Study||75
47406|NCT01549275|109143|P2|STARTED|Overall Study||29
47407|NCT01549275|109144|P1|STARTED|Overall Study||76
47408|NCT01549041|109156|P2|NOT COMPLETED|Overall Study||8
47409|NCT01549041|109157|P1|NOT COMPLETED|Overall Study||2
47410|NCT01549041|109156|P2|COMPLETED|Overall Study||10
47411|NCT01549041|109157|P1|COMPLETED|Overall Study||10
47412|NCT01549041|109156|P2|STARTED|Overall Study||18
47413|NCT01549041|109157|P1|STARTED|Overall Study||12
47414|NCT01549002|109167|P2|NOT COMPLETED|Overall Study||4
47415|NCT01549002|109168|P1|NOT COMPLETED|Overall Study||0
47416|NCT01549002|109167|P2|COMPLETED|Overall Study||6
47417|NCT01549002|109168|P1|COMPLETED|Overall Study||10
47418|NCT01549002|109167|P2|STARTED|Overall Study||10
47419|NCT01549002|109168|P1|STARTED|Overall Study||10
47420|NCT01548885|109174|P1|NOT COMPLETED|Overall Study||0
47421|NCT01548885|109174|P1|COMPLETED|Overall Study||146
47422|NCT01548885|109174|P1|STARTED|Overall Study||146
47423|NCT01548833|109179|P1|NOT COMPLETED|Overall Study||0
47424|NCT01548833|109179|P1|COMPLETED|Overall Study||39
47425|NCT01548833|109179|P1|STARTED|Overall Study||39
47426|NCT01548742|109189|P2|NOT COMPLETED|Overall Study||4
47427|NCT01548742|109190|P1|NOT COMPLETED|Overall Study||13
47428|NCT01548742|109189|P2|COMPLETED|Overall Study||54
47429|NCT01548742|109190|P1|COMPLETED|Overall Study||45
47430|NCT01548742|109189|P2|STARTED|Overall Study||58
47431|NCT01548742|109190|P1|STARTED|Overall Study||58
47432|NCT01548638|109204|P1|NOT COMPLETED|Overall Study||4
47433|NCT01548638|109204|P1|COMPLETED|Overall Study||9
47434|NCT01548638|109204|P1|STARTED|Overall Study||13
47435|NCT01548417|109213|P2|NOT COMPLETED|Overall Study||2
47436|NCT01548417|109214|P1|NOT COMPLETED|Overall Study||0
47437|NCT01548417|109213|P2|COMPLETED|Overall Study||26
47438|NCT01548417|109214|P1|COMPLETED|Overall Study||28
47439|NCT01548417|109213|P2|STARTED|Overall Study||28
47440|NCT01548417|109214|P1|STARTED|Overall Study||28
47441|NCT01548287|109226|P5|NOT COMPLETED|Randomized Period||0
47442|NCT01548287|109227|P4|NOT COMPLETED|Randomized Period||0
47443|NCT01548287|109228|P3|NOT COMPLETED|Randomized Period||7
47444|NCT01548287|109229|P2|NOT COMPLETED|Randomized Period||2
47445|NCT01548287|109230|P1|NOT COMPLETED|Randomized Period||0
47446|NCT01548287|109226|P5|COMPLETED|Randomized Period||0
47447|NCT01548287|109227|P4|COMPLETED|Randomized Period||20
47448|NCT01548287|109228|P3|COMPLETED|Randomized Period||13
47449|NCT01548287|109229|P2|COMPLETED|Randomized Period||20
47450|NCT01548287|109230|P1|COMPLETED|Randomized Period||19
47451|NCT01548287|109226|P5|STARTED|Randomized Period||0
47452|NCT01548287|109227|P4|STARTED|Randomized Period||20
47453|NCT01548287|109228|P3|STARTED|Randomized Period||20
47454|NCT01548287|109229|P2|STARTED|Randomized Period||22
47455|NCT01548287|109230|P1|STARTED|Randomized Period||19
47456|NCT01548287|109226|P5|NOT COMPLETED|Screening||83
47457|NCT01548287|109227|P4|NOT COMPLETED|Screening||0
47458|NCT01548287|109228|P3|NOT COMPLETED|Screening||0
47459|NCT01548287|109229|P2|NOT COMPLETED|Screening||0
47460|NCT01548287|109230|P1|NOT COMPLETED|Screening||0
47461|NCT01548287|109226|P5|COMPLETED|Screening||0
47462|NCT01548287|109227|P4|COMPLETED|Screening||20
47463|NCT01548287|109228|P3|COMPLETED|Screening||20
47464|NCT01548287|109229|P2|COMPLETED|Screening||22
47465|NCT01548287|109230|P1|COMPLETED|Screening||19
47466|NCT01548287|109226|P5|STARTED|Screening||83
47467|NCT01548287|109227|P4|STARTED|Screening||20
47468|NCT01548287|109228|P3|STARTED|Screening||20
47469|NCT01548287|109229|P2|STARTED|Screening||22
47470|NCT01548287|109230|P1|STARTED|Screening||19
47471|NCT01547728|109260|P1|NOT COMPLETED|Overall Study||41
47472|NCT01547728|109260|P1|COMPLETED|Overall Study||1
47473|NCT01547728|109260|P1|STARTED|Overall Study||42
47474|NCT01547715|109267|P3|NOT COMPLETED|Overall Study||0
47475|NCT01547715|109268|P2|NOT COMPLETED|Overall Study||0
47476|NCT01547715|109269|P1|NOT COMPLETED|Overall Study||0
47477|NCT01547715|109267|P3|COMPLETED|Overall Study||60
47478|NCT01547715|109268|P2|COMPLETED|Overall Study||60
47479|NCT01547715|109269|P1|COMPLETED|Overall Study||60
47480|NCT01547715|109267|P3|STARTED|Overall Study||60
47481|NCT01547715|109268|P2|STARTED|Overall Study||60
47482|NCT01547715|109269|P1|STARTED|Overall Study||60
47483|NCT01547598|109369|P2|NOT COMPLETED|Overall Study||5
47484|NCT01547598|109370|P1|NOT COMPLETED|Overall Study||6
47485|NCT01547598|109369|P2|COMPLETED|Overall Study||63
47486|NCT01547598|109370|P1|COMPLETED|Overall Study||61
47487|NCT01547598|109369|P2|STARTED|Overall Study||68
47488|NCT01547598|109370|P1|STARTED|Overall Study||67
47489|NCT01547299|109387|P2|NOT COMPLETED|Overall Study||2
47490|NCT01547299|109388|P1|NOT COMPLETED|Overall Study||2
47491|NCT01547299|109387|P2|COMPLETED|Overall Study||25
47492|NCT01547299|109388|P1|COMPLETED|Overall Study||23
47493|NCT01547299|109387|P2|STARTED|Overall Study||27
47494|NCT01547299|109388|P1|STARTED|Overall Study||25
47495|NCT01547247|109450|P2|NOT COMPLETED|Overall Study||6
47496|NCT01547247|109451|P1|NOT COMPLETED|Overall Study||6
47497|NCT01547247|109450|P2|COMPLETED|Overall Study||98
47498|NCT01547247|109451|P1|COMPLETED|Overall Study||98
47499|NCT01547247|109450|P2|STARTED|Overall Study||104
47500|NCT01547247|109451|P1|STARTED|Overall Study||104
47501|NCT01547130|109461|P2|NOT COMPLETED|Overall Study||5
47502|NCT01547130|109462|P1|NOT COMPLETED|Overall Study||9
47503|NCT01547130|109461|P2|COMPLETED|Overall Study||68
47504|NCT01547130|109462|P1|COMPLETED|Overall Study||65
47505|NCT01547130|109461|P2|STARTED|Overall Study||73
47506|NCT01547130|109462|P1|STARTED|Overall Study||74
47507|NCT01546922|109476|P2|NOT COMPLETED|Second Period of 10 Weeks||3
47508|NCT01546922|109477|P1|NOT COMPLETED|Second Period of 10 Weeks||3
47509|NCT01546922|109476|P2|COMPLETED|Second Period of 10 Weeks||25
47510|NCT01546922|109477|P1|COMPLETED|Second Period of 10 Weeks||22
47511|NCT01546922|109476|P2|STARTED|Second Period of 10 Weeks||28
47512|NCT01546922|109477|P1|STARTED|Second Period of 10 Weeks||25
47513|NCT01546922|109476|P2|NOT COMPLETED|First Period of 10 Weeks||2
47514|NCT01546922|109477|P1|NOT COMPLETED|First Period of 10 Weeks||5
47515|NCT01546922|109476|P2|COMPLETED|First Period of 10 Weeks||28
47516|NCT01546922|109477|P1|COMPLETED|First Period of 10 Weeks||25
47517|NCT01546922|109476|P2|STARTED|First Period of 10 Weeks||30
47518|NCT01546922|109477|P1|STARTED|First Period of 10 Weeks||30
47519|NCT01546883|109483|P1|NOT COMPLETED|Overall Study||12
47520|NCT01546883|109483|P1|COMPLETED|Overall Study||2
47521|NCT01546883|109483|P1|STARTED|Overall Study||14
47522|NCT01546688|109489|P2|NOT COMPLETED|Overall Study||5
47523|NCT01546688|109490|P1|NOT COMPLETED|Overall Study||3
47524|NCT01546688|109489|P2|COMPLETED|Overall Study||28
47525|NCT01546688|109490|P1|COMPLETED|Overall Study||15
47526|NCT01546688|109489|P2|STARTED|Overall Study||33
47527|NCT01546688|109490|P1|STARTED|Overall Study||18
47528|NCT01546675|109504|P2|NOT COMPLETED|Overall Study||0
47529|NCT01546675|109505|P1|NOT COMPLETED|Overall Study||0
47530|NCT01546675|109504|P2|COMPLETED|Overall Study||1
47531|NCT01546675|109505|P1|COMPLETED|Overall Study||1
47532|NCT01546675|109504|P2|STARTED|Overall Study||1
47533|NCT01546675|109505|P1|STARTED|Overall Study||1
47534|NCT01546649|109522|P2|NOT COMPLETED|Overall Study||9
47535|NCT01546649|109523|P1|NOT COMPLETED|Overall Study||8
47536|NCT01546649|109522|P2|COMPLETED|Overall Study||75
47537|NCT01546649|109523|P1|COMPLETED|Overall Study||75
47538|NCT01546649|109522|P2|STARTED|Overall Study||84
47539|NCT01546649|109523|P1|STARTED|Overall Study||83
47540|NCT01546636|109545|P2|NOT COMPLETED|Overall Study||0
47541|NCT01546636|109546|P1|NOT COMPLETED|Overall Study||0
47542|NCT01546636|109545|P2|COMPLETED|Overall Study||34
47543|NCT01546636|109546|P1|COMPLETED|Overall Study||36
47544|NCT01546636|109545|P2|STARTED|Overall Study||34
47545|NCT01546636|109546|P1|STARTED|Overall Study||36
47546|NCT01546623|109558|P2|NOT COMPLETED|Overall Study||6
47547|NCT01546623|109559|P1|NOT COMPLETED|Overall Study||6
47548|NCT01546623|109558|P2|COMPLETED|Overall Study||74
47549|NCT01546623|109559|P1|COMPLETED|Overall Study||76
47550|NCT01546623|109558|P2|Received Study Drug|Overall Study||79
47551|NCT01546623|109559|P1|Received Study Drug|Overall Study||81
47552|NCT01546623|109558|P2|STARTED|Overall Study||80
47553|NCT01546623|109559|P1|STARTED|Overall Study||82
47554|NCT01546519|109589|P4|NOT COMPLETED|Overall Study||6
47555|NCT01546519|109590|P3|NOT COMPLETED|Overall Study||8
47556|NCT01546519|109591|P2|NOT COMPLETED|Overall Study||8
47557|NCT01546519|109592|P1|NOT COMPLETED|Overall Study||9
47558|NCT01546519|109589|P4|COMPLETED|Overall Study||0
47559|NCT01546519|109590|P3|COMPLETED|Overall Study||0
47560|NCT01546519|109591|P2|COMPLETED|Overall Study||0
47561|NCT01546519|109592|P1|COMPLETED|Overall Study||0
47562|NCT01546519|109589|P4|Safety-Evaluable Participants|Overall Study||6
47563|NCT01546519|109590|P3|Safety-Evaluable Participants|Overall Study||8
47564|NCT01546519|109591|P2|Safety-Evaluable Participants|Overall Study||8
47565|NCT01546519|109592|P1|Safety-Evaluable Participants|Overall Study||9
47566|NCT01546519|109589|P4|STARTED|Overall Study||6
47567|NCT01546519|109590|P3|STARTED|Overall Study||8
47568|NCT01546519|109591|P2|STARTED|Overall Study||8
47569|NCT01546519|109592|P1|STARTED|Overall Study||9
47570|NCT01546454|109634|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
47571|NCT01546454|109634|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
47572|NCT01546454|109634|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
47573|NCT01546454|109634|P1|NOT COMPLETED|Eligard Treatment||0
47574|NCT01546454|109634|P1|COMPLETED|Eligard Treatment||4
47575|NCT01546454|109634|P1|STARTED|Eligard Treatment||4
47576|NCT01546454|109634|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
47577|NCT01546454|109634|P1|COMPLETED|Oral Contraceptive Cycle||4
47578|NCT01546454|109634|P1|STARTED|Oral Contraceptive Cycle||4
47579|NCT01546454|109634|P1|NOT COMPLETED|Natural Menstrual Cycle||0
47580|NCT01546454|109634|P1|COMPLETED|Natural Menstrual Cycle||4
47581|NCT01546454|109634|P1|STARTED|Natural Menstrual Cycle||4
47582|NCT01546402|109642|P2|NOT COMPLETED|Overall Study||0
47583|NCT01546402|109643|P1|NOT COMPLETED|Overall Study||0
47584|NCT01546402|109642|P2|COMPLETED|Overall Study||10
47585|NCT01546402|109643|P1|COMPLETED|Overall Study||10
47586|NCT01546402|109642|P2|STARTED|Overall Study||10
47587|NCT01546402|109643|P1|STARTED|Overall Study||10
47588|NCT01546285|109651|P1|NOT COMPLETED|Overall Study||0
47589|NCT01546285|109651|P1|COMPLETED|Overall Study||66
47590|NCT01546285|109651|P1|STARTED|Overall Study||66
47591|NCT01546207|109657|P1|NOT COMPLETED|Overall Study||1
47592|NCT01546207|109657|P1|COMPLETED|Overall Study||3
47593|NCT01546207|109657|P1|STARTED|Overall Study||4
47594|NCT01546194|109663|P2|NOT COMPLETED|Overall Study||35
47595|NCT01546194|109664|P1|NOT COMPLETED|Overall Study||36
47596|NCT01546194|109663|P2|COMPLETED|Overall Study||65
47597|NCT01546194|109664|P1|COMPLETED|Overall Study||64
47598|NCT01546194|109663|P2|STARTED|Overall Study||100
47599|NCT01546194|109664|P1|STARTED|Overall Study||100
47600|NCT01546142|109672|P2|NOT COMPLETED|Overall Study||34
47601|NCT01546142|109673|P1|NOT COMPLETED|Overall Study||44
47602|NCT01546142|109672|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
47697|NCT01544998|109917|P2|COMPLETED|Washout (1 Week)||15
47603|NCT01546142|109673|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
47604|NCT01546142|109672|P2|Received Treatment|Overall Study||257
47605|NCT01546142|109673|P1|Received Treatment|Overall Study||257
47606|NCT01546142|109672|P2|STARTED|Overall Study||258
47607|NCT01546142|109673|P1|STARTED|Overall Study||258
47608|NCT01545843|109688|P3|NOT COMPLETED|Overall Study||4
47609|NCT01545843|109689|P2|NOT COMPLETED|Overall Study||7
47610|NCT01545843|109690|P1|NOT COMPLETED|Overall Study||3
47611|NCT01545843|109688|P3|COMPLETED|Overall Study||21
47612|NCT01545843|109689|P2|COMPLETED|Overall Study||17
47613|NCT01545843|109690|P1|COMPLETED|Overall Study||16
47614|NCT01545843|109688|P3|STARTED|Overall Study||25
47615|NCT01545843|109689|P2|STARTED|Overall Study||24
47616|NCT01545843|109690|P1|STARTED|Overall Study||19
47617|NCT01545765|109701|P1|NOT COMPLETED|Overall Study||0
47618|NCT01545765|109701|P1|COMPLETED|Overall Study||31
47619|NCT01545765|109701|P1|STARTED|Overall Study||31
47620|NCT01545700|109718|P6|NOT COMPLETED|Overall Study||0
47621|NCT01545700|109719|P5|NOT COMPLETED|Overall Study||1
47622|NCT01545700|109720|P4|NOT COMPLETED|Overall Study||0
47623|NCT01545700|109721|P3|NOT COMPLETED|Overall Study||2
47624|NCT01545700|109722|P2|NOT COMPLETED|Overall Study||1
47625|NCT01545700|109723|P1|NOT COMPLETED|Overall Study||1
47626|NCT01545700|109718|P6|COMPLETED|Overall Study||33
47627|NCT01545700|109719|P5|COMPLETED|Overall Study||32
47628|NCT01545700|109720|P4|COMPLETED|Overall Study||34
47629|NCT01545700|109721|P3|COMPLETED|Overall Study||31
47630|NCT01545700|109722|P2|COMPLETED|Overall Study||32
47631|NCT01545700|109723|P1|COMPLETED|Overall Study||33
47632|NCT01545700|109718|P6|STARTED|Overall Study||33
47633|NCT01545700|109719|P5|STARTED|Overall Study||33
47634|NCT01545700|109720|P4|STARTED|Overall Study||34
47635|NCT01545700|109721|P3|STARTED|Overall Study||33
47636|NCT01545700|109722|P2|STARTED|Overall Study||33
47637|NCT01545700|109723|P1|STARTED|Overall Study||34
47638|NCT01545518|109757|P1|NOT COMPLETED|Overall Study||0
47639|NCT01545518|109757|P1|COMPLETED|Overall Study||20
47640|NCT01545518|109757|P1|STARTED|Overall Study||20
47641|NCT01545388|109764|P3|NOT COMPLETED|Overall Study||8
47642|NCT01545388|109765|P2|NOT COMPLETED|Overall Study||11
47643|NCT01545388|109766|P1|NOT COMPLETED|Overall Study||8
47644|NCT01545388|109764|P3|COMPLETED|Overall Study||58
47645|NCT01545388|109765|P2|COMPLETED|Overall Study||122
47646|NCT01545388|109766|P1|COMPLETED|Overall Study||130
47647|NCT01545388|109764|P3|STARTED|Overall Study||66
47648|NCT01545388|109765|P2|STARTED|Overall Study||133
47649|NCT01545388|109766|P1|STARTED|Overall Study||138
47650|NCT01545336|109785|P2|NOT COMPLETED|Overall Study||0
47651|NCT01545336|109786|P1|NOT COMPLETED|Overall Study||0
47652|NCT01545336|109785|P2|COMPLETED|Overall Study||6
47653|NCT01545336|109786|P1|COMPLETED|Overall Study||12
47654|NCT01545336|109785|P2|STARTED|Overall Study||6
47655|NCT01545336|109786|P1|STARTED|Overall Study||12
47656|NCT01545232|109798|P2|NOT COMPLETED|Overall Study||0
47657|NCT01545232|109799|P1|NOT COMPLETED|Overall Study||0
47658|NCT01545232|109798|P2|COMPLETED|Overall Study||342
47659|NCT01545232|109799|P1|COMPLETED|Overall Study||338
47660|NCT01545232|109798|P2|STARTED|Overall Study||342
47661|NCT01545232|109799|P1|STARTED|Overall Study||338
47662|NCT01545193|109829|P2|NOT COMPLETED|Overall Study||1
47663|NCT01545193|109830|P1|NOT COMPLETED|Overall Study||0
47664|NCT01545193|109829|P2|COMPLETED|Overall Study||149
47665|NCT01545193|109830|P1|COMPLETED|Overall Study||150
47666|NCT01545193|109829|P2|STARTED|Overall Study||150
47667|NCT01545193|109830|P1|STARTED|Overall Study||150
47668|NCT01544153|109846|P4|NOT COMPLETED|Overall Study||0
47669|NCT01544153|109847|P3|NOT COMPLETED|Overall Study||1
47670|NCT01544153|109848|P2|NOT COMPLETED|Overall Study||1
47671|NCT01544153|109849|P1|NOT COMPLETED|Overall Study||0
47672|NCT01544153|109846|P4|COMPLETED|Overall Study||1317
47673|NCT01544153|109847|P3|COMPLETED|Overall Study||1313
47674|NCT01544153|109848|P2|COMPLETED|Overall Study||1323
47675|NCT01544153|109849|P1|COMPLETED|Overall Study||1337
47676|NCT01544153|109846|P4|STARTED|Overall Study||1317
47677|NCT01544153|109847|P3|STARTED|Overall Study||1314
47678|NCT01544153|109848|P2|STARTED|Overall Study||1324
47679|NCT01544153|109849|P1|STARTED|Overall Study||1337
47680|NCT01544062|109865|P2|NOT COMPLETED|Overall Study||0
47681|NCT01544062|109866|P1|NOT COMPLETED|Overall Study||0
47682|NCT01544062|109865|P2|COMPLETED|Overall Study||35
47683|NCT01544062|109866|P1|COMPLETED|Overall Study||33
47684|NCT01544062|109865|P2|STARTED|Overall Study||35
47685|NCT01544062|109866|P1|STARTED|Overall Study||33
47686|NCT01544023|109912|P1|NOT COMPLETED|Overall Study||0
47687|NCT01544023|109912|P1|COMPLETED|Overall Study||207
47688|NCT01544023|109912|P1|STARTED|Overall Study|retrospective|207
47689|NCT01544998|109917|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
47690|NCT01544998|109918|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
47691|NCT01544998|109917|P2|COMPLETED|Second Intervention (3 Hours)||15
47692|NCT01544998|109918|P1|COMPLETED|Second Intervention (3 Hours)||26
47693|NCT01544998|109917|P2|STARTED|Second Intervention (3 Hours)||15
47694|NCT01544998|109918|P1|STARTED|Second Intervention (3 Hours)||26
47695|NCT01544998|109917|P2|NOT COMPLETED|Washout (1 Week)||0
47696|NCT01544998|109918|P1|NOT COMPLETED|Washout (1 Week)||0
47698|NCT01544998|109918|P1|COMPLETED|Washout (1 Week)||26
47699|NCT01544998|109917|P2|STARTED|Washout (1 Week)||15
47700|NCT01544998|109918|P1|STARTED|Washout (1 Week)||26
47701|NCT01544998|109917|P2|NOT COMPLETED|First Intervention (3 Hours)||0
47702|NCT01544998|109918|P1|NOT COMPLETED|First Intervention (3 Hours)||0
47703|NCT01544998|109917|P2|COMPLETED|First Intervention (3 Hours)||15
47704|NCT01544998|109918|P1|COMPLETED|First Intervention (3 Hours)||26
47705|NCT01544998|109917|P2|STARTED|First Intervention (3 Hours)||15
47706|NCT01544998|109918|P1|STARTED|First Intervention (3 Hours)||26
47707|NCT01544920|109930|P2|NOT COMPLETED|Overall Study||23
47708|NCT01544920|109931|P1|NOT COMPLETED|Overall Study||19
47709|NCT01544920|109930|P2|COMPLETED|Overall Study||346
47710|NCT01544920|109931|P1|COMPLETED|Overall Study||349
47711|NCT01544920|109930|P2|STARTED|Overall Study||369
47712|NCT01544920|109931|P1|STARTED|Overall Study||368
47713|NCT01544582|109942|P4|NOT COMPLETED|Analysis Population||39
47714|NCT01544582|109943|P3|NOT COMPLETED|Analysis Population||102
47715|NCT01544582|109944|P2|NOT COMPLETED|Analysis Population||118
47716|NCT01544582|109945|P1|NOT COMPLETED|Analysis Population||0
47717|NCT01544582|109942|P4|COMPLETED|Analysis Population||35
47718|NCT01544582|109943|P3|COMPLETED|Analysis Population||205
47719|NCT01544582|109944|P2|COMPLETED|Analysis Population||180
47720|NCT01544582|109945|P1|COMPLETED|Analysis Population||0
47721|NCT01544582|109942|P4|STARTED|Analysis Population||74
47722|NCT01544582|109943|P3|STARTED|Analysis Population||307
47723|NCT01544582|109944|P2|STARTED|Analysis Population||298
47724|NCT01544582|109945|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
47725|NCT01544582|109942|P4|NOT COMPLETED|Screening/Eligibility||0
47726|NCT01544582|109943|P3|NOT COMPLETED|Screening/Eligibility||0
47727|NCT01544582|109944|P2|NOT COMPLETED|Screening/Eligibility||0
47728|NCT01544582|109945|P1|NOT COMPLETED|Screening/Eligibility||34
47729|NCT01544582|109942|P4|COMPLETED|Screening/Eligibility||0
47730|NCT01544582|109943|P3|COMPLETED|Screening/Eligibility||0
47731|NCT01544582|109944|P2|COMPLETED|Screening/Eligibility||0
47732|NCT01544582|109945|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
47733|NCT01544582|109942|P4|Analysis Population|Screening/Eligibility||0
47734|NCT01544582|109943|P3|Analysis Population|Screening/Eligibility||0
47735|NCT01544582|109944|P2|Analysis Population|Screening/Eligibility||0
47736|NCT01544582|109945|P1|Analysis Population|Screening/Eligibility||679
47737|NCT01544582|109942|P4|STARTED|Screening/Eligibility||0
47738|NCT01544582|109943|P3|STARTED|Screening/Eligibility||0
47739|NCT01544582|109944|P2|STARTED|Screening/Eligibility||0
47740|NCT01544582|109945|P1|STARTED|Screening/Eligibility||713
47741|NCT01544361|110008|P5|NOT COMPLETED|Overall Study||0
47742|NCT01544361|110009|P4|NOT COMPLETED|Overall Study||0
47743|NCT01544361|110010|P3|NOT COMPLETED|Overall Study||0
47744|NCT01544361|110011|P2|NOT COMPLETED|Overall Study||0
47745|NCT01544361|110012|P1|NOT COMPLETED|Overall Study||0
47746|NCT01544361|110008|P5|COMPLETED|Overall Study||6
47747|NCT01544361|110009|P4|COMPLETED|Overall Study||6
47748|NCT01544361|110010|P3|COMPLETED|Overall Study||6
47749|NCT01544361|110011|P2|COMPLETED|Overall Study||6
47750|NCT01544361|110012|P1|COMPLETED|Overall Study||8
47751|NCT01544361|110008|P5|STARTED|Overall Study||6
47752|NCT01544361|110009|P4|STARTED|Overall Study||6
47753|NCT01544361|110010|P3|STARTED|Overall Study||6
47754|NCT01544361|110011|P2|STARTED|Overall Study||6
47755|NCT01544361|110012|P1|STARTED|Overall Study||8
47756|NCT01544348|110042|P8|NOT COMPLETED|Overall Study||0
47757|NCT01544348|110043|P7|NOT COMPLETED|Overall Study||2
47758|NCT01544348|110044|P6|NOT COMPLETED|Overall Study||3
47759|NCT01544348|110045|P5|NOT COMPLETED|Overall Study||1
47760|NCT01544348|110046|P4|NOT COMPLETED|Overall Study||0
47761|NCT01544348|110047|P3|NOT COMPLETED|Overall Study||0
47762|NCT01544348|110048|P2|NOT COMPLETED|Overall Study||0
47763|NCT01544348|110049|P1|NOT COMPLETED|Overall Study||2
47764|NCT01544348|110042|P8|COMPLETED|Overall Study||8
47765|NCT01544348|110043|P7|COMPLETED|Overall Study||12
47766|NCT01544348|110044|P6|COMPLETED|Overall Study||16
47767|NCT01544348|110045|P5|COMPLETED|Overall Study||15
47768|NCT01544348|110046|P4|COMPLETED|Overall Study||3
47769|NCT01544348|110047|P3|COMPLETED|Overall Study||3
47770|NCT01544348|110048|P2|COMPLETED|Overall Study||6
47771|NCT01544348|110049|P1|COMPLETED|Overall Study||15
47772|NCT01544348|110042|P8|Treated|Overall Study||8
47773|NCT01544348|110043|P7|Treated|Overall Study||14
47774|NCT01544348|110044|P6|Treated|Overall Study||18
47775|NCT01544348|110045|P5|Treated|Overall Study||15
47776|NCT01544348|110046|P4|Treated|Overall Study||3
47777|NCT01544348|110047|P3|Treated|Overall Study||3
47778|NCT01544348|110048|P2|Treated|Overall Study||6
47779|NCT01544348|110049|P1|Treated|Overall Study||17
47780|NCT01544348|110042|P8|STARTED|Overall Study||8
47781|NCT01544348|110043|P7|STARTED|Overall Study||14
47782|NCT01544348|110044|P6|STARTED|Overall Study||19
47783|NCT01544348|110045|P5|STARTED|Overall Study||16
47784|NCT01544348|110046|P4|STARTED|Overall Study||3
47785|NCT01544348|110047|P3|STARTED|Overall Study||3
47786|NCT01544348|110048|P2|STARTED|Overall Study||6
47787|NCT01544348|110049|P1|STARTED|Overall Study||17
47788|NCT01544309|110091|P2|NOT COMPLETED|Overall Study||11
47789|NCT01544309|110092|P1|NOT COMPLETED|Overall Study||20
47790|NCT01544309|110091|P2|COMPLETED|Overall Study||514
47791|NCT01544309|110092|P1|COMPLETED|Overall Study||504
47792|NCT01544309|110091|P2|STARTED|Overall Study||525
47793|NCT01544309|110092|P1|STARTED|Overall Study||524
47794|NCT01544179|110130|P2|NOT COMPLETED|Overall Study||46
47795|NCT01544179|110131|P1|NOT COMPLETED|Overall Study||63
47796|NCT01544179|110130|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
47797|NCT01544179|110131|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
47798|NCT01544179|110130|P2|Did Not Receive Treatment|Overall Study||0
47799|NCT01544179|110131|P1|Did Not Receive Treatment|Overall Study||1
47800|NCT01544179|110130|P2|Received Treatment|Overall Study||132
47801|NCT01544179|110131|P1|Received Treatment|Overall Study||132
47802|NCT01544179|110130|P2|STARTED|Overall Study||132
47803|NCT01544179|110131|P1|STARTED|Overall Study||133
47804|NCT01544166|110159|P1|NOT COMPLETED|Overall Study||0
47805|NCT01544166|110159|P1|COMPLETED|Overall Study||44
47806|NCT01544166|110159|P1|STARTED|Overall Study||44
47807|NCT01543958|110220|P1|NOT COMPLETED|Overall Study||4
47808|NCT01543958|110220|P1|COMPLETED|Overall Study||36
47809|NCT01543958|110220|P1|STARTED|Overall Study||40
47810|NCT01543828|110275|P2|NOT COMPLETED|Treatment 2||0
47811|NCT01543828|110276|P1|NOT COMPLETED|Treatment 2||1
47812|NCT01543828|110275|P2|COMPLETED|Treatment 2||19
47813|NCT01543828|110276|P1|COMPLETED|Treatment 2||19
47814|NCT01543828|110275|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
47815|NCT01543828|110276|P1|STARTED|Treatment 2||20
47816|NCT01543828|110275|P2|NOT COMPLETED|Treatment 1||0
47817|NCT01543828|110276|P1|NOT COMPLETED|Treatment 1||0
47818|NCT01543828|110275|P2|COMPLETED|Treatment 1||20
47819|NCT01543828|110276|P1|COMPLETED|Treatment 1||20
47820|NCT01543828|110275|P2|STARTED|Treatment 1||20
47821|NCT01543828|110276|P1|STARTED|Treatment 1||20
47822|NCT01543685|110289|P5|NOT COMPLETED|Overall Study||4
47823|NCT01543685|110290|P4|NOT COMPLETED|Overall Study||0
47824|NCT01543685|110291|P3|NOT COMPLETED|Overall Study||2
47825|NCT01543685|110292|P2|NOT COMPLETED|Overall Study||3
47826|NCT01543685|110293|P1|NOT COMPLETED|Overall Study||3
47827|NCT01543685|110289|P5|COMPLETED|Overall Study||90
47828|NCT01543685|110290|P4|COMPLETED|Overall Study||93
47829|NCT01543685|110291|P3|COMPLETED|Overall Study||89
47830|NCT01543685|110292|P2|COMPLETED|Overall Study||88
47831|NCT01543685|110293|P1|COMPLETED|Overall Study||90
47832|NCT01543685|110289|P5|STARTED|Overall Study||94
47833|NCT01543685|110290|P4|STARTED|Overall Study||93
47834|NCT01543685|110291|P3|STARTED|Overall Study||91
47835|NCT01543685|110292|P2|STARTED|Overall Study||91
47836|NCT01543685|110293|P1|STARTED|Overall Study||93
47837|NCT01543581|110340|P2|NOT COMPLETED|Overall Study||0
47838|NCT01543581|110341|P1|NOT COMPLETED|Overall Study||0
47839|NCT01543581|110340|P2|COMPLETED|Overall Study||0
47840|NCT01543581|110341|P1|COMPLETED|Overall Study||1
47841|NCT01543581|110340|P2|STARTED|Overall Study||0
47842|NCT01543581|110341|P1|STARTED|Overall Study||1
47843|NCT01543568|110347|P1|NOT COMPLETED|Overall Study||1
47844|NCT01543568|110347|P1|COMPLETED|Overall Study||45
47845|NCT01543568|110347|P1|STARTED|Overall Study||46
47846|NCT01543503|110359|P2|NOT COMPLETED|Overall Study||87
47847|NCT01543503|110360|P1|NOT COMPLETED|Overall Study||76
47848|NCT01543503|110359|P2|COMPLETED|Overall Study||711
47849|NCT01543503|110360|P1|COMPLETED|Overall Study||350
47850|NCT01543503|110359|P2|STARTED|Overall Study||798
47851|NCT01543503|110360|P1|STARTED|Overall Study||426
47852|NCT01543204|110404|P1|NOT COMPLETED|Overall Study||8
47853|NCT01543204|110404|P1|COMPLETED|Overall Study||56
47854|NCT01543204|110404|P1|STARTED|Overall Study||64
47855|NCT01543178|110451|P3|NOT COMPLETED|Double-blind Period||37
47856|NCT01543178|110452|P2|NOT COMPLETED|Double-blind Period||44
47857|NCT01543178|110453|P1|NOT COMPLETED|Double-blind Period||0
47858|NCT01543178|110451|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
47859|NCT01543178|110452|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
47860|NCT01543178|110453|P1|COMPLETED|Double-blind Period||0
47861|NCT01543178|110451|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
47862|NCT01543178|110452|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
47863|NCT01543178|110453|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
47864|NCT01543178|110451|P3|NOT COMPLETED|Open-label Period||0
47865|NCT01543178|110452|P2|NOT COMPLETED|Open-label Period||0
47866|NCT01543178|110453|P1|NOT COMPLETED|Open-label Period||1947
47867|NCT01543178|110451|P3|COMPLETED|Open-label Period||0
47868|NCT01543178|110452|P2|COMPLETED|Open-label Period||0
47869|NCT01543178|110453|P1|COMPLETED|Open-label Period||636
47870|NCT01543178|110451|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
47871|NCT01543178|110452|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
47872|NCT01543178|110453|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
47873|NCT01543074|110464|P4|NOT COMPLETED|Overall Study||0
47874|NCT01543074|110465|P3|NOT COMPLETED|Overall Study||0
47875|NCT01543074|110466|P2|NOT COMPLETED|Overall Study||0
47876|NCT01543074|110467|P1|NOT COMPLETED|Overall Study||0
47877|NCT01543074|110464|P4|COMPLETED|Overall Study||6
47878|NCT01543074|110465|P3|COMPLETED|Overall Study||5
47879|NCT01543074|110466|P2|COMPLETED|Overall Study||7
47880|NCT01543074|110467|P1|COMPLETED|Overall Study||5
47881|NCT01543074|110464|P4|STARTED|Overall Study||6
47882|NCT01543074|110465|P3|STARTED|Overall Study||5
47883|NCT01543074|110466|P2|STARTED|Overall Study||7
47884|NCT01543074|110467|P1|STARTED|Overall Study||5
47885|NCT01542957|110483|P2|NOT COMPLETED|Overall Study||10
47886|NCT01542957|110484|P1|NOT COMPLETED|Overall Study||12
47887|NCT01542957|110483|P2|COMPLETED|Overall Study||53
47888|NCT01542957|110484|P1|COMPLETED|Overall Study||53
47889|NCT01542957|110483|P2|STARTED|Overall Study||63
47890|NCT01542957|110484|P1|STARTED|Overall Study||65
47891|NCT01542788|110494|P2|NOT COMPLETED|Overall Study||71
47892|NCT01542788|110495|P1|NOT COMPLETED|Overall Study||55
47893|NCT01542788|110494|P2|COMPLETED|Overall Study||0
47894|NCT01542788|110495|P1|COMPLETED|Overall Study||154
47895|NCT01542788|110494|P2|Randomized and Treated|Overall Study||71
47896|NCT01542788|110495|P1|Randomized and Treated|Overall Study||207
47897|NCT01542788|110494|P2|STARTED|Overall Study||71
47898|NCT01542788|110495|P1|STARTED|Overall Study||209
47899|NCT01542684|110511|P1|NOT COMPLETED|Overall Study||0
47900|NCT01542684|110511|P1|COMPLETED|Overall Study||8
47901|NCT01542684|110511|P1|STARTED|Overall Study||8
47902|NCT01542645|110517|P2|NOT COMPLETED|Overall Study||3
47903|NCT01542645|110518|P1|NOT COMPLETED|Overall Study||5
47904|NCT01542645|110517|P2|COMPLETED|Overall Study||79
47905|NCT01542645|110518|P1|COMPLETED|Overall Study||77
47906|NCT01542645|110517|P2|STARTED|Overall Study||82
47907|NCT01542645|110518|P1|STARTED|Overall Study||82
47908|NCT01542632|110534|P6|NOT COMPLETED|Overall Study||0
47909|NCT01542632|110535|P5|NOT COMPLETED|Overall Study||4
47910|NCT01542632|110536|P4|NOT COMPLETED|Overall Study||2
47911|NCT01542632|110537|P3|NOT COMPLETED|Overall Study||1
47912|NCT01542632|110538|P2|NOT COMPLETED|Overall Study||1
47913|NCT01542632|110539|P1|NOT COMPLETED|Overall Study||0
47914|NCT01542632|110534|P6|COMPLETED|Overall Study||24
47915|NCT01542632|110535|P5|COMPLETED|Overall Study||17
47916|NCT01542632|110536|P4|COMPLETED|Overall Study||19
47917|NCT01542632|110537|P3|COMPLETED|Overall Study||23
47918|NCT01542632|110538|P2|COMPLETED|Overall Study||24
47919|NCT01542632|110539|P1|COMPLETED|Overall Study||25
47920|NCT01542632|110534|P6|STARTED|Overall Study||24
47921|NCT01542632|110535|P5|STARTED|Overall Study||21
47922|NCT01542632|110536|P4|STARTED|Overall Study||21
47923|NCT01542632|110537|P3|STARTED|Overall Study||24
47924|NCT01542632|110538|P2|STARTED|Overall Study||25
47925|NCT01542632|110539|P1|STARTED|Overall Study||25
47926|NCT01542541|110585|P2|NOT COMPLETED|Overall Study||0
47927|NCT01542541|110586|P1|NOT COMPLETED|Overall Study||8
47928|NCT01542541|110585|P2|COMPLETED|Overall Study||30
47929|NCT01542541|110586|P1|COMPLETED|Overall Study||30
47930|NCT01542541|110585|P2|STARTED|Overall Study||30
47931|NCT01542541|110586|P1|STARTED|Overall Study||38
47932|NCT01542502|110592|P2|NOT COMPLETED|Overall Study||0
47933|NCT01542502|110593|P1|NOT COMPLETED|Overall Study||0
47934|NCT01542502|110592|P2|COMPLETED|Overall Study||6
47935|NCT01542502|110593|P1|COMPLETED|Overall Study||6
47936|NCT01542502|110592|P2|STARTED|Overall Study||6
47937|NCT01542502|110593|P1|STARTED|Overall Study||6
47938|NCT01542255|110601|P1|NOT COMPLETED|Overall Study||0
47939|NCT01542255|110601|P1|COMPLETED|Overall Study||7
47940|NCT01542255|110601|P1|Analyzed for Time to Progression|Overall Study||7
47941|NCT01542255|110601|P1|STARTED|Overall Study||7
47942|NCT01542125|110607|P2|NOT COMPLETED|Overall Study||0
47943|NCT01542125|110608|P1|NOT COMPLETED|Overall Study||0
47944|NCT01542125|110607|P2|COMPLETED|Overall Study||141
47945|NCT01542125|110608|P1|COMPLETED|Overall Study||140
47946|NCT01542125|110607|P2|STARTED|Overall Study||141
47947|NCT01542125|110608|P1|STARTED|Overall Study||140
47948|NCT01542034|110616|P2|NOT COMPLETED|Overall Study||23
47949|NCT01542034|110617|P1|NOT COMPLETED|Overall Study||30
47950|NCT01542034|110616|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
47951|NCT01542034|110617|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
47952|NCT01542034|110616|P2|Received Treatment|Overall Study||249
47953|NCT01542034|110617|P1|Received Treatment|Overall Study||256
47954|NCT01542034|110616|P2|STARTED|Overall Study||250
47955|NCT01542034|110617|P1|STARTED|Overall Study||256
47956|NCT01541969|110631|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
47957|NCT01541969|110632|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
47958|NCT01541969|110631|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
47959|NCT01541969|110632|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
47960|NCT01541969|110631|P2|STARTED|Open Label Extension (12-36 Weeks)||48
47961|NCT01541969|110632|P1|STARTED|Open Label Extension (12-36 Weeks)||44
47962|NCT01541969|110631|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
47963|NCT01541969|110632|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
47964|NCT01541969|110631|P2|COMPLETED|Double-blind (0-12 Weeks)||48
47965|NCT01541969|110632|P1|COMPLETED|Double-blind (0-12 Weeks)||44
47966|NCT01541969|110631|P2|STARTED|Double-blind (0-12 Weeks)||50
47967|NCT01541969|110632|P1|STARTED|Double-blind (0-12 Weeks)||50
47968|NCT01541930|110648|P1|NOT COMPLETED|Overall Study||1
47969|NCT01541930|110648|P1|COMPLETED|Overall Study||20
47970|NCT01541930|110648|P1|STARTED|Overall Study||21
47971|NCT01541865|110667|P1|NOT COMPLETED|Overall Study||22
47972|NCT01541865|110667|P1|COMPLETED|Overall Study||124
47973|NCT01541865|110667|P1|STARTED|Overall Study||146
47974|NCT01541735|110684|P2|NOT COMPLETED|Overall Study||0
47975|NCT01541735|110685|P1|NOT COMPLETED|Overall Study||0
47976|NCT01541735|110684|P2|COMPLETED|Overall Study||7
47977|NCT01541735|110685|P1|COMPLETED|Overall Study||7
47978|NCT01541735|110684|P2|STARTED|Overall Study||7
47979|NCT01541735|110685|P1|STARTED|Overall Study||7
47980|NCT01541644|110697|P1|NOT COMPLETED|Overall Study||3
47981|NCT01541644|110697|P1|COMPLETED|Overall Study||24
47982|NCT01541644|110697|P1|STARTED|Overall Study||27
47983|NCT01541553|110703|P2|NOT COMPLETED|Overall Study||14
47984|NCT01541553|110704|P1|NOT COMPLETED|Overall Study||12
47985|NCT01541553|110703|P2|COMPLETED|Overall Study||148
47986|NCT01541553|110704|P1|COMPLETED|Overall Study||155
47987|NCT01541553|110703|P2|STARTED|Overall Study||162
47988|NCT01541553|110704|P1|STARTED|Overall Study||167
47989|NCT01541397|110716|P2|NOT COMPLETED|Overall Study||2
47990|NCT01541397|110717|P1|NOT COMPLETED|Overall Study||4
47991|NCT01541397|110716|P2|COMPLETED|Overall Study||0
47992|NCT01541397|110717|P1|COMPLETED|Overall Study||0
47993|NCT01541397|110716|P2|STARTED|Overall Study||2
47994|NCT01541397|110717|P1|STARTED|Overall Study||4
47995|NCT01541371|110729|P1|NOT COMPLETED|Overall Study||77
47996|NCT01541371|110729|P1|COMPLETED|Overall Study||326
47997|NCT01541371|110729|P1|Full Analysis Set|Overall Study||394
47998|NCT01541371|110729|P1|STARTED|Overall Study||403
47999|NCT01541254|110752|P1|NOT COMPLETED|Overall Study||6
48000|NCT01541254|110752|P1|COMPLETED|Overall Study||30
48001|NCT01541254|110752|P1|STARTED|Overall Study||36
48002|NCT01540981|110759|P2|NOT COMPLETED|Overall Study||0
48003|NCT01540981|110760|P1|NOT COMPLETED|Overall Study||1
48004|NCT01540981|110759|P2|COMPLETED|Overall Study||6
48005|NCT01540981|110760|P1|COMPLETED|Overall Study||5
48006|NCT01540981|110759|P2|STARTED|Overall Study||6
48007|NCT01540981|110760|P1|STARTED|Overall Study||6
48008|NCT01540851|110770|P2|NOT COMPLETED|Overall Study||18
48009|NCT01540851|110771|P1|NOT COMPLETED|Overall Study||21
48010|NCT01540851|110770|P2|COMPLETED|Overall Study||136
48011|NCT01540851|110771|P1|COMPLETED|Overall Study||133
48012|NCT01540851|110770|P2|STARTED|Overall Study||154
48013|NCT01540851|110771|P1|STARTED|Overall Study||154
48014|NCT01540825|110792|P11|NOT COMPLETED|Overall Study||0
48015|NCT01540825|110793|P10|NOT COMPLETED|Overall Study||0
48016|NCT01540825|110794|P9|NOT COMPLETED|Overall Study||0
48017|NCT01540825|110795|P8|NOT COMPLETED|Overall Study||0
48018|NCT01540825|110796|P7|NOT COMPLETED|Overall Study||0
48019|NCT01540825|110797|P6|NOT COMPLETED|Overall Study||0
48020|NCT01540825|110798|P5|NOT COMPLETED|Overall Study||0
48021|NCT01540825|110799|P4|NOT COMPLETED|Overall Study||0
48022|NCT01540825|110800|P3|NOT COMPLETED|Overall Study||0
48023|NCT01540825|110801|P2|NOT COMPLETED|Overall Study||0
48024|NCT01540825|110802|P1|NOT COMPLETED|Overall Study||0
48025|NCT01540825|110792|P11|COMPLETED|Overall Study||6
48026|NCT01540825|110793|P10|COMPLETED|Overall Study||6
48027|NCT01540825|110794|P9|COMPLETED|Overall Study||6
48028|NCT01540825|110795|P8|COMPLETED|Overall Study||6
48029|NCT01540825|110796|P7|COMPLETED|Overall Study||6
48030|NCT01540825|110797|P6|COMPLETED|Overall Study||6
48031|NCT01540825|110798|P5|COMPLETED|Overall Study||6
48032|NCT01540825|110799|P4|COMPLETED|Overall Study||6
48033|NCT01540825|110800|P3|COMPLETED|Overall Study||6
48034|NCT01540825|110801|P2|COMPLETED|Overall Study||6
48035|NCT01540825|110802|P1|COMPLETED|Overall Study||20
48036|NCT01540825|110792|P11|STARTED|Overall Study||6
48037|NCT01540825|110793|P10|STARTED|Overall Study||6
48038|NCT01540825|110794|P9|STARTED|Overall Study||6
48039|NCT01540825|110795|P8|STARTED|Overall Study||6
48040|NCT01540825|110796|P7|STARTED|Overall Study||6
48041|NCT01540825|110797|P6|STARTED|Overall Study||6
48042|NCT01540825|110798|P5|STARTED|Overall Study||6
48043|NCT01540825|110799|P4|STARTED|Overall Study||6
48044|NCT01540825|110800|P3|STARTED|Overall Study||6
48045|NCT01540825|110801|P2|STARTED|Overall Study||6
48046|NCT01540825|110802|P1|STARTED|Overall Study||20
48047|NCT01540487|110900|P2|NOT COMPLETED|Overall Study||0
48048|NCT01540487|110901|P1|NOT COMPLETED|Overall Study||1
48049|NCT01540487|110900|P2|COMPLETED|Overall Study||24
48050|NCT01540487|110901|P1|COMPLETED|Overall Study||23
48051|NCT01540487|110900|P2|STARTED|Overall Study||24
48052|NCT01540487|110901|P1|STARTED|Overall Study||24
48053|NCT01540370|110935|P1|NOT COMPLETED|Overall Study||2
48054|NCT01540370|110935|P1|COMPLETED|Overall Study||100
48055|NCT01540370|110935|P1|STARTED|Overall Study||102
48056|NCT01540266|110946|P6|NOT COMPLETED|Overall Study||0
48057|NCT01540266|110947|P5|NOT COMPLETED|Overall Study||0
48058|NCT01540266|110948|P4|NOT COMPLETED|Overall Study||0
48059|NCT01540266|110949|P3|NOT COMPLETED|Overall Study||1
48060|NCT01540266|110950|P2|NOT COMPLETED|Overall Study||1
48061|NCT01540266|110951|P1|NOT COMPLETED|Overall Study||6
48062|NCT01540266|110946|P6|COMPLETED|Overall Study||19
48063|NCT01540266|110947|P5|COMPLETED|Overall Study||20
48064|NCT01540266|110948|P4|COMPLETED|Overall Study||38
48065|NCT01540266|110949|P3|COMPLETED|Overall Study||59
48066|NCT01540266|110950|P2|COMPLETED|Overall Study||41
48067|NCT01540266|110951|P1|COMPLETED|Overall Study||57
48068|NCT01540266|110946|P6|STARTED|Overall Study||19
48069|NCT01540266|110947|P5|STARTED|Overall Study||20
48070|NCT01540266|110948|P4|STARTED|Overall Study||38
48071|NCT01540266|110949|P3|STARTED|Overall Study||60
48072|NCT01540266|110950|P2|STARTED|Overall Study||42
48073|NCT01540266|110951|P1|STARTED|Overall Study||63
48074|NCT01540162|110967|P2|NOT COMPLETED|Overall Study||0
48075|NCT01540162|110968|P1|NOT COMPLETED|Overall Study||0
48076|NCT01540162|110967|P2|COMPLETED|Overall Study||32
48077|NCT01540162|110968|P1|COMPLETED|Overall Study||30
48078|NCT01540162|110967|P2|STARTED|Overall Study||32
48079|NCT01540162|110968|P1|STARTED|Overall Study||30
48080|NCT01540045|110978|P1|NOT COMPLETED|Overall Study||0
48081|NCT01540045|110978|P1|COMPLETED|Overall Study||40
48082|NCT01540045|110978|P1|STARTED|Overall Study||40
48083|NCT01539980|111017|P1|NOT COMPLETED|Overall Study||0
48084|NCT01539980|111017|P1|COMPLETED|Overall Study||30
48085|NCT01539980|111017|P1|STARTED|Overall Study||30
48086|NCT01539811|111027|P2|NOT COMPLETED|Overall Study||0
48087|NCT01539811|111028|P1|NOT COMPLETED|Overall Study||0
48088|NCT01539811|111027|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
48089|NCT01539811|111028|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
48090|NCT01539811|111027|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
48091|NCT01539811|111028|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
48092|NCT01539759|111036|P2|NOT COMPLETED|Overall Study||8
48093|NCT01539759|111037|P1|NOT COMPLETED|Overall Study||6
48094|NCT01539759|111036|P2|COMPLETED|Overall Study||48
48095|NCT01539759|111037|P1|COMPLETED|Overall Study||50
48096|NCT01539759|111036|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
48097|NCT01539759|111037|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
48098|NCT01539759|111036|P2|IUD Removal|Overall Study||7
48099|NCT01539759|111037|P1|IUD Removal|Overall Study||2
48100|NCT01539759|111036|P2|IUD Expulsion|Overall Study||4
48101|NCT01539759|111037|P1|IUD Expulsion|Overall Study||1
48102|NCT01539759|111036|P2|Had Successful IUD Placement|Overall Study||53
48103|NCT01539759|111037|P1|Had Successful IUD Placement|Overall Study||34
48104|NCT01539759|111036|P2|STARTED|Overall Study||56
48105|NCT01539759|111037|P1|STARTED|Overall Study||56
48106|NCT01539642|111047|P2|NOT COMPLETED|Overall Study||31
48107|NCT01539642|111048|P1|NOT COMPLETED|Overall Study||36
48108|NCT01539642|111047|P2|COMPLETED|Overall Study||27
48109|NCT01539642|111048|P1|COMPLETED|Overall Study||78
48110|NCT01539642|111047|P2|STARTED|Overall Study||58
48111|NCT01539642|111048|P1|STARTED|Overall Study||114
48112|NCT01539590|111056|P2|NOT COMPLETED|Overall Study||0
48113|NCT01539590|111057|P1|NOT COMPLETED|Overall Study||3
48114|NCT01539590|111056|P2|COMPLETED|Overall Study||2
48115|NCT01539590|111057|P1|COMPLETED|Overall Study||0
48116|NCT01539590|111056|P2|Complete Study Treatment|Overall Study||2
48117|NCT01539590|111057|P1|Complete Study Treatment|Overall Study||1
48118|NCT01539590|111056|P2|STARTED|Overall Study||2
48119|NCT01539590|111057|P1|STARTED|Overall Study||3
48120|NCT01539538|111065|P2|NOT COMPLETED|Overall Study||44
48121|NCT01539538|111066|P1|NOT COMPLETED|Overall Study||31
48122|NCT01539538|111065|P2|COMPLETED|Overall Study||136
48123|NCT01539538|111066|P1|COMPLETED|Overall Study||146
48124|NCT01539538|111065|P2|STARTED|Overall Study||180
48125|NCT01539538|111066|P1|STARTED|Overall Study||177
48126|NCT01539512|111074|P2|NOT COMPLETED|Overall Study||13
48127|NCT01539512|111075|P1|NOT COMPLETED|Overall Study||23
48128|NCT01539512|111074|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
48129|NCT01539512|111075|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
48130|NCT01539512|111074|P2|STARTED|Overall Study||110
48131|NCT01539512|111075|P1|STARTED|Overall Study||110
48132|NCT01539317|111091|P2|NOT COMPLETED|Overall Study||0
48133|NCT01539317|111092|P1|NOT COMPLETED|Overall Study||1
48134|NCT01539317|111091|P2|COMPLETED|Overall Study||25
48135|NCT01539317|111092|P1|COMPLETED|Overall Study||24
48136|NCT01539317|111091|P2|STARTED|Overall Study||25
48137|NCT01539317|111092|P1|STARTED|Overall Study||25
48138|NCT01539135|111109|P2|NOT COMPLETED|Overall Study||0
48139|NCT01539135|111110|P1|NOT COMPLETED|Overall Study||0
48140|NCT01539135|111109|P2|COMPLETED|Overall Study||37
48141|NCT01539135|111110|P1|COMPLETED|Overall Study||43
48142|NCT01539135|111109|P2|STARTED|Overall Study||37
48143|NCT01539135|111110|P1|STARTED|Overall Study||43
48144|NCT01539083|111122|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
48145|NCT01539083|111123|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
48146|NCT01539083|111124|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
48147|NCT01539083|111122|P3|COMPLETED|After Randomization (TP and VTP)||92
48148|NCT01539083|111123|P2|COMPLETED|After Randomization (TP and VTP)||87
48149|NCT01539083|111124|P1|COMPLETED|After Randomization (TP and VTP)||0
48150|NCT01539083|111122|P3|Safety Population|After Randomization (TP and VTP)||103
48151|NCT01539083|111123|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
48152|NCT01539083|111124|P1|Safety Population|After Randomization (TP and VTP)||0
48153|NCT01539083|111122|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
48154|NCT01539083|111123|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
48155|NCT01539083|111124|P1|STARTED|After Randomization (TP and VTP)||0
48156|NCT01539083|111122|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
48157|NCT01539083|111123|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
48158|NCT01539083|111124|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
48159|NCT01539083|111122|P3|COMPLETED|Before Randomization (VCD Induction)||0
48160|NCT01539083|111123|P2|COMPLETED|Before Randomization (VCD Induction)||0
48161|NCT01539083|111124|P1|COMPLETED|Before Randomization (VCD Induction)||203
48162|NCT01539083|111122|P3|Treated|Before Randomization (VCD Induction)||0
48163|NCT01539083|111123|P2|Treated|Before Randomization (VCD Induction)||0
48164|NCT01539083|111124|P1|Treated|Before Randomization (VCD Induction)||254
48165|NCT01539083|111122|P3|STARTED|Before Randomization (VCD Induction)||0
48166|NCT01539083|111123|P2|STARTED|Before Randomization (VCD Induction)||0
48167|NCT01539083|111124|P1|STARTED|Before Randomization (VCD Induction)||256
48168|NCT01539070|111147|P2|NOT COMPLETED|Overall Study||39
48169|NCT01539070|111148|P1|NOT COMPLETED|Overall Study||59
48170|NCT01539070|111147|P2|COMPLETED|Overall Study||99
48171|NCT01539070|111148|P1|COMPLETED|Overall Study||109
48172|NCT01539070|111147|P2|STARTED|Overall Study||138
48173|NCT01539070|111148|P1|STARTED|Overall Study||168
48174|NCT01538472|111160|P1|NOT COMPLETED|Overall Study||4
48175|NCT01538472|111160|P1|COMPLETED|Overall Study||36
48176|NCT01538472|111160|P1|STARTED|Overall Study||40
48177|NCT01537900|111165|P1|NOT COMPLETED|Overall Study||0
48178|NCT01537900|111165|P1|COMPLETED|Overall Study||4
48179|NCT01537900|111165|P1|STARTED|Overall Study||4
48180|NCT01537835|111179|P3|NOT COMPLETED|Overall Study||0
48181|NCT01537835|111180|P2|NOT COMPLETED|Overall Study||0
48182|NCT01537835|111181|P1|NOT COMPLETED|Overall Study||0
48183|NCT01537835|111179|P3|COMPLETED|Overall Study||35
48184|NCT01537835|111180|P2|COMPLETED|Overall Study||37
48185|NCT01537835|111181|P1|COMPLETED|Overall Study||37
48186|NCT01537835|111179|P3|STARTED|Overall Study||35
48187|NCT01537835|111180|P2|STARTED|Overall Study||37
48188|NCT01537835|111181|P1|STARTED|Overall Study||37
48189|NCT01537666|111196|P4|NOT COMPLETED|Overall Study||0
48190|NCT01537666|111197|P3|NOT COMPLETED|Overall Study||0
48191|NCT01537666|111198|P2|NOT COMPLETED|Overall Study||0
48192|NCT01537666|111199|P1|NOT COMPLETED|Overall Study||0
48193|NCT01537666|111196|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
48194|NCT01537666|111197|P3|COMPLETED|Overall Study||6
48195|NCT01537666|111198|P2|COMPLETED|Overall Study||6
48196|NCT01537666|111199|P1|COMPLETED|Overall Study||6
48197|NCT01537666|111196|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
48198|NCT01537666|111197|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
48199|NCT01537666|111198|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
48200|NCT01537666|111199|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
48201|NCT01537432|111239|P2|NOT COMPLETED|Overall Study||2
48202|NCT01537432|111240|P1|NOT COMPLETED|Overall Study||6
48203|NCT01537432|111239|P2|COMPLETED|Overall Study||10
48204|NCT01537432|111240|P1|COMPLETED|Overall Study||18
48205|NCT01537432|111239|P2|STARTED|Overall Study||12
48206|NCT01537432|111240|P1|STARTED|Overall Study||24
48207|NCT01537367|111251|P3|NOT COMPLETED|Overall Study||0
48208|NCT01537367|111252|P2|NOT COMPLETED|Overall Study||0
48209|NCT01537367|111253|P1|NOT COMPLETED|Overall Study||0
48210|NCT01537367|111251|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
48211|NCT01537367|111252|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
48212|NCT01537367|111253|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
48213|NCT01537367|111251|P3|STARTED|Overall Study||613
48214|NCT01537367|111252|P2|STARTED|Overall Study||610
48215|NCT01537367|111253|P1|STARTED|Overall Study||615
48216|NCT01537315|111269|P2|NOT COMPLETED|Overall Study||0
48217|NCT01537315|111270|P1|NOT COMPLETED|Overall Study||0
48218|NCT01537315|111269|P2|COMPLETED|Overall Study||7
48219|NCT01537315|111270|P1|COMPLETED|Overall Study||1
48220|NCT01537315|111269|P2|STARTED|Overall Study||7
48221|NCT01537315|111270|P1|STARTED|Overall Study||1
48222|NCT01537302|111276|P1|NOT COMPLETED|Overall Study||2
48223|NCT01537302|111276|P1|COMPLETED|Overall Study||199
48224|NCT01537302|111276|P1|STARTED|Overall Study||201
48225|NCT01537198|111283|P1|NOT COMPLETED|Overall Study||154
48226|NCT01537198|111283|P1|COMPLETED|Overall Study||463
48227|NCT01537198|111283|P1|STARTED|Overall Study||617
48228|NCT01537185|111291|P4|NOT COMPLETED|Overall Study||2
48229|NCT01537185|111292|P3|NOT COMPLETED|Overall Study||6
48230|NCT01537185|111293|P2|NOT COMPLETED|Overall Study||6
48231|NCT01537185|111294|P1|NOT COMPLETED|Overall Study||3
48232|NCT01537185|111291|P4|COMPLETED|Overall Study||8
48233|NCT01537185|111292|P3|COMPLETED|Overall Study||4
48234|NCT01537185|111293|P2|COMPLETED|Overall Study||6
48235|NCT01537185|111294|P1|COMPLETED|Overall Study||7
48236|NCT01537185|111291|P4|STARTED|Overall Study||10
48237|NCT01537185|111292|P3|STARTED|Overall Study||10
48238|NCT01537185|111293|P2|STARTED|Overall Study||12
48239|NCT01537185|111294|P1|STARTED|Overall Study||10
48240|NCT01537133|111312|P4|NOT COMPLETED|Overall Study||0
48241|NCT01537133|111313|P3|NOT COMPLETED|Overall Study||0
48242|NCT01537133|111314|P2|NOT COMPLETED|Overall Study||0
48243|NCT01537133|111315|P1|NOT COMPLETED|Overall Study||3
48244|NCT01537133|111312|P4|COMPLETED|Overall Study||21
48245|NCT01537133|111313|P3|COMPLETED|Overall Study||21
48246|NCT01537133|111314|P2|COMPLETED|Overall Study||14
48247|NCT01537133|111315|P1|COMPLETED|Overall Study||25
48248|NCT01537133|111312|P4|STARTED|Overall Study||21
48249|NCT01537133|111313|P3|STARTED|Overall Study||21
48250|NCT01537133|111314|P2|STARTED|Overall Study||14
48251|NCT01537133|111315|P1|STARTED|Overall Study||28
48252|NCT01537120|111331|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
48253|NCT01537120|111331|P1|COMPLETED|12 Weeks Vildagliptin||23
48254|NCT01537120|111331|P1|STARTED|12 Weeks Vildagliptin||23
48255|NCT01537120|111331|P1|NOT COMPLETED|3 Weeks Placebo||1
48256|NCT01537120|111331|P1|COMPLETED|3 Weeks Placebo||23
48257|NCT01537120|111331|P1|STARTED|3 Weeks Placebo||24
48258|NCT01537120|111331|P1|NOT COMPLETED|8 Weeks Washout||1
48259|NCT01537120|111331|P1|COMPLETED|8 Weeks Washout||24
48260|NCT01537120|111331|P1|STARTED|8 Weeks Washout||25
48261|NCT01537120|111331|P1|NOT COMPLETED|Enrolled||0
48262|NCT01537120|111331|P1|COMPLETED|Enrolled||25
48263|NCT01537120|111331|P1|STARTED|Enrolled||25
48264|NCT01537081|111344|P3|NOT COMPLETED|Overall Study||16
48265|NCT01537081|111345|P2|NOT COMPLETED|Overall Study||38
48266|NCT01537081|111346|P1|NOT COMPLETED|Overall Study||39
48267|NCT01537081|111344|P3|COMPLETED|Overall Study||547
48268|NCT01537081|111345|P2|COMPLETED|Overall Study||1086
48269|NCT01537081|111346|P1|COMPLETED|Overall Study||1084
48270|NCT01537081|111344|P3|Modified Intent to Treat Population|Overall Study||556
48271|NCT01537081|111345|P2|Modified Intent to Treat Population|Overall Study||1109
48272|NCT01537081|111346|P1|Modified Intent to Treat Population|Overall Study||1106
48273|NCT01537081|111344|P3|Safety Population|Overall Study||561
48274|NCT01537081|111345|P2|Safety Population|Overall Study||1122
48275|NCT01537081|111346|P1|Safety Population|Overall Study||1122
48276|NCT01537081|111344|P3|STARTED|Overall Study||563
48277|NCT01537081|111345|P2|STARTED|Overall Study||1124
48278|NCT01537081|111346|P1|STARTED|Overall Study||1123
48279|NCT01537042|111359|P2|NOT COMPLETED|Overall Study||5
48280|NCT01537042|111360|P1|NOT COMPLETED|Overall Study||0
48281|NCT01537042|111359|P2|COMPLETED|Overall Study||15
48282|NCT01537042|111360|P1|COMPLETED|Overall Study||10
48283|NCT01537042|111359|P2|STARTED|Overall Study||20
48284|NCT01537042|111360|P1|STARTED|Overall Study||10
48285|NCT01536938|111399|P3|NOT COMPLETED|Overall Study||8
48286|NCT01536938|111400|P2|NOT COMPLETED|Overall Study||7
48287|NCT01536938|111401|P1|NOT COMPLETED|Overall Study||6
48288|NCT01536938|111399|P3|COMPLETED|Overall Study||93
48289|NCT01536938|111400|P2|COMPLETED|Overall Study||94
48290|NCT01536938|111401|P1|COMPLETED|Overall Study||94
48291|NCT01536938|111399|P3|STARTED|Overall Study||101
48292|NCT01536938|111400|P2|STARTED|Overall Study||101
48293|NCT01536938|111401|P1|STARTED|Overall Study||100
48294|NCT01536886|111413|P4|NOT COMPLETED|Overall Study||3
48295|NCT01536886|111414|P3|NOT COMPLETED|Overall Study||2
48296|NCT01536886|111415|P2|NOT COMPLETED|Overall Study||8
48297|NCT01536886|111416|P1|NOT COMPLETED|Overall Study||5
48298|NCT01536886|111413|P4|COMPLETED|Overall Study||48
48299|NCT01536886|111414|P3|COMPLETED|Overall Study||47
48300|NCT01536886|111415|P2|COMPLETED|Overall Study||127
48301|NCT01536886|111416|P1|COMPLETED|Overall Study||136
48302|NCT01536886|111413|P4|STARTED|Overall Study||51
48303|NCT01536886|111414|P3|STARTED|Overall Study||49
48304|NCT01536886|111415|P2|STARTED|Overall Study||135
48305|NCT01536886|111416|P1|STARTED|Overall Study||141
48306|NCT01536860|111426|P3|NOT COMPLETED|Third Intervention (1 Day)||0
48307|NCT01536860|111427|P2|NOT COMPLETED|Third Intervention (1 Day)||0
48308|NCT01536860|111428|P1|NOT COMPLETED|Third Intervention (1 Day)||0
48309|NCT01536860|111426|P3|COMPLETED|Third Intervention (1 Day)||4
48310|NCT01536860|111427|P2|COMPLETED|Third Intervention (1 Day)||4
48311|NCT01536860|111428|P1|COMPLETED|Third Intervention (1 Day)||3
48312|NCT01536860|111426|P3|STARTED|Third Intervention (1 Day)||4
48313|NCT01536860|111427|P2|STARTED|Third Intervention (1 Day)||4
48314|NCT01536860|111428|P1|STARTED|Third Intervention (1 Day)||3
48315|NCT01536860|111426|P3|NOT COMPLETED|Washout Period (3 Days)||0
48316|NCT01536860|111427|P2|NOT COMPLETED|Washout Period (3 Days)||0
48317|NCT01536860|111428|P1|NOT COMPLETED|Washout Period (3 Days)||1
48318|NCT01536860|111426|P3|COMPLETED|Washout Period (3 Days)||4
48319|NCT01536860|111427|P2|COMPLETED|Washout Period (3 Days)||4
48320|NCT01536860|111428|P1|COMPLETED|Washout Period (3 Days)||3
48321|NCT01536860|111426|P3|STARTED|Washout Period (3 Days)||4
48322|NCT01536860|111427|P2|STARTED|Washout Period (3 Days)||4
48323|NCT01536860|111428|P1|STARTED|Washout Period (3 Days)||4
48324|NCT01536860|111426|P3|NOT COMPLETED|Second Intervention (1 Day)||0
48325|NCT01536860|111427|P2|NOT COMPLETED|Second Intervention (1 Day)||0
48326|NCT01536860|111428|P1|NOT COMPLETED|Second Intervention (1 Day)||0
48327|NCT01536860|111426|P3|COMPLETED|Second Intervention (1 Day)||4
48328|NCT01536860|111427|P2|COMPLETED|Second Intervention (1 Day)||4
48329|NCT01536860|111428|P1|COMPLETED|Second Intervention (1 Day)||4
48330|NCT01536860|111426|P3|STARTED|Second Intervention (1 Day)||4
48331|NCT01536860|111427|P2|STARTED|Second Intervention (1 Day)||4
48332|NCT01536860|111428|P1|STARTED|Second Intervention (1 Day)||4
48333|NCT01536860|111426|P3|NOT COMPLETED|Washout Period (3 Days)||0
48334|NCT01536860|111427|P2|NOT COMPLETED|Washout Period (3 Days)||0
48335|NCT01536860|111428|P1|NOT COMPLETED|Washout Period (3 Days)||0
48336|NCT01536860|111426|P3|COMPLETED|Washout Period (3 Days)||4
48337|NCT01536860|111427|P2|COMPLETED|Washout Period (3 Days)||4
48338|NCT01536860|111428|P1|COMPLETED|Washout Period (3 Days)||4
48339|NCT01536860|111426|P3|STARTED|Washout Period (3 Days)||4
48340|NCT01536860|111427|P2|STARTED|Washout Period (3 Days)||4
48341|NCT01536860|111428|P1|STARTED|Washout Period (3 Days)||4
48342|NCT01536860|111426|P3|NOT COMPLETED|First Intervention (1 Day)||0
48343|NCT01536860|111427|P2|NOT COMPLETED|First Intervention (1 Day)||0
48344|NCT01536860|111428|P1|NOT COMPLETED|First Intervention (1 Day)||0
48345|NCT01536860|111426|P3|COMPLETED|First Intervention (1 Day)||4
48346|NCT01536860|111427|P2|COMPLETED|First Intervention (1 Day)||4
48347|NCT01536860|111428|P1|COMPLETED|First Intervention (1 Day)||4
48348|NCT01536860|111426|P3|STARTED|First Intervention (1 Day)||4
48349|NCT01536860|111427|P2|STARTED|First Intervention (1 Day)||4
48350|NCT01536860|111428|P1|STARTED|First Intervention (1 Day)||4
48351|NCT01536704|111436|P4|NOT COMPLETED|Period 4||0
48352|NCT01536704|111437|P3|NOT COMPLETED|Period 4||0
48353|NCT01536704|111438|P2|NOT COMPLETED|Period 4||0
48354|NCT01536704|111439|P1|NOT COMPLETED|Period 4||0
48355|NCT01536704|111436|P4|COMPLETED|Period 4||10
48356|NCT01536704|111437|P3|COMPLETED|Period 4||10
48357|NCT01536704|111438|P2|COMPLETED|Period 4||11
48358|NCT01536704|111439|P1|COMPLETED|Period 4||12
48359|NCT01536704|111436|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
48360|NCT01536704|111437|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
48361|NCT01536704|111438|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
48362|NCT01536704|111439|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
48363|NCT01536704|111436|P4|NOT COMPLETED|Washout Period 3||0
48364|NCT01536704|111437|P3|NOT COMPLETED|Washout Period 3||1
48365|NCT01536704|111438|P2|NOT COMPLETED|Washout Period 3||0
48366|NCT01536704|111439|P1|NOT COMPLETED|Washout Period 3||0
48367|NCT01536704|111436|P4|COMPLETED|Washout Period 3||10
48368|NCT01536704|111437|P3|COMPLETED|Washout Period 3||11
48369|NCT01536704|111438|P2|COMPLETED|Washout Period 3||12
48370|NCT01536704|111439|P1|COMPLETED|Washout Period 3||10
48371|NCT01536704|111436|P4|STARTED|Washout Period 3||10
48372|NCT01536704|111437|P3|STARTED|Washout Period 3||12
48373|NCT01536704|111438|P2|STARTED|Washout Period 3||12
48374|NCT01536704|111439|P1|STARTED|Washout Period 3||10
48375|NCT01536704|111436|P4|NOT COMPLETED|Period 3||1
48376|NCT01536704|111437|P3|NOT COMPLETED|Period 3||0
48377|NCT01536704|111438|P2|NOT COMPLETED|Period 3||0
48378|NCT01536704|111439|P1|NOT COMPLETED|Period 3||0
48379|NCT01536704|111436|P4|COMPLETED|Period 3||10
48380|NCT01536704|111437|P3|COMPLETED|Period 3||12
48381|NCT01536704|111438|P2|COMPLETED|Period 3||12
48382|NCT01536704|111439|P1|COMPLETED|Period 3||10
48383|NCT01536704|111436|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
48384|NCT01536704|111437|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
48385|NCT01536704|111438|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
48386|NCT01536704|111439|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
48387|NCT01536704|111436|P4|NOT COMPLETED|Washout Period 2||1
48388|NCT01536704|111437|P3|NOT COMPLETED|Washout Period 2||0
48389|NCT01536704|111438|P2|NOT COMPLETED|Washout Period 2||0
48390|NCT01536704|111439|P1|NOT COMPLETED|Washout Period 2||1
48391|NCT01536704|111436|P4|COMPLETED|Washout Period 2||12
48392|NCT01536704|111437|P3|COMPLETED|Washout Period 2||10
48393|NCT01536704|111438|P2|COMPLETED|Washout Period 2||11
48394|NCT01536704|111439|P1|COMPLETED|Washout Period 2||12
48395|NCT01536704|111436|P4|STARTED|Washout Period 2||13
48396|NCT01536704|111437|P3|STARTED|Washout Period 2||10
48397|NCT01536704|111438|P2|STARTED|Washout Period 2||11
48398|NCT01536704|111439|P1|STARTED|Washout Period 2||13
48399|NCT01536704|111436|P4|NOT COMPLETED|Period 2||0
48400|NCT01536704|111437|P3|NOT COMPLETED|Period 2||0
48401|NCT01536704|111438|P2|NOT COMPLETED|Period 2||0
48402|NCT01536704|111439|P1|NOT COMPLETED|Period 2||0
48403|NCT01536704|111436|P4|COMPLETED|Period 2||13
48404|NCT01536704|111437|P3|COMPLETED|Period 2||10
48405|NCT01536704|111438|P2|COMPLETED|Period 2||11
48406|NCT01536704|111439|P1|COMPLETED|Period 2||13
48407|NCT01536704|111436|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
48408|NCT01536704|111437|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
48409|NCT01536704|111438|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
48410|NCT01536704|111439|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
48411|NCT01536704|111436|P4|NOT COMPLETED|Washout Period 1||0
48412|NCT01536704|111437|P3|NOT COMPLETED|Washout Period 1||0
48413|NCT01536704|111438|P2|NOT COMPLETED|Washout Period 1||2
48414|NCT01536704|111439|P1|NOT COMPLETED|Washout Period 1||1
48415|NCT01536704|111436|P4|COMPLETED|Washout Period 1||13
48416|NCT01536704|111437|P3|COMPLETED|Washout Period 1||13
48417|NCT01536704|111438|P2|COMPLETED|Washout Period 1||10
48418|NCT01536704|111439|P1|COMPLETED|Washout Period 1||11
48419|NCT01536704|111436|P4|STARTED|Washout Period 1||13
48420|NCT01536704|111437|P3|STARTED|Washout Period 1||13
48421|NCT01536704|111438|P2|STARTED|Washout Period 1||12
48422|NCT01536704|111439|P1|STARTED|Washout Period 1||12
48423|NCT01536704|111436|P4|NOT COMPLETED|Period 1||0
48424|NCT01536704|111437|P3|NOT COMPLETED|Period 1||0
48425|NCT01536704|111438|P2|NOT COMPLETED|Period 1||0
48426|NCT01536704|111439|P1|NOT COMPLETED|Period 1||0
48427|NCT01536704|111436|P4|COMPLETED|Period 1||13
48428|NCT01536704|111437|P3|COMPLETED|Period 1||13
48429|NCT01536704|111438|P2|COMPLETED|Period 1||12
48430|NCT01536704|111439|P1|COMPLETED|Period 1||12
48431|NCT01536704|111436|P4|STARTED|Period 1||13
48432|NCT01536704|111437|P3|STARTED|Period 1||13
48433|NCT01536704|111438|P2|STARTED|Period 1||12
48434|NCT01536704|111439|P1|STARTED|Period 1||12
48435|NCT01536587|111469|P1|NOT COMPLETED|Overall Study||2
48436|NCT01536587|111469|P1|COMPLETED|Overall Study||30
48437|NCT01536587|111469|P1|STARTED|Overall Study||32
48438|NCT01536574|111508|P2|NOT COMPLETED|Overall Study||7
48439|NCT01536574|111509|P1|NOT COMPLETED|Overall Study||6
48440|NCT01536574|111508|P2|COMPLETED|Overall Study||126
48441|NCT01536574|111509|P1|COMPLETED|Overall Study||156
48442|NCT01536574|111508|P2|STARTED|Overall Study||133
48443|NCT01536574|111509|P1|STARTED|Overall Study||162
48444|NCT01536561|111527|P1|NOT COMPLETED|Long-Term Follow-Up||0
48445|NCT01536561|111527|P1|COMPLETED|Long-Term Follow-Up||13
48446|NCT01536561|111527|P1|STARTED|Long-Term Follow-Up||13
48447|NCT01536561|111527|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
48448|NCT01536561|111527|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
48449|NCT01536561|111527|P1|STARTED|Dosimetric and Therapeutic Treatment||59
48450|NCT01536496|111567|P2|NOT COMPLETED|Overall Study||1
48451|NCT01536496|111568|P1|NOT COMPLETED|Overall Study||2
48452|NCT01536496|111567|P2|COMPLETED|Overall Study||56
48453|NCT01536496|111568|P1|COMPLETED|Overall Study||55
48454|NCT01536496|111567|P2|STARTED|Overall Study||57
48455|NCT01536496|111568|P1|STARTED|Overall Study||57
48456|NCT01536405|111604|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
48457|NCT01536405|111605|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
48458|NCT01536405|111604|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
48459|NCT01536405|111605|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
48460|NCT01536405|111604|P2|STARTED|Visit 4 to Extended Study Follow-up||618
48461|NCT01536405|111605|P1|STARTED|Visit 4 to Extended Study Follow-up||615
48462|NCT01536405|111604|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
48463|NCT01536405|111605|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
48464|NCT01536405|111604|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
48465|NCT01536405|111605|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
48466|NCT01536405|111604|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
48467|NCT01536405|111605|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
48468|NCT01536405|111604|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
48469|NCT01536405|111605|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
48470|NCT01536405|111604|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
48471|NCT01536405|111605|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
48472|NCT01536405|111604|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
48473|NCT01536405|111605|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
48474|NCT01536405|111604|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
48475|NCT01536405|111605|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
48476|NCT01536405|111604|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
48477|NCT01536405|111605|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
48478|NCT01536405|111604|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
48479|NCT01536405|111605|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
48480|NCT01536405|111604|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
48481|NCT01536405|111605|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
48482|NCT01536405|111604|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
48483|NCT01536405|111605|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
48484|NCT01536405|111604|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
48485|NCT01536405|111605|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
48486|NCT01536405|111604|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
48487|NCT01536405|111605|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
48488|NCT01536405|111604|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
48489|NCT01536405|111605|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
48490|NCT01536366|111643|P2|NOT COMPLETED|Overall Study||4
48491|NCT01536366|111644|P1|NOT COMPLETED|Overall Study||13
48492|NCT01536366|111643|P2|COMPLETED|Overall Study||9
48493|NCT01536366|111644|P1|COMPLETED|Overall Study||1
48494|NCT01536366|111643|P2|Follow-up|Overall Study||9
48495|NCT01536366|111644|P1|Follow-up|Overall Study||13
48496|NCT01536366|111643|P2|Repaglinide|Overall Study||13
48497|NCT01536366|111644|P1|Repaglinide|Overall Study||14
48498|NCT01536366|111643|P2|BIA 9-1067 + Repaglinide|Overall Study||10
48499|NCT01536366|111644|P1|BIA 9-1067 + Repaglinide|Overall Study||14
48500|NCT01536366|111643|P2|STARTED|Overall Study||13
48501|NCT01536366|111644|P1|STARTED|Overall Study||14
48502|NCT01536262|111659|P3|NOT COMPLETED|Overall Study||2
48503|NCT01536262|111660|P2|NOT COMPLETED|Overall Study||2
48504|NCT01536262|111661|P1|NOT COMPLETED|Overall Study||8
48505|NCT01536262|111659|P3|COMPLETED|Overall Study||39
48506|NCT01536262|111660|P2|COMPLETED|Overall Study||38
48507|NCT01536262|111661|P1|COMPLETED|Overall Study||33
48508|NCT01536262|111659|P3|STARTED|Overall Study||41
48509|NCT01536262|111660|P2|STARTED|Overall Study||40
48510|NCT01536262|111661|P1|STARTED|Overall Study||41
48511|NCT01536197|111677|P2|NOT COMPLETED|Overall Study||0
48512|NCT01536197|111678|P1|NOT COMPLETED|Overall Study||0
48513|NCT01536197|111677|P2|COMPLETED|Overall Study||10
48514|NCT01536197|111678|P1|COMPLETED|Overall Study||17
48515|NCT01536197|111677|P2|STARTED|Overall Study||10
48516|NCT01536197|111678|P1|STARTED|Overall Study||17
48517|NCT01536184|111688|P2|NOT COMPLETED|Overall Study||0
48518|NCT01536184|111689|P1|NOT COMPLETED|Overall Study||0
48519|NCT01536184|111688|P2|COMPLETED|Overall Study||4
48520|NCT01536184|111689|P1|COMPLETED|Overall Study||8
48521|NCT01536184|111688|P2|STARTED|Overall Study||4
48522|NCT01536184|111689|P1|STARTED|Overall Study||8
48523|NCT01536171|111703|P1|NOT COMPLETED|Overall Study||1
48524|NCT01536171|111703|P1|COMPLETED|Overall Study||21
48525|NCT01536171|111703|P1|STARTED|Overall Study||22
48526|NCT01536145|111708|P11|NOT COMPLETED|Overall Study||10
48527|NCT01536145|111709|P10|NOT COMPLETED|Overall Study||6
48528|NCT01536145|111710|P9|NOT COMPLETED|Overall Study||3
48529|NCT01536145|111711|P8|NOT COMPLETED|Overall Study||4
48530|NCT01536145|111712|P7|NOT COMPLETED|Overall Study||2
48531|NCT01536145|111713|P6|NOT COMPLETED|Overall Study||3
48532|NCT01536145|111714|P5|NOT COMPLETED|Overall Study||2
48533|NCT01536145|111715|P4|NOT COMPLETED|Overall Study||2
48534|NCT01536145|111716|P3|NOT COMPLETED|Overall Study||2
48535|NCT01536145|111717|P2|NOT COMPLETED|Overall Study||4
48536|NCT01536145|111718|P1|NOT COMPLETED|Overall Study||3
48537|NCT01536145|111708|P11|COMPLETED|Overall Study||0
48538|NCT01536145|111709|P10|COMPLETED|Overall Study||1
48539|NCT01536145|111710|P9|COMPLETED|Overall Study||0
48540|NCT01536145|111711|P8|COMPLETED|Overall Study||0
48541|NCT01536145|111712|P7|COMPLETED|Overall Study||1
48542|NCT01536145|111713|P6|COMPLETED|Overall Study||0
48543|NCT01536145|111714|P5|COMPLETED|Overall Study||2
48544|NCT01536145|111715|P4|COMPLETED|Overall Study||1
48545|NCT01536145|111716|P3|COMPLETED|Overall Study||1
48546|NCT01536145|111717|P2|COMPLETED|Overall Study||0
48547|NCT01536145|111718|P1|COMPLETED|Overall Study||0
48548|NCT01536145|111708|P11|STARTED|Overall Study||10
48549|NCT01536145|111709|P10|STARTED|Overall Study||7
48550|NCT01536145|111710|P9|STARTED|Overall Study||3
48551|NCT01536145|111711|P8|STARTED|Overall Study||4
48552|NCT01536145|111712|P7|STARTED|Overall Study||3
48553|NCT01536145|111713|P6|STARTED|Overall Study||3
48554|NCT01536145|111714|P5|STARTED|Overall Study||4
48555|NCT01536145|111715|P4|STARTED|Overall Study||3
48556|NCT01536145|111716|P3|STARTED|Overall Study||3
48557|NCT01536145|111717|P2|STARTED|Overall Study||4
48558|NCT01536145|111718|P1|STARTED|Overall Study||3
48559|NCT01536119|111825|P2|NOT COMPLETED|Overall Study||14
48560|NCT01536119|111826|P1|NOT COMPLETED|Overall Study||17
48561|NCT01536119|111825|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
48562|NCT01536119|111826|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
48563|NCT01536119|111825|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
48564|NCT01536119|111826|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
48565|NCT01536093|111852|P2|NOT COMPLETED|Overall Study||3
48566|NCT01536093|111853|P1|NOT COMPLETED|Overall Study||3
48567|NCT01536093|111852|P2|COMPLETED|Overall Study||21
48568|NCT01536093|111853|P1|COMPLETED|Overall Study||21
48569|NCT01536093|111852|P2|STARTED|Overall Study||24
48570|NCT01536093|111853|P1|STARTED|Overall Study||24
48571|NCT01536067|111869|P1|NOT COMPLETED|Overall Study||1
48572|NCT01536067|111869|P1|COMPLETED|Overall Study||2
48573|NCT01536067|111869|P1|STARTED|Overall Study||3
48574|NCT01536015|111882|P2|NOT COMPLETED|Overall Study||10
48575|NCT01536015|111883|P1|NOT COMPLETED|Overall Study||8
48576|NCT01536015|111882|P2|COMPLETED|Overall Study||3
48577|NCT01536015|111883|P1|COMPLETED|Overall Study||4
48578|NCT01536015|111882|P2|STARTED|Overall Study||13
48579|NCT01536015|111883|P1|STARTED|Overall Study||12
48580|NCT01535976|111901|P2|NOT COMPLETED|Overall Study||1
48581|NCT01535976|111902|P1|NOT COMPLETED|Overall Study||1
48582|NCT01535976|111901|P2|COMPLETED|Overall Study||26
48583|NCT01535976|111902|P1|COMPLETED|Overall Study||26
48584|NCT01535976|111901|P2|STARTED|Overall Study||27
48585|NCT01535976|111902|P1|STARTED|Overall Study||27
48586|NCT01535807|111910|P2|NOT COMPLETED|Overall Study||2
48587|NCT01535807|111911|P1|NOT COMPLETED|Overall Study||2
48588|NCT01535807|111910|P2|COMPLETED|Overall Study||20
48589|NCT01535807|111911|P1|COMPLETED|Overall Study||20
48590|NCT01535807|111910|P2|STARTED|Overall Study||22
48591|NCT01535807|111911|P1|STARTED|Overall Study||22
48592|NCT01535729|111917|P1|NOT COMPLETED|Overall Study||416
48593|NCT01535729|111917|P1|COMPLETED|Overall Study||49
48594|NCT01535729|111917|P1|Treated|Overall Study||385
48595|NCT01535729|111917|P1|STARTED|Overall Study||465
48596|NCT01535664|111944|P1|NOT COMPLETED|Overall Study||0
48597|NCT01535664|111944|P1|COMPLETED|Overall Study||20
48598|NCT01535664|111944|P1|STARTED|Overall Study||20
48599|NCT01535638|111958|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
48600|NCT01535638|111959|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
48601|NCT01535638|111960|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
48602|NCT01535638|111961|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
48603|NCT01535638|111962|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
48604|NCT01535638|111963|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
48605|NCT01535638|111958|P6|COMPLETED|Treatment 3 (Single Dose)||2
48606|NCT01535638|111959|P5|COMPLETED|Treatment 3 (Single Dose)||3
48607|NCT01535638|111960|P4|COMPLETED|Treatment 3 (Single Dose)||2
48608|NCT01535638|111961|P3|COMPLETED|Treatment 3 (Single Dose)||3
48609|NCT01535638|111962|P2|COMPLETED|Treatment 3 (Single Dose)||3
48610|NCT01535638|111963|P1|COMPLETED|Treatment 3 (Single Dose)||3
48611|NCT01535638|111958|P6|STARTED|Treatment 3 (Single Dose)||2
48612|NCT01535638|111959|P5|STARTED|Treatment 3 (Single Dose)||3
48613|NCT01535638|111960|P4|STARTED|Treatment 3 (Single Dose)||3
48614|NCT01535638|111961|P3|STARTED|Treatment 3 (Single Dose)||3
48615|NCT01535638|111962|P2|STARTED|Treatment 3 (Single Dose)||3
48616|NCT01535638|111963|P1|STARTED|Treatment 3 (Single Dose)||3
48617|NCT01535638|111958|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
48618|NCT01535638|111959|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
48619|NCT01535638|111960|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
48620|NCT01535638|111961|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
48621|NCT01535638|111962|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
48622|NCT01535638|111963|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
48623|NCT01535638|111958|P6|COMPLETED|Treatment 2 (Single Dose)||2
48624|NCT01535638|111959|P5|COMPLETED|Treatment 2 (Single Dose)||3
48625|NCT01535638|111960|P4|COMPLETED|Treatment 2 (Single Dose)||3
48626|NCT01535638|111961|P3|COMPLETED|Treatment 2 (Single Dose)||3
48627|NCT01535638|111962|P2|COMPLETED|Treatment 2 (Single Dose)||3
48628|NCT01535638|111963|P1|COMPLETED|Treatment 2 (Single Dose)||3
48629|NCT01535638|111958|P6|STARTED|Treatment 2 (Single Dose)||2
48630|NCT01535638|111959|P5|STARTED|Treatment 2 (Single Dose)||3
48631|NCT01535638|111960|P4|STARTED|Treatment 2 (Single Dose)||3
48632|NCT01535638|111961|P3|STARTED|Treatment 2 (Single Dose)||3
48633|NCT01535638|111962|P2|STARTED|Treatment 2 (Single Dose)||3
48634|NCT01535638|111963|P1|STARTED|Treatment 2 (Single Dose)||3
48635|NCT01535638|111958|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
48636|NCT01535638|111959|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
48637|NCT01535638|111960|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
48638|NCT01535638|111961|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
48639|NCT01535638|111962|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
48640|NCT01535638|111963|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
48641|NCT01535638|111958|P6|COMPLETED|Treatment 1 (Single Dose)||2
48642|NCT01535638|111959|P5|COMPLETED|Treatment 1 (Single Dose)||3
48643|NCT01535638|111960|P4|COMPLETED|Treatment 1 (Single Dose)||3
48644|NCT01535638|111961|P3|COMPLETED|Treatment 1 (Single Dose)||3
48645|NCT01535638|111962|P2|COMPLETED|Treatment 1 (Single Dose)||3
48646|NCT01535638|111963|P1|COMPLETED|Treatment 1 (Single Dose)||3
48647|NCT01535638|111958|P6|STARTED|Treatment 1 (Single Dose)||3
48648|NCT01535638|111959|P5|STARTED|Treatment 1 (Single Dose)||3
48649|NCT01535638|111960|P4|STARTED|Treatment 1 (Single Dose)||3
48650|NCT01535638|111961|P3|STARTED|Treatment 1 (Single Dose)||3
48651|NCT01535638|111962|P2|STARTED|Treatment 1 (Single Dose)||3
48652|NCT01535638|111963|P1|STARTED|Treatment 1 (Single Dose)||3
48653|NCT01535599|111977|P2|NOT COMPLETED|Overall Study||96
48654|NCT01535599|111978|P1|NOT COMPLETED|Overall Study||50
48655|NCT01535599|111977|P2|COMPLETED|Overall Study||250
48656|NCT01535599|111978|P1|COMPLETED|Overall Study||297
48657|NCT01535599|111977|P2|STARTED|Overall Study||346
48658|NCT01535599|111978|P1|STARTED|Overall Study||347
48659|NCT01535560|111990|P2|NOT COMPLETED|Overall Study||96
48660|NCT01535560|111991|P1|NOT COMPLETED|Overall Study||37
48661|NCT01535560|111990|P2|COMPLETED|Overall Study||179
48662|NCT01535560|111991|P1|COMPLETED|Overall Study||237
48663|NCT01535560|111990|P2|STARTED|Overall Study||275
48664|NCT01535560|111991|P1|STARTED|Overall Study||274
48665|NCT01535365|112003|P2|NOT COMPLETED|Overall Study||0
48666|NCT01535365|112004|P1|NOT COMPLETED|Overall Study||0
48667|NCT01535365|112003|P2|COMPLETED|Overall Study||29
48668|NCT01535365|112004|P1|COMPLETED|Overall Study||31
48669|NCT01535365|112003|P2|STARTED|Overall Study||29
48670|NCT01535365|112004|P1|STARTED|Overall Study||31
48671|NCT01535326|112015|P3|NOT COMPLETED|Overall Study||0
48672|NCT01535326|112016|P2|NOT COMPLETED|Overall Study||0
48673|NCT01535326|112017|P1|NOT COMPLETED|Overall Study||0
48674|NCT01535326|112015|P3|COMPLETED|Overall Study||90
48675|NCT01535326|112016|P2|COMPLETED|Overall Study||90
48676|NCT01535326|112017|P1|COMPLETED|Overall Study||90
48677|NCT01535326|112015|P3|STARTED|Overall Study||90
48678|NCT01535326|112016|P2|STARTED|Overall Study||90
48679|NCT01535326|112017|P1|STARTED|Overall Study||90
48680|NCT01535261|112034|P1|NOT COMPLETED|Overall Study||50
48681|NCT01535261|112034|P1|COMPLETED|Overall Study||307
48682|NCT01535261|112034|P1|STARTED|Overall Study||357
48683|NCT01535235|112047|P2|NOT COMPLETED|Overall Study||0
48684|NCT01535235|112048|P1|NOT COMPLETED|Overall Study||1
48685|NCT01535235|112047|P2|COMPLETED|Overall Study||15
48686|NCT01535235|112048|P1|COMPLETED|Overall Study||15
48687|NCT01535235|112047|P2|STARTED|Overall Study||15
48688|NCT01535235|112048|P1|STARTED|Overall Study||16
48689|NCT01535222|112062|P6|NOT COMPLETED|Overall Study||0
48690|NCT01535222|112063|P5|NOT COMPLETED|Overall Study||0
48691|NCT01535222|112064|P4|NOT COMPLETED|Overall Study||0
48692|NCT01535222|112065|P3|NOT COMPLETED|Overall Study||1
48693|NCT01535222|112066|P2|NOT COMPLETED|Overall Study||0
48694|NCT01535222|112067|P1|NOT COMPLETED|Overall Study||0
48695|NCT01535222|112062|P6|COMPLETED|Overall Study||8
48696|NCT01535222|112063|P5|COMPLETED|Overall Study||6
48697|NCT01535222|112064|P4|COMPLETED|Overall Study||6
48698|NCT01535222|112065|P3|COMPLETED|Overall Study||6
48699|NCT01535222|112066|P2|COMPLETED|Overall Study||3
48700|NCT01535222|112067|P1|COMPLETED|Overall Study||3
48701|NCT01535222|112062|P6|STARTED|Overall Study||8
48702|NCT01535222|112063|P5|STARTED|Overall Study||6
48703|NCT01535222|112064|P4|STARTED|Overall Study||6
48704|NCT01535222|112065|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
48705|NCT01535222|112066|P2|STARTED|Overall Study||3
48706|NCT01535222|112067|P1|STARTED|Overall Study||3
48707|NCT01535118|112087|P1|NOT COMPLETED|Overall Study||0
48708|NCT01535118|112087|P1|COMPLETED|Overall Study||2765
48709|NCT01535118|112087|P1|STARTED|Overall Study||2765
48710|NCT01535040|112098|P2|NOT COMPLETED|Overall Study||21
48711|NCT01535040|112099|P1|NOT COMPLETED|Overall Study||30
48712|NCT01535040|112098|P2|COMPLETED|Overall Study||44
48713|NCT01535040|112099|P1|COMPLETED|Overall Study||35
48714|NCT01535040|112098|P2|STARTED|Overall Study||65
48715|NCT01535040|112099|P1|STARTED|Overall Study||65
48716|NCT01535001|112113|P2|NOT COMPLETED|Overall Study||6
48717|NCT01535001|112114|P1|NOT COMPLETED|Overall Study||3
48718|NCT01535001|112113|P2|COMPLETED|Overall Study||44
48719|NCT01535001|112114|P1|COMPLETED|Overall Study||47
48720|NCT01535001|112113|P2|STARTED|Overall Study||50
48721|NCT01535001|112114|P1|STARTED|Overall Study||50
48722|NCT01534962|112140|P4|NOT COMPLETED|Overall Study||32
48723|NCT01534962|112141|P3|NOT COMPLETED|Overall Study||24
48724|NCT01534962|112142|P2|NOT COMPLETED|Overall Study||26
48725|NCT01534962|112143|P1|NOT COMPLETED|Overall Study||37
48726|NCT01534962|112140|P4|COMPLETED|Overall Study||24
48727|NCT01534962|112141|P3|COMPLETED|Overall Study||34
48728|NCT01534962|112142|P2|COMPLETED|Overall Study||34
48729|NCT01534962|112143|P1|COMPLETED|Overall Study||30
48730|NCT01534962|112140|P4|STARTED|Overall Study||56
48731|NCT01534962|112141|P3|STARTED|Overall Study||58
48732|NCT01534962|112142|P2|STARTED|Overall Study||60
48733|NCT01534962|112143|P1|STARTED|Overall Study||67
48734|NCT01534910|112175|P2|NOT COMPLETED|Overall Study||4
48735|NCT01534910|112176|P1|NOT COMPLETED|Overall Study||4
48736|NCT01534910|112175|P2|COMPLETED|Overall Study||28
48737|NCT01534910|112176|P1|COMPLETED|Overall Study||29
48738|NCT01534910|112175|P2|STARTED|Overall Study||32
48739|NCT01534910|112176|P1|STARTED|Overall Study||33
48740|NCT01534689|112182|P1|NOT COMPLETED|Overall Study||0
48741|NCT01534689|112182|P1|COMPLETED|Overall Study||105
48742|NCT01534689|112182|P1|STARTED|Overall Study||105
48743|NCT01534676|112190|P2|NOT COMPLETED|Overall Study||1
48744|NCT01534676|112191|P1|NOT COMPLETED|Overall Study||2
48745|NCT01534676|112190|P2|COMPLETED|Overall Study||0
48746|NCT01534676|112191|P1|COMPLETED|Overall Study||0
48747|NCT01534676|112190|P2|STARTED|Overall Study||1
48748|NCT01534676|112191|P1|STARTED|Overall Study||2
48749|NCT01534637|112197|P1|NOT COMPLETED|Overall Study||9
48750|NCT01534637|112197|P1|COMPLETED|Overall Study||13
48751|NCT01534637|112197|P1|STARTED|Overall Study||22
48752|NCT01534533|112207|P4|NOT COMPLETED|Overall Study||4
48753|NCT01534533|112208|P3|NOT COMPLETED|Overall Study||8
48754|NCT01534533|112209|P2|NOT COMPLETED|Overall Study||3
48755|NCT01534533|112210|P1|NOT COMPLETED|Overall Study||8
48756|NCT01534533|112207|P4|COMPLETED|Overall Study||44
48757|NCT01534533|112208|P3|COMPLETED|Overall Study||40
48758|NCT01534533|112209|P2|COMPLETED|Overall Study||45
48759|NCT01534533|112210|P1|COMPLETED|Overall Study||40
48760|NCT01534533|112207|P4|STARTED|Overall Study||48
48761|NCT01534533|112208|P3|STARTED|Overall Study||48
48762|NCT01534533|112209|P2|STARTED|Overall Study||48
48763|NCT01534533|112210|P1|STARTED|Overall Study||48
48764|NCT01534520|112238|P2|NOT COMPLETED|Overall Study||1
48765|NCT01534520|112239|P1|NOT COMPLETED|Overall Study||0
48766|NCT01534520|112238|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
48767|NCT01534520|112239|P1|COMPLETED|Overall Study||30
48768|NCT01534520|112238|P2|STARTED|Overall Study||29
48769|NCT01534520|112239|P1|STARTED|Overall Study||30
48770|NCT01534351|112254|P3|NOT COMPLETED|Overall Study||0
48771|NCT01534351|112255|P2|NOT COMPLETED|Overall Study||0
48772|NCT01534351|112256|P1|NOT COMPLETED|Overall Study||1
48773|NCT01534351|112254|P3|COMPLETED|Overall Study||0
48774|NCT01534351|112255|P2|COMPLETED|Overall Study||0
48775|NCT01534351|112256|P1|COMPLETED|Overall Study||0
48776|NCT01534351|112254|P3|STARTED|Overall Study||0
48777|NCT01534351|112255|P2|STARTED|Overall Study||0
48778|NCT01534351|112256|P1|STARTED|Overall Study||1
48779|NCT01534208|112275|P2|NOT COMPLETED|Overall Study||49
48780|NCT01534208|112276|P1|NOT COMPLETED|Overall Study||57
48781|NCT01534208|112275|P2|COMPLETED|Overall Study||234
48782|NCT01534208|112276|P1|COMPLETED|Overall Study||159
48783|NCT01534208|112275|P2|STARTED|Overall Study||283
48784|NCT01534208|112276|P1|STARTED|Overall Study||216
48785|NCT01534182|112294|P2|NOT COMPLETED|Overall Study||10
48786|NCT01534182|112295|P1|NOT COMPLETED|Overall Study||12
48787|NCT01534182|112294|P2|COMPLETED|Overall Study||58
48788|NCT01534182|112295|P1|COMPLETED|Overall Study||218
48789|NCT01534182|112294|P2|Full Analysis Set|Overall Study||62
48790|NCT01534182|112295|P1|Full Analysis Set|Overall Study||229
48791|NCT01534182|112294|P2|Safety Set|Overall Study||64
48792|NCT01534182|112295|P1|Safety Set|Overall Study||230
48793|NCT01534182|112294|P2|STARTED|Overall Study||68
48794|NCT01534182|112295|P1|STARTED|Overall Study||230
48795|NCT01534143|112310|P1|NOT COMPLETED|Overall Study||0
48796|NCT01534143|112310|P1|COMPLETED|Overall Study||1
48797|NCT01534143|112310|P1|STARTED|Overall Study||1
48798|NCT01533974|112328|P2|NOT COMPLETED|Overall Study||50
48799|NCT01533974|112329|P1|NOT COMPLETED|Overall Study||51
48800|NCT01533974|112328|P2|COMPLETED|Overall Study||176
48801|NCT01533974|112329|P1|COMPLETED|Overall Study||173
48802|NCT01533974|112328|P2|STARTED|Overall Study||226
48803|NCT01533974|112329|P1|STARTED|Overall Study||224
48804|NCT01533935|112335|P5|NOT COMPLETED|Overall Study||8
48805|NCT01533935|112336|P4|NOT COMPLETED|Overall Study||7
48806|NCT01533935|112337|P3|NOT COMPLETED|Overall Study||8
48807|NCT01533935|112338|P2|NOT COMPLETED|Overall Study||13
48808|NCT01533935|112339|P1|NOT COMPLETED|Overall Study||6
48809|NCT01533935|112335|P5|COMPLETED|Overall Study|All treatment periods|50
48810|NCT01533935|112336|P4|COMPLETED|Overall Study|All treatment periods|52
48811|NCT01533935|112337|P3|COMPLETED|Overall Study|All treatment periods|50
48812|NCT01533935|112338|P2|COMPLETED|Overall Study|All treatment periods|45
48813|NCT01533935|112339|P1|COMPLETED|Overall Study|All treatment periods|52
48814|NCT01533935|112335|P5|Received Tio+Olo 5/5|Overall Study||55
48815|NCT01533935|112336|P4|Received Tio+Olo 5/5|Overall Study||54
48816|NCT01533935|112337|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
48817|NCT01533935|112338|P2|Received Tio+Olo 5/5|Overall Study||58
48818|NCT01533935|112339|P1|Received Tio+Olo 5/5|Overall Study||56
48819|NCT01533935|112335|P5|Received Tio+Olo 2.5/5|Overall Study||56
48820|NCT01533935|112336|P4|Received Tio+Olo 2.5/5|Overall Study||56
48821|NCT01533935|112337|P3|Received Tio+Olo 2.5/5|Overall Study||49
48822|NCT01533935|112338|P2|Received Tio+Olo 2.5/5|Overall Study||0
48823|NCT01533935|112339|P1|Received Tio+Olo 2.5/5|Overall Study||58
48824|NCT01533935|112335|P5|Received Tio 5|Overall Study||52
48825|NCT01533935|112336|P4|Received Tio 5|Overall Study||0
48826|NCT01533935|112337|P3|Received Tio 5|Overall Study||58
48827|NCT01533935|112338|P2|Received Tio 5|Overall Study||54
48828|NCT01533935|112339|P1|Received Tio 5|Overall Study||54
48829|NCT01533935|112335|P5|Received Olo 5|Overall Study||0
48830|NCT01533935|112336|P4|Received Olo 5|Overall Study||59
48831|NCT01533935|112337|P3|Received Olo 5|Overall Study||55
48832|NCT01533935|112338|P2|Received Olo 5|Overall Study||52
48833|NCT01533935|112339|P1|Received Olo 5|Overall Study||52
48834|NCT01533935|112335|P5|Received Placebo|Overall Study||58
48835|NCT01533935|112336|P4|Received Placebo|Overall Study||57
48836|NCT01533935|112337|P3|Received Placebo|Overall Study||52
48837|NCT01533935|112338|P2|Received Placebo|Overall Study||47
48838|NCT01533935|112339|P1|Received Placebo|Overall Study||0
48839|NCT01533935|112335|P5|STARTED|Overall Study||58
48840|NCT01533935|112336|P4|STARTED|Overall Study||59
48841|NCT01533935|112337|P3|STARTED|Overall Study||58
48842|NCT01533935|112338|P2|STARTED|Overall Study||58
48843|NCT01533935|112339|P1|STARTED|Overall Study||58
48844|NCT01533922|112366|P5|NOT COMPLETED|Overall Study||6
48845|NCT01533922|112367|P4|NOT COMPLETED|Overall Study||5
48846|NCT01533922|112368|P3|NOT COMPLETED|Overall Study||10
48847|NCT01533922|112369|P2|NOT COMPLETED|Overall Study||12
48848|NCT01533922|112370|P1|NOT COMPLETED|Overall Study||10
48849|NCT01533922|112366|P5|COMPLETED|Overall Study|Completed all treatment arms|53
48850|NCT01533922|112367|P4|COMPLETED|Overall Study|Completed all treatment arms|53
48851|NCT01533922|112368|P3|COMPLETED|Overall Study|Completed all treatment arms|50
48852|NCT01533922|112369|P2|COMPLETED|Overall Study|Completed all treatment arms|47
48853|NCT01533922|112370|P1|COMPLETED|Overall Study|Completed all treatment arms|49
48854|NCT01533922|112366|P5|Received Tio+Olo 5/5|Overall Study||56
48855|NCT01533922|112367|P4|Received Tio+Olo 5/5|Overall Study||53
48856|NCT01533922|112368|P3|Received Tio+Olo 5/5|Overall Study||0
48857|NCT01533922|112369|P2|Received Tio+Olo 5/5|Overall Study||59
48858|NCT01533922|112370|P1|Received Tio+Olo 5/5|Overall Study||58
48859|NCT01533922|112366|P5|Received Tio+Olo 2.5/5|Overall Study||56
48860|NCT01533922|112367|P4|Received Tio+Olo 2.5/5|Overall Study||55
48861|NCT01533922|112368|P3|Received Tio+Olo 2.5/5|Overall Study||52
48862|NCT01533922|112369|P2|Received Tio+Olo 2.5/5|Overall Study||0
48863|NCT01533922|112370|P1|Received Tio+Olo 2.5/5|Overall Study||59
48864|NCT01533922|112366|P5|Received Tio 5|Overall Study||54
48865|NCT01533922|112367|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
48866|NCT01533922|112368|P3|Received Tio 5|Overall Study||59
48867|NCT01533922|112369|P2|Received Tio 5|Overall Study||58
48868|NCT01533922|112370|P1|Received Tio 5|Overall Study||54
48869|NCT01533922|112366|P5|Received Olo 5|Overall Study||0
48870|NCT01533922|112367|P4|Received Olo 5|Overall Study||57
48871|NCT01533922|112368|P3|Received Olo 5|Overall Study||57
48872|NCT01533922|112369|P2|Received Olo 5|Overall Study||52
48873|NCT01533922|112370|P1|Received Olo 5|Overall Study||51
48874|NCT01533922|112366|P5|Received Placebo|Overall Study||59
48875|NCT01533922|112367|P4|Received Placebo|Overall Study||57
48876|NCT01533922|112368|P3|Received Placebo|Overall Study||57
48877|NCT01533922|112369|P2|Received Placebo|Overall Study||49
48878|NCT01533922|112370|P1|Received Placebo|Overall Study||0
48879|NCT01533922|112366|P5|STARTED|Overall Study||59
48880|NCT01533922|112367|P4|STARTED|Overall Study||58
48881|NCT01533922|112368|P3|STARTED|Overall Study||60
48882|NCT01533922|112369|P2|STARTED|Overall Study||59
48883|NCT01533922|112370|P1|STARTED|Overall Study||59
48884|NCT01533753|112399|P2|NOT COMPLETED|Overall Study||0
48885|NCT01533753|112400|P1|NOT COMPLETED|Overall Study||0
48886|NCT01533753|112399|P2|COMPLETED|Overall Study||3
48887|NCT01533753|112400|P1|COMPLETED|Overall Study||2
48888|NCT01533753|112399|P2|STARTED|Overall Study||3
48889|NCT01533753|112400|P1|STARTED|Overall Study||2
48890|NCT01533597|112414|P2|NOT COMPLETED|Overall Study||10
48891|NCT01533597|112415|P1|NOT COMPLETED|Overall Study||6
48892|NCT01533597|112414|P2|COMPLETED|Overall Study||25
48893|NCT01533597|112415|P1|COMPLETED|Overall Study||29
48894|NCT01533597|112414|P2|STARTED|Overall Study||35
48895|NCT01533597|112415|P1|STARTED|Overall Study||35
48896|NCT01533493|112433|P2|NOT COMPLETED|Overall Study||3
48897|NCT01533493|112434|P1|NOT COMPLETED|Overall Study||5
48898|NCT01533493|112433|P2|COMPLETED|Overall Study||11
48899|NCT01533493|112434|P1|COMPLETED|Overall Study||7
48900|NCT01533493|112433|P2|STARTED|Overall Study||14
48901|NCT01533493|112434|P1|STARTED|Overall Study||12
48902|NCT01533428|112442|P2|NOT COMPLETED|Overall Study||8
48903|NCT01533428|112443|P1|NOT COMPLETED|Overall Study||9
48904|NCT01533428|112442|P2|COMPLETED|Overall Study||175
48905|NCT01533428|112443|P1|COMPLETED|Overall Study||177
48906|NCT01533428|112442|P2|STARTED|Overall Study||183
48907|NCT01533428|112443|P1|STARTED|Overall Study||186
48908|NCT01533259|112483|P1|NOT COMPLETED|Overall Study||0
48909|NCT01533259|112483|P1|COMPLETED|Overall Study||48
48910|NCT01533259|112483|P1|STARTED|Overall Study||48
48911|NCT01533246|112489|P1|NOT COMPLETED|Overall Study||2
48912|NCT01533246|112489|P1|COMPLETED|Overall Study||15
48913|NCT01533246|112489|P1|STARTED|Overall Study||17
48914|NCT01533181|112500|P2|NOT COMPLETED|Overall Study||1
48915|NCT01533181|112501|P1|NOT COMPLETED|Overall Study||1
48916|NCT01533181|112500|P2|COMPLETED|Overall Study||28
48917|NCT01533181|112501|P1|COMPLETED|Overall Study||14
48918|NCT01533181|112500|P2|STARTED|Overall Study||29
48919|NCT01533181|112501|P1|STARTED|Overall Study||15
48920|NCT01533116|112517|P4|NOT COMPLETED|Overall Study||0
48921|NCT01533116|112518|P3|NOT COMPLETED|Overall Study||1
48922|NCT01533116|112519|P2|NOT COMPLETED|Overall Study||1
48923|NCT01533116|112520|P1|NOT COMPLETED|Overall Study||2
48924|NCT01533116|112517|P4|COMPLETED|Overall Study||12
48925|NCT01533116|112518|P3|COMPLETED|Overall Study||12
48926|NCT01533116|112519|P2|COMPLETED|Overall Study||12
48927|NCT01533116|112520|P1|COMPLETED|Overall Study||12
48928|NCT01533116|112517|P4|STARTED|Overall Study||12
48929|NCT01533116|112518|P3|STARTED|Overall Study||13
48930|NCT01533116|112519|P2|STARTED|Overall Study||13
48931|NCT01533116|112520|P1|STARTED|Overall Study||14
48932|NCT01533077|112550|P4|NOT COMPLETED|Overall Study||0
48933|NCT01533077|112551|P3|NOT COMPLETED|Overall Study||0
48934|NCT01533077|112552|P2|NOT COMPLETED|Overall Study||1
48935|NCT01533077|112553|P1|NOT COMPLETED|Overall Study||1
48936|NCT01533077|112550|P4|COMPLETED|Overall Study||4
48937|NCT01533077|112551|P3|COMPLETED|Overall Study||4
48938|NCT01533077|112552|P2|COMPLETED|Overall Study||4
48939|NCT01533077|112553|P1|COMPLETED|Overall Study||4
48940|NCT01533077|112550|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
48941|NCT01533077|112551|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
48942|NCT01533077|112552|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
48943|NCT01533077|112553|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
48944|NCT01533077|112550|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
48945|NCT01533077|112551|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
48946|NCT01533077|112552|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
48947|NCT01533077|112553|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
48948|NCT01533077|112550|P4|Sinemet® 100/25|Overall Study||4
48949|NCT01533077|112551|P3|Sinemet® 100/25|Overall Study||4
48950|NCT01533077|112552|P2|Sinemet® 100/25|Overall Study||5
48951|NCT01533077|112553|P1|Sinemet® 100/25|Overall Study||4
48952|NCT01533077|112550|P4|BIA 9-1067 50 mg|Overall Study||4
48953|NCT01533077|112551|P3|BIA 9-1067 50 mg|Overall Study||4
48954|NCT01533077|112552|P2|BIA 9-1067 50 mg|Overall Study||5
48955|NCT01533077|112553|P1|BIA 9-1067 50 mg|Overall Study||5
48956|NCT01533077|112550|P4|STARTED|Overall Study||4
48957|NCT01533077|112551|P3|STARTED|Overall Study||4
48958|NCT01533077|112552|P2|STARTED|Overall Study||5
48959|NCT01533077|112553|P1|STARTED|Overall Study||5
48960|NCT01533038|112609|P2|NOT COMPLETED|Overall Study||1
48961|NCT01533038|112610|P1|NOT COMPLETED|Overall Study||0
48962|NCT01533038|112609|P2|COMPLETED|Overall Study||34
48963|NCT01533038|112610|P1|COMPLETED|Overall Study||45
48964|NCT01533038|112609|P2|STARTED|Overall Study||35
48965|NCT01533038|112610|P1|STARTED|Overall Study||45
48966|NCT01532999|112618|P2|NOT COMPLETED|Overall Study||18
48967|NCT01532999|112619|P1|NOT COMPLETED|Overall Study||31
48968|NCT01532999|112618|P2|COMPLETED|Overall Study||77
48969|NCT01532999|112619|P1|COMPLETED|Overall Study||65
48970|NCT01532999|112618|P2|STARTED|Overall Study||95
48971|NCT01532999|112619|P1|STARTED|Overall Study||96
48972|NCT01532973|112650|P10|NOT COMPLETED|Part 3||0
48973|NCT01532973|112651|P9|NOT COMPLETED|Part 3||0
48974|NCT01532973|112652|P8|NOT COMPLETED|Part 3||0
48975|NCT01532973|112653|P7|NOT COMPLETED|Part 3||0
48976|NCT01532973|112654|P6|NOT COMPLETED|Part 3||0
48977|NCT01532973|112655|P5|NOT COMPLETED|Part 3||0
48978|NCT01532973|112656|P4|NOT COMPLETED|Part 3||0
48979|NCT01532973|112657|P3|NOT COMPLETED|Part 3||0
48980|NCT01532973|112658|P2|NOT COMPLETED|Part 3||0
48981|NCT01532973|112659|P1|NOT COMPLETED|Part 3||0
48982|NCT01532973|112650|P10|COMPLETED|Part 3||6
48983|NCT01532973|112651|P9|COMPLETED|Part 3||6
48984|NCT01532973|112652|P8|COMPLETED|Part 3||0
48985|NCT01532973|112653|P7|COMPLETED|Part 3||0
48986|NCT01532973|112654|P6|COMPLETED|Part 3||0
48987|NCT01532973|112655|P5|COMPLETED|Part 3||0
48988|NCT01532973|112656|P4|COMPLETED|Part 3||0
48989|NCT01532973|112657|P3|COMPLETED|Part 3||0
48990|NCT01532973|112658|P2|COMPLETED|Part 3||0
48991|NCT01532973|112659|P1|COMPLETED|Part 3||0
48992|NCT01532973|112650|P10|STARTED|Part 3||6
48993|NCT01532973|112651|P9|STARTED|Part 3||6
48994|NCT01532973|112652|P8|STARTED|Part 3||0
48995|NCT01532973|112653|P7|STARTED|Part 3||0
48996|NCT01532973|112654|P6|STARTED|Part 3||0
48997|NCT01532973|112655|P5|STARTED|Part 3||0
48998|NCT01532973|112656|P4|STARTED|Part 3||0
48999|NCT01532973|112657|P3|STARTED|Part 3||0
49000|NCT01532973|112658|P2|STARTED|Part 3||0
49001|NCT01532973|112659|P1|STARTED|Part 3||0
49002|NCT01532973|112650|P10|NOT COMPLETED|Part 2||0
49003|NCT01532973|112651|P9|NOT COMPLETED|Part 2||0
49004|NCT01532973|112652|P8|NOT COMPLETED|Part 2||0
49005|NCT01532973|112653|P7|NOT COMPLETED|Part 2||0
49006|NCT01532973|112654|P6|NOT COMPLETED|Part 2||0
49007|NCT01532973|112655|P5|NOT COMPLETED|Part 2||0
49008|NCT01532973|112656|P4|NOT COMPLETED|Part 2||0
49009|NCT01532973|112657|P3|NOT COMPLETED|Part 2||0
49010|NCT01532973|112658|P2|NOT COMPLETED|Part 2||0
49011|NCT01532973|112659|P1|NOT COMPLETED|Part 2||0
49012|NCT01532973|112650|P10|COMPLETED|Part 2||0
49013|NCT01532973|112651|P9|COMPLETED|Part 2||0
49014|NCT01532973|112652|P8|COMPLETED|Part 2||0
49015|NCT01532973|112653|P7|COMPLETED|Part 2||6
49016|NCT01532973|112654|P6|COMPLETED|Part 2||6
49017|NCT01532973|112655|P5|COMPLETED|Part 2||6
49018|NCT01532973|112656|P4|COMPLETED|Part 2||0
49019|NCT01532973|112657|P3|COMPLETED|Part 2||0
49020|NCT01532973|112658|P2|COMPLETED|Part 2||0
49021|NCT01532973|112659|P1|COMPLETED|Part 2||0
49022|NCT01532973|112650|P10|STARTED|Part 2||0
49023|NCT01532973|112651|P9|STARTED|Part 2||0
49024|NCT01532973|112652|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
49025|NCT01532973|112653|P7|STARTED|Part 2||6
49026|NCT01532973|112654|P6|STARTED|Part 2||6
49027|NCT01532973|112655|P5|STARTED|Part 2||6
49028|NCT01532973|112656|P4|STARTED|Part 2||0
49029|NCT01532973|112657|P3|STARTED|Part 2||0
49030|NCT01532973|112658|P2|STARTED|Part 2||0
49031|NCT01532973|112659|P1|STARTED|Part 2||0
49032|NCT01532973|112650|P10|NOT COMPLETED|Part 1||0
49033|NCT01532973|112651|P9|NOT COMPLETED|Part 1||0
49034|NCT01532973|112652|P8|NOT COMPLETED|Part 1||0
49035|NCT01532973|112653|P7|NOT COMPLETED|Part 1||0
49036|NCT01532973|112654|P6|NOT COMPLETED|Part 1||0
49037|NCT01532973|112655|P5|NOT COMPLETED|Part 1||0
49038|NCT01532973|112656|P4|NOT COMPLETED|Part 1||0
49039|NCT01532973|112657|P3|NOT COMPLETED|Part 1||0
49040|NCT01532973|112658|P2|NOT COMPLETED|Part 1||0
49041|NCT01532973|112659|P1|NOT COMPLETED|Part 1||0
49042|NCT01532973|112650|P10|COMPLETED|Part 1||0
49043|NCT01532973|112651|P9|COMPLETED|Part 1||0
49044|NCT01532973|112652|P8|COMPLETED|Part 1||0
49045|NCT01532973|112653|P7|COMPLETED|Part 1||0
49046|NCT01532973|112654|P6|COMPLETED|Part 1||0
49047|NCT01532973|112655|P5|COMPLETED|Part 1||0
49048|NCT01532973|112656|P4|COMPLETED|Part 1||0
49049|NCT01532973|112657|P3|COMPLETED|Part 1||6
49050|NCT01532973|112658|P2|COMPLETED|Part 1||6
49051|NCT01532973|112659|P1|COMPLETED|Part 1||6
49052|NCT01532973|112650|P10|STARTED|Part 1||0
49053|NCT01532973|112651|P9|STARTED|Part 1||0
49054|NCT01532973|112652|P8|STARTED|Part 1||0
49055|NCT01532973|112653|P7|STARTED|Part 1||0
49056|NCT01532973|112654|P6|STARTED|Part 1||0
49057|NCT01532973|112655|P5|STARTED|Part 1||0
49058|NCT01532973|112656|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
49059|NCT01532973|112657|P3|STARTED|Part 1||6
49060|NCT01532973|112658|P2|STARTED|Part 1||6
49061|NCT01532973|112659|P1|STARTED|Part 1||6
49062|NCT01532934|112701|P2|NOT COMPLETED|Overall Study||13
49063|NCT01532934|112702|P1|NOT COMPLETED|Overall Study||14
49064|NCT01532934|112701|P2|COMPLETED|Overall Study||39
49065|NCT01532934|112702|P1|COMPLETED|Overall Study||39
49066|NCT01532934|112701|P2|STARTED|Overall Study||52
49067|NCT01532934|112702|P1|STARTED|Overall Study||53
49068|NCT01532869|112714|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
49069|NCT01532869|112715|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
49070|NCT01532869|112714|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
49071|NCT01532869|112715|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
49072|NCT01532869|112714|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
49073|NCT01532869|112715|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
49074|NCT01532869|112714|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
49075|NCT01532869|112715|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
49076|NCT01532869|112714|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
49077|NCT01532869|112715|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
49078|NCT01532869|112714|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
49079|NCT01532869|112715|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
49080|NCT01532869|112714|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
49081|NCT01532869|112715|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
49082|NCT01532869|112714|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
49083|NCT01532869|112715|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
49084|NCT01532869|112714|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
49085|NCT01532869|112715|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
49086|NCT01532635|112752|P1|NOT COMPLETED|Overall Study||0
49087|NCT01532635|112752|P1|COMPLETED|Overall Study||4
49088|NCT01532635|112752|P1|STARTED|Overall Study||4
49089|NCT01532570|112768|P4|NOT COMPLETED|Overall Study||0
49090|NCT01532570|112769|P3|NOT COMPLETED|Overall Study||0
49091|NCT01532570|112770|P2|NOT COMPLETED|Overall Study||1
49092|NCT01532570|112771|P1|NOT COMPLETED|Overall Study||1
49093|NCT01532570|112768|P4|COMPLETED|Overall Study||4
49094|NCT01532570|112769|P3|COMPLETED|Overall Study||1
49095|NCT01532570|112770|P2|COMPLETED|Overall Study||1
49096|NCT01532570|112771|P1|COMPLETED|Overall Study||10
49097|NCT01532570|112768|P4|STARTED|Overall Study||4
49098|NCT01532570|112769|P3|STARTED|Overall Study||1
49099|NCT01532570|112770|P2|STARTED|Overall Study||2
49100|NCT01532570|112771|P1|STARTED|Overall Study||11
49101|NCT01532453|112804|P2|NOT COMPLETED|Overall Study||70
49102|NCT01532453|112805|P1|NOT COMPLETED|Overall Study||27
49103|NCT01532453|112804|P2|COMPLETED|Overall Study||90
49104|NCT01532453|112805|P1|COMPLETED|Overall Study||54
49105|NCT01532453|112804|P2|STARTED|Overall Study||160
49106|NCT01532453|112805|P1|STARTED|Overall Study||81
49107|NCT01532414|112816|P3|NOT COMPLETED|Overall Study||3
49108|NCT01532414|112817|P2|NOT COMPLETED|Overall Study||2
49109|NCT01532414|112818|P1|NOT COMPLETED|Overall Study||7
49110|NCT01532414|112816|P3|COMPLETED|Overall Study||35
49111|NCT01532414|112817|P2|COMPLETED|Overall Study||19
49112|NCT01532414|112818|P1|COMPLETED|Overall Study||85
49113|NCT01532414|112816|P3|STARTED|Overall Study||38
49114|NCT01532414|112817|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
49115|NCT01532414|112818|P1|STARTED|Overall Study||92
49116|NCT01532362|112828|P2|NOT COMPLETED|Overall Study||0
49117|NCT01532362|112829|P1|NOT COMPLETED|Overall Study||0
49118|NCT01532362|112828|P2|COMPLETED|Overall Study||0
49119|NCT01532362|112829|P1|COMPLETED|Overall Study||1
49120|NCT01532362|112828|P2|STARTED|Overall Study||0
49121|NCT01532362|112829|P1|STARTED|Overall Study||1
49122|NCT01532141|112838|P3|NOT COMPLETED|Overall Study||0
49123|NCT01532141|112839|P2|NOT COMPLETED|Overall Study||0
49124|NCT01532141|112840|P1|NOT COMPLETED|Overall Study||1
49125|NCT01532141|112838|P3|COMPLETED|Overall Study||8
49126|NCT01532141|112839|P2|COMPLETED|Overall Study||8
49127|NCT01532141|112840|P1|COMPLETED|Overall Study||8
49128|NCT01532141|112838|P3|Period 3|Overall Study||8
49129|NCT01532141|112839|P2|Period 3|Overall Study||8
49130|NCT01532141|112840|P1|Period 3|Overall Study||8
49131|NCT01532141|112838|P3|Period 2|Overall Study||8
49132|NCT01532141|112839|P2|Period 2|Overall Study||8
49133|NCT01532141|112840|P1|Period 2|Overall Study||8
49134|NCT01532141|112838|P3|Period 1|Overall Study||8
49135|NCT01532141|112839|P2|Period 1|Overall Study||8
49136|NCT01532141|112840|P1|Period 1|Overall Study||9
49137|NCT01532141|112838|P3|STARTED|Overall Study||8
49138|NCT01532141|112839|P2|STARTED|Overall Study||8
49139|NCT01532141|112840|P1|STARTED|Overall Study||9
49140|NCT01532128|112858|P3|NOT COMPLETED|Overall Study||0
49141|NCT01532128|112859|P2|NOT COMPLETED|Overall Study||0
49142|NCT01532128|112860|P1|NOT COMPLETED|Overall Study||0
49143|NCT01532128|112858|P3|COMPLETED|Overall Study||8
49144|NCT01532128|112859|P2|COMPLETED|Overall Study||8
49145|NCT01532128|112860|P1|COMPLETED|Overall Study||8
49146|NCT01532128|112858|P3|STARTED|Overall Study||8
49147|NCT01532128|112859|P2|STARTED|Overall Study||8
49148|NCT01532128|112860|P1|STARTED|Overall Study||8
49149|NCT01531998|112875|P1|NOT COMPLETED|Overall Study||3
49150|NCT01531998|112875|P1|COMPLETED|Overall Study||8
49151|NCT01531998|112875|P1|STARTED|Overall Study||11
49152|NCT01531725|112880|P1|NOT COMPLETED|Overall Study||5
49153|NCT01531725|112880|P1|COMPLETED|Overall Study||197
49154|NCT01531725|112880|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
49155|NCT01531387|112887|P2|NOT COMPLETED|Overall Study||11
49156|NCT01531387|112888|P1|NOT COMPLETED|Overall Study||11
49157|NCT01531387|112887|P2|COMPLETED|Overall Study||0
49158|NCT01531387|112888|P1|COMPLETED|Overall Study||0
49159|NCT01531387|112887|P2|STARTED|Overall Study||11
49160|NCT01531387|112888|P1|STARTED|Overall Study||11
49161|NCT01531335|112904|P2|NOT COMPLETED|Overall Study||0
49162|NCT01531335|112905|P1|NOT COMPLETED|Overall Study||0
49163|NCT01531335|112904|P2|COMPLETED|Overall Study||40
49164|NCT01531335|112905|P1|COMPLETED|Overall Study||40
49165|NCT01531335|112904|P2|STARTED|Overall Study||40
49166|NCT01531335|112905|P1|STARTED|Overall Study||40
49167|NCT01531205|112913|P1|NOT COMPLETED|Overall Study||1
49168|NCT01531205|112913|P1|COMPLETED|Overall Study||1
49169|NCT01531205|112913|P1|STARTED|Overall Study||2
49170|NCT01530477|112925|P3|NOT COMPLETED|Overall Study||0
49171|NCT01530477|112926|P2|NOT COMPLETED|Overall Study||0
49172|NCT01530477|112927|P1|NOT COMPLETED|Overall Study||0
49173|NCT01530477|112925|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
49174|NCT01530477|112926|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
49175|NCT01530477|112927|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
49176|NCT01530477|112925|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
49177|NCT01530477|112926|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
49178|NCT01530477|112927|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
49179|NCT01530464|112935|P2|NOT COMPLETED|Washout (24h)||1
49180|NCT01530464|112936|P1|NOT COMPLETED|Washout (24h)||0
49181|NCT01530464|112935|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
49182|NCT01530464|112936|P1|COMPLETED|Washout (24h)||9
49183|NCT01530464|112935|P2|STARTED|Washout (24h)||8
49184|NCT01530464|112936|P1|STARTED|Washout (24h)||9
49185|NCT01530464|112935|P2|NOT COMPLETED|Third Intervention (24h)||0
49186|NCT01530464|112936|P1|NOT COMPLETED|Third Intervention (24h)||0
49187|NCT01530464|112935|P2|COMPLETED|Third Intervention (24h)||8
49188|NCT01530464|112936|P1|COMPLETED|Third Intervention (24h)||9
49189|NCT01530464|112935|P2|STARTED|Third Intervention (24h)||8
49190|NCT01530464|112936|P1|STARTED|Third Intervention (24h)||9
49191|NCT01530464|112935|P2|NOT COMPLETED|Washout (24h)||0
49192|NCT01530464|112936|P1|NOT COMPLETED|Washout (24h)||1
49193|NCT01530464|112935|P2|COMPLETED|Washout (24h)||8
49194|NCT01530464|112936|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
49195|NCT01530464|112935|P2|STARTED|Washout (24h)||8
49196|NCT01530464|112936|P1|STARTED|Washout (24h)||10
49197|NCT01530464|112935|P2|NOT COMPLETED|Second Intervention (24h)||0
49198|NCT01530464|112936|P1|NOT COMPLETED|Second Intervention (24h)||0
49199|NCT01530464|112935|P2|COMPLETED|Second Intervention (24h)||8
49200|NCT01530464|112936|P1|COMPLETED|Second Intervention (24h)||10
49201|NCT01530464|112935|P2|STARTED|Second Intervention (24h)||8
49202|NCT01530464|112936|P1|STARTED|Second Intervention (24h)||10
49203|NCT01530464|112935|P2|NOT COMPLETED|Washout (24h)||0
49204|NCT01530464|112936|P1|NOT COMPLETED|Washout (24h)||0
49205|NCT01530464|112935|P2|COMPLETED|Washout (24h)||8
49206|NCT01530464|112936|P1|COMPLETED|Washout (24h)||10
49207|NCT01530464|112935|P2|STARTED|Washout (24h)||8
49208|NCT01530464|112936|P1|STARTED|Washout (24h)||10
49209|NCT01530464|112935|P2|NOT COMPLETED|First Intervention (24h)||0
49210|NCT01530464|112936|P1|NOT COMPLETED|First Intervention (24h)||0
49211|NCT01530464|112935|P2|COMPLETED|First Intervention (24h)||8
49212|NCT01530464|112936|P1|COMPLETED|First Intervention (24h)||10
49213|NCT01530464|112935|P2|STARTED|First Intervention (24h)||8
49214|NCT01530464|112936|P1|STARTED|First Intervention (24h)||10
49215|NCT01530399|112969|P6|NOT COMPLETED|Overall Study||1
49216|NCT01530399|112970|P5|NOT COMPLETED|Overall Study||0
49217|NCT01530399|112971|P4|NOT COMPLETED|Overall Study||0
49218|NCT01530399|112972|P3|NOT COMPLETED|Overall Study||1
49219|NCT01530399|112973|P2|NOT COMPLETED|Overall Study||2
49220|NCT01530399|112974|P1|NOT COMPLETED|Overall Study||1
49221|NCT01530399|112969|P6|COMPLETED|Overall Study||6
49222|NCT01530399|112970|P5|COMPLETED|Overall Study||6
49223|NCT01530399|112971|P4|COMPLETED|Overall Study||10
49224|NCT01530399|112972|P3|COMPLETED|Overall Study||7
49225|NCT01530399|112973|P2|COMPLETED|Overall Study||8
49226|NCT01530399|112974|P1|COMPLETED|Overall Study||7
49227|NCT01530399|112969|P6|STARTED|Overall Study||7
49228|NCT01530399|112970|P5|STARTED|Overall Study||6
49229|NCT01530399|112971|P4|STARTED|Overall Study||10
49230|NCT01530399|112972|P3|STARTED|Overall Study||8
49231|NCT01530399|112973|P2|STARTED|Overall Study||10
49232|NCT01530399|112974|P1|STARTED|Overall Study||8
49233|NCT01530334|112988|P1|NOT COMPLETED|Overall Study||51
49234|NCT01530334|112988|P1|COMPLETED|Overall Study||10
49235|NCT01530334|112988|P1|STARTED|Overall Study||61
49236|NCT01530243|113001|P4|NOT COMPLETED|Overall Study||2
49237|NCT01530243|113002|P3|NOT COMPLETED|Overall Study||3
49238|NCT01530243|113003|P2|NOT COMPLETED|Overall Study||3
49239|NCT01530243|113004|P1|NOT COMPLETED|Overall Study||2
49240|NCT01530243|113001|P4|COMPLETED|Overall Study||24
49241|NCT01530243|113002|P3|COMPLETED|Overall Study||23
49242|NCT01530243|113003|P2|COMPLETED|Overall Study||23
49243|NCT01530243|113004|P1|COMPLETED|Overall Study||24
49244|NCT01530243|113001|P4|STARTED|Overall Study||26
49245|NCT01530243|113002|P3|STARTED|Overall Study||26
49246|NCT01530243|113003|P2|STARTED|Overall Study||26
49247|NCT01530243|113004|P1|STARTED|Overall Study||26
49248|NCT01530087|113022|P1|NOT COMPLETED|Overall Study||2
49249|NCT01530087|113022|P1|COMPLETED|Overall Study||1
49250|NCT01530087|113022|P1|STARTED|Overall Study||3
49251|NCT01529645|113037|P10|NOT COMPLETED|Overall Study||0
49252|NCT01529645|113038|P9|NOT COMPLETED|Overall Study||1
49253|NCT01529645|113039|P8|NOT COMPLETED|Overall Study||0
49254|NCT01529645|113040|P7|NOT COMPLETED|Overall Study||2
49255|NCT01529645|113041|P6|NOT COMPLETED|Overall Study||1
49256|NCT01529645|113042|P5|NOT COMPLETED|Overall Study||2
49257|NCT01529645|113043|P4|NOT COMPLETED|Overall Study||2
49258|NCT01529645|113044|P3|NOT COMPLETED|Overall Study||2
49259|NCT01529645|113045|P2|NOT COMPLETED|Overall Study||1
49260|NCT01529645|113046|P1|NOT COMPLETED|Overall Study||2
49261|NCT01529645|113037|P10|COMPLETED|Overall Study||42
49262|NCT01529645|113038|P9|COMPLETED|Overall Study||41
49263|NCT01529645|113039|P8|COMPLETED|Overall Study||42
49264|NCT01529645|113040|P7|COMPLETED|Overall Study||40
49265|NCT01529645|113041|P6|COMPLETED|Overall Study||41
49266|NCT01529645|113042|P5|COMPLETED|Overall Study||40
49267|NCT01529645|113043|P4|COMPLETED|Overall Study||40
49268|NCT01529645|113044|P3|COMPLETED|Overall Study||40
49269|NCT01529645|113045|P2|COMPLETED|Overall Study||41
49270|NCT01529645|113046|P1|COMPLETED|Overall Study||40
49271|NCT01529645|113037|P10|STARTED|Overall Study||42
49272|NCT01529645|113038|P9|STARTED|Overall Study||42
49273|NCT01529645|113039|P8|STARTED|Overall Study||42
49274|NCT01529645|113040|P7|STARTED|Overall Study||42
49275|NCT01529645|113041|P6|STARTED|Overall Study||42
49276|NCT01529645|113042|P5|STARTED|Overall Study||42
49277|NCT01529645|113043|P4|STARTED|Overall Study||42
49278|NCT01529645|113044|P3|STARTED|Overall Study||42
49279|NCT01529645|113045|P2|STARTED|Overall Study||42
49280|NCT01529645|113046|P1|STARTED|Overall Study||42
49281|NCT01529632|113144|P2|NOT COMPLETED|Overall Study||3
49282|NCT01529632|113145|P1|NOT COMPLETED|Overall Study||3
49283|NCT01529632|113144|P2|COMPLETED|Overall Study||100
49284|NCT01529632|113145|P1|COMPLETED|Overall Study||87
49285|NCT01529632|113144|P2|STARTED|Overall Study||103
49286|NCT01529632|113145|P1|STARTED|Overall Study||90
49287|NCT01529515|113165|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
49288|NCT01529515|113166|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
49289|NCT01529515|113167|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
49290|NCT01529515|113168|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
49291|NCT01529515|113165|P4|COMPLETED|DOUBLE BLIND PHASE||148
49292|NCT01529515|113166|P3|COMPLETED|DOUBLE BLIND PHASE||122
49293|NCT01529515|113167|P2|COMPLETED|DOUBLE BLIND PHASE||0
49294|NCT01529515|113168|P1|COMPLETED|DOUBLE BLIND PHASE||0
49295|NCT01529515|113165|P4|STARTED|DOUBLE BLIND PHASE||160
49296|NCT01529515|113166|P3|STARTED|DOUBLE BLIND PHASE||145
49297|NCT01529515|113167|P2|STARTED|DOUBLE BLIND PHASE||0
49298|NCT01529515|113168|P1|STARTED|DOUBLE BLIND PHASE||0
49299|NCT01529515|113165|P4|NOT COMPLETED|MAINTENANCE PHASE||0
49300|NCT01529515|113166|P3|NOT COMPLETED|MAINTENANCE PHASE||0
49301|NCT01529515|113167|P2|NOT COMPLETED|MAINTENANCE PHASE||74
49302|NCT01529515|113168|P1|NOT COMPLETED|MAINTENANCE PHASE||0
49303|NCT01529515|113165|P4|COMPLETED|MAINTENANCE PHASE||0
49304|NCT01529515|113166|P3|COMPLETED|MAINTENANCE PHASE||0
49305|NCT01529515|113167|P2|COMPLETED|MAINTENANCE PHASE||305
49306|NCT01529515|113168|P1|COMPLETED|MAINTENANCE PHASE||0
49307|NCT01529515|113165|P4|STARTED|MAINTENANCE PHASE||0
49308|NCT01529515|113166|P3|STARTED|MAINTENANCE PHASE||0
49309|NCT01529515|113167|P2|STARTED|MAINTENANCE PHASE||379
49310|NCT01529515|113168|P1|STARTED|MAINTENANCE PHASE||0
49311|NCT01529515|113165|P4|NOT COMPLETED|TRANSITION PHASE||0
49312|NCT01529515|113166|P3|NOT COMPLETED|TRANSITION PHASE||0
49313|NCT01529515|113167|P2|NOT COMPLETED|TRANSITION PHASE||0
49314|NCT01529515|113168|P1|NOT COMPLETED|TRANSITION PHASE||127
49315|NCT01529515|113165|P4|COMPLETED|TRANSITION PHASE||0
49316|NCT01529515|113166|P3|COMPLETED|TRANSITION PHASE||0
49317|NCT01529515|113167|P2|COMPLETED|TRANSITION PHASE||0
49318|NCT01529515|113168|P1|COMPLETED|TRANSITION PHASE||379
49319|NCT01529515|113165|P4|STARTED|TRANSITION PHASE||0
49320|NCT01529515|113166|P3|STARTED|TRANSITION PHASE||0
49321|NCT01529515|113167|P2|STARTED|TRANSITION PHASE||0
49322|NCT01529515|113168|P1|STARTED|TRANSITION PHASE||506
49323|NCT01529450|113183|P2|NOT COMPLETED|Overall Study||2
49324|NCT01529450|113184|P1|NOT COMPLETED|Overall Study||0
49325|NCT01529450|113183|P2|COMPLETED|Overall Study||6
49326|NCT01529450|113184|P1|COMPLETED|Overall Study||3
49327|NCT01529450|113183|P2|STARTED|Overall Study||8
49328|NCT01529450|113184|P1|STARTED|Overall Study||3
49329|NCT01529385|113193|P2|NOT COMPLETED|Overall Study||1
49330|NCT01529385|113194|P1|NOT COMPLETED|Overall Study||2
49331|NCT01529385|113193|P2|COMPLETED|Overall Study||39
49332|NCT01529385|113194|P1|COMPLETED|Overall Study||38
49333|NCT01529385|113193|P2|Received Intervention|Overall Study||40
49334|NCT01529385|113194|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
49335|NCT01529385|113193|P2|STARTED|Overall Study||40
49336|NCT01529385|113194|P1|STARTED|Overall Study||40
49337|NCT01529203|113218|P1|NOT COMPLETED|Overall Study||3
49338|NCT01529203|113218|P1|COMPLETED|Overall Study||57
49339|NCT01529203|113218|P1|STARTED|Overall Study||60
49340|NCT01529112|113226|P2|NOT COMPLETED|Overall Study||41
49341|NCT01529112|113227|P1|NOT COMPLETED|Overall Study||69
49342|NCT01529112|113226|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
49343|NCT01529112|113227|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
49344|NCT01529112|113226|P2|STARTED|Overall Study||46
49345|NCT01529112|113227|P1|STARTED|Overall Study||89
49346|NCT01528969|113254|P2|NOT COMPLETED|Overall Study||0
49347|NCT01528969|113255|P1|NOT COMPLETED|Overall Study||2
49348|NCT01528969|113254|P2|COMPLETED|Overall Study||38
49349|NCT01528969|113255|P1|COMPLETED|Overall Study||35
49350|NCT01528969|113254|P2|STARTED|Overall Study||38
49351|NCT01528969|113255|P1|STARTED|Overall Study||37
49352|NCT01528891|113263|P2|NOT COMPLETED|Overall Study||0
49353|NCT01528891|113264|P1|NOT COMPLETED|Overall Study||0
49354|NCT01528891|113263|P2|COMPLETED|Overall Study||200
49355|NCT01528891|113264|P1|COMPLETED|Overall Study||200
49356|NCT01528891|113263|P2|STARTED|Overall Study||200
49357|NCT01528891|113264|P1|STARTED|Overall Study||200
49358|NCT01528735|113278|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
49359|NCT01528735|113279|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
49360|NCT01528735|113278|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
49361|NCT01528735|113279|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
49362|NCT01528735|113278|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
49363|NCT01528735|113279|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
49364|NCT01528735|113278|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
49365|NCT01528735|113279|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
49366|NCT01528735|113278|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
49367|NCT01528735|113279|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
49368|NCT01528735|113278|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
49369|NCT01528735|113279|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
49370|NCT01528605|113385|P6|NOT COMPLETED|Overall Study||0
49371|NCT01528605|113386|P5|NOT COMPLETED|Overall Study||0
49372|NCT01528605|113387|P4|NOT COMPLETED|Overall Study||1
49373|NCT01528605|113388|P3|NOT COMPLETED|Overall Study||1
49374|NCT01528605|113389|P2|NOT COMPLETED|Overall Study||0
49375|NCT01528605|113390|P1|NOT COMPLETED|Overall Study||2
49376|NCT01528605|113385|P6|COMPLETED|Overall Study||28
49377|NCT01528605|113386|P5|COMPLETED|Overall Study||28
49378|NCT01528605|113387|P4|COMPLETED|Overall Study||27
49379|NCT01528605|113388|P3|COMPLETED|Overall Study||27
49380|NCT01528605|113389|P2|COMPLETED|Overall Study||28
49381|NCT01528605|113390|P1|COMPLETED|Overall Study||26
49382|NCT01528605|113385|P6|STARTED|Overall Study||28
49383|NCT01528605|113386|P5|STARTED|Overall Study||28
49384|NCT01528605|113387|P4|STARTED|Overall Study||28
49385|NCT01528605|113388|P3|STARTED|Overall Study||28
49386|NCT01528605|113389|P2|STARTED|Overall Study||28
49387|NCT01528605|113390|P1|STARTED|Overall Study||28
49388|NCT01528592|113414|P1|NOT COMPLETED|Overall Study||0
49389|NCT01528592|113414|P1|COMPLETED|Overall Study||18
49390|NCT01528592|113414|P1|STARTED|Overall Study||18
49391|NCT01528345|113420|P2|NOT COMPLETED|Overall Study||50
49392|NCT01528345|113421|P1|NOT COMPLETED|Overall Study||47
49393|NCT01528345|113420|P2|COMPLETED|Overall Study||0
49394|NCT01528345|113421|P1|COMPLETED|Overall Study||0
49395|NCT01528345|113420|P2|STARTED|Overall Study||50
49396|NCT01528345|113421|P1|STARTED|Overall Study||47
49397|NCT01528332|113439|P2|NOT COMPLETED|Overall Study||2
49398|NCT01528332|113440|P1|NOT COMPLETED|Overall Study||4
49399|NCT01528332|113439|P2|COMPLETED|Overall Study||84
49400|NCT01528332|113440|P1|COMPLETED|Overall Study||81
49401|NCT01528332|113439|P2|STARTED|Overall Study||86
49402|NCT01528332|113440|P1|STARTED|Overall Study||85
49403|NCT01528319|113446|P1|NOT COMPLETED|Overall Study||1
49404|NCT01528319|113446|P1|COMPLETED|Overall Study||23
49405|NCT01528319|113446|P1|12 Weeks After Surgery|Overall Study||24
49406|NCT01528319|113446|P1|STARTED|Overall Study||24
49407|NCT01528293|113457|P2|NOT COMPLETED|Overall Study||0
49408|NCT01528293|113458|P1|NOT COMPLETED|Overall Study||1
49409|NCT01528293|113457|P2|COMPLETED|Overall Study||1
49410|NCT01528293|113458|P1|COMPLETED|Overall Study||0
49411|NCT01528293|113457|P2|STARTED|Overall Study||1
49412|NCT01528293|113458|P1|STARTED|Overall Study||1
49413|NCT01528215|113472|P2|NOT COMPLETED|Overall Study||1
49414|NCT01528215|113473|P1|NOT COMPLETED|Overall Study||4
49415|NCT01528215|113472|P2|COMPLETED|Overall Study||60
49416|NCT01528215|113473|P1|COMPLETED|Overall Study||55
49417|NCT01528215|113472|P2|STARTED|Overall Study||61
49418|NCT01528215|113473|P1|STARTED|Overall Study||59
49419|NCT01528150|113479|P1|NOT COMPLETED|Overall Study||44
49420|NCT01528150|113479|P1|COMPLETED|Overall Study||422
49421|NCT01528150|113479|P1|STARTED|Overall Study||466
49422|NCT01527942|113485|P2|NOT COMPLETED|Overall Study||0
49423|NCT01527942|113486|P1|NOT COMPLETED|Overall Study||0
49424|NCT01527942|113485|P2|COMPLETED|Overall Study||18
49425|NCT01527942|113486|P1|COMPLETED|Overall Study||16
49426|NCT01527942|113485|P2|STARTED|Overall Study||18
49427|NCT01527942|113486|P1|STARTED|Overall Study||16
49428|NCT01527513|113498|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
49429|NCT01527513|113499|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
49430|NCT01527513|113498|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
49431|NCT01527513|113499|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
49432|NCT01527513|113498|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
49433|NCT01527513|113499|P1|STARTED|Eligible for 1-Year Open Label Period||0
49434|NCT01527513|113498|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
49435|NCT01527513|113499|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
49436|NCT01527513|113498|P2|COMPLETED|Double Blind Period (DB) - Part I||75
49437|NCT01527513|113499|P1|COMPLETED|Double Blind Period (DB) - Part I||37
49438|NCT01527513|113498|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
49439|NCT01527513|113499|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
49440|NCT01527513|113498|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
49441|NCT01527513|113499|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
49442|NCT01527513|113498|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
49443|NCT01527513|113499|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
49444|NCT01527513|113498|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
49445|NCT01527513|113499|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
49446|NCT01527513|113498|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
49447|NCT01527513|113499|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
49448|NCT01527513|113498|P2|Safety Population|Double Blind Period (DB) - Part I||83
49449|NCT01527513|113499|P1|Safety Population|Double Blind Period (DB) - Part I||40
49450|NCT01527513|113498|P2|Randomized|Double Blind Period (DB) - Part I||83
49451|NCT01527513|113499|P1|Randomized|Double Blind Period (DB) - Part I||40
49452|NCT01527513|113498|P2|STARTED|Double Blind Period (DB) - Part I||83
49453|NCT01527513|113499|P1|STARTED|Double Blind Period (DB) - Part I||40
49454|NCT01527487|113511|P2|NOT COMPLETED|Overall Study||7
49455|NCT01527487|113512|P1|NOT COMPLETED|Overall Study||8
49456|NCT01527487|113511|P2|COMPLETED|Overall Study||15
49457|NCT01527487|113512|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
49458|NCT01527487|113511|P2|STARTED|Overall Study||22
49459|NCT01527487|113512|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
49460|NCT01527370|113524|P1|NOT COMPLETED|Overall Study||6
49461|NCT01527370|113524|P1|COMPLETED|Overall Study||244
49462|NCT01527370|113524|P1|STARTED|Overall Study||250
49463|NCT01527162|113530|P2|NOT COMPLETED|Overall Study||0
49464|NCT01527162|113531|P1|NOT COMPLETED|Overall Study||0
49465|NCT01527162|113530|P2|COMPLETED|Overall Study||5
49466|NCT01527162|113531|P1|COMPLETED|Overall Study||6
49467|NCT01527162|113530|P2|STARTED|Overall Study||5
49468|NCT01527162|113531|P1|STARTED|Overall Study||6
49469|NCT01527006|113543|P2|NOT COMPLETED|Extension Phase||8
49470|NCT01527006|113544|P1|NOT COMPLETED|Extension Phase||6
49471|NCT01527006|113543|P2|COMPLETED|Extension Phase||14
49472|NCT01527006|113544|P1|COMPLETED|Extension Phase||13
49473|NCT01527006|113543|P2|STARTED|Extension Phase||22
49474|NCT01527006|113544|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
49475|NCT01527006|113543|P2|NOT COMPLETED|Core Study||6
49476|NCT01527006|113544|P1|NOT COMPLETED|Core Study||2
49477|NCT01527006|113543|P2|COMPLETED|Core Study||22
49478|NCT01527006|113544|P1|COMPLETED|Core Study||20
49479|NCT01527006|113543|P2|STARTED|Core Study||28
49480|NCT01527006|113544|P1|STARTED|Core Study||22
49481|NCT01526902|113594|P2|NOT COMPLETED|Overall Study||0
49482|NCT01526902|113595|P1|NOT COMPLETED|Overall Study||0
49483|NCT01526902|113594|P2|COMPLETED|Overall Study||24
49484|NCT01526902|113595|P1|COMPLETED|Overall Study||25
49485|NCT01526902|113594|P2|STARTED|Overall Study||24
49486|NCT01526902|113595|P1|STARTED|Overall Study||25
49487|NCT01526785|113611|P1|NOT COMPLETED|Overall Study||13
49488|NCT01526785|113611|P1|COMPLETED|Overall Study||100
49489|NCT01526785|113611|P1|STARTED|Overall Study||113
49490|NCT01526733|113621|P2|NOT COMPLETED|Phase 2||0
49491|NCT01526733|113622|P1|NOT COMPLETED|Phase 2||0
49492|NCT01526733|113621|P2|COMPLETED|Phase 2||12
49493|NCT01526733|113622|P1|COMPLETED|Phase 2||10
49494|NCT01526733|113621|P2|STARTED|Phase 2||12
49495|NCT01526733|113622|P1|STARTED|Phase 2||10
49496|NCT01526733|113621|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
49497|NCT01526733|113622|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
49498|NCT01526733|113621|P2|COMPLETED|Washout Period of 5 to 21 Days||12
49499|NCT01526733|113622|P1|COMPLETED|Washout Period of 5 to 21 Days||10
49500|NCT01526733|113621|P2|STARTED|Washout Period of 5 to 21 Days||12
49501|NCT01526733|113622|P1|STARTED|Washout Period of 5 to 21 Days||10
49502|NCT01526733|113621|P2|NOT COMPLETED|Phase 1||1
49503|NCT01526733|113622|P1|NOT COMPLETED|Phase 1||2
49504|NCT01526733|113621|P2|COMPLETED|Phase 1||12
49505|NCT01526733|113622|P1|COMPLETED|Phase 1||10
49506|NCT01526733|113621|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
49507|NCT01526733|113622|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
49508|NCT01526733|113621|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
49509|NCT01526733|113622|P1|STARTED|Phase 1||12
49510|NCT01526551|113640|P1|NOT COMPLETED|Overall Study||424
49511|NCT01526551|113640|P1|COMPLETED|Overall Study||511
49512|NCT01526551|113640|P1|STARTED|Overall Study||935
49513|NCT01526538|113647|P2|NOT COMPLETED|Overall Study||4
49514|NCT01526538|113648|P1|NOT COMPLETED|Overall Study||9
49515|NCT01526538|113647|P2|COMPLETED|Overall Study||18
49516|NCT01526538|113648|P1|COMPLETED|Overall Study||21
49517|NCT01526538|113647|P2|STARTED|Overall Study||22
49518|NCT01526538|113648|P1|STARTED|Overall Study||30
49519|NCT01526213|113664|P6|NOT COMPLETED|Period 3 (5 Days)||0
49520|NCT01526213|113665|P5|NOT COMPLETED|Period 3 (5 Days)||0
49521|NCT01526213|113666|P4|NOT COMPLETED|Period 3 (5 Days)||0
49522|NCT01526213|113667|P3|NOT COMPLETED|Period 3 (5 Days)||0
49523|NCT01526213|113668|P2|NOT COMPLETED|Period 3 (5 Days)||0
49524|NCT01526213|113669|P1|NOT COMPLETED|Period 3 (5 Days)||0
49525|NCT01526213|113664|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49526|NCT01526213|113665|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49527|NCT01526213|113666|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49528|NCT01526213|113667|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49529|NCT01526213|113668|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49530|NCT01526213|113669|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49531|NCT01526213|113664|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49532|NCT01526213|113665|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49533|NCT01526213|113666|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49534|NCT01526213|113667|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49535|NCT01526213|113668|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49536|NCT01526213|113669|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49537|NCT01526213|113664|P6|NOT COMPLETED|Washout 2 (10 Days)||0
49538|NCT01526213|113665|P5|NOT COMPLETED|Washout 2 (10 Days)||0
49539|NCT01526213|113666|P4|NOT COMPLETED|Washout 2 (10 Days)||0
49540|NCT01526213|113667|P3|NOT COMPLETED|Washout 2 (10 Days)||0
49541|NCT01526213|113668|P2|NOT COMPLETED|Washout 2 (10 Days)||0
49542|NCT01526213|113669|P1|NOT COMPLETED|Washout 2 (10 Days)||0
49543|NCT01526213|113664|P6|COMPLETED|Washout 2 (10 Days)||3
49544|NCT01526213|113665|P5|COMPLETED|Washout 2 (10 Days)||3
49545|NCT01526213|113666|P4|COMPLETED|Washout 2 (10 Days)||3
49546|NCT01526213|113667|P3|COMPLETED|Washout 2 (10 Days)||3
49547|NCT01526213|113668|P2|COMPLETED|Washout 2 (10 Days)||3
49548|NCT01526213|113669|P1|COMPLETED|Washout 2 (10 Days)||3
49549|NCT01526213|113664|P6|STARTED|Washout 2 (10 Days)||3
49550|NCT01526213|113665|P5|STARTED|Washout 2 (10 Days)||3
49551|NCT01526213|113666|P4|STARTED|Washout 2 (10 Days)||3
49552|NCT01526213|113667|P3|STARTED|Washout 2 (10 Days)||3
49553|NCT01526213|113668|P2|STARTED|Washout 2 (10 Days)||3
49554|NCT01526213|113669|P1|STARTED|Washout 2 (10 Days)||3
49555|NCT01526213|113664|P6|NOT COMPLETED|Period 2 (5 Days)||0
49556|NCT01526213|113665|P5|NOT COMPLETED|Period 2 (5 Days)||0
49557|NCT01526213|113666|P4|NOT COMPLETED|Period 2 (5 Days)||0
49558|NCT01526213|113667|P3|NOT COMPLETED|Period 2 (5 Days)||0
49559|NCT01526213|113668|P2|NOT COMPLETED|Period 2 (5 Days)||0
49560|NCT01526213|113669|P1|NOT COMPLETED|Period 2 (5 Days)||0
49561|NCT01526213|113664|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
49562|NCT01526213|113665|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
49563|NCT01526213|113666|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
49564|NCT01526213|113667|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
49565|NCT01526213|113668|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49566|NCT01526213|113669|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49567|NCT01526213|113664|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49568|NCT01526213|113665|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49569|NCT01526213|113666|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49570|NCT01526213|113667|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49571|NCT01526213|113668|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49572|NCT01526213|113669|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49573|NCT01526213|113664|P6|NOT COMPLETED|Washout 1 (10 Days)||0
49574|NCT01526213|113665|P5|NOT COMPLETED|Washout 1 (10 Days)||0
49575|NCT01526213|113666|P4|NOT COMPLETED|Washout 1 (10 Days)||0
49576|NCT01526213|113667|P3|NOT COMPLETED|Washout 1 (10 Days)||0
49577|NCT01526213|113668|P2|NOT COMPLETED|Washout 1 (10 Days)||0
49578|NCT01526213|113669|P1|NOT COMPLETED|Washout 1 (10 Days)||0
49579|NCT01526213|113664|P6|COMPLETED|Washout 1 (10 Days)||3
49580|NCT01526213|113665|P5|COMPLETED|Washout 1 (10 Days)||3
49581|NCT01526213|113666|P4|COMPLETED|Washout 1 (10 Days)||3
49582|NCT01526213|113667|P3|COMPLETED|Washout 1 (10 Days)||3
49583|NCT01526213|113668|P2|COMPLETED|Washout 1 (10 Days)||3
49584|NCT01526213|113669|P1|COMPLETED|Washout 1 (10 Days)||3
49585|NCT01526213|113664|P6|STARTED|Washout 1 (10 Days)||3
49586|NCT01526213|113665|P5|STARTED|Washout 1 (10 Days)||3
49587|NCT01526213|113666|P4|STARTED|Washout 1 (10 Days)||3
49588|NCT01526213|113667|P3|STARTED|Washout 1 (10 Days)||3
49589|NCT01526213|113668|P2|STARTED|Washout 1 (10 Days)||3
49590|NCT01526213|113669|P1|STARTED|Washout 1 (10 Days)||3
49591|NCT01526213|113664|P6|NOT COMPLETED|Period 1 (5 Days)||0
49592|NCT01526213|113665|P5|NOT COMPLETED|Period 1 (5 Days)||0
49593|NCT01526213|113666|P4|NOT COMPLETED|Period 1 (5 Days)||0
49594|NCT01526213|113667|P3|NOT COMPLETED|Period 1 (5 Days)||0
49595|NCT01526213|113668|P2|NOT COMPLETED|Period 1 (5 Days)||0
49596|NCT01526213|113669|P1|NOT COMPLETED|Period 1 (5 Days)||0
49597|NCT01526213|113664|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49598|NCT01526213|113665|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49599|NCT01526213|113666|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49600|NCT01526213|113667|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49601|NCT01526213|113668|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49602|NCT01526213|113669|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
49603|NCT01526213|113664|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
49604|NCT01526213|113665|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49605|NCT01526213|113666|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49606|NCT01526213|113667|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49607|NCT01526213|113668|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49608|NCT01526213|113669|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
49609|NCT01526148|113682|P2|NOT COMPLETED|Overall Study||13
49610|NCT01526148|113683|P1|NOT COMPLETED|Overall Study||15
49611|NCT01526148|113682|P2|COMPLETED|Overall Study||11
49612|NCT01526148|113683|P1|COMPLETED|Overall Study||4
49613|NCT01526148|113682|P2|STARTED|Overall Study||24
49614|NCT01526148|113683|P1|STARTED|Overall Study||19
49615|NCT01525927|113693|P1|NOT COMPLETED|Overall Study||0
49616|NCT01525927|113693|P1|COMPLETED|Overall Study||0
49617|NCT01525927|113693|P1|STARTED|Overall Study||0
49618|NCT01525745|113700|P2|NOT COMPLETED|Overall Study||1
49619|NCT01525745|113701|P1|NOT COMPLETED|Overall Study||1
49620|NCT01525745|113700|P2|COMPLETED|Overall Study||1
49621|NCT01525745|113701|P1|COMPLETED|Overall Study||3
49622|NCT01525745|113700|P2|STARTED|Overall Study||2
49623|NCT01525745|113701|P1|STARTED|Overall Study||4
49624|NCT01525667|113718|P3|NOT COMPLETED|Overall Study||0
49625|NCT01525667|113719|P2|NOT COMPLETED|Overall Study||0
49626|NCT01525667|113720|P1|NOT COMPLETED|Overall Study||0
49627|NCT01525667|113718|P3|COMPLETED|Overall Study||7
49628|NCT01525667|113719|P2|COMPLETED|Overall Study||6
49629|NCT01525667|113720|P1|COMPLETED|Overall Study||7
49630|NCT01525667|113718|P3|STARTED|Overall Study||7
49631|NCT01525667|113719|P2|STARTED|Overall Study||6
49632|NCT01525667|113720|P1|STARTED|Overall Study||7
49633|NCT01525641|113740|P1|NOT COMPLETED|Overall Study||180
49634|NCT01525641|113740|P1|COMPLETED|Overall Study||435
49635|NCT01525641|113740|P1|STARTED|Overall Study||615
49636|NCT01525628|113754|P5|NOT COMPLETED|Overall Study||3
49637|NCT01525628|113755|P4|NOT COMPLETED|Overall Study||4
49638|NCT01525628|113756|P3|NOT COMPLETED|Overall Study||5
49639|NCT01525628|113757|P2|NOT COMPLETED|Overall Study||5
49640|NCT01525628|113758|P1|NOT COMPLETED|Overall Study||2
49641|NCT01525628|113754|P5|COMPLETED|Overall Study||4
49642|NCT01525628|113755|P4|COMPLETED|Overall Study||10
49643|NCT01525628|113756|P3|COMPLETED|Overall Study||11
49644|NCT01525628|113757|P2|COMPLETED|Overall Study||14
49645|NCT01525628|113758|P1|COMPLETED|Overall Study||14
49646|NCT01525628|113754|P5|STARTED|Overall Study||7
49647|NCT01525628|113755|P4|STARTED|Overall Study||14
49648|NCT01525628|113756|P3|STARTED|Overall Study||16
49649|NCT01525628|113757|P2|STARTED|Overall Study||19
49650|NCT01525628|113758|P1|STARTED|Overall Study||16
49651|NCT01525615|113825|P3|NOT COMPLETED|Overall Study||6
49652|NCT01525615|113826|P2|NOT COMPLETED|Overall Study||7
49653|NCT01525615|113827|P1|NOT COMPLETED|Overall Study||14
49654|NCT01525615|113825|P3|COMPLETED|Overall Study||133
49655|NCT01525615|113826|P2|COMPLETED|Overall Study||126
49656|NCT01525615|113827|P1|COMPLETED|Overall Study||118
49657|NCT01525615|113825|P3|STARTED|Overall Study||139
49658|NCT01525615|113826|P2|STARTED|Overall Study||133
49659|NCT01525615|113827|P1|STARTED|Overall Study||132
49660|NCT01525563|113871|P1|NOT COMPLETED|Overall Study||212
49661|NCT01525563|113871|P1|COMPLETED|Overall Study|6 Months Follow-up|788
49662|NCT01525563|113871|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
49663|NCT01525563|113871|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
49664|NCT01525563|113871|P1|STARTED|Overall Study||1000
49665|NCT01525420|113883|P2|NOT COMPLETED|Overall Study||24
49666|NCT01525420|113884|P1|NOT COMPLETED|Overall Study||16
49667|NCT01525420|113883|P2|COMPLETED|Overall Study||38
49668|NCT01525420|113884|P1|COMPLETED|Overall Study||43
49669|NCT01525420|113883|P2|STARTED|Overall Study||62
49670|NCT01525420|113884|P1|STARTED|Overall Study||59
49671|NCT01525238|113893|P3|NOT COMPLETED|Overall Study||0
49672|NCT01525238|113894|P2|NOT COMPLETED|Overall Study||0
49673|NCT01525238|113895|P1|NOT COMPLETED|Overall Study||1
49674|NCT01525238|113893|P3|COMPLETED|Overall Study||8
49675|NCT01525238|113894|P2|COMPLETED|Overall Study||8
49676|NCT01525238|113895|P1|COMPLETED|Overall Study||7
49677|NCT01525238|113893|P3|STARTED|Overall Study||8
49678|NCT01525238|113894|P2|STARTED|Overall Study||8
49679|NCT01525238|113895|P1|STARTED|Overall Study||8
49680|NCT01525225|113960|P1|NOT COMPLETED|Treated||0
49681|NCT01525225|113960|P1|COMPLETED|Treated||2
49682|NCT01525225|113960|P1|STARTED|Treated||2
49683|NCT01525225|113960|P1|NOT COMPLETED|Enrollment||2
49684|NCT01525225|113960|P1|COMPLETED|Enrollment||2
49685|NCT01525225|113960|P1|STARTED|Enrollment||4
49686|NCT01525173|113967|P2|NOT COMPLETED|Overall Study||5
49687|NCT01525173|113968|P1|NOT COMPLETED|Overall Study||7
49688|NCT01525173|113967|P2|COMPLETED|Overall Study||62
49689|NCT01525173|113968|P1|COMPLETED|Overall Study||63
49690|NCT01525173|113967|P2|STARTED|Overall Study||67
49691|NCT01525173|113968|P1|STARTED|Overall Study||70
49692|NCT01524900|113979|P5|NOT COMPLETED|Overall Study||0
49693|NCT01524900|113980|P4|NOT COMPLETED|Overall Study||1
49694|NCT01524900|113981|P3|NOT COMPLETED|Overall Study||1
49695|NCT01524900|113982|P2|NOT COMPLETED|Overall Study||14
49696|NCT01524900|113983|P1|NOT COMPLETED|Overall Study||6
49697|NCT01524900|113979|P5|COMPLETED|Overall Study||40
49698|NCT01524900|113980|P4|COMPLETED|Overall Study||21
49699|NCT01524900|113981|P3|COMPLETED|Overall Study||29
49700|NCT01524900|113982|P2|COMPLETED|Overall Study||232
49701|NCT01524900|113983|P1|COMPLETED|Overall Study||43
49702|NCT01524900|113979|P5|STARTED|Overall Study||40
49703|NCT01524900|113980|P4|STARTED|Overall Study||22
49704|NCT01524900|113981|P3|STARTED|Overall Study||30
49705|NCT01524900|113982|P2|STARTED|Overall Study||246
49706|NCT01524900|113983|P1|STARTED|Overall Study||49
49707|NCT01524887|114028|P3|NOT COMPLETED|Overall Study||86
49708|NCT01524887|114029|P2|NOT COMPLETED|Overall Study||90
49709|NCT01524887|114030|P1|NOT COMPLETED|Overall Study||85
49710|NCT01524887|114028|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
49711|NCT01524887|114029|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
49712|NCT01524887|114030|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
49713|NCT01524887|114028|P3|Received Treatment|Overall Study||83
49714|NCT01524887|114029|P2|Received Treatment|Overall Study||85
49715|NCT01524887|114030|P1|Received Treatment|Overall Study||83
49716|NCT01524887|114028|P3|STARTED|Overall Study||86
49717|NCT01524887|114029|P2|STARTED|Overall Study||90
49718|NCT01524887|114030|P1|STARTED|Overall Study||85
49719|NCT01524796|114074|P1|NOT COMPLETED|Overall Study||28
49720|NCT01524796|114074|P1|COMPLETED|Overall Study||100
49721|NCT01524796|114074|P1|STARTED|Overall Study||128
49722|NCT01524783|114089|P2|NOT COMPLETED|Randomized and Treated||84
49723|NCT01524783|114090|P1|NOT COMPLETED|Randomized and Treated||155
49724|NCT01524783|114089|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
49725|NCT01524783|114090|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
49726|NCT01524783|114089|P2|STARTED|Randomized and Treated||97
49727|NCT01524783|114090|P1|STARTED|Randomized and Treated||203
49728|NCT01524783|114089|P2|NOT COMPLETED|Randomized But Not Treated||0
49729|NCT01524783|114090|P1|NOT COMPLETED|Randomized But Not Treated||2
49730|NCT01524783|114089|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
49731|NCT01524783|114090|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
49732|NCT01524783|114089|P2|STARTED|Randomized But Not Treated||97
49733|NCT01524783|114090|P1|STARTED|Randomized But Not Treated||205
49734|NCT01524770|114098|P2|NOT COMPLETED|Second Intervention||0
49735|NCT01524770|114099|P1|NOT COMPLETED|Second Intervention||0
49736|NCT01524770|114098|P2|COMPLETED|Second Intervention||23
49737|NCT01524770|114099|P1|COMPLETED|Second Intervention||23
49738|NCT01524770|114098|P2|STARTED|Second Intervention||23
49739|NCT01524770|114099|P1|STARTED|Second Intervention||23
49740|NCT01524770|114098|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
49741|NCT01524770|114099|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
49742|NCT01524770|114098|P2|COMPLETED|Washout Period of at Least 28 Days||23
49743|NCT01524770|114099|P1|COMPLETED|Washout Period of at Least 28 Days||23
49744|NCT01524770|114098|P2|STARTED|Washout Period of at Least 28 Days||23
49745|NCT01524770|114099|P1|STARTED|Washout Period of at Least 28 Days||23
49746|NCT01524770|114098|P2|NOT COMPLETED|First Intervention||1
49747|NCT01524770|114099|P1|NOT COMPLETED|First Intervention||3
49748|NCT01524770|114098|P2|COMPLETED|First Intervention||23
49749|NCT01524770|114099|P1|COMPLETED|First Intervention||23
49750|NCT01524770|114098|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
49751|NCT01524770|114099|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
49752|NCT01524770|114098|P2|STARTED|First Intervention||24
49753|NCT01524770|114099|P1|STARTED|First Intervention||26
49754|NCT01524302|114111|P2|NOT COMPLETED|Overall Study||0
49755|NCT01524302|114112|P1|NOT COMPLETED|Overall Study||0
49756|NCT01524302|114111|P2|COMPLETED|Overall Study||6
49757|NCT01524302|114112|P1|COMPLETED|Overall Study||6
49758|NCT01524302|114111|P2|STARTED|Overall Study||6
49759|NCT01524302|114112|P1|STARTED|Overall Study||6
49760|NCT01524198|114130|P2|NOT COMPLETED|Overall Study||16
49761|NCT01524198|114131|P1|NOT COMPLETED|Overall Study||23
49762|NCT01524198|114130|P2|COMPLETED|Overall Study||458
49763|NCT01524198|114131|P1|COMPLETED|Overall Study||448
49764|NCT01524198|114130|P2|STARTED|Overall Study||474
49765|NCT01524198|114131|P1|STARTED|Overall Study||471
49766|NCT01523964|114143|P4|NOT COMPLETED|Overall Study||0
49767|NCT01523964|114144|P3|NOT COMPLETED|Overall Study||0
49768|NCT01523964|114145|P2|NOT COMPLETED|Overall Study||0
49769|NCT01523964|114146|P1|NOT COMPLETED|Overall Study||0
49770|NCT01523964|114143|P4|COMPLETED|Overall Study||15
49771|NCT01523964|114144|P3|COMPLETED|Overall Study||16
49772|NCT01523964|114145|P2|COMPLETED|Overall Study||30
49773|NCT01523964|114146|P1|COMPLETED|Overall Study||31
49774|NCT01523964|114143|P4|STARTED|Overall Study||15
49775|NCT01523964|114144|P3|STARTED|Overall Study||16
49776|NCT01523964|114145|P2|STARTED|Overall Study||30
49777|NCT01523964|114146|P1|STARTED|Overall Study||31
49778|NCT01523886|114158|P2|NOT COMPLETED|Overall Study||1
49779|NCT01523886|114159|P1|NOT COMPLETED|Overall Study||0
49780|NCT01523886|114158|P2|COMPLETED|Overall Study||23
49781|NCT01523886|114159|P1|COMPLETED|Overall Study||25
49782|NCT01523886|114158|P2|STARTED|Overall Study||24
49783|NCT01523886|114159|P1|STARTED|Overall Study||25
49784|NCT01523873|114165|P1|NOT COMPLETED|Overall Study||422
49785|NCT01523873|114165|P1|COMPLETED|Overall Study||35499
49786|NCT01523873|114165|P1|Administered With Dotarem|Overall Study||35474
49787|NCT01523873|114165|P1|STARTED|Overall Study||35921
49788|NCT01523756|114172|P2|NOT COMPLETED|Test Period 2||1
49789|NCT01523756|114173|P1|NOT COMPLETED|Test Period 2||0
49790|NCT01523756|114172|P2|COMPLETED|Test Period 2||7
49791|NCT01523756|114173|P1|COMPLETED|Test Period 2||10
49792|NCT01523756|114172|P2|STARTED|Test Period 2||8
49793|NCT01523756|114173|P1|STARTED|Test Period 2||10
49794|NCT01523756|114172|P2|NOT COMPLETED|Test Period 1||0
49795|NCT01523756|114173|P1|NOT COMPLETED|Test Period 1||1
49796|NCT01523756|114172|P2|COMPLETED|Test Period 1||8
49797|NCT01523756|114173|P1|COMPLETED|Test Period 1||10
49798|NCT01523756|114172|P2|STARTED|Test Period 1||8
49799|NCT01523756|114173|P1|STARTED|Test Period 1||11
49800|NCT01523756|114172|P2|NOT COMPLETED|Baseline Period||1
49801|NCT01523756|114173|P1|NOT COMPLETED|Baseline Period||0
49802|NCT01523756|114172|P2|COMPLETED|Baseline Period||8
49803|NCT01523756|114173|P1|COMPLETED|Baseline Period||11
49804|NCT01523756|114172|P2|STARTED|Baseline Period||9
49805|NCT01523756|114173|P1|STARTED|Baseline Period||11
49806|NCT01523743|114181|P2|NOT COMPLETED|Period 2||2
49807|NCT01523743|114182|P1|NOT COMPLETED|Period 2||1
49808|NCT01523743|114181|P2|COMPLETED|Period 2||58
49809|NCT01523743|114182|P1|COMPLETED|Period 2||52
49810|NCT01523743|114181|P2|STARTED|Period 2||60
49811|NCT01523743|114182|P1|STARTED|Period 2||53
49812|NCT01523743|114181|P2|NOT COMPLETED|Period 1||2
49813|NCT01523743|114182|P1|NOT COMPLETED|Period 1||10
49814|NCT01523743|114181|P2|COMPLETED|Period 1||60
49815|NCT01523743|114182|P1|COMPLETED|Period 1||53
49816|NCT01523743|114181|P2|STARTED|Period 1||62
49817|NCT01523743|114182|P1|STARTED|Period 1||63
49818|NCT01523587|114190|P2|NOT COMPLETED|Overall Study||54
49819|NCT01523587|114191|P1|NOT COMPLETED|Overall Study||87
49820|NCT01523587|114190|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
49821|NCT01523587|114191|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
49822|NCT01523587|114190|P2|STARTED|Overall Study||334
49823|NCT01523587|114191|P1|STARTED|Overall Study||335
49824|NCT01523392|114211|P2|NOT COMPLETED|Treatment Period 2||0
49825|NCT01523392|114212|P1|NOT COMPLETED|Treatment Period 2||0
49826|NCT01523392|114211|P2|COMPLETED|Treatment Period 2||14
49827|NCT01523392|114212|P1|COMPLETED|Treatment Period 2||17
49828|NCT01523392|114211|P2|STARTED|Treatment Period 2||14
49829|NCT01523392|114212|P1|STARTED|Treatment Period 2||17
49830|NCT01523392|114211|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
49831|NCT01523392|114212|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
49832|NCT01523392|114211|P2|COMPLETED|Washout Period - 10 to 14 Days||14
49833|NCT01523392|114212|P1|COMPLETED|Washout Period - 10 to 14 Days||17
49834|NCT01523392|114211|P2|STARTED|Washout Period - 10 to 14 Days||14
49835|NCT01523392|114212|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
49836|NCT01523392|114211|P2|NOT COMPLETED|Treatment Period 1||0
49837|NCT01523392|114212|P1|NOT COMPLETED|Treatment Period 1||3
49838|NCT01523392|114211|P2|COMPLETED|Treatment Period 1||14
49839|NCT01523392|114212|P1|COMPLETED|Treatment Period 1||17
49840|NCT01523392|114211|P2|STARTED|Treatment Period 1||14
49841|NCT01523392|114212|P1|STARTED|Treatment Period 1||20
49842|NCT01523366|114228|P2|NOT COMPLETED|Treatment Period 2||0
49843|NCT01523366|114229|P1|NOT COMPLETED|Treatment Period 2||1
49844|NCT01523366|114228|P2|COMPLETED|Treatment Period 2||20
49845|NCT01523366|114229|P1|COMPLETED|Treatment Period 2||18
49846|NCT01523366|114228|P2|STARTED|Treatment Period 2||20
49847|NCT01523366|114229|P1|STARTED|Treatment Period 2||19
49848|NCT01523366|114228|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
49849|NCT01523366|114229|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
49850|NCT01523366|114228|P2|COMPLETED|Washout Period - 10-14 Days||20
49851|NCT01523366|114229|P1|COMPLETED|Washout Period - 10-14 Days||19
49852|NCT01523366|114228|P2|STARTED|Washout Period - 10-14 Days||20
49853|NCT01523366|114229|P1|STARTED|Washout Period - 10-14 Days||19
49854|NCT01523366|114228|P2|NOT COMPLETED|Treatment Period 1||0
49855|NCT01523366|114229|P1|NOT COMPLETED|Treatment Period 1||1
49856|NCT01523366|114228|P2|COMPLETED|Treatment Period 1||20
49857|NCT01523366|114229|P1|COMPLETED|Treatment Period 1||19
49858|NCT01523366|114228|P2|STARTED|Treatment Period 1||20
49859|NCT01523366|114229|P1|STARTED|Treatment Period 1||20
49860|NCT01523301|114245|P2|NOT COMPLETED|Overall Study||32
49861|NCT01523301|114246|P1|NOT COMPLETED|Overall Study||35
49862|NCT01523301|114245|P2|COMPLETED|Overall Study||164
49863|NCT01523301|114246|P1|COMPLETED|Overall Study||149
49864|NCT01523301|114245|P2|STARTED|Overall Study||196
49865|NCT01523301|114246|P1|STARTED|Overall Study||184
49866|NCT01522976|114267|P3|NOT COMPLETED|Overall Study||93
49867|NCT01522976|114268|P2|NOT COMPLETED|Overall Study||92
49868|NCT01522976|114269|P1|NOT COMPLETED|Overall Study||97
49869|NCT01522976|114267|P3|COMPLETED|Overall Study||0
49870|NCT01522976|114268|P2|COMPLETED|Overall Study||0
49871|NCT01522976|114269|P1|COMPLETED|Overall Study||0
49872|NCT01522976|114267|P3|STARTED|Overall Study||93
49873|NCT01522976|114268|P2|STARTED|Overall Study||92
49874|NCT01522976|114269|P1|STARTED|Overall Study||97
49875|NCT01522924|114291|P2|NOT COMPLETED|Overall Study||0
49876|NCT01522924|114292|P1|NOT COMPLETED|Overall Study||0
49877|NCT01522924|114291|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
49878|NCT01522924|114292|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
49879|NCT01522924|114291|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
49880|NCT01522924|114292|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
49881|NCT01522703|114312|P2|NOT COMPLETED|Overall Study||6
49882|NCT01522703|114313|P1|NOT COMPLETED|Overall Study||5
49883|NCT01522703|114312|P2|COMPLETED|Overall Study||20
49884|NCT01522703|114313|P1|COMPLETED|Overall Study||20
49885|NCT01522703|114312|P2|STARTED|Overall Study||26
49886|NCT01522703|114313|P1|STARTED|Overall Study||25
49887|NCT01522456|114319|P1|NOT COMPLETED|Overall Study||8
49888|NCT01522456|114319|P1|COMPLETED|Overall Study||65
49889|NCT01522456|114319|P1|STARTED|Overall Study||73
49890|NCT01522339|114380|P1|NOT COMPLETED|Overall Study||0
49891|NCT01522339|114380|P1|COMPLETED|Overall Study||15
49892|NCT01522339|114380|P1|STARTED|Overall Study||15
49893|NCT01522131|114387|P2|NOT COMPLETED|Overall Study||0
49894|NCT01522131|114388|P1|NOT COMPLETED|Overall Study||2
49895|NCT01522131|114387|P2|COMPLETED|Overall Study||17
49896|NCT01522131|114388|P1|COMPLETED|Overall Study||14
49897|NCT01522131|114387|P2|STARTED|Overall Study||17
49898|NCT01522131|114388|P1|STARTED|Overall Study||16
49899|NCT01521923|114400|P4|NOT COMPLETED|Overall Study||13
49900|NCT01521923|114401|P3|NOT COMPLETED|Overall Study||15
49901|NCT01521923|114402|P2|NOT COMPLETED|Overall Study||9
49902|NCT01521923|114403|P1|NOT COMPLETED|Overall Study||7
49903|NCT01521923|114400|P4|COMPLETED|Overall Study||70
49904|NCT01521923|114401|P3|COMPLETED|Overall Study||112
49905|NCT01521923|114402|P2|COMPLETED|Overall Study||72
49906|NCT01521923|114403|P1|COMPLETED|Overall Study||59
49907|NCT01521923|114400|P4|STARTED|Overall Study||83
49908|NCT01521923|114401|P3|STARTED|Overall Study||127
49909|NCT01521923|114402|P2|STARTED|Overall Study||81
49910|NCT01521923|114403|P1|STARTED|Overall Study||66
49911|NCT01521897|114523|P1|NOT COMPLETED|Overall Study||23
49912|NCT01521897|114523|P1|COMPLETED|Overall Study||1120
49913|NCT01521897|114523|P1|STARTED|Overall Study||1143
49914|NCT01521884|114535|P1|NOT COMPLETED|Overall Study||27
49915|NCT01521884|114535|P1|COMPLETED|Overall Study||35
49916|NCT01521884|114535|P1|STARTED|Overall Study||62
49917|NCT01521871|114554|P2|NOT COMPLETED|Overall Study||0
49918|NCT01521871|114555|P1|NOT COMPLETED|Overall Study||0
49919|NCT01521871|114554|P2|COMPLETED|Overall Study||32
49920|NCT01521871|114555|P1|COMPLETED|Overall Study||32
49921|NCT01521871|114554|P2|STARTED|Overall Study||32
49922|NCT01521871|114555|P1|STARTED|Overall Study||32
49923|NCT01521845|114595|P2|NOT COMPLETED|Overall Study||5
49924|NCT01521845|114596|P1|NOT COMPLETED|Overall Study||9
49925|NCT01521845|114595|P2|COMPLETED|Overall Study||47
49926|NCT01521845|114596|P1|COMPLETED|Overall Study||43
49927|NCT01521845|114595|P2|STARTED|Overall Study||52
49928|NCT01521845|114596|P1|STARTED|Overall Study||52
49929|NCT01521780|114606|P3|NOT COMPLETED|Overall Study||0
49930|NCT01521780|114607|P2|NOT COMPLETED|Overall Study||0
49931|NCT01521780|114608|P1|NOT COMPLETED|Overall Study||0
49932|NCT01521780|114606|P3|COMPLETED|Overall Study||2
49933|NCT01521780|114607|P2|COMPLETED|Overall Study||1
49934|NCT01521780|114608|P1|COMPLETED|Overall Study||9
49935|NCT01521780|114606|P3|STARTED|Overall Study||2
49936|NCT01521780|114607|P2|STARTED|Overall Study||1
49937|NCT01521780|114608|P1|STARTED|Overall Study||9
49938|NCT01521559|114632|P2|NOT COMPLETED|Overall Study||18
49939|NCT01521559|114633|P1|NOT COMPLETED|Overall Study||15
49940|NCT01521559|114632|P2|COMPLETED|Overall Study||73
49941|NCT01521559|114633|P1|COMPLETED|Overall Study||77
49942|NCT01521559|114632|P2|Completed Week 52|Overall Study||73
49943|NCT01521559|114633|P1|Completed Week 52|Overall Study||77
49944|NCT01521559|114632|P2|Completed Week 24|Overall Study||85
49945|NCT01521559|114633|P1|Completed Week 24|Overall Study||83
49946|NCT01521559|114632|P2|STARTED|Overall Study||91
49947|NCT01521559|114633|P1|STARTED|Overall Study||92
49948|NCT01521546|114647|P2|NOT COMPLETED|Overall Study||0
49949|NCT01521546|114648|P1|NOT COMPLETED|Overall Study||2
49950|NCT01521546|114647|P2|COMPLETED|Overall Study||20
49951|NCT01521546|114648|P1|COMPLETED|Overall Study||20
49952|NCT01521546|114647|P2|STARTED|Overall Study||20
49953|NCT01521546|114648|P1|STARTED|Overall Study||22
49954|NCT01521507|114656|P2|NOT COMPLETED|Stage 2: Observational Design||2
49955|NCT01521507|114657|P1|NOT COMPLETED|Stage 2: Observational Design||4
49956|NCT01521507|114656|P2|COMPLETED|Stage 2: Observational Design||92
49957|NCT01521507|114657|P1|COMPLETED|Stage 2: Observational Design||94
49958|NCT01521507|114656|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
49959|NCT01521507|114657|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
49960|NCT01521507|114656|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
49961|NCT01521507|114657|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
49962|NCT01521507|114656|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
49963|NCT01521507|114657|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
49964|NCT01521507|114656|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
49965|NCT01521507|114657|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
49966|NCT01521507|114656|P2|STARTED|Stage 2: Observational Design||94
49967|NCT01521507|114657|P1|STARTED|Stage 2: Observational Design||98
49968|NCT01521507|114656|P2|NOT COMPLETED|Stage 1: Randomized Design||5
49969|NCT01521507|114657|P1|NOT COMPLETED|Stage 1: Randomized Design||3
49970|NCT01521507|114656|P2|COMPLETED|Stage 1: Randomized Design||94
49971|NCT01521507|114657|P1|COMPLETED|Stage 1: Randomized Design||98
49972|NCT01521507|114656|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
49973|NCT01521507|114657|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
49974|NCT01521507|114656|P2|STARTED|Stage 1: Randomized Design||99
49975|NCT01521507|114657|P1|STARTED|Stage 1: Randomized Design||101
49976|NCT01521364|114674|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
49977|NCT01521364|114674|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
49978|NCT01521364|114674|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
49979|NCT01521364|114674|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
49980|NCT01521364|114674|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
49981|NCT01521364|114674|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
49982|NCT01521364|114674|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
49983|NCT01521364|114674|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
49984|NCT01521364|114674|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
49985|NCT01521260|114687|P2|NOT COMPLETED|Overall Study||0
49986|NCT01521260|114688|P1|NOT COMPLETED|Overall Study||0
49987|NCT01521260|114687|P2|COMPLETED|Overall Study||15
49988|NCT01521260|114688|P1|COMPLETED|Overall Study||15
49989|NCT01521260|114687|P2|STARTED|Overall Study||15
49990|NCT01521260|114688|P1|STARTED|Overall Study||15
49991|NCT01521143|114698|P4|NOT COMPLETED|Overall Study||7
49992|NCT01521143|114699|P3|NOT COMPLETED|Overall Study||8
49993|NCT01521143|114700|P2|NOT COMPLETED|Overall Study||26
49994|NCT01521143|114701|P1|NOT COMPLETED|Overall Study||29
49995|NCT01521143|114698|P4|COMPLETED|Overall Study||0
49996|NCT01521143|114699|P3|COMPLETED|Overall Study||0
49997|NCT01521143|114700|P2|COMPLETED|Overall Study||10
49998|NCT01521143|114701|P1|COMPLETED|Overall Study||11
49999|NCT01521143|114698|P4|Received Treatment|Overall Study||4
50000|NCT01521143|114699|P3|Received Treatment|Overall Study||3
50001|NCT01521143|114700|P2|Received Treatment|Overall Study||20
50002|NCT01521143|114701|P1|Received Treatment|Overall Study||20
50003|NCT01521143|114698|P4|STARTED|Overall Study||7
50004|NCT01521143|114699|P3|STARTED|Overall Study||8
50005|NCT01521143|114700|P2|STARTED|Overall Study||36
50006|NCT01521143|114701|P1|STARTED|Overall Study||40
50007|NCT01521026|114733|P2|NOT COMPLETED|Overall Study||3
50008|NCT01521026|114734|P1|NOT COMPLETED|Overall Study||15
50009|NCT01521026|114733|P2|COMPLETED|Overall Study||28
50010|NCT01521026|114734|P1|COMPLETED|Overall Study||23
50011|NCT01521026|114733|P2|STARTED|Overall Study||31
50012|NCT01521026|114734|P1|STARTED|Overall Study||38
50013|NCT01520987|114750|P8|NOT COMPLETED|Overall Study||0
50014|NCT01520987|114751|P7|NOT COMPLETED|Overall Study||0
50015|NCT01520987|114752|P6|NOT COMPLETED|Overall Study||1
50016|NCT01520987|114753|P5|NOT COMPLETED|Overall Study||0
50017|NCT01520987|114754|P4|NOT COMPLETED|Overall Study||0
50018|NCT01520987|114755|P3|NOT COMPLETED|Overall Study||0
50019|NCT01520987|114756|P2|NOT COMPLETED|Overall Study||0
50020|NCT01520987|114757|P1|NOT COMPLETED|Overall Study||1
50021|NCT01520987|114750|P8|COMPLETED|Overall Study||14
50022|NCT01520987|114751|P7|COMPLETED|Overall Study||12
50023|NCT01520987|114752|P6|COMPLETED|Overall Study||13
50024|NCT01520987|114753|P5|COMPLETED|Overall Study||14
50025|NCT01520987|114754|P4|COMPLETED|Overall Study||15
50026|NCT01520987|114755|P3|COMPLETED|Overall Study||11
50027|NCT01520987|114756|P2|COMPLETED|Overall Study||12
50028|NCT01520987|114757|P1|COMPLETED|Overall Study||12
50029|NCT01520987|114750|P8|Dosed|Overall Study||14
50030|NCT01520987|114751|P7|Dosed|Overall Study||12
50031|NCT01520987|114752|P6|Dosed|Overall Study||14
50032|NCT01520987|114753|P5|Dosed|Overall Study||14
50033|NCT01520987|114754|P4|Dosed|Overall Study||15
50034|NCT01520987|114755|P3|Dosed|Overall Study||11
50035|NCT01520987|114756|P2|Dosed|Overall Study||12
50036|NCT01520987|114757|P1|Dosed|Overall Study||13
50037|NCT01520987|114750|P8|STARTED|Overall Study||14
50038|NCT01520987|114751|P7|STARTED|Overall Study||12
50039|NCT01520987|114752|P6|STARTED|Overall Study||14
50040|NCT01520987|114753|P5|STARTED|Overall Study||14
50041|NCT01520987|114754|P4|STARTED|Overall Study||15
50042|NCT01520987|114755|P3|STARTED|Overall Study||11
50043|NCT01520987|114756|P2|STARTED|Overall Study||12
50044|NCT01520987|114757|P1|STARTED|Overall Study||13
50045|NCT01520922|114817|P2|NOT COMPLETED|Survival Follow-up||0
50046|NCT01520922|114818|P1|NOT COMPLETED|Survival Follow-up||1
50047|NCT01520922|114817|P2|COMPLETED|Survival Follow-up||40
50048|NCT01520922|114818|P1|COMPLETED|Survival Follow-up||20
50049|NCT01520922|114817|P2|STARTED|Survival Follow-up||40
50050|NCT01520922|114818|P1|STARTED|Survival Follow-up||21
50051|NCT01520922|114817|P2|NOT COMPLETED|Follow up||1
50052|NCT01520922|114818|P1|NOT COMPLETED|Follow up||0
50053|NCT01520922|114817|P2|COMPLETED|Follow up||44
50054|NCT01520922|114818|P1|COMPLETED|Follow up||44
50055|NCT01520922|114817|P2|STARTED|Follow up||45
50056|NCT01520922|114818|P1|STARTED|Follow up||44
50057|NCT01520922|114817|P2|NOT COMPLETED|Treatment Phase||8
50058|NCT01520922|114818|P1|NOT COMPLETED|Treatment Phase||5
50059|NCT01520922|114817|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
50060|NCT01520922|114818|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
50061|NCT01520922|114817|P2|STARTED|Treatment Phase||53
50062|NCT01520922|114818|P1|STARTED|Treatment Phase||44
50063|NCT01520909|114880|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
50064|NCT01520909|114881|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
50065|NCT01520909|114882|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
50066|NCT01520909|114880|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
50067|NCT01520909|114881|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
50068|NCT01520909|114882|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
50069|NCT01520909|114880|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
50070|NCT01520909|114881|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
50071|NCT01520909|114882|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
50072|NCT01520909|114880|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
50073|NCT01520909|114881|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
50074|NCT01520909|114882|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
50075|NCT01520909|114880|P3|COMPLETED|Part 1 (Randomized Period)||0
50076|NCT01520909|114881|P2|COMPLETED|Part 1 (Randomized Period)||61
50077|NCT01520909|114882|P1|COMPLETED|Part 1 (Randomized Period)||28
50078|NCT01520909|114880|P3|STARTED|Part 1 (Randomized Period)||0
50079|NCT01520909|114881|P2|STARTED|Part 1 (Randomized Period)||63
50080|NCT01520909|114882|P1|STARTED|Part 1 (Randomized Period)||29
50081|NCT01520727|114953|P9|NOT COMPLETED|Overall Study||0
50082|NCT01520727|114954|P8|NOT COMPLETED|Overall Study||0
50083|NCT01520727|114955|P7|NOT COMPLETED|Overall Study||0
50084|NCT01520727|114956|P6|NOT COMPLETED|Overall Study||0
50085|NCT01520727|114957|P5|NOT COMPLETED|Overall Study||0
50086|NCT01520727|114958|P4|NOT COMPLETED|Overall Study||0
50087|NCT01520727|114959|P3|NOT COMPLETED|Overall Study||0
50088|NCT01520727|114960|P2|NOT COMPLETED|Overall Study||0
50089|NCT01520727|114961|P1|NOT COMPLETED|Overall Study||0
50090|NCT01520727|114953|P9|COMPLETED|Overall Study||16
50091|NCT01520727|114954|P8|COMPLETED|Overall Study||6
50092|NCT01520727|114955|P7|COMPLETED|Overall Study||6
50093|NCT01520727|114956|P6|COMPLETED|Overall Study||6
50094|NCT01520727|114957|P5|COMPLETED|Overall Study||6
50095|NCT01520727|114958|P4|COMPLETED|Overall Study||6
50096|NCT01520727|114959|P3|COMPLETED|Overall Study||6
50097|NCT01520727|114960|P2|COMPLETED|Overall Study||6
50098|NCT01520727|114961|P1|COMPLETED|Overall Study||6
50099|NCT01520727|114953|P9|STARTED|Overall Study||16
50100|NCT01520727|114954|P8|STARTED|Overall Study||6
50101|NCT01520727|114955|P7|STARTED|Overall Study||6
50102|NCT01520727|114956|P6|STARTED|Overall Study||6
50103|NCT01520727|114957|P5|STARTED|Overall Study||6
50104|NCT01520727|114958|P4|STARTED|Overall Study||6
50105|NCT01520727|114959|P3|STARTED|Overall Study||6
50106|NCT01520727|114960|P2|STARTED|Overall Study||6
50107|NCT01520727|114961|P1|STARTED|Overall Study||6
50108|NCT01520714|114999|P2|NOT COMPLETED|Overall Study||6
50109|NCT01520714|115000|P1|NOT COMPLETED|Overall Study||0
50110|NCT01520714|114999|P2|COMPLETED|Overall Study||5
50111|NCT01520714|115000|P1|COMPLETED|Overall Study||0
50112|NCT01520714|114999|P2|STARTED|Overall Study||11
50113|NCT01520714|115000|P1|STARTED|Overall Study||0
50114|NCT01520532|115006|P1|NOT COMPLETED|Overall Study||0
50115|NCT01520532|115006|P1|COMPLETED|Overall Study||60
50116|NCT01520532|115006|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
50117|NCT01520506|115012|P1|NOT COMPLETED|Overall Study||6
50118|NCT01520506|115012|P1|COMPLETED|Overall Study||44
50119|NCT01520506|115012|P1|STARTED|Overall Study||50
50120|NCT01520402|115018|P1|NOT COMPLETED|Overall Study||5
50121|NCT01520402|115018|P1|COMPLETED|Overall Study||30
50122|NCT01520402|115018|P1|STARTED|Overall Study||35
50123|NCT01519960|115032|P3|NOT COMPLETED|Overall Study||10
50124|NCT01519960|115033|P2|NOT COMPLETED|Overall Study||50
50125|NCT01519960|115034|P1|NOT COMPLETED|Overall Study||101
50126|NCT01519960|115032|P3|COMPLETED|Overall Study||0
50127|NCT01519960|115033|P2|COMPLETED|Overall Study||0
50128|NCT01519960|115034|P1|COMPLETED|Overall Study||0
50129|NCT01519960|115032|P3|Completed FU Week 24|Overall Study||10
50130|NCT01519960|115033|P2|Completed FU Week 24|Overall Study||15
50131|NCT01519960|115034|P1|Completed FU Week 24|Overall Study||101
50132|NCT01519960|115032|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
50133|NCT01519960|115033|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
50134|NCT01519960|115034|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
50135|NCT01519960|115032|P3|Completed Week 48|Overall Study||10
50136|NCT01519960|115033|P2|Completed Week 48|Overall Study||47
50137|NCT01519960|115034|P1|Completed Week 48|Overall Study||99
50138|NCT01519960|115032|P3|STARTED|Overall Study||10
50139|NCT01519960|115033|P2|STARTED|Overall Study||50
50140|NCT01519960|115034|P1|STARTED|Overall Study||101
50141|NCT01519934|115140|P1|NOT COMPLETED|Overall Study||3
50142|NCT01519934|115140|P1|COMPLETED|Overall Study||45
50143|NCT01519934|115140|P1|STARTED|Overall Study||48
50144|NCT01519921|115149|P2|NOT COMPLETED|Overall Study||15
50145|NCT01519921|115150|P1|NOT COMPLETED|Overall Study||21
50146|NCT01519921|115149|P2|COMPLETED|Overall Study||49
50147|NCT01519921|115150|P1|COMPLETED|Overall Study||65
50148|NCT01519921|115149|P2|STARTED|Overall Study||64
50149|NCT01519921|115150|P1|STARTED|Overall Study||86
50150|NCT01519882|115174|P2|NOT COMPLETED|Overall Study||0
50151|NCT01519882|115175|P1|NOT COMPLETED|Overall Study||0
50152|NCT01519882|115174|P2|COMPLETED|Overall Study||0
50153|NCT01519882|115175|P1|COMPLETED|Overall Study||1
50154|NCT01519882|115174|P2|STARTED|Overall Study||0
50155|NCT01519882|115175|P1|STARTED|Overall Study||1
50156|NCT01519791|115201|P2|NOT COMPLETED|Overall Study||368
50157|NCT01519791|115202|P1|NOT COMPLETED|Overall Study||152
50158|NCT01519791|115201|P2|COMPLETED|Overall Study||292
50159|NCT01519791|115202|P1|COMPLETED|Overall Study||67
50160|NCT01519791|115201|P2|Completed Week 52|Overall Study||500
50161|NCT01519791|115202|P1|Completed Week 52|Overall Study||143
50162|NCT01519791|115201|P2|STARTED|Overall Study||660
50163|NCT01519791|115202|P1|STARTED|Overall Study||219
50164|NCT01519778|115266|P1|NOT COMPLETED|Overall Study||14
50165|NCT01519778|115266|P1|COMPLETED|Overall Study||186
50166|NCT01519778|115266|P1|STARTED|Overall Study||200
50167|NCT01519765|115272|P2|NOT COMPLETED|Overall Study||2
50168|NCT01519765|115273|P1|NOT COMPLETED|Overall Study||3
50169|NCT01519765|115272|P2|COMPLETED|Overall Study||34
50170|NCT01519765|115273|P1|COMPLETED|Overall Study||34
50171|NCT01519765|115272|P2|STARTED|Overall Study||36
50172|NCT01519765|115273|P1|STARTED|Overall Study||37
50173|NCT01519713|115322|P3|NOT COMPLETED|Overall Study||0
50174|NCT01519713|115323|P2|NOT COMPLETED|Overall Study||0
50175|NCT01519713|115324|P1|NOT COMPLETED|Overall Study||0
50176|NCT01519713|115322|P3|COMPLETED|Overall Study||4
50177|NCT01519713|115323|P2|COMPLETED|Overall Study||2
50178|NCT01519713|115324|P1|COMPLETED|Overall Study||194
50179|NCT01519713|115322|P3|STARTED|Overall Study||4
50180|NCT01519713|115323|P2|STARTED|Overall Study||2
50181|NCT01519713|115324|P1|STARTED|Overall Study||194
50182|NCT01519700|115351|P4|NOT COMPLETED|Overall Study||7
50183|NCT01519700|115352|P3|NOT COMPLETED|Overall Study||7
50184|NCT01519700|115353|P2|NOT COMPLETED|Overall Study||6
50185|NCT01519700|115354|P1|NOT COMPLETED|Overall Study||9
50186|NCT01519700|115351|P4|COMPLETED|Overall Study||47
50187|NCT01519700|115352|P3|COMPLETED|Overall Study||48
50188|NCT01519700|115353|P2|COMPLETED|Overall Study||49
50189|NCT01519700|115354|P1|COMPLETED|Overall Study||45
50190|NCT01519700|115351|P4|Treated Cycle 6 Neupogen|Overall Study||49
50191|NCT01519700|115352|P3|Treated Cycle 6 Neupogen|Overall Study||0
50192|NCT01519700|115353|P2|Treated Cycle 6 Neupogen|Overall Study||49
50193|NCT01519700|115354|P1|Treated Cycle 6 Neupogen|Overall Study||0
50194|NCT01519700|115351|P4|Treated Cycle 6 EP2006|Overall Study||0
50195|NCT01519700|115352|P3|Treated Cycle 6 EP2006|Overall Study||48
50196|NCT01519700|115353|P2|Treated Cycle 6 EP2006|Overall Study||0
50197|NCT01519700|115354|P1|Treated Cycle 6 EP2006|Overall Study||45
50198|NCT01519700|115351|P4|Treated Cycle 5 Neupogen|Overall Study||50
50199|NCT01519700|115352|P3|Treated Cycle 5 Neupogen|Overall Study||48
50200|NCT01519700|115353|P2|Treated Cycle 5 Neupogen|Overall Study||0
50201|NCT01519700|115354|P1|Treated Cycle 5 Neupogen|Overall Study||0
50202|NCT01519700|115351|P4|Treated Cycle 5 EP2006|Overall Study||0
50203|NCT01519700|115352|P3|Treated Cycle 5 EP2006|Overall Study||0
50204|NCT01519700|115353|P2|Treated Cycle 5 EP2006|Overall Study||49
50205|NCT01519700|115354|P1|Treated Cycle 5 EP2006|Overall Study||46
50206|NCT01519700|115351|P4|Treated Cycle 4 Neupogen|Overall Study||50
50207|NCT01519700|115352|P3|Treated Cycle 4 Neupogen|Overall Study||0
50208|NCT01519700|115353|P2|Treated Cycle 4 Neupogen|Overall Study||51
50209|NCT01519700|115354|P1|Treated Cycle 4 Neupogen|Overall Study||0
50210|NCT01519700|115351|P4|Treated Cycle 4 EP2006|Overall Study||0
50211|NCT01519700|115352|P3|Treated Cycle 4 EP2006|Overall Study||50
50212|NCT01519700|115353|P2|Treated Cycle 4 EP2006|Overall Study||0
50213|NCT01519700|115354|P1|Treated Cycle 4 EP2006|Overall Study||51
50214|NCT01519700|115351|P4|Treated Cycle 3 Neupogen|Overall Study||51
50215|NCT01519700|115352|P3|Treated Cycle 3 Neupogen|Overall Study||54
50216|NCT01519700|115353|P2|Treated Cycle 3 Neupogen|Overall Study||0
50217|NCT01519700|115354|P1|Treated Cycle 3 Neupogen|Overall Study||0
50218|NCT01519700|115351|P4|Treated Cycle 3 EP2006|Overall Study||0
50219|NCT01519700|115352|P3|Treated Cycle 3 EP2006|Overall Study||0
50220|NCT01519700|115353|P2|Treated Cycle 3 EP2006|Overall Study||51
50221|NCT01519700|115354|P1|Treated Cycle 3 EP2006|Overall Study||51
50222|NCT01519700|115351|P4|Treated Cycle 2 Neupogen|Overall Study||51
50223|NCT01519700|115352|P3|Treated Cycle 2 Neupogen|Overall Study||0
50224|NCT01519700|115353|P2|Treated Cycle 2 Neupogen|Overall Study||52
50225|NCT01519700|115354|P1|Treated Cycle 2 Neupogen|Overall Study||0
50226|NCT01519700|115351|P4|Treated Cycle 2 EP2006|Overall Study||0
50227|NCT01519700|115352|P3|Treated Cycle 2 EP2006|Overall Study||55
50228|NCT01519700|115353|P2|Treated Cycle 2 EP2006|Overall Study||0
50229|NCT01519700|115354|P1|Treated Cycle 2 EP2006|Overall Study||52
50230|NCT01519700|115351|P4|Treated Cycle 1 Neupogen|Overall Study||52
50231|NCT01519700|115352|P3|Treated Cycle 1 Neupogen|Overall Study||55
50232|NCT01519700|115353|P2|Treated Cycle 1 Neupogen|Overall Study||0
50233|NCT01519700|115354|P1|Treated Cycle 1 Neupogen|Overall Study||0
50234|NCT01519700|115351|P4|Treated Cycle 1 EP2006|Overall Study||0
50235|NCT01519700|115352|P3|Treated Cycle 1 EP2006|Overall Study||0
50236|NCT01519700|115353|P2|Treated Cycle 1 EP2006|Overall Study||54
50237|NCT01519700|115354|P1|Treated Cycle 1 EP2006|Overall Study||53
50238|NCT01519700|115351|P4|STARTED|Overall Study||54
50239|NCT01519700|115352|P3|STARTED|Overall Study||55
50240|NCT01519700|115353|P2|STARTED|Overall Study||55
50241|NCT01519700|115354|P1|STARTED|Overall Study||54
50242|NCT01519674|115389|P3|NOT COMPLETED|Overall Study||12
50243|NCT01519674|115390|P2|NOT COMPLETED|Overall Study||13
50244|NCT01519674|115391|P1|NOT COMPLETED|Overall Study||21
50245|NCT01519674|115389|P3|COMPLETED|Overall Study||181
50246|NCT01519674|115390|P2|COMPLETED|Overall Study||182
50247|NCT01519674|115391|P1|COMPLETED|Overall Study||173
50248|NCT01519674|115389|P3|Exposed|Overall Study||190
50249|NCT01519674|115390|P2|Exposed|Overall Study||193
50250|NCT01519674|115391|P1|Exposed|Overall Study||192
50251|NCT01519674|115389|P3|STARTED|Overall Study||193
50252|NCT01519674|115390|P2|STARTED|Overall Study||195
50253|NCT01519674|115391|P1|STARTED|Overall Study||194
50254|NCT01519661|115429|P1|NOT COMPLETED|Overall Study||61
50255|NCT01519661|115429|P1|COMPLETED|Overall Study||96
50256|NCT01519661|115429|P1|STARTED|Overall Study||157
50257|NCT01519648|115446|P2|NOT COMPLETED|Overall Study||0
50258|NCT01519648|115447|P1|NOT COMPLETED|Overall Study||0
50259|NCT01519648|115446|P2|COMPLETED|Overall Study||306
50260|NCT01519648|115447|P1|COMPLETED|Overall Study||502
50261|NCT01519648|115446|P2|STARTED|Overall Study||306
50262|NCT01519648|115447|P1|STARTED|Overall Study||502
50263|NCT01519518|115455|P2|NOT COMPLETED|Overall Study||10
50264|NCT01519518|115456|P1|NOT COMPLETED|Overall Study||7
50265|NCT01519518|115455|P2|COMPLETED|Overall Study||905
50266|NCT01519518|115456|P1|COMPLETED|Overall Study||907
50267|NCT01519518|115455|P2|STARTED|Overall Study||915
50268|NCT01519518|115456|P1|STARTED|Overall Study||914
50269|NCT01519466|115470|P2|NOT COMPLETED|Overall Study||0
50270|NCT01519466|115471|P1|NOT COMPLETED|Overall Study||0
50271|NCT01519466|115470|P2|COMPLETED|Overall Study||16
50272|NCT01519466|115471|P1|COMPLETED|Overall Study||33
50273|NCT01519466|115470|P2|STARTED|Overall Study||16
50274|NCT01519466|115471|P1|STARTED|Overall Study||33
50275|NCT01519427|115481|P1|NOT COMPLETED|Overall Study||2
50276|NCT01519427|115481|P1|COMPLETED|Overall Study||0
50277|NCT01519427|115481|P1|STARTED|Overall Study||2
50278|NCT01519323|115488|P2|NOT COMPLETED|Overall Study||3
50279|NCT01519323|115489|P1|NOT COMPLETED|Overall Study||3
50280|NCT01519323|115488|P2|COMPLETED|Overall Study||0
50281|NCT01519323|115489|P1|COMPLETED|Overall Study||0
50282|NCT01519323|115488|P2|STARTED|Overall Study||3
50283|NCT01519323|115489|P1|STARTED|Overall Study||3
50284|NCT01519284|115505|P5|NOT COMPLETED|Overall Study||0
50285|NCT01519284|115506|P4|NOT COMPLETED|Overall Study||0
50286|NCT01519284|115507|P3|NOT COMPLETED|Overall Study||2
50287|NCT01519284|115508|P2|NOT COMPLETED|Overall Study||0
50288|NCT01519284|115509|P1|NOT COMPLETED|Overall Study||0
50289|NCT01519284|115505|P5|COMPLETED|Overall Study||16
50290|NCT01519284|115506|P4|COMPLETED|Overall Study||16
50291|NCT01519284|115507|P3|COMPLETED|Overall Study||16
50292|NCT01519284|115508|P2|COMPLETED|Overall Study||16
50293|NCT01519284|115509|P1|COMPLETED|Overall Study||16
50294|NCT01519284|115505|P5|STARTED|Overall Study||16
50295|NCT01519284|115506|P4|STARTED|Overall Study||16
50296|NCT01519284|115507|P3|STARTED|Overall Study||18
50297|NCT01519284|115508|P2|STARTED|Overall Study||16
50298|NCT01519284|115509|P1|STARTED|Overall Study||16
50299|NCT01519245|115538|P2|NOT COMPLETED|Overall Study||2
50300|NCT01519245|115539|P1|NOT COMPLETED|Overall Study||1
50301|NCT01519245|115538|P2|COMPLETED|Overall Study||18
50302|NCT01519245|115539|P1|COMPLETED|Overall Study||23
50303|NCT01519245|115538|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
50304|NCT01519245|115539|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
50305|NCT01519245|115538|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
50306|NCT01519245|115539|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
50307|NCT01519245|115538|P2|STARTED|Overall Study||20
50308|NCT01519245|115539|P1|STARTED|Overall Study||24
50309|NCT01519206|115551|P1|NOT COMPLETED|Overall Study||5
50310|NCT01519206|115551|P1|COMPLETED|Overall Study||27
50311|NCT01519206|115551|P1|STARTED|Overall Study||32
50312|NCT01519167|115565|P2|NOT COMPLETED|Overall Study||8
50313|NCT01519167|115566|P1|NOT COMPLETED|Overall Study||0
50314|NCT01519167|115565|P2|COMPLETED|Overall Study||81
50315|NCT01519167|115566|P1|COMPLETED|Overall Study||1
50316|NCT01519167|115565|P2|STARTED|Overall Study||89
50317|NCT01519167|115566|P1|STARTED|Overall Study||1
50318|NCT01519089|115592|P2|NOT COMPLETED|Overall Study||15
50319|NCT01519089|115593|P1|NOT COMPLETED|Overall Study||7
50320|NCT01519089|115592|P2|COMPLETED|Overall Study||33
50321|NCT01519089|115593|P1|COMPLETED|Overall Study||40
50322|NCT01519089|115592|P2|Received Treatment|Overall Study||47
50323|NCT01519089|115593|P1|Received Treatment|Overall Study||47
50324|NCT01519089|115592|P2|STARTED|Overall Study||48
50325|NCT01519089|115593|P1|STARTED|Overall Study||47
50326|NCT01518946|115714|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
50327|NCT01518946|115715|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
50328|NCT01518946|115716|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
50329|NCT01518946|115714|P3|COMPLETED|Randomized Phase (Second Intervention)||10
50330|NCT01518946|115715|P2|COMPLETED|Randomized Phase (Second Intervention)||9
50331|NCT01518946|115716|P1|COMPLETED|Randomized Phase (Second Intervention)||0
50332|NCT01518946|115714|P3|STARTED|Randomized Phase (Second Intervention)||10
50333|NCT01518946|115715|P2|STARTED|Randomized Phase (Second Intervention)||9
50334|NCT01518946|115716|P1|STARTED|Randomized Phase (Second Intervention)||0
50335|NCT01518946|115714|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
50336|NCT01518946|115715|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
50337|NCT01518946|115716|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
50338|NCT01518946|115714|P3|COMPLETED|Randomized Phase (First Intervention)||10
50339|NCT01518946|115715|P2|COMPLETED|Randomized Phase (First Intervention)||9
50340|NCT01518946|115716|P1|COMPLETED|Randomized Phase (First Intervention)||0
50341|NCT01518946|115714|P3|STARTED|Randomized Phase (First Intervention)||10
50342|NCT01518946|115715|P2|STARTED|Randomized Phase (First Intervention)||10
50343|NCT01518946|115716|P1|STARTED|Randomized Phase (First Intervention)||0
50344|NCT01518946|115714|P3|NOT COMPLETED|Open-label Phase||0
50345|NCT01518946|115715|P2|NOT COMPLETED|Open-label Phase||0
50346|NCT01518946|115716|P1|NOT COMPLETED|Open-label Phase||4
50347|NCT01518946|115714|P3|COMPLETED|Open-label Phase||0
50348|NCT01518946|115715|P2|COMPLETED|Open-label Phase||0
50349|NCT01518946|115716|P1|COMPLETED|Open-label Phase||20
50350|NCT01518946|115714|P3|STARTED|Open-label Phase||0
50351|NCT01518946|115715|P2|STARTED|Open-label Phase||0
50352|NCT01518946|115716|P1|STARTED|Open-label Phase||24
50353|NCT01518530|115723|P1|NOT COMPLETED|Post-Treatment Follow-up||0
50354|NCT01518530|115723|P1|COMPLETED|Post-Treatment Follow-up||9
50355|NCT01518530|115723|P1|STARTED|Post-Treatment Follow-up||9
50356|NCT01518530|115723|P1|NOT COMPLETED|Active Treatment Period||1
50357|NCT01518530|115723|P1|COMPLETED|Active Treatment Period||9
50358|NCT01518530|115723|P1|STARTED|Active Treatment Period||10
50359|NCT01518322|115727|P1|NOT COMPLETED|Overall Study||13
50360|NCT01518322|115727|P1|COMPLETED|Overall Study||222
50361|NCT01518322|115727|P1|STARTED|Overall Study||235
50362|NCT01518270|115740|P1|NOT COMPLETED|Overall Study||0
50363|NCT01518270|115740|P1|COMPLETED|Overall Study||179
50364|NCT01518270|115740|P1|STARTED|Overall Study||179
50365|NCT01518257|115748|P2|NOT COMPLETED|Overall Study||0
50366|NCT01518257|115749|P1|NOT COMPLETED|Overall Study||2
50367|NCT01518257|115748|P2|COMPLETED|Overall Study||60
50368|NCT01518257|115749|P1|COMPLETED|Overall Study||59
50369|NCT01518257|115748|P2|STARTED|Overall Study||60
50370|NCT01518257|115749|P1|STARTED|Overall Study||61
50371|NCT01518244|115771|P1|NOT COMPLETED|Overall Study||3
50372|NCT01518244|115771|P1|COMPLETED|Overall Study||47
50373|NCT01518244|115771|P1|STARTED|Overall Study||50
50374|NCT01518192|115779|P3|NOT COMPLETED|Overall Study||35
50375|NCT01518192|115780|P2|NOT COMPLETED|Overall Study||26
50376|NCT01518192|115781|P1|NOT COMPLETED|Overall Study||29
50377|NCT01518192|115779|P3|COMPLETED|Overall Study||224
50378|NCT01518192|115780|P2|COMPLETED|Overall Study||114
50379|NCT01518192|115781|P1|COMPLETED|Overall Study||116
50380|NCT01518192|115779|P3|STARTED|Overall Study||259
50381|NCT01518192|115780|P2|STARTED|Overall Study||140
50382|NCT01518192|115781|P1|STARTED|Overall Study||145
50383|NCT01518153|115802|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
50384|NCT01518153|115803|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
50385|NCT01518153|115804|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
50386|NCT01518153|115802|P3|COMPLETED|Donor Lymphocyte Infusion||3
50387|NCT01518153|115803|P2|COMPLETED|Donor Lymphocyte Infusion||1
50388|NCT01518153|115804|P1|COMPLETED|Donor Lymphocyte Infusion||0
50389|NCT01518153|115802|P3|STARTED|Donor Lymphocyte Infusion||4
50390|NCT01518153|115803|P2|STARTED|Donor Lymphocyte Infusion||3
50391|NCT01518153|115804|P1|STARTED|Donor Lymphocyte Infusion||0
50392|NCT01518153|115802|P3|NOT COMPLETED|Stem Cell Transplant||0
50393|NCT01518153|115803|P2|NOT COMPLETED|Stem Cell Transplant||0
50394|NCT01518153|115804|P1|NOT COMPLETED|Stem Cell Transplant||9
50395|NCT01518153|115802|P3|COMPLETED|Stem Cell Transplant||0
50396|NCT01518153|115803|P2|COMPLETED|Stem Cell Transplant||0
50397|NCT01518153|115804|P1|COMPLETED|Stem Cell Transplant||7
50398|NCT01518153|115802|P3|STARTED|Stem Cell Transplant||0
50399|NCT01518153|115803|P2|STARTED|Stem Cell Transplant||0
50400|NCT01518153|115804|P1|STARTED|Stem Cell Transplant||16
50401|NCT01517984|115815|P4|NOT COMPLETED|Overall Study||1
50402|NCT01517984|115816|P3|NOT COMPLETED|Overall Study||4
50403|NCT01517984|115817|P2|NOT COMPLETED|Overall Study||23
50404|NCT01517984|115818|P1|NOT COMPLETED|Overall Study||5
50405|NCT01517984|115815|P4|COMPLETED|Overall Study||6
50406|NCT01517984|115816|P3|COMPLETED|Overall Study||10
50407|NCT01517984|115817|P2|COMPLETED|Overall Study||3
50408|NCT01517984|115818|P1|COMPLETED|Overall Study||0
50409|NCT01517984|115815|P4|STARTED|Overall Study||7
50410|NCT01517984|115816|P3|STARTED|Overall Study||14
50411|NCT01517984|115817|P2|STARTED|Overall Study||26
50412|NCT01517984|115818|P1|STARTED|Overall Study||5
50413|NCT01517893|115844|P2|NOT COMPLETED|Overall Study||1
50414|NCT01517893|115845|P1|NOT COMPLETED|Overall Study||2
50415|NCT01517893|115844|P2|COMPLETED|Overall Study||6
50416|NCT01517893|115845|P1|COMPLETED|Overall Study||6
50417|NCT01517893|115844|P2|STARTED|Overall Study||7
50418|NCT01517893|115845|P1|STARTED|Overall Study||8
50419|NCT01517750|115855|P4|NOT COMPLETED|Overall Study||1
50420|NCT01517750|115856|P3|NOT COMPLETED|Overall Study||4
50421|NCT01517750|115857|P2|NOT COMPLETED|Overall Study||2
50422|NCT01517750|115858|P1|NOT COMPLETED|Overall Study||1
50423|NCT01517750|115855|P4|COMPLETED|Overall Study||18
50424|NCT01517750|115856|P3|COMPLETED|Overall Study||17
50425|NCT01517750|115857|P2|COMPLETED|Overall Study||17
50426|NCT01517750|115858|P1|COMPLETED|Overall Study||20
50427|NCT01517750|115855|P4|STARTED|Overall Study||19
50428|NCT01517750|115856|P3|STARTED|Overall Study||21
50429|NCT01517750|115857|P2|STARTED|Overall Study||19
50430|NCT01517750|115858|P1|STARTED|Overall Study||21
50431|NCT01517529|115888|P1|NOT COMPLETED|Overall Study||0
50432|NCT01517529|115888|P1|COMPLETED|Overall Study||10
50433|NCT01517529|115888|P1|STARTED|Overall Study||10
50434|NCT01517412|115895|P2|NOT COMPLETED|Overall Study||24
50435|NCT01517412|115896|P1|NOT COMPLETED|Overall Study||36
50436|NCT01517412|115895|P2|COMPLETED|Overall Study||202
50437|NCT01517412|115896|P1|COMPLETED|Overall Study||189
50438|NCT01517412|115895|P2|STARTED|Overall Study||226
50439|NCT01517412|115896|P1|STARTED|Overall Study||225
50440|NCT01517373|115925|P6|NOT COMPLETED|Treatment Period||7
50441|NCT01517373|115926|P5|NOT COMPLETED|Treatment Period||6
50442|NCT01517373|115927|P4|NOT COMPLETED|Treatment Period||7
50443|NCT01517373|115928|P3|NOT COMPLETED|Treatment Period||6
50444|NCT01517373|115929|P2|NOT COMPLETED|Treatment Period||4
50445|NCT01517373|115930|P1|NOT COMPLETED|Treatment Period||0
50446|NCT01517373|115925|P6|COMPLETED|Treatment Period||54
50447|NCT01517373|115926|P5|COMPLETED|Treatment Period||55
50448|NCT01517373|115927|P4|COMPLETED|Treatment Period||54
50449|NCT01517373|115928|P3|COMPLETED|Treatment Period||54
50450|NCT01517373|115929|P2|COMPLETED|Treatment Period||57
50451|NCT01517373|115930|P1|COMPLETED|Treatment Period||0
50452|NCT01517373|115925|P6|STARTED|Treatment Period||61
50453|NCT01517373|115926|P5|STARTED|Treatment Period||61
50454|NCT01517373|115927|P4|STARTED|Treatment Period||61
50455|NCT01517373|115928|P3|STARTED|Treatment Period||60
50456|NCT01517373|115929|P2|STARTED|Treatment Period||61
50457|NCT01517373|115930|P1|STARTED|Treatment Period||0
50458|NCT01517373|115925|P6|NOT COMPLETED|Run-in Period||0
50459|NCT01517373|115926|P5|NOT COMPLETED|Run-in Period||0
50460|NCT01517373|115927|P4|NOT COMPLETED|Run-in Period||0
50461|NCT01517373|115928|P3|NOT COMPLETED|Run-in Period||0
50462|NCT01517373|115929|P2|NOT COMPLETED|Run-in Period||0
50463|NCT01517373|115930|P1|NOT COMPLETED|Run-in Period||57
50464|NCT01517373|115925|P6|COMPLETED|Run-in Period||0
50465|NCT01517373|115926|P5|COMPLETED|Run-in Period||0
50466|NCT01517373|115927|P4|COMPLETED|Run-in Period||0
50467|NCT01517373|115928|P3|COMPLETED|Run-in Period||0
50468|NCT01517373|115929|P2|COMPLETED|Run-in Period||0
50469|NCT01517373|115930|P1|COMPLETED|Run-in Period||304
50470|NCT01517373|115925|P6|STARTED|Run-in Period||0
50471|NCT01517373|115926|P5|STARTED|Run-in Period||0
50472|NCT01517373|115927|P4|STARTED|Run-in Period||0
50473|NCT01517373|115928|P3|STARTED|Run-in Period||0
50474|NCT01517373|115929|P2|STARTED|Run-in Period||0
50475|NCT01517373|115930|P1|STARTED|Run-in Period||361
50476|NCT01517295|116000|P2|NOT COMPLETED|Overall Study||0
50477|NCT01517295|116001|P1|NOT COMPLETED|Overall Study||1
50478|NCT01517295|116000|P2|COMPLETED|Overall Study||14
50479|NCT01517295|116001|P1|COMPLETED|Overall Study||15
50480|NCT01517295|116000|P2|STARTED|Overall Study||14
50481|NCT01517295|116001|P1|STARTED|Overall Study||16
50482|NCT01517282|116015|P4|NOT COMPLETED|Overall Study||1
50483|NCT01517282|116016|P3|NOT COMPLETED|Overall Study||1
50484|NCT01517282|116017|P2|NOT COMPLETED|Overall Study||1
50485|NCT01517282|116018|P1|NOT COMPLETED|Overall Study||1
50486|NCT01517282|116015|P4|COMPLETED|Overall Study||5
50487|NCT01517282|116016|P3|COMPLETED|Overall Study||8
50488|NCT01517282|116017|P2|COMPLETED|Overall Study||7
50489|NCT01517282|116018|P1|COMPLETED|Overall Study||8
50490|NCT01517282|116015|P4|STARTED|Overall Study||6
50491|NCT01517282|116016|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
50492|NCT01517282|116017|P2|STARTED|Overall Study||8
50493|NCT01517282|116018|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
50494|NCT01517178|116052|P2|NOT COMPLETED|Period 2||2
50495|NCT01517178|116053|P1|NOT COMPLETED|Period 2||6
50496|NCT01517178|116052|P2|COMPLETED|Period 2||4
50497|NCT01517178|116053|P1|COMPLETED|Period 2||5
50498|NCT01517178|116052|P2|STARTED|Period 2||6
50499|NCT01517178|116053|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
50500|NCT01517178|116052|P2|NOT COMPLETED|Period 1||5
50501|NCT01517178|116053|P1|NOT COMPLETED|Period 1||4
50502|NCT01517178|116052|P2|COMPLETED|Period 1||6
50503|NCT01517178|116053|P1|COMPLETED|Period 1||12
50504|NCT01517178|116052|P2|STARTED|Period 1||11
50505|NCT01517178|116053|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
50506|NCT01517074|116059|P1|NOT COMPLETED|Overall Study||0
50507|NCT01517074|116059|P1|COMPLETED|Overall Study||5
50508|NCT01517074|116059|P1|STARTED|Overall Study||5
50509|NCT01516970|116072|P2|NOT COMPLETED|Overall Study||21
50510|NCT01516970|116073|P1|NOT COMPLETED|Overall Study||18
50511|NCT01516970|116072|P2|COMPLETED|Overall Study||132
50512|NCT01516970|116073|P1|COMPLETED|Overall Study||141
50513|NCT01516970|116072|P2|STARTED|Overall Study||153
50514|NCT01516970|116073|P1|STARTED|Overall Study||159
50515|NCT01516892|116085|P1|NOT COMPLETED|Overall Study||343
50516|NCT01516892|116085|P1|COMPLETED|Overall Study||373
50517|NCT01516892|116085|P1|STARTED|Overall Study||716
50518|NCT01516879|116093|P2|NOT COMPLETED|Overall Study||34
50519|NCT01516879|116094|P1|NOT COMPLETED|Overall Study||16
50520|NCT01516879|116093|P2|COMPLETED|Overall Study||568
50521|NCT01516879|116094|P1|COMPLETED|Overall Study||287
50522|NCT01516879|116093|P2|Received Treatment|Overall Study||599
50523|NCT01516879|116094|P1|Received Treatment|Overall Study||302
50524|NCT01516879|116093|P2|STARTED|Overall Study||602
50525|NCT01516879|116094|P1|STARTED|Overall Study||303
50526|NCT01516749|116128|P1|NOT COMPLETED|Follow-up Off Therapy||1
50527|NCT01516749|116128|P1|COMPLETED|Follow-up Off Therapy||4
50528|NCT01516749|116128|P1|STARTED|Follow-up Off Therapy||5
50529|NCT01516749|116128|P1|NOT COMPLETED|Active Therapy||1
50530|NCT01516749|116128|P1|COMPLETED|Active Therapy||5
50531|NCT01516749|116128|P1|STARTED|Active Therapy||6
50532|NCT01516632|116137|P2|NOT COMPLETED|Overall Study||15
50533|NCT01516632|116138|P1|NOT COMPLETED|Overall Study||24
50534|NCT01516632|116137|P2|COMPLETED|Overall Study||48
50535|NCT01516632|116138|P1|COMPLETED|Overall Study||77
50536|NCT01516632|116137|P2|STARTED|Overall Study||63
50537|NCT01516632|116138|P1|STARTED|Overall Study||101
50538|NCT01516268|116150|P2|NOT COMPLETED|Overall Study||0
50539|NCT01516268|116151|P1|NOT COMPLETED|Overall Study||0
50540|NCT01516268|116150|P2|COMPLETED|Overall Study||25
50541|NCT01516268|116151|P1|COMPLETED|Overall Study||25
50542|NCT01516268|116150|P2|STARTED|Overall Study||25
50543|NCT01516268|116151|P1|STARTED|Overall Study||25
50544|NCT01516034|116157|P1|NOT COMPLETED|Overall Study||8
50545|NCT01516034|116157|P1|COMPLETED|Overall Study||0
50546|NCT01516034|116157|P1|STARTED|Overall Study||8
50547|NCT01516008|116164|P3|NOT COMPLETED|Overall Study||18
50548|NCT01516008|116165|P2|NOT COMPLETED|Overall Study||16
50549|NCT01516008|116166|P1|NOT COMPLETED|Overall Study||45
50550|NCT01516008|116164|P3|COMPLETED|Overall Study||99
50551|NCT01516008|116165|P2|COMPLETED|Overall Study||105
50552|NCT01516008|116166|P1|COMPLETED|Overall Study||69
50553|NCT01516008|116164|P3|STARTED|Overall Study||117
50554|NCT01516008|116165|P2|STARTED|Overall Study||121
50555|NCT01516008|116166|P1|STARTED|Overall Study||114
50556|NCT01515943|116201|P3|NOT COMPLETED|Overall Study||13
50557|NCT01515943|116202|P2|NOT COMPLETED|Overall Study||16
50558|NCT01515943|116203|P1|NOT COMPLETED|Overall Study||6
50559|NCT01515943|116201|P3|COMPLETED|Overall Study||31
50560|NCT01515943|116202|P2|COMPLETED|Overall Study||69
50561|NCT01515943|116203|P1|COMPLETED|Overall Study||69
50562|NCT01515943|116201|P3|STARTED|Overall Study||44
50563|NCT01515943|116202|P2|STARTED|Overall Study||85
50564|NCT01515943|116203|P1|STARTED|Overall Study||75
50565|NCT01515891|116226|P1|NOT COMPLETED|Overall Study||0
50566|NCT01515891|116226|P1|COMPLETED|Overall Study||4
50567|NCT01515891|116226|P1|STARTED|Overall Study||4
50568|NCT01515865|116233|P3|NOT COMPLETED|Part C (Randomized)||0
50569|NCT01515865|116234|P2|NOT COMPLETED|Part C (Randomized)||0
50570|NCT01515865|116235|P1|NOT COMPLETED|Part C (Randomized)||0
50571|NCT01515865|116233|P3|COMPLETED|Part C (Randomized)||34
50572|NCT01515865|116234|P2|COMPLETED|Part C (Randomized)||33
50573|NCT01515865|116235|P1|COMPLETED|Part C (Randomized)||0
50574|NCT01515865|116233|P3|STARTED|Part C (Randomized)||34
50575|NCT01515865|116234|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
50576|NCT01515865|116235|P1|STARTED|Part C (Randomized)||0
50577|NCT01515865|116233|P3|NOT COMPLETED|Part B (Open-label)||0
50578|NCT01515865|116234|P2|NOT COMPLETED|Part B (Open-label)||0
50579|NCT01515865|116235|P1|NOT COMPLETED|Part B (Open-label)||2
50580|NCT01515865|116233|P3|COMPLETED|Part B (Open-label)||0
50581|NCT01515865|116234|P2|COMPLETED|Part B (Open-label)||0
50582|NCT01515865|116235|P1|COMPLETED|Part B (Open-label)||69
50583|NCT01515865|116233|P3|STARTED|Part B (Open-label)||0
50584|NCT01515865|116234|P2|STARTED|Part B (Open-label)||0
50585|NCT01515865|116235|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
50586|NCT01515865|116233|P3|NOT COMPLETED|Part A (Open-label)||0
50587|NCT01515865|116234|P2|NOT COMPLETED|Part A (Open-label)||0
50588|NCT01515865|116235|P1|NOT COMPLETED|Part A (Open-label)||3
50589|NCT01515865|116233|P3|COMPLETED|Part A (Open-label)||0
50590|NCT01515865|116234|P2|COMPLETED|Part A (Open-label)||0
50591|NCT01515865|116235|P1|COMPLETED|Part A (Open-label)||95
50592|NCT01515865|116233|P3|STARTED|Part A (Open-label)||0
50593|NCT01515865|116234|P2|STARTED|Part A (Open-label)||0
50594|NCT01515865|116235|P1|STARTED|Part A (Open-label)||98
50595|NCT01515696|116245|P2|NOT COMPLETED|Overall Study||10
50596|NCT01515696|116246|P1|NOT COMPLETED|Overall Study||8
50597|NCT01515696|116245|P2|COMPLETED|Overall Study||39
50598|NCT01515696|116246|P1|COMPLETED|Overall Study||39
50599|NCT01515696|116245|P2|STARTED|Overall Study||49
50600|NCT01515696|116246|P1|STARTED|Overall Study||47
50601|NCT01515657|116256|P3|NOT COMPLETED|Third Intervention||0
50602|NCT01515657|116257|P2|NOT COMPLETED|Third Intervention||0
50603|NCT01515657|116258|P1|NOT COMPLETED|Third Intervention||1
50604|NCT01515657|116256|P3|COMPLETED|Third Intervention||13
50605|NCT01515657|116257|P2|COMPLETED|Third Intervention||11
50606|NCT01515657|116258|P1|COMPLETED|Third Intervention||13
50607|NCT01515657|116256|P3|STARTED|Third Intervention||13
50608|NCT01515657|116257|P2|STARTED|Third Intervention||11
50609|NCT01515657|116258|P1|STARTED|Third Intervention||14
50610|NCT01515657|116256|P3|NOT COMPLETED|Second Intervention||0
50611|NCT01515657|116257|P2|NOT COMPLETED|Second Intervention||1
50612|NCT01515657|116258|P1|NOT COMPLETED|Second Intervention||0
50613|NCT01515657|116256|P3|COMPLETED|Second Intervention||13
50614|NCT01515657|116257|P2|COMPLETED|Second Intervention||11
50615|NCT01515657|116258|P1|COMPLETED|Second Intervention||14
50616|NCT01515657|116256|P3|STARTED|Second Intervention||13
50617|NCT01515657|116257|P2|STARTED|Second Intervention||12
50618|NCT01515657|116258|P1|STARTED|Second Intervention||14
50619|NCT01515657|116256|P3|NOT COMPLETED|First Intervention||0
50620|NCT01515657|116257|P2|NOT COMPLETED|First Intervention||1
50621|NCT01515657|116258|P1|NOT COMPLETED|First Intervention||0
50622|NCT01515657|116256|P3|COMPLETED|First Intervention||13
50623|NCT01515657|116257|P2|COMPLETED|First Intervention||12
50624|NCT01515657|116258|P1|COMPLETED|First Intervention||14
50625|NCT01515657|116256|P3|STARTED|First Intervention||13
50626|NCT01515657|116257|P2|STARTED|First Intervention||13
50627|NCT01515657|116258|P1|STARTED|First Intervention||14
50628|NCT01515566|116268|P2|NOT COMPLETED|Overall Study||0
50629|NCT01515566|116269|P1|NOT COMPLETED|Overall Study||0
50630|NCT01515566|116268|P2|COMPLETED|Overall Study||10
50631|NCT01515566|116269|P1|COMPLETED|Overall Study||10
50632|NCT01515566|116268|P2|STARTED|Overall Study||10
50633|NCT01515566|116269|P1|STARTED|Overall Study||10
50634|NCT01515540|116281|P2|NOT COMPLETED|Overall Study||3
50635|NCT01515540|116282|P1|NOT COMPLETED|Overall Study||5
50636|NCT01515540|116281|P2|COMPLETED|Overall Study||15
50637|NCT01515540|116282|P1|COMPLETED|Overall Study||15
50638|NCT01515540|116281|P2|STARTED|Overall Study||18
50639|NCT01515540|116282|P1|STARTED|Overall Study||20
50640|NCT01515488|116290|P2|NOT COMPLETED|Overall Study||0
50641|NCT01515488|116291|P1|NOT COMPLETED|Overall Study||0
50642|NCT01515488|116290|P2|COMPLETED|Overall Study||200
50643|NCT01515488|116291|P1|COMPLETED|Overall Study||200
50644|NCT01515488|116290|P2|STARTED|Overall Study||200
50645|NCT01515488|116291|P1|STARTED|Overall Study||200
50646|NCT01515423|116303|P3|NOT COMPLETED|DOUBLE BLIND||92
50647|NCT01515423|116304|P2|NOT COMPLETED|DOUBLE BLIND||82
50648|NCT01515423|116305|P1|NOT COMPLETED|DOUBLE BLIND||0
50649|NCT01515423|116303|P3|COMPLETED|DOUBLE BLIND||420
50650|NCT01515423|116304|P2|COMPLETED|DOUBLE BLIND||422
50651|NCT01515423|116305|P1|COMPLETED|DOUBLE BLIND||0
50652|NCT01515423|116303|P3|STARTED|DOUBLE BLIND||512
50653|NCT01515423|116304|P2|STARTED|DOUBLE BLIND||504
50654|NCT01515423|116305|P1|STARTED|DOUBLE BLIND||0
50655|NCT01515423|116303|P3|NOT COMPLETED|Open Label Phase||0
50656|NCT01515423|116304|P2|NOT COMPLETED|Open Label Phase||0
50657|NCT01515423|116305|P1|NOT COMPLETED|Open Label Phase||413
50658|NCT01515423|116303|P3|COMPLETED|Open Label Phase||0
50659|NCT01515423|116304|P2|COMPLETED|Open Label Phase||0
50660|NCT01515423|116305|P1|COMPLETED|Open Label Phase||1016
50661|NCT01515423|116303|P3|STARTED|Open Label Phase||0
50662|NCT01515423|116304|P2|STARTED|Open Label Phase||0
50663|NCT01515423|116305|P1|STARTED|Open Label Phase||1429
50664|NCT01515410|116324|P2|NOT COMPLETED|Overall Study||0
50665|NCT01515410|116325|P1|NOT COMPLETED|Overall Study||0
50666|NCT01515410|116324|P2|COMPLETED|Overall Study||15
50667|NCT01515410|116325|P1|COMPLETED|Overall Study||19
50668|NCT01515410|116324|P2|STARTED|Overall Study||15
50669|NCT01515410|116325|P1|STARTED|Overall Study||19
50670|NCT01515345|116333|P2|NOT COMPLETED|Overall Study||0
50671|NCT01515345|116334|P1|NOT COMPLETED|Overall Study||1
50672|NCT01515345|116333|P2|COMPLETED|Overall Study||343
50673|NCT01515345|116334|P1|COMPLETED|Overall Study||664
50674|NCT01515345|116333|P2|STARTED|Overall Study||343
50675|NCT01515345|116334|P1|STARTED|Overall Study||665
50676|NCT01515306|116346|P2|NOT COMPLETED|Overall Study||14
50677|NCT01515306|116347|P1|NOT COMPLETED|Overall Study||12
50678|NCT01515306|116346|P2|COMPLETED|Overall Study||2
50679|NCT01515306|116347|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
50680|NCT01515306|116346|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
50681|NCT01515306|116347|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
50682|NCT01515306|116346|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
50683|NCT01515306|116347|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
50684|NCT01515306|116346|P2|STARTED|Overall Study||16
50685|NCT01515306|116347|P1|STARTED|Overall Study||24
50686|NCT01514864|116360|P2|NOT COMPLETED|Overall Study||5
50687|NCT01514864|116361|P1|NOT COMPLETED|Overall Study||9
50688|NCT01514864|116360|P2|COMPLETED|Overall Study||0
50689|NCT01514864|116361|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
50690|NCT01514864|116360|P2|STARTED|Overall Study||5
50691|NCT01514864|116361|P1|STARTED|Overall Study||9
50692|NCT01514760|116377|P1|NOT COMPLETED|Overall Study||2
50693|NCT01514760|116377|P1|COMPLETED|Overall Study||20
50694|NCT01514760|116377|P1|STARTED|Overall Study||22
50695|NCT01514734|116384|P1|NOT COMPLETED|Overall Study||0
50696|NCT01514734|116384|P1|COMPLETED|Overall Study||9
50697|NCT01514734|116384|P1|STARTED|Overall Study||9
50698|NCT01514630|116388|P1|NOT COMPLETED|Overall Study||3
50699|NCT01514630|116388|P1|COMPLETED|Overall Study||11
50700|NCT01514630|116388|P1|STARTED|Overall Study||14
50701|NCT01514513|116394|P2|NOT COMPLETED|Overall Study||1
50702|NCT01514513|116395|P1|NOT COMPLETED|Overall Study||1
50703|NCT01514513|116394|P2|COMPLETED|Overall Study||20
50704|NCT01514513|116395|P1|COMPLETED|Overall Study||20
50705|NCT01514513|116394|P2|STARTED|Overall Study||21
50706|NCT01514513|116395|P1|STARTED|Overall Study||21
50707|NCT01514461|116406|P3|NOT COMPLETED|Overall Study||4
50708|NCT01514461|116407|P2|NOT COMPLETED|Overall Study||3
50709|NCT01514461|116408|P1|NOT COMPLETED|Overall Study||5
50710|NCT01514461|116406|P3|COMPLETED|Overall Study||11
50711|NCT01514461|116407|P2|COMPLETED|Overall Study||12
50712|NCT01514461|116408|P1|COMPLETED|Overall Study||10
50713|NCT01514461|116406|P3|STARTED|Overall Study||15
50714|NCT01514461|116407|P2|STARTED|Overall Study||15
50715|NCT01514461|116408|P1|STARTED|Overall Study||15
50716|NCT01514422|116445|P1|NOT COMPLETED|Overall Study||1
50717|NCT01514422|116445|P1|COMPLETED|Overall Study||19
50718|NCT01514422|116445|P1|STARTED|Overall Study||20
50719|NCT01514318|116451|P1|NOT COMPLETED|Overall Study||0
50720|NCT01514318|116451|P1|COMPLETED|Overall Study||8
50721|NCT01514318|116451|P1|STARTED|Overall Study||8
50722|NCT01514292|116457|P1|NOT COMPLETED|Overall Study||0
50723|NCT01514292|116457|P1|COMPLETED|Overall Study||72
50724|NCT01514292|116457|P1|STARTED|Overall Study||72
50725|NCT01514240|116463|P2|NOT COMPLETED|Overall Study||11
50726|NCT01514240|116464|P1|NOT COMPLETED|Overall Study||6
50727|NCT01514240|116463|P2|COMPLETED|Overall Study||45
50728|NCT01514240|116464|P1|COMPLETED|Overall Study||50
50729|NCT01514240|116463|P2|STARTED|Overall Study||56
50730|NCT01514240|116464|P1|STARTED|Overall Study||56
50731|NCT01514136|116540|P8|NOT COMPLETED|Test Period; Test D*||0
50732|NCT01514136|116541|P7|NOT COMPLETED|Test Period; Test D*||0
50733|NCT01514136|116542|P6|NOT COMPLETED|Test Period; Test D*||0
50734|NCT01514136|116543|P5|NOT COMPLETED|Test Period; Test D*||0
50735|NCT01514136|116544|P4|NOT COMPLETED|Test Period; Test D*||0
50736|NCT01514136|116545|P3|NOT COMPLETED|Test Period; Test D*||0
50737|NCT01514136|116546|P2|NOT COMPLETED|Test Period; Test D*||0
50738|NCT01514136|116547|P1|NOT COMPLETED|Test Period; Test D*||0
50739|NCT01514136|116540|P8|COMPLETED|Test Period; Test D*||23
50740|NCT01514136|116541|P7|COMPLETED|Test Period; Test D*||0
50741|NCT01514136|116542|P6|COMPLETED|Test Period; Test D*||0
50742|NCT01514136|116543|P5|COMPLETED|Test Period; Test D*||0
50743|NCT01514136|116544|P4|COMPLETED|Test Period; Test D*||0
50744|NCT01514136|116545|P3|COMPLETED|Test Period; Test D*||0
50745|NCT01514136|116546|P2|COMPLETED|Test Period; Test D*||0
50746|NCT01514136|116547|P1|COMPLETED|Test Period; Test D*||0
50747|NCT01514136|116540|P8|STARTED|Test Period; Test D*||23
50748|NCT01514136|116541|P7|STARTED|Test Period; Test D*||0
50749|NCT01514136|116542|P6|STARTED|Test Period; Test D*||0
50750|NCT01514136|116543|P5|STARTED|Test Period; Test D*||0
50751|NCT01514136|116544|P4|STARTED|Test Period; Test D*||0
50752|NCT01514136|116545|P3|STARTED|Test Period; Test D*||0
50753|NCT01514136|116546|P2|STARTED|Test Period; Test D*||0
50754|NCT01514136|116547|P1|STARTED|Test Period; Test D*||0
50755|NCT01514136|116540|P8|NOT COMPLETED|Test Period 2; Test C*||0
50756|NCT01514136|116541|P7|NOT COMPLETED|Test Period 2; Test C*||3
50757|NCT01514136|116542|P6|NOT COMPLETED|Test Period 2; Test C*||0
50758|NCT01514136|116543|P5|NOT COMPLETED|Test Period 2; Test C*||0
50759|NCT01514136|116544|P4|NOT COMPLETED|Test Period 2; Test C*||0
50760|NCT01514136|116545|P3|NOT COMPLETED|Test Period 2; Test C*||0
50761|NCT01514136|116546|P2|NOT COMPLETED|Test Period 2; Test C*||0
50762|NCT01514136|116547|P1|NOT COMPLETED|Test Period 2; Test C*||0
50763|NCT01514136|116540|P8|COMPLETED|Test Period 2; Test C*||0
50764|NCT01514136|116541|P7|COMPLETED|Test Period 2; Test C*||23
50765|NCT01514136|116542|P6|COMPLETED|Test Period 2; Test C*||0
50766|NCT01514136|116543|P5|COMPLETED|Test Period 2; Test C*||0
50767|NCT01514136|116544|P4|COMPLETED|Test Period 2; Test C*||0
50768|NCT01514136|116545|P3|COMPLETED|Test Period 2; Test C*||0
50769|NCT01514136|116546|P2|COMPLETED|Test Period 2; Test C*||0
50770|NCT01514136|116547|P1|COMPLETED|Test Period 2; Test C*||0
50771|NCT01514136|116540|P8|STARTED|Test Period 2; Test C*||0
50772|NCT01514136|116541|P7|STARTED|Test Period 2; Test C*||26
50773|NCT01514136|116542|P6|STARTED|Test Period 2; Test C*||0
50774|NCT01514136|116543|P5|STARTED|Test Period 2; Test C*||0
50775|NCT01514136|116544|P4|STARTED|Test Period 2; Test C*||0
50776|NCT01514136|116545|P3|STARTED|Test Period 2; Test C*||0
50777|NCT01514136|116546|P2|STARTED|Test Period 2; Test C*||0
50778|NCT01514136|116547|P1|STARTED|Test Period 2; Test C*||0
50779|NCT01514136|116540|P8|NOT COMPLETED|Test Period 2; Test B*||0
50780|NCT01514136|116541|P7|NOT COMPLETED|Test Period 2; Test B*||0
50781|NCT01514136|116542|P6|NOT COMPLETED|Test Period 2; Test B*||2
50782|NCT01514136|116543|P5|NOT COMPLETED|Test Period 2; Test B*||0
50783|NCT01514136|116544|P4|NOT COMPLETED|Test Period 2; Test B*||0
50784|NCT01514136|116545|P3|NOT COMPLETED|Test Period 2; Test B*||0
50785|NCT01514136|116546|P2|NOT COMPLETED|Test Period 2; Test B*||0
50786|NCT01514136|116547|P1|NOT COMPLETED|Test Period 2; Test B*||0
50787|NCT01514136|116540|P8|COMPLETED|Test Period 2; Test B*||0
50788|NCT01514136|116541|P7|COMPLETED|Test Period 2; Test B*||0
50789|NCT01514136|116542|P6|COMPLETED|Test Period 2; Test B*||26
50790|NCT01514136|116543|P5|COMPLETED|Test Period 2; Test B*||0
50791|NCT01514136|116544|P4|COMPLETED|Test Period 2; Test B*||0
50792|NCT01514136|116545|P3|COMPLETED|Test Period 2; Test B*||0
50793|NCT01514136|116546|P2|COMPLETED|Test Period 2; Test B*||0
50794|NCT01514136|116547|P1|COMPLETED|Test Period 2; Test B*||0
50795|NCT01514136|116540|P8|STARTED|Test Period 2; Test B*||0
50796|NCT01514136|116541|P7|STARTED|Test Period 2; Test B*||0
50797|NCT01514136|116542|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
50798|NCT01514136|116543|P5|STARTED|Test Period 2; Test B*||0
50799|NCT01514136|116544|P4|STARTED|Test Period 2; Test B*||0
50800|NCT01514136|116545|P3|STARTED|Test Period 2; Test B*||0
50801|NCT01514136|116546|P2|STARTED|Test Period 2; Test B*||0
50802|NCT01514136|116547|P1|STARTED|Test Period 2; Test B*||0
50803|NCT01514136|116540|P8|NOT COMPLETED|Test Period 2; Test A*||0
50804|NCT01514136|116541|P7|NOT COMPLETED|Test Period 2; Test A*||0
50805|NCT01514136|116542|P6|NOT COMPLETED|Test Period 2; Test A*||0
50806|NCT01514136|116543|P5|NOT COMPLETED|Test Period 2; Test A*||2
50807|NCT01514136|116544|P4|NOT COMPLETED|Test Period 2; Test A*||0
50808|NCT01514136|116545|P3|NOT COMPLETED|Test Period 2; Test A*||0
50809|NCT01514136|116546|P2|NOT COMPLETED|Test Period 2; Test A*||0
50810|NCT01514136|116547|P1|NOT COMPLETED|Test Period 2; Test A*||0
50811|NCT01514136|116540|P8|COMPLETED|Test Period 2; Test A*||0
50812|NCT01514136|116541|P7|COMPLETED|Test Period 2; Test A*||0
50813|NCT01514136|116542|P6|COMPLETED|Test Period 2; Test A*||0
50814|NCT01514136|116543|P5|COMPLETED|Test Period 2; Test A*||26
50815|NCT01514136|116544|P4|COMPLETED|Test Period 2; Test A*||0
50816|NCT01514136|116545|P3|COMPLETED|Test Period 2; Test A*||0
50817|NCT01514136|116546|P2|COMPLETED|Test Period 2; Test A*||0
50818|NCT01514136|116547|P1|COMPLETED|Test Period 2; Test A*||0
50819|NCT01514136|116540|P8|STARTED|Test Period 2; Test A*||0
50820|NCT01514136|116541|P7|STARTED|Test Period 2; Test A*||0
50821|NCT01514136|116542|P6|STARTED|Test Period 2; Test A*||0
50822|NCT01514136|116543|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
50823|NCT01514136|116544|P4|STARTED|Test Period 2; Test A*||0
50824|NCT01514136|116545|P3|STARTED|Test Period 2; Test A*||0
50825|NCT01514136|116546|P2|STARTED|Test Period 2; Test A*||0
50826|NCT01514136|116547|P1|STARTED|Test Period 2; Test A*||0
50827|NCT01514136|116540|P8|NOT COMPLETED|Test Period 1; Test D||0
50828|NCT01514136|116541|P7|NOT COMPLETED|Test Period 1; Test D||0
50829|NCT01514136|116542|P6|NOT COMPLETED|Test Period 1; Test D||0
50830|NCT01514136|116543|P5|NOT COMPLETED|Test Period 1; Test D||0
50831|NCT01514136|116544|P4|NOT COMPLETED|Test Period 1; Test D||2
50832|NCT01514136|116545|P3|NOT COMPLETED|Test Period 1; Test D||0
50833|NCT01514136|116546|P2|NOT COMPLETED|Test Period 1; Test D||0
50834|NCT01514136|116547|P1|NOT COMPLETED|Test Period 1; Test D||0
50835|NCT01514136|116540|P8|COMPLETED|Test Period 1; Test D||0
50836|NCT01514136|116541|P7|COMPLETED|Test Period 1; Test D||0
50837|NCT01514136|116542|P6|COMPLETED|Test Period 1; Test D||0
50838|NCT01514136|116543|P5|COMPLETED|Test Period 1; Test D||0
50839|NCT01514136|116544|P4|COMPLETED|Test Period 1; Test D||24
50840|NCT01514136|116545|P3|COMPLETED|Test Period 1; Test D||0
50841|NCT01514136|116546|P2|COMPLETED|Test Period 1; Test D||0
50842|NCT01514136|116547|P1|COMPLETED|Test Period 1; Test D||0
50843|NCT01514136|116540|P8|STARTED|Test Period 1; Test D||0
50844|NCT01514136|116541|P7|STARTED|Test Period 1; Test D||0
50845|NCT01514136|116542|P6|STARTED|Test Period 1; Test D||0
50846|NCT01514136|116543|P5|STARTED|Test Period 1; Test D||0
50847|NCT01514136|116544|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
50848|NCT01514136|116545|P3|STARTED|Test Period 1; Test D||0
50849|NCT01514136|116546|P2|STARTED|Test Period 1; Test D||0
50850|NCT01514136|116547|P1|STARTED|Test Period 1; Test D||0
50851|NCT01514136|116540|P8|NOT COMPLETED|Test Period 1; Test C||0
50852|NCT01514136|116541|P7|NOT COMPLETED|Test Period 1; Test C||0
50853|NCT01514136|116542|P6|NOT COMPLETED|Test Period 1; Test C||0
50854|NCT01514136|116543|P5|NOT COMPLETED|Test Period 1; Test C||0
50855|NCT01514136|116544|P4|NOT COMPLETED|Test Period 1; Test C||0
50856|NCT01514136|116545|P3|NOT COMPLETED|Test Period 1; Test C||0
50857|NCT01514136|116546|P2|NOT COMPLETED|Test Period 1; Test C||0
50858|NCT01514136|116547|P1|NOT COMPLETED|Test Period 1; Test C||0
50859|NCT01514136|116540|P8|COMPLETED|Test Period 1; Test C||0
50860|NCT01514136|116541|P7|COMPLETED|Test Period 1; Test C||0
50861|NCT01514136|116542|P6|COMPLETED|Test Period 1; Test C||0
50862|NCT01514136|116543|P5|COMPLETED|Test Period 1; Test C||0
50863|NCT01514136|116544|P4|COMPLETED|Test Period 1; Test C||0
50864|NCT01514136|116545|P3|COMPLETED|Test Period 1; Test C||24
50865|NCT01514136|116546|P2|COMPLETED|Test Period 1; Test C||0
50866|NCT01514136|116547|P1|COMPLETED|Test Period 1; Test C||0
50867|NCT01514136|116540|P8|STARTED|Test Period 1; Test C||0
50868|NCT01514136|116541|P7|STARTED|Test Period 1; Test C||0
50869|NCT01514136|116542|P6|STARTED|Test Period 1; Test C||0
50870|NCT01514136|116543|P5|STARTED|Test Period 1; Test C||0
50871|NCT01514136|116544|P4|STARTED|Test Period 1; Test C||0
50872|NCT01514136|116545|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
50873|NCT01514136|116546|P2|STARTED|Test Period 1; Test C||0
50874|NCT01514136|116547|P1|STARTED|Test Period 1; Test C||0
50875|NCT01514136|116540|P8|NOT COMPLETED|Test Period 1; Test B||0
50876|NCT01514136|116541|P7|NOT COMPLETED|Test Period 1; Test B||0
50877|NCT01514136|116542|P6|NOT COMPLETED|Test Period 1; Test B||0
50878|NCT01514136|116543|P5|NOT COMPLETED|Test Period 1; Test B||0
50879|NCT01514136|116544|P4|NOT COMPLETED|Test Period 1; Test B||0
50880|NCT01514136|116545|P3|NOT COMPLETED|Test Period 1; Test B||0
50881|NCT01514136|116546|P2|NOT COMPLETED|Test Period 1; Test B||1
50882|NCT01514136|116547|P1|NOT COMPLETED|Test Period 1; Test B||0
50883|NCT01514136|116540|P8|COMPLETED|Test Period 1; Test B||0
50884|NCT01514136|116541|P7|COMPLETED|Test Period 1; Test B||0
50885|NCT01514136|116542|P6|COMPLETED|Test Period 1; Test B||0
50886|NCT01514136|116543|P5|COMPLETED|Test Period 1; Test B||0
50887|NCT01514136|116544|P4|COMPLETED|Test Period 1; Test B||0
50888|NCT01514136|116545|P3|COMPLETED|Test Period 1; Test B||0
50889|NCT01514136|116546|P2|COMPLETED|Test Period 1; Test B||23
50890|NCT01514136|116547|P1|COMPLETED|Test Period 1; Test B||0
50891|NCT01514136|116540|P8|STARTED|Test Period 1; Test B||0
50892|NCT01514136|116541|P7|STARTED|Test Period 1; Test B||0
50893|NCT01514136|116542|P6|STARTED|Test Period 1; Test B||0
50894|NCT01514136|116543|P5|STARTED|Test Period 1; Test B||0
50895|NCT01514136|116544|P4|STARTED|Test Period 1; Test B||0
50896|NCT01514136|116545|P3|STARTED|Test Period 1; Test B||0
50897|NCT01514136|116546|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
50898|NCT01514136|116547|P1|STARTED|Test Period 1; Test B||0
50899|NCT01514136|116540|P8|NOT COMPLETED|Test Period 1; Test A||0
50900|NCT01514136|116541|P7|NOT COMPLETED|Test Period 1; Test A||0
50901|NCT01514136|116542|P6|NOT COMPLETED|Test Period 1; Test A||0
50902|NCT01514136|116543|P5|NOT COMPLETED|Test Period 1; Test A||0
50903|NCT01514136|116544|P4|NOT COMPLETED|Test Period 1; Test A||0
50904|NCT01514136|116545|P3|NOT COMPLETED|Test Period 1; Test A||0
50905|NCT01514136|116546|P2|NOT COMPLETED|Test Period 1; Test A||0
50906|NCT01514136|116547|P1|NOT COMPLETED|Test Period 1; Test A||3
50907|NCT01514136|116540|P8|COMPLETED|Test Period 1; Test A||0
50908|NCT01514136|116541|P7|COMPLETED|Test Period 1; Test A||0
50909|NCT01514136|116542|P6|COMPLETED|Test Period 1; Test A||0
50910|NCT01514136|116543|P5|COMPLETED|Test Period 1; Test A||0
50911|NCT01514136|116544|P4|COMPLETED|Test Period 1; Test A||0
50912|NCT01514136|116545|P3|COMPLETED|Test Period 1; Test A||0
50913|NCT01514136|116546|P2|COMPLETED|Test Period 1; Test A||0
50914|NCT01514136|116547|P1|COMPLETED|Test Period 1; Test A||22
50915|NCT01514136|116540|P8|STARTED|Test Period 1; Test A||0
50916|NCT01514136|116541|P7|STARTED|Test Period 1; Test A||0
50917|NCT01514136|116542|P6|STARTED|Test Period 1; Test A||0
50918|NCT01514136|116543|P5|STARTED|Test Period 1; Test A||0
50919|NCT01514136|116544|P4|STARTED|Test Period 1; Test A||0
50920|NCT01514136|116545|P3|STARTED|Test Period 1; Test A||0
50921|NCT01514136|116546|P2|STARTED|Test Period 1; Test A||0
50922|NCT01514136|116547|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
50923|NCT01513902|116576|P3|NOT COMPLETED|Overall Study||0
50924|NCT01513902|116577|P2|NOT COMPLETED|Overall Study||0
50925|NCT01513902|116578|P1|NOT COMPLETED|Overall Study||0
50926|NCT01513902|116576|P3|COMPLETED|Overall Study||9
50927|NCT01513902|116577|P2|COMPLETED|Overall Study||9
50928|NCT01513902|116578|P1|COMPLETED|Overall Study||8
50929|NCT01513902|116576|P3|STARTED|Overall Study||9
50930|NCT01513902|116577|P2|STARTED|Overall Study||9
50931|NCT01513902|116578|P1|STARTED|Overall Study||8
50932|NCT01513590|116615|P2|NOT COMPLETED|Overall Study||13
50933|NCT01513590|116616|P1|NOT COMPLETED|Overall Study||10
50934|NCT01513590|116615|P2|COMPLETED|Overall Study||184
50935|NCT01513590|116616|P1|COMPLETED|Overall Study||187
50936|NCT01513590|116615|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
50937|NCT01513590|116616|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
50938|NCT01513590|116615|P2|STARTED|Overall Study||197
50939|NCT01513590|116616|P1|STARTED|Overall Study||197
50940|NCT01513473|116636|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
50941|NCT01513473|116637|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
50942|NCT01513473|116636|P2|COMPLETED|Extension Trial (26 Weeks)||122
50943|NCT01513473|116637|P1|COMPLETED|Extension Trial (26 Weeks)||151
50944|NCT01513473|116636|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
50945|NCT01513473|116637|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
50946|NCT01513473|116636|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
50947|NCT01513473|116637|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
50948|NCT01513473|116636|P2|COMPLETED|Main Trial (26 Weeks)||165
50949|NCT01513473|116637|P1|COMPLETED|Main Trial (26 Weeks)||170
50950|NCT01513473|116636|P2|Exposed|Main Trial (26 Weeks)||175
50951|NCT01513473|116637|P1|Exposed|Main Trial (26 Weeks)||174
50952|NCT01513473|116636|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
50953|NCT01513473|116637|P1|STARTED|Main Trial (26 Weeks)||174
50954|NCT01513460|116664|P3|NOT COMPLETED|Overall Study||56
50955|NCT01513460|116665|P2|NOT COMPLETED|Overall Study||32
50956|NCT01513460|116666|P1|NOT COMPLETED|Overall Study||29
50957|NCT01513460|116664|P3|COMPLETED|Overall Study||201
50958|NCT01513460|116665|P2|COMPLETED|Overall Study||226
50959|NCT01513460|116666|P1|COMPLETED|Overall Study||229
50960|NCT01513460|116664|P3|Per-protocol Set|Overall Study||166
50961|NCT01513460|116665|P2|Per-protocol Set|Overall Study||186
50962|NCT01513460|116666|P1|Per-protocol Set|Overall Study||196
50963|NCT01513460|116664|P3|Full Analysis Set|Overall Study||257
50964|NCT01513460|116665|P2|Full Analysis Set|Overall Study||258
50965|NCT01513460|116666|P1|Full Analysis Set|Overall Study||257
50966|NCT01513460|116664|P3|STARTED|Overall Study||257
50967|NCT01513460|116665|P2|STARTED|Overall Study||258
50968|NCT01513460|116666|P1|STARTED|Overall Study||258
50969|NCT01513447|116692|P2|NOT COMPLETED|Overall Study||0
50970|NCT01513447|116693|P1|NOT COMPLETED|Overall Study||0
50971|NCT01513447|116692|P2|COMPLETED|Overall Study||5
50972|NCT01513447|116693|P1|COMPLETED|Overall Study||3
50973|NCT01513447|116692|P2|STARTED|Overall Study||5
50974|NCT01513447|116693|P1|STARTED|Overall Study||3
50975|NCT01513330|116701|P2|NOT COMPLETED|Standard Care First,||4
50976|NCT01513330|116702|P1|NOT COMPLETED|Standard Care First,||4
50977|NCT01513330|116701|P2|COMPLETED|Standard Care First,||52
50978|NCT01513330|116702|P1|COMPLETED|Standard Care First,||56
50979|NCT01513330|116701|P2|STARTED|Standard Care First,||56
50980|NCT01513330|116702|P1|STARTED|Standard Care First,||60
50981|NCT01513330|116701|P2|NOT COMPLETED|SenSura Mio First,||2
50982|NCT01513330|116702|P1|NOT COMPLETED|SenSura Mio First,||4
50983|NCT01513330|116701|P2|COMPLETED|SenSura Mio First,||56
50984|NCT01513330|116702|P1|COMPLETED|SenSura Mio First,||60
50985|NCT01513330|116701|P2|STARTED|SenSura Mio First,||58
50986|NCT01513330|116702|P1|STARTED|SenSura Mio First,||64
50987|NCT01513317|116710|P2|NOT COMPLETED|Overall Study||24
50988|NCT01513317|116711|P1|NOT COMPLETED|Overall Study||34
50989|NCT01513317|116710|P2|COMPLETED|Overall Study||2
50990|NCT01513317|116711|P1|COMPLETED|Overall Study||16
50991|NCT01513317|116710|P2|STARTED|Overall Study||26
50992|NCT01513317|116711|P1|STARTED|Overall Study||50
50993|NCT01513291|116729|P5|NOT COMPLETED|Run-out Period||0
50994|NCT01513291|116730|P4|NOT COMPLETED|Run-out Period||2
50995|NCT01513291|116731|P3|NOT COMPLETED|Run-out Period||0
50996|NCT01513291|116732|P2|NOT COMPLETED|Run-out Period||0
50997|NCT01513291|116733|P1|NOT COMPLETED|Run-out Period||0
50998|NCT01513291|116729|P5|COMPLETED|Run-out Period||101
50999|NCT01513291|116730|P4|COMPLETED|Run-out Period||45
51000|NCT01513291|116731|P3|COMPLETED|Run-out Period||50
51001|NCT01513291|116732|P2|COMPLETED|Run-out Period||0
51002|NCT01513291|116733|P1|COMPLETED|Run-out Period||0
51003|NCT01513291|116729|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
51004|NCT01513291|116730|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
51005|NCT01513291|116731|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
51006|NCT01513291|116732|P2|STARTED|Run-out Period||0
51007|NCT01513291|116733|P1|STARTED|Run-out Period||0
51008|NCT01513291|116729|P5|NOT COMPLETED|Treatment Period||0
51009|NCT01513291|116730|P4|NOT COMPLETED|Treatment Period||0
51010|NCT01513291|116731|P3|NOT COMPLETED|Treatment Period||0
51011|NCT01513291|116732|P2|NOT COMPLETED|Treatment Period||16
51012|NCT01513291|116733|P1|NOT COMPLETED|Treatment Period||23
51013|NCT01513291|116729|P5|COMPLETED|Treatment Period||0
51014|NCT01513291|116730|P4|COMPLETED|Treatment Period||0
51015|NCT01513291|116731|P3|COMPLETED|Treatment Period||0
51016|NCT01513291|116732|P2|COMPLETED|Treatment Period||101
51017|NCT01513291|116733|P1|COMPLETED|Treatment Period||97
51018|NCT01513291|116729|P5|Treated|Treatment Period||0
51019|NCT01513291|116730|P4|Treated|Treatment Period||0
51020|NCT01513291|116731|P3|Treated|Treatment Period||0
51021|NCT01513291|116732|P2|Treated|Treatment Period||115
51022|NCT01513291|116733|P1|Treated|Treatment Period||120
51023|NCT01513291|116729|P5|STARTED|Treatment Period||0
51024|NCT01513291|116730|P4|STARTED|Treatment Period||0
51025|NCT01513291|116731|P3|STARTED|Treatment Period||0
51026|NCT01513291|116732|P2|STARTED|Treatment Period||117
51027|NCT01513291|116733|P1|STARTED|Treatment Period||120
51028|NCT01513239|116761|P3|NOT COMPLETED|Overall Study||88
51029|NCT01513239|116762|P2|NOT COMPLETED|Overall Study||70
51030|NCT01513239|116763|P1|NOT COMPLETED|Overall Study||75
51031|NCT01513239|116761|P3|COMPLETED|Overall Study||311
51032|NCT01513239|116762|P2|COMPLETED|Overall Study||337
51033|NCT01513239|116763|P1|COMPLETED|Overall Study||322
51034|NCT01513239|116761|P3|All Participants as Treated|Overall Study|Treatment actually received|381
51035|NCT01513239|116762|P2|All Participants as Treated|Overall Study|Treatment actually received|396
51036|NCT01513239|116763|P1|All Participants as Treated|Overall Study|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
51037|NCT01513239|116761|P3|Treated|Overall Study|Treated participants|381
51038|NCT01513239|116762|P2|Treated|Overall Study|Treated participants|396
51039|NCT01513239|116763|P1|Treated|Overall Study|Treated participants|391
51040|NCT01513239|116761|P3|STARTED|Overall Study|Randomized participants|399
51041|NCT01513239|116762|P2|STARTED|Overall Study|Randomized participants|407
51042|NCT01513239|116763|P1|STARTED|Overall Study|Randomized participants|397
51043|NCT01513148|116813|P2|NOT COMPLETED|Overall Study||2
51044|NCT01513148|116814|P1|NOT COMPLETED|Overall Study||2
51045|NCT01513148|116813|P2|COMPLETED|Overall Study||14
51046|NCT01513148|116814|P1|COMPLETED|Overall Study||14
51047|NCT01513148|116813|P2|STARTED|Overall Study||16
51048|NCT01513148|116814|P1|STARTED|Overall Study||16
51049|NCT01513122|116862|P2|NOT COMPLETED|Overall Study||3
51050|NCT01513122|116863|P1|NOT COMPLETED|Overall Study||11
51051|NCT01513122|116862|P2|COMPLETED|Overall Study||105
51052|NCT01513122|116863|P1|COMPLETED|Overall Study||91
51053|NCT01513122|116862|P2|STARTED|Overall Study||108
51054|NCT01513122|116863|P1|STARTED|Overall Study||102
51055|NCT01512979|116881|P2|NOT COMPLETED|Overall Study||22
51056|NCT01512979|116882|P1|NOT COMPLETED|Overall Study||19
51057|NCT01512979|116881|P2|COMPLETED|Overall Study||135
51058|NCT01512979|116882|P1|COMPLETED|Overall Study||140
51059|NCT01512979|116881|P2|STARTED|Overall Study|Randomised and treated|157
51060|NCT01512979|116882|P1|STARTED|Overall Study|Randomised and treated|159
51061|NCT01512849|116902|P4|NOT COMPLETED|Crossover Period 2||0
51062|NCT01512849|116903|P3|NOT COMPLETED|Crossover Period 2||0
51063|NCT01512849|116904|P2|NOT COMPLETED|Crossover Period 2||0
51064|NCT01512849|116905|P1|NOT COMPLETED|Crossover Period 2||0
51065|NCT01512849|116902|P4|COMPLETED|Crossover Period 2||6
51066|NCT01512849|116903|P3|COMPLETED|Crossover Period 2||6
51067|NCT01512849|116904|P2|COMPLETED|Crossover Period 2||6
51068|NCT01512849|116905|P1|COMPLETED|Crossover Period 2||6
51069|NCT01512849|116902|P4|STARTED|Crossover Period 2||6
51070|NCT01512849|116903|P3|STARTED|Crossover Period 2||6
51071|NCT01512849|116904|P2|STARTED|Crossover Period 2||6
51072|NCT01512849|116905|P1|STARTED|Crossover Period 2||6
51073|NCT01512849|116902|P4|NOT COMPLETED|Crossover Period 1||0
51074|NCT01512849|116903|P3|NOT COMPLETED|Crossover Period 1||0
51075|NCT01512849|116904|P2|NOT COMPLETED|Crossover Period 1||0
51076|NCT01512849|116905|P1|NOT COMPLETED|Crossover Period 1||0
51077|NCT01512849|116902|P4|COMPLETED|Crossover Period 1||6
51078|NCT01512849|116903|P3|COMPLETED|Crossover Period 1||6
51079|NCT01512849|116904|P2|COMPLETED|Crossover Period 1||6
51080|NCT01512849|116905|P1|COMPLETED|Crossover Period 1||6
51081|NCT01512849|116902|P4|STARTED|Crossover Period 1||6
51082|NCT01512849|116903|P3|STARTED|Crossover Period 1||6
51083|NCT01512849|116904|P2|STARTED|Crossover Period 1||6
51084|NCT01512849|116905|P1|STARTED|Crossover Period 1||6
51085|NCT01512745|116929|P2|NOT COMPLETED|Overall Study||20
51086|NCT01512745|116930|P1|NOT COMPLETED|Overall Study||40
51087|NCT01512745|116929|P2|COMPLETED|Overall Study||71
51088|NCT01512745|116930|P1|COMPLETED|Overall Study||136
51089|NCT01512745|116929|P2|STARTED|Overall Study||91
51090|NCT01512745|116930|P1|STARTED|Overall Study||176
51091|NCT01512368|116944|P1|NOT COMPLETED|Overall Study||3
51092|NCT01512368|116944|P1|COMPLETED|Overall Study||60
51093|NCT01512368|116944|P1|STARTED|Overall Study||63
51094|NCT01512160|116957|P4|NOT COMPLETED|Overall Study||1
51095|NCT01512160|116958|P3|NOT COMPLETED|Overall Study||0
51096|NCT01512160|116959|P2|NOT COMPLETED|Overall Study||0
51097|NCT01512160|116960|P1|NOT COMPLETED|Overall Study||2
51098|NCT01512160|116957|P4|COMPLETED|Overall Study||22
51099|NCT01512160|116958|P3|COMPLETED|Overall Study||22
51100|NCT01512160|116959|P2|COMPLETED|Overall Study||23
51101|NCT01512160|116960|P1|COMPLETED|Overall Study||20
51102|NCT01512160|116957|P4|STARTED|Overall Study||23
51103|NCT01512160|116958|P3|STARTED|Overall Study||22
51104|NCT01512160|116959|P2|STARTED|Overall Study||23
51105|NCT01512160|116960|P1|STARTED|Overall Study||22
51106|NCT01512108|117052|P2|NOT COMPLETED|Overall Study||9
51107|NCT01512108|117053|P1|NOT COMPLETED|Overall Study||22
51108|NCT01512108|117052|P2|COMPLETED|Overall Study||111
51109|NCT01512108|117053|P1|COMPLETED|Overall Study||221
51110|NCT01512108|117052|P2|Exposed|Overall Study||120
51111|NCT01512108|117053|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
51112|NCT01512108|117052|P2|STARTED|Overall Study||120
51113|NCT01512108|117053|P1|STARTED|Overall Study||243
51114|NCT01511939|117068|P3|NOT COMPLETED|Overall Study||0
51115|NCT01511939|117069|P2|NOT COMPLETED|Overall Study||1
51116|NCT01511939|117070|P1|NOT COMPLETED|Overall Study||2
51117|NCT01511939|117068|P3|COMPLETED|Overall Study||8
51118|NCT01511939|117069|P2|COMPLETED|Overall Study||4
51119|NCT01511939|117070|P1|COMPLETED|Overall Study||7
51120|NCT01511939|117068|P3|STARTED|Overall Study||8
51121|NCT01511939|117069|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
51122|NCT01511939|117070|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
51123|NCT01511809|117089|P2|NOT COMPLETED|Overall Study||7
51124|NCT01511809|117090|P1|NOT COMPLETED|Overall Study||7
51125|NCT01511809|117089|P2|COMPLETED|Overall Study||52
51126|NCT01511809|117090|P1|COMPLETED|Overall Study||51
51127|NCT01511809|117089|P2|STARTED|Overall Study||59
51128|NCT01511809|117090|P1|STARTED|Overall Study||58
51129|NCT01511536|117099|P3|NOT COMPLETED|Phase 2||9
51130|NCT01511536|117100|P2|NOT COMPLETED|Phase 2||0
51131|NCT01511536|117101|P1|NOT COMPLETED|Phase 2||0
51132|NCT01511536|117099|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
51133|NCT01511536|117100|P2|COMPLETED|Phase 2||0
51134|NCT01511536|117101|P1|COMPLETED|Phase 2||0
51135|NCT01511536|117099|P3|STARTED|Phase 2||27
51136|NCT01511536|117100|P2|STARTED|Phase 2||0
51137|NCT01511536|117101|P1|STARTED|Phase 2||0
51138|NCT01511536|117099|P3|NOT COMPLETED|Phase 1||0
51139|NCT01511536|117100|P2|NOT COMPLETED|Phase 1||1
51140|NCT01511536|117101|P1|NOT COMPLETED|Phase 1||0
51141|NCT01511536|117099|P3|COMPLETED|Phase 1||0
51142|NCT01511536|117100|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
51143|NCT01511536|117101|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
51144|NCT01511536|117099|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
51145|NCT01511536|117100|P2|STARTED|Phase 1||7
51146|NCT01511536|117101|P1|STARTED|Phase 1||3
51147|NCT01511315|117121|P1|NOT COMPLETED|Overall Study||4
51148|NCT01511315|117121|P1|COMPLETED|Overall Study||32
51149|NCT01511315|117121|P1|STARTED|Overall Study||36
51150|NCT01511107|117133|P2|NOT COMPLETED|Overall Study||41
51151|NCT01511107|117134|P1|NOT COMPLETED|Overall Study||22
51152|NCT01511107|117133|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
51153|NCT01511107|117134|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
51154|NCT01511107|117133|P2|STARTED|Overall Study|Randomized to the treatment group.|260
51155|NCT01511107|117134|P1|STARTED|Overall Study|Randomized to the treatment group.|260
51156|NCT01511016|117184|P2|NOT COMPLETED|Overall Study||2
51157|NCT01511016|117185|P1|NOT COMPLETED|Overall Study||2
51158|NCT01511016|117184|P2|COMPLETED|Overall Study||7
51159|NCT01511016|117185|P1|COMPLETED|Overall Study||6
51160|NCT01511016|117184|P2|STARTED|Overall Study||9
51161|NCT01511016|117185|P1|STARTED|Overall Study||8
51162|NCT01510912|117201|P1|NOT COMPLETED|Overall Study||242
51163|NCT01510912|117201|P1|COMPLETED|Overall Study||360
51164|NCT01510912|117201|P1|STARTED|Overall Study||602
51165|NCT01510834|117207|P1|NOT COMPLETED|Overall Study||33
51166|NCT01510834|117207|P1|COMPLETED|Overall Study||57
51167|NCT01510834|117207|P1|STARTED|Overall Study||90
51168|NCT01510769|117217|P3|NOT COMPLETED|Overall Study||22
51169|NCT01510769|117218|P2|NOT COMPLETED|Overall Study||25
51170|NCT01510769|117219|P1|NOT COMPLETED|Overall Study||27
51171|NCT01510769|117217|P3|COMPLETED|Overall Study||87
51172|NCT01510769|117218|P2|COMPLETED|Overall Study||84
51173|NCT01510769|117219|P1|COMPLETED|Overall Study||79
51174|NCT01510769|117217|P3|STARTED|Overall Study||109
51175|NCT01510769|117218|P2|STARTED|Overall Study||109
51176|NCT01510769|117219|P1|STARTED|Overall Study||106
51177|NCT01510756|117236|P1|NOT COMPLETED|Overall Study||4
51178|NCT01510756|117236|P1|COMPLETED|Overall Study||0
51179|NCT01510756|117236|P1|STARTED|Overall Study||4
51180|NCT01510717|117244|P2|NOT COMPLETED|Overall Study||5
51181|NCT01510717|117245|P1|NOT COMPLETED|Overall Study||2
51182|NCT01510717|117244|P2|COMPLETED|Overall Study||160
51183|NCT01510717|117245|P1|COMPLETED|Overall Study||153
51184|NCT01510717|117244|P2|STARTED|Overall Study||165
51185|NCT01510717|117245|P1|STARTED|Overall Study||155
51186|NCT01510704|117273|P4|NOT COMPLETED|Overall Study||0
51187|NCT01510704|117274|P3|NOT COMPLETED|Overall Study||0
51188|NCT01510704|117275|P2|NOT COMPLETED|Overall Study||0
51189|NCT01510704|117276|P1|NOT COMPLETED|Overall Study||0
51190|NCT01510704|117273|P4|COMPLETED|Overall Study||53
51191|NCT01510704|117274|P3|COMPLETED|Overall Study||50
51192|NCT01510704|117275|P2|COMPLETED|Overall Study||58
51193|NCT01510704|117276|P1|COMPLETED|Overall Study||54
51194|NCT01510704|117273|P4|STARTED|Overall Study||53
51195|NCT01510704|117274|P3|STARTED|Overall Study||50
51196|NCT01510704|117275|P2|STARTED|Overall Study||58
51197|NCT01510704|117276|P1|STARTED|Overall Study||54
51198|NCT01510652|117288|P2|NOT COMPLETED|Overall Study||67
51199|NCT01510652|117289|P1|NOT COMPLETED|Overall Study||92
51200|NCT01510652|117288|P2|COMPLETED|Overall Study||288
51201|NCT01510652|117289|P1|COMPLETED|Overall Study||627
51202|NCT01510652|117288|P2|Baseline|Overall Study||348
51203|NCT01510652|117289|P1|Baseline|Overall Study||718
51204|NCT01510652|117288|P2|STARTED|Overall Study||355
51205|NCT01510652|117289|P1|STARTED|Overall Study||719
51206|NCT01510457|117301|P2|NOT COMPLETED|Overall Study||3
51207|NCT01510457|117302|P1|NOT COMPLETED|Overall Study||5
51208|NCT01510457|117301|P2|COMPLETED|Overall Study||26
51209|NCT01510457|117302|P1|COMPLETED|Overall Study||12
51210|NCT01510457|117301|P2|STARTED|Overall Study||29
51211|NCT01510457|117302|P1|STARTED|Overall Study||17
51212|NCT01510379|117322|P2|NOT COMPLETED|Overall Study||0
51213|NCT01510379|117323|P1|NOT COMPLETED|Overall Study||0
51214|NCT01510379|117322|P2|COMPLETED|Overall Study||51
51215|NCT01510379|117323|P1|COMPLETED|Overall Study||49
51216|NCT01510379|117322|P2|STARTED|Overall Study||51
51217|NCT01510379|117323|P1|STARTED|Overall Study||49
51218|NCT01510327|117331|P1|NOT COMPLETED|Overall Study||0
51219|NCT01510327|117331|P1|COMPLETED|Overall Study||22
51220|NCT01510327|117331|P1|STARTED|Overall Study||22
51221|NCT01510158|117365|P3|NOT COMPLETED|Overall Study||50
51222|NCT01510158|117366|P2|NOT COMPLETED|Overall Study||53
51223|NCT01510158|117367|P1|NOT COMPLETED|Overall Study||51
51224|NCT01510158|117365|P3|COMPLETED|Overall Study||152
51225|NCT01510158|117366|P2|COMPLETED|Overall Study||150
51226|NCT01510158|117367|P1|COMPLETED|Overall Study||151
51227|NCT01510158|117365|P3|STARTED|Overall Study||202
51228|NCT01510158|117366|P2|STARTED|Overall Study||203
51229|NCT01510158|117367|P1|STARTED|Overall Study||202
51230|NCT01510145|117381|P1|NOT COMPLETED|Overall Study||18
51231|NCT01510145|117381|P1|COMPLETED|Overall Study||173
51232|NCT01510145|117381|P1|STARTED|Overall Study||191
51233|NCT01509807|117388|P2|NOT COMPLETED|Overall Study||1
51234|NCT01509807|117389|P1|NOT COMPLETED|Overall Study||1
51235|NCT01509807|117388|P2|COMPLETED|Overall Study||16
51236|NCT01509807|117389|P1|COMPLETED|Overall Study||15
51237|NCT01509807|117388|P2|STARTED|Overall Study||17
51238|NCT01509807|117389|P1|STARTED|Overall Study||16
51239|NCT01509664|117415|P2|NOT COMPLETED|Overall Study||21
51240|NCT01509664|117416|P1|NOT COMPLETED|Overall Study||15
51241|NCT01509664|117415|P2|COMPLETED|Overall Study||28
51242|NCT01509664|117416|P1|COMPLETED|Overall Study||34
51243|NCT01509664|117415|P2|T3 Follow-up|Overall Study||33
51244|NCT01509664|117416|P1|T3 Follow-up|Overall Study||40
51245|NCT01509664|117415|P2|T2 Follow-up|Overall Study||38
51246|NCT01509664|117416|P1|T2 Follow-up|Overall Study||45
51247|NCT01509664|117415|P2|STARTED|Overall Study||49
51248|NCT01509664|117416|P1|STARTED|Overall Study||49
51249|NCT01509638|117424|P2|NOT COMPLETED|Overall Study||2
51250|NCT01509638|117425|P1|NOT COMPLETED|Overall Study||3
51251|NCT01509638|117424|P2|COMPLETED|Overall Study||24
51252|NCT01509638|117425|P1|COMPLETED|Overall Study||20
51253|NCT01509638|117424|P2|STARTED|Overall Study||26
51254|NCT01509638|117425|P1|STARTED|Overall Study||23
51255|NCT01509625|117449|P1|NOT COMPLETED|Overall Study||9
51256|NCT01509625|117449|P1|COMPLETED|Overall Study||263
51257|NCT01509625|117449|P1|STARTED|Overall Study||272
51258|NCT01509586|117467|P2|NOT COMPLETED|Overall Study||0
51259|NCT01509586|117468|P1|NOT COMPLETED|Overall Study||0
51260|NCT01509586|117467|P2|COMPLETED|Overall Study|final intent to treat sample|610
51261|NCT01509586|117468|P1|COMPLETED|Overall Study|final intent to treat sample|626
51262|NCT01509586|117467|P2|Week 58 (Month 12)|Overall Study||499
51263|NCT01509586|117468|P1|Week 58 (Month 12)|Overall Study||492
51264|NCT01509586|117467|P2|Week 46|Overall Study||494
51265|NCT01509586|117468|P1|Week 46|Overall Study||483
51266|NCT01509586|117467|P2|Week 32 (Month 6)|Overall Study||523
51267|NCT01509586|117468|P1|Week 32 (Month 6)|Overall Study||504
51268|NCT01509586|117467|P2|Week18|Overall Study||555
51269|NCT01509586|117468|P1|Week18|Overall Study||529
51270|NCT01509586|117467|P2|Week 14|Overall Study||566
51271|NCT01509586|117468|P1|Week 14|Overall Study||528
51272|NCT01509586|117467|P2|Week 10|Overall Study||574
51273|NCT01509586|117468|P1|Week 10|Overall Study||537
51274|NCT01509586|117467|P2|Week 6|Overall Study||585
51275|NCT01509586|117468|P1|Week 6|Overall Study||551
51276|NCT01509586|117467|P2|Week 3|Overall Study||585
51277|NCT01509586|117468|P1|Week 3|Overall Study||574
51278|NCT01509586|117467|P2|STARTED|Overall Study|Week 0|610
51279|NCT01509586|117468|P1|STARTED|Overall Study|Week 0|626
51280|NCT01509105|117474|P1|NOT COMPLETED|Overall Study||0
51281|NCT01509105|117474|P1|COMPLETED|Overall Study||649
51282|NCT01509105|117474|P1|STARTED|Overall Study||649
51283|NCT01509079|117491|P2|NOT COMPLETED|Overall Study||3
51284|NCT01509079|117492|P1|NOT COMPLETED|Overall Study||0
51285|NCT01509079|117491|P2|COMPLETED|Overall Study||56
51286|NCT01509079|117492|P1|COMPLETED|Overall Study||57
51287|NCT01509079|117491|P2|STARTED|Overall Study||59
51288|NCT01509079|117492|P1|STARTED|Overall Study||57
51289|NCT01509053|117508|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
51290|NCT01509053|117508|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
51291|NCT01509053|117508|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
51292|NCT01509053|117508|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
51293|NCT01509053|117508|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
51294|NCT01509053|117508|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
51295|NCT01509053|117508|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
51296|NCT01509053|117508|P1|COMPLETED|Oral Aripirazole (Phase A)||8
51297|NCT01509053|117508|P1|STARTED|Oral Aripirazole (Phase A)||19
51298|NCT01509040|117522|P3|NOT COMPLETED|Overall Study||0
51299|NCT01509040|117523|P2|NOT COMPLETED|Overall Study||1
51300|NCT01509040|117524|P1|NOT COMPLETED|Overall Study||0
51301|NCT01509040|117522|P3|COMPLETED|Overall Study||0
51302|NCT01509040|117523|P2|COMPLETED|Overall Study||1
51303|NCT01509040|117524|P1|COMPLETED|Overall Study||0
51304|NCT01509040|117522|P3|STARTED|Overall Study||0
51305|NCT01509040|117523|P2|STARTED|Overall Study||2
51306|NCT01509040|117524|P1|STARTED|Overall Study||0
51307|NCT01508936|117570|P2|NOT COMPLETED|Overall Study||79
51308|NCT01508936|117571|P1|NOT COMPLETED|Overall Study||23
51309|NCT01508936|117570|P2|COMPLETED|Overall Study||330
51310|NCT01508936|117571|P1|COMPLETED|Overall Study||79
51311|NCT01508936|117570|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
51312|NCT01508936|117571|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
51313|NCT01508936|117570|P2|Full Analysis Set|Overall Study||395
51314|NCT01508936|117571|P1|Full Analysis Set|Overall Study||97
51315|NCT01508936|117570|P2|Safety Analysis Set|Overall Study||395
51316|NCT01508936|117571|P1|Safety Analysis Set|Overall Study||97
51317|NCT01508936|117570|P2|Randomized, Not Treated|Overall Study||3
51318|NCT01508936|117571|P1|Randomized, Not Treated|Overall Study||1
51319|NCT01508936|117570|P2|Randomized|Overall Study||398
51320|NCT01508936|117571|P1|Randomized|Overall Study||98
51321|NCT01508936|117570|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
51322|NCT01508936|117571|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
51323|NCT01508936|117570|P2|STARTED|Overall Study||409
51324|NCT01508936|117571|P1|STARTED|Overall Study||102
51325|NCT01508910|117610|P4|NOT COMPLETED|Treatment||3
51326|NCT01508910|117611|P3|NOT COMPLETED|Treatment||10
51327|NCT01508910|117612|P2|NOT COMPLETED|Treatment||4
51328|NCT01508910|117613|P1|NOT COMPLETED|Treatment||2
51329|NCT01508910|117610|P4|COMPLETED|Treatment||3
51330|NCT01508910|117611|P3|COMPLETED|Treatment||18
51331|NCT01508910|117612|P2|COMPLETED|Treatment||24
51332|NCT01508910|117613|P1|COMPLETED|Treatment||48
51333|NCT01508910|117610|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
51334|NCT01508910|117611|P3|STARTED|Treatment||28
51335|NCT01508910|117612|P2|STARTED|Treatment||28
51336|NCT01508910|117613|P1|STARTED|Treatment||50
51337|NCT01508910|117610|P4|NOT COMPLETED|Randomization||0
51338|NCT01508910|117611|P3|NOT COMPLETED|Randomization||0
51339|NCT01508910|117612|P2|NOT COMPLETED|Randomization||0
51340|NCT01508910|117613|P1|NOT COMPLETED|Randomization||0
51341|NCT01508910|117610|P4|COMPLETED|Randomization||0
51342|NCT01508910|117611|P3|COMPLETED|Randomization||28
51343|NCT01508910|117612|P2|COMPLETED|Randomization||27
51344|NCT01508910|117613|P1|COMPLETED|Randomization||57
51345|NCT01508910|117610|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
51346|NCT01508910|117611|P3|STARTED|Randomization||28
51347|NCT01508910|117612|P2|STARTED|Randomization||27
51348|NCT01508910|117613|P1|STARTED|Randomization||57
51349|NCT01508832|117637|P2|NOT COMPLETED|Overall Study||0
51350|NCT01508832|117638|P1|NOT COMPLETED|Overall Study||0
51351|NCT01508832|117637|P2|COMPLETED|Overall Study||6
51352|NCT01508832|117638|P1|COMPLETED|Overall Study||6
51353|NCT01508832|117637|P2|STARTED|Overall Study||6
51354|NCT01508832|117638|P1|STARTED|Overall Study||6
51355|NCT01508702|117646|P2|NOT COMPLETED|Overall Study||13
51356|NCT01508702|117647|P1|NOT COMPLETED|Overall Study||23
51357|NCT01508702|117646|P2|COMPLETED|Overall Study||94
51358|NCT01508702|117647|P1|COMPLETED|Overall Study||84
51359|NCT01508702|117646|P2|STARTED|Overall Study||107
51360|NCT01508702|117647|P1|STARTED|Overall Study||107
51361|NCT01508676|117655|P2|NOT COMPLETED|Phase II (2 Weeks)||1
51362|NCT01508676|117656|P1|NOT COMPLETED|Phase II (2 Weeks)||1
51363|NCT01508676|117655|P2|COMPLETED|Phase II (2 Weeks)||13
51364|NCT01508676|117656|P1|COMPLETED|Phase II (2 Weeks)||15
51365|NCT01508676|117655|P2|STARTED|Phase II (2 Weeks)||14
51366|NCT01508676|117656|P1|STARTED|Phase II (2 Weeks)||16
51367|NCT01508676|117655|P2|NOT COMPLETED|Washout Period (1 Week)||0
51368|NCT01508676|117656|P1|NOT COMPLETED|Washout Period (1 Week)||0
51369|NCT01508676|117655|P2|COMPLETED|Washout Period (1 Week)||14
51370|NCT01508676|117656|P1|COMPLETED|Washout Period (1 Week)||16
51371|NCT01508676|117655|P2|STARTED|Washout Period (1 Week)||14
51372|NCT01508676|117656|P1|STARTED|Washout Period (1 Week)||16
51373|NCT01508676|117655|P2|NOT COMPLETED|Phase I (2 Weeks)||3
51374|NCT01508676|117656|P1|NOT COMPLETED|Phase I (2 Weeks)||2
51375|NCT01508676|117655|P2|COMPLETED|Phase I (2 Weeks)||14
51376|NCT01508676|117656|P1|COMPLETED|Phase I (2 Weeks)||16
51377|NCT01508676|117655|P2|STARTED|Phase I (2 Weeks)||17
51378|NCT01508676|117656|P1|STARTED|Phase I (2 Weeks)||18
51379|NCT01508455|117666|P1|NOT COMPLETED|Overall Study||0
51380|NCT01508455|117666|P1|COMPLETED|Overall Study||6
51381|NCT01508455|117666|P1|STARTED|Overall Study||6
51382|NCT01508325|117677|P2|NOT COMPLETED|Overall Study||21
51383|NCT01508325|117678|P1|NOT COMPLETED|Overall Study||18
51384|NCT01508325|117677|P2|COMPLETED|Overall Study||72
51385|NCT01508325|117678|P1|COMPLETED|Overall Study||75
51386|NCT01508325|117677|P2|STARTED|Overall Study||93
51387|NCT01508325|117678|P1|STARTED|Overall Study||93
51388|NCT01508169|117708|P2|NOT COMPLETED|Overall Study||2
51389|NCT01508169|117709|P1|NOT COMPLETED|Overall Study||3
51390|NCT01508169|117708|P2|COMPLETED|Overall Study||45
51391|NCT01508169|117709|P1|COMPLETED|Overall Study||44
51392|NCT01508169|117708|P2|STARTED|Overall Study||47
51393|NCT01508169|117709|P1|STARTED|Overall Study||47
51394|NCT01508130|117723|P2|NOT COMPLETED|Overall Study||69
51395|NCT01508130|117724|P1|NOT COMPLETED|Overall Study||227
51396|NCT01508130|117723|P2|COMPLETED|Overall Study||73
51397|NCT01508130|117724|P1|COMPLETED|Overall Study||266
51398|NCT01508130|117723|P2|mTRT|Overall Study||142
51399|NCT01508130|117724|P1|mTRT|Overall Study||493
51400|NCT01508130|117723|P2|STARTED|Overall Study||142
51401|NCT01508130|117724|P1|STARTED|Overall Study||493
51402|NCT01508052|117768|P2|NOT COMPLETED|Overall Study||0
51403|NCT01508052|117769|P1|NOT COMPLETED|Overall Study||0
51404|NCT01508052|117768|P2|COMPLETED|Overall Study||20
51405|NCT01508052|117769|P1|COMPLETED|Overall Study||20
51406|NCT01508052|117768|P2|STARTED|Overall Study||20
51407|NCT01508052|117769|P1|STARTED|Overall Study||20
51408|NCT01508013|117777|P2|NOT COMPLETED|Overall Study||23
51409|NCT01508013|117778|P1|NOT COMPLETED|Overall Study||32
51410|NCT01508013|117777|P2|COMPLETED|Overall Study||206
51411|NCT01508013|117778|P1|COMPLETED|Overall Study||182
51412|NCT01508013|117777|P2|STARTED|Overall Study||229
51413|NCT01508013|117778|P1|STARTED|Overall Study||214
51414|NCT01507896|117788|P1|NOT COMPLETED|Overall Study||2
51415|NCT01507896|117788|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
51416|NCT01507896|117788|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
51417|NCT01507831|117831|P2|NOT COMPLETED|Overall Study||440
51418|NCT01507831|117832|P1|NOT COMPLETED|Overall Study||193
51419|NCT01507831|117831|P2|COMPLETED|Overall Study||1113
51420|NCT01507831|117832|P1|COMPLETED|Overall Study||595
51421|NCT01507831|117831|P2|Treated|Overall Study||1550
51422|NCT01507831|117832|P1|Treated|Overall Study||788
51423|NCT01507831|117831|P2|STARTED|Overall Study|Randomized|1553
51424|NCT01507831|117832|P1|STARTED|Overall Study|Randomized|788
51425|NCT01507493|117902|P2|NOT COMPLETED|Overall Study||0
51426|NCT01507493|117903|P1|NOT COMPLETED|Overall Study||0
51427|NCT01507493|117902|P2|COMPLETED|Overall Study||178
51428|NCT01507493|117903|P1|COMPLETED|Overall Study||22
51429|NCT01507493|117902|P2|STARTED|Overall Study||178
51430|NCT01507493|117903|P1|STARTED|Overall Study||22
51431|NCT01507246|117919|P2|NOT COMPLETED|Overall Study||1
51432|NCT01507246|117920|P1|NOT COMPLETED|Overall Study||2
51433|NCT01507246|117919|P2|COMPLETED|Overall Study||21
51434|NCT01507246|117920|P1|COMPLETED|Overall Study||18
51435|NCT01507246|117919|P2|STARTED|Overall Study||22
51436|NCT01507246|117920|P1|STARTED|Overall Study||20
51437|NCT01507233|117934|P2|NOT COMPLETED|Overall Study||0
51438|NCT01507233|117935|P1|NOT COMPLETED|Overall Study||0
51439|NCT01507233|117934|P2|COMPLETED|Overall Study||0
51440|NCT01507233|117935|P1|COMPLETED|Overall Study||5
51441|NCT01507233|117934|P2|STARTED|Overall Study||0
51442|NCT01507233|117935|P1|STARTED|Overall Study||5
51443|NCT01507220|117947|P2|NOT COMPLETED|Overall Study||0
51444|NCT01507220|117948|P1|NOT COMPLETED|Overall Study||0
51445|NCT01507220|117947|P2|COMPLETED|Overall Study||0
51446|NCT01507220|117948|P1|COMPLETED|Overall Study||2
51447|NCT01507220|117947|P2|STARTED|Overall Study||0
51448|NCT01507220|117948|P1|STARTED|Overall Study||2
51449|NCT01507181|117962|P2|NOT COMPLETED|Overall Study||0
51450|NCT01507181|117963|P1|NOT COMPLETED|Overall Study||0
51451|NCT01507181|117962|P2|COMPLETED|Overall Study||12
51452|NCT01507181|117963|P1|COMPLETED|Overall Study||12
51453|NCT01507181|117962|P2|STARTED|Overall Study||12
51454|NCT01507181|117963|P1|STARTED|Overall Study||12
51455|NCT01507155|117983|P2|NOT COMPLETED|Overall Study||0
51456|NCT01507155|117984|P1|NOT COMPLETED|Overall Study||0
51457|NCT01507155|117983|P2|COMPLETED|Overall Study||60
51458|NCT01507155|117984|P1|COMPLETED|Overall Study||625
51459|NCT01507155|117983|P2|STARTED|Overall Study||60
51460|NCT01507155|117984|P1|STARTED|Overall Study||625
51461|NCT01507103|117993|P3|NOT COMPLETED|Overall Study||0
51462|NCT01507103|117994|P2|NOT COMPLETED|Overall Study||0
51463|NCT01507103|117995|P1|NOT COMPLETED|Overall Study||0
51464|NCT01507103|117993|P3|COMPLETED|Overall Study||42
51465|NCT01507103|117994|P2|COMPLETED|Overall Study||41
51466|NCT01507103|117995|P1|COMPLETED|Overall Study||41
51467|NCT01507103|117993|P3|STARTED|Overall Study||42
51468|NCT01507103|117994|P2|STARTED|Overall Study||41
51469|NCT01507103|117995|P1|STARTED|Overall Study||41
51470|NCT01507090|118018|P1|NOT COMPLETED|Overall Study||18
51471|NCT01507090|118018|P1|COMPLETED|Overall Study||624
51472|NCT01507090|118018|P1|STARTED|Overall Study||642
51473|NCT01507051|118057|P4|NOT COMPLETED|Overall Study||7
51474|NCT01507051|118058|P3|NOT COMPLETED|Overall Study||1
51475|NCT01507051|118059|P2|NOT COMPLETED|Overall Study||3
51476|NCT01507051|118060|P1|NOT COMPLETED|Overall Study||2
51477|NCT01507051|118057|P4|COMPLETED|Overall Study||0
51478|NCT01507051|118058|P3|COMPLETED|Overall Study||28
51479|NCT01507051|118059|P2|COMPLETED|Overall Study||28
51480|NCT01507051|118060|P1|COMPLETED|Overall Study||27
51481|NCT01507051|118057|P4|Received Placebo or Rivaroxaban|Overall Study||0
51482|NCT01507051|118058|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
51483|NCT01507051|118059|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
51484|NCT01507051|118060|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
51485|NCT01507051|118057|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
51486|NCT01507051|118058|P3|Warfarin run-in Phase|Overall Study||0
51487|NCT01507051|118059|P2|Warfarin run-in Phase|Overall Study||28
51488|NCT01507051|118060|P1|Warfarin run-in Phase|Overall Study||28
51489|NCT01507051|118057|P4|STARTED|Overall Study||7
51490|NCT01507051|118058|P3|STARTED|Overall Study||29
51491|NCT01507051|118059|P2|STARTED|Overall Study||31
51492|NCT01507051|118060|P1|STARTED|Overall Study||29
51493|NCT01506960|118178|P1|NOT COMPLETED|Overall Study||47
51494|NCT01506960|118178|P1|COMPLETED|Overall Study||17
51495|NCT01506960|118178|P1|STARTED|Overall Study||64
51496|NCT01506908|118186|P2|NOT COMPLETED|Overall Study||0
51497|NCT01506908|118187|P1|NOT COMPLETED|Overall Study||1
51498|NCT01506908|118186|P2|COMPLETED|Overall Study||161
51499|NCT01506908|118187|P1|COMPLETED|Overall Study||161
51500|NCT01506908|118186|P2|STARTED|Overall Study||161
51501|NCT01506908|118187|P1|STARTED|Overall Study||162
51502|NCT01506882|118205|P2|NOT COMPLETED|Overall Study||7
51503|NCT01506882|118206|P1|NOT COMPLETED|Overall Study||22
51504|NCT01506882|118205|P2|COMPLETED|Overall Study||3
51505|NCT01506882|118206|P1|COMPLETED|Overall Study||39
51506|NCT01506882|118205|P2|STARTED|Overall Study||10
51507|NCT01506882|118206|P1|STARTED|Overall Study||61
51508|NCT01506726|118220|P2|NOT COMPLETED|Overall Study||2
51509|NCT01506726|118221|P1|NOT COMPLETED|Overall Study||1
51510|NCT01506726|118220|P2|COMPLETED|Overall Study||3
51511|NCT01506726|118221|P1|COMPLETED|Overall Study||5
51512|NCT01506726|118220|P2|STARTED|Overall Study||5
51513|NCT01506726|118221|P1|STARTED|Overall Study||6
51514|NCT01506596|118261|P1|NOT COMPLETED|Overall Study||1
51515|NCT01506596|118261|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
51516|NCT01506596|118261|P1|STARTED|Overall Study||42
51517|NCT01506362|118269|P1|NOT COMPLETED|Overall Study||6
51518|NCT01506362|118269|P1|COMPLETED|Overall Study||16
51519|NCT01506362|118269|P1|STARTED|Overall Study||22
51520|NCT01506323|118275|P2|NOT COMPLETED|Overall Study||13
51521|NCT01506323|118276|P1|NOT COMPLETED|Overall Study||24
51522|NCT01506323|118275|P2|COMPLETED|Overall Study||71
51523|NCT01506323|118276|P1|COMPLETED|Overall Study||65
51524|NCT01506323|118275|P2|Post-treatment Completed CAPS|Overall Study||72
51525|NCT01506323|118276|P1|Post-treatment Completed CAPS|Overall Study||68
51526|NCT01506323|118275|P2|Post-treatment Completers|Overall Study||72
51527|NCT01506323|118276|P1|Post-treatment Completers|Overall Study||69
51528|NCT01506323|118275|P2|STARTED|Overall Study||84
51529|NCT01506323|118276|P1|STARTED|Overall Study||89
51530|NCT01506193|118305|P3|NOT COMPLETED|Overall Study||14
51531|NCT01506193|118306|P2|NOT COMPLETED|Overall Study||4
51532|NCT01506193|118307|P1|NOT COMPLETED|Overall Study||14
51533|NCT01506193|118305|P3|COMPLETED|Overall Study||168
51534|NCT01506193|118306|P2|COMPLETED|Overall Study||179
51535|NCT01506193|118307|P1|COMPLETED|Overall Study||337
51536|NCT01506193|118305|P3|STARTED|Overall Study||182
51537|NCT01506193|118306|P2|STARTED|Overall Study||183
51538|NCT01506193|118307|P1|STARTED|Overall Study||351
51539|NCT01505881|118340|P2|NOT COMPLETED|Overall Study||1
51540|NCT01505881|118341|P1|NOT COMPLETED|Overall Study||4
51541|NCT01505881|118340|P2|COMPLETED|Overall Study||58
51542|NCT01505881|118341|P1|COMPLETED|Overall Study||95
51543|NCT01505881|118340|P2|STARTED|Overall Study||59
51544|NCT01505881|118341|P1|STARTED|Overall Study||99
51545|NCT01505647|118355|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
51546|NCT01505647|118356|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
51547|NCT01505647|118355|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
51548|NCT01505647|118356|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
51549|NCT01505647|118355|P2|STARTED|Day 43 Through Day 182 Follow-up||166
51550|NCT01505647|118356|P1|STARTED|Day 43 Through Day 182 Follow-up||329
51551|NCT01505647|118355|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
51552|NCT01505647|118356|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
51553|NCT01505647|118355|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
51554|NCT01505647|118356|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
51555|NCT01505647|118355|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
51556|NCT01505647|118356|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
51557|NCT01505647|118355|P2|STARTED|Day 1 Through Day 42 Follow-up||166
51558|NCT01505647|118356|P1|STARTED|Day 1 Through Day 42 Follow-up||332
51559|NCT01505608|118372|P2|NOT COMPLETED|Phase II||2
51560|NCT01505608|118373|P1|NOT COMPLETED|Phase II||2
51561|NCT01505608|118372|P2|COMPLETED|Phase II||2
51562|NCT01505608|118373|P1|COMPLETED|Phase II||0
51563|NCT01505608|118372|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
51564|NCT01505608|118373|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
51565|NCT01505608|118372|P2|NOT COMPLETED|Phase I||6
51566|NCT01505608|118373|P1|NOT COMPLETED|Phase I||0
51567|NCT01505608|118372|P2|COMPLETED|Phase I||2
51568|NCT01505608|118373|P1|COMPLETED|Phase I||0
51569|NCT01505608|118372|P2|STARTED|Phase I||8
51570|NCT01505608|118373|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
51571|NCT01505387|118391|P2|NOT COMPLETED|Overall Study||1
51572|NCT01505387|118392|P1|NOT COMPLETED|Overall Study||2
51573|NCT01505387|118391|P2|COMPLETED|Overall Study||24
51574|NCT01505387|118392|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
51575|NCT01505387|118391|P2|Treated|Overall Study||24
51576|NCT01505387|118392|P1|Treated|Overall Study||24
51577|NCT01505387|118391|P2|STARTED|Overall Study||25
51578|NCT01505387|118392|P1|STARTED|Overall Study||25
51579|NCT01504997|118398|P1|NOT COMPLETED|Overall Study||0
51580|NCT01504997|118398|P1|COMPLETED|Overall Study||18
51581|NCT01504997|118398|P1|STARTED|Overall Study||18
51582|NCT01504971|118402|P1|NOT COMPLETED|Overall Study||13
51583|NCT01504971|118402|P1|COMPLETED|Overall Study||82
51584|NCT01504971|118402|P1|STARTED|Overall Study||95
51585|NCT01504867|118412|P2|NOT COMPLETED|Overall Study||3
51586|NCT01504867|118413|P1|NOT COMPLETED|Overall Study||7
51587|NCT01504867|118412|P2|COMPLETED|Overall Study||195
51588|NCT01504867|118413|P1|COMPLETED|Overall Study||195
51589|NCT01504867|118412|P2|STARTED|Overall Study||198
51590|NCT01504867|118413|P1|STARTED|Overall Study||202
51591|NCT01504854|118433|P2|NOT COMPLETED|Overall Study||7
51592|NCT01504854|118434|P1|NOT COMPLETED|Overall Study||8
51593|NCT01504854|118433|P2|COMPLETED|Overall Study||48
51594|NCT01504854|118434|P1|COMPLETED|Overall Study||56
51595|NCT01504854|118433|P2|STARTED|Overall Study||55
51596|NCT01504854|118434|P1|STARTED|Overall Study||64
51597|NCT01503749|118451|P3|NOT COMPLETED|Overall Study||0
51598|NCT01503749|118452|P2|NOT COMPLETED|Overall Study||0
51599|NCT01503749|118453|P1|NOT COMPLETED|Overall Study||0
51600|NCT01503749|118451|P3|COMPLETED|Overall Study||3
51601|NCT01503749|118452|P2|COMPLETED|Overall Study||3
51602|NCT01503749|118453|P1|COMPLETED|Overall Study||3
51603|NCT01503749|118451|P3|STARTED|Overall Study||3
51604|NCT01503749|118452|P2|STARTED|Overall Study||3
51605|NCT01503749|118453|P1|STARTED|Overall Study||3
51606|NCT01503021|118466|P2|NOT COMPLETED|Overall Study||26
51607|NCT01503021|118467|P1|NOT COMPLETED|Overall Study||27
51608|NCT01503021|118466|P2|COMPLETED|Overall Study||332
51609|NCT01503021|118467|P1|COMPLETED|Overall Study||333
51610|NCT01503021|118466|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
51611|NCT01503021|118467|P1|Completed Treatment|Overall Study||333
51612|NCT01503021|118466|P2|Dosed|Overall Study||352
51613|NCT01503021|118467|P1|Dosed|Overall Study||351
51614|NCT01503021|118466|P2|STARTED|Overall Study||358
51615|NCT01503021|118467|P1|STARTED|Overall Study||360
51616|NCT01502787|118514|P2|NOT COMPLETED|Overall Study||0
51617|NCT01502787|118515|P1|NOT COMPLETED|Overall Study||0
51618|NCT01502787|118514|P2|COMPLETED|Overall Study||10
51619|NCT01502787|118515|P1|COMPLETED|Overall Study||11
51620|NCT01502787|118514|P2|STARTED|Overall Study||10
51621|NCT01502787|118515|P1|STARTED|Overall Study||11
51622|NCT01502709|118523|P2|NOT COMPLETED|Overall Study||0
51623|NCT01502709|118524|P1|NOT COMPLETED|Overall Study||4
51624|NCT01502709|118523|P2|COMPLETED|Overall Study||0
51625|NCT01502709|118524|P1|COMPLETED|Overall Study||1
51626|NCT01502709|118523|P2|STARTED|Overall Study||0
51627|NCT01502709|118524|P1|STARTED|Overall Study||5
51628|NCT01502423|118536|P2|NOT COMPLETED|Overall Study||1
51629|NCT01502423|118537|P1|NOT COMPLETED|Overall Study||0
51630|NCT01502423|118536|P2|COMPLETED|Overall Study||29
51631|NCT01502423|118537|P1|COMPLETED|Overall Study||31
51632|NCT01502423|118536|P2|STARTED|Overall Study||30
51633|NCT01502423|118537|P1|STARTED|Overall Study||31
51634|NCT01502410|118559|P4|NOT COMPLETED|Overall Study||0
51635|NCT01502410|118560|P3|NOT COMPLETED|Overall Study||0
51636|NCT01502410|118561|P2|NOT COMPLETED|Overall Study||10
51637|NCT01502410|118562|P1|NOT COMPLETED|Overall Study||10
51638|NCT01502410|118559|P4|COMPLETED|Overall Study||0
51639|NCT01502410|118560|P3|COMPLETED|Overall Study||0
51640|NCT01502410|118561|P2|COMPLETED|Overall Study||0
51641|NCT01502410|118562|P1|COMPLETED|Overall Study||0
51642|NCT01502410|118559|P4|STARTED|Overall Study||0
51643|NCT01502410|118560|P3|STARTED|Overall Study||0
51644|NCT01502410|118561|P2|STARTED|Overall Study||10
51645|NCT01502410|118562|P1|STARTED|Overall Study||10
51646|NCT01502371|118575|P5|NOT COMPLETED|Overall Study||52
51647|NCT01502371|118576|P4|NOT COMPLETED|Overall Study||37
51648|NCT01502371|118577|P3|NOT COMPLETED|Overall Study||25
51649|NCT01502371|118578|P2|NOT COMPLETED|Overall Study||32
51650|NCT01502371|118579|P1|NOT COMPLETED|Overall Study||41
51651|NCT01502371|118575|P5|COMPLETED|Overall Study||60
51652|NCT01502371|118576|P4|COMPLETED|Overall Study||88
51653|NCT01502371|118577|P3|COMPLETED|Overall Study||83
51654|NCT01502371|118578|P2|COMPLETED|Overall Study||81
51655|NCT01502371|118579|P1|COMPLETED|Overall Study||79
51656|NCT01502371|118575|P5|STARTED|Overall Study||112
51657|NCT01502371|118576|P4|STARTED|Overall Study||125
51658|NCT01502371|118577|P3|STARTED|Overall Study||108
51659|NCT01502371|118578|P2|STARTED|Overall Study||113
51660|NCT01502371|118579|P1|STARTED|Overall Study||120
51661|NCT01502332|118604|P2|NOT COMPLETED|Overall Study||0
51662|NCT01502332|118605|P1|NOT COMPLETED|Overall Study||0
51663|NCT01502332|118604|P2|COMPLETED|Overall Study||163
51664|NCT01502332|118605|P1|COMPLETED|Overall Study||157
51665|NCT01502332|118604|P2|STARTED|Overall Study||163
51666|NCT01502332|118605|P1|STARTED|Overall Study||157
51667|NCT01502033|118619|P1|NOT COMPLETED|Overall Study||3
51668|NCT01502033|118619|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
51669|NCT01502033|118619|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
51670|NCT01500434|118625|P1|NOT COMPLETED|Overall Study||7
51671|NCT01500434|118625|P1|COMPLETED|Overall Study||95
51672|NCT01500434|118625|P1|STARTED|Overall Study||102
51673|NCT01500382|118658|P4|NOT COMPLETED|Treatment Period 2||0
51674|NCT01500382|118659|P3|NOT COMPLETED|Treatment Period 2||0
51675|NCT01500382|118660|P2|NOT COMPLETED|Treatment Period 2||0
51676|NCT01500382|118661|P1|NOT COMPLETED|Treatment Period 2||0
51677|NCT01500382|118658|P4|COMPLETED|Treatment Period 2||1
51678|NCT01500382|118659|P3|COMPLETED|Treatment Period 2||0
51679|NCT01500382|118660|P2|COMPLETED|Treatment Period 2||1
51680|NCT01500382|118661|P1|COMPLETED|Treatment Period 2||1
51681|NCT01500382|118658|P4|STARTED|Treatment Period 2||1
51682|NCT01500382|118659|P3|STARTED|Treatment Period 2||0
51683|NCT01500382|118660|P2|STARTED|Treatment Period 2||1
51684|NCT01500382|118661|P1|STARTED|Treatment Period 2||1
51685|NCT01500382|118658|P4|NOT COMPLETED|Washout Period||0
51686|NCT01500382|118659|P3|NOT COMPLETED|Washout Period||1
51687|NCT01500382|118660|P2|NOT COMPLETED|Washout Period||0
51688|NCT01500382|118661|P1|NOT COMPLETED|Washout Period||0
51689|NCT01500382|118658|P4|COMPLETED|Washout Period||1
51690|NCT01500382|118659|P3|COMPLETED|Washout Period||0
51691|NCT01500382|118660|P2|COMPLETED|Washout Period||1
51692|NCT01500382|118661|P1|COMPLETED|Washout Period||1
51693|NCT01500382|118658|P4|STARTED|Washout Period||1
51694|NCT01500382|118659|P3|STARTED|Washout Period||1
51695|NCT01500382|118660|P2|STARTED|Washout Period||1
51696|NCT01500382|118661|P1|STARTED|Washout Period||1
51697|NCT01500382|118658|P4|NOT COMPLETED|Treatment Period 1||0
51698|NCT01500382|118659|P3|NOT COMPLETED|Treatment Period 1||0
51699|NCT01500382|118660|P2|NOT COMPLETED|Treatment Period 1||0
51700|NCT01500382|118661|P1|NOT COMPLETED|Treatment Period 1||0
51701|NCT01500382|118658|P4|COMPLETED|Treatment Period 1||1
51702|NCT01500382|118659|P3|COMPLETED|Treatment Period 1||1
51703|NCT01500382|118660|P2|COMPLETED|Treatment Period 1||1
51704|NCT01500382|118661|P1|COMPLETED|Treatment Period 1||1
51705|NCT01500382|118658|P4|STARTED|Treatment Period 1||1
51706|NCT01500382|118659|P3|STARTED|Treatment Period 1||1
51707|NCT01500382|118660|P2|STARTED|Treatment Period 1||1
51708|NCT01500382|118661|P1|STARTED|Treatment Period 1||1
51709|NCT01501162|118685|P2|NOT COMPLETED|Overall Study||5
51710|NCT01501162|118686|P1|NOT COMPLETED|Overall Study||8
51711|NCT01501162|118685|P2|COMPLETED|Overall Study||60
51712|NCT01501162|118686|P1|COMPLETED|Overall Study||57
51713|NCT01501162|118685|P2|STARTED|Overall Study||65
51714|NCT01501162|118686|P1|STARTED|Overall Study||65
51715|NCT01501110|118696|P2|NOT COMPLETED|Overall Study||1
51716|NCT01501110|118697|P1|NOT COMPLETED|Overall Study||0
51717|NCT01501110|118696|P2|COMPLETED|Overall Study||33
51718|NCT01501110|118697|P1|COMPLETED|Overall Study||34
51719|NCT01501110|118696|P2|STARTED|Overall Study||34
51720|NCT01501110|118697|P1|STARTED|Overall Study||34
51721|NCT01500772|118703|P1|NOT COMPLETED|Overall Study||6
51722|NCT01500772|118703|P1|COMPLETED|Overall Study||0
51723|NCT01500772|118703|P1|STARTED|Overall Study||6
51724|NCT01500746|118712|P2|NOT COMPLETED|Overall Study||0
51725|NCT01500746|118713|P1|NOT COMPLETED|Overall Study||0
51726|NCT01500746|118712|P2|COMPLETED|Overall Study||4
51727|NCT01500746|118713|P1|COMPLETED|Overall Study||4
51728|NCT01500746|118712|P2|STARTED|Overall Study||4
51729|NCT01500746|118713|P1|STARTED|Overall Study||4
51730|NCT01500720|118721|P2|NOT COMPLETED|Overall Study||9
51731|NCT01500720|118722|P1|NOT COMPLETED|Overall Study||5
51732|NCT01500720|118721|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
51733|NCT01500720|118722|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
51734|NCT01500720|118721|P2|Treated|Overall Study||88
51735|NCT01500720|118722|P1|Treated|Overall Study||89
51736|NCT01500720|118721|P2|STARTED|Overall Study|Randomized|89
51737|NCT01500720|118722|P1|STARTED|Overall Study|Randomized|90
51738|NCT01500629|118736|P2|NOT COMPLETED|Period 2 (Single Dose)||0
51739|NCT01500629|118737|P1|NOT COMPLETED|Period 2 (Single Dose)||0
51740|NCT01500629|118736|P2|COMPLETED|Period 2 (Single Dose)||10
51741|NCT01500629|118737|P1|COMPLETED|Period 2 (Single Dose)||10
51742|NCT01500629|118736|P2|STARTED|Period 2 (Single Dose)||10
51743|NCT01500629|118737|P1|STARTED|Period 2 (Single Dose)||10
51744|NCT01500629|118736|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
51745|NCT01500629|118737|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
51746|NCT01500629|118736|P2|COMPLETED|Washout Period of 14 to 30 Days||10
51747|NCT01500629|118737|P1|COMPLETED|Washout Period of 14 to 30 Days||10
51748|NCT01500629|118736|P2|STARTED|Washout Period of 14 to 30 Days||10
51749|NCT01500629|118737|P1|STARTED|Washout Period of 14 to 30 Days||11
51750|NCT01500629|118736|P2|NOT COMPLETED|Period 1 (Single Dose)||0
51751|NCT01500629|118737|P1|NOT COMPLETED|Period 1 (Single Dose)||0
51752|NCT01500629|118736|P2|COMPLETED|Period 1 (Single Dose)||10
51753|NCT01500629|118737|P1|COMPLETED|Period 1 (Single Dose)||11
51754|NCT01500629|118736|P2|STARTED|Period 1 (Single Dose)||10
51755|NCT01500629|118737|P1|STARTED|Period 1 (Single Dose)||11
51756|NCT01500317|118824|P3|NOT COMPLETED|Overall Study||0
51757|NCT01500317|118825|P2|NOT COMPLETED|Overall Study||2
51758|NCT01500317|118826|P1|NOT COMPLETED|Overall Study||3
51759|NCT01500317|118824|P3|COMPLETED|Overall Study||13
51760|NCT01500317|118825|P2|COMPLETED|Overall Study||10
51761|NCT01500317|118826|P1|COMPLETED|Overall Study||10
51762|NCT01500317|118824|P3|STARTED|Overall Study||13
51763|NCT01500317|118825|P2|STARTED|Overall Study||12
51764|NCT01500317|118826|P1|STARTED|Overall Study||13
51765|NCT01500252|118848|P2|NOT COMPLETED|Overall Study||6
51766|NCT01500252|118849|P1|NOT COMPLETED|Overall Study||9
51767|NCT01500252|118848|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
51768|NCT01500252|118849|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
51769|NCT01500252|118848|P2|Ten Years|Overall Study||11
51770|NCT01500252|118849|P1|Ten Years|Overall Study||12
51771|NCT01500252|118848|P2|Five Years|Overall Study||13
51772|NCT01500252|118849|P1|Five Years|Overall Study||17
51773|NCT01500252|118848|P2|One Years|Overall Study||16
51774|NCT01500252|118849|P1|One Years|Overall Study||20
51775|NCT01500252|118848|P2|STARTED|Overall Study||17
51776|NCT01500252|118849|P1|STARTED|Overall Study||21
51777|NCT01500226|118875|P2|NOT COMPLETED|Overall Study||494
51778|NCT01500226|118876|P1|NOT COMPLETED|Overall Study||499
51779|NCT01500226|118875|P2|COMPLETED|Overall Study||191
51780|NCT01500226|118876|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
51781|NCT01500226|118875|P2|STARTED|Overall Study||685
51782|NCT01500226|118876|P1|STARTED|Overall Study|Number of randomized patients|684
51783|NCT01500213|118888|P2|NOT COMPLETED|Overall Study||224
51784|NCT01500213|118889|P1|NOT COMPLETED|Overall Study||217
51785|NCT01500213|118888|P2|COMPLETED|Overall Study||53
51786|NCT01500213|118889|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
51787|NCT01500213|118888|P2|STARTED|Overall Study||277
51788|NCT01500213|118889|P1|STARTED|Overall Study|Number of randomized patients|278
51789|NCT01500135|118901|P2|NOT COMPLETED|Overall Study||11
51790|NCT01500135|118902|P1|NOT COMPLETED|Overall Study||17
51791|NCT01500135|118901|P2|COMPLETED|Overall Study||39
51792|NCT01500135|118902|P1|COMPLETED|Overall Study||83
51793|NCT01500135|118901|P2|STARTED|Overall Study||50
51794|NCT01500135|118902|P1|STARTED|Overall Study||100
51795|NCT01500109|118915|P3|NOT COMPLETED|Overall Study||0
51796|NCT01500109|118916|P2|NOT COMPLETED|Overall Study||0
51797|NCT01500109|118917|P1|NOT COMPLETED|Overall Study||0
51798|NCT01500109|118915|P3|COMPLETED|Overall Study||16
51799|NCT01500109|118916|P2|COMPLETED|Overall Study||14
51800|NCT01500109|118917|P1|COMPLETED|Overall Study||15
51801|NCT01500109|118915|P3|STARTED|Overall Study||16
51802|NCT01500109|118916|P2|STARTED|Overall Study||14
51803|NCT01500109|118917|P1|STARTED|Overall Study||15
51804|NCT01500083|118927|P2|NOT COMPLETED|Overall Study||43
51805|NCT01500083|118928|P1|NOT COMPLETED|Overall Study||12
51806|NCT01500083|118927|P2|COMPLETED|Overall Study||31
51807|NCT01500083|118928|P1|COMPLETED|Overall Study||4
51808|NCT01500083|118927|P2|STARTED|Overall Study||74
51809|NCT01500083|118928|P1|STARTED|Overall Study||16
51810|NCT01500031|118934|P1|NOT COMPLETED|Overall Study||5
51811|NCT01500031|118934|P1|COMPLETED|Overall Study||87
51812|NCT01500031|118934|P1|STARTED|Overall Study||92
51813|NCT01499862|118949|P1|NOT COMPLETED|Overall Study||0
51814|NCT01499862|118949|P1|COMPLETED|Overall Study||3
51815|NCT01499862|118949|P1|STARTED|Overall Study||3
51816|NCT01499849|118969|P2|NOT COMPLETED|Overall Study||226
51817|NCT01499849|118970|P1|NOT COMPLETED|Overall Study||224
51818|NCT01499849|118969|P2|COMPLETED|Overall Study||40
51819|NCT01499849|118970|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
51820|NCT01499849|118969|P2|STARTED|Overall Study||266
51821|NCT01499849|118970|P1|STARTED|Overall Study|Number of randomized patients|266
51822|NCT01499810|118980|P1|NOT COMPLETED|Overall Study||12
51823|NCT01499810|118980|P1|COMPLETED|Overall Study||41
51824|NCT01499810|118980|P1|STARTED|Overall Study||53
51825|NCT01499667|119030|P3|NOT COMPLETED|Overall Study||10
51826|NCT01499667|119031|P2|NOT COMPLETED|Overall Study||11
51827|NCT01499667|119032|P1|NOT COMPLETED|Overall Study||9
51828|NCT01499667|119030|P3|COMPLETED|Overall Study||40
51829|NCT01499667|119031|P2|COMPLETED|Overall Study||31
51830|NCT01499667|119032|P1|COMPLETED|Overall Study||41
51831|NCT01499667|119030|P3|Modified Full Analysis Set|Overall Study||39
51832|NCT01499667|119031|P2|Modified Full Analysis Set|Overall Study||29
51833|NCT01499667|119032|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
51834|NCT01499667|119030|P3|Full Analysis Set (FAS)|Overall Study||50
51835|NCT01499667|119031|P2|Full Analysis Set (FAS)|Overall Study||42
51836|NCT01499667|119032|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
51837|NCT01499667|119030|P3|STARTED|Overall Study||50
51838|NCT01499667|119031|P2|STARTED|Overall Study||42
51839|NCT01499667|119032|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
51840|NCT01499654|119061|P1|NOT COMPLETED|Overall Study||0
51841|NCT01499654|119061|P1|COMPLETED|Overall Study||64
51842|NCT01499654|119061|P1|STARTED|Overall Study||64
51843|NCT01499576|119080|P1|NOT COMPLETED|Overall Study||21
51844|NCT01499576|119080|P1|COMPLETED|Overall Study||105
51845|NCT01499576|119080|P1|STARTED|Overall Study||126
51846|NCT01499498|119086|P1|NOT COMPLETED|Overall Study||0
51847|NCT01499498|119086|P1|COMPLETED|Overall Study||13
51848|NCT01499498|119086|P1|STARTED|Overall Study||13
51849|NCT01499355|119094|P4|NOT COMPLETED|Double-Blind Period||23
51850|NCT01499355|119095|P3|NOT COMPLETED|Double-Blind Period||25
51851|NCT01499355|119096|P2|NOT COMPLETED|Double-Blind Period||23
51852|NCT01499355|119097|P1|NOT COMPLETED|Double-Blind Period||0
51853|NCT01499355|119094|P4|COMPLETED|Double-Blind Period||39
51854|NCT01499355|119095|P3|COMPLETED|Double-Blind Period||38
51855|NCT01499355|119096|P2|COMPLETED|Double-Blind Period||40
51856|NCT01499355|119097|P1|COMPLETED|Double-Blind Period||0
51857|NCT01499355|119094|P4|STARTED|Double-Blind Period||62
51858|NCT01499355|119095|P3|STARTED|Double-Blind Period||63
51859|NCT01499355|119096|P2|STARTED|Double-Blind Period||63
51860|NCT01499355|119097|P1|STARTED|Double-Blind Period||0
51861|NCT01499355|119094|P4|NOT COMPLETED|Run-In Period||0
51862|NCT01499355|119095|P3|NOT COMPLETED|Run-In Period||0
51863|NCT01499355|119096|P2|NOT COMPLETED|Run-In Period||0
51864|NCT01499355|119097|P1|NOT COMPLETED|Run-In Period||31
51865|NCT01499355|119094|P4|COMPLETED|Run-In Period||0
51866|NCT01499355|119095|P3|COMPLETED|Run-In Period||0
51867|NCT01499355|119096|P2|COMPLETED|Run-In Period||0
51868|NCT01499355|119097|P1|COMPLETED|Run-In Period||245
51869|NCT01499355|119094|P4|STARTED|Run-In Period||0
51870|NCT01499355|119095|P3|STARTED|Run-In Period||0
51871|NCT01499355|119096|P2|STARTED|Run-In Period||0
51872|NCT01499355|119097|P1|STARTED|Run-In Period||276
51873|NCT01499303|119130|P2|NOT COMPLETED|Overall Study||7
51874|NCT01499303|119131|P1|NOT COMPLETED|Overall Study||3
51875|NCT01499303|119130|P2|COMPLETED|Overall Study||40
51876|NCT01499303|119131|P1|COMPLETED|Overall Study||18
51877|NCT01499303|119130|P2|STARTED|Overall Study||47
51878|NCT01499303|119131|P1|STARTED|Overall Study||21
51879|NCT01499290|119139|P2|NOT COMPLETED|Overall Study||35
51880|NCT01499290|119140|P1|NOT COMPLETED|Overall Study||55
51881|NCT01499290|119139|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
51882|NCT01499290|119140|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
51883|NCT01499290|119139|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
51884|NCT01499290|119140|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
51885|NCT01499277|119190|P2|NOT COMPLETED|Overall Study||32
51886|NCT01499277|119191|P1|NOT COMPLETED|Overall Study||47
51887|NCT01499277|119190|P2|COMPLETED|Overall Study||223
51888|NCT01499277|119191|P1|COMPLETED|Overall Study||459
51889|NCT01499277|119190|P2|STARTED|Overall Study||255
51890|NCT01499277|119191|P1|STARTED|Overall Study||506
51891|NCT01499199|119213|P1|NOT COMPLETED|Overall Study||2
51892|NCT01499199|119213|P1|COMPLETED|Overall Study||11
51893|NCT01499199|119213|P1|STARTED|Overall Study||13
51894|NCT01499134|119234|P2|NOT COMPLETED|Overall Study||1
51895|NCT01499134|119235|P1|NOT COMPLETED|Overall Study||0
51896|NCT01499134|119234|P2|COMPLETED|Overall Study||7
51897|NCT01499134|119235|P1|COMPLETED|Overall Study||9
51898|NCT01499134|119234|P2|STARTED|Overall Study||8
51899|NCT01499134|119235|P1|STARTED|Overall Study||9
51900|NCT01499095|119257|P2|NOT COMPLETED|Overall Study||93
51901|NCT01499095|119258|P1|NOT COMPLETED|Overall Study||89
51902|NCT01499095|119257|P2|COMPLETED|Overall Study||314
51903|NCT01499095|119258|P1|COMPLETED|Overall Study||315
51904|NCT01499095|119257|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
51905|NCT01499095|119258|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
51906|NCT01499095|119257|P2|Participated in Substudy|Overall Study||0
51907|NCT01499095|119258|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
51908|NCT01499095|119257|P2|Treated|Overall Study||406
51909|NCT01499095|119258|P1|Treated|Overall Study||403
51910|NCT01499095|119257|P2|STARTED|Overall Study||407
51911|NCT01499095|119258|P1|STARTED|Overall Study||404
51912|NCT01499082|119288|P2|NOT COMPLETED|Overall Study||48
51913|NCT01499082|119289|P1|NOT COMPLETED|Overall Study||45
51914|NCT01499082|119288|P2|COMPLETED|Overall Study||355
51915|NCT01499082|119289|P1|COMPLETED|Overall Study||359
51916|NCT01499082|119288|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
51917|NCT01499082|119289|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
51918|NCT01499082|119288|P2|Participated in Substudy|Overall Study||0
51919|NCT01499082|119289|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
51920|NCT01499082|119288|P2|Treated|Overall Study||402
51921|NCT01499082|119289|P1|Treated|Overall Study||404
51922|NCT01499082|119288|P2|STARTED|Overall Study||403
51923|NCT01499082|119289|P1|STARTED|Overall Study||404
51924|NCT01498822|119319|P2|NOT COMPLETED|Overall Study||56
51925|NCT01498822|119320|P1|NOT COMPLETED|Overall Study||54
51926|NCT01498822|119319|P2|COMPLETED|Overall Study||122
51927|NCT01498822|119320|P1|COMPLETED|Overall Study||121
51928|NCT01498822|119319|P2|STARTED|Overall Study||178
51929|NCT01498822|119320|P1|STARTED|Overall Study||175
51930|NCT01498744|119334|P2|NOT COMPLETED|Overall Study||0
51931|NCT01498744|119335|P1|NOT COMPLETED|Overall Study||0
51932|NCT01498744|119334|P2|COMPLETED|Overall Study||31
51933|NCT01498744|119335|P1|COMPLETED|Overall Study||22
51934|NCT01498744|119334|P2|STARTED|Overall Study||31
51935|NCT01498744|119335|P1|STARTED|Overall Study||22
51936|NCT01498692|119347|P1|NOT COMPLETED|Overall Study||8
51937|NCT01498692|119347|P1|COMPLETED|Overall Study||86
51938|NCT01498692|119347|P1|STARTED|Overall Study||94
51939|NCT01498679|119378|P2|NOT COMPLETED|Overall Study||22
51940|NCT01498679|119379|P1|NOT COMPLETED|Overall Study||89
51941|NCT01498679|119378|P2|COMPLETED|Overall Study||131
51942|NCT01498679|119379|P1|COMPLETED|Overall Study||65
51943|NCT01498679|119378|P2|STARTED|Overall Study||153
51944|NCT01498679|119379|P1|STARTED|Overall Study||154
51945|NCT01498653|119395|P2|NOT COMPLETED|Overall Study||35
51946|NCT01498653|119396|P1|NOT COMPLETED|Overall Study||19
51947|NCT01498653|119395|P2|COMPLETED|Overall Study||119
51948|NCT01498653|119396|P1|COMPLETED|Overall Study||136
51949|NCT01498653|119395|P2|STARTED|Overall Study||154
51950|NCT01498653|119396|P1|STARTED|Overall Study||155
51951|NCT01498640|119410|P1|NOT COMPLETED|Overall Study||5
51952|NCT01498640|119410|P1|COMPLETED|Overall Study||47
51953|NCT01498640|119410|P1|STARTED|Overall Study||52
51954|NCT01498601|119426|P2|NOT COMPLETED|Overall Study||0
51955|NCT01498601|119427|P1|NOT COMPLETED|Overall Study||0
51956|NCT01498601|119426|P2|COMPLETED|Overall Study||32
51957|NCT01498601|119427|P1|COMPLETED|Overall Study||51
51958|NCT01498601|119426|P2|STARTED|Overall Study||32
51959|NCT01498601|119427|P1|STARTED|Overall Study||51
51960|NCT01498588|119433|P1|NOT COMPLETED|Overall Study||0
51961|NCT01498588|119433|P1|COMPLETED|Overall Study||7
51962|NCT01498588|119433|P1|STARTED|Overall Study||7
51963|NCT01498575|119440|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
51964|NCT01498575|119441|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
51965|NCT01498575|119440|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
51966|NCT01498575|119441|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
51967|NCT01498575|119440|P2|STARTED|On the Road Driving Assessment (ODA)||89
51968|NCT01498575|119441|P1|STARTED|On the Road Driving Assessment (ODA)||128
51969|NCT01498575|119440|P2|NOT COMPLETED|Overall Sample||14
51970|NCT01498575|119441|P1|NOT COMPLETED|Overall Sample||60
51971|NCT01498575|119440|P2|COMPLETED|Overall Sample||400
51972|NCT01498575|119441|P1|COMPLETED|Overall Sample||550
51973|NCT01498575|119440|P2|STARTED|Overall Sample||414
51974|NCT01498575|119441|P1|STARTED|Overall Sample||610
51975|NCT01498458|119447|P1|NOT COMPLETED|Overall Study||7
51976|NCT01498458|119447|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
51977|NCT01498458|119447|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
51978|NCT01498419|119460|P4|NOT COMPLETED|Overall Study||19
51979|NCT01498419|119461|P3|NOT COMPLETED|Overall Study||18
51980|NCT01498419|119462|P2|NOT COMPLETED|Overall Study||23
51981|NCT01498419|119463|P1|NOT COMPLETED|Overall Study||18
51982|NCT01498419|119460|P4|COMPLETED|Overall Study||7
51983|NCT01498419|119461|P3|COMPLETED|Overall Study||41
51984|NCT01498419|119462|P2|COMPLETED|Overall Study||39
51985|NCT01498419|119463|P1|COMPLETED|Overall Study||42
51986|NCT01498419|119460|P4|STARTED|Overall Study||26
51987|NCT01498419|119461|P3|STARTED|Overall Study||59
51988|NCT01498419|119462|P2|STARTED|Overall Study||62
51989|NCT01498419|119463|P1|STARTED|Overall Study||60
51990|NCT01498185|119502|P5|NOT COMPLETED|Overall Study||3
51991|NCT01498185|119503|P4|NOT COMPLETED|Overall Study||3
51992|NCT01498185|119504|P3|NOT COMPLETED|Overall Study||0
51993|NCT01498185|119505|P2|NOT COMPLETED|Overall Study||1
51994|NCT01498185|119506|P1|NOT COMPLETED|Overall Study||1
51995|NCT01498185|119502|P5|COMPLETED|Overall Study||12
51996|NCT01498185|119503|P4|COMPLETED|Overall Study||11
51997|NCT01498185|119504|P3|COMPLETED|Overall Study||15
51998|NCT01498185|119505|P2|COMPLETED|Overall Study||12
51999|NCT01498185|119506|P1|COMPLETED|Overall Study||12
52000|NCT01498185|119502|P5|STARTED|Overall Study||15
52001|NCT01498185|119503|P4|STARTED|Overall Study||14
52002|NCT01498185|119504|P3|STARTED|Overall Study||15
52003|NCT01498185|119505|P2|STARTED|Overall Study||13
52004|NCT01498185|119506|P1|STARTED|Overall Study||13
52005|NCT01498120|119546|P1|NOT COMPLETED|Overall Study||13
52006|NCT01498120|119546|P1|COMPLETED|Overall Study||1
52007|NCT01498120|119546|P1|STARTED|Overall Study||14
52008|NCT01498068|119553|P2|NOT COMPLETED|Overall Study||1
52009|NCT01498068|119554|P1|NOT COMPLETED|Overall Study||1
52010|NCT01498068|119553|P2|COMPLETED|Overall Study||19
52011|NCT01498068|119554|P1|COMPLETED|Overall Study||15
52012|NCT01498068|119553|P2|STARTED|Overall Study||20
52013|NCT01498068|119554|P1|STARTED|Overall Study||16
52014|NCT01497938|119572|P2|NOT COMPLETED|Overall Study||2
52015|NCT01497938|119573|P1|NOT COMPLETED|Overall Study||5
52016|NCT01497938|119572|P2|COMPLETED|Overall Study||124
52017|NCT01497938|119573|P1|COMPLETED|Overall Study||116
52018|NCT01497938|119572|P2|STARTED|Overall Study||126
52019|NCT01497938|119573|P1|STARTED|Overall Study||121
52020|NCT01497899|119585|P4|NOT COMPLETED|Open-Label Extension Phase||38
52021|NCT01497899|119586|P3|NOT COMPLETED|Open-Label Extension Phase||70
52022|NCT01497899|119587|P2|NOT COMPLETED|Open-Label Extension Phase||53
52023|NCT01497899|119588|P1|NOT COMPLETED|Open-Label Extension Phase||105
52024|NCT01497899|119585|P4|COMPLETED|Open-Label Extension Phase||0
52025|NCT01497899|119586|P3|COMPLETED|Open-Label Extension Phase||0
52026|NCT01497899|119587|P2|COMPLETED|Open-Label Extension Phase||0
52027|NCT01497899|119588|P1|COMPLETED|Open-Label Extension Phase||0
52028|NCT01497899|119585|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|38
52029|NCT01497899|119586|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|70
52030|NCT01497899|119587|P2|STARTED|Open-Label Extension Phase||53
52031|NCT01497899|119588|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
52032|NCT01497899|119585|P4|NOT COMPLETED|Double-Blind Phase||0
52033|NCT01497899|119586|P3|NOT COMPLETED|Double-Blind Phase||0
52034|NCT01497899|119587|P2|NOT COMPLETED|Double-Blind Phase||5
52035|NCT01497899|119588|P1|NOT COMPLETED|Double-Blind Phase||6
52036|NCT01497899|119585|P4|COMPLETED|Double-Blind Phase||0
52037|NCT01497899|119586|P3|COMPLETED|Double-Blind Phase||0
52038|NCT01497899|119587|P2|COMPLETED|Double-Blind Phase||53
52039|NCT01497899|119588|P1|COMPLETED|Double-Blind Phase||107
52040|NCT01497899|119585|P4|STARTED|Double-Blind Phase||0
52041|NCT01497899|119586|P3|STARTED|Double-Blind Phase||0
52042|NCT01497899|119587|P2|STARTED|Double-Blind Phase||58
52043|NCT01497899|119588|P1|STARTED|Double-Blind Phase||113
52044|NCT01497756|119601|P1|NOT COMPLETED|Overall Study||0
52045|NCT01497756|119601|P1|COMPLETED|Overall Study||10
52046|NCT01497756|119601|P1|STARTED|Overall Study||10
52047|NCT01497665|119606|P1|NOT COMPLETED|Overall Study||0
52048|NCT01497665|119606|P1|COMPLETED|Overall Study||16
52049|NCT01497665|119606|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
52050|NCT01497665|119606|P1|STARTED|Overall Study||16
52051|NCT01497366|119616|P2|NOT COMPLETED|Overall Study||88
52052|NCT01497366|119617|P1|NOT COMPLETED|Overall Study||39
52053|NCT01497366|119616|P2|COMPLETED|Overall Study||176
52054|NCT01497366|119617|P1|COMPLETED|Overall Study||224
52055|NCT01497366|119616|P2|Randomized But Not Treated|Overall Study||21
52056|NCT01497366|119617|P1|Randomized But Not Treated|Overall Study||7
52057|NCT01497366|119616|P2|STARTED|Overall Study||264
52058|NCT01497366|119617|P1|STARTED|Overall Study||263
52059|NCT01497275|119635|P1|NOT COMPLETED|Overall Study||2
52060|NCT01497275|119635|P1|COMPLETED|Overall Study||3
52061|NCT01497275|119635|P1|STARTED|Overall Study||5
52062|NCT01497262|119642|P1|NOT COMPLETED|Overall Study||11
52063|NCT01497262|119642|P1|COMPLETED|Overall Study||151
52064|NCT01497262|119642|P1|STARTED|Overall Study||162
52065|NCT01497197|119649|P2|NOT COMPLETED|Overall Study||15
52066|NCT01497197|119650|P1|NOT COMPLETED|Overall Study||17
52067|NCT01497197|119649|P2|COMPLETED|Overall Study||70
52068|NCT01497197|119650|P1|COMPLETED|Overall Study||72
52069|NCT01497197|119649|P2|STARTED|Overall Study||85
52070|NCT01497197|119650|P1|STARTED|Overall Study||89
52071|NCT01497171|119678|P2|NOT COMPLETED|Overall Study||0
52072|NCT01497171|119679|P1|NOT COMPLETED|Overall Study||0
52073|NCT01497171|119678|P2|COMPLETED|Overall Study||3
52074|NCT01497171|119679|P1|COMPLETED|Overall Study||2
52075|NCT01497171|119678|P2|STARTED|Overall Study||3
52076|NCT01497171|119679|P1|STARTED|Overall Study||2
52077|NCT01496469|119687|P2|NOT COMPLETED|Overall Study||8
52078|NCT01496469|119688|P1|NOT COMPLETED|Overall Study||10
52079|NCT01496469|119687|P2|COMPLETED|Overall Study||53
52080|NCT01496469|119688|P1|COMPLETED|Overall Study||50
52081|NCT01496469|119687|P2|STARTED|Overall Study||61
52082|NCT01496469|119688|P1|STARTED|Overall Study||60
52083|NCT01496456|119698|P1|NOT COMPLETED|Overall Study||8
52084|NCT01496456|119698|P1|COMPLETED|Overall Study||9
52085|NCT01496456|119698|P1|3-yr Final Recall|Overall Study||9
52086|NCT01496456|119698|P1|2-yr Recall|Overall Study||10
52087|NCT01496456|119698|P1|1-yr Recall|Overall Study||12
52088|NCT01496456|119698|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
52089|NCT01496456|119698|P1|STARTED|Overall Study||17
52090|NCT01496430|119711|P3|NOT COMPLETED|Overall Study||10
52091|NCT01496430|119712|P2|NOT COMPLETED|Overall Study||5
52092|NCT01496430|119713|P1|NOT COMPLETED|Overall Study||6
52093|NCT01496430|119711|P3|COMPLETED|Overall Study||25
52094|NCT01496430|119712|P2|COMPLETED|Overall Study||30
52095|NCT01496430|119713|P1|COMPLETED|Overall Study||29
52096|NCT01496430|119711|P3|STARTED|Overall Study||35
52097|NCT01496430|119712|P2|STARTED|Overall Study||35
52098|NCT01496430|119713|P1|STARTED|Overall Study||35
52099|NCT01496352|119789|P2|NOT COMPLETED|Overall Study||0
52100|NCT01496352|119790|P1|NOT COMPLETED|Overall Study||0
52101|NCT01496352|119789|P2|COMPLETED|Overall Study||6
52102|NCT01496352|119790|P1|COMPLETED|Overall Study||24
52103|NCT01496352|119789|P2|STARTED|Overall Study||6
52104|NCT01496352|119790|P1|STARTED|Overall Study||24
52105|NCT01496313|119808|P2|NOT COMPLETED|Overall Study||15
52106|NCT01496313|119809|P1|NOT COMPLETED|Overall Study||5
52107|NCT01496313|119808|P2|COMPLETED|Overall Study||26
52108|NCT01496313|119809|P1|COMPLETED|Overall Study||35
52109|NCT01496313|119808|P2|STARTED|Overall Study||41
52110|NCT01496313|119809|P1|STARTED|Overall Study||40
52111|NCT01496287|119825|P1|NOT COMPLETED|Overall Study||6
52112|NCT01496287|119825|P1|COMPLETED|Overall Study||64
52113|NCT01496287|119825|P1|STARTED|Overall Study||70
52114|NCT01496274|119835|P2|NOT COMPLETED|Overall Study||5
52115|NCT01496274|119836|P1|NOT COMPLETED|Overall Study||3
52116|NCT01496274|119835|P2|COMPLETED|Overall Study||18
52117|NCT01496274|119836|P1|COMPLETED|Overall Study||37
52118|NCT01496274|119835|P2|STARTED|Overall Study||23
52119|NCT01496274|119836|P1|STARTED|Overall Study||40
52120|NCT01496248|119868|P1|NOT COMPLETED|Overall Study||10
52121|NCT01496248|119868|P1|COMPLETED|Overall Study||25
52122|NCT01496248|119868|P1|STARTED|Overall Study||35
52123|NCT01496183|119881|P2|NOT COMPLETED|Overall Study||2
52124|NCT01496183|119882|P1|NOT COMPLETED|Overall Study||3
52125|NCT01496183|119881|P2|COMPLETED|Overall Study||13
52126|NCT01496183|119882|P1|COMPLETED|Overall Study||6
52127|NCT01496183|119881|P2|STARTED|Overall Study||15
52128|NCT01496183|119882|P1|STARTED|Overall Study||9
52129|NCT01495975|119890|P2|NOT COMPLETED|Overall Study||0
52130|NCT01495975|119891|P1|NOT COMPLETED|Overall Study||1
52131|NCT01495975|119890|P2|COMPLETED|Overall Study||14
52132|NCT01495975|119891|P1|COMPLETED|Overall Study||14
52133|NCT01495975|119890|P2|STARTED|Overall Study||14
52134|NCT01495975|119891|P1|STARTED|Overall Study||15
52135|NCT01495858|119900|P3|NOT COMPLETED|Overall Study||0
52136|NCT01495858|119901|P2|NOT COMPLETED|Overall Study||0
52137|NCT01495858|119902|P1|NOT COMPLETED|Overall Study||0
52138|NCT01495858|119900|P3|COMPLETED|Overall Study||54
52139|NCT01495858|119901|P2|COMPLETED|Overall Study||106
52140|NCT01495858|119902|P1|COMPLETED|Overall Study||107
52141|NCT01495858|119900|P3|STARTED|Overall Study||54
52142|NCT01495858|119901|P2|STARTED|Overall Study||106
52143|NCT01495858|119902|P1|STARTED|Overall Study||107
52144|NCT01495793|119982|P1|NOT COMPLETED|Overall Study||2
52145|NCT01495793|119982|P1|COMPLETED|Overall Study||22
52146|NCT01495793|119982|P1|STARTED|Overall Study||24
52147|NCT01495702|119995|P2|NOT COMPLETED|Extension Phase||0
52148|NCT01495702|119996|P1|NOT COMPLETED|Extension Phase||0
52149|NCT01495702|119995|P2|COMPLETED|Extension Phase||2
52150|NCT01495702|119996|P1|COMPLETED|Extension Phase||26
52151|NCT01495702|119995|P2|STARTED|Extension Phase||2
52152|NCT01495702|119996|P1|STARTED|Extension Phase||26
52153|NCT01495702|119995|P2|NOT COMPLETED|Randomized Phase||28
52154|NCT01495702|119996|P1|NOT COMPLETED|Randomized Phase||26
52155|NCT01495702|119995|P2|COMPLETED|Randomized Phase||119
52156|NCT01495702|119996|P1|COMPLETED|Randomized Phase||266
52157|NCT01495702|119995|P2|STARTED|Randomized Phase||147
52158|NCT01495702|119996|P1|STARTED|Randomized Phase||292
52159|NCT01495585|120012|P3|NOT COMPLETED|Overall Study||0
52160|NCT01495585|120013|P2|NOT COMPLETED|Overall Study||0
52161|NCT01495585|120014|P1|NOT COMPLETED|Overall Study||0
52162|NCT01495585|120012|P3|COMPLETED|Overall Study||4
52163|NCT01495585|120013|P2|COMPLETED|Overall Study||6
52164|NCT01495585|120014|P1|COMPLETED|Overall Study||4
52165|NCT01495585|120012|P3|Open Label Lonafarnib 200 mg|Overall Study||0
52166|NCT01495585|120013|P2|Open Label Lonafarnib 200 mg|Overall Study||0
52167|NCT01495585|120014|P1|Open Label Lonafarnib 200 mg|Overall Study||2
52168|NCT01495585|120012|P3|STARTED|Overall Study||4
52169|NCT01495585|120013|P2|STARTED|Overall Study||6
52170|NCT01495585|120014|P1|STARTED|Overall Study||4
52171|NCT01495572|120027|P2|NOT COMPLETED|Overall Study||0
52172|NCT01495572|120028|P1|NOT COMPLETED|Overall Study||0
52173|NCT01495572|120027|P2|COMPLETED|Overall Study||5
52174|NCT01495572|120028|P1|COMPLETED|Overall Study||0
52175|NCT01495572|120027|P2|STARTED|Overall Study||5
52176|NCT01495572|120028|P1|STARTED|Overall Study||0
52177|NCT01495286|120036|P1|NOT COMPLETED|Overall Study||0
52178|NCT01495286|120036|P1|COMPLETED|Overall Study||30
52179|NCT01495286|120036|P1|STARTED|Overall Study||30
52180|NCT01495000|120046|P2|NOT COMPLETED|Overall Study||12
52181|NCT01495000|120047|P1|NOT COMPLETED|Overall Study||13
52182|NCT01495000|120046|P2|COMPLETED|Overall Study||114
52183|NCT01495000|120047|P1|COMPLETED|Overall Study||111
52184|NCT01495000|120046|P2|STARTED|Overall Study||126
52185|NCT01495000|120047|P1|STARTED|Overall Study||124
52186|NCT01494987|120089|P2|NOT COMPLETED|Overall Study||28
52187|NCT01494987|120090|P1|NOT COMPLETED|Overall Study||28
52188|NCT01494987|120089|P2|COMPLETED|Overall Study||187
52189|NCT01494987|120090|P1|COMPLETED|Overall Study||188
52190|NCT01494987|120089|P2|STARTED|Overall Study||215
52191|NCT01494987|120090|P1|STARTED|Overall Study||216
52192|NCT01494818|120104|P2|NOT COMPLETED|Overall Study||2
52193|NCT01494818|120105|P1|NOT COMPLETED|Overall Study||2
52194|NCT01494818|120104|P2|COMPLETED|Overall Study||37
52195|NCT01494818|120105|P1|COMPLETED|Overall Study||37
52196|NCT01494818|120104|P2|STARTED|Overall Study||39
52197|NCT01494818|120105|P1|STARTED|Overall Study||39
52198|NCT01494753|120127|P2|NOT COMPLETED|Day42-Day84||0
52199|NCT01494753|120128|P1|NOT COMPLETED|Day42-Day84||0
52200|NCT01494753|120127|P2|COMPLETED|Day42-Day84||15
52201|NCT01494753|120128|P1|COMPLETED|Day42-Day84||15
52202|NCT01494753|120127|P2|STARTED|Day42-Day84||15
52203|NCT01494753|120128|P1|STARTED|Day42-Day84||15
52204|NCT01494753|120127|P2|NOT COMPLETED|Day0-Day42||0
52205|NCT01494753|120128|P1|NOT COMPLETED|Day0-Day42||0
52206|NCT01494753|120127|P2|COMPLETED|Day0-Day42||15
52207|NCT01494753|120128|P1|COMPLETED|Day0-Day42||15
52208|NCT01494753|120127|P2|STARTED|Day0-Day42||15
52209|NCT01494753|120128|P1|STARTED|Day0-Day42||15
52210|NCT01494649|120136|P2|NOT COMPLETED|Overall Study||1
52211|NCT01494649|120137|P1|NOT COMPLETED|Overall Study||0
52212|NCT01494649|120136|P2|COMPLETED|Overall Study||58
52213|NCT01494649|120137|P1|COMPLETED|Overall Study||59
52214|NCT01494649|120136|P2|STARTED|Overall Study||59
52215|NCT01494649|120137|P1|STARTED|Overall Study||59
52216|NCT01494610|120153|P2|NOT COMPLETED|Period 4||0
52217|NCT01494610|120154|P1|NOT COMPLETED|Period 4||1
52218|NCT01494610|120153|P2|COMPLETED|Period 4||28
52219|NCT01494610|120154|P1|COMPLETED|Period 4||27
52220|NCT01494610|120153|P2|STARTED|Period 4||28
52221|NCT01494610|120154|P1|STARTED|Period 4||28
52222|NCT01494610|120153|P2|NOT COMPLETED|Period 3||0
52223|NCT01494610|120154|P1|NOT COMPLETED|Period 3||2
52224|NCT01494610|120153|P2|COMPLETED|Period 3||28
52225|NCT01494610|120154|P1|COMPLETED|Period 3||28
52226|NCT01494610|120153|P2|STARTED|Period 3||28
52227|NCT01494610|120154|P1|STARTED|Period 3||30
52228|NCT01494610|120153|P2|NOT COMPLETED|Period 2||0
52229|NCT01494610|120154|P1|NOT COMPLETED|Period 2||0
52230|NCT01494610|120153|P2|COMPLETED|Period 2||28
52231|NCT01494610|120154|P1|COMPLETED|Period 2||30
52232|NCT01494610|120153|P2|STARTED|Period 2||28
52233|NCT01494610|120154|P1|STARTED|Period 2||30
52234|NCT01494610|120153|P2|NOT COMPLETED|Period 1||1
52235|NCT01494610|120154|P1|NOT COMPLETED|Period 1||1
52236|NCT01494610|120153|P2|COMPLETED|Period 1||28
52237|NCT01494610|120154|P1|COMPLETED|Period 1||30
52238|NCT01494610|120153|P2|STARTED|Period 1||29
52239|NCT01494610|120154|P1|STARTED|Period 1||31
52240|NCT01494584|120222|P1|NOT COMPLETED|Overall Study||1
52241|NCT01494584|120222|P1|COMPLETED|Overall Study||4
52242|NCT01494584|120222|P1|STARTED|Overall Study||5
52243|NCT01494545|120311|P1|NOT COMPLETED|Overall Study||10
52244|NCT01494545|120311|P1|COMPLETED|Overall Study||92
52245|NCT01494545|120311|P1|STARTED|Overall Study||102
52246|NCT01494532|120354|P6|NOT COMPLETED|Overall Study||0
52247|NCT01494532|120355|P5|NOT COMPLETED|Overall Study||12
52248|NCT01494532|120356|P4|NOT COMPLETED|Overall Study||15
52249|NCT01494532|120357|P3|NOT COMPLETED|Overall Study||17
52250|NCT01494532|120358|P2|NOT COMPLETED|Overall Study||4
52251|NCT01494532|120359|P1|NOT COMPLETED|Overall Study||10
52252|NCT01494532|120354|P6|COMPLETED|Overall Study||25
52253|NCT01494532|120355|P5|COMPLETED|Overall Study||64
52254|NCT01494532|120356|P4|COMPLETED|Overall Study||60
52255|NCT01494532|120357|P3|COMPLETED|Overall Study||59
52256|NCT01494532|120358|P2|COMPLETED|Overall Study||21
52257|NCT01494532|120359|P1|COMPLETED|Overall Study||65
52258|NCT01494532|120354|P6|STARTED|Overall Study||25
52259|NCT01494532|120355|P5|STARTED|Overall Study||76
52260|NCT01494532|120356|P4|STARTED|Overall Study||75
52261|NCT01494532|120357|P3|STARTED|Overall Study||76
52262|NCT01494532|120358|P2|STARTED|Overall Study||25
52263|NCT01494532|120359|P1|STARTED|Overall Study||75
52264|NCT01494506|120514|P3|NOT COMPLETED|Overall Study||103
52265|NCT01494506|120515|P2|NOT COMPLETED|Overall Study||143
52266|NCT01494506|120516|P1|NOT COMPLETED|Overall Study||148
52267|NCT01494506|120514|P3|COMPLETED|Overall Study||14
52268|NCT01494506|120515|P2|COMPLETED|Overall Study||6
52269|NCT01494506|120516|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
52270|NCT01494506|120514|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
52271|NCT01494506|120515|P2|Treated Population|Overall Study||134
52272|NCT01494506|120516|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
52273|NCT01494506|120514|P3|STARTED|Overall Study||117
52274|NCT01494506|120515|P2|STARTED|Overall Study||149
52275|NCT01494506|120516|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
52276|NCT01494467|120553|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
52277|NCT01494467|120554|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
52278|NCT01494467|120553|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
52279|NCT01494467|120554|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
52280|NCT01494467|120553|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
52281|NCT01494467|120554|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
52282|NCT01494467|120553|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
52283|NCT01494467|120554|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
52284|NCT01494467|120553|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
52285|NCT01494467|120554|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
52286|NCT01494467|120553|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
52287|NCT01494467|120554|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
52288|NCT01494467|120553|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
52289|NCT01494467|120554|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
52290|NCT01494467|120553|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
52291|NCT01494467|120554|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
52292|NCT01494467|120553|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
52293|NCT01494467|120554|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
52294|NCT01494350|120570|P1|NOT COMPLETED|Overall Study||1
52295|NCT01494350|120570|P1|COMPLETED|Overall Study||49
52296|NCT01494350|120570|P1|STARTED|Overall Study||50
52297|NCT01494298|120580|P2|NOT COMPLETED|Overall Study||8
52298|NCT01494298|120581|P1|NOT COMPLETED|Overall Study||2
52299|NCT01494298|120580|P2|COMPLETED|Overall Study||47
52300|NCT01494298|120581|P1|COMPLETED|Overall Study||54
52301|NCT01494298|120580|P2|STARTED|Overall Study||55
52302|NCT01494298|120581|P1|STARTED|Overall Study||56
52303|NCT01493947|120593|P2|NOT COMPLETED|Period B Extension Period||32
52304|NCT01493947|120594|P1|NOT COMPLETED|Period B Extension Period||33
52305|NCT01493947|120593|P2|COMPLETED|Period B Extension Period||326
52306|NCT01493947|120594|P1|COMPLETED|Period B Extension Period||366
52307|NCT01493947|120593|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
52308|NCT01493947|120594|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
52309|NCT01493947|120593|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
52310|NCT01493947|120594|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
52311|NCT01493947|120593|P2|COMPLETED|Period A Efficacy and Safety Data||456
52312|NCT01493947|120594|P1|COMPLETED|Period A Efficacy and Safety Data||446
52313|NCT01493947|120593|P2|STARTED|Period A Efficacy and Safety Data||484
52314|NCT01493947|120594|P1|STARTED|Period A Efficacy and Safety Data||478
52315|NCT01493687|120606|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
52316|NCT01493687|120607|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
52317|NCT01493687|120606|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
52318|NCT01493687|120607|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
52319|NCT01493687|120606|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
52320|NCT01493687|120607|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
52321|NCT01493687|120606|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
52322|NCT01493687|120607|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
52323|NCT01493687|120606|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
52324|NCT01493687|120607|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
52325|NCT01493687|120606|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
52326|NCT01493687|120607|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
52327|NCT01493687|120606|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
52328|NCT01493687|120607|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
52329|NCT01493687|120606|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
52330|NCT01493687|120607|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
52331|NCT01493687|120606|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
52332|NCT01493687|120607|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
52333|NCT01493557|120626|P3|NOT COMPLETED|Adding the Second Strategy||0
52334|NCT01493557|120627|P2|NOT COMPLETED|Adding the Second Strategy||4
52335|NCT01493557|120628|P1|NOT COMPLETED|Adding the Second Strategy||2
52336|NCT01493557|120626|P3|COMPLETED|Adding the Second Strategy||0
52337|NCT01493557|120627|P2|COMPLETED|Adding the Second Strategy||11
52338|NCT01493557|120628|P1|COMPLETED|Adding the Second Strategy||12
52339|NCT01493557|120626|P3|STARTED|Adding the Second Strategy||0
52340|NCT01493557|120627|P2|STARTED|Adding the Second Strategy||15
52341|NCT01493557|120628|P1|STARTED|Adding the Second Strategy||14
52342|NCT01493557|120626|P3|NOT COMPLETED|Randomized to Management Strategies||0
52343|NCT01493557|120627|P2|NOT COMPLETED|Randomized to Management Strategies||11
52344|NCT01493557|120628|P1|NOT COMPLETED|Randomized to Management Strategies||15
52345|NCT01493557|120626|P3|COMPLETED|Randomized to Management Strategies||0
52346|NCT01493557|120627|P2|COMPLETED|Randomized to Management Strategies||47
52347|NCT01493557|120628|P1|COMPLETED|Randomized to Management Strategies||44
52348|NCT01493557|120626|P3|STARTED|Randomized to Management Strategies||0
52349|NCT01493557|120627|P2|STARTED|Randomized to Management Strategies||58
52350|NCT01493557|120628|P1|STARTED|Randomized to Management Strategies||59
52351|NCT01493557|120626|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
52352|NCT01493557|120627|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
52353|NCT01493557|120628|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
52354|NCT01493557|120626|P3|COMPLETED|Not Randomized to Management Strategies||816
52355|NCT01493557|120627|P2|COMPLETED|Not Randomized to Management Strategies||0
52356|NCT01493557|120628|P1|COMPLETED|Not Randomized to Management Strategies||0
52357|NCT01493557|120626|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
52358|NCT01493557|120627|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
52359|NCT01493557|120628|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
52360|NCT01493557|120626|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
52361|NCT01493557|120627|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
52362|NCT01493557|120628|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
52363|NCT01493557|120626|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
52364|NCT01493557|120627|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
52365|NCT01493557|120628|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
52366|NCT01493557|120626|P3|STARTED|Not Randomized to Management Strategies||950
52367|NCT01493557|120627|P2|STARTED|Not Randomized to Management Strategies||0
52368|NCT01493557|120628|P1|STARTED|Not Randomized to Management Strategies||0
52369|NCT01493531|120656|P3|NOT COMPLETED|Overall Study||48
52370|NCT01493531|120657|P2|NOT COMPLETED|Overall Study||50
52371|NCT01493531|120658|P1|NOT COMPLETED|Overall Study||41
52372|NCT01493531|120656|P3|COMPLETED|Overall Study||158
52373|NCT01493531|120657|P2|COMPLETED|Overall Study||150
52374|NCT01493531|120658|P1|COMPLETED|Overall Study||163
52375|NCT01493531|120656|P3|STARTED|Overall Study||206
52376|NCT01493531|120657|P2|STARTED|Overall Study||200
52377|NCT01493531|120658|P1|STARTED|Overall Study||204
52378|NCT01493427|120672|P1|NOT COMPLETED|Overall Study||20
52379|NCT01493427|120672|P1|COMPLETED|Overall Study||179
52380|NCT01493427|120672|P1|STARTED|Overall Study||199
52381|NCT01493180|120679|P2|NOT COMPLETED|Overall Study||2
52382|NCT01493180|120680|P1|NOT COMPLETED|Overall Study||3
52383|NCT01493180|120679|P2|COMPLETED|Overall Study||49
52384|NCT01493180|120680|P1|COMPLETED|Overall Study||48
52385|NCT01493180|120679|P2|STARTED|Overall Study||51
52386|NCT01493180|120680|P1|STARTED|Overall Study||51
52387|NCT01493167|120686|P1|NOT COMPLETED|Overall Study||0
52388|NCT01493167|120686|P1|COMPLETED|Overall Study||97
52389|NCT01493167|120686|P1|STARTED|Overall Study||97
52390|NCT01493089|120692|P2|NOT COMPLETED|Overall Study||3
52391|NCT01493089|120693|P1|NOT COMPLETED|Overall Study||3
52392|NCT01493089|120692|P2|COMPLETED|Overall Study||114
52393|NCT01493089|120693|P1|COMPLETED|Overall Study||119
52394|NCT01493089|120692|P2|STARTED|Overall Study||117
52395|NCT01493089|120693|P1|STARTED|Overall Study||122
52396|NCT01492439|120711|P2|NOT COMPLETED|Overall Study||9
52397|NCT01492439|120712|P1|NOT COMPLETED|Overall Study||4
52398|NCT01492439|120711|P2|COMPLETED|Overall Study||9
52399|NCT01492439|120712|P1|COMPLETED|Overall Study||15
52400|NCT01492439|120711|P2|Post-intervention|Overall Study||13
52401|NCT01492439|120712|P1|Post-intervention|Overall Study||18
52402|NCT01492439|120711|P2|STARTED|Overall Study||18
52403|NCT01492439|120712|P1|STARTED|Overall Study||19
52404|NCT01492426|120760|P2|NOT COMPLETED|Follow-Up||10
52405|NCT01492426|120761|P1|NOT COMPLETED|Follow-Up||25
52406|NCT01492426|120760|P2|COMPLETED|Follow-Up||181
52407|NCT01492426|120761|P1|COMPLETED|Follow-Up||359
52408|NCT01492426|120760|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
52409|NCT01492426|120761|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
52410|NCT01492426|120760|P2|NOT COMPLETED|Treatment||40
52411|NCT01492426|120761|P1|NOT COMPLETED|Treatment||83
52412|NCT01492426|120760|P2|COMPLETED|Treatment||160
52413|NCT01492426|120761|P1|COMPLETED|Treatment||319
52414|NCT01492426|120760|P2|STARTED|Treatment||200
52415|NCT01492426|120761|P1|STARTED|Treatment||402
52416|NCT01492400|120779|P2|NOT COMPLETED|Overall Study||16
52417|NCT01492400|120780|P1|NOT COMPLETED|Overall Study||16
52418|NCT01492400|120779|P2|COMPLETED|Overall Study||166
52419|NCT01492400|120780|P1|COMPLETED|Overall Study||165
52420|NCT01492400|120779|P2|STARTED|Overall Study||182
52421|NCT01492400|120780|P1|STARTED|Overall Study||181
52422|NCT01491984|120792|P2|NOT COMPLETED|Overall Study||1
52423|NCT01491984|120793|P1|NOT COMPLETED|Overall Study||2
52424|NCT01491984|120792|P2|COMPLETED|Overall Study||44
52425|NCT01491984|120793|P1|COMPLETED|Overall Study||47
52426|NCT01491984|120792|P2|STARTED|Overall Study||45
52427|NCT01491984|120793|P1|STARTED|Overall Study||49
52428|NCT01491919|120802|P3|NOT COMPLETED|Overall Study||1
52429|NCT01491919|120803|P2|NOT COMPLETED|Overall Study||2
52430|NCT01491919|120804|P1|NOT COMPLETED|Overall Study||1
52431|NCT01491919|120802|P3|COMPLETED|Overall Study||2
52432|NCT01491919|120803|P2|COMPLETED|Overall Study||8
52433|NCT01491919|120804|P1|COMPLETED|Overall Study||12
52434|NCT01491919|120802|P3|STARTED|Overall Study||3
52435|NCT01491919|120803|P2|STARTED|Overall Study||10
52436|NCT01491919|120804|P1|STARTED|Overall Study||13
52437|NCT01491672|120853|P3|NOT COMPLETED|Overall Study||11
52438|NCT01491672|120854|P2|NOT COMPLETED|Overall Study||60
52439|NCT01491672|120855|P1|NOT COMPLETED|Overall Study||56
52440|NCT01491672|120853|P3|COMPLETED|Overall Study||3
52441|NCT01491672|120854|P2|COMPLETED|Overall Study||2
52442|NCT01491672|120855|P1|COMPLETED|Overall Study||2
52443|NCT01491672|120853|P3|Safety Set|Overall Study||14
52444|NCT01491672|120854|P2|Safety Set|Overall Study||61
52445|NCT01491672|120855|P1|Safety Set|Overall Study||58
52446|NCT01491672|120853|P3|STARTED|Overall Study||14
52447|NCT01491672|120854|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
52448|NCT01491672|120855|P1|STARTED|Overall Study||58
52449|NCT01491633|120880|P1|NOT COMPLETED|Overall Study||5
52450|NCT01491633|120880|P1|COMPLETED|Overall Study||0
52451|NCT01491633|120880|P1|STARTED|Overall Study||5
52452|NCT01491607|120892|P1|NOT COMPLETED|Overall Study||10
52453|NCT01491607|120892|P1|COMPLETED|Overall Study||190
52454|NCT01491607|120892|P1|STARTED|Overall Study||200
52455|NCT01491490|120990|P2|NOT COMPLETED|Overall Study||0
52456|NCT01491490|120991|P1|NOT COMPLETED|Overall Study||0
52457|NCT01491490|120990|P2|COMPLETED|Overall Study||1
52458|NCT01491490|120991|P1|COMPLETED|Overall Study||1
52459|NCT01491490|120990|P2|STARTED|Overall Study||1
52460|NCT01491490|120991|P1|STARTED|Overall Study||1
52461|NCT01491113|121002|P5|NOT COMPLETED|Overall Study||0
52462|NCT01491113|121003|P4|NOT COMPLETED|Overall Study||0
52463|NCT01491113|121004|P3|NOT COMPLETED|Overall Study||0
52464|NCT01491113|121005|P2|NOT COMPLETED|Overall Study||0
52465|NCT01491113|121006|P1|NOT COMPLETED|Overall Study||0
52466|NCT01491113|121002|P5|COMPLETED|Overall Study||6
52467|NCT01491113|121003|P4|COMPLETED|Overall Study||6
52468|NCT01491113|121004|P3|COMPLETED|Overall Study||6
52469|NCT01491113|121005|P2|COMPLETED|Overall Study||6
52470|NCT01491113|121006|P1|COMPLETED|Overall Study||6
52471|NCT01491113|121002|P5|STARTED|Overall Study||6
52472|NCT01491113|121003|P4|STARTED|Overall Study||6
52473|NCT01491113|121004|P3|STARTED|Overall Study||6
52474|NCT01491113|121005|P2|STARTED|Overall Study||6
52475|NCT01491113|121006|P1|STARTED|Overall Study||6
52476|NCT01491035|121101|P8|NOT COMPLETED|Overall Study||0
52477|NCT01491035|121102|P7|NOT COMPLETED|Overall Study||0
52478|NCT01491035|121103|P6|NOT COMPLETED|Overall Study||0
52479|NCT01491035|121104|P5|NOT COMPLETED|Overall Study||1
52480|NCT01491035|121105|P4|NOT COMPLETED|Overall Study||0
52481|NCT01491035|121106|P3|NOT COMPLETED|Overall Study||0
52482|NCT01491035|121107|P2|NOT COMPLETED|Overall Study||0
52483|NCT01491035|121108|P1|NOT COMPLETED|Overall Study||0
52484|NCT01491035|121101|P8|COMPLETED|Overall Study||6
52485|NCT01491035|121102|P7|COMPLETED|Overall Study||6
52486|NCT01491035|121103|P6|COMPLETED|Overall Study||6
52487|NCT01491035|121104|P5|COMPLETED|Overall Study||5
52488|NCT01491035|121105|P4|COMPLETED|Overall Study||6
52489|NCT01491035|121106|P3|COMPLETED|Overall Study||6
52490|NCT01491035|121107|P2|COMPLETED|Overall Study||6
52491|NCT01491035|121108|P1|COMPLETED|Overall Study||6
52492|NCT01491035|121101|P8|STARTED|Overall Study||6
52493|NCT01491035|121102|P7|STARTED|Overall Study||6
52494|NCT01491035|121103|P6|STARTED|Overall Study||6
52495|NCT01491035|121104|P5|STARTED|Overall Study||6
52496|NCT01491035|121105|P4|STARTED|Overall Study||6
52497|NCT01491035|121106|P3|STARTED|Overall Study||6
52498|NCT01491035|121107|P2|STARTED|Overall Study||6
52499|NCT01491035|121108|P1|STARTED|Overall Study||6
52500|NCT01490931|121174|P1|NOT COMPLETED|Overall Study||0
52501|NCT01490931|121174|P1|COMPLETED|Overall Study||25
52502|NCT01490931|121174|P1|STARTED|Overall Study||25
52503|NCT01490866|121190|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
52504|NCT01490866|121190|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
52505|NCT01490866|121190|P1|STARTED|Axitinib Maintenance Therapy||49
52506|NCT01490866|121190|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
52507|NCT01490866|121190|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
52508|NCT01490866|121190|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
52509|NCT01490840|121201|P2|NOT COMPLETED|Phase 2||6
52510|NCT01490840|121202|P1|NOT COMPLETED|Phase 2||6
52511|NCT01490840|121201|P2|COMPLETED|Phase 2||68
52512|NCT01490840|121202|P1|COMPLETED|Phase 2||75
52513|NCT01490840|121201|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
52514|NCT01490840|121202|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
52515|NCT01490840|121201|P2|NOT COMPLETED|Phase 1||6
52516|NCT01490840|121202|P1|NOT COMPLETED|Phase 1||10
52517|NCT01490840|121201|P2|COMPLETED|Phase 1||78
52518|NCT01490840|121202|P1|COMPLETED|Phase 1||84
52519|NCT01490840|121201|P2|Modified Full Analysis Set|Phase 1||83
52520|NCT01490840|121202|P1|Modified Full Analysis Set|Phase 1||56
52521|NCT01490840|121201|P2|STARTED|Phase 1||84
52522|NCT01490840|121202|P1|STARTED|Phase 1||94
52523|NCT01490294|121228|P4|NOT COMPLETED|Overall Study||1
52524|NCT01490294|121229|P3|NOT COMPLETED|Overall Study||1
52525|NCT01490294|121230|P2|NOT COMPLETED|Overall Study||0
52526|NCT01490294|121231|P1|NOT COMPLETED|Overall Study||5
52527|NCT01490294|121228|P4|COMPLETED|Overall Study||54
52528|NCT01490294|121229|P3|COMPLETED|Overall Study||58
52529|NCT01490294|121230|P2|COMPLETED|Overall Study||60
52530|NCT01490294|121231|P1|COMPLETED|Overall Study||53
52531|NCT01490294|121228|P4|Participant Received Treatment|Overall Study||54
52532|NCT01490294|121229|P3|Participant Received Treatment|Overall Study||58
52533|NCT01490294|121230|P2|Participant Received Treatment|Overall Study||60
52534|NCT01490294|121231|P1|Participant Received Treatment|Overall Study||54
52535|NCT01490294|121228|P4|STARTED|Overall Study||55
52536|NCT01490294|121229|P3|STARTED|Overall Study||59
52537|NCT01490294|121230|P2|STARTED|Overall Study||60
52538|NCT01490294|121231|P1|STARTED|Overall Study||58
52539|NCT01490190|121465|P1|NOT COMPLETED|Overall Study||48
52540|NCT01490190|121465|P1|COMPLETED|Overall Study||204
52541|NCT01490190|121465|P1|STARTED|Overall Study||252
52542|NCT01490125|121486|P6|NOT COMPLETED|Period III||0
52543|NCT01490125|121487|P5|NOT COMPLETED|Period III||1
52544|NCT01490125|121488|P4|NOT COMPLETED|Period III||2
52545|NCT01490125|121489|P3|NOT COMPLETED|Period III||0
52546|NCT01490125|121490|P2|NOT COMPLETED|Period III||1
52547|NCT01490125|121491|P1|NOT COMPLETED|Period III||3
52548|NCT01490125|121486|P6|COMPLETED|Period III||35
52549|NCT01490125|121487|P5|COMPLETED|Period III||31
52550|NCT01490125|121488|P4|COMPLETED|Period III||28
52551|NCT01490125|121489|P3|COMPLETED|Period III||34
52552|NCT01490125|121490|P2|COMPLETED|Period III||32
52553|NCT01490125|121491|P1|COMPLETED|Period III||31
52554|NCT01490125|121486|P6|STARTED|Period III||35
52555|NCT01490125|121487|P5|STARTED|Period III||32
52556|NCT01490125|121488|P4|STARTED|Period III||30
52557|NCT01490125|121489|P3|STARTED|Period III||34
52558|NCT01490125|121490|P2|STARTED|Period III||33
52559|NCT01490125|121491|P1|STARTED|Period III||34
52560|NCT01490125|121486|P6|NOT COMPLETED|Period II||2
52561|NCT01490125|121487|P5|NOT COMPLETED|Period II||4
52562|NCT01490125|121488|P4|NOT COMPLETED|Period II||3
52563|NCT01490125|121489|P3|NOT COMPLETED|Period II||3
52564|NCT01490125|121490|P2|NOT COMPLETED|Period II||4
52565|NCT01490125|121491|P1|NOT COMPLETED|Period II||3
52566|NCT01490125|121486|P6|COMPLETED|Period II||35
52567|NCT01490125|121487|P5|COMPLETED|Period II||32
52568|NCT01490125|121488|P4|COMPLETED|Period II||30
52569|NCT01490125|121489|P3|COMPLETED|Period II||34
52570|NCT01490125|121490|P2|COMPLETED|Period II||33
52571|NCT01490125|121491|P1|COMPLETED|Period II||34
52572|NCT01490125|121486|P6|STARTED|Period II||37
52573|NCT01490125|121487|P5|STARTED|Period II||36
52574|NCT01490125|121488|P4|STARTED|Period II||33
52575|NCT01490125|121489|P3|STARTED|Period II||37
52576|NCT01490125|121490|P2|STARTED|Period II||37
52577|NCT01490125|121491|P1|STARTED|Period II||37
52578|NCT01490125|121486|P6|NOT COMPLETED|Period I||5
52579|NCT01490125|121487|P5|NOT COMPLETED|Period I||4
52580|NCT01490125|121488|P4|NOT COMPLETED|Period I||5
52581|NCT01490125|121489|P3|NOT COMPLETED|Period I||4
52582|NCT01490125|121490|P2|NOT COMPLETED|Period I||5
52583|NCT01490125|121491|P1|NOT COMPLETED|Period I||6
52584|NCT01490125|121486|P6|COMPLETED|Period I||37
52585|NCT01490125|121487|P5|COMPLETED|Period I||36
52586|NCT01490125|121488|P4|COMPLETED|Period I||33
52587|NCT01490125|121489|P3|COMPLETED|Period I||37
52588|NCT01490125|121490|P2|COMPLETED|Period I||37
52589|NCT01490125|121491|P1|COMPLETED|Period I||37
52590|NCT01490125|121486|P6|STARTED|Period I||42
52591|NCT01490125|121487|P5|STARTED|Period I||40
52592|NCT01490125|121488|P4|STARTED|Period I||38
52593|NCT01490125|121489|P3|STARTED|Period I||41
52594|NCT01490125|121490|P2|STARTED|Period I||42
52595|NCT01490125|121491|P1|STARTED|Period I||43
52596|NCT01490086|121519|P5|NOT COMPLETED|Overall Study||11
52597|NCT01490086|121520|P4|NOT COMPLETED|Overall Study||7
52598|NCT01490086|121521|P3|NOT COMPLETED|Overall Study||7
52599|NCT01490086|121522|P2|NOT COMPLETED|Overall Study||15
52600|NCT01490086|121523|P1|NOT COMPLETED|Overall Study||8
52601|NCT01490086|121519|P5|COMPLETED|Overall Study||28
52602|NCT01490086|121520|P4|COMPLETED|Overall Study||13
52603|NCT01490086|121521|P3|COMPLETED|Overall Study||51
52604|NCT01490086|121522|P2|COMPLETED|Overall Study||44
52605|NCT01490086|121523|P1|COMPLETED|Overall Study||50
52606|NCT01490086|121519|P5|STARTED|Overall Study||39
52607|NCT01490086|121520|P4|STARTED|Overall Study||20
52608|NCT01490086|121521|P3|STARTED|Overall Study||58
52609|NCT01490086|121522|P2|STARTED|Overall Study||59
52610|NCT01490086|121523|P1|STARTED|Overall Study||58
52611|NCT01490060|121557|P4|NOT COMPLETED|Cycle 2||0
52612|NCT01490060|121558|P3|NOT COMPLETED|Cycle 2||1
52613|NCT01490060|121559|P2|NOT COMPLETED|Cycle 2||1
52614|NCT01490060|121560|P1|NOT COMPLETED|Cycle 2||2
52615|NCT01490060|121557|P4|COMPLETED|Cycle 2||8
52616|NCT01490060|121558|P3|COMPLETED|Cycle 2||8
52617|NCT01490060|121559|P2|COMPLETED|Cycle 2||11
52618|NCT01490060|121560|P1|COMPLETED|Cycle 2||9
52619|NCT01490060|121557|P4|STARTED|Cycle 2||8
52620|NCT01490060|121558|P3|STARTED|Cycle 2||9
52621|NCT01490060|121559|P2|STARTED|Cycle 2||12
52622|NCT01490060|121560|P1|STARTED|Cycle 2||11
52623|NCT01490060|121557|P4|NOT COMPLETED|Cycle 1||3
52624|NCT01490060|121558|P3|NOT COMPLETED|Cycle 1||3
52625|NCT01490060|121559|P2|NOT COMPLETED|Cycle 1||1
52626|NCT01490060|121560|P1|NOT COMPLETED|Cycle 1||0
52627|NCT01490060|121557|P4|COMPLETED|Cycle 1||8
52628|NCT01490060|121558|P3|COMPLETED|Cycle 1||9
52629|NCT01490060|121559|P2|COMPLETED|Cycle 1||12
52630|NCT01490060|121560|P1|COMPLETED|Cycle 1||11
52631|NCT01490060|121557|P4|STARTED|Cycle 1||11
52632|NCT01490060|121558|P3|STARTED|Cycle 1||12
52633|NCT01490060|121559|P2|STARTED|Cycle 1||13
52634|NCT01490060|121560|P1|STARTED|Cycle 1||11
52635|NCT01489956|121570|P3|NOT COMPLETED|Overall Study||1
52636|NCT01489956|121571|P2|NOT COMPLETED|Overall Study||0
52637|NCT01489956|121572|P1|NOT COMPLETED|Overall Study||1
52638|NCT01489956|121570|P3|COMPLETED|Overall Study||5
52639|NCT01489956|121571|P2|COMPLETED|Overall Study||0
52640|NCT01489956|121572|P1|COMPLETED|Overall Study||12
52641|NCT01489956|121570|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
52642|NCT01489956|121571|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
52643|NCT01489956|121572|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
52644|NCT01489891|121609|P2|NOT COMPLETED|Overall Study||0
52645|NCT01489891|121610|P1|NOT COMPLETED|Overall Study||1
52646|NCT01489891|121609|P2|COMPLETED|Overall Study||60
52647|NCT01489891|121610|P1|COMPLETED|Overall Study||59
52648|NCT01489891|121609|P2|STARTED|Overall Study||60
52649|NCT01489891|121610|P1|STARTED|Overall Study||60
52650|NCT01489826|121631|P9|NOT COMPLETED|Overall Study||0
52651|NCT01489826|121632|P8|NOT COMPLETED|Overall Study||0
52652|NCT01489826|121633|P7|NOT COMPLETED|Overall Study||0
52653|NCT01489826|121634|P6|NOT COMPLETED|Overall Study||0
52654|NCT01489826|121635|P5|NOT COMPLETED|Overall Study||0
52655|NCT01489826|121636|P4|NOT COMPLETED|Overall Study||0
52656|NCT01489826|121637|P3|NOT COMPLETED|Overall Study||0
52657|NCT01489826|121638|P2|NOT COMPLETED|Overall Study||0
52658|NCT01489826|121639|P1|NOT COMPLETED|Overall Study||0
52659|NCT01489826|121631|P9|COMPLETED|Overall Study||6
52660|NCT01489826|121632|P8|COMPLETED|Overall Study||3
52661|NCT01489826|121633|P7|COMPLETED|Overall Study||9
52662|NCT01489826|121634|P6|COMPLETED|Overall Study||3
52663|NCT01489826|121635|P5|COMPLETED|Overall Study||3
52664|NCT01489826|121636|P4|COMPLETED|Overall Study||7
52665|NCT01489826|121637|P3|COMPLETED|Overall Study||3
52666|NCT01489826|121638|P2|COMPLETED|Overall Study||3
52667|NCT01489826|121639|P1|COMPLETED|Overall Study||3
52668|NCT01489826|121631|P9|STARTED|Overall Study||6
52669|NCT01489826|121632|P8|STARTED|Overall Study||3
52670|NCT01489826|121633|P7|STARTED|Overall Study||9
52671|NCT01489826|121634|P6|STARTED|Overall Study||3
52672|NCT01489826|121635|P5|STARTED|Overall Study||3
52673|NCT01489826|121636|P4|STARTED|Overall Study||7
52674|NCT01489826|121637|P3|STARTED|Overall Study||3
52675|NCT01489826|121638|P2|STARTED|Overall Study||3
52676|NCT01489826|121639|P1|STARTED|Overall Study||3
52677|NCT01489670|121736|P1|NOT COMPLETED|Overall Study||53
52678|NCT01489670|121736|P1|COMPLETED|Overall Study||334
52679|NCT01489670|121736|P1|STARTED|Overall Study||387
52680|NCT01489527|121748|P2|NOT COMPLETED|Overall Study||26
52681|NCT01489527|121749|P1|NOT COMPLETED|Overall Study||22
52682|NCT01489527|121748|P2|COMPLETED|Overall Study||175
52683|NCT01489527|121749|P1|COMPLETED|Overall Study||183
52684|NCT01489527|121748|P2|STARTED|Overall Study||201
52685|NCT01489527|121749|P1|STARTED|Overall Study||205
52686|NCT01489358|121766|P3|NOT COMPLETED|Overall Study||2
52687|NCT01489358|121767|P2|NOT COMPLETED|Overall Study||0
52688|NCT01489358|121768|P1|NOT COMPLETED|Overall Study||0
52689|NCT01489358|121766|P3|COMPLETED|Overall Study||8
52690|NCT01489358|121767|P2|COMPLETED|Overall Study||10
52691|NCT01489358|121768|P1|COMPLETED|Overall Study||5
52692|NCT01489358|121766|P3|STARTED|Overall Study||10
52693|NCT01489358|121767|P2|STARTED|Overall Study||10
52694|NCT01489358|121768|P1|STARTED|Overall Study||5
52695|NCT01489254|121818|P4|NOT COMPLETED|Open-label Extension Part||58
52696|NCT01489254|121819|P3|NOT COMPLETED|Open-label Extension Part||0
52697|NCT01489254|121820|P2|NOT COMPLETED|Open-label Extension Part||0
52698|NCT01489254|121821|P1|NOT COMPLETED|Open-label Extension Part||0
52699|NCT01489254|121818|P4|COMPLETED|Open-label Extension Part||670
52700|NCT01489254|121819|P3|COMPLETED|Open-label Extension Part||0
52701|NCT01489254|121820|P2|COMPLETED|Open-label Extension Part||0
52702|NCT01489254|121821|P1|COMPLETED|Open-label Extension Part||0
52703|NCT01489254|121818|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
52704|NCT01489254|121819|P3|STARTED|Open-label Extension Part||0
52705|NCT01489254|121820|P2|STARTED|Open-label Extension Part||0
52706|NCT01489254|121821|P1|STARTED|Open-label Extension Part||0
52707|NCT01489254|121818|P4|NOT COMPLETED|Double-blind Part||0
52708|NCT01489254|121819|P3|NOT COMPLETED|Double-blind Part||3
52709|NCT01489254|121820|P2|NOT COMPLETED|Double-blind Part||33
52710|NCT01489254|121821|P1|NOT COMPLETED|Double-blind Part||25
52711|NCT01489254|121818|P4|COMPLETED|Double-blind Part||0
52712|NCT01489254|121819|P3|COMPLETED|Double-blind Part||81
52713|NCT01489254|121820|P2|COMPLETED|Double-blind Part||324
52714|NCT01489254|121821|P1|COMPLETED|Double-blind Part||330
52715|NCT01489254|121818|P4|STARTED|Double-blind Part||0
52716|NCT01489254|121819|P3|STARTED|Double-blind Part||84
52717|NCT01489254|121820|P2|STARTED|Double-blind Part||357
52718|NCT01489254|121821|P1|STARTED|Double-blind Part||355
52719|NCT01489189|121832|P2|NOT COMPLETED|Overall Study||35
52720|NCT01489189|121833|P1|NOT COMPLETED|Overall Study||31
52721|NCT01489189|121832|P2|COMPLETED|Overall Study|Number of Eyes|168
52722|NCT01489189|121833|P1|COMPLETED|Overall Study|Number of Eyes|160
52723|NCT01489189|121832|P2|STARTED|Overall Study|Number of Eyes|203
52724|NCT01489189|121833|P1|STARTED|Overall Study|Number of Eyes|191
52725|NCT01488994|121860|P2|NOT COMPLETED|Overall Study||1
52726|NCT01488994|121861|P1|NOT COMPLETED|Overall Study||0
52727|NCT01488994|121860|P2|COMPLETED|Overall Study||11
52728|NCT01488994|121861|P1|COMPLETED|Overall Study||11
52729|NCT01488994|121860|P2|STARTED|Overall Study||12
52730|NCT01488994|121861|P1|STARTED|Overall Study||11
52731|NCT01488877|121948|P3|NOT COMPLETED|Re-randomization||0
52732|NCT01488877|121949|P2|NOT COMPLETED|Re-randomization||0
52733|NCT01488877|121950|P1|NOT COMPLETED|Re-randomization||0
52734|NCT01488877|121948|P3|COMPLETED|Re-randomization||3
52735|NCT01488877|121949|P2|COMPLETED|Re-randomization||0
52736|NCT01488877|121950|P1|COMPLETED|Re-randomization||0
52737|NCT01488877|121948|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
52738|NCT01488877|121949|P2|STARTED|Re-randomization||0
52739|NCT01488877|121950|P1|STARTED|Re-randomization||0
52740|NCT01488877|121948|P3|NOT COMPLETED|Initial Randomization||0
52741|NCT01488877|121949|P2|NOT COMPLETED|Initial Randomization||0
52742|NCT01488877|121950|P1|NOT COMPLETED|Initial Randomization||0
52743|NCT01488877|121948|P3|COMPLETED|Initial Randomization||0
52744|NCT01488877|121949|P2|COMPLETED|Initial Randomization||5
52745|NCT01488877|121950|P1|COMPLETED|Initial Randomization||1
52746|NCT01488877|121948|P3|STARTED|Initial Randomization||0
52747|NCT01488877|121949|P2|STARTED|Initial Randomization||5
52748|NCT01488877|121950|P1|STARTED|Initial Randomization||1
52749|NCT01488578|121965|P1|NOT COMPLETED|Overall Study||1836
52750|NCT01488578|121965|P1|COMPLETED|Overall Study||9321
52751|NCT01488578|121965|P1|STARTED|Overall Study||11157
52752|NCT01488487|121999|P1|NOT COMPLETED|Overall Study||9
52753|NCT01488487|121999|P1|COMPLETED|Overall Study||15
52754|NCT01488487|121999|P1|Received Treatment|Overall Study||24
52755|NCT01488487|121999|P1|STARTED|Overall Study||24
52756|NCT01488448|122008|P2|NOT COMPLETED|Overall Study||17
52757|NCT01488448|122009|P1|NOT COMPLETED|Overall Study||20
52758|NCT01488448|122008|P2|COMPLETED|Overall Study||97
52759|NCT01488448|122009|P1|COMPLETED|Overall Study||93
52760|NCT01488448|122008|P2|STARTED|Overall Study||114
52761|NCT01488448|122009|P1|STARTED|Overall Study||113
52762|NCT01488409|122033|P2|NOT COMPLETED|Overall Study||4
52763|NCT01488409|122034|P1|NOT COMPLETED|Overall Study||4
52764|NCT01488409|122033|P2|COMPLETED|Overall Study||15
52765|NCT01488409|122034|P1|COMPLETED|Overall Study||16
52766|NCT01488409|122033|P2|STARTED|Overall Study||19
52767|NCT01488409|122034|P1|STARTED|Overall Study||20
52768|NCT01488188|122050|P2|NOT COMPLETED|Overall Study||0
52769|NCT01488188|122051|P1|NOT COMPLETED|Overall Study||0
52770|NCT01488188|122050|P2|COMPLETED|Overall Study||20
52771|NCT01488188|122051|P1|COMPLETED|Overall Study||20
52772|NCT01488188|122050|P2|STARTED|Overall Study||20
52773|NCT01488188|122051|P1|STARTED|Overall Study||20
52774|NCT01488097|122063|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||0
52775|NCT01488097|122063|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|8
52776|NCT01488097|122063|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
52777|NCT01488097|122063|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
52778|NCT01488097|122063|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
52779|NCT01488097|122063|P1|STARTED|Long-term Treatment (up to Week 104)||8
52780|NCT01488071|122075|P2|NOT COMPLETED|Overall Study||63
52781|NCT01488071|122076|P1|NOT COMPLETED|Overall Study||53
52782|NCT01488071|122075|P2|COMPLETED|Overall Study||179
52783|NCT01488071|122076|P1|COMPLETED|Overall Study||200
52784|NCT01488071|122075|P2|STARTED|Overall Study|APTS|242
52785|NCT01488071|122076|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
52786|NCT01487954|122110|P2|NOT COMPLETED|Overall Study||0
52787|NCT01487954|122111|P1|NOT COMPLETED|Overall Study||0
52788|NCT01487954|122110|P2|COMPLETED|Overall Study||16
52789|NCT01487954|122111|P1|COMPLETED|Overall Study||29
52790|NCT01487954|122110|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
52791|NCT01487954|122111|P1|Safety lead-in|Overall Study||10
52792|NCT01487954|122110|P2|STARTED|Overall Study||16
52793|NCT01487954|122111|P1|STARTED|Overall Study||29
52794|NCT01487668|122121|P2|NOT COMPLETED|Overall Study||17
52795|NCT01487668|122122|P1|NOT COMPLETED|Overall Study||25
52796|NCT01487668|122121|P2|COMPLETED|Overall Study||124
52797|NCT01487668|122122|P1|COMPLETED|Overall Study||121
52798|NCT01487668|122121|P2|STARTED|Overall Study||141
52799|NCT01487668|122122|P1|STARTED|Overall Study||146
52800|NCT01487577|122130|P1|NOT COMPLETED|Overall Study||1
52801|NCT01487577|122130|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
52802|NCT01487577|122130|P1|STARTED|Overall Study||19
52803|NCT01487525|122144|P2|NOT COMPLETED|Overall Study||1
52804|NCT01487525|122145|P1|NOT COMPLETED|Overall Study||0
52805|NCT01487525|122144|P2|COMPLETED|Overall Study||19
52806|NCT01487525|122145|P1|COMPLETED|Overall Study||22
52807|NCT01487525|122144|P2|STARTED|Overall Study||20
52808|NCT01487525|122145|P1|STARTED|Overall Study||22
52809|NCT01487499|122155|P1|NOT COMPLETED|Overall Study||0
52810|NCT01487499|122155|P1|COMPLETED|Overall Study||4
52811|NCT01487499|122155|P1|STARTED|Overall Study||4
52812|NCT01486966|122163|P2|NOT COMPLETED|Overall Study||2
52813|NCT01486966|122164|P1|NOT COMPLETED|Overall Study||0
52814|NCT01486966|122163|P2|COMPLETED|Overall Study||27
52815|NCT01486966|122164|P1|COMPLETED|Overall Study||29
52816|NCT01486966|122163|P2|STARTED|Overall Study||29
52817|NCT01486966|122164|P1|STARTED|Overall Study||29
52818|NCT01486927|122188|P1|NOT COMPLETED|Overall Study||13
52819|NCT01486927|122188|P1|COMPLETED|Overall Study||161
52820|NCT01486927|122188|P1|STARTED|Overall Study||174
52821|NCT01486615|122223|P4|NOT COMPLETED|Overall Study||2
52822|NCT01486615|122224|P3|NOT COMPLETED|Overall Study||2
52823|NCT01486615|122225|P2|NOT COMPLETED|Overall Study||1
52824|NCT01486615|122226|P1|NOT COMPLETED|Overall Study||0
52825|NCT01486615|122223|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
52826|NCT01486615|122224|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
52827|NCT01486615|122225|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
52828|NCT01486615|122226|P1|COMPLETED|Overall Study||20
52829|NCT01486615|122223|P4|STARTED|Overall Study||20
52830|NCT01486615|122224|P3|STARTED|Overall Study||20
52831|NCT01486615|122225|P2|STARTED|Overall Study||20
52832|NCT01486615|122226|P1|STARTED|Overall Study||20
52833|NCT01486446|122266|P2|NOT COMPLETED|Overall Study||0
52834|NCT01486446|122267|P1|NOT COMPLETED|Overall Study||1
52835|NCT01486446|122266|P2|COMPLETED|Overall Study||1
52836|NCT01486446|122267|P1|COMPLETED|Overall Study||6
52837|NCT01486446|122266|P2|STARTED|Overall Study||1
52838|NCT01486446|122267|P1|STARTED|Overall Study||7
52839|NCT01486238|122289|P2|NOT COMPLETED|Overall Study||6
52840|NCT01486238|122290|P1|NOT COMPLETED|Overall Study||2
52841|NCT01486238|122289|P2|COMPLETED|Overall Study||43
52842|NCT01486238|122290|P1|COMPLETED|Overall Study||21
52843|NCT01486238|122289|P2|STARTED|Overall Study||49
52844|NCT01486238|122290|P1|STARTED|Overall Study||23
52845|NCT01486043|122296|P1|NOT COMPLETED|Overall Study||2
52846|NCT01486043|122296|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
52847|NCT01486043|122296|P1|STARTED|Overall Study||4
52848|NCT01485991|122304|P2|NOT COMPLETED|Overall Study||36
52849|NCT01485991|122305|P1|NOT COMPLETED|Overall Study||32
52850|NCT01485991|122304|P2|COMPLETED|Overall Study||350
52851|NCT01485991|122305|P1|COMPLETED|Overall Study||353
52852|NCT01485991|122304|P2|Treated|Overall Study||384
52853|NCT01485991|122305|P1|Treated|Overall Study||379
52854|NCT01485991|122304|P2|STARTED|Overall Study||386
52855|NCT01485991|122305|P1|STARTED|Overall Study||385
52856|NCT01485887|122315|P1|NOT COMPLETED|Overall Study||12
52857|NCT01485887|122315|P1|COMPLETED|Overall Study||38
52858|NCT01485887|122315|P1|STARTED|Overall Study||50
52859|NCT01485640|122327|P1|NOT COMPLETED|Overall Study||122
52860|NCT01485640|122327|P1|COMPLETED|Overall Study||40
52861|NCT01485640|122327|P1|STARTED|Overall Study||162
52862|NCT01485536|122332|P1|NOT COMPLETED|Overall Study||4
52863|NCT01485536|122332|P1|COMPLETED|Overall Study||17
52864|NCT01485536|122332|P1|STARTED|Overall Study||21
52865|NCT01485380|122337|P1|NOT COMPLETED|Overall Study||3
52866|NCT01485380|122337|P1|COMPLETED|Overall Study||17
52867|NCT01485380|122337|P1|STARTED|Overall Study||20
52868|NCT01485172|122347|P6|NOT COMPLETED|Overall Study||4
52869|NCT01485172|122348|P5|NOT COMPLETED|Overall Study||5
52870|NCT01485172|122349|P4|NOT COMPLETED|Overall Study||8
52871|NCT01485172|122350|P3|NOT COMPLETED|Overall Study||7
52872|NCT01485172|122351|P2|NOT COMPLETED|Overall Study||1
52873|NCT01485172|122352|P1|NOT COMPLETED|Overall Study||7
52874|NCT01485172|122347|P6|COMPLETED|Overall Study||9
52875|NCT01485172|122348|P5|COMPLETED|Overall Study||34
52876|NCT01485172|122349|P4|COMPLETED|Overall Study||32
52877|NCT01485172|122350|P3|COMPLETED|Overall Study||34
52878|NCT01485172|122351|P2|COMPLETED|Overall Study||12
52879|NCT01485172|122352|P1|COMPLETED|Overall Study||33
52880|NCT01485172|122347|P6|STARTED|Overall Study||13
52881|NCT01485172|122348|P5|STARTED|Overall Study||39
52882|NCT01485172|122349|P4|STARTED|Overall Study||40
52883|NCT01485172|122350|P3|STARTED|Overall Study||41
52884|NCT01485172|122351|P2|STARTED|Overall Study||13
52885|NCT01485172|122352|P1|STARTED|Overall Study||40
52886|NCT01485094|122429|P3|NOT COMPLETED|Overall Study||1
52887|NCT01485094|122430|P2|NOT COMPLETED|Overall Study||2
52888|NCT01485094|122431|P1|NOT COMPLETED|Overall Study||3
52889|NCT01485094|122429|P3|COMPLETED|Overall Study||18
52890|NCT01485094|122430|P2|COMPLETED|Overall Study||18
52891|NCT01485094|122431|P1|COMPLETED|Overall Study||17
52892|NCT01485094|122429|P3|STARTED|Overall Study||19
52893|NCT01485094|122430|P2|STARTED|Overall Study||20
52894|NCT01485094|122431|P1|STARTED|Overall Study||20
52895|NCT01484977|122472|P1|NOT COMPLETED|Overall Study||27
52896|NCT01484977|122472|P1|COMPLETED|Overall Study||93
52897|NCT01484977|122472|P1|STARTED|Overall Study||120
52898|NCT01484951|122476|P1|NOT COMPLETED|Overall Study||5
52899|NCT01484951|122476|P1|COMPLETED|Overall Study||69
52900|NCT01484951|122476|P1|STARTED|Overall Study||74
52901|NCT01484938|122481|P1|NOT COMPLETED|Overall Study||4
52902|NCT01484938|122481|P1|COMPLETED|Overall Study||171
52903|NCT01484938|122481|P1|STARTED|Overall Study||175
52904|NCT01484912|122488|P2|NOT COMPLETED|Overall Study||1
52905|NCT01484912|122489|P1|NOT COMPLETED|Overall Study||1
52906|NCT01484912|122488|P2|COMPLETED|Overall Study||39
52907|NCT01484912|122489|P1|COMPLETED|Overall Study||38
52908|NCT01484912|122488|P2|STARTED|Overall Study||40
52909|NCT01484912|122489|P1|STARTED|Overall Study||39
52910|NCT01484873|122499|P1|NOT COMPLETED|Overall Study||2
52911|NCT01484873|122499|P1|COMPLETED|Overall Study||8
52912|NCT01484873|122499|P1|STARTED|Overall Study||10
52913|NCT01484652|122509|P2|NOT COMPLETED|Overall Study||21
52914|NCT01484652|122510|P1|NOT COMPLETED|Overall Study||15
52915|NCT01484652|122509|P2|COMPLETED|Overall Study||142
52916|NCT01484652|122510|P1|COMPLETED|Overall Study||151
52917|NCT01484652|122509|P2|STARTED|Overall Study||163
52918|NCT01484652|122510|P1|STARTED|Overall Study||166
52919|NCT01484561|122518|P2|NOT COMPLETED|Overall Study||6
52920|NCT01484561|122519|P1|NOT COMPLETED|Overall Study||9
52921|NCT01484561|122518|P2|COMPLETED|Overall Study||45
52922|NCT01484561|122519|P1|COMPLETED|Overall Study||88
52923|NCT01484561|122518|P2|STARTED|Overall Study||51
52924|NCT01484561|122519|P1|STARTED|Overall Study||97
52925|NCT01484314|122607|P1|NOT COMPLETED|Overall Study||0
52926|NCT01484314|122607|P1|COMPLETED|Overall Study||1
52927|NCT01484314|122607|P1|STARTED|Overall Study||1
52928|NCT01484197|122611|P4|NOT COMPLETED|Treatment Period 4||0
52929|NCT01484197|122612|P3|NOT COMPLETED|Treatment Period 4||0
52930|NCT01484197|122613|P2|NOT COMPLETED|Treatment Period 4||0
52931|NCT01484197|122614|P1|NOT COMPLETED|Treatment Period 4||0
52932|NCT01484197|122611|P4|COMPLETED|Treatment Period 4||6
52933|NCT01484197|122612|P3|COMPLETED|Treatment Period 4||9
52934|NCT01484197|122613|P2|COMPLETED|Treatment Period 4||8
52935|NCT01484197|122614|P1|COMPLETED|Treatment Period 4||7
52936|NCT01484197|122611|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
52937|NCT01484197|122612|P3|STARTED|Treatment Period 4||9
52938|NCT01484197|122613|P2|STARTED|Treatment Period 4||8
52939|NCT01484197|122614|P1|STARTED|Treatment Period 4||7
52940|NCT01484197|122611|P4|NOT COMPLETED|Treatment Period 3||0
52941|NCT01484197|122612|P3|NOT COMPLETED|Treatment Period 3||0
52942|NCT01484197|122613|P2|NOT COMPLETED|Treatment Period 3||0
52943|NCT01484197|122614|P1|NOT COMPLETED|Treatment Period 3||0
52944|NCT01484197|122611|P4|COMPLETED|Treatment Period 3||8
52945|NCT01484197|122612|P3|COMPLETED|Treatment Period 3||9
52946|NCT01484197|122613|P2|COMPLETED|Treatment Period 3||8
52947|NCT01484197|122614|P1|COMPLETED|Treatment Period 3||7
52948|NCT01484197|122611|P4|STARTED|Treatment Period 3||8
52949|NCT01484197|122612|P3|STARTED|Treatment Period 3||9
52950|NCT01484197|122613|P2|STARTED|Treatment Period 3||8
52951|NCT01484197|122614|P1|STARTED|Treatment Period 3||7
52952|NCT01484197|122611|P4|NOT COMPLETED|Treatment Period 2||1
52953|NCT01484197|122612|P3|NOT COMPLETED|Treatment Period 2||0
52954|NCT01484197|122613|P2|NOT COMPLETED|Treatment Period 2||0
52955|NCT01484197|122614|P1|NOT COMPLETED|Treatment Period 2||0
52956|NCT01484197|122611|P4|COMPLETED|Treatment Period 2||8
52957|NCT01484197|122612|P3|COMPLETED|Treatment Period 2||9
52958|NCT01484197|122613|P2|COMPLETED|Treatment Period 2||8
52959|NCT01484197|122614|P1|COMPLETED|Treatment Period 2||7
52960|NCT01484197|122611|P4|STARTED|Treatment Period 2||9
52961|NCT01484197|122612|P3|STARTED|Treatment Period 2||9
52962|NCT01484197|122613|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
52963|NCT01484197|122614|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
52964|NCT01484197|122611|P4|NOT COMPLETED|Treatment Period 1||0
52965|NCT01484197|122612|P3|NOT COMPLETED|Treatment Period 1||0
52966|NCT01484197|122613|P2|NOT COMPLETED|Treatment Period 1||0
52967|NCT01484197|122614|P1|NOT COMPLETED|Treatment Period 1||1
52968|NCT01484197|122611|P4|COMPLETED|Treatment Period 1||9
52969|NCT01484197|122612|P3|COMPLETED|Treatment Period 1||9
52970|NCT01484197|122613|P2|COMPLETED|Treatment Period 1||9
52971|NCT01484197|122614|P1|COMPLETED|Treatment Period 1||8
52972|NCT01484197|122611|P4|STARTED|Treatment Period 1||9
52973|NCT01484197|122612|P3|STARTED|Treatment Period 1||9
52974|NCT01484197|122613|P2|STARTED|Treatment Period 1||9
52975|NCT01484197|122614|P1|STARTED|Treatment Period 1||9
52976|NCT01484132|122697|P1|NOT COMPLETED|Overall Study||22
52977|NCT01484132|122697|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
52978|NCT01484132|122697|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
52979|NCT01484132|122697|P1|STARTED|Overall Study||113
52980|NCT01484054|122705|P2|NOT COMPLETED|Period 2||0
52981|NCT01484054|122706|P1|NOT COMPLETED|Period 2||0
52982|NCT01484054|122705|P2|COMPLETED|Period 2||49
52983|NCT01484054|122706|P1|COMPLETED|Period 2||50
52984|NCT01484054|122705|P2|STARTED|Period 2||49
52985|NCT01484054|122706|P1|STARTED|Period 2||50
52986|NCT01484054|122705|P2|NOT COMPLETED|Period 1||1
52987|NCT01484054|122706|P1|NOT COMPLETED|Period 1||0
52988|NCT01484054|122705|P2|COMPLETED|Period 1||49
52989|NCT01484054|122706|P1|COMPLETED|Period 1||50
52990|NCT01484054|122705|P2|STARTED|Period 1||50
52991|NCT01484054|122706|P1|STARTED|Period 1||50
52992|NCT01484041|122716|P1|NOT COMPLETED|Overall Study||0
52993|NCT01484041|122716|P1|COMPLETED|Overall Study||12
52994|NCT01484041|122716|P1|STARTED|Overall Study||12
52995|NCT01484028|122724|P4|NOT COMPLETED|Period 2||0
52996|NCT01484028|122725|P3|NOT COMPLETED|Period 2||0
52997|NCT01484028|122726|P2|NOT COMPLETED|Period 2||0
52998|NCT01484028|122727|P1|NOT COMPLETED|Period 2||0
52999|NCT01484028|122724|P4|COMPLETED|Period 2||66
53000|NCT01484028|122725|P3|COMPLETED|Period 2||64
53001|NCT01484028|122726|P2|COMPLETED|Period 2||67
53002|NCT01484028|122727|P1|COMPLETED|Period 2||66
53003|NCT01484028|122724|P4|STARTED|Period 2||66
53004|NCT01484028|122725|P3|STARTED|Period 2||64
53005|NCT01484028|122726|P2|STARTED|Period 2||67
53006|NCT01484028|122727|P1|STARTED|Period 2||66
53007|NCT01484028|122724|P4|NOT COMPLETED|Period 1||1
53008|NCT01484028|122725|P3|NOT COMPLETED|Period 1||0
53009|NCT01484028|122726|P2|NOT COMPLETED|Period 1||3
53010|NCT01484028|122727|P1|NOT COMPLETED|Period 1||0
53011|NCT01484028|122724|P4|COMPLETED|Period 1||66
53012|NCT01484028|122725|P3|COMPLETED|Period 1||64
53013|NCT01484028|122726|P2|COMPLETED|Period 1||67
53014|NCT01484028|122727|P1|COMPLETED|Period 1||66
53015|NCT01484028|122724|P4|STARTED|Period 1||67
53016|NCT01484028|122725|P3|STARTED|Period 1||64
53017|NCT01484028|122726|P2|STARTED|Period 1||70
53018|NCT01484028|122727|P1|STARTED|Period 1||66
53019|NCT01483937|122739|P2|NOT COMPLETED|Overall Study||3
53020|NCT01483937|122740|P1|NOT COMPLETED|Overall Study||4
53021|NCT01483937|122739|P2|COMPLETED|Overall Study||14
53022|NCT01483937|122740|P1|COMPLETED|Overall Study||11
53023|NCT01483937|122739|P2|STARTED|Overall Study||17
53024|NCT01483937|122740|P1|STARTED|Overall Study||15
53025|NCT01483924|122767|P5|NOT COMPLETED|Overall Study||2
53026|NCT01483924|122768|P4|NOT COMPLETED|Overall Study||4
53027|NCT01483924|122769|P3|NOT COMPLETED|Overall Study||1
53028|NCT01483924|122770|P2|NOT COMPLETED|Overall Study||0
53029|NCT01483924|122771|P1|NOT COMPLETED|Overall Study||2
53030|NCT01483924|122767|P5|COMPLETED|Overall Study||10
53031|NCT01483924|122768|P4|COMPLETED|Overall Study||8
53032|NCT01483924|122769|P3|COMPLETED|Overall Study||11
53033|NCT01483924|122770|P2|COMPLETED|Overall Study||12
53034|NCT01483924|122771|P1|COMPLETED|Overall Study||10
53035|NCT01483924|122767|P5|STARTED|Overall Study||12
53036|NCT01483924|122768|P4|STARTED|Overall Study||12
53037|NCT01483924|122769|P3|STARTED|Overall Study||12
53038|NCT01483924|122770|P2|STARTED|Overall Study||12
53039|NCT01483924|122771|P1|STARTED|Overall Study||12
53040|NCT01483820|122819|P1|NOT COMPLETED|Overall Study||8
53041|NCT01483820|122819|P1|COMPLETED|Overall Study||0
53042|NCT01483820|122819|P1|STARTED|Overall Study||8
53043|NCT01483651|122828|P6|NOT COMPLETED|Overall Study||1
53044|NCT01483651|122829|P5|NOT COMPLETED|Overall Study||0
53045|NCT01483651|122830|P4|NOT COMPLETED|Overall Study||0
53046|NCT01483651|122831|P3|NOT COMPLETED|Overall Study||1
53047|NCT01483651|122832|P2|NOT COMPLETED|Overall Study||1
53048|NCT01483651|122833|P1|NOT COMPLETED|Overall Study||0
53049|NCT01483651|122828|P6|COMPLETED|Overall Study||1
53050|NCT01483651|122829|P5|COMPLETED|Overall Study||2
53051|NCT01483651|122830|P4|COMPLETED|Overall Study||1
53052|NCT01483651|122831|P3|COMPLETED|Overall Study||1
53053|NCT01483651|122832|P2|COMPLETED|Overall Study||2
53054|NCT01483651|122833|P1|COMPLETED|Overall Study||1
53055|NCT01483651|122828|P6|STARTED|Overall Study||2
53056|NCT01483651|122829|P5|STARTED|Overall Study||2
53057|NCT01483651|122830|P4|STARTED|Overall Study||1
53058|NCT01483651|122831|P3|STARTED|Overall Study||2
53059|NCT01483651|122832|P2|STARTED|Overall Study||3
53060|NCT01483651|122833|P1|STARTED|Overall Study||1
53061|NCT01483625|122843|P2|NOT COMPLETED|Overall Study||2
53062|NCT01483625|122844|P1|NOT COMPLETED|Overall Study||4
53063|NCT01483625|122843|P2|COMPLETED|Overall Study||66
53064|NCT01483625|122844|P1|COMPLETED|Overall Study||68
53065|NCT01483625|122843|P2|STARTED|Overall Study||68
53066|NCT01483625|122844|P1|STARTED|Overall Study||72
53067|NCT01483378|122860|P2|NOT COMPLETED|Overall Study||0
53068|NCT01483378|122861|P1|NOT COMPLETED|Overall Study||0
53069|NCT01483378|122860|P2|COMPLETED|Overall Study||66
53070|NCT01483378|122861|P1|COMPLETED|Overall Study||100
53071|NCT01483378|122860|P2|STARTED|Overall Study||66
53072|NCT01483378|122861|P1|STARTED|Overall Study||100
53073|NCT01483352|122867|P1|NOT COMPLETED|Overall Study||0
53074|NCT01483352|122867|P1|COMPLETED|Overall Study||12
53075|NCT01483352|122867|P1|STARTED|Overall Study||12
53076|NCT01483209|122886|P1|NOT COMPLETED|Overall Study||1
53077|NCT01483209|122886|P1|COMPLETED|Overall Study||1
53078|NCT01483209|122886|P1|STARTED|Overall Study||2
53079|NCT01482910|122893|P2|NOT COMPLETED|Overall Study||9
53080|NCT01482910|122894|P1|NOT COMPLETED|Overall Study||15
53081|NCT01482910|122893|P2|COMPLETED|Overall Study||67
53082|NCT01482910|122894|P1|COMPLETED|Overall Study||213
53083|NCT01482910|122893|P2|Completed Week 28|Overall Study||71
53084|NCT01482910|122894|P1|Completed Week 28|Overall Study||216
53085|NCT01482910|122893|P2|STARTED|Overall Study||76
53086|NCT01482910|122894|P1|STARTED|Overall Study||228
53087|NCT01482884|122906|P2|NOT COMPLETED|Overall Study||18
53088|NCT01482884|122907|P1|NOT COMPLETED|Overall Study||13
53089|NCT01482884|122906|P2|COMPLETED|Overall Study||37
53090|NCT01482884|122907|P1|COMPLETED|Overall Study||43
53091|NCT01482884|122906|P2|STARTED|Overall Study||55
53092|NCT01482884|122907|P1|STARTED|Overall Study|One participant did not receive study treatment|56
53093|NCT01482819|122933|P1|NOT COMPLETED|Overall Study||2
53094|NCT01482819|122933|P1|COMPLETED|Overall Study||19
53095|NCT01482819|122933|P1|STARTED|Overall Study||21
53096|NCT01482767|122953|P2|NOT COMPLETED|Overall Study||49
53097|NCT01482767|122954|P1|NOT COMPLETED|Overall Study||54
53098|NCT01482767|122953|P2|COMPLETED|Overall Study||78
53099|NCT01482767|122954|P1|COMPLETED|Overall Study||81
53100|NCT01482767|122953|P2|STARTED|Overall Study||127
53101|NCT01482767|122954|P1|STARTED|Overall Study||135
53102|NCT01482429|122976|P2|NOT COMPLETED|Protocol||0
53103|NCT01482429|122977|P1|NOT COMPLETED|Protocol||275
53104|NCT01482429|122976|P2|COMPLETED|Protocol||0
53105|NCT01482429|122977|P1|COMPLETED|Protocol||139
53106|NCT01482429|122976|P2|STARTED|Protocol||0
53107|NCT01482429|122977|P1|STARTED|Protocol||414
53108|NCT01482429|122976|P2|NOT COMPLETED|Care Usual||173
53109|NCT01482429|122977|P1|NOT COMPLETED|Care Usual||0
53110|NCT01482429|122976|P2|COMPLETED|Care Usual||96
53111|NCT01482429|122977|P1|COMPLETED|Care Usual||0
53112|NCT01482429|122976|P2|STARTED|Care Usual||269
53113|NCT01482429|122977|P1|STARTED|Care Usual||0
53114|NCT01482325|122985|P1|NOT COMPLETED|Overall Study||0
53115|NCT01482325|122985|P1|COMPLETED|Overall Study||31
53116|NCT01482325|122985|P1|STARTED|Overall Study||31
53117|NCT01482312|122989|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
53118|NCT01482312|122990|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
53119|NCT01482312|122991|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
53120|NCT01482312|122989|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
53121|NCT01482312|122990|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
53122|NCT01482312|122991|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
53123|NCT01482312|122989|P3|STARTED|Period 3, 90 Minutes of Wear||9
53124|NCT01482312|122990|P2|STARTED|Period 3, 90 Minutes of Wear||9
53125|NCT01482312|122991|P1|STARTED|Period 3, 90 Minutes of Wear||8
53126|NCT01482312|122989|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
53127|NCT01482312|122990|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
53128|NCT01482312|122991|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
53129|NCT01482312|122989|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
53130|NCT01482312|122990|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
53131|NCT01482312|122991|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
53132|NCT01482312|122989|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
53133|NCT01482312|122990|P2|STARTED|Period 2, 90 Minutes of Wear||9
53134|NCT01482312|122991|P1|STARTED|Period 2, 90 Minutes of Wear||9
53135|NCT01482312|122989|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
53136|NCT01482312|122990|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
53137|NCT01482312|122991|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
53138|NCT01482312|122989|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
53139|NCT01482312|122990|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
53140|NCT01482312|122991|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
53141|NCT01482312|122989|P3|STARTED|Period 1, 90 Minutes of Wear||10
53142|NCT01482312|122990|P2|STARTED|Period 1, 90 Minutes of Wear||9
53143|NCT01482312|122991|P1|STARTED|Period 1, 90 Minutes of Wear||10
53144|NCT01482091|123004|P2|NOT COMPLETED|Overall Study||0
53145|NCT01482091|123005|P1|NOT COMPLETED|Overall Study||0
53146|NCT01482091|123004|P2|COMPLETED|Overall Study||24
53147|NCT01482091|123005|P1|COMPLETED|Overall Study||25
53148|NCT01482091|123004|P2|STARTED|Overall Study||24
53149|NCT01482091|123005|P1|STARTED|Overall Study||25
53150|NCT01482065|123037|P2|NOT COMPLETED|Overall Study||1
53151|NCT01482065|123038|P1|NOT COMPLETED|Overall Study||0
53152|NCT01482065|123037|P2|COMPLETED|Overall Study||4
53153|NCT01482065|123038|P1|COMPLETED|Overall Study||4
53154|NCT01482065|123037|P2|STARTED|Overall Study||5
53155|NCT01482065|123038|P1|STARTED|Overall Study||4
53156|NCT01481935|123052|P2|NOT COMPLETED|Overall Study||0
53157|NCT01481935|123053|P1|NOT COMPLETED|Overall Study||0
53158|NCT01481935|123052|P2|COMPLETED|Overall Study||93
53159|NCT01481935|123053|P1|COMPLETED|Overall Study||97
53160|NCT01481935|123052|P2|STARTED|Overall Study||93
53161|NCT01481935|123053|P1|STARTED|Overall Study||97
53162|NCT01481896|123059|P1|NOT COMPLETED|Overall Study||12
53163|NCT01481896|123059|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
53164|NCT01481896|123059|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
53165|NCT01481896|123059|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
53166|NCT01481740|123075|P2|NOT COMPLETED|Overall Study||7
53167|NCT01481740|123076|P1|NOT COMPLETED|Overall Study||11
53168|NCT01481740|123075|P2|COMPLETED|Overall Study||81
53169|NCT01481740|123076|P1|COMPLETED|Overall Study||79
53170|NCT01481740|123075|P2|STARTED|Overall Study||88
53171|NCT01481740|123076|P1|STARTED|Overall Study||90
53172|NCT01481558|123094|P2|NOT COMPLETED|Overall Study||0
53173|NCT01481558|123095|P1|NOT COMPLETED|Overall Study||0
53174|NCT01481558|123094|P2|COMPLETED|Overall Study||20
53175|NCT01481558|123095|P1|COMPLETED|Overall Study||20
53176|NCT01481558|123094|P2|STARTED|Overall Study||20
53177|NCT01481558|123095|P1|STARTED|Overall Study||20
53178|NCT01481376|123101|P1|NOT COMPLETED|Overall Study||31
53179|NCT01481376|123101|P1|COMPLETED|Overall Study||169
53180|NCT01481376|123101|P1|STARTED|Overall Study||200
53181|NCT01481324|123112|P3|NOT COMPLETED|Overall Study||2
53182|NCT01481324|123113|P2|NOT COMPLETED|Overall Study||2
53183|NCT01481324|123114|P1|NOT COMPLETED|Overall Study||0
53184|NCT01481324|123112|P3|COMPLETED|Overall Study||20
53185|NCT01481324|123113|P2|COMPLETED|Overall Study||22
53186|NCT01481324|123114|P1|COMPLETED|Overall Study||21
53187|NCT01481324|123112|P3|Month 3-Wear Rate Data|Overall Study||6
53188|NCT01481324|123113|P2|Month 3-Wear Rate Data|Overall Study||11
53189|NCT01481324|123114|P1|Month 3-Wear Rate Data|Overall Study||7
53190|NCT01481324|123112|P3|Month 2-Wear Rate Data|Overall Study||7
53191|NCT01481324|123113|P2|Month 2-Wear Rate Data|Overall Study||13
53192|NCT01481324|123114|P1|Month 2-Wear Rate Data|Overall Study||9
53193|NCT01481324|123112|P3|Month 1-Wear Rate Data|Overall Study||8
53194|NCT01481324|123113|P2|Month 1-Wear Rate Data|Overall Study||16
53195|NCT01481324|123114|P1|Month 1-Wear Rate Data|Overall Study||15
53196|NCT01481324|123112|P3|STARTED|Overall Study||22
53197|NCT01481324|123113|P2|STARTED|Overall Study||24
53198|NCT01481324|123114|P1|STARTED|Overall Study||21
53199|NCT01481116|123125|P3|NOT COMPLETED|Overall Study||813
53200|NCT01481116|123126|P2|NOT COMPLETED|Overall Study||817
53201|NCT01481116|123127|P1|NOT COMPLETED|Overall Study||824
53202|NCT01481116|123125|P3|COMPLETED|Overall Study||0
53203|NCT01481116|123126|P2|COMPLETED|Overall Study||0
53204|NCT01481116|123127|P1|COMPLETED|Overall Study||0
53205|NCT01481116|123125|P3|Treated|Overall Study||813
53206|NCT01481116|123126|P2|Treated|Overall Study||816
53207|NCT01481116|123127|P1|Treated|Overall Study||822
53208|NCT01481116|123125|P3|STARTED|Overall Study||813
53209|NCT01481116|123126|P2|STARTED|Overall Study||817
53210|NCT01481116|123127|P1|STARTED|Overall Study||824
53211|NCT01480674|123153|P1|NOT COMPLETED|Overall Study||35
53212|NCT01480674|123153|P1|COMPLETED|Overall Study||125
53213|NCT01480674|123153|P1|Analysed Set|Overall Study||128
53214|NCT01480674|123153|P1|Safety Set|Overall Study||154
53215|NCT01480674|123153|P1|STARTED|Overall Study||160
53216|NCT01480596|123167|P2|NOT COMPLETED|Overall Study||2
53217|NCT01480596|123168|P1|NOT COMPLETED|Overall Study||5
53218|NCT01480596|123167|P2|COMPLETED|Overall Study||16
53219|NCT01480596|123168|P1|COMPLETED|Overall Study||17
53220|NCT01480596|123167|P2|STARTED|Overall Study||18
53221|NCT01480596|123168|P1|STARTED|Overall Study||22
53222|NCT01480297|123210|P1|NOT COMPLETED|Overall Study||0
53223|NCT01480297|123210|P1|COMPLETED|Overall Study||8
53224|NCT01480297|123210|P1|STARTED|Overall Study||8
53225|NCT01480284|123216|P2|NOT COMPLETED|Overall Study||0
53226|NCT01480284|123217|P1|NOT COMPLETED|Overall Study||8
53227|NCT01480284|123216|P2|COMPLETED|Overall Study||56
53228|NCT01480284|123217|P1|COMPLETED|Overall Study||102
53229|NCT01480284|123216|P2|STARTED|Overall Study||56
53230|NCT01480284|123217|P1|STARTED|Overall Study||110
53231|NCT01480219|123247|P2|NOT COMPLETED|Overall Study||0
53232|NCT01480219|123248|P1|NOT COMPLETED|Overall Study||0
53233|NCT01480219|123247|P2|COMPLETED|Overall Study||142
53234|NCT01480219|123248|P1|COMPLETED|Overall Study||325
53235|NCT01480219|123247|P2|STARTED|Overall Study||142
53236|NCT01480219|123248|P1|STARTED|Overall Study||325
53237|NCT01480089|123256|P2|NOT COMPLETED|Overall Study||0
53238|NCT01480089|123257|P1|NOT COMPLETED|Overall Study||0
53239|NCT01480089|123256|P2|COMPLETED|Overall Study||30
53240|NCT01480089|123257|P1|COMPLETED|Overall Study||25
53241|NCT01480089|123256|P2|STARTED|Overall Study||30
53242|NCT01480089|123257|P1|STARTED|Overall Study||25
53243|NCT01480076|123267|P1|NOT COMPLETED|Overall Study||290
53244|NCT01480076|123267|P1|COMPLETED|Overall Study||611
53245|NCT01480076|123267|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
53246|NCT01480076|123267|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
53247|NCT01479868|123386|P1|NOT COMPLETED|Overall Study||9
53248|NCT01479868|123386|P1|COMPLETED|Overall Study||97
53341|NCT01478620|123607|P1|COMPLETED|Overall Study||119
53249|NCT01479868|123386|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
53250|NCT01479777|123401|P1|NOT COMPLETED|Overall Study||2
53251|NCT01479777|123401|P1|COMPLETED|Overall Study||10
53252|NCT01479777|123401|P1|STARTED|Overall Study||12
53253|NCT01479764|123413|P2|NOT COMPLETED|Treated||2
53254|NCT01479764|123414|P1|NOT COMPLETED|Treated||0
53255|NCT01479764|123413|P2|COMPLETED|Treated||75
53256|NCT01479764|123414|P1|COMPLETED|Treated||74
53257|NCT01479764|123413|P2|STARTED|Treated||77
53258|NCT01479764|123414|P1|STARTED|Treated||74
53259|NCT01479764|123413|P2|NOT COMPLETED|Randomized||1
53260|NCT01479764|123414|P1|NOT COMPLETED|Randomized||2
53261|NCT01479764|123413|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
53262|NCT01479764|123414|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
53263|NCT01479764|123413|P2|STARTED|Randomized||78
53264|NCT01479764|123414|P1|STARTED|Randomized||76
53265|NCT01479595|123424|P2|NOT COMPLETED|Overall Study||2
53266|NCT01479595|123425|P1|NOT COMPLETED|Overall Study||2
53267|NCT01479595|123424|P2|COMPLETED|Overall Study||19
53268|NCT01479595|123425|P1|COMPLETED|Overall Study||42
53269|NCT01479595|123424|P2|Per Protocol Analysis Set|Overall Study||20
53270|NCT01479595|123425|P1|Per Protocol Analysis Set|Overall Study||41
53271|NCT01479595|123424|P2|PK Analysis Set|Overall Study||0
53272|NCT01479595|123425|P1|PK Analysis Set|Overall Study||42
53273|NCT01479595|123424|P2|STARTED|Overall Study||21
53274|NCT01479595|123425|P1|STARTED|Overall Study||44
53275|NCT01479543|123452|P5|NOT COMPLETED|Overall Study||1
53276|NCT01479543|123453|P4|NOT COMPLETED|Overall Study||0
53277|NCT01479543|123454|P3|NOT COMPLETED|Overall Study||1
53278|NCT01479543|123455|P2|NOT COMPLETED|Overall Study||0
53279|NCT01479543|123456|P1|NOT COMPLETED|Overall Study||1
53280|NCT01479543|123452|P5|COMPLETED|Overall Study||20
53281|NCT01479543|123453|P4|COMPLETED|Overall Study||20
53282|NCT01479543|123454|P3|COMPLETED|Overall Study||20
53283|NCT01479543|123455|P2|COMPLETED|Overall Study||20
53284|NCT01479543|123456|P1|COMPLETED|Overall Study||20
53285|NCT01479543|123452|P5|STARTED|Overall Study||21
53286|NCT01479543|123453|P4|STARTED|Overall Study||20
53287|NCT01479543|123454|P3|STARTED|Overall Study||21
53288|NCT01479543|123455|P2|STARTED|Overall Study||20
53289|NCT01479543|123456|P1|STARTED|Overall Study||21
53290|NCT01479530|123470|P2|NOT COMPLETED|Overall Study||12
53291|NCT01479530|123471|P1|NOT COMPLETED|Overall Study||10
53292|NCT01479530|123470|P2|COMPLETED|Overall Study||151
53293|NCT01479530|123471|P1|COMPLETED|Overall Study||148
53294|NCT01479530|123470|P2|STARTED|Overall Study||163
53295|NCT01479530|123471|P1|STARTED|Overall Study||158
53296|NCT01479517|123486|P3|NOT COMPLETED|Overall Study||0
53297|NCT01479517|123487|P2|NOT COMPLETED|Overall Study||0
53298|NCT01479517|123488|P1|NOT COMPLETED|Overall Study||0
53299|NCT01479517|123486|P3|COMPLETED|Overall Study||10
53300|NCT01479517|123487|P2|COMPLETED|Overall Study||10
53301|NCT01479517|123488|P1|COMPLETED|Overall Study||10
53302|NCT01479517|123486|P3|STARTED|Overall Study||10
53303|NCT01479517|123487|P2|STARTED|Overall Study||10
53304|NCT01479517|123488|P1|STARTED|Overall Study||10
53305|NCT01479374|123508|P3|NOT COMPLETED|Overall Study||5
53306|NCT01479374|123509|P2|NOT COMPLETED|Overall Study||8
53307|NCT01479374|123510|P1|NOT COMPLETED|Overall Study||3
53308|NCT01479374|123508|P3|COMPLETED|Overall Study||63
53309|NCT01479374|123509|P2|COMPLETED|Overall Study||60
53310|NCT01479374|123510|P1|COMPLETED|Overall Study||63
53311|NCT01479374|123508|P3|STARTED|Overall Study||68
53312|NCT01479374|123509|P2|STARTED|Overall Study||68
53313|NCT01479374|123510|P1|STARTED|Overall Study||66
53314|NCT01479127|123536|P1|NOT COMPLETED|Overall Study||3
53315|NCT01479127|123536|P1|COMPLETED|Overall Study||5
53316|NCT01479127|123536|P1|Started LCIG|Overall Study||6
53317|NCT01479127|123536|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
53318|NCT01479010|123570|P1|NOT COMPLETED|Overall Study||1
53319|NCT01479010|123570|P1|COMPLETED|Overall Study||1
53320|NCT01479010|123570|P1|STARTED|Overall Study||2
53321|NCT01478971|123575|P1|NOT COMPLETED|Peginesatide Treatment Period||14
53322|NCT01478971|123575|P1|COMPLETED|Peginesatide Treatment Period||143
53323|NCT01478971|123575|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
53324|NCT01478971|123575|P1|NOT COMPLETED|Standard of Care Period||25
53325|NCT01478971|123575|P1|COMPLETED|Standard of Care Period||159
53326|NCT01478971|123575|P1|Received Treatment|Standard of Care Period||178
53327|NCT01478971|123575|P1|STARTED|Standard of Care Period||184
53328|NCT01478958|123592|P3|NOT COMPLETED|Overall Study||3
53329|NCT01478958|123593|P2|NOT COMPLETED|Overall Study||2
53330|NCT01478958|123594|P1|NOT COMPLETED|Overall Study||2
53331|NCT01478958|123592|P3|COMPLETED|Overall Study||66
53332|NCT01478958|123593|P2|COMPLETED|Overall Study||64
53333|NCT01478958|123594|P1|COMPLETED|Overall Study||65
53334|NCT01478958|123592|P3|STARTED|Overall Study||69
53335|NCT01478958|123593|P2|STARTED|Overall Study||66
53336|NCT01478958|123594|P1|STARTED|Overall Study||67
53337|NCT01478828|123602|P1|NOT COMPLETED|Overall Study||1
53338|NCT01478828|123602|P1|COMPLETED|Overall Study||1
53339|NCT01478828|123602|P1|STARTED|Overall Study||2
53340|NCT01478620|123607|P1|NOT COMPLETED|Overall Study||6
53342|NCT01478620|123607|P1|STARTED|Overall Study||125
53343|NCT01478594|123613|P2|NOT COMPLETED|Overall Study||28
53344|NCT01478594|123614|P1|NOT COMPLETED|Overall Study||65
53345|NCT01478594|123613|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
53346|NCT01478594|123614|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
53347|NCT01478594|123613|P2|Treated|Overall Study||87
53348|NCT01478594|123614|P1|Treated|Overall Study||177
53349|NCT01478594|123613|P2|STARTED|Overall Study||88
53350|NCT01478594|123614|P1|STARTED|Overall Study||177
53351|NCT01478373|123686|P1|NOT COMPLETED|Survival Phase||38
53352|NCT01478373|123686|P1|COMPLETED|Survival Phase||0
53353|NCT01478373|123686|P1|STARTED|Survival Phase||38
53354|NCT01478373|123686|P1|NOT COMPLETED|Treatment Phase||1
53355|NCT01478373|123686|P1|COMPLETED|Treatment Phase||38
53356|NCT01478373|123686|P1|STARTED|Treatment Phase||39
53357|NCT01478360|123699|P2|NOT COMPLETED|Overall Study||3
53358|NCT01478360|123700|P1|NOT COMPLETED|Overall Study||2
53359|NCT01478360|123699|P2|COMPLETED|Overall Study||12
53360|NCT01478360|123700|P1|COMPLETED|Overall Study||29
53361|NCT01478360|123699|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
53362|NCT01478360|123700|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
53363|NCT01478360|123699|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
53364|NCT01478360|123700|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
53365|NCT01478360|123699|P2|STARTED|Overall Study||15
53366|NCT01478360|123700|P1|STARTED|Overall Study||31
53367|NCT01478347|123706|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
53368|NCT01478347|123706|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
53369|NCT01478347|123706|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
53370|NCT01478347|123706|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
53371|NCT01478347|123706|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
53372|NCT01478347|123706|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
53373|NCT01478256|123713|P2|NOT COMPLETED|Overall Study||0
53374|NCT01478256|123714|P1|NOT COMPLETED|Overall Study||0
53375|NCT01478256|123713|P2|COMPLETED|Overall Study||15
53376|NCT01478256|123714|P1|COMPLETED|Overall Study||15
53377|NCT01478256|123713|P2|STARTED|Overall Study||15
53378|NCT01478256|123714|P1|STARTED|Overall Study||15
53379|NCT01478087|123722|P1|NOT COMPLETED|Overall Study||1
53380|NCT01478087|123722|P1|COMPLETED|Overall Study||2
53381|NCT01478087|123722|P1|STARTED|Overall Study||3
53382|NCT01478048|123729|P2|NOT COMPLETED|Overall Study||68
53383|NCT01478048|123730|P1|NOT COMPLETED|Overall Study||63
53384|NCT01478048|123729|P2|COMPLETED|Overall Study|completed=treatment on-going|7
53385|NCT01478048|123730|P1|COMPLETED|Overall Study|completed=treatment on-going|14
53386|NCT01478048|123729|P2|Received Treatment|Overall Study||75
53387|NCT01478048|123730|P1|Received Treatment|Overall Study||75
53388|NCT01478048|123729|P2|STARTED|Overall Study||75
53389|NCT01478048|123730|P1|STARTED|Overall Study||77
53390|NCT01478009|123748|P2|NOT COMPLETED|Overall Study||1
53391|NCT01478009|123749|P1|NOT COMPLETED|Overall Study||1
53392|NCT01478009|123748|P2|COMPLETED|Overall Study||49
53393|NCT01478009|123749|P1|COMPLETED|Overall Study||49
53394|NCT01478009|123748|P2|STARTED|Overall Study||50
53395|NCT01478009|123749|P1|STARTED|Overall Study||50
53396|NCT01477892|123759|P2|NOT COMPLETED|Overall Study||2
53397|NCT01477892|123760|P1|NOT COMPLETED|Overall Study||0
53398|NCT01477892|123759|P2|COMPLETED|Overall Study||5
53399|NCT01477892|123760|P1|COMPLETED|Overall Study||7
53400|NCT01477892|123759|P2|STARTED|Overall Study||7
53401|NCT01477892|123760|P1|STARTED|Overall Study||7
53402|NCT01477853|123771|P3|NOT COMPLETED|Phase B||11
53403|NCT01477853|123772|P2|NOT COMPLETED|Phase B||11
53404|NCT01477853|123773|P1|NOT COMPLETED|Phase B||12
53405|NCT01477853|123771|P3|COMPLETED|Phase B||0
53406|NCT01477853|123772|P2|COMPLETED|Phase B||0
53407|NCT01477853|123773|P1|COMPLETED|Phase B||0
53408|NCT01477853|123771|P3|STARTED|Phase B||11
53409|NCT01477853|123772|P2|STARTED|Phase B||11
53410|NCT01477853|123773|P1|STARTED|Phase B||12
53411|NCT01477853|123771|P3|NOT COMPLETED|Phase A||44
53412|NCT01477853|123772|P2|NOT COMPLETED|Phase A||45
53413|NCT01477853|123773|P1|NOT COMPLETED|Phase A||43
53414|NCT01477853|123771|P3|COMPLETED|Phase A||11
53415|NCT01477853|123772|P2|COMPLETED|Phase A||11
53416|NCT01477853|123773|P1|COMPLETED|Phase A||12
53417|NCT01477853|123771|P3|STARTED|Phase A||55
53418|NCT01477853|123772|P2|STARTED|Phase A||56
53419|NCT01477853|123773|P1|STARTED|Phase A||55
53420|NCT01477749|123811|P1|NOT COMPLETED|Overall Study||4
53421|NCT01477749|123811|P1|COMPLETED|Overall Study||43
53422|NCT01477749|123811|P1|STARTED|Overall Study||47
53423|NCT01477710|123818|P1|NOT COMPLETED|Overall Study||0
53424|NCT01477710|123818|P1|COMPLETED|Overall Study||30
53425|NCT01477710|123818|P1|STARTED|Overall Study||30
53426|NCT01477567|123833|P7|NOT COMPLETED|Overall Study||0
53427|NCT01477567|123834|P6|NOT COMPLETED|Overall Study||0
53428|NCT01477567|123835|P5|NOT COMPLETED|Overall Study||0
53429|NCT01477567|123836|P4|NOT COMPLETED|Overall Study||0
53430|NCT01477567|123837|P3|NOT COMPLETED|Overall Study||0
53431|NCT01477567|123838|P2|NOT COMPLETED|Overall Study||0
53432|NCT01477567|123839|P1|NOT COMPLETED|Overall Study||0
53433|NCT01477567|123833|P7|COMPLETED|Overall Study||6
53434|NCT01477567|123834|P6|COMPLETED|Overall Study||5
53435|NCT01477567|123835|P5|COMPLETED|Overall Study||6
53436|NCT01477567|123836|P4|COMPLETED|Overall Study||6
53437|NCT01477567|123837|P3|COMPLETED|Overall Study||6
53438|NCT01477567|123838|P2|COMPLETED|Overall Study||6
53439|NCT01477567|123839|P1|COMPLETED|Overall Study||5
53440|NCT01477567|123833|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
53441|NCT01477567|123834|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
53442|NCT01477567|123835|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
53443|NCT01477567|123836|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
53444|NCT01477567|123837|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
53445|NCT01477567|123838|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
53446|NCT01477567|123839|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
53447|NCT01477567|123833|P7|STARTED|Overall Study||6
53448|NCT01477567|123834|P6|STARTED|Overall Study||5
53449|NCT01477567|123835|P5|STARTED|Overall Study||6
53450|NCT01477567|123836|P4|STARTED|Overall Study||6
53451|NCT01477567|123837|P3|STARTED|Overall Study||6
53452|NCT01477567|123838|P2|STARTED|Overall Study||6
53453|NCT01477567|123839|P1|STARTED|Overall Study||5
53454|NCT01477463|123895|P2|NOT COMPLETED|Overall Study||0
53455|NCT01477463|123896|P1|NOT COMPLETED|Overall Study||0
53456|NCT01477463|123895|P2|COMPLETED|Overall Study||6
53457|NCT01477463|123896|P1|COMPLETED|Overall Study||18
53458|NCT01477463|123895|P2|STARTED|Overall Study||6
53459|NCT01477463|123896|P1|STARTED|Overall Study||18
53460|NCT01477450|123909|P3|NOT COMPLETED|Overall Study||0
53461|NCT01477450|123910|P2|NOT COMPLETED|Overall Study||0
53462|NCT01477450|123911|P1|NOT COMPLETED|Overall Study||0
53463|NCT01477450|123909|P3|COMPLETED|Overall Study||10
53464|NCT01477450|123910|P2|COMPLETED|Overall Study||10
53465|NCT01477450|123911|P1|COMPLETED|Overall Study||10
53466|NCT01477450|123909|P3|STARTED|Overall Study||10
53467|NCT01477450|123910|P2|STARTED|Overall Study||10
53468|NCT01477450|123911|P1|STARTED|Overall Study||10
53469|NCT01475734|123921|P2|NOT COMPLETED|Overall Study||1
53470|NCT01475734|123922|P1|NOT COMPLETED|Overall Study||2
53471|NCT01475734|123921|P2|COMPLETED|Overall Study||21
53472|NCT01475734|123922|P1|COMPLETED|Overall Study||20
53473|NCT01475734|123921|P2|STARTED|Overall Study||22
53474|NCT01475734|123922|P1|STARTED|Overall Study||22
53475|NCT01475721|123950|P2|NOT COMPLETED|Overall Study||14
53476|NCT01475721|123951|P1|NOT COMPLETED|Overall Study||11
53477|NCT01475721|123950|P2|COMPLETED|Overall Study||5831
53478|NCT01475721|123951|P1|COMPLETED|Overall Study||5823
53479|NCT01475721|123950|P2|STARTED|Overall Study||5845
53480|NCT01475721|123951|P1|STARTED|Overall Study||5834
53481|NCT01476748|123968|P3|NOT COMPLETED|Overall Study||0
53482|NCT01476748|123969|P2|NOT COMPLETED|Overall Study||0
53483|NCT01476748|123970|P1|NOT COMPLETED|Overall Study||0
53484|NCT01476748|123968|P3|COMPLETED|Overall Study||5
53485|NCT01476748|123969|P2|COMPLETED|Overall Study||5
53486|NCT01476748|123970|P1|COMPLETED|Overall Study||5
53487|NCT01476748|123968|P3|STARTED|Overall Study||5
53488|NCT01476748|123969|P2|STARTED|Overall Study||5
53489|NCT01476748|123970|P1|STARTED|Overall Study||5
53490|NCT01476722|123981|P1|NOT COMPLETED|Overall Study||1
53491|NCT01476722|123981|P1|COMPLETED|Overall Study||124
53492|NCT01476722|123981|P1|STARTED|Overall Study||125
53493|NCT01476696|123988|P3|NOT COMPLETED|Overall Study||0
53494|NCT01476696|123989|P2|NOT COMPLETED|Overall Study||1
53495|NCT01476696|123990|P1|NOT COMPLETED|Overall Study||3
53496|NCT01476696|123988|P3|COMPLETED|Overall Study||9
53497|NCT01476696|123989|P2|COMPLETED|Overall Study||8
53498|NCT01476696|123990|P1|COMPLETED|Overall Study||12
53499|NCT01476696|123988|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
53500|NCT01476696|123989|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
53501|NCT01476696|123990|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
53502|NCT01476696|123988|P3|STARTED|Overall Study||9
53503|NCT01476696|123989|P2|STARTED|Overall Study||9
53504|NCT01476696|123990|P1|STARTED|Overall Study||15
53505|NCT01476475|124006|P2|NOT COMPLETED|Overall Study||3
53506|NCT01476475|124007|P1|NOT COMPLETED|Overall Study||11
53507|NCT01476475|124006|P2|COMPLETED|Overall Study||159
53508|NCT01476475|124007|P1|COMPLETED|Overall Study||150
53509|NCT01476475|124006|P2|STARTED|Overall Study||162
53510|NCT01476475|124007|P1|STARTED|Overall Study||161
53511|NCT01476345|124039|P2|NOT COMPLETED|Period 4||0
53512|NCT01476345|124040|P1|NOT COMPLETED|Period 4||0
53513|NCT01476345|124039|P2|COMPLETED|Period 4||39
53514|NCT01476345|124040|P1|COMPLETED|Period 4||39
53515|NCT01476345|124039|P2|STARTED|Period 4||39
53516|NCT01476345|124040|P1|STARTED|Period 4||39
53517|NCT01476345|124039|P2|NOT COMPLETED|Period 3||0
53518|NCT01476345|124040|P1|NOT COMPLETED|Period 3||0
53519|NCT01476345|124039|P2|COMPLETED|Period 3||39
53520|NCT01476345|124040|P1|COMPLETED|Period 3||39
53521|NCT01476345|124039|P2|STARTED|Period 3||39
53522|NCT01476345|124040|P1|STARTED|Period 3||39
53523|NCT01476345|124039|P2|NOT COMPLETED|Period 2||0
53524|NCT01476345|124040|P1|NOT COMPLETED|Period 2||0
53525|NCT01476345|124039|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
53526|NCT01476345|124040|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
53527|NCT01476345|124039|P2|STARTED|Period 2||40
53528|NCT01476345|124040|P1|STARTED|Period 2||40
53529|NCT01476345|124039|P2|NOT COMPLETED|Period 1||0
53530|NCT01476345|124040|P1|NOT COMPLETED|Period 1||0
53531|NCT01476345|124039|P2|COMPLETED|Period 1||40
53532|NCT01476345|124040|P1|COMPLETED|Period 1||40
53533|NCT01476345|124039|P2|Received at Least 1 Dose of Study Drug|Period 1||40
53534|NCT01476345|124040|P1|Received at Least 1 Dose of Study Drug|Period 1||40
53535|NCT01476345|124039|P2|STARTED|Period 1||40
53536|NCT01476345|124040|P1|STARTED|Period 1||40
53537|NCT01476202|124055|P3|NOT COMPLETED|Overall Study||0
53538|NCT01476202|124056|P2|NOT COMPLETED|Overall Study||0
53539|NCT01476202|124057|P1|NOT COMPLETED|Overall Study||0
53540|NCT01476202|124055|P3|COMPLETED|Overall Study||40
53541|NCT01476202|124056|P2|COMPLETED|Overall Study||40
53542|NCT01476202|124057|P1|COMPLETED|Overall Study||40
53543|NCT01476202|124055|P3|STARTED|Overall Study||40
53544|NCT01476202|124056|P2|STARTED|Overall Study||40
53545|NCT01476202|124057|P1|STARTED|Overall Study||40
53546|NCT01475955|124073|P5|NOT COMPLETED|Overall Study||0
53547|NCT01475955|124074|P4|NOT COMPLETED|Overall Study||0
53548|NCT01475955|124075|P3|NOT COMPLETED|Overall Study||3
53549|NCT01475955|124076|P2|NOT COMPLETED|Overall Study||0
53550|NCT01475955|124077|P1|NOT COMPLETED|Overall Study||1
53551|NCT01475955|124073|P5|COMPLETED|Overall Study||46
53552|NCT01475955|124074|P4|COMPLETED|Overall Study||46
53553|NCT01475955|124075|P3|COMPLETED|Overall Study||44
53554|NCT01475955|124076|P2|COMPLETED|Overall Study||48
53555|NCT01475955|124077|P1|COMPLETED|Overall Study||47
53556|NCT01475955|124073|P5|STARTED|Overall Study||46
53557|NCT01475955|124074|P4|STARTED|Overall Study||46
53558|NCT01475955|124075|P3|STARTED|Overall Study||47
53559|NCT01475955|124076|P2|STARTED|Overall Study||48
53560|NCT01475955|124077|P1|STARTED|Overall Study||48
53561|NCT01475851|124436|P2|NOT COMPLETED|Overall Study||0
53562|NCT01475851|124437|P1|NOT COMPLETED|Overall Study||1
53563|NCT01475851|124436|P2|COMPLETED|Overall Study||21
53564|NCT01475851|124437|P1|COMPLETED|Overall Study||12
53565|NCT01475851|124436|P2|STARTED|Overall Study||21
53566|NCT01475851|124437|P1|STARTED|Overall Study||13
53567|NCT01475838|124465|P2|NOT COMPLETED|Extension Phase||0
53568|NCT01475838|124466|P1|NOT COMPLETED|Extension Phase||1
53569|NCT01475838|124465|P2|COMPLETED|Extension Phase||20
53570|NCT01475838|124466|P1|COMPLETED|Extension Phase||41
53571|NCT01475838|124465|P2|STARTED|Extension Phase||20
53572|NCT01475838|124466|P1|STARTED|Extension Phase||42
53573|NCT01475838|124465|P2|NOT COMPLETED|Randomized Phase||36
53574|NCT01475838|124466|P1|NOT COMPLETED|Randomized Phase||30
53575|NCT01475838|124465|P2|COMPLETED|Randomized Phase||109
53576|NCT01475838|124466|P1|COMPLETED|Randomized Phase||263
53577|NCT01475838|124465|P2|STARTED|Randomized Phase||145
53578|NCT01475838|124466|P1|STARTED|Randomized Phase||293
53579|NCT01475487|124481|P2|NOT COMPLETED|Overall Study||1
53580|NCT01475487|124482|P1|NOT COMPLETED|Overall Study||2
53581|NCT01475487|124481|P2|COMPLETED|Overall Study||24
53582|NCT01475487|124482|P1|COMPLETED|Overall Study||23
53583|NCT01475487|124481|P2|STARTED|Overall Study||25
53584|NCT01475487|124482|P1|STARTED|Overall Study||25
53585|NCT01475474|124494|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
53586|NCT01475474|124494|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
53587|NCT01475474|124494|P1|STARTED|Return to Baseline Period - 4 Weeks||73
53588|NCT01475474|124494|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
53589|NCT01475474|124494|P1|COMPLETED|Treatment Period - 12 Weeks||73
53590|NCT01475474|124494|P1|STARTED|Treatment Period - 12 Weeks||91
53591|NCT01475474|124494|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
53592|NCT01475474|124494|P1|COMPLETED|Baseline Period - 4 Weeks||91
53593|NCT01475474|124494|P1|STARTED|Baseline Period - 4 Weeks||97
53594|NCT01475461|124505|P7|NOT COMPLETED|Treatment Period||2
53595|NCT01475461|124506|P6|NOT COMPLETED|Treatment Period||5
53596|NCT01475461|124507|P5|NOT COMPLETED|Treatment Period||4
53597|NCT01475461|124508|P4|NOT COMPLETED|Treatment Period||8
53598|NCT01475461|124509|P3|NOT COMPLETED|Treatment Period||4
53599|NCT01475461|124510|P2|NOT COMPLETED|Treatment Period||9
53600|NCT01475461|124511|P1|NOT COMPLETED|Treatment Period||0
53601|NCT01475461|124505|P7|COMPLETED|Treatment Period||53
53602|NCT01475461|124506|P6|COMPLETED|Treatment Period||51
53603|NCT01475461|124507|P5|COMPLETED|Treatment Period||52
53604|NCT01475461|124508|P4|COMPLETED|Treatment Period||46
53605|NCT01475461|124509|P3|COMPLETED|Treatment Period||53
53606|NCT01475461|124510|P2|COMPLETED|Treatment Period||48
53607|NCT01475461|124511|P1|COMPLETED|Treatment Period||0
53608|NCT01475461|124505|P7|STARTED|Treatment Period||55
53609|NCT01475461|124506|P6|STARTED|Treatment Period||56
53610|NCT01475461|124507|P5|STARTED|Treatment Period||56
53611|NCT01475461|124508|P4|STARTED|Treatment Period||54
53612|NCT01475461|124509|P3|STARTED|Treatment Period||57
53613|NCT01475461|124510|P2|STARTED|Treatment Period||57
53614|NCT01475461|124511|P1|STARTED|Treatment Period||0
53615|NCT01475461|124505|P7|NOT COMPLETED|Run-in Period||0
53616|NCT01475461|124506|P6|NOT COMPLETED|Run-in Period||0
53617|NCT01475461|124507|P5|NOT COMPLETED|Run-in Period||0
53618|NCT01475461|124508|P4|NOT COMPLETED|Run-in Period||0
53619|NCT01475461|124509|P3|NOT COMPLETED|Run-in Period||0
53620|NCT01475461|124510|P2|NOT COMPLETED|Run-in Period||0
53621|NCT01475461|124511|P1|NOT COMPLETED|Run-in Period||41
53622|NCT01475461|124505|P7|COMPLETED|Run-in Period||0
53623|NCT01475461|124506|P6|COMPLETED|Run-in Period||0
53624|NCT01475461|124507|P5|COMPLETED|Run-in Period||0
53625|NCT01475461|124508|P4|COMPLETED|Run-in Period||0
53626|NCT01475461|124509|P3|COMPLETED|Run-in Period||0
53627|NCT01475461|124510|P2|COMPLETED|Run-in Period||0
53628|NCT01475461|124511|P1|COMPLETED|Run-in Period||335
53629|NCT01475461|124505|P7|STARTED|Run-in Period||0
53630|NCT01475461|124506|P6|STARTED|Run-in Period||0
53631|NCT01475461|124507|P5|STARTED|Run-in Period||0
53632|NCT01475461|124508|P4|STARTED|Run-in Period||0
53633|NCT01475461|124509|P3|STARTED|Run-in Period||0
53634|NCT01475461|124510|P2|STARTED|Run-in Period||0
53635|NCT01475461|124511|P1|STARTED|Run-in Period||376
53636|NCT01475253|124592|P4|NOT COMPLETED|Open Label Extension||0
53637|NCT01475253|124593|P3|NOT COMPLETED|Open Label Extension||0
53638|NCT01475253|124594|P2|NOT COMPLETED|Open Label Extension||0
53639|NCT01475253|124595|P1|NOT COMPLETED|Open Label Extension||0
53640|NCT01475253|124592|P4|COMPLETED|Open Label Extension||56
53641|NCT01475253|124593|P3|COMPLETED|Open Label Extension||0
53642|NCT01475253|124594|P2|COMPLETED|Open Label Extension||0
53643|NCT01475253|124595|P1|COMPLETED|Open Label Extension||0
53644|NCT01475253|124592|P4|STARTED|Open Label Extension||56
53645|NCT01475253|124593|P3|STARTED|Open Label Extension||0
53646|NCT01475253|124594|P2|STARTED|Open Label Extension||0
53647|NCT01475253|124595|P1|STARTED|Open Label Extension||0
53648|NCT01475253|124592|P4|NOT COMPLETED|Randomized, Blinded Study||0
53649|NCT01475253|124593|P3|NOT COMPLETED|Randomized, Blinded Study||0
53650|NCT01475253|124594|P2|NOT COMPLETED|Randomized, Blinded Study||1
53651|NCT01475253|124595|P1|NOT COMPLETED|Randomized, Blinded Study||2
53652|NCT01475253|124592|P4|COMPLETED|Randomized, Blinded Study||0
53653|NCT01475253|124593|P3|COMPLETED|Randomized, Blinded Study||11
53654|NCT01475253|124594|P2|COMPLETED|Randomized, Blinded Study||45
53655|NCT01475253|124595|P1|COMPLETED|Randomized, Blinded Study||45
53656|NCT01475253|124592|P4|STARTED|Randomized, Blinded Study||0
53657|NCT01475253|124593|P3|STARTED|Randomized, Blinded Study||11
53658|NCT01475253|124594|P2|STARTED|Randomized, Blinded Study||46
53659|NCT01475253|124595|P1|STARTED|Randomized, Blinded Study||47
53660|NCT01475214|124624|P3|NOT COMPLETED|Overall Study||2
53661|NCT01475214|124625|P2|NOT COMPLETED|Overall Study||4
53662|NCT01475214|124626|P1|NOT COMPLETED|Overall Study||5
53663|NCT01475214|124624|P3|COMPLETED|Overall Study||79
53664|NCT01475214|124625|P2|COMPLETED|Overall Study||75
53665|NCT01475214|124626|P1|COMPLETED|Overall Study||79
53666|NCT01475214|124624|P3|STARTED|Overall Study||81
53667|NCT01475214|124625|P2|STARTED|Overall Study||79
53668|NCT01475214|124626|P1|STARTED|Overall Study||84
53669|NCT01475175|124637|P1|NOT COMPLETED|Overall Study||0
53670|NCT01475175|124637|P1|COMPLETED|Overall Study||12
53671|NCT01475175|124637|P1|STARTED|Overall Study||12
53672|NCT01475097|124651|P2|NOT COMPLETED|Overall Study||1
53673|NCT01475097|124652|P1|NOT COMPLETED|Overall Study||1
53674|NCT01475097|124651|P2|COMPLETED|Overall Study||126
53675|NCT01475097|124652|P1|COMPLETED|Overall Study||127
53676|NCT01475097|124651|P2|STARTED|Overall Study||127
53677|NCT01475097|124652|P1|STARTED|Overall Study||128
53678|NCT01475071|124660|P1|NOT COMPLETED|Overall Study||8
53679|NCT01475071|124660|P1|COMPLETED|Overall Study||92
53680|NCT01475071|124660|P1|STARTED|Overall Study||100
53681|NCT01474993|124670|P2|NOT COMPLETED|Overall Study||3
53682|NCT01474993|124671|P1|NOT COMPLETED|Overall Study||1
53683|NCT01474993|124670|P2|COMPLETED|Overall Study||26
53684|NCT01474993|124671|P1|COMPLETED|Overall Study||14
53685|NCT01474993|124670|P2|STARTED|Overall Study||29
53686|NCT01474993|124671|P1|STARTED|Overall Study||15
53687|NCT01474915|124697|P2|NOT COMPLETED|Overall Study||10
53688|NCT01474915|124698|P1|NOT COMPLETED|Overall Study||10
53689|NCT01474915|124697|P2|COMPLETED|Overall Study||51
53690|NCT01474915|124698|P1|COMPLETED|Overall Study||50
53691|NCT01474915|124697|P2|STARTED|Overall Study||61
53692|NCT01474915|124698|P1|STARTED|Overall Study||60
53693|NCT01474876|124709|P3|NOT COMPLETED|Overall Study||0
53694|NCT01474876|124710|P2|NOT COMPLETED|Overall Study||23
53695|NCT01474876|124711|P1|NOT COMPLETED|Overall Study||66
53696|NCT01474876|124709|P3|COMPLETED|Overall Study||1
53697|NCT01474876|124710|P2|COMPLETED|Overall Study||128
53698|NCT01474876|124711|P1|COMPLETED|Overall Study||337
53699|NCT01474876|124709|P3|STARTED|Overall Study||1
53700|NCT01474876|124710|P2|STARTED|Overall Study||151
53701|NCT01474876|124711|P1|STARTED|Overall Study||403
53702|NCT01474772|124744|P2|NOT COMPLETED|Follow-up||1
53703|NCT01474772|124745|P1|NOT COMPLETED|Follow-up||0
53704|NCT01474772|124744|P2|COMPLETED|Follow-up||86
53705|NCT01474772|124745|P1|COMPLETED|Follow-up||77
53706|NCT01474772|124744|P2|STARTED|Follow-up||87
53707|NCT01474772|124745|P1|STARTED|Follow-up||77
53708|NCT01474772|124744|P2|NOT COMPLETED|Period 2||10
53709|NCT01474772|124745|P1|NOT COMPLETED|Period 2||9
53710|NCT01474772|124744|P2|COMPLETED|Period 2||87
53711|NCT01474772|124745|P1|COMPLETED|Period 2||77
53712|NCT01474772|124744|P2|STARTED|Period 2||97
53713|NCT01474772|124745|P1|STARTED|Period 2||86
53714|NCT01474772|124744|P2|NOT COMPLETED|Washout||2
53715|NCT01474772|124745|P1|NOT COMPLETED|Washout||3
53716|NCT01474772|124744|P2|COMPLETED|Washout||97
53717|NCT01474772|124745|P1|COMPLETED|Washout||86
53718|NCT01474772|124744|P2|STARTED|Washout||99
53719|NCT01474772|124745|P1|STARTED|Washout||89
53720|NCT01474772|124744|P2|NOT COMPLETED|Period 1||3
53721|NCT01474772|124745|P1|NOT COMPLETED|Period 1||12
53722|NCT01474772|124744|P2|COMPLETED|Period 1||99
53723|NCT01474772|124745|P1|COMPLETED|Period 1||89
53724|NCT01474772|124744|P2|STARTED|Period 1|STARTED=treated|102
53725|NCT01474772|124745|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
53726|NCT01474551|124793|P1|NOT COMPLETED|Overall Study||1
53727|NCT01474551|124793|P1|COMPLETED|Overall Study||1
53728|NCT01474551|124793|P1|STARTED|Overall Study||2
53729|NCT01474538|124799|P2|NOT COMPLETED|Treatment Period 2||2
53730|NCT01474538|124800|P1|NOT COMPLETED|Treatment Period 2||6
53731|NCT01474538|124799|P2|COMPLETED|Treatment Period 2||56
53732|NCT01474538|124800|P1|COMPLETED|Treatment Period 2||51
53733|NCT01474538|124799|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
53734|NCT01474538|124800|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
53735|NCT01474538|124799|P2|STARTED|Treatment Period 2||58
53736|NCT01474538|124800|P1|STARTED|Treatment Period 2||57
53737|NCT01474538|124799|P2|NOT COMPLETED|Treatment Period 1||4
53738|NCT01474538|124800|P1|NOT COMPLETED|Treatment Period 1||3
53739|NCT01474538|124799|P2|COMPLETED|Treatment Period 1||58
53740|NCT01474538|124800|P1|COMPLETED|Treatment Period 1||57
53741|NCT01474538|124799|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
53742|NCT01474538|124800|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
53743|NCT01474538|124799|P2|STARTED|Treatment Period 1||62
53744|NCT01474538|124800|P1|STARTED|Treatment Period 1||60
53745|NCT01474512|124817|P10|NOT COMPLETED|Maintenance Period||18
53746|NCT01474512|124818|P9|NOT COMPLETED|Maintenance Period||16
53747|NCT01474512|124819|P8|NOT COMPLETED|Maintenance Period||41
53748|NCT01474512|124820|P7|NOT COMPLETED|Maintenance Period||10
53749|NCT01474512|124821|P6|NOT COMPLETED|Maintenance Period||52
53750|NCT01474512|124822|P5|NOT COMPLETED|Maintenance Period||119
53751|NCT01474512|124823|P4|NOT COMPLETED|Maintenance Period||202
53752|NCT01474512|124824|P3|NOT COMPLETED|Maintenance Period||0
53753|NCT01474512|124825|P2|NOT COMPLETED|Maintenance Period||0
53754|NCT01474512|124826|P1|NOT COMPLETED|Maintenance Period||0
53755|NCT01474512|124817|P10|COMPLETED|Maintenance Period||44
53756|NCT01474512|124818|P9|COMPLETED|Maintenance Period||62
53757|NCT01474512|124819|P8|COMPLETED|Maintenance Period||350
53758|NCT01474512|124820|P7|COMPLETED|Maintenance Period||6
53759|NCT01474512|124821|P6|COMPLETED|Maintenance Period||177
53760|NCT01474512|124822|P5|COMPLETED|Maintenance Period||108
53761|NCT01474512|124823|P4|COMPLETED|Maintenance Period||24
53762|NCT01474512|124824|P3|COMPLETED|Maintenance Period||0
53763|NCT01474512|124825|P2|COMPLETED|Maintenance Period||0
53764|NCT01474512|124826|P1|COMPLETED|Maintenance Period||0
53765|NCT01474512|124817|P10|Received Study Drug|Maintenance Period||62
53766|NCT01474512|124818|P9|Received Study Drug|Maintenance Period||78
53767|NCT01474512|124819|P8|Received Study Drug|Maintenance Period||391
53768|NCT01474512|124820|P7|Received Study Drug|Maintenance Period||16
53769|NCT01474512|124821|P6|Received Study Drug|Maintenance Period||229
53770|NCT01474512|124822|P5|Received Study Drug|Maintenance Period||227
53771|NCT01474512|124823|P4|Received Study Drug|Maintenance Period||226
53772|NCT01474512|124824|P3|Received Study Drug|Maintenance Period||0
53773|NCT01474512|124825|P2|Received Study Drug|Maintenance Period||0
53774|NCT01474512|124826|P1|Received Study Drug|Maintenance Period||0
53775|NCT01474512|124817|P10|STARTED|Maintenance Period||62
53776|NCT01474512|124818|P9|STARTED|Maintenance Period||78
53777|NCT01474512|124819|P8|STARTED|Maintenance Period||391
53778|NCT01474512|124820|P7|STARTED|Maintenance Period||16
53779|NCT01474512|124821|P6|STARTED|Maintenance Period||229
53780|NCT01474512|124822|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
53781|NCT01474512|124823|P4|STARTED|Maintenance Period||226
53782|NCT01474512|124824|P3|STARTED|Maintenance Period||0
53783|NCT01474512|124825|P2|STARTED|Maintenance Period||0
53784|NCT01474512|124826|P1|STARTED|Maintenance Period||0
53785|NCT01474512|124817|P10|NOT COMPLETED|Induction Period||0
53786|NCT01474512|124818|P9|NOT COMPLETED|Induction Period||0
53787|NCT01474512|124819|P8|NOT COMPLETED|Induction Period||0
53788|NCT01474512|124820|P7|NOT COMPLETED|Induction Period||0
53789|NCT01474512|124821|P6|NOT COMPLETED|Induction Period||0
53790|NCT01474512|124822|P5|NOT COMPLETED|Induction Period||0
53791|NCT01474512|124823|P4|NOT COMPLETED|Induction Period||0
53792|NCT01474512|124824|P3|NOT COMPLETED|Induction Period||18
53793|NCT01474512|124825|P2|NOT COMPLETED|Induction Period||24
53794|NCT01474512|124826|P1|NOT COMPLETED|Induction Period||24
53795|NCT01474512|124817|P10|COMPLETED|Induction Period||0
53796|NCT01474512|124818|P9|COMPLETED|Induction Period||0
53797|NCT01474512|124819|P8|COMPLETED|Induction Period||0
53798|NCT01474512|124820|P7|COMPLETED|Induction Period||0
53799|NCT01474512|124821|P6|COMPLETED|Induction Period||0
53800|NCT01474512|124822|P5|COMPLETED|Induction Period||0
53801|NCT01474512|124823|P4|COMPLETED|Induction Period||0
53802|NCT01474512|124824|P3|COMPLETED|Induction Period||415
53803|NCT01474512|124825|P2|COMPLETED|Induction Period||408
53804|NCT01474512|124826|P1|COMPLETED|Induction Period||407
53805|NCT01474512|124817|P10|Received Study Drug|Induction Period||0
53806|NCT01474512|124818|P9|Received Study Drug|Induction Period||0
53807|NCT01474512|124819|P8|Received Study Drug|Induction Period||0
53808|NCT01474512|124820|P7|Received Study Drug|Induction Period||0
53809|NCT01474512|124821|P6|Received Study Drug|Induction Period||0
53810|NCT01474512|124822|P5|Received Study Drug|Induction Period||0
53811|NCT01474512|124823|P4|Received Study Drug|Induction Period||0
53812|NCT01474512|124824|P3|Received Study Drug|Induction Period||433
53813|NCT01474512|124825|P2|Received Study Drug|Induction Period||432
53814|NCT01474512|124826|P1|Received Study Drug|Induction Period||431
53815|NCT01474512|124817|P10|STARTED|Induction Period||0
53816|NCT01474512|124818|P9|STARTED|Induction Period||0
53817|NCT01474512|124819|P8|STARTED|Induction Period||0
53818|NCT01474512|124820|P7|STARTED|Induction Period||0
53819|NCT01474512|124821|P6|STARTED|Induction Period||0
53820|NCT01474512|124822|P5|STARTED|Induction Period||0
53821|NCT01474512|124823|P4|STARTED|Induction Period||0
53822|NCT01474512|124824|P3|STARTED|Induction Period||433
53823|NCT01474512|124825|P2|STARTED|Induction Period||432
53824|NCT01474512|124826|P1|STARTED|Induction Period||431
53825|NCT01474434|124895|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
53826|NCT01474434|124896|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
53827|NCT01474434|124897|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
53828|NCT01474434|124898|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
53829|NCT01474434|124895|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
53830|NCT01474434|124896|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
53831|NCT01474434|124897|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
53832|NCT01474434|124898|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
53833|NCT01474434|124895|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
53834|NCT01474434|124896|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
53835|NCT01474434|124897|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
53836|NCT01474434|124898|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
53837|NCT01474434|124895|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
53838|NCT01474434|124896|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
53839|NCT01474434|124897|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
53840|NCT01474434|124898|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
53841|NCT01474434|124895|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
53842|NCT01474434|124896|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
53843|NCT01474434|124897|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
53844|NCT01474434|124898|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
53845|NCT01474434|124895|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
53846|NCT01474434|124896|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
53847|NCT01474434|124897|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
53848|NCT01474434|124898|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
53849|NCT01474317|124940|P1|NOT COMPLETED|Overall Study||2
53850|NCT01474317|124940|P1|COMPLETED|Overall Study||224
53851|NCT01474317|124940|P1|STARTED|Overall Study||226
53852|NCT01474291|124949|P1|NOT COMPLETED|Overall Study||220
53853|NCT01474291|124949|P1|COMPLETED|Overall Study||383
53854|NCT01474291|124949|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
53855|NCT01474291|124949|P1|STARTED|Overall Study||603
53856|NCT01474239|124993|P2|NOT COMPLETED|Overall Study||32
53857|NCT01474239|124994|P1|NOT COMPLETED|Overall Study||59
53858|NCT01474239|124993|P2|COMPLETED|Overall Study||0
53859|NCT01474239|124994|P1|COMPLETED|Overall Study||0
53860|NCT01474239|124993|P2|STARTED|Overall Study||32
53861|NCT01474239|124994|P1|STARTED|Overall Study||59
53862|NCT01474213|125032|P2|NOT COMPLETED|Overall Study||0
53863|NCT01474213|125033|P1|NOT COMPLETED|Overall Study||0
53864|NCT01474213|125032|P2|COMPLETED|Overall Study||20
53865|NCT01474213|125033|P1|COMPLETED|Overall Study||20
53866|NCT01474213|125032|P2|STARTED|Overall Study||20
53867|NCT01474213|125033|P1|STARTED|Overall Study||20
53868|NCT01474200|125057|P2|NOT COMPLETED|Overall Study||30
53869|NCT01474200|125058|P1|NOT COMPLETED|Overall Study||29
53870|NCT01474200|125057|P2|COMPLETED|Overall Study||84
53871|NCT01474200|125058|P1|COMPLETED|Overall Study||81
53872|NCT01474200|125057|P2|STARTED|Overall Study||114
53873|NCT01474200|125058|P1|STARTED|Overall Study||110
53874|NCT01474122|125111|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
53875|NCT01474122|125112|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
53876|NCT01474122|125113|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
53877|NCT01474122|125111|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
53878|NCT01474122|125112|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
53879|NCT01474122|125113|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
53880|NCT01474122|125111|P3|STARTED|Period 2: Week 16 to End of Study||88
53881|NCT01474122|125112|P2|STARTED|Period 2: Week 16 to End of Study||86
53882|NCT01474122|125113|P1|STARTED|Period 2: Week 16 to End of Study||87
53883|NCT01474122|125111|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
53884|NCT01474122|125112|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
53885|NCT01474122|125113|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
53886|NCT01474122|125111|P3|COMPLETED|Period 1: Baseline to Week 16||88
53887|NCT01474122|125112|P2|COMPLETED|Period 1: Baseline to Week 16||86
53888|NCT01474122|125113|P1|COMPLETED|Period 1: Baseline to Week 16||87
53889|NCT01474122|125111|P3|STARTED|Period 1: Baseline to Week 16||89
53890|NCT01474122|125112|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
53891|NCT01474122|125113|P1|STARTED|Period 1: Baseline to Week 16||88
53892|NCT01474109|125139|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
53893|NCT01474109|125140|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
53894|NCT01474109|125141|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
53895|NCT01474109|125139|P3|COMPLETED|Period 2: Week 16 to End of Study||83
53896|NCT01474109|125140|P2|COMPLETED|Period 2: Week 16 to End of Study||73
53897|NCT01474109|125141|P1|COMPLETED|Period 2: Week 16 to End of Study||70
53898|NCT01474109|125139|P3|STARTED|Period 2: Week 16 to End of Study||95
53899|NCT01474109|125140|P2|STARTED|Period 2: Week 16 to End of Study||91
53900|NCT01474109|125141|P1|STARTED|Period 2: Week 16 to End of Study||88
53901|NCT01474109|125139|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
53902|NCT01474109|125140|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
53903|NCT01474109|125141|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
53904|NCT01474109|125139|P3|COMPLETED|Period 1: Baseline to Week 16||95
53905|NCT01474109|125140|P2|COMPLETED|Period 1: Baseline to Week 16||91
53906|NCT01474109|125141|P1|COMPLETED|Period 1: Baseline to Week 16||88
53907|NCT01474109|125139|P3|STARTED|Period 1: Baseline to Week 16||97
53908|NCT01474109|125140|P2|STARTED|Period 1: Baseline to Week 16||97
53909|NCT01474109|125141|P1|STARTED|Period 1: Baseline to Week 16||95
53910|NCT01473992|125166|P3|NOT COMPLETED|Overall Study||0
53911|NCT01473992|125167|P2|NOT COMPLETED|Overall Study||0
53912|NCT01473992|125168|P1|NOT COMPLETED|Overall Study||0
53913|NCT01473992|125166|P3|COMPLETED|Overall Study||5
53914|NCT01473992|125167|P2|COMPLETED|Overall Study||10
53915|NCT01473992|125168|P1|COMPLETED|Overall Study||10
53916|NCT01473992|125166|P3|STARTED|Overall Study||5
53917|NCT01473992|125167|P2|STARTED|Overall Study||10
53918|NCT01473992|125168|P1|STARTED|Overall Study||10
53919|NCT01473953|125188|P5|NOT COMPLETED|Overall Study||0
53920|NCT01473953|125189|P4|NOT COMPLETED|Overall Study||0
53921|NCT01473953|125190|P3|NOT COMPLETED|Overall Study||0
53922|NCT01473953|125191|P2|NOT COMPLETED|Overall Study||0
53923|NCT01473953|125192|P1|NOT COMPLETED|Overall Study||1
53924|NCT01473953|125188|P5|COMPLETED|Overall Study||8
53925|NCT01473953|125189|P4|COMPLETED|Overall Study||5
53926|NCT01473953|125190|P3|COMPLETED|Overall Study||6
53927|NCT01473953|125191|P2|COMPLETED|Overall Study||6
53928|NCT01473953|125192|P1|COMPLETED|Overall Study||5
53929|NCT01473953|125188|P5|STARTED|Overall Study||8
53930|NCT01473953|125189|P4|STARTED|Overall Study||5
53931|NCT01473953|125190|P3|STARTED|Overall Study||6
53932|NCT01473953|125191|P2|STARTED|Overall Study||6
53933|NCT01473953|125192|P1|STARTED|Overall Study||6
53934|NCT01473836|125234|P1|NOT COMPLETED|Overall Study||6
53935|NCT01473836|125234|P1|COMPLETED|Overall Study||32
53936|NCT01473836|125234|P1|STARTED|Overall Study||38
53937|NCT01473758|125245|P4|NOT COMPLETED|Cycle 2||0
53938|NCT01473758|125246|P3|NOT COMPLETED|Cycle 2||5
53939|NCT01473758|125247|P2|NOT COMPLETED|Cycle 2||0
53940|NCT01473758|125248|P1|NOT COMPLETED|Cycle 2||0
53941|NCT01473758|125245|P4|COMPLETED|Cycle 2||4
53942|NCT01473758|125246|P3|COMPLETED|Cycle 2||5
53943|NCT01473758|125247|P2|COMPLETED|Cycle 2||0
53944|NCT01473758|125248|P1|COMPLETED|Cycle 2||0
53945|NCT01473758|125245|P4|STARTED|Cycle 2||4
53946|NCT01473758|125246|P3|STARTED|Cycle 2||10
53947|NCT01473758|125247|P2|STARTED|Cycle 2||0
53948|NCT01473758|125248|P1|STARTED|Cycle 2||0
53949|NCT01473758|125245|P4|NOT COMPLETED|Cycle 1||0
53950|NCT01473758|125246|P3|NOT COMPLETED|Cycle 1||0
53951|NCT01473758|125247|P2|NOT COMPLETED|Cycle 1||3
53952|NCT01473758|125248|P1|NOT COMPLETED|Cycle 1||11
53953|NCT01473758|125245|P4|COMPLETED|Cycle 1||0
53954|NCT01473758|125246|P3|COMPLETED|Cycle 1||0
53955|NCT01473758|125247|P2|COMPLETED|Cycle 1||40
53956|NCT01473758|125248|P1|COMPLETED|Cycle 1||27
53957|NCT01473758|125245|P4|STARTED|Cycle 1||0
53958|NCT01473758|125246|P3|STARTED|Cycle 1||0
53959|NCT01473758|125247|P2|STARTED|Cycle 1||43
53960|NCT01473758|125248|P1|STARTED|Cycle 1||38
53961|NCT01473745|125372|P2|NOT COMPLETED|Overall Study||0
53962|NCT01473745|125373|P1|NOT COMPLETED|Overall Study||0
53963|NCT01473745|125372|P2|COMPLETED|Overall Study||24
53964|NCT01473745|125373|P1|COMPLETED|Overall Study||24
53965|NCT01473745|125372|P2|STARTED|Overall Study||24
53966|NCT01473745|125373|P1|STARTED|Overall Study||24
53967|NCT01473602|125385|P2|NOT COMPLETED|Overall Study||8
53968|NCT01473602|125386|P1|NOT COMPLETED|Overall Study||8
53969|NCT01473602|125385|P2|COMPLETED|Overall Study||13
53970|NCT01473602|125386|P1|COMPLETED|Overall Study||10
53971|NCT01473602|125385|P2|Completed 12 Months|Overall Study||13
53972|NCT01473602|125386|P1|Completed 12 Months|Overall Study||10
53973|NCT01473602|125385|P2|Completed 6 Months|Overall Study||15
53974|NCT01473602|125386|P1|Completed 6 Months|Overall Study||12
53975|NCT01473602|125385|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
53976|NCT01473602|125386|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
53977|NCT01473602|125385|P2|STARTED|Overall Study||21
53978|NCT01473602|125386|P1|STARTED|Overall Study||18
53979|NCT01473589|125422|P2|NOT COMPLETED|Overall Study||16
53980|NCT01473589|125423|P1|NOT COMPLETED|Overall Study||11
53981|NCT01473589|125422|P2|COMPLETED|Overall Study||46
53982|NCT01473589|125423|P1|COMPLETED|Overall Study||49
53983|NCT01473589|125422|P2|Completed 12 Months|Overall Study||48
53984|NCT01473589|125423|P1|Completed 12 Months|Overall Study||49
53985|NCT01473589|125422|P2|Completed 6 Months|Overall Study||54
53986|NCT01473589|125423|P1|Completed 6 Months|Overall Study||51
53987|NCT01473589|125422|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
53988|NCT01473589|125423|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
53989|NCT01473589|125422|P2|STARTED|Overall Study||62
53990|NCT01473589|125423|P1|STARTED|Overall Study||60
53991|NCT01473563|125457|P1|NOT COMPLETED|Overall Study||1
53992|NCT01473563|125457|P1|COMPLETED|Overall Study||51
53993|NCT01473563|125457|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
53994|NCT01473563|125457|P1|STARTED|Overall Study||52
53995|NCT01473524|125479|P3|NOT COMPLETED|Overall Study||3
53996|NCT01473524|125480|P2|NOT COMPLETED|Overall Study||9
53997|NCT01473524|125481|P1|NOT COMPLETED|Overall Study||7
53998|NCT01473524|125479|P3|COMPLETED|Overall Study||70
53999|NCT01473524|125480|P2|COMPLETED|Overall Study||64
54000|NCT01473524|125481|P1|COMPLETED|Overall Study||64
54001|NCT01473524|125479|P3|STARTED|Overall Study||73
54002|NCT01473524|125480|P2|STARTED|Overall Study||73
54003|NCT01473524|125481|P1|STARTED|Overall Study||71
54004|NCT01473394|125514|P2|NOT COMPLETED|Overall Study||43
54005|NCT01473394|125515|P1|NOT COMPLETED|Overall Study||45
54006|NCT01473394|125514|P2|COMPLETED|Overall Study||212
54007|NCT01473394|125515|P1|COMPLETED|Overall Study||208
54008|NCT01473394|125514|P2|STARTED|Overall Study||255
54009|NCT01473394|125515|P1|STARTED|Overall Study||253
54010|NCT01473381|125529|P4|NOT COMPLETED|Overall Study||89
54011|NCT01473381|125530|P3|NOT COMPLETED|Overall Study||102
54012|NCT01473381|125531|P2|NOT COMPLETED|Overall Study||93
54013|NCT01473381|125532|P1|NOT COMPLETED|Overall Study||80
54014|NCT01473381|125529|P4|COMPLETED|Overall Study||200
54015|NCT01473381|125530|P3|COMPLETED|Overall Study||189
54016|NCT01473381|125531|P2|COMPLETED|Overall Study||199
54017|NCT01473381|125532|P1|COMPLETED|Overall Study||210
54018|NCT01473381|125529|P4|Safety Population|Overall Study||282
54019|NCT01473381|125530|P3|Safety Population|Overall Study||287
54020|NCT01473381|125531|P2|Safety Population|Overall Study||288
54021|NCT01473381|125532|P1|Safety Population|Overall Study||281
54022|NCT01473381|125529|P4|STARTED|Overall Study||289
54023|NCT01473381|125530|P3|STARTED|Overall Study||291
54024|NCT01473381|125531|P2|STARTED|Overall Study||292
54025|NCT01473381|125532|P1|STARTED|Overall Study||290
54026|NCT01473368|125554|P4|NOT COMPLETED|Overall Study||0
54027|NCT01473368|125555|P3|NOT COMPLETED|Overall Study||3
54028|NCT01473368|125556|P2|NOT COMPLETED|Overall Study||0
54029|NCT01473368|125557|P1|NOT COMPLETED|Overall Study||1
54030|NCT01473368|125554|P4|COMPLETED|Overall Study||12
54031|NCT01473368|125555|P3|COMPLETED|Overall Study||12
54032|NCT01473368|125556|P2|COMPLETED|Overall Study||12
54033|NCT01473368|125557|P1|COMPLETED|Overall Study||13
54034|NCT01473368|125554|P4|STARTED|Overall Study||12
54035|NCT01473368|125555|P3|STARTED|Overall Study||15
54036|NCT01473368|125556|P2|STARTED|Overall Study||12
54037|NCT01473368|125557|P1|STARTED|Overall Study||14
54038|NCT01473160|125594|P1|NOT COMPLETED|Overall Study||0
54039|NCT01473160|125594|P1|COMPLETED|Overall Study||9
54040|NCT01473160|125594|P1|STARTED|Overall Study||9
54041|NCT01472939|125616|P4|NOT COMPLETED|Overall Study||20
54042|NCT01472939|125617|P3|NOT COMPLETED|Overall Study||11
54043|NCT01472939|125618|P2|NOT COMPLETED|Overall Study||14
54044|NCT01472939|125619|P1|NOT COMPLETED|Overall Study||20
54045|NCT01472939|125616|P4|COMPLETED|Overall Study||99
54046|NCT01472939|125617|P3|COMPLETED|Overall Study||108
54047|NCT01472939|125618|P2|COMPLETED|Overall Study||105
54048|NCT01472939|125619|P1|COMPLETED|Overall Study||103
54049|NCT01472939|125616|P4|STARTED|Overall Study||119
54050|NCT01472939|125617|P3|STARTED|Overall Study||119
54051|NCT01472939|125618|P2|STARTED|Overall Study||119
54052|NCT01472939|125619|P1|STARTED|Overall Study||123
54053|NCT01472874|125646|P1|NOT COMPLETED|Overall Study||0
54054|NCT01472874|125646|P1|COMPLETED|Overall Study||8
54055|NCT01472874|125646|P1|STARTED|Overall Study||8
54056|NCT01472835|125663|P2|NOT COMPLETED|Overall Study||0
54057|NCT01472835|125664|P1|NOT COMPLETED|Overall Study||2
54058|NCT01472835|125663|P2|COMPLETED|Overall Study||36
54059|NCT01472835|125664|P1|COMPLETED|Overall Study||35
54060|NCT01472835|125663|P2|STARTED|Overall Study||36
54061|NCT01472835|125664|P1|STARTED|Overall Study||37
54062|NCT01472822|125680|P2|NOT COMPLETED|Overall Study||2
54063|NCT01472822|125681|P1|NOT COMPLETED|Overall Study||2
54064|NCT01472822|125680|P2|COMPLETED|Overall Study||28
54065|NCT01472822|125681|P1|COMPLETED|Overall Study||28
54066|NCT01472822|125680|P2|STARTED|Overall Study||30
54067|NCT01472822|125681|P1|STARTED|Overall Study||30
54068|NCT01472432|125697|P2|NOT COMPLETED|Overall Study||0
54069|NCT01472432|125698|P1|NOT COMPLETED|Overall Study||0
54070|NCT01472432|125697|P2|COMPLETED|Overall Study||53
54071|NCT01472432|125698|P1|COMPLETED|Overall Study||53
54072|NCT01472432|125697|P2|Ulcer Reduction|Overall Study||33
54073|NCT01472432|125698|P1|Ulcer Reduction|Overall Study||13
54074|NCT01472432|125697|P2|STARTED|Overall Study||53
54075|NCT01472432|125698|P1|STARTED|Overall Study||53
54076|NCT01472380|125714|P1|NOT COMPLETED|Efavirenz and FFA||0
54077|NCT01472380|125714|P1|COMPLETED|Efavirenz and FFA||28
54078|NCT01472380|125714|P1|STARTED|Efavirenz and FFA||28
54079|NCT01472380|125714|P1|NOT COMPLETED|1 Day Period Between Dosing||1
54080|NCT01472380|125714|P1|COMPLETED|1 Day Period Between Dosing||28
54081|NCT01472380|125714|P1|STARTED|1 Day Period Between Dosing||29
54082|NCT01472380|125714|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
54083|NCT01472380|125714|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
54084|NCT01472380|125714|P1|STARTED|Fenofibric Acid (FFA) Alone||29
54085|NCT01472380|125714|P1|NOT COMPLETED|Efavirenz Alone||1
54086|NCT01472380|125714|P1|COMPLETED|Efavirenz Alone||29
54087|NCT01472380|125714|P1|STARTED|Efavirenz Alone||30
54088|NCT01472341|125725|P1|NOT COMPLETED|Overall Study||272
54089|NCT01472341|125725|P1|COMPLETED|Overall Study||235
54090|NCT01472341|125725|P1|STARTED|Overall Study||507
54091|NCT01472289|125731|P1|NOT COMPLETED|Overall Study||2
54092|NCT01472289|125731|P1|COMPLETED|Overall Study||15
54093|NCT01472289|125731|P1|STARTED|Overall Study||17
54094|NCT01472185|125743|P2|NOT COMPLETED|Overall Study||34
54095|NCT01472185|125744|P1|NOT COMPLETED|Overall Study||34
54096|NCT01472185|125743|P2|COMPLETED|Overall Study||199
54097|NCT01472185|125744|P1|COMPLETED|Overall Study||198
54098|NCT01472185|125743|P2|STARTED|Overall Study||233
54099|NCT01472185|125744|P1|STARTED|Overall Study||232
54100|NCT01471782|125764|P6|NOT COMPLETED|Overall Study||41
54101|NCT01471782|125765|P5|NOT COMPLETED|Overall Study||26
54102|NCT01471782|125766|P4|NOT COMPLETED|Overall Study||5
54103|NCT01471782|125767|P3|NOT COMPLETED|Overall Study||5
54104|NCT01471782|125768|P2|NOT COMPLETED|Overall Study||6
54105|NCT01471782|125769|P1|NOT COMPLETED|Overall Study||5
54106|NCT01471782|125764|P6|COMPLETED|Overall Study|Completed 5 cycles|3
54107|NCT01471782|125765|P5|COMPLETED|Overall Study|Completed 5 cycles|0
54108|NCT01471782|125766|P4|COMPLETED|Overall Study|Completed 5 cycles|1
54109|NCT01471782|125767|P3|COMPLETED|Overall Study|Completed 5 cycles|0
54110|NCT01471782|125768|P2|COMPLETED|Overall Study|Completed 5 cycles|1
54111|NCT01471782|125769|P1|COMPLETED|Overall Study|Completed 5 cycles|0
54112|NCT01471782|125764|P6|STARTED|Overall Study||44
54113|NCT01471782|125765|P5|STARTED|Overall Study||26
54114|NCT01471782|125766|P4|STARTED|Overall Study||6
54115|NCT01471782|125767|P3|STARTED|Overall Study||5
54116|NCT01471782|125768|P2|STARTED|Overall Study||7
54117|NCT01471782|125769|P1|STARTED|Overall Study||5
54118|NCT01471691|125823|P2|NOT COMPLETED|Overall Study||1
54119|NCT01471691|125824|P1|NOT COMPLETED|Overall Study||0
54120|NCT01471691|125823|P2|COMPLETED|Overall Study||5
54121|NCT01471691|125824|P1|COMPLETED|Overall Study||8
54122|NCT01471691|125823|P2|STARTED|Overall Study||6
54123|NCT01471691|125824|P1|STARTED|Overall Study||8
54124|NCT01471626|125830|P1|NOT COMPLETED|Overall Study||0
54125|NCT01471626|125830|P1|COMPLETED|Overall Study||21
54126|NCT01471626|125830|P1|STARTED|Overall Study||21
54127|NCT01471574|125838|P4|NOT COMPLETED|Follow-up Period||3
54128|NCT01471574|125839|P3|NOT COMPLETED|Follow-up Period||7
54129|NCT01471574|125840|P2|NOT COMPLETED|Follow-up Period||2
54130|NCT01471574|125841|P1|NOT COMPLETED|Follow-up Period||7
54131|NCT01471574|125838|P4|COMPLETED|Follow-up Period||21
54132|NCT01471574|125839|P3|COMPLETED|Follow-up Period||95
54133|NCT01471574|125840|P2|COMPLETED|Follow-up Period||32
54134|NCT01471574|125841|P1|COMPLETED|Follow-up Period||114
54135|NCT01471574|125838|P4|STARTED|Follow-up Period||24
54136|NCT01471574|125839|P3|STARTED|Follow-up Period||102
54137|NCT01471574|125840|P2|STARTED|Follow-up Period||34
54138|NCT01471574|125841|P1|STARTED|Follow-up Period||121
54139|NCT01471574|125838|P4|NOT COMPLETED|Treatment Period||3
54140|NCT01471574|125839|P3|NOT COMPLETED|Treatment Period||24
54141|NCT01471574|125840|P2|NOT COMPLETED|Treatment Period||10
54142|NCT01471574|125841|P1|NOT COMPLETED|Treatment Period||31
54143|NCT01471574|125838|P4|COMPLETED|Treatment Period||21
54144|NCT01471574|125839|P3|COMPLETED|Treatment Period||82
54145|NCT01471574|125840|P2|COMPLETED|Treatment Period||29
54146|NCT01471574|125841|P1|COMPLETED|Treatment Period||101
54147|NCT01471574|125838|P4|STARTED|Treatment Period||24
54148|NCT01471574|125839|P3|STARTED|Treatment Period||106
54149|NCT01471574|125840|P2|STARTED|Treatment Period||39
54150|NCT01471574|125841|P1|STARTED|Treatment Period||132
54151|NCT01471379|125873|P3|NOT COMPLETED|Overall Study||0
54152|NCT01471379|125874|P2|NOT COMPLETED|Overall Study||1
54153|NCT01471379|125875|P1|NOT COMPLETED|Overall Study||1
54154|NCT01471379|125873|P3|COMPLETED|Overall Study||0
54155|NCT01471379|125874|P2|COMPLETED|Overall Study||0
54156|NCT01471379|125875|P1|COMPLETED|Overall Study||0
54157|NCT01471379|125873|P3|STARTED|Overall Study||0
54158|NCT01471379|125874|P2|STARTED|Overall Study||1
54159|NCT01471379|125875|P1|STARTED|Overall Study||1
54160|NCT01471197|125897|P2|NOT COMPLETED|Overall Study||2
54161|NCT01471197|125898|P1|NOT COMPLETED|Overall Study||6
54162|NCT01471197|125897|P2|COMPLETED|Overall Study||0
54163|NCT01471197|125898|P1|COMPLETED|Overall Study||0
54164|NCT01471197|125897|P2|STARTED|Overall Study||2
54165|NCT01471197|125898|P1|STARTED|Overall Study||6
54166|NCT01471171|125908|P2|NOT COMPLETED|Treatment Period 2||0
54167|NCT01471171|125909|P1|NOT COMPLETED|Treatment Period 2||1
54168|NCT01471171|125908|P2|COMPLETED|Treatment Period 2||54
54169|NCT01471171|125909|P1|COMPLETED|Treatment Period 2||52
54170|NCT01471171|125908|P2|STARTED|Treatment Period 2||54
54171|NCT01471171|125909|P1|STARTED|Treatment Period 2||53
54172|NCT01471171|125908|P2|NOT COMPLETED|Treatment Period 1||1
54173|NCT01471171|125909|P1|NOT COMPLETED|Treatment Period 1||4
54174|NCT01471171|125908|P2|COMPLETED|Treatment Period 1||54
54175|NCT01471171|125909|P1|COMPLETED|Treatment Period 1||53
54176|NCT01471171|125908|P2|STARTED|Treatment Period 1||55
54177|NCT01471171|125909|P1|STARTED|Treatment Period 1||57
54178|NCT01471041|125919|P1|NOT COMPLETED|Overall Study||7
54179|NCT01471041|125919|P1|COMPLETED|Overall Study||47
54180|NCT01471041|125919|P1|STARTED|Overall Study||54
54181|NCT01471015|125927|P3|NOT COMPLETED|Overall Study||1
54182|NCT01471015|125928|P2|NOT COMPLETED|Overall Study||1
54183|NCT01471015|125929|P1|NOT COMPLETED|Overall Study||0
54184|NCT01471015|125927|P3|COMPLETED|Overall Study||9
54185|NCT01471015|125928|P2|COMPLETED|Overall Study||9
54186|NCT01471015|125929|P1|COMPLETED|Overall Study||10
54187|NCT01471015|125927|P3|STARTED|Overall Study||10
54188|NCT01471015|125928|P2|STARTED|Overall Study||10
54189|NCT01471015|125929|P1|STARTED|Overall Study||10
54190|NCT01470859|125943|P2|NOT COMPLETED|Overall Study||0
54191|NCT01470859|125944|P1|NOT COMPLETED|Overall Study||1
54192|NCT01470859|125943|P2|COMPLETED|Overall Study||15
54193|NCT01470859|125944|P1|COMPLETED|Overall Study||14
54194|NCT01470859|125943|P2|STARTED|Overall Study||15
54195|NCT01470859|125944|P1|STARTED|Overall Study||15
54196|NCT01470651|125960|P2|NOT COMPLETED|Overall Study||3
54197|NCT01470651|125961|P1|NOT COMPLETED|Overall Study||7
54198|NCT01470651|125960|P2|COMPLETED|Overall Study||10
54199|NCT01470651|125961|P1|COMPLETED|Overall Study||6
54200|NCT01470651|125960|P2|STARTED|Overall Study||13
54201|NCT01470651|125961|P1|STARTED|Overall Study||13
54202|NCT01470469|125971|P2|NOT COMPLETED|Overall Study||24
54203|NCT01470469|125972|P1|NOT COMPLETED|Overall Study||10
54204|NCT01470469|125971|P2|COMPLETED|Overall Study||38
54205|NCT01470469|125972|P1|COMPLETED|Overall Study||11
54206|NCT01470469|125971|P2|STARTED|Overall Study||62
54207|NCT01470469|125972|P1|STARTED|Overall Study||21
54208|NCT01470417|125992|P2|NOT COMPLETED|Overall Study||2
54209|NCT01470417|125993|P1|NOT COMPLETED|Overall Study||0
54210|NCT01470417|125992|P2|COMPLETED|Overall Study||5
54211|NCT01470417|125993|P1|COMPLETED|Overall Study||3
54212|NCT01470417|125992|P2|STARTED|Overall Study||7
54213|NCT01470417|125993|P1|STARTED|Overall Study||3
54214|NCT01470170|126010|P5|NOT COMPLETED|Overall Study||0
54215|NCT01470170|126011|P4|NOT COMPLETED|Overall Study||0
54216|NCT01470170|126012|P3|NOT COMPLETED|Overall Study||0
54217|NCT01470170|126013|P2|NOT COMPLETED|Overall Study||0
54218|NCT01470170|126014|P1|NOT COMPLETED|Overall Study||0
54219|NCT01470170|126010|P5|COMPLETED|Overall Study||34
54220|NCT01470170|126011|P4|COMPLETED|Overall Study||36
54221|NCT01470170|126012|P3|COMPLETED|Overall Study||34
54222|NCT01470170|126013|P2|COMPLETED|Overall Study||35
54223|NCT01470170|126014|P1|COMPLETED|Overall Study||34
54224|NCT01470170|126010|P5|STARTED|Overall Study||34
54225|NCT01470170|126011|P4|STARTED|Overall Study||36
54226|NCT01470170|126012|P3|STARTED|Overall Study||34
54227|NCT01470170|126013|P2|STARTED|Overall Study||35
54228|NCT01470170|126014|P1|STARTED|Overall Study||34
54229|NCT01470144|126046|P1|NOT COMPLETED|Overall Study||10
54230|NCT01470144|126046|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
54231|NCT01470144|126046|P1|STARTED|Overall Study||41
54232|NCT01470118|126054|P3|NOT COMPLETED|Overall Study||2
54233|NCT01470118|126055|P2|NOT COMPLETED|Overall Study||5
54234|NCT01470118|126056|P1|NOT COMPLETED|Overall Study||5
54235|NCT01470118|126054|P3|COMPLETED|Overall Study||39
54236|NCT01470118|126055|P2|COMPLETED|Overall Study||38
54237|NCT01470118|126056|P1|COMPLETED|Overall Study||38
54238|NCT01470118|126054|P3|STARTED|Overall Study||41
54239|NCT01470118|126055|P2|STARTED|Overall Study||43
54240|NCT01470118|126056|P1|STARTED|Overall Study||43
54241|NCT01469819|126085|P1|NOT COMPLETED|Overall Study||8
54242|NCT01469819|126085|P1|COMPLETED|Overall Study||29
54243|NCT01469819|126085|P1|STARTED|Overall Study||37
54244|NCT01469715|126095|P1|NOT COMPLETED|Overall Study||0
54245|NCT01469715|126095|P1|COMPLETED|Overall Study||16
54246|NCT01469715|126095|P1|STARTED|Overall Study||16
54247|NCT01469637|126101|P2|NOT COMPLETED|Second Intervention||0
54248|NCT01469637|126102|P1|NOT COMPLETED|Second Intervention||1
54249|NCT01469637|126101|P2|COMPLETED|Second Intervention||21
54250|NCT01469637|126102|P1|COMPLETED|Second Intervention||21
54251|NCT01469637|126101|P2|STARTED|Second Intervention||21
54252|NCT01469637|126102|P1|STARTED|Second Intervention||22
54253|NCT01469637|126101|P2|NOT COMPLETED|First Intervention||1
54254|NCT01469637|126102|P1|NOT COMPLETED|First Intervention||0
54255|NCT01469637|126101|P2|COMPLETED|First Intervention||21
54256|NCT01469637|126102|P1|COMPLETED|First Intervention||22
54257|NCT01469637|126101|P2|STARTED|First Intervention||22
54258|NCT01469637|126102|P1|STARTED|First Intervention||22
54259|NCT01469546|126110|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
54260|NCT01469546|126110|P1|COMPLETED|Dose Escalation to 10 mg||19
54261|NCT01469546|126110|P1|STARTED|Dose Escalation to 10 mg||19
54262|NCT01469546|126110|P1|NOT COMPLETED|Received 5 mg Dose||23
54263|NCT01469546|126110|P1|COMPLETED|Received 5 mg Dose||19
54264|NCT01469546|126110|P1|Completed First Cycle|Received 5 mg Dose||30
54265|NCT01469546|126110|P1|STARTED|Received 5 mg Dose||42
54266|NCT01469364|126117|P1|NOT COMPLETED|Overall Study||2
54267|NCT01469364|126117|P1|COMPLETED|Overall Study||28
54268|NCT01469364|126117|P1|STARTED|Overall Study||30
54269|NCT01469234|126135|P3|NOT COMPLETED|Overall Study||0
54270|NCT01469234|126136|P2|NOT COMPLETED|Overall Study||0
54271|NCT01469234|126137|P1|NOT COMPLETED|Overall Study||0
54272|NCT01469234|126135|P3|COMPLETED|Overall Study||85
54273|NCT01469234|126136|P2|COMPLETED|Overall Study||85
54274|NCT01469234|126137|P1|COMPLETED|Overall Study||85
54275|NCT01469234|126135|P3|STARTED|Overall Study||85
54276|NCT01469234|126136|P2|STARTED|Overall Study||85
54277|NCT01469234|126137|P1|STARTED|Overall Study||85
54278|NCT01469182|126168|P2|NOT COMPLETED|Overall Study||6
54279|NCT01469182|126169|P1|NOT COMPLETED|Overall Study||35
54280|NCT01469182|126168|P2|COMPLETED|Overall Study||298
54281|NCT01469182|126169|P1|COMPLETED|Overall Study||575
54282|NCT01469182|126168|P2|Treated|Overall Study||304
54283|NCT01469182|126169|P1|Treated|Overall Study||609
54284|NCT01469182|126168|P2|STARTED|Overall Study||304
54285|NCT01469182|126169|P1|STARTED|Overall Study||610
54286|NCT01469065|126196|P5|NOT COMPLETED|Overall Study||1
54287|NCT01469065|126197|P4|NOT COMPLETED|Overall Study||0
54288|NCT01469065|126198|P3|NOT COMPLETED|Overall Study||0
54289|NCT01469065|126199|P2|NOT COMPLETED|Overall Study||1
54290|NCT01469065|126200|P1|NOT COMPLETED|Overall Study||0
54291|NCT01469065|126196|P5|COMPLETED|Overall Study||16
54292|NCT01469065|126197|P4|COMPLETED|Overall Study||16
54293|NCT01469065|126198|P3|COMPLETED|Overall Study||16
54294|NCT01469065|126199|P2|COMPLETED|Overall Study||16
54295|NCT01469065|126200|P1|COMPLETED|Overall Study||16
54296|NCT01469065|126196|P5|STARTED|Overall Study||17
54297|NCT01469065|126197|P4|STARTED|Overall Study||16
54298|NCT01469065|126198|P3|STARTED|Overall Study||16
54299|NCT01469065|126199|P2|STARTED|Overall Study||17
54300|NCT01469065|126200|P1|STARTED|Overall Study||16
54301|NCT01469052|126296|P6|NOT COMPLETED|Overall Study||6
54302|NCT01469052|126297|P5|NOT COMPLETED|Overall Study||8
54303|NCT01469052|126298|P4|NOT COMPLETED|Overall Study||5
54304|NCT01469052|126299|P3|NOT COMPLETED|Overall Study||6
54305|NCT01469052|126300|P2|NOT COMPLETED|Overall Study||4
54306|NCT01469052|126301|P1|NOT COMPLETED|Overall Study||6
54307|NCT01469052|126296|P6|COMPLETED|Overall Study||0
54308|NCT01469052|126297|P5|COMPLETED|Overall Study||0
54309|NCT01469052|126298|P4|COMPLETED|Overall Study||1
54310|NCT01469052|126299|P3|COMPLETED|Overall Study||0
54311|NCT01469052|126300|P2|COMPLETED|Overall Study||0
54312|NCT01469052|126301|P1|COMPLETED|Overall Study||0
54313|NCT01469052|126296|P6|STARTED|Overall Study||6
54314|NCT01469052|126297|P5|STARTED|Overall Study||8
54315|NCT01469052|126298|P4|STARTED|Overall Study||6
54316|NCT01469052|126299|P3|STARTED|Overall Study||6
54317|NCT01469052|126300|P2|STARTED|Overall Study||4
54318|NCT01469052|126301|P1|STARTED|Overall Study||6
54319|NCT01469039|126348|P3|NOT COMPLETED|Overall Study||113
54320|NCT01469039|126349|P2|NOT COMPLETED|Overall Study||73
54321|NCT01469039|126350|P1|NOT COMPLETED|Overall Study||77
54322|NCT01469039|126348|P3|COMPLETED|Overall Study||95
54323|NCT01469039|126349|P2|COMPLETED|Overall Study||135
54324|NCT01469039|126350|P1|COMPLETED|Overall Study||130
54325|NCT01469039|126348|P3|STARTED|Overall Study||208
54326|NCT01469039|126349|P2|STARTED|Overall Study||208
54327|NCT01469039|126350|P1|STARTED|Overall Study||207
54328|NCT01469000|126363|P2|NOT COMPLETED|Overall Study||9
54329|NCT01469000|126364|P1|NOT COMPLETED|Overall Study||33
54330|NCT01469000|126363|P2|COMPLETED|Overall Study||57
54331|NCT01469000|126364|P1|COMPLETED|Overall Study||96
54332|NCT01469000|126363|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
54333|NCT01469000|126364|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
54334|NCT01469000|126363|P2|STARTED|Overall Study||66
54335|NCT01469000|126364|P1|STARTED|Overall Study||129
54336|NCT01468818|126378|P1|NOT COMPLETED|Overall Study||2
54337|NCT01468818|126378|P1|COMPLETED|Overall Study||16
54338|NCT01468818|126378|P1|STARTED|Overall Study||18
54339|NCT01468584|126383|P1|NOT COMPLETED|Overall Study||0
54340|NCT01468584|126383|P1|COMPLETED|Overall Study||10
54341|NCT01468584|126383|P1|STARTED|Overall Study||10
54342|NCT01468558|126387|P1|NOT COMPLETED|Overall Study||2
54343|NCT01468558|126387|P1|COMPLETED|Overall Study||22
54344|NCT01468558|126387|P1|STARTED|Overall Study||24
54345|NCT01468350|126402|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
54346|NCT01468350|126403|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
54347|NCT01468350|126404|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
54348|NCT01468350|126405|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
54349|NCT01468350|126402|P4|COMPLETED|(PART B) Day 1, Day 15||12
54350|NCT01468350|126403|P3|COMPLETED|(PART B) Day 1, Day 15||12
54351|NCT01468350|126404|P2|COMPLETED|(PART B) Day 1, Day 15||0
54352|NCT01468350|126405|P1|COMPLETED|(PART B) Day 1, Day 15||0
54353|NCT01468350|126402|P4|STARTED|(PART B) Day 1, Day 15||12
54354|NCT01468350|126403|P3|STARTED|(PART B) Day 1, Day 15||12
54355|NCT01468350|126404|P2|STARTED|(PART B) Day 1, Day 15||0
54356|NCT01468350|126405|P1|STARTED|(PART B) Day 1, Day 15||0
54357|NCT01468350|126402|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
54358|NCT01468350|126403|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
54359|NCT01468350|126404|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
54360|NCT01468350|126405|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
54361|NCT01468350|126402|P4|COMPLETED|(PART A) Day 1, Day 3||0
54362|NCT01468350|126403|P3|COMPLETED|(PART A) Day 1, Day 3||0
54363|NCT01468350|126404|P2|COMPLETED|(PART A) Day 1, Day 3||5
54364|NCT01468350|126405|P1|COMPLETED|(PART A) Day 1, Day 3||6
54365|NCT01468350|126402|P4|STARTED|(PART A) Day 1, Day 3||0
54366|NCT01468350|126403|P3|STARTED|(PART A) Day 1, Day 3||0
54367|NCT01468350|126404|P2|STARTED|(PART A) Day 1, Day 3||5
54368|NCT01468350|126405|P1|STARTED|(PART A) Day 1, Day 3||6
54369|NCT01468337|126415|P1|NOT COMPLETED|Overall Study||0
54370|NCT01468337|126415|P1|COMPLETED|Overall Study||5
54371|NCT01468337|126415|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
54372|NCT01468337|126415|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
54373|NCT01468337|126415|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
54374|NCT01468337|126415|P1|Week 2|Overall Study||5
54375|NCT01468337|126415|P1|STARTED|Overall Study||5
54376|NCT01468233|126429|P6|NOT COMPLETED|Treatment Period 2||23
54377|NCT01468233|126430|P5|NOT COMPLETED|Treatment Period 2||28
54378|NCT01468233|126431|P4|NOT COMPLETED|Treatment Period 2||28
54379|NCT01468233|126432|P3|NOT COMPLETED|Treatment Period 2||111
54380|NCT01468233|126433|P2|NOT COMPLETED|Treatment Period 2||0
54381|NCT01468233|126434|P1|NOT COMPLETED|Treatment Period 2||0
54382|NCT01468233|126429|P6|COMPLETED|Treatment Period 2||28
54383|NCT01468233|126430|P5|COMPLETED|Treatment Period 2||25
54384|NCT01468233|126431|P4|COMPLETED|Treatment Period 2||23
54385|NCT01468233|126432|P3|COMPLETED|Treatment Period 2||40
54386|NCT01468233|126433|P2|COMPLETED|Treatment Period 2||0
54387|NCT01468233|126434|P1|COMPLETED|Treatment Period 2||0
54388|NCT01468233|126429|P6|STARTED|Treatment Period 2||51
54389|NCT01468233|126430|P5|STARTED|Treatment Period 2||53
54390|NCT01468233|126431|P4|STARTED|Treatment Period 2||51
54391|NCT01468233|126432|P3|STARTED|Treatment Period 2||151
54392|NCT01468233|126433|P2|STARTED|Treatment Period 2||0
54393|NCT01468233|126434|P1|STARTED|Treatment Period 2||0
54394|NCT01468233|126429|P6|NOT COMPLETED|Treatment Period 1||0
54395|NCT01468233|126430|P5|NOT COMPLETED|Treatment Period 1||0
54396|NCT01468233|126431|P4|NOT COMPLETED|Treatment Period 1||0
54397|NCT01468233|126432|P3|NOT COMPLETED|Treatment Period 1||0
54398|NCT01468233|126433|P2|NOT COMPLETED|Treatment Period 1||8
54399|NCT01468233|126434|P1|NOT COMPLETED|Treatment Period 1||12
54400|NCT01468233|126429|P6|COMPLETED|Treatment Period 1||0
54401|NCT01468233|126430|P5|COMPLETED|Treatment Period 1||0
54402|NCT01468233|126431|P4|COMPLETED|Treatment Period 1||0
54403|NCT01468233|126432|P3|COMPLETED|Treatment Period 1||0
54404|NCT01468233|126433|P2|COMPLETED|Treatment Period 1||155
54405|NCT01468233|126434|P1|COMPLETED|Treatment Period 1||151
54406|NCT01468233|126429|P6|STARTED|Treatment Period 1||0
54407|NCT01468233|126430|P5|STARTED|Treatment Period 1||0
54408|NCT01468233|126431|P4|STARTED|Treatment Period 1||0
54409|NCT01468233|126432|P3|STARTED|Treatment Period 1||0
54410|NCT01468233|126433|P2|STARTED|Treatment Period 1||163
54411|NCT01468233|126434|P1|STARTED|Treatment Period 1||163
54412|NCT01468207|126456|P6|NOT COMPLETED|Treatment Period 2||20
54413|NCT01468207|126457|P5|NOT COMPLETED|Treatment Period 2||21
54414|NCT01468207|126458|P4|NOT COMPLETED|Treatment Period 2||27
54415|NCT01468207|126459|P3|NOT COMPLETED|Treatment Period 2||52
54416|NCT01468207|126460|P2|NOT COMPLETED|Treatment Period 2||0
54417|NCT01468207|126461|P1|NOT COMPLETED|Treatment Period 2||0
54418|NCT01468207|126456|P6|COMPLETED|Treatment Period 2||28
54419|NCT01468207|126457|P5|COMPLETED|Treatment Period 2||27
54420|NCT01468207|126458|P4|COMPLETED|Treatment Period 2||22
54421|NCT01468207|126459|P3|COMPLETED|Treatment Period 2||93
54422|NCT01468207|126460|P2|COMPLETED|Treatment Period 2||0
54423|NCT01468207|126461|P1|COMPLETED|Treatment Period 2||0
54424|NCT01468207|126456|P6|STARTED|Treatment Period 2||48
54425|NCT01468207|126457|P5|STARTED|Treatment Period 2||48
54426|NCT01468207|126458|P4|STARTED|Treatment Period 2||49
54427|NCT01468207|126459|P3|STARTED|Treatment Period 2||145
54428|NCT01468207|126460|P2|STARTED|Treatment Period 2||0
54429|NCT01468207|126461|P1|STARTED|Treatment Period 2||0
54430|NCT01468207|126456|P6|NOT COMPLETED|Treatment Period 1||0
54431|NCT01468207|126457|P5|NOT COMPLETED|Treatment Period 1||0
54432|NCT01468207|126458|P4|NOT COMPLETED|Treatment Period 1||0
54433|NCT01468207|126459|P3|NOT COMPLETED|Treatment Period 1||0
54434|NCT01468207|126460|P2|NOT COMPLETED|Treatment Period 1||8
54435|NCT01468207|126461|P1|NOT COMPLETED|Treatment Period 1||9
54436|NCT01468207|126456|P6|COMPLETED|Treatment Period 1||0
54437|NCT01468207|126457|P5|COMPLETED|Treatment Period 1||0
54438|NCT01468207|126458|P4|COMPLETED|Treatment Period 1||0
54439|NCT01468207|126459|P3|COMPLETED|Treatment Period 1||0
54440|NCT01468207|126460|P2|COMPLETED|Treatment Period 1||145
54441|NCT01468207|126461|P1|COMPLETED|Treatment Period 1||145
54442|NCT01468207|126456|P6|Received Study Drug|Treatment Period 1||0
54443|NCT01468207|126457|P5|Received Study Drug|Treatment Period 1||0
54444|NCT01468207|126458|P4|Received Study Drug|Treatment Period 1||0
54445|NCT01468207|126459|P3|Received Study Drug|Treatment Period 1||0
54446|NCT01468207|126460|P2|Received Study Drug|Treatment Period 1||153
54447|NCT01468207|126461|P1|Received Study Drug|Treatment Period 1||152
54448|NCT01468207|126456|P6|STARTED|Treatment Period 1||0
54449|NCT01468207|126457|P5|STARTED|Treatment Period 1||0
54450|NCT01468207|126458|P4|STARTED|Treatment Period 1||0
54451|NCT01468207|126459|P3|STARTED|Treatment Period 1||0
54452|NCT01468207|126460|P2|STARTED|Treatment Period 1||153
54453|NCT01468207|126461|P1|STARTED|Treatment Period 1||154
54454|NCT01468181|126486|P5|NOT COMPLETED|Overall Study||5
54455|NCT01468181|126487|P4|NOT COMPLETED|Overall Study||3
54456|NCT01468181|126488|P3|NOT COMPLETED|Overall Study||8
54457|NCT01468181|126489|P2|NOT COMPLETED|Overall Study||2
54458|NCT01468181|126490|P1|NOT COMPLETED|Overall Study||10
54459|NCT01468181|126486|P5|COMPLETED|Overall Study||66
54460|NCT01468181|126487|P4|COMPLETED|Overall Study||63
54461|NCT01468181|126488|P3|COMPLETED|Overall Study||57
54462|NCT01468181|126489|P2|COMPLETED|Overall Study||59
54463|NCT01468181|126490|P1|COMPLETED|Overall Study||121
54464|NCT01468181|126486|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
54465|NCT01468181|126487|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
54466|NCT01468181|126488|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
54467|NCT01468181|126489|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
54468|NCT01468181|126490|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
54469|NCT01468181|126486|P5|STARTED|Overall Study||71
54470|NCT01468181|126487|P4|STARTED|Overall Study||66
54471|NCT01468181|126488|P3|STARTED|Overall Study||65
54472|NCT01468181|126489|P2|STARTED|Overall Study||61
54473|NCT01468181|126490|P1|STARTED|Overall Study||131
54474|NCT01468077|126539|P2|NOT COMPLETED|Overall Study||3
54475|NCT01468077|126540|P1|NOT COMPLETED|Overall Study||4
54476|NCT01468077|126539|P2|COMPLETED|Overall Study||22
54477|NCT01468077|126540|P1|COMPLETED|Overall Study||18
54478|NCT01468077|126539|P2|STARTED|Overall Study||25
54479|NCT01468077|126540|P1|STARTED|Overall Study||22
54480|NCT01468012|126579|P3|NOT COMPLETED|Overall Study||4
54481|NCT01468012|126580|P2|NOT COMPLETED|Overall Study||1
54482|NCT01468012|126581|P1|NOT COMPLETED|Overall Study||2
54483|NCT01468012|126579|P3|COMPLETED|Overall Study||0
54484|NCT01468012|126580|P2|COMPLETED|Overall Study||9
54485|NCT01468012|126581|P1|COMPLETED|Overall Study||7
54486|NCT01468012|126579|P3|STARTED|Overall Study||4
54487|NCT01468012|126580|P2|STARTED|Overall Study||10
54488|NCT01468012|126581|P1|STARTED|Overall Study||9
54489|NCT01467960|126593|P6|NOT COMPLETED|Overall Study||30
54490|NCT01467960|126594|P5|NOT COMPLETED|Overall Study||30
54491|NCT01467960|126595|P4|NOT COMPLETED|Overall Study||30
54492|NCT01467960|126596|P3|NOT COMPLETED|Overall Study||0
54493|NCT01467960|126597|P2|NOT COMPLETED|Overall Study||0
54494|NCT01467960|126598|P1|NOT COMPLETED|Overall Study||0
54495|NCT01467960|126593|P6|COMPLETED|Overall Study||0
54496|NCT01467960|126594|P5|COMPLETED|Overall Study||0
54497|NCT01467960|126595|P4|COMPLETED|Overall Study||0
54498|NCT01467960|126596|P3|COMPLETED|Overall Study||30
54499|NCT01467960|126597|P2|COMPLETED|Overall Study||30
54500|NCT01467960|126598|P1|COMPLETED|Overall Study||30
54501|NCT01467960|126593|P6|STARTED|Overall Study||30
54502|NCT01467960|126594|P5|STARTED|Overall Study||30
54503|NCT01467960|126595|P4|STARTED|Overall Study||30
54504|NCT01467960|126596|P3|STARTED|Overall Study||30
54505|NCT01467960|126597|P2|STARTED|Overall Study||30
54506|NCT01467960|126598|P1|STARTED|Overall Study||30
54507|NCT01467947|126612|P1|NOT COMPLETED|Overall Study||0
54508|NCT01467947|126612|P1|COMPLETED|Overall Study||46
54509|NCT01467947|126612|P1|STARTED|Overall Study||46
54510|NCT01467934|126620|P3|NOT COMPLETED|Overall Study||0
54511|NCT01467934|126621|P2|NOT COMPLETED|Overall Study||0
54512|NCT01467934|126622|P1|NOT COMPLETED|Overall Study||0
54513|NCT01467934|126620|P3|COMPLETED|Overall Study||110
54514|NCT01467934|126621|P2|COMPLETED|Overall Study||212
54515|NCT01467934|126622|P1|COMPLETED|Overall Study||208
54516|NCT01467934|126620|P3|STARTED|Overall Study||110
54517|NCT01467934|126621|P2|STARTED|Overall Study||212
54518|NCT01467934|126622|P1|STARTED|Overall Study||208
54519|NCT01467882|126630|P1|NOT COMPLETED|Overall Study||0
54520|NCT01467882|126630|P1|COMPLETED|Overall Study||44
54521|NCT01467882|126630|P1|STARTED|Overall Study||44
54522|NCT01467713|126657|P4|NOT COMPLETED|Overall Study||109
54523|NCT01467713|126658|P3|NOT COMPLETED|Overall Study||102
54524|NCT01467713|126659|P2|NOT COMPLETED|Overall Study||104
54525|NCT01467713|126660|P1|NOT COMPLETED|Overall Study||102
54526|NCT01467713|126657|P4|COMPLETED|Overall Study||45
54527|NCT01467713|126658|P3|COMPLETED|Overall Study||58
54528|NCT01467713|126659|P2|COMPLETED|Overall Study||60
54529|NCT01467713|126660|P1|COMPLETED|Overall Study||62
54530|NCT01467713|126657|P4|Safety Analysis Set: Received Treatment|Overall Study||154
54531|NCT01467713|126658|P3|Safety Analysis Set: Received Treatment|Overall Study||159
54622|NCT01467037|126934|P1|STARTED|Overall Study||374
54532|NCT01467713|126659|P2|Safety Analysis Set: Received Treatment|Overall Study||164
54533|NCT01467713|126660|P1|Safety Analysis Set: Received Treatment|Overall Study||163
54534|NCT01467713|126657|P4|STARTED|Overall Study||154
54535|NCT01467713|126658|P3|STARTED|Overall Study||160
54536|NCT01467713|126659|P2|STARTED|Overall Study||164
54537|NCT01467713|126660|P1|STARTED|Overall Study||164
54538|NCT01467700|126714|P4|NOT COMPLETED|Overall Study||27
54539|NCT01467700|126715|P3|NOT COMPLETED|Overall Study||27
54540|NCT01467700|126716|P2|NOT COMPLETED|Overall Study||28
54541|NCT01467700|126717|P1|NOT COMPLETED|Overall Study||29
54542|NCT01467700|126714|P4|COMPLETED|Overall Study||96
54543|NCT01467700|126715|P3|COMPLETED|Overall Study||97
54544|NCT01467700|126716|P2|COMPLETED|Overall Study||100
54545|NCT01467700|126717|P1|COMPLETED|Overall Study||86
54546|NCT01467700|126714|P4|Safety Set - Received Treatment|Overall Study||123
54547|NCT01467700|126715|P3|Safety Set - Received Treatment|Overall Study||124
54548|NCT01467700|126716|P2|Safety Set - Received Treatment|Overall Study||127
54549|NCT01467700|126717|P1|Safety Set - Received Treatment|Overall Study||115
54550|NCT01467700|126714|P4|STARTED|Overall Study||123
54551|NCT01467700|126715|P3|STARTED|Overall Study||124
54552|NCT01467700|126716|P2|STARTED|Overall Study||128
54553|NCT01467700|126717|P1|STARTED|Overall Study||115
54554|NCT01467661|126759|P1|NOT COMPLETED|Overall Study||21
54555|NCT01467661|126759|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
54556|NCT01467661|126759|P1|Started Post Marketing Trial|Overall Study||33
54557|NCT01467661|126759|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
54558|NCT01467661|126759|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
54559|NCT01467661|126759|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
54560|NCT01467583|126779|P3|NOT COMPLETED|Overall Study||2
54561|NCT01467583|126780|P2|NOT COMPLETED|Overall Study||1
54562|NCT01467583|126781|P1|NOT COMPLETED|Overall Study||2
54563|NCT01467583|126779|P3|COMPLETED|Overall Study||10
54564|NCT01467583|126780|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
54565|NCT01467583|126781|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
54566|NCT01467583|126779|P3|STARTED|Overall Study||12
54567|NCT01467583|126780|P2|STARTED|Overall Study||4
54568|NCT01467583|126781|P1|STARTED|Overall Study||16
54569|NCT01467570|126794|P2|NOT COMPLETED|Overall Study||9
54570|NCT01467570|126795|P1|NOT COMPLETED|Overall Study||8
54571|NCT01467570|126794|P2|COMPLETED|Overall Study||63
54572|NCT01467570|126795|P1|COMPLETED|Overall Study||67
54573|NCT01467570|126794|P2|STARTED|Overall Study||72
54574|NCT01467570|126795|P1|STARTED|Overall Study||75
54575|NCT01467557|126821|P2|NOT COMPLETED|Overall Study||107
54576|NCT01467557|126822|P1|NOT COMPLETED|Overall Study||99
54577|NCT01467557|126821|P2|COMPLETED|Overall Study||463
54578|NCT01467557|126822|P1|COMPLETED|Overall Study||502
54579|NCT01467557|126821|P2|12 Month Survey Completed|Overall Study||463
54580|NCT01467557|126822|P1|12 Month Survey Completed|Overall Study||502
54581|NCT01467557|126821|P2|4 Month Survey Completed|Overall Study||493
54582|NCT01467557|126822|P1|4 Month Survey Completed|Overall Study||533
54583|NCT01467557|126821|P2|2 Week Survey Completed|Overall Study||522
54584|NCT01467557|126822|P1|2 Week Survey Completed|Overall Study||551
54585|NCT01467557|126821|P2|STARTED|Overall Study||570
54586|NCT01467557|126822|P1|STARTED|Overall Study||601
54587|NCT01467505|126832|P2|NOT COMPLETED|Overall Study||3
54588|NCT01467505|126833|P1|NOT COMPLETED|Overall Study||33
54589|NCT01467505|126832|P2|COMPLETED|Overall Study||7
54590|NCT01467505|126833|P1|COMPLETED|Overall Study||18
54591|NCT01467505|126832|P2|STARTED|Overall Study||10
54592|NCT01467505|126833|P1|STARTED|Overall Study||51
54593|NCT01467492|126865|P2|NOT COMPLETED|Overall Study||13
54594|NCT01467492|126866|P1|NOT COMPLETED|Overall Study||22
54595|NCT01467492|126865|P2|COMPLETED|Overall Study||25
54596|NCT01467492|126866|P1|COMPLETED|Overall Study||61
54597|NCT01467492|126865|P2|STARTED|Overall Study||38
54598|NCT01467492|126866|P1|STARTED|Overall Study||83
54599|NCT01467479|126890|P3|NOT COMPLETED|Overall Study||16
54600|NCT01467479|126891|P2|NOT COMPLETED|Overall Study||17
54601|NCT01467479|126892|P1|NOT COMPLETED|Overall Study||9
54602|NCT01467479|126890|P3|COMPLETED|Overall Study||45
54603|NCT01467479|126891|P2|COMPLETED|Overall Study||52
54604|NCT01467479|126892|P1|COMPLETED|Overall Study||46
54605|NCT01467479|126890|P3|Treated|Overall Study||59
54606|NCT01467479|126891|P2|Treated|Overall Study||69
54607|NCT01467479|126892|P1|Treated|Overall Study||54
54608|NCT01467479|126890|P3|STARTED|Overall Study||61
54609|NCT01467479|126891|P2|STARTED|Overall Study||69
54610|NCT01467479|126892|P1|STARTED|Overall Study||55
54611|NCT01467076|126922|P3|NOT COMPLETED|Overall Study||0
54612|NCT01467076|126923|P2|NOT COMPLETED|Overall Study||0
54613|NCT01467076|126924|P1|NOT COMPLETED|Overall Study||1
54614|NCT01467076|126922|P3|COMPLETED|Overall Study||2
54615|NCT01467076|126923|P2|COMPLETED|Overall Study||2
54616|NCT01467076|126924|P1|COMPLETED|Overall Study||2
54617|NCT01467076|126922|P3|STARTED|Overall Study||2
54618|NCT01467076|126923|P2|STARTED|Overall Study||2
54619|NCT01467076|126924|P1|STARTED|Overall Study||3
54620|NCT01467037|126934|P1|NOT COMPLETED|Overall Study||0
54621|NCT01467037|126934|P1|COMPLETED|Overall Study||374
54623|NCT01466881|126941|P1|NOT COMPLETED|Overall Study||40
54624|NCT01466881|126941|P1|COMPLETED|Overall Study||2
54625|NCT01466881|126941|P1|Eligible and Treated|Overall Study||37
54626|NCT01466881|126941|P1|STARTED|Overall Study||42
54627|NCT01466790|126958|P8|NOT COMPLETED|Overall Study||1
54628|NCT01466790|126959|P7|NOT COMPLETED|Overall Study||1
54629|NCT01466790|126960|P6|NOT COMPLETED|Overall Study||0
54630|NCT01466790|126961|P5|NOT COMPLETED|Overall Study||3
54631|NCT01466790|126962|P4|NOT COMPLETED|Overall Study||0
54632|NCT01466790|126963|P3|NOT COMPLETED|Overall Study||0
54633|NCT01466790|126964|P2|NOT COMPLETED|Overall Study||1
54634|NCT01466790|126965|P1|NOT COMPLETED|Overall Study||4
54635|NCT01466790|126958|P8|COMPLETED|Overall Study||13
54636|NCT01466790|126959|P7|COMPLETED|Overall Study||26
54637|NCT01466790|126960|P6|COMPLETED|Overall Study||16
54638|NCT01466790|126961|P5|COMPLETED|Overall Study||27
54639|NCT01466790|126962|P4|COMPLETED|Overall Study||14
54640|NCT01466790|126963|P3|COMPLETED|Overall Study||27
54641|NCT01466790|126964|P2|COMPLETED|Overall Study||14
54642|NCT01466790|126965|P1|COMPLETED|Overall Study||20
54643|NCT01466790|126958|P8|STARTED|Overall Study||14
54644|NCT01466790|126959|P7|STARTED|Overall Study||27
54645|NCT01466790|126960|P6|STARTED|Overall Study||16
54646|NCT01466790|126961|P5|STARTED|Overall Study||30
54647|NCT01466790|126962|P4|STARTED|Overall Study||14
54648|NCT01466790|126963|P3|STARTED|Overall Study||27
54649|NCT01466790|126964|P2|STARTED|Overall Study||15
54650|NCT01466790|126965|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
54651|NCT01466673|127029|P2|NOT COMPLETED|Overall Study||6
54652|NCT01466673|127030|P1|NOT COMPLETED|Overall Study||7
54653|NCT01466673|127029|P2|COMPLETED|Overall Study||95
54654|NCT01466673|127030|P1|COMPLETED|Overall Study||93
54655|NCT01466673|127029|P2|STARTED|Overall Study||101
54656|NCT01466673|127030|P1|STARTED|Overall Study||100
54657|NCT01466595|127056|P2|NOT COMPLETED|Overall Study||1
54658|NCT01466595|127057|P1|NOT COMPLETED|Overall Study||0
54659|NCT01466595|127056|P2|COMPLETED|Overall Study||23
54660|NCT01466595|127057|P1|COMPLETED|Overall Study||49
54661|NCT01466595|127056|P2|STARTED|Overall Study||24
54662|NCT01466595|127057|P1|STARTED|Overall Study||49
54663|NCT01466387|127153|P6|NOT COMPLETED|Overall Study||1
54664|NCT01466387|127154|P5|NOT COMPLETED|Overall Study||0
54665|NCT01466387|127155|P4|NOT COMPLETED|Overall Study||2
54666|NCT01466387|127156|P3|NOT COMPLETED|Overall Study||1
54667|NCT01466387|127157|P2|NOT COMPLETED|Overall Study||0
54668|NCT01466387|127158|P1|NOT COMPLETED|Overall Study||1
54669|NCT01466387|127153|P6|COMPLETED|Overall Study||99
54670|NCT01466387|127154|P5|COMPLETED|Overall Study||51
54671|NCT01466387|127155|P4|COMPLETED|Overall Study||99
54672|NCT01466387|127156|P3|COMPLETED|Overall Study||98
54673|NCT01466387|127157|P2|COMPLETED|Overall Study||100
54674|NCT01466387|127158|P1|COMPLETED|Overall Study||100
54675|NCT01466387|127153|P6|STARTED|Overall Study||100
54676|NCT01466387|127154|P5|STARTED|Overall Study||51
54677|NCT01466387|127155|P4|STARTED|Overall Study||101
54678|NCT01466387|127156|P3|STARTED|Overall Study||99
54679|NCT01466387|127157|P2|STARTED|Overall Study||100
54680|NCT01466387|127158|P1|STARTED|Overall Study||101
54681|NCT01466361|127200|P4|NOT COMPLETED|Overall Study||0
54682|NCT01466361|127201|P3|NOT COMPLETED|Overall Study||0
54683|NCT01466361|127202|P2|NOT COMPLETED|Overall Study||0
54684|NCT01466361|127203|P1|NOT COMPLETED|Overall Study||0
54685|NCT01466361|127200|P4|COMPLETED|Overall Study||41
54686|NCT01466361|127201|P3|COMPLETED|Overall Study||60
54687|NCT01466361|127202|P2|COMPLETED|Overall Study||34
54688|NCT01466361|127203|P1|COMPLETED|Overall Study||52
54689|NCT01466361|127200|P4|STARTED|Overall Study||41
54690|NCT01466361|127201|P3|STARTED|Overall Study||60
54691|NCT01466361|127202|P2|STARTED|Overall Study||34
54692|NCT01466361|127203|P1|STARTED|Overall Study||52
54693|NCT01466348|127219|P2|NOT COMPLETED|Period II - Second Intervention||0
54694|NCT01466348|127220|P1|NOT COMPLETED|Period II - Second Intervention||0
54695|NCT01466348|127219|P2|COMPLETED|Period II - Second Intervention||36
54696|NCT01466348|127220|P1|COMPLETED|Period II - Second Intervention||35
54697|NCT01466348|127219|P2|STARTED|Period II - Second Intervention||36
54698|NCT01466348|127220|P1|STARTED|Period II - Second Intervention||35
54699|NCT01466348|127219|P2|NOT COMPLETED|Period I - First Intervention||1
54700|NCT01466348|127220|P1|NOT COMPLETED|Period I - First Intervention||0
54701|NCT01466348|127219|P2|COMPLETED|Period I - First Intervention||35
54702|NCT01466348|127220|P1|COMPLETED|Period I - First Intervention||36
54703|NCT01466348|127219|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
54704|NCT01466348|127220|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
54705|NCT01466348|127219|P2|STARTED|Period I - First Intervention||36
54706|NCT01466348|127220|P1|STARTED|Period I - First Intervention||36
54707|NCT01466270|127248|P2|NOT COMPLETED|Overall Study||6
54708|NCT01466270|127249|P1|NOT COMPLETED|Overall Study||12
54709|NCT01466270|127248|P2|COMPLETED|Overall Study||25
54710|NCT01466270|127249|P1|COMPLETED|Overall Study||19
54711|NCT01466270|127248|P2|STARTED|Overall Study||31
54712|NCT01466270|127249|P1|STARTED|Overall Study||31
54713|NCT01466192|127261|P1|NOT COMPLETED|Overall Study||4
54714|NCT01466192|127261|P1|COMPLETED|Overall Study||104
54715|NCT01466192|127261|P1|STARTED|Overall Study||108
54716|NCT01466179|127265|P1|NOT COMPLETED|Overall Study||179
54717|NCT01466179|127265|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
54718|NCT01466179|127265|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
54719|NCT01466075|127285|P1|NOT COMPLETED|Overall Study||0
54720|NCT01466075|127285|P1|COMPLETED|Overall Study||207
54721|NCT01466075|127285|P1|STARTED|Overall Study||207
54722|NCT01466062|127292|P1|NOT COMPLETED|Overall Study||2
54723|NCT01466062|127292|P1|COMPLETED|Overall Study||26
54724|NCT01466062|127292|P1|STARTED|Overall Study||28
54725|NCT01465958|127313|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
54726|NCT01465958|127314|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
54727|NCT01465958|127313|P2|COMPLETED|Subcutaneous (SC) Phase||10
54728|NCT01465958|127314|P1|COMPLETED|Subcutaneous (SC) Phase||0
54729|NCT01465958|127313|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
54730|NCT01465958|127314|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
54731|NCT01465958|127313|P2|NOT COMPLETED|Intravenous (IV) Phase||0
54732|NCT01465958|127314|P1|NOT COMPLETED|Intravenous (IV) Phase||0
54733|NCT01465958|127313|P2|COMPLETED|Intravenous (IV) Phase||0
54734|NCT01465958|127314|P1|COMPLETED|Intravenous (IV) Phase||11
54735|NCT01465958|127313|P2|STARTED|Intravenous (IV) Phase||0
54736|NCT01465958|127314|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
54737|NCT01465958|127313|P2|NOT COMPLETED|Run-in Phase||0
54738|NCT01465958|127314|P1|NOT COMPLETED|Run-in Phase||1
54739|NCT01465958|127313|P2|COMPLETED|Run-in Phase||0
54740|NCT01465958|127314|P1|COMPLETED|Run-in Phase||10
54741|NCT01465958|127313|P2|STARTED|Run-in Phase||0
54742|NCT01465958|127314|P1|STARTED|Run-in Phase||11
54743|NCT01465802|127327|P5|NOT COMPLETED|Overall Study||12
54744|NCT01465802|127328|P4|NOT COMPLETED|Overall Study||29
54745|NCT01465802|127329|P3|NOT COMPLETED|Overall Study||0
54746|NCT01465802|127330|P2|NOT COMPLETED|Overall Study||24
54747|NCT01465802|127331|P1|NOT COMPLETED|Overall Study||33
54748|NCT01465802|127327|P5|COMPLETED|Overall Study||13
54749|NCT01465802|127328|P4|COMPLETED|Overall Study||38
54750|NCT01465802|127329|P3|COMPLETED|Overall Study||7
54751|NCT01465802|127330|P2|COMPLETED|Overall Study||42
54752|NCT01465802|127331|P1|COMPLETED|Overall Study||33
54753|NCT01465802|127327|P5|STARTED|Overall Study||25
54754|NCT01465802|127328|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
54755|NCT01465802|127329|P3|STARTED|Overall Study||7
54756|NCT01465802|127330|P2|STARTED|Overall Study||66
54757|NCT01465802|127331|P1|STARTED|Overall Study||66
54758|NCT01465763|127383|P3|NOT COMPLETED|Overall Study||4
54759|NCT01465763|127384|P2|NOT COMPLETED|Overall Study||1
54760|NCT01465763|127385|P1|NOT COMPLETED|Overall Study||31
54761|NCT01465763|127383|P3|COMPLETED|Overall Study||118
54762|NCT01465763|127384|P2|COMPLETED|Overall Study||15
54763|NCT01465763|127385|P1|COMPLETED|Overall Study||445
54764|NCT01465763|127383|P3|STARTED|Overall Study||122
54765|NCT01465763|127384|P2|STARTED|Overall Study||16
54766|NCT01465763|127385|P1|STARTED|Overall Study||476
54767|NCT01465412|127414|P4|NOT COMPLETED|Overall Study||0
54768|NCT01465412|127415|P3|NOT COMPLETED|Overall Study||0
54769|NCT01465412|127416|P2|NOT COMPLETED|Overall Study||0
54770|NCT01465412|127417|P1|NOT COMPLETED|Overall Study||0
54771|NCT01465412|127414|P4|COMPLETED|Overall Study||9
54772|NCT01465412|127415|P3|COMPLETED|Overall Study||9
54773|NCT01465412|127416|P2|COMPLETED|Overall Study||12
54774|NCT01465412|127417|P1|COMPLETED|Overall Study||12
54775|NCT01465412|127414|P4|STARTED|Overall Study||9
54776|NCT01465412|127415|P3|STARTED|Overall Study||9
54777|NCT01465412|127416|P2|STARTED|Overall Study||12
54778|NCT01465412|127417|P1|STARTED|Overall Study||12
54779|NCT01465230|127455|P1|NOT COMPLETED|Overall Study||2
54780|NCT01465230|127455|P1|COMPLETED|Overall Study||0
54781|NCT01465230|127455|P1|STARTED|Overall Study||2
54782|NCT01465178|127461|P2|NOT COMPLETED|Overall Study||0
54783|NCT01465178|127462|P1|NOT COMPLETED|Overall Study||1
54784|NCT01465178|127461|P2|COMPLETED|Overall Study||31
54785|NCT01465178|127462|P1|COMPLETED|Overall Study||30
54786|NCT01465178|127461|P2|STARTED|Overall Study||31
54787|NCT01465178|127462|P1|STARTED|Overall Study||31
54788|NCT01465048|127473|P3|NOT COMPLETED|Overall Study||0
54789|NCT01465048|127474|P2|NOT COMPLETED|Overall Study||0
54790|NCT01465048|127475|P1|NOT COMPLETED|Overall Study||0
54791|NCT01465048|127473|P3|COMPLETED|Overall Study||6
54792|NCT01465048|127474|P2|COMPLETED|Overall Study||6
54793|NCT01465048|127475|P1|COMPLETED|Overall Study||6
54794|NCT01465048|127473|P3|STARTED|Overall Study||6
54795|NCT01465048|127474|P2|STARTED|Overall Study||6
54796|NCT01465048|127475|P1|STARTED|Overall Study||6
54797|NCT01465022|127486|P3|NOT COMPLETED|Overall Study||70
54798|NCT01465022|127487|P2|NOT COMPLETED|Overall Study||23
54799|NCT01465022|127488|P1|NOT COMPLETED|Overall Study||23
54800|NCT01465022|127486|P3|COMPLETED|Overall Study||0
54801|NCT01465022|127487|P2|COMPLETED|Overall Study||40
54802|NCT01465022|127488|P1|COMPLETED|Overall Study||41
54803|NCT01465022|127486|P3|STARTED|Overall Study||70
54804|NCT01465022|127487|P2|STARTED|Overall Study||63
54805|NCT01465022|127488|P1|STARTED|Overall Study||64
54806|NCT01464996|127502|P1|NOT COMPLETED|Overall Study||0
54807|NCT01464996|127502|P1|COMPLETED|Overall Study||24
54808|NCT01464996|127502|P1|OptiBond FL|Overall Study||24
54809|NCT01464996|127502|P1|OptiBond XTR|Overall Study||23
54810|NCT01464996|127502|P1|STARTED|Overall Study||24
54811|NCT01464931|127522|P2|NOT COMPLETED|Overall Study||0
54812|NCT01464931|127523|P1|NOT COMPLETED|Overall Study||1
54813|NCT01464931|127522|P2|COMPLETED|Overall Study||16
54814|NCT01464931|127523|P1|COMPLETED|Overall Study||15
54815|NCT01464931|127522|P2|STARTED|Overall Study||16
54816|NCT01464931|127523|P1|STARTED|Overall Study||16
54817|NCT01464840|127563|P3|NOT COMPLETED|Overall Study||0
54818|NCT01464840|127564|P2|NOT COMPLETED|Overall Study||0
54819|NCT01464840|127565|P1|NOT COMPLETED|Overall Study||0
54820|NCT01464840|127563|P3|COMPLETED|Overall Study||10
54821|NCT01464840|127564|P2|COMPLETED|Overall Study||10
54822|NCT01464840|127565|P1|COMPLETED|Overall Study||10
54823|NCT01464840|127563|P3|STARTED|Overall Study||10
54824|NCT01464840|127564|P2|STARTED|Overall Study||10
54825|NCT01464840|127565|P1|STARTED|Overall Study||10
54826|NCT01464827|127587|P14|NOT COMPLETED|Overall Study||3
54827|NCT01464827|127588|P13|NOT COMPLETED|Overall Study||2
54828|NCT01464827|127589|P12|NOT COMPLETED|Overall Study||2
54829|NCT01464827|127590|P11|NOT COMPLETED|Overall Study||2
54830|NCT01464827|127591|P10|NOT COMPLETED|Overall Study||3
54831|NCT01464827|127592|P9|NOT COMPLETED|Overall Study||3
54832|NCT01464827|127593|P8|NOT COMPLETED|Overall Study||3
54833|NCT01464827|127594|P7|NOT COMPLETED|Overall Study||4
54834|NCT01464827|127595|P6|NOT COMPLETED|Overall Study||1
54835|NCT01464827|127596|P5|NOT COMPLETED|Overall Study||8
54836|NCT01464827|127597|P4|NOT COMPLETED|Overall Study||4
54837|NCT01464827|127598|P3|NOT COMPLETED|Overall Study||0
54838|NCT01464827|127599|P2|NOT COMPLETED|Overall Study||7
54839|NCT01464827|127600|P1|NOT COMPLETED|Overall Study||3
54840|NCT01464827|127587|P14|COMPLETED|Overall Study||19
54841|NCT01464827|127588|P13|COMPLETED|Overall Study||21
54842|NCT01464827|127589|P12|COMPLETED|Overall Study||21
54843|NCT01464827|127590|P11|COMPLETED|Overall Study||21
54844|NCT01464827|127591|P10|COMPLETED|Overall Study||44
54845|NCT01464827|127592|P9|COMPLETED|Overall Study||37
54846|NCT01464827|127593|P8|COMPLETED|Overall Study||37
54847|NCT01464827|127594|P7|COMPLETED|Overall Study||37
54848|NCT01464827|127595|P6|COMPLETED|Overall Study||38
54849|NCT01464827|127596|P5|COMPLETED|Overall Study||72
54850|NCT01464827|127597|P4|COMPLETED|Overall Study||36
54851|NCT01464827|127598|P3|COMPLETED|Overall Study||39
54852|NCT01464827|127599|P2|COMPLETED|Overall Study||36
54853|NCT01464827|127600|P1|COMPLETED|Overall Study||77
54854|NCT01464827|127587|P14|Treated|Overall Study||20
54855|NCT01464827|127588|P13|Treated|Overall Study||23
54856|NCT01464827|127589|P12|Treated|Overall Study||22
54857|NCT01464827|127590|P11|Treated|Overall Study||23
54858|NCT01464827|127591|P10|Treated|Overall Study||45
54859|NCT01464827|127592|P9|Treated|Overall Study||40
54860|NCT01464827|127593|P8|Treated|Overall Study||40
54861|NCT01464827|127594|P7|Treated|Overall Study||40
54862|NCT01464827|127595|P6|Treated|Overall Study||39
54863|NCT01464827|127596|P5|Treated|Overall Study||79
54864|NCT01464827|127597|P4|Treated|Overall Study||40
54865|NCT01464827|127598|P3|Treated|Overall Study||39
54866|NCT01464827|127599|P2|Treated|Overall Study||41
54867|NCT01464827|127600|P1|Treated|Overall Study||80
54868|NCT01464827|127587|P14|STARTED|Overall Study||22
54869|NCT01464827|127588|P13|STARTED|Overall Study||23
54870|NCT01464827|127589|P12|STARTED|Overall Study||23
54871|NCT01464827|127590|P11|STARTED|Overall Study||23
54872|NCT01464827|127591|P10|STARTED|Overall Study||47
54873|NCT01464827|127592|P9|STARTED|Overall Study||40
54874|NCT01464827|127593|P8|STARTED|Overall Study||40
54875|NCT01464827|127594|P7|STARTED|Overall Study||41
54876|NCT01464827|127595|P6|STARTED|Overall Study||39
54877|NCT01464827|127596|P5|STARTED|Overall Study||80
54878|NCT01464827|127597|P4|STARTED|Overall Study||40
54879|NCT01464827|127598|P3|STARTED|Overall Study||39
54880|NCT01464827|127599|P2|STARTED|Overall Study||43
54881|NCT01464827|127600|P1|STARTED|Overall Study||80
54882|NCT01464619|127646|P2|NOT COMPLETED|Overall Study||4
54883|NCT01464619|127647|P1|NOT COMPLETED|Overall Study||3
54884|NCT01464619|127646|P2|COMPLETED|Overall Study||25
54885|NCT01464619|127647|P1|COMPLETED|Overall Study||29
54886|NCT01464619|127646|P2|STARTED|Overall Study||29
54887|NCT01464619|127647|P1|STARTED|Overall Study||32
54888|NCT01464424|127667|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
54889|NCT01464424|127668|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
54890|NCT01464424|127667|P2|COMPLETED|Period 2, Second 6 Weeks||41
54891|NCT01464424|127668|P1|COMPLETED|Period 2, Second 6 Weeks||42
54892|NCT01464424|127667|P2|STARTED|Period 2, Second 6 Weeks||41
54893|NCT01464424|127668|P1|STARTED|Period 2, Second 6 Weeks||42
54894|NCT01464424|127667|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
54895|NCT01464424|127668|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
54896|NCT01464424|127667|P2|COMPLETED|Period 1, First 6 Weeks||41
54897|NCT01464424|127668|P1|COMPLETED|Period 1, First 6 Weeks||42
54898|NCT01464424|127667|P2|STARTED|Period 1, First 6 Weeks||42
54899|NCT01464424|127668|P1|STARTED|Period 1, First 6 Weeks||42
54900|NCT01464359|127676|P1|NOT COMPLETED|Overall Study||0
54901|NCT01464359|127676|P1|COMPLETED|Overall Study||3
54902|NCT01464359|127676|P1|STARTED|Overall Study||3
54903|NCT01464307|127682|P2|NOT COMPLETED|Open-Label Extension Period||0
54904|NCT01464307|127683|P1|NOT COMPLETED|Open-Label Extension Period||51
54905|NCT01464307|127682|P2|COMPLETED|Open-Label Extension Period||0
54906|NCT01464307|127683|P1|COMPLETED|Open-Label Extension Period||218
54907|NCT01464307|127682|P2|Treated|Open-Label Extension Period||0
54908|NCT01464307|127683|P1|Treated|Open-Label Extension Period||269
54909|NCT01464307|127682|P2|STARTED|Open-Label Extension Period||0
54910|NCT01464307|127683|P1|STARTED|Open-Label Extension Period||269
54911|NCT01464307|127682|P2|NOT COMPLETED|Main Period||5
54912|NCT01464307|127683|P1|NOT COMPLETED|Main Period||15
54913|NCT01464307|127682|P2|COMPLETED|Main Period||140
54914|NCT01464307|127683|P1|COMPLETED|Main Period||129
54915|NCT01464307|127682|P2|Treated|Main Period||145
54916|NCT01464307|127683|P1|Treated|Main Period||144
54917|NCT01464307|127682|P2|STARTED|Main Period||145
54918|NCT01464307|127683|P1|STARTED|Main Period||144
54919|NCT01464255|127698|P2|NOT COMPLETED|Overall Study||1
54920|NCT01464255|127699|P1|NOT COMPLETED|Overall Study||0
54921|NCT01464255|127698|P2|COMPLETED|Overall Study||24
54922|NCT01464255|127699|P1|COMPLETED|Overall Study||25
54923|NCT01464255|127698|P2|STARTED|Overall Study||25
54924|NCT01464255|127699|P1|STARTED|Overall Study||25
54925|NCT01464190|127724|P2|NOT COMPLETED|Overall Study||41
54926|NCT01464190|127725|P1|NOT COMPLETED|Overall Study||69
54927|NCT01464190|127724|P2|COMPLETED|Overall Study||227
54928|NCT01464190|127725|P1|COMPLETED|Overall Study||322
54929|NCT01464190|127724|P2|STARTED|Overall Study||268
54930|NCT01464190|127725|P1|STARTED|Overall Study||391
54931|NCT01464021|127735|P1|NOT COMPLETED|Overall Study||26
54932|NCT01464021|127735|P1|COMPLETED|Overall Study||0
54933|NCT01464021|127735|P1|STARTED|Overall Study||26
54934|NCT01463982|127751|P4|NOT COMPLETED|Overall Study||0
54935|NCT01463982|127752|P3|NOT COMPLETED|Overall Study||2
54936|NCT01463982|127753|P2|NOT COMPLETED|Overall Study||1
54937|NCT01463982|127754|P1|NOT COMPLETED|Overall Study||0
54938|NCT01463982|127751|P4|COMPLETED|Overall Study||6
54939|NCT01463982|127752|P3|COMPLETED|Overall Study||2
54940|NCT01463982|127753|P2|COMPLETED|Overall Study||7
54941|NCT01463982|127754|P1|COMPLETED|Overall Study||3
54942|NCT01463982|127751|P4|STARTED|Overall Study||6
54943|NCT01463982|127752|P3|STARTED|Overall Study||4
54944|NCT01463982|127753|P2|STARTED|Overall Study||8
54945|NCT01463982|127754|P1|STARTED|Overall Study||3
54946|NCT01463878|127770|P2|NOT COMPLETED|Overall Study||2
54947|NCT01463878|127771|P1|NOT COMPLETED|Overall Study||2
54948|NCT01463878|127770|P2|COMPLETED|Overall Study||7
54949|NCT01463878|127771|P1|COMPLETED|Overall Study||7
54950|NCT01463878|127770|P2|STARTED|Overall Study||9
54951|NCT01463878|127771|P1|STARTED|Overall Study||9
54952|NCT01463696|127785|P8|NOT COMPLETED|Overall Study||4
54953|NCT01463696|127786|P7|NOT COMPLETED|Overall Study||10
54954|NCT01463696|127787|P6|NOT COMPLETED|Overall Study||3
54955|NCT01463696|127788|P5|NOT COMPLETED|Overall Study||1
54956|NCT01463696|127789|P4|NOT COMPLETED|Overall Study||4
54957|NCT01463696|127790|P3|NOT COMPLETED|Overall Study||1
54958|NCT01463696|127791|P2|NOT COMPLETED|Overall Study||2
54959|NCT01463696|127792|P1|NOT COMPLETED|Overall Study||0
54960|NCT01463696|127785|P8|COMPLETED|Overall Study||2
54961|NCT01463696|127786|P7|COMPLETED|Overall Study||6
54962|NCT01463696|127787|P6|COMPLETED|Overall Study||3
54963|NCT01463696|127788|P5|COMPLETED|Overall Study||2
54964|NCT01463696|127789|P4|COMPLETED|Overall Study||3
54965|NCT01463696|127790|P3|COMPLETED|Overall Study||2
54966|NCT01463696|127791|P2|COMPLETED|Overall Study||4
54967|NCT01463696|127792|P1|COMPLETED|Overall Study||1
54968|NCT01463696|127785|P8|Treated|Overall Study||6
54969|NCT01463696|127786|P7|Treated|Overall Study||15
54970|NCT01463696|127787|P6|Treated|Overall Study||6
54971|NCT01463696|127788|P5|Treated|Overall Study||3
54972|NCT01463696|127789|P4|Treated|Overall Study||7
54973|NCT01463696|127790|P3|Treated|Overall Study||3
54974|NCT01463696|127791|P2|Treated|Overall Study||6
54975|NCT01463696|127792|P1|Treated|Overall Study||1
54976|NCT01463696|127785|P8|STARTED|Overall Study||6
54977|NCT01463696|127786|P7|STARTED|Overall Study||16
54978|NCT01463696|127787|P6|STARTED|Overall Study||6
54979|NCT01463696|127788|P5|STARTED|Overall Study||3
54980|NCT01463696|127789|P4|STARTED|Overall Study||7
54981|NCT01463696|127790|P3|STARTED|Overall Study||3
54982|NCT01463696|127791|P2|STARTED|Overall Study||6
54983|NCT01463696|127792|P1|STARTED|Overall Study||1
54984|NCT01463683|127845|P3|NOT COMPLETED|Overall Study||11
54985|NCT01463683|127846|P2|NOT COMPLETED|Overall Study||31
54986|NCT01463683|127847|P1|NOT COMPLETED|Overall Study||19
54987|NCT01463683|127845|P3|COMPLETED|Overall Study||93
54988|NCT01463683|127846|P2|COMPLETED|Overall Study||278
54989|NCT01463683|127847|P1|COMPLETED|Overall Study||290
54990|NCT01463683|127845|P3|Received Vaccination 3 (Month 6)|Overall Study||93
54991|NCT01463683|127846|P2|Received Vaccination 3 (Month 6)|Overall Study||281
54992|NCT01463683|127847|P1|Received Vaccination 3 (Month 6)|Overall Study||290
54993|NCT01463683|127845|P3|Received Vaccination 2 (Month 1)|Overall Study||103
54994|NCT01463683|127846|P2|Received Vaccination 2 (Month 1)|Overall Study||300
54995|NCT01463683|127847|P1|Received Vaccination 2 (Month 1)|Overall Study||302
54996|NCT01463683|127845|P3|Received Vaccination 1 (Day 1)|Overall Study||104
54997|NCT01463683|127846|P2|Received Vaccination 1 (Day 1)|Overall Study||308
54998|NCT01463683|127847|P1|Received Vaccination 1 (Day 1)|Overall Study||309
54999|NCT01463683|127845|P3|STARTED|Overall Study||104
55000|NCT01463683|127846|P2|STARTED|Overall Study||309
55001|NCT01463683|127847|P1|STARTED|Overall Study||309
55002|NCT01463527|127862|P2|NOT COMPLETED|Overall Study||7
55003|NCT01463527|127863|P1|NOT COMPLETED|Overall Study||6
55004|NCT01463527|127862|P2|COMPLETED|Overall Study||77
55005|NCT01463527|127863|P1|COMPLETED|Overall Study||77
55006|NCT01463527|127862|P2|STARTED|Overall Study||84
55007|NCT01463527|127863|P1|STARTED|Overall Study||83
55008|NCT01463384|127869|P1|NOT COMPLETED|Overall Study||0
55009|NCT01463384|127869|P1|COMPLETED|Overall Study||13
55010|NCT01463384|127869|P1|STARTED|Overall Study||13
55011|NCT01463293|127884|P3|NOT COMPLETED|Overall Study||12
55012|NCT01463293|127885|P2|NOT COMPLETED|Overall Study||16
55013|NCT01463293|127886|P1|NOT COMPLETED|Overall Study||6
55014|NCT01463293|127884|P3|COMPLETED|Overall Study||59
55015|NCT01463293|127885|P2|COMPLETED|Overall Study||63
55016|NCT01463293|127886|P1|COMPLETED|Overall Study||68
55017|NCT01463293|127884|P3|STARTED|Overall Study||71
55018|NCT01463293|127885|P2|STARTED|Overall Study||79
55019|NCT01463293|127886|P1|STARTED|Overall Study||74
55020|NCT01463033|127896|P2|NOT COMPLETED|Overall Study||6
55021|NCT01463033|127897|P1|NOT COMPLETED|Overall Study||7
55022|NCT01463033|127896|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
55023|NCT01463033|127897|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
55024|NCT01463033|127896|P2|STARTED|Overall Study||60
55025|NCT01463033|127897|P1|STARTED|Overall Study||66
55026|NCT01463007|127904|P1|NOT COMPLETED|Overall Study||1
55027|NCT01463007|127904|P1|COMPLETED|Overall Study||40
55028|NCT01463007|127904|P1|STARTED|Overall Study||41
55029|NCT01462942|127915|P5|NOT COMPLETED|Overall Study||45
55030|NCT01462942|127916|P4|NOT COMPLETED|Overall Study||50
55031|NCT01462942|127917|P3|NOT COMPLETED|Overall Study||40
55032|NCT01462942|127918|P2|NOT COMPLETED|Overall Study||34
55033|NCT01462942|127919|P1|NOT COMPLETED|Overall Study||34
55034|NCT01462942|127915|P5|COMPLETED|Overall Study||339
55035|NCT01462942|127916|P4|COMPLETED|Overall Study||335
55036|NCT01462942|127917|P3|COMPLETED|Overall Study||341
55037|NCT01462942|127918|P2|COMPLETED|Overall Study||351
55038|NCT01462942|127919|P1|COMPLETED|Overall Study||160
55039|NCT01462942|127915|P5|STARTED|Overall Study||384
55040|NCT01462942|127916|P4|STARTED|Overall Study||385
55041|NCT01462942|127917|P3|STARTED|Overall Study||381
55042|NCT01462942|127918|P2|STARTED|Overall Study||385
55043|NCT01462942|127919|P1|STARTED|Overall Study||194
55044|NCT01462929|127949|P3|NOT COMPLETED|Overall Study||5
55045|NCT01462929|127950|P2|NOT COMPLETED|Overall Study||4
55046|NCT01462929|127951|P1|NOT COMPLETED|Overall Study||5
55047|NCT01462929|127949|P3|COMPLETED|Overall Study||80
55048|NCT01462929|127950|P2|COMPLETED|Overall Study||154
55049|NCT01462929|127951|P1|COMPLETED|Overall Study||166
55050|NCT01462929|127949|P3|STARTED|Overall Study||85
55051|NCT01462929|127950|P2|STARTED|Overall Study||158
55052|NCT01462929|127951|P1|STARTED|Overall Study||171
55053|NCT01462877|127962|P1|NOT COMPLETED|Overall Study||71
55054|NCT01462877|127962|P1|COMPLETED|Overall Study||435
55055|NCT01462877|127962|P1|Per-protocol Set|Overall Study||364
55056|NCT01462877|127962|P1|Full Analysis Set|Overall Study||468
55057|NCT01462877|127962|P1|Safety Set|Overall Study||492
55058|NCT01462877|127962|P1|STARTED|Overall Study||506
55059|NCT01462812|127978|P2|NOT COMPLETED|Overall Study||1
55060|NCT01462812|127979|P1|NOT COMPLETED|Overall Study||0
55061|NCT01462812|127978|P2|COMPLETED|Overall Study||111
55062|NCT01462812|127979|P1|COMPLETED|Overall Study||111
55063|NCT01462812|127978|P2|STARTED|Overall Study||112
55064|NCT01462812|127979|P1|STARTED|Overall Study||111
55065|NCT01462773|127985|P1|NOT COMPLETED|Overall Study||0
55066|NCT01462773|127985|P1|COMPLETED|Overall Study||16
55067|NCT01462773|127985|P1|STARTED|Overall Study||16
55068|NCT01462695|127992|P2|NOT COMPLETED|Overall Study||13
55069|NCT01462695|127993|P1|NOT COMPLETED|Overall Study||17
55070|NCT01462695|127992|P2|COMPLETED|Overall Study||0
55071|NCT01462695|127993|P1|COMPLETED|Overall Study||0
55072|NCT01462695|127992|P2|STARTED|Overall Study||13
55073|NCT01462695|127993|P1|STARTED|Overall Study||17
55074|NCT01462435|128003|P4|NOT COMPLETED|Overall Study||5
55075|NCT01462435|128004|P3|NOT COMPLETED|Overall Study||1
55076|NCT01462435|128005|P2|NOT COMPLETED|Overall Study||0
55077|NCT01462435|128006|P1|NOT COMPLETED|Overall Study||1
55078|NCT01462435|128003|P4|COMPLETED|Overall Study||101
55079|NCT01462435|128004|P3|COMPLETED|Overall Study||106
55080|NCT01462435|128005|P2|COMPLETED|Overall Study||109
55081|NCT01462435|128006|P1|COMPLETED|Overall Study||105
55082|NCT01462435|128003|P4|STARTED|Overall Study||106
55083|NCT01462435|128004|P3|STARTED|Overall Study||107
55084|NCT01462435|128005|P2|STARTED|Overall Study||109
55085|NCT01462435|128006|P1|STARTED|Overall Study||106
55086|NCT01462370|128044|P2|NOT COMPLETED|Overall Study||5
55087|NCT01462370|128045|P1|NOT COMPLETED|Overall Study||1
55088|NCT01462370|128044|P2|COMPLETED|Overall Study||65
55089|NCT01462370|128045|P1|COMPLETED|Overall Study||68
55090|NCT01462370|128044|P2|STARTED|Overall Study||70
55091|NCT01462370|128045|P1|STARTED|Overall Study||69
55092|NCT01462357|128080|P3|NOT COMPLETED|Month 36||0
55093|NCT01462357|128081|P2|NOT COMPLETED|Month 36||0
55094|NCT01462357|128082|P1|NOT COMPLETED|Month 36||0
55095|NCT01462357|128080|P3|COMPLETED|Month 36||346
55096|NCT01462357|128081|P2|COMPLETED|Month 36||339
55097|NCT01462357|128082|P1|COMPLETED|Month 36||351
55098|NCT01462357|128080|P3|STARTED|Month 36||346
55099|NCT01462357|128081|P2|STARTED|Month 36||339
55100|NCT01462357|128082|P1|STARTED|Month 36||351
55101|NCT01462357|128080|P3|NOT COMPLETED|Month 24||9
55102|NCT01462357|128081|P2|NOT COMPLETED|Month 24||14
55103|NCT01462357|128082|P1|NOT COMPLETED|Month 24||4
55104|NCT01462357|128080|P3|COMPLETED|Month 24||349
55105|NCT01462357|128081|P2|COMPLETED|Month 24||344
55106|NCT01462357|128082|P1|COMPLETED|Month 24||355
55107|NCT01462357|128080|P3|STARTED|Month 24||358
55108|NCT01462357|128081|P2|STARTED|Month 24||358
55109|NCT01462357|128082|P1|STARTED|Month 24||359
55110|NCT01462357|128080|P3|NOT COMPLETED|Month 18||9
55111|NCT01462357|128081|P2|NOT COMPLETED|Month 18||11
55112|NCT01462357|128082|P1|NOT COMPLETED|Month 18||3
55113|NCT01462357|128080|P3|COMPLETED|Month 18||349
55114|NCT01462357|128081|P2|COMPLETED|Month 18||347
55115|NCT01462357|128082|P1|COMPLETED|Month 18||356
55116|NCT01462357|128080|P3|STARTED|Month 18||358
55117|NCT01462357|128081|P2|STARTED|Month 18||358
55118|NCT01462357|128082|P1|STARTED|Month 18||359
55119|NCT01462357|128080|P3|NOT COMPLETED|Month 12||8
55120|NCT01462357|128081|P2|NOT COMPLETED|Month 12||10
55121|NCT01462357|128082|P1|NOT COMPLETED|Month 12||3
55122|NCT01462357|128080|P3|COMPLETED|Month 12||350
55123|NCT01462357|128081|P2|COMPLETED|Month 12||348
55124|NCT01462357|128082|P1|COMPLETED|Month 12||356
55125|NCT01462357|128080|P3|STARTED|Month 12||358
55126|NCT01462357|128081|P2|STARTED|Month 12||358
55127|NCT01462357|128082|P1|STARTED|Month 12||359
55128|NCT01462357|128080|P3|NOT COMPLETED|Month 7||6
55129|NCT01462357|128081|P2|NOT COMPLETED|Month 7||5
55130|NCT01462357|128082|P1|NOT COMPLETED|Month 7||1
55131|NCT01462357|128080|P3|COMPLETED|Month 7||352
55132|NCT01462357|128081|P2|COMPLETED|Month 7||353
55133|NCT01462357|128082|P1|COMPLETED|Month 7||358
55134|NCT01462357|128080|P3|STARTED|Month 7||358
55135|NCT01462357|128081|P2|STARTED|Month 7||358
55136|NCT01462357|128082|P1|STARTED|Month 7||359
55137|NCT01462344|128155|P2|NOT COMPLETED|Overall Study||350
55138|NCT01462344|128156|P1|NOT COMPLETED|Overall Study||383
55139|NCT01462344|128155|P2|COMPLETED|Overall Study||2751
55140|NCT01462344|128156|P1|COMPLETED|Overall Study||2724
55141|NCT01462344|128155|P2|STARTED|Overall Study||3101
55142|NCT01462344|128156|P1|STARTED|Overall Study||3107
55143|NCT01462279|128176|P1|NOT COMPLETED|Overall Study||3
55144|NCT01462279|128176|P1|COMPLETED|Overall Study||17
55145|NCT01462279|128176|P1|STARTED|Overall Study||20
55146|NCT01462266|128182|P2|NOT COMPLETED|Overall Study||27
55147|NCT01462266|128183|P1|NOT COMPLETED|Overall Study||35
55148|NCT01462266|128182|P2|COMPLETED|Overall Study||303
55149|NCT01462266|128183|P1|COMPLETED|Overall Study||295
55150|NCT01462266|128182|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
55151|NCT01462266|128183|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
55152|NCT01462266|128182|P2|STARTED|Overall Study||330
55153|NCT01462266|128183|P1|STARTED|Overall Study||330
55154|NCT01462227|128199|P4|NOT COMPLETED|Second Assignment||0
55155|NCT01462227|128200|P3|NOT COMPLETED|Second Assignment||1
55156|NCT01462227|128201|P2|NOT COMPLETED|Second Assignment||1
55157|NCT01462227|128202|P1|NOT COMPLETED|Second Assignment||1
55158|NCT01462227|128199|P4|COMPLETED|Second Assignment||5
55159|NCT01462227|128200|P3|COMPLETED|Second Assignment||5
55160|NCT01462227|128201|P2|COMPLETED|Second Assignment||1
55161|NCT01462227|128202|P1|COMPLETED|Second Assignment||3
55162|NCT01462227|128199|P4|STARTED|Second Assignment||5
55163|NCT01462227|128200|P3|STARTED|Second Assignment||6
55164|NCT01462227|128201|P2|STARTED|Second Assignment||2
55165|NCT01462227|128202|P1|STARTED|Second Assignment||4
55166|NCT01462227|128199|P4|NOT COMPLETED|First Assignment||0
55167|NCT01462227|128200|P3|NOT COMPLETED|First Assignment||0
55168|NCT01462227|128201|P2|NOT COMPLETED|First Assignment||0
55169|NCT01462227|128202|P1|NOT COMPLETED|First Assignment||0
55170|NCT01462227|128199|P4|COMPLETED|First Assignment||5
55171|NCT01462227|128200|P3|COMPLETED|First Assignment||6
55172|NCT01462227|128201|P2|COMPLETED|First Assignment||2
55173|NCT01462227|128202|P1|COMPLETED|First Assignment||4
55174|NCT01462227|128199|P4|STARTED|First Assignment||5
55175|NCT01462227|128200|P3|STARTED|First Assignment||6
55176|NCT01462227|128201|P2|STARTED|First Assignment||2
55177|NCT01462227|128202|P1|STARTED|First Assignment||4
55178|NCT01462162|128220|P1|NOT COMPLETED|Overall Study||12
55179|NCT01462162|128220|P1|COMPLETED|Overall Study||108
55180|NCT01462162|128220|P1|STARTED|Overall Study||120
55181|NCT01462045|128248|P3|NOT COMPLETED|Overall Study||0
55182|NCT01462045|128249|P2|NOT COMPLETED|Overall Study||1
55183|NCT01462045|128250|P1|NOT COMPLETED|Overall Study||0
55184|NCT01462045|128248|P3|COMPLETED|Overall Study||7
55185|NCT01462045|128249|P2|COMPLETED|Overall Study||10
55186|NCT01462045|128250|P1|COMPLETED|Overall Study||11
55187|NCT01462045|128248|P3|STARTED|Overall Study||7
55188|NCT01462045|128249|P2|STARTED|Overall Study||11
55189|NCT01462045|128250|P1|STARTED|Overall Study||11
55190|NCT01461993|128264|P3|NOT COMPLETED|Overall Study||64
55191|NCT01461993|128265|P2|NOT COMPLETED|Overall Study||157
55192|NCT01461993|128266|P1|NOT COMPLETED|Overall Study||151
55193|NCT01461993|128264|P3|COMPLETED|Overall Study||438
55194|NCT01461993|128265|P2|COMPLETED|Overall Study||841
55195|NCT01461993|128266|P1|COMPLETED|Overall Study||848
55196|NCT01461993|128264|P3|STARTED|Overall Study||502
55197|NCT01461993|128265|P2|STARTED|Overall Study||998
55198|NCT01461993|128266|P1|STARTED|Overall Study||999
55199|NCT01461980|128291|P3|NOT COMPLETED|Overall Study||165
55200|NCT01461980|128292|P2|NOT COMPLETED|Overall Study||145
55201|NCT01461980|128293|P1|NOT COMPLETED|Overall Study||166
55202|NCT01461980|128291|P3|COMPLETED|Overall Study||717
55203|NCT01461980|128292|P2|COMPLETED|Overall Study||733
55204|NCT01461980|128293|P1|COMPLETED|Overall Study||722
55205|NCT01461980|128291|P3|Vaccination 3|Overall Study||748
55206|NCT01461980|128292|P2|Vaccination 3|Overall Study||777
55207|NCT01461980|128293|P1|Vaccination 3|Overall Study||757
55208|NCT01461980|128291|P3|Vaccination 2|Overall Study||799
55209|NCT01461980|128292|P2|Vaccination 2|Overall Study||819
55210|NCT01461980|128293|P1|Vaccination 2|Overall Study||802
55211|NCT01461980|128291|P3|Vaccination 1|Overall Study||875
55212|NCT01461980|128292|P2|Vaccination 1|Overall Study||870
55213|NCT01461980|128293|P1|Vaccination 1|Overall Study||884
55214|NCT01461980|128291|P3|STARTED|Overall Study||882
55215|NCT01461980|128292|P2|STARTED|Overall Study||878
55216|NCT01461980|128293|P1|STARTED|Overall Study||888
55217|NCT01461811|128325|P2|NOT COMPLETED|Overall Study||3
55218|NCT01461811|128326|P1|NOT COMPLETED|Overall Study||4
55219|NCT01461811|128325|P2|COMPLETED|Overall Study||46
55220|NCT01461811|128326|P1|COMPLETED|Overall Study||91
55221|NCT01461811|128325|P2|STARTED|Overall Study||49
55222|NCT01461811|128326|P1|STARTED|Overall Study||95
55223|NCT01461733|128356|P2|NOT COMPLETED|Overall Study||4
55224|NCT01461733|128357|P1|NOT COMPLETED|Overall Study||4
55225|NCT01461733|128356|P2|COMPLETED|Overall Study||8
55226|NCT01461733|128357|P1|COMPLETED|Overall Study||8
55227|NCT01461733|128356|P2|STARTED|Overall Study||12
55228|NCT01461733|128357|P1|STARTED|Overall Study||12
55229|NCT01461655|128363|P1|NOT COMPLETED|Overall Study||0
55230|NCT01461655|128363|P1|COMPLETED|Overall Study||40
55231|NCT01461655|128363|P1|STARTED|Overall Study||40
55232|NCT01461551|128383|P3|NOT COMPLETED|Overall Study||2
55233|NCT01461551|128384|P2|NOT COMPLETED|Overall Study||1
55234|NCT01461551|128385|P1|NOT COMPLETED|Overall Study||2
55235|NCT01461551|128383|P3|COMPLETED|Overall Study||33
55236|NCT01461551|128384|P2|COMPLETED|Overall Study||34
55237|NCT01461551|128385|P1|COMPLETED|Overall Study||33
55238|NCT01461551|128383|P3|STARTED|Overall Study||35
55239|NCT01461551|128384|P2|STARTED|Overall Study||35
55240|NCT01461551|128385|P1|STARTED|Overall Study||35
55241|NCT01461538|128396|P3|NOT COMPLETED|Overall Study||2
55242|NCT01461538|128397|P2|NOT COMPLETED|Overall Study||8
55243|NCT01461538|128398|P1|NOT COMPLETED|Overall Study||18
55244|NCT01461538|128396|P3|COMPLETED|Overall Study||7
55245|NCT01461538|128397|P2|COMPLETED|Overall Study||20
55246|NCT01461538|128398|P1|COMPLETED|Overall Study||28
55247|NCT01461538|128396|P3|STARTED|Overall Study||9
55248|NCT01461538|128397|P2|STARTED|Overall Study||28
55249|NCT01461538|128398|P1|STARTED|Overall Study||46
55250|NCT01461369|128437|P3|NOT COMPLETED|Overall Study||17
55251|NCT01461369|128438|P2|NOT COMPLETED|Overall Study||17
55252|NCT01461369|128439|P1|NOT COMPLETED|Overall Study||13
55253|NCT01461369|128437|P3|COMPLETED|Overall Study||86
55254|NCT01461369|128438|P2|COMPLETED|Overall Study||81
55255|NCT01461369|128439|P1|COMPLETED|Overall Study||91
55256|NCT01461369|128437|P3|STARTED|Overall Study||103
55257|NCT01461369|128438|P2|STARTED|Overall Study||98
55258|NCT01461369|128439|P1|STARTED|Overall Study||104
55259|NCT01461096|128464|P2|NOT COMPLETED|Overall Study||61
55260|NCT01461096|128465|P1|NOT COMPLETED|Overall Study||62
55261|NCT01461096|128464|P2|COMPLETED|Overall Study||226
55262|NCT01461096|128465|P1|COMPLETED|Overall Study||226
55263|NCT01461096|128464|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
55264|NCT01461096|128465|P1|Did Not Start Treatment|Overall Study||0
55265|NCT01461096|128464|P2|STARTED|Overall Study||287
55266|NCT01461096|128465|P1|STARTED|Overall Study||288
55267|NCT01461057|128481|P2|NOT COMPLETED|Overall Study||15
55268|NCT01461057|128482|P1|NOT COMPLETED|Overall Study||15
55269|NCT01461057|128481|P2|COMPLETED|Overall Study||0
55270|NCT01461057|128482|P1|COMPLETED|Overall Study||0
55271|NCT01461057|128481|P2|STARTED|Overall Study||15
55272|NCT01461057|128482|P1|STARTED|Overall Study||15
55273|NCT01461044|128492|P2|NOT COMPLETED|Overall Study||40
55274|NCT01461044|128493|P1|NOT COMPLETED|Overall Study||70
55275|NCT01461044|128492|P2|COMPLETED|Overall Study||37
55276|NCT01461044|128493|P1|COMPLETED|Overall Study||80
55277|NCT01461044|128492|P2|Participants Alive at Inclusion|Overall Study||58
55278|NCT01461044|128493|P1|Participants Alive at Inclusion|Overall Study||127
55279|NCT01461044|128492|P2|STARTED|Overall Study||77
55280|NCT01461044|128493|P1|STARTED|Overall Study||150
55281|NCT01460927|128566|P1|NOT COMPLETED|Overall Study||0
55282|NCT01460927|128566|P1|COMPLETED|Overall Study||25
55283|NCT01460927|128566|P1|STARTED|Overall Study||25
55284|NCT01460732|128574|P1|NOT COMPLETED|Overall Study||0
55285|NCT01460732|128574|P1|COMPLETED|Overall Study||81
55286|NCT01460732|128574|P1|STARTED|Overall Study||81
55287|NCT01460446|128589|P2|NOT COMPLETED|Overall Study||20
55288|NCT01460446|128590|P1|NOT COMPLETED|Overall Study||5
55289|NCT01460446|128589|P2|COMPLETED|Overall Study||93
55290|NCT01460446|128590|P1|COMPLETED|Overall Study||100
55291|NCT01460446|128589|P2|STARTED|Overall Study||113
55292|NCT01460446|128590|P1|STARTED|Overall Study||105
55293|NCT01460342|128619|P2|NOT COMPLETED|Overall Study||14
55294|NCT01460342|128620|P1|NOT COMPLETED|Overall Study||11
55295|NCT01460342|128619|P2|COMPLETED|Overall Study||292
55296|NCT01460342|128620|P1|COMPLETED|Overall Study||293
55297|NCT01460342|128619|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
55298|NCT01460342|128620|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
55299|NCT01460342|128619|P2|STARTED|Overall Study||306
55300|NCT01460342|128620|P1|STARTED|Overall Study||304
55301|NCT01460290|128640|P1|NOT COMPLETED|Overall Study||4
55302|NCT01460290|128640|P1|COMPLETED|Overall Study||11
55303|NCT01460290|128640|P1|STARTED|Overall Study||15
55304|NCT01459913|128664|P4|NOT COMPLETED|Overall Study||33
55305|NCT01459913|128665|P3|NOT COMPLETED|Overall Study||13
55306|NCT01459913|128666|P2|NOT COMPLETED|Overall Study||20
55307|NCT01459913|128667|P1|NOT COMPLETED|Overall Study||41
55308|NCT01459913|128664|P4|COMPLETED|Overall Study||29
55309|NCT01459913|128665|P3|COMPLETED|Overall Study||6
55310|NCT01459913|128666|P2|COMPLETED|Overall Study||32
55311|NCT01459913|128667|P1|COMPLETED|Overall Study||65
55312|NCT01459913|128664|P4|STARTED|Overall Study||62
55313|NCT01459913|128665|P3|STARTED|Overall Study||19
55314|NCT01459913|128666|P2|STARTED|Overall Study||52
55315|NCT01459913|128667|P1|STARTED|Overall Study||106
55316|NCT01459783|128698|P2|NOT COMPLETED|6 Months to 12 Months||30
55317|NCT01459783|128699|P1|NOT COMPLETED|6 Months to 12 Months||19
55318|NCT01459783|128698|P2|COMPLETED|6 Months to 12 Months||23
55319|NCT01459783|128699|P1|COMPLETED|6 Months to 12 Months||20
55320|NCT01459783|128698|P2|STARTED|6 Months to 12 Months||53
55321|NCT01459783|128699|P1|STARTED|6 Months to 12 Months||39
55322|NCT01459783|128698|P2|NOT COMPLETED|Baseline to 6 Months||20
55323|NCT01459783|128699|P1|NOT COMPLETED|Baseline to 6 Months||32
55324|NCT01459783|128698|P2|COMPLETED|Baseline to 6 Months||53
55325|NCT01459783|128699|P1|COMPLETED|Baseline to 6 Months||39
55326|NCT01459783|128698|P2|STARTED|Baseline to 6 Months||73
55327|NCT01459783|128699|P1|STARTED|Baseline to 6 Months||71
55328|NCT01459705|128710|P3|NOT COMPLETED|Overall Study||7
55329|NCT01459705|128711|P2|NOT COMPLETED|Overall Study||24
55330|NCT01459705|128712|P1|NOT COMPLETED|Overall Study||22
55331|NCT01459705|128710|P3|COMPLETED|Overall Study||47
55332|NCT01459705|128711|P2|COMPLETED|Overall Study||30
55333|NCT01459705|128712|P1|COMPLETED|Overall Study||32
55334|NCT01459705|128710|P3|STARTED|Overall Study||54
55335|NCT01459705|128711|P2|STARTED|Overall Study||54
55336|NCT01459705|128712|P1|STARTED|Overall Study||54
55337|NCT01459653|128730|P1|NOT COMPLETED|Overall Study||668
55338|NCT01459653|128730|P1|COMPLETED|Overall Study||828
55339|NCT01459653|128730|P1|STARTED|Overall Study||1496
55340|NCT01459588|128880|P4|NOT COMPLETED|Overall Study||1
55341|NCT01459588|128881|P3|NOT COMPLETED|Overall Study||1
55342|NCT01459588|128882|P2|NOT COMPLETED|Overall Study||2
55343|NCT01459588|128883|P1|NOT COMPLETED|Overall Study||1
55344|NCT01459588|128880|P4|COMPLETED|Overall Study||55
55345|NCT01459588|128881|P3|COMPLETED|Overall Study||102
55346|NCT01459588|128882|P2|COMPLETED|Overall Study||49
55347|NCT01459588|128883|P1|COMPLETED|Overall Study||104
55348|NCT01459588|128880|P4|STARTED|Overall Study||56
55349|NCT01459588|128881|P3|STARTED|Overall Study||103
55350|NCT01459588|128882|P2|STARTED|Overall Study||51
55351|NCT01459588|128883|P1|STARTED|Overall Study||105
55352|NCT01459068|128911|P2|NOT COMPLETED|Overall Study||34
55353|NCT01459068|128912|P1|NOT COMPLETED|Overall Study||39
55354|NCT01459068|128911|P2|COMPLETED|Overall Study||148
55355|NCT01459068|128912|P1|COMPLETED|Overall Study||126
55356|NCT01459068|128911|P2|STARTED|Overall Study||182
55357|NCT01459068|128912|P1|STARTED|Overall Study||165
55358|NCT01459016|128928|P1|NOT COMPLETED|Overall Study||15
55359|NCT01459016|128928|P1|COMPLETED|Overall Study||41
55360|NCT01459016|128928|P1|STARTED|Overall Study||56
55361|NCT01458951|128945|P3|NOT COMPLETED|Overall Study||15
55362|NCT01458951|128946|P2|NOT COMPLETED|Overall Study||1
55363|NCT01458951|128947|P1|NOT COMPLETED|Overall Study||32
55364|NCT01458951|128945|P3|COMPLETED|Overall Study||97
55365|NCT01458951|128946|P2|COMPLETED|Overall Study||5
55366|NCT01458951|128947|P1|COMPLETED|Overall Study||397
55367|NCT01458951|128945|P3|STARTED|Overall Study||112
55368|NCT01458951|128946|P2|STARTED|Overall Study||6
55369|NCT01458951|128947|P1|STARTED|Overall Study||429
55370|NCT01458639|128972|P1|NOT COMPLETED|Overall Study||6
55371|NCT01458639|128972|P1|COMPLETED|Overall Study||12
55372|NCT01458639|128972|P1|STARTED|Overall Study||18
55373|NCT01458587|128984|P2|NOT COMPLETED|Overall Study||0
55374|NCT01458587|128985|P1|NOT COMPLETED|Overall Study||1
55375|NCT01458587|128984|P2|COMPLETED|Overall Study||35
55376|NCT01458587|128985|P1|COMPLETED|Overall Study||34
55377|NCT01458587|128984|P2|STARTED|Overall Study||35
55378|NCT01458587|128985|P1|STARTED|Overall Study||35
55379|NCT01458561|129147|P2|NOT COMPLETED|Overall Study||0
55380|NCT01458561|129148|P1|NOT COMPLETED|Overall Study||0
55381|NCT01458561|129147|P2|COMPLETED|Overall Study||1
55382|NCT01458561|129148|P1|COMPLETED|Overall Study||0
55383|NCT01458561|129147|P2|STARTED|Overall Study||1
55384|NCT01458561|129148|P1|STARTED|Overall Study||0
55385|NCT01458535|129192|P6|NOT COMPLETED|Overall Study||4
55386|NCT01458535|129193|P5|NOT COMPLETED|Overall Study||4
55387|NCT01458535|129194|P4|NOT COMPLETED|Overall Study||4
55388|NCT01458535|129195|P3|NOT COMPLETED|Overall Study||2
55389|NCT01458535|129196|P2|NOT COMPLETED|Overall Study||2
55390|NCT01458535|129197|P1|NOT COMPLETED|Overall Study||0
55391|NCT01458535|129192|P6|COMPLETED|Overall Study||7
55392|NCT01458535|129193|P5|COMPLETED|Overall Study||6
55393|NCT01458535|129194|P4|COMPLETED|Overall Study||6
55394|NCT01458535|129195|P3|COMPLETED|Overall Study||8
55395|NCT01458535|129196|P2|COMPLETED|Overall Study||8
55396|NCT01458535|129197|P1|COMPLETED|Overall Study||10
55397|NCT01458535|129192|P6|STARTED|Overall Study||11
55398|NCT01458535|129193|P5|STARTED|Overall Study||10
55399|NCT01458535|129194|P4|STARTED|Overall Study||10
55400|NCT01458535|129195|P3|STARTED|Overall Study||10
55401|NCT01458535|129196|P2|STARTED|Overall Study||10
55402|NCT01458535|129197|P1|STARTED|Overall Study||10
55403|NCT01458288|129247|P1|NOT COMPLETED|Overall Study||0
55404|NCT01458288|129247|P1|COMPLETED|Overall Study||12
55405|NCT01458288|129247|P1|STARTED|Overall Study||12
55406|NCT01458275|129255|P3|NOT COMPLETED|Overall Study||9
55407|NCT01458275|129256|P2|NOT COMPLETED|Overall Study||13
55408|NCT01458275|129257|P1|NOT COMPLETED|Overall Study||14
55409|NCT01458275|129255|P3|COMPLETED|Overall Study||273
55410|NCT01458275|129256|P2|COMPLETED|Overall Study||269
55411|NCT01458275|129257|P1|COMPLETED|Overall Study||269
55412|NCT01458275|129255|P3|STARTED|Overall Study||282
55413|NCT01458275|129256|P2|STARTED|Overall Study||282
55414|NCT01458275|129257|P1|STARTED|Overall Study||283
55415|NCT01458249|129299|P1|NOT COMPLETED|Overall Study||8
55416|NCT01458249|129299|P1|COMPLETED|Overall Study||44
55417|NCT01458249|129299|P1|Participants Treated|Overall Study||51
55418|NCT01458249|129299|P1|STARTED|Overall Study||52
55419|NCT01458210|129318|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
55420|NCT01458210|129318|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
55421|NCT01458210|129318|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
55422|NCT01458210|129318|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
55423|NCT01458210|129318|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
55424|NCT01458210|129318|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
55425|NCT01458210|129318|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
55426|NCT01458210|129318|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
55427|NCT01458210|129318|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
55428|NCT01458210|129318|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
55429|NCT01458171|129335|P1|NOT COMPLETED|Overall Study||1
55430|NCT01458171|129335|P1|COMPLETED|Overall Study||22
55431|NCT01458171|129335|P1|STARTED|Overall Study||23
55432|NCT01458106|129358|P2|NOT COMPLETED|Overall Study||1
55433|NCT01458106|129359|P1|NOT COMPLETED|Overall Study||3
55434|NCT01458106|129358|P2|COMPLETED|Overall Study||34
55435|NCT01458106|129359|P1|COMPLETED|Overall Study||33
55436|NCT01458106|129358|P2|Non-PK Subgroup|Overall Study||0
55437|NCT01458106|129359|P1|Non-PK Subgroup|Overall Study||11
55438|NCT01458106|129358|P2|PK Subgroup|Overall Study||35
55439|NCT01458106|129359|P1|PK Subgroup|Overall Study||25
55440|NCT01458106|129358|P2|STARTED|Overall Study||35
55441|NCT01458106|129359|P1|STARTED|Overall Study||36
55442|NCT01457950|129436|P4|NOT COMPLETED|Open-Label Phase||2
55443|NCT01457950|129437|P3|NOT COMPLETED|Open-Label Phase||2
55444|NCT01457950|129438|P2|NOT COMPLETED|Open-Label Phase||0
55445|NCT01457950|129439|P1|NOT COMPLETED|Open-Label Phase||0
55446|NCT01457950|129436|P4|COMPLETED|Open-Label Phase||61
55447|NCT01457950|129437|P3|COMPLETED|Open-Label Phase||58
55448|NCT01457950|129438|P2|COMPLETED|Open-Label Phase||0
55449|NCT01457950|129439|P1|COMPLETED|Open-Label Phase||0
55450|NCT01457950|129436|P4|STARTED|Open-Label Phase||63
55451|NCT01457950|129437|P3|STARTED|Open-Label Phase||60
55452|NCT01457950|129438|P2|STARTED|Open-Label Phase||0
55453|NCT01457950|129439|P1|STARTED|Open-Label Phase||0
55454|NCT01457950|129436|P4|NOT COMPLETED|Double-Blind Phase||0
55455|NCT01457950|129437|P3|NOT COMPLETED|Double-Blind Phase||0
55456|NCT01457950|129438|P2|NOT COMPLETED|Double-Blind Phase||3
55457|NCT01457950|129439|P1|NOT COMPLETED|Double-Blind Phase||9
55458|NCT01457950|129436|P4|COMPLETED|Double-Blind Phase||0
55459|NCT01457950|129437|P3|COMPLETED|Double-Blind Phase||0
55460|NCT01457950|129438|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
55461|NCT01457950|129439|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
55462|NCT01457950|129436|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
55463|NCT01457950|129437|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
55638|NCT01456169|129973|P1|COMPLETED|Overall Study||123
55464|NCT01457950|129438|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
55465|NCT01457950|129439|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
55466|NCT01457950|129436|P4|STARTED|Double-Blind Phase||0
55467|NCT01457950|129437|P3|STARTED|Double-Blind Phase||0
55468|NCT01457950|129438|P2|STARTED|Double-Blind Phase||66
55469|NCT01457950|129439|P1|STARTED|Double-Blind Phase||69
55470|NCT01457885|129513|P1|NOT COMPLETED|Overall Study||0
55471|NCT01457885|129513|P1|COMPLETED|Overall Study||74
55472|NCT01457885|129513|P1|STARTED|Overall Study||74
55473|NCT01457703|129521|P2|NOT COMPLETED|Overall Study||11
55474|NCT01457703|129522|P1|NOT COMPLETED|Overall Study||6
55475|NCT01457703|129521|P2|COMPLETED|Overall Study||22
55476|NCT01457703|129522|P1|COMPLETED|Overall Study||23
55477|NCT01457703|129521|P2|STARTED|Overall Study||33
55478|NCT01457703|129522|P1|STARTED|Overall Study||29
55479|NCT01457521|129538|P2|NOT COMPLETED|Overall Study||10
55480|NCT01457521|129539|P1|NOT COMPLETED|Overall Study||12
55481|NCT01457521|129538|P2|COMPLETED|Overall Study||117
55482|NCT01457521|129539|P1|COMPLETED|Overall Study||111
55483|NCT01457521|129538|P2|STARTED|Overall Study||127
55484|NCT01457521|129539|P1|STARTED|Overall Study||123
55485|NCT01457430|129545|P1|NOT COMPLETED|Overall Study||0
55486|NCT01457430|129545|P1|COMPLETED|Overall Study||19
55487|NCT01457430|129545|P1|STARTED|Overall Study||19
55488|NCT01457417|129557|P5|NOT COMPLETED|Overall Study||0
55489|NCT01457417|129558|P4|NOT COMPLETED|Overall Study||0
55490|NCT01457417|129559|P3|NOT COMPLETED|Overall Study||0
55491|NCT01457417|129560|P2|NOT COMPLETED|Overall Study||0
55492|NCT01457417|129561|P1|NOT COMPLETED|Overall Study||0
55493|NCT01457417|129557|P5|COMPLETED|Overall Study||19
55494|NCT01457417|129558|P4|COMPLETED|Overall Study||3
55495|NCT01457417|129559|P3|COMPLETED|Overall Study||4
55496|NCT01457417|129560|P2|COMPLETED|Overall Study||3
55497|NCT01457417|129561|P1|COMPLETED|Overall Study||3
55498|NCT01457417|129557|P5|STARTED|Overall Study||19
55499|NCT01457417|129558|P4|STARTED|Overall Study||3
55500|NCT01457417|129559|P3|STARTED|Overall Study||4
55501|NCT01457417|129560|P2|STARTED|Overall Study||3
55502|NCT01457417|129561|P1|STARTED|Overall Study||3
55503|NCT01457339|129619|P2|NOT COMPLETED|Period 6 (250 mg)||1
55504|NCT01457339|129620|P1|NOT COMPLETED|Period 6 (250 mg)||1
55505|NCT01457339|129619|P2|COMPLETED|Period 6 (250 mg)||21
55506|NCT01457339|129620|P1|COMPLETED|Period 6 (250 mg)||6
55507|NCT01457339|129619|P2|STARTED|Period 6 (250 mg)||22
55508|NCT01457339|129620|P1|STARTED|Period 6 (250 mg)||7
55509|NCT01457339|129619|P2|NOT COMPLETED|Period 5 (200 mg)||1
55510|NCT01457339|129620|P1|NOT COMPLETED|Period 5 (200 mg)||0
55511|NCT01457339|129619|P2|COMPLETED|Period 5 (200 mg)||22
55512|NCT01457339|129620|P1|COMPLETED|Period 5 (200 mg)||7
55513|NCT01457339|129619|P2|STARTED|Period 5 (200 mg)||23
55514|NCT01457339|129620|P1|STARTED|Period 5 (200 mg)||7
55515|NCT01457339|129619|P2|NOT COMPLETED|Period 4 (150 mg)||0
55516|NCT01457339|129620|P1|NOT COMPLETED|Period 4 (150 mg)||0
55517|NCT01457339|129619|P2|COMPLETED|Period 4 (150 mg)||23
55518|NCT01457339|129620|P1|COMPLETED|Period 4 (150 mg)||7
55519|NCT01457339|129619|P2|STARTED|Period 4 (150 mg)||23
55520|NCT01457339|129620|P1|STARTED|Period 4 (150 mg)||7
55521|NCT01457339|129619|P2|NOT COMPLETED|Period 3 (100 mg)||1
55522|NCT01457339|129620|P1|NOT COMPLETED|Period 3 (100 mg)||0
55523|NCT01457339|129619|P2|COMPLETED|Period 3 (100 mg)||23
55524|NCT01457339|129620|P1|COMPLETED|Period 3 (100 mg)||7
55525|NCT01457339|129619|P2|STARTED|Period 3 (100 mg)||24
55526|NCT01457339|129620|P1|STARTED|Period 3 (100 mg)||7
55527|NCT01457339|129619|P2|NOT COMPLETED|Period 2 (70 mg)||0
55528|NCT01457339|129620|P1|NOT COMPLETED|Period 2 (70 mg)||0
55529|NCT01457339|129619|P2|COMPLETED|Period 2 (70 mg)||24
55530|NCT01457339|129620|P1|COMPLETED|Period 2 (70 mg)||7
55531|NCT01457339|129619|P2|STARTED|Period 2 (70 mg)||24
55532|NCT01457339|129620|P1|STARTED|Period 2 (70 mg)||7
55533|NCT01457339|129619|P2|NOT COMPLETED|Period 1 (50 mg)||0
55534|NCT01457339|129620|P1|NOT COMPLETED|Period 1 (50 mg)||0
55535|NCT01457339|129619|P2|COMPLETED|Period 1 (50 mg)||24
55536|NCT01457339|129620|P1|COMPLETED|Period 1 (50 mg)||7
55537|NCT01457339|129619|P2|STARTED|Period 1 (50 mg)||24
55538|NCT01457339|129620|P1|STARTED|Period 1 (50 mg)||7
55539|NCT01457053|129786|P2|NOT COMPLETED|Overall Study||1
55540|NCT01457053|129787|P1|NOT COMPLETED|Overall Study||1
55541|NCT01457053|129786|P2|COMPLETED|Overall Study||1
55542|NCT01457053|129787|P1|COMPLETED|Overall Study||1
55543|NCT01457053|129786|P2|STARTED|Overall Study||2
55544|NCT01457053|129787|P1|STARTED|Overall Study||2
55545|NCT01457014|129793|P4|NOT COMPLETED|Fourth Night||0
55546|NCT01457014|129794|P3|NOT COMPLETED|Fourth Night||0
55547|NCT01457014|129795|P2|NOT COMPLETED|Fourth Night||0
55548|NCT01457014|129796|P1|NOT COMPLETED|Fourth Night||0
55549|NCT01457014|129793|P4|COMPLETED|Fourth Night||11
55550|NCT01457014|129794|P3|COMPLETED|Fourth Night||12
55551|NCT01457014|129795|P2|COMPLETED|Fourth Night||11
55552|NCT01457014|129796|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
55553|NCT01457014|129793|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55731|NCT01455194|130323|P2|COMPLETED|Overall Study||89
55554|NCT01457014|129794|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
55555|NCT01457014|129795|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55556|NCT01457014|129796|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
55557|NCT01457014|129793|P4|NOT COMPLETED|Third Night||0
55558|NCT01457014|129794|P3|NOT COMPLETED|Third Night||0
55559|NCT01457014|129795|P2|NOT COMPLETED|Third Night||0
55560|NCT01457014|129796|P1|NOT COMPLETED|Third Night||0
55561|NCT01457014|129793|P4|COMPLETED|Third Night||12
55562|NCT01457014|129794|P3|COMPLETED|Third Night||11
55563|NCT01457014|129795|P2|COMPLETED|Third Night||11
55564|NCT01457014|129796|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
55565|NCT01457014|129793|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
55566|NCT01457014|129794|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55567|NCT01457014|129795|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55568|NCT01457014|129796|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
55569|NCT01457014|129793|P4|NOT COMPLETED|Second Night||0
55570|NCT01457014|129794|P3|NOT COMPLETED|Second Night||0
55571|NCT01457014|129795|P2|NOT COMPLETED|Second Night||0
55572|NCT01457014|129796|P1|NOT COMPLETED|Second Night||0
55573|NCT01457014|129793|P4|COMPLETED|Second Night||11
55574|NCT01457014|129794|P3|COMPLETED|Second Night||11
55575|NCT01457014|129795|P2|COMPLETED|Second Night||12
55576|NCT01457014|129796|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
55577|NCT01457014|129793|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55578|NCT01457014|129794|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
55579|NCT01457014|129795|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
55580|NCT01457014|129796|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
55581|NCT01457014|129793|P4|NOT COMPLETED|First Night||0
55582|NCT01457014|129794|P3|NOT COMPLETED|First Night||0
55583|NCT01457014|129795|P2|NOT COMPLETED|First Night||0
55584|NCT01457014|129796|P1|NOT COMPLETED|First Night||40
55585|NCT01457014|129793|P4|COMPLETED|First Night||0
55586|NCT01457014|129794|P3|COMPLETED|First Night||0
55587|NCT01457014|129795|P2|COMPLETED|First Night||0
55588|NCT01457014|129796|P1|COMPLETED|First Night||34
55589|NCT01457014|129793|P4|STARTED|First Night||0
55590|NCT01457014|129794|P3|STARTED|First Night||0
55591|NCT01457014|129795|P2|STARTED|First Night||0
55592|NCT01457014|129796|P1|STARTED|First Night||74
55593|NCT01456962|129813|P2|NOT COMPLETED|Overall Study||1
55594|NCT01456962|129814|P1|NOT COMPLETED|Overall Study||2
55595|NCT01456962|129813|P2|COMPLETED|Overall Study||19
55596|NCT01456962|129814|P1|COMPLETED|Overall Study||14
55597|NCT01456962|129813|P2|STARTED|Overall Study||20
55598|NCT01456962|129814|P1|STARTED|Overall Study||16
55599|NCT01456936|129824|P4|NOT COMPLETED|Overall Study||483
55600|NCT01456936|129825|P3|NOT COMPLETED|Overall Study||481
55601|NCT01456936|129826|P2|NOT COMPLETED|Overall Study||448
55602|NCT01456936|129827|P1|NOT COMPLETED|Overall Study||439
55603|NCT01456936|129824|P4|COMPLETED|Overall Study||1552
55604|NCT01456936|129825|P3|COMPLETED|Overall Study||1557
55605|NCT01456936|129826|P2|COMPLETED|Overall Study||1586
55606|NCT01456936|129827|P1|COMPLETED|Overall Study||1598
55607|NCT01456936|129824|P4|Randomized and Treated|Overall Study||2014
55608|NCT01456936|129825|P3|Randomized and Treated|Overall Study||2022
55609|NCT01456936|129826|P2|Randomized and Treated|Overall Study||2006
55610|NCT01456936|129827|P1|Randomized and Treated|Overall Study||2016
55611|NCT01456936|129824|P4|STARTED|Overall Study||2035
55612|NCT01456936|129825|P3|STARTED|Overall Study||2038
55613|NCT01456936|129826|P2|STARTED|Overall Study||2034
55614|NCT01456936|129827|P1|STARTED|Overall Study||2037
55615|NCT01456299|129936|P3|NOT COMPLETED|Overall Study||1
55616|NCT01456299|129937|P2|NOT COMPLETED|Overall Study||1
55617|NCT01456299|129938|P1|NOT COMPLETED|Overall Study||0
55618|NCT01456299|129936|P3|COMPLETED|Overall Study||33
55619|NCT01456299|129937|P2|COMPLETED|Overall Study||33
55620|NCT01456299|129938|P1|COMPLETED|Overall Study||34
55621|NCT01456299|129936|P3|STARTED|Overall Study||34
55622|NCT01456299|129937|P2|STARTED|Overall Study||34
55623|NCT01456299|129938|P1|STARTED|Overall Study||34
55624|NCT01456195|129949|P3|NOT COMPLETED|Overall Study||14
55625|NCT01456195|129950|P2|NOT COMPLETED|Overall Study||10
55626|NCT01456195|129951|P1|NOT COMPLETED|Overall Study||11
55627|NCT01456195|129949|P3|COMPLETED|Overall Study||127
55628|NCT01456195|129950|P2|COMPLETED|Overall Study||127
55629|NCT01456195|129951|P1|COMPLETED|Overall Study||132
55630|NCT01456195|129949|P3|STARTED|Overall Study||141
55631|NCT01456195|129950|P2|STARTED|Overall Study||137
55632|NCT01456195|129951|P1|STARTED|Overall Study||143
55633|NCT01456169|129971|P3|NOT COMPLETED|Overall Study||12
55634|NCT01456169|129972|P2|NOT COMPLETED|Overall Study||5
55635|NCT01456169|129973|P1|NOT COMPLETED|Overall Study||10
55636|NCT01456169|129971|P3|COMPLETED|Overall Study||123
55637|NCT01456169|129972|P2|COMPLETED|Overall Study||122
55639|NCT01456169|129971|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
55640|NCT01456169|129972|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
55641|NCT01456169|129973|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
55642|NCT01456143|130024|P1|NOT COMPLETED|Overall Study||0
55643|NCT01456143|130024|P1|COMPLETED|Overall Study||33
55644|NCT01456143|130024|P1|STARTED|Overall Study||33
55645|NCT01456130|130033|P1|NOT COMPLETED|Overall Study||10
55646|NCT01456130|130033|P1|COMPLETED|Overall Study||57
55647|NCT01456130|130033|P1|STARTED|Overall Study||67
55648|NCT01456052|130043|P3|NOT COMPLETED|Overall Study||5
55649|NCT01456052|130044|P2|NOT COMPLETED|Overall Study||5
55650|NCT01456052|130045|P1|NOT COMPLETED|Overall Study||2
55651|NCT01456052|130043|P3|COMPLETED|Overall Study||19
55652|NCT01456052|130044|P2|COMPLETED|Overall Study||20
55653|NCT01456052|130045|P1|COMPLETED|Overall Study||8
55654|NCT01456052|130043|P3|STARTED|Overall Study||24
55655|NCT01456052|130044|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
55656|NCT01456052|130045|P1|STARTED|Overall Study||10
55657|NCT01456039|130065|P3|NOT COMPLETED|Phase 2 (Second Step)||33
55658|NCT01456039|130066|P2|NOT COMPLETED|Phase 2 (Second Step)||0
55659|NCT01456039|130067|P1|NOT COMPLETED|Phase 2 (Second Step)||0
55660|NCT01456039|130065|P3|COMPLETED|Phase 2 (Second Step)||7
55661|NCT01456039|130066|P2|COMPLETED|Phase 2 (Second Step)||0
55662|NCT01456039|130067|P1|COMPLETED|Phase 2 (Second Step)||0
55663|NCT01456039|130065|P3|STARTED|Phase 2 (Second Step)||40
55664|NCT01456039|130066|P2|STARTED|Phase 2 (Second Step)||0
55665|NCT01456039|130067|P1|STARTED|Phase 2 (Second Step)||0
55666|NCT01456039|130065|P3|NOT COMPLETED|Phase 1 (First Step)||0
55667|NCT01456039|130066|P2|NOT COMPLETED|Phase 1 (First Step)||7
55668|NCT01456039|130067|P1|NOT COMPLETED|Phase 1 (First Step)||2
55669|NCT01456039|130065|P3|COMPLETED|Phase 1 (First Step)||0
55670|NCT01456039|130066|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
55671|NCT01456039|130067|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
55672|NCT01456039|130065|P3|STARTED|Phase 1 (First Step)||0
55673|NCT01456039|130066|P2|STARTED|Phase 1 (First Step)||8
55674|NCT01456039|130067|P1|STARTED|Phase 1 (First Step)||3
55675|NCT01456000|130139|P2|NOT COMPLETED|Overall Study||3
55676|NCT01456000|130140|P1|NOT COMPLETED|Overall Study||8
55677|NCT01456000|130139|P2|COMPLETED|Overall Study||172
55678|NCT01456000|130140|P1|COMPLETED|Overall Study||170
55679|NCT01456000|130139|P2|STARTED|Overall Study||175
55680|NCT01456000|130140|P1|STARTED|Overall Study||178
55681|NCT01455545|130146|P2|NOT COMPLETED|Overall Study||0
55682|NCT01455545|130147|P1|NOT COMPLETED|Overall Study||0
55683|NCT01455545|130146|P2|COMPLETED|Overall Study||45
55684|NCT01455545|130147|P1|COMPLETED|Overall Study||55
55685|NCT01455545|130146|P2|STARTED|Overall Study||45
55686|NCT01455545|130147|P1|STARTED|Overall Study||55
55687|NCT01455519|130177|P2|NOT COMPLETED|Overall Study||5
55688|NCT01455519|130178|P1|NOT COMPLETED|Overall Study||4
55689|NCT01455519|130177|P2|COMPLETED|Overall Study||18
55690|NCT01455519|130178|P1|COMPLETED|Overall Study||8
55691|NCT01455519|130177|P2|STARTED|Overall Study||23
55692|NCT01455519|130178|P1|STARTED|Overall Study||12
55693|NCT01455428|130210|P2|NOT COMPLETED|Overall Study||18
55694|NCT01455428|130211|P1|NOT COMPLETED|Overall Study||14
55695|NCT01455428|130210|P2|COMPLETED|Overall Study||92
55696|NCT01455428|130211|P1|COMPLETED|Overall Study||98
55697|NCT01455428|130210|P2|Treated|Overall Study||109
55698|NCT01455428|130211|P1|Treated|Overall Study||111
55699|NCT01455428|130210|P2|STARTED|Overall Study||110
55700|NCT01455428|130211|P1|STARTED|Overall Study||112
55701|NCT01455415|130267|P2|NOT COMPLETED|Follow-up||2
55702|NCT01455415|130268|P1|NOT COMPLETED|Follow-up||3
55703|NCT01455415|130267|P2|COMPLETED|Follow-up||104
55704|NCT01455415|130268|P1|COMPLETED|Follow-up||111
55705|NCT01455415|130267|P2|STARTED|Follow-up||106
55706|NCT01455415|130268|P1|STARTED|Follow-up||114
55707|NCT01455415|130267|P2|NOT COMPLETED|Period 2||10
55708|NCT01455415|130268|P1|NOT COMPLETED|Period 2||13
55709|NCT01455415|130267|P2|COMPLETED|Period 2||106
55710|NCT01455415|130268|P1|COMPLETED|Period 2||114
55711|NCT01455415|130267|P2|STARTED|Period 2||116
55712|NCT01455415|130268|P1|STARTED|Period 2||127
55713|NCT01455415|130267|P2|NOT COMPLETED|Washout||7
55714|NCT01455415|130268|P1|NOT COMPLETED|Washout||8
55715|NCT01455415|130267|P2|COMPLETED|Washout||116
55716|NCT01455415|130268|P1|COMPLETED|Washout||127
55717|NCT01455415|130267|P2|STARTED|Washout||123
55718|NCT01455415|130268|P1|STARTED|Washout||135
55719|NCT01455415|130267|P2|NOT COMPLETED|Period 1||24
55720|NCT01455415|130268|P1|NOT COMPLETED|Period 1||19
55721|NCT01455415|130267|P2|COMPLETED|Period 1||123
55722|NCT01455415|130268|P1|COMPLETED|Period 1||135
55723|NCT01455415|130267|P2|STARTED|Period 1|Started=Treated|147
55724|NCT01455415|130268|P1|STARTED|Period 1|Started=Treated|154
55725|NCT01455194|130321|P4|NOT COMPLETED|Overall Study||28
55726|NCT01455194|130322|P3|NOT COMPLETED|Overall Study||30
55727|NCT01455194|130323|P2|NOT COMPLETED|Overall Study||31
55728|NCT01455194|130324|P1|NOT COMPLETED|Overall Study||153
55729|NCT01455194|130321|P4|COMPLETED|Overall Study||97
55730|NCT01455194|130322|P3|COMPLETED|Overall Study||92
55732|NCT01455194|130324|P1|COMPLETED|Overall Study||0
55733|NCT01455194|130321|P4|STARTED|Overall Study||125
55734|NCT01455194|130322|P3|STARTED|Overall Study||122
55735|NCT01455194|130323|P2|STARTED|Overall Study||120
55736|NCT01455194|130324|P1|STARTED|Overall Study||153
55737|NCT01455181|130373|P1|NOT COMPLETED|Overall Study||0
55738|NCT01455181|130373|P1|COMPLETED|Overall Study||24
55739|NCT01455181|130373|P1|STARTED|Overall Study||24
55740|NCT01455064|130381|P1|NOT COMPLETED|Overall Study||1
55741|NCT01455064|130381|P1|COMPLETED|Overall Study||30
55742|NCT01455064|130381|P1|STARTED|Overall Study||31
55743|NCT01455012|130387|P2|NOT COMPLETED|Overall Study||4
55744|NCT01455012|130388|P1|NOT COMPLETED|Overall Study||11
55745|NCT01455012|130387|P2|COMPLETED|Overall Study||36
55746|NCT01455012|130388|P1|COMPLETED|Overall Study||30
55747|NCT01455012|130387|P2|STARTED|Overall Study||40
55748|NCT01455012|130388|P1|STARTED|Overall Study||41
55749|NCT01454830|130422|P2|NOT COMPLETED|Overall Study||27
55750|NCT01454830|130423|P1|NOT COMPLETED|Overall Study||31
55751|NCT01454830|130422|P2|COMPLETED|Overall Study||30
55752|NCT01454830|130423|P1|COMPLETED|Overall Study||30
55753|NCT01454830|130422|P2|STARTED|Overall Study||57
55754|NCT01454830|130423|P1|STARTED|Overall Study||61
55755|NCT01454791|130443|P2|NOT COMPLETED|Overall Study||0
55756|NCT01454791|130444|P1|NOT COMPLETED|Overall Study||0
55757|NCT01454791|130443|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
55758|NCT01454791|130444|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
55759|NCT01454791|130443|P2|STARTED|Overall Study||20
55760|NCT01454791|130444|P1|STARTED|Overall Study||20
55761|NCT01454778|130454|P1|NOT COMPLETED|Overall Study||3
55762|NCT01454778|130454|P1|COMPLETED|Overall Study||47
55763|NCT01454778|130454|P1|STARTED|Overall Study||50
55764|NCT01454726|130465|P2|NOT COMPLETED|Overall Study||1
55765|NCT01454726|130466|P1|NOT COMPLETED|Overall Study||0
55766|NCT01454726|130465|P2|COMPLETED|Overall Study||10
55767|NCT01454726|130466|P1|COMPLETED|Overall Study||16
55768|NCT01454726|130465|P2|STARTED|Overall Study||11
55769|NCT01454726|130466|P1|STARTED|Overall Study||16
55770|NCT01454583|130475|P3|NOT COMPLETED|3rd Year||297
55771|NCT01454583|130476|P2|NOT COMPLETED|3rd Year||512
55772|NCT01454583|130477|P1|NOT COMPLETED|3rd Year||1959
55773|NCT01454583|130475|P3|COMPLETED|3rd Year||285
55774|NCT01454583|130476|P2|COMPLETED|3rd Year||470
55775|NCT01454583|130477|P1|COMPLETED|3rd Year||1832
55776|NCT01454583|130475|P3|STARTED|3rd Year||582
55777|NCT01454583|130476|P2|STARTED|3rd Year||982
55778|NCT01454583|130477|P1|STARTED|3rd Year||3791
55779|NCT01454583|130475|P3|NOT COMPLETED|2nd Year||737
55780|NCT01454583|130476|P2|NOT COMPLETED|2nd Year||1049
55781|NCT01454583|130477|P1|NOT COMPLETED|2nd Year||3965
55782|NCT01454583|130475|P3|COMPLETED|2nd Year||1376
55783|NCT01454583|130476|P2|COMPLETED|2nd Year||1647
55784|NCT01454583|130477|P1|COMPLETED|2nd Year||6212
55785|NCT01454583|130475|P3|STARTED|2nd Year||2113
55786|NCT01454583|130476|P2|STARTED|2nd Year||2696
55787|NCT01454583|130477|P1|STARTED|2nd Year||10177
55788|NCT01454583|130475|P3|NOT COMPLETED|1st Year||180
55789|NCT01454583|130476|P2|NOT COMPLETED|1st Year||318
55790|NCT01454583|130477|P1|NOT COMPLETED|1st Year||1057
55791|NCT01454583|130475|P3|COMPLETED|1st Year||1933
55792|NCT01454583|130476|P2|COMPLETED|1st Year||2378
55793|NCT01454583|130477|P1|COMPLETED|1st Year||9120
55794|NCT01454583|130475|P3|STARTED|1st Year||2113
55795|NCT01454583|130476|P2|STARTED|1st Year||2696
55796|NCT01454583|130477|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
55797|NCT01454531|130545|P1|NOT COMPLETED|Overall Study||23
55798|NCT01454531|130545|P1|COMPLETED|Overall Study||173
55799|NCT01454531|130545|P1|Subjects Treated|Overall Study||192
55800|NCT01454531|130545|P1|STARTED|Overall Study||196
55801|NCT01454505|130557|P4|NOT COMPLETED|Overall Study||0
55802|NCT01454505|130558|P3|NOT COMPLETED|Overall Study||0
55803|NCT01454505|130559|P2|NOT COMPLETED|Overall Study||0
55804|NCT01454505|130560|P1|NOT COMPLETED|Overall Study||0
55805|NCT01454505|130557|P4|COMPLETED|Overall Study||20
55806|NCT01454505|130558|P3|COMPLETED|Overall Study||40
55807|NCT01454505|130559|P2|COMPLETED|Overall Study||15
55808|NCT01454505|130560|P1|COMPLETED|Overall Study||35
55809|NCT01454505|130557|P4|STARTED|Overall Study||20
55810|NCT01454505|130558|P3|STARTED|Overall Study||40
55811|NCT01454505|130559|P2|STARTED|Overall Study||15
55812|NCT01454505|130560|P1|STARTED|Overall Study||35
55813|NCT01454414|130574|P2|NOT COMPLETED|Overall Study||16
55814|NCT01454414|130575|P1|NOT COMPLETED|Overall Study||13
55815|NCT01454414|130574|P2|COMPLETED|Overall Study||64
55816|NCT01454414|130575|P1|COMPLETED|Overall Study||66
55817|NCT01454414|130574|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
55818|NCT01454414|130575|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
55819|NCT01454414|130574|P2|STARTED|Overall Study||80
55820|NCT01454414|130575|P1|STARTED|Overall Study||79
55821|NCT01454401|130581|P1|NOT COMPLETED|Overall Study||5
55822|NCT01454401|130581|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
55823|NCT01454401|130581|P1|STARTED|Overall Study|ITT|44
55824|NCT01454258|130586|P1|NOT COMPLETED|Overall Study||997
55825|NCT01454258|130586|P1|COMPLETED|Overall Study||9103
55826|NCT01454258|130586|P1|STARTED|Overall Study||10100
55827|NCT01454063|130594|P2|NOT COMPLETED|Treated||0
55828|NCT01454063|130595|P1|NOT COMPLETED|Treated||2
55829|NCT01454063|130594|P2|COMPLETED|Treated||201
55830|NCT01454063|130595|P1|COMPLETED|Treated||199
55831|NCT01454063|130594|P2|STARTED|Treated||201
55832|NCT01454063|130595|P1|STARTED|Treated||201
55833|NCT01454063|130594|P2|NOT COMPLETED|Randomized||2
55834|NCT01454063|130595|P1|NOT COMPLETED|Randomized||1
55835|NCT01454063|130594|P2|COMPLETED|Randomized||201
55836|NCT01454063|130595|P1|COMPLETED|Randomized||201
55837|NCT01454063|130594|P2|STARTED|Randomized||203
55838|NCT01454063|130595|P1|STARTED|Randomized||202
55839|NCT01453998|130616|P3|NOT COMPLETED|After Protocol Amendment 2.||0
55840|NCT01453998|130617|P2|NOT COMPLETED|After Protocol Amendment 2.||0
55841|NCT01453998|130618|P1|NOT COMPLETED|After Protocol Amendment 2.||1
55842|NCT01453998|130616|P3|COMPLETED|After Protocol Amendment 2.||183
55843|NCT01453998|130617|P2|COMPLETED|After Protocol Amendment 2.||99
55844|NCT01453998|130618|P1|COMPLETED|After Protocol Amendment 2.||102
55845|NCT01453998|130616|P3|STARTED|After Protocol Amendment 2.||183
55846|NCT01453998|130617|P2|STARTED|After Protocol Amendment 2.||99
55847|NCT01453998|130618|P1|STARTED|After Protocol Amendment 2.||103
55848|NCT01453998|130616|P3|NOT COMPLETED|Before Protocol Amendment 2||0
55849|NCT01453998|130617|P2|NOT COMPLETED|Before Protocol Amendment 2||0
55850|NCT01453998|130618|P1|NOT COMPLETED|Before Protocol Amendment 2||0
55851|NCT01453998|130616|P3|COMPLETED|Before Protocol Amendment 2||99
55852|NCT01453998|130617|P2|COMPLETED|Before Protocol Amendment 2||88
55853|NCT01453998|130618|P1|COMPLETED|Before Protocol Amendment 2||85
55854|NCT01453998|130616|P3|STARTED|Before Protocol Amendment 2||99
55855|NCT01453998|130617|P2|STARTED|Before Protocol Amendment 2||88
55856|NCT01453998|130618|P1|STARTED|Before Protocol Amendment 2||85
55857|NCT01453946|130683|P1|NOT COMPLETED|Overall Study||9
55858|NCT01453946|130683|P1|COMPLETED|Overall Study||41
55859|NCT01453946|130683|P1|STARTED|Overall Study||50
55860|NCT01453894|130691|P2|NOT COMPLETED|Overall Study||0
55861|NCT01453894|130692|P1|NOT COMPLETED|Overall Study||0
55862|NCT01453894|130691|P2|COMPLETED|Overall Study||225
55863|NCT01453894|130692|P1|COMPLETED|Overall Study||225
55864|NCT01453894|130691|P2|STARTED|Overall Study||225
55865|NCT01453894|130692|P1|STARTED|Overall Study||225
55866|NCT01453855|130700|P2|NOT COMPLETED|Overall Study||14
55867|NCT01453855|130701|P1|NOT COMPLETED|Overall Study||10
55868|NCT01453855|130700|P2|COMPLETED|Overall Study||408
55869|NCT01453855|130701|P1|COMPLETED|Overall Study||432
55870|NCT01453855|130700|P2|STARTED|Overall Study||422
55871|NCT01453855|130701|P1|STARTED|Overall Study||442
55872|NCT01453725|130709|P2|NOT COMPLETED|Overall Study||11
55873|NCT01453725|130710|P1|NOT COMPLETED|Overall Study||13
55874|NCT01453725|130709|P2|COMPLETED|Overall Study||89
55875|NCT01453725|130710|P1|COMPLETED|Overall Study||85
55876|NCT01453725|130709|P2|STARTED|Overall Study||100
55877|NCT01453725|130710|P1|STARTED|Overall Study||98
55878|NCT01453595|130733|P3|NOT COMPLETED|Overall Study||2
55879|NCT01453595|130734|P2|NOT COMPLETED|Overall Study||1
55880|NCT01453595|130735|P1|NOT COMPLETED|Overall Study||2
55881|NCT01453595|130733|P3|COMPLETED|Overall Study||0
55882|NCT01453595|130734|P2|COMPLETED|Overall Study||5
55883|NCT01453595|130735|P1|COMPLETED|Overall Study||0
55884|NCT01453595|130733|P3|STARTED|Overall Study||2
55885|NCT01453595|130734|P2|STARTED|Overall Study||6
55886|NCT01453595|130735|P1|STARTED|Overall Study||2
55887|NCT01453569|130744|P3|NOT COMPLETED|Overall Study||7
55888|NCT01453569|130745|P2|NOT COMPLETED|Overall Study||14
55889|NCT01453569|130746|P1|NOT COMPLETED|Overall Study||11
55890|NCT01453569|130744|P3|COMPLETED|Overall Study||78
55891|NCT01453569|130745|P2|COMPLETED|Overall Study||70
55892|NCT01453569|130746|P1|COMPLETED|Overall Study||75
55893|NCT01453569|130744|P3|STARTED|Overall Study||85
55894|NCT01453569|130745|P2|STARTED|Overall Study||84
55895|NCT01453569|130746|P1|STARTED|Overall Study||86
55896|NCT01453413|130763|P1|NOT COMPLETED|Overall Study||0
55897|NCT01453413|130763|P1|COMPLETED|Overall Study||297
55898|NCT01453413|130763|P1|STARTED|Overall Study||297
55899|NCT01453374|130768|P1|NOT COMPLETED|Overall Study||18
55900|NCT01453374|130768|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
55901|NCT01453374|130768|P1|STARTED|Overall Study||27
55902|NCT01453348|130787|P3|NOT COMPLETED|Overall Study||1
55903|NCT01453348|130788|P2|NOT COMPLETED|Overall Study||1
55904|NCT01453348|130789|P1|NOT COMPLETED|Overall Study||1
55905|NCT01453348|130787|P3|COMPLETED|Overall Study||83
55906|NCT01453348|130788|P2|COMPLETED|Overall Study||83
55907|NCT01453348|130789|P1|COMPLETED|Overall Study||83
55908|NCT01453348|130787|P3|STARTED|Overall Study||84
55909|NCT01453348|130788|P2|STARTED|Overall Study||84
55910|NCT01453348|130789|P1|STARTED|Overall Study||84
55911|NCT01453296|130805|P2|NOT COMPLETED|Treatment Period 2||0
55912|NCT01453296|130806|P1|NOT COMPLETED|Treatment Period 2||2
55913|NCT01453296|130805|P2|COMPLETED|Treatment Period 2||13
55914|NCT01453296|130806|P1|COMPLETED|Treatment Period 2||11
55915|NCT01453296|130805|P2|STARTED|Treatment Period 2||13
55916|NCT01453296|130806|P1|STARTED|Treatment Period 2||13
55917|NCT01453296|130805|P2|NOT COMPLETED|Washout Period||0
55918|NCT01453296|130806|P1|NOT COMPLETED|Washout Period||0
55919|NCT01453296|130805|P2|COMPLETED|Washout Period||13
55920|NCT01453296|130806|P1|COMPLETED|Washout Period||13
55921|NCT01453296|130805|P2|STARTED|Washout Period||13
55922|NCT01453296|130806|P1|STARTED|Washout Period||13
55923|NCT01453296|130805|P2|NOT COMPLETED|Treatment Period 1||1
55924|NCT01453296|130806|P1|NOT COMPLETED|Treatment Period 1||1
55925|NCT01453296|130805|P2|COMPLETED|Treatment Period 1||13
55926|NCT01453296|130806|P1|COMPLETED|Treatment Period 1||13
55927|NCT01453296|130805|P2|STARTED|Treatment Period 1||14
55928|NCT01453296|130806|P1|STARTED|Treatment Period 1||14
55929|NCT01453166|130873|P3|NOT COMPLETED|Overall Study||1
55930|NCT01453166|130874|P2|NOT COMPLETED|Overall Study||2
55931|NCT01453166|130875|P1|NOT COMPLETED|Overall Study||2
55932|NCT01453166|130873|P3|COMPLETED|Overall Study||38
55933|NCT01453166|130874|P2|COMPLETED|Overall Study||39
55934|NCT01453166|130875|P1|COMPLETED|Overall Study||40
55935|NCT01453166|130873|P3|STARTED|Overall Study||39
55936|NCT01453166|130874|P2|STARTED|Overall Study||41
55937|NCT01453166|130875|P1|STARTED|Overall Study||42
55938|NCT01453075|130897|P2|NOT COMPLETED|Overall Study||1
55939|NCT01453075|130898|P1|NOT COMPLETED|Overall Study||5
55940|NCT01453075|130897|P2|COMPLETED|Overall Study||14
55941|NCT01453075|130898|P1|COMPLETED|Overall Study||11
55942|NCT01453075|130897|P2|STARTED|Overall Study||15
55943|NCT01453075|130898|P1|STARTED|Overall Study||16
55944|NCT01453049|130906|P2|NOT COMPLETED|Overall Study||42
55945|NCT01453049|130907|P1|NOT COMPLETED|Overall Study||41
55946|NCT01453049|130906|P2|COMPLETED|Overall Study||2
55947|NCT01453049|130907|P1|COMPLETED|Overall Study||1
55948|NCT01453049|130906|P2|STARTED|Overall Study||44
55949|NCT01453049|130907|P1|STARTED|Overall Study||42
55950|NCT01453036|130980|P3|NOT COMPLETED|Overall Study||31
55951|NCT01453036|130981|P2|NOT COMPLETED|Overall Study||115
55952|NCT01453036|130982|P1|NOT COMPLETED|Overall Study||26
55953|NCT01453036|130980|P3|COMPLETED|Overall Study||277
55954|NCT01453036|130981|P2|COMPLETED|Overall Study||193
55955|NCT01453036|130982|P1|COMPLETED|Overall Study||282
55956|NCT01453036|130980|P3|STARTED|Overall Study||308
55957|NCT01453036|130981|P2|STARTED|Overall Study||308
55958|NCT01453036|130982|P1|STARTED|Overall Study||308
55959|NCT01453023|130990|P2|NOT COMPLETED|Treatment Period 2||1
55960|NCT01453023|130991|P1|NOT COMPLETED|Treatment Period 2||0
55961|NCT01453023|130990|P2|COMPLETED|Treatment Period 2||11
55962|NCT01453023|130991|P1|COMPLETED|Treatment Period 2||12
55963|NCT01453023|130990|P2|STARTED|Treatment Period 2||12
55964|NCT01453023|130991|P1|STARTED|Treatment Period 2||12
55965|NCT01453023|130990|P2|NOT COMPLETED|Washout Period||0
55966|NCT01453023|130991|P1|NOT COMPLETED|Washout Period||0
55967|NCT01453023|130990|P2|COMPLETED|Washout Period||12
55968|NCT01453023|130991|P1|COMPLETED|Washout Period||12
55969|NCT01453023|130990|P2|STARTED|Washout Period||12
55970|NCT01453023|130991|P1|STARTED|Washout Period||12
55971|NCT01453023|130990|P2|NOT COMPLETED|Treatment Period (TP) 1||1
55972|NCT01453023|130991|P1|NOT COMPLETED|Treatment Period (TP) 1||1
55973|NCT01453023|130990|P2|COMPLETED|Treatment Period (TP) 1||12
55974|NCT01453023|130991|P1|COMPLETED|Treatment Period (TP) 1||12
55975|NCT01453023|130990|P2|STARTED|Treatment Period (TP) 1||13
55976|NCT01453023|130991|P1|STARTED|Treatment Period (TP) 1||13
55977|NCT01452854|131059|P1|NOT COMPLETED|Overall Study||0
55978|NCT01452854|131059|P1|COMPLETED|Overall Study||2
55979|NCT01452854|131059|P1|STARTED|Overall Study||2
55980|NCT01452529|131065|P3|NOT COMPLETED|Double-blind (DB) Period||82
55981|NCT01452529|131066|P2|NOT COMPLETED|Double-blind (DB) Period||67
55982|NCT01452529|131067|P1|NOT COMPLETED|Double-blind (DB) Period||0
55983|NCT01452529|131065|P3|COMPLETED|Double-blind (DB) Period||210
55984|NCT01452529|131066|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
55985|NCT01452529|131067|P1|COMPLETED|Double-blind (DB) Period||0
55986|NCT01452529|131065|P3|STARTED|Double-blind (DB) Period||292
55987|NCT01452529|131066|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
55988|NCT01452529|131067|P1|STARTED|Double-blind (DB) Period||0
55989|NCT01452529|131065|P3|NOT COMPLETED|Run-in Period||0
55990|NCT01452529|131066|P2|NOT COMPLETED|Run-in Period||0
55991|NCT01452529|131067|P1|NOT COMPLETED|Run-in Period||313
55992|NCT01452529|131065|P3|COMPLETED|Run-in Period||0
55993|NCT01452529|131066|P2|COMPLETED|Run-in Period||0
55994|NCT01452529|131067|P1|COMPLETED|Run-in Period||592
55995|NCT01452529|131065|P3|STARTED|Run-in Period||0
55996|NCT01452529|131066|P2|STARTED|Run-in Period||0
55997|NCT01452529|131067|P1|STARTED|Run-in Period||905
55998|NCT01452425|131074|P1|NOT COMPLETED|Overall Study||0
55999|NCT01452425|131074|P1|COMPLETED|Overall Study||10
56000|NCT01452425|131074|P1|STARTED|Overall Study||10
56001|NCT01452347|131081|P2|NOT COMPLETED|Overall Study||7
56002|NCT01452347|131082|P1|NOT COMPLETED|Overall Study||17
56003|NCT01452347|131081|P2|COMPLETED|Overall Study||77
56004|NCT01452347|131082|P1|COMPLETED|Overall Study||151
56005|NCT01452347|131081|P2|STARTED|Overall Study||84
56006|NCT01452347|131082|P1|STARTED|Overall Study||168
56007|NCT01452269|131100|P2|NOT COMPLETED|Overall Study||5
56008|NCT01452269|131101|P1|NOT COMPLETED|Overall Study||1
56009|NCT01452269|131100|P2|COMPLETED|Overall Study||51
56010|NCT01452269|131101|P1|COMPLETED|Overall Study||47
56011|NCT01452269|131100|P2|STARTED|Overall Study||56
56012|NCT01452269|131101|P1|STARTED|Overall Study||48
56013|NCT01452152|131114|P3|NOT COMPLETED|Overall Study||4
56014|NCT01452152|131115|P2|NOT COMPLETED|Overall Study||0
56015|NCT01452152|131116|P1|NOT COMPLETED|Overall Study||5
56016|NCT01452152|131114|P3|COMPLETED|Overall Study||0
56017|NCT01452152|131115|P2|COMPLETED|Overall Study||0
56018|NCT01452152|131116|P1|COMPLETED|Overall Study||0
56019|NCT01452152|131114|P3|STARTED|Overall Study||4
56020|NCT01452152|131115|P2|STARTED|Overall Study||0
56021|NCT01452152|131116|P1|STARTED|Overall Study||5
56022|NCT01452126|131124|P1|NOT COMPLETED|Overall Study||0
56023|NCT01452126|131124|P1|COMPLETED|Overall Study||49
56024|NCT01452126|131124|P1|STARTED|Overall Study||49
56025|NCT01451983|131136|P4|NOT COMPLETED|Overall Study||0
56026|NCT01451983|131137|P3|NOT COMPLETED|Overall Study||0
56027|NCT01451983|131138|P2|NOT COMPLETED|Overall Study||0
56028|NCT01451983|131139|P1|NOT COMPLETED|Overall Study||0
56029|NCT01451983|131136|P4|COMPLETED|Overall Study||24
56030|NCT01451983|131137|P3|COMPLETED|Overall Study||61
56031|NCT01451983|131138|P2|COMPLETED|Overall Study||27
56032|NCT01451983|131139|P1|COMPLETED|Overall Study||26
56033|NCT01451983|131136|P4|STARTED|Overall Study||24
56034|NCT01451983|131137|P3|STARTED|Overall Study||61
56035|NCT01451983|131138|P2|STARTED|Overall Study||27
56036|NCT01451983|131139|P1|STARTED|Overall Study||26
56037|NCT01451931|131152|P3|NOT COMPLETED|Overall Study||43
56038|NCT01451931|131153|P2|NOT COMPLETED|Overall Study||58
56039|NCT01451931|131154|P1|NOT COMPLETED|Overall Study||33
56040|NCT01451931|131152|P3|COMPLETED|Overall Study||923
56041|NCT01451931|131153|P2|COMPLETED|Overall Study||843
56042|NCT01451931|131154|P1|COMPLETED|Overall Study||876
56043|NCT01451931|131152|P3|6-month Follow up|Overall Study||923
56044|NCT01451931|131153|P2|6-month Follow up|Overall Study||843
56045|NCT01451931|131154|P1|6-month Follow up|Overall Study||876
56046|NCT01451931|131152|P3|Baseline Data Collection|Overall Study||958
56047|NCT01451931|131153|P2|Baseline Data Collection|Overall Study||893
56048|NCT01451931|131154|P1|Baseline Data Collection|Overall Study||908
56049|NCT01451931|131152|P3|STARTED|Overall Study||966
56050|NCT01451931|131153|P2|STARTED|Overall Study||901
56051|NCT01451931|131154|P1|STARTED|Overall Study||909
56052|NCT01451814|131176|P2|NOT COMPLETED|Overall Study||5
56053|NCT01451814|131177|P1|NOT COMPLETED|Overall Study||6
56054|NCT01451814|131176|P2|COMPLETED|Overall Study||26
56055|NCT01451814|131177|P1|COMPLETED|Overall Study||29
56056|NCT01451814|131176|P2|Attended a Session|Overall Study||31
56057|NCT01451814|131177|P1|Attended a Session|Overall Study||35
56058|NCT01451814|131176|P2|STARTED|Overall Study||31
56059|NCT01451814|131177|P1|STARTED|Overall Study||35
56060|NCT01451775|131187|P6|NOT COMPLETED|Overall Study||0
56061|NCT01451775|131188|P5|NOT COMPLETED|Overall Study||0
56062|NCT01451775|131189|P4|NOT COMPLETED|Overall Study||0
56063|NCT01451775|131190|P3|NOT COMPLETED|Overall Study||0
56064|NCT01451775|131191|P2|NOT COMPLETED|Overall Study||0
56065|NCT01451775|131192|P1|NOT COMPLETED|Overall Study||0
56066|NCT01451775|131187|P6|COMPLETED|Overall Study||3
56067|NCT01451775|131188|P5|COMPLETED|Overall Study||3
56068|NCT01451775|131189|P4|COMPLETED|Overall Study||3
56069|NCT01451775|131190|P3|COMPLETED|Overall Study||3
56070|NCT01451775|131191|P2|COMPLETED|Overall Study||3
56071|NCT01451775|131192|P1|COMPLETED|Overall Study||3
56072|NCT01451775|131187|P6|STARTED|Overall Study||3
56073|NCT01451775|131188|P5|STARTED|Overall Study||3
56074|NCT01451775|131189|P4|STARTED|Overall Study||3
56075|NCT01451775|131190|P3|STARTED|Overall Study||3
56076|NCT01451775|131191|P2|STARTED|Overall Study||3
56077|NCT01451775|131192|P1|STARTED|Overall Study||3
56078|NCT01451762|131209|P3|NOT COMPLETED|Overall Study||6
56079|NCT01451762|131210|P2|NOT COMPLETED|Overall Study||6
56080|NCT01451762|131211|P1|NOT COMPLETED|Overall Study||3
56081|NCT01451762|131209|P3|COMPLETED|Overall Study||24
56082|NCT01451762|131210|P2|COMPLETED|Overall Study||24
56083|NCT01451762|131211|P1|COMPLETED|Overall Study||27
56084|NCT01451762|131209|P3|STARTED|Overall Study||30
56085|NCT01451762|131210|P2|STARTED|Overall Study||30
56086|NCT01451762|131211|P1|STARTED|Overall Study||30
56087|NCT01451749|131221|P2|NOT COMPLETED|Overall Study||14
56088|NCT01451749|131222|P1|NOT COMPLETED|Overall Study||32
56089|NCT01451749|131221|P2|COMPLETED|Overall Study||94
56090|NCT01451749|131222|P1|COMPLETED|Overall Study||184
56091|NCT01451749|131221|P2|STARTED|Overall Study||108
56092|NCT01451749|131222|P1|STARTED|Overall Study||216
56093|NCT01451723|131234|P2|NOT COMPLETED|Overall Study||5
56094|NCT01451723|131235|P1|NOT COMPLETED|Overall Study||6
56095|NCT01451723|131234|P2|COMPLETED|Overall Study||0
56096|NCT01451723|131235|P1|COMPLETED|Overall Study||0
56097|NCT01451723|131234|P2|STARTED|Overall Study||5
56098|NCT01451723|131235|P1|STARTED|Overall Study||6
56099|NCT01451645|131245|P2|NOT COMPLETED|Overall Study||8
56100|NCT01451645|131246|P1|NOT COMPLETED|Overall Study||9
56101|NCT01451645|131245|P2|COMPLETED|Overall Study||33
56102|NCT01451645|131246|P1|COMPLETED|Overall Study||32
56103|NCT01451645|131245|P2|STARTED|Overall Study||41
56104|NCT01451645|131246|P1|STARTED|Overall Study||41
56105|NCT01451632|131260|P10|NOT COMPLETED|Overall Study||0
56106|NCT01451632|131261|P9|NOT COMPLETED|Overall Study||0
56107|NCT01451632|131262|P8|NOT COMPLETED|Overall Study||0
56108|NCT01451632|131263|P7|NOT COMPLETED|Overall Study||0
56109|NCT01451632|131264|P6|NOT COMPLETED|Overall Study||0
56110|NCT01451632|131265|P5|NOT COMPLETED|Overall Study||0
56111|NCT01451632|131266|P4|NOT COMPLETED|Overall Study||0
56112|NCT01451632|131267|P3|NOT COMPLETED|Overall Study||0
56113|NCT01451632|131268|P2|NOT COMPLETED|Overall Study||0
56114|NCT01451632|131269|P1|NOT COMPLETED|Overall Study||0
56115|NCT01451632|131260|P10|COMPLETED|Overall Study||4
56116|NCT01451632|131261|P9|COMPLETED|Overall Study||4
56117|NCT01451632|131262|P8|COMPLETED|Overall Study||6
56118|NCT01451632|131263|P7|COMPLETED|Overall Study||8
56119|NCT01451632|131264|P6|COMPLETED|Overall Study||4
56120|NCT01451632|131265|P5|COMPLETED|Overall Study||4
56121|NCT01451632|131266|P4|COMPLETED|Overall Study||3
56122|NCT01451632|131267|P3|COMPLETED|Overall Study||3
56123|NCT01451632|131268|P2|COMPLETED|Overall Study||4
56124|NCT01451632|131269|P1|COMPLETED|Overall Study||8
56125|NCT01451632|131260|P10|STARTED|Overall Study||4
56126|NCT01451632|131261|P9|STARTED|Overall Study||4
56127|NCT01451632|131262|P8|STARTED|Overall Study||6
56128|NCT01451632|131263|P7|STARTED|Overall Study||8
56129|NCT01451632|131264|P6|STARTED|Overall Study||4
56130|NCT01451632|131265|P5|STARTED|Overall Study||4
56131|NCT01451632|131266|P4|STARTED|Overall Study||3
56132|NCT01451632|131267|P3|STARTED|Overall Study||3
56133|NCT01451632|131268|P2|STARTED|Overall Study||4
56134|NCT01451632|131269|P1|STARTED|Overall Study||8
56135|NCT01451554|131317|P2|NOT COMPLETED|Overall Study||9
56136|NCT01451554|131318|P1|NOT COMPLETED|Overall Study||14
56137|NCT01451554|131317|P2|COMPLETED|Overall Study||23
56138|NCT01451554|131318|P1|COMPLETED|Overall Study||19
56139|NCT01451554|131317|P2|STARTED|Overall Study||32
56140|NCT01451554|131318|P1|STARTED|Overall Study||33
56141|NCT01451541|131329|P3|NOT COMPLETED|Overall Study||27
56142|NCT01451541|131330|P2|NOT COMPLETED|Overall Study||25
56143|NCT01451541|131331|P1|NOT COMPLETED|Overall Study||36
56144|NCT01451541|131329|P3|COMPLETED|Overall Study||254
56145|NCT01451541|131330|P2|COMPLETED|Overall Study||257
56146|NCT01451541|131331|P1|COMPLETED|Overall Study||247
56147|NCT01451541|131329|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
56148|NCT01451541|131330|P2|STARTED|Overall Study||282
56149|NCT01451541|131331|P1|STARTED|Overall Study||283
56150|NCT01451437|131380|P9|NOT COMPLETED|Overall Study||4
56151|NCT01451437|131381|P8|NOT COMPLETED|Overall Study||3
56152|NCT01451437|131382|P7|NOT COMPLETED|Overall Study||6
56153|NCT01451437|131383|P6|NOT COMPLETED|Overall Study||3
56154|NCT01451437|131384|P5|NOT COMPLETED|Overall Study||4
56155|NCT01451437|131385|P4|NOT COMPLETED|Overall Study||1
56156|NCT01451437|131386|P3|NOT COMPLETED|Overall Study||3
56157|NCT01451437|131387|P2|NOT COMPLETED|Overall Study||1
56158|NCT01451437|131388|P1|NOT COMPLETED|Overall Study||1
56159|NCT01451437|131380|P9|COMPLETED|Overall Study||0
56160|NCT01451437|131381|P8|COMPLETED|Overall Study||0
56161|NCT01451437|131382|P7|COMPLETED|Overall Study||0
56162|NCT01451437|131383|P6|COMPLETED|Overall Study||0
56163|NCT01451437|131384|P5|COMPLETED|Overall Study||0
56164|NCT01451437|131385|P4|COMPLETED|Overall Study||0
56165|NCT01451437|131386|P3|COMPLETED|Overall Study||0
56166|NCT01451437|131387|P2|COMPLETED|Overall Study||0
56167|NCT01451437|131388|P1|COMPLETED|Overall Study||0
56168|NCT01451437|131380|P9|STARTED|Overall Study||4
56169|NCT01451437|131381|P8|STARTED|Overall Study||3
56170|NCT01451437|131382|P7|STARTED|Overall Study||6
56171|NCT01451437|131383|P6|STARTED|Overall Study||3
56172|NCT01451437|131384|P5|STARTED|Overall Study||4
56173|NCT01451437|131385|P4|STARTED|Overall Study||1
56174|NCT01451437|131386|P3|STARTED|Overall Study||3
56175|NCT01451437|131387|P2|STARTED|Overall Study||1
56176|NCT01451437|131388|P1|STARTED|Overall Study||1
56177|NCT01451424|131520|P4|NOT COMPLETED|Overall Study||5
56178|NCT01451424|131521|P3|NOT COMPLETED|Overall Study||1
56179|NCT01451424|131522|P2|NOT COMPLETED|Overall Study||2
56180|NCT01451424|131523|P1|NOT COMPLETED|Overall Study||1
56181|NCT01451424|131520|P4|COMPLETED|Overall Study||5
56182|NCT01451424|131521|P3|COMPLETED|Overall Study||11
56183|NCT01451424|131522|P2|COMPLETED|Overall Study||7
56184|NCT01451424|131523|P1|COMPLETED|Overall Study||8
56185|NCT01451424|131520|P4|STARTED|Overall Study||10
56186|NCT01451424|131521|P3|STARTED|Overall Study||12
56187|NCT01451424|131522|P2|STARTED|Overall Study||9
56188|NCT01451424|131523|P1|STARTED|Overall Study||9
56189|NCT01451411|131556|P2|NOT COMPLETED|Overall Study||0
56190|NCT01451411|131557|P1|NOT COMPLETED|Overall Study||0
56191|NCT01451411|131556|P2|COMPLETED|Overall Study||1
56192|NCT01451411|131557|P1|COMPLETED|Overall Study||3
56193|NCT01451411|131556|P2|STARTED|Overall Study||1
56194|NCT01451411|131557|P1|STARTED|Overall Study||3
56195|NCT01451398|131581|P2|NOT COMPLETED|Overall Study||37
56196|NCT01451398|131582|P1|NOT COMPLETED|Overall Study||27
56197|NCT01451398|131581|P2|COMPLETED|Overall Study||139
56198|NCT01451398|131582|P1|COMPLETED|Overall Study||150
56199|NCT01451398|131581|P2|STARTED|Overall Study||176
56200|NCT01451398|131582|P1|STARTED|Overall Study||177
56201|NCT01451203|131616|P2|NOT COMPLETED|Post-treatment Period||34
56202|NCT01451203|131617|P1|NOT COMPLETED|Post-treatment Period||14
56203|NCT01451203|131616|P2|COMPLETED|Post-treatment Period||74
56204|NCT01451203|131617|P1|COMPLETED|Post-treatment Period||57
56205|NCT01451203|131616|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
56206|NCT01451203|131617|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
56207|NCT01451203|131616|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
56208|NCT01451203|131617|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
56209|NCT01451203|131616|P2|NOT COMPLETED|Double-blind Treatment Period||50
56210|NCT01451203|131617|P1|NOT COMPLETED|Double-blind Treatment Period||85
56211|NCT01451203|131616|P2|COMPLETED|Double-blind Treatment Period||111
56212|NCT01451203|131617|P1|COMPLETED|Double-blind Treatment Period||73
56213|NCT01451203|131616|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
56214|NCT01451203|131617|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
56215|NCT01451203|131616|P2|Received Treatment|Double-blind Treatment Period||159
56216|NCT01451203|131617|P1|Received Treatment|Double-blind Treatment Period||157
56217|NCT01451203|131616|P2|STARTED|Double-blind Treatment Period||161
56218|NCT01451203|131617|P1|STARTED|Double-blind Treatment Period||158
56219|NCT01450800|131633|P2|NOT COMPLETED|Overall Study||3
56220|NCT01450800|131634|P1|NOT COMPLETED|Overall Study||1
56221|NCT01450800|131633|P2|COMPLETED|Overall Study||78
56222|NCT01450800|131634|P1|COMPLETED|Overall Study||81
56223|NCT01450800|131633|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
56224|NCT01450800|131634|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
56225|NCT01450787|131650|P2|NOT COMPLETED|Overall Study||0
56226|NCT01450787|131651|P1|NOT COMPLETED|Overall Study||0
56227|NCT01450787|131650|P2|COMPLETED|Overall Study||25
56228|NCT01450787|131651|P1|COMPLETED|Overall Study||38
56229|NCT01450787|131650|P2|STARTED|Overall Study||25
56230|NCT01450787|131651|P1|STARTED|Overall Study||38
56231|NCT01450761|131669|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||466
56232|NCT01450761|131670|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||464
56233|NCT01450761|131669|P2|COMPLETED|Treatment With Blinded Study Therapy||10
56234|NCT01450761|131670|P1|COMPLETED|Treatment With Blinded Study Therapy||14
56235|NCT01450761|131669|P2|STARTED|Treatment With Blinded Study Therapy||476
56236|NCT01450761|131670|P1|STARTED|Treatment With Blinded Study Therapy||478
56237|NCT01450761|131669|P2|NOT COMPLETED|Lead-in Chemotherapy||85
56238|NCT01450761|131670|P1|NOT COMPLETED|Lead-in Chemotherapy||84
56239|NCT01450761|131669|P2|COMPLETED|Lead-in Chemotherapy||476
56240|NCT01450761|131670|P1|COMPLETED|Lead-in Chemotherapy||478
56241|NCT01450761|131669|P2|STARTED|Lead-in Chemotherapy||561
56242|NCT01450761|131670|P1|STARTED|Lead-in Chemotherapy||562
56243|NCT01450761|131669|P2|NOT COMPLETED|Randomization||5
56244|NCT01450761|131670|P1|NOT COMPLETED|Randomization||4
56245|NCT01450761|131669|P2|COMPLETED|Randomization||561
56246|NCT01450761|131670|P1|COMPLETED|Randomization||562
56247|NCT01450761|131669|P2|STARTED|Randomization||566
56248|NCT01450761|131670|P1|STARTED|Randomization||566
56249|NCT01450696|131682|P2|NOT COMPLETED|Overall Study||148
56250|NCT01450696|131683|P1|NOT COMPLETED|Overall Study||148
56251|NCT01450696|131682|P2|COMPLETED|Overall Study||0
56252|NCT01450696|131683|P1|COMPLETED|Overall Study||0
56253|NCT01450696|131682|P2|Treated (Safety Population)|Overall Study||147
56254|NCT01450696|131683|P1|Treated (Safety Population)|Overall Study||147
56255|NCT01450696|131682|P2|STARTED|Overall Study||148
56256|NCT01450696|131683|P1|STARTED|Overall Study||148
56257|NCT01450683|131705|P1|NOT COMPLETED|Overall Study||2
56258|NCT01450683|131705|P1|COMPLETED|Overall Study||2
56259|NCT01450683|131705|P1|STARTED|Overall Study||4
56260|NCT01450631|131711|P2|NOT COMPLETED|Overall Study||4
56261|NCT01450631|131712|P1|NOT COMPLETED|Overall Study||3
56262|NCT01450631|131711|P2|COMPLETED|Overall Study||42
56263|NCT01450631|131712|P1|COMPLETED|Overall Study||43
56264|NCT01450631|131711|P2|STARTED|Overall Study||46
56265|NCT01450631|131712|P1|STARTED|Overall Study||46
56266|NCT01450397|131720|P1|NOT COMPLETED|Overall Study||0
56267|NCT01450397|131720|P1|COMPLETED|Overall Study||5
56268|NCT01450397|131720|P1|STARTED|Overall Study||5
56269|NCT01450319|131724|P1|NOT COMPLETED|Overall Study||0
56270|NCT01450319|131724|P1|COMPLETED|Overall Study||70
56271|NCT01450319|131724|P1|STARTED|Overall Study||70
56272|NCT01450306|131737|P2|NOT COMPLETED|Overall Study||0
56273|NCT01450306|131738|P1|NOT COMPLETED|Overall Study||0
56274|NCT01450306|131737|P2|COMPLETED|Overall Study||10
56275|NCT01450306|131738|P1|COMPLETED|Overall Study||10
56276|NCT01450306|131737|P2|STARTED|Overall Study||10
56277|NCT01450306|131738|P1|STARTED|Overall Study||10
56278|NCT01450189|131751|P3|NOT COMPLETED|Overall Study||0
56279|NCT01450189|131752|P2|NOT COMPLETED|Overall Study||0
56280|NCT01450189|131753|P1|NOT COMPLETED|Overall Study||0
56281|NCT01450189|131751|P3|COMPLETED|Overall Study||19
56282|NCT01450189|131752|P2|COMPLETED|Overall Study||18
56283|NCT01450189|131753|P1|COMPLETED|Overall Study||9
56284|NCT01450189|131751|P3|STARTED|Overall Study||19
56285|NCT01450189|131752|P2|STARTED|Overall Study||18
56286|NCT01450189|131753|P1|STARTED|Overall Study||9
56287|NCT01450007|131843|P3|NOT COMPLETED|Overall Study||3
56288|NCT01450007|131844|P2|NOT COMPLETED|Overall Study||5
56289|NCT01450007|131845|P1|NOT COMPLETED|Overall Study||2
56290|NCT01450007|131843|P3|COMPLETED|Overall Study||41
56291|NCT01450007|131844|P2|COMPLETED|Overall Study||37
56292|NCT01450007|131845|P1|COMPLETED|Overall Study||42
56293|NCT01450007|131843|P3|STARTED|Overall Study||44
56294|NCT01450007|131844|P2|STARTED|Overall Study||42
56295|NCT01450007|131845|P1|STARTED|Overall Study||44
56296|NCT01449955|131864|P2|NOT COMPLETED|Overall Study||2
56297|NCT01449955|131865|P1|NOT COMPLETED|Overall Study||1
56298|NCT01449955|131864|P2|COMPLETED|Overall Study||24
56299|NCT01449955|131865|P1|COMPLETED|Overall Study||27
56300|NCT01449955|131864|P2|STARTED|Overall Study||26
56301|NCT01449955|131865|P1|STARTED|Overall Study||28
56302|NCT01449929|131873|P2|NOT COMPLETED|Overall Study||242
56303|NCT01449929|131874|P1|NOT COMPLETED|Overall Study||242
56304|NCT01449929|131873|P2|COMPLETED|Overall Study||0
56305|NCT01449929|131874|P1|COMPLETED|Overall Study||0
56306|NCT01449929|131873|P2|Ongoing|Overall Study||213
56307|NCT01449929|131874|P1|Ongoing|Overall Study||224
56308|NCT01449929|131873|P2|STARTED|Overall Study||242
56309|NCT01449929|131874|P1|STARTED|Overall Study||242
56310|NCT01449747|131912|P2|NOT COMPLETED|Overall Study||0
56311|NCT01449747|131913|P1|NOT COMPLETED|Overall Study||0
56312|NCT01449747|131912|P2|COMPLETED|Overall Study||12
56313|NCT01449747|131913|P1|COMPLETED|Overall Study||12
56314|NCT01449747|131912|P2|STARTED|Overall Study||12
56315|NCT01449747|131913|P1|STARTED|Overall Study||12
56316|NCT01449734|131927|P1|NOT COMPLETED|Overall Study||0
56317|NCT01449734|131927|P1|COMPLETED|Overall Study||215
56318|NCT01449734|131927|P1|STARTED|Overall Study||215
56319|NCT01449708|131933|P2|NOT COMPLETED|Overall Study||3
56320|NCT01449708|131934|P1|NOT COMPLETED|Overall Study||2
56321|NCT01449708|131933|P2|COMPLETED|Overall Study||60
56322|NCT01449708|131934|P1|COMPLETED|Overall Study||59
56323|NCT01449708|131933|P2|STARTED|Overall Study||63
56324|NCT01449708|131934|P1|STARTED|Overall Study||61
56325|NCT01449539|131943|P1|NOT COMPLETED|Overall Study||4
56326|NCT01449539|131943|P1|COMPLETED|Overall Study||4
56327|NCT01449539|131943|P1|STARTED|Overall Study||8
56328|NCT01449526|131949|P2|NOT COMPLETED|Overall Study||6
56329|NCT01449526|131950|P1|NOT COMPLETED|Overall Study||2
56330|NCT01449526|131949|P2|COMPLETED|Overall Study||77
56331|NCT01449526|131950|P1|COMPLETED|Overall Study||81
56332|NCT01449526|131949|P2|STARTED|Overall Study||83
56333|NCT01449526|131950|P1|STARTED|Overall Study||83
56334|NCT01449513|131960|P2|NOT COMPLETED|Overall Study||0
56335|NCT01449513|131961|P1|NOT COMPLETED|Overall Study||0
56336|NCT01449513|131960|P2|COMPLETED|Overall Study||8
56337|NCT01449513|131961|P1|COMPLETED|Overall Study||16
56338|NCT01449513|131960|P2|STARTED|Overall Study||8
56339|NCT01449513|131961|P1|STARTED|Overall Study||16
56340|NCT01449305|132013|P1|NOT COMPLETED|Overall Study||2
56341|NCT01449305|132013|P1|COMPLETED|Overall Study||42
56342|NCT01449305|132013|P1|STARTED|Overall Study||44
56343|NCT01449266|132018|P1|NOT COMPLETED|Overall Study||0
56344|NCT01449266|132018|P1|COMPLETED|Overall Study||10
56345|NCT01449266|132018|P1|STARTED|Overall Study||10
56346|NCT01449240|132025|P1|NOT COMPLETED|Overall Study||0
56347|NCT01449240|132025|P1|COMPLETED|Overall Study||10
56348|NCT01449240|132025|P1|STARTED|Overall Study||10
56349|NCT01449006|132032|P2|NOT COMPLETED|Overall Study||0
56350|NCT01449006|132033|P1|NOT COMPLETED|Overall Study||3
56351|NCT01449006|132032|P2|COMPLETED|Overall Study||9
56352|NCT01449006|132033|P1|COMPLETED|Overall Study||5
56353|NCT01449006|132032|P2|STARTED|Overall Study||9
56354|NCT01449006|132033|P1|STARTED|Overall Study||8
56355|NCT01448850|132047|P2|NOT COMPLETED|Overall Study||40
56356|NCT01448850|132048|P1|NOT COMPLETED|Overall Study||34
56357|NCT01448850|132047|P2|COMPLETED|Overall Study||120
56358|NCT01448850|132048|P1|COMPLETED|Overall Study||130
56359|NCT01448850|132047|P2|STARTED|Overall Study||160
56360|NCT01448850|132048|P1|STARTED|Overall Study||164
56361|NCT01448707|132073|P2|NOT COMPLETED|Overall Study||18
56362|NCT01448707|132074|P1|NOT COMPLETED|Overall Study||18
56363|NCT01448707|132073|P2|COMPLETED|Overall Study||118
56364|NCT01448707|132074|P1|COMPLETED|Overall Study||119
56365|NCT01448707|132073|P2|STARTED|Overall Study||136
56366|NCT01448707|132074|P1|STARTED|Overall Study||137
56367|NCT01448616|132095|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
56368|NCT01448616|132096|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
56369|NCT01448616|132097|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
56370|NCT01448616|132098|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
56371|NCT01448616|132095|P4|COMPLETED|Study Drug (Treatment Phase)||9
56372|NCT01448616|132096|P3|COMPLETED|Study Drug (Treatment Phase)||23
56373|NCT01448616|132097|P2|COMPLETED|Study Drug (Treatment Phase)||22
56374|NCT01448616|132098|P1|COMPLETED|Study Drug (Treatment Phase)||0
56375|NCT01448616|132095|P4|STARTED|Study Drug (Treatment Phase)||13
56376|NCT01448616|132096|P3|STARTED|Study Drug (Treatment Phase)||27
56377|NCT01448616|132097|P2|STARTED|Study Drug (Treatment Phase)||24
56378|NCT01448616|132098|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
56379|NCT01448616|132095|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
56380|NCT01448616|132096|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
56381|NCT01448616|132097|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
56382|NCT01448616|132098|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
56383|NCT01448616|132095|P4|COMPLETED|Lead-In (Observational Phase)||0
56384|NCT01448616|132096|P3|COMPLETED|Lead-In (Observational Phase)||0
56385|NCT01448616|132097|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
56386|NCT01448616|132098|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
56387|NCT01448616|132095|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
56388|NCT01448616|132096|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
56389|NCT01448616|132097|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
56390|NCT01448616|132098|P1|STARTED|Lead-In (Observational Phase)||73
56391|NCT01448525|132118|P2|NOT COMPLETED|Overall Study||2
56392|NCT01448525|132119|P1|NOT COMPLETED|Overall Study||1
56393|NCT01448525|132118|P2|COMPLETED|Overall Study||42
56394|NCT01448525|132119|P1|COMPLETED|Overall Study||43
56395|NCT01448525|132118|P2|STARTED|Overall Study||44
56396|NCT01448525|132119|P1|STARTED|Overall Study||44
56397|NCT01448486|132129|P2|NOT COMPLETED|Overall Study||0
56398|NCT01448486|132130|P1|NOT COMPLETED|Overall Study||0
56399|NCT01448486|132129|P2|COMPLETED|Overall Study||3
56400|NCT01448486|132130|P1|COMPLETED|Overall Study||3
56401|NCT01448486|132129|P2|STARTED|Overall Study||3
56402|NCT01448486|132130|P1|STARTED|Overall Study||3
56403|NCT01448356|132138|P1|NOT COMPLETED|Overall Study||0
56404|NCT01448356|132138|P1|COMPLETED|Overall Study|cross-over|10
56405|NCT01448356|132138|P1|STARTED|Overall Study||10
56406|NCT01448213|132145|P2|NOT COMPLETED|Overall Study||22
56407|NCT01448213|132146|P1|NOT COMPLETED|Overall Study||17
56408|NCT01448213|132145|P2|COMPLETED|Overall Study||112
56409|NCT01448213|132146|P1|COMPLETED|Overall Study||113
56410|NCT01448213|132145|P2|STARTED|Overall Study||134
56411|NCT01448213|132146|P1|STARTED|Overall Study||130
56412|NCT01448057|132156|P2|NOT COMPLETED|Overall Study||4
56413|NCT01448057|132157|P1|NOT COMPLETED|Overall Study||8
56414|NCT01448057|132156|P2|COMPLETED|Overall Study||167
56415|NCT01448057|132157|P1|COMPLETED|Overall Study||162
56416|NCT01448057|132156|P2|STARTED|Overall Study||171
56417|NCT01448057|132157|P1|STARTED|Overall Study||170
56418|NCT01448044|132167|P2|NOT COMPLETED|Follow Up Period||14
56419|NCT01448044|132168|P1|NOT COMPLETED|Follow Up Period||12
56420|NCT01448044|132167|P2|COMPLETED|Follow Up Period||26
56421|NCT01448044|132168|P1|COMPLETED|Follow Up Period||65
56422|NCT01448044|132167|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
56423|NCT01448044|132168|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
56424|NCT01448044|132167|P2|NOT COMPLETED|Treatment Period||16
56425|NCT01448044|132168|P1|NOT COMPLETED|Treatment Period||23
56426|NCT01448044|132167|P2|COMPLETED|Treatment Period||26
56427|NCT01448044|132168|P1|COMPLETED|Treatment Period||59
56428|NCT01448044|132167|P2|STARTED|Treatment Period||42
56429|NCT01448044|132168|P1|STARTED|Treatment Period||82
56430|NCT01447927|132184|P2|NOT COMPLETED|Overall Study||3
56431|NCT01447927|132185|P1|NOT COMPLETED|Overall Study||5
56432|NCT01447927|132184|P2|COMPLETED|Overall Study||33
56433|NCT01447927|132185|P1|COMPLETED|Overall Study||33
56434|NCT01447927|132184|P2|STARTED|Overall Study||36
56435|NCT01447927|132185|P1|STARTED|Overall Study||38
56436|NCT01447914|132193|P1|NOT COMPLETED|Overall Study||0
56437|NCT01447914|132193|P1|COMPLETED|Overall Study||16
56438|NCT01447914|132193|P1|STARTED|Overall Study||16
56439|NCT01447849|132202|P4|NOT COMPLETED|Second Intervention||0
56440|NCT01447849|132203|P3|NOT COMPLETED|Second Intervention||0
56441|NCT01447849|132204|P2|NOT COMPLETED|Second Intervention||0
56442|NCT01447849|132205|P1|NOT COMPLETED|Second Intervention||0
56443|NCT01447849|132202|P4|COMPLETED|Second Intervention||10
56444|NCT01447849|132203|P3|COMPLETED|Second Intervention||10
56445|NCT01447849|132204|P2|COMPLETED|Second Intervention||10
56446|NCT01447849|132205|P1|COMPLETED|Second Intervention||10
56447|NCT01447849|132202|P4|STARTED|Second Intervention||10
56448|NCT01447849|132203|P3|STARTED|Second Intervention||10
56449|NCT01447849|132204|P2|STARTED|Second Intervention||10
56450|NCT01447849|132205|P1|STARTED|Second Intervention||10
56451|NCT01447849|132202|P4|NOT COMPLETED|Washout Period for 1 Week||0
56452|NCT01447849|132203|P3|NOT COMPLETED|Washout Period for 1 Week||0
56453|NCT01447849|132204|P2|NOT COMPLETED|Washout Period for 1 Week||0
56454|NCT01447849|132205|P1|NOT COMPLETED|Washout Period for 1 Week||0
56455|NCT01447849|132202|P4|COMPLETED|Washout Period for 1 Week||10
56456|NCT01447849|132203|P3|COMPLETED|Washout Period for 1 Week||10
56457|NCT01447849|132204|P2|COMPLETED|Washout Period for 1 Week||10
56458|NCT01447849|132205|P1|COMPLETED|Washout Period for 1 Week||10
56459|NCT01447849|132202|P4|STARTED|Washout Period for 1 Week||10
56460|NCT01447849|132203|P3|STARTED|Washout Period for 1 Week||10
56461|NCT01447849|132204|P2|STARTED|Washout Period for 1 Week||10
56462|NCT01447849|132205|P1|STARTED|Washout Period for 1 Week||10
56463|NCT01447849|132202|P4|NOT COMPLETED|First Intervention||0
56464|NCT01447849|132203|P3|NOT COMPLETED|First Intervention||0
56465|NCT01447849|132204|P2|NOT COMPLETED|First Intervention||0
56466|NCT01447849|132205|P1|NOT COMPLETED|First Intervention||0
56467|NCT01447849|132202|P4|COMPLETED|First Intervention||10
56468|NCT01447849|132203|P3|COMPLETED|First Intervention||10
56469|NCT01447849|132204|P2|COMPLETED|First Intervention||10
56470|NCT01447849|132205|P1|COMPLETED|First Intervention||10
56471|NCT01447849|132202|P4|STARTED|First Intervention||10
56472|NCT01447849|132203|P3|STARTED|First Intervention||10
56473|NCT01447849|132204|P2|STARTED|First Intervention||10
56474|NCT01447849|132205|P1|STARTED|First Intervention||10
56475|NCT01447719|132215|P1|NOT COMPLETED|Overall Study||93
56476|NCT01447719|132215|P1|COMPLETED|Overall Study||59
56477|NCT01447719|132215|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
56478|NCT01447719|132215|P1|Valid AV-45 Scan Acquired|Overall Study||147
56479|NCT01447719|132215|P1|STARTED|Overall Study||152
56480|NCT01447706|132228|P2|NOT COMPLETED|Overall Study||3
56481|NCT01447706|132229|P1|NOT COMPLETED|Overall Study||0
56482|NCT01447706|132228|P2|COMPLETED|Overall Study||80
56483|NCT01447706|132229|P1|COMPLETED|Overall Study||140
56484|NCT01447706|132228|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
56485|NCT01447706|132229|P1|STARTED|Overall Study||140
56486|NCT01447576|132241|P1|NOT COMPLETED|Overall Study||476
56487|NCT01447576|132241|P1|COMPLETED|Overall Study||560
56488|NCT01447576|132241|P1|STARTED|Overall Study||1036
56489|NCT01447511|132252|P5|NOT COMPLETED|Rifampin Period||0
56490|NCT01447511|132253|P4|NOT COMPLETED|Rifampin Period||1
56491|NCT01447511|132254|P3|NOT COMPLETED|Rifampin Period||0
56492|NCT01447511|132255|P2|NOT COMPLETED|Rifampin Period||0
56493|NCT01447511|132256|P1|NOT COMPLETED|Rifampin Period||0
56494|NCT01447511|132252|P5|COMPLETED|Rifampin Period||4
56495|NCT01447511|132253|P4|COMPLETED|Rifampin Period||2
56496|NCT01447511|132254|P3|COMPLETED|Rifampin Period||8
56497|NCT01447511|132255|P2|COMPLETED|Rifampin Period||5
56498|NCT01447511|132256|P1|COMPLETED|Rifampin Period||8
56499|NCT01447511|132252|P5|STARTED|Rifampin Period||4
56500|NCT01447511|132253|P4|STARTED|Rifampin Period||3
56501|NCT01447511|132254|P3|STARTED|Rifampin Period||8
56502|NCT01447511|132255|P2|STARTED|Rifampin Period||5
56503|NCT01447511|132256|P1|STARTED|Rifampin Period||8
56504|NCT01447511|132252|P5|NOT COMPLETED|Fluconazole Period||0
56505|NCT01447511|132253|P4|NOT COMPLETED|Fluconazole Period||0
56506|NCT01447511|132254|P3|NOT COMPLETED|Fluconazole Period||1
56507|NCT01447511|132255|P2|NOT COMPLETED|Fluconazole Period||0
56508|NCT01447511|132256|P1|NOT COMPLETED|Fluconazole Period||0
56509|NCT01447511|132252|P5|COMPLETED|Fluconazole Period||4
56510|NCT01447511|132253|P4|COMPLETED|Fluconazole Period||3
56511|NCT01447511|132254|P3|COMPLETED|Fluconazole Period||8
56512|NCT01447511|132255|P2|COMPLETED|Fluconazole Period||0
56513|NCT01447511|132256|P1|COMPLETED|Fluconazole Period||8
56514|NCT01447511|132252|P5|STARTED|Fluconazole Period||4
56515|NCT01447511|132253|P4|STARTED|Fluconazole Period||3
56516|NCT01447511|132254|P3|STARTED|Fluconazole Period||9
56517|NCT01447511|132255|P2|STARTED|Fluconazole Period||0
56518|NCT01447511|132256|P1|STARTED|Fluconazole Period||8
56519|NCT01447511|132252|P5|NOT COMPLETED|Control Period||0
56520|NCT01447511|132253|P4|NOT COMPLETED|Control Period||0
56521|NCT01447511|132254|P3|NOT COMPLETED|Control Period||0
56522|NCT01447511|132255|P2|NOT COMPLETED|Control Period||0
56523|NCT01447511|132256|P1|NOT COMPLETED|Control Period||0
56524|NCT01447511|132252|P5|COMPLETED|Control Period||4
56525|NCT01447511|132253|P4|COMPLETED|Control Period||3
56526|NCT01447511|132254|P3|COMPLETED|Control Period||9
56527|NCT01447511|132255|P2|COMPLETED|Control Period||5
56528|NCT01447511|132256|P1|COMPLETED|Control Period||8
56529|NCT01447511|132252|P5|STARTED|Control Period||4
56530|NCT01447511|132253|P4|STARTED|Control Period||3
56531|NCT01447511|132254|P3|STARTED|Control Period||9
56532|NCT01447511|132255|P2|STARTED|Control Period||5
56533|NCT01447511|132256|P1|STARTED|Control Period||8
56534|NCT01447433|132270|P2|NOT COMPLETED|Overall Study||6
56535|NCT01447433|132271|P1|NOT COMPLETED|Overall Study||4
56536|NCT01447433|132270|P2|COMPLETED|Overall Study||21
56537|NCT01447433|132271|P1|COMPLETED|Overall Study||22
56538|NCT01447433|132270|P2|STARTED|Overall Study||27
56539|NCT01447433|132271|P1|STARTED|Overall Study||26
56540|NCT01447420|132298|P3|NOT COMPLETED|Overall Study||10
56541|NCT01447420|132299|P2|NOT COMPLETED|Overall Study||27
56542|NCT01447420|132300|P1|NOT COMPLETED|Overall Study||10
56543|NCT01447420|132298|P3|COMPLETED|Overall Study||8
56544|NCT01447420|132299|P2|COMPLETED|Overall Study||45
56545|NCT01447420|132300|P1|COMPLETED|Overall Study||29
56546|NCT01447420|132298|P3|STARTED|Overall Study||18
56547|NCT01447420|132299|P2|STARTED|Overall Study||72
56548|NCT01447420|132300|P1|STARTED|Overall Study||39
56549|NCT01447225|132320|P10|NOT COMPLETED|Overall Study||0
56550|NCT01447225|132321|P9|NOT COMPLETED|Overall Study||0
56551|NCT01447225|132322|P8|NOT COMPLETED|Overall Study||0
56552|NCT01447225|132323|P7|NOT COMPLETED|Overall Study||0
56553|NCT01447225|132324|P6|NOT COMPLETED|Overall Study||0
56554|NCT01447225|132325|P5|NOT COMPLETED|Overall Study||0
56555|NCT01447225|132326|P4|NOT COMPLETED|Overall Study||0
56556|NCT01447225|132327|P3|NOT COMPLETED|Overall Study||0
56557|NCT01447225|132328|P2|NOT COMPLETED|Overall Study||0
56558|NCT01447225|132329|P1|NOT COMPLETED|Overall Study||0
56559|NCT01447225|132320|P10|COMPLETED|Overall Study||4
56560|NCT01447225|132321|P9|COMPLETED|Overall Study||3
56561|NCT01447225|132322|P8|COMPLETED|Overall Study||4
56562|NCT01447225|132323|P7|COMPLETED|Overall Study||7
56563|NCT01447225|132324|P6|COMPLETED|Overall Study||3
56564|NCT01447225|132325|P5|COMPLETED|Overall Study||3
56565|NCT01447225|132326|P4|COMPLETED|Overall Study||3
56566|NCT01447225|132327|P3|COMPLETED|Overall Study||5
56567|NCT01447225|132328|P2|COMPLETED|Overall Study||8
56568|NCT01447225|132329|P1|COMPLETED|Overall Study||3
56569|NCT01447225|132320|P10|STARTED|Overall Study||4
56570|NCT01447225|132321|P9|STARTED|Overall Study||3
56571|NCT01447225|132322|P8|STARTED|Overall Study||4
56572|NCT01447225|132323|P7|STARTED|Overall Study||7
56573|NCT01447225|132324|P6|STARTED|Overall Study||3
56574|NCT01447225|132325|P5|STARTED|Overall Study||3
56575|NCT01447225|132326|P4|STARTED|Overall Study||3
56576|NCT01447225|132327|P3|STARTED|Overall Study||5
56577|NCT01447225|132328|P2|STARTED|Overall Study||8
56578|NCT01447225|132329|P1|STARTED|Overall Study||3
56579|NCT01447121|132399|P1|NOT COMPLETED|Overall Study||0
56580|NCT01447121|132399|P1|COMPLETED|Overall Study||118
56581|NCT01447121|132399|P1|STARTED|Overall Study||118
56582|NCT01447017|132406|P2|NOT COMPLETED|Overall Study||10
56583|NCT01447017|132407|P1|NOT COMPLETED|Overall Study||10
56584|NCT01447017|132406|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
56585|NCT01447017|132407|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
56586|NCT01447017|132406|P2|Performed Visit 2|Overall Study||24
56587|NCT01447017|132407|P1|Performed Visit 2|Overall Study||43
56588|NCT01447017|132406|P2|STARTED|Overall Study||24
56589|NCT01447017|132407|P1|STARTED|Overall Study||45
56590|NCT01446796|132413|P2|NOT COMPLETED|Overall Study||0
56591|NCT01446796|132414|P1|NOT COMPLETED|Overall Study||1
56592|NCT01446796|132413|P2|COMPLETED|Overall Study|Study terminated early|0
56593|NCT01446796|132414|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
56594|NCT01446796|132413|P2|STARTED|Overall Study||0
56595|NCT01446796|132414|P1|STARTED|Overall Study||3
56596|NCT01446705|132428|P2|NOT COMPLETED|Overall Study||0
56597|NCT01446705|132429|P1|NOT COMPLETED|Overall Study||0
56598|NCT01446705|132428|P2|COMPLETED|Overall Study||6627
56599|NCT01446705|132429|P1|COMPLETED|Overall Study||50446
56600|NCT01446705|132428|P2|STARTED|Overall Study||6627
56601|NCT01446705|132429|P1|STARTED|Overall Study||50446
56602|NCT01446419|132439|P2|NOT COMPLETED|Overall Study||1
56603|NCT01446419|132440|P1|NOT COMPLETED|Overall Study||5
56604|NCT01446419|132439|P2|COMPLETED|Overall Study||77
56605|NCT01446419|132440|P1|COMPLETED|Overall Study||142
56606|NCT01446419|132439|P2|12 Month Follow-up|Overall Study||77
56607|NCT01446419|132440|P1|12 Month Follow-up|Overall Study||142
56608|NCT01446419|132439|P2|6 Month Follow-up|Overall Study||77
56609|NCT01446419|132440|P1|6 Month Follow-up|Overall Study||144
56610|NCT01446419|132439|P2|3 Month Follow-up|Overall Study||77
56611|NCT01446419|132440|P1|3 Month Follow-up|Overall Study||146
56612|NCT01446419|132439|P2|STARTED|Overall Study||78
56613|NCT01446419|132440|P1|STARTED|Overall Study||147
56614|NCT01446289|132454|P4|NOT COMPLETED|Overall Study||0
56615|NCT01446289|132455|P3|NOT COMPLETED|Overall Study||1
56616|NCT01446289|132456|P2|NOT COMPLETED|Overall Study||0
56617|NCT01446289|132457|P1|NOT COMPLETED|Overall Study||1
56618|NCT01446289|132454|P4|COMPLETED|Overall Study||35
56619|NCT01446289|132455|P3|COMPLETED|Overall Study||50
56620|NCT01446289|132456|P2|COMPLETED|Overall Study||35
56621|NCT01446289|132457|P1|COMPLETED|Overall Study||50
56622|NCT01446289|132454|P4|STARTED|Overall Study||35
56623|NCT01446289|132455|P3|STARTED|Overall Study||51
56624|NCT01446289|132456|P2|STARTED|Overall Study||35
56625|NCT01446289|132457|P1|STARTED|Overall Study||51
56626|NCT01446250|132485|P4|NOT COMPLETED|Follow-up||6
56627|NCT01446250|132486|P3|NOT COMPLETED|Follow-up||0
56628|NCT01446250|132487|P2|NOT COMPLETED|Follow-up||0
56629|NCT01446250|132488|P1|NOT COMPLETED|Follow-up||0
56630|NCT01446250|132485|P4|COMPLETED|Follow-up||0
56631|NCT01446250|132486|P3|COMPLETED|Follow-up||0
56632|NCT01446250|132487|P2|COMPLETED|Follow-up||0
56633|NCT01446250|132488|P1|COMPLETED|Follow-up||0
56634|NCT01446250|132485|P4|STARTED|Follow-up||6
56635|NCT01446250|132486|P3|STARTED|Follow-up||0
56636|NCT01446250|132487|P2|STARTED|Follow-up||0
56637|NCT01446250|132488|P1|STARTED|Follow-up||0
56638|NCT01446250|132485|P4|NOT COMPLETED|Treatment Period 2||0
56639|NCT01446250|132486|P3|NOT COMPLETED|Treatment Period 2||0
56640|NCT01446250|132487|P2|NOT COMPLETED|Treatment Period 2||1
56641|NCT01446250|132488|P1|NOT COMPLETED|Treatment Period 2||0
56642|NCT01446250|132485|P4|COMPLETED|Treatment Period 2||0
56643|NCT01446250|132486|P3|COMPLETED|Treatment Period 2||0
56644|NCT01446250|132487|P2|COMPLETED|Treatment Period 2||6
56645|NCT01446250|132488|P1|COMPLETED|Treatment Period 2||0
56646|NCT01446250|132485|P4|STARTED|Treatment Period 2||0
56647|NCT01446250|132486|P3|STARTED|Treatment Period 2||0
56648|NCT01446250|132487|P2|STARTED|Treatment Period 2||7
56649|NCT01446250|132488|P1|STARTED|Treatment Period 2||0
56650|NCT01446250|132485|P4|NOT COMPLETED|Clinical Hold||0
56651|NCT01446250|132486|P3|NOT COMPLETED|Clinical Hold||0
56652|NCT01446250|132487|P2|NOT COMPLETED|Clinical Hold||0
56653|NCT01446250|132488|P1|NOT COMPLETED|Clinical Hold||0
56654|NCT01446250|132485|P4|COMPLETED|Clinical Hold||0
56655|NCT01446250|132486|P3|COMPLETED|Clinical Hold||5
56656|NCT01446250|132487|P2|COMPLETED|Clinical Hold||2
56657|NCT01446250|132488|P1|COMPLETED|Clinical Hold||0
56658|NCT01446250|132485|P4|STARTED|Clinical Hold||0
56659|NCT01446250|132486|P3|STARTED|Clinical Hold||5
56660|NCT01446250|132487|P2|STARTED|Clinical Hold||2
56661|NCT01446250|132488|P1|STARTED|Clinical Hold||0
56662|NCT01446250|132485|P4|NOT COMPLETED|Treatment Period 1||0
56663|NCT01446250|132486|P3|NOT COMPLETED|Treatment Period 1||0
56664|NCT01446250|132487|P2|NOT COMPLETED|Treatment Period 1||1
56665|NCT01446250|132488|P1|NOT COMPLETED|Treatment Period 1||0
56666|NCT01446250|132485|P4|COMPLETED|Treatment Period 1||0
56667|NCT01446250|132486|P3|COMPLETED|Treatment Period 1||0
56668|NCT01446250|132487|P2|COMPLETED|Treatment Period 1||2
56669|NCT01446250|132488|P1|COMPLETED|Treatment Period 1||5
56670|NCT01446250|132485|P4|STARTED|Treatment Period 1||0
56671|NCT01446250|132486|P3|STARTED|Treatment Period 1||0
56672|NCT01446250|132487|P2|STARTED|Treatment Period 1||3
56673|NCT01446250|132488|P1|STARTED|Treatment Period 1||5
56674|NCT01445951|132503|P3|NOT COMPLETED|Overall Study||19
56675|NCT01445951|132504|P2|NOT COMPLETED|Overall Study||36
56676|NCT01445951|132505|P1|NOT COMPLETED|Overall Study||44
56677|NCT01445951|132503|P3|COMPLETED|Overall Study||151
56678|NCT01445951|132504|P2|COMPLETED|Overall Study||138
56679|NCT01445951|132505|P1|COMPLETED|Overall Study||130
56680|NCT01445951|132503|P3|STARTED|Overall Study||170
56681|NCT01445951|132504|P2|STARTED|Overall Study||174
56682|NCT01445951|132505|P1|STARTED|Overall Study||174
56683|NCT01445873|132543|P1|NOT COMPLETED|Overall Study||0
56684|NCT01445873|132543|P1|COMPLETED|Overall Study||36
56685|NCT01445873|132543|P1|STARTED|Overall Study||36
56686|NCT01445847|132573|P2|NOT COMPLETED|Overall Study||147
56687|NCT01445847|132574|P1|NOT COMPLETED|Overall Study||146
56688|NCT01445847|132573|P2|COMPLETED|Overall Study||36
56689|NCT01445847|132574|P1|COMPLETED|Overall Study||36
56690|NCT01445847|132573|P2|STARTED|Overall Study||183
56691|NCT01445847|132574|P1|STARTED|Overall Study||182
56692|NCT01445769|132580|P1|NOT COMPLETED|Overall Study||8
56693|NCT01445769|132580|P1|COMPLETED|Overall Study||37
56694|NCT01445769|132580|P1|STARTED|Overall Study||45
56695|NCT01445678|132600|P2|NOT COMPLETED|Overall Study||21
56696|NCT01445678|132601|P1|NOT COMPLETED|Overall Study||30
56697|NCT01445678|132600|P2|COMPLETED|Overall Study||476
56698|NCT01445678|132601|P1|COMPLETED|Overall Study||452
56699|NCT01445678|132600|P2|STARTED|Overall Study||497
56700|NCT01445678|132601|P1|STARTED|Overall Study||482
56701|NCT01445652|132619|P2|NOT COMPLETED|Overall Study||3
56702|NCT01445652|132620|P1|NOT COMPLETED|Overall Study||10
56703|NCT01445652|132619|P2|COMPLETED|Overall Study||50
56704|NCT01445652|132620|P1|COMPLETED|Overall Study||47
56705|NCT01445652|132619|P2|STARTED|Overall Study||53
56706|NCT01445652|132620|P1|STARTED|Overall Study||57
56707|NCT01445626|132628|P1|NOT COMPLETED|Overall Study||0
56708|NCT01445626|132628|P1|COMPLETED|Overall Study||87
56709|NCT01445626|132628|P1|STARTED|Overall Study||87
56710|NCT01445613|132638|P1|NOT COMPLETED|1-year Follow-up||77
56711|NCT01445613|132638|P1|COMPLETED|1-year Follow-up||1088
56712|NCT01445613|132638|P1|STARTED|1-year Follow-up||1165
56713|NCT01445613|132638|P1|NOT COMPLETED|30-day Follow-up||35
56714|NCT01445613|132638|P1|COMPLETED|30-day Follow-up||1165
56715|NCT01445613|132638|P1|STARTED|30-day Follow-up||1200
56716|NCT01445548|132656|P1|NOT COMPLETED|Overall Study||1
56717|NCT01445548|132656|P1|COMPLETED|Overall Study||5
56718|NCT01445548|132656|P1|STARTED|Overall Study||6
56719|NCT01444924|132679|P2|NOT COMPLETED|Overall Study||0
56720|NCT01444924|132680|P1|NOT COMPLETED|Overall Study||0
56721|NCT01444924|132679|P2|COMPLETED|Overall Study||33
56722|NCT01444924|132680|P1|COMPLETED|Overall Study||31
56723|NCT01444924|132679|P2|STARTED|Overall Study||33
56724|NCT01444924|132680|P1|STARTED|Overall Study||31
56725|NCT01444898|132686|P1|NOT COMPLETED|Overall Study||1
56726|NCT01444898|132686|P1|COMPLETED|Overall Study||9
56727|NCT01444898|132686|P1|STARTED|Overall Study||10
56728|NCT01444781|132701|P3|NOT COMPLETED|Overall Study||3
56729|NCT01444781|132702|P2|NOT COMPLETED|Overall Study||4
56730|NCT01444781|132703|P1|NOT COMPLETED|Overall Study||3
56731|NCT01444781|132701|P3|COMPLETED|Overall Study||272
56732|NCT01444781|132702|P2|COMPLETED|Overall Study||411
56733|NCT01444781|132703|P1|COMPLETED|Overall Study||413
56734|NCT01444781|132701|P3|STARTED|Overall Study||275
56735|NCT01444781|132702|P2|STARTED|Overall Study||415
56736|NCT01444781|132703|P1|STARTED|Overall Study||416
56737|NCT01444651|132743|P2|NOT COMPLETED|Overall Study||9
56738|NCT01444651|132744|P1|NOT COMPLETED|Overall Study||11
56739|NCT01444651|132743|P2|COMPLETED|Overall Study||28
56740|NCT01444651|132744|P1|COMPLETED|Overall Study||25
56741|NCT01444651|132743|P2|STARTED|Overall Study||37
56742|NCT01444651|132744|P1|STARTED|Overall Study||36
56743|NCT01444456|132760|P1|NOT COMPLETED|Overall Study||285
56744|NCT01444456|132760|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
56745|NCT01444456|132760|P1|Received Darbepoetin Alfa|Overall Study||1134
56746|NCT01444456|132760|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
56747|NCT01444456|132760|P1|STARTED|Overall Study||1262
56748|NCT01444430|132771|P2|NOT COMPLETED|Overall Study||81
56749|NCT01444430|132772|P1|NOT COMPLETED|Overall Study||61
56750|NCT01444430|132771|P2|COMPLETED|Overall Study||5766
56751|NCT01444430|132772|P1|COMPLETED|Overall Study||5785
56752|NCT01444430|132771|P2|STARTED|Overall Study||5847
56753|NCT01444430|132772|P1|STARTED|Overall Study||5846
56754|NCT01444417|132794|P2|NOT COMPLETED|Overall Study||1
56755|NCT01444417|132795|P1|NOT COMPLETED|Overall Study||2
56756|NCT01444417|132794|P2|COMPLETED|Overall Study||41
56757|NCT01444417|132795|P1|COMPLETED|Overall Study||18
56758|NCT01444417|132794|P2|Received Treatment|Overall Study||42
56759|NCT01444417|132795|P1|Received Treatment|Overall Study||19
56760|NCT01444417|132794|P2|STARTED|Overall Study||42
56761|NCT01444417|132795|P1|STARTED|Overall Study||20
56762|NCT01444391|132811|P1|NOT COMPLETED|Overall Study||1
56763|NCT01444391|132811|P1|COMPLETED|Overall Study||41
56764|NCT01444391|132811|P1|STARTED|Overall Study||42
56765|NCT01444300|132821|P2|NOT COMPLETED|Overall Study||0
56766|NCT01444300|132822|P1|NOT COMPLETED|Overall Study||4
56767|NCT01444300|132821|P2|COMPLETED|Overall Study||12
56768|NCT01444300|132822|P1|COMPLETED|Overall Study||8
56769|NCT01444300|132821|P2|STARTED|Overall Study||12
56770|NCT01444300|132822|P1|STARTED|Overall Study||12
56771|NCT01444287|132832|P1|NOT COMPLETED|Period 4||0
56772|NCT01444287|132832|P1|COMPLETED|Period 4||22
56773|NCT01444287|132832|P1|STARTED|Period 4||22
56774|NCT01444287|132832|P1|NOT COMPLETED|Period 3||0
56775|NCT01444287|132832|P1|COMPLETED|Period 3||22
56776|NCT01444287|132832|P1|STARTED|Period 3||22
56777|NCT01444287|132832|P1|NOT COMPLETED|Period 2||0
56778|NCT01444287|132832|P1|COMPLETED|Period 2||22
56779|NCT01444287|132832|P1|STARTED|Period 2||22
56780|NCT01444287|132832|P1|NOT COMPLETED|Period 1||0
56781|NCT01444287|132832|P1|COMPLETED|Period 1||22
56782|NCT01444287|132832|P1|STARTED|Period 1||22
56783|NCT01444092|132854|P1|NOT COMPLETED|Overall Study||17
56784|NCT01444092|132854|P1|COMPLETED|Overall Study||91
56785|NCT01444092|132854|P1|INFORMED CONSENT OBTAINED|Overall Study||108
56786|NCT01444092|132854|P1|STARTED|Overall Study||108
56787|NCT01443923|132862|P2|NOT COMPLETED|Overall Study||0
56788|NCT01443923|132863|P1|NOT COMPLETED|Overall Study||1
56789|NCT01443923|132862|P2|COMPLETED|Overall Study||1
56790|NCT01443923|132863|P1|COMPLETED|Overall Study||2
56791|NCT01443923|132862|P2|STARTED|Overall Study||1
56792|NCT01443923|132863|P1|STARTED|Overall Study||3
56793|NCT01443858|132880|P3|NOT COMPLETED|Overall Study||7
56794|NCT01443858|132881|P2|NOT COMPLETED|Overall Study||13
56795|NCT01443858|132882|P1|NOT COMPLETED|Overall Study||15
56796|NCT01443858|132880|P3|COMPLETED|Overall Study||18
56797|NCT01443858|132881|P2|COMPLETED|Overall Study||12
56798|NCT01443858|132882|P1|COMPLETED|Overall Study||10
56799|NCT01443858|132880|P3|STARTED|Overall Study||25
56800|NCT01443858|132881|P2|STARTED|Overall Study||25
56801|NCT01443858|132882|P1|STARTED|Overall Study||25
56802|NCT01443845|132904|P2|NOT COMPLETED|Overall Study||337
56803|NCT01443845|132905|P1|NOT COMPLETED|Overall Study||254
56804|NCT01443845|132904|P2|COMPLETED|Overall Study||841
56805|NCT01443845|132905|P1|COMPLETED|Overall Study||922
56806|NCT01443845|132904|P2|STARTED|Overall Study||1178
56807|NCT01443845|132905|P1|STARTED|Overall Study||1176
56808|NCT01443494|132917|P1|NOT COMPLETED|Overall Study||0
56809|NCT01443494|132917|P1|COMPLETED|Overall Study||19
56810|NCT01443494|132917|P1|STARTED|Overall Study||19
56811|NCT01443364|132922|P1|NOT COMPLETED|Overall Study||41
56812|NCT01443364|132922|P1|COMPLETED|Overall Study||91
56813|NCT01443364|132922|P1|STARTED|Overall Study||132
56814|NCT01443130|133051|P6|NOT COMPLETED|Overall Study||34
56815|NCT01443130|133052|P5|NOT COMPLETED|Overall Study||44
56816|NCT01443130|133053|P4|NOT COMPLETED|Overall Study||39
56817|NCT01443130|133054|P3|NOT COMPLETED|Overall Study||77
56818|NCT01443130|133055|P2|NOT COMPLETED|Overall Study||69
56819|NCT01443130|133056|P1|NOT COMPLETED|Overall Study||68
56820|NCT01443130|133051|P6|COMPLETED|Overall Study||225
56821|NCT01443130|133052|P5|COMPLETED|Overall Study||230
56822|NCT01443130|133053|P4|COMPLETED|Overall Study||231
56823|NCT01443130|133054|P3|COMPLETED|Overall Study||223
56824|NCT01443130|133055|P2|COMPLETED|Overall Study||231
56825|NCT01443130|133056|P1|COMPLETED|Overall Study||232
56826|NCT01443130|133051|P6|STARTED|Overall Study||259
56827|NCT01443130|133052|P5|STARTED|Overall Study||274
56828|NCT01443130|133053|P4|STARTED|Overall Study||270
56829|NCT01443130|133054|P3|STARTED|Overall Study||300
56830|NCT01443130|133055|P2|STARTED|Overall Study||300
56831|NCT01443130|133056|P1|STARTED|Overall Study||300
56832|NCT01443078|133106|P1|NOT COMPLETED|Overall Study||29
56833|NCT01443078|133106|P1|COMPLETED|Overall Study||13
56834|NCT01443078|133106|P1|STARTED|Overall Study||42
56835|NCT01443026|133112|P2|NOT COMPLETED|Overall Study||5
56836|NCT01443026|133113|P1|NOT COMPLETED|Overall Study||3
56837|NCT01443026|133112|P2|COMPLETED|Overall Study||32
56838|NCT01443026|133113|P1|COMPLETED|Overall Study||26
56839|NCT01443026|133112|P2|STARTED|Overall Study||37
56840|NCT01443026|133113|P1|STARTED|Overall Study||29
56841|NCT01442844|133121|P2|NOT COMPLETED|Overall Study||0
56842|NCT01442844|133122|P1|NOT COMPLETED|Overall Study||0
56843|NCT01442844|133121|P2|COMPLETED|Overall Study||2
56844|NCT01442844|133122|P1|COMPLETED|Overall Study||1
56845|NCT01442844|133121|P2|STARTED|Overall Study||2
56846|NCT01442844|133122|P1|STARTED|Overall Study||1
56847|NCT01442779|133128|P1|NOT COMPLETED|Overall Study||7
56848|NCT01442779|133128|P1|COMPLETED|Overall Study||11
56849|NCT01442779|133128|P1|STARTED|Overall Study||18
56850|NCT01442688|133136|P2|NOT COMPLETED|Second Intervention||0
56851|NCT01442688|133137|P1|NOT COMPLETED|Second Intervention||1
56852|NCT01442688|133136|P2|COMPLETED|Second Intervention||31
56853|NCT01442688|133137|P1|COMPLETED|Second Intervention||28
56854|NCT01442688|133136|P2|STARTED|Second Intervention||31
56855|NCT01442688|133137|P1|STARTED|Second Intervention||29
56856|NCT01442688|133136|P2|NOT COMPLETED|First Intervention||0
56857|NCT01442688|133137|P1|NOT COMPLETED|First Intervention||2
56858|NCT01442688|133136|P2|COMPLETED|First Intervention||31
56859|NCT01442688|133137|P1|COMPLETED|First Intervention||29
56860|NCT01442688|133136|P2|STARTED|First Intervention||31
56861|NCT01442688|133137|P1|STARTED|First Intervention||31
56862|NCT01442675|133145|P1|NOT COMPLETED|Overall Study||12
56863|NCT01442675|133145|P1|COMPLETED|Overall Study||822
56864|NCT01442675|133145|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
56865|NCT01442675|133145|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
56866|NCT01442675|133145|P1|STARTED|Overall Study||834
56867|NCT01442376|133158|P3|NOT COMPLETED|Overall Study||5
56868|NCT01442376|133159|P2|NOT COMPLETED|Overall Study||9
56869|NCT01442376|133160|P1|NOT COMPLETED|Overall Study||3
56870|NCT01442376|133158|P3|COMPLETED|Overall Study||159
56871|NCT01442376|133159|P2|COMPLETED|Overall Study||160
56872|NCT01442376|133160|P1|COMPLETED|Overall Study||166
56873|NCT01442376|133158|P3|STARTED|Overall Study|Randomized patients|164
56874|NCT01442376|133159|P2|STARTED|Overall Study|Randomized patients|169
56875|NCT01442376|133160|P1|STARTED|Overall Study|Randomized patients|169
56876|NCT01442181|133173|P2|NOT COMPLETED|Overall Study||3
56877|NCT01442181|133174|P1|NOT COMPLETED|Overall Study||4
56878|NCT01442181|133173|P2|COMPLETED|Overall Study||8
56879|NCT01442181|133174|P1|COMPLETED|Overall Study||10
56880|NCT01442181|133173|P2|STARTED|Overall Study||11
56881|NCT01442181|133174|P1|STARTED|Overall Study||14
56882|NCT01442155|133198|P1|NOT COMPLETED|Overall Study||65
56883|NCT01442155|133198|P1|COMPLETED|Overall Study||9
56884|NCT01442155|133198|P1|STARTED|Overall Study||74
56885|NCT01442129|133205|P2|NOT COMPLETED|Overall Study||0
56886|NCT01442129|133206|P1|NOT COMPLETED|Overall Study||0
56887|NCT01442129|133205|P2|COMPLETED|Overall Study||10
56888|NCT01442129|133206|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
56889|NCT01442129|133205|P2|STARTED|Overall Study||10
56890|NCT01442129|133206|P1|STARTED|Overall Study||20
56891|NCT01442103|133214|P1|NOT COMPLETED|Overall Study||2
56892|NCT01442103|133214|P1|COMPLETED|Overall Study||8
56893|NCT01442103|133214|P1|STARTED|Overall Study||10
56894|NCT01442064|133224|P6|NOT COMPLETED|Overall Study||99
56895|NCT01442064|133225|P5|NOT COMPLETED|Overall Study||106
56896|NCT01442064|133226|P4|NOT COMPLETED|Overall Study||98
56897|NCT01442064|133227|P3|NOT COMPLETED|Overall Study||104
56898|NCT01442064|133228|P2|NOT COMPLETED|Overall Study||101
56899|NCT01442064|133229|P1|NOT COMPLETED|Overall Study||97
56900|NCT01442064|133224|P6|COMPLETED|Overall Study||0
56901|NCT01442064|133225|P5|COMPLETED|Overall Study||1
56902|NCT01442064|133226|P4|COMPLETED|Overall Study||0
56903|NCT01442064|133227|P3|COMPLETED|Overall Study||0
56904|NCT01442064|133228|P2|COMPLETED|Overall Study||2
56905|NCT01442064|133229|P1|COMPLETED|Overall Study||0
56906|NCT01442064|133224|P6|Received Study Drug in Extension Study|Overall Study||81
56907|NCT01442064|133225|P5|Received Study Drug in Extension Study|Overall Study||89
56908|NCT01442064|133226|P4|Received Study Drug in Extension Study|Overall Study||70
56909|NCT01442064|133227|P3|Received Study Drug in Extension Study|Overall Study||60
56910|NCT01442064|133228|P2|Received Study Drug in Extension Study|Overall Study||70
56911|NCT01442064|133229|P1|Received Study Drug in Extension Study|Overall Study||61
56912|NCT01442064|133224|P6|Ranibizumab-Treated Subjects|Overall Study||99
56913|NCT01442064|133225|P5|Ranibizumab-Treated Subjects|Overall Study||107
56914|NCT01442064|133226|P4|Ranibizumab-Treated Subjects|Overall Study||96
56915|NCT01442064|133227|P3|Ranibizumab-Treated Subjects|Overall Study||104
56916|NCT01442064|133228|P2|Ranibizumab-Treated Subjects|Overall Study||103
56917|NCT01442064|133229|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
56918|NCT01442064|133224|P6|STARTED|Overall Study||99
56919|NCT01442064|133225|P5|STARTED|Overall Study||107
56920|NCT01442064|133226|P4|STARTED|Overall Study||98
56921|NCT01442064|133227|P3|STARTED|Overall Study||104
56922|NCT01442064|133228|P2|STARTED|Overall Study||103
56923|NCT01442064|133229|P1|STARTED|Overall Study||97
56924|NCT01442038|133266|P2|NOT COMPLETED|Overall Study||279
56925|NCT01442038|133267|P1|NOT COMPLETED|Overall Study||303
56926|NCT01442038|133266|P2|COMPLETED|Overall Study||1040
56927|NCT01442038|133267|P1|COMPLETED|Overall Study||1029
56928|NCT01442038|133266|P2|STARTED|Overall Study||1319
56929|NCT01442038|133267|P1|STARTED|Overall Study||1332
56930|NCT01441973|133281|P2|NOT COMPLETED|Overall Study||5
56931|NCT01441973|133282|P1|NOT COMPLETED|Overall Study||8
56932|NCT01441973|133281|P2|COMPLETED|Overall Study|Still receiving treatment|11
56933|NCT01441973|133282|P1|COMPLETED|Overall Study|Still receiving treatment|7
56934|NCT01441973|133281|P2|STARTED|Overall Study||16
56935|NCT01441973|133282|P1|STARTED|Overall Study||15
56936|NCT01441960|133296|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
56937|NCT01441960|133297|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
56938|NCT01441960|133296|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
56939|NCT01441960|133297|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
56940|NCT01441960|133296|P2|STARTED|Second Neuromuscular Blocking Agent||13
56941|NCT01441960|133297|P1|STARTED|Second Neuromuscular Blocking Agent||18
56942|NCT01441960|133296|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
56943|NCT01441960|133297|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
56944|NCT01441960|133296|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
56945|NCT01441960|133297|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
56946|NCT01441960|133296|P2|STARTED|First Neuromuscular Blocking Agent:||19
56947|NCT01441960|133297|P1|STARTED|First Neuromuscular Blocking Agent:||26
56948|NCT01441843|133309|P2|NOT COMPLETED|Overall Study||5
56949|NCT01441843|133310|P1|NOT COMPLETED|Overall Study||12
56950|NCT01441843|133309|P2|COMPLETED|Overall Study||195
56951|NCT01441843|133310|P1|COMPLETED|Overall Study||188
56952|NCT01441843|133309|P2|STARTED|Overall Study||200
56953|NCT01441843|133310|P1|STARTED|Overall Study||200
56954|NCT01441765|133318|P2|NOT COMPLETED|Overall Study||0
56955|NCT01441765|133319|P1|NOT COMPLETED|Overall Study||1
56956|NCT01441765|133318|P2|COMPLETED|Overall Study|not opened|0
56957|NCT01441765|133319|P1|COMPLETED|Overall Study||10
56958|NCT01441765|133318|P2|STARTED|Overall Study|not opened|0
56959|NCT01441765|133319|P1|STARTED|Overall Study||11
56960|NCT01441596|133336|P3|NOT COMPLETED|Overall Study||4
56961|NCT01441596|133337|P2|NOT COMPLETED|Overall Study||3
56962|NCT01441596|133338|P1|NOT COMPLETED|Overall Study||4
56963|NCT01441596|133336|P3|COMPLETED|Overall Study||39
56964|NCT01441596|133337|P2|COMPLETED|Overall Study||35
56965|NCT01441596|133338|P1|COMPLETED|Overall Study||36
56966|NCT01441596|133336|P3|STARTED|Overall Study||43
56967|NCT01441596|133337|P2|STARTED|Overall Study||38
56968|NCT01441596|133338|P1|STARTED|Overall Study||40
56969|NCT01441466|133354|P2|NOT COMPLETED|Overall Study||0
56970|NCT01441466|133355|P1|NOT COMPLETED|Overall Study||0
56971|NCT01441466|133354|P2|COMPLETED|Overall Study||11
56972|NCT01441466|133355|P1|COMPLETED|Overall Study||37
56973|NCT01441466|133354|P2|STARTED|Overall Study||11
56974|NCT01441466|133355|P1|STARTED|Overall Study||37
56975|NCT01441440|133374|P3|NOT COMPLETED|Overall Study||22
56976|NCT01441440|133375|P2|NOT COMPLETED|Overall Study||23
56977|NCT01441440|133376|P1|NOT COMPLETED|Overall Study||17
56978|NCT01441440|133374|P3|COMPLETED|Overall Study||158
56979|NCT01441440|133375|P2|COMPLETED|Overall Study||151
56980|NCT01441440|133376|P1|COMPLETED|Overall Study||166
56981|NCT01441440|133374|P3|STARTED|Overall Study|Safety analysis set|180
56982|NCT01441440|133375|P2|STARTED|Overall Study|Safety analysis set|174
56983|NCT01441440|133376|P1|STARTED|Overall Study|Safety analysis set|183
56984|NCT01441414|133399|P1|NOT COMPLETED|Overall Study||15
56985|NCT01441414|133399|P1|COMPLETED|Overall Study||3
56986|NCT01441414|133399|P1|STARTED|Overall Study||18
56987|NCT01441401|133424|P1|NOT COMPLETED|Overall Study||0
56988|NCT01441401|133424|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
56989|NCT01441401|133424|P1|STARTED|Overall Study||82
56990|NCT01441245|133452|P2|NOT COMPLETED|Overall Study||0
56991|NCT01441245|133453|P1|NOT COMPLETED|Overall Study||0
56992|NCT01441245|133452|P2|COMPLETED|Overall Study||27
56993|NCT01441245|133453|P1|COMPLETED|Overall Study||30
56994|NCT01441245|133452|P2|STARTED|Overall Study||27
56995|NCT01441245|133453|P1|STARTED|Overall Study||30
56996|NCT01441180|133478|P3|NOT COMPLETED|Overall Study||3
56997|NCT01441180|133479|P2|NOT COMPLETED|Overall Study||1
56998|NCT01441180|133480|P1|NOT COMPLETED|Overall Study||1
56999|NCT01441180|133478|P3|COMPLETED|Overall Study||22
57000|NCT01441180|133479|P2|COMPLETED|Overall Study||24
57001|NCT01441180|133480|P1|COMPLETED|Overall Study||9
57002|NCT01441180|133478|P3|STARTED|Overall Study||25
57003|NCT01441180|133479|P2|STARTED|Overall Study||25
57004|NCT01441180|133480|P1|STARTED|Overall Study||10
57005|NCT01441102|133491|P1|NOT COMPLETED|Overall Study||5
57006|NCT01441102|133491|P1|COMPLETED|Overall Study|Three participants have withdrawn (2 prior to and 1 after month 6) and two are currently active.|2
57007|NCT01441102|133491|P1|Completed Month 6|Overall Study||5
57008|NCT01441102|133491|P1|STARTED|Overall Study||7
57009|NCT01440972|133498|P2|NOT COMPLETED|Overall Study||2
57010|NCT01440972|133499|P1|NOT COMPLETED|Overall Study||3
57011|NCT01440972|133498|P2|COMPLETED|Overall Study||19
57012|NCT01440972|133499|P1|COMPLETED|Overall Study||21
57013|NCT01440972|133498|P2|STARTED|Overall Study||21
57014|NCT01440972|133499|P1|STARTED|Overall Study||24
57015|NCT01440959|133513|P1|NOT COMPLETED|Overall Study||0
57016|NCT01440959|133513|P1|COMPLETED|Overall Study||30
57017|NCT01440959|133513|P1|STARTED|Overall Study||30
57018|NCT01440946|133523|P2|NOT COMPLETED|Overall Study||1
57019|NCT01440946|133524|P1|NOT COMPLETED|Overall Study||2
57020|NCT01440946|133523|P2|COMPLETED|Overall Study||14
57021|NCT01440946|133524|P1|COMPLETED|Overall Study||13
57022|NCT01440946|133523|P2|STARTED|Overall Study||15
57023|NCT01440946|133524|P1|STARTED|Overall Study||15
57024|NCT01440881|133563|P2|NOT COMPLETED|Overall Study||1
57025|NCT01440881|133564|P1|NOT COMPLETED|Overall Study||0
57026|NCT01440881|133563|P2|COMPLETED|Overall Study||14
57027|NCT01440881|133564|P1|COMPLETED|Overall Study||14
57028|NCT01440881|133563|P2|STARTED|Overall Study||15
57029|NCT01440881|133564|P1|STARTED|Overall Study||14
57030|NCT01440647|133578|P2|NOT COMPLETED|Overall Study||3
57031|NCT01440647|133579|P1|NOT COMPLETED|Overall Study||2
57032|NCT01440647|133578|P2|COMPLETED|Overall Study||15
57033|NCT01440647|133579|P1|COMPLETED|Overall Study||14
57034|NCT01440647|133578|P2|STARTED|Overall Study||18
57035|NCT01440647|133579|P1|STARTED|Overall Study||16
57036|NCT01440634|133589|P2|NOT COMPLETED|Randomization Phase||10
57037|NCT01440634|133590|P1|NOT COMPLETED|Randomization Phase||6
57038|NCT01440634|133589|P2|COMPLETED|Randomization Phase||14
57039|NCT01440634|133590|P1|COMPLETED|Randomization Phase||24
57040|NCT01440634|133589|P2|STARTED|Randomization Phase||24
57041|NCT01440634|133590|P1|STARTED|Randomization Phase||30
57042|NCT01440634|133589|P2|NOT COMPLETED|Cross Sectional Phase||0
57043|NCT01440634|133590|P1|NOT COMPLETED|Cross Sectional Phase||0
57044|NCT01440634|133589|P2|COMPLETED|Cross Sectional Phase||347
57045|NCT01440634|133590|P1|COMPLETED|Cross Sectional Phase||0
57046|NCT01440634|133589|P2|STARTED|Cross Sectional Phase||347
57047|NCT01440634|133590|P1|STARTED|Cross Sectional Phase||0
57048|NCT01440595|133598|P3|NOT COMPLETED|Overall Study||1
57049|NCT01440595|133599|P2|NOT COMPLETED|Overall Study||3
57050|NCT01440595|133600|P1|NOT COMPLETED|Overall Study||1
57051|NCT01440595|133598|P3|COMPLETED|Overall Study||0
57052|NCT01440595|133599|P2|COMPLETED|Overall Study||0
57053|NCT01440595|133600|P1|COMPLETED|Overall Study||0
57054|NCT01440595|133598|P3|STARTED|Overall Study||1
57055|NCT01440595|133599|P2|STARTED|Overall Study||3
57056|NCT01440595|133600|P1|STARTED|Overall Study||1
57057|NCT01440569|133620|P2|NOT COMPLETED|Open-Label Rollover Phase||6
57058|NCT01440569|133621|P1|NOT COMPLETED|Open-Label Rollover Phase||47
57059|NCT01440569|133620|P2|COMPLETED|Open-Label Rollover Phase||7
57060|NCT01440569|133621|P1|COMPLETED|Open-Label Rollover Phase||204
57061|NCT01440569|133620|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
57062|NCT01440569|133621|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
57063|NCT01440569|133620|P2|NOT COMPLETED|Main Study||4
57064|NCT01440569|133621|P1|NOT COMPLETED|Main Study||36
57065|NCT01440569|133620|P2|COMPLETED|Main Study||14
57066|NCT01440569|133621|P1|COMPLETED|Main Study||260
57067|NCT01440569|133620|P2|Enrolled and Treated|Main Study||18
57068|NCT01440569|133621|P1|Enrolled and Treated|Main Study||295
57069|NCT01440569|133620|P2|STARTED|Main Study||18
57070|NCT01440569|133621|P1|STARTED|Main Study||296
57071|NCT01440543|133643|P4|NOT COMPLETED|Overall Study||6
57072|NCT01440543|133644|P3|NOT COMPLETED|Overall Study||2
57073|NCT01440543|133645|P2|NOT COMPLETED|Overall Study||4
57074|NCT01440543|133646|P1|NOT COMPLETED|Overall Study||4
57075|NCT01440543|133643|P4|COMPLETED|Overall Study||101
57076|NCT01440543|133644|P3|COMPLETED|Overall Study||100
57077|NCT01440543|133645|P2|COMPLETED|Overall Study||101
57078|NCT01440543|133646|P1|COMPLETED|Overall Study||102
57079|NCT01440543|133643|P4|STARTED|Overall Study||107
57080|NCT01440543|133644|P3|STARTED|Overall Study||102
57081|NCT01440543|133645|P2|STARTED|Overall Study||105
57082|NCT01440543|133646|P1|STARTED|Overall Study||106
57083|NCT01440517|133656|P1|NOT COMPLETED|Overall Study||1
57084|NCT01440517|133656|P1|COMPLETED|Overall Study||4
57085|NCT01440517|133656|P1|STARTED|Overall Study||5
57086|NCT01440387|133663|P2|NOT COMPLETED|Overall Study||0
57087|NCT01440387|133664|P1|NOT COMPLETED|Overall Study||0
57088|NCT01440387|133663|P2|COMPLETED|Overall Study||56
57089|NCT01440387|133664|P1|COMPLETED|Overall Study||56
57090|NCT01440387|133663|P2|STARTED|Overall Study||56
57091|NCT01440387|133664|P1|STARTED|Overall Study||56
57092|NCT01440374|133687|P3|NOT COMPLETED|Part 2; Double-blind Phase||26
57093|NCT01440374|133688|P2|NOT COMPLETED|Part 2; Double-blind Phase||12
57094|NCT01440374|133689|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
57095|NCT01440374|133687|P3|COMPLETED|Part 2; Double-blind Phase||72
57096|NCT01440374|133688|P2|COMPLETED|Part 2; Double-blind Phase||35
57097|NCT01440374|133689|P1|COMPLETED|Part 2; Double-blind Phase||0
57098|NCT01440374|133687|P3|Ongoing|Part 2; Double-blind Phase||11
57099|NCT01440374|133688|P2|Ongoing|Part 2; Double-blind Phase||4
57100|NCT01440374|133689|P1|Ongoing|Part 2; Double-blind Phase||0
57101|NCT01440374|133687|P3|STARTED|Part 2; Double-blind Phase||98
57102|NCT01440374|133688|P2|STARTED|Part 2; Double-blind Phase||47
57103|NCT01440374|133689|P1|STARTED|Part 2; Double-blind Phase||0
57104|NCT01440374|133687|P3|NOT COMPLETED|Part 1: Open-label Phase||0
57105|NCT01440374|133688|P2|NOT COMPLETED|Part 1: Open-label Phase||0
57106|NCT01440374|133689|P1|NOT COMPLETED|Part 1: Open-label Phase||3
57107|NCT01440374|133687|P3|COMPLETED|Part 1: Open-label Phase||0
57108|NCT01440374|133688|P2|COMPLETED|Part 1: Open-label Phase||0
57109|NCT01440374|133689|P1|COMPLETED|Part 1: Open-label Phase||14
57110|NCT01440374|133687|P3|STARTED|Part 1: Open-label Phase||0
57111|NCT01440374|133688|P2|STARTED|Part 1: Open-label Phase||0
57112|NCT01440374|133689|P1|STARTED|Part 1: Open-label Phase||17
57113|NCT01440322|133699|P2|NOT COMPLETED|Overall Study||1
57114|NCT01440322|133700|P1|NOT COMPLETED|Overall Study||7
57115|NCT01440322|133699|P2|COMPLETED|Overall Study||49
57116|NCT01440322|133700|P1|COMPLETED|Overall Study||90
57117|NCT01440322|133699|P2|STARTED|Overall Study||50
57118|NCT01440322|133700|P1|STARTED|Overall Study||97
57119|NCT01440283|133722|P1|NOT COMPLETED|Overall Study||10
57120|NCT01440283|133722|P1|COMPLETED|Overall Study||4
57121|NCT01440283|133722|P1|STARTED|Overall Study||14
57122|NCT01440101|133737|P3|NOT COMPLETED|Overall Study||1
57123|NCT01440101|133738|P2|NOT COMPLETED|Overall Study||4
57124|NCT01440101|133739|P1|NOT COMPLETED|Overall Study||2
57125|NCT01440101|133737|P3|COMPLETED|Overall Study||46
57126|NCT01440101|133738|P2|COMPLETED|Overall Study||43
57127|NCT01440101|133739|P1|COMPLETED|Overall Study||10
57128|NCT01440101|133737|P3|STARTED|Overall Study||47
57129|NCT01440101|133738|P2|STARTED|Overall Study||47
57130|NCT01440101|133739|P1|STARTED|Overall Study||12
57131|NCT01440049|133772|P1|NOT COMPLETED|Overall Study||5
57132|NCT01440049|133772|P1|COMPLETED|Overall Study||155
57133|NCT01440049|133772|P1|STARTED|Overall Study||160
57134|NCT01439724|133801|P2|NOT COMPLETED|Overall Study||8
57135|NCT01439724|133802|P1|NOT COMPLETED|Overall Study||9
57136|NCT01439724|133801|P2|COMPLETED|Overall Study||39
57137|NCT01439724|133802|P1|COMPLETED|Overall Study||38
57138|NCT01439724|133801|P2|STARTED|Overall Study||47
57139|NCT01439724|133802|P1|STARTED|Overall Study||47
57140|NCT01439672|133808|P1|NOT COMPLETED|Overall Study||24
57141|NCT01439672|133808|P1|COMPLETED|Overall Study||11
57142|NCT01439672|133808|P1|STARTED|Overall Study||35
57143|NCT01439282|133814|P2|NOT COMPLETED|Overall Study||1
57144|NCT01439282|133815|P1|NOT COMPLETED|Overall Study||8
57145|NCT01439282|133814|P2|COMPLETED|Overall Study||9
57146|NCT01439282|133815|P1|COMPLETED|Overall Study||59
57147|NCT01439282|133814|P2|STARTED|Overall Study||10
57148|NCT01439282|133815|P1|STARTED|Overall Study||67
57149|NCT01439204|133825|P2|NOT COMPLETED|Overall Study||3
57150|NCT01439204|133826|P1|NOT COMPLETED|Overall Study||4
57151|NCT01439204|133825|P2|COMPLETED|Overall Study||33
57152|NCT01439204|133826|P1|COMPLETED|Overall Study||32
57153|NCT01439204|133825|P2|STARTED|Overall Study||36
57154|NCT01439204|133826|P1|STARTED|Overall Study||36
57155|NCT01439126|133860|P2|NOT COMPLETED|Overall Study||42
57156|NCT01439126|133861|P1|NOT COMPLETED|Overall Study||31
57157|NCT01439126|133860|P2|COMPLETED|Overall Study||25
57158|NCT01439126|133861|P1|COMPLETED|Overall Study||37
57159|NCT01439126|133860|P2|STARTED|Overall Study||67
57160|NCT01439126|133861|P1|STARTED|Overall Study||68
57161|NCT01439074|133883|P2|NOT COMPLETED|Overall Study||13
57162|NCT01439074|133884|P1|NOT COMPLETED|Overall Study||9
57163|NCT01439074|133883|P2|COMPLETED|Overall Study||74
57164|NCT01439074|133884|P1|COMPLETED|Overall Study||66
57165|NCT01439074|133883|P2|STARTED|Overall Study||87
57166|NCT01439074|133884|P1|STARTED|Overall Study||75
57167|NCT01438996|133899|P3|NOT COMPLETED|Overall Study||0
57168|NCT01438996|133900|P2|NOT COMPLETED|Overall Study||1
57169|NCT01438996|133901|P1|NOT COMPLETED|Overall Study||4
57170|NCT01438996|133899|P3|COMPLETED|Overall Study||20
57171|NCT01438996|133900|P2|COMPLETED|Overall Study||12
57172|NCT01438996|133901|P1|COMPLETED|Overall Study||14
57173|NCT01438996|133899|P3|STARTED|Overall Study||20
57174|NCT01438996|133900|P2|STARTED|Overall Study||13
57175|NCT01438996|133901|P1|STARTED|Overall Study||18
57176|NCT01438814|133935|P2|NOT COMPLETED|Overall Study||14
57177|NCT01438814|133936|P1|NOT COMPLETED|Overall Study||14
57178|NCT01438814|133935|P2|COMPLETED|Overall Study||331
57179|NCT01438814|133936|P1|COMPLETED|Overall Study||330
57180|NCT01438814|133935|P2|STARTED|Overall Study||345
57181|NCT01438814|133936|P1|STARTED|Overall Study||344
57182|NCT01438710|133966|P2|NOT COMPLETED|Second Week of Treatment||0
57183|NCT01438710|133967|P1|NOT COMPLETED|Second Week of Treatment||1
57184|NCT01438710|133966|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
57185|NCT01438710|133967|P1|COMPLETED|Second Week of Treatment||40
57186|NCT01438710|133966|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
57187|NCT01438710|133967|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
57188|NCT01438710|133966|P2|NOT COMPLETED|First Week of Treatment||3
57189|NCT01438710|133967|P1|NOT COMPLETED|First Week of Treatment||0
57190|NCT01438710|133966|P2|COMPLETED|First Week of Treatment||41
57191|NCT01438710|133967|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
57192|NCT01438710|133966|P2|STARTED|First Week of Treatment||44
57193|NCT01438710|133967|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
57194|NCT01438541|133972|P1|NOT COMPLETED|Overall Study||7
57195|NCT01438541|133972|P1|COMPLETED|Overall Study||22
57196|NCT01438541|133972|P1|STARTED|Overall Study||29
57197|NCT01438489|133981|P3|NOT COMPLETED|Overall Study||19
57198|NCT01438489|133982|P2|NOT COMPLETED|Overall Study||16
57199|NCT01438489|133983|P1|NOT COMPLETED|Overall Study||26
57200|NCT01438489|133981|P3|COMPLETED|Overall Study||85
57201|NCT01438489|133982|P2|COMPLETED|Overall Study||84
57202|NCT01438489|133983|P1|COMPLETED|Overall Study||77
57203|NCT01438489|133981|P3|STARTED|Overall Study||104
57204|NCT01438489|133982|P2|STARTED|Overall Study||100
57205|NCT01438489|133983|P1|STARTED|Overall Study||103
57206|NCT01438424|134026|P1|NOT COMPLETED|Overall Study||417
57207|NCT01438424|134026|P1|COMPLETED|Overall Study|Completed treatment|634
57208|NCT01438424|134026|P1|STARTED|Overall Study|Received treatment|1051
57209|NCT01438294|134064|P2|NOT COMPLETED|Overall Study||7
57210|NCT01438294|134065|P1|NOT COMPLETED|Overall Study||3
57211|NCT01438294|134064|P2|COMPLETED|Overall Study||13
57212|NCT01438294|134065|P1|COMPLETED|Overall Study||13
57213|NCT01438294|134064|P2|STARTED|Overall Study||20
57214|NCT01438294|134065|P1|STARTED|Overall Study||16
57215|NCT01438229|134075|P1|NOT COMPLETED|Overall Study||3
57216|NCT01438229|134075|P1|COMPLETED|Overall Study||44
57217|NCT01438229|134075|P1|Underwent Procedure|Overall Study||46
57218|NCT01438229|134075|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
57219|NCT01438229|134075|P1|STARTED|Overall Study||47
57220|NCT01438177|134108|P1|NOT COMPLETED|Overall Study||2
57221|NCT01438177|134108|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
57222|NCT01438177|134108|P1|STARTED|Overall Study||11
57223|NCT01438151|134114|P1|NOT COMPLETED|Overall Study||8
57224|NCT01438151|134114|P1|COMPLETED|Overall Study||3
57225|NCT01438151|134114|P1|STARTED|Overall Study||11
57226|NCT01438060|134120|P2|NOT COMPLETED|On Study Beyond Week 140||8
57227|NCT01438060|134121|P1|NOT COMPLETED|On Study Beyond Week 140||0
57228|NCT01438060|134120|P2|COMPLETED|On Study Beyond Week 140||1
57229|NCT01438060|134121|P1|COMPLETED|On Study Beyond Week 140||0
57230|NCT01438060|134120|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
57231|NCT01438060|134121|P1|STARTED|On Study Beyond Week 140||0
57232|NCT01438060|134120|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
57233|NCT01438060|134121|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
57234|NCT01438060|134120|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
57235|NCT01438060|134121|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
57236|NCT01438060|134120|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
57237|NCT01438060|134121|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
57238|NCT01438060|134120|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
57239|NCT01438060|134121|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
57240|NCT01438060|134120|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
57241|NCT01438060|134121|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
57242|NCT01438060|134120|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
57243|NCT01438060|134121|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
57244|NCT01437878|134201|P2|NOT COMPLETED|Overall Study||0
57245|NCT01437878|134202|P1|NOT COMPLETED|Overall Study||1
57246|NCT01437878|134201|P2|COMPLETED|Overall Study||1
57247|NCT01437878|134202|P1|COMPLETED|Overall Study||0
57248|NCT01437878|134201|P2|STARTED|Overall Study||1
57249|NCT01437878|134202|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
57250|NCT01437501|134244|P2|NOT COMPLETED|Overall Study||11
57251|NCT01437501|134245|P1|NOT COMPLETED|Overall Study||13
57252|NCT01437501|134244|P2|COMPLETED|Overall Study||132
57253|NCT01437501|134245|P1|COMPLETED|Overall Study||135
57254|NCT01437501|134244|P2|STARTED|Overall Study||143
57255|NCT01437501|134245|P1|STARTED|Overall Study||148
57256|NCT01437423|134251|P1|NOT COMPLETED|Overall Study||15
57257|NCT01437423|134251|P1|COMPLETED|Overall Study||647
57258|NCT01437423|134251|P1|STARTED|Overall Study||662
57259|NCT01437319|134258|P3|NOT COMPLETED|Phase II||37
57260|NCT01437319|134259|P2|NOT COMPLETED|Phase II||44
57261|NCT01437319|134260|P1|NOT COMPLETED|Phase II||0
57262|NCT01437319|134258|P3|COMPLETED|Phase II||75
57263|NCT01437319|134259|P2|COMPLETED|Phase II||71
57264|NCT01437319|134260|P1|COMPLETED|Phase II||0
57265|NCT01437319|134258|P3|STARTED|Phase II||112
57266|NCT01437319|134259|P2|STARTED|Phase II||115
57267|NCT01437319|134260|P1|STARTED|Phase II||0
57268|NCT01437319|134258|P3|NOT COMPLETED|Phase I||0
57269|NCT01437319|134259|P2|NOT COMPLETED|Phase I||0
57270|NCT01437319|134260|P1|NOT COMPLETED|Phase I||55
57271|NCT01437319|134258|P3|COMPLETED|Phase I||0
57272|NCT01437319|134259|P2|COMPLETED|Phase I||0
57273|NCT01437319|134260|P1|COMPLETED|Phase I||227
57274|NCT01437319|134258|P3|STARTED|Phase I||0
57275|NCT01437319|134259|P2|STARTED|Phase I||0
57276|NCT01437319|134260|P1|STARTED|Phase I||282
57277|NCT01437267|134275|P6|NOT COMPLETED|Overall Study||0
57278|NCT01437267|134276|P5|NOT COMPLETED|Overall Study||0
57279|NCT01437267|134277|P4|NOT COMPLETED|Overall Study||1
57280|NCT01437267|134278|P3|NOT COMPLETED|Overall Study||0
57281|NCT01437267|134279|P2|NOT COMPLETED|Overall Study||1
57282|NCT01437267|134280|P1|NOT COMPLETED|Overall Study||0
57283|NCT01437267|134275|P6|COMPLETED|Overall Study||20
57284|NCT01437267|134276|P5|COMPLETED|Overall Study||20
57285|NCT01437267|134277|P4|COMPLETED|Overall Study||19
57286|NCT01437267|134278|P3|COMPLETED|Overall Study||20
57287|NCT01437267|134279|P2|COMPLETED|Overall Study||19
57288|NCT01437267|134280|P1|COMPLETED|Overall Study||20
57289|NCT01437267|134275|P6|STARTED|Overall Study||20
57290|NCT01437267|134276|P5|STARTED|Overall Study||20
57291|NCT01437267|134277|P4|STARTED|Overall Study||20
57292|NCT01437267|134278|P3|STARTED|Overall Study||20
57293|NCT01437267|134279|P2|STARTED|Overall Study||20
57294|NCT01437267|134280|P1|STARTED|Overall Study||20
57295|NCT01437124|134318|P1|NOT COMPLETED|Overall Study||0
57296|NCT01437124|134318|P1|COMPLETED|Overall Study||83
57297|NCT01437124|134318|P1|STARTED|Overall Study||83
57298|NCT01437111|134323|P1|NOT COMPLETED|Overall Study||18
57299|NCT01437111|134323|P1|COMPLETED|Overall Study||182
57300|NCT01437111|134323|P1|Treated Participants|Overall Study||198
57301|NCT01437111|134323|P1|STARTED|Overall Study||200
57302|NCT01437098|134334|P1|NOT COMPLETED|Overall Study||13
57303|NCT01437098|134334|P1|COMPLETED|Overall Study||42
57304|NCT01437098|134334|P1|36 Months|Overall Study||36
57305|NCT01437098|134334|P1|24 Months|Overall Study||42
57306|NCT01437098|134334|P1|12 Months|Overall Study||45
57307|NCT01437098|134334|P1|6 Months|Overall Study||47
57308|NCT01437098|134334|P1|30 Days|Overall Study||51
57309|NCT01437098|134334|P1|STARTED|Overall Study||55
57310|NCT01436799|134391|P2|NOT COMPLETED|Overall Study||0
57311|NCT01436799|134392|P1|NOT COMPLETED|Overall Study||0
57312|NCT01436799|134391|P2|COMPLETED|Overall Study||20
57313|NCT01436799|134392|P1|COMPLETED|Overall Study||20
57314|NCT01436799|134391|P2|STARTED|Overall Study||20
57315|NCT01436799|134392|P1|STARTED|Overall Study||20
57316|NCT01436643|134401|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
57317|NCT01436643|134402|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
57318|NCT01436643|134403|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
57319|NCT01436643|134404|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
57320|NCT01436643|134401|P4|COMPLETED|Core Phase (16 Weeks)||0
57321|NCT01436643|134402|P3|COMPLETED|Core Phase (16 Weeks)||17
57322|NCT01436643|134403|P2|COMPLETED|Core Phase (16 Weeks)||11
57323|NCT01436643|134404|P1|COMPLETED|Core Phase (16 Weeks)||16
57324|NCT01436643|134401|P4|STARTED|Core Phase (16 Weeks)||0
57325|NCT01436643|134402|P3|STARTED|Core Phase (16 Weeks)||20
57326|NCT01436643|134403|P2|STARTED|Core Phase (16 Weeks)||15
57327|NCT01436643|134404|P1|STARTED|Core Phase (16 Weeks)||17
57328|NCT01436643|134401|P4|NOT COMPLETED|2-week Pre-treatment||10
57329|NCT01436643|134402|P3|NOT COMPLETED|2-week Pre-treatment||0
57330|NCT01436643|134403|P2|NOT COMPLETED|2-week Pre-treatment||0
57331|NCT01436643|134404|P1|NOT COMPLETED|2-week Pre-treatment||0
57332|NCT01436643|134401|P4|COMPLETED|2-week Pre-treatment||44
57333|NCT01436643|134402|P3|COMPLETED|2-week Pre-treatment||0
57334|NCT01436643|134403|P2|COMPLETED|2-week Pre-treatment||0
57335|NCT01436643|134404|P1|COMPLETED|2-week Pre-treatment||0
57336|NCT01436643|134401|P4|STARTED|2-week Pre-treatment||54
57337|NCT01436643|134402|P3|STARTED|2-week Pre-treatment||0
57338|NCT01436643|134403|P2|STARTED|2-week Pre-treatment||0
57339|NCT01436643|134404|P1|STARTED|2-week Pre-treatment||0
57340|NCT01436526|134416|P2|NOT COMPLETED|Period 2||0
57341|NCT01436526|134417|P1|NOT COMPLETED|Period 2||0
57342|NCT01436526|134416|P2|COMPLETED|Period 2||13
57343|NCT01436526|134417|P1|COMPLETED|Period 2||13
57344|NCT01436526|134416|P2|Participants Received Treatment|Period 2||13
57345|NCT01436526|134417|P1|Participants Received Treatment|Period 2||13
57346|NCT01436526|134416|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
57347|NCT01436526|134417|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
57348|NCT01436526|134416|P2|NOT COMPLETED|Period 1||0
57349|NCT01436526|134417|P1|NOT COMPLETED|Period 1||0
57350|NCT01436526|134416|P2|COMPLETED|Period 1||14
57351|NCT01436526|134417|P1|COMPLETED|Period 1||14
57352|NCT01436526|134416|P2|Participants Received Treatment|Period 1||14
57353|NCT01436526|134417|P1|Participants Received Treatment|Period 1||14
57354|NCT01436526|134416|P2|STARTED|Period 1||14
57355|NCT01436526|134417|P1|STARTED|Period 1||14
57356|NCT01436500|134439|P2|NOT COMPLETED|Overall Study||4
57357|NCT01436500|134440|P1|NOT COMPLETED|Overall Study||12
57358|NCT01436500|134439|P2|COMPLETED|Overall Study||9
57359|NCT01436500|134440|P1|COMPLETED|Overall Study||30
57360|NCT01436500|134439|P2|STARTED|Overall Study||13
57361|NCT01436500|134440|P1|STARTED|Overall Study||42
57362|NCT01436435|134494|P1|NOT COMPLETED|Overall Study||64
57363|NCT01436435|134494|P1|COMPLETED|Overall Study||177
57364|NCT01436435|134494|P1|STARTED|Overall Study||241
57365|NCT01436370|134511|P8|NOT COMPLETED|Overall Study||0
57366|NCT01436370|134512|P7|NOT COMPLETED|Overall Study||0
57367|NCT01436370|134513|P6|NOT COMPLETED|Overall Study||0
57368|NCT01436370|134514|P5|NOT COMPLETED|Overall Study||1
57369|NCT01436370|134515|P4|NOT COMPLETED|Overall Study||0
57370|NCT01436370|134516|P3|NOT COMPLETED|Overall Study||0
57371|NCT01436370|134517|P2|NOT COMPLETED|Overall Study||0
57372|NCT01436370|134518|P1|NOT COMPLETED|Overall Study||0
57373|NCT01436370|134511|P8|COMPLETED|Overall Study||16
57374|NCT01436370|134512|P7|COMPLETED|Overall Study||16
57375|NCT01436370|134513|P6|COMPLETED|Overall Study||19
57376|NCT01436370|134514|P5|COMPLETED|Overall Study||18
57377|NCT01436370|134515|P4|COMPLETED|Overall Study||10
57378|NCT01436370|134516|P3|COMPLETED|Overall Study||10
57379|NCT01436370|134517|P2|COMPLETED|Overall Study||6
57380|NCT01436370|134518|P1|COMPLETED|Overall Study||6
57381|NCT01436370|134511|P8|STARTED|Overall Study||16
57382|NCT01436370|134512|P7|STARTED|Overall Study||16
57383|NCT01436370|134513|P6|STARTED|Overall Study||19
57384|NCT01436370|134514|P5|STARTED|Overall Study||19
57385|NCT01436370|134515|P4|STARTED|Overall Study||10
57386|NCT01436370|134516|P3|STARTED|Overall Study||10
57387|NCT01436370|134517|P2|STARTED|Overall Study||6
57388|NCT01436370|134518|P1|STARTED|Overall Study||6
57389|NCT01436253|134596|P1|NOT COMPLETED|Overall Study||299
57390|NCT01436253|134596|P1|COMPLETED|Overall Study||1897
57391|NCT01436253|134596|P1|STARTED|Overall Study||2196
57392|NCT01436201|134601|P1|NOT COMPLETED|Overall Study||4
57393|NCT01436201|134601|P1|COMPLETED|Overall Study||20
57394|NCT01436201|134601|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
57395|NCT01436201|134601|P1|STARTED|Overall Study||24
57396|NCT01436175|134611|P1|NOT COMPLETED|Overall Study||1270
57397|NCT01436175|134611|P1|COMPLETED|Overall Study||300
57398|NCT01436175|134611|P1|STARTED|Overall Study||1570
57399|NCT01436162|134638|P3|NOT COMPLETED|Randomized Phase||25
57400|NCT01436162|134639|P2|NOT COMPLETED|Randomized Phase||31
57401|NCT01436162|134640|P1|NOT COMPLETED|Randomized Phase||44
57402|NCT01436162|134638|P3|COMPLETED|Randomized Phase||189
57403|NCT01436162|134639|P2|COMPLETED|Randomized Phase||181
57404|NCT01436162|134640|P1|COMPLETED|Randomized Phase||353
57405|NCT01436162|134638|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
57406|NCT01436162|134639|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
57407|NCT01436162|134640|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
57408|NCT01436162|134638|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
57409|NCT01436162|134639|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
57410|NCT01436162|134640|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
57411|NCT01436162|134638|P3|COMPLETED|Single-blind Lead-in Phase||0
57412|NCT01436162|134639|P2|COMPLETED|Single-blind Lead-in Phase||0
57413|NCT01436162|134640|P1|COMPLETED|Single-blind Lead-in Phase||823
57414|NCT01436162|134638|P3|STARTED|Single-blind Lead-in Phase||0
57415|NCT01436162|134639|P2|STARTED|Single-blind Lead-in Phase||0
57416|NCT01436162|134640|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
57417|NCT01436149|134674|P3|NOT COMPLETED|Randomized Phase||42
57418|NCT01436149|134675|P2|NOT COMPLETED|Randomized Phase||38
57419|NCT01436149|134676|P1|NOT COMPLETED|Randomized Phase||77
57420|NCT01436149|134674|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
57421|NCT01436149|134675|P2|COMPLETED|Randomized Phase||164
57422|NCT01436149|134676|P1|COMPLETED|Randomized Phase||415
57423|NCT01436149|134674|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
57424|NCT01436149|134675|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
57425|NCT01436149|134676|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
57426|NCT01436149|134674|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
57427|NCT01436149|134675|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
57428|NCT01436149|134676|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
57429|NCT01436149|134674|P3|COMPLETED|Antidepressant Lead-in Phase||0
57430|NCT01436149|134675|P2|COMPLETED|Antidepressant Lead-in Phase||0
57431|NCT01436149|134676|P1|COMPLETED|Antidepressant Lead-in Phase||896
57432|NCT01436149|134674|P3|STARTED|Antidepressant Lead-in Phase||0
57433|NCT01436149|134675|P2|STARTED|Antidepressant Lead-in Phase||0
57434|NCT01436149|134676|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
57435|NCT01436110|134707|P3|NOT COMPLETED|Overall Study||23
57436|NCT01436110|134708|P2|NOT COMPLETED|Overall Study||26
57437|NCT01436110|134709|P1|NOT COMPLETED|Overall Study||39
57438|NCT01436110|134707|P3|COMPLETED|Overall Study||95
57439|NCT01436110|134708|P2|COMPLETED|Overall Study||91
57440|NCT01436110|134709|P1|COMPLETED|Overall Study||77
57441|NCT01436110|134707|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
57442|NCT01436110|134708|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
57443|NCT01436110|134709|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
57444|NCT01436110|134707|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
57445|NCT01436110|134708|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
57446|NCT01436110|134709|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
57447|NCT01436084|134732|P1|NOT COMPLETED|Overall Study||4
57448|NCT01436084|134732|P1|COMPLETED|Overall Study||0
57449|NCT01436084|134732|P1|STARTED|Overall Study||4
57450|NCT01436071|134738|P2|NOT COMPLETED|Overall Study||14
57451|NCT01436071|134739|P1|NOT COMPLETED|Overall Study||26
57452|NCT01436071|134738|P2|COMPLETED|Overall Study||110
57453|NCT01436071|134739|P1|COMPLETED|Overall Study||98
57454|NCT01436071|134738|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
57455|NCT01436071|134739|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
57456|NCT01436071|134738|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
57457|NCT01436071|134739|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
57458|NCT01436045|134755|P2|NOT COMPLETED|Overall Study||0
57459|NCT01436045|134756|P1|NOT COMPLETED|Overall Study||0
57460|NCT01436045|134755|P2|COMPLETED|Overall Study||6
57461|NCT01436045|134756|P1|COMPLETED|Overall Study||6
57462|NCT01436045|134755|P2|STARTED|Overall Study||6
57463|NCT01436045|134756|P1|STARTED|Overall Study||6
57464|NCT01436006|134767|P1|NOT COMPLETED|Overall Study||37
57465|NCT01436006|134767|P1|COMPLETED|Overall Study||6663
57466|NCT01436006|134767|P1|STARTED|Overall Study||6700
57467|NCT01435928|134781|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
57468|NCT01435928|134782|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
57469|NCT01435928|134783|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
57470|NCT01435928|134781|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
57471|NCT01435928|134782|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
57472|NCT01435928|134783|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
57473|NCT01435928|134781|P3|STARTED|Double Blind Phase - 28 Weeks||141
57474|NCT01435928|134782|P2|STARTED|Double Blind Phase - 28 Weeks||144
57475|NCT01435928|134783|P1|STARTED|Double Blind Phase - 28 Weeks||0
57476|NCT01435928|134781|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
57477|NCT01435928|134782|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
57478|NCT01435928|134783|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
57479|NCT01435928|134781|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
57480|NCT01435928|134782|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
57481|NCT01435928|134783|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
57482|NCT01435928|134781|P3|STARTED|Open Label Phase - up to 24 Weeks||0
57483|NCT01435928|134782|P2|STARTED|Open Label Phase - up to 24 Weeks||0
57484|NCT01435928|134783|P1|STARTED|Open Label Phase - up to 24 Weeks||676
57485|NCT01435759|134815|P6|NOT COMPLETED|Double-blind Phase||9
57486|NCT01435759|134816|P5|NOT COMPLETED|Double-blind Phase||9
57487|NCT01435759|134817|P4|NOT COMPLETED|Double-blind Phase||9
57488|NCT01435759|134818|P3|NOT COMPLETED|Double-blind Phase||7
57489|NCT01435759|134819|P2|NOT COMPLETED|Double-blind Phase||7
57490|NCT01435759|134820|P1|NOT COMPLETED|Double-blind Phase||66
57491|NCT01435759|134815|P6|COMPLETED|Double-blind Phase||71
57492|NCT01435759|134816|P5|COMPLETED|Double-blind Phase||69
57493|NCT01435759|134817|P4|COMPLETED|Double-blind Phase||69
57494|NCT01435759|134818|P3|COMPLETED|Double-blind Phase||71
57495|NCT01435759|134819|P2|COMPLETED|Double-blind Phase||71
57496|NCT01435759|134820|P1|COMPLETED|Double-blind Phase||397
57497|NCT01435759|134815|P6|STARTED|Double-blind Phase||80
57498|NCT01435759|134816|P5|STARTED|Double-blind Phase||78
57499|NCT01435759|134817|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
57500|NCT01435759|134818|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
57501|NCT01435759|134819|P2|STARTED|Double-blind Phase||78
57502|NCT01435759|134820|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
57503|NCT01435759|134815|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
57504|NCT01435759|134816|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
57505|NCT01435759|134817|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
57506|NCT01435759|134818|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
57507|NCT01435759|134819|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
57508|NCT01435759|134820|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
57509|NCT01435759|134815|P6|COMPLETED|Antidepressant Lead-in Phase||0
57510|NCT01435759|134816|P5|COMPLETED|Antidepressant Lead-in Phase||0
57511|NCT01435759|134817|P4|COMPLETED|Antidepressant Lead-in Phase||0
57512|NCT01435759|134818|P3|COMPLETED|Antidepressant Lead-in Phase||0
57513|NCT01435759|134819|P2|COMPLETED|Antidepressant Lead-in Phase||0
57514|NCT01435759|134820|P1|COMPLETED|Antidepressant Lead-in Phase||855
57515|NCT01435759|134815|P6|STARTED|Antidepressant Lead-in Phase||0
57516|NCT01435759|134816|P5|STARTED|Antidepressant Lead-in Phase||0
57517|NCT01435759|134817|P4|STARTED|Antidepressant Lead-in Phase||0
57518|NCT01435759|134818|P3|STARTED|Antidepressant Lead-in Phase||0
57519|NCT01435759|134819|P2|STARTED|Antidepressant Lead-in Phase||0
57520|NCT01435759|134820|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
57521|NCT01435655|134847|P1|NOT COMPLETED|Overall Study||3
57522|NCT01435655|134847|P1|COMPLETED|Overall Study||7
57523|NCT01435655|134847|P1|STARTED|Overall Study||10
57524|NCT01435577|134861|P2|NOT COMPLETED|Overall Study||52
57525|NCT01435577|134862|P1|NOT COMPLETED|Overall Study||17
57526|NCT01435577|134861|P2|COMPLETED|Overall Study||13
57527|NCT01435577|134862|P1|COMPLETED|Overall Study||47
57528|NCT01435577|134861|P2|STARTED|Overall Study||65
57529|NCT01435577|134862|P1|STARTED|Overall Study||64
57530|NCT01435460|134912|P2|NOT COMPLETED|Overall Study||6
57531|NCT01435460|134913|P1|NOT COMPLETED|Overall Study||11
57532|NCT01435460|134912|P2|COMPLETED|Overall Study||143
57533|NCT01435460|134913|P1|COMPLETED|Overall Study||140
57534|NCT01435460|134912|P2|STARTED|Overall Study||149
57535|NCT01435460|134913|P1|STARTED|Overall Study||151
57536|NCT01435265|134927|P2|NOT COMPLETED|Overall Study||1
57537|NCT01435265|134928|P1|NOT COMPLETED|Overall Study||0
57538|NCT01435265|134927|P2|COMPLETED|Overall Study||3
57539|NCT01435265|134928|P1|COMPLETED|Overall Study||3
57540|NCT01435265|134927|P2|STARTED|Overall Study||4
57541|NCT01435265|134928|P1|STARTED|Overall Study||3
57542|NCT01435174|134938|P1|NOT COMPLETED|Overall Study||9
57543|NCT01435174|134938|P1|COMPLETED|Overall Study||8
57544|NCT01435174|134938|P1|STARTED|Overall Study||17
57545|NCT01435031|134942|P1|NOT COMPLETED|ITT at 1 Year||3
57546|NCT01435031|134942|P1|COMPLETED|ITT at 1 Year||209
57547|NCT01435031|134942|P1|STARTED|ITT at 1 Year||212
57548|NCT01435031|134942|P1|NOT COMPLETED|ITT at 6 Months||4
57549|NCT01435031|134942|P1|COMPLETED|ITT at 6 Months||212
57550|NCT01435031|134942|P1|STARTED|ITT at 6 Months||216
57551|NCT01435031|134942|P1|NOT COMPLETED|ITT at 1 Month||6
57552|NCT01435031|134942|P1|COMPLETED|ITT at 1 Month||216
57553|NCT01435031|134942|P1|PP Population|ITT at 1 Month|PP population|183
57554|NCT01435031|134942|P1|STARTED|ITT at 1 Month|ITT population|222
57555|NCT01434823|135009|P2|NOT COMPLETED|Overall Study||7
57556|NCT01434823|135010|P1|NOT COMPLETED|Overall Study||4
57557|NCT01434823|135009|P2|COMPLETED|Overall Study||778
57558|NCT01434823|135010|P1|COMPLETED|Overall Study||820
57559|NCT01434823|135009|P2|STARTED|Overall Study||785
57560|NCT01434823|135010|P1|STARTED|Overall Study||824
57561|NCT01434693|135028|P4|NOT COMPLETED|Overall Study||1
57562|NCT01434693|135029|P3|NOT COMPLETED|Overall Study||1
57563|NCT01434693|135030|P2|NOT COMPLETED|Overall Study||0
57564|NCT01434693|135031|P1|NOT COMPLETED|Overall Study||3
57565|NCT01434693|135028|P4|COMPLETED|Overall Study||8
57566|NCT01434693|135029|P3|COMPLETED|Overall Study||8
57567|NCT01434693|135030|P2|COMPLETED|Overall Study||9
57568|NCT01434693|135031|P1|COMPLETED|Overall Study||6
57569|NCT01434693|135028|P4|STARTED|Overall Study||9
57570|NCT01434693|135029|P3|STARTED|Overall Study||9
57571|NCT01434693|135030|P2|STARTED|Overall Study||9
57572|NCT01434693|135031|P1|STARTED|Overall Study||9
57573|NCT01434680|135045|P4|NOT COMPLETED|Overall Study||0
57574|NCT01434680|135046|P3|NOT COMPLETED|Overall Study||2
57575|NCT01434680|135047|P2|NOT COMPLETED|Overall Study||2
57576|NCT01434680|135048|P1|NOT COMPLETED|Overall Study||3
57577|NCT01434680|135045|P4|COMPLETED|Overall Study||119
57578|NCT01434680|135046|P3|COMPLETED|Overall Study||304
57579|NCT01434680|135047|P2|COMPLETED|Overall Study||266
57580|NCT01434680|135048|P1|COMPLETED|Overall Study||296
57581|NCT01434680|135045|P4|STARTED|Overall Study||119
57582|NCT01434680|135046|P3|STARTED|Overall Study||306
57583|NCT01434680|135047|P2|STARTED|Overall Study||268
57584|NCT01434680|135048|P1|STARTED|Overall Study||299
57585|NCT01434654|135065|P2|NOT COMPLETED|Overall Study||0
57586|NCT01434654|135066|P1|NOT COMPLETED|Overall Study||2
57587|NCT01434654|135065|P2|COMPLETED|Overall Study||12
57588|NCT01434654|135066|P1|COMPLETED|Overall Study||5
57589|NCT01434654|135065|P2|STARTED|Overall Study||12
57590|NCT01434654|135066|P1|STARTED|Overall Study||7
57591|NCT01434641|135078|P1|NOT COMPLETED|Overall Study||0
57592|NCT01434641|135078|P1|COMPLETED|Overall Study||102
57593|NCT01434641|135078|P1|STARTED|Overall Study||102
57594|NCT01434511|135083|P1|NOT COMPLETED|Overall Study||0
57595|NCT01434511|135083|P1|COMPLETED|Overall Study||1
57596|NCT01434511|135083|P1|STARTED|Overall Study||1
57597|NCT01434121|135103|P3|NOT COMPLETED|Overall Study||0
57598|NCT01434121|135104|P2|NOT COMPLETED|Overall Study||0
57599|NCT01434121|135105|P1|NOT COMPLETED|Overall Study||0
57600|NCT01434121|135103|P3|COMPLETED|Overall Study||8
57601|NCT01434121|135104|P2|COMPLETED|Overall Study||8
57602|NCT01434121|135105|P1|COMPLETED|Overall Study||8
57603|NCT01434121|135103|P3|STARTED|Overall Study||8
57604|NCT01434121|135104|P2|STARTED|Overall Study||8
57605|NCT01434121|135105|P1|STARTED|Overall Study||8
57606|NCT01434030|135113|P1|NOT COMPLETED|Overall Study||1
57607|NCT01434030|135113|P1|COMPLETED|Overall Study||56
57608|NCT01434030|135113|P1|STARTED|Overall Study||57
57609|NCT01433913|135120|P2|NOT COMPLETED|Overall Study||0
57610|NCT01433913|135121|P1|NOT COMPLETED|Overall Study||1
57611|NCT01433913|135120|P2|COMPLETED|Overall Study||10
57612|NCT01433913|135121|P1|COMPLETED|Overall Study||9
57613|NCT01433913|135120|P2|STARTED|Overall Study||10
57614|NCT01433913|135121|P1|STARTED|Overall Study||10
57615|NCT01433731|135131|P4|NOT COMPLETED|Overall Study||0
57616|NCT01433731|135132|P3|NOT COMPLETED|Overall Study||0
57617|NCT01433731|135133|P2|NOT COMPLETED|Overall Study||0
57618|NCT01433731|135134|P1|NOT COMPLETED|Overall Study||0
57619|NCT01433731|135131|P4|COMPLETED|Overall Study||5
57620|NCT01433731|135132|P3|COMPLETED|Overall Study||5
57621|NCT01433731|135133|P2|COMPLETED|Overall Study||5
57622|NCT01433731|135134|P1|COMPLETED|Overall Study||3
57623|NCT01433731|135131|P4|STARTED|Overall Study||5
57624|NCT01433731|135132|P3|STARTED|Overall Study||5
57625|NCT01433731|135133|P2|STARTED|Overall Study||5
57626|NCT01433731|135134|P1|STARTED|Overall Study||3
57627|NCT01433549|135142|P2|NOT COMPLETED|Phase 2: Second Study Product||1
57628|NCT01433549|135143|P1|NOT COMPLETED|Phase 2: Second Study Product||0
57629|NCT01433549|135142|P2|COMPLETED|Phase 2: Second Study Product||12
57630|NCT01433549|135143|P1|COMPLETED|Phase 2: Second Study Product||12
57631|NCT01433549|135142|P2|STARTED|Phase 2: Second Study Product||13
57632|NCT01433549|135143|P1|STARTED|Phase 2: Second Study Product||12
57633|NCT01433549|135142|P2|NOT COMPLETED|Phase 1: First Study Product||0
57634|NCT01433549|135143|P1|NOT COMPLETED|Phase 1: First Study Product||0
57635|NCT01433549|135142|P2|COMPLETED|Phase 1: First Study Product||13
57636|NCT01433549|135143|P1|COMPLETED|Phase 1: First Study Product||12
57637|NCT01433549|135142|P2|STARTED|Phase 1: First Study Product||13
57638|NCT01433549|135143|P1|STARTED|Phase 1: First Study Product||12
57639|NCT01433471|135153|P2|NOT COMPLETED|Overall Study||1
57640|NCT01433471|135154|P1|NOT COMPLETED|Overall Study||0
57641|NCT01433471|135153|P2|COMPLETED|Overall Study||1
57642|NCT01433471|135154|P1|COMPLETED|Overall Study||2
57643|NCT01433471|135153|P2|STARTED|Overall Study||2
57644|NCT01433471|135154|P1|STARTED|Overall Study||2
57645|NCT01433354|135170|P1|NOT COMPLETED|Overall Study||119
57646|NCT01433354|135170|P1|COMPLETED|Overall Study||0
57647|NCT01433354|135170|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
57648|NCT01433263|135186|P2|NOT COMPLETED|Overall Study||12
57649|NCT01433263|135187|P1|NOT COMPLETED|Overall Study||19
57650|NCT01433263|135186|P2|COMPLETED|Overall Study||16
57651|NCT01433263|135187|P1|COMPLETED|Overall Study||10
57652|NCT01433263|135186|P2|STARTED|Overall Study||28
57653|NCT01433263|135187|P1|STARTED|Overall Study||29
57654|NCT01433250|135216|P2|NOT COMPLETED|Overall Study||3
57655|NCT01433250|135217|P1|NOT COMPLETED|Overall Study||3
57656|NCT01433250|135216|P2|COMPLETED|Overall Study||14
57657|NCT01433250|135217|P1|COMPLETED|Overall Study||19
57658|NCT01433250|135216|P2|STARTED|Overall Study||17
57659|NCT01433250|135217|P1|STARTED|Overall Study||22
57660|NCT01433159|135235|P2|NOT COMPLETED|Overall Study||1
57661|NCT01433159|135236|P1|NOT COMPLETED|Overall Study||2
57662|NCT01433159|135235|P2|COMPLETED|Overall Study||9
57663|NCT01433159|135236|P1|COMPLETED|Overall Study||7
57664|NCT01433159|135235|P2|STARTED|Overall Study||10
57665|NCT01433159|135236|P1|STARTED|Overall Study||9
57666|NCT01433107|135244|P2|NOT COMPLETED|Overall Study||17
57667|NCT01433107|135245|P1|NOT COMPLETED|Overall Study||27
57668|NCT01433107|135244|P2|COMPLETED|Overall Study||128
57669|NCT01433107|135245|P1|COMPLETED|Overall Study||118
57670|NCT01433107|135244|P2|STARTED|Overall Study||145
57671|NCT01433107|135245|P1|STARTED|Overall Study||145
57672|NCT01433081|135257|P2|NOT COMPLETED|Overall Study||2
57673|NCT01433081|135258|P1|NOT COMPLETED|Overall Study||2
57674|NCT01433081|135257|P2|COMPLETED|Overall Study||23
57675|NCT01433081|135258|P1|COMPLETED|Overall Study||23
57676|NCT01433081|135257|P2|STARTED|Overall Study||25
57677|NCT01433081|135258|P1|STARTED|Overall Study||25
57678|NCT01433042|135266|P1|NOT COMPLETED|Overall Study||1
57679|NCT01433042|135266|P1|COMPLETED|Overall Study||224
57680|NCT01433042|135266|P1|STARTED|Overall Study||225
57681|NCT01433016|135270|P1|NOT COMPLETED|Overall Study||0
57682|NCT01433016|135270|P1|COMPLETED|Overall Study||20
57683|NCT01433016|135270|P1|STARTED|Overall Study||20
57684|NCT01432938|135274|P2|NOT COMPLETED|Second Intervention||0
57685|NCT01432938|135275|P1|NOT COMPLETED|Second Intervention||1
57686|NCT01432938|135274|P2|COMPLETED|Second Intervention||14
57687|NCT01432938|135275|P1|COMPLETED|Second Intervention||11
57688|NCT01432938|135274|P2|STARTED|Second Intervention||14
57689|NCT01432938|135275|P1|STARTED|Second Intervention||12
57690|NCT01432938|135274|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
57691|NCT01432938|135275|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
57692|NCT01432938|135274|P2|COMPLETED|Washout Period of at Least 24 Days||14
57693|NCT01432938|135275|P1|COMPLETED|Washout Period of at Least 24 Days||12
57694|NCT01432938|135274|P2|STARTED|Washout Period of at Least 24 Days||14
57695|NCT01432938|135275|P1|STARTED|Washout Period of at Least 24 Days||12
57696|NCT01432938|135274|P2|NOT COMPLETED|First Intervention||0
57697|NCT01432938|135275|P1|NOT COMPLETED|First Intervention||2
57698|NCT01432938|135274|P2|COMPLETED|First Intervention||14
57699|NCT01432938|135275|P1|COMPLETED|First Intervention||12
57700|NCT01432938|135274|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
57701|NCT01432938|135275|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
57702|NCT01432938|135274|P2|STARTED|First Intervention||14
57703|NCT01432938|135275|P1|STARTED|First Intervention||14
57704|NCT01432886|135292|P2|NOT COMPLETED|Overall Study||0
57705|NCT01432886|135293|P1|NOT COMPLETED|Overall Study||0
57706|NCT01432886|135292|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
57707|NCT01432886|135293|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
57708|NCT01432886|135292|P2|STARTED|Overall Study||6
57709|NCT01432886|135293|P1|STARTED|Overall Study||6
57710|NCT01432756|135305|P4|NOT COMPLETED|Overall Study||1
57711|NCT01432756|135306|P3|NOT COMPLETED|Overall Study||2
57712|NCT01432756|135307|P2|NOT COMPLETED|Overall Study||0
57713|NCT01432756|135308|P1|NOT COMPLETED|Overall Study||1
57714|NCT01432756|135305|P4|COMPLETED|Overall Study||33
57715|NCT01432756|135306|P3|COMPLETED|Overall Study||30
57716|NCT01432756|135307|P2|COMPLETED|Overall Study||34
57717|NCT01432756|135308|P1|COMPLETED|Overall Study||31
57718|NCT01432756|135305|P4|STARTED|Overall Study||34
57719|NCT01432756|135306|P3|STARTED|Overall Study||32
57720|NCT01432756|135307|P2|STARTED|Overall Study||34
57721|NCT01432756|135308|P1|STARTED|Overall Study||32
57722|NCT01432626|135316|P1|NOT COMPLETED|Overall Study||7
57723|NCT01432626|135316|P1|COMPLETED|Overall Study|Completed both images|3
57724|NCT01432626|135316|P1|STARTED|Overall Study||10
57725|NCT01432574|135320|P1|NOT COMPLETED|Overall Study||3
57726|NCT01432574|135320|P1|COMPLETED|Overall Study||147
57727|NCT01432574|135320|P1|STARTED|Overall Study||150
57728|NCT01432561|135326|P1|NOT COMPLETED|Overall Study||0
57729|NCT01432561|135326|P1|COMPLETED|Overall Study||8
57730|NCT01432561|135326|P1|STARTED|Overall Study||8
57731|NCT01432535|135335|P3|NOT COMPLETED|Overall Study||0
57732|NCT01432535|135336|P2|NOT COMPLETED|Overall Study||0
57733|NCT01432535|135337|P1|NOT COMPLETED|Overall Study||0
57734|NCT01432535|135335|P3|COMPLETED|Overall Study||6
57735|NCT01432535|135336|P2|COMPLETED|Overall Study||7
57736|NCT01432535|135337|P1|COMPLETED|Overall Study||12
57737|NCT01432535|135335|P3|STARTED|Overall Study||6
57738|NCT01432535|135336|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
57739|NCT01432535|135337|P1|STARTED|Overall Study||12
57740|NCT01432457|135366|P3|NOT COMPLETED|Overall Study||59
57741|NCT01432457|135367|P2|NOT COMPLETED|Overall Study||48
57742|NCT01432457|135368|P1|NOT COMPLETED|Overall Study||37
57743|NCT01432457|135366|P3|COMPLETED|Overall Study||253
57744|NCT01432457|135367|P2|COMPLETED|Overall Study||258
57745|NCT01432457|135368|P1|COMPLETED|Overall Study||269
57746|NCT01432457|135366|P3|STARTED|Overall Study||312
57747|NCT01432457|135367|P2|STARTED|Overall Study||306
57748|NCT01432457|135368|P1|STARTED|Overall Study||306
57749|NCT01432444|135397|P3|NOT COMPLETED|Extension Phase||192
57750|NCT01432444|135398|P2|NOT COMPLETED|Extension Phase||0
57751|NCT01432444|135399|P1|NOT COMPLETED|Extension Phase||0
57752|NCT01432444|135397|P3|COMPLETED|Extension Phase||0
57753|NCT01432444|135398|P2|COMPLETED|Extension Phase||0
57754|NCT01432444|135399|P1|COMPLETED|Extension Phase||0
57755|NCT01432444|135397|P3|STARTED|Extension Phase||192
57756|NCT01432444|135398|P2|STARTED|Extension Phase||0
57757|NCT01432444|135399|P1|STARTED|Extension Phase||0
57758|NCT01432444|135397|P3|NOT COMPLETED|Treatment Phase||0
57759|NCT01432444|135398|P2|NOT COMPLETED|Treatment Phase||140
57760|NCT01432444|135399|P1|NOT COMPLETED|Treatment Phase||0
57761|NCT01432444|135397|P3|COMPLETED|Treatment Phase||0
57762|NCT01432444|135398|P2|COMPLETED|Treatment Phase||293
57763|NCT01432444|135399|P1|COMPLETED|Treatment Phase||0
57764|NCT01432444|135397|P3|STARTED|Treatment Phase||0
57765|NCT01432444|135398|P2|STARTED|Treatment Phase||433
57766|NCT01432444|135399|P1|STARTED|Treatment Phase||0
57767|NCT01432444|135397|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
57768|NCT01432444|135398|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
57769|NCT01432444|135399|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
57770|NCT01432444|135397|P3|COMPLETED|Tolerability/Cross-titration Phase||0
57771|NCT01432444|135398|P2|COMPLETED|Tolerability/Cross-titration Phase||0
57772|NCT01432444|135399|P1|COMPLETED|Tolerability/Cross-titration Phase||265
57773|NCT01432444|135397|P3|STARTED|Tolerability/Cross-titration Phase||0
57774|NCT01432444|135398|P2|STARTED|Tolerability/Cross-titration Phase||0
57775|NCT01432444|135399|P1|STARTED|Tolerability/Cross-titration Phase||325
57776|NCT01432405|135411|P2|NOT COMPLETED|Overall Study||2
57777|NCT01432405|135412|P1|NOT COMPLETED|Overall Study||1
57778|NCT01432405|135411|P2|COMPLETED|Overall Study||10
57779|NCT01432405|135412|P1|COMPLETED|Overall Study||11
57780|NCT01432405|135411|P2|STARTED|Overall Study||12
57781|NCT01432405|135412|P1|STARTED|Overall Study||12
57782|NCT01432379|135420|P1|NOT COMPLETED|Overall Study||385
57783|NCT01432379|135420|P1|COMPLETED|Overall Study||783
57784|NCT01432379|135420|P1|STARTED|Overall Study||1168
57785|NCT01432366|135425|P1|NOT COMPLETED|Overall Study||68
57786|NCT01432366|135425|P1|COMPLETED|Overall Study||392
57787|NCT01432366|135425|P1|STARTED|Overall Study||460
57788|NCT01432327|135447|P4|NOT COMPLETED|Posttest 1 Year||23
57789|NCT01432327|135448|P3|NOT COMPLETED|Posttest 1 Year||20
57790|NCT01432327|135449|P2|NOT COMPLETED|Posttest 1 Year||28
57791|NCT01432327|135450|P1|NOT COMPLETED|Posttest 1 Year||24
57792|NCT01432327|135447|P4|COMPLETED|Posttest 1 Year||31
57793|NCT01432327|135448|P3|COMPLETED|Posttest 1 Year||30
57794|NCT01432327|135449|P2|COMPLETED|Posttest 1 Year||27
57795|NCT01432327|135450|P1|COMPLETED|Posttest 1 Year||28
57796|NCT01432327|135447|P4|STARTED|Posttest 1 Year||54
57797|NCT01432327|135448|P3|STARTED|Posttest 1 Year||50
57798|NCT01432327|135449|P2|STARTED|Posttest 1 Year||55
57799|NCT01432327|135450|P1|STARTED|Posttest 1 Year||52
57800|NCT01432327|135447|P4|NOT COMPLETED|Posttest 6 Months||2
57801|NCT01432327|135448|P3|NOT COMPLETED|Posttest 6 Months||5
57802|NCT01432327|135449|P2|NOT COMPLETED|Posttest 6 Months||0
57803|NCT01432327|135450|P1|NOT COMPLETED|Posttest 6 Months||0
57804|NCT01432327|135447|P4|COMPLETED|Posttest 6 Months||54
57805|NCT01432327|135448|P3|COMPLETED|Posttest 6 Months||50
57806|NCT01432327|135449|P2|COMPLETED|Posttest 6 Months||55
57807|NCT01432327|135450|P1|COMPLETED|Posttest 6 Months||52
57808|NCT01432327|135447|P4|STARTED|Posttest 6 Months||56
57809|NCT01432327|135448|P3|STARTED|Posttest 6 Months||55
57810|NCT01432327|135449|P2|STARTED|Posttest 6 Months||55
57811|NCT01432327|135450|P1|STARTED|Posttest 6 Months||52
57812|NCT01432327|135447|P4|NOT COMPLETED|Posttest 3 Months||1
57813|NCT01432327|135448|P3|NOT COMPLETED|Posttest 3 Months||2
57814|NCT01432327|135449|P2|NOT COMPLETED|Posttest 3 Months||2
57815|NCT01432327|135450|P1|NOT COMPLETED|Posttest 3 Months||4
57816|NCT01432327|135447|P4|COMPLETED|Posttest 3 Months||56
57817|NCT01432327|135448|P3|COMPLETED|Posttest 3 Months||55
57818|NCT01432327|135449|P2|COMPLETED|Posttest 3 Months||55
57819|NCT01432327|135450|P1|COMPLETED|Posttest 3 Months||52
57820|NCT01432327|135447|P4|STARTED|Posttest 3 Months||57
57821|NCT01432327|135448|P3|STARTED|Posttest 3 Months||57
57822|NCT01432327|135449|P2|STARTED|Posttest 3 Months||57
57823|NCT01432327|135450|P1|STARTED|Posttest 3 Months||56
57824|NCT01432327|135447|P4|NOT COMPLETED|Baseline||0
57825|NCT01432327|135448|P3|NOT COMPLETED|Baseline||0
57826|NCT01432327|135449|P2|NOT COMPLETED|Baseline||0
57827|NCT01432327|135450|P1|NOT COMPLETED|Baseline||0
57828|NCT01432327|135447|P4|COMPLETED|Baseline||57
57829|NCT01432327|135448|P3|COMPLETED|Baseline||57
57830|NCT01432327|135449|P2|COMPLETED|Baseline||57
57831|NCT01432327|135450|P1|COMPLETED|Baseline||56
57832|NCT01432327|135447|P4|STARTED|Baseline||57
57833|NCT01432327|135448|P3|STARTED|Baseline||57
57834|NCT01432327|135449|P2|STARTED|Baseline||57
57835|NCT01432327|135450|P1|STARTED|Baseline||56
57836|NCT01432262|135462|P2|NOT COMPLETED|Overall Study||1
57837|NCT01432262|135463|P1|NOT COMPLETED|Overall Study||2
57838|NCT01432262|135462|P2|COMPLETED|Overall Study||161
57839|NCT01432262|135463|P1|COMPLETED|Overall Study||160
57840|NCT01432262|135462|P2|Vaccinated|Overall Study||161
57841|NCT01432262|135463|P1|Vaccinated|Overall Study||162
57842|NCT01432262|135462|P2|STARTED|Overall Study||162
57843|NCT01432262|135463|P1|STARTED|Overall Study||162
57844|NCT01432236|135481|P2|NOT COMPLETED|Overall Study||18
57845|NCT01432236|135482|P1|NOT COMPLETED|Overall Study||26
57846|NCT01432236|135481|P2|COMPLETED|Overall Study||79
57847|NCT01432236|135482|P1|COMPLETED|Overall Study||70
57848|NCT01432236|135481|P2|STARTED|Overall Study||97
57849|NCT01432236|135482|P1|STARTED|Overall Study||96
57850|NCT01432015|135529|P2|NOT COMPLETED|Overall Study||0
57851|NCT01432015|135530|P1|NOT COMPLETED|Overall Study||0
57852|NCT01432015|135529|P2|COMPLETED|Overall Study||10
57853|NCT01432015|135530|P1|COMPLETED|Overall Study||10
57854|NCT01432015|135529|P2|STARTED|Overall Study||10
57855|NCT01432015|135530|P1|STARTED|Overall Study||10
57856|NCT01431989|135538|P2|NOT COMPLETED|Period 2||0
57857|NCT01431989|135539|P1|NOT COMPLETED|Period 2||0
57858|NCT01431989|135538|P2|COMPLETED|Period 2||14
57859|NCT01431989|135539|P1|COMPLETED|Period 2||14
57860|NCT01431989|135538|P2|STARTED|Period 2||14
57861|NCT01431989|135539|P1|STARTED|Period 2||14
57862|NCT01431989|135538|P2|NOT COMPLETED|14-Day Washout Period||0
57863|NCT01431989|135539|P1|NOT COMPLETED|14-Day Washout Period||0
57864|NCT01431989|135538|P2|COMPLETED|14-Day Washout Period||14
57865|NCT01431989|135539|P1|COMPLETED|14-Day Washout Period||14
57866|NCT01431989|135538|P2|STARTED|14-Day Washout Period||14
57867|NCT01431989|135539|P1|STARTED|14-Day Washout Period||14
57868|NCT01431989|135538|P2|NOT COMPLETED|Period 1||0
57869|NCT01431989|135539|P1|NOT COMPLETED|Period 1||0
57870|NCT01431989|135538|P2|COMPLETED|Period 1||14
57871|NCT01431989|135539|P1|COMPLETED|Period 1||14
57872|NCT01431989|135538|P2|STARTED|Period 1||14
57873|NCT01431989|135539|P1|STARTED|Period 1||14
57874|NCT01431976|135557|P1|NOT COMPLETED|Overall Study||14
57875|NCT01431976|135557|P1|COMPLETED|Overall Study||6
57876|NCT01431976|135557|P1|STARTED|Overall Study||20
57877|NCT01431963|135568|P1|NOT COMPLETED|Overall Study||35
57878|NCT01431963|135568|P1|COMPLETED|Overall Study||32
57879|NCT01431963|135568|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
57880|NCT01431963|135568|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
57881|NCT01431963|135568|P1|Complete MP (24 Weeks)|Overall Study||42
57882|NCT01431963|135568|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
57883|NCT01431963|135568|P1|Complete EP (6 Weeks)|Overall Study||52
57884|NCT01431963|135568|P1|Received Treatment|Overall Study||65
57885|NCT01431963|135568|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
57886|NCT01431963|135568|P1|STARTED|Overall Study||67
57887|NCT01431950|135576|P2|NOT COMPLETED|Overall Study||15
57888|NCT01431950|135577|P1|NOT COMPLETED|Overall Study||19
57889|NCT01431950|135576|P2|COMPLETED|Overall Study||104
57890|NCT01431950|135577|P1|COMPLETED|Overall Study||100
57891|NCT01431950|135576|P2|STARTED|Overall Study||119
57892|NCT01431950|135577|P1|STARTED|Overall Study||119
57893|NCT01431846|135594|P3|NOT COMPLETED|Overall Study||0
57894|NCT01431846|135595|P2|NOT COMPLETED|Overall Study||0
57895|NCT01431846|135596|P1|NOT COMPLETED|Overall Study||0
57896|NCT01431846|135594|P3|COMPLETED|Overall Study||8
57897|NCT01431846|135595|P2|COMPLETED|Overall Study||3
57898|NCT01431846|135596|P1|COMPLETED|Overall Study||8
57899|NCT01431846|135594|P3|STARTED|Overall Study||8
57900|NCT01431846|135595|P2|STARTED|Overall Study||3
57901|NCT01431846|135596|P1|STARTED|Overall Study||8
57902|NCT01431755|135604|P1|NOT COMPLETED|Overall Study||5
57903|NCT01431755|135604|P1|COMPLETED|Overall Study||49
57904|NCT01431755|135604|P1|STARTED|Overall Study||54
57905|NCT01431716|135615|P1|NOT COMPLETED|Overall Study||1
57906|NCT01431716|135615|P1|COMPLETED|Overall Study||41
57907|NCT01431716|135615|P1|STARTED|Overall Study||42
57908|NCT01431521|135636|P4|NOT COMPLETED|Overall Study||0
57909|NCT01431521|135637|P3|NOT COMPLETED|Overall Study||1
57910|NCT01431521|135638|P2|NOT COMPLETED|Overall Study||0
57911|NCT01431521|135639|P1|NOT COMPLETED|Overall Study||0
57912|NCT01431521|135636|P4|COMPLETED|Overall Study||5
57913|NCT01431521|135637|P3|COMPLETED|Overall Study||10
57914|NCT01431521|135638|P2|COMPLETED|Overall Study||5
57915|NCT01431521|135639|P1|COMPLETED|Overall Study||10
57916|NCT01431521|135636|P4|Treated|Overall Study||5
57917|NCT01431521|135637|P3|Treated|Overall Study||10
57918|NCT01431521|135638|P2|Treated|Overall Study||5
57919|NCT01431521|135639|P1|Treated|Overall Study||10
57920|NCT01431521|135636|P4|STARTED|Overall Study||5
57921|NCT01431521|135637|P3|STARTED|Overall Study||11
57922|NCT01431521|135638|P2|STARTED|Overall Study||5
57923|NCT01431521|135639|P1|STARTED|Overall Study||10
57924|NCT01431508|135660|P1|NOT COMPLETED|Overall Study||2
57925|NCT01431508|135660|P1|COMPLETED|Overall Study||13
57926|NCT01431508|135660|P1|STARTED|Overall Study||15
57927|NCT01431339|135666|P2|NOT COMPLETED|Overall Study||35
57928|NCT01431339|135667|P1|NOT COMPLETED|Overall Study||39
57929|NCT01431339|135666|P2|COMPLETED|Overall Study||333
57930|NCT01431339|135667|P1|COMPLETED|Overall Study||332
57931|NCT01431339|135666|P2|Safety Population|Overall Study||367
57932|NCT01431339|135667|P1|Safety Population|Overall Study||368
57933|NCT01431339|135666|P2|STARTED|Overall Study||368
57934|NCT01431339|135667|P1|STARTED|Overall Study||371
57935|NCT01431300|135682|P3|NOT COMPLETED|Overall Study||0
57936|NCT01431300|135683|P2|NOT COMPLETED|Overall Study||0
57937|NCT01431300|135684|P1|NOT COMPLETED|Overall Study||1
57938|NCT01431300|135682|P3|COMPLETED|Overall Study||10
57939|NCT01431300|135683|P2|COMPLETED|Overall Study||10
57940|NCT01431300|135684|P1|COMPLETED|Overall Study||10
57941|NCT01431300|135682|P3|STARTED|Overall Study||10
57942|NCT01431300|135683|P2|STARTED|Overall Study||10
57943|NCT01431300|135684|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
57944|NCT01431287|135700|P5|NOT COMPLETED|Overall Study||77
57945|NCT01431287|135701|P4|NOT COMPLETED|Overall Study||63
57946|NCT01431287|135702|P3|NOT COMPLETED|Overall Study||97
57947|NCT01431287|135703|P2|NOT COMPLETED|Overall Study||98
57948|NCT01431287|135704|P1|NOT COMPLETED|Overall Study||98
57949|NCT01431287|135700|P5|COMPLETED|Overall Study||430
57950|NCT01431287|135701|P4|COMPLETED|Overall Study||445
57951|NCT01431287|135702|P3|COMPLETED|Overall Study||410
57952|NCT01431287|135703|P2|COMPLETED|Overall Study||409
57953|NCT01431287|135704|P1|COMPLETED|Overall Study||412
57954|NCT01431287|135700|P5|STARTED|Overall Study||507
57955|NCT01431287|135701|P4|STARTED|Overall Study||508
57956|NCT01431287|135702|P3|STARTED|Overall Study||507
57957|NCT01431287|135703|P2|STARTED|Overall Study||507
57958|NCT01431287|135704|P1|STARTED|Overall Study|started are actually the randomized|510
57959|NCT01431274|135866|P5|NOT COMPLETED|Overall Study||56
57960|NCT01431274|135867|P4|NOT COMPLETED|Overall Study||60
57961|NCT01431274|135868|P3|NOT COMPLETED|Overall Study||72
57962|NCT01431274|135869|P2|NOT COMPLETED|Overall Study||77
57963|NCT01431274|135870|P1|NOT COMPLETED|Overall Study||97
57964|NCT01431274|135866|P5|COMPLETED|Overall Study||466
57965|NCT01431274|135867|P4|COMPLETED|Overall Study||462
57966|NCT01431274|135868|P3|COMPLETED|Overall Study||455
57967|NCT01431274|135869|P2|COMPLETED|Overall Study||448
57968|NCT01431274|135870|P1|COMPLETED|Overall Study||431
57969|NCT01431274|135866|P5|STARTED|Overall Study||522
57970|NCT01431274|135867|P4|STARTED|Overall Study||522
57971|NCT01431274|135868|P3|STARTED|Overall Study||527
57972|NCT01431274|135869|P2|STARTED|Overall Study||525
57973|NCT01431274|135870|P1|STARTED|Overall Study||528
57974|NCT01431170|136029|P2|NOT COMPLETED|Overall Study||1
57975|NCT01431170|136030|P1|NOT COMPLETED|Overall Study||3
57976|NCT01431170|136029|P2|COMPLETED|Overall Study||11
57977|NCT01431170|136030|P1|COMPLETED|Overall Study||9
57978|NCT01431170|136029|P2|STARTED|Overall Study||12
57979|NCT01431170|136030|P1|STARTED|Overall Study||12
57980|NCT01431144|136048|P2|NOT COMPLETED|Overall Study||0
57981|NCT01431144|136049|P1|NOT COMPLETED|Overall Study||2
57982|NCT01431144|136048|P2|COMPLETED|Overall Study||14
57983|NCT01431144|136049|P1|COMPLETED|Overall Study||11
57984|NCT01431144|136048|P2|STARTED|Overall Study||14
57985|NCT01431144|136049|P1|STARTED|Overall Study||13
57986|NCT01431131|136057|P2|NOT COMPLETED|Overall Study||0
57987|NCT01431131|136058|P1|NOT COMPLETED|Overall Study||0
57988|NCT01431131|136057|P2|COMPLETED|Overall Study||12
57989|NCT01431131|136058|P1|COMPLETED|Overall Study||12
57990|NCT01431131|136057|P2|STARTED|Overall Study||12
57991|NCT01431131|136058|P1|STARTED|Overall Study||12
57992|NCT01431079|136068|P2|NOT COMPLETED|Overall Study||39
57993|NCT01431079|136069|P1|NOT COMPLETED|Overall Study||35
57994|NCT01431079|136068|P2|COMPLETED|Overall Study||6
57995|NCT01431079|136069|P1|COMPLETED|Overall Study||10
57996|NCT01431079|136068|P2|Post-test|Overall Study||45
57997|NCT01431079|136069|P1|Post-test|Overall Study||45
57998|NCT01431079|136068|P2|STARTED|Overall Study||45
57999|NCT01431079|136069|P1|STARTED|Overall Study||45
58000|NCT01431014|136123|P2|NOT COMPLETED|Overall Study||9
58001|NCT01431014|136124|P1|NOT COMPLETED|Overall Study||3
58002|NCT01431014|136123|P2|COMPLETED|Overall Study||25
58003|NCT01431014|136124|P1|COMPLETED|Overall Study||31
58004|NCT01431014|136123|P2|STARTED|Overall Study||34
58005|NCT01431014|136124|P1|STARTED|Overall Study||34
58006|NCT01430819|136132|P2|NOT COMPLETED|Overall Study||0
58007|NCT01430819|136133|P1|NOT COMPLETED|Overall Study||0
58008|NCT01430819|136132|P2|COMPLETED|Overall Study||150
58009|NCT01430819|136133|P1|COMPLETED|Overall Study||150
58010|NCT01430819|136132|P2|STARTED|Overall Study||150
58011|NCT01430819|136133|P1|STARTED|Overall Study||150
58012|NCT01430754|136148|P2|NOT COMPLETED|Randomized Phase||0
58013|NCT01430754|136149|P1|NOT COMPLETED|Randomized Phase||0
58014|NCT01430754|136148|P2|COMPLETED|Randomized Phase||10
58015|NCT01430754|136149|P1|COMPLETED|Randomized Phase||10
58016|NCT01430754|136148|P2|STARTED|Randomized Phase||10
58017|NCT01430754|136149|P1|STARTED|Randomized Phase||10
58018|NCT01430754|136148|P2|NOT COMPLETED|Run-In Phase||0
58019|NCT01430754|136149|P1|NOT COMPLETED|Run-In Phase||37
58020|NCT01430754|136148|P2|COMPLETED|Run-In Phase||0
58021|NCT01430754|136149|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
58022|NCT01430754|136148|P2|Entrained - After Run-In Phase|Run-In Phase||0
58023|NCT01430754|136149|P1|Entrained - After Run-In Phase|Run-In Phase||24
58024|NCT01430754|136148|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
58025|NCT01430754|136149|P1|STARTED|Run-In Phase||57
58026|NCT01430624|136170|P3|NOT COMPLETED|Overall Study||29
58027|NCT01430624|136171|P2|NOT COMPLETED|Overall Study||34
58028|NCT01430624|136172|P1|NOT COMPLETED|Overall Study||28
58029|NCT01430624|136170|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
58030|NCT01430624|136171|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
58031|NCT01430624|136172|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
58032|NCT01430624|136170|P3|Eligible Baseline Completes|Overall Study||79
58033|NCT01430624|136171|P2|Eligible Baseline Completes|Overall Study||77
58034|NCT01430624|136172|P1|Eligible Baseline Completes|Overall Study||77
58035|NCT01430624|136170|P3|STARTED|Overall Study||81
58036|NCT01430624|136171|P2|STARTED|Overall Study||82
58037|NCT01430624|136172|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
58038|NCT01430611|136203|P2|NOT COMPLETED|Overall Study||15
58039|NCT01430611|136204|P1|NOT COMPLETED|Overall Study||17
58040|NCT01430611|136203|P2|COMPLETED|Overall Study||318
58041|NCT01430611|136204|P1|COMPLETED|Overall Study||315
58042|NCT01430611|136203|P2|STARTED|Overall Study||333
58043|NCT01430611|136204|P1|STARTED|Overall Study||332
58044|NCT01430585|136222|P1|NOT COMPLETED|Overall Study||14
58045|NCT01430585|136222|P1|COMPLETED|Overall Study||0
58046|NCT01430585|136222|P1|STARTED|Overall Study||14
58047|NCT01430403|136258|P3|NOT COMPLETED|Overall Study||8
58048|NCT01430403|136259|P2|NOT COMPLETED|Overall Study||9
58049|NCT01430403|136260|P1|NOT COMPLETED|Overall Study||17
58050|NCT01430403|136258|P3|COMPLETED|Overall Study||81
58051|NCT01430403|136259|P2|COMPLETED|Overall Study||121
58052|NCT01430403|136260|P1|COMPLETED|Overall Study||242
58053|NCT01430403|136258|P3|STARTED|Overall Study|Intent-to-treat|89
58054|NCT01430403|136259|P2|STARTED|Overall Study|Intent-to-treat|130
58055|NCT01430403|136260|P1|STARTED|Overall Study|Intent-to-treat|259
58056|NCT01430325|136305|P4|NOT COMPLETED|Overall Study||0
58057|NCT01430325|136306|P3|NOT COMPLETED|Overall Study||0
58058|NCT01430325|136307|P2|NOT COMPLETED|Overall Study||0
58059|NCT01430325|136308|P1|NOT COMPLETED|Overall Study||0
58060|NCT01430325|136305|P4|COMPLETED|Overall Study||12
58061|NCT01430325|136306|P3|COMPLETED|Overall Study||8
58062|NCT01430325|136307|P2|COMPLETED|Overall Study||12
58063|NCT01430325|136308|P1|COMPLETED|Overall Study||10
58064|NCT01430325|136305|P4|STARTED|Overall Study||12
58065|NCT01430325|136306|P3|STARTED|Overall Study||8
58066|NCT01430325|136307|P2|STARTED|Overall Study||12
58067|NCT01430325|136308|P1|STARTED|Overall Study||10
58068|NCT01430182|136328|P2|NOT COMPLETED|Overall Study||0
58069|NCT01430182|136329|P1|NOT COMPLETED|Overall Study||0
58070|NCT01430182|136328|P2|COMPLETED|Overall Study||8
58071|NCT01430182|136329|P1|COMPLETED|Overall Study||9
58072|NCT01430182|136328|P2|STARTED|Overall Study||8
58073|NCT01430182|136329|P1|STARTED|Overall Study||9
58074|NCT01430169|136335|P1|NOT COMPLETED|Overall Study||0
58075|NCT01430169|136335|P1|COMPLETED|Overall Study||20
58076|NCT01430169|136335|P1|STARTED|Overall Study||20
58077|NCT01430130|136350|P1|NOT COMPLETED|Overall Study||2
58078|NCT01430130|136350|P1|COMPLETED|Overall Study||10
58079|NCT01430130|136350|P1|STARTED|Overall Study||12
58080|NCT01430104|136356|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
58081|NCT01430104|136356|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
58082|NCT01430104|136356|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
58083|NCT01430104|136356|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
58084|NCT01430104|136356|P1|NOT COMPLETED|14-Day Lead-In Period||0
58085|NCT01430104|136356|P1|COMPLETED|14-Day Lead-In Period||30
58086|NCT01430104|136356|P1|STARTED|14-Day Lead-In Period||30
58087|NCT01430091|136368|P1|NOT COMPLETED|Overall Study||0
58088|NCT01430091|136368|P1|COMPLETED|Overall Study||18
58089|NCT01430091|136368|P1|STARTED|Overall Study||18
58090|NCT01429584|136392|P2|NOT COMPLETED|Overall Study||1
58091|NCT01429584|136393|P1|NOT COMPLETED|Overall Study||1
58092|NCT01429584|136392|P2|COMPLETED|Overall Study||14
58093|NCT01429584|136393|P1|COMPLETED|Overall Study||14
58094|NCT01429584|136392|P2|STARTED|Overall Study||15
58095|NCT01429584|136393|P1|STARTED|Overall Study||15
58096|NCT01429532|136406|P3|NOT COMPLETED|Overall Study||0
58097|NCT01429532|136407|P2|NOT COMPLETED|Overall Study||0
58098|NCT01429532|136408|P1|NOT COMPLETED|Overall Study||0
58099|NCT01429532|136406|P3|COMPLETED|Overall Study||40
58100|NCT01429532|136407|P2|COMPLETED|Overall Study||40
58101|NCT01429532|136408|P1|COMPLETED|Overall Study||40
58102|NCT01429532|136406|P3|STARTED|Overall Study||40
58103|NCT01429532|136407|P2|STARTED|Overall Study||40
58104|NCT01429532|136408|P1|STARTED|Overall Study||40
58105|NCT01429441|136424|P2|NOT COMPLETED|Overall Study||23
58106|NCT01429441|136425|P1|NOT COMPLETED|Overall Study||38
58107|NCT01429441|136424|P2|COMPLETED|Overall Study||51
58108|NCT01429441|136425|P1|COMPLETED|Overall Study||108
58109|NCT01429441|136424|P2|STARTED|Overall Study||74
58110|NCT01429441|136425|P1|STARTED|Overall Study||146
58111|NCT01429259|136433|P1|NOT COMPLETED|Overall Study||0
58112|NCT01429259|136433|P1|COMPLETED|Overall Study||30
58113|NCT01429259|136433|P1|STARTED|Overall Study||30
58114|NCT01429077|136440|P2|NOT COMPLETED|Overall Study||3
58115|NCT01429077|136441|P1|NOT COMPLETED|Overall Study||0
58116|NCT01429077|136440|P2|COMPLETED|Overall Study||14
58117|NCT01429077|136441|P1|COMPLETED|Overall Study||19
58118|NCT01429077|136440|P2|Completed 6-week Intervention|Overall Study||17
58119|NCT01429077|136441|P1|Completed 6-week Intervention|Overall Study||19
58120|NCT01429077|136440|P2|STARTED|Overall Study||17
58121|NCT01429077|136441|P1|STARTED|Overall Study||19
58122|NCT01429064|136451|P4|NOT COMPLETED|Overall Study||0
58123|NCT01429064|136452|P3|NOT COMPLETED|Overall Study||0
58124|NCT01429064|136453|P2|NOT COMPLETED|Overall Study||0
58125|NCT01429064|136454|P1|NOT COMPLETED|Overall Study||0
58126|NCT01429064|136451|P4|COMPLETED|Overall Study||16
58127|NCT01429064|136452|P3|COMPLETED|Overall Study||19
58128|NCT01429064|136453|P2|COMPLETED|Overall Study||22
58129|NCT01429064|136454|P1|COMPLETED|Overall Study||19
58130|NCT01429064|136451|P4|STARTED|Overall Study||16
58131|NCT01429064|136452|P3|STARTED|Overall Study||19
58132|NCT01429064|136453|P2|STARTED|Overall Study||22
58133|NCT01429064|136454|P1|STARTED|Overall Study||19
58134|NCT01429051|136464|P1|NOT COMPLETED|Tolerability Phase||15
58135|NCT01429051|136464|P1|COMPLETED|Tolerability Phase||16
58136|NCT01429051|136464|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
58137|NCT01429051|136464|P1|NOT COMPLETED|Efficacy Phase||2
58138|NCT01429051|136464|P1|COMPLETED|Efficacy Phase||13
58139|NCT01429051|136464|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
58140|NCT01429051|136464|P1|NOT COMPLETED|Titration Phase||12
58141|NCT01429051|136464|P1|COMPLETED|Titration Phase||33
58142|NCT01429051|136464|P1|STARTED|Titration Phase||45
58143|NCT01428882|136487|P2|NOT COMPLETED|Overall Study||10
58144|NCT01428882|136488|P1|NOT COMPLETED|Overall Study||6
58145|NCT01428882|136487|P2|COMPLETED|Overall Study||58
58146|NCT01428882|136488|P1|COMPLETED|Overall Study||61
58147|NCT01428882|136487|P2|STARTED|Overall Study||68
58148|NCT01428882|136488|P1|STARTED|Overall Study||67
58149|NCT01428765|136500|P1|NOT COMPLETED|Overall Study||0
58150|NCT01428765|136500|P1|COMPLETED|Overall Study||1063
58151|NCT01428765|136500|P1|STARTED|Overall Study||1063
58152|NCT01428713|136511|P2|NOT COMPLETED|Overall Study||5
58153|NCT01428713|136512|P1|NOT COMPLETED|Overall Study||3
58154|NCT01428713|136511|P2|COMPLETED|Overall Study||3
58155|NCT01428713|136512|P1|COMPLETED|Overall Study||6
58156|NCT01428713|136511|P2|STARTED|Overall Study||8
58157|NCT01428713|136512|P1|STARTED|Overall Study||9
58158|NCT01428661|136521|P3|NOT COMPLETED|Open Label Extension||320
58159|NCT01428661|136522|P2|NOT COMPLETED|Open Label Extension||0
58160|NCT01428661|136523|P1|NOT COMPLETED|Open Label Extension||0
58161|NCT01428661|136521|P3|COMPLETED|Open Label Extension||19
58162|NCT01428661|136522|P2|COMPLETED|Open Label Extension|Does not apply.|0
58163|NCT01428661|136523|P1|COMPLETED|Open Label Extension|Does not apply.|0
58164|NCT01428661|136521|P3|STARTED|Open Label Extension||339
58165|NCT01428661|136522|P2|STARTED|Open Label Extension|Does not apply.|0
58166|NCT01428661|136523|P1|STARTED|Open Label Extension|Does not apply.|0
58167|NCT01428661|136521|P3|NOT COMPLETED|Double-Masked Phase||0
58168|NCT01428661|136522|P2|NOT COMPLETED|Double-Masked Phase||49
58169|NCT01428661|136523|P1|NOT COMPLETED|Double-Masked Phase||57
58170|NCT01428661|136521|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
58171|NCT01428661|136522|P2|COMPLETED|Double-Masked Phase||204
58172|NCT01428661|136523|P1|COMPLETED|Double-Masked Phase||197
58173|NCT01428661|136521|P3|STARTED|Double-Masked Phase|Does not apply.|0
58174|NCT01428661|136522|P2|STARTED|Double-Masked Phase||253
58175|NCT01428661|136523|P1|STARTED|Double-Masked Phase||254
58176|NCT01428583|136531|P1|NOT COMPLETED|Overall Study||237
58177|NCT01428583|136531|P1|COMPLETED|Overall Study||158
58178|NCT01428583|136531|P1|STARTED|Overall Study||395
58179|NCT01428219|136553|P1|NOT COMPLETED|Overall Study||0
58180|NCT01428219|136553|P1|COMPLETED|Overall Study||25
58181|NCT01428219|136553|P1|STARTED|Overall Study||25
58182|NCT01428128|136557|P1|NOT COMPLETED|Overall Study||17
58183|NCT01428128|136557|P1|COMPLETED|Overall Study||33
58184|NCT01428128|136557|P1|STARTED|Overall Study||50
58185|NCT01428115|136561|P1|NOT COMPLETED|Overall Study||21
58186|NCT01428115|136561|P1|COMPLETED|Overall Study||62
58187|NCT01428115|136561|P1|STARTED|Overall Study||83
58188|NCT01428076|136576|P2|NOT COMPLETED|Overall Study||1
58189|NCT01428076|136577|P1|NOT COMPLETED|Overall Study||0
58190|NCT01428076|136576|P2|COMPLETED|Overall Study||11
58191|NCT01428076|136577|P1|COMPLETED|Overall Study||9
58192|NCT01428076|136576|P2|STARTED|Overall Study||12
58193|NCT01428076|136577|P1|STARTED|Overall Study||9
58194|NCT01428063|136588|P3|NOT COMPLETED|Overall Study||1
58195|NCT01428063|136589|P2|NOT COMPLETED|Overall Study||10
58196|NCT01428063|136590|P1|NOT COMPLETED|Overall Study||10
58197|NCT01428063|136588|P3|COMPLETED|Overall Study||5
58198|NCT01428063|136589|P2|COMPLETED|Overall Study||112
58199|NCT01428063|136590|P1|COMPLETED|Overall Study||89
58200|NCT01428063|136588|P3|STARTED|Overall Study||6
58201|NCT01428063|136589|P2|STARTED|Overall Study||122
58202|NCT01428063|136590|P1|STARTED|Overall Study||99
58203|NCT01427933|136661|P2|NOT COMPLETED|Overall Study||13
58204|NCT01427933|136662|P1|NOT COMPLETED|Overall Study||8
58205|NCT01427933|136661|P2|COMPLETED|Overall Study||57
58206|NCT01427933|136662|P1|COMPLETED|Overall Study||63
58207|NCT01427933|136661|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
58208|NCT01427933|136662|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
58209|NCT01427933|136661|P2|STARTED|Overall Study||70
58210|NCT01427933|136662|P1|STARTED|Overall Study||71
58211|NCT01427920|136682|P2|NOT COMPLETED|Overall Study||17
58212|NCT01427920|136683|P1|NOT COMPLETED|Overall Study||9
58213|NCT01427920|136682|P2|COMPLETED|Overall Study||157
58214|NCT01427920|136683|P1|COMPLETED|Overall Study||165
58215|NCT01427920|136682|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
58216|NCT01427920|136683|P1|Exposed|Overall Study||174
58217|NCT01427920|136682|P2|STARTED|Overall Study||174
58218|NCT01427920|136683|P1|STARTED|Overall Study||174
58219|NCT01427907|136703|P2|NOT COMPLETED|Overall Study||4
58220|NCT01427907|136704|P1|NOT COMPLETED|Overall Study||3
58221|NCT01427907|136703|P2|COMPLETED|Overall Study|Completed study|14
58222|NCT01427907|136704|P1|COMPLETED|Overall Study|Completed study|17
58223|NCT01427907|136703|P2|STARTED|Overall Study|Randomized|18
58224|NCT01427907|136704|P1|STARTED|Overall Study|Randomized|20
58225|NCT01427803|136712|P2|NOT COMPLETED|Overall Study||26
58226|NCT01427803|136713|P1|NOT COMPLETED|Overall Study||63
58227|NCT01427803|136712|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
58228|NCT01427803|136713|P1|COMPLETED|Overall Study||463
58229|NCT01427803|136712|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
58230|NCT01427803|136713|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
58231|NCT01427803|136712|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
58232|NCT01427803|136713|P1|Baseline Assessment|Overall Study||516
58233|NCT01427803|136712|P2|Purchased Product|Overall Study||252
58234|NCT01427803|136713|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
58235|NCT01427803|136712|P2|STARTED|Overall Study||252
58236|NCT01427803|136713|P1|STARTED|Overall Study||526
58237|NCT01427751|136727|P2|NOT COMPLETED|Overall Study||14
58238|NCT01427751|136728|P1|NOT COMPLETED|Overall Study||42
58239|NCT01427751|136727|P2|COMPLETED|Overall Study||139
58240|NCT01427751|136728|P1|COMPLETED|Overall Study||112
58241|NCT01427751|136727|P2|STARTED|Overall Study||153
58242|NCT01427751|136728|P1|STARTED|Overall Study||154
58243|NCT01427738|136748|P2|NOT COMPLETED|Overall Study||21
58244|NCT01427738|136749|P1|NOT COMPLETED|Overall Study||19
58245|NCT01427738|136748|P2|COMPLETED|Overall Study||90
58246|NCT01427738|136749|P1|COMPLETED|Overall Study||91
58247|NCT01427738|136748|P2|STARTED|Overall Study||111
58248|NCT01427738|136749|P1|STARTED|Overall Study||110
58249|NCT01427517|136770|P3|NOT COMPLETED|Overall Study||0
58250|NCT01427517|136771|P2|NOT COMPLETED|Overall Study||0
58251|NCT01427517|136772|P1|NOT COMPLETED|Overall Study||0
58252|NCT01427517|136770|P3|COMPLETED|Overall Study||3
58253|NCT01427517|136771|P2|COMPLETED|Overall Study||3
58254|NCT01427517|136772|P1|COMPLETED|Overall Study||3
58255|NCT01427517|136770|P3|STARTED|Overall Study||3
58256|NCT01427517|136771|P2|STARTED|Overall Study||3
58257|NCT01427517|136772|P1|STARTED|Overall Study||3
58258|NCT01427504|136786|P6|NOT COMPLETED|Overall Study||2
58259|NCT01427504|136787|P5|NOT COMPLETED|Overall Study||1
58260|NCT01427504|136788|P4|NOT COMPLETED|Overall Study||1
58261|NCT01427504|136789|P3|NOT COMPLETED|Overall Study||1
58262|NCT01427504|136790|P2|NOT COMPLETED|Overall Study||1
58263|NCT01427504|136791|P1|NOT COMPLETED|Overall Study||0
58264|NCT01427504|136786|P6|COMPLETED|Overall Study||4
58265|NCT01427504|136787|P5|COMPLETED|Overall Study||2
58266|NCT01427504|136788|P4|COMPLETED|Overall Study||5
58267|NCT01427504|136789|P3|COMPLETED|Overall Study||3
58268|NCT01427504|136790|P2|COMPLETED|Overall Study||2
58269|NCT01427504|136791|P1|COMPLETED|Overall Study||4
58270|NCT01427504|136786|P6|Received Combination|Overall Study||6
58271|NCT01427504|136787|P5|Received Combination|Overall Study||3
58272|NCT01427504|136788|P4|Received Combination|Overall Study||6
58273|NCT01427504|136789|P3|Received Combination|Overall Study||3
58274|NCT01427504|136790|P2|Received Combination|Overall Study||3
58275|NCT01427504|136791|P1|Received Combination|Overall Study||4
58276|NCT01427504|136786|P6|Received Etravirine|Overall Study||4
58277|NCT01427504|136787|P5|Received Etravirine|Overall Study||2
58278|NCT01427504|136788|P4|Received Etravirine|Overall Study||6
58279|NCT01427504|136789|P3|Received Etravirine|Overall Study||4
58280|NCT01427504|136790|P2|Received Etravirine|Overall Study||2
58281|NCT01427504|136791|P1|Received Etravirine|Overall Study||4
58282|NCT01427504|136786|P6|Received Boceprevir|Overall Study||4
58283|NCT01427504|136787|P5|Received Boceprevir|Overall Study||2
58284|NCT01427504|136788|P4|Received Boceprevir|Overall Study||5
58285|NCT01427504|136789|P3|Received Boceprevir|Overall Study||3
58286|NCT01427504|136790|P2|Received Boceprevir|Overall Study||3
58287|NCT01427504|136791|P1|Received Boceprevir|Overall Study||4
58288|NCT01427504|136786|P6|STARTED|Overall Study||6
58289|NCT01427504|136787|P5|STARTED|Overall Study||3
58290|NCT01427504|136788|P4|STARTED|Overall Study||6
58291|NCT01427504|136789|P3|STARTED|Overall Study||4
58292|NCT01427504|136790|P2|STARTED|Overall Study||3
58293|NCT01427504|136791|P1|STARTED|Overall Study||4
58294|NCT01427309|136812|P4|NOT COMPLETED|Overall Study||376
58295|NCT01427309|136813|P3|NOT COMPLETED|Overall Study||361
58296|NCT01427309|136814|P2|NOT COMPLETED|Overall Study||407
58297|NCT01427309|136815|P1|NOT COMPLETED|Overall Study||372
58298|NCT01427309|136812|P4|COMPLETED|Overall Study||8373
58299|NCT01427309|136813|P3|COMPLETED|Overall Study||8376
58300|NCT01427309|136814|P2|COMPLETED|Overall Study||6837
58301|NCT01427309|136815|P1|COMPLETED|Overall Study||6881
58302|NCT01427309|136812|P4|STARTED|Overall Study||8749
58303|NCT01427309|136813|P3|STARTED|Overall Study||8737
58304|NCT01427309|136814|P2|STARTED|Overall Study||7244
58305|NCT01427309|136815|P1|STARTED|Overall Study||7253
58306|NCT01426958|136853|P1|NOT COMPLETED|Overall Study||2
58307|NCT01426958|136853|P1|COMPLETED|Overall Study||22
58308|NCT01426958|136853|P1|STARTED|Overall Study||24
58309|NCT01426867|136870|P3|NOT COMPLETED|Overall Study||0
58310|NCT01426867|136871|P2|NOT COMPLETED|Overall Study||0
58311|NCT01426867|136872|P1|NOT COMPLETED|Overall Study||0
58312|NCT01426867|136870|P3|COMPLETED|Overall Study||34
58313|NCT01426867|136871|P2|COMPLETED|Overall Study||34
58314|NCT01426867|136872|P1|COMPLETED|Overall Study||33
58315|NCT01426867|136870|P3|STARTED|Overall Study||34
58316|NCT01426867|136871|P2|STARTED|Overall Study||34
58317|NCT01426867|136872|P1|STARTED|Overall Study||33
58318|NCT01426854|136882|P2|NOT COMPLETED|Overall Study||31
58319|NCT01426854|136883|P1|NOT COMPLETED|Overall Study||12
58320|NCT01426854|136882|P2|COMPLETED|Overall Study||98
58321|NCT01426854|136883|P1|COMPLETED|Overall Study||119
58322|NCT01426854|136882|P2|STARTED|Overall Study||129
58323|NCT01426854|136883|P1|STARTED|Overall Study||131
58324|NCT01426789|136893|P6|NOT COMPLETED|Part 2||0
58325|NCT01426789|136894|P5|NOT COMPLETED|Part 2||8
58326|NCT01426789|136895|P4|NOT COMPLETED|Part 2||1
58327|NCT01426789|136896|P3|NOT COMPLETED|Part 2||15
58328|NCT01426789|136897|P2|NOT COMPLETED|Part 2||0
58329|NCT01426789|136898|P1|NOT COMPLETED|Part 2||0
58330|NCT01426789|136893|P6|COMPLETED|Part 2||1
58331|NCT01426789|136894|P5|COMPLETED|Part 2||19
58332|NCT01426789|136895|P4|COMPLETED|Part 2||12
58333|NCT01426789|136896|P3|COMPLETED|Part 2||34
58334|NCT01426789|136897|P2|COMPLETED|Part 2||0
58335|NCT01426789|136898|P1|COMPLETED|Part 2||0
58336|NCT01426789|136893|P6|STARTED|Part 2||1
58337|NCT01426789|136894|P5|STARTED|Part 2||27
58338|NCT01426789|136895|P4|STARTED|Part 2||13
58339|NCT01426789|136896|P3|STARTED|Part 2||49
58340|NCT01426789|136897|P2|STARTED|Part 2||0
58341|NCT01426789|136898|P1|STARTED|Part 2||0
58342|NCT01426789|136893|P6|NOT COMPLETED|Part 1||0
58343|NCT01426789|136894|P5|NOT COMPLETED|Part 1||0
58344|NCT01426789|136895|P4|NOT COMPLETED|Part 1||0
58345|NCT01426789|136896|P3|NOT COMPLETED|Part 1||0
58346|NCT01426789|136897|P2|NOT COMPLETED|Part 1||4
58347|NCT01426789|136898|P1|NOT COMPLETED|Part 1||6
58348|NCT01426789|136893|P6|COMPLETED|Part 1||0
58349|NCT01426789|136894|P5|COMPLETED|Part 1||0
58350|NCT01426789|136895|P4|COMPLETED|Part 1||0
58351|NCT01426789|136896|P3|COMPLETED|Part 1||0
58352|NCT01426789|136897|P2|COMPLETED|Part 1||28
58353|NCT01426789|136898|P1|COMPLETED|Part 1||62
58354|NCT01426789|136893|P6|STARTED|Part 1||0
58355|NCT01426789|136894|P5|STARTED|Part 1||0
58356|NCT01426789|136895|P4|STARTED|Part 1||0
58357|NCT01426789|136896|P3|STARTED|Part 1||0
58358|NCT01426789|136897|P2|STARTED|Part 1||32
58359|NCT01426789|136898|P1|STARTED|Part 1||68
58360|NCT01426763|136914|P2|NOT COMPLETED|Overall Study||0
58361|NCT01426763|136915|P1|NOT COMPLETED|Overall Study||0
58362|NCT01426763|136914|P2|COMPLETED|Overall Study||6
58363|NCT01426763|136915|P1|COMPLETED|Overall Study||6
58364|NCT01426763|136914|P2|STARTED|Overall Study||6
58365|NCT01426763|136915|P1|STARTED|Overall Study||6
58366|NCT01426555|136923|P2|NOT COMPLETED|Overall Study||15
58367|NCT01426555|136924|P1|NOT COMPLETED|Overall Study||18
58368|NCT01426555|136923|P2|COMPLETED|Overall Study||20
58369|NCT01426555|136924|P1|COMPLETED|Overall Study||17
58370|NCT01426555|136923|P2|STARTED|Overall Study||35
58371|NCT01426555|136924|P1|STARTED|Overall Study||35
58372|NCT01426516|136934|P2|NOT COMPLETED|Overall Study||0
58373|NCT01426516|136935|P1|NOT COMPLETED|Overall Study||0
58374|NCT01426516|136934|P2|COMPLETED|Overall Study||17
58375|NCT01426516|136935|P1|COMPLETED|Overall Study||12
58376|NCT01426516|136934|P2|STARTED|Overall Study||17
58377|NCT01426516|136935|P1|STARTED|Overall Study||12
58378|NCT01426438|136943|P2|NOT COMPLETED|Overall Study||10
58379|NCT01426438|136944|P1|NOT COMPLETED|Overall Study||15
58380|NCT01426438|136943|P2|COMPLETED|Overall Study||39
58381|NCT01426438|136944|P1|COMPLETED|Overall Study||35
58382|NCT01426438|136943|P2|STARTED|Overall Study||49
58383|NCT01426438|136944|P1|STARTED|Overall Study||50
58384|NCT01426373|136976|P1|NOT COMPLETED|Overall Study||34
58385|NCT01426373|136976|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
58386|NCT01426373|136976|P1|STARTED|Overall Study||165
58387|NCT01426360|136994|P2|NOT COMPLETED|Overall Study||0
58388|NCT01426360|136995|P1|NOT COMPLETED|Overall Study||0
58389|NCT01426360|136994|P2|COMPLETED|Overall Study||41
58390|NCT01426360|136995|P1|COMPLETED|Overall Study||38
58391|NCT01426360|136994|P2|STARTED|Overall Study||41
58392|NCT01426360|136995|P1|STARTED|Overall Study||38
58393|NCT01426269|137007|P3|NOT COMPLETED|Period 2: 40 Weeks||47
58394|NCT01426269|137008|P2|NOT COMPLETED|Period 2: 40 Weeks||38
58395|NCT01426269|137009|P1|NOT COMPLETED|Period 2: 40 Weeks||0
58396|NCT01426269|137007|P3|COMPLETED|Period 2: 40 Weeks||18
58397|NCT01426269|137008|P2|COMPLETED|Period 2: 40 Weeks||27
58398|NCT01426269|137009|P1|COMPLETED|Period 2: 40 Weeks||0
58399|NCT01426269|137007|P3|STARTED|Period 2: 40 Weeks||65
58400|NCT01426269|137008|P2|STARTED|Period 2: 40 Weeks||65
58401|NCT01426269|137009|P1|STARTED|Period 2: 40 Weeks||0
58402|NCT01426269|137007|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
58403|NCT01426269|137008|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
58404|NCT01426269|137009|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
58405|NCT01426269|137007|P3|COMPLETED|Eligibility for Period 2, Randomization||0
58406|NCT01426269|137008|P2|COMPLETED|Eligibility for Period 2, Randomization||0
58407|NCT01426269|137009|P1|COMPLETED|Eligibility for Period 2, Randomization||130
58408|NCT01426269|137007|P3|STARTED|Eligibility for Period 2, Randomization||0
58409|NCT01426269|137008|P2|STARTED|Eligibility for Period 2, Randomization||0
58410|NCT01426269|137009|P1|STARTED|Eligibility for Period 2, Randomization||180
58411|NCT01426269|137007|P3|NOT COMPLETED|Period 1: 12 Weeks||0
58412|NCT01426269|137008|P2|NOT COMPLETED|Period 1: 12 Weeks||0
58413|NCT01426269|137009|P1|NOT COMPLETED|Period 1: 12 Weeks||55
58414|NCT01426269|137007|P3|COMPLETED|Period 1: 12 Weeks||0
58415|NCT01426269|137008|P2|COMPLETED|Period 1: 12 Weeks||0
58416|NCT01426269|137009|P1|COMPLETED|Period 1: 12 Weeks||180
58417|NCT01426269|137007|P3|STARTED|Period 1: 12 Weeks||0
58418|NCT01426269|137008|P2|STARTED|Period 1: 12 Weeks||0
58419|NCT01426269|137009|P1|STARTED|Period 1: 12 Weeks||235
58420|NCT01426230|137036|P2|NOT COMPLETED|Overall Study||27
58421|NCT01426230|137037|P1|NOT COMPLETED|Overall Study||31
58422|NCT01426230|137036|P2|COMPLETED|Overall Study||84
58423|NCT01426230|137037|P1|COMPLETED|Overall Study||55
58424|NCT01426230|137036|P2|STARTED|Overall Study||111
58425|NCT01426230|137037|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
58426|NCT01426113|137044|P2|NOT COMPLETED|Overall Study||2
58427|NCT01426113|137045|P1|NOT COMPLETED|Overall Study||1
58428|NCT01426113|137044|P2|COMPLETED|Overall Study||1
58429|NCT01426113|137045|P1|COMPLETED|Overall Study||2
58430|NCT01426113|137044|P2|STARTED|Overall Study||3
58431|NCT01426113|137045|P1|STARTED|Overall Study||3
58432|NCT01425879|137051|P1|NOT COMPLETED|Overall Study||0
58433|NCT01425879|137051|P1|COMPLETED|Overall Study||8
58434|NCT01425879|137051|P1|STARTED|Overall Study||8
58435|NCT01425853|137060|P2|NOT COMPLETED|Overall Study||77
58436|NCT01425853|137061|P1|NOT COMPLETED|Overall Study||64
58437|NCT01425853|137060|P2|COMPLETED|Overall Study||225
58438|NCT01425853|137061|P1|COMPLETED|Overall Study||240
58439|NCT01425853|137060|P2|Per Protocol (PP)|Overall Study||258
58440|NCT01425853|137061|P1|Per Protocol (PP)|Overall Study||264
58441|NCT01425853|137060|P2|Safety Population|Overall Study||299
58442|NCT01425853|137061|P1|Safety Population|Overall Study||304
58443|NCT01425853|137060|P2|STARTED|Overall Study||302
58444|NCT01425853|137061|P1|STARTED|Overall Study||304
58445|NCT01425749|137093|P2|NOT COMPLETED|Overall Study||1
58446|NCT01425749|137094|P1|NOT COMPLETED|Overall Study||0
58447|NCT01425749|137093|P2|COMPLETED|Overall Study||11
58448|NCT01425749|137094|P1|COMPLETED|Overall Study||13
58449|NCT01425749|137093|P2|STARTED|Overall Study||12
58450|NCT01425749|137094|P1|STARTED|Overall Study||13
58451|NCT01425632|137112|P3|NOT COMPLETED|Overall Study||4
58452|NCT01425632|137113|P2|NOT COMPLETED|Overall Study||1
58453|NCT01425632|137114|P1|NOT COMPLETED|Overall Study||1
58454|NCT01425632|137112|P3|COMPLETED|Overall Study||159
58455|NCT01425632|137113|P2|COMPLETED|Overall Study||165
58456|NCT01425632|137114|P1|COMPLETED|Overall Study||160
58457|NCT01425632|137112|P3|STARTED|Overall Study||163
58458|NCT01425632|137113|P2|STARTED|Overall Study||166
58459|NCT01425632|137114|P1|STARTED|Overall Study||161
58460|NCT01425528|137124|P2|NOT COMPLETED|Overall Study||1
58461|NCT01425528|137125|P1|NOT COMPLETED|Overall Study||1
58462|NCT01425528|137124|P2|COMPLETED|Overall Study||5
58463|NCT01425528|137125|P1|COMPLETED|Overall Study||5
58464|NCT01425528|137124|P2|STARTED|Overall Study||6
58465|NCT01425528|137125|P1|STARTED|Overall Study||6
58466|NCT01425463|137133|P2|NOT COMPLETED|Overall Study||24
58467|NCT01425463|137134|P1|NOT COMPLETED|Overall Study||24
58468|NCT01425463|137133|P2|COMPLETED|Overall Study||102
58469|NCT01425463|137134|P1|COMPLETED|Overall Study||106
58470|NCT01425463|137133|P2|Full Analysis Set|Overall Study||116
58471|NCT01425463|137134|P1|Full Analysis Set|Overall Study||122
58472|NCT01425463|137133|P2|Safety Set|Overall Study||122
58473|NCT01425463|137134|P1|Safety Set|Overall Study||126
58474|NCT01425463|137133|P2|STARTED|Overall Study||126
58475|NCT01425463|137134|P1|STARTED|Overall Study||130
58476|NCT01425359|137150|P2|NOT COMPLETED|Overall Study||22
58477|NCT01425359|137151|P1|NOT COMPLETED|Overall Study||19
58478|NCT01425359|137150|P2|COMPLETED|Overall Study||451
58479|NCT01425359|137151|P1|COMPLETED|Overall Study||457
58480|NCT01425359|137150|P2|STARTED|Overall Study||473
58481|NCT01425359|137151|P1|STARTED|Overall Study||476
58482|NCT01425229|137167|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
58483|NCT01425229|137167|P1|COMPLETED|Bosentan During Clarithromycin||16
58484|NCT01425229|137167|P1|STARTED|Bosentan During Clarithromycin||16
58485|NCT01425229|137167|P1|NOT COMPLETED|Bosentan Steady-state||0
58486|NCT01425229|137167|P1|COMPLETED|Bosentan Steady-state||16
58487|NCT01425229|137167|P1|STARTED|Bosentan Steady-state||16
58488|NCT01425229|137167|P1|NOT COMPLETED|Bosentan Single Dose||0
58489|NCT01425229|137167|P1|COMPLETED|Bosentan Single Dose||16
58490|NCT01425229|137167|P1|STARTED|Bosentan Single Dose||16
58491|NCT01425203|137180|P3|NOT COMPLETED|Follow-up Phase||0
58492|NCT01425203|137181|P2|NOT COMPLETED|Follow-up Phase||0
58493|NCT01425203|137182|P1|NOT COMPLETED|Follow-up Phase||0
58494|NCT01425203|137180|P3|COMPLETED|Follow-up Phase||27
58495|NCT01425203|137181|P2|COMPLETED|Follow-up Phase||49
58496|NCT01425203|137182|P1|COMPLETED|Follow-up Phase||153
58497|NCT01425203|137180|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
58498|NCT01425203|137181|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
58499|NCT01425203|137182|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
58500|NCT01425203|137180|P3|NOT COMPLETED|Crossover Phase||6
58501|NCT01425203|137181|P2|NOT COMPLETED|Crossover Phase||0
58502|NCT01425203|137182|P1|NOT COMPLETED|Crossover Phase||0
58503|NCT01425203|137180|P3|COMPLETED|Crossover Phase||21
58504|NCT01425203|137181|P2|COMPLETED|Crossover Phase||0
58505|NCT01425203|137182|P1|COMPLETED|Crossover Phase||0
58506|NCT01425203|137180|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
58507|NCT01425203|137181|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
58508|NCT01425203|137182|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
58509|NCT01425203|137180|P3|NOT COMPLETED|Treatment Phase||0
58510|NCT01425203|137181|P2|NOT COMPLETED|Treatment Phase||37
58511|NCT01425203|137182|P1|NOT COMPLETED|Treatment Phase||27
58512|NCT01425203|137180|P3|COMPLETED|Treatment Phase||0
58513|NCT01425203|137181|P2|COMPLETED|Treatment Phase||42
58514|NCT01425203|137182|P1|COMPLETED|Treatment Phase||132
58515|NCT01425203|137180|P3|Treated (FAS)|Treatment Phase||0
58516|NCT01425203|137181|P2|Treated (FAS)|Treatment Phase||78
58517|NCT01425203|137182|P1|Treated (FAS)|Treatment Phase||159
58518|NCT01425203|137180|P3|STARTED|Treatment Phase||0
58519|NCT01425203|137181|P2|STARTED|Treatment Phase||79
58520|NCT01425203|137182|P1|STARTED|Treatment Phase||159
58521|NCT01425190|137199|P3|NOT COMPLETED|Overall Study||0
58522|NCT01425190|137200|P2|NOT COMPLETED|Overall Study||0
58523|NCT01425190|137201|P1|NOT COMPLETED|Overall Study||1
58524|NCT01425190|137199|P3|COMPLETED|Overall Study||0
58525|NCT01425190|137200|P2|COMPLETED|Overall Study||0
58526|NCT01425190|137201|P1|COMPLETED|Overall Study||15
58527|NCT01425190|137199|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
58528|NCT01425190|137200|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
58529|NCT01425190|137201|P1|STARTED|Overall Study||16
58530|NCT01424943|137220|P2|NOT COMPLETED|Overall Study||1
58531|NCT01424943|137221|P1|NOT COMPLETED|Overall Study||13
58532|NCT01424943|137220|P2|COMPLETED|Overall Study||23
58533|NCT01424943|137221|P1|COMPLETED|Overall Study||12
58534|NCT01424943|137220|P2|STARTED|Overall Study||24
58535|NCT01424943|137221|P1|STARTED|Overall Study||25
58536|NCT01424930|137237|P2|NOT COMPLETED|Overall Study||14
58537|NCT01424930|137238|P1|NOT COMPLETED|Overall Study||4
58538|NCT01424930|137237|P2|COMPLETED|Overall Study||4
58539|NCT01424930|137238|P1|COMPLETED|Overall Study||3
58540|NCT01424930|137237|P2|Completed Food Safety Evaluation|Overall Study||18
58541|NCT01424930|137238|P1|Completed Food Safety Evaluation|Overall Study||6
58542|NCT01424930|137237|P2|STARTED|Overall Study||18
58543|NCT01424930|137238|P1|STARTED|Overall Study||7
58544|NCT01424813|137252|P2|NOT COMPLETED|Overall Study||2
58545|NCT01424813|137253|P1|NOT COMPLETED|Overall Study||5
58546|NCT01424813|137252|P2|COMPLETED|Overall Study||77
58547|NCT01424813|137253|P1|COMPLETED|Overall Study||74
58548|NCT01424813|137252|P2|Treated|Overall Study|Safety set and full analysis set|78
58549|NCT01424813|137253|P1|Treated|Overall Study|Safety set and full analysis set|79
58550|NCT01424813|137252|P2|STARTED|Overall Study||79
58551|NCT01424813|137253|P1|STARTED|Overall Study||79
58552|NCT01424644|137273|P2|NOT COMPLETED|Overall Study||27
58553|NCT01424644|137274|P1|NOT COMPLETED|Overall Study||33
58554|NCT01424644|137273|P2|COMPLETED|Overall Study||372
58555|NCT01424644|137274|P1|COMPLETED|Overall Study||369
58556|NCT01424644|137273|P2|STARTED|Overall Study||399
58557|NCT01424644|137274|P1|STARTED|Overall Study||402
58558|NCT01424501|137294|P6|NOT COMPLETED|Overall Study||0
58559|NCT01424501|137295|P5|NOT COMPLETED|Overall Study||0
58560|NCT01424501|137296|P4|NOT COMPLETED|Overall Study||0
58561|NCT01424501|137297|P3|NOT COMPLETED|Overall Study||2
58562|NCT01424501|137298|P2|NOT COMPLETED|Overall Study||1
58563|NCT01424501|137299|P1|NOT COMPLETED|Overall Study||1
58564|NCT01424501|137294|P6|COMPLETED|Overall Study||40
58565|NCT01424501|137295|P5|COMPLETED|Overall Study||40
58566|NCT01424501|137296|P4|COMPLETED|Overall Study||25
58567|NCT01424501|137297|P3|COMPLETED|Overall Study||22
58568|NCT01424501|137298|P2|COMPLETED|Overall Study||5
58569|NCT01424501|137299|P1|COMPLETED|Overall Study||6
58570|NCT01424501|137294|P6|STARTED|Overall Study||40
58571|NCT01424501|137295|P5|STARTED|Overall Study||40
58572|NCT01424501|137296|P4|STARTED|Overall Study||25
58573|NCT01424501|137297|P3|STARTED|Overall Study||24
58574|NCT01424501|137298|P2|STARTED|Overall Study||6
58575|NCT01424501|137299|P1|STARTED|Overall Study||7
58576|NCT01424228|137465|P2|NOT COMPLETED|Overall Study||47
58577|NCT01424228|137466|P1|NOT COMPLETED|Overall Study||56
58578|NCT01424228|137465|P2|COMPLETED|Overall Study||135
58579|NCT01424228|137466|P1|COMPLETED|Overall Study||126
58580|NCT01424228|137465|P2|STARTED|Overall Study||182
58581|NCT01424228|137466|P1|STARTED|Overall Study||182
58582|NCT01424072|137507|P3|NOT COMPLETED|Overall Study||0
58583|NCT01424072|137508|P2|NOT COMPLETED|Overall Study||0
58584|NCT01424072|137509|P1|NOT COMPLETED|Overall Study||0
58585|NCT01424072|137507|P3|COMPLETED|Overall Study||22
58586|NCT01424072|137508|P2|COMPLETED|Overall Study||26
58587|NCT01424072|137509|P1|COMPLETED|Overall Study||27
58588|NCT01424072|137507|P3|STARTED|Overall Study||22
58589|NCT01424072|137508|P2|STARTED|Overall Study||26
58590|NCT01424072|137509|P1|STARTED|Overall Study||27
58591|NCT01424033|137526|P1|NOT COMPLETED|Overall Study||0
58592|NCT01424033|137526|P1|COMPLETED|Overall Study||0
58593|NCT01424033|137526|P1|STARTED|Overall Study||0
58594|NCT01423916|137533|P3|NOT COMPLETED|Overall Study||7
58595|NCT01423916|137534|P2|NOT COMPLETED|Overall Study||20
58596|NCT01423916|137535|P1|NOT COMPLETED|Overall Study||11
58597|NCT01423916|137533|P3|COMPLETED|Overall Study||64
58598|NCT01423916|137534|P2|COMPLETED|Overall Study||53
58599|NCT01423916|137535|P1|COMPLETED|Overall Study||63
58600|NCT01423916|137533|P3|STARTED|Overall Study||71
58601|NCT01423916|137534|P2|STARTED|Overall Study||73
58602|NCT01423916|137535|P1|STARTED|Overall Study||74
58603|NCT01423773|137589|P2|NOT COMPLETED|Period 2, 2 Days||0
58604|NCT01423773|137590|P1|NOT COMPLETED|Period 2, 2 Days||0
58605|NCT01423773|137589|P2|COMPLETED|Period 2, 2 Days||10
58606|NCT01423773|137590|P1|COMPLETED|Period 2, 2 Days||10
58607|NCT01423773|137589|P2|STARTED|Period 2, 2 Days||10
58608|NCT01423773|137590|P1|STARTED|Period 2, 2 Days||10
58609|NCT01423773|137589|P2|NOT COMPLETED|Period One, 2 Days||0
58610|NCT01423773|137590|P1|NOT COMPLETED|Period One, 2 Days||0
58611|NCT01423773|137589|P2|COMPLETED|Period One, 2 Days||10
58612|NCT01423773|137590|P1|COMPLETED|Period One, 2 Days||10
58613|NCT01423773|137589|P2|STARTED|Period One, 2 Days||10
58614|NCT01423773|137590|P1|STARTED|Period One, 2 Days||10
58615|NCT01423760|137598|P2|NOT COMPLETED|Overall Study||0
58616|NCT01423760|137599|P1|NOT COMPLETED|Overall Study||0
58617|NCT01423760|137598|P2|COMPLETED|Overall Study||13
58618|NCT01423760|137599|P1|COMPLETED|Overall Study||14
58619|NCT01423760|137598|P2|Safety Analysis Set|Overall Study||8
58620|NCT01423760|137599|P1|Safety Analysis Set|Overall Study||12
58621|NCT01423760|137598|P2|Number of Non-treatment Subjects|Overall Study||5
58622|NCT01423760|137599|P1|Number of Non-treatment Subjects|Overall Study||2
58623|NCT01423760|137598|P2|Number of Tecemotide Subjects|Overall Study||8
58624|NCT01423760|137599|P1|Number of Tecemotide Subjects|Overall Study||12
58625|NCT01423760|137598|P2|STARTED|Overall Study||13
58626|NCT01423760|137599|P1|STARTED|Overall Study||14
58627|NCT01423617|137609|P2|NOT COMPLETED|Overall Study||1
58628|NCT01423617|137610|P1|NOT COMPLETED|Overall Study||0
58629|NCT01423617|137609|P2|COMPLETED|Overall Study||45
58630|NCT01423617|137610|P1|COMPLETED|Overall Study||46
58631|NCT01423617|137609|P2|STARTED|Overall Study||46
58632|NCT01423617|137610|P1|STARTED|Overall Study||46
58633|NCT01423604|137627|P2|NOT COMPLETED|Randomized||63
58634|NCT01423604|137628|P1|NOT COMPLETED|Randomized||63
58635|NCT01423604|137627|P2|COMPLETED|Randomized||0
58636|NCT01423604|137628|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
58637|NCT01423604|137627|P2|STARTED|Randomized||63
58638|NCT01423604|137628|P1|STARTED|Randomized||64
58639|NCT01423604|137627|P2|NOT COMPLETED|Safety Run-In||0
58640|NCT01423604|137628|P1|NOT COMPLETED|Safety Run-In||9
58641|NCT01423604|137627|P2|COMPLETED|Safety Run-In||0
58642|NCT01423604|137628|P1|COMPLETED|Safety Run-In||0
58643|NCT01423604|137627|P2|STARTED|Safety Run-In||0
58644|NCT01423604|137628|P1|STARTED|Safety Run-In||9
58645|NCT01423253|137643|P1|NOT COMPLETED|Overall Study||9
58646|NCT01423253|137643|P1|COMPLETED|Overall Study||39
58647|NCT01423253|137643|P1|STARTED|Overall Study||48
58648|NCT01423162|137656|P2|NOT COMPLETED|Overall Study||0
58649|NCT01423162|137657|P1|NOT COMPLETED|Overall Study||0
58650|NCT01423162|137656|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
58651|NCT01423162|137657|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
58652|NCT01423162|137656|P2|STARTED|Overall Study||9
58653|NCT01423162|137657|P1|STARTED|Overall Study||11
58654|NCT01423084|137665|P2|NOT COMPLETED|Overall Study||4
58655|NCT01423084|137666|P1|NOT COMPLETED|Overall Study||2
58656|NCT01423084|137665|P2|COMPLETED|Overall Study||170
58657|NCT01423084|137666|P1|COMPLETED|Overall Study||168
58658|NCT01423084|137665|P2|STARTED|Overall Study||174
58659|NCT01423084|137666|P1|STARTED|Overall Study||170
58660|NCT01422889|137696|P1|NOT COMPLETED|Overall Study||9
58661|NCT01422889|137696|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
58662|NCT01422889|137696|P1|STARTED|Overall Study||1120
58663|NCT01422876|137711|P10|NOT COMPLETED|Week 52||17
58664|NCT01422876|137712|P9|NOT COMPLETED|Week 52||21
58665|NCT01422876|137713|P8|NOT COMPLETED|Week 52||23
58666|NCT01422876|137714|P7|NOT COMPLETED|Week 52||16
58667|NCT01422876|137715|P6|NOT COMPLETED|Week 52||17
58668|NCT01422876|137716|P5|NOT COMPLETED|Week 52||15
58669|NCT01422876|137717|P4|NOT COMPLETED|Week 52||18
58670|NCT01422876|137718|P3|NOT COMPLETED|Week 52||13
58671|NCT01422876|137719|P2|NOT COMPLETED|Week 52||10
58672|NCT01422876|137720|P1|NOT COMPLETED|Week 52||12
58673|NCT01422876|137711|P10|COMPLETED|Week 52||118
58674|NCT01422876|137712|P9|COMPLETED|Week 52||113
58675|NCT01422876|137713|P8|COMPLETED|Week 52||112
58676|NCT01422876|137714|P7|COMPLETED|Week 52||120
58677|NCT01422876|137715|P6|COMPLETED|Week 52||120
58678|NCT01422876|137716|P5|COMPLETED|Week 52||117
58679|NCT01422876|137717|P4|COMPLETED|Week 52||122
58680|NCT01422876|137718|P3|COMPLETED|Week 52||128
58681|NCT01422876|137719|P2|COMPLETED|Week 52||126
58682|NCT01422876|137720|P1|COMPLETED|Week 52||125
58683|NCT01422876|137711|P10|STARTED|Week 52||135
58684|NCT01422876|137712|P9|STARTED|Week 52||134
58685|NCT01422876|137713|P8|STARTED|Week 52||135
58686|NCT01422876|137714|P7|STARTED|Week 52||136
58687|NCT01422876|137715|P6|STARTED|Week 52||137
58688|NCT01422876|137716|P5|STARTED|Week 52||132
58689|NCT01422876|137717|P4|STARTED|Week 52||140
58690|NCT01422876|137718|P3|STARTED|Week 52||141
58691|NCT01422876|137719|P2|STARTED|Week 52||136
58692|NCT01422876|137720|P1|STARTED|Week 52||137
58693|NCT01422876|137711|P10|NOT COMPLETED|Week 24||10
58694|NCT01422876|137712|P9|NOT COMPLETED|Week 24||6
58695|NCT01422876|137713|P8|NOT COMPLETED|Week 24||7
58696|NCT01422876|137714|P7|NOT COMPLETED|Week 24||6
58697|NCT01422876|137715|P6|NOT COMPLETED|Week 24||6
58698|NCT01422876|137716|P5|NOT COMPLETED|Week 24||7
58699|NCT01422876|137717|P4|NOT COMPLETED|Week 24||8
58700|NCT01422876|137718|P3|NOT COMPLETED|Week 24||5
58701|NCT01422876|137719|P2|NOT COMPLETED|Week 24||3
58702|NCT01422876|137720|P1|NOT COMPLETED|Week 24||6
58703|NCT01422876|137711|P10|COMPLETED|Week 24||125
58704|NCT01422876|137712|P9|COMPLETED|Week 24||128
58705|NCT01422876|137713|P8|COMPLETED|Week 24||128
58706|NCT01422876|137714|P7|COMPLETED|Week 24||130
58707|NCT01422876|137715|P6|COMPLETED|Week 24||131
58708|NCT01422876|137716|P5|COMPLETED|Week 24||125
58709|NCT01422876|137717|P4|COMPLETED|Week 24||132
58710|NCT01422876|137718|P3|COMPLETED|Week 24||136
58711|NCT01422876|137719|P2|COMPLETED|Week 24||133
58712|NCT01422876|137720|P1|COMPLETED|Week 24||131
58713|NCT01422876|137711|P10|STARTED|Week 24||135
58714|NCT01422876|137712|P9|STARTED|Week 24||134
58715|NCT01422876|137713|P8|STARTED|Week 24||135
58716|NCT01422876|137714|P7|STARTED|Week 24||136
58717|NCT01422876|137715|P6|STARTED|Week 24||137
58718|NCT01422876|137716|P5|STARTED|Week 24||132
58719|NCT01422876|137717|P4|STARTED|Week 24||140
58720|NCT01422876|137718|P3|STARTED|Week 24||141
58721|NCT01422876|137719|P2|STARTED|Week 24||136
58722|NCT01422876|137720|P1|STARTED|Week 24||137
58723|NCT01422850|137767|P1|NOT COMPLETED|Overall Study||3
58724|NCT01422850|137767|P1|COMPLETED|Overall Study||18
58725|NCT01422850|137767|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
58726|NCT01422850|137767|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
58727|NCT01422850|137767|P1|Week 9 - Second Treatment|Overall Study||20
58728|NCT01422850|137767|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
58729|NCT01422850|137767|P1|Week 4 - First Treatment|Overall Study||21
58730|NCT01422850|137767|P1|STARTED|Overall Study||21
58731|NCT01422824|137773|P1|NOT COMPLETED|Overall Study||38
58732|NCT01422824|137773|P1|COMPLETED|Overall Study||147
58733|NCT01422824|137773|P1|Treated|Overall Study||184
58734|NCT01422824|137773|P1|STARTED|Overall Study||185
58735|NCT01422720|137778|P1|NOT COMPLETED|Overall Study||22
58736|NCT01422720|137778|P1|COMPLETED|Overall Study||50
58737|NCT01422720|137778|P1|Per-Protocol Set (PPS)|Overall Study||55
58738|NCT01422720|137778|P1|Full Analysis Set (FAS)|Overall Study||71
58739|NCT01422720|137778|P1|Safety Set|Overall Study||72
58740|NCT01422720|137778|P1|STARTED|Overall Study||72
58741|NCT01422538|137789|P3|NOT COMPLETED|Overall Study||2
58742|NCT01422538|137790|P2|NOT COMPLETED|Overall Study||2
58743|NCT01422538|137791|P1|NOT COMPLETED|Overall Study||0
58744|NCT01422538|137789|P3|COMPLETED|Overall Study||8
58745|NCT01422538|137790|P2|COMPLETED|Overall Study||8
58746|NCT01422538|137791|P1|COMPLETED|Overall Study||10
58747|NCT01422538|137789|P3|STARTED|Overall Study||10
58748|NCT01422538|137790|P2|STARTED|Overall Study||10
58749|NCT01422538|137791|P1|STARTED|Overall Study||10
58750|NCT01422434|137816|P3|NOT COMPLETED|Overall Study||6
58751|NCT01422434|137817|P2|NOT COMPLETED|Overall Study||5
58752|NCT01422434|137818|P1|NOT COMPLETED|Overall Study||11
58753|NCT01422434|137816|P3|COMPLETED|Overall Study||217
58754|NCT01422434|137817|P2|COMPLETED|Overall Study||221
58755|NCT01422434|137818|P1|COMPLETED|Overall Study||216
58756|NCT01422434|137816|P3|STARTED|Overall Study||223
58757|NCT01422434|137817|P2|STARTED|Overall Study||226
58758|NCT01422434|137818|P1|STARTED|Overall Study||227
58759|NCT01422382|137835|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
58760|NCT01422382|137835|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
58761|NCT01422382|137835|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
58762|NCT01422382|137835|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
58763|NCT01422382|137835|P1|COMPLETED|Diltiazem 240 mg QD||28
58764|NCT01422382|137835|P1|STARTED|Diltiazem 240 mg QD||28
58765|NCT01422382|137835|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
58766|NCT01422382|137835|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
58767|NCT01422382|137835|P1|STARTED|NK-104 4mg Once Daily (QD)||28
58768|NCT01422369|137840|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
58769|NCT01422369|137840|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
58770|NCT01422369|137840|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
58771|NCT01422369|137840|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
58772|NCT01422369|137840|P1|COMPLETED|Prezista 800mg/100mg QD||28
58773|NCT01422369|137840|P1|STARTED|Prezista 800mg/100mg QD||28
58774|NCT01422369|137840|P1|NOT COMPLETED|NK-104 4mg QD||0
58775|NCT01422369|137840|P1|COMPLETED|NK-104 4mg QD||28
58776|NCT01422369|137840|P1|STARTED|NK-104 4mg QD||28
58777|NCT01422356|137845|P1|NOT COMPLETED|Overall Study||31
58778|NCT01422356|137845|P1|COMPLETED|Overall Study||169
58779|NCT01422356|137845|P1|STARTED|Overall Study||200
58780|NCT01422304|137851|P2|NOT COMPLETED|Overall Study||37
58781|NCT01422304|137852|P1|NOT COMPLETED|Overall Study||24
58782|NCT01422304|137851|P2|COMPLETED|Overall Study||563
58783|NCT01422304|137852|P1|COMPLETED|Overall Study||574
58784|NCT01422304|137851|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
58785|NCT01422304|137852|P1|Treated|Overall Study||595
58786|NCT01422304|137851|P2|STARTED|Overall Study|Randomized|600
58787|NCT01422304|137852|P1|STARTED|Overall Study|Randomized|598
58788|NCT01422239|137884|P2|NOT COMPLETED|Overall Study||3
58789|NCT01422239|137885|P1|NOT COMPLETED|Overall Study||4
58790|NCT01422239|137884|P2|COMPLETED|Overall Study||3
58791|NCT01422239|137885|P1|COMPLETED|Overall Study||10
58792|NCT01422239|137884|P2|STARTED|Overall Study||6
58793|NCT01422239|137885|P1|STARTED|Overall Study||14
58794|NCT01422226|137897|P2|NOT COMPLETED|Overall Study||0
58795|NCT01422226|137898|P1|NOT COMPLETED|Overall Study||0
58796|NCT01422226|137897|P2|COMPLETED|Overall Study||2
58797|NCT01422226|137898|P1|COMPLETED|Overall Study||1
58798|NCT01422226|137897|P2|STARTED|Overall Study||2
58799|NCT01422226|137898|P1|STARTED|Overall Study||1
58800|NCT01422213|137907|P3|NOT COMPLETED|Overall Study||29
58801|NCT01422213|137908|P2|NOT COMPLETED|Overall Study||22
58802|NCT01422213|137909|P1|NOT COMPLETED|Overall Study||33
58803|NCT01422213|137907|P3|COMPLETED|Overall Study||178
58804|NCT01422213|137908|P2|COMPLETED|Overall Study||173
58805|NCT01422213|137909|P1|COMPLETED|Overall Study||163
58806|NCT01422213|137907|P3|STARTED|Overall Study||207
58807|NCT01422213|137908|P2|STARTED|Overall Study||195
58808|NCT01422213|137909|P1|STARTED|Overall Study||196
58809|NCT01422187|137970|P3|NOT COMPLETED|Overall Study||0
58810|NCT01422187|137971|P2|NOT COMPLETED|Overall Study||1
58811|NCT01422187|137972|P1|NOT COMPLETED|Overall Study||1
58812|NCT01422187|137970|P3|COMPLETED|Overall Study||2
58813|NCT01422187|137971|P2|COMPLETED|Overall Study||8
58814|NCT01422187|137972|P1|COMPLETED|Overall Study||7
58815|NCT01422187|137970|P3|STARTED|Overall Study||2
58816|NCT01422187|137971|P2|STARTED|Overall Study||9
58817|NCT01422187|137972|P1|STARTED|Overall Study||8
58818|NCT01422070|137991|P2|NOT COMPLETED|Overall Study||0
58819|NCT01422070|137992|P1|NOT COMPLETED|Overall Study||0
58820|NCT01422070|137991|P2|COMPLETED|Overall Study||803
58821|NCT01422070|137992|P1|COMPLETED|Overall Study||5031
58822|NCT01422070|137991|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
58823|NCT01422070|137992|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
58824|NCT01421667|138007|P4|NOT COMPLETED|Overall Study||1
58825|NCT01421667|138008|P3|NOT COMPLETED|Overall Study||2
58826|NCT01421667|138009|P2|NOT COMPLETED|Overall Study||2
58827|NCT01421667|138010|P1|NOT COMPLETED|Overall Study||0
58828|NCT01421667|138007|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
58918|NCT01420848|138277|P3|COMPLETED|Overall Study||22
58829|NCT01421667|138008|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
58830|NCT01421667|138009|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
58831|NCT01421667|138010|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
58832|NCT01421667|138007|P4|STARTED|Overall Study||16
58833|NCT01421667|138008|P3|STARTED|Overall Study||53
58834|NCT01421667|138009|P2|STARTED|Overall Study||68
58835|NCT01421667|138010|P1|STARTED|Overall Study||35
58836|NCT01421654|138062|P2|NOT COMPLETED|Overall Study||0
58837|NCT01421654|138063|P1|NOT COMPLETED|Overall Study||0
58838|NCT01421654|138062|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
58839|NCT01421654|138063|P1|COMPLETED|Overall Study||11
58840|NCT01421654|138062|P2|STARTED|Overall Study||9
58841|NCT01421654|138063|P1|STARTED|Overall Study||11
58842|NCT01421641|138071|P2|NOT COMPLETED|Overall Study||2
58843|NCT01421641|138072|P1|NOT COMPLETED|Overall Study||2
58844|NCT01421641|138071|P2|COMPLETED|Overall Study||35
58845|NCT01421641|138072|P1|COMPLETED|Overall Study||35
58846|NCT01421641|138071|P2|STARTED|Overall Study||37
58847|NCT01421641|138072|P1|STARTED|Overall Study||37
58848|NCT01421589|138082|P1|NOT COMPLETED|Overall Study||0
58849|NCT01421589|138082|P1|COMPLETED|Overall Study||15
58850|NCT01421589|138082|P1|STARTED|Overall Study||15
58851|NCT01421511|138094|P2|NOT COMPLETED|Overall Study||28
58852|NCT01421511|138095|P1|NOT COMPLETED|Overall Study||19
58853|NCT01421511|138094|P2|COMPLETED|Overall Study||306
58854|NCT01421511|138095|P1|COMPLETED|Overall Study||313
58855|NCT01421511|138094|P2|STARTED|Overall Study||334
58856|NCT01421511|138095|P1|STARTED|Overall Study||332
58857|NCT01421472|138119|P4|NOT COMPLETED|Overall Study||0
58858|NCT01421472|138120|P3|NOT COMPLETED|Overall Study||0
58859|NCT01421472|138121|P2|NOT COMPLETED|Overall Study||0
58860|NCT01421472|138122|P1|NOT COMPLETED|Overall Study||0
58861|NCT01421472|138119|P4|COMPLETED|Overall Study||32
58862|NCT01421472|138120|P3|COMPLETED|Overall Study||64
58863|NCT01421472|138121|P2|COMPLETED|Overall Study||33
58864|NCT01421472|138122|P1|COMPLETED|Overall Study||67
58865|NCT01421472|138119|P4|STARTED|Overall Study||32
58866|NCT01421472|138120|P3|STARTED|Overall Study||64
58867|NCT01421472|138121|P2|STARTED|Overall Study||33
58868|NCT01421472|138122|P1|STARTED|Overall Study||67
58869|NCT01421459|138134|P2|NOT COMPLETED|Overall Study||52
58870|NCT01421459|138135|P1|NOT COMPLETED|Overall Study||45
58871|NCT01421459|138134|P2|COMPLETED|Overall Study||328
58872|NCT01421459|138135|P1|COMPLETED|Overall Study||334
58873|NCT01421459|138134|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
58874|NCT01421459|138135|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
58875|NCT01421459|138134|P2|STARTED|Overall Study||380
58876|NCT01421459|138135|P1|STARTED|Overall Study||379
58877|NCT01421355|138169|P1|NOT COMPLETED|Overall Study||6
58878|NCT01421355|138169|P1|COMPLETED|Overall Study||15
58879|NCT01421355|138169|P1|STARTED|Overall Study||21
58880|NCT01421303|138173|P1|NOT COMPLETED|Overall Study||22
58881|NCT01421303|138173|P1|COMPLETED|Overall Study||58
58882|NCT01421303|138173|P1|STARTED|Overall Study||80
58883|NCT01421277|138200|P2|NOT COMPLETED|Overall Study||92
58884|NCT01421277|138201|P1|NOT COMPLETED|Overall Study||0
58885|NCT01421277|138200|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
58886|NCT01421277|138201|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
58887|NCT01421277|138200|P2|STARTED|Overall Study||191
58888|NCT01421277|138201|P1|STARTED|Overall Study||25
58889|NCT01421147|138213|P2|NOT COMPLETED|Extension Period||11
58890|NCT01421147|138214|P1|NOT COMPLETED|Extension Period||8
58891|NCT01421147|138213|P2|COMPLETED|Extension Period||245
58892|NCT01421147|138214|P1|COMPLETED|Extension Period||245
58893|NCT01421147|138213|P2|STARTED|Extension Period||256
58894|NCT01421147|138214|P1|STARTED|Extension Period||253
58895|NCT01421147|138213|P2|NOT COMPLETED|Treatment Period||11
58896|NCT01421147|138214|P1|NOT COMPLETED|Treatment Period||16
58897|NCT01421147|138213|P2|COMPLETED|Treatment Period||256
58898|NCT01421147|138214|P1|COMPLETED|Treatment Period||253
58899|NCT01421147|138213|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
58900|NCT01421147|138214|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
58901|NCT01421147|138213|P2|STARTED|Treatment Period||267
58902|NCT01421147|138214|P1|STARTED|Treatment Period||269
58903|NCT01421134|138246|P2|NOT COMPLETED|Overall Study||15
58904|NCT01421134|138247|P1|NOT COMPLETED|Overall Study||7
58905|NCT01421134|138246|P2|COMPLETED|Overall Study||87
58906|NCT01421134|138247|P1|COMPLETED|Overall Study||102
58907|NCT01421134|138246|P2|STARTED|Overall Study||102
58908|NCT01421134|138247|P1|STARTED|Overall Study||109
58909|NCT01420926|138267|P2|NOT COMPLETED|Overall Study||65
58910|NCT01420926|138268|P1|NOT COMPLETED|Overall Study||60
58911|NCT01420926|138267|P2|COMPLETED|Overall Study||16
58912|NCT01420926|138268|P1|COMPLETED|Overall Study||22
58913|NCT01420926|138267|P2|STARTED|Overall Study||81
58914|NCT01420926|138268|P1|STARTED|Overall Study||82
58915|NCT01420848|138277|P3|NOT COMPLETED|Overall Study||0
58916|NCT01420848|138278|P2|NOT COMPLETED|Overall Study||0
58917|NCT01420848|138279|P1|NOT COMPLETED|Overall Study||0
58919|NCT01420848|138278|P2|COMPLETED|Overall Study||25
58920|NCT01420848|138279|P1|COMPLETED|Overall Study||24
58921|NCT01420848|138277|P3|STARTED|Overall Study||22
58922|NCT01420848|138278|P2|STARTED|Overall Study||25
58923|NCT01420848|138279|P1|STARTED|Overall Study||24
58924|NCT01420289|138292|P2|NOT COMPLETED|Overall Study||0
58925|NCT01420289|138293|P1|NOT COMPLETED|Overall Study||0
58926|NCT01420289|138292|P2|COMPLETED|Overall Study||16
58927|NCT01420289|138293|P1|COMPLETED|Overall Study||18
58928|NCT01420289|138292|P2|STARTED|Overall Study||16
58929|NCT01420289|138293|P1|STARTED|Overall Study||18
58930|NCT01420081|138314|P9|NOT COMPLETED|Overall Study||3
58931|NCT01420081|138315|P8|NOT COMPLETED|Overall Study||3
58932|NCT01420081|138316|P7|NOT COMPLETED|Overall Study||3
58933|NCT01420081|138317|P6|NOT COMPLETED|Overall Study||20
58934|NCT01420081|138318|P5|NOT COMPLETED|Overall Study||20
58935|NCT01420081|138319|P4|NOT COMPLETED|Overall Study||3
58936|NCT01420081|138320|P3|NOT COMPLETED|Overall Study||11
58937|NCT01420081|138321|P2|NOT COMPLETED|Overall Study||1
58938|NCT01420081|138322|P1|NOT COMPLETED|Overall Study||3
58939|NCT01420081|138314|P9|COMPLETED|Overall Study||0
58940|NCT01420081|138315|P8|COMPLETED|Overall Study||0
58941|NCT01420081|138316|P7|COMPLETED|Overall Study||0
58942|NCT01420081|138317|P6|COMPLETED|Overall Study||0
58943|NCT01420081|138318|P5|COMPLETED|Overall Study||0
58944|NCT01420081|138319|P4|COMPLETED|Overall Study||0
58945|NCT01420081|138320|P3|COMPLETED|Overall Study||0
58946|NCT01420081|138321|P2|COMPLETED|Overall Study||0
58947|NCT01420081|138322|P1|COMPLETED|Overall Study||0
58948|NCT01420081|138314|P9|STARTED|Overall Study||3
58949|NCT01420081|138315|P8|STARTED|Overall Study||3
58950|NCT01420081|138316|P7|STARTED|Overall Study||3
58951|NCT01420081|138317|P6|STARTED|Overall Study||20
58952|NCT01420081|138318|P5|STARTED|Overall Study||20
58953|NCT01420081|138319|P4|STARTED|Overall Study||3
58954|NCT01420081|138320|P3|STARTED|Overall Study||11
58955|NCT01420081|138321|P2|STARTED|Overall Study||1
58956|NCT01420081|138322|P1|STARTED|Overall Study||3
58957|NCT01419977|138356|P2|NOT COMPLETED|Overall Study||0
58958|NCT01419977|138357|P1|NOT COMPLETED|Overall Study||0
58959|NCT01419977|138356|P2|COMPLETED|Overall Study||13
58960|NCT01419977|138357|P1|COMPLETED|Overall Study||16
58961|NCT01419977|138356|P2|STARTED|Overall Study||13
58962|NCT01419977|138357|P1|STARTED|Overall Study||16
58963|NCT01419769|138369|P1|NOT COMPLETED|Overall Study||4
58964|NCT01419769|138369|P1|COMPLETED|Overall Study||29
58965|NCT01419769|138369|P1|STARTED|Overall Study||33
58966|NCT01419639|138382|P1|NOT COMPLETED|Overall Study||1
58967|NCT01419639|138382|P1|COMPLETED|Overall Study||9
58968|NCT01419639|138382|P1|STARTED|Overall Study||10
58969|NCT01419314|138390|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
58970|NCT01419314|138391|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
58971|NCT01419314|138390|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
58972|NCT01419314|138391|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
58973|NCT01419314|138390|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
58974|NCT01419314|138391|P1|STARTED|Follow-up at Week 6 of the Trial||17
58975|NCT01419314|138390|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
58976|NCT01419314|138391|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
58977|NCT01419314|138390|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
58978|NCT01419314|138391|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
58979|NCT01419314|138390|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
58980|NCT01419314|138391|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
58981|NCT01419314|138390|P2|NOT COMPLETED|Start of Study||0
58982|NCT01419314|138391|P1|NOT COMPLETED|Start of Study||0
58983|NCT01419314|138390|P2|COMPLETED|Start of Study||22
58984|NCT01419314|138391|P1|COMPLETED|Start of Study||23
58985|NCT01419314|138390|P2|STARTED|Start of Study|No comfort issues reported.|22
58986|NCT01419314|138391|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
58987|NCT01419249|138413|P2|NOT COMPLETED|Overall Study||0
58988|NCT01419249|138414|P1|NOT COMPLETED|Overall Study||0
58989|NCT01419249|138413|P2|COMPLETED|Overall Study||140
58990|NCT01419249|138414|P1|COMPLETED|Overall Study||318
58991|NCT01419249|138413|P2|STARTED|Overall Study||140
58992|NCT01419249|138414|P1|STARTED|Overall Study||318
58993|NCT01419236|138428|P2|NOT COMPLETED|Overall Study||5
58994|NCT01419236|138429|P1|NOT COMPLETED|Overall Study||5
58995|NCT01419236|138428|P2|COMPLETED|Overall Study||35
58996|NCT01419236|138429|P1|COMPLETED|Overall Study||31
58997|NCT01419236|138428|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
58998|NCT01419236|138429|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
58999|NCT01419236|138428|P2|STARTED|Overall Study||40
59000|NCT01419236|138429|P1|STARTED|Overall Study||36
59001|NCT01419197|138453|P2|NOT COMPLETED|Overall Study||198
59002|NCT01419197|138454|P1|NOT COMPLETED|Overall Study||404
59003|NCT01419197|138453|P2|COMPLETED|Overall Study||0
59004|NCT01419197|138454|P1|COMPLETED|Overall Study||0
59005|NCT01419197|138453|P2|Switched to Trastuzumab Emtansine|Overall Study||94
59006|NCT01419197|138454|P1|Switched to Trastuzumab Emtansine|Overall Study||0
59007|NCT01419197|138453|P2|STARTED|Overall Study||198
59008|NCT01419197|138454|P1|STARTED|Overall Study||404
59009|NCT01419184|138479|P2|NOT COMPLETED|Overall Study||15
59010|NCT01419184|138480|P1|NOT COMPLETED|Overall Study||10
59011|NCT01419184|138479|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
59012|NCT01419184|138480|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
59013|NCT01419184|138479|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
59014|NCT01419184|138480|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
59015|NCT01419184|138479|P2|STARTED|Overall Study||121
59016|NCT01419184|138480|P1|STARTED|Overall Study||128
59017|NCT01419171|138496|P1|NOT COMPLETED|Overall Study||0
59018|NCT01419171|138496|P1|COMPLETED|Overall Study||328
59019|NCT01419171|138496|P1|STARTED|Overall Study||328
59020|NCT01419028|138513|P1|NOT COMPLETED|Overall Study||0
59021|NCT01419028|138513|P1|COMPLETED|Overall Study||48
59022|NCT01419028|138513|P1|STARTED|Overall Study||48
59023|NCT01418937|138518|P1|NOT COMPLETED|Overall Study||8
59024|NCT01418937|138518|P1|COMPLETED|Overall Study||156
59025|NCT01418937|138518|P1|STARTED|Overall Study||164
59026|NCT01418703|138527|P4|NOT COMPLETED|Overall Study||0
59027|NCT01418703|138528|P3|NOT COMPLETED|Overall Study||0
59028|NCT01418703|138529|P2|NOT COMPLETED|Overall Study||0
59029|NCT01418703|138530|P1|NOT COMPLETED|Overall Study||0
59030|NCT01418703|138527|P4|COMPLETED|Overall Study||6
59031|NCT01418703|138528|P3|COMPLETED|Overall Study||6
59032|NCT01418703|138529|P2|COMPLETED|Overall Study||13
59033|NCT01418703|138530|P1|COMPLETED|Overall Study||13
59034|NCT01418703|138527|P4|STARTED|Overall Study||6
59035|NCT01418703|138528|P3|STARTED|Overall Study||6
59036|NCT01418703|138529|P2|STARTED|Overall Study||13
59037|NCT01418703|138530|P1|STARTED|Overall Study||13
59038|NCT01418365|138543|P2|NOT COMPLETED|Second Intervention||1
59039|NCT01418365|138544|P1|NOT COMPLETED|Second Intervention||0
59040|NCT01418365|138543|P2|COMPLETED|Second Intervention||13
59041|NCT01418365|138544|P1|COMPLETED|Second Intervention||14
59042|NCT01418365|138543|P2|STARTED|Second Intervention||14
59043|NCT01418365|138544|P1|STARTED|Second Intervention||14
59044|NCT01418365|138543|P2|NOT COMPLETED|First Intervention||1
59045|NCT01418365|138544|P1|NOT COMPLETED|First Intervention||1
59046|NCT01418365|138543|P2|COMPLETED|First Intervention||14
59047|NCT01418365|138544|P1|COMPLETED|First Intervention||14
59048|NCT01418365|138543|P2|STARTED|First Intervention||15
59049|NCT01418365|138544|P1|STARTED|First Intervention||15
59050|NCT01418209|138555|P3|NOT COMPLETED|Overall Study||4
59051|NCT01418209|138556|P2|NOT COMPLETED|Overall Study||3
59052|NCT01418209|138557|P1|NOT COMPLETED|Overall Study||2
59053|NCT01418209|138555|P3|COMPLETED|Overall Study||142
59054|NCT01418209|138556|P2|COMPLETED|Overall Study||93
59055|NCT01418209|138557|P1|COMPLETED|Overall Study||95
59056|NCT01418209|138555|P3|STARTED|Overall Study||146
59057|NCT01418209|138556|P2|STARTED|Overall Study||96
59058|NCT01418209|138557|P1|STARTED|Overall Study||97
59059|NCT01418001|138586|P1|NOT COMPLETED|Overall Study||0
59060|NCT01418001|138586|P1|COMPLETED|Overall Study||5
59061|NCT01418001|138586|P1|STARTED|Overall Study||5
59062|NCT01417936|138590|P1|NOT COMPLETED|Overall Study||0
59063|NCT01417936|138590|P1|COMPLETED|Overall Study||26
59064|NCT01417936|138590|P1|STARTED|Overall Study||26
59065|NCT01417481|138611|P2|NOT COMPLETED|Second Period (8 Weeks)||0
59066|NCT01417481|138612|P1|NOT COMPLETED|Second Period (8 Weeks)||0
59067|NCT01417481|138611|P2|COMPLETED|Second Period (8 Weeks)||5
59068|NCT01417481|138612|P1|COMPLETED|Second Period (8 Weeks)||8
59069|NCT01417481|138611|P2|STARTED|Second Period (8 Weeks)||5
59070|NCT01417481|138612|P1|STARTED|Second Period (8 Weeks)||8
59071|NCT01417481|138611|P2|NOT COMPLETED|Washout (2 Weeks)||0
59072|NCT01417481|138612|P1|NOT COMPLETED|Washout (2 Weeks)||0
59073|NCT01417481|138611|P2|COMPLETED|Washout (2 Weeks)||5
59074|NCT01417481|138612|P1|COMPLETED|Washout (2 Weeks)||8
59075|NCT01417481|138611|P2|STARTED|Washout (2 Weeks)||5
59076|NCT01417481|138612|P1|STARTED|Washout (2 Weeks)||8
59077|NCT01417481|138611|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
59078|NCT01417481|138612|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
59079|NCT01417481|138611|P2|COMPLETED|First Intervention (8 Weeks)||5
59080|NCT01417481|138612|P1|COMPLETED|First Intervention (8 Weeks)||8
59081|NCT01417481|138611|P2|STARTED|First Intervention (8 Weeks)||7
59082|NCT01417481|138612|P1|STARTED|First Intervention (8 Weeks)||8
59083|NCT01417455|138644|P8|NOT COMPLETED|Overall Study||0
59084|NCT01417455|138645|P7|NOT COMPLETED|Overall Study||0
59085|NCT01417455|138646|P6|NOT COMPLETED|Overall Study||0
59086|NCT01417455|138647|P5|NOT COMPLETED|Overall Study||0
59087|NCT01417455|138648|P4|NOT COMPLETED|Overall Study||0
59088|NCT01417455|138649|P3|NOT COMPLETED|Overall Study||0
59089|NCT01417455|138650|P2|NOT COMPLETED|Overall Study||0
59090|NCT01417455|138651|P1|NOT COMPLETED|Overall Study||0
59091|NCT01417455|138644|P8|COMPLETED|Overall Study||25
59092|NCT01417455|138645|P7|COMPLETED|Overall Study||13
59093|NCT01417455|138646|P6|COMPLETED|Overall Study||13
59094|NCT01417455|138647|P5|COMPLETED|Overall Study||30
59095|NCT01417455|138648|P4|COMPLETED|Overall Study||17
59096|NCT01417455|138649|P3|COMPLETED|Overall Study||17
59097|NCT01417455|138650|P2|COMPLETED|Overall Study||16
59098|NCT01417455|138651|P1|COMPLETED|Overall Study||16
59099|NCT01417455|138644|P8|STARTED|Overall Study||25
59100|NCT01417455|138645|P7|STARTED|Overall Study||13
59101|NCT01417455|138646|P6|STARTED|Overall Study||13
59102|NCT01417455|138647|P5|STARTED|Overall Study||30
59103|NCT01417455|138648|P4|STARTED|Overall Study||17
59104|NCT01417455|138649|P3|STARTED|Overall Study||17
59105|NCT01417455|138650|P2|STARTED|Overall Study||16
59106|NCT01417455|138651|P1|STARTED|Overall Study||16
59107|NCT01417377|138677|P1|NOT COMPLETED|Overall Study||13
59108|NCT01417377|138677|P1|COMPLETED|Overall Study||9
59109|NCT01417377|138677|P1|Treated|Overall Study||21
59110|NCT01417377|138677|P1|STARTED|Overall Study||22
59111|NCT01417195|138686|P2|NOT COMPLETED|Overall Study||1
59112|NCT01417195|138687|P1|NOT COMPLETED|Overall Study||3
59113|NCT01417195|138686|P2|COMPLETED|Overall Study||61
59114|NCT01417195|138687|P1|COMPLETED|Overall Study||57
59115|NCT01417195|138686|P2|STARTED|Overall Study||62
59116|NCT01417195|138687|P1|STARTED|Overall Study||60
59117|NCT01417104|138705|P2|NOT COMPLETED|Overall Study||2
59118|NCT01417104|138706|P1|NOT COMPLETED|Overall Study||6
59119|NCT01417104|138705|P2|COMPLETED|Overall Study||35
59120|NCT01417104|138706|P1|COMPLETED|Overall Study||28
59121|NCT01417104|138705|P2|STARTED|Overall Study||37
59122|NCT01417104|138706|P1|STARTED|Overall Study||34
59123|NCT01416610|138716|P1|NOT COMPLETED|Overall Study||43
59124|NCT01416610|138716|P1|COMPLETED|Overall Study||45
59125|NCT01416610|138716|P1|Completed Follow-up|Overall Study||45
59126|NCT01416610|138716|P1|Completed Treatment|Overall Study||47
59127|NCT01416610|138716|P1|Per Protocol|Overall Study||83
59128|NCT01416610|138716|P1|Safety Population|Overall Study||86
59129|NCT01416610|138716|P1|Intention to Treat|Overall Study||88
59130|NCT01416610|138716|P1|STARTED|Overall Study||88
59131|NCT01416571|138730|P1|NOT COMPLETED|Overall Study||2
59132|NCT01416571|138730|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
59133|NCT01416571|138730|P1|STARTED|Overall Study||78
59134|NCT01416272|138757|P1|NOT COMPLETED|Overall Study||4
59135|NCT01416272|138757|P1|COMPLETED|Overall Study||8
59136|NCT01416272|138757|P1|STARTED|Overall Study||12
59137|NCT01416155|138763|P1|NOT COMPLETED|Overall Study||58
59138|NCT01416155|138763|P1|COMPLETED|Overall Study||39
59139|NCT01416155|138763|P1|STARTED|Overall Study||97
59140|NCT01416142|138770|P3|NOT COMPLETED|PureVision2 HD||1
59141|NCT01416142|138771|P2|NOT COMPLETED|PureVision2 HD||0
59142|NCT01416142|138772|P1|NOT COMPLETED|PureVision2 HD||0
59143|NCT01416142|138770|P3|COMPLETED|PureVision2 HD||62
59144|NCT01416142|138771|P2|COMPLETED|PureVision2 HD||0
59145|NCT01416142|138772|P1|COMPLETED|PureVision2 HD||0
59146|NCT01416142|138770|P3|STARTED|PureVision2 HD||63
59147|NCT01416142|138771|P2|STARTED|PureVision2 HD||0
59148|NCT01416142|138772|P1|STARTED|PureVision2 HD||0
59149|NCT01416142|138770|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
59150|NCT01416142|138771|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
59151|NCT01416142|138772|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
59152|NCT01416142|138770|P3|COMPLETED|Cross Over at Movie Intermission||0
59153|NCT01416142|138771|P2|COMPLETED|Cross Over at Movie Intermission||31
59154|NCT01416142|138772|P1|COMPLETED|Cross Over at Movie Intermission||32
59155|NCT01416142|138770|P3|STARTED|Cross Over at Movie Intermission||0
59156|NCT01416142|138771|P2|STARTED|Cross Over at Movie Intermission||31
59157|NCT01416142|138772|P1|STARTED|Cross Over at Movie Intermission||32
59158|NCT01416129|138783|P2|NOT COMPLETED|Experimental Condition: Brimless||0
59159|NCT01416129|138784|P1|NOT COMPLETED|Experimental Condition: Brimless||0
59160|NCT01416129|138783|P2|COMPLETED|Experimental Condition: Brimless||5
59161|NCT01416129|138784|P1|COMPLETED|Experimental Condition: Brimless||5
59162|NCT01416129|138783|P2|STARTED|Experimental Condition: Brimless||5
59163|NCT01416129|138784|P1|STARTED|Experimental Condition: Brimless||5
59164|NCT01416129|138783|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
59165|NCT01416129|138784|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
59166|NCT01416129|138783|P2|COMPLETED|Control Condition: Ischial Containment||5
59167|NCT01416129|138784|P1|COMPLETED|Control Condition: Ischial Containment||5
59168|NCT01416129|138783|P2|STARTED|Control Condition: Ischial Containment||5
59169|NCT01416129|138784|P1|STARTED|Control Condition: Ischial Containment||5
59170|NCT01416025|138792|P2|NOT COMPLETED|Overall Study||0
59171|NCT01416025|138793|P1|NOT COMPLETED|Overall Study||0
59172|NCT01416025|138792|P2|COMPLETED|Overall Study||15
59173|NCT01416025|138793|P1|COMPLETED|Overall Study||14
59174|NCT01416025|138792|P2|STARTED|Overall Study||15
59175|NCT01416025|138793|P1|STARTED|Overall Study||14
59176|NCT01415986|138799|P1|NOT COMPLETED|Overall Study||1
59177|NCT01415986|138799|P1|COMPLETED|Overall Study|Study terminated|0
59178|NCT01415986|138799|P1|STARTED|Overall Study||1
59179|NCT01415960|138804|P1|NOT COMPLETED|Overall Study||12
59180|NCT01415960|138804|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
59181|NCT01415960|138804|P1|PK Subgroup|Overall Study||30
59182|NCT01415960|138804|P1|ITT|Overall Study||161
59183|NCT01415960|138804|P1|STARTED|Overall Study||163
59184|NCT01415921|138816|P2|NOT COMPLETED|Overall Study||3
59185|NCT01415921|138817|P1|NOT COMPLETED|Overall Study||3
59186|NCT01415921|138816|P2|COMPLETED|Overall Study||14
59187|NCT01415921|138817|P1|COMPLETED|Overall Study||13
59188|NCT01415921|138816|P2|STARTED|Overall Study||17
59189|NCT01415921|138817|P1|STARTED|Overall Study||16
59190|NCT01415908|138827|P2|NOT COMPLETED|Overall Study||0
59191|NCT01415908|138828|P1|NOT COMPLETED|Overall Study||1
59192|NCT01415908|138827|P2|COMPLETED|Overall Study||4
59193|NCT01415908|138828|P1|COMPLETED|Overall Study||10
59194|NCT01415908|138827|P2|STARTED|Overall Study||4
59195|NCT01415908|138828|P1|STARTED|Overall Study||11
59196|NCT01415531|138856|P2|NOT COMPLETED|Overall Study||37
59197|NCT01415531|138857|P1|NOT COMPLETED|Overall Study||25
59198|NCT01415531|138856|P2|COMPLETED|Overall Study||390
59199|NCT01415531|138857|P1|COMPLETED|Overall Study||189
59200|NCT01415531|138856|P2|STARTED|Overall Study||427
59201|NCT01415531|138857|P1|STARTED|Overall Study||214
59202|NCT01415518|138867|P2|NOT COMPLETED|Overall Study||31
59203|NCT01415518|138868|P1|NOT COMPLETED|Overall Study||16
59204|NCT01415518|138867|P2|COMPLETED|Overall Study||261
59205|NCT01415518|138868|P1|COMPLETED|Overall Study||276
59206|NCT01415518|138867|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
59207|NCT01415518|138868|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
59208|NCT01415518|138867|P2|Patients Who Received Study Treatment|Overall Study||292
59209|NCT01415518|138868|P1|Patients Who Received Study Treatment|Overall Study||290
59210|NCT01415518|138867|P2|STARTED|Overall Study||292
59211|NCT01415518|138868|P1|STARTED|Overall Study||292
59212|NCT01415453|138920|P1|NOT COMPLETED|Overall Study||0
59213|NCT01415453|138920|P1|COMPLETED|Overall Study||1
59214|NCT01415453|138920|P1|Imaging Study|Overall Study||1
59215|NCT01415453|138920|P1|STARTED|Overall Study||1
59216|NCT01415401|138924|P1|NOT COMPLETED|Overall Study||7
59217|NCT01415401|138924|P1|COMPLETED|Overall Study||47
59218|NCT01415401|138924|P1|STARTED|Overall Study||54
59219|NCT01415349|138929|P2|NOT COMPLETED|Treatment Period 2||0
59220|NCT01415349|138930|P1|NOT COMPLETED|Treatment Period 2||0
59221|NCT01415349|138929|P2|COMPLETED|Treatment Period 2||19
59222|NCT01415349|138930|P1|COMPLETED|Treatment Period 2||21
59223|NCT01415349|138929|P2|STARTED|Treatment Period 2||19
59224|NCT01415349|138930|P1|STARTED|Treatment Period 2||21
59225|NCT01415349|138929|P2|NOT COMPLETED|Treatment Period 1||2
59226|NCT01415349|138930|P1|NOT COMPLETED|Treatment Period 1||0
59227|NCT01415349|138929|P2|COMPLETED|Treatment Period 1||19
59228|NCT01415349|138930|P1|COMPLETED|Treatment Period 1||21
59229|NCT01415349|138929|P2|STARTED|Treatment Period 1||21
59230|NCT01415349|138930|P1|STARTED|Treatment Period 1||21
59231|NCT01415232|138938|P1|NOT COMPLETED|Overall Study||0
59232|NCT01415232|138938|P1|COMPLETED|Overall Study||160
59233|NCT01415232|138938|P1|STARTED|Overall Study||160
59234|NCT01414855|138942|P1|NOT COMPLETED|Overall Study||13
59235|NCT01414855|138942|P1|COMPLETED|Overall Study|Completed=Completed treatment.|87
59236|NCT01414855|138942|P1|STARTED|Overall Study||100
59237|NCT01414634|138958|P8|NOT COMPLETED|Overall Study||0
59238|NCT01414634|138959|P7|NOT COMPLETED|Overall Study||0
59239|NCT01414634|138960|P6|NOT COMPLETED|Overall Study||0
59240|NCT01414634|138961|P5|NOT COMPLETED|Overall Study||0
59241|NCT01414634|138962|P4|NOT COMPLETED|Overall Study||0
59242|NCT01414634|138963|P3|NOT COMPLETED|Overall Study||0
59243|NCT01414634|138964|P2|NOT COMPLETED|Overall Study||0
59244|NCT01414634|138965|P1|NOT COMPLETED|Overall Study||0
59245|NCT01414634|138958|P8|COMPLETED|Overall Study||1
59246|NCT01414634|138959|P7|COMPLETED|Overall Study||1
59247|NCT01414634|138960|P6|COMPLETED|Overall Study||2
59248|NCT01414634|138961|P5|COMPLETED|Overall Study||1
59249|NCT01414634|138962|P4|COMPLETED|Overall Study||1
59250|NCT01414634|138963|P3|COMPLETED|Overall Study||1
59251|NCT01414634|138964|P2|COMPLETED|Overall Study||1
59252|NCT01414634|138965|P1|COMPLETED|Overall Study||1
59253|NCT01414634|138958|P8|STARTED|Overall Study||1
59254|NCT01414634|138959|P7|STARTED|Overall Study||1
59255|NCT01414634|138960|P6|STARTED|Overall Study||2
59256|NCT01414634|138961|P5|STARTED|Overall Study||1
59257|NCT01414634|138962|P4|STARTED|Overall Study||1
59258|NCT01414634|138963|P3|STARTED|Overall Study||1
59259|NCT01414634|138964|P2|STARTED|Overall Study||1
59260|NCT01414634|138965|P1|STARTED|Overall Study||1
59261|NCT01414413|138978|P2|NOT COMPLETED|Overall Study||0
59262|NCT01414413|138979|P1|NOT COMPLETED|Overall Study||0
59263|NCT01414413|138978|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
59264|NCT01414413|138979|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
59265|NCT01414413|138978|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
59266|NCT01414413|138979|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
59267|NCT01412983|138991|P2|NOT COMPLETED|2nd Period||0
59268|NCT01412983|138992|P1|NOT COMPLETED|2nd Period||0
59269|NCT01412983|138991|P2|COMPLETED|2nd Period||46
59270|NCT01412983|138992|P1|COMPLETED|2nd Period||50
59271|NCT01412983|138991|P2|STARTED|2nd Period||46
59272|NCT01412983|138992|P1|STARTED|2nd Period||50
59273|NCT01412983|138991|P2|NOT COMPLETED|1st Period||4
59274|NCT01412983|138992|P1|NOT COMPLETED|1st Period||0
59275|NCT01412983|138991|P2|COMPLETED|1st Period||46
59276|NCT01412983|138992|P1|COMPLETED|1st Period||50
59277|NCT01412983|138991|P2|STARTED|1st Period||50
59278|NCT01412983|138992|P1|STARTED|1st Period||50
59279|NCT01414205|139002|P2|NOT COMPLETED|Overall Study||6
59280|NCT01414205|139003|P1|NOT COMPLETED|Overall Study||4
59281|NCT01414205|139002|P2|COMPLETED|Overall Study||33
59282|NCT01414205|139003|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|37
59283|NCT01414205|139002|P2|Received Study Drug|Overall Study||38
59284|NCT01414205|139003|P1|Received Study Drug|Overall Study||40
59285|NCT01414205|139002|P2|STARTED|Overall Study||39
59286|NCT01414205|139003|P1|STARTED|Overall Study||41
59287|NCT01414192|139033|P4|NOT COMPLETED|Overall Study||0
59288|NCT01414192|139034|P3|NOT COMPLETED|Overall Study||0
59289|NCT01414192|139035|P2|NOT COMPLETED|Overall Study||0
59290|NCT01414192|139036|P1|NOT COMPLETED|Overall Study||0
59291|NCT01414192|139033|P4|COMPLETED|Overall Study||1726
59292|NCT01414192|139034|P3|COMPLETED|Overall Study||424
59293|NCT01414192|139035|P2|COMPLETED|Overall Study||575
59294|NCT01414192|139036|P1|COMPLETED|Overall Study||490
59295|NCT01414192|139033|P4|STARTED|Overall Study||1726
59296|NCT01414192|139034|P3|STARTED|Overall Study||424
59297|NCT01414192|139035|P2|STARTED|Overall Study||575
59298|NCT01414192|139036|P1|STARTED|Overall Study||490
59299|NCT01414166|139066|P2|NOT COMPLETED|Overall Study||83
59300|NCT01414166|139067|P1|NOT COMPLETED|Overall Study||91
59301|NCT01414166|139066|P2|COMPLETED|Overall Study||39
59302|NCT01414166|139067|P1|COMPLETED|Overall Study||31
59303|NCT01414166|139066|P2|Treated|Overall Study||121
59304|NCT01414166|139067|P1|Treated|Overall Study||120
59305|NCT01414166|139066|P2|STARTED|Overall Study||122
59306|NCT01414166|139067|P1|STARTED|Overall Study||122
59307|NCT01414153|139093|P4|NOT COMPLETED|Overall Study||4
59308|NCT01414153|139094|P3|NOT COMPLETED|Overall Study||4
59309|NCT01414153|139095|P2|NOT COMPLETED|Overall Study||2
59310|NCT01414153|139096|P1|NOT COMPLETED|Overall Study||8
59311|NCT01414153|139093|P4|COMPLETED|Overall Study||37
59312|NCT01414153|139094|P3|COMPLETED|Overall Study||35
59313|NCT01414153|139095|P2|COMPLETED|Overall Study||38
59314|NCT01414153|139096|P1|COMPLETED|Overall Study||30
59315|NCT01414153|139093|P4|STARTED|Overall Study||41
59316|NCT01414153|139094|P3|STARTED|Overall Study||39
59317|NCT01414153|139095|P2|STARTED|Overall Study||40
59318|NCT01414153|139096|P1|STARTED|Overall Study||38
59319|NCT01414036|139132|P2|NOT COMPLETED|Completed 3 Month Survey||5
59320|NCT01414036|139133|P1|NOT COMPLETED|Completed 3 Month Survey||9
59321|NCT01414036|139132|P2|COMPLETED|Completed 3 Month Survey||19
59322|NCT01414036|139133|P1|COMPLETED|Completed 3 Month Survey||14
59323|NCT01414036|139132|P2|STARTED|Completed 3 Month Survey||24
59324|NCT01414036|139133|P1|STARTED|Completed 3 Month Survey||23
59325|NCT01414036|139132|P2|NOT COMPLETED|Received Allocated Intervention||13
59326|NCT01414036|139133|P1|NOT COMPLETED|Received Allocated Intervention||0
59327|NCT01414036|139132|P2|COMPLETED|Received Allocated Intervention||11
59328|NCT01414036|139133|P1|COMPLETED|Received Allocated Intervention||23
59329|NCT01414036|139132|P2|STARTED|Received Allocated Intervention||24
59330|NCT01414036|139133|P1|STARTED|Received Allocated Intervention||23
59331|NCT01413958|139145|P2|NOT COMPLETED|Overall Study||1
59332|NCT01413958|139146|P1|NOT COMPLETED|Overall Study||0
59333|NCT01413958|139145|P2|COMPLETED|Overall Study||286
59334|NCT01413958|139146|P1|COMPLETED|Overall Study||288
59335|NCT01413958|139145|P2|STARTED|Overall Study||287
59336|NCT01413958|139146|P1|STARTED|Overall Study||288
59337|NCT01413750|139181|P4|NOT COMPLETED|Overall Study||0
59338|NCT01413750|139182|P3|NOT COMPLETED|Overall Study||0
59339|NCT01413750|139183|P2|NOT COMPLETED|Overall Study||0
59340|NCT01413750|139184|P1|NOT COMPLETED|Overall Study||0
59341|NCT01413750|139181|P4|COMPLETED|Overall Study||7
59342|NCT01413750|139182|P3|COMPLETED|Overall Study||4
59343|NCT01413750|139183|P2|COMPLETED|Overall Study||6
59344|NCT01413750|139184|P1|COMPLETED|Overall Study||6
59345|NCT01413750|139181|P4|STARTED|Overall Study||7
59346|NCT01413750|139182|P3|STARTED|Overall Study||4
59347|NCT01413750|139183|P2|STARTED|Overall Study||6
59348|NCT01413750|139184|P1|STARTED|Overall Study||6
59349|NCT01413542|139197|P4|NOT COMPLETED|Overall Study||1
59350|NCT01413542|139198|P3|NOT COMPLETED|Overall Study||3
59351|NCT01413542|139199|P2|NOT COMPLETED|Overall Study||0
59352|NCT01413542|139200|P1|NOT COMPLETED|Overall Study||1
59353|NCT01413542|139197|P4|COMPLETED|Overall Study||7
59354|NCT01413542|139198|P3|COMPLETED|Overall Study||6
59355|NCT01413542|139199|P2|COMPLETED|Overall Study||6
59356|NCT01413542|139200|P1|COMPLETED|Overall Study||5
59357|NCT01413542|139197|P4|STARTED|Overall Study||8
59358|NCT01413542|139198|P3|STARTED|Overall Study||9
59359|NCT01413542|139199|P2|STARTED|Overall Study||6
59360|NCT01413542|139200|P1|STARTED|Overall Study||6
59361|NCT01413516|139215|P2|NOT COMPLETED|Overall Study||0
59362|NCT01413516|139216|P1|NOT COMPLETED|Overall Study||0
59363|NCT01413516|139215|P2|COMPLETED|Overall Study||9
59364|NCT01413516|139216|P1|COMPLETED|Overall Study||8
59365|NCT01413516|139215|P2|STARTED|Overall Study||9
59366|NCT01413516|139216|P1|STARTED|Overall Study||8
59367|NCT01413360|139222|P1|NOT COMPLETED|Overall Study||3
59368|NCT01413360|139222|P1|COMPLETED|Overall Study||7
59369|NCT01413360|139222|P1|STARTED|Overall Study||10
59370|NCT01413204|139230|P3|NOT COMPLETED|Overall Study||19
59371|NCT01413204|139231|P2|NOT COMPLETED|Overall Study||6
59372|NCT01413204|139232|P1|NOT COMPLETED|Overall Study||6
59373|NCT01413204|139230|P3|COMPLETED|Overall Study||74
59374|NCT01413204|139231|P2|COMPLETED|Overall Study||83
59375|NCT01413204|139232|P1|COMPLETED|Overall Study||84
59376|NCT01413204|139230|P3|STARTED|Overall Study||93
59377|NCT01413204|139231|P2|STARTED|Overall Study||89
59378|NCT01413204|139232|P1|STARTED|Overall Study||90
59379|NCT01413191|139240|P1|NOT COMPLETED|Overall Study||11
59380|NCT01413191|139240|P1|COMPLETED|Overall Study||7
59381|NCT01413191|139240|P1|STARTED|Overall Study||18
59382|NCT01412957|139246|P2|NOT COMPLETED|Overall Study||157
59383|NCT01412957|139247|P1|NOT COMPLETED|Overall Study||149
59384|NCT01412957|139246|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
59385|NCT01412957|139247|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
59386|NCT01412957|139246|P2|STARTED|Overall Study||188
59387|NCT01412957|139247|P1|STARTED|Overall Study||189
59388|NCT01412944|139269|P6|NOT COMPLETED|Follow-up||0
59389|NCT01412944|139270|P5|NOT COMPLETED|Follow-up||0
59390|NCT01412944|139271|P4|NOT COMPLETED|Follow-up||0
59391|NCT01412944|139272|P3|NOT COMPLETED|Follow-up||0
59392|NCT01412944|139273|P2|NOT COMPLETED|Follow-up||0
59393|NCT01412944|139274|P1|NOT COMPLETED|Follow-up||0
59394|NCT01412944|139269|P6|COMPLETED|Follow-up||0
59395|NCT01412944|139270|P5|COMPLETED|Follow-up||2
59396|NCT01412944|139271|P4|COMPLETED|Follow-up||1
59397|NCT01412944|139272|P3|COMPLETED|Follow-up||2
59398|NCT01412944|139273|P2|COMPLETED|Follow-up||0
59399|NCT01412944|139274|P1|COMPLETED|Follow-up||0
59400|NCT01412944|139269|P6|STARTED|Follow-up||0
59401|NCT01412944|139270|P5|STARTED|Follow-up||2
59402|NCT01412944|139271|P4|STARTED|Follow-up||1
59403|NCT01412944|139272|P3|STARTED|Follow-up||2
59404|NCT01412944|139273|P2|STARTED|Follow-up||0
59405|NCT01412944|139274|P1|STARTED|Follow-up||0
59406|NCT01412944|139269|P6|NOT COMPLETED|Entire: IV + Maintenance||0
59407|NCT01412944|139270|P5|NOT COMPLETED|Entire: IV + Maintenance||0
59408|NCT01412944|139271|P4|NOT COMPLETED|Entire: IV + Maintenance||0
59409|NCT01412944|139272|P3|NOT COMPLETED|Entire: IV + Maintenance||0
59410|NCT01412944|139273|P2|NOT COMPLETED|Entire: IV + Maintenance||5
59411|NCT01412944|139274|P1|NOT COMPLETED|Entire: IV + Maintenance||2
59412|NCT01412944|139269|P6|COMPLETED|Entire: IV + Maintenance||0
59413|NCT01412944|139270|P5|COMPLETED|Entire: IV + Maintenance||0
59414|NCT01412944|139271|P4|COMPLETED|Entire: IV + Maintenance||0
59415|NCT01412944|139272|P3|COMPLETED|Entire: IV + Maintenance||0
59416|NCT01412944|139273|P2|COMPLETED|Entire: IV + Maintenance||17
59417|NCT01412944|139274|P1|COMPLETED|Entire: IV + Maintenance||19
59418|NCT01412944|139269|P6|STARTED|Entire: IV + Maintenance||0
59419|NCT01412944|139270|P5|STARTED|Entire: IV + Maintenance||0
59420|NCT01412944|139271|P4|STARTED|Entire: IV + Maintenance||0
59421|NCT01412944|139272|P3|STARTED|Entire: IV + Maintenance||0
59422|NCT01412944|139273|P2|STARTED|Entire: IV + Maintenance||22
59423|NCT01412944|139274|P1|STARTED|Entire: IV + Maintenance||21
59424|NCT01412944|139269|P6|NOT COMPLETED|Entire: IV + Maintenance||2
59425|NCT01412944|139270|P5|NOT COMPLETED|Entire: IV + Maintenance||3
59426|NCT01412944|139271|P4|NOT COMPLETED|Entire: IV + Maintenance||1
59427|NCT01412944|139272|P3|NOT COMPLETED|Entire: IV + Maintenance||1
59428|NCT01412944|139273|P2|NOT COMPLETED|Entire: IV + Maintenance||0
59429|NCT01412944|139274|P1|NOT COMPLETED|Entire: IV + Maintenance||0
59430|NCT01412944|139269|P6|COMPLETED|Entire: IV + Maintenance||6
59431|NCT01412944|139270|P5|COMPLETED|Entire: IV + Maintenance||11
59432|NCT01412944|139271|P4|COMPLETED|Entire: IV + Maintenance||5
59433|NCT01412944|139272|P3|COMPLETED|Entire: IV + Maintenance||14
59434|NCT01412944|139273|P2|COMPLETED|Entire: IV + Maintenance||0
59435|NCT01412944|139274|P1|COMPLETED|Entire: IV + Maintenance||0
59436|NCT01412944|139269|P6|STARTED|Entire: IV + Maintenance||8
59437|NCT01412944|139270|P5|STARTED|Entire: IV + Maintenance||14
59438|NCT01412944|139271|P4|STARTED|Entire: IV + Maintenance||6
59439|NCT01412944|139272|P3|STARTED|Entire: IV + Maintenance||15
59440|NCT01412944|139273|P2|STARTED|Entire: IV + Maintenance||0
59441|NCT01412944|139274|P1|STARTED|Entire: IV + Maintenance||0
59442|NCT01412944|139269|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
59443|NCT01412944|139270|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
59444|NCT01412944|139271|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
59445|NCT01412944|139272|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
59446|NCT01412944|139273|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
59447|NCT01412944|139274|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
59448|NCT01412944|139269|P6|COMPLETED|IV: Per CAIN457A2307||0
59449|NCT01412944|139270|P5|COMPLETED|IV: Per CAIN457A2307||0
59450|NCT01412944|139271|P4|COMPLETED|IV: Per CAIN457A2307||0
59451|NCT01412944|139272|P3|COMPLETED|IV: Per CAIN457A2307||0
59452|NCT01412944|139273|P2|COMPLETED|IV: Per CAIN457A2307||20
59453|NCT01412944|139274|P1|COMPLETED|IV: Per CAIN457A2307||20
59454|NCT01412944|139269|P6|STARTED|IV: Per CAIN457A2307||0
59455|NCT01412944|139270|P5|STARTED|IV: Per CAIN457A2307||0
59456|NCT01412944|139271|P4|STARTED|IV: Per CAIN457A2307||0
59457|NCT01412944|139272|P3|STARTED|IV: Per CAIN457A2307||0
59458|NCT01412944|139273|P2|STARTED|IV: Per CAIN457A2307||22
59459|NCT01412944|139274|P1|STARTED|IV: Per CAIN457A2307||21
59460|NCT01412944|139269|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
59461|NCT01412944|139270|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59462|NCT01412944|139271|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59463|NCT01412944|139272|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
59464|NCT01412944|139273|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59465|NCT01412944|139274|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59466|NCT01412944|139269|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
59467|NCT01412944|139270|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
59468|NCT01412944|139271|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
59469|NCT01412944|139272|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
59470|NCT01412944|139273|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59471|NCT01412944|139274|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
59472|NCT01412944|139269|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
59473|NCT01412944|139270|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
59474|NCT01412944|139271|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
59475|NCT01412944|139272|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
59476|NCT01412944|139273|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
59477|NCT01412944|139274|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
59478|NCT01412918|139310|P2|NOT COMPLETED|Overall Study||0
59479|NCT01412918|139311|P1|NOT COMPLETED|Overall Study||0
59480|NCT01412918|139310|P2|COMPLETED|Overall Study||1
59481|NCT01412918|139311|P1|COMPLETED|Overall Study||20
59482|NCT01412918|139310|P2|STARTED|Overall Study||1
59483|NCT01412918|139311|P1|STARTED|Overall Study||20
59484|NCT01412801|139324|P6|NOT COMPLETED|Overall Study||3
59485|NCT01412801|139325|P5|NOT COMPLETED|Overall Study||3
59486|NCT01412801|139326|P4|NOT COMPLETED|Overall Study||4
59487|NCT01412801|139327|P3|NOT COMPLETED|Overall Study||7
59488|NCT01412801|139328|P2|NOT COMPLETED|Overall Study||5
59489|NCT01412801|139329|P1|NOT COMPLETED|Overall Study||4
59490|NCT01412801|139324|P6|COMPLETED|Overall Study||84
59491|NCT01412801|139325|P5|COMPLETED|Overall Study||85
59492|NCT01412801|139326|P4|COMPLETED|Overall Study||87
59493|NCT01412801|139327|P3|COMPLETED|Overall Study||83
59494|NCT01412801|139328|P2|COMPLETED|Overall Study||84
59495|NCT01412801|139329|P1|COMPLETED|Overall Study||87
59496|NCT01412801|139324|P6|STARTED|Overall Study||87
59497|NCT01412801|139325|P5|STARTED|Overall Study||88
59498|NCT01412801|139326|P4|STARTED|Overall Study||91
59499|NCT01412801|139327|P3|STARTED|Overall Study||90
59500|NCT01412801|139328|P2|STARTED|Overall Study||89
59501|NCT01412801|139329|P1|STARTED|Overall Study||91
59502|NCT01412541|139368|P2|NOT COMPLETED|Overall Study||20
59503|NCT01412541|139369|P1|NOT COMPLETED|Overall Study||36
59504|NCT01412541|139368|P2|COMPLETED|Overall Study||140
59505|NCT01412541|139369|P1|COMPLETED|Overall Study||280
59506|NCT01412541|139368|P2|STARTED|Overall Study||160
59507|NCT01412541|139369|P1|STARTED|Overall Study||316
59508|NCT01412424|139477|P1|NOT COMPLETED|Extension Treatment Period||6
59509|NCT01412424|139477|P1|COMPLETED|Extension Treatment Period||82
59510|NCT01412424|139477|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
59511|NCT01412424|139477|P1|NOT COMPLETED|Core Treatment Period||53
59512|NCT01412424|139477|P1|COMPLETED|Core Treatment Period||102
59513|NCT01412424|139477|P1|STARTED|Core Treatment Period||155
59514|NCT01412281|139497|P4|NOT COMPLETED|Overall Study||0
59515|NCT01412281|139498|P3|NOT COMPLETED|Overall Study||0
59516|NCT01412281|139499|P2|NOT COMPLETED|Overall Study||0
59517|NCT01412281|139500|P1|NOT COMPLETED|Overall Study||0
59518|NCT01412281|139497|P4|COMPLETED|Overall Study||110
59519|NCT01412281|139498|P3|COMPLETED|Overall Study||110
59520|NCT01412281|139499|P2|COMPLETED|Overall Study||110
59521|NCT01412281|139500|P1|COMPLETED|Overall Study||110
59522|NCT01412281|139497|P4|STARTED|Overall Study||110
59523|NCT01412281|139498|P3|STARTED|Overall Study||110
59524|NCT01412281|139499|P2|STARTED|Overall Study||110
59525|NCT01412281|139500|P1|STARTED|Overall Study||110
59526|NCT01412164|139522|P1|NOT COMPLETED|Overall Study||18
59527|NCT01412164|139522|P1|COMPLETED|Overall Study||712
59528|NCT01412164|139522|P1|STARTED|Overall Study||730
59529|NCT01412151|139526|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
59530|NCT01412151|139526|P1|COMPLETED|Week 306 - 310 - Washout Period||3
59531|NCT01412151|139526|P1|STARTED|Week 306 - 310 - Washout Period||5
59532|NCT01412151|139526|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
59533|NCT01412151|139526|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
59534|NCT01412151|139526|P1|STARTED|Week 0 - 306 - Treatment Period||10
59535|NCT01412086|139530|P1|NOT COMPLETED|Overall Study||0
59536|NCT01412086|139530|P1|COMPLETED|Overall Study||112
59537|NCT01412086|139530|P1|STARTED|Overall Study||112
59538|NCT01411891|139537|P2|NOT COMPLETED|Overall Study||2
59539|NCT01411891|139538|P1|NOT COMPLETED|Overall Study||3
59540|NCT01411891|139537|P2|COMPLETED|Overall Study||48
59541|NCT01411891|139538|P1|COMPLETED|Overall Study||47
59542|NCT01411891|139537|P2|STARTED|Overall Study||50
59543|NCT01411891|139538|P1|STARTED|Overall Study||50
59544|NCT01411852|139546|P2|NOT COMPLETED|Hospital Intervention Phase||18
59545|NCT01411852|139547|P1|NOT COMPLETED|Hospital Intervention Phase||24
59546|NCT01411852|139546|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
59547|NCT01411852|139547|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
59548|NCT01411852|139546|P2|STARTED|Hospital Intervention Phase||89
59549|NCT01411852|139547|P1|STARTED|Hospital Intervention Phase||83
59550|NCT01411852|139546|P2|NOT COMPLETED|Prehospital Intervention Phase||7
59551|NCT01411852|139547|P1|NOT COMPLETED|Prehospital Intervention Phase||12
59552|NCT01411852|139546|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
59553|NCT01411852|139547|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
59554|NCT01411852|139546|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
59555|NCT01411852|139547|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
59556|NCT01411696|139590|P1|NOT COMPLETED|Overall Study||0
59557|NCT01411696|139590|P1|COMPLETED|Overall Study||289
59558|NCT01411696|139590|P1|STARTED|Overall Study||289
59559|NCT01411592|139599|P2|NOT COMPLETED|Overall Study||0
59560|NCT01411592|139600|P1|NOT COMPLETED|Overall Study||0
59561|NCT01411592|139599|P2|COMPLETED|Overall Study||16
59562|NCT01411592|139600|P1|COMPLETED|Overall Study||14
59563|NCT01411592|139599|P2|5-Year Time Frame|Overall Study||16
59564|NCT01411592|139600|P1|5-Year Time Frame|Overall Study||14
59565|NCT01411592|139599|P2|STARTED|Overall Study||16
59566|NCT01411592|139600|P1|STARTED|Overall Study||14
59567|NCT01411501|139612|P4|NOT COMPLETED|Overall Study||7
59568|NCT01411501|139613|P3|NOT COMPLETED|Overall Study||6
59569|NCT01411501|139614|P2|NOT COMPLETED|Overall Study||6
59570|NCT01411501|139615|P1|NOT COMPLETED|Overall Study||10
59571|NCT01411501|139612|P4|COMPLETED|Overall Study||163
59572|NCT01411501|139613|P3|COMPLETED|Overall Study||159
59573|NCT01411501|139614|P2|COMPLETED|Overall Study||166
59574|NCT01411501|139615|P1|COMPLETED|Overall Study||158
59575|NCT01411501|139612|P4|STARTED|Overall Study||170
59576|NCT01411501|139613|P3|STARTED|Overall Study||165
59577|NCT01411501|139614|P2|STARTED|Overall Study||172
59578|NCT01411501|139615|P1|STARTED|Overall Study||168
59579|NCT01411228|139648|P3|NOT COMPLETED|Overall Study||1
59580|NCT01411228|139649|P2|NOT COMPLETED|Overall Study||0
59581|NCT01411228|139650|P1|NOT COMPLETED|Overall Study||1
59582|NCT01411228|139648|P3|COMPLETED|Overall Study||4
59583|NCT01411228|139649|P2|COMPLETED|Overall Study||5
59584|NCT01411228|139650|P1|COMPLETED|Overall Study||4
59585|NCT01411228|139648|P3|STARTED|Overall Study||5
59586|NCT01411228|139649|P2|STARTED|Overall Study||5
59587|NCT01411228|139650|P1|STARTED|Overall Study||5
59588|NCT01411215|139672|P2|NOT COMPLETED|Overall Study||84
59589|NCT01411215|139673|P1|NOT COMPLETED|Overall Study||66
59590|NCT01411215|139672|P2|COMPLETED|Overall Study||7
59591|NCT01411215|139673|P1|COMPLETED|Overall Study||3
59592|NCT01411215|139672|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
59593|NCT01411215|139673|P1|Treated|Overall Study||69
59594|NCT01411215|139672|P2|STARTED|Overall Study||91
59595|NCT01411215|139673|P1|STARTED|Overall Study||69
59596|NCT01410773|139706|P1|NOT COMPLETED|Overall Study||0
59597|NCT01410773|139706|P1|COMPLETED|Overall Study||110
59598|NCT01410773|139706|P1|STARTED|Overall Study||110
59599|NCT01410604|139713|P2|NOT COMPLETED|Overall Study||2
59600|NCT01410604|139714|P1|NOT COMPLETED|Overall Study||3
59601|NCT01410604|139713|P2|COMPLETED|Overall Study||14
59602|NCT01410604|139714|P1|COMPLETED|Overall Study||12
59603|NCT01410604|139713|P2|STARTED|Overall Study||16
59604|NCT01410604|139714|P1|STARTED|Overall Study||15
59605|NCT01410565|139736|P3|NOT COMPLETED|Double Blind Phase||0
59606|NCT01410565|139737|P2|NOT COMPLETED|Double Blind Phase||15
59607|NCT01410565|139738|P1|NOT COMPLETED|Double Blind Phase||13
59608|NCT01410565|139736|P3|COMPLETED|Double Blind Phase||0
59609|NCT01410565|139737|P2|COMPLETED|Double Blind Phase||0
59610|NCT01410565|139738|P1|COMPLETED|Double Blind Phase||0
59611|NCT01410565|139736|P3|STARTED|Double Blind Phase||0
59612|NCT01410565|139737|P2|STARTED|Double Blind Phase||15
59613|NCT01410565|139738|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
59614|NCT01410565|139736|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
59615|NCT01410565|139737|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
59616|NCT01410565|139738|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
59617|NCT01410565|139736|P3|COMPLETED|Open Label Phase Apaziquone||58
59618|NCT01410565|139737|P2|COMPLETED|Open Label Phase Apaziquone||0
59619|NCT01410565|139738|P1|COMPLETED|Open Label Phase Apaziquone||0
59620|NCT01410565|139736|P3|STARTED|Open Label Phase Apaziquone||66
59621|NCT01410565|139737|P2|STARTED|Open Label Phase Apaziquone||0
59622|NCT01410565|139738|P1|STARTED|Open Label Phase Apaziquone||0
59623|NCT01410474|139750|P2|NOT COMPLETED|Overall Study||1
59624|NCT01410474|139751|P1|NOT COMPLETED|Overall Study||0
59625|NCT01410474|139750|P2|COMPLETED|Overall Study||167
59626|NCT01410474|139751|P1|COMPLETED|Overall Study||173
59627|NCT01410474|139750|P2|STARTED|Overall Study||168
59628|NCT01410474|139751|P1|STARTED|Overall Study||173
59629|NCT01410409|139774|P2|NOT COMPLETED|Overall Study||4
59630|NCT01410409|139775|P1|NOT COMPLETED|Overall Study||1
59631|NCT01410409|139774|P2|COMPLETED|Overall Study||46
59632|NCT01410409|139775|P1|COMPLETED|Overall Study||49
59633|NCT01410409|139774|P2|STARTED|Overall Study||50
59634|NCT01410409|139775|P1|STARTED|Overall Study||50
59635|NCT01410240|139800|P3|NOT COMPLETED|Overall Study||2
59636|NCT01410240|139801|P2|NOT COMPLETED|Overall Study||1
59637|NCT01410240|139802|P1|NOT COMPLETED|Overall Study||1
59638|NCT01410240|139800|P3|COMPLETED|Overall Study||10
59639|NCT01410240|139801|P2|COMPLETED|Overall Study||52
59640|NCT01410240|139802|P1|COMPLETED|Overall Study||52
59641|NCT01410240|139800|P3|STARTED|Overall Study||12
59642|NCT01410240|139801|P2|STARTED|Overall Study||53
59643|NCT01410240|139802|P1|STARTED|Overall Study||53
59644|NCT01410227|139873|P4|NOT COMPLETED|Overall Study||1
59645|NCT01410227|139874|P3|NOT COMPLETED|Overall Study||2
59646|NCT01410227|139875|P2|NOT COMPLETED|Overall Study||0
59647|NCT01410227|139876|P1|NOT COMPLETED|Overall Study||4
59648|NCT01410227|139873|P4|COMPLETED|Overall Study||5
59649|NCT01410227|139874|P3|COMPLETED|Overall Study||13
59650|NCT01410227|139875|P2|COMPLETED|Overall Study||8
59651|NCT01410227|139876|P1|COMPLETED|Overall Study||4
59652|NCT01410227|139873|P4|STARTED|Overall Study||6
59653|NCT01410227|139874|P3|STARTED|Overall Study||15
59654|NCT01410227|139875|P2|STARTED|Overall Study||8
59655|NCT01410227|139876|P1|STARTED|Overall Study||8
59656|NCT01410110|139948|P2|NOT COMPLETED|Overall Study||2
59657|NCT01410110|139949|P1|NOT COMPLETED|Overall Study||4
59658|NCT01410110|139948|P2|COMPLETED|Overall Study||22
59659|NCT01410110|139949|P1|COMPLETED|Overall Study||20
59660|NCT01410110|139948|P2|6 Month Follow-up|Overall Study||22
59661|NCT01410110|139949|P1|6 Month Follow-up|Overall Study||20
59662|NCT01410110|139948|P2|3 Months (End of Intervention)|Overall Study||22
59663|NCT01410110|139949|P1|3 Months (End of Intervention)|Overall Study||20
59664|NCT01410110|139948|P2|Randomization|Overall Study||24
59665|NCT01410110|139949|P1|Randomization|Overall Study||24
59666|NCT01410110|139948|P2|STARTED|Overall Study||24
59667|NCT01410110|139949|P1|STARTED|Overall Study||24
59668|NCT01409837|139973|P2|NOT COMPLETED|Overall Study||2
59669|NCT01409837|139974|P1|NOT COMPLETED|Overall Study||3
59670|NCT01409837|139973|P2|COMPLETED|Overall Study||14
59671|NCT01409837|139974|P1|COMPLETED|Overall Study||14
59672|NCT01409837|139973|P2|282nd Week|Overall Study||14
59673|NCT01409837|139974|P1|282nd Week|Overall Study||14
59674|NCT01409837|139973|P2|186th Week|Overall Study||14
59675|NCT01409837|139974|P1|186th Week|Overall Study|Moved away to another location|14
59676|NCT01409837|139973|P2|138th Week|Overall Study||14
59677|NCT01409837|139974|P1|138th Week|Overall Study||15
59678|NCT01409837|139973|P2|114th Week|Overall Study||14
59679|NCT01409837|139974|P1|114th Week|Overall Study||15
59680|NCT01409837|139973|P2|102nd Week|Overall Study|Married another wife|14
59681|NCT01409837|139974|P1|102nd Week|Overall Study||15
59682|NCT01409837|139973|P2|96th Week|Overall Study||15
59683|NCT01409837|139974|P1|96th Week|Overall Study||15
59684|NCT01409837|139973|P2|48th Week|Overall Study||15
59685|NCT01409837|139974|P1|48th Week|Overall Study|Lost to follow-up|15
59686|NCT01409837|139973|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
59687|NCT01409837|139974|P1|24th Week|Overall Study||16
59688|NCT01409837|139973|P2|12th Week|Overall Study||16
59689|NCT01409837|139974|P1|12th Week|Overall Study|Moved away to another location|16
59690|NCT01409837|139973|P2|6th Week|Overall Study||16
59691|NCT01409837|139974|P1|6th Week|Overall Study||17
59692|NCT01409837|139973|P2|STARTED|Overall Study||16
59693|NCT01409837|139974|P1|STARTED|Overall Study||17
59694|NCT01409707|139999|P3|NOT COMPLETED|Overall Study||16
59695|NCT01409707|140000|P2|NOT COMPLETED|Overall Study||17
59696|NCT01409707|140001|P1|NOT COMPLETED|Overall Study||5
59697|NCT01409707|139999|P3|COMPLETED|Overall Study||24
59698|NCT01409707|140000|P2|COMPLETED|Overall Study||28
59699|NCT01409707|140001|P1|COMPLETED|Overall Study||36
59700|NCT01409707|139999|P3|STARTED|Overall Study||40
59701|NCT01409707|140000|P2|STARTED|Overall Study||45
59702|NCT01409707|140001|P1|STARTED|Overall Study||41
59703|NCT01408628|140011|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
59704|NCT01408628|140011|P1|COMPLETED|Completed 6 Month Follow-Up||25
59705|NCT01408628|140011|P1|STARTED|Completed 6 Month Follow-Up||39
59706|NCT01408628|140011|P1|NOT COMPLETED|Started Classes/Intervention||0
59707|NCT01408628|140011|P1|COMPLETED|Started Classes/Intervention||39
59708|NCT01408628|140011|P1|STARTED|Started Classes/Intervention||39
59709|NCT01408628|140011|P1|NOT COMPLETED|Consented||12
59710|NCT01408628|140011|P1|COMPLETED|Consented||39
59711|NCT01408628|140011|P1|STARTED|Consented||51
59712|NCT01408537|140017|P1|NOT COMPLETED|Overall Study||8
59713|NCT01408537|140017|P1|COMPLETED|Overall Study||144
59714|NCT01408537|140017|P1|STARTED|Overall Study||152
59715|NCT01408485|140033|P1|NOT COMPLETED|Overall Study||21
59716|NCT01408485|140033|P1|COMPLETED|Overall Study||179
59717|NCT01408485|140033|P1|STARTED|Overall Study||200
59718|NCT01409564|140041|P2|NOT COMPLETED|Overall Study||5
59719|NCT01409564|140042|P1|NOT COMPLETED|Overall Study||5
59720|NCT01409564|140041|P2|COMPLETED|Overall Study||18
59721|NCT01409564|140042|P1|COMPLETED|Overall Study||18
59722|NCT01409564|140041|P2|STARTED|Overall Study||23
59723|NCT01409564|140042|P1|STARTED|Overall Study||23
59724|NCT01409434|140060|P1|NOT COMPLETED|Overall Study||4
59725|NCT01409434|140060|P1|COMPLETED|Overall Study||40
59726|NCT01409434|140060|P1|STARTED|Overall Study||44
59727|NCT01409382|140070|P2|NOT COMPLETED|Overall Study||80
59728|NCT01409382|140071|P1|NOT COMPLETED|Overall Study||81
59729|NCT01409382|140070|P2|COMPLETED|Overall Study||160
59730|NCT01409382|140071|P1|COMPLETED|Overall Study||159
59731|NCT01409382|140070|P2|STARTED|Overall Study||240
59732|NCT01409382|140071|P1|STARTED|Overall Study||240
59733|NCT01409291|140085|P2|NOT COMPLETED|Overall Study||9
59734|NCT01409291|140086|P1|NOT COMPLETED|Overall Study||7
59735|NCT01409291|140085|P2|COMPLETED|Overall Study||19
59736|NCT01409291|140086|P1|COMPLETED|Overall Study||29
59737|NCT01409291|140085|P2|STARTED|Overall Study||28
59738|NCT01409291|140086|P1|STARTED|Overall Study||36
59739|NCT01409239|140096|P2|NOT COMPLETED|Overall Study||0
59740|NCT01409239|140097|P1|NOT COMPLETED|Overall Study||0
59741|NCT01409239|140096|P2|COMPLETED|Overall Study||17
59742|NCT01409239|140097|P1|COMPLETED|Overall Study||16
59743|NCT01409239|140096|P2|STARTED|Overall Study||17
59744|NCT01409239|140097|P1|STARTED|Overall Study||16
59745|NCT01409213|140103|P1|NOT COMPLETED|Overall Study||0
59746|NCT01409213|140103|P1|COMPLETED|Overall Study||1523
59747|NCT01409213|140103|P1|STARTED|Overall Study||1523
59748|NCT01409096|140110|P2|NOT COMPLETED|Overall Study||5
59749|NCT01409096|140111|P1|NOT COMPLETED|Overall Study||2
59750|NCT01409096|140110|P2|COMPLETED|Overall Study||35
59751|NCT01409096|140111|P1|COMPLETED|Overall Study||38
59752|NCT01409096|140110|P2|STARTED|Overall Study||40
59753|NCT01409096|140111|P1|STARTED|Overall Study||40
59754|NCT01408992|140123|P1|NOT COMPLETED|Overall Study||0
59755|NCT01408992|140123|P1|COMPLETED|Overall Study||558
59756|NCT01408992|140123|P1|STARTED|Overall Study||558
59757|NCT01408888|140135|P2|NOT COMPLETED|Second Intervention||0
59758|NCT01408888|140136|P1|NOT COMPLETED|Second Intervention||2
59759|NCT01408888|140135|P2|COMPLETED|Second Intervention||8
59760|NCT01408888|140136|P1|COMPLETED|Second Intervention||16
59761|NCT01408888|140135|P2|STARTED|Second Intervention||8
59762|NCT01408888|140136|P1|STARTED|Second Intervention||18
59763|NCT01408888|140135|P2|NOT COMPLETED|Washout of at Least 21 Days||0
59764|NCT01408888|140136|P1|NOT COMPLETED|Washout of at Least 21 Days||0
59765|NCT01408888|140135|P2|COMPLETED|Washout of at Least 21 Days||8
59766|NCT01408888|140136|P1|COMPLETED|Washout of at Least 21 Days||18
59767|NCT01408888|140135|P2|STARTED|Washout of at Least 21 Days||8
59768|NCT01408888|140136|P1|STARTED|Washout of at Least 21 Days||18
59769|NCT01408888|140135|P2|NOT COMPLETED|First Intervention||3
59770|NCT01408888|140136|P1|NOT COMPLETED|First Intervention||0
59771|NCT01408888|140135|P2|COMPLETED|First Intervention||8
59772|NCT01408888|140136|P1|COMPLETED|First Intervention||18
59773|NCT01408888|140135|P2|Received at Least 1 Dose of Drug|First Intervention||11
59774|NCT01408888|140136|P1|Received at Least 1 Dose of Drug|First Intervention||18
59775|NCT01408888|140135|P2|STARTED|First Intervention||11
59776|NCT01408888|140136|P1|STARTED|First Intervention||18
59777|NCT01408862|140159|P1|NOT COMPLETED|Overall Study||0
59778|NCT01408862|140159|P1|COMPLETED|Overall Study||20
59779|NCT01408862|140159|P1|STARTED|Overall Study||20
59780|NCT01408719|140184|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
59781|NCT01408719|140185|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
59782|NCT01408719|140186|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
59783|NCT01408719|140187|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
59784|NCT01408719|140188|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
59785|NCT01408719|140189|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
59786|NCT01408719|140190|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
59787|NCT01408719|140191|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
59788|NCT01408719|140192|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
59789|NCT01408719|140193|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
59790|NCT01408719|140194|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
59791|NCT01408719|140195|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
59792|NCT01408719|140196|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
59793|NCT01408719|140197|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
59794|NCT01408719|140198|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
59795|NCT01408719|140199|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
59796|NCT01408719|140200|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
59797|NCT01408719|140201|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
59798|NCT01408719|140202|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
59799|NCT01408719|140203|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
59800|NCT01408719|140184|P20|COMPLETED|Fourth Intervention (35 Days)||1
59801|NCT01408719|140185|P19|COMPLETED|Fourth Intervention (35 Days)||0
59802|NCT01408719|140186|P18|COMPLETED|Fourth Intervention (35 Days)||2
59803|NCT01408719|140187|P17|COMPLETED|Fourth Intervention (35 Days)||2
59804|NCT01408719|140188|P16|COMPLETED|Fourth Intervention (35 Days)||1
59805|NCT01408719|140189|P15|COMPLETED|Fourth Intervention (35 Days)||1
59806|NCT01408719|140190|P14|COMPLETED|Fourth Intervention (35 Days)||3
59807|NCT01408719|140191|P13|COMPLETED|Fourth Intervention (35 Days)||1
59808|NCT01408719|140192|P12|COMPLETED|Fourth Intervention (35 Days)||2
59809|NCT01408719|140193|P11|COMPLETED|Fourth Intervention (35 Days)||2
59810|NCT01408719|140194|P10|COMPLETED|Fourth Intervention (35 Days)||1
59811|NCT01408719|140195|P9|COMPLETED|Fourth Intervention (35 Days)||1
59812|NCT01408719|140196|P8|COMPLETED|Fourth Intervention (35 Days)||2
59813|NCT01408719|140197|P7|COMPLETED|Fourth Intervention (35 Days)||2
59814|NCT01408719|140198|P6|COMPLETED|Fourth Intervention (35 Days)||3
59815|NCT01408719|140199|P5|COMPLETED|Fourth Intervention (35 Days)||3
59816|NCT01408719|140200|P4|COMPLETED|Fourth Intervention (35 Days)||2
59817|NCT01408719|140201|P3|COMPLETED|Fourth Intervention (35 Days)||1
59818|NCT01408719|140202|P2|COMPLETED|Fourth Intervention (35 Days)||3
59819|NCT01408719|140203|P1|COMPLETED|Fourth Intervention (35 Days)||2
59820|NCT01408719|140184|P20|STARTED|Fourth Intervention (35 Days)||1
59821|NCT01408719|140185|P19|STARTED|Fourth Intervention (35 Days)||0
59822|NCT01408719|140186|P18|STARTED|Fourth Intervention (35 Days)||2
59823|NCT01408719|140187|P17|STARTED|Fourth Intervention (35 Days)||2
59824|NCT01408719|140188|P16|STARTED|Fourth Intervention (35 Days)||1
59825|NCT01408719|140189|P15|STARTED|Fourth Intervention (35 Days)||1
59826|NCT01408719|140190|P14|STARTED|Fourth Intervention (35 Days)||3
59827|NCT01408719|140191|P13|STARTED|Fourth Intervention (35 Days)||1
59828|NCT01408719|140192|P12|STARTED|Fourth Intervention (35 Days)||2
59829|NCT01408719|140193|P11|STARTED|Fourth Intervention (35 Days)||2
59830|NCT01408719|140194|P10|STARTED|Fourth Intervention (35 Days)||1
59831|NCT01408719|140195|P9|STARTED|Fourth Intervention (35 Days)||1
59832|NCT01408719|140196|P8|STARTED|Fourth Intervention (35 Days)||2
59833|NCT01408719|140197|P7|STARTED|Fourth Intervention (35 Days)||2
59834|NCT01408719|140198|P6|STARTED|Fourth Intervention (35 Days)||3
59835|NCT01408719|140199|P5|STARTED|Fourth Intervention (35 Days)||3
59836|NCT01408719|140200|P4|STARTED|Fourth Intervention (35 Days)||2
59837|NCT01408719|140201|P3|STARTED|Fourth Intervention (35 Days)||1
59838|NCT01408719|140202|P2|STARTED|Fourth Intervention (35 Days)||3
59839|NCT01408719|140203|P1|STARTED|Fourth Intervention (35 Days)||2
59840|NCT01408719|140184|P20|NOT COMPLETED|Washout Period (28 Days)||0
59841|NCT01408719|140185|P19|NOT COMPLETED|Washout Period (28 Days)||0
59842|NCT01408719|140186|P18|NOT COMPLETED|Washout Period (28 Days)||0
59843|NCT01408719|140187|P17|NOT COMPLETED|Washout Period (28 Days)||0
59844|NCT01408719|140188|P16|NOT COMPLETED|Washout Period (28 Days)||0
59845|NCT01408719|140189|P15|NOT COMPLETED|Washout Period (28 Days)||0
59846|NCT01408719|140190|P14|NOT COMPLETED|Washout Period (28 Days)||0
59847|NCT01408719|140191|P13|NOT COMPLETED|Washout Period (28 Days)||0
59848|NCT01408719|140192|P12|NOT COMPLETED|Washout Period (28 Days)||0
59849|NCT01408719|140193|P11|NOT COMPLETED|Washout Period (28 Days)||0
59850|NCT01408719|140194|P10|NOT COMPLETED|Washout Period (28 Days)||0
59851|NCT01408719|140195|P9|NOT COMPLETED|Washout Period (28 Days)||0
59852|NCT01408719|140196|P8|NOT COMPLETED|Washout Period (28 Days)||0
59853|NCT01408719|140197|P7|NOT COMPLETED|Washout Period (28 Days)||0
59854|NCT01408719|140198|P6|NOT COMPLETED|Washout Period (28 Days)||0
59855|NCT01408719|140199|P5|NOT COMPLETED|Washout Period (28 Days)||0
59856|NCT01408719|140200|P4|NOT COMPLETED|Washout Period (28 Days)||0
59857|NCT01408719|140201|P3|NOT COMPLETED|Washout Period (28 Days)||0
59858|NCT01408719|140202|P2|NOT COMPLETED|Washout Period (28 Days)||0
59859|NCT01408719|140203|P1|NOT COMPLETED|Washout Period (28 Days)||0
59860|NCT01408719|140184|P20|COMPLETED|Washout Period (28 Days)||1
59861|NCT01408719|140185|P19|COMPLETED|Washout Period (28 Days)||0
59862|NCT01408719|140186|P18|COMPLETED|Washout Period (28 Days)||2
59863|NCT01408719|140187|P17|COMPLETED|Washout Period (28 Days)||2
59864|NCT01408719|140188|P16|COMPLETED|Washout Period (28 Days)||1
59865|NCT01408719|140189|P15|COMPLETED|Washout Period (28 Days)||1
59866|NCT01408719|140190|P14|COMPLETED|Washout Period (28 Days)||3
59867|NCT01408719|140191|P13|COMPLETED|Washout Period (28 Days)||1
59868|NCT01408719|140192|P12|COMPLETED|Washout Period (28 Days)||2
59869|NCT01408719|140193|P11|COMPLETED|Washout Period (28 Days)||2
59870|NCT01408719|140194|P10|COMPLETED|Washout Period (28 Days)||1
59871|NCT01408719|140195|P9|COMPLETED|Washout Period (28 Days)||1
59872|NCT01408719|140196|P8|COMPLETED|Washout Period (28 Days)||2
59873|NCT01408719|140197|P7|COMPLETED|Washout Period (28 Days)||2
59874|NCT01408719|140198|P6|COMPLETED|Washout Period (28 Days)||3
59875|NCT01408719|140199|P5|COMPLETED|Washout Period (28 Days)||3
59876|NCT01408719|140200|P4|COMPLETED|Washout Period (28 Days)||2
59877|NCT01408719|140201|P3|COMPLETED|Washout Period (28 Days)||1
59878|NCT01408719|140202|P2|COMPLETED|Washout Period (28 Days)||3
59879|NCT01408719|140203|P1|COMPLETED|Washout Period (28 Days)||2
59880|NCT01408719|140184|P20|STARTED|Washout Period (28 Days)||1
59881|NCT01408719|140185|P19|STARTED|Washout Period (28 Days)||0
59882|NCT01408719|140186|P18|STARTED|Washout Period (28 Days)||2
59883|NCT01408719|140187|P17|STARTED|Washout Period (28 Days)||2
59884|NCT01408719|140188|P16|STARTED|Washout Period (28 Days)||1
59885|NCT01408719|140189|P15|STARTED|Washout Period (28 Days)||1
59886|NCT01408719|140190|P14|STARTED|Washout Period (28 Days)||3
59887|NCT01408719|140191|P13|STARTED|Washout Period (28 Days)||1
59888|NCT01408719|140192|P12|STARTED|Washout Period (28 Days)||2
59889|NCT01408719|140193|P11|STARTED|Washout Period (28 Days)||2
59890|NCT01408719|140194|P10|STARTED|Washout Period (28 Days)||1
59891|NCT01408719|140195|P9|STARTED|Washout Period (28 Days)||1
59892|NCT01408719|140196|P8|STARTED|Washout Period (28 Days)||2
59893|NCT01408719|140197|P7|STARTED|Washout Period (28 Days)||2
59894|NCT01408719|140198|P6|STARTED|Washout Period (28 Days)||3
59895|NCT01408719|140199|P5|STARTED|Washout Period (28 Days)||3
59896|NCT01408719|140200|P4|STARTED|Washout Period (28 Days)||2
59897|NCT01408719|140201|P3|STARTED|Washout Period (28 Days)||1
59898|NCT01408719|140202|P2|STARTED|Washout Period (28 Days)||3
59899|NCT01408719|140203|P1|STARTED|Washout Period (28 Days)||2
59900|NCT01408719|140184|P20|NOT COMPLETED|Third Intervention (35 Days)||0
59901|NCT01408719|140185|P19|NOT COMPLETED|Third Intervention (35 Days)||0
59902|NCT01408719|140186|P18|NOT COMPLETED|Third Intervention (35 Days)||0
59903|NCT01408719|140187|P17|NOT COMPLETED|Third Intervention (35 Days)||0
59904|NCT01408719|140188|P16|NOT COMPLETED|Third Intervention (35 Days)||0
59905|NCT01408719|140189|P15|NOT COMPLETED|Third Intervention (35 Days)||0
59906|NCT01408719|140190|P14|NOT COMPLETED|Third Intervention (35 Days)||0
59907|NCT01408719|140191|P13|NOT COMPLETED|Third Intervention (35 Days)||0
59908|NCT01408719|140192|P12|NOT COMPLETED|Third Intervention (35 Days)||0
59909|NCT01408719|140193|P11|NOT COMPLETED|Third Intervention (35 Days)||0
59910|NCT01408719|140194|P10|NOT COMPLETED|Third Intervention (35 Days)||0
59911|NCT01408719|140195|P9|NOT COMPLETED|Third Intervention (35 Days)||0
59912|NCT01408719|140196|P8|NOT COMPLETED|Third Intervention (35 Days)||1
59913|NCT01408719|140197|P7|NOT COMPLETED|Third Intervention (35 Days)||0
59914|NCT01408719|140198|P6|NOT COMPLETED|Third Intervention (35 Days)||0
59915|NCT01408719|140199|P5|NOT COMPLETED|Third Intervention (35 Days)||0
59916|NCT01408719|140200|P4|NOT COMPLETED|Third Intervention (35 Days)||0
59917|NCT01408719|140201|P3|NOT COMPLETED|Third Intervention (35 Days)||0
59918|NCT01408719|140202|P2|NOT COMPLETED|Third Intervention (35 Days)||0
59919|NCT01408719|140203|P1|NOT COMPLETED|Third Intervention (35 Days)||0
59920|NCT01408719|140184|P20|COMPLETED|Third Intervention (35 Days)||1
59921|NCT01408719|140185|P19|COMPLETED|Third Intervention (35 Days)||0
59922|NCT01408719|140186|P18|COMPLETED|Third Intervention (35 Days)||2
59923|NCT01408719|140187|P17|COMPLETED|Third Intervention (35 Days)||2
59924|NCT01408719|140188|P16|COMPLETED|Third Intervention (35 Days)||1
59925|NCT01408719|140189|P15|COMPLETED|Third Intervention (35 Days)||1
59926|NCT01408719|140190|P14|COMPLETED|Third Intervention (35 Days)||3
59927|NCT01408719|140191|P13|COMPLETED|Third Intervention (35 Days)||2
59928|NCT01408719|140192|P12|COMPLETED|Third Intervention (35 Days)||2
59929|NCT01408719|140193|P11|COMPLETED|Third Intervention (35 Days)||2
59930|NCT01408719|140194|P10|COMPLETED|Third Intervention (35 Days)||1
59931|NCT01408719|140195|P9|COMPLETED|Third Intervention (35 Days)||1
59932|NCT01408719|140196|P8|COMPLETED|Third Intervention (35 Days)||2
59933|NCT01408719|140197|P7|COMPLETED|Third Intervention (35 Days)||2
59934|NCT01408719|140198|P6|COMPLETED|Third Intervention (35 Days)||3
59935|NCT01408719|140199|P5|COMPLETED|Third Intervention (35 Days)||3
59936|NCT01408719|140200|P4|COMPLETED|Third Intervention (35 Days)||2
59937|NCT01408719|140201|P3|COMPLETED|Third Intervention (35 Days)||1
59938|NCT01408719|140202|P2|COMPLETED|Third Intervention (35 Days)||3
59939|NCT01408719|140203|P1|COMPLETED|Third Intervention (35 Days)||2
59940|NCT01408719|140184|P20|STARTED|Third Intervention (35 Days)||1
59941|NCT01408719|140185|P19|STARTED|Third Intervention (35 Days)||0
59942|NCT01408719|140186|P18|STARTED|Third Intervention (35 Days)||2
59943|NCT01408719|140187|P17|STARTED|Third Intervention (35 Days)||2
59944|NCT01408719|140188|P16|STARTED|Third Intervention (35 Days)||1
59945|NCT01408719|140189|P15|STARTED|Third Intervention (35 Days)||1
59946|NCT01408719|140190|P14|STARTED|Third Intervention (35 Days)||3
59947|NCT01408719|140191|P13|STARTED|Third Intervention (35 Days)||2
59948|NCT01408719|140192|P12|STARTED|Third Intervention (35 Days)||2
59949|NCT01408719|140193|P11|STARTED|Third Intervention (35 Days)||2
59950|NCT01408719|140194|P10|STARTED|Third Intervention (35 Days)||1
59951|NCT01408719|140195|P9|STARTED|Third Intervention (35 Days)||1
59952|NCT01408719|140196|P8|STARTED|Third Intervention (35 Days)||3
59953|NCT01408719|140197|P7|STARTED|Third Intervention (35 Days)||2
59954|NCT01408719|140198|P6|STARTED|Third Intervention (35 Days)||3
59955|NCT01408719|140199|P5|STARTED|Third Intervention (35 Days)||3
59956|NCT01408719|140200|P4|STARTED|Third Intervention (35 Days)||2
59957|NCT01408719|140201|P3|STARTED|Third Intervention (35 Days)||1
59958|NCT01408719|140202|P2|STARTED|Third Intervention (35 Days)||3
59959|NCT01408719|140203|P1|STARTED|Third Intervention (35 Days)||2
59960|NCT01408719|140184|P20|NOT COMPLETED|Washout Period (28 Days)||0
59961|NCT01408719|140185|P19|NOT COMPLETED|Washout Period (28 Days)||0
59962|NCT01408719|140186|P18|NOT COMPLETED|Washout Period (28 Days)||0
59963|NCT01408719|140187|P17|NOT COMPLETED|Washout Period (28 Days)||0
59964|NCT01408719|140188|P16|NOT COMPLETED|Washout Period (28 Days)||0
59965|NCT01408719|140189|P15|NOT COMPLETED|Washout Period (28 Days)||0
59966|NCT01408719|140190|P14|NOT COMPLETED|Washout Period (28 Days)||0
59967|NCT01408719|140191|P13|NOT COMPLETED|Washout Period (28 Days)||0
59968|NCT01408719|140192|P12|NOT COMPLETED|Washout Period (28 Days)||0
59969|NCT01408719|140193|P11|NOT COMPLETED|Washout Period (28 Days)||0
59970|NCT01408719|140194|P10|NOT COMPLETED|Washout Period (28 Days)||0
59971|NCT01408719|140195|P9|NOT COMPLETED|Washout Period (28 Days)||0
59972|NCT01408719|140196|P8|NOT COMPLETED|Washout Period (28 Days)||0
59973|NCT01408719|140197|P7|NOT COMPLETED|Washout Period (28 Days)||0
59974|NCT01408719|140198|P6|NOT COMPLETED|Washout Period (28 Days)||0
59975|NCT01408719|140199|P5|NOT COMPLETED|Washout Period (28 Days)||0
59976|NCT01408719|140200|P4|NOT COMPLETED|Washout Period (28 Days)||0
59977|NCT01408719|140201|P3|NOT COMPLETED|Washout Period (28 Days)||0
59978|NCT01408719|140202|P2|NOT COMPLETED|Washout Period (28 Days)||0
59979|NCT01408719|140203|P1|NOT COMPLETED|Washout Period (28 Days)||0
59980|NCT01408719|140184|P20|COMPLETED|Washout Period (28 Days)||1
59981|NCT01408719|140185|P19|COMPLETED|Washout Period (28 Days)||0
59982|NCT01408719|140186|P18|COMPLETED|Washout Period (28 Days)||2
59983|NCT01408719|140187|P17|COMPLETED|Washout Period (28 Days)||2
59984|NCT01408719|140188|P16|COMPLETED|Washout Period (28 Days)||1
59985|NCT01408719|140189|P15|COMPLETED|Washout Period (28 Days)||1
59986|NCT01408719|140190|P14|COMPLETED|Washout Period (28 Days)||3
59987|NCT01408719|140191|P13|COMPLETED|Washout Period (28 Days)||2
59988|NCT01408719|140192|P12|COMPLETED|Washout Period (28 Days)||2
59989|NCT01408719|140193|P11|COMPLETED|Washout Period (28 Days)||2
59990|NCT01408719|140194|P10|COMPLETED|Washout Period (28 Days)||1
59991|NCT01408719|140195|P9|COMPLETED|Washout Period (28 Days)||1
59992|NCT01408719|140196|P8|COMPLETED|Washout Period (28 Days)||3
59993|NCT01408719|140197|P7|COMPLETED|Washout Period (28 Days)||2
59994|NCT01408719|140198|P6|COMPLETED|Washout Period (28 Days)||3
59995|NCT01408719|140199|P5|COMPLETED|Washout Period (28 Days)||3
59996|NCT01408719|140200|P4|COMPLETED|Washout Period (28 Days)||2
59997|NCT01408719|140201|P3|COMPLETED|Washout Period (28 Days)||1
59998|NCT01408719|140202|P2|COMPLETED|Washout Period (28 Days)||3
59999|NCT01408719|140203|P1|COMPLETED|Washout Period (28 Days)||2
60000|NCT01408719|140184|P20|STARTED|Washout Period (28 Days)||1
60001|NCT01408719|140185|P19|STARTED|Washout Period (28 Days)||0
60002|NCT01408719|140186|P18|STARTED|Washout Period (28 Days)||2
60003|NCT01408719|140187|P17|STARTED|Washout Period (28 Days)||2
60004|NCT01408719|140188|P16|STARTED|Washout Period (28 Days)||1
60005|NCT01408719|140189|P15|STARTED|Washout Period (28 Days)||1
60006|NCT01408719|140190|P14|STARTED|Washout Period (28 Days)||3
60007|NCT01408719|140191|P13|STARTED|Washout Period (28 Days)||2
60008|NCT01408719|140192|P12|STARTED|Washout Period (28 Days)||2
60009|NCT01408719|140193|P11|STARTED|Washout Period (28 Days)||2
60010|NCT01408719|140194|P10|STARTED|Washout Period (28 Days)||1
60011|NCT01408719|140195|P9|STARTED|Washout Period (28 Days)||1
60012|NCT01408719|140196|P8|STARTED|Washout Period (28 Days)||3
60013|NCT01408719|140197|P7|STARTED|Washout Period (28 Days)||2
60014|NCT01408719|140198|P6|STARTED|Washout Period (28 Days)||3
60015|NCT01408719|140199|P5|STARTED|Washout Period (28 Days)||3
60016|NCT01408719|140200|P4|STARTED|Washout Period (28 Days)||2
60017|NCT01408719|140201|P3|STARTED|Washout Period (28 Days)||1
60018|NCT01408719|140202|P2|STARTED|Washout Period (28 Days)||3
60019|NCT01408719|140203|P1|STARTED|Washout Period (28 Days)||2
60020|NCT01408719|140184|P20|NOT COMPLETED|Second Intervention (35 Days)||0
60021|NCT01408719|140185|P19|NOT COMPLETED|Second Intervention (35 Days)||0
60022|NCT01408719|140186|P18|NOT COMPLETED|Second Intervention (35 Days)||0
60023|NCT01408719|140187|P17|NOT COMPLETED|Second Intervention (35 Days)||0
60024|NCT01408719|140188|P16|NOT COMPLETED|Second Intervention (35 Days)||0
60025|NCT01408719|140189|P15|NOT COMPLETED|Second Intervention (35 Days)||0
60026|NCT01408719|140190|P14|NOT COMPLETED|Second Intervention (35 Days)||1
60027|NCT01408719|140191|P13|NOT COMPLETED|Second Intervention (35 Days)||0
60028|NCT01408719|140192|P12|NOT COMPLETED|Second Intervention (35 Days)||0
60029|NCT01408719|140193|P11|NOT COMPLETED|Second Intervention (35 Days)||0
60030|NCT01408719|140194|P10|NOT COMPLETED|Second Intervention (35 Days)||0
60031|NCT01408719|140195|P9|NOT COMPLETED|Second Intervention (35 Days)||0
60032|NCT01408719|140196|P8|NOT COMPLETED|Second Intervention (35 Days)||0
60033|NCT01408719|140197|P7|NOT COMPLETED|Second Intervention (35 Days)||0
60034|NCT01408719|140198|P6|NOT COMPLETED|Second Intervention (35 Days)||0
60035|NCT01408719|140199|P5|NOT COMPLETED|Second Intervention (35 Days)||0
60036|NCT01408719|140200|P4|NOT COMPLETED|Second Intervention (35 Days)||0
60037|NCT01408719|140201|P3|NOT COMPLETED|Second Intervention (35 Days)||0
60038|NCT01408719|140202|P2|NOT COMPLETED|Second Intervention (35 Days)||0
60039|NCT01408719|140203|P1|NOT COMPLETED|Second Intervention (35 Days)||0
60040|NCT01408719|140184|P20|COMPLETED|Second Intervention (35 Days)||1
60041|NCT01408719|140185|P19|COMPLETED|Second Intervention (35 Days)||0
60042|NCT01408719|140186|P18|COMPLETED|Second Intervention (35 Days)||2
60043|NCT01408719|140187|P17|COMPLETED|Second Intervention (35 Days)||2
60044|NCT01408719|140188|P16|COMPLETED|Second Intervention (35 Days)||2
60045|NCT01408719|140189|P15|COMPLETED|Second Intervention (35 Days)||1
60046|NCT01408719|140190|P14|COMPLETED|Second Intervention (35 Days)||3
60047|NCT01408719|140191|P13|COMPLETED|Second Intervention (35 Days)||2
60048|NCT01408719|140192|P12|COMPLETED|Second Intervention (35 Days)||2
60049|NCT01408719|140193|P11|COMPLETED|Second Intervention (35 Days)||2
60050|NCT01408719|140194|P10|COMPLETED|Second Intervention (35 Days)||1
60051|NCT01408719|140195|P9|COMPLETED|Second Intervention (35 Days)||1
60052|NCT01408719|140196|P8|COMPLETED|Second Intervention (35 Days)||3
60053|NCT01408719|140197|P7|COMPLETED|Second Intervention (35 Days)||2
60054|NCT01408719|140198|P6|COMPLETED|Second Intervention (35 Days)||3
60055|NCT01408719|140199|P5|COMPLETED|Second Intervention (35 Days)||3
60056|NCT01408719|140200|P4|COMPLETED|Second Intervention (35 Days)||2
60057|NCT01408719|140201|P3|COMPLETED|Second Intervention (35 Days)||1
60058|NCT01408719|140202|P2|COMPLETED|Second Intervention (35 Days)||3
60059|NCT01408719|140203|P1|COMPLETED|Second Intervention (35 Days)||2
60060|NCT01408719|140184|P20|STARTED|Second Intervention (35 Days)||1
60061|NCT01408719|140185|P19|STARTED|Second Intervention (35 Days)||0
60062|NCT01408719|140186|P18|STARTED|Second Intervention (35 Days)||2
60063|NCT01408719|140187|P17|STARTED|Second Intervention (35 Days)||2
60064|NCT01408719|140188|P16|STARTED|Second Intervention (35 Days)||2
60065|NCT01408719|140189|P15|STARTED|Second Intervention (35 Days)||1
60066|NCT01408719|140190|P14|STARTED|Second Intervention (35 Days)||4
60067|NCT01408719|140191|P13|STARTED|Second Intervention (35 Days)||2
60068|NCT01408719|140192|P12|STARTED|Second Intervention (35 Days)||2
60069|NCT01408719|140193|P11|STARTED|Second Intervention (35 Days)||2
60070|NCT01408719|140194|P10|STARTED|Second Intervention (35 Days)||1
60071|NCT01408719|140195|P9|STARTED|Second Intervention (35 Days)||1
60072|NCT01408719|140196|P8|STARTED|Second Intervention (35 Days)||3
60073|NCT01408719|140197|P7|STARTED|Second Intervention (35 Days)||2
60074|NCT01408719|140198|P6|STARTED|Second Intervention (35 Days)||3
60075|NCT01408719|140199|P5|STARTED|Second Intervention (35 Days)||3
60076|NCT01408719|140200|P4|STARTED|Second Intervention (35 Days)||2
60077|NCT01408719|140201|P3|STARTED|Second Intervention (35 Days)||1
60078|NCT01408719|140202|P2|STARTED|Second Intervention (35 Days)||3
60079|NCT01408719|140203|P1|STARTED|Second Intervention (35 Days)||2
60080|NCT01408719|140184|P20|NOT COMPLETED|Washout Period (28 Days)||0
60081|NCT01408719|140185|P19|NOT COMPLETED|Washout Period (28 Days)||0
60082|NCT01408719|140186|P18|NOT COMPLETED|Washout Period (28 Days)||0
60083|NCT01408719|140187|P17|NOT COMPLETED|Washout Period (28 Days)||0
60084|NCT01408719|140188|P16|NOT COMPLETED|Washout Period (28 Days)||0
60085|NCT01408719|140189|P15|NOT COMPLETED|Washout Period (28 Days)||0
60086|NCT01408719|140190|P14|NOT COMPLETED|Washout Period (28 Days)||0
60087|NCT01408719|140191|P13|NOT COMPLETED|Washout Period (28 Days)||0
60088|NCT01408719|140192|P12|NOT COMPLETED|Washout Period (28 Days)||0
60089|NCT01408719|140193|P11|NOT COMPLETED|Washout Period (28 Days)||0
60090|NCT01408719|140194|P10|NOT COMPLETED|Washout Period (28 Days)||0
60091|NCT01408719|140195|P9|NOT COMPLETED|Washout Period (28 Days)||0
60092|NCT01408719|140196|P8|NOT COMPLETED|Washout Period (28 Days)||0
60093|NCT01408719|140197|P7|NOT COMPLETED|Washout Period (28 Days)||0
60094|NCT01408719|140198|P6|NOT COMPLETED|Washout Period (28 Days)||0
60095|NCT01408719|140199|P5|NOT COMPLETED|Washout Period (28 Days)||0
60096|NCT01408719|140200|P4|NOT COMPLETED|Washout Period (28 Days)||0
60097|NCT01408719|140201|P3|NOT COMPLETED|Washout Period (28 Days)||0
60098|NCT01408719|140202|P2|NOT COMPLETED|Washout Period (28 Days)||0
60099|NCT01408719|140203|P1|NOT COMPLETED|Washout Period (28 Days)||0
60100|NCT01408719|140184|P20|COMPLETED|Washout Period (28 Days)||1
60101|NCT01408719|140185|P19|COMPLETED|Washout Period (28 Days)||0
60102|NCT01408719|140186|P18|COMPLETED|Washout Period (28 Days)||2
60103|NCT01408719|140187|P17|COMPLETED|Washout Period (28 Days)||2
60104|NCT01408719|140188|P16|COMPLETED|Washout Period (28 Days)||2
60105|NCT01408719|140189|P15|COMPLETED|Washout Period (28 Days)||1
60106|NCT01408719|140190|P14|COMPLETED|Washout Period (28 Days)||4
60107|NCT01408719|140191|P13|COMPLETED|Washout Period (28 Days)||2
60108|NCT01408719|140192|P12|COMPLETED|Washout Period (28 Days)||2
60109|NCT01408719|140193|P11|COMPLETED|Washout Period (28 Days)||2
60110|NCT01408719|140194|P10|COMPLETED|Washout Period (28 Days)||1
60111|NCT01408719|140195|P9|COMPLETED|Washout Period (28 Days)||1
60112|NCT01408719|140196|P8|COMPLETED|Washout Period (28 Days)||3
60113|NCT01408719|140197|P7|COMPLETED|Washout Period (28 Days)||2
60114|NCT01408719|140198|P6|COMPLETED|Washout Period (28 Days)||3
60115|NCT01408719|140199|P5|COMPLETED|Washout Period (28 Days)||3
60116|NCT01408719|140200|P4|COMPLETED|Washout Period (28 Days)||2
60117|NCT01408719|140201|P3|COMPLETED|Washout Period (28 Days)||1
60118|NCT01408719|140202|P2|COMPLETED|Washout Period (28 Days)||3
60119|NCT01408719|140203|P1|COMPLETED|Washout Period (28 Days)||2
60120|NCT01408719|140184|P20|STARTED|Washout Period (28 Days)||1
60121|NCT01408719|140185|P19|STARTED|Washout Period (28 Days)||0
60122|NCT01408719|140186|P18|STARTED|Washout Period (28 Days)||2
60123|NCT01408719|140187|P17|STARTED|Washout Period (28 Days)||2
60124|NCT01408719|140188|P16|STARTED|Washout Period (28 Days)||2
60125|NCT01408719|140189|P15|STARTED|Washout Period (28 Days)||1
60126|NCT01408719|140190|P14|STARTED|Washout Period (28 Days)||4
60127|NCT01408719|140191|P13|STARTED|Washout Period (28 Days)||2
60128|NCT01408719|140192|P12|STARTED|Washout Period (28 Days)||2
60129|NCT01408719|140193|P11|STARTED|Washout Period (28 Days)||2
60130|NCT01408719|140194|P10|STARTED|Washout Period (28 Days)||1
60131|NCT01408719|140195|P9|STARTED|Washout Period (28 Days)||1
60132|NCT01408719|140196|P8|STARTED|Washout Period (28 Days)||3
60133|NCT01408719|140197|P7|STARTED|Washout Period (28 Days)||2
60134|NCT01408719|140198|P6|STARTED|Washout Period (28 Days)||3
60135|NCT01408719|140199|P5|STARTED|Washout Period (28 Days)||3
60136|NCT01408719|140200|P4|STARTED|Washout Period (28 Days)||2
60137|NCT01408719|140201|P3|STARTED|Washout Period (28 Days)||1
60138|NCT01408719|140202|P2|STARTED|Washout Period (28 Days)||3
60139|NCT01408719|140203|P1|STARTED|Washout Period (28 Days)||2
60140|NCT01408719|140184|P20|NOT COMPLETED|First Intervention (35 Days)||0
60141|NCT01408719|140185|P19|NOT COMPLETED|First Intervention (35 Days)||1
60142|NCT01408719|140186|P18|NOT COMPLETED|First Intervention (35 Days)||0
60143|NCT01408719|140187|P17|NOT COMPLETED|First Intervention (35 Days)||1
60144|NCT01408719|140188|P16|NOT COMPLETED|First Intervention (35 Days)||0
60145|NCT01408719|140189|P15|NOT COMPLETED|First Intervention (35 Days)||0
60146|NCT01408719|140190|P14|NOT COMPLETED|First Intervention (35 Days)||1
60147|NCT01408719|140191|P13|NOT COMPLETED|First Intervention (35 Days)||0
60148|NCT01408719|140192|P12|NOT COMPLETED|First Intervention (35 Days)||0
60149|NCT01408719|140193|P11|NOT COMPLETED|First Intervention (35 Days)||0
60150|NCT01408719|140194|P10|NOT COMPLETED|First Intervention (35 Days)||0
60151|NCT01408719|140195|P9|NOT COMPLETED|First Intervention (35 Days)||1
60152|NCT01408719|140196|P8|NOT COMPLETED|First Intervention (35 Days)||0
60153|NCT01408719|140197|P7|NOT COMPLETED|First Intervention (35 Days)||0
60154|NCT01408719|140198|P6|NOT COMPLETED|First Intervention (35 Days)||0
60155|NCT01408719|140199|P5|NOT COMPLETED|First Intervention (35 Days)||1
60156|NCT01408719|140200|P4|NOT COMPLETED|First Intervention (35 Days)||0
60157|NCT01408719|140201|P3|NOT COMPLETED|First Intervention (35 Days)||1
60158|NCT01408719|140202|P2|NOT COMPLETED|First Intervention (35 Days)||0
60159|NCT01408719|140203|P1|NOT COMPLETED|First Intervention (35 Days)||0
60160|NCT01408719|140184|P20|COMPLETED|First Intervention (35 Days)||1
60161|NCT01408719|140185|P19|COMPLETED|First Intervention (35 Days)||0
60162|NCT01408719|140186|P18|COMPLETED|First Intervention (35 Days)||2
60163|NCT01408719|140187|P17|COMPLETED|First Intervention (35 Days)||2
60164|NCT01408719|140188|P16|COMPLETED|First Intervention (35 Days)||2
60165|NCT01408719|140189|P15|COMPLETED|First Intervention (35 Days)||1
60166|NCT01408719|140190|P14|COMPLETED|First Intervention (35 Days)||4
60167|NCT01408719|140191|P13|COMPLETED|First Intervention (35 Days)||2
60168|NCT01408719|140192|P12|COMPLETED|First Intervention (35 Days)||2
60169|NCT01408719|140193|P11|COMPLETED|First Intervention (35 Days)||2
60170|NCT01408719|140194|P10|COMPLETED|First Intervention (35 Days)||1
60171|NCT01408719|140195|P9|COMPLETED|First Intervention (35 Days)||1
60172|NCT01408719|140196|P8|COMPLETED|First Intervention (35 Days)||3
60173|NCT01408719|140197|P7|COMPLETED|First Intervention (35 Days)||2
60174|NCT01408719|140198|P6|COMPLETED|First Intervention (35 Days)||3
60175|NCT01408719|140199|P5|COMPLETED|First Intervention (35 Days)||3
60176|NCT01408719|140200|P4|COMPLETED|First Intervention (35 Days)||2
60177|NCT01408719|140201|P3|COMPLETED|First Intervention (35 Days)||1
60178|NCT01408719|140202|P2|COMPLETED|First Intervention (35 Days)||3
60179|NCT01408719|140203|P1|COMPLETED|First Intervention (35 Days)||2
60180|NCT01408719|140184|P20|STARTED|First Intervention (35 Days)||1
60181|NCT01408719|140185|P19|STARTED|First Intervention (35 Days)||1
60182|NCT01408719|140186|P18|STARTED|First Intervention (35 Days)||2
60183|NCT01408719|140187|P17|STARTED|First Intervention (35 Days)||3
60184|NCT01408719|140188|P16|STARTED|First Intervention (35 Days)||2
60185|NCT01408719|140189|P15|STARTED|First Intervention (35 Days)||1
60186|NCT01408719|140190|P14|STARTED|First Intervention (35 Days)||5
60187|NCT01408719|140191|P13|STARTED|First Intervention (35 Days)||2
60188|NCT01408719|140192|P12|STARTED|First Intervention (35 Days)||2
60189|NCT01408719|140193|P11|STARTED|First Intervention (35 Days)||2
60190|NCT01408719|140194|P10|STARTED|First Intervention (35 Days)||1
60191|NCT01408719|140195|P9|STARTED|First Intervention (35 Days)||2
60192|NCT01408719|140196|P8|STARTED|First Intervention (35 Days)||3
60193|NCT01408719|140197|P7|STARTED|First Intervention (35 Days)||2
60194|NCT01408719|140198|P6|STARTED|First Intervention (35 Days)||3
60195|NCT01408719|140199|P5|STARTED|First Intervention (35 Days)||4
60196|NCT01408719|140200|P4|STARTED|First Intervention (35 Days)||2
60197|NCT01408719|140201|P3|STARTED|First Intervention (35 Days)||2
60198|NCT01408719|140202|P2|STARTED|First Intervention (35 Days)||3
60199|NCT01408719|140203|P1|STARTED|First Intervention (35 Days)||2
60200|NCT01408329|140215|P2|NOT COMPLETED|Overall Study||4
60201|NCT01408329|140216|P1|NOT COMPLETED|Overall Study||3
60202|NCT01408329|140215|P2|COMPLETED|Overall Study||11
60203|NCT01408329|140216|P1|COMPLETED|Overall Study||10
60204|NCT01408329|140215|P2|STARTED|Overall Study||15
60205|NCT01408329|140216|P1|STARTED|Overall Study||13
60206|NCT01408303|140225|P3|NOT COMPLETED|Overall Study||6
60207|NCT01408303|140226|P2|NOT COMPLETED|Overall Study||12
60208|NCT01408303|140227|P1|NOT COMPLETED|Overall Study||6
60209|NCT01408303|140225|P3|COMPLETED|Overall Study||210
60210|NCT01408303|140226|P2|COMPLETED|Overall Study||204
60211|NCT01408303|140227|P1|COMPLETED|Overall Study||209
60212|NCT01408303|140225|P3|STARTED|Overall Study||216
60213|NCT01408303|140226|P2|STARTED|Overall Study||216
60214|NCT01408303|140227|P1|STARTED|Overall Study||215
60215|NCT01408277|140237|P2|NOT COMPLETED|Overall Study||4
60216|NCT01408277|140238|P1|NOT COMPLETED|Overall Study||8
60217|NCT01408277|140237|P2|COMPLETED|Overall Study||23
60218|NCT01408277|140238|P1|COMPLETED|Overall Study||20
60219|NCT01408277|140237|P2|STARTED|Overall Study||27
60220|NCT01408277|140238|P1|STARTED|Overall Study||28
60221|NCT01407575|140246|P2|NOT COMPLETED|Overall Study||1
60222|NCT01407575|140247|P1|NOT COMPLETED|Overall Study||2
60223|NCT01407575|140246|P2|COMPLETED|Overall Study||5
60224|NCT01407575|140247|P1|COMPLETED|Overall Study||5
60225|NCT01407575|140246|P2|STARTED|Overall Study||6
60226|NCT01407575|140247|P1|STARTED|Overall Study||7
60227|NCT01407523|140265|P1|NOT COMPLETED|Overall Study||0
60228|NCT01407523|140265|P1|COMPLETED|Overall Study||16
60229|NCT01407523|140265|P1|STARTED|Overall Study||16
60230|NCT01407354|140275|P2|NOT COMPLETED|Second Intervention||2
60231|NCT01407354|140276|P1|NOT COMPLETED|Second Intervention||0
60232|NCT01407354|140275|P2|COMPLETED|Second Intervention||13
60233|NCT01407354|140276|P1|COMPLETED|Second Intervention||18
60234|NCT01407354|140275|P2|STARTED|Second Intervention||15
60235|NCT01407354|140276|P1|STARTED|Second Intervention||18
60236|NCT01407354|140275|P2|NOT COMPLETED|First Intervention||2
60237|NCT01407354|140276|P1|NOT COMPLETED|First Intervention||2
60238|NCT01407354|140275|P2|COMPLETED|First Intervention||15
60239|NCT01407354|140276|P1|COMPLETED|First Intervention||18
60240|NCT01407354|140275|P2|STARTED|First Intervention||17
60241|NCT01407354|140276|P1|STARTED|First Intervention||20
60242|NCT01407276|140292|P8|NOT COMPLETED|Overall Study||1
60243|NCT01407276|140293|P7|NOT COMPLETED|Overall Study||0
60244|NCT01407276|140294|P6|NOT COMPLETED|Overall Study||0
60245|NCT01407276|140295|P5|NOT COMPLETED|Overall Study||0
60246|NCT01407276|140296|P4|NOT COMPLETED|Overall Study||0
60247|NCT01407276|140297|P3|NOT COMPLETED|Overall Study||0
60248|NCT01407276|140298|P2|NOT COMPLETED|Overall Study||0
60249|NCT01407276|140299|P1|NOT COMPLETED|Overall Study||0
60250|NCT01407276|140292|P8|COMPLETED|Overall Study||6
60251|NCT01407276|140293|P7|COMPLETED|Overall Study||6
60252|NCT01407276|140294|P6|COMPLETED|Overall Study||6
60253|NCT01407276|140295|P5|COMPLETED|Overall Study||6
60254|NCT01407276|140296|P4|COMPLETED|Overall Study||6
60255|NCT01407276|140297|P3|COMPLETED|Overall Study||6
60256|NCT01407276|140298|P2|COMPLETED|Overall Study||6
60257|NCT01407276|140299|P1|COMPLETED|Overall Study||6
60258|NCT01407276|140292|P8|STARTED|Overall Study||7
60259|NCT01407276|140293|P7|STARTED|Overall Study||6
60260|NCT01407276|140294|P6|STARTED|Overall Study||6
60261|NCT01407276|140295|P5|STARTED|Overall Study||6
60262|NCT01407276|140296|P4|STARTED|Overall Study||6
60263|NCT01407276|140297|P3|STARTED|Overall Study||6
60264|NCT01407276|140298|P2|STARTED|Overall Study||6
60265|NCT01407276|140299|P1|STARTED|Overall Study||6
60266|NCT01407068|140423|P1|NOT COMPLETED|Overall Study||0
60267|NCT01407068|140423|P1|COMPLETED|Overall Study||60
60268|NCT01407068|140423|P1|STARTED|Overall Study||60
60269|NCT01406990|140432|P1|NOT COMPLETED|Overall Study||0
60270|NCT01406990|140432|P1|COMPLETED|Overall Study||15
60271|NCT01406990|140432|P1|STARTED|Overall Study||15
60272|NCT01406938|140438|P6|NOT COMPLETED|Follow up||3
60273|NCT01406938|140439|P5|NOT COMPLETED|Follow up||9
60274|NCT01406938|140440|P4|NOT COMPLETED|Follow up||3
60275|NCT01406938|140441|P3|NOT COMPLETED|Follow up||8
60276|NCT01406938|140442|P2|NOT COMPLETED|Follow up||5
60277|NCT01406938|140443|P1|NOT COMPLETED|Follow up||8
60278|NCT01406938|140438|P6|COMPLETED|Follow up||32
60279|NCT01406938|140439|P5|COMPLETED|Follow up||31
60280|NCT01406938|140440|P4|COMPLETED|Follow up||36
60281|NCT01406938|140441|P3|COMPLETED|Follow up||32
60282|NCT01406938|140442|P2|COMPLETED|Follow up||18
60283|NCT01406938|140443|P1|COMPLETED|Follow up||18
60284|NCT01406938|140438|P6|STARTED|Follow up||35
60285|NCT01406938|140439|P5|STARTED|Follow up||40
60286|NCT01406938|140440|P4|STARTED|Follow up||39
60287|NCT01406938|140441|P3|STARTED|Follow up||40
60288|NCT01406938|140442|P2|STARTED|Follow up||23
60289|NCT01406938|140443|P1|STARTED|Follow up||26
60290|NCT01406938|140438|P6|NOT COMPLETED|Maintenance Period||16
60291|NCT01406938|140439|P5|NOT COMPLETED|Maintenance Period||25
60292|NCT01406938|140440|P4|NOT COMPLETED|Maintenance Period||18
60293|NCT01406938|140441|P3|NOT COMPLETED|Maintenance Period||17
60294|NCT01406938|140442|P2|NOT COMPLETED|Maintenance Period||0
60295|NCT01406938|140443|P1|NOT COMPLETED|Maintenance Period||0
60296|NCT01406938|140438|P6|COMPLETED|Maintenance Period||201
60297|NCT01406938|140439|P5|COMPLETED|Maintenance Period||181
60298|NCT01406938|140440|P4|COMPLETED|Maintenance Period||199
60299|NCT01406938|140441|P3|COMPLETED|Maintenance Period||186
60300|NCT01406938|140442|P2|COMPLETED|Maintenance Period||0
60301|NCT01406938|140443|P1|COMPLETED|Maintenance Period||0
60302|NCT01406938|140438|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
60303|NCT01406938|140439|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
60304|NCT01406938|140440|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
60305|NCT01406938|140441|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
60306|NCT01406938|140442|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
60307|NCT01406938|140443|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
60308|NCT01406938|140438|P6|STARTED|Maintenance Period||217
60309|NCT01406938|140439|P5|STARTED|Maintenance Period||206
60310|NCT01406938|140440|P4|STARTED|Maintenance Period||217
60311|NCT01406938|140441|P3|STARTED|Maintenance Period||203
60312|NCT01406938|140442|P2|STARTED|Maintenance Period||0
60313|NCT01406938|140443|P1|STARTED|Maintenance Period||0
60314|NCT01406938|140438|P6|NOT COMPLETED|Induction Period||0
60315|NCT01406938|140439|P5|NOT COMPLETED|Induction Period||0
60316|NCT01406938|140440|P4|NOT COMPLETED|Induction Period||0
60317|NCT01406938|140441|P3|NOT COMPLETED|Induction Period||0
60318|NCT01406938|140442|P2|NOT COMPLETED|Induction Period||20
60319|NCT01406938|140443|P1|NOT COMPLETED|Induction Period||18
60320|NCT01406938|140438|P6|COMPLETED|Induction Period||0
60321|NCT01406938|140439|P5|COMPLETED|Induction Period||0
60322|NCT01406938|140440|P4|COMPLETED|Induction Period||0
60323|NCT01406938|140441|P3|COMPLETED|Induction Period||0
60324|NCT01406938|140442|P2|COMPLETED|Induction Period||464
60325|NCT01406938|140443|P1|COMPLETED|Induction Period||464
60326|NCT01406938|140438|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
60327|NCT01406938|140439|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
60328|NCT01406938|140440|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
60329|NCT01406938|140441|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
60330|NCT01406938|140442|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
60331|NCT01406938|140443|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
60332|NCT01406938|140438|P6|STARTED|Induction Period||0
60333|NCT01406938|140439|P5|STARTED|Induction Period||0
60334|NCT01406938|140440|P4|STARTED|Induction Period||0
60335|NCT01406938|140441|P3|STARTED|Induction Period||0
60336|NCT01406938|140442|P2|STARTED|Induction Period||484
60337|NCT01406938|140443|P1|STARTED|Induction Period||482
60338|NCT01406574|140559|P4|NOT COMPLETED|Overall Study||4
60339|NCT01406574|140560|P3|NOT COMPLETED|Overall Study||1
60340|NCT01406574|140561|P2|NOT COMPLETED|Overall Study||1
60341|NCT01406574|140562|P1|NOT COMPLETED|Overall Study||1
60342|NCT01406574|140559|P4|COMPLETED|Overall Study||1
60343|NCT01406574|140560|P3|COMPLETED|Overall Study||6
60344|NCT01406574|140561|P2|COMPLETED|Overall Study||3
60345|NCT01406574|140562|P1|COMPLETED|Overall Study||6
60346|NCT01406574|140559|P4|STARTED|Overall Study||5
60347|NCT01406574|140560|P3|STARTED|Overall Study||7
60348|NCT01406574|140561|P2|STARTED|Overall Study||4
60349|NCT01406574|140562|P1|STARTED|Overall Study||7
60350|NCT01405950|140576|P4|NOT COMPLETED|Overall Study||0
60351|NCT01405950|140577|P3|NOT COMPLETED|Overall Study||0
60352|NCT01405950|140578|P2|NOT COMPLETED|Overall Study||0
60353|NCT01405950|140579|P1|NOT COMPLETED|Overall Study||1
60354|NCT01405950|140576|P4|COMPLETED|Overall Study||0
60355|NCT01405950|140577|P3|COMPLETED|Overall Study||0
60356|NCT01405950|140578|P2|COMPLETED|Overall Study||2
60357|NCT01405950|140579|P1|COMPLETED|Overall Study||7
60358|NCT01405950|140576|P4|STARTED|Overall Study||0
60359|NCT01405950|140577|P3|STARTED|Overall Study||0
60360|NCT01405950|140578|P2|STARTED|Overall Study||2
60361|NCT01405950|140579|P1|STARTED|Overall Study||8
60362|NCT01405937|140593|P2|NOT COMPLETED|Overall Study||0
60363|NCT01405937|140594|P1|NOT COMPLETED|Overall Study||0
60364|NCT01405937|140593|P2|COMPLETED|Overall Study||26
60365|NCT01405937|140594|P1|COMPLETED|Overall Study||25
60366|NCT01405937|140593|P2|STARTED|Overall Study||26
60367|NCT01405937|140594|P1|STARTED|Overall Study||25
60368|NCT01405924|140614|P1|NOT COMPLETED|Overall Study||10
60369|NCT01405924|140614|P1|COMPLETED|Overall Study||101
60370|NCT01405924|140614|P1|STARTED|Overall Study||111
60371|NCT01405898|140626|P2|NOT COMPLETED|Overall Study||2
60372|NCT01405898|140627|P1|NOT COMPLETED|Overall Study||2
60373|NCT01405898|140626|P2|COMPLETED|Overall Study||32
60374|NCT01405898|140627|P1|COMPLETED|Overall Study||32
60375|NCT01405898|140626|P2|STARTED|Overall Study||34
60376|NCT01405898|140627|P1|STARTED|Overall Study||34
60377|NCT01405820|140651|P6|NOT COMPLETED|Open-Label Treatment Period||2
60378|NCT01405820|140652|P5|NOT COMPLETED|Open-Label Treatment Period||2
60379|NCT01405820|140653|P4|NOT COMPLETED|Open-Label Treatment Period||5
60380|NCT01405820|140654|P3|NOT COMPLETED|Open-Label Treatment Period||3
60381|NCT01405820|140655|P2|NOT COMPLETED|Open-Label Treatment Period||2
60382|NCT01405820|140656|P1|NOT COMPLETED|Open-Label Treatment Period||4
60383|NCT01405820|140651|P6|COMPLETED|Open-Label Treatment Period||30
60384|NCT01405820|140652|P5|COMPLETED|Open-Label Treatment Period||40
60385|NCT01405820|140653|P4|COMPLETED|Open-Label Treatment Period||37
60386|NCT01405820|140654|P3|COMPLETED|Open-Label Treatment Period||39
60387|NCT01405820|140655|P2|COMPLETED|Open-Label Treatment Period||33
60388|NCT01405820|140656|P1|COMPLETED|Open-Label Treatment Period||40
60389|NCT01405820|140651|P6|STARTED|Open-Label Treatment Period||32
60390|NCT01405820|140652|P5|STARTED|Open-Label Treatment Period||42
60391|NCT01405820|140653|P4|STARTED|Open-Label Treatment Period||42
60392|NCT01405820|140654|P3|STARTED|Open-Label Treatment Period||42
60393|NCT01405820|140655|P2|STARTED|Open-Label Treatment Period||35
60394|NCT01405820|140656|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
60395|NCT01405820|140651|P6|NOT COMPLETED|Randomized Treatment Period||37
60396|NCT01405820|140652|P5|NOT COMPLETED|Randomized Treatment Period||45
60397|NCT01405820|140653|P4|NOT COMPLETED|Randomized Treatment Period||51
60398|NCT01405820|140654|P3|NOT COMPLETED|Randomized Treatment Period||43
60399|NCT01405820|140655|P2|NOT COMPLETED|Randomized Treatment Period||10
60400|NCT01405820|140656|P1|NOT COMPLETED|Randomized Treatment Period||11
60401|NCT01405820|140651|P6|COMPLETED|Randomized Treatment Period||1
60402|NCT01405820|140652|P5|COMPLETED|Randomized Treatment Period||2
60403|NCT01405820|140653|P4|COMPLETED|Randomized Treatment Period||3
60404|NCT01405820|140654|P3|COMPLETED|Randomized Treatment Period||9
60405|NCT01405820|140655|P2|COMPLETED|Randomized Treatment Period||35
60406|NCT01405820|140656|P1|COMPLETED|Randomized Treatment Period||43
60407|NCT01405820|140651|P6|Safety Population|Randomized Treatment Period||38
60408|NCT01405820|140652|P5|Safety Population|Randomized Treatment Period||47
60409|NCT01405820|140653|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
60410|NCT01405820|140654|P3|Safety Population|Randomized Treatment Period||52
60411|NCT01405820|140655|P2|Safety Population|Randomized Treatment Period||45
60412|NCT01405820|140656|P1|Safety Population|Randomized Treatment Period||54
60413|NCT01405820|140651|P6|STARTED|Randomized Treatment Period||38
60414|NCT01405820|140652|P5|STARTED|Randomized Treatment Period||47
60415|NCT01405820|140653|P4|STARTED|Randomized Treatment Period||54
60416|NCT01405820|140654|P3|STARTED|Randomized Treatment Period||52
60417|NCT01405820|140655|P2|STARTED|Randomized Treatment Period||45
60418|NCT01405820|140656|P1|STARTED|Randomized Treatment Period||54
60419|NCT01405794|140676|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
60420|NCT01405794|140676|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
60421|NCT01405794|140676|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
60422|NCT01405794|140676|P1|NOT COMPLETED|72 hr Washout||0
60423|NCT01405794|140676|P1|COMPLETED|72 hr Washout||12
60424|NCT01405794|140676|P1|STARTED|72 hr Washout||12
60425|NCT01405794|140676|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
60426|NCT01405794|140676|P1|COMPLETED|First Dose Placebo (14 Days)||12
60427|NCT01405794|140676|P1|STARTED|First Dose Placebo (14 Days)||12
60428|NCT01405768|140752|P2|NOT COMPLETED|Overall Study||0
60429|NCT01405768|140753|P1|NOT COMPLETED|Overall Study||4
60430|NCT01405768|140752|P2|COMPLETED|Overall Study||28
60431|NCT01405768|140753|P1|COMPLETED|Overall Study||24
60432|NCT01405768|140752|P2|STARTED|Overall Study||28
60433|NCT01405768|140753|P1|STARTED|Overall Study||28
60434|NCT01405742|140765|P2|NOT COMPLETED|Overall Study||0
60435|NCT01405742|140766|P1|NOT COMPLETED|Overall Study||1
60436|NCT01405742|140765|P2|COMPLETED|Overall Study||2
60437|NCT01405742|140766|P1|COMPLETED|Overall Study||1
60438|NCT01405742|140765|P2|STARTED|Overall Study||2
60439|NCT01405742|140766|P1|STARTED|Overall Study||2
60440|NCT01405560|140776|P1|NOT COMPLETED|Overall Study||1
60441|NCT01405560|140776|P1|COMPLETED|Overall Study||41
60442|NCT01405560|140776|P1|STARTED|Overall Study||42
60443|NCT01405508|140791|P4|NOT COMPLETED|Overall Study||0
60444|NCT01405508|140792|P3|NOT COMPLETED|Overall Study||0
60445|NCT01405508|140793|P2|NOT COMPLETED|Overall Study||1
60446|NCT01405508|140794|P1|NOT COMPLETED|Overall Study||1
60447|NCT01405508|140791|P4|COMPLETED|Overall Study||26
60448|NCT01405508|140792|P3|COMPLETED|Overall Study||27
60449|NCT01405508|140793|P2|COMPLETED|Overall Study||25
60450|NCT01405508|140794|P1|COMPLETED|Overall Study||25
60451|NCT01405508|140791|P4|STARTED|Overall Study||26
60452|NCT01405508|140792|P3|STARTED|Overall Study||27
60453|NCT01405508|140793|P2|STARTED|Overall Study||26
60454|NCT01405508|140794|P1|STARTED|Overall Study||26
60455|NCT01405469|140812|P1|NOT COMPLETED|Overall Study||0
60456|NCT01405469|140812|P1|COMPLETED|Overall Study||16
60457|NCT01405469|140812|P1|STARTED|Overall Study||16
60458|NCT01405027|140826|P2|NOT COMPLETED|Overall Study||51
60459|NCT01405027|140827|P1|NOT COMPLETED|Overall Study||32
60460|NCT01405027|140826|P2|COMPLETED|Overall Study||62
60461|NCT01405027|140827|P1|COMPLETED|Overall Study||52
60462|NCT01405027|140826|P2|STARTED|Overall Study||113
60463|NCT01405027|140827|P1|STARTED|Overall Study||84
60464|NCT01404988|140844|P3|NOT COMPLETED|Overall Study||3
60465|NCT01404988|140845|P2|NOT COMPLETED|Overall Study||4
60466|NCT01404988|140846|P1|NOT COMPLETED|Overall Study||6
60467|NCT01404988|140844|P3|COMPLETED|Overall Study||30
60468|NCT01404988|140845|P2|COMPLETED|Overall Study||29
60469|NCT01404988|140846|P1|COMPLETED|Overall Study||27
60470|NCT01404988|140844|P3|STARTED|Overall Study||33
60471|NCT01404988|140845|P2|STARTED|Overall Study||33
60472|NCT01404988|140846|P1|STARTED|Overall Study||33
60473|NCT01404936|140863|P1|NOT COMPLETED|Overall Study||0
60474|NCT01404936|140863|P1|COMPLETED|Overall Study||30
60475|NCT01404936|140863|P1|STARTED|Overall Study||30
60476|NCT01404923|140869|P2|NOT COMPLETED|Overall Study||17
60477|NCT01404923|140870|P1|NOT COMPLETED|Overall Study||23
60478|NCT01404923|140869|P2|COMPLETED|Overall Study||197
60479|NCT01404923|140870|P1|COMPLETED|Overall Study||199
60480|NCT01404923|140869|P2|STARTED|Overall Study||214
60481|NCT01404923|140870|P1|STARTED|Overall Study||222
60482|NCT01404832|140878|P1|NOT COMPLETED|Overall Study||0
60483|NCT01404832|140878|P1|COMPLETED|Overall Study||21
60484|NCT01404832|140878|P1|STARTED|Overall Study||21
60485|NCT01404650|140883|P1|NOT COMPLETED|Overall Study||0
60486|NCT01404650|140883|P1|COMPLETED|Overall Study||25
60487|NCT01404650|140883|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
60488|NCT01404611|140893|P3|NOT COMPLETED|Overall Study||5
60489|NCT01404611|140894|P2|NOT COMPLETED|Overall Study||19
60490|NCT01404611|140895|P1|NOT COMPLETED|Overall Study||8
60491|NCT01404611|140893|P3|COMPLETED|Overall Study||106
60492|NCT01404611|140894|P2|COMPLETED|Overall Study||89
60493|NCT01404611|140895|P1|COMPLETED|Overall Study||104
60494|NCT01404611|140893|P3|STARTED|Overall Study||111
60495|NCT01404611|140894|P2|STARTED|Overall Study||108
60496|NCT01404611|140895|P1|STARTED|Overall Study||112
60497|NCT01404572|140903|P3|NOT COMPLETED|Overall Study||0
60498|NCT01404572|140904|P2|NOT COMPLETED|Overall Study||0
60499|NCT01404572|140905|P1|NOT COMPLETED|Overall Study||0
60500|NCT01404572|140903|P3|COMPLETED|Overall Study||4
60501|NCT01404572|140904|P2|COMPLETED|Overall Study||4
60502|NCT01404572|140905|P1|COMPLETED|Overall Study||4
60503|NCT01404572|140903|P3|STARTED|Overall Study||4
60504|NCT01404572|140904|P2|STARTED|Overall Study||4
60505|NCT01404572|140905|P1|STARTED|Overall Study||4
60506|NCT01404559|140936|P4|NOT COMPLETED|Overall Study||0
60507|NCT01404559|140937|P3|NOT COMPLETED|Overall Study||0
60508|NCT01404559|140938|P2|NOT COMPLETED|Overall Study||0
60509|NCT01404559|140939|P1|NOT COMPLETED|Overall Study||0
60510|NCT01404559|140936|P4|COMPLETED|Overall Study||14
60511|NCT01404559|140937|P3|COMPLETED|Overall Study||4
60512|NCT01404559|140938|P2|COMPLETED|Overall Study||5
60513|NCT01404559|140939|P1|COMPLETED|Overall Study||5
60514|NCT01404559|140936|P4|STARTED|Overall Study||14
60515|NCT01404559|140937|P3|STARTED|Overall Study||4
60516|NCT01404559|140938|P2|STARTED|Overall Study||5
60517|NCT01404559|140939|P1|STARTED|Overall Study||5
60518|NCT01404429|140952|P2|NOT COMPLETED|Overall Study||7
60519|NCT01404429|140953|P1|NOT COMPLETED|Overall Study||9
60520|NCT01404429|140952|P2|COMPLETED|Overall Study||46
60521|NCT01404429|140953|P1|COMPLETED|Overall Study||38
60522|NCT01404429|140952|P2|STARTED|Overall Study||53
60523|NCT01404429|140953|P1|STARTED|Overall Study||47
60524|NCT01404260|140967|P2|NOT COMPLETED|Overall Study||9
60525|NCT01404260|140968|P1|NOT COMPLETED|Overall Study||3
60526|NCT01404260|140967|P2|COMPLETED|Overall Study||101
60527|NCT01404260|140968|P1|COMPLETED|Overall Study||106
60528|NCT01404260|140967|P2|STARTED|Overall Study||110
60529|NCT01404260|140968|P1|STARTED|Overall Study||109
60530|NCT01404234|140974|P1|NOT COMPLETED|Overall Study||2
60531|NCT01404234|140974|P1|COMPLETED|Overall Study||59
60532|NCT01404234|140974|P1|STARTED|Overall Study||61
60533|NCT01404078|140990|P2|NOT COMPLETED|Overall Study||20
60534|NCT01404078|140991|P1|NOT COMPLETED|Overall Study||18
60535|NCT01404078|140990|P2|COMPLETED|Overall Study||237
60536|NCT01404078|140991|P1|COMPLETED|Overall Study||243
60537|NCT01404078|140990|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
60538|NCT01404078|140991|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
60539|NCT01403987|141000|P3|NOT COMPLETED|Overall Study||18
60540|NCT01403987|141001|P2|NOT COMPLETED|Overall Study||17
60541|NCT01403987|141002|P1|NOT COMPLETED|Overall Study||18
60542|NCT01403987|141000|P3|COMPLETED|Overall Study||50
60543|NCT01403987|141001|P2|COMPLETED|Overall Study||17
60544|NCT01403987|141002|P1|COMPLETED|Overall Study||16
60545|NCT01403987|141000|P3|STARTED|Overall Study||68
60546|NCT01403987|141001|P2|STARTED|Overall Study||34
60547|NCT01403987|141002|P1|STARTED|Overall Study||34
60548|NCT01403805|141018|P2|NOT COMPLETED|Overall Study||7
60549|NCT01403805|141019|P1|NOT COMPLETED|Overall Study||0
60550|NCT01403805|141018|P2|COMPLETED|Overall Study||98
60551|NCT01403805|141019|P1|COMPLETED|Overall Study||94
60552|NCT01403805|141018|P2|Pneumonia Diagnosis|Overall Study||2
60553|NCT01403805|141019|P1|Pneumonia Diagnosis|Overall Study||21
60554|NCT01403805|141018|P2|STARTED|Overall Study||105
60555|NCT01403805|141019|P1|STARTED|Overall Study||94
60556|NCT01403376|141034|P3|NOT COMPLETED|Overall Study||0
60557|NCT01403376|141035|P2|NOT COMPLETED|Overall Study||0
60558|NCT01403376|141036|P1|NOT COMPLETED|Overall Study||0
60559|NCT01403376|141034|P3|COMPLETED|Overall Study||46
60560|NCT01403376|141035|P2|COMPLETED|Overall Study||41
60561|NCT01403376|141036|P1|COMPLETED|Overall Study||41
60562|NCT01403376|141034|P3|STARTED|Overall Study||46
60563|NCT01403376|141035|P2|STARTED|Overall Study||41
60564|NCT01403376|141036|P1|STARTED|Overall Study||41
60565|NCT01403194|141056|P1|NOT COMPLETED|Overall Study||10
60566|NCT01403194|141056|P1|COMPLETED|Overall Study||1
60567|NCT01403194|141056|P1|STARTED|Overall Study||11
60568|NCT01403090|141062|P1|NOT COMPLETED|Overall Study||0
60569|NCT01403090|141062|P1|COMPLETED|Overall Study||8
60570|NCT01403090|141062|P1|STARTED|Overall Study||8
60571|NCT01403051|141068|P2|NOT COMPLETED|Overall Study||6
60572|NCT01403051|141069|P1|NOT COMPLETED|Overall Study||10
60573|NCT01403051|141068|P2|COMPLETED|Overall Study||80
60574|NCT01403051|141069|P1|COMPLETED|Overall Study||71
60575|NCT01403051|141068|P2|Initiated Study Treatment|Overall Study||86
60576|NCT01403051|141069|P1|Initiated Study Treatment|Overall Study||81
60577|NCT01403051|141068|P2|STARTED|Overall Study||86
60578|NCT01403051|141069|P1|STARTED|Overall Study||81
60579|NCT01402947|141103|P2|NOT COMPLETED|Second Intervention||0
60580|NCT01402947|141104|P1|NOT COMPLETED|Second Intervention||0
60581|NCT01402947|141103|P2|COMPLETED|Second Intervention||14
60582|NCT01402947|141104|P1|COMPLETED|Second Intervention||15
60583|NCT01402947|141103|P2|STARTED|Second Intervention||14
60584|NCT01402947|141104|P1|STARTED|Second Intervention||15
60585|NCT01402947|141103|P2|NOT COMPLETED|First Intervention||1
60586|NCT01402947|141104|P1|NOT COMPLETED|First Intervention||0
60587|NCT01402947|141103|P2|COMPLETED|First Intervention||14
60588|NCT01402947|141104|P1|COMPLETED|First Intervention||15
60589|NCT01402947|141103|P2|STARTED|First Intervention||15
60590|NCT01402947|141104|P1|STARTED|First Intervention||15
60591|NCT01402869|141115|P3|NOT COMPLETED|Overall Study||1
60592|NCT01402869|141116|P2|NOT COMPLETED|Overall Study||0
60593|NCT01402869|141117|P1|NOT COMPLETED|Overall Study||0
60594|NCT01402869|141115|P3|COMPLETED|Overall Study||30
60595|NCT01402869|141116|P2|COMPLETED|Overall Study||30
60596|NCT01402869|141117|P1|COMPLETED|Overall Study||30
60597|NCT01402869|141115|P3|STARTED|Overall Study||31
60598|NCT01402869|141116|P2|STARTED|Overall Study||30
60599|NCT01402869|141117|P1|STARTED|Overall Study||30
60600|NCT01402817|141131|P1|NOT COMPLETED|Overall Study||11
60601|NCT01402817|141131|P1|COMPLETED|Overall Study||8
60602|NCT01402817|141131|P1|STARTED|Overall Study||19
60603|NCT01402700|141136|P1|NOT COMPLETED|Overall Study||7
60604|NCT01402700|141136|P1|COMPLETED|Overall Study||68
60605|NCT01402700|141136|P1|STARTED|Overall Study||75
60606|NCT01402570|141140|P1|NOT COMPLETED|Overall Study||1
60607|NCT01402570|141140|P1|COMPLETED|Overall Study||19
60608|NCT01402570|141140|P1|STARTED|Overall Study||20
60609|NCT01402427|141149|P2|NOT COMPLETED|Overall Study||0
60610|NCT01402427|141150|P1|NOT COMPLETED|Overall Study||0
60611|NCT01402427|141149|P2|COMPLETED|Overall Study||294
60612|NCT01402427|141150|P1|COMPLETED|Overall Study||297
60613|NCT01402427|141149|P2|STARTED|Overall Study||294
60614|NCT01402427|141150|P1|STARTED|Overall Study||297
60615|NCT01402141|141170|P2|NOT COMPLETED|Overall Study||2
60616|NCT01402141|141171|P1|NOT COMPLETED|Overall Study||1
60617|NCT01402141|141170|P2|COMPLETED|Overall Study||28
60618|NCT01402141|141171|P1|COMPLETED|Overall Study||29
60619|NCT01402141|141170|P2|STARTED|Overall Study||30
60620|NCT01402141|141171|P1|STARTED|Overall Study||30
60621|NCT01402128|141193|P2|NOT COMPLETED|Overall Study||0
60622|NCT01402128|141194|P1|NOT COMPLETED|Overall Study||1
60623|NCT01402128|141193|P2|COMPLETED|Overall Study||40
60624|NCT01402128|141194|P1|COMPLETED|Overall Study||39
60625|NCT01402128|141193|P2|STARTED|Overall Study||40
60626|NCT01402128|141194|P1|STARTED|Overall Study||40
60627|NCT01402115|141222|P2|NOT COMPLETED|Overall Study||1
60628|NCT01402115|141223|P1|NOT COMPLETED|Overall Study||1
60629|NCT01402115|141222|P2|COMPLETED|Overall Study||29
60630|NCT01402115|141223|P1|COMPLETED|Overall Study||29
60631|NCT01402115|141222|P2|STARTED|Overall Study||30
60632|NCT01402115|141223|P1|STARTED|Overall Study||30
60633|NCT01402102|141239|P2|NOT COMPLETED|Overall Study||3
60634|NCT01402102|141240|P1|NOT COMPLETED|Overall Study||2
60635|NCT01402102|141239|P2|COMPLETED|Overall Study||27
60636|NCT01402102|141240|P1|COMPLETED|Overall Study||28
60637|NCT01402102|141239|P2|STARTED|Overall Study||30
60638|NCT01402102|141240|P1|STARTED|Overall Study||30
60639|NCT01402063|141260|P2|NOT COMPLETED|Overall Study||3
60640|NCT01402063|141261|P1|NOT COMPLETED|Overall Study||3
60641|NCT01402063|141260|P2|COMPLETED|Overall Study||18
60642|NCT01402063|141261|P1|COMPLETED|Overall Study||39
60643|NCT01402063|141260|P2|STARTED|Overall Study||21
60644|NCT01402063|141261|P1|STARTED|Overall Study||42
60645|NCT01401842|141269|P2|NOT COMPLETED|Overall Study||67
60646|NCT01401842|141270|P1|NOT COMPLETED|Overall Study||68
60647|NCT01401842|141269|P2|COMPLETED|Overall Study||217
60648|NCT01401842|141270|P1|COMPLETED|Overall Study||230
60649|NCT01401842|141269|P2|STARTED|Overall Study||284
60650|NCT01401842|141270|P1|STARTED|Overall Study||298
60651|NCT01400698|141284|P6|NOT COMPLETED|Overall Study||6
60652|NCT01400698|141285|P5|NOT COMPLETED|Overall Study||7
60653|NCT01400698|141286|P4|NOT COMPLETED|Overall Study||8
60654|NCT01400698|141287|P3|NOT COMPLETED|Overall Study||2
60655|NCT01400698|141288|P2|NOT COMPLETED|Overall Study||11
60656|NCT01400698|141289|P1|NOT COMPLETED|Overall Study||15
60657|NCT01400698|141284|P6|COMPLETED|Overall Study||9
60658|NCT01400698|141285|P5|COMPLETED|Overall Study||7
60659|NCT01400698|141286|P4|COMPLETED|Overall Study||6
60660|NCT01400698|141287|P3|COMPLETED|Overall Study||0
60661|NCT01400698|141288|P2|COMPLETED|Overall Study||12
60662|NCT01400698|141289|P1|COMPLETED|Overall Study||8
60663|NCT01400698|141284|P6|STARTED|Overall Study||15
60664|NCT01400698|141285|P5|STARTED|Overall Study||14
60665|NCT01400698|141286|P4|STARTED|Overall Study||14
60666|NCT01400698|141287|P3|STARTED|Overall Study||2
60667|NCT01400698|141288|P2|STARTED|Overall Study||23
60668|NCT01400698|141289|P1|STARTED|Overall Study||23
60669|NCT01401647|141314|P3|NOT COMPLETED|Overall Study||3
60670|NCT01401647|141315|P2|NOT COMPLETED|Overall Study||8
60671|NCT01401647|141316|P1|NOT COMPLETED|Overall Study||4
60672|NCT01401647|141314|P3|COMPLETED|Overall Study||1056
60673|NCT01401647|141315|P2|COMPLETED|Overall Study||985
60674|NCT01401647|141316|P1|COMPLETED|Overall Study||968
60675|NCT01401647|141314|P3|STARTED|Overall Study||1059
60676|NCT01401647|141315|P2|STARTED|Overall Study||993
60677|NCT01401647|141316|P1|STARTED|Overall Study||972
60678|NCT01401517|141330|P3|NOT COMPLETED|Overall Study||3
60679|NCT01401517|141331|P2|NOT COMPLETED|Overall Study||2
60680|NCT01401517|141332|P1|NOT COMPLETED|Overall Study||3
60681|NCT01401517|141330|P3|COMPLETED|Overall Study||15
60682|NCT01401517|141331|P2|COMPLETED|Overall Study||17
60683|NCT01401517|141332|P1|COMPLETED|Overall Study||15
60684|NCT01401517|141330|P3|STARTED|Overall Study||18
60685|NCT01401517|141331|P2|STARTED|Overall Study||19
60686|NCT01401517|141332|P1|STARTED|Overall Study||18
60687|NCT01401478|141340|P1|NOT COMPLETED|Overall Study||31
60688|NCT01401478|141340|P1|COMPLETED|Overall Study||55
60689|NCT01401478|141340|P1|STARTED|Overall Study||86
60690|NCT01401465|141353|P2|NOT COMPLETED|Treatment Period 2||2
60691|NCT01401465|141354|P1|NOT COMPLETED|Treatment Period 2||0
60692|NCT01401465|141353|P2|COMPLETED|Treatment Period 2||144
60693|NCT01401465|141354|P1|COMPLETED|Treatment Period 2||150
60694|NCT01401465|141353|P2|STARTED|Treatment Period 2||146
60695|NCT01401465|141354|P1|STARTED|Treatment Period 2||150
60696|NCT01401465|141353|P2|NOT COMPLETED|Washout||0
60697|NCT01401465|141354|P1|NOT COMPLETED|Washout||0
60698|NCT01401465|141353|P2|COMPLETED|Washout||146
60699|NCT01401465|141354|P1|COMPLETED|Washout||150
60700|NCT01401465|141353|P2|STARTED|Washout||146
60701|NCT01401465|141354|P1|STARTED|Washout||150
60702|NCT01401465|141353|P2|NOT COMPLETED|Treatment Period 1||16
60703|NCT01401465|141354|P1|NOT COMPLETED|Treatment Period 1||15
60704|NCT01401465|141353|P2|COMPLETED|Treatment Period 1||146
60705|NCT01401465|141354|P1|COMPLETED|Treatment Period 1||150
60706|NCT01401465|141353|P2|STARTED|Treatment Period 1||162
60707|NCT01401465|141354|P1|STARTED|Treatment Period 1||165
60708|NCT01401361|141417|P1|NOT COMPLETED|Overall Study||28
60709|NCT01401361|141417|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
60710|NCT01401361|141417|P1|STARTED|Overall Study||150
60711|NCT01401322|141423|P1|NOT COMPLETED|Overall Study||2
60712|NCT01401322|141423|P1|COMPLETED|Overall Study||3
60713|NCT01401322|141423|P1|STARTED|Overall Study||5
60714|NCT01401283|141429|P2|NOT COMPLETED|Overall Study||10
60715|NCT01401283|141430|P1|NOT COMPLETED|Overall Study||10
60716|NCT01401283|141429|P2|COMPLETED|Overall Study||81
60717|NCT01401283|141430|P1|COMPLETED|Overall Study||79
60718|NCT01401283|141429|P2|STARTED|Overall Study||91
60719|NCT01401283|141430|P1|STARTED|Overall Study||89
60720|NCT01401257|141442|P4|NOT COMPLETED|Overall Study||2
60721|NCT01401257|141443|P3|NOT COMPLETED|Overall Study||3
60722|NCT01401257|141444|P2|NOT COMPLETED|Overall Study||2
60723|NCT01401257|141445|P1|NOT COMPLETED|Overall Study||0
60724|NCT01401257|141442|P4|COMPLETED|Overall Study||17
60725|NCT01401257|141443|P3|COMPLETED|Overall Study||16
60726|NCT01401257|141444|P2|COMPLETED|Overall Study||19
60727|NCT01401257|141445|P1|COMPLETED|Overall Study||21
60728|NCT01401257|141442|P4|STARTED|Overall Study||19
60729|NCT01401257|141443|P3|STARTED|Overall Study||19
60730|NCT01401257|141444|P2|STARTED|Overall Study||21
60731|NCT01401257|141445|P1|STARTED|Overall Study||21
60732|NCT01401166|141455|P4|NOT COMPLETED|Safety Follow-up Period||141
60733|NCT01401166|141456|P3|NOT COMPLETED|Safety Follow-up Period||226
60734|NCT01401166|141457|P2|NOT COMPLETED|Safety Follow-up Period||0
60735|NCT01401166|141458|P1|NOT COMPLETED|Safety Follow-up Period||0
60736|NCT01401166|141455|P4|COMPLETED|Safety Follow-up Period||12
60737|NCT01401166|141456|P3|COMPLETED|Safety Follow-up Period||22
60738|NCT01401166|141457|P2|COMPLETED|Safety Follow-up Period||0
60739|NCT01401166|141458|P1|COMPLETED|Safety Follow-up Period||0
60740|NCT01401166|141455|P4|STARTED|Safety Follow-up Period|Some of the participants in Cohort 2 were still receiving treatment and did not start this period.|153
60741|NCT01401166|141456|P3|STARTED|Safety Follow-up Period|All 248 randomized participants in Cohort 1 started the safety follow-up period.|248
60742|NCT01401166|141457|P2|STARTED|Safety Follow-up Period|There were no participants in this reporting group in this period.|0
60743|NCT01401166|141458|P1|STARTED|Safety Follow-up Period|There were no participants in this reporting group in this period.|0
60744|NCT01401166|141455|P4|NOT COMPLETED|Continuation Period||87
60745|NCT01401166|141456|P3|NOT COMPLETED|Continuation Period||0
60746|NCT01401166|141457|P2|NOT COMPLETED|Continuation Period||0
60747|NCT01401166|141458|P1|NOT COMPLETED|Continuation Period||0
60748|NCT01401166|141455|P4|COMPLETED|Continuation Period||119
60749|NCT01401166|141456|P3|COMPLETED|Continuation Period||226
60750|NCT01401166|141457|P2|COMPLETED|Continuation Period||0
60751|NCT01401166|141458|P1|COMPLETED|Continuation Period||0
60752|NCT01401166|141455|P4|STARTED|Continuation Period|Not all participants who completed crossover treatment 2 started the continuation period.|206
60753|NCT01401166|141456|P3|STARTED|Continuation Period|Not all participants who completed crossover treatment 2 started the continuation period.|226
60754|NCT01401166|141457|P2|STARTED|Continuation Period|There were no participants in this reporting group in this period.|0
60755|NCT01401166|141458|P1|STARTED|Continuation Period|There were no participants in this reporting group in this period.|0
60756|NCT01401166|141455|P4|NOT COMPLETED|Crossover Treatment 2||0
60757|NCT01401166|141456|P3|NOT COMPLETED|Crossover Treatment 2||0
60758|NCT01401166|141457|P2|NOT COMPLETED|Crossover Treatment 2||0
60759|NCT01401166|141458|P1|NOT COMPLETED|Crossover Treatment 2||0
60760|NCT01401166|141455|P4|COMPLETED|Crossover Treatment 2||0
60761|NCT01401166|141456|P3|COMPLETED|Crossover Treatment 2||0
60762|NCT01401166|141457|P2|COMPLETED|Crossover Treatment 2||237
60763|NCT01401166|141458|P1|COMPLETED|Crossover Treatment 2||241
60764|NCT01401166|141455|P4|STARTED|Crossover Treatment 2|There were no participants in this reporting group in this period.|0
60765|NCT01401166|141456|P3|STARTED|Crossover Treatment 2|There were no participants in this reporting group in this period.|0
60766|NCT01401166|141457|P2|STARTED|Crossover Treatment 2|Not all participants who completed crossover treatment 1 started crossover treatment 2.|237
60767|NCT01401166|141458|P1|STARTED|Crossover Treatment 2|Not all participants who completed crossover treatment 1 started crossover treatment 2.|241
60768|NCT01401166|141455|P4|NOT COMPLETED|Crossover Treatment 1||0
60769|NCT01401166|141456|P3|NOT COMPLETED|Crossover Treatment 1||0
60770|NCT01401166|141457|P2|NOT COMPLETED|Crossover Treatment 1||0
60771|NCT01401166|141458|P1|NOT COMPLETED|Crossover Treatment 1||0
60772|NCT01401166|141455|P4|COMPLETED|Crossover Treatment 1||0
60773|NCT01401166|141456|P3|COMPLETED|Crossover Treatment 1||0
60774|NCT01401166|141457|P2|COMPLETED|Crossover Treatment 1||240
60775|NCT01401166|141458|P1|COMPLETED|Crossover Treatment 1||243
60776|NCT01401166|141455|P4|STARTED|Crossover Treatment 1|There were no participants in this reporting group in this period.|0
60777|NCT01401166|141456|P3|STARTED|Crossover Treatment 1|There were no participants in this reporting group in this period.|0
60778|NCT01401166|141457|P2|STARTED|Crossover Treatment 1||240
60779|NCT01401166|141458|P1|STARTED|Crossover Treatment 1||243
60780|NCT01401153|141475|P2|NOT COMPLETED|Second Test Day||5
60781|NCT01401153|141476|P1|NOT COMPLETED|Second Test Day||0
60782|NCT01401153|141475|P2|COMPLETED|Second Test Day||60
60783|NCT01401153|141476|P1|COMPLETED|Second Test Day||45
60784|NCT01401153|141475|P2|STARTED|Second Test Day||65
60785|NCT01401153|141476|P1|STARTED|Second Test Day||45
60786|NCT01401153|141475|P2|NOT COMPLETED|First Test Day||10
60787|NCT01401153|141476|P1|NOT COMPLETED|First Test Day||1
60788|NCT01401153|141475|P2|COMPLETED|First Test Day||45
60789|NCT01401153|141476|P1|COMPLETED|First Test Day||65
60790|NCT01401153|141475|P2|STARTED|First Test Day||55
60791|NCT01401153|141476|P1|STARTED|First Test Day||66
60792|NCT01401101|141510|P2|NOT COMPLETED|Overall Study||27
60793|NCT01401101|141511|P1|NOT COMPLETED|Overall Study||22
60794|NCT01401101|141510|P2|COMPLETED|Overall Study||171
60795|NCT01401101|141511|P1|COMPLETED|Overall Study||184
60796|NCT01401101|141510|P2|STARTED|Overall Study||198
60797|NCT01401101|141511|P1|STARTED|Overall Study||206
60798|NCT01401049|141523|P2|NOT COMPLETED|Overall Study||0
60799|NCT01401049|141524|P1|NOT COMPLETED|Overall Study||0
60800|NCT01401049|141523|P2|COMPLETED|Overall Study||0
60801|NCT01401049|141524|P1|COMPLETED|Overall Study||0
60802|NCT01401049|141523|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
60803|NCT01401049|141524|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
60804|NCT01401023|141530|P1|NOT COMPLETED|Overall Study||0
60805|NCT01401023|141530|P1|COMPLETED|Overall Study||10
60806|NCT01401023|141530|P1|STARTED|Overall Study||10
60807|NCT01401010|141538|P2|NOT COMPLETED|Overall Study||0
60808|NCT01401010|141539|P1|NOT COMPLETED|Overall Study||1
60809|NCT01401010|141538|P2|COMPLETED|Overall Study||6
60810|NCT01401010|141539|P1|COMPLETED|Overall Study||5
60811|NCT01401010|141538|P2|STARTED|Overall Study||6
60812|NCT01401010|141539|P1|STARTED|Overall Study||6
60813|NCT01400958|141564|P2|NOT COMPLETED|Overall Study||2
60814|NCT01400958|141565|P1|NOT COMPLETED|Overall Study||1
60815|NCT01400958|141564|P2|COMPLETED|Overall Study||1
60816|NCT01400958|141565|P1|COMPLETED|Overall Study||2
60817|NCT01400958|141564|P2|STARTED|Overall Study||3
60818|NCT01400958|141565|P1|STARTED|Overall Study||3
60819|NCT01400932|141575|P2|NOT COMPLETED|Overall Study||15
60820|NCT01400932|141576|P1|NOT COMPLETED|Overall Study||14
60821|NCT01400932|141575|P2|COMPLETED|Overall Study||167
60822|NCT01400932|141576|P1|COMPLETED|Overall Study||164
60823|NCT01400932|141575|P2|STARTED|Overall Study||182
60824|NCT01400932|141576|P1|STARTED|Overall Study||178
60825|NCT01400919|141598|P1|NOT COMPLETED|Overall Study||8
60826|NCT01400919|141598|P1|COMPLETED|Overall Study||67
60827|NCT01400919|141598|P1|STARTED|Overall Study||75
60828|NCT01400906|141602|P6|NOT COMPLETED|Treatment Period 3||0
60829|NCT01400906|141603|P5|NOT COMPLETED|Treatment Period 3||0
60830|NCT01400906|141604|P4|NOT COMPLETED|Treatment Period 3||0
60831|NCT01400906|141605|P3|NOT COMPLETED|Treatment Period 3||0
60832|NCT01400906|141606|P2|NOT COMPLETED|Treatment Period 3||0
60833|NCT01400906|141607|P1|NOT COMPLETED|Treatment Period 3||0
60834|NCT01400906|141602|P6|COMPLETED|Treatment Period 3||5
60835|NCT01400906|141603|P5|COMPLETED|Treatment Period 3||6
60836|NCT01400906|141604|P4|COMPLETED|Treatment Period 3||6
60837|NCT01400906|141605|P3|COMPLETED|Treatment Period 3||6
60838|NCT01400906|141606|P2|COMPLETED|Treatment Period 3||6
60839|NCT01400906|141607|P1|COMPLETED|Treatment Period 3||6
60840|NCT01400906|141602|P6|STARTED|Treatment Period 3||5
60841|NCT01400906|141603|P5|STARTED|Treatment Period 3||6
60842|NCT01400906|141604|P4|STARTED|Treatment Period 3||6
60843|NCT01400906|141605|P3|STARTED|Treatment Period 3||6
60844|NCT01400906|141606|P2|STARTED|Treatment Period 3||6
60845|NCT01400906|141607|P1|STARTED|Treatment Period 3||6
60846|NCT01400906|141602|P6|NOT COMPLETED|Washout Period 2||0
60847|NCT01400906|141603|P5|NOT COMPLETED|Washout Period 2||0
60848|NCT01400906|141604|P4|NOT COMPLETED|Washout Period 2||0
60849|NCT01400906|141605|P3|NOT COMPLETED|Washout Period 2||0
60850|NCT01400906|141606|P2|NOT COMPLETED|Washout Period 2||0
60851|NCT01400906|141607|P1|NOT COMPLETED|Washout Period 2||0
60852|NCT01400906|141602|P6|COMPLETED|Washout Period 2||5
60853|NCT01400906|141603|P5|COMPLETED|Washout Period 2||6
60854|NCT01400906|141604|P4|COMPLETED|Washout Period 2||6
60855|NCT01400906|141605|P3|COMPLETED|Washout Period 2||6
60856|NCT01400906|141606|P2|COMPLETED|Washout Period 2||6
60857|NCT01400906|141607|P1|COMPLETED|Washout Period 2||6
60858|NCT01400906|141602|P6|STARTED|Washout Period 2||5
60859|NCT01400906|141603|P5|STARTED|Washout Period 2||6
60860|NCT01400906|141604|P4|STARTED|Washout Period 2||6
60861|NCT01400906|141605|P3|STARTED|Washout Period 2||6
60862|NCT01400906|141606|P2|STARTED|Washout Period 2||6
60863|NCT01400906|141607|P1|STARTED|Washout Period 2||6
60864|NCT01400906|141602|P6|NOT COMPLETED|Treatment Period 2||0
60865|NCT01400906|141603|P5|NOT COMPLETED|Treatment Period 2||0
60866|NCT01400906|141604|P4|NOT COMPLETED|Treatment Period 2||0
60867|NCT01400906|141605|P3|NOT COMPLETED|Treatment Period 2||0
60868|NCT01400906|141606|P2|NOT COMPLETED|Treatment Period 2||0
60869|NCT01400906|141607|P1|NOT COMPLETED|Treatment Period 2||0
60870|NCT01400906|141602|P6|COMPLETED|Treatment Period 2||5
60871|NCT01400906|141603|P5|COMPLETED|Treatment Period 2||6
60872|NCT01400906|141604|P4|COMPLETED|Treatment Period 2||6
60873|NCT01400906|141605|P3|COMPLETED|Treatment Period 2||6
60874|NCT01400906|141606|P2|COMPLETED|Treatment Period 2||6
60875|NCT01400906|141607|P1|COMPLETED|Treatment Period 2||6
60876|NCT01400906|141602|P6|STARTED|Treatment Period 2||5
60877|NCT01400906|141603|P5|STARTED|Treatment Period 2||6
60878|NCT01400906|141604|P4|STARTED|Treatment Period 2||6
60879|NCT01400906|141605|P3|STARTED|Treatment Period 2||6
60880|NCT01400906|141606|P2|STARTED|Treatment Period 2||6
60881|NCT01400906|141607|P1|STARTED|Treatment Period 2||6
60882|NCT01400906|141602|P6|NOT COMPLETED|Washout Period 1||0
60883|NCT01400906|141603|P5|NOT COMPLETED|Washout Period 1||0
60884|NCT01400906|141604|P4|NOT COMPLETED|Washout Period 1||0
60885|NCT01400906|141605|P3|NOT COMPLETED|Washout Period 1||0
60886|NCT01400906|141606|P2|NOT COMPLETED|Washout Period 1||0
60887|NCT01400906|141607|P1|NOT COMPLETED|Washout Period 1||0
60888|NCT01400906|141602|P6|COMPLETED|Washout Period 1||5
60889|NCT01400906|141603|P5|COMPLETED|Washout Period 1||6
60890|NCT01400906|141604|P4|COMPLETED|Washout Period 1||6
60891|NCT01400906|141605|P3|COMPLETED|Washout Period 1||6
60892|NCT01400906|141606|P2|COMPLETED|Washout Period 1||6
60893|NCT01400906|141607|P1|COMPLETED|Washout Period 1||6
60894|NCT01400906|141602|P6|STARTED|Washout Period 1||5
60895|NCT01400906|141603|P5|STARTED|Washout Period 1||6
60896|NCT01400906|141604|P4|STARTED|Washout Period 1||6
60897|NCT01400906|141605|P3|STARTED|Washout Period 1||6
60898|NCT01400906|141606|P2|STARTED|Washout Period 1||6
60899|NCT01400906|141607|P1|STARTED|Washout Period 1||6
60900|NCT01400906|141602|P6|NOT COMPLETED|Treatment Period 1||0
60901|NCT01400906|141603|P5|NOT COMPLETED|Treatment Period 1||0
60902|NCT01400906|141604|P4|NOT COMPLETED|Treatment Period 1||0
60903|NCT01400906|141605|P3|NOT COMPLETED|Treatment Period 1||0
60904|NCT01400906|141606|P2|NOT COMPLETED|Treatment Period 1||0
60905|NCT01400906|141607|P1|NOT COMPLETED|Treatment Period 1||0
60906|NCT01400906|141602|P6|COMPLETED|Treatment Period 1||5
60907|NCT01400906|141603|P5|COMPLETED|Treatment Period 1||6
60908|NCT01400906|141604|P4|COMPLETED|Treatment Period 1||6
60909|NCT01400906|141605|P3|COMPLETED|Treatment Period 1||6
60910|NCT01400906|141606|P2|COMPLETED|Treatment Period 1||6
60911|NCT01400906|141607|P1|COMPLETED|Treatment Period 1||6
60912|NCT01400906|141602|P6|STARTED|Treatment Period 1||5
60913|NCT01400906|141603|P5|STARTED|Treatment Period 1||6
60914|NCT01400906|141604|P4|STARTED|Treatment Period 1||6
60915|NCT01400906|141605|P3|STARTED|Treatment Period 1||6
60916|NCT01400906|141606|P2|STARTED|Treatment Period 1||6
60917|NCT01400906|141607|P1|STARTED|Treatment Period 1||6
60918|NCT01400880|141639|P1|NOT COMPLETED|Overall Study||2
60919|NCT01400880|141639|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
60920|NCT01400880|141639|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
60921|NCT01400841|141643|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
60922|NCT01400841|141643|P1|COMPLETED|Extended Study Phase (2 Years)||11
60923|NCT01400841|141643|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
60924|NCT01400841|141643|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
60925|NCT01400841|141643|P1|COMPLETED|Initial Study Phase (6 Months)||15
60926|NCT01400841|141643|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
60927|NCT01400451|141680|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
60928|NCT01400451|141681|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
60929|NCT01400451|141682|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
60930|NCT01400451|141680|P3|COMPLETED|Combination Treatment (or Intended)||0
60931|NCT01400451|141681|P2|COMPLETED|Combination Treatment (or Intended)||0
60932|NCT01400451|141682|P1|COMPLETED|Combination Treatment (or Intended)||0
60933|NCT01400451|141680|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
60934|NCT01400451|141681|P2|STARTED|Combination Treatment (or Intended)||4
60935|NCT01400451|141682|P1|STARTED|Combination Treatment (or Intended)||6
60936|NCT01400451|141680|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
60937|NCT01400451|141681|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
60938|NCT01400451|141682|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
60939|NCT01400451|141680|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
60940|NCT01400451|141681|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
60941|NCT01400451|141682|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
60942|NCT01400451|141680|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
60943|NCT01400451|141681|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
60944|NCT01400451|141682|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
60945|NCT01400425|141696|P1|NOT COMPLETED|Overall Study||10
60946|NCT01400425|141696|P1|COMPLETED|Overall Study||229
60947|NCT01400425|141696|P1|STARTED|Overall Study||239
60948|NCT01400412|141709|P2|NOT COMPLETED|Overall Study||17
60949|NCT01400412|141710|P1|NOT COMPLETED|Overall Study||10
60950|NCT01400412|141709|P2|COMPLETED|Overall Study||115
60951|NCT01400412|141710|P1|COMPLETED|Overall Study||120
60952|NCT01400412|141709|P2|STARTED|Overall Study||132
60953|NCT01400412|141710|P1|STARTED|Overall Study||130
60954|NCT01400243|141756|P2|NOT COMPLETED|Overall Study||11
60955|NCT01400243|141757|P1|NOT COMPLETED|Overall Study||8
60956|NCT01400243|141756|P2|COMPLETED|Overall Study||52
60957|NCT01400243|141757|P1|COMPLETED|Overall Study||56
60958|NCT01400243|141756|P2|STARTED|Overall Study||63
60959|NCT01400243|141757|P1|STARTED|Overall Study||64
60960|NCT01400139|141779|P1|NOT COMPLETED|HYD Extension Period||23
60961|NCT01400139|141779|P1|COMPLETED|HYD Extension Period||83
60962|NCT01400139|141779|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
60963|NCT01400139|141779|P1|NOT COMPLETED|HYD Core Study||512
60964|NCT01400139|141779|P1|COMPLETED|HYD Core Study||410
60965|NCT01400139|141779|P1|STARTED|HYD Core Study||922
60966|NCT01400113|141789|P2|NOT COMPLETED|Overall Study||1
60967|NCT01400113|141790|P1|NOT COMPLETED|Overall Study||1
60968|NCT01400113|141789|P2|COMPLETED|Overall Study||59
60969|NCT01400113|141790|P1|COMPLETED|Overall Study||59
60970|NCT01400113|141789|P2|STARTED|Overall Study||60
60971|NCT01400113|141790|P1|STARTED|Overall Study||60
60972|NCT01399866|141798|P2|NOT COMPLETED|Overall Study||2
60973|NCT01399866|141799|P1|NOT COMPLETED|Overall Study||4
60974|NCT01399866|141798|P2|COMPLETED|Overall Study||28
60975|NCT01399866|141799|P1|COMPLETED|Overall Study||28
60976|NCT01399866|141798|P2|STARTED|Overall Study||30
60977|NCT01399866|141799|P1|STARTED|Overall Study||32
60978|NCT01399788|141805|P2|NOT COMPLETED|Second Intervention Period||0
60979|NCT01399788|141806|P1|NOT COMPLETED|Second Intervention Period||0
60980|NCT01399788|141805|P2|COMPLETED|Second Intervention Period||18
60981|NCT01399788|141806|P1|COMPLETED|Second Intervention Period||17
60982|NCT01399788|141805|P2|STARTED|Second Intervention Period||18
60983|NCT01399788|141806|P1|STARTED|Second Intervention Period||17
60984|NCT01399788|141805|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
60985|NCT01399788|141806|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
60986|NCT01399788|141805|P2|COMPLETED|Washout Period (at Least 1 Week)||18
60987|NCT01399788|141806|P1|COMPLETED|Washout Period (at Least 1 Week)||17
60988|NCT01399788|141805|P2|STARTED|Washout Period (at Least 1 Week)||18
60989|NCT01399788|141806|P1|STARTED|Washout Period (at Least 1 Week)||17
60990|NCT01399788|141805|P2|NOT COMPLETED|First Intervention Period||0
60991|NCT01399788|141806|P1|NOT COMPLETED|First Intervention Period||1
60992|NCT01399788|141805|P2|COMPLETED|First Intervention Period||18
60993|NCT01399788|141806|P1|COMPLETED|First Intervention Period||17
60994|NCT01399788|141805|P2|STARTED|First Intervention Period||18
60995|NCT01399788|141806|P1|STARTED|First Intervention Period||18
60996|NCT01399723|141828|P2|NOT COMPLETED|Overall Study||1
60997|NCT01399723|141829|P1|NOT COMPLETED|Overall Study||0
60998|NCT01399723|141828|P2|COMPLETED|Overall Study||263
60999|NCT01399723|141829|P1|COMPLETED|Overall Study||263
61000|NCT01399723|141828|P2|STARTED|Overall Study||264
61001|NCT01399723|141829|P1|STARTED|Overall Study||263
61002|NCT01399697|141842|P3|NOT COMPLETED|Overall Study||4
61003|NCT01399697|141843|P2|NOT COMPLETED|Overall Study||3
61004|NCT01399697|141844|P1|NOT COMPLETED|Overall Study||41
61005|NCT01399697|141842|P3|COMPLETED|Overall Study||78
61006|NCT01399697|141843|P2|COMPLETED|Overall Study||80
61007|NCT01399697|141844|P1|COMPLETED|Overall Study||55
61008|NCT01399697|141842|P3|STARTED|Overall Study||82
61009|NCT01399697|141843|P2|STARTED|Overall Study||83
61010|NCT01399697|141844|P1|STARTED|Overall Study||96
61011|NCT01399619|141871|P4|NOT COMPLETED|Overall Study||17
61012|NCT01399619|141872|P3|NOT COMPLETED|Overall Study||12
61013|NCT01399619|141873|P2|NOT COMPLETED|Overall Study||0
61014|NCT01399619|141874|P1|NOT COMPLETED|Overall Study||25
61015|NCT01399619|141871|P4|COMPLETED|Overall Study||0
61016|NCT01399619|141872|P3|COMPLETED|Overall Study||74
61017|NCT01399619|141873|P2|COMPLETED|Overall Study||84
61018|NCT01399619|141874|P1|COMPLETED|Overall Study||98
61019|NCT01399619|141871|P4|STARTED|Overall Study||17
61020|NCT01399619|141872|P3|STARTED|Overall Study||86
61021|NCT01399619|141873|P2|STARTED|Overall Study||84
61022|NCT01399619|141874|P1|STARTED|Overall Study||123
61023|NCT01399229|141935|P3|NOT COMPLETED|Overall Study||0
61024|NCT01399229|141936|P2|NOT COMPLETED|Overall Study||0
61025|NCT01399229|141937|P1|NOT COMPLETED|Overall Study||0
61026|NCT01399229|141935|P3|COMPLETED|Overall Study||5
61027|NCT01399229|141936|P2|COMPLETED|Overall Study||5
61028|NCT01399229|141937|P1|COMPLETED|Overall Study||20
61029|NCT01399229|141935|P3|STARTED|Overall Study||5
61030|NCT01399229|141936|P2|STARTED|Overall Study||5
61031|NCT01399229|141937|P1|STARTED|Overall Study||20
61032|NCT01399190|141941|P1|NOT COMPLETED|Overall Study||20
61033|NCT01399190|141941|P1|COMPLETED|Overall Study||48
61034|NCT01399190|141941|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
61035|NCT01399190|141941|P1|Included in Final Analysis|Overall Study||63
61036|NCT01399190|141941|P1|STARTED|Overall Study||68
61037|NCT01399125|141949|P2|NOT COMPLETED|Overall Study||60
61038|NCT01399125|141950|P1|NOT COMPLETED|Overall Study||51
61039|NCT01399125|141949|P2|COMPLETED|Overall Study||193
61040|NCT01399125|141950|P1|COMPLETED|Overall Study||197
61041|NCT01399125|141949|P2|Per Protocol (PP) Population|Overall Study||188
61042|NCT01399125|141950|P1|Per Protocol (PP) Population|Overall Study||192
61043|NCT01399125|141949|P2|STARTED|Overall Study||253
61044|NCT01399125|141950|P1|STARTED|Overall Study||248
61045|NCT01399099|141964|P1|NOT COMPLETED|Overall Study||31
61046|NCT01399099|141964|P1|COMPLETED|Overall Study||36
61047|NCT01399099|141964|P1|6 Months|Overall Study||47
61048|NCT01399099|141964|P1|STARTED|Overall Study||67
61049|NCT01399047|141971|P2|NOT COMPLETED|Overall Study||1
61050|NCT01399047|141972|P1|NOT COMPLETED|Overall Study||0
61051|NCT01399047|141971|P2|COMPLETED|Overall Study||8
61052|NCT01399047|141972|P1|COMPLETED|Overall Study||10
61053|NCT01399047|141971|P2|STARTED|Overall Study||9
61054|NCT01399047|141972|P1|STARTED|Overall Study||10
61055|NCT01399008|141981|P3|NOT COMPLETED|Overall Study||2
61056|NCT01399008|141982|P2|NOT COMPLETED|Overall Study||5
61057|NCT01399008|141983|P1|NOT COMPLETED|Overall Study||3
61058|NCT01399008|141981|P3|COMPLETED|Overall Study||31
61059|NCT01399008|141982|P2|COMPLETED|Overall Study||27
61060|NCT01399008|141983|P1|COMPLETED|Overall Study||32
61061|NCT01399008|141981|P3|STARTED|Overall Study||33
61062|NCT01399008|141982|P2|STARTED|Overall Study||32
61063|NCT01399008|141983|P1|STARTED|Overall Study||35
61064|NCT01398982|141993|P2|NOT COMPLETED|Overall Study||2
61065|NCT01398982|141994|P1|NOT COMPLETED|Overall Study||6
61066|NCT01398982|141993|P2|COMPLETED|Overall Study||47
61067|NCT01398982|141994|P1|COMPLETED|Overall Study||38
61068|NCT01398982|141993|P2|STARTED|Overall Study||49
61069|NCT01398982|141994|P1|STARTED|Overall Study||44
61070|NCT01398852|142000|P1|NOT COMPLETED|Overall Study||372
61071|NCT01398852|142000|P1|COMPLETED|Overall Study||0
61072|NCT01398852|142000|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
61073|NCT01398839|142006|P2|NOT COMPLETED|Overall Study||0
61074|NCT01398839|142007|P1|NOT COMPLETED|Overall Study||0
61075|NCT01398839|142006|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
61076|NCT01398839|142007|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
61077|NCT01398839|142006|P2|STARTED|Overall Study||37
61078|NCT01398839|142007|P1|STARTED|Overall Study||35
61079|NCT01398787|142013|P1|NOT COMPLETED|Overall Study||1
61080|NCT01398787|142013|P1|COMPLETED|Overall Study||197
61081|NCT01398787|142013|P1|STARTED|Overall Study||198
61082|NCT01398514|142031|P2|NOT COMPLETED|Overall Study||6
61083|NCT01398514|142032|P1|NOT COMPLETED|Overall Study||8
61084|NCT01398514|142031|P2|COMPLETED|Overall Study||20
61085|NCT01398514|142032|P1|COMPLETED|Overall Study||18
61086|NCT01398514|142031|P2|STARTED|Overall Study||26
61087|NCT01398514|142032|P1|STARTED|Overall Study||26
61088|NCT01398410|142046|P2|NOT COMPLETED|Overall Study||56
61089|NCT01398410|142047|P1|NOT COMPLETED|Overall Study||58
61090|NCT01398410|142046|P2|COMPLETED|Overall Study||148
61091|NCT01398410|142047|P1|COMPLETED|Overall Study||143
61092|NCT01398410|142046|P2|STARTED|Overall Study||204
61093|NCT01398410|142047|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
61094|NCT01398176|142057|P2|NOT COMPLETED|Overall Study||6
61095|NCT01398176|142058|P1|NOT COMPLETED|Overall Study||3
61096|NCT01398176|142057|P2|COMPLETED|Overall Study||19
61097|NCT01398176|142058|P1|COMPLETED|Overall Study||23
61098|NCT01398176|142057|P2|STARTED|Overall Study||25
61099|NCT01398176|142058|P1|STARTED|Overall Study||26
61100|NCT01397890|142066|P2|NOT COMPLETED|Overall Study||31
61101|NCT01397890|142067|P1|NOT COMPLETED|Overall Study||23
61102|NCT01397890|142066|P2|COMPLETED|Overall Study||260
61103|NCT01397890|142067|P1|COMPLETED|Overall Study||264
61104|NCT01397890|142066|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
61105|NCT01397890|142067|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
61106|NCT01397890|142066|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
61107|NCT01397890|142067|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
61108|NCT01397890|142066|P2|STARTED|Overall Study||291
61109|NCT01397890|142067|P1|STARTED|Overall Study||287
61110|NCT01397851|142121|P2|NOT COMPLETED|Overall Study||46
61111|NCT01397851|142122|P1|NOT COMPLETED|Overall Study||79
61112|NCT01397851|142121|P2|COMPLETED|Overall Study||39917
61113|NCT01397851|142122|P1|COMPLETED|Overall Study||41555
61114|NCT01397851|142121|P2|STARTED|Overall Study||39963
61115|NCT01397851|142122|P1|STARTED|Overall Study||41634
61116|NCT01397747|142134|P1|NOT COMPLETED|Overall Study||1027
61117|NCT01397747|142134|P1|COMPLETED|Overall Study||9989
61118|NCT01397747|142134|P1|STARTED|Overall Study||11016
61119|NCT01397617|142142|P3|NOT COMPLETED|Overall Study||29
61120|NCT01397617|142143|P2|NOT COMPLETED|Overall Study||23
61121|NCT01397617|142144|P1|NOT COMPLETED|Overall Study||31
61122|NCT01397617|142142|P3|COMPLETED|Overall Study||31
61123|NCT01397617|142143|P2|COMPLETED|Overall Study||30
61124|NCT01397617|142144|P1|COMPLETED|Overall Study||33
61125|NCT01397617|142142|P3|STARTED|Overall Study||60
61126|NCT01397617|142143|P2|STARTED|Overall Study||53
61127|NCT01397617|142144|P1|STARTED|Overall Study||64
61128|NCT01397591|142155|P1|NOT COMPLETED|Overall Study||0
61129|NCT01397591|142155|P1|COMPLETED|Overall Study||2
61130|NCT01397591|142155|P1|STARTED|Overall Study||2
61131|NCT01397461|142166|P3|NOT COMPLETED|Overall Study||2
61132|NCT01397461|142167|P2|NOT COMPLETED|Overall Study||6
61133|NCT01397461|142168|P1|NOT COMPLETED|Overall Study||2
61134|NCT01397461|142166|P3|COMPLETED|Overall Study||152
61135|NCT01397461|142167|P2|COMPLETED|Overall Study||150
61136|NCT01397461|142168|P1|COMPLETED|Overall Study||153
61137|NCT01397461|142166|P3|STARTED|Overall Study||154
61138|NCT01397461|142167|P2|STARTED|Overall Study||156
61139|NCT01397461|142168|P1|STARTED|Overall Study||155
61140|NCT01397448|142179|P3|NOT COMPLETED|Overall Study||18
61141|NCT01397448|142180|P2|NOT COMPLETED|Overall Study||15
61142|NCT01397448|142181|P1|NOT COMPLETED|Overall Study||18
61143|NCT01397448|142179|P3|COMPLETED|Overall Study||140
61144|NCT01397448|142180|P2|COMPLETED|Overall Study||142
61145|NCT01397448|142181|P1|COMPLETED|Overall Study||138
61146|NCT01397448|142179|P3|STARTED|Overall Study||158
61147|NCT01397448|142180|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
61148|NCT01397448|142181|P1|STARTED|Overall Study||156
61149|NCT01397409|142202|P10|NOT COMPLETED|Stage 3||0
61150|NCT01397409|142203|P9|NOT COMPLETED|Stage 3||0
61151|NCT01397409|142204|P8|NOT COMPLETED|Stage 3||2
61152|NCT01397409|142205|P7|NOT COMPLETED|Stage 3||0
61153|NCT01397409|142206|P6|NOT COMPLETED|Stage 3||0
61154|NCT01397409|142207|P5|NOT COMPLETED|Stage 3||0
61155|NCT01397409|142208|P4|NOT COMPLETED|Stage 3||0
61156|NCT01397409|142209|P3|NOT COMPLETED|Stage 3||0
61157|NCT01397409|142210|P2|NOT COMPLETED|Stage 3||0
61158|NCT01397409|142211|P1|NOT COMPLETED|Stage 3||0
61159|NCT01397409|142202|P10|COMPLETED|Stage 3||16
61160|NCT01397409|142203|P9|COMPLETED|Stage 3||25
61161|NCT01397409|142204|P8|COMPLETED|Stage 3||21
61162|NCT01397409|142205|P7|COMPLETED|Stage 3||0
61163|NCT01397409|142206|P6|COMPLETED|Stage 3||0
61164|NCT01397409|142207|P5|COMPLETED|Stage 3||0
61165|NCT01397409|142208|P4|COMPLETED|Stage 3||0
61166|NCT01397409|142209|P3|COMPLETED|Stage 3||0
61167|NCT01397409|142210|P2|COMPLETED|Stage 3||0
61168|NCT01397409|142211|P1|COMPLETED|Stage 3||0
61169|NCT01397409|142202|P10|STARTED|Stage 3||16
61170|NCT01397409|142203|P9|STARTED|Stage 3||25
61171|NCT01397409|142204|P8|STARTED|Stage 3||23
61172|NCT01397409|142205|P7|STARTED|Stage 3||0
61173|NCT01397409|142206|P6|STARTED|Stage 3||0
61174|NCT01397409|142207|P5|STARTED|Stage 3||0
61175|NCT01397409|142208|P4|STARTED|Stage 3||0
61176|NCT01397409|142209|P3|STARTED|Stage 3||0
61177|NCT01397409|142210|P2|STARTED|Stage 3||0
61178|NCT01397409|142211|P1|STARTED|Stage 3||0
61179|NCT01397409|142202|P10|NOT COMPLETED|Stage 2||0
61180|NCT01397409|142203|P9|NOT COMPLETED|Stage 2||0
61181|NCT01397409|142204|P8|NOT COMPLETED|Stage 2||0
61182|NCT01397409|142205|P7|NOT COMPLETED|Stage 2||0
61183|NCT01397409|142206|P6|NOT COMPLETED|Stage 2||4
61184|NCT01397409|142207|P5|NOT COMPLETED|Stage 2||8
61185|NCT01397409|142208|P4|NOT COMPLETED|Stage 2||0
61186|NCT01397409|142209|P3|NOT COMPLETED|Stage 2||0
61187|NCT01397409|142210|P2|NOT COMPLETED|Stage 2||0
61188|NCT01397409|142211|P1|NOT COMPLETED|Stage 2||0
61189|NCT01397409|142202|P10|COMPLETED|Stage 2||0
61190|NCT01397409|142203|P9|COMPLETED|Stage 2||0
61191|NCT01397409|142204|P8|COMPLETED|Stage 2||0
61192|NCT01397409|142205|P7|COMPLETED|Stage 2||58
61193|NCT01397409|142206|P6|COMPLETED|Stage 2||54
61194|NCT01397409|142207|P5|COMPLETED|Stage 2||59
61195|NCT01397409|142208|P4|COMPLETED|Stage 2||0
61196|NCT01397409|142209|P3|COMPLETED|Stage 2||0
61197|NCT01397409|142210|P2|COMPLETED|Stage 2||0
61198|NCT01397409|142211|P1|COMPLETED|Stage 2||0
61199|NCT01397409|142202|P10|STARTED|Stage 2||0
61200|NCT01397409|142203|P9|STARTED|Stage 2||0
61201|NCT01397409|142204|P8|STARTED|Stage 2||0
61202|NCT01397409|142205|P7|STARTED|Stage 2||58
61203|NCT01397409|142206|P6|STARTED|Stage 2||58
61204|NCT01397409|142207|P5|STARTED|Stage 2||67
61205|NCT01397409|142208|P4|STARTED|Stage 2||0
61206|NCT01397409|142209|P3|STARTED|Stage 2||0
61207|NCT01397409|142210|P2|STARTED|Stage 2||0
61208|NCT01397409|142211|P1|STARTED|Stage 2||0
61209|NCT01397409|142202|P10|NOT COMPLETED|Stage 1||0
61210|NCT01397409|142203|P9|NOT COMPLETED|Stage 1||0
61211|NCT01397409|142204|P8|NOT COMPLETED|Stage 1||0
61212|NCT01397409|142205|P7|NOT COMPLETED|Stage 1||0
61213|NCT01397409|142206|P6|NOT COMPLETED|Stage 1||0
61214|NCT01397409|142207|P5|NOT COMPLETED|Stage 1||0
61215|NCT01397409|142208|P4|NOT COMPLETED|Stage 1||0
61216|NCT01397409|142209|P3|NOT COMPLETED|Stage 1||0
61217|NCT01397409|142210|P2|NOT COMPLETED|Stage 1||0
61218|NCT01397409|142211|P1|NOT COMPLETED|Stage 1||0
61219|NCT01397409|142202|P10|COMPLETED|Stage 1||0
61220|NCT01397409|142203|P9|COMPLETED|Stage 1||0
61221|NCT01397409|142204|P8|COMPLETED|Stage 1||0
61222|NCT01397409|142205|P7|COMPLETED|Stage 1||0
61223|NCT01397409|142206|P6|COMPLETED|Stage 1||0
61224|NCT01397409|142207|P5|COMPLETED|Stage 1||0
61225|NCT01397409|142208|P4|COMPLETED|Stage 1||3
61226|NCT01397409|142209|P3|COMPLETED|Stage 1||6
61227|NCT01397409|142210|P2|COMPLETED|Stage 1||6
61228|NCT01397409|142211|P1|COMPLETED|Stage 1||9
61229|NCT01397409|142202|P10|STARTED|Stage 1||0
61230|NCT01397409|142203|P9|STARTED|Stage 1||0
61231|NCT01397409|142204|P8|STARTED|Stage 1||0
61232|NCT01397409|142205|P7|STARTED|Stage 1||0
61233|NCT01397409|142206|P6|STARTED|Stage 1||0
61234|NCT01397409|142207|P5|STARTED|Stage 1||0
61235|NCT01397409|142208|P4|STARTED|Stage 1||3
61236|NCT01397409|142209|P3|STARTED|Stage 1||6
61237|NCT01397409|142210|P2|STARTED|Stage 1||6
61238|NCT01397409|142211|P1|STARTED|Stage 1||9
61239|NCT01397253|142251|P2|NOT COMPLETED|Overall Study||149
61240|NCT01397253|142252|P1|NOT COMPLETED|Overall Study||126
61241|NCT01397253|142251|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
61242|NCT01397253|142252|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
61243|NCT01397253|142251|P2|STARTED|Overall Study||392
61244|NCT01397253|142252|P1|STARTED|Overall Study||443
61245|NCT01397084|142258|P1|NOT COMPLETED|Overall Study||8
61246|NCT01397084|142258|P1|COMPLETED|Overall Study||100
61247|NCT01397084|142258|P1|STARTED|Overall Study||108
61248|NCT01396525|142265|P1|NOT COMPLETED|Overall Study||26
61249|NCT01396525|142265|P1|COMPLETED|Overall Study||127
61250|NCT01396525|142265|P1|STARTED|Overall Study||153
61251|NCT01396512|142365|P2|NOT COMPLETED|Overall Study||1
61252|NCT01396512|142366|P1|NOT COMPLETED|Overall Study||0
61253|NCT01396512|142365|P2|COMPLETED|Overall Study||136
61254|NCT01396512|142366|P1|COMPLETED|Overall Study||137
61255|NCT01396512|142365|P2|STARTED|Overall Study||137
61256|NCT01396512|142366|P1|STARTED|Overall Study||137
61257|NCT01396434|142381|P3|NOT COMPLETED|Overall Study||0
61258|NCT01396434|142382|P2|NOT COMPLETED|Overall Study||0
61259|NCT01396434|142383|P1|NOT COMPLETED|Overall Study||11
61260|NCT01396434|142381|P3|COMPLETED|Overall Study||14
61261|NCT01396434|142382|P2|COMPLETED|Overall Study||175
61262|NCT01396434|142383|P1|COMPLETED|Overall Study||2806
61263|NCT01396434|142381|P3|STARTED|Overall Study||14
61264|NCT01396434|142382|P2|STARTED|Overall Study||175
61265|NCT01396434|142383|P1|STARTED|Overall Study||2817
61266|NCT01396421|142395|P4|NOT COMPLETED|Overall Study||75
61267|NCT01396421|142396|P3|NOT COMPLETED|Overall Study||34
61268|NCT01396421|142397|P2|NOT COMPLETED|Overall Study||58
61269|NCT01396421|142398|P1|NOT COMPLETED|Overall Study||59
61270|NCT01396421|142395|P4|COMPLETED|Overall Study||109
61271|NCT01396421|142396|P3|COMPLETED|Overall Study||56
61272|NCT01396421|142397|P2|COMPLETED|Overall Study||124
61273|NCT01396421|142398|P1|COMPLETED|Overall Study||121
61274|NCT01396421|142395|P4|STARTED|Overall Study||184
61275|NCT01396421|142396|P3|STARTED|Overall Study||90
61276|NCT01396421|142397|P2|STARTED|Overall Study||182
61277|NCT01396421|142398|P1|STARTED|Overall Study||180
61278|NCT01396395|142470|P2|NOT COMPLETED|Overall Study||27
61279|NCT01396395|142471|P1|NOT COMPLETED|Overall Study||40
61280|NCT01396395|142470|P2|COMPLETED|Overall Study||175
61281|NCT01396395|142471|P1|COMPLETED|Overall Study||160
61282|NCT01396395|142470|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
61283|NCT01396395|142471|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
61284|NCT01396395|142470|P2|STARTED|Overall Study||202
61285|NCT01396395|142471|P1|STARTED|Overall Study||200
61286|NCT01396382|142506|P1|NOT COMPLETED|Overall Study||0
61287|NCT01396382|142506|P1|COMPLETED|Overall Study||97
61288|NCT01396382|142506|P1|STARTED|Overall Study||97
61289|NCT01396265|142511|P1|NOT COMPLETED|Rifa+Afatinib||1
61290|NCT01396265|142511|P1|COMPLETED|Rifa+Afatinib||21
61291|NCT01396265|142511|P1|STARTED|Rifa+Afatinib||22
61292|NCT01396265|142511|P1|NOT COMPLETED|Washout||0
61293|NCT01396265|142511|P1|COMPLETED|Washout||22
61294|NCT01396265|142511|P1|STARTED|Washout||22
61295|NCT01396265|142511|P1|NOT COMPLETED|Afatinib||0
61296|NCT01396265|142511|P1|COMPLETED|Afatinib||22
61297|NCT01396265|142511|P1|STARTED|Afatinib||22
61298|NCT01396239|142538|P4|NOT COMPLETED|Overall Study||0
61299|NCT01396239|142539|P3|NOT COMPLETED|Overall Study||0
61300|NCT01396239|142540|P2|NOT COMPLETED|Overall Study||0
61301|NCT01396239|142541|P1|NOT COMPLETED|Overall Study||0
61302|NCT01396239|142538|P4|COMPLETED|Overall Study||2
61303|NCT01396239|142539|P3|COMPLETED|Overall Study||4
61304|NCT01396239|142540|P2|COMPLETED|Overall Study||2
61305|NCT01396239|142541|P1|COMPLETED|Overall Study||4
61306|NCT01396239|142538|P4|STARTED|Overall Study||2
61307|NCT01396239|142539|P3|STARTED|Overall Study||4
61308|NCT01396239|142540|P2|STARTED|Overall Study||2
61309|NCT01396239|142541|P1|STARTED|Overall Study||4
61310|NCT01396226|142564|P2|NOT COMPLETED|Overall Study||0
61311|NCT01396226|142565|P1|NOT COMPLETED|Overall Study||0
61312|NCT01396226|142564|P2|COMPLETED|Overall Study||6
61313|NCT01396226|142565|P1|COMPLETED|Overall Study||12
61314|NCT01396226|142564|P2|Patients Who Completed Treatment|Overall Study||6
61315|NCT01396226|142565|P1|Patients Who Completed Treatment|Overall Study||12
61316|NCT01396226|142564|P2|Patients Who Received Treatment|Overall Study||6
61317|NCT01396226|142565|P1|Patients Who Received Treatment|Overall Study||12
61318|NCT01396226|142564|P2|STARTED|Overall Study||6
61319|NCT01396226|142565|P1|STARTED|Overall Study||12
61320|NCT01396187|142600|P5|NOT COMPLETED|Overall Study||1
61321|NCT01396187|142601|P4|NOT COMPLETED|Overall Study||0
61322|NCT01396187|142602|P3|NOT COMPLETED|Overall Study||1
61323|NCT01396187|142603|P2|NOT COMPLETED|Overall Study||3
61324|NCT01396187|142604|P1|NOT COMPLETED|Overall Study||1
61325|NCT01396187|142600|P5|COMPLETED|Overall Study||9
61326|NCT01396187|142601|P4|COMPLETED|Overall Study||10
61327|NCT01396187|142602|P3|COMPLETED|Overall Study||9
61328|NCT01396187|142603|P2|COMPLETED|Overall Study||9
61329|NCT01396187|142604|P1|COMPLETED|Overall Study||7
61330|NCT01396187|142600|P5|STARTED|Overall Study||10
61331|NCT01396187|142601|P4|STARTED|Overall Study||10
61332|NCT01396187|142602|P3|STARTED|Overall Study||10
61333|NCT01396187|142603|P2|STARTED|Overall Study||12
61334|NCT01396187|142604|P1|STARTED|Overall Study||8
61335|NCT01396161|142704|P7|NOT COMPLETED|Overall Study||1
61336|NCT01396161|142705|P6|NOT COMPLETED|Overall Study||0
61337|NCT01396161|142706|P5|NOT COMPLETED|Overall Study||1
61338|NCT01396161|142707|P4|NOT COMPLETED|Overall Study||0
61339|NCT01396161|142708|P3|NOT COMPLETED|Overall Study||0
61340|NCT01396161|142709|P2|NOT COMPLETED|Overall Study||0
61341|NCT01396161|142710|P1|NOT COMPLETED|Overall Study||0
61342|NCT01396161|142704|P7|COMPLETED|Overall Study||10
61343|NCT01396161|142705|P6|COMPLETED|Overall Study||9
61344|NCT01396161|142706|P5|COMPLETED|Overall Study||8
61345|NCT01396161|142707|P4|COMPLETED|Overall Study||9
61346|NCT01396161|142708|P3|COMPLETED|Overall Study||9
61347|NCT01396161|142709|P2|COMPLETED|Overall Study||5
61348|NCT01396161|142710|P1|COMPLETED|Overall Study||12
61349|NCT01396161|142704|P7|STARTED|Overall Study||11
61350|NCT01396161|142705|P6|STARTED|Overall Study||9
61351|NCT01396161|142706|P5|STARTED|Overall Study||9
61352|NCT01396161|142707|P4|STARTED|Overall Study||9
61353|NCT01396161|142708|P3|STARTED|Overall Study||9
61354|NCT01396161|142709|P2|STARTED|Overall Study||5
61355|NCT01396161|142710|P1|STARTED|Overall Study||12
61356|NCT01396083|142765|P2|NOT COMPLETED|Overall Study||47
61357|NCT01396083|142766|P1|NOT COMPLETED|Overall Study||11
61358|NCT01396083|142765|P2|COMPLETED|Overall Study||72
61359|NCT01396083|142766|P1|COMPLETED|Overall Study||113
61360|NCT01396083|142765|P2|STARTED|Overall Study||119
61361|NCT01396083|142766|P1|STARTED|Overall Study||124
61362|NCT01396057|142792|P2|NOT COMPLETED|Overall Study||18
61363|NCT01396057|142793|P1|NOT COMPLETED|Overall Study||11
61364|NCT01396057|142792|P2|COMPLETED|Overall Study||100
61365|NCT01396057|142793|P1|COMPLETED|Overall Study||115
61366|NCT01396057|142792|P2|STARTED|Overall Study||118
61367|NCT01396057|142793|P1|STARTED|Overall Study||126
61368|NCT01396044|142819|P2|NOT COMPLETED|Overall Study||0
61369|NCT01396044|142820|P1|NOT COMPLETED|Overall Study||0
61370|NCT01396044|142819|P2|COMPLETED|Overall Study||171
61371|NCT01396044|142820|P1|COMPLETED|Overall Study||125
61372|NCT01396044|142819|P2|STARTED|Overall Study||171
61373|NCT01396044|142820|P1|STARTED|Overall Study||125
61374|NCT01396005|142842|P2|NOT COMPLETED|Overall Study||2
61375|NCT01396005|142843|P1|NOT COMPLETED|Overall Study||0
61376|NCT01396005|142842|P2|COMPLETED|Overall Study||9
61377|NCT01396005|142843|P1|COMPLETED|Overall Study||10
61378|NCT01396005|142842|P2|STARTED|Overall Study||11
61379|NCT01396005|142843|P1|STARTED|Overall Study||10
61380|NCT01395966|142862|P3|NOT COMPLETED|Overall Study||8
61381|NCT01395966|142863|P2|NOT COMPLETED|Overall Study||19
61382|NCT01395966|142864|P1|NOT COMPLETED|Overall Study||10
61383|NCT01395966|142862|P3|COMPLETED|Overall Study||104
61384|NCT01395966|142863|P2|COMPLETED|Overall Study||91
61385|NCT01395966|142864|P1|COMPLETED|Overall Study||99
61386|NCT01395966|142862|P3|STARTED|Overall Study||112
61387|NCT01395966|142863|P2|STARTED|Overall Study||110
61388|NCT01395966|142864|P1|STARTED|Overall Study||109
61389|NCT01395901|142874|P2|NOT COMPLETED|Overall Study||5
61390|NCT01395901|142875|P1|NOT COMPLETED|Overall Study||10
61391|NCT01395901|142874|P2|COMPLETED|Overall Study|Treated patients completing the study|329
61392|NCT01395901|142875|P1|COMPLETED|Overall Study|Treated patients completing the study|326
61393|NCT01395901|142874|P2|STARTED|Overall Study|Randomized Population|334
61394|NCT01395901|142875|P1|STARTED|Overall Study|Randomized Population|336
61395|NCT01395888|142891|P3|NOT COMPLETED|Treatment Period (TP)||17
61396|NCT01395888|142892|P2|NOT COMPLETED|Treatment Period (TP)||15
61397|NCT01395888|142893|P1|NOT COMPLETED|Treatment Period (TP)||0
61398|NCT01395888|142891|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
61399|NCT01395888|142892|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
61400|NCT01395888|142893|P1|COMPLETED|Treatment Period (TP)||0
61401|NCT01395888|142891|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
61402|NCT01395888|142892|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
61403|NCT01395888|142893|P1|Completed the Treatment Period|Treatment Period (TP)||0
61404|NCT01395888|142891|P3|STARTED|Treatment Period (TP)||130
61405|NCT01395888|142892|P2|STARTED|Treatment Period (TP)||127
61406|NCT01395888|142893|P1|STARTED|Treatment Period (TP)||0
61407|NCT01395888|142891|P3|NOT COMPLETED|2-week Run-in Period||0
61408|NCT01395888|142892|P2|NOT COMPLETED|2-week Run-in Period||0
61409|NCT01395888|142893|P1|NOT COMPLETED|2-week Run-in Period||22
61410|NCT01395888|142891|P3|COMPLETED|2-week Run-in Period||0
61411|NCT01395888|142892|P2|COMPLETED|2-week Run-in Period||0
61412|NCT01395888|142893|P1|COMPLETED|2-week Run-in Period||257
61413|NCT01395888|142891|P3|STARTED|2-week Run-in Period||0
61414|NCT01395888|142892|P2|STARTED|2-week Run-in Period||0
61415|NCT01395888|142893|P1|STARTED|2-week Run-in Period||279
61416|NCT01395823|142901|P2|NOT COMPLETED|Overall Study||9
61417|NCT01395823|142902|P1|NOT COMPLETED|Overall Study||15
61418|NCT01395823|142901|P2|COMPLETED|Overall Study||130
61419|NCT01395823|142902|P1|COMPLETED|Overall Study||122
61420|NCT01395823|142901|P2|STARTED|Overall Study||139
61421|NCT01395823|142902|P1|STARTED|Overall Study||137
61422|NCT01395784|142908|P1|NOT COMPLETED|Overall Study||15
61423|NCT01395784|142908|P1|COMPLETED|Overall Study||17
61424|NCT01395784|142908|P1|STARTED|Overall Study||32
61425|NCT01395524|142916|P3|NOT COMPLETED|Overall Study||17
61426|NCT01395524|142917|P2|NOT COMPLETED|Overall Study||16
61427|NCT01395524|142918|P1|NOT COMPLETED|Overall Study||18
61428|NCT01395524|142916|P3|COMPLETED|Overall Study||89
61429|NCT01395524|142917|P2|COMPLETED|Overall Study||83
61430|NCT01395524|142918|P1|COMPLETED|Overall Study||79
61431|NCT01395524|142916|P3|STARTED|Overall Study||106
61432|NCT01395524|142917|P2|STARTED|Overall Study||99
61433|NCT01395524|142918|P1|STARTED|Overall Study||97
61434|NCT01395394|142941|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
61435|NCT01395394|142942|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
61436|NCT01395394|142943|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
61437|NCT01395394|142941|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
61438|NCT01395394|142942|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
61439|NCT01395394|142943|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
61440|NCT01395394|142941|P3|STARTED|Study Visit 2 (Non-responders Only)||0
61441|NCT01395394|142942|P2|STARTED|Study Visit 2 (Non-responders Only)||0
61442|NCT01395394|142943|P1|STARTED|Study Visit 2 (Non-responders Only)||3
61443|NCT01395394|142941|P3|NOT COMPLETED|Baseline Study Visit||0
61444|NCT01395394|142942|P2|NOT COMPLETED|Baseline Study Visit||0
61445|NCT01395394|142943|P1|NOT COMPLETED|Baseline Study Visit||1
61446|NCT01395394|142941|P3|COMPLETED|Baseline Study Visit||5
61447|NCT01395394|142942|P2|COMPLETED|Baseline Study Visit||3
61448|NCT01395394|142943|P1|COMPLETED|Baseline Study Visit||3
61449|NCT01395394|142941|P3|STARTED|Baseline Study Visit||5
61450|NCT01395394|142942|P2|STARTED|Baseline Study Visit||3
61451|NCT01395394|142943|P1|STARTED|Baseline Study Visit||4
61452|NCT01395368|142954|P1|NOT COMPLETED|Overall Study||16
61453|NCT01395368|142954|P1|COMPLETED|Overall Study||92
61454|NCT01395368|142954|P1|STARTED|Overall Study||108
61455|NCT01395277|142960|P2|NOT COMPLETED|Overall Study||0
61456|NCT01395277|142961|P1|NOT COMPLETED|Overall Study||0
61457|NCT01395277|142960|P2|COMPLETED|Overall Study||15
61458|NCT01395277|142961|P1|COMPLETED|Overall Study||15
61459|NCT01395277|142960|P2|STARTED|Overall Study||15
61460|NCT01395277|142961|P1|STARTED|Overall Study||15
61461|NCT01395043|142969|P1|NOT COMPLETED|Overall Study||0
61462|NCT01395043|142969|P1|COMPLETED|Overall Study||15
61463|NCT01395043|142969|P1|STARTED|Overall Study||15
61464|NCT01395017|142976|P2|NOT COMPLETED|Overall Study||102
61465|NCT01395017|142977|P1|NOT COMPLETED|Overall Study||100
61466|NCT01395017|142976|P2|COMPLETED|Overall Study||0
61467|NCT01395017|142977|P1|COMPLETED|Overall Study||0
61468|NCT01395017|142976|P2|Treated|Overall Study||101
61469|NCT01395017|142977|P1|Treated|Overall Study||98
61470|NCT01395017|142976|P2|STARTED|Overall Study||102
61471|NCT01395017|142977|P1|STARTED|Overall Study||100
61472|NCT01394991|142987|P2|NOT COMPLETED|Overall Study||72
61473|NCT01394991|142988|P1|NOT COMPLETED|Overall Study||59
61474|NCT01394991|142987|P2|COMPLETED|Overall Study||190
61475|NCT01394991|142988|P1|COMPLETED|Overall Study||183
61476|NCT01394991|142987|P2|STARTED|Overall Study||262
61477|NCT01394991|142988|P1|STARTED|Overall Study||242
61478|NCT01394926|143008|P1|NOT COMPLETED|Overall Study||0
61479|NCT01394926|143008|P1|COMPLETED|Overall Study||21
61480|NCT01394926|143008|P1|STARTED|Overall Study||21
61481|NCT01394718|143019|P2|NOT COMPLETED|Overall Study||1
61482|NCT01394718|143020|P1|NOT COMPLETED|Overall Study||2
61483|NCT01394718|143019|P2|COMPLETED|Overall Study||29
61484|NCT01394718|143020|P1|COMPLETED|Overall Study||28
61485|NCT01394718|143019|P2|STARTED|Overall Study||30
61486|NCT01394718|143020|P1|STARTED|Overall Study||30
61487|NCT01394692|143034|P2|NOT COMPLETED|Overall Study||0
61488|NCT01394692|143035|P1|NOT COMPLETED|Overall Study||0
61489|NCT01394692|143034|P2|COMPLETED|Overall Study||29
61490|NCT01394692|143035|P1|COMPLETED|Overall Study||29
61491|NCT01394692|143034|P2|STARTED|Overall Study||29
61492|NCT01394692|143035|P1|STARTED|Overall Study||29
61493|NCT01394614|143043|P2|NOT COMPLETED|Overall Study||0
61494|NCT01394614|143044|P1|NOT COMPLETED|Overall Study||0
61495|NCT01394614|143043|P2|COMPLETED|Overall Study||16
61496|NCT01394614|143044|P1|COMPLETED|Overall Study||8
61497|NCT01394614|143043|P2|STARTED|Overall Study||16
61498|NCT01394614|143044|P1|STARTED|Overall Study||8
61499|NCT01394510|143050|P1|NOT COMPLETED|Overall Study||0
61500|NCT01394510|143050|P1|COMPLETED|Overall Study||13
61501|NCT01394510|143050|P1|STARTED|Overall Study||13
61502|NCT01394276|143056|P1|NOT COMPLETED|Overall Study||62
61503|NCT01394276|143056|P1|COMPLETED|Overall Study||260
61504|NCT01394276|143056|P1|STARTED|Overall Study||322
61505|NCT01394250|143080|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
61506|NCT01394250|143081|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
61507|NCT01394250|143080|P2|COMPLETED|Successful IV Placement & Follow-Up||110
61508|NCT01394250|143081|P1|COMPLETED|Successful IV Placement & Follow-Up||114
61509|NCT01394250|143080|P2|STARTED|Successful IV Placement & Follow-Up||121
61510|NCT01394250|143081|P1|STARTED|Successful IV Placement & Follow-Up||120
61511|NCT01394250|143080|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
61512|NCT01394250|143081|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
61513|NCT01394250|143080|P2|COMPLETED|Randomization and IV Placement Attempt||121
61514|NCT01394250|143081|P1|COMPLETED|Randomization and IV Placement Attempt||120
61515|NCT01394250|143080|P2|STARTED|Randomization and IV Placement Attempt||134
61516|NCT01394250|143081|P1|STARTED|Randomization and IV Placement Attempt||134
61517|NCT01394159|143091|P2|NOT COMPLETED|Overall Study||0
61518|NCT01394159|143092|P1|NOT COMPLETED|Overall Study||0
61519|NCT01394159|143091|P2|COMPLETED|Overall Study||28
61520|NCT01394159|143092|P1|COMPLETED|Overall Study||28
61521|NCT01394159|143091|P2|STARTED|Overall Study||28
61522|NCT01394159|143092|P1|STARTED|Overall Study||28
61523|NCT01393964|143105|P3|NOT COMPLETED|Overall Study||5
61524|NCT01393964|143106|P2|NOT COMPLETED|Overall Study||4
61525|NCT01393964|143107|P1|NOT COMPLETED|Overall Study||6
61526|NCT01393964|143105|P3|COMPLETED|Overall Study|completed=treatment on-going|4
61527|NCT01393964|143106|P2|COMPLETED|Overall Study|Completed=Treatment on-going|5
61528|NCT01393964|143107|P1|COMPLETED|Overall Study|Completed=treatment on-going|2
61529|NCT01393964|143105|P3|STARTED|Overall Study||9
61530|NCT01393964|143106|P2|STARTED|Overall Study||9
61531|NCT01393964|143107|P1|STARTED|Overall Study||8
61532|NCT01393899|143148|P3|NOT COMPLETED|Overall Study||23
61533|NCT01393899|143149|P2|NOT COMPLETED|Overall Study||28
61534|NCT01393899|143150|P1|NOT COMPLETED|Overall Study||32
61535|NCT01393899|143148|P3|COMPLETED|Overall Study||38
61536|NCT01393899|143149|P2|COMPLETED|Overall Study||32
61537|NCT01393899|143150|P1|COMPLETED|Overall Study||27
61538|NCT01393899|143148|P3|STARTED|Overall Study||61
61539|NCT01393899|143149|P2|STARTED|Overall Study||60
61540|NCT01393899|143150|P1|STARTED|Overall Study||59
61541|NCT01393743|143204|P2|NOT COMPLETED|Overall Study||13
61542|NCT01393743|143205|P1|NOT COMPLETED|Overall Study||10
61543|NCT01393743|143204|P2|COMPLETED|Overall Study||68
61544|NCT01393743|143205|P1|COMPLETED|Overall Study||72
61545|NCT01393743|143204|P2|STARTED|Overall Study|A total of 82 participants were enrolled but one participant withdrew prior to receiving treatment.|81
61546|NCT01393743|143205|P1|STARTED|Overall Study||82
61547|NCT01393613|143227|P4|NOT COMPLETED|Overall Study||66
61548|NCT01393613|143228|P3|NOT COMPLETED|Overall Study||54
61549|NCT01393613|143229|P2|NOT COMPLETED|Overall Study||57
61550|NCT01393613|143230|P1|NOT COMPLETED|Overall Study||39
61551|NCT01393613|143227|P4|COMPLETED|Overall Study||118
61552|NCT01393613|143228|P3|COMPLETED|Overall Study||130
61553|NCT01393613|143229|P2|COMPLETED|Overall Study||129
61554|NCT01393613|143230|P1|COMPLETED|Overall Study||81
61555|NCT01393613|143227|P4|STARTED|Overall Study||184
61556|NCT01393613|143228|P3|STARTED|Overall Study||184
61557|NCT01393613|143229|P2|STARTED|Overall Study||186
61558|NCT01393613|143230|P1|STARTED|Overall Study||120
61559|NCT01393444|143292|P1|NOT COMPLETED|Overall Study||3
61560|NCT01393444|143292|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
61561|NCT01393444|143292|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
61562|NCT01393444|143292|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
61563|NCT01393444|143292|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
61564|NCT01393444|143292|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
61565|NCT01393444|143292|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
61566|NCT01393444|143292|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
61567|NCT01393444|143292|P1|STARTED|Overall Study||6
61568|NCT01393132|143299|P2|NOT COMPLETED|Overall Study||0
61569|NCT01393132|143300|P1|NOT COMPLETED|Overall Study||0
61570|NCT01393132|143299|P2|COMPLETED|Overall Study||3
61571|NCT01393132|143300|P1|COMPLETED|Overall Study||6
61572|NCT01393132|143299|P2|STARTED|Overall Study||3
61573|NCT01393132|143300|P1|STARTED|Overall Study||6
61574|NCT01393106|143312|P1|NOT COMPLETED|Overall Study||5
61575|NCT01393106|143312|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
61576|NCT01393106|143312|P1|STARTED|Overall Study||25
61577|NCT01392742|143329|P1|NOT COMPLETED|Overall Study||201
61578|NCT01392742|143329|P1|COMPLETED|Overall Study||242
61579|NCT01392742|143329|P1|STARTED|Overall Study||443
61580|NCT01392703|143344|P3|NOT COMPLETED|Day 9||0
61581|NCT01392703|143345|P2|NOT COMPLETED|Day 9||0
61582|NCT01392703|143346|P1|NOT COMPLETED|Day 9||0
61583|NCT01392703|143344|P3|COMPLETED|Day 9||25
61584|NCT01392703|143345|P2|COMPLETED|Day 9||26
61585|NCT01392703|143346|P1|COMPLETED|Day 9||26
61586|NCT01392703|143344|P3|STARTED|Day 9||25
61587|NCT01392703|143345|P2|STARTED|Day 9||26
61588|NCT01392703|143346|P1|STARTED|Day 9||26
61589|NCT01392703|143344|P3|NOT COMPLETED|Day 5||0
61590|NCT01392703|143345|P2|NOT COMPLETED|Day 5||0
61591|NCT01392703|143346|P1|NOT COMPLETED|Day 5||0
61592|NCT01392703|143344|P3|COMPLETED|Day 5||26
61593|NCT01392703|143345|P2|COMPLETED|Day 5||25
61594|NCT01392703|143346|P1|COMPLETED|Day 5||26
61595|NCT01392703|143344|P3|STARTED|Day 5||26
61596|NCT01392703|143345|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
61597|NCT01392703|143346|P1|STARTED|Day 5||26
61598|NCT01392703|143344|P3|NOT COMPLETED|Day 1||0
61599|NCT01392703|143345|P2|NOT COMPLETED|Day 1||0
61600|NCT01392703|143346|P1|NOT COMPLETED|Day 1||0
61601|NCT01392703|143344|P3|COMPLETED|Day 1||26
61602|NCT01392703|143345|P2|COMPLETED|Day 1||26
61603|NCT01392703|143346|P1|COMPLETED|Day 1||26
61604|NCT01392703|143344|P3|STARTED|Day 1||26
61605|NCT01392703|143345|P2|STARTED|Day 1||26
61606|NCT01392703|143346|P1|STARTED|Day 1||26
61607|NCT01392677|143375|P2|NOT COMPLETED|Overall Study||8
61608|NCT01392677|143376|P1|NOT COMPLETED|Overall Study||8
61609|NCT01392677|143375|P2|COMPLETED|Overall Study||101
61610|NCT01392677|143376|P1|COMPLETED|Overall Study||101
61611|NCT01392677|143375|P2|STARTED|Overall Study||109
61612|NCT01392677|143376|P1|STARTED|Overall Study||109
61613|NCT01392573|143392|P2|NOT COMPLETED|Overall Study||35
61614|NCT01392573|143393|P1|NOT COMPLETED|Overall Study||32
61615|NCT01392573|143392|P2|COMPLETED|Overall Study||171
61616|NCT01392573|143393|P1|COMPLETED|Overall Study||175
61617|NCT01392573|143392|P2|Exposed|Overall Study||206
61618|NCT01392573|143393|P1|Exposed|Overall Study||207
61619|NCT01392573|143392|P2|STARTED|Overall Study||206
61620|NCT01392573|143393|P1|STARTED|Overall Study||207
61621|NCT01392560|143401|P1|NOT COMPLETED|Overall Study||12
61622|NCT01392560|143401|P1|COMPLETED|Overall Study||40
61623|NCT01392560|143401|P1|STARTED|Overall Study||52
61624|NCT01392547|143407|P1|NOT COMPLETED|Overall Study||8
61625|NCT01392547|143407|P1|COMPLETED|Overall Study||64
61626|NCT01392547|143407|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
61627|NCT01392495|143421|P1|NOT COMPLETED|Overall Study||16
61628|NCT01392495|143421|P1|COMPLETED|Overall Study||1
61629|NCT01392495|143421|P1|Received 400 mg|Overall Study||13
61630|NCT01392495|143421|P1|Received 200 mg|Overall Study||4
61631|NCT01392495|143421|P1|STARTED|Overall Study||17
61632|NCT01392378|143438|P5|NOT COMPLETED|Toddler Dose||1
61633|NCT01392378|143439|P4|NOT COMPLETED|Toddler Dose||2
61634|NCT01392378|143440|P3|NOT COMPLETED|Toddler Dose||0
61635|NCT01392378|143441|P2|NOT COMPLETED|Toddler Dose||1
61636|NCT01392378|143442|P1|NOT COMPLETED|Toddler Dose||0
61637|NCT01392378|143438|P5|COMPLETED|Toddler Dose||208
61638|NCT01392378|143439|P4|COMPLETED|Toddler Dose||173
61639|NCT01392378|143440|P3|COMPLETED|Toddler Dose||170
61640|NCT01392378|143441|P2|COMPLETED|Toddler Dose||172
61641|NCT01392378|143442|P1|COMPLETED|Toddler Dose||169
61642|NCT01392378|143438|P5|STARTED|Toddler Dose||209
61643|NCT01392378|143439|P4|STARTED|Toddler Dose||175
61644|NCT01392378|143440|P3|STARTED|Toddler Dose||170
61645|NCT01392378|143441|P2|STARTED|Toddler Dose||173
61646|NCT01392378|143442|P1|STARTED|Toddler Dose||169
61647|NCT01392378|143438|P5|NOT COMPLETED|After Infant Series||1
61648|NCT01392378|143439|P4|NOT COMPLETED|After Infant Series||0
61649|NCT01392378|143440|P3|NOT COMPLETED|After Infant Series||2
61650|NCT01392378|143441|P2|NOT COMPLETED|After Infant Series||1
61651|NCT01392378|143442|P1|NOT COMPLETED|After Infant Series||0
61652|NCT01392378|143438|P5|COMPLETED|After Infant Series||209
61653|NCT01392378|143439|P4|COMPLETED|After Infant Series||175
61654|NCT01392378|143440|P3|COMPLETED|After Infant Series||170
61655|NCT01392378|143441|P2|COMPLETED|After Infant Series||173
61656|NCT01392378|143442|P1|COMPLETED|After Infant Series||169
61657|NCT01392378|143438|P5|STARTED|After Infant Series||210
61658|NCT01392378|143439|P4|STARTED|After Infant Series||175
61659|NCT01392378|143440|P3|STARTED|After Infant Series||172
61660|NCT01392378|143441|P2|STARTED|After Infant Series||174
61661|NCT01392378|143442|P1|STARTED|After Infant Series||169
61662|NCT01392378|143438|P5|NOT COMPLETED|Infant Series||0
61663|NCT01392378|143439|P4|NOT COMPLETED|Infant Series||2
61664|NCT01392378|143440|P3|NOT COMPLETED|Infant Series||0
61665|NCT01392378|143441|P2|NOT COMPLETED|Infant Series||2
61666|NCT01392378|143442|P1|NOT COMPLETED|Infant Series||4
61667|NCT01392378|143438|P5|COMPLETED|Infant Series||210
61668|NCT01392378|143439|P4|COMPLETED|Infant Series||175
61669|NCT01392378|143440|P3|COMPLETED|Infant Series||172
61670|NCT01392378|143441|P2|COMPLETED|Infant Series||174
61671|NCT01392378|143442|P1|COMPLETED|Infant Series||169
61672|NCT01392378|143438|P5|Vaccinated Dose 3|Infant Series||210
61673|NCT01392378|143439|P4|Vaccinated Dose 3|Infant Series||176
61674|NCT01392378|143440|P3|Vaccinated Dose 3|Infant Series||172
61675|NCT01392378|143441|P2|Vaccinated Dose 3|Infant Series||174
61676|NCT01392378|143442|P1|Vaccinated Dose 3|Infant Series||170
61677|NCT01392378|143438|P5|Vaccinated Dose 2|Infant Series||210
61678|NCT01392378|143439|P4|Vaccinated Dose 2|Infant Series||177
61679|NCT01392378|143440|P3|Vaccinated Dose 2|Infant Series||172
61680|NCT01392378|143441|P2|Vaccinated Dose 2|Infant Series||174
61681|NCT01392378|143442|P1|Vaccinated Dose 2|Infant Series||171
61682|NCT01392378|143438|P5|Vaccinated Dose 1|Infant Series||210
61683|NCT01392378|143439|P4|Vaccinated Dose 1|Infant Series||177
61684|NCT01392378|143440|P3|Vaccinated Dose 1|Infant Series||172
61685|NCT01392378|143441|P2|Vaccinated Dose 1|Infant Series||176
61686|NCT01392378|143442|P1|Vaccinated Dose 1|Infant Series||173
61687|NCT01392378|143438|P5|STARTED|Infant Series||210
61688|NCT01392378|143439|P4|STARTED|Infant Series||177
61689|NCT01392378|143440|P3|STARTED|Infant Series||172
61690|NCT01392378|143441|P2|STARTED|Infant Series||176
61691|NCT01392378|143442|P1|STARTED|Infant Series||173
61692|NCT01392326|143582|P3|NOT COMPLETED|Overall Study||48
61693|NCT01392326|143583|P2|NOT COMPLETED|Overall Study||35
61694|NCT01392326|143584|P1|NOT COMPLETED|Overall Study||47
61695|NCT01392326|143582|P3|COMPLETED|Overall Study||154
61696|NCT01392326|143583|P2|COMPLETED|Overall Study||167
61697|NCT01392326|143584|P1|COMPLETED|Overall Study||155
61698|NCT01392326|143582|P3|STARTED|Overall Study||202
61699|NCT01392326|143583|P2|STARTED|Overall Study||202
61700|NCT01392326|143584|P1|STARTED|Overall Study||202
61701|NCT01391559|143619|P2|NOT COMPLETED|Second Intervention||0
61702|NCT01391559|143620|P1|NOT COMPLETED|Second Intervention||0
61703|NCT01391559|143619|P2|COMPLETED|Second Intervention||10
61704|NCT01391559|143620|P1|COMPLETED|Second Intervention||10
61705|NCT01391559|143619|P2|STARTED|Second Intervention||10
61706|NCT01391559|143620|P1|STARTED|Second Intervention||10
61707|NCT01391559|143619|P2|NOT COMPLETED|First Intervention||0
61708|NCT01391559|143620|P1|NOT COMPLETED|First Intervention||0
61709|NCT01391559|143619|P2|COMPLETED|First Intervention||10
61710|NCT01391559|143620|P1|COMPLETED|First Intervention||10
61711|NCT01391559|143619|P2|STARTED|First Intervention||10
61712|NCT01391559|143620|P1|STARTED|First Intervention||10
61713|NCT01391507|143630|P4|NOT COMPLETED|Overall Study||7
61714|NCT01391507|143631|P3|NOT COMPLETED|Overall Study||4
61715|NCT01391507|143632|P2|NOT COMPLETED|Overall Study||4
61716|NCT01391507|143633|P1|NOT COMPLETED|Overall Study||4
61717|NCT01391507|143630|P4|COMPLETED|Overall Study||5
61718|NCT01391507|143631|P3|COMPLETED|Overall Study||2
61719|NCT01391507|143632|P2|COMPLETED|Overall Study||4
61720|NCT01391507|143633|P1|COMPLETED|Overall Study||6
61721|NCT01391507|143630|P4|STARTED|Overall Study||12
61722|NCT01391507|143631|P3|STARTED|Overall Study||6
61723|NCT01391507|143632|P2|STARTED|Overall Study||8
61724|NCT01391507|143633|P1|STARTED|Overall Study||10
61725|NCT01392300|143681|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
61726|NCT01392300|143682|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
61727|NCT01392300|143683|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
61728|NCT01392300|143681|P3|COMPLETED|Open Label Extension (OLEX) Period||248
61729|NCT01392300|143682|P2|COMPLETED|Open Label Extension (OLEX) Period||0
61730|NCT01392300|143683|P1|COMPLETED|Open Label Extension (OLEX) Period||0
61731|NCT01392300|143681|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
61732|NCT01392300|143682|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
61733|NCT01392300|143683|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
61734|NCT01392300|143681|P3|NOT COMPLETED|Main Period (MP)||0
61735|NCT01392300|143682|P2|NOT COMPLETED|Main Period (MP)||7
61736|NCT01392300|143683|P1|NOT COMPLETED|Main Period (MP)||11
61737|NCT01392300|143681|P3|COMPLETED|Main Period (MP)||0
61738|NCT01392300|143682|P2|COMPLETED|Main Period (MP)||100
61739|NCT01392300|143683|P1|COMPLETED|Main Period (MP)||199
61740|NCT01392300|143681|P3|STARTED|Main Period (MP)||0
61741|NCT01392300|143682|P2|STARTED|Main Period (MP)||107
61742|NCT01392300|143683|P1|STARTED|Main Period (MP)||210
61743|NCT01392170|143788|P1|NOT COMPLETED|Overall Study||2
61744|NCT01392170|143788|P1|COMPLETED|Overall Study||0
61745|NCT01392170|143788|P1|STARTED|Overall Study||2
61746|NCT01392053|143794|P2|NOT COMPLETED|Overall Study||0
61747|NCT01392053|143795|P1|NOT COMPLETED|Overall Study||0
61748|NCT01392053|143794|P2|COMPLETED|Overall Study||23
61749|NCT01392053|143795|P1|COMPLETED|Overall Study||23
61750|NCT01392053|143794|P2|STARTED|Overall Study||23
61751|NCT01392053|143795|P1|STARTED|Overall Study||23
61752|NCT01391858|143815|P2|NOT COMPLETED|Overall Study||0
61753|NCT01391858|143816|P1|NOT COMPLETED|Overall Study||2
61754|NCT01391858|143815|P2|COMPLETED|Overall Study||24
61755|NCT01391858|143816|P1|COMPLETED|Overall Study||23
61756|NCT01391858|143815|P2|STARTED|Overall Study||24
61757|NCT01391858|143816|P1|STARTED|Overall Study||25
61758|NCT01391663|143840|P4|NOT COMPLETED|Overall Study||0
61759|NCT01391663|143841|P3|NOT COMPLETED|Overall Study||1
61760|NCT01391663|143842|P2|NOT COMPLETED|Overall Study||0
61761|NCT01391663|143843|P1|NOT COMPLETED|Overall Study||0
61762|NCT01391663|143840|P4|COMPLETED|Overall Study||12
61763|NCT01391663|143841|P3|COMPLETED|Overall Study||11
61764|NCT01391663|143842|P2|COMPLETED|Overall Study||12
61765|NCT01391663|143843|P1|COMPLETED|Overall Study||12
61766|NCT01391663|143840|P4|STARTED|Overall Study||12
61767|NCT01391663|143841|P3|STARTED|Overall Study||12
61768|NCT01391663|143842|P2|STARTED|Overall Study||12
61769|NCT01391663|143843|P1|STARTED|Overall Study||12
61770|NCT01391468|143875|P2|NOT COMPLETED|Overall Study||2
61771|NCT01391468|143876|P1|NOT COMPLETED|Overall Study||6
61772|NCT01391468|143875|P2|COMPLETED|Overall Study||21
61773|NCT01391468|143876|P1|COMPLETED|Overall Study||18
61774|NCT01391468|143875|P2|STARTED|Overall Study||23
61775|NCT01391468|143876|P1|STARTED|Overall Study||24
61776|NCT01391325|143888|P1|NOT COMPLETED|Overall Study||494
61777|NCT01391325|143888|P1|COMPLETED|Overall Study||1238
61778|NCT01391325|143888|P1|STARTED|Overall Study||1732
61779|NCT01391312|143897|P2|NOT COMPLETED|Overall Study||1
61780|NCT01391312|143898|P1|NOT COMPLETED|Overall Study||2
61781|NCT01391312|143897|P2|COMPLETED|Overall Study||19
61782|NCT01391312|143898|P1|COMPLETED|Overall Study||18
61783|NCT01391312|143897|P2|STARTED|Overall Study||20
61784|NCT01391312|143898|P1|STARTED|Overall Study||20
61785|NCT01391299|143911|P3|NOT COMPLETED|Overall Study||2
61786|NCT01391299|143912|P2|NOT COMPLETED|Overall Study||1
61787|NCT01391299|143913|P1|NOT COMPLETED|Overall Study||0
61788|NCT01391299|143911|P3|COMPLETED|Overall Study||56
61789|NCT01391299|143912|P2|COMPLETED|Overall Study||59
61790|NCT01391299|143913|P1|COMPLETED|Overall Study||57
61791|NCT01391299|143911|P3|STARTED|Overall Study||58
61792|NCT01391299|143912|P2|STARTED|Overall Study||60
61793|NCT01391299|143913|P1|STARTED|Overall Study||57
61794|NCT01391286|143935|P2|NOT COMPLETED|Overall Study||0
61795|NCT01391286|143936|P1|NOT COMPLETED|Overall Study||0
61796|NCT01391286|143935|P2|COMPLETED|Overall Study||18
61797|NCT01391286|143936|P1|COMPLETED|Overall Study||18
61798|NCT01391286|143935|P2|STARTED|Overall Study||18
61799|NCT01391286|143936|P1|STARTED|Overall Study||18
61800|NCT01391273|143950|P2|NOT COMPLETED|Overall Study||2
61801|NCT01391273|143951|P1|NOT COMPLETED|Overall Study||4
61802|NCT01391273|143950|P2|COMPLETED|Overall Study||83
61803|NCT01391273|143951|P1|COMPLETED|Overall Study||84
61804|NCT01391273|143950|P2|STARTED|Overall Study||85
61805|NCT01391273|143951|P1|STARTED|Overall Study||88
61806|NCT01391013|143965|P2|NOT COMPLETED|Overall Study||0
61807|NCT01391013|143966|P1|NOT COMPLETED|Overall Study||0
61808|NCT01391013|143965|P2|COMPLETED|Overall Study||15
61809|NCT01391013|143966|P1|COMPLETED|Overall Study||15
61810|NCT01391013|143965|P2|STARTED|Overall Study||15
61811|NCT01391013|143966|P1|STARTED|Overall Study||15
61812|NCT01390909|144010|P6|NOT COMPLETED|Overall Study||0
61813|NCT01390909|144011|P5|NOT COMPLETED|Overall Study||0
61814|NCT01390909|144012|P4|NOT COMPLETED|Overall Study||0
61815|NCT01390909|144013|P3|NOT COMPLETED|Overall Study||0
61816|NCT01390909|144014|P2|NOT COMPLETED|Overall Study||0
61817|NCT01390909|144015|P1|NOT COMPLETED|Overall Study||0
61818|NCT01390909|144010|P6|COMPLETED|Overall Study||613
61819|NCT01390909|144011|P5|COMPLETED|Overall Study||613
61820|NCT01390909|144012|P4|COMPLETED|Overall Study||602
61821|NCT01390909|144013|P3|COMPLETED|Overall Study||3552
61822|NCT01390909|144014|P2|COMPLETED|Overall Study||3552
61823|NCT01390909|144015|P1|COMPLETED|Overall Study||3454
61824|NCT01390909|144010|P6|Participants in Subgroup|Overall Study||0
61825|NCT01390909|144011|P5|Participants in Subgroup|Overall Study||602
61826|NCT01390909|144012|P4|Participants in Subgroup|Overall Study||0
61827|NCT01390909|144013|P3|Participants in Subgroup|Overall Study||0
61828|NCT01390909|144014|P2|Participants in Subgroup|Overall Study||3454
61829|NCT01390909|144015|P1|Participants in Subgroup|Overall Study||0
61830|NCT01390909|144010|P6|STARTED|Overall Study||613
61831|NCT01390909|144011|P5|STARTED|Overall Study||613
61832|NCT01390909|144012|P4|STARTED|Overall Study||602
61833|NCT01390909|144013|P3|STARTED|Overall Study||3552
61834|NCT01390909|144014|P2|STARTED|Overall Study||3552
61835|NCT01390909|144015|P1|STARTED|Overall Study||3454
61836|NCT01390870|144033|P1|NOT COMPLETED|Overall Study||0
61837|NCT01390870|144033|P1|COMPLETED|Overall Study||400
61838|NCT01390870|144033|P1|STARTED|Overall Study||400
61839|NCT01390857|144037|P1|NOT COMPLETED|Overall Study||10
61840|NCT01390857|144037|P1|COMPLETED|Overall Study||369
61841|NCT01390857|144037|P1|STARTED|Overall Study||379
61842|NCT01390844|144048|P4|NOT COMPLETED|Follow-Up Phase||0
61843|NCT01390844|144049|P3|NOT COMPLETED|Follow-Up Phase||1
61844|NCT01390844|144050|P2|NOT COMPLETED|Follow-Up Phase||1
61845|NCT01390844|144051|P1|NOT COMPLETED|Follow-Up Phase||1
61846|NCT01390844|144048|P4|COMPLETED|Follow-Up Phase||8
61847|NCT01390844|144049|P3|COMPLETED|Follow-Up Phase||25
61848|NCT01390844|144050|P2|COMPLETED|Follow-Up Phase||36
61849|NCT01390844|144051|P1|COMPLETED|Follow-Up Phase||92
61850|NCT01390844|144048|P4|STARTED|Follow-Up Phase||8
61851|NCT01390844|144049|P3|STARTED|Follow-Up Phase||26
61852|NCT01390844|144050|P2|STARTED|Follow-Up Phase||37
61853|NCT01390844|144051|P1|STARTED|Follow-Up Phase||93
61854|NCT01390844|144048|P4|NOT COMPLETED|Treatment Phase||19
61855|NCT01390844|144049|P3|NOT COMPLETED|Treatment Phase||31
61856|NCT01390844|144050|P2|NOT COMPLETED|Treatment Phase||28
61857|NCT01390844|144051|P1|NOT COMPLETED|Treatment Phase||40
61858|NCT01390844|144048|P4|COMPLETED|Treatment Phase||8
61859|NCT01390844|144049|P3|COMPLETED|Treatment Phase||26
61860|NCT01390844|144050|P2|COMPLETED|Treatment Phase||37
61861|NCT01390844|144051|P1|COMPLETED|Treatment Phase||93
61862|NCT01390844|144048|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
61863|NCT01390844|144049|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
61864|NCT01390844|144050|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
61865|NCT01390844|144051|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
61866|NCT01390844|144048|P4|STARTED|Treatment Phase||27
61867|NCT01390844|144049|P3|STARTED|Treatment Phase||57
61868|NCT01390844|144050|P2|STARTED|Treatment Phase||65
61869|NCT01390844|144051|P1|STARTED|Treatment Phase||133
61870|NCT01390779|144077|P1|NOT COMPLETED|Overall Study||1
61871|NCT01390779|144077|P1|COMPLETED|Overall Study||32
61872|NCT01390779|144077|P1|STARTED|Overall Study||33
61873|NCT01390649|144082|P1|NOT COMPLETED|Overall Study||1
61874|NCT01390649|144082|P1|COMPLETED|Overall Study||56
61875|NCT01390649|144082|P1|STARTED|Overall Study|Subjects treated with Privigen|57
61876|NCT01390441|144092|P5|NOT COMPLETED|Extension Period||0
61877|NCT01390441|144093|P4|NOT COMPLETED|Extension Period||1
61878|NCT01390441|144094|P3|NOT COMPLETED|Extension Period||0
61879|NCT01390441|144095|P2|NOT COMPLETED|Extension Period||1
61880|NCT01390441|144096|P1|NOT COMPLETED|Extension Period||3
61881|NCT01390441|144092|P5|COMPLETED|Extension Period||3
61882|NCT01390441|144093|P4|COMPLETED|Extension Period||0
61883|NCT01390441|144094|P3|COMPLETED|Extension Period||1
61884|NCT01390441|144095|P2|COMPLETED|Extension Period||12
61885|NCT01390441|144096|P1|COMPLETED|Extension Period||12
61886|NCT01390441|144092|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
61887|NCT01390441|144093|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
61888|NCT01390441|144094|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
61889|NCT01390441|144095|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
61890|NCT01390441|144096|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
61891|NCT01390441|144092|P5|NOT COMPLETED|Treatment Period||11
61892|NCT01390441|144093|P4|NOT COMPLETED|Treatment Period||13
61893|NCT01390441|144094|P3|NOT COMPLETED|Treatment Period||10
61894|NCT01390441|144095|P2|NOT COMPLETED|Treatment Period||1
61895|NCT01390441|144096|P1|NOT COMPLETED|Treatment Period||1
61896|NCT01390441|144092|P5|COMPLETED|Treatment Period||7
61897|NCT01390441|144093|P4|COMPLETED|Treatment Period||6
61898|NCT01390441|144094|P3|COMPLETED|Treatment Period||8
61899|NCT01390441|144095|P2|COMPLETED|Treatment Period||21
61900|NCT01390441|144096|P1|COMPLETED|Treatment Period||22
61901|NCT01390441|144092|P5|STARTED|Treatment Period||18
61902|NCT01390441|144093|P4|STARTED|Treatment Period||19
61903|NCT01390441|144094|P3|STARTED|Treatment Period||18
61904|NCT01390441|144095|P2|STARTED|Treatment Period||22
61905|NCT01390441|144096|P1|STARTED|Treatment Period||23
61906|NCT01390428|144161|P6|NOT COMPLETED|Overall Study||0
61907|NCT01390428|144162|P5|NOT COMPLETED|Overall Study||1
61908|NCT01390428|144163|P4|NOT COMPLETED|Overall Study||0
61909|NCT01390428|144164|P3|NOT COMPLETED|Overall Study||1
61910|NCT01390428|144165|P2|NOT COMPLETED|Overall Study||0
61911|NCT01390428|144166|P1|NOT COMPLETED|Overall Study||0
61912|NCT01390428|144161|P6|COMPLETED|Overall Study||8
61913|NCT01390428|144162|P5|COMPLETED|Overall Study||7
61914|NCT01390428|144163|P4|COMPLETED|Overall Study||9
61915|NCT01390428|144164|P3|COMPLETED|Overall Study||8
61916|NCT01390428|144165|P2|COMPLETED|Overall Study||8
61917|NCT01390428|144166|P1|COMPLETED|Overall Study||8
61918|NCT01390428|144161|P6|STARTED|Overall Study||8
61919|NCT01390428|144162|P5|STARTED|Overall Study||8
61920|NCT01390428|144163|P4|STARTED|Overall Study||9
61921|NCT01390428|144164|P3|STARTED|Overall Study||9
61922|NCT01390428|144165|P2|STARTED|Overall Study||8
61923|NCT01390428|144166|P1|STARTED|Overall Study||8
61924|NCT01390415|144218|P2|NOT COMPLETED|Overall Study||0
61925|NCT01390415|144219|P1|NOT COMPLETED|Overall Study||0
61926|NCT01390415|144218|P2|COMPLETED|Overall Study||37
61927|NCT01390415|144219|P1|COMPLETED|Overall Study||99
61928|NCT01390415|144218|P2|STARTED|Overall Study||37
61929|NCT01390415|144219|P1|STARTED|Overall Study||99
61930|NCT01390402|144229|P1|NOT COMPLETED|Overall Study||5
61931|NCT01390402|144229|P1|COMPLETED|Overall Study||1
61932|NCT01390402|144229|P1|STARTED|Overall Study||6
61933|NCT01390389|144235|P2|NOT COMPLETED|Overall Study||1
61934|NCT01390389|144236|P1|NOT COMPLETED|Overall Study||4
61935|NCT01390389|144235|P2|COMPLETED|Overall Study||8
61936|NCT01390389|144236|P1|COMPLETED|Overall Study||6
61937|NCT01390389|144235|P2|STARTED|Overall Study||9
61938|NCT01390389|144236|P1|STARTED|Overall Study||10
61939|NCT01390259|144242|P2|NOT COMPLETED|Overall Study||0
61940|NCT01390259|144243|P1|NOT COMPLETED|Overall Study||0
61941|NCT01390259|144242|P2|COMPLETED|Overall Study||6
61942|NCT01390259|144243|P1|COMPLETED|Overall Study||5
61943|NCT01390259|144242|P2|STARTED|Overall Study||6
61944|NCT01390259|144243|P1|STARTED|Overall Study||5
61945|NCT01390233|144255|P3|NOT COMPLETED|Overall Study||6
61946|NCT01390233|144256|P2|NOT COMPLETED|Overall Study||2
61947|NCT01390233|144257|P1|NOT COMPLETED|Overall Study||5
61948|NCT01390233|144255|P3|COMPLETED|Overall Study||30
61949|NCT01390233|144256|P2|COMPLETED|Overall Study||29
61950|NCT01390233|144257|P1|COMPLETED|Overall Study||30
61951|NCT01390233|144255|P3|STARTED|Overall Study||36
61952|NCT01390233|144256|P2|STARTED|Overall Study||31
61953|NCT01390233|144257|P1|STARTED|Overall Study||35
61954|NCT01390038|144265|P1|NOT COMPLETED|Overall Study||8
61955|NCT01390038|144265|P1|COMPLETED|Overall Study||149
61956|NCT01390038|144265|P1|STARTED|Overall Study||157
61957|NCT01389973|144275|P1|NOT COMPLETED|Overall Study||20
61958|NCT01389973|144275|P1|COMPLETED|Overall Study||0
61959|NCT01389973|144275|P1|STARTED|Overall Study||20
61960|NCT01389882|144285|P2|NOT COMPLETED|Overall Study||4
61961|NCT01389882|144286|P1|NOT COMPLETED|Overall Study||1
61962|NCT01389882|144285|P2|COMPLETED|Overall Study||7
61963|NCT01389882|144286|P1|COMPLETED|Overall Study||12
61964|NCT01389882|144285|P2|STARTED|Overall Study||11
61965|NCT01389882|144286|P1|STARTED|Overall Study||13
61966|NCT01389856|144316|P2|NOT COMPLETED|Overall Study||0
61967|NCT01389856|144317|P1|NOT COMPLETED|Overall Study||0
61968|NCT01389856|144316|P2|COMPLETED|Overall Study||8
61969|NCT01389856|144317|P1|COMPLETED|Overall Study||13
61970|NCT01389856|144316|P2|STARTED|Overall Study|Randomized and treated.|8
61971|NCT01389856|144317|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
61972|NCT01389817|144374|P2|NOT COMPLETED|Overall Study||0
61973|NCT01389817|144375|P1|NOT COMPLETED|Overall Study||4
61974|NCT01389817|144374|P2|COMPLETED|Overall Study||0
61975|NCT01389817|144375|P1|COMPLETED|Overall Study||0
61976|NCT01389817|144374|P2|STARTED|Overall Study||0
61977|NCT01389817|144375|P1|STARTED|Overall Study||4
61978|NCT01389323|144381|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
61979|NCT01389323|144381|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
61980|NCT01389323|144381|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
61981|NCT01389323|144381|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
61982|NCT01389323|144381|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
61983|NCT01389323|144381|P1|STARTED|Treatment Period (up to 48 Weeks)||246
61984|NCT01389284|144404|P3|NOT COMPLETED|Overall Study||0
61985|NCT01389284|144405|P2|NOT COMPLETED|Overall Study||0
61986|NCT01389284|144406|P1|NOT COMPLETED|Overall Study||0
61987|NCT01389284|144404|P3|COMPLETED|Overall Study||60
61988|NCT01389284|144405|P2|COMPLETED|Overall Study||120
61989|NCT01389284|144406|P1|COMPLETED|Overall Study||120
61990|NCT01389284|144404|P3|STARTED|Overall Study||60
61991|NCT01389284|144405|P2|STARTED|Overall Study||120
61992|NCT01389284|144406|P1|STARTED|Overall Study||120
61993|NCT01389102|144444|P6|NOT COMPLETED|Overall Study||8
61994|NCT01389102|144445|P5|NOT COMPLETED|Overall Study||13
61995|NCT01389102|144446|P4|NOT COMPLETED|Overall Study||7
61996|NCT01389102|144447|P3|NOT COMPLETED|Overall Study||19
61997|NCT01389102|144448|P2|NOT COMPLETED|Overall Study||12
61998|NCT01389102|144449|P1|NOT COMPLETED|Overall Study||18
61999|NCT01389102|144444|P6|COMPLETED|Overall Study||68
62000|NCT01389102|144445|P5|COMPLETED|Overall Study||61
62001|NCT01389102|144446|P4|COMPLETED|Overall Study||69
62002|NCT01389102|144447|P3|COMPLETED|Overall Study||58
62003|NCT01389102|144448|P2|COMPLETED|Overall Study||64
62004|NCT01389102|144449|P1|COMPLETED|Overall Study||57
62005|NCT01389102|144444|P6|STARTED|Overall Study||76
62006|NCT01389102|144445|P5|STARTED|Overall Study||74
62007|NCT01389102|144446|P4|STARTED|Overall Study||76
62008|NCT01389102|144447|P3|STARTED|Overall Study||77
62009|NCT01389102|144448|P2|STARTED|Overall Study||76
62010|NCT01389102|144449|P1|STARTED|Overall Study||75
62011|NCT01389076|144469|P1|NOT COMPLETED|Overall Study||0
62012|NCT01389076|144469|P1|COMPLETED|Overall Study||22
62013|NCT01389076|144469|P1|STARTED|Overall Study||22
62014|NCT01388946|144479|P2|NOT COMPLETED|Overall Study||3
62015|NCT01388946|144480|P1|NOT COMPLETED|Overall Study||6
62016|NCT01388946|144479|P2|COMPLETED|Overall Study||52
62017|NCT01388946|144480|P1|COMPLETED|Overall Study||49
62018|NCT01388946|144479|P2|STARTED|Overall Study||55
62019|NCT01388946|144480|P1|STARTED|Overall Study||55
62020|NCT01388920|144515|P3|NOT COMPLETED|Overall Study||0
62021|NCT01388920|144516|P2|NOT COMPLETED|Overall Study||0
62022|NCT01388920|144517|P1|NOT COMPLETED|Overall Study||0
62023|NCT01388920|144515|P3|COMPLETED|Overall Study||0
62024|NCT01388920|144516|P2|COMPLETED|Overall Study||1
62025|NCT01388920|144517|P1|COMPLETED|Overall Study||1
62026|NCT01388920|144515|P3|STARTED|Overall Study||0
62027|NCT01388920|144516|P2|STARTED|Overall Study||1
62028|NCT01388920|144517|P1|STARTED|Overall Study||1
62029|NCT01388907|144527|P2|NOT COMPLETED|Overall Study||0
62030|NCT01388907|144528|P1|NOT COMPLETED|Overall Study||2
62031|NCT01388907|144527|P2|COMPLETED|Overall Study||28
62032|NCT01388907|144528|P1|COMPLETED|Overall Study||31
62033|NCT01388907|144527|P2|STARTED|Overall Study||28
62034|NCT01388907|144528|P1|STARTED|Overall Study||33
62035|NCT01388816|144544|P4|NOT COMPLETED|Overall Study||0
62036|NCT01388816|144545|P3|NOT COMPLETED|Overall Study||3
62037|NCT01388816|144546|P2|NOT COMPLETED|Overall Study||4
62038|NCT01388816|144547|P1|NOT COMPLETED|Overall Study||2
62039|NCT01388816|144544|P4|COMPLETED|Overall Study||44
62040|NCT01388816|144545|P3|COMPLETED|Overall Study||41
62041|NCT01388816|144546|P2|COMPLETED|Overall Study||39
62042|NCT01388816|144547|P1|COMPLETED|Overall Study||43
62043|NCT01388816|144544|P4|STARTED|Overall Study||44
62044|NCT01388816|144545|P3|STARTED|Overall Study||44
62045|NCT01388816|144546|P2|STARTED|Overall Study||43
62046|NCT01388816|144547|P1|STARTED|Overall Study||45
62047|NCT01388790|144576|P1|NOT COMPLETED|Overall Study||8
62048|NCT01388790|144576|P1|COMPLETED|Overall Study||32
62049|NCT01388790|144576|P1|STARTED|Overall Study||40
62050|NCT01388647|144583|P2|NOT COMPLETED|Overall Study||2
62051|NCT01388647|144584|P1|NOT COMPLETED|Overall Study||1
62052|NCT01388647|144583|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
62053|NCT01388647|144584|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
62054|NCT01388647|144583|P2|STARTED|Overall Study||6
62055|NCT01388647|144584|P1|STARTED|Overall Study||6
62056|NCT01388530|144595|P1|NOT COMPLETED|Overall Study||5
62057|NCT01388530|144595|P1|COMPLETED|Overall Study||20
62058|NCT01388530|144595|P1|STARTED|Overall Study||25
62059|NCT01388491|144604|P2|NOT COMPLETED|Overall Study||29
62060|NCT01388491|144605|P1|NOT COMPLETED|Overall Study||34
62061|NCT01388491|144604|P2|COMPLETED|Overall Study||114
62062|NCT01388491|144605|P1|COMPLETED|Overall Study||116
62063|NCT01388491|144604|P2|Per Protocol (PP) Population|Overall Study||121
62064|NCT01388491|144605|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
62065|NCT01388491|144604|P2|Intent-to-Treat (ITT) Population|Overall Study||136
62066|NCT01388491|144605|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
62067|NCT01388491|144604|P2|Safety Population|Overall Study||142
62068|NCT01388491|144605|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
62069|NCT01388491|144604|P2|STARTED|Overall Study||143
62070|NCT01388491|144605|P1|STARTED|Overall Study|number randomized|150
62071|NCT01388361|144640|P3|NOT COMPLETED|Overall Study||14
62072|NCT01388361|144641|P2|NOT COMPLETED|Overall Study||12
62073|NCT01388361|144642|P1|NOT COMPLETED|Overall Study||12
62074|NCT01388361|144640|P3|COMPLETED|Overall Study||75
62075|NCT01388361|144641|P2|COMPLETED|Overall Study||76
62076|NCT01388361|144642|P1|COMPLETED|Overall Study||224
62077|NCT01388361|144640|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
62078|NCT01388361|144641|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
62079|NCT01388361|144642|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
62080|NCT01388361|144640|P3|STARTED|Overall Study||89
62081|NCT01388361|144641|P2|STARTED|Overall Study||88
62082|NCT01388361|144642|P1|STARTED|Overall Study||236
62083|NCT01388166|144659|P1|NOT COMPLETED|Overall Study||59
62084|NCT01388166|144659|P1|COMPLETED|Overall Study||1194
62085|NCT01388166|144659|P1|STARTED|Overall Study||1253
62086|NCT01387789|144665|P1|NOT COMPLETED|Overall Study||8
62087|NCT01387789|144665|P1|COMPLETED|Overall Study||63
62088|NCT01387789|144665|P1|STARTED|Overall Study||71
62089|NCT01387737|144679|P2|NOT COMPLETED|Overall Study||74
62090|NCT01387737|144680|P1|NOT COMPLETED|Overall Study||52
62091|NCT01387737|144679|P2|COMPLETED|Overall Study||641
62092|NCT01387737|144680|P1|COMPLETED|Overall Study||532
62093|NCT01387737|144679|P2|STARTED|Overall Study||715
62094|NCT01387737|144680|P1|STARTED|Overall Study||584
62095|NCT01387672|144692|P6|NOT COMPLETED|Overall Study||0
62096|NCT01387672|144693|P5|NOT COMPLETED|Overall Study||4
62097|NCT01387672|144694|P4|NOT COMPLETED|Overall Study||4
62098|NCT01387672|144695|P3|NOT COMPLETED|Overall Study||5
62099|NCT01387672|144696|P2|NOT COMPLETED|Overall Study||7
62100|NCT01387672|144697|P1|NOT COMPLETED|Overall Study||7
62101|NCT01387672|144692|P6|COMPLETED|Overall Study||37
62102|NCT01387672|144693|P5|COMPLETED|Overall Study||34
62103|NCT01387672|144694|P4|COMPLETED|Overall Study||35
62104|NCT01387672|144695|P3|COMPLETED|Overall Study||33
62105|NCT01387672|144696|P2|COMPLETED|Overall Study||31
62106|NCT01387672|144697|P1|COMPLETED|Overall Study||32
62107|NCT01387672|144692|P6|STARTED|Overall Study||37
62108|NCT01387672|144693|P5|STARTED|Overall Study||38
62109|NCT01387672|144694|P4|STARTED|Overall Study||39
62110|NCT01387672|144695|P3|STARTED|Overall Study||38
62111|NCT01387672|144696|P2|STARTED|Overall Study||38
62112|NCT01387672|144697|P1|STARTED|Overall Study||39
62113|NCT01387581|144715|P3|NOT COMPLETED|Overall Study||3
62114|NCT01387581|144716|P2|NOT COMPLETED|Overall Study||6
62115|NCT01387581|144717|P1|NOT COMPLETED|Overall Study||7
62116|NCT01387581|144715|P3|COMPLETED|Overall Study||9
62117|NCT01387581|144716|P2|COMPLETED|Overall Study||101
62118|NCT01387581|144717|P1|COMPLETED|Overall Study||101
62119|NCT01387581|144715|P3|STARTED|Overall Study||12
62120|NCT01387581|144716|P2|STARTED|Overall Study||107
62121|NCT01387581|144717|P1|STARTED|Overall Study||108
62122|NCT01387542|144728|P1|NOT COMPLETED|Overall Study||8
62123|NCT01387542|144728|P1|COMPLETED|Overall Study||32
62124|NCT01387542|144728|P1|Treated|Overall Study||38
62125|NCT01387542|144728|P1|STARTED|Overall Study||40
62126|NCT01387464|144737|P2|NOT COMPLETED|Overall Study||1
62127|NCT01387464|144738|P1|NOT COMPLETED|Overall Study||1
62128|NCT01387464|144737|P2|COMPLETED|Overall Study||29
62129|NCT01387464|144738|P1|COMPLETED|Overall Study||29
62130|NCT01387464|144737|P2|Per-Protocol Population|Overall Study||29
62131|NCT01387464|144738|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
62132|NCT01387464|144737|P2|Safety Population|Overall Study||29
62133|NCT01387464|144738|P1|Safety Population|Overall Study||30
62134|NCT01387464|144737|P2|STARTED|Overall Study||30
62135|NCT01387464|144738|P1|STARTED|Overall Study||30
62136|NCT01387347|144746|P2|NOT COMPLETED|Overall Study||1
62137|NCT01387347|144747|P1|NOT COMPLETED|Overall Study||2
62138|NCT01387347|144746|P2|COMPLETED|Overall Study||35
62139|NCT01387347|144747|P1|COMPLETED|Overall Study||34
62140|NCT01387347|144746|P2|STARTED|Overall Study||36
62141|NCT01387347|144747|P1|STARTED|Overall Study||36
62142|NCT01387230|144760|P3|NOT COMPLETED|Overall Study||13
62143|NCT01387230|144761|P2|NOT COMPLETED|Overall Study||7
62144|NCT01387230|144762|P1|NOT COMPLETED|Overall Study||18
62145|NCT01387230|144760|P3|COMPLETED|Overall Study||56
62146|NCT01387230|144761|P2|COMPLETED|Overall Study||62
62147|NCT01387230|144762|P1|COMPLETED|Overall Study||50
62148|NCT01387230|144760|P3|STARTED|Overall Study||69
62149|NCT01387230|144761|P2|STARTED|Overall Study||69
62150|NCT01387230|144762|P1|STARTED|Overall Study||68
62151|NCT01387178|144778|P2|NOT COMPLETED|Overall Study||0
62152|NCT01387178|144779|P1|NOT COMPLETED|Overall Study||0
62153|NCT01387178|144778|P2|COMPLETED|Overall Study||10641
62154|NCT01387178|144779|P1|COMPLETED|Overall Study||11582
62155|NCT01387178|144778|P2|STARTED|Overall Study||10641
62156|NCT01387178|144779|P1|STARTED|Overall Study||11582
62157|NCT01387139|144791|P2|NOT COMPLETED|Overall Study||0
62158|NCT01387139|144792|P1|NOT COMPLETED|Overall Study||0
62159|NCT01387139|144791|P2|COMPLETED|Overall Study||84
62160|NCT01387139|144792|P1|COMPLETED|Overall Study||99
62161|NCT01387139|144791|P2|STARTED|Overall Study||84
62162|NCT01387139|144792|P1|STARTED|Overall Study||99
62163|NCT01387074|144808|P1|NOT COMPLETED|Overall Study||8
62164|NCT01387074|144808|P1|COMPLETED|Overall Study||100
62165|NCT01387074|144808|P1|STARTED|Overall Study||108
62166|NCT01386008|144819|P1|NOT COMPLETED|Overall Study||20
62167|NCT01386008|144819|P1|COMPLETED|Overall Study||0
62168|NCT01386008|144819|P1|STARTED|Overall Study||20
62169|NCT01385995|144828|P2|NOT COMPLETED|Period 2, 2 Months||0
62170|NCT01385995|144829|P1|NOT COMPLETED|Period 2, 2 Months||0
62171|NCT01385995|144828|P2|COMPLETED|Period 2, 2 Months||25
62172|NCT01385995|144829|P1|COMPLETED|Period 2, 2 Months||24
62173|NCT01385995|144828|P2|STARTED|Period 2, 2 Months||25
62174|NCT01385995|144829|P1|STARTED|Period 2, 2 Months||24
62175|NCT01385995|144828|P2|NOT COMPLETED|Washout Period, 1 Month||0
62176|NCT01385995|144829|P1|NOT COMPLETED|Washout Period, 1 Month||0
62177|NCT01385995|144828|P2|COMPLETED|Washout Period, 1 Month||25
62178|NCT01385995|144829|P1|COMPLETED|Washout Period, 1 Month||24
62179|NCT01385995|144828|P2|STARTED|Washout Period, 1 Month||25
62180|NCT01385995|144829|P1|STARTED|Washout Period, 1 Month||24
62181|NCT01385995|144828|P2|NOT COMPLETED|Period 1, 2 Months||0
62182|NCT01385995|144829|P1|NOT COMPLETED|Period 1, 2 Months||1
62183|NCT01385995|144828|P2|COMPLETED|Period 1, 2 Months||25
62184|NCT01385995|144829|P1|COMPLETED|Period 1, 2 Months||24
62185|NCT01385995|144828|P2|STARTED|Period 1, 2 Months||25
62186|NCT01385995|144829|P1|STARTED|Period 1, 2 Months||25
62187|NCT01386983|144845|P2|NOT COMPLETED|Overall Study||0
62188|NCT01386983|144846|P1|NOT COMPLETED|Overall Study||0
62189|NCT01386983|144845|P2|COMPLETED|Overall Study||68
62190|NCT01386983|144846|P1|COMPLETED|Overall Study||264
62191|NCT01386983|144845|P2|STARTED|Overall Study||68
62192|NCT01386983|144846|P1|STARTED|Overall Study||264
62193|NCT01386944|144854|P1|NOT COMPLETED|Overall Study||56
62194|NCT01386944|144854|P1|COMPLETED|Overall Study||46
62195|NCT01386944|144854|P1|STARTED|Overall Study||102
62196|NCT01386788|144864|P1|NOT COMPLETED|Overall Study||2
62197|NCT01386788|144864|P1|COMPLETED|Overall Study||100
62198|NCT01386788|144864|P1|STARTED|Overall Study||102
62199|NCT01386606|144873|P4|NOT COMPLETED|Overall Study||1
62200|NCT01386606|144874|P3|NOT COMPLETED|Overall Study||3
62201|NCT01386606|144875|P2|NOT COMPLETED|Overall Study||4
62202|NCT01386606|144876|P1|NOT COMPLETED|Overall Study||4
62203|NCT01386606|144873|P4|COMPLETED|Overall Study||13
62204|NCT01386606|144874|P3|COMPLETED|Overall Study||13
62205|NCT01386606|144875|P2|COMPLETED|Overall Study||10
62206|NCT01386606|144876|P1|COMPLETED|Overall Study||12
62207|NCT01386606|144873|P4|STARTED|Overall Study||14
62208|NCT01386606|144874|P3|STARTED|Overall Study||16
62209|NCT01386606|144875|P2|STARTED|Overall Study||14
62210|NCT01386606|144876|P1|STARTED|Overall Study||16
62211|NCT01386125|144906|P2|NOT COMPLETED|Overall Study||37
62212|NCT01386125|144907|P1|NOT COMPLETED|Overall Study||25
62213|NCT01386125|144906|P2|COMPLETED|Overall Study||336
62214|NCT01386125|144907|P1|COMPLETED|Overall Study||350
62215|NCT01386125|144906|P2|STARTED|Overall Study||373
62216|NCT01386125|144907|P1|STARTED|Overall Study||375
62217|NCT01385696|144915|P2|NOT COMPLETED|Overall Study||0
62218|NCT01385696|144916|P1|NOT COMPLETED|Overall Study||0
62219|NCT01385696|144915|P2|COMPLETED|Overall Study||64
62220|NCT01385696|144916|P1|COMPLETED|Overall Study||66
62221|NCT01385696|144915|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
62222|NCT01385696|144916|P1|STARTED|Overall Study||66
62223|NCT01385644|144927|P2|NOT COMPLETED|Overall Study||0
62224|NCT01385644|144928|P1|NOT COMPLETED|Overall Study||0
62225|NCT01385644|144927|P2|COMPLETED|Overall Study||4
62226|NCT01385644|144928|P1|COMPLETED|Overall Study||4
62227|NCT01385644|144927|P2|STARTED|Overall Study||4
62228|NCT01385644|144928|P1|STARTED|Overall Study||4
62229|NCT01385579|144942|P2|NOT COMPLETED|Overall Study||0
62230|NCT01385579|144943|P1|NOT COMPLETED|Overall Study||0
62231|NCT01385579|144942|P2|COMPLETED|Overall Study||104
62232|NCT01385579|144943|P1|COMPLETED|Overall Study||98
62233|NCT01385579|144942|P2|STARTED|Overall Study||104
62234|NCT01385579|144943|P1|STARTED|Overall Study||98
62235|NCT01385566|144955|P6|NOT COMPLETED|Overall Study||0
62236|NCT01385566|144956|P5|NOT COMPLETED|Overall Study||0
62237|NCT01385566|144957|P4|NOT COMPLETED|Overall Study||1
62238|NCT01385566|144958|P3|NOT COMPLETED|Overall Study||0
62239|NCT01385566|144959|P2|NOT COMPLETED|Overall Study||0
62240|NCT01385566|144960|P1|NOT COMPLETED|Overall Study||1
62241|NCT01385566|144955|P6|COMPLETED|Overall Study||34
62242|NCT01385566|144956|P5|COMPLETED|Overall Study||34
62243|NCT01385566|144957|P4|COMPLETED|Overall Study||34
62244|NCT01385566|144958|P3|COMPLETED|Overall Study||34
62245|NCT01385566|144959|P2|COMPLETED|Overall Study||34
62246|NCT01385566|144960|P1|COMPLETED|Overall Study||51
62247|NCT01385566|144955|P6|STARTED|Overall Study||34
62248|NCT01385566|144956|P5|STARTED|Overall Study||34
62249|NCT01385566|144957|P4|STARTED|Overall Study||35
62250|NCT01385566|144958|P3|STARTED|Overall Study||34
62251|NCT01385566|144959|P2|STARTED|Overall Study||34
62252|NCT01385566|144960|P1|STARTED|Overall Study||52
62253|NCT01385371|145014|P2|NOT COMPLETED|Overall Study||97
62254|NCT01385371|145015|P1|NOT COMPLETED|Overall Study||149
62255|NCT01385371|145014|P2|COMPLETED|Overall Study||652
62256|NCT01385371|145015|P1|COMPLETED|Overall Study||603
62257|NCT01385371|145014|P2|STARTED|Overall Study||749
62258|NCT01385371|145015|P1|STARTED|Overall Study||752
62259|NCT01385202|145035|P1|NOT COMPLETED|Overall Study||18
62260|NCT01385202|145035|P1|COMPLETED|Overall Study||154
62261|NCT01385202|145035|P1|Undergoing Ablation|Overall Study||160
62262|NCT01385202|145035|P1|Study Catheter Inserted|Overall Study||161
62263|NCT01385202|145035|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
62264|NCT01385033|145044|P6|NOT COMPLETED|Part III||0
62265|NCT01385033|145045|P5|NOT COMPLETED|Part III||0
62266|NCT01385033|145046|P4|NOT COMPLETED|Part III||0
62267|NCT01385033|145047|P3|NOT COMPLETED|Part III||0
62268|NCT01385033|145048|P2|NOT COMPLETED|Part III||0
62269|NCT01385033|145049|P1|NOT COMPLETED|Part III||0
62270|NCT01385033|145044|P6|COMPLETED|Part III||0
62271|NCT01385033|145045|P5|COMPLETED|Part III||0
62272|NCT01385033|145046|P4|COMPLETED|Part III||0
62273|NCT01385033|145047|P3|COMPLETED|Part III||0
62274|NCT01385033|145048|P2|COMPLETED|Part III||0
62275|NCT01385033|145049|P1|COMPLETED|Part III||0
62276|NCT01385033|145044|P6|STARTED|Part III||0
62277|NCT01385033|145045|P5|STARTED|Part III||0
62278|NCT01385033|145046|P4|STARTED|Part III||0
62279|NCT01385033|145047|P3|STARTED|Part III||0
62280|NCT01385033|145048|P2|STARTED|Part III||0
62281|NCT01385033|145049|P1|STARTED|Part III||0
62282|NCT01385033|145044|P6|NOT COMPLETED|Part II||0
62283|NCT01385033|145045|P5|NOT COMPLETED|Part II||0
62284|NCT01385033|145046|P4|NOT COMPLETED|Part II||0
62285|NCT01385033|145047|P3|NOT COMPLETED|Part II||0
62286|NCT01385033|145048|P2|NOT COMPLETED|Part II||0
62287|NCT01385033|145049|P1|NOT COMPLETED|Part II||0
62288|NCT01385033|145044|P6|COMPLETED|Part II||0
62289|NCT01385033|145045|P5|COMPLETED|Part II||0
62290|NCT01385033|145046|P4|COMPLETED|Part II||0
62291|NCT01385033|145047|P3|COMPLETED|Part II||0
62292|NCT01385033|145048|P2|COMPLETED|Part II||0
62293|NCT01385033|145049|P1|COMPLETED|Part II||0
62294|NCT01385033|145044|P6|STARTED|Part II||0
62295|NCT01385033|145045|P5|STARTED|Part II||0
62296|NCT01385033|145046|P4|STARTED|Part II||0
62297|NCT01385033|145047|P3|STARTED|Part II||0
62298|NCT01385033|145048|P2|STARTED|Part II||0
62299|NCT01385033|145049|P1|STARTED|Part II||0
62300|NCT01385033|145044|P6|NOT COMPLETED|Part I||0
62301|NCT01385033|145045|P5|NOT COMPLETED|Part I||0
62302|NCT01385033|145046|P4|NOT COMPLETED|Part I||0
62303|NCT01385033|145047|P3|NOT COMPLETED|Part I||0
62304|NCT01385033|145048|P2|NOT COMPLETED|Part I||0
62305|NCT01385033|145049|P1|NOT COMPLETED|Part I||0
62306|NCT01385033|145044|P6|COMPLETED|Part I||0
62307|NCT01385033|145045|P5|COMPLETED|Part I||0
62308|NCT01385033|145046|P4|COMPLETED|Part I||0
62309|NCT01385033|145047|P3|COMPLETED|Part I||0
62310|NCT01385033|145048|P2|COMPLETED|Part I||14
62311|NCT01385033|145049|P1|COMPLETED|Part I||6
62312|NCT01385033|145044|P6|STARTED|Part I||0
62313|NCT01385033|145045|P5|STARTED|Part I||0
62314|NCT01385033|145046|P4|STARTED|Part I||0
62315|NCT01385033|145047|P3|STARTED|Part I||0
62316|NCT01385033|145048|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
62317|NCT01385033|145049|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
62318|NCT01384760|145058|P2|NOT COMPLETED|Overall Study||6
62319|NCT01384760|145059|P1|NOT COMPLETED|Overall Study||16
62320|NCT01384760|145058|P2|COMPLETED|Overall Study||37
62321|NCT01384760|145059|P1|COMPLETED|Overall Study||45
62322|NCT01384760|145058|P2|Randomized|Overall Study||43
62323|NCT01384760|145059|P1|Randomized|Overall Study||61
62324|NCT01384760|145058|P2|STARTED|Overall Study||43
62325|NCT01384760|145059|P1|STARTED|Overall Study||61
62326|NCT01384292|145070|P3|NOT COMPLETED|Part B||0
62327|NCT01384292|145071|P2|NOT COMPLETED|Part B||0
62328|NCT01384292|145072|P1|NOT COMPLETED|Part B||1
62329|NCT01384292|145070|P3|COMPLETED|Part B||0
62330|NCT01384292|145071|P2|COMPLETED|Part B||6
62331|NCT01384292|145072|P1|COMPLETED|Part B||2
62332|NCT01384292|145070|P3|STARTED|Part B||0
62333|NCT01384292|145071|P2|STARTED|Part B||6
62334|NCT01384292|145072|P1|STARTED|Part B||3
62335|NCT01384292|145070|P3|NOT COMPLETED|Part A||0
62336|NCT01384292|145071|P2|NOT COMPLETED|Part A||0
62337|NCT01384292|145072|P1|NOT COMPLETED|Part A||0
62338|NCT01384292|145070|P3|COMPLETED|Part A||4
62339|NCT01384292|145071|P2|COMPLETED|Part A||5
62340|NCT01384292|145072|P1|COMPLETED|Part A||5
62341|NCT01384292|145070|P3|STARTED|Part A||4
62342|NCT01384292|145071|P2|STARTED|Part A||5
62343|NCT01384292|145072|P1|STARTED|Part A||5
62344|NCT01384019|145084|P2|NOT COMPLETED|Overall Study||6
62345|NCT01384019|145085|P1|NOT COMPLETED|Overall Study||10
62346|NCT01384019|145084|P2|COMPLETED|Overall Study||55
62347|NCT01384019|145085|P1|COMPLETED|Overall Study||55
62348|NCT01384019|145084|P2|STARTED|Overall Study||61
62349|NCT01384019|145085|P1|STARTED|Overall Study||65
62350|NCT01383993|145094|P3|NOT COMPLETED|Overall Study||1
62351|NCT01383993|145095|P2|NOT COMPLETED|Overall Study||1
62352|NCT01383993|145096|P1|NOT COMPLETED|Overall Study||3
62353|NCT01383993|145094|P3|COMPLETED|Overall Study||1
62354|NCT01383993|145095|P2|COMPLETED|Overall Study||3
62355|NCT01383993|145096|P1|COMPLETED|Overall Study||12
62356|NCT01383993|145094|P3|STARTED|Overall Study||2
62357|NCT01383993|145095|P2|STARTED|Overall Study||4
62358|NCT01383993|145096|P1|STARTED|Overall Study||15
62359|NCT01383928|145146|P3|NOT COMPLETED|Phase 2||40
62360|NCT01383928|145147|P2|NOT COMPLETED|Phase 2||0
62361|NCT01383928|145148|P1|NOT COMPLETED|Phase 2||0
62362|NCT01383928|145146|P3|COMPLETED|Phase 2||10
62363|NCT01383928|145147|P2|COMPLETED|Phase 2||0
62364|NCT01383928|145148|P1|COMPLETED|Phase 2||0
62365|NCT01383928|145146|P3|STARTED|Phase 2||50
62366|NCT01383928|145147|P2|STARTED|Phase 2||0
62367|NCT01383928|145148|P1|STARTED|Phase 2||0
62368|NCT01383928|145146|P3|NOT COMPLETED|Phase 1||0
62369|NCT01383928|145147|P2|NOT COMPLETED|Phase 1||7
62370|NCT01383928|145148|P1|NOT COMPLETED|Phase 1||5
62371|NCT01383928|145146|P3|COMPLETED|Phase 1||0
62372|NCT01383928|145147|P2|COMPLETED|Phase 1||0
62373|NCT01383928|145148|P1|COMPLETED|Phase 1||2
62374|NCT01383928|145146|P3|STARTED|Phase 1||0
62375|NCT01383928|145147|P2|STARTED|Phase 1||7
62376|NCT01383928|145148|P1|STARTED|Phase 1||7
62377|NCT01383720|145190|P1|NOT COMPLETED|Overall Study||0
62378|NCT01383720|145190|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
62379|NCT01383720|145190|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
62380|NCT01383720|145190|P1|STARTED|Overall Study||11
62381|NCT01383707|145212|P1|NOT COMPLETED|Overall Study||17
62382|NCT01383707|145212|P1|COMPLETED|Overall Study||60
62383|NCT01383707|145212|P1|STARTED|Overall Study||77
62384|NCT01383681|145221|P1|NOT COMPLETED|Overall Study||46
62385|NCT01383681|145221|P1|COMPLETED|Overall Study||189
62386|NCT01383681|145221|P1|STARTED|Overall Study||235
62387|NCT01383499|145226|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
62388|NCT01383499|145227|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
62389|NCT01383499|145228|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
62390|NCT01383499|145229|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
62391|NCT01383499|145226|P4|COMPLETED|Period 3 (4 Weeks)||25
62392|NCT01383499|145227|P3|COMPLETED|Period 3 (4 Weeks)||25
62393|NCT01383499|145228|P2|COMPLETED|Period 3 (4 Weeks)||24
62394|NCT01383499|145229|P1|COMPLETED|Period 3 (4 Weeks)||26
62395|NCT01383499|145226|P4|STARTED|Period 3 (4 Weeks)||25
62396|NCT01383499|145227|P3|STARTED|Period 3 (4 Weeks)||25
62397|NCT01383499|145228|P2|STARTED|Period 3 (4 Weeks)||24
62398|NCT01383499|145229|P1|STARTED|Period 3 (4 Weeks)||26
62399|NCT01383499|145226|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
62400|NCT01383499|145227|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
62401|NCT01383499|145228|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
62402|NCT01383499|145229|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
62403|NCT01383499|145226|P4|COMPLETED|Period 2 (4 Weeks)||25
62404|NCT01383499|145227|P3|COMPLETED|Period 2 (4 Weeks)||25
62405|NCT01383499|145228|P2|COMPLETED|Period 2 (4 Weeks)||24
62406|NCT01383499|145229|P1|COMPLETED|Period 2 (4 Weeks)||26
62407|NCT01383499|145226|P4|STARTED|Period 2 (4 Weeks)||25
62408|NCT01383499|145227|P3|STARTED|Period 2 (4 Weeks)||25
62409|NCT01383499|145228|P2|STARTED|Period 2 (4 Weeks)||24
62410|NCT01383499|145229|P1|STARTED|Period 2 (4 Weeks)||26
62411|NCT01383499|145226|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
62412|NCT01383499|145227|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
62413|NCT01383499|145228|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
62414|NCT01383499|145229|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
62415|NCT01383499|145226|P4|COMPLETED|Period 1 (4 Weeks)||25
62416|NCT01383499|145227|P3|COMPLETED|Period 1 (4 Weeks)||25
62417|NCT01383499|145228|P2|COMPLETED|Period 1 (4 Weeks)||24
62418|NCT01383499|145229|P1|COMPLETED|Period 1 (4 Weeks)||26
62419|NCT01383499|145226|P4|STARTED|Period 1 (4 Weeks)||25
62420|NCT01383499|145227|P3|STARTED|Period 1 (4 Weeks)||25
62421|NCT01383499|145228|P2|STARTED|Period 1 (4 Weeks)||24
62422|NCT01383499|145229|P1|STARTED|Period 1 (4 Weeks)||27
62423|NCT01383486|145279|P1|NOT COMPLETED|Overall Study||18
62500|NCT01383096|145345|P2|STARTED|Third Intervention (8 Days)||16
62424|NCT01383486|145279|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
62425|NCT01383486|145279|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
62426|NCT01383486|145279|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
62427|NCT01383356|145285|P2|NOT COMPLETED|Period 2||0
62428|NCT01383356|145286|P1|NOT COMPLETED|Period 2||0
62429|NCT01383356|145285|P2|COMPLETED|Period 2|Completed period 2.|23
62430|NCT01383356|145286|P1|COMPLETED|Period 2|Completed period 2.|21
62431|NCT01383356|145285|P2|STARTED|Period 2|Entered and treated.|23
62432|NCT01383356|145286|P1|STARTED|Period 2|Entered and treated.|21
62433|NCT01383356|145285|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
62434|NCT01383356|145286|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
62435|NCT01383356|145285|P2|COMPLETED|Washout Period (at Least 35 Days)||23
62436|NCT01383356|145286|P1|COMPLETED|Washout Period (at Least 35 Days)||21
62437|NCT01383356|145285|P2|STARTED|Washout Period (at Least 35 Days)||23
62438|NCT01383356|145286|P1|STARTED|Washout Period (at Least 35 Days)||21
62439|NCT01383356|145285|P2|NOT COMPLETED|Period 1||6
62440|NCT01383356|145286|P1|NOT COMPLETED|Period 1||8
62441|NCT01383356|145285|P2|COMPLETED|Period 1|Completed period 1.|23
62442|NCT01383356|145286|P1|COMPLETED|Period 1|Completed period 1.|21
62443|NCT01383356|145285|P2|STARTED|Period 1|Entered and treated.|29
62444|NCT01383356|145286|P1|STARTED|Period 1|Entered and treated.|29
62445|NCT01383213|145298|P2|NOT COMPLETED|Overall Study||0
62446|NCT01383213|145299|P1|NOT COMPLETED|Overall Study||0
62447|NCT01383213|145298|P2|COMPLETED|Overall Study||41
62448|NCT01383213|145299|P1|COMPLETED|Overall Study||40
62449|NCT01383213|145298|P2|STARTED|Overall Study||41
62450|NCT01383213|145299|P1|STARTED|Overall Study||40
62451|NCT01383200|145307|P2|NOT COMPLETED|Overall Study||0
62452|NCT01383200|145308|P1|NOT COMPLETED|Overall Study||0
62453|NCT01383200|145307|P2|COMPLETED|Overall Study||6
62454|NCT01383200|145308|P1|COMPLETED|Overall Study||5
62455|NCT01383200|145307|P2|STARTED|Overall Study||6
62456|NCT01383200|145308|P1|STARTED|Overall Study||5
62457|NCT01383174|145316|P2|NOT COMPLETED|6 Month Assessment||1
62458|NCT01383174|145317|P1|NOT COMPLETED|6 Month Assessment||5
62459|NCT01383174|145316|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
62460|NCT01383174|145317|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
62461|NCT01383174|145316|P2|STARTED|6 Month Assessment||74
62462|NCT01383174|145317|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
62463|NCT01383174|145316|P2|NOT COMPLETED|3 Month Assessment||1
62464|NCT01383174|145317|P1|NOT COMPLETED|3 Month Assessment||6
62465|NCT01383174|145316|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
62466|NCT01383174|145317|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
62467|NCT01383174|145316|P2|STARTED|3 Month Assessment||75
62468|NCT01383174|145317|P1|STARTED|3 Month Assessment||76
62469|NCT01383174|145316|P2|NOT COMPLETED|Baseline Assessment||0
62470|NCT01383174|145317|P1|NOT COMPLETED|Baseline Assessment||0
62471|NCT01383174|145316|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
62472|NCT01383174|145317|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
62473|NCT01383174|145316|P2|STARTED|Baseline Assessment||75
62474|NCT01383174|145317|P1|STARTED|Baseline Assessment||76
62475|NCT01383096|145344|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
62476|NCT01383096|145345|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
62477|NCT01383096|145346|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
62478|NCT01383096|145344|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62479|NCT01383096|145345|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
62480|NCT01383096|145346|P1|COMPLETED|Fifth Intervention (8 Days)||11
62481|NCT01383096|145344|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62482|NCT01383096|145345|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
62483|NCT01383096|145346|P1|STARTED|Fifth Intervention (8 Days)||13
62484|NCT01383096|145344|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
62485|NCT01383096|145345|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
62486|NCT01383096|145346|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
62487|NCT01383096|145344|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62488|NCT01383096|145345|P2|COMPLETED|Fourth Intervention (8 Days)||12
62489|NCT01383096|145346|P1|COMPLETED|Fourth Intervention (8 Days)||13
62490|NCT01383096|145344|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62491|NCT01383096|145345|P2|STARTED|Fourth Intervention (8 Days)||12
62492|NCT01383096|145346|P1|STARTED|Fourth Intervention (8 Days)||15
62493|NCT01383096|145344|P3|NOT COMPLETED|Third Intervention (8 Days)||0
62494|NCT01383096|145345|P2|NOT COMPLETED|Third Intervention (8 Days)||4
62495|NCT01383096|145346|P1|NOT COMPLETED|Third Intervention (8 Days)||4
62496|NCT01383096|145344|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62497|NCT01383096|145345|P2|COMPLETED|Third Intervention (8 Days)||12
62498|NCT01383096|145346|P1|COMPLETED|Third Intervention (8 Days)||15
62499|NCT01383096|145344|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
62501|NCT01383096|145346|P1|STARTED|Third Intervention (8 Days)||19
62502|NCT01383096|145344|P3|NOT COMPLETED|Second Intervention (8 Days)||2
62503|NCT01383096|145345|P2|NOT COMPLETED|Second Intervention (8 Days)||1
62504|NCT01383096|145346|P1|NOT COMPLETED|Second Intervention (8 Days)||0
62505|NCT01383096|145344|P3|COMPLETED|Second Intervention (8 Days)||14
62506|NCT01383096|145345|P2|COMPLETED|Second Intervention (8 Days)||16
62507|NCT01383096|145346|P1|COMPLETED|Second Intervention (8 Days)||19
62508|NCT01383096|145344|P3|STARTED|Second Intervention (8 Days)||16
62509|NCT01383096|145345|P2|STARTED|Second Intervention (8 Days)||17
62510|NCT01383096|145346|P1|STARTED|Second Intervention (8 Days)||19
62511|NCT01383096|145344|P3|NOT COMPLETED|First Intervention (8 Days)||0
62512|NCT01383096|145345|P2|NOT COMPLETED|First Intervention (8 Days)||0
62513|NCT01383096|145346|P1|NOT COMPLETED|First Intervention (8 Days)||0
62514|NCT01383096|145344|P3|COMPLETED|First Intervention (8 Days)||16
62515|NCT01383096|145345|P2|COMPLETED|First Intervention (8 Days)||17
62516|NCT01383096|145346|P1|COMPLETED|First Intervention (8 Days)||19
62517|NCT01383096|145344|P3|STARTED|First Intervention (8 Days)||16
62518|NCT01383096|145345|P2|STARTED|First Intervention (8 Days)||17
62519|NCT01383096|145346|P1|STARTED|First Intervention (8 Days)||19
62520|NCT01383005|145394|P2|NOT COMPLETED|Overall Study||0
62521|NCT01383005|145395|P1|NOT COMPLETED|Overall Study||0
62522|NCT01383005|145394|P2|COMPLETED|Overall Study||60
62523|NCT01383005|145395|P1|COMPLETED|Overall Study||34
62524|NCT01383005|145394|P2|STARTED|Overall Study||60
62525|NCT01383005|145395|P1|STARTED|Overall Study||34
62526|NCT01382940|145414|P1|NOT COMPLETED|Overall Study||73
62527|NCT01382940|145414|P1|COMPLETED|Overall Study||278
62528|NCT01382940|145414|P1|Received Day 182 Infusion|Overall Study||278
62529|NCT01382940|145414|P1|Received Day 168 Infusion|Overall Study||290
62530|NCT01382940|145414|P1|Received Day 15 Infusions|Overall Study||341
62531|NCT01382940|145414|P1|Received Day 1 Infusion|Overall Study||351
62532|NCT01382940|145414|P1|STARTED|Overall Study||351
62533|NCT01382901|145426|P2|NOT COMPLETED|Overall Study||14
62534|NCT01382901|145427|P1|NOT COMPLETED|Overall Study||17
62535|NCT01382901|145426|P2|COMPLETED|Overall Study||7
62536|NCT01382901|145427|P1|COMPLETED|Overall Study||7
62537|NCT01382901|145426|P2|STARTED|Overall Study||21
62538|NCT01382901|145427|P1|STARTED|Overall Study||24
62539|NCT01382719|145437|P4|NOT COMPLETED|Overall Study||33
62540|NCT01382719|145438|P3|NOT COMPLETED|Overall Study||34
62541|NCT01382719|145439|P2|NOT COMPLETED|Overall Study||19
62542|NCT01382719|145440|P1|NOT COMPLETED|Overall Study||18
62543|NCT01382719|145437|P4|COMPLETED|Overall Study||66
62544|NCT01382719|145438|P3|COMPLETED|Overall Study||66
62545|NCT01382719|145439|P2|COMPLETED|Overall Study||81
62546|NCT01382719|145440|P1|COMPLETED|Overall Study||80
62547|NCT01382719|145437|P4|Subjects Not Dosed|Overall Study||1
62548|NCT01382719|145438|P3|Subjects Not Dosed|Overall Study||1
62549|NCT01382719|145439|P2|Subjects Not Dosed|Overall Study||0
62550|NCT01382719|145440|P1|Subjects Not Dosed|Overall Study||1
62551|NCT01382719|145437|P4|STARTED|Overall Study||99
62552|NCT01382719|145438|P3|STARTED|Overall Study||100
62553|NCT01382719|145439|P2|STARTED|Overall Study||100
62554|NCT01382719|145440|P1|STARTED|Overall Study||98
62555|NCT01382446|145476|P2|NOT COMPLETED|Overall Study||4
62556|NCT01382446|145477|P1|NOT COMPLETED|Overall Study||3
62557|NCT01382446|145476|P2|COMPLETED|Overall Study||29
62558|NCT01382446|145477|P1|COMPLETED|Overall Study||30
62559|NCT01382446|145476|P2|STARTED|Overall Study||33
62560|NCT01382446|145477|P1|STARTED|Overall Study||33
62561|NCT01382251|145485|P2|NOT COMPLETED|Overall Study||21
62562|NCT01382251|145486|P1|NOT COMPLETED|Overall Study||21
62563|NCT01382251|145485|P2|COMPLETED|Overall Study||102
62564|NCT01382251|145486|P1|COMPLETED|Overall Study||102
62565|NCT01382251|145485|P2|STARTED|Overall Study||123
62566|NCT01382251|145486|P1|STARTED|Overall Study||123
62567|NCT01382225|145499|P2|NOT COMPLETED|Overall Study||7
62568|NCT01382225|145500|P1|NOT COMPLETED|Overall Study||14
62569|NCT01382225|145499|P2|COMPLETED|Overall Study||722
62570|NCT01382225|145500|P1|COMPLETED|Overall Study||711
62571|NCT01382225|145499|P2|STARTED|Overall Study||729
62572|NCT01382225|145500|P1|STARTED|Overall Study||725
62573|NCT01382212|145522|P1|NOT COMPLETED|Overall Study||2
62574|NCT01382212|145522|P1|COMPLETED|Overall Study||11
62575|NCT01382212|145522|P1|STARTED|Overall Study||13
62576|NCT01382186|145548|P2|NOT COMPLETED|Overall Study||0
62577|NCT01382186|145549|P1|NOT COMPLETED|Overall Study||1
62578|NCT01382186|145548|P2|COMPLETED|Overall Study||819
62579|NCT01382186|145549|P1|COMPLETED|Overall Study||32
62580|NCT01382186|145548|P2|STARTED|Overall Study||819
62581|NCT01382186|145549|P1|STARTED|Overall Study||33
62582|NCT01382108|145565|P2|NOT COMPLETED|Overall Study||0
62583|NCT01382108|145566|P1|NOT COMPLETED|Overall Study||0
62584|NCT01382108|145565|P2|COMPLETED|Overall Study||19
62585|NCT01382108|145566|P1|COMPLETED|Overall Study||20
62586|NCT01382108|145565|P2|STARTED|Overall Study||19
62587|NCT01382108|145566|P1|STARTED|Overall Study||20
62588|NCT01381952|145576|P1|NOT COMPLETED|Overall Study||0
62589|NCT01381952|145576|P1|COMPLETED|Overall Study||20
62590|NCT01381952|145576|P1|Collected Dose and Image Information|Overall Study||20
62591|NCT01381952|145576|P1|STARTED|Overall Study||20
62592|NCT01381900|145586|P3|NOT COMPLETED|Overall Study||12
62593|NCT01381900|145587|P2|NOT COMPLETED|Overall Study||9
62594|NCT01381900|145588|P1|NOT COMPLETED|Overall Study||9
62595|NCT01381900|145586|P3|COMPLETED|Overall Study||215
62596|NCT01381900|145587|P2|COMPLETED|Overall Study||214
62597|NCT01381900|145588|P1|COMPLETED|Overall Study||217
62598|NCT01381900|145586|P3|STARTED|Overall Study||227
62599|NCT01381900|145587|P2|STARTED|Overall Study||223
62600|NCT01381900|145588|P1|STARTED|Overall Study||226
62601|NCT01381679|145608|P1|NOT COMPLETED|Overall Study||888
62602|NCT01381679|145608|P1|COMPLETED|Overall Study||794
62603|NCT01381679|145608|P1|STARTED|Overall Study||1682
62604|NCT01381575|145623|P3|NOT COMPLETED|Overall Study||7
62605|NCT01381575|145624|P2|NOT COMPLETED|Overall Study||10
62606|NCT01381575|145625|P1|NOT COMPLETED|Overall Study||2
62607|NCT01381575|145623|P3|COMPLETED|Overall Study||408
62608|NCT01381575|145624|P2|COMPLETED|Overall Study||472
62609|NCT01381575|145625|P1|COMPLETED|Overall Study||548
62610|NCT01381575|145623|P3|STARTED|Overall Study||415
62611|NCT01381575|145624|P2|STARTED|Overall Study||482
62612|NCT01381575|145625|P1|STARTED|Overall Study||550
62613|NCT01381471|145679|P1|NOT COMPLETED|Overall Study||0
62614|NCT01381471|145679|P1|COMPLETED|Overall Study||11060
62615|NCT01381471|145679|P1|STARTED|Overall Study||11060
62616|NCT01381406|145686|P2|NOT COMPLETED|Overall Study||0
62617|NCT01381406|145687|P1|NOT COMPLETED|Overall Study||0
62618|NCT01381406|145686|P2|COMPLETED|Overall Study||852
62619|NCT01381406|145687|P1|COMPLETED|Overall Study||2481
62620|NCT01381406|145686|P2|STARTED|Overall Study||852
62621|NCT01381406|145687|P1|STARTED|Overall Study||2481
62622|NCT01381120|145699|P2|NOT COMPLETED|Overall Study||9
62623|NCT01381120|145700|P1|NOT COMPLETED|Overall Study||11
62624|NCT01381120|145699|P2|COMPLETED|Overall Study||18
62625|NCT01381120|145700|P1|COMPLETED|Overall Study||39
62626|NCT01381120|145699|P2|STARTED|Overall Study||27
62627|NCT01381120|145700|P1|STARTED|Overall Study||50
62628|NCT01381016|145710|P2|NOT COMPLETED|Overall Study||6
62629|NCT01381016|145711|P1|NOT COMPLETED|Overall Study||3
62630|NCT01381016|145710|P2|COMPLETED|Overall Study||11
62631|NCT01381016|145711|P1|COMPLETED|Overall Study||10
62632|NCT01381016|145710|P2|STARTED|Overall Study||17
62633|NCT01381016|145711|P1|STARTED|Overall Study||13
62634|NCT01380834|145721|P2|NOT COMPLETED|Overall Study||0
62635|NCT01380834|145722|P1|NOT COMPLETED|Overall Study||1
62636|NCT01380834|145721|P2|COMPLETED|Overall Study||42
62637|NCT01380834|145722|P1|COMPLETED|Overall Study||41
62638|NCT01380834|145721|P2|STARTED|Overall Study||42
62639|NCT01380834|145722|P1|STARTED|Overall Study||42
62640|NCT01380782|145734|P4|NOT COMPLETED|Overall Study||4
62641|NCT01380782|145735|P3|NOT COMPLETED|Overall Study||11
62642|NCT01380782|145736|P2|NOT COMPLETED|Overall Study||10
62643|NCT01380782|145737|P1|NOT COMPLETED|Overall Study||12
62644|NCT01380782|145734|P4|COMPLETED|Overall Study||0
62645|NCT01380782|145735|P3|COMPLETED|Overall Study||0
62646|NCT01380782|145736|P2|COMPLETED|Overall Study||0
62647|NCT01380782|145737|P1|COMPLETED|Overall Study||0
62648|NCT01380782|145734|P4|STARTED|Overall Study||4
62649|NCT01380782|145735|P3|STARTED|Overall Study||11
62650|NCT01380782|145736|P2|STARTED|Overall Study||10
62651|NCT01380782|145737|P1|STARTED|Overall Study||12
62652|NCT01380730|145766|P8|NOT COMPLETED|Overall Study||0
62653|NCT01380730|145767|P7|NOT COMPLETED|Overall Study||0
62654|NCT01380730|145768|P6|NOT COMPLETED|Overall Study||0
62655|NCT01380730|145769|P5|NOT COMPLETED|Overall Study||1
62656|NCT01380730|145770|P4|NOT COMPLETED|Overall Study||0
62657|NCT01380730|145771|P3|NOT COMPLETED|Overall Study||0
62658|NCT01380730|145772|P2|NOT COMPLETED|Overall Study||0
62659|NCT01380730|145773|P1|NOT COMPLETED|Overall Study||0
62660|NCT01380730|145766|P8|COMPLETED|Overall Study||80
62661|NCT01380730|145767|P7|COMPLETED|Overall Study||79
62662|NCT01380730|145768|P6|COMPLETED|Overall Study||79
62663|NCT01380730|145769|P5|COMPLETED|Overall Study||77
62664|NCT01380730|145770|P4|COMPLETED|Overall Study||79
62665|NCT01380730|145771|P3|COMPLETED|Overall Study||79
62666|NCT01380730|145772|P2|COMPLETED|Overall Study||79
62667|NCT01380730|145773|P1|COMPLETED|Overall Study||78
62668|NCT01380730|145766|P8|Received Treatment|Overall Study||80
62669|NCT01380730|145767|P7|Received Treatment|Overall Study||79
62670|NCT01380730|145768|P6|Received Treatment|Overall Study||79
62671|NCT01380730|145769|P5|Received Treatment|Overall Study||78
62672|NCT01380730|145770|P4|Received Treatment|Overall Study||79
62673|NCT01380730|145771|P3|Received Treatment|Overall Study||79
62674|NCT01380730|145772|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
62675|NCT01380730|145773|P1|Received Treatment|Overall Study||78
62676|NCT01380730|145766|P8|STARTED|Overall Study||80
62677|NCT01380730|145767|P7|STARTED|Overall Study||79
62678|NCT01380730|145768|P6|STARTED|Overall Study||79
62679|NCT01380730|145769|P5|STARTED|Overall Study||78
62680|NCT01380730|145770|P4|STARTED|Overall Study||79
62681|NCT01380730|145771|P3|STARTED|Overall Study||79
62682|NCT01380730|145772|P2|STARTED|Overall Study||79
62683|NCT01380730|145773|P1|STARTED|Overall Study||78
62684|NCT01380639|145833|P2|NOT COMPLETED|Overall Study||4
62685|NCT01380639|145834|P1|NOT COMPLETED|Overall Study||6
62686|NCT01380639|145833|P2|COMPLETED|Overall Study||36
62687|NCT01380639|145834|P1|COMPLETED|Overall Study||36
62688|NCT01380639|145833|P2|STARTED|Overall Study||40
62689|NCT01380639|145834|P1|STARTED|Overall Study||42
62690|NCT01380379|145840|P1|NOT COMPLETED|Overall Study||1
62691|NCT01380379|145840|P1|COMPLETED|Overall Study||8
62692|NCT01380379|145840|P1|STARTED|Overall Study||9
62693|NCT01380366|145845|P1|NOT COMPLETED|Overall Study||0
62694|NCT01380366|145845|P1|COMPLETED|Overall Study||15
62695|NCT01380366|145845|P1|STARTED|Overall Study||15
62696|NCT01380327|145853|P3|NOT COMPLETED|Overall Study||7
62697|NCT01380327|145854|P2|NOT COMPLETED|Overall Study||3
62698|NCT01380327|145855|P1|NOT COMPLETED|Overall Study||3
62699|NCT01380327|145853|P3|COMPLETED|Overall Study||21
62700|NCT01380327|145854|P2|COMPLETED|Overall Study||28
62701|NCT01380327|145855|P1|COMPLETED|Overall Study||27
62702|NCT01380327|145853|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
62703|NCT01380327|145854|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
62704|NCT01380327|145855|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
62705|NCT01379183|145877|P2|NOT COMPLETED|Overall Study||0
62706|NCT01379183|145878|P1|NOT COMPLETED|Overall Study||0
62707|NCT01379183|145877|P2|COMPLETED|Overall Study||21
62708|NCT01379183|145878|P1|COMPLETED|Overall Study||19
62709|NCT01379183|145877|P2|STARTED|Overall Study||21
62710|NCT01379183|145878|P1|STARTED|Overall Study||19
62711|NCT01380197|145896|P2|NOT COMPLETED|Overall Study||0
62712|NCT01380197|145897|P1|NOT COMPLETED|Overall Study||0
62713|NCT01380197|145896|P2|COMPLETED|Overall Study||20
62714|NCT01380197|145897|P1|COMPLETED|Overall Study||20
62715|NCT01380197|145896|P2|STARTED|Overall Study||20
62716|NCT01380197|145897|P1|STARTED|Overall Study||20
62717|NCT01380145|145905|P1|NOT COMPLETED|Overall Study||4
62718|NCT01380145|145905|P1|COMPLETED|Overall Study||9
62719|NCT01380145|145905|P1|STARTED|Overall Study||13
62720|NCT01380093|145913|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
62721|NCT01380093|145914|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
62722|NCT01380093|145915|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
62723|NCT01380093|145916|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
62724|NCT01380093|145917|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
62725|NCT01380093|145918|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
62726|NCT01380093|145919|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
62727|NCT01380093|145920|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
62728|NCT01380093|145921|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
62729|NCT01380093|145913|P9|COMPLETED|Treatment Phase: Third Intervention||4
62730|NCT01380093|145914|P8|COMPLETED|Treatment Phase: Third Intervention||6
62731|NCT01380093|145915|P7|COMPLETED|Treatment Phase: Third Intervention||6
62732|NCT01380093|145916|P6|COMPLETED|Treatment Phase: Third Intervention||6
62733|NCT01380093|145917|P5|COMPLETED|Treatment Phase: Third Intervention||6
62734|NCT01380093|145918|P4|COMPLETED|Treatment Phase: Third Intervention||5
62735|NCT01380093|145919|P3|COMPLETED|Treatment Phase: Third Intervention||0
62736|NCT01380093|145920|P2|COMPLETED|Treatment Phase: Third Intervention||0
62737|NCT01380093|145921|P1|COMPLETED|Treatment Phase: Third Intervention||0
62738|NCT01380093|145913|P9|STARTED|Treatment Phase: Third Intervention||6
62739|NCT01380093|145914|P8|STARTED|Treatment Phase: Third Intervention||6
62740|NCT01380093|145915|P7|STARTED|Treatment Phase: Third Intervention||6
62741|NCT01380093|145916|P6|STARTED|Treatment Phase: Third Intervention||6
62742|NCT01380093|145917|P5|STARTED|Treatment Phase: Third Intervention||6
62743|NCT01380093|145918|P4|STARTED|Treatment Phase: Third Intervention||5
62744|NCT01380093|145919|P3|STARTED|Treatment Phase: Third Intervention||0
62745|NCT01380093|145920|P2|STARTED|Treatment Phase: Third Intervention||0
62746|NCT01380093|145921|P1|STARTED|Treatment Phase: Third Intervention||0
62747|NCT01380093|145913|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
62748|NCT01380093|145914|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
62749|NCT01380093|145915|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
62750|NCT01380093|145916|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
62751|NCT01380093|145917|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
62752|NCT01380093|145918|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
62753|NCT01380093|145919|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
62754|NCT01380093|145920|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
62755|NCT01380093|145921|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
62756|NCT01380093|145913|P9|COMPLETED|Treatment Phase: Washout Period||6
62757|NCT01380093|145914|P8|COMPLETED|Treatment Phase: Washout Period||6
62758|NCT01380093|145915|P7|COMPLETED|Treatment Phase: Washout Period||6
62759|NCT01380093|145916|P6|COMPLETED|Treatment Phase: Washout Period||6
62760|NCT01380093|145917|P5|COMPLETED|Treatment Phase: Washout Period||6
62761|NCT01380093|145918|P4|COMPLETED|Treatment Phase: Washout Period||5
62762|NCT01380093|145919|P3|COMPLETED|Treatment Phase: Washout Period||0
62763|NCT01380093|145920|P2|COMPLETED|Treatment Phase: Washout Period||0
62764|NCT01380093|145921|P1|COMPLETED|Treatment Phase: Washout Period||0
62765|NCT01380093|145913|P9|STARTED|Treatment Phase: Washout Period||6
62766|NCT01380093|145914|P8|STARTED|Treatment Phase: Washout Period||6
62767|NCT01380093|145915|P7|STARTED|Treatment Phase: Washout Period||6
62768|NCT01380093|145916|P6|STARTED|Treatment Phase: Washout Period||6
62769|NCT01380093|145917|P5|STARTED|Treatment Phase: Washout Period||6
62770|NCT01380093|145918|P4|STARTED|Treatment Phase: Washout Period||5
62771|NCT01380093|145919|P3|STARTED|Treatment Phase: Washout Period||0
62772|NCT01380093|145920|P2|STARTED|Treatment Phase: Washout Period||0
62773|NCT01380093|145921|P1|STARTED|Treatment Phase: Washout Period||0
62774|NCT01380093|145913|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
62775|NCT01380093|145914|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
62776|NCT01380093|145915|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
62777|NCT01380093|145916|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
62778|NCT01380093|145917|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
62779|NCT01380093|145918|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
62780|NCT01380093|145919|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
62781|NCT01380093|145920|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
62782|NCT01380093|145921|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
62783|NCT01380093|145913|P9|COMPLETED|Treatment Phase: Second Intervention||6
62784|NCT01380093|145914|P8|COMPLETED|Treatment Phase: Second Intervention||6
62785|NCT01380093|145915|P7|COMPLETED|Treatment Phase: Second Intervention||6
62786|NCT01380093|145916|P6|COMPLETED|Treatment Phase: Second Intervention||6
62787|NCT01380093|145917|P5|COMPLETED|Treatment Phase: Second Intervention||6
62788|NCT01380093|145918|P4|COMPLETED|Treatment Phase: Second Intervention||5
62789|NCT01380093|145919|P3|COMPLETED|Treatment Phase: Second Intervention||0
62790|NCT01380093|145920|P2|COMPLETED|Treatment Phase: Second Intervention||0
62791|NCT01380093|145921|P1|COMPLETED|Treatment Phase: Second Intervention||0
62792|NCT01380093|145913|P9|STARTED|Treatment Phase: Second Intervention||6
62793|NCT01380093|145914|P8|STARTED|Treatment Phase: Second Intervention||6
62794|NCT01380093|145915|P7|STARTED|Treatment Phase: Second Intervention||6
62795|NCT01380093|145916|P6|STARTED|Treatment Phase: Second Intervention||6
62796|NCT01380093|145917|P5|STARTED|Treatment Phase: Second Intervention||6
62797|NCT01380093|145918|P4|STARTED|Treatment Phase: Second Intervention||6
62798|NCT01380093|145919|P3|STARTED|Treatment Phase: Second Intervention||0
62799|NCT01380093|145920|P2|STARTED|Treatment Phase: Second Intervention||0
62800|NCT01380093|145921|P1|STARTED|Treatment Phase: Second Intervention||0
62801|NCT01380093|145913|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
62802|NCT01380093|145914|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
62803|NCT01380093|145915|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
62804|NCT01380093|145916|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
62805|NCT01380093|145917|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
62806|NCT01380093|145918|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
62807|NCT01380093|145919|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
62808|NCT01380093|145920|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
62809|NCT01380093|145921|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
62810|NCT01380093|145913|P9|COMPLETED|Treatment Phase: Washout Period||6
62811|NCT01380093|145914|P8|COMPLETED|Treatment Phase: Washout Period||6
62812|NCT01380093|145915|P7|COMPLETED|Treatment Phase: Washout Period||6
62813|NCT01380093|145916|P6|COMPLETED|Treatment Phase: Washout Period||6
62814|NCT01380093|145917|P5|COMPLETED|Treatment Phase: Washout Period||6
62815|NCT01380093|145918|P4|COMPLETED|Treatment Phase: Washout Period||6
62816|NCT01380093|145919|P3|COMPLETED|Treatment Phase: Washout Period||0
62817|NCT01380093|145920|P2|COMPLETED|Treatment Phase: Washout Period||0
62818|NCT01380093|145921|P1|COMPLETED|Treatment Phase: Washout Period||0
62819|NCT01380093|145913|P9|STARTED|Treatment Phase: Washout Period||6
62820|NCT01380093|145914|P8|STARTED|Treatment Phase: Washout Period||6
62821|NCT01380093|145915|P7|STARTED|Treatment Phase: Washout Period||6
62822|NCT01380093|145916|P6|STARTED|Treatment Phase: Washout Period||6
62823|NCT01380093|145917|P5|STARTED|Treatment Phase: Washout Period||6
62824|NCT01380093|145918|P4|STARTED|Treatment Phase: Washout Period||6
62825|NCT01380093|145919|P3|STARTED|Treatment Phase: Washout Period||0
62826|NCT01380093|145920|P2|STARTED|Treatment Phase: Washout Period||0
62827|NCT01380093|145921|P1|STARTED|Treatment Phase: Washout Period||0
62828|NCT01380093|145913|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
62829|NCT01380093|145914|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
62830|NCT01380093|145915|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
62831|NCT01380093|145916|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
62832|NCT01380093|145917|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
62833|NCT01380093|145918|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
62834|NCT01380093|145919|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
62835|NCT01380093|145920|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
62836|NCT01380093|145921|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
62837|NCT01380093|145913|P9|COMPLETED|Treatment Phase: First Intervention||6
62838|NCT01380093|145914|P8|COMPLETED|Treatment Phase: First Intervention||6
62839|NCT01380093|145915|P7|COMPLETED|Treatment Phase: First Intervention||6
62840|NCT01380093|145916|P6|COMPLETED|Treatment Phase: First Intervention||6
62841|NCT01380093|145917|P5|COMPLETED|Treatment Phase: First Intervention||6
62842|NCT01380093|145918|P4|COMPLETED|Treatment Phase: First Intervention||6
62843|NCT01380093|145919|P3|COMPLETED|Treatment Phase: First Intervention||0
62844|NCT01380093|145920|P2|COMPLETED|Treatment Phase: First Intervention||0
62845|NCT01380093|145921|P1|COMPLETED|Treatment Phase: First Intervention||0
62846|NCT01380093|145913|P9|STARTED|Treatment Phase: First Intervention||6
62847|NCT01380093|145914|P8|STARTED|Treatment Phase: First Intervention||6
62848|NCT01380093|145915|P7|STARTED|Treatment Phase: First Intervention||6
62849|NCT01380093|145916|P6|STARTED|Treatment Phase: First Intervention||6
62850|NCT01380093|145917|P5|STARTED|Treatment Phase: First Intervention||6
62851|NCT01380093|145918|P4|STARTED|Treatment Phase: First Intervention||6
62852|NCT01380093|145919|P3|STARTED|Treatment Phase: First Intervention||0
62853|NCT01380093|145920|P2|STARTED|Treatment Phase: First Intervention||0
62854|NCT01380093|145921|P1|STARTED|Treatment Phase: First Intervention||0
62855|NCT01380093|145913|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62856|NCT01380093|145914|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62857|NCT01380093|145915|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62858|NCT01380093|145916|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62859|NCT01380093|145917|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62860|NCT01380093|145918|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62861|NCT01380093|145919|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
62862|NCT01380093|145920|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
62863|NCT01380093|145921|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
62864|NCT01380093|145913|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
62865|NCT01380093|145914|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
62866|NCT01380093|145915|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
62867|NCT01380093|145916|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
62868|NCT01380093|145917|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
62869|NCT01380093|145918|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
62870|NCT01380093|145919|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
62871|NCT01380093|145920|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
62872|NCT01380093|145921|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
62873|NCT01380093|145913|P9|STARTED|Drug Discrimination Phase: Day 2||0
62874|NCT01380093|145914|P8|STARTED|Drug Discrimination Phase: Day 2||0
62875|NCT01380093|145915|P7|STARTED|Drug Discrimination Phase: Day 2||0
62876|NCT01380093|145916|P6|STARTED|Drug Discrimination Phase: Day 2||0
62877|NCT01380093|145917|P5|STARTED|Drug Discrimination Phase: Day 2||0
62878|NCT01380093|145918|P4|STARTED|Drug Discrimination Phase: Day 2||0
62879|NCT01380093|145919|P3|STARTED|Drug Discrimination Phase: Day 2||29
62880|NCT01380093|145920|P2|STARTED|Drug Discrimination Phase: Day 2||29
62881|NCT01380093|145921|P1|STARTED|Drug Discrimination Phase: Day 2||0
62882|NCT01380093|145913|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62883|NCT01380093|145914|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62884|NCT01380093|145915|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62885|NCT01380093|145916|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62886|NCT01380093|145917|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62887|NCT01380093|145918|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62888|NCT01380093|145919|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62889|NCT01380093|145920|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
62890|NCT01380093|145921|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
62891|NCT01380093|145913|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
62892|NCT01380093|145914|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
62893|NCT01380093|145915|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
62894|NCT01380093|145916|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
62895|NCT01380093|145917|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
62896|NCT01380093|145918|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
62897|NCT01380093|145919|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
62898|NCT01380093|145920|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
62899|NCT01380093|145921|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
62900|NCT01380093|145913|P9|STARTED|Drug Discrimination Phase: Day 1||0
62901|NCT01380093|145914|P8|STARTED|Drug Discrimination Phase: Day 1||0
62902|NCT01380093|145915|P7|STARTED|Drug Discrimination Phase: Day 1||0
62903|NCT01380093|145916|P6|STARTED|Drug Discrimination Phase: Day 1||0
62904|NCT01380093|145917|P5|STARTED|Drug Discrimination Phase: Day 1||0
62905|NCT01380093|145918|P4|STARTED|Drug Discrimination Phase: Day 1||0
62906|NCT01380093|145919|P3|STARTED|Drug Discrimination Phase: Day 1||29
62907|NCT01380093|145920|P2|STARTED|Drug Discrimination Phase: Day 1||30
62908|NCT01380093|145921|P1|STARTED|Drug Discrimination Phase: Day 1||0
62909|NCT01380093|145913|P9|NOT COMPLETED|Naloxone Challenge Phase||0
62910|NCT01380093|145914|P8|NOT COMPLETED|Naloxone Challenge Phase||0
62911|NCT01380093|145915|P7|NOT COMPLETED|Naloxone Challenge Phase||0
62912|NCT01380093|145916|P6|NOT COMPLETED|Naloxone Challenge Phase||0
62913|NCT01380093|145917|P5|NOT COMPLETED|Naloxone Challenge Phase||0
62914|NCT01380093|145918|P4|NOT COMPLETED|Naloxone Challenge Phase||0
62915|NCT01380093|145919|P3|NOT COMPLETED|Naloxone Challenge Phase||0
62916|NCT01380093|145920|P2|NOT COMPLETED|Naloxone Challenge Phase||0
62917|NCT01380093|145921|P1|NOT COMPLETED|Naloxone Challenge Phase||21
62918|NCT01380093|145913|P9|COMPLETED|Naloxone Challenge Phase||0
62919|NCT01380093|145914|P8|COMPLETED|Naloxone Challenge Phase||0
62920|NCT01380093|145915|P7|COMPLETED|Naloxone Challenge Phase||0
62921|NCT01380093|145916|P6|COMPLETED|Naloxone Challenge Phase||0
62922|NCT01380093|145917|P5|COMPLETED|Naloxone Challenge Phase||0
62923|NCT01380093|145918|P4|COMPLETED|Naloxone Challenge Phase||0
62924|NCT01380093|145919|P3|COMPLETED|Naloxone Challenge Phase||0
62925|NCT01380093|145920|P2|COMPLETED|Naloxone Challenge Phase||0
62926|NCT01380093|145921|P1|COMPLETED|Naloxone Challenge Phase||59
62927|NCT01380093|145913|P9|TREATED|Naloxone Challenge Phase||0
62928|NCT01380093|145914|P8|TREATED|Naloxone Challenge Phase||0
62929|NCT01380093|145915|P7|TREATED|Naloxone Challenge Phase||0
62930|NCT01380093|145916|P6|TREATED|Naloxone Challenge Phase||0
62931|NCT01380093|145917|P5|TREATED|Naloxone Challenge Phase||0
62932|NCT01380093|145918|P4|TREATED|Naloxone Challenge Phase||0
62933|NCT01380093|145919|P3|TREATED|Naloxone Challenge Phase||0
62934|NCT01380093|145920|P2|TREATED|Naloxone Challenge Phase||0
62935|NCT01380093|145921|P1|TREATED|Naloxone Challenge Phase||59
62936|NCT01380093|145913|P9|STARTED|Naloxone Challenge Phase||0
62937|NCT01380093|145914|P8|STARTED|Naloxone Challenge Phase||0
62938|NCT01380093|145915|P7|STARTED|Naloxone Challenge Phase||0
62939|NCT01380093|145916|P6|STARTED|Naloxone Challenge Phase||0
62940|NCT01380093|145917|P5|STARTED|Naloxone Challenge Phase||0
62941|NCT01380093|145918|P4|STARTED|Naloxone Challenge Phase||0
62942|NCT01380093|145919|P3|STARTED|Naloxone Challenge Phase||0
62943|NCT01380093|145920|P2|STARTED|Naloxone Challenge Phase||0
62944|NCT01380093|145921|P1|STARTED|Naloxone Challenge Phase||80
62945|NCT01380080|146213|P2|NOT COMPLETED|Overall Study||23
62946|NCT01380080|146214|P1|NOT COMPLETED|Overall Study||33
62947|NCT01380080|146213|P2|COMPLETED|Overall Study||403
62948|NCT01380080|146214|P1|COMPLETED|Overall Study||391
62949|NCT01380080|146213|P2|STARTED|Overall Study||426
62950|NCT01380080|146214|P1|STARTED|Overall Study||424
62951|NCT01379963|146230|P1|NOT COMPLETED|Overall Study||0
62952|NCT01379963|146230|P1|COMPLETED|Overall Study||780
62953|NCT01379963|146230|P1|STARTED|Overall Study||780
62954|NCT01379937|146239|P4|NOT COMPLETED|Overall Study||1
62955|NCT01379937|146240|P3|NOT COMPLETED|Overall Study||2
62956|NCT01379937|146241|P2|NOT COMPLETED|Overall Study||3
62957|NCT01379937|146242|P1|NOT COMPLETED|Overall Study||1
62958|NCT01379937|146239|P4|COMPLETED|Overall Study||103
62959|NCT01379937|146240|P3|COMPLETED|Overall Study||102
62960|NCT01379937|146241|P2|COMPLETED|Overall Study||153
62961|NCT01379937|146242|P1|COMPLETED|Overall Study||155
62962|NCT01379937|146239|P4|STARTED|Overall Study||104
62963|NCT01379937|146240|P3|STARTED|Overall Study||104
62964|NCT01379937|146241|P2|STARTED|Overall Study||156
62965|NCT01379937|146242|P1|STARTED|Overall Study||156
62966|NCT01379781|146324|P2|NOT COMPLETED|Overall Study||8
62967|NCT01379781|146325|P1|NOT COMPLETED|Overall Study||11
62968|NCT01379781|146324|P2|COMPLETED|Overall Study||19
62969|NCT01379781|146325|P1|COMPLETED|Overall Study||16
62970|NCT01379781|146324|P2|STARTED|Overall Study||27
62971|NCT01379781|146325|P1|STARTED|Overall Study||27
62972|NCT01379768|146334|P3|NOT COMPLETED|Overall Study||0
62973|NCT01379768|146335|P2|NOT COMPLETED|Overall Study||1
62974|NCT01379768|146336|P1|NOT COMPLETED|Overall Study||3
62975|NCT01379768|146334|P3|COMPLETED|Overall Study||20
62976|NCT01379768|146335|P2|COMPLETED|Overall Study||21
62977|NCT01379768|146336|P1|COMPLETED|Overall Study||20
62978|NCT01379768|146334|P3|STARTED|Overall Study||20
62979|NCT01379768|146335|P2|STARTED|Overall Study||22
62980|NCT01379768|146336|P1|STARTED|Overall Study||23
62981|NCT01379703|146359|P3|NOT COMPLETED|9 Months Through 18 Months||0
62982|NCT01379703|146360|P2|NOT COMPLETED|9 Months Through 18 Months||230
62983|NCT01379703|146361|P1|NOT COMPLETED|9 Months Through 18 Months||0
62984|NCT01379703|146359|P3|COMPLETED|9 Months Through 18 Months||0
62985|NCT01379703|146360|P2|COMPLETED|9 Months Through 18 Months||854
62986|NCT01379703|146361|P1|COMPLETED|9 Months Through 18 Months||0
62987|NCT01379703|146359|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
62988|NCT01379703|146360|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
62989|NCT01379703|146361|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
62990|NCT01379703|146359|P3|NOT COMPLETED|Study Start Through 9 Months||143
62991|NCT01379703|146360|P2|NOT COMPLETED|Study Start Through 9 Months||122
62992|NCT01379703|146361|P1|NOT COMPLETED|Study Start Through 9 Months||4
62993|NCT01379703|146359|P3|COMPLETED|Study Start Through 9 Months||873
62994|NCT01379703|146360|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
62995|NCT01379703|146361|P1|COMPLETED|Study Start Through 9 Months||62
62996|NCT01379703|146359|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
62997|NCT01379703|146360|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
62998|NCT01379703|146361|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
62999|NCT01379651|146424|P2|NOT COMPLETED|Overall Study||0
63000|NCT01379651|146425|P1|NOT COMPLETED|Overall Study||0
63001|NCT01379651|146424|P2|COMPLETED|Overall Study||10
63002|NCT01379651|146425|P1|COMPLETED|Overall Study||10
63003|NCT01379651|146424|P2|STARTED|Overall Study||10
63004|NCT01379651|146425|P1|STARTED|Overall Study||10
63005|NCT01379534|146435|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
63006|NCT01379534|146436|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
63007|NCT01379534|146435|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
63008|NCT01379534|146436|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
63009|NCT01379534|146435|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
63010|NCT01379534|146436|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
63011|NCT01379534|146435|P2|NOT COMPLETED|Treatment Phase||31
63012|NCT01379534|146436|P1|NOT COMPLETED|Treatment Phase||22
63013|NCT01379534|146435|P2|COMPLETED|Treatment Phase||0
63014|NCT01379534|146436|P1|COMPLETED|Treatment Phase||0
63015|NCT01379534|146435|P2|STARTED|Treatment Phase||31
63016|NCT01379534|146436|P1|STARTED|Treatment Phase||22
63017|NCT01378988|146456|P2|NOT COMPLETED|Overall Study||0
63018|NCT01378988|146457|P1|NOT COMPLETED|Overall Study||0
63019|NCT01378988|146456|P2|COMPLETED|Overall Study||3
63020|NCT01378988|146457|P1|COMPLETED|Overall Study||2
63021|NCT01378988|146456|P2|STARTED|Overall Study||3
63022|NCT01378988|146457|P1|STARTED|Overall Study||2
63023|NCT01378975|146487|P2|NOT COMPLETED|Overall Study||50
63024|NCT01378975|146488|P1|NOT COMPLETED|Overall Study||86
63025|NCT01378975|146487|P2|COMPLETED|Overall Study||6
63026|NCT01378975|146488|P1|COMPLETED|Overall Study||4
63027|NCT01378975|146487|P2|STARTED|Overall Study||56
63028|NCT01378975|146488|P1|STARTED|Overall Study||90
63029|NCT01378962|146514|P1|NOT COMPLETED|Overall Study||17
63030|NCT01378962|146514|P1|COMPLETED|Overall Study||33
63031|NCT01378962|146514|P1|STARTED|Overall Study||50
63032|NCT01378520|146527|P2|NOT COMPLETED|Second Intervention||0
63033|NCT01378520|146528|P1|NOT COMPLETED|Second Intervention||0
63034|NCT01378520|146527|P2|COMPLETED|Second Intervention||10
63035|NCT01378520|146528|P1|COMPLETED|Second Intervention||10
63036|NCT01378520|146527|P2|STARTED|Second Intervention||10
63037|NCT01378520|146528|P1|STARTED|Second Intervention||10
63038|NCT01378520|146527|P2|NOT COMPLETED|First Intervention||0
63039|NCT01378520|146528|P1|NOT COMPLETED|First Intervention||0
63040|NCT01378520|146527|P2|COMPLETED|First Intervention||10
63041|NCT01378520|146528|P1|COMPLETED|First Intervention||10
63042|NCT01378520|146527|P2|STARTED|First Intervention||10
63043|NCT01378520|146528|P1|STARTED|First Intervention||10
63044|NCT01378429|146540|P2|NOT COMPLETED|Overall Study||0
63045|NCT01378429|146541|P1|NOT COMPLETED|Overall Study||1
63046|NCT01378429|146540|P2|COMPLETED|Overall Study||47
63047|NCT01378429|146541|P1|COMPLETED|Overall Study||41
63048|NCT01378429|146540|P2|STARTED|Overall Study||47
63049|NCT01378429|146541|P1|STARTED|Overall Study||42
63050|NCT01378416|146573|P1|NOT COMPLETED|Overall Study||0
63051|NCT01378416|146573|P1|COMPLETED|Overall Study||16
63052|NCT01378416|146573|P1|STARTED|Overall Study||16
63053|NCT01378325|146583|P2|NOT COMPLETED|Overall Study||1
63054|NCT01378325|146584|P1|NOT COMPLETED|Overall Study||0
63055|NCT01378325|146583|P2|COMPLETED|Overall Study||39
63056|NCT01378325|146584|P1|COMPLETED|Overall Study||40
63057|NCT01378325|146583|P2|STARTED|Overall Study||40
63058|NCT01378325|146584|P1|STARTED|Overall Study||40
63059|NCT01378221|146592|P2|NOT COMPLETED|Overall Study||9
63060|NCT01378221|146593|P1|NOT COMPLETED|Overall Study||7
63061|NCT01378221|146592|P2|COMPLETED|Overall Study||30
63062|NCT01378221|146593|P1|COMPLETED|Overall Study||29
63063|NCT01378221|146592|P2|STARTED|Overall Study||39
63064|NCT01378221|146593|P1|STARTED|Overall Study||36
63065|NCT01378195|146601|P2|NOT COMPLETED|Overall Study||18
63066|NCT01378195|146602|P1|NOT COMPLETED|Overall Study||29
63067|NCT01378195|146601|P2|COMPLETED|Overall Study||57
63068|NCT01378195|146602|P1|COMPLETED|Overall Study||46
63069|NCT01378195|146601|P2|STARTED|Overall Study||75
63070|NCT01378195|146602|P1|STARTED|Overall Study||75
63071|NCT01378117|146615|P3|NOT COMPLETED|Overall Study||3
63072|NCT01378117|146616|P2|NOT COMPLETED|Overall Study||1
63073|NCT01378117|146617|P1|NOT COMPLETED|Overall Study||4
63074|NCT01378117|146615|P3|COMPLETED|Overall Study||26
63075|NCT01378117|146616|P2|COMPLETED|Overall Study||29
63076|NCT01378117|146617|P1|COMPLETED|Overall Study||27
63077|NCT01378117|146615|P3|STARTED|Overall Study||29
63078|NCT01378117|146616|P2|STARTED|Overall Study||30
63079|NCT01378117|146617|P1|STARTED|Overall Study||31
63080|NCT01378104|146627|P2|NOT COMPLETED|Overall Study||26
63081|NCT01378104|146628|P1|NOT COMPLETED|Overall Study||27
63082|NCT01378104|146627|P2|COMPLETED|Overall Study||60
63083|NCT01378104|146628|P1|COMPLETED|Overall Study||65
63084|NCT01378104|146627|P2|STARTED|Overall Study||86
63085|NCT01378104|146628|P1|STARTED|Overall Study||92
63086|NCT01378065|146636|P1|NOT COMPLETED|Overall Study||0
63087|NCT01378065|146636|P1|COMPLETED|Overall Study||30
63088|NCT01378065|146636|P1|12 Months|Overall Study||30
63089|NCT01378065|146636|P1|6 Months|Overall Study||30
63090|NCT01378065|146636|P1|3 Months|Overall Study||30
63091|NCT01378065|146636|P1|6 Week|Overall Study||30
63092|NCT01378065|146636|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
63093|NCT01377636|146673|P1|NOT COMPLETED|Overall Study||0
63094|NCT01377636|146673|P1|COMPLETED|Overall Study||20
63095|NCT01377636|146673|P1|STARTED|Overall Study||20
63096|NCT01377623|146687|P2|NOT COMPLETED|Overall Study||5
63097|NCT01377623|146688|P1|NOT COMPLETED|Overall Study||7
63098|NCT01377623|146687|P2|COMPLETED|Overall Study||28
63099|NCT01377623|146688|P1|COMPLETED|Overall Study||26
63100|NCT01377623|146687|P2|STARTED|Overall Study||33
63101|NCT01377623|146688|P1|STARTED|Overall Study||33
63102|NCT01377480|146706|P4|NOT COMPLETED|Overall Study||11
63103|NCT01377480|146707|P3|NOT COMPLETED|Overall Study||10
63104|NCT01377480|146708|P2|NOT COMPLETED|Overall Study||1
63105|NCT01377480|146709|P1|NOT COMPLETED|Overall Study||0
63106|NCT01377480|146706|P4|COMPLETED|Overall Study||19
63107|NCT01377480|146707|P3|COMPLETED|Overall Study||18
63108|NCT01377480|146708|P2|COMPLETED|Overall Study||29
63109|NCT01377480|146709|P1|COMPLETED|Overall Study||32
63110|NCT01377480|146706|P4|STARTED|Overall Study||30
63111|NCT01377480|146707|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
63112|NCT01377480|146708|P2|STARTED|Overall Study||30
63113|NCT01377480|146709|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
63114|NCT01377467|146721|P2|NOT COMPLETED|Overall Study||0
63115|NCT01377467|146722|P1|NOT COMPLETED|Overall Study||0
63116|NCT01377467|146721|P2|COMPLETED|Overall Study||44
63117|NCT01377467|146722|P1|COMPLETED|Overall Study||46
63118|NCT01377467|146721|P2|STARTED|Overall Study||44
63119|NCT01377467|146722|P1|STARTED|Overall Study||46
63120|NCT01377441|146770|P2|NOT COMPLETED|Overall Study||0
63121|NCT01377441|146771|P1|NOT COMPLETED|Overall Study||0
63122|NCT01377441|146770|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
63123|NCT01377441|146771|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
63124|NCT01377441|146770|P2|STARTED|Overall Study||0
63125|NCT01377441|146771|P1|STARTED|Overall Study||0
63126|NCT01377402|146777|P1|NOT COMPLETED|Overall Study||0
63127|NCT01377402|146777|P1|COMPLETED|Overall Study||982
63128|NCT01377402|146777|P1|STARTED|Overall Study||982
63129|NCT01377233|146786|P5|NOT COMPLETED|Double-blind||2
63130|NCT01377233|146787|P4|NOT COMPLETED|Double-blind||4
63131|NCT01377233|146788|P3|NOT COMPLETED|Double-blind||2
63132|NCT01377233|146789|P2|NOT COMPLETED|Double-blind||1
63133|NCT01377233|146790|P1|NOT COMPLETED|Double-blind||0
63134|NCT01377233|146786|P5|COMPLETED|Double-blind||8
63135|NCT01377233|146787|P4|COMPLETED|Double-blind||7
63136|NCT01377233|146788|P3|COMPLETED|Double-blind||8
63137|NCT01377233|146789|P2|COMPLETED|Double-blind||10
63138|NCT01377233|146790|P1|COMPLETED|Double-blind||0
63139|NCT01377233|146786|P5|STARTED|Double-blind||10
63140|NCT01377233|146787|P4|STARTED|Double-blind||11
63141|NCT01377233|146788|P3|STARTED|Double-blind||10
63142|NCT01377233|146789|P2|STARTED|Double-blind||11
63143|NCT01377233|146790|P1|STARTED|Double-blind||0
63144|NCT01377233|146786|P5|NOT COMPLETED|Open-label||0
63145|NCT01377233|146787|P4|NOT COMPLETED|Open-label||0
63146|NCT01377233|146788|P3|NOT COMPLETED|Open-label||0
63147|NCT01377233|146789|P2|NOT COMPLETED|Open-label||0
63148|NCT01377233|146790|P1|NOT COMPLETED|Open-label||4
63149|NCT01377233|146786|P5|COMPLETED|Open-label||0
63150|NCT01377233|146787|P4|COMPLETED|Open-label||0
63151|NCT01377233|146788|P3|COMPLETED|Open-label||0
63152|NCT01377233|146789|P2|COMPLETED|Open-label||0
63153|NCT01377233|146790|P1|COMPLETED|Open-label||42
63154|NCT01377233|146786|P5|STARTED|Open-label||0
63155|NCT01377233|146787|P4|STARTED|Open-label||0
63156|NCT01377233|146788|P3|STARTED|Open-label||0
63157|NCT01377233|146789|P2|STARTED|Open-label||0
63158|NCT01377233|146790|P1|STARTED|Open-label||46
63159|NCT01377194|146817|P3|NOT COMPLETED|Overall Study||46
63160|NCT01377194|146818|P2|NOT COMPLETED|Overall Study||43
63161|NCT01377194|146819|P1|NOT COMPLETED|Overall Study||32
63162|NCT01377194|146817|P3|COMPLETED|Overall Study||142
63163|NCT01377194|146818|P2|COMPLETED|Overall Study||145
63164|NCT01377194|146819|P1|COMPLETED|Overall Study||154
63165|NCT01377194|146817|P3|STARTED|Overall Study||188
63166|NCT01377194|146818|P2|STARTED|Overall Study||188
63167|NCT01377194|146819|P1|STARTED|Overall Study||186
63168|NCT01376908|146832|P2|NOT COMPLETED|Overall Study||3
63169|NCT01376908|146833|P1|NOT COMPLETED|Overall Study||2
63170|NCT01376908|146832|P2|COMPLETED|Overall Study||26
63171|NCT01376908|146833|P1|COMPLETED|Overall Study||25
63172|NCT01376908|146832|P2|STARTED|Overall Study||29
63173|NCT01376908|146833|P1|STARTED|Overall Study||27
63174|NCT01376804|146866|P1|NOT COMPLETED|Follow-up Period||0
63175|NCT01376804|146866|P1|COMPLETED|Follow-up Period||55
63176|NCT01376804|146866|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
63177|NCT01376804|146866|P1|NOT COMPLETED|Treatment Period||8
63178|NCT01376804|146866|P1|COMPLETED|Treatment Period||49
63179|NCT01376804|146866|P1|Received Study Drug|Treatment Period||56
63180|NCT01376804|146866|P1|STARTED|Treatment Period||57
63181|NCT01376700|146877|P1|NOT COMPLETED|Overall Study||16
63182|NCT01376700|146877|P1|COMPLETED|Overall Study||3
63183|NCT01376700|146877|P1|STARTED|Overall Study||19
63184|NCT01376557|146898|P5|NOT COMPLETED|Overall Study||7
63185|NCT01376557|146899|P4|NOT COMPLETED|Overall Study||6
63186|NCT01376557|146900|P3|NOT COMPLETED|Overall Study||5
63187|NCT01376557|146901|P2|NOT COMPLETED|Overall Study||6
63188|NCT01376557|146902|P1|NOT COMPLETED|Overall Study||8
63189|NCT01376557|146898|P5|COMPLETED|Overall Study||53
63190|NCT01376557|146899|P4|COMPLETED|Overall Study||54
63191|NCT01376557|146900|P3|COMPLETED|Overall Study||55
63192|NCT01376557|146901|P2|COMPLETED|Overall Study||54
63193|NCT01376557|146902|P1|COMPLETED|Overall Study||51
63194|NCT01376557|146898|P5|STARTED|Overall Study||60
63195|NCT01376557|146899|P4|STARTED|Overall Study||60
63196|NCT01376557|146900|P3|STARTED|Overall Study||60
63197|NCT01376557|146901|P2|STARTED|Overall Study||60
63198|NCT01376557|146902|P1|STARTED|Overall Study||59
63199|NCT01376388|146939|P1|NOT COMPLETED|Overall Study||18
63200|NCT01376388|146939|P1|COMPLETED|Overall Study||112
63201|NCT01376388|146939|P1|STARTED|Overall Study||130
63202|NCT01376362|146954|P1|NOT COMPLETED|Overall Study||0
63203|NCT01376362|146954|P1|COMPLETED|Overall Study||5
63204|NCT01376362|146954|P1|STARTED|Overall Study||5
63205|NCT01376297|146976|P2|NOT COMPLETED|Overall Study||49
63206|NCT01376297|146977|P1|NOT COMPLETED|Overall Study||128
63207|NCT01376297|146976|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
63208|NCT01376297|146977|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
63209|NCT01376297|146976|P2|STARTED|Overall Study|number of randomised patients|104
63210|NCT01376297|146977|P1|STARTED|Overall Study|number of randomised patients|309
63211|NCT01376245|146987|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
63212|NCT01376245|146988|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
63213|NCT01376245|146989|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
63214|NCT01376245|146990|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
63215|NCT01376245|146991|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
63216|NCT01376245|146987|P5|COMPLETED|24-week, Double-blind Treatment Period||134
63217|NCT01376245|146988|P4|COMPLETED|24-week, Double-blind Treatment Period||138
63218|NCT01376245|146989|P3|COMPLETED|24-week, Double-blind Treatment Period||135
63219|NCT01376245|146990|P2|COMPLETED|24-week, Double-blind Treatment Period||130
63220|NCT01376245|146991|P1|COMPLETED|24-week, Double-blind Treatment Period||0
63221|NCT01376245|146987|P5|STARTED|24-week, Double-blind Treatment Period||160
63222|NCT01376245|146988|P4|STARTED|24-week, Double-blind Treatment Period||161
63223|NCT01376245|146989|P3|STARTED|24-week, Double-blind Treatment Period||160
63224|NCT01376245|146990|P2|STARTED|24-week, Double-blind Treatment Period||162
63225|NCT01376245|146991|P1|STARTED|24-week, Double-blind Treatment Period||0
63226|NCT01376245|146987|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63227|NCT01376245|146988|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63228|NCT01376245|146989|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63229|NCT01376245|146990|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63230|NCT01376245|146991|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
63231|NCT01376245|146987|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63232|NCT01376245|146988|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63233|NCT01376245|146989|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63234|NCT01376245|146990|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
63235|NCT01376245|146991|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
63236|NCT01376245|146987|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
63237|NCT01376245|146988|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
63238|NCT01376245|146989|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
63239|NCT01376245|146990|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
63240|NCT01376245|146991|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
63241|NCT01376089|147007|P2|NOT COMPLETED|Overall Study||4
63242|NCT01376089|147008|P1|NOT COMPLETED|Overall Study||3
63243|NCT01376089|147007|P2|COMPLETED|Overall Study||144
63244|NCT01376089|147008|P1|COMPLETED|Overall Study||148
63245|NCT01376089|147007|P2|STARTED|Overall Study||148
63246|NCT01376089|147008|P1|STARTED|Overall Study||151
63247|NCT01376050|147020|P2|NOT COMPLETED|Overall Study||0
63248|NCT01376050|147021|P1|NOT COMPLETED|Overall Study||0
63249|NCT01376050|147020|P2|COMPLETED|Overall Study||11
63250|NCT01376050|147021|P1|COMPLETED|Overall Study||13
63251|NCT01376050|147020|P2|STARTED|Overall Study||11
63252|NCT01376050|147021|P1|STARTED|Overall Study||13
63253|NCT01376037|147031|P2|NOT COMPLETED|Overall Study||2
63254|NCT01376037|147032|P1|NOT COMPLETED|Overall Study||0
63255|NCT01376037|147031|P2|COMPLETED|Overall Study||29
63256|NCT01376037|147032|P1|COMPLETED|Overall Study||31
63257|NCT01376037|147031|P2|STARTED|Overall Study||31
63258|NCT01376037|147032|P1|STARTED|Overall Study||31
63259|NCT01375777|147047|P9|NOT COMPLETED|Overall Study||2
63260|NCT01375777|147048|P8|NOT COMPLETED|Overall Study||2
63261|NCT01375777|147049|P7|NOT COMPLETED|Overall Study||2
63262|NCT01375777|147050|P6|NOT COMPLETED|Overall Study||1
63263|NCT01375777|147051|P5|NOT COMPLETED|Overall Study||1
63264|NCT01375777|147052|P4|NOT COMPLETED|Overall Study||0
63265|NCT01375777|147053|P3|NOT COMPLETED|Overall Study||1
63266|NCT01375777|147054|P2|NOT COMPLETED|Overall Study||3
63267|NCT01375777|147055|P1|NOT COMPLETED|Overall Study||2
63268|NCT01375777|147047|P9|COMPLETED|Overall Study||44
63269|NCT01375777|147048|P8|COMPLETED|Overall Study||44
63270|NCT01375777|147049|P7|COMPLETED|Overall Study||44
63271|NCT01375777|147050|P6|COMPLETED|Overall Study||44
63272|NCT01375777|147051|P5|COMPLETED|Overall Study||45
63273|NCT01375777|147052|P4|COMPLETED|Overall Study||45
63274|NCT01375777|147053|P3|COMPLETED|Overall Study||45
63275|NCT01375777|147054|P2|COMPLETED|Overall Study||42
63276|NCT01375777|147055|P1|COMPLETED|Overall Study||44
63277|NCT01375777|147047|P9|Received Treatment|Overall Study||45
63278|NCT01375777|147048|P8|Received Treatment|Overall Study||45
63279|NCT01375777|147049|P7|Received Treatment|Overall Study||45
63280|NCT01375777|147050|P6|Received Treatment|Overall Study||45
63281|NCT01375777|147051|P5|Received Treatment|Overall Study||46
63282|NCT01375777|147052|P4|Received Treatment|Overall Study||45
63283|NCT01375777|147053|P3|Received Treatment|Overall Study||45
63284|NCT01375777|147054|P2|Received Treatment|Overall Study||45
63285|NCT01375777|147055|P1|Received Treatment|Overall Study||45
63286|NCT01375777|147047|P9|STARTED|Overall Study||46
63287|NCT01375777|147048|P8|STARTED|Overall Study||46
63288|NCT01375777|147049|P7|STARTED|Overall Study||46
63289|NCT01375777|147050|P6|STARTED|Overall Study||45
63290|NCT01375777|147051|P5|STARTED|Overall Study||46
63291|NCT01375777|147052|P4|STARTED|Overall Study||45
63292|NCT01375777|147053|P3|STARTED|Overall Study||46
63293|NCT01375777|147054|P2|STARTED|Overall Study||45
63294|NCT01375777|147055|P1|STARTED|Overall Study||46
63295|NCT01375764|147125|P5|NOT COMPLETED|Overall Study||1
63296|NCT01375764|147126|P4|NOT COMPLETED|Overall Study||1
63297|NCT01375764|147127|P3|NOT COMPLETED|Overall Study||0
63298|NCT01375764|147128|P2|NOT COMPLETED|Overall Study||1
63299|NCT01375764|147129|P1|NOT COMPLETED|Overall Study||2
63300|NCT01375764|147125|P5|COMPLETED|Overall Study||31
63301|NCT01375764|147126|P4|COMPLETED|Overall Study||31
63302|NCT01375764|147127|P3|COMPLETED|Overall Study||32
63303|NCT01375764|147128|P2|COMPLETED|Overall Study||30
63304|NCT01375764|147129|P1|COMPLETED|Overall Study||31
63305|NCT01375764|147125|P5|Received Treatment|Overall Study||32
63306|NCT01375764|147126|P4|Received Treatment|Overall Study||31
63307|NCT01375764|147127|P3|Received Treatment|Overall Study||32
63308|NCT01375764|147128|P2|Received Treatment|Overall Study||30
63309|NCT01375764|147129|P1|Received Treatment|Overall Study||32
63310|NCT01375764|147125|P5|STARTED|Overall Study||32
63311|NCT01375764|147126|P4|STARTED|Overall Study||32
63312|NCT01375764|147127|P3|STARTED|Overall Study||32
63313|NCT01375764|147128|P2|STARTED|Overall Study||31
63314|NCT01375764|147129|P1|STARTED|Overall Study||33
63315|NCT01375751|147175|P3|NOT COMPLETED|Overall Study||0
63316|NCT01375751|147176|P2|NOT COMPLETED|Overall Study||1
63317|NCT01375751|147177|P1|NOT COMPLETED|Overall Study||0
63318|NCT01375751|147175|P3|COMPLETED|Overall Study||56
63319|NCT01375751|147176|P2|COMPLETED|Overall Study||55
63320|NCT01375751|147177|P1|COMPLETED|Overall Study||56
63321|NCT01375751|147175|P3|Received Treatment|Overall Study||56
63322|NCT01375751|147176|P2|Received Treatment|Overall Study||55
63323|NCT01375751|147177|P1|Received Treatment|Overall Study||56
63324|NCT01375751|147175|P3|STARTED|Overall Study||56
63325|NCT01375751|147176|P2|STARTED|Overall Study||56
63326|NCT01375751|147177|P1|STARTED|Overall Study||56
63327|NCT01375660|147202|P2|NOT COMPLETED|Overall Study||16
63328|NCT01375660|147203|P1|NOT COMPLETED|Overall Study||16
63329|NCT01375660|147202|P2|COMPLETED|Overall Study||87
63330|NCT01375660|147203|P1|COMPLETED|Overall Study||86
63331|NCT01375660|147202|P2|STARTED|Overall Study||103
63332|NCT01375660|147203|P1|STARTED|Overall Study||102
63333|NCT01375569|147221|P1|NOT COMPLETED|Overall Study||0
63334|NCT01375569|147221|P1|COMPLETED|Overall Study||11
63335|NCT01375569|147221|P1|STARTED|Overall Study||11
63336|NCT01375374|147226|P1|NOT COMPLETED|Overall Study||1
63337|NCT01375374|147226|P1|COMPLETED|Overall Study||10
63338|NCT01375374|147226|P1|STARTED|Overall Study||11
63339|NCT01375127|147239|P6|NOT COMPLETED|Overall Study||0
63340|NCT01375127|147240|P5|NOT COMPLETED|Overall Study||0
63341|NCT01375127|147241|P4|NOT COMPLETED|Overall Study||0
63342|NCT01375127|147242|P3|NOT COMPLETED|Overall Study||0
63343|NCT01375127|147243|P2|NOT COMPLETED|Overall Study||0
63344|NCT01375127|147244|P1|NOT COMPLETED|Overall Study||0
63345|NCT01375127|147239|P6|COMPLETED|Overall Study||3
63346|NCT01375127|147240|P5|COMPLETED|Overall Study||5
63347|NCT01375127|147241|P4|COMPLETED|Overall Study||33
63348|NCT01375127|147242|P3|COMPLETED|Overall Study||40
63349|NCT01375127|147243|P2|COMPLETED|Overall Study||1
63350|NCT01375127|147244|P1|COMPLETED|Overall Study||1
63351|NCT01375127|147239|P6|STARTED|Overall Study||3
63352|NCT01375127|147240|P5|STARTED|Overall Study||5
63353|NCT01375127|147241|P4|STARTED|Overall Study||33
63354|NCT01375127|147242|P3|STARTED|Overall Study||40
63355|NCT01375127|147243|P2|STARTED|Overall Study||1
63356|NCT01375127|147244|P1|STARTED|Overall Study||1
63357|NCT01375049|147276|P1|NOT COMPLETED|Overall Study||50
63358|NCT01375049|147276|P1|COMPLETED|Overall Study||55
63359|NCT01375049|147276|P1|STARTED|Overall Study||105
63360|NCT01374971|147291|P1|NOT COMPLETED|Overall Study||1
63361|NCT01374971|147291|P1|COMPLETED|Overall Study||11
63362|NCT01374971|147291|P1|STARTED|Overall Study||12
63363|NCT01374919|147296|P1|NOT COMPLETED|Overall Study||2
63364|NCT01374919|147296|P1|COMPLETED|Overall Study||58
63365|NCT01374919|147296|P1|STARTED|Overall Study||60
63366|NCT01374802|147301|P1|NOT COMPLETED|Overall Study||0
63367|NCT01374802|147301|P1|COMPLETED|Overall Study||14
63368|NCT01374802|147301|P1|STARTED|Overall Study||14
63369|NCT01374451|147315|P2|NOT COMPLETED|Overall Study||0
63370|NCT01374451|147316|P1|NOT COMPLETED|Overall Study||1
63371|NCT01374451|147315|P2|COMPLETED|Overall Study||81
63372|NCT01374451|147316|P1|COMPLETED|Overall Study||78
63373|NCT01374451|147315|P2|STARTED|Overall Study||81
63374|NCT01374451|147316|P1|STARTED|Overall Study||79
63375|NCT01374438|147345|P2|NOT COMPLETED|Overall Study||0
63376|NCT01374438|147346|P1|NOT COMPLETED|Overall Study||0
63377|NCT01374438|147345|P2|COMPLETED|Overall Study||13
63378|NCT01374438|147346|P1|COMPLETED|Overall Study||16
63379|NCT01374438|147345|P2|STARTED|Overall Study||13
63380|NCT01374438|147346|P1|STARTED|Overall Study||16
63381|NCT01374425|147362|P2|NOT COMPLETED|Overall Study||188
63382|NCT01374425|147363|P1|NOT COMPLETED|Overall Study||188
63383|NCT01374425|147362|P2|COMPLETED|Overall Study||0
63384|NCT01374425|147363|P1|COMPLETED|Overall Study||0
63385|NCT01374425|147362|P2|STARTED|Overall Study||188
63386|NCT01374425|147363|P1|STARTED|Overall Study||188
63387|NCT01374269|147443|P2|NOT COMPLETED|Overall Study||5
63388|NCT01374269|147444|P1|NOT COMPLETED|Overall Study||6
63389|NCT01374269|147443|P2|COMPLETED|Overall Study||39
63390|NCT01374269|147444|P1|COMPLETED|Overall Study||40
63391|NCT01374269|147443|P2|STARTED|Overall Study||44
63392|NCT01374269|147444|P1|STARTED|Overall Study||46
63393|NCT01374178|147572|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
63394|NCT01374178|147573|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
63395|NCT01374178|147572|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
63396|NCT01374178|147573|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
63397|NCT01374178|147572|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
63398|NCT01374178|147573|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
63399|NCT01374178|147572|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
63400|NCT01374178|147573|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
63401|NCT01374178|147572|P2|COMPLETED|Washout Period of at Least 7 Days||5
63402|NCT01374178|147573|P1|COMPLETED|Washout Period of at Least 7 Days||10
63403|NCT01374178|147572|P2|STARTED|Washout Period of at Least 7 Days||5
63404|NCT01374178|147573|P1|STARTED|Washout Period of at Least 7 Days||11
63405|NCT01374178|147572|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
63406|NCT01374178|147573|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
63407|NCT01374178|147572|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
63408|NCT01374178|147573|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
63409|NCT01374178|147572|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
63410|NCT01374178|147573|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
63411|NCT01374178|147572|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
63412|NCT01374178|147573|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
63413|NCT01373918|147591|P2|NOT COMPLETED|Overall Study||1
63414|NCT01373918|147592|P1|NOT COMPLETED|Overall Study||0
63415|NCT01373918|147591|P2|COMPLETED|Overall Study||15
63416|NCT01373918|147592|P1|COMPLETED|Overall Study||20
63417|NCT01373918|147591|P2|STARTED|Overall Study||16
63418|NCT01373918|147592|P1|STARTED|Overall Study||20
63419|NCT01373671|147604|P1|NOT COMPLETED|Overall Study||92
63420|NCT01373671|147604|P1|COMPLETED|Overall Study||672
63421|NCT01373671|147604|P1|STARTED|Overall Study||764
63422|NCT01373450|147609|P6|NOT COMPLETED|Crossover Period 4||0
63423|NCT01373450|147610|P5|NOT COMPLETED|Crossover Period 4||0
63424|NCT01373450|147611|P4|NOT COMPLETED|Crossover Period 4||0
63425|NCT01373450|147612|P3|NOT COMPLETED|Crossover Period 4||0
63426|NCT01373450|147613|P2|NOT COMPLETED|Crossover Period 4||0
63427|NCT01373450|147614|P1|NOT COMPLETED|Crossover Period 4||0
63428|NCT01373450|147609|P6|COMPLETED|Crossover Period 4||2
63429|NCT01373450|147610|P5|COMPLETED|Crossover Period 4||2
63430|NCT01373450|147611|P4|COMPLETED|Crossover Period 4||2
63431|NCT01373450|147612|P3|COMPLETED|Crossover Period 4||2
63432|NCT01373450|147613|P2|COMPLETED|Crossover Period 4||2
63433|NCT01373450|147614|P1|COMPLETED|Crossover Period 4||2
63434|NCT01373450|147609|P6|STARTED|Crossover Period 4||2
63435|NCT01373450|147610|P5|STARTED|Crossover Period 4||2
63436|NCT01373450|147611|P4|STARTED|Crossover Period 4||2
63437|NCT01373450|147612|P3|STARTED|Crossover Period 4||2
63438|NCT01373450|147613|P2|STARTED|Crossover Period 4||2
63439|NCT01373450|147614|P1|STARTED|Crossover Period 4||2
63440|NCT01373450|147609|P6|NOT COMPLETED|7 Day Wash-out||0
63441|NCT01373450|147610|P5|NOT COMPLETED|7 Day Wash-out||0
63442|NCT01373450|147611|P4|NOT COMPLETED|7 Day Wash-out||0
63443|NCT01373450|147612|P3|NOT COMPLETED|7 Day Wash-out||0
63444|NCT01373450|147613|P2|NOT COMPLETED|7 Day Wash-out||0
63445|NCT01373450|147614|P1|NOT COMPLETED|7 Day Wash-out||0
63446|NCT01373450|147609|P6|COMPLETED|7 Day Wash-out||2
63447|NCT01373450|147610|P5|COMPLETED|7 Day Wash-out||2
63448|NCT01373450|147611|P4|COMPLETED|7 Day Wash-out||2
63449|NCT01373450|147612|P3|COMPLETED|7 Day Wash-out||2
63450|NCT01373450|147613|P2|COMPLETED|7 Day Wash-out||2
63451|NCT01373450|147614|P1|COMPLETED|7 Day Wash-out||2
63452|NCT01373450|147609|P6|STARTED|7 Day Wash-out||2
63453|NCT01373450|147610|P5|STARTED|7 Day Wash-out||2
63454|NCT01373450|147611|P4|STARTED|7 Day Wash-out||2
63455|NCT01373450|147612|P3|STARTED|7 Day Wash-out||2
63456|NCT01373450|147613|P2|STARTED|7 Day Wash-out||2
63457|NCT01373450|147614|P1|STARTED|7 Day Wash-out||2
63458|NCT01373450|147609|P6|NOT COMPLETED|Crossover Period 3||0
63459|NCT01373450|147610|P5|NOT COMPLETED|Crossover Period 3||0
63460|NCT01373450|147611|P4|NOT COMPLETED|Crossover Period 3||0
63461|NCT01373450|147612|P3|NOT COMPLETED|Crossover Period 3||0
63462|NCT01373450|147613|P2|NOT COMPLETED|Crossover Period 3||0
63463|NCT01373450|147614|P1|NOT COMPLETED|Crossover Period 3||0
63464|NCT01373450|147609|P6|COMPLETED|Crossover Period 3||2
63465|NCT01373450|147610|P5|COMPLETED|Crossover Period 3||2
63466|NCT01373450|147611|P4|COMPLETED|Crossover Period 3||2
63467|NCT01373450|147612|P3|COMPLETED|Crossover Period 3||2
63468|NCT01373450|147613|P2|COMPLETED|Crossover Period 3||2
63469|NCT01373450|147614|P1|COMPLETED|Crossover Period 3||2
63470|NCT01373450|147609|P6|STARTED|Crossover Period 3||2
63471|NCT01373450|147610|P5|STARTED|Crossover Period 3||2
63472|NCT01373450|147611|P4|STARTED|Crossover Period 3||2
63473|NCT01373450|147612|P3|STARTED|Crossover Period 3||2
63474|NCT01373450|147613|P2|STARTED|Crossover Period 3||2
63475|NCT01373450|147614|P1|STARTED|Crossover Period 3||2
63476|NCT01373450|147609|P6|NOT COMPLETED|7 Day Wash-out||0
63477|NCT01373450|147610|P5|NOT COMPLETED|7 Day Wash-out||0
63478|NCT01373450|147611|P4|NOT COMPLETED|7 Day Wash-out||0
63479|NCT01373450|147612|P3|NOT COMPLETED|7 Day Wash-out||0
63480|NCT01373450|147613|P2|NOT COMPLETED|7 Day Wash-out||0
63481|NCT01373450|147614|P1|NOT COMPLETED|7 Day Wash-out||0
63482|NCT01373450|147609|P6|COMPLETED|7 Day Wash-out||2
63483|NCT01373450|147610|P5|COMPLETED|7 Day Wash-out||2
63484|NCT01373450|147611|P4|COMPLETED|7 Day Wash-out||2
63485|NCT01373450|147612|P3|COMPLETED|7 Day Wash-out||2
63486|NCT01373450|147613|P2|COMPLETED|7 Day Wash-out||2
63487|NCT01373450|147614|P1|COMPLETED|7 Day Wash-out||2
63488|NCT01373450|147609|P6|STARTED|7 Day Wash-out||2
63489|NCT01373450|147610|P5|STARTED|7 Day Wash-out||2
63490|NCT01373450|147611|P4|STARTED|7 Day Wash-out||2
63491|NCT01373450|147612|P3|STARTED|7 Day Wash-out||2
63492|NCT01373450|147613|P2|STARTED|7 Day Wash-out||2
63493|NCT01373450|147614|P1|STARTED|7 Day Wash-out||2
63494|NCT01373450|147609|P6|NOT COMPLETED|Crossover Period 2||0
63495|NCT01373450|147610|P5|NOT COMPLETED|Crossover Period 2||0
63496|NCT01373450|147611|P4|NOT COMPLETED|Crossover Period 2||0
63497|NCT01373450|147612|P3|NOT COMPLETED|Crossover Period 2||0
63498|NCT01373450|147613|P2|NOT COMPLETED|Crossover Period 2||0
63499|NCT01373450|147614|P1|NOT COMPLETED|Crossover Period 2||0
63500|NCT01373450|147609|P6|COMPLETED|Crossover Period 2||2
63501|NCT01373450|147610|P5|COMPLETED|Crossover Period 2||2
63502|NCT01373450|147611|P4|COMPLETED|Crossover Period 2||2
63503|NCT01373450|147612|P3|COMPLETED|Crossover Period 2||2
63504|NCT01373450|147613|P2|COMPLETED|Crossover Period 2||2
63505|NCT01373450|147614|P1|COMPLETED|Crossover Period 2||2
63506|NCT01373450|147609|P6|STARTED|Crossover Period 2||2
63507|NCT01373450|147610|P5|STARTED|Crossover Period 2||2
63508|NCT01373450|147611|P4|STARTED|Crossover Period 2||2
63509|NCT01373450|147612|P3|STARTED|Crossover Period 2||2
63510|NCT01373450|147613|P2|STARTED|Crossover Period 2||2
63511|NCT01373450|147614|P1|STARTED|Crossover Period 2||2
63512|NCT01373450|147609|P6|NOT COMPLETED|7 Day Wash-out||0
63513|NCT01373450|147610|P5|NOT COMPLETED|7 Day Wash-out||0
63514|NCT01373450|147611|P4|NOT COMPLETED|7 Day Wash-out||0
63515|NCT01373450|147612|P3|NOT COMPLETED|7 Day Wash-out||0
63516|NCT01373450|147613|P2|NOT COMPLETED|7 Day Wash-out||0
63517|NCT01373450|147614|P1|NOT COMPLETED|7 Day Wash-out||0
63518|NCT01373450|147609|P6|COMPLETED|7 Day Wash-out||2
63519|NCT01373450|147610|P5|COMPLETED|7 Day Wash-out||2
63520|NCT01373450|147611|P4|COMPLETED|7 Day Wash-out||2
63521|NCT01373450|147612|P3|COMPLETED|7 Day Wash-out||2
63522|NCT01373450|147613|P2|COMPLETED|7 Day Wash-out||2
63523|NCT01373450|147614|P1|COMPLETED|7 Day Wash-out||2
63524|NCT01373450|147609|P6|STARTED|7 Day Wash-out||2
63525|NCT01373450|147610|P5|STARTED|7 Day Wash-out||2
63526|NCT01373450|147611|P4|STARTED|7 Day Wash-out||2
63527|NCT01373450|147612|P3|STARTED|7 Day Wash-out||2
63528|NCT01373450|147613|P2|STARTED|7 Day Wash-out||2
63529|NCT01373450|147614|P1|STARTED|7 Day Wash-out||2
63530|NCT01373450|147609|P6|NOT COMPLETED|Crossover Period 1||0
63531|NCT01373450|147610|P5|NOT COMPLETED|Crossover Period 1||0
63532|NCT01373450|147611|P4|NOT COMPLETED|Crossover Period 1||0
63533|NCT01373450|147612|P3|NOT COMPLETED|Crossover Period 1||0
63534|NCT01373450|147613|P2|NOT COMPLETED|Crossover Period 1||0
63535|NCT01373450|147614|P1|NOT COMPLETED|Crossover Period 1||0
63536|NCT01373450|147609|P6|COMPLETED|Crossover Period 1||2
63537|NCT01373450|147610|P5|COMPLETED|Crossover Period 1||2
63538|NCT01373450|147611|P4|COMPLETED|Crossover Period 1||2
63539|NCT01373450|147612|P3|COMPLETED|Crossover Period 1||2
63540|NCT01373450|147613|P2|COMPLETED|Crossover Period 1||2
63541|NCT01373450|147614|P1|COMPLETED|Crossover Period 1||2
63542|NCT01373450|147609|P6|STARTED|Crossover Period 1||2
63543|NCT01373450|147610|P5|STARTED|Crossover Period 1||2
63544|NCT01373450|147611|P4|STARTED|Crossover Period 1||2
63545|NCT01373450|147612|P3|STARTED|Crossover Period 1||2
63546|NCT01373450|147613|P2|STARTED|Crossover Period 1||2
63547|NCT01373450|147614|P1|STARTED|Crossover Period 1||2
63548|NCT01373346|147636|P1|NOT COMPLETED|Overall Study||1
63549|NCT01373346|147636|P1|COMPLETED|Overall Study||14
63550|NCT01373346|147636|P1|STARTED|Overall Study||15
63551|NCT01373294|147659|P2|NOT COMPLETED|Overall Study||0
63552|NCT01373294|147660|P1|NOT COMPLETED|Overall Study||1
63553|NCT01373294|147659|P2|COMPLETED|Overall Study||2
63554|NCT01373294|147660|P1|COMPLETED|Overall Study||14
63555|NCT01373294|147659|P2|STARTED|Overall Study||2
63556|NCT01373294|147660|P1|STARTED|Overall Study||15
63557|NCT01373281|147669|P2|NOT COMPLETED|Overall Study||45
63558|NCT01373281|147670|P1|NOT COMPLETED|Overall Study||79
63559|NCT01373281|147669|P2|COMPLETED|Overall Study||3379
63560|NCT01373281|147670|P1|COMPLETED|Overall Study||6772
63561|NCT01373281|147669|P2|STARTED|Overall Study||3424
63562|NCT01373281|147670|P1|STARTED|Overall Study||6851
63563|NCT01372995|147689|P3|NOT COMPLETED|Overall Study||1
63564|NCT01372995|147690|P2|NOT COMPLETED|Overall Study||1
63565|NCT01372995|147691|P1|NOT COMPLETED|Overall Study||0
63566|NCT01372995|147689|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
63567|NCT01372995|147690|P2|COMPLETED|Overall Study||9
63568|NCT01372995|147691|P1|COMPLETED|Overall Study||10
63569|NCT01372995|147689|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
63570|NCT01372995|147690|P2|STARTED|Overall Study||10
63571|NCT01372995|147691|P1|STARTED|Overall Study||10
63572|NCT01372878|147738|P1|NOT COMPLETED|Overall Study||184
63573|NCT01372878|147738|P1|COMPLETED|Overall Study||700
63574|NCT01372878|147738|P1|STARTED|Overall Study||884
63575|NCT01372813|147743|P1|NOT COMPLETED|Overall Study||0
63576|NCT01372813|147743|P1|COMPLETED|Overall Study||3
63577|NCT01372813|147743|P1|STARTED|Overall Study||3
63578|NCT01372748|147758|P2|NOT COMPLETED|Overall Study||39
63579|NCT01372748|147759|P1|NOT COMPLETED|Overall Study||23
63580|NCT01372748|147758|P2|COMPLETED|Overall Study|defined as having vital status|12603
63581|NCT01372748|147759|P1|COMPLETED|Overall Study|defined as having vital status|11022
63582|NCT01372748|147758|P2|STARTED|Overall Study||12642
63583|NCT01372748|147759|P1|STARTED|Overall Study||11045
63584|NCT01372605|147769|P2|NOT COMPLETED|Overall Study||10
63585|NCT01372605|147770|P1|NOT COMPLETED|Overall Study||12
63586|NCT01372605|147769|P2|COMPLETED|Overall Study||145
63587|NCT01372605|147770|P1|COMPLETED|Overall Study||137
63588|NCT01372605|147769|P2|STARTED|Overall Study||155
63589|NCT01372605|147770|P1|STARTED|Overall Study||149
63590|NCT01372501|147796|P1|NOT COMPLETED|Overall Study||5
63591|NCT01372501|147796|P1|COMPLETED|Overall Study||14
63592|NCT01372501|147796|P1|STARTED|Overall Study||19
63593|NCT01372462|147801|P1|NOT COMPLETED|No Treatment Control||0
63594|NCT01372462|147801|P1|COMPLETED|No Treatment Control||15
63595|NCT01372462|147801|P1|STARTED|No Treatment Control||15
63596|NCT01372462|147801|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
63597|NCT01372462|147801|P1|COMPLETED|Oxygen Nasal Cannula||15
63598|NCT01372462|147801|P1|STARTED|Oxygen Nasal Cannula||15
63599|NCT01372462|147801|P1|NOT COMPLETED|NIOV - Oxygen||0
63600|NCT01372462|147801|P1|COMPLETED|NIOV - Oxygen||15
63601|NCT01372462|147801|P1|STARTED|NIOV - Oxygen||15
63602|NCT01372462|147801|P1|NOT COMPLETED|NIOV - Room Air||0
63603|NCT01372462|147801|P1|COMPLETED|NIOV - Room Air||15
63604|NCT01372462|147801|P1|STARTED|NIOV - Room Air||15
63605|NCT01372410|147819|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63606|NCT01372410|147820|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63607|NCT01372410|147821|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
63608|NCT01372410|147822|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63609|NCT01372410|147823|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63610|NCT01372410|147824|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
63611|NCT01372410|147825|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63612|NCT01372410|147826|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
63613|NCT01372410|147819|P8|COMPLETED|Treatment Period 3 (7 Days)||18
63614|NCT01372410|147820|P7|COMPLETED|Treatment Period 3 (7 Days)||15
63615|NCT01372410|147821|P6|COMPLETED|Treatment Period 3 (7 Days)||18
63616|NCT01372410|147822|P5|COMPLETED|Treatment Period 3 (7 Days)||20
63617|NCT01372410|147823|P4|COMPLETED|Treatment Period 3 (7 Days)||22
63618|NCT01372410|147824|P3|COMPLETED|Treatment Period 3 (7 Days)||15
63619|NCT01372410|147825|P2|COMPLETED|Treatment Period 3 (7 Days)||18
63620|NCT01372410|147826|P1|COMPLETED|Treatment Period 3 (7 Days)||21
63621|NCT01372410|147819|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
63622|NCT01372410|147820|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
63623|NCT01372410|147821|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
63624|NCT01372410|147822|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
63625|NCT01372410|147823|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
63626|NCT01372410|147824|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
63627|NCT01372410|147825|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
63628|NCT01372410|147826|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
63629|NCT01372410|147819|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
63630|NCT01372410|147820|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
63631|NCT01372410|147821|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
63632|NCT01372410|147822|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
63633|NCT01372410|147823|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
63634|NCT01372410|147824|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
63635|NCT01372410|147825|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
63636|NCT01372410|147826|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
63637|NCT01372410|147819|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
63638|NCT01372410|147820|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
63639|NCT01372410|147821|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
63640|NCT01372410|147822|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
63641|NCT01372410|147823|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
63642|NCT01372410|147824|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
63643|NCT01372410|147825|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
63644|NCT01372410|147826|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
63645|NCT01372410|147819|P8|STARTED|Washout Period 2 (10-14 Days)||19
63646|NCT01372410|147820|P7|STARTED|Washout Period 2 (10-14 Days)||21
63647|NCT01372410|147821|P6|STARTED|Washout Period 2 (10-14 Days)||16
63648|NCT01372410|147822|P5|STARTED|Washout Period 2 (10-14 Days)||19
63649|NCT01372410|147823|P4|STARTED|Washout Period 2 (10-14 Days)||17
63650|NCT01372410|147824|P3|STARTED|Washout Period 2 (10-14 Days)||22
63651|NCT01372410|147825|P2|STARTED|Washout Period 2 (10-14 Days)||21
63652|NCT01372410|147826|P1|STARTED|Washout Period 2 (10-14 Days)||19
63653|NCT01372410|147819|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63654|NCT01372410|147820|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63655|NCT01372410|147821|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63656|NCT01372410|147822|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63657|NCT01372410|147823|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63658|NCT01372410|147824|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63659|NCT01372410|147825|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63660|NCT01372410|147826|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
63661|NCT01372410|147819|P8|COMPLETED|Treatment Period 2 (7 Days)||19
63662|NCT01372410|147820|P7|COMPLETED|Treatment Period 2 (7 Days)||21
63663|NCT01372410|147821|P6|COMPLETED|Treatment Period 2 (7 Days)||16
63664|NCT01372410|147822|P5|COMPLETED|Treatment Period 2 (7 Days)||19
63665|NCT01372410|147823|P4|COMPLETED|Treatment Period 2 (7 Days)||17
63666|NCT01372410|147824|P3|COMPLETED|Treatment Period 2 (7 Days)||22
63667|NCT01372410|147825|P2|COMPLETED|Treatment Period 2 (7 Days)||21
63668|NCT01372410|147826|P1|COMPLETED|Treatment Period 2 (7 Days)||19
63669|NCT01372410|147819|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
63670|NCT01372410|147820|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
63671|NCT01372410|147821|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
63672|NCT01372410|147822|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
63673|NCT01372410|147823|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
63674|NCT01372410|147824|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
63675|NCT01372410|147825|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
63676|NCT01372410|147826|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
63677|NCT01372410|147819|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
63678|NCT01372410|147820|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63679|NCT01372410|147821|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63680|NCT01372410|147822|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63681|NCT01372410|147823|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63682|NCT01372410|147824|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63683|NCT01372410|147825|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
63684|NCT01372410|147826|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
63685|NCT01372410|147819|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
63686|NCT01372410|147820|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
63687|NCT01372410|147821|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
63688|NCT01372410|147822|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
63689|NCT01372410|147823|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
63690|NCT01372410|147824|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
63691|NCT01372410|147825|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
63692|NCT01372410|147826|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
63693|NCT01372410|147819|P8|STARTED|Washout Period 1 (10-14 Days)||19
63694|NCT01372410|147820|P7|STARTED|Washout Period 1 (10-14 Days)||20
63695|NCT01372410|147821|P6|STARTED|Washout Period 1 (10-14 Days)||21
63696|NCT01372410|147822|P5|STARTED|Washout Period 1 (10-14 Days)||19
63697|NCT01372410|147823|P4|STARTED|Washout Period 1 (10-14 Days)||20
63698|NCT01372410|147824|P3|STARTED|Washout Period 1 (10-14 Days)||19
63699|NCT01372410|147825|P2|STARTED|Washout Period 1 (10-14 Days)||19
63700|NCT01372410|147826|P1|STARTED|Washout Period 1 (10-14 Days)||19
63701|NCT01372410|147819|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
63702|NCT01372410|147820|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
63703|NCT01372410|147821|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
63704|NCT01372410|147822|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
63705|NCT01372410|147823|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
63706|NCT01372410|147824|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
63707|NCT01372410|147825|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
63708|NCT01372410|147826|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
63709|NCT01372410|147819|P8|COMPLETED|Treatment Period 1 (7 Days)||19
63710|NCT01372410|147820|P7|COMPLETED|Treatment Period 1 (7 Days)||20
63711|NCT01372410|147821|P6|COMPLETED|Treatment Period 1 (7 Days)||21
63712|NCT01372410|147822|P5|COMPLETED|Treatment Period 1 (7 Days)||19
63713|NCT01372410|147823|P4|COMPLETED|Treatment Period 1 (7 Days)||20
63714|NCT01372410|147824|P3|COMPLETED|Treatment Period 1 (7 Days)||19
63715|NCT01372410|147825|P2|COMPLETED|Treatment Period 1 (7 Days)||19
63716|NCT01372410|147826|P1|COMPLETED|Treatment Period 1 (7 Days)||19
63717|NCT01372410|147819|P8|STARTED|Treatment Period 1 (7 Days)||19
63718|NCT01372410|147820|P7|STARTED|Treatment Period 1 (7 Days)||22
63719|NCT01372410|147821|P6|STARTED|Treatment Period 1 (7 Days)||21
63720|NCT01372410|147822|P5|STARTED|Treatment Period 1 (7 Days)||21
63721|NCT01372410|147823|P4|STARTED|Treatment Period 1 (7 Days)||20
63722|NCT01372410|147824|P3|STARTED|Treatment Period 1 (7 Days)||19
63723|NCT01372410|147825|P2|STARTED|Treatment Period 1 (7 Days)||21
63724|NCT01372410|147826|P1|STARTED|Treatment Period 1 (7 Days)||20
63725|NCT01372384|147863|P1|NOT COMPLETED|Overall Study||3
63726|NCT01372384|147863|P1|COMPLETED|Overall Study||3
63727|NCT01372384|147863|P1|STARTED|Overall Study||6
63728|NCT01372150|147873|P3|NOT COMPLETED|Overall Study||16
63729|NCT01372150|147874|P2|NOT COMPLETED|Overall Study||14
63730|NCT01372150|147875|P1|NOT COMPLETED|Overall Study||13
63731|NCT01372150|147873|P3|COMPLETED|Overall Study||99
63732|NCT01372150|147874|P2|COMPLETED|Overall Study||99
63733|NCT01372150|147875|P1|COMPLETED|Overall Study||99
63734|NCT01372150|147873|P3|Treated|Overall Study||115
63735|NCT01372150|147874|P2|Treated|Overall Study||112
63736|NCT01372150|147875|P1|Treated|Overall Study||112
63737|NCT01372150|147873|P3|STARTED|Overall Study||115
63738|NCT01372150|147874|P2|STARTED|Overall Study||113
63739|NCT01372150|147875|P1|STARTED|Overall Study||112
63740|NCT01371994|147894|P2|NOT COMPLETED|Overall Study||42
63741|NCT01371994|147895|P1|NOT COMPLETED|Overall Study||57
63742|NCT01371994|147894|P2|COMPLETED|Overall Study||278
63743|NCT01371994|147895|P1|COMPLETED|Overall Study||263
63744|NCT01371994|147894|P2|Received Treatment|Overall Study||313
63745|NCT01371994|147895|P1|Received Treatment|Overall Study||310
63746|NCT01371994|147894|P2|STARTED|Overall Study||320
63747|NCT01371994|147895|P1|STARTED|Overall Study||320
63748|NCT01371877|147939|P2|NOT COMPLETED|Overall Study||4
63749|NCT01371877|147940|P1|NOT COMPLETED|Overall Study||0
63750|NCT01371877|147939|P2|COMPLETED|Overall Study||17
63751|NCT01371877|147940|P1|COMPLETED|Overall Study||21
63752|NCT01371877|147939|P2|STARTED|Overall Study||21
63753|NCT01371877|147940|P1|STARTED|Overall Study||21
63754|NCT01371851|147952|P2|NOT COMPLETED|Overall Study||9
63755|NCT01371851|147953|P1|NOT COMPLETED|Overall Study||8
63756|NCT01371851|147952|P2|COMPLETED|Overall Study||2
63757|NCT01371851|147953|P1|COMPLETED|Overall Study||3
63758|NCT01371851|147952|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
63759|NCT01371851|147953|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
63760|NCT01371838|147961|P2|NOT COMPLETED|Overall Study||66
63761|NCT01371838|147962|P1|NOT COMPLETED|Overall Study||49
63762|NCT01371838|147961|P2|COMPLETED|Overall Study||317
63763|NCT01371838|147962|P1|COMPLETED|Overall Study||332
63764|NCT01371838|147961|P2|STARTED|Overall Study||383
63765|NCT01371838|147962|P1|STARTED|Overall Study||381
63766|NCT01371825|147998|P1|NOT COMPLETED|Long-term Treatment Period||0
63767|NCT01371825|147998|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
63768|NCT01371825|147998|P1|STARTED|Long-term Treatment Period||6
63769|NCT01371825|147998|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
63770|NCT01371825|147998|P1|COMPLETED|Primary Efficacy Analysis Period||6
63771|NCT01371825|147998|P1|STARTED|Primary Efficacy Analysis Period||9
63772|NCT01371786|148012|P2|NOT COMPLETED|Overall Study||0
63773|NCT01371786|148013|P1|NOT COMPLETED|Overall Study||0
63774|NCT01371786|148012|P2|COMPLETED|Overall Study||7
63775|NCT01371786|148013|P1|COMPLETED|Overall Study||7
63776|NCT01371786|148012|P2|STARTED|Overall Study||7
63777|NCT01371786|148013|P1|STARTED|Overall Study||7
63778|NCT01371747|148033|P6|NOT COMPLETED|Overall Study||14
63779|NCT01371747|148034|P5|NOT COMPLETED|Overall Study||7
63780|NCT01371747|148035|P4|NOT COMPLETED|Overall Study||9
63781|NCT01371747|148036|P3|NOT COMPLETED|Overall Study||24
63782|NCT01371747|148037|P2|NOT COMPLETED|Overall Study||23
63783|NCT01371747|148038|P1|NOT COMPLETED|Overall Study||18
63784|NCT01371747|148033|P6|COMPLETED|Overall Study||16
63785|NCT01371747|148034|P5|COMPLETED|Overall Study||21
63786|NCT01371747|148035|P4|COMPLETED|Overall Study||17
63787|NCT01371747|148036|P3|COMPLETED|Overall Study||50
63788|NCT01371747|148037|P2|COMPLETED|Overall Study||51
63789|NCT01371747|148038|P1|COMPLETED|Overall Study||56
63790|NCT01371747|148033|P6|STARTED|Overall Study||30
63791|NCT01371747|148034|P5|STARTED|Overall Study||28
63792|NCT01371747|148035|P4|STARTED|Overall Study||26
63793|NCT01371747|148036|P3|STARTED|Overall Study||74
63794|NCT01371747|148037|P2|STARTED|Overall Study||74
63795|NCT01371747|148038|P1|STARTED|Overall Study||74
63796|NCT01371721|148103|P3|NOT COMPLETED|Overall Study||30
63797|NCT01371721|148104|P2|NOT COMPLETED|Overall Study||24
63798|NCT01371721|148105|P1|NOT COMPLETED|Overall Study||29
63799|NCT01371721|148103|P3|COMPLETED|Overall Study||62
63800|NCT01371721|148104|P2|COMPLETED|Overall Study||65
63801|NCT01371721|148105|P1|COMPLETED|Overall Study||59
63802|NCT01371721|148103|P3|Treated|Overall Study||92
63803|NCT01371721|148104|P2|Treated|Overall Study||89
63804|NCT01371721|148105|P1|Treated|Overall Study||87
63805|NCT01371721|148103|P3|STARTED|Overall Study||92
63806|NCT01371721|148104|P2|STARTED|Overall Study||89
63807|NCT01371721|148105|P1|STARTED|Overall Study||88
63808|NCT01371708|148138|P3|NOT COMPLETED|Overall Study||39
63809|NCT01371708|148139|P2|NOT COMPLETED|Overall Study||30
63810|NCT01371708|148140|P1|NOT COMPLETED|Overall Study||26
63811|NCT01371708|148138|P3|COMPLETED|Overall Study||59
63812|NCT01371708|148139|P2|COMPLETED|Overall Study||63
63813|NCT01371708|148140|P1|COMPLETED|Overall Study||66
63814|NCT01371708|148138|P3|Received Treatment|Overall Study||97
63815|NCT01371708|148139|P2|Received Treatment|Overall Study||93
63816|NCT01371708|148140|P1|Received Treatment|Overall Study||91
63817|NCT01371708|148138|P3|STARTED|Overall Study||98
63818|NCT01371708|148139|P2|STARTED|Overall Study||93
63819|NCT01371708|148140|P1|STARTED|Overall Study||92
63820|NCT01371643|148172|P2|NOT COMPLETED|Overall Study||0
63821|NCT01371643|148173|P1|NOT COMPLETED|Overall Study||3
63822|NCT01371643|148172|P2|COMPLETED|Overall Study||26
63823|NCT01371643|148173|P1|COMPLETED|Overall Study||12
63824|NCT01371643|148172|P2|STARTED|Overall Study||26
63825|NCT01371643|148173|P1|STARTED|Overall Study||15
63826|NCT01371565|148183|P1|NOT COMPLETED|Overall Study||3
63827|NCT01371565|148183|P1|COMPLETED|Overall Study||1
63828|NCT01371565|148183|P1|STARTED|Overall Study||4
63829|NCT01371552|148187|P6|NOT COMPLETED|Part 2, One Week||0
63830|NCT01371552|148188|P5|NOT COMPLETED|Part 2, One Week||0
63831|NCT01371552|148189|P4|NOT COMPLETED|Part 2, One Week||0
63832|NCT01371552|148190|P3|NOT COMPLETED|Part 2, One Week||0
63833|NCT01371552|148191|P2|NOT COMPLETED|Part 2, One Week||0
63834|NCT01371552|148192|P1|NOT COMPLETED|Part 2, One Week||0
63835|NCT01371552|148187|P6|COMPLETED|Part 2, One Week||18
63836|NCT01371552|148188|P5|COMPLETED|Part 2, One Week||15
63837|NCT01371552|148189|P4|COMPLETED|Part 2, One Week||20
63838|NCT01371552|148190|P3|COMPLETED|Part 2, One Week||18
63839|NCT01371552|148191|P2|COMPLETED|Part 2, One Week||17
63840|NCT01371552|148192|P1|COMPLETED|Part 2, One Week||18
63841|NCT01371552|148187|P6|STARTED|Part 2, One Week||18
63842|NCT01371552|148188|P5|STARTED|Part 2, One Week||15
63843|NCT01371552|148189|P4|STARTED|Part 2, One Week||20
63844|NCT01371552|148190|P3|STARTED|Part 2, One Week||18
63845|NCT01371552|148191|P2|STARTED|Part 2, One Week||17
63846|NCT01371552|148192|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
63847|NCT01371552|148187|P6|NOT COMPLETED|Part 1, Third 3 Days||1
63848|NCT01371552|148188|P5|NOT COMPLETED|Part 1, Third 3 Days||1
63849|NCT01371552|148189|P4|NOT COMPLETED|Part 1, Third 3 Days||0
63850|NCT01371552|148190|P3|NOT COMPLETED|Part 1, Third 3 Days||0
63851|NCT01371552|148191|P2|NOT COMPLETED|Part 1, Third 3 Days||0
63852|NCT01371552|148192|P1|NOT COMPLETED|Part 1, Third 3 Days||0
63853|NCT01371552|148187|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
63854|NCT01371552|148188|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
63855|NCT01371552|148189|P4|COMPLETED|Part 1, Third 3 Days||20
63856|NCT01371552|148190|P3|COMPLETED|Part 1, Third 3 Days||18
63857|NCT01371552|148191|P2|COMPLETED|Part 1, Third 3 Days||17
63858|NCT01371552|148192|P1|COMPLETED|Part 1, Third 3 Days||19
63859|NCT01371552|148187|P6|STARTED|Part 1, Third 3 Days||18
63860|NCT01371552|148188|P5|STARTED|Part 1, Third 3 Days||15
63861|NCT01371552|148189|P4|STARTED|Part 1, Third 3 Days||20
63862|NCT01371552|148190|P3|STARTED|Part 1, Third 3 Days||18
63863|NCT01371552|148191|P2|STARTED|Part 1, Third 3 Days||17
63864|NCT01371552|148192|P1|STARTED|Part 1, Third 3 Days||19
63865|NCT01371552|148187|P6|NOT COMPLETED|Part 1, Second 3 Days||0
63866|NCT01371552|148188|P5|NOT COMPLETED|Part 1, Second 3 Days||0
63867|NCT01371552|148189|P4|NOT COMPLETED|Part 1, Second 3 Days||0
63868|NCT01371552|148190|P3|NOT COMPLETED|Part 1, Second 3 Days||0
63869|NCT01371552|148191|P2|NOT COMPLETED|Part 1, Second 3 Days||0
63870|NCT01371552|148192|P1|NOT COMPLETED|Part 1, Second 3 Days||1
63871|NCT01371552|148187|P6|COMPLETED|Part 1, Second 3 Days||18
63872|NCT01371552|148188|P5|COMPLETED|Part 1, Second 3 Days||15
63873|NCT01371552|148189|P4|COMPLETED|Part 1, Second 3 Days||20
63874|NCT01371552|148190|P3|COMPLETED|Part 1, Second 3 Days||18
63875|NCT01371552|148191|P2|COMPLETED|Part 1, Second 3 Days||17
63876|NCT01371552|148192|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
63877|NCT01371552|148187|P6|STARTED|Part 1, Second 3 Days||18
63878|NCT01371552|148188|P5|STARTED|Part 1, Second 3 Days||15
63879|NCT01371552|148189|P4|STARTED|Part 1, Second 3 Days||20
63880|NCT01371552|148190|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
63881|NCT01371552|148191|P2|STARTED|Part 1, Second 3 Days||17
63882|NCT01371552|148192|P1|STARTED|Part 1, Second 3 Days||19
63883|NCT01371552|148187|P6|NOT COMPLETED|Part 1, First 3 Days||0
63884|NCT01371552|148188|P5|NOT COMPLETED|Part 1, First 3 Days||0
63885|NCT01371552|148189|P4|NOT COMPLETED|Part 1, First 3 Days||0
63886|NCT01371552|148190|P3|NOT COMPLETED|Part 1, First 3 Days||1
63887|NCT01371552|148191|P2|NOT COMPLETED|Part 1, First 3 Days||0
63888|NCT01371552|148192|P1|NOT COMPLETED|Part 1, First 3 Days||0
63889|NCT01371552|148187|P6|COMPLETED|Part 1, First 3 Days||18
63890|NCT01371552|148188|P5|COMPLETED|Part 1, First 3 Days||15
63891|NCT01371552|148189|P4|COMPLETED|Part 1, First 3 Days||20
63892|NCT01371552|148190|P3|COMPLETED|Part 1, First 3 Days||19
63893|NCT01371552|148191|P2|COMPLETED|Part 1, First 3 Days||17
63894|NCT01371552|148192|P1|COMPLETED|Part 1, First 3 Days||19
63895|NCT01371552|148187|P6|STARTED|Part 1, First 3 Days||18
63896|NCT01371552|148188|P5|STARTED|Part 1, First 3 Days||15
63897|NCT01371552|148189|P4|STARTED|Part 1, First 3 Days||20
63898|NCT01371552|148190|P3|STARTED|Part 1, First 3 Days||20
63899|NCT01371552|148191|P2|STARTED|Part 1, First 3 Days||17
63900|NCT01371552|148192|P1|STARTED|Part 1, First 3 Days||19
63901|NCT01371539|148219|P2|NOT COMPLETED|Period Two: One Week||3
63902|NCT01371539|148220|P1|NOT COMPLETED|Period Two: One Week||0
63903|NCT01371539|148219|P2|COMPLETED|Period Two: One Week||47
63904|NCT01371539|148220|P1|COMPLETED|Period Two: One Week||53
63905|NCT01371539|148219|P2|STARTED|Period Two: One Week||50
63906|NCT01371539|148220|P1|STARTED|Period Two: One Week||53
63907|NCT01371539|148219|P2|NOT COMPLETED|Period One: One Week||1
63908|NCT01371539|148220|P1|NOT COMPLETED|Period One: One Week||0
63909|NCT01371539|148219|P2|COMPLETED|Period One: One Week||50
63910|NCT01371539|148220|P1|COMPLETED|Period One: One Week||53
63911|NCT01371539|148219|P2|STARTED|Period One: One Week||51
63912|NCT01371539|148220|P1|STARTED|Period One: One Week||53
63913|NCT01371006|148230|P2|NOT COMPLETED|Overall Study||0
63914|NCT01371006|148231|P1|NOT COMPLETED|Overall Study||1
63915|NCT01371006|148230|P2|COMPLETED|Overall Study||15
63916|NCT01371006|148231|P1|COMPLETED|Overall Study||13
63917|NCT01371006|148230|P2|STARTED|Overall Study||15
63918|NCT01371006|148231|P1|STARTED|Overall Study||14
63919|NCT01370863|148272|P2|NOT COMPLETED|Overall Study||3
63920|NCT01370863|148273|P1|NOT COMPLETED|Overall Study||2
63921|NCT01370863|148272|P2|COMPLETED|Overall Study||30
63922|NCT01370863|148273|P1|COMPLETED|Overall Study||32
63923|NCT01370863|148272|P2|STARTED|Overall Study||33
63924|NCT01370863|148273|P1|STARTED|Overall Study||34
63925|NCT01370837|148286|P3|NOT COMPLETED|Overall Study||0
63926|NCT01370837|148287|P2|NOT COMPLETED|Overall Study||0
63927|NCT01370837|148288|P1|NOT COMPLETED|Overall Study||0
63928|NCT01370837|148286|P3|COMPLETED|Overall Study||17
63929|NCT01370837|148287|P2|COMPLETED|Overall Study||12
63930|NCT01370837|148288|P1|COMPLETED|Overall Study||12
63931|NCT01370837|148286|P3|STARTED|Overall Study||17
63932|NCT01370837|148287|P2|STARTED|Overall Study||12
63933|NCT01370837|148288|P1|STARTED|Overall Study||12
63934|NCT01370733|148298|P2|NOT COMPLETED|Overall Study||22
63935|NCT01370733|148299|P1|NOT COMPLETED|Overall Study||17
63936|NCT01370733|148298|P2|COMPLETED|Overall Study||77
63937|NCT01370733|148299|P1|COMPLETED|Overall Study||86
63938|NCT01370733|148298|P2|STARTED|Overall Study||99
63939|NCT01370733|148299|P1|STARTED|Overall Study||103
63940|NCT01370694|148321|P1|NOT COMPLETED|Overall Study||6
63941|NCT01370694|148321|P1|COMPLETED|Overall Study||1
63942|NCT01370694|148321|P1|STARTED|Overall Study||7
63943|NCT01370642|148334|P3|NOT COMPLETED|Overall Study||29
63944|NCT01370642|148335|P2|NOT COMPLETED|Overall Study||6
63945|NCT01370642|148336|P1|NOT COMPLETED|Overall Study||8
63946|NCT01370642|148334|P3|COMPLETED|Overall Study||69
63947|NCT01370642|148335|P2|COMPLETED|Overall Study||92
63948|NCT01370642|148336|P1|COMPLETED|Overall Study||90
63949|NCT01370642|148334|P3|FAS Population|Overall Study||98
63950|NCT01370642|148335|P2|FAS Population|Overall Study||97
63951|NCT01370642|148336|P1|FAS Population|Overall Study||98
63952|NCT01370642|148334|P3|STARTED|Overall Study||98
63953|NCT01370642|148335|P2|STARTED|Overall Study||98
63954|NCT01370642|148336|P1|STARTED|Overall Study||98
63955|NCT01370616|148367|P2|NOT COMPLETED|Overall Study||67
63956|NCT01370616|148368|P1|NOT COMPLETED|Overall Study||62
63957|NCT01370616|148367|P2|COMPLETED|Overall Study||216
63958|NCT01370616|148368|P1|COMPLETED|Overall Study||220
63959|NCT01370616|148367|P2|Treated|Overall Study||275
63960|NCT01370616|148368|P1|Treated|Overall Study||275
63961|NCT01370616|148367|P2|STARTED|Overall Study|Participants randomized|283
63962|NCT01370616|148368|P1|STARTED|Overall Study|Participants randomized|282
63963|NCT01370603|148392|P2|NOT COMPLETED|Period 2||4
63964|NCT01370603|148393|P1|NOT COMPLETED|Period 2||3
63965|NCT01370603|148392|P2|COMPLETED|Period 2||146
63966|NCT01370603|148393|P1|COMPLETED|Period 2||138
63967|NCT01370603|148392|P2|STARTED|Period 2||150
63968|NCT01370603|148393|P1|STARTED|Period 2||141
63969|NCT01370603|148392|P2|NOT COMPLETED|Crossover Washout||4
63970|NCT01370603|148393|P1|NOT COMPLETED|Crossover Washout||9
63971|NCT01370603|148392|P2|COMPLETED|Crossover Washout||150
63972|NCT01370603|148393|P1|COMPLETED|Crossover Washout||141
63973|NCT01370603|148392|P2|STARTED|Crossover Washout||154
63974|NCT01370603|148393|P1|STARTED|Crossover Washout||150
63975|NCT01370603|148392|P2|NOT COMPLETED|Period 1||10
63976|NCT01370603|148393|P1|NOT COMPLETED|Period 1||14
63977|NCT01370603|148392|P2|COMPLETED|Period 1||154
63978|NCT01370603|148393|P1|COMPLETED|Period 1||150
63979|NCT01370603|148392|P2|STARTED|Period 1||164
63980|NCT01370603|148393|P1|STARTED|Period 1||164
63981|NCT01370590|148411|P2|NOT COMPLETED|Period 2||2
63982|NCT01370590|148412|P1|NOT COMPLETED|Period 2||1
63983|NCT01370590|148411|P2|COMPLETED|Period 2||184
63984|NCT01370590|148412|P1|COMPLETED|Period 2||180
63985|NCT01370590|148411|P2|STARTED|Period 2||186
63986|NCT01370590|148412|P1|STARTED|Period 2||181
63987|NCT01370590|148411|P2|NOT COMPLETED|Crossover Washout Period||6
63988|NCT01370590|148412|P1|NOT COMPLETED|Crossover Washout Period||6
63989|NCT01370590|148411|P2|COMPLETED|Crossover Washout Period||186
63990|NCT01370590|148412|P1|COMPLETED|Crossover Washout Period||181
63991|NCT01370590|148411|P2|STARTED|Crossover Washout Period||192
63992|NCT01370590|148412|P1|STARTED|Crossover Washout Period||187
63993|NCT01370590|148411|P2|NOT COMPLETED|Period 1||11
63994|NCT01370590|148412|P1|NOT COMPLETED|Period 1||16
63995|NCT01370590|148411|P2|COMPLETED|Period 1||192
63996|NCT01370590|148412|P1|COMPLETED|Period 1||187
63997|NCT01370590|148411|P2|STARTED|Period 1||203
63998|NCT01370590|148412|P1|STARTED|Period 1||203
63999|NCT01370538|148430|P2|NOT COMPLETED|Overall Study||19
64000|NCT01370538|148431|P1|NOT COMPLETED|Overall Study||19
64001|NCT01370538|148430|P2|COMPLETED|Overall Study||152
64002|NCT01370538|148431|P1|COMPLETED|Overall Study||151
64003|NCT01370538|148430|P2|Patients Who Completed Treatment|Overall Study||152
64004|NCT01370538|148431|P1|Patients Who Completed Treatment|Overall Study||151
64005|NCT01370538|148430|P2|Patients Who Received Treatment|Overall Study||161
64006|NCT01370538|148431|P1|Patients Who Received Treatment|Overall Study||165
64007|NCT01370538|148430|P2|STARTED|Overall Study||171
64008|NCT01370538|148431|P1|STARTED|Overall Study||170
64009|NCT01370525|148447|P2|NOT COMPLETED|Overall Study||11
64010|NCT01370525|148448|P1|NOT COMPLETED|Overall Study||8
64011|NCT01370525|148447|P2|COMPLETED|Overall Study||158
64012|NCT01370525|148448|P1|COMPLETED|Overall Study||163
64013|NCT01370525|148447|P2|Patients Who Completed Treatment|Overall Study||158
64014|NCT01370525|148448|P1|Patients Who Completed Treatment|Overall Study||163
64015|NCT01370525|148447|P2|Patients Who Received Treatment|Overall Study||163
64016|NCT01370525|148448|P1|Patients Who Received Treatment|Overall Study||168
64017|NCT01370525|148447|P2|STARTED|Overall Study||169
64018|NCT01370525|148448|P1|STARTED|Overall Study||171
64019|NCT01370460|148464|P2|NOT COMPLETED|Overall Study||0
64020|NCT01370460|148465|P1|NOT COMPLETED|Overall Study||0
64021|NCT01370460|148464|P2|COMPLETED|Overall Study||51
64022|NCT01370460|148465|P1|COMPLETED|Overall Study||50
64023|NCT01370460|148464|P2|STARTED|Overall Study||51
64024|NCT01370460|148465|P1|STARTED|Overall Study||50
64025|NCT01370408|148472|P1|NOT COMPLETED|Overall Study||9
64026|NCT01370408|148472|P1|COMPLETED|Overall Study||76
64027|NCT01370408|148472|P1|STARTED|Overall Study||85
64028|NCT01370356|148485|P2|NOT COMPLETED|Overall Study||227
64029|NCT01370356|148486|P1|NOT COMPLETED|Overall Study||192
64030|NCT01370356|148485|P2|COMPLETED|Overall Study||515
64031|NCT01370356|148486|P1|COMPLETED|Overall Study||559
64032|NCT01370356|148485|P2|STARTED|Overall Study||742
64033|NCT01370356|148486|P1|STARTED|Overall Study||751
64034|NCT01370265|148500|P2|NOT COMPLETED|Second Intervention||0
64035|NCT01370265|148501|P1|NOT COMPLETED|Second Intervention||0
64036|NCT01370265|148500|P2|COMPLETED|Second Intervention||5
64037|NCT01370265|148501|P1|COMPLETED|Second Intervention||5
64038|NCT01370265|148500|P2|STARTED|Second Intervention||5
64039|NCT01370265|148501|P1|STARTED|Second Intervention||5
64040|NCT01370265|148500|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
64041|NCT01370265|148501|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
64042|NCT01370265|148500|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
64043|NCT01370265|148501|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
64044|NCT01370265|148500|P2|STARTED|Washout Period (50-minute Period Decay)||5
64045|NCT01370265|148501|P1|STARTED|Washout Period (50-minute Period Decay)||5
64046|NCT01370265|148500|P2|NOT COMPLETED|First Intervention||1
64047|NCT01370265|148501|P1|NOT COMPLETED|First Intervention||1
64048|NCT01370265|148500|P2|COMPLETED|First Intervention||5
64049|NCT01370265|148501|P1|COMPLETED|First Intervention||5
64050|NCT01370265|148500|P2|STARTED|First Intervention||6
64051|NCT01370265|148501|P1|STARTED|First Intervention||6
64052|NCT01370265|148500|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
64053|NCT01370265|148501|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
64054|NCT01370265|148500|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
64055|NCT01370265|148501|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
64056|NCT01370265|148500|P2|STARTED|Washout Period (50-minute Period Decay)||6
64057|NCT01370265|148501|P1|STARTED|Washout Period (50-minute Period Decay)||6
64058|NCT01370265|148500|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
64059|NCT01370265|148501|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
64060|NCT01370265|148500|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
64061|NCT01370265|148501|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
64062|NCT01370265|148500|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
64063|NCT01370265|148501|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
64064|NCT01370083|148520|P2|NOT COMPLETED|Overall Study||1
64065|NCT01370083|148521|P1|NOT COMPLETED|Overall Study||2
64066|NCT01370083|148520|P2|COMPLETED|Overall Study||6
64067|NCT01370083|148521|P1|COMPLETED|Overall Study||5
64068|NCT01370083|148520|P2|STARTED|Overall Study||7
64069|NCT01370083|148521|P1|STARTED|Overall Study||7
64070|NCT01370005|148534|P3|NOT COMPLETED|Overall Study||11
64071|NCT01370005|148535|P2|NOT COMPLETED|Overall Study||11
64072|NCT01370005|148536|P1|NOT COMPLETED|Overall Study||16
64073|NCT01370005|148534|P3|COMPLETED|Overall Study||266
64074|NCT01370005|148535|P2|COMPLETED|Overall Study||265
64075|NCT01370005|148536|P1|COMPLETED|Overall Study||256
64076|NCT01370005|148534|P3|STARTED|Overall Study||277
64077|NCT01370005|148535|P2|STARTED|Overall Study||276
64078|NCT01370005|148536|P1|STARTED|Overall Study||272
64079|NCT01369888|148593|P4|NOT COMPLETED|Overall Study||0
64080|NCT01369888|148594|P3|NOT COMPLETED|Overall Study||0
64081|NCT01369888|148595|P2|NOT COMPLETED|Overall Study||0
64082|NCT01369888|148596|P1|NOT COMPLETED|Overall Study||0
64083|NCT01369888|148593|P4|COMPLETED|Overall Study||0
64084|NCT01369888|148594|P3|COMPLETED|Overall Study||0
64085|NCT01369888|148595|P2|COMPLETED|Overall Study||2
64086|NCT01369888|148596|P1|COMPLETED|Overall Study||1
64087|NCT01369888|148593|P4|STARTED|Overall Study||0
64088|NCT01369888|148594|P3|STARTED|Overall Study||0
64089|NCT01369888|148595|P2|STARTED|Overall Study||2
64090|NCT01369888|148596|P1|STARTED|Overall Study||1
64091|NCT01369875|148606|P2|NOT COMPLETED|Overall Study||0
64092|NCT01369875|148607|P1|NOT COMPLETED|Overall Study||0
64093|NCT01369875|148606|P2|COMPLETED|Overall Study||1
64094|NCT01369875|148607|P1|COMPLETED|Overall Study||1
64095|NCT01369875|148606|P2|STARTED|Overall Study||1
64096|NCT01369875|148607|P1|STARTED|Overall Study||1
64097|NCT01369849|148618|P3|NOT COMPLETED|Overall Study||1
64098|NCT01369849|148619|P2|NOT COMPLETED|Overall Study||0
64099|NCT01369849|148620|P1|NOT COMPLETED|Overall Study||0
64100|NCT01369849|148618|P3|COMPLETED|Overall Study||4
64101|NCT01369849|148619|P2|COMPLETED|Overall Study||4
64102|NCT01369849|148620|P1|COMPLETED|Overall Study||6
64103|NCT01369849|148618|P3|STARTED|Overall Study||5
64104|NCT01369849|148619|P2|STARTED|Overall Study||4
64105|NCT01369849|148620|P1|STARTED|Overall Study||6
64106|NCT01369784|148629|P1|NOT COMPLETED|Overall Study||12
64107|NCT01369784|148629|P1|COMPLETED|Overall Study||146
64108|NCT01369784|148629|P1|STARTED|Overall Study||158
64109|NCT01369745|148659|P5|NOT COMPLETED|Overall Study||18
64110|NCT01369745|148660|P4|NOT COMPLETED|Overall Study||20
64111|NCT01369745|148661|P3|NOT COMPLETED|Overall Study||2
64112|NCT01369745|148662|P2|NOT COMPLETED|Overall Study||13
64113|NCT01369745|148663|P1|NOT COMPLETED|Overall Study||7
64114|NCT01369745|148659|P5|COMPLETED|Overall Study||65
64115|NCT01369745|148660|P4|COMPLETED|Overall Study||64
64116|NCT01369745|148661|P3|COMPLETED|Overall Study||16
64117|NCT01369745|148662|P2|COMPLETED|Overall Study||28
64118|NCT01369745|148663|P1|COMPLETED|Overall Study||25
64119|NCT01369745|148659|P5|STARTED|Overall Study||83
64120|NCT01369745|148660|P4|STARTED|Overall Study||84
64121|NCT01369745|148661|P3|STARTED|Overall Study||18
64122|NCT01369745|148662|P2|STARTED|Overall Study||41
64123|NCT01369745|148663|P1|STARTED|Overall Study||32
64124|NCT01369732|148697|P2|NOT COMPLETED|Overall Study||2
64125|NCT01369732|148698|P1|NOT COMPLETED|Overall Study||4
64126|NCT01369732|148697|P2|COMPLETED|Overall Study||31
64127|NCT01369732|148698|P1|COMPLETED|Overall Study||29
64128|NCT01369732|148697|P2|STARTED|Overall Study||33
64129|NCT01369732|148698|P1|STARTED|Overall Study||33
64130|NCT01369706|148704|P1|NOT COMPLETED|Overall Study||0
64131|NCT01369706|148704|P1|COMPLETED|Overall Study||388
64132|NCT01369706|148704|P1|STARTED|Overall Study||388
64133|NCT01369680|148712|P4|NOT COMPLETED|Overall Study||2
64134|NCT01369680|148713|P3|NOT COMPLETED|Overall Study||1
64135|NCT01369680|148714|P2|NOT COMPLETED|Overall Study||0
64136|NCT01369680|148715|P1|NOT COMPLETED|Overall Study||0
64137|NCT01369680|148712|P4|COMPLETED|Overall Study||1
64138|NCT01369680|148713|P3|COMPLETED|Overall Study||2
64139|NCT01369680|148714|P2|COMPLETED|Overall Study||3
64140|NCT01369680|148715|P1|COMPLETED|Overall Study||3
64141|NCT01369680|148712|P4|STARTED|Overall Study||3
64142|NCT01369680|148713|P3|STARTED|Overall Study||3
64143|NCT01369680|148714|P2|STARTED|Overall Study||3
64144|NCT01369680|148715|P1|STARTED|Overall Study||3
64145|NCT01369641|148736|P1|NOT COMPLETED|Overall Study||1
64146|NCT01369641|148736|P1|COMPLETED|Overall Study||0
64147|NCT01369641|148736|P1|STARTED|Overall Study||1
64148|NCT01369615|148742|P2|NOT COMPLETED|Overall Study||2
64149|NCT01369615|148743|P1|NOT COMPLETED|Overall Study||0
64150|NCT01369615|148742|P2|COMPLETED|Overall Study||12
64151|NCT01369615|148743|P1|COMPLETED|Overall Study||9
64152|NCT01369615|148742|P2|STARTED|Overall Study||14
64153|NCT01369615|148743|P1|STARTED|Overall Study||9
64154|NCT01369485|148751|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
64155|NCT01369485|148752|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
64156|NCT01369485|148751|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
64157|NCT01369485|148752|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
64158|NCT01369485|148751|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
64159|NCT01369485|148752|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
64160|NCT01369485|148751|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
64161|NCT01369485|148752|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
64162|NCT01369485|148751|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
64163|NCT01369485|148752|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
64164|NCT01369485|148751|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
64165|NCT01369485|148752|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
64166|NCT01369342|148795|P3|NOT COMPLETED|Overall Study||3
64167|NCT01369342|148796|P2|NOT COMPLETED|Overall Study||9
64168|NCT01369342|148797|P1|NOT COMPLETED|Overall Study||13
64169|NCT01369342|148795|P3|COMPLETED|Overall Study||210
64170|NCT01369342|148796|P2|COMPLETED|Overall Study||204
64171|NCT01369342|148797|P1|COMPLETED|Overall Study||201
64172|NCT01369342|148795|P3|STARTED|Overall Study||213
64173|NCT01369342|148796|P2|STARTED|Overall Study||213
64174|NCT01369342|148797|P1|STARTED|Overall Study||214
64175|NCT01369329|148820|P3|NOT COMPLETED|Overall Study||14
64176|NCT01369329|148821|P2|NOT COMPLETED|Overall Study||11
64177|NCT01369329|148822|P1|NOT COMPLETED|Overall Study||12
64178|NCT01369329|148820|P3|COMPLETED|Overall Study||245
64179|NCT01369329|148821|P2|COMPLETED|Overall Study||243
64180|NCT01369329|148822|P1|COMPLETED|Overall Study||244
64181|NCT01369329|148820|P3|STARTED|Overall Study||259
64182|NCT01369329|148821|P2|STARTED|Overall Study||254
64183|NCT01369329|148822|P1|STARTED|Overall Study||256
64184|NCT01369030|148842|P1|NOT COMPLETED|Overall Study||40
64185|NCT01369030|148842|P1|COMPLETED|Overall Study||554
64186|NCT01369030|148842|P1|STARTED|Overall Study||594
64187|NCT01368965|148848|P1|NOT COMPLETED|Overall Study||12
64188|NCT01368965|148848|P1|COMPLETED|Overall Study||40
64189|NCT01368965|148848|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
64190|NCT01368965|148848|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
64191|NCT01368900|148857|P1|NOT COMPLETED|Overall Study||7
64192|NCT01368900|148857|P1|COMPLETED|Overall Study||61
64193|NCT01368900|148857|P1|STARTED|Overall Study||68
64194|NCT01368874|148870|P3|NOT COMPLETED|Overall Study||1
64195|NCT01368874|148871|P2|NOT COMPLETED|Overall Study||0
64196|NCT01368874|148872|P1|NOT COMPLETED|Overall Study||3
64197|NCT01368874|148870|P3|COMPLETED|Overall Study||24
64198|NCT01368874|148871|P2|COMPLETED|Overall Study||5
64199|NCT01368874|148872|P1|COMPLETED|Overall Study||31
64200|NCT01368874|148870|P3|STARTED|Overall Study||25
64201|NCT01368874|148871|P2|STARTED|Overall Study||5
64202|NCT01368874|148872|P1|STARTED|Overall Study||34
64203|NCT01368835|148932|P1|NOT COMPLETED|Overall Study||33
64204|NCT01368835|148932|P1|COMPLETED|Overall Study||70
64205|NCT01368835|148932|P1|STARTED|Overall Study|103 Subjects Enrolled|103
64206|NCT01368809|148941|P2|NOT COMPLETED|Overall Study||0
64207|NCT01368809|148942|P1|NOT COMPLETED|Overall Study||0
64208|NCT01368809|148941|P2|COMPLETED|Overall Study||50
64209|NCT01368809|148942|P1|COMPLETED|Overall Study||50
64210|NCT01368809|148941|P2|STARTED|Overall Study||50
64211|NCT01368809|148942|P1|STARTED|Overall Study||50
64212|NCT01368653|148954|P2|NOT COMPLETED|Overall Study||9
64213|NCT01368653|148955|P1|NOT COMPLETED|Overall Study||6
64214|NCT01368653|148954|P2|COMPLETED|Overall Study||37
64215|NCT01368653|148955|P1|COMPLETED|Overall Study||41
64216|NCT01368653|148954|P2|Randomized to Advice Only in Phase 2|Overall Study||10
64217|NCT01368653|148955|P1|Randomized to Advice Only in Phase 2|Overall Study||10
64218|NCT01368653|148954|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
64219|NCT01368653|148955|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
64220|NCT01368653|148954|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
64221|NCT01368653|148955|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
64222|NCT01368653|148954|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
64223|NCT01368653|148955|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
64224|NCT01368653|148954|P2|Completed 4-week Follow-up|Overall Study||37
64225|NCT01368653|148955|P1|Completed 4-week Follow-up|Overall Study||44
64226|NCT01368653|148954|P2|STARTED|Overall Study||46
64227|NCT01368653|148955|P1|STARTED|Overall Study||47
64228|NCT01368536|148974|P3|NOT COMPLETED|Overall Study||59
64229|NCT01368536|148975|P2|NOT COMPLETED|Overall Study||59
64230|NCT01368536|148976|P1|NOT COMPLETED|Overall Study||51
64231|NCT01368536|148974|P3|COMPLETED|Overall Study||83
64232|NCT01368536|148975|P2|COMPLETED|Overall Study||78
64233|NCT01368536|148976|P1|COMPLETED|Overall Study||87
64234|NCT01368536|148974|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
64235|NCT01368536|148975|P2|Full Analysis Set|Overall Study||137
64236|NCT01368536|148976|P1|Full Analysis Set|Overall Study||138
64237|NCT01368536|148974|P3|STARTED|Overall Study||142
64238|NCT01368536|148975|P2|STARTED|Overall Study||137
64239|NCT01368536|148976|P1|STARTED|Overall Study||138
64240|NCT01368432|148999|P2|NOT COMPLETED|Overall Study||1
64241|NCT01368432|149000|P1|NOT COMPLETED|Overall Study||0
64242|NCT01368432|148999|P2|COMPLETED|Overall Study||7
64243|NCT01368432|149000|P1|COMPLETED|Overall Study||6
64244|NCT01368432|148999|P2|STARTED|Overall Study||8
64245|NCT01368432|149000|P1|STARTED|Overall Study||6
64246|NCT01368406|149034|P2|NOT COMPLETED|Overall Study||13
64247|NCT01368406|149035|P1|NOT COMPLETED|Overall Study||21
64248|NCT01368406|149034|P2|COMPLETED|Overall Study||66
64249|NCT01368406|149035|P1|COMPLETED|Overall Study||60
64250|NCT01368406|149034|P2|STARTED|Overall Study||79
64251|NCT01368406|149035|P1|STARTED|Overall Study||81
64252|NCT01368276|149043|P2|NOT COMPLETED|Overall Study||10
64253|NCT01368276|149044|P1|NOT COMPLETED|Overall Study||1
64254|NCT01368276|149043|P2|COMPLETED|Overall Study||18
64255|NCT01368276|149044|P1|COMPLETED|Overall Study||2
64256|NCT01368276|149043|P2|STARTED|Overall Study||28
64257|NCT01368276|149044|P1|STARTED|Overall Study||3
64258|NCT01368263|149057|P3|NOT COMPLETED|Overall Study||0
64259|NCT01368263|149058|P2|NOT COMPLETED|Overall Study||0
64260|NCT01368263|149059|P1|NOT COMPLETED|Overall Study||0
64261|NCT01368263|149057|P3|COMPLETED|Overall Study||1
64262|NCT01368263|149058|P2|COMPLETED|Overall Study||1
64263|NCT01368263|149059|P1|COMPLETED|Overall Study||6
64264|NCT01368263|149057|P3|STARTED|Overall Study||1
64265|NCT01368263|149058|P2|STARTED|Overall Study||1
64266|NCT01368263|149059|P1|STARTED|Overall Study||6
64267|NCT01368211|149081|P2|NOT COMPLETED|Second Platelets Transfusion||2
64268|NCT01368211|149082|P1|NOT COMPLETED|Second Platelets Transfusion||1
64269|NCT01368211|149081|P2|COMPLETED|Second Platelets Transfusion||5
64270|NCT01368211|149082|P1|COMPLETED|Second Platelets Transfusion||7
64271|NCT01368211|149081|P2|STARTED|Second Platelets Transfusion||7
64272|NCT01368211|149082|P1|STARTED|Second Platelets Transfusion||8
64273|NCT01368211|149081|P2|NOT COMPLETED|First Platelets Transfusion||0
64274|NCT01368211|149082|P1|NOT COMPLETED|First Platelets Transfusion||0
64275|NCT01368211|149081|P2|COMPLETED|First Platelets Transfusion||7
64276|NCT01368211|149082|P1|COMPLETED|First Platelets Transfusion||8
64277|NCT01368211|149081|P2|STARTED|First Platelets Transfusion||7
64278|NCT01368211|149082|P1|STARTED|First Platelets Transfusion||8
64279|NCT01368185|149090|P1|NOT COMPLETED|Overall Study||0
64280|NCT01368185|149090|P1|COMPLETED|Overall Study||1705
64281|NCT01368185|149090|P1|STARTED|Overall Study||1705
64282|NCT01368081|149110|P13|NOT COMPLETED|Overall Study||7
64283|NCT01368081|149111|P12|NOT COMPLETED|Overall Study||3
64284|NCT01368081|149112|P11|NOT COMPLETED|Overall Study||9
64285|NCT01368081|149113|P10|NOT COMPLETED|Overall Study||10
64286|NCT01368081|149114|P9|NOT COMPLETED|Overall Study||8
64287|NCT01368081|149115|P8|NOT COMPLETED|Overall Study||7
64288|NCT01368081|149116|P7|NOT COMPLETED|Overall Study||12
64289|NCT01368081|149117|P6|NOT COMPLETED|Overall Study||10
64290|NCT01368081|149118|P5|NOT COMPLETED|Overall Study||2
64291|NCT01368081|149119|P4|NOT COMPLETED|Overall Study||5
64292|NCT01368081|149120|P3|NOT COMPLETED|Overall Study||4
64293|NCT01368081|149121|P2|NOT COMPLETED|Overall Study||9
64294|NCT01368081|149122|P1|NOT COMPLETED|Overall Study||10
64295|NCT01368081|149110|P13|COMPLETED|Overall Study||63
64296|NCT01368081|149111|P12|COMPLETED|Overall Study||67
64297|NCT01368081|149112|P11|COMPLETED|Overall Study||62
64298|NCT01368081|149113|P10|COMPLETED|Overall Study||58
64299|NCT01368081|149114|P9|COMPLETED|Overall Study||62
64300|NCT01368081|149115|P8|COMPLETED|Overall Study||62
64301|NCT01368081|149116|P7|COMPLETED|Overall Study||124
64302|NCT01368081|149117|P6|COMPLETED|Overall Study||127
64303|NCT01368081|149118|P5|COMPLETED|Overall Study||63
64304|NCT01368081|149119|P4|COMPLETED|Overall Study||63
64305|NCT01368081|149120|P3|COMPLETED|Overall Study||59
64306|NCT01368081|149121|P2|COMPLETED|Overall Study||128
64307|NCT01368081|149122|P1|COMPLETED|Overall Study||126
64308|NCT01368081|149110|P13|STARTED|Overall Study||70
64309|NCT01368081|149111|P12|STARTED|Overall Study||70
64310|NCT01368081|149112|P11|STARTED|Overall Study||71
64311|NCT01368081|149113|P10|STARTED|Overall Study||68
64312|NCT01368081|149114|P9|STARTED|Overall Study||70
64313|NCT01368081|149115|P8|STARTED|Overall Study||69
64314|NCT01368081|149116|P7|STARTED|Overall Study||136
64315|NCT01368081|149117|P6|STARTED|Overall Study||137
64316|NCT01368081|149118|P5|STARTED|Overall Study||65
64317|NCT01368081|149119|P4|STARTED|Overall Study||68
64318|NCT01368081|149120|P3|STARTED|Overall Study||63
64319|NCT01368081|149121|P2|STARTED|Overall Study||137
64320|NCT01368081|149122|P1|STARTED|Overall Study||136
64321|NCT01368042|149176|P1|NOT COMPLETED|Overall Study||30
64322|NCT01368042|149176|P1|COMPLETED|Overall Study||235
64323|NCT01368042|149176|P1|STARTED|Overall Study||265
64324|NCT01367886|149196|P1|NOT COMPLETED|Overall Study||7
64325|NCT01367886|149196|P1|COMPLETED|Overall Study||14
64326|NCT01367886|149196|P1|STARTED|Overall Study||21
64327|NCT01367860|149205|P2|NOT COMPLETED|Overall Study||0
64328|NCT01367860|149206|P1|NOT COMPLETED|Overall Study||0
64329|NCT01367860|149205|P2|COMPLETED|Overall Study||20
64330|NCT01367860|149206|P1|COMPLETED|Overall Study||20
64331|NCT01367860|149205|P2|STARTED|Overall Study||20
64332|NCT01367860|149206|P1|STARTED|Overall Study||20
64333|NCT01367704|149246|P2|NOT COMPLETED|Overall Study||161
64334|NCT01367704|149247|P1|NOT COMPLETED|Overall Study||47
64335|NCT01367704|149246|P2|COMPLETED|Overall Study||847
64336|NCT01367704|149247|P1|COMPLETED|Overall Study||951
64337|NCT01367704|149246|P2|STARTED|Overall Study||1008
64338|NCT01367704|149247|P1|STARTED|Overall Study||998
64339|NCT01367665|149259|P2|NOT COMPLETED|Overall Study||24
64340|NCT01367665|149260|P1|NOT COMPLETED|Overall Study||377
64341|NCT01367665|149259|P2|COMPLETED|Overall Study||7
64342|NCT01367665|149260|P1|COMPLETED|Overall Study||93
64343|NCT01367665|149259|P2|STARTED|Overall Study||31
64344|NCT01367665|149260|P1|STARTED|Overall Study||470
64345|NCT01367457|149269|P3|NOT COMPLETED|Overall Study||0
64346|NCT01367457|149270|P2|NOT COMPLETED|Overall Study||0
64347|NCT01367457|149271|P1|NOT COMPLETED|Overall Study||188
64348|NCT01367457|149269|P3|COMPLETED|Overall Study||26
64349|NCT01367457|149270|P2|COMPLETED|Overall Study||23
64350|NCT01367457|149271|P1|COMPLETED|Overall Study||5
64351|NCT01367457|149269|P3|STARTED|Overall Study||26
64352|NCT01367457|149270|P2|STARTED|Overall Study||23
64353|NCT01367457|149271|P1|STARTED|Overall Study||193
64354|NCT01367249|149293|P2|NOT COMPLETED|Overall Study||16
64355|NCT01367249|149294|P1|NOT COMPLETED|Overall Study||9
64356|NCT01367249|149293|P2|COMPLETED|Overall Study||202
64357|NCT01367249|149294|P1|COMPLETED|Overall Study||213
64358|NCT01367249|149293|P2|STARTED|Overall Study||218
64359|NCT01367249|149294|P1|STARTED|Overall Study||222
64360|NCT01367158|149313|P11|NOT COMPLETED|Overall Study||1
64361|NCT01367158|149314|P10|NOT COMPLETED|Overall Study||0
64362|NCT01367158|149315|P9|NOT COMPLETED|Overall Study||0
64363|NCT01367158|149316|P8|NOT COMPLETED|Overall Study||2
64364|NCT01367158|149317|P7|NOT COMPLETED|Overall Study||0
64365|NCT01367158|149318|P6|NOT COMPLETED|Overall Study||2
64366|NCT01367158|149319|P5|NOT COMPLETED|Overall Study||2
64367|NCT01367158|149320|P4|NOT COMPLETED|Overall Study||1
64368|NCT01367158|149321|P3|NOT COMPLETED|Overall Study||1
64369|NCT01367158|149322|P2|NOT COMPLETED|Overall Study||3
64370|NCT01367158|149323|P1|NOT COMPLETED|Overall Study||0
64371|NCT01367158|149313|P11|COMPLETED|Overall Study||72
64372|NCT01367158|149314|P10|COMPLETED|Overall Study||50
64373|NCT01367158|149315|P9|COMPLETED|Overall Study||23
64374|NCT01367158|149316|P8|COMPLETED|Overall Study||47
64375|NCT01367158|149317|P7|COMPLETED|Overall Study||25
64376|NCT01367158|149318|P6|COMPLETED|Overall Study||46
64377|NCT01367158|149319|P5|COMPLETED|Overall Study||23
64378|NCT01367158|149320|P4|COMPLETED|Overall Study||48
64379|NCT01367158|149321|P3|COMPLETED|Overall Study||23
64380|NCT01367158|149322|P2|COMPLETED|Overall Study||46
64381|NCT01367158|149323|P1|COMPLETED|Overall Study||25
64382|NCT01367158|149313|P11|STARTED|Overall Study||73
64383|NCT01367158|149314|P10|STARTED|Overall Study||50
64384|NCT01367158|149315|P9|STARTED|Overall Study||23
64385|NCT01367158|149316|P8|STARTED|Overall Study||49
64386|NCT01367158|149317|P7|STARTED|Overall Study||25
64387|NCT01367158|149318|P6|STARTED|Overall Study||48
64388|NCT01367158|149319|P5|STARTED|Overall Study||25
64389|NCT01367158|149320|P4|STARTED|Overall Study||49
64390|NCT01367158|149321|P3|STARTED|Overall Study||24
64391|NCT01367158|149322|P2|STARTED|Overall Study||49
64392|NCT01367158|149323|P1|STARTED|Overall Study||25
64393|NCT01367119|149467|P2|NOT COMPLETED|Overall Study||1
64394|NCT01367119|149468|P1|NOT COMPLETED|Overall Study||2
64395|NCT01367119|149467|P2|COMPLETED|Overall Study||16
64396|NCT01367119|149468|P1|COMPLETED|Overall Study||19
64397|NCT01367119|149467|P2|STARTED|Overall Study||17
64398|NCT01367119|149468|P1|STARTED|Overall Study||21
64399|NCT01367080|149480|P2|NOT COMPLETED|2nd Administration||0
64400|NCT01367080|149481|P1|NOT COMPLETED|2nd Administration||0
64401|NCT01367080|149480|P2|COMPLETED|2nd Administration||6
64402|NCT01367080|149481|P1|COMPLETED|2nd Administration||6
64403|NCT01367080|149480|P2|STARTED|2nd Administration||6
64404|NCT01367080|149481|P1|STARTED|2nd Administration||6
64405|NCT01367080|149480|P2|NOT COMPLETED|1st Administration||0
64406|NCT01367080|149481|P1|NOT COMPLETED|1st Administration||0
64407|NCT01367080|149480|P2|COMPLETED|1st Administration||6
64408|NCT01367080|149481|P1|COMPLETED|1st Administration||6
64409|NCT01367080|149480|P2|STARTED|1st Administration||6
64410|NCT01367080|149481|P1|STARTED|1st Administration||6
64411|NCT01366976|149495|P2|NOT COMPLETED|Overall Study||0
64412|NCT01366976|149496|P1|NOT COMPLETED|Overall Study||0
64413|NCT01366976|149495|P2|COMPLETED|Overall Study||30
64414|NCT01366976|149496|P1|COMPLETED|Overall Study||30
64415|NCT01366976|149495|P2|STARTED|Overall Study||30
64416|NCT01366976|149496|P1|STARTED|Overall Study||30
64417|NCT01366885|149508|P1|NOT COMPLETED|Overall Study||1
64418|NCT01366885|149508|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
64506|NCT01364558|149711|P1|COMPLETED|Dose Two||8
64419|NCT01366885|149508|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
64420|NCT01366872|149513|P1|NOT COMPLETED|Overall Study||0
64421|NCT01366872|149513|P1|COMPLETED|Overall Study||50
64422|NCT01366872|149513|P1|STARTED|Overall Study||50
64423|NCT01366846|149523|P2|NOT COMPLETED|Overall Study||5
64424|NCT01366846|149524|P1|NOT COMPLETED|Overall Study||4
64425|NCT01366846|149523|P2|COMPLETED|Overall Study||269
64426|NCT01366846|149524|P1|COMPLETED|Overall Study||278
64427|NCT01366846|149523|P2|STARTED|Overall Study||274
64428|NCT01366846|149524|P1|STARTED|Overall Study||282
64429|NCT01366638|149547|P3|NOT COMPLETED|Overall Study||6
64430|NCT01366638|149548|P2|NOT COMPLETED|Overall Study||0
64431|NCT01366638|149549|P1|NOT COMPLETED|Overall Study||1
64432|NCT01366638|149547|P3|COMPLETED|Overall Study||20
64433|NCT01366638|149548|P2|COMPLETED|Overall Study||29
64434|NCT01366638|149549|P1|COMPLETED|Overall Study||23
64435|NCT01366638|149547|P3|STARTED|Overall Study||26
64436|NCT01366638|149548|P2|STARTED|Overall Study||29
64437|NCT01366638|149549|P1|STARTED|Overall Study||24
64438|NCT01366521|149587|P4|NOT COMPLETED|Overall Study||0
64439|NCT01366521|149588|P3|NOT COMPLETED|Overall Study||2
64440|NCT01366521|149589|P2|NOT COMPLETED|Overall Study||1
64441|NCT01366521|149590|P1|NOT COMPLETED|Overall Study||1
64442|NCT01366521|149587|P4|COMPLETED|Overall Study||11
64443|NCT01366521|149588|P3|COMPLETED|Overall Study||21
64444|NCT01366521|149589|P2|COMPLETED|Overall Study||14
64445|NCT01366521|149590|P1|COMPLETED|Overall Study||20
64446|NCT01366521|149587|P4|STARTED|Overall Study||11
64447|NCT01366521|149588|P3|STARTED|Overall Study||23
64448|NCT01366521|149589|P2|STARTED|Overall Study||15
64449|NCT01366521|149590|P1|STARTED|Overall Study||21
64450|NCT01366443|149665|P1|NOT COMPLETED|Overall Study||3
64451|NCT01366443|149665|P1|COMPLETED|Overall Study||285
64452|NCT01366443|149665|P1|STARTED|Overall Study||288
64453|NCT01366417|149670|P1|NOT COMPLETED|Overall Study||18
64454|NCT01366417|149670|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
64455|NCT01366417|149670|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
64456|NCT01366417|149670|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
64457|NCT01366417|149670|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
64458|NCT01366417|149670|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
64459|NCT01366417|149670|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
64460|NCT01366417|149670|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
64461|NCT01366417|149670|P1|STARTED|Overall Study||43
64462|NCT01366209|149679|P2|NOT COMPLETED|Overall Study||36
64463|NCT01366209|149680|P1|NOT COMPLETED|Overall Study||35
64464|NCT01366209|149679|P2|COMPLETED|Overall Study||241
64465|NCT01366209|149680|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
64466|NCT01366209|149679|P2|STARTED|Overall Study||277
64467|NCT01366209|149680|P1|STARTED|Overall Study||278
64468|NCT01366092|149686|P1|NOT COMPLETED|Overall Study||4
64469|NCT01366092|149686|P1|COMPLETED|Overall Study||31
64470|NCT01366092|149686|P1|STARTED|Overall Study||35
64471|NCT01365910|149695|P1|NOT COMPLETED|Overall Study||30
64472|NCT01365910|149695|P1|COMPLETED|Overall Study||0
64473|NCT01365910|149695|P1|STARTED|Overall Study||30
64474|NCT01365845|149702|P3|NOT COMPLETED|Treatment Phase||0
64475|NCT01365845|149703|P2|NOT COMPLETED|Treatment Phase||0
64476|NCT01365845|149704|P1|NOT COMPLETED|Treatment Phase||0
64477|NCT01365845|149702|P3|COMPLETED|Treatment Phase||18
64478|NCT01365845|149703|P2|COMPLETED|Treatment Phase||0
64479|NCT01365845|149704|P1|COMPLETED|Treatment Phase||0
64480|NCT01365845|149702|P3|STARTED|Treatment Phase||18
64481|NCT01365845|149703|P2|STARTED|Treatment Phase||0
64482|NCT01365845|149704|P1|STARTED|Treatment Phase||0
64483|NCT01365845|149702|P3|NOT COMPLETED|Induction Phase||0
64484|NCT01365845|149703|P2|NOT COMPLETED|Induction Phase||0
64485|NCT01365845|149704|P1|NOT COMPLETED|Induction Phase||0
64486|NCT01365845|149702|P3|COMPLETED|Induction Phase||0
64487|NCT01365845|149703|P2|COMPLETED|Induction Phase||0
64488|NCT01365845|149704|P1|COMPLETED|Induction Phase||18
64489|NCT01365845|149702|P3|STARTED|Induction Phase||0
64490|NCT01365845|149703|P2|STARTED|Induction Phase||0
64491|NCT01365845|149704|P1|STARTED|Induction Phase||18
64492|NCT01364558|149709|P3|NOT COMPLETED|Dose Three||0
64493|NCT01364558|149710|P2|NOT COMPLETED|Dose Three||0
64494|NCT01364558|149711|P1|NOT COMPLETED|Dose Three||0
64495|NCT01364558|149709|P3|COMPLETED|Dose Three||8
64496|NCT01364558|149710|P2|COMPLETED|Dose Three||8
64497|NCT01364558|149711|P1|COMPLETED|Dose Three||8
64498|NCT01364558|149709|P3|STARTED|Dose Three||8
64499|NCT01364558|149710|P2|STARTED|Dose Three||8
64500|NCT01364558|149711|P1|STARTED|Dose Three||8
64501|NCT01364558|149709|P3|NOT COMPLETED|Dose Two||0
64502|NCT01364558|149710|P2|NOT COMPLETED|Dose Two||0
64503|NCT01364558|149711|P1|NOT COMPLETED|Dose Two||0
64504|NCT01364558|149709|P3|COMPLETED|Dose Two||8
64505|NCT01364558|149710|P2|COMPLETED|Dose Two||8
64507|NCT01364558|149709|P3|STARTED|Dose Two||8
64508|NCT01364558|149710|P2|STARTED|Dose Two||8
64509|NCT01364558|149711|P1|STARTED|Dose Two||8
64510|NCT01364558|149709|P3|NOT COMPLETED|Dose One||0
64511|NCT01364558|149710|P2|NOT COMPLETED|Dose One||0
64512|NCT01364558|149711|P1|NOT COMPLETED|Dose One||0
64513|NCT01364558|149709|P3|COMPLETED|Dose One||8
64514|NCT01364558|149710|P2|COMPLETED|Dose One||8
64515|NCT01364558|149711|P1|COMPLETED|Dose One||8
64516|NCT01364558|149709|P3|STARTED|Dose One||8
64517|NCT01364558|149710|P2|STARTED|Dose One||8
64518|NCT01364558|149711|P1|STARTED|Dose One||8
64519|NCT01365650|149719|P1|NOT COMPLETED|Treatment C||0
64520|NCT01365650|149719|P1|COMPLETED|Treatment C||24
64521|NCT01365650|149719|P1|STARTED|Treatment C||24
64522|NCT01365650|149719|P1|NOT COMPLETED|Treatment B||0
64523|NCT01365650|149719|P1|COMPLETED|Treatment B||24
64524|NCT01365650|149719|P1|STARTED|Treatment B||24
64525|NCT01365650|149719|P1|NOT COMPLETED|Treatment A||0
64526|NCT01365650|149719|P1|COMPLETED|Treatment A||24
64527|NCT01365650|149719|P1|STARTED|Treatment A||24
64528|NCT01365624|149744|P2|NOT COMPLETED|Overall Study||0
64529|NCT01365624|149745|P1|NOT COMPLETED|Overall Study||0
64530|NCT01365624|149744|P2|COMPLETED|Overall Study||15
64531|NCT01365624|149745|P1|COMPLETED|Overall Study||15
64532|NCT01365624|149744|P2|STARTED|Overall Study||15
64533|NCT01365624|149745|P1|STARTED|Overall Study||15
64534|NCT01365611|149761|P1|NOT COMPLETED|Overall Study||0
64535|NCT01365611|149761|P1|COMPLETED|Overall Study||36
64536|NCT01365611|149761|P1|STARTED|Overall Study||36
64537|NCT01365585|149777|P1|NOT COMPLETED|Overall Study||0
64538|NCT01365585|149777|P1|COMPLETED|Overall Study||227
64539|NCT01365585|149777|P1|STARTED|Overall Study||227
64540|NCT01365546|149791|P1|NOT COMPLETED|Overall Study||11
64541|NCT01365546|149791|P1|COMPLETED|Overall Study||30
64542|NCT01365546|149791|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
64543|NCT01365507|149801|P2|NOT COMPLETED|Overall Study||9
64544|NCT01365507|149802|P1|NOT COMPLETED|Overall Study||9
64545|NCT01365507|149801|P2|COMPLETED|Overall Study||131
64546|NCT01365507|149802|P1|COMPLETED|Overall Study||127
64547|NCT01365507|149801|P2|Exposed|Overall Study||140
64548|NCT01365507|149802|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
64549|NCT01365507|149801|P2|STARTED|Overall Study||140
64550|NCT01365507|149802|P1|STARTED|Overall Study||136
64551|NCT01365494|149818|P2|NOT COMPLETED|Overall Study||3
64552|NCT01365494|149819|P1|NOT COMPLETED|Overall Study||2
64553|NCT01365494|149818|P2|COMPLETED|Overall Study||121
64554|NCT01365494|149819|P1|COMPLETED|Overall Study||124
64555|NCT01365494|149818|P2|STARTED|Overall Study||124
64556|NCT01365494|149819|P1|STARTED|Overall Study||126
64557|NCT01365481|149835|P4|NOT COMPLETED|Overall Study||7
64558|NCT01365481|149836|P3|NOT COMPLETED|Overall Study||4
64559|NCT01365481|149837|P2|NOT COMPLETED|Overall Study||15
64560|NCT01365481|149838|P1|NOT COMPLETED|Overall Study||7
64561|NCT01365481|149835|P4|COMPLETED|Overall Study||50
64562|NCT01365481|149836|P3|COMPLETED|Overall Study||14
64563|NCT01365481|149837|P2|COMPLETED|Overall Study||37
64564|NCT01365481|149838|P1|COMPLETED|Overall Study||16
64565|NCT01365481|149835|P4|STARTED|Overall Study||57
64566|NCT01365481|149836|P3|STARTED|Overall Study||18
64567|NCT01365481|149837|P2|STARTED|Overall Study||52
64568|NCT01365481|149838|P1|STARTED|Overall Study||23
64569|NCT01365468|149858|P2|NOT COMPLETED|Overall Study||0
64570|NCT01365468|149859|P1|NOT COMPLETED|Overall Study||4
64571|NCT01365468|149858|P2|COMPLETED|Overall Study||5
64572|NCT01365468|149859|P1|COMPLETED|Overall Study||0
64573|NCT01365468|149858|P2|STARTED|Overall Study||5
64574|NCT01365468|149859|P1|STARTED|Overall Study||4
64575|NCT01365455|149874|P5|NOT COMPLETED|Follow-up Period||0
64576|NCT01365455|149875|P4|NOT COMPLETED|Follow-up Period||0
64577|NCT01365455|149876|P3|NOT COMPLETED|Follow-up Period||0
64578|NCT01365455|149877|P2|NOT COMPLETED|Follow-up Period||0
64579|NCT01365455|149878|P1|NOT COMPLETED|Follow-up Period||0
64580|NCT01365455|149874|P5|COMPLETED|Follow-up Period||0
64581|NCT01365455|149875|P4|COMPLETED|Follow-up Period||0
64582|NCT01365455|149876|P3|COMPLETED|Follow-up Period||18
64583|NCT01365455|149877|P2|COMPLETED|Follow-up Period||47
64584|NCT01365455|149878|P1|COMPLETED|Follow-up Period||58
64585|NCT01365455|149874|P5|STARTED|Follow-up Period||0
64586|NCT01365455|149875|P4|STARTED|Follow-up Period||0
64587|NCT01365455|149876|P3|STARTED|Follow-up Period||18
64588|NCT01365455|149877|P2|STARTED|Follow-up Period||47
64589|NCT01365455|149878|P1|STARTED|Follow-up Period||58
64590|NCT01365455|149874|P5|NOT COMPLETED|Maintenance Period||13
64591|NCT01365455|149875|P4|NOT COMPLETED|Maintenance Period||9
64592|NCT01365455|149876|P3|NOT COMPLETED|Maintenance Period||3
64593|NCT01365455|149877|P2|NOT COMPLETED|Maintenance Period||23
64594|NCT01365455|149878|P1|NOT COMPLETED|Maintenance Period||29
64595|NCT01365455|149874|P5|COMPLETED|Maintenance Period||92
64596|NCT01365455|149875|P4|COMPLETED|Maintenance Period||100
64597|NCT01365455|149876|P3|COMPLETED|Maintenance Period||15
64598|NCT01365455|149877|P2|COMPLETED|Maintenance Period||215
64599|NCT01365455|149878|P1|COMPLETED|Maintenance Period||201
64600|NCT01365455|149874|P5|STARTED|Maintenance Period||105
64601|NCT01365455|149875|P4|STARTED|Maintenance Period||109
64602|NCT01365455|149876|P3|STARTED|Maintenance Period||18
64603|NCT01365455|149877|P2|STARTED|Maintenance Period||238
64604|NCT01365455|149878|P1|STARTED|Maintenance Period||230
64605|NCT01365455|149874|P5|NOT COMPLETED|Induction Period||0
64606|NCT01365455|149875|P4|NOT COMPLETED|Induction Period||0
64607|NCT01365455|149876|P3|NOT COMPLETED|Induction Period||16
64608|NCT01365455|149877|P2|NOT COMPLETED|Induction Period||7
64609|NCT01365455|149878|P1|NOT COMPLETED|Induction Period||15
64610|NCT01365455|149874|P5|COMPLETED|Induction Period||0
64611|NCT01365455|149875|P4|COMPLETED|Induction Period||0
64612|NCT01365455|149876|P3|COMPLETED|Induction Period||232
64613|NCT01365455|149877|P2|COMPLETED|Induction Period||238
64614|NCT01365455|149878|P1|COMPLETED|Induction Period||230
64615|NCT01365455|149874|P5|STARTED|Induction Period||0
64616|NCT01365455|149875|P4|STARTED|Induction Period||0
64617|NCT01365455|149876|P3|STARTED|Induction Period||248
64618|NCT01365455|149877|P2|STARTED|Induction Period||245
64619|NCT01365455|149878|P1|STARTED|Induction Period||245
64620|NCT01365273|149968|P2|NOT COMPLETED|Overall Study||1
64621|NCT01365273|149969|P1|NOT COMPLETED|Overall Study||2
64622|NCT01365273|149968|P2|COMPLETED|Overall Study||20
64623|NCT01365273|149969|P1|COMPLETED|Overall Study||20
64624|NCT01365273|149968|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
64625|NCT01365273|149969|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
64626|NCT01365273|149968|P2|STARTED|Overall Study||21
64627|NCT01365273|149969|P1|STARTED|Overall Study||22
64628|NCT01365130|149979|P1|NOT COMPLETED|Overall Study||2
64629|NCT01365130|149979|P1|COMPLETED|Overall Study||13
64630|NCT01365130|149979|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
64631|NCT01365091|149987|P4|NOT COMPLETED|Period 2||0
64632|NCT01365091|149988|P3|NOT COMPLETED|Period 2||1
64633|NCT01365091|149989|P2|NOT COMPLETED|Period 2||0
64634|NCT01365091|149990|P1|NOT COMPLETED|Period 2||1
64635|NCT01365091|149987|P4|COMPLETED|Period 2||25
64636|NCT01365091|149988|P3|COMPLETED|Period 2||24
64637|NCT01365091|149989|P2|COMPLETED|Period 2||26
64638|NCT01365091|149990|P1|COMPLETED|Period 2||25
64639|NCT01365091|149987|P4|STARTED|Period 2||25
64640|NCT01365091|149988|P3|STARTED|Period 2||25
64641|NCT01365091|149989|P2|STARTED|Period 2||26
64642|NCT01365091|149990|P1|STARTED|Period 2||26
64643|NCT01365091|149987|P4|NOT COMPLETED|Period 1||3
64644|NCT01365091|149988|P3|NOT COMPLETED|Period 1||3
64645|NCT01365091|149989|P2|NOT COMPLETED|Period 1||2
64646|NCT01365091|149990|P1|NOT COMPLETED|Period 1||2
64647|NCT01365091|149987|P4|COMPLETED|Period 1||25
64648|NCT01365091|149988|P3|COMPLETED|Period 1||25
64649|NCT01365091|149989|P2|COMPLETED|Period 1||26
64650|NCT01365091|149990|P1|COMPLETED|Period 1||26
64651|NCT01365091|149987|P4|STARTED|Period 1||28
64652|NCT01365091|149988|P3|STARTED|Period 1||28
64653|NCT01365091|149989|P2|STARTED|Period 1||28
64654|NCT01365091|149990|P1|STARTED|Period 1||28
64655|NCT01365052|150018|P2|NOT COMPLETED|Overall Study||4
64656|NCT01365052|150019|P1|NOT COMPLETED|Overall Study||4
64657|NCT01365052|150018|P2|COMPLETED|Overall Study||105
64658|NCT01365052|150019|P1|COMPLETED|Overall Study||213
64659|NCT01365052|150018|P2|STARTED|Overall Study||109
64660|NCT01365052|150019|P1|STARTED|Overall Study||217
64661|NCT01365039|150035|P2|NOT COMPLETED|Overall Study||0
64662|NCT01365039|150036|P1|NOT COMPLETED|Overall Study||1
64663|NCT01365039|150035|P2|COMPLETED|Overall Study||87
64664|NCT01365039|150036|P1|COMPLETED|Overall Study||85
64665|NCT01365039|150035|P2|STARTED|Overall Study||87
64666|NCT01365039|150036|P1|STARTED|Overall Study||86
64667|NCT01364922|150047|P3|NOT COMPLETED|Double-Blind (DB) Period||5
64668|NCT01364922|150048|P2|NOT COMPLETED|Double-Blind (DB) Period||5
64669|NCT01364922|150049|P1|NOT COMPLETED|Double-Blind (DB) Period||0
64670|NCT01364922|150047|P3|COMPLETED|Double-Blind (DB) Period||42
64671|NCT01364922|150048|P2|COMPLETED|Double-Blind (DB) Period||94
64672|NCT01364922|150049|P1|COMPLETED|Double-Blind (DB) Period||0
64673|NCT01364922|150047|P3|STARTED|Double-Blind (DB) Period||47
64674|NCT01364922|150048|P2|STARTED|Double-Blind (DB) Period||99
64675|NCT01364922|150049|P1|STARTED|Double-Blind (DB) Period||0
64676|NCT01364922|150047|P3|NOT COMPLETED|Open-label (OL) Period||0
64677|NCT01364922|150048|P2|NOT COMPLETED|Open-label (OL) Period||0
64678|NCT01364922|150049|P1|NOT COMPLETED|Open-label (OL) Period||22
64679|NCT01364922|150047|P3|COMPLETED|Open-label (OL) Period||0
64680|NCT01364922|150048|P2|COMPLETED|Open-label (OL) Period||0
64681|NCT01364922|150049|P1|COMPLETED|Open-label (OL) Period||146
64682|NCT01364922|150047|P3|STARTED|Open-label (OL) Period||0
64683|NCT01364922|150048|P2|STARTED|Open-label (OL) Period||0
64684|NCT01364922|150049|P1|STARTED|Open-label (OL) Period||168
64685|NCT01364896|150060|P1|NOT COMPLETED|Overall Study||0
64686|NCT01364896|150060|P1|COMPLETED|Overall Study||46
64687|NCT01364896|150060|P1|STARTED|Overall Study||46
64688|NCT01364740|150068|P1|NOT COMPLETED|Overall Study||0
64689|NCT01364740|150068|P1|COMPLETED|Overall Study||10
64690|NCT01364740|150068|P1|STARTED|Overall Study||10
64691|NCT01364649|150078|P2|NOT COMPLETED|Overall Study||43
64692|NCT01364649|150079|P1|NOT COMPLETED|Overall Study||56
64693|NCT01364649|150078|P2|COMPLETED|Overall Study||179
64694|NCT01364649|150079|P1|COMPLETED|Overall Study||169
64695|NCT01364649|150078|P2|STARTED|Overall Study||222
64696|NCT01364649|150079|P1|STARTED|Overall Study||225
64697|NCT01364428|150091|P2|NOT COMPLETED|Overall Study||15
64698|NCT01364428|150092|P1|NOT COMPLETED|Overall Study||20
64699|NCT01364428|150091|P2|COMPLETED|Overall Study||172
64700|NCT01364428|150092|P1|COMPLETED|Overall Study||166
64701|NCT01364428|150091|P2|Exposed|Overall Study||187
64702|NCT01364428|150092|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
64703|NCT01364428|150091|P2|STARTED|Overall Study||187
64704|NCT01364428|150092|P1|STARTED|Overall Study||186
64705|NCT01364389|150109|P3|NOT COMPLETED|Overall Study||1
64706|NCT01364389|150110|P2|NOT COMPLETED|Overall Study||1
64707|NCT01364389|150111|P1|NOT COMPLETED|Overall Study||2
64708|NCT01364389|150109|P3|COMPLETED|Overall Study||4
64709|NCT01364389|150110|P2|COMPLETED|Overall Study||5
64710|NCT01364389|150111|P1|COMPLETED|Overall Study||3
64711|NCT01364389|150109|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
64712|NCT01364389|150110|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
64713|NCT01364389|150111|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
64714|NCT01364389|150109|P3|STARTED|Overall Study||5
64715|NCT01364389|150110|P2|STARTED|Overall Study||6
64716|NCT01364389|150111|P1|STARTED|Overall Study||5
64717|NCT01364298|150130|P2|NOT COMPLETED|Overall Study||23
64718|NCT01364298|150131|P1|NOT COMPLETED|Overall Study||14
64719|NCT01364298|150130|P2|COMPLETED|Overall Study||154
64720|NCT01364298|150131|P1|COMPLETED|Overall Study||162
64721|NCT01364298|150130|P2|Treated|Overall Study||174
64722|NCT01364298|150131|P1|Treated|Overall Study||174
64723|NCT01364298|150130|P2|STARTED|Overall Study||177
64724|NCT01364298|150131|P1|STARTED|Overall Study||176
64725|NCT01364207|150153|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
64726|NCT01364207|150154|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
64727|NCT01364207|150153|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
64728|NCT01364207|150154|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
64729|NCT01364207|150153|P2|STARTED|Second Visit (~1.5-2 Hours)||54
64730|NCT01364207|150154|P1|STARTED|Second Visit (~1.5-2 Hours)||52
64731|NCT01364207|150153|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
64732|NCT01364207|150154|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
64733|NCT01364207|150153|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
64734|NCT01364207|150154|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
64735|NCT01364207|150153|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
64736|NCT01364207|150154|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
64737|NCT01364207|150153|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
64738|NCT01364207|150154|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
64739|NCT01364207|150153|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
64740|NCT01364207|150154|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
64741|NCT01364207|150153|P2|STARTED|First Visit (~1.5-2 Hours)||58
64742|NCT01364207|150154|P1|STARTED|First Visit (~1.5-2 Hours)||54
64743|NCT01363986|150162|P1|NOT COMPLETED|Overall Study||1
64744|NCT01363986|150162|P1|COMPLETED|Overall Study||2
64745|NCT01363986|150162|P1|STARTED|Overall Study||3
64746|NCT01363908|150172|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
64747|NCT01363908|150173|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
64748|NCT01363908|150172|P2|COMPLETED|Chronic Dosing (CD) Phase||10
64749|NCT01363908|150173|P1|COMPLETED|Chronic Dosing (CD) Phase||3
64750|NCT01363908|150172|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
64751|NCT01363908|150173|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
64752|NCT01363908|150172|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
64753|NCT01363908|150173|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
64754|NCT01363908|150172|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
64755|NCT01363908|150173|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
64756|NCT01363908|150172|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
64757|NCT01363908|150173|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
64758|NCT01363908|150172|P2|NOT COMPLETED|Screening/Enrollment||0
64759|NCT01363908|150173|P1|NOT COMPLETED|Screening/Enrollment||1
64760|NCT01363908|150172|P2|COMPLETED|Screening/Enrollment||16
64761|NCT01363908|150173|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
64762|NCT01363908|150172|P2|STARTED|Screening/Enrollment||16
64763|NCT01363908|150173|P1|STARTED|Screening/Enrollment||14
64764|NCT01363843|150203|P1|NOT COMPLETED|Overall Study||1
64765|NCT01363843|150203|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
64766|NCT01363843|150203|P1|STARTED|Overall Study||39
64767|NCT01363765|150209|P2|NOT COMPLETED|Overall Study||4731
64768|NCT01363765|150210|P1|NOT COMPLETED|Overall Study||5800
64769|NCT01363765|150209|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
64770|NCT01363765|150210|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
64771|NCT01363765|150209|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
64772|NCT01363765|150210|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
64773|NCT01363713|150222|P1|NOT COMPLETED|Overall Study||6
64774|NCT01363713|150222|P1|COMPLETED|Overall Study|Analysed (n=130)|124
64775|NCT01363713|150222|P1|ALLOCATED|Overall Study||130
64776|NCT01363713|150222|P1|STARTED|Overall Study|Assessed for eligibility|130
64777|NCT01363700|150231|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
64778|NCT01363700|150232|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
64779|NCT01363700|150233|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
64780|NCT01363700|150234|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
64781|NCT01363700|150235|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
64782|NCT01363700|150231|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
64783|NCT01363700|150232|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
64784|NCT01363700|150233|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
64785|NCT01363700|150234|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
64786|NCT01363700|150235|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
64787|NCT01363700|150231|P5|STARTED|Epinastine vs Olopatadine Period2||43
64788|NCT01363700|150232|P4|STARTED|Epinastine vs Olopatadine Period2||43
64789|NCT01363700|150233|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
64790|NCT01363700|150234|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
64791|NCT01363700|150235|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
64792|NCT01363700|150231|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
64793|NCT01363700|150232|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
64794|NCT01363700|150233|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
64795|NCT01363700|150234|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
64796|NCT01363700|150235|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
64797|NCT01363700|150231|P5|COMPLETED|Epinastine vs Placebo Period1||0
64798|NCT01363700|150232|P4|COMPLETED|Epinastine vs Placebo Period1||0
64799|NCT01363700|150233|P3|COMPLETED|Epinastine vs Placebo Period1||22
64800|NCT01363700|150234|P2|COMPLETED|Epinastine vs Placebo Period1||21
64801|NCT01363700|150235|P1|COMPLETED|Epinastine vs Placebo Period1||43
64802|NCT01363700|150231|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
64803|NCT01363700|150232|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
64804|NCT01363700|150233|P3|STARTED|Epinastine vs Placebo Period1||22
64805|NCT01363700|150234|P2|STARTED|Epinastine vs Placebo Period1||22
64806|NCT01363700|150235|P1|STARTED|Epinastine vs Placebo Period1||43
64807|NCT01363661|150254|P2|NOT COMPLETED|Overall Study||4
64808|NCT01363661|150255|P1|NOT COMPLETED|Overall Study||14
64809|NCT01363661|150254|P2|COMPLETED|Overall Study||28
64810|NCT01363661|150255|P1|COMPLETED|Overall Study||18
64811|NCT01363661|150254|P2|STARTED|Overall Study||32
64812|NCT01363661|150255|P1|STARTED|Overall Study||32
64813|NCT01363492|150271|P1|NOT COMPLETED|Overall Study||0
64814|NCT01363492|150271|P1|COMPLETED|Overall Study||14
64815|NCT01363492|150271|P1|STARTED|Overall Study||14
64816|NCT01363479|150286|P2|NOT COMPLETED|Overall Study||21
64817|NCT01363479|150287|P1|NOT COMPLETED|Overall Study||12
64818|NCT01363479|150286|P2|COMPLETED|Overall Study||351
64819|NCT01363479|150287|P1|COMPLETED|Overall Study||359
64820|NCT01363479|150286|P2|STARTED|Overall Study|number of randomised patients|372
64821|NCT01363479|150287|P1|STARTED|Overall Study|number of randomised patients|371
64822|NCT01363440|150296|P3|NOT COMPLETED|Overall Study||27
64823|NCT01363440|150297|P2|NOT COMPLETED|Overall Study||31
64824|NCT01363440|150298|P1|NOT COMPLETED|Overall Study||23
64825|NCT01363440|150296|P3|COMPLETED|Overall Study|Completed Week 100|127
64826|NCT01363440|150297|P2|COMPLETED|Overall Study|Completed Week 100|125
64827|NCT01363440|150298|P1|COMPLETED|Overall Study|Completed Week 100|133
64828|NCT01363440|150296|P3|Completed Week 100|Overall Study||127
64829|NCT01363440|150297|P2|Completed Week 100|Overall Study||125
64830|NCT01363440|150298|P1|Completed Week 100|Overall Study||133
64831|NCT01363440|150296|P3|Completed Week 52|Overall Study||144
64832|NCT01363440|150297|P2|Completed Week 52|Overall Study||146
64833|NCT01363440|150298|P1|Completed Week 52|Overall Study||145
64834|NCT01363440|150296|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
64835|NCT01363440|150297|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
64836|NCT01363440|150298|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
64837|NCT01363440|150296|P3|STARTED|Overall Study|randomized|154
64838|NCT01363440|150297|P2|STARTED|Overall Study|randomized|156
64839|NCT01363440|150298|P1|STARTED|Overall Study|randomized|156
64840|NCT01363401|150329|P2|NOT COMPLETED|Overall Study||4
64841|NCT01363401|150330|P1|NOT COMPLETED|Overall Study||2
64842|NCT01363401|150329|P2|COMPLETED|Overall Study||27
64843|NCT01363401|150330|P1|COMPLETED|Overall Study||39
64844|NCT01363401|150329|P2|STARTED|Overall Study||31
64845|NCT01363401|150330|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
64846|NCT01363349|150344|P2|NOT COMPLETED|Overall Study||70
64847|NCT01363349|150345|P1|NOT COMPLETED|Overall Study||67
64848|NCT01363349|150344|P2|COMPLETED|Overall Study||66
64849|NCT01363349|150345|P1|COMPLETED|Overall Study||66
64850|NCT01363349|150344|P2|Randomized|Overall Study||136
64851|NCT01363349|150345|P1|Randomized|Overall Study||133
64852|NCT01363349|150344|P2|STARTED|Overall Study||136
64853|NCT01363349|150345|P1|STARTED|Overall Study||133
64854|NCT01363076|150353|P2|NOT COMPLETED|Overall Study||1
64855|NCT01363076|150354|P1|NOT COMPLETED|Overall Study||0
64856|NCT01363076|150353|P2|COMPLETED|Overall Study||12
64857|NCT01363076|150354|P1|COMPLETED|Overall Study||7
64858|NCT01363076|150353|P2|STARTED|Overall Study||13
64859|NCT01363076|150354|P1|STARTED|Overall Study||7
64860|NCT01363050|150372|P1|NOT COMPLETED|Overall Study||0
64861|NCT01363050|150372|P1|COMPLETED|Overall Study||15
64862|NCT01363050|150372|P1|STARTED|Overall Study||15
64863|NCT01363011|150386|P2|NOT COMPLETED|Extension Phase||8
64864|NCT01363011|150387|P1|NOT COMPLETED|Extension Phase||5
64865|NCT01363011|150386|P2|COMPLETED|Extension Phase||41
64866|NCT01363011|150387|P1|COMPLETED|Extension Phase||13
64867|NCT01363011|150386|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
64868|NCT01363011|150387|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
64869|NCT01363011|150386|P2|NOT COMPLETED|Main Study||9
64870|NCT01363011|150387|P1|NOT COMPLETED|Main Study||4
64871|NCT01363011|150386|P2|COMPLETED|Main Study||64
64872|NCT01363011|150387|P1|COMPLETED|Main Study||29
64873|NCT01363011|150386|P2|STARTED|Main Study||73
64874|NCT01363011|150387|P1|STARTED|Main Study||33
64875|NCT01362946|150427|P2|NOT COMPLETED|Second Behavior Modification Block||0
64876|NCT01362946|150428|P1|NOT COMPLETED|Second Behavior Modification Block||0
64877|NCT01362946|150427|P2|COMPLETED|Second Behavior Modification Block||24
64878|NCT01362946|150428|P1|COMPLETED|Second Behavior Modification Block||23
64879|NCT01362946|150427|P2|STARTED|Second Behavior Modification Block||24
64880|NCT01362946|150428|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
64881|NCT01362946|150427|P2|NOT COMPLETED|First Behavior Modification Block||0
64882|NCT01362946|150428|P1|NOT COMPLETED|First Behavior Modification Block||0
64883|NCT01362946|150427|P2|COMPLETED|First Behavior Modification Block||24
64884|NCT01362946|150428|P1|COMPLETED|First Behavior Modification Block||24
64885|NCT01362946|150427|P2|STARTED|First Behavior Modification Block||24
64886|NCT01362946|150428|P1|STARTED|First Behavior Modification Block||24
64887|NCT01362907|150461|P2|NOT COMPLETED|Period 2, One Week||0
64888|NCT01362907|150462|P1|NOT COMPLETED|Period 2, One Week||0
64889|NCT01362907|150461|P2|COMPLETED|Period 2, One Week||20
64890|NCT01362907|150462|P1|COMPLETED|Period 2, One Week||20
64891|NCT01362907|150461|P2|STARTED|Period 2, One Week||20
64892|NCT01362907|150462|P1|STARTED|Period 2, One Week||20
64893|NCT01362907|150461|P2|NOT COMPLETED|Period 1, One Week||0
64894|NCT01362907|150462|P1|NOT COMPLETED|Period 1, One Week||0
64895|NCT01362907|150461|P2|COMPLETED|Period 1, One Week||20
64896|NCT01362907|150462|P1|COMPLETED|Period 1, One Week||20
64897|NCT01362907|150461|P2|STARTED|Period 1, One Week||20
64898|NCT01362907|150462|P1|STARTED|Period 1, One Week||20
64899|NCT01362894|150476|P2|NOT COMPLETED|Period Two, 1 Week||0
64900|NCT01362894|150477|P1|NOT COMPLETED|Period Two, 1 Week||0
64901|NCT01362894|150476|P2|COMPLETED|Period Two, 1 Week||115
64902|NCT01362894|150477|P1|COMPLETED|Period Two, 1 Week||118
64903|NCT01362894|150476|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
64904|NCT01362894|150477|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
64905|NCT01362894|150476|P2|NOT COMPLETED|Period One, 1 Week||0
64906|NCT01362894|150477|P1|NOT COMPLETED|Period One, 1 Week||0
64907|NCT01362894|150476|P2|COMPLETED|Period One, 1 Week||117
64908|NCT01362894|150477|P1|COMPLETED|Period One, 1 Week||119
64909|NCT01362894|150476|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
64910|NCT01362894|150477|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
64911|NCT01362530|150493|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
64912|NCT01362530|150494|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
64913|NCT01362530|150493|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
64914|NCT01362530|150494|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
64915|NCT01362530|150493|P2|STARTED|Optional Extension (Cycles 2-6)||0
64916|NCT01362530|150494|P1|STARTED|Optional Extension (Cycles 2-6)||171
64917|NCT01362530|150493|P2|NOT COMPLETED|Base Study (Cycle 1)||3
64918|NCT01362530|150494|P1|NOT COMPLETED|Base Study (Cycle 1)||5
64919|NCT01362530|150493|P2|COMPLETED|Base Study (Cycle 1)||149
64920|NCT01362530|150494|P1|COMPLETED|Base Study (Cycle 1)||150
64921|NCT01362530|150493|P2|Received Study Treatment|Base Study (Cycle 1)||150
64922|NCT01362530|150494|P1|Received Study Treatment|Base Study (Cycle 1)||152
64923|NCT01362530|150493|P2|STARTED|Base Study (Cycle 1)||152
64924|NCT01362530|150494|P1|STARTED|Base Study (Cycle 1)||155
64925|NCT01362517|150507|P1|NOT COMPLETED|Overall Study||2
64926|NCT01362517|150507|P1|COMPLETED|Overall Study||129
64927|NCT01362517|150507|P1|STARTED|Overall Study||131
64928|NCT01362491|150518|P3|NOT COMPLETED|Overall Study||0
64929|NCT01362491|150519|P2|NOT COMPLETED|Overall Study||0
64930|NCT01362491|150520|P1|NOT COMPLETED|Overall Study||1
64931|NCT01362491|150518|P3|COMPLETED|Overall Study||46
64932|NCT01362491|150519|P2|COMPLETED|Overall Study||89
64933|NCT01362491|150520|P1|COMPLETED|Overall Study||90
64934|NCT01362491|150518|P3|STARTED|Overall Study||46
64935|NCT01362491|150519|P2|STARTED|Overall Study||89
64936|NCT01362491|150520|P1|STARTED|Overall Study||91
64937|NCT01362439|150568|P1|NOT COMPLETED|Overall Study||15
64938|NCT01362439|150568|P1|COMPLETED|Overall Study||118
64939|NCT01362439|150568|P1|STARTED|Overall Study||133
64940|NCT01362296|150585|P4|NOT COMPLETED|Crossover Phase||2
64941|NCT01362296|150586|P3|NOT COMPLETED|Crossover Phase||23
64942|NCT01362296|150587|P2|NOT COMPLETED|Crossover Phase||0
64943|NCT01362296|150588|P1|NOT COMPLETED|Crossover Phase||0
64944|NCT01362296|150585|P4|COMPLETED|Crossover Phase||0
64945|NCT01362296|150586|P3|COMPLETED|Crossover Phase||0
64946|NCT01362296|150587|P2|COMPLETED|Crossover Phase||0
64947|NCT01362296|150588|P1|COMPLETED|Crossover Phase||0
64948|NCT01362296|150585|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
64949|NCT01362296|150586|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
64950|NCT01362296|150587|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
64951|NCT01362296|150588|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
64952|NCT01362296|150585|P4|NOT COMPLETED|Randomized Phase (RP)||0
64953|NCT01362296|150586|P3|NOT COMPLETED|Randomized Phase (RP)||0
64954|NCT01362296|150587|P2|NOT COMPLETED|Randomized Phase (RP)||43
64955|NCT01362296|150588|P1|NOT COMPLETED|Randomized Phase (RP)||87
64956|NCT01362296|150585|P4|COMPLETED|Randomized Phase (RP)||0
64957|NCT01362296|150586|P3|COMPLETED|Randomized Phase (RP)||0
64958|NCT01362296|150587|P2|COMPLETED|Randomized Phase (RP)||0
64959|NCT01362296|150588|P1|COMPLETED|Randomized Phase (RP)||0
64960|NCT01362296|150585|P4|STARTED|Randomized Phase (RP)||0
64961|NCT01362296|150586|P3|STARTED|Randomized Phase (RP)||0
64962|NCT01362296|150587|P2|STARTED|Randomized Phase (RP)||43
64963|NCT01362296|150588|P1|STARTED|Randomized Phase (RP)||87
64964|NCT01362244|150636|P2|NOT COMPLETED|Overall Study||32
64965|NCT01362244|150637|P1|NOT COMPLETED|Overall Study||32
64966|NCT01362244|150636|P2|COMPLETED|Overall Study||19
64967|NCT01362244|150637|P1|COMPLETED|Overall Study||22
64968|NCT01362244|150636|P2|STARTED|Overall Study||51
64969|NCT01362244|150637|P1|STARTED|Overall Study||54
64970|NCT01362192|150708|P1|NOT COMPLETED|Overall Study||4
64971|NCT01362192|150708|P1|COMPLETED|Overall Study||16
64972|NCT01362192|150708|P1|STARTED|Overall Study||20
64973|NCT01362140|150720|P2|NOT COMPLETED|Overall Study||11
64974|NCT01362140|150721|P1|NOT COMPLETED|Overall Study||10
64975|NCT01362140|150720|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
64976|NCT01362140|150721|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
64977|NCT01362140|150720|P2|Received Treatment|Overall Study||97
64978|NCT01362140|150721|P1|Received Treatment|Overall Study||49
64979|NCT01362140|150720|P2|STARTED|Overall Study||98
64980|NCT01362140|150721|P1|STARTED|Overall Study||49
64981|NCT01362062|150745|P2|NOT COMPLETED|Overall Study||0
64982|NCT01362062|150746|P1|NOT COMPLETED|Overall Study||26
64983|NCT01362062|150745|P2|COMPLETED|Overall Study||62
64984|NCT01362062|150746|P1|COMPLETED|Overall Study||22
64985|NCT01362062|150745|P2|STARTED|Overall Study||62
64986|NCT01362062|150746|P1|STARTED|Overall Study||48
64987|NCT01361854|150763|P2|NOT COMPLETED|Second Intervention||0
64988|NCT01361854|150764|P1|NOT COMPLETED|Second Intervention||0
64989|NCT01361854|150763|P2|COMPLETED|Second Intervention||48
64990|NCT01361854|150764|P1|COMPLETED|Second Intervention||47
64991|NCT01361854|150763|P2|STARTED|Second Intervention||48
64992|NCT01361854|150764|P1|STARTED|Second Intervention||47
64993|NCT01361854|150763|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
64994|NCT01361854|150764|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
64995|NCT01361854|150763|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
64996|NCT01361854|150764|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
64997|NCT01361854|150763|P2|STARTED|Wash-out, Maximum 2 Weeks||48
64998|NCT01361854|150764|P1|STARTED|Wash-out, Maximum 2 Weeks||47
64999|NCT01361854|150763|P2|NOT COMPLETED|Day 1||3
65000|NCT01361854|150764|P1|NOT COMPLETED|Day 1||4
65001|NCT01361854|150763|P2|COMPLETED|Day 1||48
65002|NCT01361854|150764|P1|COMPLETED|Day 1||47
65003|NCT01361854|150763|P2|STARTED|Day 1||51
65004|NCT01361854|150764|P1|STARTED|Day 1||51
65005|NCT01361633|150772|P2|NOT COMPLETED|Overall Study||3
65006|NCT01361633|150773|P1|NOT COMPLETED|Overall Study||6
65007|NCT01361633|150772|P2|COMPLETED|Overall Study||23
65008|NCT01361633|150773|P1|COMPLETED|Overall Study||19
65009|NCT01361633|150772|P2|STARTED|Overall Study||26
65010|NCT01361633|150773|P1|STARTED|Overall Study||25
65011|NCT01361620|150779|P1|NOT COMPLETED|Overall Study||0
65012|NCT01361620|150779|P1|COMPLETED|Overall Study||132
65013|NCT01361620|150779|P1|STARTED|Overall Study||132
65014|NCT01361594|150785|P2|NOT COMPLETED|Overall Study||2
65015|NCT01361594|150786|P1|NOT COMPLETED|Overall Study||1
65016|NCT01361594|150785|P2|COMPLETED|Overall Study||151
65017|NCT01361594|150786|P1|COMPLETED|Overall Study||151
65018|NCT01361594|150785|P2|STARTED|Overall Study||153
65019|NCT01361594|150786|P1|STARTED|Overall Study||152
65020|NCT01361568|150800|P6|NOT COMPLETED|Overall Study||2
65021|NCT01361568|150801|P5|NOT COMPLETED|Overall Study||1
65022|NCT01361568|150802|P4|NOT COMPLETED|Overall Study||0
65023|NCT01361568|150803|P3|NOT COMPLETED|Overall Study||0
65024|NCT01361568|150804|P2|NOT COMPLETED|Overall Study||1
65025|NCT01361568|150805|P1|NOT COMPLETED|Overall Study||2
65026|NCT01361568|150800|P6|COMPLETED|Overall Study||11
65027|NCT01361568|150801|P5|COMPLETED|Overall Study||6
65028|NCT01361568|150802|P4|COMPLETED|Overall Study||21
65029|NCT01361568|150803|P3|COMPLETED|Overall Study||20
65030|NCT01361568|150804|P2|COMPLETED|Overall Study||70
65031|NCT01361568|150805|P1|COMPLETED|Overall Study||69
65032|NCT01361568|150800|P6|STARTED|Overall Study||13
65033|NCT01361568|150801|P5|STARTED|Overall Study||7
65034|NCT01361568|150802|P4|STARTED|Overall Study||21
65035|NCT01361568|150803|P3|STARTED|Overall Study||20
65036|NCT01361568|150804|P2|STARTED|Overall Study||71
65037|NCT01361568|150805|P1|STARTED|Overall Study||71
65038|NCT01361464|150835|P1|NOT COMPLETED|Overall Study||3
65039|NCT01361464|150835|P1|COMPLETED|Overall Study||18
65040|NCT01361464|150835|P1|STARTED|Overall Study||21
65041|NCT01361308|150844|P2|NOT COMPLETED|Overall Study||30
65042|NCT01361308|150845|P1|NOT COMPLETED|Overall Study||35
65043|NCT01361308|150844|P2|COMPLETED|Overall Study||278
65044|NCT01361308|150845|P1|COMPLETED|Overall Study||271
65045|NCT01361308|150844|P2|STARTED|Overall Study||308
65046|NCT01361308|150845|P1|STARTED|Overall Study||306
65047|NCT01361126|150887|P2|NOT COMPLETED|Overall Study||2
65048|NCT01361126|150888|P1|NOT COMPLETED|Overall Study||0
65049|NCT01361126|150887|P2|COMPLETED|Overall Study||2
65050|NCT01361126|150888|P1|COMPLETED|Overall Study||13
65051|NCT01361126|150887|P2|STARTED|Overall Study||4
65052|NCT01361126|150888|P1|STARTED|Overall Study||13
65053|NCT01361048|150906|P3|NOT COMPLETED|Overall Study||1
65054|NCT01361048|150907|P2|NOT COMPLETED|Overall Study||0
65055|NCT01361048|150908|P1|NOT COMPLETED|Overall Study||0
65056|NCT01361048|150906|P3|COMPLETED|Overall Study||9
65057|NCT01361048|150907|P2|COMPLETED|Overall Study||10
65058|NCT01361048|150908|P1|COMPLETED|Overall Study||20
65059|NCT01361048|150906|P3|STARTED|Overall Study||10
65060|NCT01361048|150907|P2|STARTED|Overall Study||10
65061|NCT01361048|150908|P1|STARTED|Overall Study||20
65062|NCT01361009|150916|P1|NOT COMPLETED|Overall Study||116
65063|NCT01361009|150916|P1|COMPLETED|Overall Study||1901
65064|NCT01361009|150916|P1|STARTED|Overall Study||2017
65065|NCT01360840|150926|P3|NOT COMPLETED|Overall Study||9
65066|NCT01360840|150927|P2|NOT COMPLETED|Overall Study||10
65067|NCT01360840|150928|P1|NOT COMPLETED|Overall Study||10
65068|NCT01360840|150926|P3|COMPLETED|Overall Study||51
65069|NCT01360840|150927|P2|COMPLETED|Overall Study||50
65070|NCT01360840|150928|P1|COMPLETED|Overall Study||50
65071|NCT01360840|150926|P3|STARTED|Overall Study||60
65072|NCT01360840|150927|P2|STARTED|Overall Study||60
65073|NCT01360840|150928|P1|STARTED|Overall Study||60
65074|NCT01360645|150980|P4|NOT COMPLETED|Phase A+||24
65075|NCT01360645|150981|P3|NOT COMPLETED|Phase A+||0
65076|NCT01360645|150982|P2|NOT COMPLETED|Phase A+||0
65077|NCT01360645|150983|P1|NOT COMPLETED|Phase A+||0
65078|NCT01360645|150980|P4|COMPLETED|Phase A+||307
65079|NCT01360645|150981|P3|COMPLETED|Phase A+||0
65080|NCT01360645|150982|P2|COMPLETED|Phase A+||0
65081|NCT01360645|150983|P1|COMPLETED|Phase A+||0
65082|NCT01360645|150980|P4|STARTED|Phase A+||331
65083|NCT01360645|150981|P3|STARTED|Phase A+||0
65084|NCT01360645|150982|P2|STARTED|Phase A+||0
65085|NCT01360645|150983|P1|STARTED|Phase A+||0
65086|NCT01360645|150980|P4|NOT COMPLETED|Phase B (6 Weeks)||0
65087|NCT01360645|150981|P3|NOT COMPLETED|Phase B (6 Weeks)||13
65088|NCT01360645|150982|P2|NOT COMPLETED|Phase B (6 Weeks)||14
65089|NCT01360645|150983|P1|NOT COMPLETED|Phase B (6 Weeks)||0
65090|NCT01360645|150980|P4|COMPLETED|Phase B (6 Weeks)||0
65091|NCT01360645|150981|P3|COMPLETED|Phase B (6 Weeks)||178
65092|NCT01360645|150982|P2|COMPLETED|Phase B (6 Weeks)||174
65093|NCT01360645|150983|P1|COMPLETED|Phase B (6 Weeks)||0
65094|NCT01360645|150980|P4|STARTED|Phase B (6 Weeks)||0
65095|NCT01360645|150981|P3|STARTED|Phase B (6 Weeks)||191
65096|NCT01360645|150982|P2|STARTED|Phase B (6 Weeks)||188
65097|NCT01360645|150983|P1|STARTED|Phase B (6 Weeks)||0
65098|NCT01360645|150980|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65099|NCT01360645|150981|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65100|NCT01360645|150982|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65101|NCT01360645|150983|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
65102|NCT01360645|150980|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65103|NCT01360645|150981|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65104|NCT01360645|150982|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65105|NCT01360645|150983|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
65106|NCT01360645|150980|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65107|NCT01360645|150981|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65108|NCT01360645|150982|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
65109|NCT01360645|150983|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
65110|NCT01360632|151038|P5|NOT COMPLETED|Phase A+||25
65111|NCT01360632|151039|P4|NOT COMPLETED|Phase A+||0
65112|NCT01360632|151040|P3|NOT COMPLETED|Phase A+||0
65113|NCT01360632|151041|P2|NOT COMPLETED|Phase A+||0
65114|NCT01360632|151042|P1|NOT COMPLETED|Phase A+||0
65115|NCT01360632|151038|P5|COMPLETED|Phase A+||575
65116|NCT01360632|151039|P4|COMPLETED|Phase A+||0
65117|NCT01360632|151040|P3|COMPLETED|Phase A+||0
65118|NCT01360632|151041|P2|COMPLETED|Phase A+||0
65119|NCT01360632|151042|P1|COMPLETED|Phase A+||0
65120|NCT01360632|151038|P5|STARTED|Phase A+||600
65121|NCT01360632|151039|P4|STARTED|Phase A+||0
65122|NCT01360632|151040|P3|STARTED|Phase A+||0
65123|NCT01360632|151041|P2|STARTED|Phase A+||0
65124|NCT01360632|151042|P1|STARTED|Phase A+||0
65125|NCT01360632|151038|P5|NOT COMPLETED|Phase B (6 Weeks)||0
65126|NCT01360632|151039|P4|NOT COMPLETED|Phase B (6 Weeks)||13
65127|NCT01360632|151040|P3|NOT COMPLETED|Phase B (6 Weeks)||20
65128|NCT01360632|151041|P2|NOT COMPLETED|Phase B (6 Weeks)||10
65129|NCT01360632|151042|P1|NOT COMPLETED|Phase B (6 Weeks)||0
65130|NCT01360632|151038|P5|COMPLETED|Phase B (6 Weeks)||0
65131|NCT01360632|151039|P4|COMPLETED|Phase B (6 Weeks)||208
65132|NCT01360632|151040|P3|COMPLETED|Phase B (6 Weeks)||210
65133|NCT01360632|151041|P2|COMPLETED|Phase B (6 Weeks)||216
65134|NCT01360632|151042|P1|COMPLETED|Phase B (6 Weeks)||0
65135|NCT01360632|151038|P5|STARTED|Phase B (6 Weeks)||0
65136|NCT01360632|151039|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
65137|NCT01360632|151040|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
65138|NCT01360632|151041|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
65139|NCT01360632|151042|P1|STARTED|Phase B (6 Weeks)||0
65140|NCT01360632|151038|P5|NOT COMPLETED|Phase A (8 Weeks)||0
65141|NCT01360632|151039|P4|NOT COMPLETED|Phase A (8 Weeks)||0
65142|NCT01360632|151040|P3|NOT COMPLETED|Phase A (8 Weeks)||0
65143|NCT01360632|151041|P2|NOT COMPLETED|Phase A (8 Weeks)||0
65144|NCT01360632|151042|P1|NOT COMPLETED|Phase A (8 Weeks)||255
65145|NCT01360632|151038|P5|COMPLETED|Phase A (8 Weeks)||0
65146|NCT01360632|151039|P4|COMPLETED|Phase A (8 Weeks)||0
65147|NCT01360632|151040|P3|COMPLETED|Phase A (8 Weeks)||0
65148|NCT01360632|151041|P2|COMPLETED|Phase A (8 Weeks)||0
65149|NCT01360632|151042|P1|COMPLETED|Phase A (8 Weeks)||1277
65150|NCT01360632|151038|P5|STARTED|Phase A (8 Weeks)||0
65151|NCT01360632|151039|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
65152|NCT01360632|151040|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
65153|NCT01360632|151041|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
65154|NCT01360632|151042|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
65155|NCT01360021|151122|P3|NOT COMPLETED|Overall Study||7
65156|NCT01360021|151123|P2|NOT COMPLETED|Overall Study||4
65157|NCT01360021|151124|P1|NOT COMPLETED|Overall Study||8
65158|NCT01360021|151122|P3|COMPLETED|Overall Study|Patients who completed study|65
65159|NCT01360021|151123|P2|COMPLETED|Overall Study|Patients who completed study|67
65160|NCT01360021|151124|P1|COMPLETED|Overall Study|Patients who completed study|63
65161|NCT01360021|151122|P3|STARTED|Overall Study|Patients randomized|72
65162|NCT01360021|151123|P2|STARTED|Overall Study|Patients randomized|71
65163|NCT01360021|151124|P1|STARTED|Overall Study|Patients randomized|71
65164|NCT01359943|151150|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
65165|NCT01359943|151151|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
65166|NCT01359943|151152|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
65167|NCT01359943|151150|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
65168|NCT01359943|151151|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
65169|NCT01359943|151152|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
65170|NCT01359943|151150|P3|STARTED|Follow-up (Weeks 52 - 60)||44
65171|NCT01359943|151151|P2|STARTED|Follow-up (Weeks 52 - 60)||84
65172|NCT01359943|151152|P1|STARTED|Follow-up (Weeks 52 - 60)||86
65173|NCT01359943|151150|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
65174|NCT01359943|151151|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
65175|NCT01359943|151152|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
65176|NCT01359943|151150|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
65177|NCT01359943|151151|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
65178|NCT01359943|151152|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
65179|NCT01359943|151150|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
65180|NCT01359943|151151|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
65181|NCT01359943|151152|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
65182|NCT01359943|151150|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
65183|NCT01359943|151151|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
65184|NCT01359943|151152|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
65185|NCT01359943|151150|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
65186|NCT01359943|151151|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
65187|NCT01359943|151152|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
65188|NCT01359943|151150|P3|STARTED|Double-blind (Weeks 0 - 16)||44
65189|NCT01359943|151151|P2|STARTED|Double-blind (Weeks 0 - 16)||89
65190|NCT01359943|151152|P1|STARTED|Double-blind (Weeks 0 - 16)||88
65191|NCT01359904|151200|P2|NOT COMPLETED|Overall Study||0
65192|NCT01359904|151201|P1|NOT COMPLETED|Overall Study||1
65193|NCT01359904|151200|P2|COMPLETED|Overall Study||19
65194|NCT01359904|151201|P1|COMPLETED|Overall Study||14
65195|NCT01359904|151200|P2|STARTED|Overall Study||19
65196|NCT01359904|151201|P1|STARTED|Overall Study||15
65197|NCT01359748|151217|P4|NOT COMPLETED|Overall Study||0
65198|NCT01359748|151218|P3|NOT COMPLETED|Overall Study||0
65199|NCT01359748|151219|P2|NOT COMPLETED|Overall Study||0
65200|NCT01359748|151220|P1|NOT COMPLETED|Overall Study||0
65201|NCT01359748|151217|P4|COMPLETED|Overall Study||11
65202|NCT01359748|151218|P3|COMPLETED|Overall Study||10
65203|NCT01359748|151219|P2|COMPLETED|Overall Study||20
65204|NCT01359748|151220|P1|COMPLETED|Overall Study||48
65205|NCT01359748|151217|P4|STARTED|Overall Study||11
65206|NCT01359748|151218|P3|STARTED|Overall Study||10
65207|NCT01359748|151219|P2|STARTED|Overall Study||20
65208|NCT01359748|151220|P1|STARTED|Overall Study||48
65209|NCT01359644|151238|P10|NOT COMPLETED|Follow-up Period||0
65210|NCT01359644|151239|P9|NOT COMPLETED|Follow-up Period||0
65211|NCT01359644|151240|P8|NOT COMPLETED|Follow-up Period||2
65212|NCT01359644|151241|P7|NOT COMPLETED|Follow-up Period||1
65213|NCT01359644|151242|P6|NOT COMPLETED|Follow-up Period||1
65214|NCT01359644|151243|P5|NOT COMPLETED|Follow-up Period||0
65215|NCT01359644|151244|P4|NOT COMPLETED|Follow-up Period||0
65216|NCT01359644|151245|P3|NOT COMPLETED|Follow-up Period||0
65217|NCT01359644|151246|P2|NOT COMPLETED|Follow-up Period||0
65218|NCT01359644|151247|P1|NOT COMPLETED|Follow-up Period||0
65219|NCT01359644|151238|P10|COMPLETED|Follow-up Period||20
65220|NCT01359644|151239|P9|COMPLETED|Follow-up Period||21
65221|NCT01359644|151240|P8|COMPLETED|Follow-up Period||39
65222|NCT01359644|151241|P7|COMPLETED|Follow-up Period||40
65223|NCT01359644|151242|P6|COMPLETED|Follow-up Period||12
65224|NCT01359644|151243|P5|COMPLETED|Follow-up Period||15
65225|NCT01359644|151244|P4|COMPLETED|Follow-up Period||14
65226|NCT01359644|151245|P3|COMPLETED|Follow-up Period||14
65227|NCT01359644|151246|P2|COMPLETED|Follow-up Period||16
65228|NCT01359644|151247|P1|COMPLETED|Follow-up Period||15
65229|NCT01359644|151238|P10|STARTED|Follow-up Period||20
65230|NCT01359644|151239|P9|STARTED|Follow-up Period||21
65231|NCT01359644|151240|P8|STARTED|Follow-up Period||41
65232|NCT01359644|151241|P7|STARTED|Follow-up Period||41
65233|NCT01359644|151242|P6|STARTED|Follow-up Period||13
65234|NCT01359644|151243|P5|STARTED|Follow-up Period||15
65235|NCT01359644|151244|P4|STARTED|Follow-up Period||14
65236|NCT01359644|151245|P3|STARTED|Follow-up Period||14
65237|NCT01359644|151246|P2|STARTED|Follow-up Period||16
65238|NCT01359644|151247|P1|STARTED|Follow-up Period||15
65239|NCT01359644|151238|P10|NOT COMPLETED|Treatment Period||0
65240|NCT01359644|151239|P9|NOT COMPLETED|Treatment Period||0
65241|NCT01359644|151240|P8|NOT COMPLETED|Treatment Period||0
65242|NCT01359644|151241|P7|NOT COMPLETED|Treatment Period||0
65243|NCT01359644|151242|P6|NOT COMPLETED|Treatment Period||2
65244|NCT01359644|151243|P5|NOT COMPLETED|Treatment Period||0
65245|NCT01359644|151244|P4|NOT COMPLETED|Treatment Period||0
65246|NCT01359644|151245|P3|NOT COMPLETED|Treatment Period||1
65247|NCT01359644|151246|P2|NOT COMPLETED|Treatment Period||1
65248|NCT01359644|151247|P1|NOT COMPLETED|Treatment Period||0
65249|NCT01359644|151238|P10|COMPLETED|Treatment Period||20
65250|NCT01359644|151239|P9|COMPLETED|Treatment Period||21
65251|NCT01359644|151240|P8|COMPLETED|Treatment Period||41
65252|NCT01359644|151241|P7|COMPLETED|Treatment Period||41
65253|NCT01359644|151242|P6|COMPLETED|Treatment Period||12
65254|NCT01359644|151243|P5|COMPLETED|Treatment Period||15
65255|NCT01359644|151244|P4|COMPLETED|Treatment Period||14
65256|NCT01359644|151245|P3|COMPLETED|Treatment Period||13
65257|NCT01359644|151246|P2|COMPLETED|Treatment Period||15
65258|NCT01359644|151247|P1|COMPLETED|Treatment Period||15
65259|NCT01359644|151238|P10|STARTED|Treatment Period||20
65260|NCT01359644|151239|P9|STARTED|Treatment Period||21
65261|NCT01359644|151240|P8|STARTED|Treatment Period||41
65262|NCT01359644|151241|P7|STARTED|Treatment Period||41
65263|NCT01359644|151242|P6|STARTED|Treatment Period||14
65264|NCT01359644|151243|P5|STARTED|Treatment Period||15
65265|NCT01359644|151244|P4|STARTED|Treatment Period||14
65266|NCT01359644|151245|P3|STARTED|Treatment Period||14
65267|NCT01359644|151246|P2|STARTED|Treatment Period||16
65268|NCT01359644|151247|P1|STARTED|Treatment Period||15
65269|NCT01359449|151291|P2|NOT COMPLETED|Overall Study||4
65270|NCT01359449|151292|P1|NOT COMPLETED|Overall Study||4
65271|NCT01359449|151291|P2|COMPLETED|Overall Study||58
65272|NCT01359449|151292|P1|COMPLETED|Overall Study||57
65273|NCT01359449|151291|P2|STARTED|Overall Study||62
65274|NCT01359449|151292|P1|STARTED|Overall Study||61
65275|NCT01359371|151314|P1|NOT COMPLETED|Overall Study||0
65276|NCT01359371|151314|P1|COMPLETED|Overall Study||41
65277|NCT01359371|151314|P1|STARTED|Overall Study||41
65278|NCT01359254|151321|P2|NOT COMPLETED|Overall Study||0
65279|NCT01359254|151322|P1|NOT COMPLETED|Overall Study||1
65280|NCT01359254|151321|P2|COMPLETED|Overall Study||0
65281|NCT01359254|151322|P1|COMPLETED|Overall Study||0
65282|NCT01359254|151321|P2|STARTED|Overall Study||0
65283|NCT01359254|151322|P1|STARTED|Overall Study||1
65284|NCT01359150|151332|P2|NOT COMPLETED|Overall Study||5
65285|NCT01359150|151333|P1|NOT COMPLETED|Overall Study||7
65286|NCT01359150|151332|P2|COMPLETED|Overall Study||106
65287|NCT01359150|151333|P1|COMPLETED|Overall Study||105
65288|NCT01359150|151332|P2|STARTED|Overall Study||111
65289|NCT01359150|151333|P1|STARTED|Overall Study||112
65290|NCT01359111|151355|P1|NOT COMPLETED|Overall Study||0
65291|NCT01359111|151355|P1|COMPLETED|Overall Study||20
65292|NCT01359111|151355|P1|STARTED|Overall Study||20
65293|NCT01358864|151370|P8|NOT COMPLETED|Overall Study||55
65294|NCT01358864|151371|P7|NOT COMPLETED|Overall Study||65
65295|NCT01358864|151372|P6|NOT COMPLETED|Overall Study||13
65296|NCT01358864|151373|P5|NOT COMPLETED|Overall Study||11
65297|NCT01358864|151374|P4|NOT COMPLETED|Overall Study||19
65298|NCT01358864|151375|P3|NOT COMPLETED|Overall Study||16
65299|NCT01358864|151376|P2|NOT COMPLETED|Overall Study||13
65300|NCT01358864|151377|P1|NOT COMPLETED|Overall Study||31
65301|NCT01358864|151370|P8|COMPLETED|Overall Study||85
65302|NCT01358864|151371|P7|COMPLETED|Overall Study||81
65303|NCT01358864|151372|P6|COMPLETED|Overall Study||42
65304|NCT01358864|151373|P5|COMPLETED|Overall Study||46
65305|NCT01358864|151374|P4|COMPLETED|Overall Study||10
65306|NCT01358864|151375|P3|COMPLETED|Overall Study||87
65307|NCT01358864|151376|P2|COMPLETED|Overall Study||86
65308|NCT01358864|151377|P1|COMPLETED|Overall Study||18
65309|NCT01358864|151370|P8|STARTED|Overall Study||140
65310|NCT01358864|151371|P7|STARTED|Overall Study||146
65311|NCT01358864|151372|P6|STARTED|Overall Study||55
65312|NCT01358864|151373|P5|STARTED|Overall Study||57
65313|NCT01358864|151374|P4|STARTED|Overall Study||29
65314|NCT01358864|151375|P3|STARTED|Overall Study||103
65315|NCT01358864|151376|P2|STARTED|Overall Study||99
65316|NCT01358864|151377|P1|STARTED|Overall Study||49
65317|NCT01358825|151468|P2|NOT COMPLETED|Overall Study||1
65318|NCT01358825|151469|P1|NOT COMPLETED|Overall Study||0
65319|NCT01358825|151468|P2|COMPLETED|Overall Study||45
65320|NCT01358825|151469|P1|COMPLETED|Overall Study||12
65321|NCT01358825|151468|P2|STARTED|Overall Study||46
65322|NCT01358825|151469|P1|STARTED|Overall Study||12
65323|NCT01358734|151493|P3|NOT COMPLETED|Overall Study||29
65324|NCT01358734|151494|P2|NOT COMPLETED|Overall Study||37
65325|NCT01358734|151495|P1|NOT COMPLETED|Overall Study||15
65326|NCT01358734|151493|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
65327|NCT01358734|151494|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
65328|NCT01358734|151495|P1|COMPLETED|Overall Study||0
65329|NCT01358734|151493|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
65330|NCT01358734|151494|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
65331|NCT01358734|151495|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
65332|NCT01358734|151493|P3|STARTED|Overall Study||34
65333|NCT01358734|151494|P2|STARTED|Overall Study||39
65334|NCT01358734|151495|P1|STARTED|Overall Study||15
65335|NCT01358708|151514|P2|NOT COMPLETED|Open-Label Treatment Phase||0
65336|NCT01358708|151515|P1|NOT COMPLETED|Open-Label Treatment Phase||0
65337|NCT01358708|151514|P2|COMPLETED|Open-Label Treatment Phase||12
65338|NCT01358708|151515|P1|COMPLETED|Open-Label Treatment Phase||5
65339|NCT01358708|151514|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
65340|NCT01358708|151515|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
65341|NCT01358708|151514|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
65342|NCT01358708|151515|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
65343|NCT01358708|151514|P2|COMPLETED|Double-Blind Treatment Phase||13
65344|NCT01358708|151515|P1|COMPLETED|Double-Blind Treatment Phase||10
65345|NCT01358708|151514|P2|Received Study Medication|Double-Blind Treatment Phase||13
65346|NCT01358708|151515|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
65347|NCT01358708|151514|P2|Randomized|Double-Blind Treatment Phase||13
65348|NCT01358708|151515|P1|Randomized|Double-Blind Treatment Phase||13
65349|NCT01358708|151514|P2|STARTED|Double-Blind Treatment Phase||13
65350|NCT01358708|151515|P1|STARTED|Double-Blind Treatment Phase||13
65351|NCT01358578|151538|P6|NOT COMPLETED|Follow-up Period||0
65352|NCT01358578|151539|P5|NOT COMPLETED|Follow-up Period||0
65353|NCT01358578|151540|P4|NOT COMPLETED|Follow-up Period||19
65354|NCT01358578|151541|P3|NOT COMPLETED|Follow-up Period||5
65355|NCT01358578|151542|P2|NOT COMPLETED|Follow-up Period||6
65356|NCT01358578|151543|P1|NOT COMPLETED|Follow-up Period||10
65357|NCT01358578|151538|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
65358|NCT01358578|151539|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
65359|NCT01358578|151540|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
65360|NCT01358578|151541|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
65361|NCT01358578|151542|P2|COMPLETED|Follow-up Period||119
65362|NCT01358578|151543|P1|COMPLETED|Follow-up Period||138
65363|NCT01358578|151538|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
65364|NCT01358578|151539|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
65365|NCT01358578|151540|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
65366|NCT01358578|151541|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
65367|NCT01358578|151542|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
65368|NCT01358578|151543|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
65369|NCT01358578|151538|P6|NOT COMPLETED|Maintenance Period||11
65370|NCT01358578|151539|P5|NOT COMPLETED|Maintenance Period||17
65371|NCT01358578|151540|P4|NOT COMPLETED|Maintenance Period||42
65372|NCT01358578|151541|P3|NOT COMPLETED|Maintenance Period||2
65373|NCT01358578|151542|P2|NOT COMPLETED|Maintenance Period||22
65374|NCT01358578|151543|P1|NOT COMPLETED|Maintenance Period||39
65375|NCT01358578|151538|P6|COMPLETED|Maintenance Period||131
65376|NCT01358578|151539|P5|COMPLETED|Maintenance Period||125
65377|NCT01358578|151540|P4|COMPLETED|Maintenance Period||263
65378|NCT01358578|151541|P3|COMPLETED|Maintenance Period||15
65379|NCT01358578|151542|P2|COMPLETED|Maintenance Period||290
65380|NCT01358578|151543|P1|COMPLETED|Maintenance Period||276
65381|NCT01358578|151538|P6|STARTED|Maintenance Period||142
65382|NCT01358578|151539|P5|STARTED|Maintenance Period||142
65383|NCT01358578|151540|P4|STARTED|Maintenance Period||305
65384|NCT01358578|151541|P3|STARTED|Maintenance Period||17
65385|NCT01358578|151542|P2|STARTED|Maintenance Period||312
65386|NCT01358578|151543|P1|STARTED|Maintenance Period||315
65387|NCT01358578|151538|P6|NOT COMPLETED|Induction Period||0
65388|NCT01358578|151539|P5|NOT COMPLETED|Induction Period||0
65389|NCT01358578|151540|P4|NOT COMPLETED|Induction Period||21
65390|NCT01358578|151541|P3|NOT COMPLETED|Induction Period||25
65391|NCT01358578|151542|P2|NOT COMPLETED|Induction Period||15
65392|NCT01358578|151543|P1|NOT COMPLETED|Induction Period||12
65393|NCT01358578|151538|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
65394|NCT01358578|151539|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
65395|NCT01358578|151540|P4|COMPLETED|Induction Period||305
65396|NCT01358578|151541|P3|COMPLETED|Induction Period||301
65397|NCT01358578|151542|P2|COMPLETED|Induction Period||312
65398|NCT01358578|151543|P1|COMPLETED|Induction Period||315
65399|NCT01358578|151538|P6|STARTED|Induction Period|These groups are populated after the induction period|0
65400|NCT01358578|151539|P5|STARTED|Induction Period|These groups are populated after the induction period|0
65401|NCT01358578|151540|P4|STARTED|Induction Period||326
65402|NCT01358578|151541|P3|STARTED|Induction Period||326
65403|NCT01358578|151542|P2|STARTED|Induction Period||327
65404|NCT01358578|151543|P1|STARTED|Induction Period||327
65405|NCT01358526|151595|P3|NOT COMPLETED|Double-blind Phase||121
65406|NCT01358526|151596|P2|NOT COMPLETED|Double-blind Phase||80
65407|NCT01358526|151597|P1|NOT COMPLETED|Double-blind Phase||0
65408|NCT01358526|151595|P3|COMPLETED|Double-blind Phase||181
65409|NCT01358526|151596|P2|COMPLETED|Double-blind Phase||218
65410|NCT01358526|151597|P1|COMPLETED|Double-blind Phase||0
65411|NCT01358526|151595|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
65412|NCT01358526|151596|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
65413|NCT01358526|151597|P1|STARTED|Double-blind Phase||0
65414|NCT01358526|151595|P3|NOT COMPLETED|Open-label Titration Period||0
65415|NCT01358526|151596|P2|NOT COMPLETED|Open-label Titration Period||0
65416|NCT01358526|151597|P1|NOT COMPLETED|Open-label Titration Period||494
65417|NCT01358526|151595|P3|COMPLETED|Open-label Titration Period||0
65418|NCT01358526|151596|P2|COMPLETED|Open-label Titration Period||0
65419|NCT01358526|151597|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
65420|NCT01358526|151595|P3|STARTED|Open-label Titration Period||0
65421|NCT01358526|151596|P2|STARTED|Open-label Titration Period||0
65422|NCT01358526|151597|P1|STARTED|Open-label Titration Period||1095
65423|NCT01358357|151614|P3|NOT COMPLETED|Double-Blind Phase||0
65424|NCT01358357|151615|P2|NOT COMPLETED|Double-Blind Phase||100
65425|NCT01358357|151616|P1|NOT COMPLETED|Double-Blind Phase||80
65426|NCT01358357|151614|P3|COMPLETED|Double-Blind Phase||0
65427|NCT01358357|151615|P2|COMPLETED|Double-Blind Phase||150
65428|NCT01358357|151616|P1|COMPLETED|Double-Blind Phase||166
65429|NCT01358357|151614|P3|STARTED|Double-Blind Phase||0
65430|NCT01358357|151615|P2|STARTED|Double-Blind Phase||250
65431|NCT01358357|151616|P1|STARTED|Double-Blind Phase||246
65432|NCT01358357|151614|P3|NOT COMPLETED|Open Label Phase||462
65433|NCT01358357|151615|P2|NOT COMPLETED|Open Label Phase||0
65434|NCT01358357|151616|P1|NOT COMPLETED|Open Label Phase||0
65435|NCT01358357|151614|P3|COMPLETED|Open Label Phase||503
65436|NCT01358357|151615|P2|COMPLETED|Open Label Phase||0
65437|NCT01358357|151616|P1|COMPLETED|Open Label Phase||0
65438|NCT01358357|151614|P3|STARTED|Open Label Phase||965
65439|NCT01358357|151615|P2|STARTED|Open Label Phase||0
65440|NCT01358357|151616|P1|STARTED|Open Label Phase||0
65441|NCT01358175|151652|P3|NOT COMPLETED|Overall Study||32
65442|NCT01358175|151653|P2|NOT COMPLETED|Overall Study||28
65443|NCT01358175|151654|P1|NOT COMPLETED|Overall Study||21
65444|NCT01358175|151652|P3|COMPLETED|Overall Study||90
65445|NCT01358175|151653|P2|COMPLETED|Overall Study||97
65446|NCT01358175|151654|P1|COMPLETED|Overall Study||103
65447|NCT01358175|151652|P3|STARTED|Overall Study||122
65448|NCT01358175|151653|P2|STARTED|Overall Study||125
65449|NCT01358175|151654|P1|STARTED|Overall Study||124
65450|NCT01357980|151691|P4|NOT COMPLETED|Overall Study||0
65451|NCT01357980|151692|P3|NOT COMPLETED|Overall Study||1
65452|NCT01357980|151693|P2|NOT COMPLETED|Overall Study||1
65453|NCT01357980|151694|P1|NOT COMPLETED|Overall Study||0
65454|NCT01357980|151691|P4|COMPLETED|Overall Study||7
65455|NCT01357980|151692|P3|COMPLETED|Overall Study||16
65456|NCT01357980|151693|P2|COMPLETED|Overall Study||6
65457|NCT01357980|151694|P1|COMPLETED|Overall Study||16
65458|NCT01357980|151691|P4|STARTED|Overall Study||7
65459|NCT01357980|151692|P3|STARTED|Overall Study||17
65460|NCT01357980|151693|P2|STARTED|Overall Study||7
65461|NCT01357980|151694|P1|STARTED|Overall Study||16
65462|NCT01357889|151738|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
65463|NCT01357889|151739|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
65464|NCT01357889|151738|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
65465|NCT01357889|151739|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
65466|NCT01357889|151738|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
65467|NCT01357889|151739|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
65468|NCT01357889|151738|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
65469|NCT01357889|151739|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
65470|NCT01357889|151738|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
65471|NCT01357889|151739|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
65472|NCT01357889|151738|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
65473|NCT01357889|151739|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
65474|NCT01357889|151738|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
65475|NCT01357889|151739|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
65476|NCT01357889|151738|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
65477|NCT01357889|151739|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
65478|NCT01357889|151738|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
65479|NCT01357889|151739|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
65480|NCT01357850|151783|P4|NOT COMPLETED|Overall Study||0
65481|NCT01357850|151784|P3|NOT COMPLETED|Overall Study||0
65482|NCT01357850|151785|P2|NOT COMPLETED|Overall Study||0
65483|NCT01357850|151786|P1|NOT COMPLETED|Overall Study||1
65484|NCT01357850|151783|P4|COMPLETED|Overall Study||27
65485|NCT01357850|151784|P3|COMPLETED|Overall Study||13
65486|NCT01357850|151785|P2|COMPLETED|Overall Study||12
65487|NCT01357850|151786|P1|COMPLETED|Overall Study||29
65488|NCT01357850|151783|P4|STARTED|Overall Study||27
65489|NCT01357850|151784|P3|STARTED|Overall Study||13
65490|NCT01357850|151785|P2|STARTED|Overall Study||12
65491|NCT01357850|151786|P1|STARTED|Overall Study||30
65492|NCT01357720|151860|P2|NOT COMPLETED|Overall Study||5
65493|NCT01357720|151861|P1|NOT COMPLETED|Overall Study||2
65494|NCT01357720|151860|P2|COMPLETED|Overall Study||195
65495|NCT01357720|151861|P1|COMPLETED|Overall Study||198
65496|NCT01357720|151860|P2|STARTED|Overall Study||200
65497|NCT01357720|151861|P1|STARTED|Overall Study||200
65498|NCT01357616|151877|P2|NOT COMPLETED|Overall Study||9
65499|NCT01357616|151878|P1|NOT COMPLETED|Overall Study||10
65500|NCT01357616|151877|P2|COMPLETED|Overall Study||153
65501|NCT01357616|151878|P1|COMPLETED|Overall Study||156
65502|NCT01357616|151877|P2|STARTED|Overall Study||162
65503|NCT01357616|151878|P1|STARTED|Overall Study||166
65504|NCT01357551|151892|P2|NOT COMPLETED|Overall Study||11
65505|NCT01357551|151893|P1|NOT COMPLETED|Overall Study||22
65506|NCT01357551|151892|P2|COMPLETED|Overall Study||101
65507|NCT01357551|151893|P1|COMPLETED|Overall Study||88
65508|NCT01357551|151892|P2|STARTED|Overall Study||112
65509|NCT01357551|151893|P1|STARTED|Overall Study||110
65510|NCT01357512|151907|P2|NOT COMPLETED|Overall Study||5
65511|NCT01357512|151908|P1|NOT COMPLETED|Overall Study||12
65512|NCT01357512|151907|P2|COMPLETED|Overall Study||60
65513|NCT01357512|151908|P1|COMPLETED|Overall Study||53
65514|NCT01357512|151907|P2|STARTED|Overall Study||65
65515|NCT01357512|151908|P1|STARTED|Overall Study||65
65516|NCT01357239|151920|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
65517|NCT01357239|151921|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
65518|NCT01357239|151922|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
65519|NCT01357239|151923|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
65520|NCT01357239|151920|P4|COMPLETED|Stratum II: Partially-Methylated||18
65521|NCT01357239|151921|P3|COMPLETED|Stratum II: Partially-Methylated||21
65522|NCT01357239|151922|P2|COMPLETED|Stratum II: Partially-Methylated||21
65523|NCT01357239|151923|P1|COMPLETED|Stratum II: Partially-Methylated||23
65524|NCT01357239|151920|P4|STARTED|Stratum II: Partially-Methylated||20
65525|NCT01357239|151921|P3|STARTED|Stratum II: Partially-Methylated||22
65526|NCT01357239|151922|P2|STARTED|Stratum II: Partially-Methylated||21
65527|NCT01357239|151923|P1|STARTED|Stratum II: Partially-Methylated||23
65528|NCT01357239|151920|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
65529|NCT01357239|151921|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
65530|NCT01357239|151922|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
65531|NCT01357239|151923|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
65532|NCT01357239|151920|P4|COMPLETED|Stratum I: Fully-Methylated||22
65533|NCT01357239|151921|P3|COMPLETED|Stratum I: Fully-Methylated||16
65534|NCT01357239|151922|P2|COMPLETED|Stratum I: Fully-Methylated||6
65535|NCT01357239|151923|P1|COMPLETED|Stratum I: Fully-Methylated||8
65536|NCT01357239|151920|P4|STARTED|Stratum I: Fully-Methylated||22
65537|NCT01357239|151921|P3|STARTED|Stratum I: Fully-Methylated||17
65538|NCT01357239|151922|P2|STARTED|Stratum I: Fully-Methylated||6
65539|NCT01357239|151923|P1|STARTED|Stratum I: Fully-Methylated||8
65540|NCT01357239|151920|P4|NOT COMPLETED|Stratum: All Patients||2
65541|NCT01357239|151921|P3|NOT COMPLETED|Stratum: All Patients||2
65542|NCT01357239|151922|P2|NOT COMPLETED|Stratum: All Patients||0
65543|NCT01357239|151923|P1|NOT COMPLETED|Stratum: All Patients||0
65544|NCT01357239|151920|P4|COMPLETED|Stratum: All Patients||40
65545|NCT01357239|151921|P3|COMPLETED|Stratum: All Patients||37
65546|NCT01357239|151922|P2|COMPLETED|Stratum: All Patients||27
65547|NCT01357239|151923|P1|COMPLETED|Stratum: All Patients||31
65548|NCT01357239|151920|P4|STARTED|Stratum: All Patients||42
65549|NCT01357239|151921|P3|STARTED|Stratum: All Patients||39
65550|NCT01357239|151922|P2|STARTED|Stratum: All Patients||27
65551|NCT01357239|151923|P1|STARTED|Stratum: All Patients||31
65552|NCT01357148|151978|P1|NOT COMPLETED|Overall Study||0
65553|NCT01357148|151978|P1|COMPLETED|Overall Study||143
65554|NCT01357148|151978|P1|STARTED|Overall Study||143
65555|NCT01357135|151988|P3|NOT COMPLETED|Overall Study||263
65556|NCT01357135|151989|P2|NOT COMPLETED|Overall Study||223
65557|NCT01357135|151990|P1|NOT COMPLETED|Overall Study||598
65558|NCT01357135|151988|P3|COMPLETED|Overall Study||583
65559|NCT01357135|151989|P2|COMPLETED|Overall Study||510
65560|NCT01357135|151990|P1|COMPLETED|Overall Study||1276
65561|NCT01357135|151988|P3|STARTED|Overall Study||846
65562|NCT01357135|151989|P2|STARTED|Overall Study||733
65563|NCT01357135|151990|P1|STARTED|Overall Study||1874
65564|NCT01356966|152001|P2|NOT COMPLETED|Overall Study||2
65565|NCT01356966|152002|P1|NOT COMPLETED|Overall Study||2
65566|NCT01356966|152001|P2|COMPLETED|Overall Study||12
65567|NCT01356966|152002|P1|COMPLETED|Overall Study||16
65568|NCT01356966|152001|P2|STARTED|Overall Study||14
65569|NCT01356966|152002|P1|STARTED|Overall Study||18
65570|NCT01356940|152014|P2|NOT COMPLETED|Second Intervention (28 Days)||0
65571|NCT01356940|152015|P1|NOT COMPLETED|Second Intervention (28 Days)||1
65572|NCT01356940|152014|P2|COMPLETED|Second Intervention (28 Days)||21
65573|NCT01356940|152015|P1|COMPLETED|Second Intervention (28 Days)||20
65574|NCT01356940|152014|P2|STARTED|Second Intervention (28 Days)||21
65575|NCT01356940|152015|P1|STARTED|Second Intervention (28 Days)||21
65576|NCT01356940|152014|P2|NOT COMPLETED|Washout (14 Days)||0
65577|NCT01356940|152015|P1|NOT COMPLETED|Washout (14 Days)||0
65578|NCT01356940|152014|P2|COMPLETED|Washout (14 Days)||21
65579|NCT01356940|152015|P1|COMPLETED|Washout (14 Days)||21
65580|NCT01356940|152014|P2|STARTED|Washout (14 Days)||21
65581|NCT01356940|152015|P1|STARTED|Washout (14 Days)||21
65582|NCT01356940|152014|P2|NOT COMPLETED|First Intervention (28 Days)||0
65583|NCT01356940|152015|P1|NOT COMPLETED|First Intervention (28 Days)||1
65584|NCT01356940|152014|P2|COMPLETED|First Intervention (28 Days)||21
65585|NCT01356940|152015|P1|COMPLETED|First Intervention (28 Days)||21
65586|NCT01356940|152014|P2|STARTED|First Intervention (28 Days)||21
65587|NCT01356940|152015|P1|STARTED|First Intervention (28 Days)||22
65588|NCT01356667|152023|P2|NOT COMPLETED|Overall Study||6
65589|NCT01356667|152024|P1|NOT COMPLETED|Overall Study||4
65590|NCT01356667|152023|P2|COMPLETED|Overall Study||0
65591|NCT01356667|152024|P1|COMPLETED|Overall Study||0
65592|NCT01356667|152023|P2|STARTED|Overall Study||6
65593|NCT01356667|152024|P1|STARTED|Overall Study||4
65594|NCT01356602|152037|P3|NOT COMPLETED|Overall Study||24
65595|NCT01356602|152038|P2|NOT COMPLETED|Overall Study||15
65596|NCT01356602|152039|P1|NOT COMPLETED|Overall Study||9
65597|NCT01356602|152037|P3|COMPLETED|Overall Study||108
65598|NCT01356602|152038|P2|COMPLETED|Overall Study||117
65599|NCT01356602|152039|P1|COMPLETED|Overall Study||124
65600|NCT01356602|152037|P3|Full Analysis Set|Overall Study||129
65601|NCT01356602|152038|P2|Full Analysis Set|Overall Study||129
65602|NCT01356602|152039|P1|Full Analysis Set|Overall Study||131
65603|NCT01356602|152037|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
65604|NCT01356602|152038|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
65605|NCT01356602|152039|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
65606|NCT01356602|152037|P3|STARTED|Overall Study||132
65607|NCT01356602|152038|P2|STARTED|Overall Study||132
65608|NCT01356602|152039|P1|STARTED|Overall Study||133
65609|NCT01356589|152098|P1|NOT COMPLETED|Overall Study||5
65610|NCT01356589|152098|P1|COMPLETED|Overall Study||1283
65611|NCT01356589|152098|P1|Treated|Overall Study||1285
65612|NCT01356589|152098|P1|STARTED|Overall Study||1288
65613|NCT01356498|152110|P6|NOT COMPLETED|Overall Study||14
65614|NCT01356498|152111|P5|NOT COMPLETED|Overall Study||20
65615|NCT01356498|152112|P4|NOT COMPLETED|Overall Study||14
65616|NCT01356498|152113|P3|NOT COMPLETED|Overall Study||12
65617|NCT01356498|152114|P2|NOT COMPLETED|Overall Study||8
65618|NCT01356498|152115|P1|NOT COMPLETED|Overall Study||11
65619|NCT01356498|152110|P6|COMPLETED|Overall Study||2
65620|NCT01356498|152111|P5|COMPLETED|Overall Study||8
65621|NCT01356498|152112|P4|COMPLETED|Overall Study||8
65622|NCT01356498|152113|P3|COMPLETED|Overall Study||11
65623|NCT01356498|152114|P2|COMPLETED|Overall Study||17
65624|NCT01356498|152115|P1|COMPLETED|Overall Study||24
65625|NCT01356498|152110|P6|STARTED|Overall Study||16
65626|NCT01356498|152111|P5|STARTED|Overall Study||28
65627|NCT01356498|152112|P4|STARTED|Overall Study||22
65628|NCT01356498|152113|P3|STARTED|Overall Study||23
65629|NCT01356498|152114|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
65630|NCT01356498|152115|P1|STARTED|Overall Study||35
65631|NCT01356407|152155|P2|NOT COMPLETED|Overall Study||4
65632|NCT01356407|152156|P1|NOT COMPLETED|Overall Study||6
65633|NCT01356407|152155|P2|COMPLETED|Overall Study||146
65634|NCT01356407|152156|P1|COMPLETED|Overall Study||144
65635|NCT01356407|152155|P2|STARTED|Overall Study||150
65636|NCT01356407|152156|P1|STARTED|Overall Study||150
65637|NCT01356147|152174|P2|NOT COMPLETED|Overall Study||0
65638|NCT01356147|152175|P1|NOT COMPLETED|Overall Study||0
65639|NCT01356147|152174|P2|COMPLETED|Overall Study||6
65640|NCT01356147|152175|P1|COMPLETED|Overall Study||5
65641|NCT01356147|152174|P2|STARTED|Overall Study||6
65642|NCT01356147|152175|P1|STARTED|Overall Study||5
65643|NCT01355978|152181|P1|NOT COMPLETED|Overall Study||4
65644|NCT01355978|152181|P1|COMPLETED|Overall Study||18
65645|NCT01355978|152181|P1|STARTED|Overall Study||22
65646|NCT01355679|152187|P1|NOT COMPLETED|Overall Study||2
65647|NCT01355679|152187|P1|COMPLETED|Overall Study||14
65648|NCT01355679|152187|P1|STARTED|Overall Study||16
65649|NCT01355627|152196|P2|NOT COMPLETED|Overall Study||38
65650|NCT01355627|152197|P1|NOT COMPLETED|Overall Study||33
65651|NCT01355627|152196|P2|COMPLETED|Overall Study||326
65652|NCT01355627|152197|P1|COMPLETED|Overall Study||329
65653|NCT01355627|152196|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
65654|NCT01355627|152197|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
65655|NCT01355627|152196|P2|Safety Analysis Set|Overall Study||364
65656|NCT01355627|152197|P1|Safety Analysis Set|Overall Study||362
65657|NCT01355627|152196|P2|STARTED|Overall Study||364
65658|NCT01355627|152197|P1|STARTED|Overall Study||362
65659|NCT01355588|152209|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
65660|NCT01355588|152210|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
65661|NCT01355588|152211|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
65662|NCT01355588|152212|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
65663|NCT01355588|152209|P4|COMPLETED|Fourth Intervention (After Washout)||4
65664|NCT01355588|152210|P3|COMPLETED|Fourth Intervention (After Washout)||4
65665|NCT01355588|152211|P2|COMPLETED|Fourth Intervention (After Washout)||4
65666|NCT01355588|152212|P1|COMPLETED|Fourth Intervention (After Washout)||4
65667|NCT01355588|152209|P4|STARTED|Fourth Intervention (After Washout)||4
65668|NCT01355588|152210|P3|STARTED|Fourth Intervention (After Washout)||4
65669|NCT01355588|152211|P2|STARTED|Fourth Intervention (After Washout)||4
65670|NCT01355588|152212|P1|STARTED|Fourth Intervention (After Washout)||4
65671|NCT01355588|152209|P4|NOT COMPLETED|Washout (3-7 Days)||0
65672|NCT01355588|152210|P3|NOT COMPLETED|Washout (3-7 Days)||0
65673|NCT01355588|152211|P2|NOT COMPLETED|Washout (3-7 Days)||0
65674|NCT01355588|152212|P1|NOT COMPLETED|Washout (3-7 Days)||0
65675|NCT01355588|152209|P4|COMPLETED|Washout (3-7 Days)||4
65676|NCT01355588|152210|P3|COMPLETED|Washout (3-7 Days)||4
65677|NCT01355588|152211|P2|COMPLETED|Washout (3-7 Days)||4
65678|NCT01355588|152212|P1|COMPLETED|Washout (3-7 Days)||4
65679|NCT01355588|152209|P4|STARTED|Washout (3-7 Days)||4
65680|NCT01355588|152210|P3|STARTED|Washout (3-7 Days)||4
65681|NCT01355588|152211|P2|STARTED|Washout (3-7 Days)||4
65682|NCT01355588|152212|P1|STARTED|Washout (3-7 Days)||4
65683|NCT01355588|152209|P4|NOT COMPLETED|Third Intervention (After Washout)||0
65684|NCT01355588|152210|P3|NOT COMPLETED|Third Intervention (After Washout)||0
65685|NCT01355588|152211|P2|NOT COMPLETED|Third Intervention (After Washout)||0
65686|NCT01355588|152212|P1|NOT COMPLETED|Third Intervention (After Washout)||0
65687|NCT01355588|152209|P4|COMPLETED|Third Intervention (After Washout)||4
65688|NCT01355588|152210|P3|COMPLETED|Third Intervention (After Washout)||4
65689|NCT01355588|152211|P2|COMPLETED|Third Intervention (After Washout)||4
65690|NCT01355588|152212|P1|COMPLETED|Third Intervention (After Washout)||4
65691|NCT01355588|152209|P4|STARTED|Third Intervention (After Washout)||4
65692|NCT01355588|152210|P3|STARTED|Third Intervention (After Washout)||4
65693|NCT01355588|152211|P2|STARTED|Third Intervention (After Washout)||4
65694|NCT01355588|152212|P1|STARTED|Third Intervention (After Washout)||4
65695|NCT01355588|152209|P4|NOT COMPLETED|Washout (3-7 Days)||0
65696|NCT01355588|152210|P3|NOT COMPLETED|Washout (3-7 Days)||0
65697|NCT01355588|152211|P2|NOT COMPLETED|Washout (3-7 Days)||0
65698|NCT01355588|152212|P1|NOT COMPLETED|Washout (3-7 Days)||0
65699|NCT01355588|152209|P4|COMPLETED|Washout (3-7 Days)||4
65700|NCT01355588|152210|P3|COMPLETED|Washout (3-7 Days)||4
65701|NCT01355588|152211|P2|COMPLETED|Washout (3-7 Days)||4
65702|NCT01355588|152212|P1|COMPLETED|Washout (3-7 Days)||4
65703|NCT01355588|152209|P4|STARTED|Washout (3-7 Days)||4
65704|NCT01355588|152210|P3|STARTED|Washout (3-7 Days)||4
65705|NCT01355588|152211|P2|STARTED|Washout (3-7 Days)||4
65706|NCT01355588|152212|P1|STARTED|Washout (3-7 Days)||4
65707|NCT01355588|152209|P4|NOT COMPLETED|Second Intervention (After Washout)||0
65708|NCT01355588|152210|P3|NOT COMPLETED|Second Intervention (After Washout)||0
65709|NCT01355588|152211|P2|NOT COMPLETED|Second Intervention (After Washout)||0
65710|NCT01355588|152212|P1|NOT COMPLETED|Second Intervention (After Washout)||0
65711|NCT01355588|152209|P4|COMPLETED|Second Intervention (After Washout)||4
65712|NCT01355588|152210|P3|COMPLETED|Second Intervention (After Washout)||4
65713|NCT01355588|152211|P2|COMPLETED|Second Intervention (After Washout)||4
65714|NCT01355588|152212|P1|COMPLETED|Second Intervention (After Washout)||4
65715|NCT01355588|152209|P4|STARTED|Second Intervention (After Washout)||4
65716|NCT01355588|152210|P3|STARTED|Second Intervention (After Washout)||4
65717|NCT01355588|152211|P2|STARTED|Second Intervention (After Washout)||4
65718|NCT01355588|152212|P1|STARTED|Second Intervention (After Washout)||4
65719|NCT01355588|152209|P4|NOT COMPLETED|Washout (3-7 Days)||0
65720|NCT01355588|152210|P3|NOT COMPLETED|Washout (3-7 Days)||0
65721|NCT01355588|152211|P2|NOT COMPLETED|Washout (3-7 Days)||0
65722|NCT01355588|152212|P1|NOT COMPLETED|Washout (3-7 Days)||0
65723|NCT01355588|152209|P4|COMPLETED|Washout (3-7 Days)||4
65724|NCT01355588|152210|P3|COMPLETED|Washout (3-7 Days)||4
65725|NCT01355588|152211|P2|COMPLETED|Washout (3-7 Days)||4
65726|NCT01355588|152212|P1|COMPLETED|Washout (3-7 Days)||4
65727|NCT01355588|152209|P4|STARTED|Washout (3-7 Days)||4
65728|NCT01355588|152210|P3|STARTED|Washout (3-7 Days)||4
65729|NCT01355588|152211|P2|STARTED|Washout (3-7 Days)||4
65730|NCT01355588|152212|P1|STARTED|Washout (3-7 Days)||4
65731|NCT01355588|152209|P4|NOT COMPLETED|First Intervention (Day 1)||0
65732|NCT01355588|152210|P3|NOT COMPLETED|First Intervention (Day 1)||0
65733|NCT01355588|152211|P2|NOT COMPLETED|First Intervention (Day 1)||0
65734|NCT01355588|152212|P1|NOT COMPLETED|First Intervention (Day 1)||0
65735|NCT01355588|152209|P4|COMPLETED|First Intervention (Day 1)||4
65736|NCT01355588|152210|P3|COMPLETED|First Intervention (Day 1)||4
65737|NCT01355588|152211|P2|COMPLETED|First Intervention (Day 1)||4
65738|NCT01355588|152212|P1|COMPLETED|First Intervention (Day 1)||4
65739|NCT01355588|152209|P4|STARTED|First Intervention (Day 1)||4
65740|NCT01355588|152210|P3|STARTED|First Intervention (Day 1)||4
65741|NCT01355588|152211|P2|STARTED|First Intervention (Day 1)||4
65742|NCT01355588|152212|P1|STARTED|First Intervention (Day 1)||4
65743|NCT01355523|152236|P2|NOT COMPLETED|Overall Study||10
65744|NCT01355523|152237|P1|NOT COMPLETED|Overall Study||1
65745|NCT01355523|152236|P2|COMPLETED|Overall Study||16
65746|NCT01355523|152237|P1|COMPLETED|Overall Study||27
65747|NCT01355523|152236|P2|STARTED|Overall Study||26
65748|NCT01355523|152237|P1|STARTED|Overall Study||28
65749|NCT01355484|152281|P2|NOT COMPLETED|Overall Study||54
65750|NCT01355484|152282|P1|NOT COMPLETED|Overall Study||51
65751|NCT01355484|152281|P2|COMPLETED|Overall Study||107
65752|NCT01355484|152282|P1|COMPLETED|Overall Study||109
65753|NCT01355484|152281|P2|STARTED|Overall Study||161
65754|NCT01355484|152282|P1|STARTED|Overall Study||160
65755|NCT01355471|152292|P2|NOT COMPLETED|Overall Study||3
65756|NCT01355471|152293|P1|NOT COMPLETED|Overall Study||7
65757|NCT01355471|152292|P2|COMPLETED|Overall Study||142
65758|NCT01355471|152293|P1|COMPLETED|Overall Study||141
65759|NCT01355471|152292|P2|STARTED|Overall Study||145
65760|NCT01355471|152293|P1|STARTED|Overall Study||148
65761|NCT01355458|152301|P2|NOT COMPLETED|Overall Study||4
65762|NCT01355458|152302|P1|NOT COMPLETED|Overall Study||2
65763|NCT01355458|152301|P2|COMPLETED|Overall Study||127
65764|NCT01355458|152302|P1|COMPLETED|Overall Study||127
65765|NCT01355458|152301|P2|STARTED|Overall Study||131
65766|NCT01355458|152302|P1|STARTED|Overall Study||129
65767|NCT01355419|152308|P1|NOT COMPLETED|Overall Study||8
65768|NCT01355419|152308|P1|COMPLETED|Overall Study||142
65769|NCT01355419|152308|P1|STARTED|Overall Study||150
65770|NCT01355081|152316|P3|NOT COMPLETED|Overall Study||11
65771|NCT01355081|152317|P2|NOT COMPLETED|Overall Study||10
65772|NCT01355081|152318|P1|NOT COMPLETED|Overall Study||7
65773|NCT01355081|152316|P3|COMPLETED|Overall Study||113
65774|NCT01355081|152317|P2|COMPLETED|Overall Study||113
65775|NCT01355081|152318|P1|COMPLETED|Overall Study||112
65776|NCT01355081|152316|P3|STARTED|Overall Study||124
65777|NCT01355081|152317|P2|STARTED|Overall Study||123
65778|NCT01355081|152318|P1|STARTED|Overall Study||119
65779|NCT01355068|152341|P2|NOT COMPLETED|Second Intervention Period||0
65780|NCT01355068|152342|P1|NOT COMPLETED|Second Intervention Period||0
65781|NCT01355068|152341|P2|COMPLETED|Second Intervention Period||11
65782|NCT01355068|152342|P1|COMPLETED|Second Intervention Period||13
65783|NCT01355068|152341|P2|STARTED|Second Intervention Period||11
65784|NCT01355068|152342|P1|STARTED|Second Intervention Period||13
65785|NCT01355068|152341|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
65786|NCT01355068|152342|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
65787|NCT01355068|152341|P2|COMPLETED|Washout Period (at Least 7 Days)||11
65788|NCT01355068|152342|P1|COMPLETED|Washout Period (at Least 7 Days)||13
65789|NCT01355068|152341|P2|STARTED|Washout Period (at Least 7 Days)||11
65790|NCT01355068|152342|P1|STARTED|Washout Period (at Least 7 Days)||13
65791|NCT01355068|152341|P2|NOT COMPLETED|First Intervention Period||2
65792|NCT01355068|152342|P1|NOT COMPLETED|First Intervention Period||0
65793|NCT01355068|152341|P2|COMPLETED|First Intervention Period||11
65794|NCT01355068|152342|P1|COMPLETED|First Intervention Period||13
65795|NCT01355068|152341|P2|STARTED|First Intervention Period||13
65796|NCT01355068|152342|P1|STARTED|First Intervention Period||13
65797|NCT01354990|152358|P1|NOT COMPLETED|Overall Study||0
65798|NCT01354990|152358|P1|COMPLETED|Overall Study||2974
65799|NCT01354990|152358|P1|STARTED|Overall Study||2974
65800|NCT01354938|152365|P1|NOT COMPLETED|Overall Study||1
65801|NCT01354938|152365|P1|COMPLETED|Overall Study||219
65802|NCT01354938|152365|P1|STARTED|Overall Study||220
65803|NCT01354899|152371|P1|NOT COMPLETED|Overall Study||3
65804|NCT01354899|152371|P1|COMPLETED|Overall Study||21
65805|NCT01354899|152371|P1|STARTED|Overall Study||24
65806|NCT01354652|152379|P3|NOT COMPLETED|Overall Study||0
65807|NCT01354652|152380|P2|NOT COMPLETED|Overall Study||2
65808|NCT01354652|152381|P1|NOT COMPLETED|Overall Study||3
65809|NCT01354652|152379|P3|COMPLETED|Overall Study||0
65810|NCT01354652|152380|P2|COMPLETED|Overall Study||0
65811|NCT01354652|152381|P1|COMPLETED|Overall Study||0
65812|NCT01354652|152379|P3|STARTED|Overall Study||0
65813|NCT01354652|152380|P2|STARTED|Overall Study||2
65814|NCT01354652|152381|P1|STARTED|Overall Study||3
65815|NCT01354431|152392|P3|NOT COMPLETED|Participants Treated||54
65816|NCT01354431|152393|P2|NOT COMPLETED|Participants Treated||54
65817|NCT01354431|152394|P1|NOT COMPLETED|Participants Treated||59
65818|NCT01354431|152392|P3|COMPLETED|Participants Treated||0
65819|NCT01354431|152393|P2|COMPLETED|Participants Treated||0
65820|NCT01354431|152394|P1|COMPLETED|Participants Treated||0
65821|NCT01354431|152392|P3|STARTED|Participants Treated||54
65822|NCT01354431|152393|P2|STARTED|Participants Treated||54
65823|NCT01354431|152394|P1|STARTED|Participants Treated||59
65824|NCT01354431|152392|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
65825|NCT01354431|152393|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
65826|NCT01354431|152394|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
65827|NCT01354431|152392|P3|COMPLETED|Randomized to Enter Treatment Period||54
65828|NCT01354431|152393|P2|COMPLETED|Randomized to Enter Treatment Period||54
65829|NCT01354431|152394|P1|COMPLETED|Randomized to Enter Treatment Period||59
65830|NCT01354431|152392|P3|STARTED|Randomized to Enter Treatment Period||54
65831|NCT01354431|152393|P2|STARTED|Randomized to Enter Treatment Period||54
65832|NCT01354431|152394|P1|STARTED|Randomized to Enter Treatment Period||60
65833|NCT01354223|152416|P2|NOT COMPLETED|Overall Study||1
65834|NCT01354223|152417|P1|NOT COMPLETED|Overall Study||3
65835|NCT01354223|152416|P2|COMPLETED|Overall Study||29
65836|NCT01354223|152417|P1|COMPLETED|Overall Study||57
65837|NCT01354223|152416|P2|STARTED|Overall Study||30
65838|NCT01354223|152417|P1|STARTED|Overall Study||60
65839|NCT01354145|152433|P2|NOT COMPLETED|Overall Study||34
65840|NCT01354145|152434|P1|NOT COMPLETED|Overall Study||39
65841|NCT01354145|152433|P2|COMPLETED|Overall Study||63
65842|NCT01354145|152434|P1|COMPLETED|Overall Study||58
65843|NCT01354145|152433|P2|STARTED|Overall Study||97
65844|NCT01354145|152434|P1|STARTED|Overall Study||97
65845|NCT01354106|152466|P1|NOT COMPLETED|Overall Study||2
65846|NCT01354106|152466|P1|COMPLETED|Overall Study||24
65847|NCT01354106|152466|P1|STARTED|Overall Study||26
65848|NCT01354028|152472|P2|NOT COMPLETED|Overall Study||5
65849|NCT01354028|152473|P1|NOT COMPLETED|Overall Study||2
65850|NCT01354028|152472|P2|COMPLETED|Overall Study||10
65851|NCT01354028|152473|P1|COMPLETED|Overall Study||13
65852|NCT01354028|152472|P2|STARTED|Overall Study||15
65853|NCT01354028|152473|P1|STARTED|Overall Study||15
65854|NCT01354015|152487|P2|NOT COMPLETED|Overall Study||5
65855|NCT01354015|152488|P1|NOT COMPLETED|Overall Study||6
65856|NCT01354015|152487|P2|COMPLETED|Overall Study||43
65857|NCT01354015|152488|P1|COMPLETED|Overall Study||44
65858|NCT01354015|152487|P2|STARTED|Overall Study||48
65859|NCT01354015|152488|P1|STARTED|Overall Study||50
65860|NCT01353976|152498|P2|NOT COMPLETED|Overall Study||51
65861|NCT01353976|152499|P1|NOT COMPLETED|Overall Study||48
65862|NCT01353976|152498|P2|COMPLETED|Overall Study||83
65863|NCT01353976|152499|P1|COMPLETED|Overall Study||82
65864|NCT01353976|152498|P2|STARTED|Overall Study||134
65865|NCT01353976|152499|P1|STARTED|Overall Study||130
65866|NCT01353963|152509|P1|NOT COMPLETED|Overall Study||2
65867|NCT01353963|152509|P1|COMPLETED|Overall Study||11
65868|NCT01353963|152509|P1|STARTED|Overall Study||13
65869|NCT01353911|152527|P8|NOT COMPLETED|Overall Study||15
65870|NCT01353911|152528|P7|NOT COMPLETED|Overall Study||6
65871|NCT01353911|152529|P6|NOT COMPLETED|Overall Study||7
65872|NCT01353911|152530|P5|NOT COMPLETED|Overall Study||6
65873|NCT01353911|152531|P4|NOT COMPLETED|Overall Study||2
65874|NCT01353911|152532|P3|NOT COMPLETED|Overall Study||9
65875|NCT01353911|152533|P2|NOT COMPLETED|Overall Study||9
65876|NCT01353911|152534|P1|NOT COMPLETED|Overall Study||8
65877|NCT01353911|152527|P8|COMPLETED|Overall Study||51
65878|NCT01353911|152528|P7|COMPLETED|Overall Study||30
65879|NCT01353911|152529|P6|COMPLETED|Overall Study||36
65880|NCT01353911|152530|P5|COMPLETED|Overall Study||23
65881|NCT01353911|152531|P4|COMPLETED|Overall Study||22
65882|NCT01353911|152532|P3|COMPLETED|Overall Study||59
65883|NCT01353911|152533|P2|COMPLETED|Overall Study||57
65884|NCT01353911|152534|P1|COMPLETED|Overall Study||28
65885|NCT01353911|152527|P8|STARTED|Overall Study||66
65886|NCT01353911|152528|P7|STARTED|Overall Study||36
65887|NCT01353911|152529|P6|STARTED|Overall Study||43
65888|NCT01353911|152530|P5|STARTED|Overall Study||29
65889|NCT01353911|152531|P4|STARTED|Overall Study||24
65890|NCT01353911|152532|P3|STARTED|Overall Study||68
65891|NCT01353911|152533|P2|STARTED|Overall Study||66
65892|NCT01353911|152534|P1|STARTED|Overall Study||36
65893|NCT01353898|152614|P6|NOT COMPLETED|Overall Study||1
65894|NCT01353898|152615|P5|NOT COMPLETED|Overall Study||0
65895|NCT01353898|152616|P4|NOT COMPLETED|Overall Study||0
65896|NCT01353898|152617|P3|NOT COMPLETED|Overall Study||0
65897|NCT01353898|152618|P2|NOT COMPLETED|Overall Study||0
65898|NCT01353898|152619|P1|NOT COMPLETED|Overall Study||0
65899|NCT01353898|152614|P6|COMPLETED|Overall Study||1
65900|NCT01353898|152615|P5|COMPLETED|Overall Study||2
65901|NCT01353898|152616|P4|COMPLETED|Overall Study||2
65902|NCT01353898|152617|P3|COMPLETED|Overall Study||2
65903|NCT01353898|152618|P2|COMPLETED|Overall Study||2
65904|NCT01353898|152619|P1|COMPLETED|Overall Study||2
65905|NCT01353898|152614|P6|STARTED|Overall Study||2
65906|NCT01353898|152615|P5|STARTED|Overall Study||2
65907|NCT01353898|152616|P4|STARTED|Overall Study||2
65908|NCT01353898|152617|P3|STARTED|Overall Study||2
65909|NCT01353898|152618|P2|STARTED|Overall Study||2
65910|NCT01353898|152619|P1|STARTED|Overall Study||2
65911|NCT01353859|152645|P1|NOT COMPLETED|Overall Study||4
65912|NCT01353859|152645|P1|COMPLETED|Overall Study||35
65913|NCT01353859|152645|P1|STARTED|Overall Study||39
65914|NCT01353664|152658|P1|NOT COMPLETED|Overall Study||19
65915|NCT01353664|152658|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
65916|NCT01353664|152658|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
65917|NCT01353586|152664|P2|NOT COMPLETED|Overall Study||2
65918|NCT01353586|152665|P1|NOT COMPLETED|Overall Study||7
65919|NCT01353586|152664|P2|COMPLETED|Overall Study||17
65920|NCT01353586|152665|P1|COMPLETED|Overall Study||160
65921|NCT01353586|152664|P2|Participated in SNA Substudy|Overall Study||19
65922|NCT01353586|152665|P1|Participated in SNA Substudy|Overall Study||19
65923|NCT01353586|152664|P2|Participated in Roll-in Phase|Overall Study||0
65924|NCT01353586|152665|P1|Participated in Roll-in Phase|Overall Study||22
65925|NCT01353586|152664|P2|Participated in Workflow Phase|Overall Study||0
65926|NCT01353586|152665|P1|Participated in Workflow Phase|Overall Study||20
65927|NCT01353586|152664|P2|STARTED|Overall Study||19
65928|NCT01353586|152665|P1|STARTED|Overall Study||167
65929|NCT01353508|152683|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
65930|NCT01353508|152684|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
65931|NCT01353508|152685|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
65932|NCT01353508|152686|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
65933|NCT01353508|152683|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
65934|NCT01353508|152684|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
65935|NCT01353508|152685|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
65936|NCT01353508|152686|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
65937|NCT01353508|152683|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
65938|NCT01353508|152684|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
65939|NCT01353508|152685|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
65940|NCT01353508|152686|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
65941|NCT01353508|152683|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
65942|NCT01353508|152684|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
65943|NCT01353508|152685|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
65944|NCT01353508|152686|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
65945|NCT01353508|152683|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
65946|NCT01353508|152684|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
65947|NCT01353508|152685|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
65948|NCT01353508|152686|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
65949|NCT01353508|152683|P4|STARTED|Period 1 - First Intervention (7 Days)||8
65950|NCT01353508|152684|P3|STARTED|Period 1 - First Intervention (7 Days)||8
65951|NCT01353508|152685|P2|STARTED|Period 1 - First Intervention (7 Days)||8
65952|NCT01353508|152686|P1|STARTED|Period 1 - First Intervention (7 Days)||8
65953|NCT01353274|152764|P1|NOT COMPLETED|Overall Study||28
65954|NCT01353274|152764|P1|COMPLETED|Overall Study||1129
65955|NCT01353274|152764|P1|STARTED|Overall Study||1157
65956|NCT01353144|152774|P2|NOT COMPLETED|Overall Study||8
65957|NCT01353144|152775|P1|NOT COMPLETED|Overall Study||9
65958|NCT01353144|152774|P2|COMPLETED|Overall Study||81
65959|NCT01353144|152775|P1|COMPLETED|Overall Study||80
65960|NCT01353144|152774|P2|STARTED|Overall Study||89
65961|NCT01353144|152775|P1|STARTED|Overall Study||89
65962|NCT01353079|152785|P2|NOT COMPLETED|Overall Study||21
65963|NCT01353079|152786|P1|NOT COMPLETED|Overall Study||27
65964|NCT01353079|152785|P2|COMPLETED|Overall Study||190
65965|NCT01353079|152786|P1|COMPLETED|Overall Study||191
65966|NCT01353079|152785|P2|STARTED|Overall Study||211
65967|NCT01353079|152786|P1|STARTED|Overall Study||218
65968|NCT01352845|152800|P2|NOT COMPLETED|Overall Study||203
65969|NCT01352845|152801|P1|NOT COMPLETED|Overall Study||671
65970|NCT01352845|152800|P2|COMPLETED|Overall Study||619
65971|NCT01352845|152801|P1|COMPLETED|Overall Study||1800
65972|NCT01352845|152800|P2|STARTED|Overall Study||822
65973|NCT01352845|152801|P1|STARTED|Overall Study||2471
65974|NCT01352793|152890|P2|NOT COMPLETED|Overall Study||245
65975|NCT01352793|152891|P1|NOT COMPLETED|Overall Study||585
65976|NCT01352793|152890|P2|COMPLETED|Overall Study||1663
65977|NCT01352793|152891|P1|COMPLETED|Overall Study||3219
65978|NCT01352793|152890|P2|Vaccination 3|Overall Study||1710
65979|NCT01352793|152891|P1|Vaccination 3|Overall Study||3314
65980|NCT01352793|152890|P2|Vaccination 2|Overall Study||1806
65981|NCT01352793|152891|P1|Vaccination 2|Overall Study||3530
65982|NCT01352793|152890|P2|Vaccination 1|Overall Study||1908
65983|NCT01352793|152891|P1|Vaccination 1|Overall Study||3796
65984|NCT01352793|152890|P2|STARTED|Overall Study||1908
65985|NCT01352793|152891|P1|STARTED|Overall Study||3804
65986|NCT01352741|152915|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
65987|NCT01352741|152916|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
65988|NCT01352741|152915|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
65989|NCT01352741|152916|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
65990|NCT01352741|152915|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
65991|NCT01352741|152916|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
65992|NCT01352741|152915|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
65993|NCT01352741|152916|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
65994|NCT01352741|152915|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
65995|NCT01352741|152916|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
65996|NCT01352741|152915|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
65997|NCT01352741|152916|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
65998|NCT01352741|152915|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
65999|NCT01352741|152916|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
66000|NCT01352741|152915|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
66001|NCT01352741|152916|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
66002|NCT01352741|152915|P2|NOT COMPLETED|Double-blind Comparative Period||26
66003|NCT01352741|152916|P1|NOT COMPLETED|Double-blind Comparative Period||28
66004|NCT01352741|152915|P2|COMPLETED|Double-blind Comparative Period||133
66005|NCT01352741|152916|P1|COMPLETED|Double-blind Comparative Period||126
66006|NCT01352741|152915|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
66007|NCT01352741|152916|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
66008|NCT01352741|152915|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
66009|NCT01352741|152916|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
66010|NCT01352741|152915|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
66011|NCT01352741|152916|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
66012|NCT01352741|152915|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
66013|NCT01352741|152916|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
66014|NCT01352741|152915|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
66015|NCT01352741|152916|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
66016|NCT01352741|152915|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
66017|NCT01352741|152916|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
66018|NCT01352741|152915|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
66019|NCT01352741|152916|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
66020|NCT01352741|152915|P2|Per Protocol Set|Double-blind Comparative Period||149
66021|NCT01352741|152916|P1|Per Protocol Set|Double-blind Comparative Period||139
66022|NCT01352741|152915|P2|Major Protocol Deviations|Double-blind Comparative Period||8
66023|NCT01352741|152916|P1|Major Protocol Deviations|Double-blind Comparative Period||13
66024|NCT01352741|152915|P2|Full Analysis Set|Double-blind Comparative Period||157
66025|NCT01352741|152916|P1|Full Analysis Set|Double-blind Comparative Period||152
66026|NCT01352741|152915|P2|No Pain Assessments Available|Double-blind Comparative Period||2
66027|NCT01352741|152916|P1|No Pain Assessments Available|Double-blind Comparative Period||2
66028|NCT01352741|152915|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
66029|NCT01352741|152916|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
66030|NCT01352741|152915|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
66031|NCT01352741|152916|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
66032|NCT01352741|152915|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
66033|NCT01352741|152916|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
66034|NCT01352741|152915|P2|COMPLETED|Open-label Tapentadol Titration Period||0
66035|NCT01352741|152916|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
66036|NCT01352741|152915|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
66037|NCT01352741|152916|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
66038|NCT01352741|152915|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
66039|NCT01352741|152916|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
66040|NCT01352741|152915|P2|STARTED|Open-label Tapentadol Titration Period||0
66041|NCT01352741|152916|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
66042|NCT01352715|153010|P2|NOT COMPLETED|Overall Study||46
66043|NCT01352715|153011|P1|NOT COMPLETED|Overall Study||45
66044|NCT01352715|153010|P2|COMPLETED|Overall Study||209
66045|NCT01352715|153011|P1|COMPLETED|Overall Study||215
66046|NCT01352715|153010|P2|STARTED|Overall Study||255
66047|NCT01352715|153011|P1|STARTED|Overall Study||260
66048|NCT01352585|153033|P1|NOT COMPLETED|Overall Study||11
66049|NCT01352585|153033|P1|COMPLETED|Overall Study||36
66050|NCT01352585|153033|P1|STARTED|Overall Study||47
66051|NCT01352507|153046|P2|NOT COMPLETED|Extension Phase||0
66052|NCT01352507|153047|P1|NOT COMPLETED|Extension Phase||0
66053|NCT01352507|153046|P2|COMPLETED|Extension Phase||173
66054|NCT01352507|153047|P1|COMPLETED|Extension Phase||164
66055|NCT01352507|153046|P2|STARTED|Extension Phase||173
66056|NCT01352507|153047|P1|STARTED|Extension Phase||164
66057|NCT01352507|153046|P2|NOT COMPLETED|Treatment Period 2||3
66058|NCT01352507|153047|P1|NOT COMPLETED|Treatment Period 2||6
66059|NCT01352507|153046|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
66060|NCT01352507|153047|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
66061|NCT01352507|153046|P2|Received Treatment|Treatment Period 2||181
66062|NCT01352507|153047|P1|Received Treatment|Treatment Period 2||173
66063|NCT01352507|153046|P2|STARTED|Treatment Period 2||183
66064|NCT01352507|153047|P1|STARTED|Treatment Period 2||176
66065|NCT01352507|153046|P2|NOT COMPLETED|Washout Period||1
66066|NCT01352507|153047|P1|NOT COMPLETED|Washout Period||0
66067|NCT01352507|153046|P2|COMPLETED|Washout Period||183
66068|NCT01352507|153047|P1|COMPLETED|Washout Period||176
66069|NCT01352507|153046|P2|STARTED|Washout Period||184
66070|NCT01352507|153047|P1|STARTED|Washout Period||176
66071|NCT01352507|153046|P2|NOT COMPLETED|Treatment Period 1||9
66072|NCT01352507|153047|P1|NOT COMPLETED|Treatment Period 1||14
66073|NCT01352507|153046|P2|COMPLETED|Treatment Period 1||184
66074|NCT01352507|153047|P1|COMPLETED|Treatment Period 1||176
66075|NCT01352507|153046|P2|Received Treatment|Treatment Period 1||188
66076|NCT01352507|153047|P1|Received Treatment|Treatment Period 1||182
66077|NCT01352507|153046|P2|STARTED|Treatment Period 1||193
66078|NCT01352507|153047|P1|STARTED|Treatment Period 1||190
66079|NCT01352442|153078|P1|NOT COMPLETED|Overall Study||12
66080|NCT01352442|153078|P1|COMPLETED|Overall Study||139
66081|NCT01352442|153078|P1|STARTED|Overall Study||151
66082|NCT01352416|153087|P4|NOT COMPLETED|Overall Study||1
66083|NCT01352416|153088|P3|NOT COMPLETED|Overall Study||2
66084|NCT01352416|153089|P2|NOT COMPLETED|Overall Study||2
66085|NCT01352416|153090|P1|NOT COMPLETED|Overall Study||1
66086|NCT01352416|153087|P4|COMPLETED|Overall Study||1
66087|NCT01352416|153088|P3|COMPLETED|Overall Study||0
66088|NCT01352416|153089|P2|COMPLETED|Overall Study||5
66089|NCT01352416|153090|P1|COMPLETED|Overall Study||3
66090|NCT01352416|153087|P4|STARTED|Overall Study||2
66091|NCT01352416|153088|P3|STARTED|Overall Study||2
66092|NCT01352416|153089|P2|STARTED|Overall Study||7
66093|NCT01352416|153090|P1|STARTED|Overall Study||4
66094|NCT01351506|153102|P1|NOT COMPLETED|Overall Study||137
66095|NCT01351506|153102|P1|COMPLETED|Overall Study||465
66096|NCT01351506|153102|P1|STARTED|Overall Study||602
66097|NCT01351337|153112|P1|NOT COMPLETED|Overall Study||0
66098|NCT01351337|153112|P1|COMPLETED|Overall Study||58
66099|NCT01351337|153112|P1|STARTED|Overall Study||58
66100|NCT01351090|153121|P3|NOT COMPLETED|Overall Study||6
66101|NCT01351090|153122|P2|NOT COMPLETED|Overall Study||11
66102|NCT01351090|153123|P1|NOT COMPLETED|Overall Study||11
66103|NCT01351090|153121|P3|COMPLETED|Overall Study||36
66104|NCT01351090|153122|P2|COMPLETED|Overall Study||31
66105|NCT01351090|153123|P1|COMPLETED|Overall Study||32
66106|NCT01351090|153121|P3|STARTED|Overall Study||42
66107|NCT01351090|153122|P2|STARTED|Overall Study||42
66108|NCT01351090|153123|P1|STARTED|Overall Study||43
66109|NCT01351064|153142|P2|NOT COMPLETED|Overall Study||0
66110|NCT01351064|153143|P1|NOT COMPLETED|Overall Study||0
66111|NCT01351064|153142|P2|COMPLETED|Overall Study||42
66112|NCT01351064|153143|P1|COMPLETED|Overall Study||42
66113|NCT01351064|153142|P2|STARTED|Overall Study||42
66114|NCT01351064|153143|P1|STARTED|Overall Study||42
66115|NCT01351025|153153|P2|NOT COMPLETED|Week 44 - 48||0
66116|NCT01351025|153154|P1|NOT COMPLETED|Week 44 - 48||0
66117|NCT01351025|153153|P2|COMPLETED|Week 44 - 48||43
66118|NCT01351025|153154|P1|COMPLETED|Week 44 - 48||42
66119|NCT01351025|153153|P2|STARTED|Week 44 - 48||43
66120|NCT01351025|153154|P1|STARTED|Week 44 - 48||42
66121|NCT01351025|153153|P2|NOT COMPLETED|Week 24 - 44||4
66122|NCT01351025|153154|P1|NOT COMPLETED|Week 24 - 44||1
66123|NCT01351025|153153|P2|COMPLETED|Week 24 - 44||43
66124|NCT01351025|153154|P1|COMPLETED|Week 24 - 44||42
66125|NCT01351025|153153|P2|STARTED|Week 24 - 44||47
66126|NCT01351025|153154|P1|STARTED|Week 24 - 44||43
66127|NCT01351025|153153|P2|NOT COMPLETED|Week 20 - 24||0
66128|NCT01351025|153154|P1|NOT COMPLETED|Week 20 - 24||0
66129|NCT01351025|153153|P2|COMPLETED|Week 20 - 24||47
66130|NCT01351025|153154|P1|COMPLETED|Week 20 - 24||43
66131|NCT01351025|153153|P2|STARTED|Week 20 - 24||47
66132|NCT01351025|153154|P1|STARTED|Week 20 - 24||43
66133|NCT01351025|153153|P2|NOT COMPLETED|Week 0 - 20||1
66134|NCT01351025|153154|P1|NOT COMPLETED|Week 0 - 20||3
66135|NCT01351025|153153|P2|COMPLETED|Week 0 - 20||47
66136|NCT01351025|153154|P1|COMPLETED|Week 0 - 20||43
66137|NCT01351025|153153|P2|STARTED|Week 0 - 20||48
66138|NCT01351025|153154|P1|STARTED|Week 0 - 20||46
66139|NCT01350999|153187|P3|NOT COMPLETED|Overall Study||21
66140|NCT01350999|153188|P2|NOT COMPLETED|Overall Study||14
66141|NCT01350999|153189|P1|NOT COMPLETED|Overall Study||8
66142|NCT01350999|153187|P3|COMPLETED|Overall Study||146
66143|NCT01350999|153188|P2|COMPLETED|Overall Study||157
66144|NCT01350999|153189|P1|COMPLETED|Overall Study||157
66145|NCT01350999|153187|P3|Treated|Overall Study||167
66146|NCT01350999|153188|P2|Treated|Overall Study||171
66147|NCT01350999|153189|P1|Treated|Overall Study||165
66148|NCT01350999|153187|P3|STARTED|Overall Study||167
66149|NCT01350999|153188|P2|STARTED|Overall Study||171
66150|NCT01350999|153189|P1|STARTED|Overall Study||165
66151|NCT01350973|153227|P3|NOT COMPLETED|Overall Study||8
66152|NCT01350973|153228|P2|NOT COMPLETED|Overall Study||8
66153|NCT01350973|153229|P1|NOT COMPLETED|Overall Study||6
66154|NCT01350973|153227|P3|COMPLETED|Overall Study||187
66155|NCT01350973|153228|P2|COMPLETED|Overall Study||202
66156|NCT01350973|153229|P1|COMPLETED|Overall Study||200
66157|NCT01350973|153227|P3|Received Treatment|Overall Study||195
66158|NCT01350973|153228|P2|Received Treatment|Overall Study||210
66159|NCT01350973|153229|P1|Received Treatment|Overall Study||205
66160|NCT01350973|153227|P3|STARTED|Overall Study||195
66161|NCT01350973|153228|P2|STARTED|Overall Study||210
66162|NCT01350973|153229|P1|STARTED|Overall Study||206
66163|NCT01350947|153264|P1|NOT COMPLETED|Overall Study||0
66164|NCT01350947|153264|P1|COMPLETED|Overall Study||11
66165|NCT01350947|153264|P1|STARTED|Overall Study||11
66166|NCT01350934|153270|P2|NOT COMPLETED|Extension Study||4
66167|NCT01350934|153271|P1|NOT COMPLETED|Extension Study||5
66168|NCT01350934|153270|P2|COMPLETED|Extension Study||101
66169|NCT01350934|153271|P1|COMPLETED|Extension Study||95
66170|NCT01350934|153270|P2|STARTED|Extension Study||105
66171|NCT01350934|153271|P1|STARTED|Extension Study||100
66172|NCT01350934|153270|P2|NOT COMPLETED|Base Study||3
66173|NCT01350934|153271|P1|NOT COMPLETED|Base Study||11
66174|NCT01350934|153270|P2|COMPLETED|Base Study||105
66175|NCT01350934|153271|P1|COMPLETED|Base Study||100
66176|NCT01350934|153270|P2|STARTED|Base Study||108
66177|NCT01350934|153271|P1|STARTED|Base Study||111
66178|NCT01350804|153293|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
66179|NCT01350804|153294|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
66180|NCT01350804|153295|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
66181|NCT01350804|153296|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
66182|NCT01350804|153293|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
66183|NCT01350804|153294|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
66184|NCT01350804|153295|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
66185|NCT01350804|153296|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
66186|NCT01350804|153293|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
66187|NCT01350804|153294|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
66188|NCT01350804|153295|P2|STARTED|Extension Study, Weeks 52 - 260||79
66189|NCT01350804|153296|P1|STARTED|Extension Study, Weeks 52 - 260||80
66190|NCT01350804|153293|P4|NOT COMPLETED|Core Study||26
66191|NCT01350804|153294|P3|NOT COMPLETED|Core Study||47
66192|NCT01350804|153295|P2|NOT COMPLETED|Core Study||47
66193|NCT01350804|153296|P1|NOT COMPLETED|Core Study||41
66194|NCT01350804|153293|P4|COMPLETED|Core Study||112
66195|NCT01350804|153294|P3|COMPLETED|Core Study||91
66196|NCT01350804|153295|P2|COMPLETED|Core Study||90
66197|NCT01350804|153296|P1|COMPLETED|Core Study||97
66198|NCT01350804|153293|P4|Full Analysis Set|Core Study||138
66199|NCT01350804|153294|P3|Full Analysis Set|Core Study||138
66200|NCT01350804|153295|P2|Full Analysis Set|Core Study||137
66201|NCT01350804|153296|P1|Full Analysis Set|Core Study||138
66202|NCT01350804|153293|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
66203|NCT01350804|153294|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
66204|NCT01350804|153295|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
66205|NCT01350804|153296|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
66206|NCT01350804|153293|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
66207|NCT01350804|153294|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
66208|NCT01350804|153295|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
66209|NCT01350804|153296|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
66210|NCT01350804|153293|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
66211|NCT01350804|153294|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
66212|NCT01350804|153295|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
66213|NCT01350804|153296|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
66214|NCT01350804|153293|P4|STARTED|Core Study||138
66215|NCT01350804|153294|P3|STARTED|Core Study||138
66216|NCT01350804|153295|P2|STARTED|Core Study||137
66217|NCT01350804|153296|P1|STARTED|Core Study||138
66218|NCT01350583|153385|P1|NOT COMPLETED|Overall Study||0
66219|NCT01350583|153385|P1|COMPLETED|Overall Study||2
66220|NCT01350583|153385|P1|STARTED|Overall Study||2
66221|NCT01350414|153391|P1|NOT COMPLETED|Overall Study||19
66222|NCT01350414|153391|P1|COMPLETED|Overall Study||162
66223|NCT01350414|153391|P1|Year 5|Overall Study||162
66224|NCT01350414|153391|P1|Year 4|Overall Study||159
66225|NCT01350414|153391|P1|Year 3|Overall Study||162
66226|NCT01350414|153391|P1|Year 2|Overall Study||165
66227|NCT01350414|153391|P1|STARTED|Overall Study||181
66228|NCT01350388|153410|P2|NOT COMPLETED|Overall Study||1
66229|NCT01350388|153411|P1|NOT COMPLETED|Overall Study||3
66230|NCT01350388|153410|P2|COMPLETED|Overall Study||39
66231|NCT01350388|153411|P1|COMPLETED|Overall Study||37
66232|NCT01350388|153410|P2|STARTED|Overall Study||40
66233|NCT01350388|153411|P1|STARTED|Overall Study||40
66234|NCT01350271|153430|P3|NOT COMPLETED|Overall Study||26
66235|NCT01350271|153431|P2|NOT COMPLETED|Overall Study||17
66236|NCT01350271|153432|P1|NOT COMPLETED|Overall Study||21
66237|NCT01350271|153430|P3|COMPLETED|Overall Study||48
66238|NCT01350271|153431|P2|COMPLETED|Overall Study||53
66239|NCT01350271|153432|P1|COMPLETED|Overall Study||49
66240|NCT01350271|153430|P3|STARTED|Overall Study||74
66241|NCT01350271|153431|P2|STARTED|Overall Study||70
66242|NCT01350271|153432|P1|STARTED|Overall Study||70
66243|NCT01350258|153446|P1|NOT COMPLETED|Overall Study||0
66244|NCT01350258|153446|P1|COMPLETED|Overall Study||8
66245|NCT01350258|153446|P1|STARTED|Overall Study||8
66246|NCT01350245|153455|P1|NOT COMPLETED|Overall Study||0
66247|NCT01350245|153455|P1|COMPLETED|Overall Study||28
66248|NCT01350245|153455|P1|STARTED|Overall Study||28
66249|NCT01350232|153460|P1|NOT COMPLETED|Overall Study||0
66250|NCT01350232|153460|P1|COMPLETED|Overall Study||2
66251|NCT01350232|153460|P1|STARTED|Overall Study||2
66252|NCT01350115|153473|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
66253|NCT01350115|153474|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
66254|NCT01350115|153473|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
66255|NCT01350115|153474|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
66256|NCT01350115|153473|P2|STARTED|Long Term Follow-Up (All Patients)||2
66257|NCT01350115|153474|P1|STARTED|Long Term Follow-Up (All Patients)||8
66258|NCT01350115|153473|P2|NOT COMPLETED|Core Study (All Patients)||0
66259|NCT01350115|153474|P1|NOT COMPLETED|Core Study (All Patients)||0
66260|NCT01350115|153473|P2|COMPLETED|Core Study (All Patients)||2
66261|NCT01350115|153474|P1|COMPLETED|Core Study (All Patients)||8
66262|NCT01350115|153473|P2|Pharmacodynamic Set|Core Study (All Patients)||2
66263|NCT01350115|153474|P1|Pharmacodynamic Set|Core Study (All Patients)||7
66264|NCT01350115|153473|P2|Safety Anlysis Set|Core Study (All Patients)||2
66265|NCT01350115|153474|P1|Safety Anlysis Set|Core Study (All Patients)||8
66266|NCT01350115|153473|P2|STARTED|Core Study (All Patients)||2
66267|NCT01350115|153474|P1|STARTED|Core Study (All Patients)||8
66268|NCT01349959|153486|P1|NOT COMPLETED|Overall Study||7
66269|NCT01349959|153486|P1|COMPLETED|Overall Study||33
66270|NCT01349959|153486|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
66271|NCT01349933|153492|P1|NOT COMPLETED|Overall Study||0
66272|NCT01349933|153492|P1|COMPLETED|Overall Study||21
66273|NCT01349933|153492|P1|STARTED|Overall Study||21
66274|NCT01349920|153497|P1|NOT COMPLETED|Overall Study||0
66275|NCT01349920|153497|P1|COMPLETED|Overall Study||15
66276|NCT01349920|153497|P1|STARTED|Overall Study||15
66277|NCT01349907|153517|P2|NOT COMPLETED|Overall Study||43
66278|NCT01349907|153518|P1|NOT COMPLETED|Overall Study||139
66279|NCT01349907|153517|P2|COMPLETED|Overall Study||38
66280|NCT01349907|153518|P1|COMPLETED|Overall Study||102
66281|NCT01349907|153517|P2|STARTED|Overall Study|Enrolled and Treated|81
66282|NCT01349907|153518|P1|STARTED|Overall Study|Enrolled and Treated|241
66283|NCT01349829|153556|P2|NOT COMPLETED|Overall Study||23
66284|NCT01349829|153557|P1|NOT COMPLETED|Overall Study||9
66285|NCT01349829|153556|P2|COMPLETED|Overall Study||102
66286|NCT01349829|153557|P1|COMPLETED|Overall Study||117
66287|NCT01349829|153556|P2|STARTED|Overall Study||125
66288|NCT01349829|153557|P1|STARTED|Overall Study||126
66289|NCT01349803|153579|P4|NOT COMPLETED|Overall Study||2
66290|NCT01349803|153580|P3|NOT COMPLETED|Overall Study||3
66291|NCT01349803|153581|P2|NOT COMPLETED|Overall Study||1
66292|NCT01349803|153582|P1|NOT COMPLETED|Overall Study||1
66293|NCT01349803|153579|P4|COMPLETED|Overall Study||57
66294|NCT01349803|153580|P3|COMPLETED|Overall Study||57
66295|NCT01349803|153581|P2|COMPLETED|Overall Study||57
66296|NCT01349803|153582|P1|COMPLETED|Overall Study||59
66297|NCT01349803|153579|P4|STARTED|Overall Study||59
66298|NCT01349803|153580|P3|STARTED|Overall Study||60
66299|NCT01349803|153581|P2|STARTED|Overall Study||58
66300|NCT01349803|153582|P1|STARTED|Overall Study||60
66301|NCT01349595|153654|P2|NOT COMPLETED|Overall Study||2
66302|NCT01349595|153655|P1|NOT COMPLETED|Overall Study||2
66303|NCT01349595|153654|P2|COMPLETED|Overall Study||0
66304|NCT01349595|153655|P1|COMPLETED|Overall Study||0
66305|NCT01349595|153654|P2|STARTED|Overall Study||2
66306|NCT01349595|153655|P1|STARTED|Overall Study||2
66307|NCT01349465|153663|P2|NOT COMPLETED|Overall Study||22
66308|NCT01349465|153664|P1|NOT COMPLETED|Overall Study||18
66309|NCT01349465|153663|P2|COMPLETED|Overall Study||27
66310|NCT01349465|153664|P1|COMPLETED|Overall Study||182
66311|NCT01349465|153663|P2|STARTED|Overall Study||49
66312|NCT01349465|153664|P1|STARTED|Overall Study||200
66313|NCT01349231|153676|P1|NOT COMPLETED|Overall Study||0
66314|NCT01349231|153676|P1|COMPLETED|Overall Study||10
66315|NCT01349231|153676|P1|STARTED|Overall Study||10
66316|NCT01349114|153685|P2|NOT COMPLETED|Overall Study||0
66317|NCT01349114|153686|P1|NOT COMPLETED|Overall Study||0
66318|NCT01349114|153685|P2|COMPLETED|Overall Study||11
66319|NCT01349114|153686|P1|COMPLETED|Overall Study||10
66320|NCT01349114|153685|P2|STARTED|Overall Study||11
66321|NCT01349114|153686|P1|STARTED|Overall Study||10
66322|NCT01348854|153696|P2|NOT COMPLETED|Overall Study||1
66323|NCT01348854|153697|P1|NOT COMPLETED|Overall Study||3
66324|NCT01348854|153696|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
66325|NCT01348854|153697|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
66326|NCT01348854|153696|P2|STARTED|Overall Study|10 eyes of 6 participants|6
66327|NCT01348854|153697|P1|STARTED|Overall Study|53 eyes of 34 participants|34
66328|NCT01348789|153705|P1|NOT COMPLETED|Overall Study||4
66329|NCT01348789|153705|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
66330|NCT01348789|153705|P1|STARTED|Overall Study||37
66331|NCT01348776|153716|P1|NOT COMPLETED|Overall Study||3
66332|NCT01348776|153716|P1|COMPLETED|Overall Study||84
66333|NCT01348776|153716|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
66334|NCT01348607|153732|P3|NOT COMPLETED|Overall Study||0
66335|NCT01348607|153733|P2|NOT COMPLETED|Overall Study||0
66336|NCT01348607|153734|P1|NOT COMPLETED|Overall Study||0
66337|NCT01348607|153732|P3|COMPLETED|Overall Study||0
66338|NCT01348607|153733|P2|COMPLETED|Overall Study||0
66339|NCT01348607|153734|P1|COMPLETED|Overall Study||1
66340|NCT01348607|153732|P3|STARTED|Overall Study||0
66341|NCT01348607|153733|P2|STARTED|Overall Study||0
66342|NCT01348607|153734|P1|STARTED|Overall Study||1
66343|NCT01348425|153747|P2|NOT COMPLETED|Overall Study||1
66344|NCT01348425|153748|P1|NOT COMPLETED|Overall Study||1
66345|NCT01348425|153747|P2|COMPLETED|Overall Study||13
66346|NCT01348425|153748|P1|COMPLETED|Overall Study||30
66347|NCT01348425|153747|P2|STARTED|Overall Study||14
66348|NCT01348425|153748|P1|STARTED|Overall Study||31
66349|NCT01348165|153760|P7|NOT COMPLETED|Overall Study||1
66350|NCT01348165|153761|P6|NOT COMPLETED|Overall Study||0
66351|NCT01348165|153762|P5|NOT COMPLETED|Overall Study||0
66352|NCT01348165|153763|P4|NOT COMPLETED|Overall Study||0
66353|NCT01348165|153764|P3|NOT COMPLETED|Overall Study||0
66354|NCT01348165|153765|P2|NOT COMPLETED|Overall Study||0
66355|NCT01348165|153766|P1|NOT COMPLETED|Overall Study||0
66356|NCT01348165|153760|P7|COMPLETED|Overall Study||5
66357|NCT01348165|153761|P6|COMPLETED|Overall Study||1
66358|NCT01348165|153762|P5|COMPLETED|Overall Study||6
66359|NCT01348165|153763|P4|COMPLETED|Overall Study||6
66360|NCT01348165|153764|P3|COMPLETED|Overall Study||6
66361|NCT01348165|153765|P2|COMPLETED|Overall Study||5
66362|NCT01348165|153766|P1|COMPLETED|Overall Study||10
66363|NCT01348165|153760|P7|STARTED|Overall Study||6
66364|NCT01348165|153761|P6|STARTED|Overall Study||1
66365|NCT01348165|153762|P5|STARTED|Overall Study||6
66366|NCT01348165|153763|P4|STARTED|Overall Study||6
66367|NCT01348165|153764|P3|STARTED|Overall Study||6
66368|NCT01348165|153765|P2|STARTED|Overall Study||5
66369|NCT01348165|153766|P1|STARTED|Overall Study||10
66370|NCT01348139|153895|P6|NOT COMPLETED|Period 6||0
66371|NCT01348139|153896|P5|NOT COMPLETED|Period 6||0
66372|NCT01348139|153897|P4|NOT COMPLETED|Period 6||0
66373|NCT01348139|153898|P3|NOT COMPLETED|Period 6||0
66374|NCT01348139|153899|P2|NOT COMPLETED|Period 6||0
66375|NCT01348139|153900|P1|NOT COMPLETED|Period 6||0
66376|NCT01348139|153895|P6|COMPLETED|Period 6||4
66377|NCT01348139|153896|P5|COMPLETED|Period 6||5
66378|NCT01348139|153897|P4|COMPLETED|Period 6||4
66379|NCT01348139|153898|P3|COMPLETED|Period 6||4
66380|NCT01348139|153899|P2|COMPLETED|Period 6||4
66381|NCT01348139|153900|P1|COMPLETED|Period 6||4
66382|NCT01348139|153895|P6|STARTED|Period 6||4
66383|NCT01348139|153896|P5|STARTED|Period 6||5
66384|NCT01348139|153897|P4|STARTED|Period 6||4
66385|NCT01348139|153898|P3|STARTED|Period 6||4
66386|NCT01348139|153899|P2|STARTED|Period 6||4
66387|NCT01348139|153900|P1|STARTED|Period 6||4
66388|NCT01348139|153895|P6|NOT COMPLETED|Period 5||0
66389|NCT01348139|153896|P5|NOT COMPLETED|Period 5||0
66390|NCT01348139|153897|P4|NOT COMPLETED|Period 5||0
66391|NCT01348139|153898|P3|NOT COMPLETED|Period 5||0
66392|NCT01348139|153899|P2|NOT COMPLETED|Period 5||0
66393|NCT01348139|153900|P1|NOT COMPLETED|Period 5||0
66394|NCT01348139|153895|P6|COMPLETED|Period 5||4
66395|NCT01348139|153896|P5|COMPLETED|Period 5||5
66396|NCT01348139|153897|P4|COMPLETED|Period 5||4
66397|NCT01348139|153898|P3|COMPLETED|Period 5||4
66398|NCT01348139|153899|P2|COMPLETED|Period 5||4
66399|NCT01348139|153900|P1|COMPLETED|Period 5||4
66400|NCT01348139|153895|P6|STARTED|Period 5||4
66401|NCT01348139|153896|P5|STARTED|Period 5||5
66402|NCT01348139|153897|P4|STARTED|Period 5||4
66403|NCT01348139|153898|P3|STARTED|Period 5||4
66404|NCT01348139|153899|P2|STARTED|Period 5||4
66405|NCT01348139|153900|P1|STARTED|Period 5||4
66406|NCT01348139|153895|P6|NOT COMPLETED|Period 4||0
66407|NCT01348139|153896|P5|NOT COMPLETED|Period 4||0
66408|NCT01348139|153897|P4|NOT COMPLETED|Period 4||0
66409|NCT01348139|153898|P3|NOT COMPLETED|Period 4||0
66410|NCT01348139|153899|P2|NOT COMPLETED|Period 4||0
66411|NCT01348139|153900|P1|NOT COMPLETED|Period 4||0
66412|NCT01348139|153895|P6|COMPLETED|Period 4||4
66413|NCT01348139|153896|P5|COMPLETED|Period 4||5
66414|NCT01348139|153897|P4|COMPLETED|Period 4||4
66415|NCT01348139|153898|P3|COMPLETED|Period 4||4
66416|NCT01348139|153899|P2|COMPLETED|Period 4||4
66417|NCT01348139|153900|P1|COMPLETED|Period 4||4
66418|NCT01348139|153895|P6|STARTED|Period 4||4
66419|NCT01348139|153896|P5|STARTED|Period 4||5
66420|NCT01348139|153897|P4|STARTED|Period 4||4
66421|NCT01348139|153898|P3|STARTED|Period 4||4
66422|NCT01348139|153899|P2|STARTED|Period 4||4
66423|NCT01348139|153900|P1|STARTED|Period 4||4
66424|NCT01348139|153895|P6|NOT COMPLETED|Period 3||0
66425|NCT01348139|153896|P5|NOT COMPLETED|Period 3||0
66426|NCT01348139|153897|P4|NOT COMPLETED|Period 3||0
66427|NCT01348139|153898|P3|NOT COMPLETED|Period 3||0
66428|NCT01348139|153899|P2|NOT COMPLETED|Period 3||0
66429|NCT01348139|153900|P1|NOT COMPLETED|Period 3||0
66430|NCT01348139|153895|P6|COMPLETED|Period 3||4
66431|NCT01348139|153896|P5|COMPLETED|Period 3||5
66432|NCT01348139|153897|P4|COMPLETED|Period 3||4
66433|NCT01348139|153898|P3|COMPLETED|Period 3||4
66434|NCT01348139|153899|P2|COMPLETED|Period 3||4
66435|NCT01348139|153900|P1|COMPLETED|Period 3||4
66436|NCT01348139|153895|P6|STARTED|Period 3||4
66437|NCT01348139|153896|P5|STARTED|Period 3||5
66438|NCT01348139|153897|P4|STARTED|Period 3||4
66439|NCT01348139|153898|P3|STARTED|Period 3||4
66440|NCT01348139|153899|P2|STARTED|Period 3||4
66441|NCT01348139|153900|P1|STARTED|Period 3||4
66442|NCT01348139|153895|P6|NOT COMPLETED|Period 2||0
66443|NCT01348139|153896|P5|NOT COMPLETED|Period 2||0
66444|NCT01348139|153897|P4|NOT COMPLETED|Period 2||0
66445|NCT01348139|153898|P3|NOT COMPLETED|Period 2||0
66446|NCT01348139|153899|P2|NOT COMPLETED|Period 2||0
66447|NCT01348139|153900|P1|NOT COMPLETED|Period 2||0
66448|NCT01348139|153895|P6|COMPLETED|Period 2||4
66449|NCT01348139|153896|P5|COMPLETED|Period 2||5
66450|NCT01348139|153897|P4|COMPLETED|Period 2||4
66451|NCT01348139|153898|P3|COMPLETED|Period 2||4
66452|NCT01348139|153899|P2|COMPLETED|Period 2||4
66453|NCT01348139|153900|P1|COMPLETED|Period 2||4
66454|NCT01348139|153895|P6|STARTED|Period 2||4
66455|NCT01348139|153896|P5|STARTED|Period 2||5
66456|NCT01348139|153897|P4|STARTED|Period 2||4
66457|NCT01348139|153898|P3|STARTED|Period 2||4
66458|NCT01348139|153899|P2|STARTED|Period 2||4
66459|NCT01348139|153900|P1|STARTED|Period 2||4
66460|NCT01348139|153895|P6|NOT COMPLETED|Period 1||0
66461|NCT01348139|153896|P5|NOT COMPLETED|Period 1||0
66462|NCT01348139|153897|P4|NOT COMPLETED|Period 1||0
66463|NCT01348139|153898|P3|NOT COMPLETED|Period 1||0
66464|NCT01348139|153899|P2|NOT COMPLETED|Period 1||0
66465|NCT01348139|153900|P1|NOT COMPLETED|Period 1||1
66466|NCT01348139|153895|P6|COMPLETED|Period 1||4
66467|NCT01348139|153896|P5|COMPLETED|Period 1||5
66468|NCT01348139|153897|P4|COMPLETED|Period 1||4
66469|NCT01348139|153898|P3|COMPLETED|Period 1||4
66470|NCT01348139|153899|P2|COMPLETED|Period 1||4
66471|NCT01348139|153900|P1|COMPLETED|Period 1||4
66472|NCT01348139|153895|P6|STARTED|Period 1||4
66473|NCT01348139|153896|P5|STARTED|Period 1||5
66474|NCT01348139|153897|P4|STARTED|Period 1||4
66475|NCT01348139|153898|P3|STARTED|Period 1||4
66476|NCT01348139|153899|P2|STARTED|Period 1||4
66477|NCT01348139|153900|P1|STARTED|Period 1||5
66478|NCT01348100|153981|P7|NOT COMPLETED|Overall Study||3
66479|NCT01348100|153982|P6|NOT COMPLETED|Overall Study||2
66480|NCT01348100|153983|P5|NOT COMPLETED|Overall Study||1
66481|NCT01348100|153984|P4|NOT COMPLETED|Overall Study||1
66482|NCT01348100|153985|P3|NOT COMPLETED|Overall Study||2
66483|NCT01348100|153986|P2|NOT COMPLETED|Overall Study||0
66484|NCT01348100|153987|P1|NOT COMPLETED|Overall Study||0
66485|NCT01348100|153981|P7|COMPLETED|Overall Study||13
66486|NCT01348100|153982|P6|COMPLETED|Overall Study||14
66487|NCT01348100|153983|P5|COMPLETED|Overall Study||14
66488|NCT01348100|153984|P4|COMPLETED|Overall Study||14
66489|NCT01348100|153985|P3|COMPLETED|Overall Study||13
66490|NCT01348100|153986|P2|COMPLETED|Overall Study||2
66491|NCT01348100|153987|P1|COMPLETED|Overall Study||2
66492|NCT01348100|153981|P7|STARTED|Overall Study||16
66493|NCT01348100|153982|P6|STARTED|Overall Study||16
66494|NCT01348100|153983|P5|STARTED|Overall Study||15
66495|NCT01348100|153984|P4|STARTED|Overall Study||15
66496|NCT01348100|153985|P3|STARTED|Overall Study||15
66497|NCT01348100|153986|P2|STARTED|Overall Study||2
66498|NCT01348100|153987|P1|STARTED|Overall Study||2
66499|NCT01348087|154032|P1|NOT COMPLETED|Overall Study||148
66500|NCT01348087|154032|P1|COMPLETED|Overall Study||0
66501|NCT01348087|154032|P1|STARTED|Overall Study||148
66502|NCT01347931|154046|P1|NOT COMPLETED|NIOV System||0
66503|NCT01347931|154046|P1|COMPLETED|NIOV System||29
66504|NCT01347931|154046|P1|STARTED|NIOV System||29
66505|NCT01347931|154046|P1|NOT COMPLETED|Standard Oxygen Therapy||1
66506|NCT01347931|154046|P1|COMPLETED|Standard Oxygen Therapy||29
66507|NCT01347931|154046|P1|STARTED|Standard Oxygen Therapy||30
66508|NCT01347879|154058|P2|NOT COMPLETED|Overall Study||17
66509|NCT01347879|154059|P1|NOT COMPLETED|Overall Study||7
66510|NCT01347879|154058|P2|COMPLETED|Overall Study||83
66511|NCT01347879|154059|P1|COMPLETED|Overall Study||46
66512|NCT01347879|154058|P2|STARTED|Overall Study||100
66513|NCT01347879|154059|P1|STARTED|Overall Study||53
66514|NCT01347840|154091|P1|NOT COMPLETED|Overall Study||1
66515|NCT01347840|154091|P1|COMPLETED|Overall Study||0
66516|NCT01347840|154091|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
66517|NCT01347788|154104|P3|NOT COMPLETED|Overall Study||0
66518|NCT01347788|154105|P2|NOT COMPLETED|Overall Study||0
66519|NCT01347788|154106|P1|NOT COMPLETED|Overall Study||0
66520|NCT01347788|154104|P3|COMPLETED|Overall Study||13
66521|NCT01347788|154105|P2|COMPLETED|Overall Study||10
66522|NCT01347788|154106|P1|COMPLETED|Overall Study||11
66523|NCT01347788|154104|P3|STARTED|Overall Study||13
66524|NCT01347788|154105|P2|STARTED|Overall Study||10
66525|NCT01347788|154106|P1|STARTED|Overall Study||11
66526|NCT01347710|154114|P1|NOT COMPLETED|Overall Study||31
66527|NCT01347710|154114|P1|COMPLETED|Overall Study||764
66528|NCT01347710|154114|P1|STARTED|Overall Study||795
66529|NCT01347632|154129|P1|NOT COMPLETED|Overall Study||2
66530|NCT01347632|154129|P1|COMPLETED|Overall Study||33
66531|NCT01347632|154129|P1|STARTED|Overall Study||35
66532|NCT01347580|154135|P2|NOT COMPLETED|Overall Study||56
66533|NCT01347580|154136|P1|NOT COMPLETED|Overall Study||65
66534|NCT01347580|154135|P2|COMPLETED|Overall Study|based on randomized treatment|897
66535|NCT01347580|154136|P1|COMPLETED|Overall Study|based on randomized treatment|844
66536|NCT01347580|154135|P2|Safety Population|Overall Study|based on actual treatment|950
66537|NCT01347580|154136|P1|Safety Population|Overall Study|based on actual treatment|908
66538|NCT01347580|154135|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
66539|NCT01347580|154136|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
66540|NCT01347580|154135|P2|STARTED|Overall Study|based on randomized treatment|953
66541|NCT01347580|154136|P1|STARTED|Overall Study|based on randomized treatment|909
66542|NCT01347554|154166|P2|NOT COMPLETED|Overall Study||11
66543|NCT01347554|154167|P1|NOT COMPLETED|Overall Study||7
66544|NCT01347554|154166|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
66545|NCT01347554|154167|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
66546|NCT01347554|154166|P2|STARTED|Overall Study||242
66547|NCT01347554|154167|P1|STARTED|Overall Study||237
66548|NCT01347255|154179|P1|NOT COMPLETED|Overall Study||0
66549|NCT01347255|154179|P1|COMPLETED|Overall Study||24
66550|NCT01347255|154179|P1|STARTED|Overall Study||24
66551|NCT01347112|154204|P2|NOT COMPLETED|Overall Study||12
66552|NCT01347112|154205|P1|NOT COMPLETED|Overall Study||4
66553|NCT01347112|154204|P2|COMPLETED|Overall Study||5
66554|NCT01347112|154205|P1|COMPLETED|Overall Study||12
66555|NCT01347112|154204|P2|STARTED|Overall Study||17
66556|NCT01347112|154205|P1|STARTED|Overall Study||16
66557|NCT01347086|154225|P10|NOT COMPLETED|Overall Study||1
66558|NCT01347086|154226|P9|NOT COMPLETED|Overall Study||0
66559|NCT01347086|154227|P8|NOT COMPLETED|Overall Study||1
66560|NCT01347086|154228|P7|NOT COMPLETED|Overall Study||1
66561|NCT01347086|154229|P6|NOT COMPLETED|Overall Study||0
66562|NCT01347086|154230|P5|NOT COMPLETED|Overall Study||0
66563|NCT01347086|154231|P4|NOT COMPLETED|Overall Study||0
66564|NCT01347086|154232|P3|NOT COMPLETED|Overall Study||1
66565|NCT01347086|154233|P2|NOT COMPLETED|Overall Study||0
66566|NCT01347086|154234|P1|NOT COMPLETED|Overall Study||0
66567|NCT01347086|154225|P10|COMPLETED|Overall Study||6
66568|NCT01347086|154226|P9|COMPLETED|Overall Study||6
66569|NCT01347086|154227|P8|COMPLETED|Overall Study||6
66570|NCT01347086|154228|P7|COMPLETED|Overall Study||6
66571|NCT01347086|154229|P6|COMPLETED|Overall Study||6
66572|NCT01347086|154230|P5|COMPLETED|Overall Study||6
66573|NCT01347086|154231|P4|COMPLETED|Overall Study||6
66574|NCT01347086|154232|P3|COMPLETED|Overall Study||6
66575|NCT01347086|154233|P2|COMPLETED|Overall Study||6
66576|NCT01347086|154234|P1|COMPLETED|Overall Study||2
66577|NCT01347086|154225|P10|STARTED|Overall Study|One subject was not treated.|7
66578|NCT01347086|154226|P9|STARTED|Overall Study||6
66579|NCT01347086|154227|P8|STARTED|Overall Study|One subject was not treated.|7
66580|NCT01347086|154228|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
66581|NCT01347086|154229|P6|STARTED|Overall Study||6
66582|NCT01347086|154230|P5|STARTED|Overall Study||6
66583|NCT01347086|154231|P4|STARTED|Overall Study||6
66584|NCT01347086|154232|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
66585|NCT01347086|154233|P2|STARTED|Overall Study||6
66586|NCT01347086|154234|P1|STARTED|Overall Study||2
66587|NCT01347073|154333|P1|NOT COMPLETED|Overall Study||2
66588|NCT01347073|154333|P1|COMPLETED|Overall Study||21
66589|NCT01347073|154333|P1|STARTED|Overall Study||23
66590|NCT01347060|154347|P2|NOT COMPLETED|Overall Study||0
66591|NCT01347060|154348|P1|NOT COMPLETED|Overall Study||0
66592|NCT01347060|154347|P2|COMPLETED|Overall Study||7580
66593|NCT01347060|154348|P1|COMPLETED|Overall Study||9868
66594|NCT01347060|154347|P2|STARTED|Overall Study||7580
66595|NCT01347060|154348|P1|STARTED|Overall Study||9868
66596|NCT01347034|154360|P2|NOT COMPLETED|Overall Study||0
66597|NCT01347034|154361|P1|NOT COMPLETED|Overall Study||0
66598|NCT01347034|154360|P2|COMPLETED|Overall Study||14
66599|NCT01347034|154361|P1|COMPLETED|Overall Study||6
66600|NCT01347034|154360|P2|STARTED|Overall Study||14
66601|NCT01347034|154361|P1|STARTED|Overall Study||6
66602|NCT01347008|154371|P2|NOT COMPLETED|Overall Study||0
66603|NCT01347008|154372|P1|NOT COMPLETED|Overall Study||0
66604|NCT01347008|154371|P2|COMPLETED|Overall Study||20
66605|NCT01347008|154372|P1|COMPLETED|Overall Study||21
66606|NCT01347008|154371|P2|STARTED|Overall Study||20
66607|NCT01347008|154372|P1|STARTED|Overall Study||21
66608|NCT01346852|154384|P2|NOT COMPLETED|Overall Study||0
66609|NCT01346852|154385|P1|NOT COMPLETED|Overall Study||0
66610|NCT01346852|154384|P2|COMPLETED|Overall Study||59684
66611|NCT01346852|154385|P1|COMPLETED|Overall Study||41753
66612|NCT01346852|154384|P2|STARTED|Overall Study||59684
66613|NCT01346852|154385|P1|STARTED|Overall Study||41753
66614|NCT01346839|154395|P2|NOT COMPLETED|Overall Study||209
66615|NCT01346839|154396|P1|NOT COMPLETED|Overall Study||314
66616|NCT01346839|154395|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
66617|NCT01346839|154396|P1|COMPLETED|Overall Study||369
66618|NCT01346839|154395|P2|STARTED|Overall Study||573
66619|NCT01346839|154396|P1|STARTED|Overall Study||683
66620|NCT01346774|154412|P2|NOT COMPLETED|Overall Study||17
66621|NCT01346774|154413|P1|NOT COMPLETED|Overall Study||13
66622|NCT01346774|154412|P2|COMPLETED|Overall Study||63
66623|NCT01346774|154413|P1|COMPLETED|Overall Study||67
66624|NCT01346774|154412|P2|STARTED|Overall Study||80
66625|NCT01346774|154413|P1|STARTED|Overall Study||80
66626|NCT01346592|154422|P3|NOT COMPLETED|Overall Study||78
66627|NCT01346592|154423|P2|NOT COMPLETED|Overall Study||89
66628|NCT01346592|154424|P1|NOT COMPLETED|Overall Study||153
66629|NCT01346592|154422|P3|COMPLETED|Overall Study||1408
66630|NCT01346592|154423|P2|COMPLETED|Overall Study||1389
66631|NCT01346592|154424|P1|COMPLETED|Overall Study||2983
66632|NCT01346592|154422|P3|STARTED|Overall Study||1486
66633|NCT01346592|154423|P2|STARTED|Overall Study||1478
66634|NCT01346592|154424|P1|STARTED|Overall Study||3136
66635|NCT01346501|154516|P2|NOT COMPLETED|Overall Study||13
66636|NCT01346501|154517|P1|NOT COMPLETED|Overall Study||11
66637|NCT01346501|154516|P2|COMPLETED|Overall Study||80
66638|NCT01346501|154517|P1|COMPLETED|Overall Study||68
66639|NCT01346501|154516|P2|STARTED|Overall Study||93
66640|NCT01346501|154517|P1|STARTED|Overall Study||79
66641|NCT01346397|154532|P2|NOT COMPLETED|Overall Study||0
66642|NCT01346397|154533|P1|NOT COMPLETED|Overall Study||0
66643|NCT01346397|154532|P2|COMPLETED|Overall Study||85
66644|NCT01346397|154533|P1|COMPLETED|Overall Study||85
66645|NCT01346397|154532|P2|STARTED|Overall Study||85
66646|NCT01346397|154533|P1|STARTED|Overall Study||85
66647|NCT01346293|154543|P2|NOT COMPLETED|Overall Study||21
66648|NCT01346293|154544|P1|NOT COMPLETED|Overall Study||67
66649|NCT01346293|154543|P2|COMPLETED|Overall Study||608
66650|NCT01346293|154544|P1|COMPLETED|Overall Study||2676
66651|NCT01346293|154543|P2|STARTED|Overall Study||629
66652|NCT01346293|154544|P1|STARTED|Overall Study||2743
66653|NCT01346176|154573|P3|NOT COMPLETED|Completed Satisfaction Survey||6
66654|NCT01346176|154574|P2|NOT COMPLETED|Completed Satisfaction Survey||4
66655|NCT01346176|154575|P1|NOT COMPLETED|Completed Satisfaction Survey||6
66656|NCT01346176|154573|P3|COMPLETED|Completed Satisfaction Survey||27
66657|NCT01346176|154574|P2|COMPLETED|Completed Satisfaction Survey||22
66658|NCT01346176|154575|P1|COMPLETED|Completed Satisfaction Survey||29
66659|NCT01346176|154573|P3|STARTED|Completed Satisfaction Survey||33
66660|NCT01346176|154574|P2|STARTED|Completed Satisfaction Survey||26
66661|NCT01346176|154575|P1|STARTED|Completed Satisfaction Survey||35
66662|NCT01346176|154573|P3|NOT COMPLETED|Completed Advance Directive||10
66663|NCT01346176|154574|P2|NOT COMPLETED|Completed Advance Directive||14
66664|NCT01346176|154575|P1|NOT COMPLETED|Completed Advance Directive||13
66665|NCT01346176|154573|P3|COMPLETED|Completed Advance Directive||33
66666|NCT01346176|154574|P2|COMPLETED|Completed Advance Directive||26
66667|NCT01346176|154575|P1|COMPLETED|Completed Advance Directive||35
66668|NCT01346176|154573|P3|STARTED|Completed Advance Directive||43
66669|NCT01346176|154574|P2|STARTED|Completed Advance Directive||40
66670|NCT01346176|154575|P1|STARTED|Completed Advance Directive||48
66671|NCT01346176|154573|P3|NOT COMPLETED|Recruited||0
66672|NCT01346176|154574|P2|NOT COMPLETED|Recruited||0
66673|NCT01346176|154575|P1|NOT COMPLETED|Recruited||1
66674|NCT01346176|154573|P3|COMPLETED|Recruited||43
66675|NCT01346176|154574|P2|COMPLETED|Recruited||40
66676|NCT01346176|154575|P1|COMPLETED|Recruited||48
66677|NCT01346176|154573|P3|STARTED|Recruited||43
66678|NCT01346176|154574|P2|STARTED|Recruited||40
66679|NCT01346176|154575|P1|STARTED|Recruited||49
66680|NCT01346085|154586|P1|NOT COMPLETED|Overall Study||0
66681|NCT01346085|154586|P1|COMPLETED|Overall Study||10
66682|NCT01346085|154586|P1|STARTED|Overall Study||10
66683|NCT01345929|154593|P2|NOT COMPLETED|Overall Study||19
66684|NCT01345929|154594|P1|NOT COMPLETED|Overall Study||21
66685|NCT01345929|154593|P2|COMPLETED|Overall Study||516
66686|NCT01345929|154594|P1|COMPLETED|Overall Study||512
66687|NCT01345929|154593|P2|STARTED|Overall Study||535
66688|NCT01345929|154594|P1|STARTED|Overall Study||533
66689|NCT01345786|154606|P4|NOT COMPLETED|Overall Study||3
66690|NCT01345786|154607|P3|NOT COMPLETED|Overall Study||5
66691|NCT01345786|154608|P2|NOT COMPLETED|Overall Study||8
66692|NCT01345786|154609|P1|NOT COMPLETED|Overall Study||6
66693|NCT01345786|154606|P4|COMPLETED|Overall Study||35
66694|NCT01345786|154607|P3|COMPLETED|Overall Study||33
66695|NCT01345786|154608|P2|COMPLETED|Overall Study||33
66696|NCT01345786|154609|P1|COMPLETED|Overall Study||35
66697|NCT01345786|154606|P4|Treated|Overall Study||37
66698|NCT01345786|154607|P3|Treated|Overall Study||37
66699|NCT01345786|154608|P2|Treated|Overall Study||41
66700|NCT01345786|154609|P1|Treated|Overall Study||41
66701|NCT01345786|154606|P4|STARTED|Overall Study|Number randomized|38
66702|NCT01345786|154607|P3|STARTED|Overall Study|Number randomized|38
66703|NCT01345786|154608|P2|STARTED|Overall Study|Number randomized|41
66704|NCT01345786|154609|P1|STARTED|Overall Study|Number randomized|41
66705|NCT01345721|154658|P3|NOT COMPLETED|Overall Study||0
66706|NCT01345721|154659|P2|NOT COMPLETED|Overall Study||0
66707|NCT01345721|154660|P1|NOT COMPLETED|Overall Study||0
66708|NCT01345721|154658|P3|COMPLETED|Overall Study||65
66709|NCT01345721|154659|P2|COMPLETED|Overall Study||66
66710|NCT01345721|154660|P1|COMPLETED|Overall Study||74
66711|NCT01345721|154658|P3|STARTED|Overall Study||65
66712|NCT01345721|154659|P2|STARTED|Overall Study||66
66713|NCT01345721|154660|P1|STARTED|Overall Study||74
66714|NCT01345682|154689|P2|NOT COMPLETED|Overall Study||157
66715|NCT01345682|154690|P1|NOT COMPLETED|Overall Study||306
66716|NCT01345682|154689|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|4
66717|NCT01345682|154690|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|16
66718|NCT01345682|154689|P2|STARTED|Overall Study|Randomised|161
66719|NCT01345682|154690|P1|STARTED|Overall Study|Randomised|322
66720|NCT01345630|154724|P2|NOT COMPLETED|Overall Study||359
66721|NCT01345630|154725|P1|NOT COMPLETED|Overall Study||361
66722|NCT01345630|154724|P2|COMPLETED|Overall Study||42
66723|NCT01345630|154725|P1|COMPLETED|Overall Study||35
66724|NCT01345630|154724|P2|STARTED|Overall Study||401
66725|NCT01345630|154725|P1|STARTED|Overall Study||396
66726|NCT01345292|154784|P3|NOT COMPLETED|Overall Study||1
66727|NCT01345292|154785|P2|NOT COMPLETED|Overall Study||0
66728|NCT01345292|154786|P1|NOT COMPLETED|Overall Study||2
66729|NCT01345292|154784|P3|COMPLETED|Overall Study||74
66730|NCT01345292|154785|P2|COMPLETED|Overall Study||76
66731|NCT01345292|154786|P1|COMPLETED|Overall Study||73
66732|NCT01345292|154784|P3|STARTED|Overall Study||75
66733|NCT01345292|154785|P2|STARTED|Overall Study||76
66734|NCT01345292|154786|P1|STARTED|Overall Study||75
66735|NCT01345253|154817|P2|NOT COMPLETED|Overall Study||79
66736|NCT01345253|154818|P1|NOT COMPLETED|Overall Study||56
66737|NCT01345253|154817|P2|COMPLETED|Overall Study||372
66738|NCT01345253|154818|P1|COMPLETED|Overall Study||170
66739|NCT01345253|154817|P2|STARTED|Overall Study||451
66740|NCT01345253|154818|P1|STARTED|Overall Study||226
66741|NCT01345240|154837|P5|NOT COMPLETED|Overall Study||7
66742|NCT01345240|154838|P4|NOT COMPLETED|Overall Study||10
66743|NCT01345240|154839|P3|NOT COMPLETED|Overall Study||10
66744|NCT01345240|154840|P2|NOT COMPLETED|Overall Study||14
66745|NCT01345240|154841|P1|NOT COMPLETED|Overall Study||2
66746|NCT01345240|154837|P5|COMPLETED|Overall Study||132
66747|NCT01345240|154838|P4|COMPLETED|Overall Study||131
66748|NCT01345240|154839|P3|COMPLETED|Overall Study||131
66749|NCT01345240|154840|P2|COMPLETED|Overall Study||128
66750|NCT01345240|154841|P1|COMPLETED|Overall Study||140
66751|NCT01345240|154837|P5|STARTED|Overall Study||139
66752|NCT01345240|154838|P4|STARTED|Overall Study||141
66753|NCT01345240|154839|P3|STARTED|Overall Study||141
66754|NCT01345240|154840|P2|STARTED|Overall Study||142
66755|NCT01345240|154841|P1|STARTED|Overall Study||142
66756|NCT01345162|154936|P2|NOT COMPLETED|Overall Study||4
66757|NCT01345162|154937|P1|NOT COMPLETED|Overall Study||2
66758|NCT01345162|154936|P2|COMPLETED|Overall Study||96
66759|NCT01345162|154937|P1|COMPLETED|Overall Study||98
66760|NCT01345162|154936|P2|STARTED|Overall Study||100
66761|NCT01345162|154937|P1|STARTED|Overall Study||100
66762|NCT01345123|154946|P3|NOT COMPLETED|Overall Study||88
66763|NCT01345123|154947|P2|NOT COMPLETED|Overall Study||85
66764|NCT01345123|154948|P1|NOT COMPLETED|Overall Study||79
66765|NCT01345123|154946|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
66766|NCT01345123|154947|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
66767|NCT01345123|154948|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
66768|NCT01345123|154946|P3|STARTED|Overall Study||3291
66769|NCT01345123|154947|P2|STARTED|Overall Study||3311
66770|NCT01345123|154948|P1|STARTED|Overall Study||3323
66771|NCT01344876|154968|P5|NOT COMPLETED|Overall Study||1
66772|NCT01344876|154969|P4|NOT COMPLETED|Overall Study||3
66773|NCT01344876|154970|P3|NOT COMPLETED|Overall Study||1
66774|NCT01344876|154971|P2|NOT COMPLETED|Overall Study||0
66775|NCT01344876|154972|P1|NOT COMPLETED|Overall Study||1
66776|NCT01344876|154968|P5|COMPLETED|Overall Study||2
66777|NCT01344876|154969|P4|COMPLETED|Overall Study||3
66778|NCT01344876|154970|P3|COMPLETED|Overall Study||3
66779|NCT01344876|154971|P2|COMPLETED|Overall Study||3
66780|NCT01344876|154972|P1|COMPLETED|Overall Study||3
66781|NCT01344876|154968|P5|STARTED|Overall Study||3
66782|NCT01344876|154969|P4|STARTED|Overall Study||6
66783|NCT01344876|154970|P3|STARTED|Overall Study||4
66784|NCT01344876|154971|P2|STARTED|Overall Study||3
66785|NCT01344876|154972|P1|STARTED|Overall Study||4
66786|NCT01344759|154988|P2|NOT COMPLETED|Overall Study||2
66787|NCT01344759|154989|P1|NOT COMPLETED|Overall Study||0
66788|NCT01344759|154988|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
66789|NCT01344759|154989|P1|COMPLETED|Overall Study||30
66790|NCT01344759|154988|P2|STARTED|Overall Study||30
66791|NCT01344759|154989|P1|STARTED|Overall Study||30
66792|NCT01344629|155021|P2|NOT COMPLETED|Crossover Period 4||0
66793|NCT01344629|155022|P1|NOT COMPLETED|Crossover Period 4||0
66794|NCT01344629|155021|P2|COMPLETED|Crossover Period 4||31
66795|NCT01344629|155022|P1|COMPLETED|Crossover Period 4||32
66796|NCT01344629|155021|P2|STARTED|Crossover Period 4||31
66797|NCT01344629|155022|P1|STARTED|Crossover Period 4||32
66798|NCT01344629|155021|P2|NOT COMPLETED|Crossover Period 3||0
66799|NCT01344629|155022|P1|NOT COMPLETED|Crossover Period 3||0
66800|NCT01344629|155021|P2|COMPLETED|Crossover Period 3||31
66801|NCT01344629|155022|P1|COMPLETED|Crossover Period 3||32
66802|NCT01344629|155021|P2|STARTED|Crossover Period 3||31
66803|NCT01344629|155022|P1|STARTED|Crossover Period 3||32
66804|NCT01344629|155021|P2|NOT COMPLETED|Crossover Period 2||1
66805|NCT01344629|155022|P1|NOT COMPLETED|Crossover Period 2||0
66806|NCT01344629|155021|P2|COMPLETED|Crossover Period 2||31
66807|NCT01344629|155022|P1|COMPLETED|Crossover Period 2||32
66808|NCT01344629|155021|P2|STARTED|Crossover Period 2||32
66809|NCT01344629|155022|P1|STARTED|Crossover Period 2||32
66810|NCT01344629|155021|P2|NOT COMPLETED|Crossover Period 1||0
66811|NCT01344629|155022|P1|NOT COMPLETED|Crossover Period 1||0
66812|NCT01344629|155021|P2|COMPLETED|Crossover Period 1||32
66813|NCT01344629|155022|P1|COMPLETED|Crossover Period 1||32
66814|NCT01344629|155021|P2|STARTED|Crossover Period 1||32
66815|NCT01344629|155022|P1|STARTED|Crossover Period 1||32
66816|NCT01344616|155042|P2|NOT COMPLETED|Overall Study||44
66817|NCT01344616|155043|P1|NOT COMPLETED|Overall Study||35
66818|NCT01344616|155042|P2|COMPLETED|Overall Study||194
66819|NCT01344616|155043|P1|COMPLETED|Overall Study||209
66820|NCT01344616|155042|P2|STARTED|Overall Study||238
66821|NCT01344616|155043|P1|STARTED|Overall Study||244
66822|NCT01343485|155051|P2|NOT COMPLETED|Overall Study||134
66823|NCT01343485|155052|P1|NOT COMPLETED|Overall Study||149
66824|NCT01343485|155051|P2|COMPLETED|Overall Study||46
66825|NCT01343485|155052|P1|COMPLETED|Overall Study||36
66826|NCT01343485|155051|P2|STARTED|Overall Study||180
66827|NCT01343485|155052|P1|STARTED|Overall Study||185
66828|NCT01344538|155060|P2|NOT COMPLETED|Overall Study||1
66829|NCT01344538|155061|P1|NOT COMPLETED|Overall Study||2
66830|NCT01344538|155060|P2|COMPLETED|Overall Study||16
66831|NCT01344538|155061|P1|COMPLETED|Overall Study||14
66832|NCT01344538|155060|P2|STARTED|Overall Study||17
66833|NCT01344538|155061|P1|STARTED|Overall Study||16
66834|NCT01344460|155067|P1|NOT COMPLETED|Overall Study||3
66835|NCT01344460|155067|P1|COMPLETED|Overall Study||312
66836|NCT01344460|155067|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
66837|NCT01344460|155067|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
66838|NCT01344447|155112|P1|NOT COMPLETED|Overall Study||8
66839|NCT01344447|155112|P1|COMPLETED|Overall Study||471
66840|NCT01344447|155112|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
66841|NCT01344447|155112|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
66842|NCT01344369|155156|P2|NOT COMPLETED|Second Intervention||1
66843|NCT01344369|155157|P1|NOT COMPLETED|Second Intervention||0
66844|NCT01344369|155156|P2|COMPLETED|Second Intervention||16
66845|NCT01344369|155157|P1|COMPLETED|Second Intervention||17
66846|NCT01344369|155156|P2|STARTED|Second Intervention||17
66847|NCT01344369|155157|P1|STARTED|Second Intervention||17
66848|NCT01344369|155156|P2|NOT COMPLETED|Washout of 28 Days||1
66849|NCT01344369|155157|P1|NOT COMPLETED|Washout of 28 Days||1
66850|NCT01344369|155156|P2|COMPLETED|Washout of 28 Days||17
66851|NCT01344369|155157|P1|COMPLETED|Washout of 28 Days||17
66852|NCT01344369|155156|P2|STARTED|Washout of 28 Days||18
66853|NCT01344369|155157|P1|STARTED|Washout of 28 Days||18
66854|NCT01344369|155156|P2|NOT COMPLETED|First Intervention||0
66855|NCT01344369|155157|P1|NOT COMPLETED|First Intervention||0
66856|NCT01344369|155156|P2|COMPLETED|First Intervention||18
66857|NCT01344369|155157|P1|COMPLETED|First Intervention||18
66858|NCT01344369|155156|P2|STARTED|First Intervention||18
66859|NCT01344369|155157|P1|STARTED|First Intervention||18
66860|NCT01344161|155175|P2|NOT COMPLETED|Overall Study||3
66861|NCT01344161|155176|P1|NOT COMPLETED|Overall Study||5
66862|NCT01344161|155175|P2|COMPLETED|Overall Study||39
66863|NCT01344161|155176|P1|COMPLETED|Overall Study||38
66864|NCT01344161|155175|P2|STARTED|Overall Study||42
66865|NCT01344161|155176|P1|STARTED|Overall Study||43
66866|NCT01344057|155188|P1|NOT COMPLETED|Overall Study||1
66867|NCT01344057|155188|P1|COMPLETED|Overall Study||62
66868|NCT01344057|155188|P1|STARTED|Overall Study||63
66869|NCT01343888|155198|P3|NOT COMPLETED|Overall Study||22
66870|NCT01343888|155199|P2|NOT COMPLETED|Overall Study||39
66871|NCT01343888|155200|P1|NOT COMPLETED|Overall Study||25
66872|NCT01343888|155198|P3|COMPLETED|Overall Study||110
66873|NCT01343888|155199|P2|COMPLETED|Overall Study||222
66874|NCT01343888|155200|P1|COMPLETED|Overall Study||234
66875|NCT01343888|155198|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
66876|NCT01343888|155199|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
66877|NCT01343888|155200|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
66878|NCT01343823|155242|P4|NOT COMPLETED|Overall Study||1
66879|NCT01343823|155243|P3|NOT COMPLETED|Overall Study||0
66880|NCT01343823|155244|P2|NOT COMPLETED|Overall Study||0
66881|NCT01343823|155245|P1|NOT COMPLETED|Overall Study||2
66882|NCT01343823|155242|P4|COMPLETED|Overall Study||19
66883|NCT01343823|155243|P3|COMPLETED|Overall Study||19
66884|NCT01343823|155244|P2|COMPLETED|Overall Study||20
66885|NCT01343823|155245|P1|COMPLETED|Overall Study||18
66886|NCT01343823|155242|P4|STARTED|Overall Study||20
66887|NCT01343823|155243|P3|STARTED|Overall Study||19
66888|NCT01343823|155244|P2|STARTED|Overall Study||20
66889|NCT01343823|155245|P1|STARTED|Overall Study||20
66890|NCT01343667|155261|P2|NOT COMPLETED|Overall Study||56
66891|NCT01343667|155262|P1|NOT COMPLETED|Overall Study||12
66892|NCT01343667|155261|P2|COMPLETED|Overall Study||916
66893|NCT01343667|155262|P1|COMPLETED|Overall Study||413
66894|NCT01343667|155261|P2|STARTED|Overall Study||972
66895|NCT01343667|155262|P1|STARTED|Overall Study||425
66896|NCT01343277|155270|P2|NOT COMPLETED|Overall Study||193
66897|NCT01343277|155271|P1|NOT COMPLETED|Overall Study||384
66898|NCT01343277|155270|P2|COMPLETED|Overall Study||0
66899|NCT01343277|155271|P1|COMPLETED|Overall Study||0
66900|NCT01343277|155270|P2|Treated|Overall Study||172
66901|NCT01343277|155271|P1|Treated|Overall Study||378
66902|NCT01343277|155270|P2|STARTED|Overall Study||193
66903|NCT01343277|155271|P1|STARTED|Overall Study||384
66904|NCT01343251|155289|P2|NOT COMPLETED|Overall Study||0
66905|NCT01343251|155290|P1|NOT COMPLETED|Overall Study||0
66906|NCT01343251|155289|P2|COMPLETED|Overall Study||17
66907|NCT01343251|155290|P1|COMPLETED|Overall Study||16
66908|NCT01343251|155289|P2|STARTED|Overall Study||17
66909|NCT01343251|155290|P1|STARTED|Overall Study||16
66910|NCT01343082|155304|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
66911|NCT01343082|155305|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
66912|NCT01343082|155306|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
66913|NCT01343082|155304|P3|COMPLETED|Treatment Period , Switched to DE-111||31
66914|NCT01343082|155305|P2|COMPLETED|Treatment Period , Switched to DE-111||36
66915|NCT01343082|155306|P1|COMPLETED|Treatment Period , Switched to DE-111||43
66916|NCT01343082|155304|P3|STARTED|Treatment Period , Switched to DE-111||43
66917|NCT01343082|155305|P2|STARTED|Treatment Period , Switched to DE-111||45
66918|NCT01343082|155306|P1|STARTED|Treatment Period , Switched to DE-111||48
66919|NCT01343082|155304|P3|NOT COMPLETED|The run-in Period||5
66920|NCT01343082|155305|P2|NOT COMPLETED|The run-in Period||4
66921|NCT01343082|155306|P1|NOT COMPLETED|The run-in Period||3
66922|NCT01343082|155304|P3|COMPLETED|The run-in Period||43
66923|NCT01343082|155305|P2|COMPLETED|The run-in Period||45
66924|NCT01343082|155306|P1|COMPLETED|The run-in Period||48
66925|NCT01343082|155304|P3|STARTED|The run-in Period||48
66926|NCT01343082|155305|P2|STARTED|The run-in Period||49
66927|NCT01343082|155306|P1|STARTED|The run-in Period||51
66928|NCT01342965|155312|P2|NOT COMPLETED|Overall Study||107
66929|NCT01342965|155313|P1|NOT COMPLETED|Overall Study||109
66930|NCT01342965|155312|P2|COMPLETED|Overall Study||0
66931|NCT01342965|155313|P1|COMPLETED|Overall Study||1
66932|NCT01342965|155312|P2|Received Treatment|Overall Study||104
66933|NCT01342965|155313|P1|Received Treatment|Overall Study||110
66934|NCT01342965|155312|P2|STARTED|Overall Study||107
66935|NCT01342965|155313|P1|STARTED|Overall Study||110
66936|NCT01342913|155329|P3|NOT COMPLETED|Double-Blind Treatment Period||23
66937|NCT01342913|155330|P2|NOT COMPLETED|Double-Blind Treatment Period||16
66938|NCT01342913|155331|P1|NOT COMPLETED|Double-Blind Treatment Period||0
66939|NCT01342913|155329|P3|COMPLETED|Double-Blind Treatment Period||243
66940|NCT01342913|155330|P2|COMPLETED|Double-Blind Treatment Period||246
66941|NCT01342913|155331|P1|COMPLETED|Double-Blind Treatment Period||0
66942|NCT01342913|155329|P3|STARTED|Double-Blind Treatment Period||266
66943|NCT01342913|155330|P2|STARTED|Double-Blind Treatment Period||262
66944|NCT01342913|155331|P1|STARTED|Double-Blind Treatment Period||0
66945|NCT01342913|155329|P3|NOT COMPLETED|2-week Run-in Period||0
66946|NCT01342913|155330|P2|NOT COMPLETED|2-week Run-in Period||0
66947|NCT01342913|155331|P1|NOT COMPLETED|2-week Run-in Period||174
66948|NCT01342913|155329|P3|COMPLETED|2-week Run-in Period||0
66949|NCT01342913|155330|P2|COMPLETED|2-week Run-in Period||0
66950|NCT01342913|155331|P1|COMPLETED|2-week Run-in Period||528
66951|NCT01342913|155329|P3|STARTED|2-week Run-in Period||0
66952|NCT01342913|155330|P2|STARTED|2-week Run-in Period||0
66953|NCT01342913|155331|P1|STARTED|2-week Run-in Period||702
66954|NCT01342770|155341|P1|NOT COMPLETED|Overall Study||0
66955|NCT01342770|155341|P1|COMPLETED|Overall Study||6
66956|NCT01342770|155341|P1|STARTED|Overall Study||6
66957|NCT01342757|155354|P1|NOT COMPLETED|Overall Study||0
66958|NCT01342757|155354|P1|COMPLETED|Overall Study||12
66959|NCT01342757|155354|P1|STARTED|Overall Study||12
66960|NCT01342666|155361|P2|NOT COMPLETED|Overall Study||0
66961|NCT01342666|155362|P1|NOT COMPLETED|Overall Study||0
66962|NCT01342666|155361|P2|COMPLETED|Overall Study||24
66963|NCT01342666|155362|P1|COMPLETED|Overall Study||26
66964|NCT01342666|155361|P2|STARTED|Overall Study||24
66965|NCT01342666|155362|P1|STARTED|Overall Study||26
66966|NCT01342640|155368|P1|NOT COMPLETED|Overall Study||41
66967|NCT01342640|155368|P1|COMPLETED|Overall Study||29
66968|NCT01342640|155368|P1|STARTED|Overall Study||70
66969|NCT01342549|155376|P2|NOT COMPLETED|Overall Study||0
66970|NCT01342549|155377|P1|NOT COMPLETED|Overall Study||0
66971|NCT01342549|155376|P2|COMPLETED|Overall Study||31
66972|NCT01342549|155377|P1|COMPLETED|Overall Study||31
66973|NCT01342549|155376|P2|STARTED|Overall Study||31
66974|NCT01342549|155377|P1|STARTED|Overall Study||31
66975|NCT01342523|155415|P32|NOT COMPLETED|Overall Study||1
66976|NCT01342523|155416|P31|NOT COMPLETED|Overall Study||1
66977|NCT01342523|155417|P30|NOT COMPLETED|Overall Study||1
66978|NCT01342523|155418|P29|NOT COMPLETED|Overall Study||1
66979|NCT01342523|155419|P28|NOT COMPLETED|Overall Study||1
66980|NCT01342523|155420|P27|NOT COMPLETED|Overall Study||1
66981|NCT01342523|155421|P26|NOT COMPLETED|Overall Study||2
66982|NCT01342523|155422|P25|NOT COMPLETED|Overall Study||1
66983|NCT01342523|155423|P24|NOT COMPLETED|Overall Study||1
66984|NCT01342523|155424|P23|NOT COMPLETED|Overall Study||0
66985|NCT01342523|155425|P22|NOT COMPLETED|Overall Study||0
66986|NCT01342523|155426|P21|NOT COMPLETED|Overall Study||0
66987|NCT01342523|155427|P20|NOT COMPLETED|Overall Study||0
66988|NCT01342523|155428|P19|NOT COMPLETED|Overall Study||0
66989|NCT01342523|155429|P18|NOT COMPLETED|Overall Study||0
66990|NCT01342523|155430|P17|NOT COMPLETED|Overall Study||1
66991|NCT01342523|155431|P16|NOT COMPLETED|Overall Study||0
66992|NCT01342523|155432|P15|NOT COMPLETED|Overall Study||1
66993|NCT01342523|155433|P14|NOT COMPLETED|Overall Study||2
66994|NCT01342523|155434|P13|NOT COMPLETED|Overall Study||0
66995|NCT01342523|155435|P12|NOT COMPLETED|Overall Study||2
66996|NCT01342523|155436|P11|NOT COMPLETED|Overall Study||0
66997|NCT01342523|155437|P10|NOT COMPLETED|Overall Study||0
66998|NCT01342523|155438|P9|NOT COMPLETED|Overall Study||0
66999|NCT01342523|155439|P8|NOT COMPLETED|Overall Study||0
67000|NCT01342523|155440|P7|NOT COMPLETED|Overall Study||0
67001|NCT01342523|155441|P6|NOT COMPLETED|Overall Study||0
67002|NCT01342523|155442|P5|NOT COMPLETED|Overall Study||0
67003|NCT01342523|155443|P4|NOT COMPLETED|Overall Study||1
67004|NCT01342523|155444|P3|NOT COMPLETED|Overall Study||0
67005|NCT01342523|155445|P2|NOT COMPLETED|Overall Study||0
67006|NCT01342523|155446|P1|NOT COMPLETED|Overall Study||1
67007|NCT01342523|155415|P32|COMPLETED|Overall Study||27
67008|NCT01342523|155416|P31|COMPLETED|Overall Study||30
67009|NCT01342523|155417|P30|COMPLETED|Overall Study||28
67010|NCT01342523|155418|P29|COMPLETED|Overall Study||34
67011|NCT01342523|155419|P28|COMPLETED|Overall Study||30
67012|NCT01342523|155420|P27|COMPLETED|Overall Study||33
67013|NCT01342523|155421|P26|COMPLETED|Overall Study||36
67014|NCT01342523|155422|P25|COMPLETED|Overall Study||36
67015|NCT01342523|155423|P24|COMPLETED|Overall Study||35
67016|NCT01342523|155424|P23|COMPLETED|Overall Study||36
67017|NCT01342523|155425|P22|COMPLETED|Overall Study||30
67018|NCT01342523|155426|P21|COMPLETED|Overall Study||29
67019|NCT01342523|155427|P20|COMPLETED|Overall Study||27
67020|NCT01342523|155428|P19|COMPLETED|Overall Study||21
67021|NCT01342523|155429|P18|COMPLETED|Overall Study||27
67022|NCT01342523|155430|P17|COMPLETED|Overall Study||28
67023|NCT01342523|155431|P16|COMPLETED|Overall Study||32
67024|NCT01342523|155432|P15|COMPLETED|Overall Study||37
67025|NCT01342523|155433|P14|COMPLETED|Overall Study||36
67026|NCT01342523|155434|P13|COMPLETED|Overall Study||39
67027|NCT01342523|155435|P12|COMPLETED|Overall Study||36
67028|NCT01342523|155436|P11|COMPLETED|Overall Study||38
67029|NCT01342523|155437|P10|COMPLETED|Overall Study||28
67030|NCT01342523|155438|P9|COMPLETED|Overall Study||28
67031|NCT01342523|155439|P8|COMPLETED|Overall Study||27
67032|NCT01342523|155440|P7|COMPLETED|Overall Study||22
67033|NCT01342523|155441|P6|COMPLETED|Overall Study||36
67034|NCT01342523|155442|P5|COMPLETED|Overall Study||36
67035|NCT01342523|155443|P4|COMPLETED|Overall Study||32
67036|NCT01342523|155444|P3|COMPLETED|Overall Study||36
67037|NCT01342523|155445|P2|COMPLETED|Overall Study||32
67038|NCT01342523|155446|P1|COMPLETED|Overall Study||34
67039|NCT01342523|155415|P32|STARTED|Overall Study||28
67040|NCT01342523|155416|P31|STARTED|Overall Study||31
67041|NCT01342523|155417|P30|STARTED|Overall Study||29
67042|NCT01342523|155418|P29|STARTED|Overall Study||35
67043|NCT01342523|155419|P28|STARTED|Overall Study||31
67044|NCT01342523|155420|P27|STARTED|Overall Study||34
67045|NCT01342523|155421|P26|STARTED|Overall Study||38
67046|NCT01342523|155422|P25|STARTED|Overall Study||37
67047|NCT01342523|155423|P24|STARTED|Overall Study||36
67048|NCT01342523|155424|P23|STARTED|Overall Study||36
67049|NCT01342523|155425|P22|STARTED|Overall Study||30
67050|NCT01342523|155426|P21|STARTED|Overall Study||29
67051|NCT01342523|155427|P20|STARTED|Overall Study||27
67052|NCT01342523|155428|P19|STARTED|Overall Study||21
67053|NCT01342523|155429|P18|STARTED|Overall Study||27
67054|NCT01342523|155430|P17|STARTED|Overall Study||29
67055|NCT01342523|155431|P16|STARTED|Overall Study||32
67056|NCT01342523|155432|P15|STARTED|Overall Study||38
67057|NCT01342523|155433|P14|STARTED|Overall Study||38
67058|NCT01342523|155434|P13|STARTED|Overall Study||39
67059|NCT01342523|155435|P12|STARTED|Overall Study||38
67060|NCT01342523|155436|P11|STARTED|Overall Study||38
67061|NCT01342523|155437|P10|STARTED|Overall Study||28
67062|NCT01342523|155438|P9|STARTED|Overall Study||28
67063|NCT01342523|155439|P8|STARTED|Overall Study||27
67064|NCT01342523|155440|P7|STARTED|Overall Study||22
67065|NCT01342523|155441|P6|STARTED|Overall Study||36
67066|NCT01342523|155442|P5|STARTED|Overall Study||36
67067|NCT01342523|155443|P4|STARTED|Overall Study||33
67068|NCT01342523|155444|P3|STARTED|Overall Study||36
67069|NCT01342523|155445|P2|STARTED|Overall Study||32
67070|NCT01342523|155446|P1|STARTED|Overall Study||35
67071|NCT01342510|155463|P4|NOT COMPLETED|Overall Study||11
67072|NCT01342510|155464|P3|NOT COMPLETED|Overall Study||13
67073|NCT01342510|155465|P2|NOT COMPLETED|Overall Study||6
67074|NCT01342510|155466|P1|NOT COMPLETED|Overall Study||12
67075|NCT01342510|155463|P4|COMPLETED|Overall Study||39
67076|NCT01342510|155464|P3|COMPLETED|Overall Study||37
67077|NCT01342510|155465|P2|COMPLETED|Overall Study||44
67078|NCT01342510|155466|P1|COMPLETED|Overall Study||38
67079|NCT01342510|155463|P4|STARTED|Overall Study||50
67080|NCT01342510|155464|P3|STARTED|Overall Study||50
67081|NCT01342510|155465|P2|STARTED|Overall Study||50
67082|NCT01342510|155466|P1|STARTED|Overall Study||50
67083|NCT01342484|155479|P3|NOT COMPLETED|Overall Study||1
67084|NCT01342484|155480|P2|NOT COMPLETED|Overall Study||0
67085|NCT01342484|155481|P1|NOT COMPLETED|Overall Study||2
67086|NCT01342484|155479|P3|COMPLETED|Overall Study||13
67087|NCT01342484|155480|P2|COMPLETED|Overall Study||10
67088|NCT01342484|155481|P1|COMPLETED|Overall Study||13
67089|NCT01342484|155479|P3|STARTED|Overall Study||14
67090|NCT01342484|155480|P2|STARTED|Overall Study||10
67091|NCT01342484|155481|P1|STARTED|Overall Study||15
67092|NCT01342471|155497|P2|NOT COMPLETED|Overall Study||6
67093|NCT01342471|155498|P1|NOT COMPLETED|Overall Study||5
67094|NCT01342471|155497|P2|COMPLETED|Overall Study||23
67095|NCT01342471|155498|P1|COMPLETED|Overall Study||24
67096|NCT01342471|155497|P2|STARTED|Overall Study||29
67097|NCT01342471|155498|P1|STARTED|Overall Study||29
67098|NCT01342458|155514|P2|NOT COMPLETED|Overall Study||4
67099|NCT01342458|155515|P1|NOT COMPLETED|Overall Study||2
67100|NCT01342458|155514|P2|COMPLETED|Overall Study||24
67101|NCT01342458|155515|P1|COMPLETED|Overall Study||26
67102|NCT01342458|155514|P2|STARTED|Overall Study||28
67103|NCT01342458|155515|P1|STARTED|Overall Study||28
67104|NCT01342445|155537|P2|NOT COMPLETED|Overall Study||2
67105|NCT01342445|155538|P1|NOT COMPLETED|Overall Study||0
67106|NCT01342445|155537|P2|COMPLETED|Overall Study||22
67107|NCT01342445|155538|P1|COMPLETED|Overall Study||26
67108|NCT01342445|155537|P2|STARTED|Overall Study||24
67109|NCT01342445|155538|P1|STARTED|Overall Study||26
67110|NCT01342341|155554|P2|NOT COMPLETED|Overall Study||4
67111|NCT01342341|155555|P1|NOT COMPLETED|Overall Study||4
67112|NCT01342341|155554|P2|COMPLETED|Overall Study||20
67113|NCT01342341|155555|P1|COMPLETED|Overall Study||20
67114|NCT01342341|155554|P2|STARTED|Overall Study||24
67115|NCT01342341|155555|P1|STARTED|Overall Study||24
67116|NCT01342172|155561|P1|NOT COMPLETED|Overall Study||0
67117|NCT01342172|155561|P1|COMPLETED|Overall Study||9
67118|NCT01342172|155561|P1|STARTED|Overall Study||9
67119|NCT01342107|155567|P2|NOT COMPLETED|Overall Study||0
67120|NCT01342107|155568|P1|NOT COMPLETED|Overall Study||0
67121|NCT01342107|155567|P2|COMPLETED|Overall Study||32
67122|NCT01342107|155568|P1|COMPLETED|Overall Study||34
67123|NCT01342107|155567|P2|STARTED|Overall Study||32
67124|NCT01342107|155568|P1|STARTED|Overall Study||34
67125|NCT01342094|155576|P2|NOT COMPLETED|Overall Study||3
67126|NCT01342094|155577|P1|NOT COMPLETED|Overall Study||5
67127|NCT01342094|155576|P2|COMPLETED|Overall Study||81
67128|NCT01342094|155577|P1|COMPLETED|Overall Study||77
67129|NCT01342094|155576|P2|STARTED|Overall Study||84
67130|NCT01342094|155577|P1|STARTED|Overall Study||82
67131|NCT01342081|155586|P3|NOT COMPLETED|Overall Study||1
67132|NCT01342081|155587|P2|NOT COMPLETED|Overall Study||2
67133|NCT01342081|155588|P1|NOT COMPLETED|Overall Study||2
67134|NCT01342081|155586|P3|COMPLETED|Overall Study||163
67135|NCT01342081|155587|P2|COMPLETED|Overall Study||162
67136|NCT01342081|155588|P1|COMPLETED|Overall Study||159
67137|NCT01342081|155586|P3|STARTED|Overall Study||164
67138|NCT01342081|155587|P2|STARTED|Overall Study||164
67139|NCT01342081|155588|P1|STARTED|Overall Study||161
67140|NCT01341990|155598|P2|NOT COMPLETED|Overall Study||1
67141|NCT01341990|155599|P1|NOT COMPLETED|Overall Study||3
67142|NCT01341990|155598|P2|COMPLETED|Overall Study||32
67143|NCT01341990|155599|P1|COMPLETED|Overall Study||32
67144|NCT01341990|155598|P2|STARTED|Overall Study||33
67145|NCT01341990|155599|P1|STARTED|Overall Study||35
67146|NCT01341977|155609|P2|NOT COMPLETED|Overall Study||15
67147|NCT01341977|155610|P1|NOT COMPLETED|Overall Study||14
67148|NCT01341977|155609|P2|COMPLETED|Overall Study||270
67149|NCT01341977|155610|P1|COMPLETED|Overall Study||274
67150|NCT01341977|155609|P2|STARTED|Overall Study||285
67151|NCT01341977|155610|P1|STARTED|Overall Study||288
67152|NCT01341912|155616|P1|NOT COMPLETED|Overall Study||0
67153|NCT01341912|155616|P1|COMPLETED|Overall Study||3
67154|NCT01341912|155616|P1|STARTED|Overall Study||3
67155|NCT01341782|155623|P2|NOT COMPLETED|Overall Study||14
67156|NCT01341782|155624|P1|NOT COMPLETED|Overall Study||15
67157|NCT01341782|155623|P2|COMPLETED|Overall Study||114
67158|NCT01341782|155624|P1|COMPLETED|Overall Study||112
67159|NCT01341782|155623|P2|STARTED|Overall Study||128
67160|NCT01341782|155624|P1|STARTED|Overall Study||127
67161|NCT01341067|155640|P1|NOT COMPLETED|Overall Study||4
67162|NCT01341067|155640|P1|COMPLETED|Overall Study||26
67163|NCT01341067|155640|P1|STARTED|Overall Study||30
67164|NCT01340937|155651|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
67165|NCT01340937|155652|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
67166|NCT01340937|155653|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
67167|NCT01340937|155654|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
67168|NCT01340937|155651|P4|COMPLETED|Period 3: Toddler Vaccinations||319
67169|NCT01340937|155652|P3|COMPLETED|Period 3: Toddler Vaccinations||660
67170|NCT01340937|155653|P2|COMPLETED|Period 3: Toddler Vaccinations||641
67171|NCT01340937|155654|P1|COMPLETED|Period 3: Toddler Vaccinations||666
67172|NCT01340937|155651|P4|STARTED|Period 3: Toddler Vaccinations||329
67173|NCT01340937|155652|P3|STARTED|Period 3: Toddler Vaccinations||669
67174|NCT01340937|155653|P2|STARTED|Period 3: Toddler Vaccinations||658
67175|NCT01340937|155654|P1|STARTED|Period 3: Toddler Vaccinations||675
67176|NCT01340937|155651|P4|NOT COMPLETED|Period 2: Interim Period||41
67177|NCT01340937|155652|P3|NOT COMPLETED|Period 2: Interim Period||84
67178|NCT01340937|155653|P2|NOT COMPLETED|Period 2: Interim Period||79
67179|NCT01340937|155654|P1|NOT COMPLETED|Period 2: Interim Period||67
67180|NCT01340937|155651|P4|COMPLETED|Period 2: Interim Period||329
67181|NCT01340937|155652|P3|COMPLETED|Period 2: Interim Period||669
67182|NCT01340937|155653|P2|COMPLETED|Period 2: Interim Period||658
67183|NCT01340937|155654|P1|COMPLETED|Period 2: Interim Period||675
67184|NCT01340937|155651|P4|STARTED|Period 2: Interim Period||370
67185|NCT01340937|155652|P3|STARTED|Period 2: Interim Period||753
67186|NCT01340937|155653|P2|STARTED|Period 2: Interim Period||737
67187|NCT01340937|155654|P1|STARTED|Period 2: Interim Period||742
67188|NCT01340937|155651|P4|NOT COMPLETED|Period 1: Infant Series||32
67189|NCT01340937|155652|P3|NOT COMPLETED|Period 1: Infant Series||56
67190|NCT01340937|155653|P2|NOT COMPLETED|Period 1: Infant Series||60
67191|NCT01340937|155654|P1|NOT COMPLETED|Period 1: Infant Series||58
67192|NCT01340937|155651|P4|COMPLETED|Period 1: Infant Series||370
67193|NCT01340937|155652|P3|COMPLETED|Period 1: Infant Series||753
67194|NCT01340937|155653|P2|COMPLETED|Period 1: Infant Series||737
67195|NCT01340937|155654|P1|COMPLETED|Period 1: Infant Series||742
67196|NCT01340937|155651|P4|STARTED|Period 1: Infant Series||402
67197|NCT01340937|155652|P3|STARTED|Period 1: Infant Series||809
67198|NCT01340937|155653|P2|STARTED|Period 1: Infant Series||797
67199|NCT01340937|155654|P1|STARTED|Period 1: Infant Series||800
67200|NCT01340794|155813|P2|NOT COMPLETED|Overall Study||1
67201|NCT01340794|155814|P1|NOT COMPLETED|Overall Study||0
67202|NCT01340794|155813|P2|COMPLETED|Overall Study||4
67203|NCT01340794|155814|P1|COMPLETED|Overall Study||2
67204|NCT01340794|155813|P2|STARTED|Overall Study||5
67205|NCT01340794|155814|P1|STARTED|Overall Study||2
67206|NCT01340768|155830|P2|NOT COMPLETED|Overall Study||5
67207|NCT01340768|155831|P1|NOT COMPLETED|Overall Study||17
67208|NCT01340768|155830|P2|COMPLETED|Overall Study||429
67209|NCT01340768|155831|P1|COMPLETED|Overall Study||419
67210|NCT01340768|155830|P2|STARTED|Overall Study||434
67211|NCT01340768|155831|P1|STARTED|Overall Study||436
67212|NCT01340664|155842|P3|NOT COMPLETED|Overall Study||13
67213|NCT01340664|155843|P2|NOT COMPLETED|Overall Study||8
67214|NCT01340664|155844|P1|NOT COMPLETED|Overall Study||7
67215|NCT01340664|155842|P3|COMPLETED|Overall Study||80
67216|NCT01340664|155843|P2|COMPLETED|Overall Study||85
67217|NCT01340664|155844|P1|COMPLETED|Overall Study||86
67218|NCT01340664|155842|P3|STARTED|Overall Study||93
67219|NCT01340664|155843|P2|STARTED|Overall Study||93
67220|NCT01340664|155844|P1|STARTED|Overall Study||93
67221|NCT01340651|155861|P1|NOT COMPLETED|Overall Study||17
67222|NCT01340651|155861|P1|COMPLETED|Overall Study||24
67223|NCT01340651|155861|P1|STARTED|Overall Study||41
67224|NCT01340625|155877|P2|NOT COMPLETED|Second Intervention||0
67225|NCT01340625|155878|P1|NOT COMPLETED|Second Intervention||0
67226|NCT01340625|155877|P2|COMPLETED|Second Intervention||18
67227|NCT01340625|155878|P1|COMPLETED|Second Intervention||16
67228|NCT01340625|155877|P2|STARTED|Second Intervention||18
67229|NCT01340625|155878|P1|STARTED|Second Intervention||16
67230|NCT01340625|155877|P2|NOT COMPLETED|Washout Period of 28 Days||0
67231|NCT01340625|155878|P1|NOT COMPLETED|Washout Period of 28 Days||1
67232|NCT01340625|155877|P2|COMPLETED|Washout Period of 28 Days||18
67233|NCT01340625|155878|P1|COMPLETED|Washout Period of 28 Days||16
67234|NCT01340625|155877|P2|STARTED|Washout Period of 28 Days||18
67235|NCT01340625|155878|P1|STARTED|Washout Period of 28 Days||17
67236|NCT01340625|155877|P2|NOT COMPLETED|First Intervention||0
67237|NCT01340625|155878|P1|NOT COMPLETED|First Intervention||1
67238|NCT01340625|155877|P2|COMPLETED|First Intervention||18
67239|NCT01340625|155878|P1|COMPLETED|First Intervention||17
67240|NCT01340625|155877|P2|STARTED|First Intervention||18
67241|NCT01340625|155878|P1|STARTED|First Intervention||18
67242|NCT01340586|155896|P2|NOT COMPLETED|Overall Study||0
67243|NCT01340586|155897|P1|NOT COMPLETED|Overall Study||0
67244|NCT01340586|155896|P2|COMPLETED|Overall Study||8
67245|NCT01340586|155897|P1|COMPLETED|Overall Study||8
67246|NCT01340586|155896|P2|STARTED|Overall Study||8
67247|NCT01340586|155897|P1|STARTED|Overall Study||8
67248|NCT01340573|155962|P1|NOT COMPLETED|Overall Study||3
67249|NCT01340573|155962|P1|COMPLETED|Overall Study||0
67250|NCT01340573|155962|P1|STARTED|Overall Study||3
67251|NCT01340209|155986|P3|NOT COMPLETED|Overall Study||8
67252|NCT01340209|155987|P2|NOT COMPLETED|Overall Study||8
67253|NCT01340209|155988|P1|NOT COMPLETED|Overall Study||5
67254|NCT01340209|155986|P3|COMPLETED|Overall Study||106
67255|NCT01340209|155987|P2|COMPLETED|Overall Study||106
67256|NCT01340209|155988|P1|COMPLETED|Overall Study||52
67257|NCT01340209|155986|P3|STARTED|Overall Study||114
67258|NCT01340209|155987|P2|STARTED|Overall Study||114
67259|NCT01340209|155988|P1|STARTED|Overall Study||57
67260|NCT01340196|156023|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
67261|NCT01340196|156023|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
67262|NCT01340196|156023|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
67263|NCT01340196|156023|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
67264|NCT01340196|156023|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
67265|NCT01340196|156023|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
67266|NCT01340196|156023|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
67267|NCT01340196|156023|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
67268|NCT01340196|156023|P1|STARTED|Treat. Period 1 (Tenofovir)||16
67269|NCT01340144|156054|P2|NOT COMPLETED|Overall Study||58
67270|NCT01340144|156055|P1|NOT COMPLETED|Overall Study||72
67271|NCT01340144|156054|P2|COMPLETED|Overall Study||567
67272|NCT01340144|156055|P1|COMPLETED|Overall Study||553
67273|NCT01340144|156054|P2|STARTED|Overall Study||625
67274|NCT01340144|156055|P1|STARTED|Overall Study||625
67275|NCT01340066|156063|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
67276|NCT01340066|156064|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
67277|NCT01340066|156065|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
67278|NCT01340066|156063|P3|COMPLETED|5 Week Double Blind Randomization Period||31
67279|NCT01340066|156064|P2|COMPLETED|5 Week Double Blind Randomization Period||28
67280|NCT01340066|156065|P1|COMPLETED|5 Week Double Blind Randomization Period||0
67281|NCT01340066|156063|P3|STARTED|5 Week Double Blind Randomization Period||34
67282|NCT01340066|156064|P2|STARTED|5 Week Double Blind Randomization Period||33
67283|NCT01340066|156065|P1|STARTED|5 Week Double Blind Randomization Period||0
67284|NCT01340066|156063|P3|NOT COMPLETED|Placebo Run in Period||0
67285|NCT01340066|156064|P2|NOT COMPLETED|Placebo Run in Period||0
67286|NCT01340066|156065|P1|NOT COMPLETED|Placebo Run in Period||27
67287|NCT01340066|156063|P3|COMPLETED|Placebo Run in Period||0
67288|NCT01340066|156064|P2|COMPLETED|Placebo Run in Period||0
67289|NCT01340066|156065|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
67290|NCT01340066|156063|P3|STARTED|Placebo Run in Period||0
67291|NCT01340066|156064|P2|STARTED|Placebo Run in Period||0
67292|NCT01340066|156065|P1|STARTED|Placebo Run in Period||94
67293|NCT01340027|156084|P12|NOT COMPLETED|Overall Study||4
67294|NCT01340027|156085|P11|NOT COMPLETED|Overall Study||2
67295|NCT01340027|156086|P10|NOT COMPLETED|Overall Study||6
67296|NCT01340027|156087|P9|NOT COMPLETED|Overall Study||8
67297|NCT01340027|156088|P8|NOT COMPLETED|Overall Study||7
67298|NCT01340027|156089|P7|NOT COMPLETED|Overall Study||7
67299|NCT01340027|156090|P6|NOT COMPLETED|Overall Study||4
67300|NCT01340027|156091|P5|NOT COMPLETED|Overall Study||10
67301|NCT01340027|156092|P4|NOT COMPLETED|Overall Study||4
67302|NCT01340027|156093|P3|NOT COMPLETED|Overall Study||4
67303|NCT01340027|156094|P2|NOT COMPLETED|Overall Study||7
67304|NCT01340027|156095|P1|NOT COMPLETED|Overall Study||5
67305|NCT01340027|156084|P12|COMPLETED|Overall Study||77
67306|NCT01340027|156085|P11|COMPLETED|Overall Study||79
67307|NCT01340027|156086|P10|COMPLETED|Overall Study||146
67308|NCT01340027|156087|P9|COMPLETED|Overall Study||136
67309|NCT01340027|156088|P8|COMPLETED|Overall Study||142
67310|NCT01340027|156089|P7|COMPLETED|Overall Study||142
67311|NCT01340027|156090|P6|COMPLETED|Overall Study||74
67312|NCT01340027|156091|P5|COMPLETED|Overall Study||146
67313|NCT01340027|156092|P4|COMPLETED|Overall Study||75
67314|NCT01340027|156093|P3|COMPLETED|Overall Study||75
67315|NCT01340027|156094|P2|COMPLETED|Overall Study||71
67316|NCT01340027|156095|P1|COMPLETED|Overall Study||76
67317|NCT01340027|156084|P12|Received Treatment|Overall Study||81
67318|NCT01340027|156085|P11|Received Treatment|Overall Study||81
67319|NCT01340027|156086|P10|Received Treatment|Overall Study||152
67320|NCT01340027|156087|P9|Received Treatment|Overall Study||144
67321|NCT01340027|156088|P8|Received Treatment|Overall Study||149
67322|NCT01340027|156089|P7|Received Treatment|Overall Study||149
67323|NCT01340027|156090|P6|Received Treatment|Overall Study||78
67324|NCT01340027|156091|P5|Received Treatment|Overall Study||156
67325|NCT01340027|156092|P4|Received Treatment|Overall Study||79
67326|NCT01340027|156093|P3|Received Treatment|Overall Study||78
67327|NCT01340027|156094|P2|Received Treatment|Overall Study||78
67328|NCT01340027|156095|P1|Received Treatment|Overall Study||81
67329|NCT01340027|156084|P12|STARTED|Overall Study||81
67330|NCT01340027|156085|P11|STARTED|Overall Study||81
67331|NCT01340027|156086|P10|STARTED|Overall Study||152
67332|NCT01340027|156087|P9|STARTED|Overall Study||144
67333|NCT01340027|156088|P8|STARTED|Overall Study||149
67334|NCT01340027|156089|P7|STARTED|Overall Study||149
67335|NCT01340027|156090|P6|STARTED|Overall Study||78
67336|NCT01340027|156091|P5|STARTED|Overall Study||156
67337|NCT01340027|156092|P4|STARTED|Overall Study||79
67338|NCT01340027|156093|P3|STARTED|Overall Study||79
67339|NCT01340027|156094|P2|STARTED|Overall Study||78
67340|NCT01340027|156095|P1|STARTED|Overall Study||81
67341|NCT01340014|156471|P2|NOT COMPLETED|Period 2, Second 7 Days||1
67342|NCT01340014|156472|P1|NOT COMPLETED|Period 2, Second 7 Days||0
67343|NCT01340014|156471|P2|COMPLETED|Period 2, Second 7 Days||56
67344|NCT01340014|156472|P1|COMPLETED|Period 2, Second 7 Days||53
67345|NCT01340014|156471|P2|STARTED|Period 2, Second 7 Days||57
67346|NCT01340014|156472|P1|STARTED|Period 2, Second 7 Days||53
67347|NCT01340014|156471|P2|NOT COMPLETED|Period 1, First 7 Days||0
67348|NCT01340014|156472|P1|NOT COMPLETED|Period 1, First 7 Days||2
67349|NCT01340014|156471|P2|COMPLETED|Period 1, First 7 Days||57
67350|NCT01340014|156472|P1|COMPLETED|Period 1, First 7 Days||53
67351|NCT01340014|156471|P2|STARTED|Period 1, First 7 Days||57
67352|NCT01340014|156472|P1|STARTED|Period 1, First 7 Days||55
67353|NCT01339936|156480|P1|NOT COMPLETED|Overall Study||2
67354|NCT01339936|156480|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
67355|NCT01339936|156480|P1|STARTED|Overall Study|plus 2 screen failures|38
67356|NCT01339923|156493|P7|NOT COMPLETED|Overall Study||14
67357|NCT01339923|156494|P6|NOT COMPLETED|Overall Study||9
67358|NCT01339923|156495|P5|NOT COMPLETED|Overall Study||5
67359|NCT01339923|156496|P4|NOT COMPLETED|Overall Study||4
67360|NCT01339923|156497|P3|NOT COMPLETED|Overall Study||8
67361|NCT01339923|156498|P2|NOT COMPLETED|Overall Study||16
67362|NCT01339923|156499|P1|NOT COMPLETED|Overall Study||14
67363|NCT01339923|156493|P7|COMPLETED|Overall Study||111
67364|NCT01339923|156494|P6|COMPLETED|Overall Study||117
67365|NCT01339923|156495|P5|COMPLETED|Overall Study||295
67366|NCT01339923|156496|P4|COMPLETED|Overall Study||100
67367|NCT01339923|156497|P3|COMPLETED|Overall Study||243
67368|NCT01339923|156498|P2|COMPLETED|Overall Study||234
67369|NCT01339923|156499|P1|COMPLETED|Overall Study||239
67370|NCT01339923|156493|P7|STARTED|Overall Study||125
67371|NCT01339923|156494|P6|STARTED|Overall Study||126
67372|NCT01339923|156495|P5|STARTED|Overall Study||300
67373|NCT01339923|156496|P4|STARTED|Overall Study||104
67374|NCT01339923|156497|P3|STARTED|Overall Study||251
67375|NCT01339923|156498|P2|STARTED|Overall Study||250
67376|NCT01339923|156499|P1|STARTED|Overall Study||253
67377|NCT01339897|156572|P4|NOT COMPLETED|Overall Study||1
67378|NCT01339897|156573|P3|NOT COMPLETED|Overall Study||0
67379|NCT01339897|156574|P2|NOT COMPLETED|Overall Study||0
67380|NCT01339897|156575|P1|NOT COMPLETED|Overall Study||1
67381|NCT01339897|156572|P4|COMPLETED|Overall Study||5
67382|NCT01339897|156573|P3|COMPLETED|Overall Study||6
67383|NCT01339897|156574|P2|COMPLETED|Overall Study||6
67384|NCT01339897|156575|P1|COMPLETED|Overall Study||6
67385|NCT01339897|156572|P4|STARTED|Overall Study||6
67386|NCT01339897|156573|P3|STARTED|Overall Study||6
67387|NCT01339897|156574|P2|STARTED|Overall Study||6
67388|NCT01339897|156575|P1|STARTED|Overall Study||7
67389|NCT01339832|156601|P1|NOT COMPLETED|Overall Study||14
67390|NCT01339832|156601|P1|COMPLETED|Overall Study||37
67391|NCT01339832|156601|P1|STARTED|Overall Study||51
67392|NCT01339429|156612|P1|NOT COMPLETED|Overall Study||4
67393|NCT01339429|156612|P1|COMPLETED|Overall Study||37
67394|NCT01339429|156612|P1|STARTED|Overall Study||41
67395|NCT01339416|156617|P1|NOT COMPLETED|Overall Study||0
67396|NCT01339416|156617|P1|COMPLETED|Overall Study||8202
67397|NCT01339416|156617|P1|STARTED|Overall Study||8202
67398|NCT01339403|156629|P2|NOT COMPLETED|Overall Study||0
67399|NCT01339403|156630|P1|NOT COMPLETED|Overall Study||0
67400|NCT01339403|156629|P2|COMPLETED|Overall Study||257600
67401|NCT01339403|156630|P1|COMPLETED|Overall Study||24768
67402|NCT01339403|156629|P2|STARTED|Overall Study||257600
67403|NCT01339403|156630|P1|STARTED|Overall Study||24768
67404|NCT01339390|156652|P2|NOT COMPLETED|Overall Study||156
67405|NCT01339390|156653|P1|NOT COMPLETED|Overall Study||157
67406|NCT01339390|156652|P2|COMPLETED|Overall Study||1442
67407|NCT01339390|156653|P1|COMPLETED|Overall Study||1414
67408|NCT01339390|156652|P2|STARTED|Overall Study||1598
67409|NCT01339390|156653|P1|STARTED|Overall Study||1571
67410|NCT01339299|156661|P2|NOT COMPLETED|Overall Study||0
67411|NCT01339299|156662|P1|NOT COMPLETED|Overall Study||0
67412|NCT01339299|156661|P2|COMPLETED|Overall Study||50
67413|NCT01339299|156662|P1|COMPLETED|Overall Study||50
67414|NCT01339299|156661|P2|STARTED|Overall Study||50
67415|NCT01339299|156662|P1|STARTED|Overall Study||50
67416|NCT01339260|156670|P2|NOT COMPLETED|Multi-cycle Extension||193
67417|NCT01339260|156671|P1|NOT COMPLETED|Multi-cycle Extension||186
67418|NCT01339260|156670|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
67419|NCT01339260|156671|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
67420|NCT01339260|156670|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
67421|NCT01339260|156671|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
67422|NCT01339260|156670|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
67423|NCT01339260|156671|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
67424|NCT01339260|156670|P2|NOT COMPLETED|Cycle 1||10
67425|NCT01339260|156671|P1|NOT COMPLETED|Cycle 1||7
67426|NCT01339260|156670|P2|COMPLETED|Cycle 1||719
67427|NCT01339260|156671|P1|COMPLETED|Cycle 1||719
67428|NCT01339260|156670|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
67429|NCT01339260|156671|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
67430|NCT01339260|156670|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
67431|NCT01339260|156671|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
67432|NCT01339260|156670|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
67433|NCT01339260|156671|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
67434|NCT01339247|156683|P2|NOT COMPLETED|Period 2||0
67435|NCT01339247|156684|P1|NOT COMPLETED|Period 2||0
67436|NCT01339247|156683|P2|COMPLETED|Period 2||30
67437|NCT01339247|156684|P1|COMPLETED|Period 2||30
67438|NCT01339247|156683|P2|STARTED|Period 2||30
67439|NCT01339247|156684|P1|STARTED|Period 2||30
67440|NCT01339247|156683|P2|NOT COMPLETED|Period 1||0
67441|NCT01339247|156684|P1|NOT COMPLETED|Period 1||0
67442|NCT01339247|156683|P2|COMPLETED|Period 1||30
67443|NCT01339247|156684|P1|COMPLETED|Period 1||30
67444|NCT01339247|156683|P2|STARTED|Period 1||30
67445|NCT01339247|156684|P1|STARTED|Period 1||30
67446|NCT01339091|156696|P2|NOT COMPLETED|Overall Study||28
67447|NCT01339091|156697|P1|NOT COMPLETED|Overall Study||27
67448|NCT01339091|156696|P2|COMPLETED|Overall Study||257
67449|NCT01339091|156697|P1|COMPLETED|Overall Study||261
67450|NCT01339091|156696|P2|Safety Population|Overall Study||284
67451|NCT01339091|156697|P1|Safety Population|Overall Study||284
67452|NCT01339091|156696|P2|STARTED|Overall Study||285
67453|NCT01339091|156697|P1|STARTED|Overall Study||288
67454|NCT01339013|156709|P1|NOT COMPLETED|Overall Study||0
67455|NCT01339013|156709|P1|COMPLETED|Overall Study||6
67456|NCT01339013|156709|P1|STARTED|Overall Study||6
67457|NCT01339000|156715|P2|NOT COMPLETED|Overall Study||0
67458|NCT01339000|156716|P1|NOT COMPLETED|Overall Study||1
67459|NCT01339000|156715|P2|COMPLETED|Overall Study||0
67460|NCT01339000|156716|P1|COMPLETED|Overall Study||0
67461|NCT01339000|156715|P2|STARTED|Overall Study||0
67462|NCT01339000|156716|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
67463|NCT01338870|156736|P6|NOT COMPLETED|Overall Study||6
67464|NCT01338870|156737|P5|NOT COMPLETED|Overall Study||6
67465|NCT01338870|156738|P4|NOT COMPLETED|Overall Study||9
67466|NCT01338870|156739|P3|NOT COMPLETED|Overall Study||11
67467|NCT01338870|156740|P2|NOT COMPLETED|Overall Study||12
67468|NCT01338870|156741|P1|NOT COMPLETED|Overall Study||9
67469|NCT01338870|156736|P6|COMPLETED|Overall Study||44
67470|NCT01338870|156737|P5|COMPLETED|Overall Study||46
67471|NCT01338870|156738|P4|COMPLETED|Overall Study||41
67472|NCT01338870|156739|P3|COMPLETED|Overall Study||39
67473|NCT01338870|156740|P2|COMPLETED|Overall Study||37
67474|NCT01338870|156741|P1|COMPLETED|Overall Study||41
67475|NCT01338870|156736|P6|STARTED|Overall Study||50
67476|NCT01338870|156737|P5|STARTED|Overall Study||52
67477|NCT01338870|156738|P4|STARTED|Overall Study||50
67478|NCT01338870|156739|P3|STARTED|Overall Study||50
67479|NCT01338870|156740|P2|STARTED|Overall Study||49
67480|NCT01338870|156741|P1|STARTED|Overall Study||50
67481|NCT01338857|156791|P1|NOT COMPLETED|Overall Study||11
67482|NCT01338857|156791|P1|COMPLETED|Overall Study||1
67483|NCT01338857|156791|P1|STARTED|Overall Study||12
67484|NCT01338818|156796|P1|NOT COMPLETED|Overall Study||36
67485|NCT01338818|156796|P1|COMPLETED|Overall Study||262
67486|NCT01338818|156796|P1|STARTED|Overall Study||298
67487|NCT01338792|156802|P1|NOT COMPLETED|Overall Study||4
67488|NCT01338792|156802|P1|COMPLETED|Overall Study||43
67489|NCT01338792|156802|P1|STARTED|Overall Study||47
67490|NCT01338649|156810|P2|NOT COMPLETED|Overall Study||0
67491|NCT01338649|156811|P1|NOT COMPLETED|Overall Study||0
67492|NCT01338649|156810|P2|COMPLETED|Overall Study||14
67493|NCT01338649|156811|P1|COMPLETED|Overall Study||13
67494|NCT01338649|156810|P2|STARTED|Overall Study||14
67495|NCT01338649|156811|P1|STARTED|Overall Study||13
67496|NCT01338610|156820|P3|NOT COMPLETED|Overall Study||1
67497|NCT01338610|156821|P2|NOT COMPLETED|Overall Study||1
67498|NCT01338610|156822|P1|NOT COMPLETED|Overall Study||5
67499|NCT01338610|156820|P3|COMPLETED|Overall Study||28
67500|NCT01338610|156821|P2|COMPLETED|Overall Study||55
67501|NCT01338610|156822|P1|COMPLETED|Overall Study||34
67502|NCT01338610|156820|P3|STARTED|Overall Study||29
67503|NCT01338610|156821|P2|STARTED|Overall Study||56
67504|NCT01338610|156822|P1|STARTED|Overall Study||39
67505|NCT01338493|156829|P1|NOT COMPLETED|24 Months Follow up||0
67506|NCT01338493|156829|P1|COMPLETED|24 Months Follow up||104
67507|NCT01338493|156829|P1|STARTED|24 Months Follow up||104
67508|NCT01338493|156829|P1|NOT COMPLETED|12 Months Follow up||9
67509|NCT01338493|156829|P1|COMPLETED|12 Months Follow up||104
67510|NCT01338493|156829|P1|STARTED|12 Months Follow up||113
67511|NCT01338493|156829|P1|NOT COMPLETED|6 Months Follow up||19
67512|NCT01338493|156829|P1|COMPLETED|6 Months Follow up||113
67513|NCT01338493|156829|P1|STARTED|6 Months Follow up||132
67514|NCT01338493|156829|P1|NOT COMPLETED|Discharge||2
67515|NCT01338493|156829|P1|COMPLETED|Discharge||132
67516|NCT01338493|156829|P1|STARTED|Discharge||134
67517|NCT01338493|156829|P1|NOT COMPLETED|Implant||0
67518|NCT01338493|156829|P1|COMPLETED|Implant||134
67519|NCT01338493|156829|P1|STARTED|Implant||134
67520|NCT01338493|156829|P1|NOT COMPLETED|Enrolled||5
67521|NCT01338493|156829|P1|COMPLETED|Enrolled||134
67522|NCT01338493|156829|P1|STARTED|Enrolled||139
67523|NCT01338025|156836|P2|NOT COMPLETED|Overall Study||11
67524|NCT01338025|156837|P1|NOT COMPLETED|Overall Study||11
67525|NCT01338025|156836|P2|COMPLETED|Overall Study||6
67526|NCT01338025|156837|P1|COMPLETED|Overall Study||5
67527|NCT01338025|156836|P2|STARTED|Overall Study||17
67528|NCT01338025|156837|P1|STARTED|Overall Study||16
67529|NCT01337960|156852|P3|NOT COMPLETED|Overall Study||0
67530|NCT01337960|156853|P2|NOT COMPLETED|Overall Study||0
67531|NCT01337960|156854|P1|NOT COMPLETED|Overall Study||2
67532|NCT01337960|156852|P3|COMPLETED|Overall Study||6
67533|NCT01337960|156853|P2|COMPLETED|Overall Study||14
67534|NCT01337960|156854|P1|COMPLETED|Overall Study||12
67535|NCT01337960|156852|P3|STARTED|Overall Study||6
67536|NCT01337960|156853|P2|STARTED|Overall Study||14
67537|NCT01337960|156854|P1|STARTED|Overall Study||14
67538|NCT01337739|156876|P2|NOT COMPLETED|Overall Study||0
67539|NCT01337739|156877|P1|NOT COMPLETED|Overall Study||0
67540|NCT01337739|156876|P2|COMPLETED|Overall Study||4
67541|NCT01337739|156877|P1|COMPLETED|Overall Study||6
67542|NCT01337739|156876|P2|STARTED|Overall Study||4
67543|NCT01337739|156877|P1|STARTED|Overall Study||6
67544|NCT01337674|156887|P4|NOT COMPLETED|Treatment Period 2||0
67545|NCT01337674|156888|P3|NOT COMPLETED|Treatment Period 2||1
67546|NCT01337674|156889|P2|NOT COMPLETED|Treatment Period 2||0
67547|NCT01337674|156890|P1|NOT COMPLETED|Treatment Period 2||0
67548|NCT01337674|156887|P4|COMPLETED|Treatment Period 2||6
67549|NCT01337674|156888|P3|COMPLETED|Treatment Period 2||5
67550|NCT01337674|156889|P2|COMPLETED|Treatment Period 2||6
67551|NCT01337674|156890|P1|COMPLETED|Treatment Period 2||6
67552|NCT01337674|156887|P4|STARTED|Treatment Period 2||6
67553|NCT01337674|156888|P3|STARTED|Treatment Period 2||6
67554|NCT01337674|156889|P2|STARTED|Treatment Period 2||6
67555|NCT01337674|156890|P1|STARTED|Treatment Period 2||6
67556|NCT01337674|156887|P4|NOT COMPLETED|Two-week Washout Period||0
67557|NCT01337674|156888|P3|NOT COMPLETED|Two-week Washout Period||0
67558|NCT01337674|156889|P2|NOT COMPLETED|Two-week Washout Period||0
67559|NCT01337674|156890|P1|NOT COMPLETED|Two-week Washout Period||0
67560|NCT01337674|156887|P4|COMPLETED|Two-week Washout Period||6
67561|NCT01337674|156888|P3|COMPLETED|Two-week Washout Period||6
67562|NCT01337674|156889|P2|COMPLETED|Two-week Washout Period||6
67563|NCT01337674|156890|P1|COMPLETED|Two-week Washout Period||6
67564|NCT01337674|156887|P4|STARTED|Two-week Washout Period||6
67565|NCT01337674|156888|P3|STARTED|Two-week Washout Period||6
67566|NCT01337674|156889|P2|STARTED|Two-week Washout Period||6
67567|NCT01337674|156890|P1|STARTED|Two-week Washout Period||6
67568|NCT01337674|156887|P4|NOT COMPLETED|Treatment Period 1||1
67569|NCT01337674|156888|P3|NOT COMPLETED|Treatment Period 1||0
67570|NCT01337674|156889|P2|NOT COMPLETED|Treatment Period 1||1
67571|NCT01337674|156890|P1|NOT COMPLETED|Treatment Period 1||0
67572|NCT01337674|156887|P4|COMPLETED|Treatment Period 1||6
67573|NCT01337674|156888|P3|COMPLETED|Treatment Period 1||6
67574|NCT01337674|156889|P2|COMPLETED|Treatment Period 1||6
67575|NCT01337674|156890|P1|COMPLETED|Treatment Period 1||6
67576|NCT01337674|156887|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
67577|NCT01337674|156888|P3|STARTED|Treatment Period 1||6
67578|NCT01337674|156889|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
67579|NCT01337674|156890|P1|STARTED|Treatment Period 1||6
67580|NCT01337635|156908|P2|NOT COMPLETED|Overall Study||1
67581|NCT01337635|156909|P1|NOT COMPLETED|Overall Study||0
67582|NCT01337635|156908|P2|COMPLETED|Overall Study||2
67583|NCT01337635|156909|P1|COMPLETED|Overall Study||4
67584|NCT01337635|156908|P2|STARTED|Overall Study||3
67585|NCT01337635|156909|P1|STARTED|Overall Study||4
67586|NCT01337609|156918|P3|NOT COMPLETED|Overall Study||0
67587|NCT01337609|156919|P2|NOT COMPLETED|Overall Study||0
67588|NCT01337609|156920|P1|NOT COMPLETED|Overall Study||1
67589|NCT01337609|156918|P3|COMPLETED|Overall Study||2
67590|NCT01337609|156919|P2|COMPLETED|Overall Study||2
67591|NCT01337609|156920|P1|COMPLETED|Overall Study||0
67592|NCT01337609|156918|P3|STARTED|Overall Study||2
67593|NCT01337609|156919|P2|STARTED|Overall Study||2
67594|NCT01337609|156920|P1|STARTED|Overall Study||1
67595|NCT01337336|156942|P2|NOT COMPLETED|Overall Study||0
67596|NCT01337336|156943|P1|NOT COMPLETED|Overall Study||0
67597|NCT01337336|156942|P2|COMPLETED|Overall Study||2923
67598|NCT01337336|156943|P1|COMPLETED|Overall Study||1078
67599|NCT01337336|156942|P2|STARTED|Overall Study||2923
67600|NCT01337336|156943|P1|STARTED|Overall Study||1078
67601|NCT01337297|156957|P2|NOT COMPLETED|Overall Study||6
67602|NCT01337297|156958|P1|NOT COMPLETED|Overall Study||5
67603|NCT01337297|156957|P2|COMPLETED|Overall Study||3
67604|NCT01337297|156958|P1|COMPLETED|Overall Study||6
67605|NCT01337297|156957|P2|STARTED|Overall Study||9
67606|NCT01337297|156958|P1|STARTED|Overall Study||11
67607|NCT01337167|156966|P2|NOT COMPLETED|Toddler Vaccinations||13
67608|NCT01337167|156967|P1|NOT COMPLETED|Toddler Vaccinations||14
67609|NCT01337167|156966|P2|COMPLETED|Toddler Vaccinations||407
67610|NCT01337167|156967|P1|COMPLETED|Toddler Vaccinations||829
67611|NCT01337167|156966|P2|STARTED|Toddler Vaccinations||420
67612|NCT01337167|156967|P1|STARTED|Toddler Vaccinations||843
67613|NCT01337167|156966|P2|NOT COMPLETED|Interim Period||40
67614|NCT01337167|156967|P1|NOT COMPLETED|Interim Period||81
67615|NCT01337167|156966|P2|COMPLETED|Interim Period||420
67616|NCT01337167|156967|P1|COMPLETED|Interim Period||843
67617|NCT01337167|156966|P2|STARTED|Interim Period||460
67618|NCT01337167|156967|P1|STARTED|Interim Period||924
67619|NCT01337167|156966|P2|NOT COMPLETED|Infant Series||27
67620|NCT01337167|156967|P1|NOT COMPLETED|Infant Series||62
67621|NCT01337167|156966|P2|COMPLETED|Infant Series||460
67622|NCT01337167|156967|P1|COMPLETED|Infant Series||924
67623|NCT01337167|156966|P2|STARTED|Infant Series||487
67624|NCT01337167|156967|P1|STARTED|Infant Series||986
67625|NCT01337115|157035|P2|NOT COMPLETED|Overall Study||0
67626|NCT01337115|157036|P1|NOT COMPLETED|Overall Study||2
67627|NCT01337115|157035|P2|COMPLETED|Overall Study||25
67628|NCT01337115|157036|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
67629|NCT01337115|157035|P2|STARTED|Overall Study||25
67630|NCT01337115|157036|P1|STARTED|Overall Study||25
67631|NCT01337076|157048|P1|NOT COMPLETED|Overall Study||2
67632|NCT01337076|157048|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
67633|NCT01337076|157048|P1|STARTED|Overall Study|subjects implanted|21
67634|NCT01337050|157055|P3|NOT COMPLETED|Overall Study||19
67635|NCT01337050|157056|P2|NOT COMPLETED|Overall Study||13
67636|NCT01337050|157057|P1|NOT COMPLETED|Overall Study||4
67637|NCT01337050|157055|P3|COMPLETED|Overall Study||0
67638|NCT01337050|157056|P2|COMPLETED|Overall Study||0
67639|NCT01337050|157057|P1|COMPLETED|Overall Study||0
67640|NCT01337050|157055|P3|STARTED|Overall Study||19
67641|NCT01337050|157056|P2|STARTED|Overall Study||13
67642|NCT01337050|157057|P1|STARTED|Overall Study||4
67643|NCT01336738|157120|P5|NOT COMPLETED|Overall Study||10
67644|NCT01336738|157121|P4|NOT COMPLETED|Overall Study||7
67645|NCT01336738|157122|P3|NOT COMPLETED|Overall Study||8
67646|NCT01336738|157123|P2|NOT COMPLETED|Overall Study||9
67647|NCT01336738|157124|P1|NOT COMPLETED|Overall Study||7
67648|NCT01336738|157120|P5|COMPLETED|Overall Study||43
67649|NCT01336738|157121|P4|COMPLETED|Overall Study||47
67650|NCT01336738|157122|P3|COMPLETED|Overall Study||45
67651|NCT01336738|157123|P2|COMPLETED|Overall Study||45
67652|NCT01336738|157124|P1|COMPLETED|Overall Study||45
67653|NCT01336738|157120|P5|STARTED|Overall Study||53
67654|NCT01336738|157121|P4|STARTED|Overall Study||54
67655|NCT01336738|157122|P3|STARTED|Overall Study||53
67656|NCT01336738|157123|P2|STARTED|Overall Study||54
67657|NCT01336738|157124|P1|STARTED|Overall Study||52
67658|NCT01336712|157166|P1|NOT COMPLETED|Overall Study||3
67659|NCT01336712|157166|P1|COMPLETED|Overall Study||27
67660|NCT01336712|157166|P1|STARTED|Overall Study||30
67661|NCT01336647|157179|P3|NOT COMPLETED|Overall Study||3
67662|NCT01336647|157180|P2|NOT COMPLETED|Overall Study||1
67663|NCT01336647|157181|P1|NOT COMPLETED|Overall Study||4
67664|NCT01336647|157179|P3|COMPLETED|Overall Study||44
67665|NCT01336647|157180|P2|COMPLETED|Overall Study||48
67666|NCT01336647|157181|P1|COMPLETED|Overall Study||42
67667|NCT01336647|157179|P3|STARTED|Overall Study||47
67668|NCT01336647|157180|P2|STARTED|Overall Study||49
67669|NCT01336647|157181|P1|STARTED|Overall Study||46
67670|NCT01336608|157195|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
67671|NCT01336608|157196|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
67672|NCT01336608|157197|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
67673|NCT01336608|157198|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
67674|NCT01336608|157195|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
67675|NCT01336608|157196|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
67676|NCT01336608|157197|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
67677|NCT01336608|157198|P1|COMPLETED|24-week, Double-blind Treatment Period||0
67678|NCT01336608|157195|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
67679|NCT01336608|157196|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
67680|NCT01336608|157197|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
67681|NCT01336608|157198|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
67682|NCT01336608|157195|P4|STARTED|24-week, Double-blind Treatment Period||135
67683|NCT01336608|157196|P3|STARTED|24-week, Double-blind Treatment Period||154
67684|NCT01336608|157197|P2|STARTED|24-week, Double-blind Treatment Period||141
67685|NCT01336608|157198|P1|STARTED|24-week, Double-blind Treatment Period||0
67686|NCT01336608|157195|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
67687|NCT01336608|157196|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
67688|NCT01336608|157197|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
67689|NCT01336608|157198|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
67690|NCT01336608|157195|P4|COMPLETED|2-week, Single-blind Run-In Period||0
67691|NCT01336608|157196|P3|COMPLETED|2-week, Single-blind Run-In Period||0
67692|NCT01336608|157197|P2|COMPLETED|2-week, Single-blind Run-In Period||0
67693|NCT01336608|157198|P1|COMPLETED|2-week, Single-blind Run-In Period||444
67694|NCT01336608|157195|P4|STARTED|2-week, Single-blind Run-In Period||0
67695|NCT01336608|157196|P3|STARTED|2-week, Single-blind Run-In Period||0
67696|NCT01336608|157197|P2|STARTED|2-week, Single-blind Run-In Period||0
67697|NCT01336608|157198|P1|STARTED|2-week, Single-blind Run-In Period||559
67698|NCT01336569|157212|P1|NOT COMPLETED|Overall Study||4
67699|NCT01336569|157212|P1|COMPLETED|Overall Study||45
67700|NCT01336569|157212|P1|STARTED|Overall Study||49
67701|NCT01336296|157218|P2|NOT COMPLETED|Overall Study||4
67702|NCT01336296|157219|P1|NOT COMPLETED|Overall Study||5
67703|NCT01336296|157218|P2|COMPLETED|Overall Study||17
67704|NCT01336296|157219|P1|COMPLETED|Overall Study||35
67705|NCT01336296|157218|P2|STARTED|Overall Study||21
67706|NCT01336296|157219|P1|STARTED|Overall Study||40
67707|NCT01336205|157235|P2|NOT COMPLETED|Overall Study||89
67708|NCT01336205|157236|P1|NOT COMPLETED|Overall Study||233
67709|NCT01336205|157235|P2|COMPLETED|Overall Study||192
67710|NCT01336205|157236|P1|COMPLETED|Overall Study||330
67711|NCT01336205|157235|P2|STARTED|Overall Study||281
67712|NCT01336205|157236|P1|STARTED|Overall Study||563
67713|NCT01336140|157248|P2|NOT COMPLETED|Overall Study||0
67714|NCT01336140|157249|P1|NOT COMPLETED|Overall Study||0
67715|NCT01336140|157248|P2|COMPLETED|Overall Study||150
67716|NCT01336140|157249|P1|COMPLETED|Overall Study||150
67717|NCT01336140|157248|P2|STARTED|Overall Study||150
67718|NCT01336140|157249|P1|STARTED|Overall Study||150
67719|NCT01335997|157263|P2|NOT COMPLETED|Period III||79
67720|NCT01335997|157264|P1|NOT COMPLETED|Period III||78
67721|NCT01335997|157263|P2|COMPLETED|Period III||4
67722|NCT01335997|157264|P1|COMPLETED|Period III||6
67723|NCT01335997|157263|P2|STARTED|Period III||83
67724|NCT01335997|157264|P1|STARTED|Period III||84
67725|NCT01335997|157263|P2|NOT COMPLETED|Period I and II||479
67726|NCT01335997|157264|P1|NOT COMPLETED|Period I and II||493
67727|NCT01335997|157263|P2|COMPLETED|Period I and II||83
67728|NCT01335997|157264|P1|COMPLETED|Period I and II||84
67729|NCT01335997|157263|P2|STARTED|Period I and II||562
67730|NCT01335997|157264|P1|STARTED|Period I and II||577
67731|NCT01335867|157276|P2|NOT COMPLETED|Overall Study||4
67732|NCT01335867|157277|P1|NOT COMPLETED|Overall Study||7
67733|NCT01335867|157276|P2|COMPLETED|Overall Study||12
67734|NCT01335867|157277|P1|COMPLETED|Overall Study||9
67735|NCT01335867|157276|P2|STARTED|Overall Study||16
67736|NCT01335867|157277|P1|STARTED|Overall Study||16
67737|NCT01335789|157287|P2|NOT COMPLETED|Overall Study||0
67738|NCT01335789|157288|P1|NOT COMPLETED|Overall Study||0
67739|NCT01335789|157287|P2|COMPLETED|Overall Study||8
67740|NCT01335789|157288|P1|COMPLETED|Overall Study||8
67741|NCT01335789|157287|P2|STARTED|Overall Study||8
67742|NCT01335789|157288|P1|STARTED|Overall Study||8
67743|NCT01335750|157298|P1|NOT COMPLETED|Overall Study||0
67744|NCT01335750|157298|P1|COMPLETED|Overall Study||32
67745|NCT01335750|157298|P1|STARTED|Overall Study||32
67746|NCT01335724|157319|P2|NOT COMPLETED|Overall Study||0
67747|NCT01335724|157320|P1|NOT COMPLETED|Overall Study||0
67748|NCT01335724|157319|P2|COMPLETED|Overall Study||36
67749|NCT01335724|157320|P1|COMPLETED|Overall Study||36
67750|NCT01335724|157319|P2|STARTED|Overall Study||36
67751|NCT01335724|157320|P1|STARTED|Overall Study||36
67752|NCT01335698|157335|P5|NOT COMPLETED|Treatment Stage 2||6
67753|NCT01335698|157336|P4|NOT COMPLETED|Treatment Stage 2||24
67754|NCT01335698|157337|P3|NOT COMPLETED|Treatment Stage 2||16
67755|NCT01335698|157338|P2|NOT COMPLETED|Treatment Stage 2||4
67756|NCT01335698|157339|P1|NOT COMPLETED|Treatment Stage 2||15
67757|NCT01335698|157335|P5|COMPLETED|Treatment Stage 2||0
67758|NCT01335698|157336|P4|COMPLETED|Treatment Stage 2||2
67759|NCT01335698|157337|P3|COMPLETED|Treatment Stage 2||0
67760|NCT01335698|157338|P2|COMPLETED|Treatment Stage 2||0
67761|NCT01335698|157339|P1|COMPLETED|Treatment Stage 2||0
67762|NCT01335698|157335|P5|STARTED|Treatment Stage 2||6
67763|NCT01335698|157336|P4|STARTED|Treatment Stage 2||26
67764|NCT01335698|157337|P3|STARTED|Treatment Stage 2||16
67765|NCT01335698|157338|P2|STARTED|Treatment Stage 2||4
67766|NCT01335698|157339|P1|STARTED|Treatment Stage 2||15
67767|NCT01335698|157335|P5|NOT COMPLETED|Treatment Stage 1||2
67768|NCT01335698|157336|P4|NOT COMPLETED|Treatment Stage 1||9
67769|NCT01335698|157337|P3|NOT COMPLETED|Treatment Stage 1||5
67770|NCT01335698|157338|P2|NOT COMPLETED|Treatment Stage 1||8
67771|NCT01335698|157339|P1|NOT COMPLETED|Treatment Stage 1||8
67772|NCT01335698|157335|P5|COMPLETED|Treatment Stage 1||6
67773|NCT01335698|157336|P4|COMPLETED|Treatment Stage 1||26
67774|NCT01335698|157337|P3|COMPLETED|Treatment Stage 1||16
67775|NCT01335698|157338|P2|COMPLETED|Treatment Stage 1||4
67776|NCT01335698|157339|P1|COMPLETED|Treatment Stage 1||15
67777|NCT01335698|157335|P5|STARTED|Treatment Stage 1||8
67778|NCT01335698|157336|P4|STARTED|Treatment Stage 1||35
67779|NCT01335698|157337|P3|STARTED|Treatment Stage 1||21
67780|NCT01335698|157338|P2|STARTED|Treatment Stage 1||12
67781|NCT01335698|157339|P1|STARTED|Treatment Stage 1||23
67782|NCT01335542|157388|P2|NOT COMPLETED|Overall Study||0
67783|NCT01335542|157389|P1|NOT COMPLETED|Overall Study||0
67784|NCT01335542|157388|P2|COMPLETED|Overall Study||45
67785|NCT01335542|157389|P1|COMPLETED|Overall Study||45
67786|NCT01335542|157388|P2|STARTED|Overall Study||45
67787|NCT01335542|157389|P1|STARTED|Overall Study||45
67788|NCT01335477|157397|P2|NOT COMPLETED|Overall Study||59
67789|NCT01335477|157398|P1|NOT COMPLETED|Overall Study||41
67790|NCT01335477|157397|P2|COMPLETED|Overall Study||272
67791|NCT01335477|157398|P1|COMPLETED|Overall Study||179
67792|NCT01335477|157397|P2|STARTED|Overall Study||331
67793|NCT01335477|157398|P1|STARTED|Overall Study||220
67794|NCT01335464|157462|P2|NOT COMPLETED|Overall Study||49
67795|NCT01335464|157463|P1|NOT COMPLETED|Overall Study||32
67796|NCT01335464|157462|P2|COMPLETED|Overall Study||260
67797|NCT01335464|157463|P1|COMPLETED|Overall Study||174
67798|NCT01335464|157462|P2|STARTED|Overall Study||309
67799|NCT01335464|157463|P1|STARTED|Overall Study||206
67800|NCT01335230|157529|P4|NOT COMPLETED|Overall Study||0
67801|NCT01335230|157530|P3|NOT COMPLETED|Overall Study||0
67802|NCT01335230|157531|P2|NOT COMPLETED|Overall Study||0
67803|NCT01335230|157532|P1|NOT COMPLETED|Overall Study||0
67804|NCT01335230|157529|P4|COMPLETED|Overall Study|subjects|10
67805|NCT01335230|157530|P3|COMPLETED|Overall Study|subjects|10
67806|NCT01335230|157531|P2|COMPLETED|Overall Study|subjects|10
67807|NCT01335230|157532|P1|COMPLETED|Overall Study|subjects|10
67808|NCT01335230|157529|P4|STARTED|Overall Study|subjects|10
67809|NCT01335230|157530|P3|STARTED|Overall Study|subjects|10
67810|NCT01335230|157531|P2|STARTED|Overall Study|subjects|10
67811|NCT01335230|157532|P1|STARTED|Overall Study|subjects|10
67812|NCT01335191|157544|P2|NOT COMPLETED|Overall Study||0
67813|NCT01335191|157545|P1|NOT COMPLETED|Overall Study||0
67814|NCT01335191|157544|P2|COMPLETED|Overall Study||11
67815|NCT01335191|157545|P1|COMPLETED|Overall Study||16
67816|NCT01335191|157544|P2|STARTED|Overall Study||11
67817|NCT01335191|157545|P1|STARTED|Overall Study||16
67818|NCT01335061|157551|P1|NOT COMPLETED|Overall Study||0
67819|NCT01335061|157551|P1|COMPLETED|Overall Study||25
67820|NCT01335061|157551|P1|STARTED|Overall Study||25
67821|NCT01334957|157566|P1|NOT COMPLETED|Overall Study||0
67822|NCT01334957|157566|P1|COMPLETED|Overall Study||300
67823|NCT01334957|157566|P1|Received Multiple Doses|Overall Study||48
67824|NCT01334957|157566|P1|Received Single Dose|Overall Study||252
67825|NCT01334957|157566|P1|STARTED|Overall Study||300
67826|NCT01334944|157574|P2|NOT COMPLETED|Overall Study||0
67827|NCT01334944|157575|P1|NOT COMPLETED|Overall Study||0
67828|NCT01334944|157574|P2|COMPLETED|Overall Study||139
67829|NCT01334944|157575|P1|COMPLETED|Overall Study||11
67830|NCT01334944|157574|P2|Received Multiple Doses|Overall Study||43
67831|NCT01334944|157575|P1|Received Multiple Doses|Overall Study||10
67832|NCT01334944|157574|P2|Received Singel Dose|Overall Study||96
67833|NCT01334944|157575|P1|Received Singel Dose|Overall Study||1
67834|NCT01334944|157574|P2|STARTED|Overall Study||139
67835|NCT01334944|157575|P1|STARTED|Overall Study||11
67836|NCT01334918|157601|P2|NOT COMPLETED|Overall Study||1
67837|NCT01334918|157602|P1|NOT COMPLETED|Overall Study||8
67838|NCT01334918|157601|P2|COMPLETED|Overall Study||60
67839|NCT01334918|157602|P1|COMPLETED|Overall Study||55
67840|NCT01334918|157601|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
67841|NCT01334918|157602|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
67842|NCT01334918|157601|P2|STARTED|Overall Study||61
67843|NCT01334918|157602|P1|STARTED|Overall Study||63
67844|NCT01334866|157628|P1|NOT COMPLETED|Overall Study||19
67845|NCT01334866|157628|P1|COMPLETED|Overall Study||72
67846|NCT01334866|157628|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
67847|NCT01334723|157638|P2|NOT COMPLETED|Overall Study||0
67848|NCT01334723|157639|P1|NOT COMPLETED|Overall Study||0
67849|NCT01334723|157638|P2|COMPLETED|Overall Study||17739
67850|NCT01334723|157639|P1|COMPLETED|Overall Study||17293
67851|NCT01334723|157638|P2|STARTED|Overall Study||17739
67852|NCT01334723|157639|P1|STARTED|Overall Study||17293
67853|NCT01334710|157665|P1|NOT COMPLETED|Overall Study||3
67854|NCT01334710|157665|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in Hepatocellular cancer the trial was stopped.|0
67855|NCT01334710|157665|P1|STARTED|Overall Study||3
67856|NCT01334606|157669|P1|NOT COMPLETED|Overall Study||18
67857|NCT01334606|157669|P1|COMPLETED|Overall Study||3
67858|NCT01334606|157669|P1|STARTED|Overall Study||21
67859|NCT01334554|157677|P2|NOT COMPLETED|Overall Study||2
67860|NCT01334554|157678|P1|NOT COMPLETED|Overall Study||4
67861|NCT01334554|157677|P2|COMPLETED|Overall Study||21
67862|NCT01334554|157678|P1|COMPLETED|Overall Study||19
67863|NCT01334554|157677|P2|STARTED|Overall Study||23
67864|NCT01334554|157678|P1|STARTED|Overall Study||23
67865|NCT01334515|157688|P2|NOT COMPLETED|Overall Study||29
67866|NCT01334515|157689|P1|NOT COMPLETED|Overall Study||12
67867|NCT01334515|157688|P2|COMPLETED|Overall Study||7
67868|NCT01334515|157689|P1|COMPLETED|Overall Study||4
67869|NCT01334515|157688|P2|STARTED|Overall Study||36
67870|NCT01334515|157689|P1|STARTED|Overall Study||16
67871|NCT01334229|157699|P2|NOT COMPLETED|Overall Study||0
67872|NCT01334229|157700|P1|NOT COMPLETED|Overall Study||0
67873|NCT01334229|157699|P2|COMPLETED|Overall Study||11
67874|NCT01334229|157700|P1|COMPLETED|Overall Study||11
67875|NCT01334229|157699|P2|STARTED|Overall Study||11
67876|NCT01334229|157700|P1|STARTED|Overall Study||11
67877|NCT01334125|157718|P2|NOT COMPLETED|Overall Study||3
67878|NCT01334125|157719|P1|NOT COMPLETED|Overall Study||3
67879|NCT01334125|157718|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
67880|NCT01334125|157719|P1|COMPLETED|Overall Study|3 subjects move to another city|12
67881|NCT01334125|157718|P2|STARTED|Overall Study||13
67882|NCT01334125|157719|P1|STARTED|Overall Study||15
67883|NCT01333956|157735|P4|NOT COMPLETED|Overall Study||2
67884|NCT01333956|157736|P3|NOT COMPLETED|Overall Study||1
67885|NCT01333956|157737|P2|NOT COMPLETED|Overall Study||4
67886|NCT01333956|157738|P1|NOT COMPLETED|Overall Study||2
67887|NCT01333956|157735|P4|COMPLETED|Overall Study||28
67888|NCT01333956|157736|P3|COMPLETED|Overall Study||29
67889|NCT01333956|157737|P2|COMPLETED|Overall Study||26
67890|NCT01333956|157738|P1|COMPLETED|Overall Study||28
67891|NCT01333956|157735|P4|STARTED|Overall Study||30
67892|NCT01333956|157736|P3|STARTED|Overall Study||30
67893|NCT01333956|157737|P2|STARTED|Overall Study||30
67894|NCT01333956|157738|P1|STARTED|Overall Study||30
67895|NCT01333865|157772|P1|NOT COMPLETED|Overall Study||2
67896|NCT01333865|157772|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
67897|NCT01333865|157772|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
67898|NCT01333813|157777|P1|NOT COMPLETED|Overall Study||0
67899|NCT01333813|157777|P1|COMPLETED|Overall Study||297
67900|NCT01333813|157777|P1|STARTED|Overall Study||297
67901|NCT01333722|157792|P2|NOT COMPLETED|Overall Study||3
67902|NCT01333722|157793|P1|NOT COMPLETED|Overall Study||0
67903|NCT01333722|157792|P2|COMPLETED|Overall Study||46
67904|NCT01333722|157793|P1|COMPLETED|Overall Study||51
67905|NCT01333722|157792|P2|STARTED|Overall Study||49
67906|NCT01333722|157793|P1|STARTED|Overall Study||51
67907|NCT01333592|157807|P2|NOT COMPLETED|Overall Study||17
67908|NCT01333592|157808|P1|NOT COMPLETED|Overall Study||9
67909|NCT01333592|157807|P2|COMPLETED|Overall Study||52
67910|NCT01333592|157808|P1|COMPLETED|Overall Study||58
67911|NCT01333592|157807|P2|STARTED|Overall Study||69
67912|NCT01333592|157808|P1|STARTED|Overall Study||67
67913|NCT01333488|157819|P3|NOT COMPLETED|Overall Study||0
67914|NCT01333488|157820|P2|NOT COMPLETED|Overall Study||0
67915|NCT01333488|157821|P1|NOT COMPLETED|Overall Study||0
67916|NCT01333488|157819|P3|COMPLETED|Overall Study||3
67917|NCT01333488|157820|P2|COMPLETED|Overall Study||1
67918|NCT01333488|157821|P1|COMPLETED|Overall Study||2
67919|NCT01333488|157819|P3|STARTED|Overall Study||3
67920|NCT01333488|157820|P2|STARTED|Overall Study||1
67921|NCT01333488|157821|P1|STARTED|Overall Study||2
67922|NCT01333475|157837|P2|NOT COMPLETED|Overall Study||3
67923|NCT01333475|157838|P1|NOT COMPLETED|Overall Study||2
67924|NCT01333475|157837|P2|COMPLETED|Overall Study||6
67925|NCT01333475|157838|P1|COMPLETED|Overall Study||10
67926|NCT01333475|157837|P2|STARTED|Overall Study||9
67927|NCT01333475|157838|P1|STARTED|Overall Study||12
67928|NCT01333436|157848|P2|NOT COMPLETED|Overall Study||0
67929|NCT01333436|157849|P1|NOT COMPLETED|Overall Study||0
67930|NCT01333436|157848|P2|COMPLETED|Overall Study||50
67931|NCT01333436|157849|P1|COMPLETED|Overall Study||43
67932|NCT01333436|157848|P2|STARTED|Overall Study||50
67933|NCT01333436|157849|P1|STARTED|Overall Study||43
67934|NCT01333397|157864|P5|NOT COMPLETED|Overall Study||0
67935|NCT01333397|157865|P4|NOT COMPLETED|Overall Study||1
67936|NCT01333397|157866|P3|NOT COMPLETED|Overall Study||0
67937|NCT01333397|157867|P2|NOT COMPLETED|Overall Study||0
67938|NCT01333397|157868|P1|NOT COMPLETED|Overall Study||1
67939|NCT01333397|157864|P5|COMPLETED|Overall Study||35
67940|NCT01333397|157865|P4|COMPLETED|Overall Study||34
67941|NCT01333397|157866|P3|COMPLETED|Overall Study||35
67942|NCT01333397|157867|P2|COMPLETED|Overall Study||36
67943|NCT01333397|157868|P1|COMPLETED|Overall Study||34
67944|NCT01333397|157864|P5|STARTED|Overall Study||35
67945|NCT01333397|157865|P4|STARTED|Overall Study||35
67946|NCT01333397|157866|P3|STARTED|Overall Study||35
67947|NCT01333397|157867|P2|STARTED|Overall Study||36
67948|NCT01333397|157868|P1|STARTED|Overall Study||35
67949|NCT01333189|157942|P2|NOT COMPLETED|Overall Study||2
67950|NCT01333189|157943|P1|NOT COMPLETED|Overall Study||2
67951|NCT01333189|157942|P2|COMPLETED|Overall Study||11
67952|NCT01333189|157943|P1|COMPLETED|Overall Study||11
67953|NCT01333189|157942|P2|STARTED|Overall Study||13
67954|NCT01333189|157943|P1|STARTED|Overall Study||13
67955|NCT01332994|157971|P1|NOT COMPLETED|Overall Study||71
67956|NCT01332994|157971|P1|COMPLETED|Overall Study||448
67957|NCT01332994|157971|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
67958|NCT01332994|157971|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
67959|NCT01332994|157971|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
67960|NCT01332994|157971|P1|Completed Week 16|Overall Study||463
67961|NCT01332994|157971|P1|STARTED|Overall Study||519
67962|NCT01332981|158027|P1|NOT COMPLETED|Overall Study||0
67963|NCT01332981|158027|P1|COMPLETED|Overall Study||220
67964|NCT01332981|158027|P1|STARTED|Overall Study||220
67965|NCT01332721|158038|P1|NOT COMPLETED|Overall Study||0
67966|NCT01332721|158038|P1|COMPLETED|Overall Study||38
67967|NCT01332721|158038|P1|STARTED|Overall Study||38
67968|NCT01332578|158044|P2|NOT COMPLETED|Period II||0
67969|NCT01332578|158045|P1|NOT COMPLETED|Period II||0
67970|NCT01332578|158044|P2|COMPLETED|Period II||13
67971|NCT01332578|158045|P1|COMPLETED|Period II||12
67972|NCT01332578|158044|P2|STARTED|Period II||13
67973|NCT01332578|158045|P1|STARTED|Period II||12
67974|NCT01332578|158044|P2|NOT COMPLETED|Washout Period||0
67975|NCT01332578|158045|P1|NOT COMPLETED|Washout Period||0
67976|NCT01332578|158044|P2|COMPLETED|Washout Period||13
67977|NCT01332578|158045|P1|COMPLETED|Washout Period||12
67978|NCT01332578|158044|P2|STARTED|Washout Period||13
67979|NCT01332578|158045|P1|STARTED|Washout Period||12
67980|NCT01332578|158044|P2|NOT COMPLETED|Period I||0
67981|NCT01332578|158045|P1|NOT COMPLETED|Period I||0
67982|NCT01332578|158044|P2|COMPLETED|Period I||13
67983|NCT01332578|158045|P1|COMPLETED|Period I||12
67984|NCT01332578|158044|P2|STARTED|Period I||13
67985|NCT01332578|158045|P1|STARTED|Period I||12
67986|NCT01332500|158068|P4|NOT COMPLETED|Overall Study||0
67987|NCT01332500|158069|P3|NOT COMPLETED|Overall Study||0
67988|NCT01332500|158070|P2|NOT COMPLETED|Overall Study||0
67989|NCT01332500|158071|P1|NOT COMPLETED|Overall Study||0
67990|NCT01332500|158068|P4|COMPLETED|Overall Study||5806
67991|NCT01332500|158069|P3|COMPLETED|Overall Study||2903
67992|NCT01332500|158070|P2|COMPLETED|Overall Study||39771
67993|NCT01332500|158071|P1|COMPLETED|Overall Study||13257
67994|NCT01332500|158068|P4|STARTED|Overall Study||5806
67995|NCT01332500|158069|P3|STARTED|Overall Study||2903
67996|NCT01332500|158070|P2|STARTED|Overall Study||39771
67997|NCT01332500|158071|P1|STARTED|Overall Study||13257
67998|NCT01332487|158091|P2|NOT COMPLETED|Overall Study||0
67999|NCT01332487|158092|P1|NOT COMPLETED|Overall Study||0
68000|NCT01332487|158091|P2|COMPLETED|Overall Study||3063
68001|NCT01332487|158092|P1|COMPLETED|Overall Study||5554
68002|NCT01332487|158091|P2|STARTED|Overall Study||3063
68003|NCT01332487|158092|P1|STARTED|Overall Study||5554
68004|NCT01332461|158102|P2|NOT COMPLETED|Overall Study||0
68005|NCT01332461|158103|P1|NOT COMPLETED|Overall Study||0
68006|NCT01332461|158102|P2|COMPLETED|Overall Study||4386
68007|NCT01332461|158103|P1|COMPLETED|Overall Study||1291
68008|NCT01332461|158102|P2|STARTED|Overall Study||4386
68009|NCT01332461|158103|P1|STARTED|Overall Study||1291
68010|NCT01332435|158117|P4|NOT COMPLETED|Overall Study||0
68011|NCT01332435|158118|P3|NOT COMPLETED|Overall Study||0
68012|NCT01332435|158119|P2|NOT COMPLETED|Overall Study||0
68013|NCT01332435|158120|P1|NOT COMPLETED|Overall Study||0
68014|NCT01332435|158117|P4|COMPLETED|Overall Study||1656
68015|NCT01332435|158118|P3|COMPLETED|Overall Study||2604
68016|NCT01332435|158119|P2|COMPLETED|Overall Study||1064
68017|NCT01332435|158120|P1|COMPLETED|Overall Study||1572
68018|NCT01332435|158117|P4|STARTED|Overall Study||1656
68019|NCT01332435|158118|P3|STARTED|Overall Study||2604
68020|NCT01332435|158119|P2|STARTED|Overall Study||1064
68021|NCT01332435|158120|P1|STARTED|Overall Study||1572
68022|NCT01332357|158150|P1|NOT COMPLETED|Overall Study||0
68023|NCT01332357|158150|P1|COMPLETED|Overall Study||6139
68024|NCT01332357|158150|P1|STARTED|Overall Study||6139
68025|NCT01332318|158158|P4|NOT COMPLETED|Overall Study||2
68026|NCT01332318|158159|P3|NOT COMPLETED|Overall Study||1
68027|NCT01332318|158160|P2|NOT COMPLETED|Overall Study||4
68028|NCT01332318|158161|P1|NOT COMPLETED|Overall Study||2
68029|NCT01332318|158158|P4|COMPLETED|Overall Study||28
68030|NCT01332318|158159|P3|COMPLETED|Overall Study||33
68031|NCT01332318|158160|P2|COMPLETED|Overall Study||28
68032|NCT01332318|158161|P1|COMPLETED|Overall Study||32
68033|NCT01332318|158158|P4|STARTED|Overall Study||30
68034|NCT01332318|158159|P3|STARTED|Overall Study||34
68035|NCT01332318|158160|P2|STARTED|Overall Study||32
68036|NCT01332318|158161|P1|STARTED|Overall Study||34
68037|NCT01332305|158272|P5|NOT COMPLETED|Overall Study||12
68038|NCT01332305|158273|P4|NOT COMPLETED|Overall Study||8
68039|NCT01332305|158274|P3|NOT COMPLETED|Overall Study||14
68040|NCT01332305|158275|P2|NOT COMPLETED|Overall Study||14
68041|NCT01332305|158276|P1|NOT COMPLETED|Overall Study||10
68042|NCT01332305|158272|P5|COMPLETED|Overall Study||33
68043|NCT01332305|158273|P4|COMPLETED|Overall Study||30
68044|NCT01332305|158274|P3|COMPLETED|Overall Study||31
68045|NCT01332305|158275|P2|COMPLETED|Overall Study||34
68046|NCT01332305|158276|P1|COMPLETED|Overall Study||31
68047|NCT01332305|158272|P5|STARTED|Overall Study||45
68048|NCT01332305|158273|P4|STARTED|Overall Study||38
68049|NCT01332305|158274|P3|STARTED|Overall Study||45
68050|NCT01332305|158275|P2|STARTED|Overall Study||48
68051|NCT01332305|158276|P1|STARTED|Overall Study||41
68052|NCT01332292|158298|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
68053|NCT01332292|158299|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
68054|NCT01332292|158298|P2|COMPLETED|Treatment Period 2 (14 Days)||11
68055|NCT01332292|158299|P1|COMPLETED|Treatment Period 2 (14 Days)||11
68056|NCT01332292|158298|P2|STARTED|Treatment Period 2 (14 Days)||12
68057|NCT01332292|158299|P1|STARTED|Treatment Period 2 (14 Days)||12
68058|NCT01332292|158298|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
68059|NCT01332292|158299|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
68060|NCT01332292|158298|P2|COMPLETED|Washout Period (>=7 Days)||12
68061|NCT01332292|158299|P1|COMPLETED|Washout Period (>=7 Days)||12
68062|NCT01332292|158298|P2|STARTED|Washout Period (>=7 Days)||12
68063|NCT01332292|158299|P1|STARTED|Washout Period (>=7 Days)||12
68064|NCT01332292|158298|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
68065|NCT01332292|158299|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
68066|NCT01332292|158298|P2|COMPLETED|Treatment Period 1 (14 Days)||12
68067|NCT01332292|158299|P1|COMPLETED|Treatment Period 1 (14 Days)||12
68068|NCT01332292|158298|P2|STARTED|Treatment Period 1 (14 Days)||13
68069|NCT01332292|158299|P1|STARTED|Treatment Period 1 (14 Days)||14
68070|NCT01332253|158361|P2|NOT COMPLETED|Overall Study||0
68071|NCT01332253|158362|P1|NOT COMPLETED|Overall Study||0
68072|NCT01332253|158361|P2|COMPLETED|Overall Study||79
68073|NCT01332253|158362|P1|COMPLETED|Overall Study||82
68074|NCT01332253|158361|P2|STARTED|Overall Study||79
68075|NCT01332253|158362|P1|STARTED|Overall Study||82
68076|NCT01332227|158390|P2|NOT COMPLETED|Overall Study||5
68077|NCT01332227|158391|P1|NOT COMPLETED|Overall Study||16
68078|NCT01332227|158390|P2|COMPLETED|Overall Study||32
68079|NCT01332227|158391|P1|COMPLETED|Overall Study||56
68080|NCT01332227|158390|P2|STARTED|Overall Study|Participants who received treatment|37
68081|NCT01332227|158391|P1|STARTED|Overall Study|Participants who received treatment|72
68082|NCT01332149|158411|P2|NOT COMPLETED|Overall Study||38
68083|NCT01332149|158412|P1|NOT COMPLETED|Overall Study||30
68084|NCT01332149|158411|P2|COMPLETED|Overall Study||271
68085|NCT01332149|158412|P1|COMPLETED|Overall Study||284
68086|NCT01332149|158411|P2|Treated|Overall Study||307
68087|NCT01332149|158412|P1|Treated|Overall Study||313
68088|NCT01332149|158411|P2|STARTED|Overall Study|Assigned to study treatment.|309
68089|NCT01332149|158412|P1|STARTED|Overall Study|Assigned to study treatment.|314
68090|NCT01332123|158466|P1|NOT COMPLETED|Overall Study||0
68091|NCT01332123|158466|P1|COMPLETED|Overall Study||10
68092|NCT01332123|158466|P1|STARTED|Overall Study||10
68093|NCT01332071|158471|P2|NOT COMPLETED|Period 2||0
68094|NCT01332071|158472|P1|NOT COMPLETED|Period 2||0
68095|NCT01332071|158471|P2|COMPLETED|Period 2||13
68096|NCT01332071|158472|P1|COMPLETED|Period 2||13
68097|NCT01332071|158471|P2|STARTED|Period 2||13
68098|NCT01332071|158472|P1|STARTED|Period 2||13
68099|NCT01332071|158471|P2|NOT COMPLETED|7-Day Washout Period||0
68100|NCT01332071|158472|P1|NOT COMPLETED|7-Day Washout Period||0
68101|NCT01332071|158471|P2|COMPLETED|7-Day Washout Period||13
68102|NCT01332071|158472|P1|COMPLETED|7-Day Washout Period||13
68103|NCT01332071|158471|P2|STARTED|7-Day Washout Period||13
68104|NCT01332071|158472|P1|STARTED|7-Day Washout Period||13
68105|NCT01332071|158471|P2|NOT COMPLETED|Period 1||0
68106|NCT01332071|158472|P1|NOT COMPLETED|Period 1||0
68107|NCT01332071|158471|P2|COMPLETED|Period 1||13
68108|NCT01332071|158472|P1|COMPLETED|Period 1||13
68109|NCT01332071|158471|P2|STARTED|Period 1||13
68110|NCT01332071|158472|P1|STARTED|Period 1||13
68111|NCT01332019|158490|P2|NOT COMPLETED|Overall Study||122
68112|NCT01332019|158491|P1|NOT COMPLETED|Overall Study||113
68113|NCT01332019|158490|P2|COMPLETED|Overall Study||425
68114|NCT01332019|158491|P1|COMPLETED|Overall Study||417
68115|NCT01332019|158490|P2|STARTED|Overall Study||547
68116|NCT01332019|158491|P1|STARTED|Overall Study||530
68117|NCT01331824|158573|P1|NOT COMPLETED|Overall Study||13
68118|NCT01331824|158573|P1|COMPLETED|Overall Study||9
68119|NCT01331824|158573|P1|STARTED|Overall Study||22
68120|NCT01331694|158585|P6|NOT COMPLETED|Overall Study||0
68121|NCT01331694|158586|P5|NOT COMPLETED|Overall Study||0
68122|NCT01331694|158587|P4|NOT COMPLETED|Overall Study||0
68123|NCT01331694|158588|P3|NOT COMPLETED|Overall Study||0
68124|NCT01331694|158589|P2|NOT COMPLETED|Overall Study||0
68125|NCT01331694|158590|P1|NOT COMPLETED|Overall Study||0
68126|NCT01331694|158585|P6|COMPLETED|Overall Study||9126
68127|NCT01331694|158586|P5|COMPLETED|Overall Study||10617
68128|NCT01331694|158587|P4|COMPLETED|Overall Study||12595
68129|NCT01331694|158588|P3|COMPLETED|Overall Study||12659
68130|NCT01331694|158589|P2|COMPLETED|Overall Study||14449
68131|NCT01331694|158590|P1|COMPLETED|Overall Study||16684
68132|NCT01331694|158585|P6|STARTED|Overall Study||9126
68133|NCT01331694|158586|P5|STARTED|Overall Study||10617
68134|NCT01331694|158587|P4|STARTED|Overall Study||12595
68135|NCT01331694|158588|P3|STARTED|Overall Study||12659
68136|NCT01331694|158589|P2|STARTED|Overall Study||14449
68137|NCT01331694|158590|P1|STARTED|Overall Study||16684
68138|NCT01331681|158607|P3|NOT COMPLETED|Overall Study||35
68139|NCT01331681|158608|P2|NOT COMPLETED|Overall Study||34
68140|NCT01331681|158609|P1|NOT COMPLETED|Overall Study||35
68141|NCT01331681|158607|P3|COMPLETED|Overall Study|Completed Week 148|100
68142|NCT01331681|158608|P2|COMPLETED|Overall Study|Completed Week 148|101
68143|NCT01331681|158609|P1|COMPLETED|Overall Study|Completed Week 148|101
68144|NCT01331681|158607|P3|Completed Week 148|Overall Study||100
68145|NCT01331681|158608|P2|Completed Week 148|Overall Study||101
68146|NCT01331681|158609|P1|Completed Week 148|Overall Study||101
68147|NCT01331681|158607|P3|Completed Week 100|Overall Study||105
68148|NCT01331681|158608|P2|Completed Week 100|Overall Study||110
68149|NCT01331681|158609|P1|Completed Week 100|Overall Study||115
68150|NCT01331681|158607|P3|Completed Week 52|Overall Study||115
68151|NCT01331681|158608|P2|Completed Week 52|Overall Study||121
68152|NCT01331681|158609|P1|Completed Week 52|Overall Study||125
68153|NCT01331681|158607|P3|Participants Received Treatment|Overall Study|safety population|133
68154|NCT01331681|158608|P2|Participants Received Treatment|Overall Study|safety population|135
68155|NCT01331681|158609|P1|Participants Received Treatment|Overall Study|safety population|136
68156|NCT01331681|158607|P3|STARTED|Overall Study|randomized|135
68157|NCT01331681|158608|P2|STARTED|Overall Study|randomized|135
68158|NCT01331681|158609|P1|STARTED|Overall Study|randomized|136
68159|NCT01331304|158637|P2|NOT COMPLETED|Overall Study||60
68160|NCT01331304|158638|P1|NOT COMPLETED|Overall Study||58
68161|NCT01331304|158637|P2|COMPLETED|Overall Study||182
68162|NCT01331304|158638|P1|COMPLETED|Overall Study||182
68163|NCT01331304|158637|P2|STARTED|Overall Study||242
68164|NCT01331304|158638|P1|STARTED|Overall Study||240
68165|NCT01331291|158648|P2|NOT COMPLETED|Overall Study||9
68166|NCT01331291|158649|P1|NOT COMPLETED|Overall Study||2
68167|NCT01331291|158648|P2|COMPLETED|Overall Study||0
68168|NCT01331291|158649|P1|COMPLETED|Overall Study||0
68169|NCT01331291|158648|P2|STARTED|Overall Study||9
68170|NCT01331291|158649|P1|STARTED|Overall Study||2
68171|NCT01331213|158662|P2|NOT COMPLETED|Overall Study||0
68172|NCT01331213|158663|P1|NOT COMPLETED|Overall Study||0
68173|NCT01331213|158662|P2|COMPLETED|Overall Study||10
68174|NCT01331213|158663|P1|COMPLETED|Overall Study||8
68175|NCT01331213|158662|P2|STARTED|Overall Study||10
68176|NCT01331213|158663|P1|STARTED|Overall Study||8
68177|NCT01331161|158683|P2|NOT COMPLETED|Overall Study||2
68178|NCT01331161|158684|P1|NOT COMPLETED|Overall Study||1
68179|NCT01331161|158683|P2|COMPLETED|Overall Study||31
68180|NCT01331161|158684|P1|COMPLETED|Overall Study||43
68181|NCT01331161|158683|P2|STARTED|Overall Study||33
68182|NCT01331161|158684|P1|STARTED|Overall Study||44
68183|NCT01331109|158692|P1|NOT COMPLETED|Overall Study||57
68184|NCT01331109|158692|P1|COMPLETED|Overall Study||0
68185|NCT01331109|158692|P1|STARTED|Overall Study||57
68186|NCT01331005|158704|P2|NOT COMPLETED|Overall Study||4
68187|NCT01331005|158705|P1|NOT COMPLETED|Overall Study||4
68188|NCT01331005|158704|P2|COMPLETED|Overall Study||57
68189|NCT01331005|158705|P1|COMPLETED|Overall Study||60
68190|NCT01331005|158704|P2|STARTED|Overall Study||61
68191|NCT01331005|158705|P1|STARTED|Overall Study||64
68192|NCT01330914|158711|P1|NOT COMPLETED|Overall Study||7
68193|NCT01330914|158711|P1|COMPLETED|Overall Study||48
68194|NCT01330914|158711|P1|STARTED|Overall Study||55
68195|NCT01330628|158717|P2|NOT COMPLETED|Overall Study||40
68196|NCT01330628|158718|P1|NOT COMPLETED|Overall Study||70
68197|NCT01330628|158717|P2|COMPLETED|Overall Study||42
68198|NCT01330628|158718|P1|COMPLETED|Overall Study||100
68199|NCT01330628|158717|P2|6 Month Follow-up|Overall Study||60
68200|NCT01330628|158718|P1|6 Month Follow-up|Overall Study||135
68201|NCT01330628|158717|P2|30 Day Follow-up|Overall Study||73
68202|NCT01330628|158718|P1|30 Day Follow-up|Overall Study||165
68203|NCT01330628|158717|P2|STARTED|Overall Study||82
68204|NCT01330628|158718|P1|STARTED|Overall Study||170
68205|NCT01330433|158728|P2|NOT COMPLETED|Overall Study||3
68206|NCT01330433|158729|P1|NOT COMPLETED|Overall Study||2
68207|NCT01330433|158728|P2|COMPLETED|Overall Study||16
68208|NCT01330433|158729|P1|COMPLETED|Overall Study||14
68209|NCT01330433|158728|P2|STARTED|Overall Study||19
68210|NCT01330433|158729|P1|STARTED|Overall Study||16
68211|NCT01330420|158749|P1|NOT COMPLETED|Overall Study||4
68212|NCT01330420|158749|P1|COMPLETED|Overall Study||24
68213|NCT01330420|158749|P1|STARTED|Overall Study||28
68214|NCT01330394|158759|P2|NOT COMPLETED|Overall Study||0
68215|NCT01330394|158760|P1|NOT COMPLETED|Overall Study||0
68216|NCT01330394|158759|P2|COMPLETED|Overall Study||16
68217|NCT01330394|158760|P1|COMPLETED|Overall Study||17
68218|NCT01330394|158759|P2|STARTED|Overall Study||16
68219|NCT01330394|158760|P1|STARTED|Overall Study||17
68220|NCT01330381|158768|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
68221|NCT01330381|158769|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
68222|NCT01330381|158770|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
68223|NCT01330381|158768|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
68224|NCT01330381|158769|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
68225|NCT01330381|158770|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
68226|NCT01330381|158768|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
68227|NCT01330381|158769|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
68228|NCT01330381|158770|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
68229|NCT01330381|158768|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
68230|NCT01330381|158769|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
68231|NCT01330381|158770|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
68232|NCT01330381|158768|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
68233|NCT01330381|158769|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
68234|NCT01330381|158770|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
68235|NCT01330381|158768|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
68236|NCT01330381|158769|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
68237|NCT01330381|158770|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
68238|NCT01330381|158768|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
68239|NCT01330381|158769|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
68240|NCT01330381|158770|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
68241|NCT01330355|158816|P2|NOT COMPLETED|Overall Study||0
68242|NCT01330355|158817|P1|NOT COMPLETED|Overall Study||0
68243|NCT01330355|158816|P2|COMPLETED|Overall Study||17
68244|NCT01330355|158817|P1|COMPLETED|Overall Study||16
68245|NCT01330355|158816|P2|STARTED|Overall Study||17
68246|NCT01330355|158817|P1|STARTED|Overall Study||16
68247|NCT01330316|158831|P2|NOT COMPLETED|Overall Study||15
68248|NCT01330316|158832|P1|NOT COMPLETED|Overall Study||2
68249|NCT01330316|158831|P2|COMPLETED|Overall Study||60
68250|NCT01330316|158832|P1|COMPLETED|Overall Study||41
68251|NCT01330316|158831|P2|STARTED|Overall Study||75
68252|NCT01330316|158832|P1|STARTED|Overall Study||43
68253|NCT01330303|158868|P2|NOT COMPLETED|Period 2||0
68254|NCT01330303|158869|P1|NOT COMPLETED|Period 2||0
68255|NCT01330303|158868|P2|COMPLETED|Period 2||18
68256|NCT01330303|158869|P1|COMPLETED|Period 2||19
68257|NCT01330303|158868|P2|STARTED|Period 2||18
68258|NCT01330303|158869|P1|STARTED|Period 2||19
68259|NCT01330303|158868|P2|NOT COMPLETED|7-Day Washout Period||0
68260|NCT01330303|158869|P1|NOT COMPLETED|7-Day Washout Period||0
68261|NCT01330303|158868|P2|COMPLETED|7-Day Washout Period||18
68262|NCT01330303|158869|P1|COMPLETED|7-Day Washout Period||19
68263|NCT01330303|158868|P2|STARTED|7-Day Washout Period||18
68264|NCT01330303|158869|P1|STARTED|7-Day Washout Period||19
68265|NCT01330303|158868|P2|NOT COMPLETED|Period 1||2
68266|NCT01330303|158869|P1|NOT COMPLETED|Period 1||1
68267|NCT01330303|158868|P2|COMPLETED|Period 1||18
68268|NCT01330303|158869|P1|COMPLETED|Period 1||19
68269|NCT01330303|158868|P2|STARTED|Period 1||20
68270|NCT01330303|158869|P1|STARTED|Period 1||20
68271|NCT01330290|158879|P1|NOT COMPLETED|Overall Study||0
68272|NCT01330290|158879|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
68273|NCT01330290|158879|P1|STARTED|Overall Study||148
68274|NCT01330108|158903|P1|NOT COMPLETED|Overall Study||4
68275|NCT01330108|158903|P1|COMPLETED|Overall Study||28
68276|NCT01330108|158903|P1|STARTED|Overall Study||32
68277|NCT01330030|158910|P2|NOT COMPLETED|Overall Study||17
68278|NCT01330030|158911|P1|NOT COMPLETED|Overall Study||16
68279|NCT01330030|158910|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
68280|NCT01330030|158911|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
68281|NCT01330030|158910|P2|STARTED|Overall Study||122
68282|NCT01330030|158911|P1|STARTED|Overall Study||121
68283|NCT01330017|158922|P5|NOT COMPLETED|Overall Study||3
68284|NCT01330017|158923|P4|NOT COMPLETED|Overall Study||12
68285|NCT01330017|158924|P3|NOT COMPLETED|Overall Study||8
68286|NCT01330017|158925|P2|NOT COMPLETED|Overall Study||4
68287|NCT01330017|158926|P1|NOT COMPLETED|Overall Study||5
68288|NCT01330017|158922|P5|COMPLETED|Overall Study||100
68289|NCT01330017|158923|P4|COMPLETED|Overall Study||100
68290|NCT01330017|158924|P3|COMPLETED|Overall Study||99
68291|NCT01330017|158925|P2|COMPLETED|Overall Study||104
68292|NCT01330017|158926|P1|COMPLETED|Overall Study||104
68293|NCT01330017|158922|P5|STARTED|Overall Study||103
68294|NCT01330017|158923|P4|STARTED|Overall Study||112
68295|NCT01330017|158924|P3|STARTED|Overall Study||107
68296|NCT01330017|158925|P2|STARTED|Overall Study||108
68297|NCT01330017|158926|P1|STARTED|Overall Study||109
68298|NCT01329978|158975|P5|NOT COMPLETED|Rerandomization Treatment Period||4
68299|NCT01329978|158976|P4|NOT COMPLETED|Rerandomization Treatment Period||5
68300|NCT01329978|158977|P3|NOT COMPLETED|Rerandomization Treatment Period||0
68301|NCT01329978|158978|P2|NOT COMPLETED|Rerandomization Treatment Period||0
68302|NCT01329978|158979|P1|NOT COMPLETED|Rerandomization Treatment Period||0
68303|NCT01329978|158975|P5|COMPLETED|Rerandomization Treatment Period||71
68304|NCT01329978|158976|P4|COMPLETED|Rerandomization Treatment Period||70
68305|NCT01329978|158977|P3|COMPLETED|Rerandomization Treatment Period||0
68306|NCT01329978|158978|P2|COMPLETED|Rerandomization Treatment Period||0
68307|NCT01329978|158979|P1|COMPLETED|Rerandomization Treatment Period||0
68308|NCT01329978|158975|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
68309|NCT01329978|158976|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
68310|NCT01329978|158977|P3|STARTED|Rerandomization Treatment Period||0
68311|NCT01329978|158978|P2|STARTED|Rerandomization Treatment Period||0
68312|NCT01329978|158979|P1|STARTED|Rerandomization Treatment Period||0
68313|NCT01329978|158975|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
68314|NCT01329978|158976|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
68315|NCT01329978|158977|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
68316|NCT01329978|158978|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
68317|NCT01329978|158979|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
68318|NCT01329978|158975|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
68319|NCT01329978|158976|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
68320|NCT01329978|158977|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
68321|NCT01329978|158978|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
68322|NCT01329978|158979|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
68323|NCT01329978|158975|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
68324|NCT01329978|158976|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
68325|NCT01329978|158977|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
68326|NCT01329978|158978|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
68327|NCT01329978|158979|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
68328|NCT01329939|159053|P4|NOT COMPLETED|Overall Study||5
68329|NCT01329939|159054|P3|NOT COMPLETED|Overall Study||1
68330|NCT01329939|159055|P2|NOT COMPLETED|Overall Study||1
68331|NCT01329939|159056|P1|NOT COMPLETED|Overall Study||3
68332|NCT01329939|159053|P4|COMPLETED|Overall Study||4
68333|NCT01329939|159054|P3|COMPLETED|Overall Study||4
68334|NCT01329939|159055|P2|COMPLETED|Overall Study||4
68335|NCT01329939|159056|P1|COMPLETED|Overall Study||4
68336|NCT01329939|159053|P4|STARTED|Overall Study||9
68337|NCT01329939|159054|P3|STARTED|Overall Study||5
68338|NCT01329939|159055|P2|STARTED|Overall Study||5
68339|NCT01329939|159056|P1|STARTED|Overall Study||7
68340|NCT01329848|159094|P1|NOT COMPLETED|Overall Study||29
68341|NCT01329848|159094|P1|COMPLETED|Overall Study||54
68342|NCT01329848|159094|P1|STARTED|Overall Study||83
68343|NCT01329679|159099|P2|NOT COMPLETED|Overall Study||0
68344|NCT01329679|159100|P1|NOT COMPLETED|Overall Study||0
68345|NCT01329679|159099|P2|COMPLETED|Overall Study||13
68346|NCT01329679|159100|P1|COMPLETED|Overall Study||13
68347|NCT01329679|159099|P2|STARTED|Overall Study||13
68348|NCT01329679|159100|P1|STARTED|Overall Study||13
68349|NCT01329562|159120|P2|NOT COMPLETED|Overall Study||7
68350|NCT01329562|159121|P1|NOT COMPLETED|Overall Study||9
68351|NCT01329562|159120|P2|COMPLETED|Overall Study||14
68352|NCT01329562|159121|P1|COMPLETED|Overall Study||11
68353|NCT01329562|159120|P2|STARTED|Overall Study||21
68354|NCT01329562|159121|P1|STARTED|Overall Study||20
68355|NCT01329549|159170|P1|NOT COMPLETED|Overall Study||2
68356|NCT01329549|159170|P1|COMPLETED|Overall Study||0
68357|NCT01329549|159170|P1|STARTED|Overall Study||2
68358|NCT01329419|159181|P1|NOT COMPLETED|Overall Study||235
68359|NCT01329419|159181|P1|COMPLETED|Overall Study||4158
68360|NCT01329419|159181|P1|STARTED|Overall Study||4393
68361|NCT01329263|159189|P2|NOT COMPLETED|Overall Study||23
68362|NCT01329263|159190|P1|NOT COMPLETED|Overall Study||5
68363|NCT01329263|159189|P2|COMPLETED|Overall Study||22
68364|NCT01329263|159190|P1|COMPLETED|Overall Study||10
68365|NCT01329263|159189|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
68366|NCT01329263|159190|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
68367|NCT01329263|159189|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
68368|NCT01329263|159190|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
68369|NCT01329263|159189|P2|Completed Period 1 Own Menthol|Overall Study||45
68370|NCT01329263|159190|P1|Completed Period 1 Own Menthol|Overall Study||15
68371|NCT01329263|159189|P2|STARTED|Overall Study||45
68372|NCT01329263|159190|P1|STARTED|Overall Study||15
68373|NCT01329198|159204|P2|NOT COMPLETED|Overall Study||0
68374|NCT01329198|159205|P1|NOT COMPLETED|Overall Study||0
68375|NCT01329198|159204|P2|COMPLETED|Overall Study||2
68376|NCT01329198|159205|P1|COMPLETED|Overall Study||3
68377|NCT01329198|159204|P2|STARTED|Overall Study||2
68378|NCT01329198|159205|P1|STARTED|Overall Study||3
68379|NCT01329185|159218|P2|NOT COMPLETED|Overall Study||0
68380|NCT01329185|159219|P1|NOT COMPLETED|Overall Study||0
68381|NCT01329185|159218|P2|COMPLETED|Overall Study||7
68382|NCT01329185|159219|P1|COMPLETED|Overall Study||10
68383|NCT01329185|159218|P2|PTLD|Overall Study||0
68384|NCT01329185|159219|P1|PTLD|Overall Study||1
68385|NCT01329185|159218|P2|CMV Disease|Overall Study||0
68386|NCT01329185|159219|P1|CMV Disease|Overall Study||1
68387|NCT01329185|159218|P2|STARTED|Overall Study||7
68388|NCT01329185|159219|P1|STARTED|Overall Study||10
68389|NCT01329029|159227|P2|NOT COMPLETED|Overall Study||192
68390|NCT01329029|159228|P1|NOT COMPLETED|Overall Study||269
68391|NCT01329029|159227|P2|COMPLETED|Overall Study||780
68392|NCT01329029|159228|P1|COMPLETED|Overall Study||704
68393|NCT01329029|159227|P2|Safety Population|Overall Study||967
68394|NCT01329029|159228|P1|Safety Population|Overall Study||968
68395|NCT01329029|159227|P2|Full Analysis Set (FAS)|Overall Study||966
68396|NCT01329029|159228|P1|Full Analysis Set (FAS)|Overall Study||969
68397|NCT01329029|159227|P2|STARTED|Overall Study||972
68398|NCT01329029|159228|P1|STARTED|Overall Study||973
68399|NCT01328964|159301|P3|NOT COMPLETED|Overall Study||0
68400|NCT01328964|159302|P2|NOT COMPLETED|Overall Study||0
68401|NCT01328964|159303|P1|NOT COMPLETED|Overall Study||0
68402|NCT01328964|159301|P3|COMPLETED|Overall Study||4424
68403|NCT01328964|159302|P2|COMPLETED|Overall Study||3270
68404|NCT01328964|159303|P1|COMPLETED|Overall Study||2212
68405|NCT01328964|159301|P3|STARTED|Overall Study||4424
68406|NCT01328964|159302|P2|STARTED|Overall Study||3270
68407|NCT01328964|159303|P1|STARTED|Overall Study||2212
68408|NCT01328951|159318|P2|NOT COMPLETED|Overall Study||322
68409|NCT01328951|159319|P1|NOT COMPLETED|Overall Study||321
68410|NCT01328951|159318|P2|COMPLETED|Overall Study||0
68411|NCT01328951|159319|P1|COMPLETED|Overall Study||0
68412|NCT01328951|159318|P2|STARTED|Overall Study||322
68413|NCT01328951|159319|P1|STARTED|Overall Study||321
68414|NCT01328782|159346|P3|NOT COMPLETED|Overall Study||0
68415|NCT01328782|159347|P2|NOT COMPLETED|Overall Study||0
68416|NCT01328782|159348|P1|NOT COMPLETED|Overall Study||0
68417|NCT01328782|159346|P3|COMPLETED|Overall Study||39
68418|NCT01328782|159347|P2|COMPLETED|Overall Study||42
68419|NCT01328782|159348|P1|COMPLETED|Overall Study||43
68420|NCT01328782|159346|P3|STARTED|Overall Study||39
68421|NCT01328782|159347|P2|STARTED|Overall Study||42
68422|NCT01328782|159348|P1|STARTED|Overall Study||43
68423|NCT01328769|159370|P2|NOT COMPLETED|Overall Study||1
68424|NCT01328769|159371|P1|NOT COMPLETED|Overall Study||0
68425|NCT01328769|159370|P2|COMPLETED|Overall Study||23
68426|NCT01328769|159371|P1|COMPLETED|Overall Study||25
68427|NCT01328769|159370|P2|STARTED|Overall Study||24
68428|NCT01328769|159371|P1|STARTED|Overall Study||25
68429|NCT01328756|159379|P1|NOT COMPLETED|Overall Study||123
68430|NCT01328756|159379|P1|COMPLETED|Overall Study||191
68431|NCT01328756|159379|P1|STARTED|Overall Study||314
68432|NCT01328717|159396|P1|NOT COMPLETED|Overall Study||1
68433|NCT01328717|159396|P1|COMPLETED|Overall Study||77
68434|NCT01328717|159396|P1|STARTED|Overall Study||78
68435|NCT01328574|159401|P1|NOT COMPLETED|Overall Study||1
68436|NCT01328574|159401|P1|COMPLETED|Overall Study||12
68437|NCT01328574|159401|P1|STARTED|Overall Study||13
68438|NCT01328444|159413|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
68439|NCT01328444|159414|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
68440|NCT01328444|159415|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
68441|NCT01328444|159416|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
68442|NCT01328444|159417|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
68443|NCT01328444|159418|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
68444|NCT01328444|159413|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
68445|NCT01328444|159414|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
68446|NCT01328444|159415|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
68447|NCT01328444|159416|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
68448|NCT01328444|159417|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
68449|NCT01328444|159418|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
68450|NCT01328444|159413|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
68451|NCT01328444|159414|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
68452|NCT01328444|159415|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
68453|NCT01328444|159416|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
68454|NCT01328444|159417|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
68455|NCT01328444|159418|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
68456|NCT01328444|159413|P6|NOT COMPLETED|Washout Period (14 Days)||4
68457|NCT01328444|159414|P5|NOT COMPLETED|Washout Period (14 Days)||1
68458|NCT01328444|159415|P4|NOT COMPLETED|Washout Period (14 Days)||1
68459|NCT01328444|159416|P3|NOT COMPLETED|Washout Period (14 Days)||0
68460|NCT01328444|159417|P2|NOT COMPLETED|Washout Period (14 Days)||1
68461|NCT01328444|159418|P1|NOT COMPLETED|Washout Period (14 Days)||1
68462|NCT01328444|159413|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
68463|NCT01328444|159414|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
68464|NCT01328444|159415|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
68465|NCT01328444|159416|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
68466|NCT01328444|159417|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
68467|NCT01328444|159418|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
68468|NCT01328444|159413|P6|STARTED|Washout Period (14 Days)||72
68469|NCT01328444|159414|P5|STARTED|Washout Period (14 Days)||67
68470|NCT01328444|159415|P4|STARTED|Washout Period (14 Days)||33
68471|NCT01328444|159416|P3|STARTED|Washout Period (14 Days)||25
68472|NCT01328444|159417|P2|STARTED|Washout Period (14 Days)||21
68473|NCT01328444|159418|P1|STARTED|Washout Period (14 Days)||83
68474|NCT01328444|159413|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
68475|NCT01328444|159414|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
68476|NCT01328444|159415|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
68477|NCT01328444|159416|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
68478|NCT01328444|159417|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
68479|NCT01328444|159418|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
68480|NCT01328444|159413|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
68481|NCT01328444|159414|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
68482|NCT01328444|159415|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
68483|NCT01328444|159416|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
68484|NCT01328444|159417|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
68485|NCT01328444|159418|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
68486|NCT01328444|159413|P6|STARTED|Treatment Period 1 (12 Weeks)||78
68487|NCT01328444|159414|P5|STARTED|Treatment Period 1 (12 Weeks)||81
68488|NCT01328444|159415|P4|STARTED|Treatment Period 1 (12 Weeks)||41
68489|NCT01328444|159416|P3|STARTED|Treatment Period 1 (12 Weeks)||28
68490|NCT01328444|159417|P2|STARTED|Treatment Period 1 (12 Weeks)||26
68491|NCT01328444|159418|P1|STARTED|Treatment Period 1 (12 Weeks)||94
68492|NCT01328431|159464|P2|NOT COMPLETED|12 Month (12M)||97
68493|NCT01328431|159465|P1|NOT COMPLETED|12 Month (12M)||84
68494|NCT01328431|159464|P2|COMPLETED|12 Month (12M)||289
68495|NCT01328431|159465|P1|COMPLETED|12 Month (12M)||304
68496|NCT01328431|159464|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
68497|NCT01328431|159465|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
68498|NCT01328431|159464|P2|NOT COMPLETED|3 Month (3M)||72
68499|NCT01328431|159465|P1|NOT COMPLETED|3 Month (3M)||77
68500|NCT01328431|159464|P2|COMPLETED|3 Month (3M)||316
68501|NCT01328431|159465|P1|COMPLETED|3 Month (3M)||313
68502|NCT01328431|159464|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
68589|NCT01327547|159738|P1|STARTED|Overall Study||70
68503|NCT01328431|159465|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
68504|NCT01328431|159464|P2|NOT COMPLETED|1 Month (1M)||58
68505|NCT01328431|159465|P1|NOT COMPLETED|1 Month (1M)||55
68506|NCT01328431|159464|P2|COMPLETED|1 Month (1M)||330
68507|NCT01328431|159465|P1|COMPLETED|1 Month (1M)||335
68508|NCT01328431|159464|P2|STARTED|1 Month (1M)||388
68509|NCT01328431|159465|P1|STARTED|1 Month (1M)||390
68510|NCT01328431|159464|P2|NOT COMPLETED|Baseline||2
68511|NCT01328431|159465|P1|NOT COMPLETED|Baseline||0
68512|NCT01328431|159464|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
68513|NCT01328431|159465|P1|COMPLETED|Baseline||390
68514|NCT01328431|159464|P2|STARTED|Baseline||390
68515|NCT01328431|159465|P1|STARTED|Baseline||390
68516|NCT01328405|159475|P2|NOT COMPLETED|Overall Study||0
68517|NCT01328405|159476|P1|NOT COMPLETED|Overall Study||0
68518|NCT01328405|159475|P2|COMPLETED|Overall Study||48
68519|NCT01328405|159476|P1|COMPLETED|Overall Study||52
68520|NCT01328405|159475|P2|STARTED|Overall Study||48
68521|NCT01328405|159476|P1|STARTED|Overall Study||52
68522|NCT01328379|159493|P3|NOT COMPLETED|Overall Study||0
68523|NCT01328379|159494|P2|NOT COMPLETED|Overall Study||0
68524|NCT01328379|159495|P1|NOT COMPLETED|Overall Study||1
68525|NCT01328379|159493|P3|COMPLETED|Overall Study||143
68526|NCT01328379|159494|P2|COMPLETED|Overall Study||144
68527|NCT01328379|159495|P1|COMPLETED|Overall Study||142
68528|NCT01328379|159493|P3|STARTED|Overall Study||143
68529|NCT01328379|159494|P2|STARTED|Overall Study||144
68530|NCT01328379|159495|P1|STARTED|Overall Study||143
68531|NCT01328366|159521|P1|NOT COMPLETED|Overall Study||10
68532|NCT01328366|159521|P1|COMPLETED|Overall Study||143
68533|NCT01328366|159521|P1|STARTED|Overall Study||153
68534|NCT01328184|159539|P1|NOT COMPLETED|Overall Study||0
68535|NCT01328184|159539|P1|COMPLETED|Overall Study||18
68536|NCT01328184|159539|P1|STARTED|Overall Study||18
68537|NCT01328158|159579|P1|NOT COMPLETED|Overall Study||0
68538|NCT01328158|159579|P1|COMPLETED|Overall Study||220
68539|NCT01328158|159579|P1|STARTED|Overall Study||220
68540|NCT01328080|159617|P1|NOT COMPLETED|Overall Study||5
68541|NCT01328080|159617|P1|COMPLETED|Overall Study||6
68542|NCT01328080|159617|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
68543|NCT01328054|159621|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
68544|NCT01328054|159622|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
68545|NCT01328054|159621|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
68546|NCT01328054|159622|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
68547|NCT01328054|159621|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
68548|NCT01328054|159622|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
68549|NCT01328054|159621|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
68550|NCT01328054|159622|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
68551|NCT01328054|159621|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
68552|NCT01328054|159622|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
68553|NCT01328054|159621|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
68554|NCT01328054|159622|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
68555|NCT01328041|159647|P1|NOT COMPLETED|Overall Study||57
68556|NCT01328041|159647|P1|COMPLETED|Overall Study||126
68557|NCT01328041|159647|P1|STARTED|Overall Study||183
68558|NCT01327989|159669|P1|NOT COMPLETED|Overall Study||14
68559|NCT01327989|159669|P1|COMPLETED|Overall Study||188
68560|NCT01327989|159669|P1|STARTED|Overall Study||202
68561|NCT01327976|159683|P2|NOT COMPLETED|Overall Study||7
68562|NCT01327976|159684|P1|NOT COMPLETED|Overall Study||8
68563|NCT01327976|159683|P2|COMPLETED|Overall Study||70
68564|NCT01327976|159684|P1|COMPLETED|Overall Study||154
68565|NCT01327976|159683|P2|STARTED|Overall Study||77
68566|NCT01327976|159684|P1|STARTED|Overall Study||162
68567|NCT01327703|159694|P2|NOT COMPLETED|Second Treatment Period||2
68568|NCT01327703|159695|P1|NOT COMPLETED|Second Treatment Period||1
68569|NCT01327703|159694|P2|COMPLETED|Second Treatment Period||42
68570|NCT01327703|159695|P1|COMPLETED|Second Treatment Period||39
68571|NCT01327703|159694|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
68572|NCT01327703|159695|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
68573|NCT01327703|159694|P2|NOT COMPLETED|First Treatment Period||0
68574|NCT01327703|159695|P1|NOT COMPLETED|First Treatment Period||0
68575|NCT01327703|159694|P2|COMPLETED|First Treatment Period||45
68576|NCT01327703|159695|P1|COMPLETED|First Treatment Period||42
68577|NCT01327703|159694|P2|STARTED|First Treatment Period||45
68578|NCT01327703|159695|P1|STARTED|First Treatment Period||42
68579|NCT01327599|159727|P1|NOT COMPLETED|Overall Study||3
68580|NCT01327599|159727|P1|COMPLETED|Overall Study||57
68581|NCT01327599|159727|P1|STARTED|Overall Study||60
68582|NCT01327547|159737|P2|NOT COMPLETED|Overall Study||67
68583|NCT01327547|159738|P1|NOT COMPLETED|Overall Study||70
68584|NCT01327547|159737|P2|COMPLETED|Overall Study||0
68585|NCT01327547|159738|P1|COMPLETED|Overall Study||0
68586|NCT01327547|159737|P2|In Study, Off Drug|Overall Study||2
68587|NCT01327547|159738|P1|In Study, Off Drug|Overall Study||2
68588|NCT01327547|159737|P2|STARTED|Overall Study||67
68590|NCT01327508|159774|P2|NOT COMPLETED|Overall Study||0
68591|NCT01327508|159775|P1|NOT COMPLETED|Overall Study||0
68592|NCT01327508|159774|P2|COMPLETED|Overall Study||30
68593|NCT01327508|159775|P1|COMPLETED|Overall Study||30
68594|NCT01327508|159774|P2|STARTED|Overall Study||30
68595|NCT01327508|159775|P1|STARTED|Overall Study||30
68596|NCT01327482|159783|P1|NOT COMPLETED|Overall Study||1
68597|NCT01327482|159783|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
68598|NCT01327482|159783|P1|STARTED|Overall Study||10
68599|NCT01327339|159788|P1|NOT COMPLETED|Overall Study||8
68600|NCT01327339|159788|P1|COMPLETED|Overall Study||747
68601|NCT01327339|159788|P1|STARTED|Overall Study||755
68602|NCT01327313|159798|P4|NOT COMPLETED|Overall Study||0
68603|NCT01327313|159799|P3|NOT COMPLETED|Overall Study||0
68604|NCT01327313|159800|P2|NOT COMPLETED|Overall Study||0
68605|NCT01327313|159801|P1|NOT COMPLETED|Overall Study||0
68606|NCT01327313|159798|P4|COMPLETED|Overall Study||7
68607|NCT01327313|159799|P3|COMPLETED|Overall Study||6
68608|NCT01327313|159800|P2|COMPLETED|Overall Study||6
68609|NCT01327313|159801|P1|COMPLETED|Overall Study||8
68610|NCT01327313|159798|P4|STARTED|Overall Study||7
68611|NCT01327313|159799|P3|STARTED|Overall Study||6
68612|NCT01327313|159800|P2|STARTED|Overall Study||6
68613|NCT01327313|159801|P1|STARTED|Overall Study||8
68614|NCT01327300|159923|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
68615|NCT01327300|159924|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
68616|NCT01327300|159923|P2|COMPLETED|Second Intervention (12 Weeks)||2
68617|NCT01327300|159924|P1|COMPLETED|Second Intervention (12 Weeks)||4
68618|NCT01327300|159923|P2|STARTED|Second Intervention (12 Weeks)||2
68619|NCT01327300|159924|P1|STARTED|Second Intervention (12 Weeks)||4
68620|NCT01327300|159923|P2|NOT COMPLETED|Washout (3 Weeks)||0
68621|NCT01327300|159924|P1|NOT COMPLETED|Washout (3 Weeks)||1
68622|NCT01327300|159923|P2|COMPLETED|Washout (3 Weeks)||2
68623|NCT01327300|159924|P1|COMPLETED|Washout (3 Weeks)||4
68624|NCT01327300|159923|P2|STARTED|Washout (3 Weeks)||2
68625|NCT01327300|159924|P1|STARTED|Washout (3 Weeks)||5
68626|NCT01327300|159923|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
68627|NCT01327300|159924|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
68628|NCT01327300|159923|P2|COMPLETED|First Intervention (12 Weeks)||2
68629|NCT01327300|159924|P1|COMPLETED|First Intervention (12 Weeks)||5
68630|NCT01327300|159923|P2|STARTED|First Intervention (12 Weeks)||2
68631|NCT01327300|159924|P1|STARTED|First Intervention (12 Weeks)||5
68632|NCT01327053|159942|P2|NOT COMPLETED|Overall Study||105
68633|NCT01327053|159943|P1|NOT COMPLETED|Overall Study||40
68634|NCT01327053|159942|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
68635|NCT01327053|159943|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
68636|NCT01327053|159942|P2|STARTED|Overall Study||151
68637|NCT01327053|159943|P1|STARTED|Overall Study||79
68638|NCT01326962|159971|P1|NOT COMPLETED|Overall Study||7
68639|NCT01326962|159971|P1|COMPLETED|Overall Study||21
68640|NCT01326962|159971|P1|STARTED|Overall Study||28
68641|NCT01326910|159989|P2|NOT COMPLETED|Overall Study||3
68642|NCT01326910|159990|P1|NOT COMPLETED|Overall Study||4
68643|NCT01326910|159989|P2|COMPLETED|Overall Study||42
68644|NCT01326910|159990|P1|COMPLETED|Overall Study||41
68645|NCT01326910|159989|P2|STARTED|Overall Study||45
68646|NCT01326910|159990|P1|STARTED|Overall Study||45
68647|NCT01326845|160004|P2|NOT COMPLETED|Overall Study||5
68648|NCT01326845|160005|P1|NOT COMPLETED|Overall Study||7
68649|NCT01326845|160004|P2|COMPLETED|Overall Study|Study terminated early|0
68650|NCT01326845|160005|P1|COMPLETED|Overall Study|Study terminated early|0
68651|NCT01326845|160004|P2|STARTED|Overall Study||5
68652|NCT01326845|160005|P1|STARTED|Overall Study||7
68653|NCT01326533|160029|P2|NOT COMPLETED|Overall Study||0
68654|NCT01326533|160030|P1|NOT COMPLETED|Overall Study||4
68655|NCT01326533|160029|P2|COMPLETED|Overall Study||15
68656|NCT01326533|160030|P1|COMPLETED|Overall Study||13
68657|NCT01326533|160029|P2|STARTED|Overall Study||15
68658|NCT01326533|160030|P1|STARTED|Overall Study||17
68659|NCT01326026|160040|P2|NOT COMPLETED|Overall Study||13
68660|NCT01326026|160041|P1|NOT COMPLETED|Overall Study||12
68661|NCT01326026|160040|P2|COMPLETED|Overall Study||98
68662|NCT01326026|160041|P1|COMPLETED|Overall Study||99
68663|NCT01326026|160040|P2|Exposed|Overall Study||111
68664|NCT01326026|160041|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
68665|NCT01326026|160040|P2|STARTED|Overall Study||111
68666|NCT01326026|160041|P1|STARTED|Overall Study||111
68667|NCT01325870|160058|P3|NOT COMPLETED|Overall Study||8
68668|NCT01325870|160059|P2|NOT COMPLETED|Overall Study||13
68669|NCT01325870|160060|P1|NOT COMPLETED|Overall Study||11
68670|NCT01325870|160058|P3|COMPLETED|Overall Study||6
68671|NCT01325870|160059|P2|COMPLETED|Overall Study||3
68672|NCT01325870|160060|P1|COMPLETED|Overall Study||7
68673|NCT01325870|160058|P3|STARTED|Overall Study||14
68674|NCT01325870|160059|P2|STARTED|Overall Study||16
68675|NCT01325870|160060|P1|STARTED|Overall Study||18
68676|NCT01325792|160074|P1|NOT COMPLETED|Overall Study||17
68677|NCT01325792|160074|P1|COMPLETED|Overall Study||87
68678|NCT01325792|160074|P1|STARTED|Overall Study||104
68679|NCT01325714|160081|P2|NOT COMPLETED|Overall Study||31
68680|NCT01325714|160082|P1|NOT COMPLETED|Overall Study||34
68681|NCT01325714|160081|P2|COMPLETED|Overall Study||71
68682|NCT01325714|160082|P1|COMPLETED|Overall Study||67
68683|NCT01325714|160081|P2|12 Month Assessment|Overall Study||71
68684|NCT01325714|160082|P1|12 Month Assessment|Overall Study||67
68685|NCT01325714|160081|P2|6 Month Asessment|Overall Study||82
68686|NCT01325714|160082|P1|6 Month Asessment|Overall Study||75
68687|NCT01325714|160081|P2|3 Month Assessment|Overall Study||86
68688|NCT01325714|160082|P1|3 Month Assessment|Overall Study||82
68689|NCT01325714|160081|P2|STARTED|Overall Study||102
68690|NCT01325714|160082|P1|STARTED|Overall Study||101
68691|NCT01325701|160106|P2|NOT COMPLETED|Overall Study||3
68692|NCT01325701|160107|P1|NOT COMPLETED|Overall Study||21
68693|NCT01325701|160106|P2|COMPLETED|Overall Study||5
68694|NCT01325701|160107|P1|COMPLETED|Overall Study||49
68695|NCT01325701|160106|P2|STARTED|Overall Study||8
68696|NCT01325701|160107|P1|STARTED|Overall Study||70
68697|NCT01325623|160117|P1|NOT COMPLETED|Overall Study||3
68698|NCT01325623|160117|P1|COMPLETED|Overall Study||28
68699|NCT01325623|160117|P1|STARTED|Overall Study||31
68700|NCT01325532|160161|P2|NOT COMPLETED|Overall Study||0
68701|NCT01325532|160162|P1|NOT COMPLETED|Overall Study||2
68702|NCT01325532|160161|P2|COMPLETED|Overall Study||13
68703|NCT01325532|160162|P1|COMPLETED|Overall Study||15
68704|NCT01325532|160161|P2|STARTED|Overall Study||13
68705|NCT01325532|160162|P1|STARTED|Overall Study||17
68706|NCT01325493|160174|P2|NOT COMPLETED|Overall Study||3
68707|NCT01325493|160175|P1|NOT COMPLETED|Overall Study||1
68708|NCT01325493|160174|P2|COMPLETED|Overall Study||21
68709|NCT01325493|160175|P1|COMPLETED|Overall Study||29
68710|NCT01325493|160174|P2|STARTED|Overall Study||24
68711|NCT01325493|160175|P1|STARTED|Overall Study||30
68712|NCT01325428|160187|P1|NOT COMPLETED|Part B||3
68713|NCT01325428|160187|P1|COMPLETED|Part B||7
68714|NCT01325428|160187|P1|STARTED|Part B||10
68715|NCT01325428|160187|P1|NOT COMPLETED|Part A||16
68716|NCT01325428|160187|P1|COMPLETED|Part A||10
68717|NCT01325428|160187|P1|STARTED|Part A||26
68718|NCT01325350|160207|P5|NOT COMPLETED|Overall Study||12
68719|NCT01325350|160208|P4|NOT COMPLETED|Overall Study||9
68720|NCT01325350|160209|P3|NOT COMPLETED|Overall Study||17
68721|NCT01325350|160210|P2|NOT COMPLETED|Overall Study||5
68722|NCT01325350|160211|P1|NOT COMPLETED|Overall Study||6
68723|NCT01325350|160207|P5|COMPLETED|Overall Study||50
68724|NCT01325350|160208|P4|COMPLETED|Overall Study||52
68725|NCT01325350|160209|P3|COMPLETED|Overall Study||44
68726|NCT01325350|160210|P2|COMPLETED|Overall Study||56
68727|NCT01325350|160211|P1|COMPLETED|Overall Study||55
68728|NCT01325350|160207|P5|STARTED|Overall Study||62
68729|NCT01325350|160208|P4|STARTED|Overall Study||61
68730|NCT01325350|160209|P3|STARTED|Overall Study||61
68731|NCT01325350|160210|P2|STARTED|Overall Study||61
68732|NCT01325350|160211|P1|STARTED|Overall Study||61
68733|NCT01325337|160253|P5|NOT COMPLETED|Overall Study||8
68734|NCT01325337|160254|P4|NOT COMPLETED|Overall Study||10
68735|NCT01325337|160255|P3|NOT COMPLETED|Overall Study||9
68736|NCT01325337|160256|P2|NOT COMPLETED|Overall Study||9
68737|NCT01325337|160257|P1|NOT COMPLETED|Overall Study||5
68738|NCT01325337|160253|P5|COMPLETED|Overall Study||53
68739|NCT01325337|160254|P4|COMPLETED|Overall Study||52
68740|NCT01325337|160255|P3|COMPLETED|Overall Study||53
68741|NCT01325337|160256|P2|COMPLETED|Overall Study||52
68742|NCT01325337|160257|P1|COMPLETED|Overall Study||56
68743|NCT01325337|160253|P5|STARTED|Overall Study||61
68744|NCT01325337|160254|P4|STARTED|Overall Study||62
68745|NCT01325337|160255|P3|STARTED|Overall Study||62
68746|NCT01325337|160256|P2|STARTED|Overall Study||61
68747|NCT01325337|160257|P1|STARTED|Overall Study||61
68748|NCT01325311|160296|P2|NOT COMPLETED|Overall Study||0
68749|NCT01325311|160297|P1|NOT COMPLETED|Overall Study||0
68750|NCT01325311|160296|P2|COMPLETED|Overall Study||7
68751|NCT01325311|160297|P1|COMPLETED|Overall Study||8
68752|NCT01325311|160296|P2|STARTED|Overall Study||7
68753|NCT01325311|160297|P1|STARTED|Overall Study||8
68754|NCT01325181|160333|P2|NOT COMPLETED|Overall Study||2
68755|NCT01325181|160334|P1|NOT COMPLETED|Overall Study||0
68756|NCT01325181|160333|P2|COMPLETED|Overall Study||14
68757|NCT01325181|160334|P1|COMPLETED|Overall Study||18
68758|NCT01325181|160333|P2|STARTED|Overall Study||16
68759|NCT01325181|160334|P1|STARTED|Overall Study||18
68760|NCT01324947|160340|P1|NOT COMPLETED|Overall Study||74
68761|NCT01324947|160340|P1|COMPLETED|Overall Study||0
68762|NCT01324947|160340|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
68763|NCT01324947|160340|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
68764|NCT01324947|160340|P1|STARTED|Overall Study||74
68765|NCT01324882|160353|P2|NOT COMPLETED|Overall Study||0
68766|NCT01324882|160354|P1|NOT COMPLETED|Overall Study||0
68767|NCT01324882|160353|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
68768|NCT01324882|160354|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
68769|NCT01324882|160353|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
68770|NCT01324882|160354|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
68771|NCT01324687|160362|P2|NOT COMPLETED|Overall Study||15
68772|NCT01324687|160363|P1|NOT COMPLETED|Overall Study||0
68773|NCT01324687|160362|P2|COMPLETED|Overall Study||479
68774|NCT01324687|160363|P1|COMPLETED|Overall Study||1058
68775|NCT01324687|160362|P2|STARTED|Overall Study||494
68776|NCT01324687|160363|P1|STARTED|Overall Study||1058
68777|NCT01324440|160371|P2|NOT COMPLETED|Overall Study||1
68778|NCT01324440|160372|P1|NOT COMPLETED|Overall Study||0
68779|NCT01324440|160371|P2|COMPLETED|Overall Study||31
68780|NCT01324440|160372|P1|COMPLETED|Overall Study||32
68781|NCT01324440|160371|P2|STARTED|Overall Study||32
68782|NCT01324440|160372|P1|STARTED|Overall Study||32
68783|NCT01324401|160386|P2|NOT COMPLETED|Overall Study||7
68784|NCT01324401|160387|P1|NOT COMPLETED|Overall Study||1
68785|NCT01324401|160386|P2|COMPLETED|Overall Study||19
68786|NCT01324401|160387|P1|COMPLETED|Overall Study||3
68787|NCT01324401|160386|P2|STARTED|Overall Study||26
68788|NCT01324401|160387|P1|STARTED|Overall Study||4
68789|NCT01324388|160398|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
68790|NCT01324388|160399|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
68791|NCT01324388|160400|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
68792|NCT01324388|160401|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
68793|NCT01324388|160398|P4|COMPLETED|Part 2 of Study: Second Intervention||9
68794|NCT01324388|160399|P3|COMPLETED|Part 2 of Study: Second Intervention||9
68795|NCT01324388|160400|P2|COMPLETED|Part 2 of Study: Second Intervention||0
68796|NCT01324388|160401|P1|COMPLETED|Part 2 of Study: Second Intervention||0
68797|NCT01324388|160398|P4|STARTED|Part 2 of Study: Second Intervention||9
68798|NCT01324388|160399|P3|STARTED|Part 2 of Study: Second Intervention||10
68799|NCT01324388|160400|P2|STARTED|Part 2 of Study: Second Intervention||0
68800|NCT01324388|160401|P1|STARTED|Part 2 of Study: Second Intervention||0
68801|NCT01324388|160398|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
68802|NCT01324388|160399|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
68803|NCT01324388|160400|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
68804|NCT01324388|160401|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
68805|NCT01324388|160398|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
68806|NCT01324388|160399|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
68807|NCT01324388|160400|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
68808|NCT01324388|160401|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
68809|NCT01324388|160398|P4|STARTED|Part 2: Washout of at Least 21 Days||9
68810|NCT01324388|160399|P3|STARTED|Part 2: Washout of at Least 21 Days||10
68811|NCT01324388|160400|P2|STARTED|Part 2: Washout of at Least 21 Days||0
68812|NCT01324388|160401|P1|STARTED|Part 2: Washout of at Least 21 Days||0
68813|NCT01324388|160398|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
68814|NCT01324388|160399|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
68815|NCT01324388|160400|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
68816|NCT01324388|160401|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
68817|NCT01324388|160398|P4|COMPLETED|Part 2 of Study: First Intervention||9
68818|NCT01324388|160399|P3|COMPLETED|Part 2 of Study: First Intervention||10
68819|NCT01324388|160400|P2|COMPLETED|Part 2 of Study: First Intervention||0
68820|NCT01324388|160401|P1|COMPLETED|Part 2 of Study: First Intervention||0
68821|NCT01324388|160398|P4|STARTED|Part 2 of Study: First Intervention||10
68822|NCT01324388|160399|P3|STARTED|Part 2 of Study: First Intervention||10
68823|NCT01324388|160400|P2|STARTED|Part 2 of Study: First Intervention||0
68824|NCT01324388|160401|P1|STARTED|Part 2 of Study: First Intervention||0
68825|NCT01324388|160398|P4|NOT COMPLETED|Part 1 of Study||0
68826|NCT01324388|160399|P3|NOT COMPLETED|Part 1 of Study||0
68827|NCT01324388|160400|P2|NOT COMPLETED|Part 1 of Study||2
68828|NCT01324388|160401|P1|NOT COMPLETED|Part 1 of Study||4
68829|NCT01324388|160398|P4|COMPLETED|Part 1 of Study||0
68830|NCT01324388|160399|P3|COMPLETED|Part 1 of Study||0
68831|NCT01324388|160400|P2|COMPLETED|Part 1 of Study||6
68832|NCT01324388|160401|P1|COMPLETED|Part 1 of Study||19
68833|NCT01324388|160398|P4|Received at Least 1 Dose|Part 1 of Study||0
68834|NCT01324388|160399|P3|Received at Least 1 Dose|Part 1 of Study||0
68835|NCT01324388|160400|P2|Received at Least 1 Dose|Part 1 of Study||8
68836|NCT01324388|160401|P1|Received at Least 1 Dose|Part 1 of Study||23
68837|NCT01324388|160398|P4|STARTED|Part 1 of Study||0
68838|NCT01324388|160399|P3|STARTED|Part 1 of Study||0
68839|NCT01324388|160400|P2|STARTED|Part 1 of Study||8
68840|NCT01324388|160401|P1|STARTED|Part 1 of Study||23
68841|NCT01324349|160422|P2|NOT COMPLETED|Overall Study||2
68842|NCT01324349|160423|P1|NOT COMPLETED|Overall Study||1
68843|NCT01324349|160422|P2|COMPLETED|Overall Study||16
68844|NCT01324349|160423|P1|COMPLETED|Overall Study||31
68845|NCT01324349|160422|P2|STARTED|Overall Study||18
68846|NCT01324349|160423|P1|STARTED|Overall Study||32
68847|NCT01324323|160433|P1|NOT COMPLETED|Overall Study||1
68848|NCT01324323|160433|P1|COMPLETED|Overall Study||13
68849|NCT01324323|160433|P1|STARTED|Overall Study||14
68850|NCT01324310|160453|P1|NOT COMPLETED|Overall Study||2
68851|NCT01324310|160453|P1|COMPLETED|Overall Study||13
68852|NCT01324310|160453|P1|STARTED|Overall Study||15
68853|NCT01324271|160473|P2|NOT COMPLETED|Overall Study||0
68854|NCT01324271|160474|P1|NOT COMPLETED|Overall Study||4
68855|NCT01324271|160473|P2|COMPLETED|Overall Study||28
68856|NCT01324271|160474|P1|COMPLETED|Overall Study||53
68857|NCT01324271|160473|P2|STARTED|Overall Study||28
68858|NCT01324271|160474|P1|STARTED|Overall Study||57
68859|NCT01324128|160482|P4|NOT COMPLETED|Stage 2||3
68860|NCT01324128|160483|P3|NOT COMPLETED|Stage 2||8
68861|NCT01324128|160484|P2|NOT COMPLETED|Stage 2||0
68862|NCT01324128|160485|P1|NOT COMPLETED|Stage 2||0
68863|NCT01324128|160482|P4|COMPLETED|Stage 2||46
68864|NCT01324128|160483|P3|COMPLETED|Stage 2||42
68865|NCT01324128|160484|P2|COMPLETED|Stage 2||0
68866|NCT01324128|160485|P1|COMPLETED|Stage 2||0
68867|NCT01324128|160482|P4|STARTED|Stage 2||49
68868|NCT01324128|160483|P3|STARTED|Stage 2||50
68869|NCT01324128|160484|P2|STARTED|Stage 2||0
68870|NCT01324128|160485|P1|STARTED|Stage 2||0
68871|NCT01324128|160482|P4|NOT COMPLETED|Stage 1||0
68872|NCT01324128|160483|P3|NOT COMPLETED|Stage 1||0
68873|NCT01324128|160484|P2|NOT COMPLETED|Stage 1||56
68874|NCT01324128|160485|P1|NOT COMPLETED|Stage 1||195
68875|NCT01324128|160482|P4|COMPLETED|Stage 1||0
68876|NCT01324128|160483|P3|COMPLETED|Stage 1||0
68877|NCT01324128|160484|P2|COMPLETED|Stage 1||293
68878|NCT01324128|160485|P1|COMPLETED|Stage 1||515
68879|NCT01324128|160482|P4|STARTED|Stage 1||0
68880|NCT01324128|160483|P3|STARTED|Stage 1||0
68881|NCT01324128|160484|P2|STARTED|Stage 1||349
68882|NCT01324128|160485|P1|STARTED|Stage 1||710
68883|NCT01324102|160497|P2|NOT COMPLETED|Overall Study||6
68884|NCT01324102|160498|P1|NOT COMPLETED|Overall Study||1
68885|NCT01324102|160497|P2|COMPLETED|Overall Study||6
68886|NCT01324102|160498|P1|COMPLETED|Overall Study||10
68887|NCT01324102|160497|P2|STARTED|Overall Study|Yoga group 4 and 6|12
68888|NCT01324102|160498|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
68889|NCT01323998|160510|P5|NOT COMPLETED|Overall Study||0
68890|NCT01323998|160511|P4|NOT COMPLETED|Overall Study||0
68891|NCT01323998|160512|P3|NOT COMPLETED|Overall Study||0
68892|NCT01323998|160513|P2|NOT COMPLETED|Overall Study||0
68893|NCT01323998|160514|P1|NOT COMPLETED|Overall Study||0
68894|NCT01323998|160510|P5|COMPLETED|Overall Study||6735
68895|NCT01323998|160511|P4|COMPLETED|Overall Study||12052
68896|NCT01323998|160512|P3|COMPLETED|Overall Study||10294
68897|NCT01323998|160513|P2|COMPLETED|Overall Study||18681
68898|NCT01323998|160514|P1|COMPLETED|Overall Study||200631
68899|NCT01323998|160510|P5|STARTED|Overall Study||6735
68900|NCT01323998|160511|P4|STARTED|Overall Study||12052
68901|NCT01323998|160512|P3|STARTED|Overall Study||10294
68902|NCT01323998|160513|P2|STARTED|Overall Study||18681
68903|NCT01323998|160514|P1|STARTED|Overall Study||200631
68904|NCT01323920|160526|P1|NOT COMPLETED|Overall Study||6
68905|NCT01323920|160526|P1|COMPLETED|Overall Study||29
68906|NCT01323920|160526|P1|STARTED|Overall Study||35
68907|NCT01323855|160538|P5|NOT COMPLETED|Overall Study||0
68908|NCT01323855|160539|P4|NOT COMPLETED|Overall Study||0
68909|NCT01323855|160540|P3|NOT COMPLETED|Overall Study||0
68910|NCT01323855|160541|P2|NOT COMPLETED|Overall Study||0
68911|NCT01323855|160542|P1|NOT COMPLETED|Overall Study||0
68912|NCT01323855|160538|P5|COMPLETED|Overall Study||11
68913|NCT01323855|160539|P4|COMPLETED|Overall Study||9
68914|NCT01323855|160540|P3|COMPLETED|Overall Study||8
68915|NCT01323855|160541|P2|COMPLETED|Overall Study||9
68916|NCT01323855|160542|P1|COMPLETED|Overall Study||9
68917|NCT01323855|160538|P5|STARTED|Overall Study||11
68918|NCT01323855|160539|P4|STARTED|Overall Study||9
68919|NCT01323855|160540|P3|STARTED|Overall Study||8
68920|NCT01323855|160541|P2|STARTED|Overall Study||9
68921|NCT01323855|160542|P1|STARTED|Overall Study||9
68922|NCT01323790|160567|P3|NOT COMPLETED|Overall Study||45
68923|NCT01323790|160568|P2|NOT COMPLETED|Overall Study||60
68924|NCT01323790|160569|P1|NOT COMPLETED|Overall Study||55
68925|NCT01323790|160567|P3|COMPLETED|Overall Study||188
68926|NCT01323790|160568|P2|COMPLETED|Overall Study||174
68927|NCT01323790|160569|P1|COMPLETED|Overall Study||178
68928|NCT01323790|160567|P3|STARTED|Overall Study||233
68929|NCT01323790|160568|P2|STARTED|Overall Study||234
68930|NCT01323790|160569|P1|STARTED|Overall Study||233
68931|NCT01323673|160609|P2|NOT COMPLETED|Overall Study||5
68932|NCT01323673|160610|P1|NOT COMPLETED|Overall Study||3
68933|NCT01323673|160609|P2|COMPLETED|Overall Study||58
68934|NCT01323673|160610|P1|COMPLETED|Overall Study||59
68935|NCT01323673|160609|P2|STARTED|Overall Study||63
68936|NCT01323673|160610|P1|STARTED|Overall Study||62
68937|NCT01323660|160630|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
68938|NCT01323660|160631|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
68939|NCT01323660|160632|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
68940|NCT01323660|160633|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
68941|NCT01323660|160634|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
68942|NCT01323660|160635|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
68943|NCT01323660|160630|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
68944|NCT01323660|160631|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
68945|NCT01323660|160632|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
68946|NCT01323660|160633|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
68947|NCT01323660|160634|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
68948|NCT01323660|160635|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
68949|NCT01323660|160630|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
68950|NCT01323660|160631|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
68951|NCT01323660|160632|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
68952|NCT01323660|160633|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
68953|NCT01323660|160634|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
68954|NCT01323660|160635|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
68955|NCT01323660|160630|P6|NOT COMPLETED|Washout Period (14 Days)||2
68956|NCT01323660|160631|P5|NOT COMPLETED|Washout Period (14 Days)||3
68957|NCT01323660|160632|P4|NOT COMPLETED|Washout Period (14 Days)||3
68958|NCT01323660|160633|P3|NOT COMPLETED|Washout Period (14 Days)||1
68959|NCT01323660|160634|P2|NOT COMPLETED|Washout Period (14 Days)||0
68960|NCT01323660|160635|P1|NOT COMPLETED|Washout Period (14 Days)||0
68961|NCT01323660|160630|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
68962|NCT01323660|160631|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
68963|NCT01323660|160632|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
68964|NCT01323660|160633|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
68965|NCT01323660|160634|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
68966|NCT01323660|160635|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
68967|NCT01323660|160630|P6|STARTED|Washout Period (14 Days)||61
68968|NCT01323660|160631|P5|STARTED|Washout Period (14 Days)||61
68969|NCT01323660|160632|P4|STARTED|Washout Period (14 Days)||31
68970|NCT01323660|160633|P3|STARTED|Washout Period (14 Days)||19
68971|NCT01323660|160634|P2|STARTED|Washout Period (14 Days)||21
68972|NCT01323660|160635|P1|STARTED|Washout Period (14 Days)||65
68973|NCT01323660|160630|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
68974|NCT01323660|160631|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
68975|NCT01323660|160632|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
68976|NCT01323660|160633|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
68977|NCT01323660|160634|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
68978|NCT01323660|160635|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
68979|NCT01323660|160630|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
68980|NCT01323660|160631|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
68981|NCT01323660|160632|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
68982|NCT01323660|160633|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
68983|NCT01323660|160634|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
68984|NCT01323660|160635|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
68985|NCT01323660|160630|P6|STARTED|Treatment Period 1 (12 Weeks)||70
68986|NCT01323660|160631|P5|STARTED|Treatment Period 1 (12 Weeks)||71
68987|NCT01323660|160632|P4|STARTED|Treatment Period 1 (12 Weeks)||36
68988|NCT01323660|160633|P3|STARTED|Treatment Period 1 (12 Weeks)||24
68989|NCT01323660|160634|P2|STARTED|Treatment Period 1 (12 Weeks)||22
68990|NCT01323660|160635|P1|STARTED|Treatment Period 1 (12 Weeks)||84
68991|NCT01323647|160681|P2|NOT COMPLETED|Overall Study||0
68992|NCT01323647|160682|P1|NOT COMPLETED|Overall Study||9
68993|NCT01323647|160681|P2|COMPLETED|Overall Study||487
68994|NCT01323647|160682|P1|COMPLETED|Overall Study||461
68995|NCT01323647|160681|P2|STARTED|Overall Study||487
68996|NCT01323647|160682|P1|STARTED|Overall Study||470
68997|NCT01323634|160699|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
68998|NCT01323634|160700|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
68999|NCT01323634|160701|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
69000|NCT01323634|160699|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
69001|NCT01323634|160700|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
69002|NCT01323634|160701|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
69003|NCT01323634|160699|P3|STARTED|Double-Blind (DB) Treatment Period||261
69004|NCT01323634|160700|P2|STARTED|Double-Blind (DB) Treatment Period||260
69005|NCT01323634|160701|P1|STARTED|Double-Blind (DB) Treatment Period||0
69006|NCT01323634|160699|P3|NOT COMPLETED|2-week Run-in Period||0
69007|NCT01323634|160700|P2|NOT COMPLETED|2-week Run-in Period||0
69008|NCT01323634|160701|P1|NOT COMPLETED|2-week Run-in Period||212
69009|NCT01323634|160699|P3|COMPLETED|2-week Run-in Period||0
69010|NCT01323634|160700|P2|COMPLETED|2-week Run-in Period||0
69011|NCT01323634|160701|P1|COMPLETED|2-week Run-in Period||521
69012|NCT01323634|160699|P3|STARTED|2-week Run-in Period||0
69013|NCT01323634|160700|P2|STARTED|2-week Run-in Period||0
69014|NCT01323634|160701|P1|STARTED|2-week Run-in Period||733
69015|NCT01323621|160711|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
69016|NCT01323621|160712|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
69017|NCT01323621|160713|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
69018|NCT01323621|160711|P3|COMPLETED|12-week, Double-blind Treatment Period||239
69019|NCT01323621|160712|P2|COMPLETED|12-week, Double-blind Treatment Period||237
69020|NCT01323621|160713|P1|COMPLETED|12-week, Double-blind Treatment Period||0
69021|NCT01323621|160711|P3|STARTED|12-week, Double-blind Treatment Period||259
69022|NCT01323621|160712|P2|STARTED|12-week, Double-blind Treatment Period||252
69023|NCT01323621|160713|P1|STARTED|12-week, Double-blind Treatment Period||0
69024|NCT01323621|160711|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
69025|NCT01323621|160712|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
69026|NCT01323621|160713|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
69027|NCT01323621|160711|P3|COMPLETED|2-week, Single-blind Run In Period||0
69028|NCT01323621|160712|P2|COMPLETED|2-week, Single-blind Run In Period||0
69029|NCT01323621|160713|P1|COMPLETED|2-week, Single-blind Run In Period||511
69030|NCT01323621|160711|P3|STARTED|2-week, Single-blind Run In Period||0
69031|NCT01323621|160712|P2|STARTED|2-week, Single-blind Run In Period||0
69032|NCT01323621|160713|P1|STARTED|2-week, Single-blind Run In Period||739
69033|NCT01323595|160723|P2|NOT COMPLETED|Overall Study||21
69034|NCT01323595|160724|P1|NOT COMPLETED|Overall Study||23
69035|NCT01323595|160723|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
69036|NCT01323595|160724|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
69037|NCT01323595|160723|P2|STARTED|Overall Study||39
69038|NCT01323595|160724|P1|STARTED|Overall Study||39
69039|NCT01323582|160732|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
69040|NCT01323582|160733|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
69041|NCT01323582|160732|P2|COMPLETED|Weeks 8-11 (Period 2)||10
69042|NCT01323582|160733|P1|COMPLETED|Weeks 8-11 (Period 2)||10
69043|NCT01323582|160732|P2|STARTED|Weeks 8-11 (Period 2)||11
69044|NCT01323582|160733|P1|STARTED|Weeks 8-11 (Period 2)||10
69045|NCT01323582|160732|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
69046|NCT01323582|160733|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
69047|NCT01323582|160732|P2|COMPLETED|Weeks 5-7 (Washout)||11
69048|NCT01323582|160733|P1|COMPLETED|Weeks 5-7 (Washout)||10
69049|NCT01323582|160732|P2|STARTED|Weeks 5-7 (Washout)||12
69050|NCT01323582|160733|P1|STARTED|Weeks 5-7 (Washout)||10
69051|NCT01323582|160732|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
69052|NCT01323582|160733|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
69053|NCT01323582|160732|P2|COMPLETED|Weeks 1-4 (First Period)||12
69054|NCT01323582|160733|P1|COMPLETED|Weeks 1-4 (First Period)||10
69055|NCT01323582|160732|P2|STARTED|Weeks 1-4 (First Period)||14
69056|NCT01323582|160733|P1|STARTED|Weeks 1-4 (First Period)||12
69057|NCT01323478|160749|P1|NOT COMPLETED|Overall Study||24
69058|NCT01323478|160749|P1|COMPLETED|Overall Study||47
69059|NCT01323478|160749|P1|STARTED|Overall Study||71
69060|NCT01323270|160764|P2|NOT COMPLETED|Overall Study||29
69061|NCT01323270|160765|P1|NOT COMPLETED|Overall Study||43
69062|NCT01323270|160764|P2|COMPLETED|Overall Study||347
69063|NCT01323270|160765|P1|COMPLETED|Overall Study||330
69064|NCT01323270|160764|P2|STARTED|Overall Study||376
69065|NCT01323270|160765|P1|STARTED|Overall Study||373
69066|NCT01323192|160787|P2|NOT COMPLETED|Overall Study||6
69067|NCT01323192|160788|P1|NOT COMPLETED|Overall Study||9
69068|NCT01323192|160787|P2|COMPLETED|Overall Study||135
69069|NCT01323192|160788|P1|COMPLETED|Overall Study||134
69070|NCT01323192|160787|P2|STARTED|Overall Study||141
69071|NCT01323192|160788|P1|STARTED|Overall Study||143
69072|NCT01323140|160804|P1|NOT COMPLETED|Overall Study||2
69073|NCT01323140|160804|P1|COMPLETED|Overall Study||38
69074|NCT01323140|160804|P1|STARTED|Overall Study||40
69075|NCT01323010|160810|P2|NOT COMPLETED|Overall Study||0
69076|NCT01323010|160811|P1|NOT COMPLETED|Overall Study||0
69077|NCT01323010|160810|P2|COMPLETED|Overall Study||59
69078|NCT01323010|160811|P1|COMPLETED|Overall Study||60
69079|NCT01323010|160810|P2|STARTED|Overall Study||59
69080|NCT01323010|160811|P1|STARTED|Overall Study||60
69081|NCT01322971|160862|P2|NOT COMPLETED|Overall Study||1
69082|NCT01322971|160863|P1|NOT COMPLETED|Overall Study||1
69083|NCT01322971|160862|P2|COMPLETED|Overall Study||0
69084|NCT01322971|160863|P1|COMPLETED|Overall Study||0
69085|NCT01322971|160862|P2|STARTED|Overall Study||1
69086|NCT01322971|160863|P1|STARTED|Overall Study||1
69087|NCT01322945|160877|P2|NOT COMPLETED|Overall Study||0
69088|NCT01322945|160878|P1|NOT COMPLETED|Overall Study||0
69089|NCT01322945|160877|P2|COMPLETED|Overall Study||42
69090|NCT01322945|160878|P1|COMPLETED|Overall Study||52
69091|NCT01322945|160877|P2|STARTED|Overall Study||42
69092|NCT01322945|160878|P1|STARTED|Overall Study||52
69093|NCT01322841|160888|P2|NOT COMPLETED|Overall Study||0
69094|NCT01322841|160889|P1|NOT COMPLETED|Overall Study||0
69095|NCT01322841|160888|P2|COMPLETED|Overall Study||1123
69096|NCT01322841|160889|P1|COMPLETED|Overall Study||1116
69097|NCT01322841|160888|P2|STARTED|Overall Study||1123
69098|NCT01322841|160889|P1|STARTED|Overall Study||1116
69099|NCT01322815|160899|P2|NOT COMPLETED|Overall Study||0
69100|NCT01322815|160900|P1|NOT COMPLETED|Overall Study||0
69101|NCT01322815|160899|P2|COMPLETED|Overall Study||4
69102|NCT01322815|160900|P1|COMPLETED|Overall Study||7
69103|NCT01322815|160899|P2|STARTED|Overall Study||4
69104|NCT01322815|160900|P1|STARTED|Overall Study||7
69105|NCT01322633|160908|P2|NOT COMPLETED|Overall Study||0
69106|NCT01322633|160909|P1|NOT COMPLETED|Overall Study||0
69107|NCT01322633|160908|P2|COMPLETED|Overall Study||27686
69108|NCT01322633|160909|P1|COMPLETED|Overall Study||34178
69109|NCT01322633|160908|P2|STARTED|Overall Study||27686
69110|NCT01322633|160909|P1|STARTED|Overall Study||34178
69111|NCT01322607|160921|P2|NOT COMPLETED|Overall Study||0
69112|NCT01322607|160922|P1|NOT COMPLETED|Overall Study||1
69113|NCT01322607|160921|P2|COMPLETED|Overall Study||9
69114|NCT01322607|160922|P1|COMPLETED|Overall Study||10
69115|NCT01322607|160921|P2|STARTED|Overall Study||9
69116|NCT01322607|160922|P1|STARTED|Overall Study||11
69117|NCT01322594|160940|P6|NOT COMPLETED|Overall Study||0
69118|NCT01322594|160941|P5|NOT COMPLETED|Overall Study||0
69119|NCT01322594|160942|P4|NOT COMPLETED|Overall Study||0
69120|NCT01322594|160943|P3|NOT COMPLETED|Overall Study||0
69121|NCT01322594|160944|P2|NOT COMPLETED|Overall Study||0
69122|NCT01322594|160945|P1|NOT COMPLETED|Overall Study||0
69123|NCT01322594|160940|P6|COMPLETED|Overall Study||6
69124|NCT01322594|160941|P5|COMPLETED|Overall Study||7
69125|NCT01322594|160942|P4|COMPLETED|Overall Study||6
69126|NCT01322594|160943|P3|COMPLETED|Overall Study||3
69127|NCT01322594|160944|P2|COMPLETED|Overall Study||3
69128|NCT01322594|160945|P1|COMPLETED|Overall Study||6
69129|NCT01322594|160940|P6|STARTED|Overall Study||6
69130|NCT01322594|160941|P5|STARTED|Overall Study||7
69131|NCT01322594|160942|P4|STARTED|Overall Study||6
69132|NCT01322594|160943|P3|STARTED|Overall Study||3
69133|NCT01322594|160944|P2|STARTED|Overall Study||3
69134|NCT01322594|160945|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
69135|NCT01322386|161027|P2|NOT COMPLETED|Overall Study||2
69136|NCT01322386|161028|P1|NOT COMPLETED|Overall Study||0
69137|NCT01322386|161027|P2|COMPLETED|Overall Study||9
69138|NCT01322386|161028|P1|COMPLETED|Overall Study||10
69139|NCT01322386|161027|P2|STARTED|Overall Study||11
69140|NCT01322386|161028|P1|STARTED|Overall Study||10
69141|NCT01322360|161036|P1|NOT COMPLETED|Overall Study||0
69142|NCT01322360|161036|P1|COMPLETED|Overall Study||50
69143|NCT01322360|161036|P1|STARTED|Overall Study||50
69144|NCT01322347|161043|P2|NOT COMPLETED|Overall Study||35
69145|NCT01322347|161044|P1|NOT COMPLETED|Overall Study||51
69146|NCT01322347|161043|P2|COMPLETED|Overall Study||112
69147|NCT01322347|161044|P1|COMPLETED|Overall Study||96
69148|NCT01322347|161043|P2|Completed St 3|Overall Study||86
69149|NCT01322347|161044|P1|Completed St 3|Overall Study||82
69150|NCT01322347|161043|P2|Enrolled in St 3|Overall Study||113
69151|NCT01322347|161044|P1|Enrolled in St 3|Overall Study||101
69152|NCT01322347|161043|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
69153|NCT01322347|161044|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
69154|NCT01322347|161043|P2|Completed 48 Wks in St 2|Overall Study||22
69155|NCT01322347|161044|P1|Completed 48 Wks in St 2|Overall Study||28
69156|NCT01322347|161043|P2|STARTED|Overall Study||147
69157|NCT01322347|161044|P1|STARTED|Overall Study||147
69158|NCT01322022|161081|P2|NOT COMPLETED|Overall Study||2
69159|NCT01322022|161082|P1|NOT COMPLETED|Overall Study||5
69160|NCT01322022|161081|P2|COMPLETED|Overall Study||18
69161|NCT01322022|161082|P1|COMPLETED|Overall Study||15
69162|NCT01322022|161081|P2|Week 4|Overall Study||18
69163|NCT01322022|161082|P1|Week 4|Overall Study||15
69164|NCT01322022|161081|P2|STARTED|Overall Study||20
69165|NCT01322022|161082|P1|STARTED|Overall Study||20
69166|NCT01322009|161096|P2|NOT COMPLETED|Overall Study||3
69167|NCT01322009|161097|P1|NOT COMPLETED|Overall Study||0
69168|NCT01322009|161096|P2|COMPLETED|Overall Study||4
69169|NCT01322009|161097|P1|COMPLETED|Overall Study||7
69170|NCT01322009|161096|P2|STARTED|Overall Study||7
69171|NCT01322009|161097|P1|STARTED|Overall Study||7
69172|NCT01321749|161107|P2|NOT COMPLETED|Overall Study||22
69173|NCT01321749|161108|P1|NOT COMPLETED|Overall Study||13
69174|NCT01321749|161107|P2|COMPLETED|Overall Study||30
69175|NCT01321749|161108|P1|COMPLETED|Overall Study||38
69176|NCT01321749|161107|P2|STARTED|Overall Study||52
69177|NCT01321749|161108|P1|STARTED|Overall Study||51
69178|NCT01321723|161117|P3|NOT COMPLETED|Overall Study||4
69179|NCT01321723|161118|P2|NOT COMPLETED|Overall Study||5
69180|NCT01321723|161119|P1|NOT COMPLETED|Overall Study||5
69181|NCT01321723|161117|P3|COMPLETED|Overall Study||28
69182|NCT01321723|161118|P2|COMPLETED|Overall Study||28
69183|NCT01321723|161119|P1|COMPLETED|Overall Study||27
69184|NCT01321723|161117|P3|STARTED|Overall Study||32
69185|NCT01321723|161118|P2|STARTED|Overall Study||33
69186|NCT01321723|161119|P1|STARTED|Overall Study||32
69187|NCT01321710|161141|P3|NOT COMPLETED|Overall Study||0
69188|NCT01321710|161142|P2|NOT COMPLETED|Overall Study||5
69189|NCT01321710|161143|P1|NOT COMPLETED|Overall Study||4
69190|NCT01321710|161141|P3|COMPLETED|Overall Study||44
69191|NCT01321710|161142|P2|COMPLETED|Overall Study||53
69192|NCT01321710|161143|P1|COMPLETED|Overall Study||46
69193|NCT01321710|161141|P3|STARTED|Overall Study||44
69194|NCT01321710|161142|P2|STARTED|Overall Study||58
69195|NCT01321710|161143|P1|STARTED|Overall Study||50
69196|NCT01321697|161158|P1|NOT COMPLETED|Overall Study||7
69197|NCT01321697|161158|P1|COMPLETED|Overall Study||0
69198|NCT01321697|161158|P1|STARTED|Overall Study||7
69199|NCT01321554|161164|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
69200|NCT01321554|161165|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
69201|NCT01321554|161166|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
69202|NCT01321554|161167|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
69203|NCT01321554|161164|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
69204|NCT01321554|161165|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
69205|NCT01321554|161166|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
69206|NCT01321554|161167|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
69207|NCT01321554|161164|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
69208|NCT01321554|161165|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
69209|NCT01321554|161166|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
69210|NCT01321554|161167|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
69211|NCT01321554|161164|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
69212|NCT01321554|161165|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
69213|NCT01321554|161166|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
69214|NCT01321554|161167|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
69215|NCT01321554|161164|P4|STARTED|OOL Lenvatinib Treatment Period||27
69216|NCT01321554|161165|P3|STARTED|OOL Lenvatinib Treatment Period||82
69217|NCT01321554|161166|P2|STARTED|OOL Lenvatinib Treatment Period||0
69218|NCT01321554|161167|P1|STARTED|OOL Lenvatinib Treatment Period||0
69219|NCT01321554|161164|P4|NOT COMPLETED|Randomization Phase||0
69220|NCT01321554|161165|P3|NOT COMPLETED|Randomization Phase||0
69221|NCT01321554|161166|P2|NOT COMPLETED|Randomization Phase||4
69222|NCT01321554|161167|P1|NOT COMPLETED|Randomization Phase||45
69223|NCT01321554|161164|P4|COMPLETED|Randomization Phase||0
69224|NCT01321554|161165|P3|COMPLETED|Randomization Phase||0
69225|NCT01321554|161166|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
69226|NCT01321554|161167|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
69227|NCT01321554|161164|P4|Discontinued Due to Disease Progression|Randomization Phase||0
69228|NCT01321554|161165|P3|Discontinued Due to Disease Progression|Randomization Phase||0
69229|NCT01321554|161166|P2|Discontinued Due to Disease Progression|Randomization Phase||119
69230|NCT01321554|161167|P1|Discontinued Due to Disease Progression|Randomization Phase||94
69231|NCT01321554|161164|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
69232|NCT01321554|161165|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
69233|NCT01321554|161166|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
69234|NCT01321554|161167|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
69235|NCT01321554|161164|P4|STARTED|Randomization Phase||0
69236|NCT01321554|161165|P3|STARTED|Randomization Phase||0
69237|NCT01321554|161166|P2|STARTED|Randomization Phase||131
69238|NCT01321554|161167|P1|STARTED|Randomization Phase||261
69239|NCT01321008|161180|P1|NOT COMPLETED|Overall Study||1
69240|NCT01321008|161180|P1|COMPLETED|Overall Study||0
69241|NCT01321008|161180|P1|STARTED|Overall Study||1
69242|NCT01320826|161184|P1|NOT COMPLETED|Overall Study||0
69243|NCT01320826|161184|P1|COMPLETED|Overall Study||577
69244|NCT01320826|161184|P1|STARTED|Overall Study||577
69245|NCT01320735|161199|P1|NOT COMPLETED|Overall Study||106
69246|NCT01320735|161199|P1|COMPLETED|Overall Study||194
69247|NCT01320735|161199|P1|STARTED|Overall Study||300
69248|NCT01320683|161216|P1|NOT COMPLETED|Overall Study||1
69249|NCT01320683|161216|P1|COMPLETED|Overall Study||0
69250|NCT01320683|161216|P1|STARTED|Overall Study||1
69251|NCT01320553|161225|P4|NOT COMPLETED|Overall Study||1
69252|NCT01320553|161226|P3|NOT COMPLETED|Overall Study||2
69253|NCT01320553|161227|P2|NOT COMPLETED|Overall Study||4
69254|NCT01320553|161228|P1|NOT COMPLETED|Overall Study||1
69255|NCT01320553|161225|P4|COMPLETED|Overall Study||29
69256|NCT01320553|161226|P3|COMPLETED|Overall Study||29
69257|NCT01320553|161227|P2|COMPLETED|Overall Study||26
69258|NCT01320553|161228|P1|COMPLETED|Overall Study||30
69259|NCT01320553|161225|P4|STARTED|Overall Study||30
69260|NCT01320553|161226|P3|STARTED|Overall Study||31
69261|NCT01320553|161227|P2|STARTED|Overall Study||30
69262|NCT01320553|161228|P1|STARTED|Overall Study||31
69263|NCT01320293|161242|P1|NOT COMPLETED|Overall Study||2
69264|NCT01320293|161242|P1|COMPLETED|Overall Study||16
69265|NCT01320293|161242|P1|STARTED|Overall Study||18
69266|NCT01320202|161250|P2|NOT COMPLETED|Overall Study||44
69267|NCT01320202|161251|P1|NOT COMPLETED|Overall Study||56
69268|NCT01320202|161250|P2|COMPLETED|Overall Study||109
69269|NCT01320202|161251|P1|COMPLETED|Overall Study||96
69270|NCT01320202|161250|P2|Completed St 3|Overall Study||82
69271|NCT01320202|161251|P1|Completed St 3|Overall Study||79
69272|NCT01320202|161250|P2|Enrolled in St 3|Overall Study||109
69273|NCT01320202|161251|P1|Enrolled in St 3|Overall Study||98
69274|NCT01320202|161250|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
69275|NCT01320202|161251|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
69276|NCT01320202|161250|P2|Comp 48 Wks in St 2|Overall Study||27
69277|NCT01320202|161251|P1|Comp 48 Wks in St 2|Overall Study||27
69278|NCT01320202|161250|P2|STARTED|Overall Study||153
69279|NCT01320202|161251|P1|STARTED|Overall Study||152
69280|NCT01320137|161288|P2|NOT COMPLETED|Overall Study||0
69281|NCT01320137|161289|P1|NOT COMPLETED|Overall Study||0
69282|NCT01320137|161288|P2|COMPLETED|Overall Study||40
69283|NCT01320137|161289|P1|COMPLETED|Overall Study||40
69284|NCT01320137|161288|P2|STARTED|Overall Study||40
69285|NCT01320137|161289|P1|STARTED|Overall Study||40
69286|NCT01320072|161303|P2|NOT COMPLETED|Overall Study||0
69287|NCT01320072|161304|P1|NOT COMPLETED|Overall Study||0
69288|NCT01320072|161303|P2|COMPLETED|Overall Study||13
69289|NCT01320072|161304|P1|COMPLETED|Overall Study||16
69290|NCT01320072|161303|P2|STARTED|Overall Study||13
69291|NCT01320072|161304|P1|STARTED|Overall Study||16
69292|NCT01319877|161315|P2|NOT COMPLETED|Overall Study||45
69293|NCT01319877|161316|P1|NOT COMPLETED|Overall Study||108
69294|NCT01319877|161315|P2|COMPLETED|Overall Study||108
69295|NCT01319877|161316|P1|COMPLETED|Overall Study||345
69296|NCT01319877|161315|P2|STARTED|Overall Study||153
69297|NCT01319877|161316|P1|STARTED|Overall Study||453
69298|NCT01319851|161351|P1|NOT COMPLETED|Overall Study||0
69299|NCT01319851|161351|P1|COMPLETED|Overall Study||3
69300|NCT01319851|161351|P1|STARTED|Overall Study||3
69301|NCT01319773|161366|P5|NOT COMPLETED|Overall Study||0
69302|NCT01319773|161367|P4|NOT COMPLETED|Overall Study||0
69303|NCT01319773|161368|P3|NOT COMPLETED|Overall Study||0
69304|NCT01319773|161369|P2|NOT COMPLETED|Overall Study||0
69305|NCT01319773|161370|P1|NOT COMPLETED|Overall Study||0
69306|NCT01319773|161366|P5|COMPLETED|Overall Study||8
69307|NCT01319773|161367|P4|COMPLETED|Overall Study||8
69308|NCT01319773|161368|P3|COMPLETED|Overall Study||8
69309|NCT01319773|161369|P2|COMPLETED|Overall Study||10
69310|NCT01319773|161370|P1|COMPLETED|Overall Study||10
69311|NCT01319773|161366|P5|STARTED|Overall Study||8
69312|NCT01319773|161367|P4|STARTED|Overall Study||8
69313|NCT01319773|161368|P3|STARTED|Overall Study||8
69314|NCT01319773|161369|P2|STARTED|Overall Study||10
69315|NCT01319773|161370|P1|STARTED|Overall Study||10
69316|NCT01319721|161386|P2|NOT COMPLETED|Overall Study||6
69317|NCT01319721|161387|P1|NOT COMPLETED|Overall Study||1
69318|NCT01319721|161386|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
69319|NCT01319721|161387|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
69320|NCT01319721|161386|P2|STARTED|Overall Study|The unit of measure is eyes.|48
69321|NCT01319721|161387|P1|STARTED|Overall Study|The unit of measure is eyes.|48
69322|NCT01319617|161401|P1|NOT COMPLETED|Overall Study||1
69323|NCT01319617|161401|P1|COMPLETED|Overall Study||40
69324|NCT01319617|161401|P1|STARTED|Overall Study||41
69325|NCT01319552|161405|P1|NOT COMPLETED|Overall Study||0
69326|NCT01319552|161405|P1|COMPLETED|Overall Study||14
69327|NCT01319552|161405|P1|STARTED|Overall Study||14
69328|NCT01319500|161412|P2|NOT COMPLETED|Overall Study||0
69329|NCT01319500|161413|P1|NOT COMPLETED|Overall Study||0
69330|NCT01319500|161412|P2|COMPLETED|Overall Study||2589
69331|NCT01319500|161413|P1|COMPLETED|Overall Study||1187
69332|NCT01319500|161412|P2|STARTED|Overall Study||2589
69333|NCT01319500|161413|P1|STARTED|Overall Study||1187
69334|NCT01319422|161432|P2|NOT COMPLETED|Overall Study||0
69335|NCT01319422|161433|P1|NOT COMPLETED|Overall Study||1
69336|NCT01319422|161432|P2|COMPLETED|Overall Study||20
69337|NCT01319422|161433|P1|COMPLETED|Overall Study||19
69338|NCT01319422|161432|P2|STARTED|Overall Study||20
69339|NCT01319422|161433|P1|STARTED|Overall Study||20
69340|NCT01319396|161447|P1|NOT COMPLETED|Overall Study||0
69341|NCT01319396|161447|P1|COMPLETED|Overall Study||24
69342|NCT01319396|161447|P1|STARTED|Overall Study||24
69343|NCT01319318|161451|P1|NOT COMPLETED|Overall Study||0
69344|NCT01319318|161451|P1|COMPLETED|Overall Study||25
69345|NCT01319318|161451|P1|STARTED|Overall Study||25
69346|NCT01319045|161455|P1|NOT COMPLETED|Overall Study||2
69347|NCT01319045|161455|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
69348|NCT01319045|161455|P1|STARTED|Overall Study||5
69349|NCT01318967|161462|P1|NOT COMPLETED|Overall Study||0
69350|NCT01318967|161462|P1|COMPLETED|Overall Study||10
69351|NCT01318967|161462|P1|STARTED|Overall Study||10
69352|NCT01318876|161467|P1|NOT COMPLETED|Day 29 Survey||1825
69353|NCT01318876|161467|P1|COMPLETED|Day 29 Survey||5724
69354|NCT01318876|161467|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
69355|NCT01318876|161467|P1|NOT COMPLETED|Day 8 Survey||1820
69356|NCT01318876|161467|P1|COMPLETED|Day 8 Survey||5825
69357|NCT01318876|161467|P1|STARTED|Day 8 Survey||7645
69358|NCT01318733|161472|P1|NOT COMPLETED|Overall Study||170
69359|NCT01318733|161472|P1|COMPLETED|Overall Study||279
69360|NCT01318733|161472|P1|STARTED|Overall Study||449
69361|NCT01318694|161480|P4|NOT COMPLETED|Overall Study||68
69362|NCT01318694|161481|P3|NOT COMPLETED|Overall Study||43
69363|NCT01318694|161482|P2|NOT COMPLETED|Overall Study||58
69364|NCT01318694|161483|P1|NOT COMPLETED|Overall Study||52
69365|NCT01318694|161480|P4|COMPLETED|Overall Study||200
69366|NCT01318694|161481|P3|COMPLETED|Overall Study||225
69367|NCT01318694|161482|P2|COMPLETED|Overall Study||212
69368|NCT01318694|161483|P1|COMPLETED|Overall Study||223
69369|NCT01318694|161480|P4|Safety Set|Overall Study||265
69370|NCT01318694|161481|P3|Safety Set|Overall Study||265
69371|NCT01318694|161482|P2|Safety Set|Overall Study||268
69372|NCT01318694|161483|P1|Safety Set|Overall Study||273
69373|NCT01318694|161480|P4|Full Analysis Set|Overall Study||268
69374|NCT01318694|161481|P3|Full Analysis Set|Overall Study||265
69375|NCT01318694|161482|P2|Full Analysis Set|Overall Study||270
69376|NCT01318694|161483|P1|Full Analysis Set|Overall Study||274
69377|NCT01318694|161480|P4|STARTED|Overall Study||268
69378|NCT01318694|161481|P3|STARTED|Overall Study||268
69379|NCT01318694|161482|P2|STARTED|Overall Study||270
69380|NCT01318694|161483|P1|STARTED|Overall Study||275
69381|NCT01318512|161537|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
69382|NCT01318512|161537|P1|COMPLETED|Maintenance Period (6 Months)||329
69383|NCT01318512|161537|P1|STARTED|Maintenance Period (6 Months)||340
69384|NCT01318512|161537|P1|NOT COMPLETED|Titration Period (4 Months)||0
69385|NCT01318512|161537|P1|COMPLETED|Titration Period (4 Months)||340
69386|NCT01318512|161537|P1|STARTED|Titration Period (4 Months)||340
69387|NCT01318499|161556|P3|NOT COMPLETED|Overall Study||147
69388|NCT01318499|161557|P2|NOT COMPLETED|Overall Study||76
69389|NCT01318499|161558|P1|NOT COMPLETED|Overall Study||65
69390|NCT01318499|161556|P3|COMPLETED|Overall Study||121
69391|NCT01318499|161557|P2|COMPLETED|Overall Study||458
69392|NCT01318499|161558|P1|COMPLETED|Overall Study||475
69393|NCT01318499|161556|P3|STARTED|Overall Study||268
69394|NCT01318499|161557|P2|STARTED|Overall Study||534
69395|NCT01318499|161558|P1|STARTED|Overall Study||540
69396|NCT01318408|161576|P1|NOT COMPLETED|Overall Study||8
69397|NCT01318408|161576|P1|COMPLETED|Overall Study||16
69398|NCT01318408|161576|P1|STARTED|Overall Study||24
69399|NCT01318382|161581|P1|NOT COMPLETED|Overall Study||13
69400|NCT01318382|161581|P1|COMPLETED|Overall Study||289
69401|NCT01318382|161581|P1|STARTED|Overall Study||302
69402|NCT01318278|161591|P3|NOT COMPLETED|Overall Study||0
69403|NCT01318278|161592|P2|NOT COMPLETED|Overall Study||0
69404|NCT01318278|161593|P1|NOT COMPLETED|Overall Study||0
69405|NCT01318278|161591|P3|COMPLETED|Overall Study||50
69406|NCT01318278|161592|P2|COMPLETED|Overall Study||10
69407|NCT01318278|161593|P1|COMPLETED|Overall Study||10
69408|NCT01318278|161591|P3|STARTED|Overall Study||50
69409|NCT01318278|161592|P2|STARTED|Overall Study||10
69410|NCT01318278|161593|P1|STARTED|Overall Study||10
69411|NCT01318135|161639|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
69412|NCT01318135|161640|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
69413|NCT01318135|161641|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
69414|NCT01318135|161642|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
69415|NCT01318135|161643|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
69416|NCT01318135|161644|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
69417|NCT01318135|161645|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
69418|NCT01318135|161646|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
69419|NCT01318135|161639|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
69420|NCT01318135|161640|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
69421|NCT01318135|161641|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
69422|NCT01318135|161642|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
69423|NCT01318135|161643|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
69424|NCT01318135|161644|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
69425|NCT01318135|161645|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
69426|NCT01318135|161646|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
69427|NCT01318135|161639|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
69428|NCT01318135|161640|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
69429|NCT01318135|161641|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
69430|NCT01318135|161642|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
69431|NCT01318135|161643|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
69432|NCT01318135|161644|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
69433|NCT01318135|161645|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
69434|NCT01318135|161646|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
69435|NCT01318135|161639|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69436|NCT01318135|161640|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69437|NCT01318135|161641|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69438|NCT01318135|161642|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69439|NCT01318135|161643|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69440|NCT01318135|161644|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69441|NCT01318135|161645|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69442|NCT01318135|161646|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
69443|NCT01318135|161639|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
69444|NCT01318135|161640|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
69445|NCT01318135|161641|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
69446|NCT01318135|161642|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
69447|NCT01318135|161643|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
69448|NCT01318135|161644|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
69449|NCT01318135|161645|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
69450|NCT01318135|161646|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
69451|NCT01318135|161639|P8|STARTED|Enrolled - Long-Term Extension Study||49
69452|NCT01318135|161640|P7|STARTED|Enrolled - Long-Term Extension Study||50
69453|NCT01318135|161641|P6|STARTED|Enrolled - Long-Term Extension Study||90
69454|NCT01318135|161642|P5|STARTED|Enrolled - Long-Term Extension Study||91
69455|NCT01318135|161643|P4|STARTED|Enrolled - Long-Term Extension Study||49
69456|NCT01318135|161644|P3|STARTED|Enrolled - Long-Term Extension Study||46
69457|NCT01318135|161645|P2|STARTED|Enrolled - Long-Term Extension Study||102
69458|NCT01318135|161646|P1|STARTED|Enrolled - Long-Term Extension Study||99
69459|NCT01318122|161778|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
69460|NCT01318122|161779|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
69461|NCT01318122|161780|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
69462|NCT01318122|161781|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
69463|NCT01318122|161778|P4|COMPLETED|Entered - Long-Term Extension Study||48
69464|NCT01318122|161779|P3|COMPLETED|Entered - Long-Term Extension Study||49
69465|NCT01318122|161780|P2|COMPLETED|Entered - Long-Term Extension Study||99
69466|NCT01318122|161781|P1|COMPLETED|Entered - Long-Term Extension Study||96
69467|NCT01318122|161778|P4|STARTED|Entered - Long-Term Extension Study||52
69468|NCT01318122|161779|P3|STARTED|Entered - Long-Term Extension Study||55
69469|NCT01318122|161780|P2|STARTED|Entered - Long-Term Extension Study||110
69470|NCT01318122|161781|P1|STARTED|Entered - Long-Term Extension Study||105
69471|NCT01318122|161778|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
69472|NCT01318122|161779|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
69473|NCT01318122|161780|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
69474|NCT01318122|161781|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
69475|NCT01318122|161778|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
69476|NCT01318122|161779|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
69477|NCT01318122|161780|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
69478|NCT01318122|161781|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
69479|NCT01318122|161778|P4|STARTED|Enrolled - Long-Term Extension Study||53
69480|NCT01318122|161779|P3|STARTED|Enrolled - Long-Term Extension Study||57
69481|NCT01318122|161780|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
69482|NCT01318122|161781|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
69483|NCT01318109|161850|P3|NOT COMPLETED|Overall Study||0
69484|NCT01318109|161851|P2|NOT COMPLETED|Overall Study||3
69485|NCT01318109|161852|P1|NOT COMPLETED|Overall Study||1
69486|NCT01318109|161850|P3|COMPLETED|Overall Study||100
69487|NCT01318109|161851|P2|COMPLETED|Overall Study||93
69488|NCT01318109|161852|P1|COMPLETED|Overall Study||91
69489|NCT01318109|161850|P3|STARTED|Overall Study||100
69490|NCT01318109|161851|P2|STARTED|Overall Study||96
69491|NCT01318109|161852|P1|STARTED|Overall Study||92
69492|NCT01318083|161887|P3|NOT COMPLETED|Overall Study||5
69493|NCT01318083|161888|P2|NOT COMPLETED|Overall Study||2
69494|NCT01318083|161889|P1|NOT COMPLETED|Overall Study||6
69495|NCT01318083|161887|P3|COMPLETED|Overall Study||98
69496|NCT01318083|161888|P2|COMPLETED|Overall Study||102
69497|NCT01318083|161889|P1|COMPLETED|Overall Study||99
69498|NCT01318083|161887|P3|STARTED|Overall Study||103
69499|NCT01318083|161888|P2|STARTED|Overall Study||104
69500|NCT01318083|161889|P1|STARTED|Overall Study||105
69501|NCT01318070|161924|P3|NOT COMPLETED|Overall Study||7
69502|NCT01318070|161925|P2|NOT COMPLETED|Overall Study||2
69503|NCT01318070|161926|P1|NOT COMPLETED|Overall Study||2
69504|NCT01318070|161924|P3|COMPLETED|Overall Study||108
69505|NCT01318070|161925|P2|COMPLETED|Overall Study||111
69506|NCT01318070|161926|P1|COMPLETED|Overall Study||109
69507|NCT01318070|161924|P3|STARTED|Overall Study||115
69508|NCT01318070|161925|P2|STARTED|Overall Study||113
69509|NCT01318070|161926|P1|STARTED|Overall Study||111
69510|NCT01317901|161960|P1|NOT COMPLETED|Overall Study||0
69511|NCT01317901|161960|P1|COMPLETED|Overall Study||12
69512|NCT01317901|161960|P1|STARTED|Overall Study||12
69513|NCT01317797|161969|P3|NOT COMPLETED|Overall Study||1
69514|NCT01317797|161970|P2|NOT COMPLETED|Overall Study||1
69515|NCT01317797|161971|P1|NOT COMPLETED|Overall Study||0
69516|NCT01317797|161969|P3|COMPLETED|Overall Study||8
69517|NCT01317797|161970|P2|COMPLETED|Overall Study||6
69518|NCT01317797|161971|P1|COMPLETED|Overall Study||8
69519|NCT01317797|161969|P3|STARTED|Overall Study||9
69520|NCT01317797|161970|P2|STARTED|Overall Study||7
69521|NCT01317797|161971|P1|STARTED|Overall Study||8
69522|NCT01317667|162026|P3|NOT COMPLETED|Overall Study||0
69523|NCT01317667|162027|P2|NOT COMPLETED|Overall Study||0
69524|NCT01317667|162028|P1|NOT COMPLETED|Overall Study||0
69525|NCT01317667|162026|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
69526|NCT01317667|162027|P2|COMPLETED|Overall Study||10
69527|NCT01317667|162028|P1|COMPLETED|Overall Study||10
69528|NCT01317667|162026|P3|STARTED|Overall Study||10
69529|NCT01317667|162027|P2|STARTED|Overall Study||10
69530|NCT01317667|162028|P1|STARTED|Overall Study||10
69531|NCT01317615|162039|P1|NOT COMPLETED|Overall Study||49
69532|NCT01317615|162039|P1|COMPLETED|Overall Study||0
69533|NCT01317615|162039|P1|STARTED|Overall Study||49
69534|NCT01317160|162050|P2|NOT COMPLETED|Overall Study||6
69535|NCT01317160|162051|P1|NOT COMPLETED|Overall Study||4
69536|NCT01317160|162050|P2|COMPLETED|Overall Study||69
69537|NCT01317160|162051|P1|COMPLETED|Overall Study||71
69538|NCT01317160|162050|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
69539|NCT01317160|162051|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
69540|NCT01317160|162050|P2|STARTED|Overall Study||75
69541|NCT01317160|162051|P1|STARTED|Overall Study||75
69542|NCT01317004|162061|P2|NOT COMPLETED|Overall Study||9
69543|NCT01317004|162062|P1|NOT COMPLETED|Overall Study||4
69544|NCT01317004|162061|P2|COMPLETED|Overall Study||5
69545|NCT01317004|162062|P1|COMPLETED|Overall Study||47
69546|NCT01317004|162061|P2|Safety Set|Overall Study||11
69547|NCT01317004|162062|P1|Safety Set|Overall Study||50
69548|NCT01317004|162061|P2|STARTED|Overall Study||14
69549|NCT01317004|162062|P1|STARTED|Overall Study||51
69550|NCT01316926|162080|P2|NOT COMPLETED|Period 2||0
69551|NCT01316926|162081|P1|NOT COMPLETED|Period 2||0
69552|NCT01316926|162080|P2|COMPLETED|Period 2||30
69553|NCT01316926|162081|P1|COMPLETED|Period 2||29
69554|NCT01316926|162080|P2|STARTED|Period 2||30
69555|NCT01316926|162081|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
69556|NCT01316926|162080|P2|NOT COMPLETED|Period 1||0
69557|NCT01316926|162081|P1|NOT COMPLETED|Period 1||0
69558|NCT01316926|162080|P2|COMPLETED|Period 1||30
69559|NCT01316926|162081|P1|COMPLETED|Period 1||30
69560|NCT01316926|162080|P2|STARTED|Period 1||30
69561|NCT01316926|162081|P1|STARTED|Period 1||30
69562|NCT01316913|162095|P4|NOT COMPLETED|Overall Study||39
69563|NCT01316913|162096|P3|NOT COMPLETED|Overall Study||49
69564|NCT01316913|162097|P2|NOT COMPLETED|Overall Study||54
69565|NCT01316913|162098|P1|NOT COMPLETED|Overall Study||57
69566|NCT01316913|162095|P4|COMPLETED|Overall Study||176
69567|NCT01316913|162096|P3|COMPLETED|Overall Study||166
69568|NCT01316913|162097|P2|COMPLETED|Overall Study||163
69569|NCT01316913|162098|P1|COMPLETED|Overall Study||165
69570|NCT01316913|162095|P4|STARTED|Overall Study||215
69571|NCT01316913|162096|P3|STARTED|Overall Study||215
69572|NCT01316913|162097|P2|STARTED|Overall Study||217
69573|NCT01316913|162098|P1|STARTED|Overall Study||222
69574|NCT01316900|162120|P4|NOT COMPLETED|Overall Study||31
69575|NCT01316900|162121|P3|NOT COMPLETED|Overall Study||41
69576|NCT01316900|162122|P2|NOT COMPLETED|Overall Study||31
69577|NCT01316900|162123|P1|NOT COMPLETED|Overall Study||44
69578|NCT01316900|162120|P4|COMPLETED|Overall Study||177
69579|NCT01316900|162121|P3|COMPLETED|Overall Study||173
69580|NCT01316900|162122|P2|COMPLETED|Overall Study||181
69581|NCT01316900|162123|P1|COMPLETED|Overall Study||165
69582|NCT01316900|162120|P4|STARTED|Overall Study||208
69583|NCT01316900|162121|P3|STARTED|Overall Study||214
69584|NCT01316900|162122|P2|STARTED|Overall Study||212
69585|NCT01316900|162123|P1|STARTED|Overall Study||209
69586|NCT01316887|162144|P3|NOT COMPLETED|Overall Study||83
69587|NCT01316887|162145|P2|NOT COMPLETED|Overall Study||94
69588|NCT01316887|162146|P1|NOT COMPLETED|Overall Study||43
69589|NCT01316887|162144|P3|COMPLETED|Overall Study||143
69590|NCT01316887|162145|P2|COMPLETED|Overall Study||133
69591|NCT01316887|162146|P1|COMPLETED|Overall Study||66
69592|NCT01316887|162144|P3|STARTED|Overall Study||226
69593|NCT01316887|162145|P2|STARTED|Overall Study||227
69594|NCT01316887|162146|P1|STARTED|Overall Study||109
69595|NCT01316692|162208|P1|NOT COMPLETED|Overall Study||12
69596|NCT01316692|162208|P1|COMPLETED|Overall Study||0
69597|NCT01316692|162208|P1|STARTED|Overall Study||12
69598|NCT01316614|162217|P1|NOT COMPLETED|Overall Study||37
69599|NCT01316614|162217|P1|COMPLETED|Overall Study||100
69600|NCT01316614|162217|P1|STARTED|Overall Study||137
69601|NCT01316575|162234|P2|NOT COMPLETED|Overall Study||1
69602|NCT01316575|162235|P1|NOT COMPLETED|Overall Study||2
69603|NCT01316575|162234|P2|COMPLETED|Overall Study||19
69604|NCT01316575|162235|P1|COMPLETED|Overall Study||18
69605|NCT01316575|162234|P2|STARTED|Overall Study||20
69606|NCT01316575|162235|P1|STARTED|Overall Study||20
69607|NCT01316419|162247|P1|NOT COMPLETED|Overall Study||265
69608|NCT01316419|162247|P1|COMPLETED|Overall Study||1824
69609|NCT01316419|162247|P1|STARTED|Overall Study||2089
69610|NCT01316380|162273|P3|NOT COMPLETED|Overall Study||3
69611|NCT01316380|162274|P2|NOT COMPLETED|Overall Study||5
69612|NCT01316380|162275|P1|NOT COMPLETED|Overall Study||2
69613|NCT01316380|162273|P3|COMPLETED|Overall Study||152
69614|NCT01316380|162274|P2|COMPLETED|Overall Study||149
69615|NCT01316380|162275|P1|COMPLETED|Overall Study||154
69616|NCT01316380|162273|P3|STARTED|Overall Study||155
69617|NCT01316380|162274|P2|STARTED|Overall Study||154
69618|NCT01316380|162275|P1|STARTED|Overall Study||156
69619|NCT01316341|162316|P3|NOT COMPLETED|Overall Study||0
69620|NCT01316341|162317|P2|NOT COMPLETED|Overall Study||0
69621|NCT01316341|162318|P1|NOT COMPLETED|Overall Study||0
69622|NCT01316341|162316|P3|COMPLETED|Overall Study||9
69623|NCT01316341|162317|P2|COMPLETED|Overall Study||9
69624|NCT01316341|162318|P1|COMPLETED|Overall Study||6
69625|NCT01316341|162316|P3|STARTED|Overall Study||9
69626|NCT01316341|162317|P2|STARTED|Overall Study||9
69627|NCT01316341|162318|P1|STARTED|Overall Study||6
69628|NCT01316315|162386|P2|NOT COMPLETED|Sequence 2||0
69629|NCT01316315|162387|P1|NOT COMPLETED|Sequence 2||0
69630|NCT01316315|162386|P2|COMPLETED|Sequence 2||7
69631|NCT01316315|162387|P1|COMPLETED|Sequence 2||7
69632|NCT01316315|162386|P2|STARTED|Sequence 2||7
69633|NCT01316315|162387|P1|STARTED|Sequence 2||7
69634|NCT01316315|162386|P2|NOT COMPLETED|Sequence 1||0
69635|NCT01316315|162387|P1|NOT COMPLETED|Sequence 1||0
69636|NCT01316315|162386|P2|COMPLETED|Sequence 1||7
69637|NCT01316315|162387|P1|COMPLETED|Sequence 1||7
69638|NCT01316315|162386|P2|STARTED|Sequence 1||7
69639|NCT01316315|162387|P1|STARTED|Sequence 1||7
69640|NCT01316302|162401|P2|NOT COMPLETED|Overall Study||11
69641|NCT01316302|162402|P1|NOT COMPLETED|Overall Study||10
69642|NCT01316302|162401|P2|COMPLETED|Overall Study||22
69643|NCT01316302|162402|P1|COMPLETED|Overall Study||20
69644|NCT01316302|162401|P2|STARTED|Overall Study||33
69645|NCT01316302|162402|P1|STARTED|Overall Study||30
69646|NCT01316263|162414|P2|NOT COMPLETED|Overall Study||0
69647|NCT01316263|162415|P1|NOT COMPLETED|Overall Study||0
69648|NCT01316263|162414|P2|COMPLETED|Overall Study||14
69649|NCT01316263|162415|P1|COMPLETED|Overall Study||7
69650|NCT01316263|162414|P2|Received Any Study Drug|Overall Study||14
69651|NCT01316263|162415|P1|Received Any Study Drug|Overall Study||7
69652|NCT01316263|162414|P2|STARTED|Overall Study||14
69653|NCT01316263|162415|P1|STARTED|Overall Study||7
69654|NCT01316224|162441|P1|NOT COMPLETED|Overall Study||10
69655|NCT01316224|162441|P1|COMPLETED|Overall Study||42
69656|NCT01316224|162441|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
69657|NCT01316224|162441|P1|Completed Visit 4 to Dermatologist|Overall Study||42
69658|NCT01316224|162441|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
69659|NCT01316224|162441|P1|Completed Visit 3 to Dermatologist|Overall Study||48
69660|NCT01316224|162441|P1|Completed Visit 2 to Dermatologist|Overall Study||51
69661|NCT01316224|162441|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
69662|NCT01316224|162441|P1|Completed Visit 1 to Dermatologist|Overall Study||52
69663|NCT01316224|162441|P1|STARTED|Overall Study||52
69664|NCT01316055|162458|P3|NOT COMPLETED|Overall Study||0
69665|NCT01316055|162459|P2|NOT COMPLETED|Overall Study||0
69666|NCT01316055|162460|P1|NOT COMPLETED|Overall Study||1
69667|NCT01316055|162458|P3|COMPLETED|Overall Study||12
69668|NCT01316055|162459|P2|COMPLETED|Overall Study||17
69669|NCT01316055|162460|P1|COMPLETED|Overall Study||12
69670|NCT01316055|162458|P3|STARTED|Overall Study||12
69671|NCT01316055|162459|P2|STARTED|Overall Study||17
69672|NCT01316055|162460|P1|STARTED|Overall Study||13
69673|NCT01316042|162476|P2|NOT COMPLETED|Overall Study||1
69674|NCT01316042|162477|P1|NOT COMPLETED|Overall Study||0
69675|NCT01316042|162476|P2|COMPLETED|Overall Study||1
69676|NCT01316042|162477|P1|COMPLETED|Overall Study||2
69677|NCT01316042|162476|P2|STARTED|Overall Study||2
69678|NCT01316042|162477|P1|STARTED|Overall Study||2
69679|NCT01315847|162485|P2|NOT COMPLETED|Part III, Period 2||0
69680|NCT01315847|162486|P1|NOT COMPLETED|Part III, Period 2||0
69681|NCT01315847|162485|P2|COMPLETED|Part III, Period 2||3
69682|NCT01315847|162486|P1|COMPLETED|Part III, Period 2||0
69683|NCT01315847|162485|P2|Received [11C]MK-4232|Part III, Period 2||3
69684|NCT01315847|162486|P1|Received [11C]MK-4232|Part III, Period 2||0
69685|NCT01315847|162485|P2|Received Telcagepant|Part III, Period 2||3
69686|NCT01315847|162486|P1|Received Telcagepant|Part III, Period 2||0
69687|NCT01315847|162485|P2|STARTED|Part III, Period 2||3
69688|NCT01315847|162486|P1|STARTED|Part III, Period 2||0
69689|NCT01315847|162485|P2|NOT COMPLETED|Part III, Period 1||1
69690|NCT01315847|162486|P1|NOT COMPLETED|Part III, Period 1||0
69691|NCT01315847|162485|P2|COMPLETED|Part III, Period 1||3
69692|NCT01315847|162486|P1|COMPLETED|Part III, Period 1||0
69693|NCT01315847|162485|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
69694|NCT01315847|162486|P1|Received [11C]MK-4232|Part III, Period 1||0
69695|NCT01315847|162485|P2|Received Telcagepant|Part III, Period 1||4
69696|NCT01315847|162486|P1|Received Telcagepant|Part III, Period 1||0
69697|NCT01315847|162485|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
69698|NCT01315847|162486|P1|STARTED|Part III, Period 1||0
69699|NCT01315847|162485|P2|NOT COMPLETED|Part I, Period 2||0
69700|NCT01315847|162486|P1|NOT COMPLETED|Part I, Period 2||0
69701|NCT01315847|162485|P2|COMPLETED|Part I, Period 2||0
69702|NCT01315847|162486|P1|COMPLETED|Part I, Period 2||3
69703|NCT01315847|162485|P2|Received [11C]MK-4232|Part I, Period 2||0
69704|NCT01315847|162486|P1|Received [11C]MK-4232|Part I, Period 2||3
69705|NCT01315847|162485|P2|Received Telcagepant|Part I, Period 2||0
69706|NCT01315847|162486|P1|Received Telcagepant|Part I, Period 2||3
69707|NCT01315847|162485|P2|STARTED|Part I, Period 2||0
69708|NCT01315847|162486|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
69709|NCT01315847|162485|P2|NOT COMPLETED|Part I, Period 1||0
69710|NCT01315847|162486|P1|NOT COMPLETED|Part I, Period 1||3
69711|NCT01315847|162485|P2|COMPLETED|Part I, Period 1||0
69712|NCT01315847|162486|P1|COMPLETED|Part I, Period 1||2
69713|NCT01315847|162485|P2|Received [11C]MK-4232|Part I, Period 1||0
69714|NCT01315847|162486|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
69715|NCT01315847|162485|P2|Received Telcagepant|Part I, Period 1||0
69716|NCT01315847|162486|P1|Received Telcagepant|Part I, Period 1||5
69717|NCT01315847|162485|P2|STARTED|Part I, Period 1||0
69718|NCT01315847|162486|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
69719|NCT01315665|162500|P2|NOT COMPLETED|Overall Study||0
69720|NCT01315665|162501|P1|NOT COMPLETED|Overall Study||0
69721|NCT01315665|162500|P2|COMPLETED|Overall Study||5
69722|NCT01315665|162501|P1|COMPLETED|Overall Study||10
69723|NCT01315665|162500|P2|STARTED|Overall Study||5
69724|NCT01315665|162501|P1|STARTED|Overall Study||10
69725|NCT01315574|162517|P2|NOT COMPLETED|Overall Study||0
69726|NCT01315574|162518|P1|NOT COMPLETED|Overall Study||0
69727|NCT01315574|162517|P2|COMPLETED|Overall Study||7
69728|NCT01315574|162518|P1|COMPLETED|Overall Study||7
69729|NCT01315574|162517|P2|STARTED|Overall Study||7
69730|NCT01315574|162518|P1|STARTED|Overall Study||7
69731|NCT01315249|162530|P2|NOT COMPLETED|Overall Study||47
69732|NCT01315249|162531|P1|NOT COMPLETED|Overall Study||44
69733|NCT01315249|162530|P2|COMPLETED|Overall Study||217
69734|NCT01315249|162531|P1|COMPLETED|Overall Study||215
69735|NCT01315249|162530|P2|STARTED|Overall Study||264
69736|NCT01315249|162531|P1|STARTED|Overall Study||259
69737|NCT01315158|162559|P2|NOT COMPLETED|Overall Study||0
69738|NCT01315158|162560|P1|NOT COMPLETED|Overall Study||0
69739|NCT01315158|162559|P2|COMPLETED|Overall Study||19
69740|NCT01315158|162560|P1|COMPLETED|Overall Study||17
69741|NCT01315158|162559|P2|STARTED|Overall Study||19
69742|NCT01315158|162560|P1|STARTED|Overall Study||17
69743|NCT01315145|162584|P2|NOT COMPLETED|Overall Study||5
69744|NCT01315145|162585|P1|NOT COMPLETED|Overall Study||17
69745|NCT01315145|162584|P2|COMPLETED|Overall Study||11
69746|NCT01315145|162585|P1|COMPLETED|Overall Study||105
69747|NCT01315145|162584|P2|STARTED|Overall Study||16
69748|NCT01315145|162585|P1|STARTED|Overall Study||122
69749|NCT01315028|162593|P2|NOT COMPLETED|Overall Study||1
69750|NCT01315028|162594|P1|NOT COMPLETED|Overall Study||1
69751|NCT01315028|162593|P2|COMPLETED|Overall Study||9
69752|NCT01315028|162594|P1|COMPLETED|Overall Study||9
69753|NCT01315028|162593|P2|STARTED|Overall Study||10
69754|NCT01315028|162594|P1|STARTED|Overall Study||10
69755|NCT01315002|162606|P2|NOT COMPLETED|Overall Study||5
69756|NCT01315002|162607|P1|NOT COMPLETED|Overall Study||5
69757|NCT01315002|162606|P2|COMPLETED|Overall Study||55
69758|NCT01315002|162607|P1|COMPLETED|Overall Study||56
69759|NCT01315002|162606|P2|STARTED|Overall Study||60
69760|NCT01315002|162607|P1|STARTED|Overall Study||61
69761|NCT01314872|162624|P15|NOT COMPLETED|Period 2||24
69762|NCT01314872|162625|P14|NOT COMPLETED|Period 2||53
69763|NCT01314872|162626|P13|NOT COMPLETED|Period 2||60
69764|NCT01314872|162627|P12|NOT COMPLETED|Period 2||48
69765|NCT01314872|162628|P11|NOT COMPLETED|Period 2||0
69766|NCT01314872|162629|P10|NOT COMPLETED|Period 2||0
69767|NCT01314872|162630|P9|NOT COMPLETED|Period 2||0
69768|NCT01314872|162631|P8|NOT COMPLETED|Period 2||0
69769|NCT01314872|162632|P7|NOT COMPLETED|Period 2||0
69770|NCT01314872|162633|P6|NOT COMPLETED|Period 2||0
69771|NCT01314872|162634|P5|NOT COMPLETED|Period 2||0
69772|NCT01314872|162635|P4|NOT COMPLETED|Period 2||0
69773|NCT01314872|162636|P3|NOT COMPLETED|Period 2||0
69774|NCT01314872|162637|P2|NOT COMPLETED|Period 2||0
69775|NCT01314872|162638|P1|NOT COMPLETED|Period 2||0
69776|NCT01314872|162624|P15|COMPLETED|Period 2||110
69777|NCT01314872|162625|P14|COMPLETED|Period 2||187
69778|NCT01314872|162626|P13|COMPLETED|Period 2||188
69779|NCT01314872|162627|P12|COMPLETED|Period 2||175
69780|NCT01314872|162628|P11|COMPLETED|Period 2||0
69781|NCT01314872|162629|P10|COMPLETED|Period 2||0
69782|NCT01314872|162630|P9|COMPLETED|Period 2||0
69783|NCT01314872|162631|P8|COMPLETED|Period 2||0
69784|NCT01314872|162632|P7|COMPLETED|Period 2||0
69785|NCT01314872|162633|P6|COMPLETED|Period 2||0
69786|NCT01314872|162634|P5|COMPLETED|Period 2||0
69787|NCT01314872|162635|P4|COMPLETED|Period 2||0
69788|NCT01314872|162636|P3|COMPLETED|Period 2||0
69789|NCT01314872|162637|P2|COMPLETED|Period 2||0
69790|NCT01314872|162638|P1|COMPLETED|Period 2||0
69791|NCT01314872|162624|P15|STARTED|Period 2||134
69792|NCT01314872|162625|P14|STARTED|Period 2||240
69793|NCT01314872|162626|P13|STARTED|Period 2||248
69794|NCT01314872|162627|P12|STARTED|Period 2||223
69795|NCT01314872|162628|P11|STARTED|Period 2||0
69796|NCT01314872|162629|P10|STARTED|Period 2||0
69797|NCT01314872|162630|P9|STARTED|Period 2||0
69798|NCT01314872|162631|P8|STARTED|Period 2||0
69799|NCT01314872|162632|P7|STARTED|Period 2||0
69800|NCT01314872|162633|P6|STARTED|Period 2||0
69801|NCT01314872|162634|P5|STARTED|Period 2||0
69802|NCT01314872|162635|P4|STARTED|Period 2||0
69803|NCT01314872|162636|P3|STARTED|Period 2||0
69804|NCT01314872|162637|P2|STARTED|Period 2||0
69805|NCT01314872|162638|P1|STARTED|Period 2||0
69806|NCT01314872|162624|P15|NOT COMPLETED|Treatment Period 1||0
69807|NCT01314872|162625|P14|NOT COMPLETED|Treatment Period 1||0
69808|NCT01314872|162626|P13|NOT COMPLETED|Treatment Period 1||0
69809|NCT01314872|162627|P12|NOT COMPLETED|Treatment Period 1||0
69810|NCT01314872|162628|P11|NOT COMPLETED|Treatment Period 1||3
69811|NCT01314872|162629|P10|NOT COMPLETED|Treatment Period 1||4
69812|NCT01314872|162630|P9|NOT COMPLETED|Treatment Period 1||6
69813|NCT01314872|162631|P8|NOT COMPLETED|Treatment Period 1||7
69814|NCT01314872|162632|P7|NOT COMPLETED|Treatment Period 1||8
69815|NCT01314872|162633|P6|NOT COMPLETED|Treatment Period 1||7
69816|NCT01314872|162634|P5|NOT COMPLETED|Treatment Period 1||7
69817|NCT01314872|162635|P4|NOT COMPLETED|Treatment Period 1||7
69818|NCT01314872|162636|P3|NOT COMPLETED|Treatment Period 1||6
69819|NCT01314872|162637|P2|NOT COMPLETED|Treatment Period 1||6
69820|NCT01314872|162638|P1|NOT COMPLETED|Treatment Period 1||10
69821|NCT01314872|162624|P15|COMPLETED|Treatment Period 1||0
69822|NCT01314872|162625|P14|COMPLETED|Treatment Period 1||0
69823|NCT01314872|162626|P13|COMPLETED|Treatment Period 1||0
69824|NCT01314872|162627|P12|COMPLETED|Treatment Period 1||0
69825|NCT01314872|162628|P11|COMPLETED|Treatment Period 1||107
69826|NCT01314872|162629|P10|COMPLETED|Treatment Period 1||118
69827|NCT01314872|162630|P9|COMPLETED|Treatment Period 1||106
69828|NCT01314872|162631|P8|COMPLETED|Treatment Period 1||57
69829|NCT01314872|162632|P7|COMPLETED|Treatment Period 1||126
69830|NCT01314872|162633|P6|COMPLETED|Treatment Period 1||128
69831|NCT01314872|162634|P5|COMPLETED|Treatment Period 1||142
69832|NCT01314872|162635|P4|COMPLETED|Treatment Period 1||143
69833|NCT01314872|162636|P3|COMPLETED|Treatment Period 1||128
69834|NCT01314872|162637|P2|COMPLETED|Treatment Period 1||138
69835|NCT01314872|162638|P1|COMPLETED|Treatment Period 1||131
69836|NCT01314872|162624|P15|STARTED|Treatment Period 1||0
69837|NCT01314872|162625|P14|STARTED|Treatment Period 1||0
69838|NCT01314872|162626|P13|STARTED|Treatment Period 1||0
69839|NCT01314872|162627|P12|STARTED|Treatment Period 1||0
69840|NCT01314872|162628|P11|STARTED|Treatment Period 1||110
69841|NCT01314872|162629|P10|STARTED|Treatment Period 1||122
69842|NCT01314872|162630|P9|STARTED|Treatment Period 1||112
69843|NCT01314872|162631|P8|STARTED|Treatment Period 1||64
69844|NCT01314872|162632|P7|STARTED|Treatment Period 1||134
69845|NCT01314872|162633|P6|STARTED|Treatment Period 1||135
69846|NCT01314872|162634|P5|STARTED|Treatment Period 1||149
69847|NCT01314872|162635|P4|STARTED|Treatment Period 1||150
69848|NCT01314872|162636|P3|STARTED|Treatment Period 1||134
69849|NCT01314872|162637|P2|STARTED|Treatment Period 1||144
69850|NCT01314872|162638|P1|STARTED|Treatment Period 1||141
69851|NCT01314742|162731|P2|NOT COMPLETED|Overall Study||0
69852|NCT01314742|162732|P1|NOT COMPLETED|Overall Study||0
69853|NCT01314742|162731|P2|COMPLETED|Overall Study||21
69854|NCT01314742|162732|P1|COMPLETED|Overall Study||20
69855|NCT01314742|162731|P2|STARTED|Overall Study||21
69856|NCT01314742|162732|P1|STARTED|Overall Study||20
69857|NCT01314716|162742|P2|NOT COMPLETED|Open-Label Phase||12
69858|NCT01314716|162743|P1|NOT COMPLETED|Open-Label Phase||10
69859|NCT01314716|162742|P2|COMPLETED|Open-Label Phase||98
69860|NCT01314716|162743|P1|COMPLETED|Open-Label Phase||102
69861|NCT01314716|162742|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
69862|NCT01314716|162743|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
69863|NCT01314716|162742|P2|NOT COMPLETED|Double-Blind Phase||15
69864|NCT01314716|162743|P1|NOT COMPLETED|Double-Blind Phase||17
69865|NCT01314716|162742|P2|COMPLETED|Double-Blind Phase||123
69866|NCT01314716|162743|P1|COMPLETED|Double-Blind Phase||119
69867|NCT01314716|162742|P2|Randomized and Treated|Double-Blind Phase||137
69868|NCT01314716|162743|P1|Randomized and Treated|Double-Blind Phase||135
69869|NCT01314716|162742|P2|STARTED|Double-Blind Phase||138
69870|NCT01314716|162743|P1|STARTED|Double-Blind Phase||136
69871|NCT01314703|162755|P1|NOT COMPLETED|Overall Study||8
69872|NCT01314703|162755|P1|COMPLETED|Overall Study||27
69873|NCT01314703|162755|P1|Discontinued When Enrollment Completed|Overall Study||3
69874|NCT01314703|162755|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
69875|NCT01314703|162755|P1|Excluded Prior to Screening Baseline|Overall Study||2
69876|NCT01314703|162755|P1|Completed Study|Overall Study||27
69877|NCT01314703|162755|P1|Completed Treatment Visit|Overall Study||27
69878|NCT01314703|162755|P1|Completed Screen Visit|Overall Study||33
69879|NCT01314703|162755|P1|Signed Informed Consent|Overall Study||35
69880|NCT01314703|162755|P1|STARTED|Overall Study||35
69881|NCT01314443|162764|P4|NOT COMPLETED|Overall Study||2
69882|NCT01314443|162765|P3|NOT COMPLETED|Overall Study||2
69883|NCT01314443|162766|P2|NOT COMPLETED|Overall Study||3
69884|NCT01314443|162767|P1|NOT COMPLETED|Overall Study||4
69885|NCT01314443|162764|P4|COMPLETED|Overall Study||13
69886|NCT01314443|162765|P3|COMPLETED|Overall Study||13
69887|NCT01314443|162766|P2|COMPLETED|Overall Study||16
69888|NCT01314443|162767|P1|COMPLETED|Overall Study||14
69889|NCT01314443|162764|P4|STARTED|Overall Study||15
69890|NCT01314443|162765|P3|STARTED|Overall Study||15
69891|NCT01314443|162766|P2|STARTED|Overall Study||19
69892|NCT01314443|162767|P1|STARTED|Overall Study||18
69893|NCT01314417|162785|P1|NOT COMPLETED|Overall Study||0
69894|NCT01314417|162785|P1|COMPLETED|Overall Study||2
69895|NCT01314417|162785|P1|STARTED|Overall Study||2
69896|NCT01314261|162816|P4|NOT COMPLETED|Overall Study||3
69897|NCT01314261|162817|P3|NOT COMPLETED|Overall Study||3
69898|NCT01314261|162818|P2|NOT COMPLETED|Overall Study||4
69899|NCT01314261|162819|P1|NOT COMPLETED|Overall Study||2
69900|NCT01314261|162816|P4|COMPLETED|Overall Study||6
69901|NCT01314261|162817|P3|COMPLETED|Overall Study||7
69902|NCT01314261|162818|P2|COMPLETED|Overall Study||5
69903|NCT01314261|162819|P1|COMPLETED|Overall Study||7
69904|NCT01314261|162816|P4|Discontinued pegIFN/RBV|Overall Study||1
69905|NCT01314261|162817|P3|Discontinued pegIFN/RBV|Overall Study||5
69906|NCT01314261|162818|P2|Discontinued pegIFN/RBV|Overall Study||4
69907|NCT01314261|162819|P1|Discontinued pegIFN/RBV|Overall Study||1
69908|NCT01314261|162816|P4|Discontinued ABT-267 or Placebo|Overall Study||0
69909|NCT01314261|162817|P3|Discontinued ABT-267 or Placebo|Overall Study||1
69910|NCT01314261|162818|P2|Discontinued ABT-267 or Placebo|Overall Study||0
69911|NCT01314261|162819|P1|Discontinued ABT-267 or Placebo|Overall Study||1
69912|NCT01314261|162816|P4|STARTED|Overall Study||9
69913|NCT01314261|162817|P3|STARTED|Overall Study||10
69914|NCT01314261|162818|P2|STARTED|Overall Study||9
69915|NCT01314261|162819|P1|STARTED|Overall Study||9
69916|NCT01314118|162870|P1|NOT COMPLETED|Overall Study||131
69917|NCT01314118|162870|P1|COMPLETED|Overall Study||0
69918|NCT01314118|162870|P1|STARTED|Overall Study||131
69919|NCT01314105|162879|P2|NOT COMPLETED|Overall Study||4
69920|NCT01314105|162880|P1|NOT COMPLETED|Overall Study||6
69921|NCT01314105|162879|P2|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|2
69922|NCT01314105|162880|P1|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|1
69923|NCT01314105|162879|P2|STARTED|Overall Study||6
69924|NCT01314105|162880|P1|STARTED|Overall Study||7
69925|NCT01314014|162902|P1|NOT COMPLETED|Overall Study||0
69926|NCT01314014|162902|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
69927|NCT01314014|162902|P1|STARTED|Overall Study||22
69928|NCT01314001|162913|P6|NOT COMPLETED|Overall Study||71
69929|NCT01314001|162914|P5|NOT COMPLETED|Overall Study||72
69930|NCT01314001|162915|P4|NOT COMPLETED|Overall Study||69
69931|NCT01314001|162916|P3|NOT COMPLETED|Overall Study||69
69932|NCT01314001|162917|P2|NOT COMPLETED|Overall Study||69
69933|NCT01314001|162918|P1|NOT COMPLETED|Overall Study||75
69934|NCT01314001|162913|P6|COMPLETED|Overall Study||129
69935|NCT01314001|162914|P5|COMPLETED|Overall Study||148
69936|NCT01314001|162915|P4|COMPLETED|Overall Study||122
69937|NCT01314001|162916|P3|COMPLETED|Overall Study||158
69938|NCT01314001|162917|P2|COMPLETED|Overall Study||124
69939|NCT01314001|162918|P1|COMPLETED|Overall Study||140
69940|NCT01314001|162913|P6|6-Month Follow Up Survey|Overall Study||139
69941|NCT01314001|162914|P5|6-Month Follow Up Survey|Overall Study||157
69942|NCT01314001|162915|P4|6-Month Follow Up Survey|Overall Study||135
69943|NCT01314001|162916|P3|6-Month Follow Up Survey|Overall Study||165
69944|NCT01314001|162917|P2|6-Month Follow Up Survey|Overall Study||137
69945|NCT01314001|162918|P1|6-Month Follow Up Survey|Overall Study||146
69946|NCT01314001|162913|P6|End-of-Treatment Visit|Overall Study||160
69947|NCT01314001|162914|P5|End-of-Treatment Visit|Overall Study||174
69948|NCT01314001|162915|P4|End-of-Treatment Visit|Overall Study||146
69949|NCT01314001|162916|P3|End-of-Treatment Visit|Overall Study||179
69950|NCT01314001|162917|P2|End-of-Treatment Visit|Overall Study||141
69951|NCT01314001|162918|P1|End-of-Treatment Visit|Overall Study||156
69952|NCT01314001|162913|P6|STARTED|Overall Study||200
69953|NCT01314001|162914|P5|STARTED|Overall Study||220
69954|NCT01314001|162915|P4|STARTED|Overall Study||191
69955|NCT01314001|162916|P3|STARTED|Overall Study||227
69956|NCT01314001|162917|P2|STARTED|Overall Study||193
69957|NCT01314001|162918|P1|STARTED|Overall Study||215
69958|NCT01313936|162964|P2|NOT COMPLETED|Overall Study||0
69959|NCT01313936|162965|P1|NOT COMPLETED|Overall Study||0
69960|NCT01313936|162964|P2|COMPLETED|Overall Study||26
69961|NCT01313936|162965|P1|COMPLETED|Overall Study||6
69962|NCT01313936|162964|P2|STARTED|Overall Study||26
69963|NCT01313936|162965|P1|STARTED|Overall Study||6
69964|NCT01313923|162973|P1|NOT COMPLETED|Overall Study||3
69965|NCT01313923|162973|P1|COMPLETED|Overall Study||0
69966|NCT01313923|162973|P1|STARTED|Overall Study||3
69967|NCT01313884|162977|P1|NOT COMPLETED|Overall Study||1
69968|NCT01313884|162977|P1|COMPLETED|Overall Study||2
69969|NCT01313884|162977|P1|STARTED|Overall Study||3
69970|NCT01313858|162984|P3|NOT COMPLETED|Overall Study||238
69971|NCT01313858|162985|P2|NOT COMPLETED|Overall Study||270
69972|NCT01313858|162986|P1|NOT COMPLETED|Overall Study||286
69973|NCT01313858|162984|P3|COMPLETED|Overall Study||305
69974|NCT01313858|162985|P2|COMPLETED|Overall Study||276
69975|NCT01313858|162986|P1|COMPLETED|Overall Study||238
69976|NCT01313858|162984|P3|STARTED|Overall Study||543
69977|NCT01313858|162985|P2|STARTED|Overall Study||546
69978|NCT01313858|162986|P1|STARTED|Overall Study||524
69979|NCT01313780|163009|P2|NOT COMPLETED|Overall Study||28
69980|NCT01313780|163010|P1|NOT COMPLETED|Overall Study||25
69981|NCT01313780|163009|P2|COMPLETED|Overall Study|PPS|31
69982|NCT01313780|163010|P1|COMPLETED|Overall Study|PPS|33
69983|NCT01313780|163009|P2|STARTED|Overall Study|FAS|59
69984|NCT01313780|163010|P1|STARTED|Overall Study|FAS|58
69985|NCT01313728|163018|P1|NOT COMPLETED|Baseline to Completion||0
69986|NCT01313728|163018|P1|COMPLETED|Baseline to Completion||25
69987|NCT01313728|163018|P1|STARTED|Baseline to Completion||25
69988|NCT01313728|163018|P1|NOT COMPLETED|Informed Consent to Baseline||1
69989|NCT01313728|163018|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
69990|NCT01313728|163018|P1|STARTED|Informed Consent to Baseline||26
69991|NCT01313689|163035|P4|NOT COMPLETED|24-Week Randomization 2||1
69992|NCT01313689|163036|P3|NOT COMPLETED|24-Week Randomization 2||3
69993|NCT01313689|163037|P2|NOT COMPLETED|24-Week Randomization 2||0
69994|NCT01313689|163038|P1|NOT COMPLETED|24-Week Randomization 2||0
69995|NCT01313689|163035|P4|COMPLETED|24-Week Randomization 2||12
69996|NCT01313689|163036|P3|COMPLETED|24-Week Randomization 2||21
69997|NCT01313689|163037|P2|COMPLETED|24-Week Randomization 2||0
69998|NCT01313689|163038|P1|COMPLETED|24-Week Randomization 2||0
69999|NCT01313689|163035|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
70000|NCT01313689|163036|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
70001|NCT01313689|163037|P2|STARTED|24-Week Randomization 2||0
70002|NCT01313689|163038|P1|STARTED|24-Week Randomization 2||0
70003|NCT01313689|163035|P4|NOT COMPLETED|24-Week Randomization 1||0
70004|NCT01313689|163036|P3|NOT COMPLETED|24-Week Randomization 1||0
70005|NCT01313689|163037|P2|NOT COMPLETED|24-Week Randomization 1||10
70006|NCT01313689|163038|P1|NOT COMPLETED|24-Week Randomization 1||19
70007|NCT01313689|163035|P4|COMPLETED|24-Week Randomization 1||0
70008|NCT01313689|163036|P3|COMPLETED|24-Week Randomization 1||0
70009|NCT01313689|163037|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
70010|NCT01313689|163038|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
70011|NCT01313689|163035|P4|STARTED|24-Week Randomization 1||0
70012|NCT01313689|163036|P3|STARTED|24-Week Randomization 1||0
70013|NCT01313689|163037|P2|STARTED|24-Week Randomization 1||43
70014|NCT01313689|163038|P1|STARTED|24-Week Randomization 1||79
70015|NCT01313676|163105|P4|NOT COMPLETED|Overall Study||994
70016|NCT01313676|163106|P3|NOT COMPLETED|Overall Study||1088
70017|NCT01313676|163107|P2|NOT COMPLETED|Overall Study||1113
70018|NCT01313676|163108|P1|NOT COMPLETED|Overall Study||1250
70019|NCT01313676|163105|P4|COMPLETED|Overall Study||3146
70020|NCT01313676|163106|P3|COMPLETED|Overall Study||3052
70021|NCT01313676|163107|P2|COMPLETED|Overall Study||3044
70022|NCT01313676|163108|P1|COMPLETED|Overall Study||2881
70023|NCT01313676|163105|P4|STARTED|Overall Study||4140
70024|NCT01313676|163106|P3|STARTED|Overall Study||4140
70025|NCT01313676|163107|P2|STARTED|Overall Study||4157
70026|NCT01313676|163108|P1|STARTED|Overall Study||4131
70027|NCT01313663|163128|P2|NOT COMPLETED|Overall Study||8
70028|NCT01313663|163129|P1|NOT COMPLETED|Overall Study||4
70029|NCT01313663|163128|P2|COMPLETED|Overall Study||3
70030|NCT01313663|163129|P1|COMPLETED|Overall Study||5
70031|NCT01313663|163128|P2|STARTED|Overall Study||11
70032|NCT01313663|163129|P1|STARTED|Overall Study||9
70033|NCT01313650|163167|P4|NOT COMPLETED|Overall Study||81
70034|NCT01313650|163168|P3|NOT COMPLETED|Overall Study||103
70035|NCT01313650|163169|P2|NOT COMPLETED|Overall Study||94
70036|NCT01313650|163170|P1|NOT COMPLETED|Overall Study||76
70037|NCT01313650|163167|P4|COMPLETED|Overall Study||332
70038|NCT01313650|163168|P3|COMPLETED|Overall Study||318
70039|NCT01313650|163169|P2|COMPLETED|Overall Study||324
70040|NCT01313650|163170|P1|COMPLETED|Overall Study||204
70041|NCT01313650|163167|P4|STARTED|Overall Study||413
70042|NCT01313650|163168|P3|STARTED|Overall Study||421
70043|NCT01313650|163169|P2|STARTED|Overall Study||418
70044|NCT01313650|163170|P1|STARTED|Overall Study||280
70045|NCT01313637|163196|P4|NOT COMPLETED|Overall Study||78
70046|NCT01313637|163197|P3|NOT COMPLETED|Overall Study||106
70047|NCT01313637|163198|P2|NOT COMPLETED|Overall Study||95
70048|NCT01313637|163199|P1|NOT COMPLETED|Overall Study||92
70049|NCT01313637|163196|P4|COMPLETED|Overall Study||325
70050|NCT01313637|163197|P3|COMPLETED|Overall Study||298
70051|NCT01313637|163198|P2|COMPLETED|Overall Study||312
70052|NCT01313637|163199|P1|COMPLETED|Overall Study||183
70053|NCT01313637|163196|P4|STARTED|Overall Study||403
70054|NCT01313637|163197|P3|STARTED|Overall Study||404
70055|NCT01313637|163198|P2|STARTED|Overall Study||407
70056|NCT01313637|163199|P1|STARTED|Overall Study||275
70057|NCT01313624|163223|P2|NOT COMPLETED|Open-Label Phase||13
70058|NCT01313624|163224|P1|NOT COMPLETED|Open-Label Phase||4
70059|NCT01313624|163223|P2|COMPLETED|Open-Label Phase||109
70060|NCT01313624|163224|P1|COMPLETED|Open-Label Phase||92
70061|NCT01313624|163223|P2|STARTED|Open-Label Phase||122
70062|NCT01313624|163224|P1|STARTED|Open-Label Phase||96
70063|NCT01313624|163223|P2|NOT COMPLETED|Double-Blind Phase||10
70064|NCT01313624|163224|P1|NOT COMPLETED|Double-Blind Phase||38
70065|NCT01313624|163223|P2|COMPLETED|Double-Blind Phase||122
70066|NCT01313624|163224|P1|COMPLETED|Double-Blind Phase||96
70067|NCT01313624|163223|P2|STARTED|Double-Blind Phase||132
70068|NCT01313624|163224|P1|STARTED|Double-Blind Phase||134
70069|NCT01313520|163238|P2|NOT COMPLETED|Overall Study||0
70070|NCT01313520|163239|P1|NOT COMPLETED|Overall Study||0
70071|NCT01313520|163238|P2|COMPLETED|Overall Study||31
70072|NCT01313520|163239|P1|COMPLETED|Overall Study||30
70073|NCT01313520|163238|P2|STARTED|Overall Study||31
70074|NCT01313520|163239|P1|STARTED|Overall Study||30
70075|NCT01313494|163261|P2|NOT COMPLETED|Overall Study||50
70076|NCT01313494|163262|P1|NOT COMPLETED|Overall Study||67
70077|NCT01313494|163261|P2|COMPLETED|Overall Study||263
70078|NCT01313494|163262|P1|COMPLETED|Overall Study||246
70079|NCT01313494|163261|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
70080|NCT01313494|163262|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
70081|NCT01313494|163261|P2|STARTED|Overall Study||313
70082|NCT01313494|163262|P1|STARTED|Overall Study||313
70083|NCT01313299|163317|P3|NOT COMPLETED|Overall Study||4
70084|NCT01313299|163318|P2|NOT COMPLETED|Overall Study||3
70085|NCT01313299|163319|P1|NOT COMPLETED|Overall Study||7
70086|NCT01313299|163317|P3|COMPLETED|Overall Study||77
70087|NCT01313299|163318|P2|COMPLETED|Overall Study||78
70088|NCT01313299|163319|P1|COMPLETED|Overall Study||74
70089|NCT01313299|163317|P3|STARTED|Overall Study||81
70090|NCT01313299|163318|P2|STARTED|Overall Study||81
70091|NCT01313299|163319|P1|STARTED|Overall Study||81
70092|NCT01313273|163335|P2|NOT COMPLETED|Overall Study||1
70093|NCT01313273|163336|P1|NOT COMPLETED|Overall Study||2
70094|NCT01313273|163335|P2|COMPLETED|Overall Study||0
70095|NCT01313273|163336|P1|COMPLETED|Overall Study||0
70096|NCT01313273|163335|P2|STARTED|Overall Study||1
70097|NCT01313273|163336|P1|STARTED|Overall Study||2
70098|NCT01313221|163351|P3|NOT COMPLETED|Overall Study||23
70099|NCT01313221|163352|P2|NOT COMPLETED|Overall Study||8
70100|NCT01313221|163353|P1|NOT COMPLETED|Overall Study||12
70101|NCT01313221|163351|P3|COMPLETED|Overall Study||0
70102|NCT01313221|163352|P2|COMPLETED|Overall Study||135
70103|NCT01313221|163353|P1|COMPLETED|Overall Study||132
70104|NCT01313221|163351|P3|Randomized|Overall Study||0
70105|NCT01313221|163352|P2|Randomized|Overall Study||143
70106|NCT01313221|163353|P1|Randomized|Overall Study||144
70107|NCT01313221|163351|P3|STARTED|Overall Study||23
70108|NCT01313221|163352|P2|STARTED|Overall Study||143
70109|NCT01313221|163353|P1|STARTED|Overall Study||144
70110|NCT01313208|163405|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
70111|NCT01313208|163406|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
70112|NCT01313208|163405|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
70113|NCT01313208|163406|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
70114|NCT01313208|163405|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
70115|NCT01313208|163406|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
70116|NCT01313208|163405|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
70117|NCT01313208|163406|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
70118|NCT01313208|163405|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
70119|NCT01313208|163406|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
70120|NCT01313208|163405|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
70121|NCT01313208|163406|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
70122|NCT01313182|163496|P2|NOT COMPLETED|Overall Study||92
70123|NCT01313182|163497|P1|NOT COMPLETED|Overall Study||66
70124|NCT01313182|163496|P2|COMPLETED|Overall Study||763
70125|NCT01313182|163497|P1|COMPLETED|Overall Study||776
70126|NCT01313182|163496|P2|STARTED|Overall Study||855
70127|NCT01313182|163497|P1|STARTED|Overall Study||842
70128|NCT01313117|163503|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
70129|NCT01313117|163503|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
70130|NCT01313117|163503|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
70131|NCT01313117|163503|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
70132|NCT01313117|163503|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
70133|NCT01313117|163503|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
70134|NCT01313117|163503|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
70135|NCT01313117|163503|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
70136|NCT01313117|163503|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
70137|NCT01313117|163503|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
70138|NCT01313117|163503|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
70139|NCT01313117|163503|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
70140|NCT01313117|163503|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
70141|NCT01313117|163503|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
70142|NCT01313117|163503|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
70143|NCT01313078|163510|P1|NOT COMPLETED|Overall Study||3
70144|NCT01313078|163510|P1|COMPLETED|Overall Study||1
70145|NCT01313078|163510|P1|STARTED|Overall Study||4
70146|NCT01313039|163515|P1|NOT COMPLETED|Overall Study||2
70147|NCT01313039|163515|P1|COMPLETED|Overall Study||2
70148|NCT01313039|163515|P1|STARTED|Overall Study||4
70149|NCT01312948|163519|P1|NOT COMPLETED|Overall Study||0
70150|NCT01312948|163519|P1|COMPLETED|Overall Study||6
70151|NCT01312948|163519|P1|STARTED|Overall Study||6
70152|NCT01312818|163526|P1|NOT COMPLETED|Overall Study||0
70153|NCT01312818|163526|P1|COMPLETED|Overall Study||2
70154|NCT01312818|163526|P1|STARTED|Overall Study||2
70155|NCT01312805|163534|P2|NOT COMPLETED|Overall Study||0
70156|NCT01312805|163535|P1|NOT COMPLETED|Overall Study||0
70157|NCT01312805|163534|P2|COMPLETED|Overall Study||1082
70158|NCT01312805|163535|P1|COMPLETED|Overall Study||1016
70159|NCT01312805|163534|P2|STARTED|Overall Study||1082
70160|NCT01312805|163535|P1|STARTED|Overall Study||1016
70161|NCT01312766|163543|P2|NOT COMPLETED|Overall Study||5
70162|NCT01312766|163544|P1|NOT COMPLETED|Overall Study||6
70163|NCT01312766|163543|P2|COMPLETED|Overall Study||130
70164|NCT01312766|163544|P1|COMPLETED|Overall Study||129
70165|NCT01312766|163543|P2|STARTED|Overall Study||135
70166|NCT01312766|163544|P1|STARTED|Overall Study||135
70167|NCT01312519|163576|P2|NOT COMPLETED|Overall Study||0
70168|NCT01312519|163577|P1|NOT COMPLETED|Overall Study||0
70169|NCT01312519|163576|P2|COMPLETED|Overall Study||24
70170|NCT01312519|163577|P1|COMPLETED|Overall Study||26
70171|NCT01312519|163576|P2|STARTED|Overall Study||24
70172|NCT01312519|163577|P1|STARTED|Overall Study||26
70173|NCT01312467|163585|P1|NOT COMPLETED|Overall Study||13
70174|NCT01312467|163585|P1|COMPLETED|Overall Study||32
70175|NCT01312467|163585|P1|STARTED|Overall Study||45
70176|NCT01312428|163591|P2|NOT COMPLETED|Overall Study||4
70177|NCT01312428|163592|P1|NOT COMPLETED|Overall Study||3
70178|NCT01312428|163591|P2|COMPLETED|Overall Study||0
70179|NCT01312428|163592|P1|COMPLETED|Overall Study||0
70180|NCT01312428|163591|P2|STARTED|Overall Study||4
70181|NCT01312428|163592|P1|STARTED|Overall Study||3
70182|NCT01312272|163600|P2|NOT COMPLETED|Overall Study||1
70183|NCT01312272|163601|P1|NOT COMPLETED|Overall Study||0
70184|NCT01312272|163600|P2|COMPLETED|Overall Study||11
70185|NCT01312272|163601|P1|COMPLETED|Overall Study||12
70186|NCT01312272|163600|P2|STARTED|Overall Study||12
70187|NCT01312272|163601|P1|STARTED|Overall Study||12
70188|NCT01312129|163619|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
70189|NCT01312129|163620|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
70190|NCT01312129|163619|P2|COMPLETED|Second Intervention (24 Hours)||6
70191|NCT01312129|163620|P1|COMPLETED|Second Intervention (24 Hours)||6
70192|NCT01312129|163619|P2|Alcohol Cue|Second Intervention (24 Hours)||6
70193|NCT01312129|163620|P1|Alcohol Cue|Second Intervention (24 Hours)||6
70194|NCT01312129|163619|P2|Control Cue|Second Intervention (24 Hours)||6
70195|NCT01312129|163620|P1|Control Cue|Second Intervention (24 Hours)||6
70196|NCT01312129|163619|P2|STARTED|Second Intervention (24 Hours)||7
70197|NCT01312129|163620|P1|STARTED|Second Intervention (24 Hours)||6
70198|NCT01312129|163619|P2|NOT COMPLETED|Washout (1 Week)||0
70199|NCT01312129|163620|P1|NOT COMPLETED|Washout (1 Week)||0
70200|NCT01312129|163619|P2|COMPLETED|Washout (1 Week)||7
70201|NCT01312129|163620|P1|COMPLETED|Washout (1 Week)||6
70202|NCT01312129|163619|P2|STARTED|Washout (1 Week)||7
70203|NCT01312129|163620|P1|STARTED|Washout (1 Week)||6
70204|NCT01312129|163619|P2|NOT COMPLETED|First Intervention (24 Hours)||0
70205|NCT01312129|163620|P1|NOT COMPLETED|First Intervention (24 Hours)||0
70206|NCT01312129|163619|P2|COMPLETED|First Intervention (24 Hours)||7
70207|NCT01312129|163620|P1|COMPLETED|First Intervention (24 Hours)||6
70208|NCT01312129|163619|P2|Alcohol Cue|First Intervention (24 Hours)||7
70209|NCT01312129|163620|P1|Alcohol Cue|First Intervention (24 Hours)||6
70210|NCT01312129|163619|P2|Control Cue|First Intervention (24 Hours)||7
70211|NCT01312129|163620|P1|Control Cue|First Intervention (24 Hours)||6
70212|NCT01312129|163619|P2|STARTED|First Intervention (24 Hours)||7
70213|NCT01312129|163620|P1|STARTED|First Intervention (24 Hours)||6
70214|NCT01312038|163628|P2|NOT COMPLETED|Overall Study||0
70215|NCT01312038|163629|P1|NOT COMPLETED|Overall Study||0
70216|NCT01312038|163628|P2|COMPLETED|Overall Study||12
70217|NCT01312038|163629|P1|COMPLETED|Overall Study||13
70218|NCT01312038|163628|P2|STARTED|Overall Study||12
70219|NCT01312038|163629|P1|STARTED|Overall Study||13
70220|NCT01311687|163637|P2|NOT COMPLETED|PFS Follow-up Phase||1
70221|NCT01311687|163638|P1|NOT COMPLETED|PFS Follow-up Phase||3
70222|NCT01311687|163637|P2|COMPLETED|PFS Follow-up Phase||7
70223|NCT01311687|163638|P1|COMPLETED|PFS Follow-up Phase||5
70224|NCT01311687|163637|P2|STARTED|PFS Follow-up Phase||8
70225|NCT01311687|163638|P1|STARTED|PFS Follow-up Phase||8
70226|NCT01311687|163637|P2|NOT COMPLETED|Treatment Phase||11
70227|NCT01311687|163638|P1|NOT COMPLETED|Treatment Phase||60
70228|NCT01311687|163637|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
70229|NCT01311687|163638|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
70230|NCT01311687|163637|P2|Received Study Treatment|Treatment Phase||150
70231|NCT01311687|163638|P1|Received Study Treatment|Treatment Phase||300
70232|NCT01311687|163637|P2|STARTED|Treatment Phase||153
70233|NCT01311687|163638|P1|STARTED|Treatment Phase||302
70234|NCT01311661|163688|P1|NOT COMPLETED|Overall Study||7
70235|NCT01311661|163688|P1|COMPLETED|Overall Study||199
70236|NCT01311661|163688|P1|Received Olo 10 mcg qd|Overall Study||102
70237|NCT01311661|163688|P1|Received Olo 5 mcg Bid|Overall Study||101
70238|NCT01311661|163688|P1|Received Olo 5 mcg qd|Overall Study||101
70239|NCT01311661|163688|P1|Received Olo 2.5 mcg Bid|Overall Study||101
70240|NCT01311661|163688|P1|Received Placebo|Overall Study||201
70241|NCT01311661|163688|P1|STARTED|Overall Study|Entered and treated|206
70242|NCT01311557|163832|P2|NOT COMPLETED|Overall Study||6
70243|NCT01311557|163833|P1|NOT COMPLETED|Overall Study||5
70244|NCT01311557|163832|P2|COMPLETED|Overall Study||645
70245|NCT01311557|163833|P1|COMPLETED|Overall Study||646
70246|NCT01311557|163832|P2|STARTED|Overall Study||651
70247|NCT01311557|163833|P1|STARTED|Overall Study||651
70248|NCT01311505|163849|P2|NOT COMPLETED|Second Intervention Period||0
70249|NCT01311505|163850|P1|NOT COMPLETED|Second Intervention Period||0
70250|NCT01311505|163849|P2|COMPLETED|Second Intervention Period||10
70251|NCT01311505|163850|P1|COMPLETED|Second Intervention Period||10
70252|NCT01311505|163849|P2|STARTED|Second Intervention Period||10
70253|NCT01311505|163850|P1|STARTED|Second Intervention Period||10
70254|NCT01311505|163849|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
70255|NCT01311505|163850|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
70256|NCT01311505|163849|P2|COMPLETED|Washout Period (at Least 7 Days)||10
70257|NCT01311505|163850|P1|COMPLETED|Washout Period (at Least 7 Days)||10
70258|NCT01311505|163849|P2|STARTED|Washout Period (at Least 7 Days)||10
70259|NCT01311505|163850|P1|STARTED|Washout Period (at Least 7 Days)||10
70260|NCT01311505|163849|P2|NOT COMPLETED|First Intervention Period||1
70261|NCT01311505|163850|P1|NOT COMPLETED|First Intervention Period||0
70262|NCT01311505|163849|P2|COMPLETED|First Intervention Period||10
70263|NCT01311505|163850|P1|COMPLETED|First Intervention Period||10
70264|NCT01311505|163849|P2|STARTED|First Intervention Period||11
70265|NCT01311505|163850|P1|STARTED|First Intervention Period||10
70266|NCT01311362|163878|P1|NOT COMPLETED|Ambrisentan and SJW||0
70267|NCT01311362|163878|P1|COMPLETED|Ambrisentan and SJW||20
70268|NCT01311362|163878|P1|STARTED|Ambrisentan and SJW||20
70269|NCT01311362|163878|P1|NOT COMPLETED|Ambrisentan Steady-state||0
70270|NCT01311362|163878|P1|COMPLETED|Ambrisentan Steady-state||20
70271|NCT01311362|163878|P1|STARTED|Ambrisentan Steady-state||20
70272|NCT01311362|163878|P1|NOT COMPLETED|Ambrisentan Single Dose||0
70273|NCT01311362|163878|P1|COMPLETED|Ambrisentan Single Dose||20
70274|NCT01311362|163878|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
70275|NCT01311102|163891|P2|NOT COMPLETED|Overall Study||0
70276|NCT01311102|163892|P1|NOT COMPLETED|Overall Study||0
70277|NCT01311102|163891|P2|COMPLETED|Overall Study||20
70278|NCT01311102|163892|P1|COMPLETED|Overall Study||20
70279|NCT01311102|163891|P2|STARTED|Overall Study||20
70280|NCT01311102|163892|P1|STARTED|Overall Study||20
70281|NCT01311024|163906|P2|NOT COMPLETED|Overall Study||22
70282|NCT01311024|163907|P1|NOT COMPLETED|Overall Study||35
70283|NCT01311024|163906|P2|COMPLETED|Overall Study||789
70284|NCT01311024|163907|P1|COMPLETED|Overall Study||1495
70285|NCT01311024|163906|P2|STARTED|Overall Study||811
70286|NCT01311024|163907|P1|STARTED|Overall Study||1530
70287|NCT01310855|163915|P2|NOT COMPLETED|Overall Study||37
70288|NCT01310855|163916|P1|NOT COMPLETED|Overall Study||37
70289|NCT01310855|163915|P2|COMPLETED|Overall Study||19
70290|NCT01310855|163916|P1|COMPLETED|Overall Study||19
70291|NCT01310855|163915|P2|STARTED|Overall Study||56
70292|NCT01310855|163916|P1|STARTED|Overall Study||56
70293|NCT01310803|163924|P2|NOT COMPLETED|Overall Study||0
70294|NCT01310803|163925|P1|NOT COMPLETED|Overall Study||1
70295|NCT01310803|163924|P2|COMPLETED|Overall Study||0
70296|NCT01310803|163925|P1|COMPLETED|Overall Study||0
70297|NCT01310803|163924|P2|STARTED|Overall Study||0
70298|NCT01310803|163925|P1|STARTED|Overall Study||1
70299|NCT01310777|163936|P3|NOT COMPLETED|Overall Study||30
70300|NCT01310777|163937|P2|NOT COMPLETED|Overall Study||14
70301|NCT01310777|163938|P1|NOT COMPLETED|Overall Study||33
70302|NCT01310777|163936|P3|COMPLETED|Overall Study||145
70303|NCT01310777|163937|P2|COMPLETED|Overall Study||178
70304|NCT01310777|163938|P1|COMPLETED|Overall Study||160
70305|NCT01310777|163936|P3|STARTED|Overall Study||175
70306|NCT01310777|163937|P2|STARTED|Overall Study||192
70307|NCT01310777|163938|P1|STARTED|Overall Study||193
70308|NCT01310582|163948|P2|NOT COMPLETED|Overall Study||0
70309|NCT01310582|163949|P1|NOT COMPLETED|Overall Study||0
70310|NCT01310582|163948|P2|COMPLETED|Overall Study||26
70311|NCT01310582|163949|P1|COMPLETED|Overall Study||31
70312|NCT01310582|163948|P2|STARTED|Overall Study||26
70313|NCT01310582|163949|P1|STARTED|Overall Study||31
70314|NCT01310413|163963|P7|NOT COMPLETED|From Day U0 to Day U385||3
70315|NCT01310413|163964|P6|NOT COMPLETED|From Day U0 to Day U385||0
70316|NCT01310413|163965|P5|NOT COMPLETED|From Day U0 to Day U385||0
70317|NCT01310413|163966|P4|NOT COMPLETED|From Day U0 to Day U385||0
70318|NCT01310413|163967|P3|NOT COMPLETED|From Day U0 to Day U385||0
70319|NCT01310413|163968|P2|NOT COMPLETED|From Day U0 to Day U385||0
70320|NCT01310413|163969|P1|NOT COMPLETED|From Day U0 to Day U385||0
70321|NCT01310413|163963|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
70322|NCT01310413|163964|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70323|NCT01310413|163965|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70324|NCT01310413|163966|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70325|NCT01310413|163967|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70326|NCT01310413|163968|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70327|NCT01310413|163969|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70328|NCT01310413|163963|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
70329|NCT01310413|163964|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70330|NCT01310413|163965|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70331|NCT01310413|163966|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
70332|NCT01310413|163967|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70333|NCT01310413|163968|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70334|NCT01310413|163969|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
70335|NCT01310413|163963|P7|NOT COMPLETED|Day 0 to Day 385||0
70336|NCT01310413|163964|P6|NOT COMPLETED|Day 0 to Day 385||3
70337|NCT01310413|163965|P5|NOT COMPLETED|Day 0 to Day 385||3
70338|NCT01310413|163966|P4|NOT COMPLETED|Day 0 to Day 385||8
70339|NCT01310413|163967|P3|NOT COMPLETED|Day 0 to Day 385||7
70340|NCT01310413|163968|P2|NOT COMPLETED|Day 0 to Day 385||8
70341|NCT01310413|163969|P1|NOT COMPLETED|Day 0 to Day 385||27
70342|NCT01310413|163963|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
70343|NCT01310413|163964|P6|COMPLETED|Day 0 to Day 385||77
70344|NCT01310413|163965|P5|COMPLETED|Day 0 to Day 385||73
70345|NCT01310413|163966|P4|COMPLETED|Day 0 to Day 385||67
70346|NCT01310413|163967|P3|COMPLETED|Day 0 to Day 385||203
70347|NCT01310413|163968|P2|COMPLETED|Day 0 to Day 385||190
70348|NCT01310413|163969|P1|COMPLETED|Day 0 to Day 385||172
70349|NCT01310413|163963|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
70350|NCT01310413|163964|P6|STARTED|Day 0 to Day 385||80
70351|NCT01310413|163965|P5|STARTED|Day 0 to Day 385||76
70352|NCT01310413|163966|P4|STARTED|Day 0 to Day 385||75
70353|NCT01310413|163967|P3|STARTED|Day 0 to Day 385||210
70354|NCT01310413|163968|P2|STARTED|Day 0 to Day 385||198
70355|NCT01310413|163969|P1|STARTED|Day 0 to Day 385||199
70356|NCT01310400|164125|P3|NOT COMPLETED|Overall Study||30
70357|NCT01310400|164126|P2|NOT COMPLETED|Overall Study||32
70358|NCT01310400|164127|P1|NOT COMPLETED|Overall Study||28
70359|NCT01310400|164125|P3|COMPLETED|Overall Study||422
70360|NCT01310400|164126|P2|COMPLETED|Overall Study||420
70361|NCT01310400|164127|P1|COMPLETED|Overall Study||424
70362|NCT01310400|164125|P3|STARTED|Overall Study||452
70363|NCT01310400|164126|P2|STARTED|Overall Study||452
70364|NCT01310400|164127|P1|STARTED|Overall Study||452
70365|NCT01310179|164144|P1|NOT COMPLETED|Overall Study||0
70366|NCT01310179|164144|P1|COMPLETED|Overall Study||12
70367|NCT01310179|164144|P1|STARTED|Overall Study||12
70368|NCT01310127|164151|P2|NOT COMPLETED|Overall Study||1
70369|NCT01310127|164152|P1|NOT COMPLETED|Overall Study||2
70370|NCT01310127|164151|P2|COMPLETED|Overall Study||10
70371|NCT01310127|164152|P1|COMPLETED|Overall Study||10
70372|NCT01310127|164151|P2|STARTED|Overall Study||11
70373|NCT01310127|164152|P1|STARTED|Overall Study||12
70374|NCT01309997|164166|P2|NOT COMPLETED|Overall Study||6
70375|NCT01309997|164167|P1|NOT COMPLETED|Overall Study||5
70376|NCT01309997|164166|P2|COMPLETED|Overall Study||31
70377|NCT01309997|164167|P1|COMPLETED|Overall Study||30
70378|NCT01309997|164166|P2|Crossed Over to Second Arm|Overall Study||23
70379|NCT01309997|164167|P1|Crossed Over to Second Arm|Overall Study||19
70380|NCT01309997|164166|P2|Remained on First Arm Only|Overall Study||14
70381|NCT01309997|164167|P1|Remained on First Arm Only|Overall Study||16
70382|NCT01309997|164166|P2|STARTED|Overall Study||37
70383|NCT01309997|164167|P1|STARTED|Overall Study||35
70384|NCT01309919|164191|P2|NOT COMPLETED|Overall Study||48
70385|NCT01309919|164192|P1|NOT COMPLETED|Overall Study||17
70386|NCT01309919|164191|P2|COMPLETED|Overall Study||27
70387|NCT01309919|164192|P1|COMPLETED|Overall Study||58
70388|NCT01309919|164191|P2|STARTED|Overall Study||75
70389|NCT01309919|164192|P1|STARTED|Overall Study||75
70390|NCT01309893|164204|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
70391|NCT01309893|164205|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
70392|NCT01309893|164204|P2|COMPLETED|Week 2 - Crossover Intervention||32
70393|NCT01309893|164205|P1|COMPLETED|Week 2 - Crossover Intervention||32
70394|NCT01309893|164204|P2|STARTED|Week 2 - Crossover Intervention||33
70395|NCT01309893|164205|P1|STARTED|Week 2 - Crossover Intervention||33
70396|NCT01309893|164204|P2|NOT COMPLETED|Week 1 - First Intervention||0
70397|NCT01309893|164205|P1|NOT COMPLETED|Week 1 - First Intervention||0
70398|NCT01309893|164204|P2|COMPLETED|Week 1 - First Intervention||33
70399|NCT01309893|164205|P1|COMPLETED|Week 1 - First Intervention||33
70400|NCT01309893|164204|P2|STARTED|Week 1 - First Intervention||33
70401|NCT01309893|164205|P1|STARTED|Week 1 - First Intervention||33
70402|NCT01309880|164215|P2|NOT COMPLETED|Overall Study||0
70403|NCT01309880|164216|P1|NOT COMPLETED|Overall Study||0
70404|NCT01309880|164215|P2|COMPLETED|Overall Study||33
70405|NCT01309880|164216|P1|COMPLETED|Overall Study||33
70406|NCT01309880|164215|P2|STARTED|Overall Study||33
70407|NCT01309880|164216|P1|STARTED|Overall Study||33
70408|NCT01309841|164229|P3|NOT COMPLETED|Overall Study||37
70409|NCT01309841|164230|P2|NOT COMPLETED|Overall Study||41
70410|NCT01309841|164231|P1|NOT COMPLETED|Overall Study||39
70411|NCT01309841|164229|P3|COMPLETED|Overall Study||180
70412|NCT01309841|164230|P2|COMPLETED|Overall Study||177
70413|NCT01309841|164231|P1|COMPLETED|Overall Study||178
70414|NCT01309841|164229|P3|STARTED|Overall Study||217
70415|NCT01309841|164230|P2|STARTED|Overall Study||218
70416|NCT01309841|164231|P1|STARTED|Overall Study||217
70417|NCT01309828|164271|P2|NOT COMPLETED|Overall Study||16
70418|NCT01309828|164272|P1|NOT COMPLETED|Overall Study||16
70419|NCT01309828|164271|P2|COMPLETED|Overall Study||60
70420|NCT01309828|164272|P1|COMPLETED|Overall Study||61
70421|NCT01309828|164271|P2|STARTED|Overall Study||76
70422|NCT01309828|164272|P1|STARTED|Overall Study||77
70423|NCT01309737|164287|P5|NOT COMPLETED|Week 16 to 52||33
70424|NCT01309737|164288|P4|NOT COMPLETED|Week 16 to 52||34
70425|NCT01309737|164289|P3|NOT COMPLETED|Week 16 to 52||0
70426|NCT01309737|164290|P2|NOT COMPLETED|Week 16 to 52||103
70427|NCT01309737|164291|P1|NOT COMPLETED|Week 16 to 52||133
70428|NCT01309737|164287|P5|COMPLETED|Week 16 to 52||44
70429|NCT01309737|164288|P4|COMPLETED|Week 16 to 52||41
70430|NCT01309737|164289|P3|COMPLETED|Week 16 to 52||0
70431|NCT01309737|164290|P2|COMPLETED|Week 16 to 52||238
70432|NCT01309737|164291|P1|COMPLETED|Week 16 to 52||198
70433|NCT01309737|164287|P5|STARTED|Week 16 to 52||77
70434|NCT01309737|164288|P4|STARTED|Week 16 to 52||75
70435|NCT01309737|164289|P3|STARTED|Week 16 to 52||0
70436|NCT01309737|164290|P2|STARTED|Week 16 to 52||341
70437|NCT01309737|164291|P1|STARTED|Week 16 to 52||331
70438|NCT01309737|164287|P5|NOT COMPLETED|Week 0 to 16||0
70439|NCT01309737|164288|P4|NOT COMPLETED|Week 0 to 16||0
70440|NCT01309737|164289|P3|NOT COMPLETED|Week 0 to 16||44
70441|NCT01309737|164290|P2|NOT COMPLETED|Week 0 to 16||40
70442|NCT01309737|164291|P1|NOT COMPLETED|Week 0 to 16||52
70443|NCT01309737|164287|P5|COMPLETED|Week 0 to 16||0
70444|NCT01309737|164288|P4|COMPLETED|Week 0 to 16||0
70445|NCT01309737|164289|P3|COMPLETED|Week 0 to 16||152
70446|NCT01309737|164290|P2|COMPLETED|Week 0 to 16||341
70447|NCT01309737|164291|P1|COMPLETED|Week 0 to 16||331
70448|NCT01309737|164287|P5|Treated|Week 0 to 16||0
70449|NCT01309737|164288|P4|Treated|Week 0 to 16||0
70450|NCT01309737|164289|P3|Treated|Week 0 to 16||196
70451|NCT01309737|164290|P2|Treated|Week 0 to 16||381
70452|NCT01309737|164291|P1|Treated|Week 0 to 16||382
70453|NCT01309737|164287|P5|STARTED|Week 0 to 16||0
70454|NCT01309737|164288|P4|STARTED|Week 0 to 16||0
70455|NCT01309737|164289|P3|STARTED|Week 0 to 16||196
70456|NCT01309737|164290|P2|STARTED|Week 0 to 16||381
70457|NCT01309737|164291|P1|STARTED|Week 0 to 16||383
70458|NCT01309659|164488|P2|NOT COMPLETED|Overall Study||1
70459|NCT01309659|164489|P1|NOT COMPLETED|Overall Study||0
70460|NCT01309659|164488|P2|COMPLETED|Overall Study||9
70461|NCT01309659|164489|P1|COMPLETED|Overall Study||9
70462|NCT01309659|164488|P2|STARTED|Overall Study||10
70463|NCT01309659|164489|P1|STARTED|Overall Study||9
70464|NCT01309646|164531|P2|NOT COMPLETED|Overall Study||0
70465|NCT01309646|164532|P1|NOT COMPLETED|Overall Study||0
70466|NCT01309646|164531|P2|COMPLETED|Overall Study||227
70467|NCT01309646|164532|P1|COMPLETED|Overall Study||224
70468|NCT01309646|164531|P2|STARTED|Overall Study||227
70469|NCT01309646|164532|P1|STARTED|Overall Study||224
70470|NCT01309581|164572|P2|NOT COMPLETED|Overall Study||0
70471|NCT01309581|164573|P1|NOT COMPLETED|Overall Study||0
70472|NCT01309581|164572|P2|COMPLETED|Overall Study||1
70473|NCT01309581|164573|P1|COMPLETED|Overall Study||2
70474|NCT01309581|164572|P2|STARTED|Overall Study||1
70475|NCT01309581|164573|P1|STARTED|Overall Study||2
70476|NCT01309451|164583|P2|NOT COMPLETED|Overall Study||3
70477|NCT01309451|164584|P1|NOT COMPLETED|Overall Study||2
70478|NCT01309451|164583|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
70479|NCT01309451|164584|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
70480|NCT01309451|164583|P2|STARTED|Overall Study|unit of measure is number of eyes|21
70481|NCT01309451|164584|P1|STARTED|Overall Study|unit of measure is number of eyes|19
70482|NCT01309386|164594|P2|NOT COMPLETED|Overall Study||21
70483|NCT01309386|164595|P1|NOT COMPLETED|Overall Study||22
70484|NCT01309386|164594|P2|COMPLETED|Overall Study||29
70485|NCT01309386|164595|P1|COMPLETED|Overall Study||28
70486|NCT01309386|164594|P2|STARTED|Overall Study||50
70487|NCT01309386|164595|P1|STARTED|Overall Study||50
70488|NCT01309360|164616|P3|NOT COMPLETED|Overall Study||0
70489|NCT01309360|164617|P2|NOT COMPLETED|Overall Study||0
70490|NCT01309360|164618|P1|NOT COMPLETED|Overall Study||0
70491|NCT01309360|164616|P3|COMPLETED|Overall Study||40
70492|NCT01309360|164617|P2|COMPLETED|Overall Study||40
70493|NCT01309360|164618|P1|COMPLETED|Overall Study||40
70494|NCT01309360|164616|P3|STARTED|Overall Study||40
70495|NCT01309360|164617|P2|STARTED|Overall Study||40
70496|NCT01309360|164618|P1|STARTED|Overall Study||40
70497|NCT01309308|164643|P2|NOT COMPLETED|Overall Study||4
70498|NCT01309308|164644|P1|NOT COMPLETED|Overall Study||6
70499|NCT01309308|164643|P2|COMPLETED|Overall Study||71
70500|NCT01309308|164644|P1|COMPLETED|Overall Study||69
70501|NCT01309308|164643|P2|STARTED|Overall Study||75
70502|NCT01309308|164644|P1|STARTED|Overall Study||75
70503|NCT01309282|164652|P1|NOT COMPLETED|Overall Study||1
70504|NCT01309282|164652|P1|COMPLETED|Overall Study||8
70505|NCT01309282|164652|P1|STARTED|Overall Study||9
70506|NCT01309269|164669|P1|NOT COMPLETED|Overall Study||840
70507|NCT01309269|164669|P1|COMPLETED|Overall Study||245
70508|NCT01309269|164669|P1|Treated|Overall Study||978
70509|NCT01309269|164669|P1|STARTED|Overall Study||1085
70510|NCT01309243|164677|P2|NOT COMPLETED|Extension Phase||0
70511|NCT01309243|164678|P1|NOT COMPLETED|Extension Phase||6
70512|NCT01309243|164677|P2|COMPLETED|Extension Phase||117
70513|NCT01309243|164678|P1|COMPLETED|Extension Phase||34
70514|NCT01309243|164677|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
70515|NCT01309243|164678|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
70516|NCT01309243|164677|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
70517|NCT01309243|164678|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
70518|NCT01309243|164677|P2|COMPLETED|Randomized Phase Through Week 96||290
70519|NCT01309243|164678|P1|COMPLETED|Randomized Phase Through Week 96||316
70520|NCT01309243|164677|P2|Randomized and Treated|Randomized Phase Through Week 96||392
70521|NCT01309243|164678|P1|Randomized and Treated|Randomized Phase Through Week 96||394
70522|NCT01309243|164677|P2|STARTED|Randomized Phase Through Week 96||399
70523|NCT01309243|164678|P1|STARTED|Randomized Phase Through Week 96||400
70524|NCT01309204|164704|P2|NOT COMPLETED|Overall Study||75
70525|NCT01309204|164705|P1|NOT COMPLETED|Overall Study||67
70526|NCT01309204|164704|P2|COMPLETED|Overall Study||361
70527|NCT01309204|164705|P1|COMPLETED|Overall Study||385
70528|NCT01309204|164704|P2|STARTED|Overall Study||436
70529|NCT01309204|164705|P1|STARTED|Overall Study||452
70530|NCT01309100|164711|P1|NOT COMPLETED|Overall Study||2
70531|NCT01309100|164711|P1|COMPLETED|Overall Study||142
70532|NCT01309100|164711|P1|STARTED|Overall Study||144
70533|NCT01308918|164722|P1|NOT COMPLETED|Overall Study||0
70534|NCT01308918|164722|P1|COMPLETED|Overall Study||50
70535|NCT01308918|164722|P1|STARTED|Overall Study||50
70536|NCT01308840|164729|P1|NOT COMPLETED|Overall Study||0
70537|NCT01308840|164729|P1|COMPLETED|Overall Study||31
70538|NCT01308840|164729|P1|STARTED|Overall Study||31
70539|NCT01308788|164738|P2|NOT COMPLETED|2-year Treatment||11
70540|NCT01308788|164739|P1|NOT COMPLETED|2-year Treatment||4
70541|NCT01308788|164738|P2|COMPLETED|2-year Treatment||10
70542|NCT01308788|164739|P1|COMPLETED|2-year Treatment||10
70543|NCT01308788|164738|P2|STARTED|2-year Treatment||21
70544|NCT01308788|164739|P1|STARTED|2-year Treatment||14
70545|NCT01308788|164738|P2|NOT COMPLETED|6-month Treatment||0
70546|NCT01308788|164739|P1|NOT COMPLETED|6-month Treatment||0
70547|NCT01308788|164738|P2|COMPLETED|6-month Treatment||21
70548|NCT01308788|164739|P1|COMPLETED|6-month Treatment||14
70549|NCT01308788|164738|P2|STARTED|6-month Treatment||21
70550|NCT01308788|164739|P1|STARTED|6-month Treatment||14
70551|NCT01308762|164774|P3|NOT COMPLETED|Overall Study||0
70552|NCT01308762|164775|P2|NOT COMPLETED|Overall Study||1
70553|NCT01308762|164776|P1|NOT COMPLETED|Overall Study||0
70554|NCT01308762|164774|P3|COMPLETED|Overall Study||6
70555|NCT01308762|164775|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
70556|NCT01308762|164776|P1|COMPLETED|Overall Study||6
70557|NCT01308762|164774|P3|STARTED|Overall Study||6
70558|NCT01308762|164775|P2|STARTED|Overall Study||7
70559|NCT01308762|164776|P1|STARTED|Overall Study||6
70560|NCT01308736|164789|P2|NOT COMPLETED|Overall Study||5
70561|NCT01308736|164790|P1|NOT COMPLETED|Overall Study||6
70562|NCT01308736|164789|P2|COMPLETED|Overall Study||27
70563|NCT01308736|164790|P1|COMPLETED|Overall Study||25
70564|NCT01308736|164789|P2|STARTED|Overall Study||32
70565|NCT01308736|164790|P1|STARTED|Overall Study||31
70566|NCT01308619|164798|P2|NOT COMPLETED|Overall Study||3
70567|NCT01308619|164799|P1|NOT COMPLETED|Overall Study||7
70568|NCT01308619|164798|P2|COMPLETED|Overall Study||83
70569|NCT01308619|164799|P1|COMPLETED|Overall Study||77
70570|NCT01308619|164798|P2|STARTED|Overall Study||86
70571|NCT01308619|164799|P1|STARTED|Overall Study||84
70572|NCT01308580|164813|P2|NOT COMPLETED|Overall Study||7
70573|NCT01308580|164814|P1|NOT COMPLETED|Overall Study||12
70574|NCT01308580|164813|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
70575|NCT01308580|164814|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
70576|NCT01308580|164813|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
70577|NCT01308580|164814|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
70578|NCT01308580|164813|P2|STARTED|Overall Study||602
70579|NCT01308580|164814|P1|STARTED|Overall Study||598
70580|NCT01308476|164856|P2|NOT COMPLETED|Overall Study||2
70581|NCT01308476|164857|P1|NOT COMPLETED|Overall Study||3
70582|NCT01308476|164856|P2|COMPLETED|Overall Study||45
70583|NCT01308476|164857|P1|COMPLETED|Overall Study||45
70584|NCT01308476|164856|P2|STARTED|Overall Study|Entered and treated.|47
70585|NCT01308476|164857|P1|STARTED|Overall Study|Entered and treated.|48
70586|NCT01308450|164877|P1|NOT COMPLETED|Overall Study||2
70587|NCT01308450|164877|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
70588|NCT01308450|164877|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
70589|NCT01308424|164883|P3|NOT COMPLETED|Randomization||2
70590|NCT01308424|164884|P2|NOT COMPLETED|Randomization||3
70591|NCT01308424|164885|P1|NOT COMPLETED|Randomization||0
70592|NCT01308424|164883|P3|COMPLETED|Randomization||82
70593|NCT01308424|164884|P2|COMPLETED|Randomization||84
70594|NCT01308424|164885|P1|COMPLETED|Randomization||0
70595|NCT01308424|164883|P3|STARTED|Randomization||84
70596|NCT01308424|164884|P2|STARTED|Randomization||87
70597|NCT01308424|164885|P1|STARTED|Randomization||0
70598|NCT01308424|164883|P3|NOT COMPLETED|Baseline Eligibility||0
70599|NCT01308424|164884|P2|NOT COMPLETED|Baseline Eligibility||0
70600|NCT01308424|164885|P1|NOT COMPLETED|Baseline Eligibility||71
70601|NCT01308424|164883|P3|COMPLETED|Baseline Eligibility||0
70602|NCT01308424|164884|P2|COMPLETED|Baseline Eligibility||0
70603|NCT01308424|164885|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
70604|NCT01308424|164883|P3|STARTED|Baseline Eligibility||0
70605|NCT01308424|164884|P2|STARTED|Baseline Eligibility||0
70606|NCT01308424|164885|P1|STARTED|Baseline Eligibility||242
70607|NCT01307787|164894|P2|NOT COMPLETED|Overall Study||0
70608|NCT01307787|164895|P1|NOT COMPLETED|Overall Study||2
70609|NCT01307787|164894|P2|COMPLETED|Overall Study||15
70610|NCT01307787|164895|P1|COMPLETED|Overall Study||17
70611|NCT01307787|164894|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
70612|NCT01307787|164895|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
70613|NCT01307787|164894|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
70614|NCT01307787|164895|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
70615|NCT01307787|164894|P2|STARTED|Overall Study||15
70616|NCT01307787|164895|P1|STARTED|Overall Study||19
70617|NCT01307618|164917|P2|NOT COMPLETED|Overall Study||0
70618|NCT01307618|164918|P1|NOT COMPLETED|Overall Study||0
70619|NCT01307618|164917|P2|COMPLETED|Overall Study||5
70620|NCT01307618|164918|P1|COMPLETED|Overall Study||5
70621|NCT01307618|164917|P2|STARTED|Overall Study||5
70622|NCT01307618|164918|P1|STARTED|Overall Study||5
70623|NCT01307423|164937|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
70624|NCT01307423|164938|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
70625|NCT01307423|164939|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
70626|NCT01307423|164940|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
70627|NCT01307423|164941|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
70628|NCT01307423|164942|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
70629|NCT01307423|164943|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
70630|NCT01307423|164937|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
70631|NCT01307423|164938|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
70632|NCT01307423|164939|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
70633|NCT01307423|164940|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
70634|NCT01307423|164941|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
70635|NCT01307423|164942|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
70636|NCT01307423|164943|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
70637|NCT01307423|164937|P7|STARTED|Active Treatment Phase (Week 25-52)||26
70638|NCT01307423|164938|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
70639|NCT01307423|164939|P5|STARTED|Active Treatment Phase (Week 25-52)||26
70640|NCT01307423|164940|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
70641|NCT01307423|164941|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
70642|NCT01307423|164942|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
70643|NCT01307423|164943|P1|STARTED|Active Treatment Phase (Week 25-52)||0
70644|NCT01307423|164937|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70645|NCT01307423|164938|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70646|NCT01307423|164939|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70647|NCT01307423|164940|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70648|NCT01307423|164941|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
70649|NCT01307423|164942|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
70650|NCT01307423|164943|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
70651|NCT01307423|164937|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70652|NCT01307423|164938|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70653|NCT01307423|164939|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70654|NCT01307423|164940|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
70655|NCT01307423|164941|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
70656|NCT01307423|164942|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
70657|NCT01307423|164943|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
70658|NCT01307423|164937|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70659|NCT01307423|164938|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70660|NCT01307423|164939|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70661|NCT01307423|164940|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70662|NCT01307423|164941|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
70663|NCT01307423|164942|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
70664|NCT01307423|164943|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
70665|NCT01307423|164937|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70666|NCT01307423|164938|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70667|NCT01307423|164939|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70668|NCT01307423|164940|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
70669|NCT01307423|164941|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
70670|NCT01307423|164942|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
70671|NCT01307423|164943|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
70672|NCT01307423|164937|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
70673|NCT01307423|164938|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
70674|NCT01307423|164939|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
70675|NCT01307423|164940|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
70676|NCT01307423|164941|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
70677|NCT01307423|164942|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
70678|NCT01307423|164943|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
70679|NCT01307423|164937|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
70680|NCT01307423|164938|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
70681|NCT01307423|164939|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
70682|NCT01307423|164940|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
70683|NCT01307423|164941|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
70684|NCT01307423|164942|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
70685|NCT01307423|164943|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
70686|NCT01307319|165055|P3|NOT COMPLETED|Overall Study||7
70687|NCT01307319|165056|P2|NOT COMPLETED|Overall Study||8
70688|NCT01307319|165057|P1|NOT COMPLETED|Overall Study||4
70689|NCT01307319|165055|P3|COMPLETED|Overall Study||227
70690|NCT01307319|165056|P2|COMPLETED|Overall Study||234
70691|NCT01307319|165057|P1|COMPLETED|Overall Study||235
70692|NCT01307319|165055|P3|ITT Population|Overall Study||234
70693|NCT01307319|165056|P2|ITT Population|Overall Study||241
70694|NCT01307319|165057|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
70695|NCT01307319|165055|P3|Safety Population|Overall Study||234
70696|NCT01307319|165056|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
70697|NCT01307319|165057|P1|Safety Population|Overall Study||239
70698|NCT01307319|165055|P3|STARTED|Overall Study|Randomized|234
70699|NCT01307319|165056|P2|STARTED|Overall Study|Randomized|242
70700|NCT01307319|165057|P1|STARTED|Overall Study|Randomized|239
70701|NCT01307111|165071|P2|NOT COMPLETED|1-2 Week IUD Check up||2
70702|NCT01307111|165072|P1|NOT COMPLETED|1-2 Week IUD Check up||2
70703|NCT01307111|165071|P2|COMPLETED|1-2 Week IUD Check up||38
70704|NCT01307111|165072|P1|COMPLETED|1-2 Week IUD Check up||38
70705|NCT01307111|165071|P2|STARTED|1-2 Week IUD Check up||40
70706|NCT01307111|165072|P1|STARTED|1-2 Week IUD Check up||40
70707|NCT01307111|165071|P2|NOT COMPLETED|IUD Insertion||0
70708|NCT01307111|165072|P1|NOT COMPLETED|IUD Insertion||2
70709|NCT01307111|165071|P2|COMPLETED|IUD Insertion||40
70710|NCT01307111|165072|P1|COMPLETED|IUD Insertion||40
70711|NCT01307111|165071|P2|STARTED|IUD Insertion||40
70712|NCT01307111|165072|P1|STARTED|IUD Insertion||42
70713|NCT01307046|165082|P2|NOT COMPLETED|Overall Study||11
70714|NCT01307046|165083|P1|NOT COMPLETED|Overall Study||12
70715|NCT01307046|165082|P2|COMPLETED|Overall Study||159
70716|NCT01307046|165083|P1|COMPLETED|Overall Study||154
70717|NCT01307046|165082|P2|STARTED|Overall Study||170
70718|NCT01307046|165083|P1|STARTED|Overall Study||166
70719|NCT01307033|165095|P4|NOT COMPLETED|44-week Open-label Extension||12
70720|NCT01307033|165096|P3|NOT COMPLETED|44-week Open-label Extension||11
70721|NCT01307033|165097|P2|NOT COMPLETED|44-week Open-label Extension||0
70722|NCT01307033|165098|P1|NOT COMPLETED|44-week Open-label Extension||0
70723|NCT01307033|165095|P4|COMPLETED|44-week Open-label Extension||115
70724|NCT01307033|165096|P3|COMPLETED|44-week Open-label Extension||120
70725|NCT01307033|165097|P2|COMPLETED|44-week Open-label Extension||0
70726|NCT01307033|165098|P1|COMPLETED|44-week Open-label Extension||0
70727|NCT01307033|165095|P4|STARTED|44-week Open-label Extension||127
70728|NCT01307033|165096|P3|STARTED|44-week Open-label Extension||131
70729|NCT01307033|165097|P2|STARTED|44-week Open-label Extension||0
70730|NCT01307033|165098|P1|STARTED|44-week Open-label Extension||0
70731|NCT01307033|165095|P4|NOT COMPLETED|8-week Double-blind Period||0
70732|NCT01307033|165096|P3|NOT COMPLETED|8-week Double-blind Period||0
70733|NCT01307033|165097|P2|NOT COMPLETED|8-week Double-blind Period||7
70734|NCT01307033|165098|P1|NOT COMPLETED|8-week Double-blind Period||13
70735|NCT01307033|165095|P4|COMPLETED|8-week Double-blind Period||0
70736|NCT01307033|165096|P3|COMPLETED|8-week Double-blind Period||0
70737|NCT01307033|165097|P2|COMPLETED|8-week Double-blind Period||127
70738|NCT01307033|165098|P1|COMPLETED|8-week Double-blind Period||131
70739|NCT01307033|165095|P4|STARTED|8-week Double-blind Period||0
70740|NCT01307033|165096|P3|STARTED|8-week Double-blind Period||0
70741|NCT01307033|165097|P2|STARTED|8-week Double-blind Period||134
70742|NCT01307033|165098|P1|STARTED|8-week Double-blind Period||144
70743|NCT01307020|165120|P10|NOT COMPLETED|Overall Study||0
70744|NCT01307020|165121|P9|NOT COMPLETED|Overall Study||0
70745|NCT01307020|165122|P8|NOT COMPLETED|Overall Study||0
70746|NCT01307020|165123|P7|NOT COMPLETED|Overall Study||1
70747|NCT01307020|165124|P6|NOT COMPLETED|Overall Study||0
70748|NCT01307020|165125|P5|NOT COMPLETED|Overall Study||0
70749|NCT01307020|165126|P4|NOT COMPLETED|Overall Study||1
70750|NCT01307020|165127|P3|NOT COMPLETED|Overall Study||1
70751|NCT01307020|165128|P2|NOT COMPLETED|Overall Study||1
70752|NCT01307020|165129|P1|NOT COMPLETED|Overall Study||0
70753|NCT01307020|165120|P10|COMPLETED|Overall Study||62
70754|NCT01307020|165121|P9|COMPLETED|Overall Study||61
70755|NCT01307020|165122|P8|COMPLETED|Overall Study||60
70756|NCT01307020|165123|P7|COMPLETED|Overall Study||58
70757|NCT01307020|165124|P6|COMPLETED|Overall Study||61
70758|NCT01307020|165125|P5|COMPLETED|Overall Study||60
70759|NCT01307020|165126|P4|COMPLETED|Overall Study||60
70760|NCT01307020|165127|P3|COMPLETED|Overall Study||62
70761|NCT01307020|165128|P2|COMPLETED|Overall Study||62
70762|NCT01307020|165129|P1|COMPLETED|Overall Study||61
70848|NCT01306292|165298|P1|COMPLETED|Washout (at Least 10 Minutes)||10
70763|NCT01307020|165120|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
70764|NCT01307020|165121|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
70765|NCT01307020|165122|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
70766|NCT01307020|165123|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
70767|NCT01307020|165124|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
70768|NCT01307020|165125|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
70769|NCT01307020|165126|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
70770|NCT01307020|165127|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
70771|NCT01307020|165128|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
70772|NCT01307020|165129|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
70773|NCT01307020|165120|P10|Safety Population|Overall Study||62
70774|NCT01307020|165121|P9|Safety Population|Overall Study||61
70775|NCT01307020|165122|P8|Safety Population|Overall Study||60
70776|NCT01307020|165123|P7|Safety Population|Overall Study||59
70777|NCT01307020|165124|P6|Safety Population|Overall Study||61
70778|NCT01307020|165125|P5|Safety Population|Overall Study||60
70779|NCT01307020|165126|P4|Safety Population|Overall Study||61
70780|NCT01307020|165127|P3|Safety Population|Overall Study||63
70781|NCT01307020|165128|P2|Safety Population|Overall Study||63
70782|NCT01307020|165129|P1|Safety Population|Overall Study||61
70783|NCT01307020|165120|P10|STARTED|Overall Study||62
70784|NCT01307020|165121|P9|STARTED|Overall Study||61
70785|NCT01307020|165122|P8|STARTED|Overall Study||60
70786|NCT01307020|165123|P7|STARTED|Overall Study||59
70787|NCT01307020|165124|P6|STARTED|Overall Study||61
70788|NCT01307020|165125|P5|STARTED|Overall Study||60
70789|NCT01307020|165126|P4|STARTED|Overall Study||61
70790|NCT01307020|165127|P3|STARTED|Overall Study||63
70791|NCT01307020|165128|P2|STARTED|Overall Study||63
70792|NCT01307020|165129|P1|STARTED|Overall Study||61
70793|NCT01306968|165175|P4|NOT COMPLETED|Overall Study||4
70794|NCT01306968|165176|P3|NOT COMPLETED|Overall Study||1
70795|NCT01306968|165177|P2|NOT COMPLETED|Overall Study||3
70796|NCT01306968|165178|P1|NOT COMPLETED|Overall Study||1
70797|NCT01306968|165175|P4|COMPLETED|Overall Study||21
70798|NCT01306968|165176|P3|COMPLETED|Overall Study||23
70799|NCT01306968|165177|P2|COMPLETED|Overall Study||20
70800|NCT01306968|165178|P1|COMPLETED|Overall Study||6
70801|NCT01306968|165175|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
70802|NCT01306968|165176|P3|STARTED|Overall Study||24
70803|NCT01306968|165177|P2|STARTED|Overall Study||23
70804|NCT01306968|165178|P1|STARTED|Overall Study||7
70805|NCT01306877|165202|P2|NOT COMPLETED|Overall Study||4
70806|NCT01306877|165203|P1|NOT COMPLETED|Overall Study||3
70807|NCT01306877|165202|P2|COMPLETED|Overall Study||67
70808|NCT01306877|165203|P1|COMPLETED|Overall Study||75
70809|NCT01306877|165202|P2|STARTED|Overall Study||71
70810|NCT01306877|165203|P1|STARTED|Overall Study||78
70811|NCT01306643|165221|P1|NOT COMPLETED|Overall Study||13
70812|NCT01306643|165221|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
70813|NCT01306643|165221|P1|STARTED|Overall Study||18
70814|NCT01306617|165233|P3|NOT COMPLETED|Overall Study||5
70815|NCT01306617|165234|P2|NOT COMPLETED|Overall Study||1
70816|NCT01306617|165235|P1|NOT COMPLETED|Overall Study||1
70817|NCT01306617|165233|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
70818|NCT01306617|165234|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
70819|NCT01306617|165235|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
70820|NCT01306617|165233|P3|STARTED|Overall Study||17
70821|NCT01306617|165234|P2|STARTED|Overall Study||14
70822|NCT01306617|165235|P1|STARTED|Overall Study||19
70823|NCT01306305|165278|P2|NOT COMPLETED|Overall Study||0
70824|NCT01306305|165279|P1|NOT COMPLETED|Overall Study||2
70825|NCT01306305|165278|P2|COMPLETED|Overall Study||55
70826|NCT01306305|165279|P1|COMPLETED|Overall Study||53
70827|NCT01306305|165278|P2|STARTED|Overall Study||55
70828|NCT01306305|165279|P1|STARTED|Overall Study||55
70829|NCT01306292|165295|P4|NOT COMPLETED|Second Injection||0
70830|NCT01306292|165296|P3|NOT COMPLETED|Second Injection||1
70831|NCT01306292|165297|P2|NOT COMPLETED|Second Injection||0
70832|NCT01306292|165298|P1|NOT COMPLETED|Second Injection||0
70833|NCT01306292|165295|P4|COMPLETED|Second Injection||10
70834|NCT01306292|165296|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
70835|NCT01306292|165297|P2|COMPLETED|Second Injection||8
70836|NCT01306292|165298|P1|COMPLETED|Second Injection||10
70837|NCT01306292|165295|P4|STARTED|Second Injection||10
70838|NCT01306292|165296|P3|STARTED|Second Injection||8
70839|NCT01306292|165297|P2|STARTED|Second Injection||8
70840|NCT01306292|165298|P1|STARTED|Second Injection||10
70841|NCT01306292|165295|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
70842|NCT01306292|165296|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
70843|NCT01306292|165297|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
70844|NCT01306292|165298|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
70845|NCT01306292|165295|P4|COMPLETED|Washout (at Least 10 Minutes)||10
70846|NCT01306292|165296|P3|COMPLETED|Washout (at Least 10 Minutes)||8
70847|NCT01306292|165297|P2|COMPLETED|Washout (at Least 10 Minutes)||8
70849|NCT01306292|165295|P4|STARTED|Washout (at Least 10 Minutes)||10
70850|NCT01306292|165296|P3|STARTED|Washout (at Least 10 Minutes)||8
70851|NCT01306292|165297|P2|STARTED|Washout (at Least 10 Minutes)||8
70852|NCT01306292|165298|P1|STARTED|Washout (at Least 10 Minutes)||10
70853|NCT01306292|165295|P4|NOT COMPLETED|First Injection||0
70854|NCT01306292|165296|P3|NOT COMPLETED|First Injection||0
70855|NCT01306292|165297|P2|NOT COMPLETED|First Injection||0
70856|NCT01306292|165298|P1|NOT COMPLETED|First Injection||0
70857|NCT01306292|165295|P4|COMPLETED|First Injection||10
70858|NCT01306292|165296|P3|COMPLETED|First Injection||8
70859|NCT01306292|165297|P2|COMPLETED|First Injection||8
70860|NCT01306292|165298|P1|COMPLETED|First Injection||10
70861|NCT01306292|165295|P4|STARTED|First Injection||10
70862|NCT01306292|165296|P3|STARTED|First Injection||8
70863|NCT01306292|165297|P2|STARTED|First Injection||8
70864|NCT01306292|165298|P1|STARTED|First Injection||10
70865|NCT01306253|165316|P2|NOT COMPLETED|Overall Study||1
70866|NCT01306253|165317|P1|NOT COMPLETED|Overall Study||1
70867|NCT01306253|165316|P2|COMPLETED|Overall Study||56
70868|NCT01306253|165317|P1|COMPLETED|Overall Study||56
70869|NCT01306253|165316|P2|STARTED|Overall Study||57
70870|NCT01306253|165317|P1|STARTED|Overall Study||57
70871|NCT01306214|165334|P3|NOT COMPLETED|Overall Study||22
70872|NCT01306214|165335|P2|NOT COMPLETED|Overall Study||28
70873|NCT01306214|165336|P1|NOT COMPLETED|Overall Study||28
70874|NCT01306214|165334|P3|COMPLETED|Overall Study||168
70875|NCT01306214|165335|P2|COMPLETED|Overall Study||159
70876|NCT01306214|165336|P1|COMPLETED|Overall Study||161
70877|NCT01306214|165334|P3|STARTED|Overall Study||190
70878|NCT01306214|165335|P2|STARTED|Overall Study||187
70879|NCT01306214|165336|P1|STARTED|Overall Study||189
70880|NCT01306201|165353|P1|NOT COMPLETED|Overall Study||10
70881|NCT01306201|165353|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
70882|NCT01306201|165353|P1|STARTED|Overall Study||63
70883|NCT01306175|165361|P1|NOT COMPLETED|Second Intervention||0
70884|NCT01306175|165361|P1|COMPLETED|Second Intervention||20
70885|NCT01306175|165361|P1|STARTED|Second Intervention||20
70886|NCT01306175|165361|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
70887|NCT01306175|165361|P1|COMPLETED|Washout Period of at Least 14 Days||20
70888|NCT01306175|165361|P1|STARTED|Washout Period of at Least 14 Days||20
70889|NCT01306175|165361|P1|NOT COMPLETED|First Intervention||0
70890|NCT01306175|165361|P1|COMPLETED|First Intervention||20
70891|NCT01306175|165361|P1|STARTED|First Intervention||20
70892|NCT01306162|165375|P4|NOT COMPLETED|Period 4||0
70893|NCT01306162|165376|P3|NOT COMPLETED|Period 4||0
70894|NCT01306162|165377|P2|NOT COMPLETED|Period 4||0
70895|NCT01306162|165378|P1|NOT COMPLETED|Period 4||0
70896|NCT01306162|165375|P4|COMPLETED|Period 4||8
70897|NCT01306162|165376|P3|COMPLETED|Period 4||9
70898|NCT01306162|165377|P2|COMPLETED|Period 4||8
70899|NCT01306162|165378|P1|COMPLETED|Period 4||9
70900|NCT01306162|165375|P4|STARTED|Period 4||8
70901|NCT01306162|165376|P3|STARTED|Period 4||9
70902|NCT01306162|165377|P2|STARTED|Period 4||8
70903|NCT01306162|165378|P1|STARTED|Period 4||9
70904|NCT01306162|165375|P4|NOT COMPLETED|Washout 2||0
70905|NCT01306162|165376|P3|NOT COMPLETED|Washout 2||0
70906|NCT01306162|165377|P2|NOT COMPLETED|Washout 2||0
70907|NCT01306162|165378|P1|NOT COMPLETED|Washout 2||0
70908|NCT01306162|165375|P4|COMPLETED|Washout 2||8
70909|NCT01306162|165376|P3|COMPLETED|Washout 2||9
70910|NCT01306162|165377|P2|COMPLETED|Washout 2||8
70911|NCT01306162|165378|P1|COMPLETED|Washout 2||9
70912|NCT01306162|165375|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
70913|NCT01306162|165376|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
70914|NCT01306162|165377|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
70915|NCT01306162|165378|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
70916|NCT01306162|165375|P4|NOT COMPLETED|Period 3||0
70917|NCT01306162|165376|P3|NOT COMPLETED|Period 3||0
70918|NCT01306162|165377|P2|NOT COMPLETED|Period 3||0
70919|NCT01306162|165378|P1|NOT COMPLETED|Period 3||0
70920|NCT01306162|165375|P4|COMPLETED|Period 3||8
70921|NCT01306162|165376|P3|COMPLETED|Period 3||9
70922|NCT01306162|165377|P2|COMPLETED|Period 3||8
70923|NCT01306162|165378|P1|COMPLETED|Period 3||9
70924|NCT01306162|165375|P4|STARTED|Period 3||8
70925|NCT01306162|165376|P3|STARTED|Period 3||9
70926|NCT01306162|165377|P2|STARTED|Period 3||8
70927|NCT01306162|165378|P1|STARTED|Period 3||9
70928|NCT01306162|165375|P4|NOT COMPLETED|Period 2||0
70929|NCT01306162|165376|P3|NOT COMPLETED|Period 2||0
70930|NCT01306162|165377|P2|NOT COMPLETED|Period 2||0
70931|NCT01306162|165378|P1|NOT COMPLETED|Period 2||0
70932|NCT01306162|165375|P4|COMPLETED|Period 2||8
70933|NCT01306162|165376|P3|COMPLETED|Period 2||9
70934|NCT01306162|165377|P2|COMPLETED|Period 2||8
70935|NCT01306162|165378|P1|COMPLETED|Period 2||9
70936|NCT01306162|165375|P4|STARTED|Period 2|No washout phase after Period 2.|8
70937|NCT01306162|165376|P3|STARTED|Period 2|No washout phase after Period 2.|9
70938|NCT01306162|165377|P2|STARTED|Period 2|No washout phase after Period 2.|8
70939|NCT01306162|165378|P1|STARTED|Period 2|No washout phase after Period 2.|9
70940|NCT01306162|165375|P4|NOT COMPLETED|Washout 1||0
70941|NCT01306162|165376|P3|NOT COMPLETED|Washout 1||0
70942|NCT01306162|165377|P2|NOT COMPLETED|Washout 1||1
70943|NCT01306162|165378|P1|NOT COMPLETED|Washout 1||0
70944|NCT01306162|165375|P4|COMPLETED|Washout 1||8
70945|NCT01306162|165376|P3|COMPLETED|Washout 1||9
70946|NCT01306162|165377|P2|COMPLETED|Washout 1||8
70947|NCT01306162|165378|P1|COMPLETED|Washout 1||9
70948|NCT01306162|165375|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
70949|NCT01306162|165376|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
70950|NCT01306162|165377|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
70951|NCT01306162|165378|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
70952|NCT01306162|165375|P4|NOT COMPLETED|Period 1||1
70953|NCT01306162|165376|P3|NOT COMPLETED|Period 1||0
70954|NCT01306162|165377|P2|NOT COMPLETED|Period 1||0
70955|NCT01306162|165378|P1|NOT COMPLETED|Period 1||0
70956|NCT01306162|165375|P4|COMPLETED|Period 1||8
70957|NCT01306162|165376|P3|COMPLETED|Period 1||9
70958|NCT01306162|165377|P2|COMPLETED|Period 1||9
70959|NCT01306162|165378|P1|COMPLETED|Period 1||9
70960|NCT01306162|165375|P4|STARTED|Period 1||9
70961|NCT01306162|165376|P3|STARTED|Period 1||9
70962|NCT01306162|165377|P2|STARTED|Period 1||9
70963|NCT01306162|165378|P1|STARTED|Period 1||9
70964|NCT01306032|165412|P6|NOT COMPLETED|Disease Progression/Crossover||0
70965|NCT01306032|165413|P5|NOT COMPLETED|Disease Progression/Crossover||0
70966|NCT01306032|165414|P4|NOT COMPLETED|Disease Progression/Crossover||3
70967|NCT01306032|165415|P3|NOT COMPLETED|Disease Progression/Crossover||0
70968|NCT01306032|165416|P2|NOT COMPLETED|Disease Progression/Crossover||2
70969|NCT01306032|165417|P1|NOT COMPLETED|Disease Progression/Crossover||0
70970|NCT01306032|165412|P6|COMPLETED|Disease Progression/Crossover||0
70971|NCT01306032|165413|P5|COMPLETED|Disease Progression/Crossover||0
70972|NCT01306032|165414|P4|COMPLETED|Disease Progression/Crossover||26
70973|NCT01306032|165415|P3|COMPLETED|Disease Progression/Crossover||0
70974|NCT01306032|165416|P2|COMPLETED|Disease Progression/Crossover||14
70975|NCT01306032|165417|P1|COMPLETED|Disease Progression/Crossover||0
70976|NCT01306032|165412|P6|STARTED|Disease Progression/Crossover||0
70977|NCT01306032|165413|P5|STARTED|Disease Progression/Crossover||0
70978|NCT01306032|165414|P4|STARTED|Disease Progression/Crossover||29
70979|NCT01306032|165415|P3|STARTED|Disease Progression/Crossover||0
70980|NCT01306032|165416|P2|STARTED|Disease Progression/Crossover||16
70981|NCT01306032|165417|P1|STARTED|Disease Progression/Crossover||0
70982|NCT01306032|165412|P6|NOT COMPLETED|First Intervention||2
70983|NCT01306032|165413|P5|NOT COMPLETED|First Intervention||2
70984|NCT01306032|165414|P4|NOT COMPLETED|First Intervention||1
70985|NCT01306032|165415|P3|NOT COMPLETED|First Intervention||2
70986|NCT01306032|165416|P2|NOT COMPLETED|First Intervention||2
70987|NCT01306032|165417|P1|NOT COMPLETED|First Intervention||1
70988|NCT01306032|165412|P6|COMPLETED|First Intervention||0
70989|NCT01306032|165413|P5|COMPLETED|First Intervention||0
70990|NCT01306032|165414|P4|COMPLETED|First Intervention||37
70991|NCT01306032|165415|P3|COMPLETED|First Intervention||35
70992|NCT01306032|165416|P2|COMPLETED|First Intervention||18
70993|NCT01306032|165417|P1|COMPLETED|First Intervention||21
70994|NCT01306032|165412|P6|STARTED|First Intervention||2
70995|NCT01306032|165413|P5|STARTED|First Intervention||2
70996|NCT01306032|165414|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
70997|NCT01306032|165415|P3|STARTED|First Intervention||37
70998|NCT01306032|165416|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
70999|NCT01306032|165417|P1|STARTED|First Intervention||22
71000|NCT01305811|165447|P2|NOT COMPLETED|Overall Study||11
71001|NCT01305811|165448|P1|NOT COMPLETED|Overall Study||8
71002|NCT01305811|165447|P2|COMPLETED|Overall Study||41
71003|NCT01305811|165448|P1|COMPLETED|Overall Study||44
71004|NCT01305811|165447|P2|STARTED|Overall Study||52
71005|NCT01305811|165448|P1|STARTED|Overall Study||52
71006|NCT01305772|165458|P2|NOT COMPLETED|Overall Study||0
71007|NCT01305772|165459|P1|NOT COMPLETED|Overall Study||0
71008|NCT01305772|165458|P2|COMPLETED|Overall Study||1
71009|NCT01305772|165459|P1|COMPLETED|Overall Study||5
71010|NCT01305772|165458|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
71011|NCT01305772|165459|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
71012|NCT01305772|165458|P2|Surgery/Biopsy #2|Overall Study||1
71013|NCT01305772|165459|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
71014|NCT01305772|165458|P2|Research PET/CT #2|Overall Study||1
71015|NCT01305772|165459|P1|Research PET/CT #2|Overall Study||5
71016|NCT01305772|165458|P2|Panitumumab Dose #1|Overall Study||1
71017|NCT01305772|165459|P1|Panitumumab Dose #1|Overall Study||5
71018|NCT01305772|165458|P2|Research PET/CT #1|Overall Study||1
71019|NCT01305772|165459|P1|Research PET/CT #1|Overall Study||5
71020|NCT01305772|165458|P2|Genomic Screening + Biopsy #1|Overall Study||1
71021|NCT01305772|165459|P1|Genomic Screening + Biopsy #1|Overall Study||5
71022|NCT01305772|165458|P2|STARTED|Overall Study||1
71023|NCT01305772|165459|P1|STARTED|Overall Study||5
71024|NCT01305655|165466|P1|NOT COMPLETED|Overall Study||0
71025|NCT01305655|165466|P1|COMPLETED|Overall Study|December 31, 2014|47
71026|NCT01305655|165466|P1|STARTED|Overall Study|July 2008|47
71027|NCT01305577|165473|P3|NOT COMPLETED|Overall Study||10
71028|NCT01305577|165474|P2|NOT COMPLETED|Overall Study||11
71029|NCT01305577|165475|P1|NOT COMPLETED|Overall Study||13
71030|NCT01305577|165473|P3|COMPLETED|Overall Study||112
71031|NCT01305577|165474|P2|COMPLETED|Overall Study||110
71032|NCT01305577|165475|P1|COMPLETED|Overall Study||107
71033|NCT01305577|165473|P3|Received Treatment|Overall Study||122
71034|NCT01305577|165474|P2|Received Treatment|Overall Study||121
71035|NCT01305577|165475|P1|Received Treatment|Overall Study||119
71036|NCT01305577|165473|P3|STARTED|Overall Study||122
71037|NCT01305577|165474|P2|STARTED|Overall Study||121
71038|NCT01305577|165475|P1|STARTED|Overall Study||120
71039|NCT01305564|165504|P1|NOT COMPLETED|Overall Study||37
71040|NCT01305564|165504|P1|COMPLETED|Overall Study||163
71041|NCT01305564|165504|P1|STARTED|Overall Study||200
71042|NCT01305473|165519|P1|NOT COMPLETED|Overall Study||0
71043|NCT01305473|165519|P1|COMPLETED|Overall Study||90
71044|NCT01305473|165519|P1|STARTED|Overall Study||90
71045|NCT01305408|165531|P2|NOT COMPLETED|Overall Study||31
71046|NCT01305408|165532|P1|NOT COMPLETED|Overall Study||32
71047|NCT01305408|165531|P2|COMPLETED|Overall Study||169
71048|NCT01305408|165532|P1|COMPLETED|Overall Study||167
71049|NCT01305408|165531|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
71050|NCT01305408|165532|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
71051|NCT01305408|165531|P2|Safety Population|Overall Study|Treated participants.|200
71052|NCT01305408|165532|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
71053|NCT01305408|165531|P2|STARTED|Overall Study||200
71054|NCT01305408|165532|P1|STARTED|Overall Study||199
71055|NCT01305265|165584|P2|NOT COMPLETED|Overall Study||6
71056|NCT01305265|165585|P1|NOT COMPLETED|Overall Study||2
71057|NCT01305265|165584|P2|COMPLETED|Overall Study||64
71058|NCT01305265|165585|P1|COMPLETED|Overall Study||69
71059|NCT01305265|165584|P2|STARTED|Overall Study||70
71060|NCT01305265|165585|P1|STARTED|Overall Study||71
71061|NCT01305239|165591|P1|NOT COMPLETED|Overall Study||23
71062|NCT01305239|165591|P1|COMPLETED|Overall Study||375
71063|NCT01305239|165591|P1|Intent to Treat Population|Overall Study||287
71064|NCT01305239|165591|P1|Safety Set|Overall Study||397
71065|NCT01305239|165591|P1|STARTED|Overall Study||398
71066|NCT01305044|165601|P2|NOT COMPLETED|Overall Study||6
71067|NCT01305044|165602|P1|NOT COMPLETED|Overall Study||3
71068|NCT01305044|165601|P2|COMPLETED|Overall Study||25
71069|NCT01305044|165602|P1|COMPLETED|Overall Study||29
71070|NCT01305044|165601|P2|STARTED|Overall Study||31
71071|NCT01305044|165602|P1|STARTED|Overall Study||32
71072|NCT01304966|165626|P1|NOT COMPLETED|Overall Study||0
71073|NCT01304966|165626|P1|COMPLETED|Overall Study||15
71074|NCT01304966|165626|P1|STARTED|Overall Study||15
71075|NCT01304706|165632|P1|NOT COMPLETED|Overall Study||17
71076|NCT01304706|165632|P1|COMPLETED|Overall Study||104
71077|NCT01304706|165632|P1|STARTED|Overall Study||121
71078|NCT01304693|165641|P5|NOT COMPLETED|Overall Study||1
71079|NCT01304693|165642|P4|NOT COMPLETED|Overall Study||1
71080|NCT01304693|165643|P3|NOT COMPLETED|Overall Study||1
71081|NCT01304693|165644|P2|NOT COMPLETED|Overall Study||0
71082|NCT01304693|165645|P1|NOT COMPLETED|Overall Study||0
71083|NCT01304693|165641|P5|COMPLETED|Overall Study||60
71084|NCT01304693|165642|P4|COMPLETED|Overall Study||39
71085|NCT01304693|165643|P3|COMPLETED|Overall Study||47
71086|NCT01304693|165644|P2|COMPLETED|Overall Study||35
71087|NCT01304693|165645|P1|COMPLETED|Overall Study||10
71088|NCT01304693|165641|P5|STARTED|Overall Study||61
71089|NCT01304693|165642|P4|STARTED|Overall Study||40
71090|NCT01304693|165643|P3|STARTED|Overall Study||48
71091|NCT01304693|165644|P2|STARTED|Overall Study||35
71092|NCT01304693|165645|P1|STARTED|Overall Study||10
71093|NCT01304641|165664|P2|NOT COMPLETED|Overall Study||0
71094|NCT01304641|165665|P1|NOT COMPLETED|Overall Study||0
71095|NCT01304641|165664|P2|COMPLETED|Overall Study||20132
71096|NCT01304641|165665|P1|COMPLETED|Overall Study||11470
71097|NCT01304641|165664|P2|STARTED|Overall Study||20132
71098|NCT01304641|165665|P1|STARTED|Overall Study||11470
71099|NCT01304589|165683|P1|NOT COMPLETED|Overall Study||13
71100|NCT01304589|165683|P1|COMPLETED|Overall Study||18
71101|NCT01304589|165683|P1|STARTED|Overall Study||31
71102|NCT01304329|165690|P6|NOT COMPLETED|Third Intervention (3 Days)||0
71103|NCT01304329|165691|P5|NOT COMPLETED|Third Intervention (3 Days)||0
71104|NCT01304329|165692|P4|NOT COMPLETED|Third Intervention (3 Days)||0
71105|NCT01304329|165693|P3|NOT COMPLETED|Third Intervention (3 Days)||0
71106|NCT01304329|165694|P2|NOT COMPLETED|Third Intervention (3 Days)||1
71107|NCT01304329|165695|P1|NOT COMPLETED|Third Intervention (3 Days)||0
71108|NCT01304329|165690|P6|COMPLETED|Third Intervention (3 Days)||3
71109|NCT01304329|165691|P5|COMPLETED|Third Intervention (3 Days)||3
71110|NCT01304329|165692|P4|COMPLETED|Third Intervention (3 Days)||3
71111|NCT01304329|165693|P3|COMPLETED|Third Intervention (3 Days)||3
71112|NCT01304329|165694|P2|COMPLETED|Third Intervention (3 Days)||2
71113|NCT01304329|165695|P1|COMPLETED|Third Intervention (3 Days)||3
71114|NCT01304329|165690|P6|STARTED|Third Intervention (3 Days)||3
71115|NCT01304329|165691|P5|STARTED|Third Intervention (3 Days)||3
71116|NCT01304329|165692|P4|STARTED|Third Intervention (3 Days)||3
71117|NCT01304329|165693|P3|STARTED|Third Intervention (3 Days)||3
71118|NCT01304329|165694|P2|STARTED|Third Intervention (3 Days)||3
71119|NCT01304329|165695|P1|STARTED|Third Intervention (3 Days)||3
71120|NCT01304329|165690|P6|NOT COMPLETED|Second Intervention (3 Days)||0
71121|NCT01304329|165691|P5|NOT COMPLETED|Second Intervention (3 Days)||0
71122|NCT01304329|165692|P4|NOT COMPLETED|Second Intervention (3 Days)||0
71123|NCT01304329|165693|P3|NOT COMPLETED|Second Intervention (3 Days)||0
71124|NCT01304329|165694|P2|NOT COMPLETED|Second Intervention (3 Days)||0
71125|NCT01304329|165695|P1|NOT COMPLETED|Second Intervention (3 Days)||0
71126|NCT01304329|165690|P6|COMPLETED|Second Intervention (3 Days)||3
71127|NCT01304329|165691|P5|COMPLETED|Second Intervention (3 Days)||3
71128|NCT01304329|165692|P4|COMPLETED|Second Intervention (3 Days)||3
71129|NCT01304329|165693|P3|COMPLETED|Second Intervention (3 Days)||3
71130|NCT01304329|165694|P2|COMPLETED|Second Intervention (3 Days)||3
71131|NCT01304329|165695|P1|COMPLETED|Second Intervention (3 Days)||3
71132|NCT01304329|165690|P6|STARTED|Second Intervention (3 Days)||3
71133|NCT01304329|165691|P5|STARTED|Second Intervention (3 Days)||3
71134|NCT01304329|165692|P4|STARTED|Second Intervention (3 Days)||3
71135|NCT01304329|165693|P3|STARTED|Second Intervention (3 Days)||3
71136|NCT01304329|165694|P2|STARTED|Second Intervention (3 Days)||3
71137|NCT01304329|165695|P1|STARTED|Second Intervention (3 Days)||3
71138|NCT01304329|165690|P6|NOT COMPLETED|First Intervention (3 Days)||0
71139|NCT01304329|165691|P5|NOT COMPLETED|First Intervention (3 Days)||0
71140|NCT01304329|165692|P4|NOT COMPLETED|First Intervention (3 Days)||0
71141|NCT01304329|165693|P3|NOT COMPLETED|First Intervention (3 Days)||0
71142|NCT01304329|165694|P2|NOT COMPLETED|First Intervention (3 Days)||0
71143|NCT01304329|165695|P1|NOT COMPLETED|First Intervention (3 Days)||0
71144|NCT01304329|165690|P6|COMPLETED|First Intervention (3 Days)||3
71145|NCT01304329|165691|P5|COMPLETED|First Intervention (3 Days)||3
71146|NCT01304329|165692|P4|COMPLETED|First Intervention (3 Days)||3
71147|NCT01304329|165693|P3|COMPLETED|First Intervention (3 Days)||3
71148|NCT01304329|165694|P2|COMPLETED|First Intervention (3 Days)||3
71149|NCT01304329|165695|P1|COMPLETED|First Intervention (3 Days)||3
71150|NCT01304329|165690|P6|STARTED|First Intervention (3 Days)||3
71151|NCT01304329|165691|P5|STARTED|First Intervention (3 Days)||3
71152|NCT01304329|165692|P4|STARTED|First Intervention (3 Days)||3
71153|NCT01304329|165693|P3|STARTED|First Intervention (3 Days)||3
71154|NCT01304329|165694|P2|STARTED|First Intervention (3 Days)||3
71155|NCT01304329|165695|P1|STARTED|First Intervention (3 Days)||3
71156|NCT01304277|165712|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
71157|NCT01304277|165712|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
71158|NCT01304277|165712|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
71159|NCT01304277|165712|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
71160|NCT01304277|165712|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
71161|NCT01304277|165712|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
71162|NCT01304238|165734|P10|NOT COMPLETED|Overall Study||0
71163|NCT01304238|165735|P9|NOT COMPLETED|Overall Study||0
71164|NCT01304238|165736|P8|NOT COMPLETED|Overall Study||0
71165|NCT01304238|165737|P7|NOT COMPLETED|Overall Study||0
71166|NCT01304238|165738|P6|NOT COMPLETED|Overall Study||0
71167|NCT01304238|165739|P5|NOT COMPLETED|Overall Study||0
71168|NCT01304238|165740|P4|NOT COMPLETED|Overall Study||0
71169|NCT01304238|165741|P3|NOT COMPLETED|Overall Study||0
71170|NCT01304238|165742|P2|NOT COMPLETED|Overall Study||0
71171|NCT01304238|165743|P1|NOT COMPLETED|Overall Study||0
71172|NCT01304238|165734|P10|COMPLETED|Overall Study||3
71173|NCT01304238|165735|P9|COMPLETED|Overall Study||1
71174|NCT01304238|165736|P8|COMPLETED|Overall Study||4
71175|NCT01304238|165737|P7|COMPLETED|Overall Study||5
71176|NCT01304238|165738|P6|COMPLETED|Overall Study||11
71177|NCT01304238|165739|P5|COMPLETED|Overall Study||11
71178|NCT01304238|165740|P4|COMPLETED|Overall Study||78
71179|NCT01304238|165741|P3|COMPLETED|Overall Study||46
71180|NCT01304238|165742|P2|COMPLETED|Overall Study||4
71181|NCT01304238|165743|P1|COMPLETED|Overall Study||32
71182|NCT01304238|165734|P10|STARTED|Overall Study||3
71183|NCT01304238|165735|P9|STARTED|Overall Study||1
71184|NCT01304238|165736|P8|STARTED|Overall Study||4
71185|NCT01304238|165737|P7|STARTED|Overall Study||5
71186|NCT01304238|165738|P6|STARTED|Overall Study||11
71187|NCT01304238|165739|P5|STARTED|Overall Study||11
71188|NCT01304238|165740|P4|STARTED|Overall Study||78
71189|NCT01304238|165741|P3|STARTED|Overall Study||46
71190|NCT01304238|165742|P2|STARTED|Overall Study||4
71191|NCT01304238|165743|P1|STARTED|Overall Study||32
71192|NCT01304147|165815|P2|NOT COMPLETED|Second Intervention (7days)||1
71193|NCT01304147|165816|P1|NOT COMPLETED|Second Intervention (7days)||1
71194|NCT01304147|165815|P2|COMPLETED|Second Intervention (7days)||9
71195|NCT01304147|165816|P1|COMPLETED|Second Intervention (7days)||9
71196|NCT01304147|165815|P2|STARTED|Second Intervention (7days)||10
71197|NCT01304147|165816|P1|STARTED|Second Intervention (7days)||10
71198|NCT01304147|165815|P2|NOT COMPLETED|Washout (1 Day)||0
71199|NCT01304147|165816|P1|NOT COMPLETED|Washout (1 Day)||0
71200|NCT01304147|165815|P2|COMPLETED|Washout (1 Day)||10
71201|NCT01304147|165816|P1|COMPLETED|Washout (1 Day)||10
71202|NCT01304147|165815|P2|STARTED|Washout (1 Day)||10
71203|NCT01304147|165816|P1|STARTED|Washout (1 Day)||10
71204|NCT01304147|165815|P2|NOT COMPLETED|First Intervention (7days)||0
71205|NCT01304147|165816|P1|NOT COMPLETED|First Intervention (7days)||0
71206|NCT01304147|165815|P2|COMPLETED|First Intervention (7days)||10
71207|NCT01304147|165816|P1|COMPLETED|First Intervention (7days)||10
71208|NCT01304147|165815|P2|STARTED|First Intervention (7days)||10
71209|NCT01304147|165816|P1|STARTED|First Intervention (7days)||10
71210|NCT01303861|165829|P4|NOT COMPLETED|Overall Study||59
71211|NCT01303861|165830|P3|NOT COMPLETED|Overall Study||36
71212|NCT01303861|165831|P2|NOT COMPLETED|Overall Study||25
71213|NCT01303861|165832|P1|NOT COMPLETED|Overall Study||58
71214|NCT01303861|165829|P4|COMPLETED|Overall Study||54
71215|NCT01303861|165830|P3|COMPLETED|Overall Study||19
71216|NCT01303861|165831|P2|COMPLETED|Overall Study||25
71217|NCT01303861|165832|P1|COMPLETED|Overall Study||51
71218|NCT01303861|165829|P4|Finished Treatment Phase|Overall Study||72
71219|NCT01303861|165830|P3|Finished Treatment Phase|Overall Study||39
71220|NCT01303861|165831|P2|Finished Treatment Phase|Overall Study||34
71221|NCT01303861|165832|P1|Finished Treatment Phase|Overall Study||71
71222|NCT01303861|165829|P4|STARTED|Overall Study||113
71223|NCT01303861|165830|P3|STARTED|Overall Study||55
71224|NCT01303861|165831|P2|STARTED|Overall Study||50
71225|NCT01303861|165832|P1|STARTED|Overall Study||109
71226|NCT01303835|165853|P2|NOT COMPLETED|Overall Study||25
71227|NCT01303835|165854|P1|NOT COMPLETED|Overall Study||19
71228|NCT01303835|165853|P2|COMPLETED|Overall Study||31
71229|NCT01303835|165854|P1|COMPLETED|Overall Study||35
71230|NCT01303835|165853|P2|STARTED|Overall Study||56
71231|NCT01303835|165854|P1|STARTED|Overall Study||54
71232|NCT01303744|165868|P4|NOT COMPLETED|Overall Study||0
71233|NCT01303744|165869|P3|NOT COMPLETED|Overall Study||0
71234|NCT01303744|165870|P2|NOT COMPLETED|Overall Study||0
71235|NCT01303744|165871|P1|NOT COMPLETED|Overall Study||0
71236|NCT01303744|165868|P4|COMPLETED|Overall Study||24
71237|NCT01303744|165869|P3|COMPLETED|Overall Study||24
71238|NCT01303744|165870|P2|COMPLETED|Overall Study||24
71239|NCT01303744|165871|P1|COMPLETED|Overall Study||24
71240|NCT01303744|165868|P4|STARTED|Overall Study||24
71241|NCT01303744|165869|P3|STARTED|Overall Study||24
71242|NCT01303744|165870|P2|STARTED|Overall Study||24
71243|NCT01303744|165871|P1|STARTED|Overall Study||24
71244|NCT01303627|165891|P2|NOT COMPLETED|Overall Study||1
71245|NCT01303627|165892|P1|NOT COMPLETED|Overall Study||0
71246|NCT01303627|165891|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
71247|NCT01303627|165892|P1|COMPLETED|Overall Study||21
71248|NCT01303627|165891|P2|STARTED|Overall Study||21
71249|NCT01303627|165892|P1|STARTED|Overall Study||21
71250|NCT01303510|165900|P2|NOT COMPLETED|Overall Study||0
71251|NCT01303510|165901|P1|NOT COMPLETED|Overall Study||1
71252|NCT01303510|165900|P2|COMPLETED|Overall Study||56
71253|NCT01303510|165901|P1|COMPLETED|Overall Study||54
71254|NCT01303510|165900|P2|STARTED|Overall Study||56
71255|NCT01303510|165901|P1|STARTED|Overall Study||55
71256|NCT01303445|165915|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
71257|NCT01303445|165916|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
71258|NCT01303445|165915|P2|COMPLETED|Follow-up Period (14 Days)||25
71259|NCT01303445|165916|P1|COMPLETED|Follow-up Period (14 Days)||26
71260|NCT01303445|165915|P2|STARTED|Follow-up Period (14 Days)||26
71261|NCT01303445|165916|P1|STARTED|Follow-up Period (14 Days)||26
71262|NCT01303445|165915|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
71263|NCT01303445|165916|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
71264|NCT01303445|165915|P2|COMPLETED|Fourth Intervention (7 Days)||26
71265|NCT01303445|165916|P1|COMPLETED|Fourth Intervention (7 Days)||26
71266|NCT01303445|165915|P2|STARTED|Fourth Intervention (7 Days)||26
71267|NCT01303445|165916|P1|STARTED|Fourth Intervention (7 Days)||27
71268|NCT01303445|165915|P2|NOT COMPLETED|Third Intervention (7 Days)||0
71269|NCT01303445|165916|P1|NOT COMPLETED|Third Intervention (7 Days)||0
71270|NCT01303445|165915|P2|COMPLETED|Third Intervention (7 Days)||26
71271|NCT01303445|165916|P1|COMPLETED|Third Intervention (7 Days)||27
71272|NCT01303445|165915|P2|STARTED|Third Intervention (7 Days)||26
71273|NCT01303445|165916|P1|STARTED|Third Intervention (7 Days)||27
71274|NCT01303445|165915|P2|NOT COMPLETED|Washout (14 Days)||2
71275|NCT01303445|165916|P1|NOT COMPLETED|Washout (14 Days)||1
71276|NCT01303445|165915|P2|COMPLETED|Washout (14 Days)||26
71277|NCT01303445|165916|P1|COMPLETED|Washout (14 Days)||27
71278|NCT01303445|165915|P2|STARTED|Washout (14 Days)||28
71279|NCT01303445|165916|P1|STARTED|Washout (14 Days)||28
71280|NCT01303445|165915|P2|NOT COMPLETED|Second Intervention (7 Days)||2
71281|NCT01303445|165916|P1|NOT COMPLETED|Second Intervention (7 Days)||1
71282|NCT01303445|165915|P2|COMPLETED|Second Intervention (7 Days)||28
71283|NCT01303445|165916|P1|COMPLETED|Second Intervention (7 Days)||28
71284|NCT01303445|165915|P2|STARTED|Second Intervention (7 Days)||30
71285|NCT01303445|165916|P1|STARTED|Second Intervention (7 Days)||29
71286|NCT01303445|165915|P2|NOT COMPLETED|First Intervention (7 Days)||0
71287|NCT01303445|165916|P1|NOT COMPLETED|First Intervention (7 Days)||1
71288|NCT01303445|165915|P2|COMPLETED|First Intervention (7 Days)||30
71289|NCT01303445|165916|P1|COMPLETED|First Intervention (7 Days)||29
71290|NCT01303445|165915|P2|STARTED|First Intervention (7 Days)||30
71291|NCT01303445|165916|P1|STARTED|First Intervention (7 Days)||30
71292|NCT01303406|165948|P2|NOT COMPLETED|Overall Study||1
71293|NCT01303406|165949|P1|NOT COMPLETED|Overall Study||0
71294|NCT01303406|165948|P2|COMPLETED|Overall Study||15
71295|NCT01303406|165949|P1|COMPLETED|Overall Study||13
71296|NCT01303406|165948|P2|STARTED|Overall Study||16
71297|NCT01303406|165949|P1|STARTED|Overall Study||13
71298|NCT01303380|165957|P1|NOT COMPLETED|Overall Study||1
71299|NCT01303380|165957|P1|COMPLETED|Overall Study||8
71300|NCT01303380|165957|P1|STARTED|Overall Study||9
71301|NCT01303224|165987|P4|NOT COMPLETED|Overall Study||10
71302|NCT01303224|165988|P3|NOT COMPLETED|Overall Study||6
71303|NCT01303224|165989|P2|NOT COMPLETED|Overall Study||11
71304|NCT01303224|165990|P1|NOT COMPLETED|Overall Study||11
71305|NCT01303224|165987|P4|COMPLETED|Overall Study||133
71306|NCT01303224|165988|P3|COMPLETED|Overall Study||133
71307|NCT01303224|165989|P2|COMPLETED|Overall Study||131
71308|NCT01303224|165990|P1|COMPLETED|Overall Study||130
71309|NCT01303224|165987|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
71310|NCT01303224|165988|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
71311|NCT01303224|165989|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
71312|NCT01303224|165990|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
71313|NCT01303224|165987|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
71314|NCT01303224|165988|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
71315|NCT01303224|165989|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
71316|NCT01303224|165990|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
71317|NCT01302938|166018|P2|NOT COMPLETED|Overall Study||0
71318|NCT01302938|166019|P1|NOT COMPLETED|Overall Study||2
71319|NCT01302938|166018|P2|COMPLETED|Overall Study||6
71320|NCT01302938|166019|P1|COMPLETED|Overall Study||10
71321|NCT01302938|166018|P2|STARTED|Overall Study||6
71322|NCT01302938|166019|P1|STARTED|Overall Study||12
71323|NCT01302899|166064|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
71324|NCT01302899|166065|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
71325|NCT01302899|166064|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
71326|NCT01302899|166065|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
71327|NCT01302899|166064|P2|STARTED|Period 4 (Weeks 19 to 26)||3
71328|NCT01302899|166065|P1|STARTED|Period 4 (Weeks 19 to 26)||3
71329|NCT01302899|166064|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
71330|NCT01302899|166065|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
71331|NCT01302899|166064|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
71332|NCT01302899|166065|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
71333|NCT01302899|166064|P2|STARTED|Period 3 (Weeks 13 to 18)||3
71334|NCT01302899|166065|P1|STARTED|Period 3 (Weeks 13 to 18)||3
71335|NCT01302899|166064|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
71336|NCT01302899|166065|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
71337|NCT01302899|166064|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
71338|NCT01302899|166065|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
71339|NCT01302899|166064|P2|STARTED|Period 2 (Weeks 7 to 12)||4
71340|NCT01302899|166065|P1|STARTED|Period 2 (Weeks 7 to 12)||4
71341|NCT01302899|166064|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
71342|NCT01302899|166065|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
71343|NCT01302899|166064|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
71344|NCT01302899|166065|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
71345|NCT01302899|166064|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
71346|NCT01302899|166065|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
71347|NCT01302860|166115|P1|NOT COMPLETED|Overall Study||0
71348|NCT01302860|166115|P1|COMPLETED|Overall Study||17
71349|NCT01302860|166115|P1|STARTED|Overall Study||17
71350|NCT01302691|166129|P2|NOT COMPLETED|Overall Study||6
71351|NCT01302691|166130|P1|NOT COMPLETED|Overall Study||10
71352|NCT01302691|166129|P2|COMPLETED|Overall Study||157
71353|NCT01302691|166130|P1|COMPLETED|Overall Study||154
71354|NCT01302691|166129|P2|STARTED|Overall Study||163
71355|NCT01302691|166130|P1|STARTED|Overall Study||164
71356|NCT01302548|166150|P2|NOT COMPLETED|Overall Study||1
71357|NCT01302548|166151|P1|NOT COMPLETED|Overall Study||2
71358|NCT01302548|166150|P2|COMPLETED|Overall Study||18
71359|NCT01302548|166151|P1|COMPLETED|Overall Study||12
71360|NCT01302548|166150|P2|STARTED|Overall Study||19
71361|NCT01302548|166151|P1|STARTED|Overall Study||14
71362|NCT01302483|166163|P2|NOT COMPLETED|Overall Study||0
71363|NCT01302483|166164|P1|NOT COMPLETED|Overall Study||0
71364|NCT01302483|166163|P2|COMPLETED|Overall Study||15
71365|NCT01302483|166164|P1|COMPLETED|Overall Study||30
71366|NCT01302483|166163|P2|STARTED|Overall Study||15
71367|NCT01302483|166164|P1|STARTED|Overall Study||30
71368|NCT01302444|166180|P2|NOT COMPLETED|Overall Study||0
71369|NCT01302444|166181|P1|NOT COMPLETED|Overall Study||0
71370|NCT01302444|166180|P2|COMPLETED|Overall Study||0
71371|NCT01302444|166181|P1|COMPLETED|Overall Study||1
71372|NCT01302444|166180|P2|STARTED|Overall Study||0
71373|NCT01302444|166181|P1|STARTED|Overall Study||1
71374|NCT01302418|166201|P1|NOT COMPLETED|Overall Study||18
71375|NCT01302418|166201|P1|COMPLETED|Overall Study||254
71376|NCT01302418|166201|P1|STARTED|Overall Study||272
71377|NCT01302392|166207|P2|NOT COMPLETED|Overall Study||1
71378|NCT01302392|166208|P1|NOT COMPLETED|Overall Study||7
71379|NCT01302392|166207|P2|COMPLETED|Overall Study||156
71380|NCT01302392|166208|P1|COMPLETED|Overall Study||151
71381|NCT01302392|166207|P2|Treated|Overall Study||157
71382|NCT01302392|166208|P1|Treated|Overall Study||153
71383|NCT01302392|166207|P2|STARTED|Overall Study||157
71384|NCT01302392|166208|P1|STARTED|Overall Study||158
71385|NCT01302366|166228|P1|NOT COMPLETED|Overall Study||5
71386|NCT01302366|166228|P1|COMPLETED|Overall Study||15
71387|NCT01302366|166228|P1|STARTED|Overall Study||20
71388|NCT01302119|166236|P2|NOT COMPLETED|Overall Study||28
71389|NCT01302119|166237|P1|NOT COMPLETED|Overall Study||50
71390|NCT01302119|166236|P2|COMPLETED|Overall Study||177
71391|NCT01302119|166237|P1|COMPLETED|Overall Study||349
71392|NCT01302119|166236|P2|STARTED|Overall Study||205
71393|NCT01302119|166237|P1|STARTED|Overall Study||399
71394|NCT01302067|166252|P3|NOT COMPLETED|Overall Study||98
71395|NCT01302067|166253|P2|NOT COMPLETED|Overall Study||34
71396|NCT01302067|166254|P1|NOT COMPLETED|Overall Study||78
71397|NCT01302067|166252|P3|COMPLETED|Overall Study||681
71398|NCT01302067|166253|P2|COMPLETED|Overall Study||352
71399|NCT01302067|166254|P1|COMPLETED|Overall Study||712
71400|NCT01302067|166252|P3|STARTED|Overall Study||779
71401|NCT01302067|166253|P2|STARTED|Overall Study||386
71402|NCT01302067|166254|P1|STARTED|Overall Study||790
71403|NCT01302054|166325|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
71404|NCT01302054|166326|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
71405|NCT01302054|166327|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
71406|NCT01302054|166325|P3|COMPLETED|Double-Blind Treatment Phase||255
71407|NCT01302054|166326|P2|COMPLETED|Double-Blind Treatment Phase||281
71408|NCT01302054|166327|P1|COMPLETED|Double-Blind Treatment Phase||0
71409|NCT01302054|166325|P3|STARTED|Double-Blind Treatment Phase||301
71410|NCT01302054|166326|P2|STARTED|Double-Blind Treatment Phase||308
71411|NCT01302054|166327|P1|STARTED|Double-Blind Treatment Phase||0
71412|NCT01302054|166325|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
71413|NCT01302054|166326|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
71414|NCT01302054|166327|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
71415|NCT01302054|166325|P3|COMPLETED|Between Open-Label and Double Blind||0
71416|NCT01302054|166326|P2|COMPLETED|Between Open-Label and Double Blind||0
71417|NCT01302054|166327|P1|COMPLETED|Between Open-Label and Double Blind||609
71418|NCT01302054|166325|P3|STARTED|Between Open-Label and Double Blind||0
71419|NCT01302054|166326|P2|STARTED|Between Open-Label and Double Blind||0
71420|NCT01302054|166327|P1|STARTED|Between Open-Label and Double Blind||611
71421|NCT01302054|166325|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
71422|NCT01302054|166326|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
71423|NCT01302054|166327|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
71424|NCT01302054|166325|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
71425|NCT01302054|166326|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
71426|NCT01302054|166327|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
71427|NCT01302054|166325|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
71428|NCT01302054|166326|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
71429|NCT01302054|166327|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
71430|NCT01302041|166354|P1|NOT COMPLETED|Overall Study||50
71431|NCT01302041|166354|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|17
71432|NCT01302041|166354|P1|STARTED|Overall Study||67
71433|NCT01301963|166385|P2|NOT COMPLETED|Overall Study||0
71434|NCT01301963|166386|P1|NOT COMPLETED|Overall Study||0
71435|NCT01301963|166385|P2|COMPLETED|Overall Study||4
71436|NCT01301963|166386|P1|COMPLETED|Overall Study||5
71437|NCT01301963|166385|P2|STARTED|Overall Study||4
71438|NCT01301963|166386|P1|STARTED|Overall Study||5
71439|NCT01301950|166396|P2|NOT COMPLETED|Overall Study||1
71440|NCT01301950|166397|P1|NOT COMPLETED|Overall Study||0
71441|NCT01301950|166396|P2|COMPLETED|Overall Study||14
71442|NCT01301950|166397|P1|COMPLETED|Overall Study||15
71443|NCT01301950|166396|P2|STARTED|Overall Study||15
71444|NCT01301950|166397|P1|STARTED|Overall Study||15
71445|NCT01301833|166415|P4|NOT COMPLETED|Overall Study||7
71446|NCT01301833|166416|P3|NOT COMPLETED|Overall Study||7
71447|NCT01301833|166417|P2|NOT COMPLETED|Overall Study||8
71448|NCT01301833|166418|P1|NOT COMPLETED|Overall Study||15
71449|NCT01301833|166415|P4|COMPLETED|Overall Study||68
71450|NCT01301833|166416|P3|COMPLETED|Overall Study||88
71451|NCT01301833|166417|P2|COMPLETED|Overall Study||72
71452|NCT01301833|166418|P1|COMPLETED|Overall Study||197
71453|NCT01301833|166415|P4|STARTED|Overall Study||75
71454|NCT01301833|166416|P3|STARTED|Overall Study||95
71455|NCT01301833|166417|P2|STARTED|Overall Study||80
71456|NCT01301833|166418|P1|STARTED|Overall Study||212
71457|NCT01301742|166444|P2|NOT COMPLETED|Second Intervention||0
71458|NCT01301742|166445|P1|NOT COMPLETED|Second Intervention||0
71459|NCT01301742|166444|P2|COMPLETED|Second Intervention||9
71460|NCT01301742|166445|P1|COMPLETED|Second Intervention||9
71461|NCT01301742|166444|P2|STARTED|Second Intervention||9
71462|NCT01301742|166445|P1|STARTED|Second Intervention||9
71463|NCT01301742|166444|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
71464|NCT01301742|166445|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
71465|NCT01301742|166444|P2|COMPLETED|Washout Period of at Least 7 Days||9
71466|NCT01301742|166445|P1|COMPLETED|Washout Period of at Least 7 Days||9
71467|NCT01301742|166444|P2|STARTED|Washout Period of at Least 7 Days||9
71468|NCT01301742|166445|P1|STARTED|Washout Period of at Least 7 Days||9
71469|NCT01301742|166444|P2|NOT COMPLETED|First Intervention||0
71470|NCT01301742|166445|P1|NOT COMPLETED|First Intervention||0
71471|NCT01301742|166444|P2|COMPLETED|First Intervention||9
71472|NCT01301742|166445|P1|COMPLETED|First Intervention||9
71473|NCT01301742|166444|P2|STARTED|First Intervention||9
71474|NCT01301742|166445|P1|STARTED|First Intervention||9
71475|NCT01301729|166456|P1|NOT COMPLETED|Overall Study||4
71476|NCT01301729|166456|P1|COMPLETED|Overall Study||28
71477|NCT01301729|166456|P1|STARTED|Overall Study||32
71478|NCT01301274|166469|P2|NOT COMPLETED|Overall Study||1
71479|NCT01301274|166470|P1|NOT COMPLETED|Overall Study||2
71480|NCT01301274|166469|P2|COMPLETED|Overall Study||31
71481|NCT01301274|166470|P1|COMPLETED|Overall Study||32
71482|NCT01301274|166469|P2|STARTED|Overall Study||32
71483|NCT01301274|166470|P1|STARTED|Overall Study||34
71484|NCT01301092|166485|P3|NOT COMPLETED|Overall Study||1
71485|NCT01301092|166486|P2|NOT COMPLETED|Overall Study||0
71486|NCT01301092|166487|P1|NOT COMPLETED|Overall Study||0
71487|NCT01301092|166485|P3|COMPLETED|Overall Study||7
71488|NCT01301092|166486|P2|COMPLETED|Overall Study||16
71489|NCT01301092|166487|P1|COMPLETED|Overall Study||6
71490|NCT01301092|166485|P3|STARTED|Overall Study||8
71491|NCT01301092|166486|P2|STARTED|Overall Study||16
71492|NCT01301092|166487|P1|STARTED|Overall Study||6
71493|NCT01301079|166504|P2|NOT COMPLETED|Overall Study||2
71494|NCT01301079|166505|P1|NOT COMPLETED|Overall Study||2
71495|NCT01301079|166504|P2|COMPLETED|Overall Study||28
71496|NCT01301079|166505|P1|COMPLETED|Overall Study||28
71497|NCT01301079|166504|P2|STARTED|Overall Study||30
71498|NCT01301079|166505|P1|STARTED|Overall Study||30
71499|NCT01301066|166583|P2|NOT COMPLETED|Overall Study||35
71500|NCT01301066|166584|P1|NOT COMPLETED|Overall Study||27
71501|NCT01301066|166583|P2|COMPLETED|Overall Study||91
71502|NCT01301066|166584|P1|COMPLETED|Overall Study||99
71503|NCT01301066|166583|P2|STARTED|Overall Study||126
71504|NCT01301066|166584|P1|STARTED|Overall Study||126
71505|NCT01301027|166592|P2|NOT COMPLETED|Overall Study||10
71506|NCT01301027|166593|P1|NOT COMPLETED|Overall Study||8
71507|NCT01301027|166592|P2|COMPLETED|Overall Study||37
71508|NCT01301027|166593|P1|COMPLETED|Overall Study||40
71509|NCT01301027|166592|P2|STARTED|Overall Study||47
71510|NCT01301027|166593|P1|STARTED|Overall Study||48
71511|NCT01300819|166607|P2|NOT COMPLETED|Overall Study||44
71512|NCT01300819|166608|P1|NOT COMPLETED|Overall Study||22
71513|NCT01300819|166607|P2|COMPLETED|Overall Study||180
71514|NCT01300819|166608|P1|COMPLETED|Overall Study||103
71515|NCT01300819|166607|P2|STARTED|Overall Study||224
71516|NCT01300819|166608|P1|STARTED|Overall Study||125
71517|NCT01300767|166636|P1|NOT COMPLETED|Overall Study||4
71518|NCT01300767|166636|P1|COMPLETED|Overall Study||70
71519|NCT01300767|166636|P1|STARTED|Overall Study||74
71520|NCT01300741|166664|P1|NOT COMPLETED|Overall Study||3
71521|NCT01300741|166664|P1|COMPLETED|Overall Study||72
71522|NCT01300741|166664|P1|STARTED|Overall Study||75
71523|NCT01300728|166694|P2|NOT COMPLETED|Overall Study||1
71524|NCT01300728|166695|P1|NOT COMPLETED|Overall Study||2
71525|NCT01300728|166694|P2|COMPLETED|Overall Study||25
71526|NCT01300728|166695|P1|COMPLETED|Overall Study||24
71527|NCT01300728|166694|P2|STARTED|Overall Study||26
71528|NCT01300728|166695|P1|STARTED|Overall Study||26
71529|NCT01300650|166709|P1|NOT COMPLETED|Overall Study||1
71530|NCT01300650|166709|P1|COMPLETED|Overall Study||7
71531|NCT01300650|166709|P1|STARTED|Overall Study||8
71532|NCT01300624|166715|P1|NOT COMPLETED|Overall Study||0
71533|NCT01300624|166715|P1|COMPLETED|Overall Study||11
71534|NCT01300624|166715|P1|STARTED|Overall Study||11
71535|NCT01300559|166727|P2|NOT COMPLETED|Overall Study||0
71536|NCT01300559|166728|P1|NOT COMPLETED|Overall Study||0
71537|NCT01300559|166727|P2|COMPLETED|Overall Study||30
71538|NCT01300559|166728|P1|COMPLETED|Overall Study||30
71539|NCT01300559|166727|P2|STARTED|Overall Study||30
71540|NCT01300559|166728|P1|STARTED|Overall Study||30
71541|NCT01300546|166736|P2|NOT COMPLETED|Overall Study||6
71542|NCT01300546|166737|P1|NOT COMPLETED|Overall Study||1
71543|NCT01300546|166736|P2|COMPLETED|Overall Study||14
71544|NCT01300546|166737|P1|COMPLETED|Overall Study||18
71545|NCT01300546|166736|P2|STARTED|Overall Study||20
71546|NCT01300546|166737|P1|STARTED|Overall Study||19
71547|NCT01300455|166767|P2|NOT COMPLETED|Period 2||0
71548|NCT01300455|166768|P1|NOT COMPLETED|Period 2||0
71549|NCT01300455|166767|P2|COMPLETED|Period 2||13
71550|NCT01300455|166768|P1|COMPLETED|Period 2||12
71551|NCT01300455|166767|P2|STARTED|Period 2||13
71552|NCT01300455|166768|P1|STARTED|Period 2||12
71553|NCT01300455|166767|P2|NOT COMPLETED|Washout||0
71554|NCT01300455|166768|P1|NOT COMPLETED|Washout||1
71555|NCT01300455|166767|P2|COMPLETED|Washout||13
71556|NCT01300455|166768|P1|COMPLETED|Washout||12
71557|NCT01300455|166767|P2|STARTED|Washout||13
71558|NCT01300455|166768|P1|STARTED|Washout||13
71559|NCT01300455|166767|P2|NOT COMPLETED|Period 1||0
71560|NCT01300455|166768|P1|NOT COMPLETED|Period 1||0
71561|NCT01300455|166767|P2|COMPLETED|Period 1||13
71562|NCT01300455|166768|P1|COMPLETED|Period 1||13
71563|NCT01300455|166767|P2|STARTED|Period 1||13
71564|NCT01300455|166768|P1|STARTED|Period 1||13
71565|NCT01300351|166788|P2|NOT COMPLETED|Overall Study||38
71566|NCT01300351|166789|P1|NOT COMPLETED|Overall Study||36
71567|NCT01300351|166788|P2|COMPLETED|Overall Study||72
71568|NCT01300351|166789|P1|COMPLETED|Overall Study||75
71569|NCT01300351|166788|P2|Received Study Treatment|Overall Study||110
71570|NCT01300351|166789|P1|Received Study Treatment|Overall Study||109
71571|NCT01300351|166788|P2|STARTED|Overall Study||110
71572|NCT01300351|166789|P1|STARTED|Overall Study||111
71573|NCT01300338|166805|P2|NOT COMPLETED|Overall Study||0
71574|NCT01300338|166806|P1|NOT COMPLETED|Overall Study||5
71575|NCT01300338|166805|P2|COMPLETED|Overall Study||25
71576|NCT01300338|166806|P1|COMPLETED|Overall Study||20
71577|NCT01300338|166805|P2|STARTED|Overall Study||25
71578|NCT01300338|166806|P1|STARTED|Overall Study||25
71579|NCT01300286|166814|P1|NOT COMPLETED|Overall Study||1
71580|NCT01300286|166814|P1|COMPLETED|Overall Study||22
71581|NCT01300286|166814|P1|STARTED|Overall Study||23
71582|NCT01300260|166824|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
71583|NCT01300260|166825|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
71584|NCT01300260|166824|P2|COMPLETED|Period 2 of Study: Second Intervention||15
71585|NCT01300260|166825|P1|COMPLETED|Period 2 of Study: Second Intervention||14
71586|NCT01300260|166824|P2|STARTED|Period 2 of Study: Second Intervention||16
71587|NCT01300260|166825|P1|STARTED|Period 2 of Study: Second Intervention||14
71588|NCT01300260|166824|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
71589|NCT01300260|166825|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
71590|NCT01300260|166824|P2|COMPLETED|Washout Period of at Least 28 Days||16
71591|NCT01300260|166825|P1|COMPLETED|Washout Period of at Least 28 Days||14
71592|NCT01300260|166824|P2|STARTED|Washout Period of at Least 28 Days||16
71593|NCT01300260|166825|P1|STARTED|Washout Period of at Least 28 Days||14
71594|NCT01300260|166824|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
71595|NCT01300260|166825|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
71596|NCT01300260|166824|P2|COMPLETED|Period 1 of Study: First Intervention||16
71597|NCT01300260|166825|P1|COMPLETED|Period 1 of Study: First Intervention||14
71598|NCT01300260|166824|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
71599|NCT01300260|166825|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
71600|NCT01300260|166824|P2|STARTED|Period 1 of Study: First Intervention||17
71601|NCT01300260|166825|P1|STARTED|Period 1 of Study: First Intervention||15
71602|NCT01300247|166857|P2|NOT COMPLETED|Overall Study||2
71603|NCT01300247|166858|P1|NOT COMPLETED|Overall Study||4
71604|NCT01300247|166857|P2|COMPLETED|Overall Study||18
71605|NCT01300247|166858|P1|COMPLETED|Overall Study||17
71606|NCT01300247|166857|P2|STARTED|Overall Study||20
71607|NCT01300247|166858|P1|STARTED|Overall Study||21
71608|NCT01300234|166890|P2|NOT COMPLETED|Overall Study||10
71609|NCT01300234|166891|P1|NOT COMPLETED|Overall Study||4
71610|NCT01300234|166890|P2|COMPLETED|Overall Study||245
71611|NCT01300234|166891|P1|COMPLETED|Overall Study||253
71612|NCT01300234|166890|P2|STARTED|Overall Study||255
71613|NCT01300234|166891|P1|STARTED|Overall Study||257
71614|NCT01299961|166921|P1|NOT COMPLETED|Overall Study||6
71615|NCT01299961|166921|P1|COMPLETED|Overall Study||19
71616|NCT01299961|166921|P1|STARTED|Overall Study||25
71617|NCT01299909|166930|P3|NOT COMPLETED|Overall Study||17
71618|NCT01299909|166931|P2|NOT COMPLETED|Overall Study||18
71619|NCT01299909|166932|P1|NOT COMPLETED|Overall Study||22
71620|NCT01299909|166930|P3|COMPLETED|Overall Study||23
71621|NCT01299909|166931|P2|COMPLETED|Overall Study||49
71622|NCT01299909|166932|P1|COMPLETED|Overall Study||46
71623|NCT01299909|166930|P3|STARTED|Overall Study||40
71624|NCT01299909|166931|P2|STARTED|Overall Study||67
71625|NCT01299909|166932|P1|STARTED|Overall Study||68
71626|NCT01299896|166941|P2|NOT COMPLETED|Overall Study||18
71627|NCT01299896|166942|P1|NOT COMPLETED|Overall Study||1
71628|NCT01299896|166941|P2|COMPLETED|Overall Study||296
71629|NCT01299896|166942|P1|COMPLETED|Overall Study||318
71630|NCT01299896|166941|P2|STARTED|Overall Study||314
71631|NCT01299896|166942|P1|STARTED|Overall Study||319
71632|NCT01299805|166950|P2|NOT COMPLETED|Overall Study||0
71633|NCT01299805|166951|P1|NOT COMPLETED|Overall Study||2
71634|NCT01299805|166950|P2|COMPLETED|Overall Study||5
71635|NCT01299805|166951|P1|COMPLETED|Overall Study||10
71636|NCT01299805|166950|P2|STARTED|Overall Study||5
71637|NCT01299805|166951|P1|STARTED|Overall Study||12
71638|NCT01299584|166979|P1|NOT COMPLETED|Overall Study||9
71639|NCT01299584|166979|P1|COMPLETED|Overall Study||766
71640|NCT01299584|166979|P1|STARTED|Overall Study||775
71641|NCT01299571|166986|P1|NOT COMPLETED|Overall Study||107
71642|NCT01299571|166986|P1|COMPLETED|Overall Study||3870
71643|NCT01299571|166986|P1|STARTED|Overall Study||3977
71644|NCT01299480|166997|P5|NOT COMPLETED|Overall Study||20
71645|NCT01299480|166998|P4|NOT COMPLETED|Overall Study||25
71646|NCT01299480|166999|P3|NOT COMPLETED|Overall Study||41
71647|NCT01299480|167000|P2|NOT COMPLETED|Overall Study||35
71648|NCT01299480|167001|P1|NOT COMPLETED|Overall Study||42
71649|NCT01299480|166997|P5|COMPLETED|Overall Study||123
71650|NCT01299480|166998|P4|COMPLETED|Overall Study||261
71651|NCT01299480|166999|P3|COMPLETED|Overall Study||386
71652|NCT01299480|167000|P2|COMPLETED|Overall Study||395
71653|NCT01299480|167001|P1|COMPLETED|Overall Study||385
71654|NCT01299480|166997|P5|STARTED|Overall Study||143
71655|NCT01299480|166998|P4|STARTED|Overall Study||286
71656|NCT01299480|166999|P3|STARTED|Overall Study||427
71657|NCT01299480|167000|P2|STARTED|Overall Study||430
71658|NCT01299480|167001|P1|STARTED|Overall Study||427
71659|NCT01299454|167040|P4|NOT COMPLETED|Overall Study||0
71660|NCT01299454|167041|P3|NOT COMPLETED|Overall Study||0
71661|NCT01299454|167042|P2|NOT COMPLETED|Overall Study||0
71662|NCT01299454|167043|P1|NOT COMPLETED|Overall Study||0
71663|NCT01299454|167040|P4|COMPLETED|Overall Study||23
71664|NCT01299454|167041|P3|COMPLETED|Overall Study||6
71665|NCT01299454|167042|P2|COMPLETED|Overall Study||8
71666|NCT01299454|167043|P1|COMPLETED|Overall Study||8
71667|NCT01299454|167040|P4|STARTED|Overall Study||23
71668|NCT01299454|167041|P3|STARTED|Overall Study||6
71669|NCT01299454|167042|P2|STARTED|Overall Study||8
71670|NCT01299454|167043|P1|STARTED|Overall Study||8
71671|NCT01299389|167203|P4|NOT COMPLETED|Post-observational||6
71672|NCT01299389|167204|P3|NOT COMPLETED|Post-observational||12
71673|NCT01299389|167205|P2|NOT COMPLETED|Post-observational||0
71674|NCT01299389|167206|P1|NOT COMPLETED|Post-observational||0
71675|NCT01299389|167203|P4|COMPLETED|Post-observational||149
71676|NCT01299389|167204|P3|COMPLETED|Post-observational||144
71677|NCT01299389|167205|P2|COMPLETED|Post-observational||0
71678|NCT01299389|167206|P1|COMPLETED|Post-observational||0
71679|NCT01299389|167203|P4|STARTED|Post-observational||155
71680|NCT01299389|167204|P3|STARTED|Post-observational||156
71681|NCT01299389|167205|P2|STARTED|Post-observational||0
71682|NCT01299389|167206|P1|STARTED|Post-observational||0
71683|NCT01299389|167203|P4|NOT COMPLETED|Double-blind||0
71684|NCT01299389|167204|P3|NOT COMPLETED|Double-blind||0
71685|NCT01299389|167205|P2|NOT COMPLETED|Double-blind||64
71686|NCT01299389|167206|P1|NOT COMPLETED|Double-blind||109
71687|NCT01299389|167203|P4|COMPLETED|Double-blind||0
71688|NCT01299389|167204|P3|COMPLETED|Double-blind||0
71689|NCT01299389|167205|P2|COMPLETED|Double-blind||95
71690|NCT01299389|167206|P1|COMPLETED|Double-blind||55
71691|NCT01299389|167203|P4|STARTED|Double-blind||0
71692|NCT01299389|167204|P3|STARTED|Double-blind||0
71693|NCT01299389|167205|P2|STARTED|Double-blind||159
71694|NCT01299389|167206|P1|STARTED|Double-blind||164
71695|NCT01299376|167228|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
71696|NCT01299376|167229|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
71697|NCT01299376|167228|P2|COMPLETED|Extension (Weeks 9 to 52)||118
71698|NCT01299376|167229|P1|COMPLETED|Extension (Weeks 9 to 52)||124
71699|NCT01299376|167228|P2|STARTED|Extension (Weeks 9 to 52)||133
71700|NCT01299376|167229|P1|STARTED|Extension (Weeks 9 to 52)||134
71701|NCT01299376|167228|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
71702|NCT01299376|167229|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
71703|NCT01299376|167228|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
71704|NCT01299376|167229|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
71705|NCT01299376|167228|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
71706|NCT01299376|167229|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
71707|NCT01299103|167262|P3|NOT COMPLETED|Overall Study||2
71708|NCT01299103|167263|P2|NOT COMPLETED|Overall Study||2
71709|NCT01299103|167264|P1|NOT COMPLETED|Overall Study||0
71710|NCT01299103|167262|P3|COMPLETED|Overall Study||8
71711|NCT01299103|167263|P2|COMPLETED|Overall Study||13
71712|NCT01299103|167264|P1|COMPLETED|Overall Study||15
71713|NCT01299103|167262|P3|STARTED|Overall Study||10
71714|NCT01299103|167263|P2|STARTED|Overall Study||15
71715|NCT01299103|167264|P1|STARTED|Overall Study||15
71716|NCT01299090|167275|P1|NOT COMPLETED|Overall Study||0
71717|NCT01299090|167275|P1|COMPLETED|Overall Study||49
71718|NCT01299090|167275|P1|STARTED|Overall Study||49
71719|NCT01299077|167280|P1|NOT COMPLETED|Overall Study||0
71720|NCT01299077|167280|P1|COMPLETED|Overall Study||478
71721|NCT01299077|167280|P1|STARTED|Overall Study||478
71722|NCT01299025|167290|P2|NOT COMPLETED|Overall Study||1
71723|NCT01299025|167291|P1|NOT COMPLETED|Overall Study||3
71724|NCT01299025|167290|P2|COMPLETED|Overall Study||41
71725|NCT01299025|167291|P1|COMPLETED|Overall Study||39
71726|NCT01299025|167290|P2|STARTED|Overall Study||42
71727|NCT01299025|167291|P1|STARTED|Overall Study||42
71728|NCT01298661|167306|P3|NOT COMPLETED|Overall Study||2
71729|NCT01298661|167307|P2|NOT COMPLETED|Overall Study||0
71730|NCT01298661|167308|P1|NOT COMPLETED|Overall Study||2
71731|NCT01298661|167306|P3|COMPLETED|Overall Study||32
71732|NCT01298661|167307|P2|COMPLETED|Overall Study||24
71733|NCT01298661|167308|P1|COMPLETED|Overall Study||31
71734|NCT01298661|167306|P3|STARTED|Overall Study||34
71735|NCT01298661|167307|P2|STARTED|Overall Study||24
71736|NCT01298661|167308|P1|STARTED|Overall Study||33
71737|NCT01298648|167386|P1|NOT COMPLETED|Overall Study||23
71738|NCT01298648|167386|P1|COMPLETED|Overall Study||1693
71739|NCT01298648|167386|P1|STARTED|Overall Study||1716
71740|NCT01298544|167395|P1|NOT COMPLETED|Overall Study||0
71741|NCT01298544|167395|P1|COMPLETED|Overall Study||335
71742|NCT01298544|167395|P1|STARTED|Overall Study||335
71743|NCT01298531|167406|P2|NOT COMPLETED|Overall Study||7
71744|NCT01298531|167407|P1|NOT COMPLETED|Overall Study||9
71745|NCT01298531|167406|P2|COMPLETED|Overall Study||41
71746|NCT01298531|167407|P1|COMPLETED|Overall Study||33
71747|NCT01298531|167406|P2|STARTED|Overall Study||48
71748|NCT01298531|167407|P1|STARTED|Overall Study||42
71749|NCT01298518|167536|P3|NOT COMPLETED|Overall Study||1
71750|NCT01298518|167537|P2|NOT COMPLETED|Overall Study||0
71751|NCT01298518|167538|P1|NOT COMPLETED|Overall Study||0
71752|NCT01298518|167536|P3|COMPLETED|Overall Study||15
71753|NCT01298518|167537|P2|COMPLETED|Overall Study||16
71754|NCT01298518|167538|P1|COMPLETED|Overall Study||16
71755|NCT01298518|167536|P3|STARTED|Overall Study||16
71756|NCT01298518|167537|P2|STARTED|Overall Study||16
71757|NCT01298518|167538|P1|STARTED|Overall Study||16
71758|NCT01298362|167592|P2|NOT COMPLETED|Overall Study||43
71759|NCT01298362|167593|P1|NOT COMPLETED|Overall Study||38
71760|NCT01298362|167592|P2|COMPLETED|Overall Study||123
71761|NCT01298362|167593|P1|COMPLETED|Overall Study||86
71762|NCT01298362|167592|P2|STARTED|Overall Study||166
71763|NCT01298362|167593|P1|STARTED|Overall Study||124
71764|NCT01298323|167613|P2|NOT COMPLETED|Overall Study||88
71765|NCT01298323|167614|P1|NOT COMPLETED|Overall Study||86
71766|NCT01298323|167613|P2|COMPLETED|Overall Study||15
71767|NCT01298323|167614|P1|COMPLETED|Overall Study||16
71768|NCT01298323|167613|P2|Ongoing|Overall Study||55
71769|NCT01298323|167614|P1|Ongoing|Overall Study||55
71770|NCT01298323|167613|P2|STARTED|Overall Study||103
71771|NCT01298323|167614|P1|STARTED|Overall Study||102
71772|NCT01298167|167622|P2|NOT COMPLETED|Overall Study||0
71773|NCT01298167|167623|P1|NOT COMPLETED|Overall Study||1
71774|NCT01298167|167622|P2|COMPLETED|Overall Study||8
71775|NCT01298167|167623|P1|COMPLETED|Overall Study||5
71776|NCT01298167|167622|P2|STARTED|Overall Study||8
71777|NCT01298167|167623|P1|STARTED|Overall Study||6
71778|NCT01298128|167631|P2|NOT COMPLETED|Overall Study||8
71779|NCT01298128|167632|P1|NOT COMPLETED|Overall Study||9
71780|NCT01298128|167631|P2|COMPLETED|Overall Study||27
71781|NCT01298128|167632|P1|COMPLETED|Overall Study||26
71782|NCT01298128|167631|P2|STARTED|Overall Study||35
71783|NCT01298128|167632|P1|STARTED|Overall Study||35
71784|NCT01298063|167643|P5|NOT COMPLETED|Overall Study||0
71785|NCT01298063|167644|P4|NOT COMPLETED|Overall Study||0
71786|NCT01298063|167645|P3|NOT COMPLETED|Overall Study||0
71787|NCT01298063|167646|P2|NOT COMPLETED|Overall Study||0
71788|NCT01298063|167647|P1|NOT COMPLETED|Overall Study||0
71789|NCT01298063|167643|P5|COMPLETED|Overall Study||8
71790|NCT01298063|167644|P4|COMPLETED|Overall Study||8
71791|NCT01298063|167645|P3|COMPLETED|Overall Study||8
71792|NCT01298063|167646|P2|COMPLETED|Overall Study||3
71793|NCT01298063|167647|P1|COMPLETED|Overall Study||8
71794|NCT01298063|167643|P5|STARTED|Overall Study||8
71795|NCT01298063|167644|P4|STARTED|Overall Study||8
71796|NCT01298063|167645|P3|STARTED|Overall Study||8
71797|NCT01298063|167646|P2|STARTED|Overall Study||3
71798|NCT01298063|167647|P1|STARTED|Overall Study||8
71799|NCT01297920|167677|P3|NOT COMPLETED|Overall Study||57
71800|NCT01297920|167678|P2|NOT COMPLETED|Overall Study||27
71801|NCT01297920|167679|P1|NOT COMPLETED|Overall Study||58
71802|NCT01297920|167677|P3|COMPLETED|Overall Study||178
71803|NCT01297920|167678|P2|COMPLETED|Overall Study||207
71804|NCT01297920|167679|P1|COMPLETED|Overall Study||163
71805|NCT01297920|167677|P3|STARTED|Overall Study||235
71806|NCT01297920|167678|P2|STARTED|Overall Study||234
71807|NCT01297920|167679|P1|STARTED|Overall Study||221
71808|NCT01297595|167687|P2|NOT COMPLETED|Second Intervention Period||0
71809|NCT01297595|167688|P1|NOT COMPLETED|Second Intervention Period||0
71810|NCT01297595|167687|P2|COMPLETED|Second Intervention Period||11
71811|NCT01297595|167688|P1|COMPLETED|Second Intervention Period||11
71812|NCT01297595|167687|P2|STARTED|Second Intervention Period||11
71813|NCT01297595|167688|P1|STARTED|Second Intervention Period||11
71814|NCT01297595|167687|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
71815|NCT01297595|167688|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
71816|NCT01297595|167687|P2|COMPLETED|Washout Period (At Least 14 Days)||11
71817|NCT01297595|167688|P1|COMPLETED|Washout Period (At Least 14 Days)||11
71818|NCT01297595|167687|P2|STARTED|Washout Period (At Least 14 Days)||11
71819|NCT01297595|167688|P1|STARTED|Washout Period (At Least 14 Days)||11
71820|NCT01297595|167687|P2|NOT COMPLETED|First Intervention Period||0
71821|NCT01297595|167688|P1|NOT COMPLETED|First Intervention Period||0
71822|NCT01297595|167687|P2|COMPLETED|First Intervention Period||11
71823|NCT01297595|167688|P1|COMPLETED|First Intervention Period||11
71824|NCT01297595|167687|P2|STARTED|First Intervention Period||11
71825|NCT01297595|167688|P1|STARTED|First Intervention Period||11
71826|NCT01297517|167723|P3|NOT COMPLETED|Overall Study||27
71827|NCT01297517|167724|P2|NOT COMPLETED|Overall Study||12
71828|NCT01297517|167725|P1|NOT COMPLETED|Overall Study||27
71829|NCT01297517|167723|P3|COMPLETED|Overall Study||193
71830|NCT01297517|167724|P2|COMPLETED|Overall Study||214
71831|NCT01297517|167725|P1|COMPLETED|Overall Study||187
71832|NCT01297517|167723|P3|STARTED|Overall Study||220
71833|NCT01297517|167724|P2|STARTED|Overall Study||226
71834|NCT01297517|167725|P1|STARTED|Overall Study||214
71835|NCT01297504|167733|P1|NOT COMPLETED|Overall Study||67
71836|NCT01297504|167733|P1|COMPLETED|Overall Study||397
71837|NCT01297504|167733|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
71838|NCT01297504|167733|P1|STARTED|Overall Study||464
71839|NCT01297491|167747|P2|NOT COMPLETED|Overall Study||33
71840|NCT01297491|167748|P1|NOT COMPLETED|Overall Study||30
71841|NCT01297491|167747|P2|COMPLETED|Overall Study||0
71842|NCT01297491|167748|P1|COMPLETED|Overall Study||0
71843|NCT01297491|167747|P2|STARTED|Overall Study||33
71844|NCT01297491|167748|P1|STARTED|Overall Study||30
71845|NCT01297465|167766|P2|NOT COMPLETED|Overall Study||10
71846|NCT01297465|167767|P1|NOT COMPLETED|Overall Study||8
71847|NCT01297465|167766|P2|COMPLETED|Overall Study||93
71848|NCT01297465|167767|P1|COMPLETED|Overall Study||91
71849|NCT01297465|167766|P2|STARTED|Overall Study||103
71850|NCT01297465|167767|P1|STARTED|Overall Study||99
71851|NCT01297348|167801|P2|NOT COMPLETED|Overall Study||0
71852|NCT01297348|167802|P1|NOT COMPLETED|Overall Study||0
71853|NCT01297348|167801|P2|COMPLETED|Overall Study||586401
71854|NCT01297348|167802|P1|COMPLETED|Overall Study||12281
71855|NCT01297348|167801|P2|STARTED|Overall Study||586401
71856|NCT01297348|167802|P1|STARTED|Overall Study||12281
71857|NCT01297335|167812|P1|NOT COMPLETED|Overall Study||0
71858|NCT01297335|167812|P1|COMPLETED|Overall Study||10
71859|NCT01297335|167812|P1|STARTED|Overall Study||10
71860|NCT01297322|167820|P2|NOT COMPLETED|Overall Study||1
71861|NCT01297322|167821|P1|NOT COMPLETED|Overall Study||1
71862|NCT01297322|167820|P2|COMPLETED|Overall Study||274
71863|NCT01297322|167821|P1|COMPLETED|Overall Study||141
71864|NCT01297322|167820|P2|STARTED|Overall Study||275
71865|NCT01297322|167821|P1|STARTED|Overall Study||142
71866|NCT01297283|167841|P1|NOT COMPLETED|Overall Study||19
71867|NCT01297283|167841|P1|COMPLETED|Overall Study||176
71868|NCT01297283|167841|P1|STARTED|Overall Study||195
71869|NCT01297270|167849|P3|NOT COMPLETED|Overall Study||29
71870|NCT01297270|167850|P2|NOT COMPLETED|Overall Study||72
71871|NCT01297270|167851|P1|NOT COMPLETED|Overall Study||45
71872|NCT01297270|167849|P3|COMPLETED|Overall Study||103
71873|NCT01297270|167850|P2|COMPLETED|Overall Study||192
71874|NCT01297270|167851|P1|COMPLETED|Overall Study||217
71875|NCT01297270|167849|P3|STARTED|Overall Study||132
71876|NCT01297270|167850|P2|STARTED|Overall Study||264
71877|NCT01297270|167851|P1|STARTED|Overall Study||262
71878|NCT01297257|167889|P1|NOT COMPLETED|Overall Study||0
71879|NCT01297257|167889|P1|COMPLETED|Overall Study||7740
71880|NCT01297257|167889|P1|STARTED|Overall Study||7740
71881|NCT01297062|167900|P7|NOT COMPLETED|Overall Study||8
71882|NCT01297062|167901|P6|NOT COMPLETED|Overall Study||1
71883|NCT01297062|167902|P5|NOT COMPLETED|Overall Study||2
71884|NCT01297062|167903|P4|NOT COMPLETED|Overall Study||1
71885|NCT01297062|167904|P3|NOT COMPLETED|Overall Study||2
71886|NCT01297062|167905|P2|NOT COMPLETED|Overall Study||1
71887|NCT01297062|167906|P1|NOT COMPLETED|Overall Study||4
71888|NCT01297062|167900|P7|COMPLETED|Overall Study||0
71889|NCT01297062|167901|P6|COMPLETED|Overall Study||13
71890|NCT01297062|167902|P5|COMPLETED|Overall Study||13
71891|NCT01297062|167903|P4|COMPLETED|Overall Study||13
71892|NCT01297062|167904|P3|COMPLETED|Overall Study||12
71893|NCT01297062|167905|P2|COMPLETED|Overall Study||13
71894|NCT01297062|167906|P1|COMPLETED|Overall Study||11
71895|NCT01297062|167900|P7|Evaluable Population|Overall Study||0
71896|NCT01297062|167901|P6|Evaluable Population|Overall Study||13
71897|NCT01297062|167902|P5|Evaluable Population|Overall Study||13
71898|NCT01297062|167903|P4|Evaluable Population|Overall Study||13
71899|NCT01297062|167904|P3|Evaluable Population|Overall Study||12
71900|NCT01297062|167905|P2|Evaluable Population|Overall Study||12
71901|NCT01297062|167906|P1|Evaluable Population|Overall Study||11
71902|NCT01297062|167900|P7|Intent to Treat (ITT)|Overall Study||0
71903|NCT01297062|167901|P6|Intent to Treat (ITT)|Overall Study||14
71904|NCT01297062|167902|P5|Intent to Treat (ITT)|Overall Study||15
71905|NCT01297062|167903|P4|Intent to Treat (ITT)|Overall Study||14
71906|NCT01297062|167904|P3|Intent to Treat (ITT)|Overall Study||14
71907|NCT01297062|167905|P2|Intent to Treat (ITT)|Overall Study||14
71908|NCT01297062|167906|P1|Intent to Treat (ITT)|Overall Study||15
71909|NCT01297062|167900|P7|STARTED|Overall Study||8
71910|NCT01297062|167901|P6|STARTED|Overall Study||14
71911|NCT01297062|167902|P5|STARTED|Overall Study||15
71912|NCT01297062|167903|P4|STARTED|Overall Study||14
71913|NCT01297062|167904|P3|STARTED|Overall Study||14
71914|NCT01297062|167905|P2|STARTED|Overall Study||14
71915|NCT01297062|167906|P1|STARTED|Overall Study||15
71916|NCT01296841|167930|P2|NOT COMPLETED|Overall Study||0
71917|NCT01296841|167931|P1|NOT COMPLETED|Overall Study||0
71918|NCT01296841|167930|P2|COMPLETED|Overall Study||15
71919|NCT01296841|167931|P1|COMPLETED|Overall Study||19
71920|NCT01296841|167930|P2|STARTED|Overall Study||15
71921|NCT01296841|167931|P1|STARTED|Overall Study||19
71922|NCT01296815|167943|P2|NOT COMPLETED|Overall Study||0
71923|NCT01296815|167944|P1|NOT COMPLETED|Overall Study||0
71924|NCT01296815|167943|P2|COMPLETED|Overall Study||7
71925|NCT01296815|167944|P1|COMPLETED|Overall Study||7
71926|NCT01296815|167943|P2|STARTED|Overall Study||7
71927|NCT01296815|167944|P1|STARTED|Overall Study||7
71928|NCT01296763|167953|P3|NOT COMPLETED|Overall Study||0
71929|NCT01296763|167954|P2|NOT COMPLETED|Overall Study||0
71930|NCT01296763|167955|P1|NOT COMPLETED|Overall Study||0
71931|NCT01296763|167953|P3|COMPLETED|Overall Study||6
71932|NCT01296763|167954|P2|COMPLETED|Overall Study||5
71933|NCT01296763|167955|P1|COMPLETED|Overall Study||7
71934|NCT01296763|167953|P3|STARTED|Overall Study||6
71935|NCT01296763|167954|P2|STARTED|Overall Study||5
71936|NCT01296763|167955|P1|STARTED|Overall Study||7
71937|NCT01296698|167968|P2|NOT COMPLETED|Overall Study||13
71938|NCT01296698|167969|P1|NOT COMPLETED|Overall Study||244
71939|NCT01296698|167968|P2|COMPLETED|Overall Study||0
71940|NCT01296698|167969|P1|COMPLETED|Overall Study||0
71941|NCT01296698|167968|P2|STARTED|Overall Study||13
71942|NCT01296698|167969|P1|STARTED|Overall Study||244
71943|NCT01296646|168023|P2|NOT COMPLETED|Overall Study||11
71944|NCT01296646|168024|P1|NOT COMPLETED|Overall Study||11
71945|NCT01296646|168023|P2|COMPLETED|Overall Study||29
71946|NCT01296646|168024|P1|COMPLETED|Overall Study||29
71947|NCT01296646|168023|P2|STARTED|Overall Study||40
71948|NCT01296646|168024|P1|STARTED|Overall Study||40
71949|NCT01296412|168034|P2|NOT COMPLETED|Overall Study||70
71950|NCT01296412|168035|P1|NOT COMPLETED|Overall Study||51
71951|NCT01296412|168034|P2|COMPLETED|Overall Study||257
71952|NCT01296412|168035|P1|COMPLETED|Overall Study||275
71953|NCT01296412|168034|P2|STARTED|Overall Study||327
71954|NCT01296412|168035|P1|STARTED|Overall Study||326
71955|NCT01296360|168049|P2|NOT COMPLETED|Overall Study||8
71956|NCT01296360|168050|P1|NOT COMPLETED|Overall Study||6
71957|NCT01296360|168049|P2|COMPLETED|Overall Study||142
71958|NCT01296360|168050|P1|COMPLETED|Overall Study||144
71959|NCT01296360|168049|P2|Visit 2a (Month 13)|Overall Study||0
71960|NCT01296360|168050|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
71961|NCT01296360|168049|P2|Visit 2 (Month 12)|Overall Study||149
71962|NCT01296360|168050|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
71963|NCT01296360|168049|P2|STARTED|Overall Study||150
71964|NCT01296360|168050|P1|STARTED|Overall Study||150
71965|NCT01296152|168056|P1|NOT COMPLETED|Overall Study||1
71966|NCT01296152|168056|P1|COMPLETED|Overall Study||24
71967|NCT01296152|168056|P1|STARTED|Overall Study||25
71968|NCT01296035|168083|P1|NOT COMPLETED|Overall Study||1
71969|NCT01296035|168083|P1|COMPLETED|Overall Study||7
71970|NCT01296035|168083|P1|STARTED|Overall Study||8
71971|NCT01295905|168090|P2|NOT COMPLETED|Overall Study||0
71972|NCT01295905|168091|P1|NOT COMPLETED|Overall Study||2
71973|NCT01295905|168090|P2|COMPLETED|Overall Study||30
71974|NCT01295905|168091|P1|COMPLETED|Overall Study||58
71975|NCT01295905|168090|P2|STARTED|Overall Study||30
71976|NCT01295905|168091|P1|STARTED|Overall Study||60
71977|NCT01295879|168103|P1|NOT COMPLETED|Overall Study||0
71978|NCT01295879|168103|P1|COMPLETED|Overall Study||29
71979|NCT01295879|168103|P1|STARTED|Overall Study||29
71980|NCT01295840|168109|P1|NOT COMPLETED|Overall Study||1
71981|NCT01295840|168109|P1|COMPLETED|Overall Study||50
71982|NCT01295840|168109|P1|STARTED|Overall Study||51
71983|NCT01295814|168125|P2|NOT COMPLETED|Overall Study||2
71984|NCT01295814|168126|P1|NOT COMPLETED|Overall Study||2
71985|NCT01295814|168125|P2|COMPLETED|Overall Study||19
71986|NCT01295814|168126|P1|COMPLETED|Overall Study||20
71987|NCT01295814|168125|P2|STARTED|Overall Study||21
71988|NCT01295814|168126|P1|STARTED|Overall Study||22
71989|NCT01295281|168142|P2|NOT COMPLETED|Second Intervention (7days)||0
71990|NCT01295281|168143|P1|NOT COMPLETED|Second Intervention (7days)||0
71991|NCT01295281|168142|P2|COMPLETED|Second Intervention (7days)||51
71992|NCT01295281|168143|P1|COMPLETED|Second Intervention (7days)||53
71993|NCT01295281|168142|P2|STARTED|Second Intervention (7days)||51
71994|NCT01295281|168143|P1|STARTED|Second Intervention (7days)||53
71995|NCT01295281|168142|P2|NOT COMPLETED|First Intervention (7 Days)||1
71996|NCT01295281|168143|P1|NOT COMPLETED|First Intervention (7 Days)||0
71997|NCT01295281|168142|P2|COMPLETED|First Intervention (7 Days)||51
71998|NCT01295281|168143|P1|COMPLETED|First Intervention (7 Days)||53
71999|NCT01295281|168142|P2|STARTED|First Intervention (7 Days)||52
72000|NCT01295281|168143|P1|STARTED|First Intervention (7 Days)||53
72001|NCT01294917|168149|P1|NOT COMPLETED|Overall Study||6
72002|NCT01294917|168149|P1|COMPLETED|Overall Study||36
72003|NCT01294917|168149|P1|Received OptiFree RepleniSH MPS|Overall Study||36
72004|NCT01294917|168149|P1|Received Clear Care|Overall Study||36
72005|NCT01294917|168149|P1|Received Investigational MPS|Overall Study||36
72006|NCT01294917|168149|P1|STARTED|Overall Study||42
72007|NCT01294800|168159|P4|NOT COMPLETED|Overall Study||16
72008|NCT01294800|168160|P3|NOT COMPLETED|Overall Study||17
72009|NCT01294800|168161|P2|NOT COMPLETED|Overall Study||10
72010|NCT01294800|168162|P1|NOT COMPLETED|Overall Study||11
72011|NCT01294800|168159|P4|COMPLETED|Overall Study||97
72012|NCT01294800|168160|P3|COMPLETED|Overall Study||96
72013|NCT01294800|168161|P2|COMPLETED|Overall Study||103
72014|NCT01294800|168162|P1|COMPLETED|Overall Study||100
72015|NCT01294800|168159|P4|STARTED|Overall Study||113
72016|NCT01294800|168160|P3|STARTED|Overall Study||113
72017|NCT01294800|168161|P2|STARTED|Overall Study||113
72018|NCT01294800|168162|P1|STARTED|Overall Study||111
72019|NCT01294787|168188|P6|NOT COMPLETED|Period 3||0
72020|NCT01294787|168189|P5|NOT COMPLETED|Period 3||1
72021|NCT01294787|168190|P4|NOT COMPLETED|Period 3||0
72022|NCT01294787|168191|P3|NOT COMPLETED|Period 3||0
72023|NCT01294787|168192|P2|NOT COMPLETED|Period 3||0
72024|NCT01294787|168193|P1|NOT COMPLETED|Period 3||0
72025|NCT01294787|168188|P6|COMPLETED|Period 3||13
72026|NCT01294787|168189|P5|COMPLETED|Period 3||13
72027|NCT01294787|168190|P4|COMPLETED|Period 3||9
72028|NCT01294787|168191|P3|COMPLETED|Period 3||13
72029|NCT01294787|168192|P2|COMPLETED|Period 3||13
72030|NCT01294787|168193|P1|COMPLETED|Period 3||12
72031|NCT01294787|168188|P6|STARTED|Period 3||13
72032|NCT01294787|168189|P5|STARTED|Period 3||14
72033|NCT01294787|168190|P4|STARTED|Period 3||9
72034|NCT01294787|168191|P3|STARTED|Period 3||13
72035|NCT01294787|168192|P2|STARTED|Period 3||13
72036|NCT01294787|168193|P1|STARTED|Period 3||12
72037|NCT01294787|168188|P6|NOT COMPLETED|Period 2||0
72038|NCT01294787|168189|P5|NOT COMPLETED|Period 2||0
72039|NCT01294787|168190|P4|NOT COMPLETED|Period 2||2
72040|NCT01294787|168191|P3|NOT COMPLETED|Period 2||0
72041|NCT01294787|168192|P2|NOT COMPLETED|Period 2||3
72042|NCT01294787|168193|P1|NOT COMPLETED|Period 2||0
72043|NCT01294787|168188|P6|COMPLETED|Period 2||13
72044|NCT01294787|168189|P5|COMPLETED|Period 2||14
72045|NCT01294787|168190|P4|COMPLETED|Period 2||9
72046|NCT01294787|168191|P3|COMPLETED|Period 2||13
72047|NCT01294787|168192|P2|COMPLETED|Period 2||13
72048|NCT01294787|168193|P1|COMPLETED|Period 2||12
72049|NCT01294787|168188|P6|STARTED|Period 2||13
72050|NCT01294787|168189|P5|STARTED|Period 2||14
72051|NCT01294787|168190|P4|STARTED|Period 2||11
72052|NCT01294787|168191|P3|STARTED|Period 2||13
72053|NCT01294787|168192|P2|STARTED|Period 2||16
72054|NCT01294787|168193|P1|STARTED|Period 2||12
72055|NCT01294787|168188|P6|NOT COMPLETED|Period 1||2
72056|NCT01294787|168189|P5|NOT COMPLETED|Period 1||2
72057|NCT01294787|168190|P4|NOT COMPLETED|Period 1||1
72058|NCT01294787|168191|P3|NOT COMPLETED|Period 1||1
72059|NCT01294787|168192|P2|NOT COMPLETED|Period 1||0
72060|NCT01294787|168193|P1|NOT COMPLETED|Period 1||0
72061|NCT01294787|168188|P6|COMPLETED|Period 1||13
72062|NCT01294787|168189|P5|COMPLETED|Period 1||14
72063|NCT01294787|168190|P4|COMPLETED|Period 1||11
72064|NCT01294787|168191|P3|COMPLETED|Period 1||13
72065|NCT01294787|168192|P2|COMPLETED|Period 1||16
72066|NCT01294787|168193|P1|COMPLETED|Period 1||12
72067|NCT01294787|168188|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
72068|NCT01294787|168189|P5|STARTED|Period 1||16
72069|NCT01294787|168190|P4|STARTED|Period 1||12
72070|NCT01294787|168191|P3|STARTED|Period 1||14
72071|NCT01294787|168192|P2|STARTED|Period 1||16
72072|NCT01294787|168193|P1|STARTED|Period 1||12
72073|NCT01294748|168237|P2|NOT COMPLETED|Overall Study||2
72074|NCT01294748|168238|P1|NOT COMPLETED|Overall Study||5
72075|NCT01294748|168237|P2|COMPLETED|Overall Study|At 270 days|59
72076|NCT01294748|168238|P1|COMPLETED|Overall Study|At 270 days|118
72077|NCT01294748|168237|P2|STARTED|Overall Study||61
72078|NCT01294748|168238|P1|STARTED|Overall Study||123
72079|NCT01294709|168264|P2|NOT COMPLETED|Period 2||0
72080|NCT01294709|168265|P1|NOT COMPLETED|Period 2||1
72081|NCT01294709|168264|P2|COMPLETED|Period 2||31
72082|NCT01294709|168265|P1|COMPLETED|Period 2||28
72083|NCT01294709|168264|P2|STARTED|Period 2||31
72084|NCT01294709|168265|P1|STARTED|Period 2||29
72085|NCT01294709|168264|P2|NOT COMPLETED|Washout Period||1
72086|NCT01294709|168265|P1|NOT COMPLETED|Washout Period||1
72087|NCT01294709|168264|P2|COMPLETED|Washout Period||31
72088|NCT01294709|168265|P1|COMPLETED|Washout Period||29
72089|NCT01294709|168264|P2|STARTED|Washout Period||32
72090|NCT01294709|168265|P1|STARTED|Washout Period||30
72091|NCT01294709|168264|P2|NOT COMPLETED|Period 1||1
72092|NCT01294709|168265|P1|NOT COMPLETED|Period 1||1
72093|NCT01294709|168264|P2|COMPLETED|Period 1||32
72094|NCT01294709|168265|P1|COMPLETED|Period 1||30
72095|NCT01294709|168264|P2|STARTED|Period 1||33
72096|NCT01294709|168265|P1|STARTED|Period 1||31
72097|NCT01294696|168284|P1|NOT COMPLETED|Overall Study||74
72098|NCT01294696|168284|P1|COMPLETED|Overall Study||1187
72099|NCT01294696|168284|P1|STARTED|Overall Study||1261
72100|NCT01294683|168298|P2|NOT COMPLETED|Post Crossover (Period III)||32
72101|NCT01294683|168299|P1|NOT COMPLETED|Post Crossover (Period III)||33
72102|NCT01294683|168298|P2|COMPLETED|Post Crossover (Period III)||190
72103|NCT01294683|168299|P1|COMPLETED|Post Crossover (Period III)||199
72104|NCT01294683|168298|P2|STARTED|Post Crossover (Period III)||222
72105|NCT01294683|168299|P1|STARTED|Post Crossover (Period III)||232
72106|NCT01294683|168298|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
72107|NCT01294683|168299|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
72108|NCT01294683|168298|P2|COMPLETED|Precrossover (Periods I/II)||222
72109|NCT01294683|168299|P1|COMPLETED|Precrossover (Periods I/II)||232
72110|NCT01294683|168298|P2|Treated|Precrossover (Periods I/II)||486
72111|NCT01294683|168299|P1|Treated|Precrossover (Periods I/II)||486
72112|NCT01294683|168298|P2|STARTED|Precrossover (Periods I/II)||488
72113|NCT01294683|168299|P1|STARTED|Precrossover (Periods I/II)||489
72114|NCT01294644|168352|P3|NOT COMPLETED|Overall Study||14
72115|NCT01294644|168353|P2|NOT COMPLETED|Overall Study||10
72116|NCT01294644|168354|P1|NOT COMPLETED|Overall Study||10
72117|NCT01294644|168352|P3|COMPLETED|Overall Study||103
72118|NCT01294644|168353|P2|COMPLETED|Overall Study||112
72119|NCT01294644|168354|P1|COMPLETED|Overall Study||111
72120|NCT01294644|168352|P3|Received Treatment|Overall Study||114
72121|NCT01294644|168353|P2|Received Treatment|Overall Study||122
72122|NCT01294644|168354|P1|Received Treatment|Overall Study||118
72123|NCT01294644|168352|P3|STARTED|Overall Study||117
72124|NCT01294644|168353|P2|STARTED|Overall Study||122
72125|NCT01294644|168354|P1|STARTED|Overall Study||121
72126|NCT01294592|168385|P2|NOT COMPLETED|Overall Study||73
72127|NCT01294592|168386|P1|NOT COMPLETED|Overall Study||77
72128|NCT01294592|168385|P2|COMPLETED|Overall Study||300
72129|NCT01294592|168386|P1|COMPLETED|Overall Study||292
72130|NCT01294592|168385|P2|STARTED|Overall Study||373
72131|NCT01294592|168386|P1|STARTED|Overall Study||369
72132|NCT01294553|168414|P1|NOT COMPLETED|Overall Study||269
72133|NCT01294553|168414|P1|COMPLETED|Overall Study||713
72134|NCT01294553|168414|P1|STARTED|Overall Study||982
72135|NCT01294514|168420|P1|NOT COMPLETED|Overall Study||1
72136|NCT01294514|168420|P1|COMPLETED|Overall Study||26
72137|NCT01294514|168420|P1|STARTED|Overall Study||27
72138|NCT01294462|168430|P2|NOT COMPLETED|Overall Study||63
72139|NCT01294462|168431|P1|NOT COMPLETED|Overall Study||66
72140|NCT01294462|168430|P2|COMPLETED|Overall Study||337
72141|NCT01294462|168431|P1|COMPLETED|Overall Study||335
72142|NCT01294462|168430|P2|Received Randomized Treatment|Overall Study||380
72143|NCT01294462|168431|P1|Received Randomized Treatment|Overall Study||387
72144|NCT01294462|168430|P2|STARTED|Overall Study||400
72145|NCT01294462|168431|P1|STARTED|Overall Study||401
72146|NCT01294449|168445|P2|NOT COMPLETED|Overall Study||15
72147|NCT01294449|168446|P1|NOT COMPLETED|Overall Study||12
72148|NCT01294449|168445|P2|COMPLETED|Overall Study||237
72149|NCT01294449|168446|P1|COMPLETED|Overall Study||144
72150|NCT01294449|168445|P2|Consent to Registry|Overall Study||245
72151|NCT01294449|168446|P1|Consent to Registry|Overall Study||149
72152|NCT01294449|168445|P2|STARTED|Overall Study||252
72153|NCT01294449|168446|P1|STARTED|Overall Study||156
72154|NCT01294436|168454|P2|NOT COMPLETED|Overall Study||70
72155|NCT01294436|168455|P1|NOT COMPLETED|Overall Study||28
72156|NCT01294436|168454|P2|COMPLETED|Overall Study||409
72157|NCT01294436|168455|P1|COMPLETED|Overall Study||221
72158|NCT01294436|168454|P2|STARTED|Overall Study||479
72159|NCT01294436|168455|P1|STARTED|Overall Study||249
72160|NCT01294423|168490|P3|NOT COMPLETED|Overall Study||8
72161|NCT01294423|168491|P2|NOT COMPLETED|Overall Study||9
72162|NCT01294423|168492|P1|NOT COMPLETED|Overall Study||5
72163|NCT01294423|168490|P3|COMPLETED|Overall Study||79
72164|NCT01294423|168491|P2|COMPLETED|Overall Study||79
72165|NCT01294423|168492|P1|COMPLETED|Overall Study||81
72166|NCT01294423|168490|P3|STARTED|Overall Study||87
72167|NCT01294423|168491|P2|STARTED|Overall Study||88
72168|NCT01294423|168492|P1|STARTED|Overall Study||86
72169|NCT01294384|168509|P3|NOT COMPLETED|Overall Study||9
72170|NCT01294384|168510|P2|NOT COMPLETED|Overall Study||6
72171|NCT01294384|168511|P1|NOT COMPLETED|Overall Study||4
72172|NCT01294384|168509|P3|COMPLETED|Overall Study||95
72173|NCT01294384|168510|P2|COMPLETED|Overall Study||94
72174|NCT01294384|168511|P1|COMPLETED|Overall Study||97
72175|NCT01294384|168509|P3|STARTED|Overall Study||104
72176|NCT01294384|168510|P2|STARTED|Overall Study||100
72177|NCT01294384|168511|P1|STARTED|Overall Study||101
72178|NCT01294371|168540|P1|NOT COMPLETED|Overall Study||34
72179|NCT01294371|168540|P1|COMPLETED|Overall Study||357
72180|NCT01294371|168540|P1|Treated|Overall Study||390
72181|NCT01294371|168540|P1|STARTED|Overall Study||391
72182|NCT01294306|168550|P2|NOT COMPLETED|Overall Study||0
72183|NCT01294306|168551|P1|NOT COMPLETED|Overall Study||0
72184|NCT01294306|168550|P2|COMPLETED|Overall Study||35
72185|NCT01294306|168551|P1|COMPLETED|Overall Study||45
72186|NCT01294306|168550|P2|STARTED|Overall Study||35
72187|NCT01294306|168551|P1|STARTED|Overall Study||45
72188|NCT01294228|168565|P1|NOT COMPLETED|Overall Study||0
72189|NCT01294228|168565|P1|COMPLETED|Overall Study||1001
72190|NCT01294228|168565|P1|STARTED|Overall Study||1001
72191|NCT01294163|168572|P3|NOT COMPLETED|Overall Study||3
72192|NCT01294163|168573|P2|NOT COMPLETED|Overall Study||0
72193|NCT01294163|168574|P1|NOT COMPLETED|Overall Study||1
72194|NCT01294163|168572|P3|COMPLETED|Overall Study||163
72195|NCT01294163|168573|P2|COMPLETED|Overall Study||165
72196|NCT01294163|168574|P1|COMPLETED|Overall Study||177
72197|NCT01294163|168572|P3|STARTED|Overall Study||166
72198|NCT01294163|168573|P2|STARTED|Overall Study||165
72199|NCT01294163|168574|P1|STARTED|Overall Study||178
72200|NCT01294150|168585|P2|NOT COMPLETED|Overall Study||2
72201|NCT01294150|168586|P1|NOT COMPLETED|Overall Study||2
72202|NCT01294150|168585|P2|COMPLETED|Overall Study||64
72203|NCT01294150|168586|P1|COMPLETED|Overall Study||138
72204|NCT01294150|168585|P2|STARTED|Overall Study||66
72205|NCT01294150|168586|P1|STARTED|Overall Study||140
72206|NCT01293968|168597|P2|NOT COMPLETED|Overall Study||3
72207|NCT01293968|168598|P1|NOT COMPLETED|Overall Study||3
72208|NCT01293968|168597|P2|COMPLETED|Overall Study||14
72209|NCT01293968|168598|P1|COMPLETED|Overall Study||17
72210|NCT01293968|168597|P2|STARTED|Overall Study||17
72211|NCT01293968|168598|P1|STARTED|Overall Study||20
72212|NCT01293825|168604|P1|NOT COMPLETED|Overall Study||10
72213|NCT01293825|168604|P1|COMPLETED|Overall Study||20
72214|NCT01293825|168604|P1|STARTED|Overall Study||30
72215|NCT01293695|168618|P2|NOT COMPLETED|Overall Study||7
72216|NCT01293695|168619|P1|NOT COMPLETED|Overall Study||15
72217|NCT01293695|168618|P2|COMPLETED|Overall Study||87
72218|NCT01293695|168619|P1|COMPLETED|Overall Study||78
72219|NCT01293695|168618|P2|STARTED|Overall Study||94
72220|NCT01293695|168619|P1|STARTED|Overall Study||93
72221|NCT01293240|168633|P1|NOT COMPLETED|Overall Study||2
72222|NCT01293240|168633|P1|COMPLETED|Overall Study||115
72223|NCT01293240|168633|P1|STARTED|Overall Study||117
72224|NCT01293084|168648|P1|NOT COMPLETED|Overall Study||5
72225|NCT01293084|168648|P1|COMPLETED|Overall Study||12
72226|NCT01293084|168648|P1|STARTED|Overall Study||17
72227|NCT01293032|168660|P4|NOT COMPLETED|Treatment||1
72228|NCT01293032|168661|P3|NOT COMPLETED|Treatment||1
72229|NCT01293032|168662|P2|NOT COMPLETED|Treatment||5
72230|NCT01293032|168663|P1|NOT COMPLETED|Treatment||2
72231|NCT01293032|168660|P4|COMPLETED|Treatment||13
72232|NCT01293032|168661|P3|COMPLETED|Treatment||10
72233|NCT01293032|168662|P2|COMPLETED|Treatment||14
72234|NCT01293032|168663|P1|COMPLETED|Treatment||10
72235|NCT01293032|168660|P4|STARTED|Treatment||14
72236|NCT01293032|168661|P3|STARTED|Treatment||11
72237|NCT01293032|168662|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
72238|NCT01293032|168663|P1|STARTED|Treatment||12
72239|NCT01293032|168660|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
72240|NCT01293032|168661|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
72241|NCT01293032|168662|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
72242|NCT01293032|168663|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
72243|NCT01293032|168660|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
72244|NCT01293032|168661|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
72245|NCT01293032|168662|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
72246|NCT01293032|168663|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
72247|NCT01293032|168660|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
72248|NCT01293032|168661|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
72249|NCT01293032|168662|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
72250|NCT01293032|168663|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
72251|NCT01293032|168660|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
72252|NCT01293032|168661|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
72253|NCT01293032|168662|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
72254|NCT01293032|168663|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
72255|NCT01293006|168674|P4|NOT COMPLETED|Period 2||0
72256|NCT01293006|168675|P3|NOT COMPLETED|Period 2||0
72257|NCT01293006|168676|P2|NOT COMPLETED|Period 2||0
72258|NCT01293006|168677|P1|NOT COMPLETED|Period 2||1
72259|NCT01293006|168674|P4|COMPLETED|Period 2||3
72260|NCT01293006|168675|P3|COMPLETED|Period 2||9
72261|NCT01293006|168676|P2|COMPLETED|Period 2||2
72262|NCT01293006|168677|P1|COMPLETED|Period 2||10
72263|NCT01293006|168674|P4|STARTED|Period 2||3
72264|NCT01293006|168675|P3|STARTED|Period 2||9
72265|NCT01293006|168676|P2|STARTED|Period 2||2
72266|NCT01293006|168677|P1|STARTED|Period 2||11
72267|NCT01293006|168674|P4|NOT COMPLETED|Washout||0
72268|NCT01293006|168675|P3|NOT COMPLETED|Washout||0
72269|NCT01293006|168676|P2|NOT COMPLETED|Washout||0
72270|NCT01293006|168677|P1|NOT COMPLETED|Washout||0
72271|NCT01293006|168674|P4|COMPLETED|Washout||3
72272|NCT01293006|168675|P3|COMPLETED|Washout||9
72273|NCT01293006|168676|P2|COMPLETED|Washout||2
72274|NCT01293006|168677|P1|COMPLETED|Washout||11
72275|NCT01293006|168674|P4|STARTED|Washout||3
72276|NCT01293006|168675|P3|STARTED|Washout||9
72277|NCT01293006|168676|P2|STARTED|Washout||2
72278|NCT01293006|168677|P1|STARTED|Washout||11
72279|NCT01293006|168674|P4|NOT COMPLETED|Period 1||0
72280|NCT01293006|168675|P3|NOT COMPLETED|Period 1||0
72281|NCT01293006|168676|P2|NOT COMPLETED|Period 1||0
72282|NCT01293006|168677|P1|NOT COMPLETED|Period 1||0
72283|NCT01293006|168674|P4|COMPLETED|Period 1||3
72284|NCT01293006|168675|P3|COMPLETED|Period 1||9
72285|NCT01293006|168676|P2|COMPLETED|Period 1||2
72286|NCT01293006|168677|P1|COMPLETED|Period 1||11
72287|NCT01293006|168674|P4|STARTED|Period 1||3
72288|NCT01293006|168675|P3|STARTED|Period 1||9
72289|NCT01293006|168676|P2|STARTED|Period 1||2
72290|NCT01293006|168677|P1|STARTED|Period 1||11
72291|NCT01292928|168698|P1|NOT COMPLETED|Overall Study||24
72292|NCT01292928|168698|P1|COMPLETED|Overall Study||275
72293|NCT01292928|168698|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
72294|NCT01292928|168698|P1|STARTED|Overall Study||299
72295|NCT01292837|168715|P1|NOT COMPLETED|Overall Study||2
72296|NCT01292837|168715|P1|COMPLETED|Overall Study||11
72297|NCT01292837|168715|P1|STARTED|Overall Study||13
72298|NCT01292798|168724|P1|NOT COMPLETED|Overall Study||0
72299|NCT01292798|168724|P1|COMPLETED|Overall Study||43
72300|NCT01292798|168724|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
72301|NCT01292798|168724|P1|STARTED|Overall Study||43
72302|NCT01292746|168730|P1|NOT COMPLETED|Overall Study||0
72303|NCT01292746|168730|P1|COMPLETED|Overall Study||14
72304|NCT01292746|168730|P1|STARTED|Overall Study||14
72305|NCT01292642|168734|P1|NOT COMPLETED|Overall Study||5
72306|NCT01292642|168734|P1|COMPLETED|Overall Study||7
72307|NCT01292642|168734|P1|STARTED|Overall Study||12
72308|NCT01292629|168742|P1|NOT COMPLETED|Overall Study||0
72309|NCT01292629|168742|P1|COMPLETED|Overall Study||125
72310|NCT01292629|168742|P1|STARTED|Overall Study||125
72311|NCT01292603|168752|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
72312|NCT01292603|168753|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
72313|NCT01292603|168754|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
72314|NCT01292603|168755|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
72315|NCT01292603|168756|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
72316|NCT01292603|168757|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
72317|NCT01292603|168752|P6|COMPLETED|Part 2: Survival Follow-UP||0
72318|NCT01292603|168753|P5|COMPLETED|Part 2: Survival Follow-UP||0
72319|NCT01292603|168754|P4|COMPLETED|Part 2: Survival Follow-UP||0
72320|NCT01292603|168755|P3|COMPLETED|Part 2: Survival Follow-UP||0
72321|NCT01292603|168756|P2|COMPLETED|Part 2: Survival Follow-UP||0
72322|NCT01292603|168757|P1|COMPLETED|Part 2: Survival Follow-UP||0
72323|NCT01292603|168752|P6|STARTED|Part 2: Survival Follow-UP||13
72324|NCT01292603|168753|P5|STARTED|Part 2: Survival Follow-UP||11
72325|NCT01292603|168754|P4|STARTED|Part 2: Survival Follow-UP||0
72326|NCT01292603|168755|P3|STARTED|Part 2: Survival Follow-UP||0
72327|NCT01292603|168756|P2|STARTED|Part 2: Survival Follow-UP||0
72328|NCT01292603|168757|P1|STARTED|Part 2: Survival Follow-UP||0
72329|NCT01292603|168752|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
72330|NCT01292603|168753|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
72331|NCT01292603|168754|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
72332|NCT01292603|168755|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
72333|NCT01292603|168756|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
72334|NCT01292603|168757|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
72335|NCT01292603|168752|P6|COMPLETED|Part 2: Regular Follow-Up||0
72336|NCT01292603|168753|P5|COMPLETED|Part 2: Regular Follow-Up||0
72337|NCT01292603|168754|P4|COMPLETED|Part 2: Regular Follow-Up||0
72338|NCT01292603|168755|P3|COMPLETED|Part 2: Regular Follow-Up||0
72339|NCT01292603|168756|P2|COMPLETED|Part 2: Regular Follow-Up||0
72340|NCT01292603|168757|P1|COMPLETED|Part 2: Regular Follow-Up||0
72341|NCT01292603|168752|P6|STARTED|Part 2: Regular Follow-Up||78
72342|NCT01292603|168753|P5|STARTED|Part 2: Regular Follow-Up||78
72343|NCT01292603|168754|P4|STARTED|Part 2: Regular Follow-Up||0
72344|NCT01292603|168755|P3|STARTED|Part 2: Regular Follow-Up||0
72345|NCT01292603|168756|P2|STARTED|Part 2: Regular Follow-Up||0
72346|NCT01292603|168757|P1|STARTED|Part 2: Regular Follow-Up||0
72347|NCT01292603|168752|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
72348|NCT01292603|168753|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
72349|NCT01292603|168754|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
72350|NCT01292603|168755|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
72351|NCT01292603|168756|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
72352|NCT01292603|168757|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
72353|NCT01292603|168752|P6|COMPLETED|Part 2: Dose Confirmation Period||73
72354|NCT01292603|168753|P5|COMPLETED|Part 2: Dose Confirmation Period||72
72355|NCT01292603|168754|P4|COMPLETED|Part 2: Dose Confirmation Period||0
72356|NCT01292603|168755|P3|COMPLETED|Part 2: Dose Confirmation Period||0
72357|NCT01292603|168756|P2|COMPLETED|Part 2: Dose Confirmation Period||0
72358|NCT01292603|168757|P1|COMPLETED|Part 2: Dose Confirmation Period||0
72359|NCT01292603|168752|P6|STARTED|Part 2: Dose Confirmation Period||88
72360|NCT01292603|168753|P5|STARTED|Part 2: Dose Confirmation Period||88
72361|NCT01292603|168754|P4|STARTED|Part 2: Dose Confirmation Period||0
72362|NCT01292603|168755|P3|STARTED|Part 2: Dose Confirmation Period||0
72363|NCT01292603|168756|P2|STARTED|Part 2: Dose Confirmation Period||0
72364|NCT01292603|168757|P1|STARTED|Part 2: Dose Confirmation Period||0
72365|NCT01292603|168752|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
72366|NCT01292603|168753|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
72367|NCT01292603|168754|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
72368|NCT01292603|168755|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
72369|NCT01292603|168756|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
72370|NCT01292603|168757|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
72371|NCT01292603|168752|P6|COMPLETED|Part 1: Survival Follow-Up||0
72372|NCT01292603|168753|P5|COMPLETED|Part 1: Survival Follow-Up||0
72373|NCT01292603|168754|P4|COMPLETED|Part 1: Survival Follow-Up||0
72374|NCT01292603|168755|P3|COMPLETED|Part 1: Survival Follow-Up||0
72375|NCT01292603|168756|P2|COMPLETED|Part 1: Survival Follow-Up||0
72376|NCT01292603|168757|P1|COMPLETED|Part 1: Survival Follow-Up||0
72377|NCT01292603|168752|P6|STARTED|Part 1: Survival Follow-Up||0
72378|NCT01292603|168753|P5|STARTED|Part 1: Survival Follow-Up||0
72379|NCT01292603|168754|P4|STARTED|Part 1: Survival Follow-Up||0
72380|NCT01292603|168755|P3|STARTED|Part 1: Survival Follow-Up||2
72381|NCT01292603|168756|P2|STARTED|Part 1: Survival Follow-Up||2
72382|NCT01292603|168757|P1|STARTED|Part 1: Survival Follow-Up||4
72383|NCT01292603|168752|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
72384|NCT01292603|168753|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
72385|NCT01292603|168754|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
72386|NCT01292603|168755|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
72387|NCT01292603|168756|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
72388|NCT01292603|168757|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
72389|NCT01292603|168752|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
72390|NCT01292603|168753|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
72391|NCT01292603|168754|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
72392|NCT01292603|168755|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
72393|NCT01292603|168756|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
72394|NCT01292603|168757|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
72395|NCT01292603|168752|P6|STARTED|Part 1: Regular Follow-Up Period||0
72396|NCT01292603|168753|P5|STARTED|Part 1: Regular Follow-Up Period||0
72397|NCT01292603|168754|P4|STARTED|Part 1: Regular Follow-Up Period||0
72398|NCT01292603|168755|P3|STARTED|Part 1: Regular Follow-Up Period||23
72399|NCT01292603|168756|P2|STARTED|Part 1: Regular Follow-Up Period||17
72400|NCT01292603|168757|P1|STARTED|Part 1: Regular Follow-Up Period||16
72401|NCT01292603|168752|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
72402|NCT01292603|168753|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
72403|NCT01292603|168754|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
72404|NCT01292603|168755|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
72405|NCT01292603|168756|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
72406|NCT01292603|168757|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
72407|NCT01292603|168752|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
72408|NCT01292603|168753|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
72409|NCT01292603|168754|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
72410|NCT01292603|168755|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
72411|NCT01292603|168756|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
72412|NCT01292603|168757|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
72413|NCT01292603|168752|P6|STARTED|Part 1: Pilot Dose Selection Period||0
72414|NCT01292603|168753|P5|STARTED|Part 1: Pilot Dose Selection Period||0
72415|NCT01292603|168754|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
72416|NCT01292603|168755|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
72417|NCT01292603|168756|P2|STARTED|Part 1: Pilot Dose Selection Period||17
72418|NCT01292603|168757|P1|STARTED|Part 1: Pilot Dose Selection Period||16
72419|NCT01292538|168803|P2|NOT COMPLETED|Overall Study||0
72420|NCT01292538|168804|P1|NOT COMPLETED|Overall Study||0
72421|NCT01292538|168803|P2|COMPLETED|Overall Study||32
72422|NCT01292538|168804|P1|COMPLETED|Overall Study||35
72423|NCT01292538|168803|P2|STARTED|Overall Study||32
72424|NCT01292538|168804|P1|STARTED|Overall Study||35
72425|NCT01292486|168810|P1|NOT COMPLETED|Overall Study||6
72426|NCT01292486|168810|P1|COMPLETED|Overall Study||26
72427|NCT01292486|168810|P1|STARTED|Overall Study||32
72428|NCT01292473|168824|P4|NOT COMPLETED|Overall Study||12
72429|NCT01292473|168825|P3|NOT COMPLETED|Overall Study||9
72430|NCT01292473|168826|P2|NOT COMPLETED|Overall Study||7
72431|NCT01292473|168827|P1|NOT COMPLETED|Overall Study||5
72432|NCT01292473|168824|P4|COMPLETED|Overall Study||67
72433|NCT01292473|168825|P3|COMPLETED|Overall Study||74
72434|NCT01292473|168826|P2|COMPLETED|Overall Study||75
72435|NCT01292473|168827|P1|COMPLETED|Overall Study||74
72436|NCT01292473|168824|P4|STARTED|Overall Study||79
72437|NCT01292473|168825|P3|STARTED|Overall Study||83
72438|NCT01292473|168826|P2|STARTED|Overall Study||82
72439|NCT01292473|168827|P1|STARTED|Overall Study||79
72440|NCT01292304|168869|P1|NOT COMPLETED|Overall Study||0
72441|NCT01292304|168869|P1|COMPLETED|Overall Study||10
72442|NCT01292304|168869|P1|STARTED|Overall Study||10
72443|NCT01292265|168877|P1|NOT COMPLETED|Overall Study||0
72444|NCT01292265|168877|P1|COMPLETED|Overall Study||3
72445|NCT01292265|168877|P1|STARTED|Overall Study||3
72446|NCT01292239|168886|P2|NOT COMPLETED|Overall Study||7
72447|NCT01292239|168887|P1|NOT COMPLETED|Overall Study||4
72448|NCT01292239|168886|P2|COMPLETED|Overall Study||53
72449|NCT01292239|168887|P1|COMPLETED|Overall Study||119
72450|NCT01292239|168886|P2|STARTED|Overall Study||60
72451|NCT01292239|168887|P1|STARTED|Overall Study||123
72452|NCT01292226|168908|P1|NOT COMPLETED|Overall Study||13
72453|NCT01292226|168908|P1|COMPLETED|Overall Study||32
72454|NCT01292226|168908|P1|STARTED|Overall Study||45
72455|NCT01292187|168941|P2|NOT COMPLETED|Overall Study||13
72456|NCT01292187|168942|P1|NOT COMPLETED|Overall Study||17
72457|NCT01292187|168941|P2|COMPLETED|Overall Study||30
72458|NCT01292187|168942|P1|COMPLETED|Overall Study||69
72459|NCT01292187|168941|P2|STARTED|Overall Study||43
72460|NCT01292187|168942|P1|STARTED|Overall Study||86
72461|NCT01292135|168952|P2|NOT COMPLETED|Overall Study||9
72462|NCT01292135|168953|P1|NOT COMPLETED|Overall Study||0
72463|NCT01292135|168952|P2|COMPLETED|Overall Study||21
72464|NCT01292135|168953|P1|COMPLETED|Overall Study||3
72465|NCT01292135|168952|P2|STARTED|Overall Study||30
72466|NCT01292135|168953|P1|STARTED|Overall Study||3
72467|NCT01292070|168971|P1|NOT COMPLETED|Overall Study||0
72468|NCT01292070|168971|P1|COMPLETED|Overall Study||4
72469|NCT01292070|168971|P1|STARTED|Overall Study||4
72470|NCT01292005|168977|P2|NOT COMPLETED|Overall Study||0
72471|NCT01292005|168978|P1|NOT COMPLETED|Overall Study||0
72472|NCT01292005|168977|P2|COMPLETED|Overall Study||14
72473|NCT01292005|168978|P1|COMPLETED|Overall Study||14
72474|NCT01292005|168977|P2|STARTED|Overall Study||14
72475|NCT01292005|168978|P1|STARTED|Overall Study||14
72476|NCT01291784|169002|P3|NOT COMPLETED|Overall Study||0
72477|NCT01291784|169003|P2|NOT COMPLETED|Overall Study||1
72478|NCT01291784|169004|P1|NOT COMPLETED|Overall Study||0
72479|NCT01291784|169002|P3|COMPLETED|Overall Study||1
72480|NCT01291784|169003|P2|COMPLETED|Overall Study||0
72481|NCT01291784|169004|P1|COMPLETED|Overall Study||1
72482|NCT01291784|169002|P3|STARTED|Overall Study||1
72483|NCT01291784|169003|P2|STARTED|Overall Study||1
72484|NCT01291784|169004|P1|STARTED|Overall Study||1
72485|NCT01291498|169024|P1|NOT COMPLETED|Overall Study||1
72486|NCT01291498|169024|P1|COMPLETED|Overall Study||0
72487|NCT01291498|169024|P1|STARTED|Overall Study||1
72488|NCT01291277|169032|P2|NOT COMPLETED|Overall Study||3
72489|NCT01291277|169033|P1|NOT COMPLETED|Overall Study||5
72490|NCT01291277|169032|P2|COMPLETED|Overall Study||42
72491|NCT01291277|169033|P1|COMPLETED|Overall Study||40
72492|NCT01291277|169032|P2|STARTED|Overall Study||45
72493|NCT01291277|169033|P1|STARTED|Overall Study||45
72494|NCT01291264|169039|P1|NOT COMPLETED|Overall Study||0
72495|NCT01291264|169039|P1|COMPLETED|Overall Study||260
72496|NCT01291264|169039|P1|STARTED|Overall Study||260
72497|NCT01291225|169045|P2|NOT COMPLETED|Overall Study||39
72498|NCT01291225|169046|P1|NOT COMPLETED|Overall Study||85
72499|NCT01291225|169045|P2|COMPLETED|Overall Study||121
72500|NCT01291225|169046|P1|COMPLETED|Overall Study||66
72501|NCT01291225|169045|P2|STARTED|Overall Study||160
72502|NCT01291225|169046|P1|STARTED|Overall Study||151
72503|NCT01291173|169060|P4|NOT COMPLETED|Overall Study||13
72504|NCT01291173|169061|P3|NOT COMPLETED|Overall Study||13
72505|NCT01291173|169062|P2|NOT COMPLETED|Overall Study||15
72506|NCT01291173|169063|P1|NOT COMPLETED|Overall Study||17
72507|NCT01291173|169060|P4|COMPLETED|Overall Study||52
72508|NCT01291173|169061|P3|COMPLETED|Overall Study||52
72509|NCT01291173|169062|P2|COMPLETED|Overall Study||51
72510|NCT01291173|169063|P1|COMPLETED|Overall Study||47
72511|NCT01291173|169060|P4|STARTED|Overall Study||65
72512|NCT01291173|169061|P3|STARTED|Overall Study||65
72513|NCT01291173|169062|P2|STARTED|Overall Study||66
72514|NCT01291173|169063|P1|STARTED|Overall Study||64
72515|NCT01291160|169127|P2|NOT COMPLETED|Overall Study||16
72516|NCT01291160|169128|P1|NOT COMPLETED|Overall Study||18
72517|NCT01291160|169127|P2|COMPLETED|Overall Study||48
72518|NCT01291160|169128|P1|COMPLETED|Overall Study||48
72519|NCT01291160|169127|P2|STARTED|Overall Study||64
72520|NCT01291160|169128|P1|STARTED|Overall Study||66
72521|NCT01291108|169138|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
72522|NCT01291108|169139|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
72523|NCT01291108|169140|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
72524|NCT01291108|169141|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
72525|NCT01291108|169142|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
72526|NCT01291108|169143|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
72527|NCT01291108|169138|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
72528|NCT01291108|169139|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
72529|NCT01291108|169140|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
72530|NCT01291108|169141|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
72531|NCT01291108|169142|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
72532|NCT01291108|169143|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
72533|NCT01291108|169138|P6|STARTED|Month 2 (Adjunctive Therapy)||26
72534|NCT01291108|169139|P5|STARTED|Month 2 (Adjunctive Therapy)||34
72535|NCT01291108|169140|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
72536|NCT01291108|169141|P3|STARTED|Month 2 (Adjunctive Therapy)||24
72537|NCT01291108|169142|P2|STARTED|Month 2 (Adjunctive Therapy)||40
72538|NCT01291108|169143|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
72539|NCT01291108|169138|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
72540|NCT01291108|169139|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
72541|NCT01291108|169140|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
72542|NCT01291108|169141|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
72543|NCT01291108|169142|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
72544|NCT01291108|169143|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
72545|NCT01291108|169138|P6|COMPLETED|Month 1 (Monotherapy)||0
72546|NCT01291108|169139|P5|COMPLETED|Month 1 (Monotherapy)||0
72547|NCT01291108|169140|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
72548|NCT01291108|169141|P3|COMPLETED|Month 1 (Monotherapy)||0
72549|NCT01291108|169142|P2|COMPLETED|Month 1 (Monotherapy)||0
72550|NCT01291108|169143|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
72551|NCT01291108|169138|P6|STARTED|Month 1 (Monotherapy)||0
72552|NCT01291108|169139|P5|STARTED|Month 1 (Monotherapy)||0
72553|NCT01291108|169140|P4|STARTED|Month 1 (Monotherapy)||60
72554|NCT01291108|169141|P3|STARTED|Month 1 (Monotherapy)||0
72555|NCT01291108|169142|P2|STARTED|Month 1 (Monotherapy)||0
72556|NCT01291108|169143|P1|STARTED|Month 1 (Monotherapy)||65
72557|NCT01291056|169159|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
72558|NCT01291056|169160|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
72559|NCT01291056|169159|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
72560|NCT01291056|169160|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
72561|NCT01291056|169159|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
72562|NCT01291056|169160|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
72563|NCT01291056|169159|P2|NOT COMPLETED|Washout||0
72564|NCT01291056|169160|P1|NOT COMPLETED|Washout||0
72565|NCT01291056|169159|P2|COMPLETED|Washout||10
72566|NCT01291056|169160|P1|COMPLETED|Washout||10
72567|NCT01291056|169159|P2|STARTED|Washout||10
72568|NCT01291056|169160|P1|STARTED|Washout||10
72569|NCT01291056|169159|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
72570|NCT01291056|169160|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
72571|NCT01291056|169159|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
72572|NCT01291056|169160|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
72573|NCT01291056|169159|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
72574|NCT01291056|169160|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
72575|NCT01291017|169172|P1|NOT COMPLETED|Overall Study||5
72576|NCT01291017|169172|P1|COMPLETED|Overall Study||14
72577|NCT01291017|169172|P1|STARTED|Overall Study||19
72578|NCT01290978|169180|P1|NOT COMPLETED|Overall Study||0
72579|NCT01290978|169180|P1|COMPLETED|Overall Study||22
72580|NCT01290978|169180|P1|STARTED|Overall Study||22
72581|NCT01290952|169189|P2|NOT COMPLETED|Overall Study||14
72582|NCT01290952|169190|P1|NOT COMPLETED|Overall Study||12
72583|NCT01290952|169189|P2|COMPLETED|Overall Study||193
72584|NCT01290952|169190|P1|COMPLETED|Overall Study||192
72585|NCT01290952|169189|P2|STARTED|Overall Study||207
72586|NCT01290952|169190|P1|STARTED|Overall Study||204
72587|NCT01290913|169198|P1|NOT COMPLETED|Overall Study||1
72588|NCT01290913|169198|P1|COMPLETED|Overall Study||12
72589|NCT01290913|169198|P1|STARTED|Overall Study||13
72590|NCT01290887|169205|P2|NOT COMPLETED|Overall Study||536
72591|NCT01290887|169206|P1|NOT COMPLETED|Overall Study||466
72592|NCT01290887|169205|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
72593|NCT01290887|169206|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
72594|NCT01290887|169205|P2|Safety Analysis Set|Overall Study||571
72595|NCT01290887|169206|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
72596|NCT01290887|169205|P2|STARTED|Overall Study||571
72597|NCT01290887|169206|P1|STARTED|Overall Study||481
72598|NCT01290822|169244|P1|NOT COMPLETED|Overall Study||11
72599|NCT01290822|169244|P1|COMPLETED|Overall Study||1
72600|NCT01290822|169244|P1|STARTED|Overall Study||12
72601|NCT01290796|169253|P1|NOT COMPLETED|Overall Study||17
72602|NCT01290796|169253|P1|COMPLETED|Overall Study||136
72603|NCT01290796|169253|P1|STARTED|Overall Study||153
72604|NCT01290757|169260|P2|NOT COMPLETED|Overall Study||2
72605|NCT01290757|169261|P1|NOT COMPLETED|Overall Study||2
72606|NCT01290757|169260|P2|COMPLETED|Overall Study||88
72607|NCT01290757|169261|P1|COMPLETED|Overall Study||88
72608|NCT01290757|169260|P2|STARTED|Overall Study||90
72609|NCT01290757|169261|P1|STARTED|Overall Study||90
72610|NCT01290731|169277|P1|NOT COMPLETED|Overall Study||1
72611|NCT01290731|169277|P1|COMPLETED|Overall Study||48
72612|NCT01290731|169277|P1|STARTED|Overall Study||49
72613|NCT01290718|169289|P1|NOT COMPLETED|Overall Study||4
72614|NCT01290718|169289|P1|COMPLETED|Overall Study||0
72615|NCT01290718|169289|P1|STARTED|Overall Study||4
72616|NCT01290679|169298|P2|NOT COMPLETED|Overall Study||21
72617|NCT01290679|169299|P1|NOT COMPLETED|Overall Study||16
72618|NCT01290679|169298|P2|COMPLETED|Overall Study||113
72619|NCT01290679|169299|P1|COMPLETED|Overall Study||241
72620|NCT01290679|169298|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
72621|NCT01290679|169299|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
72622|NCT01290666|169368|P1|NOT COMPLETED|Overall Study||38
72623|NCT01290666|169368|P1|COMPLETED|Overall Study||55
72624|NCT01290666|169368|P1|STARTED|Overall Study||93
72625|NCT01290640|169374|P2|NOT COMPLETED|Overall Study||0
72626|NCT01290640|169375|P1|NOT COMPLETED|Overall Study||0
72627|NCT01290640|169374|P2|COMPLETED|Overall Study||10
72628|NCT01290640|169375|P1|COMPLETED|Overall Study||12
72629|NCT01290640|169374|P2|STARTED|Overall Study||10
72630|NCT01290640|169375|P1|STARTED|Overall Study||12
72631|NCT01290627|169386|P3|NOT COMPLETED|Overall Study||0
72632|NCT01290627|169387|P2|NOT COMPLETED|Overall Study||0
72633|NCT01290627|169388|P1|NOT COMPLETED|Overall Study||0
72634|NCT01290627|169386|P3|COMPLETED|Overall Study||10
72635|NCT01290627|169387|P2|COMPLETED|Overall Study||10
72636|NCT01290627|169388|P1|COMPLETED|Overall Study||10
72637|NCT01290627|169386|P3|STARTED|Overall Study||10
72638|NCT01290627|169387|P2|STARTED|Overall Study||10
72639|NCT01290627|169388|P1|STARTED|Overall Study||10
72640|NCT01290614|169410|P2|NOT COMPLETED|Overall Study||0
72641|NCT01290614|169411|P1|NOT COMPLETED|Overall Study||552
72642|NCT01290614|169410|P2|COMPLETED|Overall Study||1129
72643|NCT01290614|169411|P1|COMPLETED|Overall Study||518
72644|NCT01290614|169410|P2|STARTED|Overall Study||1129
72645|NCT01290614|169411|P1|STARTED|Overall Study||1070
72646|NCT01290536|169419|P1|NOT COMPLETED|Overall Study||0
72647|NCT01290536|169419|P1|COMPLETED|Overall Study||42
72648|NCT01290536|169419|P1|STARTED|Overall Study||42
72649|NCT01290523|169426|P1|NOT COMPLETED|Overall Study||0
72650|NCT01290523|169426|P1|COMPLETED|Overall Study||14
72651|NCT01290523|169426|P1|STARTED|Overall Study||14
72652|NCT01290484|169431|P1|NOT COMPLETED|Overall Study||0
72653|NCT01290484|169431|P1|COMPLETED|Overall Study||7
72654|NCT01290484|169431|P1|STARTED|Overall Study||7
72655|NCT01290341|169437|P2|NOT COMPLETED|Overall Study||29
72656|NCT01290341|169438|P1|NOT COMPLETED|Overall Study||92
72657|NCT01290341|169437|P2|COMPLETED|Overall Study||258
72658|NCT01290341|169438|P1|COMPLETED|Overall Study||481
72659|NCT01290341|169437|P2|STARTED|Overall Study||287
72660|NCT01290341|169438|P1|STARTED|Overall Study||573
72661|NCT01290224|169446|P1|NOT COMPLETED|Overall Study||5
72662|NCT01290224|169446|P1|COMPLETED|Overall Study||5
72663|NCT01290224|169446|P1|STARTED|Overall Study||10
72664|NCT01290094|169457|P1|NOT COMPLETED|Overall Study||6
72665|NCT01290094|169457|P1|COMPLETED|Overall Study||35
72666|NCT01290094|169457|P1|STARTED|Overall Study||41
72667|NCT01290029|169468|P1|NOT COMPLETED|Overall Study||2
72668|NCT01290029|169468|P1|COMPLETED|Overall Study||12
72669|NCT01290029|169468|P1|Received Study Treatment|Overall Study||12
72670|NCT01290029|169468|P1|STARTED|Overall Study||14
72671|NCT01289990|169494|P13|NOT COMPLETED|Overall Study||98
72672|NCT01289990|169495|P12|NOT COMPLETED|Overall Study||68
72673|NCT01289990|169496|P11|NOT COMPLETED|Overall Study||76
72674|NCT01289990|169497|P10|NOT COMPLETED|Overall Study||86
72675|NCT01289990|169498|P9|NOT COMPLETED|Overall Study||75
72676|NCT01289990|169499|P8|NOT COMPLETED|Overall Study||55
72677|NCT01289990|169500|P7|NOT COMPLETED|Overall Study||88
72678|NCT01289990|169501|P6|NOT COMPLETED|Overall Study||74
72679|NCT01289990|169502|P5|NOT COMPLETED|Overall Study||72
72680|NCT01289990|169503|P4|NOT COMPLETED|Overall Study||87
72681|NCT01289990|169504|P3|NOT COMPLETED|Overall Study||109
72682|NCT01289990|169505|P2|NOT COMPLETED|Overall Study||81
72683|NCT01289990|169506|P1|NOT COMPLETED|Overall Study||77
72684|NCT01289990|169494|P13|COMPLETED|Overall Study||127
72685|NCT01289990|169495|P12|COMPLETED|Overall Study||150
72686|NCT01289990|169496|P11|COMPLETED|Overall Study||150
72687|NCT01289990|169497|P10|COMPLETED|Overall Study||121
72688|NCT01289990|169498|P9|COMPLETED|Overall Study||139
72689|NCT01289990|169499|P8|COMPLETED|Overall Study||162
72690|NCT01289990|169500|P7|COMPLETED|Overall Study||78
72691|NCT01289990|169501|P6|COMPLETED|Overall Study||94
72692|NCT01289990|169502|P5|COMPLETED|Overall Study||93
72693|NCT01289990|169503|P4|COMPLETED|Overall Study||136
72694|NCT01289990|169504|P3|COMPLETED|Overall Study||119
72695|NCT01289990|169505|P2|COMPLETED|Overall Study||143
72696|NCT01289990|169506|P1|COMPLETED|Overall Study||147
72697|NCT01289990|169494|P13|STARTED|Overall Study||225
72698|NCT01289990|169495|P12|STARTED|Overall Study||218
72699|NCT01289990|169496|P11|STARTED|Overall Study||226
72700|NCT01289990|169497|P10|STARTED|Overall Study||207
72701|NCT01289990|169498|P9|STARTED|Overall Study||214
72702|NCT01289990|169499|P8|STARTED|Overall Study||217
72703|NCT01289990|169500|P7|STARTED|Overall Study||166
72704|NCT01289990|169501|P6|STARTED|Overall Study||168
72705|NCT01289990|169502|P5|STARTED|Overall Study||165
72706|NCT01289990|169503|P4|STARTED|Overall Study||223
72707|NCT01289990|169504|P3|STARTED|Overall Study||228
72708|NCT01289990|169505|P2|STARTED|Overall Study||224
72709|NCT01289990|169506|P1|STARTED|Overall Study||224
72710|NCT01289847|169690|P1|NOT COMPLETED|Overall Study||1
72711|NCT01289847|169690|P1|COMPLETED|Overall Study||24
72712|NCT01289847|169690|P1|STARTED|Overall Study||25
72713|NCT01289821|169699|P1|NOT COMPLETED|Survival Follow-up Period||6
72714|NCT01289821|169699|P1|COMPLETED|Survival Follow-up Period||16
72715|NCT01289821|169699|P1|STARTED|Survival Follow-up Period||22
72716|NCT01289821|169699|P1|NOT COMPLETED|Safety Follow-up Period||4
72717|NCT01289821|169699|P1|COMPLETED|Safety Follow-up Period||22
72718|NCT01289821|169699|P1|STARTED|Safety Follow-up Period||26
72719|NCT01289821|169699|P1|NOT COMPLETED|Treatment Period||28
72720|NCT01289821|169699|P1|COMPLETED|Treatment Period||26
72721|NCT01289821|169699|P1|Participants Received Regorafenib|Treatment Period||53
72722|NCT01289821|169699|P1|STARTED|Treatment Period||54
72723|NCT01289782|169710|P2|NOT COMPLETED|Overall Study||12
72724|NCT01289782|169711|P1|NOT COMPLETED|Overall Study||25
72725|NCT01289782|169710|P2|COMPLETED|Overall Study||118
72726|NCT01289782|169711|P1|COMPLETED|Overall Study||239
72727|NCT01289782|169710|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
72728|NCT01289782|169711|P1|STARTED|Overall Study||264
72729|NCT01289639|169783|P3|NOT COMPLETED|Overall Study||0
72730|NCT01289639|169784|P2|NOT COMPLETED|Overall Study||0
72731|NCT01289639|169785|P1|NOT COMPLETED|Overall Study||1
72732|NCT01289639|169783|P3|COMPLETED|Overall Study||0
72733|NCT01289639|169784|P2|COMPLETED|Overall Study||6
72734|NCT01289639|169785|P1|COMPLETED|Overall Study||4
72735|NCT01289639|169783|P3|STARTED|Overall Study||0
72736|NCT01289639|169784|P2|STARTED|Overall Study||6
72737|NCT01289639|169785|P1|STARTED|Overall Study||5
72738|NCT01289574|169811|P3|NOT COMPLETED|Overall Study||3
72739|NCT01289574|169812|P2|NOT COMPLETED|Overall Study||3
72740|NCT01289574|169813|P1|NOT COMPLETED|Overall Study||7
72741|NCT01289574|169811|P3|COMPLETED|Overall Study||60
72742|NCT01289574|169812|P2|COMPLETED|Overall Study||57
72743|NCT01289574|169813|P1|COMPLETED|Overall Study||51
72744|NCT01289574|169811|P3|STARTED|Overall Study||63
72745|NCT01289574|169812|P2|STARTED|Overall Study||60
72746|NCT01289574|169813|P1|STARTED|Overall Study||58
72747|NCT01289548|169830|P3|NOT COMPLETED|Overall Study||0
72748|NCT01289548|169831|P2|NOT COMPLETED|Overall Study||0
72749|NCT01289548|169832|P1|NOT COMPLETED|Overall Study||0
72750|NCT01289548|169830|P3|COMPLETED|Overall Study||40
72751|NCT01289548|169831|P2|COMPLETED|Overall Study||40
72752|NCT01289548|169832|P1|COMPLETED|Overall Study||40
72753|NCT01289548|169830|P3|Recipients|Overall Study||20
72754|NCT01289548|169831|P2|Recipients|Overall Study||20
72755|NCT01289548|169832|P1|Recipients|Overall Study||20
72756|NCT01289548|169830|P3|Donors|Overall Study||20
72757|NCT01289548|169831|P2|Donors|Overall Study||20
72758|NCT01289548|169832|P1|Donors|Overall Study||20
72759|NCT01289548|169830|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
72760|NCT01289548|169831|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
72761|NCT01289548|169832|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
72762|NCT01289418|169879|P1|NOT COMPLETED|Day 29 Survey||2468
72763|NCT01289418|169879|P1|COMPLETED|Day 29 Survey||4057
72764|NCT01289418|169879|P1|STARTED|Day 29 Survey||6525
72765|NCT01289418|169879|P1|NOT COMPLETED|Day 8 Survey||2218
72766|NCT01289418|169879|P1|COMPLETED|Day 8 Survey||4307
72767|NCT01289418|169879|P1|STARTED|Day 8 Survey||6525
72768|NCT01289392|169888|P3|NOT COMPLETED|Overall Study||0
72769|NCT01289392|169889|P2|NOT COMPLETED|Overall Study||0
72770|NCT01289392|169890|P1|NOT COMPLETED|Overall Study||0
72771|NCT01289392|169888|P3|COMPLETED|Overall Study||7
72772|NCT01289392|169889|P2|COMPLETED|Overall Study||9
72773|NCT01289392|169890|P1|COMPLETED|Overall Study||9
72774|NCT01289392|169888|P3|STARTED|Overall Study||7
72775|NCT01289392|169889|P2|STARTED|Overall Study||9
72776|NCT01289392|169890|P1|STARTED|Overall Study||9
72777|NCT01289210|169898|P1|NOT COMPLETED|Overall Study||1
72778|NCT01289210|169898|P1|COMPLETED|Overall Study||1
72779|NCT01289210|169898|P1|STARTED|Overall Study||2
72780|NCT01289119|169908|P6|NOT COMPLETED|Overall Study||4
72781|NCT01289119|169909|P5|NOT COMPLETED|Overall Study||5
72782|NCT01289119|169910|P4|NOT COMPLETED|Overall Study||6
72783|NCT01289119|169911|P3|NOT COMPLETED|Overall Study||9
72784|NCT01289119|169912|P2|NOT COMPLETED|Overall Study||9
72785|NCT01289119|169913|P1|NOT COMPLETED|Overall Study||9
72786|NCT01289119|169908|P6|COMPLETED|Overall Study||57
72787|NCT01289119|169909|P5|COMPLETED|Overall Study||58
72788|NCT01289119|169910|P4|COMPLETED|Overall Study||93
72789|NCT01289119|169911|P3|COMPLETED|Overall Study||89
72790|NCT01289119|169912|P2|COMPLETED|Overall Study||83
72791|NCT01289119|169913|P1|COMPLETED|Overall Study||84
72792|NCT01289119|169908|P6|Treated|Overall Study||61
72793|NCT01289119|169909|P5|Treated|Overall Study||63
72794|NCT01289119|169910|P4|Treated|Overall Study||99
72795|NCT01289119|169911|P3|Treated|Overall Study||98
72796|NCT01289119|169912|P2|Treated|Overall Study||92
72797|NCT01289119|169913|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
72798|NCT01289119|169908|P6|STARTED|Overall Study||61
72799|NCT01289119|169909|P5|STARTED|Overall Study||63
72800|NCT01289119|169910|P4|STARTED|Overall Study||99
72801|NCT01289119|169911|P3|STARTED|Overall Study||98
72802|NCT01289119|169912|P2|STARTED|Overall Study||92
72803|NCT01289119|169913|P1|STARTED|Overall Study||93
72804|NCT01289080|169995|P2|NOT COMPLETED|Overall Study||0
72805|NCT01289080|169996|P1|NOT COMPLETED|Overall Study||0
72806|NCT01289080|169995|P2|COMPLETED|Overall Study||10
72807|NCT01289080|169996|P1|COMPLETED|Overall Study||9
72808|NCT01289080|169995|P2|STARTED|Overall Study||10
72809|NCT01289080|169996|P1|STARTED|Overall Study||9
72810|NCT01289041|170027|P1|NOT COMPLETED|Overall Study||70
72811|NCT01289041|170027|P1|COMPLETED|Overall Study||0
72812|NCT01289041|170027|P1|STARTED|Overall Study||70
72813|NCT01289028|170039|P1|NOT COMPLETED|Overall Study||83
72814|NCT01289028|170039|P1|COMPLETED|Overall Study||42
72815|NCT01289028|170039|P1|STARTED|Overall Study||125
72816|NCT01289015|170053|P2|NOT COMPLETED|Overall Study||54
72817|NCT01289015|170054|P1|NOT COMPLETED|Overall Study||99
72818|NCT01289015|170053|P2|COMPLETED|Overall Study||230
72819|NCT01289015|170054|P1|COMPLETED|Overall Study||472
72820|NCT01289015|170053|P2|STARTED|Overall Study||284
72821|NCT01289015|170054|P1|STARTED|Overall Study||571
72822|NCT01288911|170064|P2|NOT COMPLETED|Overall Study||170
72823|NCT01288911|170065|P1|NOT COMPLETED|Overall Study||125
72824|NCT01288911|170064|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
72825|NCT01288911|170065|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
72826|NCT01288911|170064|P2|Received Treatment|Overall Study||189
72827|NCT01288911|170065|P1|Received Treatment|Overall Study||183
72828|NCT01288911|170064|P2|STARTED|Overall Study||191
72829|NCT01288911|170065|P1|STARTED|Overall Study||184
72830|NCT01288859|170093|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72831|NCT01288859|170094|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72832|NCT01288859|170095|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72833|NCT01288859|170096|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72834|NCT01288859|170097|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72835|NCT01288859|170098|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72836|NCT01288859|170093|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72837|NCT01288859|170094|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
72838|NCT01288859|170095|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
72839|NCT01288859|170096|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72840|NCT01288859|170097|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72841|NCT01288859|170098|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
72842|NCT01288859|170093|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
72843|NCT01288859|170094|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
72844|NCT01288859|170095|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
72845|NCT01288859|170096|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
72846|NCT01288859|170097|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
72847|NCT01288859|170098|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
72848|NCT01288859|170093|P6|NOT COMPLETED|Washout Period of 1 Week||0
72849|NCT01288859|170094|P5|NOT COMPLETED|Washout Period of 1 Week||0
72850|NCT01288859|170095|P4|NOT COMPLETED|Washout Period of 1 Week||0
72851|NCT01288859|170096|P3|NOT COMPLETED|Washout Period of 1 Week||0
72852|NCT01288859|170097|P2|NOT COMPLETED|Washout Period of 1 Week||0
72853|NCT01288859|170098|P1|NOT COMPLETED|Washout Period of 1 Week||0
72854|NCT01288859|170093|P6|COMPLETED|Washout Period of 1 Week||0
72855|NCT01288859|170094|P5|COMPLETED|Washout Period of 1 Week||5
72856|NCT01288859|170095|P4|COMPLETED|Washout Period of 1 Week||5
72857|NCT01288859|170096|P3|COMPLETED|Washout Period of 1 Week||0
72858|NCT01288859|170097|P2|COMPLETED|Washout Period of 1 Week||0
72859|NCT01288859|170098|P1|COMPLETED|Washout Period of 1 Week||0
72860|NCT01288859|170093|P6|STARTED|Washout Period of 1 Week||0
72861|NCT01288859|170094|P5|STARTED|Washout Period of 1 Week||5
72862|NCT01288859|170095|P4|STARTED|Washout Period of 1 Week||5
72863|NCT01288859|170096|P3|STARTED|Washout Period of 1 Week||0
72864|NCT01288859|170097|P2|STARTED|Washout Period of 1 Week||0
72865|NCT01288859|170098|P1|STARTED|Washout Period of 1 Week||0
72866|NCT01288859|170093|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72867|NCT01288859|170094|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72868|NCT01288859|170095|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72869|NCT01288859|170096|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72870|NCT01288859|170097|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72871|NCT01288859|170098|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72872|NCT01288859|170093|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72873|NCT01288859|170094|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
72874|NCT01288859|170095|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
72875|NCT01288859|170096|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72876|NCT01288859|170097|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72877|NCT01288859|170098|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
72878|NCT01288859|170093|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
72879|NCT01288859|170094|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
72880|NCT01288859|170095|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
72881|NCT01288859|170096|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
72882|NCT01288859|170097|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
72883|NCT01288859|170098|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
72884|NCT01288859|170093|P6|NOT COMPLETED|Washout Period of 1 Week||0
72885|NCT01288859|170094|P5|NOT COMPLETED|Washout Period of 1 Week||0
72886|NCT01288859|170095|P4|NOT COMPLETED|Washout Period of 1 Week||0
72887|NCT01288859|170096|P3|NOT COMPLETED|Washout Period of 1 Week||0
72888|NCT01288859|170097|P2|NOT COMPLETED|Washout Period of 1 Week||0
72889|NCT01288859|170098|P1|NOT COMPLETED|Washout Period of 1 Week||0
72890|NCT01288859|170093|P6|COMPLETED|Washout Period of 1 Week||0
72891|NCT01288859|170094|P5|COMPLETED|Washout Period of 1 Week||5
72892|NCT01288859|170095|P4|COMPLETED|Washout Period of 1 Week||5
72893|NCT01288859|170096|P3|COMPLETED|Washout Period of 1 Week||0
72894|NCT01288859|170097|P2|COMPLETED|Washout Period of 1 Week||0
72895|NCT01288859|170098|P1|COMPLETED|Washout Period of 1 Week||0
72896|NCT01288859|170093|P6|STARTED|Washout Period of 1 Week||0
72897|NCT01288859|170094|P5|STARTED|Washout Period of 1 Week||5
72898|NCT01288859|170095|P4|STARTED|Washout Period of 1 Week||5
72899|NCT01288859|170096|P3|STARTED|Washout Period of 1 Week||0
72900|NCT01288859|170097|P2|STARTED|Washout Period of 1 Week||0
72901|NCT01288859|170098|P1|STARTED|Washout Period of 1 Week||0
72902|NCT01288859|170093|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72903|NCT01288859|170094|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72904|NCT01288859|170095|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72905|NCT01288859|170096|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72906|NCT01288859|170097|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72907|NCT01288859|170098|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72908|NCT01288859|170093|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72909|NCT01288859|170094|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72910|NCT01288859|170095|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72911|NCT01288859|170096|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
72912|NCT01288859|170097|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
72913|NCT01288859|170098|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72914|NCT01288859|170093|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72915|NCT01288859|170094|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72916|NCT01288859|170095|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72917|NCT01288859|170096|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
72918|NCT01288859|170097|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
72919|NCT01288859|170098|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
72920|NCT01288859|170093|P6|NOT COMPLETED|Washout Period of 1 Week||0
72921|NCT01288859|170094|P5|NOT COMPLETED|Washout Period of 1 Week||0
72922|NCT01288859|170095|P4|NOT COMPLETED|Washout Period of 1 Week||0
72923|NCT01288859|170096|P3|NOT COMPLETED|Washout Period of 1 Week||0
72924|NCT01288859|170097|P2|NOT COMPLETED|Washout Period of 1 Week||0
72925|NCT01288859|170098|P1|NOT COMPLETED|Washout Period of 1 Week||0
72926|NCT01288859|170093|P6|COMPLETED|Washout Period of 1 Week||0
72927|NCT01288859|170094|P5|COMPLETED|Washout Period of 1 Week||0
72928|NCT01288859|170095|P4|COMPLETED|Washout Period of 1 Week||0
72929|NCT01288859|170096|P3|COMPLETED|Washout Period of 1 Week||5
72930|NCT01288859|170097|P2|COMPLETED|Washout Period of 1 Week||5
72931|NCT01288859|170098|P1|COMPLETED|Washout Period of 1 Week||0
72932|NCT01288859|170093|P6|STARTED|Washout Period of 1 Week||0
72933|NCT01288859|170094|P5|STARTED|Washout Period of 1 Week||0
72934|NCT01288859|170095|P4|STARTED|Washout Period of 1 Week||0
72935|NCT01288859|170096|P3|STARTED|Washout Period of 1 Week||5
72936|NCT01288859|170097|P2|STARTED|Washout Period of 1 Week||5
72937|NCT01288859|170098|P1|STARTED|Washout Period of 1 Week||0
72938|NCT01288859|170093|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72939|NCT01288859|170094|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72940|NCT01288859|170095|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72941|NCT01288859|170096|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72942|NCT01288859|170097|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72943|NCT01288859|170098|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72944|NCT01288859|170093|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72945|NCT01288859|170094|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72946|NCT01288859|170095|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72947|NCT01288859|170096|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
72948|NCT01288859|170097|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
72949|NCT01288859|170098|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72950|NCT01288859|170093|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72951|NCT01288859|170094|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72952|NCT01288859|170095|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72953|NCT01288859|170096|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
72954|NCT01288859|170097|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
72955|NCT01288859|170098|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
72956|NCT01288859|170093|P6|NOT COMPLETED|Washout Period of 1 Week||0
72957|NCT01288859|170094|P5|NOT COMPLETED|Washout Period of 1 Week||0
72958|NCT01288859|170095|P4|NOT COMPLETED|Washout Period of 1 Week||0
72959|NCT01288859|170096|P3|NOT COMPLETED|Washout Period of 1 Week||0
72960|NCT01288859|170097|P2|NOT COMPLETED|Washout Period of 1 Week||0
72961|NCT01288859|170098|P1|NOT COMPLETED|Washout Period of 1 Week||0
72962|NCT01288859|170093|P6|COMPLETED|Washout Period of 1 Week||5
72963|NCT01288859|170094|P5|COMPLETED|Washout Period of 1 Week||0
72964|NCT01288859|170095|P4|COMPLETED|Washout Period of 1 Week||0
72965|NCT01288859|170096|P3|COMPLETED|Washout Period of 1 Week||0
72966|NCT01288859|170097|P2|COMPLETED|Washout Period of 1 Week||0
72967|NCT01288859|170098|P1|COMPLETED|Washout Period of 1 Week||5
72968|NCT01288859|170093|P6|STARTED|Washout Period of 1 Week||5
72969|NCT01288859|170094|P5|STARTED|Washout Period of 1 Week||0
72970|NCT01288859|170095|P4|STARTED|Washout Period of 1 Week||0
72971|NCT01288859|170096|P3|STARTED|Washout Period of 1 Week||0
72972|NCT01288859|170097|P2|STARTED|Washout Period of 1 Week||0
72973|NCT01288859|170098|P1|STARTED|Washout Period of 1 Week||5
72974|NCT01288859|170093|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72975|NCT01288859|170094|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72976|NCT01288859|170095|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72977|NCT01288859|170096|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72978|NCT01288859|170097|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72979|NCT01288859|170098|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72980|NCT01288859|170093|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
72981|NCT01288859|170094|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72982|NCT01288859|170095|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72983|NCT01288859|170096|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72984|NCT01288859|170097|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
72985|NCT01288859|170098|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
72986|NCT01288859|170093|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
72987|NCT01288859|170094|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
72988|NCT01288859|170095|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
72989|NCT01288859|170096|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
72990|NCT01288859|170097|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
72991|NCT01288859|170098|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
72992|NCT01288859|170093|P6|NOT COMPLETED|Washout Period of 1 Week||0
72993|NCT01288859|170094|P5|NOT COMPLETED|Washout Period of 1 Week||0
72994|NCT01288859|170095|P4|NOT COMPLETED|Washout Period of 1 Week||0
72995|NCT01288859|170096|P3|NOT COMPLETED|Washout Period of 1 Week||0
72996|NCT01288859|170097|P2|NOT COMPLETED|Washout Period of 1 Week||0
72997|NCT01288859|170098|P1|NOT COMPLETED|Washout Period of 1 Week||0
72998|NCT01288859|170093|P6|COMPLETED|Washout Period of 1 Week||5
72999|NCT01288859|170094|P5|COMPLETED|Washout Period of 1 Week||0
73000|NCT01288859|170095|P4|COMPLETED|Washout Period of 1 Week||0
73001|NCT01288859|170096|P3|COMPLETED|Washout Period of 1 Week||0
73002|NCT01288859|170097|P2|COMPLETED|Washout Period of 1 Week||0
73003|NCT01288859|170098|P1|COMPLETED|Washout Period of 1 Week||5
73004|NCT01288859|170093|P6|STARTED|Washout Period of 1 Week||5
73005|NCT01288859|170094|P5|STARTED|Washout Period of 1 Week||0
73006|NCT01288859|170095|P4|STARTED|Washout Period of 1 Week||0
73007|NCT01288859|170096|P3|STARTED|Washout Period of 1 Week||0
73008|NCT01288859|170097|P2|STARTED|Washout Period of 1 Week||0
73009|NCT01288859|170098|P1|STARTED|Washout Period of 1 Week||5
73010|NCT01288859|170093|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73011|NCT01288859|170094|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73012|NCT01288859|170095|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73013|NCT01288859|170096|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73014|NCT01288859|170097|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73015|NCT01288859|170098|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73016|NCT01288859|170093|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
73017|NCT01288859|170094|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73018|NCT01288859|170095|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73019|NCT01288859|170096|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73020|NCT01288859|170097|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
73021|NCT01288859|170098|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
73022|NCT01288859|170093|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
73023|NCT01288859|170094|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
73024|NCT01288859|170095|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
73025|NCT01288859|170096|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
73026|NCT01288859|170097|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
73027|NCT01288859|170098|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
73028|NCT01288781|170126|P2|NOT COMPLETED|Overall Study||0
73029|NCT01288781|170127|P1|NOT COMPLETED|Overall Study||0
73030|NCT01288781|170126|P2|COMPLETED|Overall Study||12
73031|NCT01288781|170127|P1|COMPLETED|Overall Study||11
73032|NCT01288781|170126|P2|STARTED|Overall Study||12
73033|NCT01288781|170127|P1|STARTED|Overall Study||11
73034|NCT01288612|170148|P3|NOT COMPLETED|Overall Study||82
73035|NCT01288612|170149|P2|NOT COMPLETED|Overall Study||82
73036|NCT01288612|170150|P1|NOT COMPLETED|Overall Study||89
73037|NCT01288612|170148|P3|COMPLETED|Overall Study||76
73038|NCT01288612|170149|P2|COMPLETED|Overall Study||69
73039|NCT01288612|170150|P1|COMPLETED|Overall Study||61
73040|NCT01288612|170148|P3|Agreed to Take Part|Overall Study||76
73041|NCT01288612|170149|P2|Agreed to Take Part|Overall Study||72
73042|NCT01288612|170150|P1|Agreed to Take Part|Overall Study||61
73043|NCT01288612|170148|P3|Contacted|Overall Study||138
73044|NCT01288612|170149|P2|Contacted|Overall Study||135
73045|NCT01288612|170150|P1|Contacted|Overall Study||139
73046|NCT01288612|170148|P3|STARTED|Overall Study||158
73047|NCT01288612|170149|P2|STARTED|Overall Study||151
73048|NCT01288612|170150|P1|STARTED|Overall Study||150
73049|NCT01288534|170179|P1|NOT COMPLETED|Overall Study||0
73050|NCT01288534|170179|P1|COMPLETED|Overall Study||68
73051|NCT01288534|170179|P1|STARTED|Overall Study||68
73052|NCT01288469|170186|P3|NOT COMPLETED|Overall Study||2
73053|NCT01288469|170187|P2|NOT COMPLETED|Overall Study||3
73054|NCT01288469|170188|P1|NOT COMPLETED|Overall Study||7
73055|NCT01288469|170186|P3|COMPLETED|Overall Study||28
73056|NCT01288469|170187|P2|COMPLETED|Overall Study||28
73057|NCT01288469|170188|P1|COMPLETED|Overall Study||24
73058|NCT01288469|170186|P3|Treated|Overall Study||30
73059|NCT01288469|170187|P2|Treated|Overall Study||31
73060|NCT01288469|170188|P1|Treated|Overall Study||31
73061|NCT01288469|170186|P3|STARTED|Overall Study|Randomized|30
73062|NCT01288469|170187|P2|STARTED|Overall Study|Randomized|31
73063|NCT01288469|170188|P1|STARTED|Overall Study|Randomized|31
73064|NCT01288443|170220|P6|NOT COMPLETED|Overall Study||5
73065|NCT01288443|170221|P5|NOT COMPLETED|Overall Study||7
73066|NCT01288443|170222|P4|NOT COMPLETED|Overall Study||4
73067|NCT01288443|170223|P3|NOT COMPLETED|Overall Study||1
73068|NCT01288443|170224|P2|NOT COMPLETED|Overall Study||1
73069|NCT01288443|170225|P1|NOT COMPLETED|Overall Study||0
73070|NCT01288443|170220|P6|COMPLETED|Overall Study||25
73071|NCT01288443|170221|P5|COMPLETED|Overall Study||23
73072|NCT01288443|170222|P4|COMPLETED|Overall Study||27
73073|NCT01288443|170223|P3|COMPLETED|Overall Study||30
73074|NCT01288443|170224|P2|COMPLETED|Overall Study||29
73075|NCT01288443|170225|P1|COMPLETED|Overall Study||31
73076|NCT01288443|170220|P6|Treated|Overall Study||30
73077|NCT01288443|170221|P5|Treated|Overall Study||29
73078|NCT01288443|170222|P4|Treated|Overall Study||31
73079|NCT01288443|170223|P3|Treated|Overall Study||31
73080|NCT01288443|170224|P2|Treated|Overall Study||30
73081|NCT01288443|170225|P1|Treated|Overall Study||31
73082|NCT01288443|170220|P6|STARTED|Overall Study|Randomized|30
73083|NCT01288443|170221|P5|STARTED|Overall Study|Randomized|30
73084|NCT01288443|170222|P4|STARTED|Overall Study|Randomized|31
73085|NCT01288443|170223|P3|STARTED|Overall Study|Randomized|31
73086|NCT01288443|170224|P2|STARTED|Overall Study|Randomized|30
73087|NCT01288443|170225|P1|STARTED|Overall Study|Randomized|31
73088|NCT01288287|170275|P1|NOT COMPLETED|Overall Study||46
73089|NCT01288287|170275|P1|COMPLETED|Overall Study||103
73090|NCT01288287|170275|P1|Full Analysis Set|Overall Study||111
73091|NCT01288287|170275|P1|Safety Set|Overall Study||147
73092|NCT01288287|170275|P1|STARTED|Overall Study||149
73093|NCT01288209|170290|P2|NOT COMPLETED|Overall Study||3
73094|NCT01288209|170291|P1|NOT COMPLETED|Overall Study||2
73095|NCT01288209|170290|P2|COMPLETED|Overall Study||50
73096|NCT01288209|170291|P1|COMPLETED|Overall Study||51
73097|NCT01288209|170290|P2|STARTED|Overall Study||53
73098|NCT01288209|170291|P1|STARTED|Overall Study||53
73099|NCT01288079|170321|P4|NOT COMPLETED|Overall Study||17
73100|NCT01288079|170322|P3|NOT COMPLETED|Overall Study||19
73101|NCT01288079|170323|P2|NOT COMPLETED|Overall Study||27
73102|NCT01288079|170324|P1|NOT COMPLETED|Overall Study||20
73103|NCT01288079|170321|P4|COMPLETED|Overall Study||18
73104|NCT01288079|170322|P3|COMPLETED|Overall Study||18
73105|NCT01288079|170323|P2|COMPLETED|Overall Study||9
73106|NCT01288079|170324|P1|COMPLETED|Overall Study||17
73107|NCT01288079|170321|P4|STARTED|Overall Study||35
73108|NCT01288079|170322|P3|STARTED|Overall Study||37
73109|NCT01288079|170323|P2|STARTED|Overall Study||36
73110|NCT01288079|170324|P1|STARTED|Overall Study||37
73111|NCT01288027|170334|P1|NOT COMPLETED|Overall Study||0
73112|NCT01288027|170334|P1|COMPLETED|Overall Study||16
73113|NCT01288027|170334|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
73114|NCT01288027|170334|P1|STARTED|Overall Study||16
73115|NCT01287897|170348|P4|NOT COMPLETED|Overall Study||7
73116|NCT01287897|170349|P3|NOT COMPLETED|Overall Study||12
73117|NCT01287897|170350|P2|NOT COMPLETED|Overall Study||11
73118|NCT01287897|170351|P1|NOT COMPLETED|Overall Study||11
73119|NCT01287897|170348|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
73120|NCT01287897|170349|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
73121|NCT01287897|170350|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
73122|NCT01287897|170351|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
73123|NCT01287897|170348|P4|Enrolled in NCT01345318|Overall Study||29
73124|NCT01287897|170349|P3|Enrolled in NCT01345318|Overall Study||56
73125|NCT01287897|170350|P2|Enrolled in NCT01345318|Overall Study||50
73126|NCT01287897|170351|P1|Enrolled in NCT01345318|Overall Study||56
73127|NCT01287897|170348|P4|Completed Follow-up Period|Overall Study||4
73128|NCT01287897|170349|P3|Completed Follow-up Period|Overall Study||3
73129|NCT01287897|170350|P2|Completed Follow-up Period|Overall Study||8
73130|NCT01287897|170351|P1|Completed Follow-up Period|Overall Study||3
73131|NCT01287897|170348|P4|Completed Treatment Period|Overall Study||29
73132|NCT01287897|170349|P3|Completed Treatment Period|Overall Study||58
73133|NCT01287897|170350|P2|Completed Treatment Period|Overall Study||52
73134|NCT01287897|170351|P1|Completed Treatment Period|Overall Study||58
73135|NCT01287897|170348|P4|Treated|Overall Study||40
73136|NCT01287897|170349|P3|Treated|Overall Study||71
73137|NCT01287897|170350|P2|Treated|Overall Study||67
73138|NCT01287897|170351|P1|Treated|Overall Study||69
73139|NCT01287897|170348|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
73140|NCT01287897|170349|P3|STARTED|Overall Study||71
73141|NCT01287897|170350|P2|STARTED|Overall Study||69
73142|NCT01287897|170351|P1|STARTED|Overall Study||70
73143|NCT01287832|170402|P2|NOT COMPLETED|Overall Study||1
73144|NCT01287832|170403|P1|NOT COMPLETED|Overall Study||1
73145|NCT01287832|170402|P2|COMPLETED|Overall Study||4
73146|NCT01287832|170403|P1|COMPLETED|Overall Study||5
73147|NCT01287832|170402|P2|STARTED|Overall Study||5
73148|NCT01287832|170403|P1|STARTED|Overall Study||6
73149|NCT01287754|170411|P2|NOT COMPLETED|Overall Study||21
73150|NCT01287754|170412|P1|NOT COMPLETED|Overall Study||3
73151|NCT01287754|170411|P2|COMPLETED|Overall Study||0
73152|NCT01287754|170412|P1|COMPLETED|Overall Study||0
73153|NCT01287754|170411|P2|STARTED|Overall Study||21
73154|NCT01287754|170412|P1|STARTED|Overall Study||3
73155|NCT01287611|170424|P2|NOT COMPLETED|Overall Study||19
73156|NCT01287611|170425|P1|NOT COMPLETED|Overall Study||33
73157|NCT01287611|170424|P2|COMPLETED|Overall Study||65
73158|NCT01287611|170425|P1|COMPLETED|Overall Study||51
73159|NCT01287611|170424|P2|The Number of Patients Who Underwent C/S|Overall Study||84
73160|NCT01287611|170425|P1|The Number of Patients Who Underwent C/S|Overall Study||84
73161|NCT01287611|170424|P2|STARTED|Overall Study||84
73162|NCT01287611|170425|P1|STARTED|Overall Study||84
73163|NCT01287416|170435|P2|NOT COMPLETED|6 Month Follow-up||2
73164|NCT01287416|170436|P1|NOT COMPLETED|6 Month Follow-up||3
73165|NCT01287416|170435|P2|COMPLETED|6 Month Follow-up||22
73166|NCT01287416|170436|P1|COMPLETED|6 Month Follow-up||28
73167|NCT01287416|170435|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
73168|NCT01287416|170436|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
73169|NCT01287416|170435|P2|NOT COMPLETED|Pre-post Training||25
73170|NCT01287416|170436|P1|NOT COMPLETED|Pre-post Training||22
73171|NCT01287416|170435|P2|COMPLETED|Pre-post Training||23
73172|NCT01287416|170436|P1|COMPLETED|Pre-post Training||26
73173|NCT01287416|170435|P2|Post Training Questionnaire|Pre-post Training||23
73174|NCT01287416|170436|P1|Post Training Questionnaire|Pre-post Training||26
73175|NCT01287416|170435|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
73176|NCT01287416|170436|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
73177|NCT01287416|170435|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
73178|NCT01287416|170436|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
73179|NCT01287403|170472|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
73180|NCT01287403|170472|P1|COMPLETED|6th and Last Intervention (1 Day)||13
73181|NCT01287403|170472|P1|STARTED|6th and Last Intervention (1 Day)||13
73182|NCT01287403|170472|P1|NOT COMPLETED|Washout (7 Days)||0
73183|NCT01287403|170472|P1|COMPLETED|Washout (7 Days)||13
73184|NCT01287403|170472|P1|STARTED|Washout (7 Days)||13
73185|NCT01287403|170472|P1|NOT COMPLETED|5th Intervention (1 Day)||0
73186|NCT01287403|170472|P1|COMPLETED|5th Intervention (1 Day)||13
73187|NCT01287403|170472|P1|STARTED|5th Intervention (1 Day)||13
73188|NCT01287403|170472|P1|NOT COMPLETED|Washout (7 Days)||0
73189|NCT01287403|170472|P1|COMPLETED|Washout (7 Days)||13
73190|NCT01287403|170472|P1|STARTED|Washout (7 Days)||13
73191|NCT01287403|170472|P1|NOT COMPLETED|4th Intervention (1 Day)||0
73192|NCT01287403|170472|P1|COMPLETED|4th Intervention (1 Day)||13
73193|NCT01287403|170472|P1|STARTED|4th Intervention (1 Day)||13
73194|NCT01287403|170472|P1|NOT COMPLETED|Washout (7 Days)||0
73195|NCT01287403|170472|P1|COMPLETED|Washout (7 Days)||13
73196|NCT01287403|170472|P1|STARTED|Washout (7 Days)||13
73197|NCT01287403|170472|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
73198|NCT01287403|170472|P1|COMPLETED|3rd Intervention (1 Day)||13
73199|NCT01287403|170472|P1|STARTED|3rd Intervention (1 Day)||13
73200|NCT01287403|170472|P1|NOT COMPLETED|Washout (7 Days)||0
73201|NCT01287403|170472|P1|COMPLETED|Washout (7 Days)||13
73202|NCT01287403|170472|P1|STARTED|Washout (7 Days)||13
73203|NCT01287403|170472|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
73204|NCT01287403|170472|P1|COMPLETED|2nd Intervention (1 Day)||13
73205|NCT01287403|170472|P1|STARTED|2nd Intervention (1 Day)||13
73206|NCT01287403|170472|P1|NOT COMPLETED|Washout 7 Days||0
73207|NCT01287403|170472|P1|COMPLETED|Washout 7 Days||13
73208|NCT01287403|170472|P1|STARTED|Washout 7 Days||13
73209|NCT01287403|170472|P1|NOT COMPLETED|1st Intervention (1 Day)||1
73210|NCT01287403|170472|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
73211|NCT01287403|170472|P1|STARTED|1st Intervention (1 Day)||14
73212|NCT01287403|170472|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
73213|NCT01287403|170472|P1|COMPLETED|Diet Restriction (7 Days)||14
73214|NCT01287403|170472|P1|STARTED|Diet Restriction (7 Days)||14
73215|NCT01287364|170488|P2|NOT COMPLETED|Overall Study||10
73216|NCT01287364|170489|P1|NOT COMPLETED|Overall Study||9
73217|NCT01287364|170488|P2|COMPLETED|Overall Study||81
73218|NCT01287364|170489|P1|COMPLETED|Overall Study||85
73219|NCT01287364|170488|P2|STARTED|Overall Study||91
73220|NCT01287364|170489|P1|STARTED|Overall Study||94
73221|NCT01287221|170511|P2|NOT COMPLETED|Overall Study||5
73222|NCT01287221|170512|P1|NOT COMPLETED|Overall Study||4
73223|NCT01287221|170511|P2|COMPLETED|Overall Study||45
73224|NCT01287221|170512|P1|COMPLETED|Overall Study||46
73225|NCT01287221|170511|P2|Completed 12 Months Follow-up|Overall Study||39
73226|NCT01287221|170512|P1|Completed 12 Months Follow-up|Overall Study||40
73227|NCT01287221|170511|P2|Completed 9 Months Follow-up|Overall Study||40
73228|NCT01287221|170512|P1|Completed 9 Months Follow-up|Overall Study||42
73229|NCT01287221|170511|P2|Completed 6 Months Follow-up|Overall Study||43
73230|NCT01287221|170512|P1|Completed 6 Months Follow-up|Overall Study||47
73231|NCT01287221|170511|P2|Completed 3 Months Follow-up|Overall Study||50
73232|NCT01287221|170512|P1|Completed 3 Months Follow-up|Overall Study||49
73233|NCT01287221|170511|P2|STARTED|Overall Study||50
73234|NCT01287221|170512|P1|STARTED|Overall Study||50
73235|NCT01287208|170532|P2|NOT COMPLETED|Phase 2: Team Competition||0
73236|NCT01287208|170533|P1|NOT COMPLETED|Phase 2: Team Competition||0
73237|NCT01287208|170532|P2|COMPLETED|Phase 2: Team Competition||49
73238|NCT01287208|170533|P1|COMPLETED|Phase 2: Team Competition||50
73239|NCT01287208|170532|P2|STARTED|Phase 2: Team Competition||49
73240|NCT01287208|170533|P1|STARTED|Phase 2: Team Competition||50
73241|NCT01287208|170532|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
73242|NCT01287208|170533|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
73243|NCT01287208|170532|P2|COMPLETED|Phase 1: Randomized Phase||49
73244|NCT01287208|170533|P1|COMPLETED|Phase 1: Randomized Phase||50
73245|NCT01287208|170532|P2|STARTED|Phase 1: Randomized Phase||52
73246|NCT01287208|170533|P1|STARTED|Phase 1: Randomized Phase||52
73247|NCT01287117|170543|P4|NOT COMPLETED|Overall Study||12
73248|NCT01287117|170544|P3|NOT COMPLETED|Overall Study||16
73249|NCT01287117|170545|P2|NOT COMPLETED|Overall Study||14
73250|NCT01287117|170546|P1|NOT COMPLETED|Overall Study||15
73251|NCT01287117|170543|P4|COMPLETED|Overall Study||69
73252|NCT01287117|170544|P3|COMPLETED|Overall Study||64
73253|NCT01287117|170545|P2|COMPLETED|Overall Study||64
73254|NCT01287117|170546|P1|COMPLETED|Overall Study||65
73255|NCT01287117|170543|P4|Received Treatment|Overall Study||81
73256|NCT01287117|170544|P3|Received Treatment|Overall Study||80
73257|NCT01287117|170545|P2|Received Treatment|Overall Study||77
73258|NCT01287117|170546|P1|Received Treatment|Overall Study||80
73259|NCT01287117|170543|P4|STARTED|Overall Study||81
73260|NCT01287117|170544|P3|STARTED|Overall Study||80
73261|NCT01287117|170545|P2|STARTED|Overall Study||78
73262|NCT01287117|170546|P1|STARTED|Overall Study||80
73263|NCT01287065|170592|P6|NOT COMPLETED|Treatment Period 3||0
73264|NCT01287065|170593|P5|NOT COMPLETED|Treatment Period 3||0
73265|NCT01287065|170594|P4|NOT COMPLETED|Treatment Period 3||0
73266|NCT01287065|170595|P3|NOT COMPLETED|Treatment Period 3||0
73267|NCT01287065|170596|P2|NOT COMPLETED|Treatment Period 3||0
73268|NCT01287065|170597|P1|NOT COMPLETED|Treatment Period 3||0
73269|NCT01287065|170592|P6|COMPLETED|Treatment Period 3||4
73270|NCT01287065|170593|P5|COMPLETED|Treatment Period 3||4
73271|NCT01287065|170594|P4|COMPLETED|Treatment Period 3||4
73272|NCT01287065|170595|P3|COMPLETED|Treatment Period 3||4
73273|NCT01287065|170596|P2|COMPLETED|Treatment Period 3||4
73274|NCT01287065|170597|P1|COMPLETED|Treatment Period 3||4
73275|NCT01287065|170592|P6|STARTED|Treatment Period 3||4
73276|NCT01287065|170593|P5|STARTED|Treatment Period 3||4
73277|NCT01287065|170594|P4|STARTED|Treatment Period 3||4
73278|NCT01287065|170595|P3|STARTED|Treatment Period 3||4
73279|NCT01287065|170596|P2|STARTED|Treatment Period 3||4
73280|NCT01287065|170597|P1|STARTED|Treatment Period 3||4
73281|NCT01287065|170592|P6|NOT COMPLETED|Washout Period 2||0
73282|NCT01287065|170593|P5|NOT COMPLETED|Washout Period 2||0
73283|NCT01287065|170594|P4|NOT COMPLETED|Washout Period 2||0
73284|NCT01287065|170595|P3|NOT COMPLETED|Washout Period 2||0
73285|NCT01287065|170596|P2|NOT COMPLETED|Washout Period 2||0
73286|NCT01287065|170597|P1|NOT COMPLETED|Washout Period 2||0
73287|NCT01287065|170592|P6|COMPLETED|Washout Period 2||4
73288|NCT01287065|170593|P5|COMPLETED|Washout Period 2||4
73289|NCT01287065|170594|P4|COMPLETED|Washout Period 2||4
73290|NCT01287065|170595|P3|COMPLETED|Washout Period 2||4
73291|NCT01287065|170596|P2|COMPLETED|Washout Period 2||4
73292|NCT01287065|170597|P1|COMPLETED|Washout Period 2||4
73293|NCT01287065|170592|P6|STARTED|Washout Period 2||4
73294|NCT01287065|170593|P5|STARTED|Washout Period 2||4
73295|NCT01287065|170594|P4|STARTED|Washout Period 2||4
73296|NCT01287065|170595|P3|STARTED|Washout Period 2||4
73297|NCT01287065|170596|P2|STARTED|Washout Period 2||4
73298|NCT01287065|170597|P1|STARTED|Washout Period 2||4
73299|NCT01287065|170592|P6|NOT COMPLETED|Treatment Period 2||0
73300|NCT01287065|170593|P5|NOT COMPLETED|Treatment Period 2||0
73301|NCT01287065|170594|P4|NOT COMPLETED|Treatment Period 2||0
73302|NCT01287065|170595|P3|NOT COMPLETED|Treatment Period 2||0
73303|NCT01287065|170596|P2|NOT COMPLETED|Treatment Period 2||0
73304|NCT01287065|170597|P1|NOT COMPLETED|Treatment Period 2||0
73305|NCT01287065|170592|P6|COMPLETED|Treatment Period 2||4
73306|NCT01287065|170593|P5|COMPLETED|Treatment Period 2||4
73307|NCT01287065|170594|P4|COMPLETED|Treatment Period 2||4
73308|NCT01287065|170595|P3|COMPLETED|Treatment Period 2||4
73309|NCT01287065|170596|P2|COMPLETED|Treatment Period 2||4
73310|NCT01287065|170597|P1|COMPLETED|Treatment Period 2||4
73311|NCT01287065|170592|P6|STARTED|Treatment Period 2||4
73312|NCT01287065|170593|P5|STARTED|Treatment Period 2||4
73313|NCT01287065|170594|P4|STARTED|Treatment Period 2||4
73314|NCT01287065|170595|P3|STARTED|Treatment Period 2||4
73315|NCT01287065|170596|P2|STARTED|Treatment Period 2||4
73316|NCT01287065|170597|P1|STARTED|Treatment Period 2||4
73317|NCT01287065|170592|P6|NOT COMPLETED|Washout Period 1||0
73318|NCT01287065|170593|P5|NOT COMPLETED|Washout Period 1||0
73319|NCT01287065|170594|P4|NOT COMPLETED|Washout Period 1||0
73320|NCT01287065|170595|P3|NOT COMPLETED|Washout Period 1||0
73321|NCT01287065|170596|P2|NOT COMPLETED|Washout Period 1||0
73322|NCT01287065|170597|P1|NOT COMPLETED|Washout Period 1||0
73323|NCT01287065|170592|P6|COMPLETED|Washout Period 1||4
73324|NCT01287065|170593|P5|COMPLETED|Washout Period 1||4
73325|NCT01287065|170594|P4|COMPLETED|Washout Period 1||4
73326|NCT01287065|170595|P3|COMPLETED|Washout Period 1||4
73327|NCT01287065|170596|P2|COMPLETED|Washout Period 1||4
73328|NCT01287065|170597|P1|COMPLETED|Washout Period 1||4
73329|NCT01287065|170592|P6|STARTED|Washout Period 1||4
73330|NCT01287065|170593|P5|STARTED|Washout Period 1||4
73331|NCT01287065|170594|P4|STARTED|Washout Period 1||4
73332|NCT01287065|170595|P3|STARTED|Washout Period 1||4
73333|NCT01287065|170596|P2|STARTED|Washout Period 1||4
73334|NCT01287065|170597|P1|STARTED|Washout Period 1||4
73335|NCT01287065|170592|P6|NOT COMPLETED|Treatment Period 1||1
73336|NCT01287065|170593|P5|NOT COMPLETED|Treatment Period 1||1
73337|NCT01287065|170594|P4|NOT COMPLETED|Treatment Period 1||0
73338|NCT01287065|170595|P3|NOT COMPLETED|Treatment Period 1||0
73339|NCT01287065|170596|P2|NOT COMPLETED|Treatment Period 1||0
73340|NCT01287065|170597|P1|NOT COMPLETED|Treatment Period 1||0
73341|NCT01287065|170592|P6|COMPLETED|Treatment Period 1||4
73342|NCT01287065|170593|P5|COMPLETED|Treatment Period 1||4
73343|NCT01287065|170594|P4|COMPLETED|Treatment Period 1||4
73344|NCT01287065|170595|P3|COMPLETED|Treatment Period 1||4
73345|NCT01287065|170596|P2|COMPLETED|Treatment Period 1||4
73346|NCT01287065|170597|P1|COMPLETED|Treatment Period 1||4
73347|NCT01287065|170592|P6|STARTED|Treatment Period 1||5
73348|NCT01287065|170593|P5|STARTED|Treatment Period 1||5
73349|NCT01287065|170594|P4|STARTED|Treatment Period 1||4
73350|NCT01287065|170595|P3|STARTED|Treatment Period 1||4
73351|NCT01287065|170596|P2|STARTED|Treatment Period 1||4
73352|NCT01287065|170597|P1|STARTED|Treatment Period 1||4
73353|NCT01287039|170616|P2|NOT COMPLETED|Overall Study||27
73354|NCT01287039|170617|P1|NOT COMPLETED|Overall Study||29
73355|NCT01287039|170616|P2|COMPLETED|Overall Study||218
73356|NCT01287039|170617|P1|COMPLETED|Overall Study||215
73357|NCT01287039|170616|P2|STARTED|Overall Study||245
73358|NCT01287039|170617|P1|STARTED|Overall Study||244
73359|NCT01286818|170647|P1|NOT COMPLETED|Overall Study||0
73360|NCT01286818|170647|P1|COMPLETED|Overall Study||6
73361|NCT01286818|170647|P1|Completed DLT Assessment Period|Overall Study||5
73362|NCT01286818|170647|P1|STARTED|Overall Study||6
73363|NCT01286805|170661|P2|NOT COMPLETED|Overall Study||1
73364|NCT01286805|170662|P1|NOT COMPLETED|Overall Study||0
73365|NCT01286805|170661|P2|COMPLETED|Overall Study||41
73366|NCT01286805|170662|P1|COMPLETED|Overall Study||41
73367|NCT01286805|170661|P2|STARTED|Overall Study||42
73368|NCT01286805|170662|P1|STARTED|Overall Study||41
73369|NCT01286753|170684|P2|NOT COMPLETED|Overall Study||25
73370|NCT01286753|170685|P1|NOT COMPLETED|Overall Study||26
73371|NCT01286753|170684|P2|COMPLETED|Overall Study||0
73372|NCT01286753|170685|P1|COMPLETED|Overall Study||0
73373|NCT01286753|170684|P2|STARTED|Overall Study||25
73374|NCT01286753|170685|P1|STARTED|Overall Study||26
73375|NCT01286740|170703|P1|NOT COMPLETED|Overall Study||2
73376|NCT01286740|170703|P1|COMPLETED|Overall Study||48
73377|NCT01286740|170703|P1|Week 12 (Primary Endpoint)|Overall Study||49
73378|NCT01286740|170703|P1|Enrolled and Treated|Overall Study||49
73379|NCT01286740|170703|P1|STARTED|Overall Study||50
73380|NCT01286558|170721|P2|NOT COMPLETED|Overall Study||2
73381|NCT01286558|170722|P1|NOT COMPLETED|Overall Study||1
73382|NCT01286558|170721|P2|COMPLETED|Overall Study||111
73383|NCT01286558|170722|P1|COMPLETED|Overall Study||111
73384|NCT01286558|170721|P2|STARTED|Overall Study||113
73385|NCT01286558|170722|P1|STARTED|Overall Study||112
73386|NCT01286493|170752|P1|NOT COMPLETED|Overall Study||3
73387|NCT01286493|170752|P1|COMPLETED|Overall Study||30
73388|NCT01286493|170752|P1|STARTED|Overall Study||33
73389|NCT01286454|170756|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
73390|NCT01286454|170757|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
73391|NCT01286454|170758|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
73392|NCT01286454|170759|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
73393|NCT01286454|170760|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
73394|NCT01286454|170761|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
73395|NCT01286454|170762|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
73396|NCT01286454|170763|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
73397|NCT01286454|170764|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
73398|NCT01286454|170765|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
73399|NCT01286454|170766|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
73400|NCT01286454|170756|P11|COMPLETED|Part II- Sixth Intervention Period||20
73401|NCT01286454|170757|P10|COMPLETED|Part II- Sixth Intervention Period||0
73402|NCT01286454|170758|P9|COMPLETED|Part II- Sixth Intervention Period||0
73403|NCT01286454|170759|P8|COMPLETED|Part II- Sixth Intervention Period||0
73404|NCT01286454|170760|P7|COMPLETED|Part II- Sixth Intervention Period||0
73405|NCT01286454|170761|P6|COMPLETED|Part II- Sixth Intervention Period||0
73406|NCT01286454|170762|P5|COMPLETED|Part II- Sixth Intervention Period||0
73407|NCT01286454|170763|P4|COMPLETED|Part II- Sixth Intervention Period||0
73408|NCT01286454|170764|P3|COMPLETED|Part II- Sixth Intervention Period||0
73409|NCT01286454|170765|P2|COMPLETED|Part II- Sixth Intervention Period||0
73410|NCT01286454|170766|P1|COMPLETED|Part II- Sixth Intervention Period||0
73411|NCT01286454|170756|P11|STARTED|Part II- Sixth Intervention Period||20
73412|NCT01286454|170757|P10|STARTED|Part II- Sixth Intervention Period||0
73413|NCT01286454|170758|P9|STARTED|Part II- Sixth Intervention Period||0
73414|NCT01286454|170759|P8|STARTED|Part II- Sixth Intervention Period||0
73415|NCT01286454|170760|P7|STARTED|Part II- Sixth Intervention Period||0
73416|NCT01286454|170761|P6|STARTED|Part II- Sixth Intervention Period||0
73417|NCT01286454|170762|P5|STARTED|Part II- Sixth Intervention Period||0
73418|NCT01286454|170763|P4|STARTED|Part II- Sixth Intervention Period||0
73419|NCT01286454|170764|P3|STARTED|Part II- Sixth Intervention Period||0
73420|NCT01286454|170765|P2|STARTED|Part II- Sixth Intervention Period||0
73421|NCT01286454|170766|P1|STARTED|Part II- Sixth Intervention Period||0
73422|NCT01286454|170756|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73423|NCT01286454|170757|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73424|NCT01286454|170758|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73425|NCT01286454|170759|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73426|NCT01286454|170760|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73427|NCT01286454|170761|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73428|NCT01286454|170762|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73429|NCT01286454|170763|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73430|NCT01286454|170764|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73431|NCT01286454|170765|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73432|NCT01286454|170766|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
73433|NCT01286454|170756|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
73434|NCT01286454|170757|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73435|NCT01286454|170758|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73436|NCT01286454|170759|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73437|NCT01286454|170760|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73438|NCT01286454|170761|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73439|NCT01286454|170762|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73440|NCT01286454|170763|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73441|NCT01286454|170764|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73442|NCT01286454|170765|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73443|NCT01286454|170766|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
73444|NCT01286454|170756|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
73445|NCT01286454|170757|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
73446|NCT01286454|170758|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
73447|NCT01286454|170759|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
73448|NCT01286454|170760|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
73449|NCT01286454|170761|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
73450|NCT01286454|170762|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
73451|NCT01286454|170763|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
73452|NCT01286454|170764|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
73453|NCT01286454|170765|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
73454|NCT01286454|170766|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
73455|NCT01286454|170756|P11|NOT COMPLETED|Fifth Intervention Period||0
73456|NCT01286454|170757|P10|NOT COMPLETED|Fifth Intervention Period||0
73457|NCT01286454|170758|P9|NOT COMPLETED|Fifth Intervention Period||0
73458|NCT01286454|170759|P8|NOT COMPLETED|Fifth Intervention Period||0
73459|NCT01286454|170760|P7|NOT COMPLETED|Fifth Intervention Period||0
73460|NCT01286454|170761|P6|NOT COMPLETED|Fifth Intervention Period||0
73461|NCT01286454|170762|P5|NOT COMPLETED|Fifth Intervention Period||0
73462|NCT01286454|170763|P4|NOT COMPLETED|Fifth Intervention Period||0
73463|NCT01286454|170764|P3|NOT COMPLETED|Fifth Intervention Period||0
73464|NCT01286454|170765|P2|NOT COMPLETED|Fifth Intervention Period||0
73465|NCT01286454|170766|P1|NOT COMPLETED|Fifth Intervention Period||0
73466|NCT01286454|170756|P11|COMPLETED|Fifth Intervention Period||0
73467|NCT01286454|170757|P10|COMPLETED|Fifth Intervention Period||2
73468|NCT01286454|170758|P9|COMPLETED|Fifth Intervention Period||2
73469|NCT01286454|170759|P8|COMPLETED|Fifth Intervention Period||2
73470|NCT01286454|170760|P7|COMPLETED|Fifth Intervention Period||2
73471|NCT01286454|170761|P6|COMPLETED|Fifth Intervention Period||2
73472|NCT01286454|170762|P5|COMPLETED|Fifth Intervention Period||2
73473|NCT01286454|170763|P4|COMPLETED|Fifth Intervention Period||2
73474|NCT01286454|170764|P3|COMPLETED|Fifth Intervention Period||2
73475|NCT01286454|170765|P2|COMPLETED|Fifth Intervention Period||2
73476|NCT01286454|170766|P1|COMPLETED|Fifth Intervention Period||2
73477|NCT01286454|170756|P11|STARTED|Fifth Intervention Period||0
73478|NCT01286454|170757|P10|STARTED|Fifth Intervention Period||2
73479|NCT01286454|170758|P9|STARTED|Fifth Intervention Period||2
73480|NCT01286454|170759|P8|STARTED|Fifth Intervention Period||2
73481|NCT01286454|170760|P7|STARTED|Fifth Intervention Period||2
73482|NCT01286454|170761|P6|STARTED|Fifth Intervention Period||2
73483|NCT01286454|170762|P5|STARTED|Fifth Intervention Period||2
73484|NCT01286454|170763|P4|STARTED|Fifth Intervention Period||2
73485|NCT01286454|170764|P3|STARTED|Fifth Intervention Period||2
73486|NCT01286454|170765|P2|STARTED|Fifth Intervention Period||2
73487|NCT01286454|170766|P1|STARTED|Fifth Intervention Period||2
73488|NCT01286454|170756|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73489|NCT01286454|170757|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73490|NCT01286454|170758|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73491|NCT01286454|170759|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73492|NCT01286454|170760|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73493|NCT01286454|170761|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73494|NCT01286454|170762|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73495|NCT01286454|170763|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73496|NCT01286454|170764|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73497|NCT01286454|170765|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73498|NCT01286454|170766|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73499|NCT01286454|170756|P11|COMPLETED|Washout Period (At Least 3 Days)||0
73500|NCT01286454|170757|P10|COMPLETED|Washout Period (At Least 3 Days)||2
73501|NCT01286454|170758|P9|COMPLETED|Washout Period (At Least 3 Days)||2
73502|NCT01286454|170759|P8|COMPLETED|Washout Period (At Least 3 Days)||2
73503|NCT01286454|170760|P7|COMPLETED|Washout Period (At Least 3 Days)||2
73504|NCT01286454|170761|P6|COMPLETED|Washout Period (At Least 3 Days)||2
73505|NCT01286454|170762|P5|COMPLETED|Washout Period (At Least 3 Days)||2
73506|NCT01286454|170763|P4|COMPLETED|Washout Period (At Least 3 Days)||2
73507|NCT01286454|170764|P3|COMPLETED|Washout Period (At Least 3 Days)||2
73508|NCT01286454|170765|P2|COMPLETED|Washout Period (At Least 3 Days)||2
73509|NCT01286454|170766|P1|COMPLETED|Washout Period (At Least 3 Days)||2
73510|NCT01286454|170756|P11|STARTED|Washout Period (At Least 3 Days)||0
73511|NCT01286454|170757|P10|STARTED|Washout Period (At Least 3 Days)||2
73512|NCT01286454|170758|P9|STARTED|Washout Period (At Least 3 Days)||2
73513|NCT01286454|170759|P8|STARTED|Washout Period (At Least 3 Days)||2
73514|NCT01286454|170760|P7|STARTED|Washout Period (At Least 3 Days)||2
73515|NCT01286454|170761|P6|STARTED|Washout Period (At Least 3 Days)||2
73516|NCT01286454|170762|P5|STARTED|Washout Period (At Least 3 Days)||2
73517|NCT01286454|170763|P4|STARTED|Washout Period (At Least 3 Days)||2
73518|NCT01286454|170764|P3|STARTED|Washout Period (At Least 3 Days)||2
73519|NCT01286454|170765|P2|STARTED|Washout Period (At Least 3 Days)||2
73520|NCT01286454|170766|P1|STARTED|Washout Period (At Least 3 Days)||2
73521|NCT01286454|170756|P11|NOT COMPLETED|Fourth Intervention Period||0
73522|NCT01286454|170757|P10|NOT COMPLETED|Fourth Intervention Period||0
73523|NCT01286454|170758|P9|NOT COMPLETED|Fourth Intervention Period||0
73524|NCT01286454|170759|P8|NOT COMPLETED|Fourth Intervention Period||0
73525|NCT01286454|170760|P7|NOT COMPLETED|Fourth Intervention Period||0
73526|NCT01286454|170761|P6|NOT COMPLETED|Fourth Intervention Period||0
73527|NCT01286454|170762|P5|NOT COMPLETED|Fourth Intervention Period||0
73528|NCT01286454|170763|P4|NOT COMPLETED|Fourth Intervention Period||0
73529|NCT01286454|170764|P3|NOT COMPLETED|Fourth Intervention Period||0
73530|NCT01286454|170765|P2|NOT COMPLETED|Fourth Intervention Period||0
73531|NCT01286454|170766|P1|NOT COMPLETED|Fourth Intervention Period||0
73532|NCT01286454|170756|P11|COMPLETED|Fourth Intervention Period||0
73533|NCT01286454|170757|P10|COMPLETED|Fourth Intervention Period||2
73534|NCT01286454|170758|P9|COMPLETED|Fourth Intervention Period||2
73535|NCT01286454|170759|P8|COMPLETED|Fourth Intervention Period||2
73536|NCT01286454|170760|P7|COMPLETED|Fourth Intervention Period||2
73537|NCT01286454|170761|P6|COMPLETED|Fourth Intervention Period||2
73538|NCT01286454|170762|P5|COMPLETED|Fourth Intervention Period||2
73539|NCT01286454|170763|P4|COMPLETED|Fourth Intervention Period||2
73540|NCT01286454|170764|P3|COMPLETED|Fourth Intervention Period||2
73541|NCT01286454|170765|P2|COMPLETED|Fourth Intervention Period||2
73542|NCT01286454|170766|P1|COMPLETED|Fourth Intervention Period||2
73543|NCT01286454|170756|P11|STARTED|Fourth Intervention Period||0
73544|NCT01286454|170757|P10|STARTED|Fourth Intervention Period||2
73545|NCT01286454|170758|P9|STARTED|Fourth Intervention Period||2
73546|NCT01286454|170759|P8|STARTED|Fourth Intervention Period||2
73547|NCT01286454|170760|P7|STARTED|Fourth Intervention Period||2
73548|NCT01286454|170761|P6|STARTED|Fourth Intervention Period||2
73549|NCT01286454|170762|P5|STARTED|Fourth Intervention Period||2
73550|NCT01286454|170763|P4|STARTED|Fourth Intervention Period||2
73551|NCT01286454|170764|P3|STARTED|Fourth Intervention Period||2
73552|NCT01286454|170765|P2|STARTED|Fourth Intervention Period||2
73553|NCT01286454|170766|P1|STARTED|Fourth Intervention Period||2
73554|NCT01286454|170756|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73555|NCT01286454|170757|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73556|NCT01286454|170758|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73557|NCT01286454|170759|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73558|NCT01286454|170760|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73559|NCT01286454|170761|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73560|NCT01286454|170762|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73561|NCT01286454|170763|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73562|NCT01286454|170764|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73563|NCT01286454|170765|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73564|NCT01286454|170766|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73565|NCT01286454|170756|P11|COMPLETED|Washout Period (At Least 3 Days)||0
73566|NCT01286454|170757|P10|COMPLETED|Washout Period (At Least 3 Days)||2
73567|NCT01286454|170758|P9|COMPLETED|Washout Period (At Least 3 Days)||2
73568|NCT01286454|170759|P8|COMPLETED|Washout Period (At Least 3 Days)||2
73569|NCT01286454|170760|P7|COMPLETED|Washout Period (At Least 3 Days)||2
73570|NCT01286454|170761|P6|COMPLETED|Washout Period (At Least 3 Days)||2
73571|NCT01286454|170762|P5|COMPLETED|Washout Period (At Least 3 Days)||2
73572|NCT01286454|170763|P4|COMPLETED|Washout Period (At Least 3 Days)||2
73573|NCT01286454|170764|P3|COMPLETED|Washout Period (At Least 3 Days)||2
73574|NCT01286454|170765|P2|COMPLETED|Washout Period (At Least 3 Days)||2
73575|NCT01286454|170766|P1|COMPLETED|Washout Period (At Least 3 Days)||2
73576|NCT01286454|170756|P11|STARTED|Washout Period (At Least 3 Days)||0
73577|NCT01286454|170757|P10|STARTED|Washout Period (At Least 3 Days)||2
73578|NCT01286454|170758|P9|STARTED|Washout Period (At Least 3 Days)||2
73579|NCT01286454|170759|P8|STARTED|Washout Period (At Least 3 Days)||2
73580|NCT01286454|170760|P7|STARTED|Washout Period (At Least 3 Days)||2
73581|NCT01286454|170761|P6|STARTED|Washout Period (At Least 3 Days)||2
73582|NCT01286454|170762|P5|STARTED|Washout Period (At Least 3 Days)||2
73583|NCT01286454|170763|P4|STARTED|Washout Period (At Least 3 Days)||2
73584|NCT01286454|170764|P3|STARTED|Washout Period (At Least 3 Days)||2
73585|NCT01286454|170765|P2|STARTED|Washout Period (At Least 3 Days)||2
73586|NCT01286454|170766|P1|STARTED|Washout Period (At Least 3 Days)||2
73587|NCT01286454|170756|P11|NOT COMPLETED|Third Intervention Period||0
73588|NCT01286454|170757|P10|NOT COMPLETED|Third Intervention Period||0
73589|NCT01286454|170758|P9|NOT COMPLETED|Third Intervention Period||0
73590|NCT01286454|170759|P8|NOT COMPLETED|Third Intervention Period||0
73591|NCT01286454|170760|P7|NOT COMPLETED|Third Intervention Period||0
73592|NCT01286454|170761|P6|NOT COMPLETED|Third Intervention Period||0
73593|NCT01286454|170762|P5|NOT COMPLETED|Third Intervention Period||0
73594|NCT01286454|170763|P4|NOT COMPLETED|Third Intervention Period||0
73595|NCT01286454|170764|P3|NOT COMPLETED|Third Intervention Period||0
73596|NCT01286454|170765|P2|NOT COMPLETED|Third Intervention Period||0
73597|NCT01286454|170766|P1|NOT COMPLETED|Third Intervention Period||0
73598|NCT01286454|170756|P11|COMPLETED|Third Intervention Period||0
73599|NCT01286454|170757|P10|COMPLETED|Third Intervention Period||2
73600|NCT01286454|170758|P9|COMPLETED|Third Intervention Period||2
73601|NCT01286454|170759|P8|COMPLETED|Third Intervention Period||2
73602|NCT01286454|170760|P7|COMPLETED|Third Intervention Period||2
73603|NCT01286454|170761|P6|COMPLETED|Third Intervention Period||2
73604|NCT01286454|170762|P5|COMPLETED|Third Intervention Period||2
73605|NCT01286454|170763|P4|COMPLETED|Third Intervention Period||2
73606|NCT01286454|170764|P3|COMPLETED|Third Intervention Period||2
73607|NCT01286454|170765|P2|COMPLETED|Third Intervention Period||2
73608|NCT01286454|170766|P1|COMPLETED|Third Intervention Period||2
73609|NCT01286454|170756|P11|STARTED|Third Intervention Period||0
73610|NCT01286454|170757|P10|STARTED|Third Intervention Period||2
73611|NCT01286454|170758|P9|STARTED|Third Intervention Period||2
73612|NCT01286454|170759|P8|STARTED|Third Intervention Period||2
73613|NCT01286454|170760|P7|STARTED|Third Intervention Period||2
73614|NCT01286454|170761|P6|STARTED|Third Intervention Period||2
73615|NCT01286454|170762|P5|STARTED|Third Intervention Period||2
73616|NCT01286454|170763|P4|STARTED|Third Intervention Period||2
73617|NCT01286454|170764|P3|STARTED|Third Intervention Period||2
73618|NCT01286454|170765|P2|STARTED|Third Intervention Period||2
73619|NCT01286454|170766|P1|STARTED|Third Intervention Period||2
73620|NCT01286454|170756|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73621|NCT01286454|170757|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73622|NCT01286454|170758|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73623|NCT01286454|170759|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73624|NCT01286454|170760|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73625|NCT01286454|170761|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73626|NCT01286454|170762|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73627|NCT01286454|170763|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73628|NCT01286454|170764|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73629|NCT01286454|170765|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73630|NCT01286454|170766|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73631|NCT01286454|170756|P11|COMPLETED|Washout Period (At Least 3 Days)||0
73632|NCT01286454|170757|P10|COMPLETED|Washout Period (At Least 3 Days)||2
73633|NCT01286454|170758|P9|COMPLETED|Washout Period (At Least 3 Days)||2
73634|NCT01286454|170759|P8|COMPLETED|Washout Period (At Least 3 Days)||2
73635|NCT01286454|170760|P7|COMPLETED|Washout Period (At Least 3 Days)||2
73636|NCT01286454|170761|P6|COMPLETED|Washout Period (At Least 3 Days)||2
73637|NCT01286454|170762|P5|COMPLETED|Washout Period (At Least 3 Days)||2
73638|NCT01286454|170763|P4|COMPLETED|Washout Period (At Least 3 Days)||2
73639|NCT01286454|170764|P3|COMPLETED|Washout Period (At Least 3 Days)||2
73640|NCT01286454|170765|P2|COMPLETED|Washout Period (At Least 3 Days)||2
73641|NCT01286454|170766|P1|COMPLETED|Washout Period (At Least 3 Days)||2
73642|NCT01286454|170756|P11|STARTED|Washout Period (At Least 3 Days)||0
73643|NCT01286454|170757|P10|STARTED|Washout Period (At Least 3 Days)||2
73644|NCT01286454|170758|P9|STARTED|Washout Period (At Least 3 Days)||2
73645|NCT01286454|170759|P8|STARTED|Washout Period (At Least 3 Days)||2
73646|NCT01286454|170760|P7|STARTED|Washout Period (At Least 3 Days)||2
73647|NCT01286454|170761|P6|STARTED|Washout Period (At Least 3 Days)||2
73648|NCT01286454|170762|P5|STARTED|Washout Period (At Least 3 Days)||2
73649|NCT01286454|170763|P4|STARTED|Washout Period (At Least 3 Days)||2
73650|NCT01286454|170764|P3|STARTED|Washout Period (At Least 3 Days)||2
73651|NCT01286454|170765|P2|STARTED|Washout Period (At Least 3 Days)||2
73652|NCT01286454|170766|P1|STARTED|Washout Period (At Least 3 Days)||2
73653|NCT01286454|170756|P11|NOT COMPLETED|Second Intervention Period||0
73654|NCT01286454|170757|P10|NOT COMPLETED|Second Intervention Period||0
73655|NCT01286454|170758|P9|NOT COMPLETED|Second Intervention Period||0
73656|NCT01286454|170759|P8|NOT COMPLETED|Second Intervention Period||0
73657|NCT01286454|170760|P7|NOT COMPLETED|Second Intervention Period||0
73658|NCT01286454|170761|P6|NOT COMPLETED|Second Intervention Period||0
73659|NCT01286454|170762|P5|NOT COMPLETED|Second Intervention Period||0
73660|NCT01286454|170763|P4|NOT COMPLETED|Second Intervention Period||0
73661|NCT01286454|170764|P3|NOT COMPLETED|Second Intervention Period||0
73662|NCT01286454|170765|P2|NOT COMPLETED|Second Intervention Period||0
73663|NCT01286454|170766|P1|NOT COMPLETED|Second Intervention Period||0
73664|NCT01286454|170756|P11|COMPLETED|Second Intervention Period||0
73665|NCT01286454|170757|P10|COMPLETED|Second Intervention Period||2
73666|NCT01286454|170758|P9|COMPLETED|Second Intervention Period||2
73667|NCT01286454|170759|P8|COMPLETED|Second Intervention Period||2
73668|NCT01286454|170760|P7|COMPLETED|Second Intervention Period||2
73669|NCT01286454|170761|P6|COMPLETED|Second Intervention Period||2
73670|NCT01286454|170762|P5|COMPLETED|Second Intervention Period||2
73671|NCT01286454|170763|P4|COMPLETED|Second Intervention Period||2
73672|NCT01286454|170764|P3|COMPLETED|Second Intervention Period||2
73673|NCT01286454|170765|P2|COMPLETED|Second Intervention Period||2
73674|NCT01286454|170766|P1|COMPLETED|Second Intervention Period||2
73675|NCT01286454|170756|P11|STARTED|Second Intervention Period||0
73676|NCT01286454|170757|P10|STARTED|Second Intervention Period||2
73677|NCT01286454|170758|P9|STARTED|Second Intervention Period||2
73678|NCT01286454|170759|P8|STARTED|Second Intervention Period||2
73679|NCT01286454|170760|P7|STARTED|Second Intervention Period||2
73680|NCT01286454|170761|P6|STARTED|Second Intervention Period||2
73681|NCT01286454|170762|P5|STARTED|Second Intervention Period||2
73682|NCT01286454|170763|P4|STARTED|Second Intervention Period||2
73683|NCT01286454|170764|P3|STARTED|Second Intervention Period||2
73684|NCT01286454|170765|P2|STARTED|Second Intervention Period||2
73685|NCT01286454|170766|P1|STARTED|Second Intervention Period||2
73686|NCT01286454|170756|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73687|NCT01286454|170757|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73688|NCT01286454|170758|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73689|NCT01286454|170759|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73690|NCT01286454|170760|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73691|NCT01286454|170761|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73692|NCT01286454|170762|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73693|NCT01286454|170763|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73694|NCT01286454|170764|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73695|NCT01286454|170765|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73696|NCT01286454|170766|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
73697|NCT01286454|170756|P11|COMPLETED|Washout Period (At Least 3 Days)||0
73698|NCT01286454|170757|P10|COMPLETED|Washout Period (At Least 3 Days)||2
73699|NCT01286454|170758|P9|COMPLETED|Washout Period (At Least 3 Days)||2
73700|NCT01286454|170759|P8|COMPLETED|Washout Period (At Least 3 Days)||2
73701|NCT01286454|170760|P7|COMPLETED|Washout Period (At Least 3 Days)||2
73702|NCT01286454|170761|P6|COMPLETED|Washout Period (At Least 3 Days)||2
73703|NCT01286454|170762|P5|COMPLETED|Washout Period (At Least 3 Days)||2
73704|NCT01286454|170763|P4|COMPLETED|Washout Period (At Least 3 Days)||2
73705|NCT01286454|170764|P3|COMPLETED|Washout Period (At Least 3 Days)||2
73706|NCT01286454|170765|P2|COMPLETED|Washout Period (At Least 3 Days)||2
73707|NCT01286454|170766|P1|COMPLETED|Washout Period (At Least 3 Days)||2
73708|NCT01286454|170756|P11|STARTED|Washout Period (At Least 3 Days)||0
73709|NCT01286454|170757|P10|STARTED|Washout Period (At Least 3 Days)||2
73710|NCT01286454|170758|P9|STARTED|Washout Period (At Least 3 Days)||2
73711|NCT01286454|170759|P8|STARTED|Washout Period (At Least 3 Days)||2
73712|NCT01286454|170760|P7|STARTED|Washout Period (At Least 3 Days)||2
73713|NCT01286454|170761|P6|STARTED|Washout Period (At Least 3 Days)||2
73714|NCT01286454|170762|P5|STARTED|Washout Period (At Least 3 Days)||2
73715|NCT01286454|170763|P4|STARTED|Washout Period (At Least 3 Days)||2
73716|NCT01286454|170764|P3|STARTED|Washout Period (At Least 3 Days)||2
73717|NCT01286454|170765|P2|STARTED|Washout Period (At Least 3 Days)||2
73718|NCT01286454|170766|P1|STARTED|Washout Period (At Least 3 Days)||2
73719|NCT01286454|170756|P11|NOT COMPLETED|Part I- First Intervention Period||0
73720|NCT01286454|170757|P10|NOT COMPLETED|Part I- First Intervention Period||0
73721|NCT01286454|170758|P9|NOT COMPLETED|Part I- First Intervention Period||0
73722|NCT01286454|170759|P8|NOT COMPLETED|Part I- First Intervention Period||0
73723|NCT01286454|170760|P7|NOT COMPLETED|Part I- First Intervention Period||0
73724|NCT01286454|170761|P6|NOT COMPLETED|Part I- First Intervention Period||0
73725|NCT01286454|170762|P5|NOT COMPLETED|Part I- First Intervention Period||0
73726|NCT01286454|170763|P4|NOT COMPLETED|Part I- First Intervention Period||0
73727|NCT01286454|170764|P3|NOT COMPLETED|Part I- First Intervention Period||0
73728|NCT01286454|170765|P2|NOT COMPLETED|Part I- First Intervention Period||0
73729|NCT01286454|170766|P1|NOT COMPLETED|Part I- First Intervention Period||0
73730|NCT01286454|170756|P11|COMPLETED|Part I- First Intervention Period||0
73731|NCT01286454|170757|P10|COMPLETED|Part I- First Intervention Period||2
73732|NCT01286454|170758|P9|COMPLETED|Part I- First Intervention Period||2
73733|NCT01286454|170759|P8|COMPLETED|Part I- First Intervention Period||2
73734|NCT01286454|170760|P7|COMPLETED|Part I- First Intervention Period||2
73735|NCT01286454|170761|P6|COMPLETED|Part I- First Intervention Period||2
73736|NCT01286454|170762|P5|COMPLETED|Part I- First Intervention Period||2
73737|NCT01286454|170763|P4|COMPLETED|Part I- First Intervention Period||2
73738|NCT01286454|170764|P3|COMPLETED|Part I- First Intervention Period||2
73739|NCT01286454|170765|P2|COMPLETED|Part I- First Intervention Period||2
73740|NCT01286454|170766|P1|COMPLETED|Part I- First Intervention Period||2
73741|NCT01286454|170756|P11|STARTED|Part I- First Intervention Period||0
73742|NCT01286454|170757|P10|STARTED|Part I- First Intervention Period||2
73743|NCT01286454|170758|P9|STARTED|Part I- First Intervention Period||2
73744|NCT01286454|170759|P8|STARTED|Part I- First Intervention Period||2
73745|NCT01286454|170760|P7|STARTED|Part I- First Intervention Period||2
73746|NCT01286454|170761|P6|STARTED|Part I- First Intervention Period||2
73747|NCT01286454|170762|P5|STARTED|Part I- First Intervention Period||2
73748|NCT01286454|170763|P4|STARTED|Part I- First Intervention Period||2
73749|NCT01286454|170764|P3|STARTED|Part I- First Intervention Period||2
73750|NCT01286454|170765|P2|STARTED|Part I- First Intervention Period||2
73751|NCT01286454|170766|P1|STARTED|Part I- First Intervention Period||2
73752|NCT01286402|170806|P2|NOT COMPLETED|Overall Study||0
73753|NCT01286402|170807|P1|NOT COMPLETED|Overall Study||0
73754|NCT01286402|170806|P2|COMPLETED|Overall Study||6
73755|NCT01286402|170807|P1|COMPLETED|Overall Study||5
73756|NCT01286402|170806|P2|STARTED|Overall Study||6
73757|NCT01286402|170807|P1|STARTED|Overall Study||5
73758|NCT01286324|170815|P2|NOT COMPLETED|Overall Study||0
73759|NCT01286324|170816|P1|NOT COMPLETED|Overall Study||0
73760|NCT01286324|170815|P2|COMPLETED|Overall Study||17
73761|NCT01286324|170816|P1|COMPLETED|Overall Study||17
73762|NCT01286324|170815|P2|STARTED|Overall Study||17
73763|NCT01286324|170816|P1|STARTED|Overall Study||17
73764|NCT01286311|170824|P2|NOT COMPLETED|Overall Study||0
73765|NCT01286311|170825|P1|NOT COMPLETED|Overall Study||14
73766|NCT01286311|170824|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
73767|NCT01286311|170825|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
73768|NCT01286311|170824|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
73769|NCT01286311|170825|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
73770|NCT01286207|170842|P3|NOT COMPLETED|Overall Study||90
73771|NCT01286207|170843|P2|NOT COMPLETED|Overall Study||248
73772|NCT01286207|170844|P1|NOT COMPLETED|Overall Study||298
73773|NCT01286207|170842|P3|COMPLETED|Overall Study||261
73774|NCT01286207|170843|P2|COMPLETED|Overall Study||609
73775|NCT01286207|170844|P1|COMPLETED|Overall Study||453
73776|NCT01286207|170842|P3|STARTED|Overall Study||351
73777|NCT01286207|170843|P2|STARTED|Overall Study||857
73778|NCT01286207|170844|P1|STARTED|Overall Study||751
73779|NCT01286168|170864|P1|NOT COMPLETED|Overall Study||3
73780|NCT01286168|170864|P1|COMPLETED|Overall Study||101
73781|NCT01286168|170864|P1|STARTED|Overall Study||104
73782|NCT01286129|170878|P2|NOT COMPLETED|Overall Study||5
73783|NCT01286129|170879|P1|NOT COMPLETED|Overall Study||8
73784|NCT01286129|170878|P2|COMPLETED|Overall Study||13
73785|NCT01286129|170879|P1|COMPLETED|Overall Study||19
73786|NCT01286129|170878|P2|STARTED|Overall Study||18
73787|NCT01286129|170879|P1|STARTED|Overall Study||27
73788|NCT01286077|170889|P2|NOT COMPLETED|Overall Study||7
73789|NCT01286077|170890|P1|NOT COMPLETED|Overall Study||10
73790|NCT01286077|170889|P2|COMPLETED|Overall Study||46
73791|NCT01286077|170890|P1|COMPLETED|Overall Study||41
73792|NCT01286077|170889|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
73793|NCT01286077|170890|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
73794|NCT01286012|170926|P2|NOT COMPLETED|Overall Study||14
73795|NCT01286012|170927|P1|NOT COMPLETED|Overall Study||13
73796|NCT01286012|170926|P2|COMPLETED|Overall Study||40
73797|NCT01286012|170927|P1|COMPLETED|Overall Study||41
73798|NCT01286012|170926|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
73799|NCT01286012|170927|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
73800|NCT01285947|170937|P2|NOT COMPLETED|Overall Study||0
73801|NCT01285947|170938|P1|NOT COMPLETED|Overall Study||0
73802|NCT01285947|170937|P2|COMPLETED|Overall Study||10
73803|NCT01285947|170938|P1|COMPLETED|Overall Study||10
73804|NCT01285947|170937|P2|STARTED|Overall Study||10
73805|NCT01285947|170938|P1|STARTED|Overall Study||10
73806|NCT01285908|170944|P3|NOT COMPLETED|Treatment Crossover||0
73807|NCT01285908|170945|P2|NOT COMPLETED|Treatment Crossover||0
73808|NCT01285908|170946|P1|NOT COMPLETED|Treatment Crossover||0
73809|NCT01285908|170944|P3|COMPLETED|Treatment Crossover||2
73810|NCT01285908|170945|P2|COMPLETED|Treatment Crossover||2
73811|NCT01285908|170946|P1|COMPLETED|Treatment Crossover||0
73812|NCT01285908|170944|P3|STARTED|Treatment Crossover||2
73813|NCT01285908|170945|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
73814|NCT01285908|170946|P1|STARTED|Treatment Crossover||0
73815|NCT01285908|170944|P3|NOT COMPLETED|Baseline Measurement||0
73816|NCT01285908|170945|P2|NOT COMPLETED|Baseline Measurement||0
73817|NCT01285908|170946|P1|NOT COMPLETED|Baseline Measurement||3
73818|NCT01285908|170944|P3|COMPLETED|Baseline Measurement||0
73819|NCT01285908|170945|P2|COMPLETED|Baseline Measurement||0
73820|NCT01285908|170946|P1|COMPLETED|Baseline Measurement||3
73821|NCT01285908|170944|P3|STARTED|Baseline Measurement||0
73822|NCT01285908|170945|P2|STARTED|Baseline Measurement||0
73823|NCT01285908|170946|P1|STARTED|Baseline Measurement||6
73824|NCT01285843|170980|P2|NOT COMPLETED|Overall Study||2
73825|NCT01285843|170981|P1|NOT COMPLETED|Overall Study||2
73826|NCT01285843|170980|P2|COMPLETED|Overall Study||18
73827|NCT01285843|170981|P1|COMPLETED|Overall Study||18
73828|NCT01285843|170980|P2|STARTED|Overall Study||20
73829|NCT01285843|170981|P1|STARTED|Overall Study||20
73830|NCT01285791|170996|P3|NOT COMPLETED|Overall Study||0
73831|NCT01285791|170997|P2|NOT COMPLETED|Overall Study||0
73832|NCT01285791|170998|P1|NOT COMPLETED|Overall Study||0
73833|NCT01285791|170996|P3|COMPLETED|Overall Study||13
73834|NCT01285791|170997|P2|COMPLETED|Overall Study||15
73835|NCT01285791|170998|P1|COMPLETED|Overall Study||11
73836|NCT01285791|170996|P3|STARTED|Overall Study||13
73837|NCT01285791|170997|P2|STARTED|Overall Study||15
73838|NCT01285791|170998|P1|STARTED|Overall Study||11
73839|NCT01285713|171008|P2|NOT COMPLETED|Overall Study||0
73840|NCT01285713|171009|P1|NOT COMPLETED|Overall Study||0
73841|NCT01285713|171008|P2|COMPLETED|Overall Study||41
73842|NCT01285713|171009|P1|COMPLETED|Overall Study||42
73843|NCT01285713|171008|P2|STARTED|Overall Study||41
73844|NCT01285713|171009|P1|STARTED|Overall Study||42
73845|NCT01285635|171018|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
73846|NCT01285635|171019|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
73847|NCT01285635|171020|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
73848|NCT01285635|171018|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
73849|NCT01285635|171019|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
73850|NCT01285635|171020|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
73851|NCT01285635|171018|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
73852|NCT01285635|171019|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
73853|NCT01285635|171020|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
73854|NCT01285635|171018|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
73855|NCT01285635|171019|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
73856|NCT01285635|171020|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
73857|NCT01285635|171018|P3|COMPLETED|First Intervention (2 Weeks)||11
73858|NCT01285635|171019|P2|COMPLETED|First Intervention (2 Weeks)||11
73859|NCT01285635|171020|P1|COMPLETED|First Intervention (2 Weeks)||13
73860|NCT01285635|171018|P3|STARTED|First Intervention (2 Weeks)||11
73861|NCT01285635|171019|P2|STARTED|First Intervention (2 Weeks)||11
73862|NCT01285635|171020|P1|STARTED|First Intervention (2 Weeks)||13
73863|NCT01285609|171040|P2|NOT COMPLETED|Treated With Blinded Therapy||353
73864|NCT01285609|171041|P1|NOT COMPLETED|Treated With Blinded Therapy||379
73865|NCT01285609|171040|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
73866|NCT01285609|171041|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
73867|NCT01285609|171040|P2|STARTED|Treated With Blinded Therapy||361
73868|NCT01285609|171041|P1|STARTED|Treated With Blinded Therapy||388
73869|NCT01285609|171040|P2|NOT COMPLETED|Randomized||116
73870|NCT01285609|171041|P1|NOT COMPLETED|Randomized||91
73871|NCT01285609|171040|P2|COMPLETED|Randomized||361
73872|NCT01285609|171041|P1|COMPLETED|Randomized||388
73873|NCT01285609|171040|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
73874|NCT01285609|171041|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
73875|NCT01285609|171040|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
73876|NCT01285609|171041|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
73877|NCT01285518|171059|P8|NOT COMPLETED|Overall Study||0
73878|NCT01285518|171060|P7|NOT COMPLETED|Overall Study||0
73879|NCT01285518|171061|P6|NOT COMPLETED|Overall Study||1
73880|NCT01285518|171062|P5|NOT COMPLETED|Overall Study||0
73881|NCT01285518|171063|P4|NOT COMPLETED|Overall Study||0
73882|NCT01285518|171064|P3|NOT COMPLETED|Overall Study||0
73883|NCT01285518|171065|P2|NOT COMPLETED|Overall Study||0
73884|NCT01285518|171066|P1|NOT COMPLETED|Overall Study||0
73885|NCT01285518|171059|P8|COMPLETED|Overall Study||14
73886|NCT01285518|171060|P7|COMPLETED|Overall Study||10
73887|NCT01285518|171061|P6|COMPLETED|Overall Study||9
73888|NCT01285518|171062|P5|COMPLETED|Overall Study||10
73889|NCT01285518|171063|P4|COMPLETED|Overall Study||10
73890|NCT01285518|171064|P3|COMPLETED|Overall Study||10
73891|NCT01285518|171065|P2|COMPLETED|Overall Study||10
73892|NCT01285518|171066|P1|COMPLETED|Overall Study||10
73893|NCT01285518|171059|P8|STARTED|Overall Study||14
73894|NCT01285518|171060|P7|STARTED|Overall Study||10
73895|NCT01285518|171061|P6|STARTED|Overall Study||10
73896|NCT01285518|171062|P5|STARTED|Overall Study||10
73897|NCT01285518|171063|P4|STARTED|Overall Study||10
73898|NCT01285518|171064|P3|STARTED|Overall Study||10
73899|NCT01285518|171065|P2|STARTED|Overall Study||10
73900|NCT01285518|171066|P1|STARTED|Overall Study||10
73901|NCT01285492|171326|P2|NOT COMPLETED|Overall Study||1
73902|NCT01285492|171327|P1|NOT COMPLETED|Overall Study||17
73903|NCT01285492|171326|P2|COMPLETED|Overall Study||38
73904|NCT01285492|171327|P1|COMPLETED|Overall Study||104
73905|NCT01285492|171326|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
73906|NCT01285492|171327|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
73907|NCT01285492|171326|P2|STARTED|Overall Study|All patients randomized to this group|39
73908|NCT01285492|171327|P1|STARTED|Overall Study|All patients randomized to this group|121
73909|NCT01285427|171345|P1|NOT COMPLETED|Overall Study||1
73910|NCT01285427|171345|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
73911|NCT01285427|171345|P1|STARTED|Overall Study||300
73912|NCT01285401|171359|P2|NOT COMPLETED|Overall Study||29
73913|NCT01285401|171360|P1|NOT COMPLETED|Overall Study||17
73914|NCT01285401|171359|P2|COMPLETED|Overall Study||88
73915|NCT01285401|171360|P1|COMPLETED|Overall Study||98
73916|NCT01285401|171359|P2|Treated|Overall Study||116
73917|NCT01285401|171360|P1|Treated|Overall Study||113
73918|NCT01285401|171359|P2|STARTED|Overall Study||117
73919|NCT01285401|171360|P1|STARTED|Overall Study||115
73920|NCT01285323|171400|P2|NOT COMPLETED|Overall Study||30
73921|NCT01285323|171401|P1|NOT COMPLETED|Overall Study||33
73922|NCT01285323|171400|P2|COMPLETED|Overall Study||202
73923|NCT01285323|171401|P1|COMPLETED|Overall Study||199
73924|NCT01285323|171400|P2|Safety Analysis Set|Overall Study||232
73925|NCT01285323|171401|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
73926|NCT01285323|171400|P2|Full Analysis Set|Overall Study||232
73927|NCT01285323|171401|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
73928|NCT01285323|171400|P2|STARTED|Overall Study||232
73929|NCT01285323|171401|P1|STARTED|Overall Study||232
73930|NCT01285310|171436|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
73931|NCT01285310|171437|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
73932|NCT01285310|171438|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
73933|NCT01285310|171439|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
73934|NCT01285310|171440|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
73935|NCT01285310|171436|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
73936|NCT01285310|171437|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
73937|NCT01285310|171438|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
73938|NCT01285310|171439|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
73939|NCT01285310|171440|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
73940|NCT01285310|171436|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
73941|NCT01285310|171437|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
73942|NCT01285310|171438|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
73943|NCT01285310|171439|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
73944|NCT01285310|171440|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
73945|NCT01285310|171436|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
73946|NCT01285310|171437|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
73947|NCT01285310|171438|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
73948|NCT01285310|171439|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
73949|NCT01285310|171440|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
73950|NCT01285310|171436|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
73951|NCT01285310|171437|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
73952|NCT01285310|171438|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
73953|NCT01285310|171439|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
73954|NCT01285310|171440|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
73955|NCT01285310|171436|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
73956|NCT01285310|171437|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
73957|NCT01285310|171438|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
73958|NCT01285310|171439|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
73959|NCT01285310|171440|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
73960|NCT01285076|171673|P1|NOT COMPLETED|Overall Study||0
73961|NCT01285076|171673|P1|COMPLETED|Overall Study||834
73962|NCT01285076|171673|P1|STARTED|Overall Study||834
73963|NCT01285050|171686|P1|NOT COMPLETED|Overall Study||1
73964|NCT01285050|171686|P1|COMPLETED|Overall Study||19
73965|NCT01285050|171686|P1|STARTED|Overall Study||20
73966|NCT01285024|171693|P2|NOT COMPLETED|Overall Study||0
73967|NCT01285024|171694|P1|NOT COMPLETED|Overall Study||0
73968|NCT01285024|171693|P2|COMPLETED|Overall Study||60
73969|NCT01285024|171694|P1|COMPLETED|Overall Study||49
73970|NCT01285024|171693|P2|STARTED|Overall Study||60
73971|NCT01285024|171694|P1|STARTED|Overall Study||49
73972|NCT01284959|171705|P3|NOT COMPLETED|Overall Study||1
73973|NCT01284959|171706|P2|NOT COMPLETED|Overall Study||0
73974|NCT01284959|171707|P1|NOT COMPLETED|Overall Study||1
73975|NCT01284959|171705|P3|COMPLETED|Overall Study||10
73976|NCT01284959|171706|P2|COMPLETED|Overall Study||12
73977|NCT01284959|171707|P1|COMPLETED|Overall Study||10
73978|NCT01284959|171705|P3|STARTED|Overall Study||11
73979|NCT01284959|171706|P2|STARTED|Overall Study||12
73980|NCT01284959|171707|P1|STARTED|Overall Study||11
73981|NCT01284634|171737|P4|NOT COMPLETED|Overall Study||1
73982|NCT01284634|171738|P3|NOT COMPLETED|Overall Study||2
73983|NCT01284634|171739|P2|NOT COMPLETED|Overall Study||0
73984|NCT01284634|171740|P1|NOT COMPLETED|Overall Study||1
73985|NCT01284634|171737|P4|COMPLETED|Overall Study||4
73986|NCT01284634|171738|P3|COMPLETED|Overall Study||5
73987|NCT01284634|171739|P2|COMPLETED|Overall Study||6
73988|NCT01284634|171740|P1|COMPLETED|Overall Study||6
73989|NCT01284634|171737|P4|STARTED|Overall Study||5
73990|NCT01284634|171738|P3|STARTED|Overall Study||7
73991|NCT01284634|171739|P2|STARTED|Overall Study||6
73992|NCT01284634|171740|P1|STARTED|Overall Study||7
73993|NCT01284621|171882|P6|NOT COMPLETED|Third Intervention (8 Days)||0
73994|NCT01284621|171883|P5|NOT COMPLETED|Third Intervention (8 Days)||0
73995|NCT01284621|171884|P4|NOT COMPLETED|Third Intervention (8 Days)||0
73996|NCT01284621|171885|P3|NOT COMPLETED|Third Intervention (8 Days)||0
73997|NCT01284621|171886|P2|NOT COMPLETED|Third Intervention (8 Days)||0
73998|NCT01284621|171887|P1|NOT COMPLETED|Third Intervention (8 Days)||0
73999|NCT01284621|171882|P6|COMPLETED|Third Intervention (8 Days)||4
74000|NCT01284621|171883|P5|COMPLETED|Third Intervention (8 Days)||3
74001|NCT01284621|171884|P4|COMPLETED|Third Intervention (8 Days)||4
74002|NCT01284621|171885|P3|COMPLETED|Third Intervention (8 Days)||4
74003|NCT01284621|171886|P2|COMPLETED|Third Intervention (8 Days)||4
74004|NCT01284621|171887|P1|COMPLETED|Third Intervention (8 Days)||3
74005|NCT01284621|171882|P6|STARTED|Third Intervention (8 Days)||4
74006|NCT01284621|171883|P5|STARTED|Third Intervention (8 Days)||3
74007|NCT01284621|171884|P4|STARTED|Third Intervention (8 Days)||4
74008|NCT01284621|171885|P3|STARTED|Third Intervention (8 Days)||4
74009|NCT01284621|171886|P2|STARTED|Third Intervention (8 Days)||4
74010|NCT01284621|171887|P1|STARTED|Third Intervention (8 Days)||3
74011|NCT01284621|171882|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
74012|NCT01284621|171883|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
74013|NCT01284621|171884|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
74014|NCT01284621|171885|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
74015|NCT01284621|171886|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
74016|NCT01284621|171887|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
74017|NCT01284621|171882|P6|COMPLETED|Washout Period 2 (7 Days)||4
74018|NCT01284621|171883|P5|COMPLETED|Washout Period 2 (7 Days)||3
74019|NCT01284621|171884|P4|COMPLETED|Washout Period 2 (7 Days)||4
74020|NCT01284621|171885|P3|COMPLETED|Washout Period 2 (7 Days)||4
74021|NCT01284621|171886|P2|COMPLETED|Washout Period 2 (7 Days)||4
74022|NCT01284621|171887|P1|COMPLETED|Washout Period 2 (7 Days)||3
74023|NCT01284621|171882|P6|STARTED|Washout Period 2 (7 Days)||4
74024|NCT01284621|171883|P5|STARTED|Washout Period 2 (7 Days)||3
74025|NCT01284621|171884|P4|STARTED|Washout Period 2 (7 Days)||4
74026|NCT01284621|171885|P3|STARTED|Washout Period 2 (7 Days)||4
74027|NCT01284621|171886|P2|STARTED|Washout Period 2 (7 Days)||4
74028|NCT01284621|171887|P1|STARTED|Washout Period 2 (7 Days)||3
74029|NCT01284621|171882|P6|NOT COMPLETED|Second Intervention (8 Days)||0
74030|NCT01284621|171883|P5|NOT COMPLETED|Second Intervention (8 Days)||0
74031|NCT01284621|171884|P4|NOT COMPLETED|Second Intervention (8 Days)||0
74032|NCT01284621|171885|P3|NOT COMPLETED|Second Intervention (8 Days)||0
74033|NCT01284621|171886|P2|NOT COMPLETED|Second Intervention (8 Days)||0
74034|NCT01284621|171887|P1|NOT COMPLETED|Second Intervention (8 Days)||0
74035|NCT01284621|171882|P6|COMPLETED|Second Intervention (8 Days)||4
74036|NCT01284621|171883|P5|COMPLETED|Second Intervention (8 Days)||3
74037|NCT01284621|171884|P4|COMPLETED|Second Intervention (8 Days)||4
74038|NCT01284621|171885|P3|COMPLETED|Second Intervention (8 Days)||4
74039|NCT01284621|171886|P2|COMPLETED|Second Intervention (8 Days)||4
74040|NCT01284621|171887|P1|COMPLETED|Second Intervention (8 Days)||3
74041|NCT01284621|171882|P6|STARTED|Second Intervention (8 Days)||4
74042|NCT01284621|171883|P5|STARTED|Second Intervention (8 Days)||3
74043|NCT01284621|171884|P4|STARTED|Second Intervention (8 Days)||4
74044|NCT01284621|171885|P3|STARTED|Second Intervention (8 Days)||4
74045|NCT01284621|171886|P2|STARTED|Second Intervention (8 Days)||4
74046|NCT01284621|171887|P1|STARTED|Second Intervention (8 Days)||3
74047|NCT01284621|171882|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
74048|NCT01284621|171883|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
74049|NCT01284621|171884|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
74050|NCT01284621|171885|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
74051|NCT01284621|171886|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
74052|NCT01284621|171887|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
74053|NCT01284621|171882|P6|COMPLETED|Washout Period 1 (7 Days)||4
74054|NCT01284621|171883|P5|COMPLETED|Washout Period 1 (7 Days)||3
74055|NCT01284621|171884|P4|COMPLETED|Washout Period 1 (7 Days)||4
74056|NCT01284621|171885|P3|COMPLETED|Washout Period 1 (7 Days)||4
74057|NCT01284621|171886|P2|COMPLETED|Washout Period 1 (7 Days)||4
74058|NCT01284621|171887|P1|COMPLETED|Washout Period 1 (7 Days)||3
74059|NCT01284621|171882|P6|STARTED|Washout Period 1 (7 Days)||4
74060|NCT01284621|171883|P5|STARTED|Washout Period 1 (7 Days)||4
74061|NCT01284621|171884|P4|STARTED|Washout Period 1 (7 Days)||4
74062|NCT01284621|171885|P3|STARTED|Washout Period 1 (7 Days)||4
74063|NCT01284621|171886|P2|STARTED|Washout Period 1 (7 Days)||4
74064|NCT01284621|171887|P1|STARTED|Washout Period 1 (7 Days)||3
74065|NCT01284621|171882|P6|NOT COMPLETED|First Intervention (8 Days)||0
74066|NCT01284621|171883|P5|NOT COMPLETED|First Intervention (8 Days)||0
74067|NCT01284621|171884|P4|NOT COMPLETED|First Intervention (8 Days)||0
74068|NCT01284621|171885|P3|NOT COMPLETED|First Intervention (8 Days)||0
74069|NCT01284621|171886|P2|NOT COMPLETED|First Intervention (8 Days)||0
74070|NCT01284621|171887|P1|NOT COMPLETED|First Intervention (8 Days)||0
74071|NCT01284621|171882|P6|COMPLETED|First Intervention (8 Days)||4
74072|NCT01284621|171883|P5|COMPLETED|First Intervention (8 Days)||4
74073|NCT01284621|171884|P4|COMPLETED|First Intervention (8 Days)||4
74074|NCT01284621|171885|P3|COMPLETED|First Intervention (8 Days)||4
74075|NCT01284621|171886|P2|COMPLETED|First Intervention (8 Days)||4
74076|NCT01284621|171887|P1|COMPLETED|First Intervention (8 Days)||3
74077|NCT01284621|171882|P6|STARTED|First Intervention (8 Days)||4
74078|NCT01284621|171883|P5|STARTED|First Intervention (8 Days)||4
74079|NCT01284621|171884|P4|STARTED|First Intervention (8 Days)||4
74080|NCT01284621|171885|P3|STARTED|First Intervention (8 Days)||4
74081|NCT01284621|171886|P2|STARTED|First Intervention (8 Days)||4
74082|NCT01284621|171887|P1|STARTED|First Intervention (8 Days)||3
74083|NCT01284517|171931|P2|NOT COMPLETED|Overall Study||36
74084|NCT01284517|171932|P1|NOT COMPLETED|Overall Study||32
74085|NCT01284517|171931|P2|COMPLETED|Overall Study||140
74086|NCT01284517|171932|P1|COMPLETED|Overall Study||148
74087|NCT01284517|171931|P2|STARTED|Overall Study||176
74088|NCT01284517|171932|P1|STARTED|Overall Study||180
74089|NCT01284504|171944|P2|NOT COMPLETED|Overall Study||0
74090|NCT01284504|171945|P1|NOT COMPLETED|Overall Study||1
74091|NCT01284504|171944|P2|COMPLETED|Overall Study||0
74092|NCT01284504|171945|P1|COMPLETED|Overall Study||0
74093|NCT01284504|171944|P2|STARTED|Overall Study||0
74094|NCT01284504|171945|P1|STARTED|Overall Study|Patient changed her mind before randomization to any of the treatment groups|1
74095|NCT01284491|171951|P1|NOT COMPLETED|Overall Study||13
74096|NCT01284491|171951|P1|COMPLETED|Overall Study||0
74097|NCT01284491|171951|P1|STARTED|Overall Study||13
74098|NCT01284426|171957|P1|NOT COMPLETED|Overall Study||2
74099|NCT01284426|171957|P1|COMPLETED|Overall Study||92
74100|NCT01284426|171957|P1|STARTED|Overall Study||94
74101|NCT01284361|171961|P1|NOT COMPLETED|Overall Study||9
74102|NCT01284361|171961|P1|COMPLETED|Overall Study||82
74103|NCT01284361|171961|P1|STARTED|Overall Study||91
74104|NCT01284296|171968|P1|NOT COMPLETED|Overall Study||0
74105|NCT01284296|171968|P1|COMPLETED|Overall Study||20
74106|NCT01284296|171968|P1|STARTED|Overall Study||20
74107|NCT01284114|171973|P1|NOT COMPLETED|Overall Study||4
74108|NCT01284114|171973|P1|COMPLETED|Overall Study||19
74109|NCT01284114|171973|P1|STARTED|Overall Study||23
74110|NCT01284062|171985|P4|NOT COMPLETED|Overall Study||14
74111|NCT01284062|171986|P3|NOT COMPLETED|Overall Study||6
74112|NCT01284062|171987|P2|NOT COMPLETED|Overall Study||8
74113|NCT01284062|171988|P1|NOT COMPLETED|Overall Study||11
74114|NCT01284062|171985|P4|COMPLETED|Overall Study||7
74115|NCT01284062|171986|P3|COMPLETED|Overall Study||15
74116|NCT01284062|171987|P2|COMPLETED|Overall Study||13
74117|NCT01284062|171988|P1|COMPLETED|Overall Study||10
74118|NCT01284062|171985|P4|STARTED|Overall Study||21
74119|NCT01284062|171986|P3|STARTED|Overall Study||21
74120|NCT01284062|171987|P2|STARTED|Overall Study||21
74121|NCT01284062|171988|P1|STARTED|Overall Study||21
74122|NCT01283971|172062|P2|NOT COMPLETED|Overall Study||12
74123|NCT01283971|172063|P1|NOT COMPLETED|Overall Study||15
74124|NCT01283971|172062|P2|COMPLETED|Overall Study||36
74125|NCT01283971|172063|P1|COMPLETED|Overall Study||33
74126|NCT01283971|172062|P2|Intent to Treat Population|Overall Study||48
74127|NCT01283971|172063|P1|Intent to Treat Population|Overall Study||46
74128|NCT01283971|172062|P2|STARTED|Overall Study||48
74129|NCT01283971|172063|P1|STARTED|Overall Study||48
74130|NCT01283581|172110|P3|NOT COMPLETED|Overall Study||20
74131|NCT01283581|172111|P2|NOT COMPLETED|Overall Study||14
74132|NCT01283581|172112|P1|NOT COMPLETED|Overall Study||12
74133|NCT01283581|172110|P3|COMPLETED|Overall Study||78
74134|NCT01283581|172111|P2|COMPLETED|Overall Study||63
74135|NCT01283581|172112|P1|COMPLETED|Overall Study||69
74136|NCT01283581|172110|P3|STARTED|Overall Study||98
74137|NCT01283581|172111|P2|STARTED|Overall Study||77
74138|NCT01283581|172112|P1|STARTED|Overall Study||81
74139|NCT01283555|172123|P2|NOT COMPLETED|Second Intervention||0
74140|NCT01283555|172124|P1|NOT COMPLETED|Second Intervention||0
74141|NCT01283555|172123|P2|COMPLETED|Second Intervention||12
74142|NCT01283555|172124|P1|COMPLETED|Second Intervention||13
74143|NCT01283555|172123|P2|STARTED|Second Intervention||12
74144|NCT01283555|172124|P1|STARTED|Second Intervention||13
74145|NCT01283555|172123|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
74146|NCT01283555|172124|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
74147|NCT01283555|172123|P2|COMPLETED|Washout Period of at Least 21 Days||12
74148|NCT01283555|172124|P1|COMPLETED|Washout Period of at Least 21 Days||13
74149|NCT01283555|172123|P2|STARTED|Washout Period of at Least 21 Days||12
74150|NCT01283555|172124|P1|STARTED|Washout Period of at Least 21 Days||13
74151|NCT01283555|172123|P2|NOT COMPLETED|First Intervention||0
74152|NCT01283555|172124|P1|NOT COMPLETED|First Intervention||0
74153|NCT01283555|172123|P2|COMPLETED|First Intervention||12
74154|NCT01283555|172124|P1|COMPLETED|First Intervention||13
74155|NCT01283555|172123|P2|STARTED|First Intervention||12
74156|NCT01283555|172124|P1|STARTED|First Intervention||13
74157|NCT01283516|172176|P9|NOT COMPLETED|Overall Study||122
74158|NCT01283516|172177|P8|NOT COMPLETED|Overall Study||3
74159|NCT01283516|172178|P7|NOT COMPLETED|Overall Study||8
74160|NCT01283516|172179|P6|NOT COMPLETED|Overall Study||8
74161|NCT01283516|172180|P5|NOT COMPLETED|Overall Study||13
74162|NCT01283516|172181|P4|NOT COMPLETED|Overall Study||3
74163|NCT01283516|172182|P3|NOT COMPLETED|Overall Study||2
74164|NCT01283516|172183|P2|NOT COMPLETED|Overall Study||2
74165|NCT01283516|172184|P1|NOT COMPLETED|Overall Study||2
74166|NCT01283516|172176|P9|COMPLETED|Overall Study||133
74167|NCT01283516|172177|P8|COMPLETED|Overall Study||2
74168|NCT01283516|172178|P7|COMPLETED|Overall Study||2
74169|NCT01283516|172179|P6|COMPLETED|Overall Study||2
74170|NCT01283516|172180|P5|COMPLETED|Overall Study||1
74171|NCT01283516|172181|P4|COMPLETED|Overall Study||0
74172|NCT01283516|172182|P3|COMPLETED|Overall Study||1
74173|NCT01283516|172183|P2|COMPLETED|Overall Study||0
74174|NCT01283516|172184|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
74175|NCT01283516|172176|P9|Dose-Determining Set (DDS)|Overall Study||8
74176|NCT01283516|172177|P8|Dose-Determining Set (DDS)|Overall Study||5
74177|NCT01283516|172178|P7|Dose-Determining Set (DDS)|Overall Study||10
74178|NCT01283516|172179|P6|Dose-Determining Set (DDS)|Overall Study||8
74179|NCT01283516|172180|P5|Dose-Determining Set (DDS)|Overall Study||14
74180|NCT01283516|172181|P4|Dose-Determining Set (DDS)|Overall Study||3
74181|NCT01283516|172182|P3|Dose-Determining Set (DDS)|Overall Study||3
74182|NCT01283516|172183|P2|Dose-Determining Set (DDS)|Overall Study||1
74183|NCT01283516|172184|P1|Dose-Determining Set (DDS)|Overall Study||2
74184|NCT01283516|172176|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
74185|NCT01283516|172177|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
74186|NCT01283516|172178|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
74187|NCT01283516|172179|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
74188|NCT01283516|172180|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
74189|NCT01283516|172181|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
74190|NCT01283516|172182|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
74191|NCT01283516|172183|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
74192|NCT01283516|172184|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
74193|NCT01283516|172176|P9|STARTED|Overall Study||255
74194|NCT01283516|172177|P8|STARTED|Overall Study||5
74195|NCT01283516|172178|P7|STARTED|Overall Study||10
74196|NCT01283516|172179|P6|STARTED|Overall Study||10
74197|NCT01283516|172180|P5|STARTED|Overall Study||14
74198|NCT01283516|172181|P4|STARTED|Overall Study||3
74199|NCT01283516|172182|P3|STARTED|Overall Study||3
74200|NCT01283516|172183|P2|STARTED|Overall Study||2
74201|NCT01283516|172184|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
74202|NCT01283464|172208|P2|NOT COMPLETED|Overall Study||1
74203|NCT01283464|172209|P1|NOT COMPLETED|Overall Study||2
74204|NCT01283464|172208|P2|COMPLETED|Overall Study||11
74205|NCT01283464|172209|P1|COMPLETED|Overall Study||10
74206|NCT01283464|172208|P2|STARTED|Overall Study||12
74207|NCT01283464|172209|P1|STARTED|Overall Study||12
74208|NCT01283334|172215|P1|NOT COMPLETED|Overall Study||7
74209|NCT01283334|172215|P1|COMPLETED|Overall Study||13
74210|NCT01283334|172215|P1|STARTED|Overall Study||20
74211|NCT01283321|172223|P2|NOT COMPLETED|Overall Study||0
74212|NCT01283321|172224|P1|NOT COMPLETED|Overall Study||0
74213|NCT01283321|172223|P2|COMPLETED|Overall Study||10
74214|NCT01283321|172224|P1|COMPLETED|Overall Study||10
74215|NCT01283321|172223|P2|STARTED|Overall Study||10
74216|NCT01283321|172224|P1|STARTED|Overall Study||10
74217|NCT01283282|172230|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
74218|NCT01283282|172231|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
74219|NCT01283282|172230|P2|COMPLETED|Second Intervention (6 Weeks)||19
74220|NCT01283282|172231|P1|COMPLETED|Second Intervention (6 Weeks)||22
74221|NCT01283282|172230|P2|STARTED|Second Intervention (6 Weeks)||19
74222|NCT01283282|172231|P1|STARTED|Second Intervention (6 Weeks)||22
74223|NCT01283282|172230|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
74224|NCT01283282|172231|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
74225|NCT01283282|172230|P2|COMPLETED|First Intervention (6 Weeks)||19
74226|NCT01283282|172231|P1|COMPLETED|First Intervention (6 Weeks)||22
74227|NCT01283282|172230|P2|STARTED|First Intervention (6 Weeks)||23
74228|NCT01283282|172231|P1|STARTED|First Intervention (6 Weeks)||25
74229|NCT01283152|172251|P2|NOT COMPLETED|Overall Study||0
74230|NCT01283152|172252|P1|NOT COMPLETED|Overall Study||2
74231|NCT01283152|172251|P2|COMPLETED|Overall Study||25
74232|NCT01283152|172252|P1|COMPLETED|Overall Study||23
74233|NCT01283152|172251|P2|24-hr HESA Attempted|Overall Study||25
74234|NCT01283152|172252|P1|24-hr HESA Attempted|Overall Study||25
74235|NCT01283152|172251|P2|Study Treatment Received|Overall Study||25
74236|NCT01283152|172252|P1|Study Treatment Received|Overall Study||25
74237|NCT01283152|172251|P2|ITT Population|Overall Study||25
74238|NCT01283152|172252|P1|ITT Population|Overall Study||25
74239|NCT01283152|172251|P2|STARTED|Overall Study||25
74240|NCT01283152|172252|P1|STARTED|Overall Study||25
74241|NCT01283139|172266|P4|NOT COMPLETED|Overall Study||15
74242|NCT01283139|172267|P3|NOT COMPLETED|Overall Study||18
74243|NCT01283139|172268|P2|NOT COMPLETED|Overall Study||18
74244|NCT01283139|172269|P1|NOT COMPLETED|Overall Study||17
74245|NCT01283139|172266|P4|COMPLETED|Overall Study||92
74246|NCT01283139|172267|P3|COMPLETED|Overall Study||91
74247|NCT01283139|172268|P2|COMPLETED|Overall Study||90
74248|NCT01283139|172269|P1|COMPLETED|Overall Study||91
74249|NCT01283139|172266|P4|STARTED|Overall Study||107
74250|NCT01283139|172267|P3|STARTED|Overall Study||109
74251|NCT01283139|172268|P2|STARTED|Overall Study||108
74252|NCT01283139|172269|P1|STARTED|Overall Study||108
74253|NCT01283035|172311|P1|NOT COMPLETED|Overall Study||1
74254|NCT01283035|172311|P1|COMPLETED|Overall Study||5
74255|NCT01283035|172311|P1|STARTED|Overall Study||6
74256|NCT01283022|172320|P1|NOT COMPLETED|Overall Study||0
74257|NCT01283022|172320|P1|COMPLETED|Overall Study||24
74258|NCT01283022|172320|P1|STARTED|Overall Study||24
74259|NCT01282866|172326|P1|NOT COMPLETED|Overall Study||1
74260|NCT01282866|172326|P1|COMPLETED|Overall Study||34
74261|NCT01282866|172326|P1|STARTED|Overall Study||35
74262|NCT01282814|172334|P2|NOT COMPLETED|Second Intervention||0
74263|NCT01282814|172335|P1|NOT COMPLETED|Second Intervention||0
74264|NCT01282814|172334|P2|COMPLETED|Second Intervention||9
74265|NCT01282814|172335|P1|COMPLETED|Second Intervention||10
74266|NCT01282814|172334|P2|STARTED|Second Intervention||9
74267|NCT01282814|172335|P1|STARTED|Second Intervention||10
74268|NCT01282814|172334|P2|NOT COMPLETED|Washout of 7 Days||0
74269|NCT01282814|172335|P1|NOT COMPLETED|Washout of 7 Days||2
74270|NCT01282814|172334|P2|COMPLETED|Washout of 7 Days||9
74271|NCT01282814|172335|P1|COMPLETED|Washout of 7 Days||10
74272|NCT01282814|172334|P2|STARTED|Washout of 7 Days||9
74273|NCT01282814|172335|P1|STARTED|Washout of 7 Days||12
74274|NCT01282814|172334|P2|NOT COMPLETED|First Intervention||3
74275|NCT01282814|172335|P1|NOT COMPLETED|First Intervention||0
74276|NCT01282814|172334|P2|COMPLETED|First Intervention||9
74277|NCT01282814|172335|P1|COMPLETED|First Intervention||12
74278|NCT01282814|172334|P2|STARTED|First Intervention||12
74279|NCT01282814|172335|P1|STARTED|First Intervention||12
74280|NCT01282801|172347|P2|NOT COMPLETED|Second Intervention||1
74281|NCT01282801|172348|P1|NOT COMPLETED|Second Intervention||0
74282|NCT01282801|172347|P2|COMPLETED|Second Intervention||8
74283|NCT01282801|172348|P1|COMPLETED|Second Intervention||9
74284|NCT01282801|172347|P2|STARTED|Second Intervention||9
74285|NCT01282801|172348|P1|STARTED|Second Intervention||9
74286|NCT01282801|172347|P2|NOT COMPLETED|Washout of 7 Days||0
74287|NCT01282801|172348|P1|NOT COMPLETED|Washout of 7 Days||0
74288|NCT01282801|172347|P2|COMPLETED|Washout of 7 Days||9
74289|NCT01282801|172348|P1|COMPLETED|Washout of 7 Days||9
74290|NCT01282801|172347|P2|STARTED|Washout of 7 Days||9
74291|NCT01282801|172348|P1|STARTED|Washout of 7 Days||9
74292|NCT01282801|172347|P2|NOT COMPLETED|First Intervention||0
74293|NCT01282801|172348|P1|NOT COMPLETED|First Intervention||0
74294|NCT01282801|172347|P2|COMPLETED|First Intervention||9
74295|NCT01282801|172348|P1|COMPLETED|First Intervention||9
74296|NCT01282801|172347|P2|STARTED|First Intervention||9
74297|NCT01282801|172348|P1|STARTED|First Intervention||9
74298|NCT01282723|172364|P1|NOT COMPLETED|Overall Study||0
74299|NCT01282723|172364|P1|COMPLETED|Overall Study||20
74300|NCT01282723|172364|P1|STARTED|Overall Study||20
74301|NCT01282710|172368|P1|NOT COMPLETED|Overall Study||0
74302|NCT01282710|172368|P1|COMPLETED|Overall Study||20
74303|NCT01282710|172368|P1|STARTED|Overall Study||20
74304|NCT01282424|172372|P1|NOT COMPLETED|Overall Study||76
74305|NCT01282424|172372|P1|COMPLETED|Overall Study||49
74306|NCT01282424|172372|P1|Completed: Death|Overall Study||8
74307|NCT01282424|172372|P1|Completed: Disease Progression|Overall Study||41
74308|NCT01282424|172372|P1|STARTED|Overall Study||125
74309|NCT01282372|172389|P1|NOT COMPLETED|Overall Study||79
74310|NCT01282372|172389|P1|COMPLETED|Overall Study||421
74311|NCT01282372|172389|P1|STARTED|Overall Study||500
74312|NCT01282294|172417|P1|NOT COMPLETED|Overall Study||19
74313|NCT01282294|172417|P1|COMPLETED|Overall Study||81
74314|NCT01282294|172417|P1|12 Months|Overall Study||86
74315|NCT01282294|172417|P1|6 Months|Overall Study||94
74316|NCT01282294|172417|P1|3 Months|Overall Study||95
74317|NCT01282294|172417|P1|6 Weeks|Overall Study||95
74318|NCT01282294|172417|P1|Post-operative|Overall Study||99
74319|NCT01282294|172417|P1|Intra-operative|Overall Study||99
74320|NCT01282294|172417|P1|STARTED|Overall Study||100
74321|NCT01282229|172435|P1|NOT COMPLETED|Overall Study||2
74322|NCT01282229|172435|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
74323|NCT01282229|172435|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
74324|NCT01282203|172465|P1|NOT COMPLETED|Overall Study||1
74325|NCT01282203|172465|P1|COMPLETED|Overall Study||1121
74326|NCT01282203|172465|P1|STARTED|Overall Study||1122
74327|NCT01282138|172487|P2|NOT COMPLETED|CAPT||0
74328|NCT01282138|172488|P1|NOT COMPLETED|CAPT||0
74329|NCT01282138|172487|P2|COMPLETED|CAPT||7
74330|NCT01282138|172488|P1|COMPLETED|CAPT||6
74331|NCT01282138|172487|P2|STARTED|CAPT||7
74332|NCT01282138|172488|P1|STARTED|CAPT||6
74333|NCT01282138|172487|P2|NOT COMPLETED|EEC||0
74334|NCT01282138|172488|P1|NOT COMPLETED|EEC||0
74335|NCT01282138|172487|P2|COMPLETED|EEC||7
74336|NCT01282138|172488|P1|COMPLETED|EEC||6
74337|NCT01282138|172487|P2|STARTED|EEC||7
74338|NCT01282138|172488|P1|STARTED|EEC||6
74339|NCT01282086|172496|P1|NOT COMPLETED|Overall Study||0
74340|NCT01282086|172496|P1|COMPLETED|Overall Study||1365
74341|NCT01282086|172496|P1|STARTED|Overall Study||1365
74342|NCT01281865|172515|P2|NOT COMPLETED|Overall Study||1
74343|NCT01281865|172516|P1|NOT COMPLETED|Overall Study||3
74344|NCT01281865|172515|P2|COMPLETED|Overall Study||1
74345|NCT01281865|172516|P1|COMPLETED|Overall Study||9
74346|NCT01281865|172515|P2|STARTED|Overall Study||2
74347|NCT01281865|172516|P1|STARTED|Overall Study||12
74348|NCT01281839|172524|P2|NOT COMPLETED|Overall Study||14
74349|NCT01281839|172525|P1|NOT COMPLETED|Overall Study||10
74350|NCT01281839|172524|P2|COMPLETED|Overall Study||119
74351|NCT01281839|172525|P1|COMPLETED|Overall Study||250
74352|NCT01281839|172524|P2|STARTED|Overall Study||133
74353|NCT01281839|172525|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
74354|NCT01281644|172586|P1|NOT COMPLETED|Overall Study||5
74355|NCT01281644|172586|P1|COMPLETED|Overall Study||18
74356|NCT01281644|172586|P1|STARTED|Overall Study||23
74357|NCT01281501|172596|P2|NOT COMPLETED|Overall Study||0
74358|NCT01281501|172597|P1|NOT COMPLETED|Overall Study||0
74359|NCT01281501|172596|P2|COMPLETED|Overall Study||43
74360|NCT01281501|172597|P1|COMPLETED|Overall Study||44
74361|NCT01281501|172596|P2|STARTED|Overall Study||43
74362|NCT01281501|172597|P1|STARTED|Overall Study||44
74363|NCT01281475|172611|P2|NOT COMPLETED|Overall Study||8
74364|NCT01281475|172612|P1|NOT COMPLETED|Overall Study||4
74365|NCT01281475|172611|P2|COMPLETED|Overall Study||26
74366|NCT01281475|172612|P1|COMPLETED|Overall Study||29
74367|NCT01281475|172611|P2|STARTED|Overall Study||34
74368|NCT01281475|172612|P1|STARTED|Overall Study||33
74369|NCT01281306|172627|P7|NOT COMPLETED|Overall Study||7
74370|NCT01281306|172628|P6|NOT COMPLETED|Overall Study||7
74371|NCT01281306|172629|P5|NOT COMPLETED|Overall Study||9
74372|NCT01281306|172630|P4|NOT COMPLETED|Overall Study||11
74373|NCT01281306|172631|P3|NOT COMPLETED|Overall Study||8
74374|NCT01281306|172632|P2|NOT COMPLETED|Overall Study||4
74375|NCT01281306|172633|P1|NOT COMPLETED|Overall Study||8
74376|NCT01281306|172627|P7|COMPLETED|Overall Study||51
74377|NCT01281306|172628|P6|COMPLETED|Overall Study||135
74378|NCT01281306|172629|P5|COMPLETED|Overall Study||134
74379|NCT01281306|172630|P4|COMPLETED|Overall Study||123
74380|NCT01281306|172631|P3|COMPLETED|Overall Study||133
74381|NCT01281306|172632|P2|COMPLETED|Overall Study||141
74382|NCT01281306|172633|P1|COMPLETED|Overall Study||136
74383|NCT01281306|172627|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
74384|NCT01281306|172628|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
74385|NCT01281306|172629|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
74386|NCT01281306|172630|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
74387|NCT01281306|172631|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
74388|NCT01281306|172632|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
74389|NCT01281306|172633|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
74390|NCT01281306|172627|P7|Safety Set|Overall Study||58
74391|NCT01281306|172628|P6|Safety Set|Overall Study||142
74392|NCT01281306|172629|P5|Safety Set|Overall Study||143
74393|NCT01281306|172630|P4|Safety Set|Overall Study||133
74394|NCT01281306|172631|P3|Safety Set|Overall Study||141
74395|NCT01281306|172632|P2|Safety Set|Overall Study||145
74396|NCT01281306|172633|P1|Safety Set|Overall Study||143
74397|NCT01281306|172627|P7|Full Analysis Set|Overall Study||58
74398|NCT01281306|172628|P6|Full Analysis Set|Overall Study||142
74399|NCT01281306|172629|P5|Full Analysis Set|Overall Study||143
74400|NCT01281306|172630|P4|Full Analysis Set|Overall Study||133
74401|NCT01281306|172631|P3|Full Analysis Set|Overall Study||141
74402|NCT01281306|172632|P2|Full Analysis Set|Overall Study||145
74403|NCT01281306|172633|P1|Full Analysis Set|Overall Study||143
74404|NCT01281306|172627|P7|STARTED|Overall Study||58
74405|NCT01281306|172628|P6|STARTED|Overall Study||142
74406|NCT01281306|172629|P5|STARTED|Overall Study||143
74407|NCT01281306|172630|P4|STARTED|Overall Study||134
74408|NCT01281306|172631|P3|STARTED|Overall Study||141
74409|NCT01281306|172632|P2|STARTED|Overall Study||145
74410|NCT01281306|172633|P1|STARTED|Overall Study||144
74411|NCT01281202|172749|P2|NOT COMPLETED|Overall Study||36
74412|NCT01281202|172750|P1|NOT COMPLETED|Overall Study||28
74413|NCT01281202|172749|P2|COMPLETED|Overall Study||68
74414|NCT01281202|172750|P1|COMPLETED|Overall Study||75
74415|NCT01281202|172749|P2|STARTED|Overall Study||104
74416|NCT01281202|172750|P1|STARTED|Overall Study||103
74417|NCT01281124|172758|P1|NOT COMPLETED|Overall Study||1
74418|NCT01281124|172758|P1|COMPLETED|Overall Study||0
74419|NCT01281124|172758|P1|STARTED|Overall Study||1
74420|NCT01281007|172766|P2|NOT COMPLETED|Overall Study||8
74421|NCT01281007|172767|P1|NOT COMPLETED|Overall Study||4
74422|NCT01281007|172766|P2|COMPLETED|Overall Study||67
74423|NCT01281007|172767|P1|COMPLETED|Overall Study||71
74424|NCT01281007|172766|P2|STARTED|Overall Study||75
74425|NCT01281007|172767|P1|STARTED|Overall Study||75
74426|NCT01280981|172773|P1|NOT COMPLETED|Overall Study||92
74427|NCT01280981|172773|P1|COMPLETED|Overall Study||196
74428|NCT01280981|172773|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
74429|NCT01280981|172773|P1|STARTED|Overall Study||288
74430|NCT01280968|172784|P2|NOT COMPLETED|Overall Study||3
74431|NCT01280968|172785|P1|NOT COMPLETED|Overall Study||18
74432|NCT01280968|172784|P2|COMPLETED|Overall Study||4
74433|NCT01280968|172785|P1|COMPLETED|Overall Study||27
74434|NCT01280968|172784|P2|STARTED|Overall Study||7
74435|NCT01280968|172785|P1|STARTED|Overall Study||45
74436|NCT01280955|172801|P1|NOT COMPLETED|Overall Study||0
74437|NCT01280955|172801|P1|COMPLETED|Overall Study||29
74438|NCT01280955|172801|P1|STARTED|Overall Study||29
74439|NCT01280695|172813|P5|NOT COMPLETED|Overall Study||2
74440|NCT01280695|172814|P4|NOT COMPLETED|Overall Study||4
74441|NCT01280695|172815|P3|NOT COMPLETED|Overall Study||5
74442|NCT01280695|172816|P2|NOT COMPLETED|Overall Study||1
74443|NCT01280695|172817|P1|NOT COMPLETED|Overall Study||0
74444|NCT01280695|172813|P5|COMPLETED|Overall Study||24
74445|NCT01280695|172814|P4|COMPLETED|Overall Study||22
74446|NCT01280695|172815|P3|COMPLETED|Overall Study||21
74447|NCT01280695|172816|P2|COMPLETED|Overall Study||24
74448|NCT01280695|172817|P1|COMPLETED|Overall Study||26
74449|NCT01280695|172813|P5|STARTED|Overall Study||26
74450|NCT01280695|172814|P4|STARTED|Overall Study||26
74451|NCT01280695|172815|P3|STARTED|Overall Study||26
74452|NCT01280695|172816|P2|STARTED|Overall Study||25
74453|NCT01280695|172817|P1|STARTED|Overall Study||26
74454|NCT01280656|172857|P3|NOT COMPLETED|Overall Study||63
74455|NCT01280656|172858|P2|NOT COMPLETED|Overall Study||47
74456|NCT01280656|172859|P1|NOT COMPLETED|Overall Study||3
74457|NCT01280656|172857|P3|COMPLETED|Overall Study||223
74458|NCT01280656|172858|P2|COMPLETED|Overall Study||265
74459|NCT01280656|172859|P1|COMPLETED|Overall Study||59
74460|NCT01280656|172857|P3|STARTED|Overall Study||286
74461|NCT01280656|172858|P2|STARTED|Overall Study||312
74462|NCT01280656|172859|P1|STARTED|Overall Study||62
74463|NCT01280604|172905|P2|NOT COMPLETED|Overall Study||5
74464|NCT01280604|172906|P1|NOT COMPLETED|Overall Study||9
74465|NCT01280604|172905|P2|COMPLETED|Overall Study||28
74466|NCT01280604|172906|P1|COMPLETED|Overall Study||24
74467|NCT01280604|172905|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
74468|NCT01280604|172906|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
74469|NCT01280604|172905|P2|STARTED|Overall Study||33
74470|NCT01280604|172906|P1|STARTED|Overall Study||33
74471|NCT01280591|172926|P4|NOT COMPLETED|Overall Study||3
74472|NCT01280591|172927|P3|NOT COMPLETED|Overall Study||0
74473|NCT01280591|172928|P2|NOT COMPLETED|Overall Study||0
74474|NCT01280591|172929|P1|NOT COMPLETED|Overall Study||0
74475|NCT01280591|172926|P4|COMPLETED|Overall Study||99
74476|NCT01280591|172927|P3|COMPLETED|Overall Study||203
74477|NCT01280591|172928|P2|COMPLETED|Overall Study||204
74478|NCT01280591|172929|P1|COMPLETED|Overall Study||203
74479|NCT01280591|172926|P4|STARTED|Overall Study||102
74480|NCT01280591|172927|P3|STARTED|Overall Study||203
74481|NCT01280591|172928|P2|STARTED|Overall Study||204
74482|NCT01280591|172929|P1|STARTED|Overall Study||203
74483|NCT01280552|173021|P2|NOT COMPLETED|Overall Study||1
74484|NCT01280552|173022|P1|NOT COMPLETED|Overall Study||6
74485|NCT01280552|173021|P2|COMPLETED|Overall Study||42
74486|NCT01280552|173022|P1|COMPLETED|Overall Study|Survival is still being assessed|75
74487|NCT01280552|173021|P2|STARTED|Overall Study||43
74488|NCT01280552|173022|P1|STARTED|Overall Study||81
74489|NCT01280357|173034|P1|NOT COMPLETED|Overall Study||26
74490|NCT01280357|173034|P1|COMPLETED|Overall Study||34
74491|NCT01280357|173034|P1|STARTED|Overall Study||60
74492|NCT01280266|173043|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
74493|NCT01280266|173044|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
74494|NCT01280266|173043|P2|COMPLETED|Second Intervention (Week 5-9)||12
74495|NCT01280266|173044|P1|COMPLETED|Second Intervention (Week 5-9)||14
74496|NCT01280266|173043|P2|STARTED|Second Intervention (Week 5-9)||12
74497|NCT01280266|173044|P1|STARTED|Second Intervention (Week 5-9)||14
74498|NCT01280266|173043|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
74499|NCT01280266|173044|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
74500|NCT01280266|173043|P2|COMPLETED|Washout Period (Week 4-5)||12
74501|NCT01280266|173044|P1|COMPLETED|Washout Period (Week 4-5)||14
74502|NCT01280266|173043|P2|STARTED|Washout Period (Week 4-5)||12
74503|NCT01280266|173044|P1|STARTED|Washout Period (Week 4-5)||14
74504|NCT01280266|173043|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
74505|NCT01280266|173044|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
74506|NCT01280266|173043|P2|COMPLETED|First Intervention (Week 1-4)||12
74507|NCT01280266|173044|P1|COMPLETED|First Intervention (Week 1-4)||14
74508|NCT01280266|173043|P2|STARTED|First Intervention (Week 1-4)||14
74509|NCT01280266|173044|P1|STARTED|First Intervention (Week 1-4)||15
74510|NCT01280123|173069|P3|NOT COMPLETED|Overall Study||1
74511|NCT01280123|173070|P2|NOT COMPLETED|Overall Study||4
74512|NCT01280123|173071|P1|NOT COMPLETED|Overall Study||1
74513|NCT01280123|173069|P3|COMPLETED|Overall Study||70
74514|NCT01280123|173070|P2|COMPLETED|Overall Study||63
74515|NCT01280123|173071|P1|COMPLETED|Overall Study||71
74516|NCT01280123|173069|P3|STARTED|Overall Study||71
74517|NCT01280123|173070|P2|STARTED|Overall Study||67
74518|NCT01280123|173071|P1|STARTED|Overall Study||72
74519|NCT01280110|173096|P2|NOT COMPLETED|Overall Study||0
74520|NCT01280110|173097|P1|NOT COMPLETED|Overall Study||0
74521|NCT01280110|173096|P2|COMPLETED|Overall Study||22
74522|NCT01280110|173097|P1|COMPLETED|Overall Study||22
74523|NCT01280110|173096|P2|STARTED|Overall Study||22
74524|NCT01280110|173097|P1|STARTED|Overall Study||22
74525|NCT01279564|173107|P2|NOT COMPLETED|Overall Study||0
74526|NCT01279564|173108|P1|NOT COMPLETED|Overall Study||0
74527|NCT01279564|173107|P2|COMPLETED|Overall Study||32
74528|NCT01279564|173108|P1|COMPLETED|Overall Study||40
74529|NCT01279564|173107|P2|STARTED|Overall Study||32
74530|NCT01279564|173108|P1|STARTED|Overall Study||40
74531|NCT01279447|173116|P2|NOT COMPLETED|Overall Study||1
74532|NCT01279447|173117|P1|NOT COMPLETED|Overall Study||3
74533|NCT01279447|173116|P2|COMPLETED|Overall Study||33
74534|NCT01279447|173117|P1|COMPLETED|Overall Study||31
74535|NCT01279447|173116|P2|STARTED|Overall Study||34
74536|NCT01279447|173117|P1|STARTED|Overall Study||34
74537|NCT01279317|173123|P2|NOT COMPLETED|Period 2||0
74538|NCT01279317|173124|P1|NOT COMPLETED|Period 2||0
74539|NCT01279317|173123|P2|COMPLETED|Period 2||6
74540|NCT01279317|173124|P1|COMPLETED|Period 2||6
74541|NCT01279317|173123|P2|STARTED|Period 2||6
74542|NCT01279317|173124|P1|STARTED|Period 2||6
74543|NCT01279317|173123|P2|NOT COMPLETED|Washout||0
74544|NCT01279317|173124|P1|NOT COMPLETED|Washout||0
74545|NCT01279317|173123|P2|COMPLETED|Washout||6
74546|NCT01279317|173124|P1|COMPLETED|Washout||6
74547|NCT01279317|173123|P2|STARTED|Washout||6
74548|NCT01279317|173124|P1|STARTED|Washout||6
74549|NCT01279317|173123|P2|NOT COMPLETED|Period 1||0
74550|NCT01279317|173124|P1|NOT COMPLETED|Period 1||0
74551|NCT01279317|173123|P2|COMPLETED|Period 1||6
74552|NCT01279317|173124|P1|COMPLETED|Period 1||6
74553|NCT01279317|173123|P2|STARTED|Period 1||6
74554|NCT01279317|173124|P1|STARTED|Period 1||6
74555|NCT01279265|173131|P2|NOT COMPLETED|Overall Study||6
74556|NCT01279265|173132|P1|NOT COMPLETED|Overall Study||4
74557|NCT01279265|173131|P2|COMPLETED|Overall Study||11
74558|NCT01279265|173132|P1|COMPLETED|Overall Study||9
74559|NCT01279265|173131|P2|STARTED|Overall Study||17
74560|NCT01279265|173132|P1|STARTED|Overall Study||13
74561|NCT01279200|173144|P2|NOT COMPLETED|Overall Study||7
74562|NCT01279200|173145|P1|NOT COMPLETED|Overall Study||2
74563|NCT01279200|173144|P2|COMPLETED|Overall Study||4
74564|NCT01279200|173145|P1|COMPLETED|Overall Study||8
74565|NCT01279200|173144|P2|STARTED|Overall Study||11
74566|NCT01279200|173145|P1|STARTED|Overall Study||10
74567|NCT01279070|173155|P2|NOT COMPLETED|Overall Study||4
74568|NCT01279070|173156|P1|NOT COMPLETED|Overall Study||5
74569|NCT01279070|173155|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
74570|NCT01279070|173156|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
74571|NCT01279070|173155|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
74572|NCT01279070|173156|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
74573|NCT01279044|173175|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
74574|NCT01279044|173176|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
74575|NCT01279044|173177|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
74576|NCT01279044|173175|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
74577|NCT01279044|173176|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
74578|NCT01279044|173177|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
74579|NCT01279044|173175|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
74580|NCT01279044|173176|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
74581|NCT01279044|173177|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
74582|NCT01279044|173175|P3|NOT COMPLETED|PHASE 1 - Formative||0
74583|NCT01279044|173176|P2|NOT COMPLETED|PHASE 1 - Formative||0
74584|NCT01279044|173177|P1|NOT COMPLETED|PHASE 1 - Formative||0
74585|NCT01279044|173175|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
74586|NCT01279044|173176|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
74587|NCT01279044|173177|P1|COMPLETED|PHASE 1 - Formative||59
74588|NCT01279044|173175|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
74589|NCT01279044|173176|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
74590|NCT01279044|173177|P1|STARTED|PHASE 1 - Formative||59
74591|NCT01278953|173197|P2|NOT COMPLETED|Overall Study||11
74592|NCT01278953|173198|P1|NOT COMPLETED|Overall Study||9
74593|NCT01278953|173197|P2|COMPLETED|Overall Study||134
74594|NCT01278953|173198|P1|COMPLETED|Overall Study||146
74595|NCT01278953|173197|P2|STARTED|Overall Study||145
74596|NCT01278953|173198|P1|STARTED|Overall Study||155
74597|NCT01278927|173210|P4|NOT COMPLETED|Overall Study||0
74598|NCT01278927|173211|P3|NOT COMPLETED|Overall Study||0
74599|NCT01278927|173212|P2|NOT COMPLETED|Overall Study||0
74600|NCT01278927|173213|P1|NOT COMPLETED|Overall Study||0
74601|NCT01278927|173210|P4|COMPLETED|Overall Study||175
74602|NCT01278927|173211|P3|COMPLETED|Overall Study||178
74603|NCT01278927|173212|P2|COMPLETED|Overall Study||178
74604|NCT01278927|173213|P1|COMPLETED|Overall Study||180
74605|NCT01278927|173210|P4|STARTED|Overall Study||175
74606|NCT01278927|173211|P3|STARTED|Overall Study||178
74607|NCT01278927|173212|P2|STARTED|Overall Study||178
74608|NCT01278927|173213|P1|STARTED|Overall Study||180
74609|NCT01278797|173251|P2|NOT COMPLETED|Period 2||0
74610|NCT01278797|173252|P1|NOT COMPLETED|Period 2||0
74611|NCT01278797|173251|P2|COMPLETED|Period 2||13
74612|NCT01278797|173252|P1|COMPLETED|Period 2||13
74613|NCT01278797|173251|P2|STARTED|Period 2||13
74614|NCT01278797|173252|P1|STARTED|Period 2||13
74615|NCT01278797|173251|P2|NOT COMPLETED|Washout Period of 21 Days||0
74616|NCT01278797|173252|P1|NOT COMPLETED|Washout Period of 21 Days||0
74617|NCT01278797|173251|P2|COMPLETED|Washout Period of 21 Days||13
74618|NCT01278797|173252|P1|COMPLETED|Washout Period of 21 Days||13
74619|NCT01278797|173251|P2|STARTED|Washout Period of 21 Days||13
74620|NCT01278797|173252|P1|STARTED|Washout Period of 21 Days||13
74621|NCT01278797|173251|P2|NOT COMPLETED|Period 1||1
74622|NCT01278797|173252|P1|NOT COMPLETED|Period 1||1
74623|NCT01278797|173251|P2|COMPLETED|Period 1||13
74624|NCT01278797|173252|P1|COMPLETED|Period 1||13
74625|NCT01278797|173251|P2|STARTED|Period 1||14
74626|NCT01278797|173252|P1|STARTED|Period 1||14
74627|NCT01278615|173262|P1|NOT COMPLETED|Overall Study||2
74628|NCT01278615|173262|P1|COMPLETED|Overall Study||14
74629|NCT01278615|173262|P1|STARTED|Overall Study||16
74630|NCT01278485|173272|P1|NOT COMPLETED|Overall Study||0
74631|NCT01278485|173272|P1|COMPLETED|Overall Study||719
74632|NCT01278485|173272|P1|STARTED|Overall Study||719
74633|NCT01278407|173288|P5|NOT COMPLETED|Extension Phase||30
74634|NCT01278407|173289|P4|NOT COMPLETED|Extension Phase||12
74635|NCT01278407|173290|P3|NOT COMPLETED|Extension Phase||0
74636|NCT01278407|173291|P2|NOT COMPLETED|Extension Phase||0
74637|NCT01278407|173292|P1|NOT COMPLETED|Extension Phase||0
74638|NCT01278407|173288|P5|COMPLETED|Extension Phase||66
74639|NCT01278407|173289|P4|COMPLETED|Extension Phase||34
74640|NCT01278407|173290|P3|COMPLETED|Extension Phase||0
74641|NCT01278407|173291|P2|COMPLETED|Extension Phase||0
74642|NCT01278407|173292|P1|COMPLETED|Extension Phase||0
74643|NCT01278407|173288|P5|STARTED|Extension Phase||96
74644|NCT01278407|173289|P4|STARTED|Extension Phase||46
74645|NCT01278407|173290|P3|STARTED|Extension Phase||0
74646|NCT01278407|173291|P2|STARTED|Extension Phase||0
74647|NCT01278407|173292|P1|STARTED|Extension Phase||0
74648|NCT01278407|173288|P5|NOT COMPLETED|Confirmatory Phase||0
74649|NCT01278407|173289|P4|NOT COMPLETED|Confirmatory Phase||0
74650|NCT01278407|173290|P3|NOT COMPLETED|Confirmatory Phase||6
74651|NCT01278407|173291|P2|NOT COMPLETED|Confirmatory Phase||16
74652|NCT01278407|173292|P1|NOT COMPLETED|Confirmatory Phase||9
74653|NCT01278407|173288|P5|COMPLETED|Confirmatory Phase||0
74654|NCT01278407|173289|P4|COMPLETED|Confirmatory Phase||0
74655|NCT01278407|173290|P3|COMPLETED|Confirmatory Phase||43
74656|NCT01278407|173291|P2|COMPLETED|Confirmatory Phase||31
74657|NCT01278407|173292|P1|COMPLETED|Confirmatory Phase||37
74658|NCT01278407|173288|P5|STARTED|Confirmatory Phase||0
74659|NCT01278407|173289|P4|STARTED|Confirmatory Phase||0
74660|NCT01278407|173290|P3|STARTED|Confirmatory Phase||49
74661|NCT01278407|173291|P2|STARTED|Confirmatory Phase||47
74662|NCT01278407|173292|P1|STARTED|Confirmatory Phase||46
74663|NCT01278394|173305|P1|NOT COMPLETED|Overall Study||1
74664|NCT01278394|173305|P1|COMPLETED|Overall Study||28
74665|NCT01278394|173305|P1|STARTED|Overall Study||29
74666|NCT01278342|173318|P3|NOT COMPLETED|Overall Study||0
74667|NCT01278342|173319|P2|NOT COMPLETED|Overall Study||1
74668|NCT01278342|173320|P1|NOT COMPLETED|Overall Study||4
74669|NCT01278342|173318|P3|COMPLETED|Overall Study||32
74670|NCT01278342|173319|P2|COMPLETED|Overall Study||30
74671|NCT01278342|173320|P1|COMPLETED|Overall Study||3
74672|NCT01278342|173318|P3|STARTED|Overall Study||32
74673|NCT01278342|173319|P2|STARTED|Overall Study||31
74674|NCT01278342|173320|P1|STARTED|Overall Study||7
74675|NCT01278303|173334|P1|NOT COMPLETED|Overall Study||0
74676|NCT01278303|173334|P1|COMPLETED|Overall Study||82
74677|NCT01278303|173334|P1|STARTED|Overall Study||82
74678|NCT01277211|173342|P2|NOT COMPLETED|Overall Study||63
74679|NCT01277211|173343|P1|NOT COMPLETED|Overall Study||150
74680|NCT01277211|173342|P2|COMPLETED|Overall Study||182
74681|NCT01277211|173343|P1|COMPLETED|Overall Study||588
74682|NCT01277211|173342|P2|Treated|Overall Study||232
74683|NCT01277211|173343|P1|Treated|Overall Study||714
74684|NCT01277211|173342|P2|STARTED|Overall Study||245
74685|NCT01277211|173343|P1|STARTED|Overall Study||738
74686|NCT01277081|173355|P2|NOT COMPLETED|Overall Study||0
74687|NCT01277081|173356|P1|NOT COMPLETED|Overall Study||0
74688|NCT01277081|173355|P2|COMPLETED|Overall Study||100
74689|NCT01277081|173356|P1|COMPLETED|Overall Study||100
74690|NCT01277081|173355|P2|STARTED|Overall Study||100
74691|NCT01277081|173356|P1|STARTED|Overall Study||100
74692|NCT01278173|173372|P1|NOT COMPLETED|Overall Study||27
74693|NCT01278173|173372|P1|COMPLETED|Overall Study||38
74694|NCT01278173|173372|P1|STARTED|Overall Study||65
74695|NCT01278160|173379|P2|NOT COMPLETED|Overall Study||6
74696|NCT01278160|173380|P1|NOT COMPLETED|Overall Study||5
74697|NCT01278160|173379|P2|COMPLETED|Overall Study||84
74698|NCT01278160|173380|P1|COMPLETED|Overall Study||84
74699|NCT01278160|173379|P2|STARTED|Overall Study||90
74700|NCT01278160|173380|P1|STARTED|Overall Study||89
74701|NCT01278030|173396|P2|NOT COMPLETED|Overall Study||4
74702|NCT01278030|173397|P1|NOT COMPLETED|Overall Study||8
74703|NCT01278030|173396|P2|COMPLETED|Overall Study||31
74704|NCT01278030|173397|P1|COMPLETED|Overall Study||35
74705|NCT01278030|173396|P2|STARTED|Overall Study||35
74706|NCT01278030|173397|P1|STARTED|Overall Study||43
74707|NCT01277861|173405|P2|NOT COMPLETED|Overall Study||2
74708|NCT01277861|173406|P1|NOT COMPLETED|Overall Study||2
74709|NCT01277861|173405|P2|COMPLETED|Overall Study||47
74710|NCT01277861|173406|P1|COMPLETED|Overall Study||49
74711|NCT01277861|173405|P2|STARTED|Overall Study||49
74712|NCT01277861|173406|P1|STARTED|Overall Study||51
74713|NCT01277822|173418|P2|NOT COMPLETED|Overall Study||11
74714|NCT01277822|173419|P1|NOT COMPLETED|Overall Study||15
74715|NCT01277822|173418|P2|COMPLETED|Overall Study||155
74716|NCT01277822|173419|P1|COMPLETED|Overall Study||153
74717|NCT01277822|173418|P2|STARTED|Overall Study||166
74718|NCT01277822|173419|P1|STARTED|Overall Study||168
74719|NCT01277757|173439|P1|NOT COMPLETED|Overall Study||2
74720|NCT01277757|173439|P1|COMPLETED|Overall Study||28
74721|NCT01277757|173439|P1|STARTED|Overall Study||30
74722|NCT01277718|173446|P2|NOT COMPLETED|Period 3 - Third Intervention||0
74723|NCT01277718|173447|P1|NOT COMPLETED|Period 3 - Third Intervention||0
74724|NCT01277718|173446|P2|COMPLETED|Period 3 - Third Intervention||7
74725|NCT01277718|173447|P1|COMPLETED|Period 3 - Third Intervention||10
74726|NCT01277718|173446|P2|STARTED|Period 3 - Third Intervention||7
74727|NCT01277718|173447|P1|STARTED|Period 3 - Third Intervention||10
74728|NCT01277718|173446|P2|NOT COMPLETED|Washout Period of 13 Days||0
74729|NCT01277718|173447|P1|NOT COMPLETED|Washout Period of 13 Days||0
74730|NCT01277718|173446|P2|COMPLETED|Washout Period of 13 Days||7
74731|NCT01277718|173447|P1|COMPLETED|Washout Period of 13 Days||10
74732|NCT01277718|173446|P2|STARTED|Washout Period of 13 Days||7
74733|NCT01277718|173447|P1|STARTED|Washout Period of 13 Days||10
74734|NCT01277718|173446|P2|NOT COMPLETED|Period 2 - Second Intervention||3
74735|NCT01277718|173447|P1|NOT COMPLETED|Period 2 - Second Intervention||0
74736|NCT01277718|173446|P2|COMPLETED|Period 2 - Second Intervention||7
74737|NCT01277718|173447|P1|COMPLETED|Period 2 - Second Intervention||10
74738|NCT01277718|173446|P2|STARTED|Period 2 - Second Intervention||10
74739|NCT01277718|173447|P1|STARTED|Period 2 - Second Intervention||10
74740|NCT01277718|173446|P2|NOT COMPLETED|Washout Period of 13 Days||0
74741|NCT01277718|173447|P1|NOT COMPLETED|Washout Period of 13 Days||0
74742|NCT01277718|173446|P2|COMPLETED|Washout Period of 13 Days||10
74743|NCT01277718|173447|P1|COMPLETED|Washout Period of 13 Days||10
74744|NCT01277718|173446|P2|STARTED|Washout Period of 13 Days||10
74745|NCT01277718|173447|P1|STARTED|Washout Period of 13 Days||10
74746|NCT01277718|173446|P2|NOT COMPLETED|Period 1 - First Intervention||0
74747|NCT01277718|173447|P1|NOT COMPLETED|Period 1 - First Intervention||0
74748|NCT01277718|173446|P2|COMPLETED|Period 1 - First Intervention||10
74749|NCT01277718|173447|P1|COMPLETED|Period 1 - First Intervention||10
74750|NCT01277718|173446|P2|STARTED|Period 1 - First Intervention||10
74751|NCT01277718|173447|P1|STARTED|Period 1 - First Intervention||10
74752|NCT01277601|173462|P4|NOT COMPLETED|Overall Study||36
74753|NCT01277601|173463|P3|NOT COMPLETED|Overall Study||27
74754|NCT01277601|173464|P2|NOT COMPLETED|Overall Study||48
74755|NCT01277601|173465|P1|NOT COMPLETED|Overall Study||37
74756|NCT01277601|173462|P4|COMPLETED|Overall Study||150
74757|NCT01277601|173463|P3|COMPLETED|Overall Study||163
74758|NCT01277601|173464|P2|COMPLETED|Overall Study||139
74759|NCT01277601|173465|P1|COMPLETED|Overall Study||151
74760|NCT01277601|173462|P4|STARTED|Overall Study||186
74761|NCT01277601|173463|P3|STARTED|Overall Study||190
74762|NCT01277601|173464|P2|STARTED|Overall Study||187
74763|NCT01277601|173465|P1|STARTED|Overall Study||188
74764|NCT01277549|173556|P2|NOT COMPLETED|Overall Study||14
74765|NCT01277549|173557|P1|NOT COMPLETED|Overall Study||26
74766|NCT01277549|173556|P2|COMPLETED|Overall Study||15
74767|NCT01277549|173557|P1|COMPLETED|Overall Study||15
74768|NCT01277549|173556|P2|STARTED|Overall Study||29
74769|NCT01277549|173557|P1|STARTED|Overall Study||41
74770|NCT01277523|173574|P3|NOT COMPLETED|Overall Study||0
74771|NCT01277523|173575|P2|NOT COMPLETED|Overall Study||1
74772|NCT01277523|173576|P1|NOT COMPLETED|Overall Study||3
74773|NCT01277523|173574|P3|COMPLETED|Overall Study||130
74774|NCT01277523|173575|P2|COMPLETED|Overall Study||126
74775|NCT01277523|173576|P1|COMPLETED|Overall Study||132
74776|NCT01277523|173574|P3|STARTED|Overall Study||130
74777|NCT01277523|173575|P2|STARTED|Overall Study||127
74778|NCT01277523|173576|P1|STARTED|Overall Study||135
74779|NCT01277510|173628|P2|NOT COMPLETED|Open-label Phase||3
74780|NCT01277510|173629|P1|NOT COMPLETED|Open-label Phase||7
74781|NCT01277510|173628|P2|COMPLETED|Open-label Phase|Completed investigational product|1
74782|NCT01277510|173629|P1|COMPLETED|Open-label Phase|Completed investigational product|1
74783|NCT01277510|173628|P2|Received Investigational Product|Open-label Phase||4
74784|NCT01277510|173629|P1|Received Investigational Product|Open-label Phase||6
74785|NCT01277510|173628|P2|STARTED|Open-label Phase||4
74786|NCT01277510|173629|P1|STARTED|Open-label Phase||8
74787|NCT01277510|173628|P2|NOT COMPLETED|Double-blind Phase||18
74788|NCT01277510|173629|P1|NOT COMPLETED|Double-blind Phase||13
74789|NCT01277510|173628|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
74790|NCT01277510|173629|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
74791|NCT01277510|173628|P2|Received Investigational Product|Double-blind Phase||22
74792|NCT01277510|173629|P1|Received Investigational Product|Double-blind Phase||21
74793|NCT01277510|173628|P2|STARTED|Double-blind Phase||22
74794|NCT01277510|173629|P1|STARTED|Double-blind Phase||21
74795|NCT01277354|173653|P2|NOT COMPLETED|Overall Study||0
74796|NCT01277354|173654|P1|NOT COMPLETED|Overall Study||0
74797|NCT01277354|173653|P2|COMPLETED|Overall Study||1
74798|NCT01277354|173654|P1|COMPLETED|Overall Study||1
74799|NCT01277354|173653|P2|STARTED|Overall Study||1
74800|NCT01277354|173654|P1|STARTED|Overall Study||1
74801|NCT01277302|173663|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
74802|NCT01277302|173664|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
74803|NCT01277302|173665|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
74804|NCT01277302|173663|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
74805|NCT01277302|173664|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
74806|NCT01277302|173665|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
74807|NCT01277302|173663|P3|STARTED|8-Month Alternate Dose Regimen Period||19
74808|NCT01277302|173664|P2|STARTED|8-Month Alternate Dose Regimen Period||86
74809|NCT01277302|173665|P1|STARTED|8-Month Alternate Dose Regimen Period||85
74810|NCT01277302|173663|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
74811|NCT01277302|173664|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
74812|NCT01277302|173665|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
74813|NCT01277302|173663|P3|COMPLETED|7-Month Fixed Treatment Period||19
74814|NCT01277302|173664|P2|COMPLETED|7-Month Fixed Treatment Period||86
74815|NCT01277302|173665|P1|COMPLETED|7-Month Fixed Treatment Period||85
74816|NCT01277302|173663|P3|STARTED|7-Month Fixed Treatment Period||31
74817|NCT01277302|173664|P2|STARTED|7-Month Fixed Treatment Period||86
74818|NCT01277302|173665|P1|STARTED|7-Month Fixed Treatment Period||85
74819|NCT01277042|173697|P2|NOT COMPLETED|Overall Study||5
74820|NCT01277042|173698|P1|NOT COMPLETED|Overall Study||8
74821|NCT01277042|173697|P2|COMPLETED|Overall Study||601
74822|NCT01277042|173698|P1|COMPLETED|Overall Study||598
74823|NCT01277042|173697|P2|STARTED|Overall Study||606
74824|NCT01277042|173698|P1|STARTED|Overall Study||606
74825|NCT01276847|173723|P3|NOT COMPLETED|Overall Study||0
74826|NCT01276847|173724|P2|NOT COMPLETED|Overall Study||0
74827|NCT01276847|173725|P1|NOT COMPLETED|Overall Study||1
74828|NCT01276847|173723|P3|COMPLETED|Overall Study||20
74829|NCT01276847|173724|P2|COMPLETED|Overall Study||10
74830|NCT01276847|173725|P1|COMPLETED|Overall Study||9
74831|NCT01276847|173723|P3|STARTED|Overall Study||20
74832|NCT01276847|173724|P2|STARTED|Overall Study||10
74833|NCT01276847|173725|P1|STARTED|Overall Study||10
74834|NCT01276821|173735|P2|NOT COMPLETED|Overall Study||1
74835|NCT01276821|173736|P1|NOT COMPLETED|Overall Study||0
74836|NCT01276821|173735|P2|COMPLETED|Overall Study||49
74837|NCT01276821|173736|P1|COMPLETED|Overall Study||50
74838|NCT01276821|173735|P2|STARTED|Overall Study||50
74839|NCT01276821|173736|P1|STARTED|Overall Study||50
74840|NCT01276756|173756|P2|NOT COMPLETED|Overall Study||2
74841|NCT01276756|173757|P1|NOT COMPLETED|Overall Study||5
74842|NCT01276756|173756|P2|COMPLETED|Overall Study||48
74843|NCT01276756|173757|P1|COMPLETED|Overall Study||45
74844|NCT01276756|173756|P2|STARTED|Overall Study||50
74845|NCT01276756|173757|P1|STARTED|Overall Study||50
74846|NCT01276639|173774|P5|NOT COMPLETED|Week 16 to 52||21
74847|NCT01276639|173775|P4|NOT COMPLETED|Week 16 to 52||16
74848|NCT01276639|173776|P3|NOT COMPLETED|Week 16 to 52||0
74849|NCT01276639|173777|P2|NOT COMPLETED|Week 16 to 52||101
74850|NCT01276639|173778|P1|NOT COMPLETED|Week 16 to 52||127
74851|NCT01276639|173774|P5|COMPLETED|Week 16 to 52||45
74852|NCT01276639|173775|P4|COMPLETED|Week 16 to 52||50
74853|NCT01276639|173776|P3|COMPLETED|Week 16 to 52||0
74854|NCT01276639|173777|P2|COMPLETED|Week 16 to 52||219
74855|NCT01276639|173778|P1|COMPLETED|Week 16 to 52||186
74856|NCT01276639|173774|P5|STARTED|Week 16 to 52||66
74857|NCT01276639|173775|P4|STARTED|Week 16 to 52||66
74858|NCT01276639|173776|P3|STARTED|Week 16 to 52||0
74859|NCT01276639|173777|P2|STARTED|Week 16 to 52||320
74860|NCT01276639|173778|P1|STARTED|Week 16 to 52||313
74861|NCT01276639|173774|P5|NOT COMPLETED|Week 0 to 16||0
74862|NCT01276639|173775|P4|NOT COMPLETED|Week 0 to 16||0
74863|NCT01276639|173776|P3|NOT COMPLETED|Week 0 to 16||45
74864|NCT01276639|173777|P2|NOT COMPLETED|Week 0 to 16||41
74865|NCT01276639|173778|P1|NOT COMPLETED|Week 0 to 16||50
74866|NCT01276639|173774|P5|COMPLETED|Week 0 to 16||0
74867|NCT01276639|173775|P4|COMPLETED|Week 0 to 16||0
74868|NCT01276639|173776|P3|COMPLETED|Week 0 to 16||132
74869|NCT01276639|173777|P2|COMPLETED|Week 0 to 16||320
74870|NCT01276639|173778|P1|COMPLETED|Week 0 to 16||313
74871|NCT01276639|173774|P5|Treated|Week 0 to 16||0
74872|NCT01276639|173775|P4|Treated|Week 0 to 16||0
74873|NCT01276639|173776|P3|Treated|Week 0 to 16||177
74874|NCT01276639|173777|P2|Treated|Week 0 to 16||360
74875|NCT01276639|173778|P1|Treated|Week 0 to 16||363
74876|NCT01276639|173774|P5|STARTED|Week 0 to 16||0
74877|NCT01276639|173775|P4|STARTED|Week 0 to 16||0
74878|NCT01276639|173776|P3|STARTED|Week 0 to 16||177
74879|NCT01276639|173777|P2|STARTED|Week 0 to 16||361
74880|NCT01276639|173778|P1|STARTED|Week 0 to 16||363
74881|NCT01276535|173973|P1|NOT COMPLETED|Overall Study||0
74882|NCT01276535|173973|P1|COMPLETED|Overall Study||12
74883|NCT01276535|173973|P1|STARTED|Overall Study||12
74884|NCT01276457|173981|P2|NOT COMPLETED|Extension Study||2
74885|NCT01276457|173982|P1|NOT COMPLETED|Extension Study||6
74886|NCT01276457|173981|P2|COMPLETED|Extension Study||110
74887|NCT01276457|173982|P1|COMPLETED|Extension Study||105
74888|NCT01276457|173981|P2|STARTED|Extension Study||112
74889|NCT01276457|173982|P1|STARTED|Extension Study||111
74890|NCT01276457|173981|P2|NOT COMPLETED|Core Study||20
74891|NCT01276457|173982|P1|NOT COMPLETED|Core Study||13
74892|NCT01276457|173981|P2|COMPLETED|Core Study||123
74893|NCT01276457|173982|P1|COMPLETED|Core Study||129
74894|NCT01276457|173981|P2|STARTED|Core Study||143
74895|NCT01276457|173982|P1|STARTED|Core Study||142
74896|NCT01276353|173996|P2|NOT COMPLETED|Extension||9
74897|NCT01276353|173997|P1|NOT COMPLETED|Extension||7
74898|NCT01276353|173996|P2|COMPLETED|Extension||14
74899|NCT01276353|173997|P1|COMPLETED|Extension||12
74900|NCT01276353|173996|P2|STARTED|Extension||23
74901|NCT01276353|173997|P1|STARTED|Extension||19
74902|NCT01276353|173996|P2|NOT COMPLETED|Double-blind||0
74903|NCT01276353|173997|P1|NOT COMPLETED|Double-blind||3
74904|NCT01276353|173996|P2|COMPLETED|Double-blind||23
74905|NCT01276353|173997|P1|COMPLETED|Double-blind||19
74906|NCT01276353|173996|P2|STARTED|Double-blind||23
74907|NCT01276353|173997|P1|STARTED|Double-blind||22
74908|NCT01276327|174009|P2|NOT COMPLETED|Overall Study||3
74909|NCT01276327|174010|P1|NOT COMPLETED|Overall Study||2
74910|NCT01276327|174009|P2|COMPLETED|Overall Study||29
74911|NCT01276327|174010|P1|COMPLETED|Overall Study||30
74912|NCT01276327|174009|P2|STARTED|Overall Study||32
74913|NCT01276327|174010|P1|STARTED|Overall Study||32
74914|NCT01276301|174032|P2|NOT COMPLETED|Second Intervention||0
74915|NCT01276301|174033|P1|NOT COMPLETED|Second Intervention||0
74916|NCT01276301|174032|P2|COMPLETED|Second Intervention||8
74917|NCT01276301|174033|P1|COMPLETED|Second Intervention||8
74918|NCT01276301|174032|P2|STARTED|Second Intervention||8
74919|NCT01276301|174033|P1|STARTED|Second Intervention||8
74920|NCT01276301|174032|P2|NOT COMPLETED|Washout Period of 7 Days||0
74921|NCT01276301|174033|P1|NOT COMPLETED|Washout Period of 7 Days||0
74922|NCT01276301|174032|P2|COMPLETED|Washout Period of 7 Days||8
74923|NCT01276301|174033|P1|COMPLETED|Washout Period of 7 Days||8
74924|NCT01276301|174032|P2|STARTED|Washout Period of 7 Days||8
74925|NCT01276301|174033|P1|STARTED|Washout Period of 7 Days||8
74926|NCT01276301|174032|P2|NOT COMPLETED|First Intervention||0
74927|NCT01276301|174033|P1|NOT COMPLETED|First Intervention||0
74928|NCT01276301|174032|P2|COMPLETED|First Intervention||8
74929|NCT01276301|174033|P1|COMPLETED|First Intervention||8
74930|NCT01276301|174032|P2|STARTED|First Intervention||8
74931|NCT01276301|174033|P1|STARTED|First Intervention||8
74932|NCT01276288|174060|P4|NOT COMPLETED|Overall Study||0
74933|NCT01276288|174061|P3|NOT COMPLETED|Overall Study||0
74934|NCT01276288|174062|P2|NOT COMPLETED|Overall Study||1
74935|NCT01276288|174063|P1|NOT COMPLETED|Overall Study||2
74936|NCT01276288|174060|P4|COMPLETED|Overall Study||5
74937|NCT01276288|174061|P3|COMPLETED|Overall Study||5
74938|NCT01276288|174062|P2|COMPLETED|Overall Study||5
74939|NCT01276288|174063|P1|COMPLETED|Overall Study||5
74940|NCT01276288|174060|P4|Received EMPA+TOR|Overall Study||5
74941|NCT01276288|174061|P3|Received EMPA+TOR|Overall Study||5
74942|NCT01276288|174062|P2|Received EMPA+TOR|Overall Study||0
74943|NCT01276288|174063|P1|Received EMPA+TOR|Overall Study||0
74944|NCT01276288|174060|P4|Received EMPA+HCT|Overall Study||0
74945|NCT01276288|174061|P3|Received EMPA+HCT|Overall Study||0
74946|NCT01276288|174062|P2|Received EMPA+HCT|Overall Study||5
74947|NCT01276288|174063|P1|Received EMPA+HCT|Overall Study||5
74948|NCT01276288|174060|P4|Received EMPA|Overall Study||5
74949|NCT01276288|174061|P3|Received EMPA|Overall Study||5
74950|NCT01276288|174062|P2|Received EMPA|Overall Study||5
74951|NCT01276288|174063|P1|Received EMPA|Overall Study||6
74952|NCT01276288|174060|P4|STARTED|Overall Study||5
74953|NCT01276288|174061|P3|STARTED|Overall Study||5
74954|NCT01276288|174062|P2|STARTED|Overall Study||6
74955|NCT01276288|174063|P1|STARTED|Overall Study||7
74956|NCT01276223|174190|P3|NOT COMPLETED|Overall Study||3
74957|NCT01276223|174191|P2|NOT COMPLETED|Overall Study||4
74958|NCT01276223|174192|P1|NOT COMPLETED|Overall Study||11
74959|NCT01276223|174190|P3|COMPLETED|Overall Study||101
74960|NCT01276223|174191|P2|COMPLETED|Overall Study||103
74961|NCT01276223|174192|P1|COMPLETED|Overall Study||67
74962|NCT01276223|174190|P3|STARTED|Overall Study||104
74963|NCT01276223|174191|P2|STARTED|Overall Study||107
74964|NCT01276223|174192|P1|STARTED|Overall Study||78
74965|NCT01276197|174201|P2|NOT COMPLETED|Overall Study||110
74966|NCT01276197|174202|P1|NOT COMPLETED|Overall Study||108
74967|NCT01276197|174201|P2|COMPLETED|Overall Study||200
74968|NCT01276197|174202|P1|COMPLETED|Overall Study||200
74969|NCT01276197|174201|P2|STARTED|Overall Study||310
74970|NCT01276197|174202|P1|STARTED|Overall Study||308
74971|NCT01276106|174214|P4|NOT COMPLETED|Overall Study||13
74972|NCT01276106|174215|P3|NOT COMPLETED|Overall Study||16
74973|NCT01276106|174216|P2|NOT COMPLETED|Overall Study||9
74974|NCT01276106|174217|P1|NOT COMPLETED|Overall Study||12
74975|NCT01276106|174214|P4|COMPLETED|Overall Study||52
74976|NCT01276106|174215|P3|COMPLETED|Overall Study||49
74977|NCT01276106|174216|P2|COMPLETED|Overall Study||55
74978|NCT01276106|174217|P1|COMPLETED|Overall Study||53
74979|NCT01276106|174214|P4|STARTED|Overall Study||65
74980|NCT01276106|174215|P3|STARTED|Overall Study||65
74981|NCT01276106|174216|P2|STARTED|Overall Study||64
74982|NCT01276106|174217|P1|STARTED|Overall Study||65
74983|NCT01276054|174229|P2|NOT COMPLETED|Overall Study||2
74984|NCT01276054|174230|P1|NOT COMPLETED|Overall Study||2
74985|NCT01276054|174229|P2|COMPLETED|Overall Study||0
74986|NCT01276054|174230|P1|COMPLETED|Overall Study||0
74987|NCT01276054|174229|P2|STARTED|Overall Study||2
74988|NCT01276054|174230|P1|STARTED|Overall Study||2
74989|NCT01275755|174238|P2|NOT COMPLETED|Run-out Placebo Period||0
74990|NCT01275755|174239|P1|NOT COMPLETED|Run-out Placebo Period||1
74991|NCT01275755|174238|P2|COMPLETED|Run-out Placebo Period||37
74992|NCT01275755|174239|P1|COMPLETED|Run-out Placebo Period||38
74993|NCT01275755|174238|P2|STARTED|Run-out Placebo Period||37
74994|NCT01275755|174239|P1|STARTED|Run-out Placebo Period||39
74995|NCT01275755|174238|P2|NOT COMPLETED|Double-blind Treatment Period||3
74996|NCT01275755|174239|P1|NOT COMPLETED|Double-blind Treatment Period||2
74997|NCT01275755|174238|P2|COMPLETED|Double-blind Treatment Period||37
74998|NCT01275755|174239|P1|COMPLETED|Double-blind Treatment Period||39
74999|NCT01275755|174238|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
75000|NCT01275755|174239|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
75001|NCT01275755|174238|P2|STARTED|Double-blind Treatment Period||40
75002|NCT01275755|174239|P1|STARTED|Double-blind Treatment Period||41
75003|NCT01275755|174238|P2|NOT COMPLETED|Run-in Placebo Period||0
75004|NCT01275755|174239|P1|NOT COMPLETED|Run-in Placebo Period||0
75005|NCT01275755|174238|P2|COMPLETED|Run-in Placebo Period||40
75006|NCT01275755|174239|P1|COMPLETED|Run-in Placebo Period||41
75007|NCT01275755|174238|P2|STARTED|Run-in Placebo Period||40
75008|NCT01275755|174239|P1|STARTED|Run-in Placebo Period||41
75009|NCT01275625|174245|P1|NOT COMPLETED|Overall Study||13
75010|NCT01275625|174245|P1|COMPLETED|Overall Study||64
75011|NCT01275625|174245|P1|Treated|Overall Study||77
75012|NCT01275625|174245|P1|STARTED|Overall Study||77
75013|NCT01275430|174259|P1|NOT COMPLETED|Overall Study||9
75014|NCT01275430|174259|P1|COMPLETED|Overall Study||18
75015|NCT01275430|174259|P1|STARTED|Overall Study||27
75016|NCT01275196|174269|P2|NOT COMPLETED|Overall Study||21
75017|NCT01275196|174270|P1|NOT COMPLETED|Overall Study||20
75018|NCT01275196|174269|P2|COMPLETED|Overall Study||113
75019|NCT01275196|174270|P1|COMPLETED|Overall Study||113
75020|NCT01275196|174269|P2|Intended to Continue Into Extension|Overall Study||113
75021|NCT01275196|174270|P1|Intended to Continue Into Extension|Overall Study||112
75022|NCT01275196|174269|P2|STARTED|Overall Study||134
75023|NCT01275196|174270|P1|STARTED|Overall Study||133
75024|NCT01275131|174313|P4|NOT COMPLETED|Period 2 (Crossover)||2
75025|NCT01275131|174314|P3|NOT COMPLETED|Period 2 (Crossover)||1
75026|NCT01275131|174315|P2|NOT COMPLETED|Period 2 (Crossover)||1
75027|NCT01275131|174316|P1|NOT COMPLETED|Period 2 (Crossover)||1
75028|NCT01275131|174313|P4|COMPLETED|Period 2 (Crossover)||8
75029|NCT01275131|174314|P3|COMPLETED|Period 2 (Crossover)||9
75030|NCT01275131|174315|P2|COMPLETED|Period 2 (Crossover)||8
75031|NCT01275131|174316|P1|COMPLETED|Period 2 (Crossover)||8
75032|NCT01275131|174313|P4|STARTED|Period 2 (Crossover)||10
75033|NCT01275131|174314|P3|STARTED|Period 2 (Crossover)||10
75034|NCT01275131|174315|P2|STARTED|Period 2 (Crossover)||9
75035|NCT01275131|174316|P1|STARTED|Period 2 (Crossover)||9
75036|NCT01275131|174313|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
75037|NCT01275131|174314|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
75038|NCT01275131|174315|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
75039|NCT01275131|174316|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
75040|NCT01275131|174313|P4|COMPLETED|5- to 14-Day Washout Period||10
75041|NCT01275131|174314|P3|COMPLETED|5- to 14-Day Washout Period||10
75042|NCT01275131|174315|P2|COMPLETED|5- to 14-Day Washout Period||9
75043|NCT01275131|174316|P1|COMPLETED|5- to 14-Day Washout Period||9
75044|NCT01275131|174313|P4|STARTED|5- to 14-Day Washout Period||10
75045|NCT01275131|174314|P3|STARTED|5- to 14-Day Washout Period||10
75046|NCT01275131|174315|P2|STARTED|5- to 14-Day Washout Period||9
75047|NCT01275131|174316|P1|STARTED|5- to 14-Day Washout Period||9
75048|NCT01275131|174313|P4|NOT COMPLETED|Period 1||2
75049|NCT01275131|174314|P3|NOT COMPLETED|Period 1||3
75050|NCT01275131|174315|P2|NOT COMPLETED|Period 1||0
75051|NCT01275131|174316|P1|NOT COMPLETED|Period 1||2
75052|NCT01275131|174313|P4|COMPLETED|Period 1||10
75053|NCT01275131|174314|P3|COMPLETED|Period 1||10
75054|NCT01275131|174315|P2|COMPLETED|Period 1||9
75055|NCT01275131|174316|P1|COMPLETED|Period 1||9
75056|NCT01275131|174313|P4|Received at Least One Dose of Study Drug|Period 1||12
75057|NCT01275131|174314|P3|Received at Least One Dose of Study Drug|Period 1||13
75058|NCT01275131|174315|P2|Received at Least One Dose of Study Drug|Period 1||9
75059|NCT01275131|174316|P1|Received at Least One Dose of Study Drug|Period 1||11
75060|NCT01275131|174313|P4|STARTED|Period 1||12
75061|NCT01275131|174314|P3|STARTED|Period 1||13
75062|NCT01275131|174315|P2|STARTED|Period 1||9
75063|NCT01275131|174316|P1|STARTED|Period 1||11
75064|NCT01275092|174350|P1|NOT COMPLETED|Overall Study||0
75065|NCT01275092|174350|P1|COMPLETED|Overall Study||164
75066|NCT01275092|174350|P1|STARTED|Overall Study||164
75067|NCT01275066|174359|P3|NOT COMPLETED|Overall Study||1
75068|NCT01275066|174360|P2|NOT COMPLETED|Overall Study||0
75069|NCT01275066|174361|P1|NOT COMPLETED|Overall Study||1
75070|NCT01275066|174359|P3|COMPLETED|Overall Study||57
75071|NCT01275066|174360|P2|COMPLETED|Overall Study||59
75072|NCT01275066|174361|P1|COMPLETED|Overall Study||59
75073|NCT01275066|174359|P3|Treated|Overall Study||58
75074|NCT01275066|174360|P2|Treated|Overall Study||59
75075|NCT01275066|174361|P1|Treated|Overall Study||59
75076|NCT01275066|174359|P3|STARTED|Overall Study||58
75077|NCT01275066|174360|P2|STARTED|Overall Study||59
75078|NCT01275066|174361|P1|STARTED|Overall Study||60
75079|NCT01274897|174377|P2|NOT COMPLETED|Overall Study||0
75080|NCT01274897|174378|P1|NOT COMPLETED|Overall Study||0
75081|NCT01274897|174377|P2|COMPLETED|Overall Study||153
75082|NCT01274897|174378|P1|COMPLETED|Overall Study||297
75083|NCT01274897|174377|P2|STARTED|Overall Study||153
75084|NCT01274897|174378|P1|STARTED|Overall Study||297
75085|NCT01274715|174390|P1|NOT COMPLETED|Overall Study||4
75086|NCT01274715|174390|P1|COMPLETED|Overall Study||8
75087|NCT01274715|174390|P1|Screened Out at Baseline|Overall Study||3
75088|NCT01274715|174390|P1|STARTED|Overall Study||12
75089|NCT01274611|174395|P1|NOT COMPLETED|Overall Study||0
75090|NCT01274611|174395|P1|COMPLETED|Overall Study||20
75091|NCT01274611|174395|P1|STARTED|Overall Study||20
75092|NCT01274585|174405|P2|NOT COMPLETED|Overall Study||0
75093|NCT01274585|174406|P1|NOT COMPLETED|Overall Study||0
75094|NCT01274585|174405|P2|COMPLETED|Overall Study||3
75095|NCT01274585|174406|P1|COMPLETED|Overall Study||2
75096|NCT01274585|174405|P2|STARTED|Overall Study||3
75097|NCT01274585|174406|P1|STARTED|Overall Study||2
75098|NCT01274559|174414|P2|NOT COMPLETED|Overall Study||145
75099|NCT01274559|174415|P1|NOT COMPLETED|Overall Study||197
75100|NCT01274559|174414|P2|COMPLETED|Overall Study||441
75101|NCT01274559|174415|P1|COMPLETED|Overall Study||390
75102|NCT01274559|174414|P2|Treated|Overall Study||572
75103|NCT01274559|174415|P1|Treated|Overall Study||572
75104|NCT01274559|174414|P2|STARTED|Overall Study||586
75105|NCT01274559|174415|P1|STARTED|Overall Study||587
75106|NCT01274533|174465|P1|NOT COMPLETED|Overall Study||4
75107|NCT01274533|174465|P1|COMPLETED|Overall Study||0
75108|NCT01274533|174465|P1|STARTED|Overall Study||4
75109|NCT01273896|174470|P1|NOT COMPLETED|Overall Study||0
75110|NCT01273896|174470|P1|COMPLETED|Overall Study||22
75111|NCT01273896|174470|P1|STARTED|Overall Study||22
75112|NCT01273883|174474|P2|NOT COMPLETED|Second Intervention||1
75113|NCT01273883|174475|P1|NOT COMPLETED|Second Intervention||2
75114|NCT01273883|174474|P2|COMPLETED|Second Intervention||17
75115|NCT01273883|174475|P1|COMPLETED|Second Intervention||15
75116|NCT01273883|174474|P2|STARTED|Second Intervention||18
75117|NCT01273883|174475|P1|STARTED|Second Intervention||17
75118|NCT01273883|174474|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
75119|NCT01273883|174475|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
75120|NCT01273883|174474|P2|COMPLETED|Washout Period of 2 Weeks||18
75121|NCT01273883|174475|P1|COMPLETED|Washout Period of 2 Weeks||17
75122|NCT01273883|174474|P2|STARTED|Washout Period of 2 Weeks||18
75123|NCT01273883|174475|P1|STARTED|Washout Period of 2 Weeks||17
75124|NCT01273883|174474|P2|NOT COMPLETED|First Intervention||1
75125|NCT01273883|174475|P1|NOT COMPLETED|First Intervention||2
75126|NCT01273883|174474|P2|COMPLETED|First Intervention||18
75127|NCT01273883|174475|P1|COMPLETED|First Intervention||17
75128|NCT01273883|174474|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
75129|NCT01273883|174475|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
75130|NCT01273857|174489|P2|NOT COMPLETED|Overall Study||0
75131|NCT01273857|174490|P1|NOT COMPLETED|Overall Study||0
75132|NCT01273857|174489|P2|COMPLETED|Overall Study||7
75133|NCT01273857|174490|P1|COMPLETED|Overall Study||7
75134|NCT01273857|174489|P2|STARTED|Overall Study||7
75135|NCT01273857|174490|P1|STARTED|Overall Study||7
75136|NCT01273818|174501|P3|NOT COMPLETED|Overall Study||9
75137|NCT01273818|174502|P2|NOT COMPLETED|Overall Study||2
75138|NCT01273818|174503|P1|NOT COMPLETED|Overall Study||13
75139|NCT01273818|174501|P3|COMPLETED|Overall Study||91
75140|NCT01273818|174502|P2|COMPLETED|Overall Study||98
75141|NCT01273818|174503|P1|COMPLETED|Overall Study||87
75142|NCT01273818|174501|P3|STARTED|Overall Study||100
75143|NCT01273818|174502|P2|STARTED|Overall Study||100
75144|NCT01273818|174503|P1|STARTED|Overall Study||100
75145|NCT01273766|174514|P3|NOT COMPLETED|Overall Study||0
75146|NCT01273766|174515|P2|NOT COMPLETED|Overall Study||0
75147|NCT01273766|174516|P1|NOT COMPLETED|Overall Study||0
75148|NCT01273766|174514|P3|COMPLETED|Overall Study||5
75149|NCT01273766|174515|P2|COMPLETED|Overall Study||7
75150|NCT01273766|174516|P1|COMPLETED|Overall Study||4
75151|NCT01273766|174514|P3|STARTED|Overall Study||5
75152|NCT01273766|174515|P2|STARTED|Overall Study||7
75153|NCT01273766|174516|P1|STARTED|Overall Study||4
75154|NCT01273623|174522|P1|NOT COMPLETED|Overall Study||29
75155|NCT01273623|174522|P1|COMPLETED|Overall Study|met IVUS criteria|26
75156|NCT01273623|174522|P1|STARTED|Overall Study|met angiographic criteria|55
75157|NCT01273597|174529|P1|NOT COMPLETED|Overall Study||8
75158|NCT01273597|174529|P1|COMPLETED|Overall Study||52
75159|NCT01273597|174529|P1|STARTED|Overall Study||60
75160|NCT01273519|174544|P3|NOT COMPLETED|Overall Study||8
75161|NCT01273519|174545|P2|NOT COMPLETED|Overall Study||5
75162|NCT01273519|174546|P1|NOT COMPLETED|Overall Study||19
75163|NCT01273519|174544|P3|COMPLETED|Overall Study||39
75164|NCT01273519|174545|P2|COMPLETED|Overall Study||25
75165|NCT01273519|174546|P1|COMPLETED|Overall Study||59
75166|NCT01273519|174544|P3|STARTED|Overall Study||47
75167|NCT01273519|174545|P2|STARTED|Overall Study||30
75168|NCT01273519|174546|P1|STARTED|Overall Study||78
75169|NCT01273181|174583|P4|NOT COMPLETED|Phase 2, Dose 2||1
75170|NCT01273181|174584|P3|NOT COMPLETED|Phase 2, Dose 2||0
75171|NCT01273181|174585|P2|NOT COMPLETED|Phase 2, Dose 2||0
75172|NCT01273181|174586|P1|NOT COMPLETED|Phase 2, Dose 2||0
75173|NCT01273181|174583|P4|COMPLETED|Phase 2, Dose 2||0
75174|NCT01273181|174584|P3|COMPLETED|Phase 2, Dose 2||0
75175|NCT01273181|174585|P2|COMPLETED|Phase 2, Dose 2||0
75176|NCT01273181|174586|P1|COMPLETED|Phase 2, Dose 2||0
75177|NCT01273181|174583|P4|STARTED|Phase 2, Dose 2||1
75178|NCT01273181|174584|P3|STARTED|Phase 2, Dose 2||0
75179|NCT01273181|174585|P2|STARTED|Phase 2, Dose 2||0
75180|NCT01273181|174586|P1|STARTED|Phase 2, Dose 2||0
75181|NCT01273181|174583|P4|NOT COMPLETED|Phase 2, Dose 1||0
75182|NCT01273181|174584|P3|NOT COMPLETED|Phase 2, Dose 1||1
75183|NCT01273181|174585|P2|NOT COMPLETED|Phase 2, Dose 1||0
75184|NCT01273181|174586|P1|NOT COMPLETED|Phase 2, Dose 1||0
75185|NCT01273181|174583|P4|COMPLETED|Phase 2, Dose 1||0
75186|NCT01273181|174584|P3|COMPLETED|Phase 2, Dose 1||1
75187|NCT01273181|174585|P2|COMPLETED|Phase 2, Dose 1||0
75188|NCT01273181|174586|P1|COMPLETED|Phase 2, Dose 1||0
75189|NCT01273181|174583|P4|STARTED|Phase 2, Dose 1||0
75190|NCT01273181|174584|P3|STARTED|Phase 2, Dose 1||2
75191|NCT01273181|174585|P2|STARTED|Phase 2, Dose 1||0
75192|NCT01273181|174586|P1|STARTED|Phase 2, Dose 1||0
75193|NCT01273181|174583|P4|NOT COMPLETED|Phase I, Dose 2||0
75194|NCT01273181|174584|P3|NOT COMPLETED|Phase I, Dose 2||0
75195|NCT01273181|174585|P2|NOT COMPLETED|Phase I, Dose 2||1
75196|NCT01273181|174586|P1|NOT COMPLETED|Phase I, Dose 2||0
75197|NCT01273181|174583|P4|COMPLETED|Phase I, Dose 2||0
75198|NCT01273181|174584|P3|COMPLETED|Phase I, Dose 2||0
75199|NCT01273181|174585|P2|COMPLETED|Phase I, Dose 2||2
75200|NCT01273181|174586|P1|COMPLETED|Phase I, Dose 2||0
75201|NCT01273181|174583|P4|STARTED|Phase I, Dose 2||0
75202|NCT01273181|174584|P3|STARTED|Phase I, Dose 2||0
75203|NCT01273181|174585|P2|STARTED|Phase I, Dose 2||3
75204|NCT01273181|174586|P1|STARTED|Phase I, Dose 2||0
75205|NCT01273181|174583|P4|NOT COMPLETED|Phase I, Dose 1||0
75206|NCT01273181|174584|P3|NOT COMPLETED|Phase I, Dose 1||0
75207|NCT01273181|174585|P2|NOT COMPLETED|Phase I, Dose 1||0
75208|NCT01273181|174586|P1|NOT COMPLETED|Phase I, Dose 1||1
75209|NCT01273181|174583|P4|COMPLETED|Phase I, Dose 1||0
75210|NCT01273181|174584|P3|COMPLETED|Phase I, Dose 1||0
75211|NCT01273181|174585|P2|COMPLETED|Phase I, Dose 1||0
75212|NCT01273181|174586|P1|COMPLETED|Phase I, Dose 1||2
75213|NCT01273181|174583|P4|STARTED|Phase I, Dose 1||0
75214|NCT01273181|174584|P3|STARTED|Phase I, Dose 1||0
75215|NCT01273181|174585|P2|STARTED|Phase I, Dose 1||0
75216|NCT01273181|174586|P1|STARTED|Phase I, Dose 1||3
75217|NCT01273064|174605|P5|NOT COMPLETED|Overall Study||10
75218|NCT01273064|174606|P4|NOT COMPLETED|Overall Study||20
75219|NCT01273064|174607|P3|NOT COMPLETED|Overall Study||31
75220|NCT01273064|174608|P2|NOT COMPLETED|Overall Study||30
75221|NCT01273064|174609|P1|NOT COMPLETED|Overall Study||23
75222|NCT01273064|174605|P5|COMPLETED|Overall Study||0
75223|NCT01273064|174606|P4|COMPLETED|Overall Study||0
75224|NCT01273064|174607|P3|COMPLETED|Overall Study||0
75225|NCT01273064|174608|P2|COMPLETED|Overall Study||0
75226|NCT01273064|174609|P1|COMPLETED|Overall Study||0
75227|NCT01273064|174605|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
75228|NCT01273064|174606|P4|STARTED|Overall Study||20
75229|NCT01273064|174607|P3|STARTED|Overall Study||31
75230|NCT01273064|174608|P2|STARTED|Overall Study||30
75231|NCT01273064|174609|P1|STARTED|Overall Study||23
75232|NCT01273038|174628|P2|NOT COMPLETED|Second Intervention (14 Days)||2
75233|NCT01273038|174629|P1|NOT COMPLETED|Second Intervention (14 Days)||0
75234|NCT01273038|174628|P2|COMPLETED|Second Intervention (14 Days)||8
75235|NCT01273038|174629|P1|COMPLETED|Second Intervention (14 Days)||10
75236|NCT01273038|174628|P2|STARTED|Second Intervention (14 Days)||10
75237|NCT01273038|174629|P1|STARTED|Second Intervention (14 Days)||10
75238|NCT01273038|174628|P2|NOT COMPLETED|First Intervention (14 Days)||0
75239|NCT01273038|174629|P1|NOT COMPLETED|First Intervention (14 Days)||0
75240|NCT01273038|174628|P2|COMPLETED|First Intervention (14 Days)||10
75241|NCT01273038|174629|P1|COMPLETED|First Intervention (14 Days)||10
75242|NCT01273038|174628|P2|STARTED|First Intervention (14 Days)||10
75243|NCT01273038|174629|P1|STARTED|First Intervention (14 Days)||10
75244|NCT01272947|174637|P2|NOT COMPLETED|Overall Study||2
75245|NCT01272947|174638|P1|NOT COMPLETED|Overall Study||2
75246|NCT01272947|174637|P2|COMPLETED|Overall Study||98
75247|NCT01272947|174638|P1|COMPLETED|Overall Study||102
75248|NCT01272947|174637|P2|STARTED|Overall Study||100
75249|NCT01272947|174638|P1|STARTED|Overall Study||104
75250|NCT01272934|174648|P2|NOT COMPLETED|Overall Study||2
75251|NCT01272934|174649|P1|NOT COMPLETED|Overall Study||0
75252|NCT01272934|174648|P2|COMPLETED|Overall Study||101
75253|NCT01272934|174649|P1|COMPLETED|Overall Study||102
75254|NCT01272934|174648|P2|STARTED|Overall Study||103
75255|NCT01272934|174649|P1|STARTED|Overall Study||102
75256|NCT01272921|174659|P2|NOT COMPLETED|Overall Study||1
75257|NCT01272921|174660|P1|NOT COMPLETED|Overall Study||2
75258|NCT01272921|174659|P2|COMPLETED|Overall Study||70
75259|NCT01272921|174660|P1|COMPLETED|Overall Study||69
75260|NCT01272921|174659|P2|STARTED|Overall Study||71
75261|NCT01272921|174660|P1|STARTED|Overall Study||71
75262|NCT01272908|174668|P1|NOT COMPLETED|Re-Treatment Period||6
75263|NCT01272908|174668|P1|COMPLETED|Re-Treatment Period||71
75264|NCT01272908|174668|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
75265|NCT01272908|174668|P1|NOT COMPLETED|Initial Treatment Period||8
75266|NCT01272908|174668|P1|COMPLETED|Initial Treatment Period||112
75267|NCT01272908|174668|P1|STARTED|Initial Treatment Period||120
75268|NCT01272882|174702|P1|NOT COMPLETED|Overall Study||0
75269|NCT01272882|174702|P1|COMPLETED|Overall Study||13
75270|NCT01272882|174702|P1|STARTED|Overall Study||13
75271|NCT01272869|174708|P2|NOT COMPLETED|Period 2 (14 Days)||0
75272|NCT01272869|174709|P1|NOT COMPLETED|Period 2 (14 Days)||1
75273|NCT01272869|174708|P2|COMPLETED|Period 2 (14 Days)||10
75274|NCT01272869|174709|P1|COMPLETED|Period 2 (14 Days)||9
75275|NCT01272869|174708|P2|STARTED|Period 2 (14 Days)||10
75276|NCT01272869|174709|P1|STARTED|Period 2 (14 Days)||10
75277|NCT01272869|174708|P2|NOT COMPLETED|Period 1 (14 Days)||0
75278|NCT01272869|174709|P1|NOT COMPLETED|Period 1 (14 Days)||0
75279|NCT01272869|174708|P2|COMPLETED|Period 1 (14 Days)||10
75280|NCT01272869|174709|P1|COMPLETED|Period 1 (14 Days)||10
75281|NCT01272869|174708|P2|STARTED|Period 1 (14 Days)||10
75282|NCT01272869|174709|P1|STARTED|Period 1 (14 Days)||10
75283|NCT01272804|174721|P6|NOT COMPLETED|Overall Study||1
75284|NCT01272804|174722|P5|NOT COMPLETED|Overall Study||2
75285|NCT01272804|174723|P4|NOT COMPLETED|Overall Study||0
75286|NCT01272804|174724|P3|NOT COMPLETED|Overall Study||0
75287|NCT01272804|174725|P2|NOT COMPLETED|Overall Study||0
75288|NCT01272804|174726|P1|NOT COMPLETED|Overall Study||1
75289|NCT01272804|174721|P6|COMPLETED|Overall Study||15
75290|NCT01272804|174722|P5|COMPLETED|Overall Study||7
75291|NCT01272804|174723|P4|COMPLETED|Overall Study||9
75292|NCT01272804|174724|P3|COMPLETED|Overall Study||9
75293|NCT01272804|174725|P2|COMPLETED|Overall Study||9
75294|NCT01272804|174726|P1|COMPLETED|Overall Study||8
75295|NCT01272804|174721|P6|STARTED|Overall Study||16
75296|NCT01272804|174722|P5|STARTED|Overall Study||9
75297|NCT01272804|174723|P4|STARTED|Overall Study||9
75298|NCT01272804|174724|P3|STARTED|Overall Study||9
75299|NCT01272804|174725|P2|STARTED|Overall Study||9
75300|NCT01272804|174726|P1|STARTED|Overall Study||9
75301|NCT01272661|174884|P3|NOT COMPLETED|Overall Study||72
75302|NCT01272661|174885|P2|NOT COMPLETED|Overall Study||209
75303|NCT01272661|174886|P1|NOT COMPLETED|Overall Study||126
75304|NCT01272661|174884|P3|COMPLETED|Overall Study||314
75305|NCT01272661|174885|P2|COMPLETED|Overall Study||288
75306|NCT01272661|174886|P1|COMPLETED|Overall Study||287
75307|NCT01272661|174884|P3|STARTED|Overall Study||386
75308|NCT01272661|174885|P2|STARTED|Overall Study||497
75309|NCT01272661|174886|P1|STARTED|Overall Study||413
75310|NCT01272635|174911|P4|NOT COMPLETED|Overall Study||23
75311|NCT01272635|174912|P3|NOT COMPLETED|Overall Study||31
75312|NCT01272635|174913|P2|NOT COMPLETED|Overall Study||20
75313|NCT01272635|174914|P1|NOT COMPLETED|Overall Study||31
75314|NCT01272635|174911|P4|COMPLETED|Overall Study||129
75315|NCT01272635|174912|P3|COMPLETED|Overall Study||117
75316|NCT01272635|174913|P2|COMPLETED|Overall Study||134
75317|NCT01272635|174914|P1|COMPLETED|Overall Study||122
75318|NCT01272635|174911|P4|STARTED|Overall Study||152
75319|NCT01272635|174912|P3|STARTED|Overall Study||148
75320|NCT01272635|174913|P2|STARTED|Overall Study||154
75321|NCT01272635|174914|P1|STARTED|Overall Study||153
75322|NCT01272583|174932|P2|NOT COMPLETED|Overall Study||0
75323|NCT01272583|174933|P1|NOT COMPLETED|Overall Study||0
75324|NCT01272583|174932|P2|COMPLETED|Overall Study||8
75325|NCT01272583|174933|P1|COMPLETED|Overall Study||8
75326|NCT01272583|174932|P2|STARTED|Overall Study||8
75327|NCT01272583|174933|P1|STARTED|Overall Study||8
75328|NCT01272284|174962|P1|NOT COMPLETED|12-month Follow-up Visit||4
75329|NCT01272284|174962|P1|COMPLETED|12-month Follow-up Visit||105
75330|NCT01272284|174962|P1|STARTED|12-month Follow-up Visit||109
75331|NCT01272284|174962|P1|NOT COMPLETED|6-month Follow-up Visit||3
75332|NCT01272284|174962|P1|COMPLETED|6-month Follow-up Visit||109
75333|NCT01272284|174962|P1|STARTED|6-month Follow-up Visit||112
75334|NCT01272284|174962|P1|NOT COMPLETED|3-month Follow-up Visit||1
75335|NCT01272284|174962|P1|COMPLETED|3-month Follow-up Visit||112
75336|NCT01272284|174962|P1|STARTED|3-month Follow-up Visit||113
75337|NCT01272232|174979|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
75338|NCT01272232|174980|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
75339|NCT01272232|174981|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
75340|NCT01272232|174979|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
75341|NCT01272232|174980|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
75342|NCT01272232|174981|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
75343|NCT01272232|174979|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
75344|NCT01272232|174980|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
75345|NCT01272232|174981|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
75346|NCT01272232|174979|P3|NOT COMPLETED|Weeks 0-56||72
75347|NCT01272232|174980|P2|NOT COMPLETED|Weeks 0-56||47
75348|NCT01272232|174981|P1|NOT COMPLETED|Weeks 0-56||99
75349|NCT01272232|174979|P3|COMPLETED|Weeks 0-56||140
75350|NCT01272232|174980|P2|COMPLETED|Weeks 0-56||164
75351|NCT01272232|174981|P1|COMPLETED|Weeks 0-56||324
75352|NCT01272232|174979|P3|Exposed|Weeks 0-56||212
75353|NCT01272232|174980|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
75354|NCT01272232|174981|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
75355|NCT01272232|174979|P3|STARTED|Weeks 0-56||212
75356|NCT01272232|174980|P2|STARTED|Weeks 0-56||211
75357|NCT01272232|174981|P1|STARTED|Weeks 0-56||423
75358|NCT01272219|175026|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
75359|NCT01272219|175027|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
75360|NCT01272219|175028|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
75361|NCT01272219|175029|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
75362|NCT01272219|175030|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
75363|NCT01272219|175031|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
75364|NCT01272219|175026|P6|COMPLETED|Main + Extension Period: Week 0-172||327
75365|NCT01272219|175027|P5|COMPLETED|Main + Extension Period: Week 0-172||783
75366|NCT01272219|175028|P4|COMPLETED|Main + Extension Period: Week 0-172||0
75367|NCT01272219|175029|P3|COMPLETED|Main + Extension Period: Week 0-172||0
75368|NCT01272219|175030|P2|COMPLETED|Main + Extension Period: Week 0-172||0
75369|NCT01272219|175031|P1|COMPLETED|Main + Extension Period: Week 0-172||0
75370|NCT01272219|175026|P6|Exposed|Main + Extension Period: Week 0-172||747
75371|NCT01272219|175027|P5|Exposed|Main + Extension Period: Week 0-172||1501
75372|NCT01272219|175028|P4|Exposed|Main + Extension Period: Week 0-172||0
75373|NCT01272219|175029|P3|Exposed|Main + Extension Period: Week 0-172||0
75374|NCT01272219|175030|P2|Exposed|Main + Extension Period: Week 0-172||0
75375|NCT01272219|175031|P1|Exposed|Main + Extension Period: Week 0-172||0
75376|NCT01272219|175026|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
75377|NCT01272219|175027|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
75378|NCT01272219|175028|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
75379|NCT01272219|175029|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
75380|NCT01272219|175030|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
75381|NCT01272219|175031|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
75382|NCT01272219|175026|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75383|NCT01272219|175027|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75384|NCT01272219|175028|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
75385|NCT01272219|175029|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
75386|NCT01272219|175030|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
75387|NCT01272219|175031|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75388|NCT01272219|175026|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75389|NCT01272219|175027|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75390|NCT01272219|175028|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
75391|NCT01272219|175029|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
75392|NCT01272219|175030|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
75393|NCT01272219|175031|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
75394|NCT01272219|175026|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
75395|NCT01272219|175027|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
75396|NCT01272219|175028|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
75397|NCT01272219|175029|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
75398|NCT01272219|175030|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
75399|NCT01272219|175031|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
75400|NCT01272219|175026|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
75401|NCT01272219|175027|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
75402|NCT01272219|175028|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
75403|NCT01272219|175029|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
75404|NCT01272219|175030|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
75405|NCT01272219|175031|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
75406|NCT01272219|175026|P6|COMPLETED|Main Period: Week 0 to Week 56||505
75407|NCT01272219|175027|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
75408|NCT01272219|175028|P4|COMPLETED|Main Period: Week 0 to Week 56||296
75409|NCT01272219|175029|P3|COMPLETED|Main Period: Week 0 to Week 56||0
75410|NCT01272219|175030|P2|COMPLETED|Main Period: Week 0 to Week 56||0
75411|NCT01272219|175031|P1|COMPLETED|Main Period: Week 0 to Week 56||679
75412|NCT01272219|175026|P6|Exposed|Main Period: Week 0 to Week 56||755
75413|NCT01272219|175027|P5|Exposed|Main Period: Week 0 to Week 56||1524
75414|NCT01272219|175028|P4|Exposed|Main Period: Week 0 to Week 56||487
75415|NCT01272219|175029|P3|Exposed|Main Period: Week 0 to Week 56||0
75416|NCT01272219|175030|P2|Exposed|Main Period: Week 0 to Week 56||0
75417|NCT01272219|175031|P1|Exposed|Main Period: Week 0 to Week 56||957
75418|NCT01272219|175026|P6|STARTED|Main Period: Week 0 to Week 56||757
75419|NCT01272219|175027|P5|STARTED|Main Period: Week 0 to Week 56||1528
75420|NCT01272219|175028|P4|STARTED|Main Period: Week 0 to Week 56||487
75421|NCT01272219|175029|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
75422|NCT01272219|175030|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
75423|NCT01272219|175031|P1|STARTED|Main Period: Week 0 to Week 56||959
75424|NCT01272193|175065|P2|NOT COMPLETED|Overall Study||12
75425|NCT01272193|175066|P1|NOT COMPLETED|Overall Study||10
75426|NCT01272193|175065|P2|COMPLETED|Overall Study||137
75427|NCT01272193|175066|P1|COMPLETED|Overall Study||137
75428|NCT01272193|175065|P2|STARTED|Overall Study||149
75429|NCT01272193|175066|P1|STARTED|Overall Study||147
75430|NCT01272180|175086|P4|NOT COMPLETED|Overall Study||14
75431|NCT01272180|175087|P3|NOT COMPLETED|Overall Study||13
75432|NCT01272180|175088|P2|NOT COMPLETED|Overall Study||21
75433|NCT01272180|175089|P1|NOT COMPLETED|Overall Study||17
75434|NCT01272180|175086|P4|COMPLETED|Overall Study||107
75435|NCT01272180|175087|P3|COMPLETED|Overall Study||109
75436|NCT01272180|175088|P2|COMPLETED|Overall Study||100
75437|NCT01272180|175089|P1|COMPLETED|Overall Study||103
75438|NCT01272180|175086|P4|STARTED|Overall Study||121
75439|NCT01272180|175087|P3|STARTED|Overall Study||122
75440|NCT01272180|175088|P2|STARTED|Overall Study||121
75441|NCT01272180|175089|P1|STARTED|Overall Study||120
75442|NCT01272141|175126|P1|NOT COMPLETED|Overall Study||0
75443|NCT01272141|175126|P1|COMPLETED|Overall Study||5
75444|NCT01272141|175126|P1|STARTED|Overall Study||5
75445|NCT01272076|175131|P1|NOT COMPLETED|Overall Study||0
75446|NCT01272076|175131|P1|COMPLETED|Overall Study||52
75447|NCT01272076|175131|P1|STARTED|Overall Study||52
75448|NCT01272011|175138|P3|NOT COMPLETED|Overall Study||0
75449|NCT01272011|175139|P2|NOT COMPLETED|Overall Study||2
75450|NCT01272011|175140|P1|NOT COMPLETED|Overall Study||0
75451|NCT01272011|175138|P3|COMPLETED|Overall Study||3
75452|NCT01272011|175139|P2|COMPLETED|Overall Study||8
75453|NCT01272011|175140|P1|COMPLETED|Overall Study||3
75454|NCT01272011|175138|P3|STARTED|Overall Study||3
75455|NCT01272011|175139|P2|STARTED|Overall Study||10
75456|NCT01272011|175140|P1|STARTED|Overall Study||3
75457|NCT01271946|175153|P2|NOT COMPLETED|Overall Study||0
75458|NCT01271946|175154|P1|NOT COMPLETED|Overall Study||0
75459|NCT01271946|175153|P2|COMPLETED|Overall Study||5
75460|NCT01271946|175154|P1|COMPLETED|Overall Study||346
75461|NCT01271946|175153|P2|STARTED|Overall Study||5
75462|NCT01271946|175154|P1|STARTED|Overall Study||346
75463|NCT01271907|175179|P3|NOT COMPLETED|Overall Study||0
75464|NCT01271907|175180|P2|NOT COMPLETED|Overall Study||0
75465|NCT01271907|175181|P1|NOT COMPLETED|Overall Study||0
75466|NCT01271907|175179|P3|COMPLETED|Overall Study||0
75467|NCT01271907|175180|P2|COMPLETED|Overall Study||0
75468|NCT01271907|175181|P1|COMPLETED|Overall Study||3
75469|NCT01271907|175179|P3|STARTED|Overall Study||0
75470|NCT01271907|175180|P2|STARTED|Overall Study||0
75471|NCT01271907|175181|P1|STARTED|Overall Study||3
75472|NCT01271803|175204|P12|NOT COMPLETED|Stage 2||39
75473|NCT01271803|175205|P11|NOT COMPLETED|Stage 2||27
75474|NCT01271803|175206|P10|NOT COMPLETED|Stage 2||0
75475|NCT01271803|175207|P9|NOT COMPLETED|Stage 2||0
75476|NCT01271803|175208|P8|NOT COMPLETED|Stage 2||0
75477|NCT01271803|175209|P7|NOT COMPLETED|Stage 2||0
75478|NCT01271803|175210|P6|NOT COMPLETED|Stage 2||0
75479|NCT01271803|175211|P5|NOT COMPLETED|Stage 2||0
75480|NCT01271803|175212|P4|NOT COMPLETED|Stage 2||0
75481|NCT01271803|175213|P3|NOT COMPLETED|Stage 2||0
75482|NCT01271803|175214|P2|NOT COMPLETED|Stage 2||0
75483|NCT01271803|175215|P1|NOT COMPLETED|Stage 2||0
75484|NCT01271803|175204|P12|COMPLETED|Stage 2||0
75485|NCT01271803|175205|P11|COMPLETED|Stage 2||0
75486|NCT01271803|175206|P10|COMPLETED|Stage 2||0
75487|NCT01271803|175207|P9|COMPLETED|Stage 2||0
75488|NCT01271803|175208|P8|COMPLETED|Stage 2||0
75489|NCT01271803|175209|P7|COMPLETED|Stage 2||0
75490|NCT01271803|175210|P6|COMPLETED|Stage 2||0
75491|NCT01271803|175211|P5|COMPLETED|Stage 2||0
75492|NCT01271803|175212|P4|COMPLETED|Stage 2||0
75493|NCT01271803|175213|P3|COMPLETED|Stage 2||0
75494|NCT01271803|175214|P2|COMPLETED|Stage 2||0
75495|NCT01271803|175215|P1|COMPLETED|Stage 2||0
75496|NCT01271803|175204|P12|STARTED|Stage 2||39
75497|NCT01271803|175205|P11|STARTED|Stage 2||27
75498|NCT01271803|175206|P10|STARTED|Stage 2||0
75499|NCT01271803|175207|P9|STARTED|Stage 2||0
75500|NCT01271803|175208|P8|STARTED|Stage 2||0
75501|NCT01271803|175209|P7|STARTED|Stage 2||0
75502|NCT01271803|175210|P6|STARTED|Stage 2||0
75503|NCT01271803|175211|P5|STARTED|Stage 2||0
75504|NCT01271803|175212|P4|STARTED|Stage 2||0
75505|NCT01271803|175213|P3|STARTED|Stage 2||0
75506|NCT01271803|175214|P2|STARTED|Stage 2||0
75507|NCT01271803|175215|P1|STARTED|Stage 2||0
75508|NCT01271803|175204|P12|NOT COMPLETED|Stage 1||0
75509|NCT01271803|175205|P11|NOT COMPLETED|Stage 1||0
75510|NCT01271803|175206|P10|NOT COMPLETED|Stage 1||2
75511|NCT01271803|175207|P9|NOT COMPLETED|Stage 1||5
75512|NCT01271803|175208|P8|NOT COMPLETED|Stage 1||3
75513|NCT01271803|175209|P7|NOT COMPLETED|Stage 1||4
75514|NCT01271803|175210|P6|NOT COMPLETED|Stage 1||4
75515|NCT01271803|175211|P5|NOT COMPLETED|Stage 1||4
75516|NCT01271803|175212|P4|NOT COMPLETED|Stage 1||3
75517|NCT01271803|175213|P3|NOT COMPLETED|Stage 1||27
75518|NCT01271803|175214|P2|NOT COMPLETED|Stage 1||8
75519|NCT01271803|175215|P1|NOT COMPLETED|Stage 1||5
75520|NCT01271803|175204|P12|COMPLETED|Stage 1||0
75521|NCT01271803|175205|P11|COMPLETED|Stage 1||0
75522|NCT01271803|175206|P10|COMPLETED|Stage 1||0
75523|NCT01271803|175207|P9|COMPLETED|Stage 1||0
75524|NCT01271803|175208|P8|COMPLETED|Stage 1||0
75525|NCT01271803|175209|P7|COMPLETED|Stage 1||0
75526|NCT01271803|175210|P6|COMPLETED|Stage 1||0
75527|NCT01271803|175211|P5|COMPLETED|Stage 1||0
75528|NCT01271803|175212|P4|COMPLETED|Stage 1||0
75529|NCT01271803|175213|P3|COMPLETED|Stage 1||0
75530|NCT01271803|175214|P2|COMPLETED|Stage 1||0
75531|NCT01271803|175215|P1|COMPLETED|Stage 1||0
75532|NCT01271803|175204|P12|STARTED|Stage 1||0
75533|NCT01271803|175205|P11|STARTED|Stage 1||0
75534|NCT01271803|175206|P10|STARTED|Stage 1||2
75535|NCT01271803|175207|P9|STARTED|Stage 1||5
75536|NCT01271803|175208|P8|STARTED|Stage 1||3
75537|NCT01271803|175209|P7|STARTED|Stage 1||4
75538|NCT01271803|175210|P6|STARTED|Stage 1||4
75539|NCT01271803|175211|P5|STARTED|Stage 1||4
75540|NCT01271803|175212|P4|STARTED|Stage 1||3
75541|NCT01271803|175213|P3|STARTED|Stage 1||27
75542|NCT01271803|175214|P2|STARTED|Stage 1||8
75543|NCT01271803|175215|P1|STARTED|Stage 1||5
75544|NCT01271712|175388|P2|NOT COMPLETED|Survival Follow-up||4
75545|NCT01271712|175389|P1|NOT COMPLETED|Survival Follow-up||27
75546|NCT01271712|175388|P2|COMPLETED|Survival Follow-up||0
75547|NCT01271712|175389|P1|COMPLETED|Survival Follow-up||0
75548|NCT01271712|175388|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|4
75549|NCT01271712|175389|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|27
75550|NCT01271712|175388|P2|NOT COMPLETED|Safety Follow-up||3
75551|NCT01271712|175389|P1|NOT COMPLETED|Safety Follow-up||9
75552|NCT01271712|175388|P2|COMPLETED|Safety Follow-up||4
75553|NCT01271712|175389|P1|COMPLETED|Safety Follow-up||27
75554|NCT01271712|175388|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|7
75555|NCT01271712|175389|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|36
75556|NCT01271712|175388|P2|NOT COMPLETED|Open Label Treatment||56
75557|NCT01271712|175389|P1|NOT COMPLETED|Open Label Treatment||41
75558|NCT01271712|175388|P2|COMPLETED|Open Label Treatment||0
75559|NCT01271712|175389|P1|COMPLETED|Open Label Treatment||0
75560|NCT01271712|175388|P2|Participants Received Treatment|Open Label Treatment||56
75561|NCT01271712|175389|P1|Participants Received Treatment|Open Label Treatment||41
75562|NCT01271712|175388|P2|STARTED|Open Label Treatment||56
75563|NCT01271712|175389|P1|STARTED|Open Label Treatment||41
75564|NCT01271712|175388|P2|NOT COMPLETED|Double Blind Treatment||10
75565|NCT01271712|175389|P1|NOT COMPLETED|Double Blind Treatment||92
75566|NCT01271712|175388|P2|COMPLETED|Double Blind Treatment|56 participants started open-label treatment with regorafenib|56
75567|NCT01271712|175389|P1|COMPLETED|Double Blind Treatment|41 participants started open-label treatment with regorafenib|41
75568|NCT01271712|175388|P2|Participants Received Treatment|Double Blind Treatment||66
75569|NCT01271712|175389|P1|Participants Received Treatment|Double Blind Treatment||132
75570|NCT01271712|175388|P2|STARTED|Double Blind Treatment||66
75571|NCT01271712|175389|P1|STARTED|Double Blind Treatment||133
75572|NCT01271686|175409|P1|NOT COMPLETED|Overall Study||0
75573|NCT01271686|175409|P1|COMPLETED|Overall Study||16
75574|NCT01271686|175409|P1|STARTED|Overall Study||16
75575|NCT01271543|175415|P2|NOT COMPLETED|Overall Study||1
75576|NCT01271543|175416|P1|NOT COMPLETED|Overall Study||1
75577|NCT01271543|175415|P2|COMPLETED|Overall Study||29
75578|NCT01271543|175416|P1|COMPLETED|Overall Study||29
75579|NCT01271543|175415|P2|STARTED|Overall Study||30
75580|NCT01271543|175416|P1|STARTED|Overall Study||30
75581|NCT01271452|175426|P2|NOT COMPLETED|Overall Study||8
75582|NCT01271452|175427|P1|NOT COMPLETED|Overall Study||7
75583|NCT01271452|175426|P2|COMPLETED|Overall Study||104
75584|NCT01271452|175427|P1|COMPLETED|Overall Study||105
75585|NCT01271452|175426|P2|STARTED|Overall Study||112
75586|NCT01271452|175427|P1|STARTED|Overall Study||112
75587|NCT01271413|175449|P2|NOT COMPLETED|Overall Study||8
75588|NCT01271413|175450|P1|NOT COMPLETED|Overall Study||9
75589|NCT01271413|175449|P2|COMPLETED|Overall Study||28
75590|NCT01271413|175450|P1|COMPLETED|Overall Study||28
75591|NCT01271413|175449|P2|STARTED|Overall Study||36
75592|NCT01271413|175450|P1|STARTED|Overall Study||37
75593|NCT01271244|175458|P2|NOT COMPLETED|Overall Study||3
75594|NCT01271244|175459|P1|NOT COMPLETED|Overall Study||7
75595|NCT01271244|175458|P2|COMPLETED|Overall Study||5
75596|NCT01271244|175459|P1|COMPLETED|Overall Study||11
75597|NCT01271244|175458|P2|STARTED|Overall Study||8
75598|NCT01271244|175459|P1|STARTED|Overall Study||18
75599|NCT01271036|175467|P2|NOT COMPLETED|Overall Study||0
75600|NCT01271036|175468|P1|NOT COMPLETED|Overall Study||0
75601|NCT01271036|175467|P2|COMPLETED|Overall Study||62
75602|NCT01271036|175468|P1|COMPLETED|Overall Study||62
75603|NCT01271036|175467|P2|STARTED|Overall Study||62
75604|NCT01271036|175468|P1|STARTED|Overall Study||62
75605|NCT01270971|175484|P2|NOT COMPLETED|Overall Study||23
75606|NCT01270971|175485|P1|NOT COMPLETED|Overall Study||52
75607|NCT01270971|175484|P2|COMPLETED|Overall Study||171
75608|NCT01270971|175485|P1|COMPLETED|Overall Study||348
75609|NCT01270971|175484|P2|STARTED|Overall Study||194
75610|NCT01270971|175485|P1|STARTED|Overall Study||400
75611|NCT01270958|175497|P1|NOT COMPLETED|Overall Study||4
75612|NCT01270958|175497|P1|COMPLETED|Overall Study||56
75613|NCT01270958|175497|P1|STARTED|Overall Study||60
75614|NCT01270919|175521|P1|NOT COMPLETED|Overall Study||0
75615|NCT01270919|175521|P1|COMPLETED|Overall Study||0
75616|NCT01270919|175521|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
75617|NCT01270880|175526|P1|NOT COMPLETED|Overall Study||1
75618|NCT01270880|175526|P1|COMPLETED|Overall Study||17
75619|NCT01270880|175526|P1|STARTED|Overall Study||18
75620|NCT01270867|175532|P2|NOT COMPLETED|Overall Study||0
75621|NCT01270867|175533|P1|NOT COMPLETED|Overall Study||1
75622|NCT01270867|175532|P2|COMPLETED|Overall Study||88
75623|NCT01270867|175533|P1|COMPLETED|Overall Study||89
75624|NCT01270867|175532|P2|STARTED|Overall Study||88
75625|NCT01270867|175533|P1|STARTED|Overall Study||90
75626|NCT01270841|175551|P4|NOT COMPLETED|Overall Study||13
75627|NCT01270841|175552|P3|NOT COMPLETED|Overall Study||11
75628|NCT01270841|175553|P2|NOT COMPLETED|Overall Study||14
75629|NCT01270841|175554|P1|NOT COMPLETED|Overall Study||13
75630|NCT01270841|175551|P4|COMPLETED|Overall Study||20
75631|NCT01270841|175552|P3|COMPLETED|Overall Study||18
75632|NCT01270841|175553|P2|COMPLETED|Overall Study||19
75633|NCT01270841|175554|P1|COMPLETED|Overall Study||16
75634|NCT01270841|175551|P4|STARTED|Overall Study||33
75635|NCT01270841|175552|P3|STARTED|Overall Study||29
75636|NCT01270841|175553|P2|STARTED|Overall Study||33
75637|NCT01270841|175554|P1|STARTED|Overall Study||29
75638|NCT01270828|175578|P3|NOT COMPLETED|Double Blind Phase||0
75639|NCT01270828|175579|P2|NOT COMPLETED|Double Blind Phase||45
75640|NCT01270828|175580|P1|NOT COMPLETED|Double Blind Phase||26
75641|NCT01270828|175578|P3|COMPLETED|Double Blind Phase||0
75642|NCT01270828|175579|P2|COMPLETED|Double Blind Phase||160
75643|NCT01270828|175580|P1|COMPLETED|Double Blind Phase||182
75644|NCT01270828|175578|P3|STARTED|Double Blind Phase||0
75645|NCT01270828|175579|P2|STARTED|Double Blind Phase||205
75646|NCT01270828|175580|P1|STARTED|Double Blind Phase||208
75647|NCT01270828|175578|P3|NOT COMPLETED|Pregabalin CR SB||146
75648|NCT01270828|175579|P2|NOT COMPLETED|Pregabalin CR SB||0
75649|NCT01270828|175580|P1|NOT COMPLETED|Pregabalin CR SB||0
75650|NCT01270828|175578|P3|COMPLETED|Pregabalin CR SB||660
75651|NCT01270828|175579|P2|COMPLETED|Pregabalin CR SB||0
75652|NCT01270828|175580|P1|COMPLETED|Pregabalin CR SB||0
75653|NCT01270828|175578|P3|STARTED|Pregabalin CR SB||806
75654|NCT01270828|175579|P2|STARTED|Pregabalin CR SB||0
75655|NCT01270828|175580|P1|STARTED|Pregabalin CR SB||0
75656|NCT01270802|175622|P2|NOT COMPLETED|Overall Study||1
75657|NCT01270802|175623|P1|NOT COMPLETED|Overall Study||2
75658|NCT01270802|175622|P2|COMPLETED|Overall Study||14
75659|NCT01270802|175623|P1|COMPLETED|Overall Study||13
75660|NCT01270802|175622|P2|STARTED|Overall Study||15
75661|NCT01270802|175623|P1|STARTED|Overall Study||15
75662|NCT01270711|175639|P8|NOT COMPLETED|Part 2: Effectiveness||0
75663|NCT01270711|175640|P7|NOT COMPLETED|Part 2: Effectiveness||0
75664|NCT01270711|175641|P6|NOT COMPLETED|Part 2: Effectiveness||0
75665|NCT01270711|175642|P5|NOT COMPLETED|Part 2: Effectiveness||0
75666|NCT01270711|175643|P4|NOT COMPLETED|Part 2: Effectiveness||0
75667|NCT01270711|175644|P3|NOT COMPLETED|Part 2: Effectiveness||0
75668|NCT01270711|175645|P2|NOT COMPLETED|Part 2: Effectiveness||0
75669|NCT01270711|175646|P1|NOT COMPLETED|Part 2: Effectiveness||0
75670|NCT01270711|175639|P8|COMPLETED|Part 2: Effectiveness||48
75671|NCT01270711|175640|P7|COMPLETED|Part 2: Effectiveness||2
75672|NCT01270711|175641|P6|COMPLETED|Part 2: Effectiveness||11
75673|NCT01270711|175642|P5|COMPLETED|Part 2: Effectiveness||0
75674|NCT01270711|175643|P4|COMPLETED|Part 2: Effectiveness||0
75675|NCT01270711|175644|P3|COMPLETED|Part 2: Effectiveness||0
75676|NCT01270711|175645|P2|COMPLETED|Part 2: Effectiveness||0
75677|NCT01270711|175646|P1|COMPLETED|Part 2: Effectiveness||0
75678|NCT01270711|175639|P8|STARTED|Part 2: Effectiveness||48
75679|NCT01270711|175640|P7|STARTED|Part 2: Effectiveness||2
75680|NCT01270711|175641|P6|STARTED|Part 2: Effectiveness||11
75681|NCT01270711|175642|P5|STARTED|Part 2: Effectiveness||0
75682|NCT01270711|175643|P4|STARTED|Part 2: Effectiveness||0
75683|NCT01270711|175644|P3|STARTED|Part 2: Effectiveness||0
75684|NCT01270711|175645|P2|STARTED|Part 2: Effectiveness||0
75685|NCT01270711|175646|P1|STARTED|Part 2: Effectiveness||0
75686|NCT01270711|175639|P8|NOT COMPLETED|Part 1: Compliance||0
75687|NCT01270711|175640|P7|NOT COMPLETED|Part 1: Compliance||0
75688|NCT01270711|175641|P6|NOT COMPLETED|Part 1: Compliance||0
75689|NCT01270711|175642|P5|NOT COMPLETED|Part 1: Compliance||0
75690|NCT01270711|175643|P4|NOT COMPLETED|Part 1: Compliance||0
75691|NCT01270711|175644|P3|NOT COMPLETED|Part 1: Compliance||0
75692|NCT01270711|175645|P2|NOT COMPLETED|Part 1: Compliance||0
75693|NCT01270711|175646|P1|NOT COMPLETED|Part 1: Compliance||0
75694|NCT01270711|175639|P8|COMPLETED|Part 1: Compliance||0
75695|NCT01270711|175640|P7|COMPLETED|Part 1: Compliance||0
75696|NCT01270711|175641|P6|COMPLETED|Part 1: Compliance||0
75697|NCT01270711|175642|P5|COMPLETED|Part 1: Compliance||2024
75698|NCT01270711|175643|P4|COMPLETED|Part 1: Compliance||5486
75699|NCT01270711|175644|P3|COMPLETED|Part 1: Compliance||326
75700|NCT01270711|175645|P2|COMPLETED|Part 1: Compliance||6580
75701|NCT01270711|175646|P1|COMPLETED|Part 1: Compliance||7537
75702|NCT01270711|175639|P8|STARTED|Part 1: Compliance||0
75703|NCT01270711|175640|P7|STARTED|Part 1: Compliance||0
75704|NCT01270711|175641|P6|STARTED|Part 1: Compliance||0
75705|NCT01270711|175642|P5|STARTED|Part 1: Compliance||2024
75706|NCT01270711|175643|P4|STARTED|Part 1: Compliance||5486
75707|NCT01270711|175644|P3|STARTED|Part 1: Compliance||326
75708|NCT01270711|175645|P2|STARTED|Part 1: Compliance||6580
75709|NCT01270711|175646|P1|STARTED|Part 1: Compliance||7537
75710|NCT01270620|175745|P2|NOT COMPLETED|Overall Study||3
75711|NCT01270620|175746|P1|NOT COMPLETED|Overall Study||1
75712|NCT01270620|175745|P2|COMPLETED|Overall Study||47
75713|NCT01270620|175746|P1|COMPLETED|Overall Study||49
75714|NCT01270620|175745|P2|STARTED|Overall Study||50
75715|NCT01270620|175746|P1|STARTED|Overall Study||50
75716|NCT01270581|175798|P2|NOT COMPLETED|Overall Study||0
75717|NCT01270581|175799|P1|NOT COMPLETED|Overall Study||1
75718|NCT01270581|175798|P2|COMPLETED|Overall Study||3
75719|NCT01270581|175799|P1|COMPLETED|Overall Study||3
75720|NCT01270581|175798|P2|STARTED|Overall Study||3
75721|NCT01270581|175799|P1|STARTED|Overall Study||4
75722|NCT01270555|175805|P1|NOT COMPLETED|Overall Study||13
75723|NCT01270555|175805|P1|COMPLETED|Overall Study||19
75724|NCT01270555|175805|P1|STARTED|Overall Study||32
75725|NCT01270529|175818|P3|NOT COMPLETED|Overall Study||0
75726|NCT01270529|175819|P2|NOT COMPLETED|Overall Study||0
75727|NCT01270529|175820|P1|NOT COMPLETED|Overall Study||0
75728|NCT01270529|175818|P3|COMPLETED|Overall Study||25
75729|NCT01270529|175819|P2|COMPLETED|Overall Study||7
75730|NCT01270529|175820|P1|COMPLETED|Overall Study||12
75731|NCT01270529|175818|P3|STARTED|Overall Study||25
75732|NCT01270529|175819|P2|STARTED|Overall Study||7
75733|NCT01270529|175820|P1|STARTED|Overall Study||12
75734|NCT01270503|175828|P1|NOT COMPLETED|Overall Study||1
75735|NCT01270503|175828|P1|COMPLETED|Overall Study||537
75736|NCT01270503|175828|P1|STARTED|Overall Study||538
75737|NCT01270464|175836|P3|NOT COMPLETED|Overall Study||18
75738|NCT01270464|175837|P2|NOT COMPLETED|Overall Study||12
75739|NCT01270464|175838|P1|NOT COMPLETED|Overall Study||20
75740|NCT01270464|175836|P3|COMPLETED|Overall Study||88
75741|NCT01270464|175837|P2|COMPLETED|Overall Study||92
75742|NCT01270464|175838|P1|COMPLETED|Overall Study||85
75743|NCT01270464|175836|P3|Pharmacokinetic Analysis Set|Overall Study||103
75744|NCT01270464|175837|P2|Pharmacokinetic Analysis Set|Overall Study||103
75745|NCT01270464|175838|P1|Pharmacokinetic Analysis Set|Overall Study||105
75746|NCT01270464|175836|P3|Full Analysis Set|Overall Study||103
75747|NCT01270464|175837|P2|Full Analysis Set|Overall Study||103
75748|NCT01270464|175838|P1|Full Analysis Set|Overall Study||105
75749|NCT01270464|175836|P3|Safety Analysis Set|Overall Study||103
75750|NCT01270464|175837|P2|Safety Analysis Set|Overall Study||103
75751|NCT01270464|175838|P1|Safety Analysis Set|Overall Study||105
75752|NCT01270464|175836|P3|STARTED|Overall Study||106
75753|NCT01270464|175837|P2|STARTED|Overall Study||104
75754|NCT01270464|175838|P1|STARTED|Overall Study||105
75755|NCT01270256|175887|P2|NOT COMPLETED|Overall Study||0
75756|NCT01270256|175888|P1|NOT COMPLETED|Overall Study||1
75757|NCT01270256|175887|P2|COMPLETED|Overall Study||20
75758|NCT01270256|175888|P1|COMPLETED|Overall Study||20
75759|NCT01270256|175887|P2|STARTED|Overall Study||20
75760|NCT01270256|175888|P1|STARTED|Overall Study||21
75761|NCT01270139|175897|P3|NOT COMPLETED|Overall Study||20
75762|NCT01270139|175898|P2|NOT COMPLETED|Overall Study||26
75763|NCT01270139|175899|P1|NOT COMPLETED|Overall Study||18
75764|NCT01270139|175897|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
75765|NCT01270139|175898|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
75766|NCT01270139|175899|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
75767|NCT01270139|175897|P3|STARTED|Overall Study|Intention-to-treat population|60
75768|NCT01270139|175898|P2|STARTED|Overall Study|Intention-to-treat population|60
75769|NCT01270139|175899|P1|STARTED|Overall Study|Intention-to-treat population|60
75770|NCT01270126|175942|P2|NOT COMPLETED|Overall Study||0
75771|NCT01270126|175943|P1|NOT COMPLETED|Overall Study||0
75772|NCT01270126|175942|P2|COMPLETED|Overall Study||10
75773|NCT01270126|175943|P1|COMPLETED|Overall Study||12
75774|NCT01270126|175942|P2|STARTED|Overall Study||10
75775|NCT01270126|175943|P1|STARTED|Overall Study||12
75776|NCT01269918|175951|P2|NOT COMPLETED|Overall Study||3
75777|NCT01269918|175952|P1|NOT COMPLETED|Overall Study||0
75778|NCT01269918|175951|P2|COMPLETED|Overall Study||68
75779|NCT01269918|175952|P1|COMPLETED|Overall Study||71
75780|NCT01269918|175951|P2|STARTED|Overall Study||71
75781|NCT01269918|175952|P1|STARTED|Overall Study||71
75782|NCT01269801|175986|P2|NOT COMPLETED|Overall Study||3
75783|NCT01269801|175987|P1|NOT COMPLETED|Overall Study||0
75784|NCT01269801|175986|P2|COMPLETED|Overall Study||77
75785|NCT01269801|175987|P1|COMPLETED|Overall Study||74
75786|NCT01269801|175986|P2|STARTED|Overall Study||80
75787|NCT01269801|175987|P1|STARTED|Overall Study||74
75788|NCT01269710|175993|P1|NOT COMPLETED|Overall Study||3
75789|NCT01269710|175993|P1|COMPLETED|Overall Study|This refers to Week 52.|1
75790|NCT01269710|175993|P1|Week 36|Overall Study||2
75791|NCT01269710|175993|P1|Week 12|Overall Study||3
75792|NCT01269710|175993|P1|STARTED|Overall Study||4
75793|NCT01269125|176004|P3|NOT COMPLETED|Overall Study||0
75794|NCT01269125|176005|P2|NOT COMPLETED|Overall Study||5
75795|NCT01269125|176006|P1|NOT COMPLETED|Overall Study||7
75796|NCT01269125|176004|P3|COMPLETED|Overall Study||60
75797|NCT01269125|176005|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
75798|NCT01269125|176006|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
75799|NCT01269125|176004|P3|STARTED|Overall Study||60
75800|NCT01269125|176005|P2|STARTED|Overall Study||60
75801|NCT01269125|176006|P1|STARTED|Overall Study||60
75802|NCT01268943|176030|P4|NOT COMPLETED|Overall Study||0
75803|NCT01268943|176031|P3|NOT COMPLETED|Overall Study||0
75804|NCT01268943|176032|P2|NOT COMPLETED|Overall Study||0
75805|NCT01268943|176033|P1|NOT COMPLETED|Overall Study||0
75806|NCT01268943|176030|P4|COMPLETED|Overall Study||6
75807|NCT01268943|176031|P3|COMPLETED|Overall Study||3
75808|NCT01268943|176032|P2|COMPLETED|Overall Study||3
75809|NCT01268943|176033|P1|COMPLETED|Overall Study||6
75810|NCT01268943|176030|P4|STARTED|Overall Study||6
75811|NCT01268943|176031|P3|STARTED|Overall Study||3
75812|NCT01268943|176032|P2|STARTED|Overall Study||3
75813|NCT01268943|176033|P1|STARTED|Overall Study||6
75814|NCT01268891|176045|P2|NOT COMPLETED|Overall Study||8
75815|NCT01268891|176046|P1|NOT COMPLETED|Overall Study||8
75816|NCT01268891|176045|P2|COMPLETED|Overall Study||58
75817|NCT01268891|176046|P1|COMPLETED|Overall Study||58
75818|NCT01268891|176045|P2|STARTED|Overall Study||66
75819|NCT01268891|176046|P1|STARTED|Overall Study||66
75820|NCT01268683|176058|P1|NOT COMPLETED|Overall Study||0
75821|NCT01268683|176058|P1|COMPLETED|Overall Study||10
75822|NCT01268683|176058|P1|STARTED|Overall Study||10
75823|NCT01268501|176065|P1|NOT COMPLETED|Overall Study||9
75824|NCT01268501|176065|P1|COMPLETED|Overall Study||87
75825|NCT01268501|176065|P1|STARTED|Overall Study||96
75826|NCT01268488|176069|P1|NOT COMPLETED|Overall Study||5
75827|NCT01268488|176069|P1|COMPLETED|Overall Study||93
75828|NCT01268488|176069|P1|STARTED|Overall Study||98
75829|NCT01268306|176076|P1|NOT COMPLETED|Overall Study||1
75830|NCT01268306|176076|P1|COMPLETED|Overall Study||7
75831|NCT01268306|176076|P1|STARTED|Overall Study||8
75832|NCT01268293|176080|P1|NOT COMPLETED|Overall Study||9
75833|NCT01268293|176080|P1|COMPLETED|Overall Study||0
75834|NCT01268293|176080|P1|Completed Cycle 1|Overall Study||9
75835|NCT01268293|176080|P1|STARTED|Overall Study||9
75836|NCT01268267|176085|P1|NOT COMPLETED|Overall Study||1
75837|NCT01268267|176085|P1|COMPLETED|Overall Study||93
75838|NCT01268267|176085|P1|STARTED|Overall Study||94
75839|NCT01268189|176092|P1|NOT COMPLETED|Overall Study||3
75840|NCT01268189|176092|P1|COMPLETED|Overall Study||17
75841|NCT01268189|176092|P1|STARTED|Overall Study||20
75842|NCT01268150|176106|P1|NOT COMPLETED|Extension Phase||27
75843|NCT01268150|176106|P1|COMPLETED|Extension Phase||1
75844|NCT01268150|176106|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
75845|NCT01268150|176106|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
75846|NCT01268150|176106|P1|NOT COMPLETED|Treatment Phase||28
75847|NCT01268150|176106|P1|COMPLETED|Treatment Phase||28
75848|NCT01268150|176106|P1|STARTED|Treatment Phase||56
75849|NCT01268111|176116|P2|NOT COMPLETED|Overall Study||0
75850|NCT01268111|176117|P1|NOT COMPLETED|Overall Study||0
75851|NCT01268111|176116|P2|COMPLETED|Overall Study||6
75852|NCT01268111|176117|P1|COMPLETED|Overall Study||6
75853|NCT01268111|176116|P2|STARTED|Overall Study||6
75854|NCT01268111|176117|P1|STARTED|Overall Study||6
75855|NCT01268098|176125|P2|NOT COMPLETED|Overall Study||0
75856|NCT01268098|176126|P1|NOT COMPLETED|Overall Study||1
75857|NCT01268098|176125|P2|COMPLETED|Overall Study||23
75858|NCT01268098|176126|P1|COMPLETED|Overall Study||18
75859|NCT01268098|176125|P2|STARTED|Overall Study||23
75860|NCT01268098|176126|P1|STARTED|Overall Study||19
75861|NCT01267994|176134|P1|NOT COMPLETED|Overall Study||2
75862|NCT01267994|176134|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
75863|NCT01267994|176134|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
75864|NCT01267929|176140|P2|NOT COMPLETED|Overall Study||0
75865|NCT01267929|176141|P1|NOT COMPLETED|Overall Study||0
75866|NCT01267929|176140|P2|COMPLETED|Overall Study||15
75867|NCT01267929|176141|P1|COMPLETED|Overall Study||15
75868|NCT01267929|176140|P2|STARTED|Overall Study||15
75869|NCT01267929|176141|P1|STARTED|Overall Study||15
75870|NCT01267422|176147|P2|NOT COMPLETED|Safety and Efficacy Study||0
75871|NCT01267422|176148|P1|NOT COMPLETED|Safety and Efficacy Study||0
75872|NCT01267422|176147|P2|COMPLETED|Safety and Efficacy Study||4
75873|NCT01267422|176148|P1|COMPLETED|Safety and Efficacy Study||5
75874|NCT01267422|176147|P2|STARTED|Safety and Efficacy Study||4
75875|NCT01267422|176148|P1|STARTED|Safety and Efficacy Study||5
75876|NCT01267422|176147|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
75877|NCT01267422|176148|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
75878|NCT01267422|176147|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
75879|NCT01267422|176148|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
75880|NCT01267422|176147|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
75881|NCT01267422|176148|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
75882|NCT01267266|176166|P2|NOT COMPLETED|Randomized Phase||0
75883|NCT01267266|176167|P1|NOT COMPLETED|Randomized Phase||0
75884|NCT01267266|176166|P2|COMPLETED|Randomized Phase||5
75885|NCT01267266|176167|P1|COMPLETED|Randomized Phase||3
75886|NCT01267266|176166|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
75887|NCT01267266|176167|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
75888|NCT01267266|176166|P2|NOT COMPLETED|Lead-in Phase||0
75889|NCT01267266|176167|P1|NOT COMPLETED|Lead-in Phase||23
75890|NCT01267266|176166|P2|COMPLETED|Lead-in Phase||0
75891|NCT01267266|176167|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
75892|NCT01267266|176166|P2|STARTED|Lead-in Phase||0
75893|NCT01267266|176167|P1|STARTED|Lead-in Phase||31
75894|NCT01267266|176166|P2|NOT COMPLETED|Enrollment Phase||0
75895|NCT01267266|176167|P1|NOT COMPLETED|Enrollment Phase||2
75896|NCT01267266|176166|P2|COMPLETED|Enrollment Phase||0
75897|NCT01267266|176167|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
75898|NCT01267266|176166|P2|STARTED|Enrollment Phase||0
75899|NCT01267266|176167|P1|STARTED|Enrollment Phase||33
75900|NCT01267253|176180|P1|NOT COMPLETED|Overall Study||3
75901|NCT01267253|176180|P1|COMPLETED|Overall Study|Eligible and treated patients|28
75902|NCT01267253|176180|P1|STARTED|Overall Study||31
75903|NCT01267227|176192|P4|NOT COMPLETED|Overall Study||3
75904|NCT01267227|176193|P3|NOT COMPLETED|Overall Study||2
75905|NCT01267227|176194|P2|NOT COMPLETED|Overall Study||1
75906|NCT01267227|176195|P1|NOT COMPLETED|Overall Study||1
75907|NCT01267227|176192|P4|COMPLETED|Overall Study||17
75908|NCT01267227|176193|P3|COMPLETED|Overall Study||18
75909|NCT01267227|176194|P2|COMPLETED|Overall Study||19
75910|NCT01267227|176195|P1|COMPLETED|Overall Study||19
75911|NCT01267227|176192|P4|STARTED|Overall Study||20
75912|NCT01267227|176193|P3|STARTED|Overall Study||20
75913|NCT01267227|176194|P2|STARTED|Overall Study||20
75914|NCT01267227|176195|P1|STARTED|Overall Study||20
75915|NCT01267201|176209|P6|NOT COMPLETED|Third Intervention Period||0
75916|NCT01267201|176210|P5|NOT COMPLETED|Third Intervention Period||0
75917|NCT01267201|176211|P4|NOT COMPLETED|Third Intervention Period||0
75918|NCT01267201|176212|P3|NOT COMPLETED|Third Intervention Period||0
75919|NCT01267201|176213|P2|NOT COMPLETED|Third Intervention Period||0
75920|NCT01267201|176214|P1|NOT COMPLETED|Third Intervention Period||0
75921|NCT01267201|176209|P6|COMPLETED|Third Intervention Period||4
75922|NCT01267201|176210|P5|COMPLETED|Third Intervention Period||4
75923|NCT01267201|176211|P4|COMPLETED|Third Intervention Period||4
75924|NCT01267201|176212|P3|COMPLETED|Third Intervention Period||4
75925|NCT01267201|176213|P2|COMPLETED|Third Intervention Period||3
75926|NCT01267201|176214|P1|COMPLETED|Third Intervention Period||3
75927|NCT01267201|176209|P6|STARTED|Third Intervention Period||4
75928|NCT01267201|176210|P5|STARTED|Third Intervention Period||4
75929|NCT01267201|176211|P4|STARTED|Third Intervention Period||4
75930|NCT01267201|176212|P3|STARTED|Third Intervention Period||4
75931|NCT01267201|176213|P2|STARTED|Third Intervention Period||3
75932|NCT01267201|176214|P1|STARTED|Third Intervention Period||3
75933|NCT01267201|176209|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75934|NCT01267201|176210|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75935|NCT01267201|176211|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75936|NCT01267201|176212|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75937|NCT01267201|176213|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75938|NCT01267201|176214|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75939|NCT01267201|176209|P6|COMPLETED|Washout Period (At Least 2 Days)||4
75940|NCT01267201|176210|P5|COMPLETED|Washout Period (At Least 2 Days)||4
75941|NCT01267201|176211|P4|COMPLETED|Washout Period (At Least 2 Days)||4
75942|NCT01267201|176212|P3|COMPLETED|Washout Period (At Least 2 Days)||4
75943|NCT01267201|176213|P2|COMPLETED|Washout Period (At Least 2 Days)||3
75944|NCT01267201|176214|P1|COMPLETED|Washout Period (At Least 2 Days)||3
75945|NCT01267201|176209|P6|STARTED|Washout Period (At Least 2 Days)||4
75946|NCT01267201|176210|P5|STARTED|Washout Period (At Least 2 Days)||4
75947|NCT01267201|176211|P4|STARTED|Washout Period (At Least 2 Days)||4
75948|NCT01267201|176212|P3|STARTED|Washout Period (At Least 2 Days)||4
75949|NCT01267201|176213|P2|STARTED|Washout Period (At Least 2 Days)||3
75950|NCT01267201|176214|P1|STARTED|Washout Period (At Least 2 Days)||3
75951|NCT01267201|176209|P6|NOT COMPLETED|Second Intervention Period||0
75952|NCT01267201|176210|P5|NOT COMPLETED|Second Intervention Period||0
75953|NCT01267201|176211|P4|NOT COMPLETED|Second Intervention Period||0
75954|NCT01267201|176212|P3|NOT COMPLETED|Second Intervention Period||0
75955|NCT01267201|176213|P2|NOT COMPLETED|Second Intervention Period||1
75956|NCT01267201|176214|P1|NOT COMPLETED|Second Intervention Period||0
75957|NCT01267201|176209|P6|COMPLETED|Second Intervention Period||4
75958|NCT01267201|176210|P5|COMPLETED|Second Intervention Period||4
75959|NCT01267201|176211|P4|COMPLETED|Second Intervention Period||4
75960|NCT01267201|176212|P3|COMPLETED|Second Intervention Period||4
75961|NCT01267201|176213|P2|COMPLETED|Second Intervention Period||3
75962|NCT01267201|176214|P1|COMPLETED|Second Intervention Period||3
75963|NCT01267201|176209|P6|STARTED|Second Intervention Period||4
75964|NCT01267201|176210|P5|STARTED|Second Intervention Period||4
75965|NCT01267201|176211|P4|STARTED|Second Intervention Period||4
75966|NCT01267201|176212|P3|STARTED|Second Intervention Period||4
75967|NCT01267201|176213|P2|STARTED|Second Intervention Period||4
75968|NCT01267201|176214|P1|STARTED|Second Intervention Period||3
75969|NCT01267201|176209|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75970|NCT01267201|176210|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75971|NCT01267201|176211|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75972|NCT01267201|176212|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75973|NCT01267201|176213|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75974|NCT01267201|176214|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
75975|NCT01267201|176209|P6|COMPLETED|Washout Period (At Least 2 Days)||4
75976|NCT01267201|176210|P5|COMPLETED|Washout Period (At Least 2 Days)||4
75977|NCT01267201|176211|P4|COMPLETED|Washout Period (At Least 2 Days)||4
75978|NCT01267201|176212|P3|COMPLETED|Washout Period (At Least 2 Days)||4
75979|NCT01267201|176213|P2|COMPLETED|Washout Period (At Least 2 Days)||4
75980|NCT01267201|176214|P1|COMPLETED|Washout Period (At Least 2 Days)||3
75981|NCT01267201|176209|P6|STARTED|Washout Period (At Least 2 Days)||4
75982|NCT01267201|176210|P5|STARTED|Washout Period (At Least 2 Days)||4
75983|NCT01267201|176211|P4|STARTED|Washout Period (At Least 2 Days)||4
75984|NCT01267201|176212|P3|STARTED|Washout Period (At Least 2 Days)||4
75985|NCT01267201|176213|P2|STARTED|Washout Period (At Least 2 Days)||4
75986|NCT01267201|176214|P1|STARTED|Washout Period (At Least 2 Days)||3
75987|NCT01267201|176209|P6|NOT COMPLETED|First Intervention Period||0
75988|NCT01267201|176210|P5|NOT COMPLETED|First Intervention Period||0
75989|NCT01267201|176211|P4|NOT COMPLETED|First Intervention Period||0
75990|NCT01267201|176212|P3|NOT COMPLETED|First Intervention Period||0
75991|NCT01267201|176213|P2|NOT COMPLETED|First Intervention Period||0
75992|NCT01267201|176214|P1|NOT COMPLETED|First Intervention Period||1
75993|NCT01267201|176209|P6|COMPLETED|First Intervention Period||4
75994|NCT01267201|176210|P5|COMPLETED|First Intervention Period||4
75995|NCT01267201|176211|P4|COMPLETED|First Intervention Period||4
75996|NCT01267201|176212|P3|COMPLETED|First Intervention Period||4
75997|NCT01267201|176213|P2|COMPLETED|First Intervention Period||4
75998|NCT01267201|176214|P1|COMPLETED|First Intervention Period||3
75999|NCT01267201|176209|P6|STARTED|First Intervention Period||4
76000|NCT01267201|176210|P5|STARTED|First Intervention Period||4
76001|NCT01267201|176211|P4|STARTED|First Intervention Period||4
76002|NCT01267201|176212|P3|STARTED|First Intervention Period||4
76003|NCT01267201|176213|P2|STARTED|First Intervention Period||4
76004|NCT01267201|176214|P1|STARTED|First Intervention Period||4
76005|NCT01267175|176231|P1|NOT COMPLETED|Overall Study||2
76006|NCT01267175|176231|P1|COMPLETED|Overall Study||29
76007|NCT01267175|176231|P1|STARTED|Overall Study||31
76008|NCT01267136|176238|P2|NOT COMPLETED|Overall Study||6
76009|NCT01267136|176239|P1|NOT COMPLETED|Overall Study||4
76010|NCT01267136|176238|P2|COMPLETED|Overall Study||36
76011|NCT01267136|176239|P1|COMPLETED|Overall Study||38
76012|NCT01267136|176238|P2|STARTED|Overall Study||42
76013|NCT01267136|176239|P1|STARTED|Overall Study||42
76014|NCT01267045|176249|P2|NOT COMPLETED|6-month Outcome||3
76015|NCT01267045|176250|P1|NOT COMPLETED|6-month Outcome||0
76016|NCT01267045|176249|P2|COMPLETED|6-month Outcome||23
76017|NCT01267045|176250|P1|COMPLETED|6-month Outcome||22
76018|NCT01267045|176249|P2|STARTED|6-month Outcome||26
76019|NCT01267045|176250|P1|STARTED|6-month Outcome||22
76020|NCT01267045|176249|P2|NOT COMPLETED|2-month Outcomes||3
76021|NCT01267045|176250|P1|NOT COMPLETED|2-month Outcomes||4
76022|NCT01267045|176249|P2|COMPLETED|2-month Outcomes||26
76023|NCT01267045|176250|P1|COMPLETED|2-month Outcomes||22
76024|NCT01267045|176249|P2|STARTED|2-month Outcomes||29
76025|NCT01267045|176250|P1|STARTED|2-month Outcomes||26
76026|NCT01266967|176284|P2|NOT COMPLETED|Overall Study||83
76027|NCT01266967|176285|P1|NOT COMPLETED|Overall Study||89
76028|NCT01266967|176284|P2|COMPLETED|Overall Study||0
76029|NCT01266967|176285|P1|COMPLETED|Overall Study||0
76030|NCT01266967|176284|P2|STARTED|Overall Study||83
76031|NCT01266967|176285|P1|STARTED|Overall Study||89
76032|NCT01266876|176337|P5|NOT COMPLETED|Overall Study||0
76033|NCT01266876|176338|P4|NOT COMPLETED|Overall Study||1
76034|NCT01266876|176339|P3|NOT COMPLETED|Overall Study||0
76035|NCT01266876|176340|P2|NOT COMPLETED|Overall Study||0
76036|NCT01266876|176341|P1|NOT COMPLETED|Overall Study||0
76037|NCT01266876|176337|P5|COMPLETED|Overall Study||16
76038|NCT01266876|176338|P4|COMPLETED|Overall Study||14
76039|NCT01266876|176339|P3|COMPLETED|Overall Study||16
76040|NCT01266876|176340|P2|COMPLETED|Overall Study||15
76041|NCT01266876|176341|P1|COMPLETED|Overall Study||15
76042|NCT01266876|176337|P5|STARTED|Overall Study||16
76043|NCT01266876|176338|P4|STARTED|Overall Study||15
76044|NCT01266876|176339|P3|STARTED|Overall Study||16
76045|NCT01266876|176340|P2|STARTED|Overall Study||15
76046|NCT01266876|176341|P1|STARTED|Overall Study||15
76047|NCT01266850|176448|P5|NOT COMPLETED|Overall Study||30
76048|NCT01266850|176449|P4|NOT COMPLETED|Overall Study||28
76049|NCT01266850|176450|P3|NOT COMPLETED|Overall Study||24
76050|NCT01266850|176451|P2|NOT COMPLETED|Overall Study||36
76051|NCT01266850|176452|P1|NOT COMPLETED|Overall Study||30
76052|NCT01266850|176448|P5|COMPLETED|Overall Study||297
76053|NCT01266850|176449|P4|COMPLETED|Overall Study||301
76054|NCT01266850|176450|P3|COMPLETED|Overall Study||214
76055|NCT01266850|176451|P2|COMPLETED|Overall Study||212
76056|NCT01266850|176452|P1|COMPLETED|Overall Study||212
76057|NCT01266850|176448|P5|Received Third Vaccine|Overall Study||299
76058|NCT01266850|176449|P4|Received Third Vaccine|Overall Study||0
76059|NCT01266850|176450|P3|Received Third Vaccine|Overall Study||217
76060|NCT01266850|176451|P2|Received Third Vaccine|Overall Study||221
76061|NCT01266850|176452|P1|Received Third Vaccine|Overall Study||221
76062|NCT01266850|176448|P5|Received Second Vaccine|Overall Study||307
76063|NCT01266850|176449|P4|Received Second Vaccine|Overall Study||311
76064|NCT01266850|176450|P3|Received Second Vaccine|Overall Study||227
76065|NCT01266850|176451|P2|Received Second Vaccine|Overall Study||233
76066|NCT01266850|176452|P1|Received Second Vaccine|Overall Study||231
76067|NCT01266850|176448|P5|STARTED|Overall Study||327
76068|NCT01266850|176449|P4|STARTED|Overall Study||329
76069|NCT01266850|176450|P3|STARTED|Overall Study||238
76070|NCT01266850|176451|P2|STARTED|Overall Study||248
76071|NCT01266850|176452|P1|STARTED|Overall Study||242
76072|NCT01266824|176506|P2|NOT COMPLETED|Overall Study||3
76073|NCT01266824|176507|P1|NOT COMPLETED|Overall Study||2
76074|NCT01266824|176506|P2|COMPLETED|Overall Study||0
76075|NCT01266824|176507|P1|COMPLETED|Overall Study||0
76076|NCT01266824|176506|P2|STARTED|Overall Study||3
76077|NCT01266824|176507|P1|STARTED|Overall Study||2
76078|NCT01266447|176519|P1|NOT COMPLETED|Overall Study||0
76079|NCT01266447|176519|P1|COMPLETED|Overall Study|Eligible and treated patients|27
76080|NCT01266447|176519|P1|STARTED|Overall Study||27
76081|NCT01266265|176530|P2|NOT COMPLETED|Overall Study||190
76082|NCT01266265|176531|P1|NOT COMPLETED|Overall Study||205
76083|NCT01266265|176530|P2|COMPLETED|Overall Study||477
76084|NCT01266265|176531|P1|COMPLETED|Overall Study||461
76085|NCT01266265|176530|P2|STARTED|Overall Study||667
76086|NCT01266265|176531|P1|STARTED|Overall Study||666
76087|NCT01266148|176539|P2|NOT COMPLETED|Overall Study||3
76088|NCT01266148|176540|P1|NOT COMPLETED|Overall Study||7
76089|NCT01266148|176539|P2|COMPLETED|Overall Study||56
76090|NCT01266148|176540|P1|COMPLETED|Overall Study||49
76091|NCT01266148|176539|P2|STARTED|Overall Study||59
76092|NCT01266148|176540|P1|STARTED|Overall Study||56
76093|NCT01266122|176568|P2|NOT COMPLETED|Overall Study||6
76094|NCT01266122|176569|P1|NOT COMPLETED|Overall Study||6
76095|NCT01266122|176568|P2|COMPLETED|Overall Study||42
76096|NCT01266122|176569|P1|COMPLETED|Overall Study||42
76097|NCT01266122|176568|P2|STARTED|Overall Study||48
76098|NCT01266122|176569|P1|STARTED|Overall Study||48
76099|NCT01266070|176577|P1|NOT COMPLETED|Overall Study||4
76100|NCT01266070|176577|P1|COMPLETED|Overall Study||2
76101|NCT01266070|176577|P1|STARTED|Overall Study||6
76102|NCT01266031|176585|P3|NOT COMPLETED|Overall Study||3
76103|NCT01266031|176586|P2|NOT COMPLETED|Overall Study||3
76104|NCT01266031|176587|P1|NOT COMPLETED|Overall Study||0
76105|NCT01266031|176585|P3|COMPLETED|Overall Study||46
76106|NCT01266031|176586|P2|COMPLETED|Overall Study||38
76107|NCT01266031|176587|P1|COMPLETED|Overall Study||6
76108|NCT01266031|176585|P3|STARTED|Overall Study||49
76109|NCT01266031|176586|P2|STARTED|Overall Study||41
76110|NCT01266031|176587|P1|STARTED|Overall Study||6
76111|NCT01265992|176595|P1|NOT COMPLETED|Overall Study||9
76112|NCT01265992|176595|P1|COMPLETED|Overall Study||41
76113|NCT01265992|176595|P1|Received Treatment|Overall Study||49
76114|NCT01265992|176595|P1|STARTED|Overall Study||50
76115|NCT01265966|176611|P3|NOT COMPLETED|Overall Study||2
76116|NCT01265966|176612|P2|NOT COMPLETED|Overall Study||2
76117|NCT01265966|176613|P1|NOT COMPLETED|Overall Study||3
76118|NCT01265966|176611|P3|COMPLETED|Overall Study||27
76119|NCT01265966|176612|P2|COMPLETED|Overall Study||39
76120|NCT01265966|176613|P1|COMPLETED|Overall Study||44
76121|NCT01265966|176611|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
76122|NCT01265966|176612|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
76123|NCT01265966|176613|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
76124|NCT01265966|176611|P3|STARTED|Overall Study||29
76125|NCT01265966|176612|P2|STARTED|Overall Study||41
76126|NCT01265966|176613|P1|STARTED|Overall Study||47
76127|NCT01265875|176621|P1|NOT COMPLETED|Overall Study||1
76128|NCT01265875|176621|P1|COMPLETED|Overall Study||11
76129|NCT01265875|176621|P1|STARTED|Overall Study||12
76130|NCT01265823|176629|P1|NOT COMPLETED|Overall Study||7
76131|NCT01265823|176629|P1|COMPLETED|Overall Study||143
76132|NCT01265823|176629|P1|STARTED|Overall Study||150
76133|NCT01265797|176658|P2|NOT COMPLETED|Open Label Month||1
76134|NCT01265797|176659|P1|NOT COMPLETED|Open Label Month||0
76135|NCT01265797|176658|P2|COMPLETED|Open Label Month||26
76136|NCT01265797|176659|P1|COMPLETED|Open Label Month||24
76137|NCT01265797|176658|P2|STARTED|Open Label Month||27
76138|NCT01265797|176659|P1|STARTED|Open Label Month||24
76139|NCT01265797|176658|P2|NOT COMPLETED|Blinded Month||2
76140|NCT01265797|176659|P1|NOT COMPLETED|Blinded Month||10
76141|NCT01265797|176658|P2|COMPLETED|Blinded Month||27
76142|NCT01265797|176659|P1|COMPLETED|Blinded Month||24
76143|NCT01265797|176658|P2|STARTED|Blinded Month||29
76144|NCT01265797|176659|P1|STARTED|Blinded Month||34
76145|NCT01265797|176658|P2|NOT COMPLETED|Run-in Month||5
76146|NCT01265797|176659|P1|NOT COMPLETED|Run-in Month||0
76147|NCT01265797|176658|P2|COMPLETED|Run-in Month||29
76148|NCT01265797|176659|P1|COMPLETED|Run-in Month||34
76149|NCT01265797|176658|P2|STARTED|Run-in Month||34
76150|NCT01265797|176659|P1|STARTED|Run-in Month||34
76151|NCT01265784|176690|P3|NOT COMPLETED|Overall Study||4
76152|NCT01265784|176691|P2|NOT COMPLETED|Overall Study||8
76153|NCT01265784|176692|P1|NOT COMPLETED|Overall Study||12
76154|NCT01265784|176690|P3|COMPLETED|Overall Study||26
76155|NCT01265784|176691|P2|COMPLETED|Overall Study||49
76156|NCT01265784|176692|P1|COMPLETED|Overall Study||44
76157|NCT01265784|176690|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
76158|NCT01265784|176691|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
76336|NCT01263691|177283|P4|COMPLETED|Overall Study||18
76159|NCT01265784|176692|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
76160|NCT01265784|176690|P3|STARTED|Overall Study||30
76161|NCT01265784|176691|P2|STARTED|Overall Study||57
76162|NCT01265784|176692|P1|STARTED|Overall Study||56
76163|NCT01265615|176762|P4|NOT COMPLETED|Overall Study||3
76164|NCT01265615|176763|P3|NOT COMPLETED|Overall Study||4
76165|NCT01265615|176764|P2|NOT COMPLETED|Overall Study||2
76166|NCT01265615|176765|P1|NOT COMPLETED|Overall Study||2
76167|NCT01265615|176762|P4|COMPLETED|Overall Study||27
76168|NCT01265615|176763|P3|COMPLETED|Overall Study||26
76169|NCT01265615|176764|P2|COMPLETED|Overall Study||28
76170|NCT01265615|176765|P1|COMPLETED|Overall Study||28
76171|NCT01265615|176762|P4|STARTED|Overall Study||30
76172|NCT01265615|176763|P3|STARTED|Overall Study||30
76173|NCT01265615|176764|P2|STARTED|Overall Study||30
76174|NCT01265615|176765|P1|STARTED|Overall Study||30
76175|NCT01265524|176813|P2|NOT COMPLETED|Overall Study||6
76176|NCT01265524|176814|P1|NOT COMPLETED|Overall Study||18
76177|NCT01265524|176813|P2|COMPLETED|Overall Study||46
76178|NCT01265524|176814|P1|COMPLETED|Overall Study||41
76179|NCT01265524|176813|P2|STARTED|Overall Study||52
76180|NCT01265524|176814|P1|STARTED|Overall Study||59
76181|NCT01265498|176834|P2|NOT COMPLETED|Overall Study||33
76182|NCT01265498|176835|P1|NOT COMPLETED|Overall Study||31
76183|NCT01265498|176834|P2|COMPLETED|Overall Study||109
76184|NCT01265498|176835|P1|COMPLETED|Overall Study||110
76185|NCT01265498|176834|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
76186|NCT01265498|176835|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
76187|NCT01265498|176834|P2|STARTED|Overall Study||142
76188|NCT01265498|176835|P1|STARTED|Overall Study||141
76189|NCT01265459|176938|P3|NOT COMPLETED|Overall Study||2
76190|NCT01265459|176939|P2|NOT COMPLETED|Overall Study||0
76191|NCT01265459|176940|P1|NOT COMPLETED|Overall Study||0
76192|NCT01265459|176938|P3|COMPLETED|Overall Study||20
76193|NCT01265459|176939|P2|COMPLETED|Overall Study||23
76194|NCT01265459|176940|P1|COMPLETED|Overall Study||23
76195|NCT01265459|176938|P3|STARTED|Overall Study||22
76196|NCT01265459|176939|P2|STARTED|Overall Study||23
76197|NCT01265459|176940|P1|STARTED|Overall Study||23
76198|NCT01265446|176962|P2|NOT COMPLETED|Overall Study||0
76199|NCT01265446|176963|P1|NOT COMPLETED|Overall Study||1
76200|NCT01265446|176962|P2|COMPLETED|Overall Study||125
76201|NCT01265446|176963|P1|COMPLETED|Overall Study||124
76202|NCT01265446|176962|P2|STARTED|Overall Study||125
76203|NCT01265446|176963|P1|STARTED|Overall Study||125
76204|NCT01265420|176971|P1|NOT COMPLETED|Overall Study||1
76205|NCT01265420|176971|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
76206|NCT01265420|176971|P1|STARTED|Overall Study||7
76207|NCT01265394|176975|P1|NOT COMPLETED|Overall Study||37
76208|NCT01265394|176975|P1|COMPLETED|Overall Study||181
76209|NCT01265394|176975|P1|STARTED|Overall Study||218
76210|NCT01265056|176982|P2|NOT COMPLETED|Overall Study||2
76211|NCT01265056|176983|P1|NOT COMPLETED|Overall Study||2
76212|NCT01265056|176982|P2|COMPLETED|Overall Study||25
76213|NCT01265056|176983|P1|COMPLETED|Overall Study||24
76214|NCT01265056|176982|P2|STARTED|Overall Study||27
76215|NCT01265056|176983|P1|STARTED|Overall Study||26
76216|NCT01264952|176992|P3|NOT COMPLETED|Overall Study||0
76217|NCT01264952|176993|P2|NOT COMPLETED|Overall Study||0
76218|NCT01264952|176994|P1|NOT COMPLETED|Overall Study||0
76219|NCT01264952|176992|P3|COMPLETED|Overall Study||8
76220|NCT01264952|176993|P2|COMPLETED|Overall Study||2
76221|NCT01264952|176994|P1|COMPLETED|Overall Study||6
76222|NCT01264952|176992|P3|STARTED|Overall Study||8
76223|NCT01264952|176993|P2|STARTED|Overall Study||2
76224|NCT01264952|176994|P1|STARTED|Overall Study||6
76225|NCT01264939|177010|P2|NOT COMPLETED|Overall Study||28
76226|NCT01264939|177011|P1|NOT COMPLETED|Overall Study||18
76227|NCT01264939|177010|P2|COMPLETED|Overall Study||224
76228|NCT01264939|177011|P1|COMPLETED|Overall Study||66
76229|NCT01264939|177010|P2|STARTED|Overall Study||252
76230|NCT01264939|177011|P1|STARTED|Overall Study||84
76231|NCT01264887|177037|P1|NOT COMPLETED|Overall Study||31
76232|NCT01264887|177037|P1|COMPLETED|Overall Study||0
76233|NCT01264887|177037|P1|STARTED|Overall Study||31
76234|NCT01264835|177048|P1|NOT COMPLETED|Overall Study||1
76235|NCT01264835|177048|P1|COMPLETED|Overall Study||1
76236|NCT01264835|177048|P1|STARTED|Overall Study||2
76237|NCT01264770|177058|P6|NOT COMPLETED|Overall Study||6
76238|NCT01264770|177059|P5|NOT COMPLETED|Overall Study||8
76239|NCT01264770|177060|P4|NOT COMPLETED|Overall Study||6
76240|NCT01264770|177061|P3|NOT COMPLETED|Overall Study||16
76241|NCT01264770|177062|P2|NOT COMPLETED|Overall Study||10
76242|NCT01264770|177063|P1|NOT COMPLETED|Overall Study||18
76243|NCT01264770|177058|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
76244|NCT01264770|177059|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
76245|NCT01264770|177060|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
76246|NCT01264770|177061|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
76247|NCT01264770|177062|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
76248|NCT01264770|177063|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
76249|NCT01264770|177058|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
76250|NCT01264770|177059|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
76251|NCT01264770|177060|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
76252|NCT01264770|177061|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
76253|NCT01264770|177062|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
76254|NCT01264770|177063|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
76255|NCT01264770|177058|P6|STARTED|Overall Study|Patients who received treatment|25
76256|NCT01264770|177059|P5|STARTED|Overall Study|Patients who received treatment|27
76257|NCT01264770|177060|P4|STARTED|Overall Study|Patients who received treatment|54
76258|NCT01264770|177061|P3|STARTED|Overall Study|Patients who received treatment|57
76259|NCT01264770|177062|P2|STARTED|Overall Study|Patients who received treatment|48
76260|NCT01264770|177063|P1|STARTED|Overall Study|Patients who received treatment|54
76261|NCT01264614|177149|P2|NOT COMPLETED|Overall Study||2
76262|NCT01264614|177150|P1|NOT COMPLETED|Overall Study||1
76263|NCT01264614|177149|P2|COMPLETED|Overall Study||7
76264|NCT01264614|177150|P1|COMPLETED|Overall Study||12
76265|NCT01264614|177149|P2|STARTED|Overall Study||9
76266|NCT01264614|177150|P1|STARTED|Overall Study||13
76267|NCT01264380|177164|P3|NOT COMPLETED|Period C||14
76268|NCT01264380|177165|P2|NOT COMPLETED|Period C||0
76269|NCT01264380|177166|P1|NOT COMPLETED|Period C||0
76270|NCT01264380|177164|P3|COMPLETED|Period C||2
76271|NCT01264380|177165|P2|COMPLETED|Period C||0
76272|NCT01264380|177166|P1|COMPLETED|Period C||0
76273|NCT01264380|177164|P3|STARTED|Period C||16
76274|NCT01264380|177165|P2|STARTED|Period C||0
76275|NCT01264380|177166|P1|STARTED|Period C||0
76276|NCT01264380|177164|P3|NOT COMPLETED|Period B||0
76277|NCT01264380|177165|P2|NOT COMPLETED|Period B||0
76278|NCT01264380|177166|P1|NOT COMPLETED|Period B||0
76279|NCT01264380|177164|P3|COMPLETED|Period B||0
76280|NCT01264380|177165|P2|COMPLETED|Period B||8
76281|NCT01264380|177166|P1|COMPLETED|Period B||8
76282|NCT01264380|177164|P3|STARTED|Period B||0
76283|NCT01264380|177165|P2|STARTED|Period B||8
76284|NCT01264380|177166|P1|STARTED|Period B||8
76285|NCT01264380|177164|P3|NOT COMPLETED|Period A||0
76286|NCT01264380|177165|P2|NOT COMPLETED|Period A||0
76287|NCT01264380|177166|P1|NOT COMPLETED|Period A||0
76288|NCT01264380|177164|P3|COMPLETED|Period A||0
76289|NCT01264380|177165|P2|COMPLETED|Period A||8
76290|NCT01264380|177166|P1|COMPLETED|Period A||8
76291|NCT01264380|177164|P3|STARTED|Period A||0
76292|NCT01264380|177165|P2|STARTED|Period A||8
76293|NCT01264380|177166|P1|STARTED|Period A||8
76294|NCT01264081|177187|P1|NOT COMPLETED|Analysis||0
76295|NCT01264081|177187|P1|COMPLETED|Analysis||2
76296|NCT01264081|177187|P1|STARTED|Analysis||2
76297|NCT01264081|177187|P1|NOT COMPLETED|Started Treatment||2
76298|NCT01264081|177187|P1|COMPLETED|Started Treatment||2
76299|NCT01264081|177187|P1|STARTED|Started Treatment||4
76300|NCT01264081|177187|P1|NOT COMPLETED|Participants Screened||30
76301|NCT01264081|177187|P1|COMPLETED|Participants Screened||4
76302|NCT01264081|177187|P1|STARTED|Participants Screened||34
76303|NCT01264016|177192|P1|NOT COMPLETED|Overall Study||2
76304|NCT01264016|177192|P1|COMPLETED|Overall Study||94
76305|NCT01264016|177192|P1|STARTED|Overall Study||96
76306|NCT01263925|177200|P2|NOT COMPLETED|Overall Study||52
76307|NCT01263925|177201|P1|NOT COMPLETED|Overall Study||51
76308|NCT01263925|177200|P2|COMPLETED|Overall Study||233
76309|NCT01263925|177201|P1|COMPLETED|Overall Study||225
76310|NCT01263925|177200|P2|Full Analysis Set|Overall Study||272
76311|NCT01263925|177201|P1|Full Analysis Set|Overall Study||269
76312|NCT01263925|177200|P2|STARTED|Overall Study||285
76313|NCT01263925|177201|P1|STARTED|Overall Study||276
76314|NCT01263873|177235|P2|NOT COMPLETED|Overall Study||1
76315|NCT01263873|177236|P1|NOT COMPLETED|Overall Study||1
76316|NCT01263873|177235|P2|COMPLETED|Overall Study||29
76317|NCT01263873|177236|P1|COMPLETED|Overall Study||29
76318|NCT01263873|177235|P2|STARTED|Overall Study||30
76319|NCT01263873|177236|P1|STARTED|Overall Study||30
76320|NCT01263717|177248|P2|NOT COMPLETED|Overall Study||6
76321|NCT01263717|177249|P1|NOT COMPLETED|Overall Study||5
76322|NCT01263717|177248|P2|COMPLETED|Overall Study||20
76323|NCT01263717|177249|P1|COMPLETED|Overall Study||23
76324|NCT01263717|177248|P2|Baseline Visit|Overall Study||22
76325|NCT01263717|177249|P1|Baseline Visit|Overall Study||28
76326|NCT01263717|177248|P2|STARTED|Overall Study||26
76327|NCT01263717|177249|P1|STARTED|Overall Study||28
76328|NCT01263691|177281|P6|NOT COMPLETED|Overall Study||0
76329|NCT01263691|177282|P5|NOT COMPLETED|Overall Study||0
76330|NCT01263691|177283|P4|NOT COMPLETED|Overall Study||1
76331|NCT01263691|177284|P3|NOT COMPLETED|Overall Study||1
76332|NCT01263691|177285|P2|NOT COMPLETED|Overall Study||0
76333|NCT01263691|177286|P1|NOT COMPLETED|Overall Study||3
76334|NCT01263691|177281|P6|COMPLETED|Overall Study||15
76335|NCT01263691|177282|P5|COMPLETED|Overall Study||18
76337|NCT01263691|177284|P3|COMPLETED|Overall Study||16
76338|NCT01263691|177285|P2|COMPLETED|Overall Study||18
76339|NCT01263691|177286|P1|COMPLETED|Overall Study||15
76340|NCT01263691|177281|P6|STARTED|Overall Study||15
76341|NCT01263691|177282|P5|STARTED|Overall Study||18
76342|NCT01263691|177283|P4|STARTED|Overall Study||19
76343|NCT01263691|177284|P3|STARTED|Overall Study||17
76344|NCT01263691|177285|P2|STARTED|Overall Study||18
76345|NCT01263691|177286|P1|STARTED|Overall Study||18
76346|NCT01263665|177396|P1|NOT COMPLETED|Overall Study||9
76347|NCT01263665|177396|P1|COMPLETED|Overall Study||62
76348|NCT01263665|177396|P1|STARTED|Overall Study||71
76349|NCT01263639|177403|P2|NOT COMPLETED|Overall Study||79
76350|NCT01263639|177404|P1|NOT COMPLETED|Overall Study||73
76351|NCT01263639|177403|P2|COMPLETED|Overall Study||42
76352|NCT01263639|177404|P1|COMPLETED|Overall Study||34
76353|NCT01263639|177403|P2|STARTED|Overall Study||121
76354|NCT01263639|177404|P1|STARTED|Overall Study||107
76355|NCT01263561|177412|P2|NOT COMPLETED|Overall Study||2
76356|NCT01263561|177413|P1|NOT COMPLETED|Overall Study||1
76357|NCT01263561|177412|P2|COMPLETED|Overall Study||31
76358|NCT01263561|177413|P1|COMPLETED|Overall Study||30
76359|NCT01263561|177412|P2|STARTED|Overall Study||33
76360|NCT01263561|177413|P1|STARTED|Overall Study||31
76361|NCT01263509|177425|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
76362|NCT01263509|177426|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
76363|NCT01263509|177427|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
76364|NCT01263509|177428|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
76365|NCT01263509|177425|P4|COMPLETED|Entered - Long-Term Extension Study||24
76366|NCT01263509|177426|P3|COMPLETED|Entered - Long-Term Extension Study||27
76367|NCT01263509|177427|P2|COMPLETED|Entered - Long-Term Extension Study||48
76368|NCT01263509|177428|P1|COMPLETED|Entered - Long-Term Extension Study||53
76369|NCT01263509|177425|P4|STARTED|Entered - Long-Term Extension Study||26
76370|NCT01263509|177426|P3|STARTED|Entered - Long-Term Extension Study||32
76371|NCT01263509|177427|P2|STARTED|Entered - Long-Term Extension Study||60
76372|NCT01263509|177428|P1|STARTED|Entered - Long-Term Extension Study||61
76373|NCT01263509|177425|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76374|NCT01263509|177426|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76375|NCT01263509|177427|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76376|NCT01263509|177428|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76377|NCT01263509|177425|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
76378|NCT01263509|177426|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
76379|NCT01263509|177427|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
76380|NCT01263509|177428|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
76381|NCT01263509|177425|P4|STARTED|Enrolled - Long-Term Extension Study||26
76382|NCT01263509|177426|P3|STARTED|Enrolled - Long-Term Extension Study||32
76383|NCT01263509|177427|P2|STARTED|Enrolled - Long-Term Extension Study||60
76384|NCT01263509|177428|P1|STARTED|Enrolled - Long-Term Extension Study||61
76385|NCT01263496|177557|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
76386|NCT01263496|177558|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
76387|NCT01263496|177559|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
76388|NCT01263496|177560|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
76389|NCT01263496|177561|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
76390|NCT01263496|177562|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
76391|NCT01263496|177563|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
76392|NCT01263496|177564|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
76393|NCT01263496|177565|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
76394|NCT01263496|177557|P9|COMPLETED|Entered - Long-Term Extension Study||15
76395|NCT01263496|177558|P8|COMPLETED|Entered - Long-Term Extension Study||16
76396|NCT01263496|177559|P7|COMPLETED|Entered - Long-Term Extension Study||16
76397|NCT01263496|177560|P6|COMPLETED|Entered - Long-Term Extension Study||16
76398|NCT01263496|177561|P5|COMPLETED|Entered - Long-Term Extension Study||61
76399|NCT01263496|177562|P4|COMPLETED|Entered - Long-Term Extension Study||68
76400|NCT01263496|177563|P3|COMPLETED|Entered - Long-Term Extension Study||62
76401|NCT01263496|177564|P2|COMPLETED|Entered - Long-Term Extension Study||59
76402|NCT01263496|177565|P1|COMPLETED|Entered - Long-Term Extension Study||62
76403|NCT01263496|177557|P9|STARTED|Entered - Long-Term Extension Study||18
76404|NCT01263496|177558|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
76405|NCT01263496|177559|P7|STARTED|Entered - Long-Term Extension Study||17
76406|NCT01263496|177560|P6|STARTED|Entered - Long-Term Extension Study||17
76407|NCT01263496|177561|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
76408|NCT01263496|177562|P4|STARTED|Entered - Long-Term Extension Study||74
76409|NCT01263496|177563|P3|STARTED|Entered - Long-Term Extension Study||72
76410|NCT01263496|177564|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
76411|NCT01263496|177565|P1|STARTED|Entered - Long-Term Extension Study||71
76412|NCT01263496|177557|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76413|NCT01263496|177558|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76414|NCT01263496|177559|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76415|NCT01263496|177560|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76416|NCT01263496|177561|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
76417|NCT01263496|177562|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
76418|NCT01263496|177563|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76419|NCT01263496|177564|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
76420|NCT01263496|177565|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
76421|NCT01263496|177557|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
76422|NCT01263496|177558|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
76423|NCT01263496|177559|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
76424|NCT01263496|177560|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
76425|NCT01263496|177561|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
76426|NCT01263496|177562|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
76427|NCT01263496|177563|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
76428|NCT01263496|177564|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
76429|NCT01263496|177565|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
76430|NCT01263496|177557|P9|STARTED|Enrolled - Long-Term Extension Study||18
76431|NCT01263496|177558|P8|STARTED|Enrolled - Long-Term Extension Study||18
76432|NCT01263496|177559|P7|STARTED|Enrolled - Long-Term Extension Study||17
76433|NCT01263496|177560|P6|STARTED|Enrolled - Long-Term Extension Study||17
76434|NCT01263496|177561|P5|STARTED|Enrolled - Long-Term Extension Study||74
76435|NCT01263496|177562|P4|STARTED|Enrolled - Long-Term Extension Study||75
76436|NCT01263496|177563|P3|STARTED|Enrolled - Long-Term Extension Study||72
76437|NCT01263496|177564|P2|STARTED|Enrolled - Long-Term Extension Study||75
76438|NCT01263496|177565|P1|STARTED|Enrolled - Long-Term Extension Study||72
76439|NCT01263483|177860|P3|NOT COMPLETED|Overall Study||5
76440|NCT01263483|177861|P2|NOT COMPLETED|Overall Study||2
76441|NCT01263483|177862|P1|NOT COMPLETED|Overall Study||7
76442|NCT01263483|177860|P3|COMPLETED|Overall Study||74
76443|NCT01263483|177861|P2|COMPLETED|Overall Study||74
76444|NCT01263483|177862|P1|COMPLETED|Overall Study||68
76445|NCT01263483|177860|P3|STARTED|Overall Study||79
76446|NCT01263483|177861|P2|STARTED|Overall Study||76
76447|NCT01263483|177862|P1|STARTED|Overall Study||75
76448|NCT01263470|177924|P6|NOT COMPLETED|Overall Study||5
76449|NCT01263470|177925|P5|NOT COMPLETED|Overall Study||3
76450|NCT01263470|177926|P4|NOT COMPLETED|Overall Study||3
76451|NCT01263470|177927|P3|NOT COMPLETED|Overall Study||4
76452|NCT01263470|177928|P2|NOT COMPLETED|Overall Study||5
76453|NCT01263470|177929|P1|NOT COMPLETED|Overall Study||2
76454|NCT01263470|177924|P6|COMPLETED|Overall Study||78
76455|NCT01263470|177925|P5|COMPLETED|Overall Study||76
76456|NCT01263470|177926|P4|COMPLETED|Overall Study||77
76457|NCT01263470|177927|P3|COMPLETED|Overall Study||80
76458|NCT01263470|177928|P2|COMPLETED|Overall Study||74
76459|NCT01263470|177929|P1|COMPLETED|Overall Study||73
76460|NCT01263470|177924|P6|STARTED|Overall Study||83
76461|NCT01263470|177925|P5|STARTED|Overall Study||79
76462|NCT01263470|177926|P4|STARTED|Overall Study||80
76463|NCT01263470|177927|P3|STARTED|Overall Study||84
76464|NCT01263470|177928|P2|STARTED|Overall Study||79
76465|NCT01263470|177929|P1|STARTED|Overall Study||75
76466|NCT01263444|178039|P1|NOT COMPLETED|Overall Study||10
76467|NCT01263444|178039|P1|COMPLETED|Overall Study||37
76468|NCT01263444|178039|P1|STARTED|Overall Study||47
76469|NCT01263301|178048|P2|NOT COMPLETED|Overall Study||0
76470|NCT01263301|178049|P1|NOT COMPLETED|Overall Study||0
76471|NCT01263301|178048|P2|COMPLETED|Overall Study||11
76472|NCT01263301|178049|P1|COMPLETED|Overall Study||5
76473|NCT01263301|178048|P2|STARTED|Overall Study||11
76474|NCT01263301|178049|P1|STARTED|Overall Study||5
76475|NCT01263132|178063|P2|NOT COMPLETED|Overall Study||0
76476|NCT01263132|178064|P1|NOT COMPLETED|Overall Study||0
76477|NCT01263132|178063|P2|COMPLETED|Overall Study||37
76478|NCT01263132|178064|P1|COMPLETED|Overall Study||38
76479|NCT01263132|178063|P2|STARTED|Overall Study||37
76480|NCT01263132|178064|P1|STARTED|Overall Study||38
76481|NCT01263054|178080|P2|NOT COMPLETED|Overall Study||6
76482|NCT01263054|178081|P1|NOT COMPLETED|Overall Study||5
76483|NCT01263054|178080|P2|COMPLETED|Overall Study||28
76484|NCT01263054|178081|P1|COMPLETED|Overall Study||24
76485|NCT01263054|178080|P2|STARTED|Overall Study||34
76486|NCT01263054|178081|P1|STARTED|Overall Study||29
76487|NCT01263028|178099|P1|NOT COMPLETED|Overall Study||6
76488|NCT01263028|178099|P1|COMPLETED|Overall Study||0
76489|NCT01263028|178099|P1|STARTED|Overall Study||6
76490|NCT01263015|178109|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
76491|NCT01263015|178110|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
76492|NCT01263015|178109|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
76493|NCT01263015|178110|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
76494|NCT01263015|178109|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
76495|NCT01263015|178110|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
76496|NCT01263015|178109|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
76497|NCT01263015|178110|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
76498|NCT01263015|178109|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
76499|NCT01263015|178110|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
76500|NCT01263015|178109|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
76501|NCT01263015|178110|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
76502|NCT01262989|178136|P2|NOT COMPLETED|Period 2||1
76503|NCT01262989|178137|P1|NOT COMPLETED|Period 2||0
76504|NCT01262989|178136|P2|COMPLETED|Period 2||16
76505|NCT01262989|178137|P1|COMPLETED|Period 2||19
76506|NCT01262989|178136|P2|STARTED|Period 2||17
76507|NCT01262989|178137|P1|STARTED|Period 2||19
76508|NCT01262989|178136|P2|NOT COMPLETED|7-Day Washout Period||0
76509|NCT01262989|178137|P1|NOT COMPLETED|7-Day Washout Period||0
76510|NCT01262989|178136|P2|COMPLETED|7-Day Washout Period||17
76511|NCT01262989|178137|P1|COMPLETED|7-Day Washout Period||19
76512|NCT01262989|178136|P2|STARTED|7-Day Washout Period||17
76513|NCT01262989|178137|P1|STARTED|7-Day Washout Period||19
76514|NCT01262989|178136|P2|NOT COMPLETED|Period 1||3
76515|NCT01262989|178137|P1|NOT COMPLETED|Period 1||1
76516|NCT01262989|178136|P2|COMPLETED|Period 1||17
76517|NCT01262989|178137|P1|COMPLETED|Period 1||19
76518|NCT01262989|178136|P2|STARTED|Period 1||20
76519|NCT01262989|178137|P1|STARTED|Period 1||20
76520|NCT01262872|178155|P8|NOT COMPLETED|Step 2||6
76521|NCT01262872|178156|P7|NOT COMPLETED|Step 2||9
76522|NCT01262872|178157|P6|NOT COMPLETED|Step 2||9
76523|NCT01262872|178158|P5|NOT COMPLETED|Step 2||5
76524|NCT01262872|178159|P4|NOT COMPLETED|Step 2||10
76525|NCT01262872|178160|P3|NOT COMPLETED|Step 2||9
76526|NCT01262872|178161|P2|NOT COMPLETED|Step 2||0
76527|NCT01262872|178162|P1|NOT COMPLETED|Step 2||0
76528|NCT01262872|178155|P8|COMPLETED|Step 2||194
76529|NCT01262872|178156|P7|COMPLETED|Step 2||191
76530|NCT01262872|178157|P6|COMPLETED|Step 2||191
76531|NCT01262872|178158|P5|COMPLETED|Step 2||195
76532|NCT01262872|178159|P4|COMPLETED|Step 2||190
76533|NCT01262872|178160|P3|COMPLETED|Step 2||191
76534|NCT01262872|178161|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76535|NCT01262872|178162|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76536|NCT01262872|178155|P8|STARTED|Step 2||200
76537|NCT01262872|178156|P7|STARTED|Step 2||200
76538|NCT01262872|178157|P6|STARTED|Step 2||200
76539|NCT01262872|178158|P5|STARTED|Step 2||200
76540|NCT01262872|178159|P4|STARTED|Step 2||200
76541|NCT01262872|178160|P3|STARTED|Step 2||200
76542|NCT01262872|178161|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76543|NCT01262872|178162|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76544|NCT01262872|178155|P8|NOT COMPLETED|Step 1||0
76545|NCT01262872|178156|P7|NOT COMPLETED|Step 1||0
76546|NCT01262872|178157|P6|NOT COMPLETED|Step 1||0
76547|NCT01262872|178158|P5|NOT COMPLETED|Step 1||0
76548|NCT01262872|178159|P4|NOT COMPLETED|Step 1||0
76549|NCT01262872|178160|P3|NOT COMPLETED|Step 1||0
76550|NCT01262872|178161|P2|NOT COMPLETED|Step 1||0
76551|NCT01262872|178162|P1|NOT COMPLETED|Step 1||0
76552|NCT01262872|178155|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76553|NCT01262872|178156|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76554|NCT01262872|178157|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76555|NCT01262872|178158|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76556|NCT01262872|178159|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
76557|NCT01262872|178160|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76558|NCT01262872|178161|P2|COMPLETED|Step 1||60
76559|NCT01262872|178162|P1|COMPLETED|Step 1||60
76560|NCT01262872|178155|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76561|NCT01262872|178156|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76562|NCT01262872|178157|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76563|NCT01262872|178158|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76564|NCT01262872|178159|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76565|NCT01262872|178160|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
76566|NCT01262872|178161|P2|STARTED|Step 1||60
76567|NCT01262872|178162|P1|STARTED|Step 1||60
76568|NCT01262820|178363|P1|NOT COMPLETED|Overall Study||15
76569|NCT01262820|178363|P1|COMPLETED|Overall Study||0
76570|NCT01262820|178363|P1|STARTED|Overall Study||15
76571|NCT01262755|178370|P1|NOT COMPLETED|Overall Study||0
76572|NCT01262755|178370|P1|COMPLETED|Overall Study||450
76573|NCT01262755|178370|P1|STARTED|Overall Study||450
76574|NCT01262599|178376|P2|NOT COMPLETED|Overall Study||0
76575|NCT01262599|178377|P1|NOT COMPLETED|Overall Study||0
76576|NCT01262599|178376|P2|COMPLETED|Overall Study||16
76577|NCT01262599|178377|P1|COMPLETED|Overall Study||16
76578|NCT01262599|178376|P2|STARTED|Overall Study||16
76579|NCT01262599|178377|P1|STARTED|Overall Study||16
76580|NCT01262573|178385|P2|NOT COMPLETED|Overall Study||1
76581|NCT01262573|178386|P1|NOT COMPLETED|Overall Study||0
76582|NCT01262573|178385|P2|COMPLETED|Overall Study||31
76583|NCT01262573|178386|P1|COMPLETED|Overall Study||32
76584|NCT01262573|178385|P2|STARTED|Overall Study||32
76585|NCT01262573|178386|P1|STARTED|Overall Study||32
76586|NCT01262547|178394|P1|NOT COMPLETED|Overall Study||0
76587|NCT01262547|178394|P1|COMPLETED|Overall Study||3
76588|NCT01262547|178394|P1|STARTED|Overall Study||3
76589|NCT01261507|178405|P1|NOT COMPLETED|Overall Study||0
76590|NCT01261507|178405|P1|COMPLETED|Overall Study||15
76591|NCT01261507|178405|P1|STARTED|Overall Study||15
76592|NCT01262456|178417|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
76593|NCT01262456|178418|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
76594|NCT01262456|178419|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
76595|NCT01262456|178417|P3|COMPLETED|1-Month Open-Label Extension Period||98
76596|NCT01262456|178418|P2|COMPLETED|1-Month Open-Label Extension Period||97
76597|NCT01262456|178419|P1|COMPLETED|1-Month Open-Label Extension Period||120
76598|NCT01262456|178417|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
76599|NCT01262456|178418|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
76600|NCT01262456|178419|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
76601|NCT01262456|178417|P3|STARTED|1-Month Open-Label Extension Period||103
76602|NCT01262456|178418|P2|STARTED|1-Month Open-Label Extension Period||100
76603|NCT01262456|178419|P1|STARTED|1-Month Open-Label Extension Period||124
76604|NCT01262456|178417|P3|NOT COMPLETED|3-Month Double-Blind Period||26
76605|NCT01262456|178418|P2|NOT COMPLETED|3-Month Double-Blind Period||23
76606|NCT01262456|178419|P1|NOT COMPLETED|3-Month Double-Blind Period||19
76607|NCT01262456|178417|P3|COMPLETED|3-Month Double-Blind Period||103
76608|NCT01262456|178418|P2|COMPLETED|3-Month Double-Blind Period||100
76609|NCT01262456|178419|P1|COMPLETED|3-Month Double-Blind Period||124
76610|NCT01262456|178417|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
76611|NCT01262456|178418|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
76612|NCT01262456|178419|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
76613|NCT01262456|178417|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
76614|NCT01262456|178418|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
76615|NCT01262456|178419|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
76616|NCT01262456|178417|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
76617|NCT01262456|178418|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
76618|NCT01262456|178419|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
76619|NCT01262352|178462|P2|NOT COMPLETED|Period 2||0
76620|NCT01262352|178463|P1|NOT COMPLETED|Period 2||0
76621|NCT01262352|178462|P2|COMPLETED|Period 2||8
76622|NCT01262352|178463|P1|COMPLETED|Period 2||9
76623|NCT01262352|178462|P2|Dosed|Period 2||8
76624|NCT01262352|178463|P1|Dosed|Period 2||9
76625|NCT01262352|178462|P2|STARTED|Period 2||8
76626|NCT01262352|178463|P1|STARTED|Period 2||9
76627|NCT01262352|178462|P2|NOT COMPLETED|Washout||2
76628|NCT01262352|178463|P1|NOT COMPLETED|Washout||1
76629|NCT01262352|178462|P2|COMPLETED|Washout||8
76630|NCT01262352|178463|P1|COMPLETED|Washout||9
76631|NCT01262352|178462|P2|STARTED|Washout||10
76632|NCT01262352|178463|P1|STARTED|Washout||10
76633|NCT01262352|178462|P2|NOT COMPLETED|Period 1||0
76634|NCT01262352|178463|P1|NOT COMPLETED|Period 1||1
76635|NCT01262352|178462|P2|COMPLETED|Period 1||10
76636|NCT01262352|178463|P1|COMPLETED|Period 1||10
76637|NCT01262352|178462|P2|Dosed|Period 1||10
76638|NCT01262352|178463|P1|Dosed|Period 1||10
76639|NCT01262352|178462|P2|STARTED|Period 1||10
76640|NCT01262352|178463|P1|STARTED|Period 1||11
76641|NCT01262339|178475|P1|NOT COMPLETED|Overall Study||0
76642|NCT01262339|178475|P1|COMPLETED|Overall Study||2
76643|NCT01262339|178475|P1|STARTED|Overall Study||2
76644|NCT01262287|178481|P2|NOT COMPLETED|Overall Study||2
76645|NCT01262287|178482|P1|NOT COMPLETED|Overall Study||2
76646|NCT01262287|178481|P2|COMPLETED|Overall Study||17
76647|NCT01262287|178482|P1|COMPLETED|Overall Study||18
76648|NCT01262287|178481|P2|STARTED|Overall Study||19
76649|NCT01262287|178482|P1|STARTED|Overall Study||20
76650|NCT01262131|178495|P3|NOT COMPLETED|Overall Study||0
76651|NCT01262131|178496|P2|NOT COMPLETED|Overall Study||0
76652|NCT01262131|178497|P1|NOT COMPLETED|Overall Study||0
76653|NCT01262131|178495|P3|COMPLETED|Overall Study||4
76654|NCT01262131|178496|P2|COMPLETED|Overall Study||4
76655|NCT01262131|178497|P1|COMPLETED|Overall Study||5
76656|NCT01262131|178495|P3|STARTED|Overall Study||4
76657|NCT01262131|178496|P2|STARTED|Overall Study||4
76658|NCT01262131|178497|P1|STARTED|Overall Study||5
76659|NCT01262118|178507|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
76660|NCT01262118|178508|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
76661|NCT01262118|178507|P2|COMPLETED|Treatment Period (6 Weeks)||0
76662|NCT01262118|178508|P1|COMPLETED|Treatment Period (6 Weeks)||36
76663|NCT01262118|178507|P2|STARTED|Treatment Period (6 Weeks)||0
76664|NCT01262118|178508|P1|STARTED|Treatment Period (6 Weeks)||36
76665|NCT01262118|178507|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
76666|NCT01262118|178508|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
76667|NCT01262118|178507|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
76668|NCT01262118|178508|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
76669|NCT01262118|178507|P2|STARTED|Baseline Assessment Period (3 Days)||33
76670|NCT01262118|178508|P1|STARTED|Baseline Assessment Period (3 Days)||36
76671|NCT01262105|178534|P2|NOT COMPLETED|Overall Study||0
76672|NCT01262105|178535|P1|NOT COMPLETED|Overall Study||0
76673|NCT01262105|178534|P2|COMPLETED|Overall Study||10
76674|NCT01262105|178535|P1|COMPLETED|Overall Study||13
76675|NCT01262105|178534|P2|STARTED|Overall Study||10
76676|NCT01262105|178535|P1|STARTED|Overall Study||13
76677|NCT01262092|178543|P2|NOT COMPLETED|Gabapentin Taper||0
76678|NCT01262092|178544|P1|NOT COMPLETED|Gabapentin Taper||1
76679|NCT01262092|178543|P2|COMPLETED|Gabapentin Taper||11
76680|NCT01262092|178544|P1|COMPLETED|Gabapentin Taper||9
76681|NCT01262092|178543|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
76682|NCT01262092|178544|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
76683|NCT01262092|178543|P2|NOT COMPLETED|Buprenorphine Taper||1
76684|NCT01262092|178544|P1|NOT COMPLETED|Buprenorphine Taper||1
76685|NCT01262092|178543|P2|COMPLETED|Buprenorphine Taper||12
76686|NCT01262092|178544|P1|COMPLETED|Buprenorphine Taper||11
76687|NCT01262092|178543|P2|STARTED|Buprenorphine Taper||13
76688|NCT01262092|178544|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
76689|NCT01262092|178543|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
76690|NCT01262092|178544|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
76691|NCT01262092|178543|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
76692|NCT01262092|178544|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
76693|NCT01262092|178543|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
76694|NCT01262092|178544|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
76695|NCT01262027|178550|P1|NOT COMPLETED|Overall Study||5
76696|NCT01262027|178550|P1|COMPLETED|Overall Study||17
76697|NCT01262027|178550|P1|STARTED|Overall Study||22
76698|NCT01261975|178555|P1|NOT COMPLETED|Overall Study||1
76699|NCT01261975|178555|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
76700|NCT01261975|178555|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
76701|NCT01261624|178576|P2|NOT COMPLETED|Week 13 to Week 24||1
76702|NCT01261624|178577|P1|NOT COMPLETED|Week 13 to Week 24||0
76703|NCT01261624|178576|P2|COMPLETED|Week 13 to Week 24||10
76704|NCT01261624|178577|P1|COMPLETED|Week 13 to Week 24||1
76705|NCT01261624|178576|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
76706|NCT01261624|178577|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
76707|NCT01261624|178576|P2|NOT COMPLETED|Week 0 to Week 12||3
76708|NCT01261624|178577|P1|NOT COMPLETED|Week 0 to Week 12||1
76709|NCT01261624|178576|P2|COMPLETED|Week 0 to Week 12||3
76710|NCT01261624|178577|P1|COMPLETED|Week 0 to Week 12||9
76711|NCT01261624|178576|P2|STARTED|Week 0 to Week 12||6
76712|NCT01261624|178577|P1|STARTED|Week 0 to Week 12||10
76713|NCT01261559|178596|P2|NOT COMPLETED|Overall Study||0
76714|NCT01261559|178597|P1|NOT COMPLETED|Overall Study||0
76715|NCT01261559|178596|P2|COMPLETED|Overall Study||36
76716|NCT01261559|178597|P1|COMPLETED|Overall Study||36
76717|NCT01261559|178596|P2|STARTED|Overall Study||36
76718|NCT01261559|178597|P1|STARTED|Overall Study||36
76719|NCT01261325|178608|P3|NOT COMPLETED|Overall Study||26
76720|NCT01261325|178609|P2|NOT COMPLETED|Overall Study||29
76721|NCT01261325|178610|P1|NOT COMPLETED|Overall Study||17
76722|NCT01261325|178608|P3|COMPLETED|Overall Study||225
76723|NCT01261325|178609|P2|COMPLETED|Overall Study||225
76724|NCT01261325|178610|P1|COMPLETED|Overall Study||246
76725|NCT01261325|178608|P3|STARTED|Overall Study||251
76726|NCT01261325|178609|P2|STARTED|Overall Study||254
76727|NCT01261325|178610|P1|STARTED|Overall Study||263
76728|NCT01261052|178642|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
76729|NCT01261052|178642|P1|COMPLETED|APD Only Intervention (33 Hours)||14
76730|NCT01261052|178642|P1|STARTED|APD Only Intervention (33 Hours)||14
76731|NCT01261052|178642|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
76732|NCT01261052|178642|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
76733|NCT01261052|178642|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
76734|NCT01260948|178650|P2|NOT COMPLETED|Second Intervention||1
76735|NCT01260948|178651|P1|NOT COMPLETED|Second Intervention||0
76736|NCT01260948|178650|P2|COMPLETED|Second Intervention||9
76737|NCT01260948|178651|P1|COMPLETED|Second Intervention||12
76738|NCT01260948|178650|P2|STARTED|Second Intervention||10
76739|NCT01260948|178651|P1|STARTED|Second Intervention||12
76740|NCT01260948|178650|P2|NOT COMPLETED|Washout of 28 Days||3
76741|NCT01260948|178651|P1|NOT COMPLETED|Washout of 28 Days||1
76742|NCT01260948|178650|P2|COMPLETED|Washout of 28 Days||10
76743|NCT01260948|178651|P1|COMPLETED|Washout of 28 Days||12
76744|NCT01260948|178650|P2|STARTED|Washout of 28 Days||13
76745|NCT01260948|178651|P1|STARTED|Washout of 28 Days||13
76746|NCT01260948|178650|P2|NOT COMPLETED|First Intervention||0
76747|NCT01260948|178651|P1|NOT COMPLETED|First Intervention||0
76748|NCT01260948|178650|P2|COMPLETED|First Intervention||13
76749|NCT01260948|178651|P1|COMPLETED|First Intervention||13
76750|NCT01260948|178650|P2|STARTED|First Intervention||13
76751|NCT01260948|178651|P1|STARTED|First Intervention||13
76752|NCT01260922|178661|P2|NOT COMPLETED|Second Intervention||2
76753|NCT01260922|178662|P1|NOT COMPLETED|Second Intervention||0
76754|NCT01260922|178661|P2|COMPLETED|Second Intervention||8
76755|NCT01260922|178662|P1|COMPLETED|Second Intervention||9
76756|NCT01260922|178661|P2|STARTED|Second Intervention||10
76757|NCT01260922|178662|P1|STARTED|Second Intervention||9
76758|NCT01260922|178661|P2|NOT COMPLETED|Washout of 28 Days||2
76759|NCT01260922|178662|P1|NOT COMPLETED|Washout of 28 Days||4
76760|NCT01260922|178661|P2|COMPLETED|Washout of 28 Days||10
76761|NCT01260922|178662|P1|COMPLETED|Washout of 28 Days||9
76762|NCT01260922|178661|P2|STARTED|Washout of 28 Days||12
76763|NCT01260922|178662|P1|STARTED|Washout of 28 Days||13
76764|NCT01260922|178661|P2|NOT COMPLETED|First Intervention||1
76765|NCT01260922|178662|P1|NOT COMPLETED|First Intervention||0
76766|NCT01260922|178661|P2|COMPLETED|First Intervention||12
76767|NCT01260922|178662|P1|COMPLETED|First Intervention||13
76768|NCT01260922|178661|P2|STARTED|First Intervention||13
76769|NCT01260922|178662|P1|STARTED|First Intervention||13
76770|NCT01260896|178672|P2|NOT COMPLETED|Second Intervention||0
76771|NCT01260896|178673|P1|NOT COMPLETED|Second Intervention||0
76772|NCT01260896|178672|P2|COMPLETED|Second Intervention||12
76773|NCT01260896|178673|P1|COMPLETED|Second Intervention||10
76774|NCT01260896|178672|P2|STARTED|Second Intervention||12
76775|NCT01260896|178673|P1|STARTED|Second Intervention||10
76776|NCT01260896|178672|P2|NOT COMPLETED|Washout of 7 Days||0
76777|NCT01260896|178673|P1|NOT COMPLETED|Washout of 7 Days||0
76778|NCT01260896|178672|P2|COMPLETED|Washout of 7 Days||12
76779|NCT01260896|178673|P1|COMPLETED|Washout of 7 Days||10
76780|NCT01260896|178672|P2|STARTED|Washout of 7 Days||12
76781|NCT01260896|178673|P1|STARTED|Washout of 7 Days||10
76782|NCT01260896|178672|P2|NOT COMPLETED|First Intervention||0
76783|NCT01260896|178673|P1|NOT COMPLETED|First Intervention||2
76784|NCT01260896|178672|P2|COMPLETED|First Intervention||12
76785|NCT01260896|178673|P1|COMPLETED|First Intervention||10
76786|NCT01260896|178672|P2|STARTED|First Intervention||12
76787|NCT01260896|178673|P1|STARTED|First Intervention||12
76788|NCT01260883|178692|P3|NOT COMPLETED|Overall Study||0
76789|NCT01260883|178693|P2|NOT COMPLETED|Overall Study||0
76790|NCT01260883|178694|P1|NOT COMPLETED|Overall Study||0
76791|NCT01260883|178692|P3|COMPLETED|Overall Study||18
76792|NCT01260883|178693|P2|COMPLETED|Overall Study||11
76793|NCT01260883|178694|P1|COMPLETED|Overall Study||22
76794|NCT01260883|178692|P3|STARTED|Overall Study||18
76795|NCT01260883|178693|P2|STARTED|Overall Study||11
76796|NCT01260883|178694|P1|STARTED|Overall Study||22
76797|NCT01260701|178731|P1|NOT COMPLETED|Overall Study||75
76798|NCT01260701|178731|P1|COMPLETED|Overall Study||0
76799|NCT01260701|178731|P1|Eligible and Began Protocol Therapy|Overall Study||70
76800|NCT01260701|178731|P1|Eligible|Overall Study||71
76801|NCT01260701|178731|P1|STARTED|Overall Study||75
76802|NCT01260688|178740|P2|NOT COMPLETED|Overall Study||0
76803|NCT01260688|178741|P1|NOT COMPLETED|Overall Study||0
76804|NCT01260688|178740|P2|COMPLETED|Overall Study||11
76805|NCT01260688|178741|P1|COMPLETED|Overall Study||11
76806|NCT01260688|178740|P2|STARTED|Overall Study||11
76807|NCT01260688|178741|P1|STARTED|Overall Study||11
76808|NCT01260662|178750|P3|NOT COMPLETED|Overall Study||0
76809|NCT01260662|178751|P2|NOT COMPLETED|Overall Study||0
76810|NCT01260662|178752|P1|NOT COMPLETED|Overall Study||0
76811|NCT01260662|178750|P3|COMPLETED|Overall Study||96
76812|NCT01260662|178751|P2|COMPLETED|Overall Study||85
76813|NCT01260662|178752|P1|COMPLETED|Overall Study||90
76814|NCT01260662|178750|P3|STARTED|Overall Study||96
76815|NCT01260662|178751|P2|STARTED|Overall Study||85
76816|NCT01260662|178752|P1|STARTED|Overall Study||90
76817|NCT01260584|178773|P4|NOT COMPLETED|Period 2||1
76818|NCT01260584|178774|P3|NOT COMPLETED|Period 2||5
76819|NCT01260584|178775|P2|NOT COMPLETED|Period 2||3
76820|NCT01260584|178776|P1|NOT COMPLETED|Period 2||1
76821|NCT01260584|178773|P4|COMPLETED|Period 2||26
76822|NCT01260584|178774|P3|COMPLETED|Period 2||20
76823|NCT01260584|178775|P2|COMPLETED|Period 2||25
76824|NCT01260584|178776|P1|COMPLETED|Period 2||26
76825|NCT01260584|178773|P4|STARTED|Period 2||27
76826|NCT01260584|178774|P3|STARTED|Period 2||25
76827|NCT01260584|178775|P2|STARTED|Period 2||28
76828|NCT01260584|178776|P1|STARTED|Period 2||27
76829|NCT01260584|178773|P4|NOT COMPLETED|Period 1||1
76830|NCT01260584|178774|P3|NOT COMPLETED|Period 1||2
76831|NCT01260584|178775|P2|NOT COMPLETED|Period 1||0
76832|NCT01260584|178776|P1|NOT COMPLETED|Period 1||0
76833|NCT01260584|178773|P4|COMPLETED|Period 1||27
76834|NCT01260584|178774|P3|COMPLETED|Period 1||25
76835|NCT01260584|178775|P2|COMPLETED|Period 1||28
76836|NCT01260584|178776|P1|COMPLETED|Period 1||27
76837|NCT01260584|178773|P4|STARTED|Period 1||28
76838|NCT01260584|178774|P3|STARTED|Period 1||27
76839|NCT01260584|178775|P2|STARTED|Period 1||28
76840|NCT01260584|178776|P1|STARTED|Period 1||27
76841|NCT01260493|178812|P2|NOT COMPLETED|Overall Study||4
76842|NCT01260493|178813|P1|NOT COMPLETED|Overall Study||16
76843|NCT01260493|178812|P2|COMPLETED|Overall Study||85
76844|NCT01260493|178813|P1|COMPLETED|Overall Study||76
76845|NCT01260493|178812|P2|STARTED|Overall Study||89
76846|NCT01260493|178813|P1|STARTED|Overall Study||92
76847|NCT01260467|178819|P1|NOT COMPLETED|Overall Study||2
76848|NCT01260467|178819|P1|COMPLETED|Overall Study||2
76849|NCT01260467|178819|P1|STARTED|Overall Study||4
76850|NCT01260454|178825|P1|NOT COMPLETED|Overall Study||0
76851|NCT01260454|178825|P1|COMPLETED|Overall Study||6
76852|NCT01260454|178825|P1|STARTED|Overall Study||6
76853|NCT01260350|178851|P22|NOT COMPLETED|Overall Study||0
76854|NCT01260350|178852|P21|NOT COMPLETED|Overall Study||3
76855|NCT01260350|178853|P20|NOT COMPLETED|Overall Study||0
76856|NCT01260350|178854|P19|NOT COMPLETED|Overall Study||0
76857|NCT01260350|178855|P18|NOT COMPLETED|Overall Study||1
76858|NCT01260350|178856|P17|NOT COMPLETED|Overall Study||0
76859|NCT01260350|178857|P16|NOT COMPLETED|Overall Study||0
76860|NCT01260350|178858|P15|NOT COMPLETED|Overall Study||0
76861|NCT01260350|178859|P14|NOT COMPLETED|Overall Study||0
76862|NCT01260350|178860|P13|NOT COMPLETED|Overall Study||0
76863|NCT01260350|178861|P12|NOT COMPLETED|Overall Study||0
76864|NCT01260350|178862|P11|NOT COMPLETED|Overall Study||0
76865|NCT01260350|178863|P10|NOT COMPLETED|Overall Study||0
76866|NCT01260350|178864|P9|NOT COMPLETED|Overall Study||1
76867|NCT01260350|178865|P8|NOT COMPLETED|Overall Study||0
76868|NCT01260350|178866|P7|NOT COMPLETED|Overall Study||0
76869|NCT01260350|178867|P6|NOT COMPLETED|Overall Study||0
76870|NCT01260350|178868|P5|NOT COMPLETED|Overall Study||0
76871|NCT01260350|178869|P4|NOT COMPLETED|Overall Study||0
76872|NCT01260350|178870|P3|NOT COMPLETED|Overall Study||0
76873|NCT01260350|178871|P2|NOT COMPLETED|Overall Study||0
76874|NCT01260350|178872|P1|NOT COMPLETED|Overall Study||0
76875|NCT01260350|178851|P22|COMPLETED|Overall Study||0
76876|NCT01260350|178852|P21|COMPLETED|Overall Study||22
76877|NCT01260350|178853|P20|COMPLETED|Overall Study||14
76878|NCT01260350|178854|P19|COMPLETED|Overall Study||0
76879|NCT01260350|178855|P18|COMPLETED|Overall Study||9
76880|NCT01260350|178856|P17|COMPLETED|Overall Study||9
76881|NCT01260350|178857|P16|COMPLETED|Overall Study||10
76882|NCT01260350|178858|P15|COMPLETED|Overall Study||25
76883|NCT01260350|178859|P14|COMPLETED|Overall Study||10
76884|NCT01260350|178860|P13|COMPLETED|Overall Study||25
76885|NCT01260350|178861|P12|COMPLETED|Overall Study||9
76886|NCT01260350|178862|P11|COMPLETED|Overall Study||10
76887|NCT01260350|178863|P10|COMPLETED|Overall Study||25
76888|NCT01260350|178864|P9|COMPLETED|Overall Study||24
76889|NCT01260350|178865|P8|COMPLETED|Overall Study||25
76890|NCT01260350|178866|P7|COMPLETED|Overall Study||10
76891|NCT01260350|178867|P6|COMPLETED|Overall Study||10
76892|NCT01260350|178868|P5|COMPLETED|Overall Study||10
76893|NCT01260350|178869|P4|COMPLETED|Overall Study||11
76894|NCT01260350|178870|P3|COMPLETED|Overall Study||10
76895|NCT01260350|178871|P2|COMPLETED|Overall Study||9
76896|NCT01260350|178872|P1|COMPLETED|Overall Study||10
76897|NCT01260350|178851|P22|STARTED|Overall Study||0
76898|NCT01260350|178852|P21|STARTED|Overall Study||25
76899|NCT01260350|178853|P20|STARTED|Overall Study||14
76900|NCT01260350|178854|P19|STARTED|Overall Study||0
76901|NCT01260350|178855|P18|STARTED|Overall Study||10
76902|NCT01260350|178856|P17|STARTED|Overall Study||9
76903|NCT01260350|178857|P16|STARTED|Overall Study||10
76904|NCT01260350|178858|P15|STARTED|Overall Study||25
76905|NCT01260350|178859|P14|STARTED|Overall Study||10
76906|NCT01260350|178860|P13|STARTED|Overall Study||25
76907|NCT01260350|178861|P12|STARTED|Overall Study||9
76908|NCT01260350|178862|P11|STARTED|Overall Study||10
76909|NCT01260350|178863|P10|STARTED|Overall Study||25
76910|NCT01260350|178864|P9|STARTED|Overall Study||25
76911|NCT01260350|178865|P8|STARTED|Overall Study||25
76912|NCT01260350|178866|P7|STARTED|Overall Study||10
76913|NCT01260350|178867|P6|STARTED|Overall Study||10
76914|NCT01260350|178868|P5|STARTED|Overall Study||10
76915|NCT01260350|178869|P4|STARTED|Overall Study||11
76916|NCT01260350|178870|P3|STARTED|Overall Study||10
76917|NCT01260350|178871|P2|STARTED|Overall Study||9
76918|NCT01260350|178872|P1|STARTED|Overall Study||10
76919|NCT01260324|179064|P2|NOT COMPLETED|Overall Study||0
76920|NCT01260324|179065|P1|NOT COMPLETED|Overall Study||0
76921|NCT01260324|179064|P2|COMPLETED|Overall Study||20000
76922|NCT01260324|179065|P1|COMPLETED|Overall Study||1283
76923|NCT01260324|179064|P2|STARTED|Overall Study||20000
76924|NCT01260324|179065|P1|STARTED|Overall Study||1283
76925|NCT01260311|179079|P1|NOT COMPLETED|Overall Study||127
76926|NCT01260311|179079|P1|COMPLETED|Overall Study||381
76927|NCT01260311|179079|P1|STARTED|Overall Study||508
76928|NCT01260272|179089|P2|NOT COMPLETED|Overall Study||2
76929|NCT01260272|179090|P1|NOT COMPLETED|Overall Study||2
76930|NCT01260272|179089|P2|COMPLETED|Overall Study||30
76931|NCT01260272|179090|P1|COMPLETED|Overall Study||15
76932|NCT01260272|179089|P2|STARTED|Overall Study||32
76933|NCT01260272|179090|P1|STARTED|Overall Study||17
76934|NCT01260194|179110|P1|NOT COMPLETED|Overall Study||1
76935|NCT01260194|179110|P1|COMPLETED|Overall Study||3
76936|NCT01260194|179110|P1|STARTED|Overall Study||4
76937|NCT01260142|179128|P6|NOT COMPLETED|Treatment Period 2||0
76938|NCT01260142|179129|P5|NOT COMPLETED|Treatment Period 2||0
76939|NCT01260142|179130|P4|NOT COMPLETED|Treatment Period 2||0
76940|NCT01260142|179131|P3|NOT COMPLETED|Treatment Period 2||0
76941|NCT01260142|179132|P2|NOT COMPLETED|Treatment Period 2||0
76942|NCT01260142|179133|P1|NOT COMPLETED|Treatment Period 2||0
76943|NCT01260142|179128|P6|COMPLETED|Treatment Period 2||3
76944|NCT01260142|179129|P5|COMPLETED|Treatment Period 2||4
76945|NCT01260142|179130|P4|COMPLETED|Treatment Period 2||6
76946|NCT01260142|179131|P3|COMPLETED|Treatment Period 2||6
76947|NCT01260142|179132|P2|COMPLETED|Treatment Period 2||5
76948|NCT01260142|179133|P1|COMPLETED|Treatment Period 2||5
76949|NCT01260142|179128|P6|STARTED|Treatment Period 2||3
76950|NCT01260142|179129|P5|STARTED|Treatment Period 2||4
76951|NCT01260142|179130|P4|STARTED|Treatment Period 2||6
76952|NCT01260142|179131|P3|STARTED|Treatment Period 2||6
76953|NCT01260142|179132|P2|STARTED|Treatment Period 2||5
76954|NCT01260142|179133|P1|STARTED|Treatment Period 2||5
76955|NCT01260142|179128|P6|NOT COMPLETED|Treatment Period 1||3
76956|NCT01260142|179129|P5|NOT COMPLETED|Treatment Period 1||2
76957|NCT01260142|179130|P4|NOT COMPLETED|Treatment Period 1||0
76958|NCT01260142|179131|P3|NOT COMPLETED|Treatment Period 1||0
76959|NCT01260142|179132|P2|NOT COMPLETED|Treatment Period 1||1
76960|NCT01260142|179133|P1|NOT COMPLETED|Treatment Period 1||1
76961|NCT01260142|179128|P6|COMPLETED|Treatment Period 1||3
76962|NCT01260142|179129|P5|COMPLETED|Treatment Period 1||4
76963|NCT01260142|179130|P4|COMPLETED|Treatment Period 1||6
76964|NCT01260142|179131|P3|COMPLETED|Treatment Period 1||6
76965|NCT01260142|179132|P2|COMPLETED|Treatment Period 1||5
76966|NCT01260142|179133|P1|COMPLETED|Treatment Period 1||5
76967|NCT01260142|179128|P6|STARTED|Treatment Period 1||6
76968|NCT01260142|179129|P5|STARTED|Treatment Period 1||6
76969|NCT01260142|179130|P4|STARTED|Treatment Period 1||6
76970|NCT01260142|179131|P3|STARTED|Treatment Period 1||6
76971|NCT01260142|179132|P2|STARTED|Treatment Period 1||6
76972|NCT01260142|179133|P1|STARTED|Treatment Period 1||6
76973|NCT01259726|179187|P4|NOT COMPLETED|Overall Study||5
76974|NCT01259726|179188|P3|NOT COMPLETED|Overall Study||4
76975|NCT01259726|179189|P2|NOT COMPLETED|Overall Study||4
76976|NCT01259726|179190|P1|NOT COMPLETED|Overall Study||5
76977|NCT01259726|179187|P4|COMPLETED|Overall Study||36
76978|NCT01259726|179188|P3|COMPLETED|Overall Study||39
76979|NCT01259726|179189|P2|COMPLETED|Overall Study||37
76980|NCT01259726|179190|P1|COMPLETED|Overall Study||38
76981|NCT01259726|179187|P4|Treated|Overall Study||39
76982|NCT01259726|179188|P3|Treated|Overall Study||41
76983|NCT01259726|179189|P2|Treated|Overall Study||37
76984|NCT01259726|179190|P1|Treated|Overall Study||40
76985|NCT01259726|179187|P4|STARTED|Overall Study||41
76986|NCT01259726|179188|P3|STARTED|Overall Study||43
76987|NCT01259726|179189|P2|STARTED|Overall Study||41
76988|NCT01259726|179190|P1|STARTED|Overall Study||43
76989|NCT01259713|179222|P2|NOT COMPLETED|Overall Study||41
76990|NCT01259713|179223|P1|NOT COMPLETED|Overall Study||95
76991|NCT01259713|179222|P2|COMPLETED|Overall Study||77
76992|NCT01259713|179223|P1|COMPLETED|Overall Study||142
76993|NCT01259713|179222|P2|STARTED|Overall Study||118
76994|NCT01259713|179223|P1|STARTED|Overall Study||237
76995|NCT01259492|179249|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
76996|NCT01259492|179250|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
76997|NCT01259492|179251|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
76998|NCT01259492|179252|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
76999|NCT01259492|179249|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
77000|NCT01259492|179250|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
77001|NCT01259492|179251|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
77002|NCT01259492|179252|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
77003|NCT01259492|179249|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
77004|NCT01259492|179250|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
77005|NCT01259492|179251|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
77006|NCT01259492|179252|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
77007|NCT01259492|179249|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
77008|NCT01259492|179250|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
77009|NCT01259492|179251|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
77010|NCT01259492|179252|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
77011|NCT01259492|179249|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
77012|NCT01259492|179250|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
77013|NCT01259492|179251|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
77014|NCT01259492|179252|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
77015|NCT01259492|179249|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
77016|NCT01259492|179250|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
77017|NCT01259492|179251|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
77018|NCT01259492|179252|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
77019|NCT01259492|179249|P4|STARTED|Period 2 (Week 10 to Week 14)||153
77020|NCT01259492|179250|P3|STARTED|Period 2 (Week 10 to Week 14)||138
77021|NCT01259492|179251|P2|STARTED|Period 2 (Week 10 to Week 14)||141
77105|NCT01259297|179361|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77022|NCT01259492|179252|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
77023|NCT01259492|179249|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
77024|NCT01259492|179250|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
77025|NCT01259492|179251|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
77026|NCT01259492|179252|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
77027|NCT01259492|179249|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
77028|NCT01259492|179250|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
77029|NCT01259492|179251|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
77030|NCT01259492|179252|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
77031|NCT01259492|179249|P4|Full Analysis Set|Period 1 (9 Weeks)||172
77032|NCT01259492|179250|P3|Full Analysis Set|Period 1 (9 Weeks)||179
77033|NCT01259492|179251|P2|Full Analysis Set|Period 1 (9 Weeks)||175
77034|NCT01259492|179252|P1|Full Analysis Set|Period 1 (9 Weeks)||174
77035|NCT01259492|179249|P4|STARTED|Period 1 (9 Weeks)||181
77036|NCT01259492|179250|P3|STARTED|Period 1 (9 Weeks)||181
77037|NCT01259492|179251|P2|STARTED|Period 1 (9 Weeks)||182
77038|NCT01259492|179252|P1|STARTED|Period 1 (9 Weeks)||181
77039|NCT01259466|179301|P2|NOT COMPLETED|Overall Study||9
77040|NCT01259466|179302|P1|NOT COMPLETED|Overall Study||1
77041|NCT01259466|179301|P2|COMPLETED|Overall Study||18
77042|NCT01259466|179302|P1|COMPLETED|Overall Study||26
77043|NCT01259466|179301|P2|STARTED|Overall Study||27
77044|NCT01259466|179302|P1|STARTED|Overall Study||27
77045|NCT01259440|179312|P2|NOT COMPLETED|Overall Study||0
77046|NCT01259440|179313|P1|NOT COMPLETED|Overall Study||0
77047|NCT01259440|179312|P2|COMPLETED|Overall Study||10
77048|NCT01259440|179313|P1|COMPLETED|Overall Study||13
77049|NCT01259440|179312|P2|STARTED|Overall Study||10
77050|NCT01259440|179313|P1|STARTED|Overall Study||13
77051|NCT01259427|179321|P2|NOT COMPLETED|Overall Study||14
77052|NCT01259427|179322|P1|NOT COMPLETED|Overall Study||18
77053|NCT01259427|179321|P2|COMPLETED|Overall Study||110
77054|NCT01259427|179322|P1|COMPLETED|Overall Study||106
77055|NCT01259427|179321|P2|STARTED|Overall Study||124
77056|NCT01259427|179322|P1|STARTED|Overall Study||124
77057|NCT01259401|179340|P2|NOT COMPLETED|4-month Follow-up||2
77058|NCT01259401|179341|P1|NOT COMPLETED|4-month Follow-up||0
77059|NCT01259401|179340|P2|COMPLETED|4-month Follow-up||19
77060|NCT01259401|179341|P1|COMPLETED|4-month Follow-up||21
77061|NCT01259401|179340|P2|STARTED|4-month Follow-up||21
77062|NCT01259401|179341|P1|STARTED|4-month Follow-up||21
77063|NCT01259401|179340|P2|NOT COMPLETED|End of 4-week Intervention||0
77064|NCT01259401|179341|P1|NOT COMPLETED|End of 4-week Intervention||0
77065|NCT01259401|179340|P2|COMPLETED|End of 4-week Intervention||21
77066|NCT01259401|179341|P1|COMPLETED|End of 4-week Intervention||21
77067|NCT01259401|179340|P2|STARTED|End of 4-week Intervention||21
77068|NCT01259401|179341|P1|STARTED|End of 4-week Intervention||21
77069|NCT01259297|179357|P8|NOT COMPLETED|Double Blind Randomized Period||3
77070|NCT01259297|179358|P7|NOT COMPLETED|Double Blind Randomized Period||6
77071|NCT01259297|179359|P6|NOT COMPLETED|Double Blind Randomized Period||8
77072|NCT01259297|179360|P5|NOT COMPLETED|Double Blind Randomized Period||4
77073|NCT01259297|179361|P4|NOT COMPLETED|Double Blind Randomized Period||4
77074|NCT01259297|179362|P3|NOT COMPLETED|Double Blind Randomized Period||1
77075|NCT01259297|179363|P2|NOT COMPLETED|Double Blind Randomized Period||3
77076|NCT01259297|179364|P1|NOT COMPLETED|Double Blind Randomized Period||2
77077|NCT01259297|179357|P8|COMPLETED|Double Blind Randomized Period||196
77078|NCT01259297|179358|P7|COMPLETED|Double Blind Randomized Period||190
77079|NCT01259297|179359|P6|COMPLETED|Double Blind Randomized Period||245
77080|NCT01259297|179360|P5|COMPLETED|Double Blind Randomized Period||247
77081|NCT01259297|179361|P4|COMPLETED|Double Blind Randomized Period||191
77082|NCT01259297|179362|P3|COMPLETED|Double Blind Randomized Period||188
77083|NCT01259297|179363|P2|COMPLETED|Double Blind Randomized Period||229
77084|NCT01259297|179364|P1|COMPLETED|Double Blind Randomized Period||242
77085|NCT01259297|179357|P8|STARTED|Double Blind Randomized Period||199
77086|NCT01259297|179358|P7|STARTED|Double Blind Randomized Period||196
77087|NCT01259297|179359|P6|STARTED|Double Blind Randomized Period||253
77088|NCT01259297|179360|P5|STARTED|Double Blind Randomized Period||251
77089|NCT01259297|179361|P4|STARTED|Double Blind Randomized Period||195
77090|NCT01259297|179362|P3|STARTED|Double Blind Randomized Period||189
77091|NCT01259297|179363|P2|STARTED|Double Blind Randomized Period||232
77092|NCT01259297|179364|P1|STARTED|Double Blind Randomized Period||244
77093|NCT01259297|179357|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77094|NCT01259297|179358|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77095|NCT01259297|179359|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77096|NCT01259297|179360|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77097|NCT01259297|179361|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77098|NCT01259297|179362|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
77099|NCT01259297|179363|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77100|NCT01259297|179364|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
77101|NCT01259297|179357|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77102|NCT01259297|179358|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77103|NCT01259297|179359|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77104|NCT01259297|179360|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77106|NCT01259297|179362|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
77107|NCT01259297|179363|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
77108|NCT01259297|179364|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
77109|NCT01259297|179357|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77110|NCT01259297|179358|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77111|NCT01259297|179359|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77112|NCT01259297|179360|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77113|NCT01259297|179361|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77114|NCT01259297|179362|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
77115|NCT01259297|179363|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
77116|NCT01259297|179364|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
77117|NCT01259284|179395|P3|NOT COMPLETED|Overall Study||0
77118|NCT01259284|179396|P2|NOT COMPLETED|Overall Study||0
77119|NCT01259284|179397|P1|NOT COMPLETED|Overall Study||2
77120|NCT01259284|179395|P3|COMPLETED|Overall Study||0
77121|NCT01259284|179396|P2|COMPLETED|Overall Study||0
77122|NCT01259284|179397|P1|COMPLETED|Overall Study||0
77123|NCT01259284|179395|P3|STARTED|Overall Study||0
77124|NCT01259284|179396|P2|STARTED|Overall Study||0
77125|NCT01259284|179397|P1|STARTED|Overall Study||2
77126|NCT01259245|179407|P2|NOT COMPLETED|Overall Study||26
77127|NCT01259245|179408|P1|NOT COMPLETED|Overall Study||28
77128|NCT01259245|179407|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
77129|NCT01259245|179408|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
77130|NCT01259245|179407|P2|STARTED|Overall Study||94
77131|NCT01259245|179408|P1|STARTED|Overall Study||98
77132|NCT01259115|179432|P2|NOT COMPLETED|Period 2||0
77133|NCT01259115|179433|P1|NOT COMPLETED|Period 2||1
77134|NCT01259115|179432|P2|COMPLETED|Period 2||9
77135|NCT01259115|179433|P1|COMPLETED|Period 2||6
77136|NCT01259115|179432|P2|STARTED|Period 2||9
77137|NCT01259115|179433|P1|STARTED|Period 2||7
77138|NCT01259115|179432|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
77139|NCT01259115|179433|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
77140|NCT01259115|179432|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
77141|NCT01259115|179433|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
77142|NCT01259115|179432|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
77143|NCT01259115|179433|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
77144|NCT01259115|179432|P2|NOT COMPLETED|Period 1||1
77145|NCT01259115|179433|P1|NOT COMPLETED|Period 1||3
77146|NCT01259115|179432|P2|COMPLETED|Period 1||9
77147|NCT01259115|179433|P1|COMPLETED|Period 1||7
77148|NCT01259115|179432|P2|STARTED|Period 1||10
77149|NCT01259115|179433|P1|STARTED|Period 1||10
77150|NCT01259102|179469|P5|NOT COMPLETED|Overall Study||1
77151|NCT01259102|179470|P4|NOT COMPLETED|Overall Study||2
77152|NCT01259102|179471|P3|NOT COMPLETED|Overall Study||2
77153|NCT01259102|179472|P2|NOT COMPLETED|Overall Study||0
77154|NCT01259102|179473|P1|NOT COMPLETED|Overall Study||1
77155|NCT01259102|179469|P5|COMPLETED|Overall Study||13
77156|NCT01259102|179470|P4|COMPLETED|Overall Study||12
77157|NCT01259102|179471|P3|COMPLETED|Overall Study||13
77158|NCT01259102|179472|P2|COMPLETED|Overall Study||14
77159|NCT01259102|179473|P1|COMPLETED|Overall Study||12
77160|NCT01259102|179469|P5|STARTED|Overall Study||14
77161|NCT01259102|179470|P4|STARTED|Overall Study||14
77162|NCT01259102|179471|P3|STARTED|Overall Study||15
77163|NCT01259102|179472|P2|STARTED|Overall Study||14
77164|NCT01259102|179473|P1|STARTED|Overall Study||13
77165|NCT01258998|179530|P1|NOT COMPLETED|Overall Study||1
77166|NCT01258998|179530|P1|COMPLETED|Overall Study||59
77167|NCT01258998|179530|P1|STARTED|Overall Study||60
77168|NCT01258985|179536|P2|NOT COMPLETED|Overall Study||0
77169|NCT01258985|179537|P1|NOT COMPLETED|Overall Study||0
77170|NCT01258985|179536|P2|COMPLETED|Overall Study||98
77171|NCT01258985|179537|P1|COMPLETED|Overall Study||106
77172|NCT01258985|179536|P2|STARTED|Overall Study||98
77173|NCT01258985|179537|P1|STARTED|Overall Study||106
77174|NCT01258803|179563|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77175|NCT01258803|179564|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77176|NCT01258803|179565|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77177|NCT01258803|179566|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77178|NCT01258803|179567|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77179|NCT01258803|179568|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
77180|NCT01258803|179563|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
77181|NCT01258803|179564|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
77182|NCT01258803|179565|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
77183|NCT01258803|179566|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
77184|NCT01258803|179567|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
77185|NCT01258803|179568|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
77186|NCT01258803|179563|P6|STARTED|Treatment Period 4 (1 Dose)||15
77187|NCT01258803|179564|P5|STARTED|Treatment Period 4 (1 Dose)||15
77188|NCT01258803|179565|P4|STARTED|Treatment Period 4 (1 Dose)||15
77189|NCT01258803|179566|P3|STARTED|Treatment Period 4 (1 Dose)||14
77190|NCT01258803|179567|P2|STARTED|Treatment Period 4 (1 Dose)||14
77191|NCT01258803|179568|P1|STARTED|Treatment Period 4 (1 Dose)||14
77192|NCT01258803|179563|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
77193|NCT01258803|179564|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
77194|NCT01258803|179565|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
77195|NCT01258803|179566|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
77196|NCT01258803|179567|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
77197|NCT01258803|179568|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
77198|NCT01258803|179563|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
77199|NCT01258803|179564|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
77200|NCT01258803|179565|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
77201|NCT01258803|179566|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
77202|NCT01258803|179567|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
77203|NCT01258803|179568|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
77204|NCT01258803|179563|P6|STARTED|Treatment Period 3 (1 Dose)||15
77205|NCT01258803|179564|P5|STARTED|Treatment Period 3 (1 Dose)||15
77206|NCT01258803|179565|P4|STARTED|Treatment Period 3 (1 Dose)||15
77207|NCT01258803|179566|P3|STARTED|Treatment Period 3 (1 Dose)||15
77208|NCT01258803|179567|P2|STARTED|Treatment Period 3 (1 Dose)||14
77209|NCT01258803|179568|P1|STARTED|Treatment Period 3 (1 Dose)||14
77210|NCT01258803|179563|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
77211|NCT01258803|179564|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
77212|NCT01258803|179565|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
77213|NCT01258803|179566|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
77214|NCT01258803|179567|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
77215|NCT01258803|179568|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
77216|NCT01258803|179563|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
77217|NCT01258803|179564|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
77218|NCT01258803|179565|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
77219|NCT01258803|179566|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
77220|NCT01258803|179567|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
77221|NCT01258803|179568|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
77222|NCT01258803|179563|P6|STARTED|Treatment Period 2 (1 Dose)||16
77223|NCT01258803|179564|P5|STARTED|Treatment Period 2 (1 Dose)||15
77224|NCT01258803|179565|P4|STARTED|Treatment Period 2 (1 Dose)||15
77225|NCT01258803|179566|P3|STARTED|Treatment Period 2 (1 Dose)||15
77226|NCT01258803|179567|P2|STARTED|Treatment Period 2 (1 Dose)||16
77227|NCT01258803|179568|P1|STARTED|Treatment Period 2 (1 Dose)||15
77228|NCT01258803|179563|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77229|NCT01258803|179564|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77230|NCT01258803|179565|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77231|NCT01258803|179566|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77232|NCT01258803|179567|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77233|NCT01258803|179568|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
77234|NCT01258803|179563|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
77235|NCT01258803|179564|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
77236|NCT01258803|179565|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
77237|NCT01258803|179566|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
77238|NCT01258803|179567|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
77239|NCT01258803|179568|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
77240|NCT01258803|179563|P6|STARTED|Treatment Period 1 (1 Dose)||16
77241|NCT01258803|179564|P5|STARTED|Treatment Period 1 (1 Dose)||15
77242|NCT01258803|179565|P4|STARTED|Treatment Period 1 (1 Dose)||15
77243|NCT01258803|179566|P3|STARTED|Treatment Period 1 (1 Dose)||15
77244|NCT01258803|179567|P2|STARTED|Treatment Period 1 (1 Dose)||16
77245|NCT01258803|179568|P1|STARTED|Treatment Period 1 (1 Dose)||15
77246|NCT01258790|179596|P2|NOT COMPLETED|Overall Study||0
77247|NCT01258790|179597|P1|NOT COMPLETED|Overall Study||0
77248|NCT01258790|179596|P2|COMPLETED|Overall Study||6
77249|NCT01258790|179597|P1|COMPLETED|Overall Study||6
77250|NCT01258790|179596|P2|STARTED|Overall Study||6
77251|NCT01258790|179597|P1|STARTED|Overall Study||6
77252|NCT01258738|179605|P2|NOT COMPLETED|Open-label Period||21
77253|NCT01258738|179606|P1|NOT COMPLETED|Open-label Period||17
77254|NCT01258738|179605|P2|COMPLETED|Open-label Period||85
77255|NCT01258738|179606|P1|COMPLETED|Open-label Period||85
77256|NCT01258738|179605|P2|STARTED|Open-label Period||106
77257|NCT01258738|179606|P1|STARTED|Open-label Period||102
77258|NCT01258738|179605|P2|NOT COMPLETED|Double-blind Period||7
77259|NCT01258738|179606|P1|NOT COMPLETED|Double-blind Period||9
77260|NCT01258738|179605|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
77261|NCT01258738|179606|P1|COMPLETED|Double-blind Period||102
77262|NCT01258738|179605|P2|Treated|Double-blind Period||113
77263|NCT01258738|179606|P1|Treated|Double-blind Period||111
77264|NCT01258738|179605|P2|STARTED|Double-blind Period||114
77265|NCT01258738|179606|P1|STARTED|Double-blind Period||111
77266|NCT01258660|179744|P2|NOT COMPLETED|Overall Study||11
77267|NCT01258660|179745|P1|NOT COMPLETED|Overall Study||11
77268|NCT01258660|179744|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
77269|NCT01258660|179745|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
77270|NCT01258660|179744|P2|Completed Treatment|Overall Study||81
77271|NCT01258660|179745|P1|Completed Treatment|Overall Study||79
77272|NCT01258660|179744|P2|Received Treatment|Overall Study||82
77273|NCT01258660|179745|P1|Received Treatment|Overall Study||79
77274|NCT01258660|179744|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
77275|NCT01258660|179745|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
77276|NCT01258595|179764|P2|NOT COMPLETED|Overall Study||1
77277|NCT01258595|179765|P1|NOT COMPLETED|Overall Study||1
77278|NCT01258595|179764|P2|COMPLETED|Overall Study||151
77279|NCT01258595|179765|P1|COMPLETED|Overall Study||147
77280|NCT01258595|179764|P2|STARTED|Overall Study||152
77281|NCT01258595|179765|P1|STARTED|Overall Study||148
77282|NCT01258582|179781|P2|NOT COMPLETED|Overall Study||258
77283|NCT01258582|179782|P1|NOT COMPLETED|Overall Study||282
77284|NCT01258582|179781|P2|COMPLETED|Overall Study||563
77285|NCT01258582|179782|P1|COMPLETED|Overall Study||548
77286|NCT01258582|179781|P2|STARTED|Overall Study||821
77287|NCT01258582|179782|P1|STARTED|Overall Study||830
77288|NCT01258504|179788|P1|NOT COMPLETED|Bosentan and SJW||0
77289|NCT01258504|179788|P1|COMPLETED|Bosentan and SJW||13
77290|NCT01258504|179788|P1|STARTED|Bosentan and SJW||13
77291|NCT01258504|179788|P1|NOT COMPLETED|Bosentan Steady-state||0
77292|NCT01258504|179788|P1|COMPLETED|Bosentan Steady-state||13
77293|NCT01258504|179788|P1|STARTED|Bosentan Steady-state||13
77294|NCT01258504|179788|P1|NOT COMPLETED|Bosentan Single Dose||0
77295|NCT01258504|179788|P1|COMPLETED|Bosentan Single Dose||13
77296|NCT01258504|179788|P1|STARTED|Bosentan Single Dose||13
77297|NCT01257204|179802|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
77298|NCT01257204|179803|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
77299|NCT01257204|179804|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
77300|NCT01257204|179802|P3|COMPLETED|Follow-up Period (up to Week 48)||39
77301|NCT01257204|179803|P2|COMPLETED|Follow-up Period (up to Week 48)||41
77302|NCT01257204|179804|P1|COMPLETED|Follow-up Period (up to Week 48)||48
77303|NCT01257204|179802|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
77304|NCT01257204|179803|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
77305|NCT01257204|179804|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
77306|NCT01257204|179802|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
77307|NCT01257204|179803|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
77308|NCT01257204|179804|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
77309|NCT01257204|179802|P3|COMPLETED|Treatment Period (up to Week 24)||42
77310|NCT01257204|179803|P2|COMPLETED|Treatment Period (up to Week 24)||44
77311|NCT01257204|179804|P1|COMPLETED|Treatment Period (up to Week 24)||45
77312|NCT01257204|179802|P3|STARTED|Treatment Period (up to Week 24)||51
77313|NCT01257204|179803|P2|STARTED|Treatment Period (up to Week 24)||50
77314|NCT01257204|179804|P1|STARTED|Treatment Period (up to Week 24)||50
77315|NCT01258387|179856|P7|NOT COMPLETED|Overall Study||0
77316|NCT01258387|179857|P6|NOT COMPLETED|Overall Study||0
77317|NCT01258387|179858|P5|NOT COMPLETED|Overall Study||0
77318|NCT01258387|179859|P4|NOT COMPLETED|Overall Study||0
77319|NCT01258387|179860|P3|NOT COMPLETED|Overall Study||0
77320|NCT01258387|179861|P2|NOT COMPLETED|Overall Study||0
77321|NCT01258387|179862|P1|NOT COMPLETED|Overall Study||0
77322|NCT01258387|179856|P7|COMPLETED|Overall Study||4
77323|NCT01258387|179857|P6|COMPLETED|Overall Study||6
77324|NCT01258387|179858|P5|COMPLETED|Overall Study||6
77325|NCT01258387|179859|P4|COMPLETED|Overall Study||6
77326|NCT01258387|179860|P3|COMPLETED|Overall Study||6
77327|NCT01258387|179861|P2|COMPLETED|Overall Study||6
77328|NCT01258387|179862|P1|COMPLETED|Overall Study||6
77329|NCT01258387|179856|P7|Patients Randomized to Placebo|Overall Study||1
77330|NCT01258387|179857|P6|Patients Randomized to Placebo|Overall Study||2
77331|NCT01258387|179858|P5|Patients Randomized to Placebo|Overall Study||2
77332|NCT01258387|179859|P4|Patients Randomized to Placebo|Overall Study||2
77333|NCT01258387|179860|P3|Patients Randomized to Placebo|Overall Study||2
77334|NCT01258387|179861|P2|Patients Randomized to Placebo|Overall Study||2
77335|NCT01258387|179862|P1|Patients Randomized to Placebo|Overall Study||2
77336|NCT01258387|179856|P7|Patients Randomized to GGF2|Overall Study||3
77337|NCT01258387|179857|P6|Patients Randomized to GGF2|Overall Study||4
77338|NCT01258387|179858|P5|Patients Randomized to GGF2|Overall Study||4
77339|NCT01258387|179859|P4|Patients Randomized to GGF2|Overall Study||4
77340|NCT01258387|179860|P3|Patients Randomized to GGF2|Overall Study||4
77341|NCT01258387|179861|P2|Patients Randomized to GGF2|Overall Study||4
77342|NCT01258387|179862|P1|Patients Randomized to GGF2|Overall Study||4
77343|NCT01258387|179856|P7|STARTED|Overall Study||4
77344|NCT01258387|179857|P6|STARTED|Overall Study||6
77345|NCT01258387|179858|P5|STARTED|Overall Study||6
77346|NCT01258387|179859|P4|STARTED|Overall Study||6
77347|NCT01258387|179860|P3|STARTED|Overall Study||6
77348|NCT01258387|179861|P2|STARTED|Overall Study||6
77349|NCT01258387|179862|P1|STARTED|Overall Study||6
77350|NCT01258153|179907|P3|NOT COMPLETED|Overall Study||1
77351|NCT01258153|179908|P2|NOT COMPLETED|Overall Study||1
77352|NCT01258153|179909|P1|NOT COMPLETED|Overall Study||1
77353|NCT01258153|179907|P3|COMPLETED|Overall Study||36
77354|NCT01258153|179908|P2|COMPLETED|Overall Study||37
77355|NCT01258153|179909|P1|COMPLETED|Overall Study||39
77356|NCT01258153|179907|P3|STARTED|Overall Study||37
77357|NCT01258153|179908|P2|STARTED|Overall Study||38
77358|NCT01258153|179909|P1|STARTED|Overall Study||40
77359|NCT01258101|179936|P4|NOT COMPLETED|Overall Study||25
77360|NCT01258101|179937|P3|NOT COMPLETED|Overall Study||11
77361|NCT01258101|179938|P2|NOT COMPLETED|Overall Study||34
77362|NCT01258101|179939|P1|NOT COMPLETED|Overall Study||33
77363|NCT01258101|179936|P4|COMPLETED|Overall Study||27
77364|NCT01258101|179937|P3|COMPLETED|Overall Study||22
77365|NCT01258101|179938|P2|COMPLETED|Overall Study||110
77366|NCT01258101|179939|P1|COMPLETED|Overall Study||118
77367|NCT01258101|179936|P4|Standard Analysis Population|Overall Study||26
77368|NCT01258101|179937|P3|Standard Analysis Population|Overall Study||21
77369|NCT01258101|179938|P2|Standard Analysis Population|Overall Study||110
77370|NCT01258101|179939|P1|Standard Analysis Population|Overall Study||115
77371|NCT01258101|179936|P4|Safety Analysis Population|Overall Study||48
77372|NCT01258101|179937|P3|Safety Analysis Population|Overall Study||30
77373|NCT01258101|179938|P2|Safety Analysis Population|Overall Study||141
77374|NCT01258101|179939|P1|Safety Analysis Population|Overall Study||144
77375|NCT01258101|179936|P4|STARTED|Overall Study||52
77376|NCT01258101|179937|P3|STARTED|Overall Study||33
77377|NCT01258101|179938|P2|STARTED|Overall Study||144
77378|NCT01258101|179939|P1|STARTED|Overall Study||151
77379|NCT01258049|179991|P2|NOT COMPLETED|Overall Study||2
77380|NCT01258049|179992|P1|NOT COMPLETED|Overall Study||2
77381|NCT01258049|179991|P2|COMPLETED|Overall Study||72
77382|NCT01258049|179992|P1|COMPLETED|Overall Study||75
77383|NCT01258049|179991|P2|STARTED|Overall Study||74
77384|NCT01258049|179992|P1|STARTED|Overall Study||77
77385|NCT01256983|180030|P2|NOT COMPLETED|Overall Study||3
77386|NCT01256983|180031|P1|NOT COMPLETED|Overall Study||1
77387|NCT01256983|180030|P2|COMPLETED|Overall Study||12
77388|NCT01256983|180031|P1|COMPLETED|Overall Study||14
77389|NCT01256983|180030|P2|STARTED|Overall Study||15
77390|NCT01256983|180031|P1|STARTED|Overall Study||15
77391|NCT01256944|180039|P2|NOT COMPLETED|Overall Study||0
77392|NCT01256944|180040|P1|NOT COMPLETED|Overall Study||0
77393|NCT01256944|180039|P2|COMPLETED|Overall Study||220
77394|NCT01256944|180040|P1|COMPLETED|Overall Study||70
77395|NCT01256944|180039|P2|STARTED|Overall Study||220
77396|NCT01256944|180040|P1|STARTED|Overall Study||70
77397|NCT01256918|180068|P1|NOT COMPLETED|Overall Study||0
77398|NCT01256918|180068|P1|COMPLETED|Overall Study||200
77399|NCT01256918|180068|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
77400|NCT01256918|180068|P1|STARTED|Overall Study||200
77401|NCT01255137|180079|P1|NOT COMPLETED|Overall Study||0
77402|NCT01255137|180079|P1|COMPLETED|Overall Study||13
77403|NCT01255137|180079|P1|STARTED|Overall Study||13
77404|NCT01257880|180086|P2|NOT COMPLETED|Overall Study||0
77405|NCT01257880|180087|P1|NOT COMPLETED|Overall Study||0
77406|NCT01257880|180086|P2|COMPLETED|Overall Study||19
77407|NCT01257880|180087|P1|COMPLETED|Overall Study||12
77408|NCT01257880|180086|P2|STARTED|Overall Study||19
77409|NCT01257880|180087|P1|STARTED|Overall Study||12
77410|NCT01257750|180095|P1|NOT COMPLETED|Overall Study||0
77411|NCT01257750|180095|P1|COMPLETED|Overall Study||20
77412|NCT01257750|180095|P1|STARTED|Overall Study||20
77413|NCT01257581|180103|P3|NOT COMPLETED|Overall Study||6
77414|NCT01257581|180104|P2|NOT COMPLETED|Overall Study||3
77415|NCT01257581|180105|P1|NOT COMPLETED|Overall Study||5
77416|NCT01257581|180103|P3|COMPLETED|Overall Study||11
77417|NCT01257581|180104|P2|COMPLETED|Overall Study||18
77418|NCT01257581|180105|P1|COMPLETED|Overall Study||17
77419|NCT01257581|180103|P3|STARTED|Overall Study||17
77420|NCT01257581|180104|P2|STARTED|Overall Study||21
77421|NCT01257581|180105|P1|STARTED|Overall Study||22
77422|NCT01257542|180145|P2|NOT COMPLETED|Overall Study||7
77423|NCT01257542|180146|P1|NOT COMPLETED|Overall Study||3
77424|NCT01257542|180145|P2|COMPLETED|Overall Study||45
77425|NCT01257542|180146|P1|COMPLETED|Overall Study||52
77426|NCT01257542|180145|P2|STARTED|Overall Study||52
77427|NCT01257542|180146|P1|STARTED|Overall Study||55
77428|NCT01257503|180166|P2|NOT COMPLETED|Overall Study||11
77429|NCT01257503|180167|P1|NOT COMPLETED|Overall Study||8
77430|NCT01257503|180166|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
77431|NCT01257503|180167|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
77432|NCT01257503|180166|P2|Returned Dosage Logbooks|Overall Study||80
77433|NCT01257503|180167|P1|Returned Dosage Logbooks|Overall Study||75
77434|NCT01257503|180166|P2|Returned Symptom Diaries|Overall Study||83
77435|NCT01257503|180167|P1|Returned Symptom Diaries|Overall Study||80
77436|NCT01257503|180166|P2|STARTED|Overall Study||130
77437|NCT01257503|180167|P1|STARTED|Overall Study||133
77438|NCT01257438|180183|P2|NOT COMPLETED|Overall Study||46
77439|NCT01257438|180184|P1|NOT COMPLETED|Overall Study||30
77440|NCT01257438|180183|P2|COMPLETED|Overall Study||97
77441|NCT01257438|180184|P1|COMPLETED|Overall Study||102
77442|NCT01257438|180183|P2|STARTED|Overall Study||143
77443|NCT01257438|180184|P1|STARTED|Overall Study||132
77444|NCT01257425|180196|P2|NOT COMPLETED|Overall Study||6
77445|NCT01257425|180197|P1|NOT COMPLETED|Overall Study||6
77446|NCT01257425|180196|P2|COMPLETED|Overall Study||45
77447|NCT01257425|180197|P1|COMPLETED|Overall Study||46
77448|NCT01257425|180196|P2|STARTED|Overall Study||51
77449|NCT01257425|180197|P1|STARTED|Overall Study||52
77450|NCT01257230|180218|P3|NOT COMPLETED|Overall Study||6
77451|NCT01257230|180219|P2|NOT COMPLETED|Overall Study||10
77452|NCT01257230|180220|P1|NOT COMPLETED|Overall Study||6
77453|NCT01257230|180218|P3|COMPLETED|Overall Study||129
77454|NCT01257230|180219|P2|COMPLETED|Overall Study||115
77455|NCT01257230|180220|P1|COMPLETED|Overall Study||132
77456|NCT01257230|180218|P3|STARTED|Overall Study||135
77457|NCT01257230|180219|P2|STARTED|Overall Study||125
77458|NCT01257230|180220|P1|STARTED|Overall Study||138
77459|NCT01256658|180275|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
77460|NCT01256658|180276|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
77461|NCT01256658|180275|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
77462|NCT01256658|180276|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
77463|NCT01256658|180275|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
77464|NCT01256658|180276|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
77465|NCT01256658|180275|P2|Death|Period 2 - Follow up Only - No Treatment||8
77466|NCT01256658|180276|P1|Death|Period 2 - Follow up Only - No Treatment||6
77467|NCT01256658|180275|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
77468|NCT01256658|180276|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
77469|NCT01256658|180275|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
77470|NCT01256658|180276|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
77471|NCT01256658|180275|P2|NOT COMPLETED|Period 1||748
77472|NCT01256658|180276|P1|NOT COMPLETED|Period 1||920
77473|NCT01256658|180275|P2|COMPLETED|Period 1||6510
77474|NCT01256658|180276|P1|COMPLETED|Period 1||5897
77475|NCT01256658|180275|P2|STARTED|Period 1||7258
77476|NCT01256658|180276|P1|STARTED|Period 1||6817
77477|NCT01256567|180326|P1|NOT COMPLETED|Overall Study||1
77478|NCT01256567|180326|P1|COMPLETED|Overall Study||6
77479|NCT01256567|180326|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
77480|NCT01256567|180326|P1|STARTED|Overall Study||7
77481|NCT01256502|180336|P1|NOT COMPLETED|Overall Study||10
77482|NCT01256502|180336|P1|COMPLETED|Overall Study||129
77483|NCT01256502|180336|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
77484|NCT01256476|180348|P2|NOT COMPLETED|Overall Study||7
77485|NCT01256476|180349|P1|NOT COMPLETED|Overall Study||6
77486|NCT01256476|180348|P2|COMPLETED|Overall Study||157
77487|NCT01256476|180349|P1|COMPLETED|Overall Study||158
77488|NCT01256476|180348|P2|STARTED|Overall Study||164
77489|NCT01256476|180349|P1|STARTED|Overall Study||164
77490|NCT01256450|180357|P3|NOT COMPLETED|Double-blind Treatment||37
77491|NCT01256450|180358|P2|NOT COMPLETED|Double-blind Treatment||28
77492|NCT01256450|180359|P1|NOT COMPLETED|Double-blind Treatment||0
77493|NCT01256450|180357|P3|COMPLETED|Double-blind Treatment||81
77494|NCT01256450|180358|P2|COMPLETED|Double-blind Treatment||89
77495|NCT01256450|180359|P1|COMPLETED|Double-blind Treatment||0
77496|NCT01256450|180357|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
77497|NCT01256450|180358|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
77498|NCT01256450|180359|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
77499|NCT01256450|180357|P3|NOT COMPLETED|Open-label Titration||0
77500|NCT01256450|180358|P2|NOT COMPLETED|Open-label Titration||0
77501|NCT01256450|180359|P1|NOT COMPLETED|Open-label Titration||99
77502|NCT01256450|180357|P3|COMPLETED|Open-label Titration||0
77503|NCT01256450|180358|P2|COMPLETED|Open-label Titration||0
77504|NCT01256450|180359|P1|COMPLETED|Open-label Titration||235
77505|NCT01256450|180357|P3|STARTED|Open-label Titration||0
77506|NCT01256450|180358|P2|STARTED|Open-label Titration||0
77507|NCT01256450|180359|P1|STARTED|Open-label Titration||334
77508|NCT01256424|180388|P4|NOT COMPLETED|Overall Study||7
77509|NCT01256424|180389|P3|NOT COMPLETED|Overall Study||7
77510|NCT01256424|180390|P2|NOT COMPLETED|Overall Study||8
77511|NCT01256424|180391|P1|NOT COMPLETED|Overall Study||9
77512|NCT01256424|180388|P4|COMPLETED|Overall Study||61
77513|NCT01256424|180389|P3|COMPLETED|Overall Study||55
77514|NCT01256424|180390|P2|COMPLETED|Overall Study||59
77515|NCT01256424|180391|P1|COMPLETED|Overall Study||56
77516|NCT01256424|180388|P4|STARTED|Overall Study||68
77517|NCT01256424|180389|P3|STARTED|Overall Study||62
77518|NCT01256424|180390|P2|STARTED|Overall Study||67
77519|NCT01256424|180391|P1|STARTED|Overall Study||65
77520|NCT01256411|180417|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
77521|NCT01256411|180418|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
77522|NCT01256411|180419|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
77523|NCT01256411|180420|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
77524|NCT01256411|180421|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
77525|NCT01256411|180422|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
77526|NCT01256411|180417|P6|COMPLETED|Extension by Mono or Combination Therapy||109
77527|NCT01256411|180418|P5|COMPLETED|Extension by Mono or Combination Therapy||211
77528|NCT01256411|180419|P4|COMPLETED|Extension by Mono or Combination Therapy||0
77529|NCT01256411|180420|P3|COMPLETED|Extension by Mono or Combination Therapy||0
77530|NCT01256411|180421|P2|COMPLETED|Extension by Mono or Combination Therapy||0
77531|NCT01256411|180422|P1|COMPLETED|Extension by Mono or Combination Therapy||0
77532|NCT01256411|180417|P6|STARTED|Extension by Mono or Combination Therapy||113
77533|NCT01256411|180418|P5|STARTED|Extension by Mono or Combination Therapy||228
77534|NCT01256411|180419|P4|STARTED|Extension by Mono or Combination Therapy||0
77535|NCT01256411|180420|P3|STARTED|Extension by Mono or Combination Therapy||0
77536|NCT01256411|180421|P2|STARTED|Extension by Mono or Combination Therapy||0
77537|NCT01256411|180422|P1|STARTED|Extension by Mono or Combination Therapy||0
77538|NCT01256411|180417|P6|NOT COMPLETED|Extension by Maximum Treatment||0
77539|NCT01256411|180418|P5|NOT COMPLETED|Extension by Maximum Treatment||0
77540|NCT01256411|180419|P4|NOT COMPLETED|Extension by Maximum Treatment||0
77541|NCT01256411|180420|P3|NOT COMPLETED|Extension by Maximum Treatment||4
77542|NCT01256411|180421|P2|NOT COMPLETED|Extension by Maximum Treatment||10
77543|NCT01256411|180422|P1|NOT COMPLETED|Extension by Maximum Treatment||7
77544|NCT01256411|180417|P6|COMPLETED|Extension by Maximum Treatment||0
77545|NCT01256411|180418|P5|COMPLETED|Extension by Maximum Treatment||0
77546|NCT01256411|180419|P4|COMPLETED|Extension by Maximum Treatment||4
77547|NCT01256411|180420|P3|COMPLETED|Extension by Maximum Treatment||105
77548|NCT01256411|180421|P2|COMPLETED|Extension by Maximum Treatment||79
77549|NCT01256411|180422|P1|COMPLETED|Extension by Maximum Treatment||132
77550|NCT01256411|180417|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
77551|NCT01256411|180418|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
77552|NCT01256411|180419|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
77553|NCT01256411|180420|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
77554|NCT01256411|180421|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
77555|NCT01256411|180422|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
77556|NCT01256411|180417|P6|STARTED|Extension by Maximum Treatment||0
77557|NCT01256411|180418|P5|STARTED|Extension by Maximum Treatment||0
77558|NCT01256411|180419|P4|STARTED|Extension by Maximum Treatment||4
77559|NCT01256411|180420|P3|STARTED|Extension by Maximum Treatment||109
77560|NCT01256411|180421|P2|STARTED|Extension by Maximum Treatment||89
77561|NCT01256411|180422|P1|STARTED|Extension by Maximum Treatment||139
77562|NCT01256385|180448|P2|NOT COMPLETED|Overall Study||3
77563|NCT01256385|180449|P1|NOT COMPLETED|Overall Study||3
77564|NCT01256385|180448|P2|COMPLETED|Overall Study||40
77565|NCT01256385|180449|P1|COMPLETED|Overall Study||40
77566|NCT01256385|180448|P2|Crossover From Arm B to Arm A|Overall Study||15
77567|NCT01256385|180449|P1|Crossover From Arm B to Arm A|Overall Study||0
77568|NCT01256385|180448|P2|STARTED|Overall Study||43
77569|NCT01256385|180449|P1|STARTED|Overall Study||43
77570|NCT01256294|180469|P2|NOT COMPLETED|Overall Study||2
77571|NCT01256294|180470|P1|NOT COMPLETED|Overall Study||4
77572|NCT01256294|180469|P2|COMPLETED|Overall Study||33
77573|NCT01256294|180470|P1|COMPLETED|Overall Study||32
77574|NCT01256294|180469|P2|STARTED|Overall Study||35
77575|NCT01256294|180470|P1|STARTED|Overall Study||36
77576|NCT01256281|180486|P1|NOT COMPLETED|Overall Study||0
77577|NCT01256281|180486|P1|COMPLETED|Overall Study||2
77578|NCT01256281|180486|P1|STARTED|Overall Study||2
77579|NCT01256190|180492|P2|NOT COMPLETED|Overall Study||0
77580|NCT01256190|180493|P1|NOT COMPLETED|Overall Study||2
77581|NCT01256190|180492|P2|COMPLETED|Overall Study||17
77582|NCT01256190|180493|P1|COMPLETED|Overall Study||37
77583|NCT01256190|180492|P2|STARTED|Overall Study||17
77584|NCT01256190|180493|P1|STARTED|Overall Study||39
77585|NCT01256177|180509|P2|NOT COMPLETED|Overall Study||37
77586|NCT01256177|180510|P1|NOT COMPLETED|Overall Study||50
77587|NCT01256177|180509|P2|COMPLETED|Overall Study||111
77588|NCT01256177|180510|P1|COMPLETED|Overall Study||98
77589|NCT01256177|180509|P2|STARTED|Overall Study||148
77590|NCT01256177|180510|P1|STARTED|Overall Study||148
77591|NCT01256164|180534|P2|NOT COMPLETED|Overall Study||0
77592|NCT01256164|180535|P1|NOT COMPLETED|Overall Study||0
77593|NCT01256164|180534|P2|COMPLETED|Overall Study||23
77594|NCT01256164|180535|P1|COMPLETED|Overall Study||47
77595|NCT01256164|180534|P2|STARTED|Overall Study||23
77596|NCT01256164|180535|P1|STARTED|Overall Study||47
77597|NCT01256086|180553|P4|NOT COMPLETED|Treatment Day 4||0
77598|NCT01256086|180554|P3|NOT COMPLETED|Treatment Day 4||0
77599|NCT01256086|180555|P2|NOT COMPLETED|Treatment Day 4||0
77600|NCT01256086|180556|P1|NOT COMPLETED|Treatment Day 4||0
77601|NCT01256086|180553|P4|COMPLETED|Treatment Day 4||11
77602|NCT01256086|180554|P3|COMPLETED|Treatment Day 4||9
77603|NCT01256086|180555|P2|COMPLETED|Treatment Day 4||10
77604|NCT01256086|180556|P1|COMPLETED|Treatment Day 4||11
77605|NCT01256086|180553|P4|STARTED|Treatment Day 4||11
77606|NCT01256086|180554|P3|STARTED|Treatment Day 4||9
77607|NCT01256086|180555|P2|STARTED|Treatment Day 4||10
77608|NCT01256086|180556|P1|STARTED|Treatment Day 4||11
77609|NCT01256086|180553|P4|NOT COMPLETED|Treatment Day 3||0
77610|NCT01256086|180554|P3|NOT COMPLETED|Treatment Day 3||0
77611|NCT01256086|180555|P2|NOT COMPLETED|Treatment Day 3||0
77612|NCT01256086|180556|P1|NOT COMPLETED|Treatment Day 3||0
77613|NCT01256086|180553|P4|COMPLETED|Treatment Day 3||11
77614|NCT01256086|180554|P3|COMPLETED|Treatment Day 3||9
77615|NCT01256086|180555|P2|COMPLETED|Treatment Day 3||10
77616|NCT01256086|180556|P1|COMPLETED|Treatment Day 3||11
77617|NCT01256086|180553|P4|STARTED|Treatment Day 3||11
77618|NCT01256086|180554|P3|STARTED|Treatment Day 3||9
77619|NCT01256086|180555|P2|STARTED|Treatment Day 3||10
77620|NCT01256086|180556|P1|STARTED|Treatment Day 3||11
77621|NCT01256086|180553|P4|NOT COMPLETED|Treatment Day 2||0
77622|NCT01256086|180554|P3|NOT COMPLETED|Treatment Day 2||0
77623|NCT01256086|180555|P2|NOT COMPLETED|Treatment Day 2||0
77624|NCT01256086|180556|P1|NOT COMPLETED|Treatment Day 2||0
77625|NCT01256086|180553|P4|COMPLETED|Treatment Day 2||11
77626|NCT01256086|180554|P3|COMPLETED|Treatment Day 2||9
77627|NCT01256086|180555|P2|COMPLETED|Treatment Day 2||10
77628|NCT01256086|180556|P1|COMPLETED|Treatment Day 2||11
77629|NCT01256086|180553|P4|STARTED|Treatment Day 2||11
77630|NCT01256086|180554|P3|STARTED|Treatment Day 2||9
77631|NCT01256086|180555|P2|STARTED|Treatment Day 2||10
77632|NCT01256086|180556|P1|STARTED|Treatment Day 2||11
77633|NCT01256086|180553|P4|NOT COMPLETED|Treatment Day 1||0
77634|NCT01256086|180554|P3|NOT COMPLETED|Treatment Day 1||0
77635|NCT01256086|180555|P2|NOT COMPLETED|Treatment Day 1||0
77636|NCT01256086|180556|P1|NOT COMPLETED|Treatment Day 1||0
77637|NCT01256086|180553|P4|COMPLETED|Treatment Day 1||11
77638|NCT01256086|180554|P3|COMPLETED|Treatment Day 1||11
77639|NCT01256086|180555|P2|COMPLETED|Treatment Day 1||11
77640|NCT01256086|180556|P1|COMPLETED|Treatment Day 1||11
77641|NCT01256086|180553|P4|STARTED|Treatment Day 1||11
77642|NCT01256086|180554|P3|STARTED|Treatment Day 1||11
77643|NCT01256086|180555|P2|STARTED|Treatment Day 1||11
77644|NCT01256086|180556|P1|STARTED|Treatment Day 1||11
77645|NCT01256060|180566|P4|NOT COMPLETED|Overall Study||0
77646|NCT01256060|180567|P3|NOT COMPLETED|Overall Study||0
77647|NCT01256060|180568|P2|NOT COMPLETED|Overall Study||1
77648|NCT01256060|180569|P1|NOT COMPLETED|Overall Study||0
77649|NCT01256060|180566|P4|COMPLETED|Overall Study||6
77650|NCT01256060|180567|P3|COMPLETED|Overall Study||3
77651|NCT01256060|180568|P2|COMPLETED|Overall Study||2
77652|NCT01256060|180569|P1|COMPLETED|Overall Study||3
77653|NCT01256060|180566|P4|STARTED|Overall Study||6
77654|NCT01256060|180567|P3|STARTED|Overall Study||3
77655|NCT01256060|180568|P2|STARTED|Overall Study||3
77656|NCT01256060|180569|P1|STARTED|Overall Study||3
77657|NCT01256034|180578|P2|NOT COMPLETED|Overall Study||25
77658|NCT01256034|180579|P1|NOT COMPLETED|Overall Study||25
77659|NCT01256034|180578|P2|COMPLETED|Overall Study||0
77660|NCT01256034|180579|P1|COMPLETED|Overall Study||0
77661|NCT01256034|180578|P2|STARTED|Overall Study||25
77662|NCT01256034|180579|P1|STARTED|Overall Study||25
77663|NCT01256008|180588|P3|NOT COMPLETED|Overall Study||21
77664|NCT01256008|180589|P2|NOT COMPLETED|Overall Study||7
77665|NCT01256008|180590|P1|NOT COMPLETED|Overall Study||8
77666|NCT01256008|180588|P3|COMPLETED|Overall Study||175
77667|NCT01256008|180589|P2|COMPLETED|Overall Study||91
77668|NCT01256008|180590|P1|COMPLETED|Overall Study||90
77669|NCT01256008|180588|P3|STARTED|Overall Study||196
77670|NCT01256008|180589|P2|STARTED|Overall Study||98
77671|NCT01256008|180590|P1|STARTED|Overall Study||98
77672|NCT01255904|180612|P2|NOT COMPLETED|Overall Study||4
77673|NCT01255904|180613|P1|NOT COMPLETED|Overall Study||1
77674|NCT01255904|180612|P2|COMPLETED|Overall Study||41
77675|NCT01255904|180613|P1|COMPLETED|Overall Study||44
77676|NCT01255904|180612|P2|STARTED|Overall Study||45
77677|NCT01255904|180613|P1|STARTED|Overall Study||45
77678|NCT01255787|180623|P4|NOT COMPLETED|Overall Study||22
77679|NCT01255787|180624|P3|NOT COMPLETED|Overall Study||18
77680|NCT01255787|180625|P2|NOT COMPLETED|Overall Study||17
77681|NCT01255787|180626|P1|NOT COMPLETED|Overall Study||16
77682|NCT01255787|180623|P4|COMPLETED|Overall Study||132
77683|NCT01255787|180624|P3|COMPLETED|Overall Study||132
77684|NCT01255787|180625|P2|COMPLETED|Overall Study||127
77685|NCT01255787|180626|P1|COMPLETED|Overall Study||136
77686|NCT01255787|180623|P4|Treated|Overall Study||150
77687|NCT01255787|180624|P3|Treated|Overall Study||148
77688|NCT01255787|180625|P2|Treated|Overall Study||144
77689|NCT01255787|180626|P1|Treated|Overall Study||152
77690|NCT01255787|180623|P4|STARTED|Overall Study||154
77691|NCT01255787|180624|P3|STARTED|Overall Study||150
77692|NCT01255787|180625|P2|STARTED|Overall Study||144
77693|NCT01255787|180626|P1|STARTED|Overall Study||152
77694|NCT01255761|180654|P2|NOT COMPLETED|Overall Study||175
77695|NCT01255761|180655|P1|NOT COMPLETED|Overall Study||182
77696|NCT01255761|180654|P2|COMPLETED|Overall Study||192
77697|NCT01255761|180655|P1|COMPLETED|Overall Study||187
77698|NCT01255761|180654|P2|STARTED|Overall Study||367
77699|NCT01255761|180655|P1|STARTED|Overall Study||369
77700|NCT01255722|180740|P3|NOT COMPLETED|Overall Study||1
77701|NCT01255722|180741|P2|NOT COMPLETED|Overall Study||1
77702|NCT01255722|180742|P1|NOT COMPLETED|Overall Study||3
77703|NCT01255722|180740|P3|COMPLETED|Overall Study||152
77704|NCT01255722|180741|P2|COMPLETED|Overall Study||159
77705|NCT01255722|180742|P1|COMPLETED|Overall Study||152
77706|NCT01255722|180740|P3|STARTED|Overall Study||153
77707|NCT01255722|180741|P2|STARTED|Overall Study||160
77708|NCT01255722|180742|P1|STARTED|Overall Study||155
77709|NCT01255631|180767|P2|NOT COMPLETED|Overall Study||6
77710|NCT01255631|180768|P1|NOT COMPLETED|Overall Study||9
77711|NCT01255631|180767|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
77712|NCT01255631|180768|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
77713|NCT01255631|180767|P2|STARTED|Overall Study||9
77714|NCT01255631|180768|P1|STARTED|Overall Study||13
77715|NCT01255592|180786|P2|NOT COMPLETED|Overall Study||1
77716|NCT01255592|180787|P1|NOT COMPLETED|Overall Study||6
77717|NCT01255592|180786|P2|COMPLETED|Overall Study||25
77718|NCT01255592|180787|P1|COMPLETED|Overall Study||20
77719|NCT01255592|180786|P2|STARTED|Overall Study||26
77720|NCT01255592|180787|P1|STARTED|Overall Study||26
77721|NCT01255449|180843|P1|NOT COMPLETED|Overall Study||0
77722|NCT01255449|180843|P1|COMPLETED|Overall Study||26
77723|NCT01255449|180843|P1|STARTED|Overall Study||26
77724|NCT01255436|180850|P2|NOT COMPLETED|Overall Study||194
77725|NCT01255436|180851|P1|NOT COMPLETED|Overall Study||182
77726|NCT01255436|180850|P2|COMPLETED|Overall Study||135
77727|NCT01255436|180851|P1|COMPLETED|Overall Study||151
77728|NCT01255436|180850|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
77729|NCT01255436|180851|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
77730|NCT01255423|180865|P2|NOT COMPLETED|Overall Study||3
77731|NCT01255423|180866|P1|NOT COMPLETED|Overall Study||3
77732|NCT01255423|180865|P2|COMPLETED|Overall Study||99
77733|NCT01255423|180866|P1|COMPLETED|Overall Study||101
77734|NCT01255423|180865|P2|STARTED|Overall Study||102
77735|NCT01255423|180866|P1|STARTED|Overall Study||104
77736|NCT01255306|180882|P2|NOT COMPLETED|Overall Study||1
77737|NCT01255306|180883|P1|NOT COMPLETED|Overall Study||1
77738|NCT01255306|180882|P2|COMPLETED|Overall Study||32
77739|NCT01255306|180883|P1|COMPLETED|Overall Study||25
77740|NCT01255306|180882|P2|STARTED|Overall Study||33
77741|NCT01255306|180883|P1|STARTED|Overall Study||26
77742|NCT01254890|180894|P2|NOT COMPLETED|Overall Study||10
77743|NCT01254890|180895|P1|NOT COMPLETED|Overall Study||1
77744|NCT01254890|180894|P2|COMPLETED|Overall Study||47
77745|NCT01254890|180895|P1|COMPLETED|Overall Study||2
77746|NCT01254890|180894|P2|STARTED|Overall Study||57
77747|NCT01254890|180895|P1|STARTED|Overall Study||3
77748|NCT01254851|180903|P2|NOT COMPLETED|Overall Study||9
77749|NCT01254851|180904|P1|NOT COMPLETED|Overall Study||8
77750|NCT01254851|180903|P2|COMPLETED|Overall Study||68
77751|NCT01254851|180904|P1|COMPLETED|Overall Study||61
77752|NCT01254851|180903|P2|STARTED|Overall Study||77
77753|NCT01254851|180904|P1|STARTED|Overall Study||69
77754|NCT01254760|180910|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
77755|NCT01254760|180911|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
77756|NCT01254760|180910|P2|COMPLETED|Second Period, 5 Days of Wear||38
77757|NCT01254760|180911|P1|COMPLETED|Second Period, 5 Days of Wear||34
77758|NCT01254760|180910|P2|STARTED|Second Period, 5 Days of Wear||38
77759|NCT01254760|180911|P1|STARTED|Second Period, 5 Days of Wear||34
77760|NCT01254760|180910|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
77761|NCT01254760|180911|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
77762|NCT01254760|180910|P2|COMPLETED|First Period, 5 Days of Wear||38
77763|NCT01254760|180911|P1|COMPLETED|First Period, 5 Days of Wear||34
77764|NCT01254760|180910|P2|STARTED|First Period, 5 Days of Wear||38
77765|NCT01254760|180911|P1|STARTED|First Period, 5 Days of Wear||34
77766|NCT01254747|180929|P4|NOT COMPLETED|Overall Study||2
77767|NCT01254747|180930|P3|NOT COMPLETED|Overall Study||4
77768|NCT01254747|180931|P2|NOT COMPLETED|Overall Study||6
77769|NCT01254747|180932|P1|NOT COMPLETED|Overall Study||0
77770|NCT01254747|180929|P4|COMPLETED|Overall Study||28
77771|NCT01254747|180930|P3|COMPLETED|Overall Study||26
77772|NCT01254747|180931|P2|COMPLETED|Overall Study||23
77773|NCT01254747|180932|P1|COMPLETED|Overall Study||40
77774|NCT01254747|180929|P4|STARTED|Overall Study||30
77775|NCT01254747|180930|P3|STARTED|Overall Study||30
77776|NCT01254747|180931|P2|STARTED|Overall Study||29
77777|NCT01254747|180932|P1|STARTED|Overall Study||40
77778|NCT01254721|180972|P2|NOT COMPLETED|Overall Study||22
77779|NCT01254721|180973|P1|NOT COMPLETED|Overall Study||15
77780|NCT01254721|180972|P2|COMPLETED|Overall Study||42
77781|NCT01254721|180973|P1|COMPLETED|Overall Study||52
77782|NCT01254721|180972|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
77783|NCT01254721|180973|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
77784|NCT01254669|180983|P2|NOT COMPLETED|Overall Study||4
77785|NCT01254669|180984|P1|NOT COMPLETED|Overall Study||3
77786|NCT01254669|180983|P2|COMPLETED|Overall Study||96
77787|NCT01254669|180984|P1|COMPLETED|Overall Study||97
77788|NCT01254669|180983|P2|STARTED|Overall Study||100
77789|NCT01254669|180984|P1|STARTED|Overall Study||100
77790|NCT01254656|180995|P3|NOT COMPLETED|Overall Study||18
77791|NCT01254656|180996|P2|NOT COMPLETED|Overall Study||43
77792|NCT01254656|180997|P1|NOT COMPLETED|Overall Study||47
77793|NCT01254656|180995|P3|COMPLETED|Overall Study||0
77794|NCT01254656|180996|P2|COMPLETED|Overall Study||0
77795|NCT01254656|180997|P1|COMPLETED|Overall Study||0
77796|NCT01254656|180995|P3|Treated|Overall Study||18
77797|NCT01254656|180996|P2|Treated|Overall Study||43
77798|NCT01254656|180997|P1|Treated|Overall Study||47
77799|NCT01254656|180995|P3|STARTED|Overall Study||18
77800|NCT01254656|180996|P2|STARTED|Overall Study||43
77801|NCT01254656|180997|P1|STARTED|Overall Study||47
77802|NCT01254643|181023|P1|NOT COMPLETED|Overall Study||1
77803|NCT01254643|181023|P1|COMPLETED|Overall Study||99
77804|NCT01254643|181023|P1|Vaccination 3|Overall Study||99
77805|NCT01254643|181023|P1|Vaccination 2|Overall Study||99
77806|NCT01254643|181023|P1|Vaccination 1|Overall Study||100
77807|NCT01254643|181023|P1|STARTED|Overall Study||100
77808|NCT01254604|181033|P2|NOT COMPLETED|Overall Study||9
77809|NCT01254604|181034|P1|NOT COMPLETED|Overall Study||8
77810|NCT01254604|181033|P2|COMPLETED|Overall Study||86
77811|NCT01254604|181034|P1|COMPLETED|Overall Study||87
77812|NCT01254604|181033|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
77813|NCT01254604|181034|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
77814|NCT01254604|181033|P2|STARTED|Overall Study||95
77815|NCT01254604|181034|P1|STARTED|Overall Study||95
77816|NCT01254409|181050|P4|NOT COMPLETED|Overall Study||0
77817|NCT01254409|181051|P3|NOT COMPLETED|Overall Study||0
77818|NCT01254409|181052|P2|NOT COMPLETED|Overall Study||1
77819|NCT01254409|181053|P1|NOT COMPLETED|Overall Study||0
77820|NCT01254409|181050|P4|COMPLETED|Overall Study||4
77821|NCT01254409|181051|P3|COMPLETED|Overall Study||5
77822|NCT01254409|181052|P2|COMPLETED|Overall Study||5
77823|NCT01254409|181053|P1|COMPLETED|Overall Study||6
77824|NCT01254409|181050|P4|STARTED|Overall Study||4
77825|NCT01254409|181051|P3|STARTED|Overall Study||5
77826|NCT01254409|181052|P2|STARTED|Overall Study||6
77827|NCT01254409|181053|P1|STARTED|Overall Study||6
77828|NCT01254396|181105|P2|NOT COMPLETED|Second Intervention Period||0
77829|NCT01254396|181106|P1|NOT COMPLETED|Second Intervention Period||0
77830|NCT01254396|181105|P2|COMPLETED|Second Intervention Period||6
77831|NCT01254396|181106|P1|COMPLETED|Second Intervention Period||6
77832|NCT01254396|181105|P2|STARTED|Second Intervention Period||6
77833|NCT01254396|181106|P1|STARTED|Second Intervention Period||6
77834|NCT01254396|181105|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
77835|NCT01254396|181106|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
77836|NCT01254396|181105|P2|COMPLETED|Washout Period (at Least 1 Day)||6
77837|NCT01254396|181106|P1|COMPLETED|Washout Period (at Least 1 Day)||6
77838|NCT01254396|181105|P2|STARTED|Washout Period (at Least 1 Day)||6
77839|NCT01254396|181106|P1|STARTED|Washout Period (at Least 1 Day)||6
77840|NCT01254396|181105|P2|NOT COMPLETED|First Intervention Period||0
77841|NCT01254396|181106|P1|NOT COMPLETED|First Intervention Period||0
77842|NCT01254396|181105|P2|COMPLETED|First Intervention Period||6
77843|NCT01254396|181106|P1|COMPLETED|First Intervention Period||6
77844|NCT01254396|181105|P2|STARTED|First Intervention Period||6
77845|NCT01254396|181106|P1|STARTED|First Intervention Period||6
77846|NCT01254344|181122|P2|NOT COMPLETED|Overall Study||19
77847|NCT01254344|181123|P1|NOT COMPLETED|Overall Study||13
77848|NCT01254344|181122|P2|COMPLETED|Overall Study||281
77849|NCT01254344|181123|P1|COMPLETED|Overall Study||286
77850|NCT01254344|181122|P2|Treated|Overall Study||297
77851|NCT01254344|181123|P1|Treated|Overall Study||290
77852|NCT01254344|181122|P2|STARTED|Overall Study||300
77853|NCT01254344|181123|P1|STARTED|Overall Study||299
77854|NCT01254331|181131|P1|NOT COMPLETED|Extension Phase||4
77855|NCT01254331|181131|P1|COMPLETED|Extension Phase||41
77856|NCT01254331|181131|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
77857|NCT01254331|181131|P1|NOT COMPLETED|Initial Phase||5
77858|NCT01254331|181131|P1|COMPLETED|Initial Phase||46
77859|NCT01254331|181131|P1|STARTED|Initial Phase||51
77860|NCT01254318|181149|P1|NOT COMPLETED|Overall Study||52
77861|NCT01254318|181149|P1|COMPLETED|Overall Study|Alive at end of study|78
77862|NCT01254318|181149|P1|STARTED|Overall Study|Alive at start of study|130
77863|NCT01254305|181158|P3|NOT COMPLETED|Overall Study||17
77864|NCT01254305|181159|P2|NOT COMPLETED|Overall Study||18
77865|NCT01254305|181160|P1|NOT COMPLETED|Overall Study||22
77866|NCT01254305|181158|P3|COMPLETED|Overall Study||62
77867|NCT01254305|181159|P2|COMPLETED|Overall Study||72
77868|NCT01254305|181160|P1|COMPLETED|Overall Study||71
77869|NCT01254305|181158|P3|Safety Population|Overall Study||77
77870|NCT01254305|181159|P2|Safety Population|Overall Study||85
77871|NCT01254305|181160|P1|Safety Population|Overall Study||89
77872|NCT01254305|181158|P3|STARTED|Overall Study||79
77873|NCT01254305|181159|P2|STARTED|Overall Study||90
77874|NCT01254305|181160|P1|STARTED|Overall Study||93
77875|NCT01254292|181176|P2|NOT COMPLETED|LCS12 Extension Phase||0
77876|NCT01254292|181177|P1|NOT COMPLETED|LCS12 Extension Phase||37
77877|NCT01254292|181176|P2|COMPLETED|LCS12 Extension Phase||0
77878|NCT01254292|181177|P1|COMPLETED|LCS12 Extension Phase||163
77879|NCT01254292|181176|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
77880|NCT01254292|181177|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
77881|NCT01254292|181176|P2|NOT COMPLETED|Comparative Phase||81
77882|NCT01254292|181177|P1|NOT COMPLETED|Comparative Phase||55
77883|NCT01254292|181176|P2|COMPLETED|Comparative Phase||204
77884|NCT01254292|181177|P1|COMPLETED|Comparative Phase||227
77885|NCT01254292|181176|P2|Participants Received Treatment|Comparative Phase|safety population|281
77886|NCT01254292|181177|P1|Participants Received Treatment|Comparative Phase|safety population|279
77887|NCT01254292|181176|P2|STARTED|Comparative Phase||285
77888|NCT01254292|181177|P1|STARTED|Comparative Phase||282
77889|NCT01254214|181235|P2|NOT COMPLETED|Overall Study||1
77890|NCT01254214|181236|P1|NOT COMPLETED|Overall Study||3
77891|NCT01254214|181235|P2|COMPLETED|Overall Study||27
77892|NCT01254214|181236|P1|COMPLETED|Overall Study||24
77893|NCT01254214|181235|P2|STARTED|Overall Study||28
77894|NCT01254214|181236|P1|STARTED|Overall Study||27
77895|NCT01254188|181250|P1|NOT COMPLETED|Overall Study||93
77896|NCT01254188|181250|P1|COMPLETED|Overall Study||328
77897|NCT01254188|181250|P1|STARTED|Overall Study||421
77898|NCT01254045|181261|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77899|NCT01254045|181262|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77900|NCT01254045|181263|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77901|NCT01254045|181264|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77902|NCT01254045|181265|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77903|NCT01254045|181266|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
77904|NCT01254045|181261|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
77905|NCT01254045|181262|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
77906|NCT01254045|181263|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
77907|NCT01254045|181264|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
77908|NCT01254045|181265|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
77909|NCT01254045|181266|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
77910|NCT01254045|181261|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
77911|NCT01254045|181262|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
77912|NCT01254045|181263|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
77913|NCT01254045|181264|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
77914|NCT01254045|181265|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
77915|NCT01254045|181266|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
77916|NCT01254045|181261|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77917|NCT01254045|181262|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77918|NCT01254045|181263|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77919|NCT01254045|181264|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77920|NCT01254045|181265|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77921|NCT01254045|181266|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
77922|NCT01254045|181261|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
77923|NCT01254045|181262|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
77924|NCT01254045|181263|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
77925|NCT01254045|181264|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
77926|NCT01254045|181265|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
77927|NCT01254045|181266|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
77928|NCT01254045|181261|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
77929|NCT01254045|181262|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
77930|NCT01254045|181263|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
77931|NCT01254045|181264|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
77932|NCT01254045|181265|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
77933|NCT01254045|181266|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
77934|NCT01254045|181261|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
77935|NCT01254045|181262|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
77936|NCT01254045|181263|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
77937|NCT01254045|181264|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
77938|NCT01254045|181265|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
77939|NCT01254045|181266|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
77940|NCT01254045|181261|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
77941|NCT01254045|181262|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
77942|NCT01254045|181263|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
77943|NCT01254045|181264|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
77944|NCT01254045|181265|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
77945|NCT01254045|181266|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
77946|NCT01254045|181261|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
77947|NCT01254045|181262|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
77948|NCT01254045|181263|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
77949|NCT01254045|181264|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
77950|NCT01254045|181265|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
77951|NCT01254045|181266|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
77952|NCT01253980|181279|P2|NOT COMPLETED|Overall Study||0
77953|NCT01253980|181280|P1|NOT COMPLETED|Overall Study||0
77954|NCT01253980|181279|P2|COMPLETED|Overall Study||39
77955|NCT01253980|181280|P1|COMPLETED|Overall Study||35
77956|NCT01253980|181279|P2|STARTED|Overall Study||39
77957|NCT01253980|181280|P1|STARTED|Overall Study||35
77958|NCT01253902|181289|P3|NOT COMPLETED|Overall Study||4
77959|NCT01253902|181290|P2|NOT COMPLETED|Overall Study||2
77960|NCT01253902|181291|P1|NOT COMPLETED|Overall Study||5
77961|NCT01253902|181289|P3|COMPLETED|Overall Study||51
77962|NCT01253902|181290|P2|COMPLETED|Overall Study||51
77963|NCT01253902|181291|P1|COMPLETED|Overall Study||51
77964|NCT01253902|181289|P3|STARTED|Overall Study||55
77965|NCT01253902|181290|P2|STARTED|Overall Study||53
77966|NCT01253902|181291|P1|STARTED|Overall Study||56
77967|NCT01253824|181307|P2|NOT COMPLETED|Overall Study||0
77968|NCT01253824|181308|P1|NOT COMPLETED|Overall Study||0
77969|NCT01253824|181307|P2|COMPLETED|Overall Study||7
77970|NCT01253824|181308|P1|COMPLETED|Overall Study||7
77971|NCT01253824|181307|P2|STARTED|Overall Study||7
77972|NCT01253824|181308|P1|STARTED|Overall Study||7
77973|NCT01253811|181320|P1|NOT COMPLETED|Overall Study||1
77974|NCT01253811|181320|P1|COMPLETED|Overall Study||5
77975|NCT01253811|181320|P1|Exposed|Overall Study||6
77976|NCT01253811|181320|P1|STARTED|Overall Study||6
77977|NCT01253577|181339|P1|NOT COMPLETED|Overall Study||3
77978|NCT01253577|181339|P1|COMPLETED|Overall Study||102
77979|NCT01253577|181339|P1|STARTED|Overall Study||105
77980|NCT01253564|181347|P1|NOT COMPLETED|Overall Study||24
77981|NCT01253564|181347|P1|COMPLETED|Overall Study||0
77982|NCT01253564|181347|P1|STARTED|Overall Study||24
77983|NCT01253525|181364|P1|NOT COMPLETED|Overall Study||0
77984|NCT01253525|181364|P1|COMPLETED|Overall Study||6
77985|NCT01253525|181364|P1|Received Any Quantity of Study Drug|Overall Study||6
77986|NCT01253525|181364|P1|STARTED|Overall Study||6
77987|NCT01253447|181391|P1|NOT COMPLETED|Overall Study||2
77988|NCT01253447|181391|P1|COMPLETED|Overall Study||17
77989|NCT01253447|181391|P1|STARTED|Overall Study||19
77990|NCT01253408|181398|P3|NOT COMPLETED|Overall Study||0
77991|NCT01253408|181399|P2|NOT COMPLETED|Overall Study||1
77992|NCT01253408|181400|P1|NOT COMPLETED|Overall Study||0
77993|NCT01253408|181398|P3|COMPLETED|Overall Study||13
77994|NCT01253408|181399|P2|COMPLETED|Overall Study||12
77995|NCT01253408|181400|P1|COMPLETED|Overall Study||10
77996|NCT01253408|181398|P3|STARTED|Overall Study||13
77997|NCT01253408|181399|P2|STARTED|Overall Study||13
77998|NCT01253408|181400|P1|STARTED|Overall Study||10
77999|NCT01253369|181423|P1|NOT COMPLETED|Overall Study||33
78000|NCT01253369|181423|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
78001|NCT01253369|181423|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
78002|NCT01253369|181423|P1|STARTED|Overall Study||33
78003|NCT01253343|181430|P2|NOT COMPLETED|Overall Study||0
78004|NCT01253343|181431|P1|NOT COMPLETED|Overall Study||0
78005|NCT01253343|181430|P2|COMPLETED|Overall Study||8
78006|NCT01253343|181431|P1|COMPLETED|Overall Study||9
78007|NCT01253343|181430|P2|STARTED|Overall Study||8
78008|NCT01253343|181431|P1|STARTED|Overall Study||9
78009|NCT01253304|181457|P4|NOT COMPLETED|Overall Study||1
78010|NCT01253304|181458|P3|NOT COMPLETED|Overall Study||0
78011|NCT01253304|181459|P2|NOT COMPLETED|Overall Study||0
78012|NCT01253304|181460|P1|NOT COMPLETED|Overall Study||0
78013|NCT01253304|181457|P4|COMPLETED|Overall Study||2
78014|NCT01253304|181458|P3|COMPLETED|Overall Study||6
78015|NCT01253304|181459|P2|COMPLETED|Overall Study||6
78016|NCT01253304|181460|P1|COMPLETED|Overall Study||11
78017|NCT01253304|181457|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
78018|NCT01253304|181458|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
78019|NCT01253304|181459|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
78020|NCT01253304|181460|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
78021|NCT01253304|181457|P4|STARTED|Overall Study||3
78022|NCT01253304|181458|P3|STARTED|Overall Study||6
78023|NCT01253304|181459|P2|STARTED|Overall Study||6
78024|NCT01253304|181460|P1|STARTED|Overall Study||11
78025|NCT01253265|181499|P5|NOT COMPLETED|Overall Study||1
78026|NCT01253265|181500|P4|NOT COMPLETED|Overall Study||0
78027|NCT01253265|181501|P3|NOT COMPLETED|Overall Study||0
78028|NCT01253265|181502|P2|NOT COMPLETED|Overall Study||0
78029|NCT01253265|181503|P1|NOT COMPLETED|Overall Study||1
78030|NCT01253265|181499|P5|COMPLETED|Overall Study||7
78031|NCT01253265|181500|P4|COMPLETED|Overall Study||6
78032|NCT01253265|181501|P3|COMPLETED|Overall Study||6
78033|NCT01253265|181502|P2|COMPLETED|Overall Study||6
78034|NCT01253265|181503|P1|COMPLETED|Overall Study||5
78035|NCT01253265|181499|P5|STARTED|Overall Study||8
78036|NCT01253265|181500|P4|STARTED|Overall Study||6
78037|NCT01253265|181501|P3|STARTED|Overall Study||6
78038|NCT01253265|181502|P2|STARTED|Overall Study||6
78039|NCT01253265|181503|P1|STARTED|Overall Study||6
78040|NCT01253187|181547|P6|NOT COMPLETED|Period 3||0
78041|NCT01253187|181548|P5|NOT COMPLETED|Period 3||1
78042|NCT01253187|181549|P4|NOT COMPLETED|Period 3||0
78043|NCT01253187|181550|P3|NOT COMPLETED|Period 3||0
78044|NCT01253187|181551|P2|NOT COMPLETED|Period 3||1
78045|NCT01253187|181552|P1|NOT COMPLETED|Period 3||1
78046|NCT01253187|181547|P6|COMPLETED|Period 3||6
78047|NCT01253187|181548|P5|COMPLETED|Period 3||7
78048|NCT01253187|181549|P4|COMPLETED|Period 3||7
78049|NCT01253187|181550|P3|COMPLETED|Period 3||7
78050|NCT01253187|181551|P2|COMPLETED|Period 3||7
78051|NCT01253187|181552|P1|COMPLETED|Period 3||6
78052|NCT01253187|181547|P6|STARTED|Period 3||6
78053|NCT01253187|181548|P5|STARTED|Period 3||8
78054|NCT01253187|181549|P4|STARTED|Period 3||7
78055|NCT01253187|181550|P3|STARTED|Period 3||7
78056|NCT01253187|181551|P2|STARTED|Period 3||8
78057|NCT01253187|181552|P1|STARTED|Period 3||7
78058|NCT01253187|181547|P6|NOT COMPLETED|Period 2||0
78059|NCT01253187|181548|P5|NOT COMPLETED|Period 2||1
78060|NCT01253187|181549|P4|NOT COMPLETED|Period 2||0
78061|NCT01253187|181550|P3|NOT COMPLETED|Period 2||0
78062|NCT01253187|181551|P2|NOT COMPLETED|Period 2||0
78063|NCT01253187|181552|P1|NOT COMPLETED|Period 2||0
78064|NCT01253187|181547|P6|COMPLETED|Period 2||6
78065|NCT01253187|181548|P5|COMPLETED|Period 2||8
78066|NCT01253187|181549|P4|COMPLETED|Period 2||7
78067|NCT01253187|181550|P3|COMPLETED|Period 2||7
78068|NCT01253187|181551|P2|COMPLETED|Period 2||8
78069|NCT01253187|181552|P1|COMPLETED|Period 2||7
78070|NCT01253187|181547|P6|STARTED|Period 2||6
78071|NCT01253187|181548|P5|STARTED|Period 2||9
78072|NCT01253187|181549|P4|STARTED|Period 2||7
78073|NCT01253187|181550|P3|STARTED|Period 2||7
78074|NCT01253187|181551|P2|STARTED|Period 2||8
78075|NCT01253187|181552|P1|STARTED|Period 2||7
78076|NCT01253187|181547|P6|NOT COMPLETED|Period 1||0
78077|NCT01253187|181548|P5|NOT COMPLETED|Period 1||0
78078|NCT01253187|181549|P4|NOT COMPLETED|Period 1||0
78079|NCT01253187|181550|P3|NOT COMPLETED|Period 1||0
78080|NCT01253187|181551|P2|NOT COMPLETED|Period 1||0
78081|NCT01253187|181552|P1|NOT COMPLETED|Period 1||0
78082|NCT01253187|181547|P6|COMPLETED|Period 1||6
78083|NCT01253187|181548|P5|COMPLETED|Period 1||9
78084|NCT01253187|181549|P4|COMPLETED|Period 1||7
78085|NCT01253187|181550|P3|COMPLETED|Period 1||7
78086|NCT01253187|181551|P2|COMPLETED|Period 1||8
78087|NCT01253187|181552|P1|COMPLETED|Period 1||7
78088|NCT01253187|181547|P6|STARTED|Period 1||6
78089|NCT01253187|181548|P5|STARTED|Period 1||9
78090|NCT01253187|181549|P4|STARTED|Period 1||7
78091|NCT01253187|181550|P3|STARTED|Period 1||7
78092|NCT01253187|181551|P2|STARTED|Period 1||8
78093|NCT01253187|181552|P1|STARTED|Period 1||7
78094|NCT01253174|181581|P6|NOT COMPLETED|Period 3||0
78095|NCT01253174|181582|P5|NOT COMPLETED|Period 3||1
78096|NCT01253174|181583|P4|NOT COMPLETED|Period 3||0
78097|NCT01253174|181584|P3|NOT COMPLETED|Period 3||1
78098|NCT01253174|181585|P2|NOT COMPLETED|Period 3||1
78099|NCT01253174|181586|P1|NOT COMPLETED|Period 3||0
78100|NCT01253174|181581|P6|COMPLETED|Period 3||7
78101|NCT01253174|181582|P5|COMPLETED|Period 3||7
78102|NCT01253174|181583|P4|COMPLETED|Period 3||7
78103|NCT01253174|181584|P3|COMPLETED|Period 3||6
78104|NCT01253174|181585|P2|COMPLETED|Period 3||8
78105|NCT01253174|181586|P1|COMPLETED|Period 3||6
78106|NCT01253174|181581|P6|STARTED|Period 3||7
78107|NCT01253174|181582|P5|STARTED|Period 3||8
78108|NCT01253174|181583|P4|STARTED|Period 3||7
78109|NCT01253174|181584|P3|STARTED|Period 3||7
78110|NCT01253174|181585|P2|STARTED|Period 3||9
78111|NCT01253174|181586|P1|STARTED|Period 3||6
78112|NCT01253174|181581|P6|NOT COMPLETED|Period 2||0
78113|NCT01253174|181582|P5|NOT COMPLETED|Period 2||0
78114|NCT01253174|181583|P4|NOT COMPLETED|Period 2||0
78115|NCT01253174|181584|P3|NOT COMPLETED|Period 2||1
78116|NCT01253174|181585|P2|NOT COMPLETED|Period 2||0
78117|NCT01253174|181586|P1|NOT COMPLETED|Period 2||0
78118|NCT01253174|181581|P6|COMPLETED|Period 2||7
78119|NCT01253174|181582|P5|COMPLETED|Period 2||8
78120|NCT01253174|181583|P4|COMPLETED|Period 2||7
78121|NCT01253174|181584|P3|COMPLETED|Period 2||7
78122|NCT01253174|181585|P2|COMPLETED|Period 2||9
78123|NCT01253174|181586|P1|COMPLETED|Period 2||6
78124|NCT01253174|181581|P6|STARTED|Period 2||7
78125|NCT01253174|181582|P5|STARTED|Period 2||8
78126|NCT01253174|181583|P4|STARTED|Period 2||7
78127|NCT01253174|181584|P3|STARTED|Period 2||8
78128|NCT01253174|181585|P2|STARTED|Period 2||9
78129|NCT01253174|181586|P1|STARTED|Period 2||6
78130|NCT01253174|181581|P6|NOT COMPLETED|Period 1||0
78131|NCT01253174|181582|P5|NOT COMPLETED|Period 1||1
78132|NCT01253174|181583|P4|NOT COMPLETED|Period 1||0
78133|NCT01253174|181584|P3|NOT COMPLETED|Period 1||1
78134|NCT01253174|181585|P2|NOT COMPLETED|Period 1||1
78135|NCT01253174|181586|P1|NOT COMPLETED|Period 1||0
78136|NCT01253174|181581|P6|COMPLETED|Period 1||7
78137|NCT01253174|181582|P5|COMPLETED|Period 1||8
78138|NCT01253174|181583|P4|COMPLETED|Period 1||7
78139|NCT01253174|181584|P3|COMPLETED|Period 1||8
78140|NCT01253174|181585|P2|COMPLETED|Period 1||9
78141|NCT01253174|181586|P1|COMPLETED|Period 1||6
78142|NCT01253174|181581|P6|STARTED|Period 1||7
78143|NCT01253174|181582|P5|STARTED|Period 1||9
78144|NCT01253174|181583|P4|STARTED|Period 1||7
78145|NCT01253174|181584|P3|STARTED|Period 1||9
78146|NCT01253174|181585|P2|STARTED|Period 1||10
78147|NCT01253174|181586|P1|STARTED|Period 1||6
78148|NCT01253148|181615|P1|NOT COMPLETED|Overall Study||0
78149|NCT01253148|181615|P1|COMPLETED|Overall Study||25
78150|NCT01253148|181615|P1|STARTED|Overall Study||25
78151|NCT01253135|181621|P1|NOT COMPLETED|Amended Protocol||1
78152|NCT01253135|181621|P1|COMPLETED|Amended Protocol||24
78153|NCT01253135|181621|P1|STARTED|Amended Protocol||25
78154|NCT01253135|181621|P1|NOT COMPLETED|Original Protocol||15
78155|NCT01253135|181621|P1|COMPLETED|Original Protocol||0
78156|NCT01253135|181621|P1|STARTED|Original Protocol||15
78157|NCT01253070|181629|P1|NOT COMPLETED|Overall Study||0
78158|NCT01253070|181629|P1|COMPLETED|Overall Study||54
78159|NCT01253070|181629|P1|STARTED|Overall Study||54
78160|NCT01253044|181640|P2|NOT COMPLETED|Overall Study||29
78161|NCT01253044|181641|P1|NOT COMPLETED|Overall Study||38
78162|NCT01253044|181640|P2|COMPLETED|Overall Study||51
78163|NCT01253044|181641|P1|COMPLETED|Overall Study||42
78164|NCT01253044|181640|P2|STARTED|Overall Study||80
78165|NCT01253044|181641|P1|STARTED|Overall Study||80
78166|NCT01253018|181651|P2|NOT COMPLETED|Overall Study||2
78167|NCT01253018|181652|P1|NOT COMPLETED|Overall Study||4
78168|NCT01253018|181651|P2|COMPLETED|Overall Study||21
78169|NCT01253018|181652|P1|COMPLETED|Overall Study||18
78170|NCT01253018|181651|P2|STARTED|Overall Study||23
78171|NCT01253018|181652|P1|STARTED|Overall Study||22
78172|NCT01252966|181666|P2|NOT COMPLETED|Overall Study||13
78173|NCT01252966|181667|P1|NOT COMPLETED|Overall Study||23
78174|NCT01252966|181666|P2|COMPLETED|Overall Study||92
78175|NCT01252966|181667|P1|COMPLETED|Overall Study||85
78176|NCT01252966|181666|P2|STARTED|Overall Study||105
78177|NCT01252966|181667|P1|STARTED|Overall Study||108
78178|NCT01252940|181683|P2|NOT COMPLETED|Extension Phase||3
78179|NCT01252940|181684|P1|NOT COMPLETED|Extension Phase||10
78180|NCT01252940|181683|P2|COMPLETED|Extension Phase||46
78181|NCT01252940|181684|P1|COMPLETED|Extension Phase||100
78182|NCT01252940|181683|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
78183|NCT01252940|181684|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
78184|NCT01252940|181683|P2|NOT COMPLETED|Main Study Phase||12
78185|NCT01252940|181684|P1|NOT COMPLETED|Main Study Phase||26
78186|NCT01252940|181683|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
78187|NCT01252940|181684|P1|COMPLETED|Main Study Phase||295
78188|NCT01252940|181683|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
78189|NCT01252940|181684|P1|Completed 24 Weeks|Main Study Phase||0
78190|NCT01252940|181683|P2|STARTED|Main Study Phase||161
78191|NCT01252940|181684|P1|STARTED|Main Study Phase||321
78192|NCT01252810|181715|P2|NOT COMPLETED|Overall Study||3
78193|NCT01252810|181716|P1|NOT COMPLETED|Overall Study||14
78194|NCT01252810|181715|P2|COMPLETED|Overall Study||139
78195|NCT01252810|181716|P1|COMPLETED|Overall Study||128
78196|NCT01252810|181715|P2|STARTED|Overall Study||142
78197|NCT01252810|181716|P1|STARTED|Overall Study||142
78198|NCT01252355|181729|P3|NOT COMPLETED|Overall Study||179
78199|NCT01252355|181730|P2|NOT COMPLETED|Overall Study||178
78200|NCT01252355|181731|P1|NOT COMPLETED|Overall Study||177
78201|NCT01252355|181729|P3|COMPLETED|Overall Study||0
78202|NCT01252355|181730|P2|COMPLETED|Overall Study||0
78203|NCT01252355|181731|P1|COMPLETED|Overall Study||0
78204|NCT01252355|181729|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
78205|NCT01252355|181730|P2|Treated|Overall Study||178
78206|NCT01252355|181731|P1|Treated|Overall Study||175
78207|NCT01252355|181729|P3|STARTED|Overall Study|Randomized.|179
78208|NCT01252355|181730|P2|STARTED|Overall Study|Randomized.|178
78209|NCT01252355|181731|P1|STARTED|Overall Study|Randomized.|177
78210|NCT01252290|181769|P1|NOT COMPLETED|Overall Study||1
78211|NCT01252290|181769|P1|COMPLETED|Overall Study||34
78212|NCT01252290|181769|P1|STARTED|Overall Study||35
78213|NCT01252277|181777|P1|NOT COMPLETED|Overall Study||2
78214|NCT01252277|181777|P1|COMPLETED|Overall Study||34
78215|NCT01252277|181777|P1|STARTED|Overall Study||36
78216|NCT01252238|181788|P3|NOT COMPLETED|Overall Study||4
78217|NCT01252238|181789|P2|NOT COMPLETED|Overall Study||4
78218|NCT01252238|181790|P1|NOT COMPLETED|Overall Study||4
78219|NCT01252238|181788|P3|COMPLETED|Overall Study|sponsor terminated study|4
78220|NCT01252238|181789|P2|COMPLETED|Overall Study|sponsor terminated study|4
78221|NCT01252238|181790|P1|COMPLETED|Overall Study|sponsor terminated study|4
78222|NCT01252238|181788|P3|STARTED|Overall Study||8
78223|NCT01252238|181789|P2|STARTED|Overall Study||8
78224|NCT01252238|181790|P1|STARTED|Overall Study||8
78225|NCT01252186|181801|P3|NOT COMPLETED|Overall Study||34
78226|NCT01252186|181802|P2|NOT COMPLETED|Overall Study||32
78227|NCT01252186|181803|P1|NOT COMPLETED|Overall Study||30
78228|NCT01252186|181801|P3|COMPLETED|Overall Study||53
78229|NCT01252186|181802|P2|COMPLETED|Overall Study||59
78230|NCT01252186|181803|P1|COMPLETED|Overall Study||57
78231|NCT01252186|181801|P3|Received Study Drug|Overall Study||80
78232|NCT01252186|181802|P2|Received Study Drug|Overall Study||89
78233|NCT01252186|181803|P1|Received Study Drug|Overall Study||83
78234|NCT01252186|181801|P3|STARTED|Overall Study||87
78235|NCT01252186|181802|P2|STARTED|Overall Study||91
78236|NCT01252186|181803|P1|STARTED|Overall Study||87
78237|NCT01252147|181871|P1|NOT COMPLETED|Overall Study||0
78238|NCT01252147|181871|P1|COMPLETED|Overall Study||68
78239|NCT01252147|181871|P1|STARTED|Overall Study||68
78240|NCT01252134|181876|P6|NOT COMPLETED|Period 3, 8 Hours||0
78241|NCT01252134|181877|P5|NOT COMPLETED|Period 3, 8 Hours||0
78242|NCT01252134|181878|P4|NOT COMPLETED|Period 3, 8 Hours||0
78243|NCT01252134|181879|P3|NOT COMPLETED|Period 3, 8 Hours||0
78244|NCT01252134|181880|P2|NOT COMPLETED|Period 3, 8 Hours||0
78245|NCT01252134|181881|P1|NOT COMPLETED|Period 3, 8 Hours||0
78246|NCT01252134|181876|P6|COMPLETED|Period 3, 8 Hours||4
78247|NCT01252134|181877|P5|COMPLETED|Period 3, 8 Hours||3
78248|NCT01252134|181878|P4|COMPLETED|Period 3, 8 Hours||5
78249|NCT01252134|181879|P3|COMPLETED|Period 3, 8 Hours||2
78250|NCT01252134|181880|P2|COMPLETED|Period 3, 8 Hours||3
78251|NCT01252134|181881|P1|COMPLETED|Period 3, 8 Hours||3
78252|NCT01252134|181876|P6|STARTED|Period 3, 8 Hours||4
78253|NCT01252134|181877|P5|STARTED|Period 3, 8 Hours||3
78254|NCT01252134|181878|P4|STARTED|Period 3, 8 Hours||5
78255|NCT01252134|181879|P3|STARTED|Period 3, 8 Hours||2
78256|NCT01252134|181880|P2|STARTED|Period 3, 8 Hours||3
78257|NCT01252134|181881|P1|STARTED|Period 3, 8 Hours||3
78258|NCT01252134|181876|P6|NOT COMPLETED|Period 2, 8 Hours||0
78259|NCT01252134|181877|P5|NOT COMPLETED|Period 2, 8 Hours||0
78260|NCT01252134|181878|P4|NOT COMPLETED|Period 2, 8 Hours||0
78261|NCT01252134|181879|P3|NOT COMPLETED|Period 2, 8 Hours||0
78262|NCT01252134|181880|P2|NOT COMPLETED|Period 2, 8 Hours||0
78263|NCT01252134|181881|P1|NOT COMPLETED|Period 2, 8 Hours||0
78264|NCT01252134|181876|P6|COMPLETED|Period 2, 8 Hours||4
78265|NCT01252134|181877|P5|COMPLETED|Period 2, 8 Hours||3
78266|NCT01252134|181878|P4|COMPLETED|Period 2, 8 Hours||5
78267|NCT01252134|181879|P3|COMPLETED|Period 2, 8 Hours||2
78268|NCT01252134|181880|P2|COMPLETED|Period 2, 8 Hours||3
78269|NCT01252134|181881|P1|COMPLETED|Period 2, 8 Hours||3
78270|NCT01252134|181876|P6|STARTED|Period 2, 8 Hours||4
78271|NCT01252134|181877|P5|STARTED|Period 2, 8 Hours||3
78272|NCT01252134|181878|P4|STARTED|Period 2, 8 Hours||5
78273|NCT01252134|181879|P3|STARTED|Period 2, 8 Hours||2
78274|NCT01252134|181880|P2|STARTED|Period 2, 8 Hours||3
78275|NCT01252134|181881|P1|STARTED|Period 2, 8 Hours||3
78276|NCT01252134|181876|P6|NOT COMPLETED|Period 1, 8 Hours||0
78277|NCT01252134|181877|P5|NOT COMPLETED|Period 1, 8 Hours||0
78278|NCT01252134|181878|P4|NOT COMPLETED|Period 1, 8 Hours||0
78279|NCT01252134|181879|P3|NOT COMPLETED|Period 1, 8 Hours||1
78280|NCT01252134|181880|P2|NOT COMPLETED|Period 1, 8 Hours||1
78281|NCT01252134|181881|P1|NOT COMPLETED|Period 1, 8 Hours||0
78282|NCT01252134|181876|P6|COMPLETED|Period 1, 8 Hours||4
78283|NCT01252134|181877|P5|COMPLETED|Period 1, 8 Hours||3
78284|NCT01252134|181878|P4|COMPLETED|Period 1, 8 Hours||5
78285|NCT01252134|181879|P3|COMPLETED|Period 1, 8 Hours||2
78286|NCT01252134|181880|P2|COMPLETED|Period 1, 8 Hours||3
78287|NCT01252134|181881|P1|COMPLETED|Period 1, 8 Hours||3
78288|NCT01252134|181876|P6|STARTED|Period 1, 8 Hours||4
78289|NCT01252134|181877|P5|STARTED|Period 1, 8 Hours||3
78290|NCT01252134|181878|P4|STARTED|Period 1, 8 Hours||5
78291|NCT01252134|181879|P3|STARTED|Period 1, 8 Hours||3
78292|NCT01252134|181880|P2|STARTED|Period 1, 8 Hours||4
78293|NCT01252134|181881|P1|STARTED|Period 1, 8 Hours||3
78294|NCT01252095|181900|P2|NOT COMPLETED|Overall Study||0
78295|NCT01252095|181901|P1|NOT COMPLETED|Overall Study||1
78296|NCT01252095|181900|P2|COMPLETED|Overall Study||1
78297|NCT01252095|181901|P1|COMPLETED|Overall Study||2
78298|NCT01252095|181900|P2|STARTED|Overall Study||1
78299|NCT01252095|181901|P1|STARTED|Overall Study||3
78300|NCT01251978|181909|P2|NOT COMPLETED|Overall Study||0
78301|NCT01251978|181910|P1|NOT COMPLETED|Overall Study||0
78302|NCT01251978|181909|P2|COMPLETED|Overall Study||3
78303|NCT01251978|181910|P1|COMPLETED|Overall Study||5
78304|NCT01251978|181909|P2|STARTED|Overall Study||3
78305|NCT01251978|181910|P1|STARTED|Overall Study||5
78306|NCT01251952|181919|P1|NOT COMPLETED|Overall Study||1
78307|NCT01251952|181919|P1|COMPLETED|Overall Study||1
78308|NCT01251952|181919|P1|STARTED|Overall Study||2
78309|NCT01251770|181925|P2|NOT COMPLETED|Overall Study||7
78310|NCT01251770|181926|P1|NOT COMPLETED|Overall Study||13
78311|NCT01251770|181925|P2|COMPLETED|Overall Study||29
78312|NCT01251770|181926|P1|COMPLETED|Overall Study||29
78313|NCT01251770|181925|P2|STARTED|Overall Study||36
78314|NCT01251770|181926|P1|STARTED|Overall Study||42
78315|NCT01251757|181937|P3|NOT COMPLETED|Overall Study||0
78316|NCT01251757|181938|P2|NOT COMPLETED|Overall Study||0
78317|NCT01251757|181939|P1|NOT COMPLETED|Overall Study||0
78318|NCT01251757|181937|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
78319|NCT01251757|181938|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
78320|NCT01251757|181939|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
78321|NCT01251757|181937|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
78322|NCT01251757|181938|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
78323|NCT01251757|181939|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
78324|NCT01251653|181977|P9|NOT COMPLETED|Overall Study||6
78325|NCT01251653|181978|P8|NOT COMPLETED|Overall Study||12
78326|NCT01251653|181979|P7|NOT COMPLETED|Overall Study||18
78327|NCT01251653|181980|P6|NOT COMPLETED|Overall Study||18
78328|NCT01251653|181981|P5|NOT COMPLETED|Overall Study||2
78329|NCT01251653|181982|P4|NOT COMPLETED|Overall Study||6
78330|NCT01251653|181983|P3|NOT COMPLETED|Overall Study||20
78331|NCT01251653|181984|P2|NOT COMPLETED|Overall Study||8
78332|NCT01251653|181985|P1|NOT COMPLETED|Overall Study||3
78333|NCT01251653|181977|P9|COMPLETED|Overall Study||0
78334|NCT01251653|181978|P8|COMPLETED|Overall Study||0
78335|NCT01251653|181979|P7|COMPLETED|Overall Study||0
78336|NCT01251653|181980|P6|COMPLETED|Overall Study||0
78337|NCT01251653|181981|P5|COMPLETED|Overall Study||0
78338|NCT01251653|181982|P4|COMPLETED|Overall Study||0
78339|NCT01251653|181983|P3|COMPLETED|Overall Study||0
78340|NCT01251653|181984|P2|COMPLETED|Overall Study||0
78341|NCT01251653|181985|P1|COMPLETED|Overall Study||0
78342|NCT01251653|181977|P9|STARTED|Overall Study||6
78343|NCT01251653|181978|P8|STARTED|Overall Study||12
78344|NCT01251653|181979|P7|STARTED|Overall Study||18
78345|NCT01251653|181980|P6|STARTED|Overall Study||18
78346|NCT01251653|181981|P5|STARTED|Overall Study||2
78347|NCT01251653|181982|P4|STARTED|Overall Study||6
78348|NCT01251653|181983|P3|STARTED|Overall Study||20
78349|NCT01251653|181984|P2|STARTED|Overall Study||8
78350|NCT01251653|181985|P1|STARTED|Overall Study||3
78351|NCT01251354|182110|P1|NOT COMPLETED|Overall Study||6
78352|NCT01251354|182110|P1|COMPLETED|Overall Study||0
78353|NCT01251354|182110|P1|STARTED|Overall Study||6
78354|NCT01251315|182126|P6|NOT COMPLETED|Overall Study||0
78355|NCT01251315|182127|P5|NOT COMPLETED|Overall Study||0
78356|NCT01251315|182128|P4|NOT COMPLETED|Overall Study||0
78357|NCT01251315|182129|P3|NOT COMPLETED|Overall Study||0
78358|NCT01251315|182130|P2|NOT COMPLETED|Overall Study||0
78359|NCT01251315|182131|P1|NOT COMPLETED|Overall Study||0
78360|NCT01251315|182126|P6|COMPLETED|Overall Study||4
78361|NCT01251315|182127|P5|COMPLETED|Overall Study||4
78362|NCT01251315|182128|P4|COMPLETED|Overall Study||4
78363|NCT01251315|182129|P3|COMPLETED|Overall Study||4
78364|NCT01251315|182130|P2|COMPLETED|Overall Study||4
78365|NCT01251315|182131|P1|COMPLETED|Overall Study||4
78366|NCT01251315|182126|P6|STARTED|Overall Study||4
78367|NCT01251315|182127|P5|STARTED|Overall Study||4
78368|NCT01251315|182128|P4|STARTED|Overall Study||4
78369|NCT01251315|182129|P3|STARTED|Overall Study||4
78370|NCT01251315|182130|P2|STARTED|Overall Study||4
78371|NCT01251315|182131|P1|STARTED|Overall Study||4
78372|NCT01251146|182153|P2|NOT COMPLETED|Overall Study||10
78373|NCT01251146|182154|P1|NOT COMPLETED|Overall Study||3
78374|NCT01251146|182153|P2|COMPLETED|Overall Study||81
78375|NCT01251146|182154|P1|COMPLETED|Overall Study||83
78376|NCT01251146|182153|P2|STARTED|Overall Study||91
78377|NCT01251146|182154|P1|STARTED|Overall Study||86
78378|NCT01251120|182176|P2|NOT COMPLETED|Overall Study||1
78379|NCT01251120|182177|P1|NOT COMPLETED|Overall Study||0
78380|NCT01251120|182176|P2|COMPLETED|Overall Study||0
78381|NCT01251120|182177|P1|COMPLETED|Overall Study||1
78382|NCT01251120|182176|P2|STARTED|Overall Study||1
78383|NCT01251120|182177|P1|STARTED|Overall Study||1
78384|NCT01251042|182199|P2|NOT COMPLETED|Overall Study||0
78385|NCT01251042|182200|P1|NOT COMPLETED|Overall Study||0
78386|NCT01251042|182199|P2|COMPLETED|Overall Study||23
78387|NCT01251042|182200|P1|COMPLETED|Overall Study||26
78388|NCT01251042|182199|P2|STARTED|Overall Study||23
78389|NCT01251042|182200|P1|STARTED|Overall Study||26
78390|NCT01250990|182232|P2|NOT COMPLETED|Overall Study||2
78391|NCT01250990|182233|P1|NOT COMPLETED|Overall Study||4
78392|NCT01250990|182232|P2|COMPLETED|Overall Study||9
78393|NCT01250990|182233|P1|COMPLETED|Overall Study||7
78394|NCT01250990|182232|P2|STARTED|Overall Study||11
78395|NCT01250990|182233|P1|STARTED|Overall Study||11
78396|NCT01250925|182242|P3|NOT COMPLETED|Overall Study||2
78397|NCT01250925|182243|P2|NOT COMPLETED|Overall Study||3
78398|NCT01250925|182244|P1|NOT COMPLETED|Overall Study||5
78399|NCT01250925|182242|P3|COMPLETED|Overall Study||30
78400|NCT01250925|182243|P2|COMPLETED|Overall Study||28
78401|NCT01250925|182244|P1|COMPLETED|Overall Study||26
78402|NCT01250925|182242|P3|STARTED|Overall Study||32
78403|NCT01250925|182243|P2|STARTED|Overall Study||31
78404|NCT01250925|182244|P1|STARTED|Overall Study||31
78405|NCT01250899|182284|P2|NOT COMPLETED|Overall Study||0
78406|NCT01250899|182285|P1|NOT COMPLETED|Overall Study||0
78407|NCT01250899|182284|P2|COMPLETED|Overall Study||82
78408|NCT01250899|182285|P1|COMPLETED|Overall Study||40
78409|NCT01250899|182284|P2|STARTED|Overall Study||82
78410|NCT01250899|182285|P1|STARTED|Overall Study||40
78411|NCT01250834|182289|P1|NOT COMPLETED|Overall Study||0
78412|NCT01250834|182289|P1|COMPLETED|Overall Study||27
78413|NCT01250834|182289|P1|STARTED|Overall Study||27
78414|NCT01250769|182310|P4|NOT COMPLETED|Overall Study||0
78415|NCT01250769|182311|P3|NOT COMPLETED|Overall Study||2
78416|NCT01250769|182312|P2|NOT COMPLETED|Overall Study||1
78417|NCT01250769|182313|P1|NOT COMPLETED|Overall Study||0
78418|NCT01250769|182310|P4|COMPLETED|Overall Study||11
78419|NCT01250769|182311|P3|COMPLETED|Overall Study||73
78420|NCT01250769|182312|P2|COMPLETED|Overall Study||72
78421|NCT01250769|182313|P1|COMPLETED|Overall Study||11
78422|NCT01250769|182310|P4|Day 14|Overall Study||11
78423|NCT01250769|182311|P3|Day 14|Overall Study||74
78424|NCT01250769|182312|P2|Day 14|Overall Study||72
78425|NCT01250769|182313|P1|Day 14|Overall Study||11
78426|NCT01250769|182310|P4|STARTED|Overall Study||11
78427|NCT01250769|182311|P3|STARTED|Overall Study||75
78428|NCT01250769|182312|P2|STARTED|Overall Study||73
78429|NCT01250769|182313|P1|STARTED|Overall Study||11
78430|NCT01250756|182345|P2|NOT COMPLETED|After Toddler Dose||1
78431|NCT01250756|182346|P1|NOT COMPLETED|After Toddler Dose||0
78432|NCT01250756|182345|P2|COMPLETED|After Toddler Dose||147
78433|NCT01250756|182346|P1|COMPLETED|After Toddler Dose||0
78434|NCT01250756|182345|P2|STARTED|After Toddler Dose||148
78435|NCT01250756|182346|P1|STARTED|After Toddler Dose||0
78436|NCT01250756|182345|P2|NOT COMPLETED|Toddler Dose||1
78437|NCT01250756|182346|P1|NOT COMPLETED|Toddler Dose||0
78438|NCT01250756|182345|P2|COMPLETED|Toddler Dose||148
78439|NCT01250756|182346|P1|COMPLETED|Toddler Dose||122
78440|NCT01250756|182345|P2|STARTED|Toddler Dose||149
78441|NCT01250756|182346|P1|STARTED|Toddler Dose||122
78442|NCT01250756|182345|P2|NOT COMPLETED|After Infant Series||4
78443|NCT01250756|182346|P1|NOT COMPLETED|After Infant Series||11
78444|NCT01250756|182345|P2|COMPLETED|After Infant Series||149
78445|NCT01250756|182346|P1|COMPLETED|After Infant Series||122
78446|NCT01250756|182345|P2|STARTED|After Infant Series||153
78447|NCT01250756|182346|P1|STARTED|After Infant Series||133
78448|NCT01250756|182345|P2|NOT COMPLETED|Infant Series||7
78449|NCT01250756|182346|P1|NOT COMPLETED|Infant Series||28
78450|NCT01250756|182345|P2|COMPLETED|Infant Series||153
78451|NCT01250756|182346|P1|COMPLETED|Infant Series||133
78452|NCT01250756|182345|P2|Vaccinated Dose 3|Infant Series||155
78453|NCT01250756|182346|P1|Vaccinated Dose 3|Infant Series||133
78454|NCT01250756|182345|P2|Vaccinated Dose 2|Infant Series||157
78455|NCT01250756|182346|P1|Vaccinated Dose 2|Infant Series||147
78456|NCT01250756|182345|P2|Vaccinated Dose 1|Infant Series||158
78457|NCT01250756|182346|P1|Vaccinated Dose 1|Infant Series||159
78458|NCT01250756|182345|P2|STARTED|Infant Series||160
78459|NCT01250756|182346|P1|STARTED|Infant Series||161
78460|NCT01250730|182399|P3|NOT COMPLETED|Overall Study||0
78461|NCT01250730|182400|P2|NOT COMPLETED|Overall Study||0
78462|NCT01250730|182401|P1|NOT COMPLETED|Overall Study||0
78463|NCT01250730|182399|P3|COMPLETED|Overall Study||6
78464|NCT01250730|182400|P2|COMPLETED|Overall Study||6
78465|NCT01250730|182401|P1|COMPLETED|Overall Study||6
78466|NCT01250730|182399|P3|STARTED|Overall Study||6
78467|NCT01250730|182400|P2|STARTED|Overall Study||6
78468|NCT01250730|182401|P1|STARTED|Overall Study||6
78469|NCT01250717|182457|P1|NOT COMPLETED|Overall Study||0
78470|NCT01250717|182457|P1|COMPLETED|Overall Study||28
78471|NCT01250717|182457|P1|STARTED|Overall Study||28
78472|NCT01250509|182463|P2|NOT COMPLETED|Overall Study||2
78473|NCT01250509|182464|P1|NOT COMPLETED|Overall Study||5
78474|NCT01250509|182463|P2|COMPLETED|Overall Study||21
78475|NCT01250509|182464|P1|COMPLETED|Overall Study||19
78476|NCT01250509|182463|P2|STARTED|Overall Study||23
78477|NCT01250509|182464|P1|STARTED|Overall Study||24
78478|NCT01250418|182478|P2|NOT COMPLETED|Overall Study||1
78479|NCT01250418|182479|P1|NOT COMPLETED|Overall Study||1
78480|NCT01250418|182478|P2|COMPLETED|Overall Study||15
78481|NCT01250418|182479|P1|COMPLETED|Overall Study||8
78482|NCT01250418|182478|P2|STARTED|Overall Study||16
78483|NCT01250418|182479|P1|STARTED|Overall Study||9
78484|NCT01250379|182487|P2|NOT COMPLETED|Overall Study||193
78485|NCT01250379|182488|P1|NOT COMPLETED|Overall Study||202
78486|NCT01250379|182487|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
78487|NCT01250379|182488|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
78488|NCT01250379|182487|P2|STARTED|Overall Study||247
78489|NCT01250379|182488|P1|STARTED|Overall Study||247
78490|NCT01250184|182549|P3|NOT COMPLETED|Overall Study||0
78491|NCT01250184|182550|P2|NOT COMPLETED|Overall Study||0
78492|NCT01250184|182551|P1|NOT COMPLETED|Overall Study||0
78493|NCT01250184|182549|P3|COMPLETED|Overall Study||43
78494|NCT01250184|182550|P2|COMPLETED|Overall Study||41
78495|NCT01250184|182551|P1|COMPLETED|Overall Study||43
78496|NCT01250184|182549|P3|STARTED|Overall Study||43
78497|NCT01250184|182550|P2|STARTED|Overall Study||41
78498|NCT01250184|182551|P1|STARTED|Overall Study||43
78499|NCT01250171|182577|P3|NOT COMPLETED|Overall Study||0
78500|NCT01250171|182578|P2|NOT COMPLETED|Overall Study||0
78501|NCT01250171|182579|P1|NOT COMPLETED|Overall Study||1
78502|NCT01250171|182577|P3|COMPLETED|Overall Study||24
78503|NCT01250171|182578|P2|COMPLETED|Overall Study||22
78504|NCT01250171|182579|P1|COMPLETED|Overall Study||25
78505|NCT01250171|182577|P3|STARTED|Overall Study||24
78506|NCT01250171|182578|P2|STARTED|Overall Study||22
78507|NCT01250171|182579|P1|STARTED|Overall Study||26
78508|NCT01250145|182610|P2|NOT COMPLETED|Overall Study||5
78509|NCT01250145|182611|P1|NOT COMPLETED|Overall Study||2
78510|NCT01250145|182610|P2|COMPLETED|Overall Study||205
78511|NCT01250145|182611|P1|COMPLETED|Overall Study||39
78512|NCT01250145|182610|P2|STARTED|Overall Study||210
78513|NCT01250145|182611|P1|STARTED|Overall Study||41
78514|NCT01250119|182631|P2|NOT COMPLETED|Treatment Phase||41
78515|NCT01250119|182632|P1|NOT COMPLETED|Treatment Phase||0
78516|NCT01250119|182631|P2|COMPLETED|Treatment Phase||0
78517|NCT01250119|182632|P1|COMPLETED|Treatment Phase||0
78518|NCT01250119|182631|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
78519|NCT01250119|182632|P1|STARTED|Treatment Phase||0
78520|NCT01250119|182631|P2|NOT COMPLETED|Diagnostic Phase||0
78521|NCT01250119|182632|P1|NOT COMPLETED|Diagnostic Phase||113
78522|NCT01250119|182631|P2|COMPLETED|Diagnostic Phase||0
78523|NCT01250119|182632|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
78524|NCT01250119|182631|P2|STARTED|Diagnostic Phase||0
78525|NCT01250119|182632|P1|STARTED|Diagnostic Phase||688
78526|NCT01250054|182647|P2|NOT COMPLETED|Period 2, One Week of Wear||0
78527|NCT01250054|182648|P1|NOT COMPLETED|Period 2, One Week of Wear||1
78528|NCT01250054|182647|P2|COMPLETED|Period 2, One Week of Wear||8
78529|NCT01250054|182648|P1|COMPLETED|Period 2, One Week of Wear||6
78530|NCT01250054|182647|P2|STARTED|Period 2, One Week of Wear||8
78531|NCT01250054|182648|P1|STARTED|Period 2, One Week of Wear||7
78532|NCT01250054|182647|P2|NOT COMPLETED|Period 1, One Week of Wear||0
78533|NCT01250054|182648|P1|NOT COMPLETED|Period 1, One Week of Wear||0
78534|NCT01250054|182647|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
78535|NCT01250054|182648|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
78618|NCT01249157|182857|P1|NOT COMPLETED|Overall Study||1
78707|NCT01249131|182863|P4|STARTED|First Intervention||3
78536|NCT01250054|182647|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
78537|NCT01250054|182648|P1|STARTED|Period 1, One Week of Wear||8
78538|NCT01250002|182656|P2|NOT COMPLETED|Overall Study||3
78539|NCT01250002|182657|P1|NOT COMPLETED|Overall Study||4
78540|NCT01250002|182656|P2|COMPLETED|Overall Study||32
78541|NCT01250002|182657|P1|COMPLETED|Overall Study||31
78542|NCT01250002|182656|P2|STARTED|Overall Study||35
78543|NCT01250002|182657|P1|STARTED|Overall Study||35
78544|NCT01249872|182671|P6|NOT COMPLETED|Overall Study||0
78545|NCT01249872|182672|P5|NOT COMPLETED|Overall Study||0
78546|NCT01249872|182673|P4|NOT COMPLETED|Overall Study||0
78547|NCT01249872|182674|P3|NOT COMPLETED|Overall Study||0
78548|NCT01249872|182675|P2|NOT COMPLETED|Overall Study||0
78549|NCT01249872|182676|P1|NOT COMPLETED|Overall Study||0
78550|NCT01249872|182671|P6|COMPLETED|Overall Study||16
78551|NCT01249872|182672|P5|COMPLETED|Overall Study||16
78552|NCT01249872|182673|P4|COMPLETED|Overall Study||16
78553|NCT01249872|182674|P3|COMPLETED|Overall Study||16
78554|NCT01249872|182675|P2|COMPLETED|Overall Study||16
78555|NCT01249872|182676|P1|COMPLETED|Overall Study||16
78556|NCT01249872|182671|P6|STARTED|Overall Study||16
78557|NCT01249872|182672|P5|STARTED|Overall Study||16
78558|NCT01249872|182673|P4|STARTED|Overall Study||16
78559|NCT01249872|182674|P3|STARTED|Overall Study||16
78560|NCT01249872|182675|P2|STARTED|Overall Study||16
78561|NCT01249872|182676|P1|STARTED|Overall Study||16
78562|NCT01249664|182722|P2|NOT COMPLETED|Overall Study||0
78563|NCT01249664|182723|P1|NOT COMPLETED|Overall Study||6
78564|NCT01249664|182722|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
78565|NCT01249664|182723|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
78566|NCT01249664|182722|P2|Completed 48 Weeks Treatment|Overall Study||24
78567|NCT01249664|182723|P1|Completed 48 Weeks Treatment|Overall Study||78
78568|NCT01249664|182722|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
78569|NCT01249664|182723|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
78570|NCT01249664|182722|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
78571|NCT01249664|182723|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
78572|NCT01249664|182722|P2|Participants Received Treatment|Overall Study|Safety population|31
78573|NCT01249664|182723|P1|Participants Received Treatment|Overall Study|Safety population|91
78574|NCT01249664|182722|P2|STARTED|Overall Study||31
78575|NCT01249664|182723|P1|STARTED|Overall Study||91
78576|NCT01249651|182773|P1|NOT COMPLETED|Overall Study||7
78577|NCT01249651|182773|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
78578|NCT01249651|182773|P1|STARTED|Overall Study|Enrolled|101
78579|NCT01249417|182783|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
78580|NCT01249417|182784|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
78581|NCT01249417|182785|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
78582|NCT01249417|182783|P3|COMPLETED|Treatment Phase - ITT Population||73
78583|NCT01249417|182784|P2|COMPLETED|Treatment Phase - ITT Population||75
78584|NCT01249417|182785|P1|COMPLETED|Treatment Phase - ITT Population||78
78585|NCT01249417|182783|P3|STARTED|Treatment Phase - ITT Population||77
78586|NCT01249417|182784|P2|STARTED|Treatment Phase - ITT Population||79
78587|NCT01249417|182785|P1|STARTED|Treatment Phase - ITT Population||79
78588|NCT01249417|182783|P3|NOT COMPLETED|Randomised Population||4
78589|NCT01249417|182784|P2|NOT COMPLETED|Randomised Population||1
78590|NCT01249417|182785|P1|NOT COMPLETED|Randomised Population||1
78591|NCT01249417|182783|P3|COMPLETED|Randomised Population||77
78592|NCT01249417|182784|P2|COMPLETED|Randomised Population||79
78593|NCT01249417|182785|P1|COMPLETED|Randomised Population||79
78594|NCT01249417|182783|P3|Treated|Randomised Population||79
78595|NCT01249417|182784|P2|Treated|Randomised Population||80
78596|NCT01249417|182785|P1|Treated|Randomised Population||80
78597|NCT01249417|182783|P3|STARTED|Randomised Population||81
78598|NCT01249417|182784|P2|STARTED|Randomised Population||80
78599|NCT01249417|182785|P1|STARTED|Randomised Population||80
78600|NCT01249274|182801|P2|NOT COMPLETED|Overall Study||6
78601|NCT01249274|182802|P1|NOT COMPLETED|Overall Study||4
78602|NCT01249274|182801|P2|COMPLETED|Overall Study||19
78603|NCT01249274|182802|P1|COMPLETED|Overall Study||21
78604|NCT01249274|182801|P2|Completed Post Trial Visit But Not tx|Overall Study||2
78605|NCT01249274|182802|P1|Completed Post Trial Visit But Not tx|Overall Study||1
78606|NCT01249274|182801|P2|Completed Treatment & Post Trial Visit|Overall Study||17
78607|NCT01249274|182802|P1|Completed Treatment & Post Trial Visit|Overall Study||20
78608|NCT01249274|182801|P2|Completed Treatment|Overall Study||19
78609|NCT01249274|182802|P1|Completed Treatment|Overall Study||21
78610|NCT01249274|182801|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
78611|NCT01249274|182802|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
78612|NCT01249261|182828|P2|NOT COMPLETED|Overall Study||0
78613|NCT01249261|182829|P1|NOT COMPLETED|Overall Study||1
78614|NCT01249261|182828|P2|COMPLETED|Overall Study||31
78615|NCT01249261|182829|P1|COMPLETED|Overall Study||29
78616|NCT01249261|182828|P2|STARTED|Overall Study||31
78617|NCT01249261|182829|P1|STARTED|Overall Study||30
78619|NCT01249157|182857|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
78620|NCT01249157|182857|P1|STARTED|Overall Study||1
78621|NCT01249131|182861|P6|NOT COMPLETED|Third Intervention||0
78622|NCT01249131|182862|P5|NOT COMPLETED|Third Intervention||0
78623|NCT01249131|182863|P4|NOT COMPLETED|Third Intervention||0
78624|NCT01249131|182864|P3|NOT COMPLETED|Third Intervention||0
78625|NCT01249131|182865|P2|NOT COMPLETED|Third Intervention||0
78626|NCT01249131|182866|P1|NOT COMPLETED|Third Intervention||0
78627|NCT01249131|182861|P6|COMPLETED|Third Intervention||4
78628|NCT01249131|182862|P5|COMPLETED|Third Intervention||2
78629|NCT01249131|182863|P4|COMPLETED|Third Intervention||3
78630|NCT01249131|182864|P3|COMPLETED|Third Intervention||4
78631|NCT01249131|182865|P2|COMPLETED|Third Intervention||3
78632|NCT01249131|182866|P1|COMPLETED|Third Intervention||3
78633|NCT01249131|182861|P6|STARTED|Third Intervention||4
78634|NCT01249131|182862|P5|STARTED|Third Intervention||2
78635|NCT01249131|182863|P4|STARTED|Third Intervention||3
78636|NCT01249131|182864|P3|STARTED|Third Intervention||4
78637|NCT01249131|182865|P2|STARTED|Third Intervention||3
78638|NCT01249131|182866|P1|STARTED|Third Intervention||3
78639|NCT01249131|182861|P6|NOT COMPLETED|Washout Period of 10 Days||0
78640|NCT01249131|182862|P5|NOT COMPLETED|Washout Period of 10 Days||0
78641|NCT01249131|182863|P4|NOT COMPLETED|Washout Period of 10 Days||0
78642|NCT01249131|182864|P3|NOT COMPLETED|Washout Period of 10 Days||0
78643|NCT01249131|182865|P2|NOT COMPLETED|Washout Period of 10 Days||0
78644|NCT01249131|182866|P1|NOT COMPLETED|Washout Period of 10 Days||0
78645|NCT01249131|182861|P6|COMPLETED|Washout Period of 10 Days||4
78646|NCT01249131|182862|P5|COMPLETED|Washout Period of 10 Days||2
78647|NCT01249131|182863|P4|COMPLETED|Washout Period of 10 Days||3
78648|NCT01249131|182864|P3|COMPLETED|Washout Period of 10 Days||4
78649|NCT01249131|182865|P2|COMPLETED|Washout Period of 10 Days||3
78650|NCT01249131|182866|P1|COMPLETED|Washout Period of 10 Days||3
78651|NCT01249131|182861|P6|STARTED|Washout Period of 10 Days||4
78652|NCT01249131|182862|P5|STARTED|Washout Period of 10 Days||2
78653|NCT01249131|182863|P4|STARTED|Washout Period of 10 Days||3
78654|NCT01249131|182864|P3|STARTED|Washout Period of 10 Days||4
78655|NCT01249131|182865|P2|STARTED|Washout Period of 10 Days||3
78656|NCT01249131|182866|P1|STARTED|Washout Period of 10 Days||3
78657|NCT01249131|182861|P6|NOT COMPLETED|Second Intervention||0
78658|NCT01249131|182862|P5|NOT COMPLETED|Second Intervention||0
78659|NCT01249131|182863|P4|NOT COMPLETED|Second Intervention||0
78660|NCT01249131|182864|P3|NOT COMPLETED|Second Intervention||0
78661|NCT01249131|182865|P2|NOT COMPLETED|Second Intervention||0
78662|NCT01249131|182866|P1|NOT COMPLETED|Second Intervention||0
78663|NCT01249131|182861|P6|COMPLETED|Second Intervention||4
78664|NCT01249131|182862|P5|COMPLETED|Second Intervention||2
78665|NCT01249131|182863|P4|COMPLETED|Second Intervention||3
78666|NCT01249131|182864|P3|COMPLETED|Second Intervention||4
78667|NCT01249131|182865|P2|COMPLETED|Second Intervention||3
78668|NCT01249131|182866|P1|COMPLETED|Second Intervention||3
78669|NCT01249131|182861|P6|STARTED|Second Intervention||4
78670|NCT01249131|182862|P5|STARTED|Second Intervention||2
78671|NCT01249131|182863|P4|STARTED|Second Intervention||3
78672|NCT01249131|182864|P3|STARTED|Second Intervention||4
78673|NCT01249131|182865|P2|STARTED|Second Intervention||3
78674|NCT01249131|182866|P1|STARTED|Second Intervention||3
78675|NCT01249131|182861|P6|NOT COMPLETED|Washout Period of 10 Days||0
78676|NCT01249131|182862|P5|NOT COMPLETED|Washout Period of 10 Days||1
78677|NCT01249131|182863|P4|NOT COMPLETED|Washout Period of 10 Days||0
78678|NCT01249131|182864|P3|NOT COMPLETED|Washout Period of 10 Days||0
78679|NCT01249131|182865|P2|NOT COMPLETED|Washout Period of 10 Days||0
78680|NCT01249131|182866|P1|NOT COMPLETED|Washout Period of 10 Days||0
78681|NCT01249131|182861|P6|COMPLETED|Washout Period of 10 Days||4
78682|NCT01249131|182862|P5|COMPLETED|Washout Period of 10 Days||2
78683|NCT01249131|182863|P4|COMPLETED|Washout Period of 10 Days||3
78684|NCT01249131|182864|P3|COMPLETED|Washout Period of 10 Days||4
78685|NCT01249131|182865|P2|COMPLETED|Washout Period of 10 Days||3
78686|NCT01249131|182866|P1|COMPLETED|Washout Period of 10 Days||3
78687|NCT01249131|182861|P6|STARTED|Washout Period of 10 Days||4
78688|NCT01249131|182862|P5|STARTED|Washout Period of 10 Days||3
78689|NCT01249131|182863|P4|STARTED|Washout Period of 10 Days||3
78690|NCT01249131|182864|P3|STARTED|Washout Period of 10 Days||4
78691|NCT01249131|182865|P2|STARTED|Washout Period of 10 Days||3
78692|NCT01249131|182866|P1|STARTED|Washout Period of 10 Days||3
78693|NCT01249131|182861|P6|NOT COMPLETED|First Intervention||0
78694|NCT01249131|182862|P5|NOT COMPLETED|First Intervention||0
78695|NCT01249131|182863|P4|NOT COMPLETED|First Intervention||0
78696|NCT01249131|182864|P3|NOT COMPLETED|First Intervention||0
78697|NCT01249131|182865|P2|NOT COMPLETED|First Intervention||0
78698|NCT01249131|182866|P1|NOT COMPLETED|First Intervention||0
78699|NCT01249131|182861|P6|COMPLETED|First Intervention||4
78700|NCT01249131|182862|P5|COMPLETED|First Intervention||3
78701|NCT01249131|182863|P4|COMPLETED|First Intervention||3
78702|NCT01249131|182864|P3|COMPLETED|First Intervention||4
78703|NCT01249131|182865|P2|COMPLETED|First Intervention||3
78704|NCT01249131|182866|P1|COMPLETED|First Intervention||3
78705|NCT01249131|182861|P6|STARTED|First Intervention||4
78706|NCT01249131|182862|P5|STARTED|First Intervention||3
78708|NCT01249131|182864|P3|STARTED|First Intervention||4
78709|NCT01249131|182865|P2|STARTED|First Intervention||3
78710|NCT01249131|182866|P1|STARTED|First Intervention||3
78711|NCT01249118|182886|P3|NOT COMPLETED|Second Washout Period||0
78712|NCT01249118|182887|P2|NOT COMPLETED|Second Washout Period||0
78713|NCT01249118|182888|P1|NOT COMPLETED|Second Washout Period||0
78714|NCT01249118|182886|P3|COMPLETED|Second Washout Period||5
78715|NCT01249118|182887|P2|COMPLETED|Second Washout Period||5
78716|NCT01249118|182888|P1|COMPLETED|Second Washout Period||2
78717|NCT01249118|182886|P3|STARTED|Second Washout Period||5
78718|NCT01249118|182887|P2|STARTED|Second Washout Period||5
78719|NCT01249118|182888|P1|STARTED|Second Washout Period||2
78720|NCT01249118|182886|P3|NOT COMPLETED|Second Intervention Period||0
78721|NCT01249118|182887|P2|NOT COMPLETED|Second Intervention Period||0
78722|NCT01249118|182888|P1|NOT COMPLETED|Second Intervention Period||0
78723|NCT01249118|182886|P3|COMPLETED|Second Intervention Period||5
78724|NCT01249118|182887|P2|COMPLETED|Second Intervention Period||5
78725|NCT01249118|182888|P1|COMPLETED|Second Intervention Period||2
78726|NCT01249118|182886|P3|STARTED|Second Intervention Period||5
78727|NCT01249118|182887|P2|STARTED|Second Intervention Period||5
78728|NCT01249118|182888|P1|STARTED|Second Intervention Period||2
78729|NCT01249118|182886|P3|NOT COMPLETED|First Washout Period||0
78730|NCT01249118|182887|P2|NOT COMPLETED|First Washout Period||1
78731|NCT01249118|182888|P1|NOT COMPLETED|First Washout Period||0
78732|NCT01249118|182886|P3|COMPLETED|First Washout Period||5
78733|NCT01249118|182887|P2|COMPLETED|First Washout Period||5
78734|NCT01249118|182888|P1|COMPLETED|First Washout Period||2
78735|NCT01249118|182886|P3|STARTED|First Washout Period||5
78736|NCT01249118|182887|P2|STARTED|First Washout Period||6
78737|NCT01249118|182888|P1|STARTED|First Washout Period||2
78738|NCT01249118|182886|P3|NOT COMPLETED|First Intervention Period||0
78739|NCT01249118|182887|P2|NOT COMPLETED|First Intervention Period||0
78740|NCT01249118|182888|P1|NOT COMPLETED|First Intervention Period||0
78741|NCT01249118|182886|P3|COMPLETED|First Intervention Period||5
78742|NCT01249118|182887|P2|COMPLETED|First Intervention Period||6
78743|NCT01249118|182888|P1|COMPLETED|First Intervention Period||2
78744|NCT01249118|182886|P3|STARTED|First Intervention Period||5
78745|NCT01249118|182887|P2|STARTED|First Intervention Period||6
78746|NCT01249118|182888|P1|STARTED|First Intervention Period||2
78747|NCT01249092|182922|P1|NOT COMPLETED|Overall Study||2
78748|NCT01249092|182922|P1|COMPLETED|Overall Study||18
78749|NCT01249092|182922|P1|STARTED|Overall Study||20
78750|NCT01248936|182928|P1|NOT COMPLETED|Overall Study||374
78751|NCT01248936|182928|P1|COMPLETED|Overall Study||0
78752|NCT01248936|182928|P1|STARTED|Overall Study||374
78753|NCT01248884|182941|P3|NOT COMPLETED|Overall Study||1
78754|NCT01248884|182942|P2|NOT COMPLETED|Overall Study||3
78755|NCT01248884|182943|P1|NOT COMPLETED|Overall Study||2
78756|NCT01248884|182941|P3|COMPLETED|Overall Study||238
78757|NCT01248884|182942|P2|COMPLETED|Overall Study||239
78758|NCT01248884|182943|P1|COMPLETED|Overall Study||238
78759|NCT01248884|182941|P3|STARTED|Overall Study||239
78760|NCT01248884|182942|P2|STARTED|Overall Study||242
78761|NCT01248884|182943|P1|STARTED|Overall Study||240
78762|NCT01248793|182995|P2|NOT COMPLETED|Overall Study||6
78763|NCT01248793|182996|P1|NOT COMPLETED|Overall Study||4
78764|NCT01248793|182995|P2|COMPLETED|Overall Study||102
78765|NCT01248793|182996|P1|COMPLETED|Overall Study||101
78766|NCT01248793|182995|P2|STARTED|Overall Study||108
78767|NCT01248793|182996|P1|STARTED|Overall Study||105
78768|NCT01248780|183010|P2|NOT COMPLETED|Overall Study||15
78769|NCT01248780|183011|P1|NOT COMPLETED|Overall Study||9
78770|NCT01248780|183010|P2|COMPLETED|Overall Study||117
78771|NCT01248780|183011|P1|COMPLETED|Overall Study||123
78772|NCT01248780|183010|P2|STARTED|Overall Study||132
78773|NCT01248780|183011|P1|STARTED|Overall Study||132
78774|NCT01248728|183025|P2|NOT COMPLETED|Overall Study||2
78775|NCT01248728|183026|P1|NOT COMPLETED|Overall Study||4
78776|NCT01248728|183025|P2|COMPLETED|Overall Study||17
78777|NCT01248728|183026|P1|COMPLETED|Overall Study||15
78778|NCT01248728|183025|P2|STARTED|Overall Study||19
78779|NCT01248728|183026|P1|STARTED|Overall Study||19
78780|NCT01248468|183043|P3|NOT COMPLETED|Overall Study||4
78781|NCT01248468|183044|P2|NOT COMPLETED|Overall Study||14
78782|NCT01248468|183045|P1|NOT COMPLETED|Overall Study||15
78783|NCT01248468|183043|P3|COMPLETED|Overall Study||145
78784|NCT01248468|183044|P2|COMPLETED|Overall Study||290
78785|NCT01248468|183045|P1|COMPLETED|Overall Study||284
78786|NCT01248468|183043|P3|ITT Population|Overall Study||125
78787|NCT01248468|183044|P2|ITT Population|Overall Study||261
78788|NCT01248468|183045|P1|ITT Population|Overall Study||256
78789|NCT01248468|183043|P3|Safety Population|Overall Study||133
78790|NCT01248468|183044|P2|Safety Population|Overall Study||271
78791|NCT01248468|183045|P1|Safety Population|Overall Study||266
78792|NCT01248468|183043|P3|STARTED|Overall Study||149
78793|NCT01248468|183044|P2|STARTED|Overall Study||304
78794|NCT01248468|183045|P1|STARTED|Overall Study||299
78795|NCT01248455|183062|P1|NOT COMPLETED|Overall Study||1
78796|NCT01248455|183062|P1|COMPLETED|Overall Study||8
78797|NCT01248455|183062|P1|STARTED|Overall Study||9
78798|NCT01248364|183071|P4|NOT COMPLETED|Overall Study||0
78799|NCT01248364|183072|P3|NOT COMPLETED|Overall Study||0
78800|NCT01248364|183073|P2|NOT COMPLETED|Overall Study||1
78801|NCT01248364|183074|P1|NOT COMPLETED|Overall Study||0
78802|NCT01248364|183071|P4|COMPLETED|Overall Study||12
78803|NCT01248364|183072|P3|COMPLETED|Overall Study||13
78804|NCT01248364|183073|P2|COMPLETED|Overall Study||33
78805|NCT01248364|183074|P1|COMPLETED|Overall Study||32
78806|NCT01248364|183071|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
78807|NCT01248364|183072|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
78808|NCT01248364|183073|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
78809|NCT01248364|183074|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
78810|NCT01248364|183071|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
78811|NCT01248364|183072|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
78812|NCT01248364|183073|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
78813|NCT01248364|183074|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
78814|NCT01248364|183071|P4|STARTED|Overall Study||12
78815|NCT01248364|183072|P3|STARTED|Overall Study||13
78816|NCT01248364|183073|P2|STARTED|Overall Study||34
78817|NCT01248364|183074|P1|STARTED|Overall Study||32
78818|NCT01248221|183122|P2|NOT COMPLETED|Overall Study||0
78819|NCT01248221|183123|P1|NOT COMPLETED|Overall Study||0
78820|NCT01248221|183122|P2|COMPLETED|Overall Study||15
78821|NCT01248221|183123|P1|COMPLETED|Overall Study||15
78822|NCT01248221|183122|P2|STARTED|Overall Study||15
78823|NCT01248221|183123|P1|STARTED|Overall Study||15
78824|NCT01248130|183137|P2|NOT COMPLETED|Overall Study||0
78825|NCT01248130|183138|P1|NOT COMPLETED|Overall Study||2
78826|NCT01248130|183137|P2|COMPLETED|Overall Study||4
78827|NCT01248130|183138|P1|COMPLETED|Overall Study||1
78828|NCT01248130|183137|P2|STARTED|Overall Study||4
78829|NCT01248130|183138|P1|STARTED|Overall Study||3
78830|NCT01248065|183146|P2|NOT COMPLETED|Overall Study||22
78831|NCT01248065|183147|P1|NOT COMPLETED|Overall Study||26
78832|NCT01248065|183146|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
78833|NCT01248065|183147|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
78834|NCT01248065|183146|P2|STARTED|Overall Study||201
78835|NCT01248065|183147|P1|STARTED|Overall Study||207
78836|NCT01248013|183157|P1|NOT COMPLETED|Overall Study||14
78837|NCT01248013|183157|P1|COMPLETED|Overall Study||75
78838|NCT01248013|183157|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
78839|NCT01248013|183157|P1|STARTED|Overall Study||89
78840|NCT01247974|183163|P2|NOT COMPLETED|Overall Study||19
78841|NCT01247974|183164|P1|NOT COMPLETED|Overall Study||26
78842|NCT01247974|183163|P2|COMPLETED|Overall Study||203
78843|NCT01247974|183164|P1|COMPLETED|Overall Study||191
78844|NCT01247974|183163|P2|STARTED|Overall Study||222
78845|NCT01247974|183164|P1|STARTED|Overall Study||217
78846|NCT01247922|183172|P1|NOT COMPLETED|Overall Study||4
78847|NCT01247922|183172|P1|COMPLETED|Overall Study||0
78848|NCT01247922|183172|P1|Treated|Overall Study||4
78849|NCT01247922|183172|P1|STARTED|Overall Study||4
78850|NCT01247428|183178|P1|NOT COMPLETED|Overall Study||0
78851|NCT01247428|183178|P1|COMPLETED|Overall Study||30
78852|NCT01247428|183178|P1|STARTED|Overall Study||30
78853|NCT01247285|183201|P2|NOT COMPLETED|Second Intervention||0
78854|NCT01247285|183202|P1|NOT COMPLETED|Second Intervention||0
78855|NCT01247285|183201|P2|COMPLETED|Second Intervention||13
78856|NCT01247285|183202|P1|COMPLETED|Second Intervention||13
78857|NCT01247285|183201|P2|STARTED|Second Intervention||13
78858|NCT01247285|183202|P1|STARTED|Second Intervention||13
78859|NCT01247285|183201|P2|NOT COMPLETED|Washout of 28 Days||0
78860|NCT01247285|183202|P1|NOT COMPLETED|Washout of 28 Days||0
78861|NCT01247285|183201|P2|COMPLETED|Washout of 28 Days||13
78862|NCT01247285|183202|P1|COMPLETED|Washout of 28 Days||13
78863|NCT01247285|183201|P2|STARTED|Washout of 28 Days||13
78864|NCT01247285|183202|P1|STARTED|Washout of 28 Days||13
78865|NCT01247285|183201|P2|NOT COMPLETED|First Intervention||0
78866|NCT01247285|183202|P1|NOT COMPLETED|First Intervention||0
78867|NCT01247285|183201|P2|COMPLETED|First Intervention||13
78868|NCT01247285|183202|P1|COMPLETED|First Intervention||13
78869|NCT01247285|183201|P2|STARTED|First Intervention||13
78870|NCT01247285|183202|P1|STARTED|First Intervention||13
78871|NCT01247272|183220|P2|NOT COMPLETED|Second Intervention||0
78872|NCT01247272|183221|P1|NOT COMPLETED|Second Intervention||0
78873|NCT01247272|183220|P2|COMPLETED|Second Intervention||13
78874|NCT01247272|183221|P1|COMPLETED|Second Intervention||13
78875|NCT01247272|183220|P2|STARTED|Second Intervention||13
78876|NCT01247272|183221|P1|STARTED|Second Intervention||13
78877|NCT01247272|183220|P2|NOT COMPLETED|Washout of 28 Days||0
78878|NCT01247272|183221|P1|NOT COMPLETED|Washout of 28 Days||0
78879|NCT01247272|183220|P2|COMPLETED|Washout of 28 Days||13
78880|NCT01247272|183221|P1|COMPLETED|Washout of 28 Days||13
78881|NCT01247272|183220|P2|STARTED|Washout of 28 Days||13
78882|NCT01247272|183221|P1|STARTED|Washout of 28 Days||13
78883|NCT01247272|183220|P2|NOT COMPLETED|First Intervention||0
78884|NCT01247272|183221|P1|NOT COMPLETED|First Intervention||0
78885|NCT01247272|183220|P2|COMPLETED|First Intervention||13
78886|NCT01247272|183221|P1|COMPLETED|First Intervention||13
78887|NCT01247272|183220|P2|STARTED|First Intervention||13
78888|NCT01247272|183221|P1|STARTED|First Intervention||13
78889|NCT01247220|183239|P2|NOT COMPLETED|Overall Study||0
78890|NCT01247220|183240|P1|NOT COMPLETED|Overall Study||0
78891|NCT01247220|183239|P2|COMPLETED|Overall Study||6
78892|NCT01247220|183240|P1|COMPLETED|Overall Study||6
78893|NCT01247220|183239|P2|STARTED|Overall Study||6
78894|NCT01247220|183240|P1|STARTED|Overall Study||6
78895|NCT01245751|183254|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78896|NCT01245751|183255|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78897|NCT01245751|183256|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78898|NCT01245751|183257|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78899|NCT01245751|183254|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78900|NCT01245751|183255|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
78901|NCT01245751|183256|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
78902|NCT01245751|183257|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
78903|NCT01245751|183254|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
78904|NCT01245751|183255|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
78905|NCT01245751|183256|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
78906|NCT01245751|183257|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
78907|NCT01245751|183254|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
78908|NCT01245751|183255|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
78909|NCT01245751|183256|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
78910|NCT01245751|183257|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
78911|NCT01245751|183254|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
78912|NCT01245751|183255|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
78913|NCT01245751|183256|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
78914|NCT01245751|183257|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
78915|NCT01245751|183254|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
78916|NCT01245751|183255|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
78917|NCT01245751|183256|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
78918|NCT01245751|183257|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
78919|NCT01245751|183254|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
78920|NCT01245751|183255|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
78921|NCT01245751|183256|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
78922|NCT01245751|183257|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
78923|NCT01245738|183270|P1|NOT COMPLETED|Overall Study||40
78924|NCT01245738|183270|P1|COMPLETED|Overall Study||474
78925|NCT01245738|183270|P1|STARTED|Overall Study||514
78926|NCT01245647|183289|P2|NOT COMPLETED|Overall Study||4
78927|NCT01245647|183290|P1|NOT COMPLETED|Overall Study||0
78928|NCT01245647|183289|P2|COMPLETED|Overall Study||8
78929|NCT01245647|183290|P1|COMPLETED|Overall Study||7
78930|NCT01245647|183289|P2|STARTED|Overall Study||12
78931|NCT01245647|183290|P1|STARTED|Overall Study||7
78932|NCT01245595|183306|P2|NOT COMPLETED|Overall Study||0
78933|NCT01245595|183307|P1|NOT COMPLETED|Overall Study||0
78934|NCT01245595|183306|P2|COMPLETED|Overall Study||72
78935|NCT01245595|183307|P1|COMPLETED|Overall Study||72
78936|NCT01245595|183306|P2|Completed Full Course of Study Drug|Overall Study||61
78937|NCT01245595|183307|P1|Completed Full Course of Study Drug|Overall Study||57
78938|NCT01245595|183306|P2|STARTED|Overall Study||72
78939|NCT01245595|183307|P1|STARTED|Overall Study||72
78940|NCT01247090|183316|P3|NOT COMPLETED|Overall Study||0
78941|NCT01247090|183317|P2|NOT COMPLETED|Overall Study||1
78942|NCT01247090|183318|P1|NOT COMPLETED|Overall Study||1
78943|NCT01247090|183316|P3|COMPLETED|Overall Study||4
78944|NCT01247090|183317|P2|COMPLETED|Overall Study||3
78945|NCT01247090|183318|P1|COMPLETED|Overall Study||3
78946|NCT01247090|183316|P3|STARTED|Overall Study||4
78947|NCT01247090|183317|P2|STARTED|Overall Study||4
78948|NCT01247090|183318|P1|STARTED|Overall Study||4
78949|NCT01247064|183328|P2|NOT COMPLETED|Overall Study||0
78950|NCT01247064|183329|P1|NOT COMPLETED|Overall Study||0
78951|NCT01247064|183328|P2|COMPLETED|Overall Study||31
78952|NCT01247064|183329|P1|COMPLETED|Overall Study||31
78953|NCT01247064|183328|P2|STARTED|Overall Study||31
78954|NCT01247064|183329|P1|STARTED|Overall Study||31
78955|NCT01246999|183347|P4|NOT COMPLETED|Overall Study||2
78956|NCT01246999|183348|P3|NOT COMPLETED|Overall Study||0
78957|NCT01246999|183349|P2|NOT COMPLETED|Overall Study||1
78958|NCT01246999|183350|P1|NOT COMPLETED|Overall Study||0
78959|NCT01246999|183347|P4|COMPLETED|Overall Study||15
78960|NCT01246999|183348|P3|COMPLETED|Overall Study||2
78961|NCT01246999|183349|P2|COMPLETED|Overall Study||3
78962|NCT01246999|183350|P1|COMPLETED|Overall Study||11
78963|NCT01246999|183347|P4|STARTED|Overall Study||17
78964|NCT01246999|183348|P3|STARTED|Overall Study||2
78965|NCT01246999|183349|P2|STARTED|Overall Study||4
78966|NCT01246999|183350|P1|STARTED|Overall Study||11
78967|NCT01246973|183385|P2|NOT COMPLETED|Overall Study||47
78968|NCT01246973|183386|P1|NOT COMPLETED|Overall Study||61
78969|NCT01246973|183385|P2|COMPLETED|Overall Study||295
78970|NCT01246973|183386|P1|COMPLETED|Overall Study||283
78971|NCT01246973|183385|P2|STARTED|Overall Study||342
78972|NCT01246973|183386|P1|STARTED|Overall Study||344
78973|NCT01246960|183396|P2|NOT COMPLETED|Overall Study||4
78974|NCT01246960|183397|P1|NOT COMPLETED|Overall Study||6
78975|NCT01246960|183396|P2|COMPLETED|Overall Study||80
78976|NCT01246960|183397|P1|COMPLETED|Overall Study||78
78977|NCT01246960|183396|P2|Received Any Quantity of Study Drug|Overall Study||80
78978|NCT01246960|183397|P1|Received Any Quantity of Study Drug|Overall Study||82
78979|NCT01246960|183396|P2|STARTED|Overall Study||84
78980|NCT01246960|183397|P1|STARTED|Overall Study||84
78981|NCT01246791|183415|P1|NOT COMPLETED|Overall Study||0
78982|NCT01246791|183415|P1|COMPLETED|Overall Study||12
78983|NCT01246791|183415|P1|STARTED|Overall Study||12
78984|NCT01246713|183430|P1|NOT COMPLETED|Overall Study||0
78985|NCT01246713|183430|P1|COMPLETED|Overall Study||15
78986|NCT01246713|183430|P1|STARTED|Overall Study||15
78987|NCT01246479|183435|P1|NOT COMPLETED|Overall Study||5
78988|NCT01246479|183435|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
78989|NCT01246479|183435|P1|STARTED|Overall Study||23
78990|NCT01246349|183441|P2|NOT COMPLETED|Overall Study||0
78991|NCT01246349|183442|P1|NOT COMPLETED|Overall Study||0
78992|NCT01246349|183441|P2|COMPLETED|Overall Study||20
78993|NCT01246349|183442|P1|COMPLETED|Overall Study||20
78994|NCT01246349|183441|P2|STARTED|Overall Study||20
78995|NCT01246349|183442|P1|STARTED|Overall Study||20
78996|NCT01246258|183454|P1|NOT COMPLETED|Overall Study||0
78997|NCT01246258|183454|P1|COMPLETED|Overall Study||5
78998|NCT01246258|183454|P1|STARTED|Overall Study||5
78999|NCT01246076|183459|P1|NOT COMPLETED|Overall Study||0
79000|NCT01246076|183459|P1|COMPLETED|Overall Study||24
79001|NCT01246076|183459|P1|STARTED|Overall Study||24
79002|NCT01246011|183471|P3|NOT COMPLETED|Overall Study||4
79003|NCT01246011|183472|P2|NOT COMPLETED|Overall Study||0
79004|NCT01246011|183473|P1|NOT COMPLETED|Overall Study||0
79005|NCT01246011|183471|P3|COMPLETED|Overall Study||5
79006|NCT01246011|183472|P2|COMPLETED|Overall Study||0
79007|NCT01246011|183473|P1|COMPLETED|Overall Study||0
79008|NCT01246011|183471|P3|STARTED|Overall Study||9
79009|NCT01246011|183472|P2|STARTED|Overall Study||0
79010|NCT01246011|183473|P1|STARTED|Overall Study||0
79011|NCT01245764|183485|P4|NOT COMPLETED|Study Phase B||0
79012|NCT01245764|183486|P3|NOT COMPLETED|Study Phase B||0
79013|NCT01245764|183487|P2|NOT COMPLETED|Study Phase B||0
79014|NCT01245764|183488|P1|NOT COMPLETED|Study Phase B||0
79015|NCT01245764|183485|P4|COMPLETED|Study Phase B||17
79016|NCT01245764|183486|P3|COMPLETED|Study Phase B||0
79017|NCT01245764|183487|P2|COMPLETED|Study Phase B||0
79018|NCT01245764|183488|P1|COMPLETED|Study Phase B||0
79019|NCT01245764|183485|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
79020|NCT01245764|183486|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
79021|NCT01245764|183487|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
79022|NCT01245764|183488|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
79023|NCT01245764|183485|P4|STARTED|Study Phase B||17
79024|NCT01245764|183486|P3|STARTED|Study Phase B||0
79025|NCT01245764|183487|P2|STARTED|Study Phase B||0
79026|NCT01245764|183488|P1|STARTED|Study Phase B||0
79027|NCT01245764|183485|P4|NOT COMPLETED|Study Phase A||3
79028|NCT01245764|183486|P3|NOT COMPLETED|Study Phase A||10
79029|NCT01245764|183487|P2|NOT COMPLETED|Study Phase A||5
79030|NCT01245764|183488|P1|NOT COMPLETED|Study Phase A||9
79031|NCT01245764|183485|P4|COMPLETED|Study Phase A||17
79032|NCT01245764|183486|P3|COMPLETED|Study Phase A||110
79033|NCT01245764|183487|P2|COMPLETED|Study Phase A||25
79034|NCT01245764|183488|P1|COMPLETED|Study Phase A||71
79035|NCT01245764|183485|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
79036|NCT01245764|183486|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
79037|NCT01245764|183487|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
79038|NCT01245764|183488|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
79039|NCT01245764|183485|P4|STARTED|Study Phase A||20
79040|NCT01245764|183486|P3|STARTED|Study Phase A||120
79041|NCT01245764|183487|P2|STARTED|Study Phase A||30
79042|NCT01245764|183488|P1|STARTED|Study Phase A||80
79043|NCT01245439|183522|P1|NOT COMPLETED|Overall Study||0
79044|NCT01245439|183522|P1|COMPLETED|Overall Study||65
79045|NCT01245439|183522|P1|STARTED|Overall Study||65
79046|NCT01245413|183553|P2|NOT COMPLETED|Athena First,||0
79047|NCT01245413|183554|P1|NOT COMPLETED|Athena First,||0
79048|NCT01245413|183553|P2|COMPLETED|Athena First,||16
79049|NCT01245413|183554|P1|COMPLETED|Athena First,||16
79050|NCT01245413|183553|P2|STARTED|Athena First,||16
79051|NCT01245413|183554|P1|STARTED|Athena First,||16
79052|NCT01245413|183553|P2|NOT COMPLETED|Sensura First,||0
79053|NCT01245413|183554|P1|NOT COMPLETED|Sensura First,||0
79054|NCT01245413|183553|P2|COMPLETED|Sensura First,||16
79055|NCT01245413|183554|P1|COMPLETED|Sensura First,||16
79056|NCT01245413|183553|P2|STARTED|Sensura First,||16
79057|NCT01245413|183554|P1|STARTED|Sensura First,||16
79058|NCT01245387|183560|P1|NOT COMPLETED|Overall Study||813
79059|NCT01245387|183560|P1|COMPLETED|Overall Study||188
79060|NCT01245387|183560|P1|STARTED|Overall Study||1001
79061|NCT01245374|183609|P1|NOT COMPLETED|Overall Study||4
79062|NCT01245374|183609|P1|COMPLETED|Overall Study||99
79063|NCT01245374|183609|P1|STARTED|Overall Study||103
79064|NCT01245283|183632|P3|NOT COMPLETED|Overall Study||11
79065|NCT01245283|183633|P2|NOT COMPLETED|Overall Study||11
79066|NCT01245283|183634|P1|NOT COMPLETED|Overall Study||14
79067|NCT01245283|183632|P3|COMPLETED|Overall Study||19
79068|NCT01245283|183633|P2|COMPLETED|Overall Study||17
79069|NCT01245283|183634|P1|COMPLETED|Overall Study||18
79070|NCT01245283|183632|P3|STARTED|Overall Study||30
79071|NCT01245283|183633|P2|STARTED|Overall Study||28
79072|NCT01245283|183634|P1|STARTED|Overall Study||32
79073|NCT01245270|183668|P2|NOT COMPLETED|Overall Study||0
79074|NCT01245270|183669|P1|NOT COMPLETED|Overall Study||0
79075|NCT01245270|183668|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
79076|NCT01245270|183669|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
79077|NCT01245270|183668|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
79078|NCT01245270|183669|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
79079|NCT01245101|183679|P2|NOT COMPLETED|Period 3 (Treatment)||0
79080|NCT01245101|183680|P1|NOT COMPLETED|Period 3 (Treatment)||1
79081|NCT01245101|183679|P2|COMPLETED|Period 3 (Treatment)||0
79082|NCT01245101|183680|P1|COMPLETED|Period 3 (Treatment)||11
79083|NCT01245101|183679|P2|STARTED|Period 3 (Treatment)||0
79084|NCT01245101|183680|P1|STARTED|Period 3 (Treatment)||12
79085|NCT01245101|183679|P2|NOT COMPLETED|Period 2 (Washout)||0
79086|NCT01245101|183680|P1|NOT COMPLETED|Period 2 (Washout)||1
79087|NCT01245101|183679|P2|COMPLETED|Period 2 (Washout)||0
79088|NCT01245101|183680|P1|COMPLETED|Period 2 (Washout)||12
79089|NCT01245101|183679|P2|STARTED|Period 2 (Washout)||0
79090|NCT01245101|183680|P1|STARTED|Period 2 (Washout)||13
79091|NCT01245101|183679|P2|NOT COMPLETED|Period 1 (Treatment)||0
79092|NCT01245101|183680|P1|NOT COMPLETED|Period 1 (Treatment)||2
79093|NCT01245101|183679|P2|COMPLETED|Period 1 (Treatment)||0
79094|NCT01245101|183680|P1|COMPLETED|Period 1 (Treatment)||13
79095|NCT01245101|183679|P2|STARTED|Period 1 (Treatment)||0
79096|NCT01245101|183680|P1|STARTED|Period 1 (Treatment)||15
79097|NCT01245062|183690|P3|NOT COMPLETED|Cross-over Phase||51
79098|NCT01245062|183691|P2|NOT COMPLETED|Cross-over Phase||0
79099|NCT01245062|183692|P1|NOT COMPLETED|Cross-over Phase||0
79100|NCT01245062|183690|P3|COMPLETED|Cross-over Phase||0
79101|NCT01245062|183691|P2|COMPLETED|Cross-over Phase||0
79102|NCT01245062|183692|P1|COMPLETED|Cross-over Phase||0
79103|NCT01245062|183690|P3|Ongoing|Cross-over Phase||34
79104|NCT01245062|183691|P2|Ongoing|Cross-over Phase||0
79105|NCT01245062|183692|P1|Ongoing|Cross-over Phase||0
79106|NCT01245062|183690|P3|STARTED|Cross-over Phase|51 of the 108 participants randomized to chemotherapy elected to cross-over to Trametinib.|51
79107|NCT01245062|183691|P2|STARTED|Cross-over Phase||0
79108|NCT01245062|183692|P1|STARTED|Cross-over Phase||0
79109|NCT01245062|183690|P3|NOT COMPLETED|Randomization Phase||0
79110|NCT01245062|183691|P2|NOT COMPLETED|Randomization Phase||108
79111|NCT01245062|183692|P1|NOT COMPLETED|Randomization Phase||214
79112|NCT01245062|183690|P3|COMPLETED|Randomization Phase||0
79113|NCT01245062|183691|P2|COMPLETED|Randomization Phase||0
79114|NCT01245062|183692|P1|COMPLETED|Randomization Phase||0
79115|NCT01245062|183690|P3|Ongoing|Randomization Phase||0
79116|NCT01245062|183691|P2|Ongoing|Randomization Phase||65
79117|NCT01245062|183692|P1|Ongoing|Randomization Phase||169
79118|NCT01245062|183690|P3|STARTED|Randomization Phase||0
79119|NCT01245062|183691|P2|STARTED|Randomization Phase||108
79120|NCT01245062|183692|P1|STARTED|Randomization Phase||214
79121|NCT01244984|183727|P3|NOT COMPLETED|Overall Study||4
79122|NCT01244984|183728|P2|NOT COMPLETED|Overall Study||14
79123|NCT01244984|183729|P1|NOT COMPLETED|Overall Study||5
79124|NCT01244984|183727|P3|COMPLETED|Overall Study||86
79125|NCT01244984|183728|P2|COMPLETED|Overall Study||79
79126|NCT01244984|183729|P1|COMPLETED|Overall Study||55
79127|NCT01244984|183727|P3|STARTED|Overall Study||90
79128|NCT01244984|183728|P2|STARTED|Overall Study||93
79129|NCT01244984|183729|P1|STARTED|Overall Study||60
79130|NCT01244906|183803|P1|NOT COMPLETED|Overall Study||8
79131|NCT01244906|183803|P1|COMPLETED|Overall Study||18
79132|NCT01244906|183803|P1|STARTED|Overall Study||26
79133|NCT01244893|183812|P2|NOT COMPLETED|Final Visit||0
79134|NCT01244893|183813|P1|NOT COMPLETED|Final Visit||0
79135|NCT01244893|183812|P2|COMPLETED|Final Visit||21
79136|NCT01244893|183813|P1|COMPLETED|Final Visit||21
79137|NCT01244893|183812|P2|STARTED|Final Visit||21
79138|NCT01244893|183813|P1|STARTED|Final Visit||21
79139|NCT01244893|183812|P2|NOT COMPLETED|1-Week Follow Up||0
79140|NCT01244893|183813|P1|NOT COMPLETED|1-Week Follow Up||1
79141|NCT01244893|183812|P2|COMPLETED|1-Week Follow Up||21
79142|NCT01244893|183813|P1|COMPLETED|1-Week Follow Up||21
79143|NCT01244893|183812|P2|STARTED|1-Week Follow Up||21
79144|NCT01244893|183813|P1|STARTED|1-Week Follow Up||22
79145|NCT01244893|183812|P2|NOT COMPLETED|Baseline||1
79146|NCT01244893|183813|P1|NOT COMPLETED|Baseline||0
79147|NCT01244893|183812|P2|COMPLETED|Baseline||21
79148|NCT01244893|183813|P1|COMPLETED|Baseline||22
79149|NCT01244893|183812|P2|STARTED|Baseline||22
79150|NCT01244893|183813|P1|STARTED|Baseline||22
79151|NCT01244828|183825|P1|NOT COMPLETED|Overall Study||78
79152|NCT01244828|183825|P1|COMPLETED|Overall Study||79
79153|NCT01244828|183825|P1|STARTED|Overall Study|Received study drug|157
79154|NCT01244815|183841|P4|NOT COMPLETED|Overall Study||12
79155|NCT01244815|183842|P3|NOT COMPLETED|Overall Study||11
79156|NCT01244815|183843|P2|NOT COMPLETED|Overall Study||17
79157|NCT01244815|183844|P1|NOT COMPLETED|Overall Study||14
79158|NCT01244815|183841|P4|COMPLETED|Overall Study||87
79159|NCT01244815|183842|P3|COMPLETED|Overall Study||88
79160|NCT01244815|183843|P2|COMPLETED|Overall Study||88
79161|NCT01244815|183844|P1|COMPLETED|Overall Study||87
79162|NCT01244815|183841|P4|Treated|Overall Study||99
79163|NCT01244815|183842|P3|Treated|Overall Study||99
79164|NCT01244815|183843|P2|Treated|Overall Study||104
79165|NCT01244815|183844|P1|Treated|Overall Study||101
79166|NCT01244815|183841|P4|STARTED|Overall Study|Randomized|99
79167|NCT01244815|183842|P3|STARTED|Overall Study|Randomized|99
79168|NCT01244815|183843|P2|STARTED|Overall Study|Randomized|105
79169|NCT01244815|183844|P1|STARTED|Overall Study|Randomized|101
79170|NCT01244724|183918|P1|NOT COMPLETED|Overall Study||8
79171|NCT01244724|183918|P1|COMPLETED|Overall Study||9
79172|NCT01244724|183918|P1|Week 2 Visit|Overall Study||15
79173|NCT01244724|183918|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
79174|NCT01244711|183922|P1|NOT COMPLETED|Overall Study||0
79175|NCT01244711|183922|P1|COMPLETED|Overall Study||1
79176|NCT01244711|183922|P1|STARTED|Overall Study||1
79177|NCT01244633|183926|P1|NOT COMPLETED|Overall Study||3
79178|NCT01244633|183926|P1|COMPLETED|Overall Study||15
79179|NCT01244633|183926|P1|STARTED|Overall Study||18
79180|NCT01244620|183930|P4|NOT COMPLETED|Overall Study||4
79181|NCT01244620|183931|P3|NOT COMPLETED|Overall Study||4
79182|NCT01244620|183932|P2|NOT COMPLETED|Overall Study||4
79183|NCT01244620|183933|P1|NOT COMPLETED|Overall Study||4
79184|NCT01244620|183930|P4|COMPLETED|Overall Study||0
79185|NCT01244620|183931|P3|COMPLETED|Overall Study||0
79186|NCT01244620|183932|P2|COMPLETED|Overall Study||0
79187|NCT01244620|183933|P1|COMPLETED|Overall Study||0
79188|NCT01244620|183930|P4|STARTED|Overall Study||4
79189|NCT01244620|183931|P3|STARTED|Overall Study||4
79190|NCT01244620|183932|P2|STARTED|Overall Study||4
79191|NCT01244620|183933|P1|STARTED|Overall Study||4
79192|NCT01244529|183967|P1|NOT COMPLETED|Overall Study||0
79193|NCT01244529|183967|P1|COMPLETED|Overall Study||41
79194|NCT01244529|183967|P1|STARTED|Overall Study||41
79195|NCT01244516|183992|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
79196|NCT01244516|183993|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
79197|NCT01244516|183994|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
79198|NCT01244516|183992|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
79199|NCT01244516|183993|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
79200|NCT01244516|183994|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
79201|NCT01244516|183992|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
79202|NCT01244516|183993|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
79203|NCT01244516|183994|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
79204|NCT01244516|183992|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
79205|NCT01244516|183993|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
79206|NCT01244516|183994|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
79207|NCT01244516|183992|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
79208|NCT01244516|183993|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
79209|NCT01244516|183994|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
79210|NCT01244516|183992|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
79211|NCT01244516|183993|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
79212|NCT01244516|183994|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
79213|NCT01244503|184007|P1|NOT COMPLETED|Overall Study||0
79214|NCT01244503|184007|P1|COMPLETED|Overall Study||61
79215|NCT01244503|184007|P1|STARTED|Overall Study||61
79216|NCT01244490|184015|P3|NOT COMPLETED|Overall Study||23
79217|NCT01244490|184016|P2|NOT COMPLETED|Overall Study||24
79218|NCT01244490|184017|P1|NOT COMPLETED|Overall Study||19
79219|NCT01244490|184015|P3|COMPLETED|Overall Study||89
79220|NCT01244490|184016|P2|COMPLETED|Overall Study||91
79221|NCT01244490|184017|P1|COMPLETED|Overall Study||92
79222|NCT01244490|184015|P3|STARTED|Overall Study||112
79223|NCT01244490|184016|P2|STARTED|Overall Study||115
79224|NCT01244490|184017|P1|STARTED|Overall Study||111
79225|NCT01244477|184072|P2|NOT COMPLETED|Overall Study||3
79226|NCT01244477|184073|P1|NOT COMPLETED|Overall Study||20
79227|NCT01244477|184072|P2|COMPLETED|Overall Study||20
79228|NCT01244477|184073|P1|COMPLETED|Overall Study||18
79229|NCT01244477|184072|P2|STARTED|Overall Study||23
79230|NCT01244477|184073|P1|STARTED|Overall Study||38
79231|NCT01244425|184085|P2|NOT COMPLETED|Overall Study||3
79232|NCT01244425|184086|P1|NOT COMPLETED|Overall Study||3
79233|NCT01244425|184085|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
79234|NCT01244425|184086|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
79235|NCT01244425|184085|P2|STARTED|Overall Study||35
79236|NCT01244425|184086|P1|STARTED|Overall Study||35
79237|NCT01244412|184106|P1|NOT COMPLETED|Overall Study||0
79238|NCT01244412|184106|P1|COMPLETED|Overall Study||1
79239|NCT01244412|184106|P1|STARTED|Overall Study||1
79240|NCT01244243|184110|P1|NOT COMPLETED|Overall Study||0
79241|NCT01244243|184110|P1|COMPLETED|Overall Study||41
79242|NCT01244243|184110|P1|STARTED|Overall Study||41
79243|NCT01244126|184118|P3|NOT COMPLETED|Overall Study||9
79244|NCT01244126|184119|P2|NOT COMPLETED|Overall Study||3
79245|NCT01244126|184120|P1|NOT COMPLETED|Overall Study||3
79246|NCT01244126|184118|P3|COMPLETED|Overall Study||48
79247|NCT01244126|184119|P2|COMPLETED|Overall Study||52
79248|NCT01244126|184120|P1|COMPLETED|Overall Study||56
79249|NCT01244126|184118|P3|STARTED|Overall Study||57
79250|NCT01244126|184119|P2|STARTED|Overall Study||55
79251|NCT01244126|184120|P1|STARTED|Overall Study||59
79252|NCT01244061|184133|P2|NOT COMPLETED|Overall Study||103
79253|NCT01244061|184134|P1|NOT COMPLETED|Overall Study||82
79254|NCT01244061|184133|P2|COMPLETED|Overall Study||144
79255|NCT01244061|184134|P1|COMPLETED|Overall Study||169
79256|NCT01244061|184133|P2|STARTED|Overall Study||247
79257|NCT01244061|184134|P1|STARTED|Overall Study||251
79258|NCT01243944|184148|P2|NOT COMPLETED|Overall Study||108
79259|NCT01243944|184149|P1|NOT COMPLETED|Overall Study||17
79260|NCT01243944|184148|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
79261|NCT01243944|184149|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
79262|NCT01243944|184148|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
79263|NCT01243944|184149|P1|STARTED|Overall Study||110
79264|NCT01243892|184173|P2|NOT COMPLETED|Overall Study||0
79265|NCT01243892|184174|P1|NOT COMPLETED|Overall Study||2
79266|NCT01243892|184173|P2|COMPLETED|Overall Study||3
79267|NCT01243892|184174|P1|COMPLETED|Overall Study||13
79268|NCT01243892|184173|P2|STARTED|Overall Study||3
79269|NCT01243892|184174|P1|STARTED|Overall Study||15
79270|NCT01243775|184184|P1|NOT COMPLETED|Overall Study||2
79271|NCT01243775|184184|P1|COMPLETED|Overall Study||31
79272|NCT01243775|184184|P1|STARTED|Overall Study||33
79273|NCT01243671|184191|P1|NOT COMPLETED|Overall Study||5
79274|NCT01243671|184191|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
79275|NCT01243671|184191|P1|Completed 52 Weeks of Treatment|Overall Study||17
79276|NCT01243671|184191|P1|Completed 24 Weeks of Treatment|Overall Study||18
79277|NCT01243671|184191|P1|STARTED|Overall Study||20
79278|NCT01243619|184204|P1|NOT COMPLETED|Overall Study||0
79279|NCT01243619|184204|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
79280|NCT01243619|184204|P1|STARTED|Overall Study||5
79281|NCT01243567|184210|P2|NOT COMPLETED|Overall Study||0
79282|NCT01243567|184211|P1|NOT COMPLETED|Overall Study||1
79283|NCT01243567|184210|P2|COMPLETED|Overall Study||38
79284|NCT01243567|184211|P1|COMPLETED|Overall Study||42
79285|NCT01243567|184210|P2|STARTED|Overall Study||38
79286|NCT01243567|184211|P1|STARTED|Overall Study||43
79287|NCT01243450|184228|P3|NOT COMPLETED|Overall Study||67
79288|NCT01243450|184229|P2|NOT COMPLETED|Overall Study||25
79289|NCT01243450|184230|P1|NOT COMPLETED|Overall Study||83
79290|NCT01243450|184228|P3|COMPLETED|Overall Study||337
79291|NCT01243450|184229|P2|COMPLETED|Overall Study||110
79292|NCT01243450|184230|P1|COMPLETED|Overall Study||318
79293|NCT01243450|184228|P3|STARTED|Overall Study||404
79294|NCT01243450|184229|P2|STARTED|Overall Study||135
79295|NCT01243450|184230|P1|STARTED|Overall Study||401
79296|NCT01243411|184238|P1|NOT COMPLETED|Overall Study||41
79297|NCT01243411|184238|P1|COMPLETED|Overall Study||306
79298|NCT01243411|184238|P1|STARTED|Overall Study||347
79299|NCT01243320|184250|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
79300|NCT01243320|184250|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
79301|NCT01243320|184250|P1|STARTED|32ppm Oral Silver (14 Days)||24
79302|NCT01243320|184250|P1|NOT COMPLETED|Washout (3 Days)||0
79303|NCT01243320|184250|P1|COMPLETED|Washout (3 Days)||36
79304|NCT01243320|184250|P1|STARTED|Washout (3 Days)||36
79305|NCT01243320|184250|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
79306|NCT01243320|184250|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
79307|NCT01243320|184250|P1|STARTED|10ppm Oral Silver (14 Days)||36
79308|NCT01243320|184250|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
79309|NCT01243320|184250|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
79310|NCT01243320|184250|P1|STARTED|10ppm Oral Silver (7 Days)||36
79311|NCT01243320|184250|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
79312|NCT01243320|184250|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
79313|NCT01243320|184250|P1|STARTED|10ppm Oral Silver (3 Days)||36
79314|NCT01243294|184326|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
79315|NCT01243294|184327|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
79316|NCT01243294|184326|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
79317|NCT01243294|184327|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
79318|NCT01243294|184326|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
79319|NCT01243294|184327|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
79320|NCT01243294|184326|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
79321|NCT01243294|184327|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
79322|NCT01243294|184326|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
79323|NCT01243294|184327|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
79324|NCT01243294|184326|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
79325|NCT01243294|184327|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
79326|NCT01243242|184345|P2|NOT COMPLETED|Overall Study||4
79327|NCT01243242|184346|P1|NOT COMPLETED|Overall Study||3
79328|NCT01243242|184345|P2|COMPLETED|Overall Study||56
79329|NCT01243242|184346|P1|COMPLETED|Overall Study||57
79330|NCT01243242|184345|P2|STARTED|Overall Study||60
79331|NCT01243242|184346|P1|STARTED|Overall Study||60
79332|NCT01243177|184360|P2|NOT COMPLETED|Overall Study||178
79333|NCT01243177|184361|P1|NOT COMPLETED|Overall Study||178
79334|NCT01243177|184360|P2|COMPLETED|Overall Study||264
79335|NCT01243177|184361|P1|COMPLETED|Overall Study||266
79336|NCT01243177|184360|P2|STARTED|Overall Study||442
79337|NCT01243177|184361|P1|STARTED|Overall Study||444
79338|NCT01243112|184377|P1|NOT COMPLETED|Overall Study||0
79339|NCT01243112|184377|P1|COMPLETED|Overall Study||25
79340|NCT01243112|184377|P1|STARTED|Overall Study||25
79341|NCT01242813|184382|P1|NOT COMPLETED|Overall Study||2
79342|NCT01242813|184382|P1|COMPLETED|Overall Study||18
79343|NCT01242813|184382|P1|STARTED|Overall Study||20
79344|NCT01242748|184404|P2|NOT COMPLETED|Overall Study||14
79345|NCT01242748|184405|P1|NOT COMPLETED|Overall Study||38
79346|NCT01242748|184404|P2|COMPLETED|Overall Study||80
79347|NCT01242748|184405|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
79348|NCT01242748|184404|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
79349|NCT01242748|184405|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
79350|NCT01242748|184404|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
79351|NCT01242748|184405|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
79352|NCT01242748|184404|P2|STARTED|Overall Study||94
79353|NCT01242748|184405|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
79354|NCT01242527|184429|P4|NOT COMPLETED|Overall Study||9
79355|NCT01242527|184430|P3|NOT COMPLETED|Overall Study||14
79356|NCT01242527|184431|P2|NOT COMPLETED|Overall Study||7
79357|NCT01242527|184432|P1|NOT COMPLETED|Overall Study||5
79358|NCT01242527|184429|P4|COMPLETED|Overall Study||90
79359|NCT01242527|184430|P3|COMPLETED|Overall Study||87
79360|NCT01242527|184431|P2|COMPLETED|Overall Study||93
79361|NCT01242527|184432|P1|COMPLETED|Overall Study||94
79362|NCT01242527|184429|P4|STARTED|Overall Study||99
79363|NCT01242527|184430|P3|STARTED|Overall Study||101
79364|NCT01242527|184431|P2|STARTED|Overall Study||100
79365|NCT01242527|184432|P1|STARTED|Overall Study||99
79366|NCT01242514|184445|P3|NOT COMPLETED|Overall Study||212
79367|NCT01242514|184446|P2|NOT COMPLETED|Overall Study||357
79368|NCT01242514|184447|P1|NOT COMPLETED|Overall Study||1343
79369|NCT01242514|184445|P3|COMPLETED|Overall Study|Due to project closure.|0
79370|NCT01242514|184446|P2|COMPLETED|Overall Study|Due to project closure.|0
79371|NCT01242514|184447|P1|COMPLETED|Overall Study|Due to project closure.|0
79372|NCT01242514|184445|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
79373|NCT01242514|184446|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
79374|NCT01242514|184447|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
79375|NCT01242514|184445|P3|STARTED|Overall Study|Patients who received treatment|212
79376|NCT01242514|184446|P2|STARTED|Overall Study|Patients who received treatment|357
79377|NCT01242514|184447|P1|STARTED|Overall Study|Patients who received treatment|1343
79378|NCT01242371|184466|P2|NOT COMPLETED|Overall Study||5
79379|NCT01242371|184467|P1|NOT COMPLETED|Overall Study||2
79380|NCT01242371|184466|P2|COMPLETED|Overall Study||27
79381|NCT01242371|184467|P1|COMPLETED|Overall Study||31
79382|NCT01242371|184466|P2|STARTED|Overall Study||32
79383|NCT01242371|184467|P1|STARTED|Overall Study||33
79384|NCT01242176|184473|P2|NOT COMPLETED|Second Intervention||0
79385|NCT01242176|184474|P1|NOT COMPLETED|Second Intervention||0
79386|NCT01242176|184473|P2|COMPLETED|Second Intervention||10
79387|NCT01242176|184474|P1|COMPLETED|Second Intervention||11
79388|NCT01242176|184473|P2|STARTED|Second Intervention||10
79389|NCT01242176|184474|P1|STARTED|Second Intervention||11
79390|NCT01242176|184473|P2|NOT COMPLETED|Washout Period of 7 Days||2
79391|NCT01242176|184474|P1|NOT COMPLETED|Washout Period of 7 Days||1
79392|NCT01242176|184473|P2|COMPLETED|Washout Period of 7 Days||10
79393|NCT01242176|184474|P1|COMPLETED|Washout Period of 7 Days||11
79394|NCT01242176|184473|P2|STARTED|Washout Period of 7 Days||12
79395|NCT01242176|184474|P1|STARTED|Washout Period of 7 Days||12
79396|NCT01242176|184473|P2|NOT COMPLETED|First Intervention||0
79397|NCT01242176|184474|P1|NOT COMPLETED|First Intervention||0
79398|NCT01242176|184473|P2|COMPLETED|First Intervention||12
79399|NCT01242176|184474|P1|COMPLETED|First Intervention||12
79400|NCT01242176|184473|P2|STARTED|First Intervention||12
79401|NCT01242176|184474|P1|STARTED|First Intervention||12
79402|NCT01242111|184484|P1|NOT COMPLETED|Overall Study||3
79403|NCT01242111|184484|P1|COMPLETED|Overall Study||17
79404|NCT01242111|184484|P1|STARTED|Overall Study||20
79405|NCT01242085|184496|P3|NOT COMPLETED|Overall Study||0
79406|NCT01242085|184497|P2|NOT COMPLETED|Overall Study||7
79407|NCT01242085|184498|P1|NOT COMPLETED|Overall Study||8
79408|NCT01242085|184496|P3|COMPLETED|Overall Study||1
79409|NCT01242085|184497|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
79410|NCT01242085|184498|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
79411|NCT01242085|184496|P3|STARTED|Overall Study||1
79412|NCT01242085|184497|P2|STARTED|Overall Study||33
79413|NCT01242085|184498|P1|STARTED|Overall Study||30
79414|NCT01241916|184508|P2|NOT COMPLETED|Overall Study||10
79415|NCT01241916|184509|P1|NOT COMPLETED|Overall Study||7
79416|NCT01241916|184508|P2|COMPLETED|Overall Study||21
79417|NCT01241916|184509|P1|COMPLETED|Overall Study||28
79418|NCT01241916|184508|P2|STARTED|Overall Study||31
79419|NCT01241916|184509|P1|STARTED|Overall Study||35
79420|NCT01241903|184519|P2|NOT COMPLETED|Overall Study||0
79421|NCT01241903|184520|P1|NOT COMPLETED|Overall Study||1
79422|NCT01241903|184519|P2|COMPLETED|Overall Study||27
79423|NCT01241903|184520|P1|COMPLETED|Overall Study||26
79424|NCT01241903|184519|P2|STARTED|Overall Study||27
79425|NCT01241903|184520|P1|STARTED|Overall Study||27
79426|NCT01241760|184528|P2|NOT COMPLETED|Overall Study||40
79427|NCT01241760|184529|P1|NOT COMPLETED|Overall Study||34
79428|NCT01241760|184528|P2|COMPLETED|Overall Study||329
79429|NCT01241760|184529|P1|COMPLETED|Overall Study||337
79430|NCT01241760|184528|P2|STARTED|Overall Study||369
79431|NCT01241760|184529|P1|STARTED|Overall Study||371
79432|NCT01241591|184552|P4|NOT COMPLETED|Overall Study||12
79433|NCT01241591|184553|P3|NOT COMPLETED|Overall Study||22
79434|NCT01241591|184554|P2|NOT COMPLETED|Overall Study||24
79435|NCT01241591|184555|P1|NOT COMPLETED|Overall Study||23
79436|NCT01241591|184552|P4|COMPLETED|Overall Study||95
79437|NCT01241591|184553|P3|COMPLETED|Overall Study||313
79438|NCT01241591|184554|P2|COMPLETED|Overall Study||306
79439|NCT01241591|184555|P1|COMPLETED|Overall Study||306
79440|NCT01241591|184552|P4|STARTED|Overall Study||107
79441|NCT01241591|184553|P3|STARTED|Overall Study||335
79442|NCT01241591|184554|P2|STARTED|Overall Study||330
79443|NCT01241591|184555|P1|STARTED|Overall Study||329
79444|NCT01241565|184745|P1|NOT COMPLETED|Overall Study||0
79445|NCT01241565|184745|P1|COMPLETED|Overall Study||50
79446|NCT01241565|184745|P1|STARTED|Overall Study||50
79447|NCT01241552|184758|P4|NOT COMPLETED|Overall Study||64
79448|NCT01241552|184759|P3|NOT COMPLETED|Overall Study||60
79449|NCT01241552|184760|P2|NOT COMPLETED|Overall Study||63
79450|NCT01241552|184761|P1|NOT COMPLETED|Overall Study||41
79451|NCT01241552|184758|P4|COMPLETED|Overall Study||340
79452|NCT01241552|184759|P3|COMPLETED|Overall Study||343
79453|NCT01241552|184760|P2|COMPLETED|Overall Study||340
79454|NCT01241552|184761|P1|COMPLETED|Overall Study||201
79455|NCT01241552|184758|P4|Treated|Overall Study||397
79456|NCT01241552|184759|P3|Treated|Overall Study||388
79457|NCT01241552|184760|P2|Treated|Overall Study||392
79458|NCT01241552|184761|P1|Treated|Overall Study||235
79459|NCT01241552|184758|P4|STARTED|Overall Study||404
79460|NCT01241552|184759|P3|STARTED|Overall Study||403
79461|NCT01241552|184760|P2|STARTED|Overall Study||403
79462|NCT01241552|184761|P1|STARTED|Overall Study||242
79463|NCT01241539|184827|P1|NOT COMPLETED|Period 2||0
79464|NCT01241539|184827|P1|COMPLETED|Period 2||7
79465|NCT01241539|184827|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
79466|NCT01241539|184827|P1|NOT COMPLETED|Period 1||0
79467|NCT01241539|184827|P1|COMPLETED|Period 1||7
79468|NCT01241539|184827|P1|STARTED|Period 1||7
79469|NCT01241513|184848|P2|NOT COMPLETED|Overall Study||0
79470|NCT01241513|184849|P1|NOT COMPLETED|Overall Study||0
79471|NCT01241513|184848|P2|COMPLETED|Overall Study||9
79472|NCT01241513|184849|P1|COMPLETED|Overall Study|Study has been completed|10
79473|NCT01241513|184848|P2|STARTED|Overall Study||9
79474|NCT01241513|184849|P1|STARTED|Overall Study||10
79475|NCT01241292|184856|P2|NOT COMPLETED|Overall Study||2
79476|NCT01241292|184857|P1|NOT COMPLETED|Overall Study||1
79477|NCT01241292|184856|P2|COMPLETED|Overall Study|completed=treatment on-going|1
79478|NCT01241292|184857|P1|COMPLETED|Overall Study|completed=treatment on-going|2
79479|NCT01241292|184856|P2|STARTED|Overall Study||3
79480|NCT01241292|184857|P1|STARTED|Overall Study||3
79481|NCT01241279|184881|P2|NOT COMPLETED|Overall Study||1
79482|NCT01241279|184882|P1|NOT COMPLETED|Overall Study||0
79483|NCT01241279|184881|P2|COMPLETED|Overall Study||1
79484|NCT01241279|184882|P1|COMPLETED|Overall Study||4
79485|NCT01241279|184881|P2|STARTED|Overall Study||2
79486|NCT01241279|184882|P1|STARTED|Overall Study||4
79487|NCT01241240|184892|P2|NOT COMPLETED|Overall Study||9
79488|NCT01241240|184893|P1|NOT COMPLETED|Overall Study||8
79489|NCT01241240|184892|P2|COMPLETED|Overall Study||89
79490|NCT01241240|184893|P1|COMPLETED|Overall Study||86
79491|NCT01241240|184892|P2|STARTED|Overall Study||98
79492|NCT01241240|184893|P1|STARTED|Overall Study||94
79493|NCT01240915|184911|P9|NOT COMPLETED|Overall Study||8
79494|NCT01240915|184912|P8|NOT COMPLETED|Overall Study||4
79495|NCT01240915|184913|P7|NOT COMPLETED|Overall Study||8
79496|NCT01240915|184914|P6|NOT COMPLETED|Overall Study||10
79497|NCT01240915|184915|P5|NOT COMPLETED|Overall Study||4
79498|NCT01240915|184916|P4|NOT COMPLETED|Overall Study||3
79499|NCT01240915|184917|P3|NOT COMPLETED|Overall Study||0
79500|NCT01240915|184918|P2|NOT COMPLETED|Overall Study||1
79501|NCT01240915|184919|P1|NOT COMPLETED|Overall Study||2
79502|NCT01240915|184911|P9|COMPLETED|Overall Study||13
79503|NCT01240915|184912|P8|COMPLETED|Overall Study||15
79504|NCT01240915|184913|P7|COMPLETED|Overall Study||17
79505|NCT01240915|184914|P6|COMPLETED|Overall Study||13
79506|NCT01240915|184915|P5|COMPLETED|Overall Study||2
79507|NCT01240915|184916|P4|COMPLETED|Overall Study||1
79508|NCT01240915|184917|P3|COMPLETED|Overall Study||2
79509|NCT01240915|184918|P2|COMPLETED|Overall Study||2
79510|NCT01240915|184919|P1|COMPLETED|Overall Study||0
79511|NCT01240915|184911|P9|STARTED|Overall Study||21
79512|NCT01240915|184912|P8|STARTED|Overall Study||19
79513|NCT01240915|184913|P7|STARTED|Overall Study||25
79514|NCT01240915|184914|P6|STARTED|Overall Study||23
79515|NCT01240915|184915|P5|STARTED|Overall Study||6
79516|NCT01240915|184916|P4|STARTED|Overall Study||4
79517|NCT01240915|184917|P3|STARTED|Overall Study||2
79518|NCT01240915|184918|P2|STARTED|Overall Study||3
79519|NCT01240915|184919|P1|STARTED|Overall Study||2
79520|NCT01240902|185102|P4|NOT COMPLETED|Overall Study||165
79521|NCT01240902|185103|P3|NOT COMPLETED|Overall Study||100
79522|NCT01240902|185104|P2|NOT COMPLETED|Overall Study||79
79523|NCT01240902|185105|P1|NOT COMPLETED|Overall Study||211
79524|NCT01240902|185102|P4|COMPLETED|Overall Study||237
79525|NCT01240902|185103|P3|COMPLETED|Overall Study||295
79526|NCT01240902|185104|P2|COMPLETED|Overall Study||77
79527|NCT01240902|185105|P1|COMPLETED|Overall Study||289
79528|NCT01240902|185102|P4|STARTED|Overall Study||402
79529|NCT01240902|185103|P3|STARTED|Overall Study||395
79530|NCT01240902|185104|P2|STARTED|Overall Study||156
79531|NCT01240902|185105|P1|STARTED|Overall Study||500
79532|NCT01240811|185194|P3|NOT COMPLETED|Overall Study||1
79533|NCT01240811|185195|P2|NOT COMPLETED|Overall Study||1
79534|NCT01240811|185196|P1|NOT COMPLETED|Overall Study||0
79535|NCT01240811|185194|P3|COMPLETED|Overall Study||16
79536|NCT01240811|185195|P2|COMPLETED|Overall Study||16
79537|NCT01240811|185196|P1|COMPLETED|Overall Study||8
79538|NCT01240811|185194|P3|STARTED|Overall Study||17
79539|NCT01240811|185195|P2|STARTED|Overall Study||17
79540|NCT01240811|185196|P1|STARTED|Overall Study||8
79541|NCT01240785|185206|P2|NOT COMPLETED|Overall Study||3
79542|NCT01240785|185207|P1|NOT COMPLETED|Overall Study||1
79543|NCT01240785|185206|P2|COMPLETED|Overall Study||107
79544|NCT01240785|185207|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
79545|NCT01240785|185206|P2|STARTED|Overall Study||110
79546|NCT01240785|185207|P1|STARTED|Overall Study||111
79547|NCT01240746|185238|P3|NOT COMPLETED|Overall Study||243
79548|NCT01240746|185239|P2|NOT COMPLETED|Overall Study||48
79549|NCT01240746|185240|P1|NOT COMPLETED|Overall Study||59
79550|NCT01240746|185238|P3|COMPLETED|Overall Study||2659
79551|NCT01240746|185239|P2|COMPLETED|Overall Study||677
79552|NCT01240746|185240|P1|COMPLETED|Overall Study||677
79553|NCT01240746|185238|P3|STARTED|Overall Study||2902
79554|NCT01240746|185239|P2|STARTED|Overall Study||725
79555|NCT01240746|185240|P1|STARTED|Overall Study||736
79556|NCT01240590|185295|P5|NOT COMPLETED|Phase II||1
79557|NCT01240590|185296|P4|NOT COMPLETED|Phase II||2
79558|NCT01240590|185297|P3|NOT COMPLETED|Phase II||0
79559|NCT01240590|185298|P2|NOT COMPLETED|Phase II||0
79560|NCT01240590|185299|P1|NOT COMPLETED|Phase II||0
79561|NCT01240590|185295|P5|COMPLETED|Phase II||0
79562|NCT01240590|185296|P4|COMPLETED|Phase II||15
79563|NCT01240590|185297|P3|COMPLETED|Phase II||0
79564|NCT01240590|185298|P2|COMPLETED|Phase II||0
79565|NCT01240590|185299|P1|COMPLETED|Phase II||0
79566|NCT01240590|185295|P5|STARTED|Phase II||1
79567|NCT01240590|185296|P4|STARTED|Phase II||17
79568|NCT01240590|185297|P3|STARTED|Phase II||0
79569|NCT01240590|185298|P2|STARTED|Phase II||0
79570|NCT01240590|185299|P1|STARTED|Phase II||0
79571|NCT01240590|185295|P5|NOT COMPLETED|Phase I||0
79572|NCT01240590|185296|P4|NOT COMPLETED|Phase I||0
79573|NCT01240590|185297|P3|NOT COMPLETED|Phase I||3
79574|NCT01240590|185298|P2|NOT COMPLETED|Phase I||0
79575|NCT01240590|185299|P1|NOT COMPLETED|Phase I||0
79576|NCT01240590|185295|P5|COMPLETED|Phase I||0
79577|NCT01240590|185296|P4|COMPLETED|Phase I||0
79578|NCT01240590|185297|P3|COMPLETED|Phase I||0
79579|NCT01240590|185298|P2|COMPLETED|Phase I||6
79580|NCT01240590|185299|P1|COMPLETED|Phase I||0
79581|NCT01240590|185295|P5|STARTED|Phase I||0
79582|NCT01240590|185296|P4|STARTED|Phase I||0
79583|NCT01240590|185297|P3|STARTED|Phase I||3
79584|NCT01240590|185298|P2|STARTED|Phase I||6
79585|NCT01240590|185299|P1|STARTED|Phase I||0
79586|NCT01240551|185317|P2|NOT COMPLETED|Overall Study||3
79587|NCT01240551|185318|P1|NOT COMPLETED|Overall Study||4
79588|NCT01240551|185317|P2|COMPLETED|Overall Study||27
79589|NCT01240551|185318|P1|COMPLETED|Overall Study||26
79590|NCT01240551|185317|P2|STARTED|Overall Study||30
79591|NCT01240551|185318|P1|STARTED|Overall Study||30
79592|NCT01240382|185328|P2|NOT COMPLETED|Overall Study||4
79593|NCT01240382|185329|P1|NOT COMPLETED|Overall Study||2
79594|NCT01240382|185328|P2|COMPLETED|Overall Study||139
79595|NCT01240382|185329|P1|COMPLETED|Overall Study||142
79596|NCT01240382|185328|P2|STARTED|Overall Study||143
79597|NCT01240382|185329|P1|STARTED|Overall Study||144
79598|NCT01240356|185339|P2|NOT COMPLETED|Overall Study||0
79599|NCT01240356|185340|P1|NOT COMPLETED|Overall Study||3
79600|NCT01240356|185339|P2|COMPLETED|Overall Study||20
79601|NCT01240356|185340|P1|COMPLETED|Overall Study||15
79602|NCT01240356|185339|P2|STARTED|Overall Study||20
79603|NCT01240356|185340|P1|STARTED|Overall Study||18
79604|NCT01240330|185351|P1|NOT COMPLETED|Overall Study||0
79605|NCT01240330|185351|P1|COMPLETED|Overall Study||33
79606|NCT01240330|185351|P1|STARTED|Overall Study||33
79607|NCT01240200|185359|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
79608|NCT01240200|185360|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
79609|NCT01240200|185359|P2|COMPLETED|12-week Crossover Phase - Period 2||23
79610|NCT01240200|185360|P1|COMPLETED|12-week Crossover Phase - Period 2||23
79611|NCT01240200|185359|P2|STARTED|12-week Crossover Phase - Period 2||23
79612|NCT01240200|185360|P1|STARTED|12-week Crossover Phase - Period 2||23
79613|NCT01240200|185359|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
79614|NCT01240200|185360|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
79615|NCT01240200|185359|P2|COMPLETED|12-week Crossover Phase - Period 1||23
79616|NCT01240200|185360|P1|COMPLETED|12-week Crossover Phase - Period 1||23
79617|NCT01240200|185359|P2|STARTED|12-week Crossover Phase - Period 1||24
79618|NCT01240200|185360|P1|STARTED|12-week Crossover Phase - Period 1||25
79619|NCT01240135|185368|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
79620|NCT01240135|185369|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
79621|NCT01240135|185368|P2|COMPLETED|Period Two, 14 Days of Wear||43
79622|NCT01240135|185369|P1|COMPLETED|Period Two, 14 Days of Wear||43
79623|NCT01240135|185368|P2|STARTED|Period Two, 14 Days of Wear||45
79624|NCT01240135|185369|P1|STARTED|Period Two, 14 Days of Wear||44
79625|NCT01240135|185368|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
79626|NCT01240135|185369|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
79627|NCT01240135|185368|P2|COMPLETED|Period One, 14 Days of Wear||45
79628|NCT01240135|185369|P1|COMPLETED|Period One, 14 Days of Wear||44
79629|NCT01240135|185368|P2|STARTED|Period One, 14 Days of Wear||45
79630|NCT01240135|185369|P1|STARTED|Period One, 14 Days of Wear||44
79631|NCT01240122|185377|P1|NOT COMPLETED|Overall Study||0
79632|NCT01240122|185377|P1|COMPLETED|Overall Study||29
79633|NCT01240122|185377|P1|STARTED|Overall Study||29
79634|NCT01239992|185384|P1|NOT COMPLETED|Overall Study||2
79635|NCT01239992|185384|P1|COMPLETED|Overall Study||10
79636|NCT01239992|185384|P1|STARTED|Overall Study||12
79637|NCT01239797|185393|P2|NOT COMPLETED|Treated Participants||274
79638|NCT01239797|185394|P1|NOT COMPLETED|Treated Participants||235
79639|NCT01239797|185393|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
79640|NCT01239797|185394|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
79641|NCT01239797|185393|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
79642|NCT01239797|185394|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
79643|NCT01239797|185393|P2|NOT COMPLETED|Randomized Participants||9
79644|NCT01239797|185394|P1|NOT COMPLETED|Randomized Participants||2
79645|NCT01239797|185393|P2|COMPLETED|Randomized Participants||316
79646|NCT01239797|185394|P1|COMPLETED|Randomized Participants||319
79647|NCT01239797|185393|P2|STARTED|Randomized Participants||325
79648|NCT01239797|185394|P1|STARTED|Randomized Participants||321
79649|NCT01239745|185402|P1|NOT COMPLETED|Overall Study||46
79650|NCT01239745|185402|P1|COMPLETED|Overall Study||0
79651|NCT01239745|185402|P1|STARTED|Overall Study||46
79652|NCT01239732|185413|P1|NOT COMPLETED|Overall Study||1021
79653|NCT01239732|185413|P1|COMPLETED|Overall Study||0
79654|NCT01239732|185413|P1|STARTED|Overall Study||1021
79655|NCT01239680|185426|P2|NOT COMPLETED|Overall Study||0
79656|NCT01239680|185427|P1|NOT COMPLETED|Overall Study||2
79657|NCT01239680|185426|P2|COMPLETED|Overall Study||2
79658|NCT01239680|185427|P1|COMPLETED|Overall Study||1
79659|NCT01239680|185426|P2|STARTED|Overall Study||2
79660|NCT01239680|185427|P1|STARTED|Overall Study||3
79661|NCT01239511|185437|P4|NOT COMPLETED|Overall Study||9
79662|NCT01239511|185438|P3|NOT COMPLETED|Overall Study||4
79663|NCT01239511|185439|P2|NOT COMPLETED|Overall Study||5
79664|NCT01239511|185440|P1|NOT COMPLETED|Overall Study||1
79665|NCT01239511|185437|P4|COMPLETED|Overall Study||38
79666|NCT01239511|185438|P3|COMPLETED|Overall Study||43
79667|NCT01239511|185439|P2|COMPLETED|Overall Study||40
79668|NCT01239511|185440|P1|COMPLETED|Overall Study||46
79669|NCT01239511|185437|P4|STARTED|Overall Study||47
79670|NCT01239511|185438|P3|STARTED|Overall Study||47
79671|NCT01239511|185439|P2|STARTED|Overall Study||45
79672|NCT01239511|185440|P1|STARTED|Overall Study||47
79673|NCT01239355|185450|P1|NOT COMPLETED|Overall Study||0
79674|NCT01239355|185450|P1|COMPLETED|Overall Study||15
79675|NCT01239355|185450|P1|STARTED|Overall Study||15
79676|NCT01239316|185456|P1|NOT COMPLETED|Overall Study||12
79677|NCT01239316|185456|P1|COMPLETED|Overall Study||0
79678|NCT01239316|185456|P1|STARTED|Overall Study||12
79679|NCT01239212|185464|P1|NOT COMPLETED|Overall Study||0
79680|NCT01239212|185464|P1|COMPLETED|Overall Study||7
79681|NCT01239212|185464|P1|STARTED|Overall Study||7
79682|NCT01239121|185471|P3|NOT COMPLETED|Overall Study||0
79683|NCT01239121|185472|P2|NOT COMPLETED|Overall Study||4
79684|NCT01239121|185473|P1|NOT COMPLETED|Overall Study||2
79685|NCT01239121|185471|P3|COMPLETED|Overall Study||15
79686|NCT01239121|185472|P2|COMPLETED|Overall Study||195
79687|NCT01239121|185473|P1|COMPLETED|Overall Study||186
79688|NCT01239121|185471|P3|STARTED|Overall Study||15
79689|NCT01239121|185472|P2|STARTED|Overall Study||199
79690|NCT01239121|185473|P1|STARTED|Overall Study||188
79691|NCT01239056|185487|P1|NOT COMPLETED|Overall Study||0
79692|NCT01239056|185487|P1|COMPLETED|Overall Study||20
79693|NCT01239056|185487|P1|STARTED|Overall Study||20
79694|NCT01239043|185495|P2|NOT COMPLETED|Overall Study||1
79695|NCT01239043|185496|P1|NOT COMPLETED|Overall Study||2
79696|NCT01239043|185495|P2|COMPLETED|Overall Study||102
79697|NCT01239043|185496|P1|COMPLETED|Overall Study||34
79698|NCT01239043|185495|P2|STARTED|Overall Study||103
79792|NCT01238341|185803|P1|NOT COMPLETED|Overall Study||0
79699|NCT01239043|185496|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
79700|NCT01238991|185524|P10|NOT COMPLETED|Overall Study||2
79701|NCT01238991|185525|P9|NOT COMPLETED|Overall Study||4
79702|NCT01238991|185526|P8|NOT COMPLETED|Overall Study||5
79703|NCT01238991|185527|P7|NOT COMPLETED|Overall Study||8
79704|NCT01238991|185528|P6|NOT COMPLETED|Overall Study||0
79705|NCT01238991|185529|P5|NOT COMPLETED|Overall Study||2
79706|NCT01238991|185530|P4|NOT COMPLETED|Overall Study||2
79707|NCT01238991|185531|P3|NOT COMPLETED|Overall Study||6
79708|NCT01238991|185532|P2|NOT COMPLETED|Overall Study||0
79709|NCT01238991|185533|P1|NOT COMPLETED|Overall Study||2
79710|NCT01238991|185524|P10|COMPLETED|Overall Study||0
79711|NCT01238991|185525|P9|COMPLETED|Overall Study||0
79712|NCT01238991|185526|P8|COMPLETED|Overall Study||0
79713|NCT01238991|185527|P7|COMPLETED|Overall Study||0
79714|NCT01238991|185528|P6|COMPLETED|Overall Study||2
79715|NCT01238991|185529|P5|COMPLETED|Overall Study||3
79716|NCT01238991|185530|P4|COMPLETED|Overall Study||4
79717|NCT01238991|185531|P3|COMPLETED|Overall Study||5
79718|NCT01238991|185532|P2|COMPLETED|Overall Study||3
79719|NCT01238991|185533|P1|COMPLETED|Overall Study||5
79720|NCT01238991|185524|P10|Received Treatment|Overall Study||2
79721|NCT01238991|185525|P9|Received Treatment|Overall Study||4
79722|NCT01238991|185526|P8|Received Treatment|Overall Study||5
79723|NCT01238991|185527|P7|Received Treatment|Overall Study||8
79724|NCT01238991|185528|P6|Received Treatment|Overall Study||2
79725|NCT01238991|185529|P5|Received Treatment|Overall Study||5
79726|NCT01238991|185530|P4|Received Treatment|Overall Study||6
79727|NCT01238991|185531|P3|Received Treatment|Overall Study||11
79728|NCT01238991|185532|P2|Received Treatment|Overall Study||3
79729|NCT01238991|185533|P1|Received Treatment|Overall Study||7
79730|NCT01238991|185524|P10|STARTED|Overall Study||2
79731|NCT01238991|185525|P9|STARTED|Overall Study||4
79732|NCT01238991|185526|P8|STARTED|Overall Study||5
79733|NCT01238991|185527|P7|STARTED|Overall Study||8
79734|NCT01238991|185528|P6|STARTED|Overall Study||2
79735|NCT01238991|185529|P5|STARTED|Overall Study||5
79736|NCT01238991|185530|P4|STARTED|Overall Study||6
79737|NCT01238991|185531|P3|STARTED|Overall Study||11
79738|NCT01238991|185532|P2|STARTED|Overall Study||3
79739|NCT01238991|185533|P1|STARTED|Overall Study||7
79740|NCT01238900|185620|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
79741|NCT01238900|185620|P1|COMPLETED|<12 Months Post Stent Removal||18
79742|NCT01238900|185620|P1|STARTED|<12 Months Post Stent Removal||23
79743|NCT01238900|185620|P1|NOT COMPLETED|6 Months Post Stent Placement||0
79744|NCT01238900|185620|P1|COMPLETED|6 Months Post Stent Placement||23
79745|NCT01238900|185620|P1|STARTED|6 Months Post Stent Placement||23
79746|NCT01238861|185634|P6|NOT COMPLETED|Overall Study||15
79747|NCT01238861|185635|P5|NOT COMPLETED|Overall Study||13
79748|NCT01238861|185636|P4|NOT COMPLETED|Overall Study||13
79749|NCT01238861|185637|P3|NOT COMPLETED|Overall Study||11
79750|NCT01238861|185638|P2|NOT COMPLETED|Overall Study||8
79751|NCT01238861|185639|P1|NOT COMPLETED|Overall Study||11
79752|NCT01238861|185634|P6|COMPLETED|Overall Study||125
79753|NCT01238861|185635|P5|COMPLETED|Overall Study||129
79754|NCT01238861|185636|P4|COMPLETED|Overall Study||69
79755|NCT01238861|185637|P3|COMPLETED|Overall Study||70
79756|NCT01238861|185638|P2|COMPLETED|Overall Study||73
79757|NCT01238861|185639|P1|COMPLETED|Overall Study||69
79758|NCT01238861|185634|P6|STARTED|Overall Study||140
79759|NCT01238861|185635|P5|STARTED|Overall Study||142
79760|NCT01238861|185636|P4|STARTED|Overall Study||82
79761|NCT01238861|185637|P3|STARTED|Overall Study||81
79762|NCT01238861|185638|P2|STARTED|Overall Study||81
79763|NCT01238861|185639|P1|STARTED|Overall Study||80
79764|NCT01238848|185719|P2|NOT COMPLETED|Overall Study||5
79765|NCT01238848|185720|P1|NOT COMPLETED|Overall Study||13
79766|NCT01238848|185719|P2|COMPLETED|Overall Study||45
79767|NCT01238848|185720|P1|COMPLETED|Overall Study||37
79768|NCT01238848|185719|P2|STARTED|Overall Study||50
79769|NCT01238848|185720|P1|STARTED|Overall Study||50
79770|NCT01238822|185728|P1|NOT COMPLETED|Overall Study||3
79771|NCT01238822|185728|P1|COMPLETED|Overall Study||93
79772|NCT01238822|185728|P1|Received High Dosage|Overall Study||93
79773|NCT01238822|185728|P1|Received Medium Dosage|Overall Study||93
79774|NCT01238822|185728|P1|Received Low Dosage|Overall Study||93
79775|NCT01238822|185728|P1|Received Placebo|Overall Study||93
79776|NCT01238822|185728|P1|STARTED|Overall Study||96
79777|NCT01238640|185738|P1|NOT COMPLETED|Overall Study||0
79778|NCT01238640|185738|P1|COMPLETED|Overall Study||84
79779|NCT01238640|185738|P1|STARTED|Overall Study||84
79780|NCT01238575|185757|P2|NOT COMPLETED|Overall Study||4
79781|NCT01238575|185758|P1|NOT COMPLETED|Overall Study||4
79782|NCT01238575|185757|P2|COMPLETED|Overall Study||28
79783|NCT01238575|185758|P1|COMPLETED|Overall Study||26
79784|NCT01238575|185757|P2|STARTED|Overall Study||32
79785|NCT01238575|185758|P1|STARTED|Overall Study||30
79786|NCT01238471|185796|P2|NOT COMPLETED|Overall Study||0
79787|NCT01238471|185797|P1|NOT COMPLETED|Overall Study||0
79788|NCT01238471|185796|P2|COMPLETED|Overall Study||10
79789|NCT01238471|185797|P1|COMPLETED|Overall Study||10
79790|NCT01238471|185796|P2|STARTED|Overall Study||10
79791|NCT01238471|185797|P1|STARTED|Overall Study||10
79793|NCT01238341|185803|P1|COMPLETED|Overall Study||7
79794|NCT01238341|185803|P1|STARTED|Overall Study||7
79795|NCT01238211|185810|P1|NOT COMPLETED|Overall Study||58
79796|NCT01238211|185810|P1|COMPLETED|Overall Study||3
79797|NCT01238211|185810|P1|STARTED|Overall Study||61
79798|NCT01237613|185814|P1|NOT COMPLETED|Overall Study||0
79799|NCT01237613|185814|P1|COMPLETED|Overall Study||4
79800|NCT01237613|185814|P1|STARTED|Overall Study||4
79801|NCT01237353|185838|P1|NOT COMPLETED|Overall Study||0
79802|NCT01237353|185838|P1|COMPLETED|Overall Study||6
79803|NCT01237353|185838|P1|STARTED|Overall Study||6
79804|NCT01237340|185843|P1|NOT COMPLETED|Overall Study||40
79805|NCT01237340|185843|P1|COMPLETED|Overall Study||19
79806|NCT01237340|185843|P1|STARTED|Overall Study||59
79807|NCT01237327|185857|P2|NOT COMPLETED|Overall Study||40
79808|NCT01237327|185858|P1|NOT COMPLETED|Overall Study||42
79809|NCT01237327|185857|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
79810|NCT01237327|185858|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
79811|NCT01237327|185857|P2|Continued Treatment in Extension Study|Overall Study||17
79812|NCT01237327|185858|P1|Continued Treatment in Extension Study|Overall Study||21
79813|NCT01237327|185857|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
79814|NCT01237327|185858|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
79815|NCT01237327|185857|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
79816|NCT01237327|185858|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
79817|NCT01237327|185857|P2|STARTED|Overall Study||41
79818|NCT01237327|185858|P1|STARTED|Overall Study||43
79819|NCT01237301|185874|P2|NOT COMPLETED|Overall Study||4
79820|NCT01237301|185875|P1|NOT COMPLETED|Overall Study||5
79821|NCT01237301|185874|P2|COMPLETED|Overall Study||55
79822|NCT01237301|185875|P1|COMPLETED|Overall Study||60
79823|NCT01237301|185874|P2|STARTED|Overall Study||59
79824|NCT01237301|185875|P1|STARTED|Overall Study||65
79825|NCT01237223|185887|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
79826|NCT01237223|185888|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
79827|NCT01237223|185889|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
79828|NCT01237223|185890|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
79829|NCT01237223|185891|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
79830|NCT01237223|185892|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
79831|NCT01237223|185887|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
79832|NCT01237223|185888|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
79833|NCT01237223|185889|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
79834|NCT01237223|185890|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
79835|NCT01237223|185891|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
79836|NCT01237223|185892|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
79837|NCT01237223|185887|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
79838|NCT01237223|185888|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
79839|NCT01237223|185889|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
79840|NCT01237223|185890|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
79841|NCT01237223|185891|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
79842|NCT01237223|185892|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
79843|NCT01237223|185887|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79844|NCT01237223|185888|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79845|NCT01237223|185889|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79846|NCT01237223|185890|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79847|NCT01237223|185891|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79848|NCT01237223|185892|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
79849|NCT01237223|185887|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79850|NCT01237223|185888|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79851|NCT01237223|185889|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79852|NCT01237223|185890|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79853|NCT01237223|185891|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
79854|NCT01237223|185892|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
79855|NCT01237223|185887|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
79856|NCT01237223|185888|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
79857|NCT01237223|185889|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
79858|NCT01237223|185890|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
79859|NCT01237223|185891|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
79860|NCT01237223|185892|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
79861|NCT01237197|185933|P2|NOT COMPLETED|Open Label Period||0
79862|NCT01237197|185934|P1|NOT COMPLETED|Open Label Period||0
79863|NCT01237197|185933|P2|COMPLETED|Open Label Period||10
79864|NCT01237197|185934|P1|COMPLETED|Open Label Period||12
79865|NCT01237197|185933|P2|STARTED|Open Label Period||10
79866|NCT01237197|185934|P1|STARTED|Open Label Period||12
79867|NCT01237197|185933|P2|NOT COMPLETED|Randomization Period||3
79868|NCT01237197|185934|P1|NOT COMPLETED|Randomization Period||1
79869|NCT01237197|185933|P2|COMPLETED|Randomization Period||10
79870|NCT01237197|185934|P1|COMPLETED|Randomization Period||12
79871|NCT01237197|185933|P2|STARTED|Randomization Period||13
79872|NCT01237197|185934|P1|STARTED|Randomization Period||13
79873|NCT01237080|185942|P2|NOT COMPLETED|Overall Study||0
79874|NCT01237080|185943|P1|NOT COMPLETED|Overall Study||0
79875|NCT01237080|185942|P2|COMPLETED|Overall Study||50
79876|NCT01237080|185943|P1|COMPLETED|Overall Study||50
79877|NCT01237080|185942|P2|STARTED|Overall Study||50
79878|NCT01237080|185943|P1|STARTED|Overall Study||50
79879|NCT01237054|185951|P1|NOT COMPLETED|Overall Study||1
79880|NCT01237054|185951|P1|COMPLETED|Overall Study||30
79881|NCT01237054|185951|P1|STARTED|Overall Study||31
79882|NCT01236573|185971|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
79883|NCT01236573|185972|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79884|NCT01236573|185973|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79885|NCT01236573|185974|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79886|NCT01236573|185975|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79887|NCT01236573|185976|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79888|NCT01236573|185977|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79889|NCT01236573|185978|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79890|NCT01236573|185979|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79891|NCT01236573|185980|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79892|NCT01236573|185981|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79893|NCT01236573|185971|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
79894|NCT01236573|185972|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79895|NCT01236573|185973|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79896|NCT01236573|185974|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79897|NCT01236573|185975|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79898|NCT01236573|185976|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79899|NCT01236573|185977|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79900|NCT01236573|185978|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79901|NCT01236573|185979|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79902|NCT01236573|185980|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79903|NCT01236573|185981|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79904|NCT01236573|185971|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
79905|NCT01236573|185972|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79906|NCT01236573|185973|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79907|NCT01236573|185974|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79908|NCT01236573|185975|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79909|NCT01236573|185976|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79910|NCT01236573|185977|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79911|NCT01236573|185978|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79912|NCT01236573|185979|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79913|NCT01236573|185980|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79914|NCT01236573|185981|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
79915|NCT01236573|185971|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79916|NCT01236573|185972|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
79917|NCT01236573|185973|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
79918|NCT01236573|185974|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79919|NCT01236573|185975|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
79920|NCT01236573|185976|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79921|NCT01236573|185977|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79922|NCT01236573|185978|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79923|NCT01236573|185979|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79924|NCT01236573|185980|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79925|NCT01236573|185981|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79926|NCT01236573|185971|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79927|NCT01236573|185972|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
79928|NCT01236573|185973|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
79929|NCT01236573|185974|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
79930|NCT01236573|185975|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
79931|NCT01236573|185976|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
79932|NCT01236573|185977|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
79933|NCT01236573|185978|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79934|NCT01236573|185979|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79935|NCT01236573|185980|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79936|NCT01236573|185981|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
79937|NCT01236573|185971|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
79938|NCT01236573|185972|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
79939|NCT01236573|185973|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
79940|NCT01236573|185974|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
79941|NCT01236573|185975|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
79942|NCT01236573|185976|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
79943|NCT01236573|185977|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
79944|NCT01236573|185978|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
79945|NCT01236573|185979|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
79946|NCT01236573|185980|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
79947|NCT01236573|185981|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
79948|NCT01236573|185971|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79949|NCT01236573|185972|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79950|NCT01236573|185973|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79951|NCT01236573|185974|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79952|NCT01236573|185975|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79953|NCT01236573|185976|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79954|NCT01236573|185977|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79955|NCT01236573|185978|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79956|NCT01236573|185979|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79957|NCT01236573|185980|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79958|NCT01236573|185981|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79959|NCT01236573|185971|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79960|NCT01236573|185972|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79961|NCT01236573|185973|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79962|NCT01236573|185974|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79963|NCT01236573|185975|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79964|NCT01236573|185976|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79965|NCT01236573|185977|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
79966|NCT01236573|185978|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
79967|NCT01236573|185979|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
79968|NCT01236573|185980|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
79969|NCT01236573|185981|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
79970|NCT01236573|185971|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79971|NCT01236573|185972|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79972|NCT01236573|185973|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79973|NCT01236573|185974|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79974|NCT01236573|185975|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79975|NCT01236573|185976|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79976|NCT01236573|185977|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
79977|NCT01236573|185978|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
79978|NCT01236573|185979|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
79979|NCT01236573|185980|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
79980|NCT01236573|185981|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
79981|NCT01236534|186019|P2|NOT COMPLETED|Overall Study||0
79982|NCT01236534|186020|P1|NOT COMPLETED|Overall Study||3
79983|NCT01236534|186019|P2|COMPLETED|Overall Study||10
79984|NCT01236534|186020|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
79985|NCT01236534|186019|P2|STARTED|Overall Study||10
79986|NCT01236534|186020|P1|STARTED|Overall Study||11
79987|NCT01236391|186028|P1|NOT COMPLETED|Overall Study||16
79988|NCT01236391|186028|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
79989|NCT01236391|186028|P1|STARTED|Overall Study|Participants who received study treatment|111
79990|NCT01236378|186036|P1|NOT COMPLETED|Overall Study||0
79991|NCT01236378|186036|P1|COMPLETED|Overall Study||24
79992|NCT01236378|186036|P1|STARTED|Overall Study||24
79993|NCT01236365|186050|P2|NOT COMPLETED|Overall Study||2
79994|NCT01236365|186051|P1|NOT COMPLETED|Overall Study||2
79995|NCT01236365|186050|P2|COMPLETED|Overall Study||19
79996|NCT01236365|186051|P1|COMPLETED|Overall Study||19
79997|NCT01236365|186050|P2|STARTED|Overall Study||21
79998|NCT01236365|186051|P1|STARTED|Overall Study||21
79999|NCT01236339|186065|P2|NOT COMPLETED|Overall Study||13
80000|NCT01236339|186066|P1|NOT COMPLETED|Overall Study||11
80001|NCT01236339|186065|P2|COMPLETED|Overall Study||0
80002|NCT01236339|186066|P1|COMPLETED|Overall Study||2
80003|NCT01236339|186065|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
80004|NCT01236339|186066|P1|LVP Crossover to TIPS|Overall Study||0
80005|NCT01236339|186065|P2|STARTED|Overall Study||13
80006|NCT01236339|186066|P1|STARTED|Overall Study||13
80007|NCT01236326|186086|P2|NOT COMPLETED|Overall Study||4
80008|NCT01236326|186087|P1|NOT COMPLETED|Overall Study||1
80009|NCT01236326|186086|P2|COMPLETED|Overall Study||51
80010|NCT01236326|186087|P1|COMPLETED|Overall Study||49
80011|NCT01236326|186086|P2|STARTED|Overall Study||55
80012|NCT01236326|186087|P1|STARTED|Overall Study||50
80013|NCT01236300|186101|P1|NOT COMPLETED|Overall Study||0
80014|NCT01236300|186101|P1|COMPLETED|Overall Study||66
80015|NCT01236300|186101|P1|STARTED|Overall Study||66
80016|NCT01236196|186111|P2|NOT COMPLETED|Overall Study||8
80017|NCT01236196|186112|P1|NOT COMPLETED|Overall Study||1
80018|NCT01236196|186111|P2|COMPLETED|Overall Study||13
80019|NCT01236196|186112|P1|COMPLETED|Overall Study||17
80020|NCT01236196|186111|P2|STARTED|Overall Study||21
80021|NCT01236196|186112|P1|STARTED|Overall Study||18
80022|NCT01236170|186124|P1|NOT COMPLETED|Overall Study||15
80023|NCT01236170|186124|P1|COMPLETED|Overall Study||482
80024|NCT01236170|186124|P1|STARTED|Overall Study||497
80025|NCT01236118|186134|P3|NOT COMPLETED|Overall Study||3
80026|NCT01236118|186135|P2|NOT COMPLETED|Overall Study||1
80027|NCT01236118|186136|P1|NOT COMPLETED|Overall Study||2
80028|NCT01236118|186134|P3|COMPLETED|Overall Study||14
80029|NCT01236118|186135|P2|COMPLETED|Overall Study||4
80030|NCT01236118|186136|P1|COMPLETED|Overall Study||4
80031|NCT01236118|186134|P3|STARTED|Overall Study||17
80032|NCT01236118|186135|P2|STARTED|Overall Study||5
80033|NCT01236118|186136|P1|STARTED|Overall Study||6
80034|NCT01236105|186144|P1|NOT COMPLETED|Overall Study||0
80035|NCT01236105|186144|P1|COMPLETED|Overall Study||21
80036|NCT01236105|186144|P1|STARTED|Overall Study||21
80037|NCT01236053|186180|P22|NOT COMPLETED|Overall Study||0
80038|NCT01236053|186181|P21|NOT COMPLETED|Overall Study||0
80039|NCT01236053|186182|P20|NOT COMPLETED|Overall Study||0
80040|NCT01236053|186183|P19|NOT COMPLETED|Overall Study||0
80041|NCT01236053|186184|P18|NOT COMPLETED|Overall Study||0
80042|NCT01236053|186185|P17|NOT COMPLETED|Overall Study||0
80043|NCT01236053|186186|P16|NOT COMPLETED|Overall Study||0
80044|NCT01236053|186187|P15|NOT COMPLETED|Overall Study||0
80045|NCT01236053|186188|P14|NOT COMPLETED|Overall Study||0
80046|NCT01236053|186189|P13|NOT COMPLETED|Overall Study||0
80047|NCT01236053|186190|P12|NOT COMPLETED|Overall Study||0
80048|NCT01236053|186191|P11|NOT COMPLETED|Overall Study||0
80049|NCT01236053|186192|P10|NOT COMPLETED|Overall Study||0
80050|NCT01236053|186193|P9|NOT COMPLETED|Overall Study||0
80051|NCT01236053|186194|P8|NOT COMPLETED|Overall Study||0
80052|NCT01236053|186195|P7|NOT COMPLETED|Overall Study||0
80053|NCT01236053|186196|P6|NOT COMPLETED|Overall Study||0
80054|NCT01236053|186197|P5|NOT COMPLETED|Overall Study||0
80055|NCT01236053|186198|P4|NOT COMPLETED|Overall Study||0
80056|NCT01236053|186199|P3|NOT COMPLETED|Overall Study||0
80057|NCT01236053|186200|P2|NOT COMPLETED|Overall Study||0
80058|NCT01236053|186201|P1|NOT COMPLETED|Overall Study||0
80059|NCT01236053|186180|P22|COMPLETED|Overall Study||12167
80060|NCT01236053|186181|P21|COMPLETED|Overall Study||1272
80061|NCT01236053|186182|P20|COMPLETED|Overall Study||20382
80062|NCT01236053|186183|P19|COMPLETED|Overall Study||2155
80063|NCT01236053|186184|P18|COMPLETED|Overall Study||380
80064|NCT01236053|186185|P17|COMPLETED|Overall Study||38
80065|NCT01236053|186186|P16|COMPLETED|Overall Study||43559
80066|NCT01236053|186187|P15|COMPLETED|Overall Study||4600
80067|NCT01236053|186188|P14|COMPLETED|Overall Study||1396
80068|NCT01236053|186189|P13|COMPLETED|Overall Study||148
80069|NCT01236053|186190|P12|COMPLETED|Overall Study||188924
80070|NCT01236053|186191|P11|COMPLETED|Overall Study||19564
80071|NCT01236053|186192|P10|COMPLETED|Overall Study||2935
80072|NCT01236053|186193|P9|COMPLETED|Overall Study||300
80073|NCT01236053|186194|P8|COMPLETED|Overall Study||102836
80074|NCT01236053|186195|P7|COMPLETED|Overall Study||10855
80075|NCT01236053|186196|P6|COMPLETED|Overall Study||2067
80076|NCT01236053|186197|P5|COMPLETED|Overall Study||212
80077|NCT01236053|186198|P4|COMPLETED|Overall Study||17853
80078|NCT01236053|186199|P3|COMPLETED|Overall Study||1877
80079|NCT01236053|186200|P2|COMPLETED|Overall Study||1710950
80080|NCT01236053|186201|P1|COMPLETED|Overall Study||179138
80081|NCT01236053|186180|P22|STARTED|Overall Study||12167
80082|NCT01236053|186181|P21|STARTED|Overall Study||1272
80083|NCT01236053|186182|P20|STARTED|Overall Study||20382
80084|NCT01236053|186183|P19|STARTED|Overall Study||2155
80085|NCT01236053|186184|P18|STARTED|Overall Study||380
80086|NCT01236053|186185|P17|STARTED|Overall Study||38
80087|NCT01236053|186186|P16|STARTED|Overall Study||43559
80088|NCT01236053|186187|P15|STARTED|Overall Study||4600
80089|NCT01236053|186188|P14|STARTED|Overall Study||1396
80090|NCT01236053|186189|P13|STARTED|Overall Study||148
80091|NCT01236053|186190|P12|STARTED|Overall Study||188924
80092|NCT01236053|186191|P11|STARTED|Overall Study||19564
80093|NCT01236053|186192|P10|STARTED|Overall Study||2935
80094|NCT01236053|186193|P9|STARTED|Overall Study||300
80095|NCT01236053|186194|P8|STARTED|Overall Study||102836
80096|NCT01236053|186195|P7|STARTED|Overall Study||10855
80097|NCT01236053|186196|P6|STARTED|Overall Study||2067
80098|NCT01236053|186197|P5|STARTED|Overall Study||212
80099|NCT01236053|186198|P4|STARTED|Overall Study||17853
80100|NCT01236053|186199|P3|STARTED|Overall Study||1877
80101|NCT01236053|186200|P2|STARTED|Overall Study||1710950
80102|NCT01236053|186201|P1|STARTED|Overall Study||179138
80103|NCT01236001|186337|P2|NOT COMPLETED|Overall Study||22
80104|NCT01236001|186338|P1|NOT COMPLETED|Overall Study||18
80105|NCT01236001|186337|P2|COMPLETED|Overall Study||65
80106|NCT01236001|186338|P1|COMPLETED|Overall Study||87
80107|NCT01236001|186337|P2|STARTED|Overall Study||87
80108|NCT01236001|186338|P1|STARTED|Overall Study||105
80109|NCT01235923|186370|P2|NOT COMPLETED|Overall Study||0
80110|NCT01235923|186371|P1|NOT COMPLETED|Overall Study||0
80111|NCT01235923|186370|P2|COMPLETED|Overall Study||10
80112|NCT01235923|186371|P1|COMPLETED|Overall Study||10
80113|NCT01235923|186370|P2|STARTED|Overall Study||10
80114|NCT01235923|186371|P1|STARTED|Overall Study||10
80115|NCT01235910|186379|P1|NOT COMPLETED|Overall Study||0
80116|NCT01235910|186379|P1|COMPLETED|Overall Study||1
80117|NCT01235910|186379|P1|STARTED|Overall Study||1
80118|NCT01235897|186383|P1|NOT COMPLETED|Overall Study||0
80119|NCT01235897|186383|P1|COMPLETED|Overall Study||16
80120|NCT01235897|186383|P1|STARTED|Overall Study||16
80121|NCT01235741|186391|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
80122|NCT01235741|186392|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
80123|NCT01235741|186393|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
80206|NCT01235338|186572|P2|STARTED|Overall Study||38
80124|NCT01235741|186391|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
80125|NCT01235741|186392|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
80126|NCT01235741|186393|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
80127|NCT01235741|186391|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
80128|NCT01235741|186392|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
80129|NCT01235741|186393|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
80130|NCT01235741|186391|P3|NOT COMPLETED|Randomized to Treatment||36
80131|NCT01235741|186392|P2|NOT COMPLETED|Randomized to Treatment||36
80132|NCT01235741|186393|P1|NOT COMPLETED|Randomized to Treatment||0
80133|NCT01235741|186391|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
80134|NCT01235741|186392|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
80135|NCT01235741|186393|P1|COMPLETED|Randomized to Treatment||0
80136|NCT01235741|186391|P3|STARTED|Randomized to Treatment||36
80137|NCT01235741|186392|P2|STARTED|Randomized to Treatment||36
80138|NCT01235741|186393|P1|STARTED|Randomized to Treatment||0
80139|NCT01235741|186391|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
80140|NCT01235741|186392|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
80141|NCT01235741|186393|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
80142|NCT01235741|186391|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
80143|NCT01235741|186392|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
80144|NCT01235741|186393|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
80145|NCT01235741|186391|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
80146|NCT01235741|186392|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
80147|NCT01235741|186393|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
80148|NCT01235728|186420|P8|NOT COMPLETED|Overall Study||0
80149|NCT01235728|186421|P7|NOT COMPLETED|Overall Study||0
80150|NCT01235728|186422|P6|NOT COMPLETED|Overall Study||0
80151|NCT01235728|186423|P5|NOT COMPLETED|Overall Study||0
80152|NCT01235728|186424|P4|NOT COMPLETED|Overall Study||1
80153|NCT01235728|186425|P3|NOT COMPLETED|Overall Study||0
80154|NCT01235728|186426|P2|NOT COMPLETED|Overall Study||0
80155|NCT01235728|186427|P1|NOT COMPLETED|Overall Study||0
80156|NCT01235728|186420|P8|COMPLETED|Overall Study||3
80157|NCT01235728|186421|P7|COMPLETED|Overall Study||3
80158|NCT01235728|186422|P6|COMPLETED|Overall Study||3
80159|NCT01235728|186423|P5|COMPLETED|Overall Study||3
80160|NCT01235728|186424|P4|COMPLETED|Overall Study||2
80161|NCT01235728|186425|P3|COMPLETED|Overall Study||3
80162|NCT01235728|186426|P2|COMPLETED|Overall Study||3
80163|NCT01235728|186427|P1|COMPLETED|Overall Study||3
80164|NCT01235728|186420|P8|STARTED|Overall Study||3
80165|NCT01235728|186421|P7|STARTED|Overall Study||3
80166|NCT01235728|186422|P6|STARTED|Overall Study||3
80167|NCT01235728|186423|P5|STARTED|Overall Study||3
80168|NCT01235728|186424|P4|STARTED|Overall Study||3
80169|NCT01235728|186425|P3|STARTED|Overall Study||3
80170|NCT01235728|186426|P2|STARTED|Overall Study||3
80171|NCT01235728|186427|P1|STARTED|Overall Study||3
80172|NCT01235715|186437|P2|NOT COMPLETED|Overall Study||2
80173|NCT01235715|186438|P1|NOT COMPLETED|Overall Study||0
80174|NCT01235715|186437|P2|COMPLETED|Overall Study||100
80175|NCT01235715|186438|P1|COMPLETED|Overall Study||98
80176|NCT01235715|186437|P2|STARTED|Overall Study||102
80177|NCT01235715|186438|P1|STARTED|Overall Study||98
80178|NCT01235598|186478|P2|NOT COMPLETED|Overall Study||4
80179|NCT01235598|186479|P1|NOT COMPLETED|Overall Study||1
80180|NCT01235598|186478|P2|COMPLETED|Overall Study||24
80181|NCT01235598|186479|P1|COMPLETED|Overall Study||12
80182|NCT01235598|186478|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
80183|NCT01235598|186479|P1|STARTED|Overall Study||13
80184|NCT01235507|186522|P1|NOT COMPLETED|Overall Study||2
80185|NCT01235507|186522|P1|COMPLETED|Overall Study||69
80186|NCT01235507|186522|P1|STARTED|Overall Study||71
80187|NCT01235442|186536|P2|NOT COMPLETED|Overall Study||44
80188|NCT01235442|186537|P1|NOT COMPLETED|Overall Study||44
80189|NCT01235442|186536|P2|COMPLETED|Overall Study||251
80190|NCT01235442|186537|P1|COMPLETED|Overall Study||253
80191|NCT01235442|186536|P2|STARTED|Overall Study||295
80192|NCT01235442|186537|P1|STARTED|Overall Study||297
80193|NCT01235403|186555|P1|NOT COMPLETED|Overall Study||26
80194|NCT01235403|186555|P1|COMPLETED|Overall Study||74
80195|NCT01235403|186555|P1|STARTED|Overall Study||100
80196|NCT01235377|186563|P2|NOT COMPLETED|Overall Study||1
80197|NCT01235377|186564|P1|NOT COMPLETED|Overall Study||1
80198|NCT01235377|186563|P2|COMPLETED|Overall Study||8
80199|NCT01235377|186564|P1|COMPLETED|Overall Study||10
80200|NCT01235377|186563|P2|STARTED|Overall Study||9
80201|NCT01235377|186564|P1|STARTED|Overall Study||11
80202|NCT01235338|186572|P2|NOT COMPLETED|Overall Study||5
80203|NCT01235338|186573|P1|NOT COMPLETED|Overall Study||11
80204|NCT01235338|186572|P2|COMPLETED|Overall Study||33
80205|NCT01235338|186573|P1|COMPLETED|Overall Study||31
80207|NCT01235338|186573|P1|STARTED|Overall Study||42
80208|NCT01235234|186618|P3|NOT COMPLETED|Overall Study||1
80209|NCT01235234|186619|P2|NOT COMPLETED|Overall Study||2
80210|NCT01235234|186620|P1|NOT COMPLETED|Overall Study||2
80211|NCT01235234|186618|P3|COMPLETED|Overall Study||80
80212|NCT01235234|186619|P2|COMPLETED|Overall Study||76
80213|NCT01235234|186620|P1|COMPLETED|Overall Study||75
80214|NCT01235234|186618|P3|STARTED|Overall Study||81
80215|NCT01235234|186619|P2|STARTED|Overall Study||78
80216|NCT01235234|186620|P1|STARTED|Overall Study||77
80217|NCT01235195|186628|P2|NOT COMPLETED|Second Intervention||0
80218|NCT01235195|186629|P1|NOT COMPLETED|Second Intervention||0
80219|NCT01235195|186628|P2|COMPLETED|Second Intervention||15
80220|NCT01235195|186629|P1|COMPLETED|Second Intervention||15
80221|NCT01235195|186628|P2|STARTED|Second Intervention||15
80222|NCT01235195|186629|P1|STARTED|Second Intervention||15
80223|NCT01235195|186628|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
80224|NCT01235195|186629|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
80225|NCT01235195|186628|P2|COMPLETED|Washout Period of At Least 8 Days||15
80226|NCT01235195|186629|P1|COMPLETED|Washout Period of At Least 8 Days||15
80227|NCT01235195|186628|P2|STARTED|Washout Period of At Least 8 Days||15
80228|NCT01235195|186629|P1|STARTED|Washout Period of At Least 8 Days||15
80229|NCT01235195|186628|P2|NOT COMPLETED|First Intervention||0
80230|NCT01235195|186629|P1|NOT COMPLETED|First Intervention||0
80231|NCT01235195|186628|P2|COMPLETED|First Intervention||15
80232|NCT01235195|186629|P1|COMPLETED|First Intervention||15
80233|NCT01235195|186628|P2|STARTED|First Intervention||15
80234|NCT01235195|186629|P1|STARTED|First Intervention||15
80235|NCT01234922|186649|P4|NOT COMPLETED|Overall Study||0
80236|NCT01234922|186650|P3|NOT COMPLETED|Overall Study||0
80237|NCT01234922|186651|P2|NOT COMPLETED|Overall Study||0
80238|NCT01234922|186652|P1|NOT COMPLETED|Overall Study||0
80239|NCT01234922|186649|P4|COMPLETED|Overall Study||2
80240|NCT01234922|186650|P3|COMPLETED|Overall Study||2
80241|NCT01234922|186651|P2|COMPLETED|Overall Study||1
80242|NCT01234922|186652|P1|COMPLETED|Overall Study||1
80243|NCT01234922|186649|P4|STARTED|Overall Study||2
80244|NCT01234922|186650|P3|STARTED|Overall Study||2
80245|NCT01234922|186651|P2|STARTED|Overall Study||1
80246|NCT01234922|186652|P1|STARTED|Overall Study||1
80247|NCT01234883|186664|P2|NOT COMPLETED|Overall Study||13
80248|NCT01234883|186665|P1|NOT COMPLETED|Overall Study||10
80249|NCT01234883|186664|P2|COMPLETED|Overall Study||36
80250|NCT01234883|186665|P1|COMPLETED|Overall Study||41
80251|NCT01234883|186664|P2|STARTED|Overall Study||49
80252|NCT01234883|186665|P1|STARTED|Overall Study||51
80253|NCT01234870|186671|P1|NOT COMPLETED|Overall Study||0
80254|NCT01234870|186671|P1|COMPLETED|Overall Study||40
80255|NCT01234870|186671|P1|STARTED|Overall Study||40
80256|NCT01234831|186678|P2|NOT COMPLETED|Overall Study||4
80257|NCT01234831|186679|P1|NOT COMPLETED|Overall Study||2
80258|NCT01234831|186678|P2|COMPLETED|Overall Study||198
80259|NCT01234831|186679|P1|COMPLETED|Overall Study||259
80260|NCT01234831|186678|P2|STARTED|Overall Study||202
80261|NCT01234831|186679|P1|STARTED|Overall Study||261
80262|NCT01234714|186690|P1|NOT COMPLETED|Overall Study||0
80263|NCT01234714|186690|P1|COMPLETED|Overall Study||84
80264|NCT01234714|186690|P1|STARTED|Overall Study||84
80265|NCT01234675|186707|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
80266|NCT01234675|186708|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
80267|NCT01234675|186707|P2|COMPLETED|Second Intervention (6 Weeks)||8
80268|NCT01234675|186708|P1|COMPLETED|Second Intervention (6 Weeks)||7
80269|NCT01234675|186707|P2|STARTED|Second Intervention (6 Weeks)||8
80270|NCT01234675|186708|P1|STARTED|Second Intervention (6 Weeks)||9
80271|NCT01234675|186707|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
80272|NCT01234675|186708|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
80273|NCT01234675|186707|P2|COMPLETED|First Intervention (6 Weeks)||8
80274|NCT01234675|186708|P1|COMPLETED|First Intervention (6 Weeks)||9
80275|NCT01234675|186707|P2|STARTED|First Intervention (6 Weeks)||9
80276|NCT01234675|186708|P1|STARTED|First Intervention (6 Weeks)||10
80277|NCT01234337|186724|P2|NOT COMPLETED|Overall Study||64
80278|NCT01234337|186725|P1|NOT COMPLETED|Overall Study||97
80279|NCT01234337|186724|P2|COMPLETED|Overall Study||207
80280|NCT01234337|186725|P1|COMPLETED|Overall Study||169
80281|NCT01234337|186724|P2|Participants Received Treatment|Overall Study||267
80282|NCT01234337|186725|P1|Participants Received Treatment|Overall Study||260
80283|NCT01234337|186724|P2|STARTED|Overall Study||271
80284|NCT01234337|186725|P1|STARTED|Overall Study||266
80285|NCT01233999|186753|P1|NOT COMPLETED|Overall Study||2
80286|NCT01233999|186753|P1|COMPLETED|Overall Study||8
80287|NCT01233999|186753|P1|STARTED|Overall Study||10
80288|NCT01233921|186759|P2|NOT COMPLETED|Overall Study||0
80289|NCT01233921|186760|P1|NOT COMPLETED|Overall Study||0
80290|NCT01233921|186759|P2|COMPLETED|Overall Study||3
80291|NCT01233921|186760|P1|COMPLETED|Overall Study||3
80292|NCT01233921|186759|P2|STARTED|Overall Study||3
80293|NCT01233921|186760|P1|STARTED|Overall Study||3
80294|NCT01233869|186772|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
80295|NCT01233869|186773|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
80296|NCT01233869|186774|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
80297|NCT01233869|186775|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
80298|NCT01233869|186772|P4|COMPLETED|Extended Treatment Period (46 Months)||18
80299|NCT01233869|186773|P3|COMPLETED|Extended Treatment Period (46 Months)||17
80300|NCT01233869|186774|P2|COMPLETED|Extended Treatment Period (46 Months)||0
80301|NCT01233869|186775|P1|COMPLETED|Extended Treatment Period (46 Months)||20
80302|NCT01233869|186772|P4|STARTED|Extended Treatment Period (46 Months)||34
80303|NCT01233869|186773|P3|STARTED|Extended Treatment Period (46 Months)||22
80304|NCT01233869|186774|P2|STARTED|Extended Treatment Period (46 Months)||3
80305|NCT01233869|186775|P1|STARTED|Extended Treatment Period (46 Months)||34
80306|NCT01233869|186772|P4|NOT COMPLETED|Washout Period 30 Days||0
80307|NCT01233869|186773|P3|NOT COMPLETED|Washout Period 30 Days||0
80308|NCT01233869|186774|P2|NOT COMPLETED|Washout Period 30 Days||0
80309|NCT01233869|186775|P1|NOT COMPLETED|Washout Period 30 Days||0
80310|NCT01233869|186772|P4|COMPLETED|Washout Period 30 Days||34
80311|NCT01233869|186773|P3|COMPLETED|Washout Period 30 Days||22
80312|NCT01233869|186774|P2|COMPLETED|Washout Period 30 Days||3
80313|NCT01233869|186775|P1|COMPLETED|Washout Period 30 Days||34
80314|NCT01233869|186772|P4|STARTED|Washout Period 30 Days||34
80315|NCT01233869|186773|P3|STARTED|Washout Period 30 Days||22
80316|NCT01233869|186774|P2|STARTED|Washout Period 30 Days||3
80317|NCT01233869|186775|P1|STARTED|Washout Period 30 Days||34
80318|NCT01233869|186772|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
80319|NCT01233869|186773|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
80320|NCT01233869|186774|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
80321|NCT01233869|186775|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
80322|NCT01233869|186772|P4|COMPLETED|Initial Treatment Period (24 Months)||34
80323|NCT01233869|186773|P3|COMPLETED|Initial Treatment Period (24 Months)||22
80324|NCT01233869|186774|P2|COMPLETED|Initial Treatment Period (24 Months)||3
80325|NCT01233869|186775|P1|COMPLETED|Initial Treatment Period (24 Months)||34
80326|NCT01233869|186772|P4|STARTED|Initial Treatment Period (24 Months)||56
80327|NCT01233869|186773|P3|STARTED|Initial Treatment Period (24 Months)||24
80328|NCT01233869|186774|P2|STARTED|Initial Treatment Period (24 Months)||31
80329|NCT01233869|186775|P1|STARTED|Initial Treatment Period (24 Months)||58
80330|NCT01233817|186861|P1|NOT COMPLETED|Overall Study||3
80331|NCT01233817|186861|P1|COMPLETED|Overall Study||9
80332|NCT01233817|186861|P1|STARTED|Overall Study||12
80333|NCT01233726|186868|P3|NOT COMPLETED|Overall Study||1
80334|NCT01233726|186869|P2|NOT COMPLETED|Overall Study||0
80335|NCT01233726|186870|P1|NOT COMPLETED|Overall Study||1
80336|NCT01233726|186868|P3|COMPLETED|Overall Study||52
80337|NCT01233726|186869|P2|COMPLETED|Overall Study||53
80338|NCT01233726|186870|P1|COMPLETED|Overall Study||52
80339|NCT01233726|186868|P3|STARTED|Overall Study||53
80340|NCT01233726|186869|P2|STARTED|Overall Study||53
80341|NCT01233726|186870|P1|STARTED|Overall Study||53
80342|NCT01233687|186908|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
80343|NCT01233687|186908|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
80344|NCT01233687|186908|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
80345|NCT01233687|186908|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
80346|NCT01233687|186908|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
80347|NCT01233687|186908|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
80348|NCT01233687|186908|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
80349|NCT01233284|186916|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
80350|NCT01233284|186917|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
80351|NCT01233284|186918|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
80352|NCT01233284|186919|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
80353|NCT01233284|186920|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
80354|NCT01233284|186916|P5|COMPLETED|Period 4 (4 Weeks)||1
80355|NCT01233284|186917|P4|COMPLETED|Period 4 (4 Weeks)||33
80356|NCT01233284|186918|P3|COMPLETED|Period 4 (4 Weeks)||35
80357|NCT01233284|186919|P2|COMPLETED|Period 4 (4 Weeks)||36
80358|NCT01233284|186920|P1|COMPLETED|Period 4 (4 Weeks)||36
80359|NCT01233284|186916|P5|STARTED|Period 4 (4 Weeks)||1
80360|NCT01233284|186917|P4|STARTED|Period 4 (4 Weeks)||34
80361|NCT01233284|186918|P3|STARTED|Period 4 (4 Weeks)||35
80362|NCT01233284|186919|P2|STARTED|Period 4 (4 Weeks)||37
80363|NCT01233284|186920|P1|STARTED|Period 4 (4 Weeks)||36
80364|NCT01233284|186916|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
80365|NCT01233284|186917|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
80366|NCT01233284|186918|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
80367|NCT01233284|186919|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
80368|NCT01233284|186920|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
80369|NCT01233284|186916|P5|COMPLETED|Period 3 (4 Weeks)||1
80370|NCT01233284|186917|P4|COMPLETED|Period 3 (4 Weeks)||34
80371|NCT01233284|186918|P3|COMPLETED|Period 3 (4 Weeks)||35
80372|NCT01233284|186919|P2|COMPLETED|Period 3 (4 Weeks)||37
80373|NCT01233284|186920|P1|COMPLETED|Period 3 (4 Weeks)||36
80374|NCT01233284|186916|P5|STARTED|Period 3 (4 Weeks)||1
80375|NCT01233284|186917|P4|STARTED|Period 3 (4 Weeks)||35
80376|NCT01233284|186918|P3|STARTED|Period 3 (4 Weeks)||36
80377|NCT01233284|186919|P2|STARTED|Period 3 (4 Weeks)||37
80378|NCT01233284|186920|P1|STARTED|Period 3 (4 Weeks)||36
80379|NCT01233284|186916|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
80380|NCT01233284|186917|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
80381|NCT01233284|186918|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
80382|NCT01233284|186919|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
80383|NCT01233284|186920|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
80384|NCT01233284|186916|P5|COMPLETED|Period 2 (4 Weeks)||1
80385|NCT01233284|186917|P4|COMPLETED|Period 2 (4 Weeks)||35
80386|NCT01233284|186918|P3|COMPLETED|Period 2 (4 Weeks)||36
80387|NCT01233284|186919|P2|COMPLETED|Period 2 (4 Weeks)||37
80388|NCT01233284|186920|P1|COMPLETED|Period 2 (4 Weeks)||36
80389|NCT01233284|186916|P5|STARTED|Period 2 (4 Weeks)||1
80390|NCT01233284|186917|P4|STARTED|Period 2 (4 Weeks)||35
80391|NCT01233284|186918|P3|STARTED|Period 2 (4 Weeks)||37
80392|NCT01233284|186919|P2|STARTED|Period 2 (4 Weeks)||37
80393|NCT01233284|186920|P1|STARTED|Period 2 (4 Weeks)||36
80394|NCT01233284|186916|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
80395|NCT01233284|186917|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
80396|NCT01233284|186918|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
80397|NCT01233284|186919|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
80398|NCT01233284|186920|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
80399|NCT01233284|186916|P5|COMPLETED|Period 1 (4 Weeks)||1
80400|NCT01233284|186917|P4|COMPLETED|Period 1 (4 Weeks)||35
80401|NCT01233284|186918|P3|COMPLETED|Period 1 (4 Weeks)||37
80402|NCT01233284|186919|P2|COMPLETED|Period 1 (4 Weeks)||37
80403|NCT01233284|186920|P1|COMPLETED|Period 1 (4 Weeks)||36
80404|NCT01233284|186916|P5|STARTED|Period 1 (4 Weeks)||1
80405|NCT01233284|186917|P4|STARTED|Period 1 (4 Weeks)||35
80406|NCT01233284|186918|P3|STARTED|Period 1 (4 Weeks)||38
80407|NCT01233284|186919|P2|STARTED|Period 1 (4 Weeks)||38
80408|NCT01233284|186920|P1|STARTED|Period 1 (4 Weeks)||37
80409|NCT01233258|187001|P6|NOT COMPLETED|Second Intervention (6 Months)||0
80410|NCT01233258|187002|P5|NOT COMPLETED|Second Intervention (6 Months)||0
80411|NCT01233258|187003|P4|NOT COMPLETED|Second Intervention (6 Months)||0
80412|NCT01233258|187004|P3|NOT COMPLETED|Second Intervention (6 Months)||0
80413|NCT01233258|187005|P2|NOT COMPLETED|Second Intervention (6 Months)||0
80414|NCT01233258|187006|P1|NOT COMPLETED|Second Intervention (6 Months)||0
80415|NCT01233258|187001|P6|COMPLETED|Second Intervention (6 Months)||15
80416|NCT01233258|187002|P5|COMPLETED|Second Intervention (6 Months)||16
80417|NCT01233258|187003|P4|COMPLETED|Second Intervention (6 Months)||15
80418|NCT01233258|187004|P3|COMPLETED|Second Intervention (6 Months)||13
80419|NCT01233258|187005|P2|COMPLETED|Second Intervention (6 Months)||10
80420|NCT01233258|187006|P1|COMPLETED|Second Intervention (6 Months)||10
80421|NCT01233258|187001|P6|STARTED|Second Intervention (6 Months)||15
80422|NCT01233258|187002|P5|STARTED|Second Intervention (6 Months)||16
80423|NCT01233258|187003|P4|STARTED|Second Intervention (6 Months)||15
80424|NCT01233258|187004|P3|STARTED|Second Intervention (6 Months)||13
80425|NCT01233258|187005|P2|STARTED|Second Intervention (6 Months)||10
80426|NCT01233258|187006|P1|STARTED|Second Intervention (6 Months)||10
80427|NCT01233258|187001|P6|NOT COMPLETED|Washout (2-3 Days)||0
80428|NCT01233258|187002|P5|NOT COMPLETED|Washout (2-3 Days)||0
80429|NCT01233258|187003|P4|NOT COMPLETED|Washout (2-3 Days)||0
80430|NCT01233258|187004|P3|NOT COMPLETED|Washout (2-3 Days)||0
80431|NCT01233258|187005|P2|NOT COMPLETED|Washout (2-3 Days)||0
80432|NCT01233258|187006|P1|NOT COMPLETED|Washout (2-3 Days)||0
80433|NCT01233258|187001|P6|COMPLETED|Washout (2-3 Days)||15
80434|NCT01233258|187002|P5|COMPLETED|Washout (2-3 Days)||16
80435|NCT01233258|187003|P4|COMPLETED|Washout (2-3 Days)||15
80436|NCT01233258|187004|P3|COMPLETED|Washout (2-3 Days)||13
80437|NCT01233258|187005|P2|COMPLETED|Washout (2-3 Days)||10
80438|NCT01233258|187006|P1|COMPLETED|Washout (2-3 Days)||10
80439|NCT01233258|187001|P6|STARTED|Washout (2-3 Days)||15
80440|NCT01233258|187002|P5|STARTED|Washout (2-3 Days)||16
80441|NCT01233258|187003|P4|STARTED|Washout (2-3 Days)||15
80442|NCT01233258|187004|P3|STARTED|Washout (2-3 Days)||13
80443|NCT01233258|187005|P2|STARTED|Washout (2-3 Days)||10
80444|NCT01233258|187006|P1|STARTED|Washout (2-3 Days)||10
80445|NCT01233258|187001|P6|NOT COMPLETED|First Intervention (6 Months)||1
80446|NCT01233258|187002|P5|NOT COMPLETED|First Intervention (6 Months)||0
80447|NCT01233258|187003|P4|NOT COMPLETED|First Intervention (6 Months)||1
80448|NCT01233258|187004|P3|NOT COMPLETED|First Intervention (6 Months)||1
80449|NCT01233258|187005|P2|NOT COMPLETED|First Intervention (6 Months)||0
80450|NCT01233258|187006|P1|NOT COMPLETED|First Intervention (6 Months)||1
80451|NCT01233258|187001|P6|COMPLETED|First Intervention (6 Months)||15
80452|NCT01233258|187002|P5|COMPLETED|First Intervention (6 Months)||16
80453|NCT01233258|187003|P4|COMPLETED|First Intervention (6 Months)||15
80454|NCT01233258|187004|P3|COMPLETED|First Intervention (6 Months)||13
80455|NCT01233258|187005|P2|COMPLETED|First Intervention (6 Months)||10
80456|NCT01233258|187006|P1|COMPLETED|First Intervention (6 Months)||10
80457|NCT01233258|187001|P6|Participants Received Treatment|First Intervention (6 Months)||15
80458|NCT01233258|187002|P5|Participants Received Treatment|First Intervention (6 Months)||16
80459|NCT01233258|187003|P4|Participants Received Treatment|First Intervention (6 Months)||15
80460|NCT01233258|187004|P3|Participants Received Treatment|First Intervention (6 Months)||13
80461|NCT01233258|187005|P2|Participants Received Treatment|First Intervention (6 Months)||10
80462|NCT01233258|187006|P1|Participants Received Treatment|First Intervention (6 Months)||11
80463|NCT01233258|187001|P6|STARTED|First Intervention (6 Months)||16
80464|NCT01233258|187002|P5|STARTED|First Intervention (6 Months)||16
80465|NCT01233258|187003|P4|STARTED|First Intervention (6 Months)||16
80466|NCT01233258|187004|P3|STARTED|First Intervention (6 Months)||14
80467|NCT01233258|187005|P2|STARTED|First Intervention (6 Months)||10
80468|NCT01233258|187006|P1|STARTED|First Intervention (6 Months)||11
80469|NCT01233232|187026|P3|NOT COMPLETED|Overall Study||0
80470|NCT01233232|187027|P2|NOT COMPLETED|Overall Study||0
80471|NCT01233232|187028|P1|NOT COMPLETED|Overall Study||1
80472|NCT01233232|187026|P3|COMPLETED|Overall Study||28
80473|NCT01233232|187027|P2|COMPLETED|Overall Study||30
80474|NCT01233232|187028|P1|COMPLETED|Overall Study||28
80475|NCT01233232|187026|P3|STARTED|Overall Study||28
80476|NCT01233232|187027|P2|STARTED|Overall Study||30
80477|NCT01233232|187028|P1|STARTED|Overall Study||29
80478|NCT01233076|187081|P2|NOT COMPLETED|Period 2, One Week||0
80479|NCT01233076|187082|P1|NOT COMPLETED|Period 2, One Week||1
80480|NCT01233076|187081|P2|COMPLETED|Period 2, One Week||30
80481|NCT01233076|187082|P1|COMPLETED|Period 2, One Week||29
80482|NCT01233076|187081|P2|STARTED|Period 2, One Week||30
80483|NCT01233076|187082|P1|STARTED|Period 2, One Week||30
80484|NCT01233076|187081|P2|NOT COMPLETED|Period 1, One Week||0
80485|NCT01233076|187082|P1|NOT COMPLETED|Period 1, One Week||0
80486|NCT01233076|187081|P2|COMPLETED|Period 1, One Week||30
80487|NCT01233076|187082|P1|COMPLETED|Period 1, One Week||30
80488|NCT01233076|187081|P2|STARTED|Period 1, One Week||30
80489|NCT01233076|187082|P1|STARTED|Period 1, One Week||30
80490|NCT01232920|187090|P2|NOT COMPLETED|Overall Study||7
80491|NCT01232920|187091|P1|NOT COMPLETED|Overall Study||6
80492|NCT01232920|187090|P2|COMPLETED|Overall Study||32
80493|NCT01232920|187091|P1|COMPLETED|Overall Study||35
80494|NCT01232920|187090|P2|STARTED|Overall Study||39
80495|NCT01232920|187091|P1|STARTED|Overall Study||41
80496|NCT01232894|187105|P2|NOT COMPLETED|Overall Study||8
80497|NCT01232894|187106|P1|NOT COMPLETED|Overall Study||12
80498|NCT01232894|187105|P2|COMPLETED|Overall Study||22
80499|NCT01232894|187106|P1|COMPLETED|Overall Study||48
80500|NCT01232894|187105|P2|Received Study Drug|Overall Study||28
80501|NCT01232894|187106|P1|Received Study Drug|Overall Study||59
80502|NCT01232894|187105|P2|STARTED|Overall Study||30
80503|NCT01232894|187106|P1|STARTED|Overall Study||60
80504|NCT01232868|187114|P2|NOT COMPLETED|Overall Study||4
80505|NCT01232868|187115|P1|NOT COMPLETED|Overall Study||2
80506|NCT01232868|187114|P2|COMPLETED|Overall Study||40
80507|NCT01232868|187115|P1|COMPLETED|Overall Study||20
80508|NCT01232868|187114|P2|STARTED|Overall Study||44
80509|NCT01232868|187115|P1|STARTED|Overall Study||22
80510|NCT01232829|187123|P1|NOT COMPLETED|Overall Study||0
80511|NCT01232829|187123|P1|COMPLETED|Overall Study||18
80512|NCT01232829|187123|P1|STARTED|Overall Study||18
80513|NCT01232790|187129|P2|NOT COMPLETED|Second Crossover||2
80514|NCT01232790|187130|P1|NOT COMPLETED|Second Crossover||1
80515|NCT01232790|187129|P2|COMPLETED|Second Crossover||9
80516|NCT01232790|187130|P1|COMPLETED|Second Crossover||10
80517|NCT01232790|187129|P2|STARTED|Second Crossover||11
80518|NCT01232790|187130|P1|STARTED|Second Crossover||11
80519|NCT01232790|187129|P2|NOT COMPLETED|First Crossover||0
80520|NCT01232790|187130|P1|NOT COMPLETED|First Crossover||1
80521|NCT01232790|187129|P2|COMPLETED|First Crossover||11
80522|NCT01232790|187130|P1|COMPLETED|First Crossover||11
80523|NCT01232790|187129|P2|STARTED|First Crossover||11
80524|NCT01232790|187130|P1|STARTED|First Crossover||12
80525|NCT01232790|187129|P2|NOT COMPLETED|Initial Assessment||1
80526|NCT01232790|187130|P1|NOT COMPLETED|Initial Assessment||0
80527|NCT01232790|187129|P2|COMPLETED|Initial Assessment||11
80528|NCT01232790|187130|P1|COMPLETED|Initial Assessment||12
80529|NCT01232790|187129|P2|STARTED|Initial Assessment||12
80530|NCT01232790|187130|P1|STARTED|Initial Assessment||12
80531|NCT01232790|187129|P2|NOT COMPLETED|Randomization||2
80532|NCT01232790|187130|P1|NOT COMPLETED|Randomization||2
80533|NCT01232790|187129|P2|COMPLETED|Randomization||12
80534|NCT01232790|187130|P1|COMPLETED|Randomization||12
80535|NCT01232790|187129|P2|STARTED|Randomization||14
80536|NCT01232790|187130|P1|STARTED|Randomization||14
80537|NCT01232569|187186|P4|NOT COMPLETED|Open-label Extension Period||27
80538|NCT01232569|187187|P3|NOT COMPLETED|Open-label Extension Period||27
80539|NCT01232569|187188|P2|NOT COMPLETED|Open-label Extension Period||0
80540|NCT01232569|187189|P1|NOT COMPLETED|Open-label Extension Period||0
80541|NCT01232569|187186|P4|COMPLETED|Open-label Extension Period||200
80542|NCT01232569|187187|P3|COMPLETED|Open-label Extension Period||203
80543|NCT01232569|187188|P2|COMPLETED|Open-label Extension Period||0
80544|NCT01232569|187189|P1|COMPLETED|Open-label Extension Period||0
80545|NCT01232569|187186|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
80546|NCT01232569|187187|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
80547|NCT01232569|187188|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
80548|NCT01232569|187189|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
80549|NCT01232569|187186|P4|NOT COMPLETED|Double-blind Treatment Period||0
80550|NCT01232569|187187|P3|NOT COMPLETED|Double-blind Treatment Period||0
80551|NCT01232569|187188|P2|NOT COMPLETED|Double-blind Treatment Period||9
80552|NCT01232569|187189|P1|NOT COMPLETED|Double-blind Treatment Period||28
80553|NCT01232569|187186|P4|COMPLETED|Double-blind Treatment Period||0
80554|NCT01232569|187187|P3|COMPLETED|Double-blind Treatment Period||0
80555|NCT01232569|187188|P2|COMPLETED|Double-blind Treatment Period||209
80556|NCT01232569|187189|P1|COMPLETED|Double-blind Treatment Period||410
80557|NCT01232569|187186|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
80558|NCT01232569|187187|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
80559|NCT01232569|187188|P2|STARTED|Double-blind Treatment Period||218
80560|NCT01232569|187189|P1|STARTED|Double-blind Treatment Period||438
80561|NCT01232504|187233|P3|NOT COMPLETED|Overall Study||8
80562|NCT01232504|187234|P2|NOT COMPLETED|Overall Study||2
80563|NCT01232504|187235|P1|NOT COMPLETED|Overall Study||9
80564|NCT01232504|187233|P3|COMPLETED|Overall Study||61
80565|NCT01232504|187234|P2|COMPLETED|Overall Study||67
80566|NCT01232504|187235|P1|COMPLETED|Overall Study||59
80567|NCT01232504|187233|P3|STARTED|Overall Study||69
80568|NCT01232504|187234|P2|STARTED|Overall Study||69
80569|NCT01232504|187235|P1|STARTED|Overall Study||68
80570|NCT01232491|187269|P2|NOT COMPLETED|Overall Study||63
80571|NCT01232491|187270|P1|NOT COMPLETED|Overall Study||60
80572|NCT01232491|187269|P2|COMPLETED|Overall Study||242
80573|NCT01232491|187270|P1|COMPLETED|Overall Study||246
80574|NCT01232491|187269|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
80575|NCT01232491|187270|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
80576|NCT01232491|187269|P2|STARTED|Overall Study||305
80577|NCT01232491|187270|P1|STARTED|Overall Study||306
80578|NCT01232465|187290|P2|NOT COMPLETED|Overall Study||0
80579|NCT01232465|187291|P1|NOT COMPLETED|Overall Study||0
80580|NCT01232465|187290|P2|COMPLETED|Overall Study||402
80581|NCT01232465|187291|P1|COMPLETED|Overall Study||337
80582|NCT01232465|187290|P2|STARTED|Overall Study||402
80583|NCT01232465|187291|P1|STARTED|Overall Study||337
80584|NCT01232296|187299|P2|NOT COMPLETED|Overall Study||83
80585|NCT01232296|187300|P1|NOT COMPLETED|Overall Study||82
80586|NCT01232296|187299|P2|COMPLETED|Overall Study||0
80587|NCT01232296|187300|P1|COMPLETED|Overall Study||0
80588|NCT01232296|187299|P2|Safety Set|Overall Study||83
80589|NCT01232296|187300|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
80590|NCT01232296|187299|P2|Full Analysis Set|Overall Study||83
80591|NCT01232296|187300|P1|Full Analysis Set|Overall Study||82
80592|NCT01232296|187299|P2|STARTED|Overall Study||83
80593|NCT01232296|187300|P1|STARTED|Overall Study||82
80594|NCT01232283|187317|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
80595|NCT01232283|187318|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
80596|NCT01232283|187319|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
80597|NCT01232283|187320|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
80598|NCT01232283|187321|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80599|NCT01232283|187322|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80600|NCT01232283|187323|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80601|NCT01232283|187324|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80602|NCT01232283|187317|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
80603|NCT01232283|187318|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
80604|NCT01232283|187319|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
80605|NCT01232283|187320|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
80606|NCT01232283|187321|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80607|NCT01232283|187322|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80608|NCT01232283|187323|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80609|NCT01232283|187324|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
80610|NCT01232283|187317|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
80611|NCT01232283|187318|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
80612|NCT01232283|187319|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80613|NCT01232283|187320|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80614|NCT01232283|187321|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80615|NCT01232283|187322|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80616|NCT01232283|187323|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80617|NCT01232283|187324|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
80618|NCT01232283|187317|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
80619|NCT01232283|187318|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
80620|NCT01232283|187319|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
80621|NCT01232283|187320|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
80622|NCT01232283|187321|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
80623|NCT01232283|187322|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
80624|NCT01232283|187323|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
80625|NCT01232283|187324|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
80626|NCT01232283|187317|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80627|NCT01232283|187318|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80628|NCT01232283|187319|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80629|NCT01232283|187320|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80630|NCT01232283|187321|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
80631|NCT01232283|187322|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
80632|NCT01232283|187323|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80633|NCT01232283|187324|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
80634|NCT01232283|187317|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
80635|NCT01232283|187318|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
80636|NCT01232283|187319|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
80637|NCT01232283|187320|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
80638|NCT01232283|187321|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
80639|NCT01232283|187322|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
80640|NCT01232283|187323|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
80641|NCT01232283|187324|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
80642|NCT01232283|187317|P8|STARTED|Maintenance Phase (Weeks16-32)||0
80643|NCT01232283|187318|P7|STARTED|Maintenance Phase (Weeks16-32)||0
80644|NCT01232283|187319|P6|STARTED|Maintenance Phase (Weeks16-32)||0
80645|NCT01232283|187320|P5|STARTED|Maintenance Phase (Weeks16-32)||0
80646|NCT01232283|187321|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
80647|NCT01232283|187322|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
80648|NCT01232283|187323|P2|STARTED|Maintenance Phase (Weeks16-32)||0
80649|NCT01232283|187324|P1|STARTED|Maintenance Phase (Weeks16-32)||0
80650|NCT01232283|187317|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80651|NCT01232283|187318|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80652|NCT01232283|187319|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80653|NCT01232283|187320|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80654|NCT01232283|187321|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80655|NCT01232283|187322|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80656|NCT01232283|187323|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
80657|NCT01232283|187324|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
80658|NCT01232283|187317|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80659|NCT01232283|187318|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80660|NCT01232283|187319|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80661|NCT01232283|187320|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80662|NCT01232283|187321|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80663|NCT01232283|187322|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
80664|NCT01232283|187323|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
80665|NCT01232283|187324|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
80666|NCT01232283|187317|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80667|NCT01232283|187318|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80668|NCT01232283|187319|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80669|NCT01232283|187320|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80670|NCT01232283|187321|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80671|NCT01232283|187322|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
80672|NCT01232283|187323|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
80673|NCT01232283|187324|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
80674|NCT01232283|187317|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80675|NCT01232283|187318|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80676|NCT01232283|187319|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80677|NCT01232283|187320|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80678|NCT01232283|187321|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80679|NCT01232283|187322|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
80680|NCT01232283|187323|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
80681|NCT01232283|187324|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
80682|NCT01232205|187356|P2|NOT COMPLETED|Overall Study||3
80683|NCT01232205|187357|P1|NOT COMPLETED|Overall Study||3
80684|NCT01232205|187356|P2|COMPLETED|Overall Study||55
80685|NCT01232205|187357|P1|COMPLETED|Overall Study||49
80686|NCT01232205|187356|P2|STARTED|Overall Study||58
80687|NCT01232205|187357|P1|STARTED|Overall Study||52
80688|NCT01232127|187363|P3|NOT COMPLETED|Period 3: Days 18-24||0
80689|NCT01232127|187364|P2|NOT COMPLETED|Period 3: Days 18-24||0
80690|NCT01232127|187365|P1|NOT COMPLETED|Period 3: Days 18-24||0
80691|NCT01232127|187363|P3|COMPLETED|Period 3: Days 18-24||24
80692|NCT01232127|187364|P2|COMPLETED|Period 3: Days 18-24||0
80693|NCT01232127|187365|P1|COMPLETED|Period 3: Days 18-24||0
80694|NCT01232127|187363|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
80695|NCT01232127|187364|P2|STARTED|Period 3: Days 18-24||0
80696|NCT01232127|187365|P1|STARTED|Period 3: Days 18-24||0
80697|NCT01232127|187363|P3|NOT COMPLETED|Period 2: Days 11-17||0
80698|NCT01232127|187364|P2|NOT COMPLETED|Period 2: Days 11-17||0
80699|NCT01232127|187365|P1|NOT COMPLETED|Period 2: Days 11-17||0
80700|NCT01232127|187363|P3|COMPLETED|Period 2: Days 11-17||0
80701|NCT01232127|187364|P2|COMPLETED|Period 2: Days 11-17||24
80702|NCT01232127|187365|P1|COMPLETED|Period 2: Days 11-17||0
80703|NCT01232127|187363|P3|STARTED|Period 2: Days 11-17||0
80704|NCT01232127|187364|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
80705|NCT01232127|187365|P1|STARTED|Period 2: Days 11-17||0
80706|NCT01232127|187363|P3|NOT COMPLETED|Period 1: Days 1-10||0
80707|NCT01232127|187364|P2|NOT COMPLETED|Period 1: Days 1-10||0
80708|NCT01232127|187365|P1|NOT COMPLETED|Period 1: Days 1-10||1
80709|NCT01232127|187363|P3|COMPLETED|Period 1: Days 1-10||0
80710|NCT01232127|187364|P2|COMPLETED|Period 1: Days 1-10||0
80711|NCT01232127|187365|P1|COMPLETED|Period 1: Days 1-10||24
80712|NCT01232127|187363|P3|STARTED|Period 1: Days 1-10||0
80713|NCT01232127|187364|P2|STARTED|Period 1: Days 1-10||0
80714|NCT01232127|187365|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
80715|NCT01231984|187389|P4|NOT COMPLETED|Study Period 2||4
80716|NCT01231984|187390|P3|NOT COMPLETED|Study Period 2||0
80717|NCT01231984|187391|P2|NOT COMPLETED|Study Period 2||2
80718|NCT01231984|187392|P1|NOT COMPLETED|Study Period 2||3
80719|NCT01231984|187389|P4|COMPLETED|Study Period 2||56
80720|NCT01231984|187390|P3|COMPLETED|Study Period 2||59
80721|NCT01231984|187391|P2|COMPLETED|Study Period 2||61
80722|NCT01231984|187392|P1|COMPLETED|Study Period 2||54
80723|NCT01231984|187389|P4|STARTED|Study Period 2||60
80724|NCT01231984|187390|P3|STARTED|Study Period 2||59
80725|NCT01231984|187391|P2|STARTED|Study Period 2||63
80726|NCT01231984|187392|P1|STARTED|Study Period 2||57
80727|NCT01231984|187389|P4|NOT COMPLETED|Study Period 1||9
80728|NCT01231984|187390|P3|NOT COMPLETED|Study Period 1||7
80729|NCT01231984|187391|P2|NOT COMPLETED|Study Period 1||7
80730|NCT01231984|187392|P1|NOT COMPLETED|Study Period 1||12
80731|NCT01231984|187389|P4|COMPLETED|Study Period 1||60
80732|NCT01231984|187390|P3|COMPLETED|Study Period 1||59
80733|NCT01231984|187391|P2|COMPLETED|Study Period 1||63
80734|NCT01231984|187392|P1|COMPLETED|Study Period 1||57
80735|NCT01231984|187389|P4|STARTED|Study Period 1||69
80736|NCT01231984|187390|P3|STARTED|Study Period 1||66
80737|NCT01231984|187391|P2|STARTED|Study Period 1||70
80738|NCT01231984|187392|P1|STARTED|Study Period 1||69
80739|NCT01231841|187413|P1|NOT COMPLETED|Overall Study||0
80740|NCT01231841|187413|P1|COMPLETED|Overall Study||20
80741|NCT01231841|187413|P1|STARTED|Overall Study||20
80742|NCT01231750|187419|P2|NOT COMPLETED|Overall Study||0
80743|NCT01231750|187420|P1|NOT COMPLETED|Overall Study||0
80744|NCT01231750|187419|P2|COMPLETED|Overall Study||4
80745|NCT01231750|187420|P1|COMPLETED|Overall Study||3
80746|NCT01231750|187419|P2|STARTED|Overall Study||4
80747|NCT01231750|187420|P1|STARTED|Overall Study||3
80748|NCT01231646|187438|P2|NOT COMPLETED|Overall Study||0
80749|NCT01231646|187439|P1|NOT COMPLETED|Overall Study||0
80750|NCT01231646|187438|P2|COMPLETED|Overall Study||10
80751|NCT01231646|187439|P1|COMPLETED|Overall Study||28
80752|NCT01231646|187438|P2|STARTED|Overall Study||10
80753|NCT01231646|187439|P1|STARTED|Overall Study||28
80754|NCT01231607|187450|P5|NOT COMPLETED|Overall Study||24
80755|NCT01231607|187451|P4|NOT COMPLETED|Overall Study||38
80756|NCT01231607|187452|P3|NOT COMPLETED|Overall Study||31
80757|NCT01231607|187453|P2|NOT COMPLETED|Overall Study||34
80758|NCT01231607|187454|P1|NOT COMPLETED|Overall Study||29
80759|NCT01231607|187450|P5|COMPLETED|Overall Study||157
80760|NCT01231607|187451|P4|COMPLETED|Overall Study||141
80761|NCT01231607|187452|P3|COMPLETED|Overall Study||153
80762|NCT01231607|187453|P2|COMPLETED|Overall Study||154
80763|NCT01231607|187454|P1|COMPLETED|Overall Study||156
80764|NCT01231607|187450|P5|STARTED|Overall Study||181
80765|NCT01231607|187451|P4|STARTED|Overall Study||179
80766|NCT01231607|187452|P3|STARTED|Overall Study||184
80767|NCT01231607|187453|P2|STARTED|Overall Study||188
80768|NCT01231607|187454|P1|STARTED|Overall Study||185
80769|NCT01231581|187546|P2|NOT COMPLETED|Overall Study||80
80770|NCT01231581|187547|P1|NOT COMPLETED|Overall Study||80
80771|NCT01231581|187546|P2|COMPLETED|Overall Study||0
80772|NCT01231581|187547|P1|COMPLETED|Overall Study||0
80773|NCT01231581|187546|P2|Ongoing|Overall Study||0
80774|NCT01231581|187547|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
80775|NCT01231581|187546|P2|STARTED|Overall Study||80
80776|NCT01231581|187547|P1|STARTED|Overall Study||80
80777|NCT01231516|187567|P2|NOT COMPLETED|Open-label Phase||26
80778|NCT01231516|187568|P1|NOT COMPLETED|Open-label Phase||295
80779|NCT01231516|187567|P2|COMPLETED|Open-label Phase||1
80780|NCT01231516|187568|P1|COMPLETED|Open-label Phase||0
80781|NCT01231516|187567|P2|Ongoing at the Time of Analysis|Open-label Phase||23
80782|NCT01231516|187568|P1|Ongoing at the Time of Analysis|Open-label Phase||282
80783|NCT01231516|187567|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
80784|NCT01231516|187568|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
80785|NCT01231516|187567|P2|NOT COMPLETED|48 Week Double-blind Phase||79
80786|NCT01231516|187568|P1|NOT COMPLETED|48 Week Double-blind Phase||58
80787|NCT01231516|187567|P2|COMPLETED|48 Week Double-blind Phase||283
80788|NCT01231516|187568|P1|COMPLETED|48 Week Double-blind Phase||299
80789|NCT01231516|187567|P2|STARTED|48 Week Double-blind Phase||362
80790|NCT01231516|187568|P1|STARTED|48 Week Double-blind Phase||357
80791|NCT01231503|187598|P8|NOT COMPLETED|Overall Study||8
80792|NCT01231503|187599|P7|NOT COMPLETED|Overall Study||7
80793|NCT01231503|187600|P6|NOT COMPLETED|Overall Study||16
80794|NCT01231503|187601|P5|NOT COMPLETED|Overall Study||10
80795|NCT01231503|187602|P4|NOT COMPLETED|Overall Study||8
80796|NCT01231503|187603|P3|NOT COMPLETED|Overall Study||12
80797|NCT01231503|187604|P2|NOT COMPLETED|Overall Study||13
80798|NCT01231503|187605|P1|NOT COMPLETED|Overall Study||14
80799|NCT01231503|187598|P8|COMPLETED|Overall Study||52
80800|NCT01231503|187599|P7|COMPLETED|Overall Study||53
80801|NCT01231503|187600|P6|COMPLETED|Overall Study||44
80802|NCT01231503|187601|P5|COMPLETED|Overall Study||50
80803|NCT01231503|187602|P4|COMPLETED|Overall Study||52
80804|NCT01231503|187603|P3|COMPLETED|Overall Study||48
80805|NCT01231503|187604|P2|COMPLETED|Overall Study||46
80806|NCT01231503|187605|P1|COMPLETED|Overall Study||46
80807|NCT01231503|187598|P8|STARTED|Overall Study||60
80808|NCT01231503|187599|P7|STARTED|Overall Study||60
80809|NCT01231503|187600|P6|STARTED|Overall Study||60
80810|NCT01231503|187601|P5|STARTED|Overall Study||60
80811|NCT01231503|187602|P4|STARTED|Overall Study||60
80812|NCT01231503|187603|P3|STARTED|Overall Study||60
80813|NCT01231503|187604|P2|STARTED|Overall Study||59
80814|NCT01231503|187605|P1|STARTED|Overall Study||60
80815|NCT01231464|187821|P2|NOT COMPLETED|Overall Study||7
80816|NCT01231464|187822|P1|NOT COMPLETED|Overall Study||5
80817|NCT01231464|187821|P2|COMPLETED|Overall Study||176
80818|NCT01231464|187822|P1|COMPLETED|Overall Study||177
80819|NCT01231464|187821|P2|STARTED|Overall Study||183
80820|NCT01231464|187822|P1|STARTED|Overall Study||182
80821|NCT01231373|187836|P4|NOT COMPLETED|Overall Study||1
80822|NCT01231373|187837|P3|NOT COMPLETED|Overall Study||0
80823|NCT01231373|187838|P2|NOT COMPLETED|Overall Study||1
80824|NCT01231373|187839|P1|NOT COMPLETED|Overall Study||3
80825|NCT01231373|187836|P4|COMPLETED|Overall Study||57
80826|NCT01231373|187837|P3|COMPLETED|Overall Study||60
80827|NCT01231373|187838|P2|COMPLETED|Overall Study||57
80828|NCT01231373|187839|P1|COMPLETED|Overall Study||56
80829|NCT01231373|187836|P4|Patients Receiving Blinded Treatment|Overall Study||58
80830|NCT01231373|187837|P3|Patients Receiving Blinded Treatment|Overall Study||60
80831|NCT01231373|187838|P2|Patients Receiving Blinded Treatment|Overall Study||57
80832|NCT01231373|187839|P1|Patients Receiving Blinded Treatment|Overall Study||57
80833|NCT01231373|187836|P4|STARTED|Overall Study||58
80834|NCT01231373|187837|P3|STARTED|Overall Study||60
80835|NCT01231373|187838|P2|STARTED|Overall Study||58
80836|NCT01231373|187839|P1|STARTED|Overall Study||59
80837|NCT01231334|187859|P2|NOT COMPLETED|Overall Study||21
80838|NCT01231334|187860|P1|NOT COMPLETED|Overall Study||19
80839|NCT01231334|187859|P2|COMPLETED|Overall Study||120
80840|NCT01231334|187860|P1|COMPLETED|Overall Study||126
80841|NCT01231334|187859|P2|STARTED|Overall Study||141
80842|NCT01231334|187860|P1|STARTED|Overall Study||145
80843|NCT01231321|187878|P1|NOT COMPLETED|Overall Study||5
80844|NCT01231321|187878|P1|COMPLETED|Overall Study||95
80845|NCT01231321|187878|P1|STARTED|Overall Study||100
80846|NCT01231230|187889|P1|NOT COMPLETED|Overall Study||0
80847|NCT01231230|187889|P1|COMPLETED|Overall Study||14
80848|NCT01231230|187889|P1|Placebo|Overall Study||14
80849|NCT01231230|187889|P1|Fluticasone/Salmeterol|Overall Study||14
80850|NCT01231230|187889|P1|Salmeterol|Overall Study||14
80851|NCT01231230|187889|P1|Fluticasone|Overall Study||14
80852|NCT01231230|187889|P1|STARTED|Overall Study||14
80853|NCT01230892|187901|P2|NOT COMPLETED|Overall Study||1
80854|NCT01230892|187902|P1|NOT COMPLETED|Overall Study||3
80855|NCT01230892|187901|P2|COMPLETED|Overall Study||13
80856|NCT01230892|187902|P1|COMPLETED|Overall Study||12
80857|NCT01230892|187901|P2|STARTED|Overall Study||14
80858|NCT01230892|187902|P1|STARTED|Overall Study||15
80859|NCT01230827|187912|P4|NOT COMPLETED|Overall Study||78
80860|NCT01230827|187913|P3|NOT COMPLETED|Overall Study||65
80861|NCT01230827|187914|P2|NOT COMPLETED|Overall Study||11
80862|NCT01230827|187915|P1|NOT COMPLETED|Overall Study||19
80863|NCT01230827|187912|P4|COMPLETED|Overall Study||0
80864|NCT01230827|187913|P3|COMPLETED|Overall Study||0
80865|NCT01230827|187914|P2|COMPLETED|Overall Study||0
80866|NCT01230827|187915|P1|COMPLETED|Overall Study||0
80867|NCT01230827|187912|P4|STARTED|Overall Study||78
80868|NCT01230827|187913|P3|STARTED|Overall Study||65
80869|NCT01230827|187914|P2|STARTED|Overall Study||11
80870|NCT01230827|187915|P1|STARTED|Overall Study||19
80871|NCT01230814|187931|P2|NOT COMPLETED|Overall Study||4
80872|NCT01230814|187932|P1|NOT COMPLETED|Overall Study||13
80873|NCT01230814|187931|P2|COMPLETED|Overall Study||112
80874|NCT01230814|187932|P1|COMPLETED|Overall Study||105
80875|NCT01230814|187931|P2|STARTED|Overall Study||116
80876|NCT01230814|187932|P1|STARTED|Overall Study||118
80877|NCT01230788|187944|P1|NOT COMPLETED|Overall Study||1
80878|NCT01230788|187944|P1|COMPLETED|Overall Study||0
80879|NCT01230788|187944|P1|STARTED|Overall Study||1
80880|NCT01230749|187956|P4|NOT COMPLETED|Overall Study||2
80881|NCT01230749|187957|P3|NOT COMPLETED|Overall Study||2
80882|NCT01230749|187958|P2|NOT COMPLETED|Overall Study||2
80883|NCT01230749|187959|P1|NOT COMPLETED|Overall Study||0
80884|NCT01230749|187956|P4|COMPLETED|Overall Study||20
80885|NCT01230749|187957|P3|COMPLETED|Overall Study||21
80886|NCT01230749|187958|P2|COMPLETED|Overall Study||20
80887|NCT01230749|187959|P1|COMPLETED|Overall Study||22
80888|NCT01230749|187956|P4|STARTED|Overall Study||22
80889|NCT01230749|187957|P3|STARTED|Overall Study||23
80890|NCT01230749|187958|P2|STARTED|Overall Study||22
80891|NCT01230749|187959|P1|STARTED|Overall Study||22
80892|NCT01230710|187994|P1|NOT COMPLETED|Overall Study||49
80893|NCT01230710|187994|P1|COMPLETED|Overall Study||2
80894|NCT01230710|187994|P1|STARTED|Overall Study||51
80895|NCT01230502|188005|P3|NOT COMPLETED|Overall Study||0
80896|NCT01230502|188006|P2|NOT COMPLETED|Overall Study||0
80897|NCT01230502|188007|P1|NOT COMPLETED|Overall Study||0
80898|NCT01230502|188005|P3|COMPLETED|Overall Study||0
80899|NCT01230502|188006|P2|COMPLETED|Overall Study||0
80900|NCT01230502|188007|P1|COMPLETED|Overall Study||9
80901|NCT01230502|188005|P3|STARTED|Overall Study||0
80902|NCT01230502|188006|P2|STARTED|Overall Study||0
80903|NCT01230502|188007|P1|STARTED|Overall Study||9
80904|NCT01230307|188020|P2|NOT COMPLETED|Overall Study||2
80905|NCT01230307|188021|P1|NOT COMPLETED|Overall Study||0
80906|NCT01230307|188020|P2|COMPLETED|Overall Study||4
80907|NCT01230307|188021|P1|COMPLETED|Overall Study||6
80908|NCT01230307|188020|P2|STARTED|Overall Study||6
80909|NCT01230307|188021|P1|STARTED|Overall Study||6
80910|NCT01230060|188033|P1|NOT COMPLETED|Overall Study||1
80911|NCT01230060|188033|P1|COMPLETED|Overall Study||121
80912|NCT01230060|188033|P1|STARTED|Overall Study||122
80913|NCT01230021|188037|P1|NOT COMPLETED|Overall Study||0
80914|NCT01230021|188037|P1|COMPLETED|Overall Study||6
80915|NCT01230021|188037|P1|STARTED|Overall Study||6
80916|NCT01229943|188059|P2|NOT COMPLETED|Overall Study||17
80917|NCT01229943|188060|P1|NOT COMPLETED|Overall Study||18
80918|NCT01229943|188059|P2|COMPLETED|Overall Study||58
80919|NCT01229943|188060|P1|COMPLETED|Overall Study||57
80920|NCT01229943|188059|P2|STARTED|Overall Study||75
80921|NCT01229943|188060|P1|STARTED|Overall Study||75
80922|NCT01229891|188073|P3|NOT COMPLETED|Overall Study||0
80923|NCT01229891|188074|P2|NOT COMPLETED|Overall Study||0
80924|NCT01229891|188075|P1|NOT COMPLETED|Overall Study||0
80925|NCT01229891|188073|P3|COMPLETED|Overall Study||30
80926|NCT01229891|188074|P2|COMPLETED|Overall Study||30
80927|NCT01229891|188075|P1|COMPLETED|Overall Study||30
80928|NCT01229891|188073|P3|STARTED|Overall Study||30
80929|NCT01229891|188074|P2|STARTED|Overall Study||30
80930|NCT01229891|188075|P1|STARTED|Overall Study||30
80931|NCT01229735|188106|P2|NOT COMPLETED|Overall Study||66
80932|NCT01229735|188107|P1|NOT COMPLETED|Overall Study||66
80933|NCT01229735|188106|P2|COMPLETED|Overall Study||100
80934|NCT01229735|188107|P1|COMPLETED|Overall Study||111
80935|NCT01229735|188106|P2|STARTED|Overall Study||166
80936|NCT01229735|188107|P1|STARTED|Overall Study||177
80937|NCT01229722|188123|P2|NOT COMPLETED|Overall Study||0
80938|NCT01229722|188124|P1|NOT COMPLETED|Overall Study||4
80939|NCT01229722|188123|P2|COMPLETED|Overall Study||36
80940|NCT01229722|188124|P1|COMPLETED|Overall Study||30
80941|NCT01229722|188123|P2|STARTED|Overall Study||36
80942|NCT01229722|188124|P1|STARTED|Overall Study||34
80943|NCT01229527|188133|P3|NOT COMPLETED|Overall Study||0
80944|NCT01229527|188134|P2|NOT COMPLETED|Overall Study||0
80945|NCT01229527|188135|P1|NOT COMPLETED|Overall Study||0
80946|NCT01229527|188133|P3|COMPLETED|Overall Study||30
80947|NCT01229527|188134|P2|COMPLETED|Overall Study||30
80948|NCT01229527|188135|P1|COMPLETED|Overall Study||30
80949|NCT01229527|188133|P3|STARTED|Overall Study||30
80950|NCT01229527|188134|P2|STARTED|Overall Study||30
80951|NCT01229527|188135|P1|STARTED|Overall Study||30
80952|NCT01229462|188148|P2|NOT COMPLETED|Overall Study||9
80953|NCT01229462|188149|P1|NOT COMPLETED|Overall Study||5
80954|NCT01229462|188148|P2|COMPLETED|Overall Study||109
80955|NCT01229462|188149|P1|COMPLETED|Overall Study||115
80956|NCT01229462|188148|P2|STARTED|Overall Study||118
80957|NCT01229462|188149|P1|STARTED|Overall Study||120
80958|NCT01229436|188155|P1|NOT COMPLETED|Overall Study||5
80959|NCT01229436|188155|P1|COMPLETED|Overall Study||249
80960|NCT01229436|188155|P1|STARTED|Overall Study||254
80961|NCT01229423|188193|P1|NOT COMPLETED|Overall Study||15
80962|NCT01229423|188193|P1|COMPLETED|Overall Study||47
80963|NCT01229423|188193|P1|STARTED|Overall Study||62
80964|NCT01229410|188204|P2|NOT COMPLETED|Overall Study||3
80965|NCT01229410|188205|P1|NOT COMPLETED|Overall Study||5
80966|NCT01229410|188204|P2|COMPLETED|Overall Study||9
80967|NCT01229410|188205|P1|COMPLETED|Overall Study||7
80968|NCT01229410|188204|P2|STARTED|Overall Study||12
80969|NCT01229410|188205|P1|STARTED|Overall Study||12
80970|NCT01229397|188217|P2|NOT COMPLETED|Overall Study||9
80971|NCT01229397|188218|P1|NOT COMPLETED|Overall Study||11
80972|NCT01229397|188217|P2|COMPLETED|Overall Study||93
80973|NCT01229397|188218|P1|COMPLETED|Overall Study||92
80974|NCT01229397|188217|P2|STARTED|Overall Study||102
80975|NCT01229397|188218|P1|STARTED|Overall Study||103
80976|NCT01229371|188236|P4|NOT COMPLETED|Overall Study||0
80977|NCT01229371|188237|P3|NOT COMPLETED|Overall Study||0
80978|NCT01229371|188238|P2|NOT COMPLETED|Overall Study||1
80979|NCT01229371|188239|P1|NOT COMPLETED|Overall Study||0
80980|NCT01229371|188236|P4|COMPLETED|Overall Study||110
80981|NCT01229371|188237|P3|COMPLETED|Overall Study||110
80982|NCT01229371|188238|P2|COMPLETED|Overall Study||110
80983|NCT01229371|188239|P1|COMPLETED|Overall Study||109
80984|NCT01229371|188236|P4|STARTED|Overall Study||110
80985|NCT01229371|188237|P3|STARTED|Overall Study||110
80986|NCT01229371|188238|P2|STARTED|Overall Study||111
80987|NCT01229371|188239|P1|STARTED|Overall Study||109
80988|NCT01229228|188266|P5|NOT COMPLETED|Overall Study||1
80989|NCT01229228|188267|P4|NOT COMPLETED|Overall Study||0
80990|NCT01229228|188268|P3|NOT COMPLETED|Overall Study||1
80991|NCT01229228|188269|P2|NOT COMPLETED|Overall Study||0
80992|NCT01229228|188270|P1|NOT COMPLETED|Overall Study||1
80993|NCT01229228|188266|P5|COMPLETED|Overall Study||50
80994|NCT01229228|188267|P4|COMPLETED|Overall Study||51
80995|NCT01229228|188268|P3|COMPLETED|Overall Study||49
80996|NCT01229228|188269|P2|COMPLETED|Overall Study||51
80997|NCT01229228|188270|P1|COMPLETED|Overall Study||50
80998|NCT01229228|188266|P5|STARTED|Overall Study||51
80999|NCT01229228|188267|P4|STARTED|Overall Study||51
81000|NCT01229228|188268|P3|STARTED|Overall Study||50
81001|NCT01229228|188269|P2|STARTED|Overall Study||51
81002|NCT01229228|188270|P1|STARTED|Overall Study||51
81003|NCT01229176|188290|P8|NOT COMPLETED|Overall Study||3
81004|NCT01229176|188291|P7|NOT COMPLETED|Overall Study||0
81005|NCT01229176|188292|P6|NOT COMPLETED|Overall Study||2
81006|NCT01229176|188293|P5|NOT COMPLETED|Overall Study||2
81007|NCT01229176|188294|P4|NOT COMPLETED|Overall Study||1
81008|NCT01229176|188295|P3|NOT COMPLETED|Overall Study||0
81009|NCT01229176|188296|P2|NOT COMPLETED|Overall Study||3
81010|NCT01229176|188297|P1|NOT COMPLETED|Overall Study||0
81011|NCT01229176|188290|P8|COMPLETED|Overall Study||17
81012|NCT01229176|188291|P7|COMPLETED|Overall Study||20
81013|NCT01229176|188292|P6|COMPLETED|Overall Study||18
81014|NCT01229176|188293|P5|COMPLETED|Overall Study||18
81015|NCT01229176|188294|P4|COMPLETED|Overall Study||19
81016|NCT01229176|188295|P3|COMPLETED|Overall Study||20
81017|NCT01229176|188296|P2|COMPLETED|Overall Study||37
81018|NCT01229176|188297|P1|COMPLETED|Overall Study||40
81019|NCT01229176|188290|P8|STARTED|Overall Study||20
81020|NCT01229176|188291|P7|STARTED|Overall Study||20
81021|NCT01229176|188292|P6|STARTED|Overall Study||20
81022|NCT01229176|188293|P5|STARTED|Overall Study||20
81023|NCT01229176|188294|P4|STARTED|Overall Study||20
81024|NCT01229176|188295|P3|STARTED|Overall Study||20
81025|NCT01229176|188296|P2|STARTED|Overall Study||40
81026|NCT01229176|188297|P1|STARTED|Overall Study||40
81027|NCT01229150|188351|P4|NOT COMPLETED|Overall Study||0
81028|NCT01229150|188352|P3|NOT COMPLETED|Overall Study||0
81029|NCT01229150|188353|P2|NOT COMPLETED|Overall Study||2
81030|NCT01229150|188354|P1|NOT COMPLETED|Overall Study||2
81031|NCT01229150|188351|P4|COMPLETED|Overall Study||19
81032|NCT01229150|188352|P3|COMPLETED|Overall Study||19
81033|NCT01229150|188353|P2|COMPLETED|Overall Study||9
81034|NCT01229150|188354|P1|COMPLETED|Overall Study||28
81035|NCT01229150|188351|P4|STARTED|Overall Study||19
81036|NCT01229150|188352|P3|STARTED|Overall Study||19
81037|NCT01229150|188353|P2|STARTED|Overall Study||11
81038|NCT01229150|188354|P1|STARTED|Overall Study||30
81039|NCT01228968|188366|P1|NOT COMPLETED|Overall Study||0
81040|NCT01228968|188366|P1|COMPLETED|Overall Study||9
81041|NCT01228968|188366|P1|STARTED|Overall Study||9
81042|NCT01228929|188376|P3|NOT COMPLETED|High Temperature Condition||0
81043|NCT01228929|188377|P2|NOT COMPLETED|High Temperature Condition||0
81044|NCT01228929|188378|P1|NOT COMPLETED|High Temperature Condition||0
81045|NCT01228929|188376|P3|COMPLETED|High Temperature Condition||6
81046|NCT01228929|188377|P2|COMPLETED|High Temperature Condition||6
81047|NCT01228929|188378|P1|COMPLETED|High Temperature Condition||6
81048|NCT01228929|188376|P3|STARTED|High Temperature Condition||6
81049|NCT01228929|188377|P2|STARTED|High Temperature Condition||6
81050|NCT01228929|188378|P1|STARTED|High Temperature Condition||6
81051|NCT01228929|188376|P3|NOT COMPLETED|Low Humidity Condition||0
81052|NCT01228929|188377|P2|NOT COMPLETED|Low Humidity Condition||0
81053|NCT01228929|188378|P1|NOT COMPLETED|Low Humidity Condition||0
81054|NCT01228929|188376|P3|COMPLETED|Low Humidity Condition||6
81055|NCT01228929|188377|P2|COMPLETED|Low Humidity Condition||6
81056|NCT01228929|188378|P1|COMPLETED|Low Humidity Condition||6
81057|NCT01228929|188376|P3|STARTED|Low Humidity Condition||6
81058|NCT01228929|188377|P2|STARTED|Low Humidity Condition||6
81059|NCT01228929|188378|P1|STARTED|Low Humidity Condition||6
81060|NCT01228929|188376|P3|NOT COMPLETED|Nominal Condition||0
81061|NCT01228929|188377|P2|NOT COMPLETED|Nominal Condition||0
81062|NCT01228929|188378|P1|NOT COMPLETED|Nominal Condition||0
81063|NCT01228929|188376|P3|COMPLETED|Nominal Condition||6
81064|NCT01228929|188377|P2|COMPLETED|Nominal Condition||6
81065|NCT01228929|188378|P1|COMPLETED|Nominal Condition||6
81066|NCT01228929|188376|P3|STARTED|Nominal Condition||6
81067|NCT01228929|188377|P2|STARTED|Nominal Condition||6
81068|NCT01228929|188378|P1|STARTED|Nominal Condition||6
81069|NCT01228747|188388|P2|NOT COMPLETED|Overall Study||45
81070|NCT01228747|188389|P1|NOT COMPLETED|Overall Study||65
81071|NCT01228747|188388|P2|COMPLETED|Overall Study||81
81072|NCT01228747|188389|P1|COMPLETED|Overall Study||60
81073|NCT01228747|188388|P2|STARTED|Overall Study||126
81074|NCT01228747|188389|P1|STARTED|Overall Study||125
81075|NCT01228591|188403|P2|NOT COMPLETED|Final Visit||0
81076|NCT01228591|188404|P1|NOT COMPLETED|Final Visit||0
81077|NCT01228591|188403|P2|COMPLETED|Final Visit||16
81078|NCT01228591|188404|P1|COMPLETED|Final Visit||17
81079|NCT01228591|188403|P2|STARTED|Final Visit||16
81080|NCT01228591|188404|P1|STARTED|Final Visit||17
81081|NCT01228591|188403|P2|NOT COMPLETED|1-Week Follow-Up||0
81082|NCT01228591|188404|P1|NOT COMPLETED|1-Week Follow-Up||0
81083|NCT01228591|188403|P2|COMPLETED|1-Week Follow-Up||16
81084|NCT01228591|188404|P1|COMPLETED|1-Week Follow-Up||17
81085|NCT01228591|188403|P2|STARTED|1-Week Follow-Up||16
81086|NCT01228591|188404|P1|STARTED|1-Week Follow-Up||17
81087|NCT01228591|188403|P2|NOT COMPLETED|Baseline||2
81088|NCT01228591|188404|P1|NOT COMPLETED|Baseline||1
81089|NCT01228591|188403|P2|COMPLETED|Baseline||16
81090|NCT01228591|188404|P1|COMPLETED|Baseline||17
81091|NCT01228591|188403|P2|STARTED|Baseline||18
81092|NCT01228591|188404|P1|STARTED|Baseline||18
81093|NCT01228435|188422|P2|NOT COMPLETED|Overall Study||0
81094|NCT01228435|188423|P1|NOT COMPLETED|Overall Study||0
81095|NCT01228435|188422|P2|COMPLETED|Overall Study||2
81096|NCT01228435|188423|P1|COMPLETED|Overall Study||1
81097|NCT01228435|188422|P2|STARTED|Overall Study||2
81098|NCT01228435|188423|P1|STARTED|Overall Study||1
81099|NCT01228175|188431|P2|NOT COMPLETED|Overall Study||53
81100|NCT01228175|188432|P1|NOT COMPLETED|Overall Study||63
81101|NCT01228175|188431|P2|COMPLETED|Overall Study||46
81102|NCT01228175|188432|P1|COMPLETED|Overall Study||56
81103|NCT01228175|188431|P2|STARTED|Overall Study||99
81104|NCT01228175|188432|P1|STARTED|Overall Study||119
81105|NCT01228084|188438|P1|NOT COMPLETED|Overall Study||4
81106|NCT01228084|188438|P1|COMPLETED|Overall Study||16
81107|NCT01228084|188438|P1|STARTED|Overall Study||20
81108|NCT01228071|188449|P1|NOT COMPLETED|Overall Study||2
81109|NCT01228071|188449|P1|COMPLETED|Overall Study||32
81110|NCT01228071|188449|P1|STARTED|Overall Study||34
81111|NCT01228019|188455|P1|NOT COMPLETED|Overall Study||304
81112|NCT01228019|188455|P1|COMPLETED|Overall Study||862
81113|NCT01228019|188455|P1|STARTED|Overall Study||1166
81114|NCT01227993|188470|P1|NOT COMPLETED|Overall Study||0
81115|NCT01227993|188470|P1|COMPLETED|Overall Study||3
81116|NCT01227993|188470|P1|STARTED|Overall Study||3
81117|NCT01227980|188482|P2|NOT COMPLETED|Overall Study||5
81118|NCT01227980|188483|P1|NOT COMPLETED|Overall Study||2
81119|NCT01227980|188482|P2|COMPLETED|Overall Study||25
81120|NCT01227980|188483|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
81121|NCT01227980|188482|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
81122|NCT01227980|188483|P1|Measure Drug Level Concentration|Overall Study||10
81123|NCT01227980|188482|P2|Scripts Challenge Sessions|Overall Study||25
81124|NCT01227980|188483|P1|Scripts Challenge Sessions|Overall Study||26
81125|NCT01227980|188482|P2|STARTED|Overall Study||30
81126|NCT01227980|188483|P1|STARTED|Overall Study||40
81127|NCT01227928|188521|P2|NOT COMPLETED|Overall Study||17
81128|NCT01227928|188522|P1|NOT COMPLETED|Overall Study||22
81129|NCT01227928|188521|P2|COMPLETED|Overall Study||56
81130|NCT01227928|188522|P1|COMPLETED|Overall Study||50
81131|NCT01227928|188521|P2|STARTED|Overall Study||73
81132|NCT01227928|188522|P1|STARTED|Overall Study||72
81133|NCT01227902|188560|P4|NOT COMPLETED|Overall Study||10
81134|NCT01227902|188561|P3|NOT COMPLETED|Overall Study||19
81135|NCT01227902|188562|P2|NOT COMPLETED|Overall Study||13
81136|NCT01227902|188563|P1|NOT COMPLETED|Overall Study||18
81137|NCT01227902|188560|P4|COMPLETED|Overall Study||42
81138|NCT01227902|188561|P3|COMPLETED|Overall Study||25
81139|NCT01227902|188562|P2|COMPLETED|Overall Study||38
81140|NCT01227902|188563|P1|COMPLETED|Overall Study||38
81141|NCT01227902|188560|P4|STARTED|Overall Study||52
81142|NCT01227902|188561|P3|STARTED|Overall Study||44
81143|NCT01227902|188562|P2|STARTED|Overall Study||51
81144|NCT01227902|188563|P1|STARTED|Overall Study||56
81145|NCT01227889|188656|P2|NOT COMPLETED|Crossover Phase||36
81146|NCT01227889|188657|P1|NOT COMPLETED|Crossover Phase||0
81147|NCT01227889|188656|P2|COMPLETED|Crossover Phase||0
81148|NCT01227889|188657|P1|COMPLETED|Crossover Phase||0
81149|NCT01227889|188656|P2|Ongoing|Crossover Phase||4
81150|NCT01227889|188657|P1|Ongoing|Crossover Phase||0
81151|NCT01227889|188656|P2|In Follow-up|Crossover Phase||11
81152|NCT01227889|188657|P1|In Follow-up|Crossover Phase||0
81153|NCT01227889|188656|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|36
81154|NCT01227889|188657|P1|STARTED|Crossover Phase||0
81155|NCT01227889|188656|P2|NOT COMPLETED|Randomized Phase (RP)||63
81156|NCT01227889|188657|P1|NOT COMPLETED|Randomized Phase (RP)||187
81157|NCT01227889|188656|P2|COMPLETED|Randomized Phase (RP)||0
81158|NCT01227889|188657|P1|COMPLETED|Randomized Phase (RP)||0
81159|NCT01227889|188656|P2|Crossed Over|Randomized Phase (RP)||36
81160|NCT01227889|188657|P1|Crossed Over|Randomized Phase (RP)||0
81161|NCT01227889|188656|P2|Ongoing|Randomized Phase (RP)||2
81162|NCT01227889|188657|P1|Ongoing|Randomized Phase (RP)||53
81163|NCT01227889|188656|P2|In Follow-up|Randomized Phase (RP)||10
81164|NCT01227889|188657|P1|In Follow-up|Randomized Phase (RP)||49
81165|NCT01227889|188656|P2|STARTED|Randomized Phase (RP)||63
81166|NCT01227889|188657|P1|STARTED|Randomized Phase (RP)||187
81167|NCT01227824|188685|P2|NOT COMPLETED|Open-label Phase||0
81168|NCT01227824|188686|P1|NOT COMPLETED|Open-label Phase||338
81169|NCT01227824|188685|P2|COMPLETED|Open-label Phase||0
81170|NCT01227824|188686|P1|COMPLETED|Open-label Phase||0
81171|NCT01227824|188685|P2|Ongoing|Open-label Phase||0
81172|NCT01227824|188686|P1|Ongoing|Open-label Phase||337
81173|NCT01227824|188685|P2|STARTED|Open-label Phase||0
81174|NCT01227824|188686|P1|STARTED|Open-label Phase|Eleven participant completing the Double-blind Phase did not continue into the Open-label Phase.|338
81175|NCT01227824|188685|P2|NOT COMPLETED|Double-blind Phase||79
81176|NCT01227824|188686|P1|NOT COMPLETED|Double-blind Phase||62
81177|NCT01227824|188685|P2|COMPLETED|Double-blind Phase||332
81178|NCT01227824|188686|P1|COMPLETED|Double-blind Phase||349
81179|NCT01227824|188685|P2|STARTED|Double-blind Phase||411
81180|NCT01227824|188686|P1|STARTED|Double-blind Phase||411
81181|NCT01227785|188714|P1|NOT COMPLETED|Overall Study||12
81182|NCT01227785|188714|P1|COMPLETED|Overall Study||108
81183|NCT01227785|188714|P1|STARTED|Overall Study||120
81184|NCT01227707|188780|P1|NOT COMPLETED|Overall Study||24
81185|NCT01227707|188780|P1|COMPLETED|Overall Study||19
81186|NCT01227707|188780|P1|STARTED|Overall Study||43
81187|NCT01227681|188799|P3|NOT COMPLETED|Overall Study||0
81188|NCT01227681|188800|P2|NOT COMPLETED|Overall Study||0
81189|NCT01227681|188801|P1|NOT COMPLETED|Overall Study||0
81190|NCT01227681|188799|P3|COMPLETED|Overall Study||0
81191|NCT01227681|188800|P2|COMPLETED|Overall Study||0
81192|NCT01227681|188801|P1|COMPLETED|Overall Study||4
81193|NCT01227681|188799|P3|STARTED|Overall Study||0
81194|NCT01227681|188800|P2|STARTED|Overall Study||0
81195|NCT01227681|188801|P1|STARTED|Overall Study||4
81196|NCT01227668|188807|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
81197|NCT01227668|188808|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
81198|NCT01227668|188807|P2|COMPLETED|Phase 2 (Randomization Phase)||19
81199|NCT01227668|188808|P1|COMPLETED|Phase 2 (Randomization Phase)||22
81200|NCT01227668|188807|P2|Received Treatment|Phase 2 (Randomization Phase)||43
81201|NCT01227668|188808|P1|Received Treatment|Phase 2 (Randomization Phase)||39
81202|NCT01227668|188807|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
81203|NCT01227668|188808|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
81204|NCT01227668|188807|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
81205|NCT01227668|188808|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
81206|NCT01227668|188807|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
81207|NCT01227668|188808|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
81208|NCT01227668|188807|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
81209|NCT01227668|188808|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
81210|NCT01227668|188807|P2|STARTED|Phase 1 (Stabilization Phase)||0
81211|NCT01227668|188808|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
81212|NCT01227655|188825|P3|NOT COMPLETED|Overall Study||14
81213|NCT01227655|188826|P2|NOT COMPLETED|Overall Study||26
81214|NCT01227655|188827|P1|NOT COMPLETED|Overall Study||11
81215|NCT01227655|188825|P3|COMPLETED|Overall Study||130
81216|NCT01227655|188826|P2|COMPLETED|Overall Study||128
81217|NCT01227655|188827|P1|COMPLETED|Overall Study||118
81218|NCT01227655|188825|P3|Full Analysis Set|Overall Study||135
81219|NCT01227655|188826|P2|Full Analysis Set|Overall Study||147
81220|NCT01227655|188827|P1|Full Analysis Set|Overall Study||125
81221|NCT01227655|188825|P3|Safety Set|Overall Study||136
81222|NCT01227655|188826|P2|Safety Set|Overall Study||150
81223|NCT01227655|188827|P1|Safety Set|Overall Study||125
81224|NCT01227655|188825|P3|STARTED|Overall Study||144
81225|NCT01227655|188826|P2|STARTED|Overall Study||154
81226|NCT01227655|188827|P1|STARTED|Overall Study||129
81227|NCT01227629|188854|P10|NOT COMPLETED|Overall Study||2
81228|NCT01227629|188855|P9|NOT COMPLETED|Overall Study||6
81229|NCT01227629|188856|P8|NOT COMPLETED|Overall Study||6
81230|NCT01227629|188857|P7|NOT COMPLETED|Overall Study||8
81231|NCT01227629|188858|P6|NOT COMPLETED|Overall Study||1
81232|NCT01227629|188859|P5|NOT COMPLETED|Overall Study||2
81233|NCT01227629|188860|P4|NOT COMPLETED|Overall Study||8
81234|NCT01227629|188861|P3|NOT COMPLETED|Overall Study||1
81235|NCT01227629|188862|P2|NOT COMPLETED|Overall Study||2
81236|NCT01227629|188863|P1|NOT COMPLETED|Overall Study||2
81237|NCT01227629|188854|P10|COMPLETED|Overall Study||68
81238|NCT01227629|188855|P9|COMPLETED|Overall Study||24
81239|NCT01227629|188856|P8|COMPLETED|Overall Study||27
81240|NCT01227629|188857|P7|COMPLETED|Overall Study||90
81241|NCT01227629|188858|P6|COMPLETED|Overall Study||32
81242|NCT01227629|188859|P5|COMPLETED|Overall Study||32
81243|NCT01227629|188860|P4|COMPLETED|Overall Study||91
81244|NCT01227629|188861|P3|COMPLETED|Overall Study||26
81245|NCT01227629|188862|P2|COMPLETED|Overall Study||18
81246|NCT01227629|188863|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
81247|NCT01227629|188854|P10|STARTED|Overall Study||70
81248|NCT01227629|188855|P9|STARTED|Overall Study||30
81249|NCT01227629|188856|P8|STARTED|Overall Study||33
81250|NCT01227629|188857|P7|STARTED|Overall Study||98
81251|NCT01227629|188858|P6|STARTED|Overall Study||33
81252|NCT01227629|188859|P5|STARTED|Overall Study||34
81253|NCT01227629|188860|P4|STARTED|Overall Study||99
81254|NCT01227629|188861|P3|STARTED|Overall Study||27
81255|NCT01227629|188862|P2|STARTED|Overall Study||20
81256|NCT01227629|188863|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
81257|NCT01227577|189099|P1|NOT COMPLETED|Overall Study||35
81258|NCT01227577|189099|P1|COMPLETED|Overall Study||93
81259|NCT01227577|189099|P1|STARTED|Overall Study||128
81260|NCT01227564|189114|P3|NOT COMPLETED|Overall Study||6
81261|NCT01227564|189115|P2|NOT COMPLETED|Overall Study||2
81262|NCT01227564|189116|P1|NOT COMPLETED|Overall Study||4
81263|NCT01227564|189114|P3|COMPLETED|Overall Study|Completed study|15
81264|NCT01227564|189115|P2|COMPLETED|Overall Study|Completed study|18
81265|NCT01227564|189116|P1|COMPLETED|Overall Study|Completed study|18
81266|NCT01227564|189114|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
81267|NCT01227564|189115|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
81268|NCT01227564|189116|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
81269|NCT01227564|189114|P3|Treated|Overall Study||21
81270|NCT01227564|189115|P2|Treated|Overall Study||20
81271|NCT01227564|189116|P1|Treated|Overall Study||22
81272|NCT01227564|189114|P3|STARTED|Overall Study||21
81273|NCT01227564|189115|P2|STARTED|Overall Study||20
81274|NCT01227564|189116|P1|STARTED|Overall Study||22
81275|NCT01227512|189249|P2|NOT COMPLETED|Overall Study||10
81276|NCT01227512|189250|P1|NOT COMPLETED|Overall Study||13
81277|NCT01227512|189249|P2|COMPLETED|Overall Study||48
81278|NCT01227512|189250|P1|COMPLETED|Overall Study||53
81279|NCT01227512|189249|P2|STARTED|Overall Study||58
81280|NCT01227512|189250|P1|STARTED|Overall Study||66
81281|NCT01227434|189272|P2|NOT COMPLETED|Overall Study||0
81282|NCT01227434|189273|P1|NOT COMPLETED|Overall Study||0
81283|NCT01227434|189272|P2|COMPLETED|Overall Study||16
81284|NCT01227434|189273|P1|COMPLETED|Overall Study||6
81285|NCT01227434|189272|P2|STARTED|Overall Study||16
81286|NCT01227434|189273|P1|STARTED|Overall Study||6
81287|NCT01227421|189284|P3|NOT COMPLETED|Overall Study||10
81288|NCT01227421|189285|P2|NOT COMPLETED|Overall Study||18
81289|NCT01227421|189286|P1|NOT COMPLETED|Overall Study||11
81290|NCT01227421|189284|P3|COMPLETED|Overall Study||201
81291|NCT01227421|189285|P2|COMPLETED|Overall Study||194
81292|NCT01227421|189286|P1|COMPLETED|Overall Study||190
81293|NCT01227421|189284|P3|STARTED|Overall Study||211
81294|NCT01227421|189285|P2|STARTED|Overall Study||212
81295|NCT01227421|189286|P1|STARTED|Overall Study||201
81296|NCT01227395|189338|P2|NOT COMPLETED|Overall Study||1
81297|NCT01227395|189339|P1|NOT COMPLETED|Overall Study||0
81298|NCT01227395|189338|P2|COMPLETED|Overall Study||84
81299|NCT01227395|189339|P1|COMPLETED|Overall Study||391
81300|NCT01227395|189338|P2|STARTED|Overall Study||85
81301|NCT01227395|189339|P1|STARTED|Overall Study||391
81302|NCT01227382|189367|P1|NOT COMPLETED|Overall Study||0
81303|NCT01227382|189367|P1|COMPLETED|Overall Study||26
81304|NCT01227382|189367|P1|STARTED|Overall Study||26
81305|NCT01227278|189379|P2|NOT COMPLETED|Overall Study||8
81306|NCT01227278|189380|P1|NOT COMPLETED|Overall Study||5
81307|NCT01227278|189379|P2|COMPLETED|Overall Study||43
81308|NCT01227278|189380|P1|COMPLETED|Overall Study||45
81309|NCT01227278|189379|P2|STARTED|Overall Study||51
81310|NCT01227278|189380|P1|STARTED|Overall Study||50
81311|NCT01227265|189407|P3|NOT COMPLETED|Overall Study||14
81312|NCT01227265|189408|P2|NOT COMPLETED|Overall Study||20
81313|NCT01227265|189409|P1|NOT COMPLETED|Overall Study||19
81314|NCT01227265|189407|P3|COMPLETED|Overall Study||145
81315|NCT01227265|189408|P2|COMPLETED|Overall Study||139
81316|NCT01227265|189409|P1|COMPLETED|Overall Study||139
81317|NCT01227265|189407|P3|Treated|Overall Study||159
81318|NCT01227265|189408|P2|Treated|Overall Study||157
81319|NCT01227265|189409|P1|Treated|Overall Study||157
81320|NCT01227265|189407|P3|STARTED|Overall Study||159
81321|NCT01227265|189408|P2|STARTED|Overall Study||159
81322|NCT01227265|189409|P1|STARTED|Overall Study||158
81323|NCT01227057|189437|P2|NOT COMPLETED|Overall Study||8
81324|NCT01227057|189438|P1|NOT COMPLETED|Overall Study||6
81325|NCT01227057|189437|P2|COMPLETED|Overall Study||19
81326|NCT01227057|189438|P1|COMPLETED|Overall Study||25
81327|NCT01227057|189437|P2|STARTED|Overall Study||27
81328|NCT01227057|189438|P1|STARTED|Overall Study||31
81329|NCT01227018|189446|P1|NOT COMPLETED|Overall Study||15
81330|NCT01227018|189446|P1|COMPLETED|Overall Study||0
81331|NCT01227018|189446|P1|STARTED|Overall Study||15
81332|NCT01227005|189456|P2|NOT COMPLETED|Overall Study||1
81333|NCT01227005|189457|P1|NOT COMPLETED|Overall Study||5
81334|NCT01227005|189456|P2|COMPLETED|Overall Study||51
81335|NCT01227005|189457|P1|COMPLETED|Overall Study||50
81336|NCT01227005|189456|P2|STARTED|Overall Study||52
81337|NCT01227005|189457|P1|STARTED|Overall Study||55
81338|NCT01226745|189473|P6|NOT COMPLETED|Overall Study||5
81339|NCT01226745|189474|P5|NOT COMPLETED|Overall Study||4
81340|NCT01226745|189475|P4|NOT COMPLETED|Overall Study||5
81341|NCT01226745|189476|P3|NOT COMPLETED|Overall Study||20
81342|NCT01226745|189477|P2|NOT COMPLETED|Overall Study||16
81343|NCT01226745|189478|P1|NOT COMPLETED|Overall Study||17
81344|NCT01226745|189473|P6|COMPLETED|Overall Study||24
81345|NCT01226745|189474|P5|COMPLETED|Overall Study||22
81346|NCT01226745|189475|P4|COMPLETED|Overall Study||24
81347|NCT01226745|189476|P3|COMPLETED|Overall Study||69
81348|NCT01226745|189477|P2|COMPLETED|Overall Study||71
81349|NCT01226745|189478|P1|COMPLETED|Overall Study||63
81350|NCT01226745|189473|P6|STARTED|Overall Study||29
81351|NCT01226745|189474|P5|STARTED|Overall Study||26
81352|NCT01226745|189475|P4|STARTED|Overall Study||29
81353|NCT01226745|189476|P3|STARTED|Overall Study||89
81354|NCT01226745|189477|P2|STARTED|Overall Study||87
81355|NCT01226745|189478|P1|STARTED|Overall Study||80
81356|NCT01226732|189558|P6|NOT COMPLETED|Overall Study||6
81357|NCT01226732|189559|P5|NOT COMPLETED|Overall Study||3
81358|NCT01226732|189560|P4|NOT COMPLETED|Overall Study||5
81359|NCT01226732|189561|P3|NOT COMPLETED|Overall Study||3
81360|NCT01226732|189562|P2|NOT COMPLETED|Overall Study||3
81361|NCT01226732|189563|P1|NOT COMPLETED|Overall Study||3
81362|NCT01226732|189558|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81363|NCT01226732|189559|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81364|NCT01226732|189560|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81365|NCT01226732|189561|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81366|NCT01226732|189562|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81367|NCT01226732|189563|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
81368|NCT01226732|189558|P6|STARTED|Overall Study||6
81369|NCT01226732|189559|P5|STARTED|Overall Study||3
81370|NCT01226732|189560|P4|STARTED|Overall Study||5
81371|NCT01226732|189561|P3|STARTED|Overall Study||3
81372|NCT01226732|189562|P2|STARTED|Overall Study||3
81373|NCT01226732|189563|P1|STARTED|Overall Study||3
81374|NCT01226719|189579|P1|NOT COMPLETED|Overall Study||13
81375|NCT01226719|189579|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
81376|NCT01226719|189579|P1|STARTED|Overall Study||15
81377|NCT01226511|189589|P2|NOT COMPLETED|Taper Period||3
81378|NCT01226511|189590|P1|NOT COMPLETED|Taper Period||5
81379|NCT01226511|189589|P2|COMPLETED|Taper Period||54
81380|NCT01226511|189590|P1|COMPLETED|Taper Period||46
81381|NCT01226511|189589|P2|STARTED|Taper Period||57
81382|NCT01226511|189590|P1|STARTED|Taper Period||51
81383|NCT01226511|189589|P2|NOT COMPLETED|Extension Treatment Period||27
81384|NCT01226511|189590|P1|NOT COMPLETED|Extension Treatment Period||27
81385|NCT01226511|189589|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
81386|NCT01226511|189590|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
81387|NCT01226511|189589|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
81388|NCT01226511|189590|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
81389|NCT01226511|189589|P2|NOT COMPLETED|Acute Treatment Period||31
81390|NCT01226511|189590|P1|NOT COMPLETED|Acute Treatment Period||32
81391|NCT01226511|189589|P2|COMPLETED|Acute Treatment Period||110
81392|NCT01226511|189590|P1|COMPLETED|Acute Treatment Period||108
81393|NCT01226511|189589|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
81394|NCT01226511|189590|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
81395|NCT01226459|189628|P2|NOT COMPLETED|Overall Study||32
81396|NCT01226459|189629|P1|NOT COMPLETED|Overall Study||21
81397|NCT01226459|189628|P2|COMPLETED|Overall Study||171
81398|NCT01226459|189629|P1|COMPLETED|Overall Study||180
81399|NCT01226459|189628|P2|STARTED|Overall Study||203
81400|NCT01226459|189629|P1|STARTED|Overall Study||201
81401|NCT01226420|189639|P1|NOT COMPLETED|Overall Study||0
81402|NCT01226420|189639|P1|COMPLETED|Overall Study||6
81403|NCT01226420|189639|P1|STARTED|Overall Study||6
81404|NCT01226121|189647|P3|NOT COMPLETED|Overall Study||1
81405|NCT01226121|189648|P2|NOT COMPLETED|Overall Study||0
81406|NCT01226121|189649|P1|NOT COMPLETED|Overall Study||2
81407|NCT01226121|189647|P3|COMPLETED|Overall Study||12
81408|NCT01226121|189648|P2|COMPLETED|Overall Study||11
81409|NCT01226121|189649|P1|COMPLETED|Overall Study||11
81410|NCT01226121|189647|P3|30 Day Evaluation|Overall Study||13
81411|NCT01226121|189648|P2|30 Day Evaluation|Overall Study||11
81412|NCT01226121|189649|P1|30 Day Evaluation|Overall Study||12
81413|NCT01226121|189647|P3|STARTED|Overall Study||13
81414|NCT01226121|189648|P2|STARTED|Overall Study||11
81415|NCT01226121|189649|P1|STARTED|Overall Study||13
81416|NCT01226095|189660|P1|NOT COMPLETED|Overall Study||1
81417|NCT01226095|189660|P1|COMPLETED|Overall Study||518
81418|NCT01226095|189660|P1|STARTED|Overall Study||519
81419|NCT01226043|189685|P4|NOT COMPLETED|30-week Observational Phase||13
81420|NCT01226043|189686|P3|NOT COMPLETED|30-week Observational Phase||6
81421|NCT01226043|189687|P2|NOT COMPLETED|30-week Observational Phase||0
81422|NCT01226043|189688|P1|NOT COMPLETED|30-week Observational Phase||0
81423|NCT01226043|189685|P4|COMPLETED|30-week Observational Phase||140
81424|NCT01226043|189686|P3|COMPLETED|30-week Observational Phase||153
81425|NCT01226043|189687|P2|COMPLETED|30-week Observational Phase||0
81426|NCT01226043|189688|P1|COMPLETED|30-week Observational Phase||0
81427|NCT01226043|189685|P4|TREATED|30-week Observational Phase||153
81428|NCT01226043|189686|P3|TREATED|30-week Observational Phase||159
81429|NCT01226043|189687|P2|TREATED|30-week Observational Phase||0
81430|NCT01226043|189688|P1|TREATED|30-week Observational Phase||0
81431|NCT01226043|189685|P4|STARTED|30-week Observational Phase||153
81432|NCT01226043|189686|P3|STARTED|30-week Observational Phase||159
81433|NCT01226043|189687|P2|STARTED|30-week Observational Phase||0
81434|NCT01226043|189688|P1|STARTED|30-week Observational Phase||0
81435|NCT01226043|189685|P4|NOT COMPLETED|6-week Re-randomization Phase||11
81436|NCT01226043|189686|P3|NOT COMPLETED|6-week Re-randomization Phase||7
81437|NCT01226043|189687|P2|NOT COMPLETED|6-week Re-randomization Phase||0
81438|NCT01226043|189688|P1|NOT COMPLETED|6-week Re-randomization Phase||0
81439|NCT01226043|189685|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
81440|NCT01226043|189686|P3|COMPLETED|6-week Re-randomization Phase||159
81441|NCT01226043|189687|P2|COMPLETED|6-week Re-randomization Phase||0
81442|NCT01226043|189688|P1|COMPLETED|6-week Re-randomization Phase||0
81443|NCT01226043|189685|P4|TREATED|6-week Re-randomization Phase||165
81444|NCT01226043|189686|P3|TREATED|6-week Re-randomization Phase||165
81445|NCT01226043|189687|P2|TREATED|6-week Re-randomization Phase||0
81446|NCT01226043|189688|P1|TREATED|6-week Re-randomization Phase||0
81447|NCT01226043|189685|P4|STARTED|6-week Re-randomization Phase||167
81448|NCT01226043|189686|P3|STARTED|6-week Re-randomization Phase||166
81449|NCT01226043|189687|P2|STARTED|6-week Re-randomization Phase||0
81450|NCT01226043|189688|P1|STARTED|6-week Re-randomization Phase||0
81451|NCT01226043|189685|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
81452|NCT01226043|189686|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
81453|NCT01226043|189687|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
81454|NCT01226043|189688|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
81455|NCT01226043|189685|P4|COMPLETED|4-week Crossover Phase - Period 2||0
81456|NCT01226043|189686|P3|COMPLETED|4-week Crossover Phase - Period 2||0
81457|NCT01226043|189687|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
81458|NCT01226043|189688|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
81459|NCT01226043|189685|P4|TREATED|4-week Crossover Phase - Period 2||0
81460|NCT01226043|189686|P3|TREATED|4-week Crossover Phase - Period 2||0
81461|NCT01226043|189687|P2|TREATED|4-week Crossover Phase - Period 2||194
81462|NCT01226043|189688|P1|TREATED|4-week Crossover Phase - Period 2||199
81463|NCT01226043|189685|P4|STARTED|4-week Crossover Phase - Period 2||0
81464|NCT01226043|189686|P3|STARTED|4-week Crossover Phase - Period 2||0
81465|NCT01226043|189687|P2|STARTED|4-week Crossover Phase - Period 2||194
81466|NCT01226043|189688|P1|STARTED|4-week Crossover Phase - Period 2||199
81467|NCT01226043|189685|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
81468|NCT01226043|189686|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
81469|NCT01226043|189687|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
81470|NCT01226043|189688|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
81471|NCT01226043|189685|P4|COMPLETED|4-week Crossover Phase - Period 1||0
81472|NCT01226043|189686|P3|COMPLETED|4-week Crossover Phase - Period 1||0
81473|NCT01226043|189687|P2|COMPLETED|4-week Crossover Phase - Period 1||194
81474|NCT01226043|189688|P1|COMPLETED|4-week Crossover Phase - Period 1||199
81475|NCT01226043|189685|P4|TREATED|4-week Crossover Phase - Period 1||0
81476|NCT01226043|189686|P3|TREATED|4-week Crossover Phase - Period 1||0
81477|NCT01226043|189687|P2|TREATED|4-week Crossover Phase - Period 1||200
81478|NCT01226043|189688|P1|TREATED|4-week Crossover Phase - Period 1||202
81479|NCT01226043|189685|P4|STARTED|4-week Crossover Phase - Period 1||0
81480|NCT01226043|189686|P3|STARTED|4-week Crossover Phase - Period 1||0
81481|NCT01226043|189687|P2|STARTED|4-week Crossover Phase - Period 1||203
81482|NCT01226043|189688|P1|STARTED|4-week Crossover Phase - Period 1||202
81483|NCT01225991|189726|P1|NOT COMPLETED|Overall Study||6
81484|NCT01225991|189726|P1|COMPLETED|Overall Study||12
81485|NCT01225991|189726|P1|STARTED|Overall Study||18
81486|NCT01225952|189733|P3|NOT COMPLETED|Overall Study||6
81487|NCT01225952|189734|P2|NOT COMPLETED|Overall Study||4
81488|NCT01225952|189735|P1|NOT COMPLETED|Overall Study||6
81489|NCT01225952|189733|P3|COMPLETED|Overall Study||25
81490|NCT01225952|189734|P2|COMPLETED|Overall Study||27
81491|NCT01225952|189735|P1|COMPLETED|Overall Study||25
81492|NCT01225952|189733|P3|STARTED|Overall Study||31
81493|NCT01225952|189734|P2|STARTED|Overall Study||31
81494|NCT01225952|189735|P1|STARTED|Overall Study||31
81495|NCT01225926|189820|P2|NOT COMPLETED|Overall Study||0
81496|NCT01225926|189821|P1|NOT COMPLETED|Overall Study||0
81497|NCT01225926|189820|P2|COMPLETED|Overall Study||12
81498|NCT01225926|189821|P1|COMPLETED|Overall Study||12
81499|NCT01225926|189820|P2|STARTED|Overall Study||12
81500|NCT01225926|189821|P1|STARTED|Overall Study||12
81501|NCT01225835|189829|P2|NOT COMPLETED|Overall Study||3
81502|NCT01225835|189830|P1|NOT COMPLETED|Overall Study||7
81503|NCT01225835|189829|P2|COMPLETED|Overall Study|hCG criterion met|59
81504|NCT01225835|189830|P1|COMPLETED|Overall Study|hCG criterion met|55
81505|NCT01225835|189829|P2|Per Protocol Population|Overall Study||58
81506|NCT01225835|189830|P1|Per Protocol Population|Overall Study||48
81507|NCT01225835|189829|P2|STARTED|Overall Study||62
81508|NCT01225835|189830|P1|STARTED|Overall Study||62
81509|NCT01225822|189878|P5|NOT COMPLETED|Overall Study||31
81510|NCT01225822|189879|P4|NOT COMPLETED|Overall Study||52
81511|NCT01225822|189880|P3|NOT COMPLETED|Overall Study||38
81512|NCT01225822|189881|P2|NOT COMPLETED|Overall Study||56
81513|NCT01225822|189882|P1|NOT COMPLETED|Overall Study||38
81514|NCT01225822|189878|P5|COMPLETED|Overall Study||361
81515|NCT01225822|189879|P4|COMPLETED|Overall Study||333
81516|NCT01225822|189880|P3|COMPLETED|Overall Study||355
81517|NCT01225822|189881|P2|COMPLETED|Overall Study||334
81518|NCT01225822|189882|P1|COMPLETED|Overall Study||351
81519|NCT01225822|189878|P5|STARTED|Overall Study||392
81520|NCT01225822|189879|P4|STARTED|Overall Study||385
81521|NCT01225822|189880|P3|STARTED|Overall Study||393
81522|NCT01225822|189881|P2|STARTED|Overall Study||390
81523|NCT01225822|189882|P1|STARTED|Overall Study||389
81524|NCT01225731|189949|P13|NOT COMPLETED|Part 3||7
81525|NCT01225731|189950|P12|NOT COMPLETED|Part 3||10
81526|NCT01225731|189951|P11|NOT COMPLETED|Part 3||6
81527|NCT01225731|189952|P10|NOT COMPLETED|Part 3||0
81528|NCT01225731|189953|P9|NOT COMPLETED|Part 3||0
81529|NCT01225731|189954|P8|NOT COMPLETED|Part 3||0
81530|NCT01225731|189955|P7|NOT COMPLETED|Part 3||0
81531|NCT01225731|189956|P6|NOT COMPLETED|Part 3||0
81532|NCT01225731|189957|P5|NOT COMPLETED|Part 3||0
81533|NCT01225731|189958|P4|NOT COMPLETED|Part 3||0
81534|NCT01225731|189959|P3|NOT COMPLETED|Part 3||0
81535|NCT01225731|189960|P2|NOT COMPLETED|Part 3||0
81536|NCT01225731|189961|P1|NOT COMPLETED|Part 3||0
81537|NCT01225731|189949|P13|COMPLETED|Part 3||60
81538|NCT01225731|189950|P12|COMPLETED|Part 3||116
81539|NCT01225731|189951|P11|COMPLETED|Part 3||80
81540|NCT01225731|189952|P10|COMPLETED|Part 3||10
81541|NCT01225731|189953|P9|COMPLETED|Part 3||0
81542|NCT01225731|189954|P8|COMPLETED|Part 3||0
81543|NCT01225731|189955|P7|COMPLETED|Part 3||0
81544|NCT01225731|189956|P6|COMPLETED|Part 3||0
81545|NCT01225731|189957|P5|COMPLETED|Part 3||0
81546|NCT01225731|189958|P4|COMPLETED|Part 3||0
81547|NCT01225731|189959|P3|COMPLETED|Part 3||0
81548|NCT01225731|189960|P2|COMPLETED|Part 3||0
81549|NCT01225731|189961|P1|COMPLETED|Part 3||0
81550|NCT01225731|189949|P13|STARTED|Part 3|Not all participants entered follow-up|67
81551|NCT01225731|189950|P12|STARTED|Part 3|Not all participants entered follow-up|126
81552|NCT01225731|189951|P11|STARTED|Part 3|Not all participants entered follow-up|86
81553|NCT01225731|189952|P10|STARTED|Part 3|Not all participants entered follow-up|10
81554|NCT01225731|189953|P9|STARTED|Part 3|Participants could enter the follow-up period|0
81555|NCT01225731|189954|P8|STARTED|Part 3|Participants could enter the follow-up period|0
81556|NCT01225731|189955|P7|STARTED|Part 3|Participants could enter the follow-up period|0
81557|NCT01225731|189956|P6|STARTED|Part 3|Participants could enter the follow-up period|0
81558|NCT01225731|189957|P5|STARTED|Part 3||0
81559|NCT01225731|189958|P4|STARTED|Part 3||0
81560|NCT01225731|189959|P3|STARTED|Part 3||0
81561|NCT01225731|189960|P2|STARTED|Part 3||0
81562|NCT01225731|189961|P1|STARTED|Part 3||0
81563|NCT01225731|189949|P13|NOT COMPLETED|Part 2||0
81564|NCT01225731|189950|P12|NOT COMPLETED|Part 2||0
81565|NCT01225731|189951|P11|NOT COMPLETED|Part 2||0
81566|NCT01225731|189952|P10|NOT COMPLETED|Part 2||0
81567|NCT01225731|189953|P9|NOT COMPLETED|Part 2||11
81568|NCT01225731|189954|P8|NOT COMPLETED|Part 2||25
81569|NCT01225731|189955|P7|NOT COMPLETED|Part 2||8
81570|NCT01225731|189956|P6|NOT COMPLETED|Part 2||3
81571|NCT01225731|189957|P5|NOT COMPLETED|Part 2||0
81572|NCT01225731|189958|P4|NOT COMPLETED|Part 2||0
81573|NCT01225731|189959|P3|NOT COMPLETED|Part 2||0
81574|NCT01225731|189960|P2|NOT COMPLETED|Part 2||0
81575|NCT01225731|189961|P1|NOT COMPLETED|Part 2||0
81576|NCT01225731|189949|P13|COMPLETED|Part 2||0
81577|NCT01225731|189950|P12|COMPLETED|Part 2||0
81578|NCT01225731|189951|P11|COMPLETED|Part 2||0
81579|NCT01225731|189952|P10|COMPLETED|Part 2||0
81580|NCT01225731|189953|P9|COMPLETED|Part 2||68
81581|NCT01225731|189954|P8|COMPLETED|Part 2||128
81582|NCT01225731|189955|P7|COMPLETED|Part 2||86
81583|NCT01225731|189956|P6|COMPLETED|Part 2||10
81584|NCT01225731|189957|P5|COMPLETED|Part 2||0
81585|NCT01225731|189958|P4|COMPLETED|Part 2||0
81586|NCT01225731|189959|P3|COMPLETED|Part 2||0
81587|NCT01225731|189960|P2|COMPLETED|Part 2||0
81588|NCT01225731|189961|P1|COMPLETED|Part 2||0
81589|NCT01225731|189949|P13|STARTED|Part 2||0
81590|NCT01225731|189950|P12|STARTED|Part 2||0
81591|NCT01225731|189951|P11|STARTED|Part 2||0
81592|NCT01225731|189952|P10|STARTED|Part 2||0
81593|NCT01225731|189953|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
81594|NCT01225731|189954|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
81595|NCT01225731|189955|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
81596|NCT01225731|189956|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
81597|NCT01225731|189957|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
81598|NCT01225731|189958|P4|STARTED|Part 2|Participants could progress into Part 2|0
81599|NCT01225731|189959|P3|STARTED|Part 2|Participants could progress into Part 2|0
81600|NCT01225731|189960|P2|STARTED|Part 2|Participants could progress into Part 2|0
81601|NCT01225731|189961|P1|STARTED|Part 2|Participants could progress into Part 2|0
81602|NCT01225731|189949|P13|NOT COMPLETED|Part 1||0
81603|NCT01225731|189950|P12|NOT COMPLETED|Part 1||0
81604|NCT01225731|189951|P11|NOT COMPLETED|Part 1||0
81605|NCT01225731|189952|P10|NOT COMPLETED|Part 1||0
81606|NCT01225731|189953|P9|NOT COMPLETED|Part 1||0
81607|NCT01225731|189954|P8|NOT COMPLETED|Part 1||0
81608|NCT01225731|189955|P7|NOT COMPLETED|Part 1||0
81609|NCT01225731|189956|P6|NOT COMPLETED|Part 1||0
81610|NCT01225731|189957|P5|NOT COMPLETED|Part 1||6
81611|NCT01225731|189958|P4|NOT COMPLETED|Part 1||2
81612|NCT01225731|189959|P3|NOT COMPLETED|Part 1||1
81613|NCT01225731|189960|P2|NOT COMPLETED|Part 1||5
81614|NCT01225731|189961|P1|NOT COMPLETED|Part 1||2
81615|NCT01225731|189949|P13|COMPLETED|Part 1||0
81616|NCT01225731|189950|P12|COMPLETED|Part 1||0
81617|NCT01225731|189951|P11|COMPLETED|Part 1||0
81618|NCT01225731|189952|P10|COMPLETED|Part 1||0
81619|NCT01225731|189953|P9|COMPLETED|Part 1||0
81620|NCT01225731|189954|P8|COMPLETED|Part 1||0
81621|NCT01225731|189955|P7|COMPLETED|Part 1||0
81622|NCT01225731|189956|P6|COMPLETED|Part 1||0
81623|NCT01225731|189957|P5|COMPLETED|Part 1||40
81624|NCT01225731|189958|P4|COMPLETED|Part 1||84
81625|NCT01225731|189959|P3|COMPLETED|Part 1||88
81626|NCT01225731|189960|P2|COMPLETED|Part 1||87
81627|NCT01225731|189961|P1|COMPLETED|Part 1||40
81628|NCT01225731|189949|P13|STARTED|Part 1||0
81629|NCT01225731|189950|P12|STARTED|Part 1||0
81630|NCT01225731|189951|P11|STARTED|Part 1||0
81631|NCT01225731|189952|P10|STARTED|Part 1||0
81632|NCT01225731|189953|P9|STARTED|Part 1||0
81633|NCT01225731|189954|P8|STARTED|Part 1||0
81634|NCT01225731|189955|P7|STARTED|Part 1||0
81635|NCT01225731|189956|P6|STARTED|Part 1||0
81636|NCT01225731|189957|P5|STARTED|Part 1||46
81637|NCT01225731|189958|P4|STARTED|Part 1||86
81638|NCT01225731|189959|P3|STARTED|Part 1||89
81639|NCT01225731|189960|P2|STARTED|Part 1||92
81640|NCT01225731|189961|P1|STARTED|Part 1||42
81641|NCT01225562|190056|P3|NOT COMPLETED|Overall Study||53
81642|NCT01225562|190057|P2|NOT COMPLETED|Overall Study||56
81643|NCT01225562|190058|P1|NOT COMPLETED|Overall Study||55
81644|NCT01225562|190056|P3|COMPLETED|Overall Study||7014
81645|NCT01225562|190057|P2|COMPLETED|Overall Study||6989
81646|NCT01225562|190058|P1|COMPLETED|Overall Study||6995
81647|NCT01225562|190056|P3|STARTED|Overall Study||7067
81648|NCT01225562|190057|P2|STARTED|Overall Study||7045
81649|NCT01225562|190058|P1|STARTED|Overall Study||7050
81650|NCT01225549|190075|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81651|NCT01225549|190076|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81652|NCT01225549|190077|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81653|NCT01225549|190078|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81654|NCT01225549|190079|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81655|NCT01225549|190080|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81656|NCT01225549|190081|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81657|NCT01225549|190082|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81658|NCT01225549|190083|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81659|NCT01225549|190084|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
81660|NCT01225549|190075|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
81661|NCT01225549|190076|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
81662|NCT01225549|190077|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
81663|NCT01225549|190078|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
81664|NCT01225549|190079|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
81665|NCT01225549|190080|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
81666|NCT01225549|190081|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
81667|NCT01225549|190082|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
81668|NCT01225549|190083|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
81669|NCT01225549|190084|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
81670|NCT01225549|190075|P10|STARTED|Period 7 - Fourth Treatment Period||1
81671|NCT01225549|190076|P9|STARTED|Period 7 - Fourth Treatment Period||4
81672|NCT01225549|190077|P8|STARTED|Period 7 - Fourth Treatment Period||1
81673|NCT01225549|190078|P7|STARTED|Period 7 - Fourth Treatment Period||3
81674|NCT01225549|190079|P6|STARTED|Period 7 - Fourth Treatment Period||1
81675|NCT01225549|190080|P5|STARTED|Period 7 - Fourth Treatment Period||1
81676|NCT01225549|190081|P4|STARTED|Period 7 - Fourth Treatment Period||0
81677|NCT01225549|190082|P3|STARTED|Period 7 - Fourth Treatment Period||3
81678|NCT01225549|190083|P2|STARTED|Period 7 - Fourth Treatment Period||3
81679|NCT01225549|190084|P1|STARTED|Period 7 - Fourth Treatment Period||1
81680|NCT01225549|190075|P10|NOT COMPLETED|Period 6 - Washout||0
81681|NCT01225549|190076|P9|NOT COMPLETED|Period 6 - Washout||0
81682|NCT01225549|190077|P8|NOT COMPLETED|Period 6 - Washout||0
81683|NCT01225549|190078|P7|NOT COMPLETED|Period 6 - Washout||0
81684|NCT01225549|190079|P6|NOT COMPLETED|Period 6 - Washout||0
81685|NCT01225549|190080|P5|NOT COMPLETED|Period 6 - Washout||0
81686|NCT01225549|190081|P4|NOT COMPLETED|Period 6 - Washout||1
81687|NCT01225549|190082|P3|NOT COMPLETED|Period 6 - Washout||0
81688|NCT01225549|190083|P2|NOT COMPLETED|Period 6 - Washout||0
81689|NCT01225549|190084|P1|NOT COMPLETED|Period 6 - Washout||0
81690|NCT01225549|190075|P10|COMPLETED|Period 6 - Washout||1
81691|NCT01225549|190076|P9|COMPLETED|Period 6 - Washout||4
81692|NCT01225549|190077|P8|COMPLETED|Period 6 - Washout||1
81693|NCT01225549|190078|P7|COMPLETED|Period 6 - Washout||3
81694|NCT01225549|190079|P6|COMPLETED|Period 6 - Washout||1
81695|NCT01225549|190080|P5|COMPLETED|Period 6 - Washout||1
81696|NCT01225549|190081|P4|COMPLETED|Period 6 - Washout||0
81697|NCT01225549|190082|P3|COMPLETED|Period 6 - Washout||3
81698|NCT01225549|190083|P2|COMPLETED|Period 6 - Washout||3
81699|NCT01225549|190084|P1|COMPLETED|Period 6 - Washout||1
81700|NCT01225549|190075|P10|STARTED|Period 6 - Washout||1
81701|NCT01225549|190076|P9|STARTED|Period 6 - Washout||4
81702|NCT01225549|190077|P8|STARTED|Period 6 - Washout||1
81703|NCT01225549|190078|P7|STARTED|Period 6 - Washout||3
81704|NCT01225549|190079|P6|STARTED|Period 6 - Washout||1
81705|NCT01225549|190080|P5|STARTED|Period 6 - Washout||1
81706|NCT01225549|190081|P4|STARTED|Period 6 - Washout||1
81707|NCT01225549|190082|P3|STARTED|Period 6 - Washout||3
81708|NCT01225549|190083|P2|STARTED|Period 6 - Washout||3
81709|NCT01225549|190084|P1|STARTED|Period 6 - Washout||1
81710|NCT01225549|190075|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
81711|NCT01225549|190076|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
81712|NCT01225549|190077|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
81713|NCT01225549|190078|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
81714|NCT01225549|190079|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
81715|NCT01225549|190080|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
81716|NCT01225549|190081|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
81717|NCT01225549|190082|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
81718|NCT01225549|190083|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
81719|NCT01225549|190084|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
81720|NCT01225549|190075|P10|COMPLETED|Period 5 - Third Treatment Period||1
81721|NCT01225549|190076|P9|COMPLETED|Period 5 - Third Treatment Period||4
81722|NCT01225549|190077|P8|COMPLETED|Period 5 - Third Treatment Period||1
81723|NCT01225549|190078|P7|COMPLETED|Period 5 - Third Treatment Period||3
81724|NCT01225549|190079|P6|COMPLETED|Period 5 - Third Treatment Period||1
81725|NCT01225549|190080|P5|COMPLETED|Period 5 - Third Treatment Period||1
81726|NCT01225549|190081|P4|COMPLETED|Period 5 - Third Treatment Period||1
81727|NCT01225549|190082|P3|COMPLETED|Period 5 - Third Treatment Period||3
81728|NCT01225549|190083|P2|COMPLETED|Period 5 - Third Treatment Period||3
81729|NCT01225549|190084|P1|COMPLETED|Period 5 - Third Treatment Period||1
81730|NCT01225549|190075|P10|STARTED|Period 5 - Third Treatment Period||1
81731|NCT01225549|190076|P9|STARTED|Period 5 - Third Treatment Period||4
81732|NCT01225549|190077|P8|STARTED|Period 5 - Third Treatment Period||1
81733|NCT01225549|190078|P7|STARTED|Period 5 - Third Treatment Period||3
81734|NCT01225549|190079|P6|STARTED|Period 5 - Third Treatment Period||1
81735|NCT01225549|190080|P5|STARTED|Period 5 - Third Treatment Period||1
81736|NCT01225549|190081|P4|STARTED|Period 5 - Third Treatment Period||1
81737|NCT01225549|190082|P3|STARTED|Period 5 - Third Treatment Period||3
81738|NCT01225549|190083|P2|STARTED|Period 5 - Third Treatment Period||3
81739|NCT01225549|190084|P1|STARTED|Period 5 - Third Treatment Period||1
81740|NCT01225549|190075|P10|NOT COMPLETED|Period 4 - Washout||0
81741|NCT01225549|190076|P9|NOT COMPLETED|Period 4 - Washout||0
81742|NCT01225549|190077|P8|NOT COMPLETED|Period 4 - Washout||0
81743|NCT01225549|190078|P7|NOT COMPLETED|Period 4 - Washout||0
81744|NCT01225549|190079|P6|NOT COMPLETED|Period 4 - Washout||0
81745|NCT01225549|190080|P5|NOT COMPLETED|Period 4 - Washout||0
81746|NCT01225549|190081|P4|NOT COMPLETED|Period 4 - Washout||0
81747|NCT01225549|190082|P3|NOT COMPLETED|Period 4 - Washout||0
81748|NCT01225549|190083|P2|NOT COMPLETED|Period 4 - Washout||1
81749|NCT01225549|190084|P1|NOT COMPLETED|Period 4 - Washout||0
81750|NCT01225549|190075|P10|COMPLETED|Period 4 - Washout||1
81751|NCT01225549|190076|P9|COMPLETED|Period 4 - Washout||4
81752|NCT01225549|190077|P8|COMPLETED|Period 4 - Washout||1
81753|NCT01225549|190078|P7|COMPLETED|Period 4 - Washout||3
81754|NCT01225549|190079|P6|COMPLETED|Period 4 - Washout||1
81755|NCT01225549|190080|P5|COMPLETED|Period 4 - Washout||1
81756|NCT01225549|190081|P4|COMPLETED|Period 4 - Washout||1
81757|NCT01225549|190082|P3|COMPLETED|Period 4 - Washout||3
81758|NCT01225549|190083|P2|COMPLETED|Period 4 - Washout||3
81759|NCT01225549|190084|P1|COMPLETED|Period 4 - Washout||1
81760|NCT01225549|190075|P10|STARTED|Period 4 - Washout||1
81761|NCT01225549|190076|P9|STARTED|Period 4 - Washout||4
81762|NCT01225549|190077|P8|STARTED|Period 4 - Washout||1
81763|NCT01225549|190078|P7|STARTED|Period 4 - Washout||3
81764|NCT01225549|190079|P6|STARTED|Period 4 - Washout||1
81765|NCT01225549|190080|P5|STARTED|Period 4 - Washout||1
81766|NCT01225549|190081|P4|STARTED|Period 4 - Washout||1
81767|NCT01225549|190082|P3|STARTED|Period 4 - Washout||3
81768|NCT01225549|190083|P2|STARTED|Period 4 - Washout||4
81769|NCT01225549|190084|P1|STARTED|Period 4 - Washout||1
81770|NCT01225549|190075|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
81771|NCT01225549|190076|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
81772|NCT01225549|190077|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
81773|NCT01225549|190078|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
81774|NCT01225549|190079|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
81775|NCT01225549|190080|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
81776|NCT01225549|190081|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
81777|NCT01225549|190082|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
81778|NCT01225549|190083|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
81779|NCT01225549|190084|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
81780|NCT01225549|190075|P10|COMPLETED|Period 3 - Second Treatment Period||1
81781|NCT01225549|190076|P9|COMPLETED|Period 3 - Second Treatment Period||4
81782|NCT01225549|190077|P8|COMPLETED|Period 3 - Second Treatment Period||1
81783|NCT01225549|190078|P7|COMPLETED|Period 3 - Second Treatment Period||3
81784|NCT01225549|190079|P6|COMPLETED|Period 3 - Second Treatment Period||1
81785|NCT01225549|190080|P5|COMPLETED|Period 3 - Second Treatment Period||1
81786|NCT01225549|190081|P4|COMPLETED|Period 3 - Second Treatment Period||1
81787|NCT01225549|190082|P3|COMPLETED|Period 3 - Second Treatment Period||3
81788|NCT01225549|190083|P2|COMPLETED|Period 3 - Second Treatment Period||4
81789|NCT01225549|190084|P1|COMPLETED|Period 3 - Second Treatment Period||1
81790|NCT01225549|190075|P10|STARTED|Period 3 - Second Treatment Period||1
81791|NCT01225549|190076|P9|STARTED|Period 3 - Second Treatment Period||4
81792|NCT01225549|190077|P8|STARTED|Period 3 - Second Treatment Period||1
81793|NCT01225549|190078|P7|STARTED|Period 3 - Second Treatment Period||3
81794|NCT01225549|190079|P6|STARTED|Period 3 - Second Treatment Period||1
81795|NCT01225549|190080|P5|STARTED|Period 3 - Second Treatment Period||1
81796|NCT01225549|190081|P4|STARTED|Period 3 - Second Treatment Period||1
81797|NCT01225549|190082|P3|STARTED|Period 3 - Second Treatment Period||3
81798|NCT01225549|190083|P2|STARTED|Period 3 - Second Treatment Period||4
81799|NCT01225549|190084|P1|STARTED|Period 3 - Second Treatment Period||1
81800|NCT01225549|190075|P10|NOT COMPLETED|Period 2 - Washout||0
81801|NCT01225549|190076|P9|NOT COMPLETED|Period 2 - Washout||0
81802|NCT01225549|190077|P8|NOT COMPLETED|Period 2 - Washout||0
81803|NCT01225549|190078|P7|NOT COMPLETED|Period 2 - Washout||0
81804|NCT01225549|190079|P6|NOT COMPLETED|Period 2 - Washout||0
81805|NCT01225549|190080|P5|NOT COMPLETED|Period 2 - Washout||0
81806|NCT01225549|190081|P4|NOT COMPLETED|Period 2 - Washout||0
81807|NCT01225549|190082|P3|NOT COMPLETED|Period 2 - Washout||0
81808|NCT01225549|190083|P2|NOT COMPLETED|Period 2 - Washout||0
81809|NCT01225549|190084|P1|NOT COMPLETED|Period 2 - Washout||0
81810|NCT01225549|190075|P10|COMPLETED|Period 2 - Washout||1
81811|NCT01225549|190076|P9|COMPLETED|Period 2 - Washout||4
81812|NCT01225549|190077|P8|COMPLETED|Period 2 - Washout||1
81813|NCT01225549|190078|P7|COMPLETED|Period 2 - Washout||3
81814|NCT01225549|190079|P6|COMPLETED|Period 2 - Washout||1
81815|NCT01225549|190080|P5|COMPLETED|Period 2 - Washout||1
81816|NCT01225549|190081|P4|COMPLETED|Period 2 - Washout||1
81817|NCT01225549|190082|P3|COMPLETED|Period 2 - Washout||3
81818|NCT01225549|190083|P2|COMPLETED|Period 2 - Washout||4
81819|NCT01225549|190084|P1|COMPLETED|Period 2 - Washout||1
81820|NCT01225549|190075|P10|STARTED|Period 2 - Washout||1
81821|NCT01225549|190076|P9|STARTED|Period 2 - Washout||4
81822|NCT01225549|190077|P8|STARTED|Period 2 - Washout||1
81823|NCT01225549|190078|P7|STARTED|Period 2 - Washout||3
81824|NCT01225549|190079|P6|STARTED|Period 2 - Washout||1
81825|NCT01225549|190080|P5|STARTED|Period 2 - Washout||1
81826|NCT01225549|190081|P4|STARTED|Period 2 - Washout||1
81827|NCT01225549|190082|P3|STARTED|Period 2 - Washout||3
81828|NCT01225549|190083|P2|STARTED|Period 2 - Washout||4
81829|NCT01225549|190084|P1|STARTED|Period 2 - Washout||1
81830|NCT01225549|190075|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
81831|NCT01225549|190076|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
81832|NCT01225549|190077|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
81833|NCT01225549|190078|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
81834|NCT01225549|190079|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
81835|NCT01225549|190080|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
81836|NCT01225549|190081|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
81837|NCT01225549|190082|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
81838|NCT01225549|190083|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
81839|NCT01225549|190084|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
81840|NCT01225549|190075|P10|COMPLETED|Period 1 - First Treatment Period||1
81841|NCT01225549|190076|P9|COMPLETED|Period 1 - First Treatment Period||4
81842|NCT01225549|190077|P8|COMPLETED|Period 1 - First Treatment Period||1
81843|NCT01225549|190078|P7|COMPLETED|Period 1 - First Treatment Period||3
81844|NCT01225549|190079|P6|COMPLETED|Period 1 - First Treatment Period||1
81845|NCT01225549|190080|P5|COMPLETED|Period 1 - First Treatment Period||1
81846|NCT01225549|190081|P4|COMPLETED|Period 1 - First Treatment Period||1
81847|NCT01225549|190082|P3|COMPLETED|Period 1 - First Treatment Period||3
81848|NCT01225549|190083|P2|COMPLETED|Period 1 - First Treatment Period||4
81849|NCT01225549|190084|P1|COMPLETED|Period 1 - First Treatment Period||1
81850|NCT01225549|190075|P10|STARTED|Period 1 - First Treatment Period||1
81851|NCT01225549|190076|P9|STARTED|Period 1 - First Treatment Period||4
81852|NCT01225549|190077|P8|STARTED|Period 1 - First Treatment Period||1
81853|NCT01225549|190078|P7|STARTED|Period 1 - First Treatment Period||3
81854|NCT01225549|190079|P6|STARTED|Period 1 - First Treatment Period||1
81855|NCT01225549|190080|P5|STARTED|Period 1 - First Treatment Period||1
81856|NCT01225549|190081|P4|STARTED|Period 1 - First Treatment Period||1
81857|NCT01225549|190082|P3|STARTED|Period 1 - First Treatment Period||3
81858|NCT01225549|190083|P2|STARTED|Period 1 - First Treatment Period||4
81859|NCT01225549|190084|P1|STARTED|Period 1 - First Treatment Period||1
81860|NCT01225354|190126|P1|NOT COMPLETED|Overall Study||1
81861|NCT01225354|190126|P1|COMPLETED|Overall Study||19
81862|NCT01225354|190126|P1|STARTED|Overall Study||20
81863|NCT01225289|190133|P2|NOT COMPLETED|Overall Study||1
81864|NCT01225289|190134|P1|NOT COMPLETED|Overall Study||0
81865|NCT01225289|190133|P2|COMPLETED|Overall Study||17
81866|NCT01225289|190134|P1|COMPLETED|Overall Study||18
81867|NCT01225289|190133|P2|STARTED|Overall Study||18
81868|NCT01225289|190134|P1|STARTED|Overall Study||18
81869|NCT01225263|190148|P2|NOT COMPLETED|Weeks 13 to 24||1
81870|NCT01225263|190149|P1|NOT COMPLETED|Weeks 13 to 24||4
81871|NCT01225263|190148|P2|COMPLETED|Weeks 13 to 24||28
81872|NCT01225263|190149|P1|COMPLETED|Weeks 13 to 24||24
81873|NCT01225263|190148|P2|STARTED|Weeks 13 to 24||29
81874|NCT01225263|190149|P1|STARTED|Weeks 13 to 24||28
81875|NCT01225263|190148|P2|NOT COMPLETED|Weeks 1 to 12||0
81876|NCT01225263|190149|P1|NOT COMPLETED|Weeks 1 to 12||0
81877|NCT01225263|190148|P2|COMPLETED|Weeks 1 to 12||29
81878|NCT01225263|190149|P1|COMPLETED|Weeks 1 to 12||28
81879|NCT01225263|190148|P2|STARTED|Weeks 1 to 12||29
81880|NCT01225263|190149|P1|STARTED|Weeks 1 to 12||28
81881|NCT01225211|190167|P10|NOT COMPLETED|Overall Study||5
81882|NCT01225211|190168|P9|NOT COMPLETED|Overall Study||1
81883|NCT01225211|190169|P8|NOT COMPLETED|Overall Study||0
81884|NCT01225211|190170|P7|NOT COMPLETED|Overall Study||1
81885|NCT01225211|190171|P6|NOT COMPLETED|Overall Study||0
81886|NCT01225211|190172|P5|NOT COMPLETED|Overall Study||0
81887|NCT01225211|190173|P4|NOT COMPLETED|Overall Study||0
81888|NCT01225211|190174|P3|NOT COMPLETED|Overall Study||1
81889|NCT01225211|190175|P2|NOT COMPLETED|Overall Study||0
81890|NCT01225211|190176|P1|NOT COMPLETED|Overall Study||0
81891|NCT01225211|190167|P10|COMPLETED|Overall Study||57
81892|NCT01225211|190168|P9|COMPLETED|Overall Study||62
81893|NCT01225211|190169|P8|COMPLETED|Overall Study||11
81894|NCT01225211|190170|P7|COMPLETED|Overall Study||41
81895|NCT01225211|190171|P6|COMPLETED|Overall Study||21
81896|NCT01225211|190172|P5|COMPLETED|Overall Study||23
81897|NCT01225211|190173|P4|COMPLETED|Overall Study||27
81898|NCT01225211|190174|P3|COMPLETED|Overall Study||20
81899|NCT01225211|190175|P2|COMPLETED|Overall Study||20
81900|NCT01225211|190176|P1|COMPLETED|Overall Study||21
81901|NCT01225211|190167|P10|STARTED|Overall Study||62
81902|NCT01225211|190168|P9|STARTED|Overall Study||63
81903|NCT01225211|190169|P8|STARTED|Overall Study||11
81904|NCT01225211|190170|P7|STARTED|Overall Study||42
81905|NCT01225211|190171|P6|STARTED|Overall Study||21
81906|NCT01225211|190172|P5|STARTED|Overall Study||23
81907|NCT01225211|190173|P4|STARTED|Overall Study||27
81908|NCT01225211|190174|P3|STARTED|Overall Study||21
81909|NCT01225211|190175|P2|STARTED|Overall Study||20
81910|NCT01225211|190176|P1|STARTED|Overall Study||21
81911|NCT01225159|190279|P2|NOT COMPLETED|Overall Study||0
81912|NCT01225159|190280|P1|NOT COMPLETED|Overall Study||1
81913|NCT01225159|190279|P2|COMPLETED|Overall Study||100
81914|NCT01225159|190280|P1|COMPLETED|Overall Study||99
81915|NCT01225159|190279|P2|STARTED|Overall Study||100
81916|NCT01225159|190280|P1|STARTED|Overall Study||100
81917|NCT01225068|190290|P2|NOT COMPLETED|Overall Study||1
81918|NCT01225068|190291|P1|NOT COMPLETED|Overall Study||4
81919|NCT01225068|190290|P2|COMPLETED|Overall Study||19
81920|NCT01225068|190291|P1|COMPLETED|Overall Study||16
81921|NCT01225068|190290|P2|STARTED|Overall Study||20
81922|NCT01225068|190291|P1|STARTED|Overall Study||20
81923|NCT01225029|190299|P2|NOT COMPLETED|Overall Study||0
81924|NCT01225029|190300|P1|NOT COMPLETED|Overall Study||0
81925|NCT01225029|190299|P2|COMPLETED|Overall Study||32
81926|NCT01225029|190300|P1|COMPLETED|Overall Study||32
81927|NCT01225029|190299|P2|STARTED|Overall Study||32
81928|NCT01225029|190300|P1|STARTED|Overall Study||32
81929|NCT01224821|190310|P1|NOT COMPLETED|Long-Term Follow-Up||11
81930|NCT01224821|190310|P1|COMPLETED|Long-Term Follow-Up||0
81931|NCT01224821|190310|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
81932|NCT01224821|190310|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
81933|NCT01224821|190310|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
81934|NCT01224821|190310|P1|STARTED|Dosimetric and Therapeutic Treatment||47
81935|NCT01224782|190329|P1|NOT COMPLETED|Overall Study||264
81936|NCT01224782|190329|P1|COMPLETED|Overall Study||730
81937|NCT01224782|190329|P1|STARTED|Overall Study||994
81938|NCT01224626|190338|P1|NOT COMPLETED|Overall Study||1
81939|NCT01224626|190338|P1|COMPLETED|Overall Study||41
81940|NCT01224626|190338|P1|STARTED|Overall Study||42
81941|NCT01224444|190344|P1|NOT COMPLETED|Overall Study||0
81942|NCT01224444|190344|P1|COMPLETED|Overall Study||269
81943|NCT01224444|190344|P1|STARTED|Overall Study||269
81944|NCT01224431|190350|P2|NOT COMPLETED|Overall Study||5
81945|NCT01224431|190351|P1|NOT COMPLETED|Overall Study||0
81946|NCT01224431|190350|P2|COMPLETED|Overall Study||25
81947|NCT01224431|190351|P1|COMPLETED|Overall Study||30
81948|NCT01224431|190350|P2|STARTED|Overall Study||30
81949|NCT01224431|190351|P1|STARTED|Overall Study||30
81950|NCT01224236|190359|P2|NOT COMPLETED|Overall Study||1
81951|NCT01224236|190360|P1|NOT COMPLETED|Overall Study||1
81952|NCT01224236|190359|P2|COMPLETED|Overall Study||73
81953|NCT01224236|190360|P1|COMPLETED|Overall Study||75
81954|NCT01224236|190359|P2|STARTED|Overall Study||74
81955|NCT01224236|190360|P1|STARTED|Overall Study||76
81956|NCT01224171|190370|P2|NOT COMPLETED|Overall Study||13
81957|NCT01224171|190371|P1|NOT COMPLETED|Overall Study||15
81958|NCT01224171|190370|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
81959|NCT01224171|190371|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
82045|NCT01222520|190679|P1|COMPLETED|Double-blind Period||86
82046|NCT01222520|190678|P2|STARTED|Double-blind Period||87
81960|NCT01224171|190370|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
81961|NCT01224171|190371|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
81962|NCT01224171|190370|P2|STARTED|Overall Study||209
81963|NCT01224171|190371|P1|STARTED|Overall Study||207
81964|NCT01224015|190394|P3|NOT COMPLETED|Overall Study||13
81965|NCT01224015|190395|P2|NOT COMPLETED|Overall Study||16
81966|NCT01224015|190396|P1|NOT COMPLETED|Overall Study||14
81967|NCT01224015|190394|P3|COMPLETED|Overall Study||83
81968|NCT01224015|190395|P2|COMPLETED|Overall Study||211
81969|NCT01224015|190396|P1|COMPLETED|Overall Study||347
81970|NCT01224015|190394|P3|STARTED|Overall Study||96
81971|NCT01224015|190395|P2|STARTED|Overall Study||227
81972|NCT01224015|190396|P1|STARTED|Overall Study||361
81973|NCT01223937|190406|P2|NOT COMPLETED|Overall Study||18
81974|NCT01223937|190407|P1|NOT COMPLETED|Overall Study||17
81975|NCT01223937|190406|P2|COMPLETED|Overall Study||119
81976|NCT01223937|190407|P1|COMPLETED|Overall Study||114
81977|NCT01223937|190406|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
81978|NCT01223937|190407|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
81979|NCT01223937|190406|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
81980|NCT01223937|190407|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
81981|NCT01223937|190406|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
81982|NCT01223937|190407|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
81983|NCT01223703|190431|P2|NOT COMPLETED|Overall Study||0
81984|NCT01223703|190432|P1|NOT COMPLETED|Overall Study||0
81985|NCT01223703|190431|P2|COMPLETED|Overall Study||66
81986|NCT01223703|190432|P1|COMPLETED|Overall Study||67
81987|NCT01223703|190431|P2|STARTED|Overall Study||66
81988|NCT01223703|190432|P1|STARTED|Overall Study||67
81989|NCT01223469|190446|P2|NOT COMPLETED|Overall Study||0
81990|NCT01223469|190447|P1|NOT COMPLETED|Overall Study||0
81991|NCT01223469|190446|P2|COMPLETED|Overall Study||43
81992|NCT01223469|190447|P1|COMPLETED|Overall Study||34
81993|NCT01223469|190446|P2|STARTED|Overall Study||43
81994|NCT01223469|190447|P1|STARTED|Overall Study||34
81995|NCT01223196|190455|P2|NOT COMPLETED|Overall Study||0
81996|NCT01223196|190456|P1|NOT COMPLETED|Overall Study||4
81997|NCT01223196|190455|P2|COMPLETED|Overall Study||11
81998|NCT01223196|190456|P1|COMPLETED|Overall Study||9
81999|NCT01223196|190455|P2|STARTED|Overall Study||11
82000|NCT01223196|190456|P1|STARTED|Overall Study||13
82001|NCT01223027|190468|P2|NOT COMPLETED|Overall Study||277
82002|NCT01223027|190469|P1|NOT COMPLETED|Overall Study||274
82003|NCT01223027|190468|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
82004|NCT01223027|190469|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
82005|NCT01223027|190468|P2|STARTED|Overall Study||286
82006|NCT01223027|190469|P1|STARTED|Overall Study||284
82007|NCT01223001|190492|P2|NOT COMPLETED|Overall Study||4
82008|NCT01223001|190493|P1|NOT COMPLETED|Overall Study||4
82009|NCT01223001|190492|P2|COMPLETED|Overall Study||0
82010|NCT01223001|190493|P1|COMPLETED|Overall Study||0
82011|NCT01223001|190492|P2|STARTED|Overall Study||4
82012|NCT01223001|190493|P1|STARTED|Overall Study||4
82013|NCT01222884|190501|P2|NOT COMPLETED|Overall Study||4
82014|NCT01222884|190502|P1|NOT COMPLETED|Overall Study||24
82015|NCT01222884|190501|P2|COMPLETED|Overall Study||113
82016|NCT01222884|190502|P1|COMPLETED|Overall Study||210
82017|NCT01222884|190501|P2|STARTED|Overall Study||117
82018|NCT01222884|190502|P1|STARTED|Overall Study||234
82019|NCT01222689|190510|P1|NOT COMPLETED|Overall Study||0
82020|NCT01222689|190510|P1|COMPLETED|Overall Study||46
82021|NCT01222689|190510|P1|STARTED|Overall Study||46
82022|NCT01222585|190523|P1|NOT COMPLETED|Overall Study||0
82023|NCT01222585|190523|P1|COMPLETED|Overall Study||24
82024|NCT01222585|190523|P1|STARTED|Overall Study||24
82025|NCT01222572|190533|P3|NOT COMPLETED|Overall Study||0
82026|NCT01222572|190534|P2|NOT COMPLETED|Overall Study||0
82027|NCT01222572|190535|P1|NOT COMPLETED|Overall Study||0
82028|NCT01222572|190533|P3|COMPLETED|Overall Study||0
82029|NCT01222572|190534|P2|COMPLETED|Overall Study||0
82030|NCT01222572|190535|P1|COMPLETED|Overall Study||1
82031|NCT01222572|190533|P3|STARTED|Overall Study||0
82032|NCT01222572|190534|P2|STARTED|Overall Study||0
82033|NCT01222572|190535|P1|STARTED|Overall Study||1
82034|NCT01222533|190539|P1|NOT COMPLETED|Overall Study||14
82035|NCT01222533|190539|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
82036|NCT01222533|190539|P1|Received Tio HH18|Overall Study||146
82037|NCT01222533|190539|P1|Received Tio R5|Overall Study||150
82038|NCT01222533|190539|P1|Received Tio R2.5|Overall Study||145
82039|NCT01222533|190539|P1|Received Tio R1.25|Overall Study||147
82040|NCT01222533|190539|P1|Received Placebo|Overall Study||147
82041|NCT01222533|190539|P1|STARTED|Overall Study|Entered and treated.|154
82042|NCT01222520|190678|P2|NOT COMPLETED|Double-blind Period||2
82043|NCT01222520|190679|P1|NOT COMPLETED|Double-blind Period||1
82044|NCT01222520|190678|P2|COMPLETED|Double-blind Period||85
82047|NCT01222520|190679|P1|STARTED|Double-blind Period||87
82048|NCT01222520|190678|P2|NOT COMPLETED|Open-label run-in Period||23
82049|NCT01222520|190679|P1|NOT COMPLETED|Open-label run-in Period||0
82050|NCT01222520|190678|P2|COMPLETED|Open-label run-in Period||174
82051|NCT01222520|190679|P1|COMPLETED|Open-label run-in Period||0
82052|NCT01222520|190678|P2|STARTED|Open-label run-in Period||197
82053|NCT01222520|190679|P1|STARTED|Open-label run-in Period||0
82054|NCT01222507|190697|P1|NOT COMPLETED|Overall Study||2
82055|NCT01222507|190697|P1|COMPLETED|Overall Study||60
82056|NCT01222507|190697|P1|STARTED|Overall Study||62
82057|NCT01222403|190703|P2|NOT COMPLETED|Overall Study||2
82058|NCT01222403|190704|P1|NOT COMPLETED|Overall Study||0
82059|NCT01222403|190703|P2|COMPLETED|Overall Study||379
82060|NCT01222403|190704|P1|COMPLETED|Overall Study||386
82061|NCT01222403|190703|P2|STARTED|Overall Study||381
82062|NCT01222403|190704|P1|STARTED|Overall Study||386
82063|NCT01222390|190714|P1|NOT COMPLETED|Overall Study||0
82064|NCT01222390|190714|P1|COMPLETED|Overall Study||12
82065|NCT01222390|190714|P1|STARTED|Overall Study||12
82066|NCT01222286|190720|P2|NOT COMPLETED|Overall Study||0
82067|NCT01222286|190721|P1|NOT COMPLETED|Overall Study||0
82068|NCT01222286|190720|P2|COMPLETED|Overall Study||14
82069|NCT01222286|190721|P1|COMPLETED|Overall Study||16
82070|NCT01222286|190720|P2|STARTED|Overall Study||14
82071|NCT01222286|190721|P1|STARTED|Overall Study||16
82072|NCT01222234|190736|P3|NOT COMPLETED|Overall Study||2
82073|NCT01222234|190737|P2|NOT COMPLETED|Overall Study||2
82074|NCT01222234|190738|P1|NOT COMPLETED|Overall Study||0
82075|NCT01222234|190736|P3|COMPLETED|Overall Study||22
82076|NCT01222234|190737|P2|COMPLETED|Overall Study||15
82077|NCT01222234|190738|P1|COMPLETED|Overall Study||15
82078|NCT01222234|190736|P3|STARTED|Overall Study||24
82079|NCT01222234|190737|P2|STARTED|Overall Study||17
82080|NCT01222234|190738|P1|STARTED|Overall Study||15
82081|NCT01222195|190747|P1|NOT COMPLETED|Overall Study||0
82082|NCT01222195|190747|P1|COMPLETED|Overall Study||1
82083|NCT01222195|190747|P1|STARTED|Overall Study||1
82084|NCT01222117|190762|P11|NOT COMPLETED|Overall Study||0
82085|NCT01222117|190763|P10|NOT COMPLETED|Overall Study||2
82086|NCT01222117|190764|P9|NOT COMPLETED|Overall Study||3
82087|NCT01222117|190765|P8|NOT COMPLETED|Overall Study||0
82088|NCT01222117|190766|P7|NOT COMPLETED|Overall Study||0
82089|NCT01222117|190767|P6|NOT COMPLETED|Overall Study||1
82090|NCT01222117|190768|P5|NOT COMPLETED|Overall Study||1
82091|NCT01222117|190769|P4|NOT COMPLETED|Overall Study||1
82092|NCT01222117|190770|P3|NOT COMPLETED|Overall Study||0
82093|NCT01222117|190771|P2|NOT COMPLETED|Overall Study||1
82094|NCT01222117|190772|P1|NOT COMPLETED|Overall Study||3
82095|NCT01222117|190762|P11|COMPLETED|Overall Study||6
82096|NCT01222117|190763|P10|COMPLETED|Overall Study||17
82097|NCT01222117|190764|P9|COMPLETED|Overall Study||20
82098|NCT01222117|190765|P8|COMPLETED|Overall Study||12
82099|NCT01222117|190766|P7|COMPLETED|Overall Study||13
82100|NCT01222117|190767|P6|COMPLETED|Overall Study||9
82101|NCT01222117|190768|P5|COMPLETED|Overall Study||8
82102|NCT01222117|190769|P4|COMPLETED|Overall Study||19
82103|NCT01222117|190770|P3|COMPLETED|Overall Study||22
82104|NCT01222117|190771|P2|COMPLETED|Overall Study||19
82105|NCT01222117|190772|P1|COMPLETED|Overall Study||17
82106|NCT01222117|190762|P11|STARTED|Overall Study||6
82107|NCT01222117|190763|P10|STARTED|Overall Study||19
82108|NCT01222117|190764|P9|STARTED|Overall Study||23
82109|NCT01222117|190765|P8|STARTED|Overall Study||12
82110|NCT01222117|190766|P7|STARTED|Overall Study||13
82111|NCT01222117|190767|P6|STARTED|Overall Study||10
82112|NCT01222117|190768|P5|STARTED|Overall Study||9
82113|NCT01222117|190769|P4|STARTED|Overall Study||20
82114|NCT01222117|190770|P3|STARTED|Overall Study||22
82115|NCT01222117|190771|P2|STARTED|Overall Study||20
82116|NCT01222117|190772|P1|STARTED|Overall Study||20
82117|NCT01222104|190807|P1|NOT COMPLETED|Overall Study||47
82118|NCT01222104|190807|P1|COMPLETED|Overall Study||587
82119|NCT01222104|190807|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
82120|NCT01222104|190807|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
82121|NCT01222104|190807|P1|Successful Deployment and Hemostasis|Overall Study||524
82122|NCT01222104|190807|P1|Successful Deployment|Overall Study||529
82123|NCT01222104|190807|P1|Angio-Seal Deployment Attempted|Overall Study||534
82124|NCT01222104|190807|P1|STARTED|Overall Study||634
82125|NCT01221948|190821|P1|NOT COMPLETED|Overall Study||14
82126|NCT01221948|190821|P1|COMPLETED|Overall Study||39
82127|NCT01221948|190821|P1|STARTED|Overall Study||53
82128|NCT01221753|190832|P1|NOT COMPLETED|Overall Study||1
82129|NCT01221753|190832|P1|COMPLETED|Overall Study||6
82130|NCT01221753|190832|P1|STARTED|Overall Study||7
82131|NCT01221727|190839|P2|NOT COMPLETED|Overall Study||1
82132|NCT01221727|190840|P1|NOT COMPLETED|Overall Study||3
82133|NCT01221727|190839|P2|COMPLETED|Overall Study||8
82134|NCT01221727|190840|P1|COMPLETED|Overall Study||18
82135|NCT01221727|190839|P2|Treated|Overall Study|Number of subjects received investigational product|8
82136|NCT01221727|190840|P1|Treated|Overall Study|Number of subjects received investigational product|19
82137|NCT01221727|190839|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
82138|NCT01221727|190840|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
82139|NCT01221623|190861|P2|NOT COMPLETED|Overall Study||14
82140|NCT01221623|190862|P1|NOT COMPLETED|Overall Study||38
82141|NCT01221623|190861|P2|COMPLETED|Overall Study||127
82142|NCT01221623|190862|P1|COMPLETED|Overall Study||236
82143|NCT01221623|190861|P2|STARTED|Overall Study||141
82144|NCT01221623|190862|P1|STARTED|Overall Study||274
82145|NCT01221597|190886|P2|NOT COMPLETED|Overall Study||16
82146|NCT01221597|190887|P1|NOT COMPLETED|Overall Study||36
82147|NCT01221597|190886|P2|COMPLETED|Overall Study||124
82148|NCT01221597|190887|P1|COMPLETED|Overall Study||241
82149|NCT01221597|190886|P2|STARTED|Overall Study||140
82150|NCT01221597|190887|P1|STARTED|Overall Study||277
82151|NCT01221441|190911|P2|NOT COMPLETED|Overall Study||12
82152|NCT01221441|190912|P1|NOT COMPLETED|Overall Study||22
82153|NCT01221441|190911|P2|COMPLETED|Overall Study||23
82154|NCT01221441|190912|P1|COMPLETED|Overall Study||45
82155|NCT01221441|190911|P2|STARTED|Overall Study||35
82156|NCT01221441|190912|P1|STARTED|Overall Study||67
82157|NCT01221363|190944|P2|NOT COMPLETED|Overall Study||5
82158|NCT01221363|190945|P1|NOT COMPLETED|Overall Study||12
82159|NCT01221363|190944|P2|COMPLETED|Overall Study||68
82160|NCT01221363|190945|P1|COMPLETED|Overall Study||81
82161|NCT01221363|190944|P2|STARTED|Overall Study||73
82162|NCT01221363|190945|P1|STARTED|Overall Study||93
82163|NCT01221350|190955|P2|NOT COMPLETED|Overall Study||3
82164|NCT01221350|190956|P1|NOT COMPLETED|Overall Study||5
82165|NCT01221350|190955|P2|COMPLETED|Overall Study||24
82166|NCT01221350|190956|P1|COMPLETED|Overall Study||23
82167|NCT01221350|190955|P2|Analysis Population|Overall Study||24
82168|NCT01221350|190956|P1|Analysis Population|Overall Study||23
82169|NCT01221350|190955|P2|Received Intervention|Overall Study||27
82170|NCT01221350|190956|P1|Received Intervention|Overall Study||28
82171|NCT01221350|190955|P2|STARTED|Overall Study||27
82172|NCT01221350|190956|P1|STARTED|Overall Study||28
82173|NCT01221298|190996|P1|NOT COMPLETED|Overall Study||0
82174|NCT01221298|190996|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
82175|NCT01221298|190996|P1|STARTED|Overall Study||11
82176|NCT01221285|191006|P1|NOT COMPLETED|Overall Study||1
82177|NCT01221285|191006|P1|COMPLETED|Overall Study||10
82178|NCT01221285|191006|P1|STARTED|Overall Study||11
82179|NCT01221272|191015|P2|NOT COMPLETED|Period 2||2
82180|NCT01221272|191016|P1|NOT COMPLETED|Period 2||0
82181|NCT01221272|191015|P2|COMPLETED|Period 2||37
82182|NCT01221272|191016|P1|COMPLETED|Period 2||39
82183|NCT01221272|191015|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
82184|NCT01221272|191016|P1|STARTED|Period 2||39
82185|NCT01221272|191015|P2|NOT COMPLETED|Period 1||2
82186|NCT01221272|191016|P1|NOT COMPLETED|Period 1||2
82187|NCT01221272|191015|P2|COMPLETED|Period 1||38
82188|NCT01221272|191016|P1|COMPLETED|Period 1||39
82189|NCT01221272|191015|P2|STARTED|Period 1||40
82190|NCT01221272|191016|P1|STARTED|Period 1||41
82191|NCT01221090|191035|P4|NOT COMPLETED|Overall Study||22
82192|NCT01221090|191036|P3|NOT COMPLETED|Overall Study||42
82193|NCT01221090|191037|P2|NOT COMPLETED|Overall Study||34
82194|NCT01221090|191038|P1|NOT COMPLETED|Overall Study||15
82195|NCT01221090|191035|P4|COMPLETED|Overall Study||73
82196|NCT01221090|191036|P3|COMPLETED|Overall Study||57
82197|NCT01221090|191037|P2|COMPLETED|Overall Study||47
82198|NCT01221090|191038|P1|COMPLETED|Overall Study||86
82199|NCT01221090|191035|P4|STARTED|Overall Study||95
82200|NCT01221090|191036|P3|STARTED|Overall Study||99
82201|NCT01221090|191037|P2|STARTED|Overall Study||81
82202|NCT01221090|191038|P1|STARTED|Overall Study||101
82203|NCT01220869|191064|P1|NOT COMPLETED|Overall Study||6
82204|NCT01220869|191064|P1|COMPLETED|Overall Study||104
82205|NCT01220869|191064|P1|STARTED|Overall Study||110
82206|NCT01220739|191074|P2|NOT COMPLETED|Overall Study||0
82207|NCT01220739|191075|P1|NOT COMPLETED|Overall Study||0
82208|NCT01220739|191074|P2|COMPLETED|Overall Study||5
82209|NCT01220739|191075|P1|COMPLETED|Overall Study||7
82210|NCT01220739|191074|P2|STARTED|Overall Study||5
82211|NCT01220739|191075|P1|STARTED|Overall Study||7
82212|NCT01220609|191083|P1|NOT COMPLETED|Overall Study||3
82213|NCT01220609|191083|P1|COMPLETED|Overall Study|Eligible and treated patients|23
82214|NCT01220609|191083|P1|STARTED|Overall Study||26
82215|NCT01220557|191091|P2|NOT COMPLETED|Overall Study||5
82216|NCT01220557|191092|P1|NOT COMPLETED|Overall Study||6
82217|NCT01220557|191091|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
82218|NCT01220557|191092|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
82219|NCT01220557|191091|P2|STARTED|Overall Study||79
82220|NCT01220557|191092|P1|STARTED|Overall Study||81
82221|NCT01220466|191101|P3|NOT COMPLETED|Overall Study||0
82222|NCT01220466|191102|P2|NOT COMPLETED|Overall Study||0
82223|NCT01220466|191103|P1|NOT COMPLETED|Overall Study||0
82224|NCT01220466|191101|P3|COMPLETED|Overall Study|16 eyes|10
82225|NCT01220466|191102|P2|COMPLETED|Overall Study|108 eyes|56
82226|NCT01220466|191103|P1|COMPLETED|Overall Study|19 eyes|11
82227|NCT01220466|191101|P3|STARTED|Overall Study|16 eyes|10
82228|NCT01220466|191102|P2|STARTED|Overall Study|108 eyes|56
82229|NCT01220466|191103|P1|STARTED|Overall Study|19 eyes|11
82230|NCT01220401|191123|P1|NOT COMPLETED|Overall Study||3
82231|NCT01220401|191123|P1|COMPLETED|Overall Study||18
82232|NCT01220401|191123|P1|STARTED|Overall Study||21
82233|NCT01220180|191133|P1|NOT COMPLETED|Overall Study||207
82234|NCT01220180|191133|P1|COMPLETED|Overall Study||3968
82235|NCT01220180|191133|P1|Treated|Overall Study||4174
82236|NCT01220180|191133|P1|STARTED|Overall Study||4175
82237|NCT01219985|191156|P1|NOT COMPLETED|Overall Study||20
82238|NCT01219985|191156|P1|COMPLETED|Overall Study||30
82239|NCT01219985|191156|P1|STARTED|Overall Study||50
82240|NCT01219933|191162|P1|NOT COMPLETED|Overall Study||38
82241|NCT01219933|191162|P1|COMPLETED|Overall Study||30
82242|NCT01219933|191162|P1|STARTED|Overall Study||68
82243|NCT01219881|191201|P2|NOT COMPLETED|Overall Study||5
82244|NCT01219881|191202|P1|NOT COMPLETED|Overall Study||4
82245|NCT01219881|191201|P2|COMPLETED|Overall Study||32
82246|NCT01219881|191202|P1|COMPLETED|Overall Study||34
82247|NCT01219881|191201|P2|STARTED|Overall Study||37
82248|NCT01219881|191202|P1|STARTED|Overall Study||38
82249|NCT01219855|191219|P5|NOT COMPLETED|Overall Study||1
82250|NCT01219855|191220|P4|NOT COMPLETED|Overall Study||1
82251|NCT01219855|191221|P3|NOT COMPLETED|Overall Study||1
82252|NCT01219855|191222|P2|NOT COMPLETED|Overall Study||5
82253|NCT01219855|191223|P1|NOT COMPLETED|Overall Study||1
82254|NCT01219855|191219|P5|COMPLETED|Overall Study||13
82255|NCT01219855|191220|P4|COMPLETED|Overall Study||12
82256|NCT01219855|191221|P3|COMPLETED|Overall Study||16
82257|NCT01219855|191222|P2|COMPLETED|Overall Study||12
82258|NCT01219855|191223|P1|COMPLETED|Overall Study||16
82259|NCT01219855|191219|P5|STARTED|Overall Study||14
82260|NCT01219855|191220|P4|STARTED|Overall Study||13
82261|NCT01219855|191221|P3|STARTED|Overall Study||17
82262|NCT01219855|191222|P2|STARTED|Overall Study||17
82263|NCT01219855|191223|P1|STARTED|Overall Study||17
82264|NCT01219777|191259|P1|NOT COMPLETED|Overall Study||0
82265|NCT01219777|191259|P1|COMPLETED|Overall Study||9
82266|NCT01219777|191259|P1|STARTED|Overall Study||9
82267|NCT01219738|191264|P1|NOT COMPLETED|Overall Study||0
82268|NCT01219738|191264|P1|COMPLETED|Overall Study||20
82269|NCT01219738|191264|P1|Budesonide 720- 4 Times|Overall Study||20
82270|NCT01219738|191264|P1|Budesonide 1440|Overall Study||20
82271|NCT01219738|191264|P1|Budesonide 720|Overall Study||20
82272|NCT01219738|191264|P1|Budesonide 360|Overall Study||20
82273|NCT01219738|191264|P1|STARTED|Overall Study||20
82274|NCT01219673|191285|P8|NOT COMPLETED|Overall Study||0
82275|NCT01219673|191286|P7|NOT COMPLETED|Overall Study||0
82276|NCT01219673|191287|P6|NOT COMPLETED|Overall Study||0
82277|NCT01219673|191288|P5|NOT COMPLETED|Overall Study||0
82278|NCT01219673|191289|P4|NOT COMPLETED|Overall Study||0
82279|NCT01219673|191290|P3|NOT COMPLETED|Overall Study||0
82280|NCT01219673|191291|P2|NOT COMPLETED|Overall Study||0
82281|NCT01219673|191292|P1|NOT COMPLETED|Overall Study||0
82282|NCT01219673|191285|P8|COMPLETED|Overall Study||0
82283|NCT01219673|191286|P7|COMPLETED|Overall Study||0
82284|NCT01219673|191287|P6|COMPLETED|Overall Study||0
82285|NCT01219673|191288|P5|COMPLETED|Overall Study||0
82286|NCT01219673|191289|P4|COMPLETED|Overall Study||0
82287|NCT01219673|191290|P3|COMPLETED|Overall Study||1
82288|NCT01219673|191291|P2|COMPLETED|Overall Study||0
82289|NCT01219673|191292|P1|COMPLETED|Overall Study||0
82290|NCT01219673|191285|P8|STARTED|Overall Study||0
82291|NCT01219673|191286|P7|STARTED|Overall Study||0
82292|NCT01219673|191287|P6|STARTED|Overall Study||0
82293|NCT01219673|191288|P5|STARTED|Overall Study||0
82294|NCT01219673|191289|P4|STARTED|Overall Study||0
82295|NCT01219673|191290|P3|STARTED|Overall Study||1
82296|NCT01219673|191291|P2|STARTED|Overall Study||0
82297|NCT01219673|191292|P1|STARTED|Overall Study||0
82298|NCT01218997|191312|P2|NOT COMPLETED|Overall Study||41
82299|NCT01218997|191313|P1|NOT COMPLETED|Overall Study||245
82300|NCT01218997|191312|P2|COMPLETED|Overall Study||24
82301|NCT01218997|191313|P1|COMPLETED|Overall Study||126
82302|NCT01218997|191312|P2|STARTED|Overall Study||65
82303|NCT01218997|191313|P1|STARTED|Overall Study||371
82304|NCT01218984|191322|P3|NOT COMPLETED|Overall Study||3
82305|NCT01218984|191323|P2|NOT COMPLETED|Overall Study||2
82306|NCT01218984|191324|P1|NOT COMPLETED|Overall Study||1
82307|NCT01218984|191322|P3|COMPLETED|Overall Study||7
82308|NCT01218984|191323|P2|COMPLETED|Overall Study||6
82309|NCT01218984|191324|P1|COMPLETED|Overall Study||8
82310|NCT01218984|191322|P3|STARTED|Overall Study||10
82311|NCT01218984|191323|P2|STARTED|Overall Study||8
82312|NCT01218984|191324|P1|STARTED|Overall Study||9
82313|NCT01218971|191334|P2|NOT COMPLETED|Overall Study||80
82314|NCT01218971|191335|P1|NOT COMPLETED|Overall Study||104
82315|NCT01218971|191334|P2|COMPLETED|Overall Study||77
82316|NCT01218971|191335|P1|COMPLETED|Overall Study||71
82317|NCT01218971|191334|P2|STARTED|Overall Study||157
82318|NCT01218971|191335|P1|STARTED|Overall Study||175
82319|NCT01218958|191348|P3|NOT COMPLETED|Overall Study||81
82320|NCT01218958|191349|P2|NOT COMPLETED|Overall Study||81
82321|NCT01218958|191350|P1|NOT COMPLETED|Overall Study||84
82322|NCT01218958|191348|P3|COMPLETED|Overall Study||128
82323|NCT01218958|191349|P2|COMPLETED|Overall Study||124
82324|NCT01218958|191350|P1|COMPLETED|Overall Study||126
82325|NCT01218958|191348|P3|STARTED|Overall Study||209
82326|NCT01218958|191349|P2|STARTED|Overall Study||205
82327|NCT01218958|191350|P1|STARTED|Overall Study||210
82328|NCT01218867|191372|P11|NOT COMPLETED|Overall Study||0
82329|NCT01218867|191373|P10|NOT COMPLETED|Overall Study||0
82330|NCT01218867|191374|P9|NOT COMPLETED|Overall Study||0
82331|NCT01218867|191375|P8|NOT COMPLETED|Overall Study||0
82332|NCT01218867|191376|P7|NOT COMPLETED|Overall Study||1
82333|NCT01218867|191377|P6|NOT COMPLETED|Overall Study||0
82334|NCT01218867|191378|P5|NOT COMPLETED|Overall Study||0
82335|NCT01218867|191379|P4|NOT COMPLETED|Overall Study||0
82336|NCT01218867|191380|P3|NOT COMPLETED|Overall Study||0
82337|NCT01218867|191381|P2|NOT COMPLETED|Overall Study||0
82338|NCT01218867|191382|P1|NOT COMPLETED|Overall Study||0
82339|NCT01218867|191372|P11|COMPLETED|Overall Study||2
82340|NCT01218867|191373|P10|COMPLETED|Overall Study||4
82341|NCT01218867|191374|P9|COMPLETED|Overall Study||3
82342|NCT01218867|191375|P8|COMPLETED|Overall Study||3
82343|NCT01218867|191376|P7|COMPLETED|Overall Study||3
82344|NCT01218867|191377|P6|COMPLETED|Overall Study||1
82345|NCT01218867|191378|P5|COMPLETED|Overall Study||1
82346|NCT01218867|191379|P4|COMPLETED|Overall Study||1
82347|NCT01218867|191380|P3|COMPLETED|Overall Study||3
82348|NCT01218867|191381|P2|COMPLETED|Overall Study||1
82349|NCT01218867|191382|P1|COMPLETED|Overall Study||1
82350|NCT01218867|191372|P11|STARTED|Overall Study||2
82351|NCT01218867|191373|P10|STARTED|Overall Study||4
82352|NCT01218867|191374|P9|STARTED|Overall Study||3
82353|NCT01218867|191375|P8|STARTED|Overall Study||3
82354|NCT01218867|191376|P7|STARTED|Overall Study||4
82355|NCT01218867|191377|P6|STARTED|Overall Study||1
82356|NCT01218867|191378|P5|STARTED|Overall Study||1
82357|NCT01218867|191379|P4|STARTED|Overall Study||1
82358|NCT01218867|191380|P3|STARTED|Overall Study||3
82359|NCT01218867|191381|P2|STARTED|Overall Study||1
82360|NCT01218867|191382|P1|STARTED|Overall Study||1
82361|NCT01218802|191430|P2|NOT COMPLETED|Overall Study||18
82362|NCT01218802|191431|P1|NOT COMPLETED|Overall Study||10
82363|NCT01218802|191430|P2|COMPLETED|Overall Study||57
82364|NCT01218802|191431|P1|COMPLETED|Overall Study||62
82365|NCT01218802|191430|P2|STARTED|Overall Study||75
82366|NCT01218802|191431|P1|STARTED|Overall Study||72
82367|NCT01218646|191443|P4|NOT COMPLETED|Overall Study||1
82368|NCT01218646|191444|P3|NOT COMPLETED|Overall Study||2
82369|NCT01218646|191445|P2|NOT COMPLETED|Overall Study||0
82370|NCT01218646|191446|P1|NOT COMPLETED|Overall Study||1
82371|NCT01218646|191443|P4|COMPLETED|Overall Study||63
82372|NCT01218646|191444|P3|COMPLETED|Overall Study||223
82373|NCT01218646|191445|P2|COMPLETED|Overall Study||225
82374|NCT01218646|191446|P1|COMPLETED|Overall Study||224
82375|NCT01218646|191443|P4|STARTED|Overall Study||64
82376|NCT01218646|191444|P3|STARTED|Overall Study||225
82377|NCT01218646|191445|P2|STARTED|Overall Study||225
82378|NCT01218646|191446|P1|STARTED|Overall Study||225
82379|NCT01218594|191484|P1|NOT COMPLETED|Overall Study||12
82380|NCT01218594|191484|P1|COMPLETED|Overall Study||36
82381|NCT01218594|191484|P1|STARTED|Overall Study||48
82382|NCT01218477|191492|P4|NOT COMPLETED|Overall Study||2
82383|NCT01218477|191493|P3|NOT COMPLETED|Overall Study||14
82384|NCT01218477|191494|P2|NOT COMPLETED|Overall Study||8
82385|NCT01218477|191495|P1|NOT COMPLETED|Overall Study||3
82386|NCT01218477|191492|P4|COMPLETED|Overall Study|Still receiving study drug|0
82387|NCT01218477|191493|P3|COMPLETED|Overall Study|Still receiving study drug|0
82388|NCT01218477|191494|P2|COMPLETED|Overall Study|Still receiving study drug|0
82389|NCT01218477|191495|P1|COMPLETED|Overall Study|Still receiving study drug|0
82390|NCT01218477|191492|P4|STARTED|Overall Study|Participants who received treatment|2
82391|NCT01218477|191493|P3|STARTED|Overall Study|Participants who received treatment|14
82392|NCT01218477|191494|P2|STARTED|Overall Study|Participants who received treatment|8
82393|NCT01218477|191495|P1|STARTED|Overall Study|Participants who received treatment|3
82394|NCT01218438|191512|P1|NOT COMPLETED|Epoch 4||3
82395|NCT01218438|191512|P1|COMPLETED|Epoch 4||67
82396|NCT01218438|191512|P1|STARTED|Epoch 4||70
82397|NCT01218438|191512|P1|NOT COMPLETED|Epoch 3||4
82398|NCT01218438|191512|P1|COMPLETED|Epoch 3||70
82399|NCT01218438|191512|P1|STARTED|Epoch 3||74
82400|NCT01218438|191512|P1|NOT COMPLETED|Epoch 2||0
82401|NCT01218438|191512|P1|COMPLETED|Epoch 2||45
82402|NCT01218438|191512|P1|STARTED|Epoch 2||45
82403|NCT01218438|191512|P1|NOT COMPLETED|Epoch 1||3
82404|NCT01218438|191512|P1|COMPLETED|Epoch 1||74
82405|NCT01218438|191512|P1|STARTED|Epoch 1||77
82406|NCT01218308|191667|P2|NOT COMPLETED|Overall Study||120
82407|NCT01218308|191668|P1|NOT COMPLETED|Overall Study||103
82408|NCT01218308|191667|P2|COMPLETED|Overall Study||2464
82409|NCT01218308|191668|P1|COMPLETED|Overall Study||2481
82410|NCT01218308|191667|P2|STARTED|Overall Study||2584
82411|NCT01218308|191668|P1|STARTED|Overall Study||2584
82412|NCT01218243|191712|P2|NOT COMPLETED|Overall Study||14
82413|NCT01218243|191713|P1|NOT COMPLETED|Overall Study||9
82414|NCT01218243|191712|P2|COMPLETED|Overall Study||36
82415|NCT01218243|191713|P1|COMPLETED|Overall Study||41
82416|NCT01218243|191712|P2|Treatment Completed|Overall Study||42
82417|NCT01218243|191713|P1|Treatment Completed|Overall Study||45
82418|NCT01218243|191712|P2|STARTED|Overall Study||50
82419|NCT01218243|191713|P1|STARTED|Overall Study||50
82420|NCT01218100|191731|P4|NOT COMPLETED|Overall Study||34
82421|NCT01218100|191732|P3|NOT COMPLETED|Overall Study||27
82422|NCT01218100|191733|P2|NOT COMPLETED|Overall Study||25
82423|NCT01218100|191734|P1|NOT COMPLETED|Overall Study||24
82424|NCT01218100|191731|P4|COMPLETED|Overall Study||156
82425|NCT01218100|191732|P3|COMPLETED|Overall Study||162
82426|NCT01218100|191733|P2|COMPLETED|Overall Study||165
82427|NCT01218100|191734|P1|COMPLETED|Overall Study||71
82428|NCT01218100|191731|P4|STARTED|Overall Study||190
82429|NCT01218100|191732|P3|STARTED|Overall Study||189
82430|NCT01218100|191733|P2|STARTED|Overall Study||190
82431|NCT01218100|191734|P1|STARTED|Overall Study||95
82432|NCT01218087|191750|P2|NOT COMPLETED|Overall Study||6
82433|NCT01218087|191751|P1|NOT COMPLETED|Overall Study||15
82434|NCT01218087|191750|P2|COMPLETED|Overall Study||35
82435|NCT01218087|191751|P1|COMPLETED|Overall Study||27
82436|NCT01218087|191750|P2|STARTED|Overall Study||41
82437|NCT01218087|191751|P1|STARTED|Overall Study||42
82438|NCT01218009|191761|P2|NOT COMPLETED|Overall Study||165
82439|NCT01218009|191762|P1|NOT COMPLETED|Overall Study||166
82440|NCT01218009|191761|P2|COMPLETED|Overall Study||0
82441|NCT01218009|191762|P1|COMPLETED|Overall Study||0
82442|NCT01218009|191761|P2|STARTED|Overall Study||165
82443|NCT01218009|191762|P1|STARTED|Overall Study||166
82444|NCT01217957|191785|P5|NOT COMPLETED|Phase 2||1
82445|NCT01217957|191786|P4|NOT COMPLETED|Phase 2||0
82446|NCT01217957|191787|P3|NOT COMPLETED|Phase 2||0
82447|NCT01217957|191788|P2|NOT COMPLETED|Phase 2||0
82448|NCT01217957|191789|P1|NOT COMPLETED|Phase 2||0
82449|NCT01217957|191785|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
82450|NCT01217957|191786|P4|COMPLETED|Phase 2||0
82451|NCT01217957|191787|P3|COMPLETED|Phase 2||0
82452|NCT01217957|191788|P2|COMPLETED|Phase 2||0
82453|NCT01217957|191789|P1|COMPLETED|Phase 2||0
82454|NCT01217957|191785|P5|STARTED|Phase 2||50
82455|NCT01217957|191786|P4|STARTED|Phase 2||0
82456|NCT01217957|191787|P3|STARTED|Phase 2||0
82457|NCT01217957|191788|P2|STARTED|Phase 2||0
82458|NCT01217957|191789|P1|STARTED|Phase 2||0
82459|NCT01217957|191785|P5|NOT COMPLETED|Phase 1||0
82460|NCT01217957|191786|P4|NOT COMPLETED|Phase 1||1
82461|NCT01217957|191787|P3|NOT COMPLETED|Phase 1||1
82462|NCT01217957|191788|P2|NOT COMPLETED|Phase 1||0
82463|NCT01217957|191789|P1|NOT COMPLETED|Phase 1||1
82464|NCT01217957|191785|P5|COMPLETED|Phase 1||0
82465|NCT01217957|191786|P4|COMPLETED|Phase 1||2
82466|NCT01217957|191787|P3|COMPLETED|Phase 1||5
82467|NCT01217957|191788|P2|COMPLETED|Phase 1||3
82468|NCT01217957|191789|P1|COMPLETED|Phase 1||2
82469|NCT01217957|191785|P5|STARTED|Phase 1||0
82470|NCT01217957|191786|P4|STARTED|Phase 1||3
82471|NCT01217957|191787|P3|STARTED|Phase 1||6
82472|NCT01217957|191788|P2|STARTED|Phase 1||3
82473|NCT01217957|191789|P1|STARTED|Phase 1||3
82474|NCT01217944|191848|P3|NOT COMPLETED|Overall Study||0
82475|NCT01217944|191849|P2|NOT COMPLETED|Overall Study||4
82476|NCT01217944|191850|P1|NOT COMPLETED|Overall Study||6
82477|NCT01217944|191848|P3|COMPLETED|Overall Study||55
82478|NCT01217944|191849|P2|COMPLETED|Overall Study||112
82479|NCT01217944|191850|P1|COMPLETED|Overall Study||100
82480|NCT01217944|191848|P3|Completed 6 Months|Overall Study||55
82481|NCT01217944|191849|P2|Completed 6 Months|Overall Study||116
82482|NCT01217944|191850|P1|Completed 6 Months|Overall Study||103
82483|NCT01217944|191848|P3|Completed 3 Months|Overall Study||55
82484|NCT01217944|191849|P2|Completed 3 Months|Overall Study||116
82485|NCT01217944|191850|P1|Completed 3 Months|Overall Study||105
82486|NCT01217944|191848|P3|STARTED|Overall Study||55
82487|NCT01217944|191849|P2|STARTED|Overall Study||116
82488|NCT01217944|191850|P1|STARTED|Overall Study||106
82489|NCT01217892|191893|P4|NOT COMPLETED|Overall Study||8
82490|NCT01217892|191894|P3|NOT COMPLETED|Overall Study||9
82491|NCT01217892|191895|P2|NOT COMPLETED|Overall Study||6
82492|NCT01217892|191896|P1|NOT COMPLETED|Overall Study||7
82493|NCT01217892|191893|P4|COMPLETED|Overall Study||93
82494|NCT01217892|191894|P3|COMPLETED|Overall Study||90
82495|NCT01217892|191895|P2|COMPLETED|Overall Study||94
82496|NCT01217892|191896|P1|COMPLETED|Overall Study||93
82497|NCT01217892|191893|P4|STARTED|Overall Study||101
82498|NCT01217892|191894|P3|STARTED|Overall Study||99
82499|NCT01217892|191895|P2|STARTED|Overall Study||100
82500|NCT01217892|191896|P1|STARTED|Overall Study||100
82501|NCT01217840|191924|P2|NOT COMPLETED|Overall Study||3
82502|NCT01217840|191925|P1|NOT COMPLETED|Overall Study||6
82503|NCT01217840|191924|P2|COMPLETED|Overall Study||17
82504|NCT01217840|191925|P1|COMPLETED|Overall Study||14
82505|NCT01217840|191924|P2|STARTED|Overall Study||20
82506|NCT01217840|191925|P1|STARTED|Overall Study||20
82507|NCT01217827|191933|P2|NOT COMPLETED|Overall Study||0
82508|NCT01217827|191934|P1|NOT COMPLETED|Overall Study||0
82509|NCT01217827|191933|P2|COMPLETED|Overall Study||43
82510|NCT01217827|191934|P1|COMPLETED|Overall Study||46
82511|NCT01217827|191933|P2|STARTED|Overall Study||43
82512|NCT01217827|191934|P1|STARTED|Overall Study||46
82513|NCT01217749|191943|P3|NOT COMPLETED|Overall Study||2
82514|NCT01217749|191944|P2|NOT COMPLETED|Overall Study||3
82515|NCT01217749|191945|P1|NOT COMPLETED|Overall Study||3
82516|NCT01217749|191943|P3|COMPLETED|Overall Study||22
82517|NCT01217749|191944|P2|COMPLETED|Overall Study||17
82518|NCT01217749|191945|P1|COMPLETED|Overall Study||24
82519|NCT01217749|191943|P3|STARTED|Overall Study||24
82520|NCT01217749|191944|P2|STARTED|Overall Study||20
82521|NCT01217749|191945|P1|STARTED|Overall Study||27
82522|NCT01217606|191963|P2|NOT COMPLETED|9-Month Masked Extension||11
82523|NCT01217606|191964|P1|NOT COMPLETED|9-Month Masked Extension||13
82524|NCT01217606|191963|P2|COMPLETED|9-Month Masked Extension||62
82525|NCT01217606|191964|P1|COMPLETED|9-Month Masked Extension||54
82526|NCT01217606|191963|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
82527|NCT01217606|191964|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
82528|NCT01217606|191963|P2|STARTED|9-Month Masked Extension||73
82529|NCT01217606|191964|P1|STARTED|9-Month Masked Extension||67
82530|NCT01217606|191963|P2|NOT COMPLETED|Initial Treatment Phase||12
82531|NCT01217606|191964|P1|NOT COMPLETED|Initial Treatment Phase||14
82532|NCT01217606|191963|P2|COMPLETED|Initial Treatment Phase||83
82533|NCT01217606|191964|P1|COMPLETED|Initial Treatment Phase||76
82534|NCT01217606|191963|P2|STARTED|Initial Treatment Phase||95
82535|NCT01217606|191964|P1|STARTED|Initial Treatment Phase||90
82536|NCT01217515|191977|P3|NOT COMPLETED|Overall Study||10
82537|NCT01217515|191978|P2|NOT COMPLETED|Overall Study||8
82538|NCT01217515|191979|P1|NOT COMPLETED|Overall Study||7
82539|NCT01217515|191977|P3|COMPLETED|Overall Study||145
82540|NCT01217515|191978|P2|COMPLETED|Overall Study||148
82541|NCT01217515|191979|P1|COMPLETED|Overall Study||147
82542|NCT01217515|191977|P3|STARTED|Overall Study||155
82543|NCT01217515|191978|P2|STARTED|Overall Study||156
82544|NCT01217515|191979|P1|STARTED|Overall Study||154
82545|NCT01217476|191995|P2|NOT COMPLETED|Overall Study||7
82546|NCT01217476|191996|P1|NOT COMPLETED|Overall Study||12
82547|NCT01217476|191995|P2|COMPLETED|Overall Study||95
82548|NCT01217476|191996|P1|COMPLETED|Overall Study||93
82549|NCT01217476|191995|P2|STARTED|Overall Study||102
82550|NCT01217476|191996|P1|STARTED|Overall Study||105
82551|NCT01217463|192006|P2|NOT COMPLETED|Overall Study||8
82552|NCT01217463|192007|P1|NOT COMPLETED|Overall Study||13
82553|NCT01217463|192006|P2|COMPLETED|Overall Study||94
82554|NCT01217463|192007|P1|COMPLETED|Overall Study||86
82555|NCT01217463|192006|P2|STARTED|Overall Study||102
82556|NCT01217463|192007|P1|STARTED|Overall Study||99
82557|NCT01217411|192018|P3|NOT COMPLETED|Overall Study||0
82558|NCT01217411|192019|P2|NOT COMPLETED|Overall Study||0
82559|NCT01217411|192020|P1|NOT COMPLETED|Overall Study||0
82560|NCT01217411|192018|P3|COMPLETED|Overall Study||0
82561|NCT01217411|192019|P2|COMPLETED|Overall Study||0
82562|NCT01217411|192020|P1|COMPLETED|Overall Study||5
82563|NCT01217411|192018|P3|STARTED|Overall Study||0
82564|NCT01217411|192019|P2|STARTED|Overall Study||0
82565|NCT01217411|192020|P1|STARTED|Overall Study||5
82566|NCT01217229|192025|P1|NOT COMPLETED|Overall Study||0
82567|NCT01217229|192025|P1|COMPLETED|Overall Study||20
82568|NCT01217229|192025|P1|STARTED|Overall Study||20
82569|NCT01217112|192034|P5|NOT COMPLETED|Overall Study||1
82570|NCT01217112|192035|P4|NOT COMPLETED|Overall Study||2
82571|NCT01217112|192036|P3|NOT COMPLETED|Overall Study||1
82572|NCT01217112|192037|P2|NOT COMPLETED|Overall Study||2
82573|NCT01217112|192038|P1|NOT COMPLETED|Overall Study||0
82574|NCT01217112|192034|P5|COMPLETED|Overall Study||13
82575|NCT01217112|192035|P4|COMPLETED|Overall Study||10
82576|NCT01217112|192036|P3|COMPLETED|Overall Study||12
82577|NCT01217112|192037|P2|COMPLETED|Overall Study||10
82578|NCT01217112|192038|P1|COMPLETED|Overall Study||11
82579|NCT01217112|192034|P5|STARTED|Overall Study||14
82580|NCT01217112|192035|P4|STARTED|Overall Study||12
82581|NCT01217112|192036|P3|STARTED|Overall Study||13
82582|NCT01217112|192037|P2|STARTED|Overall Study||12
82583|NCT01217112|192038|P1|STARTED|Overall Study||11
82584|NCT01217073|192271|P8|NOT COMPLETED|Extension Period||20
82585|NCT01217073|192272|P7|NOT COMPLETED|Extension Period||91
82586|NCT01217073|192273|P6|NOT COMPLETED|Extension Period||0
82587|NCT01217073|192274|P5|NOT COMPLETED|Extension Period||0
82588|NCT01217073|192275|P4|NOT COMPLETED|Extension Period||0
82589|NCT01217073|192276|P3|NOT COMPLETED|Extension Period||0
82590|NCT01217073|192277|P2|NOT COMPLETED|Extension Period||0
82591|NCT01217073|192278|P1|NOT COMPLETED|Extension Period||0
82592|NCT01217073|192271|P8|COMPLETED|Extension Period||60
82593|NCT01217073|192272|P7|COMPLETED|Extension Period||314
82594|NCT01217073|192273|P6|COMPLETED|Extension Period||0
82595|NCT01217073|192274|P5|COMPLETED|Extension Period||0
82596|NCT01217073|192275|P4|COMPLETED|Extension Period||0
82597|NCT01217073|192276|P3|COMPLETED|Extension Period||0
82598|NCT01217073|192277|P2|COMPLETED|Extension Period||0
82599|NCT01217073|192278|P1|COMPLETED|Extension Period||0
82600|NCT01217073|192271|P8|STARTED|Extension Period||80
82601|NCT01217073|192272|P7|STARTED|Extension Period||405
82602|NCT01217073|192273|P6|STARTED|Extension Period||0
82603|NCT01217073|192274|P5|STARTED|Extension Period||0
82604|NCT01217073|192275|P4|STARTED|Extension Period||0
82605|NCT01217073|192276|P3|STARTED|Extension Period||0
82606|NCT01217073|192277|P2|STARTED|Extension Period||0
82607|NCT01217073|192278|P1|STARTED|Extension Period||0
82608|NCT01217073|192271|P8|NOT COMPLETED|Base Period||0
82609|NCT01217073|192272|P7|NOT COMPLETED|Base Period||0
82610|NCT01217073|192273|P6|NOT COMPLETED|Base Period||9
82611|NCT01217073|192274|P5|NOT COMPLETED|Base Period||15
82612|NCT01217073|192275|P4|NOT COMPLETED|Base Period||2
82613|NCT01217073|192276|P3|NOT COMPLETED|Base Period||7
82614|NCT01217073|192277|P2|NOT COMPLETED|Base Period||5
82615|NCT01217073|192278|P1|NOT COMPLETED|Base Period||7
82616|NCT01217073|192271|P8|COMPLETED|Base Period||0
82617|NCT01217073|192272|P7|COMPLETED|Base Period||0
82618|NCT01217073|192273|P6|COMPLETED|Base Period||105
82619|NCT01217073|192274|P5|COMPLETED|Base Period||99
82620|NCT01217073|192275|P4|COMPLETED|Base Period||113
82621|NCT01217073|192276|P3|COMPLETED|Base Period||107
82622|NCT01217073|192277|P2|COMPLETED|Base Period||110
82623|NCT01217073|192278|P1|COMPLETED|Base Period||106
82624|NCT01217073|192271|P8|STARTED|Base Period||0
82625|NCT01217073|192272|P7|STARTED|Base Period||0
82626|NCT01217073|192273|P6|STARTED|Base Period||114
82627|NCT01217073|192274|P5|STARTED|Base Period||114
82628|NCT01217073|192275|P4|STARTED|Base Period||115
82629|NCT01217073|192276|P3|STARTED|Base Period||114
82630|NCT01217073|192277|P2|STARTED|Base Period||115
82631|NCT01217073|192278|P1|STARTED|Base Period||113
82632|NCT01216943|192346|P1|NOT COMPLETED|Overall Study||13
82633|NCT01216943|192346|P1|COMPLETED|Overall Study||113
82634|NCT01216943|192346|P1|STARTED|Overall Study||126
82635|NCT01216761|192350|P3|NOT COMPLETED|Overall Study||0
82636|NCT01216761|192351|P2|NOT COMPLETED|Overall Study||0
82637|NCT01216761|192352|P1|NOT COMPLETED|Overall Study||0
82638|NCT01216761|192350|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
82639|NCT01216761|192351|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
82640|NCT01216761|192352|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
82641|NCT01216761|192350|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
82642|NCT01216761|192351|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
82643|NCT01216761|192352|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
82644|NCT01216748|192360|P1|NOT COMPLETED|Overall Study||0
82645|NCT01216748|192360|P1|COMPLETED|Overall Study||10
82646|NCT01216748|192360|P1|Eucapnic Hyperventilation|Overall Study||10
82647|NCT01216748|192360|P1|Hypercapnic Hyperventilation|Overall Study||10
82648|NCT01216748|192360|P1|Hypocapnic Hyperventilation|Overall Study||10
82649|NCT01216748|192360|P1|Quiet Breathing|Overall Study||10
82650|NCT01216748|192360|P1|STARTED|Overall Study||10
82651|NCT01216735|192367|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
82652|NCT01216735|192368|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
82653|NCT01216735|192367|P2|COMPLETED|Second Intervention (3 Weeks)||7
82654|NCT01216735|192368|P1|COMPLETED|Second Intervention (3 Weeks)||8
82655|NCT01216735|192367|P2|STARTED|Second Intervention (3 Weeks)||7
82656|NCT01216735|192368|P1|STARTED|Second Intervention (3 Weeks)||8
82657|NCT01216735|192367|P2|NOT COMPLETED|Washout (3 Weeks)||0
82658|NCT01216735|192368|P1|NOT COMPLETED|Washout (3 Weeks)||0
82659|NCT01216735|192367|P2|COMPLETED|Washout (3 Weeks)||7
82660|NCT01216735|192368|P1|COMPLETED|Washout (3 Weeks)||8
82661|NCT01216735|192367|P2|STARTED|Washout (3 Weeks)||7
82662|NCT01216735|192368|P1|STARTED|Washout (3 Weeks)||8
82663|NCT01216735|192367|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
82664|NCT01216735|192368|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
82665|NCT01216735|192367|P2|COMPLETED|First Intervention (3 Weeks)||7
82666|NCT01216735|192368|P1|COMPLETED|First Intervention (3 Weeks)||8
82667|NCT01216735|192367|P2|STARTED|First Intervention (3 Weeks)||7
82668|NCT01216735|192368|P1|STARTED|First Intervention (3 Weeks)||8
82669|NCT01216631|192379|P3|NOT COMPLETED|Overall Study||0
82670|NCT01216631|192380|P2|NOT COMPLETED|Overall Study||0
82671|NCT01216631|192381|P1|NOT COMPLETED|Overall Study||0
82672|NCT01216631|192379|P3|COMPLETED|Overall Study||1
82673|NCT01216631|192380|P2|COMPLETED|Overall Study||0
82674|NCT01216631|192381|P1|COMPLETED|Overall Study||0
82675|NCT01216631|192379|P3|STARTED|Overall Study||1
82676|NCT01216631|192380|P2|STARTED|Overall Study||0
82677|NCT01216631|192381|P1|STARTED|Overall Study||0
82678|NCT01216410|192392|P3|NOT COMPLETED|Overall Study||3
82679|NCT01216410|192393|P2|NOT COMPLETED|Overall Study||1
82680|NCT01216410|192394|P1|NOT COMPLETED|Overall Study||2
82681|NCT01216410|192392|P3|COMPLETED|Overall Study||100
82682|NCT01216410|192393|P2|COMPLETED|Overall Study||99
82683|NCT01216410|192394|P1|COMPLETED|Overall Study||101
82684|NCT01216410|192392|P3|STARTED|Overall Study||103
82685|NCT01216410|192393|P2|STARTED|Overall Study||100
82686|NCT01216410|192394|P1|STARTED|Overall Study||103
82687|NCT01216397|192414|P2|NOT COMPLETED|Period 2||0
82688|NCT01216397|192415|P1|NOT COMPLETED|Period 2||0
82689|NCT01216397|192414|P2|COMPLETED|Period 2||20
82690|NCT01216397|192415|P1|COMPLETED|Period 2||20
82691|NCT01216397|192414|P2|STARTED|Period 2||20
82692|NCT01216397|192415|P1|STARTED|Period 2||20
82693|NCT01216397|192414|P2|NOT COMPLETED|Washout (35 Days)||0
82694|NCT01216397|192415|P1|NOT COMPLETED|Washout (35 Days)||0
82695|NCT01216397|192414|P2|COMPLETED|Washout (35 Days)||20
82696|NCT01216397|192415|P1|COMPLETED|Washout (35 Days)||20
82697|NCT01216397|192414|P2|STARTED|Washout (35 Days)||20
82698|NCT01216397|192415|P1|STARTED|Washout (35 Days)||20
82699|NCT01216397|192414|P2|NOT COMPLETED|Period 1||0
82700|NCT01216397|192415|P1|NOT COMPLETED|Period 1||0
82701|NCT01216397|192414|P2|COMPLETED|Period 1||20
82702|NCT01216397|192415|P1|COMPLETED|Period 1||20
82703|NCT01216397|192414|P2|STARTED|Period 1||20
82704|NCT01216397|192415|P1|STARTED|Period 1||20
82705|NCT01216319|192467|P1|NOT COMPLETED|Overall Study||4
82706|NCT01216319|192467|P1|COMPLETED|Overall Study||46
82707|NCT01216319|192467|P1|STARTED|Overall Study||50
82708|NCT01216241|192474|P2|NOT COMPLETED|Overall Study||0
82709|NCT01216241|192475|P1|NOT COMPLETED|Overall Study||0
82710|NCT01216241|192474|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
82711|NCT01216241|192475|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
82712|NCT01216241|192474|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
82713|NCT01216241|192475|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
82714|NCT01216163|192484|P3|NOT COMPLETED|Overall Study||0
82715|NCT01216163|192485|P2|NOT COMPLETED|Overall Study||1
82716|NCT01216163|192486|P1|NOT COMPLETED|Overall Study||1
82717|NCT01216163|192484|P3|COMPLETED|Overall Study||85
82718|NCT01216163|192485|P2|COMPLETED|Overall Study||87
82719|NCT01216163|192486|P1|COMPLETED|Overall Study||44
82720|NCT01216163|192484|P3|STARTED|Overall Study||85
82721|NCT01216163|192485|P2|STARTED|Overall Study||88
82722|NCT01216163|192486|P1|STARTED|Overall Study||45
82723|NCT01216072|192538|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
82724|NCT01216072|192539|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
82725|NCT01216072|192538|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
82726|NCT01216072|192539|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
82727|NCT01216072|192538|P2|Safety Set|Open-Label Extension Period (3 Months)||193
82728|NCT01216072|192539|P1|Safety Set|Open-Label Extension Period (3 Months)||0
82729|NCT01216072|192538|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
82730|NCT01216072|192539|P1|STARTED|Open-Label Extension Period (3 Months)||0
82731|NCT01216072|192538|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
82732|NCT01216072|192539|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
82733|NCT01216072|192538|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
82734|NCT01216072|192539|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
82735|NCT01216072|192538|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
82736|NCT01216072|192539|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
82737|NCT01216072|192538|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
82738|NCT01216072|192539|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
82739|NCT01216072|192538|P2|STARTED|Open-Label Core Period ( 6 Months)||263
82740|NCT01216072|192539|P1|STARTED|Open-Label Core Period ( 6 Months)||790
82741|NCT01215981|192567|P2|NOT COMPLETED|Overall Study||1
82742|NCT01215981|192568|P1|NOT COMPLETED|Overall Study||2
82743|NCT01215981|192567|P2|COMPLETED|Overall Study||32
82744|NCT01215981|192568|P1|COMPLETED|Overall Study||33
82745|NCT01215981|192567|P2|STARTED|Overall Study||33
82746|NCT01215981|192568|P1|STARTED|Overall Study||35
82747|NCT01215968|192578|P2|NOT COMPLETED|Overall Study||7
82748|NCT01215968|192579|P1|NOT COMPLETED|Overall Study||2
82749|NCT01215968|192578|P2|COMPLETED|Overall Study||18
82750|NCT01215968|192579|P1|COMPLETED|Overall Study||11
82751|NCT01215968|192578|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
82752|NCT01215968|192579|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
82753|NCT01215968|192578|P2|STARTED|Overall Study||25
82754|NCT01215968|192579|P1|STARTED|Overall Study||13
82755|NCT01215955|192599|P4|NOT COMPLETED|Overall Study||53
82756|NCT01215955|192600|P3|NOT COMPLETED|Overall Study||48
82757|NCT01215955|192601|P2|NOT COMPLETED|Overall Study||53
82758|NCT01215955|192602|P1|NOT COMPLETED|Overall Study||45
82759|NCT01215955|192599|P4|COMPLETED|Overall Study||241
82760|NCT01215955|192600|P3|COMPLETED|Overall Study||244
82761|NCT01215955|192601|P2|COMPLETED|Overall Study||210
82762|NCT01215955|192602|P1|COMPLETED|Overall Study||223
82763|NCT01215955|192599|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
82764|NCT01215955|192600|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
82765|NCT01215955|192601|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
82766|NCT01215955|192602|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
82767|NCT01215955|192599|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
82768|NCT01215955|192600|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
82769|NCT01215955|192601|P2|STARTED|Overall Study||263
82770|NCT01215955|192602|P1|STARTED|Overall Study||268
82771|NCT01215929|192670|P2|NOT COMPLETED|Overall Study||5
82772|NCT01215929|192671|P1|NOT COMPLETED|Overall Study||6
82773|NCT01215929|192670|P2|COMPLETED|Overall Study||12
82774|NCT01215929|192671|P1|COMPLETED|Overall Study||12
82775|NCT01215929|192670|P2|STARTED|Overall Study||17
82776|NCT01215929|192671|P1|STARTED|Overall Study||18
82777|NCT01215851|192683|P6|NOT COMPLETED|Follow up Period||1
82778|NCT01215851|192684|P5|NOT COMPLETED|Follow up Period||0
82779|NCT01215851|192685|P4|NOT COMPLETED|Follow up Period||0
82780|NCT01215851|192686|P3|NOT COMPLETED|Follow up Period||0
82781|NCT01215851|192687|P2|NOT COMPLETED|Follow up Period||0
82782|NCT01215851|192688|P1|NOT COMPLETED|Follow up Period||0
82783|NCT01215851|192683|P6|COMPLETED|Follow up Period||13
82784|NCT01215851|192684|P5|COMPLETED|Follow up Period||10
82785|NCT01215851|192685|P4|COMPLETED|Follow up Period||12
82786|NCT01215851|192686|P3|COMPLETED|Follow up Period||14
82787|NCT01215851|192687|P2|COMPLETED|Follow up Period||14
82788|NCT01215851|192688|P1|COMPLETED|Follow up Period||14
82789|NCT01215851|192683|P6|STARTED|Follow up Period||14
82790|NCT01215851|192684|P5|STARTED|Follow up Period||10
82791|NCT01215851|192685|P4|STARTED|Follow up Period||12
82792|NCT01215851|192686|P3|STARTED|Follow up Period||14
82793|NCT01215851|192687|P2|STARTED|Follow up Period||14
82794|NCT01215851|192688|P1|STARTED|Follow up Period||14
82795|NCT01215851|192683|P6|NOT COMPLETED|Treatment Period||1
82796|NCT01215851|192684|P5|NOT COMPLETED|Treatment Period||0
82797|NCT01215851|192685|P4|NOT COMPLETED|Treatment Period||3
82798|NCT01215851|192686|P3|NOT COMPLETED|Treatment Period||1
82799|NCT01215851|192687|P2|NOT COMPLETED|Treatment Period||1
82800|NCT01215851|192688|P1|NOT COMPLETED|Treatment Period||1
82801|NCT01215851|192683|P6|COMPLETED|Treatment Period||14
82802|NCT01215851|192684|P5|COMPLETED|Treatment Period||10
82803|NCT01215851|192685|P4|COMPLETED|Treatment Period||12
82804|NCT01215851|192686|P3|COMPLETED|Treatment Period||14
82805|NCT01215851|192687|P2|COMPLETED|Treatment Period||14
82806|NCT01215851|192688|P1|COMPLETED|Treatment Period||14
82807|NCT01215851|192683|P6|STARTED|Treatment Period||15
82808|NCT01215851|192684|P5|STARTED|Treatment Period||10
82809|NCT01215851|192685|P4|STARTED|Treatment Period||15
82810|NCT01215851|192686|P3|STARTED|Treatment Period||15
82811|NCT01215851|192687|P2|STARTED|Treatment Period||15
82812|NCT01215851|192688|P1|STARTED|Treatment Period||15
82813|NCT01215786|192729|P3|NOT COMPLETED|Overall Study||0
82814|NCT01215786|192730|P2|NOT COMPLETED|Overall Study||0
82815|NCT01215786|192731|P1|NOT COMPLETED|Overall Study||0
82816|NCT01215786|192729|P3|COMPLETED|Overall Study||10
82817|NCT01215786|192730|P2|COMPLETED|Overall Study||19
82818|NCT01215786|192731|P1|COMPLETED|Overall Study||21
82819|NCT01215786|192729|P3|STARTED|Overall Study||10
82820|NCT01215786|192730|P2|STARTED|Overall Study||19
82821|NCT01215786|192731|P1|STARTED|Overall Study||21
82822|NCT01215734|192747|P2|NOT COMPLETED|Overall Study||1
82823|NCT01215734|192748|P1|NOT COMPLETED|Overall Study||0
82824|NCT01215734|192747|P2|COMPLETED|Overall Study||14
82825|NCT01215734|192748|P1|COMPLETED|Overall Study||29
82826|NCT01215734|192747|P2|STARTED|Overall Study||15
82827|NCT01215734|192748|P1|STARTED|Overall Study||29
82828|NCT01215721|192756|P1|NOT COMPLETED|Overall Study||2
82829|NCT01215721|192756|P1|COMPLETED|Overall Study||38
82830|NCT01215721|192756|P1|STARTED|Overall Study||40
82831|NCT01215643|192765|P5|NOT COMPLETED|Overall Study||11
82832|NCT01215643|192766|P4|NOT COMPLETED|Overall Study||4
82833|NCT01215643|192767|P3|NOT COMPLETED|Overall Study||12
82834|NCT01215643|192768|P2|NOT COMPLETED|Overall Study||4
82835|NCT01215643|192769|P1|NOT COMPLETED|Overall Study||9
82836|NCT01215643|192765|P5|COMPLETED|Overall Study||29
82837|NCT01215643|192766|P4|COMPLETED|Overall Study||35
82838|NCT01215643|192767|P3|COMPLETED|Overall Study||82
82839|NCT01215643|192768|P2|COMPLETED|Overall Study||80
82840|NCT01215643|192769|P1|COMPLETED|Overall Study||74
82841|NCT01215643|192765|P5|STARTED|Overall Study||40
82842|NCT01215643|192766|P4|STARTED|Overall Study||39
82843|NCT01215643|192767|P3|STARTED|Overall Study||94
82844|NCT01215643|192768|P2|STARTED|Overall Study||84
82845|NCT01215643|192769|P1|STARTED|Overall Study||83
82846|NCT01215513|192871|P1|NOT COMPLETED|Overall Study||45
82847|NCT01215513|192871|P1|COMPLETED|Overall Study||112
82848|NCT01215513|192871|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
82849|NCT01215513|192871|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
82850|NCT01215513|192871|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
82851|NCT01215513|192871|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
82852|NCT01215435|192880|P2|NOT COMPLETED|Overall Study||16
82853|NCT01215435|192881|P1|NOT COMPLETED|Overall Study||19
82854|NCT01215435|192880|P2|COMPLETED|Overall Study||107
82855|NCT01215435|192881|P1|COMPLETED|Overall Study||103
82856|NCT01215435|192880|P2|STARTED|Overall Study||123
82857|NCT01215435|192881|P1|STARTED|Overall Study||122
82858|NCT01215422|192895|P4|NOT COMPLETED|Overall Study||8
82859|NCT01215422|192896|P3|NOT COMPLETED|Overall Study||3
82860|NCT01215422|192897|P2|NOT COMPLETED|Overall Study||0
82861|NCT01215422|192898|P1|NOT COMPLETED|Overall Study||8
82862|NCT01215422|192895|P4|COMPLETED|Overall Study||193
82863|NCT01215422|192896|P3|COMPLETED|Overall Study||193
82864|NCT01215422|192897|P2|COMPLETED|Overall Study||249
82865|NCT01215422|192898|P1|COMPLETED|Overall Study||6
82866|NCT01215422|192895|P4|STARTED|Overall Study||201
82867|NCT01215422|192896|P3|STARTED|Overall Study||196
82868|NCT01215422|192897|P2|STARTED|Overall Study||249
82869|NCT01215422|192898|P1|STARTED|Overall Study||14
82870|NCT01215357|192920|P1|NOT COMPLETED|Overall Study||12
82871|NCT01215357|192920|P1|COMPLETED|Overall Study||22
82872|NCT01215357|192920|P1|STARTED|Overall Study||34
82873|NCT01215292|192929|P5|NOT COMPLETED|Overall Study||0
82874|NCT01215292|192930|P4|NOT COMPLETED|Overall Study||0
82875|NCT01215292|192931|P3|NOT COMPLETED|Overall Study||0
82876|NCT01215292|192932|P2|NOT COMPLETED|Overall Study||0
82877|NCT01215292|192933|P1|NOT COMPLETED|Overall Study||0
82878|NCT01215292|192929|P5|COMPLETED|Overall Study||8
82879|NCT01215292|192930|P4|COMPLETED|Overall Study||8
82880|NCT01215292|192931|P3|COMPLETED|Overall Study||8
82881|NCT01215292|192932|P2|COMPLETED|Overall Study||8
82882|NCT01215292|192933|P1|COMPLETED|Overall Study||8
82883|NCT01215292|192929|P5|STARTED|Overall Study||8
82884|NCT01215292|192930|P4|STARTED|Overall Study||8
82885|NCT01215292|192931|P3|STARTED|Overall Study||8
82886|NCT01215292|192932|P2|STARTED|Overall Study||8
82887|NCT01215292|192933|P1|STARTED|Overall Study||8
82888|NCT01215279|192957|P2|NOT COMPLETED|Overall Study||0
82889|NCT01215279|192958|P1|NOT COMPLETED|Overall Study||0
82890|NCT01215279|192957|P2|COMPLETED|Overall Study||32
82891|NCT01215279|192958|P1|COMPLETED|Overall Study||31
82892|NCT01215279|192957|P2|STARTED|Overall Study||32
82893|NCT01215279|192958|P1|STARTED|Overall Study||31
82894|NCT01215227|193028|P6|NOT COMPLETED|Overall Study||58
82895|NCT01215227|193029|P5|NOT COMPLETED|Overall Study||48
82896|NCT01215227|193030|P4|NOT COMPLETED|Overall Study||49
82897|NCT01215227|193031|P3|NOT COMPLETED|Overall Study||57
82898|NCT01215227|193032|P2|NOT COMPLETED|Overall Study||119
82899|NCT01215227|193033|P1|NOT COMPLETED|Overall Study||121
82900|NCT01215227|193028|P6|COMPLETED|Overall Study||51
82901|NCT01215227|193029|P5|COMPLETED|Overall Study||45
82902|NCT01215227|193030|P4|COMPLETED|Overall Study||48
82903|NCT01215227|193031|P3|COMPLETED|Overall Study||50
82904|NCT01215227|193032|P2|COMPLETED|Overall Study||96
82905|NCT01215227|193033|P1|COMPLETED|Overall Study||97
82906|NCT01215227|193028|P6|Treated|Overall Study||108
82907|NCT01215227|193029|P5|Treated|Overall Study||93
82908|NCT01215227|193030|P4|Treated|Overall Study||96
82909|NCT01215227|193031|P3|Treated|Overall Study||106
82910|NCT01215227|193032|P2|Treated|Overall Study||215
82911|NCT01215227|193033|P1|Treated|Overall Study||218
82912|NCT01215227|193028|P6|STARTED|Overall Study||109
82913|NCT01215227|193029|P5|STARTED|Overall Study||93
82914|NCT01215227|193030|P4|STARTED|Overall Study||97
82915|NCT01215227|193031|P3|STARTED|Overall Study||107
82916|NCT01215227|193032|P2|STARTED|Overall Study||215
82917|NCT01215227|193033|P1|STARTED|Overall Study||218
82918|NCT01215123|193077|P1|NOT COMPLETED|Overall Study||0
82919|NCT01215123|193077|P1|COMPLETED|Overall Study||28
82920|NCT01215123|193077|P1|STARTED|Overall Study||28
82921|NCT01215097|193084|P2|NOT COMPLETED|Overall Study||14
82922|NCT01215097|193085|P1|NOT COMPLETED|Overall Study||12
82923|NCT01215097|193084|P2|COMPLETED|Overall Study||191
82924|NCT01215097|193085|P1|COMPLETED|Overall Study||88
82925|NCT01215097|193084|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
82926|NCT01215097|193085|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
82927|NCT01214980|193119|P2|NOT COMPLETED|Overall Study||2
82928|NCT01214980|193120|P1|NOT COMPLETED|Overall Study||3
82929|NCT01214980|193119|P2|COMPLETED|Overall Study||14
82930|NCT01214980|193120|P1|COMPLETED|Overall Study||13
82931|NCT01214980|193119|P2|STARTED|Overall Study||16
82932|NCT01214980|193120|P1|STARTED|Overall Study||16
82933|NCT01214915|193134|P1|NOT COMPLETED|Overall Study||11
82934|NCT01214915|193134|P1|COMPLETED|Overall Study||42
82935|NCT01214915|193134|P1|STARTED|Overall Study||53
82936|NCT01214850|193145|P3|NOT COMPLETED|Overall Study||161
82937|NCT01214850|193146|P2|NOT COMPLETED|Overall Study||144
82938|NCT01214850|193147|P1|NOT COMPLETED|Overall Study||183
82939|NCT01214850|193145|P3|COMPLETED|Overall Study||826
82940|NCT01214850|193146|P2|COMPLETED|Overall Study||844
82941|NCT01214850|193147|P1|COMPLETED|Overall Study||796
82942|NCT01214850|193145|P3|STARTED|Overall Study||987
82943|NCT01214850|193146|P2|STARTED|Overall Study||988
82944|NCT01214850|193147|P1|STARTED|Overall Study||979
82945|NCT01214837|193231|P3|NOT COMPLETED|Overall Study||62
82946|NCT01214837|193232|P2|NOT COMPLETED|Overall Study||64
82947|NCT01214837|193233|P1|NOT COMPLETED|Overall Study||54
82948|NCT01214837|193231|P3|COMPLETED|Overall Study||184
82949|NCT01214837|193232|P2|COMPLETED|Overall Study||192
82950|NCT01214837|193233|P1|COMPLETED|Overall Study||195
82951|NCT01214837|193231|P3|STARTED|Overall Study||246
82952|NCT01214837|193232|P2|STARTED|Overall Study||256
82953|NCT01214837|193233|P1|STARTED|Overall Study||249
82954|NCT01214824|193270|P1|NOT COMPLETED|Overall Study||3
82955|NCT01214824|193270|P1|COMPLETED|Overall Study||29
82956|NCT01214824|193270|P1|STARTED|Overall Study||32
82957|NCT01214811|193277|P1|NOT COMPLETED|Overall Study||3
82958|NCT01214811|193277|P1|COMPLETED|Overall Study||24
82959|NCT01214811|193277|P1|STARTED|Overall Study||27
82960|NCT01214759|193281|P1|NOT COMPLETED|Overall Study||48
82961|NCT01214759|193281|P1|COMPLETED|Overall Study||55
82962|NCT01214759|193281|P1|28 Days nPEP Completion|Overall Study||85
82963|NCT01214759|193281|P1|STARTED|Overall Study||103
82964|NCT01214720|193289|P2|NOT COMPLETED|Overall Study||68
82965|NCT01214720|193290|P1|NOT COMPLETED|Overall Study||85
82966|NCT01214720|193289|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
82967|NCT01214720|193290|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
82968|NCT01214720|193289|P2|STARTED|Overall Study||301
82969|NCT01214720|193290|P1|STARTED|Overall Study||306
82970|NCT01214616|193311|P4|NOT COMPLETED|Overall Study||6
82971|NCT01214616|193312|P3|NOT COMPLETED|Overall Study||3
82972|NCT01214616|193313|P2|NOT COMPLETED|Overall Study||5
82973|NCT01214616|193314|P1|NOT COMPLETED|Overall Study||3
82974|NCT01214616|193311|P4|COMPLETED|Overall Study||0
82975|NCT01214616|193312|P3|COMPLETED|Overall Study||0
82976|NCT01214616|193313|P2|COMPLETED|Overall Study||0
82977|NCT01214616|193314|P1|COMPLETED|Overall Study||0
82978|NCT01214616|193311|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
82979|NCT01214616|193312|P3|STARTED|Overall Study||3
82980|NCT01214616|193313|P2|STARTED|Overall Study||5
82981|NCT01214616|193314|P1|STARTED|Overall Study||3
82982|NCT01214434|193350|P2|NOT COMPLETED|Overall Study||2
82983|NCT01214434|193351|P1|NOT COMPLETED|Overall Study||4
82984|NCT01214434|193350|P2|COMPLETED|Overall Study||25
82985|NCT01214434|193351|P1|COMPLETED|Overall Study||11
82986|NCT01214434|193350|P2|STARTED|Overall Study||27
82987|NCT01214434|193351|P1|STARTED|Overall Study||15
82988|NCT01214395|193367|P1|NOT COMPLETED|Overall Study||5
82989|NCT01214395|193367|P1|COMPLETED|Overall Study||0
82990|NCT01214395|193367|P1|STARTED|Overall Study||5
82991|NCT01214330|193372|P1|NOT COMPLETED|Overall Study||48
82992|NCT01214330|193372|P1|COMPLETED|Overall Study||102
82993|NCT01214330|193372|P1|STARTED|Overall Study||150
82994|NCT01214252|193376|P1|NOT COMPLETED|Overall Study||82
82995|NCT01214252|193376|P1|COMPLETED|Overall Study||343
82996|NCT01214252|193376|P1|STARTED|Overall Study||425
82997|NCT01214239|193384|P2|NOT COMPLETED|Overall Study||18
82998|NCT01214239|193385|P1|NOT COMPLETED|Overall Study||12
82999|NCT01214239|193384|P2|COMPLETED|Overall Study||182
83000|NCT01214239|193385|P1|COMPLETED|Overall Study||87
83001|NCT01214239|193384|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
83002|NCT01214239|193385|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
83003|NCT01214174|193420|P3|NOT COMPLETED|Overall Study||1
83004|NCT01214174|193421|P2|NOT COMPLETED|Overall Study||0
83005|NCT01214174|193422|P1|NOT COMPLETED|Overall Study||0
83006|NCT01214174|193420|P3|COMPLETED|Overall Study||13
83007|NCT01214174|193421|P2|COMPLETED|Overall Study||16
83008|NCT01214174|193422|P1|COMPLETED|Overall Study||13
83009|NCT01214174|193420|P3|STARTED|Overall Study||14
83010|NCT01214174|193421|P2|STARTED|Overall Study||16
83011|NCT01214174|193422|P1|STARTED|Overall Study||13
83012|NCT01214161|193432|P2|NOT COMPLETED|Overall Study||0
83013|NCT01214161|193433|P1|NOT COMPLETED|Overall Study||0
83014|NCT01214161|193432|P2|COMPLETED|Overall Study||100
83015|NCT01214161|193433|P1|COMPLETED|Overall Study||100
83016|NCT01214161|193432|P2|STARTED|Overall Study||100
83017|NCT01214161|193433|P1|STARTED|Overall Study||100
83018|NCT01214109|193443|P4|NOT COMPLETED|Overall Study||0
83019|NCT01214109|193444|P3|NOT COMPLETED|Overall Study||0
83020|NCT01214109|193445|P2|NOT COMPLETED|Overall Study||0
83021|NCT01214109|193446|P1|NOT COMPLETED|Overall Study||0
83022|NCT01214109|193443|P4|COMPLETED|Overall Study||24
83023|NCT01214109|193444|P3|COMPLETED|Overall Study||24
83024|NCT01214109|193445|P2|COMPLETED|Overall Study||24
83025|NCT01214109|193446|P1|COMPLETED|Overall Study||24
83026|NCT01214109|193443|P4|STARTED|Overall Study||24
83027|NCT01214109|193444|P3|STARTED|Overall Study||24
83028|NCT01214109|193445|P2|STARTED|Overall Study||24
83029|NCT01214109|193446|P1|STARTED|Overall Study||24
83030|NCT01213966|193539|P4|NOT COMPLETED|Overall Study||1
83031|NCT01213966|193540|P3|NOT COMPLETED|Overall Study||3
83032|NCT01213966|193541|P2|NOT COMPLETED|Overall Study||0
83033|NCT01213966|193542|P1|NOT COMPLETED|Overall Study||1
83034|NCT01213966|193539|P4|COMPLETED|Overall Study||20
83035|NCT01213966|193540|P3|COMPLETED|Overall Study||17
83036|NCT01213966|193541|P2|COMPLETED|Overall Study||20
83037|NCT01213966|193542|P1|COMPLETED|Overall Study||19
83038|NCT01213966|193539|P4|STARTED|Overall Study||21
83039|NCT01213966|193540|P3|STARTED|Overall Study||20
83040|NCT01213966|193541|P2|STARTED|Overall Study||20
83041|NCT01213966|193542|P1|STARTED|Overall Study||20
83042|NCT01213836|193554|P2|NOT COMPLETED|Period 2, Second Intervention||0
83043|NCT01213836|193555|P1|NOT COMPLETED|Period 2, Second Intervention||0
83044|NCT01213836|193554|P2|COMPLETED|Period 2, Second Intervention||29
83045|NCT01213836|193555|P1|COMPLETED|Period 2, Second Intervention||31
83046|NCT01213836|193554|P2|STARTED|Period 2, Second Intervention||29
83047|NCT01213836|193555|P1|STARTED|Period 2, Second Intervention||31
83048|NCT01213836|193554|P2|NOT COMPLETED|Period 1, First Intervention||3
83049|NCT01213836|193555|P1|NOT COMPLETED|Period 1, First Intervention||3
83050|NCT01213836|193554|P2|COMPLETED|Period 1, First Intervention||29
83051|NCT01213836|193555|P1|COMPLETED|Period 1, First Intervention||31
83052|NCT01213836|193554|P2|STARTED|Period 1, First Intervention||32
83053|NCT01213836|193555|P1|STARTED|Period 1, First Intervention||34
83054|NCT01213823|193575|P2|NOT COMPLETED|Overall Study||0
83055|NCT01213823|193576|P1|NOT COMPLETED|Overall Study||0
83056|NCT01213823|193575|P2|COMPLETED|Overall Study||467
83057|NCT01213823|193576|P1|COMPLETED|Overall Study||69
83058|NCT01213823|193575|P2|STARTED|Overall Study||467
83059|NCT01213823|193576|P1|STARTED|Overall Study||69
83060|NCT01213706|193582|P1|NOT COMPLETED|WBPA||0
83061|NCT01213706|193582|P1|COMPLETED|WBPA||45
83062|NCT01213706|193582|P1|STARTED|WBPA||45
83063|NCT01213706|193582|P1|NOT COMPLETED|Washout (1 Hour)||0
83064|NCT01213706|193582|P1|COMPLETED|Washout (1 Hour)||45
83065|NCT01213706|193582|P1|STARTED|Washout (1 Hour)||45
83066|NCT01213706|193582|P1|NOT COMPLETED|Sham WBPA||0
83067|NCT01213706|193582|P1|COMPLETED|Sham WBPA||45
83068|NCT01213706|193582|P1|STARTED|Sham WBPA||45
83069|NCT01213589|193591|P3|NOT COMPLETED|Overall Study||8
83070|NCT01213589|193592|P2|NOT COMPLETED|Overall Study||5
83071|NCT01213589|193593|P1|NOT COMPLETED|Overall Study||13
83072|NCT01213589|193591|P3|COMPLETED|Overall Study||18
83073|NCT01213589|193592|P2|COMPLETED|Overall Study||19
83074|NCT01213589|193593|P1|COMPLETED|Overall Study||37
83075|NCT01213589|193591|P3|STARTED|Overall Study||26
83076|NCT01213589|193592|P2|STARTED|Overall Study||24
83077|NCT01213589|193593|P1|STARTED|Overall Study||50
83078|NCT01213576|193623|P4|NOT COMPLETED|Overall Study||4
83079|NCT01213576|193624|P3|NOT COMPLETED|Overall Study||5
83080|NCT01213576|193625|P2|NOT COMPLETED|Overall Study||4
83081|NCT01213576|193626|P1|NOT COMPLETED|Overall Study||3
83082|NCT01213576|193623|P4|COMPLETED|Overall Study||13
83083|NCT01213576|193624|P3|COMPLETED|Overall Study||13
83084|NCT01213576|193625|P2|COMPLETED|Overall Study||13
83085|NCT01213576|193626|P1|COMPLETED|Overall Study||15
83086|NCT01213576|193623|P4|STARTED|Overall Study||17
83087|NCT01213576|193624|P3|STARTED|Overall Study||18
83088|NCT01213576|193625|P2|STARTED|Overall Study||17
83089|NCT01213576|193626|P1|STARTED|Overall Study||18
83090|NCT01213329|193642|P2|NOT COMPLETED|Phase 2||0
83091|NCT01213329|193643|P1|NOT COMPLETED|Phase 2||0
83092|NCT01213329|193642|P2|COMPLETED|Phase 2||0
83093|NCT01213329|193643|P1|COMPLETED|Phase 2||0
83094|NCT01213329|193642|P2|STARTED|Phase 2||0
83095|NCT01213329|193643|P1|STARTED|Phase 2||0
83096|NCT01213329|193642|P2|NOT COMPLETED|Screening||0
83097|NCT01213329|193643|P1|NOT COMPLETED|Screening||0
83098|NCT01213329|193642|P2|COMPLETED|Screening||25
83099|NCT01213329|193643|P1|COMPLETED|Screening||25
83100|NCT01213329|193642|P2|STARTED|Screening||25
83101|NCT01213329|193643|P1|STARTED|Screening||25
83102|NCT01213316|193649|P1|NOT COMPLETED|Overall Study||0
83103|NCT01213316|193649|P1|COMPLETED|Overall Study||451
83104|NCT01213316|193649|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
83105|NCT01213316|193649|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
83106|NCT01213316|193649|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
83107|NCT01213316|193649|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
83108|NCT01213316|193649|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
83109|NCT01213264|193668|P3|NOT COMPLETED|Overall Study||6
83110|NCT01213264|193669|P2|NOT COMPLETED|Overall Study||2
83111|NCT01213264|193670|P1|NOT COMPLETED|Overall Study||2
83112|NCT01213264|193668|P3|COMPLETED|Overall Study||321
83113|NCT01213264|193669|P2|COMPLETED|Overall Study||175
83114|NCT01213264|193670|P1|COMPLETED|Overall Study||153
83115|NCT01213264|193668|P3|STARTED|Overall Study||327
83116|NCT01213264|193669|P2|STARTED|Overall Study||177
83117|NCT01213264|193670|P1|STARTED|Overall Study||155
83118|NCT01213251|193690|P3|NOT COMPLETED|Overall Study||11
83119|NCT01213251|193691|P2|NOT COMPLETED|Overall Study||4
83120|NCT01213251|193692|P1|NOT COMPLETED|Overall Study||6
83121|NCT01213251|193690|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
83122|NCT01213251|193691|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
83123|NCT01213251|193692|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
83124|NCT01213251|193690|P3|STARTED|Overall Study||45
83125|NCT01213251|193691|P2|STARTED|Overall Study||41
83126|NCT01213251|193692|P1|STARTED|Overall Study||40
83127|NCT01213199|193713|P1|NOT COMPLETED|Overall Study||4
83128|NCT01213199|193713|P1|COMPLETED|Overall Study||16
83129|NCT01213199|193713|P1|STARTED|Overall Study||20
83130|NCT01213173|193719|P2|NOT COMPLETED|Overall Study||16
83131|NCT01213173|193720|P1|NOT COMPLETED|Overall Study||12
83132|NCT01213173|193719|P2|COMPLETED|Overall Study|Patients who completed the study|110
83133|NCT01213173|193720|P1|COMPLETED|Overall Study|Patients who completed the study|113
83134|NCT01213173|193719|P2|Patients Included in PP Population|Overall Study||89
83135|NCT01213173|193720|P1|Patients Included in PP Population|Overall Study||102
83136|NCT01213173|193719|P2|Patients Included in ITT Population|Overall Study||115
83137|NCT01213173|193720|P1|Patients Included in ITT Population|Overall Study||116
83138|NCT01213173|193719|P2|Patients Included in Safety Population|Overall Study||112
83139|NCT01213173|193720|P1|Patients Included in Safety Population|Overall Study||139
83140|NCT01213173|193719|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
83141|NCT01213173|193720|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
83142|NCT01213043|193752|P2|NOT COMPLETED|Follow-up||0
83143|NCT01213043|193753|P1|NOT COMPLETED|Follow-up||0
83144|NCT01213043|193752|P2|COMPLETED|Follow-up||15
83145|NCT01213043|193753|P1|COMPLETED|Follow-up||15
83146|NCT01213043|193752|P2|STARTED|Follow-up||15
83147|NCT01213043|193753|P1|STARTED|Follow-up||15
83148|NCT01213043|193752|P2|NOT COMPLETED|Treatment Period 2||0
83149|NCT01213043|193753|P1|NOT COMPLETED|Treatment Period 2||0
83150|NCT01213043|193752|P2|COMPLETED|Treatment Period 2||15
83151|NCT01213043|193753|P1|COMPLETED|Treatment Period 2||15
83152|NCT01213043|193752|P2|STARTED|Treatment Period 2||15
83153|NCT01213043|193753|P1|STARTED|Treatment Period 2||15
83154|NCT01213043|193752|P2|NOT COMPLETED|Washout Period||0
83155|NCT01213043|193753|P1|NOT COMPLETED|Washout Period||0
83156|NCT01213043|193752|P2|COMPLETED|Washout Period||15
83157|NCT01213043|193753|P1|COMPLETED|Washout Period||15
83158|NCT01213043|193752|P2|STARTED|Washout Period||15
83159|NCT01213043|193753|P1|STARTED|Washout Period||15
83160|NCT01213043|193752|P2|NOT COMPLETED|Treatment Period 1||0
83161|NCT01213043|193753|P1|NOT COMPLETED|Treatment Period 1||0
83162|NCT01213043|193752|P2|COMPLETED|Treatment Period 1||15
83163|NCT01213043|193753|P1|COMPLETED|Treatment Period 1||15
83164|NCT01213043|193752|P2|STARTED|Treatment Period 1||15
83165|NCT01213043|193753|P1|STARTED|Treatment Period 1||15
83166|NCT01212991|193781|P2|NOT COMPLETED|Overall Study||374
83167|NCT01212991|193782|P1|NOT COMPLETED|Overall Study||613
83168|NCT01212991|193781|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
83169|NCT01212991|193782|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
83170|NCT01212991|193781|P2|STARTED|Overall Study||845
83171|NCT01212991|193782|P1|STARTED|Overall Study||872
83172|NCT01212874|193802|P2|NOT COMPLETED|Overall Study||23
83173|NCT01212874|193803|P1|NOT COMPLETED|Overall Study||22
83174|NCT01212874|193802|P2|COMPLETED|Overall Study||12
83175|NCT01212874|193803|P1|COMPLETED|Overall Study||13
83176|NCT01212874|193802|P2|Received Allocated Intervention|Overall Study||12
83177|NCT01212874|193803|P1|Received Allocated Intervention|Overall Study||13
83178|NCT01212874|193802|P2|STARTED|Overall Study||35
83179|NCT01212874|193803|P1|STARTED|Overall Study||35
83180|NCT01212770|193814|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
83181|NCT01212770|193815|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
83182|NCT01212770|193816|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
83183|NCT01212770|193817|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
83184|NCT01212770|193818|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
83185|NCT01212770|193819|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
83186|NCT01212770|193820|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
83187|NCT01212770|193814|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
83188|NCT01212770|193815|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
83189|NCT01212770|193816|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
83190|NCT01212770|193817|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
83191|NCT01212770|193818|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
83192|NCT01212770|193819|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
83193|NCT01212770|193820|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
83194|NCT01212770|193814|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
83195|NCT01212770|193815|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|47
83196|NCT01212770|193816|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
83197|NCT01212770|193817|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|43
83198|NCT01212770|193818|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Seven participants who completed the placebo-controlled phase did not enter this phase|138
83199|NCT01212770|193819|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed the placebo-controlled phase did not enter this phase|139
83200|NCT01212770|193820|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
83201|NCT01212770|193814|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83202|NCT01212770|193815|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83203|NCT01212770|193816|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83204|NCT01212770|193817|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83205|NCT01212770|193818|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
83206|NCT01212770|193819|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
83207|NCT01212770|193820|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
83208|NCT01212770|193814|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83209|NCT01212770|193815|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83210|NCT01212770|193816|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83211|NCT01212770|193817|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83212|NCT01212770|193818|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
83213|NCT01212770|193819|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
83214|NCT01212770|193820|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
83215|NCT01212770|193814|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83216|NCT01212770|193815|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83217|NCT01212770|193816|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83218|NCT01212770|193817|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83219|NCT01212770|193818|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|53
83220|NCT01212770|193819|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
83221|NCT01212770|193820|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|97
83222|NCT01212770|193814|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83223|NCT01212770|193815|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83224|NCT01212770|193816|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83225|NCT01212770|193817|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83226|NCT01212770|193818|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
83227|NCT01212770|193819|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
83228|NCT01212770|193820|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
83229|NCT01212770|193814|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83230|NCT01212770|193815|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83231|NCT01212770|193816|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83232|NCT01212770|193817|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83233|NCT01212770|193818|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
83234|NCT01212770|193819|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
83235|NCT01212770|193820|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
83236|NCT01212770|193814|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83237|NCT01212770|193815|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83238|NCT01212770|193816|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83239|NCT01212770|193817|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83240|NCT01212770|193818|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
83241|NCT01212770|193819|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
83242|NCT01212770|193820|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
83243|NCT01212757|194010|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
83244|NCT01212757|194011|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
83245|NCT01212757|194012|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
83246|NCT01212757|194013|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||8
83247|NCT01212757|194014|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||20
83248|NCT01212757|194015|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
83249|NCT01212757|194016|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
83250|NCT01212757|194010|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||28
83251|NCT01212757|194011|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
83252|NCT01212757|194012|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||25
83253|NCT01212757|194013|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||35
83254|NCT01212757|194014|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||114
83255|NCT01212757|194015|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||125
83256|NCT01212757|194016|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
83257|NCT01212757|194010|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||28
83258|NCT01212757|194011|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Two participants who escaped early and completed Week 24 did not enter the active treatment phase|41
83259|NCT01212757|194012|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||27
83260|NCT01212757|194013|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)||43
83261|NCT01212757|194014|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed Week 24 did not enter the active treatment phase|134
83262|NCT01212757|194015|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Six participants who completed Week 24 did not enter the active treatment phase|137
83263|NCT01212757|194016|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
83264|NCT01212757|194010|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83265|NCT01212757|194011|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83266|NCT01212757|194012|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83267|NCT01212757|194013|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83268|NCT01212757|194014|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
83269|NCT01212757|194015|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
83270|NCT01212757|194016|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
83271|NCT01212757|194010|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83272|NCT01212757|194011|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83273|NCT01212757|194012|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83274|NCT01212757|194013|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
83275|NCT01212757|194014|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
83276|NCT01212757|194015|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
83277|NCT01212757|194016|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
83278|NCT01212757|194010|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83279|NCT01212757|194011|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83280|NCT01212757|194012|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83281|NCT01212757|194013|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83282|NCT01212757|194014|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
83283|NCT01212757|194015|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
83284|NCT01212757|194016|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
83285|NCT01212757|194010|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83286|NCT01212757|194011|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83287|NCT01212757|194012|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83288|NCT01212757|194013|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
83289|NCT01212757|194014|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
83290|NCT01212757|194015|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
83291|NCT01212757|194016|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
83292|NCT01212757|194010|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83293|NCT01212757|194011|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83294|NCT01212757|194012|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83295|NCT01212757|194013|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
83296|NCT01212757|194014|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
83297|NCT01212757|194015|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
83298|NCT01212757|194016|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
83299|NCT01212757|194010|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83300|NCT01212757|194011|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83301|NCT01212757|194012|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83302|NCT01212757|194013|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
83303|NCT01212757|194014|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
83304|NCT01212757|194015|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
83305|NCT01212757|194016|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
83306|NCT01212627|194193|P1|NOT COMPLETED|Overall Study||0
83307|NCT01212627|194193|P1|COMPLETED|Overall Study||12
83308|NCT01212627|194193|P1|STARTED|Overall Study||12
83309|NCT01212484|194197|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
83310|NCT01212484|194198|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
83311|NCT01212484|194197|P2|COMPLETED|Second Intervention (4 Weeks)||3
83312|NCT01212484|194198|P1|COMPLETED|Second Intervention (4 Weeks)||5
83313|NCT01212484|194197|P2|STARTED|Second Intervention (4 Weeks)||4
83314|NCT01212484|194198|P1|STARTED|Second Intervention (4 Weeks)||5
83315|NCT01212484|194197|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
83316|NCT01212484|194198|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
83317|NCT01212484|194197|P2|COMPLETED|First Intervention (4 Weeks)||4
83318|NCT01212484|194198|P1|COMPLETED|First Intervention (4 Weeks)||5
83319|NCT01212484|194197|P2|STARTED|First Intervention (4 Weeks)||6
83320|NCT01212484|194198|P1|STARTED|First Intervention (4 Weeks)||5
83321|NCT01212484|194197|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
83322|NCT01212484|194198|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
83323|NCT01212484|194197|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
83324|NCT01212484|194198|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
83325|NCT01212484|194197|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
83326|NCT01212484|194198|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
83327|NCT01212445|194211|P3|NOT COMPLETED|Overall Study||0
83328|NCT01212445|194212|P2|NOT COMPLETED|Overall Study||0
83329|NCT01212445|194213|P1|NOT COMPLETED|Overall Study||0
83330|NCT01212445|194211|P3|COMPLETED|Overall Study||51
83331|NCT01212445|194212|P2|COMPLETED|Overall Study||51
83332|NCT01212445|194213|P1|COMPLETED|Overall Study||52
83333|NCT01212445|194211|P3|STARTED|Overall Study||51
83334|NCT01212445|194212|P2|STARTED|Overall Study||51
83335|NCT01212445|194213|P1|STARTED|Overall Study||52
83336|NCT01212302|194242|P1|NOT COMPLETED|Overall Study||0
83337|NCT01212302|194242|P1|COMPLETED|Overall Study||504
83338|NCT01212302|194242|P1|STARTED|Overall Study||504
83339|NCT01212185|194248|P2|NOT COMPLETED|Overall Study||1
83340|NCT01212185|194249|P1|NOT COMPLETED|Overall Study||2
83341|NCT01212185|194248|P2|COMPLETED|Overall Study||7
83342|NCT01212185|194249|P1|COMPLETED|Overall Study||4
83343|NCT01212185|194248|P2|STARTED|Overall Study||8
83344|NCT01212185|194249|P1|STARTED|Overall Study||6
83345|NCT01212172|194257|P2|NOT COMPLETED|Overall Study||1
83346|NCT01212172|194258|P1|NOT COMPLETED|Overall Study||1
83347|NCT01212172|194257|P2|COMPLETED|Overall Study||9
83348|NCT01212172|194258|P1|COMPLETED|Overall Study||9
83349|NCT01212172|194257|P2|STARTED|Overall Study||10
83350|NCT01212172|194258|P1|STARTED|Overall Study||10
83351|NCT01212159|194268|P2|NOT COMPLETED|Overall Study||12
83352|NCT01212159|194269|P1|NOT COMPLETED|Overall Study||12
83353|NCT01212159|194268|P2|COMPLETED|Overall Study||32
83354|NCT01212159|194269|P1|COMPLETED|Overall Study||14
83355|NCT01212159|194268|P2|STARTED|Overall Study||44
83356|NCT01212159|194269|P1|STARTED|Overall Study||26
83357|NCT01212094|194282|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
83358|NCT01212094|194283|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
83359|NCT01212094|194284|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
83360|NCT01212094|194282|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
83361|NCT01212094|194283|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
83362|NCT01212094|194284|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
83363|NCT01212094|194282|P3|STARTED|Years 2 & 3: Treatment Randomization||18
83364|NCT01212094|194283|P2|STARTED|Years 2 & 3: Treatment Randomization||9
83365|NCT01212094|194284|P1|STARTED|Years 2 & 3: Treatment Randomization||0
83366|NCT01212094|194282|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
83367|NCT01212094|194283|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
83368|NCT01212094|194284|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
83369|NCT01212094|194282|P3|COMPLETED|Year 1: Baseline Monitoring||0
83370|NCT01212094|194283|P2|COMPLETED|Year 1: Baseline Monitoring||0
83371|NCT01212094|194284|P1|COMPLETED|Year 1: Baseline Monitoring||27
83372|NCT01212094|194282|P3|STARTED|Year 1: Baseline Monitoring||0
83373|NCT01212094|194283|P2|STARTED|Year 1: Baseline Monitoring||0
83374|NCT01212094|194284|P1|STARTED|Year 1: Baseline Monitoring||43
83375|NCT01211873|194318|P3|NOT COMPLETED|Overall Study||2
83376|NCT01211873|194319|P2|NOT COMPLETED|Overall Study||2
83377|NCT01211873|194320|P1|NOT COMPLETED|Overall Study||5
83378|NCT01211873|194318|P3|COMPLETED|Overall Study||36
83379|NCT01211873|194319|P2|COMPLETED|Overall Study||117
83380|NCT01211873|194320|P1|COMPLETED|Overall Study||240
83381|NCT01211873|194318|P3|STARTED|Overall Study||38
83382|NCT01211873|194319|P2|STARTED|Overall Study||119
83383|NCT01211873|194320|P1|STARTED|Overall Study||245
83384|NCT01211769|194331|P4|NOT COMPLETED|Overall Study||11
83385|NCT01211769|194332|P3|NOT COMPLETED|Overall Study||8
83386|NCT01211769|194333|P2|NOT COMPLETED|Overall Study||10
83387|NCT01211769|194334|P1|NOT COMPLETED|Overall Study||9
83388|NCT01211769|194331|P4|COMPLETED|Overall Study||9
83389|NCT01211769|194332|P3|COMPLETED|Overall Study||12
83390|NCT01211769|194333|P2|COMPLETED|Overall Study||10
83391|NCT01211769|194334|P1|COMPLETED|Overall Study||11
83392|NCT01211769|194331|P4|Participants/Group|Overall Study||20
83393|NCT01211769|194332|P3|Participants/Group|Overall Study||20
83394|NCT01211769|194333|P2|Participants/Group|Overall Study||20
83395|NCT01211769|194334|P1|Participants/Group|Overall Study||20
83396|NCT01211769|194331|P4|STARTED|Overall Study||20
83397|NCT01211769|194332|P3|STARTED|Overall Study||20
83398|NCT01211769|194333|P2|STARTED|Overall Study||20
83399|NCT01211769|194334|P1|STARTED|Overall Study||20
83400|NCT01211730|194354|P2|NOT COMPLETED|Overall Study||0
83401|NCT01211730|194355|P1|NOT COMPLETED|Overall Study||0
83402|NCT01211730|194354|P2|COMPLETED|Overall Study||82
83403|NCT01211730|194355|P1|COMPLETED|Overall Study||82
83404|NCT01211730|194354|P2|STARTED|Overall Study||82
83405|NCT01211730|194355|P1|STARTED|Overall Study||82
83406|NCT01211665|194373|P2|NOT COMPLETED|Overall Study||0
83407|NCT01211665|194374|P1|NOT COMPLETED|Overall Study||2
83408|NCT01211665|194373|P2|COMPLETED|Overall Study|completed treatment with study drug|1
83409|NCT01211665|194374|P1|COMPLETED|Overall Study||0
83410|NCT01211665|194373|P2|STARTED|Overall Study||1
83411|NCT01211665|194374|P1|STARTED|Overall Study||2
83412|NCT01211613|194401|P3|NOT COMPLETED|Overall Study||2
83413|NCT01211613|194402|P2|NOT COMPLETED|Overall Study||2
83414|NCT01211613|194403|P1|NOT COMPLETED|Overall Study||3
83415|NCT01211613|194401|P3|COMPLETED|Overall Study||33
83416|NCT01211613|194402|P2|COMPLETED|Overall Study||33
83417|NCT01211613|194403|P1|COMPLETED|Overall Study||34
83418|NCT01211613|194401|P3|STARTED|Overall Study||35
83419|NCT01211613|194402|P2|STARTED|Overall Study||35
83420|NCT01211613|194403|P1|STARTED|Overall Study||37
83421|NCT01211535|194416|P2|NOT COMPLETED|Overall Study||1
83422|NCT01211535|194417|P1|NOT COMPLETED|Overall Study||0
83423|NCT01211535|194416|P2|COMPLETED|Overall Study||51
83424|NCT01211535|194417|P1|COMPLETED|Overall Study||52
83425|NCT01211535|194416|P2|STARTED|Overall Study||52
83426|NCT01211535|194417|P1|STARTED|Overall Study||52
83427|NCT01211197|194423|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83428|NCT01211197|194424|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83429|NCT01211197|194425|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83430|NCT01211197|194426|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83431|NCT01211197|194427|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83432|NCT01211197|194428|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
83433|NCT01211197|194423|P6|COMPLETED|Treatment Period 3 (1 Day)||2
83434|NCT01211197|194424|P5|COMPLETED|Treatment Period 3 (1 Day)||2
83435|NCT01211197|194425|P4|COMPLETED|Treatment Period 3 (1 Day)||3
83436|NCT01211197|194426|P3|COMPLETED|Treatment Period 3 (1 Day)||2
83437|NCT01211197|194427|P2|COMPLETED|Treatment Period 3 (1 Day)||3
83438|NCT01211197|194428|P1|COMPLETED|Treatment Period 3 (1 Day)||2
83439|NCT01211197|194423|P6|STARTED|Treatment Period 3 (1 Day)||2
83440|NCT01211197|194424|P5|STARTED|Treatment Period 3 (1 Day)||2
83441|NCT01211197|194425|P4|STARTED|Treatment Period 3 (1 Day)||3
83442|NCT01211197|194426|P3|STARTED|Treatment Period 3 (1 Day)||2
83443|NCT01211197|194427|P2|STARTED|Treatment Period 3 (1 Day)||3
83444|NCT01211197|194428|P1|STARTED|Treatment Period 3 (1 Day)||2
83445|NCT01211197|194423|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
83446|NCT01211197|194424|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
83447|NCT01211197|194425|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
83448|NCT01211197|194426|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
83449|NCT01211197|194427|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
83450|NCT01211197|194428|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
83451|NCT01211197|194423|P6|COMPLETED|Washout Period 2 (7 Days)||2
83452|NCT01211197|194424|P5|COMPLETED|Washout Period 2 (7 Days)||2
83453|NCT01211197|194425|P4|COMPLETED|Washout Period 2 (7 Days)||3
83454|NCT01211197|194426|P3|COMPLETED|Washout Period 2 (7 Days)||2
83455|NCT01211197|194427|P2|COMPLETED|Washout Period 2 (7 Days)||3
83456|NCT01211197|194428|P1|COMPLETED|Washout Period 2 (7 Days)||2
83457|NCT01211197|194423|P6|STARTED|Washout Period 2 (7 Days)||2
83458|NCT01211197|194424|P5|STARTED|Washout Period 2 (7 Days)||2
83459|NCT01211197|194425|P4|STARTED|Washout Period 2 (7 Days)||3
83460|NCT01211197|194426|P3|STARTED|Washout Period 2 (7 Days)||2
83461|NCT01211197|194427|P2|STARTED|Washout Period 2 (7 Days)||3
83462|NCT01211197|194428|P1|STARTED|Washout Period 2 (7 Days)||3
83463|NCT01211197|194423|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83464|NCT01211197|194424|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83465|NCT01211197|194425|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83466|NCT01211197|194426|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83467|NCT01211197|194427|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83468|NCT01211197|194428|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
83469|NCT01211197|194423|P6|COMPLETED|Treatment Period 2 (1 Day)||2
83470|NCT01211197|194424|P5|COMPLETED|Treatment Period 2 (1 Day)||2
83471|NCT01211197|194425|P4|COMPLETED|Treatment Period 2 (1 Day)||3
83472|NCT01211197|194426|P3|COMPLETED|Treatment Period 2 (1 Day)||2
83473|NCT01211197|194427|P2|COMPLETED|Treatment Period 2 (1 Day)||3
83474|NCT01211197|194428|P1|COMPLETED|Treatment Period 2 (1 Day)||3
83475|NCT01211197|194423|P6|STARTED|Treatment Period 2 (1 Day)||2
83476|NCT01211197|194424|P5|STARTED|Treatment Period 2 (1 Day)||2
83477|NCT01211197|194425|P4|STARTED|Treatment Period 2 (1 Day)||3
83478|NCT01211197|194426|P3|STARTED|Treatment Period 2 (1 Day)||2
83479|NCT01211197|194427|P2|STARTED|Treatment Period 2 (1 Day)||3
83480|NCT01211197|194428|P1|STARTED|Treatment Period 2 (1 Day)||3
83481|NCT01211197|194423|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
83482|NCT01211197|194424|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
83483|NCT01211197|194425|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
83484|NCT01211197|194426|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
83485|NCT01211197|194427|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
83486|NCT01211197|194428|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
83487|NCT01211197|194423|P6|COMPLETED|Washout Period 1 (7 Days)||2
83488|NCT01211197|194424|P5|COMPLETED|Washout Period 1 (7 Days)||2
83489|NCT01211197|194425|P4|COMPLETED|Washout Period 1 (7 Days)||3
83490|NCT01211197|194426|P3|COMPLETED|Washout Period 1 (7 Days)||2
83491|NCT01211197|194427|P2|COMPLETED|Washout Period 1 (7 Days)||3
83492|NCT01211197|194428|P1|COMPLETED|Washout Period 1 (7 Days)||3
83493|NCT01211197|194423|P6|STARTED|Washout Period 1 (7 Days)||2
83494|NCT01211197|194424|P5|STARTED|Washout Period 1 (7 Days)||2
83495|NCT01211197|194425|P4|STARTED|Washout Period 1 (7 Days)||3
83496|NCT01211197|194426|P3|STARTED|Washout Period 1 (7 Days)||3
83497|NCT01211197|194427|P2|STARTED|Washout Period 1 (7 Days)||3
83498|NCT01211197|194428|P1|STARTED|Washout Period 1 (7 Days)||3
83499|NCT01211197|194423|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83500|NCT01211197|194424|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83501|NCT01211197|194425|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83502|NCT01211197|194426|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83503|NCT01211197|194427|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83504|NCT01211197|194428|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
83505|NCT01211197|194423|P6|COMPLETED|Treatment Period 1 (1 Day)||2
83506|NCT01211197|194424|P5|COMPLETED|Treatment Period 1 (1 Day)||2
83507|NCT01211197|194425|P4|COMPLETED|Treatment Period 1 (1 Day)||3
83508|NCT01211197|194426|P3|COMPLETED|Treatment Period 1 (1 Day)||3
83509|NCT01211197|194427|P2|COMPLETED|Treatment Period 1 (1 Day)||3
83510|NCT01211197|194428|P1|COMPLETED|Treatment Period 1 (1 Day)||3
83511|NCT01211197|194423|P6|STARTED|Treatment Period 1 (1 Day)||2
83512|NCT01211197|194424|P5|STARTED|Treatment Period 1 (1 Day)||2
83513|NCT01211197|194425|P4|STARTED|Treatment Period 1 (1 Day)||3
83514|NCT01211197|194426|P3|STARTED|Treatment Period 1 (1 Day)||3
83515|NCT01211197|194427|P2|STARTED|Treatment Period 1 (1 Day)||3
83516|NCT01211197|194428|P1|STARTED|Treatment Period 1 (1 Day)||3
83517|NCT01211184|194475|P3|NOT COMPLETED|Overall Study||1
83518|NCT01211184|194476|P2|NOT COMPLETED|Overall Study||2
83519|NCT01211184|194477|P1|NOT COMPLETED|Overall Study||0
83520|NCT01211184|194475|P3|COMPLETED|Overall Study||19
83521|NCT01211184|194476|P2|COMPLETED|Overall Study||18
83522|NCT01211184|194477|P1|COMPLETED|Overall Study||20
83523|NCT01211184|194475|P3|STARTED|Overall Study||20
83524|NCT01211184|194476|P2|STARTED|Overall Study||20
83525|NCT01211184|194477|P1|STARTED|Overall Study||20
83526|NCT01211145|194492|P4|NOT COMPLETED|Overall Study||20
83527|NCT01211145|194493|P3|NOT COMPLETED|Overall Study||13
83528|NCT01211145|194494|P2|NOT COMPLETED|Overall Study||17
83529|NCT01211145|194495|P1|NOT COMPLETED|Overall Study||26
83530|NCT01211145|194492|P4|COMPLETED|Overall Study||268
83531|NCT01211145|194493|P3|COMPLETED|Overall Study||86
83532|NCT01211145|194494|P2|COMPLETED|Overall Study||98
83533|NCT01211145|194495|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
83534|NCT01211145|194492|P4|STARTED|Overall Study||288
83535|NCT01211145|194493|P3|STARTED|Overall Study||99
83536|NCT01211145|194494|P2|STARTED|Overall Study||115
83537|NCT01211145|194495|P1|STARTED|Overall Study||296
83538|NCT01210820|194527|P2|NOT COMPLETED|Overall Study||0
83539|NCT01210820|194528|P1|NOT COMPLETED|Overall Study||0
83540|NCT01210820|194527|P2|COMPLETED|Overall Study||4
83541|NCT01210820|194528|P1|COMPLETED|Overall Study||17
83542|NCT01210820|194527|P2|STARTED|Overall Study||4
83543|NCT01210820|194528|P1|STARTED|Overall Study||17
83544|NCT01210807|194538|P2|NOT COMPLETED|Overall Study||3
83545|NCT01210807|194539|P1|NOT COMPLETED|Overall Study||3
83546|NCT01210807|194538|P2|COMPLETED|Overall Study||31
83547|NCT01210807|194539|P1|COMPLETED|Overall Study||33
83548|NCT01210807|194538|P2|STARTED|Overall Study||34
83549|NCT01210807|194539|P1|STARTED|Overall Study||36
83550|NCT01210716|194547|P2|NOT COMPLETED|Second TPE Procedure||0
83551|NCT01210716|194548|P1|NOT COMPLETED|Second TPE Procedure||3
83552|NCT01210716|194547|P2|COMPLETED|Second TPE Procedure||15
83553|NCT01210716|194548|P1|COMPLETED|Second TPE Procedure||15
83554|NCT01210716|194547|P2|STARTED|Second TPE Procedure||15
83555|NCT01210716|194548|P1|STARTED|Second TPE Procedure||18
83556|NCT01210716|194547|P2|NOT COMPLETED|First TPE Procedure||2
83557|NCT01210716|194548|P1|NOT COMPLETED|First TPE Procedure||2
83558|NCT01210716|194547|P2|COMPLETED|First TPE Procedure||15
83559|NCT01210716|194548|P1|COMPLETED|First TPE Procedure||18
83560|NCT01210716|194547|P2|STARTED|First TPE Procedure||17
83561|NCT01210716|194548|P1|STARTED|First TPE Procedure||20
83562|NCT01210690|194554|P1|NOT COMPLETED|Overall Study||26
83563|NCT01210690|194554|P1|COMPLETED|Overall Study||75
83564|NCT01210690|194554|P1|STARTED|Overall Study||101
83565|NCT01210651|194569|P2|NOT COMPLETED|Overall Study||8
83566|NCT01210651|194570|P1|NOT COMPLETED|Overall Study||5
83567|NCT01210651|194569|P2|COMPLETED|Overall Study||10
83568|NCT01210651|194570|P1|COMPLETED|Overall Study||15
83569|NCT01210651|194569|P2|Number Attending 1st Assigned Session|Overall Study||12
83570|NCT01210651|194570|P1|Number Attending 1st Assigned Session|Overall Study||18
83571|NCT01210651|194569|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
83572|NCT01210651|194570|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
83573|NCT01210495|194588|P4|NOT COMPLETED|Overall Study||68
83574|NCT01210495|194589|P3|NOT COMPLETED|Overall Study||134
83575|NCT01210495|194590|P2|NOT COMPLETED|Overall Study||7
83576|NCT01210495|194591|P1|NOT COMPLETED|Overall Study||15
83577|NCT01210495|194588|P4|COMPLETED|Overall Study||0
83578|NCT01210495|194589|P3|COMPLETED|Overall Study||0
83579|NCT01210495|194590|P2|COMPLETED|Overall Study||0
83580|NCT01210495|194591|P1|COMPLETED|Overall Study||0
83581|NCT01210495|194588|P4|STARTED|Overall Study||68
83582|NCT01210495|194589|P3|STARTED|Overall Study||134
83583|NCT01210495|194590|P2|STARTED|Overall Study||7
83584|NCT01210495|194591|P1|STARTED|Overall Study||15
83585|NCT01210443|194653|P1|NOT COMPLETED|Overall Study||2
83586|NCT01210443|194653|P1|COMPLETED|Overall Study||0
83587|NCT01210443|194653|P1|STARTED|Overall Study||2
83588|NCT01210170|194661|P1|NOT COMPLETED|Overall Study||7
83589|NCT01210170|194661|P1|COMPLETED|Overall Study||15
83590|NCT01210170|194661|P1|STARTED|Overall Study||22
83591|NCT01210144|194677|P2|NOT COMPLETED|Overall Study||0
83592|NCT01210144|194678|P1|NOT COMPLETED|Overall Study||3
83593|NCT01210144|194677|P2|COMPLETED|Overall Study||11
83594|NCT01210144|194678|P1|COMPLETED|Overall Study||10
83595|NCT01210144|194677|P2|STARTED|Overall Study||11
83596|NCT01210144|194678|P1|STARTED|Overall Study||13
83597|NCT01210118|194700|P2|NOT COMPLETED|Overall Study||5
83598|NCT01210118|194701|P1|NOT COMPLETED|Overall Study||3
83599|NCT01210118|194700|P2|COMPLETED|Overall Study||42
83600|NCT01210118|194701|P1|COMPLETED|Overall Study||42
83601|NCT01210118|194700|P2|STARTED|Overall Study||47
83602|NCT01210118|194701|P1|STARTED|Overall Study||45
83603|NCT01210079|194715|P2|NOT COMPLETED|Overall Study||0
83604|NCT01210079|194716|P1|NOT COMPLETED|Overall Study||0
83605|NCT01210079|194715|P2|COMPLETED|Overall Study||16
83606|NCT01210079|194716|P1|COMPLETED|Overall Study||10
83607|NCT01210079|194715|P2|STARTED|Overall Study||16
83608|NCT01210079|194716|P1|STARTED|Overall Study||10
83609|NCT01210001|194725|P3|NOT COMPLETED|Overall Study||12
83610|NCT01210001|194726|P2|NOT COMPLETED|Overall Study||11
83611|NCT01210001|194727|P1|NOT COMPLETED|Overall Study||19
83612|NCT01210001|194725|P3|COMPLETED|Overall Study||156
83613|NCT01210001|194726|P2|COMPLETED|Overall Study||154
83614|NCT01210001|194727|P1|COMPLETED|Overall Study||147
83615|NCT01210001|194725|P3|STARTED|Overall Study||168
83616|NCT01210001|194726|P2|STARTED|Overall Study||165
83617|NCT01210001|194727|P1|STARTED|Overall Study||166
83618|NCT01209949|194747|P1|NOT COMPLETED|Overall Study||3
83619|NCT01209949|194747|P1|COMPLETED|Overall Study||27
83620|NCT01209949|194747|P1|STARTED|Overall Study||30
83621|NCT01209780|194757|P5|NOT COMPLETED|Overall Study||5
83622|NCT01209780|194758|P4|NOT COMPLETED|Overall Study||10
83623|NCT01209780|194759|P3|NOT COMPLETED|Overall Study||4
83624|NCT01209780|194760|P2|NOT COMPLETED|Overall Study||18
83625|NCT01209780|194761|P1|NOT COMPLETED|Overall Study||26
83626|NCT01209780|194757|P5|COMPLETED|Overall Study||407
83627|NCT01209780|194758|P4|COMPLETED|Overall Study||807
83628|NCT01209780|194759|P3|COMPLETED|Overall Study||44
83629|NCT01209780|194760|P2|COMPLETED|Overall Study||467
83630|NCT01209780|194761|P1|COMPLETED|Overall Study||1016
83631|NCT01209780|194757|P5|STARTED|Overall Study||412
83632|NCT01209780|194758|P4|STARTED|Overall Study||817
83633|NCT01209780|194759|P3|STARTED|Overall Study||48
83634|NCT01209780|194760|P2|STARTED|Overall Study||485
83635|NCT01209780|194761|P1|STARTED|Overall Study||1042
83636|NCT01209767|194787|P1|NOT COMPLETED|Overall Study||4
83637|NCT01209767|194787|P1|COMPLETED|Overall Study||18
83638|NCT01209767|194787|P1|STARTED|Overall Study||22
83639|NCT01209702|194797|P4|NOT COMPLETED|Overall Study||153
83640|NCT01209702|194798|P3|NOT COMPLETED|Overall Study||51
83641|NCT01209702|194799|P2|NOT COMPLETED|Overall Study||51
83642|NCT01209702|194800|P1|NOT COMPLETED|Overall Study||51
83643|NCT01209702|194797|P4|COMPLETED|Overall Study||0
83644|NCT01209702|194798|P3|COMPLETED|Overall Study||0
83645|NCT01209702|194799|P2|COMPLETED|Overall Study||0
83646|NCT01209702|194800|P1|COMPLETED|Overall Study||0
83647|NCT01209702|194797|P4|Completed 24 Weeks Treatment|Overall Study||10
83648|NCT01209702|194798|P3|Completed 24 Weeks Treatment|Overall Study||3
83649|NCT01209702|194799|P2|Completed 24 Weeks Treatment|Overall Study||28
83650|NCT01209702|194800|P1|Completed 24 Weeks Treatment|Overall Study||19
83651|NCT01209702|194797|P4|Completed 12 Weeks Treatment|Overall Study||59
83652|NCT01209702|194798|P3|Completed 12 Weeks Treatment|Overall Study||12
83653|NCT01209702|194799|P2|Completed 12 Weeks Treatment|Overall Study||48
83654|NCT01209702|194800|P1|Completed 12 Weeks Treatment|Overall Study||50
83655|NCT01209702|194797|P4|Escape or Switched to Tocilizumab|Overall Study||0
83656|NCT01209702|194798|P3|Escape or Switched to Tocilizumab|Overall Study||6
83657|NCT01209702|194799|P2|Escape or Switched to Tocilizumab|Overall Study||0
83658|NCT01209702|194800|P1|Escape or Switched to Tocilizumab|Overall Study||51
83659|NCT01209702|194797|P4|Treated|Overall Study||152
83660|NCT01209702|194798|P3|Treated|Overall Study||51
83661|NCT01209702|194799|P2|Treated|Overall Study||51
83662|NCT01209702|194800|P1|Treated|Overall Study||51
83663|NCT01209702|194797|P4|STARTED|Overall Study||153
83664|NCT01209702|194798|P3|STARTED|Overall Study||51
83665|NCT01209702|194799|P2|STARTED|Overall Study||51
83666|NCT01209702|194800|P1|STARTED|Overall Study||51
83667|NCT01209689|194856|P2|NOT COMPLETED|Overall Study||22
83668|NCT01209689|194857|P1|NOT COMPLETED|Overall Study||91
83669|NCT01209689|194856|P2|COMPLETED|Overall Study||0
83670|NCT01209689|194857|P1|COMPLETED|Overall Study||0
83671|NCT01209689|194856|P2|STARTED|Overall Study||22
83672|NCT01209689|194857|P1|STARTED|Overall Study||91
83673|NCT01209624|194863|P1|NOT COMPLETED|Overall Study||326
83674|NCT01209624|194863|P1|COMPLETED|Overall Study||576
83675|NCT01209624|194863|P1|Per Protocol Population|Overall Study||469
83676|NCT01209624|194863|P1|STARTED|Overall Study||902
83677|NCT01209520|194894|P1|NOT COMPLETED|Overall Study||3
83678|NCT01209520|194894|P1|COMPLETED|Overall Study||3
83679|NCT01209520|194894|P1|STARTED|Overall Study||6
83680|NCT01209286|194902|P3|NOT COMPLETED|Overall Study||3
83681|NCT01209286|194903|P2|NOT COMPLETED|Overall Study||10
83682|NCT01209286|194904|P1|NOT COMPLETED|Overall Study||5
83683|NCT01209286|194902|P3|COMPLETED|Overall Study||3
83684|NCT01209286|194903|P2|COMPLETED|Overall Study||13
83685|NCT01209286|194904|P1|COMPLETED|Overall Study||2
83686|NCT01209286|194902|P3|STARTED|Overall Study||6
83687|NCT01209286|194903|P2|STARTED|Overall Study||23
83688|NCT01209286|194904|P1|STARTED|Overall Study||7
83689|NCT01209260|194957|P2|NOT COMPLETED|Overall Study||0
83690|NCT01209260|194958|P1|NOT COMPLETED|Overall Study||0
83691|NCT01209260|194957|P2|COMPLETED|Overall Study||36
83692|NCT01209260|194958|P1|COMPLETED|Overall Study||36
83693|NCT01209260|194957|P2|STARTED|Overall Study||36
83694|NCT01209260|194958|P1|STARTED|Overall Study||36
83695|NCT01209195|194972|P6|NOT COMPLETED|Overall Study||0
83696|NCT01209195|194973|P5|NOT COMPLETED|Overall Study||0
83697|NCT01209195|194974|P4|NOT COMPLETED|Overall Study||0
83698|NCT01209195|194975|P3|NOT COMPLETED|Overall Study||0
83699|NCT01209195|194976|P2|NOT COMPLETED|Overall Study||0
83700|NCT01209195|194977|P1|NOT COMPLETED|Overall Study||0
83701|NCT01209195|194972|P6|COMPLETED|Overall Study||13
83702|NCT01209195|194973|P5|COMPLETED|Overall Study||6
83703|NCT01209195|194974|P4|COMPLETED|Overall Study||6
83704|NCT01209195|194975|P3|COMPLETED|Overall Study||6
83705|NCT01209195|194976|P2|COMPLETED|Overall Study||3
83706|NCT01209195|194977|P1|COMPLETED|Overall Study||7
83707|NCT01209195|194972|P6|STARTED|Overall Study||13
83708|NCT01209195|194973|P5|STARTED|Overall Study||6
83709|NCT01209195|194974|P4|STARTED|Overall Study||6
83710|NCT01209195|194975|P3|STARTED|Overall Study||6
83711|NCT01209195|194976|P2|STARTED|Overall Study||3
83712|NCT01209195|194977|P1|STARTED|Overall Study||7
83713|NCT01209143|195013|P2|NOT COMPLETED|Overall Study||20
83714|NCT01209143|195014|P1|NOT COMPLETED|Overall Study||19
83715|NCT01209143|195013|P2|COMPLETED|Overall Study||8
83716|NCT01209143|195014|P1|COMPLETED|Overall Study||5
83717|NCT01209143|195013|P2|STARTED|Overall Study||28
83718|NCT01209143|195014|P1|STARTED|Overall Study||24
83719|NCT01208961|195022|P2|NOT COMPLETED|High-Fat Period IV||0
83720|NCT01208961|195023|P1|NOT COMPLETED|High-Fat Period IV||0
83721|NCT01208961|195022|P2|COMPLETED|High-Fat Period IV||26
83722|NCT01208961|195023|P1|COMPLETED|High-Fat Period IV||25
83723|NCT01208961|195022|P2|STARTED|High-Fat Period IV||26
83724|NCT01208961|195023|P1|STARTED|High-Fat Period IV||25
83725|NCT01208961|195022|P2|NOT COMPLETED|High-Fat Period III||0
83726|NCT01208961|195023|P1|NOT COMPLETED|High-Fat Period III||1
83727|NCT01208961|195022|P2|COMPLETED|High-Fat Period III||26
83728|NCT01208961|195023|P1|COMPLETED|High-Fat Period III||25
83729|NCT01208961|195022|P2|STARTED|High-Fat Period III||26
83730|NCT01208961|195023|P1|STARTED|High-Fat Period III||26
83731|NCT01208961|195022|P2|NOT COMPLETED|Low-Fat Period II||0
83732|NCT01208961|195023|P1|NOT COMPLETED|Low-Fat Period II||0
83733|NCT01208961|195022|P2|COMPLETED|Low-Fat Period II||27
83734|NCT01208961|195023|P1|COMPLETED|Low-Fat Period II||26
83735|NCT01208961|195022|P2|STARTED|Low-Fat Period II||27
83736|NCT01208961|195023|P1|STARTED|Low-Fat Period II||26
83737|NCT01208961|195022|P2|NOT COMPLETED|Low-Fat Period I||0
83738|NCT01208961|195023|P1|NOT COMPLETED|Low-Fat Period I||0
83739|NCT01208961|195022|P2|COMPLETED|Low-Fat Period I||27
83740|NCT01208961|195023|P1|COMPLETED|Low-Fat Period I||27
83741|NCT01208961|195022|P2|STARTED|Low-Fat Period I||27
83742|NCT01208961|195023|P1|STARTED|Low-Fat Period I||27
83743|NCT01207596|195032|P1|NOT COMPLETED|Overall Study||9
83744|NCT01207596|195032|P1|COMPLETED|Overall Study||21
83745|NCT01207596|195032|P1|STARTED|Overall Study||30
83746|NCT01207583|195045|P3|NOT COMPLETED|Overall Study||1
83747|NCT01207583|195046|P2|NOT COMPLETED|Overall Study||5
83748|NCT01207583|195047|P1|NOT COMPLETED|Overall Study||1
83749|NCT01207583|195045|P3|COMPLETED|Overall Study||54
83750|NCT01207583|195046|P2|COMPLETED|Overall Study||26
83751|NCT01207583|195047|P1|COMPLETED|Overall Study||13
83752|NCT01207583|195045|P3|Dose 4|Overall Study||0
83753|NCT01207583|195046|P2|Dose 4|Overall Study||0
83754|NCT01207583|195047|P1|Dose 4|Overall Study||7
83755|NCT01207583|195045|P3|Dose 3|Overall Study||0
83756|NCT01207583|195046|P2|Dose 3|Overall Study||27
83757|NCT01207583|195047|P1|Dose 3|Overall Study||13
83758|NCT01207583|195045|P3|Dose 2|Overall Study||54
83759|NCT01207583|195046|P2|Dose 2|Overall Study||29
83760|NCT01207583|195047|P1|Dose 2|Overall Study||13
83761|NCT01207583|195045|P3|Dose 1|Overall Study||55
83762|NCT01207583|195046|P2|Dose 1|Overall Study||31
83763|NCT01207583|195047|P1|Dose 1|Overall Study||14
83764|NCT01207583|195045|P3|STARTED|Overall Study||55
83765|NCT01207583|195046|P2|STARTED|Overall Study||31
83766|NCT01207583|195047|P1|STARTED|Overall Study||14
83767|NCT01207570|195087|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
83768|NCT01207570|195088|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
83769|NCT01207570|195087|P2|COMPLETED|The Second Stage (After Crossover)||23
83770|NCT01207570|195088|P1|COMPLETED|The Second Stage (After Crossover)||31
83771|NCT01207570|195087|P2|STARTED|The Second Stage (After Crossover)||23
83772|NCT01207570|195088|P1|STARTED|The Second Stage (After Crossover)||31
83773|NCT01207570|195087|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
83774|NCT01207570|195088|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
83775|NCT01207570|195087|P2|COMPLETED|The First Stage (Before Crossover)||31
83776|NCT01207570|195088|P1|COMPLETED|The First Stage (Before Crossover)||23
83777|NCT01207570|195087|P2|STARTED|The First Stage (Before Crossover)||31
83778|NCT01207570|195088|P1|STARTED|The First Stage (Before Crossover)||23
83779|NCT01208402|195102|P2|NOT COMPLETED|Overall Study||0
83780|NCT01208402|195103|P1|NOT COMPLETED|Overall Study||1
83781|NCT01208402|195102|P2|COMPLETED|Overall Study||28
83782|NCT01208402|195103|P1|COMPLETED|Overall Study||30
83783|NCT01208402|195102|P2|STARTED|Overall Study||28
83784|NCT01208402|195103|P1|STARTED|Overall Study||31
83785|NCT01208337|195119|P1|NOT COMPLETED|Overall Study||3
83786|NCT01208337|195119|P1|COMPLETED|Overall Study||20
83787|NCT01208337|195119|P1|Five-year Follow-up|Overall Study||20
83788|NCT01208337|195119|P1|One-year Follow-up|Overall Study||23
83789|NCT01208337|195119|P1|STARTED|Overall Study||23
83790|NCT01208233|195133|P6|NOT COMPLETED|Overall Study||21
83791|NCT01208233|195134|P5|NOT COMPLETED|Overall Study||24
83792|NCT01208233|195135|P4|NOT COMPLETED|Overall Study||1
83793|NCT01208233|195136|P3|NOT COMPLETED|Overall Study||4
83794|NCT01208233|195137|P2|NOT COMPLETED|Overall Study||3
83795|NCT01208233|195138|P1|NOT COMPLETED|Overall Study||5
83796|NCT01208233|195133|P6|COMPLETED|Overall Study||46
83797|NCT01208233|195134|P5|COMPLETED|Overall Study||46
83798|NCT01208233|195135|P4|COMPLETED|Overall Study||9
83799|NCT01208233|195136|P3|COMPLETED|Overall Study||7
83800|NCT01208233|195137|P2|COMPLETED|Overall Study||6
83801|NCT01208233|195138|P1|COMPLETED|Overall Study||6
83802|NCT01208233|195133|P6|STARTED|Overall Study||67
83803|NCT01208233|195134|P5|STARTED|Overall Study||70
83804|NCT01208233|195135|P4|STARTED|Overall Study||10
83805|NCT01208233|195136|P3|STARTED|Overall Study||11
83806|NCT01208233|195137|P2|STARTED|Overall Study||9
83807|NCT01208233|195138|P1|STARTED|Overall Study||11
83808|NCT01208220|195251|P2|NOT COMPLETED|Overall Study||0
83809|NCT01208220|195252|P1|NOT COMPLETED|Overall Study||0
83810|NCT01208220|195251|P2|COMPLETED|Overall Study||1
83811|NCT01208220|195252|P1|COMPLETED|Overall Study||1
83812|NCT01208220|195251|P2|STARTED|Overall Study||1
83813|NCT01208220|195252|P1|STARTED|Overall Study||1
83814|NCT01208207|195263|P7|NOT COMPLETED|Part II||11
83815|NCT01208207|195264|P6|NOT COMPLETED|Part II||16
83816|NCT01208207|195265|P5|NOT COMPLETED|Part II||23
83817|NCT01208207|195266|P4|NOT COMPLETED|Part II||32
83818|NCT01208207|195267|P3|NOT COMPLETED|Part II||0
83819|NCT01208207|195268|P2|NOT COMPLETED|Part II||0
83820|NCT01208207|195269|P1|NOT COMPLETED|Part II||0
83821|NCT01208207|195263|P7|COMPLETED|Part II||131
83822|NCT01208207|195264|P6|COMPLETED|Part II||129
83823|NCT01208207|195265|P5|COMPLETED|Part II||295
83824|NCT01208207|195266|P4|COMPLETED|Part II||282
83825|NCT01208207|195267|P3|COMPLETED|Part II||0
83826|NCT01208207|195268|P2|COMPLETED|Part II||0
83827|NCT01208207|195269|P1|COMPLETED|Part II||0
83828|NCT01208207|195263|P7|STARTED|Part II||142
83829|NCT01208207|195264|P6|STARTED|Part II||145
83830|NCT01208207|195265|P5|STARTED|Part II||318
83831|NCT01208207|195266|P4|STARTED|Part II||314
83832|NCT01208207|195267|P3|STARTED|Part II||0
83833|NCT01208207|195268|P2|STARTED|Part II||0
83834|NCT01208207|195269|P1|STARTED|Part II||0
83835|NCT01208207|195263|P7|NOT COMPLETED|Part I||0
83836|NCT01208207|195264|P6|NOT COMPLETED|Part I||0
83837|NCT01208207|195265|P5|NOT COMPLETED|Part I||0
83838|NCT01208207|195266|P4|NOT COMPLETED|Part I||0
83839|NCT01208207|195267|P3|NOT COMPLETED|Part I||15
83840|NCT01208207|195268|P2|NOT COMPLETED|Part I||11
83841|NCT01208207|195269|P1|NOT COMPLETED|Part I||70
83842|NCT01208207|195263|P7|COMPLETED|Part I||0
83843|NCT01208207|195264|P6|COMPLETED|Part I||0
83844|NCT01208207|195265|P5|COMPLETED|Part I||0
83845|NCT01208207|195266|P4|COMPLETED|Part I||0
83846|NCT01208207|195267|P3|COMPLETED|Part I||142
83847|NCT01208207|195268|P2|COMPLETED|Part I||145
83848|NCT01208207|195269|P1|COMPLETED|Part I||632
83849|NCT01208207|195263|P7|STARTED|Part I||0
83850|NCT01208207|195264|P6|STARTED|Part I||0
83851|NCT01208207|195265|P5|STARTED|Part I||0
83852|NCT01208207|195266|P4|STARTED|Part I||0
83853|NCT01208207|195267|P3|STARTED|Part I||157
83854|NCT01208207|195268|P2|STARTED|Part I||156
83855|NCT01208207|195269|P1|STARTED|Part I||702
83856|NCT01208181|195296|P5|NOT COMPLETED|Part 2||0
83857|NCT01208181|195297|P4|NOT COMPLETED|Part 2||20
83858|NCT01208181|195298|P3|NOT COMPLETED|Part 2||16
83859|NCT01208181|195299|P2|NOT COMPLETED|Part 2||0
83860|NCT01208181|195300|P1|NOT COMPLETED|Part 2||0
83861|NCT01208181|195296|P5|COMPLETED|Part 2||0
83862|NCT01208181|195297|P4|COMPLETED|Part 2||343
83863|NCT01208181|195298|P3|COMPLETED|Part 2||334
83864|NCT01208181|195299|P2|COMPLETED|Part 2||0
83865|NCT01208181|195300|P1|COMPLETED|Part 2||0
83866|NCT01208181|195296|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
83867|NCT01208181|195297|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
83868|NCT01208181|195298|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
83869|NCT01208181|195299|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
83870|NCT01208181|195300|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
83871|NCT01208181|195296|P5|NOT COMPLETED|Part 1||22
83872|NCT01208181|195297|P4|NOT COMPLETED|Part 1||0
83873|NCT01208181|195298|P3|NOT COMPLETED|Part 1||0
83874|NCT01208181|195299|P2|NOT COMPLETED|Part 1||55
83875|NCT01208181|195300|P1|NOT COMPLETED|Part 1||99
83876|NCT01208181|195296|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
83877|NCT01208181|195297|P4|COMPLETED|Part 1||0
83878|NCT01208181|195298|P3|COMPLETED|Part 1||0
83879|NCT01208181|195299|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
83880|NCT01208181|195300|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
83881|NCT01208181|195296|P5|STARTED|Part 1||118
83882|NCT01208181|195297|P4|STARTED|Part 1||0
83883|NCT01208181|195298|P3|STARTED|Part 1||0
83884|NCT01208181|195299|P2|STARTED|Part 1||468
83885|NCT01208181|195300|P1|STARTED|Part 1||818
83886|NCT01207934|195332|P3|NOT COMPLETED|Overall Study||0
83887|NCT01207934|195333|P2|NOT COMPLETED|Overall Study||0
83888|NCT01207934|195334|P1|NOT COMPLETED|Overall Study||0
83889|NCT01207934|195332|P3|COMPLETED|Overall Study||6
83890|NCT01207934|195333|P2|COMPLETED|Overall Study||6
83891|NCT01207934|195334|P1|COMPLETED|Overall Study||6
83892|NCT01207934|195332|P3|STARTED|Overall Study||6
83893|NCT01207934|195333|P2|STARTED|Overall Study||6
83894|NCT01207934|195334|P1|STARTED|Overall Study||6
83895|NCT01207765|195351|P1|NOT COMPLETED|Overall Study||0
83896|NCT01207765|195351|P1|COMPLETED|Overall Study||8
83897|NCT01207765|195351|P1|STARTED|Overall Study||8
83898|NCT01207648|195357|P1|NOT COMPLETED|Overall Study||0
83899|NCT01207648|195357|P1|COMPLETED|Overall Study||307
83900|NCT01207648|195357|P1|STARTED|Overall Study||307
83901|NCT01207492|195365|P1|NOT COMPLETED|Overall Study||15
83902|NCT01207492|195365|P1|COMPLETED|Overall Study||2
83903|NCT01207492|195365|P1|STARTED|Overall Study||17
83904|NCT01207466|195371|P2|NOT COMPLETED|Period 2, One Week of Wear||0
83905|NCT01207466|195372|P1|NOT COMPLETED|Period 2, One Week of Wear||0
83906|NCT01207466|195371|P2|COMPLETED|Period 2, One Week of Wear||48
83907|NCT01207466|195372|P1|COMPLETED|Period 2, One Week of Wear||45
83908|NCT01207466|195371|P2|STARTED|Period 2, One Week of Wear||48
83909|NCT01207466|195372|P1|STARTED|Period 2, One Week of Wear||45
83910|NCT01207466|195371|P2|NOT COMPLETED|Period 1, One Week of Wear||0
83911|NCT01207466|195372|P1|NOT COMPLETED|Period 1, One Week of Wear||0
83912|NCT01207466|195371|P2|COMPLETED|Period 1, One Week of Wear||48
83913|NCT01207466|195372|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
83914|NCT01207466|195371|P2|STARTED|Period 1, One Week of Wear||48
83915|NCT01207466|195372|P1|STARTED|Period 1, One Week of Wear||46
83916|NCT01207453|195380|P2|NOT COMPLETED|2nd Intervention||2
83917|NCT01207453|195381|P1|NOT COMPLETED|2nd Intervention||2
83918|NCT01207453|195380|P2|COMPLETED|2nd Intervention||15
83919|NCT01207453|195381|P1|COMPLETED|2nd Intervention||17
83920|NCT01207453|195380|P2|STARTED|2nd Intervention||17
83921|NCT01207453|195381|P1|STARTED|2nd Intervention||19
83922|NCT01207453|195380|P2|NOT COMPLETED|Washout||0
83923|NCT01207453|195381|P1|NOT COMPLETED|Washout||2
83924|NCT01207453|195380|P2|COMPLETED|Washout||17
83925|NCT01207453|195381|P1|COMPLETED|Washout||19
83926|NCT01207453|195380|P2|STARTED|Washout||17
83927|NCT01207453|195381|P1|STARTED|Washout||21
83928|NCT01207453|195380|P2|NOT COMPLETED|First Intervention||1
83929|NCT01207453|195381|P1|NOT COMPLETED|First Intervention||2
83930|NCT01207453|195380|P2|COMPLETED|First Intervention||17
83931|NCT01207453|195381|P1|COMPLETED|First Intervention||21
83932|NCT01207453|195380|P2|STARTED|First Intervention||18
83933|NCT01207453|195381|P1|STARTED|First Intervention||23
83934|NCT01207427|195403|P3|NOT COMPLETED|Run-out Placebo Period||0
83935|NCT01207427|195404|P2|NOT COMPLETED|Run-out Placebo Period||0
83936|NCT01207427|195405|P1|NOT COMPLETED|Run-out Placebo Period||0
83937|NCT01207427|195403|P3|COMPLETED|Run-out Placebo Period||41
83938|NCT01207427|195404|P2|COMPLETED|Run-out Placebo Period||43
83939|NCT01207427|195405|P1|COMPLETED|Run-out Placebo Period||40
83940|NCT01207427|195403|P3|STARTED|Run-out Placebo Period||41
83941|NCT01207427|195404|P2|STARTED|Run-out Placebo Period||43
83942|NCT01207427|195405|P1|STARTED|Run-out Placebo Period||40
83943|NCT01207427|195403|P3|NOT COMPLETED|Double-blind Treatment Period||2
83944|NCT01207427|195404|P2|NOT COMPLETED|Double-blind Treatment Period||2
83945|NCT01207427|195405|P1|NOT COMPLETED|Double-blind Treatment Period||3
83946|NCT01207427|195403|P3|COMPLETED|Double-blind Treatment Period||41
83947|NCT01207427|195404|P2|COMPLETED|Double-blind Treatment Period||43
83948|NCT01207427|195405|P1|COMPLETED|Double-blind Treatment Period||40
83949|NCT01207427|195403|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
83950|NCT01207427|195404|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
83951|NCT01207427|195405|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
83952|NCT01207427|195403|P3|STARTED|Double-blind Treatment Period||43
83953|NCT01207427|195404|P2|STARTED|Double-blind Treatment Period||45
83954|NCT01207427|195405|P1|STARTED|Double-blind Treatment Period||43
83955|NCT01207427|195403|P3|NOT COMPLETED|Run-in Placebo Period||0
83956|NCT01207427|195404|P2|NOT COMPLETED|Run-in Placebo Period||0
83957|NCT01207427|195405|P1|NOT COMPLETED|Run-in Placebo Period||0
83958|NCT01207427|195403|P3|COMPLETED|Run-in Placebo Period||43
83959|NCT01207427|195404|P2|COMPLETED|Run-in Placebo Period||45
83960|NCT01207427|195405|P1|COMPLETED|Run-in Placebo Period||43
83961|NCT01207427|195403|P3|STARTED|Run-in Placebo Period||43
83962|NCT01207427|195404|P2|STARTED|Run-in Placebo Period||45
83963|NCT01207427|195405|P1|STARTED|Run-in Placebo Period||43
83964|NCT01207414|195415|P2|NOT COMPLETED|Overall Study||82
83965|NCT01207414|195416|P1|NOT COMPLETED|Overall Study||73
83966|NCT01207414|195415|P2|COMPLETED|Overall Study||178
83967|NCT01207414|195416|P1|COMPLETED|Overall Study||168
83968|NCT01207414|195415|P2|Safety Population: Received Study Drug|Overall Study||260
83969|NCT01207414|195416|P1|Safety Population: Received Study Drug|Overall Study||240
83970|NCT01207414|195415|P2|STARTED|Overall Study||260
83971|NCT01207414|195416|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
83972|NCT01207401|195434|P2|NOT COMPLETED|Overall Study||0
83973|NCT01207401|195435|P1|NOT COMPLETED|Overall Study||0
83974|NCT01207401|195434|P2|COMPLETED|Overall Study||24
83975|NCT01207401|195435|P1|COMPLETED|Overall Study||26
83976|NCT01207401|195434|P2|STARTED|Overall Study||24
83977|NCT01207401|195435|P1|STARTED|Overall Study||26
83978|NCT01207388|195441|P1|NOT COMPLETED|Overall Study||33
83979|NCT01207388|195441|P1|COMPLETED|Overall Study|Completed the core study|83
83980|NCT01207388|195441|P1|STARTED|Overall Study||116
83981|NCT01207219|195464|P3|NOT COMPLETED|Overall Study||7
83982|NCT01207219|195465|P2|NOT COMPLETED|Overall Study||11
83983|NCT01207219|195466|P1|NOT COMPLETED|Overall Study||11
83984|NCT01207219|195464|P3|COMPLETED|Overall Study||32
83985|NCT01207219|195465|P2|COMPLETED|Overall Study||29
83986|NCT01207219|195466|P1|COMPLETED|Overall Study||34
83987|NCT01207219|195464|P3|Included in ITT Analysis|Overall Study||38
83988|NCT01207219|195465|P2|Included in ITT Analysis|Overall Study||37
83989|NCT01207219|195466|P1|Included in ITT Analysis|Overall Study||40
83990|NCT01207219|195464|P3|STARTED|Overall Study||39
83991|NCT01207219|195465|P2|STARTED|Overall Study||40
83992|NCT01207219|195466|P1|STARTED|Overall Study||45
83993|NCT01207102|195486|P1|NOT COMPLETED|Overall Study||10
83994|NCT01207102|195486|P1|COMPLETED|Overall Study||0
83995|NCT01207102|195486|P1|STARTED|Overall Study||10
83996|NCT01206777|195491|P1|NOT COMPLETED|Overall Study||2
83997|NCT01206777|195491|P1|COMPLETED|Overall Study||50
83998|NCT01206777|195491|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
83999|NCT01206777|195491|P1|STARTED|Overall Study||52
84000|NCT01206738|195500|P3|NOT COMPLETED|Overall Study||19
84001|NCT01206738|195501|P2|NOT COMPLETED|Overall Study||25
84002|NCT01206738|195502|P1|NOT COMPLETED|Overall Study||23
84003|NCT01206738|195500|P3|COMPLETED|Overall Study||42
84004|NCT01206738|195501|P2|COMPLETED|Overall Study||49
84005|NCT01206738|195502|P1|COMPLETED|Overall Study||40
84006|NCT01206738|195500|P3|STARTED|Overall Study||61
84007|NCT01206738|195501|P2|STARTED|Overall Study||74
84008|NCT01206738|195502|P1|STARTED|Overall Study||63
84009|NCT01206660|195514|P2|NOT COMPLETED|Overall Study||0
84010|NCT01206660|195515|P1|NOT COMPLETED|Overall Study||0
84011|NCT01206660|195514|P2|COMPLETED|Overall Study||60
84012|NCT01206660|195515|P1|COMPLETED|Overall Study||60
84013|NCT01206660|195514|P2|STARTED|Overall Study||60
84014|NCT01206660|195515|P1|STARTED|Overall Study||60
84015|NCT01206608|195527|P2|NOT COMPLETED|Overall Study||0
84016|NCT01206608|195528|P1|NOT COMPLETED|Overall Study||0
84017|NCT01206608|195527|P2|COMPLETED|Overall Study||20
84018|NCT01206608|195528|P1|COMPLETED|Overall Study||20
84019|NCT01206608|195527|P2|STARTED|Overall Study||20
84020|NCT01206608|195528|P1|STARTED|Overall Study||20
84021|NCT01206595|195536|P2|NOT COMPLETED|Overall Study||0
84022|NCT01206595|195537|P1|NOT COMPLETED|Overall Study||0
84023|NCT01206595|195536|P2|COMPLETED|Overall Study||20
84024|NCT01206595|195537|P1|COMPLETED|Overall Study||38
84025|NCT01206595|195536|P2|STARTED|Overall Study||20
84026|NCT01206595|195537|P1|STARTED|Overall Study||38
84027|NCT01206582|195547|P2|NOT COMPLETED|Overall Study||2
84028|NCT01206582|195548|P1|NOT COMPLETED|Overall Study||2
84029|NCT01206582|195547|P2|COMPLETED|Overall Study||7
84030|NCT01206582|195548|P1|COMPLETED|Overall Study||9
84031|NCT01206582|195547|P2|STARTED|Overall Study||9
84032|NCT01206582|195548|P1|STARTED|Overall Study||11
84033|NCT01206517|195580|P6|NOT COMPLETED|Overall Study||0
84034|NCT01206517|195581|P5|NOT COMPLETED|Overall Study||1
84035|NCT01206517|195582|P4|NOT COMPLETED|Overall Study||0
84036|NCT01206517|195583|P3|NOT COMPLETED|Overall Study||2
84037|NCT01206517|195584|P2|NOT COMPLETED|Overall Study||0
84038|NCT01206517|195585|P1|NOT COMPLETED|Overall Study||0
84039|NCT01206517|195580|P6|COMPLETED|Overall Study||4
84040|NCT01206517|195581|P5|COMPLETED|Overall Study||3
84041|NCT01206517|195582|P4|COMPLETED|Overall Study||4
84042|NCT01206517|195583|P3|COMPLETED|Overall Study||4
84043|NCT01206517|195584|P2|COMPLETED|Overall Study||6
84044|NCT01206517|195585|P1|COMPLETED|Overall Study||6
84045|NCT01206517|195580|P6|STARTED|Overall Study||4
84046|NCT01206517|195581|P5|STARTED|Overall Study||4
84047|NCT01206517|195582|P4|STARTED|Overall Study||4
84048|NCT01206517|195583|P3|STARTED|Overall Study||6
84049|NCT01206517|195584|P2|STARTED|Overall Study||6
84050|NCT01206517|195585|P1|STARTED|Overall Study||6
84051|NCT01206478|195616|P2|NOT COMPLETED|Overall Study||5
84052|NCT01206478|195617|P1|NOT COMPLETED|Overall Study||2
84053|NCT01206478|195616|P2|COMPLETED|Overall Study||7
84054|NCT01206478|195617|P1|COMPLETED|Overall Study||7
84055|NCT01206478|195616|P2|STARTED|Overall Study||12
84056|NCT01206478|195617|P1|STARTED|Overall Study||9
84057|NCT01206439|195625|P1|NOT COMPLETED|Overall Study||1
84058|NCT01206439|195625|P1|COMPLETED|Overall Study||1
84059|NCT01206439|195625|P1|STARTED|Overall Study||2
84060|NCT01206387|195631|P2|NOT COMPLETED|Overall Study||0
84061|NCT01206387|195632|P1|NOT COMPLETED|Overall Study||1
84062|NCT01206387|195631|P2|COMPLETED|Overall Study||60
84063|NCT01206387|195632|P1|COMPLETED|Overall Study||59
84064|NCT01206387|195631|P2|STARTED|Overall Study||60
84065|NCT01206387|195632|P1|STARTED|Overall Study||60
84066|NCT01206322|195648|P4|NOT COMPLETED|Overall Study||1
84067|NCT01206322|195649|P3|NOT COMPLETED|Overall Study||0
84068|NCT01206322|195650|P2|NOT COMPLETED|Overall Study||0
84069|NCT01206322|195651|P1|NOT COMPLETED|Overall Study||0
84070|NCT01206322|195648|P4|COMPLETED|Overall Study||5
84071|NCT01206322|195649|P3|COMPLETED|Overall Study||9
84072|NCT01206322|195650|P2|COMPLETED|Overall Study||11
84073|NCT01206322|195651|P1|COMPLETED|Overall Study||4
84074|NCT01206322|195648|P4|STARTED|Overall Study||6
84075|NCT01206322|195649|P3|STARTED|Overall Study||9
84076|NCT01206322|195650|P2|STARTED|Overall Study||11
84077|NCT01206322|195651|P1|STARTED|Overall Study||4
84078|NCT01206140|195667|P2|NOT COMPLETED|Overall Study||0
84079|NCT01206140|195668|P1|NOT COMPLETED|Overall Study||1
84080|NCT01206140|195667|P2|COMPLETED|Overall Study||35
84081|NCT01206140|195668|P1|COMPLETED|Overall Study||34
84082|NCT01206140|195667|P2|STARTED|Overall Study||35
84083|NCT01206140|195668|P1|STARTED|Overall Study||35
84084|NCT01206101|195680|P2|NOT COMPLETED|Overall Study||1
84085|NCT01206101|195681|P1|NOT COMPLETED|Overall Study||2
84086|NCT01206101|195680|P2|COMPLETED|Overall Study||0
84087|NCT01206101|195681|P1|COMPLETED|Overall Study||0
84088|NCT01206101|195680|P2|STARTED|Overall Study||1
84089|NCT01206101|195681|P1|STARTED|Overall Study||2
84090|NCT01205828|195697|P1|NOT COMPLETED|Overall Study||0
84091|NCT01205828|195697|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
84092|NCT01205828|195697|P1|STARTED|Overall Study||16
84093|NCT01205685|195705|P1|NOT COMPLETED|Overall Study||11
84094|NCT01205685|195705|P1|COMPLETED|Overall Study||0
84095|NCT01205685|195705|P1|STARTED|Overall Study||11
84096|NCT01204671|195717|P5|NOT COMPLETED|Overall Study||4
84097|NCT01204671|195718|P4|NOT COMPLETED|Overall Study||13
84098|NCT01204671|195719|P3|NOT COMPLETED|Overall Study||13
84099|NCT01204671|195720|P2|NOT COMPLETED|Overall Study||15
84100|NCT01204671|195721|P1|NOT COMPLETED|Overall Study||14
84101|NCT01204671|195717|P5|COMPLETED|Overall Study||606
84102|NCT01204671|195718|P4|COMPLETED|Overall Study||997
84103|NCT01204671|195719|P3|COMPLETED|Overall Study||998
84104|NCT01204671|195720|P2|COMPLETED|Overall Study||998
84105|NCT01204671|195721|P1|COMPLETED|Overall Study||998
84106|NCT01204671|195717|P5|STARTED|Overall Study||610
84107|NCT01204671|195718|P4|STARTED|Overall Study||1010
84108|NCT01204671|195719|P3|STARTED|Overall Study||1011
84109|NCT01204671|195720|P2|STARTED|Overall Study||1013
84110|NCT01204671|195721|P1|STARTED|Overall Study||1012
84111|NCT01204658|195783|P4|NOT COMPLETED|Booster Phase||0
84112|NCT01204658|195784|P3|NOT COMPLETED|Booster Phase||0
84113|NCT01204658|195785|P2|NOT COMPLETED|Booster Phase||0
84114|NCT01204658|195786|P1|NOT COMPLETED|Booster Phase||0
84115|NCT01204658|195783|P4|COMPLETED|Booster Phase||140
84116|NCT01204658|195784|P3|COMPLETED|Booster Phase||140
84117|NCT01204658|195785|P2|COMPLETED|Booster Phase||140
84118|NCT01204658|195786|P1|COMPLETED|Booster Phase||144
84119|NCT01204658|195783|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
84120|NCT01204658|195784|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
84121|NCT01204658|195785|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
84122|NCT01204658|195786|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
84123|NCT01204658|195783|P4|NOT COMPLETED|Primary Phase||0
84124|NCT01204658|195784|P3|NOT COMPLETED|Primary Phase||1
84125|NCT01204658|195785|P2|NOT COMPLETED|Primary Phase||0
84126|NCT01204658|195786|P1|NOT COMPLETED|Primary Phase||0
84127|NCT01204658|195783|P4|COMPLETED|Primary Phase||142
84128|NCT01204658|195784|P3|COMPLETED|Primary Phase||144
84129|NCT01204658|195785|P2|COMPLETED|Primary Phase||142
84130|NCT01204658|195786|P1|COMPLETED|Primary Phase||146
84131|NCT01204658|195783|P4|STARTED|Primary Phase||142
84132|NCT01204658|195784|P3|STARTED|Primary Phase||145
84133|NCT01204658|195785|P2|STARTED|Primary Phase||142
84134|NCT01204658|195786|P1|STARTED|Primary Phase||146
84135|NCT01205646|195896|P1|NOT COMPLETED|Overall Study||0
84136|NCT01205646|195896|P1|COMPLETED|Overall Study||11
84137|NCT01205646|195896|P1|STARTED|Overall Study||11
84138|NCT01205581|195906|P6|NOT COMPLETED|Overall Study||0
84139|NCT01205581|195907|P5|NOT COMPLETED|Overall Study||0
84140|NCT01205581|195908|P4|NOT COMPLETED|Overall Study||0
84141|NCT01205581|195909|P3|NOT COMPLETED|Overall Study||0
84142|NCT01205581|195910|P2|NOT COMPLETED|Overall Study||0
84143|NCT01205581|195911|P1|NOT COMPLETED|Overall Study||1
84144|NCT01205581|195906|P6|COMPLETED|Overall Study||20
84145|NCT01205581|195907|P5|COMPLETED|Overall Study||20
84146|NCT01205581|195908|P4|COMPLETED|Overall Study||9
84147|NCT01205581|195909|P3|COMPLETED|Overall Study||8
84148|NCT01205581|195910|P2|COMPLETED|Overall Study||13
84149|NCT01205581|195911|P1|COMPLETED|Overall Study||13
84150|NCT01205581|195906|P6|STARTED|Overall Study||20
84151|NCT01205581|195907|P5|STARTED|Overall Study||20
84152|NCT01205581|195908|P4|STARTED|Overall Study||9
84153|NCT01205581|195909|P3|STARTED|Overall Study||8
84154|NCT01205581|195910|P2|STARTED|Overall Study||13
84155|NCT01205581|195911|P1|STARTED|Overall Study||14
84156|NCT01205503|195977|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
84157|NCT01205503|195978|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
84158|NCT01205503|195977|P2|COMPLETED|Second Intervention (2nd Cycle)||16
84159|NCT01205503|195978|P1|COMPLETED|Second Intervention (2nd Cycle)||16
84160|NCT01205503|195977|P2|STARTED|Second Intervention (2nd Cycle)||16
84161|NCT01205503|195978|P1|STARTED|Second Intervention (2nd Cycle)||16
84162|NCT01205503|195977|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
84163|NCT01205503|195978|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
84164|NCT01205503|195977|P2|COMPLETED|First Intervention (1st Cycle)||16
84165|NCT01205503|195978|P1|COMPLETED|First Intervention (1st Cycle)||16
84166|NCT01205503|195977|P2|STARTED|First Intervention (1st Cycle)||16
84167|NCT01205503|195978|P1|STARTED|First Intervention (1st Cycle)||16
84168|NCT01205451|195994|P2|NOT COMPLETED|Overall Study||10
84169|NCT01205451|195995|P1|NOT COMPLETED|Overall Study||6
84170|NCT01205451|195994|P2|COMPLETED|Overall Study||46
84171|NCT01205451|195995|P1|COMPLETED|Overall Study||47
84172|NCT01205451|195994|P2|STARTED|Overall Study||56
84173|NCT01205451|195995|P1|STARTED|Overall Study||53
84174|NCT01205399|196037|P1|NOT COMPLETED|Overall Study||0
84175|NCT01205399|196037|P1|COMPLETED|Overall Study||78
84176|NCT01205399|196037|P1|STARTED|Overall Study||78
84177|NCT01205269|196043|P6|NOT COMPLETED|Period 5 - Third Intervention||0
84178|NCT01205269|196044|P5|NOT COMPLETED|Period 5 - Third Intervention||0
84179|NCT01205269|196045|P4|NOT COMPLETED|Period 5 - Third Intervention||0
84180|NCT01205269|196046|P3|NOT COMPLETED|Period 5 - Third Intervention||0
84181|NCT01205269|196047|P2|NOT COMPLETED|Period 5 - Third Intervention||0
84182|NCT01205269|196048|P1|NOT COMPLETED|Period 5 - Third Intervention||0
84183|NCT01205269|196043|P6|COMPLETED|Period 5 - Third Intervention||5
84184|NCT01205269|196044|P5|COMPLETED|Period 5 - Third Intervention||5
84185|NCT01205269|196045|P4|COMPLETED|Period 5 - Third Intervention||5
84186|NCT01205269|196046|P3|COMPLETED|Period 5 - Third Intervention||4
84187|NCT01205269|196047|P2|COMPLETED|Period 5 - Third Intervention||4
84188|NCT01205269|196048|P1|COMPLETED|Period 5 - Third Intervention||4
84189|NCT01205269|196043|P6|STARTED|Period 5 - Third Intervention||5
84190|NCT01205269|196044|P5|STARTED|Period 5 - Third Intervention||5
84191|NCT01205269|196045|P4|STARTED|Period 5 - Third Intervention||5
84192|NCT01205269|196046|P3|STARTED|Period 5 - Third Intervention||4
84193|NCT01205269|196047|P2|STARTED|Period 5 - Third Intervention||4
84194|NCT01205269|196048|P1|STARTED|Period 5 - Third Intervention||4
84195|NCT01205269|196043|P6|NOT COMPLETED|Period 4 - Washout||0
84196|NCT01205269|196044|P5|NOT COMPLETED|Period 4 - Washout||0
84197|NCT01205269|196045|P4|NOT COMPLETED|Period 4 - Washout||1
84198|NCT01205269|196046|P3|NOT COMPLETED|Period 4 - Washout||0
84199|NCT01205269|196047|P2|NOT COMPLETED|Period 4 - Washout||0
84200|NCT01205269|196048|P1|NOT COMPLETED|Period 4 - Washout||0
84201|NCT01205269|196043|P6|COMPLETED|Period 4 - Washout||5
84202|NCT01205269|196044|P5|COMPLETED|Period 4 - Washout||5
84203|NCT01205269|196045|P4|COMPLETED|Period 4 - Washout||5
84204|NCT01205269|196046|P3|COMPLETED|Period 4 - Washout||4
84205|NCT01205269|196047|P2|COMPLETED|Period 4 - Washout||4
84206|NCT01205269|196048|P1|COMPLETED|Period 4 - Washout||4
84207|NCT01205269|196043|P6|STARTED|Period 4 - Washout||5
84208|NCT01205269|196044|P5|STARTED|Period 4 - Washout||5
84209|NCT01205269|196045|P4|STARTED|Period 4 - Washout||6
84210|NCT01205269|196046|P3|STARTED|Period 4 - Washout||4
84211|NCT01205269|196047|P2|STARTED|Period 4 - Washout||4
84212|NCT01205269|196048|P1|STARTED|Period 4 - Washout||4
84213|NCT01205269|196043|P6|NOT COMPLETED|Period 3 - Second Intervention||0
84214|NCT01205269|196044|P5|NOT COMPLETED|Period 3 - Second Intervention||0
84215|NCT01205269|196045|P4|NOT COMPLETED|Period 3 - Second Intervention||0
84216|NCT01205269|196046|P3|NOT COMPLETED|Period 3 - Second Intervention||0
84217|NCT01205269|196047|P2|NOT COMPLETED|Period 3 - Second Intervention||0
84218|NCT01205269|196048|P1|NOT COMPLETED|Period 3 - Second Intervention||0
84219|NCT01205269|196043|P6|COMPLETED|Period 3 - Second Intervention||5
84220|NCT01205269|196044|P5|COMPLETED|Period 3 - Second Intervention||5
84221|NCT01205269|196045|P4|COMPLETED|Period 3 - Second Intervention||6
84222|NCT01205269|196046|P3|COMPLETED|Period 3 - Second Intervention||4
84223|NCT01205269|196047|P2|COMPLETED|Period 3 - Second Intervention||4
84224|NCT01205269|196048|P1|COMPLETED|Period 3 - Second Intervention||4
84225|NCT01205269|196043|P6|STARTED|Period 3 - Second Intervention||5
84226|NCT01205269|196044|P5|STARTED|Period 3 - Second Intervention||5
84227|NCT01205269|196045|P4|STARTED|Period 3 - Second Intervention||6
84228|NCT01205269|196046|P3|STARTED|Period 3 - Second Intervention||4
84229|NCT01205269|196047|P2|STARTED|Period 3 - Second Intervention||4
84230|NCT01205269|196048|P1|STARTED|Period 3 - Second Intervention||4
84231|NCT01205269|196043|P6|NOT COMPLETED|Period 2 - Washout||0
84232|NCT01205269|196044|P5|NOT COMPLETED|Period 2 - Washout||0
84233|NCT01205269|196045|P4|NOT COMPLETED|Period 2 - Washout||0
84234|NCT01205269|196046|P3|NOT COMPLETED|Period 2 - Washout||0
84235|NCT01205269|196047|P2|NOT COMPLETED|Period 2 - Washout||0
84236|NCT01205269|196048|P1|NOT COMPLETED|Period 2 - Washout||0
84237|NCT01205269|196043|P6|COMPLETED|Period 2 - Washout||5
84238|NCT01205269|196044|P5|COMPLETED|Period 2 - Washout||5
84239|NCT01205269|196045|P4|COMPLETED|Period 2 - Washout||6
84240|NCT01205269|196046|P3|COMPLETED|Period 2 - Washout||4
84241|NCT01205269|196047|P2|COMPLETED|Period 2 - Washout||4
84242|NCT01205269|196048|P1|COMPLETED|Period 2 - Washout||4
84243|NCT01205269|196043|P6|STARTED|Period 2 - Washout||5
84244|NCT01205269|196044|P5|STARTED|Period 2 - Washout||5
84245|NCT01205269|196045|P4|STARTED|Period 2 - Washout||6
84246|NCT01205269|196046|P3|STARTED|Period 2 - Washout||4
84247|NCT01205269|196047|P2|STARTED|Period 2 - Washout||4
84248|NCT01205269|196048|P1|STARTED|Period 2 - Washout||4
84249|NCT01205269|196043|P6|NOT COMPLETED|Period 1 - First Intervention||0
84250|NCT01205269|196044|P5|NOT COMPLETED|Period 1 - First Intervention||0
84251|NCT01205269|196045|P4|NOT COMPLETED|Period 1 - First Intervention||0
84252|NCT01205269|196046|P3|NOT COMPLETED|Period 1 - First Intervention||0
84253|NCT01205269|196047|P2|NOT COMPLETED|Period 1 - First Intervention||0
84254|NCT01205269|196048|P1|NOT COMPLETED|Period 1 - First Intervention||0
84255|NCT01205269|196043|P6|COMPLETED|Period 1 - First Intervention||5
84256|NCT01205269|196044|P5|COMPLETED|Period 1 - First Intervention||5
84257|NCT01205269|196045|P4|COMPLETED|Period 1 - First Intervention||6
84258|NCT01205269|196046|P3|COMPLETED|Period 1 - First Intervention||4
84259|NCT01205269|196047|P2|COMPLETED|Period 1 - First Intervention||4
84260|NCT01205269|196048|P1|COMPLETED|Period 1 - First Intervention||4
84261|NCT01205269|196043|P6|STARTED|Period 1 - First Intervention||5
84262|NCT01205269|196044|P5|STARTED|Period 1 - First Intervention||5
84263|NCT01205269|196045|P4|STARTED|Period 1 - First Intervention||6
84264|NCT01205269|196046|P3|STARTED|Period 1 - First Intervention||4
84265|NCT01205269|196047|P2|STARTED|Period 1 - First Intervention||4
84266|NCT01205269|196048|P1|STARTED|Period 1 - First Intervention||4
84267|NCT01205230|196088|P2|NOT COMPLETED|Overall Study||0
84268|NCT01205230|196089|P1|NOT COMPLETED|Overall Study||5
84269|NCT01205230|196088|P2|COMPLETED|Overall Study||13
84270|NCT01205230|196089|P1|COMPLETED|Overall Study||16
84271|NCT01205230|196088|P2|Combination Therapy|Overall Study||13
84272|NCT01205230|196089|P1|Combination Therapy|Overall Study||21
84273|NCT01205230|196088|P2|STARTED|Overall Study||13
84274|NCT01205230|196089|P1|STARTED|Overall Study||21
84275|NCT01205126|196134|P2|NOT COMPLETED|Maintenance Phase||40
84276|NCT01205126|196135|P1|NOT COMPLETED|Maintenance Phase||37
84277|NCT01205126|196134|P2|COMPLETED|Maintenance Phase||67
84278|NCT01205126|196135|P1|COMPLETED|Maintenance Phase||70
84279|NCT01205126|196134|P2|STARTED|Maintenance Phase||107
84280|NCT01205126|196135|P1|STARTED|Maintenance Phase||107
84281|NCT01205126|196134|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
84282|NCT01205126|196135|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
84283|NCT01205126|196134|P2|COMPLETED|Between Titration & Maintenance Phase||107
84284|NCT01205126|196135|P1|COMPLETED|Between Titration & Maintenance Phase||107
84285|NCT01205126|196134|P2|STARTED|Between Titration & Maintenance Phase||111
84286|NCT01205126|196135|P1|STARTED|Between Titration & Maintenance Phase||107
84287|NCT01205126|196134|P2|NOT COMPLETED|Titration Phase||19
84288|NCT01205126|196135|P1|NOT COMPLETED|Titration Phase||23
84289|NCT01205126|196134|P2|COMPLETED|Titration Phase||111
84290|NCT01205126|196135|P1|COMPLETED|Titration Phase||107
84291|NCT01205126|196134|P2|STARTED|Titration Phase||130
84292|NCT01205126|196135|P1|STARTED|Titration Phase||130
84293|NCT01205035|196153|P2|NOT COMPLETED|Overall Study||0
84294|NCT01205035|196154|P1|NOT COMPLETED|Overall Study||2
84295|NCT01205035|196153|P2|COMPLETED|Overall Study||3
84296|NCT01205035|196154|P1|COMPLETED|Overall Study||1
84297|NCT01205035|196153|P2|STARTED|Overall Study||3
84298|NCT01205035|196154|P1|STARTED|Overall Study||3
84299|NCT01204853|196168|P1|NOT COMPLETED|Overall Study||0
84300|NCT01204853|196168|P1|COMPLETED|Overall Study||2
84301|NCT01204853|196168|P1|STARTED|Overall Study||2
84302|NCT01204788|196180|P2|NOT COMPLETED|Overall Study||3
84303|NCT01204788|196181|P1|NOT COMPLETED|Overall Study||1
84304|NCT01204788|196180|P2|COMPLETED|Overall Study||0
84305|NCT01204788|196181|P1|COMPLETED|Overall Study||0
84306|NCT01204788|196180|P2|STARTED|Overall Study||3
84307|NCT01204788|196181|P1|STARTED|Overall Study||1
84308|NCT01204736|196191|P4|NOT COMPLETED|Overall Study||0
84309|NCT01204736|196192|P3|NOT COMPLETED|Overall Study||0
84310|NCT01204736|196193|P2|NOT COMPLETED|Overall Study||0
84311|NCT01204736|196194|P1|NOT COMPLETED|Overall Study||0
84312|NCT01204736|196191|P4|COMPLETED|Overall Study||2
84313|NCT01204736|196192|P3|COMPLETED|Overall Study||3
84314|NCT01204736|196193|P2|COMPLETED|Overall Study||5
84315|NCT01204736|196194|P1|COMPLETED|Overall Study||4
84316|NCT01204736|196191|P4|STARTED|Overall Study||2
84317|NCT01204736|196192|P3|STARTED|Overall Study||3
84318|NCT01204736|196193|P2|STARTED|Overall Study||5
84319|NCT01204736|196194|P1|STARTED|Overall Study||4
84320|NCT01204697|196206|P2|NOT COMPLETED|Overall Study||36
84321|NCT01204697|196207|P1|NOT COMPLETED|Overall Study||31
84322|NCT01204697|196206|P2|COMPLETED|Overall Study||2
84323|NCT01204697|196207|P1|COMPLETED|Overall Study||5
84324|NCT01204697|196206|P2|Treated|Overall Study||37
84325|NCT01204697|196207|P1|Treated|Overall Study||36
84326|NCT01204697|196206|P2|STARTED|Overall Study||38
84327|NCT01204697|196207|P1|STARTED|Overall Study||36
84328|NCT01204398|196223|P1|NOT COMPLETED|Overall Study||1
84329|NCT01204398|196223|P1|COMPLETED|Overall Study|Completed trial medication.|26
84330|NCT01204398|196223|P1|STARTED|Overall Study|Entered and treated.|27
84331|NCT01204294|196240|P7|NOT COMPLETED|Overall Study||2
84332|NCT01204294|196241|P6|NOT COMPLETED|Overall Study||5
84333|NCT01204294|196242|P5|NOT COMPLETED|Overall Study||2
84334|NCT01204294|196243|P4|NOT COMPLETED|Overall Study||11
84335|NCT01204294|196244|P3|NOT COMPLETED|Overall Study||5
84336|NCT01204294|196245|P2|NOT COMPLETED|Overall Study||8
84337|NCT01204294|196246|P1|NOT COMPLETED|Overall Study||3
84338|NCT01204294|196240|P7|COMPLETED|Overall Study||59
84339|NCT01204294|196241|P6|COMPLETED|Overall Study||58
84340|NCT01204294|196242|P5|COMPLETED|Overall Study||83
84341|NCT01204294|196243|P4|COMPLETED|Overall Study||132
84342|NCT01204294|196244|P3|COMPLETED|Overall Study||69
84343|NCT01204294|196245|P2|COMPLETED|Overall Study||58
84344|NCT01204294|196246|P1|COMPLETED|Overall Study||79
84345|NCT01204294|196240|P7|STARTED|Overall Study||61
84346|NCT01204294|196241|P6|STARTED|Overall Study||63
84347|NCT01204294|196242|P5|STARTED|Overall Study||85
84348|NCT01204294|196243|P4|STARTED|Overall Study||143
84349|NCT01204294|196244|P3|STARTED|Overall Study||74
84350|NCT01204294|196245|P2|STARTED|Overall Study||66
84351|NCT01204294|196246|P1|STARTED|Overall Study||82
84352|NCT01204255|196269|P1|NOT COMPLETED|Overall Study||1
84353|NCT01204255|196269|P1|COMPLETED|Overall Study||10
84354|NCT01204255|196269|P1|STARTED|Overall Study||11
84355|NCT01203956|196273|P2|NOT COMPLETED|Second Two-week Period||6
84356|NCT01203956|196274|P1|NOT COMPLETED|Second Two-week Period||5
84357|NCT01203956|196273|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
84358|NCT01203956|196274|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
84359|NCT01203956|196273|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
84360|NCT01203956|196274|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
84361|NCT01203956|196273|P2|STARTED|Second Two-week Period||13
84362|NCT01203956|196274|P1|STARTED|Second Two-week Period||15
84363|NCT01203956|196273|P2|NOT COMPLETED|First Two-week Period||0
84364|NCT01203956|196274|P1|NOT COMPLETED|First Two-week Period||0
84365|NCT01203956|196273|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
84366|NCT01203956|196274|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
84367|NCT01203956|196273|P2|STARTED|First Two-week Period||13
84368|NCT01203956|196274|P1|STARTED|First Two-week Period||15
84369|NCT01203917|196281|P1|NOT COMPLETED|Overall Study||36
84370|NCT01203917|196281|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
84371|NCT01203917|196281|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
84372|NCT01203878|196294|P3|NOT COMPLETED|Overall Study||3
84373|NCT01203878|196295|P2|NOT COMPLETED|Overall Study||0
84374|NCT01203878|196296|P1|NOT COMPLETED|Overall Study||0
84375|NCT01203878|196294|P3|COMPLETED|Overall Study||0
84376|NCT01203878|196295|P2|COMPLETED|Overall Study||9
84377|NCT01203878|196296|P1|COMPLETED|Overall Study||9
84378|NCT01203878|196294|P3|STARTED|Overall Study||3
84379|NCT01203878|196295|P2|STARTED|Overall Study||9
84380|NCT01203878|196296|P1|STARTED|Overall Study||9
84381|NCT01203852|196307|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
84382|NCT01203852|196307|P1|COMPLETED|Chlorthalidone 8 Weeks||328
84383|NCT01203852|196307|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
84384|NCT01203852|196307|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
84385|NCT01203852|196307|P1|NOT COMPLETED|Washout 2 Weeks||46
84386|NCT01203852|196307|P1|COMPLETED|Washout 2 Weeks||282
84387|NCT01203852|196307|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
84388|NCT01203852|196307|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
84389|NCT01203852|196307|P1|COMPLETED|Metoprolol 8 Weeks||369
84390|NCT01203852|196307|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
84391|NCT01203787|196316|P2|NOT COMPLETED|Overall Study||27
84392|NCT01203787|196317|P1|NOT COMPLETED|Overall Study||31
84393|NCT01203787|196316|P2|COMPLETED|Overall Study||30
84394|NCT01203787|196317|P1|COMPLETED|Overall Study||32
84395|NCT01203787|196316|P2|STARTED|Overall Study||57
84396|NCT01203787|196317|P1|STARTED|Overall Study||63
84397|NCT01203644|196337|P2|NOT COMPLETED|Overall Study||0
84398|NCT01203644|196338|P1|NOT COMPLETED|Overall Study||0
84399|NCT01203644|196337|P2|COMPLETED|Overall Study||50
84400|NCT01203644|196338|P1|COMPLETED|Overall Study||26
84401|NCT01203644|196337|P2|STARTED|Overall Study||50
84402|NCT01203644|196338|P1|STARTED|Overall Study||26
84403|NCT01203319|196350|P3|NOT COMPLETED|Overall Study||5
84404|NCT01203319|196351|P2|NOT COMPLETED|Overall Study||9
84405|NCT01203319|196352|P1|NOT COMPLETED|Overall Study||6
84406|NCT01203319|196350|P3|COMPLETED|Overall Study||217
84407|NCT01203319|196351|P2|COMPLETED|Overall Study||426
84408|NCT01203319|196352|P1|COMPLETED|Overall Study||428
84409|NCT01203319|196350|P3|STARTED|Overall Study||222
84410|NCT01203319|196351|P2|STARTED|Overall Study||435
84411|NCT01203319|196352|P1|STARTED|Overall Study||434
84412|NCT01203098|196369|P3|NOT COMPLETED|Overall Study||11
84413|NCT01203098|196370|P2|NOT COMPLETED|Overall Study||4
84414|NCT01203098|196371|P1|NOT COMPLETED|Overall Study||6
84415|NCT01203098|196369|P3|COMPLETED|Overall Study||78
84416|NCT01203098|196370|P2|COMPLETED|Overall Study||82
84417|NCT01203098|196371|P1|COMPLETED|Overall Study||83
84418|NCT01203098|196369|P3|Safety Analysis Dataset|Overall Study||87
84419|NCT01203098|196370|P2|Safety Analysis Dataset|Overall Study||85
84420|NCT01203098|196371|P1|Safety Analysis Dataset|Overall Study||89
84421|NCT01203098|196369|P3|STARTED|Overall Study||89
84422|NCT01203098|196370|P2|STARTED|Overall Study||86
84423|NCT01203098|196371|P1|STARTED|Overall Study||89
84424|NCT01203072|196387|P5|NOT COMPLETED|Overall Study||6
84425|NCT01203072|196388|P4|NOT COMPLETED|Overall Study||6
84426|NCT01203072|196389|P3|NOT COMPLETED|Overall Study||3
84427|NCT01203072|196390|P2|NOT COMPLETED|Overall Study||6
84428|NCT01203072|196391|P1|NOT COMPLETED|Overall Study||10
84429|NCT01203072|196387|P5|COMPLETED|Overall Study||96
84430|NCT01203072|196388|P4|COMPLETED|Overall Study||100
84431|NCT01203072|196389|P3|COMPLETED|Overall Study||101
84432|NCT01203072|196390|P2|COMPLETED|Overall Study||100
84433|NCT01203072|196391|P1|COMPLETED|Overall Study||95
84434|NCT01203072|196387|P5|STARTED|Overall Study||102
84435|NCT01203072|196388|P4|STARTED|Overall Study||106
84436|NCT01203072|196389|P3|STARTED|Overall Study||104
84437|NCT01203072|196390|P2|STARTED|Overall Study||106
84438|NCT01203072|196391|P1|STARTED|Overall Study||105
84439|NCT01203046|196410|P2|NOT COMPLETED|Overall Study||0
84440|NCT01203046|196411|P1|NOT COMPLETED|Overall Study||0
84441|NCT01203046|196410|P2|COMPLETED|Overall Study||28
84442|NCT01203046|196411|P1|COMPLETED|Overall Study||28
84443|NCT01203046|196410|P2|STARTED|Overall Study||28
84444|NCT01203046|196411|P1|STARTED|Overall Study||28
84445|NCT01202955|196421|P2|NOT COMPLETED|Period 3: 10 Days||0
84446|NCT01202955|196422|P1|NOT COMPLETED|Period 3: 10 Days||0
84447|NCT01202955|196421|P2|COMPLETED|Period 3: 10 Days||8
84448|NCT01202955|196422|P1|COMPLETED|Period 3: 10 Days||9
84449|NCT01202955|196421|P2|STARTED|Period 3: 10 Days||8
84450|NCT01202955|196422|P1|STARTED|Period 3: 10 Days||9
84451|NCT01202955|196421|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
84452|NCT01202955|196422|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
84453|NCT01202955|196421|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
84454|NCT01202955|196422|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
84455|NCT01202955|196421|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
84456|NCT01202955|196422|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
84457|NCT01202955|196421|P2|NOT COMPLETED|Period 1: 10 Days||2
84458|NCT01202955|196422|P1|NOT COMPLETED|Period 1: 10 Days||0
84459|NCT01202955|196421|P2|COMPLETED|Period 1: 10 Days||8
84460|NCT01202955|196422|P1|COMPLETED|Period 1: 10 Days||9
84461|NCT01202955|196421|P2|STARTED|Period 1: 10 Days||10
84462|NCT01202955|196422|P1|STARTED|Period 1: 10 Days||9
84463|NCT01202903|196434|P2|NOT COMPLETED|Overall Study||16
84464|NCT01202903|196435|P1|NOT COMPLETED|Overall Study||11
84465|NCT01202903|196434|P2|COMPLETED|Overall Study||292
84466|NCT01202903|196435|P1|COMPLETED|Overall Study||297
84467|NCT01202903|196434|P2|Safety Set*|Overall Study||299
84468|NCT01202903|196435|P1|Safety Set*|Overall Study||310
84469|NCT01202903|196434|P2|Full Analysis Set|Overall Study||302
84470|NCT01202903|196435|P1|Full Analysis Set|Overall Study||306
84471|NCT01202903|196434|P2|STARTED|Overall Study||308
84472|NCT01202903|196435|P1|STARTED|Overall Study||308
84473|NCT01202877|196462|P3|NOT COMPLETED|Overall Study||6
84474|NCT01202877|196463|P2|NOT COMPLETED|Overall Study||1
84475|NCT01202877|196464|P1|NOT COMPLETED|Overall Study||0
84476|NCT01202877|196462|P3|COMPLETED|Overall Study||34
84477|NCT01202877|196463|P2|COMPLETED|Overall Study||7
84478|NCT01202877|196464|P1|COMPLETED|Overall Study||6
84479|NCT01202877|196462|P3|STARTED|Overall Study||40
84480|NCT01202877|196463|P2|STARTED|Overall Study||8
84481|NCT01202877|196464|P1|STARTED|Overall Study||6
84482|NCT01202747|196473|P1|NOT COMPLETED|Overall Study||1
84483|NCT01202747|196473|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
84484|NCT01202747|196473|P1|STARTED|Overall Study||50
84485|NCT01202656|196479|P2|NOT COMPLETED|CrossoverCycle||0
84486|NCT01202656|196480|P1|NOT COMPLETED|CrossoverCycle||0
84487|NCT01202656|196479|P2|COMPLETED|CrossoverCycle||14
84488|NCT01202656|196480|P1|COMPLETED|CrossoverCycle||18
84489|NCT01202656|196479|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
84490|NCT01202656|196480|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
84491|NCT01202656|196479|P2|NOT COMPLETED|Cycle 1||0
84492|NCT01202656|196480|P1|NOT COMPLETED|Cycle 1||0
84493|NCT01202656|196479|P2|COMPLETED|Cycle 1||62
84494|NCT01202656|196480|P1|COMPLETED|Cycle 1||67
84495|NCT01202656|196479|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
84496|NCT01202656|196480|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
84497|NCT01202643|196490|P2|NOT COMPLETED|Crossover Cycle||0
84498|NCT01202643|196491|P1|NOT COMPLETED|Crossover Cycle||0
84499|NCT01202643|196490|P2|COMPLETED|Crossover Cycle||2
84500|NCT01202643|196491|P1|COMPLETED|Crossover Cycle||1
84501|NCT01202643|196490|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
84502|NCT01202643|196491|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
84503|NCT01202643|196490|P2|NOT COMPLETED|Period 1||0
84504|NCT01202643|196491|P1|NOT COMPLETED|Period 1||0
84505|NCT01202643|196490|P2|COMPLETED|Period 1||6
84506|NCT01202643|196491|P1|COMPLETED|Period 1||6
84507|NCT01202643|196490|P2|STARTED|Period 1||6
84508|NCT01202643|196491|P1|STARTED|Period 1||6
84509|NCT01202591|196505|P6|NOT COMPLETED|Overall Study||4
84510|NCT01202591|196506|P5|NOT COMPLETED|Overall Study||5
84511|NCT01202591|196507|P4|NOT COMPLETED|Overall Study||7
84512|NCT01202591|196508|P3|NOT COMPLETED|Overall Study||11
84513|NCT01202591|196509|P2|NOT COMPLETED|Overall Study||5
84514|NCT01202591|196510|P1|NOT COMPLETED|Overall Study||5
84515|NCT01202591|196505|P6|COMPLETED|Overall Study||0
84516|NCT01202591|196506|P5|COMPLETED|Overall Study||0
84517|NCT01202591|196507|P4|COMPLETED|Overall Study||2
84518|NCT01202591|196508|P3|COMPLETED|Overall Study||1
84519|NCT01202591|196509|P2|COMPLETED|Overall Study||0
84520|NCT01202591|196510|P1|COMPLETED|Overall Study||0
84521|NCT01202591|196505|P6|STARTED|Overall Study||4
84522|NCT01202591|196506|P5|STARTED|Overall Study||5
84523|NCT01202591|196507|P4|STARTED|Overall Study||9
84524|NCT01202591|196508|P3|STARTED|Overall Study||12
84525|NCT01202591|196509|P2|STARTED|Overall Study||5
84526|NCT01202591|196510|P1|STARTED|Overall Study||5
84527|NCT01202578|196524|P1|NOT COMPLETED|Overall Study||0
84528|NCT01202578|196524|P1|COMPLETED|Overall Study||53
84529|NCT01202578|196524|P1|STARTED|Overall Study||53
84530|NCT01202565|196531|P1|NOT COMPLETED|Overall Study||67
84531|NCT01202565|196531|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
84532|NCT01202565|196531|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
84533|NCT01202565|196531|P1|STARTED|Overall Study||506
84534|NCT01202279|196556|P2|NOT COMPLETED|Overall Study||27
84535|NCT01202279|196557|P1|NOT COMPLETED|Overall Study||37
84536|NCT01202279|196556|P2|COMPLETED|Overall Study||561
84537|NCT01202279|196557|P1|COMPLETED|Overall Study||554
84538|NCT01202279|196556|P2|STARTED|Overall Study||588
84539|NCT01202279|196557|P1|STARTED|Overall Study||591
84540|NCT01202253|196565|P1|NOT COMPLETED|Overall Study||0
84541|NCT01202253|196565|P1|COMPLETED|Overall Study||50
84542|NCT01202253|196565|P1|STARTED|Overall Study||50
84543|NCT01202227|196609|P1|NOT COMPLETED|Overall Study||19
84544|NCT01202227|196609|P1|COMPLETED|Overall Study||84
84545|NCT01202227|196609|P1|STARTED|Overall Study|Treated|103
84546|NCT01202188|196633|P5|NOT COMPLETED|Overall Study||45
84547|NCT01202188|196634|P4|NOT COMPLETED|Overall Study||42
84548|NCT01202188|196635|P3|NOT COMPLETED|Overall Study||53
84549|NCT01202188|196636|P2|NOT COMPLETED|Overall Study||56
84550|NCT01202188|196637|P1|NOT COMPLETED|Overall Study||38
84551|NCT01202188|196633|P5|COMPLETED|Overall Study||189
84552|NCT01202188|196634|P4|COMPLETED|Overall Study||441
84553|NCT01202188|196635|P3|COMPLETED|Overall Study||422
84554|NCT01202188|196636|P2|COMPLETED|Overall Study||421
84555|NCT01202188|196637|P1|COMPLETED|Overall Study||437
84556|NCT01202188|196633|P5|Safety Set; Received Study Drug|Overall Study||232
84557|NCT01202188|196634|P4|Safety Set; Received Study Drug|Overall Study||480
84558|NCT01202188|196635|P3|Safety Set; Received Study Drug|Overall Study||473
84559|NCT01202188|196636|P2|Safety Set; Received Study Drug|Overall Study||476
84560|NCT01202188|196637|P1|Safety Set; Received Study Drug|Overall Study||474
84561|NCT01202188|196633|P5|STARTED|Overall Study||234
84562|NCT01202188|196634|P4|STARTED|Overall Study||483
84563|NCT01202188|196635|P3|STARTED|Overall Study||475
84564|NCT01202188|196636|P2|STARTED|Overall Study||477
84565|NCT01202188|196637|P1|STARTED|Overall Study||475
84566|NCT01202162|196745|P2|NOT COMPLETED|Overall Study||2
84567|NCT01202162|196746|P1|NOT COMPLETED|Overall Study||3
84568|NCT01202162|196745|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
84569|NCT01202162|196746|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
84570|NCT01202162|196745|P2|STARTED|Overall Study||42
84571|NCT01202162|196746|P1|STARTED|Overall Study||43
84572|NCT01202110|196756|P2|NOT COMPLETED|Overall Study||0
84573|NCT01202110|196757|P1|NOT COMPLETED|Overall Study||0
84574|NCT01202110|196756|P2|COMPLETED|Overall Study||0
84575|NCT01202110|196757|P1|COMPLETED|Overall Study||10
84576|NCT01202110|196756|P2|STARTED|Overall Study||0
84577|NCT01202110|196757|P1|STARTED|Overall Study||10
84578|NCT01202071|196761|P4|NOT COMPLETED|Overall Study||0
84579|NCT01202071|196762|P3|NOT COMPLETED|Overall Study||0
84580|NCT01202071|196763|P2|NOT COMPLETED|Overall Study||0
84581|NCT01202071|196764|P1|NOT COMPLETED|Overall Study||0
84582|NCT01202071|196761|P4|COMPLETED|Overall Study||6
84583|NCT01202071|196762|P3|COMPLETED|Overall Study||6
84584|NCT01202071|196763|P2|COMPLETED|Overall Study||6
84585|NCT01202071|196764|P1|COMPLETED|Overall Study||6
84586|NCT01202071|196761|P4|STARTED|Overall Study||6
84587|NCT01202071|196762|P3|STARTED|Overall Study||6
84588|NCT01202071|196763|P2|STARTED|Overall Study||6
84589|NCT01202071|196764|P1|STARTED|Overall Study||6
84590|NCT01201967|196784|P2|NOT COMPLETED|Overall Study||5
84591|NCT01201967|196785|P1|NOT COMPLETED|Overall Study||6
84592|NCT01201967|196784|P2|COMPLETED|Overall Study||86
84593|NCT01201967|196785|P1|COMPLETED|Overall Study||86
84594|NCT01201967|196784|P2|STARTED|Overall Study||91
84595|NCT01201967|196785|P1|STARTED|Overall Study||92
84596|NCT01201915|196810|P3|NOT COMPLETED|Overall Study||6
84597|NCT01201915|196811|P2|NOT COMPLETED|Overall Study||11
84598|NCT01201915|196812|P1|NOT COMPLETED|Overall Study||8
84599|NCT01201915|196810|P3|COMPLETED|Overall Study||19
84600|NCT01201915|196811|P2|COMPLETED|Overall Study||14
84601|NCT01201915|196812|P1|COMPLETED|Overall Study||16
84602|NCT01201915|196810|P3|STARTED|Overall Study||25
84603|NCT01201915|196811|P2|STARTED|Overall Study||25
84604|NCT01201915|196812|P1|STARTED|Overall Study||24
84605|NCT01201811|196823|P1|NOT COMPLETED|Overall Study||19
84606|NCT01201811|196823|P1|COMPLETED|Overall Study||25
84607|NCT01201811|196823|P1|STARTED|Overall Study||44
84608|NCT01201798|196845|P2|NOT COMPLETED|Overall Study||15
84609|NCT01201798|196846|P1|NOT COMPLETED|Overall Study||9
84610|NCT01201798|196845|P2|COMPLETED|Overall Study||39
84611|NCT01201798|196846|P1|COMPLETED|Overall Study||47
84612|NCT01201798|196845|P2|STARTED|Overall Study||54
84613|NCT01201798|196846|P1|STARTED|Overall Study||56
84614|NCT01201785|196870|P1|NOT COMPLETED|Overall Study||16
84615|NCT01201785|196870|P1|COMPLETED|Overall Study||20
84616|NCT01201785|196870|P1|STARTED|Overall Study||36
84617|NCT01201772|196877|P3|NOT COMPLETED|Overall Study||0
84618|NCT01201772|196878|P2|NOT COMPLETED|Overall Study||0
84619|NCT01201772|196879|P1|NOT COMPLETED|Overall Study||1
84620|NCT01201772|196877|P3|COMPLETED|Overall Study||21
84621|NCT01201772|196878|P2|COMPLETED|Overall Study||21
84622|NCT01201772|196879|P1|COMPLETED|Overall Study||22
84623|NCT01201772|196877|P3|STARTED|Overall Study||21
84624|NCT01201772|196878|P2|STARTED|Overall Study||21
84625|NCT01201772|196879|P1|STARTED|Overall Study||23
84626|NCT01201759|196887|P2|NOT COMPLETED|Visit 5||0
84627|NCT01201759|196888|P1|NOT COMPLETED|Visit 5||0
84628|NCT01201759|196887|P2|COMPLETED|Visit 5||3
84629|NCT01201759|196888|P1|COMPLETED|Visit 5||7
84630|NCT01201759|196887|P2|STARTED|Visit 5||3
84631|NCT01201759|196888|P1|STARTED|Visit 5||7
84632|NCT01201759|196887|P2|NOT COMPLETED|Visit 4 Crossover||1
84633|NCT01201759|196888|P1|NOT COMPLETED|Visit 4 Crossover||0
84634|NCT01201759|196887|P2|COMPLETED|Visit 4 Crossover||3
84635|NCT01201759|196888|P1|COMPLETED|Visit 4 Crossover||7
84636|NCT01201759|196887|P2|STARTED|Visit 4 Crossover||4
84637|NCT01201759|196888|P1|STARTED|Visit 4 Crossover||7
84638|NCT01201759|196887|P2|NOT COMPLETED|Visit 3 - Washout||3
84639|NCT01201759|196888|P1|NOT COMPLETED|Visit 3 - Washout||1
84640|NCT01201759|196887|P2|COMPLETED|Visit 3 - Washout||4
84641|NCT01201759|196888|P1|COMPLETED|Visit 3 - Washout||7
84642|NCT01201759|196887|P2|STARTED|Visit 3 - Washout||7
84643|NCT01201759|196888|P1|STARTED|Visit 3 - Washout||8
84644|NCT01201759|196887|P2|NOT COMPLETED|Visit 2||0
84645|NCT01201759|196888|P1|NOT COMPLETED|Visit 2||0
84646|NCT01201759|196887|P2|COMPLETED|Visit 2||7
84647|NCT01201759|196888|P1|COMPLETED|Visit 2||8
84648|NCT01201759|196887|P2|STARTED|Visit 2||7
84649|NCT01201759|196888|P1|STARTED|Visit 2||8
84650|NCT01201759|196887|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
84651|NCT01201759|196888|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
84652|NCT01201759|196887|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
84653|NCT01201759|196888|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
84654|NCT01201759|196887|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
84655|NCT01201759|196888|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
84656|NCT01201486|196900|P1|NOT COMPLETED|Overall Study||0
84657|NCT01201486|196900|P1|COMPLETED|Overall Study||6781
84658|NCT01201486|196900|P1|STARTED|Overall Study||6781
84659|NCT01201343|196904|P1|NOT COMPLETED|Overall Study||19
84660|NCT01201343|196904|P1|COMPLETED|Overall Study||60
84661|NCT01201343|196904|P1|Treated|Overall Study||76
84662|NCT01201343|196904|P1|STARTED|Overall Study||79
84663|NCT01201317|196918|P3|NOT COMPLETED|Overall Study||8
84664|NCT01201317|196919|P2|NOT COMPLETED|Overall Study||7
84665|NCT01201317|196920|P1|NOT COMPLETED|Overall Study||9
84666|NCT01201317|196918|P3|COMPLETED|Overall Study||33
84667|NCT01201317|196919|P2|COMPLETED|Overall Study||38
84668|NCT01201317|196920|P1|COMPLETED|Overall Study||39
84669|NCT01201317|196918|P3|STARTED|Overall Study||41
84670|NCT01201317|196919|P2|STARTED|Overall Study||45
84671|NCT01201317|196920|P1|STARTED|Overall Study||48
84672|NCT01201265|196940|P1|NOT COMPLETED|Overall Study||38
84673|NCT01201265|196940|P1|COMPLETED|Overall Study||2
84674|NCT01201265|196940|P1|STARTED|Overall Study||40
84675|NCT01200992|196954|P2|NOT COMPLETED|Overall Study||41
84676|NCT01200992|196955|P1|NOT COMPLETED|Overall Study||37
84677|NCT01200992|196954|P2|COMPLETED|Overall Study||4
84678|NCT01200992|196955|P1|COMPLETED|Overall Study||2
84679|NCT01200992|196954|P2|STARTED|Overall Study||45
84680|NCT01200992|196955|P1|STARTED|Overall Study||39
84681|NCT01200875|196961|P1|NOT COMPLETED|Overall Study||0
84682|NCT01200875|196961|P1|COMPLETED|Overall Study||25
84683|NCT01200875|196961|P1|STARTED|Overall Study||25
84684|NCT01200810|196967|P2|NOT COMPLETED|Overall Study||5
84685|NCT01200810|196968|P1|NOT COMPLETED|Overall Study||5
84686|NCT01200810|196967|P2|COMPLETED|Overall Study||0
84687|NCT01200810|196968|P1|COMPLETED|Overall Study||0
84688|NCT01200810|196967|P2|STARTED|Overall Study||5
84689|NCT01200810|196968|P1|STARTED|Overall Study||5
84690|NCT01200797|196986|P1|NOT COMPLETED|Overall Study||19
84691|NCT01200797|196986|P1|COMPLETED|Overall Study||0
84692|NCT01200797|196986|P1|STARTED|Overall Study||19
84693|NCT01200758|196996|P4|NOT COMPLETED|Stage 2||142
84694|NCT01200758|196997|P3|NOT COMPLETED|Stage 2||141
84695|NCT01200758|196998|P2|NOT COMPLETED|Stage 2||0
84696|NCT01200758|196999|P1|NOT COMPLETED|Stage 2||0
84697|NCT01200758|196996|P4|COMPLETED|Stage 2||0
84698|NCT01200758|196997|P3|COMPLETED|Stage 2||0
84699|NCT01200758|196998|P2|COMPLETED|Stage 2||0
84700|NCT01200758|196999|P1|COMPLETED|Stage 2||0
84701|NCT01200758|196996|P4|STARTED|Stage 2||142
84702|NCT01200758|196997|P3|STARTED|Stage 2||141
84703|NCT01200758|196998|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
84704|NCT01200758|196999|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
84705|NCT01200758|196996|P4|NOT COMPLETED|Stage I||0
84706|NCT01200758|196997|P3|NOT COMPLETED|Stage I||0
84707|NCT01200758|196998|P2|NOT COMPLETED|Stage I||47
84708|NCT01200758|196999|P1|NOT COMPLETED|Stage I||47
84709|NCT01200758|196996|P4|COMPLETED|Stage I||0
84710|NCT01200758|196997|P3|COMPLETED|Stage I||0
84711|NCT01200758|196998|P2|COMPLETED|Stage I|Participants completed treatment period.|16
84712|NCT01200758|196999|P1|COMPLETED|Stage I|Participants completed treatment period.|17
84713|NCT01200758|196996|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
84714|NCT01200758|196997|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
84715|NCT01200758|196998|P2|STARTED|Stage I||63
84716|NCT01200758|196999|P1|STARTED|Stage I||64
84717|NCT01200602|197043|P2|NOT COMPLETED|Overall Study||0
84718|NCT01200602|197044|P1|NOT COMPLETED|Overall Study||0
84719|NCT01200602|197043|P2|COMPLETED|Overall Study||0
84720|NCT01200602|197044|P1|COMPLETED|Overall Study||0
84721|NCT01200602|197043|P2|STARTED|Overall Study||0
84722|NCT01200602|197044|P1|STARTED|Overall Study||0
84723|NCT01200524|197061|P3|NOT COMPLETED|Overall Study||4
84724|NCT01200524|197062|P2|NOT COMPLETED|Overall Study||1
84725|NCT01200524|197063|P1|NOT COMPLETED|Overall Study||2
84726|NCT01200524|197061|P3|COMPLETED|Overall Study||40
84727|NCT01200524|197062|P2|COMPLETED|Overall Study||47
84728|NCT01200524|197063|P1|COMPLETED|Overall Study||39
84729|NCT01200524|197061|P3|STARTED|Overall Study||44
84730|NCT01200524|197062|P2|STARTED|Overall Study||48
84731|NCT01200524|197063|P1|STARTED|Overall Study||41
84732|NCT01200498|197083|P1|NOT COMPLETED|Overall Study||0
84733|NCT01200498|197083|P1|COMPLETED|Overall Study||22
84734|NCT01200498|197083|P1|STARTED|Overall Study||22
84735|NCT01200433|197089|P2|NOT COMPLETED|Overall Study||0
84736|NCT01200433|197090|P1|NOT COMPLETED|Overall Study||0
84737|NCT01200433|197089|P2|COMPLETED|Overall Study||23
84738|NCT01200433|197090|P1|COMPLETED|Overall Study||21
84739|NCT01200433|197089|P2|STARTED|Overall Study||23
84740|NCT01200433|197090|P1|STARTED|Overall Study||21
84741|NCT01200368|197113|P3|NOT COMPLETED|Toddler Dose||1
84742|NCT01200368|197114|P2|NOT COMPLETED|Toddler Dose||3
84743|NCT01200368|197115|P1|NOT COMPLETED|Toddler Dose||0
84744|NCT01200368|197113|P3|COMPLETED|Toddler Dose||168
84745|NCT01200368|197114|P2|COMPLETED|Toddler Dose||159
84746|NCT01200368|197115|P1|COMPLETED|Toddler Dose||162
84747|NCT01200368|197113|P3|STARTED|Toddler Dose||169
84748|NCT01200368|197114|P2|STARTED|Toddler Dose||162
84749|NCT01200368|197115|P1|STARTED|Toddler Dose||162
84750|NCT01200368|197113|P3|NOT COMPLETED|After Infant Series||9
84751|NCT01200368|197114|P2|NOT COMPLETED|After Infant Series||16
84752|NCT01200368|197115|P1|NOT COMPLETED|After Infant Series||18
84753|NCT01200368|197113|P3|COMPLETED|After Infant Series||169
84754|NCT01200368|197114|P2|COMPLETED|After Infant Series||162
84755|NCT01200368|197115|P1|COMPLETED|After Infant Series||162
84756|NCT01200368|197113|P3|STARTED|After Infant Series||178
84757|NCT01200368|197114|P2|STARTED|After Infant Series||178
84758|NCT01200368|197115|P1|STARTED|After Infant Series||180
84759|NCT01200368|197113|P3|NOT COMPLETED|Infant Series||6
84760|NCT01200368|197114|P2|NOT COMPLETED|Infant Series||6
84761|NCT01200368|197115|P1|NOT COMPLETED|Infant Series||3
84762|NCT01200368|197113|P3|COMPLETED|Infant Series||178
84763|NCT01200368|197114|P2|COMPLETED|Infant Series||178
84764|NCT01200368|197115|P1|COMPLETED|Infant Series||180
84765|NCT01200368|197113|P3|Vaccinated Dose 3|Infant Series||182
84766|NCT01200368|197114|P2|Vaccinated Dose 3|Infant Series||178
84767|NCT01200368|197115|P1|Vaccinated Dose 3|Infant Series||181
84768|NCT01200368|197113|P3|Vaccinated Dose 2|Infant Series||183
84769|NCT01200368|197114|P2|Vaccinated Dose 2|Infant Series||182
84770|NCT01200368|197115|P1|Vaccinated Dose 2|Infant Series||183
84771|NCT01200368|197113|P3|Vaccinated Dose 1|Infant Series||183
84772|NCT01200368|197114|P2|Vaccinated Dose 1|Infant Series||183
84773|NCT01200368|197115|P1|Vaccinated Dose 1|Infant Series||183
84774|NCT01200368|197113|P3|STARTED|Infant Series||184
84775|NCT01200368|197114|P2|STARTED|Infant Series||184
84776|NCT01200368|197115|P1|STARTED|Infant Series||183
84777|NCT01200342|197179|P1|NOT COMPLETED|Overall Study||1
84778|NCT01200342|197179|P1|COMPLETED|Overall Study||6
84779|NCT01200342|197179|P1|STARTED|Overall Study||7
84780|NCT01200160|197184|P1|NOT COMPLETED|Overall Study||62
84781|NCT01200160|197184|P1|COMPLETED|Overall Study||66
84782|NCT01200160|197184|P1|STARTED|Overall Study||128
84783|NCT01200069|197190|P2|NOT COMPLETED|Overall Study||1
84784|NCT01200069|197191|P1|NOT COMPLETED|Overall Study||0
84785|NCT01200069|197190|P2|COMPLETED|Overall Study||5
84786|NCT01200069|197191|P1|COMPLETED|Overall Study||8
84787|NCT01200069|197190|P2|STARTED|Overall Study||6
84788|NCT01200069|197191|P1|STARTED|Overall Study||8
84789|NCT01199965|197245|P2|NOT COMPLETED|Overall Study||0
84790|NCT01199965|197246|P1|NOT COMPLETED|Overall Study||1
84791|NCT01199965|197245|P2|COMPLETED|Overall Study||24
84792|NCT01199965|197246|P1|COMPLETED|Overall Study||22
84793|NCT01199965|197245|P2|STARTED|Overall Study||24
84794|NCT01199965|197246|P1|STARTED|Overall Study||23
84795|NCT01199939|197260|P1|NOT COMPLETED|Overall Study||13
84796|NCT01199939|197260|P1|COMPLETED|Overall Study||41
84797|NCT01199939|197260|P1|STARTED|Overall Study|Number of enrolled participants|54
84798|NCT01199926|197279|P2|NOT COMPLETED|Overall Study||4
84799|NCT01199926|197280|P1|NOT COMPLETED|Overall Study||7
84800|NCT01199926|197279|P2|COMPLETED|Overall Study||13
84801|NCT01199926|197280|P1|COMPLETED|Overall Study||10
84802|NCT01199926|197279|P2|STARTED|Overall Study||17
84803|NCT01199926|197280|P1|STARTED|Overall Study||17
84804|NCT01199861|197292|P2|NOT COMPLETED|Overall Study||0
84805|NCT01199861|197293|P1|NOT COMPLETED|Overall Study||2
84806|NCT01199861|197292|P2|COMPLETED|Overall Study||43
84807|NCT01199861|197293|P1|COMPLETED|Overall Study||93
84808|NCT01199861|197292|P2|STARTED|Overall Study||43
84809|NCT01199861|197293|P1|STARTED|Overall Study||95
84810|NCT01199744|197311|P1|NOT COMPLETED|Overall Study||0
84811|NCT01199744|197311|P1|COMPLETED|Overall Study||1575
84812|NCT01199744|197311|P1|STARTED|Overall Study||1575
84813|NCT01199705|197324|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
84814|NCT01199705|197324|P1|COMPLETED|SCIG Treatment (Efficacy)||24
84815|NCT01199705|197324|P1|STARTED|SCIG Treatment (Efficacy)||24
84816|NCT01199705|197324|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
84817|NCT01199705|197324|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
84818|NCT01199705|197324|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
84819|NCT01199705|197324|P1|NOT COMPLETED|IVIG Treatment||0
84820|NCT01199705|197324|P1|COMPLETED|IVIG Treatment||25
84821|NCT01199705|197324|P1|STARTED|IVIG Treatment||25
84822|NCT01199601|197356|P2|NOT COMPLETED|Overall Study||78
84823|NCT01199601|197357|P1|NOT COMPLETED|Overall Study||69
84824|NCT01199601|197356|P2|COMPLETED|Overall Study||344
84825|NCT01199601|197357|P1|COMPLETED|Overall Study||353
84826|NCT01199601|197356|P2|STARTED|Overall Study|Intervention Group|422
84827|NCT01199601|197357|P1|STARTED|Overall Study|Control Group|422
84828|NCT01199471|197367|P1|NOT COMPLETED|Overall Study||6
84829|NCT01199471|197367|P1|COMPLETED|Overall Study||3994
84830|NCT01199471|197367|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
84831|NCT01199237|197378|P2|NOT COMPLETED|Overall Study||0
84832|NCT01199237|197379|P1|NOT COMPLETED|Overall Study||0
84833|NCT01199237|197378|P2|COMPLETED|Overall Study||40
84834|NCT01199237|197379|P1|COMPLETED|Overall Study||41
84835|NCT01199237|197378|P2|STARTED|Overall Study||40
84836|NCT01199237|197379|P1|STARTED|Overall Study||41
84837|NCT01199042|197393|P1|NOT COMPLETED|At Home (3 Months)||1
84838|NCT01199042|197393|P1|COMPLETED|At Home (3 Months)||26
84839|NCT01199042|197393|P1|STARTED|At Home (3 Months)||27
84840|NCT01199042|197393|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
84841|NCT01199042|197393|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
84842|NCT01199042|197393|P1|STARTED|Sleep Laboratory (3 Nights)||29
84843|NCT01198977|197404|P2|NOT COMPLETED|Overall Study||0
84844|NCT01198977|197405|P1|NOT COMPLETED|Overall Study||1
84845|NCT01198977|197404|P2|COMPLETED|Overall Study||33
84846|NCT01198977|197405|P1|COMPLETED|Overall Study||30
84847|NCT01198977|197404|P2|STARTED|Overall Study||33
84848|NCT01198977|197405|P1|STARTED|Overall Study||31
84849|NCT01198873|197417|P2|NOT COMPLETED|Overall Study||32
84850|NCT01198873|197418|P1|NOT COMPLETED|Overall Study||37
84851|NCT01198873|197417|P2|COMPLETED|Overall Study||3
84852|NCT01198873|197418|P1|COMPLETED|Overall Study||4
84853|NCT01198873|197417|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
84854|NCT01198873|197418|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
84855|NCT01198873|197417|P2|Treated|Overall Study||35
84856|NCT01198873|197418|P1|Treated|Overall Study||41
84857|NCT01198873|197417|P2|STARTED|Overall Study||35
84858|NCT01198873|197418|P1|STARTED|Overall Study||41
84859|NCT01198795|197432|P1|NOT COMPLETED|Overall Study||82
84860|NCT01198795|197432|P1|COMPLETED|Overall Study||80
84861|NCT01198795|197432|P1|STARTED|Overall Study||162
84862|NCT01198769|197436|P1|NOT COMPLETED|Overall Study||0
84863|NCT01198769|197436|P1|COMPLETED|Overall Study||15
84864|NCT01198769|197436|P1|STARTED|Overall Study||15
84865|NCT01198756|197449|P4|NOT COMPLETED|Overall Study||26
84866|NCT01198756|197450|P3|NOT COMPLETED|Overall Study||30
84867|NCT01198756|197451|P2|NOT COMPLETED|Overall Study||40
84868|NCT01198756|197452|P1|NOT COMPLETED|Overall Study||38
84869|NCT01198756|197449|P4|COMPLETED|Overall Study||275
84870|NCT01198756|197450|P3|COMPLETED|Overall Study||902
84871|NCT01198756|197451|P2|COMPLETED|Overall Study||889
84872|NCT01198756|197452|P1|COMPLETED|Overall Study||894
84873|NCT01198756|197449|P4|STARTED|Overall Study||301
84874|NCT01198756|197450|P3|STARTED|Overall Study||932
84875|NCT01198756|197451|P2|STARTED|Overall Study||929
84876|NCT01198756|197452|P1|STARTED|Overall Study||932
84877|NCT01198691|197550|P2|NOT COMPLETED|6 Week Post-partum Survey||24
84878|NCT01198691|197551|P1|NOT COMPLETED|6 Week Post-partum Survey||29
84879|NCT01198691|197550|P2|COMPLETED|6 Week Post-partum Survey||26
84880|NCT01198691|197551|P1|COMPLETED|6 Week Post-partum Survey||21
84881|NCT01198691|197550|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
84882|NCT01198691|197551|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
84883|NCT01198691|197550|P2|NOT COMPLETED|Survey Prior to Discharge||33
84884|NCT01198691|197551|P1|NOT COMPLETED|Survey Prior to Discharge||32
84885|NCT01198691|197550|P2|COMPLETED|Survey Prior to Discharge||17
84886|NCT01198691|197551|P1|COMPLETED|Survey Prior to Discharge||18
84887|NCT01198691|197550|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
84888|NCT01198691|197551|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
84889|NCT01198691|197550|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
84890|NCT01198691|197551|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
84891|NCT01198691|197550|P2|COMPLETED|Completed VAS Score at Discharge||44
84892|NCT01198691|197551|P1|COMPLETED|Completed VAS Score at Discharge||45
84893|NCT01198691|197550|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
84894|NCT01198691|197551|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
84895|NCT01198691|197550|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
84896|NCT01198691|197551|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
84897|NCT01198691|197550|P2|COMPLETED|Completed VAS Score Postop Day 1||46
84898|NCT01198691|197551|P1|COMPLETED|Completed VAS Score Postop Day 1||47
84899|NCT01198691|197550|P2|STARTED|Completed VAS Score Postop Day 1||50
84900|NCT01198691|197551|P1|STARTED|Completed VAS Score Postop Day 1||50
84901|NCT01198691|197550|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
84902|NCT01198691|197551|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
84903|NCT01198691|197550|P2|COMPLETED|Completed Surgery -Received Intervention||50
84904|NCT01198691|197551|P1|COMPLETED|Completed Surgery -Received Intervention||50
84905|NCT01198691|197550|P2|STARTED|Completed Surgery -Received Intervention||50
84906|NCT01198691|197551|P1|STARTED|Completed Surgery -Received Intervention||50
84907|NCT01198600|197563|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
84908|NCT01198600|197564|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
84909|NCT01198600|197565|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
84910|NCT01198600|197566|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
84911|NCT01198600|197563|P4|COMPLETED|Phase 3: 43 Days of Wear||38
84912|NCT01198600|197564|P3|COMPLETED|Phase 3: 43 Days of Wear||0
84913|NCT01198600|197565|P2|COMPLETED|Phase 3: 43 Days of Wear||0
84914|NCT01198600|197566|P1|COMPLETED|Phase 3: 43 Days of Wear||0
84915|NCT01198600|197563|P4|STARTED|Phase 3: 43 Days of Wear||38
84916|NCT01198600|197564|P3|STARTED|Phase 3: 43 Days of Wear||0
84917|NCT01198600|197565|P2|STARTED|Phase 3: 43 Days of Wear||0
84918|NCT01198600|197566|P1|STARTED|Phase 3: 43 Days of Wear||0
84919|NCT01198600|197563|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
84920|NCT01198600|197564|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
84921|NCT01198600|197565|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
84922|NCT01198600|197566|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
84923|NCT01198600|197563|P4|COMPLETED|Phase 2: 56 Days of Wear||0
84924|NCT01198600|197564|P3|COMPLETED|Phase 2: 56 Days of Wear||62
84925|NCT01198600|197565|P2|COMPLETED|Phase 2: 56 Days of Wear||0
84926|NCT01198600|197566|P1|COMPLETED|Phase 2: 56 Days of Wear||0
84927|NCT01198600|197563|P4|STARTED|Phase 2: 56 Days of Wear||0
84928|NCT01198600|197564|P3|STARTED|Phase 2: 56 Days of Wear||67
84929|NCT01198600|197565|P2|STARTED|Phase 2: 56 Days of Wear||0
84930|NCT01198600|197566|P1|STARTED|Phase 2: 56 Days of Wear||0
84931|NCT01198600|197563|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
84932|NCT01198600|197564|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
84933|NCT01198600|197565|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
84934|NCT01198600|197566|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
84935|NCT01198600|197563|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
84936|NCT01198600|197564|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
84937|NCT01198600|197565|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
84938|NCT01198600|197566|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
84939|NCT01198600|197563|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
84940|NCT01198600|197564|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
84941|NCT01198600|197565|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
84942|NCT01198600|197566|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
84943|NCT01198600|197563|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
84944|NCT01198600|197564|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
84945|NCT01198600|197565|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
84946|NCT01198600|197566|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
84947|NCT01198600|197563|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
84948|NCT01198600|197564|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
84949|NCT01198600|197565|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
84950|NCT01198600|197566|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
84951|NCT01198600|197563|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
84952|NCT01198600|197564|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
84953|NCT01198600|197565|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
84954|NCT01198600|197566|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
84955|NCT01198574|197592|P4|NOT COMPLETED|Overall Study||4
84956|NCT01198574|197593|P3|NOT COMPLETED|Overall Study||1
84957|NCT01198574|197594|P2|NOT COMPLETED|Overall Study||1
84958|NCT01198574|197595|P1|NOT COMPLETED|Overall Study||4
84959|NCT01198574|197592|P4|COMPLETED|Overall Study||98
84960|NCT01198574|197593|P3|COMPLETED|Overall Study||99
84961|NCT01198574|197594|P2|COMPLETED|Overall Study||101
84962|NCT01198574|197595|P1|COMPLETED|Overall Study||94
84963|NCT01198574|197592|P4|STARTED|Overall Study||102
84964|NCT01198574|197593|P3|STARTED|Overall Study||100
84965|NCT01198574|197594|P2|STARTED|Overall Study||102
84966|NCT01198574|197595|P1|STARTED|Overall Study||98
84967|NCT01198548|197613|P1|NOT COMPLETED|Overall Study||10
84968|NCT01198548|197613|P1|COMPLETED|Overall Study||0
84969|NCT01198548|197613|P1|STARTED|Overall Study||10
84970|NCT01198509|197628|P6|NOT COMPLETED|Overall Study||0
84971|NCT01198509|197629|P5|NOT COMPLETED|Overall Study||0
84972|NCT01198509|197630|P4|NOT COMPLETED|Overall Study||0
84973|NCT01198509|197631|P3|NOT COMPLETED|Overall Study||0
84974|NCT01198509|197632|P2|NOT COMPLETED|Overall Study||0
84975|NCT01198509|197633|P1|NOT COMPLETED|Overall Study||1
84976|NCT01198509|197628|P6|COMPLETED|Overall Study||58
84977|NCT01198509|197629|P5|COMPLETED|Overall Study||20
84978|NCT01198509|197630|P4|COMPLETED|Overall Study||66
84979|NCT01198509|197631|P3|COMPLETED|Overall Study||19
84980|NCT01198509|197632|P2|COMPLETED|Overall Study||10
84981|NCT01198509|197633|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
84982|NCT01198509|197628|P6|STARTED|Overall Study||58
84983|NCT01198509|197629|P5|STARTED|Overall Study||20
84984|NCT01198509|197630|P4|STARTED|Overall Study||66
84985|NCT01198509|197631|P3|STARTED|Overall Study||19
84986|NCT01198509|197632|P2|STARTED|Overall Study||10
84987|NCT01198509|197633|P1|STARTED|Overall Study||5
84988|NCT01198366|197656|P6|NOT COMPLETED|Overall Study||13
84989|NCT01198366|197657|P5|NOT COMPLETED|Overall Study||15
84990|NCT01198366|197658|P4|NOT COMPLETED|Overall Study||5
84991|NCT01198366|197659|P3|NOT COMPLETED|Overall Study||8
84992|NCT01198366|197660|P2|NOT COMPLETED|Overall Study||7
84993|NCT01198366|197661|P1|NOT COMPLETED|Overall Study||12
84994|NCT01198366|197656|P6|COMPLETED|Overall Study||128
84995|NCT01198366|197657|P5|COMPLETED|Overall Study||125
84996|NCT01198366|197658|P4|COMPLETED|Overall Study||47
84997|NCT01198366|197659|P3|COMPLETED|Overall Study||43
84998|NCT01198366|197660|P2|COMPLETED|Overall Study||44
84999|NCT01198366|197661|P1|COMPLETED|Overall Study||40
85000|NCT01198366|197656|P6|STARTED|Overall Study||141
85001|NCT01198366|197657|P5|STARTED|Overall Study||140
85002|NCT01198366|197658|P4|STARTED|Overall Study||52
85003|NCT01198366|197659|P3|STARTED|Overall Study||51
85004|NCT01198366|197660|P2|STARTED|Overall Study||51
85005|NCT01198366|197661|P1|STARTED|Overall Study||52
85006|NCT01198327|197699|P1|NOT COMPLETED|Overall Study||10
85007|NCT01198327|197699|P1|COMPLETED|Overall Study||56
85008|NCT01198327|197699|P1|STARTED|Overall Study||66
85009|NCT01198275|197709|P2|NOT COMPLETED|Overall Study||5
85010|NCT01198275|197710|P1|NOT COMPLETED|Overall Study||6
85011|NCT01198275|197709|P2|COMPLETED|Overall Study||94
85012|NCT01198275|197710|P1|COMPLETED|Overall Study||94
85013|NCT01198275|197709|P2|STARTED|Overall Study||99
85014|NCT01198275|197710|P1|STARTED|Overall Study||100
85015|NCT01197911|197719|P3|NOT COMPLETED|Overall Study||1
85016|NCT01197911|197720|P2|NOT COMPLETED|Overall Study||0
85017|NCT01197911|197721|P1|NOT COMPLETED|Overall Study||0
85018|NCT01197911|197719|P3|COMPLETED|Overall Study||9
85019|NCT01197911|197720|P2|COMPLETED|Overall Study||10
85020|NCT01197911|197721|P1|COMPLETED|Overall Study||18
85021|NCT01197911|197719|P3|STARTED|Overall Study||10
85022|NCT01197911|197720|P2|STARTED|Overall Study||10
85023|NCT01197911|197721|P1|STARTED|Overall Study||18
85024|NCT01197898|197806|P2|NOT COMPLETED|Overall Study||0
85025|NCT01197898|197807|P1|NOT COMPLETED|Overall Study||0
85026|NCT01197898|197806|P2|COMPLETED|Overall Study||5
85027|NCT01197898|197807|P1|COMPLETED|Overall Study||5
85028|NCT01197898|197806|P2|STARTED|Overall Study||5
85029|NCT01197898|197807|P1|STARTED|Overall Study||5
85030|NCT01197833|197816|P3|NOT COMPLETED|Overall Study||0
85031|NCT01197833|197817|P2|NOT COMPLETED|Overall Study||0
85032|NCT01197833|197818|P1|NOT COMPLETED|Overall Study||0
85033|NCT01197833|197816|P3|COMPLETED|Overall Study||40
85034|NCT01197833|197817|P2|COMPLETED|Overall Study||39
85035|NCT01197833|197818|P1|COMPLETED|Overall Study||38
85036|NCT01197833|197816|P3|STARTED|Overall Study||40
85037|NCT01197833|197817|P2|STARTED|Overall Study||39
85038|NCT01197833|197818|P1|STARTED|Overall Study||38
85039|NCT01197794|197836|P7|NOT COMPLETED|Overall Study||21
85040|NCT01197794|197837|P6|NOT COMPLETED|Overall Study||19
85041|NCT01197794|197838|P5|NOT COMPLETED|Overall Study||14
85042|NCT01197794|197839|P4|NOT COMPLETED|Overall Study||12
85043|NCT01197794|197840|P3|NOT COMPLETED|Overall Study||13
85044|NCT01197794|197841|P2|NOT COMPLETED|Overall Study||15
85045|NCT01197794|197842|P1|NOT COMPLETED|Overall Study||16
85046|NCT01197794|197836|P7|COMPLETED|Overall Study||142
85047|NCT01197794|197837|P6|COMPLETED|Overall Study||144
85048|NCT01197794|197838|P5|COMPLETED|Overall Study||149
85049|NCT01197794|197839|P4|COMPLETED|Overall Study||152
85050|NCT01197794|197840|P3|COMPLETED|Overall Study||153
85051|NCT01197794|197841|P2|COMPLETED|Overall Study||146
85052|NCT01197794|197842|P1|COMPLETED|Overall Study||148
85053|NCT01197794|197836|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
85054|NCT01197794|197837|P6|STARTED|Overall Study||163
85055|NCT01197794|197838|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
85056|NCT01197794|197839|P4|STARTED|Overall Study||164
85057|NCT01197794|197840|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
85058|NCT01197794|197841|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
85059|NCT01197794|197842|P1|STARTED|Overall Study||164
85060|NCT01197755|197924|P3|NOT COMPLETED|Overall Study||54
85061|NCT01197755|197925|P2|NOT COMPLETED|Overall Study||43
85062|NCT01197755|197926|P1|NOT COMPLETED|Overall Study||38
85063|NCT01197755|197924|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
85064|NCT01197755|197925|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
85065|NCT01197755|197926|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
85066|NCT01197755|197924|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
85067|NCT01197755|197925|P2|Randomised But Did Not Receive Treatment|Overall Study||0
85068|NCT01197755|197926|P1|Randomised But Did Not Receive Treatment|Overall Study||0
85069|NCT01197755|197924|P3|STARTED|Overall Study|Patients who received treatment|109
85070|NCT01197755|197925|P2|STARTED|Overall Study|Patients who received treatment|108
85071|NCT01197755|197926|P1|STARTED|Overall Study|Patients who received treatment|105
85072|NCT01197560|197968|P2|NOT COMPLETED|Overall Study||53
85073|NCT01197560|197969|P1|NOT COMPLETED|Overall Study||46
85152|NCT01196988|198236|P4|STARTED|Overall Study||277
85074|NCT01197560|197968|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
85075|NCT01197560|197969|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
85076|NCT01197560|197968|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
85077|NCT01197560|197969|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
85078|NCT01197560|197968|P2|Lenalidomide Crossover|Overall Study||29
85079|NCT01197560|197969|P1|Lenalidomide Crossover|Overall Study||0
85080|NCT01197560|197968|P2|Received ≥ One Dose Study Drug|Overall Study||55
85081|NCT01197560|197969|P1|Received ≥ One Dose Study Drug|Overall Study||54
85082|NCT01197560|197968|P2|STARTED|Overall Study|This is the intent to treat population|57
85083|NCT01197560|197969|P1|STARTED|Overall Study|This is the intent to treat population|54
85084|NCT01197534|197996|P3|NOT COMPLETED|Overall Study||173
85085|NCT01197534|197997|P2|NOT COMPLETED|Overall Study||130
85086|NCT01197534|197998|P1|NOT COMPLETED|Overall Study||134
85087|NCT01197534|197996|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
85088|NCT01197534|197997|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
85089|NCT01197534|197998|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
85090|NCT01197534|197996|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
85091|NCT01197534|197997|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
85092|NCT01197534|197998|P1|Randomised But Did Not Receive Treatment|Overall Study||0
85093|NCT01197534|197996|P3|STARTED|Overall Study|Patients who received treatment|302
85094|NCT01197534|197997|P2|STARTED|Overall Study|Patients who received treatment|298
85095|NCT01197534|197998|P1|STARTED|Overall Study|Patients who received treatment|308
85096|NCT01197521|198042|P3|NOT COMPLETED|Overall Study||143
85097|NCT01197521|198043|P2|NOT COMPLETED|Overall Study||113
85098|NCT01197521|198044|P1|NOT COMPLETED|Overall Study||103
85099|NCT01197521|198042|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
85100|NCT01197521|198043|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
85101|NCT01197521|198044|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
85102|NCT01197521|198042|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
85103|NCT01197521|198043|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
85104|NCT01197521|198044|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
85105|NCT01197521|198042|P3|STARTED|Overall Study|Patients who received treatment|304
85106|NCT01197521|198043|P2|STARTED|Overall Study|Patients who received treatment|304
85107|NCT01197521|198044|P1|STARTED|Overall Study|Patients who received treatment|310
85108|NCT01197508|198089|P4|NOT COMPLETED|Overall Study||16
85109|NCT01197508|198090|P3|NOT COMPLETED|Overall Study||49
85110|NCT01197508|198091|P2|NOT COMPLETED|Overall Study||30
85111|NCT01197508|198092|P1|NOT COMPLETED|Overall Study||23
85112|NCT01197508|198089|P4|COMPLETED|Overall Study||158
85113|NCT01197508|198090|P3|COMPLETED|Overall Study||125
85114|NCT01197508|198091|P2|COMPLETED|Overall Study||144
85115|NCT01197508|198092|P1|COMPLETED|Overall Study||151
85116|NCT01197508|198089|P4|Received Treatment|Overall Study||174
85117|NCT01197508|198090|P3|Received Treatment|Overall Study||171
85118|NCT01197508|198091|P2|Received Treatment|Overall Study||174
85119|NCT01197508|198092|P1|Received Treatment|Overall Study||174
85120|NCT01197508|198089|P4|STARTED|Overall Study||174
85121|NCT01197508|198090|P3|STARTED|Overall Study||174
85122|NCT01197508|198091|P2|STARTED|Overall Study||174
85123|NCT01197508|198092|P1|STARTED|Overall Study||174
85124|NCT01197495|198188|P2|NOT COMPLETED|Overall Study||7
85125|NCT01197495|198189|P1|NOT COMPLETED|Overall Study||13
85126|NCT01197495|198188|P2|COMPLETED|Overall Study||49
85127|NCT01197495|198189|P1|COMPLETED|Overall Study||144
85128|NCT01197495|198188|P2|STARTED|Overall Study||56
85129|NCT01197495|198189|P1|STARTED|Overall Study||157
85130|NCT01197417|198202|P2|NOT COMPLETED|Overall Study||18
85131|NCT01197417|198203|P1|NOT COMPLETED|Overall Study||8
85132|NCT01197417|198202|P2|COMPLETED|Overall Study||86
85133|NCT01197417|198203|P1|COMPLETED|Overall Study||96
85134|NCT01197417|198202|P2|Received Study Drug|Overall Study||103
85135|NCT01197417|198203|P1|Received Study Drug|Overall Study||101
85136|NCT01197417|198202|P2|STARTED|Overall Study||104
85137|NCT01197417|198203|P1|STARTED|Overall Study||104
85138|NCT01197326|198223|P2|NOT COMPLETED|Overall Study||0
85139|NCT01197326|198224|P1|NOT COMPLETED|Overall Study||0
85140|NCT01197326|198223|P2|COMPLETED|Overall Study||209
85141|NCT01197326|198224|P1|COMPLETED|Overall Study||205
85142|NCT01197326|198223|P2|STARTED|Overall Study||209
85143|NCT01197326|198224|P1|STARTED|Overall Study||205
85144|NCT01196988|198236|P4|NOT COMPLETED|Overall Study||1
85145|NCT01196988|198237|P3|NOT COMPLETED|Overall Study||25
85146|NCT01196988|198238|P2|NOT COMPLETED|Overall Study||32
85147|NCT01196988|198239|P1|NOT COMPLETED|Overall Study||24
85148|NCT01196988|198236|P4|COMPLETED|Overall Study||276
85149|NCT01196988|198237|P3|COMPLETED|Overall Study||886
85150|NCT01196988|198238|P2|COMPLETED|Overall Study||880
85151|NCT01196988|198239|P1|COMPLETED|Overall Study||891
85153|NCT01196988|198237|P3|STARTED|Overall Study||911
85154|NCT01196988|198238|P2|STARTED|Overall Study||912
85155|NCT01196988|198239|P1|STARTED|Overall Study||915
85156|NCT01196975|198333|P5|NOT COMPLETED|Overall Study||13
85157|NCT01196975|198334|P4|NOT COMPLETED|Overall Study||6
85158|NCT01196975|198335|P3|NOT COMPLETED|Overall Study||5
85159|NCT01196975|198336|P2|NOT COMPLETED|Overall Study||9
85160|NCT01196975|198337|P1|NOT COMPLETED|Overall Study||15
85161|NCT01196975|198333|P5|COMPLETED|Overall Study||205
85162|NCT01196975|198334|P4|COMPLETED|Overall Study||207
85163|NCT01196975|198335|P3|COMPLETED|Overall Study||420
85164|NCT01196975|198336|P2|COMPLETED|Overall Study||415
85165|NCT01196975|198337|P1|COMPLETED|Overall Study||408
85166|NCT01196975|198333|P5|STARTED|Overall Study||218
85167|NCT01196975|198334|P4|STARTED|Overall Study||213
85168|NCT01196975|198335|P3|STARTED|Overall Study||425
85169|NCT01196975|198336|P2|STARTED|Overall Study||424
85170|NCT01196975|198337|P1|STARTED|Overall Study||423
85171|NCT01196923|198469|P1|NOT COMPLETED|Overall Study||0
85172|NCT01196923|198469|P1|COMPLETED|Overall Study||20
85173|NCT01196923|198469|P1|STARTED|Overall Study||20
85174|NCT01196741|198475|P2|NOT COMPLETED|Overall Study||28
85175|NCT01196741|198476|P1|NOT COMPLETED|Overall Study||60
85176|NCT01196741|198475|P2|COMPLETED|Overall Study||8
85177|NCT01196741|198476|P1|COMPLETED|Overall Study||11
85178|NCT01196741|198475|P2|STARTED|Overall Study||36
85179|NCT01196741|198476|P1|STARTED|Overall Study||71
85180|NCT01196442|198490|P1|NOT COMPLETED|Overall Study||0
85181|NCT01196442|198490|P1|COMPLETED|Overall Study||39
85182|NCT01196442|198490|P1|STARTED|Overall Study||39
85183|NCT01196104|198502|P2|NOT COMPLETED|Overall Study||5
85184|NCT01196104|198503|P1|NOT COMPLETED|Overall Study||4
85185|NCT01196104|198502|P2|COMPLETED|Overall Study||15
85186|NCT01196104|198503|P1|COMPLETED|Overall Study||15
85187|NCT01196104|198502|P2|STARTED|Overall Study||20
85188|NCT01196104|198503|P1|STARTED|Overall Study||19
85189|NCT01196078|198545|P2|NOT COMPLETED|Overall Study||37
85190|NCT01196078|198546|P1|NOT COMPLETED|Overall Study||33
85191|NCT01196078|198545|P2|COMPLETED|Overall Study||20
85192|NCT01196078|198546|P1|COMPLETED|Overall Study||24
85193|NCT01196078|198545|P2|STARTED|Overall Study||57
85194|NCT01196078|198546|P1|STARTED|Overall Study||57
85195|NCT01196052|198574|P1|NOT COMPLETED|Overall Study||23
85196|NCT01196052|198574|P1|COMPLETED|Overall Study||130
85197|NCT01196052|198574|P1|Received Trastuzumab Emtansine|Overall Study||148
85198|NCT01196052|198574|P1|STARTED|Overall Study||153
85199|NCT01196026|198591|P6|NOT COMPLETED|Overall Study||0
85200|NCT01196026|198592|P5|NOT COMPLETED|Overall Study||1
85201|NCT01196026|198593|P4|NOT COMPLETED|Overall Study||0
85202|NCT01196026|198594|P3|NOT COMPLETED|Overall Study||0
85203|NCT01196026|198595|P2|NOT COMPLETED|Overall Study||8
85204|NCT01196026|198596|P1|NOT COMPLETED|Overall Study||1
85205|NCT01196026|198591|P6|COMPLETED|Overall Study||24
85206|NCT01196026|198592|P5|COMPLETED|Overall Study||42
85207|NCT01196026|198593|P4|COMPLETED|Overall Study||10
85208|NCT01196026|198594|P3|COMPLETED|Overall Study||23
85209|NCT01196026|198595|P2|COMPLETED|Overall Study||36
85210|NCT01196026|198596|P1|COMPLETED|Overall Study||9
85211|NCT01196026|198591|P6|Completed at Day 28|Overall Study||24
85212|NCT01196026|198592|P5|Completed at Day 28|Overall Study||42
85213|NCT01196026|198593|P4|Completed at Day 28|Overall Study||10
85214|NCT01196026|198594|P3|Completed at Day 28|Overall Study||23
85215|NCT01196026|198595|P2|Completed at Day 28|Overall Study||41
85216|NCT01196026|198596|P1|Completed at Day 28|Overall Study||9
85217|NCT01196026|198591|P6|STARTED|Overall Study||24
85218|NCT01196026|198592|P5|STARTED|Overall Study||43
85219|NCT01196026|198593|P4|STARTED|Overall Study||10
85220|NCT01196026|198594|P3|STARTED|Overall Study||23
85221|NCT01196026|198595|P2|STARTED|Overall Study||44
85222|NCT01196026|198596|P1|STARTED|Overall Study||10
85223|NCT01195948|198832|P3|NOT COMPLETED|Overall Study||2
85224|NCT01195948|198833|P2|NOT COMPLETED|Overall Study||1
85225|NCT01195948|198834|P1|NOT COMPLETED|Overall Study||0
85226|NCT01195948|198832|P3|COMPLETED|Overall Study||9
85227|NCT01195948|198833|P2|COMPLETED|Overall Study||9
85228|NCT01195948|198834|P1|COMPLETED|Overall Study||10
85229|NCT01195948|198832|P3|Week 24|Overall Study||10
85230|NCT01195948|198833|P2|Week 24|Overall Study||10
85231|NCT01195948|198834|P1|Week 24|Overall Study||10
85232|NCT01195948|198832|P3|STARTED|Overall Study||11
85233|NCT01195948|198833|P2|STARTED|Overall Study||10
85234|NCT01195948|198834|P1|STARTED|Overall Study||10
85235|NCT01195922|198860|P1|NOT COMPLETED|Overall Study||0
85236|NCT01195922|198860|P1|COMPLETED|Overall Study||16
85237|NCT01195922|198860|P1|STARTED|Overall Study||16
85238|NCT01195844|198866|P1|NOT COMPLETED|Overall Study||40
85239|NCT01195844|198866|P1|COMPLETED|Overall Study||190
85240|NCT01195844|198866|P1|STARTED|Overall Study||230
85241|NCT01195831|198883|P2|NOT COMPLETED|Overall Study||10
85242|NCT01195831|198884|P1|NOT COMPLETED|Overall Study||8
85243|NCT01195831|198883|P2|COMPLETED|Overall Study||114
85244|NCT01195831|198884|P1|COMPLETED|Overall Study||112
85245|NCT01195831|198883|P2|STARTED|Overall Study||124
85246|NCT01195831|198884|P1|STARTED|Overall Study||120
85247|NCT01195779|198912|P14|NOT COMPLETED|Overall Study||0
85248|NCT01195779|198913|P13|NOT COMPLETED|Overall Study||0
85249|NCT01195779|198914|P12|NOT COMPLETED|Overall Study||0
85250|NCT01195779|198915|P11|NOT COMPLETED|Overall Study||0
85251|NCT01195779|198916|P10|NOT COMPLETED|Overall Study||0
85252|NCT01195779|198917|P9|NOT COMPLETED|Overall Study||0
85253|NCT01195779|198918|P8|NOT COMPLETED|Overall Study||0
85254|NCT01195779|198919|P7|NOT COMPLETED|Overall Study||0
85255|NCT01195779|198920|P6|NOT COMPLETED|Overall Study||0
85256|NCT01195779|198921|P5|NOT COMPLETED|Overall Study||0
85257|NCT01195779|198922|P4|NOT COMPLETED|Overall Study||0
85258|NCT01195779|198923|P3|NOT COMPLETED|Overall Study||0
85259|NCT01195779|198924|P2|NOT COMPLETED|Overall Study||0
85260|NCT01195779|198925|P1|NOT COMPLETED|Overall Study||0
85261|NCT01195779|198912|P14|COMPLETED|Overall Study||1
85262|NCT01195779|198913|P13|COMPLETED|Overall Study||0
85263|NCT01195779|198914|P12|COMPLETED|Overall Study||1
85264|NCT01195779|198915|P11|COMPLETED|Overall Study||0
85265|NCT01195779|198916|P10|COMPLETED|Overall Study||0
85266|NCT01195779|198917|P9|COMPLETED|Overall Study||0
85267|NCT01195779|198918|P8|COMPLETED|Overall Study||1
85268|NCT01195779|198919|P7|COMPLETED|Overall Study||0
85269|NCT01195779|198920|P6|COMPLETED|Overall Study||0
85270|NCT01195779|198921|P5|COMPLETED|Overall Study||1
85271|NCT01195779|198922|P4|COMPLETED|Overall Study||0
85272|NCT01195779|198923|P3|COMPLETED|Overall Study||0
85273|NCT01195779|198924|P2|COMPLETED|Overall Study||0
85274|NCT01195779|198925|P1|COMPLETED|Overall Study||0
85275|NCT01195779|198912|P14|STARTED|Overall Study||1
85276|NCT01195779|198913|P13|STARTED|Overall Study||0
85277|NCT01195779|198914|P12|STARTED|Overall Study||1
85278|NCT01195779|198915|P11|STARTED|Overall Study||0
85279|NCT01195779|198916|P10|STARTED|Overall Study||0
85280|NCT01195779|198917|P9|STARTED|Overall Study||0
85281|NCT01195779|198918|P8|STARTED|Overall Study||1
85282|NCT01195779|198919|P7|STARTED|Overall Study||0
85283|NCT01195779|198920|P6|STARTED|Overall Study||0
85284|NCT01195779|198921|P5|STARTED|Overall Study||1
85285|NCT01195779|198922|P4|STARTED|Overall Study||0
85286|NCT01195779|198923|P3|STARTED|Overall Study||0
85287|NCT01195779|198924|P2|STARTED|Overall Study||0
85288|NCT01195779|198925|P1|STARTED|Overall Study||0
85289|NCT01195701|199097|P2|NOT COMPLETED|Overall Study||5
85290|NCT01195701|199098|P1|NOT COMPLETED|Overall Study||0
85291|NCT01195701|199097|P2|COMPLETED|Overall Study||20
85292|NCT01195701|199098|P1|COMPLETED|Overall Study||10
85293|NCT01195701|199097|P2|STARTED|Overall Study||25
85294|NCT01195701|199098|P1|STARTED|Overall Study||10
85295|NCT01195675|199124|P1|NOT COMPLETED|Overall Study||3
85296|NCT01195675|199124|P1|COMPLETED|Overall Study||27
85297|NCT01195675|199124|P1|Received Placebo 2|Overall Study||28
85298|NCT01195675|199124|P1|Received Placebo 1|Overall Study||29
85299|NCT01195675|199124|P1|Received Moxifloxacin|Overall Study||29
85300|NCT01195675|199124|P1|Received Empa 200mg|Overall Study||30
85301|NCT01195675|199124|P1|Received Empa 25mg|Overall Study||28
85302|NCT01195675|199124|P1|STARTED|Overall Study||30
85303|NCT01195662|199157|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
85304|NCT01195662|199158|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
85305|NCT01195662|199159|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
85306|NCT01195662|199157|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
85307|NCT01195662|199158|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
85308|NCT01195662|199159|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
85309|NCT01195662|199157|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
85310|NCT01195662|199158|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
85311|NCT01195662|199159|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
85312|NCT01195662|199157|P3|NOT COMPLETED|Double Blind Treatment Period||14
85313|NCT01195662|199158|P2|NOT COMPLETED|Double Blind Treatment Period||14
85314|NCT01195662|199159|P1|NOT COMPLETED|Double Blind Treatment Period||22
85315|NCT01195662|199157|P3|COMPLETED|Double Blind Treatment Period||119
85316|NCT01195662|199158|P2|COMPLETED|Double Blind Treatment Period||211
85317|NCT01195662|199159|P1|COMPLETED|Double Blind Treatment Period||202
85318|NCT01195662|199157|P3|STARTED|Double Blind Treatment Period||133
85319|NCT01195662|199158|P2|STARTED|Double Blind Treatment Period||225
85320|NCT01195662|199159|P1|STARTED|Double Blind Treatment Period||224
85321|NCT01195636|199189|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
85322|NCT01195636|199190|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
85323|NCT01195636|199189|P2|COMPLETED|Second Intervention (3 Weeks)||27
85324|NCT01195636|199190|P1|COMPLETED|Second Intervention (3 Weeks)||27
85325|NCT01195636|199189|P2|STARTED|Second Intervention (3 Weeks)||29
85326|NCT01195636|199190|P1|STARTED|Second Intervention (3 Weeks)||28
85327|NCT01195636|199189|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
85328|NCT01195636|199190|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
85329|NCT01195636|199189|P2|COMPLETED|Washout Period (2 Weeks)||29
85330|NCT01195636|199190|P1|COMPLETED|Washout Period (2 Weeks)||28
85331|NCT01195636|199189|P2|STARTED|Washout Period (2 Weeks)||32
85332|NCT01195636|199190|P1|STARTED|Washout Period (2 Weeks)||30
85333|NCT01195636|199189|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
85334|NCT01195636|199190|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
85335|NCT01195636|199189|P2|COMPLETED|First Intervention (3 Weeks)||32
85336|NCT01195636|199190|P1|COMPLETED|First Intervention (3 Weeks)||30
85337|NCT01195636|199189|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
85338|NCT01195636|199190|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
85339|NCT01195636|199189|P2|STARTED|First Intervention (3 Weeks)||35
85340|NCT01195636|199190|P1|STARTED|First Intervention (3 Weeks)||35
85341|NCT01195623|199216|P2|NOT COMPLETED|Overall Study||37
85342|NCT01195623|199217|P1|NOT COMPLETED|Overall Study||35
85343|NCT01195623|199216|P2|COMPLETED|Overall Study|129 legs|108
85344|NCT01195623|199217|P1|COMPLETED|Overall Study|127 legs|113
85345|NCT01195623|199216|P2|STARTED|Overall Study|177 legs total operated|145
85346|NCT01195623|199217|P1|STARTED|Overall Study|166 legs total operated|148
85347|NCT01195597|199225|P1|NOT COMPLETED|Overall Study||13
85348|NCT01195597|199225|P1|COMPLETED|Overall Study||27
85349|NCT01195597|199225|P1|STARTED|Overall Study||40
85350|NCT01195584|199233|P3|NOT COMPLETED|Overall Study||0
85351|NCT01195584|199234|P2|NOT COMPLETED|Overall Study||0
85352|NCT01195584|199235|P1|NOT COMPLETED|Overall Study||0
85353|NCT01195584|199233|P3|COMPLETED|Overall Study||27
85354|NCT01195584|199234|P2|COMPLETED|Overall Study||25
85355|NCT01195584|199235|P1|COMPLETED|Overall Study||20
85356|NCT01195584|199233|P3|STARTED|Overall Study||27
85357|NCT01195584|199234|P2|STARTED|Overall Study||25
85358|NCT01195584|199235|P1|STARTED|Overall Study||20
85359|NCT01195467|199246|P1|NOT COMPLETED|Overall Study||10
85360|NCT01195467|199246|P1|COMPLETED|Overall Study||30
85361|NCT01195467|199246|P1|STARTED|Overall Study||40
85362|NCT01195415|199251|P1|NOT COMPLETED|Overall Study||2
85363|NCT01195415|199251|P1|COMPLETED|Overall Study||23
85364|NCT01195415|199251|P1|STARTED|Overall Study||25
85365|NCT01195363|199258|P2|NOT COMPLETED|Overall Study||9
85366|NCT01195363|199259|P1|NOT COMPLETED|Overall Study||11
85367|NCT01195363|199258|P2|COMPLETED|Overall Study||4
85368|NCT01195363|199259|P1|COMPLETED|Overall Study||4
85369|NCT01195363|199258|P2|STARTED|Overall Study||13
85370|NCT01195363|199259|P1|STARTED|Overall Study||15
85371|NCT01195272|199265|P1|NOT COMPLETED|Overall Study||4
85372|NCT01195272|199265|P1|COMPLETED|Overall Study||17
85373|NCT01195272|199265|P1|STARTED|Overall Study||21
85374|NCT01195116|199284|P2|NOT COMPLETED|Overall Study||0
85375|NCT01195116|199285|P1|NOT COMPLETED|Overall Study||0
85376|NCT01195116|199284|P2|COMPLETED|Overall Study||20
85377|NCT01195116|199285|P1|COMPLETED|Overall Study||21
85378|NCT01195116|199284|P2|STARTED|Overall Study||20
85379|NCT01195116|199285|P1|STARTED|Overall Study||21
85380|NCT01195103|199294|P3|NOT COMPLETED|Overall Study||0
85381|NCT01195103|199295|P2|NOT COMPLETED|Overall Study||0
85382|NCT01195103|199296|P1|NOT COMPLETED|Overall Study||1
85383|NCT01195103|199294|P3|COMPLETED|Overall Study||5
85384|NCT01195103|199295|P2|COMPLETED|Overall Study||2
85385|NCT01195103|199296|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
85386|NCT01195103|199294|P3|STARTED|Overall Study||5
85387|NCT01195103|199295|P2|STARTED|Overall Study||2
85388|NCT01195103|199296|P1|STARTED|Overall Study||6
85389|NCT01195090|199306|P2|NOT COMPLETED|Overall Study||8
85390|NCT01195090|199307|P1|NOT COMPLETED|Overall Study||6
85391|NCT01195090|199306|P2|COMPLETED|Overall Study||52
85392|NCT01195090|199307|P1|COMPLETED|Overall Study||54
85393|NCT01195090|199306|P2|STARTED|Overall Study||60
85394|NCT01195090|199307|P1|STARTED|Overall Study||60
85395|NCT01195025|199365|P5|NOT COMPLETED|Third Intervention C||0
85396|NCT01195025|199366|P4|NOT COMPLETED|Third Intervention C||0
85397|NCT01195025|199367|P3|NOT COMPLETED|Third Intervention C||0
85398|NCT01195025|199368|P2|NOT COMPLETED|Third Intervention C||0
85399|NCT01195025|199369|P1|NOT COMPLETED|Third Intervention C||0
85400|NCT01195025|199365|P5|COMPLETED|Third Intervention C||1
85401|NCT01195025|199366|P4|COMPLETED|Third Intervention C||2
85402|NCT01195025|199367|P3|COMPLETED|Third Intervention C||2
85403|NCT01195025|199368|P2|COMPLETED|Third Intervention C||3
85404|NCT01195025|199369|P1|COMPLETED|Third Intervention C||2
85405|NCT01195025|199365|P5|STARTED|Third Intervention C||1
85406|NCT01195025|199366|P4|STARTED|Third Intervention C||2
85407|NCT01195025|199367|P3|STARTED|Third Intervention C||2
85408|NCT01195025|199368|P2|STARTED|Third Intervention C||3
85409|NCT01195025|199369|P1|STARTED|Third Intervention C||2
85410|NCT01195025|199365|P5|NOT COMPLETED|Second Intervention B||0
85411|NCT01195025|199366|P4|NOT COMPLETED|Second Intervention B||0
85412|NCT01195025|199367|P3|NOT COMPLETED|Second Intervention B||0
85413|NCT01195025|199368|P2|NOT COMPLETED|Second Intervention B||0
85414|NCT01195025|199369|P1|NOT COMPLETED|Second Intervention B||0
85415|NCT01195025|199365|P5|COMPLETED|Second Intervention B||1
85416|NCT01195025|199366|P4|COMPLETED|Second Intervention B||2
85417|NCT01195025|199367|P3|COMPLETED|Second Intervention B||2
85418|NCT01195025|199368|P2|COMPLETED|Second Intervention B||3
85419|NCT01195025|199369|P1|COMPLETED|Second Intervention B||2
85420|NCT01195025|199365|P5|STARTED|Second Intervention B||1
85421|NCT01195025|199366|P4|STARTED|Second Intervention B||2
85422|NCT01195025|199367|P3|STARTED|Second Intervention B||2
85423|NCT01195025|199368|P2|STARTED|Second Intervention B||3
85424|NCT01195025|199369|P1|STARTED|Second Intervention B||2
85425|NCT01195025|199365|P5|NOT COMPLETED|First Intervention A||0
85426|NCT01195025|199366|P4|NOT COMPLETED|First Intervention A||0
85427|NCT01195025|199367|P3|NOT COMPLETED|First Intervention A||0
85428|NCT01195025|199368|P2|NOT COMPLETED|First Intervention A||0
85429|NCT01195025|199369|P1|NOT COMPLETED|First Intervention A||0
85430|NCT01195025|199365|P5|COMPLETED|First Intervention A||1
85431|NCT01195025|199366|P4|COMPLETED|First Intervention A||2
85432|NCT01195025|199367|P3|COMPLETED|First Intervention A||2
85433|NCT01195025|199368|P2|COMPLETED|First Intervention A||3
85434|NCT01195025|199369|P1|COMPLETED|First Intervention A||2
85435|NCT01195025|199365|P5|STARTED|First Intervention A||1
85436|NCT01195025|199366|P4|STARTED|First Intervention A||2
85437|NCT01195025|199367|P3|STARTED|First Intervention A||2
85438|NCT01195025|199368|P2|STARTED|First Intervention A||3
85439|NCT01195025|199369|P1|STARTED|First Intervention A||2
85440|NCT01194999|199376|P1|NOT COMPLETED|Overall Study||17
85441|NCT01194999|199376|P1|COMPLETED|Overall Study||115
85442|NCT01194999|199376|P1|STARTED|Overall Study||132
85443|NCT01194973|199380|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||0
85444|NCT01194973|199380|P1|COMPLETED|Post Treatment Period (Patients Who Disc||11
85445|NCT01194973|199380|P1|STARTED|Post Treatment Period (Patients Who Disc||11
85446|NCT01194973|199380|P1|NOT COMPLETED|Treatment Period (26 Weeks) and Maintena||3
85447|NCT01194973|199380|P1|COMPLETED|Treatment Period (26 Weeks) and Maintena||38
85448|NCT01194973|199380|P1|STARTED|Treatment Period (26 Weeks) and Maintena||41
85449|NCT01194973|199380|P1|NOT COMPLETED|Screening Period||3
85450|NCT01194973|199380|P1|COMPLETED|Screening Period||41
85451|NCT01194973|199380|P1|STARTED|Screening Period||44
85452|NCT01194908|199395|P1|NOT COMPLETED|Overall Study||0
85453|NCT01194908|199395|P1|COMPLETED|Overall Study||5
85454|NCT01194908|199395|P1|STARTED|Overall Study||5
85455|NCT01194869|199400|P1|NOT COMPLETED|Overall Study||4
85456|NCT01194869|199400|P1|COMPLETED|Overall Study||21
85457|NCT01194869|199400|P1|STARTED|Overall Study||25
85458|NCT01194830|199408|P2|NOT COMPLETED|Overall Study||27
85459|NCT01194830|199409|P1|NOT COMPLETED|Overall Study||36
85460|NCT01194830|199408|P2|COMPLETED|Overall Study||83
85461|NCT01194830|199409|P1|COMPLETED|Overall Study||88
85462|NCT01194830|199408|P2|STARTED|Overall Study||110
85463|NCT01194830|199409|P1|STARTED|Overall Study||124
85464|NCT01194154|199433|P2|NOT COMPLETED|Overall Study||33
85465|NCT01194154|199434|P1|NOT COMPLETED|Overall Study||49
85466|NCT01194154|199433|P2|COMPLETED|Overall Study||91
85467|NCT01194154|199434|P1|COMPLETED|Overall Study||68
85468|NCT01194154|199433|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
85469|NCT01194154|199434|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
85470|NCT01194154|199433|P2|Full Analysis Set|Overall Study||120
85471|NCT01194154|199434|P1|Full Analysis Set|Overall Study||115
85472|NCT01194154|199433|P2|STARTED|Overall Study||124
85473|NCT01194154|199434|P1|STARTED|Overall Study||117
85474|NCT01194089|199454|P2|NOT COMPLETED|Overall Study||0
85475|NCT01194089|199455|P1|NOT COMPLETED|Overall Study||0
85476|NCT01194089|199454|P2|COMPLETED|Overall Study||47
85477|NCT01194089|199455|P1|COMPLETED|Overall Study||42
85478|NCT01194089|199454|P2|STARTED|Overall Study||47
85479|NCT01194089|199455|P1|STARTED|Overall Study||42
85480|NCT01194674|199465|P1|NOT COMPLETED|Overall Study||0
85481|NCT01194674|199465|P1|COMPLETED|Overall Study||2
85482|NCT01194674|199465|P1|STARTED|Overall Study||2
85483|NCT01194531|199474|P2|NOT COMPLETED|Overall Study||3
85484|NCT01194531|199475|P1|NOT COMPLETED|Overall Study||5
85485|NCT01194531|199474|P2|COMPLETED|Overall Study||27
85486|NCT01194531|199475|P1|COMPLETED|Overall Study||24
85487|NCT01194531|199474|P2|STARTED|Overall Study||30
85488|NCT01194531|199475|P1|STARTED|Overall Study||29
85489|NCT01194479|199483|P4|NOT COMPLETED|Overall Study||0
85490|NCT01194479|199484|P3|NOT COMPLETED|Overall Study||0
85491|NCT01194479|199485|P2|NOT COMPLETED|Overall Study||0
85492|NCT01194479|199486|P1|NOT COMPLETED|Overall Study||0
85493|NCT01194479|199483|P4|COMPLETED|Overall Study||5
85494|NCT01194479|199484|P3|COMPLETED|Overall Study||2
85495|NCT01194479|199485|P2|COMPLETED|Overall Study||4
85496|NCT01194479|199486|P1|COMPLETED|Overall Study||3
85497|NCT01194479|199483|P4|Cross-over at Second Visit|Overall Study||5
85498|NCT01194479|199484|P3|Cross-over at Second Visit|Overall Study||2
85499|NCT01194479|199485|P2|Cross-over at Second Visit|Overall Study||4
85500|NCT01194479|199486|P1|Cross-over at Second Visit|Overall Study||3
85501|NCT01194479|199483|P4|STARTED|Overall Study||5
85502|NCT01194479|199484|P3|STARTED|Overall Study||2
85503|NCT01194479|199485|P2|STARTED|Overall Study||4
85504|NCT01194479|199486|P1|STARTED|Overall Study||3
85505|NCT01194453|199510|P2|NOT COMPLETED|Overall Study||17
85506|NCT01194453|199511|P1|NOT COMPLETED|Overall Study||17
85507|NCT01194453|199510|P2|COMPLETED|Overall Study||127
85508|NCT01194453|199511|P1|COMPLETED|Overall Study||127
85509|NCT01194453|199510|P2|STARTED|Overall Study||144
85510|NCT01194453|199511|P1|STARTED|Overall Study||144
85511|NCT01194440|199519|P1|NOT COMPLETED|Overall Study||12
85512|NCT01194440|199519|P1|COMPLETED|Overall Study||47
85513|NCT01194440|199519|P1|STARTED|Overall Study||59
85514|NCT01194427|199523|P1|NOT COMPLETED|Overall Study||0
85515|NCT01194427|199523|P1|COMPLETED|Overall Study||2
85516|NCT01194427|199523|P1|STARTED|Overall Study||2
85517|NCT01194414|199529|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
85518|NCT01194414|199530|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
85519|NCT01194414|199531|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
85520|NCT01194414|199532|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
85521|NCT01194414|199529|P4|COMPLETED|72 Weeks Open Label Extension||160
85522|NCT01194414|199530|P3|COMPLETED|72 Weeks Open Label Extension||40
85523|NCT01194414|199531|P2|COMPLETED|72 Weeks Open Label Extension||311
85524|NCT01194414|199532|P1|COMPLETED|72 Weeks Open Label Extension||445
85525|NCT01194414|199529|P4|STARTED|72 Weeks Open Label Extension||186
85526|NCT01194414|199530|P3|STARTED|72 Weeks Open Label Extension||48
85527|NCT01194414|199531|P2|STARTED|72 Weeks Open Label Extension||377
85528|NCT01194414|199532|P1|STARTED|72 Weeks Open Label Extension||524
85529|NCT01194414|199529|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
85530|NCT01194414|199530|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
85531|NCT01194414|199531|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
85532|NCT01194414|199532|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
85533|NCT01194414|199529|P4|COMPLETED|24 Weeks Double Blind Period||0
85534|NCT01194414|199530|P3|COMPLETED|24 Weeks Double Blind Period||0
85535|NCT01194414|199531|P2|COMPLETED|24 Weeks Double Blind Period||564
85536|NCT01194414|199532|P1|COMPLETED|24 Weeks Double Blind Period||572
85537|NCT01194414|199529|P4|Per Protocol Population|24 Weeks Double Blind Period||0
85538|NCT01194414|199530|P3|Per Protocol Population|24 Weeks Double Blind Period||0
85539|NCT01194414|199531|P2|Per Protocol Population|24 Weeks Double Blind Period||537
85540|NCT01194414|199532|P1|Per Protocol Population|24 Weeks Double Blind Period||558
85541|NCT01194414|199529|P4|STARTED|24 Weeks Double Blind Period||0
85542|NCT01194414|199530|P3|STARTED|24 Weeks Double Blind Period||0
85543|NCT01194414|199531|P2|STARTED|24 Weeks Double Blind Period||631
85544|NCT01194414|199532|P1|STARTED|24 Weeks Double Blind Period||631
85545|NCT01194297|199594|P2|NOT COMPLETED|Overall Study||0
85546|NCT01194297|199595|P1|NOT COMPLETED|Overall Study||0
85547|NCT01194297|199594|P2|COMPLETED|Overall Study||1
85548|NCT01194297|199595|P1|COMPLETED|Overall Study||2
85549|NCT01194297|199594|P2|STARTED|Overall Study||1
85550|NCT01194297|199595|P1|STARTED|Overall Study||2
85551|NCT01194258|199603|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
85552|NCT01194258|199604|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
85553|NCT01194258|199605|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
85554|NCT01194258|199606|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
85555|NCT01194258|199607|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
85556|NCT01194258|199603|P5|COMPLETED|Period 2 (12 Weeks)||30
85557|NCT01194258|199604|P4|COMPLETED|Period 2 (12 Weeks)||29
85558|NCT01194258|199605|P3|COMPLETED|Period 2 (12 Weeks)||29
85559|NCT01194258|199606|P2|COMPLETED|Period 2 (12 Weeks)||27
85560|NCT01194258|199607|P1|COMPLETED|Period 2 (12 Weeks)||0
85561|NCT01194258|199603|P5|STARTED|Period 2 (12 Weeks)||32
85562|NCT01194258|199604|P4|STARTED|Period 2 (12 Weeks)||29
85563|NCT01194258|199605|P3|STARTED|Period 2 (12 Weeks)||30
85564|NCT01194258|199606|P2|STARTED|Period 2 (12 Weeks)||29
85565|NCT01194258|199607|P1|STARTED|Period 2 (12 Weeks)||0
85566|NCT01194258|199603|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
85567|NCT01194258|199604|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
85568|NCT01194258|199605|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
85569|NCT01194258|199606|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
85570|NCT01194258|199607|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
85571|NCT01194258|199603|P5|COMPLETED|Period 1 (12 Weeks)||32
85572|NCT01194258|199604|P4|COMPLETED|Period 1 (12 Weeks)||29
85573|NCT01194258|199605|P3|COMPLETED|Period 1 (12 Weeks)||30
85574|NCT01194258|199606|P2|COMPLETED|Period 1 (12 Weeks)||29
85575|NCT01194258|199607|P1|COMPLETED|Period 1 (12 Weeks)||0
85576|NCT01194258|199603|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
85577|NCT01194258|199604|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
85578|NCT01194258|199605|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
85579|NCT01194258|199606|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
85580|NCT01194258|199607|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
85581|NCT01194258|199603|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
85582|NCT01194258|199604|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
85583|NCT01194258|199605|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
85584|NCT01194258|199606|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
85585|NCT01194258|199607|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
85586|NCT01194258|199603|P5|NOT COMPLETED|Titration Period||0
85587|NCT01194258|199604|P4|NOT COMPLETED|Titration Period||0
85588|NCT01194258|199605|P3|NOT COMPLETED|Titration Period||0
85589|NCT01194258|199606|P2|NOT COMPLETED|Titration Period||0
85590|NCT01194258|199607|P1|NOT COMPLETED|Titration Period||11
85591|NCT01194258|199603|P5|COMPLETED|Titration Period||0
85592|NCT01194258|199604|P4|COMPLETED|Titration Period||0
85593|NCT01194258|199605|P3|COMPLETED|Titration Period||0
85594|NCT01194258|199606|P2|COMPLETED|Titration Period||0
85595|NCT01194258|199607|P1|COMPLETED|Titration Period||121
85596|NCT01194258|199603|P5|STARTED|Titration Period||0
85597|NCT01194258|199604|P4|STARTED|Titration Period||0
85598|NCT01194258|199605|P3|STARTED|Titration Period||0
85599|NCT01194258|199606|P2|STARTED|Titration Period||0
85600|NCT01194258|199607|P1|STARTED|Titration Period||132
85601|NCT01194245|199631|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85602|NCT01194245|199632|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85603|NCT01194245|199633|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85604|NCT01194245|199634|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85605|NCT01194245|199635|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85606|NCT01194245|199631|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
85607|NCT01194245|199632|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
85608|NCT01194245|199633|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
85609|NCT01194245|199634|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
85610|NCT01194245|199635|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
85611|NCT01194245|199631|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
85612|NCT01194245|199632|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
85613|NCT01194245|199633|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
85614|NCT01194245|199634|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
85615|NCT01194245|199635|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
85616|NCT01194245|199631|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
85617|NCT01194245|199632|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
85618|NCT01194245|199633|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
85619|NCT01194245|199634|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
85620|NCT01194245|199635|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
85621|NCT01194245|199631|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
85622|NCT01194245|199632|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
85623|NCT01194245|199633|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
85624|NCT01194245|199634|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
85625|NCT01194245|199635|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
85626|NCT01194245|199631|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
85627|NCT01194245|199632|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
85628|NCT01194245|199633|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
85629|NCT01194245|199634|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
85630|NCT01194245|199635|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
85631|NCT01194245|199631|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
85632|NCT01194245|199632|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
85633|NCT01194245|199633|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
85634|NCT01194245|199634|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
85635|NCT01194245|199635|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
85636|NCT01194245|199631|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
85637|NCT01194245|199632|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
85638|NCT01194245|199633|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
85639|NCT01194245|199634|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
85640|NCT01194245|199635|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
85641|NCT01194245|199631|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
85642|NCT01194245|199632|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
85643|NCT01194245|199633|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
85644|NCT01194245|199634|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
85645|NCT01194245|199635|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
85646|NCT01194245|199631|P5|STARTED|Titration Period (4 to 6 Weeks)||0
85647|NCT01194245|199632|P4|STARTED|Titration Period (4 to 6 Weeks)||0
85648|NCT01194245|199633|P3|STARTED|Titration Period (4 to 6 Weeks)||0
85649|NCT01194245|199634|P2|STARTED|Titration Period (4 to 6 Weeks)||0
85650|NCT01194245|199635|P1|STARTED|Titration Period (4 to 6 Weeks)||135
85651|NCT01194219|199656|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||45
85652|NCT01194219|199657|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||61
85653|NCT01194219|199658|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
85654|NCT01194219|199659|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
85655|NCT01194219|199660|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85656|NCT01194219|199661|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85657|NCT01194219|199662|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85658|NCT01194219|199663|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85659|NCT01194219|199656|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
85660|NCT01194219|199657|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
85661|NCT01194219|199658|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
85662|NCT01194219|199659|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
85663|NCT01194219|199660|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85664|NCT01194219|199661|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85665|NCT01194219|199662|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85666|NCT01194219|199663|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
85667|NCT01194219|199656|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||91
85668|NCT01194219|199657|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||126
85669|NCT01194219|199658|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85670|NCT01194219|199659|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85671|NCT01194219|199660|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85672|NCT01194219|199661|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85673|NCT01194219|199662|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85674|NCT01194219|199663|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
85675|NCT01194219|199656|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||208
85676|NCT01194219|199657|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||245
85677|NCT01194219|199658|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
85678|NCT01194219|199659|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
85679|NCT01194219|199660|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
85680|NCT01194219|199661|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
85681|NCT01194219|199662|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
85682|NCT01194219|199663|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
85683|NCT01194219|199656|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85684|NCT01194219|199657|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85685|NCT01194219|199658|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85686|NCT01194219|199659|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85687|NCT01194219|199660|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||30
85688|NCT01194219|199661|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||70
85689|NCT01194219|199662|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85690|NCT01194219|199663|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
85691|NCT01194219|199656|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
85692|NCT01194219|199657|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
85693|NCT01194219|199658|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
85694|NCT01194219|199659|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
85695|NCT01194219|199660|P4|COMPLETED|Maintenance Phase (Weeks16-32)||215
85696|NCT01194219|199661|P3|COMPLETED|Maintenance Phase (Weeks16-32)||424
85697|NCT01194219|199662|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
85698|NCT01194219|199663|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
85699|NCT01194219|199656|P8|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85700|NCT01194219|199657|P7|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85701|NCT01194219|199658|P6|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85702|NCT01194219|199659|P5|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85703|NCT01194219|199660|P4|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|244
85704|NCT01194219|199661|P3|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|493
85705|NCT01194219|199662|P2|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85706|NCT01194219|199663|P1|Received Apremilast|Maintenance Phase (Weeks16-32)||0
85707|NCT01194219|199656|P8|STARTED|Maintenance Phase (Weeks16-32)||0
85708|NCT01194219|199657|P7|STARTED|Maintenance Phase (Weeks16-32)||0
85709|NCT01194219|199658|P6|STARTED|Maintenance Phase (Weeks16-32)||0
85710|NCT01194219|199659|P5|STARTED|Maintenance Phase (Weeks16-32)||0
85711|NCT01194219|199660|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
85712|NCT01194219|199661|P3|STARTED|Maintenance Phase (Weeks16-32)|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
85713|NCT01194219|199662|P2|STARTED|Maintenance Phase (Weeks16-32)||0
85714|NCT01194219|199663|P1|STARTED|Maintenance Phase (Weeks16-32)||0
85715|NCT01194219|199656|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85716|NCT01194219|199657|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85717|NCT01194219|199658|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85718|NCT01194219|199659|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85719|NCT01194219|199660|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85720|NCT01194219|199661|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85721|NCT01194219|199662|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||33
85722|NCT01194219|199663|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||59
85723|NCT01194219|199656|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85724|NCT01194219|199657|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85725|NCT01194219|199658|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85726|NCT01194219|199659|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85727|NCT01194219|199660|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85728|NCT01194219|199661|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
85729|NCT01194219|199662|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||249
85730|NCT01194219|199663|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||503
85731|NCT01194219|199656|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85732|NCT01194219|199657|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85733|NCT01194219|199658|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85734|NCT01194219|199659|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85735|NCT01194219|199660|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85736|NCT01194219|199661|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
85737|NCT01194219|199662|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||282
85738|NCT01194219|199663|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||560
85739|NCT01194219|199656|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85740|NCT01194219|199657|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85741|NCT01194219|199658|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85742|NCT01194219|199659|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85743|NCT01194219|199660|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85744|NCT01194219|199661|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
85745|NCT01194219|199662|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||282
85746|NCT01194219|199663|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||562
85747|NCT01193920|199703|P10|NOT COMPLETED|Overall Study||7
85748|NCT01193920|199704|P9|NOT COMPLETED|Overall Study||5
85749|NCT01193920|199705|P8|NOT COMPLETED|Overall Study||4
85750|NCT01193920|199706|P7|NOT COMPLETED|Overall Study||6
85751|NCT01193920|199707|P6|NOT COMPLETED|Overall Study||4
85752|NCT01193920|199708|P5|NOT COMPLETED|Overall Study||6
85753|NCT01193920|199709|P4|NOT COMPLETED|Overall Study||4
85754|NCT01193920|199710|P3|NOT COMPLETED|Overall Study||6
85755|NCT01193920|199711|P2|NOT COMPLETED|Overall Study||0
85756|NCT01193920|199712|P1|NOT COMPLETED|Overall Study||3
85757|NCT01193920|199703|P10|COMPLETED|Overall Study||74
85758|NCT01193920|199704|P9|COMPLETED|Overall Study||71
85759|NCT01193920|199705|P8|COMPLETED|Overall Study||76
85760|NCT01193920|199706|P7|COMPLETED|Overall Study||74
85761|NCT01193920|199707|P6|COMPLETED|Overall Study||76
85762|NCT01193920|199708|P5|COMPLETED|Overall Study||74
85763|NCT01193920|199709|P4|COMPLETED|Overall Study||76
85764|NCT01193920|199710|P3|COMPLETED|Overall Study||74
85765|NCT01193920|199711|P2|COMPLETED|Overall Study||20
85766|NCT01193920|199712|P1|COMPLETED|Overall Study||37
85767|NCT01193920|199703|P10|STARTED|Overall Study||81
85768|NCT01193920|199704|P9|STARTED|Overall Study||76
85769|NCT01193920|199705|P8|STARTED|Overall Study||80
85770|NCT01193920|199706|P7|STARTED|Overall Study||80
85771|NCT01193920|199707|P6|STARTED|Overall Study||80
85772|NCT01193920|199708|P5|STARTED|Overall Study||80
85773|NCT01193920|199709|P4|STARTED|Overall Study||80
85774|NCT01193920|199710|P3|STARTED|Overall Study||80
85775|NCT01193920|199711|P2|STARTED|Overall Study||20
85776|NCT01193920|199712|P1|STARTED|Overall Study||40
85777|NCT01193907|199766|P4|NOT COMPLETED|Overall Study||1
85778|NCT01193907|199767|P3|NOT COMPLETED|Overall Study||0
85779|NCT01193907|199768|P2|NOT COMPLETED|Overall Study||0
85780|NCT01193907|199769|P1|NOT COMPLETED|Overall Study||1
85781|NCT01193907|199766|P4|COMPLETED|Overall Study||21
85782|NCT01193907|199767|P3|COMPLETED|Overall Study||22
85783|NCT01193907|199768|P2|COMPLETED|Overall Study||22
85784|NCT01193907|199769|P1|COMPLETED|Overall Study||21
85785|NCT01193907|199766|P4|STARTED|Overall Study||22
85786|NCT01193907|199767|P3|STARTED|Overall Study||22
85787|NCT01193907|199768|P2|STARTED|Overall Study||22
85788|NCT01193907|199769|P1|STARTED|Overall Study||22
85789|NCT01193868|199791|P1|NOT COMPLETED|Overall Study||0
85790|NCT01193868|199791|P1|COMPLETED|Overall Study||6
85791|NCT01193868|199791|P1|STARTED|Overall Study||6
85792|NCT01193686|199805|P2|NOT COMPLETED|Overall Study||1
85793|NCT01193686|199806|P1|NOT COMPLETED|Overall Study||7
85794|NCT01193686|199805|P2|COMPLETED|Overall Study||8
85795|NCT01193686|199806|P1|COMPLETED|Overall Study||8
85796|NCT01193686|199805|P2|Completed Visits and Final Assessment|Overall Study||8
85797|NCT01193686|199806|P1|Completed Visits and Final Assessment|Overall Study||8
85798|NCT01193686|199805|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
85799|NCT01193686|199806|P1|Completed Mentor Training|Overall Study||9
85800|NCT01193686|199805|P2|Completed Baseline Assessment|Overall Study||9
85801|NCT01193686|199806|P1|Completed Baseline Assessment|Overall Study||15
85802|NCT01193686|199805|P2|STARTED|Overall Study||9
85803|NCT01193686|199806|P1|STARTED|Overall Study||15
85804|NCT01193660|199823|P3|NOT COMPLETED|Overall Study||2
85805|NCT01193660|199824|P2|NOT COMPLETED|Overall Study||3
85806|NCT01193660|199825|P1|NOT COMPLETED|Overall Study||4
85807|NCT01193660|199823|P3|COMPLETED|Overall Study||32
85808|NCT01193660|199824|P2|COMPLETED|Overall Study||33
85809|NCT01193660|199825|P1|COMPLETED|Overall Study||31
85810|NCT01193660|199823|P3|STARTED|Overall Study||34
85811|NCT01193660|199824|P2|STARTED|Overall Study||36
85812|NCT01193660|199825|P1|STARTED|Overall Study||35
85813|NCT01193582|199867|P4|NOT COMPLETED|12 Month Follow-up||11
85814|NCT01193582|199868|P3|NOT COMPLETED|12 Month Follow-up||4
85815|NCT01193582|199869|P2|NOT COMPLETED|12 Month Follow-up||0
85816|NCT01193582|199870|P1|NOT COMPLETED|12 Month Follow-up||6
85817|NCT01193582|199867|P4|COMPLETED|12 Month Follow-up||166
85818|NCT01193582|199868|P3|COMPLETED|12 Month Follow-up||113
85819|NCT01193582|199869|P2|COMPLETED|12 Month Follow-up||88
85820|NCT01193582|199870|P1|COMPLETED|12 Month Follow-up||83
85821|NCT01193582|199867|P4|STARTED|12 Month Follow-up||177
85822|NCT01193582|199868|P3|STARTED|12 Month Follow-up||117
85823|NCT01193582|199869|P2|STARTED|12 Month Follow-up||88
85824|NCT01193582|199870|P1|STARTED|12 Month Follow-up||89
85825|NCT01193582|199867|P4|NOT COMPLETED|Vaccination Series||3
85826|NCT01193582|199868|P3|NOT COMPLETED|Vaccination Series||8
85827|NCT01193582|199869|P2|NOT COMPLETED|Vaccination Series||13
85828|NCT01193582|199870|P1|NOT COMPLETED|Vaccination Series||11
85829|NCT01193582|199867|P4|COMPLETED|Vaccination Series||177
85830|NCT01193582|199868|P3|COMPLETED|Vaccination Series||117
85831|NCT01193582|199869|P2|COMPLETED|Vaccination Series||88
85832|NCT01193582|199870|P1|COMPLETED|Vaccination Series||89
85833|NCT01193582|199867|P4|Vaccinated Dose 4|Vaccination Series||0
85834|NCT01193582|199868|P3|Vaccinated Dose 4|Vaccination Series||0
85835|NCT01193582|199869|P2|Vaccinated Dose 4|Vaccination Series||0
85836|NCT01193582|199870|P1|Vaccinated Dose 4|Vaccination Series||90
85837|NCT01193582|199867|P4|Vaccinated Dose 3|Vaccination Series||0
85838|NCT01193582|199868|P3|Vaccinated Dose 3|Vaccination Series||0
85839|NCT01193582|199869|P2|Vaccinated Dose 3|Vaccination Series||89
85840|NCT01193582|199870|P1|Vaccinated Dose 3|Vaccination Series||90
85841|NCT01193582|199867|P4|Vaccinated Dose 2|Vaccination Series||0
85842|NCT01193582|199868|P3|Vaccinated Dose 2|Vaccination Series||118
85843|NCT01193582|199869|P2|Vaccinated Dose 2|Vaccination Series||91
85844|NCT01193582|199870|P1|Vaccinated Dose 2|Vaccination Series||92
85845|NCT01193582|199867|P4|Vaccinated Dose 1|Vaccination Series||180
85846|NCT01193582|199868|P3|Vaccinated Dose 1|Vaccination Series||125
85847|NCT01193582|199869|P2|Vaccinated Dose 1|Vaccination Series||100
85848|NCT01193582|199870|P1|Vaccinated Dose 1|Vaccination Series||100
85849|NCT01193582|199867|P4|STARTED|Vaccination Series||180
85850|NCT01193582|199868|P3|STARTED|Vaccination Series||125
85851|NCT01193582|199869|P2|STARTED|Vaccination Series||101
85852|NCT01193582|199870|P1|STARTED|Vaccination Series||100
85853|NCT01193556|199900|P2|NOT COMPLETED|Overall Study||25
85854|NCT01193556|199901|P1|NOT COMPLETED|Overall Study||26
85855|NCT01193556|199900|P2|COMPLETED|Overall Study||0
85856|NCT01193556|199901|P1|COMPLETED|Overall Study||0
85857|NCT01193556|199900|P2|STARTED|Overall Study||25
85858|NCT01193556|199901|P1|STARTED|Overall Study||26
85859|NCT01193348|199909|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
85860|NCT01193348|199909|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
85861|NCT01193348|199909|P1|STARTED|Post Treatment Period (Patients Who Disc||10
85862|NCT01193348|199909|P1|NOT COMPLETED|Extension Treatment Period||1
85863|NCT01193348|199909|P1|COMPLETED|Extension Treatment Period||16
85864|NCT01193348|199909|P1|STARTED|Extension Treatment Period||17
85865|NCT01193348|199909|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
85866|NCT01193348|199909|P1|COMPLETED|Treatment Period (26 Weeks)||19
85867|NCT01193348|199909|P1|STARTED|Treatment Period (26 Weeks)||22
85868|NCT01193348|199909|P1|NOT COMPLETED|Screening Period||5
85869|NCT01193348|199909|P1|COMPLETED|Screening Period||22
85870|NCT01193348|199909|P1|STARTED|Screening Period||27
85871|NCT01193335|199929|P2|NOT COMPLETED|2-Year Follow-up||8
85872|NCT01193335|199930|P1|NOT COMPLETED|2-Year Follow-up||7
85873|NCT01193335|199929|P2|COMPLETED|2-Year Follow-up||80
85874|NCT01193335|199930|P1|COMPLETED|2-Year Follow-up||81
85875|NCT01193335|199929|P2|STARTED|2-Year Follow-up||88
85876|NCT01193335|199930|P1|STARTED|2-Year Follow-up||88
85877|NCT01193335|199929|P2|NOT COMPLETED|1-Year Follow-up||9
85878|NCT01193335|199930|P1|NOT COMPLETED|1-Year Follow-up||11
85879|NCT01193335|199929|P2|COMPLETED|1-Year Follow-up||88
85880|NCT01193335|199930|P1|COMPLETED|1-Year Follow-up||88
85881|NCT01193335|199929|P2|STARTED|1-Year Follow-up||97
85882|NCT01193335|199930|P1|STARTED|1-Year Follow-up||99
85883|NCT01193335|199929|P2|NOT COMPLETED|Toddler Dose||0
85884|NCT01193335|199930|P1|NOT COMPLETED|Toddler Dose||0
85885|NCT01193335|199929|P2|COMPLETED|Toddler Dose||97
85886|NCT01193335|199930|P1|COMPLETED|Toddler Dose||99
85887|NCT01193335|199929|P2|STARTED|Toddler Dose||97
85888|NCT01193335|199930|P1|STARTED|Toddler Dose||99
85889|NCT01193335|199929|P2|NOT COMPLETED|After Infant Series||3
85890|NCT01193335|199930|P1|NOT COMPLETED|After Infant Series||1
85891|NCT01193335|199929|P2|COMPLETED|After Infant Series||97
85892|NCT01193335|199930|P1|COMPLETED|After Infant Series||99
85893|NCT01193335|199929|P2|STARTED|After Infant Series||100
85894|NCT01193335|199930|P1|STARTED|After Infant Series||100
85895|NCT01193335|199929|P2|NOT COMPLETED|Infant Series||0
85896|NCT01193335|199930|P1|NOT COMPLETED|Infant Series||0
85897|NCT01193335|199929|P2|COMPLETED|Infant Series||100
85898|NCT01193335|199930|P1|COMPLETED|Infant Series||100
85899|NCT01193335|199929|P2|STARTED|Infant Series||100
85900|NCT01193335|199930|P1|STARTED|Infant Series||100
85901|NCT01193283|200025|P1|NOT COMPLETED|Overall Study||1
85902|NCT01193283|200025|P1|COMPLETED|Overall Study||21
85903|NCT01193283|200025|P1|STARTED|Overall Study||22
85904|NCT01193218|200034|P8|NOT COMPLETED|12-52 Weeks||4
85905|NCT01193218|200035|P7|NOT COMPLETED|12-52 Weeks||3
85906|NCT01193218|200036|P6|NOT COMPLETED|12-52 Weeks||5
85907|NCT01193218|200037|P5|NOT COMPLETED|12-52 Weeks||4
85908|NCT01193218|200038|P4|NOT COMPLETED|12-52 Weeks||3
85909|NCT01193218|200039|P3|NOT COMPLETED|12-52 Weeks||4
85910|NCT01193218|200040|P2|NOT COMPLETED|12-52 Weeks||0
85911|NCT01193218|200041|P1|NOT COMPLETED|12-52 Weeks||5
85912|NCT01193218|200034|P8|COMPLETED|12-52 Weeks||49
85913|NCT01193218|200035|P7|COMPLETED|12-52 Weeks||51
85914|NCT01193218|200036|P6|COMPLETED|12-52 Weeks||101
85915|NCT01193218|200037|P5|COMPLETED|12-52 Weeks||104
85916|NCT01193218|200038|P4|COMPLETED|12-52 Weeks||50
85917|NCT01193218|200039|P3|COMPLETED|12-52 Weeks||50
85918|NCT01193218|200040|P2|COMPLETED|12-52 Weeks||50
85919|NCT01193218|200041|P1|COMPLETED|12-52 Weeks||45
85920|NCT01193218|200034|P8|STARTED|12-52 Weeks||53
85921|NCT01193218|200035|P7|STARTED|12-52 Weeks||54
85922|NCT01193218|200036|P6|STARTED|12-52 Weeks||106
85923|NCT01193218|200037|P5|STARTED|12-52 Weeks||108
85924|NCT01193218|200038|P4|STARTED|12-52 Weeks||53
85925|NCT01193218|200039|P3|STARTED|12-52 Weeks||54
85926|NCT01193218|200040|P2|STARTED|12-52 Weeks||50
85927|NCT01193218|200041|P1|STARTED|12-52 Weeks||50
85928|NCT01193218|200034|P8|NOT COMPLETED|0-12 Weeks||0
85929|NCT01193218|200035|P7|NOT COMPLETED|0-12 Weeks||3
85930|NCT01193218|200036|P6|NOT COMPLETED|0-12 Weeks||3
85931|NCT01193218|200037|P5|NOT COMPLETED|0-12 Weeks||1
85932|NCT01193218|200038|P4|NOT COMPLETED|0-12 Weeks||0
85933|NCT01193218|200039|P3|NOT COMPLETED|0-12 Weeks||3
85934|NCT01193218|200040|P2|NOT COMPLETED|0-12 Weeks||0
85935|NCT01193218|200041|P1|NOT COMPLETED|0-12 Weeks||9
85936|NCT01193218|200034|P8|COMPLETED|0-12 Weeks||0
85937|NCT01193218|200035|P7|COMPLETED|0-12 Weeks||107
85938|NCT01193218|200036|P6|COMPLETED|0-12 Weeks||106
85939|NCT01193218|200037|P5|COMPLETED|0-12 Weeks||108
85940|NCT01193218|200038|P4|COMPLETED|0-12 Weeks||0
85941|NCT01193218|200039|P3|COMPLETED|0-12 Weeks||107
85942|NCT01193218|200040|P2|COMPLETED|0-12 Weeks||0
85943|NCT01193218|200041|P1|COMPLETED|0-12 Weeks||100
85944|NCT01193218|200034|P8|STARTED|0-12 Weeks|It is actually N/A|0
85945|NCT01193218|200035|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
85946|NCT01193218|200036|P6|STARTED|0-12 Weeks||109
85947|NCT01193218|200037|P5|STARTED|0-12 Weeks||109
85948|NCT01193218|200038|P4|STARTED|0-12 Weeks|It is actually N/A|0
85949|NCT01193218|200039|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
85950|NCT01193218|200040|P2|STARTED|0-12 Weeks|It is actually N/A|0
85951|NCT01193218|200041|P1|STARTED|0-12 Weeks|It is actually placebo group|109
85952|NCT01193153|200072|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
85953|NCT01193153|200073|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
85954|NCT01193153|200072|P2|COMPLETED|Double Blind Relapse Prevention Period||65
85955|NCT01193153|200073|P1|COMPLETED|Double Blind Relapse Prevention Period||100
85956|NCT01193153|200072|P2|STARTED|Double Blind Relapse Prevention Period||170
85957|NCT01193153|200073|P1|STARTED|Double Blind Relapse Prevention Period||164
85958|NCT01193153|200072|P2|NOT COMPLETED|Open-label Stabilization Period||0
85959|NCT01193153|200073|P1|NOT COMPLETED|Open-label Stabilization Period||98
85960|NCT01193153|200072|P2|COMPLETED|Open-label Stabilization Period||0
85961|NCT01193153|200073|P1|COMPLETED|Open-label Stabilization Period||334
85962|NCT01193153|200072|P2|STARTED|Open-label Stabilization Period||0
85963|NCT01193153|200073|P1|STARTED|Open-label Stabilization Period||432
85964|NCT01193153|200072|P2|NOT COMPLETED|Open-label Lead in Period||0
85965|NCT01193153|200073|P1|NOT COMPLETED|Open-label Lead in Period||235
85966|NCT01193153|200072|P2|COMPLETED|Open-label Lead in Period||0
85967|NCT01193153|200073|P1|COMPLETED|Open-label Lead in Period||432
85968|NCT01193153|200072|P2|STARTED|Open-label Lead in Period||0
85969|NCT01193153|200073|P1|STARTED|Open-label Lead in Period||667
85970|NCT01193127|200108|P4|NOT COMPLETED|Treated||1
85971|NCT01193127|200109|P3|NOT COMPLETED|Treated||0
85972|NCT01193127|200110|P2|NOT COMPLETED|Treated||0
85973|NCT01193127|200111|P1|NOT COMPLETED|Treated||0
85974|NCT01193127|200108|P4|COMPLETED|Treated||55
85975|NCT01193127|200109|P3|COMPLETED|Treated||55
85976|NCT01193127|200110|P2|COMPLETED|Treated||54
85977|NCT01193127|200111|P1|COMPLETED|Treated||57
85978|NCT01193127|200108|P4|STARTED|Treated||56
85979|NCT01193127|200109|P3|STARTED|Treated||55
85980|NCT01193127|200110|P2|STARTED|Treated||54
85981|NCT01193127|200111|P1|STARTED|Treated||57
85982|NCT01193127|200108|P4|NOT COMPLETED|Randomized||1
85983|NCT01193127|200109|P3|NOT COMPLETED|Randomized||0
85984|NCT01193127|200110|P2|NOT COMPLETED|Randomized||0
85985|NCT01193127|200111|P1|NOT COMPLETED|Randomized||0
85986|NCT01193127|200108|P4|COMPLETED|Randomized||56
85987|NCT01193127|200109|P3|COMPLETED|Randomized||55
85988|NCT01193127|200110|P2|COMPLETED|Randomized||54
85989|NCT01193127|200111|P1|COMPLETED|Randomized||57
85990|NCT01193127|200108|P4|STARTED|Randomized||57
85991|NCT01193127|200109|P3|STARTED|Randomized||55
85992|NCT01193127|200110|P2|STARTED|Randomized||54
85993|NCT01193127|200111|P1|STARTED|Randomized||57
85994|NCT01193114|200415|P2|NOT COMPLETED|Overall Study||0
85995|NCT01193114|200416|P1|NOT COMPLETED|Overall Study||0
85996|NCT01193114|200415|P2|COMPLETED|Overall Study||30
85997|NCT01193114|200416|P1|COMPLETED|Overall Study||30
85998|NCT01193114|200415|P2|STARTED|Overall Study||30
85999|NCT01193114|200416|P1|STARTED|Overall Study||30
86000|NCT01193101|200436|P4|NOT COMPLETED|Overall Study||12
86001|NCT01193101|200437|P3|NOT COMPLETED|Overall Study||3
86002|NCT01193101|200438|P2|NOT COMPLETED|Overall Study||7
86003|NCT01193101|200439|P1|NOT COMPLETED|Overall Study||5
86004|NCT01193101|200436|P4|COMPLETED|Overall Study||80
86005|NCT01193101|200437|P3|COMPLETED|Overall Study||93
86006|NCT01193101|200438|P2|COMPLETED|Overall Study||94
86007|NCT01193101|200439|P1|COMPLETED|Overall Study||95
86008|NCT01193101|200436|P4|Placebo Withdrawal Set|Overall Study||80
86009|NCT01193101|200437|P3|Placebo Withdrawal Set|Overall Study||93
86010|NCT01193101|200438|P2|Placebo Withdrawal Set|Overall Study||94
86011|NCT01193101|200439|P1|Placebo Withdrawal Set|Overall Study||95
86012|NCT01193101|200436|P4|Full Analysis Set|Overall Study||92
86013|NCT01193101|200437|P3|Full Analysis Set|Overall Study||96
86014|NCT01193101|200438|P2|Full Analysis Set|Overall Study||101
86015|NCT01193101|200439|P1|Full Analysis Set|Overall Study||100
86016|NCT01193101|200436|P4|STARTED|Overall Study||92
86017|NCT01193101|200437|P3|STARTED|Overall Study||96
86018|NCT01193101|200438|P2|STARTED|Overall Study||101
86019|NCT01193101|200439|P1|STARTED|Overall Study||100
86020|NCT01193049|200495|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
86021|NCT01193049|200496|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
86022|NCT01193049|200495|P2|COMPLETED|Period 3 : Double Blind Crossover||6
86023|NCT01193049|200496|P1|COMPLETED|Period 3 : Double Blind Crossover||5
86024|NCT01193049|200495|P2|STARTED|Period 3 : Double Blind Crossover||6
86025|NCT01193049|200496|P1|STARTED|Period 3 : Double Blind Crossover||5
86026|NCT01193049|200495|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
86027|NCT01193049|200496|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
86028|NCT01193049|200495|P2|COMPLETED|Washout 2 : 21 Day Washout||6
86029|NCT01193049|200496|P1|COMPLETED|Washout 2 : 21 Day Washout||5
86030|NCT01193049|200495|P2|STARTED|Washout 2 : 21 Day Washout||6
86031|NCT01193049|200496|P1|STARTED|Washout 2 : 21 Day Washout||5
86032|NCT01193049|200495|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
86033|NCT01193049|200496|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
86034|NCT01193049|200495|P2|COMPLETED|Period 2 : Double Blind Crossover||6
86035|NCT01193049|200496|P1|COMPLETED|Period 2 : Double Blind Crossover||5
86036|NCT01193049|200495|P2|STARTED|Period 2 : Double Blind Crossover||6
86037|NCT01193049|200496|P1|STARTED|Period 2 : Double Blind Crossover||5
86038|NCT01193049|200495|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
86039|NCT01193049|200496|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
86040|NCT01193049|200495|P2|COMPLETED|Washout 1 : 21 Day Washout||6
86041|NCT01193049|200496|P1|COMPLETED|Washout 1 : 21 Day Washout||5
86042|NCT01193049|200495|P2|STARTED|Washout 1 : 21 Day Washout||6
86043|NCT01193049|200496|P1|STARTED|Washout 1 : 21 Day Washout||5
86044|NCT01193049|200495|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
86045|NCT01193049|200496|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
86046|NCT01193049|200495|P2|COMPLETED|Period 1: Placebo Run-In||6
86047|NCT01193049|200496|P1|COMPLETED|Period 1: Placebo Run-In||5
86048|NCT01193049|200495|P2|STARTED|Period 1: Placebo Run-In||6
86049|NCT01193049|200496|P1|STARTED|Period 1: Placebo Run-In||5
86050|NCT01192542|200526|P2|NOT COMPLETED|Period 2||0
86051|NCT01192542|200527|P1|NOT COMPLETED|Period 2||0
86052|NCT01192542|200526|P2|COMPLETED|Period 2||20
86053|NCT01192542|200527|P1|COMPLETED|Period 2||18
86054|NCT01192542|200526|P2|STARTED|Period 2||20
86055|NCT01192542|200527|P1|STARTED|Period 2||18
86056|NCT01192542|200526|P2|NOT COMPLETED|Period 1||0
86057|NCT01192542|200527|P1|NOT COMPLETED|Period 1||0
86058|NCT01192542|200526|P2|COMPLETED|Period 1||20
86059|NCT01192542|200527|P1|COMPLETED|Period 1||18
86060|NCT01192542|200526|P2|STARTED|Period 1||20
86061|NCT01192542|200527|P1|STARTED|Period 1||18
86062|NCT01192516|200541|P3|NOT COMPLETED|Overall Study||8
86063|NCT01192516|200542|P2|NOT COMPLETED|Overall Study||17
86064|NCT01192516|200543|P1|NOT COMPLETED|Overall Study||20
86065|NCT01192516|200541|P3|COMPLETED|Overall Study||55
86066|NCT01192516|200542|P2|COMPLETED|Overall Study||49
86067|NCT01192516|200543|P1|COMPLETED|Overall Study||46
86068|NCT01192516|200541|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
86069|NCT01192516|200542|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
86070|NCT01192516|200543|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
86071|NCT01192412|200577|P2|NOT COMPLETED|Overall Study||2
86072|NCT01192412|200578|P1|NOT COMPLETED|Overall Study||4
86073|NCT01192412|200577|P2|COMPLETED|Overall Study||488
86074|NCT01192412|200578|P1|COMPLETED|Overall Study||493
86075|NCT01192412|200577|P2|STARTED|Overall Study||490
86076|NCT01192412|200578|P1|STARTED|Overall Study||497
86077|NCT01192347|200586|P1|NOT COMPLETED|Overall Study||12
86078|NCT01192347|200586|P1|COMPLETED|Overall Study||163
86079|NCT01192347|200586|P1|STARTED|Overall Study||175
86080|NCT01192295|200609|P2|NOT COMPLETED|Overall Study||23
86081|NCT01192295|200610|P1|NOT COMPLETED|Overall Study||10
86082|NCT01192295|200609|P2|COMPLETED|Overall Study||105
86083|NCT01192295|200610|P1|COMPLETED|Overall Study||17
86084|NCT01192295|200609|P2|STARTED|Overall Study||128
86085|NCT01192295|200610|P1|STARTED|Overall Study||27
86086|NCT01192282|200627|P1|NOT COMPLETED|Overall Study||0
86087|NCT01192282|200627|P1|COMPLETED|Overall Study||156
86088|NCT01192282|200627|P1|STARTED|Overall Study||156
86089|NCT01192204|200644|P2|NOT COMPLETED|Overall Study||0
86090|NCT01192204|200645|P1|NOT COMPLETED|Overall Study||1
86091|NCT01192204|200644|P2|COMPLETED|Overall Study||18
86092|NCT01192204|200645|P1|COMPLETED|Overall Study||22
86093|NCT01192204|200644|P2|STARTED|Overall Study||18
86094|NCT01192204|200645|P1|STARTED|Overall Study||23
86095|NCT01192191|200657|P2|NOT COMPLETED|Overall Study||21
86096|NCT01192191|200658|P1|NOT COMPLETED|Overall Study||11
86097|NCT01192191|200657|P2|COMPLETED|Overall Study||106
86098|NCT01192191|200658|P1|COMPLETED|Overall Study||49
86099|NCT01192191|200657|P2|STARTED|Overall Study||127
86100|NCT01192191|200658|P1|STARTED|Overall Study||60
86101|NCT01192178|200684|P2|NOT COMPLETED|Overall Study||23
86102|NCT01192178|200685|P1|NOT COMPLETED|Overall Study||24
86103|NCT01192178|200684|P2|COMPLETED|Overall Study||145
86104|NCT01192178|200685|P1|COMPLETED|Overall Study||147
86105|NCT01192178|200684|P2|STARTED|Overall Study||168
86106|NCT01192178|200685|P1|STARTED|Overall Study||171
86107|NCT01192152|200705|P2|NOT COMPLETED|Period 3||0
86108|NCT01192152|200706|P1|NOT COMPLETED|Period 3||1
86109|NCT01192152|200705|P2|COMPLETED|Period 3||0
86110|NCT01192152|200706|P1|COMPLETED|Period 3||14
86111|NCT01192152|200705|P2|STARTED|Period 3||0
86112|NCT01192152|200706|P1|STARTED|Period 3||15
86113|NCT01192152|200705|P2|NOT COMPLETED|Period 2||0
86114|NCT01192152|200706|P1|NOT COMPLETED|Period 2||0
86115|NCT01192152|200705|P2|COMPLETED|Period 2||14
86116|NCT01192152|200706|P1|COMPLETED|Period 2||15
86117|NCT01192152|200705|P2|STARTED|Period 2||14
86118|NCT01192152|200706|P1|STARTED|Period 2||15
86119|NCT01192152|200705|P2|NOT COMPLETED|Period 1||1
86120|NCT01192152|200706|P1|NOT COMPLETED|Period 1||0
86121|NCT01192152|200705|P2|COMPLETED|Period 1||14
86122|NCT01192152|200706|P1|COMPLETED|Period 1||15
86123|NCT01192152|200705|P2|STARTED|Period 1||15
86124|NCT01192152|200706|P1|STARTED|Period 1||15
86125|NCT01192139|200807|P6|NOT COMPLETED|Period 3||0
86126|NCT01192139|200808|P5|NOT COMPLETED|Period 3||0
86127|NCT01192139|200809|P4|NOT COMPLETED|Period 3||0
86128|NCT01192139|200810|P3|NOT COMPLETED|Period 3||0
86129|NCT01192139|200811|P2|NOT COMPLETED|Period 3||0
86130|NCT01192139|200812|P1|NOT COMPLETED|Period 3||0
86131|NCT01192139|200807|P6|COMPLETED|Period 3||5
86132|NCT01192139|200808|P5|COMPLETED|Period 3||5
86133|NCT01192139|200809|P4|COMPLETED|Period 3||5
86134|NCT01192139|200810|P3|COMPLETED|Period 3||5
86135|NCT01192139|200811|P2|COMPLETED|Period 3||5
86136|NCT01192139|200812|P1|COMPLETED|Period 3||5
86137|NCT01192139|200807|P6|STARTED|Period 3||5
86138|NCT01192139|200808|P5|STARTED|Period 3||5
86139|NCT01192139|200809|P4|STARTED|Period 3||5
86140|NCT01192139|200810|P3|STARTED|Period 3||5
86141|NCT01192139|200811|P2|STARTED|Period 3||5
86142|NCT01192139|200812|P1|STARTED|Period 3||5
86143|NCT01192139|200807|P6|NOT COMPLETED|Period 2||0
86144|NCT01192139|200808|P5|NOT COMPLETED|Period 2||0
86145|NCT01192139|200809|P4|NOT COMPLETED|Period 2||0
86146|NCT01192139|200810|P3|NOT COMPLETED|Period 2||0
86147|NCT01192139|200811|P2|NOT COMPLETED|Period 2||0
86148|NCT01192139|200812|P1|NOT COMPLETED|Period 2||0
86149|NCT01192139|200807|P6|COMPLETED|Period 2||5
86150|NCT01192139|200808|P5|COMPLETED|Period 2||5
86151|NCT01192139|200809|P4|COMPLETED|Period 2||5
86152|NCT01192139|200810|P3|COMPLETED|Period 2||5
86153|NCT01192139|200811|P2|COMPLETED|Period 2||5
86154|NCT01192139|200812|P1|COMPLETED|Period 2||5
86155|NCT01192139|200807|P6|STARTED|Period 2||5
86156|NCT01192139|200808|P5|STARTED|Period 2||5
86157|NCT01192139|200809|P4|STARTED|Period 2||5
86158|NCT01192139|200810|P3|STARTED|Period 2||5
86159|NCT01192139|200811|P2|STARTED|Period 2||5
86160|NCT01192139|200812|P1|STARTED|Period 2||5
86161|NCT01192139|200807|P6|NOT COMPLETED|Period 1||0
86162|NCT01192139|200808|P5|NOT COMPLETED|Period 1||0
86163|NCT01192139|200809|P4|NOT COMPLETED|Period 1||0
86164|NCT01192139|200810|P3|NOT COMPLETED|Period 1||0
86165|NCT01192139|200811|P2|NOT COMPLETED|Period 1||0
86166|NCT01192139|200812|P1|NOT COMPLETED|Period 1||0
86167|NCT01192139|200807|P6|COMPLETED|Period 1||5
86168|NCT01192139|200808|P5|COMPLETED|Period 1||5
86169|NCT01192139|200809|P4|COMPLETED|Period 1||5
86170|NCT01192139|200810|P3|COMPLETED|Period 1||5
86171|NCT01192139|200811|P2|COMPLETED|Period 1||5
86172|NCT01192139|200812|P1|COMPLETED|Period 1||5
86173|NCT01192139|200807|P6|STARTED|Period 1||5
86174|NCT01192139|200808|P5|STARTED|Period 1||5
86175|NCT01192139|200809|P4|STARTED|Period 1||5
86176|NCT01192139|200810|P3|STARTED|Period 1||5
86177|NCT01192139|200811|P2|STARTED|Period 1||5
86178|NCT01192139|200812|P1|STARTED|Period 1||5
86179|NCT01192126|200877|P2|NOT COMPLETED|Second Intervention (1 Week)||0
86180|NCT01192126|200878|P1|NOT COMPLETED|Second Intervention (1 Week)||0
86181|NCT01192126|200877|P2|COMPLETED|Second Intervention (1 Week)||50
86182|NCT01192126|200878|P1|COMPLETED|Second Intervention (1 Week)||49
86183|NCT01192126|200877|P2|STARTED|Second Intervention (1 Week)||50
86184|NCT01192126|200878|P1|STARTED|Second Intervention (1 Week)||49
86185|NCT01192126|200877|P2|NOT COMPLETED|First Intervention (1 Week)||1
86186|NCT01192126|200878|P1|NOT COMPLETED|First Intervention (1 Week)||2
86187|NCT01192126|200877|P2|COMPLETED|First Intervention (1 Week)||50
86188|NCT01192126|200878|P1|COMPLETED|First Intervention (1 Week)||49
86189|NCT01192126|200877|P2|STARTED|First Intervention (1 Week)||51
86190|NCT01192126|200878|P1|STARTED|First Intervention (1 Week)||51
86191|NCT01192022|200890|P5|NOT COMPLETED|Overall Study||1
86192|NCT01192022|200891|P4|NOT COMPLETED|Overall Study||2
86193|NCT01192022|200892|P3|NOT COMPLETED|Overall Study||1
86194|NCT01192022|200893|P2|NOT COMPLETED|Overall Study||11
86195|NCT01192022|200894|P1|NOT COMPLETED|Overall Study||13
86196|NCT01192022|200890|P5|COMPLETED|Overall Study||11
86197|NCT01192022|200891|P4|COMPLETED|Overall Study||7
86198|NCT01192022|200892|P3|COMPLETED|Overall Study||7
86199|NCT01192022|200893|P2|COMPLETED|Overall Study||99
86200|NCT01192022|200894|P1|COMPLETED|Overall Study||101
86201|NCT01192022|200890|P5|Safety Population-Received Treatment|Overall Study||12
86202|NCT01192022|200891|P4|Safety Population-Received Treatment|Overall Study||9
86203|NCT01192022|200892|P3|Safety Population-Received Treatment|Overall Study||8
86204|NCT01192022|200893|P2|Safety Population-Received Treatment|Overall Study||109
86205|NCT01192022|200894|P1|Safety Population-Received Treatment|Overall Study||114
86206|NCT01192022|200890|P5|STARTED|Overall Study||12
86207|NCT01192022|200891|P4|STARTED|Overall Study||9
86208|NCT01192022|200892|P3|STARTED|Overall Study||8
86209|NCT01192022|200893|P2|STARTED|Overall Study||110
86210|NCT01192022|200894|P1|STARTED|Overall Study||114
86211|NCT01191944|200917|P2|NOT COMPLETED|Overall Study||19
86212|NCT01191944|200918|P1|NOT COMPLETED|Overall Study||17
86213|NCT01191944|200917|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
86214|NCT01191944|200918|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
86215|NCT01191944|200917|P2|STARTED|Overall Study|Treated titration/maintenance|239
86216|NCT01191944|200918|P1|STARTED|Overall Study|Treated titration/maintenance|234
86217|NCT01191827|200964|P2|NOT COMPLETED|Overall Study||0
86218|NCT01191827|200965|P1|NOT COMPLETED|Overall Study||0
86219|NCT01191827|200964|P2|COMPLETED|Overall Study||20
86220|NCT01191827|200965|P1|COMPLETED|Overall Study||20
86221|NCT01191827|200964|P2|STARTED|Overall Study||20
86222|NCT01191827|200965|P1|STARTED|Overall Study||20
86223|NCT01191788|200973|P2|NOT COMPLETED|Overall Study||22
86224|NCT01191788|200974|P1|NOT COMPLETED|Overall Study||21
86225|NCT01191788|200973|P2|COMPLETED|Overall Study|Completed 3-month followup|137
86226|NCT01191788|200974|P1|COMPLETED|Overall Study|Completed 3-month followup|119
86227|NCT01191788|200973|P2|STARTED|Overall Study||159
86228|NCT01191788|200974|P1|STARTED|Overall Study||140
86229|NCT01191762|200984|P2|NOT COMPLETED|Overall Study||0
86230|NCT01191762|200985|P1|NOT COMPLETED|Overall Study||1
86231|NCT01191762|200984|P2|COMPLETED|Overall Study||15
86232|NCT01191762|200985|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
86233|NCT01191762|200984|P2|STARTED|Overall Study||15
86234|NCT01191762|200985|P1|STARTED|Overall Study||15
86235|NCT01191736|200998|P7|NOT COMPLETED|Overall Study||0
86236|NCT01191736|200999|P6|NOT COMPLETED|Overall Study||0
86237|NCT01191736|201000|P5|NOT COMPLETED|Overall Study||0
86238|NCT01191736|201001|P4|NOT COMPLETED|Overall Study||0
86239|NCT01191736|201002|P3|NOT COMPLETED|Overall Study||0
86240|NCT01191736|201003|P2|NOT COMPLETED|Overall Study||0
86241|NCT01191736|201004|P1|NOT COMPLETED|Overall Study||0
86242|NCT01191736|200998|P7|COMPLETED|Overall Study||45
86243|NCT01191736|200999|P6|COMPLETED|Overall Study||50
86244|NCT01191736|201000|P5|COMPLETED|Overall Study||48
86245|NCT01191736|201001|P4|COMPLETED|Overall Study||46
86246|NCT01191736|201002|P3|COMPLETED|Overall Study||49
86247|NCT01191736|201003|P2|COMPLETED|Overall Study||47
86248|NCT01191736|201004|P1|COMPLETED|Overall Study||51
86249|NCT01191736|200998|P7|STARTED|Overall Study||45
86250|NCT01191736|200999|P6|STARTED|Overall Study||50
86251|NCT01191736|201000|P5|STARTED|Overall Study||48
86252|NCT01191736|201001|P4|STARTED|Overall Study||46
86253|NCT01191736|201002|P3|STARTED|Overall Study||49
86254|NCT01191736|201003|P2|STARTED|Overall Study||47
86255|NCT01191736|201004|P1|STARTED|Overall Study||51
86256|NCT01191723|201027|P6|NOT COMPLETED|Overall Study||0
86257|NCT01191723|201028|P5|NOT COMPLETED|Overall Study||0
86258|NCT01191723|201029|P4|NOT COMPLETED|Overall Study||0
86259|NCT01191723|201030|P3|NOT COMPLETED|Overall Study||0
86260|NCT01191723|201031|P2|NOT COMPLETED|Overall Study||0
86261|NCT01191723|201032|P1|NOT COMPLETED|Overall Study||0
86262|NCT01191723|201027|P6|COMPLETED|Overall Study||9
86263|NCT01191723|201028|P5|COMPLETED|Overall Study||9
86264|NCT01191723|201029|P4|COMPLETED|Overall Study||9
86265|NCT01191723|201030|P3|COMPLETED|Overall Study||9
86266|NCT01191723|201031|P2|COMPLETED|Overall Study||9
86267|NCT01191723|201032|P1|COMPLETED|Overall Study||9
86268|NCT01191723|201027|P6|STARTED|Overall Study||9
86269|NCT01191723|201028|P5|STARTED|Overall Study||9
86270|NCT01191723|201029|P4|STARTED|Overall Study||9
86271|NCT01191723|201030|P3|STARTED|Overall Study||9
86272|NCT01191723|201031|P2|STARTED|Overall Study||9
86273|NCT01191723|201032|P1|STARTED|Overall Study||9
86274|NCT01191476|201053|P3|NOT COMPLETED|Overall Study||0
86275|NCT01191476|201054|P2|NOT COMPLETED|Overall Study||4
86276|NCT01191476|201055|P1|NOT COMPLETED|Overall Study||3
86277|NCT01191476|201053|P3|COMPLETED|Overall Study||111
86278|NCT01191476|201054|P2|COMPLETED|Overall Study||107
86279|NCT01191476|201055|P1|COMPLETED|Overall Study||109
86280|NCT01191476|201053|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
86281|NCT01191476|201054|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
86282|NCT01191476|201055|P1|STARTED|Overall Study||112
86283|NCT01191411|201078|P3|NOT COMPLETED|Overall Study||3427
86284|NCT01191411|201079|P2|NOT COMPLETED|Overall Study||361
86285|NCT01191411|201080|P1|NOT COMPLETED|Overall Study||945
86286|NCT01191411|201078|P3|COMPLETED|Overall Study||471
86287|NCT01191411|201079|P2|COMPLETED|Overall Study||118
86288|NCT01191411|201080|P1|COMPLETED|Overall Study||648
86289|NCT01191411|201078|P3|STARTED|Overall Study||3898
86290|NCT01191411|201079|P2|STARTED|Overall Study||479
86291|NCT01191411|201080|P1|STARTED|Overall Study||1593
86292|NCT01191398|201091|P3|NOT COMPLETED|Overall Study||0
86293|NCT01191398|201092|P2|NOT COMPLETED|Overall Study||0
86294|NCT01191398|201093|P1|NOT COMPLETED|Overall Study||0
86295|NCT01191398|201091|P3|COMPLETED|Overall Study||18
86296|NCT01191398|201092|P2|COMPLETED|Overall Study||17
86297|NCT01191398|201093|P1|COMPLETED|Overall Study||17
86298|NCT01191398|201091|P3|STARTED|Overall Study||18
86299|NCT01191398|201092|P2|STARTED|Overall Study||17
86300|NCT01191398|201093|P1|STARTED|Overall Study||17
86301|NCT01191320|201107|P3|NOT COMPLETED|Overall Study||7
86302|NCT01191320|201108|P2|NOT COMPLETED|Overall Study||6
86303|NCT01191320|201109|P1|NOT COMPLETED|Overall Study||7
86304|NCT01191320|201107|P3|COMPLETED|Overall Study||31
86305|NCT01191320|201108|P2|COMPLETED|Overall Study||32
86306|NCT01191320|201109|P1|COMPLETED|Overall Study||36
86307|NCT01191320|201107|P3|STARTED|Overall Study||38
86308|NCT01191320|201108|P2|STARTED|Overall Study||38
86309|NCT01191320|201109|P1|STARTED|Overall Study||43
86310|NCT01191268|201120|P3|NOT COMPLETED|Overall Study||52
86311|NCT01191268|201121|P2|NOT COMPLETED|Overall Study||55
86312|NCT01191268|201122|P1|NOT COMPLETED|Overall Study||58
86313|NCT01191268|201120|P3|COMPLETED|Overall Study||244
86314|NCT01191268|201121|P2|COMPLETED|Overall Study||238
86315|NCT01191268|201122|P1|COMPLETED|Overall Study||237
86316|NCT01191268|201120|P3|Received at Least One Dose of Study Drug|Overall Study||296
86317|NCT01191268|201121|P2|Received at Least One Dose of Study Drug|Overall Study||293
86318|NCT01191268|201122|P1|Received at Least One Dose of Study Drug|Overall Study||295
86319|NCT01191268|201120|P3|STARTED|Overall Study||296
86320|NCT01191268|201121|P2|STARTED|Overall Study||293
86321|NCT01191268|201122|P1|STARTED|Overall Study||295
86322|NCT01191255|201219|P4|NOT COMPLETED|Efficacy Assessment Period||6
86323|NCT01191255|201220|P3|NOT COMPLETED|Efficacy Assessment Period||26
86324|NCT01191255|201221|P2|NOT COMPLETED|Efficacy Assessment Period||0
86325|NCT01191255|201222|P1|NOT COMPLETED|Efficacy Assessment Period||0
86326|NCT01191255|201219|P4|COMPLETED|Efficacy Assessment Period||90
86327|NCT01191255|201220|P3|COMPLETED|Efficacy Assessment Period||70
86328|NCT01191255|201221|P2|COMPLETED|Efficacy Assessment Period||0
86329|NCT01191255|201222|P1|COMPLETED|Efficacy Assessment Period||0
86330|NCT01191255|201219|P4|STARTED|Efficacy Assessment Period||96
86331|NCT01191255|201220|P3|STARTED|Efficacy Assessment Period||96
86332|NCT01191255|201221|P2|STARTED|Efficacy Assessment Period||0
86333|NCT01191255|201222|P1|STARTED|Efficacy Assessment Period||0
86334|NCT01191255|201219|P4|NOT COMPLETED|Safety Assessment Period||0
86335|NCT01191255|201220|P3|NOT COMPLETED|Safety Assessment Period||0
86336|NCT01191255|201221|P2|NOT COMPLETED|Safety Assessment Period||99
86337|NCT01191255|201222|P1|NOT COMPLETED|Safety Assessment Period||38
86338|NCT01191255|201219|P4|COMPLETED|Safety Assessment Period||0
86339|NCT01191255|201220|P3|COMPLETED|Safety Assessment Period||0
86340|NCT01191255|201221|P2|COMPLETED|Safety Assessment Period||193
86341|NCT01191255|201222|P1|COMPLETED|Safety Assessment Period||111
86342|NCT01191255|201219|P4|Safety Population|Safety Assessment Period||0
86343|NCT01191255|201220|P3|Safety Population|Safety Assessment Period||0
86344|NCT01191255|201221|P2|Safety Population|Safety Assessment Period||289
86345|NCT01191255|201222|P1|Safety Population|Safety Assessment Period||149
86346|NCT01191255|201219|P4|STARTED|Safety Assessment Period||0
86347|NCT01191255|201220|P3|STARTED|Safety Assessment Period||0
86348|NCT01191255|201221|P2|STARTED|Safety Assessment Period||292
86349|NCT01191255|201222|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
86350|NCT01191242|201248|P1|NOT COMPLETED|Overall Study||0
86351|NCT01191242|201248|P1|COMPLETED|Overall Study||31
86352|NCT01191242|201248|P1|STARTED|Overall Study||31
86353|NCT01191190|201263|P1|NOT COMPLETED|Overall Study||1
86354|NCT01191190|201263|P1|COMPLETED|Overall Study||20
86355|NCT01191190|201263|P1|STARTED|Overall Study||21
86356|NCT01191086|201274|P1|NOT COMPLETED|Overall Study||62
86357|NCT01191086|201274|P1|COMPLETED|Overall Study||148
86358|NCT01191086|201274|P1|STARTED|Overall Study||210
86359|NCT01190891|201280|P2|NOT COMPLETED|Overall Study||0
86360|NCT01190891|201281|P1|NOT COMPLETED|Overall Study||6
86361|NCT01190891|201280|P2|COMPLETED|Overall Study||52
86362|NCT01190891|201281|P1|COMPLETED|Overall Study||46
86363|NCT01190891|201280|P2|STARTED|Overall Study||52
86364|NCT01190891|201281|P1|STARTED|Overall Study||52
86365|NCT01190878|201293|P4|NOT COMPLETED|Overall Study||20
86366|NCT01190878|201294|P3|NOT COMPLETED|Overall Study||5
86367|NCT01190878|201295|P2|NOT COMPLETED|Overall Study||3
86368|NCT01190878|201296|P1|NOT COMPLETED|Overall Study||3
86369|NCT01190878|201293|P4|COMPLETED|Overall Study||22
86370|NCT01190878|201294|P3|COMPLETED|Overall Study||37
86371|NCT01190878|201295|P2|COMPLETED|Overall Study||42
86372|NCT01190878|201296|P1|COMPLETED|Overall Study||37
86373|NCT01190878|201293|P4|STARTED|Overall Study||42
86374|NCT01190878|201294|P3|STARTED|Overall Study||42
86375|NCT01190878|201295|P2|STARTED|Overall Study||45
86376|NCT01190878|201296|P1|STARTED|Overall Study||40
86377|NCT01190865|201306|P1|NOT COMPLETED|Overall Study||3
86378|NCT01190865|201306|P1|COMPLETED|Overall Study||25
86379|NCT01190865|201306|P1|STARTED|Overall Study||28
86380|NCT01190839|201313|P2|NOT COMPLETED|Overall Study||147
86381|NCT01190839|201314|P1|NOT COMPLETED|Overall Study||150
86382|NCT01190839|201313|P2|COMPLETED|Overall Study||0
86383|NCT01190839|201314|P1|COMPLETED|Overall Study||0
86384|NCT01190839|201313|P2|Treated|Overall Study||143
86385|NCT01190839|201314|P1|Treated|Overall Study||148
86386|NCT01190839|201313|P2|STARTED|Overall Study||147
86387|NCT01190839|201314|P1|STARTED|Overall Study||150
86388|NCT01190813|201328|P2|NOT COMPLETED|Overall Study||4
86389|NCT01190813|201329|P1|NOT COMPLETED|Overall Study||4
86390|NCT01190813|201328|P2|COMPLETED|Overall Study||45
86391|NCT01190813|201329|P1|COMPLETED|Overall Study||86
86392|NCT01190813|201328|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
86393|NCT01190813|201329|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
86394|NCT01190813|201328|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
86395|NCT01190813|201329|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
86396|NCT01190813|201328|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
86397|NCT01190813|201329|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
86398|NCT01190813|201328|P2|16-week Visit|Overall Study|2 dropped|46
86399|NCT01190813|201329|P1|16-week Visit|Overall Study|1 dropped|87
86400|NCT01190813|201328|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
86401|NCT01190813|201329|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
86402|NCT01190813|201328|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
86403|NCT01190813|201329|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
86404|NCT01190813|201328|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
86405|NCT01190813|201329|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
86406|NCT01190813|201328|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
86407|NCT01190813|201329|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
86408|NCT01190813|201328|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
86409|NCT01190813|201329|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
86410|NCT01190813|201328|P2|STARTED|Overall Study||49
86411|NCT01190813|201329|P1|STARTED|Overall Study||90
86412|NCT01190566|201421|P2|NOT COMPLETED|Overall Study||0
86413|NCT01190566|201422|P1|NOT COMPLETED|Overall Study||0
86414|NCT01190566|201421|P2|COMPLETED|Overall Study||42
86415|NCT01190566|201422|P1|COMPLETED|Overall Study||6
86416|NCT01190566|201421|P2|STARTED|Overall Study||42
86417|NCT01190566|201422|P1|STARTED|Overall Study||6
86418|NCT01190527|201443|P1|NOT COMPLETED|Overall Study||0
86419|NCT01190527|201443|P1|COMPLETED|Overall Study||42
86420|NCT01190527|201443|P1|STARTED|Overall Study||42
86421|NCT01190514|201450|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
86422|NCT01190514|201451|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
86423|NCT01190514|201452|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
86424|NCT01190514|201453|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
86425|NCT01190514|201450|P4|COMPLETED|Fourth Intervention (Period 4)||10
86426|NCT01190514|201451|P3|COMPLETED|Fourth Intervention (Period 4)||10
86427|NCT01190514|201452|P2|COMPLETED|Fourth Intervention (Period 4)||10
86428|NCT01190514|201453|P1|COMPLETED|Fourth Intervention (Period 4)||9
86429|NCT01190514|201450|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
86430|NCT01190514|201451|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
86431|NCT01190514|201452|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
86432|NCT01190514|201453|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
86433|NCT01190514|201450|P4|NOT COMPLETED|Third Intervention (Period 3)||0
86434|NCT01190514|201451|P3|NOT COMPLETED|Third Intervention (Period 3)||0
86435|NCT01190514|201452|P2|NOT COMPLETED|Third Intervention (Period 3)||0
86436|NCT01190514|201453|P1|NOT COMPLETED|Third Intervention (Period 3)||1
86437|NCT01190514|201450|P4|COMPLETED|Third Intervention (Period 3)||10
86438|NCT01190514|201451|P3|COMPLETED|Third Intervention (Period 3)||10
86439|NCT01190514|201452|P2|COMPLETED|Third Intervention (Period 3)||10
86440|NCT01190514|201453|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
86441|NCT01190514|201450|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
86442|NCT01190514|201451|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
86443|NCT01190514|201452|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
86444|NCT01190514|201453|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
86445|NCT01190514|201450|P4|NOT COMPLETED|Second Intervention (Period 2)||0
86446|NCT01190514|201451|P3|NOT COMPLETED|Second Intervention (Period 2)||0
86447|NCT01190514|201452|P2|NOT COMPLETED|Second Intervention (Period 2)||0
86448|NCT01190514|201453|P1|NOT COMPLETED|Second Intervention (Period 2)||0
86449|NCT01190514|201450|P4|COMPLETED|Second Intervention (Period 2)||10
86450|NCT01190514|201451|P3|COMPLETED|Second Intervention (Period 2)||10
86451|NCT01190514|201452|P2|COMPLETED|Second Intervention (Period 2)||10
86452|NCT01190514|201453|P1|COMPLETED|Second Intervention (Period 2)||10
86453|NCT01190514|201450|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
86454|NCT01190514|201451|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
86455|NCT01190514|201452|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
86456|NCT01190514|201453|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
86457|NCT01190514|201450|P4|NOT COMPLETED|First Intervention (Period 1)||0
86458|NCT01190514|201451|P3|NOT COMPLETED|First Intervention (Period 1)||0
86459|NCT01190514|201452|P2|NOT COMPLETED|First Intervention (Period 1)||0
86460|NCT01190514|201453|P1|NOT COMPLETED|First Intervention (Period 1)||1
86461|NCT01190514|201450|P4|COMPLETED|First Intervention (Period 1)||10
86462|NCT01190514|201451|P3|COMPLETED|First Intervention (Period 1)||10
86463|NCT01190514|201452|P2|COMPLETED|First Intervention (Period 1)||10
86464|NCT01190514|201453|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
86465|NCT01190514|201450|P4|STARTED|First Intervention (Period 1)||10
86466|NCT01190514|201451|P3|STARTED|First Intervention (Period 1)||10
86467|NCT01190514|201452|P2|STARTED|First Intervention (Period 1)||10
86468|NCT01190514|201453|P1|STARTED|First Intervention (Period 1)||11
86469|NCT01190436|201483|P1|NOT COMPLETED|Overall Study||39
86470|NCT01190436|201483|P1|COMPLETED|Overall Study||86
86471|NCT01190436|201483|P1|STARTED|Overall Study||125
86472|NCT01190306|201499|P2|NOT COMPLETED|Overall Study||0
86473|NCT01190306|201500|P1|NOT COMPLETED|Overall Study||0
86474|NCT01190306|201499|P2|COMPLETED|Overall Study||66
86475|NCT01190306|201500|P1|COMPLETED|Overall Study||61
86476|NCT01190306|201499|P2|STARTED|Overall Study||66
86477|NCT01190306|201500|P1|STARTED|Overall Study||61
86478|NCT01190267|201508|P2|NOT COMPLETED|Overall Study||4
86479|NCT01190267|201509|P1|NOT COMPLETED|Overall Study||41
86480|NCT01190267|201508|P2|COMPLETED|Overall Study||4
86481|NCT01190267|201509|P1|COMPLETED|Overall Study||155
86482|NCT01190267|201508|P2|STARTED|Overall Study||8
86483|NCT01190267|201509|P1|STARTED|Overall Study||196
86484|NCT01190254|201520|P3|NOT COMPLETED|Overall Study||22
86485|NCT01190254|201521|P2|NOT COMPLETED|Overall Study||17
86486|NCT01190254|201522|P1|NOT COMPLETED|Overall Study||21
86487|NCT01190254|201520|P3|COMPLETED|Overall Study||84
86488|NCT01190254|201521|P2|COMPLETED|Overall Study||81
86489|NCT01190254|201522|P1|COMPLETED|Overall Study||81
86490|NCT01190254|201520|P3|Treated|Overall Study||106
86491|NCT01190254|201521|P2|Treated|Overall Study||98
86492|NCT01190254|201522|P1|Treated|Overall Study||102
86493|NCT01190254|201520|P3|STARTED|Overall Study||106
86494|NCT01190254|201521|P2|STARTED|Overall Study||98
86495|NCT01190254|201522|P1|STARTED|Overall Study||102
86496|NCT01190215|201586|P2|NOT COMPLETED|Up to Month 6||0
86497|NCT01190215|201587|P1|NOT COMPLETED|Up to Month 6||2
86498|NCT01190215|201586|P2|COMPLETED|Up to Month 6||39
86499|NCT01190215|201587|P1|COMPLETED|Up to Month 6||36
86500|NCT01190215|201586|P2|STARTED|Up to Month 6||39
86501|NCT01190215|201587|P1|STARTED|Up to Month 6||38
86502|NCT01190215|201586|P2|NOT COMPLETED|Up to Day 28||0
86503|NCT01190215|201587|P1|NOT COMPLETED|Up to Day 28||0
86504|NCT01190215|201586|P2|COMPLETED|Up to Day 28||39
86505|NCT01190215|201587|P1|COMPLETED|Up to Day 28||38
86506|NCT01190215|201586|P2|STARTED|Up to Day 28||39
86507|NCT01190215|201587|P1|STARTED|Up to Day 28||38
86508|NCT01190150|201657|P2|NOT COMPLETED|Second Treatment||0
86509|NCT01190150|201658|P1|NOT COMPLETED|Second Treatment||0
86510|NCT01190150|201657|P2|COMPLETED|Second Treatment||7
86511|NCT01190150|201658|P1|COMPLETED|Second Treatment||10
86512|NCT01190150|201657|P2|STARTED|Second Treatment||7
86513|NCT01190150|201658|P1|STARTED|Second Treatment||10
86514|NCT01190150|201657|P2|NOT COMPLETED|Washout||2
86515|NCT01190150|201658|P1|NOT COMPLETED|Washout||0
86516|NCT01190150|201657|P2|COMPLETED|Washout||7
86517|NCT01190150|201658|P1|COMPLETED|Washout||10
86518|NCT01190150|201657|P2|STARTED|Washout||9
86519|NCT01190150|201658|P1|STARTED|Washout||10
86520|NCT01190150|201657|P2|NOT COMPLETED|First Treatment||0
86521|NCT01190150|201658|P1|NOT COMPLETED|First Treatment||1
86522|NCT01190150|201657|P2|COMPLETED|First Treatment||9
86523|NCT01190150|201658|P1|COMPLETED|First Treatment||10
86524|NCT01190150|201657|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
86525|NCT01190150|201658|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
86526|NCT01190124|201685|P3|NOT COMPLETED|Overall Study||1
86527|NCT01190124|201686|P2|NOT COMPLETED|Overall Study||0
86528|NCT01190124|201687|P1|NOT COMPLETED|Overall Study||17
86529|NCT01190124|201685|P3|COMPLETED|Overall Study||19
86530|NCT01190124|201686|P2|COMPLETED|Overall Study||24
86531|NCT01190124|201687|P1|COMPLETED|Overall Study||90
86532|NCT01190124|201685|P3|STARTED|Overall Study||20
86533|NCT01190124|201686|P2|STARTED|Overall Study||24
86534|NCT01190124|201687|P1|STARTED|Overall Study||107
86535|NCT01190098|201725|P2|NOT COMPLETED|Overall Study||2
86536|NCT01190098|201726|P1|NOT COMPLETED|Overall Study||3
86537|NCT01190098|201725|P2|COMPLETED|Overall Study||8
86538|NCT01190098|201726|P1|COMPLETED|Overall Study||39
86539|NCT01190098|201725|P2|STARTED|Overall Study||10
86540|NCT01190098|201726|P1|STARTED|Overall Study||42
86541|NCT01190085|201749|P3|NOT COMPLETED|Overall Study||0
86542|NCT01190085|201750|P2|NOT COMPLETED|Overall Study||0
86543|NCT01190085|201751|P1|NOT COMPLETED|Overall Study||0
86544|NCT01190085|201749|P3|COMPLETED|Overall Study||18
86545|NCT01190085|201750|P2|COMPLETED|Overall Study||14
86546|NCT01190085|201751|P1|COMPLETED|Overall Study||13
86547|NCT01190085|201749|P3|STARTED|Overall Study||18
86548|NCT01190085|201750|P2|STARTED|Overall Study||14
86549|NCT01190085|201751|P1|STARTED|Overall Study||13
86550|NCT01190007|201765|P1|NOT COMPLETED|Overall Study||14
86551|NCT01190007|201765|P1|COMPLETED|Overall Study||145
86552|NCT01190007|201765|P1|STARTED|Overall Study|Treated|159
86553|NCT01189890|201782|P2|NOT COMPLETED|Overall Study||39
86554|NCT01189890|201783|P1|NOT COMPLETED|Overall Study||37
86555|NCT01189890|201782|P2|COMPLETED|Overall Study||200
86556|NCT01189890|201783|P1|COMPLETED|Overall Study||204
86557|NCT01189890|201782|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
86558|NCT01189890|201783|P1|STARTED|Overall Study||241
86559|NCT01189812|201805|P2|NOT COMPLETED|Overall Study||8
86560|NCT01189812|201806|P1|NOT COMPLETED|Overall Study||8
86561|NCT01189812|201805|P2|COMPLETED|Overall Study||32
86562|NCT01189812|201806|P1|COMPLETED|Overall Study||32
86563|NCT01189812|201805|P2|STARTED|Overall Study||40
86564|NCT01189812|201806|P1|STARTED|Overall Study||40
86565|NCT01189760|201815|P3|NOT COMPLETED|Overall Study||51
86566|NCT01189760|201816|P2|NOT COMPLETED|Overall Study||23
86567|NCT01189760|201817|P1|NOT COMPLETED|Overall Study||14
86568|NCT01189760|201815|P3|COMPLETED|Overall Study||255
86569|NCT01189760|201816|P2|COMPLETED|Overall Study||283
86570|NCT01189760|201817|P1|COMPLETED|Overall Study||291
86571|NCT01189760|201815|P3|STARTED|Overall Study||306
86572|NCT01189760|201816|P2|STARTED|Overall Study||306
86573|NCT01189760|201817|P1|STARTED|Overall Study||305
86574|NCT01189747|201851|P2|NOT COMPLETED|Overall Study||18
86575|NCT01189747|201852|P1|NOT COMPLETED|Overall Study||12
86576|NCT01189747|201851|P2|COMPLETED|Overall Study||206
86577|NCT01189747|201852|P1|COMPLETED|Overall Study||210
86578|NCT01189747|201851|P2|STARTED|Overall Study||224
86579|NCT01189747|201852|P1|STARTED|Overall Study||222
86580|NCT01189617|201876|P2|NOT COMPLETED|Overall Study||0
86581|NCT01189617|201877|P1|NOT COMPLETED|Overall Study||0
86582|NCT01189617|201876|P2|COMPLETED|Overall Study||35
86583|NCT01189617|201877|P1|COMPLETED|Overall Study||35
86584|NCT01189617|201876|P2|STARTED|Overall Study||35
86585|NCT01189617|201877|P1|STARTED|Overall Study||35
86586|NCT01189604|201890|P7|NOT COMPLETED|Overall Study||1
86587|NCT01189604|201891|P6|NOT COMPLETED|Overall Study||1
86588|NCT01189604|201892|P5|NOT COMPLETED|Overall Study||2
86589|NCT01189604|201893|P4|NOT COMPLETED|Overall Study||0
86590|NCT01189604|201894|P3|NOT COMPLETED|Overall Study||0
86591|NCT01189604|201895|P2|NOT COMPLETED|Overall Study||1
86592|NCT01189604|201896|P1|NOT COMPLETED|Overall Study||1
86593|NCT01189604|201890|P7|COMPLETED|Overall Study||9
86594|NCT01189604|201891|P6|COMPLETED|Overall Study||10
86595|NCT01189604|201892|P5|COMPLETED|Overall Study||18
86596|NCT01189604|201893|P4|COMPLETED|Overall Study||20
86597|NCT01189604|201894|P3|COMPLETED|Overall Study||20
86598|NCT01189604|201895|P2|COMPLETED|Overall Study||20
86599|NCT01189604|201896|P1|COMPLETED|Overall Study||20
86600|NCT01189604|201890|P7|Administered Study Drug|Overall Study||10
86601|NCT01189604|201891|P6|Administered Study Drug|Overall Study||10
86602|NCT01189604|201892|P5|Administered Study Drug|Overall Study||20
86603|NCT01189604|201893|P4|Administered Study Drug|Overall Study||20
86604|NCT01189604|201894|P3|Administered Study Drug|Overall Study||20
86605|NCT01189604|201895|P2|Administered Study Drug|Overall Study||20
86606|NCT01189604|201896|P1|Administered Study Drug|Overall Study||20
86607|NCT01189604|201890|P7|STARTED|Overall Study||10
86608|NCT01189604|201891|P6|STARTED|Overall Study||11
86609|NCT01189604|201892|P5|STARTED|Overall Study||20
86610|NCT01189604|201893|P4|STARTED|Overall Study||20
86611|NCT01189604|201894|P3|STARTED|Overall Study||20
86612|NCT01189604|201895|P2|STARTED|Overall Study||21
86613|NCT01189604|201896|P1|STARTED|Overall Study||21
86614|NCT01189500|201940|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
86615|NCT01189500|201940|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
86616|NCT01189500|201940|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
86617|NCT01189500|201940|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
86618|NCT01189500|201940|P1|COMPLETED|Period 1: TAMOX Alone||29
86619|NCT01189500|201940|P1|STARTED|Period 1: TAMOX Alone||30
86620|NCT01189487|202001|P1|NOT COMPLETED|Overall Study||3
86621|NCT01189487|202001|P1|COMPLETED|Overall Study||44
86622|NCT01189487|202001|P1|STARTED|Overall Study|Treated participants|47
86623|NCT01189461|202009|P1|NOT COMPLETED|Overall Study||34
86624|NCT01189461|202009|P1|COMPLETED|Overall Study||12
86625|NCT01189461|202009|P1|STARTED|Overall Study||46
86626|NCT01189435|202016|P1|NOT COMPLETED|Overall Study||2
86627|NCT01189435|202016|P1|COMPLETED|Overall Study||0
86628|NCT01189435|202016|P1|STARTED|Overall Study||2
86629|NCT01189292|202022|P2|NOT COMPLETED|Per Protocol Analysis||16
86630|NCT01189292|202023|P1|NOT COMPLETED|Per Protocol Analysis||11
86631|NCT01189292|202022|P2|COMPLETED|Per Protocol Analysis||60
86632|NCT01189292|202023|P1|COMPLETED|Per Protocol Analysis||65
86633|NCT01189292|202022|P2|STARTED|Per Protocol Analysis||76
86634|NCT01189292|202023|P1|STARTED|Per Protocol Analysis||76
86635|NCT01189292|202022|P2|NOT COMPLETED|Intention to Treat Analysis||0
86636|NCT01189292|202023|P1|NOT COMPLETED|Intention to Treat Analysis||0
86637|NCT01189292|202022|P2|COMPLETED|Intention to Treat Analysis||76
86638|NCT01189292|202023|P1|COMPLETED|Intention to Treat Analysis||76
86639|NCT01189292|202022|P2|STARTED|Intention to Treat Analysis||76
86640|NCT01189292|202023|P1|STARTED|Intention to Treat Analysis||76
86641|NCT01189279|202044|P3|NOT COMPLETED|Overall Study||1
86642|NCT01189279|202045|P2|NOT COMPLETED|Overall Study||0
86643|NCT01189279|202046|P1|NOT COMPLETED|Overall Study||1
86644|NCT01189279|202044|P3|COMPLETED|Overall Study||13
86645|NCT01189279|202045|P2|COMPLETED|Overall Study||14
86646|NCT01189279|202046|P1|COMPLETED|Overall Study||13
86647|NCT01189279|202044|P3|STARTED|Overall Study||14
86648|NCT01189279|202045|P2|STARTED|Overall Study||14
86649|NCT01189279|202046|P1|STARTED|Overall Study||14
86650|NCT01189240|202066|P3|NOT COMPLETED|Overall Study||0
86651|NCT01189240|202067|P2|NOT COMPLETED|Overall Study||0
86652|NCT01189240|202068|P1|NOT COMPLETED|Overall Study||0
86653|NCT01189240|202066|P3|COMPLETED|Overall Study||3
86654|NCT01189240|202067|P2|COMPLETED|Overall Study||6
86655|NCT01189240|202068|P1|COMPLETED|Overall Study||4
86656|NCT01189240|202066|P3|STARTED|Overall Study||3
86657|NCT01189240|202067|P2|STARTED|Overall Study||6
86658|NCT01189240|202068|P1|STARTED|Overall Study||4
86659|NCT01189227|202089|P2|NOT COMPLETED|Overall Study||3
86660|NCT01189227|202090|P1|NOT COMPLETED|Overall Study||6
86661|NCT01189227|202089|P2|COMPLETED|Overall Study||0
86662|NCT01189227|202090|P1|COMPLETED|Overall Study||0
86663|NCT01189227|202089|P2|STARTED|Overall Study||3
86664|NCT01189227|202090|P1|STARTED|Overall Study||6
86665|NCT01189201|202096|P1|NOT COMPLETED|Overall Study||1
86666|NCT01189201|202096|P1|COMPLETED|Overall Study||41
86667|NCT01189201|202096|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
86668|NCT01189201|202096|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
86669|NCT01189201|202096|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
86670|NCT01189201|202096|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
86671|NCT01189201|202096|P1|STARTED|Overall Study||42
86672|NCT01189136|202152|P2|NOT COMPLETED|Overall Study||0
86673|NCT01189136|202153|P1|NOT COMPLETED|Overall Study||0
86674|NCT01189136|202152|P2|COMPLETED|Overall Study||42
86675|NCT01189136|202153|P1|COMPLETED|Overall Study||42
86676|NCT01189136|202152|P2|STARTED|Overall Study||42
86677|NCT01189136|202153|P1|STARTED|Overall Study||42
86678|NCT01189123|202167|P2|NOT COMPLETED|Overall Study||6
86679|NCT01189123|202168|P1|NOT COMPLETED|Overall Study||2
86680|NCT01189123|202167|P2|COMPLETED|Overall Study||47
86681|NCT01189123|202168|P1|COMPLETED|Overall Study||50
86682|NCT01189123|202167|P2|STARTED|Overall Study||53
86683|NCT01189123|202168|P1|STARTED|Overall Study||52
86684|NCT01189110|202178|P2|NOT COMPLETED|Overall Study||0
86685|NCT01189110|202179|P1|NOT COMPLETED|Overall Study||0
86686|NCT01189110|202178|P2|COMPLETED|Overall Study||61
86687|NCT01189110|202179|P1|COMPLETED|Overall Study|February, 2011|64
86688|NCT01189110|202178|P2|STARTED|Overall Study||61
86689|NCT01189110|202179|P1|STARTED|Overall Study|September, 2010|64
86690|NCT01189071|202187|P2|NOT COMPLETED|Overall Study||0
86691|NCT01189071|202188|P1|NOT COMPLETED|Overall Study||0
86692|NCT01189071|202187|P2|COMPLETED|Overall Study||0
86693|NCT01189071|202188|P1|COMPLETED|Overall Study||0
86694|NCT01189071|202187|P2|STARTED|Overall Study||0
86695|NCT01189071|202188|P1|STARTED|Overall Study||0
86696|NCT01189032|202199|P3|NOT COMPLETED|Overall Study||6
86697|NCT01189032|202200|P2|NOT COMPLETED|Overall Study||7
86698|NCT01189032|202201|P1|NOT COMPLETED|Overall Study||5
86699|NCT01189032|202199|P3|COMPLETED|Overall Study||90
86700|NCT01189032|202200|P2|COMPLETED|Overall Study||89
86701|NCT01189032|202201|P1|COMPLETED|Overall Study||89
86702|NCT01189032|202199|P3|STARTED|Overall Study||96
86703|NCT01189032|202200|P2|STARTED|Overall Study||96
86704|NCT01189032|202201|P1|STARTED|Overall Study||94
86705|NCT01188967|202211|P2|NOT COMPLETED|Overall Study||4
86706|NCT01188967|202212|P1|NOT COMPLETED|Overall Study||5
86707|NCT01188967|202211|P2|COMPLETED|Overall Study||4
86708|NCT01188967|202212|P1|COMPLETED|Overall Study||5
86709|NCT01188967|202211|P2|STARTED|Overall Study||8
86710|NCT01188967|202212|P1|STARTED|Overall Study||10
86711|NCT01188928|202228|P4|NOT COMPLETED|Overall Study||18
86712|NCT01188928|202229|P3|NOT COMPLETED|Overall Study||14
86713|NCT01188928|202230|P2|NOT COMPLETED|Overall Study||62
86714|NCT01188928|202231|P1|NOT COMPLETED|Overall Study||38
86715|NCT01188928|202228|P4|COMPLETED|Overall Study||77
86716|NCT01188928|202229|P3|COMPLETED|Overall Study||82
86717|NCT01188928|202230|P2|COMPLETED|Overall Study||417
86718|NCT01188928|202231|P1|COMPLETED|Overall Study||444
86719|NCT01188928|202228|P4|STARTED|Overall Study||95
86720|NCT01188928|202229|P3|STARTED|Overall Study||96
86721|NCT01188928|202230|P2|STARTED|Overall Study||479
86722|NCT01188928|202231|P1|STARTED|Overall Study||482
86723|NCT01188811|202255|P2|NOT COMPLETED|Overall Study||2
86724|NCT01188811|202256|P1|NOT COMPLETED|Overall Study||6
86725|NCT01188811|202255|P2|COMPLETED|Overall Study||24
86726|NCT01188811|202256|P1|COMPLETED|Overall Study||22
86727|NCT01188811|202255|P2|STARTED|Overall Study||26
86728|NCT01188811|202256|P1|STARTED|Overall Study||28
86729|NCT01188798|202268|P2|NOT COMPLETED|Overall Study||3
86730|NCT01188798|202269|P1|NOT COMPLETED|Overall Study||2
86731|NCT01188798|202268|P2|COMPLETED|Overall Study||1
86732|NCT01188798|202269|P1|COMPLETED|Overall Study||0
86733|NCT01188798|202268|P2|STARTED|Overall Study||4
86734|NCT01188798|202269|P1|STARTED|Overall Study||2
86735|NCT01188772|202281|P4|NOT COMPLETED|Overall Study||1
86736|NCT01188772|202282|P3|NOT COMPLETED|Overall Study||11
86737|NCT01188772|202283|P2|NOT COMPLETED|Overall Study||3
86738|NCT01188772|202284|P1|NOT COMPLETED|Overall Study||5
86739|NCT01188772|202281|P4|COMPLETED|Overall Study||24
86740|NCT01188772|202282|P3|COMPLETED|Overall Study||15
86741|NCT01188772|202283|P2|COMPLETED|Overall Study||45
86742|NCT01188772|202284|P1|COMPLETED|Overall Study||43
86743|NCT01188772|202281|P4|Randomized and Treated|Overall Study||25
86744|NCT01188772|202282|P3|Randomized and Treated|Overall Study||26
86745|NCT01188772|202283|P2|Randomized and Treated|Overall Study||47
86746|NCT01188772|202284|P1|Randomized and Treated|Overall Study||48
86747|NCT01188772|202281|P4|STARTED|Overall Study||25
86748|NCT01188772|202282|P3|STARTED|Overall Study||26
86749|NCT01188772|202283|P2|STARTED|Overall Study||48
86750|NCT01188772|202284|P1|STARTED|Overall Study||48
86751|NCT01188681|202343|P4|NOT COMPLETED|Overall Study||1
86752|NCT01188681|202344|P3|NOT COMPLETED|Overall Study||1
86753|NCT01188681|202345|P2|NOT COMPLETED|Overall Study||0
86754|NCT01188681|202346|P1|NOT COMPLETED|Overall Study||0
86755|NCT01188681|202343|P4|COMPLETED|Overall Study||33
86756|NCT01188681|202344|P3|COMPLETED|Overall Study||32
86757|NCT01188681|202345|P2|COMPLETED|Overall Study||6
86758|NCT01188681|202346|P1|COMPLETED|Overall Study||6
86759|NCT01188681|202343|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
86760|NCT01188681|202344|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
86761|NCT01188681|202345|P2|STARTED|Overall Study||6
86762|NCT01188681|202346|P1|STARTED|Overall Study||6
86763|NCT01188668|202360|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
86764|NCT01188668|202360|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
86765|NCT01188668|202360|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
86766|NCT01188668|202360|P1|NOT COMPLETED|Period 1: ARIP Alone||2
86767|NCT01188668|202360|P1|COMPLETED|Period 1: ARIP Alone||36
86768|NCT01188668|202360|P1|STARTED|Period 1: ARIP Alone||38
86769|NCT01188655|202393|P1|NOT COMPLETED|Overall Study||13
86770|NCT01188655|202393|P1|COMPLETED|Overall Study||76
86771|NCT01188655|202393|P1|STARTED|Overall Study||89
86772|NCT01188603|202408|P1|NOT COMPLETED|Overall Study||0
86773|NCT01188603|202408|P1|COMPLETED|Overall Study||24
86774|NCT01188603|202408|P1|STARTED|Overall Study||24
86775|NCT01188577|202418|P2|NOT COMPLETED|Visit 2||0
86776|NCT01188577|202419|P1|NOT COMPLETED|Visit 2||0
86777|NCT01188577|202418|P2|COMPLETED|Visit 2||12
86778|NCT01188577|202419|P1|COMPLETED|Visit 2||11
86779|NCT01188577|202418|P2|STARTED|Visit 2||12
86780|NCT01188577|202419|P1|STARTED|Visit 2||11
86781|NCT01188577|202418|P2|NOT COMPLETED|3-14 Day Washout||0
86782|NCT01188577|202419|P1|NOT COMPLETED|3-14 Day Washout||0
86783|NCT01188577|202418|P2|COMPLETED|3-14 Day Washout||12
86784|NCT01188577|202419|P1|COMPLETED|3-14 Day Washout||11
86785|NCT01188577|202418|P2|STARTED|3-14 Day Washout||12
86786|NCT01188577|202419|P1|STARTED|3-14 Day Washout||11
86787|NCT01188577|202418|P2|NOT COMPLETED|Visit 1||0
86788|NCT01188577|202419|P1|NOT COMPLETED|Visit 1||0
86789|NCT01188577|202418|P2|COMPLETED|Visit 1||12
86790|NCT01188577|202419|P1|COMPLETED|Visit 1||11
86791|NCT01188577|202418|P2|STARTED|Visit 1||12
86792|NCT01188577|202419|P1|STARTED|Visit 1||11
86793|NCT01188564|202437|P2|NOT COMPLETED|Open Label Phase||0
86794|NCT01188564|202438|P1|NOT COMPLETED|Open Label Phase||0
86795|NCT01188564|202437|P2|COMPLETED|Open Label Phase||20
86796|NCT01188564|202438|P1|COMPLETED|Open Label Phase||24
86797|NCT01188564|202437|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
86798|NCT01188564|202438|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
86799|NCT01188564|202437|P2|NOT COMPLETED|Double-blind Phase||0
86800|NCT01188564|202438|P1|NOT COMPLETED|Double-blind Phase||1
86801|NCT01188564|202437|P2|COMPLETED|Double-blind Phase||31
86802|NCT01188564|202438|P1|COMPLETED|Double-blind Phase||43
86803|NCT01188564|202437|P2|STARTED|Double-blind Phase||31
86804|NCT01188564|202438|P1|STARTED|Double-blind Phase||44
86805|NCT01188551|202450|P4|NOT COMPLETED|Overall Study||0
86806|NCT01188551|202451|P3|NOT COMPLETED|Overall Study||0
86807|NCT01188551|202452|P2|NOT COMPLETED|Overall Study||0
86808|NCT01188551|202453|P1|NOT COMPLETED|Overall Study||1
86809|NCT01188551|202450|P4|COMPLETED|Overall Study||25
86810|NCT01188551|202451|P3|COMPLETED|Overall Study||25
86811|NCT01188551|202452|P2|COMPLETED|Overall Study||25
86812|NCT01188551|202453|P1|COMPLETED|Overall Study||24
86813|NCT01188551|202450|P4|STARTED|Overall Study||25
86814|NCT01188551|202451|P3|STARTED|Overall Study||25
86815|NCT01188551|202452|P2|STARTED|Overall Study||25
86816|NCT01188551|202453|P1|STARTED|Overall Study||25
86817|NCT01188538|202469|P2|NOT COMPLETED|Overall Study||1
86818|NCT01188538|202470|P1|NOT COMPLETED|Overall Study||0
86819|NCT01188538|202469|P2|COMPLETED|Overall Study||19
86820|NCT01188538|202470|P1|COMPLETED|Overall Study||20
86821|NCT01188538|202469|P2|STARTED|Overall Study||20
86822|NCT01188538|202470|P1|STARTED|Overall Study||20
86823|NCT01188499|202483|P5|NOT COMPLETED|Overall Study||0
86824|NCT01188499|202484|P4|NOT COMPLETED|Overall Study||0
86825|NCT01188499|202485|P3|NOT COMPLETED|Overall Study||0
86826|NCT01188499|202486|P2|NOT COMPLETED|Overall Study||0
86827|NCT01188499|202487|P1|NOT COMPLETED|Overall Study||0
86828|NCT01188499|202483|P5|COMPLETED|Overall Study||18
86829|NCT01188499|202484|P4|COMPLETED|Overall Study||18
86830|NCT01188499|202485|P3|COMPLETED|Overall Study||33
86831|NCT01188499|202486|P2|COMPLETED|Overall Study||83
86832|NCT01188499|202487|P1|COMPLETED|Overall Study||24
86833|NCT01188499|202483|P5|STARTED|Overall Study||18
86834|NCT01188499|202484|P4|STARTED|Overall Study||18
86835|NCT01188499|202485|P3|STARTED|Overall Study||33
86836|NCT01188499|202486|P2|STARTED|Overall Study||83
86837|NCT01188499|202487|P1|STARTED|Overall Study||24
86838|NCT01188343|202507|P3|NOT COMPLETED|Overall Study||1
86839|NCT01188343|202508|P2|NOT COMPLETED|Overall Study||26
86840|NCT01188343|202509|P1|NOT COMPLETED|Overall Study||1
86841|NCT01188343|202507|P3|COMPLETED|Overall Study||220
86842|NCT01188343|202508|P2|COMPLETED|Overall Study||193
86843|NCT01188343|202509|P1|COMPLETED|Overall Study||101
86844|NCT01188343|202507|P3|STARTED|Overall Study||221
86845|NCT01188343|202508|P2|STARTED|Overall Study||219
86846|NCT01188343|202509|P1|STARTED|Overall Study||102
86847|NCT01188226|202535|P1|NOT COMPLETED|Overall Study||4
86848|NCT01188226|202535|P1|COMPLETED|Overall Study||6
86849|NCT01188226|202535|P1|STARTED|Overall Study||10
86850|NCT01188109|202574|P1|NOT COMPLETED|Overall Study||0
86851|NCT01188109|202574|P1|COMPLETED|Overall Study||22
86852|NCT01188109|202574|P1|STARTED|Overall Study||22
86853|NCT01187953|202581|P2|NOT COMPLETED|Overall Study||21
86854|NCT01187953|202582|P1|NOT COMPLETED|Overall Study||15
86855|NCT01187953|202581|P2|COMPLETED|Overall Study||254
86856|NCT01187953|202582|P1|COMPLETED|Overall Study||253
86857|NCT01187953|202581|P2|Dosed|Overall Study||271
86858|NCT01187953|202582|P1|Dosed|Overall Study||266
86859|NCT01187953|202581|P2|STARTED|Overall Study||275
86860|NCT01187953|202582|P1|STARTED|Overall Study||268
86861|NCT01187914|202590|P1|NOT COMPLETED|Overall Study||0
86862|NCT01187914|202590|P1|COMPLETED|Overall Study||40
86863|NCT01187914|202590|P1|STARTED|Overall Study||40
86864|NCT01187901|202596|P2|NOT COMPLETED|Overall Study||10
86865|NCT01187901|202597|P1|NOT COMPLETED|Overall Study||9
86866|NCT01187901|202596|P2|COMPLETED|Overall Study||36
86867|NCT01187901|202597|P1|COMPLETED|Overall Study||37
86868|NCT01187901|202596|P2|STARTED|Overall Study||46
86869|NCT01187901|202597|P1|STARTED|Overall Study||46
86870|NCT01187550|202615|P2|NOT COMPLETED|Overall Study||1
86871|NCT01187550|202616|P1|NOT COMPLETED|Overall Study||14
86872|NCT01187550|202615|P2|COMPLETED|Overall Study||29
86873|NCT01187550|202616|P1|COMPLETED|Overall Study||169
86874|NCT01187550|202615|P2|Treated|Overall Study||30
86875|NCT01187550|202616|P1|Treated|Overall Study||175
86876|NCT01187550|202615|P2|STARTED|Overall Study||30
86877|NCT01187550|202616|P1|STARTED|Overall Study||183
86878|NCT01187511|202634|P2|NOT COMPLETED|Overall Study||1
86879|NCT01187511|202635|P1|NOT COMPLETED|Overall Study||8
86880|NCT01187511|202634|P2|COMPLETED|Overall Study||21
86881|NCT01187511|202635|P1|COMPLETED|Overall Study||14
86882|NCT01187511|202634|P2|STARTED|Overall Study||22
86883|NCT01187511|202635|P1|STARTED|Overall Study||22
86884|NCT01187498|202743|P2|NOT COMPLETED|Overall Study||10
86885|NCT01187498|202744|P1|NOT COMPLETED|Overall Study||9
86886|NCT01187498|202743|P2|COMPLETED|Overall Study||60
86887|NCT01187498|202744|P1|COMPLETED|Overall Study||64
86888|NCT01187498|202743|P2|STARTED|Overall Study||70
86889|NCT01187498|202744|P1|STARTED|Overall Study||73
86890|NCT01187433|202772|P2|NOT COMPLETED|Overall Study||4
86891|NCT01187433|202773|P1|NOT COMPLETED|Overall Study||11
86892|NCT01187433|202772|P2|COMPLETED|Overall Study||46
86893|NCT01187433|202773|P1|COMPLETED|Overall Study||89
86894|NCT01187433|202772|P2|STARTED|Overall Study||50
86895|NCT01187433|202773|P1|STARTED|Overall Study||100
86896|NCT01187355|202801|P2|NOT COMPLETED|Overall Study||20
86897|NCT01187355|202802|P1|NOT COMPLETED|Overall Study||18
86898|NCT01187355|202801|P2|COMPLETED|Overall Study||277
86899|NCT01187355|202802|P1|COMPLETED|Overall Study||276
86900|NCT01187355|202801|P2|STARTED|Overall Study||297
86901|NCT01187355|202802|P1|STARTED|Overall Study||294
86902|NCT01187043|202817|P5|NOT COMPLETED|Overall Study||2
86903|NCT01187043|202818|P4|NOT COMPLETED|Overall Study||0
86904|NCT01187043|202819|P3|NOT COMPLETED|Overall Study||4
86905|NCT01187043|202820|P2|NOT COMPLETED|Overall Study||0
86906|NCT01187043|202821|P1|NOT COMPLETED|Overall Study||1
86907|NCT01187043|202817|P5|COMPLETED|Overall Study||10
86908|NCT01187043|202818|P4|COMPLETED|Overall Study||12
86909|NCT01187043|202819|P3|COMPLETED|Overall Study||8
86910|NCT01187043|202820|P2|COMPLETED|Overall Study||10
86911|NCT01187043|202821|P1|COMPLETED|Overall Study||11
86912|NCT01187043|202817|P5|STARTED|Overall Study||12
86913|NCT01187043|202818|P4|STARTED|Overall Study||12
86914|NCT01187043|202819|P3|STARTED|Overall Study||12
86915|NCT01187043|202820|P2|STARTED|Overall Study||10
86916|NCT01187043|202821|P1|STARTED|Overall Study||12
86917|NCT01187017|202833|P1|NOT COMPLETED|Overall Study||0
86918|NCT01187017|202833|P1|COMPLETED|Overall Study||1
86919|NCT01187017|202833|P1|STARTED|Overall Study||1
86920|NCT01187004|202839|P2|NOT COMPLETED|Overall Study||0
86921|NCT01187004|202840|P1|NOT COMPLETED|Overall Study||0
86922|NCT01187004|202839|P2|COMPLETED|Overall Study||144
86923|NCT01187004|202840|P1|COMPLETED|Overall Study||20
86924|NCT01187004|202839|P2|STARTED|Overall Study||144
86925|NCT01187004|202840|P1|STARTED|Overall Study||20
86926|NCT01186939|202847|P1|NOT COMPLETED|Overall Study||40
86927|NCT01186939|202847|P1|COMPLETED|Overall Study||0
86928|NCT01186939|202847|P1|STARTED|Overall Study||40
86929|NCT01186848|202851|P1|NOT COMPLETED|Overall Study||8
86930|NCT01186848|202851|P1|COMPLETED|Overall Study||22
86931|NCT01186848|202851|P1|STARTED|Overall Study||30
86932|NCT01186796|202859|P2|NOT COMPLETED|Overall Study||2
86933|NCT01186796|202860|P1|NOT COMPLETED|Overall Study||4
86934|NCT01186796|202859|P2|COMPLETED|Overall Study||14
86935|NCT01186796|202860|P1|COMPLETED|Overall Study||10
86936|NCT01186796|202859|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
86937|NCT01186796|202860|P1|STARTED|Overall Study||14
86938|NCT01186744|202880|P6|NOT COMPLETED|Overall Study||26
86939|NCT01186744|202881|P5|NOT COMPLETED|Overall Study||6
86940|NCT01186744|202882|P4|NOT COMPLETED|Overall Study||12
86941|NCT01186744|202883|P3|NOT COMPLETED|Overall Study||6
86942|NCT01186744|202884|P2|NOT COMPLETED|Overall Study||152
86943|NCT01186744|202885|P1|NOT COMPLETED|Overall Study||208
86944|NCT01186744|202880|P6|COMPLETED|Overall Study||107
86945|NCT01186744|202881|P5|COMPLETED|Overall Study||39
86946|NCT01186744|202882|P4|COMPLETED|Overall Study||70
86947|NCT01186744|202883|P3|COMPLETED|Overall Study||25
86948|NCT01186744|202884|P2|COMPLETED|Overall Study||5
86949|NCT01186744|202885|P1|COMPLETED|Overall Study||10
86950|NCT01186744|202880|P6|STARTED|Overall Study||133
86951|NCT01186744|202881|P5|STARTED|Overall Study||45
86952|NCT01186744|202882|P4|STARTED|Overall Study||82
86953|NCT01186744|202883|P3|STARTED|Overall Study||31
86954|NCT01186744|202884|P2|STARTED|Overall Study||157
86955|NCT01186744|202885|P1|STARTED|Overall Study||218
86956|NCT01186705|203301|P1|NOT COMPLETED|Overall Study||0
86957|NCT01186705|203301|P1|COMPLETED|Overall Study||1
86958|NCT01186705|203301|P1|STARTED|Overall Study||1
86959|NCT01186692|203305|P1|NOT COMPLETED|Overall Study||32
86960|NCT01186692|203305|P1|COMPLETED|Overall Study||99
86961|NCT01186692|203305|P1|STARTED|Overall Study||131
86962|NCT01186562|203315|P2|NOT COMPLETED|Overall Study||2
86963|NCT01186562|203316|P1|NOT COMPLETED|Overall Study||4
86964|NCT01186562|203315|P2|COMPLETED|Overall Study||27
86965|NCT01186562|203316|P1|COMPLETED|Overall Study||50
86966|NCT01186562|203315|P2|STARTED|Overall Study||29
86967|NCT01186562|203316|P1|STARTED|Overall Study||54
86968|NCT01186458|203332|P1|NOT COMPLETED|Overall Study||1
86969|NCT01186458|203332|P1|COMPLETED|Overall Study||3
86970|NCT01186458|203332|P1|STARTED|Overall Study||4
86971|NCT01186419|203341|P2|NOT COMPLETED|Overall Study||9
86972|NCT01186419|203342|P1|NOT COMPLETED|Overall Study||7
86973|NCT01186419|203341|P2|COMPLETED|Overall Study||18
86974|NCT01186419|203342|P1|COMPLETED|Overall Study||17
86975|NCT01186419|203341|P2|STARTED|Overall Study||27
86976|NCT01186419|203342|P1|STARTED|Overall Study||24
86977|NCT01186406|203349|P1|NOT COMPLETED|Overall Study||0
86978|NCT01186406|203349|P1|COMPLETED|Overall Study||41
86979|NCT01186406|203349|P1|STARTED|Overall Study||41
86980|NCT01186250|203358|P2|NOT COMPLETED|Overall Study||0
86981|NCT01186250|203359|P1|NOT COMPLETED|Overall Study||1
86982|NCT01186250|203358|P2|COMPLETED|Overall Study||9
86983|NCT01186250|203359|P1|COMPLETED|Overall Study||8
86984|NCT01186250|203358|P2|STARTED|Overall Study||9
86985|NCT01186250|203359|P1|STARTED|Overall Study||9
86986|NCT01185834|203377|P1|NOT COMPLETED|Overall Study||14
86987|NCT01185834|203377|P1|COMPLETED|Overall Study||104
86988|NCT01185834|203377|P1|STARTED|Overall Study||118
86989|NCT01185782|203384|P2|NOT COMPLETED|Overall Study||11
86990|NCT01185782|203385|P1|NOT COMPLETED|Overall Study||6
86991|NCT01185782|203384|P2|COMPLETED|Overall Study||125
86992|NCT01185782|203385|P1|COMPLETED|Overall Study||123
86993|NCT01185782|203384|P2|Treated|Overall Study||132
86994|NCT01185782|203385|P1|Treated|Overall Study||129
86995|NCT01185782|203384|P2|STARTED|Overall Study||136
86996|NCT01185782|203385|P1|STARTED|Overall Study||129
86997|NCT01185704|203413|P2|NOT COMPLETED|Overall Study||8
86998|NCT01185704|203414|P1|NOT COMPLETED|Overall Study||13
86999|NCT01185704|203413|P2|COMPLETED|Overall Study||60
87000|NCT01185704|203414|P1|COMPLETED|Overall Study||55
87001|NCT01185704|203413|P2|Treated|Overall Study||65
87002|NCT01185704|203414|P1|Treated|Overall Study||65
87003|NCT01185704|203413|P2|STARTED|Overall Study||68
87004|NCT01185704|203414|P1|STARTED|Overall Study||68
87005|NCT01185600|203450|P2|NOT COMPLETED|Overall Study||45
87006|NCT01185600|203451|P1|NOT COMPLETED|Overall Study||32
87007|NCT01185600|203450|P2|COMPLETED|Overall Study||59
87008|NCT01185600|203451|P1|COMPLETED|Overall Study||41
87009|NCT01185600|203450|P2|STARTED|Overall Study||104
87010|NCT01185600|203451|P1|STARTED|Overall Study||73
87011|NCT01185561|203473|P2|NOT COMPLETED|Overall Study||12
87012|NCT01185561|203474|P1|NOT COMPLETED|Overall Study||2
87013|NCT01185561|203473|P2|COMPLETED|Overall Study||26
87014|NCT01185561|203474|P1|COMPLETED|Overall Study||34
87015|NCT01185561|203473|P2|STARTED|Overall Study||38
87016|NCT01185561|203474|P1|STARTED|Overall Study||36
87017|NCT01185522|203486|P1|NOT COMPLETED|Overall Study||108
87018|NCT01185522|203486|P1|COMPLETED|Overall Study||585
87019|NCT01185522|203486|P1|STARTED|Overall Study||693
87020|NCT01185301|203514|P4|NOT COMPLETED|Overall Study||9
87021|NCT01185301|203515|P3|NOT COMPLETED|Overall Study||6
87022|NCT01185301|203516|P2|NOT COMPLETED|Overall Study||7
87023|NCT01185301|203517|P1|NOT COMPLETED|Overall Study||15
87024|NCT01185301|203514|P4|COMPLETED|Overall Study||89
87025|NCT01185301|203515|P3|COMPLETED|Overall Study||93
87026|NCT01185301|203516|P2|COMPLETED|Overall Study||93
87027|NCT01185301|203517|P1|COMPLETED|Overall Study||83
87028|NCT01185301|203514|P4|STARTED|Overall Study||98
87029|NCT01185301|203515|P3|STARTED|Overall Study||99
87030|NCT01185301|203516|P2|STARTED|Overall Study||100
87031|NCT01185301|203517|P1|STARTED|Overall Study||98
87032|NCT01185288|203577|P2|NOT COMPLETED|Overall Study||16
87033|NCT01185288|203578|P1|NOT COMPLETED|Overall Study||19
87034|NCT01185288|203577|P2|COMPLETED|Overall Study||139
87035|NCT01185288|203578|P1|COMPLETED|Overall Study||135
87036|NCT01185288|203577|P2|STARTED|Overall Study||155
87037|NCT01185288|203578|P1|STARTED|Overall Study||154
87038|NCT01185249|203596|P1|NOT COMPLETED|Overall Study||42
87039|NCT01185249|203596|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
87040|NCT01185249|203596|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
87041|NCT01185080|203604|P3|NOT COMPLETED|Overall Study||1
87042|NCT01185080|203605|P2|NOT COMPLETED|Overall Study||1
87043|NCT01185080|203606|P1|NOT COMPLETED|Overall Study||1
87044|NCT01185080|203604|P3|COMPLETED|Overall Study||16
87045|NCT01185080|203605|P2|COMPLETED|Overall Study||15
87046|NCT01185080|203606|P1|COMPLETED|Overall Study||49
87047|NCT01185080|203604|P3|STARTED|Overall Study||17
87048|NCT01185080|203605|P2|STARTED|Overall Study||16
87049|NCT01185080|203606|P1|STARTED|Overall Study||50
87050|NCT01185028|203653|P1|NOT COMPLETED|Overall Study||4
87051|NCT01185028|203653|P1|COMPLETED|Overall Study||4
87052|NCT01185028|203653|P1|STARTED|Overall Study||8
87053|NCT01184989|203658|P1|NOT COMPLETED|Overall Study||12
87054|NCT01184989|203658|P1|COMPLETED|Overall Study||100
87055|NCT01184989|203658|P1|STARTED|Overall Study|Treated Patients|112
87056|NCT01184898|203664|P1|NOT COMPLETED|Overall Study||0
87057|NCT01184898|203664|P1|COMPLETED|Overall Study||36
87058|NCT01184898|203664|P1|STARTED|Overall Study||36
87059|NCT01184885|203671|P1|NOT COMPLETED|Overall Study||0
87060|NCT01184885|203671|P1|COMPLETED|Overall Study||7
87061|NCT01184885|203671|P1|STARTED|Overall Study||7
87062|NCT01184872|203678|P2|NOT COMPLETED|Overall Study||8
87063|NCT01184872|203679|P1|NOT COMPLETED|Overall Study||10
87064|NCT01184872|203678|P2|COMPLETED|Overall Study||31
87065|NCT01184872|203679|P1|COMPLETED|Overall Study||71
87066|NCT01184872|203678|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
87067|NCT01184872|203679|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
87068|NCT01184872|203678|P2|Clinical Evaluable Set (CES)|Overall Study||30
87069|NCT01184872|203679|P1|Clinical Evaluable Set (CES)|Overall Study||73
87070|NCT01184872|203678|P2|Safety Set|Overall Study||40
87071|NCT01184872|203679|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
87072|NCT01184872|203678|P2|STARTED|Overall Study||39
87073|NCT01184872|203679|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
87074|NCT01184859|203698|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
87075|NCT01184859|203699|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
87076|NCT01184859|203700|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
87077|NCT01184859|203701|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
87078|NCT01184859|203702|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
87079|NCT01184859|203698|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
87080|NCT01184859|203699|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
87081|NCT01184859|203700|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
87082|NCT01184859|203701|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
87083|NCT01184859|203702|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
87084|NCT01184859|203698|P5|STARTED|Period 2: Daily Dose for 28 Days||23
87085|NCT01184859|203699|P4|STARTED|Period 2: Daily Dose for 28 Days||22
87086|NCT01184859|203700|P3|STARTED|Period 2: Daily Dose for 28 Days||22
87087|NCT01184859|203701|P2|STARTED|Period 2: Daily Dose for 28 Days||23
87088|NCT01184859|203702|P1|STARTED|Period 2: Daily Dose for 28 Days||23
87089|NCT01184859|203698|P5|NOT COMPLETED|Washout Period||0
87090|NCT01184859|203699|P4|NOT COMPLETED|Washout Period||0
87091|NCT01184859|203700|P3|NOT COMPLETED|Washout Period||0
87092|NCT01184859|203701|P2|NOT COMPLETED|Washout Period||0
87093|NCT01184859|203702|P1|NOT COMPLETED|Washout Period||0
87094|NCT01184859|203698|P5|COMPLETED|Washout Period||23
87095|NCT01184859|203699|P4|COMPLETED|Washout Period||22
87096|NCT01184859|203700|P3|COMPLETED|Washout Period||22
87097|NCT01184859|203701|P2|COMPLETED|Washout Period||23
87098|NCT01184859|203702|P1|COMPLETED|Washout Period||23
87099|NCT01184859|203698|P5|STARTED|Washout Period||23
87100|NCT01184859|203699|P4|STARTED|Washout Period||22
87101|NCT01184859|203700|P3|STARTED|Washout Period||22
87102|NCT01184859|203701|P2|STARTED|Washout Period||23
87103|NCT01184859|203702|P1|STARTED|Washout Period||23
87104|NCT01184859|203698|P5|NOT COMPLETED|Period 1: Single Dose||1
87105|NCT01184859|203699|P4|NOT COMPLETED|Period 1: Single Dose||0
87106|NCT01184859|203700|P3|NOT COMPLETED|Period 1: Single Dose||0
87107|NCT01184859|203701|P2|NOT COMPLETED|Period 1: Single Dose||2
87108|NCT01184859|203702|P1|NOT COMPLETED|Period 1: Single Dose||0
87109|NCT01184859|203698|P5|COMPLETED|Period 1: Single Dose||23
87110|NCT01184859|203699|P4|COMPLETED|Period 1: Single Dose||22
87111|NCT01184859|203700|P3|COMPLETED|Period 1: Single Dose||22
87112|NCT01184859|203701|P2|COMPLETED|Period 1: Single Dose||23
87113|NCT01184859|203702|P1|COMPLETED|Period 1: Single Dose||23
87114|NCT01184859|203698|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
87115|NCT01184859|203699|P4|Per Protocol (PP)|Period 1: Single Dose||21
87116|NCT01184859|203700|P3|Per Protocol (PP)|Period 1: Single Dose||22
87117|NCT01184859|203701|P2|Per Protocol (PP)|Period 1: Single Dose||23
87118|NCT01184859|203702|P1|Per Protocol (PP)|Period 1: Single Dose||23
87119|NCT01184859|203698|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
87120|NCT01184859|203699|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
87121|NCT01184859|203700|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
87122|NCT01184859|203701|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
87123|NCT01184859|203702|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
87124|NCT01184859|203698|P5|STARTED|Period 1: Single Dose||24
87125|NCT01184859|203699|P4|STARTED|Period 1: Single Dose||22
87126|NCT01184859|203700|P3|STARTED|Period 1: Single Dose||22
87127|NCT01184859|203701|P2|STARTED|Period 1: Single Dose||25
87128|NCT01184859|203702|P1|STARTED|Period 1: Single Dose||23
87129|NCT01184846|203794|P1|NOT COMPLETED|Overall Study||3
87130|NCT01184846|203794|P1|COMPLETED|Overall Study||25
87131|NCT01184846|203794|P1|STARTED|Overall Study||28
87132|NCT01184417|203814|P2|NOT COMPLETED|Overall Study||0
87133|NCT01184417|203815|P1|NOT COMPLETED|Overall Study||0
87134|NCT01184417|203814|P2|COMPLETED|Overall Study||51
87135|NCT01184417|203815|P1|COMPLETED|Overall Study||51
87136|NCT01184417|203814|P2|STARTED|Overall Study||51
87137|NCT01184417|203815|P1|STARTED|Overall Study||51
87138|NCT01184118|203835|P1|NOT COMPLETED|Overall Study||18
87139|NCT01184118|203835|P1|COMPLETED|Overall Study||18
87140|NCT01184118|203835|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
87141|NCT01184118|203835|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
87142|NCT01184118|203835|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
87143|NCT01184118|203835|P1|STARTED|Overall Study||36
87144|NCT01184079|203843|P2|NOT COMPLETED|Overall Study||2
87145|NCT01184079|203844|P1|NOT COMPLETED|Overall Study||14
87146|NCT01184079|203843|P2|COMPLETED|Overall Study||107
87147|NCT01184079|203844|P1|COMPLETED|Overall Study||97
87148|NCT01184079|203843|P2|Final Blood Draw|Overall Study||107
87149|NCT01184079|203844|P1|Final Blood Draw|Overall Study||97
87150|NCT01184079|203843|P2|Dose 3|Overall Study||107
87151|NCT01184079|203844|P1|Dose 3|Overall Study||101
87152|NCT01184079|203843|P2|Dose 2|Overall Study||108
87153|NCT01184079|203844|P1|Dose 2|Overall Study||110
87154|NCT01184079|203843|P2|STARTED|Overall Study||109
87155|NCT01184079|203844|P1|STARTED|Overall Study||111
87156|NCT01184014|203856|P2|NOT COMPLETED|Overall Study||6
87157|NCT01184014|203857|P1|NOT COMPLETED|Overall Study||5
87158|NCT01184014|203856|P2|COMPLETED|Overall Study||31
87159|NCT01184014|203857|P1|COMPLETED|Overall Study||30
87160|NCT01184014|203856|P2|STARTED|Overall Study||37
87161|NCT01184014|203857|P1|STARTED|Overall Study||35
87162|NCT01183975|203863|P1|NOT COMPLETED|Overall Study||73
87163|NCT01183975|203863|P1|COMPLETED|Overall Study||444
87164|NCT01183975|203863|P1|STARTED|Overall Study||517
87165|NCT01183858|203870|P2|NOT COMPLETED|Overall Study||156
87166|NCT01183858|203871|P1|NOT COMPLETED|Overall Study||153
87167|NCT01183858|203870|P2|COMPLETED|Overall Study||3
87168|NCT01183858|203871|P1|COMPLETED|Overall Study||1
87169|NCT01183858|203870|P2|Safety Population|Overall Study||158
87170|NCT01183858|203871|P1|Safety Population|Overall Study||154
87171|NCT01183858|203870|P2|STARTED|Overall Study||159
87172|NCT01183858|203871|P1|STARTED|Overall Study||154
87173|NCT01183780|203893|P2|NOT COMPLETED|Overall Study||40
87174|NCT01183780|203894|P1|NOT COMPLETED|Overall Study||43
87175|NCT01183780|203893|P2|COMPLETED|Overall Study||496
87176|NCT01183780|203894|P1|COMPLETED|Overall Study||493
87177|NCT01183780|203893|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
87178|NCT01183780|203894|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
87179|NCT01183780|203893|P2|STARTED|Overall Study||536
87180|NCT01183780|203894|P1|STARTED|Overall Study||536
87181|NCT01183728|203911|P1|NOT COMPLETED|Overall Study||0
87182|NCT01183728|203911|P1|COMPLETED|Overall Study||12
87183|NCT01183728|203911|P1|STARTED|Overall Study||12
87184|NCT01183650|203918|P2|NOT COMPLETED|Overall Study||0
87185|NCT01183650|203919|P1|NOT COMPLETED|Overall Study||0
87186|NCT01183650|203918|P2|COMPLETED|Overall Study||12
87187|NCT01183650|203919|P1|COMPLETED|Overall Study||12
87188|NCT01183650|203918|P2|STARTED|Overall Study||12
87189|NCT01183650|203919|P1|STARTED|Overall Study||12
87190|NCT01183546|203929|P1|NOT COMPLETED|Overall Study||0
87191|NCT01183546|203929|P1|COMPLETED|Overall Study||53
87192|NCT01183546|203929|P1|STARTED|Overall Study||53
87193|NCT01183533|203936|P1|NOT COMPLETED|Overall Study||0
87194|NCT01183533|203936|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
87195|NCT01183533|203936|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
87196|NCT01183481|203942|P1|NOT COMPLETED|Overall Study||0
87197|NCT01183481|203942|P1|COMPLETED|Overall Study||19
87198|NCT01183481|203942|P1|STARTED|Overall Study||19
87199|NCT01183468|203954|P4|NOT COMPLETED|Overall Study||0
87200|NCT01183468|203955|P3|NOT COMPLETED|Overall Study||0
87201|NCT01183468|203956|P2|NOT COMPLETED|Overall Study||2
87202|NCT01183468|203957|P1|NOT COMPLETED|Overall Study||3
87203|NCT01183468|203954|P4|COMPLETED|Overall Study||0
87204|NCT01183468|203955|P3|COMPLETED|Overall Study||0
87205|NCT01183468|203956|P2|COMPLETED|Overall Study||7
87206|NCT01183468|203957|P1|COMPLETED|Overall Study||5
87207|NCT01183468|203954|P4|STARTED|Overall Study||0
87208|NCT01183468|203955|P3|STARTED|Overall Study||0
87209|NCT01183468|203956|P2|STARTED|Overall Study||9
87210|NCT01183468|203957|P1|STARTED|Overall Study||8
87211|NCT01183390|203967|P2|NOT COMPLETED|Second Intervention||0
87212|NCT01183390|203968|P1|NOT COMPLETED|Second Intervention||0
87213|NCT01183390|203967|P2|COMPLETED|Second Intervention||10
87214|NCT01183390|203968|P1|COMPLETED|Second Intervention||11
87215|NCT01183390|203967|P2|STARTED|Second Intervention||10
87216|NCT01183390|203968|P1|STARTED|Second Intervention||11
87217|NCT01183390|203967|P2|NOT COMPLETED|Washout of 21 Days||0
87218|NCT01183390|203968|P1|NOT COMPLETED|Washout of 21 Days||0
87219|NCT01183390|203967|P2|COMPLETED|Washout of 21 Days||10
87220|NCT01183390|203968|P1|COMPLETED|Washout of 21 Days||11
87221|NCT01183390|203967|P2|STARTED|Washout of 21 Days||10
87222|NCT01183390|203968|P1|STARTED|Washout of 21 Days||11
87223|NCT01183390|203967|P2|NOT COMPLETED|First Intervention||1
87224|NCT01183390|203968|P1|NOT COMPLETED|First Intervention||0
87225|NCT01183390|203967|P2|COMPLETED|First Intervention||10
87226|NCT01183390|203968|P1|COMPLETED|First Intervention||11
87227|NCT01183390|203967|P2|STARTED|First Intervention||11
87228|NCT01183390|203968|P1|STARTED|First Intervention||11
87229|NCT01183312|203978|P2|NOT COMPLETED|Second Intervention Day||0
87230|NCT01183312|203979|P1|NOT COMPLETED|Second Intervention Day||0
87231|NCT01183312|203978|P2|COMPLETED|Second Intervention Day||5
87232|NCT01183312|203979|P1|COMPLETED|Second Intervention Day||5
87233|NCT01183312|203978|P2|STARTED|Second Intervention Day||5
87234|NCT01183312|203979|P1|STARTED|Second Intervention Day||5
87235|NCT01183312|203978|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
87236|NCT01183312|203979|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
87237|NCT01183312|203978|P2|COMPLETED|Washout Period of at Least 1 Week||5
87238|NCT01183312|203979|P1|COMPLETED|Washout Period of at Least 1 Week||5
87239|NCT01183312|203978|P2|STARTED|Washout Period of at Least 1 Week||5
87240|NCT01183312|203979|P1|STARTED|Washout Period of at Least 1 Week||5
87241|NCT01183312|203978|P2|NOT COMPLETED|First Intervention Day||0
87242|NCT01183312|203979|P1|NOT COMPLETED|First Intervention Day||0
87243|NCT01183312|203978|P2|COMPLETED|First Intervention Day||5
87244|NCT01183312|203979|P1|COMPLETED|First Intervention Day||5
87245|NCT01183312|203978|P2|STARTED|First Intervention Day||5
87246|NCT01183312|203979|P1|STARTED|First Intervention Day||5
87247|NCT01183234|203999|P2|NOT COMPLETED|Second Intervention||0
87248|NCT01183234|204000|P1|NOT COMPLETED|Second Intervention||0
87249|NCT01183234|203999|P2|COMPLETED|Second Intervention||14
87250|NCT01183234|204000|P1|COMPLETED|Second Intervention||13
87251|NCT01183234|203999|P2|STARTED|Second Intervention||14
87252|NCT01183234|204000|P1|STARTED|Second Intervention||13
87253|NCT01183234|203999|P2|NOT COMPLETED|Washout||0
87254|NCT01183234|204000|P1|NOT COMPLETED|Washout||0
87255|NCT01183234|203999|P2|COMPLETED|Washout||14
87256|NCT01183234|204000|P1|COMPLETED|Washout||13
87257|NCT01183234|203999|P2|STARTED|Washout||14
87258|NCT01183234|204000|P1|STARTED|Washout||13
87259|NCT01183234|203999|P2|NOT COMPLETED|First Intervention||0
87260|NCT01183234|204000|P1|NOT COMPLETED|First Intervention||1
87261|NCT01183234|203999|P2|COMPLETED|First Intervention||14
87262|NCT01183234|204000|P1|COMPLETED|First Intervention||13
87263|NCT01183234|203999|P2|STARTED|First Intervention||14
87264|NCT01183234|204000|P1|STARTED|First Intervention||14
87265|NCT01183169|204014|P7|NOT COMPLETED|Post-switch Phase||9
87266|NCT01183169|204015|P6|NOT COMPLETED|Post-switch Phase||14
87267|NCT01183169|204016|P5|NOT COMPLETED|Post-switch Phase||0
87268|NCT01183169|204017|P4|NOT COMPLETED|Post-switch Phase||0
87269|NCT01183169|204018|P3|NOT COMPLETED|Post-switch Phase||0
87270|NCT01183169|204019|P2|NOT COMPLETED|Post-switch Phase||0
87271|NCT01183169|204020|P1|NOT COMPLETED|Post-switch Phase||0
87272|NCT01183169|204014|P7|COMPLETED|Post-switch Phase||21
87273|NCT01183169|204015|P6|COMPLETED|Post-switch Phase||21
87274|NCT01183169|204016|P5|COMPLETED|Post-switch Phase||0
87275|NCT01183169|204017|P4|COMPLETED|Post-switch Phase||0
87276|NCT01183169|204018|P3|COMPLETED|Post-switch Phase||0
87277|NCT01183169|204019|P2|COMPLETED|Post-switch Phase||0
87278|NCT01183169|204020|P1|COMPLETED|Post-switch Phase||0
87279|NCT01183169|204014|P7|Completed Treatment|Post-switch Phase||13
87280|NCT01183169|204015|P6|Completed Treatment|Post-switch Phase||12
87281|NCT01183169|204016|P5|Completed Treatment|Post-switch Phase||0
87282|NCT01183169|204017|P4|Completed Treatment|Post-switch Phase||0
87283|NCT01183169|204018|P3|Completed Treatment|Post-switch Phase||0
87284|NCT01183169|204019|P2|Completed Treatment|Post-switch Phase||0
87285|NCT01183169|204020|P1|Completed Treatment|Post-switch Phase||0
87286|NCT01183169|204014|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
87374|NCT01182480|204227|P1|COMPLETED|Overall Study||47
87287|NCT01183169|204015|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
87288|NCT01183169|204016|P5|STARTED|Post-switch Phase|Not a post-switch group|0
87289|NCT01183169|204017|P4|STARTED|Post-switch Phase|Not a post-switch group|0
87290|NCT01183169|204018|P3|STARTED|Post-switch Phase|Not a post-switch group|0
87291|NCT01183169|204019|P2|STARTED|Post-switch Phase|Not a post-switch group|0
87292|NCT01183169|204020|P1|STARTED|Post-switch Phase|Not a post-switch group|0
87293|NCT01183169|204014|P7|NOT COMPLETED|Main Phase||0
87294|NCT01183169|204015|P6|NOT COMPLETED|Main Phase||0
87295|NCT01183169|204016|P5|NOT COMPLETED|Main Phase||26
87296|NCT01183169|204017|P4|NOT COMPLETED|Main Phase||37
87297|NCT01183169|204018|P3|NOT COMPLETED|Main Phase||41
87298|NCT01183169|204019|P2|NOT COMPLETED|Main Phase||22
87299|NCT01183169|204020|P1|NOT COMPLETED|Main Phase||27
87300|NCT01183169|204014|P7|COMPLETED|Main Phase||0
87301|NCT01183169|204015|P6|COMPLETED|Main Phase||0
87302|NCT01183169|204016|P5|COMPLETED|Main Phase||83
87303|NCT01183169|204017|P4|COMPLETED|Main Phase||18
87304|NCT01183169|204018|P3|COMPLETED|Main Phase||18
87305|NCT01183169|204019|P2|COMPLETED|Main Phase||93
87306|NCT01183169|204020|P1|COMPLETED|Main Phase||94
87307|NCT01183169|204014|P7|Switched to ALV|Main Phase||0
87308|NCT01183169|204015|P6|Switched to ALV|Main Phase||0
87309|NCT01183169|204016|P5|Switched to ALV|Main Phase||0
87310|NCT01183169|204017|P4|Switched to ALV|Main Phase||30
87311|NCT01183169|204018|P3|Switched to ALV|Main Phase||35
87312|NCT01183169|204019|P2|Switched to ALV|Main Phase||0
87313|NCT01183169|204020|P1|Switched to ALV|Main Phase||0
87314|NCT01183169|204014|P7|Completed Treatment|Main Phase||0
87315|NCT01183169|204015|P6|Completed Treatment|Main Phase||0
87316|NCT01183169|204016|P5|Completed Treatment|Main Phase||77
87317|NCT01183169|204017|P4|Completed Treatment|Main Phase||17
87318|NCT01183169|204018|P3|Completed Treatment|Main Phase||17
87319|NCT01183169|204019|P2|Completed Treatment|Main Phase||78
87320|NCT01183169|204020|P1|Completed Treatment|Main Phase||72
87321|NCT01183169|204014|P7|STARTED|Main Phase||0
87322|NCT01183169|204015|P6|STARTED|Main Phase||0
87323|NCT01183169|204016|P5|STARTED|Main Phase||109
87324|NCT01183169|204017|P4|STARTED|Main Phase||55
87325|NCT01183169|204018|P3|STARTED|Main Phase||59
87326|NCT01183169|204019|P2|STARTED|Main Phase||115
87327|NCT01183169|204020|P1|STARTED|Main Phase||121
87328|NCT01183065|204092|P1|NOT COMPLETED|Overall Study||1
87329|NCT01183065|204092|P1|COMPLETED|Overall Study||12
87330|NCT01183065|204092|P1|STARTED|Overall Study||13
87331|NCT01183013|204103|P7|NOT COMPLETED|Overall Study||37
87332|NCT01183013|204104|P6|NOT COMPLETED|Overall Study||45
87333|NCT01183013|204105|P5|NOT COMPLETED|Overall Study||36
87334|NCT01183013|204106|P4|NOT COMPLETED|Overall Study||30
87335|NCT01183013|204107|P3|NOT COMPLETED|Overall Study||41
87336|NCT01183013|204108|P2|NOT COMPLETED|Overall Study||39
87337|NCT01183013|204109|P1|NOT COMPLETED|Overall Study||45
87338|NCT01183013|204103|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
87339|NCT01183013|204104|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
87340|NCT01183013|204105|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
87341|NCT01183013|204106|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
87342|NCT01183013|204107|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
87343|NCT01183013|204108|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
87344|NCT01183013|204109|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
87345|NCT01183013|204103|P7|STARTED|Overall Study||133
87346|NCT01183013|204104|P6|STARTED|Overall Study||133
87347|NCT01183013|204105|P5|STARTED|Overall Study||126
87348|NCT01183013|204106|P4|STARTED|Overall Study||135
87349|NCT01183013|204107|P3|STARTED|Overall Study||138
87350|NCT01183013|204108|P2|STARTED|Overall Study||140
87351|NCT01183013|204109|P1|STARTED|Overall Study||131
87352|NCT01182805|204188|P1|NOT COMPLETED|Overall Study||0
87353|NCT01182805|204188|P1|COMPLETED|Overall Study||50
87354|NCT01182805|204188|P1|STARTED|Overall Study||50
87355|NCT01182727|204197|P1|NOT COMPLETED|Overall Study||0
87356|NCT01182727|204197|P1|COMPLETED|Overall Study||10
87357|NCT01182727|204197|P1|STARTED|Overall Study||10
87358|NCT01182675|204203|P2|NOT COMPLETED|Overall Study||0
87359|NCT01182675|204204|P1|NOT COMPLETED|Overall Study||0
87360|NCT01182675|204203|P2|COMPLETED|Overall Study||0
87361|NCT01182675|204204|P1|COMPLETED|Overall Study||7
87362|NCT01182675|204203|P2|STARTED|Overall Study||0
87363|NCT01182675|204204|P1|STARTED|Overall Study||7
87364|NCT01182610|204210|P1|NOT COMPLETED|Overall Study||0
87365|NCT01182610|204210|P1|COMPLETED|Overall Study||1
87366|NCT01182610|204210|P1|STARTED|Overall Study||1
87367|NCT01182493|204220|P2|NOT COMPLETED|Overall Study||7
87368|NCT01182493|204221|P1|NOT COMPLETED|Overall Study||16
87369|NCT01182493|204220|P2|COMPLETED|Overall Study||156
87370|NCT01182493|204221|P1|COMPLETED|Overall Study||152
87371|NCT01182493|204220|P2|STARTED|Overall Study||163
87372|NCT01182493|204221|P1|STARTED|Overall Study||168
87373|NCT01182480|204227|P1|NOT COMPLETED|Overall Study||0
87375|NCT01182480|204227|P1|STARTED|Overall Study||47
87376|NCT01182428|204233|P2|NOT COMPLETED|Overall Study||1
87377|NCT01182428|204234|P1|NOT COMPLETED|Overall Study||11
87378|NCT01182428|204233|P2|COMPLETED|Overall Study||150
87379|NCT01182428|204234|P1|COMPLETED|Overall Study||293
87380|NCT01182428|204233|P2|STARTED|Overall Study||151
87381|NCT01182428|204234|P1|STARTED|Overall Study||304
87382|NCT01182376|204300|P2|NOT COMPLETED|Overall Study||5
87383|NCT01182376|204301|P1|NOT COMPLETED|Overall Study||11
87384|NCT01182376|204300|P2|COMPLETED|Overall Study||13
87385|NCT01182376|204301|P1|COMPLETED|Overall Study||4
87386|NCT01182376|204300|P2|STARTED|Overall Study||18
87387|NCT01182376|204301|P1|STARTED|Overall Study||15
87388|NCT01182337|204309|P2|NOT COMPLETED|Overall Study||2
87389|NCT01182337|204310|P1|NOT COMPLETED|Overall Study||3
87390|NCT01182337|204309|P2|COMPLETED|Overall Study||7
87391|NCT01182337|204310|P1|COMPLETED|Overall Study||19
87392|NCT01182337|204309|P2|STARTED|Overall Study||9
87393|NCT01182337|204310|P1|STARTED|Overall Study||22
87394|NCT01182298|204328|P1|NOT COMPLETED|Overall Study||6
87395|NCT01182298|204328|P1|COMPLETED|Overall Study||4
87396|NCT01182298|204328|P1|STARTED|Overall Study||10
87397|NCT01182285|204332|P3|NOT COMPLETED|Third Intervention Week 11-52||8
87398|NCT01182285|204333|P2|NOT COMPLETED|Third Intervention Week 11-52||0
87399|NCT01182285|204334|P1|NOT COMPLETED|Third Intervention Week 11-52||0
87400|NCT01182285|204332|P3|COMPLETED|Third Intervention Week 11-52||0
87401|NCT01182285|204333|P2|COMPLETED|Third Intervention Week 11-52||0
87402|NCT01182285|204334|P1|COMPLETED|Third Intervention Week 11-52||0
87403|NCT01182285|204332|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
87404|NCT01182285|204333|P2|STARTED|Third Intervention Week 11-52||0
87405|NCT01182285|204334|P1|STARTED|Third Intervention Week 11-52||0
87406|NCT01182285|204332|P3|NOT COMPLETED|Second Intervention Week 11-17||0
87407|NCT01182285|204333|P2|NOT COMPLETED|Second Intervention Week 11-17||0
87408|NCT01182285|204334|P1|NOT COMPLETED|Second Intervention Week 11-17||0
87409|NCT01182285|204332|P3|COMPLETED|Second Intervention Week 11-17||0
87410|NCT01182285|204333|P2|COMPLETED|Second Intervention Week 11-17||0
87411|NCT01182285|204334|P1|COMPLETED|Second Intervention Week 11-17||0
87412|NCT01182285|204332|P3|STARTED|Second Intervention Week 11-17||0
87413|NCT01182285|204333|P2|STARTED|Second Intervention Week 11-17||0
87414|NCT01182285|204334|P1|STARTED|Second Intervention Week 11-17||0
87415|NCT01182285|204332|P3|NOT COMPLETED|First Intervention Week 1-10||0
87416|NCT01182285|204333|P2|NOT COMPLETED|First Intervention Week 1-10||0
87417|NCT01182285|204334|P1|NOT COMPLETED|First Intervention Week 1-10||3
87418|NCT01182285|204332|P3|COMPLETED|First Intervention Week 1-10||0
87419|NCT01182285|204333|P2|COMPLETED|First Intervention Week 1-10||0
87420|NCT01182285|204334|P1|COMPLETED|First Intervention Week 1-10||10
87421|NCT01182285|204332|P3|STARTED|First Intervention Week 1-10||0
87422|NCT01182285|204333|P2|STARTED|First Intervention Week 1-10||0
87423|NCT01182285|204334|P1|STARTED|First Intervention Week 1-10||13
87424|NCT01182207|204344|P2|NOT COMPLETED|Second Intervention||0
87425|NCT01182207|204345|P1|NOT COMPLETED|Second Intervention||1
87426|NCT01182207|204344|P2|COMPLETED|Second Intervention||14
87427|NCT01182207|204345|P1|COMPLETED|Second Intervention||17
87428|NCT01182207|204344|P2|STARTED|Second Intervention||14
87429|NCT01182207|204345|P1|STARTED|Second Intervention||18
87430|NCT01182207|204344|P2|NOT COMPLETED|Washout of 28 Days||0
87431|NCT01182207|204345|P1|NOT COMPLETED|Washout of 28 Days||0
87432|NCT01182207|204344|P2|COMPLETED|Washout of 28 Days||14
87433|NCT01182207|204345|P1|COMPLETED|Washout of 28 Days||18
87434|NCT01182207|204344|P2|STARTED|Washout of 28 Days||14
87435|NCT01182207|204345|P1|STARTED|Washout of 28 Days||18
87436|NCT01182207|204344|P2|NOT COMPLETED|First Intervention||1
87437|NCT01182207|204345|P1|NOT COMPLETED|First Intervention||0
87438|NCT01182207|204344|P2|COMPLETED|First Intervention||14
87439|NCT01182207|204345|P1|COMPLETED|First Intervention||18
87440|NCT01182207|204344|P2|STARTED|First Intervention||15
87441|NCT01182207|204345|P1|STARTED|First Intervention||18
87442|NCT01182194|204363|P2|NOT COMPLETED|Second Intervention||0
87443|NCT01182194|204364|P1|NOT COMPLETED|Second Intervention||0
87444|NCT01182194|204363|P2|COMPLETED|Second Intervention||16
87445|NCT01182194|204364|P1|COMPLETED|Second Intervention||15
87446|NCT01182194|204363|P2|STARTED|Second Intervention||16
87447|NCT01182194|204364|P1|STARTED|Second Intervention||15
87448|NCT01182194|204363|P2|NOT COMPLETED|Washout of 28 Days||0
87449|NCT01182194|204364|P1|NOT COMPLETED|Washout of 28 Days||1
87450|NCT01182194|204363|P2|COMPLETED|Washout of 28 Days||16
87451|NCT01182194|204364|P1|COMPLETED|Washout of 28 Days||15
87452|NCT01182194|204363|P2|STARTED|Washout of 28 Days||16
87453|NCT01182194|204364|P1|STARTED|Washout of 28 Days||16
87454|NCT01182194|204363|P2|NOT COMPLETED|First Intervention||0
87455|NCT01182194|204364|P1|NOT COMPLETED|First Intervention||0
87456|NCT01182194|204363|P2|COMPLETED|First Intervention||16
87457|NCT01182194|204364|P1|COMPLETED|First Intervention||16
87458|NCT01182194|204363|P2|STARTED|First Intervention||16
87459|NCT01182194|204364|P1|STARTED|First Intervention||16
87460|NCT01182181|204382|P2|NOT COMPLETED|Second Intervention||0
87461|NCT01182181|204383|P1|NOT COMPLETED|Second Intervention||0
87462|NCT01182181|204382|P2|COMPLETED|Second Intervention||10
87463|NCT01182181|204383|P1|COMPLETED|Second Intervention||10
87464|NCT01182181|204382|P2|STARTED|Second Intervention||10
87465|NCT01182181|204383|P1|STARTED|Second Intervention||10
87466|NCT01182181|204382|P2|NOT COMPLETED|Washout of 21 Days||1
87467|NCT01182181|204383|P1|NOT COMPLETED|Washout of 21 Days||0
87468|NCT01182181|204382|P2|COMPLETED|Washout of 21 Days||10
87469|NCT01182181|204383|P1|COMPLETED|Washout of 21 Days||10
87470|NCT01182181|204382|P2|STARTED|Washout of 21 Days||11
87471|NCT01182181|204383|P1|STARTED|Washout of 21 Days||10
87472|NCT01182181|204382|P2|NOT COMPLETED|First Intervention||0
87473|NCT01182181|204383|P1|NOT COMPLETED|First Intervention||1
87474|NCT01182181|204382|P2|COMPLETED|First Intervention||11
87475|NCT01182181|204383|P1|COMPLETED|First Intervention||10
87476|NCT01182181|204382|P2|STARTED|First Intervention||11
87477|NCT01182181|204383|P1|STARTED|First Intervention||11
87478|NCT01182103|204393|P2|NOT COMPLETED|Overall Study||0
87479|NCT01182103|204394|P1|NOT COMPLETED|Overall Study||0
87480|NCT01182103|204393|P2|COMPLETED|Overall Study||62
87481|NCT01182103|204394|P1|COMPLETED|Overall Study||48
87482|NCT01182103|204393|P2|STARTED|Overall Study||62
87483|NCT01182103|204394|P1|STARTED|Overall Study||48
87484|NCT01181986|204408|P3|NOT COMPLETED|Phase 2||0
87485|NCT01181986|204409|P2|NOT COMPLETED|Phase 2||4
87486|NCT01181986|204410|P1|NOT COMPLETED|Phase 2||0
87487|NCT01181986|204408|P3|COMPLETED|Phase 2||0
87488|NCT01181986|204409|P2|COMPLETED|Phase 2||18
87489|NCT01181986|204410|P1|COMPLETED|Phase 2||18
87490|NCT01181986|204408|P3|STARTED|Phase 2|N/A for Sub-study 2|0
87491|NCT01181986|204409|P2|STARTED|Phase 2||22
87492|NCT01181986|204410|P1|STARTED|Phase 2||18
87493|NCT01181986|204408|P3|NOT COMPLETED|Phase 1||2
87494|NCT01181986|204409|P2|NOT COMPLETED|Phase 1||1
87495|NCT01181986|204410|P1|NOT COMPLETED|Phase 1||1
87496|NCT01181986|204408|P3|COMPLETED|Phase 1||32
87497|NCT01181986|204409|P2|COMPLETED|Phase 1||22
87498|NCT01181986|204410|P1|COMPLETED|Phase 1||18
87499|NCT01181986|204408|P3|Exendin-9+Exenatide|Phase 1||33
87500|NCT01181986|204409|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
87501|NCT01181986|204410|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
87502|NCT01181986|204408|P3|Saline+Placebo|Phase 1||33
87503|NCT01181986|204409|P2|Saline+Placebo|Phase 1|N/A for this arm|0
87504|NCT01181986|204410|P1|Saline+Placebo|Phase 1|N/A for this arm|0
87505|NCT01181986|204408|P3|Saline+Exenatide|Phase 1||32
87506|NCT01181986|204409|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
87507|NCT01181986|204410|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
87508|NCT01181986|204408|P3|STARTED|Phase 1||34
87509|NCT01181986|204409|P2|STARTED|Phase 1||23
87510|NCT01181986|204410|P1|STARTED|Phase 1||19
87511|NCT01181947|204426|P1|NOT COMPLETED|Overall Study||0
87512|NCT01181947|204426|P1|COMPLETED|Overall Study||100
87513|NCT01181947|204426|P1|STARTED|Overall Study||100
87514|NCT01181921|204431|P1|NOT COMPLETED|Overall Study||1
87515|NCT01181921|204431|P1|COMPLETED|Overall Study||0
87516|NCT01181921|204431|P1|STARTED|Overall Study||1
87517|NCT01181895|204438|P3|NOT COMPLETED|Overall Study||18
87518|NCT01181895|204439|P2|NOT COMPLETED|Overall Study||14
87519|NCT01181895|204440|P1|NOT COMPLETED|Overall Study||17
87520|NCT01181895|204438|P3|COMPLETED|Overall Study||98
87521|NCT01181895|204439|P2|COMPLETED|Overall Study||101
87522|NCT01181895|204440|P1|COMPLETED|Overall Study||99
87523|NCT01181895|204438|P3|STARTED|Overall Study||116
87524|NCT01181895|204439|P2|STARTED|Overall Study||115
87525|NCT01181895|204440|P1|STARTED|Overall Study||116
87526|NCT01181804|204473|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
87527|NCT01181804|204474|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
87528|NCT01181804|204475|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
87529|NCT01181804|204476|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
87530|NCT01181804|204473|P4|COMPLETED|Period 4, Fasted (Part 2)||58
87531|NCT01181804|204474|P3|COMPLETED|Period 4, Fasted (Part 2)||58
87532|NCT01181804|204475|P2|COMPLETED|Period 4, Fasted (Part 2)||0
87533|NCT01181804|204476|P1|COMPLETED|Period 4, Fasted (Part 2)||0
87534|NCT01181804|204473|P4|STARTED|Period 4, Fasted (Part 2)||58
87535|NCT01181804|204474|P3|STARTED|Period 4, Fasted (Part 2)||59
87536|NCT01181804|204475|P2|STARTED|Period 4, Fasted (Part 2)||0
87537|NCT01181804|204476|P1|STARTED|Period 4, Fasted (Part 2)||0
87538|NCT01181804|204473|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
87539|NCT01181804|204474|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
87540|NCT01181804|204475|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
87541|NCT01181804|204476|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
87542|NCT01181804|204473|P4|COMPLETED|Period 3, Fasted (Part 2)||58
87543|NCT01181804|204474|P3|COMPLETED|Period 3, Fasted (Part 2)||59
87544|NCT01181804|204475|P2|COMPLETED|Period 3, Fasted (Part 2)||0
87545|NCT01181804|204476|P1|COMPLETED|Period 3, Fasted (Part 2)||0
87546|NCT01181804|204473|P4|STARTED|Period 3, Fasted (Part 2)||58
87547|NCT01181804|204474|P3|STARTED|Period 3, Fasted (Part 2)||59
87548|NCT01181804|204475|P2|STARTED|Period 3, Fasted (Part 2)||0
87549|NCT01181804|204476|P1|STARTED|Period 3, Fasted (Part 2)||0
87550|NCT01181804|204473|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
87551|NCT01181804|204474|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
87552|NCT01181804|204475|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
87553|NCT01181804|204476|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
87554|NCT01181804|204473|P4|COMPLETED|Period 2, Fed (Part 1)||0
87555|NCT01181804|204474|P3|COMPLETED|Period 2, Fed (Part 1)||0
87556|NCT01181804|204475|P2|COMPLETED|Period 2, Fed (Part 1)||30
87557|NCT01181804|204476|P1|COMPLETED|Period 2, Fed (Part 1)||30
87558|NCT01181804|204473|P4|STARTED|Period 2, Fed (Part 1)||0
87559|NCT01181804|204474|P3|STARTED|Period 2, Fed (Part 1)||0
87560|NCT01181804|204475|P2|STARTED|Period 2, Fed (Part 1)||30
87561|NCT01181804|204476|P1|STARTED|Period 2, Fed (Part 1)||30
87562|NCT01181804|204473|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
87563|NCT01181804|204474|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
87564|NCT01181804|204475|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
87565|NCT01181804|204476|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
87566|NCT01181804|204473|P4|COMPLETED|Period 1, Fed (Part 1)||0
87567|NCT01181804|204474|P3|COMPLETED|Period 1, Fed (Part 1)||0
87568|NCT01181804|204475|P2|COMPLETED|Period 1, Fed (Part 1)||30
87569|NCT01181804|204476|P1|COMPLETED|Period 1, Fed (Part 1)||30
87570|NCT01181804|204473|P4|STARTED|Period 1, Fed (Part 1)||0
87571|NCT01181804|204474|P3|STARTED|Period 1, Fed (Part 1)||0
87572|NCT01181804|204475|P2|STARTED|Period 1, Fed (Part 1)||30
87573|NCT01181804|204476|P1|STARTED|Period 1, Fed (Part 1)||30
87574|NCT01181778|204498|P1|NOT COMPLETED|Overall Study||48
87575|NCT01181778|204498|P1|COMPLETED|Overall Study||1871
87576|NCT01181778|204498|P1|STARTED|Overall Study||1919
87577|NCT01181726|204506|P2|NOT COMPLETED|Second Intervention||0
87578|NCT01181726|204507|P1|NOT COMPLETED|Second Intervention||0
87579|NCT01181726|204506|P2|COMPLETED|Second Intervention||20
87580|NCT01181726|204507|P1|COMPLETED|Second Intervention||19
87581|NCT01181726|204506|P2|STARTED|Second Intervention||20
87582|NCT01181726|204507|P1|STARTED|Second Intervention||19
87583|NCT01181726|204506|P2|NOT COMPLETED|Washout of 28 Days||0
87584|NCT01181726|204507|P1|NOT COMPLETED|Washout of 28 Days||0
87585|NCT01181726|204506|P2|COMPLETED|Washout of 28 Days||20
87586|NCT01181726|204507|P1|COMPLETED|Washout of 28 Days||19
87587|NCT01181726|204506|P2|STARTED|Washout of 28 Days||20
87588|NCT01181726|204507|P1|STARTED|Washout of 28 Days||19
87589|NCT01181726|204506|P2|NOT COMPLETED|First Intervention||0
87590|NCT01181726|204507|P1|NOT COMPLETED|First Intervention||1
87591|NCT01181726|204506|P2|COMPLETED|First Intervention||20
87592|NCT01181726|204507|P1|COMPLETED|First Intervention||19
87593|NCT01181726|204506|P2|STARTED|First Intervention||20
87594|NCT01181726|204507|P1|STARTED|First Intervention||20
87595|NCT01181609|204553|P1|NOT COMPLETED|Overall Study||53
87596|NCT01181609|204553|P1|COMPLETED|Overall Study||1
87597|NCT01181609|204553|P1|STARTED|Overall Study||54
87598|NCT01181531|204566|P2|NOT COMPLETED|Overall Study||53
87599|NCT01181531|204567|P1|NOT COMPLETED|Overall Study||61
87600|NCT01181531|204566|P2|COMPLETED|Overall Study||102
87601|NCT01181531|204567|P1|COMPLETED|Overall Study||96
87602|NCT01181531|204566|P2|Received Investigational Product|Overall Study||153
87603|NCT01181531|204567|P1|Received Investigational Product|Overall Study||155
87604|NCT01181531|204566|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
87605|NCT01181531|204567|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
87606|NCT01181492|204580|P3|NOT COMPLETED|Overall Study||0
87607|NCT01181492|204581|P2|NOT COMPLETED|Overall Study||0
87608|NCT01181492|204582|P1|NOT COMPLETED|Overall Study||0
87609|NCT01181492|204580|P3|COMPLETED|Overall Study||7
87610|NCT01181492|204581|P2|COMPLETED|Overall Study||66
87611|NCT01181492|204582|P1|COMPLETED|Overall Study||103
87612|NCT01181492|204580|P3|STARTED|Overall Study||7
87613|NCT01181492|204581|P2|STARTED|Overall Study||66
87614|NCT01181492|204582|P1|STARTED|Overall Study||103
87615|NCT01181349|204596|P1|NOT COMPLETED|Overall Study||0
87616|NCT01181349|204596|P1|COMPLETED|Overall Study||350
87617|NCT01181349|204596|P1|STARTED|Overall Study||350
87618|NCT01181323|204612|P4|NOT COMPLETED|Overall Study||3
87619|NCT01181323|204613|P3|NOT COMPLETED|Overall Study||1
87620|NCT01181323|204614|P2|NOT COMPLETED|Overall Study||3
87621|NCT01181323|204615|P1|NOT COMPLETED|Overall Study||1
87622|NCT01181323|204612|P4|COMPLETED|Overall Study||122
87623|NCT01181323|204613|P3|COMPLETED|Overall Study||123
87624|NCT01181323|204614|P2|COMPLETED|Overall Study||121
87625|NCT01181323|204615|P1|COMPLETED|Overall Study||123
87626|NCT01181323|204612|P4|STARTED|Overall Study||125
87627|NCT01181323|204613|P3|STARTED|Overall Study||124
87628|NCT01181323|204614|P2|STARTED|Overall Study||124
87629|NCT01181323|204615|P1|STARTED|Overall Study||124
87630|NCT01181167|204692|P2|NOT COMPLETED|Overall Study||32
87631|NCT01181167|204693|P1|NOT COMPLETED|Overall Study||23
87632|NCT01181167|204692|P2|COMPLETED|Overall Study||271
87633|NCT01181167|204693|P1|COMPLETED|Overall Study||284
87634|NCT01181167|204692|P2|Efficacy Analysis Population|Overall Study||248
87635|NCT01181167|204693|P1|Efficacy Analysis Population|Overall Study||255
87636|NCT01181167|204692|P2|STARTED|Overall Study||303
87637|NCT01181167|204693|P1|STARTED|Overall Study||307
87638|NCT01181141|204703|P2|NOT COMPLETED|Overall Study||4
87639|NCT01181141|204704|P1|NOT COMPLETED|Overall Study||12
87640|NCT01181141|204703|P2|COMPLETED|Overall Study||26
87641|NCT01181141|204704|P1|COMPLETED|Overall Study||50
87642|NCT01181141|204703|P2|Safety Analysis Population|Overall Study||29
87643|NCT01181141|204704|P1|Safety Analysis Population|Overall Study||59
87644|NCT01181141|204703|P2|STARTED|Overall Study||30
87645|NCT01181141|204704|P1|STARTED|Overall Study||62
87646|NCT01181128|204713|P3|NOT COMPLETED|Overall Study||1
87647|NCT01181128|204714|P2|NOT COMPLETED|Overall Study||5
87648|NCT01181128|204715|P1|NOT COMPLETED|Overall Study||6
87649|NCT01181128|204713|P3|COMPLETED|Overall Study||22
87650|NCT01181128|204714|P2|COMPLETED|Overall Study||19
87651|NCT01181128|204715|P1|COMPLETED|Overall Study||112
87652|NCT01181128|204713|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
87653|NCT01181128|204714|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
87654|NCT01181128|204715|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
87655|NCT01181128|204713|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
87656|NCT01181128|204714|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
87657|NCT01181128|204715|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
87658|NCT01181128|204713|P3|STARTED|Overall Study||23
87659|NCT01181128|204714|P2|STARTED|Overall Study||24
87660|NCT01181128|204715|P1|STARTED|Overall Study||118
87661|NCT01181102|204803|P2|NOT COMPLETED|Overall Study||46
87662|NCT01181102|204804|P1|NOT COMPLETED|Overall Study||51
87663|NCT01181102|204803|P2|COMPLETED|Overall Study||310
87664|NCT01181102|204804|P1|COMPLETED|Overall Study||309
87665|NCT01181102|204803|P2|Efficacy Analysis Population|Overall Study||295
87666|NCT01181102|204804|P1|Efficacy Analysis Population|Overall Study||299
87667|NCT01181102|204803|P2|Safety Analysis Set|Overall Study||349
87668|NCT01181102|204804|P1|Safety Analysis Set|Overall Study||354
87669|NCT01181102|204803|P2|STARTED|Overall Study||356
87670|NCT01181102|204804|P1|STARTED|Overall Study||360
87671|NCT01181050|204814|P2|NOT COMPLETED|Overall Study||0
87672|NCT01181050|204815|P1|NOT COMPLETED|Overall Study||0
87673|NCT01181050|204814|P2|COMPLETED|Overall Study||22
87674|NCT01181050|204815|P1|COMPLETED|Overall Study||41
87675|NCT01181050|204814|P2|STARTED|Overall Study||22
87676|NCT01181050|204815|P1|STARTED|Overall Study||41
87677|NCT01181011|204825|P1|NOT COMPLETED|Overall Study||3
87678|NCT01181011|204825|P1|COMPLETED|Overall Study||25
87679|NCT01181011|204825|P1|Received Amlodipine 5mg|Overall Study||26
87680|NCT01181011|204825|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
87681|NCT01181011|204825|P1|Received Telmisartan 80mg|Overall Study||27
87682|NCT01181011|204825|P1|STARTED|Overall Study||28
87683|NCT01180998|204875|P3|NOT COMPLETED|Overall Study||10
87684|NCT01180998|204876|P2|NOT COMPLETED|Overall Study||4
87685|NCT01180998|204877|P1|NOT COMPLETED|Overall Study||4
87686|NCT01180998|204875|P3|COMPLETED|Overall Study||51
87687|NCT01180998|204876|P2|COMPLETED|Overall Study||68
87688|NCT01180998|204877|P1|COMPLETED|Overall Study||63
87689|NCT01180998|204875|P3|STARTED|Overall Study||61
87690|NCT01180998|204876|P2|STARTED|Overall Study||72
87691|NCT01180998|204877|P1|STARTED|Overall Study||67
87692|NCT01180985|204891|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
87693|NCT01180985|204892|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
87694|NCT01180985|204891|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
87695|NCT01180985|204892|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
87696|NCT01180985|204891|P2|STARTED|Period 2 (7 +/- 1 Days)||26
87697|NCT01180985|204892|P1|STARTED|Period 2 (7 +/- 1 Days)||27
87698|NCT01180985|204891|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
87699|NCT01180985|204892|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
87700|NCT01180985|204891|P2|COMPLETED|Period 1 (7 +/- Days)||26
87701|NCT01180985|204892|P1|COMPLETED|Period 1 (7 +/- Days)||27
87702|NCT01180985|204891|P2|STARTED|Period 1 (7 +/- Days)||26
87703|NCT01180985|204892|P1|STARTED|Period 1 (7 +/- Days)||27
87704|NCT01180894|204911|P2|NOT COMPLETED|Overall Study||0
87705|NCT01180894|204912|P1|NOT COMPLETED|Overall Study||0
87706|NCT01180894|204911|P2|COMPLETED|Overall Study||75
87707|NCT01180894|204912|P1|COMPLETED|Overall Study||75
87708|NCT01180894|204911|P2|STARTED|Overall Study||75
87709|NCT01180894|204912|P1|STARTED|Overall Study||75
87710|NCT01180790|204931|P7|NOT COMPLETED|Overall Study||1
87711|NCT01180790|204932|P6|NOT COMPLETED|Overall Study||7
87712|NCT01180790|204933|P5|NOT COMPLETED|Overall Study||5
87713|NCT01180790|204934|P4|NOT COMPLETED|Overall Study||9
87714|NCT01180790|204935|P3|NOT COMPLETED|Overall Study||13
87715|NCT01180790|204936|P2|NOT COMPLETED|Overall Study||5
87716|NCT01180790|204937|P1|NOT COMPLETED|Overall Study||9
87717|NCT01180790|204931|P7|COMPLETED|Overall Study||18
87718|NCT01180790|204932|P6|COMPLETED|Overall Study||13
87719|NCT01180790|204933|P5|COMPLETED|Overall Study||14
87720|NCT01180790|204934|P4|COMPLETED|Overall Study||6
87721|NCT01180790|204935|P3|COMPLETED|Overall Study||4
87722|NCT01180790|204936|P2|COMPLETED|Overall Study||11
87723|NCT01180790|204937|P1|COMPLETED|Overall Study||7
87724|NCT01180790|204931|P7|STARTED|Overall Study||19
87725|NCT01180790|204932|P6|STARTED|Overall Study||20
87726|NCT01180790|204933|P5|STARTED|Overall Study||19
87727|NCT01180790|204934|P4|STARTED|Overall Study||15
87728|NCT01180790|204935|P3|STARTED|Overall Study||17
87729|NCT01180790|204936|P2|STARTED|Overall Study||16
87730|NCT01180790|204937|P1|STARTED|Overall Study||16
87731|NCT01180777|205002|P1|NOT COMPLETED|Overall Study||12
87732|NCT01180777|205002|P1|COMPLETED|Overall Study||80
87733|NCT01180777|205002|P1|STARTED|Overall Study||92
87734|NCT01180660|205016|P2|NOT COMPLETED|Overall Study||0
87735|NCT01180660|205017|P1|NOT COMPLETED|Overall Study||1
87736|NCT01180660|205016|P2|COMPLETED|Overall Study||26
87737|NCT01180660|205017|P1|COMPLETED|Overall Study||24
87738|NCT01180660|205016|P2|STARTED|Overall Study||26
87739|NCT01180660|205017|P1|STARTED|Overall Study||25
87740|NCT01180647|205027|P2|NOT COMPLETED|Overall Study||6
87741|NCT01180647|205028|P1|NOT COMPLETED|Overall Study||5
87742|NCT01180647|205027|P2|COMPLETED|Overall Study||11
87743|NCT01180647|205028|P1|COMPLETED|Overall Study||12
87744|NCT01180647|205027|P2|STARTED|Overall Study||17
87745|NCT01180647|205028|P1|STARTED|Overall Study||17
87746|NCT01180400|205046|P2|NOT COMPLETED|Overall Study||27
87747|NCT01180400|205047|P1|NOT COMPLETED|Overall Study||25
87748|NCT01180400|205046|P2|COMPLETED|Overall Study||121
87749|NCT01180400|205047|P1|COMPLETED|Overall Study||122
87750|NCT01180400|205046|P2|Received Treatment|Overall Study||146
87751|NCT01180400|205047|P1|Received Treatment|Overall Study||147
87752|NCT01180400|205046|P2|STARTED|Overall Study||148
87753|NCT01180400|205047|P1|STARTED|Overall Study||147
87754|NCT01180296|205095|P2|NOT COMPLETED|Overall Study||2
87755|NCT01180296|205096|P1|NOT COMPLETED|Overall Study||1
87756|NCT01180296|205095|P2|COMPLETED|Overall Study||14
87757|NCT01180296|205096|P1|COMPLETED|Overall Study||19
87758|NCT01180296|205095|P2|STARTED|Overall Study||16
87759|NCT01180296|205096|P1|STARTED|Overall Study||20
87760|NCT01180244|205104|P2|NOT COMPLETED|Overall Study||8
87761|NCT01180244|205105|P1|NOT COMPLETED|Overall Study||6
87762|NCT01180244|205104|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
87763|NCT01180244|205105|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
87764|NCT01180244|205104|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
87765|NCT01180244|205105|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
87766|NCT01180244|205104|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
87767|NCT01180244|205105|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
87768|NCT01180127|205123|P4|NOT COMPLETED|Overall Study||1
87769|NCT01180127|205124|P3|NOT COMPLETED|Overall Study||1
87770|NCT01180127|205125|P2|NOT COMPLETED|Overall Study||0
87771|NCT01180127|205126|P1|NOT COMPLETED|Overall Study||2
87772|NCT01180127|205123|P4|COMPLETED|Overall Study||9
87773|NCT01180127|205124|P3|COMPLETED|Overall Study||9
87774|NCT01180127|205125|P2|COMPLETED|Overall Study||11
87775|NCT01180127|205126|P1|COMPLETED|Overall Study||8
87776|NCT01180127|205123|P4|STARTED|Overall Study||10
87777|NCT01180127|205124|P3|STARTED|Overall Study||10
87778|NCT01180127|205125|P2|STARTED|Overall Study||11
87779|NCT01180127|205126|P1|STARTED|Overall Study||10
87780|NCT01179919|205148|P1|NOT COMPLETED|Overall Study||2
87781|NCT01179919|205148|P1|COMPLETED|Overall Study||19
87782|NCT01179919|205148|P1|STARTED|Overall Study||21
87783|NCT01179737|205157|P4|NOT COMPLETED|Extension||0
87784|NCT01179737|205158|P3|NOT COMPLETED|Extension||0
87785|NCT01179737|205159|P2|NOT COMPLETED|Extension||0
87786|NCT01179737|205160|P1|NOT COMPLETED|Extension||3
87787|NCT01179737|205157|P4|COMPLETED|Extension||0
87788|NCT01179737|205158|P3|COMPLETED|Extension||0
87789|NCT01179737|205159|P2|COMPLETED|Extension||0
87790|NCT01179737|205160|P1|COMPLETED|Extension||0
87791|NCT01179737|205157|P4|STARTED|Extension||0
87792|NCT01179737|205158|P3|STARTED|Extension||0
87793|NCT01179737|205159|P2|STARTED|Extension|One patient did not enrol in the extension|0
87794|NCT01179737|205160|P1|STARTED|Extension|Two patients did not enrol in the extension|3
87795|NCT01179737|205157|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
87796|NCT01179737|205158|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
87797|NCT01179737|205159|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
87798|NCT01179737|205160|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
87799|NCT01179737|205157|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
87800|NCT01179737|205158|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
87801|NCT01179737|205159|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
87802|NCT01179737|205160|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
87803|NCT01179737|205157|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
87804|NCT01179737|205158|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
87805|NCT01179737|205159|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
87806|NCT01179737|205160|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
87807|NCT01179737|205157|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
87808|NCT01179737|205158|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
87809|NCT01179737|205159|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
87810|NCT01179737|205160|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
87811|NCT01179737|205157|P4|COMPLETED|Cohort 1 & Cohort 2||0
87812|NCT01179737|205158|P3|COMPLETED|Cohort 1 & Cohort 2||0
87813|NCT01179737|205159|P2|COMPLETED|Cohort 1 & Cohort 2||1
87814|NCT01179737|205160|P1|COMPLETED|Cohort 1 & Cohort 2||7
87815|NCT01179737|205157|P4|STARTED|Cohort 1 & Cohort 2||4
87816|NCT01179737|205158|P3|STARTED|Cohort 1 & Cohort 2||4
87817|NCT01179737|205159|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
87818|NCT01179737|205160|P1|STARTED|Cohort 1 & Cohort 2||12
87819|NCT01179672|205171|P2|NOT COMPLETED|Overall Study||26
87820|NCT01179672|205172|P1|NOT COMPLETED|Overall Study||30
87821|NCT01179672|205171|P2|COMPLETED|Overall Study||176
87822|NCT01179672|205172|P1|COMPLETED|Overall Study||173
87823|NCT01179672|205171|P2|Entered Taper|Overall Study||177
87824|NCT01179672|205172|P1|Entered Taper|Overall Study||181
87825|NCT01179672|205171|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
87826|NCT01179672|205172|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
87827|NCT01179672|205171|P2|STARTED|Overall Study||202
87828|NCT01179672|205172|P1|STARTED|Overall Study||203
87829|NCT01179568|205202|P4|NOT COMPLETED|Overall Study||20
87830|NCT01179568|205203|P3|NOT COMPLETED|Overall Study||23
87831|NCT01179568|205204|P2|NOT COMPLETED|Overall Study||38
87832|NCT01179568|205205|P1|NOT COMPLETED|Overall Study||28
87833|NCT01179568|205202|P4|COMPLETED|Overall Study||76
87834|NCT01179568|205203|P3|COMPLETED|Overall Study||76
87835|NCT01179568|205204|P2|COMPLETED|Overall Study||61
87836|NCT01179568|205205|P1|COMPLETED|Overall Study||73
87837|NCT01179568|205202|P4|Completed Week 12 Assessment|Overall Study||75
87838|NCT01179568|205203|P3|Completed Week 12 Assessment|Overall Study||76
87839|NCT01179568|205204|P2|Completed Week 12 Assessment|Overall Study||69
87840|NCT01179568|205205|P1|Completed Week 12 Assessment|Overall Study||69
87841|NCT01179568|205202|P4|STARTED|Overall Study||96
87842|NCT01179568|205203|P3|STARTED|Overall Study||99
87843|NCT01179568|205204|P2|STARTED|Overall Study||99
87844|NCT01179568|205205|P1|STARTED|Overall Study||101
87845|NCT01179516|205228|P3|NOT COMPLETED|Overall Study||31
87846|NCT01179516|205229|P2|NOT COMPLETED|Overall Study||26
87847|NCT01179516|205230|P1|NOT COMPLETED|Overall Study||27
87848|NCT01179516|205228|P3|COMPLETED|Overall Study||121
87849|NCT01179516|205229|P2|COMPLETED|Overall Study||131
87850|NCT01179516|205230|P1|COMPLETED|Overall Study||133
87851|NCT01179516|205228|P3|Treated|Overall Study||151
87852|NCT01179516|205229|P2|Treated|Overall Study||154
87853|NCT01179516|205230|P1|Treated|Overall Study||160
87854|NCT01179516|205228|P3|STARTED|Overall Study||152
87855|NCT01179516|205229|P2|STARTED|Overall Study||157
87856|NCT01179516|205230|P1|STARTED|Overall Study||160
87857|NCT01179490|205253|P1|NOT COMPLETED|Overall Study||0
87858|NCT01179490|205253|P1|COMPLETED|Overall Study||5
87859|NCT01179490|205253|P1|STARTED|Overall Study||5
87860|NCT01179399|205274|P1|NOT COMPLETED|Overall Study||32
87861|NCT01179399|205274|P1|COMPLETED|Overall Study||0
87862|NCT01179399|205274|P1|STARTED|Overall Study||32
87863|NCT01179347|205280|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
87864|NCT01179347|205281|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
87865|NCT01179347|205280|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
87866|NCT01179347|205281|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
87867|NCT01179347|205280|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
87868|NCT01179347|205281|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
87869|NCT01179347|205280|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
87870|NCT01179347|205281|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
87871|NCT01179347|205280|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
87872|NCT01179347|205281|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
87873|NCT01179347|205280|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
87874|NCT01179347|205281|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
87875|NCT01179334|205303|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
87876|NCT01179334|205304|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
87877|NCT01179334|205303|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
87878|NCT01179334|205304|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
87879|NCT01179334|205303|P2|STARTED|Long-term Extension (LTE) Period||6
87880|NCT01179334|205304|P1|STARTED|Long-term Extension (LTE) Period||11
87881|NCT01179334|205303|P2|NOT COMPLETED|Treatment Period||0
87882|NCT01179334|205304|P1|NOT COMPLETED|Treatment Period||1
87883|NCT01179334|205303|P2|COMPLETED|Treatment Period||6
87884|NCT01179334|205304|P1|COMPLETED|Treatment Period||11
87885|NCT01179334|205303|P2|Participants Received Treatment|Treatment Period||6
87886|NCT01179334|205304|P1|Participants Received Treatment|Treatment Period||12
87887|NCT01179334|205303|P2|STARTED|Treatment Period||6
87888|NCT01179334|205304|P1|STARTED|Treatment Period||12
87889|NCT01179191|205332|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
87890|NCT01179191|205332|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
87891|NCT01179191|205332|P1|STARTED|Maintenance Phase (8 Weeks)||351
87892|NCT01179191|205332|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
87893|NCT01179191|205332|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
87894|NCT01179191|205332|P1|STARTED|Titration Phase (up to 6 Weeks)||684
87895|NCT01179113|205351|P2|NOT COMPLETED|Overall Study||0
87896|NCT01179113|205352|P1|NOT COMPLETED|Overall Study||0
87897|NCT01179113|205351|P2|COMPLETED|Overall Study||16
87898|NCT01179113|205352|P1|COMPLETED|Overall Study||17
87899|NCT01179113|205351|P2|STARTED|Overall Study||16
87900|NCT01179113|205352|P1|STARTED|Overall Study||17
87901|NCT01178853|205364|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
87902|NCT01178853|205365|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
87903|NCT01178853|205364|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
87904|NCT01178853|205365|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
87905|NCT01178853|205364|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
87906|NCT01178853|205365|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
87907|NCT01178853|205364|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
87908|NCT01178853|205365|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
87909|NCT01178853|205364|P2|COMPLETED|Period 3 (Warfarin Titration)||22
87910|NCT01178853|205365|P1|COMPLETED|Period 3 (Warfarin Titration)||21
87911|NCT01178853|205364|P2|STARTED|Period 3 (Warfarin Titration)||22
87912|NCT01178853|205365|P1|STARTED|Period 3 (Warfarin Titration)||22
87913|NCT01178853|205364|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
87914|NCT01178853|205365|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
87915|NCT01178853|205364|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
87916|NCT01178853|205365|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
87917|NCT01178853|205364|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
87918|NCT01178853|205365|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
87919|NCT01178853|205364|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
87920|NCT01178853|205365|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
87921|NCT01178853|205364|P2|COMPLETED|Period 1 (Warfarin Titration)||22
87922|NCT01178853|205365|P1|COMPLETED|Period 1 (Warfarin Titration)||23
87923|NCT01178853|205364|P2|STARTED|Period 1 (Warfarin Titration)||24
87924|NCT01178853|205365|P1|STARTED|Period 1 (Warfarin Titration)||24
87925|NCT01178827|205374|P3|NOT COMPLETED|Overall Study||0
87926|NCT01178827|205375|P2|NOT COMPLETED|Overall Study||0
87927|NCT01178827|205376|P1|NOT COMPLETED|Overall Study||0
87928|NCT01178827|205374|P3|COMPLETED|Overall Study||4
87929|NCT01178827|205375|P2|COMPLETED|Overall Study||10
87930|NCT01178827|205376|P1|COMPLETED|Overall Study||6
87931|NCT01178827|205374|P3|STARTED|Overall Study||4
87932|NCT01178827|205375|P2|STARTED|Overall Study||10
87933|NCT01178827|205376|P1|STARTED|Overall Study||6
87934|NCT01178762|205405|P1|NOT COMPLETED|Overall Study||15
87935|NCT01178762|205405|P1|COMPLETED|Overall Study||27
87936|NCT01178762|205405|P1|STARTED|Overall Study||42
87937|NCT01178671|205411|P2|NOT COMPLETED|Overall Study||15
87938|NCT01178671|205412|P1|NOT COMPLETED|Overall Study||12
87939|NCT01178671|205411|P2|COMPLETED|Overall Study||3
87940|NCT01178671|205412|P1|COMPLETED|Overall Study||6
87941|NCT01178671|205411|P2|STARTED|Overall Study||18
87942|NCT01178671|205412|P1|STARTED|Overall Study||18
87943|NCT01178528|205439|P3|NOT COMPLETED|Overall Study||0
87944|NCT01178528|205440|P2|NOT COMPLETED|Overall Study||0
87945|NCT01178528|205441|P1|NOT COMPLETED|Overall Study||0
87946|NCT01178528|205439|P3|COMPLETED|Overall Study||42
87947|NCT01178528|205440|P2|COMPLETED|Overall Study||38
87948|NCT01178528|205441|P1|COMPLETED|Overall Study||41
87949|NCT01178528|205439|P3|STARTED|Overall Study||42
87950|NCT01178528|205440|P2|STARTED|Overall Study||38
87951|NCT01178528|205441|P1|STARTED|Overall Study||41
87952|NCT01178385|205460|P2|NOT COMPLETED|Overall Study||0
87953|NCT01178385|205461|P1|NOT COMPLETED|Overall Study||2
87954|NCT01178385|205460|P2|COMPLETED|Overall Study||21
87955|NCT01178385|205461|P1|COMPLETED|Overall Study||22
87956|NCT01178385|205460|P2|STARTED|Overall Study||21
87957|NCT01178385|205461|P1|STARTED|Overall Study||24
87958|NCT01178333|205474|P3|NOT COMPLETED|Overall Study||0
87959|NCT01178333|205475|P2|NOT COMPLETED|Overall Study||0
87960|NCT01178333|205476|P1|NOT COMPLETED|Overall Study||0
87961|NCT01178333|205474|P3|COMPLETED|Overall Study||87
87962|NCT01178333|205475|P2|COMPLETED|Overall Study||284
87963|NCT01178333|205476|P1|COMPLETED|Overall Study||71
87964|NCT01178333|205474|P3|STARTED|Overall Study||87
87965|NCT01178333|205475|P2|STARTED|Overall Study||284
87966|NCT01178333|205476|P1|STARTED|Overall Study||71
87967|NCT01178294|205530|P1|NOT COMPLETED|Overall Study||11
87968|NCT01178294|205530|P1|COMPLETED|Overall Study||18
87969|NCT01178294|205530|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
87970|NCT01178281|205553|P2|NOT COMPLETED|Overall Study||77
87971|NCT01178281|205554|P1|NOT COMPLETED|Overall Study||149
87972|NCT01178281|205553|P2|COMPLETED|Overall Study|Participants remain on treatment|7
87973|NCT01178281|205554|P1|COMPLETED|Overall Study|Participants remain on treatment|19
87974|NCT01178281|205553|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
87975|NCT01178281|205554|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
87976|NCT01178268|205562|P2|NOT COMPLETED|Overall Study||1
87977|NCT01178268|205563|P1|NOT COMPLETED|Overall Study||7
87978|NCT01178268|205562|P2|COMPLETED|Overall Study||120
87979|NCT01178268|205563|P1|COMPLETED|Overall Study||360
87980|NCT01178268|205562|P2|STARTED|Overall Study||121
87981|NCT01178268|205563|P1|STARTED|Overall Study||367
87982|NCT01178138|205780|P1|NOT COMPLETED|Overall Study||23
87983|NCT01178138|205780|P1|COMPLETED|Overall Study||1
87984|NCT01178138|205780|P1|Completed 3 Sessions|Overall Study||1
87985|NCT01178138|205780|P1|Completed 5 Sessions|Overall Study||1
87986|NCT01178138|205780|P1|Completed 6 Sessions|Overall Study||1
87987|NCT01178138|205780|P1|STARTED|Overall Study||24
87988|NCT01178125|205801|P1|NOT COMPLETED|Overall Study||1178
87989|NCT01178125|205801|P1|COMPLETED|Overall Study||1680
87990|NCT01178125|205801|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
87991|NCT01178125|205801|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
87992|NCT01178125|205801|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
87993|NCT01178125|205801|P1|STARTED|Overall Study|Number enrolled.|2858
87994|NCT01178099|205832|P2|NOT COMPLETED|Overall Study||1
87995|NCT01178099|205833|P1|NOT COMPLETED|Overall Study||0
87996|NCT01178099|205832|P2|COMPLETED|Overall Study||12
87997|NCT01178099|205833|P1|COMPLETED|Overall Study||13
87998|NCT01178099|205832|P2|STARTED|Overall Study||13
87999|NCT01178099|205833|P1|STARTED|Overall Study||13
88000|NCT01178073|205874|P3|NOT COMPLETED|Overall Study||46
88001|NCT01178073|205875|P2|NOT COMPLETED|Overall Study||44
88002|NCT01178073|205876|P1|NOT COMPLETED|Overall Study||62
88003|NCT01178073|205874|P3|COMPLETED|Overall Study||105
88004|NCT01178073|205875|P2|COMPLETED|Overall Study||108
88005|NCT01178073|205876|P1|COMPLETED|Overall Study||240
88006|NCT01178073|205874|P3|STARTED|Overall Study||151
88007|NCT01178073|205875|P2|STARTED|Overall Study||152
88008|NCT01178073|205876|P1|STARTED|Overall Study||302
88009|NCT01177969|205907|P2|NOT COMPLETED|Overall Study||3
88010|NCT01177969|205908|P1|NOT COMPLETED|Overall Study||3
88011|NCT01177969|205907|P2|COMPLETED|Overall Study||11
88012|NCT01177969|205908|P1|COMPLETED|Overall Study||16
88013|NCT01177969|205907|P2|STARTED|Overall Study||14
88014|NCT01177969|205908|P1|STARTED|Overall Study||19
88015|NCT01177956|205916|P1|NOT COMPLETED|Overall Study||0
88016|NCT01177956|205916|P1|COMPLETED|Overall Study||68
88017|NCT01177956|205916|P1|STARTED|Overall Study||68
88018|NCT01177943|205931|P2|NOT COMPLETED|Second Intervention||0
88019|NCT01177943|205932|P1|NOT COMPLETED|Second Intervention||0
88020|NCT01177943|205931|P2|COMPLETED|Second Intervention||21
88021|NCT01177943|205932|P1|COMPLETED|Second Intervention||19
88022|NCT01177943|205931|P2|STARTED|Second Intervention||21
88023|NCT01177943|205932|P1|STARTED|Second Intervention||19
88024|NCT01177943|205931|P2|NOT COMPLETED|First Intervention||0
88025|NCT01177943|205932|P1|NOT COMPLETED|First Intervention||2
88026|NCT01177943|205931|P2|COMPLETED|First Intervention||21
88027|NCT01177943|205932|P1|COMPLETED|First Intervention||19
88028|NCT01177943|205931|P2|STARTED|First Intervention||21
88029|NCT01177943|205932|P1|STARTED|First Intervention||21
88030|NCT01177228|205944|P4|NOT COMPLETED|Overall Study||0
88031|NCT01177228|205945|P3|NOT COMPLETED|Overall Study||0
88032|NCT01177228|205946|P2|NOT COMPLETED|Overall Study||2
88033|NCT01177228|205947|P1|NOT COMPLETED|Overall Study||1
88034|NCT01177228|205944|P4|COMPLETED|Overall Study||11
88035|NCT01177228|205945|P3|COMPLETED|Overall Study||14
88036|NCT01177228|205946|P2|COMPLETED|Overall Study||11
88037|NCT01177228|205947|P1|COMPLETED|Overall Study||8
88038|NCT01177228|205944|P4|Received Treatment|Overall Study||11
88039|NCT01177228|205945|P3|Received Treatment|Overall Study||14
88040|NCT01177228|205946|P2|Received Treatment|Overall Study||12
88041|NCT01177228|205947|P1|Received Treatment|Overall Study||9
88042|NCT01177228|205944|P4|STARTED|Overall Study||11
88043|NCT01177228|205945|P3|STARTED|Overall Study||14
88044|NCT01177228|205946|P2|STARTED|Overall Study||13
88045|NCT01177228|205947|P1|STARTED|Overall Study||9
88046|NCT01177098|205987|P2|NOT COMPLETED|Overall Study||12
88047|NCT01177098|205988|P1|NOT COMPLETED|Overall Study||9
88048|NCT01177098|205987|P2|COMPLETED|Overall Study||271
88049|NCT01177098|205988|P1|COMPLETED|Overall Study||269
88050|NCT01177098|205987|P2|STARTED|Overall Study||283
88051|NCT01177098|205988|P1|STARTED|Overall Study||278
88052|NCT01177813|206009|P5|NOT COMPLETED|Overall Study||9
88053|NCT01177813|206010|P4|NOT COMPLETED|Overall Study||17
88054|NCT01177813|206011|P3|NOT COMPLETED|Overall Study||20
88055|NCT01177813|206012|P2|NOT COMPLETED|Overall Study||18
88056|NCT01177813|206013|P1|NOT COMPLETED|Overall Study||41
88057|NCT01177813|206009|P5|COMPLETED|Overall Study||78
88058|NCT01177813|206010|P4|COMPLETED|Overall Study||206
88059|NCT01177813|206011|P3|COMPLETED|Overall Study||204
88060|NCT01177813|206012|P2|COMPLETED|Overall Study||206
88061|NCT01177813|206013|P1|COMPLETED|Overall Study||187
88062|NCT01177813|206009|P5|STARTED|Overall Study||87
88063|NCT01177813|206010|P4|STARTED|Overall Study||223
88064|NCT01177813|206011|P3|STARTED|Overall Study||224
88065|NCT01177813|206012|P2|STARTED|Overall Study||224
88066|NCT01177813|206013|P1|STARTED|Overall Study||228
88067|NCT01177800|206042|P2|NOT COMPLETED|Overall Study||5
88068|NCT01177800|206043|P1|NOT COMPLETED|Overall Study||10
88069|NCT01177800|206042|P2|COMPLETED|Overall Study||40
88070|NCT01177800|206043|P1|COMPLETED|Overall Study||74
88071|NCT01177800|206042|P2|STARTED|Overall Study||45
88072|NCT01177800|206043|P1|STARTED|Overall Study||84
88073|NCT01177735|206057|P1|NOT COMPLETED|Overall Study||71
88074|NCT01177735|206057|P1|COMPLETED|Overall Study||0
88075|NCT01177735|206057|P1|STARTED|Overall Study||71
88076|NCT01177722|206065|P4|NOT COMPLETED|Overall Study||7
88077|NCT01177722|206066|P3|NOT COMPLETED|Overall Study||9
88078|NCT01177722|206067|P2|NOT COMPLETED|Overall Study||10
88079|NCT01177722|206068|P1|NOT COMPLETED|Overall Study||13
88080|NCT01177722|206065|P4|COMPLETED|Overall Study||338
88081|NCT01177722|206066|P3|COMPLETED|Overall Study||333
88082|NCT01177722|206067|P2|COMPLETED|Overall Study||334
88083|NCT01177722|206068|P1|COMPLETED|Overall Study||331
88084|NCT01177722|206065|P4|STARTED|Overall Study||345
88085|NCT01177722|206066|P3|STARTED|Overall Study||342
88086|NCT01177722|206067|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
88350|NCT01174446|206837|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
88087|NCT01177722|206068|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
88088|NCT01177709|206094|P1|NOT COMPLETED|Overall Study||0
88089|NCT01177709|206094|P1|COMPLETED|Overall Study||12
88090|NCT01177709|206094|P1|STARTED|Overall Study||12
88091|NCT01177670|206100|P1|NOT COMPLETED|Overall Study||169
88092|NCT01177670|206100|P1|COMPLETED|Overall Study||0
88093|NCT01177670|206100|P1|STARTED|Overall Study||169
88094|NCT01177553|206107|P2|NOT COMPLETED|Overall Study||0
88095|NCT01177553|206108|P1|NOT COMPLETED|Overall Study||1
88096|NCT01177553|206107|P2|COMPLETED|Overall Study|data as of March 2009|2
88097|NCT01177553|206108|P1|COMPLETED|Overall Study|data as of March 2009|2
88098|NCT01177553|206107|P2|STARTED|Overall Study||2
88099|NCT01177553|206108|P1|STARTED|Overall Study||3
88100|NCT01177410|206117|P3|NOT COMPLETED|Overall Study||5
88101|NCT01177410|206118|P2|NOT COMPLETED|Overall Study||7
88102|NCT01177410|206119|P1|NOT COMPLETED|Overall Study||1
88103|NCT01177410|206117|P3|COMPLETED|Overall Study||45
88104|NCT01177410|206118|P2|COMPLETED|Overall Study||40
88105|NCT01177410|206119|P1|COMPLETED|Overall Study||50
88106|NCT01177410|206117|P3|STARTED|Overall Study||50
88107|NCT01177410|206118|P2|STARTED|Overall Study||47
88108|NCT01177410|206119|P1|STARTED|Overall Study||51
88109|NCT01177384|206132|P2|NOT COMPLETED|Overall Study||26
88110|NCT01177384|206133|P1|NOT COMPLETED|Overall Study||14
88111|NCT01177384|206132|P2|COMPLETED|Overall Study||164
88112|NCT01177384|206133|P1|COMPLETED|Overall Study||177
88113|NCT01177384|206132|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
88114|NCT01177384|206133|P1|STARTED|Overall Study||191
88115|NCT01177293|206145|P2|NOT COMPLETED|Second Intervention Period||0
88116|NCT01177293|206146|P1|NOT COMPLETED|Second Intervention Period||0
88117|NCT01177293|206145|P2|COMPLETED|Second Intervention Period||6
88118|NCT01177293|206146|P1|COMPLETED|Second Intervention Period||7
88119|NCT01177293|206145|P2|STARTED|Second Intervention Period||6
88120|NCT01177293|206146|P1|STARTED|Second Intervention Period||7
88121|NCT01177293|206145|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
88122|NCT01177293|206146|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
88123|NCT01177293|206145|P2|COMPLETED|Washout Period (of 14 Days)||6
88124|NCT01177293|206146|P1|COMPLETED|Washout Period (of 14 Days)||7
88125|NCT01177293|206145|P2|STARTED|Washout Period (of 14 Days)||7
88126|NCT01177293|206146|P1|STARTED|Washout Period (of 14 Days)||7
88127|NCT01177293|206145|P2|NOT COMPLETED|First Intervention Period||0
88128|NCT01177293|206146|P1|NOT COMPLETED|First Intervention Period||0
88129|NCT01177293|206145|P2|COMPLETED|First Intervention Period||7
88130|NCT01177293|206146|P1|COMPLETED|First Intervention Period||7
88131|NCT01177293|206145|P2|STARTED|First Intervention Period||7
88132|NCT01177293|206146|P1|STARTED|First Intervention Period||7
88133|NCT01176968|206162|P2|NOT COMPLETED|Overall Study||82
88134|NCT01176968|206163|P1|NOT COMPLETED|Overall Study||84
88135|NCT01176968|206162|P2|COMPLETED|Overall Study||424
88136|NCT01176968|206163|P1|COMPLETED|Overall Study||422
88137|NCT01176968|206162|P2|Treated|Overall Study||505
88138|NCT01176968|206163|P1|Treated|Overall Study||505
88139|NCT01176968|206162|P2|STARTED|Overall Study||506
88140|NCT01176968|206163|P1|STARTED|Overall Study||506
88141|NCT01176955|206197|P2|NOT COMPLETED|Overall Study||2
88142|NCT01176955|206198|P1|NOT COMPLETED|Overall Study||3
88143|NCT01176955|206197|P2|COMPLETED|Overall Study||8
88144|NCT01176955|206198|P1|COMPLETED|Overall Study||7
88145|NCT01176955|206197|P2|STARTED|Overall Study||10
88146|NCT01176955|206198|P1|STARTED|Overall Study||10
88147|NCT01176877|206208|P1|NOT COMPLETED|Overall Study||9
88148|NCT01176877|206208|P1|COMPLETED|Overall Study||31
88149|NCT01176877|206208|P1|STARTED|Overall Study||40
88150|NCT01176773|206213|P1|NOT COMPLETED|Overall Study||3
88151|NCT01176773|206213|P1|COMPLETED|Overall Study||59
88152|NCT01176773|206213|P1|STARTED|Overall Study||62
88153|NCT01176513|206222|P1|NOT COMPLETED|Overall Study||3
88154|NCT01176513|206222|P1|COMPLETED|Overall Study||22
88155|NCT01176513|206222|P1|STARTED|Overall Study||25
88156|NCT01176448|206227|P1|NOT COMPLETED|Overall Study||0
88157|NCT01176448|206227|P1|COMPLETED|Overall Study||6
88158|NCT01176448|206227|P1|STARTED|Overall Study||6
88159|NCT01176292|206237|P2|NOT COMPLETED|Overall Study||9
88160|NCT01176292|206238|P1|NOT COMPLETED|Overall Study||5
88161|NCT01176292|206237|P2|COMPLETED|Overall Study||62
88162|NCT01176292|206238|P1|COMPLETED|Overall Study||66
88163|NCT01176292|206237|P2|STARTED|Overall Study||71
88164|NCT01176292|206238|P1|STARTED|Overall Study||71
88165|NCT01176240|206260|P2|NOT COMPLETED|Study 306B||17
88166|NCT01176240|206261|P1|NOT COMPLETED|Study 306B||26
88167|NCT01176240|206260|P2|COMPLETED|Study 306B||68
88168|NCT01176240|206261|P1|COMPLETED|Study 306B||63
88169|NCT01176240|206260|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
88170|NCT01176240|206261|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
88171|NCT01176240|206260|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
88172|NCT01176240|206261|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
88173|NCT01176240|206260|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
88174|NCT01176240|206261|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
88175|NCT01176240|206260|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
88176|NCT01176240|206261|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
88177|NCT01176240|206260|P2|STARTED|Study 306B||85
88178|NCT01176240|206261|P1|STARTED|Study 306B||89
88179|NCT01176240|206260|P2|NOT COMPLETED|Study 306A||3
88180|NCT01176240|206261|P1|NOT COMPLETED|Study 306A||3
88181|NCT01176240|206260|P2|COMPLETED|Study 306A||24
88182|NCT01176240|206261|P1|COMPLETED|Study 306A||21
88183|NCT01176240|206260|P2|STARTED|Study 306A||27
88184|NCT01176240|206261|P1|STARTED|Study 306A||24
88185|NCT01176058|206287|P2|NOT COMPLETED|Overall Study||3
88186|NCT01176058|206288|P1|NOT COMPLETED|Overall Study||4
88187|NCT01176058|206287|P2|COMPLETED|Overall Study||5
88188|NCT01176058|206288|P1|COMPLETED|Overall Study||5
88189|NCT01176058|206287|P2|STARTED|Overall Study||8
88190|NCT01176058|206288|P1|STARTED|Overall Study||9
88191|NCT01176032|206312|P2|NOT COMPLETED|Overall Study||1
88192|NCT01176032|206313|P1|NOT COMPLETED|Overall Study||6
88193|NCT01176032|206312|P2|COMPLETED|Overall Study||36
88194|NCT01176032|206313|P1|COMPLETED|Overall Study||31
88195|NCT01176032|206312|P2|Intention-to-treat (ITT) Population|Overall Study||37
88196|NCT01176032|206313|P1|Intention-to-treat (ITT) Population|Overall Study||32
88197|NCT01176032|206312|P2|STARTED|Overall Study||37
88198|NCT01176032|206313|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
88199|NCT01175902|206373|P2|NOT COMPLETED|Overall Study||0
88200|NCT01175902|206374|P1|NOT COMPLETED|Overall Study||0
88201|NCT01175902|206373|P2|COMPLETED|Overall Study||22
88202|NCT01175902|206374|P1|COMPLETED|Overall Study||22
88203|NCT01175902|206373|P2|STARTED|Overall Study||22
88204|NCT01175902|206374|P1|STARTED|Overall Study||22
88205|NCT01175850|206392|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
88206|NCT01175850|206393|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
88207|NCT01175850|206392|P2|COMPLETED|IN.PACT SFA II Phase||55
88208|NCT01175850|206393|P1|COMPLETED|IN.PACT SFA II Phase||109
88209|NCT01175850|206392|P2|STARTED|IN.PACT SFA II Phase||60
88210|NCT01175850|206393|P1|STARTED|IN.PACT SFA II Phase||121
88211|NCT01175850|206392|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
88212|NCT01175850|206393|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
88213|NCT01175850|206392|P2|COMPLETED|IN.PACT SFA I Phase||49
88214|NCT01175850|206393|P1|COMPLETED|IN.PACT SFA I Phase||88
88215|NCT01175850|206392|P2|STARTED|IN.PACT SFA I Phase||51
88216|NCT01175850|206393|P1|STARTED|IN.PACT SFA I Phase||99
88217|NCT01175824|206437|P2|NOT COMPLETED|Overall Study||22
88218|NCT01175824|206438|P1|NOT COMPLETED|Overall Study||16
88219|NCT01175824|206437|P2|COMPLETED|Overall Study||220
88220|NCT01175824|206438|P1|COMPLETED|Overall Study||220
88221|NCT01175824|206437|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
88222|NCT01175824|206438|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
88223|NCT01175824|206437|P2|STARTED|Overall Study||242
88224|NCT01175824|206438|P1|STARTED|Overall Study||236
88225|NCT01175811|206472|P2|NOT COMPLETED|Overall Study||14
88226|NCT01175811|206473|P1|NOT COMPLETED|Overall Study||16
88227|NCT01175811|206472|P2|COMPLETED|Overall Study||189
88228|NCT01175811|206473|P1|COMPLETED|Overall Study||183
88229|NCT01175811|206472|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
88230|NCT01175811|206473|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
88231|NCT01175811|206472|P2|STARTED|Overall Study||203
88232|NCT01175811|206473|P1|STARTED|Overall Study||199
88233|NCT01175798|206499|P2|NOT COMPLETED|Overall Study||21
88234|NCT01175798|206500|P1|NOT COMPLETED|Overall Study||7
88235|NCT01175798|206499|P2|COMPLETED|Overall Study||41
88236|NCT01175798|206500|P1|COMPLETED|Overall Study||27
88237|NCT01175798|206499|P2|STARTED|Overall Study||62
88238|NCT01175798|206500|P1|STARTED|Overall Study||34
88239|NCT01175707|206508|P2|NOT COMPLETED|Overall Study||6
88240|NCT01175707|206509|P1|NOT COMPLETED|Overall Study||4
88241|NCT01175707|206508|P2|COMPLETED|Overall Study||34
88242|NCT01175707|206509|P1|COMPLETED|Overall Study||36
88243|NCT01175707|206508|P2|STARTED|Overall Study||40
88244|NCT01175707|206509|P1|STARTED|Overall Study||40
88245|NCT01175668|206545|P2|NOT COMPLETED|Overall Study||0
88246|NCT01175668|206546|P1|NOT COMPLETED|Overall Study||2
88247|NCT01175668|206545|P2|COMPLETED|Overall Study||34
88248|NCT01175668|206546|P1|COMPLETED|Overall Study||32
88249|NCT01175668|206545|P2|STARTED|Overall Study||34
88250|NCT01175668|206546|P1|STARTED|Overall Study||34
88251|NCT01175590|206556|P2|NOT COMPLETED|Overall Study||10
88252|NCT01175590|206557|P1|NOT COMPLETED|Overall Study||12
88253|NCT01175590|206556|P2|COMPLETED|Overall Study||161
88254|NCT01175590|206557|P1|COMPLETED|Overall Study||335
88255|NCT01175590|206556|P2|Safety Population|Overall Study||170
88256|NCT01175590|206557|P1|Safety Population|Overall Study||344
88257|NCT01175590|206556|P2|Modified Intent to Treat Population|Overall Study||87
88258|NCT01175590|206557|P1|Modified Intent to Treat Population|Overall Study||212
88259|NCT01175590|206556|P2|STARTED|Overall Study||171
88260|NCT01175590|206557|P1|STARTED|Overall Study||347
88261|NCT01175473|206591|P2|NOT COMPLETED|Overall Study||2
88262|NCT01175473|206592|P1|NOT COMPLETED|Overall Study||2
88263|NCT01175473|206591|P2|COMPLETED|Overall Study||69
88264|NCT01175473|206592|P1|COMPLETED|Overall Study||75
88265|NCT01175473|206591|P2|Pharmacodynamic (PD) Population|Overall Study||68
88433|NCT01173718|207140|P1|NOT COMPLETED|Overall Study||44
88266|NCT01175473|206592|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
88267|NCT01175473|206591|P2|Safety Population|Overall Study||71
88268|NCT01175473|206592|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
88269|NCT01175473|206591|P2|STARTED|Overall Study||71
88270|NCT01175473|206592|P1|STARTED|Overall Study|Randomized and treated.|77
88271|NCT01175434|206618|P2|NOT COMPLETED|Overall Study||0
88272|NCT01175434|206619|P1|NOT COMPLETED|Overall Study||0
88273|NCT01175434|206618|P2|COMPLETED|Overall Study||51
88274|NCT01175434|206619|P1|COMPLETED|Overall Study||48
88275|NCT01175434|206618|P2|STARTED|Overall Study||51
88276|NCT01175434|206619|P1|STARTED|Overall Study||48
88277|NCT01175395|206625|P1|NOT COMPLETED|Overall Study||0
88278|NCT01175395|206625|P1|COMPLETED|Overall Study||10
88279|NCT01175395|206625|P1|STARTED|Overall Study||10
88280|NCT01175369|206632|P2|NOT COMPLETED|Overall Study||5
88281|NCT01175369|206633|P1|NOT COMPLETED|Overall Study||2
88282|NCT01175369|206632|P2|COMPLETED|Overall Study||260
88283|NCT01175369|206633|P1|COMPLETED|Overall Study||263
88284|NCT01175369|206632|P2|STARTED|Overall Study||265
88285|NCT01175369|206633|P1|STARTED|Overall Study||265
88286|NCT01175317|206641|P2|NOT COMPLETED|Overall Study||0
88287|NCT01175317|206642|P1|NOT COMPLETED|Overall Study||0
88288|NCT01175317|206641|P2|COMPLETED|Overall Study||31
88289|NCT01175317|206642|P1|COMPLETED|Overall Study||27
88290|NCT01175317|206641|P2|STARTED|Overall Study||31
88291|NCT01175317|206642|P1|STARTED|Overall Study||27
88292|NCT01175213|206654|P2|NOT COMPLETED|Safety Follow-up||0
88293|NCT01175213|206655|P1|NOT COMPLETED|Safety Follow-up||1
88294|NCT01175213|206654|P2|COMPLETED|Safety Follow-up||3
88295|NCT01175213|206655|P1|COMPLETED|Safety Follow-up||47
88296|NCT01175213|206654|P2|STARTED|Safety Follow-up||3
88297|NCT01175213|206655|P1|STARTED|Safety Follow-up||48
88298|NCT01175213|206654|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
88299|NCT01175213|206655|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
88300|NCT01175213|206654|P2|COMPLETED|IGSC, 10%/rHuPH20||3
88301|NCT01175213|206655|P1|COMPLETED|IGSC, 10%/rHuPH20||48
88302|NCT01175213|206654|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
88303|NCT01175213|206655|P1|STARTED|IGSC, 10%/rHuPH20||63
88304|NCT01175031|206700|P1|NOT COMPLETED|Overall Study||0
88305|NCT01175031|206700|P1|COMPLETED|Overall Study||45
88306|NCT01175031|206700|P1|STARTED|Overall Study||45
88307|NCT01175018|206710|P2|NOT COMPLETED|Overall Study||1
88308|NCT01175018|206711|P1|NOT COMPLETED|Overall Study||3
88309|NCT01175018|206710|P2|COMPLETED|Overall Study||14
88310|NCT01175018|206711|P1|COMPLETED|Overall Study||12
88311|NCT01175018|206710|P2|STARTED|Overall Study||15
88312|NCT01175018|206711|P1|STARTED|Overall Study||15
88313|NCT01175005|206747|P1|NOT COMPLETED|Overall Study||0
88314|NCT01175005|206747|P1|COMPLETED|Overall Study||62
88315|NCT01175005|206747|P1|STARTED|Overall Study||62
88316|NCT01174784|206752|P1|NOT COMPLETED|Overall Study||0
88317|NCT01174784|206752|P1|COMPLETED|Overall Study||88
88318|NCT01174784|206752|P1|STARTED|Overall Study||88
88319|NCT01174576|206757|P1|NOT COMPLETED|Overall Study||0
88320|NCT01174576|206757|P1|COMPLETED|Overall Study||16
88321|NCT01174576|206757|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
88322|NCT01174550|206800|P2|NOT COMPLETED|Overall Study||873
88323|NCT01174550|206801|P1|NOT COMPLETED|Overall Study||1270
88324|NCT01174550|206800|P2|COMPLETED|Overall Study||4123
88325|NCT01174550|206801|P1|COMPLETED|Overall Study||3737
88326|NCT01174550|206800|P2|STARTED|Overall Study||4996
88327|NCT01174550|206801|P1|STARTED|Overall Study||5007
88328|NCT01174459|206829|P1|NOT COMPLETED|Overall Study||5
88329|NCT01174459|206829|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
88330|NCT01174459|206829|P1|STARTED|Overall Study|Registered patients|571
88331|NCT01174446|206834|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
88332|NCT01174446|206835|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
88333|NCT01174446|206836|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
88334|NCT01174446|206837|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
88335|NCT01174446|206834|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
88336|NCT01174446|206835|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
88337|NCT01174446|206836|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
88338|NCT01174446|206837|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
88339|NCT01174446|206834|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
88340|NCT01174446|206835|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
88341|NCT01174446|206836|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
88342|NCT01174446|206837|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
88343|NCT01174446|206834|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
88344|NCT01174446|206835|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
88345|NCT01174446|206836|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
88346|NCT01174446|206837|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
88347|NCT01174446|206834|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
88348|NCT01174446|206835|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
88349|NCT01174446|206836|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
88351|NCT01174446|206834|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
88352|NCT01174446|206835|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
88353|NCT01174446|206836|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
88354|NCT01174446|206837|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
88355|NCT01174446|206834|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88356|NCT01174446|206835|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88357|NCT01174446|206836|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88358|NCT01174446|206837|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88359|NCT01174446|206834|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88360|NCT01174446|206835|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
88361|NCT01174446|206836|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
88362|NCT01174446|206837|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
88363|NCT01174446|206834|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
88364|NCT01174446|206835|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
88365|NCT01174446|206836|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
88366|NCT01174446|206837|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
88367|NCT01174342|207024|P1|NOT COMPLETED|Overall Study||4
88368|NCT01174342|207024|P1|COMPLETED|Overall Study||26
88369|NCT01174342|207024|P1|STARTED|Overall Study||30
88370|NCT01174264|207031|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
88371|NCT01174264|207032|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
88372|NCT01174264|207033|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
88373|NCT01174264|207031|P3|COMPLETED|Steady-state Pharmacokinetics||27
88374|NCT01174264|207032|P2|COMPLETED|Steady-state Pharmacokinetics||0
88375|NCT01174264|207033|P1|COMPLETED|Steady-state Pharmacokinetics||25
88376|NCT01174264|207031|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
88377|NCT01174264|207032|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
88378|NCT01174264|207033|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
88379|NCT01174264|207031|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
88380|NCT01174264|207032|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
88381|NCT01174264|207033|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
88382|NCT01174264|207031|P3|COMPLETED|Single Dose Pharmacokinetics||18
88383|NCT01174264|207032|P2|COMPLETED|Single Dose Pharmacokinetics||20
88384|NCT01174264|207033|P1|COMPLETED|Single Dose Pharmacokinetics||22
88385|NCT01174264|207031|P3|STARTED|Single Dose Pharmacokinetics||20
88386|NCT01174264|207032|P2|STARTED|Single Dose Pharmacokinetics||20
88387|NCT01174264|207033|P1|STARTED|Single Dose Pharmacokinetics||23
88388|NCT01174186|207067|P2|NOT COMPLETED|Overall Study||3
88389|NCT01174186|207068|P1|NOT COMPLETED|Overall Study||0
88390|NCT01174186|207067|P2|COMPLETED|Overall Study||12
88391|NCT01174186|207068|P1|COMPLETED|Overall Study||15
88392|NCT01174186|207067|P2|STARTED|Overall Study||15
88393|NCT01174186|207068|P1|STARTED|Overall Study|Patients were included over three years|15
88394|NCT01174173|207075|P1|NOT COMPLETED|Overall Study||1
88395|NCT01174173|207075|P1|COMPLETED|Overall Study||10
88396|NCT01174173|207075|P1|STARTED|Overall Study||11
88397|NCT01174160|207085|P2|NOT COMPLETED|Overall Study||6
88398|NCT01174160|207086|P1|NOT COMPLETED|Overall Study||8
88399|NCT01174160|207085|P2|COMPLETED|Overall Study||56
88400|NCT01174160|207086|P1|COMPLETED|Overall Study||53
88401|NCT01174160|207085|P2|Discontinued Post Dose|Overall Study||0
88402|NCT01174160|207086|P1|Discontinued Post Dose|Overall Study||2
88403|NCT01174160|207085|P2|Dosed|Overall Study||56
88404|NCT01174160|207086|P1|Dosed|Overall Study||55
88405|NCT01174160|207085|P2|Discontinued Pre Dose|Overall Study||6
88406|NCT01174160|207086|P1|Discontinued Pre Dose|Overall Study||6
88407|NCT01174160|207085|P2|STARTED|Overall Study||62
88408|NCT01174160|207086|P1|STARTED|Overall Study||61
88409|NCT01174043|207092|P1|NOT COMPLETED|Overall Study||11
88410|NCT01174043|207092|P1|COMPLETED|Overall Study||0
88411|NCT01174043|207092|P1|STARTED|Overall Study||11
88412|NCT01174030|207103|P5|NOT COMPLETED|Overall Study||1
88413|NCT01174030|207104|P4|NOT COMPLETED|Overall Study||2
88414|NCT01174030|207105|P3|NOT COMPLETED|Overall Study||2
88415|NCT01174030|207106|P2|NOT COMPLETED|Overall Study||2
88416|NCT01174030|207107|P1|NOT COMPLETED|Overall Study||2
88417|NCT01174030|207103|P5|COMPLETED|Overall Study||52
88418|NCT01174030|207104|P4|COMPLETED|Overall Study||53
88419|NCT01174030|207105|P3|COMPLETED|Overall Study||52
88420|NCT01174030|207106|P2|COMPLETED|Overall Study||52
88421|NCT01174030|207107|P1|COMPLETED|Overall Study||51
88422|NCT01174030|207103|P5|STARTED|Overall Study||53
88423|NCT01174030|207104|P4|STARTED|Overall Study||55
88424|NCT01174030|207105|P3|STARTED|Overall Study||54
88425|NCT01174030|207106|P2|STARTED|Overall Study||54
88426|NCT01174030|207107|P1|STARTED|Overall Study||53
88427|NCT01174004|207131|P2|NOT COMPLETED|Overall Study||16
88428|NCT01174004|207132|P1|NOT COMPLETED|Overall Study||7
88429|NCT01174004|207131|P2|COMPLETED|Overall Study||89
88430|NCT01174004|207132|P1|COMPLETED|Overall Study||87
88431|NCT01174004|207131|P2|STARTED|Overall Study||105
88432|NCT01174004|207132|P1|STARTED|Overall Study||94
88434|NCT01173718|207140|P1|COMPLETED|Overall Study||94
88435|NCT01173718|207140|P1|STARTED|Overall Study||138
88436|NCT01173653|207151|P2|NOT COMPLETED|Overall Study||41
88437|NCT01173653|207152|P1|NOT COMPLETED|Overall Study||53
88438|NCT01173653|207151|P2|COMPLETED|Overall Study||49
88439|NCT01173653|207152|P1|COMPLETED|Overall Study||56
88440|NCT01173653|207151|P2|STARTED|Overall Study||90
88441|NCT01173653|207152|P1|STARTED|Overall Study||109
88442|NCT01173471|207162|P4|NOT COMPLETED|Overall Study||1
88443|NCT01173471|207163|P3|NOT COMPLETED|Overall Study||3
88444|NCT01173471|207164|P2|NOT COMPLETED|Overall Study||0
88445|NCT01173471|207165|P1|NOT COMPLETED|Overall Study||2
88446|NCT01173471|207162|P4|COMPLETED|Overall Study|Completed study|18
88447|NCT01173471|207163|P3|COMPLETED|Overall Study|Completed study|15
88448|NCT01173471|207164|P2|COMPLETED|Overall Study|Completed study|7
88449|NCT01173471|207165|P1|COMPLETED|Overall Study|Completed study|4
88450|NCT01173471|207162|P4|Completed Treatment|Overall Study||18
88451|NCT01173471|207163|P3|Completed Treatment|Overall Study||15
88452|NCT01173471|207164|P2|Completed Treatment|Overall Study||7
88453|NCT01173471|207165|P1|Completed Treatment|Overall Study||4
88454|NCT01173471|207162|P4|Received Treatment|Overall Study||19
88455|NCT01173471|207163|P3|Received Treatment|Overall Study||18
88456|NCT01173471|207164|P2|Received Treatment|Overall Study||7
88457|NCT01173471|207165|P1|Received Treatment|Overall Study||6
88458|NCT01173471|207162|P4|STARTED|Overall Study|Randomized|19
88459|NCT01173471|207163|P3|STARTED|Overall Study|Randomized|18
88460|NCT01173471|207164|P2|STARTED|Overall Study|Randomized|7
88461|NCT01173471|207165|P1|STARTED|Overall Study|Randomized|6
88462|NCT01173211|207189|P6|NOT COMPLETED|Overall Study||0
88463|NCT01173211|207190|P5|NOT COMPLETED|Overall Study||0
88464|NCT01173211|207191|P4|NOT COMPLETED|Overall Study||0
88465|NCT01173211|207192|P3|NOT COMPLETED|Overall Study||2
88466|NCT01173211|207193|P2|NOT COMPLETED|Overall Study||1
88467|NCT01173211|207194|P1|NOT COMPLETED|Overall Study||2
88468|NCT01173211|207189|P6|COMPLETED|Overall Study||13
88469|NCT01173211|207190|P5|COMPLETED|Overall Study||16
88470|NCT01173211|207191|P4|COMPLETED|Overall Study||15
88471|NCT01173211|207192|P3|COMPLETED|Overall Study||44
88472|NCT01173211|207193|P2|COMPLETED|Overall Study||44
88473|NCT01173211|207194|P1|COMPLETED|Overall Study||46
88474|NCT01173211|207189|P6|STARTED|Overall Study||13
88475|NCT01173211|207190|P5|STARTED|Overall Study||16
88476|NCT01173211|207191|P4|STARTED|Overall Study||15
88477|NCT01173211|207192|P3|STARTED|Overall Study||46
88478|NCT01173211|207193|P2|STARTED|Overall Study||45
88479|NCT01173211|207194|P1|STARTED|Overall Study||48
88480|NCT01173120|207295|P1|NOT COMPLETED|Overall Study||62
88481|NCT01173120|207295|P1|COMPLETED|Overall Study||0
88482|NCT01173120|207295|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
88483|NCT01173120|207295|P1|Switched Back to Main Study|Overall Study||57
88484|NCT01173120|207295|P1|STARTED|Overall Study||62
88485|NCT01173055|207313|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
88486|NCT01173055|207314|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
88487|NCT01173055|207313|P2|COMPLETED|Period 2 - Day 64 to 112||9
88488|NCT01173055|207314|P1|COMPLETED|Period 2 - Day 64 to 112||8
88489|NCT01173055|207313|P2|STARTED|Period 2 - Day 64 to 112||10
88490|NCT01173055|207314|P1|STARTED|Period 2 - Day 64 to 112||8
88491|NCT01173055|207313|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
88492|NCT01173055|207314|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
88493|NCT01173055|207313|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
88494|NCT01173055|207314|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
88495|NCT01173055|207313|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
88496|NCT01173055|207314|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
88497|NCT01173055|207313|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
88498|NCT01173055|207314|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
88499|NCT01173055|207313|P2|COMPLETED|Period 1 - Day 1 to 49||10
88500|NCT01173055|207314|P1|COMPLETED|Period 1 - Day 1 to 49||8
88501|NCT01173055|207313|P2|STARTED|Period 1 - Day 1 to 49||12
88502|NCT01173055|207314|P1|STARTED|Period 1 - Day 1 to 49||10
88503|NCT01173029|207332|P2|NOT COMPLETED|Overall Study||0
88504|NCT01173029|207333|P1|NOT COMPLETED|Overall Study||0
88505|NCT01173029|207332|P2|COMPLETED|Overall Study||31
88506|NCT01173029|207333|P1|COMPLETED|Overall Study||61
88507|NCT01173029|207332|P2|STARTED|Overall Study||31
88508|NCT01173029|207333|P1|STARTED|Overall Study||61
88509|NCT01172938|207353|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
88510|NCT01172938|207354|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
88511|NCT01172938|207355|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||4
88512|NCT01172938|207356|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
88513|NCT01172938|207357|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
88514|NCT01172938|207358|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
88515|NCT01172938|207359|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
88516|NCT01172938|207353|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||22
88517|NCT01172938|207354|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
88518|NCT01172938|207355|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
88519|NCT01172938|207356|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
88520|NCT01172938|207357|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||130
88521|NCT01172938|207358|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||124
88522|NCT01172938|207359|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
88523|NCT01172938|207353|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||24
88524|NCT01172938|207354|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
88525|NCT01172938|207355|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||23
88526|NCT01172938|207356|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
88527|NCT01172938|207357|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who completed Week 24 did not enter the active treatment phase|145
88528|NCT01172938|207358|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
88529|NCT01172938|207359|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
88530|NCT01172938|207353|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88531|NCT01172938|207354|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88532|NCT01172938|207355|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88533|NCT01172938|207356|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88534|NCT01172938|207357|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
88535|NCT01172938|207358|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
88536|NCT01172938|207359|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||18
88537|NCT01172938|207353|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88538|NCT01172938|207354|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88539|NCT01172938|207355|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88540|NCT01172938|207356|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
88541|NCT01172938|207357|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||148
88542|NCT01172938|207358|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
88543|NCT01172938|207359|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|One participant who completed Week 24 did not enter the active treatment phase|150
88544|NCT01172938|207353|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88545|NCT01172938|207354|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88546|NCT01172938|207355|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88547|NCT01172938|207356|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88548|NCT01172938|207357|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||58
88549|NCT01172938|207358|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Six participants who escaped early did not complete Week 24|78
88550|NCT01172938|207359|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Five participants who escaped early did not complete Week 24|107
88551|NCT01172938|207353|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88552|NCT01172938|207354|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88553|NCT01172938|207355|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88554|NCT01172938|207356|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
88555|NCT01172938|207357|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||154
88556|NCT01172938|207358|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
88557|NCT01172938|207359|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
88558|NCT01172938|207353|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
88559|NCT01172938|207354|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
88560|NCT01172938|207355|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
88561|NCT01172938|207356|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
88562|NCT01172938|207357|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
88563|NCT01172938|207358|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
88564|NCT01172938|207359|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
88565|NCT01172938|207353|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
88566|NCT01172938|207354|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
88567|NCT01172938|207355|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
88568|NCT01172938|207356|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
88569|NCT01172938|207357|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
88570|NCT01172938|207358|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
88571|NCT01172938|207359|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
88572|NCT01172873|207538|P2|NOT COMPLETED|Overall Study||2
88573|NCT01172873|207539|P1|NOT COMPLETED|Overall Study||3
88574|NCT01172873|207538|P2|COMPLETED|Overall Study||3
88575|NCT01172873|207539|P1|COMPLETED|Overall Study||8
88576|NCT01172873|207538|P2|STARTED|Overall Study||5
88577|NCT01172873|207539|P1|STARTED|Overall Study||11
88578|NCT01172847|207549|P1|NOT COMPLETED|Overall Study||3
88579|NCT01172847|207549|P1|COMPLETED|Overall Study||21
88580|NCT01172847|207549|P1|Oseltamivir + Rimantadine|Overall Study||21
88581|NCT01172847|207549|P1|Rimantadine|Overall Study||22
88582|NCT01172847|207549|P1|Oseltamivir|Overall Study||24
88583|NCT01172847|207549|P1|STARTED|Overall Study||24
88584|NCT01172821|207578|P4|NOT COMPLETED|Overall Study||17
88585|NCT01172821|207579|P3|NOT COMPLETED|Overall Study||13
88586|NCT01172821|207580|P2|NOT COMPLETED|Overall Study||12
88587|NCT01172821|207581|P1|NOT COMPLETED|Overall Study||14
88588|NCT01172821|207578|P4|COMPLETED|Overall Study||249
88589|NCT01172821|207579|P3|COMPLETED|Overall Study||240
88590|NCT01172821|207580|P2|COMPLETED|Overall Study||245
88591|NCT01172821|207581|P1|COMPLETED|Overall Study||240
88592|NCT01172821|207578|P4|STARTED|Overall Study|Entered and Treated|266
88593|NCT01172821|207579|P3|STARTED|Overall Study|Entered and Treated|253
88594|NCT01172821|207580|P2|STARTED|Overall Study|Entered and Treated|257
88595|NCT01172821|207581|P1|STARTED|Overall Study|Entered and Treated|254
88596|NCT01172808|207671|P4|NOT COMPLETED|Overall Study||15
88597|NCT01172808|207672|P3|NOT COMPLETED|Overall Study||23
88598|NCT01172808|207673|P2|NOT COMPLETED|Overall Study||13
88599|NCT01172808|207674|P1|NOT COMPLETED|Overall Study||21
88600|NCT01172808|207671|P4|COMPLETED|Overall Study||260
88601|NCT01172808|207672|P3|COMPLETED|Overall Study||241
88602|NCT01172808|207673|P2|COMPLETED|Overall Study||249
88603|NCT01172808|207674|P1|COMPLETED|Overall Study||248
88604|NCT01172808|207671|P4|STARTED|Overall Study|Entered and Treated|275
88605|NCT01172808|207672|P3|STARTED|Overall Study|Entered and Treated|264
88606|NCT01172808|207673|P2|STARTED|Overall Study|Entered and Treated|262
88607|NCT01172808|207674|P1|STARTED|Overall Study|Entered and Treated|269
88608|NCT01172600|207762|P2|NOT COMPLETED|Overall Study||0
88609|NCT01172600|207763|P1|NOT COMPLETED|Overall Study||0
88610|NCT01172600|207762|P2|COMPLETED|Overall Study||39
88611|NCT01172600|207763|P1|COMPLETED|Overall Study||39
88612|NCT01172600|207762|P2|STARTED|Overall Study||39
88613|NCT01172600|207763|P1|STARTED|Overall Study||39
88614|NCT01172535|207793|P1|NOT COMPLETED|Overall Study||8
88615|NCT01172535|207793|P1|COMPLETED|Overall Study||89
88616|NCT01172535|207793|P1|STARTED|Overall Study||97
88617|NCT01172522|207810|P2|NOT COMPLETED|Overall Study||0
88618|NCT01172522|207811|P1|NOT COMPLETED|Overall Study||0
88619|NCT01172522|207810|P2|COMPLETED|Overall Study||15
88620|NCT01172522|207811|P1|COMPLETED|Overall Study||15
88621|NCT01172522|207810|P2|STARTED|Overall Study||15
88622|NCT01172522|207811|P1|STARTED|Overall Study||15
88623|NCT01172418|207818|P2|NOT COMPLETED|Overall Study||0
88624|NCT01172418|207819|P1|NOT COMPLETED|Overall Study||0
88625|NCT01172418|207818|P2|COMPLETED|Overall Study||100
88626|NCT01172418|207819|P1|COMPLETED|Overall Study||100
88627|NCT01172418|207818|P2|STARTED|Overall Study||100
88628|NCT01172418|207819|P1|STARTED|Overall Study||100
88629|NCT01172353|207827|P2|NOT COMPLETED|Overall Study||0
88630|NCT01172353|207828|P1|NOT COMPLETED|Overall Study||0
88631|NCT01172353|207827|P2|COMPLETED|Overall Study||151
88632|NCT01172353|207828|P1|COMPLETED|Overall Study||150
88633|NCT01172353|207827|P2|STARTED|Overall Study||151
88634|NCT01172353|207828|P1|STARTED|Overall Study||150
88635|NCT01172288|207838|P2|NOT COMPLETED|Overall Study||1
88636|NCT01172288|207839|P1|NOT COMPLETED|Overall Study||1
88637|NCT01172288|207838|P2|COMPLETED|Overall Study||13
88638|NCT01172288|207839|P1|COMPLETED|Overall Study||16
88639|NCT01172288|207838|P2|STARTED|Overall Study||14
88640|NCT01172288|207839|P1|STARTED|Overall Study||17
88641|NCT01172184|207853|P1|NOT COMPLETED|Overall Study||0
88642|NCT01172184|207853|P1|COMPLETED|Overall Study||111
88643|NCT01172184|207853|P1|STARTED|Overall Study||111
88644|NCT01172145|207861|P2|NOT COMPLETED|Overall Study||0
88645|NCT01172145|207862|P1|NOT COMPLETED|Overall Study||0
88646|NCT01172145|207861|P2|COMPLETED|Overall Study||11
88647|NCT01172145|207862|P1|COMPLETED|Overall Study||11
88648|NCT01172145|207861|P2|STARTED|Overall Study||11
88649|NCT01172145|207862|P1|STARTED|Overall Study||11
88650|NCT01171976|207885|P3|NOT COMPLETED|Overall Study||15
88651|NCT01171976|207886|P2|NOT COMPLETED|Overall Study||11
88652|NCT01171976|207887|P1|NOT COMPLETED|Overall Study||14
88653|NCT01171976|207885|P3|COMPLETED|Overall Study||108
88654|NCT01171976|207886|P2|COMPLETED|Overall Study||117
88655|NCT01171976|207887|P1|COMPLETED|Overall Study||107
88656|NCT01171976|207885|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
88657|NCT01171976|207886|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
88658|NCT01171976|207887|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
88659|NCT01171976|207885|P3|STARTED|Overall Study||123
88660|NCT01171976|207886|P2|STARTED|Overall Study||128
88661|NCT01171976|207887|P1|STARTED|Overall Study||121
88662|NCT01171963|207924|P2|NOT COMPLETED|Overall Study||168
88663|NCT01171963|207925|P1|NOT COMPLETED|Overall Study||148
88664|NCT01171963|207924|P2|COMPLETED|Overall Study||1499
88665|NCT01171963|207925|P1|COMPLETED|Overall Study||1518
88666|NCT01171963|207924|P2|STARTED|Overall Study||1667
88667|NCT01171963|207925|P1|STARTED|Overall Study||1666
88668|NCT01171924|207983|P2|NOT COMPLETED|Overall Study||23
88669|NCT01171924|207984|P1|NOT COMPLETED|Overall Study||23
88670|NCT01171924|207983|P2|COMPLETED|Overall Study||0
88671|NCT01171924|207984|P1|COMPLETED|Overall Study||0
88672|NCT01171924|207983|P2|STARTED|Overall Study||23
88673|NCT01171924|207984|P1|STARTED|Overall Study||23
88674|NCT01171820|207992|P2|NOT COMPLETED|Overall Study||6
88675|NCT01171820|207993|P1|NOT COMPLETED|Overall Study||6
88676|NCT01171820|207992|P2|COMPLETED|Overall Study||212
88677|NCT01171820|207993|P1|COMPLETED|Overall Study||100
88678|NCT01171820|207992|P2|STARTED|Overall Study||218
88679|NCT01171820|207993|P1|STARTED|Overall Study||106
88680|NCT01171690|208049|P2|NOT COMPLETED|Overall Study||0
88681|NCT01171690|208050|P1|NOT COMPLETED|Overall Study||0
88682|NCT01171690|208049|P2|COMPLETED|Overall Study||5
88683|NCT01171690|208050|P1|COMPLETED|Overall Study||5
88684|NCT01171690|208049|P2|STARTED|Overall Study||5
88685|NCT01171690|208050|P1|STARTED|Overall Study||5
88686|NCT01171677|208060|P2|NOT COMPLETED|Overall Study||3
88687|NCT01171677|208061|P1|NOT COMPLETED|Overall Study||6
88688|NCT01171677|208060|P2|COMPLETED|Overall Study||12
88689|NCT01171677|208061|P1|COMPLETED|Overall Study||11
88690|NCT01171677|208060|P2|STARTED|Overall Study||15
88691|NCT01171677|208061|P1|STARTED|Overall Study||17
88692|NCT01171612|208093|P1|NOT COMPLETED|Overall Study||51
88693|NCT01171612|208093|P1|COMPLETED|Overall Study||432
88694|NCT01171612|208093|P1|STARTED|Overall Study||483
88695|NCT01171534|208103|P2|NOT COMPLETED|Overall Study||3
88696|NCT01171534|208104|P1|NOT COMPLETED|Overall Study||0
88697|NCT01171534|208103|P2|COMPLETED|Overall Study||4
88698|NCT01171534|208104|P1|COMPLETED|Overall Study||0
88699|NCT01171534|208103|P2|STARTED|Overall Study||7
88700|NCT01171534|208104|P1|STARTED|Overall Study|retrospective arm never performed on study|0
88701|NCT01171521|208112|P1|NOT COMPLETED|Overall Study||6
88702|NCT01171521|208112|P1|COMPLETED|Overall Study||0
88703|NCT01171521|208112|P1|STARTED|Overall Study||6
88704|NCT01171183|208119|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
88705|NCT01171183|208120|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
88706|NCT01171183|208119|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
88707|NCT01171183|208120|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
88708|NCT01171183|208119|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
88709|NCT01171183|208120|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
88710|NCT01171183|208119|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
88711|NCT01171183|208120|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
88712|NCT01171183|208119|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
88713|NCT01171183|208120|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
88714|NCT01171183|208119|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
88715|NCT01171183|208120|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
88716|NCT01171118|208128|P1|NOT COMPLETED|Overall Study||0
88717|NCT01171118|208128|P1|COMPLETED|Overall Study||10
88718|NCT01171118|208128|P1|STARTED|Overall Study||10
88719|NCT01169987|208138|P1|NOT COMPLETED|Overall Study||31
88720|NCT01169987|208138|P1|COMPLETED|Overall Study||160
88721|NCT01169987|208138|P1|STARTED|Overall Study||191
88722|NCT01170962|208205|P3|NOT COMPLETED|Follow up Period||6
88723|NCT01170962|208206|P2|NOT COMPLETED|Follow up Period||27
88724|NCT01170962|208207|P1|NOT COMPLETED|Follow up Period||39
88725|NCT01170962|208205|P3|COMPLETED|Follow up Period||9
88726|NCT01170962|208206|P2|COMPLETED|Follow up Period||165
88727|NCT01170962|208207|P1|COMPLETED|Follow up Period||159
88728|NCT01170962|208205|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
88729|NCT01170962|208206|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
88730|NCT01170962|208207|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
88731|NCT01170962|208205|P3|NOT COMPLETED|Treatment Period||12
88732|NCT01170962|208206|P2|NOT COMPLETED|Treatment Period||111
88733|NCT01170962|208207|P1|NOT COMPLETED|Treatment Period||127
88734|NCT01170962|208205|P3|COMPLETED|Treatment Period||5
88735|NCT01170962|208206|P2|COMPLETED|Treatment Period||88
88736|NCT01170962|208207|P1|COMPLETED|Treatment Period||76
88737|NCT01170962|208205|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
88738|NCT01170962|208206|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
88739|NCT01170962|208207|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
88740|NCT01170962|208205|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
88741|NCT01170962|208206|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
88742|NCT01170962|208207|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
88743|NCT01170962|208205|P3|No PDR|Treatment Period||17
88744|NCT01170962|208206|P2|No PDR|Treatment Period||127
88745|NCT01170962|208207|P1|No PDR|Treatment Period||145
88746|NCT01170962|208205|P3|STARTED|Treatment Period||17
88747|NCT01170962|208206|P2|STARTED|Treatment Period||199
88748|NCT01170962|208207|P1|STARTED|Treatment Period||203
88749|NCT01170949|208253|P2|NOT COMPLETED|Overall Study||4
88750|NCT01170949|208254|P1|NOT COMPLETED|Overall Study||7
88751|NCT01170949|208253|P2|COMPLETED|Overall Study||22
88752|NCT01170949|208254|P1|COMPLETED|Overall Study||43
88753|NCT01170949|208253|P2|STARTED|Overall Study||26
88754|NCT01170949|208254|P1|STARTED|Overall Study||50
88755|NCT01170884|208262|P2|NOT COMPLETED|Overall Study||2
88756|NCT01170884|208263|P1|NOT COMPLETED|Overall Study||5
88757|NCT01170884|208262|P2|COMPLETED|Overall Study||60
88758|NCT01170884|208263|P1|COMPLETED|Overall Study||54
88759|NCT01170884|208262|P2|STARTED|Overall Study||62
88760|NCT01170884|208263|P1|STARTED|Overall Study||59
88761|NCT01170754|208271|P2|NOT COMPLETED|Overall Study||0
88762|NCT01170754|208272|P1|NOT COMPLETED|Overall Study||0
88763|NCT01170754|208271|P2|COMPLETED|Overall Study||70
88764|NCT01170754|208272|P1|COMPLETED|Overall Study||66
88765|NCT01170754|208271|P2|STARTED|Overall Study||70
88766|NCT01170754|208272|P1|STARTED|Overall Study||66
88767|NCT01170663|208280|P2|NOT COMPLETED|Overall Study||27
88768|NCT01170663|208281|P1|NOT COMPLETED|Overall Study||24
88769|NCT01170663|208280|P2|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|308
88770|NCT01170663|208281|P1|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|306
88771|NCT01170663|208280|P2|Received Any Treatment (Safety Pop)|Overall Study||329
88772|NCT01170663|208281|P1|Received Any Treatment (Safety Pop)|Overall Study||327
88773|NCT01170663|208280|P2|STARTED|Overall Study||335
88774|NCT01170663|208281|P1|STARTED|Overall Study||330
88775|NCT01170598|208309|P1|NOT COMPLETED|Overall Study||6
88776|NCT01170598|208309|P1|COMPLETED|Overall Study||29
88777|NCT01170598|208309|P1|STARTED|Overall Study||35
88778|NCT01170546|208328|P4|NOT COMPLETED|Overall Study||0
88779|NCT01170546|208329|P3|NOT COMPLETED|Overall Study||0
88780|NCT01170546|208330|P2|NOT COMPLETED|Overall Study||0
88781|NCT01170546|208331|P1|NOT COMPLETED|Overall Study||0
88782|NCT01170546|208328|P4|COMPLETED|Overall Study||8
88783|NCT01170546|208329|P3|COMPLETED|Overall Study||6
88784|NCT01170546|208330|P2|COMPLETED|Overall Study||7
88785|NCT01170546|208331|P1|COMPLETED|Overall Study||7
88786|NCT01170546|208328|P4|STARTED|Overall Study||8
88787|NCT01170546|208329|P3|STARTED|Overall Study||6
88788|NCT01170546|208330|P2|STARTED|Overall Study||7
88789|NCT01170546|208331|P1|STARTED|Overall Study||7
88790|NCT01170533|208341|P2|NOT COMPLETED|Pantoprazole Cross-over||0
88791|NCT01170533|208342|P1|NOT COMPLETED|Pantoprazole Cross-over||0
88792|NCT01170533|208341|P2|COMPLETED|Pantoprazole Cross-over||20
88793|NCT01170533|208342|P1|COMPLETED|Pantoprazole Cross-over||0
88794|NCT01170533|208341|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
88795|NCT01170533|208342|P1|STARTED|Pantoprazole Cross-over||0
88796|NCT01170533|208341|P2|NOT COMPLETED|Omeprazole Cross-over||0
88797|NCT01170533|208342|P1|NOT COMPLETED|Omeprazole Cross-over||0
88798|NCT01170533|208341|P2|COMPLETED|Omeprazole Cross-over||0
88799|NCT01170533|208342|P1|COMPLETED|Omeprazole Cross-over||20
88800|NCT01170533|208341|P2|STARTED|Omeprazole Cross-over||0
88801|NCT01170533|208342|P1|STARTED|Omeprazole Cross-over||20
88802|NCT01170390|208354|P3|NOT COMPLETED|Randomized Treatment||0
88803|NCT01170390|208355|P2|NOT COMPLETED|Randomized Treatment||1
88804|NCT01170390|208356|P1|NOT COMPLETED|Randomized Treatment||0
88805|NCT01170390|208354|P3|COMPLETED|Randomized Treatment||15
88806|NCT01170390|208355|P2|COMPLETED|Randomized Treatment||16
88807|NCT01170390|208356|P1|COMPLETED|Randomized Treatment||0
88808|NCT01170390|208354|P3|STARTED|Randomized Treatment||15
88809|NCT01170390|208355|P2|STARTED|Randomized Treatment||17
88810|NCT01170390|208356|P1|STARTED|Randomized Treatment||0
88811|NCT01170390|208354|P3|NOT COMPLETED|Oral Contraceptives||0
88812|NCT01170390|208355|P2|NOT COMPLETED|Oral Contraceptives||0
88813|NCT01170390|208356|P1|NOT COMPLETED|Oral Contraceptives||1
88814|NCT01170390|208354|P3|COMPLETED|Oral Contraceptives||0
88815|NCT01170390|208355|P2|COMPLETED|Oral Contraceptives||0
88816|NCT01170390|208356|P1|COMPLETED|Oral Contraceptives||31
88817|NCT01170390|208354|P3|STARTED|Oral Contraceptives||0
88818|NCT01170390|208355|P2|STARTED|Oral Contraceptives||0
88819|NCT01170390|208356|P1|STARTED|Oral Contraceptives||32
88820|NCT01170273|208372|P2|NOT COMPLETED|Overall Study||9
88821|NCT01170273|208373|P1|NOT COMPLETED|Overall Study||8
88822|NCT01170273|208372|P2|COMPLETED|Overall Study||57
88823|NCT01170273|208373|P1|COMPLETED|Overall Study||56
88824|NCT01170273|208372|P2|STARTED|Overall Study||66
88825|NCT01170273|208373|P1|STARTED|Overall Study||64
88826|NCT01170221|208381|P2|NOT COMPLETED|Overall Study||28
88827|NCT01170221|208382|P1|NOT COMPLETED|Overall Study||33
88828|NCT01170221|208381|P2|COMPLETED|Overall Study||307
88829|NCT01170221|208382|P1|COMPLETED|Overall Study||299
88830|NCT01170221|208381|P2|STARTED|Overall Study||335
88831|NCT01170221|208382|P1|STARTED|Overall Study||332
88832|NCT01170208|208405|P3|NOT COMPLETED|Overall Study||2
88833|NCT01170208|208406|P2|NOT COMPLETED|Overall Study||0
88834|NCT01170208|208407|P1|NOT COMPLETED|Overall Study||6
88835|NCT01170208|208405|P3|COMPLETED|Overall Study||4
88836|NCT01170208|208406|P2|COMPLETED|Overall Study||20
88837|NCT01170208|208407|P1|COMPLETED|Overall Study||14
88838|NCT01170208|208405|P3|STARTED|Overall Study||6
88839|NCT01170208|208406|P2|STARTED|Overall Study||20
88840|NCT01170208|208407|P1|STARTED|Overall Study||20
88841|NCT01170091|208415|P1|NOT COMPLETED|Overall Study||24
88842|NCT01170091|208415|P1|COMPLETED|Overall Study||627
88843|NCT01170091|208415|P1|STARTED|Overall Study||651
88844|NCT01170039|208424|P2|NOT COMPLETED|Overall Study||6
88845|NCT01170039|208425|P1|NOT COMPLETED|Overall Study||8
88846|NCT01170039|208424|P2|COMPLETED|Overall Study||33
88847|NCT01170039|208425|P1|COMPLETED|Overall Study||29
88848|NCT01170039|208424|P2|STARTED|Overall Study||39
88849|NCT01170039|208425|P1|STARTED|Overall Study||37
88850|NCT01169779|208439|P2|NOT COMPLETED|Overall Study||17
88851|NCT01169779|208440|P1|NOT COMPLETED|Overall Study||11
88852|NCT01169779|208439|P2|COMPLETED|Overall Study||179
88853|NCT01169779|208440|P1|COMPLETED|Overall Study||184
88854|NCT01169779|208439|P2|Subgroup for Standardized Meal Test|Overall Study||121
88855|NCT01169779|208440|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
88856|NCT01169779|208439|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
88857|NCT01169779|208440|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
88858|NCT01169779|208439|P2|Treated/Safety Population|Overall Study||196
88859|NCT01169779|208440|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
88860|NCT01169779|208439|P2|STARTED|Overall Study||196
88861|NCT01169779|208440|P1|STARTED|Overall Study|Randomized.|195
88862|NCT01169753|208466|P2|NOT COMPLETED|Overall Study||1
88863|NCT01169753|208467|P1|NOT COMPLETED|Overall Study||0
88864|NCT01169753|208466|P2|COMPLETED|Overall Study||0
88865|NCT01169753|208467|P1|COMPLETED|Overall Study||0
88866|NCT01169753|208466|P2|STARTED|Overall Study||1
88867|NCT01169753|208467|P1|STARTED|Overall Study||0
88868|NCT01169701|208475|P2|NOT COMPLETED|Overall Study||10
88869|NCT01169701|208476|P1|NOT COMPLETED|Overall Study||5
88870|NCT01169701|208475|P2|COMPLETED|Overall Study||25
88871|NCT01169701|208476|P1|COMPLETED|Overall Study||31
88872|NCT01169701|208475|P2|Intent to Treat (ITT) Set|Overall Study||28
88873|NCT01169701|208476|P1|Intent to Treat (ITT) Set|Overall Study||32
88874|NCT01169701|208475|P2|Safety Set|Overall Study||35
88875|NCT01169701|208476|P1|Safety Set|Overall Study||36
88876|NCT01169701|208475|P2|STARTED|Overall Study||35
88877|NCT01169701|208476|P1|STARTED|Overall Study||36
88878|NCT01169675|208513|P5|NOT COMPLETED|Overall Study||6
88879|NCT01169675|208514|P4|NOT COMPLETED|Overall Study||17
88880|NCT01169675|208515|P3|NOT COMPLETED|Overall Study||7
88881|NCT01169675|208516|P2|NOT COMPLETED|Overall Study||3
88882|NCT01169675|208517|P1|NOT COMPLETED|Overall Study||20
88883|NCT01169675|208513|P5|COMPLETED|Overall Study||0
88884|NCT01169675|208514|P4|COMPLETED|Overall Study||0
88885|NCT01169675|208515|P3|COMPLETED|Overall Study||0
88886|NCT01169675|208516|P2|COMPLETED|Overall Study||0
88887|NCT01169675|208517|P1|COMPLETED|Overall Study||0
88888|NCT01169675|208513|P5|STARTED|Overall Study||6
88889|NCT01169675|208514|P4|STARTED|Overall Study||17
88890|NCT01169675|208515|P3|STARTED|Overall Study||7
88891|NCT01169675|208516|P2|STARTED|Overall Study||3
88892|NCT01169675|208517|P1|STARTED|Overall Study||20
88893|NCT01169649|208554|P1|NOT COMPLETED|Overall Study||3
88894|NCT01169649|208554|P1|COMPLETED|Overall Study||8
88895|NCT01169649|208554|P1|STARTED|Overall Study||11
88896|NCT01169610|208558|P1|NOT COMPLETED|Overall Study||0
88897|NCT01169610|208558|P1|COMPLETED|Overall Study||1
88898|NCT01169610|208558|P1|STARTED|Overall Study||1
88899|NCT01169558|208566|P1|NOT COMPLETED|Overall Study||156
88900|NCT01169558|208566|P1|COMPLETED|Overall Study||6
88901|NCT01169558|208566|P1|STARTED|Overall Study||162
88902|NCT01169519|208573|P1|NOT COMPLETED|Overall Study||0
88903|NCT01169519|208573|P1|COMPLETED|Overall Study||21
88904|NCT01169519|208573|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
88905|NCT01169493|208591|P6|NOT COMPLETED|Period 3 (6 Months)||0
88906|NCT01169493|208592|P5|NOT COMPLETED|Period 3 (6 Months)||0
88907|NCT01169493|208593|P4|NOT COMPLETED|Period 3 (6 Months)||0
88908|NCT01169493|208594|P3|NOT COMPLETED|Period 3 (6 Months)||1
88909|NCT01169493|208595|P2|NOT COMPLETED|Period 3 (6 Months)||2
88910|NCT01169493|208596|P1|NOT COMPLETED|Period 3 (6 Months)||0
88911|NCT01169493|208591|P6|COMPLETED|Period 3 (6 Months)||2
88912|NCT01169493|208592|P5|COMPLETED|Period 3 (6 Months)||0
88913|NCT01169493|208593|P4|COMPLETED|Period 3 (6 Months)||0
88914|NCT01169493|208594|P3|COMPLETED|Period 3 (6 Months)||2
88915|NCT01169493|208595|P2|COMPLETED|Period 3 (6 Months)||1
88916|NCT01169493|208596|P1|COMPLETED|Period 3 (6 Months)||2
88917|NCT01169493|208591|P6|STARTED|Period 3 (6 Months)||2
88918|NCT01169493|208592|P5|STARTED|Period 3 (6 Months)||0
88919|NCT01169493|208593|P4|STARTED|Period 3 (6 Months)||0
88920|NCT01169493|208594|P3|STARTED|Period 3 (6 Months)||3
88921|NCT01169493|208595|P2|STARTED|Period 3 (6 Months)||3
88922|NCT01169493|208596|P1|STARTED|Period 3 (6 Months)||2
88923|NCT01169493|208591|P6|NOT COMPLETED|Period 2 (6 Months)||0
88924|NCT01169493|208592|P5|NOT COMPLETED|Period 2 (6 Months)||0
88925|NCT01169493|208593|P4|NOT COMPLETED|Period 2 (6 Months)||0
88926|NCT01169493|208594|P3|NOT COMPLETED|Period 2 (6 Months)||0
88927|NCT01169493|208595|P2|NOT COMPLETED|Period 2 (6 Months)||0
88928|NCT01169493|208596|P1|NOT COMPLETED|Period 2 (6 Months)||0
88929|NCT01169493|208591|P6|COMPLETED|Period 2 (6 Months)||2
88930|NCT01169493|208592|P5|COMPLETED|Period 2 (6 Months)||0
88931|NCT01169493|208593|P4|COMPLETED|Period 2 (6 Months)||0
88932|NCT01169493|208594|P3|COMPLETED|Period 2 (6 Months)||3
88933|NCT01169493|208595|P2|COMPLETED|Period 2 (6 Months)||3
88934|NCT01169493|208596|P1|COMPLETED|Period 2 (6 Months)||2
88935|NCT01169493|208591|P6|STARTED|Period 2 (6 Months)||2
88936|NCT01169493|208592|P5|STARTED|Period 2 (6 Months)||0
88937|NCT01169493|208593|P4|STARTED|Period 2 (6 Months)||0
88938|NCT01169493|208594|P3|STARTED|Period 2 (6 Months)||3
88939|NCT01169493|208595|P2|STARTED|Period 2 (6 Months)||3
88940|NCT01169493|208596|P1|STARTED|Period 2 (6 Months)||2
88941|NCT01169493|208591|P6|NOT COMPLETED|Period 1 (6 Months)||3
88942|NCT01169493|208592|P5|NOT COMPLETED|Period 1 (6 Months)||0
88943|NCT01169493|208593|P4|NOT COMPLETED|Period 1 (6 Months)||0
88944|NCT01169493|208594|P3|NOT COMPLETED|Period 1 (6 Months)||2
88945|NCT01169493|208595|P2|NOT COMPLETED|Period 1 (6 Months)||1
88946|NCT01169493|208596|P1|NOT COMPLETED|Period 1 (6 Months)||0
88947|NCT01169493|208591|P6|COMPLETED|Period 1 (6 Months)||2
88948|NCT01169493|208592|P5|COMPLETED|Period 1 (6 Months)||0
88949|NCT01169493|208593|P4|COMPLETED|Period 1 (6 Months)||0
88950|NCT01169493|208594|P3|COMPLETED|Period 1 (6 Months)||3
88951|NCT01169493|208595|P2|COMPLETED|Period 1 (6 Months)||3
88952|NCT01169493|208596|P1|COMPLETED|Period 1 (6 Months)||2
88953|NCT01169493|208591|P6|STARTED|Period 1 (6 Months)||5
88954|NCT01169493|208592|P5|STARTED|Period 1 (6 Months)||0
88955|NCT01169493|208593|P4|STARTED|Period 1 (6 Months)||0
88956|NCT01169493|208594|P3|STARTED|Period 1 (6 Months)||5
88957|NCT01169493|208595|P2|STARTED|Period 1 (6 Months)||4
88958|NCT01169493|208596|P1|STARTED|Period 1 (6 Months)||2
88959|NCT01169467|208627|P2|NOT COMPLETED|Overall Study||4
88960|NCT01169467|208628|P1|NOT COMPLETED|Overall Study||7
88961|NCT01169467|208627|P2|COMPLETED|Overall Study||36
88962|NCT01169467|208628|P1|COMPLETED|Overall Study||37
88963|NCT01169467|208627|P2|STARTED|Overall Study||40
88964|NCT01169467|208628|P1|STARTED|Overall Study||44
88965|NCT01169311|208642|P1|NOT COMPLETED|Overall Study||0
88966|NCT01169311|208642|P1|COMPLETED|Overall Study||27
88967|NCT01169311|208642|P1|STARTED|Overall Study||27
88968|NCT01169103|208656|P2|NOT COMPLETED|Overall Study||4
88969|NCT01169103|208657|P1|NOT COMPLETED|Overall Study||6
88970|NCT01169103|208656|P2|COMPLETED|Overall Study||7
88971|NCT01169103|208657|P1|COMPLETED|Overall Study||5
88972|NCT01169103|208656|P2|STARTED|Overall Study||11
88973|NCT01169103|208657|P1|STARTED|Overall Study||11
88974|NCT01169038|208671|P1|NOT COMPLETED|Overall Study||7
88975|NCT01169038|208671|P1|COMPLETED|Overall Study||8
88976|NCT01169038|208671|P1|STARTED|Overall Study||15
88977|NCT01168999|208679|P4|NOT COMPLETED|Overall Study||0
88978|NCT01168999|208680|P3|NOT COMPLETED|Overall Study||0
88979|NCT01168999|208681|P2|NOT COMPLETED|Overall Study||1
88980|NCT01168999|208682|P1|NOT COMPLETED|Overall Study||2
88981|NCT01168999|208679|P4|COMPLETED|Overall Study||28
88982|NCT01168999|208680|P3|COMPLETED|Overall Study||27
88983|NCT01168999|208681|P2|COMPLETED|Overall Study||26
88984|NCT01168999|208682|P1|COMPLETED|Overall Study||26
88985|NCT01168999|208679|P4|STARTED|Overall Study||28
88986|NCT01168999|208680|P3|STARTED|Overall Study||27
88987|NCT01168999|208681|P2|STARTED|Overall Study||27
88988|NCT01168999|208682|P1|STARTED|Overall Study||28
88989|NCT01168986|208727|P3|NOT COMPLETED|Overall Study||0
88990|NCT01168986|208728|P2|NOT COMPLETED|Overall Study||1
88991|NCT01168986|208729|P1|NOT COMPLETED|Overall Study||2
88992|NCT01168986|208727|P3|COMPLETED|Overall Study||21
88993|NCT01168986|208728|P2|COMPLETED|Overall Study||20
88994|NCT01168986|208729|P1|COMPLETED|Overall Study||18
88995|NCT01168986|208727|P3|STARTED|Overall Study||21
88996|NCT01168986|208728|P2|STARTED|Overall Study||21
88997|NCT01168986|208729|P1|STARTED|Overall Study||20
88998|NCT01168973|208748|P2|NOT COMPLETED|Overall Study||33
88999|NCT01168973|208749|P1|NOT COMPLETED|Overall Study||34
89000|NCT01168973|208748|P2|COMPLETED|Overall Study||592
89001|NCT01168973|208749|P1|COMPLETED|Overall Study||594
89002|NCT01168973|208748|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
89003|NCT01168973|208749|P1|Received Any Quantity of Any Study Drug|Overall Study||624
89004|NCT01168973|208748|P2|STARTED|Overall Study||625
89005|NCT01168973|208749|P1|STARTED|Overall Study||628
89006|NCT01168934|208770|P2|NOT COMPLETED|Second Intervention Period||0
89007|NCT01168934|208771|P1|NOT COMPLETED|Second Intervention Period||0
89008|NCT01168934|208770|P2|COMPLETED|Second Intervention Period||7
89009|NCT01168934|208771|P1|COMPLETED|Second Intervention Period||7
89010|NCT01168934|208770|P2|STARTED|Second Intervention Period||7
89011|NCT01168934|208771|P1|STARTED|Second Intervention Period||7
89012|NCT01168934|208770|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
89013|NCT01168934|208771|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
89014|NCT01168934|208770|P2|COMPLETED|Washout Period (at Least 14 Days)||7
89015|NCT01168934|208771|P1|COMPLETED|Washout Period (at Least 14 Days)||7
89016|NCT01168934|208770|P2|STARTED|Washout Period (at Least 14 Days)||7
89017|NCT01168934|208771|P1|STARTED|Washout Period (at Least 14 Days)||7
89018|NCT01168934|208770|P2|NOT COMPLETED|First Intervention Period||0
89019|NCT01168934|208771|P1|NOT COMPLETED|First Intervention Period||0
89020|NCT01168934|208770|P2|COMPLETED|First Intervention Period||7
89021|NCT01168934|208771|P1|COMPLETED|First Intervention Period||7
89022|NCT01168934|208770|P2|STARTED|First Intervention Period||7
89023|NCT01168934|208771|P1|STARTED|First Intervention Period||7
89024|NCT01168856|208805|P2|NOT COMPLETED|Overall Study||343
89025|NCT01168856|208806|P1|NOT COMPLETED|Overall Study||18
89026|NCT01168856|208805|P2|COMPLETED|Overall Study||215
89027|NCT01168856|208806|P1|COMPLETED|Overall Study||158
89028|NCT01168856|208805|P2|STARTED|Overall Study||558
89029|NCT01168856|208806|P1|STARTED|Overall Study||176
89030|NCT01168726|208866|P3|NOT COMPLETED|Overall Study||5
89031|NCT01168726|208867|P2|NOT COMPLETED|Overall Study||9
89032|NCT01168726|208868|P1|NOT COMPLETED|Overall Study||8
89033|NCT01168726|208866|P3|COMPLETED|Overall Study||128
89034|NCT01168726|208867|P2|COMPLETED|Overall Study||112
89035|NCT01168726|208868|P1|COMPLETED|Overall Study||103
89036|NCT01168726|208866|P3|STARTED|Overall Study||133
89037|NCT01168726|208867|P2|STARTED|Overall Study||121
89038|NCT01168726|208868|P1|STARTED|Overall Study||111
89039|NCT01168687|208887|P2|NOT COMPLETED|Overall Study||0
89040|NCT01168687|208888|P1|NOT COMPLETED|Overall Study||0
89041|NCT01168687|208887|P2|COMPLETED|Overall Study||23
89042|NCT01168687|208888|P1|COMPLETED|Overall Study||23
89043|NCT01168687|208887|P2|STARTED|Overall Study||23
89044|NCT01168687|208888|P1|STARTED|Overall Study||23
89045|NCT01168674|208894|P2|NOT COMPLETED|Overall Study||0
89046|NCT01168674|208895|P1|NOT COMPLETED|Overall Study||0
89047|NCT01168674|208894|P2|COMPLETED|Overall Study||24
89048|NCT01168674|208895|P1|COMPLETED|Overall Study||25
89049|NCT01168674|208894|P2|STARTED|Overall Study||24
89050|NCT01168674|208895|P1|STARTED|Overall Study||25
89051|NCT01168596|208904|P2|NOT COMPLETED|Overall Study||1
89052|NCT01168596|208905|P1|NOT COMPLETED|Overall Study||3
89053|NCT01168596|208904|P2|COMPLETED|Overall Study||13
89054|NCT01168596|208905|P1|COMPLETED|Overall Study||13
89055|NCT01168596|208904|P2|STARTED|Overall Study||14
89056|NCT01168596|208905|P1|STARTED|Overall Study||16
89057|NCT01168427|208949|P1|NOT COMPLETED|Overall Study||1
89058|NCT01168427|208949|P1|COMPLETED|Overall Study||65
89059|NCT01168427|208949|P1|STARTED|Overall Study||66
89060|NCT01168349|208954|P1|NOT COMPLETED|Overall Study||301
89061|NCT01168349|208954|P1|COMPLETED|Overall Study||754
89062|NCT01168349|208954|P1|STARTED|Overall Study||1055
89063|NCT01168232|209060|P1|NOT COMPLETED|Overall Study||8
89064|NCT01168232|209060|P1|COMPLETED|Overall Study|Eligible and treated patients|34
89065|NCT01168232|209060|P1|STARTED|Overall Study||42
89066|NCT01168024|209069|P2|NOT COMPLETED|Overall Study||0
89067|NCT01168024|209070|P1|NOT COMPLETED|Overall Study||0
89068|NCT01168024|209069|P2|COMPLETED|Overall Study||3
89069|NCT01168024|209070|P1|COMPLETED|Overall Study||13
89070|NCT01168024|209069|P2|STARTED|Overall Study||3
89071|NCT01168024|209070|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
89072|NCT01167881|209084|P2|NOT COMPLETED|Overall Study||191
89073|NCT01167881|209085|P1|NOT COMPLETED|Overall Study||159
89074|NCT01167881|209084|P2|COMPLETED|Overall Study||589
89075|NCT01167881|209085|P1|COMPLETED|Overall Study||610
89076|NCT01167881|209084|P2|Completed After 4 Years Treatment|Overall Study||462
89077|NCT01167881|209085|P1|Completed After 4 Years Treatment|Overall Study||515
89078|NCT01167881|209084|P2|Completed After 2 Years Treatment|Overall Study||127
89079|NCT01167881|209085|P1|Completed After 2 Years Treatment|Overall Study||95
89080|NCT01167881|209084|P2|STARTED|Overall Study||780
89081|NCT01167881|209085|P1|STARTED|Overall Study||769
89082|NCT01167829|209109|P1|NOT COMPLETED|Overall Study||0
89083|NCT01167829|209109|P1|COMPLETED|Overall Study||12
89084|NCT01167829|209109|P1|STARTED|Overall Study||12
89085|NCT01167608|209122|P1|NOT COMPLETED|Overall Study||114
89086|NCT01167608|209122|P1|COMPLETED|Overall Study||769
89087|NCT01167608|209122|P1|STARTED|Overall Study||883
89088|NCT01167582|209133|P2|NOT COMPLETED|Overall Study||1
89089|NCT01167582|209134|P1|NOT COMPLETED|Overall Study||0
89090|NCT01167582|209133|P2|COMPLETED|Overall Study||54
89091|NCT01167582|209134|P1|COMPLETED|Overall Study||55
89092|NCT01167582|209133|P2|STARTED|Overall Study||55
89093|NCT01167582|209134|P1|STARTED|Overall Study||55
89094|NCT01167504|209146|P1|NOT COMPLETED|Overall Study||3
89095|NCT01167504|209146|P1|COMPLETED|Overall Study||12
89096|NCT01167504|209146|P1|STARTED|Overall Study||15
89097|NCT01167452|209151|P1|NOT COMPLETED|Overall Study||0
89098|NCT01167452|209151|P1|COMPLETED|Overall Study||36
89099|NCT01167452|209151|P1|STARTED|Overall Study||36
89100|NCT01167426|209156|P1|NOT COMPLETED|Overall Study||10
89101|NCT01167426|209156|P1|COMPLETED|Overall Study||138
89102|NCT01167426|209156|P1|STARTED|Overall Study||148
89103|NCT01167257|209164|P2|NOT COMPLETED|Overall Study||3
89104|NCT01167257|209165|P1|NOT COMPLETED|Overall Study||3
89105|NCT01167257|209164|P2|COMPLETED|Overall Study||28
89106|NCT01167257|209165|P1|COMPLETED|Overall Study||28
89107|NCT01167257|209164|P2|STARTED|Overall Study||31
89108|NCT01167257|209165|P1|STARTED|Overall Study||31
89109|NCT01167192|209187|P1|NOT COMPLETED|Overall Study||4
89110|NCT01167192|209187|P1|COMPLETED|Overall Study||6
89111|NCT01167192|209187|P1|STARTED|Overall Study||10
89112|NCT01167153|209204|P2|NOT COMPLETED|Overall Study||33
89113|NCT01167153|209205|P1|NOT COMPLETED|Overall Study||18
89114|NCT01167153|209204|P2|COMPLETED|Overall Study||249
89115|NCT01167153|209205|P1|COMPLETED|Overall Study||264
89116|NCT01167153|209204|P2|Intention to Treat (ITT)|Overall Study||268
89117|NCT01167153|209205|P1|Intention to Treat (ITT)|Overall Study||272
89118|NCT01167153|209204|P2|STARTED|Overall Study||282
89119|NCT01167153|209205|P1|STARTED|Overall Study||282
89120|NCT01167140|209223|P1|NOT COMPLETED|Overall Study||1
89121|NCT01167140|209223|P1|COMPLETED|Overall Study||41
89122|NCT01167140|209223|P1|STARTED|Overall Study||42
89123|NCT01167023|209231|P3|NOT COMPLETED|Overall Study||2
89124|NCT01167023|209232|P2|NOT COMPLETED|Overall Study||3
89125|NCT01167023|209233|P1|NOT COMPLETED|Overall Study||0
89126|NCT01167023|209231|P3|COMPLETED|Overall Study||39
89127|NCT01167023|209232|P2|COMPLETED|Overall Study||18
89128|NCT01167023|209233|P1|COMPLETED|Overall Study||0
89224|NCT01165684|209474|P1|COMPLETED|Overall Study||173
89129|NCT01167023|209231|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
89130|NCT01167023|209232|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
89131|NCT01167023|209233|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
89132|NCT01167023|209231|P3|STARTED|Overall Study||41
89133|NCT01167023|209232|P2|STARTED|Overall Study||21
89134|NCT01167023|209233|P1|STARTED|Overall Study||0
89135|NCT01166997|209253|P2|NOT COMPLETED|Overall Study||0
89136|NCT01166997|209254|P1|NOT COMPLETED|Overall Study||2
89137|NCT01166997|209253|P2|COMPLETED|Overall Study||30
89138|NCT01166997|209254|P1|COMPLETED|Overall Study||27
89139|NCT01166997|209253|P2|STARTED|Overall Study||30
89140|NCT01166997|209254|P1|STARTED|Overall Study||29
89141|NCT01166971|209264|P2|NOT COMPLETED|Overall Study||1
89142|NCT01166971|209265|P1|NOT COMPLETED|Overall Study||1
89143|NCT01166971|209264|P2|COMPLETED|Overall Study||30
89144|NCT01166971|209265|P1|COMPLETED|Overall Study||32
89145|NCT01166971|209264|P2|STARTED|Overall Study||31
89146|NCT01166971|209265|P1|STARTED|Overall Study||33
89147|NCT01166958|209273|P2|NOT COMPLETED|Overall Study||0
89148|NCT01166958|209274|P1|NOT COMPLETED|Overall Study||1
89149|NCT01166958|209273|P2|COMPLETED|Overall Study||13
89150|NCT01166958|209274|P1|COMPLETED|Overall Study||12
89151|NCT01166958|209273|P2|STARTED|Overall Study||13
89152|NCT01166958|209274|P1|STARTED|Overall Study||13
89153|NCT01166763|209288|P1|NOT COMPLETED|Overall Study||3
89154|NCT01166763|209288|P1|COMPLETED|Overall Study||27
89155|NCT01166763|209288|P1|STARTED|Overall Study||30
89156|NCT01166750|209296|P2|NOT COMPLETED|Overall Study||0
89157|NCT01166750|209297|P1|NOT COMPLETED|Overall Study||1
89158|NCT01166750|209296|P2|COMPLETED|Overall Study||13
89159|NCT01166750|209297|P1|COMPLETED|Overall Study||9
89160|NCT01166750|209296|P2|STARTED|Overall Study||13
89161|NCT01166750|209297|P1|STARTED|Overall Study||10
89162|NCT01166659|209303|P1|NOT COMPLETED|Overall Study||13
89163|NCT01166659|209303|P1|COMPLETED|Overall Study||35
89164|NCT01166659|209303|P1|STARTED|Overall Study||48
89165|NCT01166646|209312|P2|NOT COMPLETED|Overall Study||1
89166|NCT01166646|209313|P1|NOT COMPLETED|Overall Study||1
89167|NCT01166646|209312|P2|COMPLETED|Overall Study||21
89168|NCT01166646|209313|P1|COMPLETED|Overall Study||20
89169|NCT01166646|209312|P2|STARTED|Overall Study||22
89170|NCT01166646|209313|P1|STARTED|Overall Study||21
89171|NCT01166282|209331|P3|NOT COMPLETED|Open-label Period||17
89172|NCT01166282|209332|P2|NOT COMPLETED|Open-label Period||0
89173|NCT01166282|209333|P1|NOT COMPLETED|Open-label Period||0
89174|NCT01166282|209331|P3|COMPLETED|Open-label Period||29
89175|NCT01166282|209332|P2|COMPLETED|Open-label Period||0
89176|NCT01166282|209333|P1|COMPLETED|Open-label Period||0
89177|NCT01166282|209331|P3|STARTED|Open-label Period||46
89178|NCT01166282|209332|P2|STARTED|Open-label Period||0
89179|NCT01166282|209333|P1|STARTED|Open-label Period||0
89180|NCT01166282|209331|P3|NOT COMPLETED|Double-blind Period||0
89181|NCT01166282|209332|P2|NOT COMPLETED|Double-blind Period||0
89182|NCT01166282|209333|P1|NOT COMPLETED|Double-blind Period||0
89183|NCT01166282|209331|P3|COMPLETED|Double-blind Period||0
89184|NCT01166282|209332|P2|COMPLETED|Double-blind Period||31
89185|NCT01166282|209333|P1|COMPLETED|Double-blind Period||15
89186|NCT01166282|209331|P3|STARTED|Double-blind Period||0
89187|NCT01166282|209332|P2|STARTED|Double-blind Period||31
89188|NCT01166282|209333|P1|STARTED|Double-blind Period||15
89189|NCT01166230|209357|P2|NOT COMPLETED|Overall Study||16
89190|NCT01166230|209358|P1|NOT COMPLETED|Overall Study||19
89191|NCT01166230|209357|P2|COMPLETED|Overall Study||255
89192|NCT01166230|209358|P1|COMPLETED|Overall Study||261
89193|NCT01166230|209357|P2|STARTED|Overall Study||271
89194|NCT01166230|209358|P1|STARTED|Overall Study||280
89195|NCT01166178|209372|P2|NOT COMPLETED|Overall Study||8
89196|NCT01166178|209373|P1|NOT COMPLETED|Overall Study||21
89197|NCT01166178|209372|P2|COMPLETED|Overall Study||0
89198|NCT01166178|209373|P1|COMPLETED|Overall Study||0
89199|NCT01166178|209372|P2|STARTED|Overall Study||8
89200|NCT01166178|209373|P1|STARTED|Overall Study||21
89201|NCT01166126|209399|P1|NOT COMPLETED|Overall Study||0
89202|NCT01166126|209399|P1|COMPLETED|Overall Study||4
89203|NCT01166126|209399|P1|STARTED|Overall Study||4
89204|NCT01165996|209406|P1|NOT COMPLETED|Overall Study||2
89205|NCT01165996|209406|P1|COMPLETED|Overall Study||23
89206|NCT01165996|209406|P1|Maintenance Phase|Overall Study||23
89207|NCT01165996|209406|P1|Induction Phase|Overall Study||25
89208|NCT01165996|209406|P1|STARTED|Overall Study||25
89209|NCT01165983|209414|P2|NOT COMPLETED|Overall Study||7
89210|NCT01165983|209415|P1|NOT COMPLETED|Overall Study||5
89211|NCT01165983|209414|P2|COMPLETED|Overall Study||42
89212|NCT01165983|209415|P1|COMPLETED|Overall Study||46
89213|NCT01165983|209414|P2|STARTED|Overall Study||49
89214|NCT01165983|209415|P1|STARTED|Overall Study||51
89215|NCT01165840|209459|P1|NOT COMPLETED|Overall Study||0
89216|NCT01165840|209459|P1|COMPLETED|Overall Study||36
89217|NCT01165840|209459|P1|STARTED|Overall Study||36
89218|NCT01165775|209463|P1|NOT COMPLETED|Overall Study||2
89219|NCT01165775|209463|P1|COMPLETED|Overall Study||15
89220|NCT01165775|209463|P1|STARTED|Overall Study||17
89221|NCT01165684|209473|P2|NOT COMPLETED|Overall Study||52
89222|NCT01165684|209474|P1|NOT COMPLETED|Overall Study||28
89223|NCT01165684|209473|P2|COMPLETED|Overall Study||148
89225|NCT01165684|209473|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
89226|NCT01165684|209474|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
89227|NCT01165684|209473|P2|STARTED|Overall Study||200
89228|NCT01165684|209474|P1|STARTED|Overall Study||201
89229|NCT01165554|209508|P1|NOT COMPLETED|Overall Study||23
89230|NCT01165554|209508|P1|COMPLETED|Overall Study||180
89231|NCT01165554|209508|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
89232|NCT01165541|209515|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
89233|NCT01165541|209515|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
89234|NCT01165541|209515|P1|STARTED|Quetiapine XR and Mirtazepine||16
89235|NCT01165541|209515|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
89236|NCT01165541|209515|P1|COMPLETED|Quetiapine XR Monotherapy||16
89237|NCT01165541|209515|P1|STARTED|Quetiapine XR Monotherapy||20
89238|NCT01165450|209521|P1|NOT COMPLETED|Overall Study||0
89239|NCT01165450|209521|P1|COMPLETED|Overall Study||2
89240|NCT01165450|209521|P1|STARTED|Overall Study||2
89241|NCT01165424|209531|P1|NOT COMPLETED|Overall Study||4
89242|NCT01165424|209531|P1|COMPLETED|Overall Study||76
89243|NCT01165424|209531|P1|STARTED|Overall Study||80
89244|NCT01165320|209538|P3|NOT COMPLETED|Overall Study||0
89245|NCT01165320|209539|P2|NOT COMPLETED|Overall Study||4
89246|NCT01165320|209540|P1|NOT COMPLETED|Overall Study||3
89247|NCT01165320|209538|P3|COMPLETED|Overall Study||0
89248|NCT01165320|209539|P2|COMPLETED|Overall Study||4
89249|NCT01165320|209540|P1|COMPLETED|Overall Study||9
89250|NCT01165320|209538|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
89251|NCT01165320|209539|P2|STARTED|Overall Study||8
89252|NCT01165320|209540|P1|STARTED|Overall Study||12
89253|NCT01165307|209550|P2|NOT COMPLETED|Overall Study||3
89254|NCT01165307|209551|P1|NOT COMPLETED|Overall Study||14
89255|NCT01165307|209550|P2|COMPLETED|Overall Study||31
89256|NCT01165307|209551|P1|COMPLETED|Overall Study||19
89257|NCT01165307|209550|P2|STARTED|Overall Study||34
89258|NCT01165307|209551|P1|STARTED|Overall Study||33
89259|NCT01165281|209581|P2|NOT COMPLETED|Overall Study||51
89260|NCT01165281|209582|P1|NOT COMPLETED|Overall Study||58
89261|NCT01165281|209581|P2|COMPLETED|Overall Study||121
89262|NCT01165281|209582|P1|COMPLETED|Overall Study||110
89263|NCT01165281|209581|P2|STARTED|Overall Study||172
89264|NCT01165281|209582|P1|STARTED|Overall Study||168
89265|NCT01165216|209602|P2|NOT COMPLETED|Overall Study||7
89266|NCT01165216|209603|P1|NOT COMPLETED|Overall Study||8
89267|NCT01165216|209602|P2|COMPLETED|Overall Study|Completed=still on study drug|0
89268|NCT01165216|209603|P1|COMPLETED|Overall Study|Completed=still on study drug|0
89269|NCT01165216|209602|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
89270|NCT01165216|209603|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
89271|NCT01165216|209602|P2|STARTED|Overall Study|Participants who received any study drug|7
89272|NCT01165216|209603|P1|STARTED|Overall Study|Participants who received any study drug|8
89273|NCT01165138|209626|P4|NOT COMPLETED|Overall Study||22
89274|NCT01165138|209627|P3|NOT COMPLETED|Overall Study||20
89275|NCT01165138|209628|P2|NOT COMPLETED|Overall Study||52
89276|NCT01165138|209629|P1|NOT COMPLETED|Overall Study||0
89277|NCT01165138|209626|P4|COMPLETED|Overall Study||179
89278|NCT01165138|209627|P3|COMPLETED|Overall Study||185
89279|NCT01165138|209628|P2|COMPLETED|Overall Study||151
89280|NCT01165138|209629|P1|COMPLETED|Overall Study||0
89281|NCT01165138|209626|P4|STARTED|Overall Study||201
89282|NCT01165138|209627|P3|STARTED|Overall Study||205
89283|NCT01165138|209628|P2|STARTED|Overall Study||203
89284|NCT01165138|209629|P1|STARTED|Overall Study||0
89285|NCT01165047|209688|P1|NOT COMPLETED|Overall Study||0
89286|NCT01165047|209688|P1|COMPLETED|Overall Study||10
89287|NCT01165047|209688|P1|STARTED|Overall Study||10
89288|NCT01165021|209692|P1|NOT COMPLETED|Overall Study||1
89289|NCT01165021|209692|P1|COMPLETED|Overall Study||18
89290|NCT01165021|209692|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
89291|NCT01165021|209692|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
89292|NCT01165021|209692|P1|≥1 Dose Chemo|Overall Study||19
89293|NCT01165021|209692|P1|STARTED|Overall Study||19
89294|NCT01164891|209700|P1|NOT COMPLETED|Overall Study||6
89295|NCT01164891|209700|P1|COMPLETED|Overall Study||1
89296|NCT01164891|209700|P1|STARTED|Overall Study||7
89297|NCT01164865|209720|P2|NOT COMPLETED|Overall Study||1
89298|NCT01164865|209721|P1|NOT COMPLETED|Overall Study||2
89299|NCT01164865|209720|P2|COMPLETED|Overall Study||38
89300|NCT01164865|209721|P1|COMPLETED|Overall Study||37
89301|NCT01164865|209720|P2|STARTED|Overall Study||39
89302|NCT01164865|209721|P1|STARTED|Overall Study||39
89303|NCT01164722|209731|P2|NOT COMPLETED|Overall Study||15
89304|NCT01164722|209732|P1|NOT COMPLETED|Overall Study||18
89305|NCT01164722|209731|P2|COMPLETED|Overall Study||45
89306|NCT01164722|209732|P1|COMPLETED|Overall Study||42
89307|NCT01164722|209731|P2|STARTED|Overall Study||60
89308|NCT01164722|209732|P1|STARTED|Overall Study||60
89309|NCT01164644|209748|P2|NOT COMPLETED|Overall Study||1
89310|NCT01164644|209749|P1|NOT COMPLETED|Overall Study||3
89311|NCT01164644|209748|P2|COMPLETED|Overall Study||13
89312|NCT01164644|209749|P1|COMPLETED|Overall Study||9
89313|NCT01164644|209748|P2|STARTED|Overall Study||14
89314|NCT01164644|209749|P1|STARTED|Overall Study||12
89315|NCT01164579|209762|P3|NOT COMPLETED|Overall Study||16
89316|NCT01164579|209763|P2|NOT COMPLETED|Overall Study||9
89317|NCT01164579|209764|P1|NOT COMPLETED|Overall Study||8
89318|NCT01164579|209762|P3|COMPLETED|Overall Study||21
89319|NCT01164579|209763|P2|COMPLETED|Overall Study||27
89320|NCT01164579|209764|P1|COMPLETED|Overall Study||28
89321|NCT01164579|209762|P3|STARTED|Overall Study||37
89322|NCT01164579|209763|P2|STARTED|Overall Study||36
89323|NCT01164579|209764|P1|STARTED|Overall Study||36
89324|NCT01164501|209844|P3|NOT COMPLETED|Overall Study||42
89325|NCT01164501|209845|P2|NOT COMPLETED|Overall Study||10
89326|NCT01164501|209846|P1|NOT COMPLETED|Overall Study||43
89327|NCT01164501|209844|P3|COMPLETED|Overall Study||280
89328|NCT01164501|209845|P2|COMPLETED|Overall Study||88
89329|NCT01164501|209846|P1|COMPLETED|Overall Study||278
89330|NCT01164501|209844|P3|STARTED|Overall Study||322
89331|NCT01164501|209845|P2|STARTED|Overall Study||98
89332|NCT01164501|209846|P1|STARTED|Overall Study||321
89333|NCT01164475|209863|P2|NOT COMPLETED|Overall Study||2
89334|NCT01164475|209864|P1|NOT COMPLETED|Overall Study||2
89335|NCT01164475|209863|P2|COMPLETED|Overall Study||29
89336|NCT01164475|209864|P1|COMPLETED|Overall Study||28
89337|NCT01164475|209863|P2|STARTED|Overall Study||31
89338|NCT01164475|209864|P1|STARTED|Overall Study||30
89339|NCT01164137|209890|P2|NOT COMPLETED|Overall Study||0
89340|NCT01164137|209891|P1|NOT COMPLETED|Overall Study||3
89341|NCT01164137|209890|P2|COMPLETED|Overall Study||76
89342|NCT01164137|209891|P1|COMPLETED|Overall Study||77
89343|NCT01164137|209890|P2|STARTED|Overall Study||76
89344|NCT01164137|209891|P1|STARTED|Overall Study||80
89345|NCT01163955|209907|P2|NOT COMPLETED|Overall Study||4
89346|NCT01163955|209908|P1|NOT COMPLETED|Overall Study||0
89347|NCT01163955|209907|P2|COMPLETED|Overall Study||26
89348|NCT01163955|209908|P1|COMPLETED|Overall Study||26
89349|NCT01163955|209907|P2|STARTED|Overall Study||30
89350|NCT01163955|209908|P1|STARTED|Overall Study||26
89351|NCT01163916|209917|P3|NOT COMPLETED|Overall Study||20
89352|NCT01163916|209918|P2|NOT COMPLETED|Overall Study||4
89353|NCT01163916|209919|P1|NOT COMPLETED|Overall Study||30
89354|NCT01163916|209917|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
89355|NCT01163916|209918|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
89356|NCT01163916|209919|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
89357|NCT01163916|209917|P3|Safety Population|Overall Study||91
89358|NCT01163916|209918|P2|Safety Population|Overall Study||35
89359|NCT01163916|209919|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
89360|NCT01163916|209917|P3|STARTED|Overall Study||91
89361|NCT01163916|209918|P2|STARTED|Overall Study||35
89362|NCT01163916|209919|P1|STARTED|Overall Study||126
89363|NCT01163851|209957|P2|NOT COMPLETED|Overall Study||1
89364|NCT01163851|209958|P1|NOT COMPLETED|Overall Study||1
89365|NCT01163851|209957|P2|COMPLETED|Overall Study||11
89366|NCT01163851|209958|P1|COMPLETED|Overall Study||12
89367|NCT01163851|209957|P2|TREATED|Overall Study||12
89368|NCT01163851|209958|P1|TREATED|Overall Study||12
89369|NCT01163851|209957|P2|STARTED|Overall Study||12
89370|NCT01163851|209958|P1|STARTED|Overall Study||13
89371|NCT01163760|210032|P4|NOT COMPLETED|Period 4 (Follow-up)||0
89372|NCT01163760|210033|P3|NOT COMPLETED|Period 4 (Follow-up)||0
89373|NCT01163760|210034|P2|NOT COMPLETED|Period 4 (Follow-up)||0
89374|NCT01163760|210035|P1|NOT COMPLETED|Period 4 (Follow-up)||0
89375|NCT01163760|210032|P4|COMPLETED|Period 4 (Follow-up)||12
89376|NCT01163760|210033|P3|COMPLETED|Period 4 (Follow-up)||13
89377|NCT01163760|210034|P2|COMPLETED|Period 4 (Follow-up)||13
89378|NCT01163760|210035|P1|COMPLETED|Period 4 (Follow-up)||12
89379|NCT01163760|210032|P4|STARTED|Period 4 (Follow-up)||12
89380|NCT01163760|210033|P3|STARTED|Period 4 (Follow-up)||13
89381|NCT01163760|210034|P2|STARTED|Period 4 (Follow-up)||13
89382|NCT01163760|210035|P1|STARTED|Period 4 (Follow-up)||12
89383|NCT01163760|210032|P4|NOT COMPLETED|Period 3 (Fit)||0
89384|NCT01163760|210033|P3|NOT COMPLETED|Period 3 (Fit)||0
89385|NCT01163760|210034|P2|NOT COMPLETED|Period 3 (Fit)||0
89386|NCT01163760|210035|P1|NOT COMPLETED|Period 3 (Fit)||0
89387|NCT01163760|210032|P4|COMPLETED|Period 3 (Fit)||12
89388|NCT01163760|210033|P3|COMPLETED|Period 3 (Fit)||13
89389|NCT01163760|210034|P2|COMPLETED|Period 3 (Fit)||13
89390|NCT01163760|210035|P1|COMPLETED|Period 3 (Fit)||12
89391|NCT01163760|210032|P4|STARTED|Period 3 (Fit)||12
89392|NCT01163760|210033|P3|STARTED|Period 3 (Fit)||13
89393|NCT01163760|210034|P2|STARTED|Period 3 (Fit)||13
89394|NCT01163760|210035|P1|STARTED|Period 3 (Fit)||12
89395|NCT01163760|210032|P4|NOT COMPLETED|Period 2 (Follow-up)||0
89396|NCT01163760|210033|P3|NOT COMPLETED|Period 2 (Follow-up)||0
89397|NCT01163760|210034|P2|NOT COMPLETED|Period 2 (Follow-up)||0
89398|NCT01163760|210035|P1|NOT COMPLETED|Period 2 (Follow-up)||0
89399|NCT01163760|210032|P4|COMPLETED|Period 2 (Follow-up)||12
89400|NCT01163760|210033|P3|COMPLETED|Period 2 (Follow-up)||13
89401|NCT01163760|210034|P2|COMPLETED|Period 2 (Follow-up)||13
89402|NCT01163760|210035|P1|COMPLETED|Period 2 (Follow-up)||12
89403|NCT01163760|210032|P4|STARTED|Period 2 (Follow-up)||12
89404|NCT01163760|210033|P3|STARTED|Period 2 (Follow-up)||13
89405|NCT01163760|210034|P2|STARTED|Period 2 (Follow-up)||13
89406|NCT01163760|210035|P1|STARTED|Period 2 (Follow-up)||12
89407|NCT01163760|210032|P4|NOT COMPLETED|Period 1 (Fit)||0
89408|NCT01163760|210033|P3|NOT COMPLETED|Period 1 (Fit)||0
89409|NCT01163760|210034|P2|NOT COMPLETED|Period 1 (Fit)||0
89410|NCT01163760|210035|P1|NOT COMPLETED|Period 1 (Fit)||0
89411|NCT01163760|210032|P4|COMPLETED|Period 1 (Fit)||12
89412|NCT01163760|210033|P3|COMPLETED|Period 1 (Fit)||13
89413|NCT01163760|210034|P2|COMPLETED|Period 1 (Fit)||13
89414|NCT01163760|210035|P1|COMPLETED|Period 1 (Fit)||12
89415|NCT01163760|210032|P4|STARTED|Period 1 (Fit)||12
89416|NCT01163760|210033|P3|STARTED|Period 1 (Fit)||13
89417|NCT01163760|210034|P2|STARTED|Period 1 (Fit)||13
89418|NCT01163760|210035|P1|STARTED|Period 1 (Fit)||12
89419|NCT01163747|210049|P2|NOT COMPLETED|Overall Study||11
89420|NCT01163747|210050|P1|NOT COMPLETED|Overall Study||6
89421|NCT01163747|210049|P2|COMPLETED|Overall Study||49
89422|NCT01163747|210050|P1|COMPLETED|Overall Study||25
89423|NCT01163747|210049|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
89424|NCT01163747|210050|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
89425|NCT01163747|210049|P2|STARTED|Overall Study||60
89426|NCT01163747|210050|P1|STARTED|Overall Study||31
89427|NCT01163721|210070|P2|NOT COMPLETED|Overall Study||12
89428|NCT01163721|210071|P1|NOT COMPLETED|Overall Study||8
89429|NCT01163721|210070|P2|COMPLETED|Overall Study||29
89430|NCT01163721|210071|P1|COMPLETED|Overall Study||31
89431|NCT01163721|210070|P2|STARTED|Overall Study||41
89432|NCT01163721|210071|P1|STARTED|Overall Study||39
89433|NCT01163656|210083|P2|NOT COMPLETED|Overall Study||3
89434|NCT01163656|210084|P1|NOT COMPLETED|Overall Study||3
89435|NCT01163656|210083|P2|COMPLETED|Overall Study||30
89436|NCT01163656|210084|P1|COMPLETED|Overall Study||30
89437|NCT01163656|210083|P2|STARTED|Overall Study||33
89438|NCT01163656|210084|P1|STARTED|Overall Study||33
89439|NCT01163617|210090|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89440|NCT01163617|210091|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89441|NCT01163617|210092|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89442|NCT01163617|210093|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89443|NCT01163617|210094|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89444|NCT01163617|210095|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89445|NCT01163617|210096|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89446|NCT01163617|210097|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
89447|NCT01163617|210090|P8|COMPLETED|Phase B (Injection Time), Week 4||20
89448|NCT01163617|210091|P7|COMPLETED|Phase B (Injection Time), Week 4||16
89449|NCT01163617|210092|P6|COMPLETED|Phase B (Injection Time), Week 4||27
89450|NCT01163617|210093|P5|COMPLETED|Phase B (Injection Time), Week 4||18
89451|NCT01163617|210094|P4|COMPLETED|Phase B (Injection Time), Week 4||0
89452|NCT01163617|210095|P3|COMPLETED|Phase B (Injection Time), Week 4||0
89453|NCT01163617|210096|P2|COMPLETED|Phase B (Injection Time), Week 4||0
89454|NCT01163617|210097|P1|COMPLETED|Phase B (Injection Time), Week 4||0
89455|NCT01163617|210090|P8|STARTED|Phase B (Injection Time), Week 4||20
89456|NCT01163617|210091|P7|STARTED|Phase B (Injection Time), Week 4||16
89457|NCT01163617|210092|P6|STARTED|Phase B (Injection Time), Week 4||27
89458|NCT01163617|210093|P5|STARTED|Phase B (Injection Time), Week 4||18
89459|NCT01163617|210094|P4|STARTED|Phase B (Injection Time), Week 4||0
89460|NCT01163617|210095|P3|STARTED|Phase B (Injection Time), Week 4||0
89461|NCT01163617|210096|P2|STARTED|Phase B (Injection Time), Week 4||0
89462|NCT01163617|210097|P1|STARTED|Phase B (Injection Time), Week 4||0
89463|NCT01163617|210090|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89464|NCT01163617|210091|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89465|NCT01163617|210092|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89466|NCT01163617|210093|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89467|NCT01163617|210094|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89468|NCT01163617|210095|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
89469|NCT01163617|210096|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
89470|NCT01163617|210097|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89471|NCT01163617|210090|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89472|NCT01163617|210091|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89473|NCT01163617|210092|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89474|NCT01163617|210093|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
89475|NCT01163617|210094|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
89476|NCT01163617|210095|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
89477|NCT01163617|210096|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
89478|NCT01163617|210097|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
89479|NCT01163617|210090|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
89480|NCT01163617|210091|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
89481|NCT01163617|210092|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
89482|NCT01163617|210093|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
89483|NCT01163617|210094|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
89484|NCT01163617|210095|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
89485|NCT01163617|210096|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
89486|NCT01163617|210097|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
89487|NCT01163604|210119|P2|NOT COMPLETED|Overall Study||0
89488|NCT01163604|210120|P1|NOT COMPLETED|Overall Study||0
89489|NCT01163604|210119|P2|COMPLETED|Overall Study|August 2011|56
89490|NCT01163604|210120|P1|COMPLETED|Overall Study|August 2011|58
89491|NCT01163604|210119|P2|STARTED|Overall Study|August 2010|56
89492|NCT01163604|210120|P1|STARTED|Overall Study|August 2010|58
89493|NCT01163474|210126|P1|NOT COMPLETED|Overall Study||16
89494|NCT01163474|210126|P1|COMPLETED|Overall Study||24
89495|NCT01163474|210126|P1|STARTED|Overall Study||40
89496|NCT01163461|210132|P2|NOT COMPLETED|Overall Study||0
89497|NCT01163461|210133|P1|NOT COMPLETED|Overall Study||0
89498|NCT01163461|210132|P2|COMPLETED|Overall Study||14
89499|NCT01163461|210133|P1|COMPLETED|Overall Study||14
89500|NCT01163461|210132|P2|STARTED|Overall Study||14
89501|NCT01163461|210133|P1|STARTED|Overall Study||14
89502|NCT01163318|210137|P1|NOT COMPLETED|Overall Study||268
89503|NCT01163318|210137|P1|COMPLETED|Overall Study||284
89504|NCT01163318|210137|P1|STARTED|Overall Study||552
89505|NCT01163292|210146|P2|NOT COMPLETED|Overall Study||22
89506|NCT01163292|210147|P1|NOT COMPLETED|Overall Study||41
89507|NCT01163292|210146|P2|COMPLETED|Overall Study||92
89508|NCT01163292|210147|P1|COMPLETED|Overall Study||65
89509|NCT01163292|210146|P2|STARTED|Overall Study||114
89510|NCT01163292|210147|P1|STARTED|Overall Study||106
89511|NCT01163279|210163|P2|NOT COMPLETED|Overall Study||0
89512|NCT01163279|210164|P1|NOT COMPLETED|Overall Study||2
89513|NCT01163279|210163|P2|COMPLETED|Overall Study||9
89514|NCT01163279|210164|P1|COMPLETED|Overall Study||8
89515|NCT01163279|210163|P2|STARTED|Overall Study||9
89516|NCT01163279|210164|P1|STARTED|Overall Study||10
89517|NCT01163266|210193|P3|NOT COMPLETED|Overall Study||28
89518|NCT01163266|210194|P2|NOT COMPLETED|Overall Study||31
89519|NCT01163266|210195|P1|NOT COMPLETED|Overall Study||18
89520|NCT01163266|210193|P3|COMPLETED|Overall Study||122
89521|NCT01163266|210194|P2|COMPLETED|Overall Study||124
89522|NCT01163266|210195|P1|COMPLETED|Overall Study||139
89523|NCT01163266|210193|P3|Treated|Overall Study||150
89524|NCT01163266|210194|P2|Treated|Overall Study||155
89525|NCT01163266|210195|P1|Treated|Overall Study||157
89526|NCT01163266|210193|P3|STARTED|Overall Study||150
89527|NCT01163266|210194|P2|STARTED|Overall Study||155
89528|NCT01163266|210195|P1|STARTED|Overall Study||157
89529|NCT01163214|210220|P2|NOT COMPLETED|Overall Study||0
89530|NCT01163214|210221|P1|NOT COMPLETED|Overall Study||0
89531|NCT01163214|210220|P2|COMPLETED|Overall Study||81
89532|NCT01163214|210221|P1|COMPLETED|Overall Study||79
89533|NCT01163214|210220|P2|STARTED|Overall Study||81
89534|NCT01163214|210221|P1|STARTED|Overall Study||79
89535|NCT01163162|210237|P1|NOT COMPLETED|Overall Study||0
89536|NCT01163162|210237|P1|COMPLETED|Overall Study||16
89537|NCT01163162|210237|P1|STARTED|Overall Study||16
89538|NCT01163097|210246|P3|NOT COMPLETED|Overall Study||0
89539|NCT01163097|210247|P2|NOT COMPLETED|Overall Study||0
89540|NCT01163097|210248|P1|NOT COMPLETED|Overall Study||6
89541|NCT01163097|210246|P3|COMPLETED|Overall Study||8
89542|NCT01163097|210247|P2|COMPLETED|Overall Study||16
89543|NCT01163097|210248|P1|COMPLETED|Overall Study||14
89544|NCT01163097|210246|P3|STARTED|Overall Study||8
89545|NCT01163097|210247|P2|STARTED|Overall Study||16
89546|NCT01163097|210248|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
89547|NCT01163032|210301|P3|NOT COMPLETED|Open Label Extension Phase||16
89548|NCT01163032|210302|P2|NOT COMPLETED|Open Label Extension Phase||0
89549|NCT01163032|210303|P1|NOT COMPLETED|Open Label Extension Phase||0
89550|NCT01163032|210301|P3|COMPLETED|Open Label Extension Phase||39
89551|NCT01163032|210302|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
89552|NCT01163032|210303|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
89553|NCT01163032|210301|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
89554|NCT01163032|210302|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
89555|NCT01163032|210303|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
89556|NCT01163032|210301|P3|NOT COMPLETED|Randomization Phase||0
89557|NCT01163032|210302|P2|NOT COMPLETED|Randomization Phase||12
89558|NCT01163032|210303|P1|NOT COMPLETED|Randomization Phase||10
89559|NCT01163032|210301|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
89560|NCT01163032|210302|P2|COMPLETED|Randomization Phase||30
89561|NCT01163032|210303|P1|COMPLETED|Randomization Phase||32
89562|NCT01163032|210301|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
89563|NCT01163032|210302|P2|STARTED|Randomization Phase||42
89564|NCT01163032|210303|P1|STARTED|Randomization Phase||42
89565|NCT01162863|210336|P3|NOT COMPLETED|Overall Study||0
89566|NCT01162863|210337|P2|NOT COMPLETED|Overall Study||1
89567|NCT01162863|210338|P1|NOT COMPLETED|Overall Study||1
89568|NCT01162863|210336|P3|COMPLETED|Overall Study||17
89569|NCT01162863|210337|P2|COMPLETED|Overall Study||16
89570|NCT01162863|210338|P1|COMPLETED|Overall Study||17
89571|NCT01162863|210336|P3|STARTED|Overall Study||17
89572|NCT01162863|210337|P2|STARTED|Overall Study||17
89573|NCT01162863|210338|P1|STARTED|Overall Study||18
89574|NCT01162733|210354|P2|NOT COMPLETED|Overall Study||25
89575|NCT01162733|210355|P1|NOT COMPLETED|Overall Study||27
89576|NCT01162733|210354|P2|COMPLETED|Overall Study||25
89577|NCT01162733|210355|P1|COMPLETED|Overall Study||22
89578|NCT01162733|210354|P2|STARTED|Overall Study||50
89579|NCT01162733|210355|P1|STARTED|Overall Study||49
89580|NCT01162499|210363|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
89581|NCT01162499|210364|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
89582|NCT01162499|210363|P2|COMPLETED|Intervention 2 (4 Hours)||3
89583|NCT01162499|210364|P1|COMPLETED|Intervention 2 (4 Hours)||3
89584|NCT01162499|210363|P2|STARTED|Intervention 2 (4 Hours)||3
89585|NCT01162499|210364|P1|STARTED|Intervention 2 (4 Hours)||3
89586|NCT01162499|210363|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
89587|NCT01162499|210364|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
89588|NCT01162499|210363|P2|COMPLETED|Intervention 1 (4 Hours)||3
89589|NCT01162499|210364|P1|COMPLETED|Intervention 1 (4 Hours)||3
89590|NCT01162499|210363|P2|Received Intervention|Intervention 1 (4 Hours)||3
89591|NCT01162499|210364|P1|Received Intervention|Intervention 1 (4 Hours)||3
89592|NCT01162499|210363|P2|STARTED|Intervention 1 (4 Hours)||4
89593|NCT01162499|210364|P1|STARTED|Intervention 1 (4 Hours)||3
89594|NCT01162473|210386|P2|NOT COMPLETED|Overall Study||5
89595|NCT01162473|210387|P1|NOT COMPLETED|Overall Study||2
89596|NCT01162473|210386|P2|COMPLETED|Overall Study||12
89597|NCT01162473|210387|P1|COMPLETED|Overall Study||6
89598|NCT01162473|210386|P2|STARTED|Overall Study||17
89599|NCT01162473|210387|P1|STARTED|Overall Study||8
89600|NCT01162421|210395|P2|NOT COMPLETED|Overall Study||13
89601|NCT01162421|210396|P1|NOT COMPLETED|Overall Study||8
89602|NCT01162421|210395|P2|COMPLETED|Overall Study||27
89603|NCT01162421|210396|P1|COMPLETED|Overall Study||29
89604|NCT01162421|210395|P2|STARTED|Overall Study||40
89605|NCT01162421|210396|P1|STARTED|Overall Study||37
89606|NCT01162304|210474|P1|NOT COMPLETED|Overall Study||11
89607|NCT01162304|210474|P1|COMPLETED|Overall Study||7
89608|NCT01162304|210474|P1|STARTED|Overall Study||18
89609|NCT01162135|210488|P1|NOT COMPLETED|Overall Study||3
89610|NCT01162135|210488|P1|COMPLETED|Overall Study||13
89611|NCT01162135|210488|P1|STARTED|Overall Study||16
89612|NCT01162122|210494|P2|NOT COMPLETED|Overall Study||196
89613|NCT01162122|210495|P1|NOT COMPLETED|Overall Study||191
89614|NCT01162122|210494|P2|COMPLETED|Overall Study||3356
89615|NCT01162122|210495|P1|COMPLETED|Overall Study||3361
89616|NCT01162122|210494|P2|Vaccinated|Overall Study||3541
89617|NCT01162122|210495|P1|Vaccinated|Overall Study||3541
89618|NCT01162122|210494|P2|STARTED|Overall Study||3552
89619|NCT01162122|210495|P1|STARTED|Overall Study||3552
89620|NCT01162096|210552|P1|NOT COMPLETED|Overall Study||0
89621|NCT01162096|210552|P1|COMPLETED|Overall Study||34
89622|NCT01162096|210552|P1|STARTED|Overall Study||34
89623|NCT01161771|210556|P1|NOT COMPLETED|Overall Study||0
89624|NCT01161771|210556|P1|COMPLETED|Overall Study||32
89625|NCT01161771|210556|P1|STARTED|Overall Study||32
89626|NCT01161628|210565|P1|NOT COMPLETED|Overall Study||8
89627|NCT01161628|210565|P1|COMPLETED|Overall Study||17
89628|NCT01161628|210565|P1|STARTED|Overall Study||25
89629|NCT01161563|210579|P2|NOT COMPLETED|Overall Study||6
89630|NCT01161563|210580|P1|NOT COMPLETED|Overall Study||5
89631|NCT01161563|210579|P2|COMPLETED|Overall Study||49
89632|NCT01161563|210580|P1|COMPLETED|Overall Study||58
89633|NCT01161563|210579|P2|STARTED|Overall Study||55
89634|NCT01161563|210580|P1|STARTED|Overall Study||63
89635|NCT01161537|210588|P1|NOT COMPLETED|Part B||2
89636|NCT01161537|210588|P1|COMPLETED|Part B||7
89637|NCT01161537|210588|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
89638|NCT01161537|210588|P1|NOT COMPLETED|Part A||0
89639|NCT01161537|210588|P1|COMPLETED|Part A||8
89640|NCT01161537|210588|P1|STARTED|Part A||8
89641|NCT01161498|210606|P2|NOT COMPLETED|Overall Study||1
89642|NCT01161498|210607|P1|NOT COMPLETED|Overall Study||0
89643|NCT01161498|210606|P2|COMPLETED|Overall Study||1
89644|NCT01161498|210607|P1|COMPLETED|Overall Study||3
89645|NCT01161498|210606|P2|STARTED|Overall Study||2
89646|NCT01161498|210607|P1|STARTED|Overall Study||3
89647|NCT01161472|210631|P4|NOT COMPLETED|Fourth Intervention Period||0
89648|NCT01161472|210632|P3|NOT COMPLETED|Fourth Intervention Period||0
89649|NCT01161472|210633|P2|NOT COMPLETED|Fourth Intervention Period||0
89650|NCT01161472|210634|P1|NOT COMPLETED|Fourth Intervention Period||0
89651|NCT01161472|210631|P4|COMPLETED|Fourth Intervention Period||5
89652|NCT01161472|210632|P3|COMPLETED|Fourth Intervention Period||5
89653|NCT01161472|210633|P2|COMPLETED|Fourth Intervention Period||5
89654|NCT01161472|210634|P1|COMPLETED|Fourth Intervention Period||4
89655|NCT01161472|210631|P4|STARTED|Fourth Intervention Period||5
89656|NCT01161472|210632|P3|STARTED|Fourth Intervention Period||5
89657|NCT01161472|210633|P2|STARTED|Fourth Intervention Period||5
89658|NCT01161472|210634|P1|STARTED|Fourth Intervention Period||4
89659|NCT01161472|210631|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89660|NCT01161472|210632|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89661|NCT01161472|210633|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89662|NCT01161472|210634|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89663|NCT01161472|210631|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89664|NCT01161472|210632|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89665|NCT01161472|210633|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89666|NCT01161472|210634|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
89667|NCT01161472|210631|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
89668|NCT01161472|210632|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
89669|NCT01161472|210633|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
89670|NCT01161472|210634|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
89671|NCT01161472|210631|P4|NOT COMPLETED|Third Intervention Period||0
89672|NCT01161472|210632|P3|NOT COMPLETED|Third Intervention Period||0
89673|NCT01161472|210633|P2|NOT COMPLETED|Third Intervention Period||0
89674|NCT01161472|210634|P1|NOT COMPLETED|Third Intervention Period||0
89675|NCT01161472|210631|P4|COMPLETED|Third Intervention Period||5
89676|NCT01161472|210632|P3|COMPLETED|Third Intervention Period||5
89677|NCT01161472|210633|P2|COMPLETED|Third Intervention Period||5
89678|NCT01161472|210634|P1|COMPLETED|Third Intervention Period||4
89679|NCT01161472|210631|P4|STARTED|Third Intervention Period||5
89680|NCT01161472|210632|P3|STARTED|Third Intervention Period||5
89681|NCT01161472|210633|P2|STARTED|Third Intervention Period||5
89682|NCT01161472|210634|P1|STARTED|Third Intervention Period||4
89683|NCT01161472|210631|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89684|NCT01161472|210632|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89685|NCT01161472|210633|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89686|NCT01161472|210634|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
89687|NCT01161472|210631|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89688|NCT01161472|210632|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89689|NCT01161472|210633|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89690|NCT01161472|210634|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
89691|NCT01161472|210631|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
89692|NCT01161472|210632|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
89693|NCT01161472|210633|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
89694|NCT01161472|210634|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
89695|NCT01161472|210631|P4|NOT COMPLETED|Second Intervention Period||0
89696|NCT01161472|210632|P3|NOT COMPLETED|Second Intervention Period||0
89697|NCT01161472|210633|P2|NOT COMPLETED|Second Intervention Period||0
89698|NCT01161472|210634|P1|NOT COMPLETED|Second Intervention Period||0
89699|NCT01161472|210631|P4|COMPLETED|Second Intervention Period||5
89700|NCT01161472|210632|P3|COMPLETED|Second Intervention Period||5
89701|NCT01161472|210633|P2|COMPLETED|Second Intervention Period||5
89702|NCT01161472|210634|P1|COMPLETED|Second Intervention Period||5
89703|NCT01161472|210631|P4|STARTED|Second Intervention Period||5
89704|NCT01161472|210632|P3|STARTED|Second Intervention Period||5
89705|NCT01161472|210633|P2|STARTED|Second Intervention Period||5
89706|NCT01161472|210634|P1|STARTED|Second Intervention Period||5
89707|NCT01161472|210631|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89708|NCT01161472|210632|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89709|NCT01161472|210633|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89710|NCT01161472|210634|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
89711|NCT01161472|210631|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89712|NCT01161472|210632|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89713|NCT01161472|210633|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89714|NCT01161472|210634|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
89715|NCT01161472|210631|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
89716|NCT01161472|210632|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
89717|NCT01161472|210633|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
89718|NCT01161472|210634|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
89719|NCT01161472|210631|P4|NOT COMPLETED|First Intervention Period||0
89720|NCT01161472|210632|P3|NOT COMPLETED|First Intervention Period||0
89721|NCT01161472|210633|P2|NOT COMPLETED|First Intervention Period||0
89722|NCT01161472|210634|P1|NOT COMPLETED|First Intervention Period||0
89723|NCT01161472|210631|P4|COMPLETED|First Intervention Period||5
89724|NCT01161472|210632|P3|COMPLETED|First Intervention Period||5
89725|NCT01161472|210633|P2|COMPLETED|First Intervention Period||5
89726|NCT01161472|210634|P1|COMPLETED|First Intervention Period||5
89727|NCT01161472|210631|P4|Treated|First Intervention Period||5
89728|NCT01161472|210632|P3|Treated|First Intervention Period||5
89729|NCT01161472|210633|P2|Treated|First Intervention Period||5
89730|NCT01161472|210634|P1|Treated|First Intervention Period||5
89731|NCT01161472|210631|P4|STARTED|First Intervention Period||5
89732|NCT01161472|210632|P3|STARTED|First Intervention Period||5
89733|NCT01161472|210633|P2|STARTED|First Intervention Period||5
89734|NCT01161472|210634|P1|STARTED|First Intervention Period||5
89735|NCT01161420|210688|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
89736|NCT01161420|210688|P1|COMPLETED|Withdrawal Study - Withdrawal||23
89737|NCT01161420|210688|P1|STARTED|Withdrawal Study - Withdrawal||23
89738|NCT01161420|210688|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
89739|NCT01161420|210688|P1|COMPLETED|Withdrawal Study - Maintenance||23
89740|NCT01161420|210688|P1|STARTED|Withdrawal Study - Maintenance||23
89741|NCT01161420|210688|P1|NOT COMPLETED|Inspire Therapy||2
89742|NCT01161420|210688|P1|COMPLETED|Inspire Therapy||124
89743|NCT01161420|210688|P1|STARTED|Inspire Therapy||126
89744|NCT01161407|210702|P2|NOT COMPLETED|Overall Study||1
89745|NCT01161407|210703|P1|NOT COMPLETED|Overall Study||3
89746|NCT01161407|210702|P2|COMPLETED|Overall Study||5
89747|NCT01161407|210703|P1|COMPLETED|Overall Study||3
89748|NCT01161407|210702|P2|STARTED|Overall Study||6
89749|NCT01161407|210703|P1|STARTED|Overall Study||6
89750|NCT01161329|210715|P2|NOT COMPLETED|Overall Study||10
89751|NCT01161329|210716|P1|NOT COMPLETED|Overall Study||4
89752|NCT01161329|210715|P2|COMPLETED|Overall Study||24
89753|NCT01161329|210716|P1|COMPLETED|Overall Study||29
89754|NCT01161329|210715|P2|STARTED|Overall Study||34
89755|NCT01161329|210716|P1|STARTED|Overall Study||33
89756|NCT01161225|210727|P3|NOT COMPLETED|Overall Study||2
89757|NCT01161225|210728|P2|NOT COMPLETED|Overall Study||9
89758|NCT01161225|210729|P1|NOT COMPLETED|Overall Study||14
89759|NCT01161225|210727|P3|COMPLETED|Overall Study||12
89760|NCT01161225|210728|P2|COMPLETED|Overall Study||44
89761|NCT01161225|210729|P1|COMPLETED|Overall Study||45
89762|NCT01161225|210727|P3|STARTED|Overall Study||14
89763|NCT01161225|210728|P2|STARTED|Overall Study||53
89764|NCT01161225|210729|P1|STARTED|Overall Study||59
89765|NCT01161173|210758|P1|NOT COMPLETED|Overall Study||347
89766|NCT01161173|210758|P1|COMPLETED|Overall Study||0
89767|NCT01161173|210758|P1|STARTED|Overall Study||347
89768|NCT01160848|210769|P2|NOT COMPLETED|Overall Study||0
89769|NCT01160848|210770|P1|NOT COMPLETED|Overall Study||0
89770|NCT01160848|210769|P2|COMPLETED|Overall Study||8
89771|NCT01160848|210770|P1|COMPLETED|Overall Study||12
89772|NCT01160848|210769|P2|STARTED|Overall Study||8
89773|NCT01160848|210770|P1|STARTED|Overall Study||12
89774|NCT01160822|210799|P7|NOT COMPLETED|Overall Study||9
89775|NCT01160822|210800|P6|NOT COMPLETED|Overall Study||7
89776|NCT01160822|210801|P5|NOT COMPLETED|Overall Study||9
89777|NCT01160822|210802|P4|NOT COMPLETED|Overall Study||0
89778|NCT01160822|210803|P3|NOT COMPLETED|Overall Study||0
89779|NCT01160822|210804|P2|NOT COMPLETED|Overall Study||0
89780|NCT01160822|210805|P1|NOT COMPLETED|Overall Study||0
89781|NCT01160822|210799|P7|COMPLETED|Overall Study||44
89782|NCT01160822|210800|P6|COMPLETED|Overall Study||40
89783|NCT01160822|210801|P5|COMPLETED|Overall Study||36
89784|NCT01160822|210802|P4|COMPLETED|Overall Study||5
89785|NCT01160822|210803|P3|COMPLETED|Overall Study||6
89786|NCT01160822|210804|P2|COMPLETED|Overall Study||7
89787|NCT01160822|210805|P1|COMPLETED|Overall Study||6
89788|NCT01160822|210799|P7|STARTED|Overall Study||53
89789|NCT01160822|210800|P6|STARTED|Overall Study||47
89790|NCT01160822|210801|P5|STARTED|Overall Study||45
89791|NCT01160822|210802|P4|STARTED|Overall Study||5
89792|NCT01160822|210803|P3|STARTED|Overall Study||6
89793|NCT01160822|210804|P2|STARTED|Overall Study||7
89794|NCT01160822|210805|P1|STARTED|Overall Study||6
89795|NCT01160770|210894|P1|NOT COMPLETED|Overall Study||79
89796|NCT01160770|210894|P1|COMPLETED|Overall Study||188
89797|NCT01160770|210894|P1|STARTED|Overall Study||267
89798|NCT01160744|210907|P4|NOT COMPLETED|Overall Study||22
89799|NCT01160744|210908|P3|NOT COMPLETED|Overall Study||20
89800|NCT01160744|210909|P2|NOT COMPLETED|Overall Study||25
89801|NCT01160744|210910|P1|NOT COMPLETED|Overall Study||20
89802|NCT01160744|210907|P4|COMPLETED|Overall Study||49
89803|NCT01160744|210908|P3|COMPLETED|Overall Study||49
89804|NCT01160744|210909|P2|COMPLETED|Overall Study||44
89805|NCT01160744|210910|P1|COMPLETED|Overall Study||51
89806|NCT01160744|210907|P4|Received Study Drug|Overall Study||71
89807|NCT01160744|210908|P3|Received Study Drug|Overall Study||63
89808|NCT01160744|210909|P2|Received Study Drug|Overall Study||67
89809|NCT01160744|210910|P1|Received Study Drug|Overall Study||69
89810|NCT01160744|210907|P4|STARTED|Overall Study||71
89811|NCT01160744|210908|P3|STARTED|Overall Study||69
89812|NCT01160744|210909|P2|STARTED|Overall Study||69
89813|NCT01160744|210910|P1|STARTED|Overall Study||71
89814|NCT01160640|210946|P2|NOT COMPLETED|Overall Study||6
89815|NCT01160640|210947|P1|NOT COMPLETED|Overall Study||4
89816|NCT01160640|210946|P2|COMPLETED|Overall Study||110
89817|NCT01160640|210947|P1|COMPLETED|Overall Study||113
89818|NCT01160640|210946|P2|STARTED|Overall Study||116
89819|NCT01160640|210947|P1|STARTED|Overall Study||117
89820|NCT01160614|210963|P2|NOT COMPLETED|Overall Study||2
89821|NCT01160614|210964|P1|NOT COMPLETED|Overall Study||0
89822|NCT01160614|210963|P2|COMPLETED|Overall Study||23
89823|NCT01160614|210964|P1|COMPLETED|Overall Study||5
89824|NCT01160614|210963|P2|STARTED|Overall Study||25
89825|NCT01160614|210964|P1|STARTED|Overall Study||5
89826|NCT01160484|211012|P1|NOT COMPLETED|Overall Study||18
89827|NCT01160484|211012|P1|COMPLETED|Overall Study||22
89828|NCT01160484|211012|P1|STARTED|Overall Study||40
89829|NCT01160458|211022|P1|NOT COMPLETED|Overall Study||0
89830|NCT01160458|211022|P1|COMPLETED|Overall Study||20
89831|NCT01160458|211022|P1|STARTED|Overall Study||20
89832|NCT01160445|211029|P2|NOT COMPLETED|Overall Study||0
89833|NCT01160445|211030|P1|NOT COMPLETED|Overall Study||0
89834|NCT01160445|211029|P2|COMPLETED|Overall Study||2
89835|NCT01160445|211030|P1|COMPLETED|Overall Study||7
89836|NCT01160445|211029|P2|STARTED|Overall Study||2
89837|NCT01160445|211030|P1|STARTED|Overall Study||7
89838|NCT01160380|211040|P2|NOT COMPLETED|Overall Study||5
89839|NCT01160380|211041|P1|NOT COMPLETED|Overall Study||8
89840|NCT01160380|211040|P2|COMPLETED|Overall Study||20
89841|NCT01160380|211041|P1|COMPLETED|Overall Study||17
89842|NCT01160380|211040|P2|STARTED|Overall Study||25
89843|NCT01160380|211041|P1|STARTED|Overall Study||25
89844|NCT01160237|211062|P3|NOT COMPLETED|Overall Study||0
89845|NCT01160237|211063|P2|NOT COMPLETED|Overall Study||0
89846|NCT01160237|211064|P1|NOT COMPLETED|Overall Study||0
89847|NCT01160237|211062|P3|COMPLETED|Overall Study||0
89848|NCT01160237|211063|P2|COMPLETED|Overall Study||3
89849|NCT01160237|211064|P1|COMPLETED|Overall Study||4
89850|NCT01160237|211062|P3|STARTED|Overall Study||0
89851|NCT01160237|211063|P2|STARTED|Overall Study||3
89852|NCT01160237|211064|P1|STARTED|Overall Study||4
89853|NCT01159938|211090|P5|NOT COMPLETED|Second Study Period||0
89854|NCT01159938|211091|P4|NOT COMPLETED|Second Study Period||0
89855|NCT01159938|211092|P3|NOT COMPLETED|Second Study Period||0
89856|NCT01159938|211093|P2|NOT COMPLETED|Second Study Period||0
89857|NCT01159938|211094|P1|NOT COMPLETED|Second Study Period||0
89858|NCT01159938|211090|P5|COMPLETED|Second Study Period||12
89859|NCT01159938|211091|P4|COMPLETED|Second Study Period||12
89860|NCT01159938|211092|P3|COMPLETED|Second Study Period||10
89861|NCT01159938|211093|P2|COMPLETED|Second Study Period||11
89862|NCT01159938|211094|P1|COMPLETED|Second Study Period||0
89863|NCT01159938|211090|P5|STARTED|Second Study Period||12
89864|NCT01159938|211091|P4|STARTED|Second Study Period||12
89865|NCT01159938|211092|P3|STARTED|Second Study Period||10
89866|NCT01159938|211093|P2|STARTED|Second Study Period||11
89867|NCT01159938|211094|P1|STARTED|Second Study Period||0
89868|NCT01159938|211090|P5|NOT COMPLETED|First Study Period||0
89869|NCT01159938|211091|P4|NOT COMPLETED|First Study Period||0
89870|NCT01159938|211092|P3|NOT COMPLETED|First Study Period||1
89871|NCT01159938|211093|P2|NOT COMPLETED|First Study Period||0
89872|NCT01159938|211094|P1|NOT COMPLETED|First Study Period||0
89873|NCT01159938|211090|P5|COMPLETED|First Study Period||12
89874|NCT01159938|211091|P4|COMPLETED|First Study Period||12
89875|NCT01159938|211092|P3|COMPLETED|First Study Period||10
89876|NCT01159938|211093|P2|COMPLETED|First Study Period||11
89877|NCT01159938|211094|P1|COMPLETED|First Study Period||26
89878|NCT01159938|211090|P5|Safety and Efficacy Analysis Population|First Study Period||12
89879|NCT01159938|211091|P4|Safety and Efficacy Analysis Population|First Study Period||12
89880|NCT01159938|211092|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
89881|NCT01159938|211093|P2|Safety and Efficacy Analysis Population|First Study Period||11
89882|NCT01159938|211094|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
89883|NCT01159938|211090|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
89884|NCT01159938|211091|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
89885|NCT01159938|211092|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
89886|NCT01159938|211093|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
89887|NCT01159938|211094|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
89888|NCT01159938|211090|P5|STARTED|First Study Period||12
89889|NCT01159938|211091|P4|STARTED|First Study Period||12
89890|NCT01159938|211092|P3|STARTED|First Study Period||11
89891|NCT01159938|211093|P2|STARTED|First Study Period||11
89892|NCT01159938|211094|P1|STARTED|First Study Period||26
89893|NCT01159912|211157|P3|NOT COMPLETED|Overall Study||26
89894|NCT01159912|211158|P2|NOT COMPLETED|Overall Study||22
89895|NCT01159912|211159|P1|NOT COMPLETED|Overall Study||40
89896|NCT01159912|211157|P3|COMPLETED|Overall Study||88
89897|NCT01159912|211158|P2|COMPLETED|Overall Study||92
89898|NCT01159912|211159|P1|COMPLETED|Overall Study||75
89899|NCT01159912|211157|P3|STARTED|Overall Study||114
89900|NCT01159912|211158|P2|STARTED|Overall Study||114
89901|NCT01159912|211159|P1|STARTED|Overall Study||115
89902|NCT01159769|211182|P1|NOT COMPLETED|Overall Study||1
89903|NCT01159769|211182|P1|COMPLETED|Overall Study||214
89904|NCT01159769|211182|P1|STARTED|Overall Study||215
89905|NCT01159743|211189|P2|NOT COMPLETED|Overall Study||0
89906|NCT01159743|211190|P1|NOT COMPLETED|Overall Study||0
89907|NCT01159743|211189|P2|COMPLETED|Overall Study||109
89908|NCT01159743|211190|P1|COMPLETED|Overall Study||237
89909|NCT01159743|211189|P2|STARTED|Overall Study||109
89910|NCT01159743|211190|P1|STARTED|Overall Study||237
89911|NCT01159691|211202|P1|NOT COMPLETED|Overall Study||22
89912|NCT01159691|211202|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
89913|NCT01159691|211202|P1|STARTED|Overall Study||76
89914|NCT01159665|211215|P6|NOT COMPLETED|Overall Study||0
89915|NCT01159665|211216|P5|NOT COMPLETED|Overall Study||0
89916|NCT01159665|211217|P4|NOT COMPLETED|Overall Study||0
89917|NCT01159665|211218|P3|NOT COMPLETED|Overall Study||0
89918|NCT01159665|211219|P2|NOT COMPLETED|Overall Study||1
89919|NCT01159665|211220|P1|NOT COMPLETED|Overall Study||0
89920|NCT01159665|211215|P6|COMPLETED|Overall Study||4
89921|NCT01159665|211216|P5|COMPLETED|Overall Study||4
89922|NCT01159665|211217|P4|COMPLETED|Overall Study||4
89923|NCT01159665|211218|P3|COMPLETED|Overall Study||8
89924|NCT01159665|211219|P2|COMPLETED|Overall Study||8
89925|NCT01159665|211220|P1|COMPLETED|Overall Study||9
89926|NCT01159665|211215|P6|STARTED|Overall Study||4
89927|NCT01159665|211216|P5|STARTED|Overall Study||4
89928|NCT01159665|211217|P4|STARTED|Overall Study||4
89929|NCT01159665|211218|P3|STARTED|Overall Study||8
89930|NCT01159665|211219|P2|STARTED|Overall Study||9
89931|NCT01159665|211220|P1|STARTED|Overall Study||9
89932|NCT01159600|211248|P8|NOT COMPLETED|Overall Study||18
89933|NCT01159600|211249|P7|NOT COMPLETED|Overall Study||19
89934|NCT01159600|211250|P6|NOT COMPLETED|Overall Study||18
89935|NCT01159600|211251|P5|NOT COMPLETED|Overall Study||24
89936|NCT01159600|211252|P4|NOT COMPLETED|Overall Study||11
89937|NCT01159600|211253|P3|NOT COMPLETED|Overall Study||18
89938|NCT01159600|211254|P2|NOT COMPLETED|Overall Study||8
89939|NCT01159600|211255|P1|NOT COMPLETED|Overall Study||21
89940|NCT01159600|211248|P8|COMPLETED|Overall Study||85
89941|NCT01159600|211249|P7|COMPLETED|Overall Study||199
89942|NCT01159600|211250|P6|COMPLETED|Overall Study||208
89943|NCT01159600|211251|P5|COMPLETED|Overall Study||201
89944|NCT01159600|211252|P4|COMPLETED|Overall Study||58
89945|NCT01159600|211253|P3|COMPLETED|Overall Study||196
89946|NCT01159600|211254|P2|COMPLETED|Overall Study||209
89947|NCT01159600|211255|P1|COMPLETED|Overall Study||186
89948|NCT01159600|211248|P8|STARTED|Overall Study||103
89949|NCT01159600|211249|P7|STARTED|Overall Study||218
89950|NCT01159600|211250|P6|STARTED|Overall Study||226
89951|NCT01159600|211251|P5|STARTED|Overall Study||225
89952|NCT01159600|211252|P4|STARTED|Overall Study||69
89953|NCT01159600|211253|P3|STARTED|Overall Study||214
89954|NCT01159600|211254|P2|STARTED|Overall Study||217
89955|NCT01159600|211255|P1|STARTED|Overall Study||207
89956|NCT01159535|211300|P3|NOT COMPLETED|Overall Study||31
89957|NCT01159535|211301|P2|NOT COMPLETED|Overall Study||24
89958|NCT01159535|211302|P1|NOT COMPLETED|Overall Study||24
89959|NCT01159535|211300|P3|COMPLETED|Overall Study||64
89960|NCT01159535|211301|P2|COMPLETED|Overall Study||64
89961|NCT01159535|211302|P1|COMPLETED|Overall Study||79
89962|NCT01159535|211300|P3|STARTED|Overall Study||95
89963|NCT01159535|211301|P2|STARTED|Overall Study||88
89964|NCT01159535|211302|P1|STARTED|Overall Study||103
89965|NCT01159431|211312|P2|NOT COMPLETED|Overall Study||6
89966|NCT01159431|211313|P1|NOT COMPLETED|Overall Study||2
89967|NCT01159431|211312|P2|COMPLETED|Overall Study||19
89968|NCT01159431|211313|P1|COMPLETED|Overall Study||23
89969|NCT01159431|211312|P2|STARTED|Overall Study||25
89970|NCT01159431|211313|P1|STARTED|Overall Study||25
89971|NCT01159262|211332|P3|NOT COMPLETED|Overall Study||0
89972|NCT01159262|211333|P2|NOT COMPLETED|Overall Study||0
89973|NCT01159262|211334|P1|NOT COMPLETED|Overall Study||0
89974|NCT01159262|211332|P3|COMPLETED|Overall Study||8
89975|NCT01159262|211333|P2|COMPLETED|Overall Study||14
89976|NCT01159262|211334|P1|COMPLETED|Overall Study||14
89977|NCT01159262|211332|P3|STARTED|Overall Study||8
89978|NCT01159262|211333|P2|STARTED|Overall Study||14
89979|NCT01159262|211334|P1|STARTED|Overall Study||14
89980|NCT01159171|211366|P1|NOT COMPLETED|Overall Study||50
89981|NCT01159171|211366|P1|COMPLETED|Overall Study||0
89982|NCT01159171|211366|P1|STARTED|Overall Study||50
89983|NCT01158924|211383|P2|NOT COMPLETED|Overall Study||3
89984|NCT01158924|211384|P1|NOT COMPLETED|Overall Study||1
89985|NCT01158924|211383|P2|COMPLETED|Overall Study||23
89986|NCT01158924|211384|P1|COMPLETED|Overall Study||13
89987|NCT01158924|211383|P2|STARTED|Overall Study||26
89988|NCT01158924|211384|P1|STARTED|Overall Study||14
89989|NCT01158716|211400|P2|NOT COMPLETED|Overall Study||1
89990|NCT01158716|211401|P1|NOT COMPLETED|Overall Study||1
89991|NCT01158716|211400|P2|COMPLETED|Overall Study||47
89992|NCT01158716|211401|P1|COMPLETED|Overall Study||47
89993|NCT01158716|211400|P2|STARTED|Overall Study||48
89994|NCT01158716|211401|P1|STARTED|Overall Study||48
89995|NCT01158703|211409|P2|NOT COMPLETED|Overall Study||0
89996|NCT01158703|211410|P1|NOT COMPLETED|Overall Study||0
89997|NCT01158703|211409|P2|COMPLETED|Overall Study||8
89998|NCT01158703|211410|P1|COMPLETED|Overall Study||12
89999|NCT01158703|211409|P2|STARTED|Overall Study||8
90000|NCT01158703|211410|P1|STARTED|Overall Study||12
90001|NCT01158534|211426|P1|NOT COMPLETED|Overall Study||3
90002|NCT01158534|211426|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
90003|NCT01158534|211426|P1|STARTED|Overall Study||17
90004|NCT01158378|211436|P2|NOT COMPLETED|Overall Study||9
90005|NCT01158378|211437|P1|NOT COMPLETED|Overall Study||10
90006|NCT01158378|211436|P2|COMPLETED|Overall Study||117
90007|NCT01158378|211437|P1|COMPLETED|Overall Study||114
90008|NCT01158378|211436|P2|STARTED|Overall Study||126
90009|NCT01158378|211437|P1|STARTED|Overall Study||124
90010|NCT01158261|211449|P1|NOT COMPLETED|Overall Study||17
90011|NCT01158261|211449|P1|COMPLETED|Overall Study||283
90012|NCT01158261|211449|P1|STARTED|Overall Study||300
90013|NCT01157845|211453|P1|NOT COMPLETED|Overall Study||35
90014|NCT01157845|211453|P1|COMPLETED|Overall Study||130
90015|NCT01157845|211453|P1|STARTED|Overall Study||165
90016|NCT01157533|211458|P1|NOT COMPLETED|Overall Study||0
90017|NCT01157533|211458|P1|COMPLETED|Overall Study||1
90018|NCT01157533|211458|P1|STARTED|Overall Study||1
90019|NCT01156532|211462|P1|NOT COMPLETED|Overall Study||2
90020|NCT01156532|211462|P1|COMPLETED|Overall Study||28
90021|NCT01156532|211462|P1|STARTED|Overall Study||30
90022|NCT01156480|211474|P2|NOT COMPLETED|Overall Study||1
90023|NCT01156480|211475|P1|NOT COMPLETED|Overall Study||0
90024|NCT01156480|211474|P2|COMPLETED|Overall Study||1
90025|NCT01156480|211475|P1|COMPLETED|Overall Study||0
90026|NCT01156480|211474|P2|STARTED|Overall Study||2
90027|NCT01156480|211475|P1|STARTED|Overall Study||0
90028|NCT01156376|211486|P3|NOT COMPLETED|Overall Study||4
90029|NCT01156376|211487|P2|NOT COMPLETED|Overall Study||0
90030|NCT01156376|211488|P1|NOT COMPLETED|Overall Study||1
90031|NCT01156376|211486|P3|COMPLETED|Overall Study||23
90032|NCT01156376|211487|P2|COMPLETED|Overall Study||26
90033|NCT01156376|211488|P1|COMPLETED|Overall Study||26
90034|NCT01156376|211486|P3|STARTED|Overall Study||27
90035|NCT01156376|211487|P2|STARTED|Overall Study||26
90036|NCT01156376|211488|P1|STARTED|Overall Study||27
90037|NCT01156363|211709|P1|NOT COMPLETED|Overall Study||22
90038|NCT01156363|211709|P1|COMPLETED|Overall Study||64
90039|NCT01156363|211709|P1|STARTED|Overall Study||86
90040|NCT01156311|211731|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
90041|NCT01156311|211732|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
90042|NCT01156311|211733|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
90043|NCT01156311|211734|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
90044|NCT01156311|211731|P4|COMPLETED|6-month Add-on Therapy Period||37
90045|NCT01156311|211732|P3|COMPLETED|6-month Add-on Therapy Period||45
90046|NCT01156311|211733|P2|COMPLETED|6-month Add-on Therapy Period||0
90047|NCT01156311|211734|P1|COMPLETED|6-month Add-on Therapy Period||0
90048|NCT01156311|211731|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
90049|NCT01156311|211732|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
90050|NCT01156311|211733|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
90051|NCT01156311|211734|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
90052|NCT01156311|211731|P4|STARTED|6-month Add-on Therapy Period||47
90053|NCT01156311|211732|P3|STARTED|6-month Add-on Therapy Period||57
90054|NCT01156311|211733|P2|STARTED|6-month Add-on Therapy Period||0
90055|NCT01156311|211734|P1|STARTED|6-month Add-on Therapy Period||0
90056|NCT01156311|211731|P4|NOT COMPLETED|2-Month Monotherapy Period||0
90057|NCT01156311|211732|P3|NOT COMPLETED|2-Month Monotherapy Period||0
90058|NCT01156311|211733|P2|NOT COMPLETED|2-Month Monotherapy Period||2
90059|NCT01156311|211734|P1|NOT COMPLETED|2-Month Monotherapy Period||2
90060|NCT01156311|211731|P4|COMPLETED|2-Month Monotherapy Period||0
90061|NCT01156311|211732|P3|COMPLETED|2-Month Monotherapy Period||0
90062|NCT01156311|211733|P2|COMPLETED|2-Month Monotherapy Period||47
90063|NCT01156311|211734|P1|COMPLETED|2-Month Monotherapy Period||57
90064|NCT01156311|211731|P4|STARTED|2-Month Monotherapy Period||0
90065|NCT01156311|211732|P3|STARTED|2-Month Monotherapy Period||0
90066|NCT01156311|211733|P2|STARTED|2-Month Monotherapy Period||49
90067|NCT01156311|211734|P1|STARTED|2-Month Monotherapy Period||59
90068|NCT01157377|211763|P7|NOT COMPLETED|Overall Study||2
90069|NCT01157377|211764|P6|NOT COMPLETED|Overall Study||3
90070|NCT01157377|211765|P5|NOT COMPLETED|Overall Study||2
90071|NCT01157377|211766|P4|NOT COMPLETED|Overall Study||1
90072|NCT01157377|211767|P3|NOT COMPLETED|Overall Study||1
90073|NCT01157377|211768|P2|NOT COMPLETED|Overall Study||3
90074|NCT01157377|211769|P1|NOT COMPLETED|Overall Study||2
90075|NCT01157377|211763|P7|COMPLETED|Overall Study||27
90076|NCT01157377|211764|P6|COMPLETED|Overall Study||16
90077|NCT01157377|211765|P5|COMPLETED|Overall Study||18
90078|NCT01157377|211766|P4|COMPLETED|Overall Study||14
90079|NCT01157377|211767|P3|COMPLETED|Overall Study||26
90080|NCT01157377|211768|P2|COMPLETED|Overall Study||20
90081|NCT01157377|211769|P1|COMPLETED|Overall Study||21
90082|NCT01157377|211763|P7|STARTED|Overall Study||29
90083|NCT01157377|211764|P6|STARTED|Overall Study||19
90084|NCT01157377|211765|P5|STARTED|Overall Study||20
90085|NCT01157377|211766|P4|STARTED|Overall Study||15
90086|NCT01157377|211767|P3|STARTED|Overall Study||27
90087|NCT01157377|211768|P2|STARTED|Overall Study||23
90088|NCT01157377|211769|P1|STARTED|Overall Study||23
90089|NCT01157351|211787|P2|NOT COMPLETED|Overall Study||132
90090|NCT01157351|211788|P1|NOT COMPLETED|Overall Study||137
90091|NCT01157351|211787|P2|COMPLETED|Overall Study||88
90092|NCT01157351|211788|P1|COMPLETED|Overall Study||93
90093|NCT01157351|211787|P2|Treated|Overall Study||218
90094|NCT01157351|211788|P1|Treated|Overall Study||226
90095|NCT01157351|211787|P2|STARTED|Overall Study||220
90096|NCT01157351|211788|P1|STARTED|Overall Study||230
90097|NCT01157234|211806|P2|NOT COMPLETED|Overall Study||0
90098|NCT01157234|211807|P1|NOT COMPLETED|Overall Study||1
90099|NCT01157234|211806|P2|COMPLETED|Overall Study||15
90100|NCT01157234|211807|P1|COMPLETED|Overall Study||14
90101|NCT01157234|211806|P2|STARTED|Overall Study||15
90102|NCT01157234|211807|P1|STARTED|Overall Study||15
90103|NCT01157182|211839|P2|NOT COMPLETED|Second Intervention||0
90104|NCT01157182|211840|P1|NOT COMPLETED|Second Intervention||0
90105|NCT01157182|211839|P2|COMPLETED|Second Intervention||18
90106|NCT01157182|211840|P1|COMPLETED|Second Intervention||16
90107|NCT01157182|211839|P2|STARTED|Second Intervention||18
90108|NCT01157182|211840|P1|STARTED|Second Intervention||16
90109|NCT01157182|211839|P2|NOT COMPLETED|Washout of 28 Days||0
90110|NCT01157182|211840|P1|NOT COMPLETED|Washout of 28 Days||2
90111|NCT01157182|211839|P2|COMPLETED|Washout of 28 Days||18
90112|NCT01157182|211840|P1|COMPLETED|Washout of 28 Days||16
90113|NCT01157182|211839|P2|STARTED|Washout of 28 Days||18
90114|NCT01157182|211840|P1|STARTED|Washout of 28 Days||18
90115|NCT01157182|211839|P2|NOT COMPLETED|First Intervention||0
90116|NCT01157182|211840|P1|NOT COMPLETED|First Intervention||0
90117|NCT01157182|211839|P2|COMPLETED|First Intervention||18
90118|NCT01157182|211840|P1|COMPLETED|First Intervention||18
90119|NCT01157182|211839|P2|STARTED|First Intervention||18
90120|NCT01157182|211840|P1|STARTED|First Intervention||18
90121|NCT01157169|211888|P2|NOT COMPLETED|Second Intervention||1
90122|NCT01157169|211889|P1|NOT COMPLETED|Second Intervention||0
90123|NCT01157169|211888|P2|COMPLETED|Second Intervention||17
90124|NCT01157169|211889|P1|COMPLETED|Second Intervention||16
90125|NCT01157169|211888|P2|STARTED|Second Intervention||18
90126|NCT01157169|211889|P1|STARTED|Second Intervention||16
90127|NCT01157169|211888|P2|NOT COMPLETED|Washout of 10 Days||0
90128|NCT01157169|211889|P1|NOT COMPLETED|Washout of 10 Days||0
90129|NCT01157169|211888|P2|COMPLETED|Washout of 10 Days||18
90130|NCT01157169|211889|P1|COMPLETED|Washout of 10 Days||16
90131|NCT01157169|211888|P2|STARTED|Washout of 10 Days||18
90132|NCT01157169|211889|P1|STARTED|Washout of 10 Days||16
90133|NCT01157169|211888|P2|NOT COMPLETED|First Intervention||2
90134|NCT01157169|211889|P1|NOT COMPLETED|First Intervention||4
90135|NCT01157169|211888|P2|COMPLETED|First Intervention||18
90136|NCT01157169|211889|P1|COMPLETED|First Intervention||16
90137|NCT01157169|211888|P2|STARTED|First Intervention||20
90138|NCT01157169|211889|P1|STARTED|First Intervention||20
90139|NCT01157117|211908|P3|NOT COMPLETED|Overall Study||15
90140|NCT01157117|211909|P2|NOT COMPLETED|Overall Study||11
90141|NCT01157117|211910|P1|NOT COMPLETED|Overall Study||9
90142|NCT01157117|211908|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
90143|NCT01157117|211909|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
90144|NCT01157117|211910|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
90145|NCT01157117|211908|P3|Completed Final Month 38 Study Visit|Overall Study||3
90146|NCT01157117|211909|P2|Completed Final Month 38 Study Visit|Overall Study||18
90147|NCT01157117|211910|P1|Completed Final Month 38 Study Visit|Overall Study||19
90148|NCT01157117|211908|P3|Completed Month 32 Tolerance OFC|Overall Study||0
90149|NCT01157117|211909|P2|Completed Month 32 Tolerance OFC|Overall Study||20
90150|NCT01157117|211910|P1|Completed Month 32 Tolerance OFC|Overall Study||24
90151|NCT01157117|211908|P3|Discontinued Milk OIT at Month 30|Overall Study||0
90152|NCT01157117|211909|P2|Discontinued Milk OIT at Month 30|Overall Study||20
90153|NCT01157117|211910|P1|Discontinued Milk OIT at Month 30|Overall Study||24
90154|NCT01157117|211908|P3|Completed Month 28 Desensitization OFC|Overall Study||0
90155|NCT01157117|211909|P2|Completed Month 28 Desensitization OFC|Overall Study||24
90156|NCT01157117|211910|P1|Completed Month 28 Desensitization OFC|Overall Study||26
90157|NCT01157117|211908|P3|Unblinded at Month 16|Overall Study||0
90158|NCT01157117|211909|P2|Unblinded at Month 16|Overall Study||26
90159|NCT01157117|211910|P1|Unblinded at Month 16|Overall Study||26
90160|NCT01157117|211908|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
90161|NCT01157117|211909|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
90162|NCT01157117|211910|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
90163|NCT01157117|211908|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
90164|NCT01157117|211909|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
90165|NCT01157117|211910|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
90166|NCT01157117|211908|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
90167|NCT01157117|211909|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
90168|NCT01157117|211910|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
90169|NCT01157117|211908|P3|STARTED|Overall Study||20
90170|NCT01157117|211909|P2|STARTED|Overall Study||29
90171|NCT01157117|211910|P1|STARTED|Overall Study||28
90172|NCT01157078|211951|P2|NOT COMPLETED|Overall Study||36
90173|NCT01157078|211952|P1|NOT COMPLETED|Overall Study||35
90174|NCT01157078|211951|P2|COMPLETED|Overall Study||124
90175|NCT01157078|211952|P1|COMPLETED|Overall Study||124
90176|NCT01157078|211951|P2|Received Treatment|Overall Study||159
90177|NCT01157078|211952|P1|Received Treatment|Overall Study||157
90178|NCT01157078|211951|P2|STARTED|Overall Study||160
90179|NCT01157078|211952|P1|STARTED|Overall Study||159
90180|NCT01157065|212002|P2|NOT COMPLETED|Overall Study||1
90181|NCT01157065|212003|P1|NOT COMPLETED|Overall Study||0
90182|NCT01157065|212002|P2|COMPLETED|Overall Study||10
90183|NCT01157065|212003|P1|COMPLETED|Overall Study||38
90184|NCT01157065|212002|P2|STARTED|Overall Study||11
90185|NCT01157065|212003|P1|STARTED|Overall Study||38
90186|NCT01156987|212013|P2|NOT COMPLETED|Overall Study||11
90187|NCT01156987|212014|P1|NOT COMPLETED|Overall Study||0
90188|NCT01156987|212013|P2|COMPLETED|Overall Study||12
90189|NCT01156987|212014|P1|COMPLETED|Overall Study||8
90190|NCT01156987|212013|P2|STARTED|Overall Study||23
90191|NCT01156987|212014|P1|STARTED|Overall Study||8
90192|NCT01156844|212024|P4|NOT COMPLETED|Overall Study||6
90193|NCT01156844|212025|P3|NOT COMPLETED|Overall Study||6
90194|NCT01156844|212026|P2|NOT COMPLETED|Overall Study||2
90195|NCT01156844|212027|P1|NOT COMPLETED|Overall Study||2
90196|NCT01156844|212024|P4|COMPLETED|Overall Study||41
90197|NCT01156844|212025|P3|COMPLETED|Overall Study||42
90198|NCT01156844|212026|P2|COMPLETED|Overall Study||46
90199|NCT01156844|212027|P1|COMPLETED|Overall Study||46
90200|NCT01156844|212024|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
90201|NCT01156844|212025|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
90202|NCT01156844|212026|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
90203|NCT01156844|212027|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
90204|NCT01156844|212024|P4|STARTED|Overall Study||47
90205|NCT01156844|212025|P3|STARTED|Overall Study||48
90206|NCT01156844|212026|P2|STARTED|Overall Study||48
90207|NCT01156844|212027|P1|STARTED|Overall Study|Randomized participants.|48
90208|NCT01156792|212046|P1|NOT COMPLETED|Overall Study||69
90209|NCT01156792|212046|P1|COMPLETED|Overall Study||93
90210|NCT01156792|212046|P1|STARTED|Overall Study||162
90211|NCT01156701|212111|P4|NOT COMPLETED|Overall Study||0
90212|NCT01156701|212112|P3|NOT COMPLETED|Overall Study||0
90213|NCT01156701|212113|P2|NOT COMPLETED|Overall Study||0
90214|NCT01156701|212114|P1|NOT COMPLETED|Overall Study||0
90215|NCT01156701|212111|P4|COMPLETED|Overall Study||6725
90216|NCT01156701|212112|P3|COMPLETED|Overall Study||163716
90217|NCT01156701|212113|P2|COMPLETED|Overall Study||1007
90218|NCT01156701|212114|P1|COMPLETED|Overall Study||257
90219|NCT01156701|212111|P4|STARTED|Overall Study||6725
90220|NCT01156701|212112|P3|STARTED|Overall Study||163716
90221|NCT01156701|212113|P2|STARTED|Overall Study||1007
90222|NCT01156701|212114|P1|STARTED|Overall Study||257
90223|NCT01156597|212150|P2|NOT COMPLETED|Overall Study||1
90224|NCT01156597|212151|P1|NOT COMPLETED|Overall Study||3
90225|NCT01156597|212150|P2|COMPLETED|Overall Study||13
90226|NCT01156597|212151|P1|COMPLETED|Overall Study||13
90227|NCT01156597|212150|P2|STARTED|Overall Study||14
90228|NCT01156597|212151|P1|STARTED|Overall Study||16
90229|NCT01156571|212163|P2|NOT COMPLETED|Overall Study||19
90230|NCT01156571|212164|P1|NOT COMPLETED|Overall Study||17
90231|NCT01156571|212163|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
90232|NCT01156571|212164|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
90233|NCT01156571|212163|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
90234|NCT01156571|212164|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
90235|NCT01156116|212176|P2|NOT COMPLETED|Overall Study||1
90236|NCT01156116|212177|P1|NOT COMPLETED|Overall Study||5
90237|NCT01156116|212176|P2|COMPLETED|Overall Study||12
90238|NCT01156116|212177|P1|COMPLETED|Overall Study||21
90239|NCT01156116|212176|P2|STARTED|Overall Study||13
90240|NCT01156116|212177|P1|STARTED|Overall Study||26
90241|NCT01156051|212191|P2|NOT COMPLETED|Overall Study||1
90242|NCT01156051|212192|P1|NOT COMPLETED|Overall Study||1
90243|NCT01156051|212191|P2|COMPLETED|Overall Study||16
90244|NCT01156051|212192|P1|COMPLETED|Overall Study||11
90245|NCT01156051|212191|P2|STARTED|Overall Study||17
90246|NCT01156051|212192|P1|STARTED|Overall Study||12
90247|NCT01156012|212206|P2|NOT COMPLETED|Overall Study||3
90248|NCT01156012|212207|P1|NOT COMPLETED|Overall Study||7
90249|NCT01156012|212206|P2|COMPLETED|Overall Study||186
90250|NCT01156012|212207|P1|COMPLETED|Overall Study||206
90251|NCT01156012|212206|P2|STARTED|Overall Study||189
90252|NCT01156012|212207|P1|STARTED|Overall Study||213
90253|NCT01155999|212215|P2|NOT COMPLETED|Overall Study||4
90254|NCT01155999|212216|P1|NOT COMPLETED|Overall Study||7
90255|NCT01155999|212215|P2|COMPLETED|Overall Study||136
90256|NCT01155999|212216|P1|COMPLETED|Overall Study||139
90257|NCT01155999|212215|P2|STARTED|Overall Study||140
90258|NCT01155999|212216|P1|STARTED|Overall Study||146
90259|NCT01155869|212224|P2|NOT COMPLETED|Overall Study||1
90260|NCT01155869|212225|P1|NOT COMPLETED|Overall Study||3
90261|NCT01155869|212224|P2|COMPLETED|Overall Study||3
90262|NCT01155869|212225|P1|COMPLETED|Overall Study||0
90263|NCT01155869|212224|P2|STARTED|Overall Study||4
90264|NCT01155869|212225|P1|STARTED|Overall Study||3
90265|NCT01155830|212236|P3|NOT COMPLETED|Overall Study||0
90266|NCT01155830|212237|P2|NOT COMPLETED|Overall Study||0
90267|NCT01155830|212238|P1|NOT COMPLETED|Overall Study||0
90268|NCT01155830|212236|P3|COMPLETED|Overall Study||21
90269|NCT01155830|212237|P2|COMPLETED|Overall Study||0
90270|NCT01155830|212238|P1|COMPLETED|Overall Study||0
90271|NCT01155830|212236|P3|STARTED|Overall Study||21
90272|NCT01155830|212237|P2|STARTED|Overall Study||0
90273|NCT01155830|212238|P1|STARTED|Overall Study||0
90274|NCT01155726|212249|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
90275|NCT01155726|212250|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
90276|NCT01155726|212251|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
90277|NCT01155726|212252|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
90278|NCT01155726|212249|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
90279|NCT01155726|212250|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
90280|NCT01155726|212251|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
90281|NCT01155726|212252|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
90282|NCT01155726|212249|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
90283|NCT01155726|212250|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
90284|NCT01155726|212251|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
90285|NCT01155726|212252|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
90286|NCT01155726|212249|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
90287|NCT01155726|212250|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
90288|NCT01155726|212251|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
90289|NCT01155726|212252|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
90290|NCT01155726|212249|P4|COMPLETED|Period 1, 3 Days (Masked)||25
90291|NCT01155726|212250|P3|COMPLETED|Period 1, 3 Days (Masked)||28
90292|NCT01155726|212251|P2|COMPLETED|Period 1, 3 Days (Masked)||20
90293|NCT01155726|212252|P1|COMPLETED|Period 1, 3 Days (Masked)||23
90294|NCT01155726|212249|P4|STARTED|Period 1, 3 Days (Masked)||25
90295|NCT01155726|212250|P3|STARTED|Period 1, 3 Days (Masked)||30
90296|NCT01155726|212251|P2|STARTED|Period 1, 3 Days (Masked)||20
90297|NCT01155726|212252|P1|STARTED|Period 1, 3 Days (Masked)||24
90298|NCT01155570|212274|P1|NOT COMPLETED|Overall Study||142
90299|NCT01155570|212274|P1|COMPLETED|Overall Study||592
90300|NCT01155570|212274|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
90301|NCT01155570|212274|P1|STARTED|Overall Study|Safety Analysis Population|734
90302|NCT01155531|212308|P4|NOT COMPLETED|Overall Study||1
90303|NCT01155531|212309|P3|NOT COMPLETED|Overall Study||2
90304|NCT01155531|212310|P2|NOT COMPLETED|Overall Study||0
90305|NCT01155531|212311|P1|NOT COMPLETED|Overall Study||1
90306|NCT01155531|212308|P4|COMPLETED|Overall Study||9
90307|NCT01155531|212309|P3|COMPLETED|Overall Study||8
90308|NCT01155531|212310|P2|COMPLETED|Overall Study||10
90309|NCT01155531|212311|P1|COMPLETED|Overall Study||9
90310|NCT01155531|212308|P4|STARTED|Overall Study||10
90311|NCT01155531|212309|P3|STARTED|Overall Study||10
90312|NCT01155531|212310|P2|STARTED|Overall Study||10
90313|NCT01155531|212311|P1|STARTED|Overall Study||10
90314|NCT01155479|212334|P5|NOT COMPLETED|Part II||55
90315|NCT01155479|212335|P4|NOT COMPLETED|Part II||50
90316|NCT01155479|212336|P3|NOT COMPLETED|Part II||58
90317|NCT01155479|212337|P2|NOT COMPLETED|Part II||61
90318|NCT01155479|212338|P1|NOT COMPLETED|Part II||59
90319|NCT01155479|212334|P5|COMPLETED|Part II||126
90320|NCT01155479|212335|P4|COMPLETED|Part II||127
90321|NCT01155479|212336|P3|COMPLETED|Part II||109
90322|NCT01155479|212337|P2|COMPLETED|Part II||116
90323|NCT01155479|212338|P1|COMPLETED|Part II||107
90324|NCT01155479|212334|P5|STARTED|Part II||181
90325|NCT01155479|212335|P4|STARTED|Part II||177
90326|NCT01155479|212336|P3|STARTED|Part II||167
90327|NCT01155479|212337|P2|STARTED|Part II||177
90328|NCT01155479|212338|P1|STARTED|Part II||166
90329|NCT01155479|212334|P5|NOT COMPLETED|Part I||23
90330|NCT01155479|212335|P4|NOT COMPLETED|Part I||27
90331|NCT01155479|212336|P3|NOT COMPLETED|Part I||39
90332|NCT01155479|212337|P2|NOT COMPLETED|Part I||27
90333|NCT01155479|212338|P1|NOT COMPLETED|Part I||38
90334|NCT01155479|212334|P5|COMPLETED|Part I||181
90335|NCT01155479|212335|P4|COMPLETED|Part I||177
90336|NCT01155479|212336|P3|COMPLETED|Part I||167
90337|NCT01155479|212337|P2|COMPLETED|Part I||177
90338|NCT01155479|212338|P1|COMPLETED|Part I||166
90339|NCT01155479|212334|P5|Treated|Part I||203
90340|NCT01155479|212335|P4|Treated|Part I||198
90341|NCT01155479|212336|P3|Treated|Part I||204
90342|NCT01155479|212337|P2|Treated|Part I||202
90343|NCT01155479|212338|P1|Treated|Part I||200
90344|NCT01155479|212334|P5|STARTED|Part I||204
90345|NCT01155479|212335|P4|STARTED|Part I||204
90346|NCT01155479|212336|P3|STARTED|Part I||206
90347|NCT01155479|212337|P2|STARTED|Part I||204
90348|NCT01155479|212338|P1|STARTED|Part I||204
90349|NCT01155466|212390|P5|NOT COMPLETED|Overall Study||27
90350|NCT01155466|212391|P4|NOT COMPLETED|Overall Study||21
90351|NCT01155466|212392|P3|NOT COMPLETED|Overall Study||20
90352|NCT01155466|212393|P2|NOT COMPLETED|Overall Study||25
90353|NCT01155466|212394|P1|NOT COMPLETED|Overall Study||22
90354|NCT01155466|212390|P5|COMPLETED|Overall Study|Completed treatment phase|129
90355|NCT01155466|212391|P4|COMPLETED|Overall Study|Completed treatment phase|134
90356|NCT01155466|212392|P3|COMPLETED|Overall Study|Completed treatment phase|136
90357|NCT01155466|212393|P2|COMPLETED|Overall Study|Completed treatment phase|130
90358|NCT01155466|212394|P1|COMPLETED|Overall Study|Completed treatment phase|134
90359|NCT01155466|212390|P5|Treated|Overall Study||154
90360|NCT01155466|212391|P4|Treated|Overall Study||155
90361|NCT01155466|212392|P3|Treated|Overall Study||153
90362|NCT01155466|212393|P2|Treated|Overall Study||153
90363|NCT01155466|212394|P1|Treated|Overall Study||154
90364|NCT01155466|212390|P5|STARTED|Overall Study||156
90365|NCT01155466|212391|P4|STARTED|Overall Study||155
90366|NCT01155466|212392|P3|STARTED|Overall Study||156
90367|NCT01155466|212393|P2|STARTED|Overall Study||155
90368|NCT01155466|212394|P1|STARTED|Overall Study||156
90369|NCT01155336|212448|P2|NOT COMPLETED|Overall Study||0
90370|NCT01155336|212449|P1|NOT COMPLETED|Overall Study||0
90371|NCT01155336|212448|P2|COMPLETED|Overall Study|We did not complete the study.|4
90372|NCT01155336|212449|P1|COMPLETED|Overall Study|We did not complete the study.|0
90373|NCT01155336|212448|P2|STARTED|Overall Study|We did not complete the study.|4
90374|NCT01155336|212449|P1|STARTED|Overall Study|We did not complete the study.|0
90375|NCT01155323|212455|P2|NOT COMPLETED|Second Intervention||1
90376|NCT01155323|212456|P1|NOT COMPLETED|Second Intervention||1
90377|NCT01155323|212455|P2|COMPLETED|Second Intervention||56
90378|NCT01155323|212456|P1|COMPLETED|Second Intervention||58
90379|NCT01155323|212455|P2|STARTED|Second Intervention||57
90380|NCT01155323|212456|P1|STARTED|Second Intervention||59
90381|NCT01155323|212455|P2|NOT COMPLETED|First Intervention||1
90382|NCT01155323|212456|P1|NOT COMPLETED|First Intervention||1
90383|NCT01155323|212455|P2|COMPLETED|First Intervention||57
90384|NCT01155323|212456|P1|COMPLETED|First Intervention||59
90385|NCT01155323|212455|P2|STARTED|First Intervention||58
90386|NCT01155323|212456|P1|STARTED|First Intervention||60
90387|NCT01155219|212474|P2|NOT COMPLETED|Overall Study||3
90388|NCT01155219|212475|P1|NOT COMPLETED|Overall Study||4
90389|NCT01155219|212474|P2|COMPLETED|Overall Study||70
90390|NCT01155219|212475|P1|COMPLETED|Overall Study||73
90391|NCT01155219|212474|P2|STARTED|Overall Study||73
90392|NCT01155219|212475|P1|STARTED|Overall Study||77
90393|NCT01155167|212483|P2|NOT COMPLETED|Overall Study||0
90394|NCT01155167|212484|P1|NOT COMPLETED|Overall Study||3
90395|NCT01155167|212483|P2|COMPLETED|Overall Study||43
90396|NCT01155167|212484|P1|COMPLETED|Overall Study||40
90397|NCT01155167|212483|P2|STARTED|Overall Study||43
90398|NCT01155167|212484|P1|STARTED|Overall Study||43
90399|NCT01155154|212497|P3|NOT COMPLETED|Overall Study||0
90400|NCT01155154|212498|P2|NOT COMPLETED|Overall Study||0
90401|NCT01155154|212499|P1|NOT COMPLETED|Overall Study||0
90402|NCT01155154|212497|P3|COMPLETED|Overall Study||24
90403|NCT01155154|212498|P2|COMPLETED|Overall Study||24
90404|NCT01155154|212499|P1|COMPLETED|Overall Study||25
90405|NCT01155154|212497|P3|STARTED|Overall Study||24
90406|NCT01155154|212498|P2|STARTED|Overall Study||24
90407|NCT01155154|212499|P1|STARTED|Overall Study||25
90408|NCT01155141|212507|P1|NOT COMPLETED|Overall Study||2
90409|NCT01155141|212507|P1|COMPLETED|Overall Study||14
90410|NCT01155141|212507|P1|STARTED|Overall Study||16
90411|NCT01155063|212519|P1|NOT COMPLETED|Overall Study||89
90412|NCT01155063|212519|P1|COMPLETED|Overall Study||0
90413|NCT01155063|212519|P1|STARTED|Overall Study||89
90414|NCT01155024|212529|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
90415|NCT01155024|212530|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
90416|NCT01155024|212529|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
90417|NCT01155024|212530|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
90418|NCT01155024|212529|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
90419|NCT01155024|212530|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
90420|NCT01155024|212529|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
90421|NCT01155024|212530|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
90422|NCT01155024|212529|P2|COMPLETED|Second Socket Intervention Fitting||5
90423|NCT01155024|212530|P1|COMPLETED|Second Socket Intervention Fitting||5
90424|NCT01155024|212529|P2|STARTED|Second Socket Intervention Fitting||5
90425|NCT01155024|212530|P1|STARTED|Second Socket Intervention Fitting||5
90426|NCT01155024|212529|P2|NOT COMPLETED|First Socket Intervention Fitting||0
90427|NCT01155024|212530|P1|NOT COMPLETED|First Socket Intervention Fitting||0
90428|NCT01155024|212529|P2|COMPLETED|First Socket Intervention Fitting||5
90429|NCT01155024|212530|P1|COMPLETED|First Socket Intervention Fitting||5
90430|NCT01155024|212529|P2|STARTED|First Socket Intervention Fitting||5
90431|NCT01155024|212530|P1|STARTED|First Socket Intervention Fitting||5
90432|NCT01154985|212541|P3|NOT COMPLETED|Overall Study||18
90433|NCT01154985|212542|P2|NOT COMPLETED|Overall Study||27
90434|NCT01154985|212543|P1|NOT COMPLETED|Overall Study||17
90435|NCT01154985|212541|P3|COMPLETED|Overall Study||68
90436|NCT01154985|212542|P2|COMPLETED|Overall Study||55
90437|NCT01154985|212543|P1|COMPLETED|Overall Study||58
90438|NCT01154985|212541|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
90439|NCT01154985|212542|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
90440|NCT01154985|212543|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
90441|NCT01154985|212541|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
90442|NCT01154985|212542|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
90443|NCT01154985|212543|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
90444|NCT01154985|212541|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
90445|NCT01154985|212542|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
90446|NCT01154985|212543|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
90447|NCT01154985|212541|P3|STARTED|Overall Study|Randomized|86
90448|NCT01154985|212542|P2|STARTED|Overall Study|Randomized|82
90449|NCT01154985|212543|P1|STARTED|Overall Study|Randomized|75
90450|NCT01154673|212559|P2|NOT COMPLETED|Overall Study||0
90451|NCT01154673|212560|P1|NOT COMPLETED|Overall Study||2
90452|NCT01154673|212559|P2|COMPLETED|Overall Study||16
90453|NCT01154673|212560|P1|COMPLETED|Overall Study||14
90454|NCT01154673|212559|P2|STARTED|Overall Study||16
90455|NCT01154673|212560|P1|STARTED|Overall Study||16
90456|NCT01154634|212570|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
90457|NCT01154634|212571|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
90458|NCT01154634|212572|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
90459|NCT01154634|212573|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
90460|NCT01154634|212570|P4|COMPLETED|Period 7 - Fourth Intervention||5
90461|NCT01154634|212571|P3|COMPLETED|Period 7 - Fourth Intervention||4
90462|NCT01154634|212572|P2|COMPLETED|Period 7 - Fourth Intervention||7
90463|NCT01154634|212573|P1|COMPLETED|Period 7 - Fourth Intervention||4
90464|NCT01154634|212570|P4|STARTED|Period 7 - Fourth Intervention||5
90465|NCT01154634|212571|P3|STARTED|Period 7 - Fourth Intervention||4
90466|NCT01154634|212572|P2|STARTED|Period 7 - Fourth Intervention||7
90467|NCT01154634|212573|P1|STARTED|Period 7 - Fourth Intervention||4
90468|NCT01154634|212570|P4|NOT COMPLETED|Period 6 - Washout||0
90469|NCT01154634|212571|P3|NOT COMPLETED|Period 6 - Washout||0
90470|NCT01154634|212572|P2|NOT COMPLETED|Period 6 - Washout||0
90471|NCT01154634|212573|P1|NOT COMPLETED|Period 6 - Washout||0
90472|NCT01154634|212570|P4|COMPLETED|Period 6 - Washout||5
90473|NCT01154634|212571|P3|COMPLETED|Period 6 - Washout||4
90474|NCT01154634|212572|P2|COMPLETED|Period 6 - Washout||7
90475|NCT01154634|212573|P1|COMPLETED|Period 6 - Washout||4
90476|NCT01154634|212570|P4|STARTED|Period 6 - Washout||5
90477|NCT01154634|212571|P3|STARTED|Period 6 - Washout||4
90478|NCT01154634|212572|P2|STARTED|Period 6 - Washout||7
90479|NCT01154634|212573|P1|STARTED|Period 6 - Washout||4
90480|NCT01154634|212570|P4|NOT COMPLETED|Period 5 - Third Intervention||0
90481|NCT01154634|212571|P3|NOT COMPLETED|Period 5 - Third Intervention||0
90482|NCT01154634|212572|P2|NOT COMPLETED|Period 5 - Third Intervention||0
90483|NCT01154634|212573|P1|NOT COMPLETED|Period 5 - Third Intervention||0
90484|NCT01154634|212570|P4|COMPLETED|Period 5 - Third Intervention||5
90485|NCT01154634|212571|P3|COMPLETED|Period 5 - Third Intervention||4
90486|NCT01154634|212572|P2|COMPLETED|Period 5 - Third Intervention||7
90487|NCT01154634|212573|P1|COMPLETED|Period 5 - Third Intervention||4
90488|NCT01154634|212570|P4|STARTED|Period 5 - Third Intervention||5
90489|NCT01154634|212571|P3|STARTED|Period 5 - Third Intervention||4
90490|NCT01154634|212572|P2|STARTED|Period 5 - Third Intervention||7
90491|NCT01154634|212573|P1|STARTED|Period 5 - Third Intervention||4
90492|NCT01154634|212570|P4|NOT COMPLETED|Period 4 - Washout||0
90493|NCT01154634|212571|P3|NOT COMPLETED|Period 4 - Washout||0
90494|NCT01154634|212572|P2|NOT COMPLETED|Period 4 - Washout||0
90495|NCT01154634|212573|P1|NOT COMPLETED|Period 4 - Washout||0
90496|NCT01154634|212570|P4|COMPLETED|Period 4 - Washout||5
90497|NCT01154634|212571|P3|COMPLETED|Period 4 - Washout||4
90498|NCT01154634|212572|P2|COMPLETED|Period 4 - Washout||7
90499|NCT01154634|212573|P1|COMPLETED|Period 4 - Washout||4
90500|NCT01154634|212570|P4|STARTED|Period 4 - Washout||5
90501|NCT01154634|212571|P3|STARTED|Period 4 - Washout||4
90502|NCT01154634|212572|P2|STARTED|Period 4 - Washout||7
90503|NCT01154634|212573|P1|STARTED|Period 4 - Washout||4
90504|NCT01154634|212570|P4|NOT COMPLETED|Period 3- Second Intervention||0
90505|NCT01154634|212571|P3|NOT COMPLETED|Period 3- Second Intervention||0
90506|NCT01154634|212572|P2|NOT COMPLETED|Period 3- Second Intervention||0
90507|NCT01154634|212573|P1|NOT COMPLETED|Period 3- Second Intervention||0
90508|NCT01154634|212570|P4|COMPLETED|Period 3- Second Intervention||5
90509|NCT01154634|212571|P3|COMPLETED|Period 3- Second Intervention||4
90510|NCT01154634|212572|P2|COMPLETED|Period 3- Second Intervention||7
90511|NCT01154634|212573|P1|COMPLETED|Period 3- Second Intervention||4
90512|NCT01154634|212570|P4|STARTED|Period 3- Second Intervention||5
90513|NCT01154634|212571|P3|STARTED|Period 3- Second Intervention||4
90514|NCT01154634|212572|P2|STARTED|Period 3- Second Intervention||7
90515|NCT01154634|212573|P1|STARTED|Period 3- Second Intervention||4
90516|NCT01154634|212570|P4|NOT COMPLETED|Period 2 - Washout||0
90517|NCT01154634|212571|P3|NOT COMPLETED|Period 2 - Washout||0
90518|NCT01154634|212572|P2|NOT COMPLETED|Period 2 - Washout||0
90519|NCT01154634|212573|P1|NOT COMPLETED|Period 2 - Washout||0
90520|NCT01154634|212570|P4|COMPLETED|Period 2 - Washout||5
90521|NCT01154634|212571|P3|COMPLETED|Period 2 - Washout||4
90522|NCT01154634|212572|P2|COMPLETED|Period 2 - Washout||7
90523|NCT01154634|212573|P1|COMPLETED|Period 2 - Washout||4
90524|NCT01154634|212570|P4|STARTED|Period 2 - Washout||5
90525|NCT01154634|212571|P3|STARTED|Period 2 - Washout||4
90526|NCT01154634|212572|P2|STARTED|Period 2 - Washout||7
90527|NCT01154634|212573|P1|STARTED|Period 2 - Washout||4
90528|NCT01154634|212570|P4|NOT COMPLETED|Period 1 - First Intervention||0
90529|NCT01154634|212571|P3|NOT COMPLETED|Period 1 - First Intervention||0
90530|NCT01154634|212572|P2|NOT COMPLETED|Period 1 - First Intervention||0
90531|NCT01154634|212573|P1|NOT COMPLETED|Period 1 - First Intervention||0
90532|NCT01154634|212570|P4|COMPLETED|Period 1 - First Intervention||5
90533|NCT01154634|212571|P3|COMPLETED|Period 1 - First Intervention||4
90534|NCT01154634|212572|P2|COMPLETED|Period 1 - First Intervention||7
90535|NCT01154634|212573|P1|COMPLETED|Period 1 - First Intervention||4
90536|NCT01154634|212570|P4|STARTED|Period 1 - First Intervention||5
90537|NCT01154634|212571|P3|STARTED|Period 1 - First Intervention||4
90538|NCT01154634|212572|P2|STARTED|Period 1 - First Intervention||7
90539|NCT01154634|212573|P1|STARTED|Period 1 - First Intervention||4
90540|NCT01154452|212615|P4|NOT COMPLETED|Phase II||6
90541|NCT01154452|212616|P3|NOT COMPLETED|Phase II||5
90542|NCT01154452|212617|P2|NOT COMPLETED|Phase II||0
90543|NCT01154452|212618|P1|NOT COMPLETED|Phase II||0
90544|NCT01154452|212615|P4|COMPLETED|Phase II||27
90545|NCT01154452|212616|P3|COMPLETED|Phase II||30
90546|NCT01154452|212617|P2|COMPLETED|Phase II||0
90547|NCT01154452|212618|P1|COMPLETED|Phase II||0
90548|NCT01154452|212615|P4|STARTED|Phase II||33
90549|NCT01154452|212616|P3|STARTED|Phase II||35
90550|NCT01154452|212617|P2|STARTED|Phase II||0
90551|NCT01154452|212618|P1|STARTED|Phase II||0
90552|NCT01154452|212615|P4|NOT COMPLETED|Phase Ib||0
90553|NCT01154452|212616|P3|NOT COMPLETED|Phase Ib||0
90554|NCT01154452|212617|P2|NOT COMPLETED|Phase Ib||1
90555|NCT01154452|212618|P1|NOT COMPLETED|Phase Ib||3
90556|NCT01154452|212615|P4|COMPLETED|Phase Ib||0
90557|NCT01154452|212616|P3|COMPLETED|Phase Ib||0
90558|NCT01154452|212617|P2|COMPLETED|Phase Ib||3
90559|NCT01154452|212618|P1|COMPLETED|Phase Ib||3
90560|NCT01154452|212615|P4|STARTED|Phase Ib||0
90561|NCT01154452|212616|P3|STARTED|Phase Ib||0
90562|NCT01154452|212617|P2|STARTED|Phase Ib||4
90563|NCT01154452|212618|P1|STARTED|Phase Ib||6
90564|NCT01154335|212632|P3|NOT COMPLETED|Overall Study||5
90565|NCT01154335|212633|P2|NOT COMPLETED|Overall Study||6
90566|NCT01154335|212634|P1|NOT COMPLETED|Overall Study||7
90567|NCT01154335|212632|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
90568|NCT01154335|212633|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
90569|NCT01154335|212634|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
90570|NCT01154335|212632|P3|STARTED|Overall Study||5
90571|NCT01154335|212633|P2|STARTED|Overall Study||6
90572|NCT01154335|212634|P1|STARTED|Overall Study||7
90573|NCT01154322|212641|P1|NOT COMPLETED|Overall Study||2
90574|NCT01154322|212641|P1|COMPLETED|Overall Study||14
90575|NCT01154322|212641|P1|STARTED|Overall Study||16
90576|NCT01154296|212648|P2|NOT COMPLETED|6-month Follow-up||328
90577|NCT01154296|212649|P1|NOT COMPLETED|6-month Follow-up||328
90578|NCT01154296|212648|P2|COMPLETED|6-month Follow-up||2179
90579|NCT01154296|212649|P1|COMPLETED|6-month Follow-up||2177
90580|NCT01154296|212648|P2|STARTED|6-month Follow-up||2507
90581|NCT01154296|212649|P1|STARTED|6-month Follow-up||2505
90582|NCT01154296|212648|P2|NOT COMPLETED|Randomization and Intervention||2
90583|NCT01154296|212649|P1|NOT COMPLETED|Randomization and Intervention||5
90584|NCT01154296|212648|P2|COMPLETED|Randomization and Intervention||2505
90585|NCT01154296|212649|P1|COMPLETED|Randomization and Intervention||2500
90586|NCT01154296|212648|P2|STARTED|Randomization and Intervention||2507
90587|NCT01154296|212649|P1|STARTED|Randomization and Intervention||2505
90588|NCT01154283|212667|P2|NOT COMPLETED|7-12 Weeks||1
90589|NCT01154283|212668|P1|NOT COMPLETED|7-12 Weeks||1
90590|NCT01154283|212667|P2|COMPLETED|7-12 Weeks||10
90591|NCT01154283|212668|P1|COMPLETED|7-12 Weeks||6
90592|NCT01154283|212667|P2|STARTED|7-12 Weeks||11
90593|NCT01154283|212668|P1|STARTED|7-12 Weeks||7
90594|NCT01154283|212667|P2|NOT COMPLETED|0-6 Weeks||3
90595|NCT01154283|212668|P1|NOT COMPLETED|0-6 Weeks||7
90596|NCT01154283|212667|P2|COMPLETED|0-6 Weeks||11
90597|NCT01154283|212668|P1|COMPLETED|0-6 Weeks||7
90598|NCT01154283|212667|P2|STARTED|0-6 Weeks||14
90599|NCT01154283|212668|P1|STARTED|0-6 Weeks||14
90600|NCT01154218|212680|P4|NOT COMPLETED|Fourth Intervention Period||0
90601|NCT01154218|212681|P3|NOT COMPLETED|Fourth Intervention Period||0
90602|NCT01154218|212682|P2|NOT COMPLETED|Fourth Intervention Period||0
90603|NCT01154218|212683|P1|NOT COMPLETED|Fourth Intervention Period||1
90604|NCT01154218|212680|P4|COMPLETED|Fourth Intervention Period||8
90605|NCT01154218|212681|P3|COMPLETED|Fourth Intervention Period||9
90606|NCT01154218|212682|P2|COMPLETED|Fourth Intervention Period||8
90607|NCT01154218|212683|P1|COMPLETED|Fourth Intervention Period||8
90608|NCT01154218|212680|P4|STARTED|Fourth Intervention Period||8
90609|NCT01154218|212681|P3|STARTED|Fourth Intervention Period||9
90610|NCT01154218|212682|P2|STARTED|Fourth Intervention Period||8
90611|NCT01154218|212683|P1|STARTED|Fourth Intervention Period||9
90612|NCT01154218|212680|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
90613|NCT01154218|212681|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90614|NCT01154218|212682|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90615|NCT01154218|212683|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90616|NCT01154218|212680|P4|COMPLETED|Washout Period (at Least 14 Days)||8
90617|NCT01154218|212681|P3|COMPLETED|Washout Period (at Least 14 Days)||9
90618|NCT01154218|212682|P2|COMPLETED|Washout Period (at Least 14 Days)||8
90619|NCT01154218|212683|P1|COMPLETED|Washout Period (at Least 14 Days)||9
90620|NCT01154218|212680|P4|STARTED|Washout Period (at Least 14 Days)||9
90621|NCT01154218|212681|P3|STARTED|Washout Period (at Least 14 Days)||9
90622|NCT01154218|212682|P2|STARTED|Washout Period (at Least 14 Days)||8
90623|NCT01154218|212683|P1|STARTED|Washout Period (at Least 14 Days)||9
90624|NCT01154218|212680|P4|NOT COMPLETED|Third Intervention Period||0
90625|NCT01154218|212681|P3|NOT COMPLETED|Third Intervention Period||0
90626|NCT01154218|212682|P2|NOT COMPLETED|Third Intervention Period||1
90627|NCT01154218|212683|P1|NOT COMPLETED|Third Intervention Period||0
90628|NCT01154218|212680|P4|COMPLETED|Third Intervention Period||9
90629|NCT01154218|212681|P3|COMPLETED|Third Intervention Period||9
90630|NCT01154218|212682|P2|COMPLETED|Third Intervention Period||8
90631|NCT01154218|212683|P1|COMPLETED|Third Intervention Period||9
90632|NCT01154218|212680|P4|STARTED|Third Intervention Period||9
90633|NCT01154218|212681|P3|STARTED|Third Intervention Period||9
90634|NCT01154218|212682|P2|STARTED|Third Intervention Period||9
90635|NCT01154218|212683|P1|STARTED|Third Intervention Period||9
90636|NCT01154218|212680|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90637|NCT01154218|212681|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90638|NCT01154218|212682|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90639|NCT01154218|212683|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90640|NCT01154218|212680|P4|COMPLETED|Washout Period (at Least 14 Days)||9
90641|NCT01154218|212681|P3|COMPLETED|Washout Period (at Least 14 Days)||9
90642|NCT01154218|212682|P2|COMPLETED|Washout Period (at Least 14 Days)||9
90643|NCT01154218|212683|P1|COMPLETED|Washout Period (at Least 14 Days)||9
90644|NCT01154218|212680|P4|STARTED|Washout Period (at Least 14 Days)||9
90645|NCT01154218|212681|P3|STARTED|Washout Period (at Least 14 Days)||9
90646|NCT01154218|212682|P2|STARTED|Washout Period (at Least 14 Days)||9
90647|NCT01154218|212683|P1|STARTED|Washout Period (at Least 14 Days)||9
90648|NCT01154218|212680|P4|NOT COMPLETED|Second Intervention Period||0
90649|NCT01154218|212681|P3|NOT COMPLETED|Second Intervention Period||0
90650|NCT01154218|212682|P2|NOT COMPLETED|Second Intervention Period||0
90651|NCT01154218|212683|P1|NOT COMPLETED|Second Intervention Period||0
90652|NCT01154218|212680|P4|COMPLETED|Second Intervention Period||9
90653|NCT01154218|212681|P3|COMPLETED|Second Intervention Period||9
90654|NCT01154218|212682|P2|COMPLETED|Second Intervention Period||9
90655|NCT01154218|212683|P1|COMPLETED|Second Intervention Period||9
90656|NCT01154218|212680|P4|STARTED|Second Intervention Period||9
90657|NCT01154218|212681|P3|STARTED|Second Intervention Period||9
90658|NCT01154218|212682|P2|STARTED|Second Intervention Period||9
90659|NCT01154218|212683|P1|STARTED|Second Intervention Period||9
90660|NCT01154218|212680|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90661|NCT01154218|212681|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90662|NCT01154218|212682|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90663|NCT01154218|212683|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
90664|NCT01154218|212680|P4|COMPLETED|Washout Period (at Least 14 Days)||9
90665|NCT01154218|212681|P3|COMPLETED|Washout Period (at Least 14 Days)||9
90666|NCT01154218|212682|P2|COMPLETED|Washout Period (at Least 14 Days)||9
90667|NCT01154218|212683|P1|COMPLETED|Washout Period (at Least 14 Days)||9
90668|NCT01154218|212680|P4|STARTED|Washout Period (at Least 14 Days)||9
90669|NCT01154218|212681|P3|STARTED|Washout Period (at Least 14 Days)||9
90670|NCT01154218|212682|P2|STARTED|Washout Period (at Least 14 Days)||9
90671|NCT01154218|212683|P1|STARTED|Washout Period (at Least 14 Days)||9
90672|NCT01154218|212680|P4|NOT COMPLETED|First Intervention Period||0
90673|NCT01154218|212681|P3|NOT COMPLETED|First Intervention Period||0
90674|NCT01154218|212682|P2|NOT COMPLETED|First Intervention Period||0
90675|NCT01154218|212683|P1|NOT COMPLETED|First Intervention Period||0
90676|NCT01154218|212680|P4|COMPLETED|First Intervention Period||9
90677|NCT01154218|212681|P3|COMPLETED|First Intervention Period||9
90678|NCT01154218|212682|P2|COMPLETED|First Intervention Period||9
90679|NCT01154218|212683|P1|COMPLETED|First Intervention Period||9
90680|NCT01154218|212680|P4|STARTED|First Intervention Period||9
90681|NCT01154218|212681|P3|STARTED|First Intervention Period||9
90682|NCT01154218|212682|P2|STARTED|First Intervention Period||9
90683|NCT01154218|212683|P1|STARTED|First Intervention Period||9
90684|NCT01154166|212735|P2|NOT COMPLETED|Overall Study||12
90685|NCT01154166|212736|P1|NOT COMPLETED|Overall Study||34
90686|NCT01154166|212735|P2|COMPLETED|Overall Study||163
90687|NCT01154166|212736|P1|COMPLETED|Overall Study||135
90688|NCT01154166|212735|P2|STARTED|Overall Study||175
90689|NCT01154166|212736|P1|STARTED|Overall Study||169
90690|NCT01154153|212768|P2|NOT COMPLETED|Overall Study||3
90691|NCT01154153|212769|P1|NOT COMPLETED|Overall Study||5
90692|NCT01154153|212768|P2|COMPLETED|Overall Study||66
90693|NCT01154153|212769|P1|COMPLETED|Overall Study||66
90694|NCT01154153|212768|P2|STARTED|Overall Study||69
90695|NCT01154153|212769|P1|STARTED|Overall Study||71
90696|NCT01154140|212787|P2|NOT COMPLETED|Overall Study||171
90697|NCT01154140|212788|P1|NOT COMPLETED|Overall Study||172
90698|NCT01154140|212787|P2|COMPLETED|Overall Study||0
90699|NCT01154140|212788|P1|COMPLETED|Overall Study||0
90700|NCT01154140|212787|P2|Treated|Overall Study||169
90701|NCT01154140|212788|P1|Treated|Overall Study||171
90702|NCT01154140|212787|P2|STARTED|Overall Study||171
90703|NCT01154140|212788|P1|STARTED|Overall Study||172
90704|NCT01154127|212837|P2|NOT COMPLETED|Period 2 (21 Days)||1
90705|NCT01154127|212838|P1|NOT COMPLETED|Period 2 (21 Days)||0
90706|NCT01154127|212837|P2|COMPLETED|Period 2 (21 Days)||46
90707|NCT01154127|212838|P1|COMPLETED|Period 2 (21 Days)||49
90708|NCT01154127|212837|P2|STARTED|Period 2 (21 Days)||47
90709|NCT01154127|212838|P1|STARTED|Period 2 (21 Days)||49
90710|NCT01154127|212837|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
90711|NCT01154127|212838|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
90712|NCT01154127|212837|P2|COMPLETED|Washout (14 - 28 Days)||47
90713|NCT01154127|212838|P1|COMPLETED|Washout (14 - 28 Days)||49
90714|NCT01154127|212837|P2|STARTED|Washout (14 - 28 Days)||47
90715|NCT01154127|212838|P1|STARTED|Washout (14 - 28 Days)||52
90716|NCT01154127|212837|P2|NOT COMPLETED|Period 1 (21 Days)||6
90717|NCT01154127|212838|P1|NOT COMPLETED|Period 1 (21 Days)||3
90718|NCT01154127|212837|P2|COMPLETED|Period 1 (21 Days)||47
90719|NCT01154127|212838|P1|COMPLETED|Period 1 (21 Days)||52
90720|NCT01154127|212837|P2|STARTED|Period 1 (21 Days)||53
90721|NCT01154127|212838|P1|STARTED|Period 1 (21 Days)||55
90722|NCT01154036|212863|P8|NOT COMPLETED|Phase II||6
90723|NCT01154036|212864|P7|NOT COMPLETED|Phase II||9
90724|NCT01154036|212865|P6|NOT COMPLETED|Phase II||5
90725|NCT01154036|212866|P5|NOT COMPLETED|Phase II||8
90726|NCT01154036|212867|P4|NOT COMPLETED|Phase II||1
90727|NCT01154036|212868|P3|NOT COMPLETED|Phase II||0
90728|NCT01154036|212869|P2|NOT COMPLETED|Phase II||0
90729|NCT01154036|212870|P1|NOT COMPLETED|Phase II||0
90730|NCT01154036|212863|P8|COMPLETED|Phase II||200
90731|NCT01154036|212864|P7|COMPLETED|Phase II||225
90732|NCT01154036|212865|P6|COMPLETED|Phase II||121
90733|NCT01154036|212866|P5|COMPLETED|Phase II||116
90734|NCT01154036|212867|P4|COMPLETED|Phase II||27
90735|NCT01154036|212868|P3|COMPLETED|Phase II||0
90736|NCT01154036|212869|P2|COMPLETED|Phase II||0
90737|NCT01154036|212870|P1|COMPLETED|Phase II||0
90738|NCT01154036|212863|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
90739|NCT01154036|212864|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
90740|NCT01154036|212865|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
90741|NCT01154036|212866|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
90742|NCT01154036|212867|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
90743|NCT01154036|212868|P3|STARTED|Phase II||0
90744|NCT01154036|212869|P2|STARTED|Phase II||0
90745|NCT01154036|212870|P1|STARTED|Phase II||0
90746|NCT01154036|212863|P8|NOT COMPLETED|Phase I||0
90747|NCT01154036|212864|P7|NOT COMPLETED|Phase I||0
90748|NCT01154036|212865|P6|NOT COMPLETED|Phase I||0
90749|NCT01154036|212866|P5|NOT COMPLETED|Phase I||0
90750|NCT01154036|212867|P4|NOT COMPLETED|Phase I||0
90751|NCT01154036|212868|P3|NOT COMPLETED|Phase I||56
90752|NCT01154036|212869|P2|NOT COMPLETED|Phase I||28
90753|NCT01154036|212870|P1|NOT COMPLETED|Phase I||3
90754|NCT01154036|212863|P8|COMPLETED|Phase I||0
90755|NCT01154036|212864|P7|COMPLETED|Phase I||0
90756|NCT01154036|212865|P6|COMPLETED|Phase I||0
90757|NCT01154036|212866|P5|COMPLETED|Phase I||0
90758|NCT01154036|212867|P4|COMPLETED|Phase I||0
90759|NCT01154036|212868|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
90760|NCT01154036|212869|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
90761|NCT01154036|212870|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
90762|NCT01154036|212863|P8|STARTED|Phase I||0
90763|NCT01154036|212864|P7|STARTED|Phase I||0
90764|NCT01154036|212865|P6|STARTED|Phase I||0
90765|NCT01154036|212866|P5|STARTED|Phase I||0
90766|NCT01154036|212867|P4|STARTED|Phase I||0
90767|NCT01154036|212868|P3|STARTED|Phase I||944
90768|NCT01154036|212869|P2|STARTED|Phase I||483
90769|NCT01154036|212870|P1|STARTED|Phase I||120
90770|NCT01153971|212992|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
90771|NCT01153971|212992|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
90772|NCT01153971|212992|P1|STARTED|Follow-up (Months 17-40 of Study)||41
90773|NCT01153971|212992|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
90774|NCT01153971|212992|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
90775|NCT01153971|212992|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
90776|NCT01153971|212992|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
90777|NCT01153971|212992|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
90778|NCT01153971|212992|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
90779|NCT01153958|213015|P2|NOT COMPLETED|Overall Study||32
90780|NCT01153958|213016|P1|NOT COMPLETED|Overall Study||36
90781|NCT01153958|213015|P2|COMPLETED|Overall Study||35
90782|NCT01153958|213016|P1|COMPLETED|Overall Study||30
90783|NCT01153958|213015|P2|STARTED|Overall Study||67
90784|NCT01153958|213016|P1|STARTED|Overall Study||66
90785|NCT01153893|213034|P2|NOT COMPLETED|Overall Study||0
90786|NCT01153893|213035|P1|NOT COMPLETED|Overall Study||1
90787|NCT01153893|213034|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
90788|NCT01153893|213035|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
90789|NCT01153893|213034|P2|STARTED|Overall Study||36
90790|NCT01153893|213035|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
90791|NCT01153815|213061|P2|NOT COMPLETED|Overall Study||5
90792|NCT01153815|213062|P1|NOT COMPLETED|Overall Study||9
90793|NCT01153815|213061|P2|COMPLETED|Overall Study||82
90794|NCT01153815|213062|P1|COMPLETED|Overall Study||74
90795|NCT01153815|213061|P2|STARTED|Overall Study||87
90796|NCT01153815|213062|P1|STARTED|Overall Study||83
90797|NCT01153763|213084|P1|NOT COMPLETED|Overall Study||59
90798|NCT01153763|213084|P1|COMPLETED|Overall Study||33
90799|NCT01153763|213084|P1|Ongoing (In Follow-up)|Overall Study||24
90800|NCT01153763|213084|P1|STARTED|Overall Study||92
90801|NCT01153724|213095|P1|NOT COMPLETED|Treatment Period 2||2
90802|NCT01153724|213095|P1|COMPLETED|Treatment Period 2||32
90803|NCT01153724|213095|P1|STARTED|Treatment Period 2||34
90804|NCT01153724|213095|P1|NOT COMPLETED|Treatment Period 1||1
90805|NCT01153724|213095|P1|COMPLETED|Treatment Period 1||34
90806|NCT01153724|213095|P1|STARTED|Treatment Period 1||35
90807|NCT01153711|213115|P1|NOT COMPLETED|Overall Study||0
90808|NCT01153711|213115|P1|COMPLETED|Overall Study||32
90809|NCT01153711|213115|P1|STARTED|Overall Study||32
90810|NCT01153698|213135|P1|NOT COMPLETED|Overall Study||29
90811|NCT01153698|213135|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
90812|NCT01153698|213135|P1|STARTED|Overall Study|Entered and treated.|168
90813|NCT01153685|213151|P2|NOT COMPLETED|Overall Study||0
90814|NCT01153685|213152|P1|NOT COMPLETED|Overall Study||0
90815|NCT01153685|213151|P2|COMPLETED|Overall Study||70
90816|NCT01153685|213152|P1|COMPLETED|Overall Study||50
90817|NCT01153685|213151|P2|STARTED|Overall Study||70
90818|NCT01153685|213152|P1|STARTED|Overall Study||50
90819|NCT01153672|213176|P1|NOT COMPLETED|Overall Study||2
90820|NCT01153672|213176|P1|COMPLETED|Overall Study||6
90821|NCT01153672|213176|P1|STARTED|Overall Study||8
90822|NCT01153633|213184|P2|NOT COMPLETED|Overall Study||4
90823|NCT01153633|213185|P1|NOT COMPLETED|Overall Study||4
90824|NCT01153633|213184|P2|COMPLETED|Overall Study||13
90825|NCT01153633|213185|P1|COMPLETED|Overall Study||13
90826|NCT01153633|213184|P2|STARTED|Overall Study||17
90827|NCT01153633|213185|P1|STARTED|Overall Study||17
90828|NCT01153620|213203|P2|NOT COMPLETED|Overall Study||0
90829|NCT01153620|213204|P1|NOT COMPLETED|Overall Study||0
90830|NCT01153620|213203|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
90831|NCT01153620|213204|P1|COMPLETED|Overall Study||30
90832|NCT01153620|213203|P2|STARTED|Overall Study|30 patients (31 wounds)|30
90833|NCT01153620|213204|P1|STARTED|Overall Study||30
90834|NCT01153581|213210|P1|NOT COMPLETED|Overall Study||0
90835|NCT01153581|213210|P1|COMPLETED|Overall Study||109
90836|NCT01153581|213210|P1|STARTED|Overall Study||109
90837|NCT01153503|213223|P3|NOT COMPLETED|Overall Study||0
90838|NCT01153503|213224|P2|NOT COMPLETED|Overall Study||1
90839|NCT01153503|213225|P1|NOT COMPLETED|Overall Study||0
90840|NCT01153503|213223|P3|COMPLETED|Overall Study||25
90841|NCT01153503|213224|P2|COMPLETED|Overall Study||24
90842|NCT01153503|213225|P1|COMPLETED|Overall Study||25
90843|NCT01153503|213223|P3|STARTED|Overall Study||25
90844|NCT01153503|213224|P2|STARTED|Overall Study||25
90845|NCT01153503|213225|P1|STARTED|Overall Study||25
90846|NCT01153347|213237|P4|NOT COMPLETED|Overall Study||32
90847|NCT01153347|213238|P3|NOT COMPLETED|Overall Study||50
90848|NCT01153347|213239|P2|NOT COMPLETED|Overall Study||44
90849|NCT01153347|213240|P1|NOT COMPLETED|Overall Study||33
90850|NCT01153347|213237|P4|COMPLETED|Overall Study||129
90851|NCT01153347|213238|P3|COMPLETED|Overall Study||110
90852|NCT01153347|213239|P2|COMPLETED|Overall Study||116
90853|NCT01153347|213240|P1|COMPLETED|Overall Study||127
90854|NCT01153347|213237|P4|Received Treatment|Overall Study||160
90855|NCT01153347|213238|P3|Received Treatment|Overall Study||158
90856|NCT01153347|213239|P2|Received Treatment|Overall Study||158
90857|NCT01153347|213240|P1|Received Treatment|Overall Study||160
90858|NCT01153347|213237|P4|STARTED|Overall Study||161
90859|NCT01153347|213238|P3|STARTED|Overall Study||160
90860|NCT01153347|213239|P2|STARTED|Overall Study||160
90861|NCT01153347|213240|P1|STARTED|Overall Study||160
90862|NCT01153321|213340|P2|NOT COMPLETED|Overall Study||3
90863|NCT01153321|213341|P1|NOT COMPLETED|Overall Study||1
90864|NCT01153321|213340|P2|COMPLETED|Overall Study||19
90865|NCT01153321|213341|P1|COMPLETED|Overall Study||21
90866|NCT01153321|213340|P2|STARTED|Overall Study||22
90867|NCT01153321|213341|P1|STARTED|Overall Study||22
90868|NCT01153269|213453|P1|NOT COMPLETED|Overall Study||2
90869|NCT01153269|213453|P1|COMPLETED|Overall Study||31
90870|NCT01153269|213453|P1|Participants Analyzed|Overall Study||33
90871|NCT01153269|213453|P1|STARTED|Overall Study||33
90872|NCT01153009|213516|P4|NOT COMPLETED|Overall Study||37
90873|NCT01153009|213517|P3|NOT COMPLETED|Overall Study||41
90874|NCT01153009|213518|P2|NOT COMPLETED|Overall Study||34
90875|NCT01153009|213519|P1|NOT COMPLETED|Overall Study||32
90876|NCT01153009|213516|P4|COMPLETED|Overall Study||115
90877|NCT01153009|213517|P3|COMPLETED|Overall Study||113
90878|NCT01153009|213518|P2|COMPLETED|Overall Study||113
90879|NCT01153009|213519|P1|COMPLETED|Overall Study||129
90880|NCT01153009|213516|P4|Treated|Overall Study||150
90881|NCT01153009|213517|P3|Treated|Overall Study||154
90882|NCT01153009|213518|P2|Treated|Overall Study||147
90883|NCT01153009|213519|P1|Treated|Overall Study||159
90884|NCT01153009|213516|P4|STARTED|Overall Study||152
90885|NCT01153009|213517|P3|STARTED|Overall Study||154
90886|NCT01153009|213518|P2|STARTED|Overall Study||147
90887|NCT01153009|213519|P1|STARTED|Overall Study||161
90888|NCT01152996|213549|P1|NOT COMPLETED|Overall Study||537
90889|NCT01152996|213549|P1|COMPLETED|Overall Study||538
90890|NCT01152996|213549|P1|Treated|Overall Study||1073
90891|NCT01152996|213549|P1|STARTED|Overall Study||1075
90892|NCT01152814|213562|P1|NOT COMPLETED|Overall Study||2
90893|NCT01152814|213562|P1|COMPLETED|Overall Study||62
90894|NCT01152814|213562|P1|STARTED|Overall Study||64
90895|NCT01152788|213571|P2|NOT COMPLETED|Overall Study||4
90896|NCT01152788|213572|P1|NOT COMPLETED|Overall Study||0
90897|NCT01152788|213571|P2|COMPLETED|Overall Study||28
90898|NCT01152788|213572|P1|COMPLETED|Overall Study||32
90899|NCT01152788|213571|P2|STARTED|Overall Study||32
90900|NCT01152788|213572|P1|STARTED|Overall Study||32
90901|NCT01152697|213584|P1|NOT COMPLETED|Overall Study||19
90902|NCT01152697|213584|P1|COMPLETED|Overall Study||11
90903|NCT01152697|213584|P1|STARTED|Overall Study||30
90904|NCT01152580|213609|P2|NOT COMPLETED|Overall Study||1
90905|NCT01152580|213610|P1|NOT COMPLETED|Overall Study||0
90906|NCT01152580|213609|P2|COMPLETED|Overall Study||13
90907|NCT01152580|213610|P1|COMPLETED|Overall Study||5
90908|NCT01152580|213609|P2|STARTED|Overall Study||14
90909|NCT01152580|213610|P1|STARTED|Overall Study||5
90910|NCT01152554|213632|P2|NOT COMPLETED|Overall Study||111
90911|NCT01152554|213633|P1|NOT COMPLETED|Overall Study||334
90912|NCT01152554|213632|P2|COMPLETED|Overall Study||92
90913|NCT01152554|213633|P1|COMPLETED|Overall Study||276
90914|NCT01152554|213632|P2|Received Treatment|Overall Study||201
90915|NCT01152554|213633|P1|Received Treatment|Overall Study||607
90916|NCT01152554|213632|P2|STARTED|Overall Study||203
90917|NCT01152554|213633|P1|STARTED|Overall Study||610
90918|NCT01152450|213655|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
90919|NCT01152450|213656|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
90920|NCT01152450|213657|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
90921|NCT01152450|213658|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
90922|NCT01152450|213659|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
90923|NCT01152450|213660|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
90924|NCT01152450|213655|P6|COMPLETED|Period 3 (4 Weeks)||12
90925|NCT01152450|213656|P5|COMPLETED|Period 3 (4 Weeks)||16
90926|NCT01152450|213657|P4|COMPLETED|Period 3 (4 Weeks)||15
90927|NCT01152450|213658|P3|COMPLETED|Period 3 (4 Weeks)||16
90928|NCT01152450|213659|P2|COMPLETED|Period 3 (4 Weeks)||15
90929|NCT01152450|213660|P1|COMPLETED|Period 3 (4 Weeks)||15
90930|NCT01152450|213655|P6|STARTED|Period 3 (4 Weeks)||12
90931|NCT01152450|213656|P5|STARTED|Period 3 (4 Weeks)||16
90932|NCT01152450|213657|P4|STARTED|Period 3 (4 Weeks)||15
90933|NCT01152450|213658|P3|STARTED|Period 3 (4 Weeks)||16
90934|NCT01152450|213659|P2|STARTED|Period 3 (4 Weeks)||15
90935|NCT01152450|213660|P1|STARTED|Period 3 (4 Weeks)||15
90936|NCT01152450|213655|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
90937|NCT01152450|213656|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
90938|NCT01152450|213657|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
90939|NCT01152450|213658|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
90940|NCT01152450|213659|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
90941|NCT01152450|213660|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
90942|NCT01152450|213655|P6|COMPLETED|Period 2 (4 Weeks)||12
90943|NCT01152450|213656|P5|COMPLETED|Period 2 (4 Weeks)||16
90944|NCT01152450|213657|P4|COMPLETED|Period 2 (4 Weeks)||15
90945|NCT01152450|213658|P3|COMPLETED|Period 2 (4 Weeks)||16
90946|NCT01152450|213659|P2|COMPLETED|Period 2 (4 Weeks)||15
90947|NCT01152450|213660|P1|COMPLETED|Period 2 (4 Weeks)||15
90948|NCT01152450|213655|P6|STARTED|Period 2 (4 Weeks)||12
90949|NCT01152450|213656|P5|STARTED|Period 2 (4 Weeks)||16
90950|NCT01152450|213657|P4|STARTED|Period 2 (4 Weeks)||15
90951|NCT01152450|213658|P3|STARTED|Period 2 (4 Weeks)||16
90952|NCT01152450|213659|P2|STARTED|Period 2 (4 Weeks)||15
90953|NCT01152450|213660|P1|STARTED|Period 2 (4 Weeks)||15
90954|NCT01152450|213655|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
90955|NCT01152450|213656|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
90956|NCT01152450|213657|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
90957|NCT01152450|213658|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
90958|NCT01152450|213659|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
90959|NCT01152450|213660|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
90960|NCT01152450|213655|P6|COMPLETED|Period 1 (4 Weeks)||12
90961|NCT01152450|213656|P5|COMPLETED|Period 1 (4 Weeks)||16
90962|NCT01152450|213657|P4|COMPLETED|Period 1 (4 Weeks)||15
90963|NCT01152450|213658|P3|COMPLETED|Period 1 (4 Weeks)||16
90964|NCT01152450|213659|P2|COMPLETED|Period 1 (4 Weeks)||15
90965|NCT01152450|213660|P1|COMPLETED|Period 1 (4 Weeks)||15
90966|NCT01152450|213655|P6|STARTED|Period 1 (4 Weeks)||13
90967|NCT01152450|213656|P5|STARTED|Period 1 (4 Weeks)||18
90968|NCT01152450|213657|P4|STARTED|Period 1 (4 Weeks)||15
90969|NCT01152450|213658|P3|STARTED|Period 1 (4 Weeks)||17
90970|NCT01152450|213659|P2|STARTED|Period 1 (4 Weeks)||16
90971|NCT01152450|213660|P1|STARTED|Period 1 (4 Weeks)||15
90972|NCT01152437|213731|P3|NOT COMPLETED|Overall Study||43
90973|NCT01152437|213732|P2|NOT COMPLETED|Overall Study||15
90974|NCT01152437|213733|P1|NOT COMPLETED|Overall Study||36
90975|NCT01152437|213731|P3|COMPLETED|Overall Study||0
90976|NCT01152437|213732|P2|COMPLETED|Overall Study||0
90977|NCT01152437|213733|P1|COMPLETED|Overall Study||0
90978|NCT01152437|213731|P3|STARTED|Overall Study|entered|43
90979|NCT01152437|213732|P2|STARTED|Overall Study|randomised|15
90980|NCT01152437|213733|P1|STARTED|Overall Study|randomised|36
90981|NCT01152385|213753|P4|NOT COMPLETED|Overall Study||5
90982|NCT01152385|213754|P3|NOT COMPLETED|Overall Study||5
90983|NCT01152385|213755|P2|NOT COMPLETED|Overall Study||6
90984|NCT01152385|213756|P1|NOT COMPLETED|Overall Study||9
90985|NCT01152385|213753|P4|COMPLETED|Overall Study||50
90986|NCT01152385|213754|P3|COMPLETED|Overall Study||51
90987|NCT01152385|213755|P2|COMPLETED|Overall Study||52
90988|NCT01152385|213756|P1|COMPLETED|Overall Study||46
90989|NCT01152385|213753|P4|STARTED|Overall Study||55
90990|NCT01152385|213754|P3|STARTED|Overall Study||56
90991|NCT01152385|213755|P2|STARTED|Overall Study||58
90992|NCT01152385|213756|P1|STARTED|Overall Study||55
90993|NCT01152359|213796|P2|NOT COMPLETED|Overall Study||22
90994|NCT01152359|213797|P1|NOT COMPLETED|Overall Study||24
90995|NCT01152359|213796|P2|COMPLETED|Overall Study||80
90996|NCT01152359|213797|P1|COMPLETED|Overall Study||81
90997|NCT01152359|213796|P2|STARTED|Overall Study||102
90998|NCT01152359|213797|P1|STARTED|Overall Study||105
90999|NCT01152307|213805|P2|NOT COMPLETED|Overall Study||0
91000|NCT01152307|213806|P1|NOT COMPLETED|Overall Study||0
91001|NCT01152307|213805|P2|COMPLETED|Overall Study||214
91002|NCT01152307|213806|P1|COMPLETED|Overall Study||191
91003|NCT01152307|213805|P2|STARTED|Overall Study||214
91004|NCT01152307|213806|P1|STARTED|Overall Study||191
91005|NCT01152294|213814|P2|NOT COMPLETED|Overall Study||0
91006|NCT01152294|213815|P1|NOT COMPLETED|Overall Study||0
91007|NCT01152294|213814|P2|COMPLETED|Overall Study||188
91008|NCT01152294|213815|P1|COMPLETED|Overall Study||213
91009|NCT01152294|213814|P2|STARTED|Overall Study||188
91010|NCT01152294|213815|P1|STARTED|Overall Study||213
91011|NCT01152190|213823|P2|NOT COMPLETED|Overall Study||8
91012|NCT01152190|213824|P1|NOT COMPLETED|Overall Study||5
91013|NCT01152190|213823|P2|COMPLETED|Overall Study||39
91014|NCT01152190|213824|P1|COMPLETED|Overall Study||45
91015|NCT01152190|213823|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
91016|NCT01152190|213824|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
91017|NCT01152190|213823|P2|STARTED|Overall Study||47
91018|NCT01152190|213824|P1|STARTED|Overall Study||50
91019|NCT01151904|213836|P1|NOT COMPLETED|Overall Study||0
91020|NCT01151904|213836|P1|COMPLETED|Overall Study||17
91021|NCT01151904|213836|P1|STARTED|Overall Study||17
91022|NCT01151852|213844|P2|NOT COMPLETED|Overall Study||0
91023|NCT01151852|213845|P1|NOT COMPLETED|Overall Study||0
91024|NCT01151852|213844|P2|COMPLETED|Overall Study||40
91025|NCT01151852|213845|P1|COMPLETED|Overall Study||41
91026|NCT01151852|213844|P2|STARTED|Overall Study||40
91027|NCT01151852|213845|P1|STARTED|Overall Study||41
91028|NCT01151761|213861|P1|NOT COMPLETED|Overall Study||0
91029|NCT01151761|213861|P1|COMPLETED|Overall Study||2
91030|NCT01151761|213861|P1|STARTED|Overall Study||2
91031|NCT01151579|213874|P2|NOT COMPLETED|Overall Study||7
91032|NCT01151579|213875|P1|NOT COMPLETED|Overall Study||12
91033|NCT01151579|213874|P2|COMPLETED|Overall Study||24
91034|NCT01151579|213875|P1|COMPLETED|Overall Study||46
91035|NCT01151579|213874|P2|STARTED|Overall Study||31
91036|NCT01151579|213875|P1|STARTED|Overall Study||58
91037|NCT01151553|213885|P1|NOT COMPLETED|Overall Study||0
91038|NCT01151553|213885|P1|COMPLETED|Overall Study||5
91039|NCT01151553|213885|P1|STARTED|Overall Study||5
91040|NCT01151436|213889|P1|NOT COMPLETED|Overall Study||1
91041|NCT01151436|213889|P1|COMPLETED|Overall Study||76
91042|NCT01151436|213889|P1|STARTED|Overall Study||77
91043|NCT01151410|213921|P2|NOT COMPLETED|Overall Study||15
91044|NCT01151410|213922|P1|NOT COMPLETED|Overall Study||11
91045|NCT01151410|213921|P2|COMPLETED|Overall Study||89
91046|NCT01151410|213922|P1|COMPLETED|Overall Study||93
91047|NCT01151410|213921|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
91048|NCT01151410|213922|P1|Safety Set (SAF)|Overall Study||105
91049|NCT01151410|213921|P2|STARTED|Overall Study||104
91050|NCT01151410|213922|P1|STARTED|Overall Study||104
91051|NCT01151371|213935|P3|NOT COMPLETED|Overall Study||7
91052|NCT01151371|213936|P2|NOT COMPLETED|Overall Study||1
91053|NCT01151371|213937|P1|NOT COMPLETED|Overall Study||5
91054|NCT01151371|213935|P3|COMPLETED|Overall Study||146
91055|NCT01151371|213936|P2|COMPLETED|Overall Study||149
91056|NCT01151371|213937|P1|COMPLETED|Overall Study||144
91057|NCT01151371|213935|P3|STARTED|Overall Study||153
91058|NCT01151371|213936|P2|STARTED|Overall Study||150
91059|NCT01151371|213937|P1|STARTED|Overall Study||149
91060|NCT01151345|213966|P2|NOT COMPLETED|Second Intervention Period||0
91061|NCT01151345|213967|P1|NOT COMPLETED|Second Intervention Period||0
91062|NCT01151345|213966|P2|COMPLETED|Second Intervention Period||12
91063|NCT01151345|213967|P1|COMPLETED|Second Intervention Period||13
91064|NCT01151345|213966|P2|STARTED|Second Intervention Period||12
91065|NCT01151345|213967|P1|STARTED|Second Intervention Period||13
91066|NCT01151345|213966|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
91067|NCT01151345|213967|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
91068|NCT01151345|213966|P2|COMPLETED|Wash-out Period (7 Days)||12
91069|NCT01151345|213967|P1|COMPLETED|Wash-out Period (7 Days)||13
91070|NCT01151345|213966|P2|STARTED|Wash-out Period (7 Days)||12
91071|NCT01151345|213967|P1|STARTED|Wash-out Period (7 Days)||13
91072|NCT01151345|213966|P2|NOT COMPLETED|First Intervention Period||1
91073|NCT01151345|213967|P1|NOT COMPLETED|First Intervention Period||0
91074|NCT01151345|213966|P2|COMPLETED|First Intervention Period||12
91075|NCT01151345|213967|P1|COMPLETED|First Intervention Period||13
91076|NCT01151345|213966|P2|Treated|First Intervention Period||12
91077|NCT01151345|213967|P1|Treated|First Intervention Period||13
91078|NCT01151345|213966|P2|STARTED|First Intervention Period||13
91079|NCT01151345|213967|P1|STARTED|First Intervention Period||13
91080|NCT01151280|213981|P1|NOT COMPLETED|Overall Study||4
91081|NCT01151280|213981|P1|COMPLETED|Overall Study||6
91082|NCT01151280|213981|P1|STARTED|Overall Study||10
91083|NCT01151215|213994|P3|NOT COMPLETED|Overall Study||19
91084|NCT01151215|213995|P2|NOT COMPLETED|Overall Study||23
91085|NCT01151215|213996|P1|NOT COMPLETED|Overall Study||20
91086|NCT01151215|213994|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
91087|NCT01151215|213995|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
91088|NCT01151215|213996|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
91089|NCT01151215|213994|P3|STARTED|Overall Study||121
91090|NCT01151215|213995|P2|STARTED|Overall Study||118
91091|NCT01151215|213996|P1|STARTED|Overall Study||120
91092|NCT01151189|214009|P2|NOT COMPLETED|Overall Study||10
91093|NCT01151189|214010|P1|NOT COMPLETED|Overall Study||15
91094|NCT01151189|214009|P2|COMPLETED|Overall Study||314
91095|NCT01151189|214010|P1|COMPLETED|Overall Study||311
91096|NCT01151189|214009|P2|Received Vaccine|Overall Study||324
91097|NCT01151189|214010|P1|Received Vaccine|Overall Study||325
91098|NCT01151189|214009|P2|STARTED|Overall Study||324
91099|NCT01151189|214010|P1|STARTED|Overall Study||326
91100|NCT01151137|214034|P2|NOT COMPLETED|Overall Study||28
91101|NCT01151137|214035|P1|NOT COMPLETED|Overall Study||16
91102|NCT01151137|214034|P2|COMPLETED|Overall Study||1591
91103|NCT01151137|214035|P1|COMPLETED|Overall Study||1601
91104|NCT01151137|214034|P2|Discontinued Treatment|Overall Study||342
91105|NCT01151137|214035|P1|Discontinued Treatment|Overall Study||171
91106|NCT01151137|214034|P2|Treated|Overall Study||1613
91107|NCT01151137|214035|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
91108|NCT01151137|214034|P2|STARTED|Overall Study||1619
91109|NCT01151137|214035|P1|STARTED|Overall Study||1617
91110|NCT01151098|214053|P1|NOT COMPLETED|Overall Study||117
91111|NCT01151098|214053|P1|COMPLETED|Overall Study||72
91112|NCT01151098|214053|P1|STARTED|Overall Study|Extension Safety Population|189
91113|NCT01151085|214057|P1|NOT COMPLETED|Overall Study||56
91114|NCT01151085|214057|P1|COMPLETED|Overall Study||946
91115|NCT01151085|214057|P1|STARTED|Overall Study||1002
91116|NCT01151046|214075|P2|NOT COMPLETED|Overall Study||0
91117|NCT01151046|214076|P1|NOT COMPLETED|Overall Study||3
91118|NCT01151046|214075|P2|COMPLETED|Overall Study||59
91119|NCT01151046|214076|P1|COMPLETED|Overall Study||56
91120|NCT01151046|214075|P2|STARTED|Overall Study||59
91121|NCT01151046|214076|P1|STARTED|Overall Study||59
91122|NCT01151020|214088|P1|NOT COMPLETED|Overall Study||110
91123|NCT01151020|214088|P1|COMPLETED|Overall Study||0
91124|NCT01151020|214088|P1|12-month|Overall Study||99
91125|NCT01151020|214088|P1|30-day|Overall Study||110
91126|NCT01151020|214088|P1|STARTED|Overall Study||110
91127|NCT01150981|214095|P2|NOT COMPLETED|Overall Study||2
91128|NCT01150981|214096|P1|NOT COMPLETED|Overall Study||4
91129|NCT01150981|214095|P2|COMPLETED|Overall Study||13
91130|NCT01150981|214096|P1|COMPLETED|Overall Study||16
91131|NCT01150981|214095|P2|STARTED|Overall Study||15
91132|NCT01150981|214096|P1|STARTED|Overall Study||20
91133|NCT01150903|214106|P2|NOT COMPLETED|Overall Study||0
91134|NCT01150903|214107|P1|NOT COMPLETED|Overall Study||0
91135|NCT01150903|214106|P2|COMPLETED|Overall Study||74124
91136|NCT01150903|214107|P1|COMPLETED|Overall Study||24708
91137|NCT01150903|214106|P2|STARTED|Overall Study||74124
91138|NCT01150903|214107|P1|STARTED|Overall Study||24708
91139|NCT01150760|214123|P2|NOT COMPLETED|Overall Study||0
91140|NCT01150760|214124|P1|NOT COMPLETED|Overall Study||0
91141|NCT01150760|214123|P2|COMPLETED|Overall Study||3525
91142|NCT01150760|214124|P1|COMPLETED|Overall Study||3525
91143|NCT01150760|214123|P2|STARTED|Overall Study||3525
91144|NCT01150760|214124|P1|STARTED|Overall Study||3525
91145|NCT01150500|214156|P1|NOT COMPLETED|Overall Study||65
91146|NCT01150500|214156|P1|COMPLETED|Overall Study||0
91147|NCT01150500|214156|P1|STARTED|Overall Study||65
91148|NCT01150474|214167|P2|NOT COMPLETED|Overall Study||3
91149|NCT01150474|214168|P1|NOT COMPLETED|Overall Study||10
91150|NCT01150474|214167|P2|COMPLETED|Overall Study||49
91151|NCT01150474|214168|P1|COMPLETED|Overall Study||41
91152|NCT01150474|214167|P2|STARTED|Overall Study||52
91153|NCT01150474|214168|P1|STARTED|Overall Study||51
91154|NCT01150461|214192|P2|NOT COMPLETED|Overall Study||0
91155|NCT01150461|214193|P1|NOT COMPLETED|Overall Study||0
91156|NCT01150461|214192|P2|COMPLETED|Overall Study||9
91157|NCT01150461|214193|P1|COMPLETED|Overall Study||11
91158|NCT01150461|214192|P2|STARTED|Overall Study||9
91159|NCT01150461|214193|P1|STARTED|Overall Study||11
91160|NCT01150409|214203|P2|NOT COMPLETED|Overall Study||0
91161|NCT01150409|214204|P1|NOT COMPLETED|Overall Study||0
91162|NCT01150409|214203|P2|COMPLETED|Overall Study||0
91163|NCT01150409|214204|P1|COMPLETED|Overall Study||11
91164|NCT01150409|214203|P2|STARTED|Overall Study||0
91165|NCT01150409|214204|P1|STARTED|Overall Study||11
91166|NCT01150357|214213|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
91167|NCT01150357|214214|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
91168|NCT01150357|214215|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
91169|NCT01150357|214213|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
91170|NCT01150357|214214|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
91171|NCT01150357|214215|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
91172|NCT01150357|214213|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
91173|NCT01150357|214214|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
91174|NCT01150357|214215|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
91175|NCT01150357|214213|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
91176|NCT01150357|214214|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
91177|NCT01150357|214215|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
91178|NCT01150357|214213|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
91179|NCT01150357|214214|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
91180|NCT01150357|214215|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
91181|NCT01150357|214213|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
91182|NCT01150357|214214|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
91183|NCT01150357|214215|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
91184|NCT01150357|214213|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
91185|NCT01150357|214214|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
91186|NCT01150357|214215|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
91187|NCT01150357|214213|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
91188|NCT01150357|214214|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
91189|NCT01150357|214215|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
91190|NCT01150357|214213|P3|COMPLETED|Dose Response Phase (Phase 1)||102
91191|NCT01150357|214214|P2|COMPLETED|Dose Response Phase (Phase 1)||51
91192|NCT01150357|214215|P1|COMPLETED|Dose Response Phase (Phase 1)||107
91193|NCT01150357|214213|P3|STARTED|Dose Response Phase (Phase 1)||105
91194|NCT01150357|214214|P2|STARTED|Dose Response Phase (Phase 1)||54
91195|NCT01150357|214215|P1|STARTED|Dose Response Phase (Phase 1)||108
91196|NCT01149148|214279|P2|NOT COMPLETED|Overall Study||2
91197|NCT01149148|214280|P1|NOT COMPLETED|Overall Study||2
91198|NCT01149148|214279|P2|COMPLETED|Overall Study||11
91199|NCT01149148|214280|P1|COMPLETED|Overall Study||10
91200|NCT01149148|214279|P2|STARTED|Overall Study||13
91201|NCT01149148|214280|P1|STARTED|Overall Study||12
91202|NCT01150097|214291|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
91203|NCT01150097|214292|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
91204|NCT01150097|214293|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
91205|NCT01150097|214291|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
91206|NCT01150097|214292|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
91207|NCT01150097|214293|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
91208|NCT01150097|214291|P3|STARTED|Months 24 to 48 Post-transplantation||0
91209|NCT01150097|214292|P2|STARTED|Months 24 to 48 Post-transplantation||51
91210|NCT01150097|214293|P1|STARTED|Months 24 to 48 Post-transplantation||106
91211|NCT01150097|214291|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
91212|NCT01150097|214292|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
91213|NCT01150097|214293|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
91214|NCT01150097|214291|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
91215|NCT01150097|214292|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
91216|NCT01150097|214293|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
91217|NCT01150097|214291|P3|STARTED|Months 24 to 36 Post-transplantation||125
91218|NCT01150097|214292|P2|STARTED|Months 24 to 36 Post-transplantation||51
91219|NCT01150097|214293|P1|STARTED|Months 24 to 36 Post-transplantation||106
91220|NCT01149876|214320|P4|NOT COMPLETED|Overall Study||0
91221|NCT01149876|214321|P3|NOT COMPLETED|Overall Study||1
91222|NCT01149876|214322|P2|NOT COMPLETED|Overall Study||0
91223|NCT01149876|214323|P1|NOT COMPLETED|Overall Study||1
91224|NCT01149876|214320|P4|COMPLETED|Overall Study||18
91225|NCT01149876|214321|P3|COMPLETED|Overall Study||20
91226|NCT01149876|214322|P2|COMPLETED|Overall Study||20
91227|NCT01149876|214323|P1|COMPLETED|Overall Study||20
91228|NCT01149876|214320|P4|STARTED|Overall Study||18
91229|NCT01149876|214321|P3|STARTED|Overall Study||21
91230|NCT01149876|214322|P2|STARTED|Overall Study||20
91231|NCT01149876|214323|P1|STARTED|Overall Study||21
91232|NCT01149863|214337|P1|NOT COMPLETED|Overall Study||3
91233|NCT01149863|214337|P1|COMPLETED|Overall Study||31
91234|NCT01149863|214337|P1|STARTED|Overall Study||34
91235|NCT01149785|214342|P2|NOT COMPLETED|Second Intervention||0
91236|NCT01149785|214343|P1|NOT COMPLETED|Second Intervention||0
91237|NCT01149785|214342|P2|COMPLETED|Second Intervention||15
91238|NCT01149785|214343|P1|COMPLETED|Second Intervention||0
91239|NCT01149785|214342|P2|STARTED|Second Intervention||15
91240|NCT01149785|214343|P1|STARTED|Second Intervention||0
91241|NCT01149785|214342|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
91242|NCT01149785|214343|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
91243|NCT01149785|214342|P2|COMPLETED|Washout Period of at Least 14 Days||0
91244|NCT01149785|214343|P1|COMPLETED|Washout Period of at Least 14 Days||15
91245|NCT01149785|214342|P2|STARTED|Washout Period of at Least 14 Days||0
91246|NCT01149785|214343|P1|STARTED|Washout Period of at Least 14 Days||15
91247|NCT01149785|214342|P2|NOT COMPLETED|First Intervention||0
91248|NCT01149785|214343|P1|NOT COMPLETED|First Intervention||0
91249|NCT01149785|214342|P2|COMPLETED|First Intervention||0
91250|NCT01149785|214343|P1|COMPLETED|First Intervention||15
91251|NCT01149785|214342|P2|STARTED|First Intervention||0
91252|NCT01149785|214343|P1|STARTED|First Intervention||15
91253|NCT01149772|214377|P2|NOT COMPLETED|Overall Study||21
91254|NCT01149772|214378|P1|NOT COMPLETED|Overall Study||48
91255|NCT01149772|214377|P2|COMPLETED|Overall Study||101
91256|NCT01149772|214378|P1|COMPLETED|Overall Study||132
91257|NCT01149772|214377|P2|STARTED|Overall Study||122
91258|NCT01149772|214378|P1|STARTED|Overall Study||180
91259|NCT01149733|214396|P2|NOT COMPLETED|Overall Study||0
91260|NCT01149733|214397|P1|NOT COMPLETED|Overall Study||0
91261|NCT01149733|214396|P2|COMPLETED|Overall Study||16
91262|NCT01149733|214397|P1|COMPLETED|Overall Study||16
91263|NCT01149733|214396|P2|STARTED|Overall Study||16
91264|NCT01149733|214397|P1|STARTED|Overall Study||16
91265|NCT01149655|214409|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
91266|NCT01149655|214410|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
91267|NCT01149655|214411|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
91268|NCT01149655|214412|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
91269|NCT01149655|214409|P4|COMPLETED|Period 3-DB Maintenance Phase||6
91270|NCT01149655|214410|P3|COMPLETED|Period 3-DB Maintenance Phase||15
91271|NCT01149655|214411|P2|COMPLETED|Period 3-DB Maintenance Phase||0
91272|NCT01149655|214412|P1|COMPLETED|Period 3-DB Maintenance Phase||0
91273|NCT01149655|214409|P4|STARTED|Period 3-DB Maintenance Phase||48
91274|NCT01149655|214410|P3|STARTED|Period 3-DB Maintenance Phase||98
91275|NCT01149655|214411|P2|STARTED|Period 3-DB Maintenance Phase||0
91276|NCT01149655|214412|P1|STARTED|Period 3-DB Maintenance Phase||0
91277|NCT01149655|214409|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
91278|NCT01149655|214410|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
91279|NCT01149655|214411|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
91280|NCT01149655|214412|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
91281|NCT01149655|214409|P4|COMPLETED|Period 2-Stabilization Phase||0
91282|NCT01149655|214410|P3|COMPLETED|Period 2-Stabilization Phase||0
91283|NCT01149655|214411|P2|COMPLETED|Period 2-Stabilization Phase||146
91284|NCT01149655|214412|P1|COMPLETED|Period 2-Stabilization Phase||0
91285|NCT01149655|214409|P4|STARTED|Period 2-Stabilization Phase||0
91286|NCT01149655|214410|P3|STARTED|Period 2-Stabilization Phase||0
91287|NCT01149655|214411|P2|STARTED|Period 2-Stabilization Phase||183
91288|NCT01149655|214412|P1|STARTED|Period 2-Stabilization Phase||0
91289|NCT01149655|214409|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
91290|NCT01149655|214410|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
91291|NCT01149655|214411|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
91292|NCT01149655|214412|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
91293|NCT01149655|214409|P4|COMPLETED|Period 1 - Conversion Phase||0
91294|NCT01149655|214410|P3|COMPLETED|Period 1 - Conversion Phase||0
91295|NCT01149655|214411|P2|COMPLETED|Period 1 - Conversion Phase||0
91296|NCT01149655|214412|P1|COMPLETED|Period 1 - Conversion Phase||168
91297|NCT01149655|214409|P4|STARTED|Period 1 - Conversion Phase||0
91298|NCT01149655|214410|P3|STARTED|Period 1 - Conversion Phase||0
91299|NCT01149655|214411|P2|STARTED|Period 1 - Conversion Phase||0
91300|NCT01149655|214412|P1|STARTED|Period 1 - Conversion Phase||186
91301|NCT01149538|214442|P2|NOT COMPLETED|Overall Study||4
91302|NCT01149538|214443|P1|NOT COMPLETED|Overall Study||5
91303|NCT01149538|214442|P2|COMPLETED|Overall Study||25
91304|NCT01149538|214443|P1|COMPLETED|Overall Study||26
91305|NCT01149538|214442|P2|STARTED|Overall Study||29
91306|NCT01149538|214443|P1|STARTED|Overall Study||31
91307|NCT01149486|214459|P2|NOT COMPLETED|Second Intervention||0
91308|NCT01149486|214460|P1|NOT COMPLETED|Second Intervention||0
91309|NCT01149486|214459|P2|COMPLETED|Second Intervention||9
91310|NCT01149486|214460|P1|COMPLETED|Second Intervention||10
91311|NCT01149486|214459|P2|STARTED|Second Intervention||9
91312|NCT01149486|214460|P1|STARTED|Second Intervention||10
91313|NCT01149486|214459|P2|NOT COMPLETED|Washout of 7 Days||0
91314|NCT01149486|214460|P1|NOT COMPLETED|Washout of 7 Days||0
91315|NCT01149486|214459|P2|COMPLETED|Washout of 7 Days||9
91316|NCT01149486|214460|P1|COMPLETED|Washout of 7 Days||10
91317|NCT01149486|214459|P2|STARTED|Washout of 7 Days||9
91318|NCT01149486|214460|P1|STARTED|Washout of 7 Days||10
91319|NCT01149486|214459|P2|NOT COMPLETED|First Intervention||1
91320|NCT01149486|214460|P1|NOT COMPLETED|First Intervention||0
91321|NCT01149486|214459|P2|COMPLETED|First Intervention||9
91322|NCT01149486|214460|P1|COMPLETED|First Intervention||10
91323|NCT01149486|214459|P2|STARTED|First Intervention||10
91324|NCT01149486|214460|P1|STARTED|First Intervention||10
91325|NCT01149473|214484|P2|NOT COMPLETED|Second Intervention||0
91326|NCT01149473|214485|P1|NOT COMPLETED|Second Intervention||0
91327|NCT01149473|214484|P2|COMPLETED|Second Intervention||38
91328|NCT01149473|214485|P1|COMPLETED|Second Intervention||38
91329|NCT01149473|214484|P2|STARTED|Second Intervention||38
91330|NCT01149473|214485|P1|STARTED|Second Intervention||38
91331|NCT01149473|214484|P2|NOT COMPLETED|Washout of 7 Days||1
91332|NCT01149473|214485|P1|NOT COMPLETED|Washout of 7 Days||1
91333|NCT01149473|214484|P2|COMPLETED|Washout of 7 Days||38
91334|NCT01149473|214485|P1|COMPLETED|Washout of 7 Days||38
91335|NCT01149473|214484|P2|STARTED|Washout of 7 Days||39
91336|NCT01149473|214485|P1|STARTED|Washout of 7 Days||39
91337|NCT01149473|214484|P2|NOT COMPLETED|First Intervention||1
91338|NCT01149473|214485|P1|NOT COMPLETED|First Intervention||1
91339|NCT01149473|214484|P2|COMPLETED|First Intervention||39
91340|NCT01149473|214485|P1|COMPLETED|First Intervention||39
91341|NCT01149473|214484|P2|STARTED|First Intervention||40
91342|NCT01149473|214485|P1|STARTED|First Intervention||40
91343|NCT01149460|214503|P2|NOT COMPLETED|Overall Study||2
91344|NCT01149460|214504|P1|NOT COMPLETED|Overall Study||0
91345|NCT01149460|214503|P2|COMPLETED|Overall Study||16
91346|NCT01149460|214504|P1|COMPLETED|Overall Study||18
91347|NCT01149460|214503|P2|STARTED|Overall Study||18
91348|NCT01149460|214504|P1|STARTED|Overall Study||18
91349|NCT01149434|214522|P2|NOT COMPLETED|Overall Study||5
91350|NCT01149434|214523|P1|NOT COMPLETED|Overall Study||0
91351|NCT01149434|214522|P2|COMPLETED|Overall Study||10
91352|NCT01149434|214523|P1|COMPLETED|Overall Study||4
91353|NCT01149434|214522|P2|STARTED|Overall Study||15
91354|NCT01149434|214523|P1|STARTED|Overall Study||4
91355|NCT01149421|214537|P3|NOT COMPLETED|Overall Study||44
91356|NCT01149421|214538|P2|NOT COMPLETED|Overall Study||29
91357|NCT01149421|214539|P1|NOT COMPLETED|Overall Study||52
91358|NCT01149421|214537|P3|COMPLETED|Overall Study||206
91359|NCT01149421|214538|P2|COMPLETED|Overall Study||225
91360|NCT01149421|214539|P1|COMPLETED|Overall Study||199
91361|NCT01149421|214537|P3|Received at Least One Dose of Study Drug|Overall Study||250
91362|NCT01149421|214538|P2|Received at Least One Dose of Study Drug|Overall Study||254
91363|NCT01149421|214539|P1|Received at Least One Dose of Study Drug|Overall Study||251
91364|NCT01149421|214537|P3|STARTED|Overall Study||250
91365|NCT01149421|214538|P2|STARTED|Overall Study||254
91366|NCT01149421|214539|P1|STARTED|Overall Study||251
91367|NCT01149057|214618|P1|NOT COMPLETED|Overall Study||57
91368|NCT01149057|214618|P1|COMPLETED|Overall Study||88
91369|NCT01149057|214618|P1|STARTED|Overall Study||145
91370|NCT01148836|214645|P2|NOT COMPLETED|Overall Study||2
91371|NCT01148836|214646|P1|NOT COMPLETED|Overall Study||1
91372|NCT01148836|214645|P2|COMPLETED|Overall Study||8
91373|NCT01148836|214646|P1|COMPLETED|Overall Study|Enrollment completed|7
91374|NCT01148836|214645|P2|STARTED|Overall Study||10
91375|NCT01148836|214646|P1|STARTED|Overall Study|Enrollment completed|8
91376|NCT01148771|214667|P2|NOT COMPLETED|Second Intervention||0
91377|NCT01148771|214668|P1|NOT COMPLETED|Second Intervention||0
91378|NCT01148771|214667|P2|COMPLETED|Second Intervention||5
91379|NCT01148771|214668|P1|COMPLETED|Second Intervention||6
91380|NCT01148771|214667|P2|STARTED|Second Intervention||5
91381|NCT01148771|214668|P1|STARTED|Second Intervention||6
91382|NCT01148771|214667|P2|NOT COMPLETED|Washout Period||1
91383|NCT01148771|214668|P1|NOT COMPLETED|Washout Period||0
91384|NCT01148771|214667|P2|COMPLETED|Washout Period||5
91385|NCT01148771|214668|P1|COMPLETED|Washout Period||6
91386|NCT01148771|214667|P2|STARTED|Washout Period||6
91387|NCT01148771|214668|P1|STARTED|Washout Period||6
91388|NCT01148771|214667|P2|NOT COMPLETED|First Intervention||0
91389|NCT01148771|214668|P1|NOT COMPLETED|First Intervention||0
91390|NCT01148771|214667|P2|COMPLETED|First Intervention||6
91391|NCT01148771|214668|P1|COMPLETED|First Intervention||6
91392|NCT01148771|214667|P2|STARTED|First Intervention||6
91393|NCT01148771|214668|P1|STARTED|First Intervention||6
91394|NCT01148745|214680|P1|NOT COMPLETED|Overall Study||0
91395|NCT01148745|214680|P1|COMPLETED|Overall Study||15
91396|NCT01148745|214680|P1|STARTED|Overall Study||15
91397|NCT01148693|214688|P2|NOT COMPLETED|Overall Study||10
91398|NCT01148693|214689|P1|NOT COMPLETED|Overall Study||13
91399|NCT01148693|214688|P2|COMPLETED|Overall Study||57
91400|NCT01148693|214689|P1|COMPLETED|Overall Study||57
91401|NCT01148693|214688|P2|STARTED|Overall Study||67
91402|NCT01148693|214689|P1|STARTED|Overall Study||70
91403|NCT01148537|214698|P3|NOT COMPLETED|Overall Study||3
91404|NCT01148537|214699|P2|NOT COMPLETED|Overall Study||0
91405|NCT01148537|214700|P1|NOT COMPLETED|Overall Study||3
91406|NCT01148537|214698|P3|COMPLETED|Overall Study||41
91407|NCT01148537|214699|P2|COMPLETED|Overall Study||44
91408|NCT01148537|214700|P1|COMPLETED|Overall Study||41
91409|NCT01148537|214698|P3|STARTED|Overall Study||44
91410|NCT01148537|214699|P2|STARTED|Overall Study||44
91411|NCT01148537|214700|P1|STARTED|Overall Study||44
91412|NCT01148524|214730|P9|NOT COMPLETED|Overall Study||0
91413|NCT01148524|214731|P8|NOT COMPLETED|Overall Study||0
91414|NCT01148524|214732|P7|NOT COMPLETED|Overall Study||0
91415|NCT01148524|214733|P6|NOT COMPLETED|Overall Study||0
91416|NCT01148524|214734|P5|NOT COMPLETED|Overall Study||0
91417|NCT01148524|214735|P4|NOT COMPLETED|Overall Study||0
91418|NCT01148524|214736|P3|NOT COMPLETED|Overall Study||0
91419|NCT01148524|214737|P2|NOT COMPLETED|Overall Study||0
91420|NCT01148524|214738|P1|NOT COMPLETED|Overall Study||0
91421|NCT01148524|214730|P9|COMPLETED|Overall Study||151
91422|NCT01148524|214731|P8|COMPLETED|Overall Study||51
91423|NCT01148524|214732|P7|COMPLETED|Overall Study||153
91424|NCT01148524|214733|P6|COMPLETED|Overall Study||106
91425|NCT01148524|214734|P5|COMPLETED|Overall Study||57
91426|NCT01148524|214735|P4|COMPLETED|Overall Study||102
91427|NCT01148524|214736|P3|COMPLETED|Overall Study||53
91428|NCT01148524|214737|P2|COMPLETED|Overall Study||95
91429|NCT01148524|214738|P1|COMPLETED|Overall Study||49
91430|NCT01148524|214730|P9|STARTED|Overall Study||151
91431|NCT01148524|214731|P8|STARTED|Overall Study||51
91432|NCT01148524|214732|P7|STARTED|Overall Study||153
91433|NCT01148524|214733|P6|STARTED|Overall Study||106
91434|NCT01148524|214734|P5|STARTED|Overall Study||57
91435|NCT01148524|214735|P4|STARTED|Overall Study||102
91436|NCT01148524|214736|P3|STARTED|Overall Study||53
91437|NCT01148524|214737|P2|STARTED|Overall Study||95
91438|NCT01148524|214738|P1|STARTED|Overall Study||49
91439|NCT01148511|214786|P3|NOT COMPLETED|Randomized||6
91440|NCT01148511|214787|P2|NOT COMPLETED|Randomized||10
91441|NCT01148511|214788|P1|NOT COMPLETED|Randomized||0
91442|NCT01148511|214786|P3|COMPLETED|Randomized||39
91443|NCT01148511|214787|P2|COMPLETED|Randomized||38
91444|NCT01148511|214788|P1|COMPLETED|Randomized||0
91445|NCT01148511|214786|P3|STARTED|Randomized||45
91446|NCT01148511|214787|P2|STARTED|Randomized||48
91447|NCT01148511|214788|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
91448|NCT01148511|214786|P3|NOT COMPLETED|Exposed to Study Drug||0
91449|NCT01148511|214787|P2|NOT COMPLETED|Exposed to Study Drug||0
91450|NCT01148511|214788|P1|NOT COMPLETED|Exposed to Study Drug||6
91451|NCT01148511|214786|P3|COMPLETED|Exposed to Study Drug||0
91452|NCT01148511|214787|P2|COMPLETED|Exposed to Study Drug||0
91453|NCT01148511|214788|P1|COMPLETED|Exposed to Study Drug||93
91454|NCT01148511|214786|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
91455|NCT01148511|214787|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
91456|NCT01148511|214788|P1|STARTED|Exposed to Study Drug||99
91457|NCT01148420|214807|P1|NOT COMPLETED|Overall Study||0
91458|NCT01148420|214807|P1|COMPLETED|Overall Study||48
91459|NCT01148420|214807|P1|STARTED|Overall Study||48
91460|NCT01148056|214813|P1|NOT COMPLETED|Overall Study||0
91461|NCT01148056|214813|P1|COMPLETED|Overall Study||2
91462|NCT01148056|214813|P1|STARTED|Overall Study||2
91463|NCT01148017|214826|P4|NOT COMPLETED|Overall Study||0
91464|NCT01148017|214827|P3|NOT COMPLETED|Overall Study||0
91465|NCT01148017|214828|P2|NOT COMPLETED|Overall Study||34
91466|NCT01148017|214829|P1|NOT COMPLETED|Overall Study||80
91467|NCT01148017|214826|P4|COMPLETED|Overall Study||45
91468|NCT01148017|214827|P3|COMPLETED|Overall Study||53
91469|NCT01148017|214828|P2|COMPLETED|Overall Study||87
91470|NCT01148017|214829|P1|COMPLETED|Overall Study||134
91471|NCT01148017|214826|P4|STARTED|Overall Study||45
91472|NCT01148017|214827|P3|STARTED|Overall Study||53
91473|NCT01148017|214828|P2|STARTED|Overall Study||121
91474|NCT01148017|214829|P1|STARTED|Overall Study||214
91475|NCT01147926|214868|P2|NOT COMPLETED|Overall Study||29
91476|NCT01147926|214869|P1|NOT COMPLETED|Overall Study||27
91477|NCT01147926|214868|P2|COMPLETED|Overall Study||158
91478|NCT01147926|214869|P1|COMPLETED|Overall Study||160
91479|NCT01147926|214868|P2|STARTED|Overall Study||187
91480|NCT01147926|214869|P1|STARTED|Overall Study||187
91481|NCT01147900|214904|P3|NOT COMPLETED|At Year 10||0
91482|NCT01147900|214905|P2|NOT COMPLETED|At Year 10||1
91483|NCT01147900|214906|P1|NOT COMPLETED|At Year 10||0
91484|NCT01147900|214904|P3|COMPLETED|At Year 10||62
91485|NCT01147900|214905|P2|COMPLETED|At Year 10||59
91486|NCT01147900|214906|P1|COMPLETED|At Year 10||55
91487|NCT01147900|214904|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
91488|NCT01147900|214905|P2|STARTED|At Year 10||60
91489|NCT01147900|214906|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
91490|NCT01147900|214904|P3|NOT COMPLETED|At Year 8.5||0
91491|NCT01147900|214905|P2|NOT COMPLETED|At Year 8.5||0
91492|NCT01147900|214906|P1|NOT COMPLETED|At Year 8.5||0
91493|NCT01147900|214904|P3|COMPLETED|At Year 8.5||66
91494|NCT01147900|214905|P2|COMPLETED|At Year 8.5||60
91495|NCT01147900|214906|P1|COMPLETED|At Year 8.5||54
91496|NCT01147900|214904|P3|STARTED|At Year 8.5||66
91497|NCT01147900|214905|P2|STARTED|At Year 8.5||60
91498|NCT01147900|214906|P1|STARTED|At Year 8.5||54
91499|NCT01147874|214965|P1|NOT COMPLETED|Overall Study||67
91500|NCT01147874|214965|P1|COMPLETED|Overall Study||946
91501|NCT01147874|214965|P1|STARTED|Overall Study||1013
91502|NCT01147848|214973|P3|NOT COMPLETED|Randomized Phase||46
91503|NCT01147848|214974|P2|NOT COMPLETED|Randomized Phase||45
91504|NCT01147848|214975|P1|NOT COMPLETED|Randomized Phase||0
91505|NCT01147848|214973|P3|COMPLETED|Randomized Phase||357
91506|NCT01147848|214974|P2|COMPLETED|Randomized Phase||358
91507|NCT01147848|214975|P1|COMPLETED|Randomized Phase||0
91508|NCT01147848|214973|P3|STARTED|Randomized Phase||403
91509|NCT01147848|214974|P2|STARTED|Randomized Phase||403
91510|NCT01147848|214975|P1|STARTED|Randomized Phase||0
91511|NCT01147848|214973|P3|NOT COMPLETED|Run-in Period||0
91512|NCT01147848|214974|P2|NOT COMPLETED|Run-in Period||0
91513|NCT01147848|214975|P1|NOT COMPLETED|Run-in Period||758
91514|NCT01147848|214973|P3|COMPLETED|Run-in Period||0
91515|NCT01147848|214974|P2|COMPLETED|Run-in Period||0
91516|NCT01147848|214975|P1|COMPLETED|Run-in Period||806
91517|NCT01147848|214973|P3|STARTED|Run-in Period||0
91518|NCT01147848|214974|P2|STARTED|Run-in Period||0
91519|NCT01147848|214975|P1|STARTED|Run-in Period||1564
91520|NCT01147822|215007|P2|NOT COMPLETED|Overall Study||179
91521|NCT01147822|215008|P1|NOT COMPLETED|Overall Study||188
91522|NCT01147822|215007|P2|COMPLETED|Overall Study||0
91523|NCT01147822|215008|P1|COMPLETED|Overall Study||0
91524|NCT01147822|215007|P2|Not Completed/Ongoing|Overall Study||102
91525|NCT01147822|215008|P1|Not Completed/Ongoing|Overall Study||111
91526|NCT01147822|215007|P2|STARTED|Overall Study||179
91527|NCT01147822|215008|P1|STARTED|Overall Study||188
91528|NCT01147809|215028|P6|NOT COMPLETED|Phase II (168 Days)||33
91529|NCT01147809|215029|P5|NOT COMPLETED|Phase II (168 Days)||16
91530|NCT01147809|215030|P4|NOT COMPLETED|Phase II (168 Days)||0
91531|NCT01147809|215031|P3|NOT COMPLETED|Phase II (168 Days)||0
91532|NCT01147809|215032|P2|NOT COMPLETED|Phase II (168 Days)||0
91533|NCT01147809|215033|P1|NOT COMPLETED|Phase II (168 Days)||0
91534|NCT01147809|215028|P6|COMPLETED|Phase II (168 Days)||19
91535|NCT01147809|215029|P5|COMPLETED|Phase II (168 Days)||7
91536|NCT01147809|215030|P4|COMPLETED|Phase II (168 Days)||0
91537|NCT01147809|215031|P3|COMPLETED|Phase II (168 Days)||0
91538|NCT01147809|215032|P2|COMPLETED|Phase II (168 Days)||0
91539|NCT01147809|215033|P1|COMPLETED|Phase II (168 Days)||0
91540|NCT01147809|215028|P6|Ongoing|Phase II (168 Days)||0
91541|NCT01147809|215029|P5|Ongoing|Phase II (168 Days)||1
91542|NCT01147809|215030|P4|Ongoing|Phase II (168 Days)||0
91543|NCT01147809|215031|P3|Ongoing|Phase II (168 Days)||0
91544|NCT01147809|215032|P2|Ongoing|Phase II (168 Days)||0
91545|NCT01147809|215033|P1|Ongoing|Phase II (168 Days)||0
91546|NCT01147809|215028|P6|STARTED|Phase II (168 Days)||52
91547|NCT01147809|215029|P5|STARTED|Phase II (168 Days)||23
91548|NCT01147809|215030|P4|STARTED|Phase II (168 Days)||0
91549|NCT01147809|215031|P3|STARTED|Phase II (168 Days)||0
91550|NCT01147809|215032|P2|STARTED|Phase II (168 Days)||0
91551|NCT01147809|215033|P1|STARTED|Phase II (168 Days)||0
91552|NCT01147809|215028|P6|NOT COMPLETED|Phase I (168 Days)||0
91553|NCT01147809|215029|P5|NOT COMPLETED|Phase I (168 Days)||0
91554|NCT01147809|215030|P4|NOT COMPLETED|Phase I (168 Days)||5
91555|NCT01147809|215031|P3|NOT COMPLETED|Phase I (168 Days)||2
91556|NCT01147809|215032|P2|NOT COMPLETED|Phase I (168 Days)||1
91557|NCT01147809|215033|P1|NOT COMPLETED|Phase I (168 Days)||1
91558|NCT01147809|215028|P6|COMPLETED|Phase I (168 Days)||0
91559|NCT01147809|215029|P5|COMPLETED|Phase I (168 Days)||0
91560|NCT01147809|215030|P4|COMPLETED|Phase I (168 Days)||5
91561|NCT01147809|215031|P3|COMPLETED|Phase I (168 Days)||2
91562|NCT01147809|215032|P2|COMPLETED|Phase I (168 Days)||8
91563|NCT01147809|215033|P1|COMPLETED|Phase I (168 Days)||2
91564|NCT01147809|215028|P6|STARTED|Phase I (168 Days)||0
91565|NCT01147809|215029|P5|STARTED|Phase I (168 Days)||0
91566|NCT01147809|215030|P4|STARTED|Phase I (168 Days)||10
91567|NCT01147809|215031|P3|STARTED|Phase I (168 Days)||4
91568|NCT01147809|215032|P2|STARTED|Phase I (168 Days)||9
91569|NCT01147809|215033|P1|STARTED|Phase I (168 Days)||3
91570|NCT01147640|215149|P2|NOT COMPLETED|Overall Study||1
91571|NCT01147640|215150|P1|NOT COMPLETED|Overall Study||5
91572|NCT01147640|215149|P2|COMPLETED|Overall Study||38
91573|NCT01147640|215150|P1|COMPLETED|Overall Study||78
91574|NCT01147640|215149|P2|STARTED|Overall Study||39
91575|NCT01147640|215150|P1|STARTED|Overall Study||83
91576|NCT01147627|215161|P3|NOT COMPLETED|Overall Study||18
91577|NCT01147627|215162|P2|NOT COMPLETED|Overall Study||24
91578|NCT01147627|215163|P1|NOT COMPLETED|Overall Study||32
91579|NCT01147627|215161|P3|COMPLETED|Overall Study||118
91580|NCT01147627|215162|P2|COMPLETED|Overall Study||114
91581|NCT01147627|215163|P1|COMPLETED|Overall Study||110
91582|NCT01147627|215161|P3|STARTED|Overall Study||136
91583|NCT01147627|215162|P2|STARTED|Overall Study||138
91584|NCT01147627|215163|P1|STARTED|Overall Study||142
91585|NCT01147497|215173|P2|NOT COMPLETED|Overall Study||0
91586|NCT01147497|215174|P1|NOT COMPLETED|Overall Study||2
91587|NCT01147497|215173|P2|COMPLETED|Overall Study||36
91588|NCT01147497|215174|P1|COMPLETED|Overall Study||35
91589|NCT01147497|215173|P2|STARTED|Overall Study||36
91590|NCT01147497|215174|P1|STARTED|Overall Study||37
91591|NCT01147471|215186|P2|NOT COMPLETED|6 Month Follow Up||2
91592|NCT01147471|215187|P1|NOT COMPLETED|6 Month Follow Up||4
91593|NCT01147471|215186|P2|COMPLETED|6 Month Follow Up||4
91594|NCT01147471|215187|P1|COMPLETED|6 Month Follow Up||8
91595|NCT01147471|215186|P2|STARTED|6 Month Follow Up||6
91596|NCT01147471|215187|P1|STARTED|6 Month Follow Up||12
91597|NCT01147471|215186|P2|NOT COMPLETED|3 Month Follow Up||2
91598|NCT01147471|215187|P1|NOT COMPLETED|3 Month Follow Up||1
91599|NCT01147471|215186|P2|COMPLETED|3 Month Follow Up||6
91600|NCT01147471|215187|P1|COMPLETED|3 Month Follow Up||12
91601|NCT01147471|215186|P2|STARTED|3 Month Follow Up||8
91602|NCT01147471|215187|P1|STARTED|3 Month Follow Up||13
91603|NCT01147471|215186|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
91604|NCT01147471|215187|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
91605|NCT01147471|215186|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
91606|NCT01147471|215187|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
91607|NCT01147471|215186|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
91608|NCT01147471|215187|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
91609|NCT01147471|215186|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
91610|NCT01147471|215187|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
91611|NCT01147471|215186|P2|COMPLETED|Through Initial Hospital Discharge||11
91612|NCT01147471|215187|P1|COMPLETED|Through Initial Hospital Discharge||13
91613|NCT01147471|215186|P2|STARTED|Through Initial Hospital Discharge||11
91614|NCT01147471|215187|P1|STARTED|Through Initial Hospital Discharge||13
91615|NCT01147458|215201|P4|NOT COMPLETED|Second Intervention||4
91616|NCT01147458|215202|P3|NOT COMPLETED|Second Intervention||8
91617|NCT01147458|215203|P2|NOT COMPLETED|Second Intervention||7
91618|NCT01147458|215204|P1|NOT COMPLETED|Second Intervention||9
91619|NCT01147458|215201|P4|COMPLETED|Second Intervention||30
91620|NCT01147458|215202|P3|COMPLETED|Second Intervention||27
91621|NCT01147458|215203|P2|COMPLETED|Second Intervention||24
91622|NCT01147458|215204|P1|COMPLETED|Second Intervention||25
91623|NCT01147458|215201|P4|STARTED|Second Intervention||34
91624|NCT01147458|215202|P3|STARTED|Second Intervention||35
91625|NCT01147458|215203|P2|STARTED|Second Intervention||31
91626|NCT01147458|215204|P1|STARTED|Second Intervention||34
91627|NCT01147458|215201|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
91628|NCT01147458|215202|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
91629|NCT01147458|215203|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
91630|NCT01147458|215204|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
91631|NCT01147458|215201|P4|COMPLETED|Washout Period of 2 Weeks||34
91632|NCT01147458|215202|P3|COMPLETED|Washout Period of 2 Weeks||35
91633|NCT01147458|215203|P2|COMPLETED|Washout Period of 2 Weeks||31
91634|NCT01147458|215204|P1|COMPLETED|Washout Period of 2 Weeks||34
91635|NCT01147458|215201|P4|STARTED|Washout Period of 2 Weeks||34
91636|NCT01147458|215202|P3|STARTED|Washout Period of 2 Weeks||35
91637|NCT01147458|215203|P2|STARTED|Washout Period of 2 Weeks||31
91638|NCT01147458|215204|P1|STARTED|Washout Period of 2 Weeks||34
91639|NCT01147458|215201|P4|NOT COMPLETED|First Intervention||14
91640|NCT01147458|215202|P3|NOT COMPLETED|First Intervention||12
91641|NCT01147458|215203|P2|NOT COMPLETED|First Intervention||16
91642|NCT01147458|215204|P1|NOT COMPLETED|First Intervention||14
91643|NCT01147458|215201|P4|COMPLETED|First Intervention||34
91644|NCT01147458|215202|P3|COMPLETED|First Intervention||35
91645|NCT01147458|215203|P2|COMPLETED|First Intervention||31
91646|NCT01147458|215204|P1|COMPLETED|First Intervention||34
91647|NCT01147458|215201|P4|STARTED|First Intervention||48
91648|NCT01147458|215202|P3|STARTED|First Intervention||47
91649|NCT01147458|215203|P2|STARTED|First Intervention||47
91650|NCT01147458|215204|P1|STARTED|First Intervention||48
91651|NCT01147406|215258|P6|NOT COMPLETED|Overall Study||0
91652|NCT01147406|215259|P5|NOT COMPLETED|Overall Study||0
91653|NCT01147406|215260|P4|NOT COMPLETED|Overall Study||0
91654|NCT01147406|215261|P3|NOT COMPLETED|Overall Study||0
91655|NCT01147406|215262|P2|NOT COMPLETED|Overall Study||0
91656|NCT01147406|215263|P1|NOT COMPLETED|Overall Study||0
91657|NCT01147406|215258|P6|COMPLETED|Overall Study||10
91658|NCT01147406|215259|P5|COMPLETED|Overall Study||6
91659|NCT01147406|215260|P4|COMPLETED|Overall Study||6
91660|NCT01147406|215261|P3|COMPLETED|Overall Study||1
91661|NCT01147406|215262|P2|COMPLETED|Overall Study||12
91662|NCT01147406|215263|P1|COMPLETED|Overall Study||6
91663|NCT01147406|215258|P6|STARTED|Overall Study||10
91664|NCT01147406|215259|P5|STARTED|Overall Study||6
91665|NCT01147406|215260|P4|STARTED|Overall Study||6
91666|NCT01147406|215261|P3|STARTED|Overall Study||1
91667|NCT01147406|215262|P2|STARTED|Overall Study||12
91668|NCT01147406|215263|P1|STARTED|Overall Study||6
91669|NCT01147380|215285|P2|NOT COMPLETED|Overall Study||0
91670|NCT01147380|215286|P1|NOT COMPLETED|Overall Study||0
91671|NCT01147380|215285|P2|COMPLETED|Overall Study||12
91672|NCT01147380|215286|P1|COMPLETED|Overall Study||6
91673|NCT01147380|215285|P2|STARTED|Overall Study||12
91674|NCT01147380|215286|P1|STARTED|Overall Study||6
91675|NCT01147341|215296|P2|NOT COMPLETED|Open Label Period||0
91676|NCT01147341|215297|P1|NOT COMPLETED|Open Label Period||4
91677|NCT01147341|215296|P2|COMPLETED|Open Label Period||8
91678|NCT01147341|215297|P1|COMPLETED|Open Label Period||22
91679|NCT01147341|215296|P2|STARTED|Open Label Period||8
91680|NCT01147341|215297|P1|STARTED|Open Label Period||26
91681|NCT01147341|215296|P2|NOT COMPLETED|Double Blind Period||2
91682|NCT01147341|215297|P1|NOT COMPLETED|Double Blind Period||1
91683|NCT01147341|215296|P2|COMPLETED|Double Blind Period||8
91684|NCT01147341|215297|P1|COMPLETED|Double Blind Period||26
91685|NCT01147341|215296|P2|STARTED|Double Blind Period||10
91686|NCT01147341|215297|P1|STARTED|Double Blind Period||27
91687|NCT01147302|215327|P2|NOT COMPLETED|Overall Study||0
91688|NCT01147302|215328|P1|NOT COMPLETED|Overall Study||0
91689|NCT01147302|215327|P2|COMPLETED|Overall Study||9
91690|NCT01147302|215328|P1|COMPLETED|Overall Study||9
91691|NCT01147302|215327|P2|STARTED|Overall Study||9
91692|NCT01147302|215328|P1|STARTED|Overall Study||9
91693|NCT01147250|215360|P2|NOT COMPLETED|Overall Study||105
91694|NCT01147250|215361|P1|NOT COMPLETED|Overall Study||110
91695|NCT01147250|215360|P2|COMPLETED|Overall Study||2929
91696|NCT01147250|215361|P1|COMPLETED|Overall Study||2924
91697|NCT01147250|215360|P2|Treated|Overall Study||3031
91698|NCT01147250|215361|P1|Treated|Overall Study||3032
91699|NCT01147250|215360|P2|STARTED|Overall Study||3034
91700|NCT01147250|215361|P1|STARTED|Overall Study||3034
91701|NCT01147172|215373|P1|NOT COMPLETED|Overall Study||4
91702|NCT01147172|215373|P1|COMPLETED|Overall Study||96
91703|NCT01147172|215373|P1|STARTED|Overall Study||100
91704|NCT01147068|215391|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
91705|NCT01147068|215392|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
91706|NCT01147068|215393|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
91707|NCT01147068|215394|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
91708|NCT01147068|215395|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
91709|NCT01147068|215396|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
91710|NCT01147068|215397|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
91711|NCT01147068|215391|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
91712|NCT01147068|215392|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
91713|NCT01147068|215393|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
91714|NCT01147068|215394|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
91715|NCT01147068|215395|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
91716|NCT01147068|215396|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
91717|NCT01147068|215397|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
91718|NCT01147068|215391|P7|STARTED|Subjects That Completed Safety Follow-up||55
91719|NCT01147068|215392|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
91720|NCT01147068|215393|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
91721|NCT01147068|215394|P4|STARTED|Subjects That Completed Safety Follow-up||56
91722|NCT01147068|215395|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
91723|NCT01147068|215396|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
91724|NCT01147068|215397|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
91725|NCT01147068|215391|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
91726|NCT01147068|215392|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
91727|NCT01147068|215393|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
91728|NCT01147068|215394|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
91729|NCT01147068|215395|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
91730|NCT01147068|215396|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
91731|NCT01147068|215397|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
91732|NCT01147068|215391|P7|COMPLETED|Subjects That Received 2nd Dose||55
91733|NCT01147068|215392|P6|COMPLETED|Subjects That Received 2nd Dose||51
91734|NCT01147068|215393|P5|COMPLETED|Subjects That Received 2nd Dose||55
91735|NCT01147068|215394|P4|COMPLETED|Subjects That Received 2nd Dose||56
91736|NCT01147068|215395|P3|COMPLETED|Subjects That Received 2nd Dose||52
91737|NCT01147068|215396|P2|COMPLETED|Subjects That Received 2nd Dose||52
91738|NCT01147068|215397|P1|COMPLETED|Subjects That Received 2nd Dose||59
91739|NCT01147068|215391|P7|STARTED|Subjects That Received 2nd Dose||55
91740|NCT01147068|215392|P6|STARTED|Subjects That Received 2nd Dose||53
91741|NCT01147068|215393|P5|STARTED|Subjects That Received 2nd Dose||56
91742|NCT01147068|215394|P4|STARTED|Subjects That Received 2nd Dose||56
91743|NCT01147068|215395|P3|STARTED|Subjects That Received 2nd Dose||55
91744|NCT01147068|215396|P2|STARTED|Subjects That Received 2nd Dose||57
91745|NCT01147068|215397|P1|STARTED|Subjects That Received 2nd Dose||60
91746|NCT01147068|215391|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
91747|NCT01147068|215392|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
91748|NCT01147068|215393|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
91749|NCT01147068|215394|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
91750|NCT01147068|215395|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
91751|NCT01147068|215396|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
91752|NCT01147068|215397|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
91753|NCT01147068|215391|P7|COMPLETED|Subjects That Received 1st Dose||55
91754|NCT01147068|215392|P6|COMPLETED|Subjects That Received 1st Dose||53
91755|NCT01147068|215393|P5|COMPLETED|Subjects That Received 1st Dose||56
91756|NCT01147068|215394|P4|COMPLETED|Subjects That Received 1st Dose||56
91757|NCT01147068|215395|P3|COMPLETED|Subjects That Received 1st Dose||55
91758|NCT01147068|215396|P2|COMPLETED|Subjects That Received 1st Dose||57
91759|NCT01147068|215397|P1|COMPLETED|Subjects That Received 1st Dose||60
91760|NCT01147068|215391|P7|STARTED|Subjects That Received 1st Dose||55
91761|NCT01147068|215392|P6|STARTED|Subjects That Received 1st Dose||53
91762|NCT01147068|215393|P5|STARTED|Subjects That Received 1st Dose||56
91763|NCT01147068|215394|P4|STARTED|Subjects That Received 1st Dose||56
91764|NCT01147068|215395|P3|STARTED|Subjects That Received 1st Dose||55
91765|NCT01147068|215396|P2|STARTED|Subjects That Received 1st Dose||57
91766|NCT01147068|215397|P1|STARTED|Subjects That Received 1st Dose||60
91767|NCT01147055|215427|P2|NOT COMPLETED|Second Intervention Period||0
91768|NCT01147055|215428|P1|NOT COMPLETED|Second Intervention Period||0
91769|NCT01147055|215427|P2|COMPLETED|Second Intervention Period||14
91770|NCT01147055|215428|P1|COMPLETED|Second Intervention Period||0
91771|NCT01147055|215427|P2|STARTED|Second Intervention Period||14
91772|NCT01147055|215428|P1|STARTED|Second Intervention Period||0
91773|NCT01147055|215427|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
91774|NCT01147055|215428|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
91775|NCT01147055|215427|P2|COMPLETED|Washout Period (at Least 14 Days)||0
91776|NCT01147055|215428|P1|COMPLETED|Washout Period (at Least 14 Days)||14
91777|NCT01147055|215427|P2|STARTED|Washout Period (at Least 14 Days)||0
91778|NCT01147055|215428|P1|STARTED|Washout Period (at Least 14 Days)||14
91779|NCT01147055|215427|P2|NOT COMPLETED|First Intervention Period||0
91780|NCT01147055|215428|P1|NOT COMPLETED|First Intervention Period||1
91781|NCT01147055|215427|P2|COMPLETED|First Intervention Period||0
91782|NCT01147055|215428|P1|COMPLETED|First Intervention Period||14
91783|NCT01147055|215427|P2|STARTED|First Intervention Period||0
91784|NCT01147055|215428|P1|STARTED|First Intervention Period||15
91785|NCT01146951|215462|P2|NOT COMPLETED|Overall Study||1
91786|NCT01146951|215463|P1|NOT COMPLETED|Overall Study||4
91787|NCT01146951|215462|P2|COMPLETED|Overall Study||29
91788|NCT01146951|215463|P1|COMPLETED|Overall Study||25
91789|NCT01146951|215462|P2|STARTED|Overall Study||30
91790|NCT01146951|215463|P1|STARTED|Overall Study||29
91791|NCT01146912|215484|P8|NOT COMPLETED|Overall Study||0
91792|NCT01146912|215485|P7|NOT COMPLETED|Overall Study||56
91793|NCT01146912|215486|P6|NOT COMPLETED|Overall Study||61
91794|NCT01146912|215487|P5|NOT COMPLETED|Overall Study||41
91795|NCT01146912|215488|P4|NOT COMPLETED|Overall Study||17
91796|NCT01146912|215489|P3|NOT COMPLETED|Overall Study||17
91797|NCT01146912|215490|P2|NOT COMPLETED|Overall Study||822
91798|NCT01146912|215491|P1|NOT COMPLETED|Overall Study||817
91799|NCT01146912|215484|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
91800|NCT01146912|215485|P7|COMPLETED|Overall Study||1764
91801|NCT01146912|215486|P6|COMPLETED|Overall Study||1760
91802|NCT01146912|215487|P5|COMPLETED|Overall Study||1780
91803|NCT01146912|215488|P4|COMPLETED|Overall Study||577
91804|NCT01146912|215489|P3|COMPLETED|Overall Study||576
91805|NCT01146912|215490|P2|COMPLETED|Overall Study||3784
91806|NCT01146912|215491|P1|COMPLETED|Overall Study||3790
91807|NCT01146912|215484|P8|STARTED|Overall Study||14675
91808|NCT01146912|215485|P7|STARTED|Overall Study||1820
91809|NCT01146912|215486|P6|STARTED|Overall Study||1821
91810|NCT01146912|215487|P5|STARTED|Overall Study||1821
91811|NCT01146912|215488|P4|STARTED|Overall Study||594
91812|NCT01146912|215489|P3|STARTED|Overall Study||593
91813|NCT01146912|215490|P2|STARTED|Overall Study||4606
91814|NCT01146912|215491|P1|STARTED|Overall Study||4607
91815|NCT01146873|215513|P2|NOT COMPLETED|Overall Study||6
91816|NCT01146873|215514|P1|NOT COMPLETED|Overall Study||0
91817|NCT01146873|215513|P2|COMPLETED|Overall Study||144
91818|NCT01146873|215514|P1|COMPLETED|Overall Study||148
91819|NCT01146873|215513|P2|STARTED|Overall Study||150
91820|NCT01146873|215514|P1|STARTED|Overall Study||148
91821|NCT01146860|215530|P2|NOT COMPLETED|Overall Study||1
91822|NCT01146860|215531|P1|NOT COMPLETED|Overall Study||0
91823|NCT01146860|215530|P2|COMPLETED|Overall Study||191
91824|NCT01146860|215531|P1|COMPLETED|Overall Study||194
91825|NCT01146860|215530|P2|STARTED|Overall Study||192
91826|NCT01146860|215531|P1|STARTED|Overall Study||194
91827|NCT01146782|215545|P1|NOT COMPLETED|Primary Endpoint Cohort||6
91828|NCT01146782|215545|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
91829|NCT01146782|215545|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
91830|NCT01146782|215545|P1|NOT COMPLETED|Safety Cohort||83
91831|NCT01146782|215545|P1|COMPLETED|Safety Cohort||63
91832|NCT01146782|215545|P1|STARTED|Safety Cohort||146
91833|NCT01146782|215545|P1|NOT COMPLETED|Screening Cohort||221
91834|NCT01146782|215545|P1|COMPLETED|Screening Cohort||146
91835|NCT01146782|215545|P1|STARTED|Screening Cohort||367
91836|NCT01146613|215554|P2|NOT COMPLETED|Overall Study||12
91837|NCT01146613|215555|P1|NOT COMPLETED|Overall Study||7
91838|NCT01146613|215554|P2|COMPLETED|Overall Study||89
91839|NCT01146613|215555|P1|COMPLETED|Overall Study||92
91840|NCT01146613|215554|P2|STARTED|Overall Study||101
91841|NCT01146613|215555|P1|STARTED|Overall Study||99
91842|NCT01146600|215563|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
91843|NCT01146600|215564|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
91844|NCT01146600|215563|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
91845|NCT01146600|215564|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
91846|NCT01146600|215563|P2|STARTED|Period 2 (Weeks 4 & 5)||10
91847|NCT01146600|215564|P1|STARTED|Period 2 (Weeks 4 & 5)||10
91848|NCT01146600|215563|P2|NOT COMPLETED|Washout (Week 3)||0
91849|NCT01146600|215564|P1|NOT COMPLETED|Washout (Week 3)||0
91850|NCT01146600|215563|P2|COMPLETED|Washout (Week 3)||10
91851|NCT01146600|215564|P1|COMPLETED|Washout (Week 3)||10
91852|NCT01146600|215563|P2|STARTED|Washout (Week 3)||10
91853|NCT01146600|215564|P1|STARTED|Washout (Week 3)||10
91854|NCT01146600|215563|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
91855|NCT01146600|215564|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
91856|NCT01146600|215563|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
91857|NCT01146600|215564|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
91858|NCT01146600|215563|P2|STARTED|Period 1 (Weeks 1 & 2)||10
91859|NCT01146600|215564|P1|STARTED|Period 1 (Weeks 1 & 2)||13
91860|NCT01146418|215591|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
91861|NCT01146418|215592|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
91862|NCT01146418|215593|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
91863|NCT01146418|215594|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
91864|NCT01146418|215591|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
91865|NCT01146418|215592|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
91866|NCT01146418|215593|P2|COMPLETED|Live-Born Infant Follow Up||0
91867|NCT01146418|215594|P1|COMPLETED|Live-Born Infant Follow Up||0
91868|NCT01146418|215591|P4|STARTED|Live-Born Infant Follow Up||56
91869|NCT01146418|215592|P3|STARTED|Live-Born Infant Follow Up||61
91870|NCT01146418|215593|P2|STARTED|Live-Born Infant Follow Up||0
91871|NCT01146418|215594|P1|STARTED|Live-Born Infant Follow Up||0
91872|NCT01146418|215591|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
91873|NCT01146418|215592|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
91874|NCT01146418|215593|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
91875|NCT01146418|215594|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
91876|NCT01146418|215591|P4|COMPLETED|Women/Expectant Mother Follow Up||0
91877|NCT01146418|215592|P3|COMPLETED|Women/Expectant Mother Follow Up||0
91878|NCT01146418|215593|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
91879|NCT01146418|215594|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
91880|NCT01146418|215591|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
91881|NCT01146418|215592|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
91882|NCT01146418|215593|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
91883|NCT01146418|215594|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
91884|NCT01146418|215591|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
91885|NCT01146418|215592|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
91886|NCT01146418|215593|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
91887|NCT01146418|215594|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
91888|NCT01146418|215591|P4|STARTED|Women/Expectant Mother Follow Up||0
91889|NCT01146418|215592|P3|STARTED|Women/Expectant Mother Follow Up||0
91890|NCT01146418|215593|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
91891|NCT01146418|215594|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
91892|NCT01146418|215591|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
91893|NCT01146418|215592|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
91894|NCT01146418|215593|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
91895|NCT01146418|215594|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
91896|NCT01146418|215591|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
91897|NCT01146418|215592|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
91898|NCT01146418|215593|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
91899|NCT01146418|215594|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
91900|NCT01146418|215591|P4|STARTED|Base Study P06029 (NCT01144416)||0
91901|NCT01146418|215592|P3|STARTED|Base Study P06029 (NCT01144416)||0
91902|NCT01146418|215593|P2|STARTED|Base Study P06029 (NCT01144416)||696
91903|NCT01146418|215594|P1|STARTED|Base Study P06029 (NCT01144416)||694
91904|NCT01146288|215608|P2|NOT COMPLETED|Second Intervention (1 Day)||0
91905|NCT01146288|215609|P1|NOT COMPLETED|Second Intervention (1 Day)||0
91906|NCT01146288|215608|P2|COMPLETED|Second Intervention (1 Day)||5
91907|NCT01146288|215609|P1|COMPLETED|Second Intervention (1 Day)||7
91908|NCT01146288|215608|P2|STARTED|Second Intervention (1 Day)||5
91909|NCT01146288|215609|P1|STARTED|Second Intervention (1 Day)||7
91910|NCT01146288|215608|P2|NOT COMPLETED|First Intervention(1 Day)||1
91911|NCT01146288|215609|P1|NOT COMPLETED|First Intervention(1 Day)||0
91912|NCT01146288|215608|P2|COMPLETED|First Intervention(1 Day)||5
91913|NCT01146288|215609|P1|COMPLETED|First Intervention(1 Day)||7
91914|NCT01146288|215608|P2|STARTED|First Intervention(1 Day)||6
91915|NCT01146288|215609|P1|STARTED|First Intervention(1 Day)||7
91916|NCT01146275|215618|P1|NOT COMPLETED|Overall Study||0
91917|NCT01146275|215618|P1|COMPLETED|Overall Study||6
91918|NCT01146275|215618|P1|STARTED|Overall Study||6
91919|NCT01145898|215625|P2|NOT COMPLETED|3-year Treatment||16
91920|NCT01145898|215626|P1|NOT COMPLETED|3-year Treatment||3
91921|NCT01145898|215625|P2|COMPLETED|3-year Treatment||28
91922|NCT01145898|215626|P1|COMPLETED|3-year Treatment||9
91923|NCT01145898|215625|P2|STARTED|3-year Treatment||44
91924|NCT01145898|215626|P1|STARTED|3-year Treatment||12
91925|NCT01145898|215625|P2|NOT COMPLETED|6-month Treatment||0
91926|NCT01145898|215626|P1|NOT COMPLETED|6-month Treatment||0
91927|NCT01145898|215625|P2|COMPLETED|6-month Treatment||44
91928|NCT01145898|215626|P1|COMPLETED|6-month Treatment||12
91929|NCT01145898|215625|P2|STARTED|6-month Treatment||44
91930|NCT01145898|215626|P1|STARTED|6-month Treatment||12
91931|NCT01145755|215660|P3|NOT COMPLETED|Overall Study||25
91932|NCT01145755|215661|P2|NOT COMPLETED|Overall Study||28
91933|NCT01145755|215662|P1|NOT COMPLETED|Overall Study||20
91934|NCT01145755|215660|P3|COMPLETED|Overall Study||19
91935|NCT01145755|215661|P2|COMPLETED|Overall Study||19
91936|NCT01145755|215662|P1|COMPLETED|Overall Study||20
91937|NCT01145755|215660|P3|STARTED|Overall Study||44
91938|NCT01145755|215661|P2|STARTED|Overall Study||47
91939|NCT01145755|215662|P1|STARTED|Overall Study||40
91940|NCT01145638|215678|P2|NOT COMPLETED|Overall Study||57
91941|NCT01145638|215679|P1|NOT COMPLETED|Overall Study||90
91942|NCT01145638|215678|P2|COMPLETED|Overall Study||62
91943|NCT01145638|215679|P1|COMPLETED|Overall Study||141
91944|NCT01145638|215678|P2|STARTED|Overall Study||119
91945|NCT01145638|215679|P1|STARTED|Overall Study||231
91946|NCT01145625|215689|P2|NOT COMPLETED|Overall Study||31
91947|NCT01145625|215690|P1|NOT COMPLETED|Overall Study||24
91948|NCT01145625|215689|P2|COMPLETED|Overall Study||130
91949|NCT01145625|215690|P1|COMPLETED|Overall Study||137
91950|NCT01145625|215689|P2|STARTED|Overall Study||161
91951|NCT01145625|215690|P1|STARTED|Overall Study||161
91952|NCT01145560|215703|P3|NOT COMPLETED|Overall Study||2
91953|NCT01145560|215704|P2|NOT COMPLETED|Overall Study||4
91954|NCT01145560|215705|P1|NOT COMPLETED|Overall Study||4
91955|NCT01145560|215703|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
91956|NCT01145560|215704|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
91957|NCT01145560|215705|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
91958|NCT01145560|215703|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
91959|NCT01145560|215704|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
91960|NCT01145560|215705|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
91961|NCT01145560|215703|P3|Received Treatment|Overall Study||99
91962|NCT01145560|215704|P2|Received Treatment|Overall Study||98
91963|NCT01145560|215705|P1|Received Treatment|Overall Study||99
91964|NCT01145560|215703|P3|STARTED|Overall Study||100
91965|NCT01145560|215704|P2|STARTED|Overall Study||100
91966|NCT01145560|215705|P1|STARTED|Overall Study||100
91967|NCT01145547|215722|P2|NOT COMPLETED|Overall Study||0
91968|NCT01145547|215723|P1|NOT COMPLETED|Overall Study||0
91969|NCT01145547|215722|P2|COMPLETED|Overall Study||3
91970|NCT01145547|215723|P1|COMPLETED|Overall Study||4
91971|NCT01145547|215722|P2|STARTED|Overall Study||3
91972|NCT01145547|215723|P1|STARTED|Overall Study||4
91973|NCT01145508|215731|P2|NOT COMPLETED|Overall Study||2
91974|NCT01145508|215732|P1|NOT COMPLETED|Overall Study||5
91975|NCT01145508|215731|P2|COMPLETED|Overall Study||1
91976|NCT01145508|215732|P1|COMPLETED|Overall Study||2
91977|NCT01145508|215731|P2|Treated|Overall Study||2
91978|NCT01145508|215732|P1|Treated|Overall Study||6
91979|NCT01145508|215731|P2|STARTED|Overall Study||3
91980|NCT01145508|215732|P1|STARTED|Overall Study||7
91981|NCT01145495|215738|P1|NOT COMPLETED|Overall Study||12
91982|NCT01145495|215738|P1|COMPLETED|Overall Study||51
91983|NCT01145495|215738|P1|STARTED|Overall Study||63
91984|NCT01145482|215744|P2|NOT COMPLETED|Second Intervention (1 Day)||0
91985|NCT01145482|215745|P1|NOT COMPLETED|Second Intervention (1 Day)||0
91986|NCT01145482|215744|P2|COMPLETED|Second Intervention (1 Day)||6
91987|NCT01145482|215745|P1|COMPLETED|Second Intervention (1 Day)||5
91988|NCT01145482|215744|P2|STARTED|Second Intervention (1 Day)||6
91989|NCT01145482|215745|P1|STARTED|Second Intervention (1 Day)||5
91990|NCT01145482|215744|P2|NOT COMPLETED|First Intervention (1 Day)||1
91991|NCT01145482|215745|P1|NOT COMPLETED|First Intervention (1 Day)||0
91992|NCT01145482|215744|P2|COMPLETED|First Intervention (1 Day)||5
91993|NCT01145482|215745|P1|COMPLETED|First Intervention (1 Day)||6
91994|NCT01145482|215744|P2|STARTED|First Intervention (1 Day)||6
91995|NCT01145482|215745|P1|STARTED|First Intervention (1 Day)||6
91996|NCT01145417|215755|P2|NOT COMPLETED|Overall Study||47
91997|NCT01145417|215756|P1|NOT COMPLETED|Overall Study||41
91998|NCT01145417|215755|P2|COMPLETED|Overall Study||62
91999|NCT01145417|215756|P1|COMPLETED|Overall Study||67
92000|NCT01145417|215755|P2|STARTED|Overall Study||109
92001|NCT01145417|215756|P1|STARTED|Overall Study||108
92002|NCT01145391|215780|P2|NOT COMPLETED|Overall Study||0
92003|NCT01145391|215781|P1|NOT COMPLETED|Overall Study||0
92004|NCT01145391|215780|P2|COMPLETED|Overall Study||298
92005|NCT01145391|215781|P1|COMPLETED|Overall Study||293
92006|NCT01145391|215780|P2|9 Months Post-randomization|Overall Study||298
92007|NCT01145391|215781|P1|9 Months Post-randomization|Overall Study||293
92008|NCT01145391|215780|P2|STARTED|Overall Study||298
92009|NCT01145391|215781|P1|STARTED|Overall Study||293
92010|NCT01144299|215791|P2|NOT COMPLETED|Overall Study||0
92011|NCT01144299|215792|P1|NOT COMPLETED|Overall Study||2
92012|NCT01144299|215791|P2|COMPLETED|Overall Study||54
92013|NCT01144299|215792|P1|COMPLETED|Overall Study||58
92014|NCT01144299|215791|P2|STARTED|Overall Study||54
92015|NCT01144299|215792|P1|STARTED|Overall Study||60
92016|NCT01144286|215818|P4|NOT COMPLETED|Overall Study||0
92017|NCT01144286|215819|P3|NOT COMPLETED|Overall Study||0
92018|NCT01144286|215820|P2|NOT COMPLETED|Overall Study||0
92019|NCT01144286|215821|P1|NOT COMPLETED|Overall Study||0
92020|NCT01144286|215818|P4|COMPLETED|Overall Study||56
92021|NCT01144286|215819|P3|COMPLETED|Overall Study||58
92022|NCT01144286|215820|P2|COMPLETED|Overall Study||58
92023|NCT01144286|215821|P1|COMPLETED|Overall Study||57
92024|NCT01144286|215818|P4|STARTED|Overall Study||56
92025|NCT01144286|215819|P3|STARTED|Overall Study||58
92026|NCT01144286|215820|P2|STARTED|Overall Study||58
92027|NCT01144286|215821|P1|STARTED|Overall Study||57
92028|NCT01145352|215835|P1|NOT COMPLETED|Overall Study||11
92029|NCT01145352|215835|P1|COMPLETED|Overall Study||102
92030|NCT01145352|215835|P1|STARTED|Overall Study||113
92031|NCT01145053|215843|P1|NOT COMPLETED|Overall Study||93
92032|NCT01145053|215843|P1|COMPLETED|Overall Study||248
92033|NCT01145053|215843|P1|STARTED|Overall Study||341
92034|NCT01145001|215857|P4|NOT COMPLETED|Overall Study||6
92035|NCT01145001|215858|P3|NOT COMPLETED|Overall Study||5
92036|NCT01145001|215859|P2|NOT COMPLETED|Overall Study||6
92037|NCT01145001|215860|P1|NOT COMPLETED|Overall Study||8
92038|NCT01145001|215857|P4|COMPLETED|Overall Study||31
92039|NCT01145001|215858|P3|COMPLETED|Overall Study||39
92040|NCT01145001|215859|P2|COMPLETED|Overall Study||31
92041|NCT01145001|215860|P1|COMPLETED|Overall Study||28
92042|NCT01145001|215857|P4|STARTED|Overall Study||37
92043|NCT01145001|215858|P3|STARTED|Overall Study||44
92044|NCT01145001|215859|P2|STARTED|Overall Study||37
92045|NCT01145001|215860|P1|STARTED|Overall Study||36
92046|NCT01144949|215876|P2|NOT COMPLETED|Overall Study||14
92047|NCT01144949|215877|P1|NOT COMPLETED|Overall Study||11
92048|NCT01144949|215876|P2|COMPLETED|Overall Study||106
92049|NCT01144949|215877|P1|COMPLETED|Overall Study||108
92050|NCT01144949|215876|P2|STARTED|Overall Study||120
92051|NCT01144949|215877|P1|STARTED|Overall Study||119
92052|NCT01144715|215895|P2|NOT COMPLETED|Overall Study||3
92053|NCT01144715|215896|P1|NOT COMPLETED|Overall Study||4
92054|NCT01144715|215895|P2|COMPLETED|Overall Study||45
92055|NCT01144715|215896|P1|COMPLETED|Overall Study||47
92056|NCT01144715|215895|P2|STARTED|Overall Study||48
92057|NCT01144715|215896|P1|STARTED|Overall Study||51
92058|NCT01144624|215911|P3|NOT COMPLETED|Overall Study||0
92059|NCT01144624|215912|P2|NOT COMPLETED|Overall Study||0
92060|NCT01144624|215913|P1|NOT COMPLETED|Overall Study||0
92061|NCT01144624|215911|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
92062|NCT01144624|215912|P2|COMPLETED|Overall Study||7
92063|NCT01144624|215913|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
92064|NCT01144624|215911|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
92065|NCT01144624|215912|P2|Completed Treatment|Overall Study||7
92066|NCT01144624|215913|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
92067|NCT01144624|215911|P3|Received Treatment|Overall Study||6
92068|NCT01144624|215912|P2|Received Treatment|Overall Study||7
92069|NCT01144624|215913|P1|Received Treatment|Overall Study||7
92070|NCT01144624|215911|P3|STARTED|Overall Study||6
92071|NCT01144624|215912|P2|STARTED|Overall Study||7
92072|NCT01144624|215913|P1|STARTED|Overall Study||7
92073|NCT01144598|215927|P1|NOT COMPLETED|Overall Study||0
92074|NCT01144598|215927|P1|COMPLETED|Overall Study||356
92075|NCT01144598|215927|P1|Analysis Population|Overall Study||356
92076|NCT01144598|215927|P1|STARTED|Overall Study||356
92077|NCT01144442|215945|P1|NOT COMPLETED|Overall Study||0
92078|NCT01144442|215945|P1|COMPLETED|Overall Study||10
92079|NCT01144442|215945|P1|STARTED|Overall Study||10
92080|NCT01144416|215952|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
92081|NCT01144416|215953|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
92082|NCT01144416|215952|P2|COMPLETED|Pregnancy Follow-up Period||157
92083|NCT01144416|215953|P1|COMPLETED|Pregnancy Follow-up Period||146
92084|NCT01144416|215952|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
92085|NCT01144416|215953|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
92086|NCT01144416|215952|P2|NOT COMPLETED|Intervention Period||49
92087|NCT01144416|215953|P1|NOT COMPLETED|Intervention Period||62
92088|NCT01144416|215952|P2|COMPLETED|Intervention Period||647
92089|NCT01144416|215953|P1|COMPLETED|Intervention Period||632
92090|NCT01144416|215952|P2|STARTED|Intervention Period||696
92091|NCT01144416|215953|P1|STARTED|Intervention Period||694
92092|NCT01144403|215969|P1|NOT COMPLETED|Overall Study||5
92093|NCT01144403|215969|P1|COMPLETED|Overall Study||3
92094|NCT01144403|215969|P1|STARTED|Overall Study||8
92095|NCT01144364|215978|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
92096|NCT01144364|215979|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
92097|NCT01144364|215980|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
92098|NCT01144364|215978|P3|COMPLETED|Follow-Up/Maintenance Phase||60
92099|NCT01144364|215979|P2|COMPLETED|Follow-Up/Maintenance Phase||66
92100|NCT01144364|215980|P1|COMPLETED|Follow-Up/Maintenance Phase||0
92101|NCT01144364|215978|P3|STARTED|Follow-Up/Maintenance Phase||101
92102|NCT01144364|215979|P2|STARTED|Follow-Up/Maintenance Phase||101
92103|NCT01144364|215980|P1|STARTED|Follow-Up/Maintenance Phase||0
92104|NCT01144364|215978|P3|NOT COMPLETED|Induction Phase||0
92105|NCT01144364|215979|P2|NOT COMPLETED|Induction Phase||0
92106|NCT01144364|215980|P1|NOT COMPLETED|Induction Phase||32
92107|NCT01144364|215978|P3|COMPLETED|Induction Phase||0
92108|NCT01144364|215979|P2|COMPLETED|Induction Phase||0
92109|NCT01144364|215980|P1|COMPLETED|Induction Phase||202
92110|NCT01144364|215978|P3|STARTED|Induction Phase||0
92111|NCT01144364|215979|P2|STARTED|Induction Phase||0
92112|NCT01144364|215980|P1|STARTED|Induction Phase||234
92113|NCT01144182|216006|P2|NOT COMPLETED|Overall Study||21
92114|NCT01144182|216007|P1|NOT COMPLETED|Overall Study||17
92115|NCT01144182|216006|P2|COMPLETED|Overall Study||47
92116|NCT01144182|216007|P1|COMPLETED|Overall Study||51
92117|NCT01144182|216006|P2|STARTED|Overall Study||68
92118|NCT01144182|216007|P1|STARTED|Overall Study||68
92119|NCT01144052|216039|P2|NOT COMPLETED|Overall Study||1
92120|NCT01144052|216040|P1|NOT COMPLETED|Overall Study||1
92121|NCT01144052|216039|P2|COMPLETED|Overall Study||8
92122|NCT01144052|216040|P1|COMPLETED|Overall Study||9
92123|NCT01144052|216039|P2|STARTED|Overall Study||9
92124|NCT01144052|216040|P1|STARTED|Overall Study||10
92125|NCT01144026|216062|P2|NOT COMPLETED|Overall Study||0
92126|NCT01144026|216063|P1|NOT COMPLETED|Overall Study||0
92127|NCT01144026|216062|P2|COMPLETED|Overall Study||5
92128|NCT01144026|216063|P1|COMPLETED|Overall Study||10
92129|NCT01144026|216062|P2|STARTED|Overall Study||5
92130|NCT01144026|216063|P1|STARTED|Overall Study||10
92131|NCT01143896|216071|P2|NOT COMPLETED|Overall Study||25
92132|NCT01143896|216072|P1|NOT COMPLETED|Overall Study||42
92133|NCT01143896|216071|P2|COMPLETED|Overall Study||128
92134|NCT01143896|216072|P1|COMPLETED|Overall Study||114
92135|NCT01143896|216071|P2|STARTED|Overall Study||153
92136|NCT01143896|216072|P1|STARTED|Overall Study||156
92137|NCT01143883|216090|P2|NOT COMPLETED|Overall Study||0
92138|NCT01143883|216091|P1|NOT COMPLETED|Overall Study||0
92139|NCT01143883|216090|P2|COMPLETED|Overall Study||55
92140|NCT01143883|216091|P1|COMPLETED|Overall Study||55
92141|NCT01143883|216090|P2|STARTED|Overall Study||55
92142|NCT01143883|216091|P1|STARTED|Overall Study||55
92143|NCT01143818|216097|P1|NOT COMPLETED|Overall Study||250
92144|NCT01143818|216097|P1|COMPLETED|Overall Study||799
92145|NCT01143818|216097|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
92146|NCT01143792|216107|P3|NOT COMPLETED|Overall Study||0
92147|NCT01143792|216108|P2|NOT COMPLETED|Overall Study||0
92148|NCT01143792|216109|P1|NOT COMPLETED|Overall Study||0
92149|NCT01143792|216107|P3|COMPLETED|Overall Study||91
92150|NCT01143792|216108|P2|COMPLETED|Overall Study||86
92151|NCT01143792|216109|P1|COMPLETED|Overall Study||93
92152|NCT01143792|216107|P3|STARTED|Overall Study||91
92153|NCT01143792|216108|P2|STARTED|Overall Study||86
92154|NCT01143792|216109|P1|STARTED|Overall Study||93
92155|NCT01143766|216143|P2|NOT COMPLETED|Overall Study||0
92156|NCT01143766|216144|P1|NOT COMPLETED|Overall Study||0
92157|NCT01143766|216143|P2|COMPLETED|Overall Study||31
92158|NCT01143766|216144|P1|COMPLETED|Overall Study||25
92159|NCT01143766|216143|P2|STARTED|Overall Study||31
92160|NCT01143766|216144|P1|STARTED|Overall Study||25
92161|NCT01143727|216152|P2|NOT COMPLETED|Overall Study||0
92162|NCT01143727|216153|P1|NOT COMPLETED|Overall Study||0
92163|NCT01143727|216152|P2|COMPLETED|Overall Study||8
92164|NCT01143727|216153|P1|COMPLETED|Overall Study||9
92165|NCT01143727|216152|P2|STARTED|Overall Study||8
92166|NCT01143727|216153|P1|STARTED|Overall Study||9
92167|NCT01143714|216163|P2|NOT COMPLETED|Overall Study||3
92168|NCT01143714|216164|P1|NOT COMPLETED|Overall Study||7
92169|NCT01143714|216163|P2|COMPLETED|Overall Study||25
92170|NCT01143714|216164|P1|COMPLETED|Overall Study||22
92171|NCT01143714|216163|P2|STARTED|Overall Study||28
92172|NCT01143714|216164|P1|STARTED|Overall Study||29
92173|NCT01143701|216174|P2|NOT COMPLETED|Overall Study||32
92174|NCT01143701|216175|P1|NOT COMPLETED|Overall Study||23
92175|NCT01143701|216174|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
92176|NCT01143701|216175|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
92177|NCT01143701|216174|P2|STARTED|Overall Study||319
92178|NCT01143701|216175|P1|STARTED|Overall Study||258
92179|NCT01143610|216185|P2|NOT COMPLETED|Overall Study||0
92180|NCT01143610|216186|P1|NOT COMPLETED|Overall Study||0
92181|NCT01143610|216185|P2|COMPLETED|Overall Study||8
92182|NCT01143610|216186|P1|COMPLETED|Overall Study||7
92183|NCT01143610|216185|P2|STARTED|Overall Study||8
92184|NCT01143610|216186|P1|STARTED|Overall Study||7
92185|NCT01143337|216196|P3|NOT COMPLETED|Overall Study||12
92186|NCT01143337|216197|P2|NOT COMPLETED|Overall Study||11
92187|NCT01143337|216198|P1|NOT COMPLETED|Overall Study||10
92188|NCT01143337|216196|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
92189|NCT01143337|216197|P2|COMPLETED|Overall Study||39
92190|NCT01143337|216198|P1|COMPLETED|Overall Study||39
92191|NCT01143337|216196|P3|STARTED|Overall Study||13
92192|NCT01143337|216197|P2|STARTED|Overall Study||50
92193|NCT01143337|216198|P1|STARTED|Overall Study||49
92194|NCT01143324|216212|P1|NOT COMPLETED|Overall Study||19
92195|NCT01143324|216212|P1|COMPLETED|Overall Study||233
92196|NCT01143324|216212|P1|STARTED|Overall Study||252
92197|NCT01143272|216230|P2|NOT COMPLETED|Overall Study||0
92198|NCT01143272|216231|P1|NOT COMPLETED|Overall Study||0
92199|NCT01143272|216230|P2|COMPLETED|Overall Study||231
92200|NCT01143272|216231|P1|COMPLETED|Overall Study||246
92201|NCT01143272|216230|P2|STARTED|Overall Study||231
92202|NCT01143272|216231|P1|STARTED|Overall Study||246
92203|NCT01143259|216251|P2|NOT COMPLETED|Overall Study||20
92204|NCT01143259|216252|P1|NOT COMPLETED|Overall Study||23
92205|NCT01143259|216251|P2|COMPLETED|Overall Study||118
92206|NCT01143259|216252|P1|COMPLETED|Overall Study||113
92207|NCT01143259|216251|P2|STARTED|Overall Study||138
92208|NCT01143259|216252|P1|STARTED|Overall Study||136
92209|NCT01143207|216260|P1|NOT COMPLETED|Overall Study||2
92210|NCT01143207|216260|P1|COMPLETED|Overall Study||24
92211|NCT01143207|216260|P1|STARTED|Overall Study||26
92212|NCT01143142|216271|P2|NOT COMPLETED|Overall Study||0
92213|NCT01143142|216272|P1|NOT COMPLETED|Overall Study||0
92214|NCT01143142|216271|P2|COMPLETED|Overall Study||34
92215|NCT01143142|216272|P1|COMPLETED|Overall Study||36
92216|NCT01143142|216271|P2|STARTED|Overall Study||34
92217|NCT01143142|216272|P1|STARTED|Overall Study||36
92218|NCT01143090|216280|P1|NOT COMPLETED|Overall Study||51
92219|NCT01143090|216280|P1|COMPLETED|Overall Study||98
92220|NCT01143090|216280|P1|STARTED|Overall Study||149
92221|NCT01143077|216287|P3|NOT COMPLETED|Overall Study||15
92222|NCT01143077|216288|P2|NOT COMPLETED|Overall Study||15
92223|NCT01143077|216289|P1|NOT COMPLETED|Overall Study||16
92224|NCT01143077|216287|P3|COMPLETED|Overall Study||67
92225|NCT01143077|216288|P2|COMPLETED|Overall Study||73
92226|NCT01143077|216289|P1|COMPLETED|Overall Study||58
92227|NCT01143077|216287|P3|STARTED|Overall Study||82
92228|NCT01143077|216288|P2|STARTED|Overall Study||88
92229|NCT01143077|216289|P1|STARTED|Overall Study||74
92230|NCT01143051|216306|P6|NOT COMPLETED|Visit 3||0
92231|NCT01143051|216307|P5|NOT COMPLETED|Visit 3||0
92232|NCT01143051|216308|P4|NOT COMPLETED|Visit 3||0
92233|NCT01143051|216309|P3|NOT COMPLETED|Visit 3||0
92234|NCT01143051|216310|P2|NOT COMPLETED|Visit 3||0
92235|NCT01143051|216311|P1|NOT COMPLETED|Visit 3||0
92236|NCT01143051|216306|P6|COMPLETED|Visit 3||3
92237|NCT01143051|216307|P5|COMPLETED|Visit 3||4
92238|NCT01143051|216308|P4|COMPLETED|Visit 3||4
92239|NCT01143051|216309|P3|COMPLETED|Visit 3||3
92240|NCT01143051|216310|P2|COMPLETED|Visit 3||4
92241|NCT01143051|216311|P1|COMPLETED|Visit 3||4
92242|NCT01143051|216306|P6|STARTED|Visit 3||3
92243|NCT01143051|216307|P5|STARTED|Visit 3||4
92244|NCT01143051|216308|P4|STARTED|Visit 3||4
92245|NCT01143051|216309|P3|STARTED|Visit 3||3
92246|NCT01143051|216310|P2|STARTED|Visit 3||4
92247|NCT01143051|216311|P1|STARTED|Visit 3||4
92248|NCT01143051|216306|P6|NOT COMPLETED|3-14 Day Washout||1
92249|NCT01143051|216307|P5|NOT COMPLETED|3-14 Day Washout||0
92250|NCT01143051|216308|P4|NOT COMPLETED|3-14 Day Washout||0
92251|NCT01143051|216309|P3|NOT COMPLETED|3-14 Day Washout||0
92252|NCT01143051|216310|P2|NOT COMPLETED|3-14 Day Washout||0
92253|NCT01143051|216311|P1|NOT COMPLETED|3-14 Day Washout||0
92254|NCT01143051|216306|P6|COMPLETED|3-14 Day Washout||3
92255|NCT01143051|216307|P5|COMPLETED|3-14 Day Washout||4
92256|NCT01143051|216308|P4|COMPLETED|3-14 Day Washout||4
92257|NCT01143051|216309|P3|COMPLETED|3-14 Day Washout||3
92258|NCT01143051|216310|P2|COMPLETED|3-14 Day Washout||4
92259|NCT01143051|216311|P1|COMPLETED|3-14 Day Washout||4
92260|NCT01143051|216306|P6|STARTED|3-14 Day Washout||4
92261|NCT01143051|216307|P5|STARTED|3-14 Day Washout||4
92262|NCT01143051|216308|P4|STARTED|3-14 Day Washout||4
92263|NCT01143051|216309|P3|STARTED|3-14 Day Washout||3
92264|NCT01143051|216310|P2|STARTED|3-14 Day Washout||4
92265|NCT01143051|216311|P1|STARTED|3-14 Day Washout||4
92266|NCT01143051|216306|P6|NOT COMPLETED|Visit 2||0
92267|NCT01143051|216307|P5|NOT COMPLETED|Visit 2||0
92268|NCT01143051|216308|P4|NOT COMPLETED|Visit 2||0
92269|NCT01143051|216309|P3|NOT COMPLETED|Visit 2||0
92270|NCT01143051|216310|P2|NOT COMPLETED|Visit 2||0
92271|NCT01143051|216311|P1|NOT COMPLETED|Visit 2||0
92272|NCT01143051|216306|P6|COMPLETED|Visit 2||4
92273|NCT01143051|216307|P5|COMPLETED|Visit 2||4
92274|NCT01143051|216308|P4|COMPLETED|Visit 2||4
92275|NCT01143051|216309|P3|COMPLETED|Visit 2||3
92276|NCT01143051|216310|P2|COMPLETED|Visit 2||4
92277|NCT01143051|216311|P1|COMPLETED|Visit 2||4
92278|NCT01143051|216306|P6|STARTED|Visit 2||4
92279|NCT01143051|216307|P5|STARTED|Visit 2||4
92280|NCT01143051|216308|P4|STARTED|Visit 2||4
92281|NCT01143051|216309|P3|STARTED|Visit 2||3
92282|NCT01143051|216310|P2|STARTED|Visit 2||4
92283|NCT01143051|216311|P1|STARTED|Visit 2||4
92284|NCT01143051|216306|P6|NOT COMPLETED|3-14 Day Washout||0
92285|NCT01143051|216307|P5|NOT COMPLETED|3-14 Day Washout||0
92286|NCT01143051|216308|P4|NOT COMPLETED|3-14 Day Washout||0
92287|NCT01143051|216309|P3|NOT COMPLETED|3-14 Day Washout||1
92288|NCT01143051|216310|P2|NOT COMPLETED|3-14 Day Washout||0
92289|NCT01143051|216311|P1|NOT COMPLETED|3-14 Day Washout||0
92290|NCT01143051|216306|P6|COMPLETED|3-14 Day Washout||4
92291|NCT01143051|216307|P5|COMPLETED|3-14 Day Washout||4
92292|NCT01143051|216308|P4|COMPLETED|3-14 Day Washout||4
92293|NCT01143051|216309|P3|COMPLETED|3-14 Day Washout||3
92294|NCT01143051|216310|P2|COMPLETED|3-14 Day Washout||4
92295|NCT01143051|216311|P1|COMPLETED|3-14 Day Washout||4
92296|NCT01143051|216306|P6|STARTED|3-14 Day Washout||4
92297|NCT01143051|216307|P5|STARTED|3-14 Day Washout||4
92298|NCT01143051|216308|P4|STARTED|3-14 Day Washout||4
92299|NCT01143051|216309|P3|STARTED|3-14 Day Washout||4
92300|NCT01143051|216310|P2|STARTED|3-14 Day Washout||4
92301|NCT01143051|216311|P1|STARTED|3-14 Day Washout||4
92302|NCT01143051|216306|P6|NOT COMPLETED|Visit 1||0
92303|NCT01143051|216307|P5|NOT COMPLETED|Visit 1||0
92304|NCT01143051|216308|P4|NOT COMPLETED|Visit 1||0
92305|NCT01143051|216309|P3|NOT COMPLETED|Visit 1||0
92306|NCT01143051|216310|P2|NOT COMPLETED|Visit 1||0
92307|NCT01143051|216311|P1|NOT COMPLETED|Visit 1||0
92308|NCT01143051|216306|P6|COMPLETED|Visit 1||4
92309|NCT01143051|216307|P5|COMPLETED|Visit 1||4
92310|NCT01143051|216308|P4|COMPLETED|Visit 1||4
92311|NCT01143051|216309|P3|COMPLETED|Visit 1||4
92312|NCT01143051|216310|P2|COMPLETED|Visit 1||4
92313|NCT01143051|216311|P1|COMPLETED|Visit 1||4
92314|NCT01143051|216306|P6|STARTED|Visit 1||4
92315|NCT01143051|216307|P5|STARTED|Visit 1||4
92316|NCT01143051|216308|P4|STARTED|Visit 1||4
92317|NCT01143051|216309|P3|STARTED|Visit 1||4
92318|NCT01143051|216310|P2|STARTED|Visit 1||4
92319|NCT01143051|216311|P1|STARTED|Visit 1||4
92320|NCT01143038|216334|P1|NOT COMPLETED|Overall Study||16
92321|NCT01143038|216334|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
92322|NCT01143038|216334|P1|STARTED|Overall Study||75
92323|NCT01142908|216344|P2|NOT COMPLETED|Overall Study||22
92324|NCT01142908|216345|P1|NOT COMPLETED|Overall Study||32
92325|NCT01142908|216344|P2|COMPLETED|Overall Study||191
92326|NCT01142908|216345|P1|COMPLETED|Overall Study||183
92327|NCT01142908|216344|P2|6 Month f/u|Overall Study||196
92328|NCT01142908|216345|P1|6 Month f/u|Overall Study||188
92329|NCT01142908|216344|P2|STARTED|Overall Study||213
92330|NCT01142908|216345|P1|STARTED|Overall Study||215
92331|NCT01142726|216394|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
92332|NCT01142726|216395|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
92333|NCT01142726|216396|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
92334|NCT01142726|216394|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
92335|NCT01142726|216395|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
92336|NCT01142726|216396|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
92337|NCT01142726|216394|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
92338|NCT01142726|216395|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
92339|NCT01142726|216396|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
92340|NCT01142726|216394|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
92341|NCT01142726|216395|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
92342|NCT01142726|216396|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
92343|NCT01142726|216394|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
92344|NCT01142726|216395|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
92345|NCT01142726|216396|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
92346|NCT01142726|216394|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
92347|NCT01142726|216395|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
92348|NCT01142726|216396|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
92349|NCT01142726|216394|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
92350|NCT01142726|216395|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
92351|NCT01142726|216396|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
92352|NCT01142726|216394|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
92353|NCT01142726|216395|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
92354|NCT01142726|216396|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
92355|NCT01142726|216394|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
92356|NCT01142726|216395|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
92357|NCT01142726|216396|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
92358|NCT01142661|216459|P1|NOT COMPLETED|Overall Study||4
92359|NCT01142661|216459|P1|COMPLETED|Overall Study||5
92360|NCT01142661|216459|P1|STARTED|Overall Study||9
92361|NCT01142596|216466|P2|NOT COMPLETED|Overall Study||86
92362|NCT01142596|216467|P1|NOT COMPLETED|Overall Study||29
92363|NCT01142596|216466|P2|COMPLETED|Overall Study||71
92364|NCT01142596|216467|P1|COMPLETED|Overall Study||15
92365|NCT01142596|216466|P2|STARTED|Overall Study||157
92366|NCT01142596|216467|P1|STARTED|Overall Study||44
92367|NCT01142466|216519|P2|NOT COMPLETED|Overall Study||2
92368|NCT01142466|216520|P1|NOT COMPLETED|Overall Study||3
92369|NCT01142466|216519|P2|COMPLETED|Overall Study||13
92370|NCT01142466|216520|P1|COMPLETED|Overall Study||12
92371|NCT01142466|216519|P2|STARTED|Overall Study||15
92372|NCT01142466|216520|P1|STARTED|Overall Study||15
92373|NCT01142388|216540|P2|NOT COMPLETED|Overall Study||47
92374|NCT01142388|216541|P1|NOT COMPLETED|Overall Study||47
92375|NCT01142388|216540|P2|COMPLETED|Overall Study||0
92376|NCT01142388|216541|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
92377|NCT01142388|216540|P2|Treated|Overall Study||44
92378|NCT01142388|216541|P1|Treated|Overall Study||40
92379|NCT01142388|216540|P2|Eligible|Overall Study||44
92380|NCT01142388|216541|P1|Eligible|Overall Study||43
92381|NCT01142388|216540|P2|STARTED|Overall Study||47
92382|NCT01142388|216541|P1|STARTED|Overall Study||47
92383|NCT01142323|216551|P1|NOT COMPLETED|Overall Study||0
92384|NCT01142323|216551|P1|COMPLETED|Overall Study||8
92385|NCT01142323|216551|P1|STARTED|Overall Study||8
92386|NCT01142297|216556|P1|NOT COMPLETED|Overall Study||6
92387|NCT01142297|216556|P1|COMPLETED|Overall Study||18
92388|NCT01142297|216556|P1|STARTED|Overall Study||24
92389|NCT01142193|216564|P2|NOT COMPLETED|Overall Study||11
92390|NCT01142193|216565|P1|NOT COMPLETED|Overall Study||21
92391|NCT01142193|216564|P2|COMPLETED|Overall Study||114
92392|NCT01142193|216565|P1|COMPLETED|Overall Study||103
92393|NCT01142193|216564|P2|STARTED|Overall Study||125
92394|NCT01142193|216565|P1|STARTED|Overall Study||124
92395|NCT01142128|216593|P1|NOT COMPLETED|Overall Study||4
92396|NCT01142128|216593|P1|COMPLETED|Overall Study||4
92397|NCT01142128|216593|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
92398|NCT01142128|216593|P1|Viokase 16 Plus Nexium|Overall Study||2
92399|NCT01142128|216593|P1|Placebo to Nexium, Alone|Overall Study||3
92400|NCT01142128|216593|P1|Nexium Alone|Overall Study||3
92401|NCT01142128|216593|P1|STARTED|Overall Study||8
92402|NCT01142115|216603|P2|NOT COMPLETED|Second Intervention||0
92403|NCT01142115|216604|P1|NOT COMPLETED|Second Intervention||0
92404|NCT01142115|216603|P2|COMPLETED|Second Intervention||19
92405|NCT01142115|216604|P1|COMPLETED|Second Intervention||19
92406|NCT01142115|216603|P2|STARTED|Second Intervention||19
92407|NCT01142115|216604|P1|STARTED|Second Intervention||19
92408|NCT01142115|216603|P2|NOT COMPLETED|First Intervention||1
92409|NCT01142115|216604|P1|NOT COMPLETED|First Intervention||2
92410|NCT01142115|216603|P2|COMPLETED|First Intervention||19
92411|NCT01142115|216604|P1|COMPLETED|First Intervention||19
92412|NCT01142115|216603|P2|STARTED|First Intervention||20
92413|NCT01142115|216604|P1|STARTED|First Intervention||21
92414|NCT01141660|216621|P2|NOT COMPLETED|Overall Study||12
92415|NCT01141660|216622|P1|NOT COMPLETED|Overall Study||0
92416|NCT01141660|216621|P2|COMPLETED|Overall Study||48
92417|NCT01141660|216622|P1|COMPLETED|Overall Study||71
92418|NCT01141660|216621|P2|STARTED|Overall Study||60
92419|NCT01141660|216622|P1|STARTED|Overall Study||71
92420|NCT01141595|216628|P1|NOT COMPLETED|Overall Study||2
92421|NCT01141595|216628|P1|COMPLETED|Overall Study||8
92422|NCT01141595|216628|P1|STARTED|Overall Study||10
92423|NCT01141491|216634|P2|NOT COMPLETED|Overall Study||47
92424|NCT01141491|216635|P1|NOT COMPLETED|Overall Study||48
92425|NCT01141491|216634|P2|COMPLETED|Overall Study||21
92426|NCT01141491|216635|P1|COMPLETED|Overall Study||20
92427|NCT01141491|216634|P2|STARTED|Overall Study||68
92428|NCT01141491|216635|P1|STARTED|Overall Study||68
92429|NCT01141374|216644|P3|NOT COMPLETED|Overall Study||0
92430|NCT01141374|216645|P2|NOT COMPLETED|Overall Study||0
92431|NCT01141374|216646|P1|NOT COMPLETED|Overall Study||0
92432|NCT01141374|216644|P3|COMPLETED|Overall Study||22
92433|NCT01141374|216645|P2|COMPLETED|Overall Study||27
92434|NCT01141374|216646|P1|COMPLETED|Overall Study||26
92435|NCT01141374|216644|P3|STARTED|Overall Study||22
92436|NCT01141374|216645|P2|STARTED|Overall Study||27
92437|NCT01141374|216646|P1|STARTED|Overall Study||26
92438|NCT01141283|216657|P1|NOT COMPLETED|Overall Study||88
92439|NCT01141283|216657|P1|COMPLETED|Overall Study||202
92440|NCT01141283|216657|P1|STARTED|Overall Study||290
92441|NCT01141205|216663|P2|NOT COMPLETED|Overall Study||2
92442|NCT01141205|216664|P1|NOT COMPLETED|Overall Study||3
92443|NCT01141205|216663|P2|COMPLETED|Overall Study||3
92444|NCT01141205|216664|P1|COMPLETED|Overall Study||15
92445|NCT01141205|216663|P2|STARTED|Overall Study||5
92446|NCT01141205|216664|P1|STARTED|Overall Study||18
92447|NCT01140906|216680|P4|NOT COMPLETED|Overall Study||16
92448|NCT01140906|216681|P3|NOT COMPLETED|Overall Study||26
92449|NCT01140906|216682|P2|NOT COMPLETED|Overall Study||34
92450|NCT01140906|216683|P1|NOT COMPLETED|Overall Study||25
92451|NCT01140906|216680|P4|COMPLETED|Overall Study||131
92452|NCT01140906|216681|P3|COMPLETED|Overall Study||125
92453|NCT01140906|216682|P2|COMPLETED|Overall Study||117
92454|NCT01140906|216683|P1|COMPLETED|Overall Study||133
92455|NCT01140906|216680|P4|STARTED|Overall Study||147
92456|NCT01140906|216681|P3|STARTED|Overall Study||151
92457|NCT01140906|216682|P2|STARTED|Overall Study||151
92458|NCT01140906|216683|P1|STARTED|Overall Study||158
92459|NCT01140880|216723|P2|NOT COMPLETED|Overall Study||44
92460|NCT01140880|216724|P1|NOT COMPLETED|Overall Study||14
92461|NCT01140880|216723|P2|COMPLETED|Overall Study||56
92462|NCT01140880|216724|P1|COMPLETED|Overall Study||56
92463|NCT01140880|216723|P2|STARTED|Overall Study||100
92464|NCT01140880|216724|P1|STARTED|Overall Study||70
92465|NCT01140867|216736|P1|NOT COMPLETED|Overall Study||33
92466|NCT01140867|216736|P1|COMPLETED|Overall Study||88
92467|NCT01140867|216736|P1|STARTED|Overall Study||121
92468|NCT01140815|216745|P2|NOT COMPLETED|Overall Study||0
92469|NCT01140815|216746|P1|NOT COMPLETED|Overall Study||0
92470|NCT01140815|216745|P2|COMPLETED|Overall Study||25
92471|NCT01140815|216746|P1|COMPLETED|Overall Study||25
92472|NCT01140815|216745|P2|STARTED|Overall Study||25
92473|NCT01140815|216746|P1|STARTED|Overall Study||25
92474|NCT01140646|216776|P1|NOT COMPLETED|Overall Study||9
92475|NCT01140646|216776|P1|COMPLETED|Overall Study||34
92476|NCT01140646|216776|P1|STARTED|Overall Study||43
92477|NCT01140503|216780|P1|NOT COMPLETED|Overall Study||1
92478|NCT01140503|216780|P1|COMPLETED|Overall Study||4
92479|NCT01140503|216780|P1|STARTED|Overall Study||5
92480|NCT01140477|216788|P2|NOT COMPLETED|Overall Study||6
92481|NCT01140477|216789|P1|NOT COMPLETED|Overall Study||8
92482|NCT01140477|216788|P2|COMPLETED|Overall Study||70
92483|NCT01140477|216789|P1|COMPLETED|Overall Study||145
92484|NCT01140477|216788|P2|STARTED|Overall Study||76
92485|NCT01140477|216789|P1|STARTED|Overall Study||153
92486|NCT01140347|216800|P2|NOT COMPLETED|Overall Study||14
92487|NCT01140347|216801|P1|NOT COMPLETED|Overall Study||18
92488|NCT01140347|216800|P2|COMPLETED|Overall Study||268
92489|NCT01140347|216801|P1|COMPLETED|Overall Study||265
92490|NCT01140347|216800|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
92491|NCT01140347|216801|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
92492|NCT01140347|216800|P2|STARTED|Overall Study||282
92493|NCT01140347|216801|P1|STARTED|Overall Study||283
92494|NCT01140295|216826|P2|NOT COMPLETED|Overall Study||2
92495|NCT01140295|216827|P1|NOT COMPLETED|Overall Study||1
92496|NCT01140295|216826|P2|COMPLETED|Overall Study||14
92497|NCT01140295|216827|P1|COMPLETED|Overall Study||16
92498|NCT01140295|216826|P2|STARTED|Overall Study||16
92499|NCT01140295|216827|P1|STARTED|Overall Study||17
92500|NCT01140061|216845|P10|NOT COMPLETED|Extension||1
92501|NCT01140061|216846|P9|NOT COMPLETED|Extension||0
92502|NCT01140061|216847|P8|NOT COMPLETED|Extension||0
92503|NCT01140061|216848|P7|NOT COMPLETED|Extension||0
92504|NCT01140061|216849|P6|NOT COMPLETED|Extension||0
92505|NCT01140061|216850|P5|NOT COMPLETED|Extension||0
92506|NCT01140061|216851|P4|NOT COMPLETED|Extension||0
92507|NCT01140061|216852|P3|NOT COMPLETED|Extension||0
92508|NCT01140061|216853|P2|NOT COMPLETED|Extension||0
92509|NCT01140061|216854|P1|NOT COMPLETED|Extension||0
92510|NCT01140061|216845|P10|COMPLETED|Extension||1
92511|NCT01140061|216846|P9|COMPLETED|Extension||7
92512|NCT01140061|216847|P8|COMPLETED|Extension||0
92513|NCT01140061|216848|P7|COMPLETED|Extension||0
92514|NCT01140061|216849|P6|COMPLETED|Extension||0
92515|NCT01140061|216850|P5|COMPLETED|Extension||0
92516|NCT01140061|216851|P4|COMPLETED|Extension||0
92517|NCT01140061|216852|P3|COMPLETED|Extension||0
92518|NCT01140061|216853|P2|COMPLETED|Extension||0
92519|NCT01140061|216854|P1|COMPLETED|Extension||0
92520|NCT01140061|216845|P10|STARTED|Extension||2
92521|NCT01140061|216846|P9|STARTED|Extension||7
92522|NCT01140061|216847|P8|STARTED|Extension||0
92523|NCT01140061|216848|P7|STARTED|Extension||0
92524|NCT01140061|216849|P6|STARTED|Extension||0
92525|NCT01140061|216850|P5|STARTED|Extension||0
92526|NCT01140061|216851|P4|STARTED|Extension||0
92527|NCT01140061|216852|P3|STARTED|Extension||0
92528|NCT01140061|216853|P2|STARTED|Extension||0
92529|NCT01140061|216854|P1|STARTED|Extension||0
92530|NCT01140061|216845|P10|NOT COMPLETED|Part III||0
92531|NCT01140061|216846|P9|NOT COMPLETED|Part III||0
92532|NCT01140061|216847|P8|NOT COMPLETED|Part III||0
92533|NCT01140061|216848|P7|NOT COMPLETED|Part III||0
92534|NCT01140061|216849|P6|NOT COMPLETED|Part III||0
92535|NCT01140061|216850|P5|NOT COMPLETED|Part III||0
92536|NCT01140061|216851|P4|NOT COMPLETED|Part III||0
92537|NCT01140061|216852|P3|NOT COMPLETED|Part III||0
92538|NCT01140061|216853|P2|NOT COMPLETED|Part III||0
92539|NCT01140061|216854|P1|NOT COMPLETED|Part III||0
92540|NCT01140061|216845|P10|COMPLETED|Part III||2
92541|NCT01140061|216846|P9|COMPLETED|Part III||7
92542|NCT01140061|216847|P8|COMPLETED|Part III||0
92543|NCT01140061|216848|P7|COMPLETED|Part III||0
92544|NCT01140061|216849|P6|COMPLETED|Part III||0
92545|NCT01140061|216850|P5|COMPLETED|Part III||0
92546|NCT01140061|216851|P4|COMPLETED|Part III||0
92547|NCT01140061|216852|P3|COMPLETED|Part III||0
92548|NCT01140061|216853|P2|COMPLETED|Part III||0
92549|NCT01140061|216854|P1|COMPLETED|Part III||0
92550|NCT01140061|216845|P10|STARTED|Part III|Includes 1 replacement participant|2
92551|NCT01140061|216846|P9|STARTED|Part III||7
92552|NCT01140061|216847|P8|STARTED|Part III||0
92553|NCT01140061|216848|P7|STARTED|Part III||0
92554|NCT01140061|216849|P6|STARTED|Part III||0
92555|NCT01140061|216850|P5|STARTED|Part III||0
92556|NCT01140061|216851|P4|STARTED|Part III||0
92557|NCT01140061|216852|P3|STARTED|Part III||0
92558|NCT01140061|216853|P2|STARTED|Part III||0
92559|NCT01140061|216854|P1|STARTED|Part III||0
92560|NCT01140061|216845|P10|NOT COMPLETED|Part II||0
92561|NCT01140061|216846|P9|NOT COMPLETED|Part II||0
92562|NCT01140061|216847|P8|NOT COMPLETED|Part II||0
92563|NCT01140061|216848|P7|NOT COMPLETED|Part II||0
92564|NCT01140061|216849|P6|NOT COMPLETED|Part II||0
92565|NCT01140061|216850|P5|NOT COMPLETED|Part II||0
92566|NCT01140061|216851|P4|NOT COMPLETED|Part II||0
92567|NCT01140061|216852|P3|NOT COMPLETED|Part II||0
92568|NCT01140061|216853|P2|NOT COMPLETED|Part II||0
92569|NCT01140061|216854|P1|NOT COMPLETED|Part II||0
92570|NCT01140061|216845|P10|COMPLETED|Part II||0
92571|NCT01140061|216846|P9|COMPLETED|Part II||0
92572|NCT01140061|216847|P8|COMPLETED|Part II||2
92573|NCT01140061|216848|P7|COMPLETED|Part II||6
92574|NCT01140061|216849|P6|COMPLETED|Part II||2
92575|NCT01140061|216850|P5|COMPLETED|Part II||6
92576|NCT01140061|216851|P4|COMPLETED|Part II||2
92577|NCT01140061|216852|P3|COMPLETED|Part II||6
92578|NCT01140061|216853|P2|COMPLETED|Part II||0
92579|NCT01140061|216854|P1|COMPLETED|Part II||0
92580|NCT01140061|216845|P10|STARTED|Part II||0
92581|NCT01140061|216846|P9|STARTED|Part II||0
92582|NCT01140061|216847|P8|STARTED|Part II||2
92583|NCT01140061|216848|P7|STARTED|Part II||6
92584|NCT01140061|216849|P6|STARTED|Part II||2
92585|NCT01140061|216850|P5|STARTED|Part II||6
92586|NCT01140061|216851|P4|STARTED|Part II||2
92587|NCT01140061|216852|P3|STARTED|Part II||6
92588|NCT01140061|216853|P2|STARTED|Part II||0
92589|NCT01140061|216854|P1|STARTED|Part II||0
92590|NCT01140061|216845|P10|NOT COMPLETED|Part I||0
92591|NCT01140061|216846|P9|NOT COMPLETED|Part I||0
92592|NCT01140061|216847|P8|NOT COMPLETED|Part I||0
92593|NCT01140061|216848|P7|NOT COMPLETED|Part I||0
92594|NCT01140061|216849|P6|NOT COMPLETED|Part I||0
92595|NCT01140061|216850|P5|NOT COMPLETED|Part I||0
92596|NCT01140061|216851|P4|NOT COMPLETED|Part I||0
92597|NCT01140061|216852|P3|NOT COMPLETED|Part I||0
92598|NCT01140061|216853|P2|NOT COMPLETED|Part I||0
92599|NCT01140061|216854|P1|NOT COMPLETED|Part I||1
92600|NCT01140061|216845|P10|COMPLETED|Part I||0
92601|NCT01140061|216846|P9|COMPLETED|Part I||0
92602|NCT01140061|216847|P8|COMPLETED|Part I||0
92603|NCT01140061|216848|P7|COMPLETED|Part I||0
92604|NCT01140061|216849|P6|COMPLETED|Part I||0
92605|NCT01140061|216850|P5|COMPLETED|Part I||0
92606|NCT01140061|216851|P4|COMPLETED|Part I||0
92607|NCT01140061|216852|P3|COMPLETED|Part I||0
92608|NCT01140061|216853|P2|COMPLETED|Part I||2
92609|NCT01140061|216854|P1|COMPLETED|Part I||6
92610|NCT01140061|216845|P10|STARTED|Part I||0
92611|NCT01140061|216846|P9|STARTED|Part I||0
92612|NCT01140061|216847|P8|STARTED|Part I||0
92613|NCT01140061|216848|P7|STARTED|Part I||0
92614|NCT01140061|216849|P6|STARTED|Part I||0
92615|NCT01140061|216850|P5|STARTED|Part I||0
92616|NCT01140061|216851|P4|STARTED|Part I||0
92617|NCT01140061|216852|P3|STARTED|Part I||0
92618|NCT01140061|216853|P2|STARTED|Part I||2
92619|NCT01140061|216854|P1|STARTED|Part I|Includes 1 replacement participant|7
92620|NCT01140048|216881|P1|NOT COMPLETED|Overall Study||45
92621|NCT01140048|216881|P1|COMPLETED|Overall Study||298
92622|NCT01140048|216881|P1|STARTED|Overall Study||343
92623|NCT01139879|216887|P1|NOT COMPLETED|Overall Study||0
92624|NCT01139879|216887|P1|COMPLETED|Overall Study||10
92625|NCT01139879|216887|P1|STARTED|Overall Study||10
92626|NCT01139814|216893|P1|NOT COMPLETED|Overall Study||0
92627|NCT01139814|216893|P1|COMPLETED|Overall Study||181
92628|NCT01139814|216893|P1|STARTED|Overall Study||181
92629|NCT01139762|216900|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
92630|NCT01139762|216901|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
92631|NCT01139762|216902|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
92632|NCT01139762|216900|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
92633|NCT01139762|216901|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
92634|NCT01139762|216902|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
92635|NCT01139762|216900|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
92636|NCT01139762|216901|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
92637|NCT01139762|216902|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
92638|NCT01139762|216900|P3|STARTED|Double-Blind Randomized Active Treatment||350
92639|NCT01139762|216901|P2|STARTED|Double-Blind Randomized Active Treatment||346
92640|NCT01139762|216902|P1|STARTED|Double-Blind Randomized Active Treatment||0
92641|NCT01139762|216900|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
92642|NCT01139762|216901|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
92643|NCT01139762|216902|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
92644|NCT01139762|216900|P3|COMPLETED|Washout and Placebo Lead-In Period||0
92645|NCT01139762|216901|P2|COMPLETED|Washout and Placebo Lead-In Period||0
92646|NCT01139762|216902|P1|COMPLETED|Washout and Placebo Lead-In Period||696
92647|NCT01139762|216900|P3|STARTED|Washout and Placebo Lead-In Period||0
92648|NCT01139762|216901|P2|STARTED|Washout and Placebo Lead-In Period||0
92649|NCT01139762|216902|P1|STARTED|Washout and Placebo Lead-In Period||1070
92650|NCT01139658|216937|P2|NOT COMPLETED|Overall Study||113
92651|NCT01139658|216938|P1|NOT COMPLETED|Overall Study||56
92652|NCT01139658|216937|P2|COMPLETED|Overall Study||816
92653|NCT01139658|216938|P1|COMPLETED|Overall Study||691
92654|NCT01139658|216937|P2|STARTED|Overall Study||929
92655|NCT01139658|216938|P1|STARTED|Overall Study||747
92656|NCT01139580|216976|P2|NOT COMPLETED|Overall Study||18
92657|NCT01139580|216977|P1|NOT COMPLETED|Overall Study||23
92658|NCT01139580|216976|P2|COMPLETED|Overall Study||164
92659|NCT01139580|216977|P1|COMPLETED|Overall Study||158
92660|NCT01139580|216976|P2|STARTED|Overall Study||182
92661|NCT01139580|216977|P1|STARTED|Overall Study||181
92662|NCT01139515|216993|P4|NOT COMPLETED|Fourth Intervention Period||0
92663|NCT01139515|216994|P3|NOT COMPLETED|Fourth Intervention Period||0
92664|NCT01139515|216995|P2|NOT COMPLETED|Fourth Intervention Period||0
92665|NCT01139515|216996|P1|NOT COMPLETED|Fourth Intervention Period||0
92666|NCT01139515|216993|P4|COMPLETED|Fourth Intervention Period||4
92667|NCT01139515|216994|P3|COMPLETED|Fourth Intervention Period||4
92668|NCT01139515|216995|P2|COMPLETED|Fourth Intervention Period||4
92669|NCT01139515|216996|P1|COMPLETED|Fourth Intervention Period||4
92670|NCT01139515|216993|P4|STARTED|Fourth Intervention Period||4
92671|NCT01139515|216994|P3|STARTED|Fourth Intervention Period||4
92672|NCT01139515|216995|P2|STARTED|Fourth Intervention Period||4
92673|NCT01139515|216996|P1|STARTED|Fourth Intervention Period||4
92674|NCT01139515|216993|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
92675|NCT01139515|216994|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
92676|NCT01139515|216995|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
92677|NCT01139515|216996|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
92678|NCT01139515|216993|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
92679|NCT01139515|216994|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
92680|NCT01139515|216995|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
92681|NCT01139515|216996|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
92682|NCT01139515|216993|P4|STARTED|Washout Period 3 (46 Hrs)||4
92683|NCT01139515|216994|P3|STARTED|Washout Period 3 (46 Hrs)||4
92684|NCT01139515|216995|P2|STARTED|Washout Period 3 (46 Hrs)||4
92685|NCT01139515|216996|P1|STARTED|Washout Period 3 (46 Hrs)||4
92686|NCT01139515|216993|P4|NOT COMPLETED|Third Intervention Period||0
92687|NCT01139515|216994|P3|NOT COMPLETED|Third Intervention Period||0
92688|NCT01139515|216995|P2|NOT COMPLETED|Third Intervention Period||0
92689|NCT01139515|216996|P1|NOT COMPLETED|Third Intervention Period||0
92690|NCT01139515|216993|P4|COMPLETED|Third Intervention Period||4
92691|NCT01139515|216994|P3|COMPLETED|Third Intervention Period||4
92692|NCT01139515|216995|P2|COMPLETED|Third Intervention Period||4
92693|NCT01139515|216996|P1|COMPLETED|Third Intervention Period||4
92694|NCT01139515|216993|P4|STARTED|Third Intervention Period||4
92695|NCT01139515|216994|P3|STARTED|Third Intervention Period||4
92696|NCT01139515|216995|P2|STARTED|Third Intervention Period||4
92697|NCT01139515|216996|P1|STARTED|Third Intervention Period||4
92698|NCT01139515|216993|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
92699|NCT01139515|216994|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
92700|NCT01139515|216995|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
92701|NCT01139515|216996|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
92702|NCT01139515|216993|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
92703|NCT01139515|216994|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
92704|NCT01139515|216995|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
92705|NCT01139515|216996|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
92706|NCT01139515|216993|P4|STARTED|Washout Period 2 (46 Hrs)||4
92707|NCT01139515|216994|P3|STARTED|Washout Period 2 (46 Hrs)||4
92708|NCT01139515|216995|P2|STARTED|Washout Period 2 (46 Hrs)||4
92709|NCT01139515|216996|P1|STARTED|Washout Period 2 (46 Hrs)||4
92710|NCT01139515|216993|P4|NOT COMPLETED|Second Intervention Period||0
92711|NCT01139515|216994|P3|NOT COMPLETED|Second Intervention Period||0
92712|NCT01139515|216995|P2|NOT COMPLETED|Second Intervention Period||0
92713|NCT01139515|216996|P1|NOT COMPLETED|Second Intervention Period||0
92714|NCT01139515|216993|P4|COMPLETED|Second Intervention Period||4
92715|NCT01139515|216994|P3|COMPLETED|Second Intervention Period||4
92716|NCT01139515|216995|P2|COMPLETED|Second Intervention Period||4
92717|NCT01139515|216996|P1|COMPLETED|Second Intervention Period||4
92718|NCT01139515|216993|P4|STARTED|Second Intervention Period||4
92719|NCT01139515|216994|P3|STARTED|Second Intervention Period||4
92720|NCT01139515|216995|P2|STARTED|Second Intervention Period||4
92721|NCT01139515|216996|P1|STARTED|Second Intervention Period||4
92722|NCT01139515|216993|P4|NOT COMPLETED|Washout Period I (46hrs)||0
92723|NCT01139515|216994|P3|NOT COMPLETED|Washout Period I (46hrs)||0
92724|NCT01139515|216995|P2|NOT COMPLETED|Washout Period I (46hrs)||0
92725|NCT01139515|216996|P1|NOT COMPLETED|Washout Period I (46hrs)||0
92726|NCT01139515|216993|P4|COMPLETED|Washout Period I (46hrs)||4
92727|NCT01139515|216994|P3|COMPLETED|Washout Period I (46hrs)||4
92728|NCT01139515|216995|P2|COMPLETED|Washout Period I (46hrs)||4
92729|NCT01139515|216996|P1|COMPLETED|Washout Period I (46hrs)||4
92730|NCT01139515|216993|P4|STARTED|Washout Period I (46hrs)||4
92731|NCT01139515|216994|P3|STARTED|Washout Period I (46hrs)||4
92732|NCT01139515|216995|P2|STARTED|Washout Period I (46hrs)||4
92733|NCT01139515|216996|P1|STARTED|Washout Period I (46hrs)||4
92734|NCT01139515|216993|P4|NOT COMPLETED|First Intervention Period||0
92735|NCT01139515|216994|P3|NOT COMPLETED|First Intervention Period||0
92736|NCT01139515|216995|P2|NOT COMPLETED|First Intervention Period||0
92737|NCT01139515|216996|P1|NOT COMPLETED|First Intervention Period||0
92738|NCT01139515|216993|P4|COMPLETED|First Intervention Period||4
92739|NCT01139515|216994|P3|COMPLETED|First Intervention Period||4
92740|NCT01139515|216995|P2|COMPLETED|First Intervention Period||4
92741|NCT01139515|216996|P1|COMPLETED|First Intervention Period||4
92742|NCT01139515|216993|P4|STARTED|First Intervention Period||4
92743|NCT01139515|216994|P3|STARTED|First Intervention Period||4
92744|NCT01139515|216995|P2|STARTED|First Intervention Period||4
92745|NCT01139515|216996|P1|STARTED|First Intervention Period||4
92746|NCT01139450|217025|P3|NOT COMPLETED|Overall Study||38
92747|NCT01139450|217026|P2|NOT COMPLETED|Overall Study||25
92748|NCT01139450|217027|P1|NOT COMPLETED|Overall Study||27
92749|NCT01139450|217025|P3|COMPLETED|Overall Study||262
92750|NCT01139450|217026|P2|COMPLETED|Overall Study||272
92751|NCT01139450|217027|P1|COMPLETED|Overall Study||275
92752|NCT01139450|217025|P3|STARTED|Overall Study||300
92753|NCT01139450|217026|P2|STARTED|Overall Study||297
92754|NCT01139450|217027|P1|STARTED|Overall Study||302
92755|NCT01139411|217037|P2|NOT COMPLETED|Overall Study||4
92756|NCT01139411|217038|P1|NOT COMPLETED|Overall Study||2
92757|NCT01139411|217037|P2|COMPLETED|Overall Study||19
92758|NCT01139411|217038|P1|COMPLETED|Overall Study||24
92759|NCT01139411|217037|P2|STARTED|Overall Study||23
92760|NCT01139411|217038|P1|STARTED|Overall Study||26
92761|NCT01139190|217058|P2|NOT COMPLETED|Overall Study||1
92762|NCT01139190|217059|P1|NOT COMPLETED|Overall Study||0
92763|NCT01139190|217058|P2|COMPLETED|Overall Study||38
92764|NCT01139190|217059|P1|COMPLETED|Overall Study||38
92765|NCT01139190|217058|P2|STARTED|Overall Study||39
92766|NCT01139190|217059|P1|STARTED|Overall Study||38
92767|NCT01139164|217068|P3|NOT COMPLETED|Overall Study||0
92768|NCT01139164|217069|P2|NOT COMPLETED|Overall Study||2
92769|NCT01139164|217070|P1|NOT COMPLETED|Overall Study||0
92770|NCT01139164|217068|P3|COMPLETED|Overall Study||7
92771|NCT01139164|217069|P2|COMPLETED|Overall Study||65
92772|NCT01139164|217070|P1|COMPLETED|Overall Study||4
92773|NCT01139164|217068|P3|STARTED|Overall Study||7
92774|NCT01139164|217069|P2|STARTED|Overall Study||67
92775|NCT01139164|217070|P1|STARTED|Overall Study||4
92776|NCT01139125|217084|P1|NOT COMPLETED|Overall Study||1
92777|NCT01139125|217084|P1|COMPLETED|Overall Study||2
92778|NCT01139125|217084|P1|STARTED|Overall Study||3
92779|NCT01139047|217088|P1|NOT COMPLETED|Overall Study||1
92780|NCT01139047|217088|P1|COMPLETED|Overall Study||76
92781|NCT01139047|217088|P1|STARTED|Overall Study||77
92782|NCT01139021|217103|P6|NOT COMPLETED|Overall Study||0
92783|NCT01139021|217104|P5|NOT COMPLETED|Overall Study||9
92784|NCT01139021|217105|P4|NOT COMPLETED|Overall Study||1
92785|NCT01139021|217106|P3|NOT COMPLETED|Overall Study||0
92786|NCT01139021|217107|P2|NOT COMPLETED|Overall Study||0
92787|NCT01139021|217108|P1|NOT COMPLETED|Overall Study||1
92788|NCT01139021|217103|P6|COMPLETED|Overall Study||1
92789|NCT01139021|217104|P5|COMPLETED|Overall Study||107
92790|NCT01139021|217105|P4|COMPLETED|Overall Study||18
92791|NCT01139021|217106|P3|COMPLETED|Overall Study||67
92792|NCT01139021|217107|P2|COMPLETED|Overall Study||153
92793|NCT01139021|217108|P1|COMPLETED|Overall Study||151
92794|NCT01139021|217103|P6|STARTED|Overall Study||1
92795|NCT01139021|217104|P5|STARTED|Overall Study||116
92796|NCT01139021|217105|P4|STARTED|Overall Study||19
92797|NCT01139021|217106|P3|STARTED|Overall Study||67
92798|NCT01139021|217107|P2|STARTED|Overall Study||153
92799|NCT01139021|217108|P1|STARTED|Overall Study||152
92800|NCT01139008|217144|P1|NOT COMPLETED|Overall Study||6
92801|NCT01139008|217144|P1|COMPLETED|Overall Study||74
92802|NCT01139008|217144|P1|STARTED|Overall Study||80
92803|NCT01138995|217155|P2|NOT COMPLETED|Overall Study||25
92804|NCT01138995|217156|P1|NOT COMPLETED|Overall Study||10
92805|NCT01138995|217155|P2|COMPLETED|Overall Study||74
92806|NCT01138995|217156|P1|COMPLETED|Overall Study||88
92807|NCT01138995|217155|P2|STARTED|Overall Study||99
92808|NCT01138995|217156|P1|STARTED|Overall Study||98
92809|NCT01138969|217168|P2|NOT COMPLETED|Overall Study||0
92810|NCT01138969|217169|P1|NOT COMPLETED|Overall Study||0
92811|NCT01138969|217168|P2|COMPLETED|Overall Study||82
92812|NCT01138969|217169|P1|COMPLETED|Overall Study||83
92813|NCT01138969|217168|P2|STARTED|Overall Study||82
92814|NCT01138969|217169|P1|STARTED|Overall Study||83
92815|NCT01138826|217177|P6|NOT COMPLETED|Third Intervention Period||0
92816|NCT01138826|217178|P5|NOT COMPLETED|Third Intervention Period||0
92817|NCT01138826|217179|P4|NOT COMPLETED|Third Intervention Period||0
92818|NCT01138826|217180|P3|NOT COMPLETED|Third Intervention Period||0
92819|NCT01138826|217181|P2|NOT COMPLETED|Third Intervention Period||0
92820|NCT01138826|217182|P1|NOT COMPLETED|Third Intervention Period||0
92821|NCT01138826|217177|P6|COMPLETED|Third Intervention Period||3
92822|NCT01138826|217178|P5|COMPLETED|Third Intervention Period||2
92823|NCT01138826|217179|P4|COMPLETED|Third Intervention Period||3
92824|NCT01138826|217180|P3|COMPLETED|Third Intervention Period||3
92825|NCT01138826|217181|P2|COMPLETED|Third Intervention Period||2
92826|NCT01138826|217182|P1|COMPLETED|Third Intervention Period||2
92827|NCT01138826|217177|P6|STARTED|Third Intervention Period||3
92828|NCT01138826|217178|P5|STARTED|Third Intervention Period||2
92829|NCT01138826|217179|P4|STARTED|Third Intervention Period||3
92830|NCT01138826|217180|P3|STARTED|Third Intervention Period||3
92831|NCT01138826|217181|P2|STARTED|Third Intervention Period||2
92832|NCT01138826|217182|P1|STARTED|Third Intervention Period||2
92833|NCT01138826|217177|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
92834|NCT01138826|217178|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
92835|NCT01138826|217179|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
92836|NCT01138826|217180|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
92837|NCT01138826|217181|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
92838|NCT01138826|217182|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
92839|NCT01138826|217177|P6|COMPLETED|Washout Period II (of 16 Days)||3
92840|NCT01138826|217178|P5|COMPLETED|Washout Period II (of 16 Days)||2
92841|NCT01138826|217179|P4|COMPLETED|Washout Period II (of 16 Days)||3
92842|NCT01138826|217180|P3|COMPLETED|Washout Period II (of 16 Days)||3
92843|NCT01138826|217181|P2|COMPLETED|Washout Period II (of 16 Days)||2
92844|NCT01138826|217182|P1|COMPLETED|Washout Period II (of 16 Days)||2
92845|NCT01138826|217177|P6|STARTED|Washout Period II (of 16 Days)||3
92846|NCT01138826|217178|P5|STARTED|Washout Period II (of 16 Days)||2
92847|NCT01138826|217179|P4|STARTED|Washout Period II (of 16 Days)||3
92848|NCT01138826|217180|P3|STARTED|Washout Period II (of 16 Days)||3
92849|NCT01138826|217181|P2|STARTED|Washout Period II (of 16 Days)||2
92850|NCT01138826|217182|P1|STARTED|Washout Period II (of 16 Days)||2
92851|NCT01138826|217177|P6|NOT COMPLETED|Second Intervention Period||0
92852|NCT01138826|217178|P5|NOT COMPLETED|Second Intervention Period||0
92853|NCT01138826|217179|P4|NOT COMPLETED|Second Intervention Period||0
92854|NCT01138826|217180|P3|NOT COMPLETED|Second Intervention Period||0
92855|NCT01138826|217181|P2|NOT COMPLETED|Second Intervention Period||0
92856|NCT01138826|217182|P1|NOT COMPLETED|Second Intervention Period||0
92857|NCT01138826|217177|P6|COMPLETED|Second Intervention Period||3
92858|NCT01138826|217178|P5|COMPLETED|Second Intervention Period||2
92859|NCT01138826|217179|P4|COMPLETED|Second Intervention Period||3
92860|NCT01138826|217180|P3|COMPLETED|Second Intervention Period||3
92861|NCT01138826|217181|P2|COMPLETED|Second Intervention Period||2
92862|NCT01138826|217182|P1|COMPLETED|Second Intervention Period||2
92863|NCT01138826|217177|P6|STARTED|Second Intervention Period||3
92864|NCT01138826|217178|P5|STARTED|Second Intervention Period||2
92865|NCT01138826|217179|P4|STARTED|Second Intervention Period||3
92866|NCT01138826|217180|P3|STARTED|Second Intervention Period||3
92867|NCT01138826|217181|P2|STARTED|Second Intervention Period||2
92868|NCT01138826|217182|P1|STARTED|Second Intervention Period||2
92869|NCT01138826|217177|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
92870|NCT01138826|217178|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
92871|NCT01138826|217179|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
92872|NCT01138826|217180|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
92873|NCT01138826|217181|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
92874|NCT01138826|217182|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
92875|NCT01138826|217177|P6|COMPLETED|Washout Period I (of 16 Days)||3
92876|NCT01138826|217178|P5|COMPLETED|Washout Period I (of 16 Days)||2
92877|NCT01138826|217179|P4|COMPLETED|Washout Period I (of 16 Days)||3
92878|NCT01138826|217180|P3|COMPLETED|Washout Period I (of 16 Days)||3
92879|NCT01138826|217181|P2|COMPLETED|Washout Period I (of 16 Days)||2
92880|NCT01138826|217182|P1|COMPLETED|Washout Period I (of 16 Days)||2
92881|NCT01138826|217177|P6|STARTED|Washout Period I (of 16 Days)||3
92882|NCT01138826|217178|P5|STARTED|Washout Period I (of 16 Days)||3
92883|NCT01138826|217179|P4|STARTED|Washout Period I (of 16 Days)||3
92884|NCT01138826|217180|P3|STARTED|Washout Period I (of 16 Days)||3
92885|NCT01138826|217181|P2|STARTED|Washout Period I (of 16 Days)||3
92886|NCT01138826|217182|P1|STARTED|Washout Period I (of 16 Days)||3
92887|NCT01138826|217177|P6|NOT COMPLETED|First Intervention Period||0
92888|NCT01138826|217178|P5|NOT COMPLETED|First Intervention Period||0
92889|NCT01138826|217179|P4|NOT COMPLETED|First Intervention Period||0
92890|NCT01138826|217180|P3|NOT COMPLETED|First Intervention Period||0
92891|NCT01138826|217181|P2|NOT COMPLETED|First Intervention Period||0
92892|NCT01138826|217182|P1|NOT COMPLETED|First Intervention Period||0
92893|NCT01138826|217177|P6|COMPLETED|First Intervention Period||3
92894|NCT01138826|217178|P5|COMPLETED|First Intervention Period||3
92895|NCT01138826|217179|P4|COMPLETED|First Intervention Period||3
92896|NCT01138826|217180|P3|COMPLETED|First Intervention Period||3
92897|NCT01138826|217181|P2|COMPLETED|First Intervention Period||3
92898|NCT01138826|217182|P1|COMPLETED|First Intervention Period||3
92899|NCT01138826|217177|P6|STARTED|First Intervention Period||3
92900|NCT01138826|217178|P5|STARTED|First Intervention Period||3
92901|NCT01138826|217179|P4|STARTED|First Intervention Period||3
92902|NCT01138826|217180|P3|STARTED|First Intervention Period||3
92903|NCT01138826|217181|P2|STARTED|First Intervention Period||3
92904|NCT01138826|217182|P1|STARTED|First Intervention Period||3
92905|NCT01138735|217204|P2|NOT COMPLETED|Overall Study||17
92906|NCT01138735|217205|P1|NOT COMPLETED|Overall Study||8
92907|NCT01138735|217204|P2|COMPLETED|Overall Study||126
92908|NCT01138735|217205|P1|COMPLETED|Overall Study||134
92909|NCT01138735|217204|P2|STARTED|Overall Study||143
92910|NCT01138735|217205|P1|STARTED|Overall Study||142
92911|NCT01138657|217219|P2|NOT COMPLETED|Overall Study||18
92912|NCT01138657|217220|P1|NOT COMPLETED|Overall Study||8
92913|NCT01138657|217219|P2|COMPLETED|Overall Study||101
92914|NCT01138657|217220|P1|COMPLETED|Overall Study||112
92915|NCT01138657|217219|P2|Enrolled in Japan Sub-study|Overall Study||8
92916|NCT01138657|217220|P1|Enrolled in Japan Sub-study|Overall Study||8
92917|NCT01138657|217219|P2|Enrolled in Main Study|Overall Study||111
92918|NCT01138657|217220|P1|Enrolled in Main Study|Overall Study||112
92919|NCT01138657|217219|P2|STARTED|Overall Study||119
92920|NCT01138657|217220|P1|STARTED|Overall Study||120
92921|NCT01138514|217267|P3|NOT COMPLETED|Overall Study||93
92922|NCT01138514|217268|P2|NOT COMPLETED|Overall Study||53
92923|NCT01138514|217269|P1|NOT COMPLETED|Overall Study||48
92924|NCT01138514|217267|P3|COMPLETED|Overall Study||424
92925|NCT01138514|217268|P2|COMPLETED|Overall Study||463
92926|NCT01138514|217269|P1|COMPLETED|Overall Study||474
92927|NCT01138514|217267|P3|STARTED|Overall Study||517
92928|NCT01138514|217268|P2|STARTED|Overall Study||516
92929|NCT01138514|217269|P1|STARTED|Overall Study||522
92930|NCT01138501|217283|P1|NOT COMPLETED|Overall Study||5
92931|NCT01138501|217283|P1|COMPLETED|Overall Study||60
92932|NCT01138501|217283|P1|Exposed|Overall Study||63
92933|NCT01138501|217283|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
92934|NCT01138150|217290|P2|NOT COMPLETED|Overall Study||1
92935|NCT01138150|217291|P1|NOT COMPLETED|Overall Study||1
92936|NCT01138150|217290|P2|COMPLETED|Overall Study||17
92937|NCT01138150|217291|P1|COMPLETED|Overall Study||17
92938|NCT01138150|217290|P2|STARTED|Overall Study||18
92939|NCT01138150|217291|P1|STARTED|Overall Study||18
92940|NCT01138124|217347|P4|NOT COMPLETED|Overall Study||0
92941|NCT01138124|217348|P3|NOT COMPLETED|Overall Study||0
92942|NCT01138124|217349|P2|NOT COMPLETED|Overall Study||0
92943|NCT01138124|217350|P1|NOT COMPLETED|Overall Study||0
92944|NCT01138124|217347|P4|COMPLETED|Overall Study||19046
92945|NCT01138124|217348|P3|COMPLETED|Overall Study||1981
92946|NCT01138124|217349|P2|COMPLETED|Overall Study||30026
92947|NCT01138124|217350|P1|COMPLETED|Overall Study||3149
92948|NCT01138124|217347|P4|STARTED|Overall Study||19046
92949|NCT01138124|217348|P3|STARTED|Overall Study||1981
92950|NCT01138124|217349|P2|STARTED|Overall Study||30026
92951|NCT01138124|217350|P1|STARTED|Overall Study||3149
92952|NCT01138111|217372|P1|NOT COMPLETED|Overall Study||9
92953|NCT01138111|217372|P1|COMPLETED|Overall Study||36
92954|NCT01138111|217372|P1|STARTED|Overall Study||45
92955|NCT01138098|217403|P2|NOT COMPLETED|Overall Study||0
92956|NCT01138098|217404|P1|NOT COMPLETED|Overall Study||0
92957|NCT01138098|217403|P2|COMPLETED|Overall Study||90
92958|NCT01138098|217404|P1|COMPLETED|Overall Study||95
92959|NCT01138098|217403|P2|STARTED|Overall Study||90
92960|NCT01138098|217404|P1|STARTED|Overall Study||95
92961|NCT01138046|217426|P1|NOT COMPLETED|Overall Study||6
92962|NCT01138046|217426|P1|COMPLETED|Overall Study||6
92963|NCT01138046|217426|P1|STARTED|Overall Study||12
92964|NCT01138007|217446|P3|NOT COMPLETED|Overall Study||48
92965|NCT01138007|217447|P2|NOT COMPLETED|Overall Study||30
92966|NCT01138007|217448|P1|NOT COMPLETED|Overall Study||22
92967|NCT01138007|217446|P3|COMPLETED|Overall Study||144
92968|NCT01138007|217447|P2|COMPLETED|Overall Study||160
92969|NCT01138007|217448|P1|COMPLETED|Overall Study||165
92970|NCT01138007|217446|P3|STARTED|Overall Study||192
92971|NCT01138007|217447|P2|STARTED|Overall Study||190
92972|NCT01138007|217448|P1|STARTED|Overall Study||187
92973|NCT01137812|217482|P2|NOT COMPLETED|Overall Study||168
92974|NCT01137812|217483|P1|NOT COMPLETED|Overall Study||123
92975|NCT01137812|217482|P2|COMPLETED|Overall Study||210
92976|NCT01137812|217483|P1|COMPLETED|Overall Study||254
92977|NCT01137812|217482|P2|STARTED|Overall Study||378
92978|NCT01137812|217483|P1|STARTED|Overall Study||377
92979|NCT01137786|217503|P2|NOT COMPLETED|Overall Study||3
92980|NCT01137786|217504|P1|NOT COMPLETED|Overall Study||1
92981|NCT01137786|217503|P2|COMPLETED|Overall Study||21
92982|NCT01137786|217504|P1|COMPLETED|Overall Study||24
92983|NCT01137786|217503|P2|STARTED|Overall Study||24
92984|NCT01137786|217504|P1|STARTED|Overall Study||25
92985|NCT01137682|217515|P3|NOT COMPLETED|Overall Study||3
92986|NCT01137682|217516|P2|NOT COMPLETED|Overall Study||8
92987|NCT01137682|217517|P1|NOT COMPLETED|Overall Study||6
92988|NCT01137682|217515|P3|COMPLETED|Overall Study||65
92989|NCT01137682|217516|P2|COMPLETED|Overall Study||57
92990|NCT01137682|217517|P1|COMPLETED|Overall Study||59
92991|NCT01137682|217515|P3|Safety Set|Overall Study|2 patients never received drug.|66
92992|NCT01137682|217516|P2|Safety Set|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
92993|NCT01137682|217517|P1|Safety Set|Overall Study|2 patients never received drug.|63
92994|NCT01137682|217515|P3|Continuing Into Extension|Overall Study||62
92995|NCT01137682|217516|P2|Continuing Into Extension|Overall Study||53
92996|NCT01137682|217517|P1|Continuing Into Extension|Overall Study||56
92997|NCT01137682|217515|P3|Not Continuing Into Extension|Overall Study||3
92998|NCT01137682|217516|P2|Not Continuing Into Extension|Overall Study||4
92999|NCT01137682|217517|P1|Not Continuing Into Extension|Overall Study||3
93000|NCT01137682|217515|P3|Completed 24-Week Core Phase|Overall Study||65
93001|NCT01137682|217516|P2|Completed 24-Week Core Phase|Overall Study||57
93002|NCT01137682|217517|P1|Completed 24-Week Core Phase|Overall Study||59
93003|NCT01137682|217515|P3|Treated|Overall Study||67
93004|NCT01137682|217516|P2|Treated|Overall Study||64
93005|NCT01137682|217517|P1|Treated|Overall Study||63
93006|NCT01137682|217515|P3|Not Treated|Overall Study||1
93007|NCT01137682|217516|P2|Not Treated|Overall Study||1
93008|NCT01137682|217517|P1|Not Treated|Overall Study||2
93009|NCT01137682|217515|P3|STARTED|Overall Study||68
93010|NCT01137682|217516|P2|STARTED|Overall Study||65
93011|NCT01137682|217517|P1|STARTED|Overall Study||65
93012|NCT01137604|217532|P4|NOT COMPLETED|Overall Study||11
93013|NCT01137604|217533|P3|NOT COMPLETED|Overall Study||13
93014|NCT01137604|217534|P2|NOT COMPLETED|Overall Study||10
93015|NCT01137604|217535|P1|NOT COMPLETED|Overall Study||2
93016|NCT01137604|217532|P4|COMPLETED|Overall Study||21
93017|NCT01137604|217533|P3|COMPLETED|Overall Study||26
93018|NCT01137604|217534|P2|COMPLETED|Overall Study||32
93019|NCT01137604|217535|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
93020|NCT01137604|217532|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
93021|NCT01137604|217533|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
93022|NCT01137604|217534|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
93023|NCT01137604|217535|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
93024|NCT01137604|217532|P4|Disease Progression|Overall Study||21
93025|NCT01137604|217533|P3|Disease Progression|Overall Study||25
93026|NCT01137604|217534|P2|Disease Progression|Overall Study||29
93027|NCT01137604|217535|P1|Disease Progression|Overall Study||34
93028|NCT01137604|217532|P4|STARTED|Overall Study||32
93029|NCT01137604|217533|P3|STARTED|Overall Study||39
93030|NCT01137604|217534|P2|STARTED|Overall Study||42
93031|NCT01137604|217535|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
93032|NCT01137578|217569|P3|NOT COMPLETED|Overall Study||6
93033|NCT01137578|217570|P2|NOT COMPLETED|Overall Study||2
93034|NCT01137578|217571|P1|NOT COMPLETED|Overall Study||16
93035|NCT01137578|217569|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
93036|NCT01137578|217570|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
93037|NCT01137578|217571|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
93038|NCT01137578|217569|P3|STARTED|Overall Study||43
93039|NCT01137578|217570|P2|STARTED|Overall Study||14
93040|NCT01137578|217571|P1|STARTED|Overall Study||77
93041|NCT01137474|217615|P4|NOT COMPLETED|Overall Study||21
93042|NCT01137474|217616|P3|NOT COMPLETED|Overall Study||7
93043|NCT01137474|217617|P2|NOT COMPLETED|Overall Study||12
93044|NCT01137474|217618|P1|NOT COMPLETED|Overall Study||24
93045|NCT01137474|217615|P4|COMPLETED|Overall Study||281
93046|NCT01137474|217616|P3|COMPLETED|Overall Study||158
93047|NCT01137474|217617|P2|COMPLETED|Overall Study||154
93048|NCT01137474|217618|P1|COMPLETED|Overall Study||287
93049|NCT01137474|217615|P4|Received Treatment|Overall Study||302
93050|NCT01137474|217616|P3|Received Treatment|Overall Study||165
93051|NCT01137474|217617|P2|Received Treatment|Overall Study||166
93052|NCT01137474|217618|P1|Received Treatment|Overall Study||311
93053|NCT01137474|217615|P4|STARTED|Overall Study||302
93054|NCT01137474|217616|P3|STARTED|Overall Study||165
93055|NCT01137474|217617|P2|STARTED|Overall Study||166
93056|NCT01137474|217618|P1|STARTED|Overall Study||311
93057|NCT01137435|217636|P1|NOT COMPLETED|Overall Study||28
93058|NCT01137435|217636|P1|COMPLETED|Overall Study||659
93059|NCT01137435|217636|P1|STARTED|Overall Study||687
93060|NCT01137396|217645|P2|NOT COMPLETED|Overall Study||2
93061|NCT01137396|217646|P1|NOT COMPLETED|Overall Study||8
93062|NCT01137396|217645|P2|COMPLETED|Overall Study||25
93063|NCT01137396|217646|P1|COMPLETED|Overall Study||22
93064|NCT01137396|217645|P2|STARTED|Overall Study||27
93065|NCT01137396|217646|P1|STARTED|Overall Study||30
93066|NCT01137370|217656|P2|NOT COMPLETED|Overall Study||0
93067|NCT01137370|217657|P1|NOT COMPLETED|Overall Study||0
93068|NCT01137370|217656|P2|COMPLETED|Overall Study||87
93069|NCT01137370|217657|P1|COMPLETED|Overall Study||116
93070|NCT01137370|217656|P2|STARTED|Overall Study||87
93071|NCT01137370|217657|P1|STARTED|Overall Study||116
93072|NCT01137292|217663|P1|NOT COMPLETED|Overall Study||54
93073|NCT01137292|217663|P1|COMPLETED|Overall Study||123
93074|NCT01137292|217663|P1|STARTED|Overall Study||177
93075|NCT01137071|217670|P1|NOT COMPLETED|Overall Study||14
93076|NCT01137071|217670|P1|COMPLETED|Overall Study|Of the eligible patients|15
93077|NCT01137071|217670|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
93078|NCT01137032|217731|P1|NOT COMPLETED|Overall Study||0
93079|NCT01137032|217731|P1|COMPLETED|Overall Study||19
93080|NCT01137032|217731|P1|STARTED|Overall Study||19
93081|NCT01136967|217739|P2|NOT COMPLETED|Overall Study||27
93082|NCT01136967|217740|P1|NOT COMPLETED|Overall Study||24
93083|NCT01136967|217739|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
93084|NCT01136967|217740|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
93085|NCT01136967|217739|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
93086|NCT01136967|217740|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
93087|NCT01136967|217739|P2|Disease Progression|Overall Study||56
93088|NCT01136967|217740|P1|Disease Progression|Overall Study||55
93089|NCT01136967|217739|P2|STARTED|Overall Study||89
93090|NCT01136967|217740|P1|STARTED|Overall Study||93
93091|NCT01136954|217758|P2|NOT COMPLETED|Overall Study||21
93092|NCT01136954|217759|P1|NOT COMPLETED|Overall Study||24
93093|NCT01136954|217758|P2|COMPLETED|Overall Study||51
93094|NCT01136954|217759|P1|COMPLETED|Overall Study||48
93095|NCT01136954|217758|P2|STARTED|Overall Study||72
93096|NCT01136954|217759|P1|STARTED|Overall Study||72
93097|NCT01136915|217773|P2|NOT COMPLETED|Overall Study||1
93098|NCT01136915|217774|P1|NOT COMPLETED|Overall Study||2
93099|NCT01136915|217773|P2|COMPLETED|Overall Study||6
93100|NCT01136915|217774|P1|COMPLETED|Overall Study||6
93101|NCT01136915|217773|P2|STARTED|Overall Study||7
93102|NCT01136915|217774|P1|STARTED|Overall Study||8
93103|NCT01136876|217784|P2|NOT COMPLETED|Overall Study||6
93104|NCT01136876|217785|P1|NOT COMPLETED|Overall Study||3
93105|NCT01136876|217784|P2|COMPLETED|Overall Study||23
93106|NCT01136876|217785|P1|COMPLETED|Overall Study||25
93107|NCT01136876|217784|P2|STARTED|Overall Study||29
93108|NCT01136876|217785|P1|STARTED|Overall Study||28
93109|NCT01136772|217795|P2|NOT COMPLETED|Overall Study||110
93110|NCT01136772|217796|P1|NOT COMPLETED|Overall Study||116
93111|NCT01136772|217795|P2|COMPLETED|Overall Study||44
93112|NCT01136772|217796|P1|COMPLETED|Overall Study||41
93113|NCT01136772|217795|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
93114|NCT01136772|217796|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
93115|NCT01136772|217795|P2|STARTED|Overall Study||154
93116|NCT01136772|217796|P1|STARTED|Overall Study||157
93117|NCT01136746|217806|P2|NOT COMPLETED|Overall Study||3
93118|NCT01136746|217807|P1|NOT COMPLETED|Overall Study||3
93119|NCT01136746|217806|P2|COMPLETED|Overall Study||4
93120|NCT01136746|217807|P1|COMPLETED|Overall Study||6
93121|NCT01136746|217806|P2|STARTED|Overall Study||7
93122|NCT01136746|217807|P1|STARTED|Overall Study||9
93123|NCT01136655|217867|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
93124|NCT01136655|217867|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
93125|NCT01136655|217867|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
93126|NCT01136655|217867|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
93127|NCT01136655|217867|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
93128|NCT01136655|217867|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
93129|NCT01136655|217867|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
93130|NCT01136655|217867|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
93131|NCT01136655|217867|P1|STARTED|Washout After BUD 160 (7 Days)||51
93132|NCT01136655|217867|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
93133|NCT01136655|217867|P1|COMPLETED|BUD 160 (1 Dose)||51
93134|NCT01136655|217867|P1|STARTED|BUD 160 (1 Dose)||51
93135|NCT01136655|217867|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
93136|NCT01136655|217867|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
93137|NCT01136655|217867|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
93138|NCT01136655|217867|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
93139|NCT01136655|217867|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
93140|NCT01136655|217867|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
93141|NCT01136655|217867|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
93142|NCT01136655|217867|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
93143|NCT01136655|217867|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
93144|NCT01136655|217867|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
93145|NCT01136655|217867|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
93146|NCT01136655|217867|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
93147|NCT01136655|217867|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
93148|NCT01136655|217867|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
93149|NCT01136655|217867|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
93150|NCT01136655|217867|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
93151|NCT01136655|217867|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
93152|NCT01136655|217867|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
93153|NCT01136486|217893|P1|NOT COMPLETED|Overall Study||0
93154|NCT01136486|217893|P1|COMPLETED|Overall Study||56
93155|NCT01136486|217893|P1|STARTED|Overall Study||56
93156|NCT01136408|217900|P3|NOT COMPLETED|Overall Study||5
93157|NCT01136408|217901|P2|NOT COMPLETED|Overall Study||9
93158|NCT01136408|217902|P1|NOT COMPLETED|Overall Study||5
93159|NCT01136408|217900|P3|COMPLETED|Overall Study||57
93160|NCT01136408|217901|P2|COMPLETED|Overall Study||49
93161|NCT01136408|217902|P1|COMPLETED|Overall Study||41
93162|NCT01136408|217900|P3|STARTED|Overall Study||62
93163|NCT01136408|217901|P2|STARTED|Overall Study||58
93164|NCT01136408|217902|P1|STARTED|Overall Study||46
93165|NCT01136382|217959|P2|NOT COMPLETED|Overall Study||31
93166|NCT01136382|217960|P1|NOT COMPLETED|Overall Study||60
93167|NCT01136382|217959|P2|COMPLETED|Overall Study||121
93168|NCT01136382|217960|P1|COMPLETED|Overall Study||92
93169|NCT01136382|217959|P2|STARTED|Overall Study||152
93170|NCT01136382|217960|P1|STARTED|Overall Study||152
93171|NCT01136291|217988|P2|NOT COMPLETED|Overall Study||1
93172|NCT01136291|217989|P1|NOT COMPLETED|Overall Study||1
93173|NCT01136291|217988|P2|COMPLETED|Overall Study||41
93174|NCT01136291|217989|P1|COMPLETED|Overall Study||39
93175|NCT01136291|217988|P2|Follow|Overall Study||42
93176|NCT01136291|217989|P1|Follow|Overall Study||40
93177|NCT01136291|217988|P2|STARTED|Overall Study||42
93178|NCT01136291|217989|P1|STARTED|Overall Study||40
93179|NCT01136226|217999|P1|NOT COMPLETED|Overall Study||13
93180|NCT01136226|217999|P1|COMPLETED|Overall Study||29
93181|NCT01136226|217999|P1|STARTED|Overall Study||42
93182|NCT01136174|218007|P4|NOT COMPLETED|Overall Study||4
93183|NCT01136174|218008|P3|NOT COMPLETED|Overall Study||0
93184|NCT01136174|218009|P2|NOT COMPLETED|Overall Study||0
93185|NCT01136174|218010|P1|NOT COMPLETED|Overall Study||0
93186|NCT01136174|218007|P4|COMPLETED|Overall Study||20
93187|NCT01136174|218008|P3|COMPLETED|Overall Study||8
93188|NCT01136174|218009|P2|COMPLETED|Overall Study||6
93189|NCT01136174|218010|P1|COMPLETED|Overall Study||12
93190|NCT01136174|218007|P4|STARTED|Overall Study||24
93191|NCT01136174|218008|P3|STARTED|Overall Study||8
93192|NCT01136174|218009|P2|STARTED|Overall Study||6
93193|NCT01136174|218010|P1|STARTED|Overall Study||12
93194|NCT01135992|218090|P1|NOT COMPLETED|Overall Study||21
93195|NCT01135992|218090|P1|COMPLETED|Overall Study||122
93196|NCT01135992|218090|P1|Full Analysis Set|Overall Study||129
93197|NCT01135992|218090|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
93198|NCT01135992|218090|P1|STARTED|Overall Study||143
93199|NCT01135914|218102|P3|NOT COMPLETED|Overall Study||22
93200|NCT01135914|218103|P2|NOT COMPLETED|Overall Study||5
93201|NCT01135914|218104|P1|NOT COMPLETED|Overall Study||4
93202|NCT01135914|218102|P3|COMPLETED|Overall Study||59
93203|NCT01135914|218103|P2|COMPLETED|Overall Study||75
93204|NCT01135914|218104|P1|COMPLETED|Overall Study||74
93205|NCT01135914|218102|P3|Safety Population|Overall Study||74
93206|NCT01135914|218103|P2|Safety Population|Overall Study||75
93207|NCT01135914|218104|P1|Safety Population|Overall Study||73
93208|NCT01135914|218102|P3|Intent to Treat (ITT) Population|Overall Study||72
93209|NCT01135914|218103|P2|Intent to Treat (ITT) Population|Overall Study||75
93210|NCT01135914|218104|P1|Intent to Treat (ITT) Population|Overall Study||73
93211|NCT01135914|218102|P3|STARTED|Overall Study||81
93212|NCT01135914|218103|P2|STARTED|Overall Study||80
93213|NCT01135914|218104|P1|STARTED|Overall Study||78
93214|NCT01135524|218133|P1|NOT COMPLETED|Overall Study||196
93215|NCT01135524|218133|P1|COMPLETED|Overall Study||0
93216|NCT01135524|218133|P1|STARTED|Overall Study||196
93217|NCT01135511|218146|P9|NOT COMPLETED|Overall Study||1
93218|NCT01135511|218147|P8|NOT COMPLETED|Overall Study||1
93219|NCT01135511|218148|P7|NOT COMPLETED|Overall Study||1
93220|NCT01135511|218149|P6|NOT COMPLETED|Overall Study||1
93221|NCT01135511|218150|P5|NOT COMPLETED|Overall Study||1
93222|NCT01135511|218151|P4|NOT COMPLETED|Overall Study||3
93223|NCT01135511|218152|P3|NOT COMPLETED|Overall Study||8
93224|NCT01135511|218153|P2|NOT COMPLETED|Overall Study||3
93225|NCT01135511|218154|P1|NOT COMPLETED|Overall Study||0
93226|NCT01135511|218146|P9|COMPLETED|Overall Study||20
93227|NCT01135511|218147|P8|COMPLETED|Overall Study||20
93228|NCT01135511|218148|P7|COMPLETED|Overall Study||18
93229|NCT01135511|218149|P6|COMPLETED|Overall Study||20
93230|NCT01135511|218150|P5|COMPLETED|Overall Study||38
93231|NCT01135511|218151|P4|COMPLETED|Overall Study||37
93232|NCT01135511|218152|P3|COMPLETED|Overall Study||33
93233|NCT01135511|218153|P2|COMPLETED|Overall Study||39
93234|NCT01135511|218154|P1|COMPLETED|Overall Study||41
93235|NCT01135511|218146|P9|STARTED|Overall Study||21
93236|NCT01135511|218147|P8|STARTED|Overall Study||21
93237|NCT01135511|218148|P7|STARTED|Overall Study||19
93238|NCT01135511|218149|P6|STARTED|Overall Study||21
93239|NCT01135511|218150|P5|STARTED|Overall Study||39
93240|NCT01135511|218151|P4|STARTED|Overall Study||40
93241|NCT01135511|218152|P3|STARTED|Overall Study||41
93242|NCT01135511|218153|P2|STARTED|Overall Study||42
93243|NCT01135511|218154|P1|STARTED|Overall Study||41
93244|NCT01135498|218436|P1|NOT COMPLETED|Overall Study||90
93245|NCT01135498|218436|P1|COMPLETED|Overall Study||0
93246|NCT01135498|218436|P1|STARTED|Overall Study||90
93247|NCT01135420|218447|P2|NOT COMPLETED|Overall Study||32
93248|NCT01135420|218448|P1|NOT COMPLETED|Overall Study||44
93249|NCT01135420|218447|P2|COMPLETED|Overall Study||175
93250|NCT01135420|218448|P1|COMPLETED|Overall Study||155
93251|NCT01135420|218447|P2|STARTED|Overall Study||207
93252|NCT01135420|218448|P1|STARTED|Overall Study||199
93253|NCT01135381|218458|P4|NOT COMPLETED|Overall Study||1
93254|NCT01135381|218459|P3|NOT COMPLETED|Overall Study||4
93255|NCT01135381|218460|P2|NOT COMPLETED|Overall Study||7
93256|NCT01135381|218461|P1|NOT COMPLETED|Overall Study||21
93257|NCT01135381|218458|P4|COMPLETED|Overall Study||67
93258|NCT01135381|218459|P3|COMPLETED|Overall Study||65
93259|NCT01135381|218460|P2|COMPLETED|Overall Study||178
93260|NCT01135381|218461|P1|COMPLETED|Overall Study||168
93261|NCT01135381|218458|P4|STARTED|Overall Study||68
93262|NCT01135381|218459|P3|STARTED|Overall Study||69
93263|NCT01135381|218460|P2|STARTED|Overall Study||185
93264|NCT01135381|218461|P1|STARTED|Overall Study||189
93265|NCT01135368|218479|P1|NOT COMPLETED|Overall Study||251
93266|NCT01135368|218479|P1|COMPLETED|Overall Study||255
93267|NCT01135368|218479|P1|STARTED|Overall Study||506
93268|NCT01135134|218597|P2|NOT COMPLETED|Overall Study||1
93269|NCT01135134|218598|P1|NOT COMPLETED|Overall Study||2
93270|NCT01135134|218597|P2|COMPLETED|Overall Study||112
93271|NCT01135134|218598|P1|COMPLETED|Overall Study||218
93272|NCT01135134|218597|P2|STARTED|Overall Study||113
93273|NCT01135134|218598|P1|STARTED|Overall Study||220
93274|NCT01135069|218609|P3|NOT COMPLETED|Overall Study||10
93275|NCT01135069|218610|P2|NOT COMPLETED|Overall Study||32
93276|NCT01135069|218611|P1|NOT COMPLETED|Overall Study||36
93277|NCT01135069|218609|P3|COMPLETED|Overall Study||56
93278|NCT01135069|218610|P2|COMPLETED|Overall Study||177
93279|NCT01135069|218611|P1|COMPLETED|Overall Study||169
93280|NCT01135069|218609|P3|STARTED|Overall Study||66
93281|NCT01135069|218610|P2|STARTED|Overall Study||209
93282|NCT01135069|218611|P1|STARTED|Overall Study||205
93283|NCT01135017|218621|P2|NOT COMPLETED|Overall Study||12
93284|NCT01135017|218622|P1|NOT COMPLETED|Overall Study||6
93285|NCT01135017|218621|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
93286|NCT01135017|218622|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
93287|NCT01135017|218621|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
93288|NCT01135017|218622|P1|Evaluable for Efficacy|Overall Study||55
93289|NCT01135017|218621|P2|Treated|Overall Study||57
93290|NCT01135017|218622|P1|Treated|Overall Study||55
93291|NCT01135017|218621|P2|STARTED|Overall Study||57
93292|NCT01135017|218622|P1|STARTED|Overall Study||55
93293|NCT01134952|218638|P1|NOT COMPLETED|Overall Study||0
93294|NCT01134952|218638|P1|COMPLETED|Overall Study||11
93295|NCT01134952|218638|P1|STARTED|Overall Study||11
93296|NCT01134939|218660|P8|NOT COMPLETED|Overall Study||0
93297|NCT01134939|218661|P7|NOT COMPLETED|Overall Study||9
93298|NCT01134939|218662|P6|NOT COMPLETED|Overall Study||9
93299|NCT01134939|218663|P5|NOT COMPLETED|Overall Study||10
93300|NCT01134939|218664|P4|NOT COMPLETED|Overall Study||14
93301|NCT01134939|218665|P3|NOT COMPLETED|Overall Study||10
93302|NCT01134939|218666|P2|NOT COMPLETED|Overall Study||18
93303|NCT01134939|218667|P1|NOT COMPLETED|Overall Study||17
93304|NCT01134939|218660|P8|COMPLETED|Overall Study||1
93305|NCT01134939|218661|P7|COMPLETED|Overall Study||10
93306|NCT01134939|218662|P6|COMPLETED|Overall Study||5
93307|NCT01134939|218663|P5|COMPLETED|Overall Study||23
93308|NCT01134939|218664|P4|COMPLETED|Overall Study||32
93309|NCT01134939|218665|P3|COMPLETED|Overall Study||41
93310|NCT01134939|218666|P2|COMPLETED|Overall Study||24
93311|NCT01134939|218667|P1|COMPLETED|Overall Study||42
93312|NCT01134939|218660|P8|STARTED|Overall Study||1
93313|NCT01134939|218661|P7|STARTED|Overall Study||19
93314|NCT01134939|218662|P6|STARTED|Overall Study||14
93315|NCT01134939|218663|P5|STARTED|Overall Study||33
93316|NCT01134939|218664|P4|STARTED|Overall Study||46
93317|NCT01134939|218665|P3|STARTED|Overall Study||51
93318|NCT01134939|218666|P2|STARTED|Overall Study||42
93319|NCT01134939|218667|P1|STARTED|Overall Study||59
93320|NCT01134900|218779|P2|NOT COMPLETED|Overall Study||0
93321|NCT01134900|218780|P1|NOT COMPLETED|Overall Study||0
93322|NCT01134900|218779|P2|COMPLETED|Overall Study||196
93323|NCT01134900|218780|P1|COMPLETED|Overall Study||200
93324|NCT01134900|218779|P2|STARTED|Overall Study||196
93325|NCT01134900|218780|P1|STARTED|Overall Study||200
93326|NCT01134887|218792|P4|NOT COMPLETED|Overall Study||0
93327|NCT01134887|218793|P3|NOT COMPLETED|Overall Study||0
93328|NCT01134887|218794|P2|NOT COMPLETED|Overall Study||4
93329|NCT01134887|218795|P1|NOT COMPLETED|Overall Study||0
93330|NCT01134887|218792|P4|COMPLETED|Overall Study||5
93331|NCT01134887|218793|P3|COMPLETED|Overall Study||5
93332|NCT01134887|218794|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
93333|NCT01134887|218795|P1|COMPLETED|Overall Study||9
93334|NCT01134887|218792|P4|STARTED|Overall Study||5
93335|NCT01134887|218793|P3|STARTED|Overall Study||5
93336|NCT01134887|218794|P2|STARTED|Overall Study||11
93337|NCT01134887|218795|P1|STARTED|Overall Study||9
93338|NCT01134783|218805|P2|NOT COMPLETED|Overall Study||37
93339|NCT01134783|218806|P1|NOT COMPLETED|Overall Study||36
93340|NCT01134783|218805|P2|COMPLETED|Overall Study||180
93341|NCT01134783|218806|P1|COMPLETED|Overall Study||188
93342|NCT01134783|218805|P2|STARTED|Overall Study||217
93343|NCT01134783|218806|P1|STARTED|Overall Study||224
93344|NCT01134731|218825|P3|NOT COMPLETED|Overall Study||8
93345|NCT01134731|218826|P2|NOT COMPLETED|Overall Study||11
93346|NCT01134731|218827|P1|NOT COMPLETED|Overall Study||13
93347|NCT01134731|218825|P3|COMPLETED|Overall Study||2
93348|NCT01134731|218826|P2|COMPLETED|Overall Study||10
93349|NCT01134731|218827|P1|COMPLETED|Overall Study||10
93350|NCT01134731|218825|P3|STARTED|Overall Study||10
93351|NCT01134731|218826|P2|STARTED|Overall Study||21
93352|NCT01134731|218827|P1|STARTED|Overall Study||23
93353|NCT01134705|218840|P2|NOT COMPLETED|Overall Study||22
93354|NCT01134705|218841|P1|NOT COMPLETED|Overall Study||15
93355|NCT01134705|218840|P2|COMPLETED|Overall Study||216
93356|NCT01134705|218841|P1|COMPLETED|Overall Study||221
93357|NCT01134705|218840|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
93358|NCT01134705|218841|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
93359|NCT01134705|218840|P2|STARTED|Overall Study||238
93360|NCT01134705|218841|P1|STARTED|Overall Study||236
93361|NCT01134627|218853|P2|NOT COMPLETED|Overall Study||67
93362|NCT01134627|218854|P1|NOT COMPLETED|Overall Study||69
93363|NCT01134627|218853|P2|COMPLETED|Overall Study||88
93364|NCT01134627|218854|P1|COMPLETED|Overall Study||80
93365|NCT01134627|218853|P2|STARTED|Overall Study|Number of participants treated.|155
93366|NCT01134627|218854|P1|STARTED|Overall Study|Number of participants treated.|149
93367|NCT01134614|218884|P2|NOT COMPLETED|Overall Study||122
93368|NCT01134614|218885|P1|NOT COMPLETED|Overall Study||123
93369|NCT01134614|218884|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
93370|NCT01134614|218885|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
93371|NCT01134614|218884|P2|Treated and Toxicity Assessed|Overall Study||120
93372|NCT01134614|218885|P1|Treated and Toxicity Assessed|Overall Study||118
93373|NCT01134614|218884|P2|Treated|Overall Study||121
93374|NCT01134614|218885|P1|Treated|Overall Study||119
93375|NCT01134614|218884|P2|STARTED|Overall Study||122
93376|NCT01134614|218885|P1|STARTED|Overall Study||123
93377|NCT01134510|218897|P2|NOT COMPLETED|Overall Study||1
93378|NCT01134510|218898|P1|NOT COMPLETED|Overall Study||0
93379|NCT01134510|218897|P2|COMPLETED|Overall Study||9
93380|NCT01134510|218898|P1|COMPLETED|Overall Study||10
93381|NCT01134510|218897|P2|Month 3|Overall Study||9
93382|NCT01134510|218898|P1|Month 3|Overall Study||10
93383|NCT01134510|218897|P2|Month 1|Overall Study||10
93384|NCT01134510|218898|P1|Month 1|Overall Study||10
93385|NCT01134510|218897|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
93386|NCT01134510|218898|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
93387|NCT01134510|218897|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
93388|NCT01134510|218898|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
93389|NCT01134510|218897|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
93390|NCT01134510|218898|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
93391|NCT01134510|218897|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
93392|NCT01134510|218898|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
93393|NCT01134510|218897|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
93394|NCT01134510|218898|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
93395|NCT01134510|218897|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
93396|NCT01134510|218898|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
93397|NCT01134510|218897|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
93398|NCT01134510|218898|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
93399|NCT01134510|218897|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
93400|NCT01134510|218898|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
93401|NCT01134393|218910|P1|NOT COMPLETED|Overall Study||52
93402|NCT01134393|218910|P1|COMPLETED|Overall Study|Completed trial medication.|449
93403|NCT01134393|218910|P1|STARTED|Overall Study|Entered and treated.|501
93404|NCT01134315|218926|P2|NOT COMPLETED|Overall Study||19
93405|NCT01134315|218927|P1|NOT COMPLETED|Overall Study||9
93406|NCT01134315|218926|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
93407|NCT01134315|218927|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
93408|NCT01134315|218926|P2|STARTED|Overall Study||40
93409|NCT01134315|218927|P1|STARTED|Overall Study||21
93410|NCT01134276|218949|P2|NOT COMPLETED|Overall Study||0
93411|NCT01134276|218950|P1|NOT COMPLETED|Overall Study||0
93412|NCT01134276|218949|P2|COMPLETED|Overall Study||107
93413|NCT01134276|218950|P1|COMPLETED|Overall Study||104
93414|NCT01134276|218949|P2|STARTED|Overall Study||107
93415|NCT01134276|218950|P1|STARTED|Overall Study||104
93416|NCT01134107|218962|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
93417|NCT01134107|218963|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
93418|NCT01134107|218962|P2|COMPLETED|Period 2-Second Treatment Intervention||61
93419|NCT01134107|218963|P1|COMPLETED|Period 2-Second Treatment Intervention||57
93420|NCT01134107|218962|P2|STARTED|Period 2-Second Treatment Intervention||61
93421|NCT01134107|218963|P1|STARTED|Period 2-Second Treatment Intervention||61
93422|NCT01134107|218962|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
93423|NCT01134107|218963|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
93424|NCT01134107|218962|P2|COMPLETED|Period 1-First Treatment Intervention||61
93425|NCT01134107|218963|P1|COMPLETED|Period 1-First Treatment Intervention||61
93426|NCT01134107|218962|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
93427|NCT01134107|218963|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
93428|NCT01134107|218962|P2|STARTED|Period 1-First Treatment Intervention||66
93429|NCT01134107|218963|P1|STARTED|Period 1-First Treatment Intervention||67
93430|NCT01134042|218998|P3|NOT COMPLETED|Overall Study||34
93431|NCT01134042|218999|P2|NOT COMPLETED|Overall Study||28
93432|NCT01134042|219000|P1|NOT COMPLETED|Overall Study||48
93433|NCT01134042|218998|P3|COMPLETED|Overall Study||161
93434|NCT01134042|218999|P2|COMPLETED|Overall Study||169
93435|NCT01134042|219000|P1|COMPLETED|Overall Study||146
93436|NCT01134042|218998|P3|STARTED|Overall Study||195
93437|NCT01134042|218999|P2|STARTED|Overall Study||197
93438|NCT01134042|219000|P1|STARTED|Overall Study||194
93439|NCT01134016|219038|P1|NOT COMPLETED|Overall Study||3
93440|NCT01134016|219038|P1|COMPLETED|Overall Study||10
93441|NCT01134016|219038|P1|STARTED|Overall Study||13
93442|NCT01132846|219074|P3|NOT COMPLETED|Overall Study||11
93443|NCT01132846|219075|P2|NOT COMPLETED|Overall Study||18
93444|NCT01132846|219076|P1|NOT COMPLETED|Overall Study||16
93445|NCT01132846|219074|P3|COMPLETED|Overall Study||108
93446|NCT01132846|219075|P2|COMPLETED|Overall Study||101
93447|NCT01132846|219076|P1|COMPLETED|Overall Study||106
93448|NCT01132846|219074|P3|STARTED|Overall Study||119
93449|NCT01132846|219075|P2|STARTED|Overall Study||119
93450|NCT01132846|219076|P1|STARTED|Overall Study||122
93451|NCT01133977|219131|P5|NOT COMPLETED|Overall Study||38
93452|NCT01133977|219132|P4|NOT COMPLETED|Overall Study||39
93453|NCT01133977|219133|P3|NOT COMPLETED|Overall Study||6
93454|NCT01133977|219134|P2|NOT COMPLETED|Overall Study||7
93455|NCT01133977|219135|P1|NOT COMPLETED|Overall Study||3
93456|NCT01133977|219131|P5|COMPLETED|Overall Study||1
93457|NCT01133977|219132|P4|COMPLETED|Overall Study||3
93458|NCT01133977|219133|P3|COMPLETED|Overall Study||0
93459|NCT01133977|219134|P2|COMPLETED|Overall Study||0
93460|NCT01133977|219135|P1|COMPLETED|Overall Study||0
93461|NCT01133977|219131|P5|STARTED|Overall Study|Treated|39
93462|NCT01133977|219132|P4|STARTED|Overall Study|Treated|42
93463|NCT01133977|219133|P3|STARTED|Overall Study|Treated|6
93464|NCT01133977|219134|P2|STARTED|Overall Study|Treated|7
93465|NCT01133977|219135|P1|STARTED|Overall Study|Treated|3
93466|NCT01133860|219152|P1|NOT COMPLETED|Overall Study||0
93467|NCT01133860|219152|P1|COMPLETED|Overall Study||12
93468|NCT01133860|219152|P1|STARTED|Overall Study||12
93469|NCT01133756|219162|P3|NOT COMPLETED|Overall Study||2
93470|NCT01133756|219163|P2|NOT COMPLETED|Overall Study||3
93471|NCT01133756|219164|P1|NOT COMPLETED|Overall Study||2
93472|NCT01133756|219162|P3|COMPLETED|Overall Study||0
93473|NCT01133756|219163|P2|COMPLETED|Overall Study||0
93474|NCT01133756|219164|P1|COMPLETED|Overall Study||0
93475|NCT01133756|219162|P3|Completed 6 Cycles|Overall Study||0
93476|NCT01133756|219163|P2|Completed 6 Cycles|Overall Study||0
93477|NCT01133756|219164|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
93478|NCT01133756|219162|P3|STARTED|Overall Study||2
93479|NCT01133756|219163|P2|STARTED|Overall Study||3
93480|NCT01133756|219164|P1|STARTED|Overall Study||2
93481|NCT01133704|219180|P2|NOT COMPLETED|Overall Study||26
93482|NCT01133704|219181|P1|NOT COMPLETED|Overall Study||49
93483|NCT01133704|219180|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
93484|NCT01133704|219181|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
93485|NCT01133704|219180|P2|STARTED|Overall Study||33
93486|NCT01133704|219181|P1|STARTED|Overall Study||65
93487|NCT01133665|219189|P1|NOT COMPLETED|Overall Study||2
93488|NCT01133665|219189|P1|COMPLETED|Overall Study||40
93489|NCT01133665|219189|P1|STARTED|Overall Study||42
93490|NCT01133626|219233|P3|NOT COMPLETED|Overall Study||2
93491|NCT01133626|219234|P2|NOT COMPLETED|Overall Study||5
93492|NCT01133626|219235|P1|NOT COMPLETED|Overall Study||1
93493|NCT01133626|219233|P3|COMPLETED|Overall Study||9
93494|NCT01133626|219234|P2|COMPLETED|Overall Study||41
93495|NCT01133626|219235|P1|COMPLETED|Overall Study||49
93496|NCT01133626|219233|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
93497|NCT01133626|219234|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
93498|NCT01133626|219235|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
93499|NCT01133626|219233|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
93500|NCT01133626|219234|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
93501|NCT01133626|219235|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
93502|NCT01133626|219233|P3|STARTED|Overall Study||11
93503|NCT01133626|219234|P2|STARTED|Overall Study||46
93504|NCT01133626|219235|P1|STARTED|Overall Study||50
93505|NCT01133522|219253|P10|NOT COMPLETED|Overall Study||0
93506|NCT01133522|219254|P9|NOT COMPLETED|Overall Study||0
93507|NCT01133522|219255|P8|NOT COMPLETED|Overall Study||0
93508|NCT01133522|219256|P7|NOT COMPLETED|Overall Study||0
93509|NCT01133522|219257|P6|NOT COMPLETED|Overall Study||0
93510|NCT01133522|219258|P5|NOT COMPLETED|Overall Study||1
93511|NCT01133522|219259|P4|NOT COMPLETED|Overall Study||1
93512|NCT01133522|219260|P3|NOT COMPLETED|Overall Study||0
93513|NCT01133522|219261|P2|NOT COMPLETED|Overall Study||1
93514|NCT01133522|219262|P1|NOT COMPLETED|Overall Study||0
93515|NCT01133522|219253|P10|COMPLETED|Overall Study||4
93516|NCT01133522|219254|P9|COMPLETED|Overall Study||2
93517|NCT01133522|219255|P8|COMPLETED|Overall Study||9
93518|NCT01133522|219256|P7|COMPLETED|Overall Study||2
93519|NCT01133522|219257|P6|COMPLETED|Overall Study||6
93520|NCT01133522|219258|P5|COMPLETED|Overall Study||6
93521|NCT01133522|219259|P4|COMPLETED|Overall Study||6
93522|NCT01133522|219260|P3|COMPLETED|Overall Study||6
93523|NCT01133522|219261|P2|COMPLETED|Overall Study||6
93524|NCT01133522|219262|P1|COMPLETED|Overall Study||10
93525|NCT01133522|219253|P10|Received Treatment|Overall Study||4
93526|NCT01133522|219254|P9|Received Treatment|Overall Study||2
93527|NCT01133522|219255|P8|Received Treatment|Overall Study||9
93528|NCT01133522|219256|P7|Received Treatment|Overall Study||2
93529|NCT01133522|219257|P6|Received Treatment|Overall Study||6
93530|NCT01133522|219258|P5|Received Treatment|Overall Study||6
93531|NCT01133522|219259|P4|Received Treatment|Overall Study||6
93532|NCT01133522|219260|P3|Received Treatment|Overall Study||6
93533|NCT01133522|219261|P2|Received Treatment|Overall Study||6
93534|NCT01133522|219262|P1|Received Treatment|Overall Study||10
93535|NCT01133522|219253|P10|STARTED|Overall Study||4
93536|NCT01133522|219254|P9|STARTED|Overall Study||2
93537|NCT01133522|219255|P8|STARTED|Overall Study||9
93538|NCT01133522|219256|P7|STARTED|Overall Study||2
93539|NCT01133522|219257|P6|STARTED|Overall Study||6
93540|NCT01133522|219258|P5|STARTED|Overall Study||7
93541|NCT01133522|219259|P4|STARTED|Overall Study||7
93542|NCT01133522|219260|P3|STARTED|Overall Study||6
93543|NCT01133522|219261|P2|STARTED|Overall Study||7
93544|NCT01133522|219262|P1|STARTED|Overall Study||10
93545|NCT01133392|219330|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
93546|NCT01133392|219331|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
93547|NCT01133392|219330|P2|COMPLETED|Fourth Intervention (1 Day)||16
93548|NCT01133392|219331|P1|COMPLETED|Fourth Intervention (1 Day)||20
93549|NCT01133392|219330|P2|STARTED|Fourth Intervention (1 Day)||16
93550|NCT01133392|219331|P1|STARTED|Fourth Intervention (1 Day)||20
93551|NCT01133392|219330|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
93552|NCT01133392|219331|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
93553|NCT01133392|219330|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
93554|NCT01133392|219331|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
93555|NCT01133392|219330|P2|STARTED|Interval Between Dosing (4-7 Days)||17
93556|NCT01133392|219331|P1|STARTED|Interval Between Dosing (4-7 Days)||20
93557|NCT01133392|219330|P2|NOT COMPLETED|Third Intervention (1 Day)||0
93558|NCT01133392|219331|P1|NOT COMPLETED|Third Intervention (1 Day)||0
93559|NCT01133392|219330|P2|COMPLETED|Third Intervention (1 Day)||17
93560|NCT01133392|219331|P1|COMPLETED|Third Intervention (1 Day)||20
93561|NCT01133392|219330|P2|STARTED|Third Intervention (1 Day)||17
93562|NCT01133392|219331|P1|STARTED|Third Intervention (1 Day)||20
93563|NCT01133392|219330|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
93564|NCT01133392|219331|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
93565|NCT01133392|219330|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
93566|NCT01133392|219331|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
93567|NCT01133392|219330|P2|STARTED|Interval Between Dosing (4-7 Days)||17
93568|NCT01133392|219331|P1|STARTED|Interval Between Dosing (4-7 Days)||20
93569|NCT01133392|219330|P2|NOT COMPLETED|Second Intervention (1 Day)||0
93570|NCT01133392|219331|P1|NOT COMPLETED|Second Intervention (1 Day)||0
93571|NCT01133392|219330|P2|COMPLETED|Second Intervention (1 Day)||17
93572|NCT01133392|219331|P1|COMPLETED|Second Intervention (1 Day)||20
93573|NCT01133392|219330|P2|STARTED|Second Intervention (1 Day)||17
93574|NCT01133392|219331|P1|STARTED|Second Intervention (1 Day)||20
93575|NCT01133392|219330|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
93576|NCT01133392|219331|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
93577|NCT01133392|219330|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
93578|NCT01133392|219331|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
93579|NCT01133392|219330|P2|STARTED|Interval Between Dosing (4-7 Days)||18
93580|NCT01133392|219331|P1|STARTED|Interval Between Dosing (4-7 Days)||20
93581|NCT01133392|219330|P2|NOT COMPLETED|First Intervention (1 Day )||0
93582|NCT01133392|219331|P1|NOT COMPLETED|First Intervention (1 Day )||0
93583|NCT01133392|219330|P2|COMPLETED|First Intervention (1 Day )||18
93584|NCT01133392|219331|P1|COMPLETED|First Intervention (1 Day )||20
93585|NCT01133392|219330|P2|STARTED|First Intervention (1 Day )||18
93586|NCT01133392|219331|P1|STARTED|First Intervention (1 Day )||20
93587|NCT01133379|219348|P3|NOT COMPLETED|Overall Study||2
93588|NCT01133379|219349|P2|NOT COMPLETED|Overall Study||2
93589|NCT01133379|219350|P1|NOT COMPLETED|Overall Study||1
93590|NCT01133379|219348|P3|COMPLETED|Overall Study||56
93591|NCT01133379|219349|P2|COMPLETED|Overall Study||56
93592|NCT01133379|219350|P1|COMPLETED|Overall Study||57
93593|NCT01133379|219348|P3|STARTED|Overall Study||58
93594|NCT01133379|219349|P2|STARTED|Overall Study||58
93595|NCT01133379|219350|P1|STARTED|Overall Study||58
93596|NCT01133288|219403|P1|NOT COMPLETED|Intervention Allocation||2
93597|NCT01133288|219403|P1|COMPLETED|Intervention Allocation||0
93598|NCT01133288|219403|P1|STARTED|Intervention Allocation||2
93599|NCT01133288|219403|P1|NOT COMPLETED|Eligibility Assessment||5
93600|NCT01133288|219403|P1|COMPLETED|Eligibility Assessment||2
93601|NCT01133288|219403|P1|STARTED|Eligibility Assessment||7
93602|NCT01133275|219408|P1|NOT COMPLETED|Overall Study||2
93603|NCT01133275|219408|P1|COMPLETED|Overall Study||26
93604|NCT01133275|219408|P1|STARTED|Overall Study||28
93605|NCT01133171|219416|P3|NOT COMPLETED|Overall Study||0
93606|NCT01133171|219417|P2|NOT COMPLETED|Overall Study||2
93607|NCT01133171|219418|P1|NOT COMPLETED|Overall Study||1
93608|NCT01133171|219416|P3|COMPLETED|Overall Study||25
93609|NCT01133171|219417|P2|COMPLETED|Overall Study||25
93610|NCT01133171|219418|P1|COMPLETED|Overall Study||24
93611|NCT01133171|219416|P3|STARTED|Overall Study||25
93612|NCT01133171|219417|P2|STARTED|Overall Study||27
93613|NCT01133171|219418|P1|STARTED|Overall Study||25
93614|NCT01132690|219430|P2|NOT COMPLETED|Overall Study||0
93615|NCT01132690|219431|P1|NOT COMPLETED|Overall Study||0
93616|NCT01132690|219430|P2|COMPLETED|Overall Study||5
93617|NCT01132690|219431|P1|COMPLETED|Overall Study||6
93618|NCT01132690|219430|P2|STARTED|Overall Study||5
93619|NCT01132690|219431|P1|STARTED|Overall Study||6
93620|NCT01132664|219452|P5|NOT COMPLETED|BM Cohort||6
93621|NCT01132664|219453|P4|NOT COMPLETED|BM Cohort||3
93622|NCT01132664|219454|P3|NOT COMPLETED|BM Cohort||0
93623|NCT01132664|219455|P2|NOT COMPLETED|BM Cohort||0
93624|NCT01132664|219456|P1|NOT COMPLETED|BM Cohort||0
93625|NCT01132664|219452|P5|COMPLETED|BM Cohort||0
93626|NCT01132664|219453|P4|COMPLETED|BM Cohort||0
93627|NCT01132664|219454|P3|COMPLETED|BM Cohort||0
93628|NCT01132664|219455|P2|COMPLETED|BM Cohort||0
93629|NCT01132664|219456|P1|COMPLETED|BM Cohort||0
93630|NCT01132664|219452|P5|STARTED|BM Cohort||6
93631|NCT01132664|219453|P4|STARTED|BM Cohort||3
93632|NCT01132664|219454|P3|STARTED|BM Cohort||0
93633|NCT01132664|219455|P2|STARTED|BM Cohort||0
93634|NCT01132664|219456|P1|STARTED|BM Cohort||0
93635|NCT01132664|219452|P5|NOT COMPLETED|Phase ll||0
93636|NCT01132664|219453|P4|NOT COMPLETED|Phase ll||0
93637|NCT01132664|219454|P3|NOT COMPLETED|Phase ll||50
93638|NCT01132664|219455|P2|NOT COMPLETED|Phase ll||0
93639|NCT01132664|219456|P1|NOT COMPLETED|Phase ll||0
93640|NCT01132664|219452|P5|COMPLETED|Phase ll||0
93641|NCT01132664|219453|P4|COMPLETED|Phase ll||0
93642|NCT01132664|219454|P3|COMPLETED|Phase ll||0
93643|NCT01132664|219455|P2|COMPLETED|Phase ll||0
93644|NCT01132664|219456|P1|COMPLETED|Phase ll||0
93645|NCT01132664|219452|P5|STARTED|Phase ll||0
93646|NCT01132664|219453|P4|STARTED|Phase ll||0
93647|NCT01132664|219454|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
93648|NCT01132664|219455|P2|STARTED|Phase ll||0
93649|NCT01132664|219456|P1|STARTED|Phase ll||0
93650|NCT01132664|219452|P5|NOT COMPLETED|Phase lb||0
93651|NCT01132664|219453|P4|NOT COMPLETED|Phase lb||0
93652|NCT01132664|219454|P3|NOT COMPLETED|Phase lb||0
93653|NCT01132664|219455|P2|NOT COMPLETED|Phase lb||12
93654|NCT01132664|219456|P1|NOT COMPLETED|Phase lb||5
93655|NCT01132664|219452|P5|COMPLETED|Phase lb||0
93656|NCT01132664|219453|P4|COMPLETED|Phase lb||0
93657|NCT01132664|219454|P3|COMPLETED|Phase lb||0
93658|NCT01132664|219455|P2|COMPLETED|Phase lb||0
93659|NCT01132664|219456|P1|COMPLETED|Phase lb||0
93660|NCT01132664|219452|P5|STARTED|Phase lb||0
93661|NCT01132664|219453|P4|STARTED|Phase lb||0
93662|NCT01132664|219454|P3|STARTED|Phase lb||0
93663|NCT01132664|219455|P2|STARTED|Phase lb||12
93664|NCT01132664|219456|P1|STARTED|Phase lb||5
93665|NCT01132651|219490|P2|NOT COMPLETED|Overall Study||1
93666|NCT01132651|219491|P1|NOT COMPLETED|Overall Study||1
93667|NCT01132651|219490|P2|COMPLETED|Overall Study||4
93668|NCT01132651|219491|P1|COMPLETED|Overall Study||3
93669|NCT01132651|219490|P2|STARTED|Overall Study||5
93670|NCT01132651|219491|P1|STARTED|Overall Study||4
93671|NCT01132547|219501|P2|NOT COMPLETED|Overall Study||1
93672|NCT01132547|219502|P1|NOT COMPLETED|Overall Study||4
93673|NCT01132547|219501|P2|COMPLETED|Overall Study||12
93674|NCT01132547|219502|P1|COMPLETED|Overall Study||5
93675|NCT01132547|219501|P2|STARTED|Overall Study||13
93676|NCT01132547|219502|P1|STARTED|Overall Study||9
93677|NCT01132508|219512|P1|NOT COMPLETED|Overall Study||9
93678|NCT01132508|219512|P1|COMPLETED|Overall Study||24
93679|NCT01132508|219512|P1|104 Weeks|Overall Study||27
93680|NCT01132508|219512|P1|78 Weeks|Overall Study||28
93681|NCT01132508|219512|P1|52 Weeks|Overall Study||30
93682|NCT01132508|219512|P1|26 Weeks|Overall Study||33
93683|NCT01132508|219512|P1|12 Weeks|Overall Study||33
93684|NCT01132508|219512|P1|6 Weeks|Overall Study||33
93685|NCT01132508|219512|P1|Treated at Baseline|Overall Study||33
93686|NCT01132508|219512|P1|STARTED|Overall Study||33
93687|NCT01132495|219572|P4|NOT COMPLETED|Overall Study||12
93688|NCT01132495|219573|P3|NOT COMPLETED|Overall Study||20
93689|NCT01132495|219574|P2|NOT COMPLETED|Overall Study||38
93690|NCT01132495|219575|P1|NOT COMPLETED|Overall Study||40
93691|NCT01132495|219572|P4|COMPLETED|Overall Study||104
93692|NCT01132495|219573|P3|COMPLETED|Overall Study||146
93693|NCT01132495|219574|P2|COMPLETED|Overall Study||403
93694|NCT01132495|219575|P1|COMPLETED|Overall Study||407
93695|NCT01132495|219572|P4|STARTED|Overall Study||116
93696|NCT01132495|219573|P3|STARTED|Overall Study||166
93697|NCT01132495|219574|P2|STARTED|Overall Study||441
93698|NCT01132495|219575|P1|STARTED|Overall Study||447
93699|NCT01132378|219583|P1|NOT COMPLETED|Overall Study||0
93700|NCT01132378|219583|P1|COMPLETED|Overall Study||40
93701|NCT01132378|219583|P1|STARTED|Overall Study||40
93702|NCT01132326|219588|P1|NOT COMPLETED|Overall Study||218
93703|NCT01132326|219588|P1|COMPLETED|Overall Study||132
93704|NCT01132326|219588|P1|STARTED|Overall Study||350
93705|NCT01132313|219604|P12|NOT COMPLETED|Overall Study||0
93706|NCT01132313|219605|P11|NOT COMPLETED|Overall Study||1
93707|NCT01132313|219606|P10|NOT COMPLETED|Overall Study||20
93708|NCT01132313|219607|P9|NOT COMPLETED|Overall Study||21
93709|NCT01132313|219608|P8|NOT COMPLETED|Overall Study||8
93710|NCT01132313|219609|P7|NOT COMPLETED|Overall Study||30
93711|NCT01132313|219610|P6|NOT COMPLETED|Overall Study||25
93712|NCT01132313|219611|P5|NOT COMPLETED|Overall Study||45
93713|NCT01132313|219612|P4|NOT COMPLETED|Overall Study||32
93714|NCT01132313|219613|P3|NOT COMPLETED|Overall Study||20
93715|NCT01132313|219614|P2|NOT COMPLETED|Overall Study||0
93716|NCT01132313|219615|P1|NOT COMPLETED|Overall Study||3
93717|NCT01132313|219604|P12|COMPLETED|Overall Study||2
93718|NCT01132313|219605|P11|COMPLETED|Overall Study||0
93719|NCT01132313|219606|P10|COMPLETED|Overall Study||5
93720|NCT01132313|219607|P9|COMPLETED|Overall Study||5
93721|NCT01132313|219608|P8|COMPLETED|Overall Study||24
93722|NCT01132313|219609|P7|COMPLETED|Overall Study||19
93723|NCT01132313|219610|P6|COMPLETED|Overall Study||54
93724|NCT01132313|219611|P5|COMPLETED|Overall Study||34
93725|NCT01132313|219612|P4|COMPLETED|Overall Study||48
93726|NCT01132313|219613|P3|COMPLETED|Overall Study||61
93727|NCT01132313|219614|P2|COMPLETED|Overall Study||17
93728|NCT01132313|219615|P1|COMPLETED|Overall Study||14
93729|NCT01132313|219604|P12|STARTED|Overall Study||2
93730|NCT01132313|219605|P11|STARTED|Overall Study||1
93731|NCT01132313|219606|P10|STARTED|Overall Study||25
93732|NCT01132313|219607|P9|STARTED|Overall Study||26
93733|NCT01132313|219608|P8|STARTED|Overall Study||32
93734|NCT01132313|219609|P7|STARTED|Overall Study||49
93735|NCT01132313|219610|P6|STARTED|Overall Study||79
93736|NCT01132313|219611|P5|STARTED|Overall Study||79
93737|NCT01132313|219612|P4|STARTED|Overall Study||80
93738|NCT01132313|219613|P3|STARTED|Overall Study||81
93739|NCT01132313|219614|P2|STARTED|Overall Study||17
93740|NCT01132313|219615|P1|STARTED|Overall Study||17
93741|NCT01132144|219672|P2|NOT COMPLETED|Overall Study||0
93742|NCT01132144|219673|P1|NOT COMPLETED|Overall Study||0
93743|NCT01132144|219672|P2|COMPLETED|Overall Study||79
93744|NCT01132144|219673|P1|COMPLETED|Overall Study||79
93745|NCT01132144|219672|P2|STARTED|Overall Study||79
93746|NCT01132144|219673|P1|STARTED|Overall Study||79
93747|NCT01132118|219695|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
93748|NCT01132118|219696|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
93749|NCT01132118|219695|P2|COMPLETED|Second Intervention (8 Weeks)||11
93750|NCT01132118|219696|P1|COMPLETED|Second Intervention (8 Weeks)||12
93751|NCT01132118|219695|P2|STARTED|Second Intervention (8 Weeks)||12
93752|NCT01132118|219696|P1|STARTED|Second Intervention (8 Weeks)||12
93753|NCT01132118|219695|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
93754|NCT01132118|219696|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
93755|NCT01132118|219695|P2|COMPLETED|First Intervention (8 Weeks)||12
93756|NCT01132118|219696|P1|COMPLETED|First Intervention (8 Weeks)||12
93757|NCT01132118|219695|P2|STARTED|First Intervention (8 Weeks)||15
93758|NCT01132118|219696|P1|STARTED|First Intervention (8 Weeks)||15
93759|NCT01131884|219716|P2|NOT COMPLETED|Overall Study||0
93760|NCT01131884|219717|P1|NOT COMPLETED|Overall Study||0
93761|NCT01131884|219716|P2|COMPLETED|Overall Study||0
93762|NCT01131884|219717|P1|COMPLETED|Overall Study||1
93763|NCT01131884|219716|P2|STARTED|Overall Study||0
93764|NCT01131884|219717|P1|STARTED|Overall Study||1
93765|NCT01131676|219726|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
93766|NCT01131676|219727|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
93767|NCT01131676|219728|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
93768|NCT01131676|219726|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
93769|NCT01131676|219727|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
93770|NCT01131676|219728|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
93771|NCT01131676|219726|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
93772|NCT01131676|219727|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
93773|NCT01131676|219728|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
93774|NCT01131676|219726|P3|STARTED|Discontinuation From Study (Treated Set)||2342
93775|NCT01131676|219727|P2|STARTED|Discontinuation From Study (Treated Set)||2345
93776|NCT01131676|219728|P1|STARTED|Discontinuation From Study (Treated Set)||2333
93777|NCT01131676|219726|P3|NOT COMPLETED|Discontinuation From Treatment||544
93778|NCT01131676|219727|P2|NOT COMPLETED|Discontinuation From Treatment||557
93779|NCT01131676|219728|P1|NOT COMPLETED|Discontinuation From Treatment||687
93780|NCT01131676|219726|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
93781|NCT01131676|219727|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
93782|NCT01131676|219728|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
93783|NCT01131676|219726|P3|STARTED|Discontinuation From Treatment|Randomised|2344
93784|NCT01131676|219727|P2|STARTED|Discontinuation From Treatment|Randomised|2347
93785|NCT01131676|219728|P1|STARTED|Discontinuation From Treatment|Randomised|2337
93786|NCT01131585|219763|P2|NOT COMPLETED|Overall Study||43
93787|NCT01131585|219764|P1|NOT COMPLETED|Overall Study||85
93788|NCT01131585|219763|P2|COMPLETED|Overall Study||0
93789|NCT01131585|219764|P1|COMPLETED|Overall Study||0
93790|NCT01131585|219763|P2|STARTED|Overall Study||43
93791|NCT01131585|219764|P1|STARTED|Overall Study||85
93792|NCT01131507|219770|P1|NOT COMPLETED|Overall Study||3
93793|NCT01131507|219770|P1|COMPLETED|Overall Study||12
93794|NCT01131507|219770|P1|STARTED|Overall Study||15
93795|NCT01131494|219775|P1|NOT COMPLETED|Overall Study||2
93796|NCT01131494|219775|P1|COMPLETED|Overall Study||15
93797|NCT01131494|219775|P1|STARTED|Overall Study||17
93798|NCT01131455|219785|P3|NOT COMPLETED|Overall Study||0
93799|NCT01131455|219786|P2|NOT COMPLETED|Overall Study||4
93800|NCT01131455|219787|P1|NOT COMPLETED|Overall Study||6
93801|NCT01131455|219785|P3|COMPLETED|Overall Study||0
93802|NCT01131455|219786|P2|COMPLETED|Overall Study||0
93803|NCT01131455|219787|P1|COMPLETED|Overall Study||0
93804|NCT01131455|219785|P3|STARTED|Overall Study||0
93805|NCT01131455|219786|P2|STARTED|Overall Study||4
93806|NCT01131455|219787|P1|STARTED|Overall Study||6
93807|NCT01131299|219795|P2|NOT COMPLETED|Overall Study||7
93808|NCT01131299|219796|P1|NOT COMPLETED|Overall Study||4
93809|NCT01131299|219795|P2|COMPLETED|Overall Study||37
93810|NCT01131299|219796|P1|COMPLETED|Overall Study||38
93811|NCT01131299|219795|P2|STARTED|Overall Study||44
93812|NCT01131299|219796|P1|STARTED|Overall Study||42
93813|NCT01131182|219809|P2|NOT COMPLETED|Overall Study||16
93814|NCT01131182|219810|P1|NOT COMPLETED|Overall Study||16
93815|NCT01131182|219809|P2|COMPLETED|Overall Study||521
93816|NCT01131182|219810|P1|COMPLETED|Overall Study||513
93817|NCT01131182|219809|P2|STARTED|Overall Study||537
93818|NCT01131182|219810|P1|STARTED|Overall Study||529
93819|NCT01131130|219818|P1|NOT COMPLETED|Period 3- Crossover||1
93820|NCT01131130|219818|P1|COMPLETED|Period 3- Crossover||116
93821|NCT01131130|219818|P1|STARTED|Period 3- Crossover||117
93822|NCT01131130|219818|P1|NOT COMPLETED|Period 2 - Crossover||0
93823|NCT01131130|219818|P1|COMPLETED|Period 2 - Crossover||117
93824|NCT01131130|219818|P1|STARTED|Period 2 - Crossover||117
93825|NCT01131130|219818|P1|NOT COMPLETED|Period 1 - Baseline||1
93826|NCT01131130|219818|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
93827|NCT01131130|219818|P1|STARTED|Period 1 - Baseline||118
93828|NCT01131078|219834|P3|NOT COMPLETED|Overall Study||102
93829|NCT01131078|219835|P2|NOT COMPLETED|Overall Study||101
93830|NCT01131078|219836|P1|NOT COMPLETED|Overall Study||101
93831|NCT01131078|219834|P3|COMPLETED|Overall Study||1
93832|NCT01131078|219835|P2|COMPLETED|Overall Study||1
93833|NCT01131078|219836|P1|COMPLETED|Overall Study||0
93834|NCT01131078|219834|P3|STARTED|Overall Study||103
93835|NCT01131078|219835|P2|STARTED|Overall Study||102
93836|NCT01131078|219836|P1|STARTED|Overall Study||101
93837|NCT01131065|219892|P1|NOT COMPLETED|Overall Study||0
93838|NCT01131065|219892|P1|COMPLETED|Overall Study||15
93839|NCT01131065|219892|P1|STARTED|Overall Study||15
93840|NCT01131052|219900|P2|NOT COMPLETED|Overall Study||0
93841|NCT01131052|219901|P1|NOT COMPLETED|Overall Study||0
93842|NCT01131052|219900|P2|COMPLETED|Overall Study||75
93843|NCT01131052|219901|P1|COMPLETED|Overall Study||75
93844|NCT01131052|219900|P2|STARTED|Overall Study||75
93845|NCT01131052|219901|P1|STARTED|Overall Study||75
93846|NCT01130974|219923|P2|NOT COMPLETED|Overall Study||13
93847|NCT01130974|219924|P1|NOT COMPLETED|Overall Study||15
93848|NCT01130974|219923|P2|COMPLETED|Overall Study||87
93849|NCT01130974|219924|P1|COMPLETED|Overall Study||85
93850|NCT01130974|219923|P2|STARTED|Overall Study||100
93851|NCT01130974|219924|P1|STARTED|Overall Study||100
93852|NCT01130883|219944|P1|NOT COMPLETED|Overall Study||10
93853|NCT01130883|219944|P1|COMPLETED|Overall Study||3120
93854|NCT01130883|219944|P1|Participants Analyzed|Overall Study||3128
93855|NCT01130883|219944|P1|STARTED|Overall Study||3130
93856|NCT01130844|219961|P3|NOT COMPLETED|Overall Study||0
93857|NCT01130844|219962|P2|NOT COMPLETED|Overall Study||0
93858|NCT01130844|219963|P1|NOT COMPLETED|Overall Study||0
93859|NCT01130844|219961|P3|COMPLETED|Overall Study||9
93860|NCT01130844|219962|P2|COMPLETED|Overall Study||22
93861|NCT01130844|219963|P1|COMPLETED|Overall Study||21
93862|NCT01130844|219961|P3|STARTED|Overall Study||9
93863|NCT01130844|219962|P2|STARTED|Overall Study||22
93864|NCT01130844|219963|P1|STARTED|Overall Study||21
93865|NCT01130831|220001|P1|NOT COMPLETED|Overall Study||14
93866|NCT01130831|220001|P1|COMPLETED|Overall Study||52
93867|NCT01130831|220001|P1|STARTED|Overall Study||66
93868|NCT01130740|220029|P2|NOT COMPLETED|Overall Study||15
93869|NCT01130740|220030|P1|NOT COMPLETED|Overall Study||12
93870|NCT01130740|220029|P2|COMPLETED|Overall Study||136
93871|NCT01130740|220030|P1|COMPLETED|Overall Study||137
93872|NCT01130740|220029|P2|STARTED|Overall Study||151
93873|NCT01130740|220030|P1|STARTED|Overall Study||149
93874|NCT01130597|220040|P1|NOT COMPLETED|Overall Study||7
93875|NCT01130597|220040|P1|COMPLETED|Overall Study||56
93876|NCT01130597|220040|P1|STARTED|Overall Study||63
93877|NCT01130532|220065|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
93878|NCT01130532|220066|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
93879|NCT01130532|220067|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
93880|NCT01130532|220068|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
93881|NCT01130532|220065|P4|COMPLETED|Period IV (Weeks 13-16)||552
93882|NCT01130532|220066|P3|COMPLETED|Period IV (Weeks 13-16)||0
93883|NCT01130532|220067|P2|COMPLETED|Period IV (Weeks 13-16)||0
93884|NCT01130532|220068|P1|COMPLETED|Period IV (Weeks 13-16)||0
93885|NCT01130532|220065|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
93886|NCT01130532|220066|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
93887|NCT01130532|220067|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
93888|NCT01130532|220068|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
93889|NCT01130532|220065|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
93890|NCT01130532|220066|P3|STARTED|Period IV (Weeks 13-16)||0
93891|NCT01130532|220067|P2|STARTED|Period IV (Weeks 13-16)||0
93892|NCT01130532|220068|P1|STARTED|Period IV (Weeks 13-16)||0
93893|NCT01130532|220065|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
93894|NCT01130532|220066|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
93895|NCT01130532|220067|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
93896|NCT01130532|220068|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
93897|NCT01130532|220065|P4|COMPLETED|Period III (Weeks 0-12)||0
93898|NCT01130532|220066|P3|COMPLETED|Period III (Weeks 0-12)||190
93899|NCT01130532|220067|P2|COMPLETED|Period III (Weeks 0-12)||189
93900|NCT01130532|220068|P1|COMPLETED|Period III (Weeks 0-12)||186
93901|NCT01130532|220065|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
93902|NCT01130532|220066|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
93903|NCT01130532|220067|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
93904|NCT01130532|220068|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
93905|NCT01130532|220065|P4|STARTED|Period III (Weeks 0-12)||0
93906|NCT01130532|220066|P3|STARTED|Period III (Weeks 0-12)||209
93907|NCT01130532|220067|P2|STARTED|Period III (Weeks 0-12)||207
93908|NCT01130532|220068|P1|STARTED|Period III (Weeks 0-12)||207
93909|NCT01130337|220113|P1|NOT COMPLETED|Overall Study||14
93910|NCT01130337|220113|P1|COMPLETED|Overall Study||22
93911|NCT01130337|220113|P1|STARTED|Overall Study||36
93912|NCT01130168|220120|P6|NOT COMPLETED|Period 3||0
93913|NCT01130168|220121|P5|NOT COMPLETED|Period 3||0
93914|NCT01130168|220122|P4|NOT COMPLETED|Period 3||0
93915|NCT01130168|220123|P3|NOT COMPLETED|Period 3||0
93916|NCT01130168|220124|P2|NOT COMPLETED|Period 3||0
93917|NCT01130168|220125|P1|NOT COMPLETED|Period 3||0
93918|NCT01130168|220120|P6|COMPLETED|Period 3||6
93919|NCT01130168|220121|P5|COMPLETED|Period 3||5
93920|NCT01130168|220122|P4|COMPLETED|Period 3||5
93921|NCT01130168|220123|P3|COMPLETED|Period 3||5
93922|NCT01130168|220124|P2|COMPLETED|Period 3||6
93923|NCT01130168|220125|P1|COMPLETED|Period 3||6
93924|NCT01130168|220120|P6|STARTED|Period 3||6
93925|NCT01130168|220121|P5|STARTED|Period 3||5
93926|NCT01130168|220122|P4|STARTED|Period 3||5
93927|NCT01130168|220123|P3|STARTED|Period 3||5
93928|NCT01130168|220124|P2|STARTED|Period 3||6
93929|NCT01130168|220125|P1|STARTED|Period 3||6
93930|NCT01130168|220120|P6|NOT COMPLETED|Period 2||0
93931|NCT01130168|220121|P5|NOT COMPLETED|Period 2||0
93932|NCT01130168|220122|P4|NOT COMPLETED|Period 2||0
93933|NCT01130168|220123|P3|NOT COMPLETED|Period 2||0
93934|NCT01130168|220124|P2|NOT COMPLETED|Period 2||0
93935|NCT01130168|220125|P1|NOT COMPLETED|Period 2||0
93936|NCT01130168|220120|P6|COMPLETED|Period 2||6
93937|NCT01130168|220121|P5|COMPLETED|Period 2||5
93938|NCT01130168|220122|P4|COMPLETED|Period 2||5
93939|NCT01130168|220123|P3|COMPLETED|Period 2||5
93940|NCT01130168|220124|P2|COMPLETED|Period 2||6
93941|NCT01130168|220125|P1|COMPLETED|Period 2||6
93942|NCT01130168|220120|P6|STARTED|Period 2||6
93943|NCT01130168|220121|P5|STARTED|Period 2||5
93944|NCT01130168|220122|P4|STARTED|Period 2||5
93945|NCT01130168|220123|P3|STARTED|Period 2||5
93946|NCT01130168|220124|P2|STARTED|Period 2||6
93947|NCT01130168|220125|P1|STARTED|Period 2||6
93948|NCT01130168|220120|P6|NOT COMPLETED|Period 1||0
93949|NCT01130168|220121|P5|NOT COMPLETED|Period 1||0
93950|NCT01130168|220122|P4|NOT COMPLETED|Period 1||3
93951|NCT01130168|220123|P3|NOT COMPLETED|Period 1||1
93952|NCT01130168|220124|P2|NOT COMPLETED|Period 1||1
93953|NCT01130168|220125|P1|NOT COMPLETED|Period 1||0
93954|NCT01130168|220120|P6|COMPLETED|Period 1||6
93955|NCT01130168|220121|P5|COMPLETED|Period 1||5
93956|NCT01130168|220122|P4|COMPLETED|Period 1||5
93957|NCT01130168|220123|P3|COMPLETED|Period 1||5
93958|NCT01130168|220124|P2|COMPLETED|Period 1||6
93959|NCT01130168|220125|P1|COMPLETED|Period 1||6
93960|NCT01130168|220120|P6|STARTED|Period 1||6
93961|NCT01130168|220121|P5|STARTED|Period 1||5
93962|NCT01130168|220122|P4|STARTED|Period 1||8
93963|NCT01130168|220123|P3|STARTED|Period 1||6
93964|NCT01130168|220124|P2|STARTED|Period 1||7
93965|NCT01130168|220125|P1|STARTED|Period 1||6
93966|NCT01130103|220162|P2|NOT COMPLETED|Maintenance Treatment||2
93967|NCT01130103|220163|P1|NOT COMPLETED|Maintenance Treatment||2
93968|NCT01130103|220162|P2|COMPLETED|Maintenance Treatment||11
93969|NCT01130103|220163|P1|COMPLETED|Maintenance Treatment||11
93970|NCT01130103|220162|P2|STARTED|Maintenance Treatment||13
93971|NCT01130103|220163|P1|STARTED|Maintenance Treatment||13
93972|NCT01130103|220162|P2|NOT COMPLETED|Randomized Treatment||5
93973|NCT01130103|220163|P1|NOT COMPLETED|Randomized Treatment||6
93974|NCT01130103|220162|P2|COMPLETED|Randomized Treatment||13
93975|NCT01130103|220163|P1|COMPLETED|Randomized Treatment||13
93976|NCT01130103|220162|P2|STARTED|Randomized Treatment||18
93977|NCT01130103|220163|P1|STARTED|Randomized Treatment||19
93978|NCT01130051|220177|P2|NOT COMPLETED|Period 2||0
93979|NCT01130051|220178|P1|NOT COMPLETED|Period 2||0
93980|NCT01130051|220177|P2|COMPLETED|Period 2||6
93981|NCT01130051|220178|P1|COMPLETED|Period 2||7
93982|NCT01130051|220177|P2|STARTED|Period 2||6
93983|NCT01130051|220178|P1|STARTED|Period 2||7
93984|NCT01130051|220177|P2|NOT COMPLETED|Washout Period of 14 Days||2
93985|NCT01130051|220178|P1|NOT COMPLETED|Washout Period of 14 Days||1
93986|NCT01130051|220177|P2|COMPLETED|Washout Period of 14 Days||6
93987|NCT01130051|220178|P1|COMPLETED|Washout Period of 14 Days||7
93988|NCT01130051|220177|P2|STARTED|Washout Period of 14 Days||8
93989|NCT01130051|220178|P1|STARTED|Washout Period of 14 Days||8
93990|NCT01130051|220177|P2|NOT COMPLETED|Period 1||0
93991|NCT01130051|220178|P1|NOT COMPLETED|Period 1||0
93992|NCT01130051|220177|P2|COMPLETED|Period 1||8
93993|NCT01130051|220178|P1|COMPLETED|Period 1||8
93994|NCT01130051|220177|P2|STARTED|Period 1||8
93995|NCT01130051|220178|P1|STARTED|Period 1||8
93996|NCT01129960|220192|P4|NOT COMPLETED|Overall Study||13
93997|NCT01129960|220193|P3|NOT COMPLETED|Overall Study||26
93998|NCT01129960|220194|P2|NOT COMPLETED|Overall Study||22
93999|NCT01129960|220195|P1|NOT COMPLETED|Overall Study||30
94000|NCT01129960|220192|P4|COMPLETED|Overall Study||70
94001|NCT01129960|220193|P3|COMPLETED|Overall Study||56
94002|NCT01129960|220194|P2|COMPLETED|Overall Study||61
94003|NCT01129960|220195|P1|COMPLETED|Overall Study||54
94004|NCT01129960|220192|P4|Full Analysis Set (FAS|Overall Study||71
94005|NCT01129960|220193|P3|Full Analysis Set (FAS|Overall Study||68
94006|NCT01129960|220194|P2|Full Analysis Set (FAS|Overall Study||67
94007|NCT01129960|220195|P1|Full Analysis Set (FAS|Overall Study||71
94008|NCT01129960|220192|P4|Per-Protocol|Overall Study||55
94009|NCT01129960|220193|P3|Per-Protocol|Overall Study||49
94010|NCT01129960|220194|P2|Per-Protocol|Overall Study||52
94011|NCT01129960|220195|P1|Per-Protocol|Overall Study||34
94012|NCT01129960|220192|P4|Intent-to-Treat|Overall Study||83
94013|NCT01129960|220193|P3|Intent-to-Treat|Overall Study||82
94014|NCT01129960|220194|P2|Intent-to-Treat|Overall Study||83
94015|NCT01129960|220195|P1|Intent-to-Treat|Overall Study||84
94016|NCT01129960|220192|P4|Safety|Overall Study||82
94017|NCT01129960|220193|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
94018|NCT01129960|220194|P2|Safety|Overall Study||83
94019|NCT01129960|220195|P1|Safety|Overall Study||84
94020|NCT01129960|220192|P4|STARTED|Overall Study||83
94021|NCT01129960|220193|P3|STARTED|Overall Study||82
94022|NCT01129960|220194|P2|STARTED|Overall Study||83
94023|NCT01129960|220195|P1|STARTED|Overall Study||84
94024|NCT01129921|220207|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
94025|NCT01129921|220208|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
94026|NCT01129921|220207|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
94027|NCT01129921|220208|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
94028|NCT01129921|220207|P2|STARTED|After Sham Cross-over to Mild, One Year||20
94029|NCT01129921|220208|P1|STARTED|After Sham Cross-over to Mild, One Year||20
94030|NCT01129921|220207|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
94031|NCT01129921|220208|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
94032|NCT01129921|220207|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
94033|NCT01129921|220208|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
94034|NCT01129921|220207|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
94035|NCT01129921|220208|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
94036|NCT01129765|220218|P1|NOT COMPLETED|Overall Study||0
94037|NCT01129765|220218|P1|COMPLETED|Overall Study||30
94038|NCT01129765|220218|P1|STARTED|Overall Study||30
94039|NCT01129622|220227|P1|NOT COMPLETED|Overall Study||2
94040|NCT01129622|220227|P1|COMPLETED|Overall Study||14
94041|NCT01129622|220227|P1|STARTED|Overall Study||16
94042|NCT01129583|220234|P2|NOT COMPLETED|Overall Study||2
94043|NCT01129583|220235|P1|NOT COMPLETED|Overall Study||3
94044|NCT01129583|220234|P2|COMPLETED|Overall Study||7
94045|NCT01129583|220235|P1|COMPLETED|Overall Study||6
94046|NCT01129583|220234|P2|STARTED|Overall Study||9
94047|NCT01129583|220235|P1|STARTED|Overall Study||9
94048|NCT01129557|220248|P3|NOT COMPLETED|Overall Study||4
94049|NCT01129557|220249|P2|NOT COMPLETED|Overall Study||5
94050|NCT01129557|220250|P1|NOT COMPLETED|Overall Study||4
94051|NCT01129557|220248|P3|COMPLETED|Overall Study||10
94052|NCT01129557|220249|P2|COMPLETED|Overall Study||12
94053|NCT01129557|220250|P1|COMPLETED|Overall Study||11
94054|NCT01129557|220248|P3|STARTED|Overall Study||14
94055|NCT01129557|220249|P2|STARTED|Overall Study||17
94056|NCT01129557|220250|P1|STARTED|Overall Study||15
94057|NCT01129531|220321|P3|NOT COMPLETED|Treatment Cycle 2||5
94058|NCT01129531|220322|P2|NOT COMPLETED|Treatment Cycle 2||3
94059|NCT01129531|220323|P1|NOT COMPLETED|Treatment Cycle 2||6
94060|NCT01129531|220321|P3|COMPLETED|Treatment Cycle 2||74
94061|NCT01129531|220322|P2|COMPLETED|Treatment Cycle 2||92
94062|NCT01129531|220323|P1|COMPLETED|Treatment Cycle 2||88
94063|NCT01129531|220321|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
94064|NCT01129531|220322|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
94065|NCT01129531|220323|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
94066|NCT01129531|220321|P3|NOT COMPLETED|Treatment Cycle 1||16
94067|NCT01129531|220322|P2|NOT COMPLETED|Treatment Cycle 1||6
94068|NCT01129531|220323|P1|NOT COMPLETED|Treatment Cycle 1||4
94069|NCT01129531|220321|P3|COMPLETED|Treatment Cycle 1||110
94070|NCT01129531|220322|P2|COMPLETED|Treatment Cycle 1||78
94071|NCT01129531|220323|P1|COMPLETED|Treatment Cycle 1||80
94072|NCT01129531|220321|P3|STARTED|Treatment Cycle 1||126
94073|NCT01129531|220322|P2|STARTED|Treatment Cycle 1||84
94074|NCT01129531|220323|P1|STARTED|Treatment Cycle 1||84
94075|NCT01129336|220345|P2|NOT COMPLETED|Overall Study||16
94076|NCT01129336|220346|P1|NOT COMPLETED|Overall Study||12
94077|NCT01129336|220345|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
94078|NCT01129336|220346|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
94079|NCT01129336|220345|P2|Completed Treatment|Overall Study||3
94080|NCT01129336|220346|P1|Completed Treatment|Overall Study||1
94081|NCT01129336|220345|P2|STARTED|Overall Study||29
94082|NCT01129336|220346|P1|STARTED|Overall Study||15
94083|NCT01129284|220361|P3|NOT COMPLETED|Overall Study||1
94084|NCT01129284|220362|P2|NOT COMPLETED|Overall Study||0
94085|NCT01129284|220363|P1|NOT COMPLETED|Overall Study||2
94086|NCT01129284|220361|P3|COMPLETED|Overall Study||4
94087|NCT01129284|220362|P2|COMPLETED|Overall Study||5
94088|NCT01129284|220363|P1|COMPLETED|Overall Study||3
94089|NCT01129284|220361|P3|STARTED|Overall Study||5
94090|NCT01129284|220362|P2|STARTED|Overall Study||5
94091|NCT01129284|220363|P1|STARTED|Overall Study||5
94092|NCT01129245|220376|P2|NOT COMPLETED|Overall Study||0
94093|NCT01129245|220377|P1|NOT COMPLETED|Overall Study||0
94094|NCT01129245|220376|P2|COMPLETED|Overall Study||4
94095|NCT01129245|220377|P1|COMPLETED|Overall Study||7
94096|NCT01129245|220376|P2|STARTED|Overall Study||4
94097|NCT01129245|220377|P1|STARTED|Overall Study||7
94098|NCT01129206|220383|P1|NOT COMPLETED|Overall Study||0
94099|NCT01129206|220383|P1|COMPLETED|Overall Study||6
94100|NCT01129206|220383|P1|STARTED|Overall Study||6
94101|NCT01129141|220393|P2|NOT COMPLETED|Overall Study||13
94102|NCT01129141|220394|P1|NOT COMPLETED|Overall Study||15
94103|NCT01129141|220393|P2|COMPLETED|Overall Study||91
94104|NCT01129141|220394|P1|COMPLETED|Overall Study||86
94105|NCT01129141|220393|P2|STARTED|Overall Study||104
94106|NCT01129141|220394|P1|STARTED|Overall Study||101
94107|NCT01129128|220403|P3|NOT COMPLETED|Overall Study||4
94108|NCT01129128|220404|P2|NOT COMPLETED|Overall Study||4
94109|NCT01129128|220405|P1|NOT COMPLETED|Overall Study||3
94110|NCT01129128|220403|P3|COMPLETED|Overall Study||19
94111|NCT01129128|220404|P2|COMPLETED|Overall Study||18
94112|NCT01129128|220405|P1|COMPLETED|Overall Study||19
94113|NCT01129128|220403|P3|STARTED|Overall Study||23
94114|NCT01129128|220404|P2|STARTED|Overall Study||22
94115|NCT01129128|220405|P1|STARTED|Overall Study||22
94116|NCT01129115|220429|P4|NOT COMPLETED|Overall Study||9
94117|NCT01129115|220430|P3|NOT COMPLETED|Overall Study||6
94118|NCT01129115|220431|P2|NOT COMPLETED|Overall Study||7
94119|NCT01129115|220432|P1|NOT COMPLETED|Overall Study||2
94120|NCT01129115|220429|P4|COMPLETED|Overall Study||15
94121|NCT01129115|220430|P3|COMPLETED|Overall Study||21
94122|NCT01129115|220431|P2|COMPLETED|Overall Study||18
94123|NCT01129115|220432|P1|COMPLETED|Overall Study||23
94124|NCT01129115|220429|P4|STARTED|Overall Study||24
94125|NCT01129115|220430|P3|STARTED|Overall Study||27
94126|NCT01129115|220431|P2|STARTED|Overall Study||25
94127|NCT01129115|220432|P1|STARTED|Overall Study||25
94128|NCT01129102|220469|P3|NOT COMPLETED|Overall Study||7
94129|NCT01129102|220470|P2|NOT COMPLETED|Overall Study||6
94130|NCT01129102|220471|P1|NOT COMPLETED|Overall Study||8
94131|NCT01129102|220469|P3|COMPLETED|Overall Study||48
94132|NCT01129102|220470|P2|COMPLETED|Overall Study||44
94133|NCT01129102|220471|P1|COMPLETED|Overall Study||102
94134|NCT01129102|220469|P3|STARTED|Overall Study||55
94135|NCT01129102|220470|P2|STARTED|Overall Study||50
94136|NCT01129102|220471|P1|STARTED|Overall Study||110
94137|NCT01129011|220482|P2|NOT COMPLETED|Overall Study||57
94138|NCT01129011|220483|P1|NOT COMPLETED|Overall Study||59
94139|NCT01129011|220482|P2|COMPLETED|Overall Study||153
94140|NCT01129011|220483|P1|COMPLETED|Overall Study||151
94141|NCT01129011|220482|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
94142|NCT01129011|220483|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
94143|NCT01128972|220505|P5|NOT COMPLETED|Period V||0
94144|NCT01128972|220506|P4|NOT COMPLETED|Period V||0
94145|NCT01128972|220507|P3|NOT COMPLETED|Period V||0
94146|NCT01128972|220508|P2|NOT COMPLETED|Period V||0
94147|NCT01128972|220509|P1|NOT COMPLETED|Period V||0
94148|NCT01128972|220505|P5|COMPLETED|Period V||7
94149|NCT01128972|220506|P4|COMPLETED|Period V||7
94150|NCT01128972|220507|P3|COMPLETED|Period V||7
94151|NCT01128972|220508|P2|COMPLETED|Period V||7
94152|NCT01128972|220509|P1|COMPLETED|Period V||8
94153|NCT01128972|220505|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
94154|NCT01128972|220506|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
94155|NCT01128972|220507|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
94156|NCT01128972|220508|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
94157|NCT01128972|220509|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
94158|NCT01128972|220505|P5|NOT COMPLETED|Period IV||0
94159|NCT01128972|220506|P4|NOT COMPLETED|Period IV||0
94160|NCT01128972|220507|P3|NOT COMPLETED|Period IV||0
94161|NCT01128972|220508|P2|NOT COMPLETED|Period IV||0
94162|NCT01128972|220509|P1|NOT COMPLETED|Period IV||0
94163|NCT01128972|220505|P5|COMPLETED|Period IV||7
94164|NCT01128972|220506|P4|COMPLETED|Period IV||7
94165|NCT01128972|220507|P3|COMPLETED|Period IV||7
94166|NCT01128972|220508|P2|COMPLETED|Period IV||8
94167|NCT01128972|220509|P1|COMPLETED|Period IV||7
94168|NCT01128972|220505|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
94169|NCT01128972|220506|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
94170|NCT01128972|220507|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
94171|NCT01128972|220508|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
94172|NCT01128972|220509|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
94173|NCT01128972|220505|P5|NOT COMPLETED|Period III||0
94174|NCT01128972|220506|P4|NOT COMPLETED|Period III||0
94175|NCT01128972|220507|P3|NOT COMPLETED|Period III||0
94176|NCT01128972|220508|P2|NOT COMPLETED|Period III||0
94177|NCT01128972|220509|P1|NOT COMPLETED|Period III||0
94178|NCT01128972|220505|P5|COMPLETED|Period III||7
94179|NCT01128972|220506|P4|COMPLETED|Period III||7
94180|NCT01128972|220507|P3|COMPLETED|Period III||8
94181|NCT01128972|220508|P2|COMPLETED|Period III||7
94182|NCT01128972|220509|P1|COMPLETED|Period III||7
94183|NCT01128972|220505|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
94184|NCT01128972|220506|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
94185|NCT01128972|220507|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
94186|NCT01128972|220508|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
94187|NCT01128972|220509|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
94188|NCT01128972|220505|P5|NOT COMPLETED|Period II||0
94189|NCT01128972|220506|P4|NOT COMPLETED|Period II||0
94190|NCT01128972|220507|P3|NOT COMPLETED|Period II||0
94191|NCT01128972|220508|P2|NOT COMPLETED|Period II||0
94192|NCT01128972|220509|P1|NOT COMPLETED|Period II||0
94193|NCT01128972|220505|P5|COMPLETED|Period II||7
94194|NCT01128972|220506|P4|COMPLETED|Period II||8
94195|NCT01128972|220507|P3|COMPLETED|Period II||7
94196|NCT01128972|220508|P2|COMPLETED|Period II||7
94197|NCT01128972|220509|P1|COMPLETED|Period II||7
94198|NCT01128972|220505|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
94199|NCT01128972|220506|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
94200|NCT01128972|220507|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
94201|NCT01128972|220508|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
94202|NCT01128972|220509|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
94203|NCT01128972|220505|P5|NOT COMPLETED|Period I||0
94204|NCT01128972|220506|P4|NOT COMPLETED|Period I||0
94205|NCT01128972|220507|P3|NOT COMPLETED|Period I||0
94206|NCT01128972|220508|P2|NOT COMPLETED|Period I||0
94207|NCT01128972|220509|P1|NOT COMPLETED|Period I||0
94208|NCT01128972|220505|P5|COMPLETED|Period I||8
94209|NCT01128972|220506|P4|COMPLETED|Period I||7
94210|NCT01128972|220507|P3|COMPLETED|Period I||7
94211|NCT01128972|220508|P2|COMPLETED|Period I||7
94212|NCT01128972|220509|P1|COMPLETED|Period I||7
94213|NCT01128972|220505|P5|STARTED|Period I||8
94214|NCT01128972|220506|P4|STARTED|Period I||7
94215|NCT01128972|220507|P3|STARTED|Period I||7
94216|NCT01128972|220508|P2|STARTED|Period I||7
94217|NCT01128972|220509|P1|STARTED|Period I||7
94218|NCT01128959|220538|P1|NOT COMPLETED|Treatment Period||4
94219|NCT01128959|220538|P1|COMPLETED|Treatment Period||101
94220|NCT01128959|220538|P1|STARTED|Treatment Period||105
94221|NCT01128959|220538|P1|NOT COMPLETED|Lead in Period||3
94222|NCT01128959|220538|P1|COMPLETED|Lead in Period||105
94223|NCT01128959|220538|P1|STARTED|Lead in Period||108
94224|NCT01128946|220544|P4|NOT COMPLETED|Period IV||0
94225|NCT01128946|220545|P3|NOT COMPLETED|Period IV||0
94226|NCT01128946|220546|P2|NOT COMPLETED|Period IV||0
94227|NCT01128946|220547|P1|NOT COMPLETED|Period IV||0
94228|NCT01128946|220544|P4|COMPLETED|Period IV||19
94229|NCT01128946|220545|P3|COMPLETED|Period IV||19
94230|NCT01128946|220546|P2|COMPLETED|Period IV||20
94231|NCT01128946|220547|P1|COMPLETED|Period IV||19
94232|NCT01128946|220544|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
94233|NCT01128946|220545|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
94234|NCT01128946|220546|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
94235|NCT01128946|220547|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
94236|NCT01128946|220544|P4|NOT COMPLETED|Period III||0
94237|NCT01128946|220545|P3|NOT COMPLETED|Period III||0
94238|NCT01128946|220546|P2|NOT COMPLETED|Period III||0
94239|NCT01128946|220547|P1|NOT COMPLETED|Period III||1
94240|NCT01128946|220544|P4|COMPLETED|Period III||19
94241|NCT01128946|220545|P3|COMPLETED|Period III||20
94242|NCT01128946|220546|P2|COMPLETED|Period III||19
94243|NCT01128946|220547|P1|COMPLETED|Period III||19
94244|NCT01128946|220544|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
94245|NCT01128946|220545|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
94246|NCT01128946|220546|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
94247|NCT01128946|220547|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
94248|NCT01128946|220544|P4|NOT COMPLETED|Period II||1
94249|NCT01128946|220545|P3|NOT COMPLETED|Period II||0
94250|NCT01128946|220546|P2|NOT COMPLETED|Period II||1
94251|NCT01128946|220547|P1|NOT COMPLETED|Period II||0
94252|NCT01128946|220544|P4|COMPLETED|Period II||19
94253|NCT01128946|220545|P3|COMPLETED|Period II||20
94254|NCT01128946|220546|P2|COMPLETED|Period II||19
94255|NCT01128946|220547|P1|COMPLETED|Period II||20
94256|NCT01128946|220544|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
94257|NCT01128946|220545|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
94258|NCT01128946|220546|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
94259|NCT01128946|220547|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
94260|NCT01128946|220544|P4|NOT COMPLETED|Period I||1
94261|NCT01128946|220545|P3|NOT COMPLETED|Period I||1
94262|NCT01128946|220546|P2|NOT COMPLETED|Period I||1
94263|NCT01128946|220547|P1|NOT COMPLETED|Period I||0
94264|NCT01128946|220544|P4|COMPLETED|Period I||20
94265|NCT01128946|220545|P3|COMPLETED|Period I||20
94266|NCT01128946|220546|P2|COMPLETED|Period I||20
94267|NCT01128946|220547|P1|COMPLETED|Period I||20
94268|NCT01128946|220544|P4|STARTED|Period I||21
94269|NCT01128946|220545|P3|STARTED|Period I||21
94270|NCT01128946|220546|P2|STARTED|Period I||21
94271|NCT01128946|220547|P1|STARTED|Period I||20
94272|NCT01128894|220565|P2|NOT COMPLETED|Overall Study||68
94273|NCT01128894|220566|P1|NOT COMPLETED|Overall Study||58
94274|NCT01128894|220565|P2|COMPLETED|Overall Study||340
94275|NCT01128894|220566|P1|COMPLETED|Overall Study||346
94276|NCT01128894|220565|P2|STARTED|Overall Study||408
94277|NCT01128894|220566|P1|STARTED|Overall Study||404
94278|NCT01128829|220584|P2|NOT COMPLETED|Overall Study||0
94279|NCT01128829|220585|P1|NOT COMPLETED|Overall Study||0
94280|NCT01128829|220584|P2|COMPLETED|Overall Study||11
94281|NCT01128829|220585|P1|COMPLETED|Overall Study||6
94282|NCT01128829|220584|P2|STARTED|Overall Study||11
94283|NCT01128829|220585|P1|STARTED|Overall Study||6
94284|NCT01128738|220591|P2|NOT COMPLETED|Second TP||3
94285|NCT01128738|220592|P1|NOT COMPLETED|Second TP||0
94286|NCT01128738|220591|P2|COMPLETED|Second TP||63
94287|NCT01128738|220592|P1|COMPLETED|Second TP||34
94288|NCT01128738|220591|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
94289|NCT01128738|220592|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
94290|NCT01128738|220591|P2|NOT COMPLETED|First Treatment Phase (TP)||1
94291|NCT01128738|220592|P1|NOT COMPLETED|First Treatment Phase (TP)||4
94292|NCT01128738|220591|P2|COMPLETED|First Treatment Phase (TP)||73
94293|NCT01128738|220592|P1|COMPLETED|First Treatment Phase (TP)||74
94294|NCT01128738|220591|P2|STARTED|First Treatment Phase (TP)||74
94295|NCT01128738|220592|P1|STARTED|First Treatment Phase (TP)||78
94296|NCT01128595|220715|P4|NOT COMPLETED|Treatment Period 4||0
94297|NCT01128595|220716|P3|NOT COMPLETED|Treatment Period 4||0
94298|NCT01128595|220717|P2|NOT COMPLETED|Treatment Period 4||0
94299|NCT01128595|220718|P1|NOT COMPLETED|Treatment Period 4||0
94300|NCT01128595|220715|P4|COMPLETED|Treatment Period 4||7
94301|NCT01128595|220716|P3|COMPLETED|Treatment Period 4||7
94302|NCT01128595|220717|P2|COMPLETED|Treatment Period 4||5
94303|NCT01128595|220718|P1|COMPLETED|Treatment Period 4||7
94304|NCT01128595|220715|P4|STARTED|Treatment Period 4||7
94305|NCT01128595|220716|P3|STARTED|Treatment Period 4||7
94306|NCT01128595|220717|P2|STARTED|Treatment Period 4||5
94307|NCT01128595|220718|P1|STARTED|Treatment Period 4||7
94308|NCT01128595|220715|P4|NOT COMPLETED|Washout Period 3||0
94309|NCT01128595|220716|P3|NOT COMPLETED|Washout Period 3||0
94310|NCT01128595|220717|P2|NOT COMPLETED|Washout Period 3||0
94311|NCT01128595|220718|P1|NOT COMPLETED|Washout Period 3||0
94312|NCT01128595|220715|P4|COMPLETED|Washout Period 3||7
94313|NCT01128595|220716|P3|COMPLETED|Washout Period 3||7
94314|NCT01128595|220717|P2|COMPLETED|Washout Period 3||5
94315|NCT01128595|220718|P1|COMPLETED|Washout Period 3||7
94316|NCT01128595|220715|P4|STARTED|Washout Period 3||7
94317|NCT01128595|220716|P3|STARTED|Washout Period 3||7
94318|NCT01128595|220717|P2|STARTED|Washout Period 3||5
94319|NCT01128595|220718|P1|STARTED|Washout Period 3||7
94320|NCT01128595|220715|P4|NOT COMPLETED|Treatment Period 3||0
94321|NCT01128595|220716|P3|NOT COMPLETED|Treatment Period 3||0
94322|NCT01128595|220717|P2|NOT COMPLETED|Treatment Period 3||1
94323|NCT01128595|220718|P1|NOT COMPLETED|Treatment Period 3||0
94324|NCT01128595|220715|P4|COMPLETED|Treatment Period 3||7
94325|NCT01128595|220716|P3|COMPLETED|Treatment Period 3||7
94326|NCT01128595|220717|P2|COMPLETED|Treatment Period 3||5
94327|NCT01128595|220718|P1|COMPLETED|Treatment Period 3||7
94328|NCT01128595|220715|P4|STARTED|Treatment Period 3||7
94329|NCT01128595|220716|P3|STARTED|Treatment Period 3||7
94330|NCT01128595|220717|P2|STARTED|Treatment Period 3||6
94331|NCT01128595|220718|P1|STARTED|Treatment Period 3||7
94332|NCT01128595|220715|P4|NOT COMPLETED|Washout Period 2||0
94333|NCT01128595|220716|P3|NOT COMPLETED|Washout Period 2||0
94334|NCT01128595|220717|P2|NOT COMPLETED|Washout Period 2||0
94335|NCT01128595|220718|P1|NOT COMPLETED|Washout Period 2||0
94336|NCT01128595|220715|P4|COMPLETED|Washout Period 2||7
94337|NCT01128595|220716|P3|COMPLETED|Washout Period 2||7
94338|NCT01128595|220717|P2|COMPLETED|Washout Period 2||6
94339|NCT01128595|220718|P1|COMPLETED|Washout Period 2||7
94340|NCT01128595|220715|P4|STARTED|Washout Period 2||7
94341|NCT01128595|220716|P3|STARTED|Washout Period 2||7
94342|NCT01128595|220717|P2|STARTED|Washout Period 2||6
94343|NCT01128595|220718|P1|STARTED|Washout Period 2||7
94344|NCT01128595|220715|P4|NOT COMPLETED|Treatment Period 2||0
94345|NCT01128595|220716|P3|NOT COMPLETED|Treatment Period 2||0
94346|NCT01128595|220717|P2|NOT COMPLETED|Treatment Period 2||0
94347|NCT01128595|220718|P1|NOT COMPLETED|Treatment Period 2||0
94348|NCT01128595|220715|P4|COMPLETED|Treatment Period 2||7
94349|NCT01128595|220716|P3|COMPLETED|Treatment Period 2||7
94350|NCT01128595|220717|P2|COMPLETED|Treatment Period 2||6
94351|NCT01128595|220718|P1|COMPLETED|Treatment Period 2||7
94352|NCT01128595|220715|P4|STARTED|Treatment Period 2||7
94353|NCT01128595|220716|P3|STARTED|Treatment Period 2||7
94354|NCT01128595|220717|P2|STARTED|Treatment Period 2||6
94355|NCT01128595|220718|P1|STARTED|Treatment Period 2||7
94356|NCT01128595|220715|P4|NOT COMPLETED|Washout Period 1||0
94357|NCT01128595|220716|P3|NOT COMPLETED|Washout Period 1||0
94358|NCT01128595|220717|P2|NOT COMPLETED|Washout Period 1||0
94359|NCT01128595|220718|P1|NOT COMPLETED|Washout Period 1||0
94360|NCT01128595|220715|P4|COMPLETED|Washout Period 1||7
94361|NCT01128595|220716|P3|COMPLETED|Washout Period 1||7
94362|NCT01128595|220717|P2|COMPLETED|Washout Period 1||6
94363|NCT01128595|220718|P1|COMPLETED|Washout Period 1||7
94364|NCT01128595|220715|P4|STARTED|Washout Period 1||7
94365|NCT01128595|220716|P3|STARTED|Washout Period 1||7
94366|NCT01128595|220717|P2|STARTED|Washout Period 1||6
94367|NCT01128595|220718|P1|STARTED|Washout Period 1||7
94368|NCT01128595|220715|P4|NOT COMPLETED|Treatment Period 1||0
94369|NCT01128595|220716|P3|NOT COMPLETED|Treatment Period 1||0
94370|NCT01128595|220717|P2|NOT COMPLETED|Treatment Period 1||0
94371|NCT01128595|220718|P1|NOT COMPLETED|Treatment Period 1||0
94372|NCT01128595|220715|P4|COMPLETED|Treatment Period 1||7
94373|NCT01128595|220716|P3|COMPLETED|Treatment Period 1||7
94374|NCT01128595|220717|P2|COMPLETED|Treatment Period 1||6
94375|NCT01128595|220718|P1|COMPLETED|Treatment Period 1||7
94376|NCT01128595|220715|P4|STARTED|Treatment Period 1||7
94377|NCT01128595|220716|P3|STARTED|Treatment Period 1||7
94378|NCT01128595|220717|P2|STARTED|Treatment Period 1||6
94379|NCT01128595|220718|P1|STARTED|Treatment Period 1||7
94380|NCT01128569|220748|P6|NOT COMPLETED|Treatment Period 3||0
94381|NCT01128569|220749|P5|NOT COMPLETED|Treatment Period 3||0
94382|NCT01128569|220750|P4|NOT COMPLETED|Treatment Period 3||0
94383|NCT01128569|220751|P3|NOT COMPLETED|Treatment Period 3||0
94384|NCT01128569|220752|P2|NOT COMPLETED|Treatment Period 3||0
94385|NCT01128569|220753|P1|NOT COMPLETED|Treatment Period 3||0
94386|NCT01128569|220748|P6|COMPLETED|Treatment Period 3||9
94387|NCT01128569|220749|P5|COMPLETED|Treatment Period 3||9
94388|NCT01128569|220750|P4|COMPLETED|Treatment Period 3||8
94389|NCT01128569|220751|P3|COMPLETED|Treatment Period 3||8
94390|NCT01128569|220752|P2|COMPLETED|Treatment Period 3||7
94391|NCT01128569|220753|P1|COMPLETED|Treatment Period 3||9
94392|NCT01128569|220748|P6|STARTED|Treatment Period 3||9
94393|NCT01128569|220749|P5|STARTED|Treatment Period 3||9
94394|NCT01128569|220750|P4|STARTED|Treatment Period 3||8
94395|NCT01128569|220751|P3|STARTED|Treatment Period 3||8
94396|NCT01128569|220752|P2|STARTED|Treatment Period 3||7
94397|NCT01128569|220753|P1|STARTED|Treatment Period 3||9
94398|NCT01128569|220748|P6|NOT COMPLETED|Washout Period 2||0
94399|NCT01128569|220749|P5|NOT COMPLETED|Washout Period 2||0
94400|NCT01128569|220750|P4|NOT COMPLETED|Washout Period 2||0
94401|NCT01128569|220751|P3|NOT COMPLETED|Washout Period 2||0
94402|NCT01128569|220752|P2|NOT COMPLETED|Washout Period 2||0
94403|NCT01128569|220753|P1|NOT COMPLETED|Washout Period 2||0
94404|NCT01128569|220748|P6|COMPLETED|Washout Period 2||9
94405|NCT01128569|220749|P5|COMPLETED|Washout Period 2||9
94406|NCT01128569|220750|P4|COMPLETED|Washout Period 2||8
94407|NCT01128569|220751|P3|COMPLETED|Washout Period 2||8
94408|NCT01128569|220752|P2|COMPLETED|Washout Period 2||7
94409|NCT01128569|220753|P1|COMPLETED|Washout Period 2||9
94410|NCT01128569|220748|P6|STARTED|Washout Period 2||9
94411|NCT01128569|220749|P5|STARTED|Washout Period 2||9
94412|NCT01128569|220750|P4|STARTED|Washout Period 2||8
94413|NCT01128569|220751|P3|STARTED|Washout Period 2||8
94414|NCT01128569|220752|P2|STARTED|Washout Period 2||7
94415|NCT01128569|220753|P1|STARTED|Washout Period 2||9
94416|NCT01128569|220748|P6|NOT COMPLETED|Treatment Period 2||0
94417|NCT01128569|220749|P5|NOT COMPLETED|Treatment Period 2||0
94418|NCT01128569|220750|P4|NOT COMPLETED|Treatment Period 2||0
94419|NCT01128569|220751|P3|NOT COMPLETED|Treatment Period 2||0
94420|NCT01128569|220752|P2|NOT COMPLETED|Treatment Period 2||1
94421|NCT01128569|220753|P1|NOT COMPLETED|Treatment Period 2||0
94422|NCT01128569|220748|P6|COMPLETED|Treatment Period 2||9
94423|NCT01128569|220749|P5|COMPLETED|Treatment Period 2||9
94424|NCT01128569|220750|P4|COMPLETED|Treatment Period 2||8
94425|NCT01128569|220751|P3|COMPLETED|Treatment Period 2||8
94426|NCT01128569|220752|P2|COMPLETED|Treatment Period 2||7
94427|NCT01128569|220753|P1|COMPLETED|Treatment Period 2||9
94428|NCT01128569|220748|P6|STARTED|Treatment Period 2||9
94429|NCT01128569|220749|P5|STARTED|Treatment Period 2||9
94430|NCT01128569|220750|P4|STARTED|Treatment Period 2||8
94431|NCT01128569|220751|P3|STARTED|Treatment Period 2||8
94432|NCT01128569|220752|P2|STARTED|Treatment Period 2||8
94433|NCT01128569|220753|P1|STARTED|Treatment Period 2||9
94434|NCT01128569|220748|P6|NOT COMPLETED|Washout Period 1||0
94435|NCT01128569|220749|P5|NOT COMPLETED|Washout Period 1||0
94436|NCT01128569|220750|P4|NOT COMPLETED|Washout Period 1||0
94437|NCT01128569|220751|P3|NOT COMPLETED|Washout Period 1||1
94438|NCT01128569|220752|P2|NOT COMPLETED|Washout Period 1||0
94439|NCT01128569|220753|P1|NOT COMPLETED|Washout Period 1||0
94440|NCT01128569|220748|P6|COMPLETED|Washout Period 1||9
94441|NCT01128569|220749|P5|COMPLETED|Washout Period 1||9
94442|NCT01128569|220750|P4|COMPLETED|Washout Period 1||8
94443|NCT01128569|220751|P3|COMPLETED|Washout Period 1||8
94444|NCT01128569|220752|P2|COMPLETED|Washout Period 1||8
94445|NCT01128569|220753|P1|COMPLETED|Washout Period 1||9
94446|NCT01128569|220748|P6|STARTED|Washout Period 1||9
94447|NCT01128569|220749|P5|STARTED|Washout Period 1||9
94448|NCT01128569|220750|P4|STARTED|Washout Period 1||8
94449|NCT01128569|220751|P3|STARTED|Washout Period 1||9
94450|NCT01128569|220752|P2|STARTED|Washout Period 1||8
94451|NCT01128569|220753|P1|STARTED|Washout Period 1||9
94452|NCT01128569|220748|P6|NOT COMPLETED|Treatment Period 1||0
94453|NCT01128569|220749|P5|NOT COMPLETED|Treatment Period 1||0
94454|NCT01128569|220750|P4|NOT COMPLETED|Treatment Period 1||0
94455|NCT01128569|220751|P3|NOT COMPLETED|Treatment Period 1||0
94456|NCT01128569|220752|P2|NOT COMPLETED|Treatment Period 1||0
94457|NCT01128569|220753|P1|NOT COMPLETED|Treatment Period 1||0
94458|NCT01128569|220748|P6|COMPLETED|Treatment Period 1||9
94459|NCT01128569|220749|P5|COMPLETED|Treatment Period 1||9
94460|NCT01128569|220750|P4|COMPLETED|Treatment Period 1||8
94461|NCT01128569|220751|P3|COMPLETED|Treatment Period 1||9
94462|NCT01128569|220752|P2|COMPLETED|Treatment Period 1||8
94463|NCT01128569|220753|P1|COMPLETED|Treatment Period 1||9
94464|NCT01128569|220748|P6|STARTED|Treatment Period 1||9
94465|NCT01128569|220749|P5|STARTED|Treatment Period 1||9
94466|NCT01128569|220750|P4|STARTED|Treatment Period 1||8
94467|NCT01128569|220751|P3|STARTED|Treatment Period 1||9
94468|NCT01128569|220752|P2|STARTED|Treatment Period 1||8
94469|NCT01128569|220753|P1|STARTED|Treatment Period 1||9
94470|NCT01128543|220770|P1|NOT COMPLETED|Overall Study||4
94471|NCT01128543|220770|P1|COMPLETED|Overall Study||25
94472|NCT01128543|220770|P1|STARTED|Overall Study||29
94473|NCT01128426|220776|P1|NOT COMPLETED|Overall Study||0
94474|NCT01128426|220776|P1|COMPLETED|Overall Study||53902
94475|NCT01128426|220776|P1|STARTED|Overall Study||53902
94476|NCT01128413|220796|P2|NOT COMPLETED|Overall Study||1
94477|NCT01128413|220797|P1|NOT COMPLETED|Overall Study||4
94478|NCT01128413|220796|P2|COMPLETED|Overall Study||10
94479|NCT01128413|220797|P1|COMPLETED|Overall Study||7
94480|NCT01128413|220796|P2|STARTED|Overall Study||11
94481|NCT01128413|220797|P1|STARTED|Overall Study||11
94482|NCT01128400|220806|P3|NOT COMPLETED|Overall Study||16
94483|NCT01128400|220807|P2|NOT COMPLETED|Overall Study||0
94484|NCT01128400|220808|P1|NOT COMPLETED|Overall Study||2
94485|NCT01128400|220806|P3|COMPLETED|Overall Study||7
94486|NCT01128400|220807|P2|COMPLETED|Overall Study||9
94487|NCT01128400|220808|P1|COMPLETED|Overall Study||6
94488|NCT01128400|220806|P3|STARTED|Overall Study||23
94489|NCT01128400|220807|P2|STARTED|Overall Study||9
94490|NCT01128400|220808|P1|STARTED|Overall Study||8
94491|NCT01128270|220819|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
94492|NCT01128270|220819|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
94493|NCT01128270|220819|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
94494|NCT01128270|220819|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
94495|NCT01128270|220819|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
94496|NCT01128270|220819|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
94497|NCT01128270|220819|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
94498|NCT01128270|220819|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
94499|NCT01128270|220819|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
94500|NCT01128270|220819|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
94501|NCT01128270|220819|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
94502|NCT01128270|220819|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
94503|NCT01128244|220832|P1|NOT COMPLETED|Overall Study||3
94504|NCT01128244|220832|P1|COMPLETED|Overall Study||10
94505|NCT01128244|220832|P1|STARTED|Overall Study||13
94506|NCT01128192|220842|P3|NOT COMPLETED|Overall Study||0
94507|NCT01128192|220843|P2|NOT COMPLETED|Overall Study||0
94508|NCT01128192|220844|P1|NOT COMPLETED|Overall Study||0
94509|NCT01128192|220842|P3|COMPLETED|Overall Study||7
94510|NCT01128192|220843|P2|COMPLETED|Overall Study||19
94511|NCT01128192|220844|P1|COMPLETED|Overall Study||19
94512|NCT01128192|220842|P3|STARTED|Overall Study||7
94513|NCT01128192|220843|P2|STARTED|Overall Study||19
94514|NCT01128192|220844|P1|STARTED|Overall Study||19
94515|NCT01128179|220873|P2|NOT COMPLETED|Overall Study||0
94516|NCT01128179|220874|P1|NOT COMPLETED|Overall Study||2
94517|NCT01128179|220873|P2|COMPLETED|Overall Study||12
94518|NCT01128179|220874|P1|COMPLETED|Overall Study||21
94519|NCT01128179|220873|P2|STARTED|Overall Study||12
94520|NCT01128179|220874|P1|STARTED|Overall Study||23
94521|NCT01128153|220894|P2|NOT COMPLETED|Overall Study||15
94522|NCT01128153|220895|P1|NOT COMPLETED|Overall Study||16
94523|NCT01128153|220894|P2|COMPLETED|Overall Study|Completed 24 weeks|113
94524|NCT01128153|220895|P1|COMPLETED|Overall Study|Completed 24 weeks|113
94525|NCT01128153|220894|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
94526|NCT01128153|220895|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
94527|NCT01128153|220894|P2|STARTED|Overall Study|Randomised|128
94528|NCT01128153|220895|P1|STARTED|Overall Study|Randomised|129
94529|NCT01128114|220911|P1|NOT COMPLETED|Overall Study||8
94530|NCT01128114|220911|P1|COMPLETED|Overall Study||24
94531|NCT01128114|220911|P1|STARTED|Overall Study||32
94532|NCT01128049|220918|P3|NOT COMPLETED|Overall Study||0
94533|NCT01128049|220919|P2|NOT COMPLETED|Overall Study||0
94534|NCT01128049|220920|P1|NOT COMPLETED|Overall Study||0
94535|NCT01128049|220918|P3|COMPLETED|Overall Study||5
94536|NCT01128049|220919|P2|COMPLETED|Overall Study||5
94537|NCT01128049|220920|P1|COMPLETED|Overall Study||5
94538|NCT01128049|220918|P3|STARTED|Overall Study||5
94539|NCT01128049|220919|P2|STARTED|Overall Study||5
94540|NCT01128049|220920|P1|STARTED|Overall Study||5
94541|NCT01127763|220928|P1|NOT COMPLETED|Overall Study||5
94542|NCT01127763|220928|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
94543|NCT01127763|220928|P1|STARTED|Overall Study||25
94544|NCT01127737|220939|P2|NOT COMPLETED|Overall Study||0
94545|NCT01127737|220940|P1|NOT COMPLETED|Overall Study||0
94546|NCT01127737|220939|P2|COMPLETED|Overall Study||38
94547|NCT01127737|220940|P1|COMPLETED|Overall Study||37
94548|NCT01127737|220939|P2|STARTED|Overall Study||38
94549|NCT01127737|220940|P1|STARTED|Overall Study||37
94550|NCT01127646|220948|P2|NOT COMPLETED|Overall Study||1
94551|NCT01127646|220949|P1|NOT COMPLETED|Overall Study||1
94552|NCT01127646|220948|P2|COMPLETED|Overall Study||7
94553|NCT01127646|220949|P1|COMPLETED|Overall Study||14
94554|NCT01127646|220948|P2|STARTED|Overall Study||8
94555|NCT01127646|220949|P1|STARTED|Overall Study||15
94556|NCT01127607|220983|P2|NOT COMPLETED|Phase II (Between Subjects)||2
94557|NCT01127607|220984|P1|NOT COMPLETED|Phase II (Between Subjects)||1
94558|NCT01127607|220983|P2|COMPLETED|Phase II (Between Subjects)||11
94559|NCT01127607|220984|P1|COMPLETED|Phase II (Between Subjects)||13
94560|NCT01127607|220983|P2|STARTED|Phase II (Between Subjects)||13
94561|NCT01127607|220984|P1|STARTED|Phase II (Between Subjects)||14
94562|NCT01127607|220983|P2|NOT COMPLETED|Phase I (Within Subjects)||0
94563|NCT01127607|220984|P1|NOT COMPLETED|Phase I (Within Subjects)||0
94564|NCT01127607|220983|P2|COMPLETED|Phase I (Within Subjects)||13
94565|NCT01127607|220984|P1|COMPLETED|Phase I (Within Subjects)||14
94566|NCT01127607|220983|P2|STARTED|Phase I (Within Subjects)||13
94567|NCT01127607|220984|P1|STARTED|Phase I (Within Subjects)||14
94568|NCT01127581|221057|P2|NOT COMPLETED|Overall Study||0
94569|NCT01127581|221058|P1|NOT COMPLETED|Overall Study||0
94570|NCT01127581|221057|P2|COMPLETED|Overall Study||680
94571|NCT01127581|221058|P1|COMPLETED|Overall Study||678
94572|NCT01127581|221057|P2|STARTED|Overall Study||680
94573|NCT01127581|221058|P1|STARTED|Overall Study||678
94574|NCT01127438|221090|P6|NOT COMPLETED|Overall Study||0
94575|NCT01127438|221091|P5|NOT COMPLETED|Overall Study||0
94576|NCT01127438|221092|P4|NOT COMPLETED|Overall Study||0
94577|NCT01127438|221093|P3|NOT COMPLETED|Overall Study||0
94578|NCT01127438|221094|P2|NOT COMPLETED|Overall Study||0
94579|NCT01127438|221095|P1|NOT COMPLETED|Overall Study||0
94580|NCT01127438|221090|P6|COMPLETED|Overall Study||25
94581|NCT01127438|221091|P5|COMPLETED|Overall Study||28
94582|NCT01127438|221092|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
94583|NCT01127438|221093|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
94584|NCT01127438|221094|P2|COMPLETED|Overall Study||25
94585|NCT01127438|221095|P1|COMPLETED|Overall Study||25
94586|NCT01127438|221090|P6|STARTED|Overall Study||25
94587|NCT01127438|221091|P5|STARTED|Overall Study||28
94588|NCT01127438|221092|P4|STARTED|Overall Study||24
94589|NCT01127438|221093|P3|STARTED|Overall Study||26
94590|NCT01127438|221094|P2|STARTED|Overall Study||25
94591|NCT01127438|221095|P1|STARTED|Overall Study||25
94592|NCT01127321|221122|P5|NOT COMPLETED|Overall Study||0
94593|NCT01127321|221123|P4|NOT COMPLETED|Overall Study||0
94594|NCT01127321|221124|P3|NOT COMPLETED|Overall Study||0
94595|NCT01127321|221125|P2|NOT COMPLETED|Overall Study||0
94596|NCT01127321|221126|P1|NOT COMPLETED|Overall Study||0
94597|NCT01127321|221122|P5|COMPLETED|Overall Study||5
94598|NCT01127321|221123|P4|COMPLETED|Overall Study||7
94599|NCT01127321|221124|P3|COMPLETED|Overall Study||1
94600|NCT01127321|221125|P2|COMPLETED|Overall Study||1
94601|NCT01127321|221126|P1|COMPLETED|Overall Study||3
94602|NCT01127321|221122|P5|STARTED|Overall Study||5
94603|NCT01127321|221123|P4|STARTED|Overall Study||7
94604|NCT01127321|221124|P3|STARTED|Overall Study||1
94605|NCT01127321|221125|P2|STARTED|Overall Study||1
94606|NCT01127321|221126|P1|STARTED|Overall Study||3
94607|NCT01127256|221150|P2|NOT COMPLETED|Overall Study||39
94608|NCT01127256|221151|P1|NOT COMPLETED|Overall Study||39
94609|NCT01127256|221150|P2|COMPLETED|Overall Study||65
94610|NCT01127256|221151|P1|COMPLETED|Overall Study||57
94611|NCT01127256|221150|P2|STARTED|Overall Study||104
94612|NCT01127256|221151|P1|STARTED|Overall Study||96
94613|NCT01127165|221163|P2|NOT COMPLETED|Overall Study||19
94614|NCT01127165|221164|P1|NOT COMPLETED|Overall Study||16
94615|NCT01127165|221163|P2|COMPLETED|Overall Study||41
94616|NCT01127165|221164|P1|COMPLETED|Overall Study||49
94617|NCT01127165|221163|P2|STARTED|Overall Study||60
94618|NCT01127165|221164|P1|STARTED|Overall Study||65
94619|NCT01127139|221176|P1|NOT COMPLETED|Overall Study||57
94620|NCT01127139|221176|P1|COMPLETED|Overall Study||3771
94621|NCT01127139|221176|P1|Number of Participants Analyzed|Overall Study||3828
94622|NCT01127139|221176|P1|STARTED|Overall Study||3828
94623|NCT01127087|221193|P2|NOT COMPLETED|Overall Study||0
94624|NCT01127087|221194|P1|NOT COMPLETED|Overall Study||0
94625|NCT01127087|221193|P2|COMPLETED|Overall Study||2
94626|NCT01127087|221194|P1|COMPLETED|Overall Study||8
94627|NCT01127087|221193|P2|STARTED|Overall Study||2
94628|NCT01127087|221194|P1|STARTED|Overall Study||8
94629|NCT01126801|221204|P2|NOT COMPLETED|Overall Study||0
94630|NCT01126801|221205|P1|NOT COMPLETED|Overall Study||0
94631|NCT01126801|221204|P2|COMPLETED|Overall Study||1
94632|NCT01126801|221205|P1|COMPLETED|Overall Study||1
94633|NCT01126801|221204|P2|STARTED|Overall Study||1
94634|NCT01126801|221205|P1|STARTED|Overall Study||1
94635|NCT01126723|221213|P2|NOT COMPLETED|Overall Study||3
94636|NCT01126723|221214|P1|NOT COMPLETED|Overall Study||6
94637|NCT01126723|221213|P2|COMPLETED|Overall Study||28
94638|NCT01126723|221214|P1|COMPLETED|Overall Study||29
94639|NCT01126723|221213|P2|STARTED|Overall Study||31
94640|NCT01126723|221214|P1|STARTED|Overall Study||35
94641|NCT01126671|221222|P2|NOT COMPLETED|Overall Study||0
94642|NCT01126671|221223|P1|NOT COMPLETED|Overall Study||0
94643|NCT01126671|221222|P2|COMPLETED|Overall Study||29
94644|NCT01126671|221223|P1|COMPLETED|Overall Study||25
94645|NCT01126671|221222|P2|STARTED|Overall Study||29
94646|NCT01126671|221223|P1|STARTED|Overall Study||25
94647|NCT01126619|221231|P1|NOT COMPLETED|Overall Study||17
94648|NCT01126619|221231|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
94649|NCT01126619|221231|P1|STARTED|Overall Study||103
94650|NCT01126593|221246|P3|NOT COMPLETED|Overall Study||2
94651|NCT01126593|221247|P2|NOT COMPLETED|Overall Study||2
94652|NCT01126593|221248|P1|NOT COMPLETED|Overall Study||4
94653|NCT01126593|221246|P3|COMPLETED|Overall Study||32
94654|NCT01126593|221247|P2|COMPLETED|Overall Study||27
94655|NCT01126593|221248|P1|COMPLETED|Overall Study||29
94656|NCT01126593|221246|P3|STARTED|Overall Study||34
94657|NCT01126593|221247|P2|STARTED|Overall Study||29
94658|NCT01126593|221248|P1|STARTED|Overall Study||33
94659|NCT01126580|221259|P3|NOT COMPLETED|Overall Study||55
94660|NCT01126580|221260|P2|NOT COMPLETED|Overall Study||52
94661|NCT01126580|221261|P1|NOT COMPLETED|Overall Study||49
94662|NCT01126580|221259|P3|COMPLETED|Overall Study||213
94663|NCT01126580|221260|P2|COMPLETED|Overall Study||218
94664|NCT01126580|221261|P1|COMPLETED|Overall Study||220
94665|NCT01126580|221259|P3|Completed 26 Weeks|Overall Study||226
94666|NCT01126580|221260|P2|Completed 26 Weeks|Overall Study||242
94667|NCT01126580|221261|P1|Completed 26 Weeks|Overall Study||233
94668|NCT01126580|221259|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
94669|NCT01126580|221260|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
94670|NCT01126580|221261|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
94671|NCT01126580|221259|P3|STARTED|Overall Study||268
94672|NCT01126580|221260|P2|STARTED|Overall Study||270
94673|NCT01126580|221261|P1|STARTED|Overall Study||269
94674|NCT01126541|221356|P3|NOT COMPLETED|Overall Study||26
94675|NCT01126541|221357|P2|NOT COMPLETED|Overall Study||12
94676|NCT01126541|221358|P1|NOT COMPLETED|Overall Study||10
94677|NCT01126541|221356|P3|COMPLETED|Overall Study||55
94678|NCT01126541|221357|P2|COMPLETED|Overall Study||61
94679|NCT01126541|221358|P1|COMPLETED|Overall Study||60
94680|NCT01126541|221356|P3|STARTED|Overall Study||81
94681|NCT01126541|221357|P2|STARTED|Overall Study||73
94682|NCT01126541|221358|P1|STARTED|Overall Study||70
94683|NCT01126437|221442|P3|NOT COMPLETED|Overall Study||1313
94684|NCT01126437|221443|P2|NOT COMPLETED|Overall Study||1330
94685|NCT01126437|221444|P1|NOT COMPLETED|Overall Study||1341
94686|NCT01126437|221442|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
94687|NCT01126437|221443|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
94688|NCT01126437|221444|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
94689|NCT01126437|221442|P3|STARTED|Overall Study||5713
94690|NCT01126437|221443|P2|STARTED|Overall Study||5729
94691|NCT01126437|221444|P1|STARTED|Overall Study||5741
94692|NCT01126424|221482|P6|NOT COMPLETED|Overall Study||0
94693|NCT01126424|221483|P5|NOT COMPLETED|Overall Study||2
94694|NCT01126424|221484|P4|NOT COMPLETED|Overall Study||3
94695|NCT01126424|221485|P3|NOT COMPLETED|Overall Study||1
94696|NCT01126424|221486|P2|NOT COMPLETED|Overall Study||0
94697|NCT01126424|221487|P1|NOT COMPLETED|Overall Study||0
94698|NCT01126424|221482|P6|COMPLETED|Overall Study||4
94699|NCT01126424|221483|P5|COMPLETED|Overall Study||2
94700|NCT01126424|221484|P4|COMPLETED|Overall Study||3
94701|NCT01126424|221485|P3|COMPLETED|Overall Study||4
94702|NCT01126424|221486|P2|COMPLETED|Overall Study||4
94703|NCT01126424|221487|P1|COMPLETED|Overall Study||3
94704|NCT01126424|221482|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
94705|NCT01126424|221483|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
94706|NCT01126424|221484|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
94707|NCT01126424|221485|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
94708|NCT01126424|221486|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
94709|NCT01126424|221487|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
94710|NCT01126424|221482|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
94711|NCT01126424|221483|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
94712|NCT01126424|221484|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
94713|NCT01126424|221485|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
94714|NCT01126424|221486|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
94715|NCT01126424|221487|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
94716|NCT01126359|221510|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
94717|NCT01126359|221511|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
94718|NCT01126359|221510|P2|COMPLETED|Second Intervention (20-minutes)||5
94719|NCT01126359|221511|P1|COMPLETED|Second Intervention (20-minutes)||5
94720|NCT01126359|221510|P2|STARTED|Second Intervention (20-minutes)||5
94721|NCT01126359|221511|P1|STARTED|Second Intervention (20-minutes)||5
94722|NCT01126359|221510|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
94723|NCT01126359|221511|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
94724|NCT01126359|221510|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
94725|NCT01126359|221511|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
94726|NCT01126359|221510|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
94727|NCT01126359|221511|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
94728|NCT01126359|221510|P2|NOT COMPLETED|First Intervention (20-minutes)||1
94729|NCT01126359|221511|P1|NOT COMPLETED|First Intervention (20-minutes)||0
94730|NCT01126359|221510|P2|COMPLETED|First Intervention (20-minutes)||5
94731|NCT01126359|221511|P1|COMPLETED|First Intervention (20-minutes)||5
94732|NCT01126359|221510|P2|STARTED|First Intervention (20-minutes)||6
94733|NCT01126359|221511|P1|STARTED|First Intervention (20-minutes)||5
94734|NCT01126268|221523|P1|NOT COMPLETED|Overall Study||1
94735|NCT01126268|221523|P1|COMPLETED|Overall Study||37
94736|NCT01126268|221523|P1|STARTED|Overall Study||38
94737|NCT01126099|221547|P2|NOT COMPLETED|Open-label Extension||1
94738|NCT01126099|221548|P1|NOT COMPLETED|Open-label Extension||1
94739|NCT01126099|221547|P2|COMPLETED|Open-label Extension||6
94740|NCT01126099|221548|P1|COMPLETED|Open-label Extension||4
94741|NCT01126099|221547|P2|STARTED|Open-label Extension||7
94742|NCT01126099|221548|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
94743|NCT01126099|221547|P2|NOT COMPLETED|Double Blind Phase||2
94744|NCT01126099|221548|P1|NOT COMPLETED|Double Blind Phase||4
94745|NCT01126099|221547|P2|COMPLETED|Double Blind Phase||7
94746|NCT01126099|221548|P1|COMPLETED|Double Blind Phase||7
94747|NCT01126099|221547|P2|STARTED|Double Blind Phase||9
94748|NCT01126099|221548|P1|STARTED|Double Blind Phase||11
94749|NCT01126060|221562|P2|NOT COMPLETED|Overall Study||2
94750|NCT01126060|221563|P1|NOT COMPLETED|Overall Study||0
94751|NCT01126060|221562|P2|COMPLETED|Overall Study||38
94752|NCT01126060|221563|P1|COMPLETED|Overall Study||40
94753|NCT01126060|221562|P2|STARTED|Overall Study||40
94754|NCT01126060|221563|P1|STARTED|Overall Study||40
94755|NCT01125930|221571|P2|NOT COMPLETED|Overall Study||10
94756|NCT01125930|221572|P1|NOT COMPLETED|Overall Study||1
94757|NCT01125930|221571|P2|COMPLETED|Overall Study||36
94758|NCT01125930|221572|P1|COMPLETED|Overall Study||21
94759|NCT01125930|221571|P2|STARTED|Overall Study||46
94760|NCT01125930|221572|P1|STARTED|Overall Study||22
94761|NCT01125917|221726|P1|NOT COMPLETED|Overall Study||339
94762|NCT01125917|221726|P1|COMPLETED|Overall Study||15
94763|NCT01125917|221726|P1|STARTED|Overall Study||354
94764|NCT01125813|221730|P1|NOT COMPLETED|Overall Study||6
94765|NCT01125813|221730|P1|COMPLETED|Overall Study||30
94766|NCT01125813|221730|P1|STARTED|Overall Study||36
94767|NCT01125800|221740|P5|NOT COMPLETED|Phase II||11
94768|NCT01125800|221741|P4|NOT COMPLETED|Phase II||1
94769|NCT01125800|221742|P3|NOT COMPLETED|Phase II||0
94770|NCT01125800|221743|P2|NOT COMPLETED|Phase II||0
94771|NCT01125800|221744|P1|NOT COMPLETED|Phase II||0
94772|NCT01125800|221740|P5|COMPLETED|Phase II||5
94773|NCT01125800|221741|P4|COMPLETED|Phase II||0
94774|NCT01125800|221742|P3|COMPLETED|Phase II||0
94775|NCT01125800|221743|P2|COMPLETED|Phase II||0
94776|NCT01125800|221744|P1|COMPLETED|Phase II||0
94777|NCT01125800|221740|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
94778|NCT01125800|221741|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
94779|NCT01125800|221742|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
94780|NCT01125800|221743|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
94781|NCT01125800|221744|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
94782|NCT01125800|221740|P5|NOT COMPLETED|Phase I||0
94783|NCT01125800|221741|P4|NOT COMPLETED|Phase I||11
94784|NCT01125800|221742|P3|NOT COMPLETED|Phase I||4
94785|NCT01125800|221743|P2|NOT COMPLETED|Phase I||9
94786|NCT01125800|221744|P1|NOT COMPLETED|Phase I||8
94787|NCT01125800|221740|P5|COMPLETED|Phase I||0
94788|NCT01125800|221741|P4|COMPLETED|Phase I||10
94789|NCT01125800|221742|P3|COMPLETED|Phase I||7
94790|NCT01125800|221743|P2|COMPLETED|Phase I||7
94791|NCT01125800|221744|P1|COMPLETED|Phase I||3
94792|NCT01125800|221740|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
94793|NCT01125800|221741|P4|STARTED|Phase I||21
94794|NCT01125800|221742|P3|STARTED|Phase I||11
94795|NCT01125800|221743|P2|STARTED|Phase I||16
94796|NCT01125800|221744|P1|STARTED|Phase I||11
94797|NCT01125774|221783|P4|NOT COMPLETED|Overall Study||3
94798|NCT01125774|221784|P3|NOT COMPLETED|Overall Study||9
94799|NCT01125774|221785|P2|NOT COMPLETED|Overall Study||554
94800|NCT01125774|221786|P1|NOT COMPLETED|Overall Study||1125
94801|NCT01125774|221783|P4|COMPLETED|Overall Study|Completed study at least once|3
94802|NCT01125774|221784|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
94803|NCT01125774|221785|P2|COMPLETED|Overall Study||948
94804|NCT01125774|221786|P1|COMPLETED|Overall Study||1893
94805|NCT01125774|221783|P4|Treated|Overall Study||5
94806|NCT01125774|221784|P3|Treated|Overall Study|Received telcagepant|21
94807|NCT01125774|221785|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
94808|NCT01125774|221786|P1|Treated|Overall Study||2638
94809|NCT01125774|221783|P4|STARTED|Overall Study|Unique participants randomized|6
94810|NCT01125774|221784|P3|STARTED|Overall Study|Unique participants randomized|22
94811|NCT01125774|221785|P2|STARTED|Overall Study|Randomized|1502
94812|NCT01125774|221786|P1|STARTED|Overall Study|Randomized|3018
94813|NCT01125748|221810|P2|NOT COMPLETED|Overall Study||14
94814|NCT01125748|221811|P1|NOT COMPLETED|Overall Study||10
94815|NCT01125748|221810|P2|COMPLETED|Overall Study||74
94816|NCT01125748|221811|P1|COMPLETED|Overall Study||78
94817|NCT01125748|221810|P2|STARTED|Overall Study||88
94818|NCT01125748|221811|P1|STARTED|Overall Study||88
94819|NCT01125722|221821|P2|NOT COMPLETED|Overall Study||1
94820|NCT01125722|221822|P1|NOT COMPLETED|Overall Study||3
94821|NCT01125722|221821|P2|COMPLETED|Overall Study||36
94822|NCT01125722|221822|P1|COMPLETED|Overall Study||34
94823|NCT01125722|221821|P2|STARTED|Overall Study||37
94824|NCT01125722|221822|P1|STARTED|Overall Study||37
94825|NCT01125605|221836|P1|NOT COMPLETED|Overall Study||0
94826|NCT01125605|221836|P1|COMPLETED|Overall Study||325
94827|NCT01125605|221836|P1|Safety|Overall Study|1 patient was only analysed for safety|326
94828|NCT01125605|221836|P1|STARTED|Overall Study|started = had baseline values|325
94829|NCT01125566|221869|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
94830|NCT01125566|221870|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
94831|NCT01125566|221871|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
94832|NCT01125566|221869|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
94833|NCT01125566|221870|P2|COMPLETED|Patients Who Switched From AV to TV||0
94834|NCT01125566|221871|P1|COMPLETED|Patients Who Switched From AV to TV||0
94835|NCT01125566|221869|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
94836|NCT01125566|221870|P2|STARTED|Patients Who Switched From AV to TV||0
94837|NCT01125566|221871|P1|STARTED|Patients Who Switched From AV to TV||0
94838|NCT01125566|221869|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
94839|NCT01125566|221870|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
94840|NCT01125566|221871|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
94841|NCT01125566|221869|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
94842|NCT01125566|221870|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
94843|NCT01125566|221871|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
94844|NCT01125566|221869|P3|STARTED|Patients Before the Switch (26Apr2013)||0
94845|NCT01125566|221870|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
94846|NCT01125566|221871|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
94847|NCT01125514|221884|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
94848|NCT01125514|221884|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
94849|NCT01125514|221884|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
94850|NCT01125514|221884|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
94851|NCT01125514|221884|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
94852|NCT01125514|221884|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
94853|NCT01125514|221884|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
94854|NCT01125514|221884|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
94855|NCT01125514|221884|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
94856|NCT01125514|221884|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
94857|NCT01125514|221884|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
94858|NCT01125189|221959|P3|NOT COMPLETED|Follow up Period||16
94859|NCT01125189|221960|P2|NOT COMPLETED|Follow up Period||15
94860|NCT01125189|221961|P1|NOT COMPLETED|Follow up Period||20
94861|NCT01125189|221959|P3|COMPLETED|Follow up Period||58
94862|NCT01125189|221960|P2|COMPLETED|Follow up Period||138
94863|NCT01125189|221961|P1|COMPLETED|Follow up Period||132
94864|NCT01125189|221959|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
94865|NCT01125189|221960|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
94866|NCT01125189|221961|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
94867|NCT01125189|221959|P3|NOT COMPLETED|Treatment Period||41
94868|NCT01125189|221960|P2|NOT COMPLETED|Treatment Period||35
94869|NCT01125189|221961|P1|NOT COMPLETED|Treatment Period||31
94870|NCT01125189|221959|P3|COMPLETED|Treatment Period||37
94871|NCT01125189|221960|P2|COMPLETED|Treatment Period||123
94872|NCT01125189|221961|P1|COMPLETED|Treatment Period||128
94873|NCT01125189|221959|P3|STARTED|Treatment Period||78
94874|NCT01125189|221960|P2|STARTED|Treatment Period||158
94875|NCT01125189|221961|P1|STARTED|Treatment Period||159
94876|NCT01125098|221989|P2|NOT COMPLETED|Overall Study||0
94877|NCT01125098|221990|P1|NOT COMPLETED|Overall Study||3
94878|NCT01125098|221989|P2|COMPLETED|Overall Study||90
94879|NCT01125098|221990|P1|COMPLETED|Overall Study||88
94880|NCT01125098|221989|P2|STARTED|Overall Study||90
94881|NCT01125098|221990|P1|STARTED|Overall Study||91
94882|NCT01124955|221998|P2|NOT COMPLETED|Overall Study||0
94883|NCT01124955|221999|P1|NOT COMPLETED|Overall Study||0
94884|NCT01124955|221998|P2|COMPLETED|Overall Study||40
94885|NCT01124955|221999|P1|COMPLETED|Overall Study||40
94886|NCT01124955|221998|P2|STARTED|Overall Study||40
94887|NCT01124955|221999|P1|STARTED|Overall Study||40
94888|NCT01124916|222015|P2|NOT COMPLETED|Overall Study||2
94889|NCT01124916|222016|P1|NOT COMPLETED|Overall Study||3
94890|NCT01124916|222015|P2|COMPLETED|Overall Study||38
94891|NCT01124916|222016|P1|COMPLETED|Overall Study||35
94892|NCT01124916|222015|P2|STARTED|Overall Study||40
94893|NCT01124916|222016|P1|STARTED|Overall Study||38
94894|NCT01124864|222030|P6|NOT COMPLETED|Overall Study||3
94895|NCT01124864|222031|P5|NOT COMPLETED|Overall Study||30
94896|NCT01124864|222032|P4|NOT COMPLETED|Overall Study||21
94897|NCT01124864|222033|P3|NOT COMPLETED|Overall Study||34
94898|NCT01124864|222034|P2|NOT COMPLETED|Overall Study||35
94899|NCT01124864|222035|P1|NOT COMPLETED|Overall Study||28
94900|NCT01124864|222030|P6|COMPLETED|Overall Study||0
94901|NCT01124864|222031|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
94902|NCT01124864|222032|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
94903|NCT01124864|222033|P3|COMPLETED|Overall Study||0
94904|NCT01124864|222034|P2|COMPLETED|Overall Study||0
94905|NCT01124864|222035|P1|COMPLETED|Overall Study||0
94906|NCT01124864|222030|P6|STARTED|Overall Study||3
94907|NCT01124864|222031|P5|STARTED|Overall Study||31
94908|NCT01124864|222032|P4|STARTED|Overall Study||22
94909|NCT01124864|222033|P3|STARTED|Overall Study||34
94910|NCT01124864|222034|P2|STARTED|Overall Study||35
94911|NCT01124864|222035|P1|STARTED|Overall Study||28
94912|NCT01124838|222069|P2|NOT COMPLETED|Overall Study||15
94913|NCT01124838|222070|P1|NOT COMPLETED|Overall Study||18
94914|NCT01124838|222069|P2|COMPLETED|Overall Study||116
94915|NCT01124838|222070|P1|COMPLETED|Overall Study||112
94916|NCT01124838|222069|P2|Enrolled in Japan Sub-study|Overall Study||16
94917|NCT01124838|222070|P1|Enrolled in Japan Sub-study|Overall Study||16
94918|NCT01124838|222069|P2|Enrolled in Main Study|Overall Study||115
94919|NCT01124838|222070|P1|Enrolled in Main Study|Overall Study||114
94920|NCT01124838|222069|P2|STARTED|Overall Study||131
94921|NCT01124838|222070|P1|STARTED|Overall Study||130
94922|NCT01124786|222116|P2|NOT COMPLETED|Overall Study||5
94923|NCT01124786|222117|P1|NOT COMPLETED|Overall Study||4
94924|NCT01124786|222116|P2|COMPLETED|Overall Study||180
94925|NCT01124786|222117|P1|COMPLETED|Overall Study||178
94926|NCT01124786|222116|P2|Tumor Evaluable Population|Overall Study||180
94927|NCT01124786|222117|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
94928|NCT01124786|222116|P2|Safety Population|Overall Study||181
94929|NCT01124786|222117|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
94930|NCT01124786|222116|P2|Intent-to-Treat (ITT) Population|Overall Study||185
94931|NCT01124786|222117|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
94932|NCT01124786|222116|P2|STARTED|Overall Study||185
94933|NCT01124786|222117|P1|STARTED|Overall Study||182
94934|NCT01124643|222137|P1|NOT COMPLETED|Overall Study||1
94935|NCT01124643|222137|P1|COMPLETED|Overall Study||34
94936|NCT01124643|222137|P1|STARTED|Overall Study||35
94937|NCT01124617|222151|P2|NOT COMPLETED|Overall Study||6
94938|NCT01124617|222152|P1|NOT COMPLETED|Overall Study||19
94939|NCT01124617|222151|P2|COMPLETED|Overall Study||25
94940|NCT01124617|222152|P1|COMPLETED|Overall Study||41
94941|NCT01124617|222151|P2|STARTED|Overall Study||31
94942|NCT01124617|222152|P1|STARTED|Overall Study||60
94943|NCT01124604|222184|P2|NOT COMPLETED|Overall Study||2
94944|NCT01124604|222185|P1|NOT COMPLETED|Overall Study||15
94945|NCT01124604|222184|P2|COMPLETED|Overall Study||29
94946|NCT01124604|222185|P1|COMPLETED|Overall Study||45
94947|NCT01124604|222184|P2|STARTED|Overall Study||31
94948|NCT01124604|222185|P1|STARTED|Overall Study||60
94949|NCT01124448|222224|P2|NOT COMPLETED|Overall Study||3
94950|NCT01124448|222225|P1|NOT COMPLETED|Overall Study||2
94951|NCT01124448|222224|P2|COMPLETED|Overall Study||12
94952|NCT01124448|222225|P1|COMPLETED|Overall Study||23
94953|NCT01124448|222224|P2|STARTED|Overall Study||15
94954|NCT01124448|222225|P1|STARTED|Overall Study||25
94955|NCT01124422|222233|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
94956|NCT01124422|222234|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
94957|NCT01124422|222235|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
94958|NCT01124422|222233|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
94959|NCT01124422|222234|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
94960|NCT01124422|222235|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
94961|NCT01124422|222233|P3|STARTED|4-Week Double-blind Treatment Phase||124
94962|NCT01124422|222234|P2|STARTED|4-Week Double-blind Treatment Phase||131
94963|NCT01124422|222235|P1|STARTED|4-Week Double-blind Treatment Phase||0
94964|NCT01124422|222233|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
94965|NCT01124422|222234|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
94966|NCT01124422|222235|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
94967|NCT01124422|222233|P3|COMPLETED|4-Week Open-label Run-in Phase||0
94968|NCT01124422|222234|P2|COMPLETED|4-Week Open-label Run-in Phase||0
94969|NCT01124422|222235|P1|COMPLETED|4-Week Open-label Run-in Phase||255
94970|NCT01124422|222233|P3|STARTED|4-Week Open-label Run-in Phase||0
94971|NCT01124422|222234|P2|STARTED|4-Week Open-label Run-in Phase||0
94972|NCT01124422|222235|P1|STARTED|4-Week Open-label Run-in Phase||338
94973|NCT01124370|222277|P1|NOT COMPLETED|Overall Study||20
94974|NCT01124370|222277|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
94975|NCT01124370|222277|P1|3 Month Visit|Overall Study|Defines evaluable population|47
94976|NCT01124370|222277|P1|Therapy Initiated|Overall Study||48
94977|NCT01124370|222277|P1|Successfully Implanted|Overall Study||50
94978|NCT01124370|222277|P1|STARTED|Overall Study|Underwent implant attempt|57
94979|NCT01124305|222289|P2|NOT COMPLETED|Overall Study||10
94980|NCT01124305|222290|P1|NOT COMPLETED|Overall Study||8
94981|NCT01124305|222289|P2|COMPLETED|Overall Study||26
94982|NCT01124305|222290|P1|COMPLETED|Overall Study||26
94983|NCT01124305|222289|P2|STARTED|Overall Study||36
94984|NCT01124305|222290|P1|STARTED|Overall Study||34
94985|NCT01124292|222305|P3|NOT COMPLETED|Overall Study||10
94986|NCT01124292|222306|P2|NOT COMPLETED|Overall Study||15
94987|NCT01124292|222307|P1|NOT COMPLETED|Overall Study||2
94988|NCT01124292|222305|P3|COMPLETED|Overall Study||11
94989|NCT01124292|222306|P2|COMPLETED|Overall Study||9
94990|NCT01124292|222307|P1|COMPLETED|Overall Study||14
94991|NCT01124292|222305|P3|STARTED|Overall Study||21
94992|NCT01124292|222306|P2|STARTED|Overall Study||24
94993|NCT01124292|222307|P1|STARTED|Overall Study||16
94994|NCT01124175|222365|P2|NOT COMPLETED|Second Intervention||0
94995|NCT01124175|222366|P1|NOT COMPLETED|Second Intervention||0
94996|NCT01124175|222365|P2|COMPLETED|Second Intervention||38
94997|NCT01124175|222366|P1|COMPLETED|Second Intervention||40
94998|NCT01124175|222365|P2|STARTED|Second Intervention||38
94999|NCT01124175|222366|P1|STARTED|Second Intervention||40
95000|NCT01124175|222365|P2|NOT COMPLETED|Washout of 7 Days||2
95001|NCT01124175|222366|P1|NOT COMPLETED|Washout of 7 Days||0
95002|NCT01124175|222365|P2|COMPLETED|Washout of 7 Days||38
95003|NCT01124175|222366|P1|COMPLETED|Washout of 7 Days||40
95004|NCT01124175|222365|P2|STARTED|Washout of 7 Days||40
95005|NCT01124175|222366|P1|STARTED|Washout of 7 Days||40
95006|NCT01124175|222365|P2|NOT COMPLETED|First Intervention||0
95007|NCT01124175|222366|P1|NOT COMPLETED|First Intervention||0
95008|NCT01124175|222365|P2|COMPLETED|First Intervention||40
95009|NCT01124175|222366|P1|COMPLETED|First Intervention||40
95010|NCT01124175|222365|P2|STARTED|First Intervention||40
95011|NCT01124175|222366|P1|STARTED|First Intervention||40
95012|NCT01124162|222384|P2|NOT COMPLETED|Second Intervention||0
95013|NCT01124162|222385|P1|NOT COMPLETED|Second Intervention||0
95014|NCT01124162|222384|P2|COMPLETED|Second Intervention||40
95015|NCT01124162|222385|P1|COMPLETED|Second Intervention||37
95016|NCT01124162|222384|P2|STARTED|Second Intervention||40
95017|NCT01124162|222385|P1|STARTED|Second Intervention||37
95018|NCT01124162|222384|P2|NOT COMPLETED|Washout of 7 Days||0
95019|NCT01124162|222385|P1|NOT COMPLETED|Washout of 7 Days||1
95020|NCT01124162|222384|P2|COMPLETED|Washout of 7 Days||40
95021|NCT01124162|222385|P1|COMPLETED|Washout of 7 Days||37
95022|NCT01124162|222384|P2|STARTED|Washout of 7 Days||40
95023|NCT01124162|222385|P1|STARTED|Washout of 7 Days||38
95024|NCT01124162|222384|P2|NOT COMPLETED|First Intervention||0
95025|NCT01124162|222385|P1|NOT COMPLETED|First Intervention||2
95026|NCT01124162|222384|P2|COMPLETED|First Intervention||40
95027|NCT01124162|222385|P1|COMPLETED|First Intervention||38
95028|NCT01124162|222384|P2|STARTED|First Intervention||40
95029|NCT01124162|222385|P1|STARTED|First Intervention||40
95030|NCT01124149|222401|P1|NOT COMPLETED|Maintenance Phase||96
95031|NCT01124149|222401|P1|COMPLETED|Maintenance Phase||373
95032|NCT01124149|222401|P1|STARTED|Maintenance Phase||469
95033|NCT01124149|222401|P1|NOT COMPLETED|Acute Phase||83
95034|NCT01124149|222401|P1|COMPLETED|Acute Phase||639
95035|NCT01124149|222401|P1|STARTED|Acute Phase||722
95036|NCT01124097|222421|P4|NOT COMPLETED|Overall Study||14
95037|NCT01124097|222422|P3|NOT COMPLETED|Overall Study||20
95038|NCT01124097|222423|P2|NOT COMPLETED|Overall Study||22
95039|NCT01124097|222424|P1|NOT COMPLETED|Overall Study||34
95040|NCT01124097|222421|P4|COMPLETED|Overall Study||46
95041|NCT01124097|222422|P3|COMPLETED|Overall Study||40
95042|NCT01124097|222423|P2|COMPLETED|Overall Study||38
95043|NCT01124097|222424|P1|COMPLETED|Overall Study||26
95044|NCT01124097|222421|P4|Efficacy Population|Overall Study||51
95045|NCT01124097|222422|P3|Efficacy Population|Overall Study||53
95046|NCT01124097|222423|P2|Efficacy Population|Overall Study||53
95047|NCT01124097|222424|P1|Efficacy Population|Overall Study||52
95048|NCT01124097|222421|P4|Safety Population|Overall Study||60
95049|NCT01124097|222422|P3|Safety Population|Overall Study||60
95050|NCT01124097|222423|P2|Safety Population|Overall Study||60
95051|NCT01124097|222424|P1|Safety Population|Overall Study||60
95052|NCT01124097|222421|P4|STARTED|Overall Study||60
95053|NCT01124097|222422|P3|STARTED|Overall Study||60
95054|NCT01124097|222423|P2|STARTED|Overall Study||60
95055|NCT01124097|222424|P1|STARTED|Overall Study||60
95056|NCT01124045|222436|P2|NOT COMPLETED|Overall Study||3
95057|NCT01124045|222437|P1|NOT COMPLETED|Overall Study||0
95058|NCT01124045|222436|P2|COMPLETED|Overall Study||37
95059|NCT01124045|222437|P1|COMPLETED|Overall Study||39
95060|NCT01124045|222436|P2|STARTED|Overall Study||40
95061|NCT01124045|222437|P1|STARTED|Overall Study||39
95062|NCT01124006|222470|P3|NOT COMPLETED|Overall Study||2
95063|NCT01124006|222471|P2|NOT COMPLETED|Overall Study||2
95064|NCT01124006|222472|P1|NOT COMPLETED|Overall Study||3
95065|NCT01124006|222470|P3|COMPLETED|Overall Study||2
95066|NCT01124006|222471|P2|COMPLETED|Overall Study||8
95067|NCT01124006|222472|P1|COMPLETED|Overall Study||7
95068|NCT01124006|222470|P3|STARTED|Overall Study||4
95069|NCT01124006|222471|P2|STARTED|Overall Study||10
95070|NCT01124006|222472|P1|STARTED|Overall Study||10
95071|NCT01123980|222500|P2|NOT COMPLETED|Overall Study||24
95072|NCT01123980|222501|P1|NOT COMPLETED|Overall Study||19
95073|NCT01123980|222500|P2|COMPLETED|Overall Study||236
95074|NCT01123980|222501|P1|COMPLETED|Overall Study||242
95075|NCT01123980|222500|P2|STARTED|Overall Study||260
95076|NCT01123980|222501|P1|STARTED|Overall Study||261
95077|NCT01123941|222521|P2|NOT COMPLETED|Overall Study||1
95078|NCT01123941|222522|P1|NOT COMPLETED|Overall Study||2
95079|NCT01123941|222521|P2|COMPLETED|Overall Study||24
95080|NCT01123941|222522|P1|COMPLETED|Overall Study||23
95081|NCT01123941|222521|P2|STARTED|Overall Study||25
95082|NCT01123941|222522|P1|STARTED|Overall Study||25
95083|NCT01123928|222536|P2|NOT COMPLETED|Overall Study||0
95084|NCT01123928|222537|P1|NOT COMPLETED|Overall Study||0
95085|NCT01123928|222536|P2|COMPLETED|Overall Study||222
95086|NCT01123928|222537|P1|COMPLETED|Overall Study||212
95087|NCT01123928|222536|P2|STARTED|Overall Study||222
95088|NCT01123928|222537|P1|STARTED|Overall Study||212
95089|NCT01123889|222557|P2|NOT COMPLETED|Overall Study||1
95090|NCT01123889|222558|P1|NOT COMPLETED|Overall Study||3
95091|NCT01123889|222557|P2|COMPLETED|Overall Study||6
95092|NCT01123889|222558|P1|COMPLETED|Overall Study||2
95093|NCT01123889|222557|P2|STARTED|Overall Study||7
95094|NCT01123889|222558|P1|STARTED|Overall Study||5
95095|NCT01123850|222568|P1|NOT COMPLETED|Overall Study||45
95096|NCT01123850|222568|P1|COMPLETED|Overall Study||0
95097|NCT01123850|222568|P1|STARTED|Overall Study||45
95098|NCT01123642|222573|P1|NOT COMPLETED|Overall Study||68
95099|NCT01123642|222573|P1|COMPLETED|Overall Study||277
95100|NCT01123642|222573|P1|STARTED|Overall Study||345
95101|NCT01123512|222579|P2|NOT COMPLETED|Overall Study||21
95102|NCT01123512|222580|P1|NOT COMPLETED|Overall Study||26
95103|NCT01123512|222579|P2|COMPLETED|Overall Study||126
95104|NCT01123512|222580|P1|COMPLETED|Overall Study||127
95105|NCT01123512|222579|P2|STARTED|Overall Study||147
95106|NCT01123512|222580|P1|STARTED|Overall Study||153
95107|NCT01123395|222586|P2|NOT COMPLETED|Period 2||0
95108|NCT01123395|222587|P1|NOT COMPLETED|Period 2||0
95109|NCT01123395|222586|P2|COMPLETED|Period 2||7
95110|NCT01123395|222587|P1|COMPLETED|Period 2||8
95111|NCT01123395|222586|P2|STARTED|Period 2||7
95112|NCT01123395|222587|P1|STARTED|Period 2||8
95113|NCT01123395|222586|P2|NOT COMPLETED|Washout Period of 14 Days||1
95114|NCT01123395|222587|P1|NOT COMPLETED|Washout Period of 14 Days||0
95115|NCT01123395|222586|P2|COMPLETED|Washout Period of 14 Days||7
95116|NCT01123395|222587|P1|COMPLETED|Washout Period of 14 Days||8
95117|NCT01123395|222586|P2|STARTED|Washout Period of 14 Days||8
95118|NCT01123395|222587|P1|STARTED|Washout Period of 14 Days||8
95119|NCT01123395|222586|P2|NOT COMPLETED|Period 1||0
95120|NCT01123395|222587|P1|NOT COMPLETED|Period 1||0
95121|NCT01123395|222586|P2|COMPLETED|Period 1||8
95122|NCT01123395|222587|P1|COMPLETED|Period 1||8
95123|NCT01123395|222586|P2|STARTED|Period 1||8
95124|NCT01123395|222587|P1|STARTED|Period 1||8
95125|NCT01123356|222597|P1|NOT COMPLETED|Overall Study||7
95126|NCT01123356|222597|P1|COMPLETED|Overall Study||14
95127|NCT01123356|222597|P1|STARTED|Overall Study||21
95128|NCT01123148|222605|P1|NOT COMPLETED|Overall Study||2
95129|NCT01123148|222605|P1|COMPLETED|Overall Study||12
95130|NCT01123148|222605|P1|BCI Calibration >50% Accuracy|Overall Study||13
95131|NCT01123148|222605|P1|STARTED|Overall Study||14
95132|NCT01122927|222609|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
95133|NCT01122927|222610|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
95134|NCT01122927|222609|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
95135|NCT01122927|222610|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
95136|NCT01122927|222609|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
95137|NCT01122927|222610|P1|STARTED|Period 2- Open-label Treatment Phase||0
95138|NCT01122927|222609|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
95139|NCT01122927|222610|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
95140|NCT01122927|222609|P2|COMPLETED|Period 1 - Conversion Phase||0
95141|NCT01122927|222610|P1|COMPLETED|Period 1 - Conversion Phase||283
95142|NCT01122927|222609|P2|STARTED|Period 1 - Conversion Phase||0
95143|NCT01122927|222610|P1|STARTED|Period 1 - Conversion Phase||297
95144|NCT01122862|222641|P3|NOT COMPLETED|Period 3||0
95145|NCT01122862|222642|P2|NOT COMPLETED|Period 3||0
95146|NCT01122862|222643|P1|NOT COMPLETED|Period 3||0
95147|NCT01122862|222641|P3|COMPLETED|Period 3||8
95148|NCT01122862|222642|P2|COMPLETED|Period 3||7
95149|NCT01122862|222643|P1|COMPLETED|Period 3||6
95150|NCT01122862|222641|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
95151|NCT01122862|222642|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
95152|NCT01122862|222643|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
95153|NCT01122862|222641|P3|NOT COMPLETED|Period 2||1
95154|NCT01122862|222642|P2|NOT COMPLETED|Period 2||0
95155|NCT01122862|222643|P1|NOT COMPLETED|Period 2||0
95156|NCT01122862|222641|P3|COMPLETED|Period 2||6
95157|NCT01122862|222642|P2|COMPLETED|Period 2||7
95158|NCT01122862|222643|P1|COMPLETED|Period 2||8
95159|NCT01122862|222641|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
95160|NCT01122862|222642|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
95161|NCT01122862|222643|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
95162|NCT01122862|222641|P3|NOT COMPLETED|Period 1||0
95163|NCT01122862|222642|P2|NOT COMPLETED|Period 1||1
95164|NCT01122862|222643|P1|NOT COMPLETED|Period 1||0
95165|NCT01122862|222641|P3|COMPLETED|Period 1||7
95166|NCT01122862|222642|P2|COMPLETED|Period 1||7
95167|NCT01122862|222643|P1|COMPLETED|Period 1||8
95168|NCT01122862|222641|P3|STARTED|Period 1||7
95169|NCT01122862|222642|P2|STARTED|Period 1||8
95170|NCT01122862|222643|P1|STARTED|Period 1||8
95171|NCT01122680|222661|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
95172|NCT01122680|222662|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
95173|NCT01122680|222663|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
95174|NCT01122680|222664|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
95175|NCT01122680|222661|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
95176|NCT01122680|222662|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
95177|NCT01122680|222663|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
95178|NCT01122680|222664|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
95179|NCT01122680|222661|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
95180|NCT01122680|222662|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
95181|NCT01122680|222663|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
95182|NCT01122680|222664|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
95183|NCT01122680|222661|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
95184|NCT01122680|222662|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
95185|NCT01122680|222663|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
95186|NCT01122680|222664|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
95187|NCT01122680|222661|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
95188|NCT01122680|222662|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
95189|NCT01122680|222663|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
95190|NCT01122680|222664|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
95191|NCT01122680|222661|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
95192|NCT01122680|222662|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
95193|NCT01122680|222663|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
95194|NCT01122680|222664|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
95195|NCT01122680|222661|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
95196|NCT01122680|222662|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
95197|NCT01122680|222663|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
95198|NCT01122680|222664|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
95199|NCT01122680|222661|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
95200|NCT01122680|222662|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
95201|NCT01122680|222663|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
95202|NCT01122680|222664|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
95203|NCT01122680|222661|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
95204|NCT01122680|222662|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
95205|NCT01122680|222663|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
95206|NCT01122680|222664|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
95207|NCT01122576|222729|P3|NOT COMPLETED|Post-Cataract Surgery||2
95208|NCT01122576|222730|P2|NOT COMPLETED|Post-Cataract Surgery||0
95209|NCT01122576|222731|P1|NOT COMPLETED|Post-Cataract Surgery||0
95210|NCT01122576|222729|P3|COMPLETED|Post-Cataract Surgery||22
95211|NCT01122576|222730|P2|COMPLETED|Post-Cataract Surgery||25
95212|NCT01122576|222731|P1|COMPLETED|Post-Cataract Surgery||26
95213|NCT01122576|222729|P3|STARTED|Post-Cataract Surgery||24
95214|NCT01122576|222730|P2|STARTED|Post-Cataract Surgery||25
95215|NCT01122576|222731|P1|STARTED|Post-Cataract Surgery||26
95216|NCT01122576|222729|P3|NOT COMPLETED|Pre-Cataract Surgery||2
95217|NCT01122576|222730|P2|NOT COMPLETED|Pre-Cataract Surgery||1
95218|NCT01122576|222731|P1|NOT COMPLETED|Pre-Cataract Surgery||0
95219|NCT01122576|222729|P3|COMPLETED|Pre-Cataract Surgery||24
95220|NCT01122576|222730|P2|COMPLETED|Pre-Cataract Surgery||25
95221|NCT01122576|222731|P1|COMPLETED|Pre-Cataract Surgery||26
95222|NCT01122576|222729|P3|STARTED|Pre-Cataract Surgery||26
95223|NCT01122576|222730|P2|STARTED|Pre-Cataract Surgery||26
95224|NCT01122576|222731|P1|STARTED|Pre-Cataract Surgery||26
95225|NCT01122511|222870|P2|NOT COMPLETED|Overall Study||2
95226|NCT01122511|222871|P1|NOT COMPLETED|Overall Study||2
95227|NCT01122511|222870|P2|COMPLETED|Overall Study||0
95228|NCT01122511|222871|P1|COMPLETED|Overall Study||0
95229|NCT01122511|222870|P2|STARTED|Overall Study||2
95230|NCT01122511|222871|P1|STARTED|Overall Study||2
95231|NCT01122394|222885|P2|NOT COMPLETED|Overall Study||4
95232|NCT01122394|222886|P1|NOT COMPLETED|Overall Study||3
95233|NCT01122394|222885|P2|COMPLETED|Overall Study||70
95234|NCT01122394|222886|P1|COMPLETED|Overall Study||63
95235|NCT01122394|222885|P2|STARTED|Overall Study||74
95236|NCT01122394|222886|P1|STARTED|Overall Study||66
95237|NCT01122381|222902|P2|NOT COMPLETED|Overall Study||1
95238|NCT01122381|222903|P1|NOT COMPLETED|Overall Study||0
95239|NCT01122381|222902|P2|COMPLETED|Overall Study||0
95240|NCT01122381|222903|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
95241|NCT01122381|222902|P2|STARTED|Overall Study||1
95242|NCT01122381|222903|P1|STARTED|Overall Study||1
95243|NCT01122264|222912|P3|NOT COMPLETED|Overall Study||47
95244|NCT01122264|222913|P2|NOT COMPLETED|Overall Study||29
95245|NCT01122264|222914|P1|NOT COMPLETED|Overall Study||32
95246|NCT01122264|222912|P3|COMPLETED|Overall Study||214
95247|NCT01122264|222913|P2|COMPLETED|Overall Study||228
95248|NCT01122264|222914|P1|COMPLETED|Overall Study||220
95249|NCT01122264|222912|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
95250|NCT01122264|222913|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
95251|NCT01122264|222914|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
95252|NCT01122264|222912|P3|STARTED|Overall Study||261
95253|NCT01122264|222913|P2|STARTED|Overall Study||257
95254|NCT01122264|222914|P1|STARTED|Overall Study||252
95255|NCT01122238|222987|P16|NOT COMPLETED|Overall Study||0
95256|NCT01122238|222988|P15|NOT COMPLETED|Overall Study||0
95257|NCT01122238|222989|P14|NOT COMPLETED|Overall Study||1
95258|NCT01122238|222990|P13|NOT COMPLETED|Overall Study||2
95259|NCT01122238|222991|P12|NOT COMPLETED|Overall Study||2
95260|NCT01122238|222992|P11|NOT COMPLETED|Overall Study||0
95261|NCT01122238|222993|P10|NOT COMPLETED|Overall Study||1
95262|NCT01122238|222994|P9|NOT COMPLETED|Overall Study||1
95263|NCT01122238|222995|P8|NOT COMPLETED|Overall Study||0
95264|NCT01122238|222996|P7|NOT COMPLETED|Overall Study||1
95265|NCT01122238|222997|P6|NOT COMPLETED|Overall Study||1
95266|NCT01122238|222998|P5|NOT COMPLETED|Overall Study||0
95267|NCT01122238|222999|P4|NOT COMPLETED|Overall Study||0
95268|NCT01122238|223000|P3|NOT COMPLETED|Overall Study||5
95269|NCT01122238|223001|P2|NOT COMPLETED|Overall Study||1
95270|NCT01122238|223002|P1|NOT COMPLETED|Overall Study||2
95271|NCT01122238|222987|P16|COMPLETED|Overall Study||31
95272|NCT01122238|222988|P15|COMPLETED|Overall Study||28
95273|NCT01122238|222989|P14|COMPLETED|Overall Study||31
95274|NCT01122238|222990|P13|COMPLETED|Overall Study||28
95275|NCT01122238|222991|P12|COMPLETED|Overall Study||31
95276|NCT01122238|222992|P11|COMPLETED|Overall Study||32
95277|NCT01122238|222993|P10|COMPLETED|Overall Study||33
95278|NCT01122238|222994|P9|COMPLETED|Overall Study||31
95279|NCT01122238|222995|P8|COMPLETED|Overall Study||32
95280|NCT01122238|222996|P7|COMPLETED|Overall Study||34
95281|NCT01122238|222997|P6|COMPLETED|Overall Study||31
95282|NCT01122238|222998|P5|COMPLETED|Overall Study||33
95283|NCT01122238|222999|P4|COMPLETED|Overall Study||33
95284|NCT01122238|223000|P3|COMPLETED|Overall Study||28
95285|NCT01122238|223001|P2|COMPLETED|Overall Study||36
95286|NCT01122238|223002|P1|COMPLETED|Overall Study||28
95287|NCT01122238|222987|P16|STARTED|Overall Study||31
95288|NCT01122238|222988|P15|STARTED|Overall Study||28
95289|NCT01122238|222989|P14|STARTED|Overall Study||32
95290|NCT01122238|222990|P13|STARTED|Overall Study||30
95291|NCT01122238|222991|P12|STARTED|Overall Study||33
95292|NCT01122238|222992|P11|STARTED|Overall Study||32
95293|NCT01122238|222993|P10|STARTED|Overall Study||34
95294|NCT01122238|222994|P9|STARTED|Overall Study||32
95295|NCT01122238|222995|P8|STARTED|Overall Study||32
95296|NCT01122238|222996|P7|STARTED|Overall Study||35
95297|NCT01122238|222997|P6|STARTED|Overall Study||32
95298|NCT01122238|222998|P5|STARTED|Overall Study||33
95299|NCT01122238|222999|P4|STARTED|Overall Study||33
95300|NCT01122238|223000|P3|STARTED|Overall Study||33
95301|NCT01122238|223001|P2|STARTED|Overall Study||37
95302|NCT01122238|223002|P1|STARTED|Overall Study||30
95303|NCT01122160|223024|P2|NOT COMPLETED|Second Intervention (7 Days)||0
95304|NCT01122160|223025|P1|NOT COMPLETED|Second Intervention (7 Days)||0
95305|NCT01122160|223024|P2|COMPLETED|Second Intervention (7 Days)||5
95306|NCT01122160|223025|P1|COMPLETED|Second Intervention (7 Days)||6
95307|NCT01122160|223024|P2|STARTED|Second Intervention (7 Days)||5
95308|NCT01122160|223025|P1|STARTED|Second Intervention (7 Days)||6
95309|NCT01122160|223024|P2|NOT COMPLETED|Washout (7-14 Days)||0
95310|NCT01122160|223025|P1|NOT COMPLETED|Washout (7-14 Days)||0
95311|NCT01122160|223024|P2|COMPLETED|Washout (7-14 Days)||5
95312|NCT01122160|223025|P1|COMPLETED|Washout (7-14 Days)||6
95313|NCT01122160|223024|P2|STARTED|Washout (7-14 Days)||5
95314|NCT01122160|223025|P1|STARTED|Washout (7-14 Days)||6
95315|NCT01122160|223024|P2|NOT COMPLETED|First Intervention (7 Days)||0
95316|NCT01122160|223025|P1|NOT COMPLETED|First Intervention (7 Days)||0
95317|NCT01122160|223024|P2|COMPLETED|First Intervention (7 Days)||5
95318|NCT01122160|223025|P1|COMPLETED|First Intervention (7 Days)||6
95319|NCT01122160|223024|P2|STARTED|First Intervention (7 Days)||5
95320|NCT01122160|223025|P1|STARTED|First Intervention (7 Days)||6
95321|NCT01122108|223031|P2|NOT COMPLETED|Overall Study||0
95322|NCT01122108|223032|P1|NOT COMPLETED|Overall Study||0
95323|NCT01122108|223031|P2|COMPLETED|Overall Study||21
95324|NCT01122108|223032|P1|COMPLETED|Overall Study||21
95325|NCT01122108|223031|P2|STARTED|Overall Study||21
95326|NCT01122108|223032|P1|STARTED|Overall Study||21
95327|NCT01121991|223041|P1|NOT COMPLETED|Overall Study||6
95328|NCT01121991|223041|P1|COMPLETED|Overall Study||46
95329|NCT01121991|223041|P1|STARTED|Overall Study|Number of participants treated|52
95330|NCT01121939|223052|P1|NOT COMPLETED|Overall Study||43
95331|NCT01121939|223052|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
95332|NCT01121939|223052|P1|STARTED|Overall Study||43
95333|NCT01121926|223066|P2|NOT COMPLETED|Second Intervention Period||0
95334|NCT01121926|223067|P1|NOT COMPLETED|Second Intervention Period||0
95335|NCT01121926|223066|P2|COMPLETED|Second Intervention Period||13
95336|NCT01121926|223067|P1|COMPLETED|Second Intervention Period||14
95337|NCT01121926|223066|P2|STARTED|Second Intervention Period||13
95338|NCT01121926|223067|P1|STARTED|Second Intervention Period||14
95339|NCT01121926|223066|P2|NOT COMPLETED|Washout Period||2
95340|NCT01121926|223067|P1|NOT COMPLETED|Washout Period||0
95341|NCT01121926|223066|P2|COMPLETED|Washout Period||13
95342|NCT01121926|223067|P1|COMPLETED|Washout Period||14
95343|NCT01121926|223066|P2|STARTED|Washout Period||15
95344|NCT01121926|223067|P1|STARTED|Washout Period||14
95345|NCT01121926|223066|P2|NOT COMPLETED|First Intervention Period||0
95346|NCT01121926|223067|P1|NOT COMPLETED|First Intervention Period||1
95347|NCT01121926|223066|P2|COMPLETED|First Intervention Period||15
95348|NCT01121926|223067|P1|COMPLETED|First Intervention Period||14
95349|NCT01121926|223066|P2|STARTED|First Intervention Period||15
95350|NCT01121926|223067|P1|STARTED|First Intervention Period||15
95351|NCT01121913|223085|P4|NOT COMPLETED|Fourth Intervention Period||0
95352|NCT01121913|223086|P3|NOT COMPLETED|Fourth Intervention Period||0
95353|NCT01121913|223087|P2|NOT COMPLETED|Fourth Intervention Period||0
95354|NCT01121913|223088|P1|NOT COMPLETED|Fourth Intervention Period||0
95355|NCT01121913|223085|P4|COMPLETED|Fourth Intervention Period||6
95356|NCT01121913|223086|P3|COMPLETED|Fourth Intervention Period||3
95357|NCT01121913|223087|P2|COMPLETED|Fourth Intervention Period||6
95358|NCT01121913|223088|P1|COMPLETED|Fourth Intervention Period||4
95359|NCT01121913|223085|P4|STARTED|Fourth Intervention Period||6
95360|NCT01121913|223086|P3|STARTED|Fourth Intervention Period||3
95361|NCT01121913|223087|P2|STARTED|Fourth Intervention Period||6
95362|NCT01121913|223088|P1|STARTED|Fourth Intervention Period||4
95363|NCT01121913|223085|P4|NOT COMPLETED|Third Washout Period||0
95364|NCT01121913|223086|P3|NOT COMPLETED|Third Washout Period||0
95365|NCT01121913|223087|P2|NOT COMPLETED|Third Washout Period||0
95366|NCT01121913|223088|P1|NOT COMPLETED|Third Washout Period||1
95367|NCT01121913|223085|P4|COMPLETED|Third Washout Period||6
95368|NCT01121913|223086|P3|COMPLETED|Third Washout Period||3
95369|NCT01121913|223087|P2|COMPLETED|Third Washout Period||6
95370|NCT01121913|223088|P1|COMPLETED|Third Washout Period||4
95371|NCT01121913|223085|P4|STARTED|Third Washout Period||6
95372|NCT01121913|223086|P3|STARTED|Third Washout Period||3
95373|NCT01121913|223087|P2|STARTED|Third Washout Period||6
95374|NCT01121913|223088|P1|STARTED|Third Washout Period||5
95375|NCT01121913|223085|P4|NOT COMPLETED|Third Intervention Period||0
95376|NCT01121913|223086|P3|NOT COMPLETED|Third Intervention Period||0
95377|NCT01121913|223087|P2|NOT COMPLETED|Third Intervention Period||0
95378|NCT01121913|223088|P1|NOT COMPLETED|Third Intervention Period||0
95379|NCT01121913|223085|P4|COMPLETED|Third Intervention Period||6
95380|NCT01121913|223086|P3|COMPLETED|Third Intervention Period||3
95381|NCT01121913|223087|P2|COMPLETED|Third Intervention Period||6
95382|NCT01121913|223088|P1|COMPLETED|Third Intervention Period||5
95383|NCT01121913|223085|P4|STARTED|Third Intervention Period||6
95384|NCT01121913|223086|P3|STARTED|Third Intervention Period||3
95385|NCT01121913|223087|P2|STARTED|Third Intervention Period||6
95386|NCT01121913|223088|P1|STARTED|Third Intervention Period||5
95387|NCT01121913|223085|P4|NOT COMPLETED|Second Washout Period||0
95388|NCT01121913|223086|P3|NOT COMPLETED|Second Washout Period||1
95389|NCT01121913|223087|P2|NOT COMPLETED|Second Washout Period||0
95390|NCT01121913|223088|P1|NOT COMPLETED|Second Washout Period||0
95391|NCT01121913|223085|P4|COMPLETED|Second Washout Period||6
95392|NCT01121913|223086|P3|COMPLETED|Second Washout Period||3
95393|NCT01121913|223087|P2|COMPLETED|Second Washout Period||6
95394|NCT01121913|223088|P1|COMPLETED|Second Washout Period||5
95395|NCT01121913|223085|P4|STARTED|Second Washout Period||6
95396|NCT01121913|223086|P3|STARTED|Second Washout Period||4
95397|NCT01121913|223087|P2|STARTED|Second Washout Period||6
95398|NCT01121913|223088|P1|STARTED|Second Washout Period||5
95399|NCT01121913|223085|P4|NOT COMPLETED|Second Intervention Period||0
95400|NCT01121913|223086|P3|NOT COMPLETED|Second Intervention Period||1
95401|NCT01121913|223087|P2|NOT COMPLETED|Second Intervention Period||0
95402|NCT01121913|223088|P1|NOT COMPLETED|Second Intervention Period||0
95403|NCT01121913|223085|P4|COMPLETED|Second Intervention Period||6
95404|NCT01121913|223086|P3|COMPLETED|Second Intervention Period||4
95405|NCT01121913|223087|P2|COMPLETED|Second Intervention Period||6
95406|NCT01121913|223088|P1|COMPLETED|Second Intervention Period||5
95407|NCT01121913|223085|P4|STARTED|Second Intervention Period||6
95408|NCT01121913|223086|P3|STARTED|Second Intervention Period||5
95409|NCT01121913|223087|P2|STARTED|Second Intervention Period||6
95410|NCT01121913|223088|P1|STARTED|Second Intervention Period||5
95411|NCT01121913|223085|P4|NOT COMPLETED|First Washout Period||0
95412|NCT01121913|223086|P3|NOT COMPLETED|First Washout Period||0
95413|NCT01121913|223087|P2|NOT COMPLETED|First Washout Period||0
95414|NCT01121913|223088|P1|NOT COMPLETED|First Washout Period||1
95415|NCT01121913|223085|P4|COMPLETED|First Washout Period||6
95416|NCT01121913|223086|P3|COMPLETED|First Washout Period||5
95417|NCT01121913|223087|P2|COMPLETED|First Washout Period||6
95418|NCT01121913|223088|P1|COMPLETED|First Washout Period||5
95419|NCT01121913|223085|P4|STARTED|First Washout Period||6
95420|NCT01121913|223086|P3|STARTED|First Washout Period||5
95421|NCT01121913|223087|P2|STARTED|First Washout Period||6
95422|NCT01121913|223088|P1|STARTED|First Washout Period||6
95423|NCT01121913|223085|P4|NOT COMPLETED|First Intervention Period||0
95424|NCT01121913|223086|P3|NOT COMPLETED|First Intervention Period||1
95425|NCT01121913|223087|P2|NOT COMPLETED|First Intervention Period||0
95426|NCT01121913|223088|P1|NOT COMPLETED|First Intervention Period||0
95427|NCT01121913|223085|P4|COMPLETED|First Intervention Period||6
95428|NCT01121913|223086|P3|COMPLETED|First Intervention Period||5
95429|NCT01121913|223087|P2|COMPLETED|First Intervention Period||6
95430|NCT01121913|223088|P1|COMPLETED|First Intervention Period||6
95431|NCT01121913|223085|P4|STARTED|First Intervention Period||6
95432|NCT01121913|223086|P3|STARTED|First Intervention Period||6
95433|NCT01121913|223087|P2|STARTED|First Intervention Period||6
95434|NCT01121913|223088|P1|STARTED|First Intervention Period||6
95435|NCT01121900|223118|P2|NOT COMPLETED|Second Intervention Period||0
95436|NCT01121900|223119|P1|NOT COMPLETED|Second Intervention Period||0
95437|NCT01121900|223118|P2|COMPLETED|Second Intervention Period||11
95438|NCT01121900|223119|P1|COMPLETED|Second Intervention Period||12
95439|NCT01121900|223118|P2|STARTED|Second Intervention Period||11
95440|NCT01121900|223119|P1|STARTED|Second Intervention Period||12
95441|NCT01121900|223118|P2|NOT COMPLETED|Washout Period of 7 Days||1
95442|NCT01121900|223119|P1|NOT COMPLETED|Washout Period of 7 Days||0
95443|NCT01121900|223118|P2|COMPLETED|Washout Period of 7 Days||11
95444|NCT01121900|223119|P1|COMPLETED|Washout Period of 7 Days||12
95445|NCT01121900|223118|P2|STARTED|Washout Period of 7 Days||12
95446|NCT01121900|223119|P1|STARTED|Washout Period of 7 Days||12
95447|NCT01121900|223118|P2|NOT COMPLETED|First Intervention Period||1
95448|NCT01121900|223119|P1|NOT COMPLETED|First Intervention Period||1
95449|NCT01121900|223118|P2|COMPLETED|First Intervention Period||12
95450|NCT01121900|223119|P1|COMPLETED|First Intervention Period||12
95451|NCT01121900|223118|P2|STARTED|First Intervention Period||13
95452|NCT01121900|223119|P1|STARTED|First Intervention Period||13
95453|NCT01121757|223139|P2|NOT COMPLETED|Combination||1
95454|NCT01121757|223140|P1|NOT COMPLETED|Combination||2
95455|NCT01121757|223139|P2|COMPLETED|Combination||0
95456|NCT01121757|223140|P1|COMPLETED|Combination||0
95457|NCT01121757|223139|P2|STARTED|Combination||1
95458|NCT01121757|223140|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
95459|NCT01121757|223139|P2|NOT COMPLETED|Second Drug||0
95460|NCT01121757|223140|P1|NOT COMPLETED|Second Drug||0
95461|NCT01121757|223139|P2|COMPLETED|Second Drug||1
95462|NCT01121757|223140|P1|COMPLETED|Second Drug||4
95463|NCT01121757|223139|P2|STARTED|Second Drug||1
95464|NCT01121757|223140|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
95465|NCT01121757|223139|P2|NOT COMPLETED|First Drug||2
95466|NCT01121757|223140|P1|NOT COMPLETED|First Drug||1
95467|NCT01121757|223139|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
95468|NCT01121757|223140|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
95469|NCT01121757|223139|P2|STARTED|First Drug||3
95470|NCT01121757|223140|P1|STARTED|First Drug||6
95471|NCT01121666|223156|P2|NOT COMPLETED|Overall Study||10
95472|NCT01121666|223157|P1|NOT COMPLETED|Overall Study||29
95473|NCT01121666|223156|P2|COMPLETED|Overall Study||113
95474|NCT01121666|223157|P1|COMPLETED|Overall Study||220
95475|NCT01121666|223156|P2|STARTED|Overall Study||123
95476|NCT01121666|223157|P1|STARTED|Overall Study||249
95477|NCT01121575|223213|P6|NOT COMPLETED|Overall Study||12
95478|NCT01121575|223214|P5|NOT COMPLETED|Overall Study||25
95479|NCT01121575|223215|P4|NOT COMPLETED|Overall Study||6
95480|NCT01121575|223216|P3|NOT COMPLETED|Overall Study||7
95481|NCT01121575|223217|P2|NOT COMPLETED|Overall Study||6
95482|NCT01121575|223218|P1|NOT COMPLETED|Overall Study||14
95483|NCT01121575|223213|P6|COMPLETED|Overall Study||0
95484|NCT01121575|223214|P5|COMPLETED|Overall Study||0
95485|NCT01121575|223215|P4|COMPLETED|Overall Study||0
95486|NCT01121575|223216|P3|COMPLETED|Overall Study||0
95487|NCT01121575|223217|P2|COMPLETED|Overall Study||0
95488|NCT01121575|223218|P1|COMPLETED|Overall Study||0
95489|NCT01121575|223213|P6|Treated|Overall Study||12
95490|NCT01121575|223214|P5|Treated|Overall Study||25
95491|NCT01121575|223215|P4|Treated|Overall Study||6
95492|NCT01121575|223216|P3|Treated|Overall Study||7
95493|NCT01121575|223217|P2|Treated|Overall Study||6
95494|NCT01121575|223218|P1|Treated|Overall Study||14
95495|NCT01121575|223213|P6|STARTED|Overall Study||12
95496|NCT01121575|223214|P5|STARTED|Overall Study||25
95497|NCT01121575|223215|P4|STARTED|Overall Study||6
95498|NCT01121575|223216|P3|STARTED|Overall Study||7
95499|NCT01121575|223217|P2|STARTED|Overall Study||6
95500|NCT01121575|223218|P1|STARTED|Overall Study||14
95501|NCT01121562|223342|P1|NOT COMPLETED|Overall Study||12
95502|NCT01121562|223342|P1|COMPLETED|Overall Study||0
95503|NCT01121562|223342|P1|STARTED|Overall Study||12
95504|NCT01121549|223351|P1|NOT COMPLETED|Overall Study||347
95505|NCT01121549|223351|P1|COMPLETED|Overall Study||31
95506|NCT01121549|223351|P1|STARTED|Overall Study||378
95507|NCT01121536|223362|P1|NOT COMPLETED|Overall Study||361
95508|NCT01121536|223362|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
95509|NCT01121536|223362|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
95510|NCT01121536|223362|P1|Safety Population|Overall Study|Participants treated|863
95511|NCT01121536|223362|P1|STARTED|Overall Study||867
95512|NCT01121484|223383|P2|NOT COMPLETED|Overall Study||43
95513|NCT01121484|223384|P1|NOT COMPLETED|Overall Study||33
95514|NCT01121484|223383|P2|COMPLETED|Overall Study||178
95515|NCT01121484|223384|P1|COMPLETED|Overall Study||185
95516|NCT01121484|223383|P2|Treated|Overall Study||217
95517|NCT01121484|223384|P1|Treated|Overall Study||217
95518|NCT01121484|223383|P2|STARTED|Overall Study||221
95519|NCT01121484|223384|P1|STARTED|Overall Study||218
95520|NCT01121406|223402|P2|NOT COMPLETED|Overall Study||55
95521|NCT01121406|223403|P1|NOT COMPLETED|Overall Study||55
95522|NCT01121406|223402|P2|COMPLETED|Overall Study||0
95523|NCT01121406|223403|P1|COMPLETED|Overall Study||0
95524|NCT01121406|223402|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
95525|NCT01121406|223403|P1|STARTED|Overall Study||55
95526|NCT01121393|223453|P2|NOT COMPLETED|Overall Study||84
95527|NCT01121393|223454|P1|NOT COMPLETED|Overall Study||219
95528|NCT01121393|223453|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
95529|NCT01121393|223454|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
95530|NCT01121393|223453|P2|STARTED|Overall Study|randomised|122
95531|NCT01121393|223454|P1|STARTED|Overall Study|randomised|242
95532|NCT01121263|223499|P2|NOT COMPLETED|Overall Study||15
95533|NCT01121263|223500|P1|NOT COMPLETED|Overall Study||25
95534|NCT01121263|223499|P2|COMPLETED|Overall Study||83
95535|NCT01121263|223500|P1|COMPLETED|Overall Study||175
95536|NCT01121263|223499|P2|STARTED|Overall Study||98
95537|NCT01121263|223500|P1|STARTED|Overall Study||200
95538|NCT01121185|223510|P2|NOT COMPLETED|Overall Study||1
95539|NCT01121185|223511|P1|NOT COMPLETED|Overall Study||1
95540|NCT01121185|223510|P2|COMPLETED|Overall Study||5
95541|NCT01121185|223511|P1|COMPLETED|Overall Study||6
95542|NCT01121185|223510|P2|Transplanted|Overall Study||5
95543|NCT01121185|223511|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
95544|NCT01121185|223510|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
95545|NCT01121185|223511|P1|Infused|Overall Study||7
95546|NCT01121185|223510|P2|STARTED|Overall Study||6
95547|NCT01121185|223511|P1|STARTED|Overall Study||7
95548|NCT01121172|223535|P2|NOT COMPLETED|Overall Study||0
95549|NCT01121172|223536|P1|NOT COMPLETED|Overall Study||0
95550|NCT01121172|223535|P2|COMPLETED|Overall Study||90
95551|NCT01121172|223536|P1|COMPLETED|Overall Study||90
95552|NCT01121172|223535|P2|STARTED|Overall Study||90
95553|NCT01121172|223536|P1|STARTED|Overall Study||90
95554|NCT01121146|223545|P2|NOT COMPLETED|Overall Study||42
95555|NCT01121146|223546|P1|NOT COMPLETED|Overall Study||26
95556|NCT01121146|223545|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
95557|NCT01121146|223546|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
95558|NCT01121146|223545|P2|STARTED|Overall Study||114
95559|NCT01121146|223546|P1|STARTED|Overall Study||116
95560|NCT01120990|223560|P1|NOT COMPLETED|Overall Study||0
95561|NCT01120990|223560|P1|COMPLETED|Overall Study||51
95562|NCT01120990|223560|P1|STARTED|Overall Study||51
95563|NCT01120899|223567|P1|NOT COMPLETED|Overall Study||3
95564|NCT01120899|223567|P1|COMPLETED|Overall Study||3
95565|NCT01120899|223567|P1|Month 18|Overall Study||3
95566|NCT01120899|223567|P1|Month 12|Overall Study||3
95567|NCT01120899|223567|P1|Month 6|Overall Study||5
95568|NCT01120899|223567|P1|STARTED|Overall Study||6
95569|NCT01120782|223587|P1|NOT COMPLETED|Overall Study||11
95570|NCT01120782|223587|P1|COMPLETED|Overall Study||34
95571|NCT01120782|223587|P1|STARTED|Overall Study||45
95572|NCT01120717|223593|P2|NOT COMPLETED|Overall Study||24
95573|NCT01120717|223594|P1|NOT COMPLETED|Overall Study||32
95574|NCT01120717|223593|P2|COMPLETED|Overall Study||89
95575|NCT01120717|223594|P1|COMPLETED|Overall Study||194
95576|NCT01120717|223593|P2|Safety Population: Received Study Drug|Overall Study||113
95577|NCT01120717|223594|P1|Safety Population: Received Study Drug|Overall Study||225
95578|NCT01120717|223593|P2|STARTED|Overall Study||113
95579|NCT01120717|223594|P1|STARTED|Overall Study||226
95580|NCT01120704|223642|P32|NOT COMPLETED|Overall Study||1
95581|NCT01120704|223643|P31|NOT COMPLETED|Overall Study||2
95582|NCT01120704|223644|P30|NOT COMPLETED|Overall Study||3
95583|NCT01120704|223645|P29|NOT COMPLETED|Overall Study||5
95584|NCT01120704|223646|P28|NOT COMPLETED|Overall Study||2
95585|NCT01120704|223647|P27|NOT COMPLETED|Overall Study||3
95586|NCT01120704|223648|P26|NOT COMPLETED|Overall Study||0
95587|NCT01120704|223649|P25|NOT COMPLETED|Overall Study||2
95588|NCT01120704|223650|P24|NOT COMPLETED|Overall Study||3
95589|NCT01120704|223651|P23|NOT COMPLETED|Overall Study||4
95590|NCT01120704|223652|P22|NOT COMPLETED|Overall Study||0
95591|NCT01120704|223653|P21|NOT COMPLETED|Overall Study||3
95592|NCT01120704|223654|P20|NOT COMPLETED|Overall Study||3
95593|NCT01120704|223655|P19|NOT COMPLETED|Overall Study||2
95594|NCT01120704|223656|P18|NOT COMPLETED|Overall Study||0
95595|NCT01120704|223657|P17|NOT COMPLETED|Overall Study||1
95596|NCT01120704|223658|P16|NOT COMPLETED|Overall Study||2
95597|NCT01120704|223659|P15|NOT COMPLETED|Overall Study||1
95598|NCT01120704|223660|P14|NOT COMPLETED|Overall Study||4
95599|NCT01120704|223661|P13|NOT COMPLETED|Overall Study||3
95600|NCT01120704|223662|P12|NOT COMPLETED|Overall Study||2
95601|NCT01120704|223663|P11|NOT COMPLETED|Overall Study||1
95602|NCT01120704|223664|P10|NOT COMPLETED|Overall Study||1
95603|NCT01120704|223665|P9|NOT COMPLETED|Overall Study||3
95604|NCT01120704|223666|P8|NOT COMPLETED|Overall Study||2
95605|NCT01120704|223667|P7|NOT COMPLETED|Overall Study||3
95606|NCT01120704|223668|P6|NOT COMPLETED|Overall Study||1
95607|NCT01120704|223669|P5|NOT COMPLETED|Overall Study||2
95608|NCT01120704|223670|P4|NOT COMPLETED|Overall Study||4
95609|NCT01120704|223671|P3|NOT COMPLETED|Overall Study||1
95610|NCT01120704|223672|P2|NOT COMPLETED|Overall Study||4
95611|NCT01120704|223673|P1|NOT COMPLETED|Overall Study||3
95612|NCT01120704|223642|P32|COMPLETED|Overall Study||17
95613|NCT01120704|223643|P31|COMPLETED|Overall Study||12
95614|NCT01120704|223644|P30|COMPLETED|Overall Study||12
95615|NCT01120704|223645|P29|COMPLETED|Overall Study||14
95616|NCT01120704|223646|P28|COMPLETED|Overall Study||16
95617|NCT01120704|223647|P27|COMPLETED|Overall Study||15
95618|NCT01120704|223648|P26|COMPLETED|Overall Study||14
95619|NCT01120704|223649|P25|COMPLETED|Overall Study||16
95620|NCT01120704|223650|P24|COMPLETED|Overall Study||13
95621|NCT01120704|223651|P23|COMPLETED|Overall Study||17
95622|NCT01120704|223652|P22|COMPLETED|Overall Study||16
95623|NCT01120704|223653|P21|COMPLETED|Overall Study||14
95624|NCT01120704|223654|P20|COMPLETED|Overall Study||15
95625|NCT01120704|223655|P19|COMPLETED|Overall Study||15
95626|NCT01120704|223656|P18|COMPLETED|Overall Study||16
95627|NCT01120704|223657|P17|COMPLETED|Overall Study||13
95628|NCT01120704|223658|P16|COMPLETED|Overall Study||16
95629|NCT01120704|223659|P15|COMPLETED|Overall Study||17
95630|NCT01120704|223660|P14|COMPLETED|Overall Study||15
95631|NCT01120704|223661|P13|COMPLETED|Overall Study||14
95632|NCT01120704|223662|P12|COMPLETED|Overall Study||14
95633|NCT01120704|223663|P11|COMPLETED|Overall Study||16
95634|NCT01120704|223664|P10|COMPLETED|Overall Study||19
95635|NCT01120704|223665|P9|COMPLETED|Overall Study||19
95636|NCT01120704|223666|P8|COMPLETED|Overall Study||13
95637|NCT01120704|223667|P7|COMPLETED|Overall Study||12
95638|NCT01120704|223668|P6|COMPLETED|Overall Study||18
95639|NCT01120704|223669|P5|COMPLETED|Overall Study||14
95640|NCT01120704|223670|P4|COMPLETED|Overall Study||15
95641|NCT01120704|223671|P3|COMPLETED|Overall Study||13
95642|NCT01120704|223672|P2|COMPLETED|Overall Study||13
95643|NCT01120704|223673|P1|COMPLETED|Overall Study||10
95644|NCT01120704|223642|P32|STARTED|Overall Study||18
95645|NCT01120704|223643|P31|STARTED|Overall Study||14
95646|NCT01120704|223644|P30|STARTED|Overall Study||15
95647|NCT01120704|223645|P29|STARTED|Overall Study||19
95648|NCT01120704|223646|P28|STARTED|Overall Study||18
95649|NCT01120704|223647|P27|STARTED|Overall Study||18
95650|NCT01120704|223648|P26|STARTED|Overall Study||14
95651|NCT01120704|223649|P25|STARTED|Overall Study||18
95652|NCT01120704|223650|P24|STARTED|Overall Study||16
95653|NCT01120704|223651|P23|STARTED|Overall Study||21
95654|NCT01120704|223652|P22|STARTED|Overall Study||16
95655|NCT01120704|223653|P21|STARTED|Overall Study||17
95656|NCT01120704|223654|P20|STARTED|Overall Study||18
95657|NCT01120704|223655|P19|STARTED|Overall Study||17
95658|NCT01120704|223656|P18|STARTED|Overall Study||16
95659|NCT01120704|223657|P17|STARTED|Overall Study||14
95660|NCT01120704|223658|P16|STARTED|Overall Study||18
95661|NCT01120704|223659|P15|STARTED|Overall Study||18
95662|NCT01120704|223660|P14|STARTED|Overall Study||19
95663|NCT01120704|223661|P13|STARTED|Overall Study||17
95664|NCT01120704|223662|P12|STARTED|Overall Study||16
95665|NCT01120704|223663|P11|STARTED|Overall Study||17
95666|NCT01120704|223664|P10|STARTED|Overall Study||20
95667|NCT01120704|223665|P9|STARTED|Overall Study||22
95668|NCT01120704|223666|P8|STARTED|Overall Study||15
95669|NCT01120704|223667|P7|STARTED|Overall Study||15
95670|NCT01120704|223668|P6|STARTED|Overall Study||19
95671|NCT01120704|223669|P5|STARTED|Overall Study||16
95672|NCT01120704|223670|P4|STARTED|Overall Study||19
95673|NCT01120704|223671|P3|STARTED|Overall Study||14
95674|NCT01120704|223672|P2|STARTED|Overall Study||17
95675|NCT01120704|223673|P1|STARTED|Overall Study||13
95676|NCT01120691|223700|P3|NOT COMPLETED|Overall Study||183
95677|NCT01120691|223701|P2|NOT COMPLETED|Overall Study||203
95678|NCT01120691|223702|P1|NOT COMPLETED|Overall Study||171
95679|NCT01120691|223700|P3|COMPLETED|Overall Study||559
95680|NCT01120691|223701|P2|COMPLETED|Overall Study||538
95681|NCT01120691|223702|P1|COMPLETED|Overall Study||570
95682|NCT01120691|223700|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
95683|NCT01120691|223701|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
95684|NCT01120691|223702|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
95685|NCT01120691|223700|P3|Modified Safety Set (mSAF)|Overall Study||737
95686|NCT01120691|223701|P2|Modified Safety Set (mSAF)|Overall Study||740
95687|NCT01120691|223702|P1|Modified Safety Set (mSAF)|Overall Study||729
95688|NCT01120691|223700|P3|Safety Set (SAF)|Overall Study||739
95689|NCT01120691|223701|P2|Safety Set (SAF)|Overall Study||740
95690|NCT01120691|223702|P1|Safety Set (SAF)|Overall Study||736
95691|NCT01120691|223700|P3|Full Analysis Set (FAS)|Overall Study||739
95692|NCT01120691|223701|P2|Full Analysis Set (FAS)|Overall Study||739
95693|NCT01120691|223702|P1|Full Analysis Set (FAS)|Overall Study||736
95694|NCT01120691|223700|P3|STARTED|Overall Study||742
95695|NCT01120691|223701|P2|STARTED|Overall Study||741
95696|NCT01120691|223702|P1|STARTED|Overall Study||741
95697|NCT01120626|223746|P2|NOT COMPLETED|Overall Study||0
95698|NCT01120626|223747|P1|NOT COMPLETED|Overall Study||1
95699|NCT01120626|223746|P2|COMPLETED|Overall Study||22
95700|NCT01120626|223747|P1|COMPLETED|Overall Study||19
95701|NCT01120626|223746|P2|STARTED|Overall Study||22
95702|NCT01120626|223747|P1|STARTED|Overall Study||20
95703|NCT01120405|223757|P2|NOT COMPLETED|Overall Study||33
95704|NCT01120405|223758|P1|NOT COMPLETED|Overall Study||27
95705|NCT01120405|223757|P2|COMPLETED|Overall Study||269
95706|NCT01120405|223758|P1|COMPLETED|Overall Study||271
95707|NCT01120405|223757|P2|STARTED|Overall Study||302
95708|NCT01120405|223758|P1|STARTED|Overall Study||298
95709|NCT01120379|223786|P1|NOT COMPLETED|Four Year Timepoint||368
95710|NCT01120379|223786|P1|COMPLETED|Four Year Timepoint||3923
95711|NCT01120379|223786|P1|STARTED|Four Year Timepoint||4291
95712|NCT01120379|223786|P1|NOT COMPLETED|Three Year Timepoint||214
95713|NCT01120379|223786|P1|COMPLETED|Three Year Timepoint||4291
95714|NCT01120379|223786|P1|STARTED|Three Year Timepoint||4505
95715|NCT01120379|223786|P1|NOT COMPLETED|Two Year Timepoint||237
95716|NCT01120379|223786|P1|COMPLETED|Two Year Timepoint||4505
95717|NCT01120379|223786|P1|STARTED|Two Year Timepoint||4742
95718|NCT01120379|223786|P1|NOT COMPLETED|One Year Timepoint||278
95719|NCT01120379|223786|P1|COMPLETED|One Year Timepoint||4742
95720|NCT01120379|223786|P1|STARTED|One Year Timepoint||5020
95721|NCT01120275|223822|P1|NOT COMPLETED|Overall Study||36
95722|NCT01120275|223822|P1|COMPLETED|Overall Study||0
95723|NCT01120275|223822|P1|Eligible and Treated|Overall Study||32
95724|NCT01120275|223822|P1|STARTED|Overall Study||36
95725|NCT01120236|223831|P2|NOT COMPLETED|Overall Study||0
95726|NCT01120236|223832|P1|NOT COMPLETED|Overall Study||0
95727|NCT01120236|223831|P2|COMPLETED|Overall Study||106
95728|NCT01120236|223832|P1|COMPLETED|Overall Study||105
95729|NCT01120236|223831|P2|STARTED|Overall Study||106
95730|NCT01120236|223832|P1|STARTED|Overall Study||105
95731|NCT01120223|223842|P1|NOT COMPLETED|Overall Study||4
95732|NCT01120223|223842|P1|COMPLETED|Overall Study||74
95733|NCT01120223|223842|P1|STARTED|Overall Study||78
95734|NCT01120210|223872|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
95735|NCT01120210|223873|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
95736|NCT01120210|223872|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
95737|NCT01120210|223873|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
95738|NCT01120210|223872|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
95739|NCT01120210|223873|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
95740|NCT01120210|223872|P2|NOT COMPLETED|MAIN INFUSION||1
95741|NCT01120210|223873|P1|NOT COMPLETED|MAIN INFUSION||1
95742|NCT01120210|223872|P2|COMPLETED|MAIN INFUSION||45
95743|NCT01120210|223873|P1|COMPLETED|MAIN INFUSION||15
95744|NCT01120210|223872|P2|STARTED|MAIN INFUSION||46
95745|NCT01120210|223873|P1|STARTED|MAIN INFUSION||16
95746|NCT01120197|223905|P2|NOT COMPLETED|Overall Study||10
95747|NCT01120197|223906|P1|NOT COMPLETED|Overall Study||9
95748|NCT01120197|223905|P2|COMPLETED|Overall Study||32
95749|NCT01120197|223906|P1|COMPLETED|Overall Study||38
95750|NCT01120197|223905|P2|STARTED|Overall Study||42
95751|NCT01120197|223906|P1|STARTED|Overall Study||47
95752|NCT01120093|223920|P5|NOT COMPLETED|Treatment Period 5||0
95753|NCT01120093|223921|P4|NOT COMPLETED|Treatment Period 5||1
95754|NCT01120093|223922|P3|NOT COMPLETED|Treatment Period 5||0
95755|NCT01120093|223923|P2|NOT COMPLETED|Treatment Period 5||1
95756|NCT01120093|223924|P1|NOT COMPLETED|Treatment Period 5||0
95757|NCT01120093|223920|P5|COMPLETED|Treatment Period 5||13
95758|NCT01120093|223921|P4|COMPLETED|Treatment Period 5||11
95759|NCT01120093|223922|P3|COMPLETED|Treatment Period 5||15
95760|NCT01120093|223923|P2|COMPLETED|Treatment Period 5||12
95761|NCT01120093|223924|P1|COMPLETED|Treatment Period 5||17
95762|NCT01120093|223920|P5|STARTED|Treatment Period 5||13
95763|NCT01120093|223921|P4|STARTED|Treatment Period 5||12
95764|NCT01120093|223922|P3|STARTED|Treatment Period 5||15
95765|NCT01120093|223923|P2|STARTED|Treatment Period 5||13
95766|NCT01120093|223924|P1|STARTED|Treatment Period 5||17
95767|NCT01120093|223920|P5|NOT COMPLETED|Treatment Period 4||0
95768|NCT01120093|223921|P4|NOT COMPLETED|Treatment Period 4||0
95769|NCT01120093|223922|P3|NOT COMPLETED|Treatment Period 4||0
95770|NCT01120093|223923|P2|NOT COMPLETED|Treatment Period 4||0
95771|NCT01120093|223924|P1|NOT COMPLETED|Treatment Period 4||1
95772|NCT01120093|223920|P5|COMPLETED|Treatment Period 4||13
95773|NCT01120093|223921|P4|COMPLETED|Treatment Period 4||12
95774|NCT01120093|223922|P3|COMPLETED|Treatment Period 4||15
95775|NCT01120093|223923|P2|COMPLETED|Treatment Period 4||13
95776|NCT01120093|223924|P1|COMPLETED|Treatment Period 4||17
95777|NCT01120093|223920|P5|STARTED|Treatment Period 4||13
95778|NCT01120093|223921|P4|STARTED|Treatment Period 4||12
95779|NCT01120093|223922|P3|STARTED|Treatment Period 4||15
95780|NCT01120093|223923|P2|STARTED|Treatment Period 4||13
95781|NCT01120093|223924|P1|STARTED|Treatment Period 4||18
95782|NCT01120093|223920|P5|NOT COMPLETED|Treatment Period 3||1
95783|NCT01120093|223921|P4|NOT COMPLETED|Treatment Period 3||1
95784|NCT01120093|223922|P3|NOT COMPLETED|Treatment Period 3||1
95785|NCT01120093|223923|P2|NOT COMPLETED|Treatment Period 3||0
95786|NCT01120093|223924|P1|NOT COMPLETED|Treatment Period 3||0
95787|NCT01120093|223920|P5|COMPLETED|Treatment Period 3||13
95788|NCT01120093|223921|P4|COMPLETED|Treatment Period 3||12
95789|NCT01120093|223922|P3|COMPLETED|Treatment Period 3||15
95790|NCT01120093|223923|P2|COMPLETED|Treatment Period 3||13
95791|NCT01120093|223924|P1|COMPLETED|Treatment Period 3||18
95792|NCT01120093|223920|P5|STARTED|Treatment Period 3||14
95793|NCT01120093|223921|P4|STARTED|Treatment Period 3||13
95794|NCT01120093|223922|P3|STARTED|Treatment Period 3||16
95795|NCT01120093|223923|P2|STARTED|Treatment Period 3||13
95796|NCT01120093|223924|P1|STARTED|Treatment Period 3||18
95797|NCT01120093|223920|P5|NOT COMPLETED|Treatment Period 2||1
95798|NCT01120093|223921|P4|NOT COMPLETED|Treatment Period 2||1
95799|NCT01120093|223922|P3|NOT COMPLETED|Treatment Period 2||0
95800|NCT01120093|223923|P2|NOT COMPLETED|Treatment Period 2||0
95801|NCT01120093|223924|P1|NOT COMPLETED|Treatment Period 2||0
95802|NCT01120093|223920|P5|COMPLETED|Treatment Period 2||14
95803|NCT01120093|223921|P4|COMPLETED|Treatment Period 2||13
95804|NCT01120093|223922|P3|COMPLETED|Treatment Period 2||16
95805|NCT01120093|223923|P2|COMPLETED|Treatment Period 2||13
95806|NCT01120093|223924|P1|COMPLETED|Treatment Period 2||18
95807|NCT01120093|223920|P5|STARTED|Treatment Period 2||15
95808|NCT01120093|223921|P4|STARTED|Treatment Period 2||14
95809|NCT01120093|223922|P3|STARTED|Treatment Period 2||16
95810|NCT01120093|223923|P2|STARTED|Treatment Period 2||13
95811|NCT01120093|223924|P1|STARTED|Treatment Period 2||18
95812|NCT01120093|223920|P5|NOT COMPLETED|Treatment Period 1||1
95813|NCT01120093|223921|P4|NOT COMPLETED|Treatment Period 1||0
95814|NCT01120093|223922|P3|NOT COMPLETED|Treatment Period 1||1
95815|NCT01120093|223923|P2|NOT COMPLETED|Treatment Period 1||1
95816|NCT01120093|223924|P1|NOT COMPLETED|Treatment Period 1||0
95817|NCT01120093|223920|P5|COMPLETED|Treatment Period 1||15
95818|NCT01120093|223921|P4|COMPLETED|Treatment Period 1||14
95819|NCT01120093|223922|P3|COMPLETED|Treatment Period 1||16
95820|NCT01120093|223923|P2|COMPLETED|Treatment Period 1||13
95821|NCT01120093|223924|P1|COMPLETED|Treatment Period 1||18
95822|NCT01120093|223920|P5|STARTED|Treatment Period 1||16
95823|NCT01120093|223921|P4|STARTED|Treatment Period 1||14
95824|NCT01120093|223922|P3|STARTED|Treatment Period 1||17
95825|NCT01120093|223923|P2|STARTED|Treatment Period 1||14
95826|NCT01120093|223924|P1|STARTED|Treatment Period 1||18
95827|NCT01120067|223953|P2|NOT COMPLETED|Overall Study||1
95828|NCT01120067|223954|P1|NOT COMPLETED|Overall Study||5
95829|NCT01120067|223953|P2|COMPLETED|Overall Study||10
95830|NCT01120067|223954|P1|COMPLETED|Overall Study||7
95831|NCT01120067|223953|P2|STARTED|Overall Study||11
95832|NCT01120067|223954|P1|STARTED|Overall Study||12
95833|NCT01119950|223960|P1|NOT COMPLETED|Overall Study||47
95834|NCT01119950|223960|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
95835|NCT01119950|223960|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
95836|NCT01119950|223960|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
95837|NCT01119950|223960|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
95838|NCT01119950|223960|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
95839|NCT01119950|223960|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
95840|NCT01119950|223960|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
95841|NCT01119950|223960|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
95842|NCT01119950|223960|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
95843|NCT01119950|223960|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
95844|NCT01119937|224207|P2|NOT COMPLETED|Overall Study||7
95845|NCT01119937|224208|P1|NOT COMPLETED|Overall Study||19
95846|NCT01119937|224207|P2|COMPLETED|Overall Study||33
95847|NCT01119937|224208|P1|COMPLETED|Overall Study||104
95848|NCT01119937|224207|P2|STARTED|Overall Study||40
95849|NCT01119937|224208|P1|STARTED|Overall Study||123
95850|NCT01119859|224236|P2|NOT COMPLETED|Overall Study||30
95851|NCT01119859|224237|P1|NOT COMPLETED|Overall Study||24
95852|NCT01119859|224236|P2|COMPLETED|Overall Study||133
95853|NCT01119859|224237|P1|COMPLETED|Overall Study||139
95854|NCT01119859|224236|P2|STARTED|Overall Study||163
95855|NCT01119859|224237|P1|STARTED|Overall Study||163
95856|NCT01119794|224253|P1|NOT COMPLETED|Overall Study||0
95857|NCT01119794|224253|P1|COMPLETED|Overall Study||10
95858|NCT01119794|224253|P1|STARTED|Overall Study||10
95859|NCT01119768|224259|P2|NOT COMPLETED|Follow-up||2
95860|NCT01119768|224260|P1|NOT COMPLETED|Follow-up||1
95861|NCT01119768|224259|P2|COMPLETED|Follow-up||122
95862|NCT01119768|224260|P1|COMPLETED|Follow-up||135
95863|NCT01119768|224259|P2|STARTED|Follow-up||124
95864|NCT01119768|224260|P1|STARTED|Follow-up||136
95865|NCT01119768|224259|P2|NOT COMPLETED|Treatment Period||25
95866|NCT01119768|224260|P1|NOT COMPLETED|Treatment Period||18
95867|NCT01119768|224259|P2|COMPLETED|Treatment Period||126
95868|NCT01119768|224260|P1|COMPLETED|Treatment Period||136
95869|NCT01119768|224259|P2|STARTED|Treatment Period||151
95870|NCT01119768|224260|P1|STARTED|Treatment Period||154
95871|NCT01119755|224282|P1|NOT COMPLETED|Overall Study||0
95872|NCT01119755|224282|P1|COMPLETED|Overall Study||80
95873|NCT01119755|224282|P1|STARTED|Overall Study||80
95874|NCT01119716|224293|P1|NOT COMPLETED|Overall Study||0
95875|NCT01119716|224293|P1|COMPLETED|Overall Study||4658
95876|NCT01119716|224293|P1|STARTED|Overall Study||4658
95877|NCT01119703|224316|P2|NOT COMPLETED|Overall Study||1
95878|NCT01119703|224317|P1|NOT COMPLETED|Overall Study||0
95879|NCT01119703|224316|P2|COMPLETED|Overall Study||143
95880|NCT01119703|224317|P1|COMPLETED|Overall Study||30
95881|NCT01119703|224316|P2|STARTED|Overall Study||144
95882|NCT01119703|224317|P1|STARTED|Overall Study||30
95883|NCT01119625|224331|P2|NOT COMPLETED|Overall Study||4
95884|NCT01119625|224332|P1|NOT COMPLETED|Overall Study||3
95885|NCT01119625|224331|P2|COMPLETED|Overall Study||116
95886|NCT01119625|224332|P1|COMPLETED|Overall Study||115
95887|NCT01119625|224331|P2|STARTED|Overall Study||120
95888|NCT01119625|224332|P1|STARTED|Overall Study||118
95889|NCT01119443|224374|P2|NOT COMPLETED|End of Study (All Patients)||0
95890|NCT01119443|224375|P1|NOT COMPLETED|End of Study (All Patients)||0
95891|NCT01119443|224374|P2|COMPLETED|End of Study (All Patients)||14
95892|NCT01119443|224375|P1|COMPLETED|End of Study (All Patients)||14
95893|NCT01119443|224374|P2|STARTED|End of Study (All Patients)||14
95894|NCT01119443|224375|P1|STARTED|End of Study (All Patients)||14
95895|NCT01119443|224374|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
95896|NCT01119443|224375|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
95897|NCT01119443|224374|P2|COMPLETED|Down-titration Period (1 Day)||13
95898|NCT01119443|224375|P1|COMPLETED|Down-titration Period (1 Day)||14
95899|NCT01119443|224374|P2|STARTED|Down-titration Period (1 Day)||13
95900|NCT01119443|224375|P1|STARTED|Down-titration Period (1 Day)||14
95901|NCT01119443|224374|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
95902|NCT01119443|224375|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
95903|NCT01119443|224374|P2|COMPLETED|Crossover Period 4 (5 Days)||13
95904|NCT01119443|224375|P1|COMPLETED|Crossover Period 4 (5 Days)||14
95905|NCT01119443|224374|P2|STARTED|Crossover Period 4 (5 Days)||13
95906|NCT01119443|224375|P1|STARTED|Crossover Period 4 (5 Days)||14
95907|NCT01119443|224374|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
95908|NCT01119443|224375|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
95909|NCT01119443|224374|P2|COMPLETED|Crossover Period 3 (5 Days)||13
95910|NCT01119443|224375|P1|COMPLETED|Crossover Period 3 (5 Days)||14
95911|NCT01119443|224374|P2|STARTED|Crossover Period 3 (5 Days)||13
95912|NCT01119443|224375|P1|STARTED|Crossover Period 3 (5 Days)||14
95913|NCT01119443|224374|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
95914|NCT01119443|224375|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
95915|NCT01119443|224374|P2|COMPLETED|Crossover Period 2 (5 Days)||13
95916|NCT01119443|224375|P1|COMPLETED|Crossover Period 2 (5 Days)||14
95917|NCT01119443|224374|P2|STARTED|Crossover Period 2 (5 Days)||13
95918|NCT01119443|224375|P1|STARTED|Crossover Period 2 (5 Days)||14
95919|NCT01119443|224374|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
95920|NCT01119443|224375|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
95921|NCT01119443|224374|P2|COMPLETED|Crossover Period 1 (5 Days)||13
95922|NCT01119443|224375|P1|COMPLETED|Crossover Period 1 (5 Days)||14
95923|NCT01119443|224374|P2|STARTED|Crossover Period 1 (5 Days)||14
95924|NCT01119443|224375|P1|STARTED|Crossover Period 1 (5 Days)||14
95925|NCT01119443|224374|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
95926|NCT01119443|224375|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
95927|NCT01119443|224374|P2|COMPLETED|Up-titration Period (10 Days)||14
95928|NCT01119443|224375|P1|COMPLETED|Up-titration Period (10 Days)||14
95929|NCT01119443|224374|P2|STARTED|Up-titration Period (10 Days)||14
95930|NCT01119443|224375|P1|STARTED|Up-titration Period (10 Days)||14
95931|NCT01119287|224418|P6|NOT COMPLETED|Overall Study||0
95932|NCT01119287|224419|P5|NOT COMPLETED|Overall Study||1
95933|NCT01119287|224420|P4|NOT COMPLETED|Overall Study||2
95934|NCT01119287|224421|P3|NOT COMPLETED|Overall Study||2
95935|NCT01119287|224422|P2|NOT COMPLETED|Overall Study||0
95936|NCT01119287|224423|P1|NOT COMPLETED|Overall Study||0
95937|NCT01119287|224418|P6|COMPLETED|Overall Study||32
95938|NCT01119287|224419|P5|COMPLETED|Overall Study||30
95939|NCT01119287|224420|P4|COMPLETED|Overall Study||29
95940|NCT01119287|224421|P3|COMPLETED|Overall Study||24
95941|NCT01119287|224422|P2|COMPLETED|Overall Study||24
95942|NCT01119287|224423|P1|COMPLETED|Overall Study||26
95943|NCT01119287|224418|P6|STARTED|Overall Study||32
95944|NCT01119287|224419|P5|STARTED|Overall Study||31
95945|NCT01119287|224420|P4|STARTED|Overall Study||31
95946|NCT01119287|224421|P3|STARTED|Overall Study||26
95947|NCT01119287|224422|P2|STARTED|Overall Study||24
95948|NCT01119287|224423|P1|STARTED|Overall Study||26
95949|NCT01119222|224436|P4|NOT COMPLETED|Overall Study||0
95950|NCT01119222|224437|P3|NOT COMPLETED|Overall Study||0
95951|NCT01119222|224438|P2|NOT COMPLETED|Overall Study||0
95952|NCT01119222|224439|P1|NOT COMPLETED|Overall Study||0
95953|NCT01119222|224436|P4|COMPLETED|Overall Study||4
95954|NCT01119222|224437|P3|COMPLETED|Overall Study||5
95955|NCT01119222|224438|P2|COMPLETED|Overall Study||5
95956|NCT01119222|224439|P1|COMPLETED|Overall Study||5
95957|NCT01119222|224436|P4|STARTED|Overall Study||4
95958|NCT01119222|224437|P3|STARTED|Overall Study||5
95959|NCT01119222|224438|P2|STARTED|Overall Study||5
95960|NCT01119222|224439|P1|STARTED|Overall Study||5
95961|NCT01119131|224480|P3|NOT COMPLETED|Overall Study||6
95962|NCT01119131|224481|P2|NOT COMPLETED|Overall Study||1
95963|NCT01119131|224482|P1|NOT COMPLETED|Overall Study||2
95964|NCT01119131|224480|P3|COMPLETED|Overall Study||24
95965|NCT01119131|224481|P2|COMPLETED|Overall Study||27
95966|NCT01119131|224482|P1|COMPLETED|Overall Study||8
95967|NCT01119131|224480|P3|STARTED|Overall Study||30
95968|NCT01119131|224481|P2|STARTED|Overall Study||28
95969|NCT01119131|224482|P1|STARTED|Overall Study||10
95970|NCT01119118|224511|P1|NOT COMPLETED|Overall Study||1
95971|NCT01119118|224511|P1|COMPLETED|Overall Study||5
95972|NCT01119118|224511|P1|STARTED|Overall Study||6
95973|NCT01119040|224519|P1|NOT COMPLETED|Overall Study||1
95974|NCT01119040|224519|P1|COMPLETED|Overall Study||0
95975|NCT01119040|224519|P1|STARTED|Overall Study||1
95976|NCT01119001|224523|P1|NOT COMPLETED|Overall Study||2
95977|NCT01119001|224523|P1|COMPLETED|Overall Study||11
95978|NCT01119001|224523|P1|STARTED|Overall Study||13
95979|NCT01118988|224532|P3|NOT COMPLETED|Overall Study||4
95980|NCT01118988|224533|P2|NOT COMPLETED|Overall Study||1
95981|NCT01118988|224534|P1|NOT COMPLETED|Overall Study||5
95982|NCT01118988|224532|P3|COMPLETED|Overall Study||3
95983|NCT01118988|224533|P2|COMPLETED|Overall Study||3
95984|NCT01118988|224534|P1|COMPLETED|Overall Study||11
95985|NCT01118988|224532|P3|STARTED|Overall Study||7
95986|NCT01118988|224533|P2|STARTED|Overall Study||4
95987|NCT01118988|224534|P1|STARTED|Overall Study||16
95988|NCT01118975|224567|P2|NOT COMPLETED|Overall Study||1
95989|NCT01118975|224568|P1|NOT COMPLETED|Overall Study||0
95990|NCT01118975|224567|P2|COMPLETED|Overall Study||2
95991|NCT01118975|224568|P1|COMPLETED|Overall Study||9
95992|NCT01118975|224567|P2|STARTED|Overall Study||3
95993|NCT01118975|224568|P1|STARTED|Overall Study||9
95994|NCT01118962|224574|P1|NOT COMPLETED|Overall Study||10
95995|NCT01118962|224574|P1|COMPLETED|Overall Study||29
95996|NCT01118962|224574|P1|STARTED|Overall Study||39
95997|NCT01118949|224579|P1|NOT COMPLETED|Overall Study||9
95998|NCT01118949|224579|P1|COMPLETED|Overall Study||40
95999|NCT01118949|224579|P1|STARTED|Overall Study||49
96000|NCT01118845|224588|P1|NOT COMPLETED|Overall Study||42
96001|NCT01118845|224588|P1|COMPLETED|Overall Study||17
96002|NCT01118845|224588|P1|STARTED|Overall Study||59
96003|NCT01118780|224609|P2|NOT COMPLETED|Overall Study||35
96004|NCT01118780|224610|P1|NOT COMPLETED|Overall Study||36
96005|NCT01118780|224609|P2|COMPLETED|Overall Study||105
96006|NCT01118780|224610|P1|COMPLETED|Overall Study||115
96007|NCT01118780|224609|P2|STARTED|Overall Study||140
96008|NCT01118780|224610|P1|STARTED|Overall Study||151
96009|NCT01118741|224659|P2|NOT COMPLETED|Overall Study||0
96010|NCT01118741|224660|P1|NOT COMPLETED|Overall Study||0
96011|NCT01118741|224659|P2|COMPLETED|Overall Study||10
96012|NCT01118741|224660|P1|COMPLETED|Overall Study||9
96013|NCT01118741|224659|P2|STARTED|Overall Study||10
96014|NCT01118741|224660|P1|STARTED|Overall Study||9
96015|NCT01118663|224668|P2|NOT COMPLETED|Overall Study||2
96016|NCT01118663|224669|P1|NOT COMPLETED|Overall Study||2
96017|NCT01118663|224668|P2|COMPLETED|Overall Study||8
96018|NCT01118663|224669|P1|COMPLETED|Overall Study||5
96019|NCT01118663|224668|P2|STARTED|Overall Study||10
96020|NCT01118663|224669|P1|STARTED|Overall Study||7
96021|NCT01118624|224683|P1|NOT COMPLETED|Overall Study||22
96022|NCT01118624|224683|P1|COMPLETED|Overall Study||0
96023|NCT01118624|224683|P1|STARTED|Overall Study||22
96024|NCT01118455|224692|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
96025|NCT01118455|224693|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
96026|NCT01118455|224692|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
96027|NCT01118455|224693|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
96028|NCT01118455|224692|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
96029|NCT01118455|224693|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
96030|NCT01118455|224692|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
96031|NCT01118455|224693|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
96032|NCT01118455|224692|P2|COMPLETED|Baseline [Visits 1 & 2]||69
96033|NCT01118455|224693|P1|COMPLETED|Baseline [Visits 1 & 2]||65
96034|NCT01118455|224692|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
96035|NCT01118455|224693|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
96036|NCT01118455|224692|P2|STARTED|Baseline [Visits 1 & 2]||69
96037|NCT01118455|224693|P1|STARTED|Baseline [Visits 1 & 2]||66
96038|NCT01118377|224721|P1|NOT COMPLETED|Overall Study||42
96039|NCT01118377|224721|P1|COMPLETED|Overall Study||3
96040|NCT01118377|224721|P1|STARTED|Overall Study||45
96041|NCT01118325|224730|P3|NOT COMPLETED|Overall Study||1
96042|NCT01118325|224731|P2|NOT COMPLETED|Overall Study||0
96043|NCT01118325|224732|P1|NOT COMPLETED|Overall Study||1
96044|NCT01118325|224730|P3|COMPLETED|Overall Study||45
96045|NCT01118325|224731|P2|COMPLETED|Overall Study||43
96046|NCT01118325|224732|P1|COMPLETED|Overall Study||49
96047|NCT01118325|224730|P3|STARTED|Overall Study||46
96048|NCT01118325|224731|P2|STARTED|Overall Study||43
96049|NCT01118325|224732|P1|STARTED|Overall Study||50
96050|NCT01118312|224778|P2|NOT COMPLETED|Overall Study||35
96051|NCT01118312|224779|P1|NOT COMPLETED|Overall Study||34
96052|NCT01118312|224778|P2|COMPLETED|Overall Study||164
96053|NCT01118312|224779|P1|COMPLETED|Overall Study||155
96054|NCT01118312|224778|P2|STARTED|Overall Study||199
96055|NCT01118312|224779|P1|STARTED|Overall Study||189
96056|NCT01118273|224793|P6|NOT COMPLETED|Overall Study||0
96057|NCT01118273|224794|P5|NOT COMPLETED|Overall Study||0
96058|NCT01118273|224795|P4|NOT COMPLETED|Overall Study||0
96059|NCT01118273|224796|P3|NOT COMPLETED|Overall Study||0
96060|NCT01118273|224797|P2|NOT COMPLETED|Overall Study||0
96061|NCT01118273|224798|P1|NOT COMPLETED|Overall Study||0
96062|NCT01118273|224793|P6|COMPLETED|Overall Study||27
96063|NCT01118273|224794|P5|COMPLETED|Overall Study||27
96064|NCT01118273|224795|P4|COMPLETED|Overall Study||27
96065|NCT01118273|224796|P3|COMPLETED|Overall Study||27
96066|NCT01118273|224797|P2|COMPLETED|Overall Study||27
96067|NCT01118273|224798|P1|COMPLETED|Overall Study||27
96068|NCT01118273|224793|P6|STARTED|Overall Study||27
96069|NCT01118273|224794|P5|STARTED|Overall Study||27
96070|NCT01118273|224795|P4|STARTED|Overall Study||27
96071|NCT01118273|224796|P3|STARTED|Overall Study||27
96072|NCT01118273|224797|P2|STARTED|Overall Study||27
96073|NCT01118273|224798|P1|STARTED|Overall Study||27
96074|NCT01118221|224964|P2|NOT COMPLETED|Overall Study||1
96075|NCT01118221|224965|P1|NOT COMPLETED|Overall Study||3
96076|NCT01118221|224964|P2|COMPLETED|Overall Study||10
96077|NCT01118221|224965|P1|COMPLETED|Overall Study||11
96078|NCT01118221|224964|P2|STARTED|Overall Study||11
96079|NCT01118221|224965|P1|STARTED|Overall Study||14
96080|NCT01118143|224977|P2|NOT COMPLETED|Overall Study||5
96081|NCT01118143|224978|P1|NOT COMPLETED|Overall Study||2
96082|NCT01118143|224977|P2|COMPLETED|Overall Study||64
96083|NCT01118143|224978|P1|COMPLETED|Overall Study||62
96084|NCT01118143|224977|P2|STARTED|Overall Study||69
96085|NCT01118143|224978|P1|STARTED|Overall Study||64
96086|NCT01118117|224988|P2|NOT COMPLETED|Overall Study||0
96087|NCT01118117|224989|P1|NOT COMPLETED|Overall Study||21
96088|NCT01118117|224988|P2|COMPLETED|Overall Study||15
96089|NCT01118117|224989|P1|COMPLETED|Overall Study||240
96090|NCT01118117|224988|P2|STARTED|Overall Study||15
96091|NCT01118117|224989|P1|STARTED|Overall Study||261
96092|NCT01118091|225010|P2|NOT COMPLETED|Overall Study||0
96093|NCT01118091|225011|P1|NOT COMPLETED|Overall Study||0
96094|NCT01118091|225010|P2|COMPLETED|Overall Study||5
96095|NCT01118091|225011|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
96096|NCT01118091|225010|P2|STARTED|Overall Study||5
96097|NCT01118091|225011|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
96098|NCT01117987|225023|P2|NOT COMPLETED|Overall Study||74
96099|NCT01117987|225024|P1|NOT COMPLETED|Overall Study||61
96100|NCT01117987|225023|P2|COMPLETED|Overall Study||4
96101|NCT01117987|225024|P1|COMPLETED|Overall Study||5
96102|NCT01117987|225023|P2|STARTED|Overall Study||78
96103|NCT01117987|225024|P1|STARTED|Overall Study||66
96104|NCT01117948|225036|P2|NOT COMPLETED|Open Label||47
96105|NCT01117948|225037|P1|NOT COMPLETED|Open Label||52
96106|NCT01117948|225036|P2|COMPLETED|Open Label||51
96107|NCT01117948|225037|P1|COMPLETED|Open Label||41
96108|NCT01117948|225036|P2|STARTED|Open Label||98
96109|NCT01117948|225037|P1|STARTED|Open Label||93
96110|NCT01117948|225036|P2|NOT COMPLETED|Double Blind||10
96111|NCT01117948|225037|P1|NOT COMPLETED|Double Blind||18
96112|NCT01117948|225036|P2|COMPLETED|Double Blind||98
96113|NCT01117948|225037|P1|COMPLETED|Double Blind||93
96114|NCT01117948|225036|P2|STARTED|Double Blind||108
96115|NCT01117948|225037|P1|STARTED|Double Blind||111
96116|NCT01117857|225043|P1|NOT COMPLETED|Overall Study||9
96117|NCT01117857|225043|P1|COMPLETED|Overall Study||13
96118|NCT01117857|225043|P1|STARTED|Overall Study||22
96119|NCT01117766|225051|P2|NOT COMPLETED|Second Intervention||5
96120|NCT01117766|225052|P1|NOT COMPLETED|Second Intervention||2
96121|NCT01117766|225051|P2|COMPLETED|Second Intervention||9
96122|NCT01117766|225052|P1|COMPLETED|Second Intervention||11
96123|NCT01117766|225051|P2|STARTED|Second Intervention||14
96124|NCT01117766|225052|P1|STARTED|Second Intervention||13
96125|NCT01117766|225051|P2|NOT COMPLETED|Washout Period||2
96126|NCT01117766|225052|P1|NOT COMPLETED|Washout Period||0
96127|NCT01117766|225051|P2|COMPLETED|Washout Period||14
96128|NCT01117766|225052|P1|COMPLETED|Washout Period||13
96129|NCT01117766|225051|P2|STARTED|Washout Period||16
96130|NCT01117766|225052|P1|STARTED|Washout Period||13
96131|NCT01117766|225051|P2|NOT COMPLETED|First Intervention||1
96132|NCT01117766|225052|P1|NOT COMPLETED|First Intervention||1
96133|NCT01117766|225051|P2|COMPLETED|First Intervention||16
96134|NCT01117766|225052|P1|COMPLETED|First Intervention||13
96135|NCT01117766|225051|P2|Received Treatment|First Intervention||17
96136|NCT01117766|225052|P1|Received Treatment|First Intervention||14
96137|NCT01117766|225051|P2|STARTED|First Intervention||17
96138|NCT01117766|225052|P1|STARTED|First Intervention||14
96139|NCT01117727|225076|P1|NOT COMPLETED|Overall Study||0
96140|NCT01117727|225076|P1|COMPLETED|Overall Study||1
96141|NCT01117727|225076|P1|STARTED|Overall Study||1
96142|NCT01117623|225089|P8|NOT COMPLETED|Overall Study||26
96143|NCT01117623|225090|P7|NOT COMPLETED|Overall Study||6
96144|NCT01117623|225091|P6|NOT COMPLETED|Overall Study||16
96145|NCT01117623|225092|P5|NOT COMPLETED|Overall Study||10
96146|NCT01117623|225093|P4|NOT COMPLETED|Overall Study||6
96147|NCT01117623|225094|P3|NOT COMPLETED|Overall Study||11
96148|NCT01117623|225095|P2|NOT COMPLETED|Overall Study||8
96149|NCT01117623|225096|P1|NOT COMPLETED|Overall Study||3
96150|NCT01117623|225089|P8|COMPLETED|Overall Study||0
96151|NCT01117623|225090|P7|COMPLETED|Overall Study||0
96152|NCT01117623|225091|P6|COMPLETED|Overall Study||0
96153|NCT01117623|225092|P5|COMPLETED|Overall Study||0
96154|NCT01117623|225093|P4|COMPLETED|Overall Study||0
96155|NCT01117623|225094|P3|COMPLETED|Overall Study||0
96156|NCT01117623|225095|P2|COMPLETED|Overall Study||0
96157|NCT01117623|225096|P1|COMPLETED|Overall Study||0
96158|NCT01117623|225089|P8|PK Population|Overall Study||24
96159|NCT01117623|225090|P7|PK Population|Overall Study||6
96160|NCT01117623|225091|P6|PK Population|Overall Study||14
96161|NCT01117623|225092|P5|PK Population|Overall Study||10
96162|NCT01117623|225093|P4|PK Population|Overall Study||6
96163|NCT01117623|225094|P3|PK Population|Overall Study||10
96164|NCT01117623|225095|P2|PK Population|Overall Study||8
96165|NCT01117623|225096|P1|PK Population|Overall Study||3
96166|NCT01117623|225089|P8|ITT Efficacy Analysis Population|Overall Study||22
96167|NCT01117623|225090|P7|ITT Efficacy Analysis Population|Overall Study||6
96168|NCT01117623|225091|P6|ITT Efficacy Analysis Population|Overall Study||16
96169|NCT01117623|225092|P5|ITT Efficacy Analysis Population|Overall Study||10
96170|NCT01117623|225093|P4|ITT Efficacy Analysis Population|Overall Study||5
96171|NCT01117623|225094|P3|ITT Efficacy Analysis Population|Overall Study||11
96172|NCT01117623|225095|P2|ITT Efficacy Analysis Population|Overall Study||8
96173|NCT01117623|225096|P1|ITT Efficacy Analysis Population|Overall Study||3
96174|NCT01117623|225089|P8|STARTED|Overall Study||26
96175|NCT01117623|225090|P7|STARTED|Overall Study||6
96176|NCT01117623|225091|P6|STARTED|Overall Study||16
96177|NCT01117623|225092|P5|STARTED|Overall Study||10
96178|NCT01117623|225093|P4|STARTED|Overall Study||6
96179|NCT01117623|225094|P3|STARTED|Overall Study||11
96180|NCT01117623|225095|P2|STARTED|Overall Study||8
96181|NCT01117623|225096|P1|STARTED|Overall Study||3
96182|NCT01117480|225248|P1|NOT COMPLETED|Overall Study||28
96183|NCT01117480|225248|P1|COMPLETED|Overall Study||985
96184|NCT01117480|225248|P1|STARTED|Overall Study||1013
96185|NCT01117350|225256|P2|NOT COMPLETED|Extension Period||63
96186|NCT01117350|225257|P1|NOT COMPLETED|Extension Period||0
96187|NCT01117350|225256|P2|COMPLETED|Extension Period||147
96188|NCT01117350|225257|P1|COMPLETED|Extension Period||0
96189|NCT01117350|225256|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
96190|NCT01117350|225257|P1|mITT Population (Extension)|Extension Period||0
96191|NCT01117350|225256|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
96192|NCT01117350|225257|P1|TREATED = Safety Population (Extension)|Extension Period||0
96193|NCT01117350|225256|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
96194|NCT01117350|225257|P1|STARTED|Extension Period||0
96195|NCT01117350|225256|P2|NOT COMPLETED|Comparative Period||75
96196|NCT01117350|225257|P1|NOT COMPLETED|Comparative Period||42
96197|NCT01117350|225256|P2|COMPLETED|Comparative Period||414
96198|NCT01117350|225257|P1|COMPLETED|Comparative Period||447
96199|NCT01117350|225256|P2|mITT Population|Comparative Period||470
96200|NCT01117350|225257|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
96201|NCT01117350|225256|P2|TREATED = Safety Population|Comparative Period||481
96202|NCT01117350|225257|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
96203|NCT01117350|225256|P2|STARTED|Comparative Period||489
96204|NCT01117350|225257|P1|STARTED|Comparative Period|STARTED: randomized|489
96205|NCT01117337|225289|P2|NOT COMPLETED|Overall Study||0
96206|NCT01117337|225290|P1|NOT COMPLETED|Overall Study||4
96207|NCT01117337|225289|P2|COMPLETED|Overall Study||52
96208|NCT01117337|225290|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
96209|NCT01117337|225289|P2|Underwent Surgery|Overall Study||52
96210|NCT01117337|225290|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
96211|NCT01117337|225289|P2|STARTED|Overall Study||52
96212|NCT01117337|225290|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
96213|NCT01117311|225300|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
96214|NCT01117311|225301|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
96215|NCT01117311|225300|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
96216|NCT01117311|225301|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
96217|NCT01117311|225300|P2|STARTED|Second Intervention - Mixed Meal 3||4
96218|NCT01117311|225301|P1|STARTED|Second Intervention - Mixed Meal 3||3
96219|NCT01117311|225300|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
96220|NCT01117311|225301|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
96221|NCT01117311|225300|P2|COMPLETED|First Intervention - Mixed Meal 2||4
96222|NCT01117311|225301|P1|COMPLETED|First Intervention - Mixed Meal 2||3
96223|NCT01117311|225300|P2|STARTED|First Intervention - Mixed Meal 2||4
96224|NCT01117311|225301|P1|STARTED|First Intervention - Mixed Meal 2||3
96225|NCT01117311|225300|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
96226|NCT01117311|225301|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
96227|NCT01117311|225300|P2|COMPLETED|Lead-in Mixed Meal 1||4
96228|NCT01117311|225301|P1|COMPLETED|Lead-in Mixed Meal 1||3
96229|NCT01117311|225300|P2|STARTED|Lead-in Mixed Meal 1||4
96230|NCT01117311|225301|P1|STARTED|Lead-in Mixed Meal 1||3
96231|NCT01117181|225311|P2|NOT COMPLETED|Overall Study||2
96232|NCT01117181|225312|P1|NOT COMPLETED|Overall Study||1
96233|NCT01117181|225311|P2|COMPLETED|Overall Study||29
96234|NCT01117181|225312|P1|COMPLETED|Overall Study||28
96235|NCT01117181|225311|P2|STARTED|Overall Study||31
96236|NCT01117181|225312|P1|STARTED|Overall Study||29
96237|NCT01117090|225330|P1|NOT COMPLETED|Overall Study||0
96238|NCT01117090|225330|P1|COMPLETED|Overall Study||47
96239|NCT01117090|225330|P1|STARTED|Overall Study||47
96240|NCT01117051|225343|P2|NOT COMPLETED|Overall Study||11
96241|NCT01117051|225344|P1|NOT COMPLETED|Overall Study||13
96242|NCT01117051|225343|P2|COMPLETED|Overall Study||77
96243|NCT01117051|225344|P1|COMPLETED|Overall Study||73
96244|NCT01117051|225343|P2|STARTED|Overall Study||88
96245|NCT01117051|225344|P1|STARTED|Overall Study||86
96246|NCT01117012|225354|P2|NOT COMPLETED|Overall Study||5
96247|NCT01117012|225355|P1|NOT COMPLETED|Overall Study||8
96248|NCT01117012|225354|P2|COMPLETED|Overall Study||98
96249|NCT01117012|225355|P1|COMPLETED|Overall Study||81
96250|NCT01117012|225354|P2|STARTED|Overall Study||103
96251|NCT01117012|225355|P1|STARTED|Overall Study||89
96252|NCT01116986|225403|P32|NOT COMPLETED|Overall Study||3
96253|NCT01116986|225404|P31|NOT COMPLETED|Overall Study||1
96254|NCT01116986|225405|P30|NOT COMPLETED|Overall Study||0
96255|NCT01116986|225406|P29|NOT COMPLETED|Overall Study||0
96256|NCT01116986|225407|P28|NOT COMPLETED|Overall Study||1
96257|NCT01116986|225408|P27|NOT COMPLETED|Overall Study||4
96258|NCT01116986|225409|P26|NOT COMPLETED|Overall Study||0
96259|NCT01116986|225410|P25|NOT COMPLETED|Overall Study||3
96260|NCT01116986|225411|P24|NOT COMPLETED|Overall Study||2
96261|NCT01116986|225412|P23|NOT COMPLETED|Overall Study||4
96262|NCT01116986|225413|P22|NOT COMPLETED|Overall Study||2
96263|NCT01116986|225414|P21|NOT COMPLETED|Overall Study||2
96264|NCT01116986|225415|P20|NOT COMPLETED|Overall Study||2
96265|NCT01116986|225416|P19|NOT COMPLETED|Overall Study||3
96266|NCT01116986|225417|P18|NOT COMPLETED|Overall Study||5
96267|NCT01116986|225418|P17|NOT COMPLETED|Overall Study||3
96268|NCT01116986|225419|P16|NOT COMPLETED|Overall Study||6
96269|NCT01116986|225420|P15|NOT COMPLETED|Overall Study||0
96270|NCT01116986|225421|P14|NOT COMPLETED|Overall Study||3
96271|NCT01116986|225422|P13|NOT COMPLETED|Overall Study||1
96272|NCT01116986|225423|P12|NOT COMPLETED|Overall Study||0
96273|NCT01116986|225424|P11|NOT COMPLETED|Overall Study||1
96274|NCT01116986|225425|P10|NOT COMPLETED|Overall Study||4
96275|NCT01116986|225426|P9|NOT COMPLETED|Overall Study||1
96276|NCT01116986|225427|P8|NOT COMPLETED|Overall Study||2
96277|NCT01116986|225428|P7|NOT COMPLETED|Overall Study||2
96278|NCT01116986|225429|P6|NOT COMPLETED|Overall Study||2
96279|NCT01116986|225430|P5|NOT COMPLETED|Overall Study||4
96280|NCT01116986|225431|P4|NOT COMPLETED|Overall Study||2
96281|NCT01116986|225432|P3|NOT COMPLETED|Overall Study||2
96282|NCT01116986|225433|P2|NOT COMPLETED|Overall Study||3
96283|NCT01116986|225434|P1|NOT COMPLETED|Overall Study||2
96284|NCT01116986|225403|P32|COMPLETED|Overall Study||14
96285|NCT01116986|225404|P31|COMPLETED|Overall Study||16
96286|NCT01116986|225405|P30|COMPLETED|Overall Study||17
96287|NCT01116986|225406|P29|COMPLETED|Overall Study||17
96288|NCT01116986|225407|P28|COMPLETED|Overall Study||18
96289|NCT01116986|225408|P27|COMPLETED|Overall Study||14
96290|NCT01116986|225409|P26|COMPLETED|Overall Study||19
96291|NCT01116986|225410|P25|COMPLETED|Overall Study||15
96292|NCT01116986|225411|P24|COMPLETED|Overall Study||19
96293|NCT01116986|225412|P23|COMPLETED|Overall Study||19
96294|NCT01116986|225413|P22|COMPLETED|Overall Study||18
96295|NCT01116986|225414|P21|COMPLETED|Overall Study||22
96296|NCT01116986|225415|P20|COMPLETED|Overall Study||13
96297|NCT01116986|225416|P19|COMPLETED|Overall Study||20
96298|NCT01116986|225417|P18|COMPLETED|Overall Study||19
96299|NCT01116986|225418|P17|COMPLETED|Overall Study||13
96300|NCT01116986|225419|P16|COMPLETED|Overall Study||15
96301|NCT01116986|225420|P15|COMPLETED|Overall Study||17
96302|NCT01116986|225421|P14|COMPLETED|Overall Study||16
96303|NCT01116986|225422|P13|COMPLETED|Overall Study||16
96304|NCT01116986|225423|P12|COMPLETED|Overall Study||20
96305|NCT01116986|225424|P11|COMPLETED|Overall Study||18
96306|NCT01116986|225425|P10|COMPLETED|Overall Study||19
96307|NCT01116986|225426|P9|COMPLETED|Overall Study||19
96308|NCT01116986|225427|P8|COMPLETED|Overall Study||20
96309|NCT01116986|225428|P7|COMPLETED|Overall Study||20
96310|NCT01116986|225429|P6|COMPLETED|Overall Study||20
96311|NCT01116986|225430|P5|COMPLETED|Overall Study||20
96312|NCT01116986|225431|P4|COMPLETED|Overall Study||20
96313|NCT01116986|225432|P3|COMPLETED|Overall Study||16
96314|NCT01116986|225433|P2|COMPLETED|Overall Study||16
96315|NCT01116986|225434|P1|COMPLETED|Overall Study||22
96316|NCT01116986|225403|P32|STARTED|Overall Study||17
96317|NCT01116986|225404|P31|STARTED|Overall Study||17
96318|NCT01116986|225405|P30|STARTED|Overall Study||17
96319|NCT01116986|225406|P29|STARTED|Overall Study||17
96320|NCT01116986|225407|P28|STARTED|Overall Study||19
96321|NCT01116986|225408|P27|STARTED|Overall Study||18
96322|NCT01116986|225409|P26|STARTED|Overall Study||19
96323|NCT01116986|225410|P25|STARTED|Overall Study||18
96324|NCT01116986|225411|P24|STARTED|Overall Study||21
96325|NCT01116986|225412|P23|STARTED|Overall Study||23
96326|NCT01116986|225413|P22|STARTED|Overall Study||20
96327|NCT01116986|225414|P21|STARTED|Overall Study||24
96328|NCT01116986|225415|P20|STARTED|Overall Study||15
96329|NCT01116986|225416|P19|STARTED|Overall Study||23
96330|NCT01116986|225417|P18|STARTED|Overall Study||24
96331|NCT01116986|225418|P17|STARTED|Overall Study||16
96332|NCT01116986|225419|P16|STARTED|Overall Study||21
96333|NCT01116986|225420|P15|STARTED|Overall Study||17
96334|NCT01116986|225421|P14|STARTED|Overall Study||19
96335|NCT01116986|225422|P13|STARTED|Overall Study||17
96336|NCT01116986|225423|P12|STARTED|Overall Study||20
96337|NCT01116986|225424|P11|STARTED|Overall Study||19
96338|NCT01116986|225425|P10|STARTED|Overall Study||23
96339|NCT01116986|225426|P9|STARTED|Overall Study||20
96340|NCT01116986|225427|P8|STARTED|Overall Study||22
96341|NCT01116986|225428|P7|STARTED|Overall Study||22
96342|NCT01116986|225429|P6|STARTED|Overall Study||22
96343|NCT01116986|225430|P5|STARTED|Overall Study||24
96344|NCT01116986|225431|P4|STARTED|Overall Study||22
96345|NCT01116986|225432|P3|STARTED|Overall Study||18
96346|NCT01116986|225433|P2|STARTED|Overall Study||19
96347|NCT01116986|225434|P1|STARTED|Overall Study||24
96348|NCT01116934|225468|P2|NOT COMPLETED|Overall Study||0
96349|NCT01116934|225469|P1|NOT COMPLETED|Overall Study||0
96350|NCT01116934|225468|P2|COMPLETED|Overall Study||9
96351|NCT01116934|225469|P1|COMPLETED|Overall Study||8
96352|NCT01116934|225468|P2|STARTED|Overall Study||9
96353|NCT01116934|225469|P1|STARTED|Overall Study||8
96354|NCT01116882|225477|P2|NOT COMPLETED|12-month||99
96355|NCT01116882|225478|P1|NOT COMPLETED|12-month||267
96356|NCT01116882|225477|P2|COMPLETED|12-month||787
96357|NCT01116882|225478|P1|COMPLETED|12-month||2439
96358|NCT01116882|225477|P2|STARTED|12-month||886
96359|NCT01116882|225478|P1|STARTED|12-month||2706
96360|NCT01116882|225477|P2|NOT COMPLETED|30-day||31
96361|NCT01116882|225478|P1|NOT COMPLETED|30-day||68
96362|NCT01116882|225477|P2|COMPLETED|30-day||886
96363|NCT01116882|225478|P1|COMPLETED|30-day||2706
96364|NCT01116882|225477|P2|STARTED|30-day||917
96365|NCT01116882|225478|P1|STARTED|30-day||2774
96366|NCT01116687|225516|P1|NOT COMPLETED|Overall Study||4
96367|NCT01116687|225516|P1|COMPLETED|Overall Study||33
96368|NCT01116687|225516|P1|STARTED|Overall Study||37
96369|NCT01116466|225523|P1|NOT COMPLETED|Overall Study||0
96370|NCT01116466|225523|P1|COMPLETED|Overall Study||5
96371|NCT01116466|225523|P1|STARTED|Overall Study||5
96372|NCT01116427|225533|P2|NOT COMPLETED|Extension Phase||2
96373|NCT01116427|225534|P1|NOT COMPLETED|Extension Phase||9
96374|NCT01116427|225533|P2|COMPLETED|Extension Phase||18
96375|NCT01116427|225534|P1|COMPLETED|Extension Phase||29
96376|NCT01116427|225533|P2|STARTED|Extension Phase||20
96377|NCT01116427|225534|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
96378|NCT01116427|225533|P2|NOT COMPLETED|Core Phase||1
96379|NCT01116427|225534|P1|NOT COMPLETED|Core Phase||5
96380|NCT01116427|225533|P2|COMPLETED|Core Phase||20
96381|NCT01116427|225534|P1|COMPLETED|Core Phase||39
96382|NCT01116427|225533|P2|STARTED|Core Phase||21
96383|NCT01116427|225534|P1|STARTED|Core Phase||44
96384|NCT01116232|225570|P1|NOT COMPLETED|Overall Study||1
96385|NCT01116232|225570|P1|COMPLETED|Overall Study||0
96386|NCT01116232|225570|P1|STARTED|Overall Study||1
96387|NCT01116102|225583|P8|NOT COMPLETED|Overall Study||0
96388|NCT01116102|225584|P7|NOT COMPLETED|Overall Study||0
96389|NCT01116102|225585|P6|NOT COMPLETED|Overall Study||0
96390|NCT01116102|225586|P5|NOT COMPLETED|Overall Study||0
96391|NCT01116102|225587|P4|NOT COMPLETED|Overall Study||0
96392|NCT01116102|225588|P3|NOT COMPLETED|Overall Study||0
96393|NCT01116102|225589|P2|NOT COMPLETED|Overall Study||0
96394|NCT01116102|225590|P1|NOT COMPLETED|Overall Study||0
96395|NCT01116102|225583|P8|COMPLETED|Overall Study||3
96396|NCT01116102|225584|P7|COMPLETED|Overall Study||2
96397|NCT01116102|225585|P6|COMPLETED|Overall Study||2
96398|NCT01116102|225586|P5|COMPLETED|Overall Study||2
96399|NCT01116102|225587|P4|COMPLETED|Overall Study||3
96400|NCT01116102|225588|P3|COMPLETED|Overall Study||3
96401|NCT01116102|225589|P2|COMPLETED|Overall Study||3
96402|NCT01116102|225590|P1|COMPLETED|Overall Study||2
96403|NCT01116102|225583|P8|STARTED|Overall Study||3
96404|NCT01116102|225584|P7|STARTED|Overall Study||2
96405|NCT01116102|225585|P6|STARTED|Overall Study||2
96406|NCT01116102|225586|P5|STARTED|Overall Study||2
96407|NCT01116102|225587|P4|STARTED|Overall Study||3
96408|NCT01116102|225588|P3|STARTED|Overall Study||3
96409|NCT01116102|225589|P2|STARTED|Overall Study||3
96410|NCT01116102|225590|P1|STARTED|Overall Study||2
96411|NCT01116024|225632|P1|NOT COMPLETED|Overall Study||52
96412|NCT01116024|225632|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
96413|NCT01116024|225632|P1|STARTED|Overall Study|Patient Enrollment start date|148
96414|NCT01115998|225673|P2|NOT COMPLETED|Overall Study||6
96415|NCT01115998|225674|P1|NOT COMPLETED|Overall Study||6
96416|NCT01115998|225673|P2|COMPLETED|Overall Study||11
96417|NCT01115998|225674|P1|COMPLETED|Overall Study||11
96418|NCT01115998|225673|P2|STARTED|Overall Study||17
96419|NCT01115998|225674|P1|STARTED|Overall Study||17
96420|NCT01115933|225684|P1|NOT COMPLETED|Overall Study||1
96421|NCT01115933|225684|P1|COMPLETED|Overall Study||64
96422|NCT01115933|225684|P1|STARTED|Overall Study||65
96423|NCT01115855|225781|P2|NOT COMPLETED|Overall Study||36
96424|NCT01115855|225782|P1|NOT COMPLETED|Overall Study||36
96425|NCT01115855|225781|P2|COMPLETED|Overall Study||74
96426|NCT01115855|225782|P1|COMPLETED|Overall Study||75
96427|NCT01115855|225781|P2|STARTED|Overall Study||110
96428|NCT01115855|225782|P1|STARTED|Overall Study||111
96429|NCT01115738|225833|P3|NOT COMPLETED|Overall Study||27
96430|NCT01115738|225834|P2|NOT COMPLETED|Overall Study||21
96431|NCT01115738|225835|P1|NOT COMPLETED|Overall Study||25
96432|NCT01115738|225833|P3|COMPLETED|Overall Study||62
96433|NCT01115738|225834|P2|COMPLETED|Overall Study||62
96434|NCT01115738|225835|P1|COMPLETED|Overall Study||85
96435|NCT01115738|225833|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
96436|NCT01115738|225834|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
96437|NCT01115738|225835|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
96438|NCT01115738|225833|P3|Received Any Treatment|Overall Study||88
96439|NCT01115738|225834|P2|Received Any Treatment|Overall Study||79
96440|NCT01115738|225835|P1|Received Any Treatment|Overall Study||109
96441|NCT01115738|225833|P3|STARTED|Overall Study||89
96442|NCT01115738|225834|P2|STARTED|Overall Study||83
96443|NCT01115738|225835|P1|STARTED|Overall Study||110
96444|NCT01115699|225869|P1|NOT COMPLETED|Overall Study||0
96445|NCT01115699|225869|P1|COMPLETED|Overall Study||2
96446|NCT01115699|225869|P1|STARTED|Overall Study||2
96447|NCT01115673|225877|P3|NOT COMPLETED|Overall Study||0
96448|NCT01115673|225878|P2|NOT COMPLETED|Overall Study||0
96449|NCT01115673|225879|P1|NOT COMPLETED|Overall Study||0
96450|NCT01115673|225877|P3|COMPLETED|Overall Study||60
96451|NCT01115673|225878|P2|COMPLETED|Overall Study||241
96452|NCT01115673|225879|P1|COMPLETED|Overall Study||239
96453|NCT01115673|225877|P3|STARTED|Overall Study||60
96454|NCT01115673|225878|P2|STARTED|Overall Study||241
96455|NCT01115673|225879|P1|STARTED|Overall Study||239
96456|NCT01115660|226015|P2|NOT COMPLETED|Overall Study||0
96457|NCT01115660|226016|P1|NOT COMPLETED|Overall Study||1
96458|NCT01115660|226015|P2|COMPLETED|Overall Study||10
96459|NCT01115660|226016|P1|COMPLETED|Overall Study||19
96460|NCT01115660|226015|P2|STARTED|Overall Study||10
96461|NCT01115660|226016|P1|STARTED|Overall Study||20
96462|NCT01115582|226024|P1|NOT COMPLETED|Overall Study||0
96463|NCT01115582|226024|P1|COMPLETED|Overall Study||16
96464|NCT01115582|226024|P1|STARTED|Overall Study||16
96465|NCT01115569|226033|P2|NOT COMPLETED|Maintenance Phase||139
96466|NCT01115569|226034|P1|NOT COMPLETED|Maintenance Phase||0
96467|NCT01115569|226033|P2|COMPLETED|Maintenance Phase||285
96468|NCT01115569|226034|P1|COMPLETED|Maintenance Phase||0
96469|NCT01115569|226033|P2|STARTED|Maintenance Phase||424
96470|NCT01115569|226034|P1|STARTED|Maintenance Phase||0
96471|NCT01115569|226033|P2|NOT COMPLETED|Conversion/Titration Phase||0
96472|NCT01115569|226034|P1|NOT COMPLETED|Conversion/Titration Phase||214
96473|NCT01115569|226033|P2|COMPLETED|Conversion/Titration Phase||0
96474|NCT01115569|226034|P1|COMPLETED|Conversion/Titration Phase||424
96475|NCT01115569|226033|P2|STARTED|Conversion/Titration Phase||0
96476|NCT01115569|226034|P1|STARTED|Conversion/Titration Phase||638
96477|NCT01115517|226041|P2|NOT COMPLETED|Overall Study||5
96478|NCT01115517|226042|P1|NOT COMPLETED|Overall Study||4
96479|NCT01115517|226041|P2|COMPLETED|Overall Study||16
96480|NCT01115517|226042|P1|COMPLETED|Overall Study||14
96481|NCT01115517|226041|P2|STARTED|Overall Study||21
96482|NCT01115517|226042|P1|STARTED|Overall Study||18
96483|NCT01115491|226052|P1|NOT COMPLETED|Overall Study||30
96484|NCT01115491|226052|P1|COMPLETED|Overall Study||2
96485|NCT01115491|226052|P1|STARTED|Overall Study||32
96486|NCT01115452|226061|P1|NOT COMPLETED|Overall Study||0
96487|NCT01115452|226061|P1|COMPLETED|Overall Study||32
96488|NCT01115452|226061|P1|STARTED|Overall Study||32
96489|NCT01115166|226111|P1|NOT COMPLETED|Overall Study||0
96490|NCT01115166|226111|P1|COMPLETED|Overall Study||10
96491|NCT01115166|226111|P1|STARTED|Overall Study||10
96492|NCT01115101|226119|P2|NOT COMPLETED|Overall Study||0
96493|NCT01115101|226120|P1|NOT COMPLETED|Overall Study||0
96494|NCT01115101|226119|P2|COMPLETED|Overall Study||126
96495|NCT01115101|226120|P1|COMPLETED|Overall Study||113
96496|NCT01115101|226119|P2|STARTED|Overall Study||126
96497|NCT01115101|226120|P1|STARTED|Overall Study||113
96498|NCT01114997|226129|P3|NOT COMPLETED|Overall Study||0
96499|NCT01114997|226130|P2|NOT COMPLETED|Overall Study||0
96500|NCT01114997|226131|P1|NOT COMPLETED|Overall Study||0
96501|NCT01114997|226129|P3|COMPLETED|Overall Study||11
96502|NCT01114997|226130|P2|COMPLETED|Overall Study||10
96503|NCT01114997|226131|P1|COMPLETED|Overall Study||11
96504|NCT01114997|226129|P3|STARTED|Overall Study||11
96505|NCT01114997|226130|P2|STARTED|Overall Study||10
96506|NCT01114997|226131|P1|STARTED|Overall Study||11
96507|NCT01114945|226161|P4|NOT COMPLETED|Overall Study||0
96508|NCT01114945|226162|P3|NOT COMPLETED|Overall Study||0
96509|NCT01114945|226163|P2|NOT COMPLETED|Overall Study||0
96510|NCT01114945|226164|P1|NOT COMPLETED|Overall Study||0
96511|NCT01114945|226161|P4|COMPLETED|Overall Study||31
96512|NCT01114945|226162|P3|COMPLETED|Overall Study||30
96513|NCT01114945|226163|P2|COMPLETED|Overall Study||30
96514|NCT01114945|226164|P1|COMPLETED|Overall Study||30
96515|NCT01114945|226161|P4|STARTED|Overall Study||31
96516|NCT01114945|226162|P3|STARTED|Overall Study||30
96517|NCT01114945|226163|P2|STARTED|Overall Study||30
96518|NCT01114945|226164|P1|STARTED|Overall Study||30
96519|NCT01114893|226191|P5|NOT COMPLETED|Overall Study||0
96520|NCT01114893|226192|P4|NOT COMPLETED|Overall Study||0
96521|NCT01114893|226193|P3|NOT COMPLETED|Overall Study||0
96522|NCT01114893|226194|P2|NOT COMPLETED|Overall Study||0
96523|NCT01114893|226195|P1|NOT COMPLETED|Overall Study||0
96524|NCT01114893|226191|P5|COMPLETED|Overall Study||12
96525|NCT01114893|226192|P4|COMPLETED|Overall Study||13
96526|NCT01114893|226193|P3|COMPLETED|Overall Study||14
96527|NCT01114893|226194|P2|COMPLETED|Overall Study||14
96528|NCT01114893|226195|P1|COMPLETED|Overall Study||14
96529|NCT01114893|226191|P5|STARTED|Overall Study||12
96530|NCT01114893|226192|P4|STARTED|Overall Study||13
96531|NCT01114893|226193|P3|STARTED|Overall Study||14
96532|NCT01114893|226194|P2|STARTED|Overall Study||14
96533|NCT01114893|226195|P1|STARTED|Overall Study||14
96534|NCT01114880|226214|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
96535|NCT01114880|226215|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
96536|NCT01114880|226214|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
96537|NCT01114880|226215|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
96538|NCT01114880|226214|P2|STARTED|Period 2 (Week 12 to Week 24)||113
96539|NCT01114880|226215|P1|STARTED|Period 2 (Week 12 to Week 24)||224
96540|NCT01114880|226214|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
96541|NCT01114880|226215|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
96542|NCT01114880|226214|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
96543|NCT01114880|226215|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
96544|NCT01114880|226214|P2|STARTED|Period 1 (Week 0 to Week 12)||115
96545|NCT01114880|226215|P1|STARTED|Period 1 (Week 0 to Week 12)||229
96546|NCT01114828|226267|P2|NOT COMPLETED|Overall Study||4
96547|NCT01114828|226268|P1|NOT COMPLETED|Overall Study||3
96548|NCT01114828|226267|P2|COMPLETED|Overall Study||17
96549|NCT01114828|226268|P1|COMPLETED|Overall Study||16
96550|NCT01114828|226267|P2|STARTED|Overall Study||21
96551|NCT01114828|226268|P1|STARTED|Overall Study||19
96552|NCT01114737|226278|P2|NOT COMPLETED|Open-Label Treatment Period||2
96553|NCT01114737|226279|P1|NOT COMPLETED|Open-Label Treatment Period||5
96554|NCT01114737|226278|P2|COMPLETED|Open-Label Treatment Period||95
96555|NCT01114737|226279|P1|COMPLETED|Open-Label Treatment Period||100
96556|NCT01114737|226278|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
96557|NCT01114737|226279|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
96558|NCT01114737|226278|P2|NOT COMPLETED|Randomized Treatment Period||1
96559|NCT01114737|226279|P1|NOT COMPLETED|Randomized Treatment Period||3
96560|NCT01114737|226278|P2|COMPLETED|Randomized Treatment Period||97
96561|NCT01114737|226279|P1|COMPLETED|Randomized Treatment Period||105
96562|NCT01114737|226278|P2|STARTED|Randomized Treatment Period||98
96563|NCT01114737|226279|P1|STARTED|Randomized Treatment Period||108
96564|NCT01114724|226327|P1|NOT COMPLETED|Overall Study||10
96565|NCT01114724|226327|P1|COMPLETED|Overall Study||40
96566|NCT01114724|226327|P1|STARTED|Overall Study||50
96567|NCT01114672|226347|P2|NOT COMPLETED|Overall Study||2
96568|NCT01114672|226348|P1|NOT COMPLETED|Overall Study||4
96569|NCT01114672|226347|P2|COMPLETED|Overall Study||23
96570|NCT01114672|226348|P1|COMPLETED|Overall Study||21
96571|NCT01114672|226347|P2|STARTED|Overall Study||25
96572|NCT01114672|226348|P1|STARTED|Overall Study||25
96573|NCT01114581|226356|P2|NOT COMPLETED|Overall Study||0
96574|NCT01114581|226357|P1|NOT COMPLETED|Overall Study||0
96575|NCT01114581|226356|P2|COMPLETED|Overall Study||19
96576|NCT01114581|226357|P1|COMPLETED|Overall Study||19
96577|NCT01114581|226356|P2|STARTED|Overall Study||19
96578|NCT01114581|226357|P1|STARTED|Overall Study||19
96579|NCT01114516|226367|P2|NOT COMPLETED|Overall Study||1
96580|NCT01114516|226368|P1|NOT COMPLETED|Overall Study||2
96581|NCT01114516|226367|P2|COMPLETED|Overall Study||26
96582|NCT01114516|226368|P1|COMPLETED|Overall Study||24
96583|NCT01114516|226367|P2|STARTED|Overall Study||27
96584|NCT01114516|226368|P1|STARTED|Overall Study||26
96585|NCT01114373|226382|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
96586|NCT01114373|226383|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
96587|NCT01114373|226382|P2|COMPLETED|Intervention 2 (4 Weeks)||18
96588|NCT01114373|226383|P1|COMPLETED|Intervention 2 (4 Weeks)||18
96589|NCT01114373|226382|P2|STARTED|Intervention 2 (4 Weeks)||19
96590|NCT01114373|226383|P1|STARTED|Intervention 2 (4 Weeks)||18
96591|NCT01114373|226382|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
96592|NCT01114373|226383|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
96593|NCT01114373|226382|P2|COMPLETED|Intervention 1 (4 Weeks)||19
96594|NCT01114373|226383|P1|COMPLETED|Intervention 1 (4 Weeks)||18
96595|NCT01114373|226382|P2|STARTED|Intervention 1 (4 Weeks)||19
96596|NCT01114373|226383|P1|STARTED|Intervention 1 (4 Weeks)||21
96597|NCT01114360|226415|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
96598|NCT01114360|226416|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
96599|NCT01114360|226415|P2|COMPLETED|Intervention 2 (4 Weeks)||18
96600|NCT01114360|226416|P1|COMPLETED|Intervention 2 (4 Weeks)||18
96601|NCT01114360|226415|P2|STARTED|Intervention 2 (4 Weeks)||18
96602|NCT01114360|226416|P1|STARTED|Intervention 2 (4 Weeks)||18
96603|NCT01114360|226415|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
96604|NCT01114360|226416|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
96605|NCT01114360|226415|P2|COMPLETED|Intervention 1 (4 Weeks)||18
96606|NCT01114360|226416|P1|COMPLETED|Intervention 1 (4 Weeks)||18
96607|NCT01114360|226415|P2|STARTED|Intervention 1 (4 Weeks)||19
96608|NCT01114360|226416|P1|STARTED|Intervention 1 (4 Weeks)||18
96609|NCT01113931|226454|P2|NOT COMPLETED|Overall Study||17
96610|NCT01113931|226455|P1|NOT COMPLETED|Overall Study||19
96611|NCT01113931|226454|P2|COMPLETED|Overall Study||231
96612|NCT01113931|226455|P1|COMPLETED|Overall Study||228
96613|NCT01113931|226454|P2|mITT Population|Overall Study||190
96614|NCT01113931|226455|P1|mITT Population|Overall Study||188
96615|NCT01113931|226454|P2|Safety Population|Overall Study||248
96616|NCT01113931|226455|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
96617|NCT01113931|226454|P2|STARTED|Overall Study||248
96618|NCT01113931|226455|P1|STARTED|Overall Study||247
96619|NCT01113749|226469|P2|NOT COMPLETED|Overall Study||2
96620|NCT01113749|226470|P1|NOT COMPLETED|Overall Study||1
96621|NCT01113749|226469|P2|COMPLETED|Overall Study||127
96622|NCT01113749|226470|P1|COMPLETED|Overall Study||126
96623|NCT01113749|226469|P2|STARTED|Overall Study||129
96624|NCT01113749|226470|P1|STARTED|Overall Study||127
96625|NCT01113723|226482|P2|NOT COMPLETED|Overall Study||0
96626|NCT01113723|226483|P1|NOT COMPLETED|Overall Study||0
96627|NCT01113723|226482|P2|COMPLETED|Overall Study||70
96628|NCT01113723|226483|P1|COMPLETED|Overall Study||70
96629|NCT01113723|226482|P2|STARTED|Overall Study||70
96630|NCT01113723|226483|P1|STARTED|Overall Study||70
96631|NCT01113710|226493|P1|NOT COMPLETED|Overall Study||269
96632|NCT01113710|226493|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
96633|NCT01113710|226493|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
96634|NCT01113632|226504|P2|NOT COMPLETED|Overall Study||25
96635|NCT01113632|226505|P1|NOT COMPLETED|Overall Study||31
96636|NCT01113632|226504|P2|COMPLETED|Overall Study||19
96637|NCT01113632|226505|P1|COMPLETED|Overall Study||2
96638|NCT01113632|226504|P2|STARTED|Overall Study||44
96639|NCT01113632|226505|P1|STARTED|Overall Study||33
96640|NCT01113580|226521|P2|NOT COMPLETED|Overall Study||0
96641|NCT01113580|226522|P1|NOT COMPLETED|Overall Study||1
96642|NCT01113580|226521|P2|COMPLETED|Overall Study||60
96643|NCT01113580|226522|P1|COMPLETED|Overall Study||59
96644|NCT01113580|226521|P2|STARTED|Overall Study||60
96645|NCT01113580|226522|P1|STARTED|Overall Study||60
96646|NCT01113541|226536|P1|NOT COMPLETED|Overall Study||13
96647|NCT01113541|226536|P1|COMPLETED|Overall Study||0
96648|NCT01113541|226536|P1|STARTED|Overall Study||13
96649|NCT01113463|226569|P1|NOT COMPLETED|Overall Study||5
96650|NCT01113463|226569|P1|COMPLETED|Overall Study||12
96651|NCT01113463|226569|P1|STARTED|Overall Study||17
96652|NCT01113398|226574|P1|NOT COMPLETED|Overall Study||0
96653|NCT01113398|226574|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
96654|NCT01113398|226574|P1|STARTED|Overall Study||36
96655|NCT01113385|226581|P1|NOT COMPLETED|Overall Study||0
96656|NCT01113385|226581|P1|COMPLETED|Overall Study||7
96657|NCT01113385|226581|P1|STARTED|Overall Study||7
96658|NCT01113008|226588|P2|NOT COMPLETED|Overall Study||0
96659|NCT01113008|226589|P1|NOT COMPLETED|Overall Study||0
96660|NCT01113008|226588|P2|COMPLETED|Overall Study||133
96661|NCT01113008|226589|P1|COMPLETED|Overall Study||133
96662|NCT01113008|226588|P2|STARTED|Overall Study||133
96663|NCT01113008|226589|P1|STARTED|Overall Study||133
96664|NCT01112917|226599|P2|NOT COMPLETED|Overall Study||15
96665|NCT01112917|226600|P1|NOT COMPLETED|Overall Study||7
96666|NCT01112917|226599|P2|COMPLETED|Overall Study||38
96667|NCT01112917|226600|P1|COMPLETED|Overall Study||89
96668|NCT01112917|226599|P2|STARTED|Overall Study||53
96669|NCT01112917|226600|P1|STARTED|Overall Study||96
96670|NCT01112865|226605|P2|NOT COMPLETED|Second Intervention||0
96671|NCT01112865|226606|P1|NOT COMPLETED|Second Intervention||0
96672|NCT01112865|226605|P2|COMPLETED|Second Intervention||61
96673|NCT01112865|226606|P1|COMPLETED|Second Intervention||59
96674|NCT01112865|226605|P2|STARTED|Second Intervention||61
96675|NCT01112865|226606|P1|STARTED|Second Intervention||59
96676|NCT01112865|226605|P2|NOT COMPLETED|First Intervention||0
96677|NCT01112865|226606|P1|NOT COMPLETED|First Intervention||0
96678|NCT01112865|226605|P2|COMPLETED|First Intervention||61
96679|NCT01112865|226606|P1|COMPLETED|First Intervention||59
96680|NCT01112865|226605|P2|STARTED|First Intervention||61
96681|NCT01112865|226606|P1|STARTED|First Intervention||59
96682|NCT01112696|226616|P1|NOT COMPLETED|Overall Study||2
96683|NCT01112696|226616|P1|COMPLETED|Overall Study||98
96684|NCT01112696|226616|P1|STARTED|Overall Study||100
96685|NCT01112683|226622|P2|NOT COMPLETED|Overall Study||1
96686|NCT01112683|226623|P1|NOT COMPLETED|Overall Study||1
96687|NCT01112683|226622|P2|COMPLETED|Overall Study||19
96688|NCT01112683|226623|P1|COMPLETED|Overall Study||18
96689|NCT01112683|226622|P2|STARTED|Overall Study||20
96690|NCT01112683|226623|P1|STARTED|Overall Study||19
96691|NCT01112670|226633|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96692|NCT01112670|226634|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96693|NCT01112670|226635|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96694|NCT01112670|226636|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96695|NCT01112670|226637|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96696|NCT01112670|226638|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96697|NCT01112670|226633|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
96698|NCT01112670|226634|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96699|NCT01112670|226635|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
96700|NCT01112670|226636|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96701|NCT01112670|226637|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
96702|NCT01112670|226638|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
96703|NCT01112670|226633|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
96704|NCT01112670|226634|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
96705|NCT01112670|226635|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
96706|NCT01112670|226636|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
96707|NCT01112670|226637|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
96708|NCT01112670|226638|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
96709|NCT01112670|226633|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96710|NCT01112670|226634|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
96711|NCT01112670|226635|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96712|NCT01112670|226636|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
96713|NCT01112670|226637|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96714|NCT01112670|226638|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
96715|NCT01112670|226633|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96716|NCT01112670|226634|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
96717|NCT01112670|226635|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96718|NCT01112670|226636|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
96719|NCT01112670|226637|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
96720|NCT01112670|226638|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
96721|NCT01112670|226633|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
96722|NCT01112670|226634|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
96723|NCT01112670|226635|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
96724|NCT01112670|226636|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
96725|NCT01112670|226637|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
96726|NCT01112670|226638|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
96727|NCT01112579|226676|P2|NOT COMPLETED|Overall Study||3
96728|NCT01112579|226677|P1|NOT COMPLETED|Overall Study||1
96729|NCT01112579|226676|P2|COMPLETED|Overall Study||21
96730|NCT01112579|226677|P1|COMPLETED|Overall Study||41
96731|NCT01112579|226676|P2|STARTED|Overall Study||24
96732|NCT01112579|226677|P1|STARTED|Overall Study||42
96733|NCT01112514|226687|P1|NOT COMPLETED|Overall Study||1
96734|NCT01112514|226687|P1|COMPLETED|Overall Study||3
96735|NCT01112514|226687|P1|STARTED|Overall Study||4
96736|NCT01112267|226693|P2|NOT COMPLETED|Overall Study||18
96737|NCT01112267|226694|P1|NOT COMPLETED|Overall Study||34
96738|NCT01112267|226693|P2|COMPLETED|Overall Study||104
96739|NCT01112267|226694|P1|COMPLETED|Overall Study||92
96740|NCT01112267|226693|P2|Treated|Overall Study||120
96741|NCT01112267|226694|P1|Treated|Overall Study||125
96742|NCT01112267|226693|P2|STARTED|Overall Study||122
96743|NCT01112267|226694|P1|STARTED|Overall Study||126
96744|NCT01112241|226712|P1|NOT COMPLETED|Overall Study||0
96745|NCT01112241|226712|P1|COMPLETED|Overall Study||17
96746|NCT01112241|226712|P1|STARTED|Overall Study||17
96747|NCT01111851|226727|P2|NOT COMPLETED|Overall Study||0
96748|NCT01111851|226728|P1|NOT COMPLETED|Overall Study||2
96749|NCT01111851|226727|P2|COMPLETED|Overall Study||8
96750|NCT01111851|226728|P1|COMPLETED|Overall Study||6
96751|NCT01111851|226727|P2|STARTED|Overall Study||8
96752|NCT01111851|226728|P1|STARTED|Overall Study||8
96753|NCT01111838|226740|P1|NOT COMPLETED|Overall Study||7
96754|NCT01111838|226740|P1|COMPLETED|Overall Study||15
96755|NCT01111838|226740|P1|STARTED|Overall Study||22
96756|NCT01111526|226744|P3|NOT COMPLETED|Overall Study||2
96757|NCT01111526|226745|P2|NOT COMPLETED|Overall Study||1
96758|NCT01111526|226746|P1|NOT COMPLETED|Overall Study||0
96759|NCT01111526|226744|P3|COMPLETED|Overall Study||8
96760|NCT01111526|226745|P2|COMPLETED|Overall Study||7
96761|NCT01111526|226746|P1|COMPLETED|Overall Study||4
96762|NCT01111526|226744|P3|STARTED|Overall Study||10
96763|NCT01111526|226745|P2|STARTED|Overall Study||8
96764|NCT01111526|226746|P1|STARTED|Overall Study||4
96765|NCT01111461|226758|P1|NOT COMPLETED|Overall Study||51
96766|NCT01111461|226758|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
96767|NCT01111461|226758|P1|STARTED|Overall Study||133
96768|NCT01111331|226771|P2|NOT COMPLETED|Overall Study||0
96769|NCT01111331|226772|P1|NOT COMPLETED|Overall Study||0
96770|NCT01111331|226771|P2|COMPLETED|Overall Study||9
96771|NCT01111331|226772|P1|COMPLETED|Overall Study||9
96772|NCT01111331|226771|P2|STARTED|Overall Study||9
96773|NCT01111331|226772|P1|STARTED|Overall Study||9
96774|NCT01111318|226854|P4|NOT COMPLETED|Overall Study||0
96775|NCT01111318|226855|P3|NOT COMPLETED|Overall Study||0
96776|NCT01111318|226856|P2|NOT COMPLETED|Overall Study||0
96777|NCT01111318|226857|P1|NOT COMPLETED|Overall Study||0
96778|NCT01111318|226854|P4|COMPLETED|Overall Study||8
96779|NCT01111318|226855|P3|COMPLETED|Overall Study||8
96780|NCT01111318|226856|P2|COMPLETED|Overall Study||8
96781|NCT01111318|226857|P1|COMPLETED|Overall Study||12
96782|NCT01111318|226854|P4|STARTED|Overall Study||8
96783|NCT01111318|226855|P3|STARTED|Overall Study||8
96784|NCT01111318|226856|P2|STARTED|Overall Study||8
96785|NCT01111318|226857|P1|STARTED|Overall Study||12
96786|NCT01111292|226921|P2|NOT COMPLETED|Follow-Up||0
96787|NCT01111292|226922|P1|NOT COMPLETED|Follow-Up||0
96788|NCT01111292|226921|P2|COMPLETED|Follow-Up||1
96789|NCT01111292|226922|P1|COMPLETED|Follow-Up||2
96790|NCT01111292|226921|P2|STARTED|Follow-Up||1
96791|NCT01111292|226922|P1|STARTED|Follow-Up||2
96792|NCT01111292|226921|P2|NOT COMPLETED|Post Treatment Biopsy||0
96793|NCT01111292|226922|P1|NOT COMPLETED|Post Treatment Biopsy||0
96794|NCT01111292|226921|P2|COMPLETED|Post Treatment Biopsy||1
96795|NCT01111292|226922|P1|COMPLETED|Post Treatment Biopsy||2
96796|NCT01111292|226921|P2|STARTED|Post Treatment Biopsy||1
96797|NCT01111292|226922|P1|STARTED|Post Treatment Biopsy||2
96798|NCT01111292|226921|P2|NOT COMPLETED|Treatment||1
96799|NCT01111292|226922|P1|NOT COMPLETED|Treatment||1
96800|NCT01111292|226921|P2|COMPLETED|Treatment||1
96801|NCT01111292|226922|P1|COMPLETED|Treatment||2
96802|NCT01111292|226921|P2|STARTED|Treatment||2
96803|NCT01111292|226922|P1|STARTED|Treatment||3
96804|NCT01111292|226921|P2|NOT COMPLETED|Randomization||0
96805|NCT01111292|226922|P1|NOT COMPLETED|Randomization||0
96806|NCT01111292|226921|P2|COMPLETED|Randomization||2
96807|NCT01111292|226922|P1|COMPLETED|Randomization||3
96808|NCT01111292|226921|P2|STARTED|Randomization||2
96809|NCT01111292|226922|P1|STARTED|Randomization||3
96810|NCT01111240|226928|P1|NOT COMPLETED|Overall Study||1066
96811|NCT01111240|226928|P1|COMPLETED|Overall Study||3569
96812|NCT01111240|226928|P1|STARTED|Overall Study||4635
96813|NCT01111162|226950|P1|NOT COMPLETED|Overall Study||0
96814|NCT01111162|226950|P1|COMPLETED|Overall Study||120
96815|NCT01111162|226950|P1|STARTED|Overall Study||120
96816|NCT01111149|226958|P3|NOT COMPLETED|Overall Study||4
96817|NCT01111149|226959|P2|NOT COMPLETED|Overall Study||1
96818|NCT01111149|226960|P1|NOT COMPLETED|Overall Study||2
96819|NCT01111149|226958|P3|COMPLETED|Overall Study||5
96820|NCT01111149|226959|P2|COMPLETED|Overall Study||5
96821|NCT01111149|226960|P1|COMPLETED|Overall Study||7
96822|NCT01111149|226958|P3|STARTED|Overall Study||9
96823|NCT01111149|226959|P2|STARTED|Overall Study||6
96824|NCT01111149|226960|P1|STARTED|Overall Study||9
96825|NCT01111123|227036|P2|NOT COMPLETED|Maintenance Phase||2
96826|NCT01111123|227037|P1|NOT COMPLETED|Maintenance Phase||0
96827|NCT01111123|227036|P2|COMPLETED|Maintenance Phase||18
96828|NCT01111123|227037|P1|COMPLETED|Maintenance Phase||21
96829|NCT01111123|227036|P2|STARTED|Maintenance Phase||20
96830|NCT01111123|227037|P1|STARTED|Maintenance Phase||21
96831|NCT01111123|227036|P2|NOT COMPLETED|Open- Label Phase||0
96832|NCT01111123|227037|P1|NOT COMPLETED|Open- Label Phase||14
96833|NCT01111123|227036|P2|COMPLETED|Open- Label Phase||0
96834|NCT01111123|227037|P1|COMPLETED|Open- Label Phase||41
96835|NCT01111123|227036|P2|STARTED|Open- Label Phase||0
96836|NCT01111123|227037|P1|STARTED|Open- Label Phase||55
96837|NCT01111110|227047|P2|NOT COMPLETED|Overall Study||0
96838|NCT01111110|227048|P1|NOT COMPLETED|Overall Study||0
96839|NCT01111110|227047|P2|COMPLETED|Overall Study||4
96840|NCT01111110|227048|P1|COMPLETED|Overall Study||3
96841|NCT01111110|227047|P2|STARTED|Overall Study||4
96842|NCT01111110|227048|P1|STARTED|Overall Study||3
96843|NCT01110967|227058|P1|NOT COMPLETED|Overall Study||9
96844|NCT01110967|227058|P1|COMPLETED|Overall Study||31
96845|NCT01110967|227058|P1|12 Months Follow up|Overall Study||31
96846|NCT01110967|227058|P1|6 Months Follow up|Overall Study||24
96847|NCT01110967|227058|P1|3 Months Follow up|Overall Study||28
96848|NCT01110967|227058|P1|1 Month Follow up|Overall Study||26
96849|NCT01110967|227058|P1|Surgery|Overall Study||40
96850|NCT01110967|227058|P1|STARTED|Overall Study||40
96851|NCT01110915|227071|P2|NOT COMPLETED|Overall Study||2
96852|NCT01110915|227072|P1|NOT COMPLETED|Overall Study||10
96853|NCT01110915|227071|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
96854|NCT01110915|227072|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
96855|NCT01110915|227071|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
96856|NCT01110915|227072|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
96857|NCT01110499|227095|P8|NOT COMPLETED|Overall Study||0
96858|NCT01110499|227096|P7|NOT COMPLETED|Overall Study||0
96859|NCT01110499|227097|P6|NOT COMPLETED|Overall Study||0
96860|NCT01110499|227098|P5|NOT COMPLETED|Overall Study||0
96861|NCT01110499|227099|P4|NOT COMPLETED|Overall Study||0
96862|NCT01110499|227100|P3|NOT COMPLETED|Overall Study||0
96863|NCT01110499|227101|P2|NOT COMPLETED|Overall Study||0
96864|NCT01110499|227102|P1|NOT COMPLETED|Overall Study||0
96865|NCT01110499|227095|P8|COMPLETED|Overall Study||40
96866|NCT01110499|227096|P7|COMPLETED|Overall Study||39
96867|NCT01110499|227097|P6|COMPLETED|Overall Study||14
96868|NCT01110499|227098|P5|COMPLETED|Overall Study||14
96869|NCT01110499|227099|P4|COMPLETED|Overall Study||14
96870|NCT01110499|227100|P3|COMPLETED|Overall Study||14
96871|NCT01110499|227101|P2|COMPLETED|Overall Study||14
96872|NCT01110499|227102|P1|COMPLETED|Overall Study||14
96873|NCT01110499|227095|P8|STARTED|Overall Study||40
96874|NCT01110499|227096|P7|STARTED|Overall Study||39
96875|NCT01110499|227097|P6|STARTED|Overall Study||14
96876|NCT01110499|227098|P5|STARTED|Overall Study||14
96877|NCT01110499|227099|P4|STARTED|Overall Study||14
96878|NCT01110499|227100|P3|STARTED|Overall Study||14
96879|NCT01110499|227101|P2|STARTED|Overall Study||14
96880|NCT01110499|227102|P1|STARTED|Overall Study||14
96881|NCT01110421|227124|P2|NOT COMPLETED|Overall Study||0
96882|NCT01110421|227125|P1|NOT COMPLETED|Overall Study||0
96883|NCT01110421|227124|P2|COMPLETED|Overall Study||2
96884|NCT01110421|227125|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
96885|NCT01110421|227124|P2|STARTED|Overall Study||2
96886|NCT01110421|227125|P1|STARTED|Overall Study||5
96887|NCT01110408|227145|P2|NOT COMPLETED|Overall Study||0
96888|NCT01110408|227146|P1|NOT COMPLETED|Overall Study||1
96889|NCT01110408|227145|P2|COMPLETED|Overall Study||10
96890|NCT01110408|227146|P1|COMPLETED|Overall Study||30
96891|NCT01110408|227145|P2|STARTED|Overall Study||10
96892|NCT01110408|227146|P1|STARTED|Overall Study||31
96893|NCT01110382|227166|P2|NOT COMPLETED|Overall Study||2
96894|NCT01110382|227167|P1|NOT COMPLETED|Overall Study||0
96895|NCT01110382|227166|P2|COMPLETED|Overall Study||8
96896|NCT01110382|227167|P1|COMPLETED|Overall Study||31
96897|NCT01110382|227166|P2|STARTED|Overall Study||10
96898|NCT01110382|227167|P1|STARTED|Overall Study||31
96899|NCT01110330|227188|P3|NOT COMPLETED|Overall Study||26
96900|NCT01110330|227189|P2|NOT COMPLETED|Overall Study||23
96901|NCT01110330|227190|P1|NOT COMPLETED|Overall Study||15
96902|NCT01110330|227188|P3|COMPLETED|Overall Study||208
96903|NCT01110330|227189|P2|COMPLETED|Overall Study||207
96904|NCT01110330|227190|P1|COMPLETED|Overall Study||104
96905|NCT01110330|227188|P3|Positive Baseline Culture Set|Overall Study||114
96906|NCT01110330|227189|P2|Positive Baseline Culture Set|Overall Study||111
96907|NCT01110330|227190|P1|Positive Baseline Culture Set|Overall Study||56
96908|NCT01110330|227188|P3|STARTED|Overall Study||234
96909|NCT01110330|227189|P2|STARTED|Overall Study||230
96910|NCT01110330|227190|P1|STARTED|Overall Study||119
96911|NCT01110252|227201|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
96912|NCT01110252|227201|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
96913|NCT01110252|227201|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
96914|NCT01110252|227201|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
96915|NCT01110252|227201|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
96916|NCT01110252|227201|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
96917|NCT01110239|227218|P4|NOT COMPLETED|10 Min Ischemia||0
96918|NCT01110239|227219|P3|NOT COMPLETED|10 Min Ischemia||0
96919|NCT01110239|227220|P2|NOT COMPLETED|10 Min Ischemia||0
96920|NCT01110239|227221|P1|NOT COMPLETED|10 Min Ischemia||0
96921|NCT01110239|227218|P4|COMPLETED|10 Min Ischemia||6
96922|NCT01110239|227219|P3|COMPLETED|10 Min Ischemia||0
96923|NCT01110239|227220|P2|COMPLETED|10 Min Ischemia||0
96924|NCT01110239|227221|P1|COMPLETED|10 Min Ischemia||0
96925|NCT01110239|227218|P4|STARTED|10 Min Ischemia||6
96926|NCT01110239|227219|P3|STARTED|10 Min Ischemia||0
96927|NCT01110239|227220|P2|STARTED|10 Min Ischemia||0
96928|NCT01110239|227221|P1|STARTED|10 Min Ischemia||0
96929|NCT01110239|227218|P4|NOT COMPLETED|7.5 Min Ischemia||0
96930|NCT01110239|227219|P3|NOT COMPLETED|7.5 Min Ischemia||1
96931|NCT01110239|227220|P2|NOT COMPLETED|7.5 Min Ischemia||0
96932|NCT01110239|227221|P1|NOT COMPLETED|7.5 Min Ischemia||0
96933|NCT01110239|227218|P4|COMPLETED|7.5 Min Ischemia||0
96934|NCT01110239|227219|P3|COMPLETED|7.5 Min Ischemia||6
96935|NCT01110239|227220|P2|COMPLETED|7.5 Min Ischemia||0
96936|NCT01110239|227221|P1|COMPLETED|7.5 Min Ischemia||0
96937|NCT01110239|227218|P4|STARTED|7.5 Min Ischemia||0
96938|NCT01110239|227219|P3|STARTED|7.5 Min Ischemia||7
96939|NCT01110239|227220|P2|STARTED|7.5 Min Ischemia||0
96940|NCT01110239|227221|P1|STARTED|7.5 Min Ischemia||0
96941|NCT01110239|227218|P4|NOT COMPLETED|5 Min Ischemia||0
96942|NCT01110239|227219|P3|NOT COMPLETED|5 Min Ischemia||0
96943|NCT01110239|227220|P2|NOT COMPLETED|5 Min Ischemia||14
96944|NCT01110239|227221|P1|NOT COMPLETED|5 Min Ischemia||0
96945|NCT01110239|227218|P4|COMPLETED|5 Min Ischemia||0
96946|NCT01110239|227219|P3|COMPLETED|5 Min Ischemia||0
96947|NCT01110239|227220|P2|COMPLETED|5 Min Ischemia||0
96948|NCT01110239|227221|P1|COMPLETED|5 Min Ischemia||0
96949|NCT01110239|227218|P4|STARTED|5 Min Ischemia||0
96950|NCT01110239|227219|P3|STARTED|5 Min Ischemia||0
96951|NCT01110239|227220|P2|STARTED|5 Min Ischemia||14
96952|NCT01110239|227221|P1|STARTED|5 Min Ischemia||0
96953|NCT01110239|227218|P4|NOT COMPLETED|Sham Preconditioning||0
96954|NCT01110239|227219|P3|NOT COMPLETED|Sham Preconditioning||1
96955|NCT01110239|227220|P2|NOT COMPLETED|Sham Preconditioning||0
96956|NCT01110239|227221|P1|NOT COMPLETED|Sham Preconditioning||0
96957|NCT01110239|227218|P4|COMPLETED|Sham Preconditioning||6
96958|NCT01110239|227219|P3|COMPLETED|Sham Preconditioning||6
96959|NCT01110239|227220|P2|COMPLETED|Sham Preconditioning||14
96960|NCT01110239|227221|P1|COMPLETED|Sham Preconditioning||7
96961|NCT01110239|227218|P4|STARTED|Sham Preconditioning||6
96962|NCT01110239|227219|P3|STARTED|Sham Preconditioning||7
96963|NCT01110239|227220|P2|STARTED|Sham Preconditioning||14
96964|NCT01110239|227221|P1|STARTED|Sham Preconditioning||7
96965|NCT01110200|227237|P2|NOT COMPLETED|Overall Study||121
96966|NCT01110200|227238|P1|NOT COMPLETED|Overall Study||106
96967|NCT01110200|227237|P2|COMPLETED|Overall Study||204
96968|NCT01110200|227238|P1|COMPLETED|Overall Study||208
96969|NCT01110200|227237|P2|STARTED|Overall Study||325
96970|NCT01110200|227238|P1|STARTED|Overall Study||314
96971|NCT01110187|227254|P2|NOT COMPLETED|Overall Study||0
96972|NCT01110187|227255|P1|NOT COMPLETED|Overall Study||0
96973|NCT01110187|227254|P2|COMPLETED|Overall Study|completed 7 day treatment|4
96974|NCT01110187|227255|P1|COMPLETED|Overall Study|completed 7 day treatment|7
96975|NCT01110187|227254|P2|STARTED|Overall Study||4
96976|NCT01110187|227255|P1|STARTED|Overall Study||7
96977|NCT01109979|227265|P2|NOT COMPLETED|Overall Study||1
96978|NCT01109979|227266|P1|NOT COMPLETED|Overall Study||2
96979|NCT01109979|227265|P2|COMPLETED|Overall Study||11
96980|NCT01109979|227266|P1|COMPLETED|Overall Study||10
96981|NCT01109979|227265|P2|STARTED|Overall Study||12
96982|NCT01109979|227266|P1|STARTED|Overall Study||12
96983|NCT01109602|227275|P3|NOT COMPLETED|Overall Study||1
96984|NCT01109602|227276|P2|NOT COMPLETED|Overall Study||2
96985|NCT01109602|227277|P1|NOT COMPLETED|Overall Study||1
96986|NCT01109602|227275|P3|COMPLETED|Overall Study||9
96987|NCT01109602|227276|P2|COMPLETED|Overall Study||21
96988|NCT01109602|227277|P1|COMPLETED|Overall Study||13
96989|NCT01109602|227275|P3|STARTED|Overall Study||10
96990|NCT01109602|227276|P2|STARTED|Overall Study||23
96991|NCT01109602|227277|P1|STARTED|Overall Study||14
96992|NCT01109576|227288|P1|NOT COMPLETED|Overall Study||1
96993|NCT01109576|227288|P1|COMPLETED|Overall Study||12
96994|NCT01109576|227288|P1|STARTED|Overall Study||13
96995|NCT01109524|227292|P1|NOT COMPLETED|Overall Study||57
96996|NCT01109524|227292|P1|COMPLETED|Overall Study||3
96997|NCT01109524|227292|P1|STARTED|Overall Study||60
96998|NCT01109381|227302|P1|NOT COMPLETED|Overall Study||2
96999|NCT01109381|227302|P1|COMPLETED|Overall Study||31
97000|NCT01109381|227302|P1|STARTED|Overall Study||33
97001|NCT01109316|227314|P3|NOT COMPLETED|Study Period 3||1
97002|NCT01109316|227315|P2|NOT COMPLETED|Study Period 3||2
97003|NCT01109316|227316|P1|NOT COMPLETED|Study Period 3||0
97004|NCT01109316|227314|P3|COMPLETED|Study Period 3||38
97005|NCT01109316|227315|P2|COMPLETED|Study Period 3||39
97006|NCT01109316|227316|P1|COMPLETED|Study Period 3||39
97007|NCT01109316|227314|P3|STARTED|Study Period 3||39
97008|NCT01109316|227315|P2|STARTED|Study Period 3||41
97009|NCT01109316|227316|P1|STARTED|Study Period 3||39
97010|NCT01109316|227314|P3|NOT COMPLETED|Study Period 2||2
97011|NCT01109316|227315|P2|NOT COMPLETED|Study Period 2||2
97012|NCT01109316|227316|P1|NOT COMPLETED|Study Period 2||1
97013|NCT01109316|227314|P3|COMPLETED|Study Period 2||41
97014|NCT01109316|227315|P2|COMPLETED|Study Period 2||40
97015|NCT01109316|227316|P1|COMPLETED|Study Period 2||38
97016|NCT01109316|227314|P3|STARTED|Study Period 2||43
97017|NCT01109316|227315|P2|STARTED|Study Period 2||42
97018|NCT01109316|227316|P1|STARTED|Study Period 2||39
97019|NCT01109316|227314|P3|NOT COMPLETED|Study Period 1||4
97020|NCT01109316|227315|P2|NOT COMPLETED|Study Period 1||4
97021|NCT01109316|227316|P1|NOT COMPLETED|Study Period 1||0
97022|NCT01109316|227314|P3|COMPLETED|Study Period 1||40
97023|NCT01109316|227315|P2|COMPLETED|Study Period 1||40
97024|NCT01109316|227316|P1|COMPLETED|Study Period 1||44
97025|NCT01109316|227314|P3|Received at Least One Dose of Study Drug|Study Period 1||42
97026|NCT01109316|227315|P2|Received at Least One Dose of Study Drug|Study Period 1||44
97027|NCT01109316|227316|P1|Received at Least One Dose of Study Drug|Study Period 1||44
97028|NCT01109316|227314|P3|STARTED|Study Period 1||44
97029|NCT01109316|227315|P2|STARTED|Study Period 1||44
97030|NCT01109316|227316|P1|STARTED|Study Period 1||44
97031|NCT01109173|227364|P4|NOT COMPLETED|Overall Study||93
97032|NCT01109173|227365|P3|NOT COMPLETED|Overall Study||101
97033|NCT01109173|227366|P2|NOT COMPLETED|Overall Study||86
97034|NCT01109173|227367|P1|NOT COMPLETED|Overall Study||88
97035|NCT01109173|227364|P4|COMPLETED|Overall Study||120
97036|NCT01109173|227365|P3|COMPLETED|Overall Study||110
97037|NCT01109173|227366|P2|COMPLETED|Overall Study||759
97038|NCT01109173|227367|P1|COMPLETED|Overall Study||763
97039|NCT01109173|227364|P4|STARTED|Overall Study||213
97040|NCT01109173|227365|P3|STARTED|Overall Study||211
97041|NCT01109173|227366|P2|STARTED|Overall Study||845
97042|NCT01109173|227367|P1|STARTED|Overall Study||851
97043|NCT01109147|227384|P3|NOT COMPLETED|Overall Study||10
97044|NCT01109147|227385|P2|NOT COMPLETED|Overall Study||3
97045|NCT01109147|227386|P1|NOT COMPLETED|Overall Study||2
97046|NCT01109147|227384|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
97047|NCT01109147|227385|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
97048|NCT01109147|227386|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
97049|NCT01109147|227384|P3|STARTED|Overall Study||36
97050|NCT01109147|227385|P2|STARTED|Overall Study||14
97051|NCT01109147|227386|P1|STARTED|Overall Study||17
97052|NCT01109056|227396|P2|NOT COMPLETED|Overall Study||5
97053|NCT01109056|227397|P1|NOT COMPLETED|Overall Study||7
97054|NCT01109056|227396|P2|COMPLETED|Overall Study||53
97055|NCT01109056|227397|P1|COMPLETED|Overall Study||50
97056|NCT01109056|227396|P2|STARTED|Overall Study||58
97057|NCT01109056|227397|P1|STARTED|Overall Study||57
97058|NCT01108809|227407|P1|NOT COMPLETED|Overall Study||4
97059|NCT01108809|227407|P1|COMPLETED|Overall Study||291
97060|NCT01108809|227407|P1|STARTED|Overall Study||295
97061|NCT01108796|227424|P2|NOT COMPLETED|Overall Study||7
97062|NCT01108796|227425|P1|NOT COMPLETED|Overall Study||7
97063|NCT01108796|227424|P2|COMPLETED|Overall Study||1060
97064|NCT01108796|227425|P1|COMPLETED|Overall Study||767
97065|NCT01108796|227424|P2|STARTED|Overall Study||1067
97066|NCT01108796|227425|P1|STARTED|Overall Study||774
97067|NCT01108731|227459|P2|NOT COMPLETED|Overall Study||4
97068|NCT01108731|227460|P1|NOT COMPLETED|Overall Study||4
97069|NCT01108731|227459|P2|COMPLETED|Overall Study||13
97070|NCT01108731|227460|P1|COMPLETED|Overall Study||13
97071|NCT01108731|227459|P2|STARTED|Overall Study||17
97072|NCT01108731|227460|P1|STARTED|Overall Study||17
97073|NCT01108718|227472|P2|NOT COMPLETED|Received Control (2 Months)||0
97074|NCT01108718|227473|P1|NOT COMPLETED|Received Control (2 Months)||1
97075|NCT01108718|227472|P2|COMPLETED|Received Control (2 Months)||7
97076|NCT01108718|227473|P1|COMPLETED|Received Control (2 Months)||4
97077|NCT01108718|227472|P2|STARTED|Received Control (2 Months)||7
97078|NCT01108718|227473|P1|STARTED|Received Control (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
97079|NCT01108718|227472|P2|NOT COMPLETED|Received Tempur-Pedic (2 Months)||0
97080|NCT01108718|227473|P1|NOT COMPLETED|Received Tempur-Pedic (2 Months)||0
97081|NCT01108718|227472|P2|COMPLETED|Received Tempur-Pedic (2 Months)||7
97082|NCT01108718|227473|P1|COMPLETED|Received Tempur-Pedic (2 Months)||5
97083|NCT01108718|227472|P2|STARTED|Received Tempur-Pedic (2 Months)||7
97084|NCT01108718|227473|P1|STARTED|Received Tempur-Pedic (2 Months)||5
97085|NCT01108523|227478|P1|NOT COMPLETED|Overall Study||4
97086|NCT01108523|227478|P1|COMPLETED|Overall Study||3
97087|NCT01108523|227478|P1|STARTED|Overall Study||7
97088|NCT01108510|227485|P2|NOT COMPLETED|Overall Study||268
97089|NCT01108510|227486|P1|NOT COMPLETED|Overall Study||279
97090|NCT01108510|227485|P2|COMPLETED|Overall Study||81
97091|NCT01108510|227486|P1|COMPLETED|Overall Study||70
97092|NCT01108510|227485|P2|STARTED|Overall Study||349
97093|NCT01108510|227486|P1|STARTED|Overall Study||349
97094|NCT01108445|227508|P2|NOT COMPLETED|Overall Study||49
97095|NCT01108445|227509|P1|NOT COMPLETED|Overall Study||56
97096|NCT01108445|227508|P2|COMPLETED|Overall Study||2
97097|NCT01108445|227509|P1|COMPLETED|Overall Study||1
97098|NCT01108445|227508|P2|STARTED|Overall Study||51
97099|NCT01108445|227509|P1|STARTED|Overall Study||57
97100|NCT01108406|227543|P1|NOT COMPLETED|Overall Study||0
97101|NCT01108406|227543|P1|COMPLETED|Overall Study||22
97102|NCT01108406|227543|P1|STARTED|Overall Study||22
97103|NCT01108341|227549|P1|NOT COMPLETED|Overall Study||5
97104|NCT01108341|227549|P1|COMPLETED|Overall Study||45
97105|NCT01108341|227549|P1|Safety Set (Enrolled and Treated)|Overall Study||49
97106|NCT01108341|227549|P1|STARTED|Overall Study||50
97107|NCT01108263|227556|P2|NOT COMPLETED|Overall Study||1
97108|NCT01108263|227557|P1|NOT COMPLETED|Overall Study||0
97109|NCT01108263|227556|P2|COMPLETED|Overall Study||2
97110|NCT01108263|227557|P1|COMPLETED|Overall Study||2
97111|NCT01108263|227556|P2|STARTED|Overall Study||3
97112|NCT01108263|227557|P1|STARTED|Overall Study||2
97113|NCT01108237|227567|P2|NOT COMPLETED|Overall Study||17
97114|NCT01108237|227568|P1|NOT COMPLETED|Overall Study||9
97115|NCT01108237|227567|P2|COMPLETED|Overall Study||84
97116|NCT01108237|227568|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
97117|NCT01108237|227567|P2|STARTED|Overall Study||101
97118|NCT01108237|227568|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
97119|NCT01108185|227574|P1|NOT COMPLETED|Overall Study||27
97120|NCT01108185|227574|P1|COMPLETED|Overall Study||3154
97121|NCT01108185|227574|P1|Per Protocol Population|Overall Study||3181
97122|NCT01108185|227574|P1|STARTED|Overall Study||3181
97123|NCT01108081|227591|P4|NOT COMPLETED|Overall Study||4
97124|NCT01108081|227592|P3|NOT COMPLETED|Overall Study||0
97125|NCT01108081|227593|P2|NOT COMPLETED|Overall Study||2
97126|NCT01108081|227594|P1|NOT COMPLETED|Overall Study||2
97127|NCT01108081|227591|P4|COMPLETED|Overall Study||39
97128|NCT01108081|227592|P3|COMPLETED|Overall Study||38
97129|NCT01108081|227593|P2|COMPLETED|Overall Study||40
97130|NCT01108081|227594|P1|COMPLETED|Overall Study||44
97131|NCT01108081|227591|P4|STARTED|Overall Study||43
97132|NCT01108081|227592|P3|STARTED|Overall Study||38
97133|NCT01108081|227593|P2|STARTED|Overall Study||42
97134|NCT01108081|227594|P1|STARTED|Overall Study||46
97135|NCT01108003|227610|P2|NOT COMPLETED|Overall Study||0
97136|NCT01108003|227611|P1|NOT COMPLETED|Overall Study||0
97137|NCT01108003|227610|P2|COMPLETED|Overall Study||3
97138|NCT01108003|227611|P1|COMPLETED|Overall Study||4
97139|NCT01108003|227610|P2|STARTED|Overall Study||3
97140|NCT01108003|227611|P1|STARTED|Overall Study||4
97141|NCT01107925|227623|P6|NOT COMPLETED|Period 3||0
97142|NCT01107925|227624|P5|NOT COMPLETED|Period 3||0
97143|NCT01107925|227625|P4|NOT COMPLETED|Period 3||0
97144|NCT01107925|227626|P3|NOT COMPLETED|Period 3||0
97145|NCT01107925|227627|P2|NOT COMPLETED|Period 3||0
97146|NCT01107925|227628|P1|NOT COMPLETED|Period 3||0
97147|NCT01107925|227623|P6|COMPLETED|Period 3||20
97148|NCT01107925|227624|P5|COMPLETED|Period 3||0
97149|NCT01107925|227625|P4|COMPLETED|Period 3||16
97150|NCT01107925|227626|P3|COMPLETED|Period 3||15
97151|NCT01107925|227627|P2|COMPLETED|Period 3||17
97152|NCT01107925|227628|P1|COMPLETED|Period 3||0
97153|NCT01107925|227623|P6|Took at Least 1 Dose of Study Drug|Period 3||20
97154|NCT01107925|227624|P5|Took at Least 1 Dose of Study Drug|Period 3||0
97155|NCT01107925|227625|P4|Took at Least 1 Dose of Study Drug|Period 3||16
97156|NCT01107925|227626|P3|Took at Least 1 Dose of Study Drug|Period 3||15
97157|NCT01107925|227627|P2|Took at Least 1 Dose of Study Drug|Period 3||17
97158|NCT01107925|227628|P1|Took at Least 1 Dose of Study Drug|Period 3||0
97159|NCT01107925|227623|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
97160|NCT01107925|227624|P5|STARTED|Period 3||0
97161|NCT01107925|227625|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
97162|NCT01107925|227626|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
97163|NCT01107925|227627|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
97164|NCT01107925|227628|P1|STARTED|Period 3||0
97165|NCT01107925|227623|P6|NOT COMPLETED|Period 2||1
97166|NCT01107925|227624|P5|NOT COMPLETED|Period 2||0
97167|NCT01107925|227625|P4|NOT COMPLETED|Period 2||0
97168|NCT01107925|227626|P3|NOT COMPLETED|Period 2||0
97169|NCT01107925|227627|P2|NOT COMPLETED|Period 2||1
97170|NCT01107925|227628|P1|NOT COMPLETED|Period 2||0
97171|NCT01107925|227623|P6|COMPLETED|Period 2||16
97172|NCT01107925|227624|P5|COMPLETED|Period 2||0
97173|NCT01107925|227625|P4|COMPLETED|Period 2||20
97174|NCT01107925|227626|P3|COMPLETED|Period 2||17
97175|NCT01107925|227627|P2|COMPLETED|Period 2||15
97176|NCT01107925|227628|P1|COMPLETED|Period 2||0
97177|NCT01107925|227623|P6|Took at Least 1 Dose of Study Drug|Period 2||17
97178|NCT01107925|227624|P5|Took at Least 1 Dose of Study Drug|Period 2||0
97179|NCT01107925|227625|P4|Took at Least 1 Dose of Study Drug|Period 2||20
97180|NCT01107925|227626|P3|Took at Least 1 Dose of Study Drug|Period 2||17
97181|NCT01107925|227627|P2|Took at Least 1 Dose of Study Drug|Period 2||16
97182|NCT01107925|227628|P1|Took at Least 1 Dose of Study Drug|Period 2||0
97183|NCT01107925|227623|P6|STARTED|Period 2||17
97184|NCT01107925|227624|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
97185|NCT01107925|227625|P4|STARTED|Period 2||20
97186|NCT01107925|227626|P3|STARTED|Period 2||17
97187|NCT01107925|227627|P2|STARTED|Period 2||16
97188|NCT01107925|227628|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
97189|NCT01107925|227623|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
97190|NCT01107925|227624|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
97191|NCT01107925|227625|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
97192|NCT01107925|227626|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
97193|NCT01107925|227627|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
97194|NCT01107925|227628|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
97195|NCT01107925|227623|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
97196|NCT01107925|227624|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
97197|NCT01107925|227625|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
97198|NCT01107925|227626|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
97199|NCT01107925|227627|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
97200|NCT01107925|227628|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
97201|NCT01107925|227623|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
97202|NCT01107925|227624|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
97203|NCT01107925|227625|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
97204|NCT01107925|227626|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
97205|NCT01107925|227627|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
97206|NCT01107925|227628|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
97207|NCT01107925|227623|P6|STARTED|Period 1-Randomization up Through Day 12||0
97208|NCT01107925|227624|P5|STARTED|Period 1-Randomization up Through Day 12||38
97209|NCT01107925|227625|P4|STARTED|Period 1-Randomization up Through Day 12||0
97210|NCT01107925|227626|P3|STARTED|Period 1-Randomization up Through Day 12||0
97211|NCT01107925|227627|P2|STARTED|Period 1-Randomization up Through Day 12||0
97212|NCT01107925|227628|P1|STARTED|Period 1-Randomization up Through Day 12||34
97213|NCT01107912|227666|P6|NOT COMPLETED|Period 3||0
97214|NCT01107912|227667|P5|NOT COMPLETED|Period 3||0
97215|NCT01107912|227668|P4|NOT COMPLETED|Period 3||1
97216|NCT01107912|227669|P3|NOT COMPLETED|Period 3||1
97217|NCT01107912|227670|P2|NOT COMPLETED|Period 3||1
97218|NCT01107912|227671|P1|NOT COMPLETED|Period 3||0
97219|NCT01107912|227666|P6|COMPLETED|Period 3||41
97220|NCT01107912|227667|P5|COMPLETED|Period 3||0
97221|NCT01107912|227668|P4|COMPLETED|Period 3||37
97222|NCT01107912|227669|P3|COMPLETED|Period 3||35
97223|NCT01107912|227670|P2|COMPLETED|Period 3||34
97224|NCT01107912|227671|P1|COMPLETED|Period 3||0
97225|NCT01107912|227666|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
97226|NCT01107912|227667|P5|STARTED|Period 3||0
97227|NCT01107912|227668|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
97228|NCT01107912|227669|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
97229|NCT01107912|227670|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
97230|NCT01107912|227671|P1|STARTED|Period 3||0
97231|NCT01107912|227666|P6|NOT COMPLETED|Period 2||0
97232|NCT01107912|227667|P5|NOT COMPLETED|Period 2||0
97233|NCT01107912|227668|P4|NOT COMPLETED|Period 2||0
97234|NCT01107912|227669|P3|NOT COMPLETED|Period 2||1
97235|NCT01107912|227670|P2|NOT COMPLETED|Period 2||0
97236|NCT01107912|227671|P1|NOT COMPLETED|Period 2||0
97237|NCT01107912|227666|P6|COMPLETED|Period 2||38
97238|NCT01107912|227667|P5|COMPLETED|Period 2||0
97239|NCT01107912|227668|P4|COMPLETED|Period 2||41
97240|NCT01107912|227669|P3|COMPLETED|Period 2||35
97241|NCT01107912|227670|P2|COMPLETED|Period 2||36
97242|NCT01107912|227671|P1|COMPLETED|Period 2||0
97243|NCT01107912|227666|P6|STARTED|Period 2||38
97244|NCT01107912|227667|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
97245|NCT01107912|227668|P4|STARTED|Period 2||41
97246|NCT01107912|227669|P3|STARTED|Period 2||36
97247|NCT01107912|227670|P2|STARTED|Period 2||36
97248|NCT01107912|227671|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
97249|NCT01107912|227666|P6|NOT COMPLETED|Period 1||0
97250|NCT01107912|227667|P5|NOT COMPLETED|Period 1||3
97251|NCT01107912|227668|P4|NOT COMPLETED|Period 1||0
97252|NCT01107912|227669|P3|NOT COMPLETED|Period 1||0
97253|NCT01107912|227670|P2|NOT COMPLETED|Period 1||0
97254|NCT01107912|227671|P1|NOT COMPLETED|Period 1||1
97255|NCT01107912|227666|P6|COMPLETED|Period 1||0
97256|NCT01107912|227667|P5|COMPLETED|Period 1||79
97257|NCT01107912|227668|P4|COMPLETED|Period 1||0
97258|NCT01107912|227669|P3|COMPLETED|Period 1||0
97259|NCT01107912|227670|P2|COMPLETED|Period 1||0
97260|NCT01107912|227671|P1|COMPLETED|Period 1||72
97261|NCT01107912|227666|P6|Received at Least 1 Dose of Study Drug|Period 1||0
97262|NCT01107912|227667|P5|Received at Least 1 Dose of Study Drug|Period 1||82
97263|NCT01107912|227668|P4|Received at Least 1 Dose of Study Drug|Period 1||0
97264|NCT01107912|227669|P3|Received at Least 1 Dose of Study Drug|Period 1||0
97265|NCT01107912|227670|P2|Received at Least 1 Dose of Study Drug|Period 1||0
97266|NCT01107912|227671|P1|Received at Least 1 Dose of Study Drug|Period 1||73
97267|NCT01107912|227666|P6|STARTED|Period 1||0
97268|NCT01107912|227667|P5|STARTED|Period 1||82
97269|NCT01107912|227668|P4|STARTED|Period 1||0
97270|NCT01107912|227669|P3|STARTED|Period 1||0
97271|NCT01107912|227670|P2|STARTED|Period 1||0
97272|NCT01107912|227671|P1|STARTED|Period 1||73
97273|NCT01107899|227708|P3|NOT COMPLETED|Overall Study||4
97274|NCT01107899|227709|P2|NOT COMPLETED|Overall Study||0
97275|NCT01107899|227710|P1|NOT COMPLETED|Overall Study||5
97276|NCT01107899|227708|P3|COMPLETED|Overall Study||5
97277|NCT01107899|227709|P2|COMPLETED|Overall Study||10
97278|NCT01107899|227710|P1|COMPLETED|Overall Study||5
97279|NCT01107899|227708|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
97280|NCT01107899|227709|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
97281|NCT01107899|227710|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
97282|NCT01107899|227708|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
97283|NCT01107899|227709|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
97284|NCT01107899|227710|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
97285|NCT01107899|227708|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
97286|NCT01107899|227709|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
97287|NCT01107899|227710|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
97288|NCT01107899|227708|P3|Received at Least One Dose of Study Drug|Overall Study||8
97289|NCT01107899|227709|P2|Received at Least One Dose of Study Drug|Overall Study||10
97290|NCT01107899|227710|P1|Received at Least One Dose of Study Drug|Overall Study||10
97291|NCT01107899|227708|P3|STARTED|Overall Study||9
97292|NCT01107899|227709|P2|STARTED|Overall Study||10
97293|NCT01107899|227710|P1|STARTED|Overall Study||10
97294|NCT01107886|227756|P2|NOT COMPLETED|Overall Study||214
97295|NCT01107886|227757|P1|NOT COMPLETED|Overall Study||202
97296|NCT01107886|227756|P2|COMPLETED|Overall Study|Completed subjects|7998
97297|NCT01107886|227757|P1|COMPLETED|Overall Study|Completed subjects|8078
97298|NCT01107886|227756|P2|STARTED|Overall Study|Randomized subjects|8212
97299|NCT01107886|227757|P1|STARTED|Overall Study|Randomized subjects|8280
97300|NCT01107834|227769|P2|NOT COMPLETED|Overall Study||0
97301|NCT01107834|227770|P1|NOT COMPLETED|Overall Study||0
97302|NCT01107834|227769|P2|COMPLETED|Overall Study||30
97303|NCT01107834|227770|P1|COMPLETED|Overall Study||30
97304|NCT01107834|227769|P2|STARTED|Overall Study||30
97305|NCT01107834|227770|P1|STARTED|Overall Study||30
97306|NCT01107743|227786|P1|NOT COMPLETED|Overall Study||46
97307|NCT01107743|227786|P1|COMPLETED|Overall Study||1245
97308|NCT01107743|227786|P1|STARTED|Overall Study||1291
97309|NCT01107730|227875|P3|NOT COMPLETED|Overall Study||0
97310|NCT01107730|227876|P2|NOT COMPLETED|Overall Study||0
97311|NCT01107730|227877|P1|NOT COMPLETED|Overall Study||0
97312|NCT01107730|227875|P3|COMPLETED|Overall Study||11
97313|NCT01107730|227876|P2|COMPLETED|Overall Study||11
97314|NCT01107730|227877|P1|COMPLETED|Overall Study||11
97315|NCT01107730|227875|P3|STARTED|Overall Study||11
97316|NCT01107730|227876|P2|STARTED|Overall Study||11
97317|NCT01107730|227877|P1|STARTED|Overall Study||11
97318|NCT01107535|227885|P1|NOT COMPLETED|Overall Study||5
97319|NCT01107535|227885|P1|COMPLETED|Overall Study||77
97320|NCT01107535|227885|P1|Number of Participants Analyzed|Overall Study||82
97321|NCT01107535|227885|P1|STARTED|Overall Study||82
97322|NCT01107418|227897|P1|NOT COMPLETED|Overall Study||52
97323|NCT01107418|227897|P1|COMPLETED|Overall Study||0
97324|NCT01107418|227897|P1|STARTED|Overall Study||52
97325|NCT01107405|227970|P5|NOT COMPLETED|Overall Study||3
97326|NCT01107405|227971|P4|NOT COMPLETED|Overall Study||3
97327|NCT01107405|227972|P3|NOT COMPLETED|Overall Study||2
97328|NCT01107405|227973|P2|NOT COMPLETED|Overall Study||1
97329|NCT01107405|227974|P1|NOT COMPLETED|Overall Study||2
97330|NCT01107405|227970|P5|COMPLETED|Overall Study||17
97331|NCT01107405|227971|P4|COMPLETED|Overall Study||17
97332|NCT01107405|227972|P3|COMPLETED|Overall Study||18
97333|NCT01107405|227973|P2|COMPLETED|Overall Study||19
97334|NCT01107405|227974|P1|COMPLETED|Overall Study||19
97335|NCT01107405|227970|P5|STARTED|Overall Study||20
97336|NCT01107405|227971|P4|STARTED|Overall Study||20
97337|NCT01107405|227972|P3|STARTED|Overall Study||20
97338|NCT01107405|227973|P2|STARTED|Overall Study||20
97339|NCT01107405|227974|P1|STARTED|Overall Study||21
97340|NCT01107392|228013|P2|NOT COMPLETED|Overall Study||3
97341|NCT01107392|228014|P1|NOT COMPLETED|Overall Study||5
97342|NCT01107392|228013|P2|COMPLETED|Overall Study||154
97343|NCT01107392|228014|P1|COMPLETED|Overall Study||153
97344|NCT01107392|228013|P2|STARTED|Overall Study||157
97345|NCT01107392|228014|P1|STARTED|Overall Study||158
97346|NCT01107379|228026|P1|NOT COMPLETED|Overall Study||21
97347|NCT01107379|228026|P1|COMPLETED|Overall Study||182
97348|NCT01107379|228026|P1|STARTED|Overall Study||203
97349|NCT01107353|228037|P2|NOT COMPLETED|Overall Study||0
97350|NCT01107353|228038|P1|NOT COMPLETED|Overall Study||1
97351|NCT01107353|228037|P2|COMPLETED|Overall Study||20
97352|NCT01107353|228038|P1|COMPLETED|Overall Study||19
97353|NCT01107353|228037|P2|STARTED|Overall Study||20
97354|NCT01107353|228038|P1|STARTED|Overall Study||20
97355|NCT01107197|228046|P2|NOT COMPLETED|Overall Study||23
97356|NCT01107197|228047|P1|NOT COMPLETED|Overall Study||20
97357|NCT01107197|228046|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
97358|NCT01107197|228047|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
97359|NCT01107197|228046|P2|STARTED|Overall Study||101
97360|NCT01107197|228047|P1|STARTED|Overall Study||99
97361|NCT01106976|228065|P1|NOT COMPLETED|Overall Study||8
97362|NCT01106976|228065|P1|COMPLETED|Overall Study||59
97363|NCT01106976|228065|P1|STARTED|Overall Study||67
97364|NCT01106950|228069|P1|NOT COMPLETED|Overall Study||0
97365|NCT01106950|228069|P1|COMPLETED|Overall Study||15
97366|NCT01106950|228069|P1|STARTED|Overall Study||15
97367|NCT01106911|228079|P1|NOT COMPLETED|Overall Study||5
97368|NCT01106911|228079|P1|COMPLETED|Overall Study||1080
97369|NCT01106911|228079|P1|STARTED|Overall Study||1085
97370|NCT01106859|228083|P1|NOT COMPLETED|Overall Study||0
97371|NCT01106859|228083|P1|COMPLETED|Overall Study||40
97372|NCT01106859|228083|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
97373|NCT01106846|228124|P2|NOT COMPLETED|Overall Study||1
97374|NCT01106846|228125|P1|NOT COMPLETED|Overall Study||0
97375|NCT01106846|228124|P2|COMPLETED|Overall Study||9
97376|NCT01106846|228125|P1|COMPLETED|Overall Study||12
97377|NCT01106846|228124|P2|STARTED|Overall Study||10
97378|NCT01106846|228125|P1|STARTED|Overall Study||12
97379|NCT01106690|228134|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
97380|NCT01106690|228135|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
97381|NCT01106690|228136|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
97382|NCT01106690|228134|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
97383|NCT01106690|228135|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
97384|NCT01106690|228136|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
97385|NCT01106690|228134|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
97386|NCT01106690|228135|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
97387|NCT01106690|228136|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
97388|NCT01106690|228134|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
97389|NCT01106690|228135|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
97390|NCT01106690|228136|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
97391|NCT01106690|228134|P3|COMPLETED|Core Period: Baseline to Week 26||101
97392|NCT01106690|228135|P2|COMPLETED|Core Period: Baseline to Week 26||104
97393|NCT01106690|228136|P1|COMPLETED|Core Period: Baseline to Week 26||91
97394|NCT01106690|228134|P3|STARTED|Core Period: Baseline to Week 26||114
97395|NCT01106690|228135|P2|STARTED|Core Period: Baseline to Week 26||113
97396|NCT01106690|228136|P1|STARTED|Core Period: Baseline to Week 26||115
97397|NCT01106677|228172|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
97398|NCT01106677|228173|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
97399|NCT01106677|228174|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
97400|NCT01106677|228175|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
97401|NCT01106677|228172|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
97402|NCT01106677|228173|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
97403|NCT01106677|228174|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
97404|NCT01106677|228175|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
97405|NCT01106677|228172|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
97406|NCT01106677|228173|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
97407|NCT01106677|228174|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
97408|NCT01106677|228175|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
97409|NCT01106677|228172|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
97410|NCT01106677|228173|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
97411|NCT01106677|228174|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
97412|NCT01106677|228175|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
97413|NCT01106677|228172|P4|COMPLETED|Core Period: Baseline to Week 26||319
97414|NCT01106677|228173|P3|COMPLETED|Core Period: Baseline to Week 26||323
97415|NCT01106677|228174|P2|COMPLETED|Core Period: Baseline to Week 26||322
97416|NCT01106677|228175|P1|COMPLETED|Core Period: Baseline to Week 26||155
97417|NCT01106677|228172|P4|STARTED|Core Period: Baseline to Week 26||366
97418|NCT01106677|228173|P3|STARTED|Core Period: Baseline to Week 26||367
97419|NCT01106677|228174|P2|STARTED|Core Period: Baseline to Week 26||368
97420|NCT01106677|228175|P1|STARTED|Core Period: Baseline to Week 26||183
97421|NCT01106651|228238|P3|NOT COMPLETED|Overall Study||58
97422|NCT01106651|228239|P2|NOT COMPLETED|Overall Study||57
97423|NCT01106651|228240|P1|NOT COMPLETED|Overall Study||79
97424|NCT01106651|228238|P3|COMPLETED|Overall Study||178
97425|NCT01106651|228239|P2|COMPLETED|Overall Study||184
97426|NCT01106651|228240|P1|COMPLETED|Overall Study||158
97427|NCT01106651|228238|P3|STARTED|Overall Study||236
97428|NCT01106651|228239|P2|STARTED|Overall Study||241
97429|NCT01106651|228240|P1|STARTED|Overall Study||237
97430|NCT01106625|228293|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
97431|NCT01106625|228294|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
97432|NCT01106625|228295|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
97433|NCT01106625|228293|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
97434|NCT01106625|228294|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
97435|NCT01106625|228295|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
97436|NCT01106625|228293|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
97437|NCT01106625|228294|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
97438|NCT01106625|228295|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
97439|NCT01106625|228293|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
97440|NCT01106625|228294|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
97441|NCT01106625|228295|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
97442|NCT01106625|228293|P3|COMPLETED|Core Period: Baseline to Week 26||129
97443|NCT01106625|228294|P2|COMPLETED|Core Period: Baseline to Week 26||129
97444|NCT01106625|228295|P1|COMPLETED|Core Period: Baseline to Week 26||123
97445|NCT01106625|228293|P3|STARTED|Core Period: Baseline to Week 26||156
97446|NCT01106625|228294|P2|STARTED|Core Period: Baseline to Week 26||157
97447|NCT01106625|228295|P1|STARTED|Core Period: Baseline to Week 26||156
97448|NCT01106586|228326|P2|NOT COMPLETED|Overall Study||285
97449|NCT01106586|228327|P1|NOT COMPLETED|Overall Study||285
97450|NCT01106586|228326|P2|COMPLETED|Overall Study||70
97451|NCT01106586|228327|P1|COMPLETED|Overall Study||68
97452|NCT01106586|228326|P2|STARTED|Overall Study||355
97453|NCT01106586|228327|P1|STARTED|Overall Study||353
97454|NCT01106534|228345|P1|NOT COMPLETED|Overall Study||37
97455|NCT01106534|228345|P1|COMPLETED|Overall Study||2960
97456|NCT01106534|228345|P1|STARTED|Overall Study||2997
97457|NCT01106430|228368|P2|NOT COMPLETED|Overall Study||33
97458|NCT01106430|228369|P1|NOT COMPLETED|Overall Study||33
97459|NCT01106430|228368|P2|COMPLETED|Overall Study||101
97460|NCT01106430|228369|P1|COMPLETED|Overall Study||100
97461|NCT01106430|228368|P2|STARTED|Overall Study||134
97462|NCT01106430|228369|P1|STARTED|Overall Study||133
97463|NCT01106404|228391|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
97464|NCT01106404|228392|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
97465|NCT01106404|228391|P2|COMPLETED|Period II (Second 6 Weeks)||38
97466|NCT01106404|228392|P1|COMPLETED|Period II (Second 6 Weeks)||33
97467|NCT01106404|228391|P2|STARTED|Period II (Second 6 Weeks)||38
97468|NCT01106404|228392|P1|STARTED|Period II (Second 6 Weeks)||33
97469|NCT01106404|228391|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
97470|NCT01106404|228392|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
97471|NCT01106404|228391|P2|COMPLETED|Period I (First 6 Weeks)||38
97472|NCT01106404|228392|P1|COMPLETED|Period I (First 6 Weeks)||33
97473|NCT01106404|228391|P2|STARTED|Period I (First 6 Weeks)||40
97474|NCT01106404|228392|P1|STARTED|Period I (First 6 Weeks)||36
97475|NCT01106391|228405|P1|NOT COMPLETED|Overall Study||0
97476|NCT01106391|228405|P1|COMPLETED|Overall Study||60
97477|NCT01106391|228405|P1|STARTED|Overall Study||60
97478|NCT01106352|228415|P5|NOT COMPLETED|Overall Study||8
97479|NCT01106352|228416|P4|NOT COMPLETED|Overall Study||13
97480|NCT01106352|228417|P3|NOT COMPLETED|Overall Study||2
97481|NCT01106352|228418|P2|NOT COMPLETED|Overall Study||0
97482|NCT01106352|228419|P1|NOT COMPLETED|Overall Study||1
97483|NCT01106352|228415|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
97484|NCT01106352|228416|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
97485|NCT01106352|228417|P3|COMPLETED|Overall Study||5
97486|NCT01106352|228418|P2|COMPLETED|Overall Study||3
97487|NCT01106352|228419|P1|COMPLETED|Overall Study||6
97488|NCT01106352|228415|P5|Completed Safety Cohort|Overall Study||9
97489|NCT01106352|228416|P4|Completed Safety Cohort|Overall Study||23
97490|NCT01106352|228417|P3|Completed Safety Cohort|Overall Study||0
97491|NCT01106352|228418|P2|Completed Safety Cohort|Overall Study||0
97492|NCT01106352|228419|P1|Completed Safety Cohort|Overall Study||0
97493|NCT01106352|228415|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
97494|NCT01106352|228416|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
97495|NCT01106352|228417|P3|Treated Safety Cohort|Overall Study||0
97496|NCT01106352|228418|P2|Treated Safety Cohort|Overall Study||0
97497|NCT01106352|228419|P1|Treated Safety Cohort|Overall Study||0
97498|NCT01106352|228415|P5|Started Safety Cohort|Overall Study||17
97499|NCT01106352|228416|P4|Started Safety Cohort|Overall Study||36
97500|NCT01106352|228417|P3|Started Safety Cohort|Overall Study||0
97501|NCT01106352|228418|P2|Started Safety Cohort|Overall Study||0
97502|NCT01106352|228419|P1|Started Safety Cohort|Overall Study||0
97503|NCT01106352|228415|P5|Completed Dose Escalation|Overall Study||0
97504|NCT01106352|228416|P4|Completed Dose Escalation|Overall Study||0
97505|NCT01106352|228417|P3|Completed Dose Escalation|Overall Study||5
97506|NCT01106352|228418|P2|Completed Dose Escalation|Overall Study||3
97507|NCT01106352|228419|P1|Completed Dose Escalation|Overall Study||6
97508|NCT01106352|228415|P5|Started Dose Escalation|Overall Study||0
97509|NCT01106352|228416|P4|Started Dose Escalation|Overall Study||0
97510|NCT01106352|228417|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
97511|NCT01106352|228418|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
97512|NCT01106352|228419|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
97513|NCT01106352|228415|P5|STARTED|Overall Study||17
97514|NCT01106352|228416|P4|STARTED|Overall Study||36
97515|NCT01106352|228417|P3|STARTED|Overall Study||7
97516|NCT01106352|228418|P2|STARTED|Overall Study||3
97517|NCT01106352|228419|P1|STARTED|Overall Study||7
97518|NCT01106326|228505|P1|NOT COMPLETED|Overall Study||2
97519|NCT01106326|228505|P1|COMPLETED|Overall Study||28
97520|NCT01106326|228505|P1|STARTED|Overall Study||30
97521|NCT01106287|228515|P4|NOT COMPLETED|Overall Study||0
97522|NCT01106287|228516|P3|NOT COMPLETED|Overall Study||0
97523|NCT01106287|228517|P2|NOT COMPLETED|Overall Study||0
97524|NCT01106287|228518|P1|NOT COMPLETED|Overall Study||1
97525|NCT01106287|228515|P4|COMPLETED|Overall Study||3
97526|NCT01106287|228516|P3|COMPLETED|Overall Study||3
97527|NCT01106287|228517|P2|COMPLETED|Overall Study||3
97528|NCT01106287|228518|P1|COMPLETED|Overall Study||3
97529|NCT01106287|228515|P4|STARTED|Overall Study||3
97530|NCT01106287|228516|P3|STARTED|Overall Study||3
97531|NCT01106287|228517|P2|STARTED|Overall Study||3
97532|NCT01106287|228518|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
97533|NCT01106248|228538|P1|NOT COMPLETED|Overall Study||3
97534|NCT01106248|228538|P1|COMPLETED|Overall Study||23
97535|NCT01106248|228538|P1|STARTED|Overall Study||26
97536|NCT01106157|228546|P2|NOT COMPLETED|Overall Study||0
97537|NCT01106157|228547|P1|NOT COMPLETED|Overall Study||1
97538|NCT01106157|228546|P2|COMPLETED|Overall Study||8
97539|NCT01106157|228547|P1|COMPLETED|Overall Study||16
97540|NCT01106157|228546|P2|STARTED|Overall Study||8
97541|NCT01106157|228547|P1|STARTED|Overall Study||17
97542|NCT01106040|228571|P1|NOT COMPLETED|Overall Study||11
97543|NCT01106040|228571|P1|COMPLETED|Overall Study||152
97544|NCT01106040|228571|P1|STARTED|Overall Study||163
97545|NCT01106014|228578|P2|NOT COMPLETED|Overall Study||330
97546|NCT01106014|228579|P1|NOT COMPLETED|Overall Study||285
97547|NCT01106014|228578|P2|COMPLETED|Overall Study||252
97548|NCT01106014|228579|P1|COMPLETED|Overall Study||289
97549|NCT01106014|228578|P2|STARTED|Overall Study||582
97550|NCT01106014|228579|P1|STARTED|Overall Study||574
97551|NCT01105936|228589|P4|NOT COMPLETED|Period 3||0
97552|NCT01105936|228590|P3|NOT COMPLETED|Period 3||0
97553|NCT01105936|228591|P2|NOT COMPLETED|Period 3||2
97554|NCT01105936|228592|P1|NOT COMPLETED|Period 3||0
97555|NCT01105936|228589|P4|COMPLETED|Period 3||7
97556|NCT01105936|228590|P3|COMPLETED|Period 3||7
97557|NCT01105936|228591|P2|COMPLETED|Period 3||6
97558|NCT01105936|228592|P1|COMPLETED|Period 3||7
97559|NCT01105936|228589|P4|STARTED|Period 3||7
97560|NCT01105936|228590|P3|STARTED|Period 3||7
97561|NCT01105936|228591|P2|STARTED|Period 3||8
97562|NCT01105936|228592|P1|STARTED|Period 3||7
97563|NCT01105936|228589|P4|NOT COMPLETED|Wash-out Period 2||0
97564|NCT01105936|228590|P3|NOT COMPLETED|Wash-out Period 2||0
97565|NCT01105936|228591|P2|NOT COMPLETED|Wash-out Period 2||0
97566|NCT01105936|228592|P1|NOT COMPLETED|Wash-out Period 2||0
97567|NCT01105936|228589|P4|COMPLETED|Wash-out Period 2||7
97568|NCT01105936|228590|P3|COMPLETED|Wash-out Period 2||7
97569|NCT01105936|228591|P2|COMPLETED|Wash-out Period 2||8
97570|NCT01105936|228592|P1|COMPLETED|Wash-out Period 2||7
97571|NCT01105936|228589|P4|STARTED|Wash-out Period 2||7
97572|NCT01105936|228590|P3|STARTED|Wash-out Period 2||7
97573|NCT01105936|228591|P2|STARTED|Wash-out Period 2||8
97574|NCT01105936|228592|P1|STARTED|Wash-out Period 2||7
97575|NCT01105936|228589|P4|NOT COMPLETED|Period 2||0
97576|NCT01105936|228590|P3|NOT COMPLETED|Period 2||0
97577|NCT01105936|228591|P2|NOT COMPLETED|Period 2||0
97578|NCT01105936|228592|P1|NOT COMPLETED|Period 2||1
97579|NCT01105936|228589|P4|COMPLETED|Period 2||7
97580|NCT01105936|228590|P3|COMPLETED|Period 2||7
97581|NCT01105936|228591|P2|COMPLETED|Period 2||8
97582|NCT01105936|228592|P1|COMPLETED|Period 2||7
97583|NCT01105936|228589|P4|STARTED|Period 2||7
97584|NCT01105936|228590|P3|STARTED|Period 2||7
97585|NCT01105936|228591|P2|STARTED|Period 2||8
97586|NCT01105936|228592|P1|STARTED|Period 2||8
97587|NCT01105936|228589|P4|NOT COMPLETED|Wash-out Period 1||0
97588|NCT01105936|228590|P3|NOT COMPLETED|Wash-out Period 1||0
97589|NCT01105936|228591|P2|NOT COMPLETED|Wash-out Period 1||0
97590|NCT01105936|228592|P1|NOT COMPLETED|Wash-out Period 1||0
97591|NCT01105936|228589|P4|COMPLETED|Wash-out Period 1||7
97592|NCT01105936|228590|P3|COMPLETED|Wash-out Period 1||7
97593|NCT01105936|228591|P2|COMPLETED|Wash-out Period 1||8
97594|NCT01105936|228592|P1|COMPLETED|Wash-out Period 1||8
97595|NCT01105936|228589|P4|STARTED|Wash-out Period 1||7
97596|NCT01105936|228590|P3|STARTED|Wash-out Period 1||7
97597|NCT01105936|228591|P2|STARTED|Wash-out Period 1||8
97598|NCT01105936|228592|P1|STARTED|Wash-out Period 1||8
97599|NCT01105936|228589|P4|NOT COMPLETED|Period 1||1
97600|NCT01105936|228590|P3|NOT COMPLETED|Period 1||0
97601|NCT01105936|228591|P2|NOT COMPLETED|Period 1||0
97602|NCT01105936|228592|P1|NOT COMPLETED|Period 1||0
97603|NCT01105936|228589|P4|COMPLETED|Period 1||7
97604|NCT01105936|228590|P3|COMPLETED|Period 1||7
97605|NCT01105936|228591|P2|COMPLETED|Period 1||8
97606|NCT01105936|228592|P1|COMPLETED|Period 1||8
97607|NCT01105936|228589|P4|STARTED|Period 1||8
97608|NCT01105936|228590|P3|STARTED|Period 1||7
97609|NCT01105936|228591|P2|STARTED|Period 1||8
97610|NCT01105936|228592|P1|STARTED|Period 1||8
97611|NCT01105767|228621|P3|NOT COMPLETED|Overall Study||1184
97612|NCT01105767|228622|P2|NOT COMPLETED|Overall Study||1614
97613|NCT01105767|228623|P1|NOT COMPLETED|Overall Study||1160
97614|NCT01105767|228621|P3|COMPLETED|Overall Study||8846
97615|NCT01105767|228622|P2|COMPLETED|Overall Study||9250
97616|NCT01105767|228623|P1|COMPLETED|Overall Study||8155
97617|NCT01105767|228621|P3|STARTED|Overall Study||10030
97618|NCT01105767|228622|P2|STARTED|Overall Study||10864
97619|NCT01105767|228623|P1|STARTED|Overall Study||9315
97620|NCT01105754|228636|P2|NOT COMPLETED|Overall Study||12
97621|NCT01105754|228637|P1|NOT COMPLETED|Overall Study||15
97622|NCT01105754|228636|P2|COMPLETED|Overall Study||307
97623|NCT01105754|228637|P1|COMPLETED|Overall Study||304
97624|NCT01105754|228636|P2|STARTED|Overall Study||319
97625|NCT01105754|228637|P1|STARTED|Overall Study||319
97626|NCT01105702|228645|P1|NOT COMPLETED|Overall Study||18
97627|NCT01105702|228645|P1|COMPLETED|Overall Study||10
97628|NCT01105702|228645|P1|STARTED|Overall Study||28
97629|NCT01105533|228652|P9|NOT COMPLETED|Overall Study||12
97630|NCT01105533|228653|P8|NOT COMPLETED|Overall Study||4
97631|NCT01105533|228654|P7|NOT COMPLETED|Overall Study||8
97632|NCT01105533|228655|P6|NOT COMPLETED|Overall Study||7
97633|NCT01105533|228656|P5|NOT COMPLETED|Overall Study||7
97634|NCT01105533|228657|P4|NOT COMPLETED|Overall Study||3
97635|NCT01105533|228658|P3|NOT COMPLETED|Overall Study||3
97636|NCT01105533|228659|P2|NOT COMPLETED|Overall Study||1
97637|NCT01105533|228660|P1|NOT COMPLETED|Overall Study||1
97638|NCT01105533|228652|P9|COMPLETED|Overall Study||0
97639|NCT01105533|228653|P8|COMPLETED|Overall Study||0
97640|NCT01105533|228654|P7|COMPLETED|Overall Study||0
97641|NCT01105533|228655|P6|COMPLETED|Overall Study||0
97642|NCT01105533|228656|P5|COMPLETED|Overall Study||0
97643|NCT01105533|228657|P4|COMPLETED|Overall Study||0
97644|NCT01105533|228658|P3|COMPLETED|Overall Study||0
97645|NCT01105533|228659|P2|COMPLETED|Overall Study||0
97646|NCT01105533|228660|P1|COMPLETED|Overall Study||0
97647|NCT01105533|228652|P9|STARTED|Overall Study||12
97648|NCT01105533|228653|P8|STARTED|Overall Study||4
97649|NCT01105533|228654|P7|STARTED|Overall Study||8
97650|NCT01105533|228655|P6|STARTED|Overall Study||7
97651|NCT01105533|228656|P5|STARTED|Overall Study||7
97652|NCT01105533|228657|P4|STARTED|Overall Study||3
97653|NCT01105533|228658|P3|STARTED|Overall Study||3
97654|NCT01105533|228659|P2|STARTED|Overall Study||1
97655|NCT01105533|228660|P1|STARTED|Overall Study||1
97656|NCT01105377|228750|P2|NOT COMPLETED|Overall Study||1
97657|NCT01105377|228751|P1|NOT COMPLETED|Overall Study||0
97658|NCT01105377|228750|P2|COMPLETED|Overall Study||22
97659|NCT01105377|228751|P1|COMPLETED|Overall Study||24
97660|NCT01105377|228750|P2|STARTED|Overall Study||23
97661|NCT01105377|228751|P1|STARTED|Overall Study||24
97662|NCT01105247|228761|P2|NOT COMPLETED|Overall Study||0
97663|NCT01105247|228762|P1|NOT COMPLETED|Overall Study||37
97664|NCT01105247|228761|P2|COMPLETED|Overall Study||16
97665|NCT01105247|228762|P1|COMPLETED|Overall Study||79
97666|NCT01105247|228761|P2|STARTED|Overall Study||16
97667|NCT01105247|228762|P1|STARTED|Overall Study||116
97668|NCT01105130|228778|P3|NOT COMPLETED|Overall Study||10
97669|NCT01105130|228779|P2|NOT COMPLETED|Overall Study||11
97670|NCT01105130|228780|P1|NOT COMPLETED|Overall Study||10
97671|NCT01105130|228778|P3|COMPLETED|Overall Study||37
97672|NCT01105130|228779|P2|COMPLETED|Overall Study||34
97673|NCT01105130|228780|P1|COMPLETED|Overall Study||38
97674|NCT01105130|228778|P3|STARTED|Overall Study||47
97675|NCT01105130|228779|P2|STARTED|Overall Study||45
97676|NCT01105130|228780|P1|STARTED|Overall Study||48
97677|NCT01105117|228799|P2|NOT COMPLETED|Overall Study||0
97678|NCT01105117|228800|P1|NOT COMPLETED|Overall Study||0
97679|NCT01105117|228799|P2|COMPLETED|Overall Study||1
97680|NCT01105117|228800|P1|COMPLETED|Overall Study||1
97681|NCT01105117|228799|P2|STARTED|Overall Study||1
97682|NCT01105117|228800|P1|STARTED|Overall Study||1
97683|NCT01105091|228810|P2|NOT COMPLETED|Overall Study||0
97684|NCT01105091|228811|P1|NOT COMPLETED|Overall Study||2
97685|NCT01105091|228810|P2|COMPLETED|Overall Study||10
97686|NCT01105091|228811|P1|COMPLETED|Overall Study||18
97687|NCT01105091|228810|P2|STARTED|Overall Study||10
97688|NCT01105091|228811|P1|STARTED|Overall Study||20
97689|NCT01105065|228835|P1|NOT COMPLETED|Overall Study||6
97690|NCT01105065|228835|P1|COMPLETED|Overall Study||17
97691|NCT01105065|228835|P1|STARTED|Overall Study||23
97692|NCT01104870|228844|P3|NOT COMPLETED|Overall Study||2
97693|NCT01104870|228845|P2|NOT COMPLETED|Overall Study||1
97694|NCT01104870|228846|P1|NOT COMPLETED|Overall Study||1
97695|NCT01104870|228844|P3|COMPLETED|Overall Study||18
97696|NCT01104870|228845|P2|COMPLETED|Overall Study||18
97697|NCT01104870|228846|P1|COMPLETED|Overall Study||10
97698|NCT01104870|228844|P3|STARTED|Overall Study||20
97699|NCT01104870|228845|P2|STARTED|Overall Study||19
97700|NCT01104870|228846|P1|STARTED|Overall Study||11
97701|NCT01104701|228879|P4|NOT COMPLETED|Overall Study||2
97702|NCT01104701|228880|P3|NOT COMPLETED|Overall Study||2
97703|NCT01104701|228881|P2|NOT COMPLETED|Overall Study||3
97704|NCT01104701|228882|P1|NOT COMPLETED|Overall Study||0
97705|NCT01104701|228879|P4|COMPLETED|Overall Study||28
97706|NCT01104701|228880|P3|COMPLETED|Overall Study||29
97707|NCT01104701|228881|P2|COMPLETED|Overall Study||27
97708|NCT01104701|228882|P1|COMPLETED|Overall Study||30
97709|NCT01104701|228879|P4|STARTED|Overall Study||30
97710|NCT01104701|228880|P3|STARTED|Overall Study||31
97711|NCT01104701|228881|P2|STARTED|Overall Study||30
97712|NCT01104701|228882|P1|STARTED|Overall Study||30
97713|NCT01104662|228944|P8|NOT COMPLETED|Overall Study||0
97714|NCT01104662|228945|P7|NOT COMPLETED|Overall Study||0
97715|NCT01104662|228946|P6|NOT COMPLETED|Overall Study||4
97716|NCT01104662|228947|P5|NOT COMPLETED|Overall Study||1
97717|NCT01104662|228948|P4|NOT COMPLETED|Overall Study||1
97718|NCT01104662|228949|P3|NOT COMPLETED|Overall Study||1
97719|NCT01104662|228950|P2|NOT COMPLETED|Overall Study||10
97720|NCT01104662|228951|P1|NOT COMPLETED|Overall Study||10
97721|NCT01104662|228944|P8|COMPLETED|Overall Study||6
97722|NCT01104662|228945|P7|COMPLETED|Overall Study||5
97723|NCT01104662|228946|P6|COMPLETED|Overall Study||12
97724|NCT01104662|228947|P5|COMPLETED|Overall Study||14
97725|NCT01104662|228948|P4|COMPLETED|Overall Study||3
97726|NCT01104662|228949|P3|COMPLETED|Overall Study||4
97727|NCT01104662|228950|P2|COMPLETED|Overall Study||11
97728|NCT01104662|228951|P1|COMPLETED|Overall Study||10
97729|NCT01104662|228944|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
97730|NCT01104662|228945|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
97731|NCT01104662|228946|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
97732|NCT01104662|228947|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
97733|NCT01104662|228948|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
97734|NCT01104662|228949|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
97735|NCT01104662|228950|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
97736|NCT01104662|228951|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
97737|NCT01104662|228944|P8|STARTED|Overall Study||6
97738|NCT01104662|228945|P7|STARTED|Overall Study||5
97739|NCT01104662|228946|P6|STARTED|Overall Study||16
97740|NCT01104662|228947|P5|STARTED|Overall Study||15
97741|NCT01104662|228948|P4|STARTED|Overall Study||4
97742|NCT01104662|228949|P3|STARTED|Overall Study||5
97743|NCT01104662|228950|P2|STARTED|Overall Study||21
97744|NCT01104662|228951|P1|STARTED|Overall Study||20
97745|NCT01104636|228977|P1|NOT COMPLETED|Overall Study||178
97746|NCT01104636|228977|P1|COMPLETED|Overall Study||999
97747|NCT01104636|228977|P1|STARTED|Overall Study||1177
97748|NCT01104584|228982|P1|NOT COMPLETED|Overall Study||23
97749|NCT01104584|228982|P1|COMPLETED|Overall Study|study course completed|437
97750|NCT01104584|228982|P1|Fulfilled Requirements of FAS Population|Overall Study||397
97751|NCT01104584|228982|P1|Received Treatment|Overall Study|treatment started|439
97752|NCT01104584|228982|P1|STARTED|Overall Study|screened and enrolled|460
97753|NCT01104558|229052|P1|NOT COMPLETED|Overall Study||17
97754|NCT01104558|229052|P1|COMPLETED|Overall Study||83
97755|NCT01104558|229052|P1|STARTED|Overall Study||100
97756|NCT01104493|229095|P2|NOT COMPLETED|Overall Study||2
97757|NCT01104493|229096|P1|NOT COMPLETED|Overall Study||0
97758|NCT01104493|229095|P2|COMPLETED|Overall Study||58
97759|NCT01104493|229096|P1|COMPLETED|Overall Study||240
97760|NCT01104493|229095|P2|STARTED|Overall Study||60
97761|NCT01104493|229096|P1|STARTED|Overall Study||240
97762|NCT01104376|229114|P1|NOT COMPLETED|Overall Study||28
97763|NCT01104376|229114|P1|COMPLETED|Overall Study||61
97764|NCT01104376|229114|P1|STARTED|Overall Study||89
97765|NCT01104285|229120|P2|NOT COMPLETED|Overall Study||0
97766|NCT01104285|229121|P1|NOT COMPLETED|Overall Study||0
97767|NCT01104285|229120|P2|COMPLETED|Overall Study||86
97768|NCT01104285|229121|P1|COMPLETED|Overall Study||112
97769|NCT01104285|229120|P2|STARTED|Overall Study||86
97770|NCT01104285|229121|P1|STARTED|Overall Study||112
97771|NCT01104246|229127|P1|NOT COMPLETED|Overall Study||5
97772|NCT01104246|229127|P1|COMPLETED|Overall Study||35
97773|NCT01104246|229127|P1|Baseline Characteristics Measured|Overall Study||35
97774|NCT01104246|229127|P1|STARTED|Overall Study||40
97775|NCT01104155|229133|P2|NOT COMPLETED|Overall Study||18
97776|NCT01104155|229134|P1|NOT COMPLETED|Overall Study||25
97777|NCT01104155|229133|P2|COMPLETED|Overall Study||42
97778|NCT01104155|229134|P1|COMPLETED|Overall Study||38
97779|NCT01104155|229133|P2|STARTED|Overall Study||60
97780|NCT01104155|229134|P1|STARTED|Overall Study||63
97781|NCT01104116|229148|P1|NOT COMPLETED|Overall Study||0
97782|NCT01104116|229148|P1|COMPLETED|Overall Study||1
97783|NCT01104116|229148|P1|STARTED|Overall Study||1
97784|NCT01104103|229155|P2|NOT COMPLETED|Overall Study||0
97785|NCT01104103|229156|P1|NOT COMPLETED|Overall Study||0
97786|NCT01104103|229155|P2|COMPLETED|Overall Study||224
97787|NCT01104103|229156|P1|COMPLETED|Overall Study||243
97788|NCT01104103|229155|P2|STARTED|Overall Study||224
97789|NCT01104103|229156|P1|STARTED|Overall Study||243
97790|NCT01103973|229166|P2|NOT COMPLETED|Overall Study||0
97791|NCT01103973|229167|P1|NOT COMPLETED|Overall Study||0
97792|NCT01103973|229166|P2|COMPLETED|Overall Study||46
97793|NCT01103973|229167|P1|COMPLETED|Overall Study||51
97794|NCT01103973|229166|P2|STARTED|Overall Study||46
97795|NCT01103973|229167|P1|STARTED|Overall Study||51
97796|NCT01103960|229175|P2|NOT COMPLETED|Overall Study||2
97797|NCT01103960|229176|P1|NOT COMPLETED|Overall Study||5
97798|NCT01103960|229175|P2|COMPLETED|Overall Study|Completed study medication.|158
97799|NCT01103960|229176|P1|COMPLETED|Overall Study|Completed study medication.|159
97800|NCT01103960|229175|P2|STARTED|Overall Study|Randomised and treated.|160
97801|NCT01103960|229176|P1|STARTED|Overall Study|Randomised and treated.|164
97802|NCT01103934|229202|P2|NOT COMPLETED|Overall Study||0
97803|NCT01103934|229203|P1|NOT COMPLETED|Overall Study||0
97804|NCT01103934|229202|P2|COMPLETED|Overall Study||18
97805|NCT01103934|229203|P1|COMPLETED|Overall Study||17
97806|NCT01103934|229202|P2|STARTED|Overall Study||18
97807|NCT01103934|229203|P1|STARTED|Overall Study||17
97808|NCT01103713|229211|P1|NOT COMPLETED|Overall Study||13
97809|NCT01103713|229211|P1|COMPLETED|Overall Study||155
97810|NCT01103713|229211|P1|STARTED|Overall Study||168
97811|NCT01103492|229237|P1|NOT COMPLETED|Overall Study||0
97812|NCT01103492|229237|P1|COMPLETED|Overall Study||1
97813|NCT01103492|229237|P1|STARTED|Overall Study||1
97814|NCT01103479|229244|P3|NOT COMPLETED|Overall Study||14
97815|NCT01103479|229245|P2|NOT COMPLETED|Overall Study||9
97816|NCT01103479|229246|P1|NOT COMPLETED|Overall Study||5
97817|NCT01103479|229244|P3|COMPLETED|Overall Study||174
97818|NCT01103479|229245|P2|COMPLETED|Overall Study||201
97819|NCT01103479|229246|P1|COMPLETED|Overall Study||163
97820|NCT01103479|229244|P3|STARTED|Overall Study||188
97821|NCT01103479|229245|P2|STARTED|Overall Study||210
97822|NCT01103479|229246|P1|STARTED|Overall Study||168
97823|NCT01103466|229259|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
97824|NCT01103466|229260|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
97825|NCT01103466|229261|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
97826|NCT01103466|229259|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
97827|NCT01103466|229260|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
97828|NCT01103466|229261|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
97829|NCT01103466|229259|P3|STARTED|Third Period (14 +/- 3 Days)||14
97830|NCT01103466|229260|P2|STARTED|Third Period (14 +/- 3 Days)||8
97831|NCT01103466|229261|P1|STARTED|Third Period (14 +/- 3 Days)||8
97832|NCT01103466|229259|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
97833|NCT01103466|229260|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
97834|NCT01103466|229261|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
97835|NCT01103466|229259|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
97836|NCT01103466|229260|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
97837|NCT01103466|229261|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
97838|NCT01103466|229259|P3|STARTED|Second Period (14 +/- 3 Days)||7
97839|NCT01103466|229260|P2|STARTED|Second Period (14 +/- 3 Days)||13
97840|NCT01103466|229261|P1|STARTED|Second Period (14 +/- 3 Days)||15
97841|NCT01103466|229259|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
97842|NCT01103466|229260|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
97843|NCT01103466|229261|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
97844|NCT01103466|229259|P3|COMPLETED|First Period (14 +/- 3 Days)||13
97845|NCT01103466|229260|P2|COMPLETED|First Period (14 +/- 3 Days)||12
97846|NCT01103466|229261|P1|COMPLETED|First Period (14 +/- 3 Days)||10
97847|NCT01103466|229259|P3|STARTED|First Period (14 +/- 3 Days)||13
97848|NCT01103466|229260|P2|STARTED|First Period (14 +/- 3 Days)||12
97849|NCT01103466|229261|P1|STARTED|First Period (14 +/- 3 Days)||12
97850|NCT01103414|229274|P5|NOT COMPLETED|Overall Study||15
97851|NCT01103414|229275|P4|NOT COMPLETED|Overall Study||7
97852|NCT01103414|229276|P3|NOT COMPLETED|Overall Study||15
97853|NCT01103414|229277|P2|NOT COMPLETED|Overall Study||9
97854|NCT01103414|229278|P1|NOT COMPLETED|Overall Study||13
97855|NCT01103414|229274|P5|COMPLETED|Overall Study||56
97856|NCT01103414|229275|P4|COMPLETED|Overall Study||64
97857|NCT01103414|229276|P3|COMPLETED|Overall Study||56
97858|NCT01103414|229277|P2|COMPLETED|Overall Study||62
97859|NCT01103414|229278|P1|COMPLETED|Overall Study||59
97860|NCT01103414|229274|P5|STARTED|Overall Study||71
97861|NCT01103414|229275|P4|STARTED|Overall Study||71
97862|NCT01103414|229276|P3|STARTED|Overall Study||71
97863|NCT01103414|229277|P2|STARTED|Overall Study||71
97864|NCT01103414|229278|P1|STARTED|Overall Study||72
97865|NCT01103362|229340|P1|NOT COMPLETED|Overall Study||596
97866|NCT01103362|229340|P1|COMPLETED|Overall Study||0
97867|NCT01103362|229340|P1|STARTED|Overall Study||596
97868|NCT01103323|229346|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
97869|NCT01103323|229347|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
97870|NCT01103323|229346|P2|COMPLETED|Switched From Placebo to Regorafenib||3
97871|NCT01103323|229347|P1|COMPLETED|Switched From Placebo to Regorafenib||0
97872|NCT01103323|229346|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
97873|NCT01103323|229347|P1|STARTED|Switched From Placebo to Regorafenib||0
97874|NCT01103323|229346|P2|NOT COMPLETED|Without/Before Drug Switch||18
97875|NCT01103323|229347|P1|NOT COMPLETED|Without/Before Drug Switch||76
97876|NCT01103323|229346|P2|COMPLETED|Without/Before Drug Switch||237
97877|NCT01103323|229347|P1|COMPLETED|Without/Before Drug Switch||429
97878|NCT01103323|229346|P2|Participants Received Treatment|Without/Before Drug Switch||253
97879|NCT01103323|229347|P1|Participants Received Treatment|Without/Before Drug Switch||500
97880|NCT01103323|229346|P2|STARTED|Without/Before Drug Switch||255
97881|NCT01103323|229347|P1|STARTED|Without/Before Drug Switch||505
97882|NCT01103284|229364|P2|NOT COMPLETED|Overall Study||44
97883|NCT01103284|229365|P1|NOT COMPLETED|Overall Study||42
97884|NCT01103284|229364|P2|COMPLETED|Overall Study||195
97885|NCT01103284|229365|P1|COMPLETED|Overall Study||194
97886|NCT01103284|229364|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
97887|NCT01103284|229365|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
97888|NCT01103284|229364|P2|Treated|Overall Study||238
97889|NCT01103284|229365|P1|Treated|Overall Study||236
97890|NCT01103284|229364|P2|STARTED|Overall Study||239
97891|NCT01103284|229365|P1|STARTED|Overall Study||236
97892|NCT01103271|229381|P2|NOT COMPLETED|Overall Study||4
97893|NCT01103271|229382|P1|NOT COMPLETED|Overall Study||1
97894|NCT01103271|229381|P2|COMPLETED|Overall Study||5
97895|NCT01103271|229382|P1|COMPLETED|Overall Study||10
97896|NCT01103271|229381|P2|STARTED|Overall Study||9
97897|NCT01103271|229382|P1|STARTED|Overall Study||11
97898|NCT01103232|229391|P2|NOT COMPLETED|Overall Study||2
97899|NCT01103232|229392|P1|NOT COMPLETED|Overall Study||1
97900|NCT01103232|229391|P2|COMPLETED|Overall Study||11
97901|NCT01103232|229392|P1|COMPLETED|Overall Study||12
97902|NCT01103232|229391|P2|STARTED|Overall Study||13
97903|NCT01103232|229392|P1|STARTED|Overall Study||13
97904|NCT01103063|229400|P2|NOT COMPLETED|Overall Study||421
97905|NCT01103063|229401|P1|NOT COMPLETED|Overall Study||477
97906|NCT01103063|229400|P2|COMPLETED|Overall Study||1024
97907|NCT01103063|229401|P1|COMPLETED|Overall Study||969
97908|NCT01103063|229400|P2|STARTED|Overall Study||1445
97909|NCT01103063|229401|P1|STARTED|Overall Study||1446
97910|NCT01102972|229469|P2|NOT COMPLETED|Overall Study||14
97911|NCT01102972|229470|P1|NOT COMPLETED|Overall Study||29
97912|NCT01102972|229469|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
97913|NCT01102972|229470|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
97914|NCT01102972|229469|P2|Completed Week 24|Overall Study||88
97915|NCT01102972|229470|P1|Completed Week 24|Overall Study||180
97916|NCT01102972|229469|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
97917|NCT01102972|229470|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
97918|NCT01102894|229522|P1|NOT COMPLETED|Overall Study||0
97919|NCT01102894|229522|P1|COMPLETED|Overall Study||10
97920|NCT01102894|229522|P1|STARTED|Overall Study||10
97921|NCT01102803|229534|P2|NOT COMPLETED|Post to Follow-Up||3
97922|NCT01102803|229535|P1|NOT COMPLETED|Post to Follow-Up||1
97923|NCT01102803|229534|P2|COMPLETED|Post to Follow-Up||12
97924|NCT01102803|229535|P1|COMPLETED|Post to Follow-Up||10
97925|NCT01102803|229534|P2|STARTED|Post to Follow-Up||15
97926|NCT01102803|229535|P1|STARTED|Post to Follow-Up||11
97927|NCT01102803|229534|P2|NOT COMPLETED|Baseline to Post-Treatment||0
97928|NCT01102803|229535|P1|NOT COMPLETED|Baseline to Post-Treatment||3
97929|NCT01102803|229534|P2|COMPLETED|Baseline to Post-Treatment||15
97930|NCT01102803|229535|P1|COMPLETED|Baseline to Post-Treatment||11
97931|NCT01102803|229534|P2|STARTED|Baseline to Post-Treatment||15
97932|NCT01102803|229535|P1|STARTED|Baseline to Post-Treatment||14
97933|NCT01102777|229549|P2|NOT COMPLETED|Overall Study||16
97934|NCT01102777|229550|P1|NOT COMPLETED|Overall Study||9
97935|NCT01102777|229549|P2|COMPLETED|Overall Study||139
97936|NCT01102777|229550|P1|COMPLETED|Overall Study||75
97937|NCT01102777|229549|P2|STARTED|Overall Study||155
97938|NCT01102777|229550|P1|STARTED|Overall Study||84
97939|NCT01102764|229576|P2|NOT COMPLETED|Overall Study||13
97940|NCT01102764|229577|P1|NOT COMPLETED|Overall Study||21
97941|NCT01102764|229576|P2|COMPLETED|Overall Study||55
97942|NCT01102764|229577|P1|COMPLETED|Overall Study||43
97943|NCT01102764|229576|P2|STARTED|Overall Study||68
97944|NCT01102764|229577|P1|STARTED|Overall Study||64
97945|NCT01102491|229589|P2|NOT COMPLETED|Overall Study||12
97946|NCT01102491|229590|P1|NOT COMPLETED|Overall Study||11
97947|NCT01102491|229589|P2|COMPLETED|Overall Study|12 patients were excluded|59
97948|NCT01102491|229590|P1|COMPLETED|Overall Study|11 patient excluded|60
97949|NCT01102491|229589|P2|STARTED|Overall Study||71
97950|NCT01102491|229590|P1|STARTED|Overall Study||71
97951|NCT01102413|229598|P2|NOT COMPLETED|Overall Study||12
97952|NCT01102413|229599|P1|NOT COMPLETED|Overall Study||25
97953|NCT01102413|229598|P2|COMPLETED|Overall Study||106
97954|NCT01102413|229599|P1|COMPLETED|Overall Study||208
97955|NCT01102413|229598|P2|STARTED|Overall Study||118
97956|NCT01102413|229599|P1|STARTED|Overall Study||233
97957|NCT01102257|229609|P2|NOT COMPLETED|Overall Study||0
97958|NCT01102257|229610|P1|NOT COMPLETED|Overall Study||2
97959|NCT01102257|229609|P2|COMPLETED|Overall Study||9
97960|NCT01102257|229610|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
97961|NCT01102257|229609|P2|STARTED|Overall Study||9
97962|NCT01102257|229610|P1|STARTED|Overall Study||9
97963|NCT01102218|229618|P2|NOT COMPLETED|Overall Study||10
97964|NCT01102218|229619|P1|NOT COMPLETED|Overall Study||11
97965|NCT01102218|229618|P2|COMPLETED|Overall Study||14
97966|NCT01102218|229619|P1|COMPLETED|Overall Study||13
97967|NCT01102218|229618|P2|STARTED|Overall Study||24
97968|NCT01102218|229619|P1|STARTED|Overall Study||24
97969|NCT01101958|229627|P2|NOT COMPLETED|Overall Study||5
97970|NCT01101958|229628|P1|NOT COMPLETED|Overall Study||11
97971|NCT01101958|229627|P2|COMPLETED|Overall Study||29
97972|NCT01101958|229628|P1|COMPLETED|Overall Study||51
97973|NCT01101958|229627|P2|STARTED|Overall Study||34
97974|NCT01101958|229628|P1|STARTED|Overall Study||62
97975|NCT01101867|229636|P2|NOT COMPLETED|Overall Study||4
97976|NCT01101867|229637|P1|NOT COMPLETED|Overall Study||1
97977|NCT01101867|229636|P2|COMPLETED|Overall Study||59
97978|NCT01101867|229637|P1|COMPLETED|Overall Study||62
97979|NCT01101867|229636|P2|STARTED|Overall Study||63
97980|NCT01101867|229637|P1|STARTED|Overall Study||63
97981|NCT01101841|229649|P2|NOT COMPLETED|Overall Study||67
97982|NCT01101841|229650|P1|NOT COMPLETED|Overall Study||50
97983|NCT01101841|229649|P2|COMPLETED|Overall Study||218
97984|NCT01101841|229650|P1|COMPLETED|Overall Study||235
97985|NCT01101841|229649|P2|STARTED|Overall Study||285
97986|NCT01101841|229650|P1|STARTED|Overall Study||285
97987|NCT01101542|229688|P1|NOT COMPLETED|Year 6 Surveillance Period||991
97988|NCT01101542|229688|P1|COMPLETED|Year 6 Surveillance Period||2100
97989|NCT01101542|229688|P1|STARTED|Year 6 Surveillance Period||3091
97990|NCT01101542|229688|P1|NOT COMPLETED|Year 5 Surveillance Period||141
97991|NCT01101542|229688|P1|COMPLETED|Year 5 Surveillance Period||668
97992|NCT01101542|229688|P1|STARTED|Year 5 Surveillance Period||809
97993|NCT01101542|229688|P1|NOT COMPLETED|Year 4 Surveillance Period||287
97994|NCT01101542|229688|P1|COMPLETED|Year 4 Surveillance Period||282
97995|NCT01101542|229688|P1|STARTED|Year 4 Surveillance Period||569
97996|NCT01101542|229688|P1|NOT COMPLETED|Year 3 Surveillance Period||11
97997|NCT01101542|229688|P1|COMPLETED|Year 3 Surveillance Period||94
97998|NCT01101542|229688|P1|STARTED|Year 3 Surveillance Period||105
97999|NCT01101477|229707|P3|NOT COMPLETED|Overall Study||1
98000|NCT01101477|229708|P2|NOT COMPLETED|Overall Study||3
98001|NCT01101477|229709|P1|NOT COMPLETED|Overall Study||5
98002|NCT01101477|229707|P3|COMPLETED|Overall Study||45
98003|NCT01101477|229708|P2|COMPLETED|Overall Study||46
98004|NCT01101477|229709|P1|COMPLETED|Overall Study||44
98005|NCT01101477|229707|P3|STARTED|Overall Study||46
98006|NCT01101477|229708|P2|STARTED|Overall Study||49
98007|NCT01101477|229709|P1|STARTED|Overall Study||49
98008|NCT01101464|229719|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
98009|NCT01101464|229720|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
98010|NCT01101464|229719|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
98011|NCT01101464|229720|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
98012|NCT01101464|229719|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
98013|NCT01101464|229720|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
98014|NCT01101464|229719|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
98015|NCT01101464|229720|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
98016|NCT01101464|229719|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
98017|NCT01101464|229720|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
98018|NCT01101464|229719|P2|STARTED|Day 1 Through AM Dose of Day 5||4
98019|NCT01101464|229720|P1|STARTED|Day 1 Through AM Dose of Day 5||4
98020|NCT01101321|229730|P2|NOT COMPLETED|Period 2||0
98021|NCT01101321|229731|P1|NOT COMPLETED|Period 2||0
98022|NCT01101321|229730|P2|COMPLETED|Period 2||24
98023|NCT01101321|229731|P1|COMPLETED|Period 2||26
98024|NCT01101321|229730|P2|STARTED|Period 2||24
98025|NCT01101321|229731|P1|STARTED|Period 2||26
98026|NCT01101321|229730|P2|NOT COMPLETED|Period 1||4
98027|NCT01101321|229731|P1|NOT COMPLETED|Period 1||4
98028|NCT01101321|229730|P2|COMPLETED|Period 1||24
98029|NCT01101321|229731|P1|COMPLETED|Period 1||26
98030|NCT01101321|229730|P2|STARTED|Period 1||28
98031|NCT01101321|229731|P1|STARTED|Period 1||30
98032|NCT01101308|229741|P2|NOT COMPLETED|Period 2||0
98033|NCT01101308|229742|P1|NOT COMPLETED|Period 2||0
98034|NCT01101308|229741|P2|COMPLETED|Period 2||27
98035|NCT01101308|229742|P1|COMPLETED|Period 2||24
98036|NCT01101308|229741|P2|STARTED|Period 2||27
98037|NCT01101308|229742|P1|STARTED|Period 2||24
98038|NCT01101308|229741|P2|NOT COMPLETED|Period 1||1
98039|NCT01101308|229742|P1|NOT COMPLETED|Period 1||3
98040|NCT01101308|229741|P2|COMPLETED|Period 1||27
98041|NCT01101308|229742|P1|COMPLETED|Period 1||24
98042|NCT01101308|229741|P2|STARTED|Period 1||28
98043|NCT01101308|229742|P1|STARTED|Period 1||27
98044|NCT01101191|229753|P2|NOT COMPLETED|Period 2||0
98045|NCT01101191|229754|P1|NOT COMPLETED|Period 2||0
98046|NCT01101191|229753|P2|COMPLETED|Period 2||40
98047|NCT01101191|229754|P1|COMPLETED|Period 2||40
98048|NCT01101191|229753|P2|STARTED|Period 2||40
98049|NCT01101191|229754|P1|STARTED|Period 2||40
98050|NCT01101191|229753|P2|NOT COMPLETED|Period 1||2
98051|NCT01101191|229754|P1|NOT COMPLETED|Period 1||2
98052|NCT01101191|229753|P2|COMPLETED|Period 1||40
98053|NCT01101191|229754|P1|COMPLETED|Period 1||40
98054|NCT01101191|229753|P2|STARTED|Period 1||42
98055|NCT01101191|229754|P1|STARTED|Period 1||42
98056|NCT01101178|229765|P2|NOT COMPLETED|Period 2||1
98057|NCT01101178|229766|P1|NOT COMPLETED|Period 2||0
98058|NCT01101178|229765|P2|COMPLETED|Period 2||34
98059|NCT01101178|229766|P1|COMPLETED|Period 2||36
98060|NCT01101178|229765|P2|STARTED|Period 2||35
98061|NCT01101178|229766|P1|STARTED|Period 2||36
98062|NCT01101178|229765|P2|NOT COMPLETED|Period 1||4
98063|NCT01101178|229766|P1|NOT COMPLETED|Period 1||4
98064|NCT01101178|229765|P2|COMPLETED|Period 1||35
98065|NCT01101178|229766|P1|COMPLETED|Period 1||36
98066|NCT01101178|229765|P2|STARTED|Period 1||39
98067|NCT01101178|229766|P1|STARTED|Period 1||40
98068|NCT01101165|229777|P2|NOT COMPLETED|Period 2||1
98069|NCT01101165|229778|P1|NOT COMPLETED|Period 2||4
98070|NCT01101165|229777|P2|COMPLETED|Period 2||39
98071|NCT01101165|229778|P1|COMPLETED|Period 2||41
98072|NCT01101165|229777|P2|STARTED|Period 2||40
98073|NCT01101165|229778|P1|STARTED|Period 2||45
98074|NCT01101165|229777|P2|NOT COMPLETED|Period 1||5
98075|NCT01101165|229778|P1|NOT COMPLETED|Period 1||2
98076|NCT01101165|229777|P2|COMPLETED|Period 1||40
98077|NCT01101165|229778|P1|COMPLETED|Period 1||45
98078|NCT01101165|229777|P2|STARTED|Period 1||45
98079|NCT01101165|229778|P1|STARTED|Period 1||47
98080|NCT01101022|229790|P2|NOT COMPLETED|Overall Study||27
98081|NCT01101022|229791|P1|NOT COMPLETED|Overall Study||17
98082|NCT01101022|229790|P2|COMPLETED|Overall Study||53
98083|NCT01101022|229791|P1|COMPLETED|Overall Study||62
98084|NCT01101022|229790|P2|STARTED|Overall Study||80
98085|NCT01101022|229791|P1|STARTED|Overall Study||79
98086|NCT01100944|229825|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
98087|NCT01100944|229826|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
98088|NCT01100944|229827|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
98089|NCT01100944|229825|P3|COMPLETED|Expansion Phase - Phase 2||18
98090|NCT01100944|229826|P2|COMPLETED|Expansion Phase - Phase 2||0
98091|NCT01100944|229827|P1|COMPLETED|Expansion Phase - Phase 2||0
98092|NCT01100944|229825|P3|STARTED|Expansion Phase - Phase 2||18
98093|NCT01100944|229826|P2|STARTED|Expansion Phase - Phase 2||0
98094|NCT01100944|229827|P1|STARTED|Expansion Phase - Phase 2||0
98095|NCT01100944|229825|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
98096|NCT01100944|229826|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
98097|NCT01100944|229827|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
98098|NCT01100944|229825|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
98099|NCT01100944|229826|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
98100|NCT01100944|229827|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
98101|NCT01100944|229825|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
98102|NCT01100944|229826|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
98103|NCT01100944|229827|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
98104|NCT01100944|229825|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
98105|NCT01100944|229826|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
98106|NCT01100944|229827|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
98107|NCT01100944|229825|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
98108|NCT01100944|229826|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
98109|NCT01100944|229827|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
98110|NCT01100944|229825|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
98111|NCT01100944|229826|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
98112|NCT01100944|229827|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
98113|NCT01100931|229874|P2|NOT COMPLETED|Phase II||0
98114|NCT01100931|229875|P1|NOT COMPLETED|Phase II||0
98115|NCT01100931|229874|P2|COMPLETED|Phase II||19
98116|NCT01100931|229875|P1|COMPLETED|Phase II||0
98117|NCT01100931|229874|P2|STARTED|Phase II||19
98118|NCT01100931|229875|P1|STARTED|Phase II||0
98119|NCT01100931|229874|P2|NOT COMPLETED|Phase I||0
98120|NCT01100931|229875|P1|NOT COMPLETED|Phase I||0
98121|NCT01100931|229874|P2|COMPLETED|Phase I||0
98122|NCT01100931|229875|P1|COMPLETED|Phase I||22
98123|NCT01100931|229874|P2|STARTED|Phase I||0
98124|NCT01100931|229875|P1|STARTED|Phase I||22
98125|NCT01100853|229885|P2|NOT COMPLETED|Overall Study||23
98126|NCT01100853|229886|P1|NOT COMPLETED|Overall Study||27
98127|NCT01100853|229885|P2|COMPLETED|Overall Study||26
98128|NCT01100853|229886|P1|COMPLETED|Overall Study||24
98129|NCT01100853|229885|P2|STARTED|Overall Study||49
98130|NCT01100853|229886|P1|STARTED|Overall Study||51
98131|NCT01100762|229902|P1|NOT COMPLETED|Overall Study||0
98132|NCT01100762|229902|P1|COMPLETED|Overall Study||10
98133|NCT01100762|229902|P1|STARTED|Overall Study||10
98134|NCT01100723|229923|P1|NOT COMPLETED|Overall Study||14
98135|NCT01100723|229923|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
98136|NCT01100723|229923|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
98137|NCT01100723|229923|P1|STARTED|Overall Study||92
98138|NCT01100658|229932|P1|NOT COMPLETED|Overall Study||1
98139|NCT01100658|229932|P1|COMPLETED|Overall Study||0
98140|NCT01100658|229932|P1|STARTED|Overall Study||1
98141|NCT01100606|229937|P2|NOT COMPLETED|Second Treatment Period||0
98142|NCT01100606|229938|P1|NOT COMPLETED|Second Treatment Period||0
98143|NCT01100606|229937|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
98144|NCT01100606|229938|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
98145|NCT01100606|229937|P2|STARTED|Second Treatment Period||7
98146|NCT01100606|229938|P1|STARTED|Second Treatment Period||8
98147|NCT01100606|229937|P2|NOT COMPLETED|First Treatment Period||0
98148|NCT01100606|229938|P1|NOT COMPLETED|First Treatment Period||0
98149|NCT01100606|229937|P2|COMPLETED|First Treatment Period||7
98150|NCT01100606|229938|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
98151|NCT01100606|229937|P2|STARTED|First Treatment Period||7
98152|NCT01100606|229938|P1|STARTED|First Treatment Period||8
98153|NCT01100502|229964|P2|NOT COMPLETED|Long-Term Follow-up||139
98154|NCT01100502|229965|P1|NOT COMPLETED|Long-Term Follow-up||137
98155|NCT01100502|229964|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
98156|NCT01100502|229965|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
98157|NCT01100502|229964|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
98158|NCT01100502|229965|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
98159|NCT01100502|229964|P2|NOT COMPLETED|Treatment Period||83
98160|NCT01100502|229965|P1|NOT COMPLETED|Treatment Period||87
98161|NCT01100502|229964|P2|COMPLETED|Treatment Period||81
98162|NCT01100502|229965|P1|COMPLETED|Treatment Period||78
98163|NCT01100502|229964|P2|STARTED|Treatment Period||164
98164|NCT01100502|229965|P1|STARTED|Treatment Period||165
98165|NCT01100437|229975|P3|NOT COMPLETED|Treatment 2||0
98166|NCT01100437|229976|P2|NOT COMPLETED|Treatment 2||0
98167|NCT01100437|229977|P1|NOT COMPLETED|Treatment 2||0
98168|NCT01100437|229975|P3|COMPLETED|Treatment 2||0
98169|NCT01100437|229976|P2|COMPLETED|Treatment 2||2
98170|NCT01100437|229977|P1|COMPLETED|Treatment 2||4
98171|NCT01100437|229975|P3|STARTED|Treatment 2||0
98172|NCT01100437|229976|P2|STARTED|Treatment 2||2
98173|NCT01100437|229977|P1|STARTED|Treatment 2||4
98174|NCT01100437|229975|P3|NOT COMPLETED|Washout (4 Days)||0
98175|NCT01100437|229976|P2|NOT COMPLETED|Washout (4 Days)||0
98176|NCT01100437|229977|P1|NOT COMPLETED|Washout (4 Days)||0
98177|NCT01100437|229975|P3|COMPLETED|Washout (4 Days)||0
98178|NCT01100437|229976|P2|COMPLETED|Washout (4 Days)||2
98179|NCT01100437|229977|P1|COMPLETED|Washout (4 Days)||4
98180|NCT01100437|229975|P3|STARTED|Washout (4 Days)||0
98181|NCT01100437|229976|P2|STARTED|Washout (4 Days)||2
98182|NCT01100437|229977|P1|STARTED|Washout (4 Days)||4
98183|NCT01100437|229975|P3|NOT COMPLETED|Treatment 1||0
98184|NCT01100437|229976|P2|NOT COMPLETED|Treatment 1||0
98185|NCT01100437|229977|P1|NOT COMPLETED|Treatment 1||0
98186|NCT01100437|229975|P3|COMPLETED|Treatment 1||0
98187|NCT01100437|229976|P2|COMPLETED|Treatment 1||2
98188|NCT01100437|229977|P1|COMPLETED|Treatment 1||4
98189|NCT01100437|229975|P3|STARTED|Treatment 1||0
98190|NCT01100437|229976|P2|STARTED|Treatment 1||2
98191|NCT01100437|229977|P1|STARTED|Treatment 1||4
98192|NCT01100437|229975|P3|NOT COMPLETED|Maintenance||2
98193|NCT01100437|229976|P2|NOT COMPLETED|Maintenance||0
98194|NCT01100437|229977|P1|NOT COMPLETED|Maintenance||0
98195|NCT01100437|229975|P3|COMPLETED|Maintenance||0
98196|NCT01100437|229976|P2|COMPLETED|Maintenance||2
98197|NCT01100437|229977|P1|COMPLETED|Maintenance||4
98198|NCT01100437|229975|P3|STARTED|Maintenance||2
98199|NCT01100437|229976|P2|STARTED|Maintenance||2
98200|NCT01100437|229977|P1|STARTED|Maintenance||4
98201|NCT01100437|229975|P3|NOT COMPLETED|Titration/Stabilization||6
98202|NCT01100437|229976|P2|NOT COMPLETED|Titration/Stabilization||0
98203|NCT01100437|229977|P1|NOT COMPLETED|Titration/Stabilization||0
98204|NCT01100437|229975|P3|COMPLETED|Titration/Stabilization||2
98205|NCT01100437|229976|P2|COMPLETED|Titration/Stabilization||2
98206|NCT01100437|229977|P1|COMPLETED|Titration/Stabilization||4
98207|NCT01100437|229975|P3|STARTED|Titration/Stabilization||8
98208|NCT01100437|229976|P2|STARTED|Titration/Stabilization||2
98209|NCT01100437|229977|P1|STARTED|Titration/Stabilization||4
98210|NCT01100437|229975|P3|NOT COMPLETED|Screening||0
98211|NCT01100437|229976|P2|NOT COMPLETED|Screening||0
98212|NCT01100437|229977|P1|NOT COMPLETED|Screening||0
98213|NCT01100437|229975|P3|COMPLETED|Screening||8
98214|NCT01100437|229976|P2|COMPLETED|Screening||2
98215|NCT01100437|229977|P1|COMPLETED|Screening||4
98216|NCT01100437|229975|P3|STARTED|Screening||8
98217|NCT01100437|229976|P2|STARTED|Screening||2
98218|NCT01100437|229977|P1|STARTED|Screening||4
98219|NCT01100320|230014|P2|NOT COMPLETED|Period 2||1
98220|NCT01100320|230015|P1|NOT COMPLETED|Period 2||1
98221|NCT01100320|230014|P2|COMPLETED|Period 2||37
98222|NCT01100320|230015|P1|COMPLETED|Period 2||37
98223|NCT01100320|230014|P2|STARTED|Period 2||38
98224|NCT01100320|230015|P1|STARTED|Period 2||38
98225|NCT01100320|230014|P2|NOT COMPLETED|Period 1||7
98226|NCT01100320|230015|P1|NOT COMPLETED|Period 1||5
98227|NCT01100320|230014|P2|COMPLETED|Period 1||38
98228|NCT01100320|230015|P1|COMPLETED|Period 1||38
98229|NCT01100320|230014|P2|STARTED|Period 1||45
98230|NCT01100320|230015|P1|STARTED|Period 1||43
98231|NCT01100307|230027|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
98232|NCT01100307|230028|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
98233|NCT01100307|230027|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
98234|NCT01100307|230028|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
98235|NCT01100307|230027|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
98236|NCT01100307|230028|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
98237|NCT01100307|230027|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
98238|NCT01100307|230028|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
98239|NCT01100307|230027|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
98240|NCT01100307|230028|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
98241|NCT01100307|230027|P2|STARTED|Double Masked Phase (Up to Week 24)||120
98242|NCT01100307|230028|P1|STARTED|Double Masked Phase (Up to Week 24)||123
98243|NCT01100268|230070|P1|NOT COMPLETED|Overall Study||0
98244|NCT01100268|230070|P1|COMPLETED|Overall Study||4
98245|NCT01100268|230070|P1|STARTED|Overall Study||4
98246|NCT01100255|230077|P2|NOT COMPLETED|Overall Study||0
98247|NCT01100255|230078|P1|NOT COMPLETED|Overall Study||0
98248|NCT01100255|230077|P2|COMPLETED|Overall Study||7
98249|NCT01100255|230078|P1|COMPLETED|Overall Study||8
98250|NCT01100255|230077|P2|STARTED|Overall Study||7
98251|NCT01100255|230078|P1|STARTED|Overall Study||8
98252|NCT01100242|230084|P1|NOT COMPLETED|Overall Study||0
98253|NCT01100242|230084|P1|COMPLETED|Overall Study||17
98254|NCT01100242|230084|P1|STARTED|Overall Study||17
98255|NCT01100112|230090|P1|NOT COMPLETED|Overall Study||8
98256|NCT01100112|230090|P1|COMPLETED|Overall Study||52
98257|NCT01100112|230090|P1|STARTED|Overall Study||60
98258|NCT01100086|230097|P2|NOT COMPLETED|Period 2||0
98259|NCT01100086|230098|P1|NOT COMPLETED|Period 2||0
98260|NCT01100086|230097|P2|COMPLETED|Period 2||41
98261|NCT01100086|230098|P1|COMPLETED|Period 2||42
98262|NCT01100086|230097|P2|STARTED|Period 2||41
98263|NCT01100086|230098|P1|STARTED|Period 2||42
98264|NCT01100086|230097|P2|NOT COMPLETED|Period 1||0
98265|NCT01100086|230098|P1|NOT COMPLETED|Period 1||1
98266|NCT01100086|230097|P2|COMPLETED|Period 1||41
98267|NCT01100086|230098|P1|COMPLETED|Period 1||42
98268|NCT01100086|230097|P2|STARTED|Period 1||41
98269|NCT01100086|230098|P1|STARTED|Period 1||43
98270|NCT01100073|230108|P1|NOT COMPLETED|Overall Study||100
98271|NCT01100073|230108|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
98272|NCT01100073|230108|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
98273|NCT01099917|230123|P1|NOT COMPLETED|Overall Study||27
98274|NCT01099917|230123|P1|COMPLETED|Overall Study||18
98275|NCT01099917|230123|P1|STARTED|Overall Study||45
98276|NCT01099774|230129|P2|NOT COMPLETED|Overall Study||6
98277|NCT01099774|230130|P1|NOT COMPLETED|Overall Study||6
98278|NCT01099774|230129|P2|COMPLETED|Overall Study||289
98279|NCT01099774|230130|P1|COMPLETED|Overall Study||296
98280|NCT01099774|230129|P2|STARTED|Overall Study||295
98281|NCT01099774|230130|P1|STARTED|Overall Study||302
98282|NCT01099761|230146|P4|NOT COMPLETED|Overall Study||0
98283|NCT01099761|230147|P3|NOT COMPLETED|Overall Study||0
98284|NCT01099761|230148|P2|NOT COMPLETED|Overall Study||0
98285|NCT01099761|230149|P1|NOT COMPLETED|Overall Study||0
98286|NCT01099761|230146|P4|COMPLETED|Overall Study||6
98287|NCT01099761|230147|P3|COMPLETED|Overall Study||0
98288|NCT01099761|230148|P2|COMPLETED|Overall Study||9
98289|NCT01099761|230149|P1|COMPLETED|Overall Study||9
98290|NCT01099761|230146|P4|STARTED|Overall Study||6
98291|NCT01099761|230147|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
98292|NCT01099761|230148|P2|STARTED|Overall Study||9
98293|NCT01099761|230149|P1|STARTED|Overall Study||9
98294|NCT01099709|230185|P2|NOT COMPLETED|Period 2||0
98295|NCT01099709|230186|P1|NOT COMPLETED|Period 2||0
98296|NCT01099709|230185|P2|COMPLETED|Period 2||41
98297|NCT01099709|230186|P1|COMPLETED|Period 2||41
98298|NCT01099709|230185|P2|STARTED|Period 2||41
98299|NCT01099709|230186|P1|STARTED|Period 2||41
98300|NCT01099709|230185|P2|NOT COMPLETED|Period 1||2
98301|NCT01099709|230186|P1|NOT COMPLETED|Period 1||1
98302|NCT01099709|230185|P2|COMPLETED|Period 1||41
98303|NCT01099709|230186|P1|COMPLETED|Period 1||41
98304|NCT01099709|230185|P2|STARTED|Period 1||43
98305|NCT01099709|230186|P1|STARTED|Period 1||42
98306|NCT01099618|230199|P3|NOT COMPLETED|Overall Study||0
98307|NCT01099618|230200|P2|NOT COMPLETED|Overall Study||0
98308|NCT01099618|230201|P1|NOT COMPLETED|Overall Study||0
98309|NCT01099618|230199|P3|COMPLETED|Overall Study||15
98310|NCT01099618|230200|P2|COMPLETED|Overall Study||16
98311|NCT01099618|230201|P1|COMPLETED|Overall Study||17
98312|NCT01099618|230199|P3|STARTED|Overall Study||15
98313|NCT01099618|230200|P2|STARTED|Overall Study||16
98314|NCT01099618|230201|P1|STARTED|Overall Study||17
98315|NCT01099579|230212|P3|NOT COMPLETED|Stage 2 (ATV Capsules )||15
98316|NCT01099579|230213|P2|NOT COMPLETED|Stage 2 (ATV Capsules )||14
98317|NCT01099579|230214|P1|NOT COMPLETED|Stage 2 (ATV Capsules )||16
98318|NCT01099579|230212|P3|COMPLETED|Stage 2 (ATV Capsules )||0
98319|NCT01099579|230213|P2|COMPLETED|Stage 2 (ATV Capsules )||0
98320|NCT01099579|230214|P1|COMPLETED|Stage 2 (ATV Capsules )||0
98321|NCT01099579|230212|P3|STARTED|Stage 2 (ATV Capsules )||15
98322|NCT01099579|230213|P2|STARTED|Stage 2 (ATV Capsules )||14
98323|NCT01099579|230214|P1|STARTED|Stage 2 (ATV Capsules )||16
98324|NCT01099579|230212|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
98325|NCT01099579|230213|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
98326|NCT01099579|230214|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
98327|NCT01099579|230212|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
98328|NCT01099579|230213|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
98329|NCT01099579|230214|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
98330|NCT01099579|230212|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
98331|NCT01099579|230213|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
98332|NCT01099579|230214|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
98333|NCT01099475|230270|P2|NOT COMPLETED|Overall Study||0
98334|NCT01099475|230271|P1|NOT COMPLETED|Overall Study||0
98335|NCT01099475|230270|P2|COMPLETED|Overall Study||10
98336|NCT01099475|230271|P1|COMPLETED|Overall Study||10
98337|NCT01099475|230270|P2|STARTED|Overall Study||10
98338|NCT01099475|230271|P1|STARTED|Overall Study||10
98339|NCT01099397|230283|P1|NOT COMPLETED|Overall Study||13
98340|NCT01099397|230283|P1|COMPLETED|Overall Study||26
98341|NCT01099397|230283|P1|STARTED|Overall Study||39
98342|NCT01099358|230288|P4|NOT COMPLETED|Overall Study||4
98343|NCT01099358|230289|P3|NOT COMPLETED|Overall Study||8
98344|NCT01099358|230290|P2|NOT COMPLETED|Overall Study||1
98345|NCT01099358|230291|P1|NOT COMPLETED|Overall Study||3
98346|NCT01099358|230288|P4|COMPLETED|Overall Study||12
98347|NCT01099358|230289|P3|COMPLETED|Overall Study||13
98348|NCT01099358|230290|P2|COMPLETED|Overall Study||5
98349|NCT01099358|230291|P1|COMPLETED|Overall Study||1
98350|NCT01099358|230288|P4|Received at Least One Dose of Study Drug|Overall Study||15
98351|NCT01099358|230289|P3|Received at Least One Dose of Study Drug|Overall Study||20
98352|NCT01099358|230290|P2|Received at Least One Dose of Study Drug|Overall Study||6
98353|NCT01099358|230291|P1|Received at Least One Dose of Study Drug|Overall Study||3
98354|NCT01099358|230288|P4|STARTED|Overall Study||16
98355|NCT01099358|230289|P3|STARTED|Overall Study||21
98356|NCT01099358|230290|P2|STARTED|Overall Study||6
98357|NCT01099358|230291|P1|STARTED|Overall Study||4
98358|NCT01099267|230310|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
98359|NCT01099267|230310|P1|COMPLETED|MDS-009 Extension Follow-up||54
98531|NCT01097915|230736|P3|STARTED|Overall Study||50
98360|NCT01099267|230310|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
98361|NCT01099267|230310|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
98362|NCT01099267|230310|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
98363|NCT01099267|230310|P1|NOT COMPLETED|MDS-003 Study||124
98364|NCT01099267|230310|P1|COMPLETED|MDS-003 Study||24
98365|NCT01099267|230310|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
98366|NCT01099215|230320|P2|NOT COMPLETED|Overall Study||1
98367|NCT01099215|230321|P1|NOT COMPLETED|Overall Study||1
98368|NCT01099215|230320|P2|COMPLETED|Overall Study||9
98369|NCT01099215|230321|P1|COMPLETED|Overall Study||10
98370|NCT01099215|230320|P2|STARTED|Overall Study||10
98371|NCT01099215|230321|P1|STARTED|Overall Study||11
98372|NCT01099202|230359|P2|NOT COMPLETED|Overall Study||0
98373|NCT01099202|230360|P1|NOT COMPLETED|Overall Study||0
98374|NCT01099202|230359|P2|COMPLETED|Overall Study||54
98375|NCT01099202|230360|P1|COMPLETED|Overall Study||55
98376|NCT01099202|230359|P2|STARTED|Overall Study||54
98377|NCT01099202|230360|P1|STARTED|Overall Study||55
98378|NCT01099111|230373|P5|NOT COMPLETED|Overall Study||0
98379|NCT01099111|230374|P4|NOT COMPLETED|Overall Study||0
98380|NCT01099111|230375|P3|NOT COMPLETED|Overall Study||0
98381|NCT01099111|230376|P2|NOT COMPLETED|Overall Study||0
98382|NCT01099111|230377|P1|NOT COMPLETED|Overall Study||0
98383|NCT01099111|230373|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
98384|NCT01099111|230374|P4|COMPLETED|Overall Study||29
98385|NCT01099111|230375|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
98386|NCT01099111|230376|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
98387|NCT01099111|230377|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
98388|NCT01099111|230373|P5|STARTED|Overall Study||50
98389|NCT01099111|230374|P4|STARTED|Overall Study||29
98390|NCT01099111|230375|P3|STARTED|Overall Study||46
98391|NCT01099111|230376|P2|STARTED|Overall Study||50
98392|NCT01099111|230377|P1|STARTED|Overall Study||50
98393|NCT01098851|230391|P2|NOT COMPLETED|Overall Study||0
98394|NCT01098851|230392|P1|NOT COMPLETED|Overall Study||1
98395|NCT01098851|230391|P2|COMPLETED|Overall Study||10
98396|NCT01098851|230392|P1|COMPLETED|Overall Study||10
98397|NCT01098851|230391|P2|STARTED|Overall Study||10
98398|NCT01098851|230392|P1|STARTED|Overall Study||11
98399|NCT01098812|230403|P3|NOT COMPLETED|Overall Study||1
98400|NCT01098812|230404|P2|NOT COMPLETED|Overall Study||1
98401|NCT01098812|230405|P1|NOT COMPLETED|Overall Study||2
98402|NCT01098812|230403|P3|COMPLETED|Overall Study||71
98403|NCT01098812|230404|P2|COMPLETED|Overall Study||101
98404|NCT01098812|230405|P1|COMPLETED|Overall Study||93
98405|NCT01098812|230403|P3|STARTED|Overall Study||72
98406|NCT01098812|230404|P2|STARTED|Overall Study||102
98407|NCT01098812|230405|P1|STARTED|Overall Study||95
98408|NCT01098747|230419|P4|NOT COMPLETED|Overall Study||0
98409|NCT01098747|230420|P3|NOT COMPLETED|Overall Study||0
98410|NCT01098747|230421|P2|NOT COMPLETED|Overall Study||0
98411|NCT01098747|230422|P1|NOT COMPLETED|Overall Study||0
98412|NCT01098747|230419|P4|COMPLETED|Overall Study||87
98413|NCT01098747|230420|P3|COMPLETED|Overall Study||86
98414|NCT01098747|230421|P2|COMPLETED|Overall Study||95
98415|NCT01098747|230422|P1|COMPLETED|Overall Study||48
98416|NCT01098747|230419|P4|STARTED|Overall Study||87
98417|NCT01098747|230420|P3|STARTED|Overall Study||86
98418|NCT01098747|230421|P2|STARTED|Overall Study||95
98419|NCT01098747|230422|P1|STARTED|Overall Study||48
98420|NCT01098578|230472|P1|NOT COMPLETED|Overall Study||0
98421|NCT01098578|230472|P1|COMPLETED|Overall Study||20
98422|NCT01098578|230472|P1|STARTED|Overall Study||20
98423|NCT01098539|230481|P2|NOT COMPLETED|Overall Study||68
98424|NCT01098539|230482|P1|NOT COMPLETED|Overall Study||51
98425|NCT01098539|230481|P2|COMPLETED|Overall Study||178
98426|NCT01098539|230482|P1|COMPLETED|Overall Study||198
98427|NCT01098539|230481|P2|STARTED|Overall Study||246
98428|NCT01098539|230482|P1|STARTED|Overall Study||249
98429|NCT01098500|230518|P1|NOT COMPLETED|Overall Study||0
98430|NCT01098500|230518|P1|COMPLETED|Overall Study||3800
98431|NCT01098500|230518|P1|STARTED|Overall Study||3800
98432|NCT01098487|230533|P1|NOT COMPLETED|Overall Study||44
98433|NCT01098487|230533|P1|COMPLETED|Overall Study||118
98434|NCT01098487|230533|P1|STARTED|Overall Study||162
98435|NCT01098461|230549|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
98436|NCT01098461|230550|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
98437|NCT01098461|230551|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
98438|NCT01098461|230552|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
98439|NCT01098461|230549|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
98440|NCT01098461|230550|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
98441|NCT01098461|230551|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
98442|NCT01098461|230552|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
98443|NCT01098461|230549|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
98532|NCT01097915|230737|P2|STARTED|Overall Study||70
98444|NCT01098461|230550|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
98445|NCT01098461|230551|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
98446|NCT01098461|230552|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
98447|NCT01098461|230549|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
98448|NCT01098461|230550|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
98449|NCT01098461|230551|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
98450|NCT01098461|230552|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
98451|NCT01098461|230549|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
98452|NCT01098461|230550|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
98453|NCT01098461|230551|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
98454|NCT01098461|230552|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
98455|NCT01098461|230549|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
98456|NCT01098461|230550|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
98457|NCT01098461|230551|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
98458|NCT01098461|230552|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
98459|NCT01098318|230585|P3|NOT COMPLETED|Overall Study||3
98460|NCT01098318|230586|P2|NOT COMPLETED|Overall Study||7
98461|NCT01098318|230587|P1|NOT COMPLETED|Overall Study||3
98462|NCT01098318|230585|P3|COMPLETED|Overall Study||15
98463|NCT01098318|230586|P2|COMPLETED|Overall Study||12
98464|NCT01098318|230587|P1|COMPLETED|Overall Study||17
98465|NCT01098318|230585|P3|STARTED|Overall Study||18
98466|NCT01098318|230586|P2|STARTED|Overall Study||19
98467|NCT01098318|230587|P1|STARTED|Overall Study||20
98468|NCT01098305|230597|P2|NOT COMPLETED|Overall Study||33
98469|NCT01098305|230598|P1|NOT COMPLETED|Overall Study||31
98470|NCT01098305|230597|P2|COMPLETED|Overall Study||85
98471|NCT01098305|230598|P1|COMPLETED|Overall Study||88
98472|NCT01098305|230597|P2|STARTED|Overall Study||118
98473|NCT01098305|230598|P1|STARTED|Overall Study||119
98474|NCT01098253|230608|P2|NOT COMPLETED|Overall Study||0
98475|NCT01098253|230609|P1|NOT COMPLETED|Overall Study||2
98476|NCT01098253|230608|P2|COMPLETED|Overall Study||88
98477|NCT01098253|230609|P1|COMPLETED|Overall Study||92
98478|NCT01098253|230608|P2|STARTED|Overall Study||88
98479|NCT01098253|230609|P1|STARTED|Overall Study||94
98480|NCT01098240|230617|P3|NOT COMPLETED|Double-Blind Phase||22
98481|NCT01098240|230618|P2|NOT COMPLETED|Double-Blind Phase||17
98482|NCT01098240|230619|P1|NOT COMPLETED|Double-Blind Phase||0
98483|NCT01098240|230617|P3|COMPLETED|Double-Blind Phase||63
98484|NCT01098240|230618|P2|COMPLETED|Double-Blind Phase||60
98485|NCT01098240|230619|P1|COMPLETED|Double-Blind Phase||0
98486|NCT01098240|230617|P3|STARTED|Double-Blind Phase||85
98487|NCT01098240|230618|P2|STARTED|Double-Blind Phase||77
98488|NCT01098240|230619|P1|STARTED|Double-Blind Phase||0
98489|NCT01098240|230617|P3|NOT COMPLETED|Open-Label Phase||0
98490|NCT01098240|230618|P2|NOT COMPLETED|Open-Label Phase||0
98491|NCT01098240|230619|P1|NOT COMPLETED|Open-Label Phase||135
98492|NCT01098240|230617|P3|COMPLETED|Open-Label Phase||0
98493|NCT01098240|230618|P2|COMPLETED|Open-Label Phase||0
98494|NCT01098240|230619|P1|COMPLETED|Open-Label Phase||162
98495|NCT01098240|230617|P3|STARTED|Open-Label Phase||0
98496|NCT01098240|230618|P2|STARTED|Open-Label Phase||0
98497|NCT01098240|230619|P1|STARTED|Open-Label Phase||297
98498|NCT01098162|230649|P1|NOT COMPLETED|Overall Study||112
98499|NCT01098162|230649|P1|COMPLETED|Overall Study||461
98500|NCT01098162|230649|P1|STARTED|Overall Study||573
98501|NCT01098110|230661|P3|NOT COMPLETED|Overall Study||94
98502|NCT01098110|230662|P2|NOT COMPLETED|Overall Study||73
98503|NCT01098110|230663|P1|NOT COMPLETED|Overall Study||62
98504|NCT01098110|230661|P3|COMPLETED|Overall Study||80
98505|NCT01098110|230662|P2|COMPLETED|Overall Study||109
98506|NCT01098110|230663|P1|COMPLETED|Overall Study||114
98507|NCT01098110|230661|P3|Treated|Overall Study|Received at least one dose of trial medication|174
98508|NCT01098110|230662|P2|Treated|Overall Study|Received at least one dose of trial medication|181
98509|NCT01098110|230663|P1|Treated|Overall Study|Received at least one dose of trial medication|175
98510|NCT01098110|230661|P3|STARTED|Overall Study|Randomized participants|174
98511|NCT01098110|230662|P2|STARTED|Overall Study|Randomized participants|182
98512|NCT01098110|230663|P1|STARTED|Overall Study|Randomized participants|176
98513|NCT01098097|230704|P1|NOT COMPLETED|Overall Study||82
98514|NCT01098097|230704|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
98515|NCT01098097|230704|P1|STARTED|Overall Study||963
98516|NCT01098071|230713|P1|NOT COMPLETED|Overall Study||15
98517|NCT01098071|230713|P1|COMPLETED|Overall Study||19
98518|NCT01098071|230713|P1|STARTED|Overall Study||34
98519|NCT01098032|230726|P2|NOT COMPLETED|Overall Study||1
98520|NCT01098032|230727|P1|NOT COMPLETED|Overall Study||1
98521|NCT01098032|230726|P2|COMPLETED|Overall Study||146
98522|NCT01098032|230727|P1|COMPLETED|Overall Study||146
98523|NCT01098032|230726|P2|STARTED|Overall Study||147
98524|NCT01098032|230727|P1|STARTED|Overall Study||147
98525|NCT01097915|230736|P3|NOT COMPLETED|Overall Study||30
98526|NCT01097915|230737|P2|NOT COMPLETED|Overall Study||42
98527|NCT01097915|230738|P1|NOT COMPLETED|Overall Study||23
98528|NCT01097915|230736|P3|COMPLETED|Overall Study||20
98529|NCT01097915|230737|P2|COMPLETED|Overall Study||28
98530|NCT01097915|230738|P1|COMPLETED|Overall Study||27
98533|NCT01097915|230738|P1|STARTED|Overall Study||50
98534|NCT01097863|230755|P3|NOT COMPLETED|Overall Study||2
98535|NCT01097863|230756|P2|NOT COMPLETED|Overall Study||0
98536|NCT01097863|230757|P1|NOT COMPLETED|Overall Study||1
98537|NCT01097863|230755|P3|COMPLETED|Overall Study||89
98538|NCT01097863|230756|P2|COMPLETED|Overall Study||98
98539|NCT01097863|230757|P1|COMPLETED|Overall Study||89
98540|NCT01097863|230755|P3|STARTED|Overall Study||91
98541|NCT01097863|230756|P2|STARTED|Overall Study||98
98542|NCT01097863|230757|P1|STARTED|Overall Study||90
98543|NCT01097785|230767|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
98544|NCT01097785|230768|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
98545|NCT01097785|230767|P2|COMPLETED|Cycle 3 (30 Days)||6
98546|NCT01097785|230768|P1|COMPLETED|Cycle 3 (30 Days)||6
98547|NCT01097785|230767|P2|STARTED|Cycle 3 (30 Days)||6
98548|NCT01097785|230768|P1|STARTED|Cycle 3 (30 Days)||6
98549|NCT01097785|230767|P2|NOT COMPLETED|Washout (2 Weeks)||0
98550|NCT01097785|230768|P1|NOT COMPLETED|Washout (2 Weeks)||0
98551|NCT01097785|230767|P2|COMPLETED|Washout (2 Weeks)||6
98552|NCT01097785|230768|P1|COMPLETED|Washout (2 Weeks)||6
98553|NCT01097785|230767|P2|STARTED|Washout (2 Weeks)||6
98554|NCT01097785|230768|P1|STARTED|Washout (2 Weeks)||6
98555|NCT01097785|230767|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
98556|NCT01097785|230768|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
98557|NCT01097785|230767|P2|COMPLETED|Cycle 1 (30 Days)||6
98558|NCT01097785|230768|P1|COMPLETED|Cycle 1 (30 Days)||6
98559|NCT01097785|230767|P2|STARTED|Cycle 1 (30 Days)||6
98560|NCT01097785|230768|P1|STARTED|Cycle 1 (30 Days)||6
98561|NCT01097668|230778|P2|NOT COMPLETED|Overall Study||2
98562|NCT01097668|230779|P1|NOT COMPLETED|Overall Study||2
98563|NCT01097668|230778|P2|COMPLETED|Overall Study||20
98564|NCT01097668|230779|P1|COMPLETED|Overall Study||19
98565|NCT01097668|230778|P2|Week 48|Overall Study||20
98566|NCT01097668|230779|P1|Week 48|Overall Study||19
98567|NCT01097668|230778|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
98568|NCT01097668|230779|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
98569|NCT01097668|230778|P2|STARTED|Overall Study||22
98570|NCT01097668|230779|P1|STARTED|Overall Study||21
98571|NCT01097629|230792|P8|NOT COMPLETED|DB RO Phase||1
98572|NCT01097629|230793|P7|NOT COMPLETED|DB RO Phase||3
98573|NCT01097629|230794|P6|NOT COMPLETED|DB RO Phase||1
98574|NCT01097629|230795|P5|NOT COMPLETED|DB RO Phase||0
98575|NCT01097629|230796|P4|NOT COMPLETED|DB RO Phase||1
98576|NCT01097629|230797|P3|NOT COMPLETED|DB RO Phase||0
98577|NCT01097629|230798|P2|NOT COMPLETED|DB RO Phase||0
98578|NCT01097629|230799|P1|NOT COMPLETED|DB RO Phase||0
98579|NCT01097629|230792|P8|COMPLETED|DB RO Phase||326
98580|NCT01097629|230793|P7|COMPLETED|DB RO Phase||168
98581|NCT01097629|230794|P6|COMPLETED|DB RO Phase||172
98582|NCT01097629|230795|P5|COMPLETED|DB RO Phase||108
98583|NCT01097629|230796|P4|COMPLETED|DB RO Phase||96
98584|NCT01097629|230797|P3|COMPLETED|DB RO Phase||0
98585|NCT01097629|230798|P2|COMPLETED|DB RO Phase||0
98586|NCT01097629|230799|P1|COMPLETED|DB RO Phase||0
98587|NCT01097629|230792|P8|STARTED|DB RO Phase||327
98588|NCT01097629|230793|P7|STARTED|DB RO Phase||171
98589|NCT01097629|230794|P6|STARTED|DB RO Phase||173
98590|NCT01097629|230795|P5|STARTED|DB RO Phase||108
98591|NCT01097629|230796|P4|STARTED|DB RO Phase||97
98592|NCT01097629|230797|P3|STARTED|DB RO Phase||0
98593|NCT01097629|230798|P2|STARTED|DB RO Phase||0
98594|NCT01097629|230799|P1|STARTED|DB RO Phase||0
98595|NCT01097629|230792|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98596|NCT01097629|230793|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98597|NCT01097629|230794|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98598|NCT01097629|230795|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98599|NCT01097629|230796|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98600|NCT01097629|230797|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
98601|NCT01097629|230798|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
98602|NCT01097629|230799|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
98603|NCT01097629|230792|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98604|NCT01097629|230793|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98605|NCT01097629|230794|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98606|NCT01097629|230795|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98607|NCT01097629|230796|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98608|NCT01097629|230797|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
98609|NCT01097629|230798|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
98610|NCT01097629|230799|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
98611|NCT01097629|230792|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98612|NCT01097629|230793|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98613|NCT01097629|230794|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98614|NCT01097629|230795|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98615|NCT01097629|230796|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98616|NCT01097629|230797|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
98617|NCT01097629|230798|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
98618|NCT01097629|230799|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
98619|NCT01097629|230792|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98620|NCT01097629|230793|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98621|NCT01097629|230794|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98622|NCT01097629|230795|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98623|NCT01097629|230796|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98624|NCT01097629|230797|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
98625|NCT01097629|230798|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
98626|NCT01097629|230799|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
98627|NCT01097616|230850|P8|NOT COMPLETED|DB RO Phase||1
98628|NCT01097616|230851|P7|NOT COMPLETED|DB RO Phase||1
98629|NCT01097616|230852|P6|NOT COMPLETED|DB RO Phase||2
98630|NCT01097616|230853|P5|NOT COMPLETED|DB RO Phase||1
98631|NCT01097616|230854|P4|NOT COMPLETED|DB RO Phase||1
98632|NCT01097616|230855|P3|NOT COMPLETED|DB RO Phase||0
98633|NCT01097616|230856|P2|NOT COMPLETED|DB RO Phase||0
98634|NCT01097616|230857|P1|NOT COMPLETED|DB RO Phase||0
98635|NCT01097616|230850|P8|COMPLETED|DB RO Phase||326
98636|NCT01097616|230851|P7|COMPLETED|DB RO Phase||161
98637|NCT01097616|230852|P6|COMPLETED|DB RO Phase||159
98638|NCT01097616|230853|P5|COMPLETED|DB RO Phase||111
98639|NCT01097616|230854|P4|COMPLETED|DB RO Phase||100
98640|NCT01097616|230855|P3|COMPLETED|DB RO Phase||0
98641|NCT01097616|230856|P2|COMPLETED|DB RO Phase||0
98642|NCT01097616|230857|P1|COMPLETED|DB RO Phase||0
98643|NCT01097616|230850|P8|STARTED|DB RO Phase||327
98644|NCT01097616|230851|P7|STARTED|DB RO Phase||162
98645|NCT01097616|230852|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
98646|NCT01097616|230853|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
98647|NCT01097616|230854|P4|STARTED|DB RO Phase||101
98648|NCT01097616|230855|P3|STARTED|DB RO Phase||0
98649|NCT01097616|230856|P2|STARTED|DB RO Phase||0
98650|NCT01097616|230857|P1|STARTED|DB RO Phase||0
98651|NCT01097616|230850|P8|NOT COMPLETED|Optional DB EXT Phase||0
98652|NCT01097616|230851|P7|NOT COMPLETED|Optional DB EXT Phase||0
98653|NCT01097616|230852|P6|NOT COMPLETED|Optional DB EXT Phase||0
98654|NCT01097616|230853|P5|NOT COMPLETED|Optional DB EXT Phase||0
98655|NCT01097616|230854|P4|NOT COMPLETED|Optional DB EXT Phase||0
98656|NCT01097616|230855|P3|NOT COMPLETED|Optional DB EXT Phase||10
98657|NCT01097616|230856|P2|NOT COMPLETED|Optional DB EXT Phase||21
98658|NCT01097616|230857|P1|NOT COMPLETED|Optional DB EXT Phase||15
98659|NCT01097616|230850|P8|COMPLETED|Optional DB EXT Phase||0
98660|NCT01097616|230851|P7|COMPLETED|Optional DB EXT Phase||0
98661|NCT01097616|230852|P6|COMPLETED|Optional DB EXT Phase||0
98662|NCT01097616|230853|P5|COMPLETED|Optional DB EXT Phase||0
98663|NCT01097616|230854|P4|COMPLETED|Optional DB EXT Phase||0
98664|NCT01097616|230855|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
98665|NCT01097616|230856|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
98666|NCT01097616|230857|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
98667|NCT01097616|230850|P8|STARTED|Optional DB EXT Phase||0
98668|NCT01097616|230851|P7|STARTED|Optional DB EXT Phase||0
98669|NCT01097616|230852|P6|STARTED|Optional DB EXT Phase||0
98670|NCT01097616|230853|P5|STARTED|Optional DB EXT Phase||0
98671|NCT01097616|230854|P4|STARTED|Optional DB EXT Phase||0
98672|NCT01097616|230855|P3|STARTED|Optional DB EXT Phase||151
98673|NCT01097616|230856|P2|STARTED|Optional DB EXT Phase||172
98674|NCT01097616|230857|P1|STARTED|Optional DB EXT Phase||100
98675|NCT01097616|230850|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98676|NCT01097616|230851|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98677|NCT01097616|230852|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98678|NCT01097616|230853|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98679|NCT01097616|230854|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98680|NCT01097616|230855|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
98681|NCT01097616|230856|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
98682|NCT01097616|230857|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
98683|NCT01097616|230850|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98684|NCT01097616|230851|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98685|NCT01097616|230852|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98686|NCT01097616|230853|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98687|NCT01097616|230854|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
98688|NCT01097616|230855|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
98689|NCT01097616|230856|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
98690|NCT01097616|230857|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
98691|NCT01097616|230850|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98692|NCT01097616|230851|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98693|NCT01097616|230852|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98694|NCT01097616|230853|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98695|NCT01097616|230854|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
98696|NCT01097616|230855|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
98697|NCT01097616|230856|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
98698|NCT01097616|230857|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
98699|NCT01097616|230850|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98700|NCT01097616|230851|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98701|NCT01097616|230852|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98702|NCT01097616|230853|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98703|NCT01097616|230854|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
98704|NCT01097616|230855|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
98705|NCT01097616|230856|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
98706|NCT01097616|230857|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
98707|NCT01096589|230932|P4|NOT COMPLETED|Overall Study||3
98708|NCT01096589|230933|P3|NOT COMPLETED|Overall Study||4
98709|NCT01096589|230934|P2|NOT COMPLETED|Overall Study||2
98710|NCT01096589|230935|P1|NOT COMPLETED|Overall Study||4
98711|NCT01096589|230932|P4|COMPLETED|Overall Study||15
98712|NCT01096589|230933|P3|COMPLETED|Overall Study||18
98713|NCT01096589|230934|P2|COMPLETED|Overall Study||18
98714|NCT01096589|230935|P1|COMPLETED|Overall Study||18
98715|NCT01096589|230932|P4|STARTED|Overall Study||18
98716|NCT01096589|230933|P3|STARTED|Overall Study||22
98717|NCT01096589|230934|P2|STARTED|Overall Study||20
98718|NCT01096589|230935|P1|STARTED|Overall Study||22
98719|NCT01097460|230945|P1|NOT COMPLETED|Overall Study||0
98720|NCT01097460|230945|P1|COMPLETED|Overall Study||16
98721|NCT01097460|230945|P1|STARTED|Overall Study||16
98722|NCT01097421|230949|P1|NOT COMPLETED|Overall Study||14
98723|NCT01097421|230949|P1|COMPLETED|Overall Study||314
98724|NCT01097421|230949|P1|STARTED|Overall Study||328
98725|NCT01097343|230959|P2|NOT COMPLETED|Second Intervention- 30 Days||0
98726|NCT01097343|230960|P1|NOT COMPLETED|Second Intervention- 30 Days||0
98727|NCT01097343|230959|P2|COMPLETED|Second Intervention- 30 Days||25
98728|NCT01097343|230960|P1|COMPLETED|Second Intervention- 30 Days||25
98729|NCT01097343|230959|P2|STARTED|Second Intervention- 30 Days||25
98730|NCT01097343|230960|P1|STARTED|Second Intervention- 30 Days||25
98731|NCT01097343|230959|P2|NOT COMPLETED|First Intervention- 30 Days||0
98732|NCT01097343|230960|P1|NOT COMPLETED|First Intervention- 30 Days||0
98733|NCT01097343|230959|P2|COMPLETED|First Intervention- 30 Days||25
98734|NCT01097343|230960|P1|COMPLETED|First Intervention- 30 Days||25
98735|NCT01097343|230959|P2|STARTED|First Intervention- 30 Days||25
98736|NCT01097343|230960|P1|STARTED|First Intervention- 30 Days||25
98737|NCT01097304|230966|P1|NOT COMPLETED|Overall Study||7
98738|NCT01097304|230966|P1|COMPLETED|Overall Study||29
98739|NCT01097304|230966|P1|STARTED|Overall Study||36
98740|NCT01097005|230970|P1|NOT COMPLETED|Overall Study||365
98741|NCT01097005|230970|P1|COMPLETED|Overall Study||101
98742|NCT01097005|230970|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
98743|NCT01097005|230970|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
98744|NCT01097005|230970|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
98745|NCT01097005|230970|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
98746|NCT01097005|230970|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
98747|NCT01096875|230978|P2|NOT COMPLETED|Overall Study||1
98748|NCT01096875|230979|P1|NOT COMPLETED|Overall Study||0
98749|NCT01096875|230978|P2|COMPLETED|Overall Study||29
98750|NCT01096875|230979|P1|COMPLETED|Overall Study||30
98751|NCT01096875|230978|P2|STARTED|Overall Study||30
98752|NCT01096875|230979|P1|STARTED|Overall Study||30
98753|NCT01096823|230993|P2|NOT COMPLETED|Overall Study||1
98754|NCT01096823|230994|P1|NOT COMPLETED|Overall Study||3
98755|NCT01096823|230993|P2|COMPLETED|Overall Study||15
98756|NCT01096823|230994|P1|COMPLETED|Overall Study||11
98757|NCT01096823|230993|P2|STARTED|Overall Study||16
98758|NCT01096823|230994|P1|STARTED|Overall Study||14
98759|NCT01096810|231006|P1|NOT COMPLETED|Overall Study||0
98760|NCT01096810|231006|P1|COMPLETED|Overall Study||20
98761|NCT01096810|231006|P1|STARTED|Overall Study||20
98762|NCT01096771|231014|P2|NOT COMPLETED|Overall Study||0
98763|NCT01096771|231015|P1|NOT COMPLETED|Overall Study||0
98764|NCT01096771|231014|P2|COMPLETED|Overall Study||7
98765|NCT01096771|231015|P1|COMPLETED|Overall Study||7
98766|NCT01096771|231014|P2|STARTED|Overall Study||7
98767|NCT01096771|231015|P1|STARTED|Overall Study||7
98768|NCT01096680|231044|P5|NOT COMPLETED|Overall Study||0
98769|NCT01096680|231045|P4|NOT COMPLETED|Overall Study||0
98770|NCT01096680|231046|P3|NOT COMPLETED|Overall Study||0
98771|NCT01096680|231047|P2|NOT COMPLETED|Overall Study||0
98772|NCT01096680|231048|P1|NOT COMPLETED|Overall Study||0
98773|NCT01096680|231044|P5|COMPLETED|Overall Study||27
98774|NCT01096680|231045|P4|COMPLETED|Overall Study||27
98775|NCT01096680|231046|P3|COMPLETED|Overall Study||27
98776|NCT01096680|231047|P2|COMPLETED|Overall Study||27
98777|NCT01096680|231048|P1|COMPLETED|Overall Study||27
98778|NCT01096680|231044|P5|STARTED|Overall Study||27
98779|NCT01096680|231045|P4|STARTED|Overall Study||27
98780|NCT01096680|231046|P3|STARTED|Overall Study||27
98781|NCT01096680|231047|P2|STARTED|Overall Study||27
98782|NCT01096680|231048|P1|STARTED|Overall Study||27
98783|NCT01096550|231082|P2|NOT COMPLETED|Overall Study||29
98784|NCT01096550|231083|P1|NOT COMPLETED|Overall Study||37
98785|NCT01096550|231082|P2|COMPLETED|Overall Study||146
98786|NCT01096550|231083|P1|COMPLETED|Overall Study||133
98787|NCT01096550|231082|P2|STARTED|Overall Study||175
98788|NCT01096550|231083|P1|STARTED|Overall Study||170
98789|NCT01096446|231091|P2|NOT COMPLETED|Overall Study||0
98790|NCT01096446|231092|P1|NOT COMPLETED|Overall Study||3
98791|NCT01096446|231091|P2|COMPLETED|Overall Study||10
98792|NCT01096446|231092|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
98793|NCT01096446|231091|P2|STARTED|Overall Study||10
98794|NCT01096446|231092|P1|STARTED|Overall Study||12
98795|NCT01096342|231097|P1|NOT COMPLETED|Overall Study||1
98796|NCT01096342|231097|P1|COMPLETED|Overall Study||15
98797|NCT01096342|231097|P1|STARTED|Overall Study||16
98798|NCT01096316|231105|P2|NOT COMPLETED|Overall Study||9
98799|NCT01096316|231106|P1|NOT COMPLETED|Overall Study||15
98800|NCT01096316|231105|P2|COMPLETED|Overall Study||94
98801|NCT01096316|231106|P1|COMPLETED|Overall Study||87
98802|NCT01096316|231105|P2|STARTED|Overall Study||103
98803|NCT01096316|231106|P1|STARTED|Overall Study||102
98804|NCT01096186|231116|P1|NOT COMPLETED|Overall Study||50
98805|NCT01096186|231116|P1|COMPLETED|Overall Study||567
98806|NCT01096186|231116|P1|STARTED|Overall Study||617
98807|NCT01096056|231124|P2|NOT COMPLETED|Overall Study||1
98808|NCT01096056|231125|P1|NOT COMPLETED|Overall Study||0
98809|NCT01096056|231124|P2|COMPLETED|Overall Study||19
98810|NCT01096056|231125|P1|COMPLETED|Overall Study||20
98811|NCT01096056|231124|P2|Completed at Day 42|Overall Study||20
98812|NCT01096056|231125|P1|Completed at Day 42|Overall Study||20
98813|NCT01096056|231124|P2|STARTED|Overall Study||20
98814|NCT01096056|231125|P1|STARTED|Overall Study||20
98815|NCT01096017|231157|P2|NOT COMPLETED|Treatment Period 2||1
98816|NCT01096017|231158|P1|NOT COMPLETED|Treatment Period 2||1
98817|NCT01096017|231157|P2|COMPLETED|Treatment Period 2||11
98818|NCT01096017|231158|P1|COMPLETED|Treatment Period 2||11
98819|NCT01096017|231157|P2|STARTED|Treatment Period 2||12
98820|NCT01096017|231158|P1|STARTED|Treatment Period 2||12
98821|NCT01096017|231157|P2|NOT COMPLETED|Washout 1 - 14 Days||0
98822|NCT01096017|231158|P1|NOT COMPLETED|Washout 1 - 14 Days||0
98823|NCT01096017|231157|P2|COMPLETED|Washout 1 - 14 Days||12
98824|NCT01096017|231158|P1|COMPLETED|Washout 1 - 14 Days||12
98825|NCT01096017|231157|P2|STARTED|Washout 1 - 14 Days||12
98826|NCT01096017|231158|P1|STARTED|Washout 1 - 14 Days||12
98827|NCT01096017|231157|P2|NOT COMPLETED|Treatment Period 1||0
98828|NCT01096017|231158|P1|NOT COMPLETED|Treatment Period 1||0
98829|NCT01096017|231157|P2|COMPLETED|Treatment Period 1||12
98830|NCT01096017|231158|P1|COMPLETED|Treatment Period 1||12
98831|NCT01096017|231157|P2|STARTED|Treatment Period 1||12
98832|NCT01096017|231158|P1|STARTED|Treatment Period 1||12
98833|NCT01095978|231186|P1|NOT COMPLETED|Overall Study||3
98834|NCT01095978|231186|P1|COMPLETED|Overall Study||2819
98835|NCT01095978|231186|P1|STARTED|Overall Study||2822
98836|NCT01095887|231213|P1|NOT COMPLETED|Overall Study||0
98837|NCT01095887|231213|P1|COMPLETED|Overall Study||6
98838|NCT01095887|231213|P1|STARTED|Overall Study||6
98839|NCT01095835|231220|P3|NOT COMPLETED|Overall Study||8
98840|NCT01095835|231221|P2|NOT COMPLETED|Overall Study||12
98841|NCT01095835|231222|P1|NOT COMPLETED|Overall Study||10
98842|NCT01095835|231220|P3|COMPLETED|Overall Study||17
98843|NCT01095835|231221|P2|COMPLETED|Overall Study||40
98844|NCT01095835|231222|P1|COMPLETED|Overall Study||41
98845|NCT01095835|231220|P3|STARTED|Overall Study||25
98846|NCT01095835|231221|P2|STARTED|Overall Study||52
98847|NCT01095835|231222|P1|STARTED|Overall Study||51
98848|NCT01095796|231260|P2|NOT COMPLETED|Overall Study||289
98849|NCT01095796|231261|P1|NOT COMPLETED|Overall Study||295
98850|NCT01095796|231260|P2|COMPLETED|Overall Study||65
98851|NCT01095796|231261|P1|COMPLETED|Overall Study||58
98852|NCT01095796|231260|P2|STARTED|Overall Study||354
98853|NCT01095796|231261|P1|STARTED|Overall Study||353
98854|NCT01095757|231279|P1|NOT COMPLETED|Overall Study||0
98855|NCT01095757|231279|P1|COMPLETED|Overall Study||45
98856|NCT01095757|231279|P1|STARTED|Overall Study||45
98857|NCT01095653|231291|P3|NOT COMPLETED|Overall Study||16
98858|NCT01095653|231292|P2|NOT COMPLETED|Overall Study||15
98859|NCT01095653|231293|P1|NOT COMPLETED|Overall Study||19
98860|NCT01095653|231291|P3|COMPLETED|Overall Study||117
98861|NCT01095653|231292|P2|COMPLETED|Overall Study||113
98862|NCT01095653|231293|P1|COMPLETED|Overall Study||113
98863|NCT01095653|231291|P3|STARTED|Overall Study||133
98864|NCT01095653|231292|P2|STARTED|Overall Study||128
98865|NCT01095653|231293|P1|STARTED|Overall Study||132
98866|NCT01095510|231316|P4|NOT COMPLETED|Overall Study||0
98867|NCT01095510|231317|P3|NOT COMPLETED|Overall Study||0
98868|NCT01095510|231318|P2|NOT COMPLETED|Overall Study||0
98869|NCT01095510|231319|P1|NOT COMPLETED|Overall Study||0
98870|NCT01095510|231316|P4|COMPLETED|Overall Study||3
98871|NCT01095510|231317|P3|COMPLETED|Overall Study||3
98872|NCT01095510|231318|P2|COMPLETED|Overall Study||0
98873|NCT01095510|231319|P1|COMPLETED|Overall Study||3
98874|NCT01095510|231316|P4|STARTED|Overall Study||3
98875|NCT01095510|231317|P3|STARTED|Overall Study||3
98876|NCT01095510|231318|P2|STARTED|Overall Study||0
98877|NCT01095510|231319|P1|STARTED|Overall Study||3
98878|NCT01095497|231338|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
98879|NCT01095497|231339|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
98880|NCT01095497|231338|P2|COMPLETED|Subcutaneous CINRYZE||12
98881|NCT01095497|231339|P1|COMPLETED|Subcutaneous CINRYZE||12
98882|NCT01095497|231338|P2|STARTED|Subcutaneous CINRYZE||12
98883|NCT01095497|231339|P1|STARTED|Subcutaneous CINRYZE||13
98884|NCT01095497|231338|P2|NOT COMPLETED|Intravenous CINRYZE||0
98885|NCT01095497|231339|P1|NOT COMPLETED|Intravenous CINRYZE||1
98886|NCT01095497|231338|P2|COMPLETED|Intravenous CINRYZE||12
98887|NCT01095497|231339|P1|COMPLETED|Intravenous CINRYZE||13
98888|NCT01095497|231338|P2|STARTED|Intravenous CINRYZE||12
98889|NCT01095497|231339|P1|STARTED|Intravenous CINRYZE||14
98890|NCT01095250|231351|P4|NOT COMPLETED|Overall Study||5
98891|NCT01095250|231352|P3|NOT COMPLETED|Overall Study||8
98892|NCT01095250|231353|P2|NOT COMPLETED|Overall Study||10
98893|NCT01095250|231354|P1|NOT COMPLETED|Overall Study||8
98894|NCT01095250|231351|P4|COMPLETED|Overall Study||0
98895|NCT01095250|231352|P3|COMPLETED|Overall Study||0
98896|NCT01095250|231353|P2|COMPLETED|Overall Study||0
98897|NCT01095250|231354|P1|COMPLETED|Overall Study||0
98898|NCT01095250|231351|P4|STARTED|Overall Study||5
98899|NCT01095250|231352|P3|STARTED|Overall Study||8
98900|NCT01095250|231353|P2|STARTED|Overall Study||10
98901|NCT01095250|231354|P1|STARTED|Overall Study||8
98902|NCT01095094|231384|P1|NOT COMPLETED|Overall Study||3
98903|NCT01095094|231384|P1|COMPLETED|Overall Study||16
98904|NCT01095094|231384|P1|STARTED|Overall Study||19
98905|NCT01094886|231389|P1|NOT COMPLETED|Overall Study||7
98906|NCT01094886|231389|P1|COMPLETED|Overall Study||46
98907|NCT01094886|231389|P1|STARTED|Overall Study||53
98908|NCT01094808|231399|P3|NOT COMPLETED|Overall Study||0
98909|NCT01094808|231400|P2|NOT COMPLETED|Overall Study||1
98910|NCT01094808|231401|P1|NOT COMPLETED|Overall Study||1
98911|NCT01094808|231399|P3|COMPLETED|Overall Study||21
98912|NCT01094808|231400|P2|COMPLETED|Overall Study||19
98913|NCT01094808|231401|P1|COMPLETED|Overall Study||20
98914|NCT01094808|231399|P3|STARTED|Overall Study||21
98915|NCT01094808|231400|P2|STARTED|Overall Study||20
98916|NCT01094808|231401|P1|STARTED|Overall Study||21
98917|NCT01094743|231436|P1|NOT COMPLETED|Period 2||0
98918|NCT01094743|231436|P1|COMPLETED|Period 2||50
98919|NCT01094743|231436|P1|STARTED|Period 2||50
98920|NCT01094743|231436|P1|NOT COMPLETED|Period 1||2
98921|NCT01094743|231436|P1|COMPLETED|Period 1||50
98922|NCT01094743|231436|P1|STARTED|Period 1||52
98923|NCT01094730|231453|P2|NOT COMPLETED|Period 2 (14 Days)||2
98924|NCT01094730|231454|P1|NOT COMPLETED|Period 2 (14 Days)||3
98925|NCT01094730|231453|P2|COMPLETED|Period 2 (14 Days)||84
98926|NCT01094730|231454|P1|COMPLETED|Period 2 (14 Days)||87
98927|NCT01094730|231453|P2|STARTED|Period 2 (14 Days)||86
98928|NCT01094730|231454|P1|STARTED|Period 2 (14 Days)||90
98929|NCT01094730|231453|P2|NOT COMPLETED|Period 1 (14 Days)||2
98930|NCT01094730|231454|P1|NOT COMPLETED|Period 1 (14 Days)||2
98931|NCT01094730|231453|P2|COMPLETED|Period 1 (14 Days)||86
98932|NCT01094730|231454|P1|COMPLETED|Period 1 (14 Days)||90
98933|NCT01094730|231453|P2|STARTED|Period 1 (14 Days)||88
98934|NCT01094730|231454|P1|STARTED|Period 1 (14 Days)||92
98935|NCT01094704|231467|P2|NOT COMPLETED|Overall Study||0
98936|NCT01094704|231468|P1|NOT COMPLETED|Overall Study||0
98937|NCT01094704|231467|P2|COMPLETED|Overall Study||8
98938|NCT01094704|231468|P1|COMPLETED|Overall Study||8
98939|NCT01094704|231467|P2|STARTED|Overall Study||8
98940|NCT01094704|231468|P1|STARTED|Overall Study||8
98941|NCT01094561|231474|P1|NOT COMPLETED|Overall Study||6
98942|NCT01094561|231474|P1|COMPLETED|Overall Study||17
98943|NCT01094561|231474|P1|STARTED|Overall Study||23
98944|NCT01094548|231481|P2|NOT COMPLETED|Overall Study||0
98945|NCT01094548|231482|P1|NOT COMPLETED|Overall Study||0
98946|NCT01094548|231481|P2|COMPLETED|Overall Study||17
98947|NCT01094548|231482|P1|COMPLETED|Overall Study||17
98948|NCT01094548|231481|P2|STARTED|Overall Study||17
98949|NCT01094548|231482|P1|STARTED|Overall Study||17
98950|NCT01093222|231500|P1|NOT COMPLETED|Overall Study||40
98951|NCT01093222|231500|P1|COMPLETED|Overall Study||0
98952|NCT01093222|231500|P1|Eligible and Began Protocol Therapy|Overall Study||34
98953|NCT01093222|231500|P1|STARTED|Overall Study||40
98954|NCT01094171|231507|P1|NOT COMPLETED|Overall Study||10
98955|NCT01094171|231507|P1|COMPLETED|Overall Study||390
98956|NCT01094171|231507|P1|STARTED|Overall Study||400
98957|NCT01093976|231514|P1|NOT COMPLETED|Overall Study||0
98958|NCT01093976|231514|P1|COMPLETED|Overall Study||14
98959|NCT01093976|231514|P1|STARTED|Overall Study||14
98960|NCT01093846|231521|P3|NOT COMPLETED|Overall Study||21
98961|NCT01093846|231522|P2|NOT COMPLETED|Overall Study||18
98962|NCT01093846|231523|P1|NOT COMPLETED|Overall Study||19
98963|NCT01093846|231521|P3|COMPLETED|Overall Study||1
98964|NCT01093846|231522|P2|COMPLETED|Overall Study||0
98965|NCT01093846|231523|P1|COMPLETED|Overall Study||0
98966|NCT01093846|231521|P3|STARTED|Overall Study||22
98967|NCT01093846|231522|P2|STARTED|Overall Study||18
98968|NCT01093846|231523|P1|STARTED|Overall Study||19
98969|NCT01093794|231529|P4|NOT COMPLETED|Treatment Period 4||0
98970|NCT01093794|231530|P3|NOT COMPLETED|Treatment Period 4||0
98971|NCT01093794|231531|P2|NOT COMPLETED|Treatment Period 4||0
98972|NCT01093794|231532|P1|NOT COMPLETED|Treatment Period 4||0
98973|NCT01093794|231529|P4|COMPLETED|Treatment Period 4||7
98974|NCT01093794|231530|P3|COMPLETED|Treatment Period 4||6
98975|NCT01093794|231531|P2|COMPLETED|Treatment Period 4||7
98976|NCT01093794|231532|P1|COMPLETED|Treatment Period 4||7
98977|NCT01093794|231529|P4|STARTED|Treatment Period 4||7
98978|NCT01093794|231530|P3|STARTED|Treatment Period 4||6
98979|NCT01093794|231531|P2|STARTED|Treatment Period 4||7
98980|NCT01093794|231532|P1|STARTED|Treatment Period 4||7
98981|NCT01093794|231529|P4|NOT COMPLETED|Treatment Period 3||0
98982|NCT01093794|231530|P3|NOT COMPLETED|Treatment Period 3||0
98983|NCT01093794|231531|P2|NOT COMPLETED|Treatment Period 3||0
98984|NCT01093794|231532|P1|NOT COMPLETED|Treatment Period 3||0
98985|NCT01093794|231529|P4|COMPLETED|Treatment Period 3||7
98986|NCT01093794|231530|P3|COMPLETED|Treatment Period 3||6
98987|NCT01093794|231531|P2|COMPLETED|Treatment Period 3||7
98988|NCT01093794|231532|P1|COMPLETED|Treatment Period 3||7
98989|NCT01093794|231529|P4|STARTED|Treatment Period 3||7
98990|NCT01093794|231530|P3|STARTED|Treatment Period 3||6
98991|NCT01093794|231531|P2|STARTED|Treatment Period 3||7
98992|NCT01093794|231532|P1|STARTED|Treatment Period 3||7
98993|NCT01093794|231529|P4|NOT COMPLETED|Treatment Period 2||0
98994|NCT01093794|231530|P3|NOT COMPLETED|Treatment Period 2||0
98995|NCT01093794|231531|P2|NOT COMPLETED|Treatment Period 2||0
98996|NCT01093794|231532|P1|NOT COMPLETED|Treatment Period 2||0
98997|NCT01093794|231529|P4|COMPLETED|Treatment Period 2||7
98998|NCT01093794|231530|P3|COMPLETED|Treatment Period 2||6
98999|NCT01093794|231531|P2|COMPLETED|Treatment Period 2||7
99000|NCT01093794|231532|P1|COMPLETED|Treatment Period 2||7
99001|NCT01093794|231529|P4|STARTED|Treatment Period 2||7
99002|NCT01093794|231530|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
99003|NCT01093794|231531|P2|STARTED|Treatment Period 2||7
99004|NCT01093794|231532|P1|STARTED|Treatment Period 2||7
99005|NCT01093794|231529|P4|NOT COMPLETED|Treatment Period 1||0
99006|NCT01093794|231530|P3|NOT COMPLETED|Treatment Period 1||0
99007|NCT01093794|231531|P2|NOT COMPLETED|Treatment Period 1||0
99008|NCT01093794|231532|P1|NOT COMPLETED|Treatment Period 1||0
99009|NCT01093794|231529|P4|COMPLETED|Treatment Period 1||7
99010|NCT01093794|231530|P3|COMPLETED|Treatment Period 1||7
99011|NCT01093794|231531|P2|COMPLETED|Treatment Period 1||7
99012|NCT01093794|231532|P1|COMPLETED|Treatment Period 1||7
99013|NCT01093794|231529|P4|STARTED|Treatment Period 1||7
99014|NCT01093794|231530|P3|STARTED|Treatment Period 1||7
99015|NCT01093794|231531|P2|STARTED|Treatment Period 1||7
99016|NCT01093794|231532|P1|STARTED|Treatment Period 1||7
99017|NCT01093755|231548|P2|NOT COMPLETED|Overall Study||4
99018|NCT01093755|231549|P1|NOT COMPLETED|Overall Study||3
99019|NCT01093755|231548|P2|COMPLETED|Overall Study||10
99020|NCT01093755|231549|P1|COMPLETED|Overall Study||13
99021|NCT01093755|231548|P2|STARTED|Overall Study||14
99022|NCT01093755|231549|P1|STARTED|Overall Study||16
99023|NCT01093690|231559|P2|NOT COMPLETED|Overall Study||0
99024|NCT01093690|231560|P1|NOT COMPLETED|Overall Study||0
99025|NCT01093690|231559|P2|COMPLETED|Overall Study||79
99026|NCT01093690|231560|P1|COMPLETED|Overall Study||83
99027|NCT01093690|231559|P2|STARTED|Overall Study||79
99028|NCT01093690|231560|P1|STARTED|Overall Study||83
99029|NCT01093651|231568|P2|NOT COMPLETED|Overall Study||0
99030|NCT01093651|231569|P1|NOT COMPLETED|Overall Study||0
99031|NCT01093651|231568|P2|COMPLETED|Overall Study||10
99032|NCT01093651|231569|P1|COMPLETED|Overall Study||10
99033|NCT01093651|231568|P2|STARTED|Overall Study||10
99034|NCT01093651|231569|P1|STARTED|Overall Study||10
99035|NCT01093625|231589|P2|NOT COMPLETED|1-Year Visit||3
99036|NCT01093625|231590|P1|NOT COMPLETED|1-Year Visit||5
99037|NCT01093625|231589|P2|COMPLETED|1-Year Visit||37
99038|NCT01093625|231590|P1|COMPLETED|1-Year Visit||29
99039|NCT01093625|231589|P2|STARTED|1-Year Visit||40
99040|NCT01093625|231590|P1|STARTED|1-Year Visit||34
99041|NCT01093625|231589|P2|NOT COMPLETED|6-Month Visit||9
99042|NCT01093625|231590|P1|NOT COMPLETED|6-Month Visit||8
99043|NCT01093625|231589|P2|COMPLETED|6-Month Visit||40
99044|NCT01093625|231590|P1|COMPLETED|6-Month Visit||34
99045|NCT01093625|231589|P2|STARTED|6-Month Visit||49
99046|NCT01093625|231590|P1|STARTED|6-Month Visit||42
99047|NCT01093625|231589|P2|NOT COMPLETED|3-Month Visit||0
99048|NCT01093625|231590|P1|NOT COMPLETED|3-Month Visit||2
99049|NCT01093625|231589|P2|COMPLETED|3-Month Visit||49
99050|NCT01093625|231590|P1|COMPLETED|3-Month Visit||42
99051|NCT01093625|231589|P2|STARTED|3-Month Visit||49
99052|NCT01093625|231590|P1|STARTED|3-Month Visit||44
99053|NCT01093625|231589|P2|NOT COMPLETED|1-Month Visit||0
99054|NCT01093625|231590|P1|NOT COMPLETED|1-Month Visit||2
99055|NCT01093625|231589|P2|COMPLETED|1-Month Visit||49
99056|NCT01093625|231590|P1|COMPLETED|1-Month Visit||44
99057|NCT01093625|231589|P2|STARTED|1-Month Visit||49
99058|NCT01093625|231590|P1|STARTED|1-Month Visit||46
99059|NCT01093625|231589|P2|NOT COMPLETED|2-Week Visit||0
99060|NCT01093625|231590|P1|NOT COMPLETED|2-Week Visit||1
99061|NCT01093625|231589|P2|COMPLETED|2-Week Visit||49
99062|NCT01093625|231590|P1|COMPLETED|2-Week Visit||46
99063|NCT01093625|231589|P2|STARTED|2-Week Visit||49
99064|NCT01093625|231590|P1|STARTED|2-Week Visit||47
99065|NCT01093625|231589|P2|NOT COMPLETED|Baseline and Dispensed||0
99066|NCT01093625|231590|P1|NOT COMPLETED|Baseline and Dispensed||2
99067|NCT01093625|231589|P2|COMPLETED|Baseline and Dispensed||49
99068|NCT01093625|231590|P1|COMPLETED|Baseline and Dispensed||47
99069|NCT01093625|231589|P2|STARTED|Baseline and Dispensed||49
99070|NCT01093625|231590|P1|STARTED|Baseline and Dispensed||49
99071|NCT01093599|231610|P2|NOT COMPLETED|Overall Study||46
99072|NCT01093599|231611|P1|NOT COMPLETED|Overall Study||32
99073|NCT01093599|231610|P2|COMPLETED|Overall Study||59
99074|NCT01093599|231611|P1|COMPLETED|Overall Study||59
99075|NCT01093599|231610|P2|STARTED|Overall Study||105
99076|NCT01093599|231611|P1|STARTED|Overall Study||91
99077|NCT01093534|231620|P3|NOT COMPLETED|Overall Study||9
99078|NCT01093534|231621|P2|NOT COMPLETED|Overall Study||16
99079|NCT01093534|231622|P1|NOT COMPLETED|Overall Study||10
99080|NCT01093534|231620|P3|COMPLETED|Overall Study||169
99081|NCT01093534|231621|P2|COMPLETED|Overall Study||167
99082|NCT01093534|231622|P1|COMPLETED|Overall Study||176
99083|NCT01093534|231620|P3|Received Study Treatment|Overall Study||175
99084|NCT01093534|231621|P2|Received Study Treatment|Overall Study||182
99085|NCT01093534|231622|P1|Received Study Treatment|Overall Study||186
99086|NCT01093534|231620|P3|STARTED|Overall Study||178
99087|NCT01093534|231621|P2|STARTED|Overall Study||183
99088|NCT01093534|231622|P1|STARTED|Overall Study||186
99089|NCT01093521|231727|P1|NOT COMPLETED|Overall Study||0
99090|NCT01093521|231727|P1|COMPLETED|Overall Study||20
99091|NCT01093521|231727|P1|STARTED|Overall Study||20
99092|NCT01093417|231744|P2|NOT COMPLETED|Overall Study||1
99093|NCT01093417|231745|P1|NOT COMPLETED|Overall Study||0
99094|NCT01093417|231744|P2|COMPLETED|Overall Study||29
99095|NCT01093417|231745|P1|COMPLETED|Overall Study||15
99096|NCT01093417|231744|P2|STARTED|Overall Study||30
99097|NCT01093417|231745|P1|STARTED|Overall Study||15
99098|NCT01093027|231755|P2|NOT COMPLETED|Visit 2||0
99099|NCT01093027|231756|P1|NOT COMPLETED|Visit 2||0
99100|NCT01093027|231755|P2|COMPLETED|Visit 2||10
99101|NCT01093027|231756|P1|COMPLETED|Visit 2||10
99102|NCT01093027|231755|P2|STARTED|Visit 2||10
99103|NCT01093027|231756|P1|STARTED|Visit 2||10
99104|NCT01093027|231755|P2|NOT COMPLETED|Visit 1||0
99105|NCT01093027|231756|P1|NOT COMPLETED|Visit 1||0
99106|NCT01093027|231755|P2|COMPLETED|Visit 1||10
99107|NCT01093027|231756|P1|COMPLETED|Visit 1||10
99108|NCT01093027|231755|P2|STARTED|Visit 1||10
99109|NCT01093027|231756|P1|STARTED|Visit 1||10
99110|NCT01093014|231767|P3|NOT COMPLETED|Overall Study||0
99111|NCT01093014|231768|P2|NOT COMPLETED|Overall Study||0
99112|NCT01093014|231769|P1|NOT COMPLETED|Overall Study||0
99113|NCT01093014|231767|P3|COMPLETED|Overall Study||12
99114|NCT01093014|231768|P2|COMPLETED|Overall Study||9
99115|NCT01093014|231769|P1|COMPLETED|Overall Study||12
99116|NCT01093014|231767|P3|STARTED|Overall Study||12
99117|NCT01093014|231768|P2|STARTED|Overall Study||9
99118|NCT01093014|231769|P1|STARTED|Overall Study||12
99119|NCT01092923|231788|P2|NOT COMPLETED|Overall Study||0
99120|NCT01092923|231789|P1|NOT COMPLETED|Overall Study||0
99121|NCT01092923|231788|P2|COMPLETED|Overall Study||10
99122|NCT01092923|231789|P1|COMPLETED|Overall Study||10
99123|NCT01092923|231788|P2|STARTED|Overall Study||10
99124|NCT01092923|231789|P1|STARTED|Overall Study||10
99125|NCT01092910|231798|P1|NOT COMPLETED|Overall Study||5
99126|NCT01092910|231798|P1|COMPLETED|Overall Study||52
99127|NCT01092910|231798|P1|10 Month Follow-up|Overall Study||52
99128|NCT01092910|231798|P1|4 Month Follow-up|Overall Study||54
99129|NCT01092910|231798|P1|STARTED|Overall Study||57
99130|NCT01092832|231810|P2|NOT COMPLETED|Overall Study||0
99131|NCT01092832|231811|P1|NOT COMPLETED|Overall Study||1
99132|NCT01092832|231810|P2|COMPLETED|Overall Study||8
99133|NCT01092832|231811|P1|COMPLETED|Overall Study||13
99134|NCT01092832|231810|P2|STARTED|Overall Study||8
99135|NCT01092832|231811|P1|STARTED|Overall Study||14
99136|NCT01092780|231823|P4|NOT COMPLETED|Treatment Period 4||0
99137|NCT01092780|231824|P3|NOT COMPLETED|Treatment Period 4||0
99138|NCT01092780|231825|P2|NOT COMPLETED|Treatment Period 4||0
99139|NCT01092780|231826|P1|NOT COMPLETED|Treatment Period 4||0
99140|NCT01092780|231823|P4|COMPLETED|Treatment Period 4||13
99141|NCT01092780|231824|P3|COMPLETED|Treatment Period 4||13
99142|NCT01092780|231825|P2|COMPLETED|Treatment Period 4||13
99143|NCT01092780|231826|P1|COMPLETED|Treatment Period 4||13
99144|NCT01092780|231823|P4|STARTED|Treatment Period 4||13
99145|NCT01092780|231824|P3|STARTED|Treatment Period 4||13
99146|NCT01092780|231825|P2|STARTED|Treatment Period 4||13
99147|NCT01092780|231826|P1|STARTED|Treatment Period 4||13
99148|NCT01092780|231823|P4|NOT COMPLETED|Washout Period 3||0
99149|NCT01092780|231824|P3|NOT COMPLETED|Washout Period 3||0
99150|NCT01092780|231825|P2|NOT COMPLETED|Washout Period 3||0
99151|NCT01092780|231826|P1|NOT COMPLETED|Washout Period 3||0
99152|NCT01092780|231823|P4|COMPLETED|Washout Period 3||13
99153|NCT01092780|231824|P3|COMPLETED|Washout Period 3||13
99154|NCT01092780|231825|P2|COMPLETED|Washout Period 3||13
99155|NCT01092780|231826|P1|COMPLETED|Washout Period 3||13
99156|NCT01092780|231823|P4|STARTED|Washout Period 3||13
99157|NCT01092780|231824|P3|STARTED|Washout Period 3||13
99158|NCT01092780|231825|P2|STARTED|Washout Period 3||13
99159|NCT01092780|231826|P1|STARTED|Washout Period 3||13
99160|NCT01092780|231823|P4|NOT COMPLETED|Treatment Period 3||0
99161|NCT01092780|231824|P3|NOT COMPLETED|Treatment Period 3||0
99162|NCT01092780|231825|P2|NOT COMPLETED|Treatment Period 3||0
99163|NCT01092780|231826|P1|NOT COMPLETED|Treatment Period 3||0
99164|NCT01092780|231823|P4|COMPLETED|Treatment Period 3||13
99165|NCT01092780|231824|P3|COMPLETED|Treatment Period 3||13
99166|NCT01092780|231825|P2|COMPLETED|Treatment Period 3||13
99167|NCT01092780|231826|P1|COMPLETED|Treatment Period 3||13
99168|NCT01092780|231823|P4|STARTED|Treatment Period 3||13
99169|NCT01092780|231824|P3|STARTED|Treatment Period 3||13
99170|NCT01092780|231825|P2|STARTED|Treatment Period 3||13
99171|NCT01092780|231826|P1|STARTED|Treatment Period 3||13
99172|NCT01092780|231823|P4|NOT COMPLETED|Washout Period 2||0
99173|NCT01092780|231824|P3|NOT COMPLETED|Washout Period 2||1
99174|NCT01092780|231825|P2|NOT COMPLETED|Washout Period 2||1
99175|NCT01092780|231826|P1|NOT COMPLETED|Washout Period 2||0
99176|NCT01092780|231823|P4|COMPLETED|Washout Period 2||13
99177|NCT01092780|231824|P3|COMPLETED|Washout Period 2||13
99178|NCT01092780|231825|P2|COMPLETED|Washout Period 2||13
99179|NCT01092780|231826|P1|COMPLETED|Washout Period 2||13
99180|NCT01092780|231823|P4|STARTED|Washout Period 2||13
99181|NCT01092780|231824|P3|STARTED|Washout Period 2||14
99182|NCT01092780|231825|P2|STARTED|Washout Period 2||14
99183|NCT01092780|231826|P1|STARTED|Washout Period 2||13
99184|NCT01092780|231823|P4|NOT COMPLETED|Treatment Period 2||0
99185|NCT01092780|231824|P3|NOT COMPLETED|Treatment Period 2||0
99186|NCT01092780|231825|P2|NOT COMPLETED|Treatment Period 2||0
99187|NCT01092780|231826|P1|NOT COMPLETED|Treatment Period 2||0
99188|NCT01092780|231823|P4|COMPLETED|Treatment Period 2||13
99189|NCT01092780|231824|P3|COMPLETED|Treatment Period 2||14
99190|NCT01092780|231825|P2|COMPLETED|Treatment Period 2||14
99191|NCT01092780|231826|P1|COMPLETED|Treatment Period 2||13
99192|NCT01092780|231823|P4|STARTED|Treatment Period 2||13
99193|NCT01092780|231824|P3|STARTED|Treatment Period 2||14
99194|NCT01092780|231825|P2|STARTED|Treatment Period 2||14
99195|NCT01092780|231826|P1|STARTED|Treatment Period 2||13
99196|NCT01092780|231823|P4|NOT COMPLETED|Washout Period 1||0
99197|NCT01092780|231824|P3|NOT COMPLETED|Washout Period 1||0
99198|NCT01092780|231825|P2|NOT COMPLETED|Washout Period 1||1
99199|NCT01092780|231826|P1|NOT COMPLETED|Washout Period 1||1
99200|NCT01092780|231823|P4|COMPLETED|Washout Period 1||13
99201|NCT01092780|231824|P3|COMPLETED|Washout Period 1||14
99202|NCT01092780|231825|P2|COMPLETED|Washout Period 1||14
99203|NCT01092780|231826|P1|COMPLETED|Washout Period 1||13
99204|NCT01092780|231823|P4|STARTED|Washout Period 1||13
99205|NCT01092780|231824|P3|STARTED|Washout Period 1||14
99206|NCT01092780|231825|P2|STARTED|Washout Period 1||15
99207|NCT01092780|231826|P1|STARTED|Washout Period 1||14
99208|NCT01092780|231823|P4|NOT COMPLETED|Treatment Period 1||0
99209|NCT01092780|231824|P3|NOT COMPLETED|Treatment Period 1||0
99210|NCT01092780|231825|P2|NOT COMPLETED|Treatment Period 1||0
99211|NCT01092780|231826|P1|NOT COMPLETED|Treatment Period 1||0
99212|NCT01092780|231823|P4|COMPLETED|Treatment Period 1||13
99213|NCT01092780|231824|P3|COMPLETED|Treatment Period 1||14
99214|NCT01092780|231825|P2|COMPLETED|Treatment Period 1||15
99215|NCT01092780|231826|P1|COMPLETED|Treatment Period 1||14
99216|NCT01092780|231823|P4|STARTED|Treatment Period 1||13
99217|NCT01092780|231824|P3|STARTED|Treatment Period 1||14
99218|NCT01092780|231825|P2|STARTED|Treatment Period 1||15
99219|NCT01092780|231826|P1|STARTED|Treatment Period 1||14
99220|NCT01092767|231856|P1|NOT COMPLETED|Overall Study||5
99221|NCT01092767|231856|P1|COMPLETED|Overall Study||45
99222|NCT01092767|231856|P1|STARTED|Overall Study||50
99223|NCT01092728|231862|P2|NOT COMPLETED|Overall Study||14
99224|NCT01092728|231863|P1|NOT COMPLETED|Overall Study||4
99225|NCT01092728|231862|P2|COMPLETED|Overall Study||0
99226|NCT01092728|231863|P1|COMPLETED|Overall Study||0
99227|NCT01092728|231862|P2|STARTED|Overall Study||14
99228|NCT01092728|231863|P1|STARTED|Overall Study||4
99229|NCT01092702|231871|P1|NOT COMPLETED|Overall Study||9
99230|NCT01092702|231871|P1|COMPLETED|Overall Study||23
99231|NCT01092702|231871|P1|STARTED|Overall Study||32
99232|NCT01092663|231877|P2|NOT COMPLETED|Overall Study||4
99233|NCT01092663|231878|P1|NOT COMPLETED|Overall Study||7
99234|NCT01092663|231877|P2|COMPLETED|Overall Study||26
99235|NCT01092663|231878|P1|COMPLETED|Overall Study||24
99236|NCT01092663|231877|P2|STARTED|Overall Study||30
99237|NCT01092663|231878|P1|STARTED|Overall Study||31
99238|NCT01092637|231926|P2|NOT COMPLETED|Overall Study||49
99239|NCT01092637|231927|P1|NOT COMPLETED|Overall Study||47
99240|NCT01092637|231926|P2|COMPLETED|Overall Study||86
99241|NCT01092637|231927|P1|COMPLETED|Overall Study||98
99242|NCT01092637|231926|P2|STARTED|Overall Study||135
99243|NCT01092637|231927|P1|STARTED|Overall Study||145
99244|NCT01092559|231937|P1|NOT COMPLETED|Overall Study||0
99245|NCT01092559|231937|P1|COMPLETED|Overall Study||10
99246|NCT01092559|231937|P1|STARTED|Overall Study||10
99247|NCT01092546|231942|P1|NOT COMPLETED|Overall Study||4
99248|NCT01092546|231942|P1|COMPLETED|Overall Study||12
99249|NCT01092546|231942|P1|STARTED|Overall Study||16
99250|NCT01092507|231949|P2|NOT COMPLETED|Overall Study||0
99251|NCT01092507|231950|P1|NOT COMPLETED|Overall Study||2
99252|NCT01092507|231949|P2|COMPLETED|Overall Study||150
99253|NCT01092507|231950|P1|COMPLETED|Overall Study||147
99254|NCT01092507|231949|P2|STARTED|Overall Study||150
99255|NCT01092507|231950|P1|STARTED|Overall Study||149
99256|NCT01092442|231970|P2|NOT COMPLETED|Overall Study||0
99257|NCT01092442|231971|P1|NOT COMPLETED|Overall Study||0
99258|NCT01092442|231970|P2|COMPLETED|Overall Study||60
99259|NCT01092442|231971|P1|COMPLETED|Overall Study||80
99260|NCT01092442|231970|P2|STARTED|Overall Study||60
99261|NCT01092442|231971|P1|STARTED|Overall Study||80
99262|NCT01092416|231985|P1|NOT COMPLETED|12-Month Follow-up||25
99263|NCT01092416|231985|P1|COMPLETED|12-Month Follow-up||413
99264|NCT01092416|231985|P1|STARTED|12-Month Follow-up||438
99265|NCT01092416|231985|P1|NOT COMPLETED|30-Day Follow-up||10
99266|NCT01092416|231985|P1|COMPLETED|30-Day Follow-up||430
99267|NCT01092416|231985|P1|STARTED|30-Day Follow-up||440
99268|NCT01092416|231985|P1|NOT COMPLETED|Enrollment||3
99269|NCT01092416|231985|P1|COMPLETED|Enrollment||440
99270|NCT01092416|231985|P1|STARTED|Enrollment||443
99271|NCT01092338|231996|P2|NOT COMPLETED|Overall Study||1
99272|NCT01092338|231997|P1|NOT COMPLETED|Overall Study||1
99273|NCT01092338|231996|P2|COMPLETED|Overall Study||21
99274|NCT01092338|231997|P1|COMPLETED|Overall Study||21
99275|NCT01092338|231996|P2|STARTED|Overall Study||22
99276|NCT01092338|231997|P1|STARTED|Overall Study||22
99277|NCT01091974|232009|P4|NOT COMPLETED|Overall Study||7
99278|NCT01091974|232010|P3|NOT COMPLETED|Overall Study||6
99279|NCT01091974|232011|P2|NOT COMPLETED|Overall Study||5
99280|NCT01091974|232012|P1|NOT COMPLETED|Overall Study||5
99281|NCT01091974|232009|P4|COMPLETED|Overall Study||17
99282|NCT01091974|232010|P3|COMPLETED|Overall Study||19
99283|NCT01091974|232011|P2|COMPLETED|Overall Study||18
99284|NCT01091974|232012|P1|COMPLETED|Overall Study||19
99285|NCT01091974|232009|P4|STARTED|Overall Study||24
99286|NCT01091974|232010|P3|STARTED|Overall Study||25
99287|NCT01091974|232011|P2|STARTED|Overall Study||23
99288|NCT01091974|232012|P1|STARTED|Overall Study||24
99289|NCT01091948|232028|P2|NOT COMPLETED|Overall Study||0
99290|NCT01091948|232029|P1|NOT COMPLETED|Overall Study||0
99291|NCT01091948|232028|P2|COMPLETED|Overall Study||38
99292|NCT01091948|232029|P1|COMPLETED|Overall Study||37
99293|NCT01091948|232028|P2|STARTED|Overall Study||38
99294|NCT01091948|232029|P1|STARTED|Overall Study||37
99295|NCT01091675|232047|P1|NOT COMPLETED|Overall Study||34
99296|NCT01091675|232047|P1|COMPLETED|Overall Study||23
99297|NCT01091675|232047|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
99298|NCT01091662|232053|P2|NOT COMPLETED|Overall Study||34
99299|NCT01091662|232054|P1|NOT COMPLETED|Overall Study||17
99300|NCT01091662|232053|P2|COMPLETED|Overall Study||80
99301|NCT01091662|232054|P1|COMPLETED|Overall Study||41
99302|NCT01091662|232053|P2|STARTED|Overall Study||114
99303|NCT01091662|232054|P1|STARTED|Overall Study||58
99304|NCT01091519|232092|P2|NOT COMPLETED|Overall Study||73
99305|NCT01091519|232093|P1|NOT COMPLETED|Overall Study||55
99306|NCT01091519|232092|P2|COMPLETED|Overall Study||362
99307|NCT01091519|232093|P1|COMPLETED|Overall Study||291
99308|NCT01091519|232092|P2|Treated|Overall Study||431
99309|NCT01091519|232093|P1|Treated|Overall Study||342
99310|NCT01091519|232092|P2|STARTED|Overall Study||435
99311|NCT01091519|232093|P1|STARTED|Overall Study||346
99312|NCT01091259|232105|P1|NOT COMPLETED|Overall Study||5
99313|NCT01091259|232105|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
99314|NCT01091259|232105|P1|STARTED|Overall Study||29
99315|NCT01091246|232116|P3|NOT COMPLETED|Overall Study||13
99316|NCT01091246|232117|P2|NOT COMPLETED|Overall Study||16
99317|NCT01091246|232118|P1|NOT COMPLETED|Overall Study||35
99318|NCT01091246|232116|P3|COMPLETED|Overall Study||450
99319|NCT01091246|232117|P2|COMPLETED|Overall Study||448
99320|NCT01091246|232118|P1|COMPLETED|Overall Study||1350
99321|NCT01091246|232116|P3|STARTED|Overall Study||463
99322|NCT01091246|232117|P2|STARTED|Overall Study||464
99323|NCT01091246|232118|P1|STARTED|Overall Study||1385
99324|NCT01091155|232192|P1|NOT COMPLETED|Overall Study||9
99325|NCT01091155|232192|P1|COMPLETED|Overall Study||279
99326|NCT01091155|232192|P1|STARTED|Overall Study||288
99327|NCT01091116|232201|P5|NOT COMPLETED|Overall Study||11
99328|NCT01091116|232202|P4|NOT COMPLETED|Overall Study||4
99329|NCT01091116|232203|P3|NOT COMPLETED|Overall Study||11
99330|NCT01091116|232204|P2|NOT COMPLETED|Overall Study||8
99331|NCT01091116|232205|P1|NOT COMPLETED|Overall Study||6
99332|NCT01091116|232201|P5|COMPLETED|Overall Study||73
99333|NCT01091116|232202|P4|COMPLETED|Overall Study||80
99334|NCT01091116|232203|P3|COMPLETED|Overall Study||73
99335|NCT01091116|232204|P2|COMPLETED|Overall Study||80
99336|NCT01091116|232205|P1|COMPLETED|Overall Study||77
99337|NCT01091116|232201|P5|STARTED|Overall Study||84
99338|NCT01091116|232202|P4|STARTED|Overall Study||84
99339|NCT01091116|232203|P3|STARTED|Overall Study||84
99340|NCT01091116|232204|P2|STARTED|Overall Study||88
99341|NCT01091116|232205|P1|STARTED|Overall Study||83
99342|NCT01091103|232257|P1|NOT COMPLETED|Overall Study||4
99343|NCT01091103|232257|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
99344|NCT01091103|232257|P1|STARTED|Overall Study||60
99345|NCT01090973|232277|P1|NOT COMPLETED|Overall Study||1
99346|NCT01090973|232277|P1|COMPLETED|Overall Study||0
99347|NCT01090973|232277|P1|STARTED|Overall Study||1
99348|NCT01090765|232293|P6|NOT COMPLETED|Overall Study||1
99349|NCT01090765|232294|P5|NOT COMPLETED|Overall Study||2
99350|NCT01090765|232295|P4|NOT COMPLETED|Overall Study||1
99351|NCT01090765|232296|P3|NOT COMPLETED|Overall Study||0
99352|NCT01090765|232297|P2|NOT COMPLETED|Overall Study||0
99353|NCT01090765|232298|P1|NOT COMPLETED|Overall Study||0
99354|NCT01090765|232293|P6|COMPLETED|Overall Study||3
99355|NCT01090765|232294|P5|COMPLETED|Overall Study||4
99356|NCT01090765|232295|P4|COMPLETED|Overall Study||1
99357|NCT01090765|232296|P3|COMPLETED|Overall Study||3
99358|NCT01090765|232297|P2|COMPLETED|Overall Study||3
99359|NCT01090765|232298|P1|COMPLETED|Overall Study||3
99360|NCT01090765|232293|P6|STARTED|Overall Study||4
99361|NCT01090765|232294|P5|STARTED|Overall Study||6
99362|NCT01090765|232295|P4|STARTED|Overall Study||2
99363|NCT01090765|232296|P3|STARTED|Overall Study||3
99364|NCT01090765|232297|P2|STARTED|Overall Study||3
99365|NCT01090765|232298|P1|STARTED|Overall Study||3
99366|NCT01090752|232315|P2|NOT COMPLETED|Overall Study||0
99367|NCT01090752|232316|P1|NOT COMPLETED|Overall Study||0
99368|NCT01090752|232315|P2|COMPLETED|Overall Study||8
99369|NCT01090752|232316|P1|COMPLETED|Overall Study||8
99370|NCT01090752|232315|P2|STARTED|Overall Study||8
99371|NCT01090752|232316|P1|STARTED|Overall Study||8
99372|NCT01090739|232326|P1|NOT COMPLETED|36 Month Follow-up||23
99373|NCT01090739|232326|P1|COMPLETED|36 Month Follow-up||115
99374|NCT01090739|232326|P1|STARTED|36 Month Follow-up||138
99375|NCT01090739|232326|P1|NOT COMPLETED|24 Month Follow-up||9
99376|NCT01090739|232326|P1|COMPLETED|24 Month Follow-up||138
99377|NCT01090739|232326|P1|STARTED|24 Month Follow-up||147
99378|NCT01090739|232326|P1|NOT COMPLETED|12 Month Follow-up||5
99379|NCT01090739|232326|P1|COMPLETED|12 Month Follow-up||147
99380|NCT01090739|232326|P1|STARTED|12 Month Follow-up||152
99381|NCT01090739|232326|P1|NOT COMPLETED|Enrollment||55
99382|NCT01090739|232326|P1|COMPLETED|Enrollment||152
99383|NCT01090739|232326|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
99384|NCT01090479|232345|P2|NOT COMPLETED|Overall Study||0
99385|NCT01090479|232346|P1|NOT COMPLETED|Overall Study||0
99386|NCT01090479|232345|P2|COMPLETED|Overall Study||50
99387|NCT01090479|232346|P1|COMPLETED|Overall Study||50
99388|NCT01090479|232345|P2|STARTED|Overall Study||50
99389|NCT01090479|232346|P1|STARTED|Overall Study||50
99390|NCT01090453|232354|P2|NOT COMPLETED|Overall Study||14
99391|NCT01090453|232355|P1|NOT COMPLETED|Overall Study||13
99392|NCT01090453|232354|P2|COMPLETED|Overall Study||228
99393|NCT01090453|232355|P1|COMPLETED|Overall Study||225
99394|NCT01090453|232354|P2|STARTED|Overall Study||242
99395|NCT01090453|232355|P1|STARTED|Overall Study||238
99396|NCT01090427|232402|P7|NOT COMPLETED|After Controlled Period||2
99397|NCT01090427|232403|P6|NOT COMPLETED|After Controlled Period||5
99398|NCT01090427|232404|P5|NOT COMPLETED|After Controlled Period||0
99399|NCT01090427|232405|P4|NOT COMPLETED|After Controlled Period||2
99400|NCT01090427|232406|P3|NOT COMPLETED|After Controlled Period||0
99401|NCT01090427|232407|P2|NOT COMPLETED|After Controlled Period||0
99402|NCT01090427|232408|P1|NOT COMPLETED|After Controlled Period||0
99403|NCT01090427|232402|P7|COMPLETED|After Controlled Period||34
99404|NCT01090427|232403|P6|COMPLETED|After Controlled Period||32
99405|NCT01090427|232404|P5|COMPLETED|After Controlled Period||18
99406|NCT01090427|232405|P4|COMPLETED|After Controlled Period||17
99407|NCT01090427|232406|P3|COMPLETED|After Controlled Period||0
99408|NCT01090427|232407|P2|COMPLETED|After Controlled Period||0
99409|NCT01090427|232408|P1|COMPLETED|After Controlled Period||0
99410|NCT01090427|232402|P7|STARTED|After Controlled Period||36
99411|NCT01090427|232403|P6|STARTED|After Controlled Period||37
99412|NCT01090427|232404|P5|STARTED|After Controlled Period||18
99413|NCT01090427|232405|P4|STARTED|After Controlled Period||19
99414|NCT01090427|232406|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
99415|NCT01090427|232407|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
99416|NCT01090427|232408|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
99417|NCT01090427|232402|P7|NOT COMPLETED|Controlled Period||0
99418|NCT01090427|232403|P6|NOT COMPLETED|Controlled Period||0
99419|NCT01090427|232404|P5|NOT COMPLETED|Controlled Period||0
99420|NCT01090427|232405|P4|NOT COMPLETED|Controlled Period||0
99421|NCT01090427|232406|P3|NOT COMPLETED|Controlled Period||0
99422|NCT01090427|232407|P2|NOT COMPLETED|Controlled Period||0
99423|NCT01090427|232408|P1|NOT COMPLETED|Controlled Period||0
99424|NCT01090427|232402|P7|COMPLETED|Controlled Period||0
99425|NCT01090427|232403|P6|COMPLETED|Controlled Period||0
99426|NCT01090427|232404|P5|COMPLETED|Controlled Period||0
99427|NCT01090427|232405|P4|COMPLETED|Controlled Period||0
99428|NCT01090427|232406|P3|COMPLETED|Controlled Period||36
99429|NCT01090427|232407|P2|COMPLETED|Controlled Period||37
99430|NCT01090427|232408|P1|COMPLETED|Controlled Period||37
99431|NCT01090427|232402|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
99432|NCT01090427|232403|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
99433|NCT01090427|232404|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
99434|NCT01090427|232405|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
99435|NCT01090427|232406|P3|STARTED|Controlled Period||36
99436|NCT01090427|232407|P2|STARTED|Controlled Period||37
99437|NCT01090427|232408|P1|STARTED|Controlled Period||37
99438|NCT01090323|232443|P2|NOT COMPLETED|Overall Study||34
99439|NCT01090323|232444|P1|NOT COMPLETED|Overall Study||89
99440|NCT01090323|232443|P2|COMPLETED|Overall Study||19
99441|NCT01090323|232444|P1|COMPLETED|Overall Study||43
99442|NCT01090323|232443|P2|STARTED|Overall Study||53
99443|NCT01090323|232444|P1|STARTED|Overall Study||132
99444|NCT01090310|232456|P4|NOT COMPLETED|Extension Study||20
99445|NCT01090310|232457|P3|NOT COMPLETED|Extension Study||15
99446|NCT01090310|232458|P2|NOT COMPLETED|Extension Study||16
99447|NCT01090310|232459|P1|NOT COMPLETED|Extension Study||14
99448|NCT01090310|232456|P4|COMPLETED|Extension Study||1
99449|NCT01090310|232457|P3|COMPLETED|Extension Study||1
99450|NCT01090310|232458|P2|COMPLETED|Extension Study||0
99451|NCT01090310|232459|P1|COMPLETED|Extension Study||3
99452|NCT01090310|232456|P4|STARTED|Extension Study||21
99453|NCT01090310|232457|P3|STARTED|Extension Study||16
99454|NCT01090310|232458|P2|STARTED|Extension Study||16
99455|NCT01090310|232459|P1|STARTED|Extension Study||17
99456|NCT01090310|232456|P4|NOT COMPLETED|Core Study||7
99457|NCT01090310|232457|P3|NOT COMPLETED|Core Study||7
99458|NCT01090310|232458|P2|NOT COMPLETED|Core Study||11
99459|NCT01090310|232459|P1|NOT COMPLETED|Core Study||8
99460|NCT01090310|232456|P4|COMPLETED|Core Study||27
99461|NCT01090310|232457|P3|COMPLETED|Core Study||24
99462|NCT01090310|232458|P2|COMPLETED|Core Study||20
99463|NCT01090310|232459|P1|COMPLETED|Core Study||21
99464|NCT01090310|232456|P4|STARTED|Core Study||34
99465|NCT01090310|232457|P3|STARTED|Core Study||31
99466|NCT01090310|232458|P2|STARTED|Core Study||31
99467|NCT01090310|232459|P1|STARTED|Core Study||29
99468|NCT01090180|232487|P2|NOT COMPLETED|Overall Study||8
99469|NCT01090180|232488|P1|NOT COMPLETED|Overall Study||11
99470|NCT01090180|232487|P2|COMPLETED|Overall Study||21
99471|NCT01090180|232488|P1|COMPLETED|Overall Study||22
99472|NCT01090180|232487|P2|STARTED|Overall Study||29
99473|NCT01090180|232488|P1|STARTED|Overall Study||33
99474|NCT01090102|232498|P2|NOT COMPLETED|Second 12 Weeks||1
99475|NCT01090102|232499|P1|NOT COMPLETED|Second 12 Weeks||0
99476|NCT01090102|232498|P2|COMPLETED|Second 12 Weeks||15
99477|NCT01090102|232499|P1|COMPLETED|Second 12 Weeks||11
99478|NCT01090102|232498|P2|STARTED|Second 12 Weeks||16
99479|NCT01090102|232499|P1|STARTED|Second 12 Weeks||11
99480|NCT01090102|232498|P2|NOT COMPLETED|First 12 Weeks||2
99481|NCT01090102|232499|P1|NOT COMPLETED|First 12 Weeks||4
99482|NCT01090102|232498|P2|COMPLETED|First 12 Weeks||16
99483|NCT01090102|232499|P1|COMPLETED|First 12 Weeks||11
99484|NCT01090102|232498|P2|STARTED|First 12 Weeks||18
99485|NCT01090102|232499|P1|STARTED|First 12 Weeks||15
99486|NCT01090076|232509|P2|NOT COMPLETED|Overall Study||2
99487|NCT01090076|232510|P1|NOT COMPLETED|Overall Study||1
99488|NCT01090076|232509|P2|COMPLETED|Overall Study||12
99489|NCT01090076|232510|P1|COMPLETED|Overall Study||11
99490|NCT01090076|232509|P2|STARTED|Overall Study||14
99491|NCT01090076|232510|P1|STARTED|Overall Study||12
99492|NCT01090063|232520|P1|NOT COMPLETED|Treatment||4
99493|NCT01090063|232520|P1|COMPLETED|Treatment||20
99494|NCT01090063|232520|P1|STARTED|Treatment||24
99495|NCT01090063|232520|P1|NOT COMPLETED|Screen||4
99496|NCT01090063|232520|P1|COMPLETED|Screen||24
99497|NCT01090063|232520|P1|STARTED|Screen||28
99498|NCT01090050|232536|P2|NOT COMPLETED|Overall Study||7
99499|NCT01090050|232537|P1|NOT COMPLETED|Overall Study||1
99500|NCT01090050|232536|P2|COMPLETED|Overall Study||5
99501|NCT01090050|232537|P1|COMPLETED|Overall Study||15
99502|NCT01090050|232536|P2|STARTED|Overall Study||12
99503|NCT01090050|232537|P1|STARTED|Overall Study||16
99504|NCT01090011|232557|P1|NOT COMPLETED|Overall Study||171
99505|NCT01090011|232557|P1|COMPLETED|Overall Study||0
99506|NCT01090011|232557|P1|STARTED|Overall Study||171
99507|NCT01089751|232627|P2|NOT COMPLETED|Overall Study||27
99508|NCT01089751|232628|P1|NOT COMPLETED|Overall Study||34
99509|NCT01089751|232627|P2|COMPLETED|Overall Study||132
99510|NCT01089751|232628|P1|COMPLETED|Overall Study||129
99511|NCT01089751|232627|P2|STARTED|Overall Study||159
99512|NCT01089751|232628|P1|STARTED|Overall Study||163
99513|NCT01089608|232650|P2|NOT COMPLETED|Overall Study||6
99514|NCT01089608|232651|P1|NOT COMPLETED|Overall Study||0
99515|NCT01089608|232650|P2|COMPLETED|Overall Study||44
99516|NCT01089608|232651|P1|COMPLETED|Overall Study||43
99517|NCT01089608|232650|P2|STARTED|Overall Study||50
99518|NCT01089608|232651|P1|STARTED|Overall Study||43
99519|NCT01089582|232657|P1|NOT COMPLETED|Overall Study||30
99520|NCT01089582|232657|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
99521|NCT01089582|232657|P1|STARTED|Overall Study||603
99522|NCT01089556|232669|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
99523|NCT01089556|232670|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
99524|NCT01089556|232671|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
99525|NCT01089556|232672|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
99526|NCT01089556|232673|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
99527|NCT01089556|232674|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
99528|NCT01089556|232669|P6|COMPLETED|Study Period III (Weeks 9-16)||92
99529|NCT01089556|232670|P5|COMPLETED|Study Period III (Weeks 9-16)||83
99530|NCT01089556|232671|P4|COMPLETED|Study Period III (Weeks 9-16)||66
99531|NCT01089556|232672|P3|COMPLETED|Study Period III (Weeks 9-16)||60
99532|NCT01089556|232673|P2|COMPLETED|Study Period III (Weeks 9-16)||0
99533|NCT01089556|232674|P1|COMPLETED|Study Period III (Weeks 9-16)||0
99534|NCT01089556|232669|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
99535|NCT01089556|232670|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
99536|NCT01089556|232671|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
99537|NCT01089556|232672|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
99538|NCT01089556|232673|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
99539|NCT01089556|232674|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
99540|NCT01089556|232669|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
99541|NCT01089556|232670|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
99542|NCT01089556|232671|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
99543|NCT01089556|232672|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
99544|NCT01089556|232673|P2|STARTED|Study Period III (Weeks 9-16)||0
99545|NCT01089556|232674|P1|STARTED|Study Period III (Weeks 9-16)||0
99546|NCT01089556|232669|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
99547|NCT01089556|232670|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
99548|NCT01089556|232671|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
99549|NCT01089556|232672|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
99550|NCT01089556|232673|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
99551|NCT01089556|232674|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
99552|NCT01089556|232669|P6|COMPLETED|Study Period II (Weeks 1-8)||0
99553|NCT01089556|232670|P5|COMPLETED|Study Period II (Weeks 1-8)||0
99554|NCT01089556|232671|P4|COMPLETED|Study Period II (Weeks 1-8)||0
99555|NCT01089556|232672|P3|COMPLETED|Study Period II (Weeks 1-8)||0
99556|NCT01089556|232673|P2|COMPLETED|Study Period II (Weeks 1-8)||333
99557|NCT01089556|232674|P1|COMPLETED|Study Period II (Weeks 1-8)||333
99558|NCT01089556|232669|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
99559|NCT01089556|232670|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
99560|NCT01089556|232671|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
99561|NCT01089556|232672|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
99562|NCT01089556|232673|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
99563|NCT01089556|232674|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
99564|NCT01089556|232669|P6|Safety Population|Study Period II (Weeks 1-8)||0
99565|NCT01089556|232670|P5|Safety Population|Study Period II (Weeks 1-8)||0
99566|NCT01089556|232671|P4|Safety Population|Study Period II (Weeks 1-8)||0
99567|NCT01089556|232672|P3|Safety Population|Study Period II (Weeks 1-8)||0
99568|NCT01089556|232673|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
99569|NCT01089556|232674|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
99570|NCT01089556|232669|P6|STARTED|Study Period II (Weeks 1-8)||0
99571|NCT01089556|232670|P5|STARTED|Study Period II (Weeks 1-8)||0
99572|NCT01089556|232671|P4|STARTED|Study Period II (Weeks 1-8)||0
99573|NCT01089556|232672|P3|STARTED|Study Period II (Weeks 1-8)||0
99574|NCT01089556|232673|P2|STARTED|Study Period II (Weeks 1-8)||407
99575|NCT01089556|232674|P1|STARTED|Study Period II (Weeks 1-8)||404
99576|NCT01089543|232748|P4|NOT COMPLETED|Overall Study||2
99577|NCT01089543|232749|P3|NOT COMPLETED|Overall Study||3
99578|NCT01089543|232750|P2|NOT COMPLETED|Overall Study||4
99579|NCT01089543|232751|P1|NOT COMPLETED|Overall Study||3
99580|NCT01089543|232748|P4|COMPLETED|Overall Study||83
99581|NCT01089543|232749|P3|COMPLETED|Overall Study||81
99582|NCT01089543|232750|P2|COMPLETED|Overall Study||81
99583|NCT01089543|232751|P1|COMPLETED|Overall Study||81
99584|NCT01089543|232748|P4|STARTED|Overall Study||85
99585|NCT01089543|232749|P3|STARTED|Overall Study||84
99586|NCT01089543|232750|P2|STARTED|Overall Study||85
99587|NCT01089543|232751|P1|STARTED|Overall Study||84
99588|NCT01089517|232768|P3|NOT COMPLETED|Overall Study||5
99589|NCT01089517|232769|P2|NOT COMPLETED|Overall Study||5
99590|NCT01089517|232770|P1|NOT COMPLETED|Overall Study||4
99591|NCT01089517|232768|P3|COMPLETED|Overall Study||147
99592|NCT01089517|232769|P2|COMPLETED|Overall Study||144
99593|NCT01089517|232770|P1|COMPLETED|Overall Study||144
99594|NCT01089517|232768|P3|STARTED|Overall Study||152
99595|NCT01089517|232769|P2|STARTED|Overall Study||149
99596|NCT01089517|232770|P1|STARTED|Overall Study||148
99597|NCT01089504|232786|P2|NOT COMPLETED|Overall Study||1
99598|NCT01089504|232787|P1|NOT COMPLETED|Overall Study||3
99599|NCT01089504|232786|P2|COMPLETED|Overall Study||4
99600|NCT01089504|232787|P1|COMPLETED|Overall Study||5
99601|NCT01089504|232786|P2|STARTED|Overall Study||5
99602|NCT01089504|232787|P1|STARTED|Overall Study||8
99603|NCT01089413|232800|P1|NOT COMPLETED|Overall Study||201
99604|NCT01089413|232800|P1|COMPLETED|Overall Study||0
99605|NCT01089413|232800|P1|Received Bevacizumab in First Line|Overall Study||199
99606|NCT01089413|232800|P1|STARTED|Overall Study||201
99607|NCT01089231|232821|P4|NOT COMPLETED|Overall Study||1
99608|NCT01089231|232822|P3|NOT COMPLETED|Overall Study||2
99609|NCT01089231|232823|P2|NOT COMPLETED|Overall Study||2
99610|NCT01089231|232824|P1|NOT COMPLETED|Overall Study||4
99611|NCT01089231|232821|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
99612|NCT01089231|232822|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
99613|NCT01089231|232823|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
99614|NCT01089231|232824|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
99615|NCT01089231|232821|P4|STARTED|Overall Study||10
99616|NCT01089231|232822|P3|STARTED|Overall Study||10
99617|NCT01089231|232823|P2|STARTED|Overall Study||10
99618|NCT01089231|232824|P1|STARTED|Overall Study||10
99619|NCT01089127|232848|P6|NOT COMPLETED|Overall Study||3
99620|NCT01089127|232849|P5|NOT COMPLETED|Overall Study||2
99621|NCT01089127|232850|P4|NOT COMPLETED|Overall Study||1
99622|NCT01089127|232851|P3|NOT COMPLETED|Overall Study||2
99623|NCT01089127|232852|P2|NOT COMPLETED|Overall Study||5
99624|NCT01089127|232853|P1|NOT COMPLETED|Overall Study||8
99625|NCT01089127|232848|P6|COMPLETED|Overall Study||88
99626|NCT01089127|232849|P5|COMPLETED|Overall Study||90
99627|NCT01089127|232850|P4|COMPLETED|Overall Study||91
99628|NCT01089127|232851|P3|COMPLETED|Overall Study||92
99629|NCT01089127|232852|P2|COMPLETED|Overall Study||86
99630|NCT01089127|232853|P1|COMPLETED|Overall Study||84
99631|NCT01089127|232848|P6|Exposed to Study Drug|Overall Study||91
99632|NCT01089127|232849|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
99633|NCT01089127|232850|P4|Exposed to Study Drug|Overall Study||92
99634|NCT01089127|232851|P3|Exposed to Study Drug|Overall Study||94
99635|NCT01089127|232852|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
99636|NCT01089127|232853|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
99637|NCT01089127|232848|P6|STARTED|Overall Study||91
99638|NCT01089127|232849|P5|STARTED|Overall Study||92
99639|NCT01089127|232850|P4|STARTED|Overall Study||92
99640|NCT01089127|232851|P3|STARTED|Overall Study||94
99641|NCT01089127|232852|P2|STARTED|Overall Study||91
99642|NCT01089127|232853|P1|STARTED|Overall Study||92
99643|NCT01089062|232879|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99644|NCT01089062|232880|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99645|NCT01089062|232881|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99646|NCT01089062|232882|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99647|NCT01089062|232883|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99648|NCT01089062|232884|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
99649|NCT01089062|232879|P6|COMPLETED|Follow-up Visit (Final Visit)||3
99650|NCT01089062|232880|P5|COMPLETED|Follow-up Visit (Final Visit)||3
99651|NCT01089062|232881|P4|COMPLETED|Follow-up Visit (Final Visit)||3
99652|NCT01089062|232882|P3|COMPLETED|Follow-up Visit (Final Visit)||3
99653|NCT01089062|232883|P2|COMPLETED|Follow-up Visit (Final Visit)||3
99654|NCT01089062|232884|P1|COMPLETED|Follow-up Visit (Final Visit)||3
99655|NCT01089062|232879|P6|STARTED|Follow-up Visit (Final Visit)||3
99656|NCT01089062|232880|P5|STARTED|Follow-up Visit (Final Visit)||3
99657|NCT01089062|232881|P4|STARTED|Follow-up Visit (Final Visit)||3
99658|NCT01089062|232882|P3|STARTED|Follow-up Visit (Final Visit)||3
99659|NCT01089062|232883|P2|STARTED|Follow-up Visit (Final Visit)||3
99660|NCT01089062|232884|P1|STARTED|Follow-up Visit (Final Visit)||3
99661|NCT01089062|232879|P6|NOT COMPLETED|Visit 4||0
99662|NCT01089062|232880|P5|NOT COMPLETED|Visit 4||0
99663|NCT01089062|232881|P4|NOT COMPLETED|Visit 4||0
99664|NCT01089062|232882|P3|NOT COMPLETED|Visit 4||0
99665|NCT01089062|232883|P2|NOT COMPLETED|Visit 4||0
99666|NCT01089062|232884|P1|NOT COMPLETED|Visit 4||0
99667|NCT01089062|232879|P6|COMPLETED|Visit 4||3
99668|NCT01089062|232880|P5|COMPLETED|Visit 4||3
99669|NCT01089062|232881|P4|COMPLETED|Visit 4||3
99670|NCT01089062|232882|P3|COMPLETED|Visit 4||3
99671|NCT01089062|232883|P2|COMPLETED|Visit 4||3
99672|NCT01089062|232884|P1|COMPLETED|Visit 4||3
99673|NCT01089062|232879|P6|STARTED|Visit 4||3
99674|NCT01089062|232880|P5|STARTED|Visit 4||3
99675|NCT01089062|232881|P4|STARTED|Visit 4||3
99676|NCT01089062|232882|P3|STARTED|Visit 4||3
99677|NCT01089062|232883|P2|STARTED|Visit 4||3
99678|NCT01089062|232884|P1|STARTED|Visit 4||3
99679|NCT01089062|232879|P6|NOT COMPLETED|Visit 3||0
99680|NCT01089062|232880|P5|NOT COMPLETED|Visit 3||0
99681|NCT01089062|232881|P4|NOT COMPLETED|Visit 3||1
99682|NCT01089062|232882|P3|NOT COMPLETED|Visit 3||0
99683|NCT01089062|232883|P2|NOT COMPLETED|Visit 3||0
99684|NCT01089062|232884|P1|NOT COMPLETED|Visit 3||0
99685|NCT01089062|232879|P6|COMPLETED|Visit 3||3
99686|NCT01089062|232880|P5|COMPLETED|Visit 3||3
99687|NCT01089062|232881|P4|COMPLETED|Visit 3||3
99688|NCT01089062|232882|P3|COMPLETED|Visit 3||3
99689|NCT01089062|232883|P2|COMPLETED|Visit 3||3
99690|NCT01089062|232884|P1|COMPLETED|Visit 3||3
99691|NCT01089062|232879|P6|STARTED|Visit 3||3
99692|NCT01089062|232880|P5|STARTED|Visit 3||3
99693|NCT01089062|232881|P4|STARTED|Visit 3||4
99694|NCT01089062|232882|P3|STARTED|Visit 3||3
99695|NCT01089062|232883|P2|STARTED|Visit 3||3
99696|NCT01089062|232884|P1|STARTED|Visit 3||3
99697|NCT01089062|232879|P6|NOT COMPLETED|Visit 2 (Randomization)||1
99698|NCT01089062|232880|P5|NOT COMPLETED|Visit 2 (Randomization)||1
99699|NCT01089062|232881|P4|NOT COMPLETED|Visit 2 (Randomization)||0
99700|NCT01089062|232882|P3|NOT COMPLETED|Visit 2 (Randomization)||1
99701|NCT01089062|232883|P2|NOT COMPLETED|Visit 2 (Randomization)||1
99702|NCT01089062|232884|P1|NOT COMPLETED|Visit 2 (Randomization)||1
99703|NCT01089062|232879|P6|COMPLETED|Visit 2 (Randomization)||3
99704|NCT01089062|232880|P5|COMPLETED|Visit 2 (Randomization)||3
99705|NCT01089062|232881|P4|COMPLETED|Visit 2 (Randomization)||4
99706|NCT01089062|232882|P3|COMPLETED|Visit 2 (Randomization)||3
99707|NCT01089062|232883|P2|COMPLETED|Visit 2 (Randomization)||3
99708|NCT01089062|232884|P1|COMPLETED|Visit 2 (Randomization)||3
99709|NCT01089062|232879|P6|STARTED|Visit 2 (Randomization)||4
99710|NCT01089062|232880|P5|STARTED|Visit 2 (Randomization)||4
99711|NCT01089062|232881|P4|STARTED|Visit 2 (Randomization)||4
99712|NCT01089062|232882|P3|STARTED|Visit 2 (Randomization)||4
99713|NCT01089062|232883|P2|STARTED|Visit 2 (Randomization)||4
99714|NCT01089062|232884|P1|STARTED|Visit 2 (Randomization)||4
99715|NCT01089023|232907|P1|NOT COMPLETED|Overall Study||7
99716|NCT01089023|232907|P1|COMPLETED|Overall Study||88
99717|NCT01089023|232907|P1|STARTED|Overall Study||95
99718|NCT01088997|232921|P2|NOT COMPLETED|Overall Study||3
99719|NCT01088997|232922|P1|NOT COMPLETED|Overall Study||3
99720|NCT01088997|232921|P2|COMPLETED|Overall Study||2
99721|NCT01088997|232922|P1|COMPLETED|Overall Study||4
99722|NCT01088997|232921|P2|STARTED|Overall Study||5
99723|NCT01088997|232922|P1|STARTED|Overall Study||7
99724|NCT01088984|232933|P2|NOT COMPLETED|Phase 2||32
99725|NCT01088984|232934|P1|NOT COMPLETED|Phase 2||0
99726|NCT01088984|232933|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
99727|NCT01088984|232934|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
99728|NCT01088984|232933|P2|STARTED|Phase 2||32
99729|NCT01088984|232934|P1|STARTED|Phase 2||0
99730|NCT01088984|232933|P2|NOT COMPLETED|Phase 1||6
99731|NCT01088984|232934|P1|NOT COMPLETED|Phase 1||5
99732|NCT01088984|232933|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
99733|NCT01088984|232934|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
99734|NCT01088984|232933|P2|STARTED|Phase 1||6
99735|NCT01088984|232934|P1|STARTED|Phase 1||5
99736|NCT01088711|232956|P4|NOT COMPLETED|Overall Study||0
99737|NCT01088711|232957|P3|NOT COMPLETED|Overall Study||0
99738|NCT01088711|232958|P2|NOT COMPLETED|Overall Study||0
99739|NCT01088711|232959|P1|NOT COMPLETED|Overall Study||0
99740|NCT01088711|232956|P4|COMPLETED|Overall Study||2
99741|NCT01088711|232957|P3|COMPLETED|Overall Study||6
99742|NCT01088711|232958|P2|COMPLETED|Overall Study||6
99743|NCT01088711|232959|P1|COMPLETED|Overall Study||18
99744|NCT01088711|232956|P4|STARTED|Overall Study||2
99745|NCT01088711|232957|P3|STARTED|Overall Study||6
99746|NCT01088711|232958|P2|STARTED|Overall Study||6
99747|NCT01088711|232959|P1|STARTED|Overall Study||18
99748|NCT01088672|232983|P1|NOT COMPLETED|Overall Study||0
99749|NCT01088672|232983|P1|COMPLETED|Overall Study||60
99750|NCT01088672|232983|P1|STARTED|Overall Study||60
99751|NCT01088646|232989|P1|NOT COMPLETED|Overall Study||0
99752|NCT01088646|232989|P1|COMPLETED|Overall Study||25
99753|NCT01088646|232989|P1|STARTED|Overall Study||25
99754|NCT01088529|232995|P2|NOT COMPLETED|Overall Study||1
99755|NCT01088529|232996|P1|NOT COMPLETED|Overall Study||0
99756|NCT01088529|232995|P2|COMPLETED|Overall Study||21
99757|NCT01088529|232996|P1|COMPLETED|Overall Study||44
99758|NCT01088529|232995|P2|Received Treatment|Overall Study||21
99759|NCT01088529|232996|P1|Received Treatment|Overall Study||44
99760|NCT01088529|232995|P2|STARTED|Overall Study||22
99761|NCT01088529|232996|P1|STARTED|Overall Study||44
99762|NCT01088503|233009|P3|NOT COMPLETED|Overall Study||17
99763|NCT01088503|233010|P2|NOT COMPLETED|Overall Study||685
99764|NCT01088503|233011|P1|NOT COMPLETED|Overall Study||182
99765|NCT01088503|233009|P3|COMPLETED|Overall Study||241
99766|NCT01088503|233010|P2|COMPLETED|Overall Study||8161
99767|NCT01088503|233011|P1|COMPLETED|Overall Study||2941
99768|NCT01088503|233009|P3|STARTED|Overall Study||258
99769|NCT01088503|233010|P2|STARTED|Overall Study||8846
99770|NCT01088503|233011|P1|STARTED|Overall Study||3123
99771|NCT01088464|233035|P3|NOT COMPLETED|Overall Study||0
99772|NCT01088464|233036|P2|NOT COMPLETED|Overall Study||0
99773|NCT01088464|233037|P1|NOT COMPLETED|Overall Study||0
99774|NCT01088464|233035|P3|COMPLETED|Overall Study||6
99775|NCT01088464|233036|P2|COMPLETED|Overall Study||6
99776|NCT01088464|233037|P1|COMPLETED|Overall Study||3
99777|NCT01088464|233035|P3|Received Any Quantity of Study Drug|Overall Study||6
99778|NCT01088464|233036|P2|Received Any Quantity of Study Drug|Overall Study||6
99779|NCT01088464|233037|P1|Received Any Quantity of Study Drug|Overall Study||3
99780|NCT01088464|233035|P3|STARTED|Overall Study||6
99781|NCT01088464|233036|P2|STARTED|Overall Study||6
99782|NCT01088464|233037|P1|STARTED|Overall Study||3
99783|NCT01088438|233089|P2|NOT COMPLETED|Overall Study||36
99784|NCT01088438|233090|P1|NOT COMPLETED|Overall Study||29
99785|NCT01088438|233089|P2|COMPLETED|Overall Study||59
99786|NCT01088438|233090|P1|COMPLETED|Overall Study||65
99787|NCT01088438|233089|P2|STARTED|Overall Study||95
99788|NCT01088438|233090|P1|STARTED|Overall Study||94
99789|NCT01088399|233103|P3|NOT COMPLETED|Overall Study||281
99790|NCT01088399|233104|P2|NOT COMPLETED|Overall Study||1347
99791|NCT01088399|233105|P1|NOT COMPLETED|Overall Study||7121
99792|NCT01088399|233103|P3|COMPLETED|Overall Study||21
99793|NCT01088399|233104|P2|COMPLETED|Overall Study||308
99794|NCT01088399|233105|P1|COMPLETED|Overall Study||1595
99795|NCT01088399|233103|P3|STARTED|Overall Study||302
99796|NCT01088399|233104|P2|STARTED|Overall Study||1655
99797|NCT01088399|233105|P1|STARTED|Overall Study||8716
99798|NCT01088295|233128|P1|NOT COMPLETED|Overall Study||1
99799|NCT01088295|233128|P1|COMPLETED|Overall Study||35
99800|NCT01088295|233128|P1|STARTED|Overall Study||36
99801|NCT01087996|233134|P2|NOT COMPLETED|Overall Study||0
99802|NCT01087996|233135|P1|NOT COMPLETED|Overall Study||0
99803|NCT01087996|233134|P2|COMPLETED|Overall Study||15
99804|NCT01087996|233135|P1|COMPLETED|Overall Study||15
99805|NCT01087996|233134|P2|STARTED|Overall Study||15
99806|NCT01087996|233135|P1|STARTED|Overall Study||15
99807|NCT01087970|233157|P1|NOT COMPLETED|Overall Study||2
99808|NCT01087970|233157|P1|COMPLETED|Overall Study||67
99809|NCT01087970|233157|P1|Received Carboplatin|Overall Study||63
99810|NCT01087970|233157|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
99811|NCT01087970|233157|P1|Completed 6 Cycles|Overall Study||69
99812|NCT01087970|233157|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
99813|NCT01087970|233157|P1|STARTED|Overall Study||69
99814|NCT01087957|233169|P2|NOT COMPLETED|Overall Study||55
99815|NCT01087957|233170|P1|NOT COMPLETED|Overall Study||41
99816|NCT01087957|233169|P2|COMPLETED|Overall Study||187
99817|NCT01087957|233170|P1|COMPLETED|Overall Study||212
99818|NCT01087957|233169|P2|STARTED|Overall Study||242
99819|NCT01087957|233170|P1|STARTED|Overall Study||253
99820|NCT01087944|233196|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
99821|NCT01087944|233197|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
99822|NCT01087944|233196|P2|COMPLETED|Period 2 (Week 4-6)||28
99823|NCT01087944|233197|P1|COMPLETED|Period 2 (Week 4-6)||29
99824|NCT01087944|233196|P2|STARTED|Period 2 (Week 4-6)||30
99825|NCT01087944|233197|P1|STARTED|Period 2 (Week 4-6)||29
99826|NCT01087944|233196|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
99827|NCT01087944|233197|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
99828|NCT01087944|233196|P2|COMPLETED|Period 1 (Week 1-3)||30
99829|NCT01087944|233197|P1|COMPLETED|Period 1 (Week 1-3)||29
99830|NCT01087944|233196|P2|STARTED|Period 1 (Week 1-3)||30
99831|NCT01087944|233197|P1|STARTED|Period 1 (Week 1-3)||30
99832|NCT01087918|233227|P2|NOT COMPLETED|Overall Study||0
99833|NCT01087918|233228|P1|NOT COMPLETED|Overall Study||0
99834|NCT01087918|233227|P2|COMPLETED|Overall Study||4
99835|NCT01087918|233228|P1|COMPLETED|Overall Study||5
99836|NCT01087918|233227|P2|STARTED|Overall Study||4
99837|NCT01087918|233228|P1|STARTED|Overall Study||5
99838|NCT01087905|233262|P8|NOT COMPLETED|Overall Study||29
99839|NCT01087905|233263|P7|NOT COMPLETED|Overall Study||23
99840|NCT01087905|233264|P6|NOT COMPLETED|Overall Study||28
99841|NCT01087905|233265|P5|NOT COMPLETED|Overall Study||31
99842|NCT01087905|233266|P4|NOT COMPLETED|Overall Study||36
99843|NCT01087905|233267|P3|NOT COMPLETED|Overall Study||22
99844|NCT01087905|233268|P2|NOT COMPLETED|Overall Study||32
99845|NCT01087905|233269|P1|NOT COMPLETED|Overall Study||29
99846|NCT01087905|233262|P8|COMPLETED|Overall Study||98
99847|NCT01087905|233263|P7|COMPLETED|Overall Study||98
99848|NCT01087905|233264|P6|COMPLETED|Overall Study||99
99849|NCT01087905|233265|P5|COMPLETED|Overall Study||91
99850|NCT01087905|233266|P4|COMPLETED|Overall Study||86
99851|NCT01087905|233267|P3|COMPLETED|Overall Study||101
99852|NCT01087905|233268|P2|COMPLETED|Overall Study||94
99853|NCT01087905|233269|P1|COMPLETED|Overall Study||90
99854|NCT01087905|233262|P8|STARTED|Overall Study||127
99855|NCT01087905|233263|P7|STARTED|Overall Study||121
99856|NCT01087905|233264|P6|STARTED|Overall Study||127
99857|NCT01087905|233265|P5|STARTED|Overall Study||122
99858|NCT01087905|233266|P4|STARTED|Overall Study||122
99859|NCT01087905|233267|P3|STARTED|Overall Study||123
99860|NCT01087905|233268|P2|STARTED|Overall Study||126
99861|NCT01087905|233269|P1|STARTED|Overall Study||119
99862|NCT01087814|233291|P2|NOT COMPLETED|Second Intervention (5 Days)||0
99863|NCT01087814|233292|P1|NOT COMPLETED|Second Intervention (5 Days)||1
99864|NCT01087814|233291|P2|COMPLETED|Second Intervention (5 Days)||6
99865|NCT01087814|233292|P1|COMPLETED|Second Intervention (5 Days)||4
99866|NCT01087814|233291|P2|STARTED|Second Intervention (5 Days)||6
99867|NCT01087814|233292|P1|STARTED|Second Intervention (5 Days)||5
99868|NCT01087814|233291|P2|NOT COMPLETED|First Intervention (5 Days)||1
99869|NCT01087814|233292|P1|NOT COMPLETED|First Intervention (5 Days)||3
99870|NCT01087814|233291|P2|COMPLETED|First Intervention (5 Days)||6
99871|NCT01087814|233292|P1|COMPLETED|First Intervention (5 Days)||5
99872|NCT01087814|233291|P2|STARTED|First Intervention (5 Days)||7
99873|NCT01087814|233292|P1|STARTED|First Intervention (5 Days)||8
99874|NCT01087801|233300|P2|NOT COMPLETED|Overall Study||5
99875|NCT01087801|233301|P1|NOT COMPLETED|Overall Study||4
99876|NCT01087801|233300|P2|COMPLETED|Overall Study||29
99877|NCT01087801|233301|P1|COMPLETED|Overall Study||26
99878|NCT01087801|233300|P2|STARTED|Overall Study||34
99879|NCT01087801|233301|P1|STARTED|Overall Study||30
99880|NCT01087788|233310|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
99881|NCT01087788|233311|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
99882|NCT01087788|233312|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
99883|NCT01087788|233310|P3|COMPLETED|Open-Label Period (OL-P)||86
99884|NCT01087788|233311|P2|COMPLETED|Open-Label Period (OL-P)||97
99885|NCT01087788|233312|P1|COMPLETED|Open-Label Period (OL-P)||81
99886|NCT01087788|233310|P3|STARTED|Open-Label Period (OL-P)||114
99887|NCT01087788|233311|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
99888|NCT01087788|233312|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
99889|NCT01087788|233310|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
99890|NCT01087788|233311|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
99891|NCT01087788|233312|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
99892|NCT01087788|233310|P3|COMPLETED|24-weeks Dose-blind Period||114
99893|NCT01087788|233311|P2|COMPLETED|24-weeks Dose-blind Period||123
99894|NCT01087788|233312|P1|COMPLETED|24-weeks Dose-blind Period||113
99895|NCT01087788|233310|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
99896|NCT01087788|233311|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
99897|NCT01087788|233312|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
99898|NCT01087788|233310|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
99899|NCT01087788|233311|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
99900|NCT01087788|233312|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
99901|NCT01087788|233310|P3|STARTED|24-weeks Dose-blind Period||120
99902|NCT01087788|233311|P2|STARTED|24-weeks Dose-blind Period||128
99903|NCT01087788|233312|P1|STARTED|24-weeks Dose-blind Period||120
99904|NCT01087788|233310|P3|NOT COMPLETED|24-weeks Double-blind Period||15
99905|NCT01087788|233311|P2|NOT COMPLETED|24-weeks Double-blind Period||10
99906|NCT01087788|233312|P1|NOT COMPLETED|24-weeks Double-blind Period||16
99907|NCT01087788|233310|P3|COMPLETED|24-weeks Double-blind Period||120
99908|NCT01087788|233311|P2|COMPLETED|24-weeks Double-blind Period||128
99909|NCT01087788|233312|P1|COMPLETED|24-weeks Double-blind Period||120
99910|NCT01087788|233310|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
99911|NCT01087788|233311|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
99912|NCT01087788|233312|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
99913|NCT01087788|233310|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
99914|NCT01087788|233311|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
99915|NCT01087788|233312|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
99916|NCT01087788|233310|P3|STARTED|24-weeks Double-blind Period||135
99917|NCT01087788|233311|P2|STARTED|24-weeks Double-blind Period||138
99918|NCT01087788|233312|P1|STARTED|24-weeks Double-blind Period||136
99919|NCT01087762|233342|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
99920|NCT01087762|233343|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
99921|NCT01087762|233344|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
99922|NCT01087762|233345|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
99923|NCT01087762|233346|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
99924|NCT01087762|233342|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
99925|NCT01087762|233343|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
99926|NCT01087762|233344|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
99927|NCT01087762|233345|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
99928|NCT01087762|233346|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
99929|NCT01087762|233342|P5|STARTED|Open-Label Period (Weeks 48-204)||157
99930|NCT01087762|233343|P4|STARTED|Open-Label Period (Weeks 48-204)||158
99931|NCT01087762|233344|P3|STARTED|Open-Label Period (Weeks 48-204)||0
99932|NCT01087762|233345|P2|STARTED|Open-Label Period (Weeks 48-204)||0
99933|NCT01087762|233346|P1|STARTED|Open-Label Period (Weeks 48-204)||0
99934|NCT01087762|233342|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
99935|NCT01087762|233343|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
99936|NCT01087762|233344|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
99937|NCT01087762|233345|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
99938|NCT01087762|233346|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
99939|NCT01087762|233342|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
99940|NCT01087762|233343|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
99941|NCT01087762|233344|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
99942|NCT01087762|233345|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
99943|NCT01087762|233346|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
99944|NCT01087762|233342|P5|STARTED|Double Blind Period (Weeks 0-24)||0
99945|NCT01087762|233343|P4|STARTED|Double Blind Period (Weeks 0-24)||0
99946|NCT01087762|233344|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
99947|NCT01087762|233345|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
99948|NCT01087762|233346|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
99949|NCT01087736|233394|P2|NOT COMPLETED|Overall Study||2
99950|NCT01087736|233395|P1|NOT COMPLETED|Overall Study||1
99951|NCT01087736|233394|P2|COMPLETED|Overall Study||14
99952|NCT01087736|233395|P1|COMPLETED|Overall Study||13
99953|NCT01087736|233394|P2|STARTED|Overall Study||16
99954|NCT01087736|233395|P1|STARTED|Overall Study||14
99955|NCT01087723|233405|P2|NOT COMPLETED|Overall Study||20
99956|NCT01087723|233406|P1|NOT COMPLETED|Overall Study||14
99957|NCT01087723|233405|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
99958|NCT01087723|233406|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
99959|NCT01087723|233405|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
99960|NCT01087723|233406|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
99961|NCT01087723|233405|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
99962|NCT01087723|233406|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
99963|NCT01087541|233430|P2|NOT COMPLETED|Overall Study||0
99964|NCT01087541|233431|P1|NOT COMPLETED|Overall Study||0
99965|NCT01087541|233430|P2|COMPLETED|Overall Study||3523
99966|NCT01087541|233431|P1|COMPLETED|Overall Study||3307
99967|NCT01087541|233430|P2|STARTED|Overall Study||3523
99968|NCT01087541|233431|P1|STARTED|Overall Study||3307
99969|NCT01087528|233447|P1|NOT COMPLETED|Overall Study||7
99970|NCT01087528|233447|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
99971|NCT01087528|233447|P1|STARTED|Overall Study||51
99972|NCT01087502|233453|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
99973|NCT01087502|233454|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
99974|NCT01087502|233453|P2|COMPLETED|Up to Final Analysis (Week 52)||95
99975|NCT01087502|233454|P1|COMPLETED|Up to Final Analysis (Week 52)||90
99976|NCT01087502|233453|P2|STARTED|Up to Final Analysis (Week 52)||118
99977|NCT01087502|233454|P1|STARTED|Up to Final Analysis (Week 52)||123
99978|NCT01087502|233453|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
99979|NCT01087502|233454|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
99980|NCT01087502|233453|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
99981|NCT01087502|233454|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
99982|NCT01087502|233453|P2|STARTED|Up to Interim Analysis (Week 12)||118
99983|NCT01087502|233454|P1|STARTED|Up to Interim Analysis (Week 12)||123
99984|NCT01087489|233473|P2|NOT COMPLETED|Overall Study||3
99985|NCT01087489|233474|P1|NOT COMPLETED|Overall Study||0
99986|NCT01087489|233473|P2|COMPLETED|Overall Study||31
99987|NCT01087489|233474|P1|COMPLETED|Overall Study||19
99988|NCT01087489|233473|P2|STARTED|Overall Study||34
99989|NCT01087489|233474|P1|STARTED|Overall Study||19
99990|NCT01086969|233487|P3|NOT COMPLETED|Overall Study||0
99991|NCT01086969|233488|P2|NOT COMPLETED|Overall Study||2
99992|NCT01086969|233489|P1|NOT COMPLETED|Overall Study||1
99993|NCT01086969|233487|P3|COMPLETED|Overall Study||100
99994|NCT01086969|233488|P2|COMPLETED|Overall Study||98
99995|NCT01086969|233489|P1|COMPLETED|Overall Study||99
99996|NCT01086969|233487|P3|STARTED|Overall Study||100
99997|NCT01086969|233488|P2|STARTED|Overall Study||100
99998|NCT01086969|233489|P1|STARTED|Overall Study||100
99999|NCT01086852|233506|P1|NOT COMPLETED|Overall Study||0
100000|NCT01086852|233506|P1|COMPLETED|Overall Study||4
100001|NCT01086852|233506|P1|STARTED|Overall Study||4
100002|NCT01086761|233522|P6|NOT COMPLETED|Overall Study||0
100003|NCT01086761|233523|P5|NOT COMPLETED|Overall Study||0
100004|NCT01086761|233524|P4|NOT COMPLETED|Overall Study||0
100005|NCT01086761|233525|P3|NOT COMPLETED|Overall Study||0
100006|NCT01086761|233526|P2|NOT COMPLETED|Overall Study||0
100007|NCT01086761|233527|P1|NOT COMPLETED|Overall Study||0
100008|NCT01086761|233522|P6|COMPLETED|Overall Study||0
100009|NCT01086761|233523|P5|COMPLETED|Overall Study||4
100010|NCT01086761|233524|P4|COMPLETED|Overall Study||6
100011|NCT01086761|233525|P3|COMPLETED|Overall Study||6
100012|NCT01086761|233526|P2|COMPLETED|Overall Study||7
100013|NCT01086761|233527|P1|COMPLETED|Overall Study||9
100014|NCT01086761|233522|P6|STARTED|Overall Study||0
100015|NCT01086761|233523|P5|STARTED|Overall Study||4
100016|NCT01086761|233524|P4|STARTED|Overall Study||6
100017|NCT01086761|233525|P3|STARTED|Overall Study||6
100018|NCT01086761|233526|P2|STARTED|Overall Study||7
100019|NCT01086761|233527|P1|STARTED|Overall Study||9
100020|NCT01086475|233567|P2|NOT COMPLETED|Overall Study||0
100021|NCT01086475|233568|P1|NOT COMPLETED|Overall Study||0
100022|NCT01086475|233567|P2|COMPLETED|Overall Study||33
100023|NCT01086475|233568|P1|COMPLETED|Overall Study||34
100024|NCT01086475|233567|P2|STARTED|Overall Study||33
100025|NCT01086475|233568|P1|STARTED|Overall Study||34
100026|NCT01086410|233582|P4|NOT COMPLETED|Overall Study||2
100027|NCT01086410|233583|P3|NOT COMPLETED|Overall Study||1
100028|NCT01086410|233584|P2|NOT COMPLETED|Overall Study||2
100029|NCT01086410|233585|P1|NOT COMPLETED|Overall Study||3
100030|NCT01086410|233582|P4|COMPLETED|Overall Study||13
100031|NCT01086410|233583|P3|COMPLETED|Overall Study||55
100032|NCT01086410|233584|P2|COMPLETED|Overall Study||54
100033|NCT01086410|233585|P1|COMPLETED|Overall Study||55
100034|NCT01086410|233582|P4|STARTED|Overall Study||15
100035|NCT01086410|233583|P3|STARTED|Overall Study||56
100036|NCT01086410|233584|P2|STARTED|Overall Study||56
100037|NCT01086410|233585|P1|STARTED|Overall Study||58
100038|NCT01086384|233681|P3|NOT COMPLETED|Treatment Period||124
100039|NCT01086384|233682|P2|NOT COMPLETED|Treatment Period||148
100040|NCT01086384|233683|P1|NOT COMPLETED|Treatment Period||0
100041|NCT01086384|233681|P3|COMPLETED|Treatment Period||885
100042|NCT01086384|233682|P2|COMPLETED|Treatment Period||863
100043|NCT01086384|233683|P1|COMPLETED|Treatment Period||0
100044|NCT01086384|233681|P3|STARTED|Treatment Period||1009
100045|NCT01086384|233682|P2|STARTED|Treatment Period||1011
100046|NCT01086384|233683|P1|STARTED|Treatment Period||0
100047|NCT01086384|233681|P3|NOT COMPLETED|2-week Run-in Period||0
100048|NCT01086384|233682|P2|NOT COMPLETED|2-week Run-in Period||0
100049|NCT01086384|233683|P1|NOT COMPLETED|2-week Run-in Period||163
100050|NCT01086384|233681|P3|COMPLETED|2-week Run-in Period||0
100051|NCT01086384|233682|P2|COMPLETED|2-week Run-in Period||0
100052|NCT01086384|233683|P1|COMPLETED|2-week Run-in Period||2020
100053|NCT01086384|233681|P3|STARTED|2-week Run-in Period||0
100054|NCT01086384|233682|P2|STARTED|2-week Run-in Period||0
100055|NCT01086384|233683|P1|STARTED|2-week Run-in Period||2183
100056|NCT01086215|233697|P4|NOT COMPLETED|Overall Study||3
100057|NCT01086215|233698|P3|NOT COMPLETED|Overall Study||26
100058|NCT01086215|233699|P2|NOT COMPLETED|Overall Study||47
100059|NCT01086215|233700|P1|NOT COMPLETED|Overall Study||36
100060|NCT01086215|233697|P4|COMPLETED|Overall Study||11
100061|NCT01086215|233698|P3|COMPLETED|Overall Study||47
100062|NCT01086215|233699|P2|COMPLETED|Overall Study||154
100063|NCT01086215|233700|P1|COMPLETED|Overall Study||176
100064|NCT01086215|233697|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
100065|NCT01086215|233698|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
100066|NCT01086215|233699|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
100067|NCT01086215|233700|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
100068|NCT01086215|233697|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
100069|NCT01086215|233698|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
100070|NCT01086215|233699|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
100071|NCT01086215|233700|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
100072|NCT01086215|233697|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
100073|NCT01086215|233698|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
100074|NCT01086215|233699|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
100075|NCT01086215|233700|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
100076|NCT01086215|233697|P4|STARTED|Overall Study||14
100077|NCT01086215|233698|P3|STARTED|Overall Study||73
100078|NCT01086215|233699|P2|STARTED|Overall Study||201
100079|NCT01086215|233700|P1|STARTED|Overall Study||212
100080|NCT01086033|233718|P1|NOT COMPLETED|Overall Study||304
100081|NCT01086033|233718|P1|COMPLETED|Overall Study||262
100082|NCT01086033|233718|P1|STARTED|Overall Study||566
100083|NCT01085968|233732|P2|NOT COMPLETED|Overall Study||4
100084|NCT01085968|233733|P1|NOT COMPLETED|Overall Study||10
100085|NCT01085968|233732|P2|COMPLETED|Overall Study||21
100086|NCT01085968|233733|P1|COMPLETED|Overall Study||19
100087|NCT01085968|233732|P2|STARTED|Overall Study||25
100088|NCT01085968|233733|P1|STARTED|Overall Study||29
100089|NCT01085903|233749|P3|NOT COMPLETED|Overall Study||0
100090|NCT01085903|233750|P2|NOT COMPLETED|Overall Study||0
100091|NCT01085903|233751|P1|NOT COMPLETED|Overall Study||0
100092|NCT01085903|233749|P3|COMPLETED|Overall Study||3
100093|NCT01085903|233750|P2|COMPLETED|Overall Study||4
100094|NCT01085903|233751|P1|COMPLETED|Overall Study||21
100095|NCT01085903|233749|P3|STARTED|Overall Study||3
100096|NCT01085903|233750|P2|STARTED|Overall Study||4
100097|NCT01085903|233751|P1|STARTED|Overall Study||21
100098|NCT01085825|233777|P2|NOT COMPLETED|Overall Study||1
100099|NCT01085825|233778|P1|NOT COMPLETED|Overall Study||1
100100|NCT01085825|233777|P2|COMPLETED|Overall Study||247
100101|NCT01085825|233778|P1|COMPLETED|Overall Study||251
100102|NCT01085825|233777|P2|STARTED|Overall Study||248
100103|NCT01085825|233778|P1|STARTED|Overall Study|1st participant enrolled|252
100104|NCT01085786|233786|P2|NOT COMPLETED|Overall Study||0
100105|NCT01085786|233787|P1|NOT COMPLETED|Overall Study||0
100106|NCT01085786|233786|P2|COMPLETED|Overall Study||117
100107|NCT01085786|233787|P1|COMPLETED|Overall Study||123
100108|NCT01085786|233786|P2|STARTED|Overall Study||117
100109|NCT01085786|233787|P1|STARTED|Overall Study||123
100110|NCT01085760|233797|P4|NOT COMPLETED|Overall Study||3
100111|NCT01085760|233798|P3|NOT COMPLETED|Overall Study||2
100112|NCT01085760|233799|P2|NOT COMPLETED|Overall Study||1
100113|NCT01085760|233800|P1|NOT COMPLETED|Overall Study||1
100114|NCT01085760|233797|P4|COMPLETED|Overall Study||6
100115|NCT01085760|233798|P3|COMPLETED|Overall Study||7
100116|NCT01085760|233799|P2|COMPLETED|Overall Study||8
100117|NCT01085760|233800|P1|COMPLETED|Overall Study||7
100118|NCT01085760|233797|P4|STARTED|Overall Study||9
100119|NCT01085760|233798|P3|STARTED|Overall Study||9
100120|NCT01085760|233799|P2|STARTED|Overall Study||9
100121|NCT01085760|233800|P1|STARTED|Overall Study||8
100122|NCT01085734|233824|P2|NOT COMPLETED|Overall Study||4
100123|NCT01085734|233825|P1|NOT COMPLETED|Overall Study||1
100124|NCT01085734|233824|P2|COMPLETED|Overall Study||11
100125|NCT01085734|233825|P1|COMPLETED|Overall Study||14
100126|NCT01085734|233824|P2|STARTED|Overall Study||15
100127|NCT01085734|233825|P1|STARTED|Overall Study||15
100128|NCT01085682|233837|P2|NOT COMPLETED|Overall Study||25
100129|NCT01085682|233838|P1|NOT COMPLETED|Overall Study||25
100130|NCT01085682|233837|P2|COMPLETED|Overall Study||3
100131|NCT01085682|233838|P1|COMPLETED|Overall Study||6
100132|NCT01085682|233837|P2|STARTED|Overall Study||28
100133|NCT01085682|233838|P1|STARTED|Overall Study||31
100134|NCT01085643|233844|P1|NOT COMPLETED|Overall Study||0
100135|NCT01085643|233844|P1|COMPLETED|Overall Study||4
100136|NCT01085643|233844|P1|STARTED|Overall Study||4
100137|NCT01085591|233856|P3|NOT COMPLETED|Overall Study||7
100138|NCT01085591|233857|P2|NOT COMPLETED|Overall Study||6
100139|NCT01085591|233858|P1|NOT COMPLETED|Overall Study||3
100140|NCT01085591|233856|P3|COMPLETED|Overall Study||63
100141|NCT01085591|233857|P2|COMPLETED|Overall Study||65
100142|NCT01085591|233858|P1|COMPLETED|Overall Study||66
100143|NCT01085591|233856|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
100144|NCT01085591|233857|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
100145|NCT01085591|233858|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
100146|NCT01085591|233856|P3|STARTED|Overall Study||70
100147|NCT01085591|233857|P2|STARTED|Overall Study||71
100148|NCT01085591|233858|P1|STARTED|Overall Study||69
100149|NCT01085539|233881|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
100150|NCT01085539|233881|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
100151|NCT01085539|233881|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
100152|NCT01085539|233881|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
100153|NCT01085539|233881|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
100154|NCT01085539|233881|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
100155|NCT01085539|233881|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
100156|NCT01085539|233881|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
100157|NCT01085539|233881|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
100158|NCT01085539|233881|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
100159|NCT01085539|233881|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
100160|NCT01085539|233881|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
100161|NCT01085539|233881|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
100162|NCT01085539|233881|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
100163|NCT01085539|233881|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
100164|NCT01085513|233887|P2|NOT COMPLETED|Overall Study||0
100165|NCT01085513|233888|P1|NOT COMPLETED|Overall Study||0
100166|NCT01085513|233887|P2|COMPLETED|Overall Study||68
100167|NCT01085513|233888|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
100168|NCT01085513|233887|P2|STARTED|Overall Study||68
100169|NCT01085513|233888|P1|STARTED|Overall Study||75
100170|NCT01085500|233896|P2|NOT COMPLETED|Overall Study||0
100171|NCT01085500|233897|P1|NOT COMPLETED|Overall Study||0
100172|NCT01085500|233896|P2|COMPLETED|Overall Study||24
100173|NCT01085500|233897|P1|COMPLETED|Overall Study||26
100174|NCT01085500|233896|P2|STARTED|Overall Study||24
100175|NCT01085500|233897|P1|STARTED|Overall Study||26
100176|NCT01085357|233909|P2|NOT COMPLETED|Overall Study||6
100177|NCT01085357|233910|P1|NOT COMPLETED|Overall Study||19
100178|NCT01085357|233909|P2|COMPLETED|Overall Study||125
100179|NCT01085357|233910|P1|COMPLETED|Overall Study||355
100180|NCT01085357|233909|P2|STARTED|Overall Study||131
100181|NCT01085357|233910|P1|STARTED|Overall Study||374
100182|NCT01085331|233922|P2|NOT COMPLETED|Overall Study||0
100183|NCT01085331|233923|P1|NOT COMPLETED|Overall Study||0
100184|NCT01085331|233922|P2|COMPLETED|Overall Study||6
100185|NCT01085331|233923|P1|COMPLETED|Overall Study||10
100186|NCT01085331|233922|P2|STARTED|Overall Study||6
100187|NCT01085331|233923|P1|STARTED|Overall Study||10
100188|NCT01085318|233962|P2|NOT COMPLETED|Overall Study||0
100189|NCT01085318|233963|P1|NOT COMPLETED|Overall Study||2
100190|NCT01085318|233962|P2|COMPLETED|Overall Study||15
100191|NCT01085318|233963|P1|COMPLETED|Overall Study||21
100192|NCT01085318|233962|P2|STARTED|Overall Study||15
100193|NCT01085318|233963|P1|STARTED|Overall Study||23
100194|NCT01085214|233973|P1|NOT COMPLETED|Overall Study||1
100195|NCT01085214|233973|P1|COMPLETED|Overall Study||36
100196|NCT01085214|233973|P1|STARTED|Overall Study||37
100197|NCT01085201|233985|P5|NOT COMPLETED|Overall Study||0
100198|NCT01085201|233986|P4|NOT COMPLETED|Overall Study||0
100199|NCT01085201|233987|P3|NOT COMPLETED|Overall Study||2
100200|NCT01085201|233988|P2|NOT COMPLETED|Overall Study||1
100201|NCT01085201|233989|P1|NOT COMPLETED|Overall Study||3
100202|NCT01085201|233985|P5|COMPLETED|Overall Study||3
100203|NCT01085201|233986|P4|COMPLETED|Overall Study||6
100204|NCT01085201|233987|P3|COMPLETED|Overall Study||3
100205|NCT01085201|233988|P2|COMPLETED|Overall Study||6
100206|NCT01085201|233989|P1|COMPLETED|Overall Study||15
100207|NCT01085201|233985|P5|STARTED|Overall Study||3
100208|NCT01085201|233986|P4|STARTED|Overall Study||6
100209|NCT01085201|233987|P3|STARTED|Overall Study||5
100210|NCT01085201|233988|P2|STARTED|Overall Study||7
100211|NCT01085201|233989|P1|STARTED|Overall Study||18
100212|NCT01085136|234011|P3|NOT COMPLETED|Part B||26
100213|NCT01085136|234012|P2|NOT COMPLETED|Part B||48
100214|NCT01085136|234013|P1|NOT COMPLETED|Part B||0
100215|NCT01085136|234011|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
100216|NCT01085136|234012|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|86
100217|NCT01085136|234013|P1|COMPLETED|Part B||0
100218|NCT01085136|234011|P3|STARTED|Part B||68
100219|NCT01085136|234012|P2|STARTED|Part B||134
100220|NCT01085136|234013|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
100221|NCT01085136|234011|P3|NOT COMPLETED|Part A||0
100222|NCT01085136|234012|P2|NOT COMPLETED|Part A||0
100223|NCT01085136|234013|P1|NOT COMPLETED|Part A||322
100224|NCT01085136|234011|P3|COMPLETED|Part A||0
100225|NCT01085136|234012|P2|COMPLETED|Part A||0
100226|NCT01085136|234013|P1|COMPLETED|Part A|On-going, progressive disease, clinical progression and discontinued Part A -randomized to Part B|832
100227|NCT01085136|234011|P3|STARTED|Part A||0
100228|NCT01085136|234012|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
100229|NCT01085136|234013|P1|STARTED|Part A||1154
100230|NCT01085006|234028|P2|NOT COMPLETED|Overall Study||0
100231|NCT01085006|234029|P1|NOT COMPLETED|Overall Study||0
100232|NCT01085006|234028|P2|COMPLETED|Overall Study||50
100233|NCT01085006|234029|P1|COMPLETED|Overall Study||50
100234|NCT01085006|234028|P2|STARTED|Overall Study||50
100235|NCT01085006|234029|P1|STARTED|Overall Study||50
100236|NCT01084759|234035|P1|NOT COMPLETED|Overall Study||2
100237|NCT01084759|234035|P1|COMPLETED|Overall Study||14
100238|NCT01084759|234035|P1|STARTED|Overall Study||16
100239|NCT01084707|234041|P1|NOT COMPLETED|Overall Study||6
100240|NCT01084707|234041|P1|COMPLETED|Overall Study||34
100241|NCT01084707|234041|P1|STARTED|Overall Study||40
100242|NCT01084668|234075|P1|NOT COMPLETED|Overall Study||9
100243|NCT01084668|234075|P1|COMPLETED|Overall Study||33
100244|NCT01084668|234075|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
100245|NCT01084603|234084|P1|NOT COMPLETED|Oral Nicotine 4||0
100246|NCT01084603|234084|P1|COMPLETED|Oral Nicotine 4||39
100247|NCT01084603|234084|P1|STARTED|Oral Nicotine 4||39
100248|NCT01084603|234084|P1|NOT COMPLETED|Washout Period 4||1
100249|NCT01084603|234084|P1|COMPLETED|Washout Period 4||39
100250|NCT01084603|234084|P1|STARTED|Washout Period 4||40
100251|NCT01084603|234084|P1|NOT COMPLETED|Oral Nicotine 2||0
100252|NCT01084603|234084|P1|COMPLETED|Oral Nicotine 2||40
100253|NCT01084603|234084|P1|STARTED|Oral Nicotine 2||40
100254|NCT01084603|234084|P1|NOT COMPLETED|Washout Period 3||0
100255|NCT01084603|234084|P1|COMPLETED|Washout Period 3||40
100256|NCT01084603|234084|P1|STARTED|Washout Period 3||40
100257|NCT01084603|234084|P1|NOT COMPLETED|Oral Nicotine 1||1
100258|NCT01084603|234084|P1|COMPLETED|Oral Nicotine 1||40
100259|NCT01084603|234084|P1|STARTED|Oral Nicotine 1||41
100260|NCT01084603|234084|P1|NOT COMPLETED|Washout Period 2||0
100261|NCT01084603|234084|P1|COMPLETED|Washout Period 2||41
100262|NCT01084603|234084|P1|STARTED|Washout Period 2||41
100263|NCT01084603|234084|P1|NOT COMPLETED|Nicorette® Gum||1
100264|NCT01084603|234084|P1|COMPLETED|Nicorette® Gum||41
100265|NCT01084603|234084|P1|STARTED|Nicorette® Gum||42
100266|NCT01084603|234084|P1|NOT COMPLETED|Washout Period 1||0
100267|NCT01084603|234084|P1|COMPLETED|Washout Period 1||42
100268|NCT01084603|234084|P1|STARTED|Washout Period 1||42
100269|NCT01084603|234084|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
100270|NCT01084603|234084|P1|COMPLETED|NiQuitinTM Lozenge||42
100271|NCT01084603|234084|P1|STARTED|NiQuitinTM Lozenge||43
100272|NCT01084603|234084|P1|NOT COMPLETED|Baseline||2
100273|NCT01084603|234084|P1|COMPLETED|Baseline||43
100274|NCT01084603|234084|P1|STARTED|Baseline||45
100275|NCT01084551|234120|P3|NOT COMPLETED|Overall Study||8
100276|NCT01084551|234121|P2|NOT COMPLETED|Overall Study||14
100277|NCT01084551|234122|P1|NOT COMPLETED|Overall Study||9
100278|NCT01084551|234120|P3|COMPLETED|Overall Study||86
100279|NCT01084551|234121|P2|COMPLETED|Overall Study||81
100280|NCT01084551|234122|P1|COMPLETED|Overall Study||86
100281|NCT01084551|234120|P3|STARTED|Overall Study||94
100282|NCT01084551|234121|P2|STARTED|Overall Study||95
100283|NCT01084551|234122|P1|STARTED|Overall Study||95
100284|NCT01084538|234160|P1|NOT COMPLETED|Overall Study||68
100285|NCT01084538|234160|P1|COMPLETED|Overall Study||113
100286|NCT01084538|234160|P1|STARTED|Overall Study||181
100287|NCT01084278|234172|P5|NOT COMPLETED|Overall Study||0
100288|NCT01084278|234173|P4|NOT COMPLETED|Overall Study||0
100289|NCT01084278|234174|P3|NOT COMPLETED|Overall Study||0
100290|NCT01084278|234175|P2|NOT COMPLETED|Overall Study||0
100291|NCT01084278|234176|P1|NOT COMPLETED|Overall Study||0
100292|NCT01084278|234172|P5|COMPLETED|Overall Study||8
100293|NCT01084278|234173|P4|COMPLETED|Overall Study||8
100294|NCT01084278|234174|P3|COMPLETED|Overall Study||8
100295|NCT01084278|234175|P2|COMPLETED|Overall Study||8
100296|NCT01084278|234176|P1|COMPLETED|Overall Study||8
100297|NCT01084278|234172|P5|STARTED|Overall Study||8
100298|NCT01084278|234173|P4|STARTED|Overall Study||8
100299|NCT01084278|234174|P3|STARTED|Overall Study||8
100300|NCT01084278|234175|P2|STARTED|Overall Study||8
100301|NCT01084278|234176|P1|STARTED|Overall Study||8
100302|NCT01084265|234257|P1|NOT COMPLETED|Overall Study||0
100303|NCT01084265|234257|P1|COMPLETED|Overall Study||31
100304|NCT01084265|234257|P1|STARTED|Overall Study||31
100305|NCT01084239|234271|P2|NOT COMPLETED|28-Day Follow-up||9
100306|NCT01084239|234272|P1|NOT COMPLETED|28-Day Follow-up||4
100307|NCT01084239|234271|P2|COMPLETED|28-Day Follow-up||490
100308|NCT01084239|234272|P1|COMPLETED|28-Day Follow-up||497
100309|NCT01084239|234271|P2|STARTED|28-Day Follow-up||499
100310|NCT01084239|234272|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
100311|NCT01084239|234271|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
100312|NCT01084239|234272|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
100313|NCT01084239|234271|P2|COMPLETED|Randomization - Index Hospitalization||499
100314|NCT01084239|234272|P1|COMPLETED|Randomization - Index Hospitalization||501
100315|NCT01084239|234271|P2|STARTED|Randomization - Index Hospitalization||499
100316|NCT01084239|234272|P1|STARTED|Randomization - Index Hospitalization||501
100317|NCT01084148|234290|P2|NOT COMPLETED|Overall Study||16
100318|NCT01084148|234291|P1|NOT COMPLETED|Overall Study||30
100319|NCT01084148|234290|P2|COMPLETED|Overall Study||102
100320|NCT01084148|234291|P1|COMPLETED|Overall Study||88
100321|NCT01084148|234290|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
100322|NCT01084148|234291|P1|STARTED|Overall Study||118
100323|NCT01084135|234301|P2|NOT COMPLETED|20 Week||1
100324|NCT01084135|234302|P1|NOT COMPLETED|20 Week||0
100325|NCT01084135|234301|P2|COMPLETED|20 Week||10
100326|NCT01084135|234302|P1|COMPLETED|20 Week||12
100327|NCT01084135|234301|P2|STARTED|20 Week||11
100328|NCT01084135|234302|P1|STARTED|20 Week||12
100329|NCT01084135|234301|P2|NOT COMPLETED|12 Week||0
100330|NCT01084135|234302|P1|NOT COMPLETED|12 Week||0
100331|NCT01084135|234301|P2|COMPLETED|12 Week||4
100332|NCT01084135|234302|P1|COMPLETED|12 Week||4
100333|NCT01084135|234301|P2|STARTED|12 Week||4
100334|NCT01084135|234302|P1|STARTED|12 Week||4
100335|NCT01084083|234312|P1|NOT COMPLETED|Overall Study||12
100336|NCT01084083|234312|P1|COMPLETED|Overall Study||78
100337|NCT01084083|234312|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
100338|NCT01084083|234312|P1|CR to Induction Therapy|Overall Study||56
100339|NCT01084083|234312|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
100340|NCT01084083|234312|P1|Eligible|Overall Study||81
100341|NCT01084083|234312|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
100342|NCT01084083|234312|P1|STARTED|Overall Study||90
100343|NCT01084005|234320|P2|NOT COMPLETED|Overall Study||16
100344|NCT01084005|234321|P1|NOT COMPLETED|Overall Study||5
100345|NCT01084005|234320|P2|COMPLETED|Overall Study||146
100346|NCT01084005|234321|P1|COMPLETED|Overall Study||74
100347|NCT01084005|234320|P2|STARTED|Overall Study||162
100348|NCT01084005|234321|P1|STARTED|Overall Study||79
100349|NCT01083979|234349|P1|NOT COMPLETED|Overall Study||0
100350|NCT01083979|234349|P1|COMPLETED|Overall Study||1
100351|NCT01083979|234349|P1|STARTED|Overall Study||1
100352|NCT01083901|234357|P3|NOT COMPLETED|Overall Study||2
100353|NCT01083901|234358|P2|NOT COMPLETED|Overall Study||2
100354|NCT01083901|234359|P1|NOT COMPLETED|Overall Study||1
100355|NCT01083901|234357|P3|COMPLETED|Overall Study||11
100356|NCT01083901|234358|P2|COMPLETED|Overall Study||6
100357|NCT01083901|234359|P1|COMPLETED|Overall Study||12
100358|NCT01083901|234357|P3|STARTED|Overall Study||13
100359|NCT01083901|234358|P2|STARTED|Overall Study||8
100360|NCT01083901|234359|P1|STARTED|Overall Study||13
100361|NCT01083849|234378|P2|NOT COMPLETED|Overall Study||111
100362|NCT01083849|234379|P1|NOT COMPLETED|Overall Study||60
100363|NCT01083849|234378|P2|COMPLETED|Overall Study||527
100364|NCT01083849|234379|P1|COMPLETED|Overall Study||61
100365|NCT01083849|234378|P2|STARTED|Overall Study||638
100366|NCT01083849|234379|P1|STARTED|Overall Study||121
100367|NCT01083810|234402|P3|NOT COMPLETED|Overall Study||20
100368|NCT01083810|234403|P2|NOT COMPLETED|Overall Study||45
100369|NCT01083810|234404|P1|NOT COMPLETED|Overall Study||65
100370|NCT01083810|234402|P3|COMPLETED|Overall Study||35
100371|NCT01083810|234403|P2|COMPLETED|Overall Study||47
100372|NCT01083810|234404|P1|COMPLETED|Overall Study||72
100373|NCT01083810|234402|P3|STARTED|Overall Study||55
100374|NCT01083810|234403|P2|STARTED|Overall Study||92
100375|NCT01083810|234404|P1|STARTED|Overall Study||137
100376|NCT01083771|234425|P1|NOT COMPLETED|Overall Study||5
100377|NCT01083771|234425|P1|COMPLETED|Overall Study||16
100378|NCT01083771|234425|P1|STARTED|Overall Study||21
100379|NCT01083758|234430|P1|NOT COMPLETED|Overall Study||2
100380|NCT01083758|234430|P1|COMPLETED|Overall Study||29
100381|NCT01083758|234430|P1|STARTED|Overall Study||31
100382|NCT01083732|234464|P3|NOT COMPLETED|Overall Study||0
100383|NCT01083732|234465|P2|NOT COMPLETED|Overall Study||0
100384|NCT01083732|234466|P1|NOT COMPLETED|Overall Study||0
100385|NCT01083732|234464|P3|COMPLETED|Overall Study||3
100386|NCT01083732|234465|P2|COMPLETED|Overall Study||9
100387|NCT01083732|234466|P1|COMPLETED|Overall Study||6
100388|NCT01083732|234464|P3|STARTED|Overall Study||3
100389|NCT01083732|234465|P2|STARTED|Overall Study||9
100390|NCT01083732|234466|P1|STARTED|Overall Study||6
100391|NCT01083693|234520|P3|NOT COMPLETED|Overall Study||7
100392|NCT01083693|234521|P2|NOT COMPLETED|Overall Study||6
100393|NCT01083693|234522|P1|NOT COMPLETED|Overall Study||20
100394|NCT01083693|234520|P3|COMPLETED|Overall Study||33
100395|NCT01083693|234521|P2|COMPLETED|Overall Study||22
100396|NCT01083693|234522|P1|COMPLETED|Overall Study||73
100397|NCT01083693|234520|P3|STARTED|Overall Study||40
100398|NCT01083693|234521|P2|STARTED|Overall Study||28
100399|NCT01083693|234522|P1|STARTED|Overall Study||93
100400|NCT01083654|234559|P2|NOT COMPLETED|Overall Study||0
100401|NCT01083654|234560|P1|NOT COMPLETED|Overall Study||0
100402|NCT01083654|234559|P2|COMPLETED|Overall Study||50
100403|NCT01083654|234560|P1|COMPLETED|Overall Study||53
100404|NCT01083654|234559|P2|STARTED|Overall Study||50
100405|NCT01083654|234560|P1|STARTED|Overall Study||53
100406|NCT01083602|234566|P1|NOT COMPLETED|Overall Study||55
100407|NCT01083602|234566|P1|COMPLETED|Overall Study||0
100408|NCT01083602|234566|P1|STARTED|Overall Study||55
100409|NCT01083576|234577|P2|NOT COMPLETED|Overall Study||1
100410|NCT01083576|234578|P1|NOT COMPLETED|Overall Study||6
100411|NCT01083576|234577|P2|COMPLETED|Overall Study||14
100412|NCT01083576|234578|P1|COMPLETED|Overall Study||9
100413|NCT01083576|234577|P2|STARTED|Overall Study||15
100414|NCT01083576|234578|P1|STARTED|Overall Study||15
100415|NCT01083485|234608|P2|NOT COMPLETED|Overall Study||3
100416|NCT01083485|234609|P1|NOT COMPLETED|Overall Study||7
100417|NCT01083485|234608|P2|COMPLETED|Overall Study||64
100418|NCT01083485|234609|P1|COMPLETED|Overall Study||63
100419|NCT01083485|234608|P2|STARTED|Overall Study||67
100420|NCT01083485|234609|P1|STARTED|Overall Study||70
100421|NCT01083472|234619|P2|NOT COMPLETED|Overall Study||0
100422|NCT01083472|234620|P1|NOT COMPLETED|Overall Study||0
100423|NCT01083472|234619|P2|COMPLETED|Overall Study||19
100424|NCT01083472|234620|P1|COMPLETED|Overall Study||18
100425|NCT01083472|234619|P2|STARTED|Overall Study||19
100426|NCT01083472|234620|P1|STARTED|Overall Study||18
100427|NCT01083316|234626|P1|NOT COMPLETED|Overall Study||3
100428|NCT01083316|234626|P1|COMPLETED|Overall Study||32
100429|NCT01083316|234626|P1|STARTED|Overall Study||35
100430|NCT01083199|234632|P1|NOT COMPLETED|Overall Study||0
100431|NCT01083199|234632|P1|COMPLETED|Overall Study||10
100432|NCT01083199|234632|P1|STARTED|Overall Study||10
100433|NCT01083186|234637|P1|NOT COMPLETED|Overall Study||94
100434|NCT01083186|234637|P1|COMPLETED|Overall Study||406
100435|NCT01083186|234637|P1|STARTED|Overall Study||500
100436|NCT01083173|234678|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
100437|NCT01083173|234679|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
100438|NCT01083173|234678|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
100439|NCT01083173|234679|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
100440|NCT01083173|234678|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
100441|NCT01083173|234679|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
100442|NCT01083173|234678|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
100443|NCT01083173|234679|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
100444|NCT01083173|234678|P2|COMPLETED|Long-term Surveillance: Safety Group||479
100445|NCT01083173|234679|P1|COMPLETED|Long-term Surveillance: Safety Group||0
100446|NCT01083173|234678|P2|STARTED|Long-term Surveillance: Safety Group||595
100447|NCT01083173|234679|P1|STARTED|Long-term Surveillance: Safety Group||0
100448|NCT01083173|234678|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
100449|NCT01083173|234679|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
100450|NCT01083173|234678|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
100451|NCT01083173|234679|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
100452|NCT01083173|234678|P2|STARTED|Main Surveillance: Effectiveness Group||0
100453|NCT01083173|234679|P1|STARTED|Main Surveillance: Effectiveness Group||580
100454|NCT01083173|234678|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
100455|NCT01083173|234679|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
100456|NCT01083173|234678|P2|COMPLETED|Main Surveillance: Safety Group||0
100457|NCT01083173|234679|P1|COMPLETED|Main Surveillance: Safety Group||580
100458|NCT01083173|234678|P2|STARTED|Main Surveillance: Safety Group||0
100459|NCT01083173|234679|P1|STARTED|Main Surveillance: Safety Group||595
100460|NCT01083160|234697|P1|NOT COMPLETED|Overall Study||1
100461|NCT01083160|234697|P1|COMPLETED|Overall Study||81
100462|NCT01083160|234697|P1|Evaluable Population|Overall Study||71
100463|NCT01083160|234697|P1|STARTED|Overall Study||82
100464|NCT01083121|234704|P1|NOT COMPLETED|Overall Study||81
100465|NCT01083121|234704|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
100466|NCT01083121|234704|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
100467|NCT01082965|234714|P2|NOT COMPLETED|Overall Study||2
100468|NCT01082965|234715|P1|NOT COMPLETED|Overall Study||1
100469|NCT01082965|234714|P2|COMPLETED|Overall Study||6
100470|NCT01082965|234715|P1|COMPLETED|Overall Study||9
100471|NCT01082965|234714|P2|STARTED|Overall Study||8
100472|NCT01082965|234715|P1|STARTED|Overall Study||10
100473|NCT01082952|234735|P2|NOT COMPLETED|Overall Study||0
100474|NCT01082952|234736|P1|NOT COMPLETED|Overall Study||0
100475|NCT01082952|234735|P2|COMPLETED|Overall Study||6
100476|NCT01082952|234736|P1|COMPLETED|Overall Study||6
100477|NCT01082952|234735|P2|STARTED|Overall Study||6
100478|NCT01082952|234736|P1|STARTED|Overall Study||6
100479|NCT01082939|234744|P1|NOT COMPLETED|Overall Study||0
100480|NCT01082939|234744|P1|COMPLETED|Overall Study||80
100481|NCT01082939|234744|P1|STARTED|Overall Study||80
100482|NCT01082874|234752|P4|NOT COMPLETED|Overall Study||13
100483|NCT01082874|234753|P3|NOT COMPLETED|Overall Study||11
100484|NCT01082874|234754|P2|NOT COMPLETED|Overall Study||12
100485|NCT01082874|234755|P1|NOT COMPLETED|Overall Study||11
100486|NCT01082874|234752|P4|COMPLETED|Overall Study||2489
100487|NCT01082874|234753|P3|COMPLETED|Overall Study||2488
100488|NCT01082874|234754|P2|COMPLETED|Overall Study||2498
100489|NCT01082874|234755|P1|COMPLETED|Overall Study||2488
100490|NCT01082874|234752|P4|STARTED|Overall Study||2502
100491|NCT01082874|234753|P3|STARTED|Overall Study||2499
100492|NCT01082874|234754|P2|STARTED|Overall Study||2510
100493|NCT01082874|234755|P1|STARTED|Overall Study||2499
100494|NCT01082640|234768|P3|NOT COMPLETED|Overall Study||8
100495|NCT01082640|234769|P2|NOT COMPLETED|Overall Study||15
100496|NCT01082640|234770|P1|NOT COMPLETED|Overall Study||17
100497|NCT01082640|234768|P3|COMPLETED|Overall Study||24
100498|NCT01082640|234769|P2|COMPLETED|Overall Study||17
100499|NCT01082640|234770|P1|COMPLETED|Overall Study||15
100500|NCT01082640|234768|P3|STARTED|Overall Study||32
100501|NCT01082640|234769|P2|STARTED|Overall Study||32
100502|NCT01082640|234770|P1|STARTED|Overall Study||32
100503|NCT01082614|234792|P2|NOT COMPLETED|Overall Study||5
100504|NCT01082614|234793|P1|NOT COMPLETED|Overall Study||3
100505|NCT01082614|234792|P2|COMPLETED|Overall Study||18
100506|NCT01082614|234793|P1|COMPLETED|Overall Study||20
100507|NCT01082614|234792|P2|STARTED|Overall Study||23
100508|NCT01082614|234793|P1|STARTED|Overall Study||23
100509|NCT01082588|234801|P2|NOT COMPLETED|Overall Study||5
100510|NCT01082588|234802|P1|NOT COMPLETED|Overall Study||6
100511|NCT01082588|234801|P2|COMPLETED|Overall Study||25
100512|NCT01082588|234802|P1|COMPLETED|Overall Study||24
100513|NCT01082588|234801|P2|STARTED|Overall Study||30
100514|NCT01082588|234802|P1|STARTED|Overall Study||30
100515|NCT01082575|234820|P1|NOT COMPLETED|Overall Study||0
100516|NCT01082575|234820|P1|COMPLETED|Overall Study||100
100517|NCT01082575|234820|P1|STARTED|Overall Study||100
100518|NCT01082380|234825|P1|NOT COMPLETED|Overall Study||0
100519|NCT01082380|234825|P1|COMPLETED|Overall Study||6
100520|NCT01082380|234825|P1|STARTED|Overall Study||6
100521|NCT01082367|234860|P2|NOT COMPLETED|Follow-up (F-U) Period||1
100522|NCT01082367|234861|P1|NOT COMPLETED|Follow-up (F-U) Period||2
100523|NCT01082367|234860|P2|COMPLETED|Follow-up (F-U) Period||9
100524|NCT01082367|234861|P1|COMPLETED|Follow-up (F-U) Period||17
100525|NCT01082367|234860|P2|Treated in F-U|Follow-up (F-U) Period||5
100526|NCT01082367|234861|P1|Treated in F-U|Follow-up (F-U) Period||5
100527|NCT01082367|234860|P2|STARTED|Follow-up (F-U) Period||10
100528|NCT01082367|234861|P1|STARTED|Follow-up (F-U) Period||19
100529|NCT01082367|234860|P2|NOT COMPLETED|Double-blind Period||13
100530|NCT01082367|234861|P1|NOT COMPLETED|Double-blind Period||5
100531|NCT01082367|234860|P2|COMPLETED|Double-blind Period||12
100532|NCT01082367|234861|P1|COMPLETED|Double-blind Period||21
100533|NCT01082367|234860|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
100534|NCT01082367|234861|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
100535|NCT01082367|234860|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
100536|NCT01082367|234861|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
100537|NCT01082367|234860|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
100538|NCT01082367|234861|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
100539|NCT01082367|234860|P2|Entered OL TOBI|Double-blind Period||18
100540|NCT01082367|234861|P1|Entered OL TOBI|Double-blind Period||4
100541|NCT01082367|234860|P2|Stage 2:no tx|Double-blind Period||0
100542|NCT01082367|234861|P1|Stage 2:no tx|Double-blind Period||0
100543|NCT01082367|234860|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
100544|NCT01082367|234861|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
100545|NCT01082367|234860|P2|STARTED|Double-blind Period||25
100546|NCT01082367|234861|P1|STARTED|Double-blind Period||26
100547|NCT01082328|234875|P1|NOT COMPLETED|Overall Study||1
100548|NCT01082328|234875|P1|COMPLETED|Overall Study||58
100549|NCT01082328|234875|P1|STARTED|Overall Study||59
100550|NCT01082159|234884|P1|NOT COMPLETED|Overall Study||9
100551|NCT01082159|234884|P1|COMPLETED|Overall Study||46
100552|NCT01082159|234884|P1|STARTED|Overall Study||55
100553|NCT01082081|234893|P3|NOT COMPLETED|Overall Study||2
100554|NCT01082081|234894|P2|NOT COMPLETED|Overall Study||1
100555|NCT01082081|234895|P1|NOT COMPLETED|Overall Study||0
100556|NCT01082081|234893|P3|COMPLETED|Overall Study||58
100557|NCT01082081|234894|P2|COMPLETED|Overall Study||118
100558|NCT01082081|234895|P1|COMPLETED|Overall Study||121
100559|NCT01082081|234893|P3|STARTED|Overall Study||60
100560|NCT01082081|234894|P2|STARTED|Overall Study||119
100561|NCT01082081|234895|P1|STARTED|Overall Study||121
100562|NCT01081951|234947|P2|NOT COMPLETED|Overall Study||55
100563|NCT01081951|234948|P1|NOT COMPLETED|Overall Study||56
100564|NCT01081951|234947|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
100565|NCT01081951|234948|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
100566|NCT01081951|234947|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
100567|NCT01081951|234948|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
100568|NCT01081951|234947|P2|Entered Maintenance Phase|Overall Study||55
100569|NCT01081951|234948|P1|Entered Maintenance Phase|Overall Study||66
100570|NCT01081951|234947|P2|Received Study Treatment|Overall Study||75
100571|NCT01081951|234948|P1|Received Study Treatment|Overall Study||81
100572|NCT01081951|234947|P2|STARTED|Overall Study||81
100573|NCT01081951|234948|P1|STARTED|Overall Study||81
100574|NCT01081912|234958|P3|NOT COMPLETED|Maintenance Treatment||92
100575|NCT01081912|234959|P2|NOT COMPLETED|Maintenance Treatment||27
100576|NCT01081912|234960|P1|NOT COMPLETED|Maintenance Treatment||0
100577|NCT01081912|234958|P3|COMPLETED|Maintenance Treatment||59
100578|NCT01081912|234959|P2|COMPLETED|Maintenance Treatment||124
100579|NCT01081912|234960|P1|COMPLETED|Maintenance Treatment||0
100580|NCT01081912|234958|P3|STARTED|Maintenance Treatment||151
100581|NCT01081912|234959|P2|STARTED|Maintenance Treatment||151
100582|NCT01081912|234960|P1|STARTED|Maintenance Treatment||0
100583|NCT01081912|234958|P3|NOT COMPLETED|Conversion/Titration||0
100584|NCT01081912|234959|P2|NOT COMPLETED|Conversion/Titration||0
100585|NCT01081912|234960|P1|NOT COMPLETED|Conversion/Titration||208
100586|NCT01081912|234958|P3|COMPLETED|Conversion/Titration||0
100587|NCT01081912|234959|P2|COMPLETED|Conversion/Titration||0
100588|NCT01081912|234960|P1|COMPLETED|Conversion/Titration||302
100589|NCT01081912|234958|P3|STARTED|Conversion/Titration||0
100590|NCT01081912|234959|P2|STARTED|Conversion/Titration||0
100591|NCT01081912|234960|P1|STARTED|Conversion/Titration||510
100592|NCT01081886|234969|P2|NOT COMPLETED|Overall Study||13
100593|NCT01081886|234970|P1|NOT COMPLETED|Overall Study||11
100594|NCT01081886|234969|P2|COMPLETED|Overall Study||0
100595|NCT01081886|234970|P1|COMPLETED|Overall Study||0
100596|NCT01081886|234969|P2|STARTED|Overall Study||13
100597|NCT01081886|234970|P1|STARTED|Overall Study||11
100598|NCT01081873|234978|P1|NOT COMPLETED|Overall Study||298
100599|NCT01081873|234978|P1|COMPLETED|Overall Study||2416
100600|NCT01081873|234978|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
100601|NCT01081834|235050|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
100602|NCT01081834|235051|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
100603|NCT01081834|235052|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
100604|NCT01081834|235053|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
100605|NCT01081834|235054|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
100606|NCT01081834|235050|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
100607|NCT01081834|235051|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
100608|NCT01081834|235052|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
100609|NCT01081834|235053|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
100610|NCT01081834|235054|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
100611|NCT01081834|235050|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
100612|NCT01081834|235051|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
100613|NCT01081834|235052|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
100614|NCT01081834|235053|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
100615|NCT01081834|235054|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
100616|NCT01081834|235050|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
100617|NCT01081834|235051|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
100618|NCT01081834|235052|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
100619|NCT01081834|235053|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
100620|NCT01081834|235054|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
100621|NCT01081834|235050|P5|COMPLETED|Core Period: Baseline to Week 26||40
100622|NCT01081834|235051|P4|COMPLETED|Core Period: Baseline to Week 26||40
100623|NCT01081834|235052|P3|COMPLETED|Core Period: Baseline to Week 26||175
100624|NCT01081834|235053|P2|COMPLETED|Core Period: Baseline to Week 26||172
100625|NCT01081834|235054|P1|COMPLETED|Core Period: Baseline to Week 26||160
100626|NCT01081834|235050|P5|STARTED|Core Period: Baseline to Week 26||44
100627|NCT01081834|235051|P4|STARTED|Core Period: Baseline to Week 26||47
100628|NCT01081834|235052|P3|STARTED|Core Period: Baseline to Week 26||197
100629|NCT01081834|235053|P2|STARTED|Core Period: Baseline to Week 26||195
100630|NCT01081834|235054|P1|STARTED|Core Period: Baseline to Week 26||192
100631|NCT01081795|235115|P3|NOT COMPLETED|Overall Study||30
100632|NCT01081795|235116|P2|NOT COMPLETED|Overall Study||35
100633|NCT01081795|235117|P1|NOT COMPLETED|Overall Study||33
100634|NCT01081795|235115|P3|COMPLETED|Overall Study||97
100635|NCT01081795|235116|P2|COMPLETED|Overall Study||95
100636|NCT01081795|235117|P1|COMPLETED|Overall Study||97
100637|NCT01081795|235115|P3|STARTED|Overall Study||127
100638|NCT01081795|235116|P2|STARTED|Overall Study||130
100639|NCT01081795|235117|P1|STARTED|Overall Study||130
100640|NCT01081769|235154|P2|NOT COMPLETED|CORE Intent-To-Treat||97
100641|NCT01081769|235155|P1|NOT COMPLETED|CORE Intent-To-Treat||80
100642|NCT01081769|235154|P2|COMPLETED|CORE Intent-To-Treat||266
100643|NCT01081769|235155|P1|COMPLETED|CORE Intent-To-Treat||272
100644|NCT01081769|235154|P2|STARTED|CORE Intent-To-Treat||363
100645|NCT01081769|235155|P1|STARTED|CORE Intent-To-Treat||352
100646|NCT01081769|235154|P2|NOT COMPLETED|Whole Intent-to-Treat||25
100647|NCT01081769|235155|P1|NOT COMPLETED|Whole Intent-to-Treat||24
100648|NCT01081769|235154|P2|COMPLETED|Whole Intent-to-Treat||363
100649|NCT01081769|235155|P1|COMPLETED|Whole Intent-to-Treat||352
100650|NCT01081769|235154|P2|STARTED|Whole Intent-to-Treat||388
100651|NCT01081769|235155|P1|STARTED|Whole Intent-to-Treat||376
100652|NCT01081665|235189|P1|NOT COMPLETED|Overall Study||95
100653|NCT01081665|235189|P1|COMPLETED|Overall Study||142
100654|NCT01081665|235189|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
100655|NCT01081665|235189|P1|Full Analysis Set|Overall Study||237
100656|NCT01081665|235189|P1|STARTED|Overall Study||237
100657|NCT01081626|235201|P2|NOT COMPLETED|Overall Study||61
100658|NCT01081626|235202|P1|NOT COMPLETED|Overall Study||60
100659|NCT01081626|235201|P2|COMPLETED|Overall Study||94
100660|NCT01081626|235202|P1|COMPLETED|Overall Study||95
100661|NCT01081626|235201|P2|Assessed for Efficacy|Overall Study||125
100662|NCT01081626|235202|P1|Assessed for Efficacy|Overall Study||122
100663|NCT01081626|235201|P2|STARTED|Overall Study||155
100664|NCT01081626|235202|P1|STARTED|Overall Study||155
100665|NCT01081301|235228|P1|NOT COMPLETED|Overall Study||14
100666|NCT01081301|235228|P1|COMPLETED|Overall Study||22
100667|NCT01081301|235228|P1|STARTED|Overall Study||36
100668|NCT01081249|235266|P2|NOT COMPLETED|Overall Study||1
100669|NCT01081249|235267|P1|NOT COMPLETED|Overall Study||0
100670|NCT01081249|235266|P2|COMPLETED|Overall Study||6
100671|NCT01081249|235267|P1|COMPLETED|Overall Study||11
100672|NCT01081249|235266|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
100673|NCT01081249|235267|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
100674|NCT01081249|235266|P2|Washout (5-10 Days)|Overall Study||6
100675|NCT01081249|235267|P1|Washout (5-10 Days)|Overall Study||11
100676|NCT01081249|235266|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
100677|NCT01081249|235267|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
100678|NCT01081249|235266|P2|STARTED|Overall Study||7
100679|NCT01081249|235267|P1|STARTED|Overall Study||11
100680|NCT01081145|235273|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
100681|NCT01081145|235274|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
100682|NCT01081145|235273|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
100683|NCT01081145|235274|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
100684|NCT01081145|235273|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
100685|NCT01081145|235274|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
100686|NCT01081145|235273|P2|NOT COMPLETED|Open-Label Phase||0
100687|NCT01081145|235274|P1|NOT COMPLETED|Open-Label Phase||212
100688|NCT01081145|235273|P2|COMPLETED|Open-Label Phase||0
100689|NCT01081145|235274|P1|COMPLETED|Open-Label Phase||316
100690|NCT01081145|235273|P2|STARTED|Open-Label Phase||0
100691|NCT01081145|235274|P1|STARTED|Open-Label Phase||528
100692|NCT01081132|235302|P2|NOT COMPLETED|Overall Study||52
100693|NCT01081132|235303|P1|NOT COMPLETED|Overall Study||55
100694|NCT01081132|235302|P2|COMPLETED|Overall Study||105
100695|NCT01081132|235303|P1|COMPLETED|Overall Study||102
100696|NCT01081132|235302|P2|STARTED|Overall Study||157
100697|NCT01081132|235303|P1|STARTED|Overall Study||157
100698|NCT01081041|235344|P3|NOT COMPLETED|Overall Study||2
100699|NCT01081041|235345|P2|NOT COMPLETED|Overall Study||4
100700|NCT01081041|235346|P1|NOT COMPLETED|Overall Study||0
100701|NCT01081041|235344|P3|COMPLETED|Overall Study||71
100702|NCT01081041|235345|P2|COMPLETED|Overall Study||77
100703|NCT01081041|235346|P1|COMPLETED|Overall Study||33
100704|NCT01081041|235344|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
100705|NCT01081041|235345|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
100706|NCT01081041|235346|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
100707|NCT01081041|235344|P3|STARTED|Overall Study||73
100708|NCT01081041|235345|P2|STARTED|Overall Study||81
100709|NCT01081041|235346|P1|STARTED|Overall Study||33
100710|NCT01080807|235376|P2|NOT COMPLETED|Overall Study||23
100711|NCT01080807|235377|P1|NOT COMPLETED|Overall Study||35
100712|NCT01080807|235376|P2|COMPLETED|Overall Study||167
100713|NCT01080807|235377|P1|COMPLETED|Overall Study||158
100714|NCT01080807|235376|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
100715|NCT01080807|235377|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
100716|NCT01080768|235433|P2|NOT COMPLETED|Overall Study||1
100717|NCT01080768|235434|P1|NOT COMPLETED|Overall Study||2
100718|NCT01080768|235433|P2|COMPLETED|Overall Study||16
100719|NCT01080768|235434|P1|COMPLETED|Overall Study||12
100720|NCT01080768|235433|P2|STARTED|Overall Study||17
100721|NCT01080768|235434|P1|STARTED|Overall Study||14
100722|NCT01080625|235443|P3|NOT COMPLETED|Overall Study||1
100723|NCT01080625|235444|P2|NOT COMPLETED|Overall Study||2
100724|NCT01080625|235445|P1|NOT COMPLETED|Overall Study||0
100725|NCT01080625|235443|P3|COMPLETED|Overall Study||31
100726|NCT01080625|235444|P2|COMPLETED|Overall Study||31
100727|NCT01080625|235445|P1|COMPLETED|Overall Study||31
100728|NCT01080625|235443|P3|STARTED|Overall Study||32
100729|NCT01080625|235444|P2|STARTED|Overall Study||33
100730|NCT01080625|235445|P1|STARTED|Overall Study||31
100731|NCT01080391|235455|P2|NOT COMPLETED|Overall Study||13
100732|NCT01080391|235456|P1|NOT COMPLETED|Overall Study||23
100733|NCT01080391|235455|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
100734|NCT01080391|235456|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
100735|NCT01080391|235455|P2|Treated|Overall Study||392
100736|NCT01080391|235456|P1|Treated|Overall Study||389
100737|NCT01080391|235455|P2|STARTED|Overall Study||396
100738|NCT01080391|235456|P1|STARTED|Overall Study||396
100739|NCT01080326|235474|P1|NOT COMPLETED|Overall Study||4
100740|NCT01080326|235474|P1|COMPLETED|Overall Study||3
100741|NCT01080326|235474|P1|STARTED|Overall Study||7
100742|NCT01080300|235480|P2|NOT COMPLETED|Overall Study||104
100743|NCT01080300|235481|P1|NOT COMPLETED|Overall Study||94
100744|NCT01080300|235480|P2|COMPLETED|Overall Study||191
100745|NCT01080300|235481|P1|COMPLETED|Overall Study||206
100746|NCT01080300|235480|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
100747|NCT01080300|235481|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
100748|NCT01080261|235489|P1|NOT COMPLETED|Overall Study||0
100749|NCT01080261|235489|P1|COMPLETED|Overall Study||60
100750|NCT01080261|235489|P1|STARTED|Overall Study||60
100751|NCT01080248|235504|P1|NOT COMPLETED|Overall Study||0
100752|NCT01080248|235504|P1|COMPLETED|Overall Study||2
100753|NCT01080248|235504|P1|STARTED|Overall Study||2
100754|NCT01080209|235518|P7|NOT COMPLETED|Overall Study||7
100755|NCT01080209|235519|P6|NOT COMPLETED|Overall Study||0
100756|NCT01080209|235520|P5|NOT COMPLETED|Overall Study||0
100757|NCT01080209|235521|P4|NOT COMPLETED|Overall Study||5
100758|NCT01080209|235522|P3|NOT COMPLETED|Overall Study||5
100759|NCT01080209|235523|P2|NOT COMPLETED|Overall Study||11
100760|NCT01080209|235524|P1|NOT COMPLETED|Overall Study||6
100761|NCT01080209|235518|P7|COMPLETED|Overall Study||44
100762|NCT01080209|235519|P6|COMPLETED|Overall Study||2
100763|NCT01080209|235520|P5|COMPLETED|Overall Study||6
100764|NCT01080209|235521|P4|COMPLETED|Overall Study||37
100765|NCT01080209|235522|P3|COMPLETED|Overall Study||28
100766|NCT01080209|235523|P2|COMPLETED|Overall Study||42
100767|NCT01080209|235524|P1|COMPLETED|Overall Study||22
100768|NCT01080209|235518|P7|STARTED|Overall Study||51
100769|NCT01080209|235519|P6|STARTED|Overall Study||2
100770|NCT01080209|235520|P5|STARTED|Overall Study||6
100771|NCT01080209|235521|P4|STARTED|Overall Study||42
100772|NCT01080209|235522|P3|STARTED|Overall Study||33
100773|NCT01080209|235523|P2|STARTED|Overall Study||53
100774|NCT01080209|235524|P1|STARTED|Overall Study||28
100775|NCT01080131|235549|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
100776|NCT01080131|235550|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
100777|NCT01080131|235549|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
100778|NCT01080131|235550|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
100779|NCT01080131|235549|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
100780|NCT01080131|235550|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
100781|NCT01080131|235549|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
100782|NCT01080131|235550|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
100783|NCT01080131|235549|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
100784|NCT01080131|235550|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
100785|NCT01080131|235549|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
100786|NCT01080131|235550|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
100787|NCT01080131|235549|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
100788|NCT01080131|235550|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
100789|NCT01080131|235549|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
100790|NCT01080131|235550|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
100791|NCT01080131|235549|P2|COMPLETED|Core Study (0- 12 Weeks)||103
100792|NCT01080131|235550|P1|COMPLETED|Core Study (0- 12 Weeks)||99
100793|NCT01080131|235549|P2|STARTED|Core Study (0- 12 Weeks)||114
100794|NCT01080131|235550|P1|STARTED|Core Study (0- 12 Weeks)||112
100795|NCT01080118|235629|P4|NOT COMPLETED|Overall Study||0
100796|NCT01080118|235630|P3|NOT COMPLETED|Overall Study||0
100797|NCT01080118|235631|P2|NOT COMPLETED|Overall Study||0
100798|NCT01080118|235632|P1|NOT COMPLETED|Overall Study||0
100799|NCT01080118|235629|P4|COMPLETED|Overall Study||30
100800|NCT01080118|235630|P3|COMPLETED|Overall Study||30
100801|NCT01080118|235631|P2|COMPLETED|Overall Study||15
100802|NCT01080118|235632|P1|COMPLETED|Overall Study||15
100803|NCT01080118|235629|P4|STARTED|Overall Study||30
100804|NCT01080118|235630|P3|STARTED|Overall Study||30
100805|NCT01080118|235631|P2|STARTED|Overall Study||15
100806|NCT01080118|235632|P1|STARTED|Overall Study||15
100807|NCT01079988|235645|P5|NOT COMPLETED|Overall Study||1
100808|NCT01079988|235646|P4|NOT COMPLETED|Overall Study||3
100809|NCT01079988|235647|P3|NOT COMPLETED|Overall Study||0
100810|NCT01079988|235648|P2|NOT COMPLETED|Overall Study||0
100811|NCT01079988|235649|P1|NOT COMPLETED|Overall Study||1
100812|NCT01079988|235645|P5|COMPLETED|Overall Study||1
100813|NCT01079988|235646|P4|COMPLETED|Overall Study||17
100814|NCT01079988|235647|P3|COMPLETED|Overall Study||8
100815|NCT01079988|235648|P2|COMPLETED|Overall Study||1
100816|NCT01079988|235649|P1|COMPLETED|Overall Study||9
100817|NCT01079988|235645|P5|STARTED|Overall Study||2
100818|NCT01079988|235646|P4|STARTED|Overall Study||20
100819|NCT01079988|235647|P3|STARTED|Overall Study||8
100820|NCT01079988|235648|P2|STARTED|Overall Study||1
100821|NCT01079988|235649|P1|STARTED|Overall Study||10
100822|NCT01079962|235668|P2|NOT COMPLETED|Overall Study||15
100823|NCT01079962|235669|P1|NOT COMPLETED|Overall Study||15
100824|NCT01079962|235668|P2|COMPLETED|Overall Study||89
100825|NCT01079962|235669|P1|COMPLETED|Overall Study||90
100826|NCT01079962|235668|P2|STARTED|Overall Study||104
100827|NCT01079962|235669|P1|STARTED|Overall Study||105
100828|NCT01079949|235697|P2|NOT COMPLETED|Overall Study||13
100829|NCT01079949|235698|P1|NOT COMPLETED|Overall Study||15
100830|NCT01079949|235697|P2|COMPLETED|Overall Study||34
100831|NCT01079949|235698|P1|COMPLETED|Overall Study||31
100832|NCT01079949|235697|P2|STARTED|Overall Study||47
100833|NCT01079949|235698|P1|STARTED|Overall Study||46
100834|NCT01079936|235744|P5|NOT COMPLETED|Phase II||1
100835|NCT01079936|235745|P4|NOT COMPLETED|Phase II||0
100836|NCT01079936|235746|P3|NOT COMPLETED|Phase II||1
100837|NCT01079936|235747|P2|NOT COMPLETED|Phase II||0
100838|NCT01079936|235748|P1|NOT COMPLETED|Phase II||0
100839|NCT01079936|235744|P5|COMPLETED|Phase II||25
100840|NCT01079936|235745|P4|COMPLETED|Phase II||24
100841|NCT01079936|235746|P3|COMPLETED|Phase II||5
100842|NCT01079936|235747|P2|COMPLETED|Phase II||3
100843|NCT01079936|235748|P1|COMPLETED|Phase II||0
100844|NCT01079936|235744|P5|STARTED|Phase II||26
100845|NCT01079936|235745|P4|STARTED|Phase II||24
100846|NCT01079936|235746|P3|STARTED|Phase II||6
100847|NCT01079936|235747|P2|STARTED|Phase II||3
100848|NCT01079936|235748|P1|STARTED|Phase II||0
100849|NCT01079936|235744|P5|NOT COMPLETED|Phase I: MTD||0
100850|NCT01079936|235745|P4|NOT COMPLETED|Phase I: MTD||0
100851|NCT01079936|235746|P3|NOT COMPLETED|Phase I: MTD||0
100852|NCT01079936|235747|P2|NOT COMPLETED|Phase I: MTD||0
100853|NCT01079936|235748|P1|NOT COMPLETED|Phase I: MTD||4
100854|NCT01079936|235744|P5|COMPLETED|Phase I: MTD||0
100855|NCT01079936|235745|P4|COMPLETED|Phase I: MTD||0
100856|NCT01079936|235746|P3|COMPLETED|Phase I: MTD||0
100857|NCT01079936|235747|P2|COMPLETED|Phase I: MTD||0
100858|NCT01079936|235748|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
100859|NCT01079936|235744|P5|STARTED|Phase I: MTD||0
100860|NCT01079936|235745|P4|STARTED|Phase I: MTD||0
100861|NCT01079936|235746|P3|STARTED|Phase I: MTD||0
100862|NCT01079936|235747|P2|STARTED|Phase I: MTD||0
100863|NCT01079936|235748|P1|STARTED|Phase I: MTD||16
100864|NCT01079832|235767|P1|NOT COMPLETED|Overall Study||1
100865|NCT01079832|235767|P1|COMPLETED|Overall Study||49
100866|NCT01079832|235767|P1|STARTED|Overall Study||50
100867|NCT01079806|235777|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
100868|NCT01079806|235778|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
100869|NCT01079806|235777|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
100870|NCT01079806|235778|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
100871|NCT01079806|235777|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
100872|NCT01079806|235778|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
100873|NCT01079806|235777|P2|NOT COMPLETED|Day 1 to Week 96||4
100874|NCT01079806|235778|P1|NOT COMPLETED|Day 1 to Week 96||4
100875|NCT01079806|235777|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
100876|NCT01079806|235778|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
100877|NCT01079806|235777|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
100878|NCT01079806|235778|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
100879|NCT01079806|235777|P2|Received Treatment|Day 1 to Week 96||60
100880|NCT01079806|235778|P1|Received Treatment|Day 1 to Week 96||120
100881|NCT01079806|235777|P2|STARTED|Day 1 to Week 96|Randomized|60
100882|NCT01079806|235778|P1|STARTED|Day 1 to Week 96|Randomized|120
100883|NCT01079299|235800|P2|NOT COMPLETED|Overall Study||0
100884|NCT01079299|235801|P1|NOT COMPLETED|Overall Study||0
100885|NCT01079299|235800|P2|COMPLETED|Overall Study||25
100886|NCT01079299|235801|P1|COMPLETED|Overall Study||27
100887|NCT01079299|235800|P2|STARTED|Overall Study||25
100888|NCT01079299|235801|P1|STARTED|Overall Study||27
100889|NCT01079234|235810|P4|NOT COMPLETED|Extension: Week 27 to 52||16
100890|NCT01079234|235811|P3|NOT COMPLETED|Extension: Week 27 to 52||11
100891|NCT01079234|235812|P2|NOT COMPLETED|Extension: Week 27 to 52||0
100892|NCT01079234|235813|P1|NOT COMPLETED|Extension: Week 27 to 52||0
100893|NCT01079234|235810|P4|COMPLETED|Extension: Week 27 to 52||223
100894|NCT01079234|235811|P3|COMPLETED|Extension: Week 27 to 52||122
100895|NCT01079234|235812|P2|COMPLETED|Extension: Week 27 to 52||0
100896|NCT01079234|235813|P1|COMPLETED|Extension: Week 27 to 52||0
100897|NCT01079234|235810|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
100898|NCT01079234|235811|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
100899|NCT01079234|235812|P2|STARTED|Extension: Week 27 to 52||0
100900|NCT01079234|235813|P1|STARTED|Extension: Week 27 to 52||0
100901|NCT01079234|235810|P4|NOT COMPLETED|Main: Week 0 to 26||0
100902|NCT01079234|235811|P3|NOT COMPLETED|Main: Week 0 to 26||12
100903|NCT01079234|235812|P2|NOT COMPLETED|Main: Week 0 to 26||26
100904|NCT01079234|235813|P1|NOT COMPLETED|Main: Week 0 to 26||26
100905|NCT01079234|235810|P4|COMPLETED|Main: Week 0 to 26||0
100906|NCT01079234|235811|P3|COMPLETED|Main: Week 0 to 26||152
100907|NCT01079234|235812|P2|COMPLETED|Main: Week 0 to 26||139
100908|NCT01079234|235813|P1|COMPLETED|Main: Week 0 to 26||138
100909|NCT01079234|235810|P4|Exposed|Main: Week 0 to 26||0
100910|NCT01079234|235811|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
100911|NCT01079234|235812|P2|Exposed|Main: Week 0 to 26||165
100912|NCT01079234|235813|P1|Exposed|Main: Week 0 to 26||164
100913|NCT01079234|235810|P4|STARTED|Main: Week 0 to 26||0
100914|NCT01079234|235811|P3|STARTED|Main: Week 0 to 26||164
100915|NCT01079234|235812|P2|STARTED|Main: Week 0 to 26||165
100916|NCT01079234|235813|P1|STARTED|Main: Week 0 to 26||164
100917|NCT01079195|235831|P1|NOT COMPLETED|Overall Study||1431
100918|NCT01079195|235831|P1|COMPLETED|Overall Study||14442
100919|NCT01079195|235831|P1|STARTED|Overall Study||15873
100920|NCT01079182|235837|P1|NOT COMPLETED|Overall Study||2719
100921|NCT01079182|235837|P1|COMPLETED|Overall Study||1962
100922|NCT01079182|235837|P1|STARTED|Overall Study||4681
100923|NCT01079143|235868|P4|NOT COMPLETED|Overall Study||5
100924|NCT01079143|235869|P3|NOT COMPLETED|Overall Study||5
100925|NCT01079143|235870|P2|NOT COMPLETED|Overall Study||17
100926|NCT01079143|235871|P1|NOT COMPLETED|Overall Study||9
100927|NCT01079143|235868|P4|COMPLETED|Overall Study||54
100928|NCT01079143|235869|P3|COMPLETED|Overall Study||34
100929|NCT01079143|235870|P2|COMPLETED|Overall Study||43
100930|NCT01079143|235871|P1|COMPLETED|Overall Study||27
100931|NCT01079143|235868|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
100932|NCT01079143|235869|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
100933|NCT01079143|235870|P2|M3 and M12 Biopsies|Overall Study||43
100934|NCT01079143|235871|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
100935|NCT01079143|235868|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
100936|NCT01079143|235869|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
100937|NCT01079143|235870|P2|Month 12 (M12) Biopsies|Overall Study||43
100938|NCT01079143|235871|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
100939|NCT01079143|235868|P4|Month 3 (M3) Biopsies|Overall Study||59
100940|NCT01079143|235869|P3|Month 3 (M3) Biopsies|Overall Study||39
100941|NCT01079143|235870|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
100942|NCT01079143|235871|P1|Month 3 (M3) Biopsies|Overall Study||36
100943|NCT01079143|235868|P4|Exposed|Overall Study||59
100944|NCT01079143|235869|P3|Exposed|Overall Study||39
100945|NCT01079143|235870|P2|Exposed|Overall Study||60
100946|NCT01079143|235871|P1|Exposed|Overall Study||36
100947|NCT01079143|235868|P4|STARTED|Overall Study||59
100948|NCT01079143|235869|P3|STARTED|Overall Study||39
100949|NCT01079143|235870|P2|STARTED|Overall Study||60
100950|NCT01079143|235871|P1|STARTED|Overall Study||36
100951|NCT01079130|235945|P6|NOT COMPLETED|Overall Study||5
100952|NCT01079130|235946|P5|NOT COMPLETED|Overall Study||8
100953|NCT01079130|235947|P4|NOT COMPLETED|Overall Study||5
100954|NCT01079130|235948|P3|NOT COMPLETED|Overall Study||1
100955|NCT01079130|235949|P2|NOT COMPLETED|Overall Study||7
100956|NCT01079130|235950|P1|NOT COMPLETED|Overall Study||2
100957|NCT01079130|235945|P6|COMPLETED|Overall Study||80
100958|NCT01079130|235946|P5|COMPLETED|Overall Study||78
100959|NCT01079130|235947|P4|COMPLETED|Overall Study||81
100960|NCT01079130|235948|P3|COMPLETED|Overall Study||83
100961|NCT01079130|235949|P2|COMPLETED|Overall Study||78
100962|NCT01079130|235950|P1|COMPLETED|Overall Study||83
100963|NCT01079130|235945|P6|Full Analysis Set (FAS)|Overall Study||84
100964|NCT01079130|235946|P5|Full Analysis Set (FAS)|Overall Study||84
100965|NCT01079130|235947|P4|Full Analysis Set (FAS)|Overall Study||85
100966|NCT01079130|235948|P3|Full Analysis Set (FAS)|Overall Study||83
100967|NCT01079130|235949|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
100968|NCT01079130|235950|P1|Full Analysis Set (FAS)|Overall Study||84
100969|NCT01079130|235945|P6|Safety Set: Received Study Drug|Overall Study||84
100970|NCT01079130|235946|P5|Safety Set: Received Study Drug|Overall Study||84
100971|NCT01079130|235947|P4|Safety Set: Received Study Drug|Overall Study||85
100972|NCT01079130|235948|P3|Safety Set: Received Study Drug|Overall Study||84
100973|NCT01079130|235949|P2|Safety Set: Received Study Drug|Overall Study||81
100974|NCT01079130|235950|P1|Safety Set: Received Study Drug|Overall Study||84
100975|NCT01079130|235945|P6|STARTED|Overall Study||85
100976|NCT01079130|235946|P5|STARTED|Overall Study||86
100977|NCT01079130|235947|P4|STARTED|Overall Study||86
100978|NCT01079130|235948|P3|STARTED|Overall Study||84
100979|NCT01079130|235949|P2|STARTED|Overall Study||85
100980|NCT01079130|235950|P1|STARTED|Overall Study||85
100981|NCT01078974|235970|P1|NOT COMPLETED|Overall Study||3
100982|NCT01078974|235970|P1|COMPLETED|Overall Study||4
100983|NCT01078974|235970|P1|STARTED|Overall Study||7
100984|NCT01078922|235975|P1|NOT COMPLETED|Overall Study||1
100985|NCT01078922|235975|P1|COMPLETED|Overall Study||10
100986|NCT01078922|235975|P1|STARTED|Overall Study||11
100987|NCT01078805|235980|P1|NOT COMPLETED|Overall Study||2050
100988|NCT01078805|235980|P1|COMPLETED|Overall Study||2117
100989|NCT01078805|235980|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
100990|NCT01078805|235980|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
100991|NCT01078805|235980|P1|STARTED|Overall Study||4167
100992|NCT01078753|235994|P2|NOT COMPLETED|Treatment Period II||0
100993|NCT01078753|235995|P1|NOT COMPLETED|Treatment Period II||0
100994|NCT01078753|235994|P2|COMPLETED|Treatment Period II||44
100995|NCT01078753|235995|P1|COMPLETED|Treatment Period II||45
100996|NCT01078753|235994|P2|Full Analysis Set|Treatment Period II||44
100997|NCT01078753|235995|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
100998|NCT01078753|235994|P2|STARTED|Treatment Period II||44
100999|NCT01078753|235995|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
101000|NCT01078753|235994|P2|NOT COMPLETED|Treatment Period I||0
101001|NCT01078753|235995|P1|NOT COMPLETED|Treatment Period I||0
101002|NCT01078753|235994|P2|COMPLETED|Treatment Period I||44
101003|NCT01078753|235995|P1|COMPLETED|Treatment Period I||45
101004|NCT01078753|235994|P2|Full Analysis Set|Treatment Period I||44
101005|NCT01078753|235995|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
101006|NCT01078753|235994|P2|STARTED|Treatment Period I||44
101007|NCT01078753|235995|P1|STARTED|Treatment Period I||45
101008|NCT01078675|236007|P2|NOT COMPLETED|Overall Study||6
101009|NCT01078675|236008|P1|NOT COMPLETED|Overall Study||68
101010|NCT01078675|236007|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
101011|NCT01078675|236008|P1|COMPLETED|Overall Study||182
101012|NCT01078675|236007|P2|Patients Treated|Overall Study||0
101013|NCT01078675|236008|P1|Patients Treated|Overall Study||198
101014|NCT01078675|236007|P2|STARTED|Overall Study||65
101015|NCT01078675|236008|P1|STARTED|Overall Study||250
101016|NCT01078662|236030|P5|NOT COMPLETED|Overall Study||11
101017|NCT01078662|236031|P4|NOT COMPLETED|Overall Study||7
101018|NCT01078662|236032|P3|NOT COMPLETED|Overall Study||21
101019|NCT01078662|236033|P2|NOT COMPLETED|Overall Study||168
101020|NCT01078662|236034|P1|NOT COMPLETED|Overall Study||58
101021|NCT01078662|236030|P5|COMPLETED|Overall Study||1
101022|NCT01078662|236031|P4|COMPLETED|Overall Study||1
101023|NCT01078662|236032|P3|COMPLETED|Overall Study||2
101024|NCT01078662|236033|P2|COMPLETED|Overall Study||25
101025|NCT01078662|236034|P1|COMPLETED|Overall Study||4
101026|NCT01078662|236030|P5|STARTED|Overall Study||12
101027|NCT01078662|236031|P4|STARTED|Overall Study||8
101028|NCT01078662|236032|P3|STARTED|Overall Study||23
101029|NCT01078662|236033|P2|STARTED|Overall Study||193
101030|NCT01078662|236034|P1|STARTED|Overall Study||62
101031|NCT01078623|236073|P20|NOT COMPLETED|Treatment Period 4||0
101032|NCT01078623|236074|P19|NOT COMPLETED|Treatment Period 4||0
101033|NCT01078623|236075|P18|NOT COMPLETED|Treatment Period 4||0
101034|NCT01078623|236076|P17|NOT COMPLETED|Treatment Period 4||0
101035|NCT01078623|236077|P16|NOT COMPLETED|Treatment Period 4||1
101036|NCT01078623|236078|P15|NOT COMPLETED|Treatment Period 4||0
101037|NCT01078623|236079|P14|NOT COMPLETED|Treatment Period 4||0
101038|NCT01078623|236080|P13|NOT COMPLETED|Treatment Period 4||0
101039|NCT01078623|236081|P12|NOT COMPLETED|Treatment Period 4||0
101040|NCT01078623|236082|P11|NOT COMPLETED|Treatment Period 4||0
101041|NCT01078623|236083|P10|NOT COMPLETED|Treatment Period 4||0
101042|NCT01078623|236084|P9|NOT COMPLETED|Treatment Period 4||0
101043|NCT01078623|236085|P8|NOT COMPLETED|Treatment Period 4||0
101044|NCT01078623|236086|P7|NOT COMPLETED|Treatment Period 4||0
101045|NCT01078623|236087|P6|NOT COMPLETED|Treatment Period 4||0
101046|NCT01078623|236088|P5|NOT COMPLETED|Treatment Period 4||0
101047|NCT01078623|236089|P4|NOT COMPLETED|Treatment Period 4||0
101048|NCT01078623|236090|P3|NOT COMPLETED|Treatment Period 4||1
101049|NCT01078623|236091|P2|NOT COMPLETED|Treatment Period 4||0
101050|NCT01078623|236092|P1|NOT COMPLETED|Treatment Period 4||0
101051|NCT01078623|236073|P20|COMPLETED|Treatment Period 4||7
101052|NCT01078623|236074|P19|COMPLETED|Treatment Period 4||6
101053|NCT01078623|236075|P18|COMPLETED|Treatment Period 4||7
101054|NCT01078623|236076|P17|COMPLETED|Treatment Period 4||7
101055|NCT01078623|236077|P16|COMPLETED|Treatment Period 4||6
101056|NCT01078623|236078|P15|COMPLETED|Treatment Period 4||7
101057|NCT01078623|236079|P14|COMPLETED|Treatment Period 4||6
101058|NCT01078623|236080|P13|COMPLETED|Treatment Period 4||7
101059|NCT01078623|236081|P12|COMPLETED|Treatment Period 4||7
101060|NCT01078623|236082|P11|COMPLETED|Treatment Period 4||6
101061|NCT01078623|236083|P10|COMPLETED|Treatment Period 4||6
101062|NCT01078623|236084|P9|COMPLETED|Treatment Period 4||5
101063|NCT01078623|236085|P8|COMPLETED|Treatment Period 4||6
101064|NCT01078623|236086|P7|COMPLETED|Treatment Period 4||5
101065|NCT01078623|236087|P6|COMPLETED|Treatment Period 4||4
101066|NCT01078623|236088|P5|COMPLETED|Treatment Period 4||6
101067|NCT01078623|236089|P4|COMPLETED|Treatment Period 4||6
101068|NCT01078623|236090|P3|COMPLETED|Treatment Period 4||5
101069|NCT01078623|236091|P2|COMPLETED|Treatment Period 4||5
101070|NCT01078623|236092|P1|COMPLETED|Treatment Period 4||5
101071|NCT01078623|236073|P20|STARTED|Treatment Period 4||7
101072|NCT01078623|236074|P19|STARTED|Treatment Period 4||6
101073|NCT01078623|236075|P18|STARTED|Treatment Period 4||7
101074|NCT01078623|236076|P17|STARTED|Treatment Period 4||7
101075|NCT01078623|236077|P16|STARTED|Treatment Period 4||7
101076|NCT01078623|236078|P15|STARTED|Treatment Period 4||7
101077|NCT01078623|236079|P14|STARTED|Treatment Period 4||6
101078|NCT01078623|236080|P13|STARTED|Treatment Period 4||7
101079|NCT01078623|236081|P12|STARTED|Treatment Period 4||7
101080|NCT01078623|236082|P11|STARTED|Treatment Period 4||6
101081|NCT01078623|236083|P10|STARTED|Treatment Period 4||6
101082|NCT01078623|236084|P9|STARTED|Treatment Period 4||5
101083|NCT01078623|236085|P8|STARTED|Treatment Period 4||6
101084|NCT01078623|236086|P7|STARTED|Treatment Period 4||5
101085|NCT01078623|236087|P6|STARTED|Treatment Period 4||4
101086|NCT01078623|236088|P5|STARTED|Treatment Period 4||6
101087|NCT01078623|236089|P4|STARTED|Treatment Period 4||6
101088|NCT01078623|236090|P3|STARTED|Treatment Period 4||6
101089|NCT01078623|236091|P2|STARTED|Treatment Period 4||5
101090|NCT01078623|236092|P1|STARTED|Treatment Period 4||5
101091|NCT01078623|236073|P20|NOT COMPLETED|Treatment Period 3||0
101092|NCT01078623|236074|P19|NOT COMPLETED|Treatment Period 3||0
101093|NCT01078623|236075|P18|NOT COMPLETED|Treatment Period 3||0
101094|NCT01078623|236076|P17|NOT COMPLETED|Treatment Period 3||0
101095|NCT01078623|236077|P16|NOT COMPLETED|Treatment Period 3||0
101096|NCT01078623|236078|P15|NOT COMPLETED|Treatment Period 3||0
101097|NCT01078623|236079|P14|NOT COMPLETED|Treatment Period 3||1
101098|NCT01078623|236080|P13|NOT COMPLETED|Treatment Period 3||0
101099|NCT01078623|236081|P12|NOT COMPLETED|Treatment Period 3||0
101100|NCT01078623|236082|P11|NOT COMPLETED|Treatment Period 3||0
101101|NCT01078623|236083|P10|NOT COMPLETED|Treatment Period 3||0
101102|NCT01078623|236084|P9|NOT COMPLETED|Treatment Period 3||0
101103|NCT01078623|236085|P8|NOT COMPLETED|Treatment Period 3||0
101104|NCT01078623|236086|P7|NOT COMPLETED|Treatment Period 3||0
101105|NCT01078623|236087|P6|NOT COMPLETED|Treatment Period 3||0
101106|NCT01078623|236088|P5|NOT COMPLETED|Treatment Period 3||1
101107|NCT01078623|236089|P4|NOT COMPLETED|Treatment Period 3||0
101108|NCT01078623|236090|P3|NOT COMPLETED|Treatment Period 3||0
101109|NCT01078623|236091|P2|NOT COMPLETED|Treatment Period 3||0
101110|NCT01078623|236092|P1|NOT COMPLETED|Treatment Period 3||0
101111|NCT01078623|236073|P20|COMPLETED|Treatment Period 3||7
101112|NCT01078623|236074|P19|COMPLETED|Treatment Period 3||6
101113|NCT01078623|236075|P18|COMPLETED|Treatment Period 3||7
101114|NCT01078623|236076|P17|COMPLETED|Treatment Period 3||7
101115|NCT01078623|236077|P16|COMPLETED|Treatment Period 3||7
101116|NCT01078623|236078|P15|COMPLETED|Treatment Period 3||7
101117|NCT01078623|236079|P14|COMPLETED|Treatment Period 3||6
101118|NCT01078623|236080|P13|COMPLETED|Treatment Period 3||7
101119|NCT01078623|236081|P12|COMPLETED|Treatment Period 3||7
101120|NCT01078623|236082|P11|COMPLETED|Treatment Period 3||6
101121|NCT01078623|236083|P10|COMPLETED|Treatment Period 3||6
101122|NCT01078623|236084|P9|COMPLETED|Treatment Period 3||5
101123|NCT01078623|236085|P8|COMPLETED|Treatment Period 3||6
101124|NCT01078623|236086|P7|COMPLETED|Treatment Period 3||5
101125|NCT01078623|236087|P6|COMPLETED|Treatment Period 3||4
101126|NCT01078623|236088|P5|COMPLETED|Treatment Period 3||6
101127|NCT01078623|236089|P4|COMPLETED|Treatment Period 3||6
101128|NCT01078623|236090|P3|COMPLETED|Treatment Period 3||6
101129|NCT01078623|236091|P2|COMPLETED|Treatment Period 3||5
101130|NCT01078623|236092|P1|COMPLETED|Treatment Period 3||5
101131|NCT01078623|236073|P20|STARTED|Treatment Period 3||7
101132|NCT01078623|236074|P19|STARTED|Treatment Period 3||6
101133|NCT01078623|236075|P18|STARTED|Treatment Period 3||7
101134|NCT01078623|236076|P17|STARTED|Treatment Period 3||7
101135|NCT01078623|236077|P16|STARTED|Treatment Period 3||7
101136|NCT01078623|236078|P15|STARTED|Treatment Period 3||7
101137|NCT01078623|236079|P14|STARTED|Treatment Period 3||7
101138|NCT01078623|236080|P13|STARTED|Treatment Period 3||7
101139|NCT01078623|236081|P12|STARTED|Treatment Period 3||7
101140|NCT01078623|236082|P11|STARTED|Treatment Period 3||6
101141|NCT01078623|236083|P10|STARTED|Treatment Period 3||6
101142|NCT01078623|236084|P9|STARTED|Treatment Period 3||5
101143|NCT01078623|236085|P8|STARTED|Treatment Period 3||6
101144|NCT01078623|236086|P7|STARTED|Treatment Period 3||5
101145|NCT01078623|236087|P6|STARTED|Treatment Period 3||4
101146|NCT01078623|236088|P5|STARTED|Treatment Period 3||7
101147|NCT01078623|236089|P4|STARTED|Treatment Period 3||6
101148|NCT01078623|236090|P3|STARTED|Treatment Period 3||6
101149|NCT01078623|236091|P2|STARTED|Treatment Period 3||5
101150|NCT01078623|236092|P1|STARTED|Treatment Period 3||5
101151|NCT01078623|236073|P20|NOT COMPLETED|Treatment Period 2||0
101152|NCT01078623|236074|P19|NOT COMPLETED|Treatment Period 2||1
101153|NCT01078623|236075|P18|NOT COMPLETED|Treatment Period 2||0
101154|NCT01078623|236076|P17|NOT COMPLETED|Treatment Period 2||0
101155|NCT01078623|236077|P16|NOT COMPLETED|Treatment Period 2||0
101156|NCT01078623|236078|P15|NOT COMPLETED|Treatment Period 2||0
101157|NCT01078623|236079|P14|NOT COMPLETED|Treatment Period 2||0
101158|NCT01078623|236080|P13|NOT COMPLETED|Treatment Period 2||0
101159|NCT01078623|236081|P12|NOT COMPLETED|Treatment Period 2||0
101160|NCT01078623|236082|P11|NOT COMPLETED|Treatment Period 2||0
101161|NCT01078623|236083|P10|NOT COMPLETED|Treatment Period 2||0
101162|NCT01078623|236084|P9|NOT COMPLETED|Treatment Period 2||0
101163|NCT01078623|236085|P8|NOT COMPLETED|Treatment Period 2||0
101164|NCT01078623|236086|P7|NOT COMPLETED|Treatment Period 2||1
101165|NCT01078623|236087|P6|NOT COMPLETED|Treatment Period 2||1
101166|NCT01078623|236088|P5|NOT COMPLETED|Treatment Period 2||0
101167|NCT01078623|236089|P4|NOT COMPLETED|Treatment Period 2||0
101168|NCT01078623|236090|P3|NOT COMPLETED|Treatment Period 2||0
101169|NCT01078623|236091|P2|NOT COMPLETED|Treatment Period 2||0
101170|NCT01078623|236092|P1|NOT COMPLETED|Treatment Period 2||0
101171|NCT01078623|236073|P20|COMPLETED|Treatment Period 2||7
101172|NCT01078623|236074|P19|COMPLETED|Treatment Period 2||6
101173|NCT01078623|236075|P18|COMPLETED|Treatment Period 2||7
101174|NCT01078623|236076|P17|COMPLETED|Treatment Period 2||7
101175|NCT01078623|236077|P16|COMPLETED|Treatment Period 2||7
101176|NCT01078623|236078|P15|COMPLETED|Treatment Period 2||7
101177|NCT01078623|236079|P14|COMPLETED|Treatment Period 2||7
101178|NCT01078623|236080|P13|COMPLETED|Treatment Period 2||7
101179|NCT01078623|236081|P12|COMPLETED|Treatment Period 2||7
101180|NCT01078623|236082|P11|COMPLETED|Treatment Period 2||6
101181|NCT01078623|236083|P10|COMPLETED|Treatment Period 2||6
101182|NCT01078623|236084|P9|COMPLETED|Treatment Period 2||5
101183|NCT01078623|236085|P8|COMPLETED|Treatment Period 2||6
101184|NCT01078623|236086|P7|COMPLETED|Treatment Period 2||5
101185|NCT01078623|236087|P6|COMPLETED|Treatment Period 2||4
101186|NCT01078623|236088|P5|COMPLETED|Treatment Period 2||7
101187|NCT01078623|236089|P4|COMPLETED|Treatment Period 2||6
101188|NCT01078623|236090|P3|COMPLETED|Treatment Period 2||6
101189|NCT01078623|236091|P2|COMPLETED|Treatment Period 2||5
101190|NCT01078623|236092|P1|COMPLETED|Treatment Period 2||5
101191|NCT01078623|236073|P20|STARTED|Treatment Period 2||7
101192|NCT01078623|236074|P19|STARTED|Treatment Period 2||7
101193|NCT01078623|236075|P18|STARTED|Treatment Period 2||7
101194|NCT01078623|236076|P17|STARTED|Treatment Period 2||7
101195|NCT01078623|236077|P16|STARTED|Treatment Period 2||7
101196|NCT01078623|236078|P15|STARTED|Treatment Period 2||7
101197|NCT01078623|236079|P14|STARTED|Treatment Period 2||7
101198|NCT01078623|236080|P13|STARTED|Treatment Period 2||7
101199|NCT01078623|236081|P12|STARTED|Treatment Period 2||7
101200|NCT01078623|236082|P11|STARTED|Treatment Period 2||6
101201|NCT01078623|236083|P10|STARTED|Treatment Period 2||6
101202|NCT01078623|236084|P9|STARTED|Treatment Period 2||5
101203|NCT01078623|236085|P8|STARTED|Treatment Period 2||6
101204|NCT01078623|236086|P7|STARTED|Treatment Period 2||6
101205|NCT01078623|236087|P6|STARTED|Treatment Period 2||5
101206|NCT01078623|236088|P5|STARTED|Treatment Period 2||7
101207|NCT01078623|236089|P4|STARTED|Treatment Period 2||6
101208|NCT01078623|236090|P3|STARTED|Treatment Period 2||6
101209|NCT01078623|236091|P2|STARTED|Treatment Period 2||5
101210|NCT01078623|236092|P1|STARTED|Treatment Period 2||5
101211|NCT01078623|236073|P20|NOT COMPLETED|Treatment Period 1||0
101212|NCT01078623|236074|P19|NOT COMPLETED|Treatment Period 1||0
101213|NCT01078623|236075|P18|NOT COMPLETED|Treatment Period 1||0
101214|NCT01078623|236076|P17|NOT COMPLETED|Treatment Period 1||0
101215|NCT01078623|236077|P16|NOT COMPLETED|Treatment Period 1||0
101216|NCT01078623|236078|P15|NOT COMPLETED|Treatment Period 1||0
101217|NCT01078623|236079|P14|NOT COMPLETED|Treatment Period 1||0
101218|NCT01078623|236080|P13|NOT COMPLETED|Treatment Period 1||0
101219|NCT01078623|236081|P12|NOT COMPLETED|Treatment Period 1||0
101220|NCT01078623|236082|P11|NOT COMPLETED|Treatment Period 1||1
101221|NCT01078623|236083|P10|NOT COMPLETED|Treatment Period 1||1
101222|NCT01078623|236084|P9|NOT COMPLETED|Treatment Period 1||1
101223|NCT01078623|236085|P8|NOT COMPLETED|Treatment Period 1||1
101224|NCT01078623|236086|P7|NOT COMPLETED|Treatment Period 1||1
101225|NCT01078623|236087|P6|NOT COMPLETED|Treatment Period 1||1
101226|NCT01078623|236088|P5|NOT COMPLETED|Treatment Period 1||0
101227|NCT01078623|236089|P4|NOT COMPLETED|Treatment Period 1||0
101228|NCT01078623|236090|P3|NOT COMPLETED|Treatment Period 1||1
101229|NCT01078623|236091|P2|NOT COMPLETED|Treatment Period 1||1
101230|NCT01078623|236092|P1|NOT COMPLETED|Treatment Period 1||1
101231|NCT01078623|236073|P20|COMPLETED|Treatment Period 1||7
101232|NCT01078623|236074|P19|COMPLETED|Treatment Period 1||7
101233|NCT01078623|236075|P18|COMPLETED|Treatment Period 1||7
101234|NCT01078623|236076|P17|COMPLETED|Treatment Period 1||7
101235|NCT01078623|236077|P16|COMPLETED|Treatment Period 1||7
101236|NCT01078623|236078|P15|COMPLETED|Treatment Period 1||7
101237|NCT01078623|236079|P14|COMPLETED|Treatment Period 1||7
101238|NCT01078623|236080|P13|COMPLETED|Treatment Period 1||7
101239|NCT01078623|236081|P12|COMPLETED|Treatment Period 1||7
101240|NCT01078623|236082|P11|COMPLETED|Treatment Period 1||6
101241|NCT01078623|236083|P10|COMPLETED|Treatment Period 1||6
101242|NCT01078623|236084|P9|COMPLETED|Treatment Period 1||5
101243|NCT01078623|236085|P8|COMPLETED|Treatment Period 1||6
101244|NCT01078623|236086|P7|COMPLETED|Treatment Period 1||6
101245|NCT01078623|236087|P6|COMPLETED|Treatment Period 1||5
101246|NCT01078623|236088|P5|COMPLETED|Treatment Period 1||7
101247|NCT01078623|236089|P4|COMPLETED|Treatment Period 1||6
101248|NCT01078623|236090|P3|COMPLETED|Treatment Period 1||6
101249|NCT01078623|236091|P2|COMPLETED|Treatment Period 1||5
101250|NCT01078623|236092|P1|COMPLETED|Treatment Period 1||5
101251|NCT01078623|236073|P20|STARTED|Treatment Period 1||7
101252|NCT01078623|236074|P19|STARTED|Treatment Period 1||7
101253|NCT01078623|236075|P18|STARTED|Treatment Period 1||7
101254|NCT01078623|236076|P17|STARTED|Treatment Period 1||7
101255|NCT01078623|236077|P16|STARTED|Treatment Period 1||7
101256|NCT01078623|236078|P15|STARTED|Treatment Period 1||7
101257|NCT01078623|236079|P14|STARTED|Treatment Period 1||7
101258|NCT01078623|236080|P13|STARTED|Treatment Period 1||7
101259|NCT01078623|236081|P12|STARTED|Treatment Period 1||7
101260|NCT01078623|236082|P11|STARTED|Treatment Period 1||7
101261|NCT01078623|236083|P10|STARTED|Treatment Period 1||7
101262|NCT01078623|236084|P9|STARTED|Treatment Period 1||6
101263|NCT01078623|236085|P8|STARTED|Treatment Period 1||7
101264|NCT01078623|236086|P7|STARTED|Treatment Period 1||7
101265|NCT01078623|236087|P6|STARTED|Treatment Period 1||6
101266|NCT01078623|236088|P5|STARTED|Treatment Period 1||7
101267|NCT01078623|236089|P4|STARTED|Treatment Period 1||6
101268|NCT01078623|236090|P3|STARTED|Treatment Period 1||7
101269|NCT01078623|236091|P2|STARTED|Treatment Period 1||6
101270|NCT01078623|236092|P1|STARTED|Treatment Period 1||6
101271|NCT01078584|236114|P1|NOT COMPLETED|Overall Study||3010
101272|NCT01078584|236114|P1|COMPLETED|Overall Study||4983
101273|NCT01078584|236114|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
101274|NCT01078584|236114|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
101275|NCT01078584|236114|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
101276|NCT01078584|236114|P1|STARTED|Overall Study||7993
101277|NCT01078571|236195|P1|NOT COMPLETED|Overall Study||115
101278|NCT01078571|236195|P1|COMPLETED|Overall Study||590
101279|NCT01078571|236195|P1|Intent-to-treat (ITT) Population|Overall Study||591
101280|NCT01078571|236195|P1|Safety Population|Overall Study||675
101281|NCT01078571|236195|P1|STARTED|Overall Study||705
101282|NCT01078545|236211|P1|NOT COMPLETED|Overall Study||26
101283|NCT01078545|236211|P1|COMPLETED|Overall Study||703
101284|NCT01078545|236211|P1|Per Protocol Population|Overall Study||661
101285|NCT01078545|236211|P1|Intent-to-treat Population|Overall Study||729
101286|NCT01078545|236211|P1|STARTED|Overall Study||729
101287|NCT01078454|236221|P2|NOT COMPLETED|Overall Study||2
101288|NCT01078454|236222|P1|NOT COMPLETED|Overall Study||1
101289|NCT01078454|236221|P2|COMPLETED|Overall Study||3
101290|NCT01078454|236222|P1|COMPLETED|Overall Study||5
101291|NCT01078454|236221|P2|STARTED|Overall Study||5
101292|NCT01078454|236222|P1|STARTED|Overall Study||6
101293|NCT01078441|236228|P1|NOT COMPLETED|Overall Study||1
101294|NCT01078441|236228|P1|COMPLETED|Overall Study||1
101295|NCT01078441|236228|P1|STARTED|Overall Study||2
101296|NCT01078402|236235|P3|NOT COMPLETED|Overall Study||68
101297|NCT01078402|236236|P2|NOT COMPLETED|Overall Study||29
101298|NCT01078402|236237|P1|NOT COMPLETED|Overall Study||107
101299|NCT01078402|236235|P3|COMPLETED|Overall Study||166
101300|NCT01078402|236236|P2|COMPLETED|Overall Study||95
101301|NCT01078402|236237|P1|COMPLETED|Overall Study||324
101302|NCT01078402|236235|P3|STARTED|Overall Study||234
101303|NCT01078402|236236|P2|STARTED|Overall Study||124
101304|NCT01078402|236237|P1|STARTED|Overall Study||431
101305|NCT01078389|236268|P2|NOT COMPLETED|Overall Study||67
101306|NCT01078389|236269|P1|NOT COMPLETED|Overall Study||64
101307|NCT01078389|236268|P2|COMPLETED|Overall Study||90
101308|NCT01078389|236269|P1|COMPLETED|Overall Study||93
101309|NCT01078389|236268|P2|STARTED|Overall Study||157
101310|NCT01078389|236269|P1|STARTED|Overall Study||157
101311|NCT01078376|236287|P4|NOT COMPLETED|Overall Study||0
101312|NCT01078376|236288|P3|NOT COMPLETED|Overall Study||0
101313|NCT01078376|236289|P2|NOT COMPLETED|Overall Study||0
101314|NCT01078376|236290|P1|NOT COMPLETED|Overall Study||0
101315|NCT01078376|236287|P4|COMPLETED|Overall Study||3
101316|NCT01078376|236288|P3|COMPLETED|Overall Study||8
101317|NCT01078376|236289|P2|COMPLETED|Overall Study||9
101318|NCT01078376|236290|P1|COMPLETED|Overall Study||9
101319|NCT01078376|236287|P4|STARTED|Overall Study||3
101320|NCT01078376|236288|P3|STARTED|Overall Study||8
101321|NCT01078376|236289|P2|STARTED|Overall Study||9
101322|NCT01078376|236290|P1|STARTED|Overall Study||9
101323|NCT01078363|236411|P2|NOT COMPLETED|Overall Study||0
101324|NCT01078363|236412|P1|NOT COMPLETED|Overall Study||0
101325|NCT01078363|236411|P2|COMPLETED|Overall Study||49
101326|NCT01078363|236412|P1|COMPLETED|Overall Study||47
101327|NCT01078363|236411|P2|STARTED|Overall Study||49
101328|NCT01078363|236412|P1|STARTED|Overall Study||47
101329|NCT01078298|236430|P2|NOT COMPLETED|Overall Study||90
101330|NCT01078298|236431|P1|NOT COMPLETED|Overall Study||81
101331|NCT01078298|236430|P2|COMPLETED|Overall Study||179
101332|NCT01078298|236431|P1|COMPLETED|Overall Study||175
101333|NCT01078298|236430|P2|STARTED|Overall Study||269
101334|NCT01078298|236431|P1|STARTED|Overall Study||256
101335|NCT01078246|236464|P7|NOT COMPLETED|Overall Study||0
101336|NCT01078246|236465|P6|NOT COMPLETED|Overall Study||0
101337|NCT01078246|236466|P5|NOT COMPLETED|Overall Study||0
101338|NCT01078246|236467|P4|NOT COMPLETED|Overall Study||0
101339|NCT01078246|236468|P3|NOT COMPLETED|Overall Study||0
101340|NCT01078246|236469|P2|NOT COMPLETED|Overall Study||0
101341|NCT01078246|236470|P1|NOT COMPLETED|Overall Study||0
101342|NCT01078246|236464|P7|COMPLETED|Overall Study||22
101343|NCT01078246|236465|P6|COMPLETED|Overall Study||231
101344|NCT01078246|236466|P5|COMPLETED|Overall Study||3310
101345|NCT01078246|236467|P4|COMPLETED|Overall Study||152
101346|NCT01078246|236468|P3|COMPLETED|Overall Study||1963
101347|NCT01078246|236469|P2|COMPLETED|Overall Study||405
101348|NCT01078246|236470|P1|COMPLETED|Overall Study||1041
101349|NCT01078246|236464|P7|STARTED|Overall Study||22
101350|NCT01078246|236465|P6|STARTED|Overall Study||231
101351|NCT01078246|236466|P5|STARTED|Overall Study||3310
101352|NCT01078246|236467|P4|STARTED|Overall Study||152
101353|NCT01078246|236468|P3|STARTED|Overall Study||1963
101354|NCT01078246|236469|P2|STARTED|Overall Study||405
101355|NCT01078246|236470|P1|STARTED|Overall Study||1041
101356|NCT01078233|236502|P6|NOT COMPLETED|Overall Study||0
101357|NCT01078233|236503|P5|NOT COMPLETED|Overall Study||0
101358|NCT01078233|236504|P4|NOT COMPLETED|Overall Study||0
101359|NCT01078233|236505|P3|NOT COMPLETED|Overall Study||0
101360|NCT01078233|236506|P2|NOT COMPLETED|Overall Study||0
101361|NCT01078233|236507|P1|NOT COMPLETED|Overall Study||0
101362|NCT01078233|236502|P6|COMPLETED|Overall Study||154
101363|NCT01078233|236503|P5|COMPLETED|Overall Study||3199
101364|NCT01078233|236504|P4|COMPLETED|Overall Study||631
101365|NCT01078233|236505|P3|COMPLETED|Overall Study||1681
101366|NCT01078233|236506|P2|COMPLETED|Overall Study||296
101367|NCT01078233|236507|P1|COMPLETED|Overall Study||656
101368|NCT01078233|236502|P6|STARTED|Overall Study||154
101369|NCT01078233|236503|P5|STARTED|Overall Study||3199
101370|NCT01078233|236504|P4|STARTED|Overall Study||631
101371|NCT01078233|236505|P3|STARTED|Overall Study||1681
101372|NCT01078233|236506|P2|STARTED|Overall Study||296
101373|NCT01078233|236507|P1|STARTED|Overall Study||656
101374|NCT01078220|236524|P1|NOT COMPLETED|Overall Study||0
101375|NCT01078220|236524|P1|COMPLETED|Overall Study||189629
101376|NCT01078220|236524|P1|STARTED|Overall Study||189629
101377|NCT01078207|236534|P1|NOT COMPLETED|Overall Study||0
101378|NCT01078207|236534|P1|COMPLETED|Overall Study||100
101379|NCT01078207|236534|P1|STARTED|Overall Study||100
101380|NCT01078155|236539|P1|NOT COMPLETED|Overall Study||44
101381|NCT01078155|236539|P1|COMPLETED|Overall Study||87
101382|NCT01078155|236539|P1|STARTED|Overall Study||131
101383|NCT01078116|236555|P1|NOT COMPLETED|Overall Study||48
101384|NCT01078116|236555|P1|COMPLETED|Overall Study||76
101385|NCT01078116|236555|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
101386|NCT01078090|236563|P1|NOT COMPLETED|Overall Study||4593
101387|NCT01078090|236563|P1|COMPLETED|Overall Study||1152
101388|NCT01078090|236563|P1|STARTED|Overall Study||5745
101389|NCT01077973|236607|P3|NOT COMPLETED|Overall Study||0
101390|NCT01077973|236608|P2|NOT COMPLETED|Overall Study||0
101391|NCT01077973|236609|P1|NOT COMPLETED|Overall Study||0
101392|NCT01077973|236607|P3|COMPLETED|Overall Study||80
101393|NCT01077973|236608|P2|COMPLETED|Overall Study||79
101394|NCT01077973|236609|P1|COMPLETED|Overall Study||41
101395|NCT01077973|236607|P3|STARTED|Overall Study||80
101396|NCT01077973|236608|P2|STARTED|Overall Study||79
101397|NCT01077973|236609|P1|STARTED|Overall Study||41
101398|NCT01077960|236657|P1|NOT COMPLETED|Overall Study||16
101399|NCT01077960|236657|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
101400|NCT01077960|236657|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
101401|NCT01077921|236668|P2|NOT COMPLETED|Second Intervention||1
101402|NCT01077921|236669|P1|NOT COMPLETED|Second Intervention||0
101403|NCT01077921|236668|P2|COMPLETED|Second Intervention||9
101404|NCT01077921|236669|P1|COMPLETED|Second Intervention||13
101405|NCT01077921|236668|P2|STARTED|Second Intervention||10
101406|NCT01077921|236669|P1|STARTED|Second Intervention||13
101407|NCT01077921|236668|P2|NOT COMPLETED|Washout||2
101408|NCT01077921|236669|P1|NOT COMPLETED|Washout||0
101409|NCT01077921|236668|P2|COMPLETED|Washout||10
101410|NCT01077921|236669|P1|COMPLETED|Washout||13
101411|NCT01077921|236668|P2|STARTED|Washout||12
101412|NCT01077921|236669|P1|STARTED|Washout||13
101413|NCT01077921|236668|P2|NOT COMPLETED|First Intervention||1
101414|NCT01077921|236669|P1|NOT COMPLETED|First Intervention||1
101415|NCT01077921|236668|P2|COMPLETED|First Intervention||12
101416|NCT01077921|236669|P1|COMPLETED|First Intervention||13
101417|NCT01077921|236668|P2|STARTED|First Intervention||13
101418|NCT01077921|236669|P1|STARTED|First Intervention||14
101419|NCT01077856|236702|P3|NOT COMPLETED|Overall Study||0
101420|NCT01077856|236703|P2|NOT COMPLETED|Overall Study||0
101421|NCT01077856|236704|P1|NOT COMPLETED|Overall Study||0
101422|NCT01077856|236702|P3|COMPLETED|Overall Study||15713
101423|NCT01077856|236703|P2|COMPLETED|Overall Study||16604
101424|NCT01077856|236704|P1|COMPLETED|Overall Study||22199
101425|NCT01077856|236702|P3|STARTED|Overall Study||15713
101426|NCT01077856|236703|P2|STARTED|Overall Study||16604
101427|NCT01077856|236704|P1|STARTED|Overall Study||22199
101428|NCT01077830|236885|P2|NOT COMPLETED|Overall Study||0
101429|NCT01077830|236886|P1|NOT COMPLETED|Overall Study||0
101430|NCT01077830|236885|P2|COMPLETED|Overall Study||682
101431|NCT01077830|236886|P1|COMPLETED|Overall Study||677
101432|NCT01077830|236885|P2|STARTED|Overall Study||682
101433|NCT01077830|236886|P1|STARTED|Overall Study||677
101434|NCT01077817|236896|P1|NOT COMPLETED|Overall Study||0
101435|NCT01077817|236896|P1|COMPLETED|Overall Study||684815
101436|NCT01077817|236896|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
101437|NCT01077804|236907|P1|NOT COMPLETED|Overall Study||199
101438|NCT01077804|236907|P1|COMPLETED|Overall Study||7386
101439|NCT01077804|236907|P1|STARTED|Overall Study||7585
101440|NCT01077739|236916|P2|NOT COMPLETED|Overall Study||10
101441|NCT01077739|236917|P1|NOT COMPLETED|Overall Study||5
101442|NCT01077739|236916|P2|COMPLETED|Overall Study||40
101443|NCT01077739|236917|P1|COMPLETED|Overall Study||20
101444|NCT01077739|236916|P2|STARTED|Overall Study||50
101445|NCT01077739|236917|P1|STARTED|Overall Study||25
101446|NCT01077713|236931|P2|NOT COMPLETED|Overall Study||36
101447|NCT01077713|236932|P1|NOT COMPLETED|Overall Study||36
101448|NCT01077713|236931|P2|COMPLETED|Overall Study||6
101449|NCT01077713|236932|P1|COMPLETED|Overall Study||8
101450|NCT01077713|236931|P2|STARTED|Overall Study||42
101451|NCT01077713|236932|P1|STARTED|Overall Study||44
101452|NCT01077622|236956|P1|NOT COMPLETED|Overall Study||3
101453|NCT01077622|236956|P1|COMPLETED|Overall Study||7
101454|NCT01077622|236956|P1|STARTED|Overall Study||10
101455|NCT01077596|237014|P12|NOT COMPLETED|Overall Study||0
101456|NCT01077596|237015|P11|NOT COMPLETED|Overall Study||0
101457|NCT01077596|237016|P10|NOT COMPLETED|Overall Study||0
101458|NCT01077596|237017|P9|NOT COMPLETED|Overall Study||0
101459|NCT01077596|237018|P8|NOT COMPLETED|Overall Study||0
101460|NCT01077596|237019|P7|NOT COMPLETED|Overall Study||0
101461|NCT01077596|237020|P6|NOT COMPLETED|Overall Study||0
101462|NCT01077596|237021|P5|NOT COMPLETED|Overall Study||0
101463|NCT01077596|237022|P4|NOT COMPLETED|Overall Study||0
101464|NCT01077596|237023|P3|NOT COMPLETED|Overall Study||0
101465|NCT01077596|237024|P2|NOT COMPLETED|Overall Study||0
101466|NCT01077596|237025|P1|NOT COMPLETED|Overall Study||0
101467|NCT01077596|237014|P12|COMPLETED|Overall Study||22150
101468|NCT01077596|237015|P11|COMPLETED|Overall Study||2215
101469|NCT01077596|237016|P10|COMPLETED|Overall Study||28420
101470|NCT01077596|237017|P9|COMPLETED|Overall Study||2842
101471|NCT01077596|237018|P8|COMPLETED|Overall Study||837
101472|NCT01077596|237019|P7|COMPLETED|Overall Study||308
101473|NCT01077596|237020|P6|COMPLETED|Overall Study||882
101474|NCT01077596|237021|P5|COMPLETED|Overall Study||294
101475|NCT01077596|237022|P4|COMPLETED|Overall Study||1370
101476|NCT01077596|237023|P3|COMPLETED|Overall Study||457
101477|NCT01077596|237024|P2|COMPLETED|Overall Study||1050
101478|NCT01077596|237025|P1|COMPLETED|Overall Study||350
101479|NCT01077596|237014|P12|STARTED|Overall Study||22150
101480|NCT01077596|237015|P11|STARTED|Overall Study||2215
101481|NCT01077596|237016|P10|STARTED|Overall Study||28420
101482|NCT01077596|237017|P9|STARTED|Overall Study||2842
101483|NCT01077596|237018|P8|STARTED|Overall Study||837
101484|NCT01077596|237019|P7|STARTED|Overall Study||308
101485|NCT01077596|237020|P6|STARTED|Overall Study||882
101486|NCT01077596|237021|P5|STARTED|Overall Study||294
101487|NCT01077596|237022|P4|STARTED|Overall Study||1370
101488|NCT01077596|237023|P3|STARTED|Overall Study||457
101489|NCT01077596|237024|P2|STARTED|Overall Study||1050
101490|NCT01077596|237025|P1|STARTED|Overall Study||350
101491|NCT01077544|237076|P2|NOT COMPLETED|Overall Study||5
101492|NCT01077544|237077|P1|NOT COMPLETED|Overall Study||3
101493|NCT01077544|237076|P2|COMPLETED|Overall Study||2
101494|NCT01077544|237077|P1|COMPLETED|Overall Study||5
101495|NCT01077544|237076|P2|STARTED|Overall Study||7
101496|NCT01077544|237077|P1|STARTED|Overall Study||8
101497|NCT01077375|237105|P2|NOT COMPLETED|Overall Study||35
101498|NCT01077375|237106|P1|NOT COMPLETED|Overall Study||10
101499|NCT01077375|237105|P2|COMPLETED|Overall Study||51
101500|NCT01077375|237106|P1|COMPLETED|Overall Study||11
101501|NCT01077375|237105|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
101502|NCT01077375|237106|P1|STARTED|Overall Study||21
101503|NCT01077362|237117|P3|NOT COMPLETED|Overall Study||24
101504|NCT01077362|237118|P2|NOT COMPLETED|Overall Study||19
101505|NCT01077362|237119|P1|NOT COMPLETED|Overall Study||31
101506|NCT01077362|237117|P3|COMPLETED|Overall Study||81
101507|NCT01077362|237118|P2|COMPLETED|Overall Study||84
101508|NCT01077362|237119|P1|COMPLETED|Overall Study||73
101509|NCT01077362|237117|P3|STARTED|Overall Study||105
101510|NCT01077362|237118|P2|STARTED|Overall Study||103
101511|NCT01077362|237119|P1|STARTED|Overall Study||104
101512|NCT01077323|237155|P3|NOT COMPLETED|Overall Study||11912089
101513|NCT01077323|237156|P2|NOT COMPLETED|Overall Study||386263
101514|NCT01077323|237157|P1|NOT COMPLETED|Overall Study||11378
101515|NCT01077323|237155|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
101516|NCT01077323|237156|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
101517|NCT01077323|237157|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
101518|NCT01077323|237155|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
101519|NCT01077323|237156|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
101520|NCT01077323|237157|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
101521|NCT01077310|237176|P2|NOT COMPLETED|Overall Study||0
101522|NCT01077310|237177|P1|NOT COMPLETED|Overall Study||0
101523|NCT01077310|237176|P2|COMPLETED|Overall Study||33
101524|NCT01077310|237177|P1|COMPLETED|Overall Study||67
101525|NCT01077310|237176|P2|STARTED|Overall Study||33
101526|NCT01077310|237177|P1|STARTED|Overall Study||67
101527|NCT01077284|237196|P3|NOT COMPLETED|Overall Study||3
101528|NCT01077284|237197|P2|NOT COMPLETED|Overall Study||5
101529|NCT01077284|237198|P1|NOT COMPLETED|Overall Study||5
101530|NCT01077284|237196|P3|COMPLETED|Overall Study||30
101531|NCT01077284|237197|P2|COMPLETED|Overall Study||28
101532|NCT01077284|237198|P1|COMPLETED|Overall Study||28
101533|NCT01077284|237196|P3|STARTED|Overall Study||33
101534|NCT01077284|237197|P2|STARTED|Overall Study||33
101535|NCT01077284|237198|P1|STARTED|Overall Study||33
101536|NCT01077271|237219|P1|NOT COMPLETED|Overall Study||22
101537|NCT01077271|237219|P1|COMPLETED|Overall Study||102
101538|NCT01077271|237219|P1|Number of Participants Analyzed|Overall Study||120
101539|NCT01077271|237219|P1|Participants Treated With Palivizumab|Overall Study||120
101540|NCT01077271|237219|P1|STARTED|Overall Study||124
101541|NCT01077258|237257|P1|NOT COMPLETED|Overall Study||2568
101542|NCT01077258|237257|P1|COMPLETED|Overall Study||1640
101543|NCT01077258|237257|P1|STARTED|Overall Study||4208
101544|NCT01077193|237293|P1|NOT COMPLETED|Overall Study||44
101545|NCT01077193|237293|P1|COMPLETED|Overall Study||0
101546|NCT01077193|237293|P1|STARTED|Overall Study||44
101547|NCT01077128|237297|P1|NOT COMPLETED|Overall Study||67
101548|NCT01077128|237297|P1|COMPLETED|Overall Study||433
101549|NCT01077128|237297|P1|STARTED|Overall Study||500
101550|NCT01077076|237355|P6|NOT COMPLETED|Third Intervention||1
101551|NCT01077076|237356|P5|NOT COMPLETED|Third Intervention||0
101552|NCT01077076|237357|P4|NOT COMPLETED|Third Intervention||0
101553|NCT01077076|237358|P3|NOT COMPLETED|Third Intervention||0
101554|NCT01077076|237359|P2|NOT COMPLETED|Third Intervention||0
101555|NCT01077076|237360|P1|NOT COMPLETED|Third Intervention||0
101556|NCT01077076|237355|P6|COMPLETED|Third Intervention||4
101557|NCT01077076|237356|P5|COMPLETED|Third Intervention||5
101558|NCT01077076|237357|P4|COMPLETED|Third Intervention||5
101559|NCT01077076|237358|P3|COMPLETED|Third Intervention||5
101560|NCT01077076|237359|P2|COMPLETED|Third Intervention||5
101561|NCT01077076|237360|P1|COMPLETED|Third Intervention||4
101562|NCT01077076|237355|P6|STARTED|Third Intervention||5
101563|NCT01077076|237356|P5|STARTED|Third Intervention||5
101564|NCT01077076|237357|P4|STARTED|Third Intervention||5
101565|NCT01077076|237358|P3|STARTED|Third Intervention||5
101566|NCT01077076|237359|P2|STARTED|Third Intervention||5
101567|NCT01077076|237360|P1|STARTED|Third Intervention||4
101568|NCT01077076|237355|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
101569|NCT01077076|237356|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
101570|NCT01077076|237357|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
101571|NCT01077076|237358|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
101572|NCT01077076|237359|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
101573|NCT01077076|237360|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
101574|NCT01077076|237355|P6|COMPLETED|Washout Period of 2 Weeks||5
101575|NCT01077076|237356|P5|COMPLETED|Washout Period of 2 Weeks||5
101576|NCT01077076|237357|P4|COMPLETED|Washout Period of 2 Weeks||5
101577|NCT01077076|237358|P3|COMPLETED|Washout Period of 2 Weeks||5
101578|NCT01077076|237359|P2|COMPLETED|Washout Period of 2 Weeks||5
101579|NCT01077076|237360|P1|COMPLETED|Washout Period of 2 Weeks||4
101580|NCT01077076|237355|P6|STARTED|Washout Period of 2 Weeks||5
101581|NCT01077076|237356|P5|STARTED|Washout Period of 2 Weeks||5
101582|NCT01077076|237357|P4|STARTED|Washout Period of 2 Weeks||5
101583|NCT01077076|237358|P3|STARTED|Washout Period of 2 Weeks||5
101584|NCT01077076|237359|P2|STARTED|Washout Period of 2 Weeks||5
101585|NCT01077076|237360|P1|STARTED|Washout Period of 2 Weeks||4
101586|NCT01077076|237355|P6|NOT COMPLETED|Second Intervention||0
101587|NCT01077076|237356|P5|NOT COMPLETED|Second Intervention||0
101588|NCT01077076|237357|P4|NOT COMPLETED|Second Intervention||0
101589|NCT01077076|237358|P3|NOT COMPLETED|Second Intervention||0
101590|NCT01077076|237359|P2|NOT COMPLETED|Second Intervention||0
101591|NCT01077076|237360|P1|NOT COMPLETED|Second Intervention||0
101592|NCT01077076|237355|P6|COMPLETED|Second Intervention||5
101593|NCT01077076|237356|P5|COMPLETED|Second Intervention||5
101594|NCT01077076|237357|P4|COMPLETED|Second Intervention||5
101595|NCT01077076|237358|P3|COMPLETED|Second Intervention||5
101596|NCT01077076|237359|P2|COMPLETED|Second Intervention||5
101597|NCT01077076|237360|P1|COMPLETED|Second Intervention||4
101598|NCT01077076|237355|P6|STARTED|Second Intervention||5
101599|NCT01077076|237356|P5|STARTED|Second Intervention||5
101600|NCT01077076|237357|P4|STARTED|Second Intervention||5
101601|NCT01077076|237358|P3|STARTED|Second Intervention||5
101602|NCT01077076|237359|P2|STARTED|Second Intervention||5
101603|NCT01077076|237360|P1|STARTED|Second Intervention||4
101604|NCT01077076|237355|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
101605|NCT01077076|237356|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
101606|NCT01077076|237357|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
101607|NCT01077076|237358|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
101608|NCT01077076|237359|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
101609|NCT01077076|237360|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
101610|NCT01077076|237355|P6|COMPLETED|Washout Period of 2 Weeks||5
101611|NCT01077076|237356|P5|COMPLETED|Washout Period of 2 Weeks||5
101612|NCT01077076|237357|P4|COMPLETED|Washout Period of 2 Weeks||5
101613|NCT01077076|237358|P3|COMPLETED|Washout Period of 2 Weeks||5
101614|NCT01077076|237359|P2|COMPLETED|Washout Period of 2 Weeks||5
101615|NCT01077076|237360|P1|COMPLETED|Washout Period of 2 Weeks||4
101616|NCT01077076|237355|P6|STARTED|Washout Period of 2 Weeks||5
101617|NCT01077076|237356|P5|STARTED|Washout Period of 2 Weeks||5
101618|NCT01077076|237357|P4|STARTED|Washout Period of 2 Weeks||5
101619|NCT01077076|237358|P3|STARTED|Washout Period of 2 Weeks||5
101620|NCT01077076|237359|P2|STARTED|Washout Period of 2 Weeks||5
101621|NCT01077076|237360|P1|STARTED|Washout Period of 2 Weeks||4
101622|NCT01077076|237355|P6|NOT COMPLETED|First Intervention||0
101623|NCT01077076|237356|P5|NOT COMPLETED|First Intervention||0
101624|NCT01077076|237357|P4|NOT COMPLETED|First Intervention||0
101625|NCT01077076|237358|P3|NOT COMPLETED|First Intervention||0
101626|NCT01077076|237359|P2|NOT COMPLETED|First Intervention||0
101627|NCT01077076|237360|P1|NOT COMPLETED|First Intervention||1
101628|NCT01077076|237355|P6|COMPLETED|First Intervention||5
101629|NCT01077076|237356|P5|COMPLETED|First Intervention||5
101630|NCT01077076|237357|P4|COMPLETED|First Intervention||5
101631|NCT01077076|237358|P3|COMPLETED|First Intervention||5
101632|NCT01077076|237359|P2|COMPLETED|First Intervention||5
101633|NCT01077076|237360|P1|COMPLETED|First Intervention||4
101634|NCT01077076|237355|P6|STARTED|First Intervention||5
101635|NCT01077076|237356|P5|STARTED|First Intervention||5
101636|NCT01077076|237357|P4|STARTED|First Intervention||5
101637|NCT01077076|237358|P3|STARTED|First Intervention||5
101638|NCT01077076|237359|P2|STARTED|First Intervention||5
101639|NCT01077076|237360|P1|STARTED|First Intervention||5
101640|NCT01077063|237370|P2|NOT COMPLETED|Overall Study||3
101641|NCT01077063|237371|P1|NOT COMPLETED|Overall Study||4
101642|NCT01077063|237370|P2|COMPLETED|Overall Study||0
101643|NCT01077063|237371|P1|COMPLETED|Overall Study||0
101644|NCT01077063|237370|P2|STARTED|Overall Study||3
101645|NCT01077063|237371|P1|STARTED|Overall Study||4
101646|NCT01077050|237377|P1|NOT COMPLETED|Overall Study||9
101647|NCT01077050|237377|P1|COMPLETED|Overall Study||1942
101648|NCT01077050|237377|P1|STARTED|Overall Study||1951
101649|NCT01077024|237383|P2|NOT COMPLETED|Overall Study||28
101650|NCT01077024|237384|P1|NOT COMPLETED|Overall Study||31
101651|NCT01077024|237383|P2|COMPLETED|Overall Study||243
101652|NCT01077024|237384|P1|COMPLETED|Overall Study||236
101653|NCT01077024|237383|P2|STARTED|Overall Study||271
101654|NCT01077024|237384|P1|STARTED|Overall Study||267
101655|NCT01076985|237402|P1|NOT COMPLETED|Overall Study||0
101656|NCT01076985|237402|P1|COMPLETED|Overall Study||24
101657|NCT01076985|237402|P1|STARTED|Overall Study||24
101658|NCT01076972|237408|P1|NOT COMPLETED|Overall Study||0
101659|NCT01076972|237408|P1|COMPLETED|Overall Study||1184
101660|NCT01076972|237408|P1|STARTED|Overall Study||1184
101661|NCT01076959|237423|P1|NOT COMPLETED|Overall Study||2250
101662|NCT01076959|237423|P1|COMPLETED|Overall Study||5490
101663|NCT01076959|237423|P1|STARTED|Overall Study||7740
101664|NCT01076686|237444|P4|NOT COMPLETED|Overall Study||0
101665|NCT01076686|237445|P3|NOT COMPLETED|Overall Study||0
101666|NCT01076686|237446|P2|NOT COMPLETED|Overall Study||0
101667|NCT01076686|237447|P1|NOT COMPLETED|Overall Study||0
101668|NCT01076686|237444|P4|COMPLETED|Overall Study||31
101669|NCT01076686|237445|P3|COMPLETED|Overall Study||32
101670|NCT01076686|237446|P2|COMPLETED|Overall Study||14
101671|NCT01076686|237447|P1|COMPLETED|Overall Study||17
101672|NCT01076686|237444|P4|STARTED|Overall Study||31
101673|NCT01076686|237445|P3|STARTED|Overall Study||32
101674|NCT01076686|237446|P2|STARTED|Overall Study||14
101675|NCT01076686|237447|P1|STARTED|Overall Study||17
101676|NCT01076647|237459|P2|NOT COMPLETED|Overall Study||25
101677|NCT01076647|237460|P1|NOT COMPLETED|Overall Study||25
101678|NCT01076647|237459|P2|COMPLETED|Overall Study||209
101679|NCT01076647|237460|P1|COMPLETED|Overall Study||208
101680|NCT01076647|237459|P2|STARTED|Overall Study||234
101681|NCT01076647|237460|P1|STARTED|Overall Study||233
101682|NCT01076504|237468|P1|NOT COMPLETED|Overall Study||80
101683|NCT01076504|237468|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
101684|NCT01076504|237468|P1|STARTED|Overall Study||80
101685|NCT01076452|237478|P2|NOT COMPLETED|Overall Study||14
101686|NCT01076452|237479|P1|NOT COMPLETED|Overall Study||24
101687|NCT01076452|237478|P2|COMPLETED|Overall Study||138
101688|NCT01076452|237479|P1|COMPLETED|Overall Study||123
101689|NCT01076452|237478|P2|STARTED|Overall Study||152
101690|NCT01076452|237479|P1|STARTED|Overall Study||147
101691|NCT01076361|237491|P1|NOT COMPLETED|Overall Study||21
101692|NCT01076361|237491|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
101693|NCT01076361|237491|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
101694|NCT01076348|237495|P1|NOT COMPLETED|Overall Study||22
101695|NCT01076348|237495|P1|COMPLETED|Overall Study||51
101696|NCT01076348|237495|P1|STARTED|Overall Study||73
101697|NCT01076335|237499|P1|NOT COMPLETED|Overall Study||4
101698|NCT01076335|237499|P1|COMPLETED|Overall Study||36
101699|NCT01076335|237499|P1|STARTED|Overall Study||40
101700|NCT01076296|237503|P8|NOT COMPLETED|Overall Study||0
101701|NCT01076296|237504|P7|NOT COMPLETED|Overall Study||0
101702|NCT01076296|237505|P6|NOT COMPLETED|Overall Study||0
101703|NCT01076296|237506|P5|NOT COMPLETED|Overall Study||0
101704|NCT01076296|237507|P4|NOT COMPLETED|Overall Study||0
101705|NCT01076296|237508|P3|NOT COMPLETED|Overall Study||0
101706|NCT01076296|237509|P2|NOT COMPLETED|Overall Study||0
101707|NCT01076296|237510|P1|NOT COMPLETED|Overall Study||0
101708|NCT01076296|237503|P8|COMPLETED|Overall Study||199
101709|NCT01076296|237504|P7|COMPLETED|Overall Study||51
101710|NCT01076296|237505|P6|COMPLETED|Overall Study||191
101711|NCT01076296|237506|P5|COMPLETED|Overall Study||59
101712|NCT01076296|237507|P4|COMPLETED|Overall Study||199
101713|NCT01076296|237508|P3|COMPLETED|Overall Study||51
101714|NCT01076296|237509|P2|COMPLETED|Overall Study||196
101715|NCT01076296|237510|P1|COMPLETED|Overall Study||54
101716|NCT01076296|237503|P8|STARTED|Overall Study||199
101717|NCT01076296|237504|P7|STARTED|Overall Study||51
101718|NCT01076296|237505|P6|STARTED|Overall Study||191
101719|NCT01076296|237506|P5|STARTED|Overall Study||59
101720|NCT01076296|237507|P4|STARTED|Overall Study||199
101721|NCT01076296|237508|P3|STARTED|Overall Study||51
101722|NCT01076296|237509|P2|STARTED|Overall Study||196
101723|NCT01076296|237510|P1|STARTED|Overall Study||54
101724|NCT01076283|237530|P2|NOT COMPLETED|Overall Study||0
101725|NCT01076283|237531|P1|NOT COMPLETED|Overall Study||1
101726|NCT01076283|237530|P2|COMPLETED|Overall Study||7
101727|NCT01076283|237531|P1|COMPLETED|Overall Study||6
101728|NCT01076283|237530|P2|STARTED|Overall Study||7
101729|NCT01076283|237531|P1|STARTED|Overall Study||7
101730|NCT01076244|237539|P1|NOT COMPLETED|Overall Study||4
101731|NCT01076244|237539|P1|COMPLETED|Overall Study||42
101732|NCT01076244|237539|P1|STARTED|Overall Study||46
101733|NCT01076192|237546|P1|NOT COMPLETED|Overall Study||197
101734|NCT01076192|237546|P1|COMPLETED|Overall Study||350
101735|NCT01076192|237546|P1|STARTED|Overall Study||547
101736|NCT01076166|237561|P1|NOT COMPLETED|Overall Study||9
101737|NCT01076166|237561|P1|COMPLETED|Overall Study||328
101738|NCT01076166|237561|P1|STARTED|Overall Study||337
101739|NCT01076153|237568|P1|NOT COMPLETED|Overall Study||11
101740|NCT01076153|237568|P1|COMPLETED|Overall Study||749
101741|NCT01076153|237568|P1|STARTED|Overall Study||760
101742|NCT01076088|237582|P6|NOT COMPLETED|Overall Study||23
101743|NCT01076088|237583|P5|NOT COMPLETED|Overall Study||16
101744|NCT01076088|237584|P4|NOT COMPLETED|Overall Study||15
101745|NCT01076088|237585|P3|NOT COMPLETED|Overall Study||17
101746|NCT01076088|237586|P2|NOT COMPLETED|Overall Study||18
101747|NCT01076088|237587|P1|NOT COMPLETED|Overall Study||11
101748|NCT01076088|237582|P6|COMPLETED|Overall Study||104
101749|NCT01076088|237583|P5|COMPLETED|Overall Study||104
101750|NCT01076088|237584|P4|COMPLETED|Overall Study||109
101751|NCT01076088|237585|P3|COMPLETED|Overall Study||109
101752|NCT01076088|237586|P2|COMPLETED|Overall Study||107
101753|NCT01076088|237587|P1|COMPLETED|Overall Study||111
101754|NCT01076088|237582|P6|STARTED|Overall Study||127
101755|NCT01076088|237583|P5|STARTED|Overall Study||120
101756|NCT01076088|237584|P4|STARTED|Overall Study||124
101757|NCT01076088|237585|P3|STARTED|Overall Study||126
101758|NCT01076088|237586|P2|STARTED|Overall Study||125
101759|NCT01076088|237587|P1|STARTED|Overall Study||122
101760|NCT01076075|237615|P2|NOT COMPLETED|Overall Study||47
101761|NCT01076075|237616|P1|NOT COMPLETED|Overall Study||41
101762|NCT01076075|237615|P2|COMPLETED|Overall Study||167
101763|NCT01076075|237616|P1|COMPLETED|Overall Study||172
101764|NCT01076075|237615|P2|Completed Phase A|Overall Study||189
101765|NCT01076075|237616|P1|Completed Phase A|Overall Study||199
101766|NCT01076075|237615|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
101767|NCT01076075|237616|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
101768|NCT01076036|237630|P1|NOT COMPLETED|Overall Study||2
101769|NCT01076036|237630|P1|COMPLETED|Overall Study||8
101770|NCT01076036|237630|P1|Complete CorPath Procedures|Overall Study||8
101771|NCT01076036|237630|P1|# of Procedures|Overall Study||8
101772|NCT01076036|237630|P1|STARTED|Overall Study||10
101773|NCT01075984|237640|P5|NOT COMPLETED|Follow-up Phase||47
101774|NCT01075984|237641|P4|NOT COMPLETED|Follow-up Phase||2
101775|NCT01075984|237642|P3|NOT COMPLETED|Follow-up Phase||1
101776|NCT01075984|237643|P2|NOT COMPLETED|Follow-up Phase||0
101777|NCT01075984|237644|P1|NOT COMPLETED|Follow-up Phase||0
101778|NCT01075984|237640|P5|COMPLETED|Follow-up Phase||165
101779|NCT01075984|237641|P4|COMPLETED|Follow-up Phase||19
101780|NCT01075984|237642|P3|COMPLETED|Follow-up Phase||19
101781|NCT01075984|237643|P2|COMPLETED|Follow-up Phase||10
101782|NCT01075984|237644|P1|COMPLETED|Follow-up Phase||10
101783|NCT01075984|237640|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
101784|NCT01075984|237641|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
101785|NCT01075984|237642|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
101786|NCT01075984|237643|P2|STARTED|Follow-up Phase||10
101787|NCT01075984|237644|P1|STARTED|Follow-up Phase||10
101788|NCT01075984|237640|P5|NOT COMPLETED|Treatment Phase||60
101789|NCT01075984|237641|P4|NOT COMPLETED|Treatment Phase||7
101790|NCT01075984|237642|P3|NOT COMPLETED|Treatment Phase||7
101791|NCT01075984|237643|P2|NOT COMPLETED|Treatment Phase||1
101792|NCT01075984|237644|P1|NOT COMPLETED|Treatment Phase||0
101793|NCT01075984|237640|P5|COMPLETED|Treatment Phase||153
101794|NCT01075984|237641|P4|COMPLETED|Treatment Phase||17
101795|NCT01075984|237642|P3|COMPLETED|Treatment Phase||14
101796|NCT01075984|237643|P2|COMPLETED|Treatment Phase||10
101797|NCT01075984|237644|P1|COMPLETED|Treatment Phase||10
101798|NCT01075984|237640|P5|STARTED|Treatment Phase||213
101799|NCT01075984|237641|P4|STARTED|Treatment Phase||24
101800|NCT01075984|237642|P3|STARTED|Treatment Phase||21
101801|NCT01075984|237643|P2|STARTED|Treatment Phase||11
101802|NCT01075984|237644|P1|STARTED|Treatment Phase||10
101803|NCT01075971|237698|P1|NOT COMPLETED|Overall Study||0
101804|NCT01075971|237698|P1|COMPLETED|Overall Study||52
101805|NCT01075971|237698|P1|STARTED|Overall Study||52
101806|NCT01075958|237702|P1|NOT COMPLETED|Overall Study||44
101807|NCT01075958|237702|P1|COMPLETED|Overall Study||239
101808|NCT01075958|237702|P1|STARTED|Overall Study||283
101809|NCT01075815|237718|P2|NOT COMPLETED|Overall Study||4
101810|NCT01075815|237719|P1|NOT COMPLETED|Overall Study||10
101811|NCT01075815|237718|P2|COMPLETED|Overall Study||31
101812|NCT01075815|237719|P1|COMPLETED|Overall Study||30
101813|NCT01075815|237718|P2|STARTED|Overall Study|Number of participants treated.|35
101814|NCT01075815|237719|P1|STARTED|Overall Study|Number of participants treated.|40
101815|NCT01075763|237757|P2|NOT COMPLETED|Overall Study||4
101816|NCT01075763|237758|P1|NOT COMPLETED|Overall Study||4
101817|NCT01075763|237757|P2|COMPLETED|Overall Study||15
101818|NCT01075763|237758|P1|COMPLETED|Overall Study||19
101819|NCT01075763|237757|P2|STARTED|Overall Study||19
101820|NCT01075763|237758|P1|STARTED|Overall Study||23
101821|NCT01075685|237782|P2|NOT COMPLETED|Overall Study||226
101822|NCT01075685|237783|P1|NOT COMPLETED|Overall Study||592
101823|NCT01075685|237782|P2|COMPLETED|Overall Study||188
101824|NCT01075685|237783|P1|COMPLETED|Overall Study||151
101825|NCT01075685|237782|P2|Completed Baseline Measures|Overall Study||263
101826|NCT01075685|237783|P1|Completed Baseline Measures|Overall Study||225
101827|NCT01075685|237782|P2|Met Inclusion Criteria|Overall Study||413
101828|NCT01075685|237783|P1|Met Inclusion Criteria|Overall Study||734
101829|NCT01075685|237782|P2|STARTED|Overall Study||414
101830|NCT01075685|237783|P1|STARTED|Overall Study||743
101831|NCT01075646|237799|P4|NOT COMPLETED|Overall Study||2
101832|NCT01075646|237800|P3|NOT COMPLETED|Overall Study||1
101833|NCT01075646|237801|P2|NOT COMPLETED|Overall Study||3
101834|NCT01075646|237802|P1|NOT COMPLETED|Overall Study||4
101835|NCT01075646|237799|P4|COMPLETED|Overall Study||44
101836|NCT01075646|237800|P3|COMPLETED|Overall Study||52
101837|NCT01075646|237801|P2|COMPLETED|Overall Study||31
101838|NCT01075646|237802|P1|COMPLETED|Overall Study||29
101839|NCT01075646|237799|P4|STARTED|Overall Study||46
101840|NCT01075646|237800|P3|STARTED|Overall Study||53
101841|NCT01075646|237801|P2|STARTED|Overall Study||34
101842|NCT01075646|237802|P1|STARTED|Overall Study||33
101843|NCT01075399|237832|P1|NOT COMPLETED|Overall Study||8
101844|NCT01075399|237832|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
101845|NCT01075399|237832|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
101846|NCT01075347|237838|P2|NOT COMPLETED|Overall Study||0
101847|NCT01075347|237839|P1|NOT COMPLETED|Overall Study||0
101848|NCT01075347|237838|P2|COMPLETED|Overall Study||83
101849|NCT01075347|237839|P1|COMPLETED|Overall Study||82
101850|NCT01075347|237838|P2|STARTED|Overall Study||83
101851|NCT01075347|237839|P1|STARTED|Overall Study||82
101852|NCT01075282|237850|P3|NOT COMPLETED|Overall Study||27
101853|NCT01075282|237851|P2|NOT COMPLETED|Overall Study||29
101854|NCT01075282|237852|P1|NOT COMPLETED|Overall Study||31
101855|NCT01075282|237850|P3|COMPLETED|Overall Study||238
101856|NCT01075282|237851|P2|COMPLETED|Overall Study||243
101857|NCT01075282|237852|P1|COMPLETED|Overall Study||242
101858|NCT01075282|237850|P3|Received at Least One Dose of Study Drug|Overall Study||262
101859|NCT01075282|237851|P2|Received at Least One Dose of Study Drug|Overall Study||272
101860|NCT01075282|237852|P1|Received at Least One Dose of Study Drug|Overall Study||273
101861|NCT01075282|237850|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
101862|NCT01075282|237851|P2|STARTED|Overall Study||272
101863|NCT01075282|237852|P1|STARTED|Overall Study||273
101864|NCT01075256|237935|P3|NOT COMPLETED|Overall Study||0
101865|NCT01075256|237936|P2|NOT COMPLETED|Overall Study||0
101866|NCT01075256|237937|P1|NOT COMPLETED|Overall Study||1
101867|NCT01075256|237935|P3|COMPLETED|Overall Study||65
101868|NCT01075256|237936|P2|COMPLETED|Overall Study||66
101869|NCT01075256|237937|P1|COMPLETED|Overall Study||63
101870|NCT01075256|237935|P3|STARTED|Overall Study||65
101871|NCT01075256|237936|P2|STARTED|Overall Study||66
101872|NCT01075256|237937|P1|STARTED|Overall Study||64
101873|NCT01075243|237969|P3|NOT COMPLETED|Overall Study||0
101874|NCT01075243|237970|P2|NOT COMPLETED|Overall Study||3
101875|NCT01075243|237971|P1|NOT COMPLETED|Overall Study||6
101876|NCT01075243|237969|P3|COMPLETED|Overall Study||80
101877|NCT01075243|237970|P2|COMPLETED|Overall Study||155
101878|NCT01075243|237971|P1|COMPLETED|Overall Study||157
101879|NCT01075243|237969|P3|STARTED|Overall Study||80
101880|NCT01075243|237970|P2|STARTED|Overall Study||158
101881|NCT01075243|237971|P1|STARTED|Overall Study||163
101882|NCT01075217|238023|P2|NOT COMPLETED|Overall Study||1
101883|NCT01075217|238024|P1|NOT COMPLETED|Overall Study||2
101884|NCT01075217|238023|P2|COMPLETED|Overall Study||84
101885|NCT01075217|238024|P1|COMPLETED|Overall Study||82
101886|NCT01075217|238023|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
101887|NCT01075217|238024|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
101888|NCT01075204|238040|P1|NOT COMPLETED|Overall Study||0
101889|NCT01075204|238040|P1|COMPLETED|Overall Study||335
101890|NCT01075204|238040|P1|STARTED|Overall Study||335
101891|NCT01075191|238057|P1|NOT COMPLETED|Overall Study||18
101892|NCT01075191|238057|P1|COMPLETED|Overall Study||42
101893|NCT01075191|238057|P1|Discontinued Year 3|Overall Study||5
101894|NCT01075191|238057|P1|Discontinued Year 2|Overall Study||6
101895|NCT01075191|238057|P1|Discontinued Year 1|Overall Study||7
101896|NCT01075191|238057|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
101897|NCT01075178|238068|P2|NOT COMPLETED|Subject Chart Review||9
101898|NCT01075178|238069|P1|NOT COMPLETED|Subject Chart Review||9
101899|NCT01075178|238068|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
101900|NCT01075178|238069|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
101901|NCT01075178|238068|P2|STARTED|Subject Chart Review|subjects matched|1018
101902|NCT01075178|238069|P1|STARTED|Subject Chart Review|subjects matched|1018
101903|NCT01075178|238068|P2|NOT COMPLETED|Subject Matching||403
101904|NCT01075178|238069|P1|NOT COMPLETED|Subject Matching||130
101905|NCT01075178|238068|P2|COMPLETED|Subject Matching|subjects matched|1018
101906|NCT01075178|238069|P1|COMPLETED|Subject Matching|subjects matched|1018
101907|NCT01075178|238068|P2|STARTED|Subject Matching|eligible for matching|1421
101908|NCT01075178|238069|P1|STARTED|Subject Matching|eligible for matching|1148
101909|NCT01075152|238083|P2|NOT COMPLETED|Overall Study||0
101910|NCT01075152|238084|P1|NOT COMPLETED|Overall Study||1
101911|NCT01075152|238083|P2|COMPLETED|Overall Study||89
101912|NCT01075152|238084|P1|COMPLETED|Overall Study||87
101913|NCT01075152|238083|P2|STARTED|Overall Study|randomized|89
101914|NCT01075152|238084|P1|STARTED|Overall Study|randomized|88
101915|NCT01075100|238110|P2|NOT COMPLETED|Overall Study||53
101916|NCT01075100|238111|P1|NOT COMPLETED|Overall Study||49
101917|NCT01075100|238110|P2|COMPLETED|Overall Study||1
101918|NCT01075100|238111|P1|COMPLETED|Overall Study||0
101919|NCT01075100|238110|P2|STARTED|Overall Study||54
101920|NCT01075100|238111|P1|STARTED|Overall Study||49
101921|NCT01075087|238129|P2|NOT COMPLETED|Overall Study||0
101922|NCT01075087|238130|P1|NOT COMPLETED|Overall Study||0
101923|NCT01075087|238129|P2|COMPLETED|Overall Study||10
101924|NCT01075087|238130|P1|COMPLETED|Overall Study||9
101925|NCT01075087|238129|P2|STARTED|Overall Study||10
101926|NCT01075087|238130|P1|STARTED|Overall Study||9
101927|NCT01075074|238141|P3|NOT COMPLETED|Overall Study||2
101928|NCT01075074|238142|P2|NOT COMPLETED|Overall Study||2
101929|NCT01075074|238143|P1|NOT COMPLETED|Overall Study||1
101930|NCT01075074|238141|P3|COMPLETED|Overall Study||23
101931|NCT01075074|238142|P2|COMPLETED|Overall Study||23
101932|NCT01075074|238143|P1|COMPLETED|Overall Study||24
101933|NCT01075074|238141|P3|STARTED|Overall Study||25
101934|NCT01075074|238142|P2|STARTED|Overall Study||25
101935|NCT01075074|238143|P1|STARTED|Overall Study||25
101936|NCT01074944|238160|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
101937|NCT01074944|238161|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
101938|NCT01074944|238162|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
101939|NCT01074944|238163|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
101940|NCT01074944|238164|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
101941|NCT01074944|238160|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
101942|NCT01074944|238161|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
101943|NCT01074944|238162|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
101944|NCT01074944|238163|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
101945|NCT01074944|238164|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
101946|NCT01074944|238160|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
101947|NCT01074944|238161|P4|STARTED|Extended Treatment (up to 42 Months)||0
101948|NCT01074944|238162|P3|STARTED|Extended Treatment (up to 42 Months)||0
101949|NCT01074944|238163|P2|STARTED|Extended Treatment (up to 42 Months)||0
101950|NCT01074944|238164|P1|STARTED|Extended Treatment (up to 42 Months)||0
101951|NCT01074944|238160|P5|NOT COMPLETED|Long Term Treatment||0
101952|NCT01074944|238161|P4|NOT COMPLETED|Long Term Treatment||26
101953|NCT01074944|238162|P3|NOT COMPLETED|Long Term Treatment||0
101954|NCT01074944|238163|P2|NOT COMPLETED|Long Term Treatment||0
101955|NCT01074944|238164|P1|NOT COMPLETED|Long Term Treatment||0
101956|NCT01074944|238160|P5|COMPLETED|Long Term Treatment||0
101957|NCT01074944|238161|P4|COMPLETED|Long Term Treatment||95
101958|NCT01074944|238162|P3|COMPLETED|Long Term Treatment||0
101959|NCT01074944|238163|P2|COMPLETED|Long Term Treatment||0
101960|NCT01074944|238164|P1|COMPLETED|Long Term Treatment||0
101961|NCT01074944|238160|P5|STARTED|Long Term Treatment||0
101962|NCT01074944|238161|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
101963|NCT01074944|238162|P3|STARTED|Long Term Treatment||0
101964|NCT01074944|238163|P2|STARTED|Long Term Treatment||0
101965|NCT01074944|238164|P1|STARTED|Long Term Treatment||0
101966|NCT01074944|238160|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101967|NCT01074944|238161|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101968|NCT01074944|238162|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
101969|NCT01074944|238163|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
101970|NCT01074944|238164|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101971|NCT01074944|238160|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101972|NCT01074944|238161|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101973|NCT01074944|238162|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
101974|NCT01074944|238163|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
101975|NCT01074944|238164|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
101976|NCT01074944|238160|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
101977|NCT01074944|238161|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
101978|NCT01074944|238162|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
101979|NCT01074944|238163|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
101980|NCT01074944|238164|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
101981|NCT01074944|238160|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
101982|NCT01074944|238161|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
101983|NCT01074944|238162|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
101984|NCT01074944|238163|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
101985|NCT01074944|238164|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
101986|NCT01074944|238160|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
101987|NCT01074944|238161|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
101988|NCT01074944|238162|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
101989|NCT01074944|238163|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
101990|NCT01074944|238164|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
101991|NCT01074944|238160|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
101992|NCT01074944|238161|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
101993|NCT01074944|238162|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
101994|NCT01074944|238163|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
101995|NCT01074944|238164|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
101996|NCT01074931|238218|P1|NOT COMPLETED|Overall Study||6
101997|NCT01074931|238218|P1|COMPLETED|Overall Study||92
101998|NCT01074931|238218|P1|STARTED|Overall Study||98
101999|NCT01074658|238230|P1|NOT COMPLETED|Overall Study||19
102000|NCT01074658|238230|P1|COMPLETED|Overall Study||996
102001|NCT01074658|238230|P1|Attempted Implant|Overall Study||996
102002|NCT01074658|238230|P1|STARTED|Overall Study||1015
102003|NCT01074554|238238|P2|NOT COMPLETED|Overall Study||4
102004|NCT01074554|238239|P1|NOT COMPLETED|Overall Study||3
102005|NCT01074554|238238|P2|COMPLETED|Overall Study||11
102006|NCT01074554|238239|P1|COMPLETED|Overall Study||11
102007|NCT01074554|238238|P2|STARTED|Overall Study||15
102008|NCT01074554|238239|P1|STARTED|Overall Study||14
102009|NCT01074502|238249|P1|NOT COMPLETED|Overall Study||1
102010|NCT01074502|238249|P1|COMPLETED|Overall Study||2
102011|NCT01074502|238249|P1|STARTED|Overall Study||3
102012|NCT01074463|238260|P2|NOT COMPLETED|Second Intervention||0
102013|NCT01074463|238261|P1|NOT COMPLETED|Second Intervention||0
102014|NCT01074463|238260|P2|COMPLETED|Second Intervention||12
102015|NCT01074463|238261|P1|COMPLETED|Second Intervention||12
102016|NCT01074463|238260|P2|STARTED|Second Intervention||12
102017|NCT01074463|238261|P1|STARTED|Second Intervention||12
102018|NCT01074463|238260|P2|NOT COMPLETED|Washout of 7 Days||0
102019|NCT01074463|238261|P1|NOT COMPLETED|Washout of 7 Days||0
102020|NCT01074463|238260|P2|COMPLETED|Washout of 7 Days||12
102021|NCT01074463|238261|P1|COMPLETED|Washout of 7 Days||12
102022|NCT01074463|238260|P2|STARTED|Washout of 7 Days||12
102023|NCT01074463|238261|P1|STARTED|Washout of 7 Days||12
102024|NCT01074463|238260|P2|NOT COMPLETED|First Intervention||0
102025|NCT01074463|238261|P1|NOT COMPLETED|First Intervention||0
102026|NCT01074463|238260|P2|COMPLETED|First Intervention||12
102027|NCT01074463|238261|P1|COMPLETED|First Intervention||12
102028|NCT01074463|238260|P2|STARTED|First Intervention||12
102029|NCT01074463|238261|P1|STARTED|First Intervention||12
102030|NCT01074450|238273|P2|NOT COMPLETED|Second Intervention||1
102031|NCT01074450|238274|P1|NOT COMPLETED|Second Intervention||1
102032|NCT01074450|238273|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
102033|NCT01074450|238274|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
102034|NCT01074450|238273|P2|STARTED|Second Intervention||10
102035|NCT01074450|238274|P1|STARTED|Second Intervention||12
102036|NCT01074450|238273|P2|NOT COMPLETED|Washout of 7 Days||0
102037|NCT01074450|238274|P1|NOT COMPLETED|Washout of 7 Days||0
102038|NCT01074450|238273|P2|COMPLETED|Washout of 7 Days||10
102039|NCT01074450|238274|P1|COMPLETED|Washout of 7 Days||12
102040|NCT01074450|238273|P2|STARTED|Washout of 7 Days||10
102041|NCT01074450|238274|P1|STARTED|Washout of 7 Days||12
102042|NCT01074450|238273|P2|NOT COMPLETED|First Intervention||2
102043|NCT01074450|238274|P1|NOT COMPLETED|First Intervention||0
102044|NCT01074450|238273|P2|COMPLETED|First Intervention||10
102045|NCT01074450|238274|P1|COMPLETED|First Intervention||12
102046|NCT01074450|238273|P2|STARTED|First Intervention||12
102047|NCT01074450|238274|P1|STARTED|First Intervention||12
102048|NCT01074437|238286|P2|NOT COMPLETED|Overall Study||0
102049|NCT01074437|238287|P1|NOT COMPLETED|Overall Study||0
102050|NCT01074437|238286|P2|COMPLETED|Overall Study||5
102051|NCT01074437|238287|P1|COMPLETED|Overall Study||4
102052|NCT01074437|238286|P2|STARTED|Overall Study||5
102053|NCT01074437|238287|P1|STARTED|Overall Study||4
102054|NCT01074307|238295|P2|NOT COMPLETED|Overall Study||12
102055|NCT01074307|238296|P1|NOT COMPLETED|Overall Study||22
102056|NCT01074307|238295|P2|COMPLETED|Overall Study||102
102057|NCT01074307|238296|P1|COMPLETED|Overall Study||44
102058|NCT01074307|238295|P2|STARTED|Overall Study||114
102059|NCT01074307|238296|P1|STARTED|Overall Study||66
102060|NCT01074268|238318|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
102061|NCT01074268|238319|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
102062|NCT01074268|238318|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
102063|NCT01074268|238319|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
102064|NCT01074268|238318|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
102065|NCT01074268|238319|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
102066|NCT01074268|238318|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
102067|NCT01074268|238319|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
102068|NCT01074268|238318|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
102069|NCT01074268|238319|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
102070|NCT01074268|238318|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
102071|NCT01074268|238319|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
102072|NCT01074268|238318|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
102073|NCT01074268|238319|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
102074|NCT01074268|238318|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
102075|NCT01074268|238319|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
102076|NCT01074255|238345|P1|NOT COMPLETED|Overall Study||2
102077|NCT01074255|238345|P1|COMPLETED|Overall Study||3139
102078|NCT01074255|238345|P1|Treated|Overall Study||3139
102079|NCT01074255|238345|P1|STARTED|Overall Study||3141
102080|NCT01074242|238349|P1|NOT COMPLETED|Overall Study||403
102081|NCT01074242|238349|P1|COMPLETED|Overall Study||3395
102082|NCT01074242|238349|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
102083|NCT01074242|238349|P1|STARTED|Overall Study||3798
102084|NCT01074229|238357|P3|NOT COMPLETED|Overall Study||4
102085|NCT01074229|238358|P2|NOT COMPLETED|Overall Study||3
102086|NCT01074229|238359|P1|NOT COMPLETED|Overall Study||2
102087|NCT01074229|238357|P3|COMPLETED|Overall Study||21
102088|NCT01074229|238358|P2|COMPLETED|Overall Study||22
102089|NCT01074229|238359|P1|COMPLETED|Overall Study||23
102090|NCT01074229|238357|P3|STARTED|Overall Study||25
102091|NCT01074229|238358|P2|STARTED|Overall Study||25
102092|NCT01074229|238359|P1|STARTED|Overall Study||25
102093|NCT01074216|238370|P1|NOT COMPLETED|Overall Study||13
102094|NCT01074216|238370|P1|COMPLETED|Overall Study||41
102095|NCT01074216|238370|P1|STARTED|Overall Study||54
102096|NCT01074164|238376|P2|NOT COMPLETED|Overall Study||1
102097|NCT01074164|238377|P1|NOT COMPLETED|Overall Study||3
102098|NCT01074164|238376|P2|COMPLETED|Overall Study||7
102099|NCT01074164|238377|P1|COMPLETED|Overall Study||4
102100|NCT01074164|238376|P2|STARTED|Overall Study||8
102101|NCT01074164|238377|P1|STARTED|Overall Study||7
102102|NCT01074125|238398|P3|NOT COMPLETED|Overall Study||12
102103|NCT01074125|238399|P2|NOT COMPLETED|Overall Study||5
102104|NCT01074125|238400|P1|NOT COMPLETED|Overall Study||12
102105|NCT01074125|238398|P3|COMPLETED|Overall Study||36
102106|NCT01074125|238399|P2|COMPLETED|Overall Study||47
102107|NCT01074125|238400|P1|COMPLETED|Overall Study||39
102108|NCT01074125|238398|P3|STARTED|Overall Study||48
102109|NCT01074125|238399|P2|STARTED|Overall Study||52
102110|NCT01074125|238400|P1|STARTED|Overall Study||51
102111|NCT01074099|238416|P2|NOT COMPLETED|Overall Study||0
102112|NCT01074099|238417|P1|NOT COMPLETED|Overall Study||0
102113|NCT01074099|238416|P2|COMPLETED|Overall Study||3
102114|NCT01074099|238417|P1|COMPLETED|Overall Study||2
102115|NCT01074099|238416|P2|STARTED|Overall Study||3
102116|NCT01074099|238417|P1|STARTED|Overall Study||2
102117|NCT01074047|238427|P2|NOT COMPLETED|Survival Follow-Up Phase||136
102118|NCT01074047|238428|P1|NOT COMPLETED|Survival Follow-Up Phase||124
102119|NCT01074047|238427|P2|COMPLETED|Survival Follow-Up Phase||27
102120|NCT01074047|238428|P1|COMPLETED|Survival Follow-Up Phase||16
102121|NCT01074047|238427|P2|STARTED|Survival Follow-Up Phase||163
102122|NCT01074047|238428|P1|STARTED|Survival Follow-Up Phase||140
102123|NCT01074047|238427|P2|NOT COMPLETED|Treatment Phase||247
102124|NCT01074047|238428|P1|NOT COMPLETED|Treatment Phase||241
102125|NCT01074047|238427|P2|COMPLETED|Treatment Phase||0
102126|NCT01074047|238428|P1|COMPLETED|Treatment Phase||0
102127|NCT01074047|238427|P2|Evaluable Population|Treatment Phase|Those with no major protocol violations, given 1 cycle of therapy, and had 1 efficacy assessment|191
102128|NCT01074047|238428|P1|Evaluable Population|Treatment Phase|Those with no major protocol violations, given 1 cycle of therapy, and had 1 efficacy assessment|179
102129|NCT01074047|238427|P2|Safety Population|Treatment Phase|Includes those who received one dose of study medication and had one post dose safety assessment|235
102130|NCT01074047|238428|P1|Safety Population|Treatment Phase|Includes those who received one dose of study medication and had one post dose safety assessment|236
102131|NCT01074047|238427|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
102132|NCT01074047|238428|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
102133|NCT01074047|238427|P2|STARTED|Treatment Phase||247
102134|NCT01074047|238428|P1|STARTED|Treatment Phase||241
102135|NCT01074008|238509|P9|NOT COMPLETED|Overall Study||4
102136|NCT01074008|238510|P8|NOT COMPLETED|Overall Study||0
102137|NCT01074008|238511|P7|NOT COMPLETED|Overall Study||1
102138|NCT01074008|238512|P6|NOT COMPLETED|Overall Study||0
102139|NCT01074008|238513|P5|NOT COMPLETED|Overall Study||2
102140|NCT01074008|238514|P4|NOT COMPLETED|Overall Study||1
102141|NCT01074008|238515|P3|NOT COMPLETED|Overall Study||2
102142|NCT01074008|238516|P2|NOT COMPLETED|Overall Study||3
102143|NCT01074008|238517|P1|NOT COMPLETED|Overall Study||1
102144|NCT01074008|238509|P9|COMPLETED|Overall Study||7
102145|NCT01074008|238510|P8|COMPLETED|Overall Study||8
102146|NCT01074008|238511|P7|COMPLETED|Overall Study||7
102147|NCT01074008|238512|P6|COMPLETED|Overall Study||7
102148|NCT01074008|238513|P5|COMPLETED|Overall Study||6
102149|NCT01074008|238514|P4|COMPLETED|Overall Study||7
102150|NCT01074008|238515|P3|COMPLETED|Overall Study||6
102151|NCT01074008|238516|P2|COMPLETED|Overall Study||5
102152|NCT01074008|238517|P1|COMPLETED|Overall Study||7
102153|NCT01074008|238509|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
102154|NCT01074008|238510|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
102155|NCT01074008|238511|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
102156|NCT01074008|238512|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
102157|NCT01074008|238513|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
102158|NCT01074008|238514|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
102159|NCT01074008|238515|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
102160|NCT01074008|238516|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
102161|NCT01074008|238517|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
102162|NCT01074008|238509|P9|STARTED|Overall Study||11
102163|NCT01074008|238510|P8|STARTED|Overall Study||8
102164|NCT01074008|238511|P7|STARTED|Overall Study||8
102165|NCT01074008|238512|P6|STARTED|Overall Study||7
102166|NCT01074008|238513|P5|STARTED|Overall Study||8
102167|NCT01074008|238514|P4|STARTED|Overall Study||8
102168|NCT01074008|238515|P3|STARTED|Overall Study||8
102169|NCT01074008|238516|P2|STARTED|Overall Study||8
102170|NCT01074008|238517|P1|STARTED|Overall Study||8
102171|NCT01073943|238627|P2|NOT COMPLETED|Overall Study||8
102172|NCT01073943|238628|P1|NOT COMPLETED|Overall Study||13
102173|NCT01073943|238627|P2|COMPLETED|Overall Study||295
102174|NCT01073943|238628|P1|COMPLETED|Overall Study||287
102175|NCT01073943|238627|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
102176|NCT01073943|238628|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
102177|NCT01073943|238627|P2|Safety Population (Treated)|Overall Study||302
102178|NCT01073943|238628|P1|Safety Population (Treated)|Overall Study||296
102179|NCT01073943|238627|P2|STARTED|Overall Study||303
102180|NCT01073943|238628|P1|STARTED|Overall Study||300
102181|NCT01073930|238654|P2|NOT COMPLETED|Overall Study||6
102182|NCT01073930|238655|P1|NOT COMPLETED|Overall Study||3
102183|NCT01073930|238654|P2|COMPLETED|Overall Study||295
102184|NCT01073930|238655|P1|COMPLETED|Overall Study||304
102185|NCT01073930|238654|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
102186|NCT01073930|238655|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
102187|NCT01073930|238654|P2|Safety Population (Treated)|Overall Study||298
102188|NCT01073930|238655|P1|Safety Population (Treated)|Overall Study||305
102189|NCT01073930|238654|P2|STARTED|Overall Study||301
102190|NCT01073930|238655|P1|STARTED|Overall Study||307
102191|NCT01073865|238679|P2|NOT COMPLETED|Overall Study||39
102192|NCT01073865|238680|P1|NOT COMPLETED|Overall Study||28
102193|NCT01073865|238679|P2|COMPLETED|Overall Study|Number of patients completed the study|74
102194|NCT01073865|238680|P1|COMPLETED|Overall Study|Number of patients completed the study|81
102195|NCT01073865|238679|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
102196|NCT01073865|238680|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
102197|NCT01073865|238679|P2|STARTED|Overall Study|Number of patients randomised|113
102198|NCT01073865|238680|P1|STARTED|Overall Study|Number of patients randomised|109
102199|NCT01073657|238692|P2|NOT COMPLETED|Overall Study||0
102200|NCT01073657|238693|P1|NOT COMPLETED|Overall Study||0
102201|NCT01073657|238692|P2|COMPLETED|Overall Study||16
102202|NCT01073657|238693|P1|COMPLETED|Overall Study||17
102203|NCT01073657|238692|P2|STARTED|Overall Study||16
102204|NCT01073657|238693|P1|STARTED|Overall Study||17
102205|NCT01073631|238699|P1|NOT COMPLETED|Overall Study||169
102206|NCT01073631|238699|P1|COMPLETED|Overall Study||374
102207|NCT01073631|238699|P1|STARTED|Overall Study||543
102208|NCT01073618|238704|P1|NOT COMPLETED|Overall Study||307
102209|NCT01073618|238704|P1|COMPLETED|Overall Study||385
102210|NCT01073618|238704|P1|STARTED|Overall Study||692
102211|NCT01073605|238712|P3|NOT COMPLETED|Overall Study||61
102212|NCT01073605|238713|P2|NOT COMPLETED|Overall Study||67
102213|NCT01073605|238714|P1|NOT COMPLETED|Overall Study||62
102214|NCT01073605|238712|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
102215|NCT01073605|238713|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
102216|NCT01073605|238714|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
102217|NCT01073605|238712|P3|Received Treatment|Overall Study||68
102218|NCT01073605|238713|P2|Received Treatment|Overall Study||70
102219|NCT01073605|238714|P1|Received Treatment|Overall Study||68
102220|NCT01073605|238712|P3|STARTED|Overall Study||69
102221|NCT01073605|238713|P2|STARTED|Overall Study||71
102222|NCT01073605|238714|P1|STARTED|Overall Study||68
102223|NCT01073566|238760|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
102224|NCT01073566|238761|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
102225|NCT01073566|238760|P2|COMPLETED|Period 2 (6 Weeks)||19
102226|NCT01073566|238761|P1|COMPLETED|Period 2 (6 Weeks)||18
102227|NCT01073566|238760|P2|STARTED|Period 2 (6 Weeks)||19
102228|NCT01073566|238761|P1|STARTED|Period 2 (6 Weeks)||19
102229|NCT01073566|238760|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
102230|NCT01073566|238761|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
102231|NCT01073566|238760|P2|COMPLETED|Period 1 (6 Weeks)||19
102232|NCT01073566|238761|P1|COMPLETED|Period 1 (6 Weeks)||19
102233|NCT01073566|238760|P2|STARTED|Period 1 (6 Weeks)||19
102234|NCT01073566|238761|P1|STARTED|Period 1 (6 Weeks)||19
102235|NCT01073462|238773|P1|NOT COMPLETED|Overall Study||41
102236|NCT01073462|238773|P1|COMPLETED|Overall Study||26
102237|NCT01073462|238773|P1|STARTED|Overall Study||67
102238|NCT01073449|238784|P1|NOT COMPLETED|Overall Study||0
102239|NCT01073449|238784|P1|COMPLETED|Overall Study||3362
102240|NCT01073449|238784|P1|STARTED|Overall Study||3362
102241|NCT01073293|238792|P2|NOT COMPLETED|Overall Study||11
102242|NCT01073293|238793|P1|NOT COMPLETED|Overall Study||5
102243|NCT01073293|238792|P2|COMPLETED|Overall Study||517
102244|NCT01073293|238793|P1|COMPLETED|Overall Study||521
102245|NCT01073293|238792|P2|STARTED|Overall Study||528
102246|NCT01073293|238793|P1|STARTED|Overall Study||526
102247|NCT01073267|238815|P1|NOT COMPLETED|Overall Study||3
102248|NCT01073267|238815|P1|COMPLETED|Overall Study||1
102249|NCT01073267|238815|P1|STARTED|Overall Study||4
102250|NCT01073163|238819|P1|NOT COMPLETED|Overall Study||3
102251|NCT01073163|238819|P1|COMPLETED|Overall Study|Patients completed study|51
102252|NCT01073163|238819|P1|Treated With >=6 Cycles|Overall Study||49
102253|NCT01073163|238819|P1|Treated With <6 Cycles|Overall Study||4
102254|NCT01073163|238819|P1|Enrolled But Not Treated|Overall Study||1
102255|NCT01073163|238819|P1|STARTED|Overall Study||54
102256|NCT01072929|238842|P3|NOT COMPLETED|Overall Study||9
102257|NCT01072929|238843|P2|NOT COMPLETED|Overall Study||51
102258|NCT01072929|238844|P1|NOT COMPLETED|Overall Study||44
102259|NCT01072929|238842|P3|COMPLETED|Overall Study||24
102260|NCT01072929|238843|P2|COMPLETED|Overall Study||150
102261|NCT01072929|238844|P1|COMPLETED|Overall Study||155
102262|NCT01072929|238842|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
102263|NCT01072929|238843|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
102264|NCT01072929|238844|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
102265|NCT01072929|238842|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
102266|NCT01072929|238843|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
102267|NCT01072929|238844|P1|Safety Population|Overall Study|Treated participants|199
102268|NCT01072929|238842|P3|STARTED|Overall Study||33
102269|NCT01072929|238843|P2|STARTED|Overall Study||201
102270|NCT01072929|238844|P1|STARTED|Overall Study||199
102271|NCT01072877|238923|P5|NOT COMPLETED|Overall Study||0
102272|NCT01072877|238924|P4|NOT COMPLETED|Overall Study||2
102273|NCT01072877|238925|P3|NOT COMPLETED|Overall Study||0
102274|NCT01072877|238926|P2|NOT COMPLETED|Overall Study||1
102275|NCT01072877|238927|P1|NOT COMPLETED|Overall Study||1
102276|NCT01072877|238923|P5|COMPLETED|Overall Study||63
102277|NCT01072877|238924|P4|COMPLETED|Overall Study||50
102278|NCT01072877|238925|P3|COMPLETED|Overall Study||51
102279|NCT01072877|238926|P2|COMPLETED|Overall Study||56
102280|NCT01072877|238927|P1|COMPLETED|Overall Study||55
102281|NCT01072877|238923|P5|STARTED|Overall Study||63
102282|NCT01072877|238924|P4|STARTED|Overall Study||52
102283|NCT01072877|238925|P3|STARTED|Overall Study||51
102284|NCT01072877|238926|P2|STARTED|Overall Study||57
102285|NCT01072877|238927|P1|STARTED|Overall Study||56
102286|NCT01072773|238949|P1|NOT COMPLETED|Overall Study||0
102287|NCT01072773|238949|P1|COMPLETED|Overall Study||2
102288|NCT01072773|238949|P1|STARTED|Overall Study||2
102289|NCT01072669|238960|P2|NOT COMPLETED|Overall Study||0
102290|NCT01072669|238961|P1|NOT COMPLETED|Overall Study||0
102291|NCT01072669|238960|P2|COMPLETED|Overall Study||5
102292|NCT01072669|238961|P1|COMPLETED|Overall Study||15
102293|NCT01072669|238960|P2|STARTED|Overall Study||5
102294|NCT01072669|238961|P1|STARTED|Overall Study||15
102295|NCT01072656|238969|P2|NOT COMPLETED|Second Intervention||0
102296|NCT01072656|238970|P1|NOT COMPLETED|Second Intervention||0
102297|NCT01072656|238969|P2|COMPLETED|Second Intervention||4
102298|NCT01072656|238970|P1|COMPLETED|Second Intervention||5
102299|NCT01072656|238969|P2|STARTED|Second Intervention||4
102300|NCT01072656|238970|P1|STARTED|Second Intervention||5
102301|NCT01072656|238969|P2|NOT COMPLETED|First Intervention||0
102302|NCT01072656|238970|P1|NOT COMPLETED|First Intervention||0
102303|NCT01072656|238969|P2|COMPLETED|First Intervention||4
102304|NCT01072656|238970|P1|COMPLETED|First Intervention||5
102305|NCT01072656|238969|P2|STARTED|First Intervention||4
102306|NCT01072656|238970|P1|STARTED|First Intervention||5
102307|NCT01072643|238977|P1|NOT COMPLETED|Overall Study||0
102308|NCT01072643|238977|P1|COMPLETED|Overall Study||4
102309|NCT01072643|238977|P1|STARTED|Overall Study||4
102310|NCT01072630|238987|P3|NOT COMPLETED|Overall Study||13
102311|NCT01072630|238988|P2|NOT COMPLETED|Overall Study||60
102312|NCT01072630|238989|P1|NOT COMPLETED|Overall Study||55
102313|NCT01072630|238987|P3|COMPLETED|Overall Study||17
102314|NCT01072630|238988|P2|COMPLETED|Overall Study||172
102315|NCT01072630|238989|P1|COMPLETED|Overall Study||175
102316|NCT01072630|238987|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
102317|NCT01072630|238988|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
102318|NCT01072630|238989|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
102319|NCT01072630|238987|P3|Safety Population|Overall Study|Treated participants.|30
102320|NCT01072630|238988|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
102321|NCT01072630|238989|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
102322|NCT01072630|238987|P3|STARTED|Overall Study||30
102323|NCT01072630|238988|P2|STARTED|Overall Study||232
102324|NCT01072630|238989|P1|STARTED|Overall Study||230
102325|NCT01072539|239063|P1|NOT COMPLETED|Overall Study||3
102416|NCT01072175|239184|P11|Ongoing|Part D (HPMC Capsules)||12
102326|NCT01072539|239063|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
102327|NCT01072539|239063|P1|STARTED|Overall Study||3172
102328|NCT01072526|239071|P2|NOT COMPLETED|Overall Study||0
102329|NCT01072526|239072|P1|NOT COMPLETED|Overall Study||0
102330|NCT01072526|239071|P2|COMPLETED|Overall Study||0
102331|NCT01072526|239072|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
102332|NCT01072526|239071|P2|STARTED|Overall Study||0
102333|NCT01072526|239072|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
102334|NCT01072500|239087|P2|NOT COMPLETED|Overall Study||14
102335|NCT01072500|239088|P1|NOT COMPLETED|Overall Study||24
102336|NCT01072500|239087|P2|COMPLETED|Overall Study||803
102337|NCT01072500|239088|P1|COMPLETED|Overall Study||794
102338|NCT01072500|239087|P2|STARTED|Overall Study||817
102339|NCT01072500|239088|P1|STARTED|Overall Study||818
102340|NCT01072448|239098|P2|NOT COMPLETED|Overall Study||30
102341|NCT01072448|239099|P1|NOT COMPLETED|Overall Study||19
102342|NCT01072448|239098|P2|COMPLETED|Overall Study||130
102343|NCT01072448|239099|P1|COMPLETED|Overall Study||144
102344|NCT01072448|239098|P2|STARTED|Overall Study||160
102345|NCT01072448|239099|P1|STARTED|Overall Study||163
102346|NCT01072409|239107|P1|NOT COMPLETED|Overall Study||7
102347|NCT01072409|239107|P1|COMPLETED|Overall Study||38
102348|NCT01072409|239107|P1|STARTED|Overall Study||45
102349|NCT01072396|239113|P2|NOT COMPLETED|Period Two||3
102350|NCT01072396|239114|P1|NOT COMPLETED|Period Two||1
102351|NCT01072396|239113|P2|COMPLETED|Period Two||57
102352|NCT01072396|239114|P1|COMPLETED|Period Two||57
102353|NCT01072396|239113|P2|STARTED|Period Two||60
102354|NCT01072396|239114|P1|STARTED|Period Two||58
102355|NCT01072396|239113|P2|NOT COMPLETED|Washout Period||1
102356|NCT01072396|239114|P1|NOT COMPLETED|Washout Period||0
102357|NCT01072396|239113|P2|COMPLETED|Washout Period||60
102358|NCT01072396|239114|P1|COMPLETED|Washout Period||58
102359|NCT01072396|239113|P2|STARTED|Washout Period||61
102360|NCT01072396|239114|P1|STARTED|Washout Period||58
102361|NCT01072396|239113|P2|NOT COMPLETED|Period One||2
102362|NCT01072396|239114|P1|NOT COMPLETED|Period One||5
102363|NCT01072396|239113|P2|COMPLETED|Period One||61
102364|NCT01072396|239114|P1|COMPLETED|Period One||58
102365|NCT01072396|239113|P2|STARTED|Period One||63
102366|NCT01072396|239114|P1|STARTED|Period One||63
102367|NCT01072331|239127|P3|NOT COMPLETED|Overall Study||0
102368|NCT01072331|239128|P2|NOT COMPLETED|Overall Study||0
102369|NCT01072331|239129|P1|NOT COMPLETED|Overall Study||0
102370|NCT01072331|239127|P3|COMPLETED|Overall Study||32
102371|NCT01072331|239128|P2|COMPLETED|Overall Study||33
102372|NCT01072331|239129|P1|COMPLETED|Overall Study||34
102373|NCT01072331|239127|P3|STARTED|Overall Study||32
102374|NCT01072331|239128|P2|STARTED|Overall Study||33
102375|NCT01072331|239129|P1|STARTED|Overall Study||34
102376|NCT01072201|239148|P2|NOT COMPLETED|Overall Study||1
102377|NCT01072201|239149|P1|NOT COMPLETED|Overall Study||0
102378|NCT01072201|239148|P2|COMPLETED|Overall Study||29
102379|NCT01072201|239149|P1|COMPLETED|Overall Study||30
102380|NCT01072201|239148|P2|STARTED|Overall Study||30
102381|NCT01072201|239149|P1|STARTED|Overall Study||30
102382|NCT01072188|239161|P2|NOT COMPLETED|Overall Study||0
102383|NCT01072188|239162|P1|NOT COMPLETED|Overall Study||0
102384|NCT01072188|239161|P2|COMPLETED|Overall Study||23
102385|NCT01072188|239162|P1|COMPLETED|Overall Study||22
102386|NCT01072188|239161|P2|STARTED|Overall Study||23
102387|NCT01072188|239162|P1|STARTED|Overall Study||22
102388|NCT01072175|239182|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
102389|NCT01072175|239183|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
102390|NCT01072175|239184|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
102391|NCT01072175|239185|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
102392|NCT01072175|239186|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
102393|NCT01072175|239187|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
102394|NCT01072175|239188|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
102395|NCT01072175|239189|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
102396|NCT01072175|239190|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
102397|NCT01072175|239191|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
102398|NCT01072175|239192|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
102399|NCT01072175|239193|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
102400|NCT01072175|239194|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
102401|NCT01072175|239182|P13|COMPLETED|Part D (HPMC Capsules)||0
102402|NCT01072175|239183|P12|COMPLETED|Part D (HPMC Capsules)||0
102403|NCT01072175|239184|P11|COMPLETED|Part D (HPMC Capsules)||0
102404|NCT01072175|239185|P10|COMPLETED|Part D (HPMC Capsules)||0
102405|NCT01072175|239186|P9|COMPLETED|Part D (HPMC Capsules)||0
102406|NCT01072175|239187|P8|COMPLETED|Part D (HPMC Capsules)||0
102407|NCT01072175|239188|P7|COMPLETED|Part D (HPMC Capsules)||0
102408|NCT01072175|239189|P6|COMPLETED|Part D (HPMC Capsules)||0
102409|NCT01072175|239190|P5|COMPLETED|Part D (HPMC Capsules)||0
102410|NCT01072175|239191|P4|COMPLETED|Part D (HPMC Capsules)||0
102411|NCT01072175|239192|P3|COMPLETED|Part D (HPMC Capsules)||0
102412|NCT01072175|239193|P2|COMPLETED|Part D (HPMC Capsules)||0
102413|NCT01072175|239194|P1|COMPLETED|Part D (HPMC Capsules)||0
102414|NCT01072175|239182|P13|Ongoing|Part D (HPMC Capsules)||34
102415|NCT01072175|239183|P12|Ongoing|Part D (HPMC Capsules)||34
102417|NCT01072175|239185|P10|Ongoing|Part D (HPMC Capsules)||10
102418|NCT01072175|239186|P9|Ongoing|Part D (HPMC Capsules)||0
102419|NCT01072175|239187|P8|Ongoing|Part D (HPMC Capsules)||0
102420|NCT01072175|239188|P7|Ongoing|Part D (HPMC Capsules)||0
102421|NCT01072175|239189|P6|Ongoing|Part D (HPMC Capsules)||0
102422|NCT01072175|239190|P5|Ongoing|Part D (HPMC Capsules)||0
102423|NCT01072175|239191|P4|Ongoing|Part D (HPMC Capsules)||0
102424|NCT01072175|239192|P3|Ongoing|Part D (HPMC Capsules)||0
102425|NCT01072175|239193|P2|Ongoing|Part D (HPMC Capsules)||0
102426|NCT01072175|239194|P1|Ongoing|Part D (HPMC Capsules)||0
102427|NCT01072175|239182|P13|STARTED|Part D (HPMC Capsules)||39
102428|NCT01072175|239183|P12|STARTED|Part D (HPMC Capsules)||43
102429|NCT01072175|239184|P11|STARTED|Part D (HPMC Capsules)||16
102430|NCT01072175|239185|P10|STARTED|Part D (HPMC Capsules)||12
102431|NCT01072175|239186|P9|STARTED|Part D (HPMC Capsules)||0
102432|NCT01072175|239187|P8|STARTED|Part D (HPMC Capsules)||0
102433|NCT01072175|239188|P7|STARTED|Part D (HPMC Capsules)||0
102434|NCT01072175|239189|P6|STARTED|Part D (HPMC Capsules)||0
102435|NCT01072175|239190|P5|STARTED|Part D (HPMC Capsules)||0
102436|NCT01072175|239191|P4|STARTED|Part D (HPMC Capsules)||0
102437|NCT01072175|239192|P3|STARTED|Part D (HPMC Capsules)||0
102438|NCT01072175|239193|P2|STARTED|Part D (HPMC Capsules)||0
102439|NCT01072175|239194|P1|STARTED|Part D (HPMC Capsules)||0
102440|NCT01072175|239182|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102441|NCT01072175|239183|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102442|NCT01072175|239184|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102443|NCT01072175|239185|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102444|NCT01072175|239186|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
102445|NCT01072175|239187|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102446|NCT01072175|239188|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102447|NCT01072175|239189|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102448|NCT01072175|239190|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102449|NCT01072175|239191|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102450|NCT01072175|239192|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102451|NCT01072175|239193|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102452|NCT01072175|239194|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102453|NCT01072175|239182|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102454|NCT01072175|239183|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102455|NCT01072175|239184|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102456|NCT01072175|239185|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102457|NCT01072175|239186|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102458|NCT01072175|239187|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102459|NCT01072175|239188|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102460|NCT01072175|239189|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102461|NCT01072175|239190|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102462|NCT01072175|239191|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102463|NCT01072175|239192|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102464|NCT01072175|239193|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102465|NCT01072175|239194|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
102466|NCT01072175|239182|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102467|NCT01072175|239183|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102468|NCT01072175|239184|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102469|NCT01072175|239185|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102470|NCT01072175|239186|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
102471|NCT01072175|239187|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102472|NCT01072175|239188|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102473|NCT01072175|239189|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102474|NCT01072175|239190|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102475|NCT01072175|239191|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102476|NCT01072175|239192|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102477|NCT01072175|239193|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102478|NCT01072175|239194|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
102479|NCT01072175|239182|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102480|NCT01072175|239183|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102481|NCT01072175|239184|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102482|NCT01072175|239185|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102483|NCT01072175|239186|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
102484|NCT01072175|239187|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102485|NCT01072175|239188|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102486|NCT01072175|239189|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102487|NCT01072175|239190|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102488|NCT01072175|239191|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102489|NCT01072175|239192|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102490|NCT01072175|239193|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102491|NCT01072175|239194|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
102492|NCT01072175|239182|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102493|NCT01072175|239183|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102494|NCT01072175|239184|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102495|NCT01072175|239185|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102496|NCT01072175|239186|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102497|NCT01072175|239187|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
102498|NCT01072175|239188|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
102499|NCT01072175|239189|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
102500|NCT01072175|239190|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102501|NCT01072175|239191|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102502|NCT01072175|239192|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102503|NCT01072175|239193|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102504|NCT01072175|239194|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
102505|NCT01072175|239182|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
102506|NCT01072175|239183|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
102507|NCT01072175|239184|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
102508|NCT01072175|239185|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
102509|NCT01072175|239186|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
102510|NCT01072175|239187|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
102511|NCT01072175|239188|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
102512|NCT01072175|239189|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
102513|NCT01072175|239190|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
102514|NCT01072175|239191|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
102515|NCT01072175|239192|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
102516|NCT01072175|239193|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
102517|NCT01072175|239194|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
102518|NCT01072175|239182|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
102519|NCT01072175|239183|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
102520|NCT01072175|239184|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
102521|NCT01072175|239185|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
102522|NCT01072175|239186|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
102523|NCT01072175|239187|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
102524|NCT01072175|239188|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
102525|NCT01072175|239189|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
102526|NCT01072175|239190|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
102527|NCT01072175|239191|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
102528|NCT01072175|239192|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
102529|NCT01072175|239193|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
102530|NCT01072175|239194|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
102531|NCT01072175|239182|P13|STARTED|Part C (Phase II: Randomized Phase)||0
102532|NCT01072175|239183|P12|STARTED|Part C (Phase II: Randomized Phase)||0
102533|NCT01072175|239184|P11|STARTED|Part C (Phase II: Randomized Phase)||0
102534|NCT01072175|239185|P10|STARTED|Part C (Phase II: Randomized Phase)||0
102535|NCT01072175|239186|P9|STARTED|Part C (Phase II: Randomized Phase)||0
102536|NCT01072175|239187|P8|STARTED|Part C (Phase II: Randomized Phase)||54
102537|NCT01072175|239188|P7|STARTED|Part C (Phase II: Randomized Phase)||54
102538|NCT01072175|239189|P6|STARTED|Part C (Phase II: Randomized Phase)||54
102539|NCT01072175|239190|P5|STARTED|Part C (Phase II: Randomized Phase)||0
102540|NCT01072175|239191|P4|STARTED|Part C (Phase II: Randomized Phase)||0
102541|NCT01072175|239192|P3|STARTED|Part C (Phase II: Randomized Phase)||0
102542|NCT01072175|239193|P2|STARTED|Part C (Phase II: Randomized Phase)||0
102543|NCT01072175|239194|P1|STARTED|Part C (Phase II: Randomized Phase)||0
102544|NCT01072175|239182|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102545|NCT01072175|239183|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102546|NCT01072175|239184|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102547|NCT01072175|239185|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102548|NCT01072175|239186|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102549|NCT01072175|239187|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102550|NCT01072175|239188|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102551|NCT01072175|239189|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102552|NCT01072175|239190|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
102553|NCT01072175|239191|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
102554|NCT01072175|239192|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
102555|NCT01072175|239193|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
102556|NCT01072175|239194|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
102557|NCT01072175|239182|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
102558|NCT01072175|239183|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
102559|NCT01072175|239184|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
102560|NCT01072175|239185|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
102561|NCT01072175|239186|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
102562|NCT01072175|239187|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
102563|NCT01072175|239188|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
102564|NCT01072175|239189|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
102565|NCT01072175|239190|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
102566|NCT01072175|239191|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
102567|NCT01072175|239192|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
102568|NCT01072175|239193|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
102569|NCT01072175|239194|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
102570|NCT01072175|239182|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
102571|NCT01072175|239183|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
102572|NCT01072175|239184|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
102573|NCT01072175|239185|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
102574|NCT01072175|239186|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
102575|NCT01072175|239187|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
102576|NCT01072175|239188|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
102577|NCT01072175|239189|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
102578|NCT01072175|239190|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
102579|NCT01072175|239191|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
102580|NCT01072175|239192|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
102581|NCT01072175|239193|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
102582|NCT01072175|239194|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
102583|NCT01072175|239182|P13|STARTED|Part B (Dose Escalation and Expansion)||0
102584|NCT01072175|239183|P12|STARTED|Part B (Dose Escalation and Expansion)||0
102585|NCT01072175|239184|P11|STARTED|Part B (Dose Escalation and Expansion)||0
102586|NCT01072175|239185|P10|STARTED|Part B (Dose Escalation and Expansion)||0
102587|NCT01072175|239186|P9|STARTED|Part B (Dose Escalation and Expansion)||0
102588|NCT01072175|239187|P8|STARTED|Part B (Dose Escalation and Expansion)||0
102589|NCT01072175|239188|P7|STARTED|Part B (Dose Escalation and Expansion)||0
102590|NCT01072175|239189|P6|STARTED|Part B (Dose Escalation and Expansion)||0
102591|NCT01072175|239190|P5|STARTED|Part B (Dose Escalation and Expansion)||79
102592|NCT01072175|239191|P4|STARTED|Part B (Dose Escalation and Expansion)||27
102593|NCT01072175|239192|P3|STARTED|Part B (Dose Escalation and Expansion)||23
102594|NCT01072175|239193|P2|STARTED|Part B (Dose Escalation and Expansion)||6
102595|NCT01072175|239194|P1|STARTED|Part B (Dose Escalation and Expansion)||0
102596|NCT01072175|239182|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102597|NCT01072175|239183|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102598|NCT01072175|239184|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102599|NCT01072175|239185|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102600|NCT01072175|239186|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102601|NCT01072175|239187|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102602|NCT01072175|239188|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102603|NCT01072175|239189|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102604|NCT01072175|239190|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102605|NCT01072175|239191|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102606|NCT01072175|239192|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102607|NCT01072175|239193|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
102608|NCT01072175|239194|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
102609|NCT01072175|239182|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
102610|NCT01072175|239183|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
102611|NCT01072175|239184|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
102612|NCT01072175|239185|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
102613|NCT01072175|239186|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
102614|NCT01072175|239187|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
102615|NCT01072175|239188|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
102616|NCT01072175|239189|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
102617|NCT01072175|239190|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
102618|NCT01072175|239191|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
102619|NCT01072175|239192|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
102620|NCT01072175|239193|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
102621|NCT01072175|239194|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
102622|NCT01072175|239182|P13|STARTED|Part A (Drug-Drug Interaction)||0
102623|NCT01072175|239183|P12|STARTED|Part A (Drug-Drug Interaction)||0
102624|NCT01072175|239184|P11|STARTED|Part A (Drug-Drug Interaction)||0
102625|NCT01072175|239185|P10|STARTED|Part A (Drug-Drug Interaction)||0
102626|NCT01072175|239186|P9|STARTED|Part A (Drug-Drug Interaction)||0
102627|NCT01072175|239187|P8|STARTED|Part A (Drug-Drug Interaction)||0
102628|NCT01072175|239188|P7|STARTED|Part A (Drug-Drug Interaction)||0
102629|NCT01072175|239189|P6|STARTED|Part A (Drug-Drug Interaction)||0
102630|NCT01072175|239190|P5|STARTED|Part A (Drug-Drug Interaction)||0
102631|NCT01072175|239191|P4|STARTED|Part A (Drug-Drug Interaction)||0
102632|NCT01072175|239192|P3|STARTED|Part A (Drug-Drug Interaction)||0
102633|NCT01072175|239193|P2|STARTED|Part A (Drug-Drug Interaction)||0
102634|NCT01072175|239194|P1|STARTED|Part A (Drug-Drug Interaction)||8
102635|NCT01072149|239377|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102636|NCT01072149|239378|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102637|NCT01072149|239379|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102638|NCT01072149|239380|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102639|NCT01072149|239381|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
102640|NCT01072149|239382|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102641|NCT01072149|239383|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102642|NCT01072149|239384|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102643|NCT01072149|239385|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102644|NCT01072149|239386|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102645|NCT01072149|239387|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102646|NCT01072149|239388|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102647|NCT01072149|239389|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102648|NCT01072149|239390|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102649|NCT01072149|239391|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102650|NCT01072149|239392|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
102651|NCT01072149|239393|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102652|NCT01072149|239394|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
102653|NCT01072149|239377|P18|COMPLETED|Treatment Period 3 (28 Days)||2
102654|NCT01072149|239378|P17|COMPLETED|Treatment Period 3 (28 Days)||3
102655|NCT01072149|239379|P16|COMPLETED|Treatment Period 3 (28 Days)||1
102656|NCT01072149|239380|P15|COMPLETED|Treatment Period 3 (28 Days)||3
102657|NCT01072149|239381|P14|COMPLETED|Treatment Period 3 (28 Days)||2
102658|NCT01072149|239382|P13|COMPLETED|Treatment Period 3 (28 Days)||2
102659|NCT01072149|239383|P12|COMPLETED|Treatment Period 3 (28 Days)||3
102660|NCT01072149|239384|P11|COMPLETED|Treatment Period 3 (28 Days)||2
102661|NCT01072149|239385|P10|COMPLETED|Treatment Period 3 (28 Days)||3
102662|NCT01072149|239386|P9|COMPLETED|Treatment Period 3 (28 Days)||3
102663|NCT01072149|239387|P8|COMPLETED|Treatment Period 3 (28 Days)||2
102664|NCT01072149|239388|P7|COMPLETED|Treatment Period 3 (28 Days)||3
102665|NCT01072149|239389|P6|COMPLETED|Treatment Period 3 (28 Days)||3
102666|NCT01072149|239390|P5|COMPLETED|Treatment Period 3 (28 Days)||3
102667|NCT01072149|239391|P4|COMPLETED|Treatment Period 3 (28 Days)||3
102668|NCT01072149|239392|P3|COMPLETED|Treatment Period 3 (28 Days)||0
102669|NCT01072149|239393|P2|COMPLETED|Treatment Period 3 (28 Days)||2
102670|NCT01072149|239394|P1|COMPLETED|Treatment Period 3 (28 Days)||2
102671|NCT01072149|239377|P18|STARTED|Treatment Period 3 (28 Days)||2
102672|NCT01072149|239378|P17|STARTED|Treatment Period 3 (28 Days)||3
102673|NCT01072149|239379|P16|STARTED|Treatment Period 3 (28 Days)||1
102674|NCT01072149|239380|P15|STARTED|Treatment Period 3 (28 Days)||3
102675|NCT01072149|239381|P14|STARTED|Treatment Period 3 (28 Days)||3
102676|NCT01072149|239382|P13|STARTED|Treatment Period 3 (28 Days)||2
102677|NCT01072149|239383|P12|STARTED|Treatment Period 3 (28 Days)||3
102678|NCT01072149|239384|P11|STARTED|Treatment Period 3 (28 Days)||2
102679|NCT01072149|239385|P10|STARTED|Treatment Period 3 (28 Days)||3
102680|NCT01072149|239386|P9|STARTED|Treatment Period 3 (28 Days)||3
102681|NCT01072149|239387|P8|STARTED|Treatment Period 3 (28 Days)||2
102682|NCT01072149|239388|P7|STARTED|Treatment Period 3 (28 Days)||3
102683|NCT01072149|239389|P6|STARTED|Treatment Period 3 (28 Days)||3
102684|NCT01072149|239390|P5|STARTED|Treatment Period 3 (28 Days)||3
102685|NCT01072149|239391|P4|STARTED|Treatment Period 3 (28 Days)||3
102686|NCT01072149|239392|P3|STARTED|Treatment Period 3 (28 Days)||1
102687|NCT01072149|239393|P2|STARTED|Treatment Period 3 (28 Days)||2
102688|NCT01072149|239394|P1|STARTED|Treatment Period 3 (28 Days)||2
102689|NCT01072149|239377|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
102690|NCT01072149|239378|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
102691|NCT01072149|239379|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
102692|NCT01072149|239380|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
102693|NCT01072149|239381|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
102694|NCT01072149|239382|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
102695|NCT01072149|239383|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
102696|NCT01072149|239384|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
102697|NCT01072149|239385|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
102698|NCT01072149|239386|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
102699|NCT01072149|239387|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
102700|NCT01072149|239388|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
102701|NCT01072149|239389|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
102702|NCT01072149|239390|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
102703|NCT01072149|239391|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
102704|NCT01072149|239392|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
102705|NCT01072149|239393|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
102706|NCT01072149|239394|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
102707|NCT01072149|239377|P18|COMPLETED|Washout Period 2 (14 Days)||2
102708|NCT01072149|239378|P17|COMPLETED|Washout Period 2 (14 Days)||3
102709|NCT01072149|239379|P16|COMPLETED|Washout Period 2 (14 Days)||1
102710|NCT01072149|239380|P15|COMPLETED|Washout Period 2 (14 Days)||3
102711|NCT01072149|239381|P14|COMPLETED|Washout Period 2 (14 Days)||3
102712|NCT01072149|239382|P13|COMPLETED|Washout Period 2 (14 Days)||2
102713|NCT01072149|239383|P12|COMPLETED|Washout Period 2 (14 Days)||3
102714|NCT01072149|239384|P11|COMPLETED|Washout Period 2 (14 Days)||2
102715|NCT01072149|239385|P10|COMPLETED|Washout Period 2 (14 Days)||3
102716|NCT01072149|239386|P9|COMPLETED|Washout Period 2 (14 Days)||3
102717|NCT01072149|239387|P8|COMPLETED|Washout Period 2 (14 Days)||2
102718|NCT01072149|239388|P7|COMPLETED|Washout Period 2 (14 Days)||3
102719|NCT01072149|239389|P6|COMPLETED|Washout Period 2 (14 Days)||3
102720|NCT01072149|239390|P5|COMPLETED|Washout Period 2 (14 Days)||3
102721|NCT01072149|239391|P4|COMPLETED|Washout Period 2 (14 Days)||3
102722|NCT01072149|239392|P3|COMPLETED|Washout Period 2 (14 Days)||1
102723|NCT01072149|239393|P2|COMPLETED|Washout Period 2 (14 Days)||2
102724|NCT01072149|239394|P1|COMPLETED|Washout Period 2 (14 Days)||2
102725|NCT01072149|239377|P18|STARTED|Washout Period 2 (14 Days)||2
102726|NCT01072149|239378|P17|STARTED|Washout Period 2 (14 Days)||3
102727|NCT01072149|239379|P16|STARTED|Washout Period 2 (14 Days)||3
102728|NCT01072149|239380|P15|STARTED|Washout Period 2 (14 Days)||3
102729|NCT01072149|239381|P14|STARTED|Washout Period 2 (14 Days)||3
102730|NCT01072149|239382|P13|STARTED|Washout Period 2 (14 Days)||3
102731|NCT01072149|239383|P12|STARTED|Washout Period 2 (14 Days)||3
102732|NCT01072149|239384|P11|STARTED|Washout Period 2 (14 Days)||2
102733|NCT01072149|239385|P10|STARTED|Washout Period 2 (14 Days)||3
102734|NCT01072149|239386|P9|STARTED|Washout Period 2 (14 Days)||3
102735|NCT01072149|239387|P8|STARTED|Washout Period 2 (14 Days)||2
102736|NCT01072149|239388|P7|STARTED|Washout Period 2 (14 Days)||3
102737|NCT01072149|239389|P6|STARTED|Washout Period 2 (14 Days)||3
102738|NCT01072149|239390|P5|STARTED|Washout Period 2 (14 Days)||3
102739|NCT01072149|239391|P4|STARTED|Washout Period 2 (14 Days)||3
102740|NCT01072149|239392|P3|STARTED|Washout Period 2 (14 Days)||1
102741|NCT01072149|239393|P2|STARTED|Washout Period 2 (14 Days)||2
102742|NCT01072149|239394|P1|STARTED|Washout Period 2 (14 Days)||3
102743|NCT01072149|239377|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102744|NCT01072149|239378|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102745|NCT01072149|239379|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102746|NCT01072149|239380|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102747|NCT01072149|239381|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102748|NCT01072149|239382|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102749|NCT01072149|239383|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102750|NCT01072149|239384|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102751|NCT01072149|239385|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102752|NCT01072149|239386|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102753|NCT01072149|239387|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
102754|NCT01072149|239388|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102755|NCT01072149|239389|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102756|NCT01072149|239390|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102757|NCT01072149|239391|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102758|NCT01072149|239392|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
102759|NCT01072149|239393|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
102760|NCT01072149|239394|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
102761|NCT01072149|239377|P18|COMPLETED|Treatment Period 2 (28 Days)||2
102762|NCT01072149|239378|P17|COMPLETED|Treatment Period 2 (28 Days)||3
102763|NCT01072149|239379|P16|COMPLETED|Treatment Period 2 (28 Days)||3
102764|NCT01072149|239380|P15|COMPLETED|Treatment Period 2 (28 Days)||3
102765|NCT01072149|239381|P14|COMPLETED|Treatment Period 2 (28 Days)||3
102766|NCT01072149|239382|P13|COMPLETED|Treatment Period 2 (28 Days)||3
102767|NCT01072149|239383|P12|COMPLETED|Treatment Period 2 (28 Days)||3
102768|NCT01072149|239384|P11|COMPLETED|Treatment Period 2 (28 Days)||2
102769|NCT01072149|239385|P10|COMPLETED|Treatment Period 2 (28 Days)||3
102770|NCT01072149|239386|P9|COMPLETED|Treatment Period 2 (28 Days)||3
102771|NCT01072149|239387|P8|COMPLETED|Treatment Period 2 (28 Days)||2
102772|NCT01072149|239388|P7|COMPLETED|Treatment Period 2 (28 Days)||3
102773|NCT01072149|239389|P6|COMPLETED|Treatment Period 2 (28 Days)||3
102774|NCT01072149|239390|P5|COMPLETED|Treatment Period 2 (28 Days)||3
102775|NCT01072149|239391|P4|COMPLETED|Treatment Period 2 (28 Days)||3
102776|NCT01072149|239392|P3|COMPLETED|Treatment Period 2 (28 Days)||1
102777|NCT01072149|239393|P2|COMPLETED|Treatment Period 2 (28 Days)||2
102778|NCT01072149|239394|P1|COMPLETED|Treatment Period 2 (28 Days)||3
102779|NCT01072149|239377|P18|STARTED|Treatment Period 2 (28 Days)||2
102780|NCT01072149|239378|P17|STARTED|Treatment Period 2 (28 Days)||3
102781|NCT01072149|239379|P16|STARTED|Treatment Period 2 (28 Days)||3
102782|NCT01072149|239380|P15|STARTED|Treatment Period 2 (28 Days)||3
102783|NCT01072149|239381|P14|STARTED|Treatment Period 2 (28 Days)||3
102784|NCT01072149|239382|P13|STARTED|Treatment Period 2 (28 Days)||3
102785|NCT01072149|239383|P12|STARTED|Treatment Period 2 (28 Days)||3
102786|NCT01072149|239384|P11|STARTED|Treatment Period 2 (28 Days)||2
102787|NCT01072149|239385|P10|STARTED|Treatment Period 2 (28 Days)||3
102788|NCT01072149|239386|P9|STARTED|Treatment Period 2 (28 Days)||3
102789|NCT01072149|239387|P8|STARTED|Treatment Period 2 (28 Days)||3
102790|NCT01072149|239388|P7|STARTED|Treatment Period 2 (28 Days)||3
102791|NCT01072149|239389|P6|STARTED|Treatment Period 2 (28 Days)||3
102792|NCT01072149|239390|P5|STARTED|Treatment Period 2 (28 Days)||3
102793|NCT01072149|239391|P4|STARTED|Treatment Period 2 (28 Days)||3
102794|NCT01072149|239392|P3|STARTED|Treatment Period 2 (28 Days)||2
102795|NCT01072149|239393|P2|STARTED|Treatment Period 2 (28 Days)||3
102796|NCT01072149|239394|P1|STARTED|Treatment Period 2 (28 Days)||3
102797|NCT01072149|239377|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
102798|NCT01072149|239378|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
102799|NCT01072149|239379|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
102800|NCT01072149|239380|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
102801|NCT01072149|239381|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
102802|NCT01072149|239382|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
102803|NCT01072149|239383|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
102804|NCT01072149|239384|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
102805|NCT01072149|239385|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
102806|NCT01072149|239386|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
102807|NCT01072149|239387|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
102808|NCT01072149|239388|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
102809|NCT01072149|239389|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
102810|NCT01072149|239390|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
102811|NCT01072149|239391|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
102812|NCT01072149|239392|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
102813|NCT01072149|239393|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
102814|NCT01072149|239394|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
102815|NCT01072149|239377|P18|COMPLETED|Washout Period 1 (14 Days)||2
102816|NCT01072149|239378|P17|COMPLETED|Washout Period 1 (14 Days)||3
102817|NCT01072149|239379|P16|COMPLETED|Washout Period 1 (14 Days)||3
102818|NCT01072149|239380|P15|COMPLETED|Washout Period 1 (14 Days)||3
102819|NCT01072149|239381|P14|COMPLETED|Washout Period 1 (14 Days)||3
102820|NCT01072149|239382|P13|COMPLETED|Washout Period 1 (14 Days)||3
102821|NCT01072149|239383|P12|COMPLETED|Washout Period 1 (14 Days)||3
102822|NCT01072149|239384|P11|COMPLETED|Washout Period 1 (14 Days)||2
102823|NCT01072149|239385|P10|COMPLETED|Washout Period 1 (14 Days)||3
102824|NCT01072149|239386|P9|COMPLETED|Washout Period 1 (14 Days)||3
102825|NCT01072149|239387|P8|COMPLETED|Washout Period 1 (14 Days)||3
102826|NCT01072149|239388|P7|COMPLETED|Washout Period 1 (14 Days)||3
102827|NCT01072149|239389|P6|COMPLETED|Washout Period 1 (14 Days)||3
102828|NCT01072149|239390|P5|COMPLETED|Washout Period 1 (14 Days)||3
102829|NCT01072149|239391|P4|COMPLETED|Washout Period 1 (14 Days)||3
102830|NCT01072149|239392|P3|COMPLETED|Washout Period 1 (14 Days)||2
102831|NCT01072149|239393|P2|COMPLETED|Washout Period 1 (14 Days)||3
102832|NCT01072149|239394|P1|COMPLETED|Washout Period 1 (14 Days)||3
102833|NCT01072149|239377|P18|STARTED|Washout Period 1 (14 Days)||2
102834|NCT01072149|239378|P17|STARTED|Washout Period 1 (14 Days)||3
102835|NCT01072149|239379|P16|STARTED|Washout Period 1 (14 Days)||3
102836|NCT01072149|239380|P15|STARTED|Washout Period 1 (14 Days)||3
102837|NCT01072149|239381|P14|STARTED|Washout Period 1 (14 Days)||3
102838|NCT01072149|239382|P13|STARTED|Washout Period 1 (14 Days)||3
102839|NCT01072149|239383|P12|STARTED|Washout Period 1 (14 Days)||3
102840|NCT01072149|239384|P11|STARTED|Washout Period 1 (14 Days)||2
102841|NCT01072149|239385|P10|STARTED|Washout Period 1 (14 Days)||3
102842|NCT01072149|239386|P9|STARTED|Washout Period 1 (14 Days)||3
102843|NCT01072149|239387|P8|STARTED|Washout Period 1 (14 Days)||3
102844|NCT01072149|239388|P7|STARTED|Washout Period 1 (14 Days)||3
102845|NCT01072149|239389|P6|STARTED|Washout Period 1 (14 Days)||3
102846|NCT01072149|239390|P5|STARTED|Washout Period 1 (14 Days)||3
102847|NCT01072149|239391|P4|STARTED|Washout Period 1 (14 Days)||3
102848|NCT01072149|239392|P3|STARTED|Washout Period 1 (14 Days)||2
102849|NCT01072149|239393|P2|STARTED|Washout Period 1 (14 Days)||3
102850|NCT01072149|239394|P1|STARTED|Washout Period 1 (14 Days)||3
102851|NCT01072149|239377|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
102852|NCT01072149|239378|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102853|NCT01072149|239379|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102854|NCT01072149|239380|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102855|NCT01072149|239381|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102856|NCT01072149|239382|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102857|NCT01072149|239383|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102858|NCT01072149|239384|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
102859|NCT01072149|239385|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102860|NCT01072149|239386|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102861|NCT01072149|239387|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102862|NCT01072149|239388|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102863|NCT01072149|239389|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102864|NCT01072149|239390|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102865|NCT01072149|239391|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102866|NCT01072149|239392|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
102867|NCT01072149|239393|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102868|NCT01072149|239394|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
102869|NCT01072149|239377|P18|COMPLETED|Treatment Period 1 (28 Days)||2
102870|NCT01072149|239378|P17|COMPLETED|Treatment Period 1 (28 Days)||3
102871|NCT01072149|239379|P16|COMPLETED|Treatment Period 1 (28 Days)||3
102872|NCT01072149|239380|P15|COMPLETED|Treatment Period 1 (28 Days)||3
102873|NCT01072149|239381|P14|COMPLETED|Treatment Period 1 (28 Days)||3
102874|NCT01072149|239382|P13|COMPLETED|Treatment Period 1 (28 Days)||3
102875|NCT01072149|239383|P12|COMPLETED|Treatment Period 1 (28 Days)||3
102876|NCT01072149|239384|P11|COMPLETED|Treatment Period 1 (28 Days)||2
102877|NCT01072149|239385|P10|COMPLETED|Treatment Period 1 (28 Days)||3
102878|NCT01072149|239386|P9|COMPLETED|Treatment Period 1 (28 Days)||3
102879|NCT01072149|239387|P8|COMPLETED|Treatment Period 1 (28 Days)||3
102880|NCT01072149|239388|P7|COMPLETED|Treatment Period 1 (28 Days)||3
102881|NCT01072149|239389|P6|COMPLETED|Treatment Period 1 (28 Days)||3
102882|NCT01072149|239390|P5|COMPLETED|Treatment Period 1 (28 Days)||3
102883|NCT01072149|239391|P4|COMPLETED|Treatment Period 1 (28 Days)||3
102884|NCT01072149|239392|P3|COMPLETED|Treatment Period 1 (28 Days)||2
102885|NCT01072149|239393|P2|COMPLETED|Treatment Period 1 (28 Days)||3
102886|NCT01072149|239394|P1|COMPLETED|Treatment Period 1 (28 Days)||3
102887|NCT01072149|239377|P18|STARTED|Treatment Period 1 (28 Days)||3
102888|NCT01072149|239378|P17|STARTED|Treatment Period 1 (28 Days)||3
102889|NCT01072149|239379|P16|STARTED|Treatment Period 1 (28 Days)||3
102890|NCT01072149|239380|P15|STARTED|Treatment Period 1 (28 Days)||3
102891|NCT01072149|239381|P14|STARTED|Treatment Period 1 (28 Days)||3
102892|NCT01072149|239382|P13|STARTED|Treatment Period 1 (28 Days)||3
102893|NCT01072149|239383|P12|STARTED|Treatment Period 1 (28 Days)||3
102894|NCT01072149|239384|P11|STARTED|Treatment Period 1 (28 Days)||3
102895|NCT01072149|239385|P10|STARTED|Treatment Period 1 (28 Days)||3
102896|NCT01072149|239386|P9|STARTED|Treatment Period 1 (28 Days)||3
102897|NCT01072149|239387|P8|STARTED|Treatment Period 1 (28 Days)||3
102898|NCT01072149|239388|P7|STARTED|Treatment Period 1 (28 Days)||3
102899|NCT01072149|239389|P6|STARTED|Treatment Period 1 (28 Days)||3
102900|NCT01072149|239390|P5|STARTED|Treatment Period 1 (28 Days)||3
102901|NCT01072149|239391|P4|STARTED|Treatment Period 1 (28 Days)||3
102902|NCT01072149|239392|P3|STARTED|Treatment Period 1 (28 Days)||3
102903|NCT01072149|239393|P2|STARTED|Treatment Period 1 (28 Days)||3
102904|NCT01072149|239394|P1|STARTED|Treatment Period 1 (28 Days)||3
102905|NCT01072136|239414|P2|NOT COMPLETED|Overall Study||31
102906|NCT01072136|239415|P1|NOT COMPLETED|Overall Study||23
102907|NCT01072136|239414|P2|COMPLETED|Overall Study||12
102908|NCT01072136|239415|P1|COMPLETED|Overall Study||21
102909|NCT01072136|239414|P2|Met All Enrollment Criteria|Overall Study||25
102910|NCT01072136|239415|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
102911|NCT01072136|239414|P2|STARTED|Overall Study||43
102912|NCT01072136|239415|P1|STARTED|Overall Study||44
102913|NCT01072032|239439|P2|NOT COMPLETED|Overall Study||9
102914|NCT01072032|239440|P1|NOT COMPLETED|Overall Study||8
102915|NCT01072032|239439|P2|COMPLETED|Overall Study||5
102916|NCT01072032|239440|P1|COMPLETED|Overall Study||5
102917|NCT01072032|239439|P2|STARTED|Overall Study||14
102918|NCT01072032|239440|P1|STARTED|Overall Study||13
102919|NCT01071915|239450|P1|NOT COMPLETED|Overall Study||9
102920|NCT01071915|239450|P1|COMPLETED|Overall Study||148
102921|NCT01071915|239450|P1|Safety Analysis Set|Overall Study||156
102922|NCT01071915|239450|P1|Full Analysis Set (FAS)|Overall Study||155
102923|NCT01071915|239450|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
102924|NCT01071798|239460|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
102925|NCT01071798|239460|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
102926|NCT01071798|239460|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
102927|NCT01071798|239460|P1|STARTED|Subpopulation Who Received Two Cycles||820
102928|NCT01071798|239460|P1|NOT COMPLETED|Participants Who Received One Cycle||65
102929|NCT01071798|239460|P1|COMPLETED|Participants Who Received One Cycle||1588
102930|NCT01071798|239460|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
102931|NCT01071798|239460|P1|STARTED|Participants Who Received One Cycle||1653
102932|NCT01071538|239480|P1|NOT COMPLETED|Overall Study||2
102933|NCT01071538|239480|P1|COMPLETED|Overall Study||13
102934|NCT01071538|239480|P1|STARTED|Overall Study||15
102935|NCT01071395|239492|P2|NOT COMPLETED|Overall Study||2
102936|NCT01071395|239493|P1|NOT COMPLETED|Overall Study||5
102937|NCT01071395|239492|P2|COMPLETED|Overall Study||30
102938|NCT01071395|239493|P1|COMPLETED|Overall Study||31
102939|NCT01071395|239492|P2|STARTED|Overall Study||32
102940|NCT01071395|239493|P1|STARTED|Overall Study||36
102941|NCT01071278|239499|P1|NOT COMPLETED|Overall Study||713
102942|NCT01071278|239499|P1|COMPLETED|Overall Study||1677
102943|NCT01071278|239499|P1|STARTED|Overall Study||2390
102944|NCT01071252|239510|P5|NOT COMPLETED|Overall Study||11
102945|NCT01071252|239511|P4|NOT COMPLETED|Overall Study||7
102946|NCT01071252|239512|P3|NOT COMPLETED|Overall Study||4
102947|NCT01071252|239513|P2|NOT COMPLETED|Overall Study||10
102948|NCT01071252|239514|P1|NOT COMPLETED|Overall Study||15
102949|NCT01071252|239510|P5|COMPLETED|Overall Study||11
102950|NCT01071252|239511|P4|COMPLETED|Overall Study||20
102951|NCT01071252|239512|P3|COMPLETED|Overall Study||17
102952|NCT01071252|239513|P2|COMPLETED|Overall Study||16
102953|NCT01071252|239514|P1|COMPLETED|Overall Study||14
102954|NCT01071252|239510|P5|STARTED|Overall Study||22
102955|NCT01071252|239511|P4|STARTED|Overall Study||27
102956|NCT01071252|239512|P3|STARTED|Overall Study||21
102957|NCT01071252|239513|P2|STARTED|Overall Study||26
102958|NCT01071252|239514|P1|STARTED|Overall Study||29
102959|NCT01071200|239542|P2|NOT COMPLETED|Overall Study||3
102960|NCT01071200|239543|P1|NOT COMPLETED|Overall Study||7
102961|NCT01071200|239542|P2|COMPLETED|Overall Study||63
102962|NCT01071200|239543|P1|COMPLETED|Overall Study||60
102963|NCT01071200|239542|P2|STARTED|Overall Study||66
102964|NCT01071200|239543|P1|STARTED|Overall Study||67
102965|NCT01071096|239575|P2|NOT COMPLETED|Second Intervention (90 Days)||0
102966|NCT01071096|239576|P1|NOT COMPLETED|Second Intervention (90 Days)||0
102967|NCT01071096|239575|P2|COMPLETED|Second Intervention (90 Days)||10
102968|NCT01071096|239576|P1|COMPLETED|Second Intervention (90 Days)||9
102969|NCT01071096|239575|P2|STARTED|Second Intervention (90 Days)||10
102970|NCT01071096|239576|P1|STARTED|Second Intervention (90 Days)||9
102971|NCT01071096|239575|P2|NOT COMPLETED|Washout Period (30 Days)||0
102972|NCT01071096|239576|P1|NOT COMPLETED|Washout Period (30 Days)||0
102973|NCT01071096|239575|P2|COMPLETED|Washout Period (30 Days)||10
102974|NCT01071096|239576|P1|COMPLETED|Washout Period (30 Days)||9
102975|NCT01071096|239575|P2|STARTED|Washout Period (30 Days)||10
102976|NCT01071096|239576|P1|STARTED|Washout Period (30 Days)||9
102977|NCT01071096|239575|P2|NOT COMPLETED|First Intervention (90 Days)||0
102978|NCT01071096|239576|P1|NOT COMPLETED|First Intervention (90 Days)||1
102979|NCT01071096|239575|P2|COMPLETED|First Intervention (90 Days)||10
102980|NCT01071096|239576|P1|COMPLETED|First Intervention (90 Days)||9
102981|NCT01071096|239575|P2|STARTED|First Intervention (90 Days)||10
102982|NCT01071096|239576|P1|STARTED|First Intervention (90 Days)||10
102983|NCT01071083|239600|P5|NOT COMPLETED|Overall Study||8
102984|NCT01071083|239601|P4|NOT COMPLETED|Overall Study||2
102985|NCT01071083|239602|P3|NOT COMPLETED|Overall Study||5
102986|NCT01071083|239603|P2|NOT COMPLETED|Overall Study||2
102987|NCT01071083|239604|P1|NOT COMPLETED|Overall Study||7
102988|NCT01071083|239600|P5|COMPLETED|Overall Study||46
102989|NCT01071083|239601|P4|COMPLETED|Overall Study||15
102990|NCT01071083|239602|P3|COMPLETED|Overall Study||12
102991|NCT01071083|239603|P2|COMPLETED|Overall Study||43
102992|NCT01071083|239604|P1|COMPLETED|Overall Study||35
102993|NCT01071083|239600|P5|STARTED|Overall Study||54
102994|NCT01071083|239601|P4|STARTED|Overall Study||17
102995|NCT01071083|239602|P3|STARTED|Overall Study||17
102996|NCT01071083|239603|P2|STARTED|Overall Study||45
102997|NCT01071083|239604|P1|STARTED|Overall Study||42
102998|NCT01071070|239623|P2|NOT COMPLETED|Overall Study||3
102999|NCT01071070|239624|P1|NOT COMPLETED|Overall Study||4
103000|NCT01071070|239623|P2|COMPLETED|Overall Study||105
103001|NCT01071070|239624|P1|COMPLETED|Overall Study||104
103002|NCT01071070|239623|P2|STARTED|Overall Study||108
103003|NCT01071070|239624|P1|STARTED|Overall Study||108
103004|NCT01071044|239648|P2|NOT COMPLETED|Overall Study||0
103005|NCT01071044|239649|P1|NOT COMPLETED|Overall Study||2
103006|NCT01071044|239648|P2|COMPLETED|Overall Study||11
103007|NCT01071044|239649|P1|COMPLETED|Overall Study||13
103008|NCT01071044|239648|P2|STARTED|Overall Study||11
103009|NCT01071044|239649|P1|STARTED|Overall Study||15
103010|NCT01070979|239670|P3|NOT COMPLETED|Overall Study||13
103011|NCT01070979|239671|P2|NOT COMPLETED|Overall Study||12
103012|NCT01070979|239672|P1|NOT COMPLETED|Overall Study||11
103013|NCT01070979|239670|P3|COMPLETED|Overall Study||72
103014|NCT01070979|239671|P2|COMPLETED|Overall Study||73
103015|NCT01070979|239672|P1|COMPLETED|Overall Study||68
103016|NCT01070979|239670|P3|STARTED|Overall Study||85
103017|NCT01070979|239671|P2|STARTED|Overall Study||85
103018|NCT01070979|239672|P1|STARTED|Overall Study||79
103019|NCT01070966|239698|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
103020|NCT01070966|239698|P1|COMPLETED|Participants for Efficacy Evaluation||1929
103021|NCT01070966|239698|P1|STARTED|Participants for Efficacy Evaluation||2011
103022|NCT01070966|239698|P1|NOT COMPLETED|Participants for Safety Evaluation||78
103023|NCT01070966|239698|P1|COMPLETED|Participants for Safety Evaluation||2011
103024|NCT01070966|239698|P1|STARTED|Participants for Safety Evaluation||2089
103025|NCT01070953|239709|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
103026|NCT01070953|239709|P1|COMPLETED|Participants for Efficacy Evaluation||3309
103027|NCT01070953|239709|P1|STARTED|Participants for Efficacy Evaluation||3536
103028|NCT01070953|239709|P1|NOT COMPLETED|Participants for Safety Evaluation||931
103029|NCT01070953|239709|P1|COMPLETED|Participants for Safety Evaluation||3536
103030|NCT01070953|239709|P1|STARTED|Participants for Safety Evaluation||4467
103031|NCT01070888|239722|P2|NOT COMPLETED|Second Intervention (14 Days)||0
103032|NCT01070888|239723|P1|NOT COMPLETED|Second Intervention (14 Days)||0
103033|NCT01070888|239722|P2|COMPLETED|Second Intervention (14 Days)||2
103034|NCT01070888|239723|P1|COMPLETED|Second Intervention (14 Days)||1
103035|NCT01070888|239722|P2|STARTED|Second Intervention (14 Days)||2
103036|NCT01070888|239723|P1|STARTED|Second Intervention (14 Days)||1
103037|NCT01070888|239722|P2|NOT COMPLETED|Washout (14 Days)||0
103038|NCT01070888|239723|P1|NOT COMPLETED|Washout (14 Days)||1
103039|NCT01070888|239722|P2|COMPLETED|Washout (14 Days)||2
103040|NCT01070888|239723|P1|COMPLETED|Washout (14 Days)||1
103041|NCT01070888|239722|P2|STARTED|Washout (14 Days)||2
103042|NCT01070888|239723|P1|STARTED|Washout (14 Days)||2
103043|NCT01070888|239722|P2|NOT COMPLETED|First Intervention (14 Days)||2
103044|NCT01070888|239723|P1|NOT COMPLETED|First Intervention (14 Days)||0
103045|NCT01070888|239722|P2|COMPLETED|First Intervention (14 Days)||2
103046|NCT01070888|239723|P1|COMPLETED|First Intervention (14 Days)||2
103047|NCT01070888|239722|P2|STARTED|First Intervention (14 Days)||4
103048|NCT01070888|239723|P1|STARTED|First Intervention (14 Days)||2
103049|NCT01070784|239731|P2|NOT COMPLETED|Overall Study||18
103050|NCT01070784|239732|P1|NOT COMPLETED|Overall Study||20
103051|NCT01070784|239731|P2|COMPLETED|Overall Study||112
103052|NCT01070784|239732|P1|COMPLETED|Overall Study||110
103053|NCT01070784|239731|P2|STARTED|Overall Study||130
103054|NCT01070784|239732|P1|STARTED|Overall Study||130
103055|NCT01070771|239820|P1|NOT COMPLETED|Overall Study||3
103056|NCT01070771|239820|P1|COMPLETED|Overall Study|August 2012|200
103057|NCT01070771|239820|P1|STARTED|Overall Study|September 2008|203
103058|NCT01070693|239827|P2|NOT COMPLETED|Overall Study||39
103059|NCT01070693|239828|P1|NOT COMPLETED|Overall Study||28
103060|NCT01070693|239827|P2|COMPLETED|Overall Study||110
103061|NCT01070693|239828|P1|COMPLETED|Overall Study||122
103062|NCT01070693|239827|P2|STARTED|Overall Study||149
103063|NCT01070693|239828|P1|STARTED|Overall Study||150
103064|NCT01070550|239840|P6|NOT COMPLETED|Overall Study||7
103065|NCT01070550|239841|P5|NOT COMPLETED|Overall Study||1
103066|NCT01070550|239842|P4|NOT COMPLETED|Overall Study||77
103067|NCT01070550|239843|P3|NOT COMPLETED|Overall Study||216
103068|NCT01070550|239844|P2|NOT COMPLETED|Overall Study||62
103069|NCT01070550|239845|P1|NOT COMPLETED|Overall Study||1285
103070|NCT01070550|239840|P6|COMPLETED|Overall Study||35
103071|NCT01070550|239841|P5|COMPLETED|Overall Study||20
103072|NCT01070550|239842|P4|COMPLETED|Overall Study||124
103073|NCT01070550|239843|P3|COMPLETED|Overall Study||528
103074|NCT01070550|239844|P2|COMPLETED|Overall Study||254
103075|NCT01070550|239845|P1|COMPLETED|Overall Study||2071
103076|NCT01070550|239840|P6|STARTED|Overall Study||42
103077|NCT01070550|239841|P5|STARTED|Overall Study||21
103078|NCT01070550|239842|P4|STARTED|Overall Study||201
103079|NCT01070550|239843|P3|STARTED|Overall Study||744
103080|NCT01070550|239844|P2|STARTED|Overall Study||316
103081|NCT01070550|239845|P1|STARTED|Overall Study||3356
103082|NCT01070394|239985|P1|NOT COMPLETED|Overall Study||7
103083|NCT01070394|239985|P1|COMPLETED|Overall Study||33
103084|NCT01070394|239985|P1|STARTED|Overall Study||40
103085|NCT01070381|239996|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
103086|NCT01070381|239997|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
103087|NCT01070381|239996|P2|COMPLETED|Period 2, 1 Week of Wear||106
103088|NCT01070381|239997|P1|COMPLETED|Period 2, 1 Week of Wear||108
103089|NCT01070381|239996|P2|STARTED|Period 2, 1 Week of Wear||107
103090|NCT01070381|239997|P1|STARTED|Period 2, 1 Week of Wear||109
103091|NCT01070381|239996|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
103092|NCT01070381|239997|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
103093|NCT01070381|239996|P2|COMPLETED|Period 1, 1 Week of Wear||107
103094|NCT01070381|239997|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
103095|NCT01070381|239996|P2|STARTED|Period 1, 1 Week of Wear||107
103096|NCT01070381|239997|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
103097|NCT01070329|240005|P2|NOT COMPLETED|Overall Study||49
103098|NCT01070329|240006|P1|NOT COMPLETED|Overall Study||52
103099|NCT01070329|240005|P2|COMPLETED|Overall Study||217
103100|NCT01070329|240006|P1|COMPLETED|Overall Study||209
103101|NCT01070329|240005|P2|STARTED|Overall Study||266
103102|NCT01070329|240006|P1|STARTED|Overall Study||261
103103|NCT01070316|240038|P1|NOT COMPLETED|Extension Phase||4
103104|NCT01070316|240038|P1|COMPLETED|Extension Phase||14
103105|NCT01070316|240038|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
103106|NCT01070316|240038|P1|NOT COMPLETED|Main Phase||0
103107|NCT01070316|240038|P1|COMPLETED|Main Phase||20
103108|NCT01070316|240038|P1|STARTED|Main Phase||20
103109|NCT01070303|240045|P1|NOT COMPLETED|Overall Study||89
103110|NCT01070303|240045|P1|COMPLETED|Overall Study||88
103111|NCT01070303|240045|P1|STARTED|Overall Study||177
103112|NCT01070173|240104|P3|NOT COMPLETED|Overall Study||0
103113|NCT01070173|240105|P2|NOT COMPLETED|Overall Study||0
103114|NCT01070173|240106|P1|NOT COMPLETED|Overall Study||0
103115|NCT01070173|240104|P3|COMPLETED|Overall Study||11
103116|NCT01070173|240105|P2|COMPLETED|Overall Study||8
103117|NCT01070173|240106|P1|COMPLETED|Overall Study||33
103118|NCT01070173|240104|P3|STARTED|Overall Study||11
103119|NCT01070173|240105|P2|STARTED|Overall Study||8
103120|NCT01070173|240106|P1|STARTED|Overall Study||33
103121|NCT01070043|240119|P3|NOT COMPLETED|Double-Blind Treatment||2
103122|NCT01070043|240120|P2|NOT COMPLETED|Double-Blind Treatment||0
103123|NCT01070043|240121|P1|NOT COMPLETED|Double-Blind Treatment||0
103124|NCT01070043|240119|P3|COMPLETED|Double-Blind Treatment||19
103125|NCT01070043|240120|P2|COMPLETED|Double-Blind Treatment||21
103126|NCT01070043|240121|P1|COMPLETED|Double-Blind Treatment||0
103127|NCT01070043|240119|P3|STARTED|Double-Blind Treatment||21
103128|NCT01070043|240120|P2|STARTED|Double-Blind Treatment||21
103129|NCT01070043|240121|P1|STARTED|Double-Blind Treatment||0
103130|NCT01070043|240119|P3|NOT COMPLETED|Run-In Phase||0
103131|NCT01070043|240120|P2|NOT COMPLETED|Run-In Phase||0
103132|NCT01070043|240121|P1|NOT COMPLETED|Run-In Phase||18
103133|NCT01070043|240119|P3|COMPLETED|Run-In Phase||0
103134|NCT01070043|240120|P2|COMPLETED|Run-In Phase||0
103135|NCT01070043|240121|P1|COMPLETED|Run-In Phase||42
103136|NCT01070043|240119|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
103137|NCT01070043|240120|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
103138|NCT01070043|240121|P1|STARTED|Run-In Phase||60
103139|NCT01069939|240137|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
103140|NCT01069939|240138|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
103141|NCT01069939|240137|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
103142|NCT01069939|240138|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
103143|NCT01069939|240137|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
103144|NCT01069939|240138|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
103145|NCT01069939|240137|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
103146|NCT01069939|240138|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
103147|NCT01069939|240137|P2|COMPLETED|Randomised and Included in the Analyses||137
103148|NCT01069939|240138|P1|COMPLETED|Randomised and Included in the Analyses||164
103149|NCT01069939|240137|P2|STARTED|Randomised and Included in the Analyses||214
103150|NCT01069939|240138|P1|STARTED|Randomised and Included in the Analyses||213
103151|NCT01069900|240164|P2|NOT COMPLETED|Overall Study||4
103152|NCT01069900|240165|P1|NOT COMPLETED|Overall Study||18
103153|NCT01069900|240164|P2|COMPLETED|Overall Study||149
103154|NCT01069900|240165|P1|COMPLETED|Overall Study||287
103155|NCT01069900|240164|P2|Treated|Overall Study||150
103156|NCT01069900|240165|P1|Treated|Overall Study||301
103157|NCT01069900|240164|P2|STARTED|Overall Study||153
103158|NCT01069900|240165|P1|STARTED|Overall Study||305
103159|NCT01069861|240209|P1|NOT COMPLETED|Overall Study||3
103160|NCT01069861|240209|P1|COMPLETED|Overall Study||1
103161|NCT01069861|240209|P1|STARTED|Overall Study||4
103162|NCT01069627|240222|P1|NOT COMPLETED|Overall Study||20
103163|NCT01069627|240222|P1|COMPLETED|Overall Study||0
103164|NCT01069627|240222|P1|STARTED|Overall Study||20
103165|NCT01069562|240245|P2|NOT COMPLETED|Overall Study||0
103166|NCT01069562|240246|P1|NOT COMPLETED|Overall Study||0
103167|NCT01069562|240245|P2|COMPLETED|Overall Study||20
103168|NCT01069562|240246|P1|COMPLETED|Overall Study||20
103169|NCT01069562|240245|P2|STARTED|Overall Study||20
103170|NCT01069562|240246|P1|STARTED|Overall Study||20
103171|NCT01069523|240272|P2|NOT COMPLETED|Overall Study||7
103172|NCT01069523|240273|P1|NOT COMPLETED|Overall Study||4
103173|NCT01069523|240272|P2|COMPLETED|Overall Study||9
103174|NCT01069523|240273|P1|COMPLETED|Overall Study||9
103175|NCT01069523|240272|P2|STARTED|Overall Study||16
103176|NCT01069523|240273|P1|STARTED|Overall Study||13
103177|NCT01069484|240283|P2|NOT COMPLETED|Overall Study||3
103178|NCT01069484|240284|P1|NOT COMPLETED|Overall Study||12
103179|NCT01069484|240283|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
103180|NCT01069484|240284|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
103181|NCT01069484|240283|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
103182|NCT01069484|240284|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
103183|NCT01069419|240292|P1|NOT COMPLETED|Overall Study||715
103184|NCT01069419|240292|P1|COMPLETED|Overall Study||402
103185|NCT01069419|240292|P1|Full Analysis Set|Overall Study||851
103186|NCT01069419|240292|P1|Safety Set|Overall Study||1111
103187|NCT01069419|240292|P1|STARTED|Overall Study||1117
103188|NCT01069341|240299|P1|NOT COMPLETED|Overall Study||1
103189|NCT01069341|240299|P1|COMPLETED|Overall Study||3
103190|NCT01069341|240299|P1|STARTED|Overall Study||4
103191|NCT01069289|240312|P2|NOT COMPLETED|Overall Study||56
103192|NCT01069289|240313|P1|NOT COMPLETED|Overall Study||42
103193|NCT01069289|240312|P2|COMPLETED|Overall Study||601
103194|NCT01069289|240313|P1|COMPLETED|Overall Study||594
103195|NCT01069289|240312|P2|STARTED|Overall Study||657
103196|NCT01069289|240313|P1|STARTED|Overall Study||636
103197|NCT01069172|240351|P2|NOT COMPLETED|Overall Study||0
103198|NCT01069172|240352|P1|NOT COMPLETED|Overall Study||1
103199|NCT01069172|240351|P2|COMPLETED|Overall Study|30 eyes|30
103200|NCT01069172|240352|P1|COMPLETED|Overall Study|29 eyes|29
103201|NCT01069172|240351|P2|STARTED|Overall Study|30 eyes|30
103202|NCT01069172|240352|P1|STARTED|Overall Study|30 eyes|30
103203|NCT01069120|240362|P1|NOT COMPLETED|Overall Study||27
103204|NCT01069120|240362|P1|COMPLETED|Overall Study||0
103205|NCT01069120|240362|P1|STARTED|Overall Study||27
103206|NCT01069003|240371|P3|NOT COMPLETED|Overall Study||475
103207|NCT01069003|240372|P2|NOT COMPLETED|Overall Study||54
103208|NCT01069003|240373|P1|NOT COMPLETED|Overall Study||46
103209|NCT01069003|240371|P3|COMPLETED|Overall Study||976
103210|NCT01069003|240372|P2|COMPLETED|Overall Study||358
103211|NCT01069003|240373|P1|COMPLETED|Overall Study||353
103212|NCT01069003|240371|P3|STARTED|Overall Study||1451
103213|NCT01069003|240372|P2|STARTED|Overall Study||412
103214|NCT01069003|240373|P1|STARTED|Overall Study||399
103215|NCT01068964|240389|P2|NOT COMPLETED|Overall Study||10
103216|NCT01068964|240390|P1|NOT COMPLETED|Overall Study||8
103217|NCT01068964|240389|P2|COMPLETED|Overall Study||104
103218|NCT01068964|240390|P1|COMPLETED|Overall Study||113
103219|NCT01068964|240389|P2|STARTED|Overall Study||114
103220|NCT01068964|240390|P1|STARTED|Overall Study||121
103221|NCT01068912|240399|P3|NOT COMPLETED|Overall Study||15
103222|NCT01068912|240400|P2|NOT COMPLETED|Overall Study||22
103223|NCT01068912|240401|P1|NOT COMPLETED|Overall Study||11
103224|NCT01068912|240399|P3|COMPLETED|Overall Study||186
103225|NCT01068912|240400|P2|COMPLETED|Overall Study||173
103226|NCT01068912|240401|P1|COMPLETED|Overall Study||123
103227|NCT01068912|240399|P3|STARTED|Overall Study||201
103228|NCT01068912|240400|P2|STARTED|Overall Study||195
103229|NCT01068912|240401|P1|STARTED|Overall Study||134
103230|NCT01068860|240419|P10|NOT COMPLETED|Overall Study||4
103231|NCT01068860|240420|P9|NOT COMPLETED|Overall Study||0
103232|NCT01068860|240421|P8|NOT COMPLETED|Overall Study||0
103233|NCT01068860|240422|P7|NOT COMPLETED|Overall Study||0
103234|NCT01068860|240423|P6|NOT COMPLETED|Overall Study||2
103235|NCT01068860|240424|P5|NOT COMPLETED|Overall Study||0
103236|NCT01068860|240425|P4|NOT COMPLETED|Overall Study||1
103237|NCT01068860|240426|P3|NOT COMPLETED|Overall Study||0
103238|NCT01068860|240427|P2|NOT COMPLETED|Overall Study||1
103239|NCT01068860|240428|P1|NOT COMPLETED|Overall Study||0
103240|NCT01068860|240419|P10|COMPLETED|Overall Study||23
103241|NCT01068860|240420|P9|COMPLETED|Overall Study||28
103242|NCT01068860|240421|P8|COMPLETED|Overall Study||15
103243|NCT01068860|240422|P7|COMPLETED|Overall Study||28
103244|NCT01068860|240423|P6|COMPLETED|Overall Study||14
103245|NCT01068860|240424|P5|COMPLETED|Overall Study||32
103246|NCT01068860|240425|P4|COMPLETED|Overall Study||16
103247|NCT01068860|240426|P3|COMPLETED|Overall Study||33
103248|NCT01068860|240427|P2|COMPLETED|Overall Study||16
103249|NCT01068860|240428|P1|COMPLETED|Overall Study||33
103250|NCT01068860|240419|P10|STARTED|Overall Study||27
103251|NCT01068860|240420|P9|STARTED|Overall Study||28
103252|NCT01068860|240421|P8|STARTED|Overall Study||15
103253|NCT01068860|240422|P7|STARTED|Overall Study||28
103254|NCT01068860|240423|P6|STARTED|Overall Study||16
103255|NCT01068860|240424|P5|STARTED|Overall Study||32
103256|NCT01068860|240425|P4|STARTED|Overall Study||17
103257|NCT01068860|240426|P3|STARTED|Overall Study||33
103258|NCT01068860|240427|P2|STARTED|Overall Study||17
103259|NCT01068860|240428|P1|STARTED|Overall Study||33
103260|NCT01068821|240602|P2|NOT COMPLETED|Overall Study||0
103261|NCT01068821|240603|P1|NOT COMPLETED|Overall Study||1
103262|NCT01068821|240602|P2|COMPLETED|Overall Study||29
103263|NCT01068821|240603|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
103264|NCT01068821|240602|P2|STARTED|Overall Study||29
103265|NCT01068821|240603|P1|STARTED|Overall Study||31
103266|NCT01068769|240611|P1|NOT COMPLETED|Overall Study||1
103267|NCT01068769|240611|P1|COMPLETED|Overall Study||33
103268|NCT01068769|240611|P1|STARTED|Overall Study||34
103269|NCT01068743|240616|P4|NOT COMPLETED|Period 4||0
103270|NCT01068743|240617|P3|NOT COMPLETED|Period 4||0
103271|NCT01068743|240618|P2|NOT COMPLETED|Period 4||0
103272|NCT01068743|240619|P1|NOT COMPLETED|Period 4||0
103273|NCT01068743|240616|P4|COMPLETED|Period 4||6
103274|NCT01068743|240617|P3|COMPLETED|Period 4||6
103275|NCT01068743|240618|P2|COMPLETED|Period 4||5
103276|NCT01068743|240619|P1|COMPLETED|Period 4||6
103277|NCT01068743|240616|P4|STARTED|Period 4||6
103278|NCT01068743|240617|P3|STARTED|Period 4||6
103279|NCT01068743|240618|P2|STARTED|Period 4||5
103280|NCT01068743|240619|P1|STARTED|Period 4||6
103281|NCT01068743|240616|P4|NOT COMPLETED|Period 3||0
103282|NCT01068743|240617|P3|NOT COMPLETED|Period 3||0
103283|NCT01068743|240618|P2|NOT COMPLETED|Period 3||1
103284|NCT01068743|240619|P1|NOT COMPLETED|Period 3||0
103285|NCT01068743|240616|P4|COMPLETED|Period 3||6
103286|NCT01068743|240617|P3|COMPLETED|Period 3||6
103287|NCT01068743|240618|P2|COMPLETED|Period 3||5
103288|NCT01068743|240619|P1|COMPLETED|Period 3||6
103289|NCT01068743|240616|P4|STARTED|Period 3||6
103290|NCT01068743|240617|P3|STARTED|Period 3||6
103291|NCT01068743|240618|P2|STARTED|Period 3||6
103292|NCT01068743|240619|P1|STARTED|Period 3||6
103293|NCT01068743|240616|P4|NOT COMPLETED|Period 2||0
103294|NCT01068743|240617|P3|NOT COMPLETED|Period 2||0
103295|NCT01068743|240618|P2|NOT COMPLETED|Period 2||0
103296|NCT01068743|240619|P1|NOT COMPLETED|Period 2||0
103297|NCT01068743|240616|P4|COMPLETED|Period 2||6
103298|NCT01068743|240617|P3|COMPLETED|Period 2||6
103299|NCT01068743|240618|P2|COMPLETED|Period 2||6
103300|NCT01068743|240619|P1|COMPLETED|Period 2||6
103301|NCT01068743|240616|P4|STARTED|Period 2||6
103302|NCT01068743|240617|P3|STARTED|Period 2||6
103303|NCT01068743|240618|P2|STARTED|Period 2||6
103304|NCT01068743|240619|P1|STARTED|Period 2||6
103305|NCT01068743|240616|P4|NOT COMPLETED|Period 1||0
103306|NCT01068743|240617|P3|NOT COMPLETED|Period 1||0
103307|NCT01068743|240618|P2|NOT COMPLETED|Period 1||0
103308|NCT01068743|240619|P1|NOT COMPLETED|Period 1||0
103309|NCT01068743|240616|P4|COMPLETED|Period 1||6
103310|NCT01068743|240617|P3|COMPLETED|Period 1||6
103311|NCT01068743|240618|P2|COMPLETED|Period 1||6
103312|NCT01068743|240619|P1|COMPLETED|Period 1||6
103313|NCT01068743|240616|P4|STARTED|Period 1||6
103314|NCT01068743|240617|P3|STARTED|Period 1||6
103315|NCT01068743|240618|P2|STARTED|Period 1||6
103316|NCT01068743|240619|P1|STARTED|Period 1||6
103317|NCT01068730|240693|P4|NOT COMPLETED|Period 4||0
103318|NCT01068730|240694|P3|NOT COMPLETED|Period 4||0
103319|NCT01068730|240695|P2|NOT COMPLETED|Period 4||1
103320|NCT01068730|240696|P1|NOT COMPLETED|Period 4||0
103321|NCT01068730|240693|P4|COMPLETED|Period 4||7
103322|NCT01068730|240694|P3|COMPLETED|Period 4||7
103323|NCT01068730|240695|P2|COMPLETED|Period 4||6
103324|NCT01068730|240696|P1|COMPLETED|Period 4||6
103325|NCT01068730|240693|P4|STARTED|Period 4||7
103326|NCT01068730|240694|P3|STARTED|Period 4||7
103327|NCT01068730|240695|P2|STARTED|Period 4||7
103328|NCT01068730|240696|P1|STARTED|Period 4||6
103329|NCT01068730|240693|P4|NOT COMPLETED|Period 3||0
103330|NCT01068730|240694|P3|NOT COMPLETED|Period 3||0
103331|NCT01068730|240695|P2|NOT COMPLETED|Period 3||0
103332|NCT01068730|240696|P1|NOT COMPLETED|Period 3||1
103333|NCT01068730|240693|P4|COMPLETED|Period 3||7
103334|NCT01068730|240694|P3|COMPLETED|Period 3||7
103335|NCT01068730|240695|P2|COMPLETED|Period 3||7
103336|NCT01068730|240696|P1|COMPLETED|Period 3||6
103337|NCT01068730|240693|P4|STARTED|Period 3||7
103338|NCT01068730|240694|P3|STARTED|Period 3||7
103339|NCT01068730|240695|P2|STARTED|Period 3||7
103340|NCT01068730|240696|P1|STARTED|Period 3||7
103341|NCT01068730|240693|P4|NOT COMPLETED|Period 2||0
103342|NCT01068730|240694|P3|NOT COMPLETED|Period 2||0
103343|NCT01068730|240695|P2|NOT COMPLETED|Period 2||0
103344|NCT01068730|240696|P1|NOT COMPLETED|Period 2||0
103345|NCT01068730|240693|P4|COMPLETED|Period 2||7
103346|NCT01068730|240694|P3|COMPLETED|Period 2||7
103347|NCT01068730|240695|P2|COMPLETED|Period 2||7
103348|NCT01068730|240696|P1|COMPLETED|Period 2||7
103349|NCT01068730|240693|P4|STARTED|Period 2||7
103350|NCT01068730|240694|P3|STARTED|Period 2||7
103351|NCT01068730|240695|P2|STARTED|Period 2||7
103352|NCT01068730|240696|P1|STARTED|Period 2||7
103353|NCT01068730|240693|P4|NOT COMPLETED|Period 1||0
103354|NCT01068730|240694|P3|NOT COMPLETED|Period 1||0
103355|NCT01068730|240695|P2|NOT COMPLETED|Period 1||0
103356|NCT01068730|240696|P1|NOT COMPLETED|Period 1||0
103357|NCT01068730|240693|P4|COMPLETED|Period 1||7
103358|NCT01068730|240694|P3|COMPLETED|Period 1||7
103359|NCT01068730|240695|P2|COMPLETED|Period 1||7
103360|NCT01068730|240696|P1|COMPLETED|Period 1||7
103361|NCT01068730|240693|P4|STARTED|Period 1||7
103362|NCT01068730|240694|P3|STARTED|Period 1||7
103363|NCT01068730|240695|P2|STARTED|Period 1||7
103364|NCT01068730|240696|P1|STARTED|Period 1||7
103365|NCT01068717|240750|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
103366|NCT01068717|240751|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
103367|NCT01068717|240752|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
103368|NCT01068717|240753|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
103369|NCT01068717|240750|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
103370|NCT01068717|240751|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
103371|NCT01068717|240752|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
103372|NCT01068717|240753|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
103373|NCT01068717|240750|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
103374|NCT01068717|240751|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
103375|NCT01068717|240752|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
103376|NCT01068717|240753|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
103377|NCT01068717|240750|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
103378|NCT01068717|240751|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
103379|NCT01068717|240752|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
103380|NCT01068717|240753|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
103381|NCT01068717|240750|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
103382|NCT01068717|240751|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
103383|NCT01068717|240752|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
103384|NCT01068717|240753|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
103385|NCT01068717|240750|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
103386|NCT01068717|240751|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
103387|NCT01068717|240752|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
103388|NCT01068717|240753|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
103389|NCT01068717|240750|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
103390|NCT01068717|240751|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
103391|NCT01068717|240752|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
103392|NCT01068717|240753|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
103393|NCT01068717|240750|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
103394|NCT01068717|240751|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
103395|NCT01068717|240752|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
103396|NCT01068717|240753|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
103397|NCT01068717|240750|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
103398|NCT01068717|240751|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
103399|NCT01068717|240752|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
103400|NCT01068717|240753|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
103401|NCT01068717|240750|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
103402|NCT01068717|240751|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
103403|NCT01068717|240752|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
103404|NCT01068717|240753|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
103405|NCT01068717|240750|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
103406|NCT01068717|240751|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
103407|NCT01068717|240752|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
103408|NCT01068717|240753|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
103409|NCT01068717|240750|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
103410|NCT01068717|240751|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
103411|NCT01068717|240752|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
103412|NCT01068717|240753|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
103413|NCT01068678|240809|P2|NOT COMPLETED|Overall Study||24
103414|NCT01068678|240810|P1|NOT COMPLETED|Overall Study||38
103415|NCT01068678|240809|P2|COMPLETED|Overall Study||206
103416|NCT01068678|240810|P1|COMPLETED|Overall Study||192
103417|NCT01068678|240809|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
103418|NCT01068678|240810|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
103419|NCT01068678|240809|P2|STARTED|Overall Study||230
103420|NCT01068678|240810|P1|STARTED|Overall Study||230
103421|NCT01068665|240820|P2|NOT COMPLETED|Overall Study||29
103422|NCT01068665|240821|P1|NOT COMPLETED|Overall Study||30
103423|NCT01068665|240820|P2|COMPLETED|Overall Study||201
103424|NCT01068665|240821|P1|COMPLETED|Overall Study||200
103425|NCT01068665|240820|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
103426|NCT01068665|240821|P1|Exposed|Overall Study||228
103427|NCT01068665|240820|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
103428|NCT01068665|240821|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
103429|NCT01068665|240820|P2|STARTED|Overall Study||230
103430|NCT01068665|240821|P1|STARTED|Overall Study||230
103431|NCT01068652|240831|P2|NOT COMPLETED|Overall Study||15
103432|NCT01068652|240832|P1|NOT COMPLETED|Overall Study||18
103433|NCT01068652|240831|P2|COMPLETED|Overall Study||188
103434|NCT01068652|240832|P1|COMPLETED|Overall Study||182
103435|NCT01068652|240831|P2|STARTED|Overall Study||203
103436|NCT01068652|240832|P1|STARTED|Overall Study||200
103437|NCT01068626|240872|P2|NOT COMPLETED|Overall Study||2
103438|NCT01068626|240873|P1|NOT COMPLETED|Overall Study||3
103439|NCT01068626|240872|P2|COMPLETED|Overall Study||27
103440|NCT01068626|240873|P1|COMPLETED|Overall Study||27
103441|NCT01068626|240872|P2|STARTED|Overall Study||29
103442|NCT01068626|240873|P1|STARTED|Overall Study||30
103443|NCT01068600|240891|P2|NOT COMPLETED|Overall Study||17
103444|NCT01068600|240892|P1|NOT COMPLETED|Overall Study||11
103445|NCT01068600|240891|P2|COMPLETED|Overall Study||142
103446|NCT01068600|240892|P1|COMPLETED|Overall Study||148
103447|NCT01068600|240891|P2|STARTED|Overall Study||159
103448|NCT01068600|240892|P1|STARTED|Overall Study||159
103449|NCT01068548|240902|P2|NOT COMPLETED|Overall Study||0
103450|NCT01068548|240903|P1|NOT COMPLETED|Overall Study||0
103451|NCT01068548|240902|P2|COMPLETED|Overall Study||63
103452|NCT01068548|240903|P1|COMPLETED|Overall Study||66
103453|NCT01068548|240902|P2|STARTED|Overall Study||63
103454|NCT01068548|240903|P1|STARTED|Overall Study||66
103455|NCT01068509|240912|P3|NOT COMPLETED|Overall Study||21
103456|NCT01068509|240913|P2|NOT COMPLETED|Overall Study||22
103457|NCT01068509|240914|P1|NOT COMPLETED|Overall Study||6
103458|NCT01068509|240912|P3|COMPLETED|Overall Study||6
103459|NCT01068509|240913|P2|COMPLETED|Overall Study||7
103460|NCT01068509|240914|P1|COMPLETED|Overall Study||1
103461|NCT01068509|240912|P3|STARTED|Overall Study||27
103462|NCT01068509|240913|P2|STARTED|Overall Study||29
103463|NCT01068509|240914|P1|STARTED|Overall Study||7
103464|NCT01068418|240927|P1|NOT COMPLETED|Overall Study||12
103465|NCT01068418|240927|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
103466|NCT01068418|240927|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
103467|NCT01068418|240927|P1|STARTED|Overall Study|26 participants found to be eligible|26
103468|NCT01068158|240934|P2|NOT COMPLETED|Overall Study||4
103469|NCT01068158|240935|P1|NOT COMPLETED|Overall Study||8
103470|NCT01068158|240934|P2|COMPLETED|Overall Study||198
103471|NCT01068158|240935|P1|COMPLETED|Overall Study||161
103472|NCT01068158|240934|P2|STARTED|Overall Study||202
103473|NCT01068158|240935|P1|STARTED|Overall Study||169
103474|NCT01067976|240947|P1|NOT COMPLETED|Overall Study||22
103475|NCT01067976|240947|P1|COMPLETED|Overall Study|study course completed|424
103476|NCT01067976|240947|P1|Fulfilled Requirements of FAS Population|Overall Study||390
103477|NCT01067976|240947|P1|Received Treatment|Overall Study|treatment started|426
103478|NCT01067976|240947|P1|STARTED|Overall Study|screened and enrolled|446
103479|NCT01067846|241008|P2|NOT COMPLETED|Overall Study||19
103480|NCT01067846|241009|P1|NOT COMPLETED|Overall Study||19
103481|NCT01067846|241008|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
103482|NCT01067846|241009|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
103483|NCT01067846|241008|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
103484|NCT01067846|241009|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
103485|NCT01067846|241008|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
103486|NCT01067846|241009|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
103487|NCT01067781|241021|P4|NOT COMPLETED|Up to Day 720||101
103488|NCT01067781|241022|P3|NOT COMPLETED|Up to Day 720||97
103489|NCT01067781|241023|P2|NOT COMPLETED|Up to Day 720||195
103490|NCT01067781|241024|P1|NOT COMPLETED|Up to Day 720||200
103491|NCT01067781|241021|P4|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
103492|NCT01067781|241022|P3|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
103493|NCT01067781|241023|P2|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
103494|NCT01067781|241024|P1|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
103495|NCT01067781|241021|P4|STARTED|Up to Day 720||101
103496|NCT01067781|241022|P3|STARTED|Up to Day 720||97
103497|NCT01067781|241023|P2|STARTED|Up to Day 720||199
103498|NCT01067781|241024|P1|STARTED|Up to Day 720||203
103499|NCT01067781|241021|P4|NOT COMPLETED|Up to Day 180||12
103500|NCT01067781|241022|P3|NOT COMPLETED|Up to Day 180||8
103501|NCT01067781|241023|P2|NOT COMPLETED|Up to Day 180||31
103502|NCT01067781|241024|P1|NOT COMPLETED|Up to Day 180||30
103503|NCT01067781|241021|P4|COMPLETED|Up to Day 180||89
103504|NCT01067781|241022|P3|COMPLETED|Up to Day 180||89
103505|NCT01067781|241023|P2|COMPLETED|Up to Day 180||168
103506|NCT01067781|241024|P1|COMPLETED|Up to Day 180||173
103507|NCT01067781|241021|P4|STARTED|Up to Day 180||101
103508|NCT01067781|241022|P3|STARTED|Up to Day 180||97
103509|NCT01067781|241023|P2|STARTED|Up to Day 180||199
103510|NCT01067781|241024|P1|STARTED|Up to Day 180||203
103511|NCT01067768|241034|P2|NOT COMPLETED|Overall Study||0
103512|NCT01067768|241035|P1|NOT COMPLETED|Overall Study||0
103513|NCT01067768|241034|P2|COMPLETED|Overall Study||605
103514|NCT01067768|241035|P1|COMPLETED|Overall Study||604
103515|NCT01067768|241034|P2|STARTED|Overall Study||605
103516|NCT01067768|241035|P1|STARTED|Overall Study||604
103517|NCT01067716|241046|P3|NOT COMPLETED|Overall Study||0
103518|NCT01067716|241047|P2|NOT COMPLETED|Overall Study||0
103519|NCT01067716|241048|P1|NOT COMPLETED|Overall Study||0
103520|NCT01067716|241046|P3|COMPLETED|Overall Study|15 eyes|9
103521|NCT01067716|241047|P2|COMPLETED|Overall Study|25 eyes|13
103522|NCT01067716|241048|P1|COMPLETED|Overall Study|110 eyes|57
103523|NCT01067716|241046|P3|STARTED|Overall Study|15 eyes|9
103524|NCT01067716|241047|P2|STARTED|Overall Study|25 eyes|13
103525|NCT01067716|241048|P1|STARTED|Overall Study|110 eyes|57
103526|NCT01067456|241067|P2|NOT COMPLETED|Overall Study||0
103527|NCT01067456|241068|P1|NOT COMPLETED|Overall Study||0
103528|NCT01067456|241067|P2|COMPLETED|Overall Study||29
103529|NCT01067456|241068|P1|COMPLETED|Overall Study||30
103530|NCT01067456|241067|P2|STARTED|Overall Study||29
103531|NCT01067456|241068|P1|STARTED|Overall Study||30
103532|NCT01067352|241077|P3|NOT COMPLETED|Overall Study||1
103533|NCT01067352|241078|P2|NOT COMPLETED|Overall Study||3
103534|NCT01067352|241079|P1|NOT COMPLETED|Overall Study||1
103535|NCT01067352|241077|P3|COMPLETED|Overall Study||9
103536|NCT01067352|241078|P2|COMPLETED|Overall Study||3
103537|NCT01067352|241079|P1|COMPLETED|Overall Study||8
103538|NCT01067352|241077|P3|STARTED|Overall Study||10
103539|NCT01067352|241078|P2|STARTED|Overall Study||6
103540|NCT01067352|241079|P1|STARTED|Overall Study||9
103541|NCT01067326|241095|P2|NOT COMPLETED|Overall Study||3
103542|NCT01067326|241096|P1|NOT COMPLETED|Overall Study||2
103543|NCT01067326|241095|P2|COMPLETED|Overall Study||5
103544|NCT01067326|241096|P1|COMPLETED|Overall Study||12
103545|NCT01067326|241095|P2|STARTED|Overall Study||8
103546|NCT01067326|241096|P1|STARTED|Overall Study||14
103547|NCT01067105|241108|P1|NOT COMPLETED|Overall Study||141
103548|NCT01067105|241108|P1|COMPLETED|Overall Study||683
103549|NCT01067105|241108|P1|STARTED|Overall Study||824
103550|NCT01066923|241129|P4|NOT COMPLETED|Overall Study||8
103551|NCT01066923|241130|P3|NOT COMPLETED|Overall Study||8
103552|NCT01066923|241131|P2|NOT COMPLETED|Overall Study||3
103553|NCT01066923|241132|P1|NOT COMPLETED|Overall Study||3
103554|NCT01066923|241129|P4|COMPLETED|Overall Study||23
103555|NCT01066923|241130|P3|COMPLETED|Overall Study||25
103556|NCT01066923|241131|P2|COMPLETED|Overall Study||29
103557|NCT01066923|241132|P1|COMPLETED|Overall Study||25
103558|NCT01066923|241129|P4|Retinal Imaging|Overall Study||0
103559|NCT01066923|241130|P3|Retinal Imaging|Overall Study||0
103560|NCT01066923|241131|P2|Retinal Imaging|Overall Study||0
103561|NCT01066923|241132|P1|Retinal Imaging|Overall Study||0
103562|NCT01066923|241129|P4|Activation of Coagulation|Overall Study||0
103563|NCT01066923|241130|P3|Activation of Coagulation|Overall Study||0
103564|NCT01066923|241131|P2|Activation of Coagulation|Overall Study||0
103565|NCT01066923|241132|P1|Activation of Coagulation|Overall Study||0
103566|NCT01066923|241129|P4|Vascular Function|Overall Study||13
103567|NCT01066923|241130|P3|Vascular Function|Overall Study||12
103568|NCT01066923|241131|P2|Vascular Function|Overall Study||14
103569|NCT01066923|241132|P1|Vascular Function|Overall Study||13
103570|NCT01066923|241129|P4|Platelet Closure Time|Overall Study||23
103571|NCT01066923|241130|P3|Platelet Closure Time|Overall Study||25
103572|NCT01066923|241131|P2|Platelet Closure Time|Overall Study||29
103573|NCT01066923|241132|P1|Platelet Closure Time|Overall Study||25
103574|NCT01066923|241129|P4|STARTED|Overall Study||31
103575|NCT01066923|241130|P3|STARTED|Overall Study||33
103576|NCT01066923|241131|P2|STARTED|Overall Study||32
103577|NCT01066923|241132|P1|STARTED|Overall Study||28
103578|NCT01066871|241150|P4|NOT COMPLETED|Overall Study||5
103579|NCT01066871|241151|P3|NOT COMPLETED|Overall Study||6
103580|NCT01066871|241152|P2|NOT COMPLETED|Overall Study||5
103581|NCT01066871|241153|P1|NOT COMPLETED|Overall Study||4
103582|NCT01066871|241150|P4|COMPLETED|Overall Study||13
103583|NCT01066871|241151|P3|COMPLETED|Overall Study||12
103584|NCT01066871|241152|P2|COMPLETED|Overall Study||13
103585|NCT01066871|241153|P1|COMPLETED|Overall Study||16
103586|NCT01066871|241150|P4|STARTED|Overall Study||18
103587|NCT01066871|241151|P3|STARTED|Overall Study||18
103588|NCT01066871|241152|P2|STARTED|Overall Study||18
103589|NCT01066871|241153|P1|STARTED|Overall Study||20
103590|NCT01066819|241217|P6|NOT COMPLETED|Overall Study||6
103591|NCT01066819|241218|P5|NOT COMPLETED|Overall Study||4
103592|NCT01066819|241219|P4|NOT COMPLETED|Overall Study||17
103593|NCT01066819|241220|P3|NOT COMPLETED|Overall Study||146
103594|NCT01066819|241221|P2|NOT COMPLETED|Overall Study||171
103595|NCT01066819|241222|P1|NOT COMPLETED|Overall Study||689
103596|NCT01066819|241217|P6|COMPLETED|Overall Study||7
103597|NCT01066819|241218|P5|COMPLETED|Overall Study||3
103598|NCT01066819|241219|P4|COMPLETED|Overall Study||8
103599|NCT01066819|241220|P3|COMPLETED|Overall Study||111
103600|NCT01066819|241221|P2|COMPLETED|Overall Study||177
103601|NCT01066819|241222|P1|COMPLETED|Overall Study||317
103602|NCT01066819|241217|P6|STARTED|Overall Study||13
103603|NCT01066819|241218|P5|STARTED|Overall Study||7
103604|NCT01066819|241219|P4|STARTED|Overall Study||25
103605|NCT01066819|241220|P3|STARTED|Overall Study||257
103606|NCT01066819|241221|P2|STARTED|Overall Study||348
103607|NCT01066819|241222|P1|STARTED|Overall Study||1006
103608|NCT01066793|241363|P6|NOT COMPLETED|Overall Study||1
103609|NCT01066793|241364|P5|NOT COMPLETED|Overall Study||0
103610|NCT01066793|241365|P4|NOT COMPLETED|Overall Study||49
103611|NCT01066793|241366|P3|NOT COMPLETED|Overall Study||115
103612|NCT01066793|241367|P2|NOT COMPLETED|Overall Study||77
103613|NCT01066793|241368|P1|NOT COMPLETED|Overall Study||374
103614|NCT01066793|241363|P6|COMPLETED|Overall Study||4
103615|NCT01066793|241364|P5|COMPLETED|Overall Study||11
103616|NCT01066793|241365|P4|COMPLETED|Overall Study||94
103617|NCT01066793|241366|P3|COMPLETED|Overall Study||369
103618|NCT01066793|241367|P2|COMPLETED|Overall Study||495
103619|NCT01066793|241368|P1|COMPLETED|Overall Study||754
103620|NCT01066793|241363|P6|STARTED|Overall Study||5
103621|NCT01066793|241364|P5|STARTED|Overall Study||11
103622|NCT01066793|241365|P4|STARTED|Overall Study||143
103623|NCT01066793|241366|P3|STARTED|Overall Study||484
103624|NCT01066793|241367|P2|STARTED|Overall Study||572
103625|NCT01066793|241368|P1|STARTED|Overall Study||1128
103626|NCT01066780|241508|P2|NOT COMPLETED|Overall Study||1
103627|NCT01066780|241509|P1|NOT COMPLETED|Overall Study||1
103628|NCT01066780|241508|P2|COMPLETED|Overall Study||23
103629|NCT01066780|241509|P1|COMPLETED|Overall Study||23
103630|NCT01066780|241508|P2|STARTED|Overall Study||24
103631|NCT01066780|241509|P1|STARTED|Overall Study||24
103632|NCT01066624|241516|P3|NOT COMPLETED|Overall Study||0
103633|NCT01066624|241517|P2|NOT COMPLETED|Overall Study||0
103634|NCT01066624|241518|P1|NOT COMPLETED|Overall Study||0
103635|NCT01066624|241516|P3|COMPLETED|Overall Study||39
103636|NCT01066624|241517|P2|COMPLETED|Overall Study||40
103637|NCT01066624|241518|P1|COMPLETED|Overall Study||38
103638|NCT01066624|241516|P3|STARTED|Overall Study||39
103639|NCT01066624|241517|P2|STARTED|Overall Study||40
103640|NCT01066624|241518|P1|STARTED|Overall Study||38
103641|NCT01066585|241528|P2|NOT COMPLETED|Overall Study||3
103642|NCT01066585|241529|P1|NOT COMPLETED|Overall Study||1
103643|NCT01066585|241528|P2|COMPLETED|Overall Study||196
103644|NCT01066585|241529|P1|COMPLETED|Overall Study||210
103645|NCT01066585|241528|P2|STARTED|Overall Study||199
103646|NCT01066585|241529|P1|STARTED|Overall Study||211
103647|NCT01066546|241541|P1|NOT COMPLETED|Overall Study||5
103648|NCT01066546|241541|P1|COMPLETED|Overall Study||0
103649|NCT01066546|241541|P1|STARTED|Overall Study||5
103650|NCT01066520|241555|P3|NOT COMPLETED|Overall Study||0
103651|NCT01066520|241556|P2|NOT COMPLETED|Overall Study||0
103652|NCT01066520|241557|P1|NOT COMPLETED|Overall Study||0
103653|NCT01066520|241555|P3|COMPLETED|Overall Study||137
103654|NCT01066520|241556|P2|COMPLETED|Overall Study||140
103655|NCT01066520|241557|P1|COMPLETED|Overall Study||143
103656|NCT01066520|241555|P3|STARTED|Overall Study||137
103657|NCT01066520|241556|P2|STARTED|Overall Study||140
103658|NCT01066520|241557|P1|STARTED|Overall Study||143
103659|NCT01066039|241571|P1|NOT COMPLETED|Overall Study||44
103660|NCT01066039|241571|P1|COMPLETED|Overall Study||158
103661|NCT01066039|241571|P1|Treated|Overall Study||200
103662|NCT01066039|241571|P1|STARTED|Overall Study||202
103663|NCT01066000|241584|P1|NOT COMPLETED|Overall Study||9
103664|NCT01066000|241584|P1|COMPLETED|Overall Study||24
103665|NCT01066000|241584|P1|STARTED|Overall Study||33
103666|NCT01065844|241595|P1|NOT COMPLETED|Overall Study||5
103667|NCT01065844|241595|P1|COMPLETED|Overall Study||10
103668|NCT01065844|241595|P1|STARTED|Overall Study||15
103669|NCT01065779|241599|P1|NOT COMPLETED|Overall Study||82
103670|NCT01065779|241599|P1|COMPLETED|Overall Study||798
103671|NCT01065779|241599|P1|STARTED|Overall Study||880
103672|NCT01065766|241610|P1|NOT COMPLETED|Overall Study||32
103673|NCT01065766|241610|P1|COMPLETED|Overall Study||4033
103674|NCT01065766|241610|P1|STARTED|Overall Study||4065
103675|NCT01065714|241622|P1|NOT COMPLETED|Overall Study||0
103676|NCT01065714|241622|P1|COMPLETED|Overall Study||20
103677|NCT01065714|241622|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
103678|NCT01065597|241629|P1|NOT COMPLETED|Overall Study||1
103679|NCT01065597|241629|P1|COMPLETED|Overall Study||12
103680|NCT01065597|241629|P1|STARTED|Overall Study||13
103681|NCT01065558|241636|P1|NOT COMPLETED|Overall Study||0
103682|NCT01065558|241636|P1|COMPLETED|Overall Study||5
103683|NCT01065558|241636|P1|STARTED|Overall Study||5
103684|NCT01065506|241643|P2|NOT COMPLETED|Overall Study||38
103685|NCT01065506|241644|P1|NOT COMPLETED|Overall Study||32
103686|NCT01065506|241643|P2|COMPLETED|Overall Study||34
103687|NCT01065506|241644|P1|COMPLETED|Overall Study||32
103688|NCT01065506|241643|P2|4-Month Follow-Up|Overall Study||34
103689|NCT01065506|241644|P1|4-Month Follow-Up|Overall Study||35
103690|NCT01065506|241643|P2|End of Treatment|Overall Study||37
103691|NCT01065506|241644|P1|End of Treatment|Overall Study||44
103692|NCT01065506|241643|P2|STARTED|Overall Study||72
103693|NCT01065506|241644|P1|STARTED|Overall Study||64
103694|NCT01065454|241654|P4|NOT COMPLETED|Follow up||44
103695|NCT01065454|241655|P3|NOT COMPLETED|Follow up||17
103696|NCT01065454|241656|P2|NOT COMPLETED|Follow up||24
103697|NCT01065454|241657|P1|NOT COMPLETED|Follow up||39
103698|NCT01065454|241654|P4|COMPLETED|Follow up||13
103699|NCT01065454|241655|P3|COMPLETED|Follow up||6
103700|NCT01065454|241656|P2|COMPLETED|Follow up||4
103701|NCT01065454|241657|P1|COMPLETED|Follow up||15
103702|NCT01065454|241654|P4|Entering Follow-up|Follow up||51
103703|NCT01065454|241655|P3|Entering Follow-up|Follow up||23
103704|NCT01065454|241656|P2|Entering Follow-up|Follow up||27
103705|NCT01065454|241657|P1|Entering Follow-up|Follow up||49
103706|NCT01065454|241654|P4|STARTED|Follow up||57
103707|NCT01065454|241655|P3|STARTED|Follow up||23
103708|NCT01065454|241656|P2|STARTED|Follow up||28
103709|NCT01065454|241657|P1|STARTED|Follow up||54
103710|NCT01065454|241654|P4|NOT COMPLETED|Treatment||12
103711|NCT01065454|241655|P3|NOT COMPLETED|Treatment||9
103712|NCT01065454|241656|P2|NOT COMPLETED|Treatment||5
103713|NCT01065454|241657|P1|NOT COMPLETED|Treatment||13
103714|NCT01065454|241654|P4|COMPLETED|Treatment||57
103715|NCT01065454|241655|P3|COMPLETED|Treatment||23
103716|NCT01065454|241656|P2|COMPLETED|Treatment||28
103717|NCT01065454|241657|P1|COMPLETED|Treatment||54
103718|NCT01065454|241654|P4|STARTED|Treatment||69
103719|NCT01065454|241655|P3|STARTED|Treatment||32
103720|NCT01065454|241656|P2|STARTED|Treatment||33
103721|NCT01065454|241657|P1|STARTED|Treatment||67
103722|NCT01065428|241769|P2|NOT COMPLETED|Overall Study||0
103723|NCT01065428|241770|P1|NOT COMPLETED|Overall Study||0
103724|NCT01065428|241769|P2|COMPLETED|Overall Study||35
103725|NCT01065428|241770|P1|COMPLETED|Overall Study||17
103726|NCT01065428|241769|P2|STARTED|Overall Study||35
103727|NCT01065428|241770|P1|STARTED|Overall Study||17
103728|NCT01065350|241780|P2|NOT COMPLETED|Overall Study||1
103729|NCT01065350|241781|P1|NOT COMPLETED|Overall Study||0
103730|NCT01065350|241780|P2|COMPLETED|Overall Study||41
103731|NCT01065350|241781|P1|COMPLETED|Overall Study||43
103732|NCT01065350|241780|P2|STARTED|Overall Study||42
103733|NCT01065350|241781|P1|STARTED|Overall Study||43
103734|NCT01065051|241815|P2|NOT COMPLETED|Overall Study||0
103735|NCT01065051|241816|P1|NOT COMPLETED|Overall Study||0
103736|NCT01065051|241815|P2|COMPLETED|Overall Study||0
103737|NCT01065051|241816|P1|COMPLETED|Overall Study||1
103738|NCT01065051|241815|P2|STARTED|Overall Study||0
103739|NCT01065051|241816|P1|STARTED|Overall Study||1
103740|NCT01064947|241842|P1|NOT COMPLETED|Overall Study||41
103741|NCT01064947|241842|P1|COMPLETED|Overall Study||29
103742|NCT01064947|241842|P1|STARTED|Overall Study||70
103743|NCT01064882|241853|P3|NOT COMPLETED|Overall Study||2
103744|NCT01064882|241854|P2|NOT COMPLETED|Overall Study||2
103745|NCT01064882|241855|P1|NOT COMPLETED|Overall Study||2
103746|NCT01064882|241853|P3|COMPLETED|Overall Study||32
103747|NCT01064882|241854|P2|COMPLETED|Overall Study||32
103748|NCT01064882|241855|P1|COMPLETED|Overall Study||34
103749|NCT01064882|241853|P3|STARTED|Overall Study||34
103750|NCT01064882|241854|P2|STARTED|Overall Study||34
103751|NCT01064882|241855|P1|STARTED|Overall Study||36
103752|NCT01064856|241883|P4|NOT COMPLETED|Open-label (OL) Period||20
103753|NCT01064856|241884|P3|NOT COMPLETED|Open-label (OL) Period||26
103754|NCT01064856|241885|P2|NOT COMPLETED|Open-label (OL) Period||0
103755|NCT01064856|241886|P1|NOT COMPLETED|Open-label (OL) Period||0
103756|NCT01064856|241883|P4|COMPLETED|Open-label (OL) Period||61
103757|NCT01064856|241884|P3|COMPLETED|Open-label (OL) Period||56
103758|NCT01064856|241885|P2|COMPLETED|Open-label (OL) Period||0
103759|NCT01064856|241886|P1|COMPLETED|Open-label (OL) Period||0
103760|NCT01064856|241883|P4|STARTED|Open-label (OL) Period||81
103761|NCT01064856|241884|P3|STARTED|Open-label (OL) Period||82
103762|NCT01064856|241885|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
103763|NCT01064856|241886|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
103764|NCT01064856|241883|P4|NOT COMPLETED|Double-blind (DB) Period||0
103765|NCT01064856|241884|P3|NOT COMPLETED|Double-blind (DB) Period||0
103766|NCT01064856|241885|P2|NOT COMPLETED|Double-blind (DB) Period||0
103767|NCT01064856|241886|P1|NOT COMPLETED|Double-blind (DB) Period||2
103768|NCT01064856|241883|P4|COMPLETED|Double-blind (DB) Period||0
103769|NCT01064856|241884|P3|COMPLETED|Double-blind (DB) Period||0
103770|NCT01064856|241885|P2|COMPLETED|Double-blind (DB) Period||81
103771|NCT01064856|241886|P1|COMPLETED|Double-blind (DB) Period||82
103772|NCT01064856|241883|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
103773|NCT01064856|241884|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
103774|NCT01064856|241885|P2|STARTED|Double-blind (DB) Period||81
103775|NCT01064856|241886|P1|STARTED|Double-blind (DB) Period||84
103776|NCT01064830|241919|P2|NOT COMPLETED|Overall Study||4
103777|NCT01064830|241920|P1|NOT COMPLETED|Overall Study||2
103778|NCT01064830|241919|P2|COMPLETED|Overall Study||7
103779|NCT01064830|241920|P1|COMPLETED|Overall Study||8
103780|NCT01064830|241919|P2|STARTED|Overall Study||11
103781|NCT01064830|241920|P1|STARTED|Overall Study||10
103782|NCT01064817|241930|P2|NOT COMPLETED|Study Completion||0
103783|NCT01064817|241931|P1|NOT COMPLETED|Study Completion||2
103784|NCT01064817|241930|P2|COMPLETED|Study Completion||62
103785|NCT01064817|241931|P1|COMPLETED|Study Completion||60
103786|NCT01064817|241930|P2|STARTED|Study Completion||62
103787|NCT01064817|241931|P1|STARTED|Study Completion||62
103788|NCT01064817|241930|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
103789|NCT01064817|241931|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
103790|NCT01064817|241930|P2|COMPLETED|All Study Treatment Days 1-9||62
103791|NCT01064817|241931|P1|COMPLETED|All Study Treatment Days 1-9||62
103792|NCT01064817|241930|P2|STARTED|All Study Treatment Days 1-9||62
103793|NCT01064817|241931|P1|STARTED|All Study Treatment Days 1-9||62
103794|NCT01064739|241943|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
103795|NCT01064739|241943|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
103796|NCT01064739|241943|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
103797|NCT01064739|241943|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
103798|NCT01064739|241943|P1|COMPLETED|Fixed Sodium Study Diet||14
103799|NCT01064739|241943|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
103800|NCT01064687|242003|P4|NOT COMPLETED|Overall Study||17
103801|NCT01064687|242004|P3|NOT COMPLETED|Overall Study||41
103802|NCT01064687|242005|P2|NOT COMPLETED|Overall Study||26
103803|NCT01064687|242006|P1|NOT COMPLETED|Overall Study||34
103804|NCT01064687|242003|P4|COMPLETED|Overall Study||124
103805|NCT01064687|242004|P3|COMPLETED|Overall Study||237
103806|NCT01064687|242005|P2|COMPLETED|Overall Study||254
103807|NCT01064687|242006|P1|COMPLETED|Overall Study||245
103808|NCT01064687|242003|P4|Completed 26 Weeks|Overall Study||124
103809|NCT01064687|242004|P3|Completed 26 Weeks|Overall Study||252
103810|NCT01064687|242005|P2|Completed 26 Weeks|Overall Study||263
103811|NCT01064687|242006|P1|Completed 26 Weeks|Overall Study||260
103812|NCT01064687|242003|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
103813|NCT01064687|242004|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
103814|NCT01064687|242005|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
103815|NCT01064687|242006|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
103816|NCT01064687|242003|P4|STARTED|Overall Study||141
103817|NCT01064687|242004|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
103818|NCT01064687|242005|P2|STARTED|Overall Study||280
103819|NCT01064687|242006|P1|STARTED|Overall Study||279
103820|NCT01064622|242186|P2|NOT COMPLETED|Crossover of Arm I||0
103821|NCT01064622|242187|P1|NOT COMPLETED|Crossover of Arm I||0
103822|NCT01064622|242186|P2|COMPLETED|Crossover of Arm I||0
103823|NCT01064622|242187|P1|COMPLETED|Crossover of Arm I||22
103824|NCT01064622|242186|P2|STARTED|Crossover of Arm I||0
103825|NCT01064622|242187|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
103826|NCT01064622|242186|P2|NOT COMPLETED|Randomized Phase II||3
103827|NCT01064622|242187|P1|NOT COMPLETED|Randomized Phase II||2
103828|NCT01064622|242186|P2|COMPLETED|Randomized Phase II||53
103829|NCT01064622|242187|P1|COMPLETED|Randomized Phase II||53
103830|NCT01064622|242186|P2|STARTED|Randomized Phase II||56
103831|NCT01064622|242187|P1|STARTED|Randomized Phase II||55
103832|NCT01064622|242186|P2|NOT COMPLETED|Lead-in Phase I||0
103833|NCT01064622|242187|P1|NOT COMPLETED|Lead-in Phase I||0
103834|NCT01064622|242186|P2|COMPLETED|Lead-in Phase I||7
103835|NCT01064622|242187|P1|COMPLETED|Lead-in Phase I||0
103836|NCT01064622|242186|P2|STARTED|Lead-in Phase I||7
103837|NCT01064622|242187|P1|STARTED|Lead-in Phase I||0
103838|NCT01064414|242211|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
103839|NCT01064414|242212|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
103840|NCT01064414|242213|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
103841|NCT01064414|242211|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
103842|NCT01064414|242212|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
103843|NCT01064414|242213|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
103844|NCT01064414|242211|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
103845|NCT01064414|242212|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
103846|NCT01064414|242213|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
103847|NCT01064414|242211|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
103848|NCT01064414|242212|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
103849|NCT01064414|242213|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
103850|NCT01064414|242211|P3|COMPLETED|Core Period: Baseline to Week 26||82
103851|NCT01064414|242212|P2|COMPLETED|Core Period: Baseline to Week 26||75
103852|NCT01064414|242213|P1|COMPLETED|Core Period: Baseline to Week 26||77
103853|NCT01064414|242211|P3|STARTED|Core Period: Baseline to Week 26||89
103854|NCT01064414|242212|P2|STARTED|Core Period: Baseline to Week 26||90
103855|NCT01064414|242213|P1|STARTED|Core Period: Baseline to Week 26||90
103856|NCT01064401|242232|P2|NOT COMPLETED|Overall Study||195
103857|NCT01064401|242233|P1|NOT COMPLETED|Overall Study||228
103858|NCT01064401|242232|P2|COMPLETED|Overall Study||724
103859|NCT01064401|242233|P1|COMPLETED|Overall Study||694
103860|NCT01064401|242232|P2|STARTED|Overall Study||919
103861|NCT01064401|242233|P1|STARTED|Overall Study||922
103862|NCT01064362|242249|P2|NOT COMPLETED|Overall Study||0
103863|NCT01064362|242250|P1|NOT COMPLETED|Overall Study||0
103864|NCT01064362|242249|P2|COMPLETED|Overall Study||11883
103865|NCT01064362|242250|P1|COMPLETED|Overall Study||1559
103866|NCT01064362|242249|P2|STARTED|Overall Study||11883
103867|NCT01064362|242250|P1|STARTED|Overall Study||1559
103868|NCT01064310|242260|P2|NOT COMPLETED|Period 2||6
103869|NCT01064310|242261|P1|NOT COMPLETED|Period 2||4
103870|NCT01064310|242260|P2|COMPLETED|Period 2||62
103871|NCT01064310|242261|P1|COMPLETED|Period 2||64
103872|NCT01064310|242260|P2|STARTED|Period 2||68
103873|NCT01064310|242261|P1|STARTED|Period 2||68
103874|NCT01064310|242260|P2|NOT COMPLETED|Period 1||18
103875|NCT01064310|242261|P1|NOT COMPLETED|Period 1||14
103876|NCT01064310|242260|P2|COMPLETED|Period 1||68
103877|NCT01064310|242261|P1|COMPLETED|Period 1||68
103878|NCT01064310|242260|P2|STARTED|Period 1||86
103879|NCT01064310|242261|P1|STARTED|Period 1||82
103880|NCT01064297|242290|P3|NOT COMPLETED|Overall Study||133
103881|NCT01064297|242291|P2|NOT COMPLETED|Overall Study||48
103882|NCT01064297|242292|P1|NOT COMPLETED|Overall Study||791
103883|NCT01064297|242290|P3|COMPLETED|Overall Study||497
103884|NCT01064297|242291|P2|COMPLETED|Overall Study||171
103885|NCT01064297|242292|P1|COMPLETED|Overall Study||1776
103886|NCT01064297|242290|P3|STARTED|Overall Study||630
103887|NCT01064297|242291|P2|STARTED|Overall Study||219
103888|NCT01064297|242292|P1|STARTED|Overall Study||2567
103889|NCT01064167|242338|P2|NOT COMPLETED|Overall Study||15
103890|NCT01064167|242339|P1|NOT COMPLETED|Overall Study||14
103891|NCT01064167|242338|P2|COMPLETED|Overall Study||115
103892|NCT01064167|242339|P1|COMPLETED|Overall Study||116
103893|NCT01064167|242338|P2|STARTED|Overall Study||130
103894|NCT01064167|242339|P1|STARTED|Overall Study||130
103895|NCT01063907|242347|P2|NOT COMPLETED|Overall Study||0
103896|NCT01063907|242348|P1|NOT COMPLETED|Overall Study||0
103897|NCT01063907|242347|P2|COMPLETED|Overall Study||80
103898|NCT01063907|242348|P1|COMPLETED|Overall Study||15
103899|NCT01063907|242347|P2|STARTED|Overall Study||80
103900|NCT01063907|242348|P1|STARTED|Overall Study||15
103901|NCT01063881|242381|P3|NOT COMPLETED|Overall Study||1
103902|NCT01063881|242382|P2|NOT COMPLETED|Overall Study||11
103903|NCT01063881|242383|P1|NOT COMPLETED|Overall Study||55
103904|NCT01063881|242381|P3|COMPLETED|Overall Study||12
103905|NCT01063881|242382|P2|COMPLETED|Overall Study||114
103906|NCT01063881|242383|P1|COMPLETED|Overall Study||92
103907|NCT01063881|242381|P3|STARTED|Overall Study||13
103908|NCT01063881|242382|P2|STARTED|Overall Study||125
103909|NCT01063881|242383|P1|STARTED|Overall Study||147
103910|NCT01063868|242407|P2|NOT COMPLETED|Overall Study||12
103911|NCT01063868|242408|P1|NOT COMPLETED|Overall Study||35
103912|NCT01063868|242407|P2|COMPLETED|Overall Study||0
103913|NCT01063868|242408|P1|COMPLETED|Overall Study||0
103914|NCT01063868|242407|P2|STARTED|Overall Study||12
103915|NCT01063868|242408|P1|STARTED|Overall Study||35
103916|NCT01063855|242416|P2|NOT COMPLETED|Overall Study||29
103917|NCT01063855|242417|P1|NOT COMPLETED|Overall Study||37
103918|NCT01063855|242416|P2|COMPLETED|Overall Study||221
103919|NCT01063855|242417|P1|COMPLETED|Overall Study||208
103920|NCT01063855|242416|P2|STARTED|Overall Study||250
103921|NCT01063855|242417|P1|STARTED|Overall Study||245
103922|NCT01063764|242439|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
103923|NCT01063764|242439|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
103924|NCT01063764|242439|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
103925|NCT01063764|242439|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
103926|NCT01063764|242439|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
103927|NCT01063764|242439|P1|STARTED|1st Period (From Week 8 to Week 22)||73
103928|NCT01063712|242453|P1|NOT COMPLETED|Overall Study||0
103929|NCT01063712|242453|P1|COMPLETED|Overall Study||29
103930|NCT01063712|242453|P1|STARTED|Overall Study||29
103931|NCT01063595|242458|P2|NOT COMPLETED|Second Intervention||0
103932|NCT01063595|242459|P1|NOT COMPLETED|Second Intervention||0
103933|NCT01063595|242458|P2|COMPLETED|Second Intervention||24
103934|NCT01063595|242459|P1|COMPLETED|Second Intervention||29
103935|NCT01063595|242458|P2|STARTED|Second Intervention||24
103936|NCT01063595|242459|P1|STARTED|Second Intervention||29
103937|NCT01063595|242458|P2|NOT COMPLETED|First Intervention||5
103938|NCT01063595|242459|P1|NOT COMPLETED|First Intervention||2
103939|NCT01063595|242458|P2|COMPLETED|First Intervention||24
103940|NCT01063595|242459|P1|COMPLETED|First Intervention||29
103941|NCT01063595|242458|P2|STARTED|First Intervention||29
103942|NCT01063595|242459|P1|STARTED|First Intervention||31
103943|NCT01063595|242458|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
103944|NCT01063595|242459|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
103945|NCT01063595|242458|P2|COMPLETED|Enrolled in Study and Randomized||29
103946|NCT01063595|242459|P1|COMPLETED|Enrolled in Study and Randomized||31
103947|NCT01063595|242458|P2|Received Treatment|Enrolled in Study and Randomized||29
103948|NCT01063595|242459|P1|Received Treatment|Enrolled in Study and Randomized||31
103949|NCT01063595|242458|P2|STARTED|Enrolled in Study and Randomized||31
103950|NCT01063595|242459|P1|STARTED|Enrolled in Study and Randomized||32
103951|NCT01063517|242471|P2|NOT COMPLETED|Overall Study||60
103952|NCT01063517|242472|P1|NOT COMPLETED|Overall Study||58
103953|NCT01063517|242471|P2|COMPLETED|Overall Study||2
103954|NCT01063517|242472|P1|COMPLETED|Overall Study||4
103955|NCT01063517|242471|P2|Received Randomised Treatment|Overall Study||62
103956|NCT01063517|242472|P1|Received Randomised Treatment|Overall Study||61
103957|NCT01063517|242471|P2|STARTED|Overall Study||62
103958|NCT01063517|242472|P1|STARTED|Overall Study||62
103959|NCT01063348|242512|P2|NOT COMPLETED|Overall Study||10
103960|NCT01063348|242513|P1|NOT COMPLETED|Overall Study||3
103961|NCT01063348|242512|P2|COMPLETED|Overall Study||21
103962|NCT01063348|242513|P1|COMPLETED|Overall Study||32
103963|NCT01063348|242512|P2|STARTED|Overall Study||31
103964|NCT01063348|242513|P1|STARTED|Overall Study||35
103965|NCT01063153|242523|P2|NOT COMPLETED|Overall Study||12
103966|NCT01063153|242524|P1|NOT COMPLETED|Overall Study||2
103967|NCT01063153|242523|P2|COMPLETED|Overall Study||26
103968|NCT01063153|242524|P1|COMPLETED|Overall Study||31
103969|NCT01063153|242523|P2|STARTED|Overall Study||38
103970|NCT01063153|242524|P1|STARTED|Overall Study||33
103971|NCT01063075|242530|P4|NOT COMPLETED|Overall Study||1
103972|NCT01063075|242531|P3|NOT COMPLETED|Overall Study||5
103973|NCT01063075|242532|P2|NOT COMPLETED|Overall Study||2
103974|NCT01063075|242533|P1|NOT COMPLETED|Overall Study||1
103975|NCT01063075|242530|P4|COMPLETED|Overall Study||14
103976|NCT01063075|242531|P3|COMPLETED|Overall Study||9
103977|NCT01063075|242532|P2|COMPLETED|Overall Study||1
103978|NCT01063075|242533|P1|COMPLETED|Overall Study||1
103979|NCT01063075|242530|P4|STARTED|Overall Study||15
103980|NCT01063075|242531|P3|STARTED|Overall Study||14
103981|NCT01063075|242532|P2|STARTED|Overall Study||3
103982|NCT01063075|242533|P1|STARTED|Overall Study||2
103983|NCT01063062|242551|P2|NOT COMPLETED|Overall Study||12
103984|NCT01063062|242552|P1|NOT COMPLETED|Overall Study||8
103985|NCT01063062|242551|P2|COMPLETED|Overall Study||65
103986|NCT01063062|242552|P1|COMPLETED|Overall Study||22
103987|NCT01063062|242551|P2|Received Study Drug|Overall Study||76
103988|NCT01063062|242552|P1|Received Study Drug|Overall Study||29
103989|NCT01063062|242551|P2|STARTED|Overall Study||77
103990|NCT01063062|242552|P1|STARTED|Overall Study||30
103991|NCT01063049|242593|P3|NOT COMPLETED|Overall Study||0
103992|NCT01063049|242594|P2|NOT COMPLETED|Overall Study||0
103993|NCT01063049|242595|P1|NOT COMPLETED|Overall Study||0
103994|NCT01063049|242593|P3|COMPLETED|Overall Study||200
103995|NCT01063049|242594|P2|COMPLETED|Overall Study||200
103996|NCT01063049|242595|P1|COMPLETED|Overall Study||200
103997|NCT01063049|242593|P3|STARTED|Overall Study||200
103998|NCT01063049|242594|P2|STARTED|Overall Study||200
103999|NCT01063049|242595|P1|STARTED|Overall Study||200
104000|NCT01063036|242606|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
104001|NCT01063036|242606|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
104002|NCT01063036|242606|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
104003|NCT01063036|242606|P1|NOT COMPLETED|Participants Treated With Study Drug||6
104004|NCT01063036|242606|P1|COMPLETED|Participants Treated With Study Drug||86
104005|NCT01063036|242606|P1|STARTED|Participants Treated With Study Drug||92
104006|NCT01062841|242622|P2|NOT COMPLETED|Overall Study||53
104007|NCT01062841|242623|P1|NOT COMPLETED|Overall Study||49
104008|NCT01062841|242622|P2|COMPLETED|Overall Study||162
104009|NCT01062841|242623|P1|COMPLETED|Overall Study||154
104010|NCT01062841|242622|P2|STARTED|Overall Study||215
104011|NCT01062841|242623|P1|STARTED|Overall Study||203
104012|NCT01062763|242653|P2|NOT COMPLETED|Overall Study||4
104013|NCT01062763|242654|P1|NOT COMPLETED|Overall Study||3
104014|NCT01062763|242653|P2|COMPLETED|Overall Study||57
104015|NCT01062763|242654|P1|COMPLETED|Overall Study||55
104016|NCT01062763|242653|P2|STARTED|Overall Study||61
104017|NCT01062763|242654|P1|STARTED|Overall Study|119 randomized.|58
104018|NCT01062425|242666|P2|NOT COMPLETED|Overall Study||6
104019|NCT01062425|242667|P1|NOT COMPLETED|Overall Study||3
104020|NCT01062425|242666|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
104021|NCT01062425|242667|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
104022|NCT01062425|242666|P2|STARTED|Overall Study||103
104023|NCT01062425|242667|P1|STARTED|Overall Study||55
104024|NCT01062308|242681|P2|NOT COMPLETED|Overall Study||10
104025|NCT01062308|242682|P1|NOT COMPLETED|Overall Study||16
104026|NCT01062308|242681|P2|COMPLETED|Overall Study||72
104027|NCT01062308|242682|P1|COMPLETED|Overall Study||64
104028|NCT01062308|242681|P2|STARTED|Overall Study||82
104029|NCT01062308|242682|P1|STARTED|Overall Study||80
104030|NCT01062269|242690|P1|NOT COMPLETED|Overall Study||0
104031|NCT01062269|242690|P1|COMPLETED|Overall Study||42
104032|NCT01062269|242690|P1|STARTED|Overall Study||42
104033|NCT01062256|242704|P3|NOT COMPLETED|Overall Study||4
104034|NCT01062256|242705|P2|NOT COMPLETED|Overall Study||7
104035|NCT01062256|242706|P1|NOT COMPLETED|Overall Study||3
104036|NCT01062256|242704|P3|COMPLETED|Overall Study||103
104037|NCT01062256|242705|P2|COMPLETED|Overall Study||96
104038|NCT01062256|242706|P1|COMPLETED|Overall Study||52
104039|NCT01062256|242704|P3|STARTED|Overall Study||107
104040|NCT01062256|242705|P2|STARTED|Overall Study||103
104041|NCT01062256|242706|P1|STARTED|Overall Study||55
104042|NCT01062230|242729|P1|NOT COMPLETED|Overall Study||0
104043|NCT01062230|242729|P1|COMPLETED|Overall Study||6
104044|NCT01062230|242729|P1|STARTED|Overall Study||6
104045|NCT01062165|242733|P1|NOT COMPLETED|Overall Study||0
104046|NCT01062165|242733|P1|COMPLETED|Overall Study||18
104047|NCT01062165|242733|P1|STARTED|Overall Study||18
104048|NCT01062113|242740|P3|NOT COMPLETED|Overall Study||31
104049|NCT01062113|242741|P2|NOT COMPLETED|Overall Study||22
104050|NCT01062113|242742|P1|NOT COMPLETED|Overall Study||40
104051|NCT01062113|242740|P3|COMPLETED|Overall Study||27
104052|NCT01062113|242741|P2|COMPLETED|Overall Study||42
104053|NCT01062113|242742|P1|COMPLETED|Overall Study||93
104054|NCT01062113|242740|P3|STARTED|Overall Study||58
104055|NCT01062113|242741|P2|STARTED|Overall Study||64
104056|NCT01062113|242742|P1|STARTED|Overall Study||133
104057|NCT01062074|242755|P1|NOT COMPLETED|Overall Study||0
104058|NCT01062074|242755|P1|COMPLETED|Overall Study||3605
104059|NCT01062074|242755|P1|STARTED|Overall Study||3605
104060|NCT01062061|242760|P1|NOT COMPLETED|Overall Study||27
104061|NCT01062061|242760|P1|COMPLETED|Overall Study||727
104062|NCT01062061|242760|P1|STARTED|Overall Study||754
104063|NCT01061866|242774|P1|NOT COMPLETED|Overall Study||2
104064|NCT01061866|242774|P1|COMPLETED|Overall Study||5
104065|NCT01061866|242774|P1|STARTED|Overall Study||7
104066|NCT01061775|242778|P1|NOT COMPLETED|Overall Study||3
104067|NCT01061775|242778|P1|COMPLETED|Overall Study||16
104068|NCT01061775|242778|P1|STARTED|Overall Study||19
104069|NCT01061710|242785|P1|NOT COMPLETED|Overall Study||14
104070|NCT01061710|242785|P1|COMPLETED|Overall Study||6
104071|NCT01061710|242785|P1|STARTED|Overall Study||20
104072|NCT01061671|242795|P2|NOT COMPLETED|Overall Study||55
104073|NCT01061671|242796|P1|NOT COMPLETED|Overall Study||47
104074|NCT01061671|242795|P2|COMPLETED|Overall Study||397
104075|NCT01061671|242796|P1|COMPLETED|Overall Study||386
104076|NCT01061671|242795|P2|STARTED|Overall Study||452
104077|NCT01061671|242796|P1|STARTED|Overall Study||433
104078|NCT01061606|242808|P1|NOT COMPLETED|Overall Study||8
104079|NCT01061606|242808|P1|COMPLETED|Overall Study||0
104080|NCT01061606|242808|P1|STARTED|Overall Study||8
104081|NCT01061567|242817|P1|NOT COMPLETED|Overall Study||76
104082|NCT01061567|242817|P1|COMPLETED|Overall Study||1738
104083|NCT01061567|242817|P1|STARTED|Overall Study||1814
104084|NCT01061476|242826|P1|NOT COMPLETED|Overall Study||0
104085|NCT01061476|242826|P1|COMPLETED|Overall Study||12
104086|NCT01061476|242826|P1|STARTED|Overall Study||12
104087|NCT01061385|242832|P2|NOT COMPLETED|Overall Study||1
104088|NCT01061385|242833|P1|NOT COMPLETED|Overall Study||1
104089|NCT01061385|242832|P2|COMPLETED|Overall Study||8
104090|NCT01061385|242833|P1|COMPLETED|Overall Study||20
104091|NCT01061385|242832|P2|STARTED|Overall Study||9
104092|NCT01061385|242833|P1|STARTED|Overall Study||21
104093|NCT01061359|242841|P1|NOT COMPLETED|Overall Study||1302
104094|NCT01061359|242841|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
104095|NCT01061359|242841|P1|STARTED|Overall Study||1972
104096|NCT01061333|242847|P2|NOT COMPLETED|Period 7: Mometasone||0
104097|NCT01061333|242848|P1|NOT COMPLETED|Period 7: Mometasone||0
104098|NCT01061333|242847|P2|COMPLETED|Period 7: Mometasone||7
104099|NCT01061333|242848|P1|COMPLETED|Period 7: Mometasone||8
104100|NCT01061333|242847|P2|STARTED|Period 7: Mometasone||7
104101|NCT01061333|242848|P1|STARTED|Period 7: Mometasone||8
104102|NCT01061333|242847|P2|NOT COMPLETED|Period 6: 20-day Washout||0
104103|NCT01061333|242848|P1|NOT COMPLETED|Period 6: 20-day Washout||0
104104|NCT01061333|242847|P2|COMPLETED|Period 6: 20-day Washout||7
104105|NCT01061333|242848|P1|COMPLETED|Period 6: 20-day Washout||8
104106|NCT01061333|242847|P2|STARTED|Period 6: 20-day Washout||7
104107|NCT01061333|242848|P1|STARTED|Period 6: 20-day Washout||8
104108|NCT01061333|242847|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
104109|NCT01061333|242848|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
104110|NCT01061333|242847|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
104111|NCT01061333|242848|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
104112|NCT01061333|242847|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
104113|NCT01061333|242848|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
104114|NCT01061333|242847|P2|NOT COMPLETED|Period 4: 20-day Washout||1
104115|NCT01061333|242848|P1|NOT COMPLETED|Period 4: 20-day Washout||0
104116|NCT01061333|242847|P2|COMPLETED|Period 4: 20-day Washout||7
104117|NCT01061333|242848|P1|COMPLETED|Period 4: 20-day Washout||8
104118|NCT01061333|242847|P2|STARTED|Period 4: 20-day Washout||8
104119|NCT01061333|242848|P1|STARTED|Period 4: 20-day Washout||8
104120|NCT01061333|242847|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
104121|NCT01061333|242848|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
104122|NCT01061333|242847|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
104123|NCT01061333|242848|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
104124|NCT01061333|242847|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
104125|NCT01061333|242848|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
104126|NCT01061333|242847|P2|NOT COMPLETED|Period 2: 20-day Washout||0
104127|NCT01061333|242848|P1|NOT COMPLETED|Period 2: 20-day Washout||0
104128|NCT01061333|242847|P2|COMPLETED|Period 2: 20-day Washout||8
104129|NCT01061333|242848|P1|COMPLETED|Period 2: 20-day Washout||8
104130|NCT01061333|242847|P2|STARTED|Period 2: 20-day Washout||8
104131|NCT01061333|242848|P1|STARTED|Period 2: 20-day Washout||8
104132|NCT01061333|242847|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
104133|NCT01061333|242848|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
104134|NCT01061333|242847|P2|COMPLETED|Period 1: Placebo Run-in||8
104135|NCT01061333|242848|P1|COMPLETED|Period 1: Placebo Run-in||8
104136|NCT01061333|242847|P2|STARTED|Period 1: Placebo Run-in||8
104137|NCT01061333|242848|P1|STARTED|Period 1: Placebo Run-in||8
104138|NCT01061034|242886|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
104139|NCT01061034|242886|P1|COMPLETED|Aspirin Plus Omeprazole||9
104140|NCT01061034|242886|P1|STARTED|Aspirin Plus Omeprazole||9
104141|NCT01061034|242886|P1|NOT COMPLETED|Aspirin||0
104142|NCT01061034|242886|P1|COMPLETED|Aspirin||9
104143|NCT01061034|242886|P1|STARTED|Aspirin||9
104144|NCT01061008|242893|P2|NOT COMPLETED|Overall Study||6
104145|NCT01061008|242894|P1|NOT COMPLETED|Overall Study||6
104146|NCT01061008|242893|P2|COMPLETED|Overall Study||9
104147|NCT01061008|242894|P1|COMPLETED|Overall Study||10
104148|NCT01061008|242893|P2|STARTED|Overall Study||15
104149|NCT01061008|242894|P1|STARTED|Overall Study||16
104150|NCT01060670|242902|P2|NOT COMPLETED|Follow up Phase||35
104151|NCT01060670|242903|P1|NOT COMPLETED|Follow up Phase||22
104152|NCT01060670|242902|P2|COMPLETED|Follow up Phase||82
104153|NCT01060670|242903|P1|COMPLETED|Follow up Phase||106
104154|NCT01060670|242902|P2|Withdrew From Follow up Phase|Follow up Phase||35
104155|NCT01060670|242903|P1|Withdrew From Follow up Phase|Follow up Phase||22
104156|NCT01060670|242902|P2|Recurrence|Follow up Phase||9
104157|NCT01060670|242903|P1|Recurrence|Follow up Phase||14
104158|NCT01060670|242902|P2|STARTED|Follow up Phase||117
104159|NCT01060670|242903|P1|STARTED|Follow up Phase||128
104160|NCT01060670|242902|P2|NOT COMPLETED|Treatment Phase||36
104161|NCT01060670|242903|P1|NOT COMPLETED|Treatment Phase||26
104162|NCT01060670|242902|P2|COMPLETED|Treatment Phase||117
104163|NCT01060670|242903|P1|COMPLETED|Treatment Phase||128
104164|NCT01060670|242902|P2|Withdrew From Treatment|Treatment Phase||36
104165|NCT01060670|242903|P1|Withdrew From Treatment|Treatment Phase||26
104166|NCT01060670|242902|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
104167|NCT01060670|242903|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
104168|NCT01060670|242902|P2|Healed at End of Treatment Phase|Treatment Phase||49
104169|NCT01060670|242903|P1|Healed at End of Treatment Phase|Treatment Phase||79
104170|NCT01060670|242902|P2|STARTED|Treatment Phase||153
104171|NCT01060670|242903|P1|STARTED|Treatment Phase||154
104172|NCT01060670|242902|P2|NOT COMPLETED|Run In||238
104173|NCT01060670|242903|P1|NOT COMPLETED|Run In||0
104174|NCT01060670|242902|P2|COMPLETED|Run In||307
104175|NCT01060670|242903|P1|COMPLETED|Run In||0
104176|NCT01060670|242902|P2|STARTED|Run In||545
104177|NCT01060670|242903|P1|STARTED|Run In||0
104178|NCT01060592|242923|P2|NOT COMPLETED|12m||18
104179|NCT01060592|242924|P1|NOT COMPLETED|12m||0
104180|NCT01060592|242923|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
104181|NCT01060592|242924|P1|COMPLETED|12m||35
104182|NCT01060592|242923|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
104183|NCT01060592|242924|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
104184|NCT01060592|242923|P2|NOT COMPLETED|4-6w||10
104185|NCT01060592|242924|P1|NOT COMPLETED|4-6w||12
104186|NCT01060592|242923|P2|COMPLETED|4-6w||39
104187|NCT01060592|242924|P1|COMPLETED|4-6w||23
104188|NCT01060592|242923|P2|STARTED|4-6w||49
104189|NCT01060592|242924|P1|STARTED|4-6w||35
104190|NCT01060553|242938|P2|NOT COMPLETED|Overall Study||10
104191|NCT01060553|242939|P1|NOT COMPLETED|Overall Study||9
104192|NCT01060553|242938|P2|COMPLETED|Overall Study||5
104193|NCT01060553|242939|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
104194|NCT01060553|242938|P2|STARTED|Overall Study||15
104195|NCT01060553|242939|P1|STARTED|Overall Study||15
104196|NCT01060540|242946|P2|NOT COMPLETED|Overall Study||65
104197|NCT01060540|242947|P1|NOT COMPLETED|Overall Study||64
104198|NCT01060540|242946|P2|COMPLETED|Overall Study||233
104199|NCT01060540|242947|P1|COMPLETED|Overall Study||239
104200|NCT01060540|242946|P2|STARTED|Overall Study||298
104201|NCT01060540|242947|P1|STARTED|Overall Study||303
104202|NCT01060150|242961|P1|NOT COMPLETED|Overall Study||23
104203|NCT01060150|242961|P1|COMPLETED|Overall Study||92
104204|NCT01060150|242961|P1|Treated|Overall Study||113
104205|NCT01060150|242961|P1|STARTED|Overall Study||115
104206|NCT01060124|242976|P1|NOT COMPLETED|Overall Study||37
104207|NCT01060124|242976|P1|COMPLETED|Overall Study||66
104208|NCT01060124|242976|P1|STARTED|Overall Study||103
104209|NCT01060111|242987|P3|NOT COMPLETED|Overall Study||35
104210|NCT01060111|242988|P2|NOT COMPLETED|Overall Study||23
104211|NCT01060111|242989|P1|NOT COMPLETED|Overall Study||27
104212|NCT01060111|242987|P3|COMPLETED|Overall Study||45
104213|NCT01060111|242988|P2|COMPLETED|Overall Study||61
104214|NCT01060111|242989|P1|COMPLETED|Overall Study||54
104215|NCT01060111|242987|P3|Treated|Overall Study||79
104216|NCT01060111|242988|P2|Treated|Overall Study||83
104217|NCT01060111|242989|P1|Treated|Overall Study||81
104218|NCT01060111|242987|P3|STARTED|Overall Study||80
104219|NCT01060111|242988|P2|STARTED|Overall Study||84
104220|NCT01060111|242989|P1|STARTED|Overall Study||81
104221|NCT01060072|243008|P2|NOT COMPLETED|Overall Study||5
104222|NCT01060072|243009|P1|NOT COMPLETED|Overall Study||2
104223|NCT01060072|243008|P2|COMPLETED|Overall Study||196
104224|NCT01060072|243009|P1|COMPLETED|Overall Study||204
104225|NCT01060072|243008|P2|STARTED|Overall Study||201
104226|NCT01060072|243009|P1|STARTED|Overall Study||206
104227|NCT01060059|243025|P2|NOT COMPLETED|Overall Study||67
104228|NCT01060059|243026|P1|NOT COMPLETED|Overall Study||67
104229|NCT01060059|243025|P2|COMPLETED|Overall Study||371
104230|NCT01060059|243026|P1|COMPLETED|Overall Study||377
104231|NCT01060059|243025|P2|STARTED|Overall Study||438
104232|NCT01060059|243026|P1|STARTED|Overall Study||444
104233|NCT01060007|243076|P1|NOT COMPLETED|Overall Study||4
104234|NCT01060007|243076|P1|COMPLETED|Overall Study||76
104235|NCT01060007|243076|P1|STARTED|Overall Study||80
104236|NCT01059994|243091|P4|NOT COMPLETED|Overall Study||1
104237|NCT01059994|243092|P3|NOT COMPLETED|Overall Study||0
104238|NCT01059994|243093|P2|NOT COMPLETED|Overall Study||0
104239|NCT01059994|243094|P1|NOT COMPLETED|Overall Study||0
104240|NCT01059994|243091|P4|COMPLETED|Overall Study||3
104241|NCT01059994|243092|P3|COMPLETED|Overall Study||3
104242|NCT01059994|243093|P2|COMPLETED|Overall Study||2
104243|NCT01059994|243094|P1|COMPLETED|Overall Study||3
104244|NCT01059994|243091|P4|STARTED|Overall Study||4
104245|NCT01059994|243092|P3|STARTED|Overall Study||3
104246|NCT01059994|243093|P2|STARTED|Overall Study||2
104247|NCT01059994|243094|P1|STARTED|Overall Study||3
104248|NCT01059903|243110|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
104249|NCT01059903|243111|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
104250|NCT01059903|243110|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
104251|NCT01059903|243111|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
104252|NCT01059903|243110|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
104253|NCT01059903|243111|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
104254|NCT01059903|243110|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
104255|NCT01059903|243111|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
104256|NCT01059903|243110|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
104257|NCT01059903|243111|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
104258|NCT01059903|243110|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
104259|NCT01059903|243111|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
104260|NCT01059903|243110|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
104261|NCT01059903|243111|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
104262|NCT01059903|243110|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
104263|NCT01059903|243111|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
104264|NCT01059903|243110|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
104265|NCT01059903|243111|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
104266|NCT01059903|243110|P2|STARTED|Period 1: First Intervention- 24 Hours||25
104267|NCT01059903|243111|P1|STARTED|Period 1: First Intervention- 24 Hours||25
104268|NCT01059864|243145|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
104269|NCT01059864|243146|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
104270|NCT01059864|243147|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
104271|NCT01059864|243145|P3|COMPLETED|Double-Blind Treatment Phase||45
104272|NCT01059864|243146|P2|COMPLETED|Double-Blind Treatment Phase||47
104273|NCT01059864|243147|P1|COMPLETED|Double-Blind Treatment Phase||0
104274|NCT01059864|243145|P3|Treated|Double-Blind Treatment Phase||47
104275|NCT01059864|243146|P2|Treated|Double-Blind Treatment Phase||50
104276|NCT01059864|243147|P1|Treated|Double-Blind Treatment Phase||0
104277|NCT01059864|243145|P3|STARTED|Double-Blind Treatment Phase||48
104278|NCT01059864|243146|P2|STARTED|Double-Blind Treatment Phase||50
104279|NCT01059864|243147|P1|STARTED|Double-Blind Treatment Phase||0
104280|NCT01059864|243145|P3|NOT COMPLETED|Open-Label Run-In Phase||0
104281|NCT01059864|243146|P2|NOT COMPLETED|Open-Label Run-In Phase||0
104282|NCT01059864|243147|P1|NOT COMPLETED|Open-Label Run-In Phase||13
104283|NCT01059864|243145|P3|COMPLETED|Open-Label Run-In Phase||0
104284|NCT01059864|243146|P2|COMPLETED|Open-Label Run-In Phase||0
104285|NCT01059864|243147|P1|COMPLETED|Open-Label Run-In Phase||98
104286|NCT01059864|243145|P3|STARTED|Open-Label Run-In Phase||0
104287|NCT01059864|243146|P2|STARTED|Open-Label Run-In Phase||0
104288|NCT01059864|243147|P1|STARTED|Open-Label Run-In Phase||111
104289|NCT01059851|243196|P6|NOT COMPLETED|Overall Study||0
104290|NCT01059851|243197|P5|NOT COMPLETED|Overall Study||0
104291|NCT01059851|243198|P4|NOT COMPLETED|Overall Study||0
104292|NCT01059851|243199|P3|NOT COMPLETED|Overall Study||0
104293|NCT01059851|243200|P2|NOT COMPLETED|Overall Study||0
104294|NCT01059851|243201|P1|NOT COMPLETED|Overall Study||0
104295|NCT01059851|243196|P6|COMPLETED|Overall Study||0
104296|NCT01059851|243197|P5|COMPLETED|Overall Study||0
104297|NCT01059851|243198|P4|COMPLETED|Overall Study||0
104298|NCT01059851|243199|P3|COMPLETED|Overall Study||0
104299|NCT01059851|243200|P2|COMPLETED|Overall Study||8
104300|NCT01059851|243201|P1|COMPLETED|Overall Study||8
104301|NCT01059851|243196|P6|STARTED|Overall Study||0
104302|NCT01059851|243197|P5|STARTED|Overall Study||0
104303|NCT01059851|243198|P4|STARTED|Overall Study||0
104304|NCT01059851|243199|P3|STARTED|Overall Study||0
104305|NCT01059851|243200|P2|STARTED|Overall Study||8
104306|NCT01059851|243201|P1|STARTED|Overall Study||8
104307|NCT01059812|243217|P2|NOT COMPLETED|Overall Study||16
104308|NCT01059812|243218|P1|NOT COMPLETED|Overall Study||37
104309|NCT01059812|243217|P2|COMPLETED|Overall Study||126
104310|NCT01059812|243218|P1|COMPLETED|Overall Study||245
104311|NCT01059812|243217|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
104312|NCT01059812|243218|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
104313|NCT01059812|243217|P2|STARTED|Overall Study||142
104314|NCT01059812|243218|P1|STARTED|Overall Study||282
104315|NCT01059799|243234|P2|NOT COMPLETED|Overall Study||10
104316|NCT01059799|243235|P1|NOT COMPLETED|Overall Study||31
104317|NCT01059799|243234|P2|COMPLETED|Overall Study||136
104318|NCT01059799|243235|P1|COMPLETED|Overall Study||258
104319|NCT01059799|243234|P2|Exposed|Overall Study||146
104320|NCT01059799|243235|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
104321|NCT01059799|243234|P2|STARTED|Overall Study||146
104322|NCT01059799|243235|P1|STARTED|Overall Study||289
104323|NCT01059773|243249|P2|NOT COMPLETED|Overall Study||24
104324|NCT01059773|243250|P1|NOT COMPLETED|Overall Study||20
104325|NCT01059773|243249|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
104326|NCT01059773|243250|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
104327|NCT01059773|243249|P2|STARTED|Overall Study||245
104328|NCT01059773|243250|P1|STARTED|Overall Study||244
104329|NCT01059630|243282|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
104330|NCT01059630|243283|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
104331|NCT01059630|243282|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
104332|NCT01059630|243283|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
104333|NCT01059630|243282|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
104334|NCT01059630|243283|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
104335|NCT01059630|243282|P2|NOT COMPLETED|Induction Period (6 Months)||38
104336|NCT01059630|243283|P1|NOT COMPLETED|Induction Period (6 Months)||73
104337|NCT01059630|243282|P2|COMPLETED|Induction Period (6 Months)||156
104338|NCT01059630|243283|P1|COMPLETED|Induction Period (6 Months)||129
104339|NCT01059630|243282|P2|Treated|Induction Period (6 Months)||194
104340|NCT01059630|243283|P1|Treated|Induction Period (6 Months)||198
104341|NCT01059630|243282|P2|STARTED|Induction Period (6 Months)||194
104342|NCT01059630|243283|P1|STARTED|Induction Period (6 Months)||202
104343|NCT01059617|243343|P4|NOT COMPLETED|Overall Study||6
104344|NCT01059617|243344|P3|NOT COMPLETED|Overall Study||8
104345|NCT01059617|243345|P2|NOT COMPLETED|Overall Study||1
104346|NCT01059617|243346|P1|NOT COMPLETED|Overall Study||7
104347|NCT01059617|243343|P4|COMPLETED|Overall Study||27
104348|NCT01059617|243344|P3|COMPLETED|Overall Study||25
104349|NCT01059617|243345|P2|COMPLETED|Overall Study||33
104350|NCT01059617|243346|P1|COMPLETED|Overall Study||26
104351|NCT01059617|243343|P4|STARTED|Overall Study||33
104352|NCT01059617|243344|P3|STARTED|Overall Study||33
104353|NCT01059617|243345|P2|STARTED|Overall Study||34
104354|NCT01059617|243346|P1|STARTED|Overall Study||33
104355|NCT01059565|243522|P2|NOT COMPLETED|24-Week Open-Label Phase||3
104356|NCT01059565|243523|P1|NOT COMPLETED|24-Week Open-Label Phase||5
104357|NCT01059565|243522|P2|COMPLETED|24-Week Open-Label Phase||42
104358|NCT01059565|243523|P1|COMPLETED|24-Week Open-Label Phase||34
104359|NCT01059565|243522|P2|STARTED|24-Week Open-Label Phase||45
104360|NCT01059565|243523|P1|STARTED|24-Week Open-Label Phase||39
104361|NCT01059565|243522|P2|NOT COMPLETED|24-Week Randomized Phase||7
104362|NCT01059565|243523|P1|NOT COMPLETED|24-Week Randomized Phase||10
104363|NCT01059565|243522|P2|COMPLETED|24-Week Randomized Phase||45
104364|NCT01059565|243523|P1|COMPLETED|24-Week Randomized Phase||39
104365|NCT01059565|243522|P2|Randomized and Treated|24-Week Randomized Phase||52
104366|NCT01059565|243523|P1|Randomized and Treated|24-Week Randomized Phase||48
104367|NCT01059565|243522|P2|STARTED|24-Week Randomized Phase||52
104368|NCT01059565|243523|P1|STARTED|24-Week Randomized Phase||49
104369|NCT01059526|243559|P2|NOT COMPLETED|Overall Study||22
104370|NCT01059526|243560|P1|NOT COMPLETED|Overall Study||30
104371|NCT01059526|243559|P2|COMPLETED|Overall Study||18
104372|NCT01059526|243560|P1|COMPLETED|Overall Study||11
104373|NCT01059526|243559|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
104374|NCT01059526|243560|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
104375|NCT01059526|243559|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
104376|NCT01059526|243560|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
104377|NCT01059071|243568|P4|NOT COMPLETED|Overall Study||6
104378|NCT01059071|243569|P3|NOT COMPLETED|Overall Study||2
104379|NCT01059071|243570|P2|NOT COMPLETED|Overall Study||4
104380|NCT01059071|243571|P1|NOT COMPLETED|Overall Study||2
104381|NCT01059071|243568|P4|COMPLETED|Overall Study||3
104382|NCT01059071|243569|P3|COMPLETED|Overall Study||1
104383|NCT01059071|243570|P2|COMPLETED|Overall Study||1
104384|NCT01059071|243571|P1|COMPLETED|Overall Study||2
104385|NCT01059071|243568|P4|STARTED|Overall Study||9
104386|NCT01059071|243569|P3|STARTED|Overall Study||3
104387|NCT01059071|243570|P2|STARTED|Overall Study||5
104388|NCT01059071|243571|P1|STARTED|Overall Study||4
104389|NCT01058993|243583|P1|NOT COMPLETED|Overall Study||0
104390|NCT01058993|243583|P1|COMPLETED|Overall Study||6
104391|NCT01058993|243583|P1|STARTED|Overall Study||6
104392|NCT01058863|243587|P1|NOT COMPLETED|Overall Study||4
104393|NCT01058863|243587|P1|COMPLETED|Overall Study||68
104394|NCT01058863|243587|P1|Treated With Placebo Inhaler|Overall Study||69
104395|NCT01058863|243587|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
104396|NCT01058863|243587|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
104397|NCT01058863|243587|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
104398|NCT01058863|243587|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
104399|NCT01058863|243587|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
104400|NCT01058863|243587|P1|STARTED|Overall Study||72
104401|NCT01058642|243609|P4|NOT COMPLETED|Treatment Period 2||0
104402|NCT01058642|243610|P3|NOT COMPLETED|Treatment Period 2||0
104403|NCT01058642|243611|P2|NOT COMPLETED|Treatment Period 2||0
104404|NCT01058642|243612|P1|NOT COMPLETED|Treatment Period 2||0
104405|NCT01058642|243609|P4|COMPLETED|Treatment Period 2||7
104406|NCT01058642|243610|P3|COMPLETED|Treatment Period 2||9
104407|NCT01058642|243611|P2|COMPLETED|Treatment Period 2||11
104408|NCT01058642|243612|P1|COMPLETED|Treatment Period 2||7
104409|NCT01058642|243609|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
104410|NCT01058642|243610|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
104411|NCT01058642|243611|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
104412|NCT01058642|243612|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
104413|NCT01058642|243609|P4|STARTED|Treatment Period 2||7
104414|NCT01058642|243610|P3|STARTED|Treatment Period 2||9
104415|NCT01058642|243611|P2|STARTED|Treatment Period 2||11
104416|NCT01058642|243612|P1|STARTED|Treatment Period 2||7
104417|NCT01058642|243609|P4|NOT COMPLETED|Washout Period||0
104418|NCT01058642|243610|P3|NOT COMPLETED|Washout Period||0
104419|NCT01058642|243611|P2|NOT COMPLETED|Washout Period||0
104420|NCT01058642|243612|P1|NOT COMPLETED|Washout Period||0
104421|NCT01058642|243609|P4|COMPLETED|Washout Period||7
104422|NCT01058642|243610|P3|COMPLETED|Washout Period||9
104423|NCT01058642|243611|P2|COMPLETED|Washout Period||11
104424|NCT01058642|243612|P1|COMPLETED|Washout Period||7
104425|NCT01058642|243609|P4|STARTED|Washout Period||7
104426|NCT01058642|243610|P3|STARTED|Washout Period||9
104427|NCT01058642|243611|P2|STARTED|Washout Period||11
104428|NCT01058642|243612|P1|STARTED|Washout Period||7
104429|NCT01058642|243609|P4|NOT COMPLETED|Treatment Period 1||2
104430|NCT01058642|243610|P3|NOT COMPLETED|Treatment Period 1||2
104431|NCT01058642|243611|P2|NOT COMPLETED|Treatment Period 1||1
104432|NCT01058642|243612|P1|NOT COMPLETED|Treatment Period 1||2
104433|NCT01058642|243609|P4|COMPLETED|Treatment Period 1||7
104434|NCT01058642|243610|P3|COMPLETED|Treatment Period 1||9
104435|NCT01058642|243611|P2|COMPLETED|Treatment Period 1||11
104436|NCT01058642|243612|P1|COMPLETED|Treatment Period 1||7
104437|NCT01058642|243609|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
104438|NCT01058642|243610|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
104439|NCT01058642|243611|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
104440|NCT01058642|243612|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
104441|NCT01058642|243609|P4|STARTED|Treatment Period 1||9
104442|NCT01058642|243610|P3|STARTED|Treatment Period 1||11
104443|NCT01058642|243611|P2|STARTED|Treatment Period 1||12
104444|NCT01058642|243612|P1|STARTED|Treatment Period 1||9
104445|NCT01058356|243620|P1|NOT COMPLETED|Overall Study||42
104446|NCT01058356|243620|P1|COMPLETED|Overall Study||172
104447|NCT01058356|243620|P1|STARTED|Overall Study||214
104448|NCT01058304|243627|P2|NOT COMPLETED|Overall Study||33
104449|NCT01058304|243628|P1|NOT COMPLETED|Overall Study||27
104450|NCT01058304|243627|P2|COMPLETED|Overall Study||128
104451|NCT01058304|243628|P1|COMPLETED|Overall Study||132
104452|NCT01058304|243627|P2|STARTED|Overall Study||161
104453|NCT01058304|243628|P1|STARTED|Overall Study||159
104454|NCT01058265|243638|P2|NOT COMPLETED|Overall Study||12
104455|NCT01058265|243639|P1|NOT COMPLETED|Overall Study||11
104456|NCT01058265|243638|P2|COMPLETED|Overall Study||13
104457|NCT01058265|243639|P1|COMPLETED|Overall Study||11
104458|NCT01058265|243638|P2|STARTED|Overall Study||25
104459|NCT01058265|243639|P1|STARTED|Overall Study||22
104460|NCT01058070|243647|P1|NOT COMPLETED|Overall Study||11
104461|NCT01058070|243647|P1|COMPLETED|Overall Study||33
104462|NCT01058070|243647|P1|STARTED|Overall Study||44
104463|NCT01058005|243655|P3|NOT COMPLETED|Overall Study||20
104464|NCT01058005|243656|P2|NOT COMPLETED|Overall Study||25
104465|NCT01058005|243657|P1|NOT COMPLETED|Overall Study||38
104466|NCT01058005|243655|P3|COMPLETED|Overall Study||1
104467|NCT01058005|243656|P2|COMPLETED|Overall Study||0
104468|NCT01058005|243657|P1|COMPLETED|Overall Study||0
104469|NCT01058005|243655|P3|Dosed With Study Treatment|Overall Study||17
104470|NCT01058005|243656|P2|Dosed With Study Treatment|Overall Study||22
104471|NCT01058005|243657|P1|Dosed With Study Treatment|Overall Study||36
104472|NCT01058005|243655|P3|STARTED|Overall Study||21
104473|NCT01058005|243656|P2|STARTED|Overall Study||25
104474|NCT01058005|243657|P1|STARTED|Overall Study||38
104475|NCT01057901|243667|P2|NOT COMPLETED|Overall Study||246
104476|NCT01057901|243668|P1|NOT COMPLETED|Overall Study||260
104477|NCT01057901|243667|P2|COMPLETED|Overall Study||126
104478|NCT01057901|243668|P1|COMPLETED|Overall Study||116
104479|NCT01057901|243667|P2|STARTED|Overall Study||372
104480|NCT01057901|243668|P1|STARTED|Overall Study||376
104481|NCT01057888|243679|P3|NOT COMPLETED|Overall Study||0
104482|NCT01057888|243680|P2|NOT COMPLETED|Overall Study||0
104483|NCT01057888|243681|P1|NOT COMPLETED|Overall Study||0
104484|NCT01057888|243679|P3|COMPLETED|Overall Study||2494
104485|NCT01057888|243680|P2|COMPLETED|Overall Study||2406
104486|NCT01057888|243681|P1|COMPLETED|Overall Study||2504
104487|NCT01057888|243679|P3|STARTED|Overall Study||2494
104488|NCT01057888|243680|P2|STARTED|Overall Study||2406
104489|NCT01057888|243681|P1|STARTED|Overall Study||2504
104490|NCT01057810|243692|P2|NOT COMPLETED|Overall Study||398
104491|NCT01057810|243693|P1|NOT COMPLETED|Overall Study||198
104492|NCT01057810|243692|P2|COMPLETED|Overall Study||1
104493|NCT01057810|243693|P1|COMPLETED|Overall Study||1
104494|NCT01057810|243692|P2|STARTED|Overall Study||399
104495|NCT01057810|243693|P1|STARTED|Overall Study||199
104496|NCT01057693|243709|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
104497|NCT01057693|243710|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
104498|NCT01057693|243711|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
104499|NCT01057693|243709|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
104500|NCT01057693|243710|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
104501|NCT01057693|243711|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
104502|NCT01057693|243709|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
104503|NCT01057693|243710|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
104504|NCT01057693|243711|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
104505|NCT01057693|243709|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
104506|NCT01057693|243710|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
104507|NCT01057693|243711|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
104508|NCT01057693|243709|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
104509|NCT01057693|243710|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
104510|NCT01057693|243711|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
104511|NCT01057693|243709|P3|COMPLETED|Between Single-Blind and Double-Blind||0
104512|NCT01057693|243710|P2|COMPLETED|Between Single-Blind and Double-Blind||0
104513|NCT01057693|243711|P1|COMPLETED|Between Single-Blind and Double-Blind||296
104514|NCT01057693|243709|P3|STARTED|Between Single-Blind and Double-Blind||0
104515|NCT01057693|243710|P2|STARTED|Between Single-Blind and Double-Blind||0
104516|NCT01057693|243711|P1|STARTED|Between Single-Blind and Double-Blind||566
104517|NCT01057693|243709|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
104518|NCT01057693|243710|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
104519|NCT01057693|243711|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
104520|NCT01057693|243709|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
104521|NCT01057693|243710|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
104522|NCT01057693|243711|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
104523|NCT01057693|243709|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
104524|NCT01057693|243710|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
104525|NCT01057693|243711|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
104526|NCT01057589|243757|P1|NOT COMPLETED|Overall Study||66
104527|NCT01057589|243757|P1|COMPLETED|Overall Study||0
104528|NCT01057589|243757|P1|STARTED|Overall Study||66
104529|NCT01057433|243766|P1|NOT COMPLETED|Overall Study||1
104530|NCT01057433|243766|P1|COMPLETED|Overall Study||23
104531|NCT01057433|243766|P1|STARTED|Overall Study||24
104532|NCT01057394|243770|P2|NOT COMPLETED|Overall Study||2
104533|NCT01057394|243771|P1|NOT COMPLETED|Overall Study||0
104534|NCT01057394|243770|P2|COMPLETED|Overall Study|19 treated participants|19
104535|NCT01057394|243771|P1|COMPLETED|Overall Study||0
104536|NCT01057394|243770|P2|STARTED|Overall Study|21 enrolled participants|21
104537|NCT01057394|243771|P1|STARTED|Overall Study||0
104538|NCT01057277|243775|P1|NOT COMPLETED|Overall Study||0
104539|NCT01057277|243775|P1|COMPLETED|Overall Study||3
104540|NCT01057277|243775|P1|STARTED|Overall Study||3
104541|NCT01057251|243781|P2|NOT COMPLETED|Overall Study||29
104542|NCT01057251|243782|P1|NOT COMPLETED|Overall Study||28
104543|NCT01057251|243781|P2|COMPLETED|Overall Study||114
104544|NCT01057251|243782|P1|COMPLETED|Overall Study||262
104545|NCT01057251|243781|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
104546|NCT01057251|243782|P1|STARTED|Overall Study||290
104547|NCT01057225|243790|P6|NOT COMPLETED|Overall Study||0
104548|NCT01057225|243791|P5|NOT COMPLETED|Overall Study||0
104549|NCT01057225|243792|P4|NOT COMPLETED|Overall Study||0
104550|NCT01057225|243793|P3|NOT COMPLETED|Overall Study||0
104551|NCT01057225|243794|P2|NOT COMPLETED|Overall Study||0
104552|NCT01057225|243795|P1|NOT COMPLETED|Overall Study||0
104553|NCT01057225|243790|P6|COMPLETED|Overall Study||23
104554|NCT01057225|243791|P5|COMPLETED|Overall Study||22
104555|NCT01057225|243792|P4|COMPLETED|Overall Study||7
104556|NCT01057225|243793|P3|COMPLETED|Overall Study||6
104557|NCT01057225|243794|P2|COMPLETED|Overall Study||3
104558|NCT01057225|243795|P1|COMPLETED|Overall Study||3
104559|NCT01057225|243790|P6|STARTED|Overall Study||23
104560|NCT01057225|243791|P5|STARTED|Overall Study||22
104561|NCT01057225|243792|P4|STARTED|Overall Study||7
104562|NCT01057225|243793|P3|STARTED|Overall Study||6
104563|NCT01057225|243794|P2|STARTED|Overall Study||3
104564|NCT01057225|243795|P1|STARTED|Overall Study||3
104565|NCT01057121|243817|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104566|NCT01057121|243818|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104567|NCT01057121|243819|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104568|NCT01057121|243820|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104569|NCT01057121|243821|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104570|NCT01057121|243817|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
104571|NCT01057121|243818|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104572|NCT01057121|243819|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104573|NCT01057121|243820|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104574|NCT01057121|243821|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
104575|NCT01057121|243817|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
104576|NCT01057121|243818|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
104577|NCT01057121|243819|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
104578|NCT01057121|243820|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
104579|NCT01057121|243821|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
104580|NCT01057121|243817|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104581|NCT01057121|243818|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104582|NCT01057121|243819|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104583|NCT01057121|243820|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104584|NCT01057121|243821|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104585|NCT01057121|243817|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104586|NCT01057121|243818|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
104587|NCT01057121|243819|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104588|NCT01057121|243820|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104589|NCT01057121|243821|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
104590|NCT01057121|243817|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
104591|NCT01057121|243818|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
104592|NCT01057121|243819|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
104593|NCT01057121|243820|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
104594|NCT01057121|243821|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
104595|NCT01057121|243817|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104596|NCT01057121|243818|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104597|NCT01057121|243819|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104598|NCT01057121|243820|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104599|NCT01057121|243821|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104600|NCT01057121|243817|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104601|NCT01057121|243818|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104602|NCT01057121|243819|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
104603|NCT01057121|243820|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104604|NCT01057121|243821|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
104605|NCT01057121|243817|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
104606|NCT01057121|243818|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
104607|NCT01057121|243819|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
104608|NCT01057121|243820|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
104609|NCT01057121|243821|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
104610|NCT01057121|243817|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104611|NCT01057121|243818|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104612|NCT01057121|243819|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104613|NCT01057121|243820|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104614|NCT01057121|243821|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104615|NCT01057121|243817|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104616|NCT01057121|243818|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104617|NCT01057121|243819|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104618|NCT01057121|243820|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
104619|NCT01057121|243821|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
104620|NCT01057121|243817|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
104621|NCT01057121|243818|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
104622|NCT01057121|243819|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
104623|NCT01057121|243820|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
104624|NCT01057121|243821|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
104625|NCT01057121|243817|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104626|NCT01057121|243818|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104627|NCT01057121|243819|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104628|NCT01057121|243820|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104629|NCT01057121|243821|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104630|NCT01057121|243817|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104631|NCT01057121|243818|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104632|NCT01057121|243819|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104633|NCT01057121|243820|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
104634|NCT01057121|243821|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
104635|NCT01057121|243817|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
104636|NCT01057121|243818|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
104637|NCT01057121|243819|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
104638|NCT01057121|243820|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
104639|NCT01057121|243821|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
104640|NCT01057017|243850|P1|NOT COMPLETED|Overall Study||0
104641|NCT01057017|243850|P1|COMPLETED|Overall Study||5
104642|NCT01057017|243850|P1|STARTED|Overall Study||5
104643|NCT01056913|243854|P1|NOT COMPLETED|Overall Study||0
104644|NCT01056913|243854|P1|COMPLETED|Overall Study||62
104645|NCT01056913|243854|P1|STARTED|Overall Study||62
104646|NCT01056822|243860|P2|NOT COMPLETED|Overall Study||7
104647|NCT01056822|243861|P1|NOT COMPLETED|Overall Study||8
104648|NCT01056822|243860|P2|COMPLETED|Overall Study||35
104649|NCT01056822|243861|P1|COMPLETED|Overall Study||39
104650|NCT01056822|243860|P2|Safety (SAF) Population: NO|Overall Study||2
104651|NCT01056822|243861|P1|Safety (SAF) Population: NO|Overall Study||1
104652|NCT01056822|243860|P2|Safety (SAF) Population: YES|Overall Study||40
104653|NCT01056822|243861|P1|Safety (SAF) Population: YES|Overall Study||46
104654|NCT01056822|243860|P2|Per-protocol (PP) Population: NO|Overall Study||17
104655|NCT01056822|243861|P1|Per-protocol (PP) Population: NO|Overall Study||18
104656|NCT01056822|243860|P2|Per-protocol (PP) Population: YES|Overall Study||25
104657|NCT01056822|243861|P1|Per-protocol (PP) Population: YES|Overall Study||29
104658|NCT01056822|243860|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
104659|NCT01056822|243861|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
104660|NCT01056822|243860|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
104661|NCT01056822|243861|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
104662|NCT01056822|243860|P2|STARTED|Overall Study||42
104663|NCT01056822|243861|P1|STARTED|Overall Study||47
104664|NCT01056718|243910|P1|NOT COMPLETED|Overall Study||3
104665|NCT01056718|243910|P1|COMPLETED|Overall Study||50
104666|NCT01056718|243910|P1|STARTED|Overall Study||53
104667|NCT01056640|243942|P2|NOT COMPLETED|Overall Study||12
104668|NCT01056640|243943|P1|NOT COMPLETED|Overall Study||26
104669|NCT01056640|243942|P2|COMPLETED|Overall Study||91
104670|NCT01056640|243943|P1|COMPLETED|Overall Study||76
104671|NCT01056640|243942|P2|STARTED|Overall Study||103
104672|NCT01056640|243943|P1|STARTED|Overall Study||102
104673|NCT01056601|243949|P1|NOT COMPLETED|Overall Study||0
104674|NCT01056601|243949|P1|COMPLETED|Overall Study||7
104675|NCT01056601|243949|P1|STARTED|Overall Study||7
104676|NCT01056523|243955|P7|NOT COMPLETED|Overall Study||1
104677|NCT01056523|243956|P6|NOT COMPLETED|Overall Study||0
104678|NCT01056523|243957|P5|NOT COMPLETED|Overall Study||0
104679|NCT01056523|243958|P4|NOT COMPLETED|Overall Study||3
104680|NCT01056523|243959|P3|NOT COMPLETED|Overall Study||2
104681|NCT01056523|243960|P2|NOT COMPLETED|Overall Study||0
104682|NCT01056523|243961|P1|NOT COMPLETED|Overall Study||1
104683|NCT01056523|243955|P7|COMPLETED|Overall Study||4
104684|NCT01056523|243956|P6|COMPLETED|Overall Study||3
104685|NCT01056523|243957|P5|COMPLETED|Overall Study||3
104686|NCT01056523|243958|P4|COMPLETED|Overall Study||3
104687|NCT01056523|243959|P3|COMPLETED|Overall Study||3
104688|NCT01056523|243960|P2|COMPLETED|Overall Study||3
104689|NCT01056523|243961|P1|COMPLETED|Overall Study||3
104690|NCT01056523|243955|P7|STARTED|Overall Study||5
104691|NCT01056523|243956|P6|STARTED|Overall Study||3
104692|NCT01056523|243957|P5|STARTED|Overall Study||3
104693|NCT01056523|243958|P4|STARTED|Overall Study||6
104694|NCT01056523|243959|P3|STARTED|Overall Study||5
104695|NCT01056523|243960|P2|STARTED|Overall Study||3
104696|NCT01056523|243961|P1|STARTED|Overall Study||4
104697|NCT01056510|243971|P2|NOT COMPLETED|Overall Study||64
104698|NCT01056510|243972|P1|NOT COMPLETED|Overall Study||54
104699|NCT01056510|243971|P2|COMPLETED|Overall Study||115
104700|NCT01056510|243972|P1|COMPLETED|Overall Study||124
104701|NCT01056510|243971|P2|STARTED|Overall Study||179
104702|NCT01056510|243972|P1|STARTED|Overall Study||178
104703|NCT01056484|244018|P2|NOT COMPLETED|Follow up - Non-randomized||2
104704|NCT01056484|244019|P1|NOT COMPLETED|Follow up - Non-randomized||0
104705|NCT01056484|244018|P2|COMPLETED|Follow up - Non-randomized||56
104706|NCT01056484|244019|P1|COMPLETED|Follow up - Non-randomized||57
104707|NCT01056484|244018|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
104708|NCT01056484|244019|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
104709|NCT01056484|244018|P2|NOT COMPLETED|Randomized Controlled Trial||1
104710|NCT01056484|244019|P1|NOT COMPLETED|Randomized Controlled Trial||7
104711|NCT01056484|244018|P2|COMPLETED|Randomized Controlled Trial||58
104712|NCT01056484|244019|P1|COMPLETED|Randomized Controlled Trial||57
104713|NCT01056484|244018|P2|STARTED|Randomized Controlled Trial||59
104714|NCT01056484|244019|P1|STARTED|Randomized Controlled Trial||64
104715|NCT01056341|244038|P5|NOT COMPLETED|Overall Study||14
104716|NCT01056341|244039|P4|NOT COMPLETED|Overall Study||36
104717|NCT01056341|244040|P3|NOT COMPLETED|Overall Study||15
104718|NCT01056341|244041|P2|NOT COMPLETED|Overall Study||36
104719|NCT01056341|244042|P1|NOT COMPLETED|Overall Study||36
104720|NCT01056341|244038|P5|COMPLETED|Overall Study||88
104721|NCT01056341|244039|P4|COMPLETED|Overall Study||65
104722|NCT01056341|244040|P3|COMPLETED|Overall Study||88
104723|NCT01056341|244041|P2|COMPLETED|Overall Study||63
104724|NCT01056341|244042|P1|COMPLETED|Overall Study||19
104725|NCT01056341|244038|P5|Interim Analysis|Overall Study||43
104726|NCT01056341|244039|P4|Interim Analysis|Overall Study||40
104727|NCT01056341|244040|P3|Interim Analysis|Overall Study||41
104728|NCT01056341|244041|P2|Interim Analysis|Overall Study||41
104729|NCT01056341|244042|P1|Interim Analysis|Overall Study||25
104730|NCT01056341|244038|P5|STARTED|Overall Study||102
104731|NCT01056341|244039|P4|STARTED|Overall Study||101
104732|NCT01056341|244040|P3|STARTED|Overall Study||103
104733|NCT01056341|244041|P2|STARTED|Overall Study||99
104734|NCT01056341|244042|P1|STARTED|Overall Study||55
104735|NCT01056328|244063|P2|NOT COMPLETED|Overall Study||16
104736|NCT01056328|244064|P1|NOT COMPLETED|Overall Study||17
104737|NCT01056328|244063|P2|COMPLETED|Overall Study||144
104738|NCT01056328|244064|P1|COMPLETED|Overall Study||147
104739|NCT01056328|244063|P2|STARTED|Overall Study||160
104740|NCT01056328|244064|P1|STARTED|Overall Study||164
104741|NCT01056315|244080|P2|NOT COMPLETED|Overall Study||11
104742|NCT01056315|244081|P1|NOT COMPLETED|Overall Study||14
104743|NCT01056315|244080|P2|COMPLETED|Overall Study||12
104744|NCT01056315|244081|P1|COMPLETED|Overall Study||13
104745|NCT01056315|244080|P2|STARTED|Overall Study||23
104746|NCT01056315|244081|P1|STARTED|Overall Study||27
104747|NCT01056289|244115|P4|NOT COMPLETED|Double-blind Phase||10
104748|NCT01056289|244116|P3|NOT COMPLETED|Double-blind Phase||13
104749|NCT01056289|244117|P2|NOT COMPLETED|Double-blind Phase||4
104750|NCT01056289|244118|P1|NOT COMPLETED|Double-blind Phase||0
104751|NCT01056289|244115|P4|COMPLETED|Double-blind Phase||138
104752|NCT01056289|244116|P3|COMPLETED|Double-blind Phase||127
104753|NCT01056289|244117|P2|COMPLETED|Double-blind Phase||69
104754|NCT01056289|244118|P1|COMPLETED|Double-blind Phase||0
104755|NCT01056289|244115|P4|STARTED|Double-blind Phase||148
104756|NCT01056289|244116|P3|STARTED|Double-blind Phase||140
104757|NCT01056289|244117|P2|STARTED|Double-blind Phase||73
104758|NCT01056289|244118|P1|STARTED|Double-blind Phase||0
104759|NCT01056289|244115|P4|NOT COMPLETED|Open-label Phase||0
104760|NCT01056289|244116|P3|NOT COMPLETED|Open-label Phase||0
104761|NCT01056289|244117|P2|NOT COMPLETED|Open-label Phase||0
104762|NCT01056289|244118|P1|NOT COMPLETED|Open-label Phase||119
104763|NCT01056289|244115|P4|COMPLETED|Open-label Phase||0
104764|NCT01056289|244116|P3|COMPLETED|Open-label Phase||0
104765|NCT01056289|244117|P2|COMPLETED|Open-label Phase||0
104766|NCT01056289|244118|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
104767|NCT01056289|244115|P4|STARTED|Open-label Phase||0
104768|NCT01056289|244116|P3|STARTED|Open-label Phase||0
104769|NCT01056289|244117|P2|STARTED|Open-label Phase||0
104770|NCT01056289|244118|P1|STARTED|Open-label Phase||480
104771|NCT01056263|244133|P1|NOT COMPLETED|Overall Study||52
104772|NCT01056263|244133|P1|COMPLETED|Overall Study||0
104773|NCT01056263|244133|P1|STARTED|Overall Study||52
104774|NCT01056198|244139|P2|NOT COMPLETED|Overall Study||0
104775|NCT01056198|244140|P1|NOT COMPLETED|Overall Study||0
104776|NCT01056198|244139|P2|COMPLETED|Overall Study||24
104777|NCT01056198|244140|P1|COMPLETED|Overall Study||24
104778|NCT01056198|244139|P2|STARTED|Overall Study||24
104779|NCT01056198|244140|P1|STARTED|Overall Study||24
104780|NCT01056107|244156|P4|NOT COMPLETED|Overall Study||0
104781|NCT01056107|244157|P3|NOT COMPLETED|Overall Study||3
104782|NCT01056107|244158|P2|NOT COMPLETED|Overall Study||1
104783|NCT01056107|244159|P1|NOT COMPLETED|Overall Study||0
104784|NCT01056107|244156|P4|COMPLETED|Overall Study||12
104785|NCT01056107|244157|P3|COMPLETED|Overall Study||9
104786|NCT01056107|244158|P2|COMPLETED|Overall Study||10
104787|NCT01056107|244159|P1|COMPLETED|Overall Study||11
104788|NCT01056107|244156|P4|STARTED|Overall Study||12
104789|NCT01056107|244157|P3|STARTED|Overall Study||12
104790|NCT01056107|244158|P2|STARTED|Overall Study||11
104791|NCT01056107|244159|P1|STARTED|Overall Study||11
104792|NCT01056016|244207|P2|NOT COMPLETED|Overall Study||1
104793|NCT01056016|244208|P1|NOT COMPLETED|Overall Study||2
104794|NCT01056016|244207|P2|COMPLETED|Overall Study||26
104795|NCT01056016|244208|P1|COMPLETED|Overall Study||20
104796|NCT01056016|244207|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
104797|NCT01056016|244208|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
104798|NCT01055886|244216|P2|NOT COMPLETED|Overall Study||11
104799|NCT01055886|244217|P1|NOT COMPLETED|Overall Study||5
104800|NCT01055886|244216|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
104801|NCT01055886|244217|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
104802|NCT01055886|244216|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
104803|NCT01055886|244217|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
104804|NCT01055886|244216|P2|STARTED|Overall Study||32
104805|NCT01055886|244217|P1|STARTED|Overall Study||33
104806|NCT01055834|244229|P2|NOT COMPLETED|Treatment Period III||0
104807|NCT01055834|244230|P1|NOT COMPLETED|Treatment Period III||0
104808|NCT01055834|244229|P2|COMPLETED|Treatment Period III||14
104809|NCT01055834|244230|P1|COMPLETED|Treatment Period III||0
104810|NCT01055834|244229|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
104811|NCT01055834|244230|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
104812|NCT01055834|244229|P2|NOT COMPLETED|Treatment Period II||0
104813|NCT01055834|244230|P1|NOT COMPLETED|Treatment Period II||0
104814|NCT01055834|244229|P2|COMPLETED|Treatment Period II||21
104815|NCT01055834|244230|P1|COMPLETED|Treatment Period II||20
104816|NCT01055834|244229|P2|STARTED|Treatment Period II||21
104817|NCT01055834|244230|P1|STARTED|Treatment Period II||20
104818|NCT01055834|244229|P2|NOT COMPLETED|Treatment Period I||0
104819|NCT01055834|244230|P1|NOT COMPLETED|Treatment Period I||1
104820|NCT01055834|244229|P2|COMPLETED|Treatment Period I||21
104821|NCT01055834|244230|P1|COMPLETED|Treatment Period I||20
104822|NCT01055834|244229|P2|STARTED|Treatment Period I||21
104823|NCT01055834|244230|P1|STARTED|Treatment Period I||21
104824|NCT01055782|244244|P2|NOT COMPLETED|Overall Study||0
104825|NCT01055782|244245|P1|NOT COMPLETED|Overall Study||0
104826|NCT01055782|244244|P2|COMPLETED|Overall Study||449
104827|NCT01055782|244245|P1|COMPLETED|Overall Study||555
104828|NCT01055782|244244|P2|STARTED|Overall Study||449
104829|NCT01055782|244245|P1|STARTED|Overall Study||555
104830|NCT01055769|244253|P2|NOT COMPLETED|Second Intervention||0
104831|NCT01055769|244254|P1|NOT COMPLETED|Second Intervention||0
104832|NCT01055769|244253|P2|COMPLETED|Second Intervention||10
104833|NCT01055769|244254|P1|COMPLETED|Second Intervention||10
104834|NCT01055769|244253|P2|STARTED|Second Intervention||10
104835|NCT01055769|244254|P1|STARTED|Second Intervention||10
104836|NCT01055769|244253|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
104837|NCT01055769|244254|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
104838|NCT01055769|244253|P2|COMPLETED|Washout Period of Atleast 4 Days||10
104839|NCT01055769|244254|P1|COMPLETED|Washout Period of Atleast 4 Days||10
104840|NCT01055769|244253|P2|STARTED|Washout Period of Atleast 4 Days||10
104841|NCT01055769|244254|P1|STARTED|Washout Period of Atleast 4 Days||10
104842|NCT01055769|244253|P2|NOT COMPLETED|First Intervention||0
104843|NCT01055769|244254|P1|NOT COMPLETED|First Intervention||0
104844|NCT01055769|244253|P2|COMPLETED|First Intervention||10
104845|NCT01055769|244254|P1|COMPLETED|First Intervention||10
104846|NCT01055769|244253|P2|STARTED|First Intervention||10
104847|NCT01055769|244254|P1|STARTED|First Intervention||10
104848|NCT01055704|244272|P4|NOT COMPLETED|Overall Study||0
104849|NCT01055704|244273|P3|NOT COMPLETED|Overall Study||0
104850|NCT01055704|244274|P2|NOT COMPLETED|Overall Study||0
104851|NCT01055704|244275|P1|NOT COMPLETED|Overall Study||0
104852|NCT01055704|244272|P4|COMPLETED|Overall Study||8
104853|NCT01055704|244273|P3|COMPLETED|Overall Study||16
104854|NCT01055704|244274|P2|COMPLETED|Overall Study||8
104855|NCT01055704|244275|P1|COMPLETED|Overall Study||16
104856|NCT01055704|244272|P4|STARTED|Overall Study||8
104857|NCT01055704|244273|P3|STARTED|Overall Study||16
104858|NCT01055704|244274|P2|STARTED|Overall Study||8
104859|NCT01055704|244275|P1|STARTED|Overall Study||16
104860|NCT01055639|244315|P2|NOT COMPLETED|Overall Study||29
104861|NCT01055639|244316|P1|NOT COMPLETED|Overall Study||21
104862|NCT01055639|244315|P2|COMPLETED|Overall Study||31
104863|NCT01055639|244316|P1|COMPLETED|Overall Study||45
104864|NCT01055639|244315|P2|STARTED|Overall Study||60
104865|NCT01055639|244316|P1|STARTED|Overall Study||66
104866|NCT01055613|244340|P2|NOT COMPLETED|Overall Study||4
104867|NCT01055613|244341|P1|NOT COMPLETED|Overall Study||9
104868|NCT01055613|244340|P2|COMPLETED|Overall Study||96
104869|NCT01055613|244341|P1|COMPLETED|Overall Study||191
104870|NCT01055613|244340|P2|STARTED|Overall Study||100
104871|NCT01055613|244341|P1|STARTED|Overall Study||200
104872|NCT01055457|244349|P10|NOT COMPLETED|Overall Study||1
104873|NCT01055457|244350|P9|NOT COMPLETED|Overall Study||0
104874|NCT01055457|244351|P8|NOT COMPLETED|Overall Study||1
104875|NCT01055457|244352|P7|NOT COMPLETED|Overall Study||1
104876|NCT01055457|244353|P6|NOT COMPLETED|Overall Study||3
104877|NCT01055457|244354|P5|NOT COMPLETED|Overall Study||3
104878|NCT01055457|244355|P4|NOT COMPLETED|Overall Study||3
104879|NCT01055457|244356|P3|NOT COMPLETED|Overall Study||2
104880|NCT01055457|244357|P2|NOT COMPLETED|Overall Study||1
104881|NCT01055457|244358|P1|NOT COMPLETED|Overall Study||1
104882|NCT01055457|244349|P10|COMPLETED|Overall Study||19
104883|NCT01055457|244350|P9|COMPLETED|Overall Study||20
104884|NCT01055457|244351|P8|COMPLETED|Overall Study||18
104885|NCT01055457|244352|P7|COMPLETED|Overall Study||18
104886|NCT01055457|244353|P6|COMPLETED|Overall Study||15
104887|NCT01055457|244354|P5|COMPLETED|Overall Study||38
104888|NCT01055457|244355|P4|COMPLETED|Overall Study||37
104889|NCT01055457|244356|P3|COMPLETED|Overall Study||36
104890|NCT01055457|244357|P2|COMPLETED|Overall Study||39
104891|NCT01055457|244358|P1|COMPLETED|Overall Study||39
104892|NCT01055457|244349|P10|STARTED|Overall Study||20
104893|NCT01055457|244350|P9|STARTED|Overall Study||20
104894|NCT01055457|244351|P8|STARTED|Overall Study||19
104895|NCT01055457|244352|P7|STARTED|Overall Study||19
104896|NCT01055457|244353|P6|STARTED|Overall Study||18
104897|NCT01055457|244354|P5|STARTED|Overall Study||41
104898|NCT01055457|244355|P4|STARTED|Overall Study||40
104899|NCT01055457|244356|P3|STARTED|Overall Study||38
104900|NCT01055457|244357|P2|STARTED|Overall Study||40
104901|NCT01055457|244358|P1|STARTED|Overall Study||40
104902|NCT01055262|244390|P1|NOT COMPLETED|Overall Study||9
104903|NCT01055262|244390|P1|COMPLETED|Overall Study||160
104904|NCT01055262|244390|P1|STARTED|Overall Study||169
104905|NCT01055223|244401|P1|NOT COMPLETED|Overall Study||0
104906|NCT01055223|244401|P1|COMPLETED|Overall Study||98483
104907|NCT01055223|244401|P1|STARTED|Overall Study||98483
104908|NCT01055197|244431|P2|NOT COMPLETED|Overall Study||2
104909|NCT01055197|244432|P1|NOT COMPLETED|Overall Study||9
104910|NCT01055197|244431|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
104911|NCT01055197|244432|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
104912|NCT01055197|244431|P2|STARTED|Overall Study||46
104913|NCT01055197|244432|P1|STARTED|Overall Study||51
104914|NCT01055184|244438|P1|NOT COMPLETED|Overall Study||0
104915|NCT01055184|244438|P1|COMPLETED|Overall Study||34
104916|NCT01055184|244438|P1|STARTED|Overall Study||34
104917|NCT01055171|244444|P2|NOT COMPLETED|Overall Study||7
104918|NCT01055171|244445|P1|NOT COMPLETED|Overall Study||11
104919|NCT01055171|244444|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
104920|NCT01055171|244445|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
104921|NCT01055171|244444|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
104922|NCT01055171|244445|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
104923|NCT01055171|244444|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
104924|NCT01055171|244445|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
104925|NCT01055171|244444|P2|STARTED|Overall Study|Randomized to receive placebo.|28
104926|NCT01055171|244445|P1|STARTED|Overall Study|Randomized to receive medication.|29
104927|NCT01055132|244459|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
104928|NCT01055132|244460|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
104929|NCT01055132|244459|P2|COMPLETED|Period 2 (5-9 Days)||32
104930|NCT01055132|244460|P1|COMPLETED|Period 2 (5-9 Days)||35
104931|NCT01055132|244459|P2|STARTED|Period 2 (5-9 Days)||33
104932|NCT01055132|244460|P1|STARTED|Period 2 (5-9 Days)||35
104933|NCT01055132|244459|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
104934|NCT01055132|244460|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
104935|NCT01055132|244459|P2|COMPLETED|Period 1 (5-9 Days)||33
104936|NCT01055132|244460|P1|COMPLETED|Period 1 (5-9 Days)||35
104937|NCT01055132|244459|P2|STARTED|Period 1 (5-9 Days)||33
104938|NCT01055132|244460|P1|STARTED|Period 1 (5-9 Days)||36
104939|NCT01054976|244471|P1|NOT COMPLETED|Overall Study||35
104940|NCT01054976|244471|P1|COMPLETED|Overall Study||57
104941|NCT01054976|244471|P1|STARTED|Overall Study||92
104942|NCT01054911|244479|P1|NOT COMPLETED|Overall Study||0
104943|NCT01054911|244479|P1|COMPLETED|Overall Study||5
104944|NCT01054911|244479|P1|STARTED|Overall Study||5
104945|NCT01054885|244492|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
104946|NCT01054885|244493|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
104947|NCT01054885|244494|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
104948|NCT01054885|244495|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
104949|NCT01054885|244496|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
104950|NCT01054885|244497|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
104951|NCT01054885|244498|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
104952|NCT01054885|244492|P7|COMPLETED|24-week, Double-blind Treatment Period||158
104953|NCT01054885|244493|P6|COMPLETED|24-week, Double-blind Treatment Period||144
104954|NCT01054885|244494|P5|COMPLETED|24-week, Double-blind Treatment Period||161
104955|NCT01054885|244495|P4|COMPLETED|24-week, Double-blind Treatment Period||160
104956|NCT01054885|244496|P3|COMPLETED|24-week, Double-blind Treatment Period||155
104957|NCT01054885|244497|P2|COMPLETED|24-week, Double-blind Treatment Period||146
104958|NCT01054885|244498|P1|COMPLETED|24-week, Double-blind Treatment Period||0
104959|NCT01054885|244492|P7|STARTED|24-week, Double-blind Treatment Period||205
104960|NCT01054885|244493|P6|STARTED|24-week, Double-blind Treatment Period||204
104961|NCT01054885|244494|P5|STARTED|24-week, Double-blind Treatment Period||203
104962|NCT01054885|244495|P4|STARTED|24-week, Double-blind Treatment Period||203
104963|NCT01054885|244496|P3|STARTED|24-week, Double-blind Treatment Period||204
104964|NCT01054885|244497|P2|STARTED|24-week, Double-blind Treatment Period||205
104965|NCT01054885|244498|P1|STARTED|24-week, Double-blind Treatment Period||0
104966|NCT01054885|244492|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104967|NCT01054885|244493|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104968|NCT01054885|244494|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104969|NCT01054885|244495|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104970|NCT01054885|244496|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104971|NCT01054885|244497|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
104972|NCT01054885|244498|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
104973|NCT01054885|244492|P7|COMPLETED|2-week, Single-blind Run-In Period||0
104974|NCT01054885|244493|P6|COMPLETED|2-week, Single-blind Run-In Period||0
104975|NCT01054885|244494|P5|COMPLETED|2-week, Single-blind Run-In Period||0
104976|NCT01054885|244495|P4|COMPLETED|2-week, Single-blind Run-In Period||0
104977|NCT01054885|244496|P3|COMPLETED|2-week, Single-blind Run-In Period||0
104978|NCT01054885|244497|P2|COMPLETED|2-week, Single-blind Run-In Period||0
104979|NCT01054885|244498|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
104980|NCT01054885|244492|P7|STARTED|2-week, Single-blind Run-In Period||0
104981|NCT01054885|244493|P6|STARTED|2-week, Single-blind Run-In Period||0
104982|NCT01054885|244494|P5|STARTED|2-week, Single-blind Run-In Period||0
104983|NCT01054885|244495|P4|STARTED|2-week, Single-blind Run-In Period||0
104984|NCT01054885|244496|P3|STARTED|2-week, Single-blind Run-In Period||0
104985|NCT01054885|244497|P2|STARTED|2-week, Single-blind Run-In Period||0
104986|NCT01054885|244498|P1|STARTED|2-week, Single-blind Run-In Period||1577
104987|NCT01054846|244538|P2|NOT COMPLETED|Overall Study||17
104988|NCT01054846|244539|P1|NOT COMPLETED|Overall Study||76
104989|NCT01054846|244538|P2|COMPLETED|Overall Study||51
104990|NCT01054846|244539|P1|COMPLETED|Overall Study||246
104991|NCT01054846|244538|P2|STARTED|Overall Study||68
104992|NCT01054846|244539|P1|STARTED|Overall Study||322
104993|NCT01054820|244546|P1|NOT COMPLETED|Overall Study||2
104994|NCT01054820|244546|P1|COMPLETED|Overall Study||121
104995|NCT01054820|244546|P1|STARTED|Overall Study||123
104996|NCT01054742|244560|P1|NOT COMPLETED|Overall Study||0
104997|NCT01054742|244560|P1|COMPLETED|Overall Study||2
104998|NCT01054742|244560|P1|STARTED|Overall Study||2
104999|NCT01054729|244568|P4|NOT COMPLETED|Overall Study||3
105000|NCT01054729|244569|P3|NOT COMPLETED|Overall Study||6
105001|NCT01054729|244570|P2|NOT COMPLETED|Overall Study||5
105002|NCT01054729|244571|P1|NOT COMPLETED|Overall Study||4
105003|NCT01054729|244568|P4|COMPLETED|Overall Study||11
105004|NCT01054729|244569|P3|COMPLETED|Overall Study||9
105005|NCT01054729|244570|P2|COMPLETED|Overall Study||14
105006|NCT01054729|244571|P1|COMPLETED|Overall Study||12
105007|NCT01054729|244568|P4|Randomized and Treated|Overall Study||14
105008|NCT01054729|244569|P3|Randomized and Treated|Overall Study||15
105009|NCT01054729|244570|P2|Randomized and Treated|Overall Study||18
105010|NCT01054729|244571|P1|Randomized and Treated|Overall Study||16
105011|NCT01054729|244568|P4|STARTED|Overall Study||14
105012|NCT01054729|244569|P3|STARTED|Overall Study||15
105013|NCT01054729|244570|P2|STARTED|Overall Study||19
105014|NCT01054729|244571|P1|STARTED|Overall Study||16
105015|NCT01054703|244632|P1|NOT COMPLETED|Overall Study||0
105016|NCT01054703|244632|P1|COMPLETED|Overall Study||14
105017|NCT01054703|244632|P1|STARTED|Overall Study||14
105018|NCT01054625|244639|P3|NOT COMPLETED|Overall Study||1
105019|NCT01054625|244640|P2|NOT COMPLETED|Overall Study||3
105020|NCT01054625|244641|P1|NOT COMPLETED|Overall Study||2
105021|NCT01054625|244639|P3|COMPLETED|Overall Study||9
105022|NCT01054625|244640|P2|COMPLETED|Overall Study||9
105023|NCT01054625|244641|P1|COMPLETED|Overall Study||6
105024|NCT01054625|244639|P3|STARTED|Overall Study||10
105025|NCT01054625|244640|P2|STARTED|Overall Study||12
105026|NCT01054625|244641|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
105027|NCT01054586|244671|P4|NOT COMPLETED|Overall Study||0
105028|NCT01054586|244672|P3|NOT COMPLETED|Overall Study||0
105029|NCT01054586|244673|P2|NOT COMPLETED|Overall Study||0
105030|NCT01054586|244674|P1|NOT COMPLETED|Overall Study||0
105031|NCT01054586|244671|P4|COMPLETED|Overall Study||101
105032|NCT01054586|244672|P3|COMPLETED|Overall Study||8
105033|NCT01054586|244673|P2|COMPLETED|Overall Study||15
105034|NCT01054586|244674|P1|COMPLETED|Overall Study||43
105035|NCT01054586|244671|P4|STARTED|Overall Study||101
105036|NCT01054586|244672|P3|STARTED|Overall Study||8
105037|NCT01054586|244673|P2|STARTED|Overall Study||15
105038|NCT01054586|244674|P1|STARTED|Overall Study||43
105039|NCT01054573|244766|P4|NOT COMPLETED|Overall Study||2
105040|NCT01054573|244767|P3|NOT COMPLETED|Overall Study||3
105041|NCT01054573|244768|P2|NOT COMPLETED|Overall Study||4
105042|NCT01054573|244769|P1|NOT COMPLETED|Overall Study||1
105043|NCT01054573|244766|P4|COMPLETED|Overall Study||25
105044|NCT01054573|244767|P3|COMPLETED|Overall Study||19
105045|NCT01054573|244768|P2|COMPLETED|Overall Study||28
105046|NCT01054573|244769|P1|COMPLETED|Overall Study||8
105047|NCT01054573|244766|P4|STARTED|Overall Study||27
105048|NCT01054573|244767|P3|STARTED|Overall Study||22
105049|NCT01054573|244768|P2|STARTED|Overall Study||32
105050|NCT01054573|244769|P1|STARTED|Overall Study||9
105051|NCT01054560|244815|P2|NOT COMPLETED|Overall Study||28
105052|NCT01054560|244816|P1|NOT COMPLETED|Overall Study||13
105053|NCT01054560|244815|P2|COMPLETED|Overall Study||27
105054|NCT01054560|244816|P1|COMPLETED|Overall Study||45
105055|NCT01054560|244815|P2|STARTED|Overall Study||55
105056|NCT01054560|244816|P1|STARTED|Overall Study||58
105057|NCT01054404|244840|P2|NOT COMPLETED|Overall Study||0
105058|NCT01054404|244841|P1|NOT COMPLETED|Overall Study||0
105059|NCT01054404|244840|P2|COMPLETED|Overall Study||13
105060|NCT01054404|244841|P1|COMPLETED|Overall Study||10
105061|NCT01054404|244840|P2|STARTED|Overall Study||13
105062|NCT01054404|244841|P1|STARTED|Overall Study||10
105063|NCT01054339|244850|P3|NOT COMPLETED|Overall Study||0
105064|NCT01054339|244851|P2|NOT COMPLETED|Overall Study||0
105065|NCT01054339|244852|P1|NOT COMPLETED|Overall Study||0
105066|NCT01054339|244850|P3|COMPLETED|Overall Study||3
105067|NCT01054339|244851|P2|COMPLETED|Overall Study||3
105068|NCT01054339|244852|P1|COMPLETED|Overall Study||3
105069|NCT01054339|244850|P3|STARTED|Overall Study||3
105070|NCT01054339|244851|P2|STARTED|Overall Study||3
105071|NCT01054339|244852|P1|STARTED|Overall Study||3
105072|NCT01054222|244866|P1|NOT COMPLETED|Overall Study||11
105073|NCT01054222|244866|P1|COMPLETED|Overall Study||20
105074|NCT01054222|244866|P1|STARTED|Overall Study||31
105075|NCT01054183|244887|P2|NOT COMPLETED|Overall Study||0
105076|NCT01054183|244888|P1|NOT COMPLETED|Overall Study||0
105077|NCT01054183|244887|P2|COMPLETED|Overall Study||12
105078|NCT01054183|244888|P1|COMPLETED|Overall Study||10
105079|NCT01054183|244887|P2|STARTED|Overall Study||12
105080|NCT01054183|244888|P1|STARTED|Overall Study||10
105081|NCT01054170|244898|P2|NOT COMPLETED|Overall Study||6
105082|NCT01054170|244899|P1|NOT COMPLETED|Overall Study||4
105083|NCT01054170|244898|P2|COMPLETED|Overall Study||21
105084|NCT01054170|244899|P1|COMPLETED|Overall Study||21
105085|NCT01054170|244898|P2|STARTED|Overall Study||27
105086|NCT01054170|244899|P1|STARTED|Overall Study||25
105087|NCT01054079|244951|P1|NOT COMPLETED|Overall Study||0
105088|NCT01054079|244951|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
105089|NCT01054079|244951|P1|# Recieved Proper PSA Testing|Overall Study||10
105090|NCT01054079|244951|P1|STARTED|Overall Study||20
105091|NCT01053988|244960|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
105092|NCT01053988|244961|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
105093|NCT01053988|244962|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
105094|NCT01053988|244963|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
105095|NCT01053988|244964|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
105096|NCT01053988|244965|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
105097|NCT01053988|244960|P6|COMPLETED|24-week, Double-blind Treatment Period||151
105098|NCT01053988|244961|P5|COMPLETED|24-week, Double-blind Treatment Period||147
105099|NCT01053988|244962|P4|COMPLETED|24-week, Double-blind Treatment Period||142
105100|NCT01053988|244963|P3|COMPLETED|24-week, Double-blind Treatment Period||145
105101|NCT01053988|244964|P2|COMPLETED|24-week, Double-blind Treatment Period||138
105102|NCT01053988|244965|P1|COMPLETED|24-week, Double-blind Treatment Period||0
105103|NCT01053988|244960|P6|STARTED|24-week, Double-blind Treatment Period||206
105104|NCT01053988|244961|P5|STARTED|24-week, Double-blind Treatment Period||206
105105|NCT01053988|244962|P4|STARTED|24-week, Double-blind Treatment Period||205
105106|NCT01053988|244963|P3|STARTED|24-week, Double-blind Treatment Period||206
105107|NCT01053988|244964|P2|STARTED|24-week, Double-blind Treatment Period||207
105108|NCT01053988|244965|P1|STARTED|24-week, Double-blind Treatment Period||0
105109|NCT01053988|244960|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
105110|NCT01053988|244961|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
105111|NCT01053988|244962|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
105112|NCT01053988|244963|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
105113|NCT01053988|244964|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
105114|NCT01053988|244965|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
105115|NCT01053988|244960|P6|COMPLETED|2-week, Single-blind Run-In Period||0
105116|NCT01053988|244961|P5|COMPLETED|2-week, Single-blind Run-In Period||0
105117|NCT01053988|244962|P4|COMPLETED|2-week, Single-blind Run-In Period||0
105118|NCT01053988|244963|P3|COMPLETED|2-week, Single-blind Run-In Period||0
105119|NCT01053988|244964|P2|COMPLETED|2-week, Single-blind Run-In Period||0
105120|NCT01053988|244965|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
105121|NCT01053988|244960|P6|STARTED|2-week, Single-blind Run-In Period||0
105122|NCT01053988|244961|P5|STARTED|2-week, Single-blind Run-In Period||0
105123|NCT01053988|244962|P4|STARTED|2-week, Single-blind Run-In Period||0
105124|NCT01053988|244963|P3|STARTED|2-week, Single-blind Run-In Period||0
105125|NCT01053988|244964|P2|STARTED|2-week, Single-blind Run-In Period||0
105126|NCT01053988|244965|P1|STARTED|2-week, Single-blind Run-In Period||1390
105127|NCT01053897|244997|P1|NOT COMPLETED|Overall Study||0
105128|NCT01053897|244997|P1|COMPLETED|Overall Study||5
105129|NCT01053897|244997|P1|STARTED|Overall Study||5
105130|NCT01053819|245009|P1|NOT COMPLETED|Overall Study||0
105131|NCT01053819|245009|P1|COMPLETED|Overall Study||6
105132|NCT01053819|245009|P1|STARTED|Overall Study||6
105133|NCT01053663|245016|P1|NOT COMPLETED|Overall Study||6
105134|NCT01053663|245016|P1|COMPLETED|Overall Study||3
105135|NCT01053663|245016|P1|STARTED|Overall Study||9
105136|NCT01053507|245059|P2|NOT COMPLETED|Overall Study||1
105137|NCT01053507|245060|P1|NOT COMPLETED|Overall Study||3
105138|NCT01053507|245059|P2|COMPLETED|Overall Study||11
105139|NCT01053507|245060|P1|COMPLETED|Overall Study||8
105140|NCT01053507|245059|P2|STARTED|Overall Study||12
105141|NCT01053507|245060|P1|STARTED|Overall Study||11
105142|NCT01053429|245074|P1|NOT COMPLETED|Overall Study||373
105143|NCT01053429|245074|P1|COMPLETED|Overall Study||3018
105144|NCT01053429|245074|P1|STARTED|Overall Study||3391
105145|NCT01053312|245083|P1|NOT COMPLETED|Overall Study||0
105146|NCT01053312|245083|P1|COMPLETED|Overall Study||7
105147|NCT01053312|245083|P1|STARTED|Overall Study||7
105148|NCT01053247|245104|P3|NOT COMPLETED|Overall Study||28
105149|NCT01053247|245105|P2|NOT COMPLETED|Overall Study||19
105150|NCT01053247|245106|P1|NOT COMPLETED|Overall Study||20
105151|NCT01053247|245104|P3|COMPLETED|Overall Study||236
105152|NCT01053247|245105|P2|COMPLETED|Overall Study||241
105153|NCT01053247|245106|P1|COMPLETED|Overall Study||249
105154|NCT01053247|245104|P3|STARTED|Overall Study||264
105155|NCT01053247|245105|P2|STARTED|Overall Study||260
105156|NCT01053247|245106|P1|STARTED|Overall Study||269
105157|NCT01053156|245116|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
105158|NCT01053156|245117|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
105159|NCT01053156|245116|P2|COMPLETED|Second Intervention (Week 13-24)||22
105160|NCT01053156|245117|P1|COMPLETED|Second Intervention (Week 13-24)||26
105161|NCT01053156|245116|P2|STARTED|Second Intervention (Week 13-24)||27
105162|NCT01053156|245117|P1|STARTED|Second Intervention (Week 13-24)||28
105163|NCT01053156|245116|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
105164|NCT01053156|245117|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
105165|NCT01053156|245116|P2|COMPLETED|First Intervention (Week 1-12)||27
105166|NCT01053156|245117|P1|COMPLETED|First Intervention (Week 1-12)||28
105167|NCT01053156|245116|P2|STARTED|First Intervention (Week 1-12)||33
105168|NCT01053156|245117|P1|STARTED|First Intervention (Week 1-12)||33
105169|NCT01053078|245155|P2|NOT COMPLETED|Overall Study||3
105170|NCT01053078|245156|P1|NOT COMPLETED|Overall Study||4
105171|NCT01053078|245155|P2|COMPLETED|Overall Study||12
105172|NCT01053078|245156|P1|COMPLETED|Overall Study||10
105173|NCT01053078|245155|P2|STARTED|Overall Study||15
105174|NCT01053078|245156|P1|STARTED|Overall Study||14
105175|NCT01053000|245162|P2|NOT COMPLETED|Overall Study||0
105176|NCT01053000|245163|P1|NOT COMPLETED|Overall Study||0
105177|NCT01053000|245162|P2|COMPLETED|Overall Study||5
105178|NCT01053000|245163|P1|COMPLETED|Overall Study||5
105179|NCT01053000|245162|P2|STARTED|Overall Study||5
105180|NCT01053000|245163|P1|STARTED|Overall Study||5
105181|NCT01052948|245173|P4|NOT COMPLETED|Overall Study||0
105182|NCT01052948|245174|P3|NOT COMPLETED|Overall Study||0
105183|NCT01052948|245175|P2|NOT COMPLETED|Overall Study||0
105184|NCT01052948|245176|P1|NOT COMPLETED|Overall Study||0
105185|NCT01052948|245173|P4|COMPLETED|Overall Study||29311
105186|NCT01052948|245174|P3|COMPLETED|Overall Study||15147
105187|NCT01052948|245175|P2|COMPLETED|Overall Study||14669
105188|NCT01052948|245176|P1|COMPLETED|Overall Study||27812
105189|NCT01052948|245173|P4|STARTED|Overall Study||29311
105190|NCT01052948|245174|P3|STARTED|Overall Study||15147
105191|NCT01052948|245175|P2|STARTED|Overall Study||14669
105192|NCT01052948|245176|P1|STARTED|Overall Study||27812
105193|NCT01052844|245200|P2|NOT COMPLETED|Overall Study||1
105194|NCT01052844|245201|P1|NOT COMPLETED|Overall Study||0
105195|NCT01052844|245200|P2|COMPLETED|Overall Study||39
105196|NCT01052844|245201|P1|COMPLETED|Overall Study||40
105197|NCT01052844|245200|P2|STARTED|Overall Study||40
105198|NCT01052844|245201|P1|STARTED|Overall Study||40
105199|NCT01052831|245211|P2|NOT COMPLETED|Overall Study||1
105200|NCT01052831|245212|P1|NOT COMPLETED|Overall Study||4
105201|NCT01052831|245211|P2|COMPLETED|Overall Study||23
105202|NCT01052831|245212|P1|COMPLETED|Overall Study||22
105203|NCT01052831|245211|P2|STARTED|Overall Study||24
105204|NCT01052831|245212|P1|STARTED|Overall Study||26
105205|NCT01052662|245223|P3|NOT COMPLETED|Overall Study||22
105206|NCT01052662|245224|P2|NOT COMPLETED|Overall Study||22
105207|NCT01052662|245225|P1|NOT COMPLETED|Overall Study||22
105208|NCT01052662|245223|P3|COMPLETED|Overall Study||10
105209|NCT01052662|245224|P2|COMPLETED|Overall Study||5
105210|NCT01052662|245225|P1|COMPLETED|Overall Study||6
105211|NCT01052662|245223|P3|Discontinuation Phase|Overall Study||10
105212|NCT01052662|245224|P2|Discontinuation Phase|Overall Study||5
105213|NCT01052662|245225|P1|Discontinuation Phase|Overall Study||6
105214|NCT01052662|245223|P3|Stabilization Phase|Overall Study||26
105215|NCT01052662|245224|P2|Stabilization Phase|Overall Study||21
105216|NCT01052662|245225|P1|Stabilization Phase|Overall Study||21
105217|NCT01052662|245223|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
105218|NCT01052662|245224|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
105219|NCT01052662|245225|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
105220|NCT01052545|245241|P2|NOT COMPLETED|Overall Study||0
105221|NCT01052545|245242|P1|NOT COMPLETED|Overall Study||0
105222|NCT01052545|245241|P2|COMPLETED|Overall Study||731
105223|NCT01052545|245242|P1|COMPLETED|Overall Study||867
105224|NCT01052545|245241|P2|STARTED|Overall Study||731
105225|NCT01052545|245242|P1|STARTED|Overall Study||867
105226|NCT01052428|245256|P2|NOT COMPLETED|Overall Study||1
105227|NCT01052428|245257|P1|NOT COMPLETED|Overall Study||1
105228|NCT01052428|245256|P2|COMPLETED|Overall Study||18
105229|NCT01052428|245257|P1|COMPLETED|Overall Study||18
105230|NCT01052428|245256|P2|STARTED|Overall Study||19
105231|NCT01052428|245257|P1|STARTED|Overall Study||19
105232|NCT01052272|245279|P4|NOT COMPLETED|Overall Study||7
105233|NCT01052272|245280|P3|NOT COMPLETED|Overall Study||8
105234|NCT01052272|245281|P2|NOT COMPLETED|Overall Study||7
105235|NCT01052272|245282|P1|NOT COMPLETED|Overall Study||5
105236|NCT01052272|245279|P4|COMPLETED|Overall Study||11
105237|NCT01052272|245280|P3|COMPLETED|Overall Study||10
105238|NCT01052272|245281|P2|COMPLETED|Overall Study||11
105239|NCT01052272|245282|P1|COMPLETED|Overall Study||13
105240|NCT01052272|245279|P4|STARTED|Overall Study||18
105241|NCT01052272|245280|P3|STARTED|Overall Study||18
105242|NCT01052272|245281|P2|STARTED|Overall Study||18
105243|NCT01052272|245282|P1|STARTED|Overall Study||18
105244|NCT01052207|245318|P2|NOT COMPLETED|Overall Study||0
105245|NCT01052207|245319|P1|NOT COMPLETED|Overall Study||0
105246|NCT01052207|245318|P2|COMPLETED|Overall Study||42
105247|NCT01052207|245319|P1|COMPLETED|Overall Study||60
105248|NCT01052207|245318|P2|STARTED|Overall Study||42
105249|NCT01052207|245319|P1|STARTED|Overall Study||60
105250|NCT01052116|245327|P2|NOT COMPLETED|Overall Study||27
105251|NCT01052116|245328|P1|NOT COMPLETED|Overall Study||14
105252|NCT01052116|245327|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
105253|NCT01052116|245328|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
105254|NCT01052116|245327|P2|STARTED|Overall Study||193
105255|NCT01052116|245328|P1|STARTED|Overall Study||193
105256|NCT01052077|245336|P4|NOT COMPLETED|Phase A+||21
105257|NCT01052077|245337|P3|NOT COMPLETED|Phase A+||0
105258|NCT01052077|245338|P2|NOT COMPLETED|Phase A+||0
105259|NCT01052077|245339|P1|NOT COMPLETED|Phase A+||0
105260|NCT01052077|245336|P4|COMPLETED|Phase A+||230
105261|NCT01052077|245337|P3|COMPLETED|Phase A+||0
105262|NCT01052077|245338|P2|COMPLETED|Phase A+||0
105263|NCT01052077|245339|P1|COMPLETED|Phase A+||0
105264|NCT01052077|245336|P4|STARTED|Phase A+||251
105265|NCT01052077|245337|P3|STARTED|Phase A+||0
105266|NCT01052077|245338|P2|STARTED|Phase A+||0
105267|NCT01052077|245339|P1|STARTED|Phase A+||0
105268|NCT01052077|245336|P4|NOT COMPLETED|Phase B||0
105269|NCT01052077|245337|P3|NOT COMPLETED|Phase B||16
105270|NCT01052077|245338|P2|NOT COMPLETED|Phase B||18
105271|NCT01052077|245339|P1|NOT COMPLETED|Phase B||0
105272|NCT01052077|245336|P4|COMPLETED|Phase B||0
105273|NCT01052077|245337|P3|COMPLETED|Phase B||171
105274|NCT01052077|245338|P2|COMPLETED|Phase B||167
105275|NCT01052077|245339|P1|COMPLETED|Phase B||0
105276|NCT01052077|245336|P4|STARTED|Phase B||0
105277|NCT01052077|245337|P3|STARTED|Phase B||187
105278|NCT01052077|245338|P2|STARTED|Phase B||185
105279|NCT01052077|245339|P1|STARTED|Phase B||0
105280|NCT01052077|245336|P4|NOT COMPLETED|Phase A||0
105281|NCT01052077|245337|P3|NOT COMPLETED|Phase A||0
105282|NCT01052077|245338|P2|NOT COMPLETED|Phase A||0
105283|NCT01052077|245339|P1|NOT COMPLETED|Phase A||146
105284|NCT01052077|245336|P4|COMPLETED|Phase A||0
105285|NCT01052077|245337|P3|COMPLETED|Phase A||0
105286|NCT01052077|245338|P2|COMPLETED|Phase A||0
105287|NCT01052077|245339|P1|COMPLETED|Phase A||623
105288|NCT01052077|245336|P4|STARTED|Phase A||0
105289|NCT01052077|245337|P3|STARTED|Phase A||0
105290|NCT01052077|245338|P2|STARTED|Phase A||0
105291|NCT01052077|245339|P1|STARTED|Phase A||769
105292|NCT01052038|245366|P3|NOT COMPLETED|Overall Study||4
105293|NCT01052038|245367|P2|NOT COMPLETED|Overall Study||6
105294|NCT01052038|245368|P1|NOT COMPLETED|Overall Study||4
105295|NCT01052038|245366|P3|COMPLETED|Overall Study||36
105296|NCT01052038|245367|P2|COMPLETED|Overall Study||34
105297|NCT01052038|245368|P1|COMPLETED|Overall Study||36
105298|NCT01052038|245366|P3|STARTED|Overall Study||40
105299|NCT01052038|245367|P2|STARTED|Overall Study||40
105300|NCT01052038|245368|P1|STARTED|Overall Study||40
105301|NCT01051986|245390|P2|NOT COMPLETED|Overall Study||4
105302|NCT01051986|245391|P1|NOT COMPLETED|Overall Study||5
105303|NCT01051986|245390|P2|COMPLETED|Overall Study||108
105304|NCT01051986|245391|P1|COMPLETED|Overall Study||107
105305|NCT01051986|245390|P2|STARTED|Overall Study||112
105306|NCT01051986|245391|P1|STARTED|Overall Study||112
105307|NCT01051921|245405|P1|NOT COMPLETED|Overall Study||30
105308|NCT01051921|245405|P1|COMPLETED|Overall Study||37
105309|NCT01051921|245405|P1|STARTED|Overall Study||67
105310|NCT01051856|245412|P2|NOT COMPLETED|Overall Study||0
105311|NCT01051856|245413|P1|NOT COMPLETED|Overall Study||1
105312|NCT01051856|245412|P2|COMPLETED|Overall Study||35
105313|NCT01051856|245413|P1|COMPLETED|Overall Study||32
105314|NCT01051856|245412|P2|STARTED|Overall Study||35
105315|NCT01051856|245413|P1|STARTED|Overall Study||33
105316|NCT01051817|245423|P2|NOT COMPLETED|Overall Study||9
105317|NCT01051817|245424|P1|NOT COMPLETED|Overall Study||3
105318|NCT01051817|245423|P2|COMPLETED|Overall Study||26
105319|NCT01051817|245424|P1|COMPLETED|Overall Study||35
105320|NCT01051817|245423|P2|STARTED|Overall Study||35
105321|NCT01051817|245424|P1|STARTED|Overall Study||38
105322|NCT01051778|245436|P2|NOT COMPLETED|Overall Study||0
105323|NCT01051778|245437|P1|NOT COMPLETED|Overall Study||0
105324|NCT01051778|245436|P2|COMPLETED|Overall Study|November 2009|30
105325|NCT01051778|245437|P1|COMPLETED|Overall Study|November 2009|30
105326|NCT01051778|245436|P2|STARTED|Overall Study|June 2006|30
105327|NCT01051778|245437|P1|STARTED|Overall Study|June 2006|30
105328|NCT01051739|245445|P2|NOT COMPLETED|Overall Study||13
105329|NCT01051739|245446|P1|NOT COMPLETED|Overall Study||28
105330|NCT01051739|245445|P2|COMPLETED|Overall Study||47
105331|NCT01051739|245446|P1|COMPLETED|Overall Study||92
105332|NCT01051739|245445|P2|STARTED|Overall Study||60
105333|NCT01051739|245446|P1|STARTED|Overall Study||120
105334|NCT01051570|245452|P1|NOT COMPLETED|Overall Study||0
105335|NCT01051570|245452|P1|COMPLETED|Overall Study||26
105336|NCT01051570|245452|P1|STARTED|Overall Study||26
105337|NCT01051557|245463|P7|NOT COMPLETED|Overall Study||6
105338|NCT01051557|245464|P6|NOT COMPLETED|Overall Study||6
105339|NCT01051557|245465|P5|NOT COMPLETED|Overall Study||7
105340|NCT01051557|245466|P4|NOT COMPLETED|Overall Study||3
105341|NCT01051557|245467|P3|NOT COMPLETED|Overall Study||6
105342|NCT01051557|245468|P2|NOT COMPLETED|Overall Study||3
105343|NCT01051557|245469|P1|NOT COMPLETED|Overall Study||4
105344|NCT01051557|245463|P7|COMPLETED|Overall Study||0
105345|NCT01051557|245464|P6|COMPLETED|Overall Study||0
105346|NCT01051557|245465|P5|COMPLETED|Overall Study||1
105347|NCT01051557|245466|P4|COMPLETED|Overall Study||0
105348|NCT01051557|245467|P3|COMPLETED|Overall Study||0
105349|NCT01051557|245468|P2|COMPLETED|Overall Study||0
105350|NCT01051557|245469|P1|COMPLETED|Overall Study||0
105351|NCT01051557|245463|P7|STARTED|Overall Study||6
105352|NCT01051557|245464|P6|STARTED|Overall Study||6
105353|NCT01051557|245465|P5|STARTED|Overall Study||8
105354|NCT01051557|245466|P4|STARTED|Overall Study||3
105355|NCT01051557|245467|P3|STARTED|Overall Study||6
105356|NCT01051557|245468|P2|STARTED|Overall Study||3
105357|NCT01051557|245469|P1|STARTED|Overall Study||4
105358|NCT01051466|245481|P2|NOT COMPLETED|Overall Study||5
105359|NCT01051466|245482|P1|NOT COMPLETED|Overall Study||8
105360|NCT01051466|245481|P2|COMPLETED|Overall Study||23
105361|NCT01051466|245482|P1|COMPLETED|Overall Study||24
105362|NCT01051466|245481|P2|STARTED|Overall Study||28
105363|NCT01051466|245482|P1|STARTED|Overall Study||32
105364|NCT01051440|245516|P2|NOT COMPLETED|Overall Study||0
105365|NCT01051440|245517|P1|NOT COMPLETED|Overall Study||0
105366|NCT01051440|245516|P2|COMPLETED|Overall Study||1
105367|NCT01051440|245517|P1|COMPLETED|Overall Study||1
105368|NCT01051440|245516|P2|STARTED|Overall Study||1
105369|NCT01051440|245517|P1|STARTED|Overall Study||1
105370|NCT01051323|245529|P1|NOT COMPLETED|Overall Study||539
105371|NCT01051323|245529|P1|COMPLETED|Overall Study||1041
105372|NCT01051323|245529|P1|Received at Least One Dose|Overall Study||1547
105373|NCT01051323|245529|P1|STARTED|Overall Study||1580
105374|NCT01050998|245556|P5|NOT COMPLETED|Overall Study||14
105375|NCT01050998|245557|P4|NOT COMPLETED|Overall Study||3
105376|NCT01050998|245558|P3|NOT COMPLETED|Overall Study||3
105377|NCT01050998|245559|P2|NOT COMPLETED|Overall Study||2
105378|NCT01050998|245560|P1|NOT COMPLETED|Overall Study||4
105379|NCT01050998|245556|P5|COMPLETED|Overall Study||82
105380|NCT01050998|245557|P4|COMPLETED|Overall Study||45
105381|NCT01050998|245558|P3|COMPLETED|Overall Study||46
105382|NCT01050998|245559|P2|COMPLETED|Overall Study||47
105383|NCT01050998|245560|P1|COMPLETED|Overall Study||44
105384|NCT01050998|245556|P5|STARTED|Overall Study||96
105385|NCT01050998|245557|P4|STARTED|Overall Study||48
105386|NCT01050998|245558|P3|STARTED|Overall Study||49
105387|NCT01050998|245559|P2|STARTED|Overall Study||49
105388|NCT01050998|245560|P1|STARTED|Overall Study||48
105389|NCT01050946|245884|P1|NOT COMPLETED|Overall Study||0
105390|NCT01050946|245884|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
105391|NCT01050946|245884|P1|STARTED|Overall Study||1
105392|NCT01050816|245894|P1|NOT COMPLETED|Overall Study||4
105393|NCT01050816|245894|P1|COMPLETED|Overall Study||26
105394|NCT01050816|245894|P1|STARTED|Overall Study||30
105395|NCT01050790|245900|P1|NOT COMPLETED|Overall Study||1
105396|NCT01050790|245900|P1|COMPLETED|Overall Study||16
105397|NCT01050790|245900|P1|STARTED|Overall Study||17
105398|NCT01050673|245912|P2|NOT COMPLETED|Overall Study||5
105399|NCT01050673|245913|P1|NOT COMPLETED|Overall Study||4
105400|NCT01050673|245912|P2|COMPLETED|Overall Study||14
105401|NCT01050673|245913|P1|COMPLETED|Overall Study||17
105402|NCT01050673|245912|P2|STARTED|Overall Study||19
105403|NCT01050673|245913|P1|STARTED|Overall Study||21
105404|NCT01050660|245937|P2|NOT COMPLETED|Overall Study||0
105405|NCT01050660|245938|P1|NOT COMPLETED|Overall Study||0
105406|NCT01050660|245937|P2|COMPLETED|Overall Study||69
105407|NCT01050660|245938|P1|COMPLETED|Overall Study||67
105408|NCT01050660|245937|P2|STARTED|Overall Study||69
105409|NCT01050660|245938|P1|STARTED|Overall Study||67
105410|NCT01050634|245962|P1|NOT COMPLETED|Overall Study||128
105411|NCT01050634|245962|P1|COMPLETED|Overall Study||852
105412|NCT01050634|245962|P1|Received Treatment|Overall Study||924
105413|NCT01050634|245962|P1|STARTED|Overall Study||980
105414|NCT01050582|245972|P2|NOT COMPLETED|Overall Study||0
105415|NCT01050582|245973|P1|NOT COMPLETED|Overall Study||0
105416|NCT01050582|245972|P2|COMPLETED|Overall Study||51
105417|NCT01050582|245973|P1|COMPLETED|Overall Study||133
105418|NCT01050582|245972|P2|STARTED|Overall Study||51
105419|NCT01050582|245973|P1|STARTED|Overall Study||133
105420|NCT01050569|245986|P3|NOT COMPLETED|Overall Study||33
105421|NCT01050569|245987|P2|NOT COMPLETED|Overall Study||24
105422|NCT01050569|245988|P1|NOT COMPLETED|Overall Study||38
105423|NCT01050569|245986|P3|COMPLETED|Overall Study||47
105424|NCT01050569|245987|P2|COMPLETED|Overall Study||52
105425|NCT01050569|245988|P1|COMPLETED|Overall Study||41
105426|NCT01050569|245986|P3|STARTED|Overall Study||80
105427|NCT01050569|245987|P2|STARTED|Overall Study||76
105428|NCT01050569|245988|P1|STARTED|Overall Study||79
105429|NCT01050543|246007|P2|NOT COMPLETED|Overall Study||4
105430|NCT01050543|246008|P1|NOT COMPLETED|Overall Study||4
105431|NCT01050543|246007|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
105432|NCT01050543|246008|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
105433|NCT01050543|246007|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
105434|NCT01050543|246008|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
105435|NCT01050530|246016|P2|NOT COMPLETED|Overall Study||10
105436|NCT01050530|246017|P1|NOT COMPLETED|Overall Study||8
105437|NCT01050530|246016|P2|COMPLETED|Overall Study||70
105438|NCT01050530|246017|P1|COMPLETED|Overall Study||74
105439|NCT01050530|246016|P2|STARTED|Overall Study||80
105440|NCT01050530|246017|P1|STARTED|Overall Study||82
105441|NCT01050257|246028|P3|NOT COMPLETED|Overall Study||7
105442|NCT01050257|246029|P2|NOT COMPLETED|Overall Study||13
105443|NCT01050257|246030|P1|NOT COMPLETED|Overall Study||11
105444|NCT01050257|246028|P3|COMPLETED|Overall Study||8
105445|NCT01050257|246029|P2|COMPLETED|Overall Study||40
105446|NCT01050257|246030|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
105447|NCT01050257|246028|P3|Switched to Oral Treatment|Overall Study||3
105448|NCT01050257|246029|P2|Switched to Oral Treatment|Overall Study||31
105449|NCT01050257|246030|P1|Switched to Oral Treatment|Overall Study||28
105450|NCT01050257|246028|P3|Intent-to-treat Infected Confirmed|Overall Study||10
105451|NCT01050257|246029|P2|Intent-to-treat Infected Confirmed|Overall Study||32
105452|NCT01050257|246030|P1|Intent-to-treat Infected Confirmed|Overall Study||30
105453|NCT01050257|246028|P3|Safety Population: Actual Dose Received|Overall Study||14
105454|NCT01050257|246029|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
105455|NCT01050257|246030|P1|Safety Population: Actual Dose Received|Overall Study||48
105456|NCT01050257|246028|P3|Received Treatment|Overall Study||14
105457|NCT01050257|246029|P2|Received Treatment|Overall Study||50
105458|NCT01050257|246030|P1|Received Treatment|Overall Study||49
105459|NCT01050257|246028|P3|STARTED|Overall Study||15
105460|NCT01050257|246029|P2|STARTED|Overall Study||53
105461|NCT01050257|246030|P1|STARTED|Overall Study||50
105462|NCT01050218|246065|P1|NOT COMPLETED|Overall Study||95
105463|NCT01050218|246065|P1|COMPLETED|Overall Study||142
105464|NCT01050218|246065|P1|STARTED|Overall Study||237
105465|NCT01050153|246071|P2|NOT COMPLETED|Overall Study||0
105466|NCT01050153|246072|P1|NOT COMPLETED|Overall Study||0
105467|NCT01050153|246071|P2|COMPLETED|Overall Study||25
105468|NCT01050153|246072|P1|COMPLETED|Overall Study||25
105469|NCT01050153|246071|P2|STARTED|Overall Study||25
105470|NCT01050153|246072|P1|STARTED|Overall Study||25
105471|NCT01050062|246098|P2|NOT COMPLETED|Overall Study||112
105472|NCT01050062|246099|P1|NOT COMPLETED|Overall Study||271
105473|NCT01050062|246098|P2|COMPLETED|Overall Study||243
105474|NCT01050062|246099|P1|COMPLETED|Overall Study||799
105475|NCT01050062|246098|P2|STARTED|Overall Study||355
105476|NCT01050062|246099|P1|STARTED|Overall Study||1070
105477|NCT01049984|246121|P2|NOT COMPLETED|Overall Study||19
105478|NCT01049984|246122|P1|NOT COMPLETED|Overall Study||19
105479|NCT01049984|246121|P2|COMPLETED|Overall Study||146
105480|NCT01049984|246122|P1|COMPLETED|Overall Study||144
105481|NCT01049984|246121|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
105482|NCT01049984|246122|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
105483|NCT01049984|246121|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
105484|NCT01049984|246122|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
105485|NCT01049984|246121|P2|STARTED|Overall Study||165
105486|NCT01049984|246122|P1|STARTED|Overall Study||163
105487|NCT01049945|246140|P6|NOT COMPLETED|Overall Study||0
105488|NCT01049945|246141|P5|NOT COMPLETED|Overall Study||0
105489|NCT01049945|246142|P4|NOT COMPLETED|Overall Study||0
105490|NCT01049945|246143|P3|NOT COMPLETED|Overall Study||0
105491|NCT01049945|246144|P2|NOT COMPLETED|Overall Study||0
105492|NCT01049945|246145|P1|NOT COMPLETED|Overall Study||0
105493|NCT01049945|246140|P6|COMPLETED|Overall Study||49
105494|NCT01049945|246141|P5|COMPLETED|Overall Study||3
105495|NCT01049945|246142|P4|COMPLETED|Overall Study||6
105496|NCT01049945|246143|P3|COMPLETED|Overall Study||3
105497|NCT01049945|246144|P2|COMPLETED|Overall Study||6
105498|NCT01049945|246145|P1|COMPLETED|Overall Study||3
105499|NCT01049945|246140|P6|STARTED|Overall Study||49
105500|NCT01049945|246141|P5|STARTED|Overall Study||3
105501|NCT01049945|246142|P4|STARTED|Overall Study||6
105502|NCT01049945|246143|P3|STARTED|Overall Study||3
105503|NCT01049945|246144|P2|STARTED|Overall Study||6
105504|NCT01049945|246145|P1|STARTED|Overall Study||3
105505|NCT01049802|246161|P2|NOT COMPLETED|Overall Study||0
105506|NCT01049802|246162|P1|NOT COMPLETED|Overall Study||0
105507|NCT01049802|246161|P2|COMPLETED|Overall Study||10
105508|NCT01049802|246162|P1|COMPLETED|Overall Study||20
105509|NCT01049802|246161|P2|STARTED|Overall Study||10
105510|NCT01049802|246162|P1|STARTED|Overall Study||20
105511|NCT01049776|246176|P1|NOT COMPLETED|Overall Study||20
105512|NCT01049776|246176|P1|COMPLETED|Overall Study||12
105513|NCT01049776|246176|P1|STARTED|Overall Study||32
105514|NCT01049581|246182|P2|NOT COMPLETED|Overall Study||1
105515|NCT01049581|246183|P1|NOT COMPLETED|Overall Study||2
105516|NCT01049581|246182|P2|COMPLETED|Overall Study||13
105517|NCT01049581|246183|P1|COMPLETED|Overall Study||11
105518|NCT01049581|246182|P2|STARTED|Overall Study||14
105519|NCT01049581|246183|P1|STARTED|Overall Study||13
105520|NCT01049503|246198|P6|NOT COMPLETED|Overall Study||8
105521|NCT01049503|246199|P5|NOT COMPLETED|Overall Study||27
105522|NCT01049503|246200|P4|NOT COMPLETED|Overall Study||26
105523|NCT01049503|246201|P3|NOT COMPLETED|Overall Study||24
105524|NCT01049503|246202|P2|NOT COMPLETED|Overall Study||12
105525|NCT01049503|246203|P1|NOT COMPLETED|Overall Study||11
105526|NCT01049503|246198|P6|COMPLETED|Overall Study||40
105527|NCT01049503|246199|P5|COMPLETED|Overall Study||29
105528|NCT01049503|246200|P4|COMPLETED|Overall Study||29
105529|NCT01049503|246201|P3|COMPLETED|Overall Study||32
105530|NCT01049503|246202|P2|COMPLETED|Overall Study||36
105531|NCT01049503|246203|P1|COMPLETED|Overall Study||41
105532|NCT01049503|246198|P6|STARTED|Overall Study||48
105533|NCT01049503|246199|P5|STARTED|Overall Study||56
105534|NCT01049503|246200|P4|STARTED|Overall Study||55
105535|NCT01049503|246201|P3|STARTED|Overall Study||56
105536|NCT01049503|246202|P2|STARTED|Overall Study||48
105537|NCT01049503|246203|P1|STARTED|Overall Study||52
105538|NCT01049373|246234|P2|NOT COMPLETED|Overall Study||44
105539|NCT01049373|246235|P1|NOT COMPLETED|Overall Study||39
105540|NCT01049373|246234|P2|COMPLETED|Overall Study||65
105541|NCT01049373|246235|P1|COMPLETED|Overall Study||73
105542|NCT01049373|246234|P2|STARTED|Overall Study||109
105543|NCT01049373|246235|P1|STARTED|Overall Study||112
105544|NCT01049360|246249|P20|NOT COMPLETED|Period 4||0
105545|NCT01049360|246250|P19|NOT COMPLETED|Period 4||0
105546|NCT01049360|246251|P18|NOT COMPLETED|Period 4||1
105547|NCT01049360|246252|P17|NOT COMPLETED|Period 4||0
105548|NCT01049360|246253|P16|NOT COMPLETED|Period 4||0
105549|NCT01049360|246254|P15|NOT COMPLETED|Period 4||0
105550|NCT01049360|246255|P14|NOT COMPLETED|Period 4||0
105551|NCT01049360|246256|P13|NOT COMPLETED|Period 4||0
105552|NCT01049360|246257|P12|NOT COMPLETED|Period 4||0
105553|NCT01049360|246258|P11|NOT COMPLETED|Period 4||0
105554|NCT01049360|246259|P10|NOT COMPLETED|Period 4||0
105555|NCT01049360|246260|P9|NOT COMPLETED|Period 4||0
105556|NCT01049360|246261|P8|NOT COMPLETED|Period 4||0
105557|NCT01049360|246262|P7|NOT COMPLETED|Period 4||0
105558|NCT01049360|246263|P6|NOT COMPLETED|Period 4||0
105559|NCT01049360|246264|P5|NOT COMPLETED|Period 4||0
105560|NCT01049360|246265|P4|NOT COMPLETED|Period 4||1
105561|NCT01049360|246266|P3|NOT COMPLETED|Period 4||0
105562|NCT01049360|246267|P2|NOT COMPLETED|Period 4||0
105563|NCT01049360|246268|P1|NOT COMPLETED|Period 4||0
105564|NCT01049360|246249|P20|COMPLETED|Period 4||5
105565|NCT01049360|246250|P19|COMPLETED|Period 4||5
105566|NCT01049360|246251|P18|COMPLETED|Period 4||5
105567|NCT01049360|246252|P17|COMPLETED|Period 4||5
105568|NCT01049360|246253|P16|COMPLETED|Period 4||6
105569|NCT01049360|246254|P15|COMPLETED|Period 4||5
105570|NCT01049360|246255|P14|COMPLETED|Period 4||6
105571|NCT01049360|246256|P13|COMPLETED|Period 4||4
105572|NCT01049360|246257|P12|COMPLETED|Period 4||6
105573|NCT01049360|246258|P11|COMPLETED|Period 4||5
105574|NCT01049360|246259|P10|COMPLETED|Period 4||6
105575|NCT01049360|246260|P9|COMPLETED|Period 4||4
105576|NCT01049360|246261|P8|COMPLETED|Period 4||4
105577|NCT01049360|246262|P7|COMPLETED|Period 4||6
105578|NCT01049360|246263|P6|COMPLETED|Period 4||5
105579|NCT01049360|246264|P5|COMPLETED|Period 4||7
105580|NCT01049360|246265|P4|COMPLETED|Period 4||3
105581|NCT01049360|246266|P3|COMPLETED|Period 4||7
105582|NCT01049360|246267|P2|COMPLETED|Period 4||4
105583|NCT01049360|246268|P1|COMPLETED|Period 4||6
105584|NCT01049360|246249|P20|STARTED|Period 4||5
105585|NCT01049360|246250|P19|STARTED|Period 4||5
105586|NCT01049360|246251|P18|STARTED|Period 4||6
105587|NCT01049360|246252|P17|STARTED|Period 4||5
105588|NCT01049360|246253|P16|STARTED|Period 4||6
105589|NCT01049360|246254|P15|STARTED|Period 4||5
105590|NCT01049360|246255|P14|STARTED|Period 4||6
105591|NCT01049360|246256|P13|STARTED|Period 4||4
105592|NCT01049360|246257|P12|STARTED|Period 4||6
105593|NCT01049360|246258|P11|STARTED|Period 4||5
105594|NCT01049360|246259|P10|STARTED|Period 4||6
105595|NCT01049360|246260|P9|STARTED|Period 4||4
105596|NCT01049360|246261|P8|STARTED|Period 4||4
105597|NCT01049360|246262|P7|STARTED|Period 4||6
105598|NCT01049360|246263|P6|STARTED|Period 4||5
105599|NCT01049360|246264|P5|STARTED|Period 4||7
105600|NCT01049360|246265|P4|STARTED|Period 4||4
105601|NCT01049360|246266|P3|STARTED|Period 4||7
105602|NCT01049360|246267|P2|STARTED|Period 4||4
105603|NCT01049360|246268|P1|STARTED|Period 4||6
105604|NCT01049360|246249|P20|NOT COMPLETED|Period 3||0
105605|NCT01049360|246250|P19|NOT COMPLETED|Period 3||0
105606|NCT01049360|246251|P18|NOT COMPLETED|Period 3||0
105607|NCT01049360|246252|P17|NOT COMPLETED|Period 3||0
105608|NCT01049360|246253|P16|NOT COMPLETED|Period 3||0
105609|NCT01049360|246254|P15|NOT COMPLETED|Period 3||0
105610|NCT01049360|246255|P14|NOT COMPLETED|Period 3||0
105611|NCT01049360|246256|P13|NOT COMPLETED|Period 3||0
105612|NCT01049360|246257|P12|NOT COMPLETED|Period 3||0
105613|NCT01049360|246258|P11|NOT COMPLETED|Period 3||0
105614|NCT01049360|246259|P10|NOT COMPLETED|Period 3||0
105615|NCT01049360|246260|P9|NOT COMPLETED|Period 3||0
105616|NCT01049360|246261|P8|NOT COMPLETED|Period 3||0
105617|NCT01049360|246262|P7|NOT COMPLETED|Period 3||0
105618|NCT01049360|246263|P6|NOT COMPLETED|Period 3||0
105619|NCT01049360|246264|P5|NOT COMPLETED|Period 3||0
105620|NCT01049360|246265|P4|NOT COMPLETED|Period 3||0
105621|NCT01049360|246266|P3|NOT COMPLETED|Period 3||0
105622|NCT01049360|246267|P2|NOT COMPLETED|Period 3||0
105623|NCT01049360|246268|P1|NOT COMPLETED|Period 3||0
105624|NCT01049360|246249|P20|COMPLETED|Period 3||5
105625|NCT01049360|246250|P19|COMPLETED|Period 3||5
105626|NCT01049360|246251|P18|COMPLETED|Period 3||6
105627|NCT01049360|246252|P17|COMPLETED|Period 3||5
105628|NCT01049360|246253|P16|COMPLETED|Period 3||6
105629|NCT01049360|246254|P15|COMPLETED|Period 3||5
105630|NCT01049360|246255|P14|COMPLETED|Period 3||6
105631|NCT01049360|246256|P13|COMPLETED|Period 3||4
105632|NCT01049360|246257|P12|COMPLETED|Period 3||6
105633|NCT01049360|246258|P11|COMPLETED|Period 3||5
105634|NCT01049360|246259|P10|COMPLETED|Period 3||6
105635|NCT01049360|246260|P9|COMPLETED|Period 3||4
105636|NCT01049360|246261|P8|COMPLETED|Period 3||4
105637|NCT01049360|246262|P7|COMPLETED|Period 3||6
105638|NCT01049360|246263|P6|COMPLETED|Period 3||5
105639|NCT01049360|246264|P5|COMPLETED|Period 3||7
105640|NCT01049360|246265|P4|COMPLETED|Period 3||4
105641|NCT01049360|246266|P3|COMPLETED|Period 3||7
105642|NCT01049360|246267|P2|COMPLETED|Period 3||4
105643|NCT01049360|246268|P1|COMPLETED|Period 3||6
105644|NCT01049360|246249|P20|STARTED|Period 3||5
105645|NCT01049360|246250|P19|STARTED|Period 3||5
105646|NCT01049360|246251|P18|STARTED|Period 3||6
105647|NCT01049360|246252|P17|STARTED|Period 3||5
105648|NCT01049360|246253|P16|STARTED|Period 3||6
105649|NCT01049360|246254|P15|STARTED|Period 3||5
105650|NCT01049360|246255|P14|STARTED|Period 3||6
105651|NCT01049360|246256|P13|STARTED|Period 3||4
105652|NCT01049360|246257|P12|STARTED|Period 3||6
105653|NCT01049360|246258|P11|STARTED|Period 3||5
105654|NCT01049360|246259|P10|STARTED|Period 3||6
105655|NCT01049360|246260|P9|STARTED|Period 3||4
105656|NCT01049360|246261|P8|STARTED|Period 3||4
105657|NCT01049360|246262|P7|STARTED|Period 3||6
105658|NCT01049360|246263|P6|STARTED|Period 3||5
105659|NCT01049360|246264|P5|STARTED|Period 3||7
105660|NCT01049360|246265|P4|STARTED|Period 3||4
105661|NCT01049360|246266|P3|STARTED|Period 3||7
105662|NCT01049360|246267|P2|STARTED|Period 3||4
105663|NCT01049360|246268|P1|STARTED|Period 3||6
105664|NCT01049360|246249|P20|NOT COMPLETED|Period 2||2
105665|NCT01049360|246250|P19|NOT COMPLETED|Period 2||0
105666|NCT01049360|246251|P18|NOT COMPLETED|Period 2||0
105667|NCT01049360|246252|P17|NOT COMPLETED|Period 2||0
105668|NCT01049360|246253|P16|NOT COMPLETED|Period 2||1
105669|NCT01049360|246254|P15|NOT COMPLETED|Period 2||2
105670|NCT01049360|246255|P14|NOT COMPLETED|Period 2||0
105671|NCT01049360|246256|P13|NOT COMPLETED|Period 2||0
105672|NCT01049360|246257|P12|NOT COMPLETED|Period 2||0
105673|NCT01049360|246258|P11|NOT COMPLETED|Period 2||0
105674|NCT01049360|246259|P10|NOT COMPLETED|Period 2||0
105675|NCT01049360|246260|P9|NOT COMPLETED|Period 2||1
105676|NCT01049360|246261|P8|NOT COMPLETED|Period 2||0
105677|NCT01049360|246262|P7|NOT COMPLETED|Period 2||0
105678|NCT01049360|246263|P6|NOT COMPLETED|Period 2||1
105679|NCT01049360|246264|P5|NOT COMPLETED|Period 2||0
105680|NCT01049360|246265|P4|NOT COMPLETED|Period 2||2
105681|NCT01049360|246266|P3|NOT COMPLETED|Period 2||0
105682|NCT01049360|246267|P2|NOT COMPLETED|Period 2||1
105683|NCT01049360|246268|P1|NOT COMPLETED|Period 2||0
105684|NCT01049360|246249|P20|COMPLETED|Period 2||5
105685|NCT01049360|246250|P19|COMPLETED|Period 2||5
105686|NCT01049360|246251|P18|COMPLETED|Period 2||6
105687|NCT01049360|246252|P17|COMPLETED|Period 2||5
105688|NCT01049360|246253|P16|COMPLETED|Period 2||6
105689|NCT01049360|246254|P15|COMPLETED|Period 2||5
105690|NCT01049360|246255|P14|COMPLETED|Period 2||6
105691|NCT01049360|246256|P13|COMPLETED|Period 2||4
105692|NCT01049360|246257|P12|COMPLETED|Period 2||6
105693|NCT01049360|246258|P11|COMPLETED|Period 2||5
105694|NCT01049360|246259|P10|COMPLETED|Period 2||6
105695|NCT01049360|246260|P9|COMPLETED|Period 2||4
105696|NCT01049360|246261|P8|COMPLETED|Period 2||4
105697|NCT01049360|246262|P7|COMPLETED|Period 2||6
105698|NCT01049360|246263|P6|COMPLETED|Period 2||5
105699|NCT01049360|246264|P5|COMPLETED|Period 2||7
105700|NCT01049360|246265|P4|COMPLETED|Period 2||4
105701|NCT01049360|246266|P3|COMPLETED|Period 2||7
105702|NCT01049360|246267|P2|COMPLETED|Period 2||4
105703|NCT01049360|246268|P1|COMPLETED|Period 2||6
105704|NCT01049360|246249|P20|STARTED|Period 2||7
105705|NCT01049360|246250|P19|STARTED|Period 2||5
105706|NCT01049360|246251|P18|STARTED|Period 2||6
105707|NCT01049360|246252|P17|STARTED|Period 2||5
105708|NCT01049360|246253|P16|STARTED|Period 2||7
105709|NCT01049360|246254|P15|STARTED|Period 2||7
105710|NCT01049360|246255|P14|STARTED|Period 2||6
105711|NCT01049360|246256|P13|STARTED|Period 2||4
105712|NCT01049360|246257|P12|STARTED|Period 2||6
105713|NCT01049360|246258|P11|STARTED|Period 2||5
105714|NCT01049360|246259|P10|STARTED|Period 2||6
105715|NCT01049360|246260|P9|STARTED|Period 2||5
105716|NCT01049360|246261|P8|STARTED|Period 2||4
105717|NCT01049360|246262|P7|STARTED|Period 2||6
105718|NCT01049360|246263|P6|STARTED|Period 2||6
105719|NCT01049360|246264|P5|STARTED|Period 2||7
105720|NCT01049360|246265|P4|STARTED|Period 2||6
105721|NCT01049360|246266|P3|STARTED|Period 2||7
105722|NCT01049360|246267|P2|STARTED|Period 2||5
105723|NCT01049360|246268|P1|STARTED|Period 2||6
105724|NCT01049360|246249|P20|NOT COMPLETED|Period 1||0
105725|NCT01049360|246250|P19|NOT COMPLETED|Period 1||1
105726|NCT01049360|246251|P18|NOT COMPLETED|Period 1||0
105727|NCT01049360|246252|P17|NOT COMPLETED|Period 1||1
105728|NCT01049360|246253|P16|NOT COMPLETED|Period 1||0
105729|NCT01049360|246254|P15|NOT COMPLETED|Period 1||0
105730|NCT01049360|246255|P14|NOT COMPLETED|Period 1||1
105731|NCT01049360|246256|P13|NOT COMPLETED|Period 1||2
105732|NCT01049360|246257|P12|NOT COMPLETED|Period 1||0
105733|NCT01049360|246258|P11|NOT COMPLETED|Period 1||1
105734|NCT01049360|246259|P10|NOT COMPLETED|Period 1||0
105735|NCT01049360|246260|P9|NOT COMPLETED|Period 1||2
105736|NCT01049360|246261|P8|NOT COMPLETED|Period 1||2
105737|NCT01049360|246262|P7|NOT COMPLETED|Period 1||0
105738|NCT01049360|246263|P6|NOT COMPLETED|Period 1||0
105739|NCT01049360|246264|P5|NOT COMPLETED|Period 1||0
105740|NCT01049360|246265|P4|NOT COMPLETED|Period 1||1
105741|NCT01049360|246266|P3|NOT COMPLETED|Period 1||0
105742|NCT01049360|246267|P2|NOT COMPLETED|Period 1||1
105743|NCT01049360|246268|P1|NOT COMPLETED|Period 1||0
105744|NCT01049360|246249|P20|COMPLETED|Period 1||7
105745|NCT01049360|246250|P19|COMPLETED|Period 1||5
105746|NCT01049360|246251|P18|COMPLETED|Period 1||6
105747|NCT01049360|246252|P17|COMPLETED|Period 1||5
105748|NCT01049360|246253|P16|COMPLETED|Period 1||7
105749|NCT01049360|246254|P15|COMPLETED|Period 1||7
105750|NCT01049360|246255|P14|COMPLETED|Period 1||6
105751|NCT01049360|246256|P13|COMPLETED|Period 1||4
105752|NCT01049360|246257|P12|COMPLETED|Period 1||6
105753|NCT01049360|246258|P11|COMPLETED|Period 1||5
105754|NCT01049360|246259|P10|COMPLETED|Period 1||6
105755|NCT01049360|246260|P9|COMPLETED|Period 1||5
105756|NCT01049360|246261|P8|COMPLETED|Period 1||4
105757|NCT01049360|246262|P7|COMPLETED|Period 1||6
105758|NCT01049360|246263|P6|COMPLETED|Period 1||6
105759|NCT01049360|246264|P5|COMPLETED|Period 1||7
105760|NCT01049360|246265|P4|COMPLETED|Period 1||6
105761|NCT01049360|246266|P3|COMPLETED|Period 1||7
105762|NCT01049360|246267|P2|COMPLETED|Period 1||5
105763|NCT01049360|246268|P1|COMPLETED|Period 1||6
105764|NCT01049360|246249|P20|STARTED|Period 1||7
105765|NCT01049360|246250|P19|STARTED|Period 1||6
105766|NCT01049360|246251|P18|STARTED|Period 1||6
105767|NCT01049360|246252|P17|STARTED|Period 1||6
105768|NCT01049360|246253|P16|STARTED|Period 1||7
105769|NCT01049360|246254|P15|STARTED|Period 1||7
105770|NCT01049360|246255|P14|STARTED|Period 1||7
105771|NCT01049360|246256|P13|STARTED|Period 1||6
105772|NCT01049360|246257|P12|STARTED|Period 1||6
105773|NCT01049360|246258|P11|STARTED|Period 1||6
105774|NCT01049360|246259|P10|STARTED|Period 1||6
105775|NCT01049360|246260|P9|STARTED|Period 1||7
105776|NCT01049360|246261|P8|STARTED|Period 1||6
105777|NCT01049360|246262|P7|STARTED|Period 1||6
105778|NCT01049360|246263|P6|STARTED|Period 1||6
105779|NCT01049360|246264|P5|STARTED|Period 1||7
105780|NCT01049360|246265|P4|STARTED|Period 1||7
105781|NCT01049360|246266|P3|STARTED|Period 1||7
105782|NCT01049360|246267|P2|STARTED|Period 1||6
105783|NCT01049360|246268|P1|STARTED|Period 1||6
105784|NCT01049308|246290|P1|NOT COMPLETED|Pill Counts||83
105785|NCT01049308|246290|P1|COMPLETED|Pill Counts||168
105786|NCT01049308|246290|P1|STARTED|Pill Counts||251
105787|NCT01049308|246290|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
105788|NCT01049308|246290|P1|COMPLETED|Evaluation of Cognitive Impairment||251
105789|NCT01049308|246290|P1|STARTED|Evaluation of Cognitive Impairment||251
105790|NCT01049243|246297|P1|NOT COMPLETED|Overall Study||2
105791|NCT01049243|246297|P1|COMPLETED|Overall Study||18
105792|NCT01049243|246297|P1|STARTED|Overall Study||20
105793|NCT01049217|246303|P2|NOT COMPLETED|Overall Study||63
105794|NCT01049217|246304|P1|NOT COMPLETED|Overall Study||56
105795|NCT01049217|246303|P2|COMPLETED|Overall Study||131
105796|NCT01049217|246304|P1|COMPLETED|Overall Study||127
105797|NCT01049217|246303|P2|Treated|Overall Study||192
105798|NCT01049217|246304|P1|Treated|Overall Study||183
105799|NCT01049217|246303|P2|STARTED|Overall Study||194
105800|NCT01049217|246304|P1|STARTED|Overall Study||183
105801|NCT01049009|246376|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
105802|NCT01049009|246377|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
105803|NCT01049009|246376|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
105804|NCT01049009|246377|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
105805|NCT01049009|246376|P2|STARTED|Treatment Period 2 (12 Weeks)||18
105806|NCT01049009|246377|P1|STARTED|Treatment Period 2 (12 Weeks)||21
105807|NCT01049009|246376|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
105808|NCT01049009|246377|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
105809|NCT01049009|246376|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
105810|NCT01049009|246377|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
105811|NCT01049009|246376|P2|STARTED|Treatment Period 1 (12 Weeks)||21
105812|NCT01049009|246377|P1|STARTED|Treatment Period 1 (12 Weeks)||23
105813|NCT01048944|246389|P4|NOT COMPLETED|Overall Study||2
105814|NCT01048944|246390|P3|NOT COMPLETED|Overall Study||10
105815|NCT01048944|246391|P2|NOT COMPLETED|Overall Study||10
105816|NCT01048944|246392|P1|NOT COMPLETED|Overall Study||8
105817|NCT01048944|246389|P4|COMPLETED|Overall Study||19
105818|NCT01048944|246390|P3|COMPLETED|Overall Study||25
105819|NCT01048944|246391|P2|COMPLETED|Overall Study||28
105820|NCT01048944|246392|P1|COMPLETED|Overall Study||24
105821|NCT01048944|246389|P4|STARTED|Overall Study||21
105822|NCT01048944|246390|P3|STARTED|Overall Study||35
105823|NCT01048944|246391|P2|STARTED|Overall Study||38
105824|NCT01048944|246392|P1|STARTED|Overall Study||32
105825|NCT01048879|246409|P3|NOT COMPLETED|Overall Study||0
105826|NCT01048879|246410|P2|NOT COMPLETED|Overall Study||0
105827|NCT01048879|246411|P1|NOT COMPLETED|Overall Study||0
105828|NCT01048879|246409|P3|COMPLETED|Overall Study||5
105829|NCT01048879|246410|P2|COMPLETED|Overall Study||9
105830|NCT01048879|246411|P1|COMPLETED|Overall Study||1
105831|NCT01048879|246409|P3|STARTED|Overall Study||5
105832|NCT01048879|246410|P2|STARTED|Overall Study||9
105833|NCT01048879|246411|P1|STARTED|Overall Study||1
105834|NCT01048788|246425|P3|NOT COMPLETED|Overall Study||2
105835|NCT01048788|246426|P2|NOT COMPLETED|Overall Study||2
105836|NCT01048788|246427|P1|NOT COMPLETED|Overall Study||5
105837|NCT01048788|246425|P3|COMPLETED|Overall Study||11
105838|NCT01048788|246426|P2|COMPLETED|Overall Study||28
105839|NCT01048788|246427|P1|COMPLETED|Overall Study||3
105840|NCT01048788|246425|P3|STARTED|Overall Study||13
105841|NCT01048788|246426|P2|STARTED|Overall Study||30
105842|NCT01048788|246427|P1|STARTED|Overall Study||8
105843|NCT01048723|246435|P1|NOT COMPLETED|Overall Study||0
105844|NCT01048723|246435|P1|COMPLETED|Overall Study||2
105845|NCT01048723|246435|P1|STARTED|Overall Study||2
105846|NCT01048697|246442|P1|NOT COMPLETED|Overall Study||0
105847|NCT01048697|246442|P1|COMPLETED|Overall Study||18
105848|NCT01048697|246442|P1|STARTED|Overall Study||18
105849|NCT01048671|246449|P3|NOT COMPLETED|Overall Study||1
105850|NCT01048671|246450|P2|NOT COMPLETED|Overall Study||1
105851|NCT01048671|246451|P1|NOT COMPLETED|Overall Study||0
105852|NCT01048671|246449|P3|COMPLETED|Overall Study||151
105853|NCT01048671|246450|P2|COMPLETED|Overall Study||263
105854|NCT01048671|246451|P1|COMPLETED|Overall Study||66
105855|NCT01048671|246449|P3|STARTED|Overall Study||152
105856|NCT01048671|246450|P2|STARTED|Overall Study||264
105857|NCT01048671|246451|P1|STARTED|Overall Study||66
105858|NCT01048606|246476|P4|NOT COMPLETED|Overall Study||5
105859|NCT01048606|246477|P3|NOT COMPLETED|Overall Study||10
105860|NCT01048606|246478|P2|NOT COMPLETED|Overall Study||7
105861|NCT01048606|246479|P1|NOT COMPLETED|Overall Study||12
105862|NCT01048606|246476|P4|COMPLETED|Overall Study||5
105863|NCT01048606|246477|P3|COMPLETED|Overall Study||16
105864|NCT01048606|246478|P2|COMPLETED|Overall Study||8
105865|NCT01048606|246479|P1|COMPLETED|Overall Study||16
105866|NCT01048606|246476|P4|STARTED|Overall Study||10
105867|NCT01048606|246477|P3|STARTED|Overall Study||26
105868|NCT01048606|246478|P2|STARTED|Overall Study||15
105869|NCT01048606|246479|P1|STARTED|Overall Study||28
105870|NCT01048593|246492|P3|NOT COMPLETED|Overall Study||0
105871|NCT01048593|246493|P2|NOT COMPLETED|Overall Study||0
105872|NCT01048593|246494|P1|NOT COMPLETED|Overall Study||0
105873|NCT01048593|246492|P3|COMPLETED|Overall Study||1
105874|NCT01048593|246493|P2|COMPLETED|Overall Study||2
105875|NCT01048593|246494|P1|COMPLETED|Overall Study||3
105876|NCT01048593|246492|P3|STARTED|Overall Study||1
105877|NCT01048593|246493|P2|STARTED|Overall Study||2
105878|NCT01048593|246494|P1|STARTED|Overall Study||3
105879|NCT01048541|246502|P2|NOT COMPLETED|Overall Study||0
105880|NCT01048541|246503|P1|NOT COMPLETED|Overall Study||1
105881|NCT01048541|246502|P2|COMPLETED|Overall Study||19
105882|NCT01048541|246503|P1|COMPLETED|Overall Study||17
105883|NCT01048541|246502|P2|STARTED|Overall Study||19
105884|NCT01048541|246503|P1|STARTED|Overall Study||18
105885|NCT01048502|246513|P4|NOT COMPLETED|Overall Study||4
105886|NCT01048502|246514|P3|NOT COMPLETED|Overall Study||5
105887|NCT01048502|246515|P2|NOT COMPLETED|Overall Study||7
105888|NCT01048502|246516|P1|NOT COMPLETED|Overall Study||4
105889|NCT01048502|246513|P4|COMPLETED|Overall Study||21
105890|NCT01048502|246514|P3|COMPLETED|Overall Study||23
105891|NCT01048502|246515|P2|COMPLETED|Overall Study||16
105892|NCT01048502|246516|P1|COMPLETED|Overall Study||20
105893|NCT01048502|246513|P4|STARTED|Overall Study||25
105894|NCT01048502|246514|P3|STARTED|Overall Study||28
105895|NCT01048502|246515|P2|STARTED|Overall Study||23
105896|NCT01048502|246516|P1|STARTED|Overall Study||24
105897|NCT01048424|246529|P2|NOT COMPLETED|Overall Study||0
105898|NCT01048424|246530|P1|NOT COMPLETED|Overall Study||2
105899|NCT01048424|246529|P2|COMPLETED|Overall Study||10
105900|NCT01048424|246530|P1|COMPLETED|Overall Study||8
105901|NCT01048424|246529|P2|STARTED|Overall Study||10
105902|NCT01048424|246530|P1|STARTED|Overall Study||10
105903|NCT01048333|246552|P6|NOT COMPLETED|Treatment Period 3||0
105904|NCT01048333|246553|P5|NOT COMPLETED|Treatment Period 3||0
105905|NCT01048333|246554|P4|NOT COMPLETED|Treatment Period 3||0
105906|NCT01048333|246555|P3|NOT COMPLETED|Treatment Period 3||0
105907|NCT01048333|246556|P2|NOT COMPLETED|Treatment Period 3||0
105908|NCT01048333|246557|P1|NOT COMPLETED|Treatment Period 3||0
105909|NCT01048333|246552|P6|COMPLETED|Treatment Period 3||18
105910|NCT01048333|246553|P5|COMPLETED|Treatment Period 3||17
105911|NCT01048333|246554|P4|COMPLETED|Treatment Period 3||18
105912|NCT01048333|246555|P3|COMPLETED|Treatment Period 3||16
105913|NCT01048333|246556|P2|COMPLETED|Treatment Period 3||18
105914|NCT01048333|246557|P1|COMPLETED|Treatment Period 3||21
105915|NCT01048333|246552|P6|STARTED|Treatment Period 3||18
105916|NCT01048333|246553|P5|STARTED|Treatment Period 3||17
105917|NCT01048333|246554|P4|STARTED|Treatment Period 3||18
105918|NCT01048333|246555|P3|STARTED|Treatment Period 3||16
105919|NCT01048333|246556|P2|STARTED|Treatment Period 3||18
105920|NCT01048333|246557|P1|STARTED|Treatment Period 3||21
105921|NCT01048333|246552|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
105922|NCT01048333|246553|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
105923|NCT01048333|246554|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
105924|NCT01048333|246555|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
105925|NCT01048333|246556|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
105926|NCT01048333|246557|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
105927|NCT01048333|246552|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
105928|NCT01048333|246553|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
105929|NCT01048333|246554|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
105930|NCT01048333|246555|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
105931|NCT01048333|246556|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
105932|NCT01048333|246557|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
105933|NCT01048333|246552|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
105934|NCT01048333|246553|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
105935|NCT01048333|246554|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
105936|NCT01048333|246555|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
105937|NCT01048333|246556|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
105938|NCT01048333|246557|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
105939|NCT01048333|246552|P6|NOT COMPLETED|Treatment Period 2||0
105940|NCT01048333|246553|P5|NOT COMPLETED|Treatment Period 2||0
105941|NCT01048333|246554|P4|NOT COMPLETED|Treatment Period 2||0
105942|NCT01048333|246555|P3|NOT COMPLETED|Treatment Period 2||0
105943|NCT01048333|246556|P2|NOT COMPLETED|Treatment Period 2||0
105944|NCT01048333|246557|P1|NOT COMPLETED|Treatment Period 2||0
105945|NCT01048333|246552|P6|COMPLETED|Treatment Period 2||18
105946|NCT01048333|246553|P5|COMPLETED|Treatment Period 2||17
105947|NCT01048333|246554|P4|COMPLETED|Treatment Period 2||18
105948|NCT01048333|246555|P3|COMPLETED|Treatment Period 2||16
105949|NCT01048333|246556|P2|COMPLETED|Treatment Period 2||19
105950|NCT01048333|246557|P1|COMPLETED|Treatment Period 2||21
105951|NCT01048333|246552|P6|STARTED|Treatment Period 2||18
105952|NCT01048333|246553|P5|STARTED|Treatment Period 2||17
105953|NCT01048333|246554|P4|STARTED|Treatment Period 2||18
105954|NCT01048333|246555|P3|STARTED|Treatment Period 2||16
105955|NCT01048333|246556|P2|STARTED|Treatment Period 2||19
105956|NCT01048333|246557|P1|STARTED|Treatment Period 2||21
105957|NCT01048333|246552|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105958|NCT01048333|246553|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105959|NCT01048333|246554|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105960|NCT01048333|246555|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105961|NCT01048333|246556|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105962|NCT01048333|246557|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
105963|NCT01048333|246552|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
105964|NCT01048333|246553|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
105965|NCT01048333|246554|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
105966|NCT01048333|246555|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
105967|NCT01048333|246556|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
105968|NCT01048333|246557|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
105969|NCT01048333|246552|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
105970|NCT01048333|246553|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
105971|NCT01048333|246554|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
105972|NCT01048333|246555|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
105973|NCT01048333|246556|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
105974|NCT01048333|246557|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
105975|NCT01048333|246552|P6|NOT COMPLETED|Treatment Period 1||0
105976|NCT01048333|246553|P5|NOT COMPLETED|Treatment Period 1||0
105977|NCT01048333|246554|P4|NOT COMPLETED|Treatment Period 1||0
105978|NCT01048333|246555|P3|NOT COMPLETED|Treatment Period 1||0
105979|NCT01048333|246556|P2|NOT COMPLETED|Treatment Period 1||0
105980|NCT01048333|246557|P1|NOT COMPLETED|Treatment Period 1||0
105981|NCT01048333|246552|P6|COMPLETED|Treatment Period 1||18
105982|NCT01048333|246553|P5|COMPLETED|Treatment Period 1||17
105983|NCT01048333|246554|P4|COMPLETED|Treatment Period 1||18
105984|NCT01048333|246555|P3|COMPLETED|Treatment Period 1||16
105985|NCT01048333|246556|P2|COMPLETED|Treatment Period 1||19
105986|NCT01048333|246557|P1|COMPLETED|Treatment Period 1||21
105987|NCT01048333|246552|P6|STARTED|Treatment Period 1||18
105988|NCT01048333|246553|P5|STARTED|Treatment Period 1||17
105989|NCT01048333|246554|P4|STARTED|Treatment Period 1||18
105990|NCT01048333|246555|P3|STARTED|Treatment Period 1||16
105991|NCT01048333|246556|P2|STARTED|Treatment Period 1||19
105992|NCT01048333|246557|P1|STARTED|Treatment Period 1||21
105993|NCT01048125|246579|P2|NOT COMPLETED|Overall Study||0
105994|NCT01048125|246580|P1|NOT COMPLETED|Overall Study||0
105995|NCT01048125|246579|P2|COMPLETED|Overall Study||0
105996|NCT01048125|246580|P1|COMPLETED|Overall Study||0
105997|NCT01048125|246579|P2|STARTED|Overall Study||0
105998|NCT01048125|246580|P1|STARTED|Overall Study||0
105999|NCT01048099|246586|P1|NOT COMPLETED|Treatment Per Protocol||14
106000|NCT01048099|246586|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
106001|NCT01048099|246586|P1|STARTED|Treatment Per Protocol||14
106002|NCT01048099|246586|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
106003|NCT01048099|246586|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
106004|NCT01048099|246586|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
106005|NCT01048099|246586|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
106006|NCT01048099|246586|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
106007|NCT01048099|246586|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
106008|NCT01048099|246586|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
106009|NCT01048099|246586|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
106010|NCT01048099|246586|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
106011|NCT01047839|246597|P3|NOT COMPLETED|Overall Study||6
106012|NCT01047839|246598|P2|NOT COMPLETED|Overall Study||0
106013|NCT01047839|246599|P1|NOT COMPLETED|Overall Study||2
106014|NCT01047839|246597|P3|COMPLETED|Overall Study||53
106015|NCT01047839|246598|P2|COMPLETED|Overall Study||29
106016|NCT01047839|246599|P1|COMPLETED|Overall Study||10
106017|NCT01047839|246597|P3|STARTED|Overall Study||59
106018|NCT01047839|246598|P2|STARTED|Overall Study||29
106019|NCT01047839|246599|P1|STARTED|Overall Study||12
106020|NCT01047709|246607|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
106021|NCT01047709|246608|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
106022|NCT01047709|246607|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
106023|NCT01047709|246608|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
106024|NCT01047709|246607|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
106025|NCT01047709|246608|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
106026|NCT01047709|246607|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
106027|NCT01047709|246608|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
106028|NCT01047709|246607|P2|COMPLETED|Positional Therapy (1 Night)||9
106029|NCT01047709|246608|P1|COMPLETED|Positional Therapy (1 Night)||9
106030|NCT01047709|246607|P2|STARTED|Positional Therapy (1 Night)||9
106031|NCT01047709|246608|P1|STARTED|Positional Therapy (1 Night)||9
106032|NCT01047553|246616|P2|NOT COMPLETED|Overall Study||9
106033|NCT01047553|246617|P1|NOT COMPLETED|Overall Study||17
106034|NCT01047553|246616|P2|COMPLETED|Overall Study||117
106035|NCT01047553|246617|P1|COMPLETED|Overall Study||108
106036|NCT01047553|246616|P2|STARTED|Overall Study||126
106037|NCT01047553|246617|P1|STARTED|Overall Study||125
106038|NCT01047527|246702|P3|NOT COMPLETED|Overall Study||65
106039|NCT01047527|246703|P2|NOT COMPLETED|Overall Study||61
106040|NCT01047527|246704|P1|NOT COMPLETED|Overall Study||85
106041|NCT01047527|246702|P3|COMPLETED|Overall Study||107
106042|NCT01047527|246703|P2|COMPLETED|Overall Study||112
106043|NCT01047527|246704|P1|COMPLETED|Overall Study||95
106044|NCT01047527|246702|P3|24 Weeks|Overall Study||119
106045|NCT01047527|246703|P2|24 Weeks|Overall Study||123
106046|NCT01047527|246704|P1|24 Weeks|Overall Study||111
106047|NCT01047527|246702|P3|8 Weeks|Overall Study||138
106048|NCT01047527|246703|P2|8 Weeks|Overall Study||142
106049|NCT01047527|246704|P1|8 Weeks|Overall Study||148
106050|NCT01047527|246702|P3|STARTED|Overall Study||172
106051|NCT01047527|246703|P2|STARTED|Overall Study||173
106052|NCT01047527|246704|P1|STARTED|Overall Study||180
106053|NCT01047475|246715|P2|NOT COMPLETED|Overall Study||7
106054|NCT01047475|246716|P1|NOT COMPLETED|Overall Study||5
106055|NCT01047475|246715|P2|COMPLETED|Overall Study||31
106056|NCT01047475|246716|P1|COMPLETED|Overall Study||29
106057|NCT01047475|246715|P2|STARTED|Overall Study||38
106058|NCT01047475|246716|P1|STARTED|Overall Study||34
106059|NCT01047436|246724|P2|NOT COMPLETED|Overall Study||0
106060|NCT01047436|246725|P1|NOT COMPLETED|Overall Study||1
106061|NCT01047436|246724|P2|COMPLETED|Overall Study||15
106062|NCT01047436|246725|P1|COMPLETED|Overall Study||15
106063|NCT01047436|246724|P2|STARTED|Overall Study||15
106064|NCT01047436|246725|P1|STARTED|Overall Study||16
106065|NCT01047358|246741|P1|NOT COMPLETED|Overall Study||0
106066|NCT01047358|246741|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
106067|NCT01047358|246741|P1|STARTED|Overall Study||206
106068|NCT01047345|246750|P3|NOT COMPLETED|Extension||6
106069|NCT01047345|246751|P2|NOT COMPLETED|Extension||0
106070|NCT01047345|246752|P1|NOT COMPLETED|Extension||0
106071|NCT01047345|246750|P3|COMPLETED|Extension||96
106072|NCT01047345|246751|P2|COMPLETED|Extension||0
106073|NCT01047345|246752|P1|COMPLETED|Extension||0
106074|NCT01047345|246750|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
106075|NCT01047345|246751|P2|Vaccination 6|Extension||0
106076|NCT01047345|246752|P1|Vaccination 6|Extension||0
106077|NCT01047345|246750|P3|Vaccination 5|Extension||99
106078|NCT01047345|246751|P2|Vaccination 5|Extension||0
106079|NCT01047345|246752|P1|Vaccination 5|Extension||0
106080|NCT01047345|246750|P3|Vaccination 4|Extension||102
106081|NCT01047345|246751|P2|Vaccination 4|Extension||0
106082|NCT01047345|246752|P1|Vaccination 4|Extension||0
106083|NCT01047345|246750|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
106084|NCT01047345|246751|P2|STARTED|Extension||0
106085|NCT01047345|246752|P1|STARTED|Extension||0
106086|NCT01047345|246750|P3|NOT COMPLETED|Base Study||0
106087|NCT01047345|246751|P2|NOT COMPLETED|Base Study||6
106088|NCT01047345|246752|P1|NOT COMPLETED|Base Study||22
106089|NCT01047345|246750|P3|COMPLETED|Base Study||0
106090|NCT01047345|246751|P2|COMPLETED|Base Study||300
106091|NCT01047345|246752|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
106092|NCT01047345|246750|P3|Vaccination 3|Base Study||0
106093|NCT01047345|246751|P2|Vaccination 3|Base Study||300
106094|NCT01047345|246752|P1|Vaccination 3|Base Study||597
106095|NCT01047345|246750|P3|Vaccination 2|Base Study||0
106096|NCT01047345|246751|P2|Vaccination 2|Base Study||304
106097|NCT01047345|246752|P1|Vaccination 2|Base Study||604
106098|NCT01047345|246750|P3|Vaccination 1|Base Study||0
106099|NCT01047345|246751|P2|Vaccination 1|Base Study||306
106100|NCT01047345|246752|P1|Vaccination 1|Base Study||615
106101|NCT01047345|246750|P3|STARTED|Base Study||0
106102|NCT01047345|246751|P2|STARTED|Base Study||306
106103|NCT01047345|246752|P1|STARTED|Base Study||618
106104|NCT01047306|246774|P2|NOT COMPLETED|Overall Study||0
106105|NCT01047306|246775|P1|NOT COMPLETED|Overall Study||3
106106|NCT01047306|246774|P2|COMPLETED|Overall Study||6
106107|NCT01047306|246775|P1|COMPLETED|Overall Study||16
106108|NCT01047306|246774|P2|Discontinued From the Study|Overall Study||0
106109|NCT01047306|246775|P1|Discontinued From the Study|Overall Study||3
106110|NCT01047306|246774|P2|STARTED|Overall Study||6
106111|NCT01047306|246775|P1|STARTED|Overall Study||19
106112|NCT01047241|246849|P1|NOT COMPLETED|Overall Study||0
106113|NCT01047241|246849|P1|COMPLETED|Overall Study||50
106114|NCT01047241|246849|P1|STARTED|Overall Study||50
106115|NCT01047189|246860|P2|NOT COMPLETED|Overall Study||0
106116|NCT01047189|246861|P1|NOT COMPLETED|Overall Study||4
106117|NCT01047189|246860|P2|COMPLETED|Overall Study||13
106118|NCT01047189|246861|P1|COMPLETED|Overall Study||9
106119|NCT01047189|246860|P2|STARTED|Overall Study||13
106120|NCT01047189|246861|P1|STARTED|Overall Study||13
106121|NCT01046903|246869|P1|NOT COMPLETED|Overall Study||28
106122|NCT01046903|246869|P1|COMPLETED|Overall Study||475
106123|NCT01046903|246869|P1|STARTED|Overall Study||503
106124|NCT01046877|246882|P1|NOT COMPLETED|Overall Study||18
106125|NCT01046877|246882|P1|COMPLETED|Overall Study||7
106126|NCT01046877|246882|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
106127|NCT01046877|246882|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
106128|NCT01046877|246882|P1|STARTED|Overall Study||25
106129|NCT01046695|246898|P2|NOT COMPLETED|Overall Study||2
106130|NCT01046695|246899|P1|NOT COMPLETED|Overall Study||0
106131|NCT01046695|246898|P2|COMPLETED|Overall Study||20
106132|NCT01046695|246899|P1|COMPLETED|Overall Study||20
106133|NCT01046695|246898|P2|STARTED|Overall Study||22
106134|NCT01046695|246899|P1|STARTED|Overall Study||20
106135|NCT01046682|246911|P2|NOT COMPLETED|Overall Study||0
106136|NCT01046682|246912|P1|NOT COMPLETED|Overall Study||2
106137|NCT01046682|246911|P2|COMPLETED|Overall Study||20
106138|NCT01046682|246912|P1|COMPLETED|Overall Study||18
106139|NCT01046682|246911|P2|STARTED|Overall Study||20
106140|NCT01046682|246912|P1|STARTED|Overall Study||20
106141|NCT01046643|246920|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
106142|NCT01046643|246921|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
106143|NCT01046643|246922|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
106144|NCT01046643|246923|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
106145|NCT01046643|246920|P4|COMPLETED|Second Period Treatment or Placebo||7
106146|NCT01046643|246921|P3|COMPLETED|Second Period Treatment or Placebo||7
106147|NCT01046643|246922|P2|COMPLETED|Second Period Treatment or Placebo||6
106148|NCT01046643|246923|P1|COMPLETED|Second Period Treatment or Placebo||9
106149|NCT01046643|246920|P4|STARTED|Second Period Treatment or Placebo||7
106150|NCT01046643|246921|P3|STARTED|Second Period Treatment or Placebo||7
106151|NCT01046643|246922|P2|STARTED|Second Period Treatment or Placebo||6
106152|NCT01046643|246923|P1|STARTED|Second Period Treatment or Placebo||9
106153|NCT01046643|246920|P4|NOT COMPLETED|Washout Period||0
106154|NCT01046643|246921|P3|NOT COMPLETED|Washout Period||0
106155|NCT01046643|246922|P2|NOT COMPLETED|Washout Period||0
106156|NCT01046643|246923|P1|NOT COMPLETED|Washout Period||0
106157|NCT01046643|246920|P4|COMPLETED|Washout Period||7
106158|NCT01046643|246921|P3|COMPLETED|Washout Period||7
106159|NCT01046643|246922|P2|COMPLETED|Washout Period||6
106160|NCT01046643|246923|P1|COMPLETED|Washout Period||9
106161|NCT01046643|246920|P4|STARTED|Washout Period||7
106162|NCT01046643|246921|P3|STARTED|Washout Period||7
106163|NCT01046643|246922|P2|STARTED|Washout Period||6
106164|NCT01046643|246923|P1|STARTED|Washout Period||9
106165|NCT01046643|246920|P4|NOT COMPLETED|First Period Treatment or Placebo||0
106166|NCT01046643|246921|P3|NOT COMPLETED|First Period Treatment or Placebo||0
106167|NCT01046643|246922|P2|NOT COMPLETED|First Period Treatment or Placebo||1
106168|NCT01046643|246923|P1|NOT COMPLETED|First Period Treatment or Placebo||0
106169|NCT01046643|246920|P4|COMPLETED|First Period Treatment or Placebo||7
106170|NCT01046643|246921|P3|COMPLETED|First Period Treatment or Placebo||7
106171|NCT01046643|246922|P2|COMPLETED|First Period Treatment or Placebo||6
106172|NCT01046643|246923|P1|COMPLETED|First Period Treatment or Placebo||9
106173|NCT01046643|246920|P4|STARTED|First Period Treatment or Placebo||7
106174|NCT01046643|246921|P3|STARTED|First Period Treatment or Placebo||7
106175|NCT01046643|246922|P2|STARTED|First Period Treatment or Placebo||7
106176|NCT01046643|246923|P1|STARTED|First Period Treatment or Placebo||9
106177|NCT01046565|246945|P1|NOT COMPLETED|Overall Study||9
106178|NCT01046565|246945|P1|COMPLETED|Overall Study||66
106179|NCT01046565|246945|P1|STARTED|Overall Study||75
106180|NCT01046396|246954|P1|NOT COMPLETED|Overall Study||5
106181|NCT01046396|246954|P1|COMPLETED|Overall Study||64
106182|NCT01046396|246954|P1|STARTED|Overall Study||69
106183|NCT01046253|246965|P2|NOT COMPLETED|Fourth Intervention||0
106184|NCT01046253|246966|P1|NOT COMPLETED|Fourth Intervention||0
106185|NCT01046253|246965|P2|COMPLETED|Fourth Intervention||23
106186|NCT01046253|246966|P1|COMPLETED|Fourth Intervention||25
106187|NCT01046253|246965|P2|STARTED|Fourth Intervention||23
106188|NCT01046253|246966|P1|STARTED|Fourth Intervention||25
106189|NCT01046253|246965|P2|NOT COMPLETED|Third Washout of 7 Days||0
106190|NCT01046253|246966|P1|NOT COMPLETED|Third Washout of 7 Days||0
106191|NCT01046253|246965|P2|COMPLETED|Third Washout of 7 Days||23
106192|NCT01046253|246966|P1|COMPLETED|Third Washout of 7 Days||25
106193|NCT01046253|246965|P2|STARTED|Third Washout of 7 Days||23
106194|NCT01046253|246966|P1|STARTED|Third Washout of 7 Days||25
106195|NCT01046253|246965|P2|NOT COMPLETED|Third Intervention||0
106196|NCT01046253|246966|P1|NOT COMPLETED|Third Intervention||0
106197|NCT01046253|246965|P2|COMPLETED|Third Intervention||23
106198|NCT01046253|246966|P1|COMPLETED|Third Intervention||25
106199|NCT01046253|246965|P2|STARTED|Third Intervention||23
106200|NCT01046253|246966|P1|STARTED|Third Intervention||25
106201|NCT01046253|246965|P2|NOT COMPLETED|Second Washout of 7 Days||0
106202|NCT01046253|246966|P1|NOT COMPLETED|Second Washout of 7 Days||0
106203|NCT01046253|246965|P2|COMPLETED|Second Washout of 7 Days||23
106204|NCT01046253|246966|P1|COMPLETED|Second Washout of 7 Days||25
106205|NCT01046253|246965|P2|STARTED|Second Washout of 7 Days||23
106206|NCT01046253|246966|P1|STARTED|Second Washout of 7 Days||25
106207|NCT01046253|246965|P2|NOT COMPLETED|Second Intervention||2
106208|NCT01046253|246966|P1|NOT COMPLETED|Second Intervention||0
106209|NCT01046253|246965|P2|COMPLETED|Second Intervention||23
106210|NCT01046253|246966|P1|COMPLETED|Second Intervention||25
106211|NCT01046253|246965|P2|STARTED|Second Intervention||25
106212|NCT01046253|246966|P1|STARTED|Second Intervention||25
106213|NCT01046253|246965|P2|NOT COMPLETED|First Washout of 7 Days||0
106214|NCT01046253|246966|P1|NOT COMPLETED|First Washout of 7 Days||0
106215|NCT01046253|246965|P2|COMPLETED|First Washout of 7 Days||25
106216|NCT01046253|246966|P1|COMPLETED|First Washout of 7 Days||25
106217|NCT01046253|246965|P2|STARTED|First Washout of 7 Days||25
106218|NCT01046253|246966|P1|STARTED|First Washout of 7 Days||25
106219|NCT01046253|246965|P2|NOT COMPLETED|First Intervention||0
106220|NCT01046253|246966|P1|NOT COMPLETED|First Intervention||0
106221|NCT01046253|246965|P2|COMPLETED|First Intervention||25
106222|NCT01046253|246966|P1|COMPLETED|First Intervention||25
106223|NCT01046253|246965|P2|STARTED|First Intervention||25
106224|NCT01046253|246966|P1|STARTED|First Intervention||25
106225|NCT01046136|246978|P2|NOT COMPLETED|Overall Study||8
106226|NCT01046136|246979|P1|NOT COMPLETED|Overall Study||4
106227|NCT01046136|246978|P2|COMPLETED|Overall Study||182
106228|NCT01046136|246979|P1|COMPLETED|Overall Study||184
106229|NCT01046136|246978|P2|STARTED|Overall Study||190
106230|NCT01046136|246979|P1|STARTED|Overall Study||188
106231|NCT01046110|246991|P2|NOT COMPLETED|Overall Study||55
106232|NCT01046110|246992|P1|NOT COMPLETED|Overall Study||55
106233|NCT01046110|246991|P2|COMPLETED|Overall Study||174
106234|NCT01046110|246992|P1|COMPLETED|Overall Study||174
106235|NCT01046110|246991|P2|Exposed|Overall Study|1 subject was randomised in error|228
106236|NCT01046110|246992|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
106237|NCT01046110|246991|P2|STARTED|Overall Study||229
106238|NCT01046110|246992|P1|STARTED|Overall Study||229
106239|NCT01046084|247002|P2|NOT COMPLETED|Fourth Intervention||0
106240|NCT01046084|247003|P1|NOT COMPLETED|Fourth Intervention||0
106241|NCT01046084|247002|P2|COMPLETED|Fourth Intervention||25
106242|NCT01046084|247003|P1|COMPLETED|Fourth Intervention||23
106243|NCT01046084|247002|P2|STARTED|Fourth Intervention||25
106244|NCT01046084|247003|P1|STARTED|Fourth Intervention||23
106245|NCT01046084|247002|P2|NOT COMPLETED|Third Washout of 7 Days||0
106246|NCT01046084|247003|P1|NOT COMPLETED|Third Washout of 7 Days||2
106247|NCT01046084|247002|P2|COMPLETED|Third Washout of 7 Days||25
106248|NCT01046084|247003|P1|COMPLETED|Third Washout of 7 Days||23
106249|NCT01046084|247002|P2|STARTED|Third Washout of 7 Days||25
106250|NCT01046084|247003|P1|STARTED|Third Washout of 7 Days||25
106251|NCT01046084|247002|P2|NOT COMPLETED|Third Intervention||0
106252|NCT01046084|247003|P1|NOT COMPLETED|Third Intervention||0
106253|NCT01046084|247002|P2|COMPLETED|Third Intervention||25
106254|NCT01046084|247003|P1|COMPLETED|Third Intervention||25
106255|NCT01046084|247002|P2|STARTED|Third Intervention||25
106256|NCT01046084|247003|P1|STARTED|Third Intervention||25
106257|NCT01046084|247002|P2|NOT COMPLETED|Second Washout of 7 Days||0
106258|NCT01046084|247003|P1|NOT COMPLETED|Second Washout of 7 Days||0
106259|NCT01046084|247002|P2|COMPLETED|Second Washout of 7 Days||25
106260|NCT01046084|247003|P1|COMPLETED|Second Washout of 7 Days||25
106261|NCT01046084|247002|P2|STARTED|Second Washout of 7 Days||25
106262|NCT01046084|247003|P1|STARTED|Second Washout of 7 Days||25
106263|NCT01046084|247002|P2|NOT COMPLETED|Second Intervention||0
106264|NCT01046084|247003|P1|NOT COMPLETED|Second Intervention||0
106265|NCT01046084|247002|P2|COMPLETED|Second Intervention||25
106266|NCT01046084|247003|P1|COMPLETED|Second Intervention||25
106267|NCT01046084|247002|P2|STARTED|Second Intervention||25
106268|NCT01046084|247003|P1|STARTED|Second Intervention||25
106269|NCT01046084|247002|P2|NOT COMPLETED|First Washout of 7 Days||0
106270|NCT01046084|247003|P1|NOT COMPLETED|First Washout of 7 Days||0
106271|NCT01046084|247002|P2|COMPLETED|First Washout of 7 Days||25
106272|NCT01046084|247003|P1|COMPLETED|First Washout of 7 Days||25
106273|NCT01046084|247002|P2|STARTED|First Washout of 7 Days||25
106274|NCT01046084|247003|P1|STARTED|First Washout of 7 Days||25
106275|NCT01046084|247002|P2|NOT COMPLETED|First Intervention||0
106276|NCT01046084|247003|P1|NOT COMPLETED|First Intervention||0
106277|NCT01046084|247002|P2|COMPLETED|First Intervention||25
106278|NCT01046084|247003|P1|COMPLETED|First Intervention||25
106279|NCT01046084|247002|P2|STARTED|First Intervention||25
106280|NCT01046084|247003|P1|STARTED|First Intervention||25
106281|NCT01045993|247017|P4|NOT COMPLETED|Overall Study||0
106282|NCT01045993|247018|P3|NOT COMPLETED|Overall Study||0
106283|NCT01045993|247019|P2|NOT COMPLETED|Overall Study||1
106284|NCT01045993|247020|P1|NOT COMPLETED|Overall Study||0
106285|NCT01045993|247017|P4|COMPLETED|Overall Study||25
106286|NCT01045993|247018|P3|COMPLETED|Overall Study||5
106287|NCT01045993|247019|P2|COMPLETED|Overall Study||4
106288|NCT01045993|247020|P1|COMPLETED|Overall Study||26
106289|NCT01045993|247017|P4|STARTED|Overall Study||25
106290|NCT01045993|247018|P3|STARTED|Overall Study||5
106291|NCT01045993|247019|P2|STARTED|Overall Study||5
106292|NCT01045993|247020|P1|STARTED|Overall Study||26
106293|NCT01045967|247096|P2|NOT COMPLETED|Second Intervention||1
106294|NCT01045967|247097|P1|NOT COMPLETED|Second Intervention||0
106295|NCT01045967|247096|P2|COMPLETED|Second Intervention||27
106296|NCT01045967|247097|P1|COMPLETED|Second Intervention||28
106297|NCT01045967|247096|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
106298|NCT01045967|247097|P1|STARTED|Second Intervention||28
106299|NCT01045967|247096|P2|NOT COMPLETED|Washout of 7 Days||0
106300|NCT01045967|247097|P1|NOT COMPLETED|Washout of 7 Days||0
106301|NCT01045967|247096|P2|COMPLETED|Washout of 7 Days||28
106302|NCT01045967|247097|P1|COMPLETED|Washout of 7 Days||28
106303|NCT01045967|247096|P2|STARTED|Washout of 7 Days||28
106304|NCT01045967|247097|P1|STARTED|Washout of 7 Days||28
106305|NCT01045967|247096|P2|NOT COMPLETED|First Intervention||0
106306|NCT01045967|247097|P1|NOT COMPLETED|First Intervention||0
106307|NCT01045967|247096|P2|COMPLETED|First Intervention||28
106308|NCT01045967|247097|P1|COMPLETED|First Intervention||28
106309|NCT01045967|247096|P2|STARTED|First Intervention||28
106310|NCT01045967|247097|P1|STARTED|First Intervention||28
106311|NCT01045798|247109|P2|NOT COMPLETED|Overall Study||4
106312|NCT01045798|247110|P1|NOT COMPLETED|Overall Study||2
106313|NCT01045798|247109|P2|COMPLETED|Overall Study||5
106314|NCT01045798|247110|P1|COMPLETED|Overall Study||4
106315|NCT01045798|247109|P2|STARTED|Overall Study||9
106316|NCT01045798|247110|P1|STARTED|Overall Study||6
106317|NCT01045707|247118|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
106318|NCT01045707|247119|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
106319|NCT01045707|247118|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
106320|NCT01045707|247119|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
106321|NCT01045707|247118|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
106322|NCT01045707|247119|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
106323|NCT01045707|247118|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
106324|NCT01045707|247119|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
106325|NCT01045707|247118|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
106326|NCT01045707|247119|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
106327|NCT01045707|247118|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
106328|NCT01045707|247119|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
106329|NCT01045707|247118|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
106330|NCT01045707|247119|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
106331|NCT01045551|247135|P1|NOT COMPLETED|Overall Study||0
106332|NCT01045551|247135|P1|COMPLETED|Overall Study||10
106333|NCT01045551|247135|P1|STARTED|Overall Study||10
106334|NCT01045447|247145|P2|NOT COMPLETED|Overall Study||28
106335|NCT01045447|247146|P1|NOT COMPLETED|Overall Study||36
106336|NCT01045447|247145|P2|COMPLETED|Overall Study||205
106337|NCT01045447|247146|P1|COMPLETED|Overall Study||196
106338|NCT01045447|247145|P2|Exposed|Overall Study||233
106339|NCT01045447|247146|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
106340|NCT01045447|247145|P2|STARTED|Overall Study||233
106341|NCT01045447|247146|P1|STARTED|Overall Study||232
106342|NCT01045421|247160|P11|NOT COMPLETED|Phase 2||2
106343|NCT01045421|247161|P10|NOT COMPLETED|Phase 2||3
106344|NCT01045421|247162|P9|NOT COMPLETED|Phase 2||2
106345|NCT01045421|247163|P8|NOT COMPLETED|Phase 2||5
106346|NCT01045421|247164|P7|NOT COMPLETED|Phase 2||0
106347|NCT01045421|247165|P6|NOT COMPLETED|Phase 2||0
106348|NCT01045421|247166|P5|NOT COMPLETED|Phase 2||0
106349|NCT01045421|247167|P4|NOT COMPLETED|Phase 2||0
106350|NCT01045421|247168|P3|NOT COMPLETED|Phase 2||0
106351|NCT01045421|247169|P2|NOT COMPLETED|Phase 2||0
106352|NCT01045421|247170|P1|NOT COMPLETED|Phase 2||0
106353|NCT01045421|247160|P11|COMPLETED|Phase 2||58
106354|NCT01045421|247161|P10|COMPLETED|Phase 2||23
106355|NCT01045421|247162|P9|COMPLETED|Phase 2||53
106356|NCT01045421|247163|P8|COMPLETED|Phase 2||50
106357|NCT01045421|247164|P7|COMPLETED|Phase 2||53
106358|NCT01045421|247165|P6|COMPLETED|Phase 2||0
106359|NCT01045421|247166|P5|COMPLETED|Phase 2||0
106360|NCT01045421|247167|P4|COMPLETED|Phase 2||0
106361|NCT01045421|247168|P3|COMPLETED|Phase 2||0
106362|NCT01045421|247169|P2|COMPLETED|Phase 2||0
106363|NCT01045421|247170|P1|COMPLETED|Phase 2||0
106364|NCT01045421|247160|P11|STARTED|Phase 2||60
106365|NCT01045421|247161|P10|STARTED|Phase 2||26
106366|NCT01045421|247162|P9|STARTED|Phase 2||55
106367|NCT01045421|247163|P8|STARTED|Phase 2||55
106368|NCT01045421|247164|P7|STARTED|Phase 2||53
106369|NCT01045421|247165|P6|STARTED|Phase 2||0
106370|NCT01045421|247166|P5|STARTED|Phase 2||0
106371|NCT01045421|247167|P4|STARTED|Phase 2||0
106372|NCT01045421|247168|P3|STARTED|Phase 2||0
106373|NCT01045421|247169|P2|STARTED|Phase 2||0
106374|NCT01045421|247170|P1|STARTED|Phase 2||0
106375|NCT01045421|247160|P11|NOT COMPLETED|Phase 1||0
106376|NCT01045421|247161|P10|NOT COMPLETED|Phase 1||0
106377|NCT01045421|247162|P9|NOT COMPLETED|Phase 1||0
106378|NCT01045421|247163|P8|NOT COMPLETED|Phase 1||0
106379|NCT01045421|247164|P7|NOT COMPLETED|Phase 1||0
106380|NCT01045421|247165|P6|NOT COMPLETED|Phase 1||0
106381|NCT01045421|247166|P5|NOT COMPLETED|Phase 1||1
106382|NCT01045421|247167|P4|NOT COMPLETED|Phase 1||1
106383|NCT01045421|247168|P3|NOT COMPLETED|Phase 1||0
106384|NCT01045421|247169|P2|NOT COMPLETED|Phase 1||0
106385|NCT01045421|247170|P1|NOT COMPLETED|Phase 1||0
106386|NCT01045421|247160|P11|COMPLETED|Phase 1||0
106387|NCT01045421|247161|P10|COMPLETED|Phase 1||0
106388|NCT01045421|247162|P9|COMPLETED|Phase 1||0
106389|NCT01045421|247163|P8|COMPLETED|Phase 1||0
106390|NCT01045421|247164|P7|COMPLETED|Phase 1||0
106391|NCT01045421|247165|P6|COMPLETED|Phase 1||1
106392|NCT01045421|247166|P5|COMPLETED|Phase 1||2
106393|NCT01045421|247167|P4|COMPLETED|Phase 1||11
106394|NCT01045421|247168|P3|COMPLETED|Phase 1||4
106395|NCT01045421|247169|P2|COMPLETED|Phase 1||3
106396|NCT01045421|247170|P1|COMPLETED|Phase 1||1
106397|NCT01045421|247160|P11|STARTED|Phase 1||0
106398|NCT01045421|247161|P10|STARTED|Phase 1||0
106399|NCT01045421|247162|P9|STARTED|Phase 1||0
106400|NCT01045421|247163|P8|STARTED|Phase 1||0
106401|NCT01045421|247164|P7|STARTED|Phase 1||0
106402|NCT01045421|247165|P6|STARTED|Phase 1||1
106403|NCT01045421|247166|P5|STARTED|Phase 1||3
106404|NCT01045421|247167|P4|STARTED|Phase 1||12
106405|NCT01045421|247168|P3|STARTED|Phase 1||4
106406|NCT01045421|247169|P2|STARTED|Phase 1||3
106407|NCT01045421|247170|P1|STARTED|Phase 1||1
106408|NCT01045265|247250|P1|NOT COMPLETED|Overall Study||0
106409|NCT01045265|247250|P1|COMPLETED|Overall Study||16
106410|NCT01045265|247250|P1|STARTED|Overall Study||16
106411|NCT01045187|247257|P1|NOT COMPLETED|Overall Study||0
106412|NCT01045187|247257|P1|COMPLETED|Overall Study||15
106413|NCT01045187|247257|P1|STARTED|Overall Study||15
106414|NCT01045161|247264|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
106415|NCT01045161|247265|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
106416|NCT01045161|247266|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
106417|NCT01045161|247264|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
106418|NCT01045161|247265|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
106419|NCT01045161|247266|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
106420|NCT01045161|247264|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
106421|NCT01045161|247265|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
106422|NCT01045161|247266|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
106423|NCT01045161|247264|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
106424|NCT01045161|247265|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
106425|NCT01045161|247266|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
106426|NCT01045161|247264|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
106427|NCT01045161|247265|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
106428|NCT01045161|247266|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
106429|NCT01045161|247264|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
106430|NCT01045161|247265|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
106431|NCT01045161|247266|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
106432|NCT01045122|247286|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
106433|NCT01045122|247287|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
106434|NCT01045122|247286|P2|COMPLETED|Propofol Then Dexmedetomidine||6
106435|NCT01045122|247287|P1|COMPLETED|Propofol Then Dexmedetomidine||5
106436|NCT01045122|247286|P2|STARTED|Propofol Then Dexmedetomidine||6
106437|NCT01045122|247287|P1|STARTED|Propofol Then Dexmedetomidine||5
106438|NCT01045122|247286|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
106439|NCT01045122|247287|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
106440|NCT01045122|247286|P2|COMPLETED|Dexmedetomidine Then Propofol||6
106441|NCT01045122|247287|P1|COMPLETED|Dexmedetomidine Then Propofol||5
106442|NCT01045122|247286|P2|STARTED|Dexmedetomidine Then Propofol||6
106443|NCT01045122|247287|P1|STARTED|Dexmedetomidine Then Propofol||5
106444|NCT01045096|247296|P3|NOT COMPLETED|Overall Study||0
106445|NCT01045096|247297|P2|NOT COMPLETED|Overall Study||0
106446|NCT01045096|247298|P1|NOT COMPLETED|Overall Study||3
106447|NCT01045096|247296|P3|COMPLETED|Overall Study||12
106448|NCT01045096|247297|P2|COMPLETED|Overall Study||12
106449|NCT01045096|247298|P1|COMPLETED|Overall Study||9
106450|NCT01045096|247296|P3|Pharmacokinetic Set|Overall Study||11
106451|NCT01045096|247297|P2|Pharmacokinetic Set|Overall Study||11
106452|NCT01045096|247298|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
106453|NCT01045096|247296|P3|STARTED|Overall Study||12
106454|NCT01045096|247297|P2|STARTED|Overall Study||12
106455|NCT01045096|247298|P1|STARTED|Overall Study||12
106456|NCT01045057|247324|P1|NOT COMPLETED|Overall Study||0
106457|NCT01045057|247324|P1|COMPLETED|Overall Study||27
106458|NCT01045057|247324|P1|STARTED|Overall Study||27
106459|NCT01045031|247333|P2|NOT COMPLETED|Overall Study||6
106460|NCT01045031|247334|P1|NOT COMPLETED|Overall Study||9
106461|NCT01045031|247333|P2|COMPLETED|Overall Study||50
106462|NCT01045031|247334|P1|COMPLETED|Overall Study||49
106463|NCT01045031|247333|P2|STARTED|Overall Study||56
106464|NCT01045031|247334|P1|STARTED|Overall Study||58
106465|NCT01044862|247347|P3|NOT COMPLETED|Overall Study||52
106466|NCT01044862|247348|P2|NOT COMPLETED|Overall Study||49
106467|NCT01044862|247349|P1|NOT COMPLETED|Overall Study||53
106468|NCT01044862|247347|P3|COMPLETED|Overall Study||249
106469|NCT01044862|247348|P2|COMPLETED|Overall Study||251
106470|NCT01044862|247349|P1|COMPLETED|Overall Study||246
106471|NCT01044862|247347|P3|STARTED|Overall Study||301
106472|NCT01044862|247348|P2|STARTED|Overall Study||300
106473|NCT01044862|247349|P1|STARTED|Overall Study||299
106474|NCT01044771|247366|P1|NOT COMPLETED|Overall Study||0
106475|NCT01044771|247366|P1|COMPLETED|Overall Study||20
106476|NCT01044771|247366|P1|STARTED|Overall Study||20
106477|NCT01044732|247373|P2|NOT COMPLETED|Overall Study||50
106478|NCT01044732|247374|P1|NOT COMPLETED|Overall Study||49
106479|NCT01044732|247373|P2|COMPLETED|Overall Study||176
106480|NCT01044732|247374|P1|COMPLETED|Overall Study||173
106481|NCT01044732|247373|P2|STARTED|Overall Study||226
106482|NCT01044732|247374|P1|STARTED|Overall Study||222
106483|NCT01044706|247384|P2|NOT COMPLETED|Overall Study||0
106484|NCT01044706|247385|P1|NOT COMPLETED|Overall Study||0
106485|NCT01044706|247384|P2|COMPLETED|Overall Study||30
106486|NCT01044706|247385|P1|COMPLETED|Overall Study||30
106487|NCT01044706|247384|P2|STARTED|Overall Study||30
106488|NCT01044706|247385|P1|STARTED|Overall Study||30
106489|NCT01044693|247393|P16|NOT COMPLETED|Overall Study||0
106490|NCT01044693|247394|P15|NOT COMPLETED|Overall Study||0
106491|NCT01044693|247395|P14|NOT COMPLETED|Overall Study||0
106492|NCT01044693|247396|P13|NOT COMPLETED|Overall Study||0
106493|NCT01044693|247397|P12|NOT COMPLETED|Overall Study||0
106494|NCT01044693|247398|P11|NOT COMPLETED|Overall Study||0
106495|NCT01044693|247399|P10|NOT COMPLETED|Overall Study||0
106496|NCT01044693|247400|P9|NOT COMPLETED|Overall Study||0
106497|NCT01044693|247401|P8|NOT COMPLETED|Overall Study||0
106498|NCT01044693|247402|P7|NOT COMPLETED|Overall Study||0
106499|NCT01044693|247403|P6|NOT COMPLETED|Overall Study||0
106500|NCT01044693|247404|P5|NOT COMPLETED|Overall Study||0
106501|NCT01044693|247405|P4|NOT COMPLETED|Overall Study||0
106502|NCT01044693|247406|P3|NOT COMPLETED|Overall Study||0
106503|NCT01044693|247407|P2|NOT COMPLETED|Overall Study||0
106504|NCT01044693|247408|P1|NOT COMPLETED|Overall Study||0
106505|NCT01044693|247393|P16|COMPLETED|Overall Study||1
106506|NCT01044693|247394|P15|COMPLETED|Overall Study||1
106507|NCT01044693|247395|P14|COMPLETED|Overall Study||1
106508|NCT01044693|247396|P13|COMPLETED|Overall Study||2
106509|NCT01044693|247397|P12|COMPLETED|Overall Study||1
106510|NCT01044693|247398|P11|COMPLETED|Overall Study||1
106511|NCT01044693|247399|P10|COMPLETED|Overall Study||1
106512|NCT01044693|247400|P9|COMPLETED|Overall Study||1
106513|NCT01044693|247401|P8|COMPLETED|Overall Study||1
106514|NCT01044693|247402|P7|COMPLETED|Overall Study||1
106515|NCT01044693|247403|P6|COMPLETED|Overall Study||2
106516|NCT01044693|247404|P5|COMPLETED|Overall Study||1
106517|NCT01044693|247405|P4|COMPLETED|Overall Study||1
106518|NCT01044693|247406|P3|COMPLETED|Overall Study||1
106519|NCT01044693|247407|P2|COMPLETED|Overall Study||1
106520|NCT01044693|247408|P1|COMPLETED|Overall Study||3
106521|NCT01044693|247393|P16|STARTED|Overall Study||1
106522|NCT01044693|247394|P15|STARTED|Overall Study||1
106523|NCT01044693|247395|P14|STARTED|Overall Study||1
106524|NCT01044693|247396|P13|STARTED|Overall Study||2
106525|NCT01044693|247397|P12|STARTED|Overall Study||1
106526|NCT01044693|247398|P11|STARTED|Overall Study||1
106527|NCT01044693|247399|P10|STARTED|Overall Study||1
106528|NCT01044693|247400|P9|STARTED|Overall Study||1
106529|NCT01044693|247401|P8|STARTED|Overall Study||1
106530|NCT01044693|247402|P7|STARTED|Overall Study||1
106531|NCT01044693|247403|P6|STARTED|Overall Study||2
106532|NCT01044693|247404|P5|STARTED|Overall Study||1
106533|NCT01044693|247405|P4|STARTED|Overall Study||1
106534|NCT01044693|247406|P3|STARTED|Overall Study||1
106535|NCT01044693|247407|P2|STARTED|Overall Study||1
106536|NCT01044693|247408|P1|STARTED|Overall Study||3
106537|NCT01044498|247432|P2|NOT COMPLETED|Overall Study||2
106538|NCT01044498|247433|P1|NOT COMPLETED|Overall Study||3
106539|NCT01044498|247432|P2|COMPLETED|Overall Study||21
106540|NCT01044498|247433|P1|COMPLETED|Overall Study||20
106541|NCT01044498|247432|P2|STARTED|Overall Study||23
106542|NCT01044498|247433|P1|STARTED|Overall Study||23
106543|NCT01044459|247459|P2|NOT COMPLETED|Overall Study||131
106544|NCT01044459|247460|P1|NOT COMPLETED|Overall Study||133
106545|NCT01044459|247459|P2|COMPLETED|Overall Study||162
106546|NCT01044459|247460|P1|COMPLETED|Overall Study||179
106547|NCT01044459|247459|P2|STARTED|Overall Study||293
106548|NCT01044459|247460|P1|STARTED|Overall Study||312
106549|NCT01044303|247468|P1|NOT COMPLETED|Overall Study||2
106550|NCT01044303|247468|P1|COMPLETED|Overall Study||30
106551|NCT01044303|247468|P1|STARTED|Overall Study||32
106552|NCT01044290|247478|P3|NOT COMPLETED|Follow-Up 2||2
106553|NCT01044290|247479|P2|NOT COMPLETED|Follow-Up 2||2
106554|NCT01044290|247480|P1|NOT COMPLETED|Follow-Up 2||0
106555|NCT01044290|247478|P3|COMPLETED|Follow-Up 2||69
106556|NCT01044290|247479|P2|COMPLETED|Follow-Up 2||67
106557|NCT01044290|247480|P1|COMPLETED|Follow-Up 2||70
106558|NCT01044290|247478|P3|Completed F2 Interview|Follow-Up 2||64
106559|NCT01044290|247479|P2|Completed F2 Interview|Follow-Up 2||57
106560|NCT01044290|247480|P1|Completed F2 Interview|Follow-Up 2||64
106561|NCT01044290|247478|P3|STARTED|Follow-Up 2||71
106562|NCT01044290|247479|P2|STARTED|Follow-Up 2||69
106563|NCT01044290|247480|P1|STARTED|Follow-Up 2||70
106564|NCT01044290|247478|P3|NOT COMPLETED|Follow-up 1||1
106565|NCT01044290|247479|P2|NOT COMPLETED|Follow-up 1||5
106566|NCT01044290|247480|P1|NOT COMPLETED|Follow-up 1||5
106567|NCT01044290|247478|P3|COMPLETED|Follow-up 1||71
106568|NCT01044290|247479|P2|COMPLETED|Follow-up 1||69
106569|NCT01044290|247480|P1|COMPLETED|Follow-up 1||70
106570|NCT01044290|247478|P3|Completed F1 Interview|Follow-up 1||61
106571|NCT01044290|247479|P2|Completed F1 Interview|Follow-up 1||60
106572|NCT01044290|247480|P1|Completed F1 Interview|Follow-up 1||61
106573|NCT01044290|247478|P3|STARTED|Follow-up 1||72
106574|NCT01044290|247479|P2|STARTED|Follow-up 1||74
106575|NCT01044290|247480|P1|STARTED|Follow-up 1||75
106576|NCT01044290|247478|P3|NOT COMPLETED|Randomization||0
106577|NCT01044290|247479|P2|NOT COMPLETED|Randomization||0
106578|NCT01044290|247480|P1|NOT COMPLETED|Randomization||0
106579|NCT01044290|247478|P3|COMPLETED|Randomization||72
106580|NCT01044290|247479|P2|COMPLETED|Randomization||74
106581|NCT01044290|247480|P1|COMPLETED|Randomization||75
106582|NCT01044290|247478|P3|Randomized|Randomization||72
106583|NCT01044290|247479|P2|Randomized|Randomization||74
106584|NCT01044290|247480|P1|Randomized|Randomization||75
106585|NCT01044290|247478|P3|STARTED|Randomization||72
106586|NCT01044290|247479|P2|STARTED|Randomization||74
106587|NCT01044290|247480|P1|STARTED|Randomization||75
106588|NCT01044264|247506|P3|NOT COMPLETED|Overall Study||92
106589|NCT01044264|247507|P2|NOT COMPLETED|Overall Study||94
106590|NCT01044264|247508|P1|NOT COMPLETED|Overall Study||90
106591|NCT01044264|247506|P3|COMPLETED|Overall Study||108
106592|NCT01044264|247507|P2|COMPLETED|Overall Study||108
106593|NCT01044264|247508|P1|COMPLETED|Overall Study||110
106594|NCT01044264|247506|P3|STARTED|Overall Study||200
106595|NCT01044264|247507|P2|STARTED|Overall Study||202
106596|NCT01044264|247508|P1|STARTED|Overall Study||200
106597|NCT01044212|247518|P2|NOT COMPLETED|Overall Study||7
106598|NCT01044212|247519|P1|NOT COMPLETED|Overall Study||5
106599|NCT01044212|247518|P2|COMPLETED|Overall Study||30
106600|NCT01044212|247519|P1|COMPLETED|Overall Study||30
106601|NCT01044212|247518|P2|STARTED|Overall Study||37
106602|NCT01044212|247519|P1|STARTED|Overall Study||35
106603|NCT01044056|247532|P3|NOT COMPLETED|Overall Study||0
106604|NCT01044056|247533|P2|NOT COMPLETED|Overall Study||0
106605|NCT01044056|247534|P1|NOT COMPLETED|Overall Study||0
106606|NCT01044056|247532|P3|COMPLETED|Overall Study||8
106607|NCT01044056|247533|P2|COMPLETED|Overall Study||8
106608|NCT01044056|247534|P1|COMPLETED|Overall Study||8
106609|NCT01044056|247532|P3|STARTED|Overall Study||8
106610|NCT01044056|247533|P2|STARTED|Overall Study||8
106611|NCT01044056|247534|P1|STARTED|Overall Study||8
106612|NCT01044030|247553|P2|NOT COMPLETED|Overall Study||20
106613|NCT01044030|247554|P1|NOT COMPLETED|Overall Study||19
106614|NCT01044030|247553|P2|COMPLETED|Overall Study||146
106615|NCT01044030|247554|P1|COMPLETED|Overall Study||141
106616|NCT01044030|247553|P2|STARTED|Overall Study||166
106617|NCT01044030|247554|P1|STARTED|Overall Study||160
106618|NCT01043939|247564|P2|NOT COMPLETED|Second Intervention||0
106619|NCT01043939|247565|P1|NOT COMPLETED|Second Intervention||0
106620|NCT01043939|247564|P2|COMPLETED|Second Intervention||12
106621|NCT01043939|247565|P1|COMPLETED|Second Intervention||12
106622|NCT01043939|247564|P2|STARTED|Second Intervention||12
106623|NCT01043939|247565|P1|STARTED|Second Intervention||12
106624|NCT01043939|247564|P2|NOT COMPLETED|Washout Period||0
106625|NCT01043939|247565|P1|NOT COMPLETED|Washout Period||0
106626|NCT01043939|247564|P2|COMPLETED|Washout Period||12
106627|NCT01043939|247565|P1|COMPLETED|Washout Period||12
106628|NCT01043939|247564|P2|STARTED|Washout Period||12
106629|NCT01043939|247565|P1|STARTED|Washout Period||12
106630|NCT01043939|247564|P2|NOT COMPLETED|First Intervention||0
106631|NCT01043939|247565|P1|NOT COMPLETED|First Intervention||0
106632|NCT01043939|247564|P2|COMPLETED|First Intervention||12
106633|NCT01043939|247565|P1|COMPLETED|First Intervention||12
106634|NCT01043939|247564|P2|STARTED|First Intervention||12
106635|NCT01043939|247565|P1|STARTED|First Intervention||12
106636|NCT01043926|247579|P4|NOT COMPLETED|Overall Study||0
106637|NCT01043926|247580|P3|NOT COMPLETED|Overall Study||0
106638|NCT01043926|247581|P2|NOT COMPLETED|Overall Study||0
106639|NCT01043926|247582|P1|NOT COMPLETED|Overall Study||0
106640|NCT01043926|247579|P4|COMPLETED|Overall Study||0
106641|NCT01043926|247580|P3|COMPLETED|Overall Study||0
106642|NCT01043926|247581|P2|COMPLETED|Overall Study||8
106643|NCT01043926|247582|P1|COMPLETED|Overall Study||8
106644|NCT01043926|247579|P4|STARTED|Overall Study||0
106645|NCT01043926|247580|P3|STARTED|Overall Study||0
106646|NCT01043926|247581|P2|STARTED|Overall Study||8
106647|NCT01043926|247582|P1|STARTED|Overall Study||8
106648|NCT01043874|247596|P1|NOT COMPLETED|Overall Study||6
106649|NCT01043874|247596|P1|COMPLETED|Overall Study||39
106650|NCT01043874|247596|P1|STARTED|Overall Study||45
106651|NCT01043705|247606|P3|NOT COMPLETED|Overall Study||80
106652|NCT01043705|247607|P2|NOT COMPLETED|Overall Study||131
106653|NCT01043705|247608|P1|NOT COMPLETED|Overall Study||107
106654|NCT01043705|247606|P3|COMPLETED|Overall Study||498
106655|NCT01043705|247607|P2|COMPLETED|Overall Study||447
106656|NCT01043705|247608|P1|COMPLETED|Overall Study||352
106657|NCT01043705|247606|P3|STARTED|Overall Study||578
106658|NCT01043705|247607|P2|STARTED|Overall Study||578
106659|NCT01043705|247608|P1|STARTED|Overall Study||459
106660|NCT01043653|247618|P1|NOT COMPLETED|Overall Study||64
106661|NCT01043653|247618|P1|COMPLETED|Overall Study||186
106662|NCT01043653|247618|P1|STARTED|Overall Study||250
106663|NCT01043523|247623|P1|NOT COMPLETED|Overall Study||0
106664|NCT01043523|247623|P1|COMPLETED|Overall Study||52
106665|NCT01043523|247623|P1|Participants With Unenhanced Images|Overall Study||51
106666|NCT01043523|247623|P1|STARTED|Overall Study||52
106667|NCT01043432|247652|P4|NOT COMPLETED|Overall Study||0
106668|NCT01043432|247653|P3|NOT COMPLETED|Overall Study||0
106669|NCT01043432|247654|P2|NOT COMPLETED|Overall Study||0
106670|NCT01043432|247655|P1|NOT COMPLETED|Overall Study||0
106671|NCT01043432|247652|P4|COMPLETED|Overall Study||48
106672|NCT01043432|247653|P3|COMPLETED|Overall Study||12
106673|NCT01043432|247654|P2|COMPLETED|Overall Study||51
106674|NCT01043432|247655|P1|COMPLETED|Overall Study||22
106675|NCT01043432|247652|P4|STARTED|Overall Study||48
106676|NCT01043432|247653|P3|STARTED|Overall Study||12
106677|NCT01043432|247654|P2|STARTED|Overall Study||51
106678|NCT01043432|247655|P1|STARTED|Overall Study||22
106679|NCT01043393|247664|P2|NOT COMPLETED|Overall Study||0
106680|NCT01043393|247665|P1|NOT COMPLETED|Overall Study||0
106681|NCT01043393|247664|P2|COMPLETED|Overall Study||12
106682|NCT01043393|247665|P1|COMPLETED|Overall Study||12
106683|NCT01043393|247664|P2|STARTED|Overall Study||12
106684|NCT01043393|247665|P1|STARTED|Overall Study||12
106685|NCT01043185|247675|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
106686|NCT01043185|247676|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
106687|NCT01043185|247677|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
106688|NCT01043185|247678|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
106689|NCT01043185|247679|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
106690|NCT01043185|247680|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
106691|NCT01043185|247681|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
106692|NCT01043185|247682|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
106693|NCT01043185|247683|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
106694|NCT01043185|247684|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
106695|NCT01043185|247675|P10|COMPLETED|Period 7 - Fourth Intervention||3
106696|NCT01043185|247676|P9|COMPLETED|Period 7 - Fourth Intervention||2
106697|NCT01043185|247677|P8|COMPLETED|Period 7 - Fourth Intervention||3
106698|NCT01043185|247678|P7|COMPLETED|Period 7 - Fourth Intervention||3
106699|NCT01043185|247679|P6|COMPLETED|Period 7 - Fourth Intervention||3
106700|NCT01043185|247680|P5|COMPLETED|Period 7 - Fourth Intervention||2
106701|NCT01043185|247681|P4|COMPLETED|Period 7 - Fourth Intervention||2
106702|NCT01043185|247682|P3|COMPLETED|Period 7 - Fourth Intervention||3
106703|NCT01043185|247683|P2|COMPLETED|Period 7 - Fourth Intervention||2
106704|NCT01043185|247684|P1|COMPLETED|Period 7 - Fourth Intervention||3
106705|NCT01043185|247675|P10|STARTED|Period 7 - Fourth Intervention||3
106706|NCT01043185|247676|P9|STARTED|Period 7 - Fourth Intervention||2
106707|NCT01043185|247677|P8|STARTED|Period 7 - Fourth Intervention||3
106708|NCT01043185|247678|P7|STARTED|Period 7 - Fourth Intervention||3
106709|NCT01043185|247679|P6|STARTED|Period 7 - Fourth Intervention||3
106710|NCT01043185|247680|P5|STARTED|Period 7 - Fourth Intervention||2
106711|NCT01043185|247681|P4|STARTED|Period 7 - Fourth Intervention||2
106712|NCT01043185|247682|P3|STARTED|Period 7 - Fourth Intervention||3
106713|NCT01043185|247683|P2|STARTED|Period 7 - Fourth Intervention||2
106714|NCT01043185|247684|P1|STARTED|Period 7 - Fourth Intervention||3
106715|NCT01043185|247675|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
106716|NCT01043185|247676|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
106717|NCT01043185|247677|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
106718|NCT01043185|247678|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
106719|NCT01043185|247679|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
106720|NCT01043185|247680|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
106721|NCT01043185|247681|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
106722|NCT01043185|247682|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
106723|NCT01043185|247683|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
106724|NCT01043185|247684|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
106725|NCT01043185|247675|P10|COMPLETED|Period 6 - Third Washout Period||3
106726|NCT01043185|247676|P9|COMPLETED|Period 6 - Third Washout Period||2
106727|NCT01043185|247677|P8|COMPLETED|Period 6 - Third Washout Period||3
106728|NCT01043185|247678|P7|COMPLETED|Period 6 - Third Washout Period||3
106729|NCT01043185|247679|P6|COMPLETED|Period 6 - Third Washout Period||3
106730|NCT01043185|247680|P5|COMPLETED|Period 6 - Third Washout Period||2
106731|NCT01043185|247681|P4|COMPLETED|Period 6 - Third Washout Period||2
106732|NCT01043185|247682|P3|COMPLETED|Period 6 - Third Washout Period||3
106733|NCT01043185|247683|P2|COMPLETED|Period 6 - Third Washout Period||2
106734|NCT01043185|247684|P1|COMPLETED|Period 6 - Third Washout Period||3
106735|NCT01043185|247675|P10|STARTED|Period 6 - Third Washout Period||3
106736|NCT01043185|247676|P9|STARTED|Period 6 - Third Washout Period||3
106737|NCT01043185|247677|P8|STARTED|Period 6 - Third Washout Period||3
106738|NCT01043185|247678|P7|STARTED|Period 6 - Third Washout Period||3
106739|NCT01043185|247679|P6|STARTED|Period 6 - Third Washout Period||3
106740|NCT01043185|247680|P5|STARTED|Period 6 - Third Washout Period||2
106741|NCT01043185|247681|P4|STARTED|Period 6 - Third Washout Period||2
106742|NCT01043185|247682|P3|STARTED|Period 6 - Third Washout Period||3
106743|NCT01043185|247683|P2|STARTED|Period 6 - Third Washout Period||2
106744|NCT01043185|247684|P1|STARTED|Period 6 - Third Washout Period||3
106745|NCT01043185|247675|P10|NOT COMPLETED|Period 5 - Third Intervention||0
106746|NCT01043185|247676|P9|NOT COMPLETED|Period 5 - Third Intervention||0
106747|NCT01043185|247677|P8|NOT COMPLETED|Period 5 - Third Intervention||0
106748|NCT01043185|247678|P7|NOT COMPLETED|Period 5 - Third Intervention||0
106749|NCT01043185|247679|P6|NOT COMPLETED|Period 5 - Third Intervention||0
106750|NCT01043185|247680|P5|NOT COMPLETED|Period 5 - Third Intervention||0
106751|NCT01043185|247681|P4|NOT COMPLETED|Period 5 - Third Intervention||0
106752|NCT01043185|247682|P3|NOT COMPLETED|Period 5 - Third Intervention||0
106753|NCT01043185|247683|P2|NOT COMPLETED|Period 5 - Third Intervention||0
106754|NCT01043185|247684|P1|NOT COMPLETED|Period 5 - Third Intervention||0
106755|NCT01043185|247675|P10|COMPLETED|Period 5 - Third Intervention||3
106756|NCT01043185|247676|P9|COMPLETED|Period 5 - Third Intervention||3
106757|NCT01043185|247677|P8|COMPLETED|Period 5 - Third Intervention||3
106758|NCT01043185|247678|P7|COMPLETED|Period 5 - Third Intervention||3
106759|NCT01043185|247679|P6|COMPLETED|Period 5 - Third Intervention||3
106760|NCT01043185|247680|P5|COMPLETED|Period 5 - Third Intervention||2
106761|NCT01043185|247681|P4|COMPLETED|Period 5 - Third Intervention||2
106762|NCT01043185|247682|P3|COMPLETED|Period 5 - Third Intervention||3
106763|NCT01043185|247683|P2|COMPLETED|Period 5 - Third Intervention||2
106764|NCT01043185|247684|P1|COMPLETED|Period 5 - Third Intervention||3
106765|NCT01043185|247675|P10|STARTED|Period 5 - Third Intervention||3
106766|NCT01043185|247676|P9|STARTED|Period 5 - Third Intervention||3
106767|NCT01043185|247677|P8|STARTED|Period 5 - Third Intervention||3
106768|NCT01043185|247678|P7|STARTED|Period 5 - Third Intervention||3
106769|NCT01043185|247679|P6|STARTED|Period 5 - Third Intervention||3
106770|NCT01043185|247680|P5|STARTED|Period 5 - Third Intervention||2
106771|NCT01043185|247681|P4|STARTED|Period 5 - Third Intervention||2
106772|NCT01043185|247682|P3|STARTED|Period 5 - Third Intervention||3
106773|NCT01043185|247683|P2|STARTED|Period 5 - Third Intervention||2
106774|NCT01043185|247684|P1|STARTED|Period 5 - Third Intervention||3
106775|NCT01043185|247675|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
106776|NCT01043185|247676|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
106777|NCT01043185|247677|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
106778|NCT01043185|247678|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
106779|NCT01043185|247679|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
106780|NCT01043185|247680|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
106781|NCT01043185|247681|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
106782|NCT01043185|247682|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
106783|NCT01043185|247683|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
106784|NCT01043185|247684|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
106785|NCT01043185|247675|P10|COMPLETED|Period 4 - Second Washout Period||3
106786|NCT01043185|247676|P9|COMPLETED|Period 4 - Second Washout Period||3
106787|NCT01043185|247677|P8|COMPLETED|Period 4 - Second Washout Period||3
106788|NCT01043185|247678|P7|COMPLETED|Period 4 - Second Washout Period||3
106789|NCT01043185|247679|P6|COMPLETED|Period 4 - Second Washout Period||3
106790|NCT01043185|247680|P5|COMPLETED|Period 4 - Second Washout Period||2
106791|NCT01043185|247681|P4|COMPLETED|Period 4 - Second Washout Period||2
106792|NCT01043185|247682|P3|COMPLETED|Period 4 - Second Washout Period||3
106793|NCT01043185|247683|P2|COMPLETED|Period 4 - Second Washout Period||2
106794|NCT01043185|247684|P1|COMPLETED|Period 4 - Second Washout Period||3
106795|NCT01043185|247675|P10|STARTED|Period 4 - Second Washout Period||3
106796|NCT01043185|247676|P9|STARTED|Period 4 - Second Washout Period||3
106797|NCT01043185|247677|P8|STARTED|Period 4 - Second Washout Period||3
106798|NCT01043185|247678|P7|STARTED|Period 4 - Second Washout Period||3
106799|NCT01043185|247679|P6|STARTED|Period 4 - Second Washout Period||3
106800|NCT01043185|247680|P5|STARTED|Period 4 - Second Washout Period||2
106801|NCT01043185|247681|P4|STARTED|Period 4 - Second Washout Period||2
106802|NCT01043185|247682|P3|STARTED|Period 4 - Second Washout Period||3
106803|NCT01043185|247683|P2|STARTED|Period 4 - Second Washout Period||2
106804|NCT01043185|247684|P1|STARTED|Period 4 - Second Washout Period||3
106805|NCT01043185|247675|P10|NOT COMPLETED|Period 3 - Second Intervention||0
106806|NCT01043185|247676|P9|NOT COMPLETED|Period 3 - Second Intervention||0
106807|NCT01043185|247677|P8|NOT COMPLETED|Period 3 - Second Intervention||0
106808|NCT01043185|247678|P7|NOT COMPLETED|Period 3 - Second Intervention||0
106809|NCT01043185|247679|P6|NOT COMPLETED|Period 3 - Second Intervention||0
106810|NCT01043185|247680|P5|NOT COMPLETED|Period 3 - Second Intervention||0
106811|NCT01043185|247681|P4|NOT COMPLETED|Period 3 - Second Intervention||0
106812|NCT01043185|247682|P3|NOT COMPLETED|Period 3 - Second Intervention||0
106813|NCT01043185|247683|P2|NOT COMPLETED|Period 3 - Second Intervention||0
106814|NCT01043185|247684|P1|NOT COMPLETED|Period 3 - Second Intervention||0
106815|NCT01043185|247675|P10|COMPLETED|Period 3 - Second Intervention||3
106816|NCT01043185|247676|P9|COMPLETED|Period 3 - Second Intervention||3
106817|NCT01043185|247677|P8|COMPLETED|Period 3 - Second Intervention||3
106818|NCT01043185|247678|P7|COMPLETED|Period 3 - Second Intervention||3
106819|NCT01043185|247679|P6|COMPLETED|Period 3 - Second Intervention||3
106820|NCT01043185|247680|P5|COMPLETED|Period 3 - Second Intervention||2
106821|NCT01043185|247681|P4|COMPLETED|Period 3 - Second Intervention||2
106822|NCT01043185|247682|P3|COMPLETED|Period 3 - Second Intervention||3
106823|NCT01043185|247683|P2|COMPLETED|Period 3 - Second Intervention||2
106824|NCT01043185|247684|P1|COMPLETED|Period 3 - Second Intervention||3
106825|NCT01043185|247675|P10|STARTED|Period 3 - Second Intervention||3
106826|NCT01043185|247676|P9|STARTED|Period 3 - Second Intervention||3
106827|NCT01043185|247677|P8|STARTED|Period 3 - Second Intervention||3
106828|NCT01043185|247678|P7|STARTED|Period 3 - Second Intervention||3
106829|NCT01043185|247679|P6|STARTED|Period 3 - Second Intervention||3
106830|NCT01043185|247680|P5|STARTED|Period 3 - Second Intervention||2
106831|NCT01043185|247681|P4|STARTED|Period 3 - Second Intervention||2
106832|NCT01043185|247682|P3|STARTED|Period 3 - Second Intervention||3
106833|NCT01043185|247683|P2|STARTED|Period 3 - Second Intervention||2
106834|NCT01043185|247684|P1|STARTED|Period 3 - Second Intervention||3
106835|NCT01043185|247675|P10|NOT COMPLETED|Period 2 - First Washout Period||0
106836|NCT01043185|247676|P9|NOT COMPLETED|Period 2 - First Washout Period||0
106837|NCT01043185|247677|P8|NOT COMPLETED|Period 2 - First Washout Period||0
106838|NCT01043185|247678|P7|NOT COMPLETED|Period 2 - First Washout Period||0
106839|NCT01043185|247679|P6|NOT COMPLETED|Period 2 - First Washout Period||0
106840|NCT01043185|247680|P5|NOT COMPLETED|Period 2 - First Washout Period||0
106841|NCT01043185|247681|P4|NOT COMPLETED|Period 2 - First Washout Period||0
106842|NCT01043185|247682|P3|NOT COMPLETED|Period 2 - First Washout Period||0
106843|NCT01043185|247683|P2|NOT COMPLETED|Period 2 - First Washout Period||0
106844|NCT01043185|247684|P1|NOT COMPLETED|Period 2 - First Washout Period||0
106845|NCT01043185|247675|P10|COMPLETED|Period 2 - First Washout Period||3
106846|NCT01043185|247676|P9|COMPLETED|Period 2 - First Washout Period||3
106847|NCT01043185|247677|P8|COMPLETED|Period 2 - First Washout Period||3
106848|NCT01043185|247678|P7|COMPLETED|Period 2 - First Washout Period||3
106849|NCT01043185|247679|P6|COMPLETED|Period 2 - First Washout Period||3
106850|NCT01043185|247680|P5|COMPLETED|Period 2 - First Washout Period||2
106851|NCT01043185|247681|P4|COMPLETED|Period 2 - First Washout Period||2
106852|NCT01043185|247682|P3|COMPLETED|Period 2 - First Washout Period||3
106853|NCT01043185|247683|P2|COMPLETED|Period 2 - First Washout Period||2
106854|NCT01043185|247684|P1|COMPLETED|Period 2 - First Washout Period||3
106855|NCT01043185|247675|P10|STARTED|Period 2 - First Washout Period||3
106856|NCT01043185|247676|P9|STARTED|Period 2 - First Washout Period||3
106857|NCT01043185|247677|P8|STARTED|Period 2 - First Washout Period||3
106858|NCT01043185|247678|P7|STARTED|Period 2 - First Washout Period||3
106859|NCT01043185|247679|P6|STARTED|Period 2 - First Washout Period||3
106860|NCT01043185|247680|P5|STARTED|Period 2 - First Washout Period||2
106861|NCT01043185|247681|P4|STARTED|Period 2 - First Washout Period||2
106862|NCT01043185|247682|P3|STARTED|Period 2 - First Washout Period||3
106863|NCT01043185|247683|P2|STARTED|Period 2 - First Washout Period||2
106864|NCT01043185|247684|P1|STARTED|Period 2 - First Washout Period||3
106865|NCT01043185|247675|P10|NOT COMPLETED|Period 1 - First Intervention||0
106866|NCT01043185|247676|P9|NOT COMPLETED|Period 1 - First Intervention||0
106867|NCT01043185|247677|P8|NOT COMPLETED|Period 1 - First Intervention||0
106868|NCT01043185|247678|P7|NOT COMPLETED|Period 1 - First Intervention||0
106869|NCT01043185|247679|P6|NOT COMPLETED|Period 1 - First Intervention||0
106870|NCT01043185|247680|P5|NOT COMPLETED|Period 1 - First Intervention||0
106871|NCT01043185|247681|P4|NOT COMPLETED|Period 1 - First Intervention||0
106872|NCT01043185|247682|P3|NOT COMPLETED|Period 1 - First Intervention||0
106873|NCT01043185|247683|P2|NOT COMPLETED|Period 1 - First Intervention||0
106874|NCT01043185|247684|P1|NOT COMPLETED|Period 1 - First Intervention||0
106875|NCT01043185|247675|P10|COMPLETED|Period 1 - First Intervention||3
106876|NCT01043185|247676|P9|COMPLETED|Period 1 - First Intervention||3
106877|NCT01043185|247677|P8|COMPLETED|Period 1 - First Intervention||3
106878|NCT01043185|247678|P7|COMPLETED|Period 1 - First Intervention||3
106879|NCT01043185|247679|P6|COMPLETED|Period 1 - First Intervention||3
106880|NCT01043185|247680|P5|COMPLETED|Period 1 - First Intervention||2
106881|NCT01043185|247681|P4|COMPLETED|Period 1 - First Intervention||2
106882|NCT01043185|247682|P3|COMPLETED|Period 1 - First Intervention||3
106883|NCT01043185|247683|P2|COMPLETED|Period 1 - First Intervention||2
106884|NCT01043185|247684|P1|COMPLETED|Period 1 - First Intervention||3
106885|NCT01043185|247675|P10|STARTED|Period 1 - First Intervention||3
106886|NCT01043185|247676|P9|STARTED|Period 1 - First Intervention||3
106887|NCT01043185|247677|P8|STARTED|Period 1 - First Intervention||3
106888|NCT01043185|247678|P7|STARTED|Period 1 - First Intervention||3
106889|NCT01043185|247679|P6|STARTED|Period 1 - First Intervention||3
106890|NCT01043185|247680|P5|STARTED|Period 1 - First Intervention||2
106891|NCT01043185|247681|P4|STARTED|Period 1 - First Intervention||2
106892|NCT01043185|247682|P3|STARTED|Period 1 - First Intervention||3
106893|NCT01043185|247683|P2|STARTED|Period 1 - First Intervention||2
106894|NCT01043185|247684|P1|STARTED|Period 1 - First Intervention||3
106895|NCT01043146|247717|P6|NOT COMPLETED|Overall Study||0
106896|NCT01043146|247718|P5|NOT COMPLETED|Overall Study||0
106897|NCT01043146|247719|P4|NOT COMPLETED|Overall Study||0
106898|NCT01043146|247720|P3|NOT COMPLETED|Overall Study||0
106899|NCT01043146|247721|P2|NOT COMPLETED|Overall Study||0
106900|NCT01043146|247722|P1|NOT COMPLETED|Overall Study||0
106901|NCT01043146|247717|P6|COMPLETED|Overall Study||8
106902|NCT01043146|247718|P5|COMPLETED|Overall Study||8
106903|NCT01043146|247719|P4|COMPLETED|Overall Study||8
106904|NCT01043146|247720|P3|COMPLETED|Overall Study||8
106905|NCT01043146|247721|P2|COMPLETED|Overall Study||8
106906|NCT01043146|247722|P1|COMPLETED|Overall Study||10
106907|NCT01043146|247717|P6|STARTED|Overall Study||8
106908|NCT01043146|247718|P5|STARTED|Overall Study||8
106909|NCT01043146|247719|P4|STARTED|Overall Study||8
106910|NCT01043146|247720|P3|STARTED|Overall Study||8
106911|NCT01043146|247721|P2|STARTED|Overall Study||8
106912|NCT01043146|247722|P1|STARTED|Overall Study||10
106913|NCT01043133|247738|P2|NOT COMPLETED|Overall Study||2
106914|NCT01043133|247739|P1|NOT COMPLETED|Overall Study||1
106915|NCT01043133|247738|P2|COMPLETED|Overall Study||78
106916|NCT01043133|247739|P1|COMPLETED|Overall Study||74
106917|NCT01043133|247738|P2|STARTED|Overall Study||80
106918|NCT01043133|247739|P1|STARTED|Overall Study||75
106919|NCT01043094|247749|P2|NOT COMPLETED|Overall Study||0
106920|NCT01043094|247750|P1|NOT COMPLETED|Overall Study||0
106921|NCT01043094|247749|P2|COMPLETED|Overall Study||8
106922|NCT01043094|247750|P1|COMPLETED|Overall Study||8
106923|NCT01043094|247749|P2|STARTED|Overall Study||8
106924|NCT01043094|247750|P1|STARTED|Overall Study||8
106925|NCT01042977|247760|P2|NOT COMPLETED|Overall Study||55
106926|NCT01042977|247761|P1|NOT COMPLETED|Overall Study||41
106927|NCT01042977|247760|P2|COMPLETED|Overall Study||428
106928|NCT01042977|247761|P1|COMPLETED|Overall Study||441
106929|NCT01042977|247760|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
106930|NCT01042977|247761|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
106931|NCT01042938|247781|P2|NOT COMPLETED|Overall Study||2
106932|NCT01042938|247782|P1|NOT COMPLETED|Overall Study||3
106933|NCT01042938|247781|P2|COMPLETED|Overall Study||16
106934|NCT01042938|247782|P1|COMPLETED|Overall Study||14
106935|NCT01042938|247781|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
106936|NCT01042938|247782|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
106937|NCT01042678|247797|P6|NOT COMPLETED|Overall Study||0
106938|NCT01042678|247798|P5|NOT COMPLETED|Overall Study||0
106939|NCT01042678|247799|P4|NOT COMPLETED|Overall Study||0
106940|NCT01042678|247800|P3|NOT COMPLETED|Overall Study||0
106941|NCT01042678|247801|P2|NOT COMPLETED|Overall Study||0
106942|NCT01042678|247802|P1|NOT COMPLETED|Overall Study||1
106943|NCT01042678|247797|P6|COMPLETED|Overall Study||0
106944|NCT01042678|247798|P5|COMPLETED|Overall Study||0
106945|NCT01042678|247799|P4|COMPLETED|Overall Study||0
106946|NCT01042678|247800|P3|COMPLETED|Overall Study||6
106947|NCT01042678|247801|P2|COMPLETED|Overall Study||6
106948|NCT01042678|247802|P1|COMPLETED|Overall Study||5
106949|NCT01042678|247797|P6|STARTED|Overall Study||0
106950|NCT01042678|247798|P5|STARTED|Overall Study||0
106951|NCT01042678|247799|P4|STARTED|Overall Study||0
106952|NCT01042678|247800|P3|STARTED|Overall Study||6
106953|NCT01042678|247801|P2|STARTED|Overall Study||6
106954|NCT01042678|247802|P1|STARTED|Overall Study||6
106955|NCT01042613|247827|P2|NOT COMPLETED|Overall Study||0
106956|NCT01042613|247828|P1|NOT COMPLETED|Overall Study||0
106957|NCT01042613|247827|P2|COMPLETED|Overall Study||74
106958|NCT01042613|247828|P1|COMPLETED|Overall Study||72
106959|NCT01042613|247827|P2|STARTED|Overall Study||74
106960|NCT01042613|247828|P1|STARTED|Overall Study||72
106961|NCT01042600|247840|P2|NOT COMPLETED|Overall Study||0
106962|NCT01042600|247841|P1|NOT COMPLETED|Overall Study||1
106963|NCT01042600|247840|P2|COMPLETED|Overall Study||30
106964|NCT01042600|247841|P1|COMPLETED|Overall Study||30
106965|NCT01042600|247840|P2|STARTED|Overall Study||30
106966|NCT01042600|247841|P1|STARTED|Overall Study||31
106967|NCT01042535|247849|P1|NOT COMPLETED|Overall Study||8
106968|NCT01042535|247849|P1|COMPLETED|Overall Study||36
106969|NCT01042535|247849|P1|STARTED|Overall Study||44
106970|NCT01042509|247857|P1|NOT COMPLETED|Overall Study||0
106971|NCT01042509|247857|P1|COMPLETED|Overall Study||15
106972|NCT01042509|247857|P1|STARTED|Overall Study||15
106973|NCT01042496|247864|P2|NOT COMPLETED|Overall Study||0
106974|NCT01042496|247865|P1|NOT COMPLETED|Overall Study||0
106975|NCT01042496|247864|P2|COMPLETED|Overall Study||33
106976|NCT01042496|247865|P1|COMPLETED|Overall Study||29
106977|NCT01042496|247864|P2|STARTED|Overall Study||33
106978|NCT01042496|247865|P1|STARTED|Overall Study||29
106979|NCT01042392|247883|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
106980|NCT01042392|247884|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
106981|NCT01042392|247885|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
106982|NCT01042392|247886|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
106983|NCT01042392|247883|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
106984|NCT01042392|247884|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
106985|NCT01042392|247885|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
106986|NCT01042392|247886|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
106987|NCT01042392|247883|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
106988|NCT01042392|247884|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
106989|NCT01042392|247885|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
106990|NCT01042392|247886|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
106991|NCT01042392|247883|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
106992|NCT01042392|247884|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
106993|NCT01042392|247885|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
106994|NCT01042392|247886|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
106995|NCT01042392|247883|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
106996|NCT01042392|247884|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
106997|NCT01042392|247885|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
106998|NCT01042392|247886|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
106999|NCT01042392|247883|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
107000|NCT01042392|247884|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
107001|NCT01042392|247885|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
107002|NCT01042392|247886|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
107003|NCT01042392|247883|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
107004|NCT01042392|247884|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
107005|NCT01042392|247885|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
107006|NCT01042392|247886|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
107007|NCT01042392|247883|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
107008|NCT01042392|247884|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
107009|NCT01042392|247885|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
107010|NCT01042392|247886|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
107011|NCT01042288|247912|P1|NOT COMPLETED|Overall Study||69
107012|NCT01042288|247912|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
107013|NCT01042288|247912|P1|Maintenance|Overall Study||27
107014|NCT01042288|247912|P1|STARTED|Overall Study||69
107015|NCT01042236|247920|P6|NOT COMPLETED|Treatment Period 3||0
107016|NCT01042236|247921|P5|NOT COMPLETED|Treatment Period 3||0
107017|NCT01042236|247922|P4|NOT COMPLETED|Treatment Period 3||2
107018|NCT01042236|247923|P3|NOT COMPLETED|Treatment Period 3||0
107019|NCT01042236|247924|P2|NOT COMPLETED|Treatment Period 3||0
107020|NCT01042236|247925|P1|NOT COMPLETED|Treatment Period 3||0
107021|NCT01042236|247920|P6|COMPLETED|Treatment Period 3||3
107022|NCT01042236|247921|P5|COMPLETED|Treatment Period 3||3
107023|NCT01042236|247922|P4|COMPLETED|Treatment Period 3||3
107024|NCT01042236|247923|P3|COMPLETED|Treatment Period 3||3
107025|NCT01042236|247924|P2|COMPLETED|Treatment Period 3||3
107026|NCT01042236|247925|P1|COMPLETED|Treatment Period 3||3
107027|NCT01042236|247920|P6|STARTED|Treatment Period 3||3
107028|NCT01042236|247921|P5|STARTED|Treatment Period 3||3
107029|NCT01042236|247922|P4|STARTED|Treatment Period 3||5
107030|NCT01042236|247923|P3|STARTED|Treatment Period 3||3
107031|NCT01042236|247924|P2|STARTED|Treatment Period 3||3
107032|NCT01042236|247925|P1|STARTED|Treatment Period 3||3
107033|NCT01042236|247920|P6|NOT COMPLETED|Treatment Period 2||0
107034|NCT01042236|247921|P5|NOT COMPLETED|Treatment Period 2||0
107035|NCT01042236|247922|P4|NOT COMPLETED|Treatment Period 2||0
107036|NCT01042236|247923|P3|NOT COMPLETED|Treatment Period 2||0
107037|NCT01042236|247924|P2|NOT COMPLETED|Treatment Period 2||0
107038|NCT01042236|247925|P1|NOT COMPLETED|Treatment Period 2||0
107039|NCT01042236|247920|P6|COMPLETED|Treatment Period 2||3
107040|NCT01042236|247921|P5|COMPLETED|Treatment Period 2||3
107041|NCT01042236|247922|P4|COMPLETED|Treatment Period 2||5
107042|NCT01042236|247923|P3|COMPLETED|Treatment Period 2||3
107043|NCT01042236|247924|P2|COMPLETED|Treatment Period 2||3
107044|NCT01042236|247925|P1|COMPLETED|Treatment Period 2||3
107045|NCT01042236|247920|P6|STARTED|Treatment Period 2||3
107046|NCT01042236|247921|P5|STARTED|Treatment Period 2||3
107047|NCT01042236|247922|P4|STARTED|Treatment Period 2||5
107048|NCT01042236|247923|P3|STARTED|Treatment Period 2||3
107049|NCT01042236|247924|P2|STARTED|Treatment Period 2||3
107050|NCT01042236|247925|P1|STARTED|Treatment Period 2||3
107051|NCT01042236|247920|P6|NOT COMPLETED|Treatment Period 1||0
107052|NCT01042236|247921|P5|NOT COMPLETED|Treatment Period 1||1
107053|NCT01042236|247922|P4|NOT COMPLETED|Treatment Period 1||0
107054|NCT01042236|247923|P3|NOT COMPLETED|Treatment Period 1||0
107055|NCT01042236|247924|P2|NOT COMPLETED|Treatment Period 1||1
107056|NCT01042236|247925|P1|NOT COMPLETED|Treatment Period 1||0
107057|NCT01042236|247920|P6|COMPLETED|Treatment Period 1||3
107058|NCT01042236|247921|P5|COMPLETED|Treatment Period 1||3
107059|NCT01042236|247922|P4|COMPLETED|Treatment Period 1||5
107060|NCT01042236|247923|P3|COMPLETED|Treatment Period 1||3
107061|NCT01042236|247924|P2|COMPLETED|Treatment Period 1||3
107062|NCT01042236|247925|P1|COMPLETED|Treatment Period 1||3
107063|NCT01042236|247920|P6|STARTED|Treatment Period 1||3
107064|NCT01042236|247921|P5|STARTED|Treatment Period 1||4
107065|NCT01042236|247922|P4|STARTED|Treatment Period 1||5
107066|NCT01042236|247923|P3|STARTED|Treatment Period 1||3
107067|NCT01042236|247924|P2|STARTED|Treatment Period 1||4
107068|NCT01042236|247925|P1|STARTED|Treatment Period 1||3
107069|NCT01042145|247964|P2|NOT COMPLETED|Overall Study||1
107070|NCT01042145|247965|P1|NOT COMPLETED|Overall Study||1
107071|NCT01042145|247964|P2|COMPLETED|Overall Study||45
107072|NCT01042145|247965|P1|COMPLETED|Overall Study||40
107073|NCT01042145|247964|P2|STARTED|Overall Study||46
107074|NCT01042145|247965|P1|STARTED|Overall Study||41
107075|NCT01042093|247985|P4|NOT COMPLETED|Overall Study||4
107076|NCT01042093|247986|P3|NOT COMPLETED|Overall Study||2
107077|NCT01042093|247987|P2|NOT COMPLETED|Overall Study||2
107078|NCT01042093|247988|P1|NOT COMPLETED|Overall Study||2
107079|NCT01042093|247985|P4|COMPLETED|Overall Study||36
107080|NCT01042093|247986|P3|COMPLETED|Overall Study||38
107081|NCT01042093|247987|P2|COMPLETED|Overall Study||38
107082|NCT01042093|247988|P1|COMPLETED|Overall Study||38
107083|NCT01042093|247985|P4|STARTED|Overall Study||40
107084|NCT01042093|247986|P3|STARTED|Overall Study||40
107085|NCT01042093|247987|P2|STARTED|Overall Study||40
107086|NCT01042093|247988|P1|STARTED|Overall Study||40
107087|NCT01041976|248008|P2|NOT COMPLETED|Overall Study||4
107088|NCT01041976|248009|P1|NOT COMPLETED|Overall Study||5
107089|NCT01041976|248008|P2|COMPLETED|Overall Study||38
107090|NCT01041976|248009|P1|COMPLETED|Overall Study||37
107091|NCT01041976|248008|P2|18 Month Follow-up|Overall Study||38
107092|NCT01041976|248009|P1|18 Month Follow-up|Overall Study||37
107093|NCT01041976|248008|P2|12 Month Follow-up|Overall Study||38
107094|NCT01041976|248009|P1|12 Month Follow-up|Overall Study||37
107095|NCT01041976|248008|P2|6 Month Follow-up|Overall Study||41
107096|NCT01041976|248009|P1|6 Month Follow-up|Overall Study||39
107097|NCT01041976|248008|P2|STARTED|Overall Study||42
107098|NCT01041976|248009|P1|STARTED|Overall Study||42
107099|NCT01041859|248019|P3|NOT COMPLETED|Double-Blind Maintenance||45
107100|NCT01041859|248020|P2|NOT COMPLETED|Double-Blind Maintenance||46
107101|NCT01041859|248021|P1|NOT COMPLETED|Double-Blind Maintenance||0
107102|NCT01041859|248019|P3|COMPLETED|Double-Blind Maintenance||107
107103|NCT01041859|248020|P2|COMPLETED|Double-Blind Maintenance||120
107104|NCT01041859|248021|P1|COMPLETED|Double-Blind Maintenance||0
107105|NCT01041859|248019|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
107106|NCT01041859|248020|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
107107|NCT01041859|248021|P1|STARTED|Double-Blind Maintenance||0
107108|NCT01041859|248019|P3|NOT COMPLETED|Open-Label Titration||0
107109|NCT01041859|248020|P2|NOT COMPLETED|Open-Label Titration||0
107110|NCT01041859|248021|P1|NOT COMPLETED|Open-Label Titration||101
107111|NCT01041859|248019|P3|COMPLETED|Open-Label Titration||0
107112|NCT01041859|248020|P2|COMPLETED|Open-Label Titration||0
107113|NCT01041859|248021|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
107114|NCT01041859|248019|P3|STARTED|Open-Label Titration||0
107115|NCT01041859|248020|P2|STARTED|Open-Label Titration||0
107116|NCT01041859|248021|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
107117|NCT01041638|248036|P1|NOT COMPLETED|Overall Study||27
107118|NCT01041638|248036|P1|COMPLETED|Overall Study||78
107119|NCT01041638|248036|P1|STARTED|Overall Study||105
107120|NCT01041573|248044|P4|NOT COMPLETED|Overall Study||2
107121|NCT01041573|248045|P3|NOT COMPLETED|Overall Study||7
107122|NCT01041573|248046|P2|NOT COMPLETED|Overall Study||13
107123|NCT01041573|248047|P1|NOT COMPLETED|Overall Study||5
107124|NCT01041573|248044|P4|COMPLETED|Overall Study||62
107125|NCT01041573|248045|P3|COMPLETED|Overall Study||387
107126|NCT01041573|248046|P2|COMPLETED|Overall Study||858
107127|NCT01041573|248047|P1|COMPLETED|Overall Study||535
107128|NCT01041573|248044|P4|STARTED|Overall Study||64
107129|NCT01041573|248045|P3|STARTED|Overall Study||394
107130|NCT01041573|248046|P2|STARTED|Overall Study||871
107131|NCT01041573|248047|P1|STARTED|Overall Study||540
107132|NCT01041417|248059|P2|NOT COMPLETED|Overall Study||3
107133|NCT01041417|248060|P1|NOT COMPLETED|Overall Study||7
107134|NCT01041417|248059|P2|COMPLETED|Overall Study||76
107135|NCT01041417|248060|P1|COMPLETED|Overall Study||73
107136|NCT01041417|248059|P2|STARTED|Overall Study||79
107137|NCT01041417|248060|P1|STARTED|Overall Study||80
107138|NCT01041404|248098|P2|NOT COMPLETED|Overall Study||294
107139|NCT01041404|248099|P1|NOT COMPLETED|Overall Study||290
107140|NCT01041404|248098|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
107141|NCT01041404|248099|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
107142|NCT01041404|248098|P2|Alive in Follow-up|Overall Study||41
107143|NCT01041404|248099|P1|Alive in Follow-up|Overall Study||40
107144|NCT01041404|248098|P2|Lost to Follow-up|Overall Study||10
107145|NCT01041404|248099|P1|Lost to Follow-up|Overall Study||12
107146|NCT01041404|248098|P2|Died in Follow-up|Overall Study||200
107147|NCT01041404|248099|P1|Died in Follow-up|Overall Study||199
107148|NCT01041404|248098|P2|Entered Follow-Up|Overall Study||251
107149|NCT01041404|248099|P1|Entered Follow-Up|Overall Study||251
107150|NCT01041404|248098|P2|STARTED|Overall Study||294
107151|NCT01041404|248099|P1|STARTED|Overall Study||290
107152|NCT01041287|248140|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
107153|NCT01041287|248141|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
107154|NCT01041287|248140|P2|COMPLETED|Treatment Period 2 (3 Months)||14
107155|NCT01041287|248141|P1|COMPLETED|Treatment Period 2 (3 Months)||16
107156|NCT01041287|248140|P2|STARTED|Treatment Period 2 (3 Months)||19
107157|NCT01041287|248141|P1|STARTED|Treatment Period 2 (3 Months)||19
107158|NCT01041287|248140|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
107159|NCT01041287|248141|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
107160|NCT01041287|248140|P2|COMPLETED|Treatment Period 1 (3 Months)||19
107161|NCT01041287|248141|P1|COMPLETED|Treatment Period 1 (3 Months)||19
107162|NCT01041287|248140|P2|STARTED|Treatment Period 1 (3 Months)||19
107163|NCT01041287|248141|P1|STARTED|Treatment Period 1 (3 Months)||19
107164|NCT01041209|248153|P2|NOT COMPLETED|Overall Study||0
107165|NCT01041209|248154|P1|NOT COMPLETED|Overall Study||0
107166|NCT01041209|248153|P2|COMPLETED|Overall Study||60
107167|NCT01041209|248154|P1|COMPLETED|Overall Study||60
107168|NCT01041209|248153|P2|STARTED|Overall Study||60
107169|NCT01041209|248154|P1|STARTED|Overall Study||60
107170|NCT01040871|248164|P2|NOT COMPLETED|Overall Study||7
107171|NCT01040871|248165|P1|NOT COMPLETED|Overall Study||13
107172|NCT01040871|248164|P2|COMPLETED|Overall Study||73
107173|NCT01040871|248165|P1|COMPLETED|Overall Study||71
107174|NCT01040871|248164|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
107175|NCT01040871|248165|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
107176|NCT01040858|248185|P2|NOT COMPLETED|Overall Study||0
107177|NCT01040858|248186|P1|NOT COMPLETED|Overall Study||9
107178|NCT01040858|248185|P2|COMPLETED|Overall Study||69
107179|NCT01040858|248186|P1|COMPLETED|Overall Study||50
107180|NCT01040858|248185|P2|STARTED|Overall Study||69
107181|NCT01040858|248186|P1|STARTED|Overall Study||59
107182|NCT01040845|248216|P2|NOT COMPLETED|Overall Study||1
107183|NCT01040845|248217|P1|NOT COMPLETED|Overall Study||2
107184|NCT01040845|248216|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
107185|NCT01040845|248217|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
107186|NCT01040845|248216|P2|STARTED|Overall Study||15
107187|NCT01040845|248217|P1|STARTED|Overall Study||15
107188|NCT01040832|248232|P2|NOT COMPLETED|Overall Study||37
107189|NCT01040832|248233|P1|NOT COMPLETED|Overall Study||46
107190|NCT01040832|248232|P2|COMPLETED|Overall Study||16
107191|NCT01040832|248233|P1|COMPLETED|Overall Study||8
107192|NCT01040832|248232|P2|STARTED|Overall Study||53
107193|NCT01040832|248233|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
107194|NCT01040819|248249|P2|NOT COMPLETED|Overall Study||0
107195|NCT01040819|248250|P1|NOT COMPLETED|Overall Study||0
107196|NCT01040819|248249|P2|COMPLETED|Overall Study||12
107197|NCT01040819|248250|P1|COMPLETED|Overall Study||13
107198|NCT01040819|248249|P2|STARTED|Overall Study||12
107199|NCT01040819|248250|P1|STARTED|Overall Study||13
107200|NCT01040793|248256|P6|NOT COMPLETED|Overall Study||1
107201|NCT01040793|248257|P5|NOT COMPLETED|Overall Study||4
107202|NCT01040793|248258|P4|NOT COMPLETED|Overall Study||4
107203|NCT01040793|248259|P3|NOT COMPLETED|Overall Study||3
107204|NCT01040793|248260|P2|NOT COMPLETED|Overall Study||5
107205|NCT01040793|248261|P1|NOT COMPLETED|Overall Study||6
107206|NCT01040793|248256|P6|COMPLETED|Overall Study||26
107207|NCT01040793|248257|P5|COMPLETED|Overall Study||22
107208|NCT01040793|248258|P4|COMPLETED|Overall Study||22
107209|NCT01040793|248259|P3|COMPLETED|Overall Study||23
107210|NCT01040793|248260|P2|COMPLETED|Overall Study||21
107211|NCT01040793|248261|P1|COMPLETED|Overall Study||20
107212|NCT01040793|248256|P6|STARTED|Overall Study||27
107213|NCT01040793|248257|P5|STARTED|Overall Study||26
107214|NCT01040793|248258|P4|STARTED|Overall Study||26
107215|NCT01040793|248259|P3|STARTED|Overall Study||26
107216|NCT01040793|248260|P2|STARTED|Overall Study||26
107217|NCT01040793|248261|P1|STARTED|Overall Study|Entered and treated|26
107218|NCT01040780|248340|P2|NOT COMPLETED|Overall Study||3
107219|NCT01040780|248341|P1|NOT COMPLETED|Overall Study||1
107220|NCT01040780|248340|P2|COMPLETED|Overall Study||196
107221|NCT01040780|248341|P1|COMPLETED|Overall Study||199
107222|NCT01040780|248340|P2|STARTED|Overall Study||199
107223|NCT01040780|248341|P1|STARTED|Overall Study||200
107224|NCT01040728|248355|P4|NOT COMPLETED|Overall Study||6
107225|NCT01040728|248356|P3|NOT COMPLETED|Overall Study||1
107226|NCT01040728|248357|P2|NOT COMPLETED|Overall Study||11
107227|NCT01040728|248358|P1|NOT COMPLETED|Overall Study||4
107228|NCT01040728|248355|P4|COMPLETED|Overall Study||24
107229|NCT01040728|248356|P3|COMPLETED|Overall Study||30
107230|NCT01040728|248357|P2|COMPLETED|Overall Study||19
107231|NCT01040728|248358|P1|COMPLETED|Overall Study||27
107232|NCT01040728|248355|P4|STARTED|Overall Study||30
107233|NCT01040728|248356|P3|STARTED|Overall Study||31
107234|NCT01040728|248357|P2|STARTED|Overall Study||30
107235|NCT01040728|248358|P1|STARTED|Overall Study||31
107236|NCT01040689|248428|P4|NOT COMPLETED|Overall Study||4
107237|NCT01040689|248429|P3|NOT COMPLETED|Overall Study||4
107238|NCT01040689|248430|P2|NOT COMPLETED|Overall Study||2
107239|NCT01040689|248431|P1|NOT COMPLETED|Overall Study||3
107240|NCT01040689|248428|P4|COMPLETED|Overall Study||23
107241|NCT01040689|248429|P3|COMPLETED|Overall Study||23
107242|NCT01040689|248430|P2|COMPLETED|Overall Study||25
107243|NCT01040689|248431|P1|COMPLETED|Overall Study||24
107244|NCT01040689|248428|P4|STARTED|Overall Study||27
107245|NCT01040689|248429|P3|STARTED|Overall Study||27
107246|NCT01040689|248430|P2|STARTED|Overall Study||27
107247|NCT01040689|248431|P1|STARTED|Overall Study||27
107248|NCT01040624|248503|P2|NOT COMPLETED|Overall Study||0
107249|NCT01040624|248504|P1|NOT COMPLETED|Overall Study||0
107250|NCT01040624|248503|P2|COMPLETED|Overall Study||19
107251|NCT01040624|248504|P1|COMPLETED|Overall Study||58
107252|NCT01040624|248503|P2|STARTED|Overall Study||19
107253|NCT01040624|248504|P1|STARTED|Overall Study||58
107254|NCT01039519|248510|P1|NOT COMPLETED|Survival Follow-up||27
107255|NCT01039519|248510|P1|COMPLETED|Survival Follow-up||0
107256|NCT01039519|248510|P1|STARTED|Survival Follow-up||27
107257|NCT01039519|248510|P1|NOT COMPLETED|Treatment||27
107258|NCT01039519|248510|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
107259|NCT01039519|248510|P1|STARTED|Treatment||27
107260|NCT01040403|248519|P1|NOT COMPLETED|Overall Study||20
107261|NCT01040403|248519|P1|COMPLETED|Overall Study|All treatment periods|213
107262|NCT01040403|248519|P1|Completed T+O 5/10|Overall Study||107
107263|NCT01040403|248519|P1|Completed T+O 2.5/10|Overall Study||110
107264|NCT01040403|248519|P1|Completed T+O 1.25/10|Overall Study||106
107265|NCT01040403|248519|P1|Completed Olo 10|Overall Study||109
107266|NCT01040403|248519|P1|Completed T+O 5/5|Overall Study||106
107267|NCT01040403|248519|P1|Completed T+O 2.5/5|Overall Study||111
107268|NCT01040403|248519|P1|Completed T+O 1.25/5|Overall Study||105
107269|NCT01040403|248519|P1|Completed Olo 5|Overall Study||106
107270|NCT01040403|248519|P1|STARTED|Overall Study||233
107271|NCT01040351|248707|P2|NOT COMPLETED|Overall Study||2
107272|NCT01040351|248708|P1|NOT COMPLETED|Overall Study||1
107273|NCT01040351|248707|P2|COMPLETED|Overall Study|May 2010|53
107274|NCT01040351|248708|P1|COMPLETED|Overall Study|May 2010|54
107275|NCT01040351|248707|P2|STARTED|Overall Study|October 2006|55
107276|NCT01040351|248708|P1|STARTED|Overall Study|October 2006|55
107277|NCT01040260|248718|P2|NOT COMPLETED|Overall Study||11
107278|NCT01040260|248719|P1|NOT COMPLETED|Overall Study||15
107279|NCT01040260|248718|P2|COMPLETED|Overall Study||39
107280|NCT01040260|248719|P1|COMPLETED|Overall Study||38
107281|NCT01040260|248718|P2|STARTED|Overall Study||50
107282|NCT01040260|248719|P1|STARTED|Overall Study||53
107283|NCT01040208|248728|P3|NOT COMPLETED|Overall Study||3
107284|NCT01040208|248729|P2|NOT COMPLETED|Overall Study||13
107285|NCT01040208|248730|P1|NOT COMPLETED|Overall Study||6
107286|NCT01040208|248728|P3|COMPLETED|Overall Study||35
107287|NCT01040208|248729|P2|COMPLETED|Overall Study||15
107288|NCT01040208|248730|P1|COMPLETED|Overall Study||39
107289|NCT01040208|248728|P3|STARTED|Overall Study||38
107290|NCT01040208|248729|P2|STARTED|Overall Study||28
107291|NCT01040208|248730|P1|STARTED|Overall Study||45
107292|NCT01040169|248746|P2|NOT COMPLETED|Overall Study||8
107293|NCT01040169|248747|P1|NOT COMPLETED|Overall Study||3
107294|NCT01040169|248746|P2|COMPLETED|Overall Study||36
107295|NCT01040169|248747|P1|COMPLETED|Overall Study||32
107296|NCT01040169|248746|P2|STARTED|Overall Study||44
107297|NCT01040169|248747|P1|STARTED|Overall Study||35
107298|NCT01040130|248755|P6|NOT COMPLETED|Overall Study||4
107299|NCT01040130|248756|P5|NOT COMPLETED|Overall Study||0
107300|NCT01040130|248757|P4|NOT COMPLETED|Overall Study||5
107301|NCT01040130|248758|P3|NOT COMPLETED|Overall Study||2
107302|NCT01040130|248759|P2|NOT COMPLETED|Overall Study||3
107303|NCT01040130|248760|P1|NOT COMPLETED|Overall Study||3
107304|NCT01040130|248755|P6|COMPLETED|Overall Study||22
107305|NCT01040130|248756|P5|COMPLETED|Overall Study||25
107306|NCT01040130|248757|P4|COMPLETED|Overall Study||20
107307|NCT01040130|248758|P3|COMPLETED|Overall Study||23
107308|NCT01040130|248759|P2|COMPLETED|Overall Study||22
107309|NCT01040130|248760|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
107310|NCT01040130|248755|P6|STARTED|Overall Study||26
107311|NCT01040130|248756|P5|STARTED|Overall Study||25
107312|NCT01040130|248757|P4|STARTED|Overall Study||25
107313|NCT01040130|248758|P3|STARTED|Overall Study||25
107314|NCT01040130|248759|P2|STARTED|Overall Study||25
107315|NCT01040130|248760|P1|STARTED|Overall Study|Number of patients entered and treated|25
107316|NCT01040052|248837|P1|NOT COMPLETED|Overall Study||0
107317|NCT01040052|248837|P1|COMPLETED|Overall Study||30
107318|NCT01040052|248837|P1|STARTED|Overall Study||30
107319|NCT01039675|248843|P2|NOT COMPLETED|Overall Study||7
107320|NCT01039675|248844|P1|NOT COMPLETED|Overall Study||0
107321|NCT01039675|248843|P2|COMPLETED|Overall Study||35
107322|NCT01039675|248844|P1|COMPLETED|Overall Study||9
107323|NCT01039675|248843|P2|STARTED|Overall Study||42
107324|NCT01039675|248844|P1|STARTED|Overall Study||9
107325|NCT01039584|248857|P3|NOT COMPLETED|Overall Study||57
107326|NCT01039584|248858|P2|NOT COMPLETED|Overall Study||97
107327|NCT01039584|248859|P1|NOT COMPLETED|Overall Study||103
107328|NCT01039584|248857|P3|COMPLETED|Overall Study||65
107329|NCT01039584|248858|P2|COMPLETED|Overall Study||146
107330|NCT01039584|248859|P1|COMPLETED|Overall Study||143
107331|NCT01039584|248857|P3|STARTED|Overall Study||122
107332|NCT01039584|248858|P2|STARTED|Overall Study||243
107333|NCT01039584|248859|P1|STARTED|Overall Study||246
107334|NCT01039428|248875|P2|NOT COMPLETED|Overall Study||0
107335|NCT01039428|248876|P1|NOT COMPLETED|Overall Study||2
107336|NCT01039428|248875|P2|COMPLETED|Overall Study||28
107337|NCT01039428|248876|P1|COMPLETED|Overall Study||33
107338|NCT01039428|248875|P2|STARTED|Overall Study||28
107339|NCT01039428|248876|P1|STARTED|Overall Study||35
107340|NCT01039376|248900|P2|NOT COMPLETED|Overall Study||202
107341|NCT01039376|248901|P1|NOT COMPLETED|Overall Study||206
107342|NCT01039376|248900|P2|COMPLETED|Overall Study||34
107343|NCT01039376|248901|P1|COMPLETED|Overall Study||32
107344|NCT01039376|248900|P2|Ongoing|Overall Study||182
107345|NCT01039376|248901|P1|Ongoing|Overall Study||189
107346|NCT01039376|248900|P2|STARTED|Overall Study||236
107347|NCT01039376|248901|P1|STARTED|Overall Study||238
107348|NCT01038921|248961|P2|NOT COMPLETED|Overall Study||0
107349|NCT01038921|248962|P1|NOT COMPLETED|Overall Study||2
107350|NCT01038921|248961|P2|COMPLETED|Overall Study||20
107351|NCT01038921|248962|P1|COMPLETED|Overall Study|2 subjects withdrew|17
107352|NCT01038921|248961|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
107353|NCT01038921|248962|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
107354|NCT01038869|248968|P1|NOT COMPLETED|Overall Study||7
107355|NCT01038869|248968|P1|COMPLETED|Overall Study||13
107356|NCT01038869|248968|P1|STARTED|Overall Study||20
107357|NCT01038752|248978|P2|NOT COMPLETED|Overall Study||5
107358|NCT01038752|248979|P1|NOT COMPLETED|Overall Study||5
107359|NCT01038752|248978|P2|COMPLETED|Overall Study||1
107360|NCT01038752|248979|P1|COMPLETED|Overall Study||3
107361|NCT01038752|248978|P2|STARTED|Overall Study||6
107362|NCT01038752|248979|P1|STARTED|Overall Study||8
107363|NCT01038713|249002|P3|NOT COMPLETED|Overall Study||1
107364|NCT01038713|249003|P2|NOT COMPLETED|Overall Study||3
107365|NCT01038713|249004|P1|NOT COMPLETED|Overall Study||5
107366|NCT01038713|249002|P3|COMPLETED|Overall Study||16
107367|NCT01038713|249003|P2|COMPLETED|Overall Study||17
107368|NCT01038713|249004|P1|COMPLETED|Overall Study||21
107369|NCT01038713|249002|P3|STARTED|Overall Study||17
107370|NCT01038713|249003|P2|STARTED|Overall Study||20
107371|NCT01038713|249004|P1|STARTED|Overall Study||26
107372|NCT01038635|249033|P9|NOT COMPLETED|Overall Study||2
107373|NCT01038635|249034|P8|NOT COMPLETED|Overall Study||5
107374|NCT01038635|249035|P7|NOT COMPLETED|Overall Study||2
107375|NCT01038635|249036|P6|NOT COMPLETED|Overall Study||0
107376|NCT01038635|249037|P5|NOT COMPLETED|Overall Study||1
107377|NCT01038635|249038|P4|NOT COMPLETED|Overall Study||0
107378|NCT01038635|249039|P3|NOT COMPLETED|Overall Study||0
107379|NCT01038635|249040|P2|NOT COMPLETED|Overall Study||0
107380|NCT01038635|249041|P1|NOT COMPLETED|Overall Study||2
107381|NCT01038635|249033|P9|COMPLETED|Overall Study||38
107382|NCT01038635|249034|P8|COMPLETED|Overall Study||15
107383|NCT01038635|249035|P7|COMPLETED|Overall Study||5
107384|NCT01038635|249036|P6|COMPLETED|Overall Study||3
107385|NCT01038635|249037|P5|COMPLETED|Overall Study||3
107386|NCT01038635|249038|P4|COMPLETED|Overall Study||3
107387|NCT01038635|249039|P3|COMPLETED|Overall Study||3
107388|NCT01038635|249040|P2|COMPLETED|Overall Study||3
107389|NCT01038635|249041|P1|COMPLETED|Overall Study||3
107390|NCT01038635|249033|P9|STARTED|Overall Study||40
107391|NCT01038635|249034|P8|STARTED|Overall Study||20
107392|NCT01038635|249035|P7|STARTED|Overall Study||7
107393|NCT01038635|249036|P6|STARTED|Overall Study||3
107394|NCT01038635|249037|P5|STARTED|Overall Study||4
107395|NCT01038635|249038|P4|STARTED|Overall Study||3
107396|NCT01038635|249039|P3|STARTED|Overall Study||3
107397|NCT01038635|249040|P2|STARTED|Overall Study||3
107398|NCT01038635|249041|P1|STARTED|Overall Study||5
107399|NCT01038609|249067|P5|NOT COMPLETED|Overall Study||1
107400|NCT01038609|249068|P4|NOT COMPLETED|Overall Study||1
107401|NCT01038609|249069|P3|NOT COMPLETED|Overall Study||1
107402|NCT01038609|249070|P2|NOT COMPLETED|Overall Study||1
107403|NCT01038609|249071|P1|NOT COMPLETED|Overall Study||1
107404|NCT01038609|249067|P5|COMPLETED|Overall Study||50
107405|NCT01038609|249068|P4|COMPLETED|Overall Study||47
107406|NCT01038609|249069|P3|COMPLETED|Overall Study||48
107407|NCT01038609|249070|P2|COMPLETED|Overall Study||51
107408|NCT01038609|249071|P1|COMPLETED|Overall Study||49
107409|NCT01038609|249067|P5|STARTED|Overall Study||51
107410|NCT01038609|249068|P4|STARTED|Overall Study||48
107411|NCT01038609|249069|P3|STARTED|Overall Study||49
107412|NCT01038609|249070|P2|STARTED|Overall Study||52
107413|NCT01038609|249071|P1|STARTED|Overall Study||50
107414|NCT01038336|249116|P3|NOT COMPLETED|Overall Study||0
107415|NCT01038336|249117|P2|NOT COMPLETED|Overall Study||0
107416|NCT01038336|249118|P1|NOT COMPLETED|Overall Study||0
107417|NCT01038336|249116|P3|COMPLETED|Overall Study||44
107418|NCT01038336|249117|P2|COMPLETED|Overall Study||42
107419|NCT01038336|249118|P1|COMPLETED|Overall Study||43
107420|NCT01038336|249116|P3|STARTED|Overall Study||44
107421|NCT01038336|249117|P2|STARTED|Overall Study||42
107422|NCT01038336|249118|P1|STARTED|Overall Study||43
107423|NCT01038323|249150|P3|NOT COMPLETED|Overall Study||4
107424|NCT01038323|249151|P2|NOT COMPLETED|Overall Study||2
107425|NCT01038323|249152|P1|NOT COMPLETED|Overall Study||3
107426|NCT01038323|249150|P3|COMPLETED|Overall Study||15
107427|NCT01038323|249151|P2|COMPLETED|Overall Study||17
107428|NCT01038323|249152|P1|COMPLETED|Overall Study||17
107429|NCT01038323|249150|P3|STARTED|Overall Study||19
107430|NCT01038323|249151|P2|STARTED|Overall Study||19
107431|NCT01038323|249152|P1|STARTED|Overall Study||20
107432|NCT01038128|249163|P1|NOT COMPLETED|Overall Study||4
107433|NCT01038128|249163|P1|COMPLETED|Overall Study||1
107434|NCT01038128|249163|P1|Baseline Visit|Overall Study||3
107435|NCT01038128|249163|P1|STARTED|Overall Study||5
107436|NCT01037452|249175|P4|NOT COMPLETED|Overall Study||0
107437|NCT01037452|249176|P3|NOT COMPLETED|Overall Study||0
107438|NCT01037452|249177|P2|NOT COMPLETED|Overall Study||0
107439|NCT01037452|249178|P1|NOT COMPLETED|Overall Study||0
107440|NCT01037452|249175|P4|COMPLETED|Overall Study||30
107441|NCT01037452|249176|P3|COMPLETED|Overall Study||30
107442|NCT01037452|249177|P2|COMPLETED|Overall Study||30
107443|NCT01037452|249178|P1|COMPLETED|Overall Study||30
107444|NCT01037452|249175|P4|STARTED|Overall Study||30
107445|NCT01037452|249176|P3|STARTED|Overall Study||30
107446|NCT01037452|249177|P2|STARTED|Overall Study||30
107447|NCT01037452|249178|P1|STARTED|Overall Study||30
107448|NCT01037309|249206|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
107449|NCT01037309|249207|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
107450|NCT01037309|249208|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
107451|NCT01037309|249209|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
107452|NCT01037309|249210|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
107453|NCT01037309|249211|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
107454|NCT01037309|249212|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
107455|NCT01037309|249213|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
107456|NCT01037309|249214|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
107457|NCT01037309|249206|P9|COMPLETED|Intravenous Period 7 - 9||3
107458|NCT01037309|249207|P8|COMPLETED|Intravenous Period 7 - 9||3
107459|NCT01037309|249208|P7|COMPLETED|Intravenous Period 7 - 9||3
107460|NCT01037309|249209|P6|COMPLETED|Intravenous Period 7 - 9||0
107461|NCT01037309|249210|P5|COMPLETED|Intravenous Period 7 - 9||0
107462|NCT01037309|249211|P4|COMPLETED|Intravenous Period 7 - 9||0
107463|NCT01037309|249212|P3|COMPLETED|Intravenous Period 7 - 9||0
107464|NCT01037309|249213|P2|COMPLETED|Intravenous Period 7 - 9||0
107465|NCT01037309|249214|P1|COMPLETED|Intravenous Period 7 - 9||0
107466|NCT01037309|249206|P9|STARTED|Intravenous Period 7 - 9||3
107467|NCT01037309|249207|P8|STARTED|Intravenous Period 7 - 9||3
107468|NCT01037309|249208|P7|STARTED|Intravenous Period 7 - 9||3
107469|NCT01037309|249209|P6|STARTED|Intravenous Period 7 - 9||0
107470|NCT01037309|249210|P5|STARTED|Intravenous Period 7 - 9||0
107471|NCT01037309|249211|P4|STARTED|Intravenous Period 7 - 9||0
107472|NCT01037309|249212|P3|STARTED|Intravenous Period 7 - 9||0
107473|NCT01037309|249213|P2|STARTED|Intravenous Period 7 - 9||0
107474|NCT01037309|249214|P1|STARTED|Intravenous Period 7 - 9||0
107475|NCT01037309|249206|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107476|NCT01037309|249207|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107477|NCT01037309|249208|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107478|NCT01037309|249209|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107479|NCT01037309|249210|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107480|NCT01037309|249211|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107481|NCT01037309|249212|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107482|NCT01037309|249213|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107483|NCT01037309|249214|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
107484|NCT01037309|249206|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
107485|NCT01037309|249207|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
107486|NCT01037309|249208|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
107487|NCT01037309|249209|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
107488|NCT01037309|249210|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
107489|NCT01037309|249211|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
107490|NCT01037309|249212|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
107491|NCT01037309|249213|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
107492|NCT01037309|249214|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
107493|NCT01037309|249206|P9|STARTED|Subcutaneous Cohort 1 - 6||0
107494|NCT01037309|249207|P8|STARTED|Subcutaneous Cohort 1 - 6||0
107495|NCT01037309|249208|P7|STARTED|Subcutaneous Cohort 1 - 6||0
107496|NCT01037309|249209|P6|STARTED|Subcutaneous Cohort 1 - 6||3
107497|NCT01037309|249210|P5|STARTED|Subcutaneous Cohort 1 - 6||3
107498|NCT01037309|249211|P4|STARTED|Subcutaneous Cohort 1 - 6||3
107499|NCT01037309|249212|P3|STARTED|Subcutaneous Cohort 1 - 6||3
107500|NCT01037309|249213|P2|STARTED|Subcutaneous Cohort 1 - 6||3
107501|NCT01037309|249214|P1|STARTED|Subcutaneous Cohort 1 - 6||3
107502|NCT01037244|249247|P4|NOT COMPLETED|Overall Study||14
107503|NCT01037244|249248|P3|NOT COMPLETED|Overall Study||14
107504|NCT01037244|249249|P2|NOT COMPLETED|Overall Study||14
107505|NCT01037244|249250|P1|NOT COMPLETED|Overall Study||13
107506|NCT01037244|249247|P4|COMPLETED|Overall Study||140
107507|NCT01037244|249248|P3|COMPLETED|Overall Study||144
107508|NCT01037244|249249|P2|COMPLETED|Overall Study||138
107509|NCT01037244|249250|P1|COMPLETED|Overall Study||141
107510|NCT01037244|249247|P4|Safety Population|Overall Study||152
107511|NCT01037244|249248|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
107512|NCT01037244|249249|P2|Safety Population|Overall Study||150
107513|NCT01037244|249250|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
107514|NCT01037244|249247|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
107515|NCT01037244|249248|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
107516|NCT01037244|249249|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
107517|NCT01037244|249250|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
107518|NCT01037244|249247|P4|STARTED|Overall Study||154
107519|NCT01037244|249248|P3|STARTED|Overall Study||158
107520|NCT01037244|249249|P2|STARTED|Overall Study||152
107521|NCT01037244|249250|P1|STARTED|Overall Study||154
107522|NCT01037218|249312|P4|NOT COMPLETED|Overall Study||16
107523|NCT01037218|249313|P3|NOT COMPLETED|Overall Study||21
107524|NCT01037218|249314|P2|NOT COMPLETED|Overall Study||21
107525|NCT01037218|249315|P1|NOT COMPLETED|Overall Study||16
107526|NCT01037218|249312|P4|COMPLETED|Overall Study||134
107527|NCT01037218|249313|P3|COMPLETED|Overall Study||134
107528|NCT01037218|249314|P2|COMPLETED|Overall Study||128
107529|NCT01037218|249315|P1|COMPLETED|Overall Study||131
107530|NCT01037218|249312|P4|mITT Population|Overall Study||141
107531|NCT01037218|249313|P3|mITT Population|Overall Study||147
107532|NCT01037218|249314|P2|mITT Population|Overall Study||140
107533|NCT01037218|249315|P1|mITT Population|Overall Study||141
107534|NCT01037218|249312|P4|Safety Population|Overall Study||150
107535|NCT01037218|249313|P3|Safety Population|Overall Study||154
107536|NCT01037218|249314|P2|Safety Population|Overall Study||148
107537|NCT01037218|249315|P1|Safety Population|Overall Study||147
107538|NCT01037218|249312|P4|STARTED|Overall Study||150
107539|NCT01037218|249313|P3|STARTED|Overall Study||155
107540|NCT01037218|249314|P2|STARTED|Overall Study||149
107541|NCT01037218|249315|P1|STARTED|Overall Study||147
107542|NCT01037192|249375|P2|NOT COMPLETED|Overall Study||0
107543|NCT01037192|249376|P1|NOT COMPLETED|Overall Study||0
107544|NCT01037192|249375|P2|COMPLETED|Overall Study||1
107545|NCT01037192|249376|P1|COMPLETED|Overall Study||3
107546|NCT01037192|249375|P2|STARTED|Overall Study||1
107547|NCT01037192|249376|P1|STARTED|Overall Study||3
107548|NCT01037127|249386|P2|NOT COMPLETED|Overall Study||21
107549|NCT01037127|249387|P1|NOT COMPLETED|Overall Study||5
107550|NCT01037127|249386|P2|COMPLETED|Overall Study||36
107551|NCT01037127|249387|P1|COMPLETED|Overall Study||35
107552|NCT01037127|249386|P2|STARTED|Overall Study||57
107553|NCT01037127|249387|P1|STARTED|Overall Study||40
107554|NCT01037114|249419|P1|NOT COMPLETED|Year 20||1
107555|NCT01037114|249419|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
107556|NCT01037114|249419|P1|STARTED|Year 20||45
107557|NCT01037114|249419|P1|NOT COMPLETED|Year 19||0
107558|NCT01037114|249419|P1|COMPLETED|Year 19||45
107559|NCT01037114|249419|P1|STARTED|Year 19||45
107560|NCT01037114|249419|P1|NOT COMPLETED|Year 18||0
107561|NCT01037114|249419|P1|COMPLETED|Year 18||44
107562|NCT01037114|249419|P1|STARTED|Year 18||44
107563|NCT01037114|249419|P1|NOT COMPLETED|Year 17||0
107564|NCT01037114|249419|P1|COMPLETED|Year 17||48
107565|NCT01037114|249419|P1|STARTED|Year 17||48
107566|NCT01037114|249419|P1|NOT COMPLETED|Year 16||0
107567|NCT01037114|249419|P1|COMPLETED|Year 16||49
107568|NCT01037114|249419|P1|STARTED|Year 16||49
107569|NCT01037088|249432|P1|NOT COMPLETED|Overall Study||3
107570|NCT01037088|249432|P1|COMPLETED|Overall Study||36
107571|NCT01037088|249432|P1|Received Placebo|Overall Study||38
107572|NCT01037088|249432|P1|Received 1.29% THC|Overall Study||37
107573|NCT01037088|249432|P1|Received 3.53% THC|Overall Study||36
107574|NCT01037088|249432|P1|STARTED|Overall Study||39
107575|NCT01036802|249442|P2|NOT COMPLETED|Overall Study||0
107576|NCT01036802|249443|P1|NOT COMPLETED|Overall Study||0
107577|NCT01036802|249442|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
107578|NCT01036802|249443|P1|COMPLETED|Overall Study||2
107579|NCT01036802|249442|P2|STARTED|Overall Study||1
107580|NCT01036802|249443|P1|STARTED|Overall Study||2
107581|NCT01036763|249461|P1|NOT COMPLETED|Overall Study||93
107582|NCT01036763|249461|P1|COMPLETED|Overall Study||1171
107583|NCT01036763|249461|P1|STARTED|Overall Study||1264
107584|NCT01036724|249473|P2|NOT COMPLETED|Overall Study||8
107585|NCT01036724|249474|P1|NOT COMPLETED|Overall Study||6
107586|NCT01036724|249473|P2|COMPLETED|Overall Study||47
107587|NCT01036724|249474|P1|COMPLETED|Overall Study||46
107588|NCT01036724|249473|P2|STARTED|Overall Study||55
107589|NCT01036724|249474|P1|STARTED|Overall Study||52
107590|NCT01036529|249484|P2|NOT COMPLETED|Overall Study||15
107591|NCT01036529|249485|P1|NOT COMPLETED|Overall Study||13
107592|NCT01036529|249484|P2|COMPLETED|Overall Study||0
107593|NCT01036529|249485|P1|COMPLETED|Overall Study||0
107594|NCT01036529|249484|P2|Crossover to Other Group|Overall Study||1
107595|NCT01036529|249485|P1|Crossover to Other Group|Overall Study||1
107596|NCT01036529|249484|P2|Requested Crossover|Overall Study||2
107597|NCT01036529|249485|P1|Requested Crossover|Overall Study||1
107598|NCT01036529|249484|P2|12 Month Follow-up|Overall Study||3
107599|NCT01036529|249485|P1|12 Month Follow-up|Overall Study||4
107600|NCT01036529|249484|P2|6 Month Follow-up|Overall Study||7
107601|NCT01036529|249485|P1|6 Month Follow-up|Overall Study||6
107602|NCT01036529|249484|P2|3 Month Follow-up|Overall Study||9
107603|NCT01036529|249485|P1|3 Month Follow-up|Overall Study||7
107604|NCT01036529|249484|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
107605|NCT01036529|249485|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
107606|NCT01036529|249484|P2|Baseline Visit|Overall Study||13
107607|NCT01036529|249485|P1|Baseline Visit|Overall Study||10
107608|NCT01036529|249484|P2|STARTED|Overall Study||15
107609|NCT01036529|249485|P1|STARTED|Overall Study||13
107610|NCT01036490|249493|P2|NOT COMPLETED|Overall Study||0
107611|NCT01036490|249494|P1|NOT COMPLETED|Overall Study||4
107612|NCT01036490|249493|P2|COMPLETED|Overall Study||18
107613|NCT01036490|249494|P1|COMPLETED|Overall Study||14
107614|NCT01036490|249493|P2|STARTED|Overall Study||18
107615|NCT01036490|249494|P1|STARTED|Overall Study||18
107616|NCT01036438|249512|P2|NOT COMPLETED|Overall Study||10
107617|NCT01036438|249513|P1|NOT COMPLETED|Overall Study||10
107618|NCT01036438|249512|P2|COMPLETED|Overall Study||90
107619|NCT01036438|249513|P1|COMPLETED|Overall Study||91
107620|NCT01036438|249512|P2|STARTED|Overall Study||100
107621|NCT01036438|249513|P1|STARTED|Overall Study||101
107622|NCT01036321|249521|P2|NOT COMPLETED|Overall Study||4
107623|NCT01036321|249522|P1|NOT COMPLETED|Overall Study||5
107624|NCT01036321|249521|P2|COMPLETED|Overall Study||31
107625|NCT01036321|249522|P1|COMPLETED|Overall Study||31
107626|NCT01036321|249521|P2|STARTED|Overall Study||35
107627|NCT01036321|249522|P1|STARTED|Overall Study||36
107628|NCT01036165|249546|P1|NOT COMPLETED|Overall Study||15
107629|NCT01036165|249546|P1|COMPLETED|Overall Study||88
107630|NCT01036165|249546|P1|STARTED|Overall Study||103
107631|NCT01036009|249553|P2|NOT COMPLETED|Overall Study||0
107632|NCT01036009|249554|P1|NOT COMPLETED|Overall Study||0
107633|NCT01036009|249553|P2|COMPLETED|Overall Study||26
107634|NCT01036009|249554|P1|COMPLETED|Overall Study||17
107635|NCT01036009|249553|P2|STARTED|Overall Study||26
107636|NCT01036009|249554|P1|STARTED|Overall Study||17
107637|NCT01035944|249572|P4|NOT COMPLETED|Overall Study||0
107638|NCT01035944|249573|P3|NOT COMPLETED|Overall Study||1
107639|NCT01035944|249574|P2|NOT COMPLETED|Overall Study||1
107640|NCT01035944|249575|P1|NOT COMPLETED|Overall Study||3
107641|NCT01035944|249572|P4|COMPLETED|Overall Study||4
107642|NCT01035944|249573|P3|COMPLETED|Overall Study||4
107643|NCT01035944|249574|P2|COMPLETED|Overall Study||13
107644|NCT01035944|249575|P1|COMPLETED|Overall Study||11
107645|NCT01035944|249572|P4|STARTED|Overall Study||4
107646|NCT01035944|249573|P3|STARTED|Overall Study||5
107647|NCT01035944|249574|P2|STARTED|Overall Study||14
107648|NCT01035944|249575|P1|STARTED|Overall Study||14
107649|NCT01035905|249587|P2|NOT COMPLETED|Overall Study||1
107650|NCT01035905|249588|P1|NOT COMPLETED|Overall Study||1
107651|NCT01035905|249587|P2|COMPLETED|Overall Study||30
107652|NCT01035905|249588|P1|COMPLETED|Overall Study||31
107653|NCT01035905|249587|P2|STARTED|Overall Study||31
107654|NCT01035905|249588|P1|STARTED|Overall Study||32
107655|NCT01035788|249596|P2|NOT COMPLETED|Overall Study||14
107656|NCT01035788|249597|P1|NOT COMPLETED|Overall Study||6
107657|NCT01035788|249596|P2|COMPLETED|Overall Study||9
107658|NCT01035788|249597|P1|COMPLETED|Overall Study||17
107659|NCT01035788|249596|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
107660|NCT01035788|249597|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
107661|NCT01035749|249607|P4|NOT COMPLETED|Overall Study||0
107662|NCT01035749|249608|P3|NOT COMPLETED|Overall Study||0
107663|NCT01035749|249609|P2|NOT COMPLETED|Overall Study||0
107664|NCT01035749|249610|P1|NOT COMPLETED|Overall Study||0
107665|NCT01035749|249607|P4|COMPLETED|Overall Study||110
107666|NCT01035749|249608|P3|COMPLETED|Overall Study||68
107667|NCT01035749|249609|P2|COMPLETED|Overall Study||66
107668|NCT01035749|249610|P1|COMPLETED|Overall Study||66
107669|NCT01035749|249607|P4|STARTED|Overall Study||110
107670|NCT01035749|249608|P3|STARTED|Overall Study||68
107671|NCT01035749|249609|P2|STARTED|Overall Study||66
107672|NCT01035749|249610|P1|STARTED|Overall Study||66
107673|NCT01035658|249732|P4|NOT COMPLETED|Overall Study||0
107674|NCT01035658|249733|P3|NOT COMPLETED|Overall Study||0
107675|NCT01035658|249734|P2|NOT COMPLETED|Overall Study||0
107676|NCT01035658|249735|P1|NOT COMPLETED|Overall Study||0
107677|NCT01035658|249732|P4|COMPLETED|Overall Study||6
107678|NCT01035658|249733|P3|COMPLETED|Overall Study||3
107679|NCT01035658|249734|P2|COMPLETED|Overall Study||8
107680|NCT01035658|249735|P1|COMPLETED|Overall Study||5
107681|NCT01035658|249732|P4|STARTED|Overall Study||6
107682|NCT01035658|249733|P3|STARTED|Overall Study||3
107683|NCT01035658|249734|P2|STARTED|Overall Study||8
107684|NCT01035658|249735|P1|STARTED|Overall Study||5
107685|NCT01035346|249760|P2|NOT COMPLETED|Overall Study||0
107686|NCT01035346|249761|P1|NOT COMPLETED|Overall Study||0
107687|NCT01035346|249760|P2|COMPLETED|Overall Study||9
107688|NCT01035346|249761|P1|COMPLETED|Overall Study||7
107689|NCT01035346|249760|P2|STARTED|Overall Study||9
107690|NCT01035346|249761|P1|STARTED|Overall Study||7
107691|NCT01035333|249779|P1|NOT COMPLETED|Overall Study||10
107692|NCT01035333|249779|P1|COMPLETED|Overall Study||9
107693|NCT01035333|249779|P1|STARTED|Overall Study||19
107694|NCT01035255|249786|P2|NOT COMPLETED|Overall Study||862
107695|NCT01035255|249787|P1|NOT COMPLETED|Overall Study||741
107696|NCT01035255|249786|P2|COMPLETED|Overall Study||3371
107697|NCT01035255|249787|P1|COMPLETED|Overall Study||3468
107698|NCT01035255|249786|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
107699|NCT01035255|249787|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
107700|NCT01035255|249786|P2|Mis-randomized|Overall Study||2
107701|NCT01035255|249787|P1|Mis-randomized|Overall Study||4
107702|NCT01035255|249786|P2|GCP Violations|Overall Study||19
107703|NCT01035255|249787|P1|GCP Violations|Overall Study||18
107704|NCT01035255|249786|P2|STARTED|Overall Study||4233
107705|NCT01035255|249787|P1|STARTED|Overall Study||4209
107706|NCT01035229|249805|P2|NOT COMPLETED|Overall Study||184
107707|NCT01035229|249806|P1|NOT COMPLETED|Overall Study||362
107708|NCT01035229|249805|P2|COMPLETED|Overall Study||0
107709|NCT01035229|249806|P1|COMPLETED|Overall Study||0
107710|NCT01035229|249805|P2|STARTED|Overall Study||184
107711|NCT01035229|249806|P1|STARTED|Overall Study||362
107712|NCT01035138|249827|P3|NOT COMPLETED|Overall Study||47
107713|NCT01035138|249828|P2|NOT COMPLETED|Overall Study||60
107714|NCT01035138|249829|P1|NOT COMPLETED|Overall Study||73
107715|NCT01035138|249827|P3|COMPLETED|Overall Study||0
107716|NCT01035138|249828|P2|COMPLETED|Overall Study||0
107717|NCT01035138|249829|P1|COMPLETED|Overall Study||0
107718|NCT01035138|249827|P3|STARTED|Overall Study||47
107719|NCT01035138|249828|P2|STARTED|Overall Study||60
107720|NCT01035138|249829|P1|STARTED|Overall Study||73
107721|NCT01035060|249885|P2|NOT COMPLETED|Overall Study||14
107722|NCT01035060|249886|P1|NOT COMPLETED|Overall Study||24
107723|NCT01035060|249885|P2|COMPLETED|Overall Study||15
107724|NCT01035060|249886|P1|COMPLETED|Overall Study||15
107725|NCT01035060|249885|P2|STARTED|Overall Study||29
107726|NCT01035060|249886|P1|STARTED|Overall Study||39
107727|NCT01035047|249894|P2|NOT COMPLETED|Overall Study||0
107728|NCT01035047|249895|P1|NOT COMPLETED|Overall Study||0
107729|NCT01035047|249894|P2|COMPLETED|Overall Study||53
107730|NCT01035047|249895|P1|COMPLETED|Overall Study||52
107731|NCT01035047|249894|P2|STARTED|Overall Study||53
107732|NCT01035047|249895|P1|STARTED|Overall Study||52
107733|NCT01034709|249911|P2|NOT COMPLETED|Overall Study||16
107734|NCT01034709|249912|P1|NOT COMPLETED|Overall Study||9
107735|NCT01034709|249911|P2|COMPLETED|Overall Study||42
107736|NCT01034709|249912|P1|COMPLETED|Overall Study||44
107737|NCT01034709|249911|P2|STARTED|Overall Study||58
107738|NCT01034709|249912|P1|STARTED|Overall Study||53
107739|NCT01034657|249918|P3|NOT COMPLETED|Randomized Phase||1
107740|NCT01034657|249919|P2|NOT COMPLETED|Randomized Phase||6
107741|NCT01034657|249920|P1|NOT COMPLETED|Randomized Phase||5
107742|NCT01034657|249918|P3|COMPLETED|Randomized Phase||0
107743|NCT01034657|249919|P2|COMPLETED|Randomized Phase||0
107744|NCT01034657|249920|P1|COMPLETED|Randomized Phase||1
107745|NCT01034657|249918|P3|STARTED|Randomized Phase||1
107746|NCT01034657|249919|P2|STARTED|Randomized Phase||6
107747|NCT01034657|249920|P1|STARTED|Randomized Phase||6
107748|NCT01034657|249918|P3|NOT COMPLETED|Core Phase||0
107749|NCT01034657|249919|P2|NOT COMPLETED|Core Phase||0
107750|NCT01034657|249920|P1|NOT COMPLETED|Core Phase||14
107751|NCT01034657|249918|P3|COMPLETED|Core Phase||0
107752|NCT01034657|249919|P2|COMPLETED|Core Phase||0
107753|NCT01034657|249920|P1|COMPLETED|Core Phase||20
107754|NCT01034657|249918|P3|STARTED|Core Phase||0
107755|NCT01034657|249919|P2|STARTED|Core Phase||0
107756|NCT01034657|249920|P1|STARTED|Core Phase||34
107757|NCT01034592|249958|P1|NOT COMPLETED|Overall Study||0
107758|NCT01034592|249958|P1|COMPLETED|Overall Study||2
107759|NCT01034592|249958|P1|STARTED|Overall Study||2
107760|NCT01034579|249964|P2|NOT COMPLETED|Overall Study||0
107761|NCT01034579|249965|P1|NOT COMPLETED|Overall Study||0
107762|NCT01034579|249964|P2|COMPLETED|Overall Study||166
107763|NCT01034579|249965|P1|COMPLETED|Overall Study||158
107764|NCT01034579|249964|P2|STARTED|Overall Study||166
107765|NCT01034579|249965|P1|STARTED|Overall Study||158
107766|NCT01034553|249979|P6|NOT COMPLETED|Overall Study||0
107767|NCT01034553|249980|P5|NOT COMPLETED|Overall Study||0
107768|NCT01034553|249981|P4|NOT COMPLETED|Overall Study||0
107769|NCT01034553|249982|P3|NOT COMPLETED|Overall Study||0
107770|NCT01034553|249983|P2|NOT COMPLETED|Overall Study||0
107771|NCT01034553|249984|P1|NOT COMPLETED|Overall Study||0
107772|NCT01034553|249979|P6|COMPLETED|Overall Study||7
107773|NCT01034553|249980|P5|COMPLETED|Overall Study||6
107774|NCT01034553|249981|P4|COMPLETED|Overall Study||3
107775|NCT01034553|249982|P3|COMPLETED|Overall Study||3
107776|NCT01034553|249983|P2|COMPLETED|Overall Study||4
107777|NCT01034553|249984|P1|COMPLETED|Overall Study||3
107778|NCT01034553|249979|P6|STARTED|Overall Study||7
107779|NCT01034553|249980|P5|STARTED|Overall Study||6
107780|NCT01034553|249981|P4|STARTED|Overall Study||3
107781|NCT01034553|249982|P3|STARTED|Overall Study||3
107782|NCT01034553|249983|P2|STARTED|Overall Study||4
107783|NCT01034553|249984|P1|STARTED|Overall Study||3
107784|NCT01034540|250000|P2|NOT COMPLETED|Overall Study||1
107785|NCT01034540|250001|P1|NOT COMPLETED|Overall Study||0
107786|NCT01034540|250000|P2|COMPLETED|Overall Study||11
107787|NCT01034540|250001|P1|COMPLETED|Overall Study||11
107788|NCT01034540|250000|P2|Completed 1st Treatment Intervention|Overall Study||11
107789|NCT01034540|250001|P1|Completed 1st Treatment Intervention|Overall Study||11
107790|NCT01034540|250000|P2|STARTED|Overall Study||12
107791|NCT01034540|250001|P1|STARTED|Overall Study||11
107792|NCT01034462|250011|P2|NOT COMPLETED|Overall Study||54
107793|NCT01034462|250012|P1|NOT COMPLETED|Overall Study||45
107794|NCT01034462|250011|P2|COMPLETED|Overall Study||163
107795|NCT01034462|250012|P1|COMPLETED|Overall Study||172
107796|NCT01034462|250011|P2|STARTED|Overall Study||217
107797|NCT01034462|250012|P1|STARTED|Overall Study||217
107798|NCT01034397|250022|P2|NOT COMPLETED|Overall Study||2
107799|NCT01034397|250023|P1|NOT COMPLETED|Overall Study||7
107800|NCT01034397|250022|P2|COMPLETED|Overall Study||17
107801|NCT01034397|250023|P1|COMPLETED|Overall Study||28
107802|NCT01034397|250022|P2|STARTED|Overall Study||19
107803|NCT01034397|250023|P1|STARTED|Overall Study||35
107804|NCT01034358|250172|P1|NOT COMPLETED|Overall Study||2
107805|NCT01034358|250172|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
107806|NCT01034358|250172|P1|STARTED|Overall Study||15
107807|NCT01034306|250178|P2|NOT COMPLETED|Overall Study||3
107808|NCT01034306|250179|P1|NOT COMPLETED|Overall Study||5
107809|NCT01034306|250178|P2|COMPLETED|Overall Study||34
107810|NCT01034306|250179|P1|COMPLETED|Overall Study||37
107811|NCT01034306|250178|P2|STARTED|Overall Study||37
107812|NCT01034306|250179|P1|STARTED|Overall Study||42
107813|NCT01034163|250187|P2|NOT COMPLETED|Overall Study||14
107814|NCT01034163|250188|P1|NOT COMPLETED|Overall Study||27
107815|NCT01034163|250187|P2|COMPLETED|Overall Study||0
107816|NCT01034163|250188|P1|COMPLETED|Overall Study||0
107817|NCT01034163|250187|P2|In Open Label Phase After Unblinding|Overall Study||0
107818|NCT01034163|250188|P1|In Open Label Phase After Unblinding|Overall Study||5
107819|NCT01034163|250187|P2|Safety Set|Overall Study||12
107820|NCT01034163|250188|P1|Safety Set|Overall Study||26
107821|NCT01034163|250187|P2|Untreated (Not in Safety Set)|Overall Study||2
107822|NCT01034163|250188|P1|Untreated (Not in Safety Set)|Overall Study||1
107823|NCT01034163|250187|P2|STARTED|Overall Study||14
107824|NCT01034163|250188|P1|STARTED|Overall Study||27
107825|NCT01034137|250197|P3|NOT COMPLETED|Overall Study||30
107826|NCT01034137|250198|P2|NOT COMPLETED|Overall Study||22
107827|NCT01034137|250199|P1|NOT COMPLETED|Overall Study||28
107828|NCT01034137|250197|P3|COMPLETED|Overall Study||78
107829|NCT01034137|250198|P2|COMPLETED|Overall Study||81
107830|NCT01034137|250199|P1|COMPLETED|Overall Study||78
107831|NCT01034137|250197|P3|STARTED|Overall Study||108
107832|NCT01034137|250198|P2|STARTED|Overall Study||103
107833|NCT01034137|250199|P1|STARTED|Overall Study||106
107834|NCT01034111|250330|P1|NOT COMPLETED|Overall Study||0
107835|NCT01034111|250330|P1|COMPLETED|Overall Study||30
107836|NCT01034111|250330|P1|STARTED|Overall Study||30
107837|NCT01033864|250337|P2|NOT COMPLETED|Overall Study||0
107838|NCT01033864|250338|P1|NOT COMPLETED|Overall Study||0
107839|NCT01033864|250337|P2|COMPLETED|Overall Study||11
107840|NCT01033864|250338|P1|COMPLETED|Overall Study||12
107841|NCT01033864|250337|P2|STARTED|Overall Study||11
107842|NCT01033864|250338|P1|STARTED|Overall Study||12
107843|NCT01033851|250363|P2|NOT COMPLETED|Overall Study||7
107844|NCT01033851|250364|P1|NOT COMPLETED|Overall Study||3
107845|NCT01033851|250363|P2|COMPLETED|Overall Study||34
107846|NCT01033851|250364|P1|COMPLETED|Overall Study||45
107847|NCT01033851|250363|P2|STARTED|Overall Study||41
107848|NCT01033851|250364|P1|STARTED|Overall Study||48
107849|NCT01033825|250379|P7|NOT COMPLETED|Overall Study||0
107850|NCT01033825|250380|P6|NOT COMPLETED|Overall Study||0
107851|NCT01033825|250381|P5|NOT COMPLETED|Overall Study||2
107852|NCT01033825|250382|P4|NOT COMPLETED|Overall Study||2
107853|NCT01033825|250383|P3|NOT COMPLETED|Overall Study||2
107854|NCT01033825|250384|P2|NOT COMPLETED|Overall Study||3
107855|NCT01033825|250385|P1|NOT COMPLETED|Overall Study||3
107856|NCT01033825|250379|P7|COMPLETED|Overall Study||18
107857|NCT01033825|250380|P6|COMPLETED|Overall Study||18
107858|NCT01033825|250381|P5|COMPLETED|Overall Study||56
107859|NCT01033825|250382|P4|COMPLETED|Overall Study||46
107860|NCT01033825|250383|P3|COMPLETED|Overall Study||55
107861|NCT01033825|250384|P2|COMPLETED|Overall Study||57
107862|NCT01033825|250385|P1|COMPLETED|Overall Study||48
107863|NCT01033825|250379|P7|STARTED|Overall Study||18
107864|NCT01033825|250380|P6|STARTED|Overall Study||18
107865|NCT01033825|250381|P5|STARTED|Overall Study||58
107866|NCT01033825|250382|P4|STARTED|Overall Study||48
107867|NCT01033825|250383|P3|STARTED|Overall Study||57
107868|NCT01033825|250384|P2|STARTED|Overall Study||60
107869|NCT01033825|250385|P1|STARTED|Overall Study||51
107870|NCT01033747|250606|P2|NOT COMPLETED|Overall Study||15
107871|NCT01033747|250607|P1|NOT COMPLETED|Overall Study||37
107872|NCT01033747|250606|P2|COMPLETED|Overall Study||4
107873|NCT01033747|250607|P1|COMPLETED|Overall Study||14
107874|NCT01033747|250606|P2|STARTED|Overall Study||19
107875|NCT01033747|250607|P1|STARTED|Overall Study||51
107876|NCT01033734|250615|P1|NOT COMPLETED|Overall Study||1
107877|NCT01033734|250615|P1|COMPLETED|Overall Study||7
107878|NCT01033734|250615|P1|STARTED|Overall Study||8
107879|NCT01033565|250667|P1|NOT COMPLETED|Overall Study||0
107880|NCT01033565|250667|P1|COMPLETED|Overall Study||1
107881|NCT01033565|250667|P1|STARTED|Overall Study||1
107882|NCT01033487|250671|P10|NOT COMPLETED|Fifth Intervention Period||0
107883|NCT01033487|250672|P9|NOT COMPLETED|Fifth Intervention Period||0
107884|NCT01033487|250673|P8|NOT COMPLETED|Fifth Intervention Period||0
107885|NCT01033487|250674|P7|NOT COMPLETED|Fifth Intervention Period||0
107886|NCT01033487|250675|P6|NOT COMPLETED|Fifth Intervention Period||0
107887|NCT01033487|250676|P5|NOT COMPLETED|Fifth Intervention Period||0
107888|NCT01033487|250677|P4|NOT COMPLETED|Fifth Intervention Period||0
107889|NCT01033487|250678|P3|NOT COMPLETED|Fifth Intervention Period||0
107890|NCT01033487|250679|P2|NOT COMPLETED|Fifth Intervention Period||0
107891|NCT01033487|250680|P1|NOT COMPLETED|Fifth Intervention Period||0
107892|NCT01033487|250671|P10|COMPLETED|Fifth Intervention Period||2
107893|NCT01033487|250672|P9|COMPLETED|Fifth Intervention Period||1
107894|NCT01033487|250673|P8|COMPLETED|Fifth Intervention Period||3
107895|NCT01033487|250674|P7|COMPLETED|Fifth Intervention Period||2
107896|NCT01033487|250675|P6|COMPLETED|Fifth Intervention Period||2
107897|NCT01033487|250676|P5|COMPLETED|Fifth Intervention Period||2
107898|NCT01033487|250677|P4|COMPLETED|Fifth Intervention Period||2
107899|NCT01033487|250678|P3|COMPLETED|Fifth Intervention Period||2
107900|NCT01033487|250679|P2|COMPLETED|Fifth Intervention Period||3
107901|NCT01033487|250680|P1|COMPLETED|Fifth Intervention Period||2
107902|NCT01033487|250671|P10|STARTED|Fifth Intervention Period||2
107903|NCT01033487|250672|P9|STARTED|Fifth Intervention Period||1
107904|NCT01033487|250673|P8|STARTED|Fifth Intervention Period||3
107905|NCT01033487|250674|P7|STARTED|Fifth Intervention Period||2
107906|NCT01033487|250675|P6|STARTED|Fifth Intervention Period||2
107907|NCT01033487|250676|P5|STARTED|Fifth Intervention Period||2
107908|NCT01033487|250677|P4|STARTED|Fifth Intervention Period||2
107909|NCT01033487|250678|P3|STARTED|Fifth Intervention Period||2
107910|NCT01033487|250679|P2|STARTED|Fifth Intervention Period||3
107911|NCT01033487|250680|P1|STARTED|Fifth Intervention Period||2
107912|NCT01033487|250671|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107913|NCT01033487|250672|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107914|NCT01033487|250673|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107915|NCT01033487|250674|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107916|NCT01033487|250675|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107917|NCT01033487|250676|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107918|NCT01033487|250677|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107919|NCT01033487|250678|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107920|NCT01033487|250679|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107921|NCT01033487|250680|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
107922|NCT01033487|250671|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107923|NCT01033487|250672|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
107924|NCT01033487|250673|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
107925|NCT01033487|250674|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107926|NCT01033487|250675|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107927|NCT01033487|250676|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107928|NCT01033487|250677|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107929|NCT01033487|250678|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107930|NCT01033487|250679|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
107931|NCT01033487|250680|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
107932|NCT01033487|250671|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107933|NCT01033487|250672|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
107934|NCT01033487|250673|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
107935|NCT01033487|250674|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107936|NCT01033487|250675|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107937|NCT01033487|250676|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107938|NCT01033487|250677|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107939|NCT01033487|250678|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107940|NCT01033487|250679|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
107941|NCT01033487|250680|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
107942|NCT01033487|250671|P10|NOT COMPLETED|Fourth Intervention Period||0
107943|NCT01033487|250672|P9|NOT COMPLETED|Fourth Intervention Period||1
107944|NCT01033487|250673|P8|NOT COMPLETED|Fourth Intervention Period||0
107945|NCT01033487|250674|P7|NOT COMPLETED|Fourth Intervention Period||0
107946|NCT01033487|250675|P6|NOT COMPLETED|Fourth Intervention Period||0
107947|NCT01033487|250676|P5|NOT COMPLETED|Fourth Intervention Period||0
107948|NCT01033487|250677|P4|NOT COMPLETED|Fourth Intervention Period||0
107949|NCT01033487|250678|P3|NOT COMPLETED|Fourth Intervention Period||0
107950|NCT01033487|250679|P2|NOT COMPLETED|Fourth Intervention Period||0
107951|NCT01033487|250680|P1|NOT COMPLETED|Fourth Intervention Period||0
107952|NCT01033487|250671|P10|COMPLETED|Fourth Intervention Period||2
107953|NCT01033487|250672|P9|COMPLETED|Fourth Intervention Period||1
107954|NCT01033487|250673|P8|COMPLETED|Fourth Intervention Period||3
107955|NCT01033487|250674|P7|COMPLETED|Fourth Intervention Period||2
107956|NCT01033487|250675|P6|COMPLETED|Fourth Intervention Period||2
107957|NCT01033487|250676|P5|COMPLETED|Fourth Intervention Period||2
107958|NCT01033487|250677|P4|COMPLETED|Fourth Intervention Period||2
107959|NCT01033487|250678|P3|COMPLETED|Fourth Intervention Period||2
107960|NCT01033487|250679|P2|COMPLETED|Fourth Intervention Period||3
107961|NCT01033487|250680|P1|COMPLETED|Fourth Intervention Period||2
107962|NCT01033487|250671|P10|STARTED|Fourth Intervention Period||2
107963|NCT01033487|250672|P9|STARTED|Fourth Intervention Period||2
107964|NCT01033487|250673|P8|STARTED|Fourth Intervention Period||3
107965|NCT01033487|250674|P7|STARTED|Fourth Intervention Period||2
107966|NCT01033487|250675|P6|STARTED|Fourth Intervention Period||2
107967|NCT01033487|250676|P5|STARTED|Fourth Intervention Period||2
107968|NCT01033487|250677|P4|STARTED|Fourth Intervention Period||2
107969|NCT01033487|250678|P3|STARTED|Fourth Intervention Period||2
107970|NCT01033487|250679|P2|STARTED|Fourth Intervention Period||3
107971|NCT01033487|250680|P1|STARTED|Fourth Intervention Period||2
107972|NCT01033487|250671|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107973|NCT01033487|250672|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107974|NCT01033487|250673|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107975|NCT01033487|250674|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107976|NCT01033487|250675|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107977|NCT01033487|250676|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107978|NCT01033487|250677|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107979|NCT01033487|250678|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107980|NCT01033487|250679|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107981|NCT01033487|250680|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
107982|NCT01033487|250671|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107983|NCT01033487|250672|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107984|NCT01033487|250673|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
107985|NCT01033487|250674|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107986|NCT01033487|250675|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107987|NCT01033487|250676|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107988|NCT01033487|250677|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107989|NCT01033487|250678|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107990|NCT01033487|250679|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
107991|NCT01033487|250680|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
107992|NCT01033487|250671|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107993|NCT01033487|250672|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107994|NCT01033487|250673|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
107995|NCT01033487|250674|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107996|NCT01033487|250675|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107997|NCT01033487|250676|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107998|NCT01033487|250677|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
107999|NCT01033487|250678|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
108000|NCT01033487|250679|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
108001|NCT01033487|250680|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
108002|NCT01033487|250671|P10|NOT COMPLETED|Third Intervention Period||0
108003|NCT01033487|250672|P9|NOT COMPLETED|Third Intervention Period||0
108004|NCT01033487|250673|P8|NOT COMPLETED|Third Intervention Period||0
108005|NCT01033487|250674|P7|NOT COMPLETED|Third Intervention Period||0
108006|NCT01033487|250675|P6|NOT COMPLETED|Third Intervention Period||0
108007|NCT01033487|250676|P5|NOT COMPLETED|Third Intervention Period||0
108008|NCT01033487|250677|P4|NOT COMPLETED|Third Intervention Period||0
108009|NCT01033487|250678|P3|NOT COMPLETED|Third Intervention Period||0
108010|NCT01033487|250679|P2|NOT COMPLETED|Third Intervention Period||0
108011|NCT01033487|250680|P1|NOT COMPLETED|Third Intervention Period||0
108012|NCT01033487|250671|P10|COMPLETED|Third Intervention Period||2
108013|NCT01033487|250672|P9|COMPLETED|Third Intervention Period||2
108014|NCT01033487|250673|P8|COMPLETED|Third Intervention Period||3
108015|NCT01033487|250674|P7|COMPLETED|Third Intervention Period||2
108016|NCT01033487|250675|P6|COMPLETED|Third Intervention Period||2
108017|NCT01033487|250676|P5|COMPLETED|Third Intervention Period||2
108018|NCT01033487|250677|P4|COMPLETED|Third Intervention Period||2
108019|NCT01033487|250678|P3|COMPLETED|Third Intervention Period||2
108020|NCT01033487|250679|P2|COMPLETED|Third Intervention Period||3
108021|NCT01033487|250680|P1|COMPLETED|Third Intervention Period||2
108022|NCT01033487|250671|P10|STARTED|Third Intervention Period||2
108023|NCT01033487|250672|P9|STARTED|Third Intervention Period||2
108024|NCT01033487|250673|P8|STARTED|Third Intervention Period||3
108025|NCT01033487|250674|P7|STARTED|Third Intervention Period||2
108026|NCT01033487|250675|P6|STARTED|Third Intervention Period||2
108027|NCT01033487|250676|P5|STARTED|Third Intervention Period||2
108028|NCT01033487|250677|P4|STARTED|Third Intervention Period||2
108029|NCT01033487|250678|P3|STARTED|Third Intervention Period||2
108030|NCT01033487|250679|P2|STARTED|Third Intervention Period||3
108031|NCT01033487|250680|P1|STARTED|Third Intervention Period||2
108032|NCT01033487|250671|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108033|NCT01033487|250672|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108034|NCT01033487|250673|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108035|NCT01033487|250674|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108036|NCT01033487|250675|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108037|NCT01033487|250676|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108038|NCT01033487|250677|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108039|NCT01033487|250678|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108040|NCT01033487|250679|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108041|NCT01033487|250680|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
108042|NCT01033487|250671|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108043|NCT01033487|250672|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108044|NCT01033487|250673|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
108045|NCT01033487|250674|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108046|NCT01033487|250675|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108047|NCT01033487|250676|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108048|NCT01033487|250677|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108049|NCT01033487|250678|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108050|NCT01033487|250679|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
108051|NCT01033487|250680|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
108052|NCT01033487|250671|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108053|NCT01033487|250672|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108054|NCT01033487|250673|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
108055|NCT01033487|250674|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108056|NCT01033487|250675|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108057|NCT01033487|250676|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108058|NCT01033487|250677|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108059|NCT01033487|250678|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108060|NCT01033487|250679|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
108061|NCT01033487|250680|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
108062|NCT01033487|250671|P10|NOT COMPLETED|Second Intervention Period||0
108063|NCT01033487|250672|P9|NOT COMPLETED|Second Intervention Period||0
108064|NCT01033487|250673|P8|NOT COMPLETED|Second Intervention Period||0
108065|NCT01033487|250674|P7|NOT COMPLETED|Second Intervention Period||0
108066|NCT01033487|250675|P6|NOT COMPLETED|Second Intervention Period||0
108067|NCT01033487|250676|P5|NOT COMPLETED|Second Intervention Period||0
108068|NCT01033487|250677|P4|NOT COMPLETED|Second Intervention Period||0
108069|NCT01033487|250678|P3|NOT COMPLETED|Second Intervention Period||0
108070|NCT01033487|250679|P2|NOT COMPLETED|Second Intervention Period||0
108071|NCT01033487|250680|P1|NOT COMPLETED|Second Intervention Period||0
108072|NCT01033487|250671|P10|COMPLETED|Second Intervention Period||2
108073|NCT01033487|250672|P9|COMPLETED|Second Intervention Period||2
108074|NCT01033487|250673|P8|COMPLETED|Second Intervention Period||3
108075|NCT01033487|250674|P7|COMPLETED|Second Intervention Period||2
108076|NCT01033487|250675|P6|COMPLETED|Second Intervention Period||2
108077|NCT01033487|250676|P5|COMPLETED|Second Intervention Period||2
108078|NCT01033487|250677|P4|COMPLETED|Second Intervention Period||2
108079|NCT01033487|250678|P3|COMPLETED|Second Intervention Period||2
108080|NCT01033487|250679|P2|COMPLETED|Second Intervention Period||3
108081|NCT01033487|250680|P1|COMPLETED|Second Intervention Period||2
108082|NCT01033487|250671|P10|STARTED|Second Intervention Period||2
108083|NCT01033487|250672|P9|STARTED|Second Intervention Period||2
108084|NCT01033487|250673|P8|STARTED|Second Intervention Period||3
108085|NCT01033487|250674|P7|STARTED|Second Intervention Period||2
108086|NCT01033487|250675|P6|STARTED|Second Intervention Period||2
108087|NCT01033487|250676|P5|STARTED|Second Intervention Period||2
108088|NCT01033487|250677|P4|STARTED|Second Intervention Period||2
108089|NCT01033487|250678|P3|STARTED|Second Intervention Period||2
108090|NCT01033487|250679|P2|STARTED|Second Intervention Period||3
108091|NCT01033487|250680|P1|STARTED|Second Intervention Period||2
108092|NCT01033487|250671|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108093|NCT01033487|250672|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108094|NCT01033487|250673|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108095|NCT01033487|250674|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108096|NCT01033487|250675|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108097|NCT01033487|250676|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108098|NCT01033487|250677|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108099|NCT01033487|250678|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108100|NCT01033487|250679|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108101|NCT01033487|250680|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
108102|NCT01033487|250671|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108103|NCT01033487|250672|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108104|NCT01033487|250673|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
108105|NCT01033487|250674|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108106|NCT01033487|250675|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108107|NCT01033487|250676|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108108|NCT01033487|250677|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108109|NCT01033487|250678|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108110|NCT01033487|250679|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
108111|NCT01033487|250680|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
108112|NCT01033487|250671|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108113|NCT01033487|250672|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108114|NCT01033487|250673|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
108115|NCT01033487|250674|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108116|NCT01033487|250675|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108117|NCT01033487|250676|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108118|NCT01033487|250677|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108119|NCT01033487|250678|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108120|NCT01033487|250679|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
108121|NCT01033487|250680|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
108122|NCT01033487|250671|P10|NOT COMPLETED|First Intervention Period||0
108123|NCT01033487|250672|P9|NOT COMPLETED|First Intervention Period||0
108124|NCT01033487|250673|P8|NOT COMPLETED|First Intervention Period||0
108125|NCT01033487|250674|P7|NOT COMPLETED|First Intervention Period||0
108126|NCT01033487|250675|P6|NOT COMPLETED|First Intervention Period||0
108127|NCT01033487|250676|P5|NOT COMPLETED|First Intervention Period||0
108128|NCT01033487|250677|P4|NOT COMPLETED|First Intervention Period||0
108129|NCT01033487|250678|P3|NOT COMPLETED|First Intervention Period||0
108130|NCT01033487|250679|P2|NOT COMPLETED|First Intervention Period||0
108131|NCT01033487|250680|P1|NOT COMPLETED|First Intervention Period||0
108132|NCT01033487|250671|P10|COMPLETED|First Intervention Period||2
108133|NCT01033487|250672|P9|COMPLETED|First Intervention Period||2
108134|NCT01033487|250673|P8|COMPLETED|First Intervention Period||3
108135|NCT01033487|250674|P7|COMPLETED|First Intervention Period||2
108136|NCT01033487|250675|P6|COMPLETED|First Intervention Period||2
108137|NCT01033487|250676|P5|COMPLETED|First Intervention Period||2
108138|NCT01033487|250677|P4|COMPLETED|First Intervention Period||2
108139|NCT01033487|250678|P3|COMPLETED|First Intervention Period||2
108140|NCT01033487|250679|P2|COMPLETED|First Intervention Period||3
108141|NCT01033487|250680|P1|COMPLETED|First Intervention Period||2
108142|NCT01033487|250671|P10|STARTED|First Intervention Period||2
108143|NCT01033487|250672|P9|STARTED|First Intervention Period||2
108144|NCT01033487|250673|P8|STARTED|First Intervention Period||3
108145|NCT01033487|250674|P7|STARTED|First Intervention Period||2
108146|NCT01033487|250675|P6|STARTED|First Intervention Period||2
108147|NCT01033487|250676|P5|STARTED|First Intervention Period||2
108148|NCT01033487|250677|P4|STARTED|First Intervention Period||2
108149|NCT01033487|250678|P3|STARTED|First Intervention Period||2
108150|NCT01033487|250679|P2|STARTED|First Intervention Period||3
108151|NCT01033487|250680|P1|STARTED|First Intervention Period||2
108152|NCT01033383|250738|P4|NOT COMPLETED|Overall Study||0
108153|NCT01033383|250739|P3|NOT COMPLETED|Overall Study||0
108154|NCT01033383|250740|P2|NOT COMPLETED|Overall Study||0
108155|NCT01033383|250741|P1|NOT COMPLETED|Overall Study||0
108156|NCT01033383|250738|P4|COMPLETED|Overall Study||20
108157|NCT01033383|250739|P3|COMPLETED|Overall Study||20
108158|NCT01033383|250740|P2|COMPLETED|Overall Study||20
108159|NCT01033383|250741|P1|COMPLETED|Overall Study||20
108160|NCT01033383|250738|P4|STARTED|Overall Study||20
108161|NCT01033383|250739|P3|STARTED|Overall Study||20
108162|NCT01033383|250740|P2|STARTED|Overall Study||20
108163|NCT01033383|250741|P1|STARTED|Overall Study||20
108164|NCT01033227|250761|P2|NOT COMPLETED|Overall Study||0
108165|NCT01033227|250762|P1|NOT COMPLETED|Overall Study||0
108166|NCT01033227|250761|P2|COMPLETED|Overall Study||2
108167|NCT01033227|250762|P1|COMPLETED|Overall Study||3
108168|NCT01033227|250761|P2|STARTED|Overall Study||2
108169|NCT01033227|250762|P1|STARTED|Overall Study||3
108170|NCT01033071|250771|P3|NOT COMPLETED|Overall Study||47
108171|NCT01033071|250772|P2|NOT COMPLETED|Overall Study||77
108172|NCT01033071|250773|P1|NOT COMPLETED|Overall Study||55
108173|NCT01033071|250771|P3|COMPLETED|Overall Study||317
108174|NCT01033071|250772|P2|COMPLETED|Overall Study||275
108175|NCT01033071|250773|P1|COMPLETED|Overall Study||300
108176|NCT01033071|250771|P3|STARTED|Overall Study||364
108177|NCT01033071|250772|P2|STARTED|Overall Study||352
108178|NCT01033071|250773|P1|STARTED|Overall Study||355
108179|NCT01033032|250832|P4|NOT COMPLETED|Phase II||0
108180|NCT01033032|250833|P3|NOT COMPLETED|Phase II||66
108181|NCT01033032|250834|P2|NOT COMPLETED|Phase II||0
108182|NCT01033032|250835|P1|NOT COMPLETED|Phase II||0
108183|NCT01033032|250832|P4|COMPLETED|Phase II||0
108184|NCT01033032|250833|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
108185|NCT01033032|250834|P2|COMPLETED|Phase II||0
108186|NCT01033032|250835|P1|COMPLETED|Phase II||0
108187|NCT01033032|250832|P4|STARTED|Phase II||0
108188|NCT01033032|250833|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
108189|NCT01033032|250834|P2|STARTED|Phase II||0
108190|NCT01033032|250835|P1|STARTED|Phase II||0
108191|NCT01033032|250832|P4|NOT COMPLETED|Phase I||6
108192|NCT01033032|250833|P3|NOT COMPLETED|Phase I||0
108193|NCT01033032|250834|P2|NOT COMPLETED|Phase I||3
108194|NCT01033032|250835|P1|NOT COMPLETED|Phase I||3
108195|NCT01033032|250832|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
108196|NCT01033032|250833|P3|COMPLETED|Phase I||3
108197|NCT01033032|250834|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
108198|NCT01033032|250835|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
108199|NCT01033032|250832|P4|STARTED|Phase I||6
108200|NCT01033032|250833|P3|STARTED|Phase I||3
108201|NCT01033032|250834|P2|STARTED|Phase I||3
108202|NCT01033032|250835|P1|STARTED|Phase I||3
108203|NCT01033019|250844|P2|NOT COMPLETED|Overall Study||0
108204|NCT01033019|250845|P1|NOT COMPLETED|Overall Study||1
108205|NCT01033019|250844|P2|COMPLETED|Overall Study||8
108206|NCT01033019|250845|P1|COMPLETED|Overall Study||15
108207|NCT01033019|250844|P2|STARTED|Overall Study||8
108208|NCT01033019|250845|P1|STARTED|Overall Study||16
108209|NCT01032993|250854|P2|NOT COMPLETED|Overall Study||0
108210|NCT01032993|250855|P1|NOT COMPLETED|Overall Study||0
108211|NCT01032993|250854|P2|COMPLETED|Overall Study||20
108212|NCT01032993|250855|P1|COMPLETED|Overall Study||19
108213|NCT01032993|250854|P2|STARTED|Overall Study||20
108214|NCT01032993|250855|P1|STARTED|Overall Study||19
108215|NCT01032928|250867|P1|NOT COMPLETED|Overall Study||0
108216|NCT01032928|250867|P1|COMPLETED|Overall Study||30
108217|NCT01032928|250867|P1|STARTED|Overall Study||30
108218|NCT01032915|250883|P4|NOT COMPLETED|Overall Study||7
108219|NCT01032915|250884|P3|NOT COMPLETED|Overall Study||7
108220|NCT01032915|250885|P2|NOT COMPLETED|Overall Study||11
108221|NCT01032915|250886|P1|NOT COMPLETED|Overall Study||8
108222|NCT01032915|250883|P4|COMPLETED|Overall Study||27
108223|NCT01032915|250884|P3|COMPLETED|Overall Study||24
108224|NCT01032915|250885|P2|COMPLETED|Overall Study||20
108225|NCT01032915|250886|P1|COMPLETED|Overall Study||21
108226|NCT01032915|250883|P4|STARTED|Overall Study||34
108227|NCT01032915|250884|P3|STARTED|Overall Study||31
108228|NCT01032915|250885|P2|STARTED|Overall Study||31
108229|NCT01032915|250886|P1|STARTED|Overall Study||29
108230|NCT01032889|250911|P3|NOT COMPLETED|Overall Study||3
108231|NCT01032889|250912|P2|NOT COMPLETED|Overall Study||15
108232|NCT01032889|250913|P1|NOT COMPLETED|Overall Study||8
108233|NCT01032889|250911|P3|COMPLETED|Overall Study||42
108234|NCT01032889|250912|P2|COMPLETED|Overall Study||28
108235|NCT01032889|250913|P1|COMPLETED|Overall Study||33
108236|NCT01032889|250911|P3|Received Treatment|Overall Study||45
108237|NCT01032889|250912|P2|Received Treatment|Overall Study||43
108238|NCT01032889|250913|P1|Received Treatment|Overall Study||41
108239|NCT01032889|250911|P3|STARTED|Overall Study||45
108240|NCT01032889|250912|P2|STARTED|Overall Study||43
108241|NCT01032889|250913|P1|STARTED|Overall Study||41
108242|NCT01032850|250933|P1|NOT COMPLETED|Overall Study||2
108243|NCT01032850|250933|P1|COMPLETED|Overall Study||13
108244|NCT01032850|250933|P1|STARTED|Overall Study||15
108245|NCT01032837|250944|P4|NOT COMPLETED|Overall Study||3
108246|NCT01032837|250945|P3|NOT COMPLETED|Overall Study||1
108247|NCT01032837|250946|P2|NOT COMPLETED|Overall Study||3
108248|NCT01032837|250947|P1|NOT COMPLETED|Overall Study||0
108249|NCT01032837|250944|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
108250|NCT01032837|250945|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
108251|NCT01032837|250946|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
108252|NCT01032837|250947|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
108253|NCT01032837|250944|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
108254|NCT01032837|250945|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
108255|NCT01032837|250946|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
108256|NCT01032837|250947|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
108257|NCT01032837|250944|P4|STARTED|Overall Study||25
108258|NCT01032837|250945|P3|STARTED|Overall Study||25
108259|NCT01032837|250946|P2|STARTED|Overall Study||26
108260|NCT01032837|250947|P1|STARTED|Overall Study||26
108261|NCT01032759|250995|P2|NOT COMPLETED|Overall Study||3
108262|NCT01032759|250996|P1|NOT COMPLETED|Overall Study||1
108263|NCT01032759|250995|P2|COMPLETED|Overall Study||28
108264|NCT01032759|250996|P1|COMPLETED|Overall Study||31
108265|NCT01032759|250995|P2|Completed 48 Hour Assessment|Overall Study||28
108266|NCT01032759|250996|P1|Completed 48 Hour Assessment|Overall Study||31
108267|NCT01032759|250995|P2|Completed 24 Hour Assessment|Overall Study||30
108268|NCT01032759|250996|P1|Completed 24 Hour Assessment|Overall Study||32
108269|NCT01032759|250995|P2|STARTED|Overall Study||31
108270|NCT01032759|250996|P1|STARTED|Overall Study||32
108271|NCT01032733|251016|P2|NOT COMPLETED|Overall Study||1
108272|NCT01032733|251017|P1|NOT COMPLETED|Overall Study||1
108273|NCT01032733|251016|P2|COMPLETED|Overall Study||16
108274|NCT01032733|251017|P1|COMPLETED|Overall Study||16
108275|NCT01032733|251016|P2|STARTED|Overall Study||17
108276|NCT01032733|251017|P1|STARTED|Overall Study||17
108277|NCT01032694|251033|P2|NOT COMPLETED|Overall Study||0
108278|NCT01032694|251034|P1|NOT COMPLETED|Overall Study||0
108279|NCT01032694|251033|P2|COMPLETED|Overall Study||10
108280|NCT01032694|251034|P1|COMPLETED|Overall Study||20
108281|NCT01032694|251033|P2|STARTED|Overall Study||10
108282|NCT01032694|251034|P1|STARTED|Overall Study||20
108283|NCT01032538|251044|P1|NOT COMPLETED|Overall Study||0
108284|NCT01032538|251044|P1|COMPLETED|Overall Study|Knees|99
108285|NCT01032538|251044|P1|STARTED|Overall Study|Knees|99
108286|NCT01032382|251052|P2|NOT COMPLETED|Overall Study||5
108287|NCT01032382|251053|P1|NOT COMPLETED|Overall Study||5
108288|NCT01032382|251052|P2|COMPLETED|Overall Study||9
108289|NCT01032382|251053|P1|COMPLETED|Overall Study||11
108290|NCT01032382|251052|P2|STARTED|Overall Study||14
108291|NCT01032382|251053|P1|STARTED|Overall Study||16
108292|NCT01032291|251082|P3|NOT COMPLETED|Proof of Concept||3
108293|NCT01032291|251083|P2|NOT COMPLETED|Proof of Concept||8
108294|NCT01032291|251084|P1|NOT COMPLETED|Proof of Concept||0
108295|NCT01032291|251082|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
108296|NCT01032291|251083|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
108297|NCT01032291|251084|P1|COMPLETED|Proof of Concept||0
108298|NCT01032291|251082|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
108299|NCT01032291|251083|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
108300|NCT01032291|251084|P1|Intent to Treat and Safety Populations|Proof of Concept||0
108301|NCT01032291|251082|P3|STARTED|Proof of Concept||21
108302|NCT01032291|251083|P2|STARTED|Proof of Concept||22
108303|NCT01032291|251084|P1|STARTED|Proof of Concept||0
108304|NCT01032291|251082|P3|NOT COMPLETED|Safety Lead-in||0
108305|NCT01032291|251083|P2|NOT COMPLETED|Safety Lead-in||0
108306|NCT01032291|251084|P1|NOT COMPLETED|Safety Lead-in||2
108307|NCT01032291|251082|P3|COMPLETED|Safety Lead-in||0
108308|NCT01032291|251083|P2|COMPLETED|Safety Lead-in||0
108309|NCT01032291|251084|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
108310|NCT01032291|251082|P3|STARTED|Safety Lead-in||0
108311|NCT01032291|251083|P2|STARTED|Safety Lead-in||0
108312|NCT01032291|251084|P1|STARTED|Safety Lead-in||8
108313|NCT01032265|251110|P2|NOT COMPLETED|Overall Study||17
108314|NCT01032265|251111|P1|NOT COMPLETED|Overall Study||13
108315|NCT01032265|251110|P2|COMPLETED|Overall Study||107
108316|NCT01032265|251111|P1|COMPLETED|Overall Study||113
108317|NCT01032265|251110|P2|STARTED|Overall Study||124
108318|NCT01032265|251111|P1|STARTED|Overall Study||126
108319|NCT01032200|251131|P2|NOT COMPLETED|Overall Study||7
108320|NCT01032200|251132|P1|NOT COMPLETED|Overall Study||4
108321|NCT01032200|251131|P2|COMPLETED|Overall Study||21
108322|NCT01032200|251132|P1|COMPLETED|Overall Study||22
108323|NCT01032200|251131|P2|STARTED|Overall Study||28
108324|NCT01032200|251132|P1|STARTED|Overall Study||26
108325|NCT01032174|251148|P2|NOT COMPLETED|Overall Study||1
108326|NCT01032174|251149|P1|NOT COMPLETED|Overall Study||0
108327|NCT01032174|251148|P2|COMPLETED|Overall Study||59
108328|NCT01032174|251149|P1|COMPLETED|Overall Study||63
108329|NCT01032174|251148|P2|STARTED|Overall Study||60
108330|NCT01032174|251149|P1|STARTED|Overall Study||63
108331|NCT01032070|251161|P2|NOT COMPLETED|Overall Study||12
108332|NCT01032070|251162|P1|NOT COMPLETED|Overall Study||13
108333|NCT01032070|251161|P2|COMPLETED|Overall Study||0
108334|NCT01032070|251162|P1|COMPLETED|Overall Study||0
108335|NCT01032070|251161|P2|STARTED|Overall Study||12
108336|NCT01032070|251162|P1|STARTED|Overall Study||13
108337|NCT01032044|251191|P2|NOT COMPLETED|Overall Study||20
108338|NCT01032044|251192|P1|NOT COMPLETED|Overall Study||25
108339|NCT01032044|251191|P2|COMPLETED|Overall Study||62
108340|NCT01032044|251192|P1|COMPLETED|Overall Study||57
108341|NCT01032044|251191|P2|Procedure|Overall Study||75
108342|NCT01032044|251192|P1|Procedure|Overall Study||74
108343|NCT01032044|251191|P2|STARTED|Overall Study||82
108344|NCT01032044|251192|P1|STARTED|Overall Study||82
108345|NCT01032018|251200|P2|NOT COMPLETED|Overall Study||6
108346|NCT01032018|251201|P1|NOT COMPLETED|Overall Study||6
108347|NCT01032018|251200|P2|COMPLETED|Overall Study||67
108348|NCT01032018|251201|P1|COMPLETED|Overall Study||71
108349|NCT01032018|251200|P2|STARTED|Overall Study||73
108350|NCT01032018|251201|P1|STARTED|Overall Study||77
108351|NCT01031953|251209|P1|NOT COMPLETED|Overall Study||0
108352|NCT01031953|251209|P1|COMPLETED|Overall Study||11
108353|NCT01031953|251209|P1|STARTED|Overall Study||11
108354|NCT01031914|251220|P1|NOT COMPLETED|Overall Study||0
108355|NCT01031914|251220|P1|COMPLETED|Overall Study||36
108356|NCT01031914|251220|P1|STARTED|Overall Study||36
108357|NCT01031810|251224|P1|NOT COMPLETED|Overall Study||4
108358|NCT01031810|251224|P1|COMPLETED|Overall Study||9
108359|NCT01031810|251224|P1|STARTED|Overall Study||13
108360|NCT01031706|251235|P2|NOT COMPLETED|Overall Study||1
108361|NCT01031706|251236|P1|NOT COMPLETED|Overall Study||2
108362|NCT01031706|251235|P2|COMPLETED|Overall Study||8
108363|NCT01031706|251236|P1|COMPLETED|Overall Study||12
108364|NCT01031706|251235|P2|STARTED|Overall Study||9
108365|NCT01031706|251236|P1|STARTED|Overall Study||14
108366|NCT01031680|251246|P2|NOT COMPLETED|Overall Study||58
108367|NCT01031680|251247|P1|NOT COMPLETED|Overall Study||57
108368|NCT01031680|251246|P2|COMPLETED|Overall Study||404
108369|NCT01031680|251247|P1|COMPLETED|Overall Study||403
108370|NCT01031680|251246|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
108371|NCT01031680|251247|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
108372|NCT01031628|251267|P4|NOT COMPLETED|Overall Study||0
108373|NCT01031628|251268|P3|NOT COMPLETED|Overall Study||3
108374|NCT01031628|251269|P2|NOT COMPLETED|Overall Study||1
108375|NCT01031628|251270|P1|NOT COMPLETED|Overall Study||0
108376|NCT01031628|251267|P4|COMPLETED|Overall Study||0
108377|NCT01031628|251268|P3|COMPLETED|Overall Study||0
108378|NCT01031628|251269|P2|COMPLETED|Overall Study||0
108379|NCT01031628|251270|P1|COMPLETED|Overall Study||0
108380|NCT01031628|251267|P4|STARTED|Overall Study||0
108381|NCT01031628|251268|P3|STARTED|Overall Study||3
108382|NCT01031628|251269|P2|STARTED|Overall Study||1
108383|NCT01031628|251270|P1|STARTED|Overall Study||0
108384|NCT01031550|251282|P2|NOT COMPLETED|Overall Study||0
108385|NCT01031550|251283|P1|NOT COMPLETED|Overall Study||0
108386|NCT01031550|251282|P2|COMPLETED|Overall Study||3
108387|NCT01031550|251283|P1|COMPLETED|Overall Study||5
108388|NCT01031550|251282|P2|STARTED|Overall Study||3
108389|NCT01031550|251283|P1|STARTED|Overall Study||5
108390|NCT01031498|251298|P3|NOT COMPLETED|Overall Study||2
108391|NCT01031498|251299|P2|NOT COMPLETED|Overall Study||3
108392|NCT01031498|251300|P1|NOT COMPLETED|Overall Study||2
108393|NCT01031498|251298|P3|COMPLETED|Overall Study||48
108394|NCT01031498|251299|P2|COMPLETED|Overall Study||48
108395|NCT01031498|251300|P1|COMPLETED|Overall Study||47
108396|NCT01031498|251298|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
108397|NCT01031498|251299|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
108398|NCT01031498|251300|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
108399|NCT01031446|251308|P1|NOT COMPLETED|Overall Study||55
108400|NCT01031446|251308|P1|COMPLETED|Overall Study||0
108401|NCT01031446|251308|P1|STARTED|Overall Study||55
108402|NCT01031381|251317|P1|NOT COMPLETED|Overall Study||9
108403|NCT01031381|251317|P1|COMPLETED|Overall Study||50
108404|NCT01031381|251317|P1|STARTED|Overall Study||59
108405|NCT01031095|251324|P2|NOT COMPLETED|Overall Study||0
108406|NCT01031095|251325|P1|NOT COMPLETED|Overall Study||0
108407|NCT01031095|251324|P2|COMPLETED|Overall Study||100
108408|NCT01031095|251325|P1|COMPLETED|Overall Study||100
108409|NCT01031095|251324|P2|STARTED|Overall Study||100
108410|NCT01031095|251325|P1|STARTED|Overall Study||100
108411|NCT01031043|251331|P1|NOT COMPLETED|Overall Study||1
108412|NCT01031043|251331|P1|COMPLETED|Overall Study||4
108413|NCT01031043|251331|P1|STARTED|Overall Study||5
108414|NCT01031004|251337|P2|NOT COMPLETED|Overall Study||1
108415|NCT01031004|251338|P1|NOT COMPLETED|Overall Study||1
108416|NCT01031004|251337|P2|COMPLETED|Overall Study||24
108417|NCT01031004|251338|P1|COMPLETED|Overall Study||24
108418|NCT01031004|251337|P2|STARTED|Overall Study||25
108419|NCT01031004|251338|P1|STARTED|Overall Study||25
108420|NCT01030965|251382|P4|NOT COMPLETED|Overall Study||7
108421|NCT01030965|251383|P3|NOT COMPLETED|Overall Study||4
108422|NCT01030965|251384|P2|NOT COMPLETED|Overall Study||6
108423|NCT01030965|251385|P1|NOT COMPLETED|Overall Study||4
108424|NCT01030965|251382|P4|COMPLETED|Overall Study||64
108425|NCT01030965|251383|P3|COMPLETED|Overall Study||68
108426|NCT01030965|251384|P2|COMPLETED|Overall Study||65
108427|NCT01030965|251385|P1|COMPLETED|Overall Study||67
108428|NCT01030965|251382|P4|STARTED|Overall Study||71
108429|NCT01030965|251383|P3|STARTED|Overall Study||72
108430|NCT01030965|251384|P2|STARTED|Overall Study||71
108431|NCT01030965|251385|P1|STARTED|Overall Study||71
108432|NCT01030952|251405|P2|NOT COMPLETED|Overall Study||3
108433|NCT01030952|251406|P1|NOT COMPLETED|Overall Study||2
108434|NCT01030952|251405|P2|COMPLETED|Overall Study||49
108435|NCT01030952|251406|P1|COMPLETED|Overall Study||49
108436|NCT01030952|251405|P2|STARTED|Overall Study||52
108437|NCT01030952|251406|P1|STARTED|Overall Study||51
108438|NCT01030757|251440|P1|NOT COMPLETED|Overall Study||0
108439|NCT01030757|251440|P1|COMPLETED|Overall Study||2
108440|NCT01030757|251440|P1|STARTED|Overall Study||2
108441|NCT01030718|251448|P3|NOT COMPLETED|Study CA180-036 Only||5
108442|NCT01030718|251449|P2|NOT COMPLETED|Study CA180-036 Only||7
108443|NCT01030718|251450|P1|NOT COMPLETED|Study CA180-036 Only||3
108444|NCT01030718|251448|P3|COMPLETED|Study CA180-036 Only||1
108445|NCT01030718|251449|P2|COMPLETED|Study CA180-036 Only||2
108446|NCT01030718|251450|P1|COMPLETED|Study CA180-036 Only||26
108447|NCT01030718|251448|P3|STARTED|Study CA180-036 Only||6
108448|NCT01030718|251449|P2|STARTED|Study CA180-036 Only||9
108449|NCT01030718|251450|P1|STARTED|Study CA180-036 Only||29
108450|NCT01030718|251448|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
108451|NCT01030718|251449|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
108452|NCT01030718|251450|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
108453|NCT01030718|251448|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
108454|NCT01030718|251449|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
108455|NCT01030718|251450|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
108456|NCT01030718|251448|P3|STARTED|Studies CA180-031 and -036 Combined||13
108457|NCT01030718|251449|P2|STARTED|Studies CA180-031 and -036 Combined||11
108458|NCT01030718|251450|P1|STARTED|Studies CA180-031 and -036 Combined||30
108459|NCT01030666|251511|P2|NOT COMPLETED|Overall Study||2
108460|NCT01030666|251512|P1|NOT COMPLETED|Overall Study||3
108461|NCT01030666|251511|P2|COMPLETED|Overall Study||31
108462|NCT01030666|251512|P1|COMPLETED|Overall Study||25
108463|NCT01030666|251511|P2|STARTED|Overall Study||33
108464|NCT01030666|251512|P1|STARTED|Overall Study||28
108465|NCT01030653|251522|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
108466|NCT01030653|251523|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
108467|NCT01030653|251522|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
108468|NCT01030653|251523|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
108469|NCT01030653|251522|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
108470|NCT01030653|251523|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
108471|NCT01030653|251522|P2|NOT COMPLETED|7-Day Washout Period||0
108472|NCT01030653|251523|P1|NOT COMPLETED|7-Day Washout Period||0
108473|NCT01030653|251522|P2|COMPLETED|7-Day Washout Period||4
108474|NCT01030653|251523|P1|COMPLETED|7-Day Washout Period||4
108475|NCT01030653|251522|P2|STARTED|7-Day Washout Period||4
108476|NCT01030653|251523|P1|STARTED|7-Day Washout Period||4
108477|NCT01030653|251522|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
108478|NCT01030653|251523|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
108479|NCT01030653|251522|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
108480|NCT01030653|251523|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
108481|NCT01030653|251522|P2|STARTED|Loading Dose & First Maintenance Regimen||4
108482|NCT01030653|251523|P1|STARTED|Loading Dose & First Maintenance Regimen||4
108483|NCT01030458|251534|P2|NOT COMPLETED|Overall Study||32
108484|NCT01030458|251535|P1|NOT COMPLETED|Overall Study||27
108485|NCT01030458|251534|P2|COMPLETED|Overall Study||57
108486|NCT01030458|251535|P1|COMPLETED|Overall Study||67
108487|NCT01030458|251534|P2|STARTED|Overall Study||89
108488|NCT01030458|251535|P1|STARTED|Overall Study||94
108489|NCT01029925|251547|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
108490|NCT01029925|251547|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
108491|NCT01029925|251547|P1|STARTED|Completion of Cycle 2 (56 Days)||3
108492|NCT01029925|251547|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
108493|NCT01029925|251547|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
108494|NCT01029925|251547|P1|STARTED|Completion of Cycle 1 (28 Days)||7
108495|NCT01029886|251553|P2|NOT COMPLETED|Overall Study||60
108496|NCT01029886|251554|P1|NOT COMPLETED|Overall Study||61
108497|NCT01029886|251553|P2|COMPLETED|Overall Study||391
108498|NCT01029886|251554|P1|COMPLETED|Overall Study||400
108499|NCT01029886|251553|P2|Intent to Treat (ITT)|Overall Study||450
108500|NCT01029886|251554|P1|Intent to Treat (ITT)|Overall Study||461
108501|NCT01029886|251553|P2|STARTED|Overall Study||451
108502|NCT01029886|251554|P1|STARTED|Overall Study||461
108503|NCT01029795|251582|P2|NOT COMPLETED|Overall Study||22
108504|NCT01029795|251583|P1|NOT COMPLETED|Overall Study||16
108505|NCT01029795|251582|P2|COMPLETED|Overall Study||0
108506|NCT01029795|251583|P1|COMPLETED|Overall Study||0
108507|NCT01029795|251582|P2|STARTED|Overall Study||22
108508|NCT01029795|251583|P1|STARTED|Overall Study||16
108509|NCT01029730|251635|P1|NOT COMPLETED|Maintenance Therapy||23
108510|NCT01029730|251635|P1|COMPLETED|Maintenance Therapy||14
108511|NCT01029730|251635|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
108512|NCT01029730|251635|P1|NOT COMPLETED|Combination Therapy||16
108513|NCT01029730|251635|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
108514|NCT01029730|251635|P1|STARTED|Combination Therapy||55
108515|NCT01029704|251647|P5|NOT COMPLETED|Overall Study||0
108516|NCT01029704|251648|P4|NOT COMPLETED|Overall Study||0
108517|NCT01029704|251649|P3|NOT COMPLETED|Overall Study||0
108518|NCT01029704|251650|P2|NOT COMPLETED|Overall Study||0
108519|NCT01029704|251651|P1|NOT COMPLETED|Overall Study||0
108520|NCT01029704|251647|P5|COMPLETED|Overall Study||26
108521|NCT01029704|251648|P4|COMPLETED|Overall Study||28
108522|NCT01029704|251649|P3|COMPLETED|Overall Study||23
108523|NCT01029704|251650|P2|COMPLETED|Overall Study||24
108524|NCT01029704|251651|P1|COMPLETED|Overall Study||28
108525|NCT01029704|251647|P5|STARTED|Overall Study||26
108526|NCT01029704|251648|P4|STARTED|Overall Study||28
108527|NCT01029704|251649|P3|STARTED|Overall Study||23
108528|NCT01029704|251650|P2|STARTED|Overall Study||24
108529|NCT01029704|251651|P1|STARTED|Overall Study||28
108530|NCT01029652|251680|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
108531|NCT01029652|251681|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
108532|NCT01029652|251680|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
108533|NCT01029652|251681|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
108534|NCT01029652|251680|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
108535|NCT01029652|251681|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
108536|NCT01029652|251680|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
108537|NCT01029652|251681|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
108538|NCT01029652|251680|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
108539|NCT01029652|251681|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
108540|NCT01029652|251680|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
108541|NCT01029652|251681|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
108542|NCT01029652|251680|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
108543|NCT01029652|251681|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
108544|NCT01029652|251680|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
108545|NCT01029652|251681|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
108546|NCT01029652|251680|P2|COMPLETED|Core Study (0-12 Weeks)||105
108547|NCT01029652|251681|P1|COMPLETED|Core Study (0-12 Weeks)||109
108548|NCT01029652|251680|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
108549|NCT01029652|251681|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
108550|NCT01029652|251680|P2|STARTED|Core Study (0-12 Weeks)||115
108551|NCT01029652|251681|P1|STARTED|Core Study (0-12 Weeks)||115
108552|NCT01029535|251759|P1|NOT COMPLETED|Overall Study||31
108553|NCT01029535|251759|P1|COMPLETED|Overall Study||72
108554|NCT01029535|251759|P1|STARTED|Overall Study||103
108555|NCT01029340|251789|P6|NOT COMPLETED|Part C Follow up Period||0
108556|NCT01029340|251790|P5|NOT COMPLETED|Part C Follow up Period||0
108557|NCT01029340|251791|P4|NOT COMPLETED|Part C Follow up Period||0
108558|NCT01029340|251792|P3|NOT COMPLETED|Part C Follow up Period||0
108559|NCT01029340|251793|P2|NOT COMPLETED|Part C Follow up Period||0
108560|NCT01029340|251794|P1|NOT COMPLETED|Part C Follow up Period||0
108561|NCT01029340|251789|P6|COMPLETED|Part C Follow up Period||0
108562|NCT01029340|251790|P5|COMPLETED|Part C Follow up Period||5
108563|NCT01029340|251791|P4|COMPLETED|Part C Follow up Period||0
108564|NCT01029340|251792|P3|COMPLETED|Part C Follow up Period||0
108565|NCT01029340|251793|P2|COMPLETED|Part C Follow up Period||0
108566|NCT01029340|251794|P1|COMPLETED|Part C Follow up Period||0
108567|NCT01029340|251789|P6|STARTED|Part C Follow up Period||0
108568|NCT01029340|251790|P5|STARTED|Part C Follow up Period||5
108569|NCT01029340|251791|P4|STARTED|Part C Follow up Period||0
108570|NCT01029340|251792|P3|STARTED|Part C Follow up Period||0
108571|NCT01029340|251793|P2|STARTED|Part C Follow up Period||0
108572|NCT01029340|251794|P1|STARTED|Part C Follow up Period||0
108573|NCT01029340|251789|P6|NOT COMPLETED|Part C Treatment Period||0
108574|NCT01029340|251790|P5|NOT COMPLETED|Part C Treatment Period||0
108575|NCT01029340|251791|P4|NOT COMPLETED|Part C Treatment Period||0
108576|NCT01029340|251792|P3|NOT COMPLETED|Part C Treatment Period||0
108577|NCT01029340|251793|P2|NOT COMPLETED|Part C Treatment Period||0
108578|NCT01029340|251794|P1|NOT COMPLETED|Part C Treatment Period||0
108579|NCT01029340|251789|P6|COMPLETED|Part C Treatment Period||0
108580|NCT01029340|251790|P5|COMPLETED|Part C Treatment Period||5
108581|NCT01029340|251791|P4|COMPLETED|Part C Treatment Period||0
108582|NCT01029340|251792|P3|COMPLETED|Part C Treatment Period||0
108583|NCT01029340|251793|P2|COMPLETED|Part C Treatment Period||0
108584|NCT01029340|251794|P1|COMPLETED|Part C Treatment Period||0
108585|NCT01029340|251789|P6|Participants Received Treatment|Part C Treatment Period||0
108586|NCT01029340|251790|P5|Participants Received Treatment|Part C Treatment Period||5
108587|NCT01029340|251791|P4|Participants Received Treatment|Part C Treatment Period||0
108588|NCT01029340|251792|P3|Participants Received Treatment|Part C Treatment Period||0
108589|NCT01029340|251793|P2|Participants Received Treatment|Part C Treatment Period||0
108590|NCT01029340|251794|P1|Participants Received Treatment|Part C Treatment Period||0
108591|NCT01029340|251789|P6|STARTED|Part C Treatment Period||0
108592|NCT01029340|251790|P5|STARTED|Part C Treatment Period||5
108593|NCT01029340|251791|P4|STARTED|Part C Treatment Period||0
108594|NCT01029340|251792|P3|STARTED|Part C Treatment Period||0
108595|NCT01029340|251793|P2|STARTED|Part C Treatment Period||0
108596|NCT01029340|251794|P1|STARTED|Part C Treatment Period||0
108597|NCT01029340|251789|P6|NOT COMPLETED|Extension Period||12
108598|NCT01029340|251790|P5|NOT COMPLETED|Extension Period||0
108599|NCT01029340|251791|P4|NOT COMPLETED|Extension Period||0
108600|NCT01029340|251792|P3|NOT COMPLETED|Extension Period||0
108601|NCT01029340|251793|P2|NOT COMPLETED|Extension Period||0
108602|NCT01029340|251794|P1|NOT COMPLETED|Extension Period||0
108603|NCT01029340|251789|P6|COMPLETED|Extension Period||43
108604|NCT01029340|251790|P5|COMPLETED|Extension Period||0
108605|NCT01029340|251791|P4|COMPLETED|Extension Period||0
108606|NCT01029340|251792|P3|COMPLETED|Extension Period||0
108607|NCT01029340|251793|P2|COMPLETED|Extension Period||0
108608|NCT01029340|251794|P1|COMPLETED|Extension Period||0
108609|NCT01029340|251789|P6|STARTED|Extension Period||55
108610|NCT01029340|251790|P5|STARTED|Extension Period||0
108611|NCT01029340|251791|P4|STARTED|Extension Period||0
108612|NCT01029340|251792|P3|STARTED|Extension Period||0
108613|NCT01029340|251793|P2|STARTED|Extension Period||0
108614|NCT01029340|251794|P1|STARTED|Extension Period||0
108615|NCT01029340|251789|P6|NOT COMPLETED|Part B Follow up Period||0
108616|NCT01029340|251790|P5|NOT COMPLETED|Part B Follow up Period||0
108617|NCT01029340|251791|P4|NOT COMPLETED|Part B Follow up Period||0
108618|NCT01029340|251792|P3|NOT COMPLETED|Part B Follow up Period||0
108619|NCT01029340|251793|P2|NOT COMPLETED|Part B Follow up Period||0
108620|NCT01029340|251794|P1|NOT COMPLETED|Part B Follow up Period||0
108621|NCT01029340|251789|P6|COMPLETED|Part B Follow up Period||0
108622|NCT01029340|251790|P5|COMPLETED|Part B Follow up Period||0
108623|NCT01029340|251791|P4|COMPLETED|Part B Follow up Period||32
108624|NCT01029340|251792|P3|COMPLETED|Part B Follow up Period||29
108625|NCT01029340|251793|P2|COMPLETED|Part B Follow up Period||0
108626|NCT01029340|251794|P1|COMPLETED|Part B Follow up Period||0
108627|NCT01029340|251789|P6|STARTED|Part B Follow up Period||0
108628|NCT01029340|251790|P5|STARTED|Part B Follow up Period||0
108629|NCT01029340|251791|P4|STARTED|Part B Follow up Period||32
108630|NCT01029340|251792|P3|STARTED|Part B Follow up Period||29
108631|NCT01029340|251793|P2|STARTED|Part B Follow up Period||0
108632|NCT01029340|251794|P1|STARTED|Part B Follow up Period||0
108633|NCT01029340|251789|P6|NOT COMPLETED|Part B Treatment Period||0
108634|NCT01029340|251790|P5|NOT COMPLETED|Part B Treatment Period||0
108635|NCT01029340|251791|P4|NOT COMPLETED|Part B Treatment Period||0
108636|NCT01029340|251792|P3|NOT COMPLETED|Part B Treatment Period||2
108637|NCT01029340|251793|P2|NOT COMPLETED|Part B Treatment Period||0
108638|NCT01029340|251794|P1|NOT COMPLETED|Part B Treatment Period||0
108639|NCT01029340|251789|P6|COMPLETED|Part B Treatment Period||0
108640|NCT01029340|251790|P5|COMPLETED|Part B Treatment Period||0
108641|NCT01029340|251791|P4|COMPLETED|Part B Treatment Period||32
108642|NCT01029340|251792|P3|COMPLETED|Part B Treatment Period||29
108643|NCT01029340|251793|P2|COMPLETED|Part B Treatment Period||0
108644|NCT01029340|251794|P1|COMPLETED|Part B Treatment Period||0
108645|NCT01029340|251789|P6|Participants Received Treatment|Part B Treatment Period||0
108646|NCT01029340|251790|P5|Participants Received Treatment|Part B Treatment Period||0
108647|NCT01029340|251791|P4|Participants Received Treatment|Part B Treatment Period||32
108648|NCT01029340|251792|P3|Participants Received Treatment|Part B Treatment Period||30
108649|NCT01029340|251793|P2|Participants Received Treatment|Part B Treatment Period||0
108650|NCT01029340|251794|P1|Participants Received Treatment|Part B Treatment Period||0
108651|NCT01029340|251789|P6|STARTED|Part B Treatment Period||0
108652|NCT01029340|251790|P5|STARTED|Part B Treatment Period||0
108653|NCT01029340|251791|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
108654|NCT01029340|251792|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
108655|NCT01029340|251793|P2|STARTED|Part B Treatment Period||0
108656|NCT01029340|251794|P1|STARTED|Part B Treatment Period||0
108657|NCT01029340|251789|P6|NOT COMPLETED|Part A Follow up Period||0
108658|NCT01029340|251790|P5|NOT COMPLETED|Part A Follow up Period||0
108659|NCT01029340|251791|P4|NOT COMPLETED|Part A Follow up Period||0
108660|NCT01029340|251792|P3|NOT COMPLETED|Part A Follow up Period||0
108661|NCT01029340|251793|P2|NOT COMPLETED|Part A Follow up Period||0
108662|NCT01029340|251794|P1|NOT COMPLETED|Part A Follow up Period||0
108663|NCT01029340|251789|P6|COMPLETED|Part A Follow up Period||0
108664|NCT01029340|251790|P5|COMPLETED|Part A Follow up Period||0
108665|NCT01029340|251791|P4|COMPLETED|Part A Follow up Period||0
108666|NCT01029340|251792|P3|COMPLETED|Part A Follow up Period||0
108667|NCT01029340|251793|P2|COMPLETED|Part A Follow up Period||14
108668|NCT01029340|251794|P1|COMPLETED|Part A Follow up Period||14
108669|NCT01029340|251789|P6|STARTED|Part A Follow up Period||0
108670|NCT01029340|251790|P5|STARTED|Part A Follow up Period||0
108671|NCT01029340|251791|P4|STARTED|Part A Follow up Period||0
108672|NCT01029340|251792|P3|STARTED|Part A Follow up Period||0
108673|NCT01029340|251793|P2|STARTED|Part A Follow up Period||14
108674|NCT01029340|251794|P1|STARTED|Part A Follow up Period||14
108675|NCT01029340|251789|P6|NOT COMPLETED|Part A Treatment Period||0
108676|NCT01029340|251790|P5|NOT COMPLETED|Part A Treatment Period||0
108677|NCT01029340|251791|P4|NOT COMPLETED|Part A Treatment Period||0
108678|NCT01029340|251792|P3|NOT COMPLETED|Part A Treatment Period||0
108679|NCT01029340|251793|P2|NOT COMPLETED|Part A Treatment Period||0
108680|NCT01029340|251794|P1|NOT COMPLETED|Part A Treatment Period||0
108681|NCT01029340|251789|P6|COMPLETED|Part A Treatment Period||0
108682|NCT01029340|251790|P5|COMPLETED|Part A Treatment Period||0
108683|NCT01029340|251791|P4|COMPLETED|Part A Treatment Period||0
108684|NCT01029340|251792|P3|COMPLETED|Part A Treatment Period||0
108685|NCT01029340|251793|P2|COMPLETED|Part A Treatment Period||14
108686|NCT01029340|251794|P1|COMPLETED|Part A Treatment Period||14
108687|NCT01029340|251789|P6|Safety Population|Part A Treatment Period||0
108688|NCT01029340|251790|P5|Safety Population|Part A Treatment Period||0
108689|NCT01029340|251791|P4|Safety Population|Part A Treatment Period||0
108690|NCT01029340|251792|P3|Safety Population|Part A Treatment Period||0
108691|NCT01029340|251793|P2|Safety Population|Part A Treatment Period||14
108692|NCT01029340|251794|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
108693|NCT01029340|251789|P6|Participants Received Treatment|Part A Treatment Period||0
108694|NCT01029340|251790|P5|Participants Received Treatment|Part A Treatment Period||0
108695|NCT01029340|251791|P4|Participants Received Treatment|Part A Treatment Period||0
108696|NCT01029340|251792|P3|Participants Received Treatment|Part A Treatment Period||0
108697|NCT01029340|251793|P2|Participants Received Treatment|Part A Treatment Period||14
108698|NCT01029340|251794|P1|Participants Received Treatment|Part A Treatment Period||14
108699|NCT01029340|251789|P6|STARTED|Part A Treatment Period||0
108700|NCT01029340|251790|P5|STARTED|Part A Treatment Period||0
108701|NCT01029340|251791|P4|STARTED|Part A Treatment Period||0
108702|NCT01029340|251792|P3|STARTED|Part A Treatment Period||0
108703|NCT01029340|251793|P2|STARTED|Part A Treatment Period||14
108704|NCT01029340|251794|P1|STARTED|Part A Treatment Period||14
108705|NCT01029262|251825|P2|NOT COMPLETED|Overall Study||145
108706|NCT01029262|251826|P1|NOT COMPLETED|Overall Study||78
108707|NCT01029262|251825|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
108708|NCT01029262|251826|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
108709|NCT01029262|251825|P2|STARTED|Overall Study||160
108710|NCT01029262|251826|P1|STARTED|Overall Study||79
108711|NCT01029054|251882|P3|NOT COMPLETED|Phase II||0
108712|NCT01029054|251883|P2|NOT COMPLETED|Phase II||0
108713|NCT01029054|251884|P1|NOT COMPLETED|Phase II||0
108714|NCT01029054|251882|P3|COMPLETED|Phase II||18
108715|NCT01029054|251883|P2|COMPLETED|Phase II||0
108716|NCT01029054|251884|P1|COMPLETED|Phase II||0
108717|NCT01029054|251882|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
108718|NCT01029054|251883|P2|STARTED|Phase II||0
108719|NCT01029054|251884|P1|STARTED|Phase II||0
108720|NCT01029054|251882|P3|NOT COMPLETED|Phase I||0
108721|NCT01029054|251883|P2|NOT COMPLETED|Phase I||0
108722|NCT01029054|251884|P1|NOT COMPLETED|Phase I||0
108723|NCT01029054|251882|P3|COMPLETED|Phase I||18
108724|NCT01029054|251883|P2|COMPLETED|Phase I||13
108725|NCT01029054|251884|P1|COMPLETED|Phase I||4
108726|NCT01029054|251882|P3|STARTED|Phase I||18
108727|NCT01029054|251883|P2|STARTED|Phase I||13
108728|NCT01029054|251884|P1|STARTED|Phase I||4
108729|NCT01028911|251892|P2|NOT COMPLETED|Overall Study||0
108730|NCT01028911|251893|P1|NOT COMPLETED|Overall Study||0
108731|NCT01028911|251892|P2|COMPLETED|Overall Study||2
108732|NCT01028911|251893|P1|COMPLETED|Overall Study||7
108733|NCT01028911|251892|P2|STARTED|Overall Study||2
108734|NCT01028911|251893|P1|STARTED|Overall Study||7
108735|NCT01028820|251958|P1|NOT COMPLETED|Overall Study||1
108736|NCT01028820|251958|P1|COMPLETED|Overall Study||12
108737|NCT01028820|251958|P1|STARTED|Overall Study||13
108738|NCT01027364|251969|P4|NOT COMPLETED|Overall Study||1
108739|NCT01027364|251970|P3|NOT COMPLETED|Overall Study||1
108740|NCT01027364|251971|P2|NOT COMPLETED|Overall Study||2
108741|NCT01027364|251972|P1|NOT COMPLETED|Overall Study||4
108742|NCT01027364|251969|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
108743|NCT01027364|251970|P3|COMPLETED|Overall Study||26
108744|NCT01027364|251971|P2|COMPLETED|Overall Study||27
108745|NCT01027364|251972|P1|COMPLETED|Overall Study||59
108746|NCT01027364|251969|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
108747|NCT01027364|251970|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
108748|NCT01027364|251971|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
108749|NCT01027364|251972|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
108750|NCT01027364|251969|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
108751|NCT01027364|251970|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
108752|NCT01027364|251971|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
108753|NCT01027364|251972|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
108754|NCT01027364|251969|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
108846|NCT01028027|252282|P2|STARTED|Overall Study||177
108755|NCT01027364|251970|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
108756|NCT01027364|251971|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
108757|NCT01027364|251972|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
108758|NCT01027364|251969|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
108759|NCT01027364|251970|P3|STARTED|Overall Study||27
108760|NCT01027364|251971|P2|STARTED|Overall Study||29
108761|NCT01027364|251972|P1|STARTED|Overall Study||63
108762|NCT01027351|252067|P6|NOT COMPLETED|Overall Study||5
108763|NCT01027351|252068|P5|NOT COMPLETED|Overall Study||11
108764|NCT01027351|252069|P4|NOT COMPLETED|Overall Study||2
108765|NCT01027351|252070|P3|NOT COMPLETED|Overall Study||1
108766|NCT01027351|252071|P2|NOT COMPLETED|Overall Study||1
108767|NCT01027351|252072|P1|NOT COMPLETED|Overall Study||3
108768|NCT01027351|252067|P6|COMPLETED|Overall Study||45
108769|NCT01027351|252068|P5|COMPLETED|Overall Study||32
108770|NCT01027351|252069|P4|COMPLETED|Overall Study||6
108771|NCT01027351|252070|P3|COMPLETED|Overall Study||13
108772|NCT01027351|252071|P2|COMPLETED|Overall Study||18
108773|NCT01027351|252072|P1|COMPLETED|Overall Study||26
108774|NCT01027351|252067|P6|STARTED|Overall Study||50
108775|NCT01027351|252068|P5|STARTED|Overall Study||43
108776|NCT01027351|252069|P4|STARTED|Overall Study||8
108777|NCT01027351|252070|P3|STARTED|Overall Study||14
108778|NCT01027351|252071|P2|STARTED|Overall Study||19
108779|NCT01027351|252072|P1|STARTED|Overall Study||29
108780|NCT01027286|252156|P2|NOT COMPLETED|Overall Study||1
108781|NCT01027286|252157|P1|NOT COMPLETED|Overall Study||1
108782|NCT01027286|252156|P2|COMPLETED|Overall Study||49
108783|NCT01027286|252157|P1|COMPLETED|Overall Study||49
108784|NCT01027286|252156|P2|12 Week Postoperative|Overall Study||49
108785|NCT01027286|252157|P1|12 Week Postoperative|Overall Study||49
108786|NCT01027286|252156|P2|4 Week Postoperative|Overall Study||50
108787|NCT01027286|252157|P1|4 Week Postoperative|Overall Study||49
108788|NCT01027286|252156|P2|Day of Surgery|Overall Study||50
108789|NCT01027286|252157|P1|Day of Surgery|Overall Study||50
108790|NCT01027286|252156|P2|Preoperative|Overall Study||50
108791|NCT01027286|252157|P1|Preoperative|Overall Study||50
108792|NCT01027286|252156|P2|STARTED|Overall Study||50
108793|NCT01027286|252157|P1|STARTED|Overall Study||50
108794|NCT01027273|252177|P2|NOT COMPLETED|Overall Study||33
108795|NCT01027273|252178|P1|NOT COMPLETED|Overall Study||59
108796|NCT01027273|252177|P2|COMPLETED|Overall Study||266
108797|NCT01027273|252178|P1|COMPLETED|Overall Study||242
108798|NCT01027273|252177|P2|STARTED|Overall Study||299
108799|NCT01027273|252178|P1|STARTED|Overall Study||301
108800|NCT01028391|252196|P2|NOT COMPLETED|Overall Study||11
108801|NCT01028391|252197|P1|NOT COMPLETED|Overall Study||14
108802|NCT01028391|252196|P2|COMPLETED|Overall Study||142
108803|NCT01028391|252197|P1|COMPLETED|Overall Study||150
108804|NCT01028391|252196|P2|STARTED|Overall Study||153
108805|NCT01028391|252197|P1|STARTED|Overall Study||164
108806|NCT01028378|252205|P1|NOT COMPLETED|Overall Study||17
108807|NCT01028378|252205|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
108808|NCT01028378|252205|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
108809|NCT01028352|252217|P1|NOT COMPLETED|Overall Study||6
108810|NCT01028352|252217|P1|COMPLETED|Overall Study||29
108811|NCT01028352|252217|P1|STARTED|Overall Study||35
108812|NCT01028300|252222|P1|NOT COMPLETED|Overall Study||4
108813|NCT01028300|252222|P1|COMPLETED|Overall Study||0
108814|NCT01028300|252222|P1|STARTED|Overall Study||4
108815|NCT01028222|252231|P2|NOT COMPLETED|Overall Study||13
108816|NCT01028222|252232|P1|NOT COMPLETED|Overall Study||38
108817|NCT01028222|252231|P2|COMPLETED|Overall Study||0
108818|NCT01028222|252232|P1|COMPLETED|Overall Study||4
108819|NCT01028222|252231|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
108820|NCT01028222|252232|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
108821|NCT01028222|252231|P2|STARTED|Overall Study||13
108822|NCT01028222|252232|P1|STARTED|Overall Study||42
108823|NCT01028131|252257|P4|NOT COMPLETED|Overall Study||4
108824|NCT01028131|252258|P3|NOT COMPLETED|Overall Study||6
108825|NCT01028131|252259|P2|NOT COMPLETED|Overall Study||3
108826|NCT01028131|252260|P1|NOT COMPLETED|Overall Study||3
108827|NCT01028131|252257|P4|COMPLETED|Overall Study||26
108828|NCT01028131|252258|P3|COMPLETED|Overall Study||22
108829|NCT01028131|252259|P2|COMPLETED|Overall Study||23
108830|NCT01028131|252260|P1|COMPLETED|Overall Study||23
108831|NCT01028131|252257|P4|Completed Intervention/Control Session|Overall Study||30
108832|NCT01028131|252258|P3|Completed Intervention/Control Session|Overall Study||28
108833|NCT01028131|252259|P2|Completed Intervention/Control Session|Overall Study||26
108834|NCT01028131|252260|P1|Completed Intervention/Control Session|Overall Study||26
108835|NCT01028131|252257|P4|STARTED|Overall Study||30
108836|NCT01028131|252258|P3|STARTED|Overall Study||28
108837|NCT01028131|252259|P2|STARTED|Overall Study||26
108838|NCT01028131|252260|P1|STARTED|Overall Study||26
108839|NCT01028053|252274|P1|NOT COMPLETED|Overall Study||133
108840|NCT01028053|252274|P1|COMPLETED|Overall Study||232
108841|NCT01028053|252274|P1|STARTED|Overall Study||365
108842|NCT01028027|252282|P2|NOT COMPLETED|Overall Study||13
108843|NCT01028027|252283|P1|NOT COMPLETED|Overall Study||16
108844|NCT01028027|252282|P2|COMPLETED|Overall Study||164
108845|NCT01028027|252283|P1|COMPLETED|Overall Study||164
108847|NCT01028027|252283|P1|STARTED|Overall Study||180
108848|NCT01028014|252305|P6|NOT COMPLETED|Overall Study||2
108849|NCT01028014|252306|P5|NOT COMPLETED|Overall Study||1
108850|NCT01028014|252307|P4|NOT COMPLETED|Overall Study||1
108851|NCT01028014|252308|P3|NOT COMPLETED|Overall Study||0
108852|NCT01028014|252309|P2|NOT COMPLETED|Overall Study||2
108853|NCT01028014|252310|P1|NOT COMPLETED|Overall Study||1
108854|NCT01028014|252305|P6|COMPLETED|Overall Study||4
108855|NCT01028014|252306|P5|COMPLETED|Overall Study||9
108856|NCT01028014|252307|P4|COMPLETED|Overall Study||9
108857|NCT01028014|252308|P3|COMPLETED|Overall Study||10
108858|NCT01028014|252309|P2|COMPLETED|Overall Study||8
108859|NCT01028014|252310|P1|COMPLETED|Overall Study||9
108860|NCT01028014|252305|P6|STARTED|Overall Study||6
108861|NCT01028014|252306|P5|STARTED|Overall Study||10
108862|NCT01028014|252307|P4|STARTED|Overall Study||10
108863|NCT01028014|252308|P3|STARTED|Overall Study||10
108864|NCT01028014|252309|P2|STARTED|Overall Study||10
108865|NCT01028014|252310|P1|STARTED|Overall Study||10
108866|NCT01027910|252338|P2|NOT COMPLETED|Overall Study||0
108867|NCT01027910|252339|P1|NOT COMPLETED|Overall Study||0
108868|NCT01027910|252338|P2|COMPLETED|Overall Study||14
108869|NCT01027910|252339|P1|COMPLETED|Overall Study||6
108870|NCT01027910|252338|P2|STARTED|Overall Study||14
108871|NCT01027910|252339|P1|STARTED|Overall Study||6
108872|NCT01027897|252351|P1|NOT COMPLETED|Overall Study||2
108873|NCT01027897|252351|P1|COMPLETED|Overall Study||28
108874|NCT01027897|252351|P1|STARTED|Overall Study||30
108875|NCT01027884|252359|P2|NOT COMPLETED|Overall Study||7
108876|NCT01027884|252360|P1|NOT COMPLETED|Overall Study||4
108877|NCT01027884|252359|P2|COMPLETED|Overall Study||25
108878|NCT01027884|252360|P1|COMPLETED|Overall Study||30
108879|NCT01027884|252359|P2|STARTED|Overall Study||32
108880|NCT01027884|252360|P1|STARTED|Overall Study||34
108881|NCT01027819|252376|P2|NOT COMPLETED|Overall Study||0
108882|NCT01027819|252377|P1|NOT COMPLETED|Overall Study||0
108883|NCT01027819|252376|P2|COMPLETED|Overall Study||40
108884|NCT01027819|252377|P1|COMPLETED|Overall Study||40
108885|NCT01027819|252376|P2|STARTED|Overall Study||40
108886|NCT01027819|252377|P1|STARTED|Overall Study||40
108887|NCT01027780|252385|P2|NOT COMPLETED|Overall Study||1
108888|NCT01027780|252386|P1|NOT COMPLETED|Overall Study||0
108889|NCT01027780|252385|P2|COMPLETED|Overall Study||102
108890|NCT01027780|252386|P1|COMPLETED|Overall Study||105
108891|NCT01027780|252385|P2|STARTED|Overall Study||103
108892|NCT01027780|252386|P1|STARTED|Overall Study||105
108893|NCT01027650|252404|P8|NOT COMPLETED|Overall Study||0
108894|NCT01027650|252405|P7|NOT COMPLETED|Overall Study||1
108895|NCT01027650|252406|P6|NOT COMPLETED|Overall Study||2
108896|NCT01027650|252407|P5|NOT COMPLETED|Overall Study||2
108897|NCT01027650|252408|P4|NOT COMPLETED|Overall Study||0
108898|NCT01027650|252409|P3|NOT COMPLETED|Overall Study||0
108899|NCT01027650|252410|P2|NOT COMPLETED|Overall Study||0
108900|NCT01027650|252411|P1|NOT COMPLETED|Overall Study||0
108901|NCT01027650|252404|P8|COMPLETED|Overall Study||24
108902|NCT01027650|252405|P7|COMPLETED|Overall Study||24
108903|NCT01027650|252406|P6|COMPLETED|Overall Study||24
108904|NCT01027650|252407|P5|COMPLETED|Overall Study||23
108905|NCT01027650|252408|P4|COMPLETED|Overall Study||3
108906|NCT01027650|252409|P3|COMPLETED|Overall Study||6
108907|NCT01027650|252410|P2|COMPLETED|Overall Study||6
108908|NCT01027650|252411|P1|COMPLETED|Overall Study||6
108909|NCT01027650|252404|P8|STARTED|Overall Study||24
108910|NCT01027650|252405|P7|STARTED|Overall Study||25
108911|NCT01027650|252406|P6|STARTED|Overall Study||26
108912|NCT01027650|252407|P5|STARTED|Overall Study||25
108913|NCT01027650|252408|P4|STARTED|Overall Study||3
108914|NCT01027650|252409|P3|STARTED|Overall Study||6
108915|NCT01027650|252410|P2|STARTED|Overall Study||6
108916|NCT01027650|252411|P1|STARTED|Overall Study||6
108917|NCT01027598|252455|P2|NOT COMPLETED|Overall Study||67
108918|NCT01027598|252456|P1|NOT COMPLETED|Overall Study||134
108919|NCT01027598|252455|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
108920|NCT01027598|252456|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
108921|NCT01027598|252455|P2|STARTED|Overall Study||67
108922|NCT01027598|252456|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
108923|NCT01027468|252466|P1|NOT COMPLETED|Overall Study||0
108924|NCT01027468|252466|P1|COMPLETED|Overall Study||160
108925|NCT01027468|252466|P1|STARTED|Overall Study||160
108926|NCT01027195|252472|P2|NOT COMPLETED|Overall Study||0
108927|NCT01027195|252473|P1|NOT COMPLETED|Overall Study||0
108928|NCT01027195|252472|P2|COMPLETED|Overall Study||69
108929|NCT01027195|252473|P1|COMPLETED|Overall Study||71
108930|NCT01027195|252472|P2|STARTED|Overall Study||69
108931|NCT01027195|252473|P1|STARTED|Overall Study||71
108932|NCT01026974|252497|P4|NOT COMPLETED|Overall Study||3
108933|NCT01026974|252498|P3|NOT COMPLETED|Overall Study||12
108934|NCT01026974|252499|P2|NOT COMPLETED|Overall Study||2
108935|NCT01026974|252500|P1|NOT COMPLETED|Overall Study||1
108936|NCT01026974|252497|P4|COMPLETED|Overall Study||46
108937|NCT01026974|252498|P3|COMPLETED|Overall Study||29
108938|NCT01026974|252499|P2|COMPLETED|Overall Study||12
108939|NCT01026974|252500|P1|COMPLETED|Overall Study||15
108940|NCT01026974|252497|P4|STARTED|Overall Study||49
108941|NCT01026974|252498|P3|STARTED|Overall Study||41
108942|NCT01026974|252499|P2|STARTED|Overall Study||14
108943|NCT01026974|252500|P1|STARTED|Overall Study||16
108944|NCT01026948|252557|P1|NOT COMPLETED|Overall Study||8
108945|NCT01026948|252557|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
108946|NCT01026948|252557|P1|STARTED|Overall Study||70
108947|NCT01026909|252564|P2|NOT COMPLETED|Overall Study||0
108948|NCT01026909|252565|P1|NOT COMPLETED|Overall Study||0
108949|NCT01026909|252564|P2|COMPLETED|Overall Study||2
108950|NCT01026909|252565|P1|COMPLETED|Overall Study||1
108951|NCT01026909|252564|P2|STARTED|Overall Study||2
108952|NCT01026909|252565|P1|STARTED|Overall Study||1
108953|NCT01026844|252575|P2|NOT COMPLETED|Overall Study||0
108954|NCT01026844|252576|P1|NOT COMPLETED|Overall Study||0
108955|NCT01026844|252575|P2|COMPLETED|Overall Study||8
108956|NCT01026844|252576|P1|COMPLETED|Overall Study||19
108957|NCT01026844|252575|P2|STARTED|Overall Study||8
108958|NCT01026844|252576|P1|STARTED|Overall Study||19
108959|NCT01026831|252590|P2|NOT COMPLETED|Overall Study||11
108960|NCT01026831|252591|P1|NOT COMPLETED|Overall Study||14
108961|NCT01026831|252590|P2|COMPLETED|Overall Study||312
108962|NCT01026831|252591|P1|COMPLETED|Overall Study||306
108963|NCT01026831|252590|P2|STARTED|Overall Study|randomized|323
108964|NCT01026831|252591|P1|STARTED|Overall Study|randomized|320
108965|NCT01026818|252602|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
108966|NCT01026818|252603|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
108967|NCT01026818|252604|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
108968|NCT01026818|252605|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
108969|NCT01026818|252602|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
108970|NCT01026818|252603|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
108971|NCT01026818|252604|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
108972|NCT01026818|252605|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
108973|NCT01026818|252602|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
108974|NCT01026818|252603|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
108975|NCT01026818|252604|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
108976|NCT01026818|252605|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
108977|NCT01026818|252602|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
108978|NCT01026818|252603|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
108979|NCT01026818|252604|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
108980|NCT01026818|252605|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
108981|NCT01026818|252602|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
108982|NCT01026818|252603|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
108983|NCT01026818|252604|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
108984|NCT01026818|252605|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
108985|NCT01026818|252602|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
108986|NCT01026818|252603|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
108987|NCT01026818|252604|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
108988|NCT01026818|252605|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
108989|NCT01026818|252602|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
108990|NCT01026818|252603|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
108991|NCT01026818|252604|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
108992|NCT01026818|252605|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
108993|NCT01026818|252602|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
108994|NCT01026818|252603|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
108995|NCT01026818|252604|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
108996|NCT01026818|252605|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
108997|NCT01026818|252602|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
108998|NCT01026818|252603|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
108999|NCT01026818|252604|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
109000|NCT01026818|252605|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
109001|NCT01026818|252602|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
109002|NCT01026818|252603|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
109003|NCT01026818|252604|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
109004|NCT01026818|252605|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
109005|NCT01026818|252602|P4|NOT COMPLETED|Screening Period||0
109006|NCT01026818|252603|P3|NOT COMPLETED|Screening Period||0
109007|NCT01026818|252604|P2|NOT COMPLETED|Screening Period||0
109008|NCT01026818|252605|P1|NOT COMPLETED|Screening Period||160
109009|NCT01026818|252602|P4|COMPLETED|Screening Period||0
109010|NCT01026818|252603|P3|COMPLETED|Screening Period||0
109011|NCT01026818|252604|P2|COMPLETED|Screening Period||0
109012|NCT01026818|252605|P1|COMPLETED|Screening Period||423
109013|NCT01026818|252602|P4|STARTED|Screening Period||0
109014|NCT01026818|252603|P3|STARTED|Screening Period||0
109015|NCT01026818|252604|P2|STARTED|Screening Period||0
109016|NCT01026818|252605|P1|STARTED|Screening Period||583
109017|NCT01026805|252683|P1|NOT COMPLETED|Overall Study||0
109018|NCT01026805|252683|P1|COMPLETED|Overall Study||11
109019|NCT01026805|252683|P1|STARTED|Overall Study||11
109020|NCT01026792|252693|P1|NOT COMPLETED|Overall Study||1
109021|NCT01026792|252693|P1|COMPLETED|Overall Study||37
109022|NCT01026792|252693|P1|STARTED|Overall Study||38
109023|NCT01026454|252699|P2|NOT COMPLETED|Second Intervention||1
109024|NCT01026454|252700|P1|NOT COMPLETED|Second Intervention||1
109025|NCT01026454|252699|P2|COMPLETED|Second Intervention||13
109026|NCT01026454|252700|P1|COMPLETED|Second Intervention||16
109027|NCT01026454|252699|P2|STARTED|Second Intervention||14
109028|NCT01026454|252700|P1|STARTED|Second Intervention||17
109029|NCT01026454|252699|P2|NOT COMPLETED|Washout||0
109030|NCT01026454|252700|P1|NOT COMPLETED|Washout||0
109031|NCT01026454|252699|P2|COMPLETED|Washout||14
109032|NCT01026454|252700|P1|COMPLETED|Washout||18
109033|NCT01026454|252699|P2|STARTED|Washout||14
109034|NCT01026454|252700|P1|STARTED|Washout||18
109035|NCT01026454|252699|P2|NOT COMPLETED|First Intervention||0
109036|NCT01026454|252700|P1|NOT COMPLETED|First Intervention||0
109037|NCT01026454|252699|P2|COMPLETED|First Intervention||14
109038|NCT01026454|252700|P1|COMPLETED|First Intervention||18
109039|NCT01026454|252699|P2|STARTED|First Intervention||14
109040|NCT01026454|252700|P1|STARTED|First Intervention||18
109041|NCT01026402|252723|P17|NOT COMPLETED|Overall Study||0
109042|NCT01026402|252724|P16|NOT COMPLETED|Overall Study||0
109043|NCT01026402|252725|P15|NOT COMPLETED|Overall Study||0
109044|NCT01026402|252726|P14|NOT COMPLETED|Overall Study||0
109045|NCT01026402|252727|P13|NOT COMPLETED|Overall Study||0
109046|NCT01026402|252728|P12|NOT COMPLETED|Overall Study||0
109047|NCT01026402|252729|P11|NOT COMPLETED|Overall Study||0
109048|NCT01026402|252730|P10|NOT COMPLETED|Overall Study||0
109049|NCT01026402|252731|P9|NOT COMPLETED|Overall Study||0
109050|NCT01026402|252732|P8|NOT COMPLETED|Overall Study||0
109051|NCT01026402|252733|P7|NOT COMPLETED|Overall Study||0
109052|NCT01026402|252734|P6|NOT COMPLETED|Overall Study||0
109053|NCT01026402|252735|P5|NOT COMPLETED|Overall Study||0
109054|NCT01026402|252736|P4|NOT COMPLETED|Overall Study||0
109055|NCT01026402|252737|P3|NOT COMPLETED|Overall Study||0
109056|NCT01026402|252738|P2|NOT COMPLETED|Overall Study||0
109057|NCT01026402|252739|P1|NOT COMPLETED|Overall Study||0
109058|NCT01026402|252723|P17|COMPLETED|Overall Study||4
109059|NCT01026402|252724|P16|COMPLETED|Overall Study||5
109060|NCT01026402|252725|P15|COMPLETED|Overall Study||3
109061|NCT01026402|252726|P14|COMPLETED|Overall Study||6
109062|NCT01026402|252727|P13|COMPLETED|Overall Study||8
109063|NCT01026402|252728|P12|COMPLETED|Overall Study||8
109064|NCT01026402|252729|P11|COMPLETED|Overall Study||7
109065|NCT01026402|252730|P10|COMPLETED|Overall Study||3
109066|NCT01026402|252731|P9|COMPLETED|Overall Study||7
109067|NCT01026402|252732|P8|COMPLETED|Overall Study||3
109068|NCT01026402|252733|P7|COMPLETED|Overall Study||8
109069|NCT01026402|252734|P6|COMPLETED|Overall Study||5
109070|NCT01026402|252735|P5|COMPLETED|Overall Study||3
109071|NCT01026402|252736|P4|COMPLETED|Overall Study||18
109072|NCT01026402|252737|P3|COMPLETED|Overall Study||33
109073|NCT01026402|252738|P2|COMPLETED|Overall Study||8
109074|NCT01026402|252739|P1|COMPLETED|Overall Study||6
109075|NCT01026402|252723|P17|STARTED|Overall Study||4
109076|NCT01026402|252724|P16|STARTED|Overall Study||5
109077|NCT01026402|252725|P15|STARTED|Overall Study||3
109078|NCT01026402|252726|P14|STARTED|Overall Study||6
109079|NCT01026402|252727|P13|STARTED|Overall Study||8
109080|NCT01026402|252728|P12|STARTED|Overall Study||8
109081|NCT01026402|252729|P11|STARTED|Overall Study||7
109082|NCT01026402|252730|P10|STARTED|Overall Study||3
109083|NCT01026402|252731|P9|STARTED|Overall Study||7
109084|NCT01026402|252732|P8|STARTED|Overall Study||3
109085|NCT01026402|252733|P7|STARTED|Overall Study||8
109086|NCT01026402|252734|P6|STARTED|Overall Study||5
109087|NCT01026402|252735|P5|STARTED|Overall Study||3
109088|NCT01026402|252736|P4|STARTED|Overall Study||18
109089|NCT01026402|252737|P3|STARTED|Overall Study||33
109090|NCT01026402|252738|P2|STARTED|Overall Study||8
109091|NCT01026402|252739|P1|STARTED|Overall Study||6
109092|NCT01026389|253049|P2|NOT COMPLETED|Overall Study||5
109093|NCT01026389|253050|P1|NOT COMPLETED|Overall Study||5
109094|NCT01026389|253049|P2|COMPLETED|Overall Study||88
109095|NCT01026389|253050|P1|COMPLETED|Overall Study||88
109096|NCT01026389|253049|P2|STARTED|Overall Study||93
109097|NCT01026389|253050|P1|STARTED|Overall Study||93
109098|NCT01026324|253065|P3|NOT COMPLETED|Follow up/Survival||0
109099|NCT01026324|253066|P2|NOT COMPLETED|Follow up/Survival||0
109100|NCT01026324|253067|P1|NOT COMPLETED|Follow up/Survival||1
109101|NCT01026324|253065|P3|COMPLETED|Follow up/Survival||4
109102|NCT01026324|253066|P2|COMPLETED|Follow up/Survival||3
109103|NCT01026324|253067|P1|COMPLETED|Follow up/Survival||4
109104|NCT01026324|253065|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
109105|NCT01026324|253066|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
109106|NCT01026324|253067|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
109107|NCT01026324|253065|P3|STARTED|Follow up/Survival||4
109108|NCT01026324|253066|P2|STARTED|Follow up/Survival||3
109109|NCT01026324|253067|P1|STARTED|Follow up/Survival||5
109110|NCT01026324|253065|P3|NOT COMPLETED|Treatment Allocation||0
109111|NCT01026324|253066|P2|NOT COMPLETED|Treatment Allocation||0
109112|NCT01026324|253067|P1|NOT COMPLETED|Treatment Allocation||0
109113|NCT01026324|253065|P3|COMPLETED|Treatment Allocation||4
109114|NCT01026324|253066|P2|COMPLETED|Treatment Allocation||3
109115|NCT01026324|253067|P1|COMPLETED|Treatment Allocation||5
109116|NCT01026324|253065|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
109117|NCT01026324|253066|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
109118|NCT01026324|253067|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
109119|NCT01026324|253065|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
109120|NCT01026324|253066|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
109121|NCT01026324|253067|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
109122|NCT01026324|253065|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
109123|NCT01026324|253066|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
109124|NCT01026324|253067|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
109125|NCT01026324|253065|P3|STARTED|Treatment Allocation||4
109126|NCT01026324|253066|P2|STARTED|Treatment Allocation||3
109127|NCT01026324|253067|P1|STARTED|Treatment Allocation||5
109128|NCT01026194|253077|P2|NOT COMPLETED|Period 2：Open-label Period||10
109129|NCT01026194|253078|P1|NOT COMPLETED|Period 2：Open-label Period||7
109130|NCT01026194|253077|P2|COMPLETED|Period 2：Open-label Period||88
109131|NCT01026194|253078|P1|COMPLETED|Period 2：Open-label Period||91
109132|NCT01026194|253077|P2|STARTED|Period 2：Open-label Period||98
109133|NCT01026194|253078|P1|STARTED|Period 2：Open-label Period||98
109134|NCT01026194|253077|P2|NOT COMPLETED|Period 1：Double Blind Period||5
109135|NCT01026194|253078|P1|NOT COMPLETED|Period 1：Double Blind Period||3
109136|NCT01026194|253077|P2|COMPLETED|Period 1：Double Blind Period||98
109137|NCT01026194|253078|P1|COMPLETED|Period 1：Double Blind Period||98
109138|NCT01026194|253077|P2|STARTED|Period 1：Double Blind Period||103
109139|NCT01026194|253078|P1|STARTED|Period 1：Double Blind Period||101
109140|NCT01026142|253094|P2|NOT COMPLETED|Overall Study||121
109141|NCT01026142|253095|P1|NOT COMPLETED|Overall Study||139
109142|NCT01026142|253094|P2|COMPLETED|Overall Study||107
109143|NCT01026142|253095|P1|COMPLETED|Overall Study||79
109144|NCT01026142|253094|P2|STARTED|Overall Study||228
109145|NCT01026142|253095|P1|STARTED|Overall Study||218
109146|NCT01026103|253117|P1|NOT COMPLETED|Overall Study||2
109147|NCT01026103|253117|P1|COMPLETED|Overall Study||28
109148|NCT01026103|253117|P1|Consented|Overall Study||30
109149|NCT01026103|253117|P1|STARTED|Overall Study||30
109150|NCT01026038|253127|P3|NOT COMPLETED|Overall Study||0
109151|NCT01026038|253128|P2|NOT COMPLETED|Overall Study||1
109152|NCT01026038|253129|P1|NOT COMPLETED|Overall Study||1
109153|NCT01026038|253127|P3|COMPLETED|Overall Study||67
109154|NCT01026038|253128|P2|COMPLETED|Overall Study||64
109155|NCT01026038|253129|P1|COMPLETED|Overall Study||129
109156|NCT01026038|253127|P3|STARTED|Overall Study||67
109157|NCT01026038|253128|P2|STARTED|Overall Study||65
109158|NCT01026038|253129|P1|STARTED|Overall Study||130
109159|NCT01026012|253164|P1|NOT COMPLETED|Overall Study||0
109160|NCT01026012|253164|P1|COMPLETED|Overall Study||40
109161|NCT01026012|253164|P1|STARTED|Overall Study||40
109162|NCT01025843|253178|P10|NOT COMPLETED|Period 5||0
109163|NCT01025843|253179|P9|NOT COMPLETED|Period 5||0
109164|NCT01025843|253180|P8|NOT COMPLETED|Period 5||0
109165|NCT01025843|253181|P7|NOT COMPLETED|Period 5||0
109166|NCT01025843|253182|P6|NOT COMPLETED|Period 5||0
109167|NCT01025843|253183|P5|NOT COMPLETED|Period 5||0
109168|NCT01025843|253184|P4|NOT COMPLETED|Period 5||0
109169|NCT01025843|253185|P3|NOT COMPLETED|Period 5||0
109170|NCT01025843|253186|P2|NOT COMPLETED|Period 5||0
109171|NCT01025843|253187|P1|NOT COMPLETED|Period 5||0
109172|NCT01025843|253178|P10|COMPLETED|Period 5||2
109173|NCT01025843|253179|P9|COMPLETED|Period 5||2
109174|NCT01025843|253180|P8|COMPLETED|Period 5||2
109175|NCT01025843|253181|P7|COMPLETED|Period 5||2
109176|NCT01025843|253182|P6|COMPLETED|Period 5||2
109177|NCT01025843|253183|P5|COMPLETED|Period 5||2
109178|NCT01025843|253184|P4|COMPLETED|Period 5||1
109179|NCT01025843|253185|P3|COMPLETED|Period 5||1
109180|NCT01025843|253186|P2|COMPLETED|Period 5||2
109181|NCT01025843|253187|P1|COMPLETED|Period 5||2
109182|NCT01025843|253178|P10|STARTED|Period 5||2
109183|NCT01025843|253179|P9|STARTED|Period 5||2
109184|NCT01025843|253180|P8|STARTED|Period 5||2
109185|NCT01025843|253181|P7|STARTED|Period 5||2
109186|NCT01025843|253182|P6|STARTED|Period 5||2
109187|NCT01025843|253183|P5|STARTED|Period 5||2
109188|NCT01025843|253184|P4|STARTED|Period 5||1
109189|NCT01025843|253185|P3|STARTED|Period 5||1
109190|NCT01025843|253186|P2|STARTED|Period 5||2
109191|NCT01025843|253187|P1|STARTED|Period 5||2
109192|NCT01025843|253178|P10|NOT COMPLETED|Washout 4||0
109193|NCT01025843|253179|P9|NOT COMPLETED|Washout 4||0
109194|NCT01025843|253180|P8|NOT COMPLETED|Washout 4||0
109195|NCT01025843|253181|P7|NOT COMPLETED|Washout 4||0
109196|NCT01025843|253182|P6|NOT COMPLETED|Washout 4||0
109197|NCT01025843|253183|P5|NOT COMPLETED|Washout 4||0
109198|NCT01025843|253184|P4|NOT COMPLETED|Washout 4||1
109199|NCT01025843|253185|P3|NOT COMPLETED|Washout 4||1
109200|NCT01025843|253186|P2|NOT COMPLETED|Washout 4||0
109201|NCT01025843|253187|P1|NOT COMPLETED|Washout 4||0
109202|NCT01025843|253178|P10|COMPLETED|Washout 4||2
109203|NCT01025843|253179|P9|COMPLETED|Washout 4||2
109204|NCT01025843|253180|P8|COMPLETED|Washout 4||2
109205|NCT01025843|253181|P7|COMPLETED|Washout 4||2
109206|NCT01025843|253182|P6|COMPLETED|Washout 4||2
109207|NCT01025843|253183|P5|COMPLETED|Washout 4||2
109208|NCT01025843|253184|P4|COMPLETED|Washout 4||1
109209|NCT01025843|253185|P3|COMPLETED|Washout 4||1
109210|NCT01025843|253186|P2|COMPLETED|Washout 4||2
109211|NCT01025843|253187|P1|COMPLETED|Washout 4||2
109212|NCT01025843|253178|P10|STARTED|Washout 4||2
109213|NCT01025843|253179|P9|STARTED|Washout 4||2
109214|NCT01025843|253180|P8|STARTED|Washout 4||2
109215|NCT01025843|253181|P7|STARTED|Washout 4||2
109216|NCT01025843|253182|P6|STARTED|Washout 4||2
109217|NCT01025843|253183|P5|STARTED|Washout 4||2
109218|NCT01025843|253184|P4|STARTED|Washout 4||2
109219|NCT01025843|253185|P3|STARTED|Washout 4||2
109220|NCT01025843|253186|P2|STARTED|Washout 4||2
109221|NCT01025843|253187|P1|STARTED|Washout 4||2
109222|NCT01025843|253178|P10|NOT COMPLETED|Period 4||0
109223|NCT01025843|253179|P9|NOT COMPLETED|Period 4||0
109224|NCT01025843|253180|P8|NOT COMPLETED|Period 4||0
109225|NCT01025843|253181|P7|NOT COMPLETED|Period 4||0
109226|NCT01025843|253182|P6|NOT COMPLETED|Period 4||0
109227|NCT01025843|253183|P5|NOT COMPLETED|Period 4||0
109228|NCT01025843|253184|P4|NOT COMPLETED|Period 4||0
109229|NCT01025843|253185|P3|NOT COMPLETED|Period 4||0
109230|NCT01025843|253186|P2|NOT COMPLETED|Period 4||0
109231|NCT01025843|253187|P1|NOT COMPLETED|Period 4||0
109232|NCT01025843|253178|P10|COMPLETED|Period 4||2
109233|NCT01025843|253179|P9|COMPLETED|Period 4||2
109234|NCT01025843|253180|P8|COMPLETED|Period 4||2
109235|NCT01025843|253181|P7|COMPLETED|Period 4||2
109236|NCT01025843|253182|P6|COMPLETED|Period 4||2
109237|NCT01025843|253183|P5|COMPLETED|Period 4||2
109238|NCT01025843|253184|P4|COMPLETED|Period 4||2
109239|NCT01025843|253185|P3|COMPLETED|Period 4||2
109240|NCT01025843|253186|P2|COMPLETED|Period 4||2
109241|NCT01025843|253187|P1|COMPLETED|Period 4||2
109242|NCT01025843|253178|P10|STARTED|Period 4||2
109243|NCT01025843|253179|P9|STARTED|Period 4||2
109244|NCT01025843|253180|P8|STARTED|Period 4||2
109245|NCT01025843|253181|P7|STARTED|Period 4||2
109246|NCT01025843|253182|P6|STARTED|Period 4||2
109247|NCT01025843|253183|P5|STARTED|Period 4||2
109248|NCT01025843|253184|P4|STARTED|Period 4||2
109249|NCT01025843|253185|P3|STARTED|Period 4||2
109250|NCT01025843|253186|P2|STARTED|Period 4||2
109251|NCT01025843|253187|P1|STARTED|Period 4||2
109252|NCT01025843|253178|P10|NOT COMPLETED|Washout 3||0
109253|NCT01025843|253179|P9|NOT COMPLETED|Washout 3||0
109254|NCT01025843|253180|P8|NOT COMPLETED|Washout 3||0
109255|NCT01025843|253181|P7|NOT COMPLETED|Washout 3||0
109256|NCT01025843|253182|P6|NOT COMPLETED|Washout 3||0
109257|NCT01025843|253183|P5|NOT COMPLETED|Washout 3||0
109258|NCT01025843|253184|P4|NOT COMPLETED|Washout 3||0
109259|NCT01025843|253185|P3|NOT COMPLETED|Washout 3||0
109260|NCT01025843|253186|P2|NOT COMPLETED|Washout 3||0
109261|NCT01025843|253187|P1|NOT COMPLETED|Washout 3||0
109262|NCT01025843|253178|P10|COMPLETED|Washout 3||2
109263|NCT01025843|253179|P9|COMPLETED|Washout 3||2
109264|NCT01025843|253180|P8|COMPLETED|Washout 3||2
109265|NCT01025843|253181|P7|COMPLETED|Washout 3||2
109266|NCT01025843|253182|P6|COMPLETED|Washout 3||2
109267|NCT01025843|253183|P5|COMPLETED|Washout 3||2
109268|NCT01025843|253184|P4|COMPLETED|Washout 3||2
109269|NCT01025843|253185|P3|COMPLETED|Washout 3||2
109270|NCT01025843|253186|P2|COMPLETED|Washout 3||2
109271|NCT01025843|253187|P1|COMPLETED|Washout 3||2
109272|NCT01025843|253178|P10|STARTED|Washout 3||2
109273|NCT01025843|253179|P9|STARTED|Washout 3||2
109274|NCT01025843|253180|P8|STARTED|Washout 3||2
109275|NCT01025843|253181|P7|STARTED|Washout 3||2
109276|NCT01025843|253182|P6|STARTED|Washout 3||2
109277|NCT01025843|253183|P5|STARTED|Washout 3||2
109278|NCT01025843|253184|P4|STARTED|Washout 3||2
109279|NCT01025843|253185|P3|STARTED|Washout 3||2
109280|NCT01025843|253186|P2|STARTED|Washout 3||2
109281|NCT01025843|253187|P1|STARTED|Washout 3||2
109282|NCT01025843|253178|P10|NOT COMPLETED|Period 3||0
109283|NCT01025843|253179|P9|NOT COMPLETED|Period 3||0
109284|NCT01025843|253180|P8|NOT COMPLETED|Period 3||0
109285|NCT01025843|253181|P7|NOT COMPLETED|Period 3||0
109286|NCT01025843|253182|P6|NOT COMPLETED|Period 3||0
109287|NCT01025843|253183|P5|NOT COMPLETED|Period 3||0
109288|NCT01025843|253184|P4|NOT COMPLETED|Period 3||0
109289|NCT01025843|253185|P3|NOT COMPLETED|Period 3||0
109290|NCT01025843|253186|P2|NOT COMPLETED|Period 3||0
109291|NCT01025843|253187|P1|NOT COMPLETED|Period 3||0
109292|NCT01025843|253178|P10|COMPLETED|Period 3||2
109293|NCT01025843|253179|P9|COMPLETED|Period 3||2
109294|NCT01025843|253180|P8|COMPLETED|Period 3||2
109295|NCT01025843|253181|P7|COMPLETED|Period 3||2
109296|NCT01025843|253182|P6|COMPLETED|Period 3||2
109297|NCT01025843|253183|P5|COMPLETED|Period 3||2
109298|NCT01025843|253184|P4|COMPLETED|Period 3||2
109299|NCT01025843|253185|P3|COMPLETED|Period 3||2
109300|NCT01025843|253186|P2|COMPLETED|Period 3||2
109301|NCT01025843|253187|P1|COMPLETED|Period 3||2
109302|NCT01025843|253178|P10|STARTED|Period 3||2
109303|NCT01025843|253179|P9|STARTED|Period 3||2
109304|NCT01025843|253180|P8|STARTED|Period 3||2
109305|NCT01025843|253181|P7|STARTED|Period 3||2
109306|NCT01025843|253182|P6|STARTED|Period 3||2
109307|NCT01025843|253183|P5|STARTED|Period 3||2
109308|NCT01025843|253184|P4|STARTED|Period 3||2
109309|NCT01025843|253185|P3|STARTED|Period 3||2
109310|NCT01025843|253186|P2|STARTED|Period 3||2
109311|NCT01025843|253187|P1|STARTED|Period 3||2
109312|NCT01025843|253178|P10|NOT COMPLETED|Washout 2||0
109313|NCT01025843|253179|P9|NOT COMPLETED|Washout 2||0
109314|NCT01025843|253180|P8|NOT COMPLETED|Washout 2||0
109315|NCT01025843|253181|P7|NOT COMPLETED|Washout 2||0
109316|NCT01025843|253182|P6|NOT COMPLETED|Washout 2||0
109317|NCT01025843|253183|P5|NOT COMPLETED|Washout 2||0
109318|NCT01025843|253184|P4|NOT COMPLETED|Washout 2||0
109319|NCT01025843|253185|P3|NOT COMPLETED|Washout 2||0
109320|NCT01025843|253186|P2|NOT COMPLETED|Washout 2||0
109321|NCT01025843|253187|P1|NOT COMPLETED|Washout 2||0
109322|NCT01025843|253178|P10|COMPLETED|Washout 2||2
109323|NCT01025843|253179|P9|COMPLETED|Washout 2||2
109324|NCT01025843|253180|P8|COMPLETED|Washout 2||2
109325|NCT01025843|253181|P7|COMPLETED|Washout 2||2
109326|NCT01025843|253182|P6|COMPLETED|Washout 2||2
109327|NCT01025843|253183|P5|COMPLETED|Washout 2||2
109328|NCT01025843|253184|P4|COMPLETED|Washout 2||2
109329|NCT01025843|253185|P3|COMPLETED|Washout 2||2
109330|NCT01025843|253186|P2|COMPLETED|Washout 2||2
109331|NCT01025843|253187|P1|COMPLETED|Washout 2||2
109332|NCT01025843|253178|P10|STARTED|Washout 2||2
109333|NCT01025843|253179|P9|STARTED|Washout 2||2
109334|NCT01025843|253180|P8|STARTED|Washout 2||2
109335|NCT01025843|253181|P7|STARTED|Washout 2||2
109336|NCT01025843|253182|P6|STARTED|Washout 2||2
109337|NCT01025843|253183|P5|STARTED|Washout 2||2
109338|NCT01025843|253184|P4|STARTED|Washout 2||2
109339|NCT01025843|253185|P3|STARTED|Washout 2||2
109340|NCT01025843|253186|P2|STARTED|Washout 2||2
109341|NCT01025843|253187|P1|STARTED|Washout 2||2
109342|NCT01025843|253178|P10|NOT COMPLETED|Period 2||0
109343|NCT01025843|253179|P9|NOT COMPLETED|Period 2||0
109344|NCT01025843|253180|P8|NOT COMPLETED|Period 2||0
109345|NCT01025843|253181|P7|NOT COMPLETED|Period 2||0
109346|NCT01025843|253182|P6|NOT COMPLETED|Period 2||0
109347|NCT01025843|253183|P5|NOT COMPLETED|Period 2||0
109348|NCT01025843|253184|P4|NOT COMPLETED|Period 2||0
109349|NCT01025843|253185|P3|NOT COMPLETED|Period 2||0
109350|NCT01025843|253186|P2|NOT COMPLETED|Period 2||0
109351|NCT01025843|253187|P1|NOT COMPLETED|Period 2||0
109352|NCT01025843|253178|P10|COMPLETED|Period 2||2
109353|NCT01025843|253179|P9|COMPLETED|Period 2||2
109354|NCT01025843|253180|P8|COMPLETED|Period 2||2
109355|NCT01025843|253181|P7|COMPLETED|Period 2||2
109356|NCT01025843|253182|P6|COMPLETED|Period 2||2
109357|NCT01025843|253183|P5|COMPLETED|Period 2||2
109358|NCT01025843|253184|P4|COMPLETED|Period 2||2
109359|NCT01025843|253185|P3|COMPLETED|Period 2||2
109360|NCT01025843|253186|P2|COMPLETED|Period 2||2
109361|NCT01025843|253187|P1|COMPLETED|Period 2||2
109362|NCT01025843|253178|P10|STARTED|Period 2||2
109363|NCT01025843|253179|P9|STARTED|Period 2||2
109364|NCT01025843|253180|P8|STARTED|Period 2||2
109365|NCT01025843|253181|P7|STARTED|Period 2||2
109366|NCT01025843|253182|P6|STARTED|Period 2||2
109367|NCT01025843|253183|P5|STARTED|Period 2||2
109368|NCT01025843|253184|P4|STARTED|Period 2||2
109369|NCT01025843|253185|P3|STARTED|Period 2||2
109370|NCT01025843|253186|P2|STARTED|Period 2||2
109371|NCT01025843|253187|P1|STARTED|Period 2||2
109372|NCT01025843|253178|P10|NOT COMPLETED|Washout 1||0
109373|NCT01025843|253179|P9|NOT COMPLETED|Washout 1||0
109374|NCT01025843|253180|P8|NOT COMPLETED|Washout 1||0
109375|NCT01025843|253181|P7|NOT COMPLETED|Washout 1||0
109376|NCT01025843|253182|P6|NOT COMPLETED|Washout 1||0
109377|NCT01025843|253183|P5|NOT COMPLETED|Washout 1||0
109378|NCT01025843|253184|P4|NOT COMPLETED|Washout 1||0
109379|NCT01025843|253185|P3|NOT COMPLETED|Washout 1||0
109380|NCT01025843|253186|P2|NOT COMPLETED|Washout 1||0
109381|NCT01025843|253187|P1|NOT COMPLETED|Washout 1||0
109382|NCT01025843|253178|P10|COMPLETED|Washout 1||2
109383|NCT01025843|253179|P9|COMPLETED|Washout 1||2
109384|NCT01025843|253180|P8|COMPLETED|Washout 1||2
109385|NCT01025843|253181|P7|COMPLETED|Washout 1||2
109386|NCT01025843|253182|P6|COMPLETED|Washout 1||2
109387|NCT01025843|253183|P5|COMPLETED|Washout 1||2
109388|NCT01025843|253184|P4|COMPLETED|Washout 1||2
109389|NCT01025843|253185|P3|COMPLETED|Washout 1||2
109390|NCT01025843|253186|P2|COMPLETED|Washout 1||2
109391|NCT01025843|253187|P1|COMPLETED|Washout 1||2
109392|NCT01025843|253178|P10|STARTED|Washout 1||2
109393|NCT01025843|253179|P9|STARTED|Washout 1||2
109394|NCT01025843|253180|P8|STARTED|Washout 1||2
109395|NCT01025843|253181|P7|STARTED|Washout 1||2
109396|NCT01025843|253182|P6|STARTED|Washout 1||2
109397|NCT01025843|253183|P5|STARTED|Washout 1||2
109398|NCT01025843|253184|P4|STARTED|Washout 1||2
109399|NCT01025843|253185|P3|STARTED|Washout 1||2
109400|NCT01025843|253186|P2|STARTED|Washout 1||2
109401|NCT01025843|253187|P1|STARTED|Washout 1||2
109402|NCT01025843|253178|P10|NOT COMPLETED|Period 1||0
109403|NCT01025843|253179|P9|NOT COMPLETED|Period 1||0
109404|NCT01025843|253180|P8|NOT COMPLETED|Period 1||0
109405|NCT01025843|253181|P7|NOT COMPLETED|Period 1||0
109406|NCT01025843|253182|P6|NOT COMPLETED|Period 1||0
109407|NCT01025843|253183|P5|NOT COMPLETED|Period 1||0
109408|NCT01025843|253184|P4|NOT COMPLETED|Period 1||0
109409|NCT01025843|253185|P3|NOT COMPLETED|Period 1||0
109410|NCT01025843|253186|P2|NOT COMPLETED|Period 1||0
109411|NCT01025843|253187|P1|NOT COMPLETED|Period 1||0
109412|NCT01025843|253178|P10|COMPLETED|Period 1||2
109413|NCT01025843|253179|P9|COMPLETED|Period 1||2
109414|NCT01025843|253180|P8|COMPLETED|Period 1||2
109415|NCT01025843|253181|P7|COMPLETED|Period 1||2
109416|NCT01025843|253182|P6|COMPLETED|Period 1||2
109417|NCT01025843|253183|P5|COMPLETED|Period 1||2
109418|NCT01025843|253184|P4|COMPLETED|Period 1||2
109419|NCT01025843|253185|P3|COMPLETED|Period 1||2
109420|NCT01025843|253186|P2|COMPLETED|Period 1||2
109421|NCT01025843|253187|P1|COMPLETED|Period 1||2
109422|NCT01025843|253178|P10|STARTED|Period 1||2
109423|NCT01025843|253179|P9|STARTED|Period 1||2
109424|NCT01025843|253180|P8|STARTED|Period 1||2
109425|NCT01025843|253181|P7|STARTED|Period 1||2
109426|NCT01025843|253182|P6|STARTED|Period 1||2
109427|NCT01025843|253183|P5|STARTED|Period 1||2
109428|NCT01025843|253184|P4|STARTED|Period 1||2
109429|NCT01025843|253185|P3|STARTED|Period 1||2
109430|NCT01025843|253186|P2|STARTED|Period 1||2
109431|NCT01025843|253187|P1|STARTED|Period 1||2
109432|NCT01025830|253261|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
109433|NCT01025830|253262|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
109434|NCT01025830|253261|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
109435|NCT01025830|253262|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
109436|NCT01025830|253261|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
109437|NCT01025830|253262|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
109438|NCT01025830|253261|P2|NOT COMPLETED|Washout Period of 30 Days||0
109439|NCT01025830|253262|P1|NOT COMPLETED|Washout Period of 30 Days||0
109440|NCT01025830|253261|P2|COMPLETED|Washout Period of 30 Days||12
109441|NCT01025830|253262|P1|COMPLETED|Washout Period of 30 Days||8
109442|NCT01025830|253261|P2|STARTED|Washout Period of 30 Days||12
109443|NCT01025830|253262|P1|STARTED|Washout Period of 30 Days||8
109444|NCT01025830|253261|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
109445|NCT01025830|253262|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
109446|NCT01025830|253261|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
109447|NCT01025830|253262|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
109448|NCT01025830|253261|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
109449|NCT01025830|253262|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
109450|NCT01025817|253281|P2|NOT COMPLETED|Completed Study||22
109451|NCT01025817|253282|P1|NOT COMPLETED|Completed Study||16
109452|NCT01025817|253281|P2|COMPLETED|Completed Study|Completed study phase|282
109453|NCT01025817|253282|P1|COMPLETED|Completed Study|Completed study phase|293
109454|NCT01025817|253281|P2|STARTED|Completed Study||304
109455|NCT01025817|253282|P1|STARTED|Completed Study||309
109456|NCT01025817|253281|P2|NOT COMPLETED|Completed Study Medication||72
109457|NCT01025817|253282|P1|NOT COMPLETED|Completed Study Medication||105
109458|NCT01025817|253281|P2|COMPLETED|Completed Study Medication||232
109459|NCT01025817|253282|P1|COMPLETED|Completed Study Medication||204
109460|NCT01025817|253281|P2|STARTED|Completed Study Medication||304
109461|NCT01025817|253282|P1|STARTED|Completed Study Medication||309
109462|NCT01025635|253302|P2|NOT COMPLETED|Overall Study||25
109463|NCT01025635|253303|P1|NOT COMPLETED|Overall Study||23
109464|NCT01025635|253302|P2|COMPLETED|Overall Study||178
109465|NCT01025635|253303|P1|COMPLETED|Overall Study||175
109466|NCT01025635|253302|P2|STARTED|Overall Study||203
109467|NCT01025635|253303|P1|STARTED|Overall Study||198
109468|NCT01025492|253315|P1|NOT COMPLETED|Overall Study||0
109469|NCT01025492|253315|P1|COMPLETED|Overall Study||24
109470|NCT01025492|253315|P1|STARTED|Overall Study||24
109471|NCT01025336|253324|P5|NOT COMPLETED|Overall Study||0
109472|NCT01025336|253325|P4|NOT COMPLETED|Overall Study||2
109473|NCT01025336|253326|P3|NOT COMPLETED|Overall Study||0
109474|NCT01025336|253327|P2|NOT COMPLETED|Overall Study||0
109475|NCT01025336|253328|P1|NOT COMPLETED|Overall Study||0
109476|NCT01025336|253324|P5|COMPLETED|Overall Study||222
109477|NCT01025336|253325|P4|COMPLETED|Overall Study||219
109478|NCT01025336|253326|P3|COMPLETED|Overall Study||179
109479|NCT01025336|253327|P2|COMPLETED|Overall Study||210
109480|NCT01025336|253328|P1|COMPLETED|Overall Study||130
109481|NCT01025336|253324|P5|STARTED|Overall Study||222
109482|NCT01025336|253325|P4|STARTED|Overall Study||221
109483|NCT01025336|253326|P3|STARTED|Overall Study||179
109484|NCT01025336|253327|P2|STARTED|Overall Study||210
109485|NCT01025336|253328|P1|STARTED|Overall Study||130
109486|NCT01025271|253380|P1|NOT COMPLETED|Overall Study||0
109487|NCT01025271|253380|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
109488|NCT01025271|253380|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
109489|NCT01025232|253387|P2|NOT COMPLETED|Overall Study||6
109490|NCT01025232|253388|P1|NOT COMPLETED|Overall Study||3
109491|NCT01025232|253387|P2|COMPLETED|Overall Study||36
109492|NCT01025232|253388|P1|COMPLETED|Overall Study||43
109493|NCT01025232|253387|P2|STARTED|Overall Study||42
109494|NCT01025232|253388|P1|STARTED|Overall Study||46
109495|NCT01025154|253406|P1|NOT COMPLETED|Overall Study||2
109496|NCT01025154|253406|P1|COMPLETED|Overall Study||57
109497|NCT01025154|253406|P1|STARTED|Overall Study||59
109498|NCT01025076|253411|P1|NOT COMPLETED|Overall Study||0
109499|NCT01025076|253411|P1|COMPLETED|Overall Study||14
109500|NCT01025076|253411|P1|STARTED|Overall Study||14
109501|NCT01025037|253415|P1|NOT COMPLETED|Overall Study||11
109502|NCT01025037|253415|P1|COMPLETED|Overall Study||50
109503|NCT01025037|253415|P1|STARTED|Overall Study||61
109504|NCT01024972|253426|P2|NOT COMPLETED|Overall Study||0
109505|NCT01024972|253427|P1|NOT COMPLETED|Overall Study||0
109506|NCT01024972|253426|P2|COMPLETED|Overall Study||15
109507|NCT01024972|253427|P1|COMPLETED|Overall Study||16
109508|NCT01024972|253426|P2|STARTED|Overall Study||15
109509|NCT01024972|253427|P1|STARTED|Overall Study||16
109510|NCT01024959|253437|P1|NOT COMPLETED|Overall Study||41
109511|NCT01024959|253437|P1|COMPLETED|Overall Study||466
109512|NCT01024959|253437|P1|STARTED|Overall Study||507
109513|NCT01024946|253446|P1|NOT COMPLETED|Overall Study||5
109514|NCT01024946|253446|P1|COMPLETED|Overall Study||6
109515|NCT01024946|253446|P1|STARTED|Overall Study||11
109516|NCT01024855|253450|P1|NOT COMPLETED|Overall Study||1
109517|NCT01024855|253450|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
109518|NCT01024855|253450|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
109519|NCT01024751|253457|P2|NOT COMPLETED|Eligible Participants||3
109520|NCT01024751|253458|P1|NOT COMPLETED|Eligible Participants||0
109521|NCT01024751|253457|P2|COMPLETED|Eligible Participants||149
109522|NCT01024751|253458|P1|COMPLETED|Eligible Participants||153
109523|NCT01024751|253457|P2|STARTED|Eligible Participants||152
109524|NCT01024751|253458|P1|STARTED|Eligible Participants||153
109525|NCT01024751|253457|P2|NOT COMPLETED|Enrolled Participants||4
109526|NCT01024751|253458|P1|NOT COMPLETED|Enrolled Participants||3
109527|NCT01024751|253457|P2|COMPLETED|Enrolled Participants||152
109528|NCT01024751|253458|P1|COMPLETED|Enrolled Participants||153
109529|NCT01024751|253457|P2|STARTED|Enrolled Participants||156
109530|NCT01024751|253458|P1|STARTED|Enrolled Participants||156
109531|NCT01024738|253469|P3|NOT COMPLETED|Third Intervention:||0
109532|NCT01024738|253470|P2|NOT COMPLETED|Third Intervention:||0
109533|NCT01024738|253471|P1|NOT COMPLETED|Third Intervention:||0
109534|NCT01024738|253469|P3|COMPLETED|Third Intervention:||8
109535|NCT01024738|253470|P2|COMPLETED|Third Intervention:||7
109536|NCT01024738|253471|P1|COMPLETED|Third Intervention:||7
109537|NCT01024738|253469|P3|STARTED|Third Intervention:||8
109538|NCT01024738|253470|P2|STARTED|Third Intervention:||7
109539|NCT01024738|253471|P1|STARTED|Third Intervention:||7
109540|NCT01024738|253469|P3|NOT COMPLETED|Washout After 2nd Intervention||0
109541|NCT01024738|253470|P2|NOT COMPLETED|Washout After 2nd Intervention||0
109542|NCT01024738|253471|P1|NOT COMPLETED|Washout After 2nd Intervention||0
109543|NCT01024738|253469|P3|COMPLETED|Washout After 2nd Intervention||8
109544|NCT01024738|253470|P2|COMPLETED|Washout After 2nd Intervention||7
109545|NCT01024738|253471|P1|COMPLETED|Washout After 2nd Intervention||7
109546|NCT01024738|253469|P3|STARTED|Washout After 2nd Intervention||8
109547|NCT01024738|253470|P2|STARTED|Washout After 2nd Intervention||7
109548|NCT01024738|253471|P1|STARTED|Washout After 2nd Intervention||7
109549|NCT01024738|253469|P3|NOT COMPLETED|Second Intervention:||0
109550|NCT01024738|253470|P2|NOT COMPLETED|Second Intervention:||0
109551|NCT01024738|253471|P1|NOT COMPLETED|Second Intervention:||0
109552|NCT01024738|253469|P3|COMPLETED|Second Intervention:||8
109553|NCT01024738|253470|P2|COMPLETED|Second Intervention:||7
109554|NCT01024738|253471|P1|COMPLETED|Second Intervention:||7
109555|NCT01024738|253469|P3|STARTED|Second Intervention:||8
109556|NCT01024738|253470|P2|STARTED|Second Intervention:||7
109557|NCT01024738|253471|P1|STARTED|Second Intervention:||7
109558|NCT01024738|253469|P3|NOT COMPLETED|Washout After 1st Intervention||0
109559|NCT01024738|253470|P2|NOT COMPLETED|Washout After 1st Intervention||0
109560|NCT01024738|253471|P1|NOT COMPLETED|Washout After 1st Intervention||0
109561|NCT01024738|253469|P3|COMPLETED|Washout After 1st Intervention||8
109562|NCT01024738|253470|P2|COMPLETED|Washout After 1st Intervention||7
109563|NCT01024738|253471|P1|COMPLETED|Washout After 1st Intervention||7
109564|NCT01024738|253469|P3|STARTED|Washout After 1st Intervention||8
109565|NCT01024738|253470|P2|STARTED|Washout After 1st Intervention||7
109566|NCT01024738|253471|P1|STARTED|Washout After 1st Intervention||7
109567|NCT01024738|253469|P3|NOT COMPLETED|First Intervention:||0
109568|NCT01024738|253470|P2|NOT COMPLETED|First Intervention:||0
109569|NCT01024738|253471|P1|NOT COMPLETED|First Intervention:||0
109570|NCT01024738|253469|P3|COMPLETED|First Intervention:||8
109571|NCT01024738|253470|P2|COMPLETED|First Intervention:||7
109572|NCT01024738|253471|P1|COMPLETED|First Intervention:||7
109573|NCT01024738|253469|P3|STARTED|First Intervention:||8
109574|NCT01024738|253470|P2|STARTED|First Intervention:||7
109575|NCT01024738|253471|P1|STARTED|First Intervention:||7
109576|NCT01024608|253481|P2|NOT COMPLETED|Overall Study||4
109577|NCT01024608|253482|P1|NOT COMPLETED|Overall Study||4
109578|NCT01024608|253481|P2|COMPLETED|Overall Study||167
109579|NCT01024608|253482|P1|COMPLETED|Overall Study||165
109580|NCT01024608|253481|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
109581|NCT01024608|253482|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
109582|NCT01024608|253481|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
109583|NCT01024608|253482|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
109584|NCT01024608|253481|P2|STARTED|Overall Study||171
109585|NCT01024608|253482|P1|STARTED|Overall Study||169
109586|NCT01024465|253494|P1|NOT COMPLETED|Overall Study||3
109587|NCT01024465|253494|P1|COMPLETED|Overall Study||23
109588|NCT01024465|253494|P1|STARTED|Overall Study||26
109589|NCT01024335|253500|P2|NOT COMPLETED|Overall Study||26
109590|NCT01024335|253501|P1|NOT COMPLETED|Overall Study||13
109591|NCT01024335|253500|P2|COMPLETED|Overall Study||14
109592|NCT01024335|253501|P1|COMPLETED|Overall Study||7
109593|NCT01024335|253500|P2|STARTED|Overall Study||40
109594|NCT01024335|253501|P1|STARTED|Overall Study||20
109595|NCT01024309|253511|P2|NOT COMPLETED|Overall Study||4
109596|NCT01024309|253512|P1|NOT COMPLETED|Overall Study||8
109597|NCT01024309|253511|P2|COMPLETED|Overall Study||27
109598|NCT01024309|253512|P1|COMPLETED|Overall Study||27
109599|NCT01024309|253511|P2|STARTED|Overall Study||31
109600|NCT01024309|253512|P1|STARTED|Overall Study||35
109601|NCT01024244|253539|P5|NOT COMPLETED|Overall Study||14
109602|NCT01024244|253540|P4|NOT COMPLETED|Overall Study||13
109603|NCT01024244|253541|P3|NOT COMPLETED|Overall Study||14
109604|NCT01024244|253542|P2|NOT COMPLETED|Overall Study||11
109605|NCT01024244|253543|P1|NOT COMPLETED|Overall Study||17
109606|NCT01024244|253539|P5|COMPLETED|Overall Study||1
109607|NCT01024244|253540|P4|COMPLETED|Overall Study||1
109608|NCT01024244|253541|P3|COMPLETED|Overall Study||1
109609|NCT01024244|253542|P2|COMPLETED|Overall Study||1
109610|NCT01024244|253543|P1|COMPLETED|Overall Study||5
109611|NCT01024244|253539|P5|STARTED|Overall Study||15
109612|NCT01024244|253540|P4|STARTED|Overall Study||14
109613|NCT01024244|253541|P3|STARTED|Overall Study||15
109614|NCT01024244|253542|P2|STARTED|Overall Study||12
109615|NCT01024244|253543|P1|STARTED|Overall Study||22
109616|NCT01024036|253657|P2|NOT COMPLETED|Unblinded Treatment||0
109617|NCT01024036|253658|P1|NOT COMPLETED|Unblinded Treatment||3
109618|NCT01024036|253657|P2|COMPLETED|Unblinded Treatment||0
109619|NCT01024036|253658|P1|COMPLETED|Unblinded Treatment||10
109620|NCT01024036|253657|P2|STARTED|Unblinded Treatment|No participants received Placebo+BSC during unblinded treatment period|0
109621|NCT01024036|253658|P1|STARTED|Unblinded Treatment|Only 13 participants from Placebo+BSC group received siltuximab+BSC in unblinded treatment period|13
109622|NCT01024036|253657|P2|NOT COMPLETED|Blinded Treatment||20
109623|NCT01024036|253658|P1|NOT COMPLETED|Blinded Treatment||22
109624|NCT01024036|253657|P2|COMPLETED|Blinded Treatment||6
109625|NCT01024036|253658|P1|COMPLETED|Blinded Treatment||31
109626|NCT01024036|253657|P2|STARTED|Blinded Treatment||26
109627|NCT01024036|253658|P1|STARTED|Blinded Treatment||53
109628|NCT01023841|253688|P2|NOT COMPLETED|Overall Study||0
109629|NCT01023841|253689|P1|NOT COMPLETED|Overall Study||1
109630|NCT01023841|253688|P2|COMPLETED|Overall Study||23
109631|NCT01023841|253689|P1|COMPLETED|Overall Study||47
109632|NCT01023841|253688|P2|STARTED|Overall Study||23
109633|NCT01023841|253689|P1|STARTED|Overall Study||48
109634|NCT01023815|253707|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
109635|NCT01023815|253708|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
109636|NCT01023815|253709|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
109637|NCT01023815|253710|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
109638|NCT01023815|253707|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
109639|NCT01023815|253708|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
109640|NCT01023815|253709|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
109641|NCT01023815|253710|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
109642|NCT01023815|253707|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
109643|NCT01023815|253708|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
109644|NCT01023815|253709|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
109645|NCT01023815|253710|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
109646|NCT01023815|253707|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109647|NCT01023815|253708|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109648|NCT01023815|253709|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109649|NCT01023815|253710|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
109650|NCT01023815|253707|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109651|NCT01023815|253708|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109652|NCT01023815|253709|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
109653|NCT01023815|253710|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
109654|NCT01023815|253707|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
109655|NCT01023815|253708|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
109656|NCT01023815|253709|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
109657|NCT01023815|253710|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
109658|NCT01023776|253729|P1|NOT COMPLETED|Overall Study||0
109659|NCT01023776|253729|P1|COMPLETED|Overall Study||20
109660|NCT01023776|253729|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
109661|NCT01023724|253736|P2|NOT COMPLETED|Overall Study||3
109662|NCT01023724|253737|P1|NOT COMPLETED|Overall Study||4
109663|NCT01023724|253736|P2|COMPLETED|Overall Study||22
109664|NCT01023724|253737|P1|COMPLETED|Overall Study||21
109665|NCT01023724|253736|P2|STARTED|Overall Study||25
109666|NCT01023724|253737|P1|STARTED|Overall Study||25
109667|NCT01023711|253743|P1|NOT COMPLETED|Overall Study||0
109668|NCT01023711|253743|P1|COMPLETED|Overall Study||107
109669|NCT01023711|253743|P1|STARTED|Overall Study||107
109670|NCT01023672|253748|P1|NOT COMPLETED|Overall Study||3
109671|NCT01023672|253748|P1|COMPLETED|Overall Study||17
109672|NCT01023672|253748|P1|STARTED|Overall Study||20
109673|NCT01023659|253755|P3|NOT COMPLETED|Overall Study||102
109674|NCT01023659|253756|P2|NOT COMPLETED|Overall Study||251
109675|NCT01023659|253757|P1|NOT COMPLETED|Overall Study||73
109676|NCT01023659|253755|P3|COMPLETED|Overall Study||163
109677|NCT01023659|253756|P2|COMPLETED|Overall Study||148
109678|NCT01023659|253757|P1|COMPLETED|Overall Study||186
109679|NCT01023659|253755|P3|STARTED|Overall Study||265
109680|NCT01023659|253756|P2|STARTED|Overall Study||399
109681|NCT01023659|253757|P1|STARTED|Overall Study||259
109682|NCT01023581|253773|P7|NOT COMPLETED|Overall Study||20
109683|NCT01023581|253774|P6|NOT COMPLETED|Overall Study||19
109684|NCT01023581|253775|P5|NOT COMPLETED|Overall Study||16
109685|NCT01023581|253776|P4|NOT COMPLETED|Overall Study||20
109686|NCT01023581|253777|P3|NOT COMPLETED|Overall Study||42
109687|NCT01023581|253778|P2|NOT COMPLETED|Overall Study||23
109688|NCT01023581|253779|P1|NOT COMPLETED|Overall Study||35
109689|NCT01023581|253773|P7|COMPLETED|Overall Study||94
109690|NCT01023581|253774|P6|COMPLETED|Overall Study||92
109691|NCT01023581|253775|P5|COMPLETED|Overall Study||95
109692|NCT01023581|253776|P4|COMPLETED|Overall Study||94
109693|NCT01023581|253777|P3|COMPLETED|Overall Study||71
109694|NCT01023581|253778|P2|COMPLETED|Overall Study||89
109695|NCT01023581|253779|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
109696|NCT01023581|253773|P7|Received Study Treatment|Overall Study||114
109697|NCT01023581|253774|P6|Received Study Treatment|Overall Study||106
109698|NCT01023581|253775|P5|Received Study Treatment|Overall Study||111
109699|NCT01023581|253776|P4|Received Study Treatment|Overall Study||109
109700|NCT01023581|253777|P3|Received Study Treatment|Overall Study||110
109701|NCT01023581|253778|P2|Received Study Treatment|Overall Study||112
109702|NCT01023581|253779|P1|Received Study Treatment|Overall Study||106
109703|NCT01023581|253773|P7|STARTED|Overall Study||114
109704|NCT01023581|253774|P6|STARTED|Overall Study||111
109705|NCT01023581|253775|P5|STARTED|Overall Study||111
109706|NCT01023581|253776|P4|STARTED|Overall Study||114
109707|NCT01023581|253777|P3|STARTED|Overall Study||113
109708|NCT01023581|253778|P2|STARTED|Overall Study||112
109709|NCT01023581|253779|P1|STARTED|Overall Study||109
109710|NCT01023568|253812|P3|NOT COMPLETED|Overall Study||0
109711|NCT01023568|253813|P2|NOT COMPLETED|Overall Study||0
109712|NCT01023568|253814|P1|NOT COMPLETED|Overall Study||0
109713|NCT01023568|253812|P3|COMPLETED|Overall Study||45
109714|NCT01023568|253813|P2|COMPLETED|Overall Study||44
109715|NCT01023568|253814|P1|COMPLETED|Overall Study||45
109716|NCT01023568|253812|P3|STARTED|Overall Study||45
109717|NCT01023568|253813|P2|STARTED|Overall Study||44
109718|NCT01023568|253814|P1|STARTED|Overall Study||45
109719|NCT01023516|253836|P2|NOT COMPLETED|Overall Study||18
109720|NCT01023516|253837|P1|NOT COMPLETED|Overall Study||24
109721|NCT01023516|253836|P2|COMPLETED|Overall Study||284
109722|NCT01023516|253837|P1|COMPLETED|Overall Study||289
109723|NCT01023516|253836|P2|STARTED|Overall Study||302
109724|NCT01023516|253837|P1|STARTED|Overall Study||313
109725|NCT01023308|253919|P2|NOT COMPLETED|Overall Study||279
109726|NCT01023308|253920|P1|NOT COMPLETED|Overall Study||285
109727|NCT01023308|253919|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
109728|NCT01023308|253920|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
109729|NCT01023308|253919|P2|STARTED|Overall Study||381
109730|NCT01023308|253920|P1|STARTED|Overall Study||387
109731|NCT01023256|253950|P4|NOT COMPLETED|Overall Study||5
109732|NCT01023256|253951|P3|NOT COMPLETED|Overall Study||1
109733|NCT01023256|253952|P2|NOT COMPLETED|Overall Study||3
109734|NCT01023256|253953|P1|NOT COMPLETED|Overall Study||4
109735|NCT01023256|253950|P4|COMPLETED|Overall Study||22
109736|NCT01023256|253951|P3|COMPLETED|Overall Study||23
109737|NCT01023256|253952|P2|COMPLETED|Overall Study||19
109738|NCT01023256|253953|P1|COMPLETED|Overall Study||21
109739|NCT01023256|253950|P4|STARTED|Overall Study||27
109740|NCT01023256|253951|P3|STARTED|Overall Study||24
109741|NCT01023256|253952|P2|STARTED|Overall Study||22
109742|NCT01023256|253953|P1|STARTED|Overall Study||25
109743|NCT01023217|253995|P2|NOT COMPLETED|Overall Study||0
109744|NCT01023217|253996|P1|NOT COMPLETED|Overall Study||1
109745|NCT01023217|253995|P2|COMPLETED|Overall Study||45
109746|NCT01023217|253996|P1|COMPLETED|Overall Study||44
109747|NCT01023217|253995|P2|STARTED|Overall Study||45
109748|NCT01023217|253996|P1|STARTED|Overall Study||45
109749|NCT01023178|254005|P3|NOT COMPLETED|Overall Study||3
109750|NCT01023178|254006|P2|NOT COMPLETED|Overall Study||2
109751|NCT01023178|254007|P1|NOT COMPLETED|Overall Study||2
109752|NCT01023178|254005|P3|COMPLETED|Overall Study||4
109753|NCT01023178|254006|P2|COMPLETED|Overall Study||6
109754|NCT01023178|254007|P1|COMPLETED|Overall Study||3
109755|NCT01023178|254005|P3|STARTED|Overall Study||7
109756|NCT01023178|254006|P2|STARTED|Overall Study||8
109757|NCT01023178|254007|P1|STARTED|Overall Study||5
109758|NCT01023074|254018|P3|NOT COMPLETED|Overall Study||0
109759|NCT01023074|254019|P2|NOT COMPLETED|Overall Study||0
109760|NCT01023074|254020|P1|NOT COMPLETED|Overall Study||0
109761|NCT01023074|254018|P3|COMPLETED|Overall Study||13
109762|NCT01023074|254019|P2|COMPLETED|Overall Study||13
109763|NCT01023074|254020|P1|COMPLETED|Overall Study||26
109764|NCT01023074|254018|P3|STARTED|Overall Study||13
109765|NCT01023074|254019|P2|STARTED|Overall Study||13
109766|NCT01023074|254020|P1|STARTED|Overall Study||26
109767|NCT01023035|254037|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
109768|NCT01023035|254038|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
109769|NCT01023035|254039|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
109770|NCT01023035|254037|P3|COMPLETED|Follow-up Period (up to Week 72)||108
109771|NCT01023035|254038|P2|COMPLETED|Follow-up Period (up to Week 72)||207
109772|NCT01023035|254039|P1|COMPLETED|Follow-up Period (up to Week 72)||210
109773|NCT01023035|254037|P3|STARTED|Follow-up Period (up to Week 72)||147
109774|NCT01023035|254038|P2|STARTED|Follow-up Period (up to Week 72)||235
109775|NCT01023035|254039|P1|STARTED|Follow-up Period (up to Week 72)||238
109776|NCT01023035|254037|P3|NOT COMPLETED|Treatment Period||118
109777|NCT01023035|254038|P2|NOT COMPLETED|Treatment Period||85
109778|NCT01023035|254039|P1|NOT COMPLETED|Treatment Period||72
109779|NCT01023035|254037|P3|COMPLETED|Treatment Period||69
109780|NCT01023035|254038|P2|COMPLETED|Treatment Period||166
109781|NCT01023035|254039|P1|COMPLETED|Treatment Period||177
109782|NCT01023035|254037|P3|STARTED|Treatment Period||187
109783|NCT01023035|254038|P2|STARTED|Treatment Period||251
109784|NCT01023035|254039|P1|STARTED|Treatment Period||249
109785|NCT01023022|254049|P1|NOT COMPLETED|Overall Study||14
109786|NCT01023022|254049|P1|COMPLETED|Overall Study||162
109787|NCT01023022|254049|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
109788|NCT01022502|254055|P1|NOT COMPLETED|Overall Study||3
109789|NCT01022502|254055|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
109790|NCT01022502|254055|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
109791|NCT01022996|254069|P1|NOT COMPLETED|Overall Study||57
109792|NCT01022996|254069|P1|COMPLETED|Overall Study||0
109793|NCT01022996|254069|P1|STARTED|Overall Study||57
109794|NCT01022762|254080|P2|NOT COMPLETED|Overall Study||28
109795|NCT01022762|254081|P1|NOT COMPLETED|Overall Study||22
109796|NCT01022762|254080|P2|COMPLETED|Overall Study||194
109797|NCT01022762|254081|P1|COMPLETED|Overall Study||196
109798|NCT01022762|254080|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
109799|NCT01022762|254081|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
109800|NCT01022762|254080|P2|STARTED|Overall Study||222
109801|NCT01022762|254081|P1|STARTED|Overall Study||218
109802|NCT01022398|254109|P2|NOT COMPLETED|Overall Study||2
109803|NCT01022398|254110|P1|NOT COMPLETED|Overall Study||2
109804|NCT01022398|254109|P2|COMPLETED|Overall Study||0
109805|NCT01022398|254110|P1|COMPLETED|Overall Study||0
109806|NCT01022398|254109|P2|STARTED|Overall Study||2
109807|NCT01022398|254110|P1|STARTED|Overall Study||2
109808|NCT01022307|254117|P2|NOT COMPLETED|Overall Study||4
109809|NCT01022307|254118|P1|NOT COMPLETED|Overall Study||0
109810|NCT01022307|254117|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
109811|NCT01022307|254118|P1|COMPLETED|Overall Study||184
109812|NCT01022307|254117|P2|STARTED|Overall Study||28
109813|NCT01022307|254118|P1|STARTED|Overall Study||184
109814|NCT01022242|254126|P2|NOT COMPLETED|Overall Study||19
109815|NCT01022242|254127|P1|NOT COMPLETED|Overall Study||21
109816|NCT01022242|254126|P2|COMPLETED|Overall Study||46
109817|NCT01022242|254127|P1|COMPLETED|Overall Study||49
109818|NCT01022242|254126|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
109819|NCT01022242|254127|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
109820|NCT01022203|254135|P2|NOT COMPLETED|Follow-Up Assessment||2
109821|NCT01022203|254136|P1|NOT COMPLETED|Follow-Up Assessment||2
109822|NCT01022203|254135|P2|COMPLETED|Follow-Up Assessment||40
109823|NCT01022203|254136|P1|COMPLETED|Follow-Up Assessment||42
109824|NCT01022203|254135|P2|STARTED|Follow-Up Assessment||42
109825|NCT01022203|254136|P1|STARTED|Follow-Up Assessment||44
109826|NCT01022203|254135|P2|NOT COMPLETED|Post Treatment Assessment||14
109827|NCT01022203|254136|P1|NOT COMPLETED|Post Treatment Assessment||14
109828|NCT01022203|254135|P2|COMPLETED|Post Treatment Assessment||42
109829|NCT01022203|254136|P1|COMPLETED|Post Treatment Assessment||44
109830|NCT01022203|254135|P2|STARTED|Post Treatment Assessment||56
109831|NCT01022203|254136|P1|STARTED|Post Treatment Assessment||58
109832|NCT01022203|254135|P2|NOT COMPLETED|PreTreatment Assessment||0
109833|NCT01022203|254136|P1|NOT COMPLETED|PreTreatment Assessment||0
109834|NCT01022203|254135|P2|COMPLETED|PreTreatment Assessment||56
109835|NCT01022203|254136|P1|COMPLETED|PreTreatment Assessment||58
109836|NCT01022203|254135|P2|STARTED|PreTreatment Assessment||56
109837|NCT01022203|254136|P1|STARTED|PreTreatment Assessment||58
109838|NCT01022190|254146|P1|NOT COMPLETED|Overall Study||0
109839|NCT01022190|254146|P1|COMPLETED|Overall Study||42
109840|NCT01022190|254146|P1|STARTED|Overall Study||42
109841|NCT01022112|254155|P5|NOT COMPLETED|Overall Study||10
109842|NCT01022112|254156|P4|NOT COMPLETED|Overall Study||3
109843|NCT01022112|254157|P3|NOT COMPLETED|Overall Study||3
109844|NCT01022112|254158|P2|NOT COMPLETED|Overall Study||3
109845|NCT01022112|254159|P1|NOT COMPLETED|Overall Study||3
109846|NCT01022112|254155|P5|COMPLETED|Overall Study||65
109847|NCT01022112|254156|P4|COMPLETED|Overall Study||72
109848|NCT01022112|254157|P3|COMPLETED|Overall Study||74
109849|NCT01022112|254158|P2|COMPLETED|Overall Study||71
109850|NCT01022112|254159|P1|COMPLETED|Overall Study||79
109851|NCT01022112|254155|P5|STARTED|Overall Study||75
109852|NCT01022112|254156|P4|STARTED|Overall Study||75
109853|NCT01022112|254157|P3|STARTED|Overall Study||77
109854|NCT01022112|254158|P2|STARTED|Overall Study||74
109855|NCT01022112|254159|P1|STARTED|Overall Study||82
109856|NCT01022073|254173|P2|NOT COMPLETED|Overall Study||18
109857|NCT01022073|254174|P1|NOT COMPLETED|Overall Study||19
109858|NCT01022073|254173|P2|COMPLETED|Overall Study||52
109859|NCT01022073|254174|P1|COMPLETED|Overall Study||67
109860|NCT01022073|254173|P2|STARTED|Overall Study||70
109861|NCT01022073|254174|P1|STARTED|Overall Study||86
109862|NCT01021878|254182|P2|NOT COMPLETED|Overall Study||10
109863|NCT01021878|254183|P1|NOT COMPLETED|Overall Study||16
109864|NCT01021878|254182|P2|COMPLETED|Overall Study||17
109865|NCT01021878|254183|P1|COMPLETED|Overall Study||17
109866|NCT01021878|254182|P2|Completed Follow-up|Overall Study||17
109867|NCT01021878|254183|P1|Completed Follow-up|Overall Study||17
109868|NCT01021878|254182|P2|STARTED|Overall Study||27
109869|NCT01021878|254183|P1|STARTED|Overall Study||33
109870|NCT01021852|254205|P8|NOT COMPLETED|Treatment Period 2||2
109871|NCT01021852|254206|P7|NOT COMPLETED|Treatment Period 2||3
109872|NCT01021852|254207|P6|NOT COMPLETED|Treatment Period 2||1
109873|NCT01021852|254208|P5|NOT COMPLETED|Treatment Period 2||2
109874|NCT01021852|254209|P4|NOT COMPLETED|Treatment Period 2||0
109875|NCT01021852|254210|P3|NOT COMPLETED|Treatment Period 2||1
109876|NCT01021852|254211|P2|NOT COMPLETED|Treatment Period 2||1
109877|NCT01021852|254212|P1|NOT COMPLETED|Treatment Period 2||0
109878|NCT01021852|254205|P8|COMPLETED|Treatment Period 2||38
109879|NCT01021852|254206|P7|COMPLETED|Treatment Period 2||37
109880|NCT01021852|254207|P6|COMPLETED|Treatment Period 2||37
109881|NCT01021852|254208|P5|COMPLETED|Treatment Period 2||37
109882|NCT01021852|254209|P4|COMPLETED|Treatment Period 2||37
109883|NCT01021852|254210|P3|COMPLETED|Treatment Period 2||38
109884|NCT01021852|254211|P2|COMPLETED|Treatment Period 2||38
109885|NCT01021852|254212|P1|COMPLETED|Treatment Period 2||37
109886|NCT01021852|254205|P8|STARTED|Treatment Period 2||40
109887|NCT01021852|254206|P7|STARTED|Treatment Period 2||40
109888|NCT01021852|254207|P6|STARTED|Treatment Period 2||38
109889|NCT01021852|254208|P5|STARTED|Treatment Period 2||39
109890|NCT01021852|254209|P4|STARTED|Treatment Period 2||37
109891|NCT01021852|254210|P3|STARTED|Treatment Period 2||39
109892|NCT01021852|254211|P2|STARTED|Treatment Period 2||39
109893|NCT01021852|254212|P1|STARTED|Treatment Period 2||37
109894|NCT01021852|254205|P8|NOT COMPLETED|Washout Period-No Drug||0
109895|NCT01021852|254206|P7|NOT COMPLETED|Washout Period-No Drug||0
109896|NCT01021852|254207|P6|NOT COMPLETED|Washout Period-No Drug||1
109897|NCT01021852|254208|P5|NOT COMPLETED|Washout Period-No Drug||0
109898|NCT01021852|254209|P4|NOT COMPLETED|Washout Period-No Drug||0
109899|NCT01021852|254210|P3|NOT COMPLETED|Washout Period-No Drug||0
109900|NCT01021852|254211|P2|NOT COMPLETED|Washout Period-No Drug||0
109901|NCT01021852|254212|P1|NOT COMPLETED|Washout Period-No Drug||1
109902|NCT01021852|254205|P8|COMPLETED|Washout Period-No Drug||40
109903|NCT01021852|254206|P7|COMPLETED|Washout Period-No Drug||40
109904|NCT01021852|254207|P6|COMPLETED|Washout Period-No Drug||38
109905|NCT01021852|254208|P5|COMPLETED|Washout Period-No Drug||39
109906|NCT01021852|254209|P4|COMPLETED|Washout Period-No Drug||37
109907|NCT01021852|254210|P3|COMPLETED|Washout Period-No Drug||39
109908|NCT01021852|254211|P2|COMPLETED|Washout Period-No Drug||39
109909|NCT01021852|254212|P1|COMPLETED|Washout Period-No Drug||37
109910|NCT01021852|254205|P8|STARTED|Washout Period-No Drug||40
109911|NCT01021852|254206|P7|STARTED|Washout Period-No Drug||40
109912|NCT01021852|254207|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
109913|NCT01021852|254208|P5|STARTED|Washout Period-No Drug||39
109914|NCT01021852|254209|P4|STARTED|Washout Period-No Drug||37
109915|NCT01021852|254210|P3|STARTED|Washout Period-No Drug||39
109916|NCT01021852|254211|P2|STARTED|Washout Period-No Drug||39
109917|NCT01021852|254212|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
109918|NCT01021852|254205|P8|NOT COMPLETED|Washout Period-Placebo||0
109919|NCT01021852|254206|P7|NOT COMPLETED|Washout Period-Placebo||1
109920|NCT01021852|254207|P6|NOT COMPLETED|Washout Period-Placebo||1
109921|NCT01021852|254208|P5|NOT COMPLETED|Washout Period-Placebo||1
109922|NCT01021852|254209|P4|NOT COMPLETED|Washout Period-Placebo||1
109923|NCT01021852|254210|P3|NOT COMPLETED|Washout Period-Placebo||0
109924|NCT01021852|254211|P2|NOT COMPLETED|Washout Period-Placebo||0
109925|NCT01021852|254212|P1|NOT COMPLETED|Washout Period-Placebo||0
109926|NCT01021852|254205|P8|COMPLETED|Washout Period-Placebo||40
109927|NCT01021852|254206|P7|COMPLETED|Washout Period-Placebo||40
109928|NCT01021852|254207|P6|COMPLETED|Washout Period-Placebo||38
109929|NCT01021852|254208|P5|COMPLETED|Washout Period-Placebo||39
109930|NCT01021852|254209|P4|COMPLETED|Washout Period-Placebo||37
109931|NCT01021852|254210|P3|COMPLETED|Washout Period-Placebo||39
109932|NCT01021852|254211|P2|COMPLETED|Washout Period-Placebo||39
109933|NCT01021852|254212|P1|COMPLETED|Washout Period-Placebo||37
109934|NCT01021852|254205|P8|STARTED|Washout Period-Placebo||40
109935|NCT01021852|254206|P7|STARTED|Washout Period-Placebo||41
109936|NCT01021852|254207|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
109937|NCT01021852|254208|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
109938|NCT01021852|254209|P4|STARTED|Washout Period-Placebo||38
109939|NCT01021852|254210|P3|STARTED|Washout Period-Placebo||39
109940|NCT01021852|254211|P2|STARTED|Washout Period-Placebo||39
109941|NCT01021852|254212|P1|STARTED|Washout Period-Placebo||37
109942|NCT01021852|254205|P8|NOT COMPLETED|Treatment Period 1||1
109943|NCT01021852|254206|P7|NOT COMPLETED|Treatment Period 1||0
109944|NCT01021852|254207|P6|NOT COMPLETED|Treatment Period 1||2
109945|NCT01021852|254208|P5|NOT COMPLETED|Treatment Period 1||3
109946|NCT01021852|254209|P4|NOT COMPLETED|Treatment Period 1||2
109947|NCT01021852|254210|P3|NOT COMPLETED|Treatment Period 1||2
109948|NCT01021852|254211|P2|NOT COMPLETED|Treatment Period 1||1
109949|NCT01021852|254212|P1|NOT COMPLETED|Treatment Period 1||3
109950|NCT01021852|254205|P8|COMPLETED|Treatment Period 1||40
109951|NCT01021852|254206|P7|COMPLETED|Treatment Period 1||41
109952|NCT01021852|254207|P6|COMPLETED|Treatment Period 1||39
109953|NCT01021852|254208|P5|COMPLETED|Treatment Period 1||39
109954|NCT01021852|254209|P4|COMPLETED|Treatment Period 1||38
109955|NCT01021852|254210|P3|COMPLETED|Treatment Period 1||39
109956|NCT01021852|254211|P2|COMPLETED|Treatment Period 1||39
109957|NCT01021852|254212|P1|COMPLETED|Treatment Period 1||37
109958|NCT01021852|254205|P8|Treated|Treatment Period 1||41
109959|NCT01021852|254206|P7|Treated|Treatment Period 1||41
109960|NCT01021852|254207|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
109961|NCT01021852|254208|P5|Treated|Treatment Period 1||42
109962|NCT01021852|254209|P4|Treated|Treatment Period 1||38
109963|NCT01021852|254210|P3|Treated|Treatment Period 1||41
109964|NCT01021852|254211|P2|Treated|Treatment Period 1||40
109965|NCT01021852|254212|P1|Treated|Treatment Period 1||40
109966|NCT01021852|254205|P8|STARTED|Treatment Period 1||41
109967|NCT01021852|254206|P7|STARTED|Treatment Period 1||41
109968|NCT01021852|254207|P6|STARTED|Treatment Period 1||41
109969|NCT01021852|254208|P5|STARTED|Treatment Period 1||42
109970|NCT01021852|254209|P4|STARTED|Treatment Period 1||40
109971|NCT01021852|254210|P3|STARTED|Treatment Period 1||41
109972|NCT01021852|254211|P2|STARTED|Treatment Period 1||40
109973|NCT01021852|254212|P1|STARTED|Treatment Period 1||40
109974|NCT01021813|254248|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
109975|NCT01021813|254249|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
109976|NCT01021813|254250|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
109977|NCT01021813|254251|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
109978|NCT01021813|254252|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
109979|NCT01021813|254248|P5|COMPLETED|DB Randomized Discontinuation Phase||157
109980|NCT01021813|254249|P4|COMPLETED|DB Randomized Discontinuation Phase||161
109981|NCT01021813|254250|P3|COMPLETED|DB Randomized Discontinuation Phase||152
109982|NCT01021813|254251|P2|COMPLETED|DB Randomized Discontinuation Phase||0
109983|NCT01021813|254252|P1|COMPLETED|DB Randomized Discontinuation Phase||0
109984|NCT01021813|254248|P5|STARTED|DB Randomized Discontinuation Phase||162
109985|NCT01021813|254249|P4|STARTED|DB Randomized Discontinuation Phase||166
109986|NCT01021813|254250|P3|STARTED|DB Randomized Discontinuation Phase||156
109987|NCT01021813|254251|P2|STARTED|DB Randomized Discontinuation Phase||0
109988|NCT01021813|254252|P1|STARTED|DB Randomized Discontinuation Phase||0
109989|NCT01021813|254248|P5|NOT COMPLETED|DB Treatment Phase||0
109990|NCT01021813|254249|P4|NOT COMPLETED|DB Treatment Phase||0
109991|NCT01021813|254250|P3|NOT COMPLETED|DB Treatment Phase||0
109992|NCT01021813|254251|P2|NOT COMPLETED|DB Treatment Phase||97
109993|NCT01021813|254252|P1|NOT COMPLETED|DB Treatment Phase||200
109994|NCT01021813|254248|P5|COMPLETED|DB Treatment Phase||0
109995|NCT01021813|254249|P4|COMPLETED|DB Treatment Phase||0
109996|NCT01021813|254250|P3|COMPLETED|DB Treatment Phase||0
109997|NCT01021813|254251|P2|COMPLETED|DB Treatment Phase||162
109998|NCT01021813|254252|P1|COMPLETED|DB Treatment Phase||322
109999|NCT01021813|254248|P5|Treated|DB Treatment Phase||0
110000|NCT01021813|254249|P4|Treated|DB Treatment Phase||0
110001|NCT01021813|254250|P3|Treated|DB Treatment Phase||0
110002|NCT01021813|254251|P2|Treated|DB Treatment Phase||258
110003|NCT01021813|254252|P1|Treated|DB Treatment Phase||521
110004|NCT01021813|254248|P5|STARTED|DB Treatment Phase||0
110005|NCT01021813|254249|P4|STARTED|DB Treatment Phase||0
110006|NCT01021813|254250|P3|STARTED|DB Treatment Phase||0
110007|NCT01021813|254251|P2|STARTED|DB Treatment Phase||259
110008|NCT01021813|254252|P1|STARTED|DB Treatment Phase||522
110009|NCT01021761|254294|P3|NOT COMPLETED|Overall Study||0
110010|NCT01021761|254295|P2|NOT COMPLETED|Overall Study||4
110011|NCT01021761|254296|P1|NOT COMPLETED|Overall Study||1
110012|NCT01021761|254294|P3|COMPLETED|Overall Study||42
110013|NCT01021761|254295|P2|COMPLETED|Overall Study||38
110014|NCT01021761|254296|P1|COMPLETED|Overall Study||41
110015|NCT01021761|254294|P3|STARTED|Overall Study||42
110016|NCT01021761|254295|P2|STARTED|Overall Study||42
110017|NCT01021761|254296|P1|STARTED|Overall Study||42
110018|NCT01021683|254304|P1|NOT COMPLETED|Overall Study||71
110019|NCT01021683|254304|P1|COMPLETED|Overall Study||132
110020|NCT01021683|254304|P1|STARTED|Overall Study||203
110021|NCT01021618|254318|P2|NOT COMPLETED|Overall Study||0
110022|NCT01021618|254319|P1|NOT COMPLETED|Overall Study||0
110023|NCT01021618|254318|P2|COMPLETED|Overall Study||96
110024|NCT01021618|254319|P1|COMPLETED|Overall Study||44
110025|NCT01021618|254318|P2|STARTED|Overall Study||96
110026|NCT01021618|254319|P1|STARTED|Overall Study||44
110027|NCT01020526|254327|P1|NOT COMPLETED|Overall Study||14
110028|NCT01020526|254327|P1|COMPLETED|Overall Study||49
110029|NCT01020526|254327|P1|STARTED|Overall Study||63
110030|NCT01020474|254333|P2|NOT COMPLETED|Overall Study||17
110031|NCT01020474|254334|P1|NOT COMPLETED|Overall Study||10
110032|NCT01020474|254333|P2|COMPLETED|Overall Study||36
110033|NCT01020474|254334|P1|COMPLETED|Overall Study||44
110034|NCT01020474|254333|P2|STARTED|Overall Study||53
110035|NCT01020474|254334|P1|STARTED|Overall Study||54
110036|NCT01020448|254354|P1|NOT COMPLETED|Treatment||26
110037|NCT01020448|254354|P1|COMPLETED|Treatment||299
110038|NCT01020448|254354|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
110039|NCT01020448|254354|P1|NOT COMPLETED|Pre-assignment||13
110040|NCT01020448|254354|P1|COMPLETED|Pre-assignment||326
110041|NCT01020448|254354|P1|STARTED|Pre-assignment||339
110042|NCT01021423|254365|P2|NOT COMPLETED|Overall Study||5
110043|NCT01021423|254366|P1|NOT COMPLETED|Overall Study||4
110044|NCT01021423|254365|P2|COMPLETED|Overall Study||0
110045|NCT01021423|254366|P1|COMPLETED|Overall Study||0
110046|NCT01021423|254365|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
110047|NCT01021423|254366|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
110048|NCT01021332|254382|P1|NOT COMPLETED|Overall Study||106
110049|NCT01021332|254382|P1|COMPLETED|Overall Study||960
110050|NCT01021332|254382|P1|Full Analysis Set (FAS)|Overall Study||1009
110051|NCT01021332|254382|P1|Safety Analysis Set (SAF)|Overall Study||1066
110052|NCT01021332|254382|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
110053|NCT01021306|254420|P4|NOT COMPLETED|6 Month (Follow-up)||3
110054|NCT01021306|254421|P3|NOT COMPLETED|6 Month (Follow-up)||0
110055|NCT01021306|254422|P2|NOT COMPLETED|6 Month (Follow-up)||1
110056|NCT01021306|254423|P1|NOT COMPLETED|6 Month (Follow-up)||3
110057|NCT01021306|254420|P4|COMPLETED|6 Month (Follow-up)||14
110058|NCT01021306|254421|P3|COMPLETED|6 Month (Follow-up)||14
110059|NCT01021306|254422|P2|COMPLETED|6 Month (Follow-up)||13
110060|NCT01021306|254423|P1|COMPLETED|6 Month (Follow-up)||11
110061|NCT01021306|254420|P4|STARTED|6 Month (Follow-up)||17
110062|NCT01021306|254421|P3|STARTED|6 Month (Follow-up)||14
110063|NCT01021306|254422|P2|STARTED|6 Month (Follow-up)||14
110064|NCT01021306|254423|P1|STARTED|6 Month (Follow-up)||14
110065|NCT01021306|254420|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
110066|NCT01021306|254421|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
110067|NCT01021306|254422|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
110068|NCT01021306|254423|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
110069|NCT01021306|254420|P4|COMPLETED|2 Month (Primary Outcome)||17
110070|NCT01021306|254421|P3|COMPLETED|2 Month (Primary Outcome)||14
110071|NCT01021306|254422|P2|COMPLETED|2 Month (Primary Outcome)||14
110072|NCT01021306|254423|P1|COMPLETED|2 Month (Primary Outcome)||14
110073|NCT01021306|254420|P4|STARTED|2 Month (Primary Outcome)||21
110074|NCT01021306|254421|P3|STARTED|2 Month (Primary Outcome)||19
110075|NCT01021306|254422|P2|STARTED|2 Month (Primary Outcome)||20
110076|NCT01021306|254423|P1|STARTED|2 Month (Primary Outcome)||20
110077|NCT01021215|254443|P2|NOT COMPLETED|Overall Study||0
110078|NCT01021215|254444|P1|NOT COMPLETED|Overall Study||3
110079|NCT01021215|254443|P2|COMPLETED|Overall Study||20
110080|NCT01021215|254444|P1|COMPLETED|Overall Study||57
110081|NCT01021215|254443|P2|Received Allocated Intervention|Overall Study||20
110082|NCT01021215|254444|P1|Received Allocated Intervention|Overall Study||60
110083|NCT01021215|254443|P2|STARTED|Overall Study||20
110084|NCT01021215|254444|P1|STARTED|Overall Study||60
110085|NCT01021020|254454|P1|NOT COMPLETED|Period III||0
110086|NCT01021020|254454|P1|COMPLETED|Period III||25
110087|NCT01021020|254454|P1|STARTED|Period III||25
110088|NCT01021020|254454|P1|NOT COMPLETED|14 Day Washout Period B||0
110089|NCT01021020|254454|P1|COMPLETED|14 Day Washout Period B||25
110090|NCT01021020|254454|P1|STARTED|14 Day Washout Period B||25
110091|NCT01021020|254454|P1|NOT COMPLETED|Period II||0
110092|NCT01021020|254454|P1|COMPLETED|Period II||25
110093|NCT01021020|254454|P1|STARTED|Period II||25
110094|NCT01021020|254454|P1|NOT COMPLETED|14 Day Washout Period A||1
110095|NCT01021020|254454|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
110096|NCT01021020|254454|P1|STARTED|14 Day Washout Period A||26
110097|NCT01021020|254454|P1|NOT COMPLETED|Period I||2
110098|NCT01021020|254454|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
110099|NCT01021020|254454|P1|STARTED|Period I||28
110100|NCT01021007|254470|P2|NOT COMPLETED|Overall Study||4
110101|NCT01021007|254471|P1|NOT COMPLETED|Overall Study||2
110102|NCT01021007|254470|P2|COMPLETED|Overall Study||33
110103|NCT01021007|254471|P1|COMPLETED|Overall Study||34
110104|NCT01021007|254470|P2|STARTED|Overall Study||37
110105|NCT01021007|254471|P1|STARTED|Overall Study||36
110106|NCT01020981|254483|P2|NOT COMPLETED|Overall Study||90
110107|NCT01020981|254484|P1|NOT COMPLETED|Overall Study||84
110108|NCT01020981|254483|P2|COMPLETED|Overall Study||60
110109|NCT01020981|254484|P1|COMPLETED|Overall Study||66
110110|NCT01020981|254483|P2|STARTED|Overall Study||150
110111|NCT01020981|254484|P1|STARTED|Overall Study||150
110112|NCT01020903|254496|P2|NOT COMPLETED|Overall Study||0
110113|NCT01020903|254497|P1|NOT COMPLETED|Overall Study||0
110114|NCT01020903|254496|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
110115|NCT01020903|254497|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
110116|NCT01020903|254496|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
110117|NCT01020903|254497|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
110118|NCT01020877|254505|P2|NOT COMPLETED|Second Intervention||0
110119|NCT01020877|254506|P1|NOT COMPLETED|Second Intervention||1
110120|NCT01020877|254505|P2|COMPLETED|Second Intervention||19
110121|NCT01020877|254506|P1|COMPLETED|Second Intervention||18
110122|NCT01020877|254505|P2|STARTED|Second Intervention||19
110123|NCT01020877|254506|P1|STARTED|Second Intervention||19
110124|NCT01020877|254505|P2|NOT COMPLETED|Washout of 7 Days||0
110125|NCT01020877|254506|P1|NOT COMPLETED|Washout of 7 Days||0
110126|NCT01020877|254505|P2|COMPLETED|Washout of 7 Days||19
110127|NCT01020877|254506|P1|COMPLETED|Washout of 7 Days||19
110128|NCT01020877|254505|P2|STARTED|Washout of 7 Days||19
110129|NCT01020877|254506|P1|STARTED|Washout of 7 Days||19
110130|NCT01020877|254505|P2|NOT COMPLETED|First Intervention||0
110131|NCT01020877|254506|P1|NOT COMPLETED|First Intervention||0
110132|NCT01020877|254505|P2|COMPLETED|First Intervention||19
110133|NCT01020877|254506|P1|COMPLETED|First Intervention||19
110134|NCT01020877|254505|P2|STARTED|First Intervention||19
110135|NCT01020877|254506|P1|STARTED|First Intervention||19
110136|NCT01020838|254516|P1|NOT COMPLETED|Overall Study||183
110137|NCT01020838|254516|P1|COMPLETED|Overall Study||35
110138|NCT01020838|254516|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
110139|NCT01020838|254516|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
110140|NCT01020838|254516|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
110141|NCT01020838|254516|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
110142|NCT01020838|254516|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
110143|NCT01020838|254516|P1|STARTED|Overall Study||218
110144|NCT01020812|254531|P1|NOT COMPLETED|Overall Study||3
110145|NCT01020812|254531|P1|COMPLETED|Overall Study||8
110146|NCT01020812|254531|P1|STARTED|Overall Study||11
110147|NCT01020799|254541|P3|NOT COMPLETED|Overall Study||7
110148|NCT01020799|254542|P2|NOT COMPLETED|Overall Study||14
110149|NCT01020799|254543|P1|NOT COMPLETED|Overall Study||19
110150|NCT01020799|254541|P3|COMPLETED|Overall Study||43
110151|NCT01020799|254542|P2|COMPLETED|Overall Study||85
110152|NCT01020799|254543|P1|COMPLETED|Overall Study||79
110153|NCT01020799|254541|P3|Full Analysis Set|Overall Study||49
110154|NCT01020799|254542|P2|Full Analysis Set|Overall Study||94
110155|NCT01020799|254543|P1|Full Analysis Set|Overall Study||91
110156|NCT01020799|254541|P3|Patients Received Treatment|Overall Study||50
110157|NCT01020799|254542|P2|Patients Received Treatment|Overall Study||99
110158|NCT01020799|254543|P1|Patients Received Treatment|Overall Study||96
110159|NCT01020799|254541|P3|STARTED|Overall Study||50
110160|NCT01020799|254542|P2|STARTED|Overall Study||99
110161|NCT01020799|254543|P1|STARTED|Overall Study||98
110162|NCT01020786|254566|P1|NOT COMPLETED|Maintenance Period||60
110163|NCT01020786|254566|P1|COMPLETED|Maintenance Period||0
110164|NCT01020786|254566|P1|STARTED|Maintenance Period||60
110165|NCT01020786|254566|P1|NOT COMPLETED|Induction Period||49
110166|NCT01020786|254566|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
110167|NCT01020786|254566|P1|STARTED|Induction Period||109
110168|NCT01020773|254580|P2|NOT COMPLETED|Overall Study||3
110169|NCT01020773|254581|P1|NOT COMPLETED|Overall Study||4
110170|NCT01020773|254580|P2|COMPLETED|Overall Study||29
110171|NCT01020773|254581|P1|COMPLETED|Overall Study||31
110172|NCT01020773|254580|P2|STARTED|Overall Study||32
110173|NCT01020773|254581|P1|STARTED|Overall Study||35
110174|NCT01020747|254587|P1|NOT COMPLETED|Overall Study||1
110175|NCT01020747|254587|P1|COMPLETED|Overall Study||19
110176|NCT01020747|254587|P1|STARTED|Overall Study||20
110177|NCT01020305|254592|P1|NOT COMPLETED|Overall Study||2
110178|NCT01020305|254592|P1|COMPLETED|Overall Study||3
110179|NCT01020305|254592|P1|STARTED|Overall Study||5
110180|NCT01020123|254603|P7|NOT COMPLETED|Extention Period||1
110181|NCT01020123|254604|P6|NOT COMPLETED|Extention Period||2
110182|NCT01020123|254605|P5|NOT COMPLETED|Extention Period||0
110183|NCT01020123|254606|P4|NOT COMPLETED|Extention Period||1
110184|NCT01020123|254607|P3|NOT COMPLETED|Extention Period||2
110185|NCT01020123|254608|P2|NOT COMPLETED|Extention Period||2
110186|NCT01020123|254609|P1|NOT COMPLETED|Extention Period||3
110187|NCT01020123|254603|P7|COMPLETED|Extention Period||18
110188|NCT01020123|254604|P6|COMPLETED|Extention Period||36
110189|NCT01020123|254605|P5|COMPLETED|Extention Period||31
110190|NCT01020123|254606|P4|COMPLETED|Extention Period||12
110191|NCT01020123|254607|P3|COMPLETED|Extention Period||17
110192|NCT01020123|254608|P2|COMPLETED|Extention Period||33
110193|NCT01020123|254609|P1|COMPLETED|Extention Period||37
110194|NCT01020123|254603|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
110282|NCT01019694|254891|P2|NOT COMPLETED|Overall Study||38
110195|NCT01020123|254604|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
110196|NCT01020123|254605|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
110197|NCT01020123|254606|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
110198|NCT01020123|254607|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
110199|NCT01020123|254608|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
110200|NCT01020123|254609|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
110201|NCT01020123|254603|P7|NOT COMPLETED|Main Period||11
110202|NCT01020123|254604|P6|NOT COMPLETED|Main Period||11
110203|NCT01020123|254605|P5|NOT COMPLETED|Main Period||11
110204|NCT01020123|254606|P4|NOT COMPLETED|Main Period||7
110205|NCT01020123|254607|P3|NOT COMPLETED|Main Period||8
110206|NCT01020123|254608|P2|NOT COMPLETED|Main Period||14
110207|NCT01020123|254609|P1|NOT COMPLETED|Main Period||17
110208|NCT01020123|254603|P7|COMPLETED|Main Period||61
110209|NCT01020123|254604|P6|COMPLETED|Main Period||83
110210|NCT01020123|254605|P5|COMPLETED|Main Period||77
110211|NCT01020123|254606|P4|COMPLETED|Main Period||33
110212|NCT01020123|254607|P3|COMPLETED|Main Period||44
110213|NCT01020123|254608|P2|COMPLETED|Main Period||77
110214|NCT01020123|254609|P1|COMPLETED|Main Period||76
110215|NCT01020123|254603|P7|STARTED|Main Period||72
110216|NCT01020123|254604|P6|STARTED|Main Period||94
110217|NCT01020123|254605|P5|STARTED|Main Period||88
110218|NCT01020123|254606|P4|STARTED|Main Period||40
110219|NCT01020123|254607|P3|STARTED|Main Period||52
110220|NCT01020123|254608|P2|STARTED|Main Period||91
110221|NCT01020123|254609|P1|STARTED|Main Period||93
110222|NCT01020019|254804|P2|NOT COMPLETED|Overall Study||29
110223|NCT01020019|254805|P1|NOT COMPLETED|Overall Study||26
110224|NCT01020019|254804|P2|COMPLETED|Overall Study||32
110225|NCT01020019|254805|P1|COMPLETED|Overall Study||35
110226|NCT01020019|254804|P2|STARTED|Overall Study||61
110227|NCT01020019|254805|P1|STARTED|Overall Study||61
110228|NCT01020006|254814|P3|NOT COMPLETED|Overall Study||16
110229|NCT01020006|254815|P2|NOT COMPLETED|Overall Study||18
110230|NCT01020006|254816|P1|NOT COMPLETED|Overall Study||8
110231|NCT01020006|254814|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
110232|NCT01020006|254815|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
110233|NCT01020006|254816|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
110234|NCT01020006|254814|P3|STARTED|Overall Study||16
110235|NCT01020006|254815|P2|STARTED|Overall Study||18
110236|NCT01020006|254816|P1|STARTED|Overall Study||8
110237|NCT01019980|254826|P2|NOT COMPLETED|Overall Study||0
110238|NCT01019980|254827|P1|NOT COMPLETED|Overall Study||2
110239|NCT01019980|254826|P2|COMPLETED|Overall Study||0
110240|NCT01019980|254827|P1|COMPLETED|Overall Study||0
110241|NCT01019980|254826|P2|Discontinued|Overall Study||0
110242|NCT01019980|254827|P1|Discontinued|Overall Study||2
110243|NCT01019980|254826|P2|STARTED|Overall Study||0
110244|NCT01019980|254827|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
110245|NCT01019928|254835|P2|NOT COMPLETED|Period 3||0
110246|NCT01019928|254836|P1|NOT COMPLETED|Period 3||0
110247|NCT01019928|254835|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
110248|NCT01019928|254836|P1|COMPLETED|Period 3||7
110249|NCT01019928|254835|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
110250|NCT01019928|254836|P1|STARTED|Period 3||7
110251|NCT01019928|254835|P2|NOT COMPLETED|Period 2||1
110252|NCT01019928|254836|P1|NOT COMPLETED|Period 2||0
110253|NCT01019928|254835|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
110254|NCT01019928|254836|P1|COMPLETED|Period 2||7
110255|NCT01019928|254835|P2|STARTED|Period 2||7
110256|NCT01019928|254836|P1|STARTED|Period 2||7
110257|NCT01019928|254835|P2|NOT COMPLETED|Period 1||0
110258|NCT01019928|254836|P1|NOT COMPLETED|Period 1||0
110259|NCT01019928|254835|P2|COMPLETED|Period 1||7
110260|NCT01019928|254836|P1|COMPLETED|Period 1||7
110261|NCT01019928|254835|P2|STARTED|Period 1||7
110262|NCT01019928|254836|P1|STARTED|Period 1||7
110263|NCT01019707|254876|P2|NOT COMPLETED|Second Phase||0
110264|NCT01019707|254877|P1|NOT COMPLETED|Second Phase||0
110265|NCT01019707|254876|P2|COMPLETED|Second Phase||1
110266|NCT01019707|254877|P1|COMPLETED|Second Phase||3
110267|NCT01019707|254876|P2|STARTED|Second Phase||1
110268|NCT01019707|254877|P1|STARTED|Second Phase||3
110269|NCT01019707|254876|P2|NOT COMPLETED|Washout||2
110270|NCT01019707|254877|P1|NOT COMPLETED|Washout||0
110271|NCT01019707|254876|P2|COMPLETED|Washout||1
110272|NCT01019707|254877|P1|COMPLETED|Washout||3
110273|NCT01019707|254876|P2|STARTED|Washout||3
110274|NCT01019707|254877|P1|STARTED|Washout||3
110275|NCT01019707|254876|P2|NOT COMPLETED|First Phase||0
110276|NCT01019707|254877|P1|NOT COMPLETED|First Phase||0
110277|NCT01019707|254876|P2|COMPLETED|First Phase||3
110278|NCT01019707|254877|P1|COMPLETED|First Phase||3
110279|NCT01019707|254876|P2|STARTED|First Phase||3
110280|NCT01019707|254877|P1|STARTED|First Phase||3
110281|NCT01019694|254890|P3|NOT COMPLETED|Overall Study||47
110283|NCT01019694|254892|P1|NOT COMPLETED|Overall Study||24
110284|NCT01019694|254890|P3|COMPLETED|Overall Study||110
110285|NCT01019694|254891|P2|COMPLETED|Overall Study||118
110286|NCT01019694|254892|P1|COMPLETED|Overall Study||133
110287|NCT01019694|254890|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
110288|NCT01019694|254891|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
110289|NCT01019694|254892|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
110290|NCT01019486|255017|P3|NOT COMPLETED|Overall Study||1
110291|NCT01019486|255018|P2|NOT COMPLETED|Overall Study||1
110292|NCT01019486|255019|P1|NOT COMPLETED|Overall Study||1
110293|NCT01019486|255017|P3|COMPLETED|Overall Study||15
110294|NCT01019486|255018|P2|COMPLETED|Overall Study||4
110295|NCT01019486|255019|P1|COMPLETED|Overall Study||4
110296|NCT01019486|255017|P3|STARTED|Overall Study||16
110297|NCT01019486|255018|P2|STARTED|Overall Study||5
110298|NCT01019486|255019|P1|STARTED|Overall Study||5
110299|NCT01019369|255033|P2|NOT COMPLETED|Overall Study||7
110300|NCT01019369|255034|P1|NOT COMPLETED|Overall Study||10
110301|NCT01019369|255033|P2|COMPLETED|Overall Study||39
110302|NCT01019369|255034|P1|COMPLETED|Overall Study||76
110303|NCT01019369|255033|P2|STARTED|Overall Study||46
110304|NCT01019369|255034|P1|STARTED|Overall Study||86
110305|NCT01019317|255040|P1|NOT COMPLETED|Overall Study||4
110306|NCT01019317|255040|P1|COMPLETED|Overall Study||147
110307|NCT01019317|255040|P1|STARTED|Overall Study||151
110308|NCT01019135|255047|P3|NOT COMPLETED|Overall Study||31
110309|NCT01019135|255048|P2|NOT COMPLETED|Overall Study||19
110310|NCT01019135|255049|P1|NOT COMPLETED|Overall Study||20
110311|NCT01019135|255047|P3|COMPLETED|Overall Study||24
110312|NCT01019135|255048|P2|COMPLETED|Overall Study||40
110313|NCT01019135|255049|P1|COMPLETED|Overall Study||35
110314|NCT01019135|255047|P3|STARTED|Overall Study||55
110315|NCT01019135|255048|P2|STARTED|Overall Study||59
110316|NCT01019135|255049|P1|STARTED|Overall Study||55
110317|NCT01018992|255077|P2|NOT COMPLETED|Overall Study||16
110318|NCT01018992|255078|P1|NOT COMPLETED|Overall Study||16
110319|NCT01018992|255077|P2|COMPLETED|Overall Study||49
110320|NCT01018992|255078|P1|COMPLETED|Overall Study||47
110321|NCT01018992|255077|P2|STARTED|Overall Study||65
110322|NCT01018992|255078|P1|STARTED|Overall Study||63
110323|NCT01018979|255092|P2|NOT COMPLETED|Overall Study||10
110324|NCT01018979|255093|P1|NOT COMPLETED|Overall Study||3
110325|NCT01018979|255092|P2|COMPLETED|Overall Study||3
110326|NCT01018979|255093|P1|COMPLETED|Overall Study||4
110327|NCT01018979|255092|P2|Received at Least One Dose|Overall Study||12
110328|NCT01018979|255093|P1|Received at Least One Dose|Overall Study||7
110329|NCT01018979|255092|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
110330|NCT01018979|255093|P1|STARTED|Overall Study||7
110331|NCT01018953|255123|P1|NOT COMPLETED|Overall Study||8
110332|NCT01018953|255123|P1|COMPLETED|Overall Study||0
110333|NCT01018953|255123|P1|BIM 23A760 4 mg|Overall Study||3
110334|NCT01018953|255123|P1|BIM 23A760 2 mg|Overall Study||2
110335|NCT01018953|255123|P1|BIM 23A760 1 mg|Overall Study||3
110336|NCT01018953|255123|P1|STARTED|Overall Study||8
110337|NCT01018862|255136|P3|NOT COMPLETED|Overall Study||16
110338|NCT01018862|255137|P2|NOT COMPLETED|Overall Study||10
110339|NCT01018862|255138|P1|NOT COMPLETED|Overall Study||13
110340|NCT01018862|255136|P3|COMPLETED|Overall Study||146
110341|NCT01018862|255137|P2|COMPLETED|Overall Study||156
110342|NCT01018862|255138|P1|COMPLETED|Overall Study||148
110343|NCT01018862|255136|P3|STARTED|Overall Study||162
110344|NCT01018862|255137|P2|STARTED|Overall Study||166
110345|NCT01018862|255138|P1|STARTED|Overall Study||161
110346|NCT01018810|255160|P5|NOT COMPLETED|Overall Study||1
110347|NCT01018810|255161|P4|NOT COMPLETED|Overall Study||1
110348|NCT01018810|255162|P3|NOT COMPLETED|Overall Study||1
110349|NCT01018810|255163|P2|NOT COMPLETED|Overall Study||1
110350|NCT01018810|255164|P1|NOT COMPLETED|Overall Study||2
110351|NCT01018810|255160|P5|COMPLETED|Overall Study||0
110352|NCT01018810|255161|P4|COMPLETED|Overall Study||0
110353|NCT01018810|255162|P3|COMPLETED|Overall Study||0
110354|NCT01018810|255163|P2|COMPLETED|Overall Study||0
110355|NCT01018810|255164|P1|COMPLETED|Overall Study||2
110356|NCT01018810|255160|P5|STARTED|Overall Study||1
110357|NCT01018810|255161|P4|STARTED|Overall Study||1
110358|NCT01018810|255162|P3|STARTED|Overall Study||1
110359|NCT01018810|255163|P2|STARTED|Overall Study||1
110360|NCT01018810|255164|P1|STARTED|Overall Study||4
110361|NCT01018732|255224|P3|NOT COMPLETED|Overall Study||4
110362|NCT01018732|255225|P2|NOT COMPLETED|Overall Study||2
110363|NCT01018732|255226|P1|NOT COMPLETED|Overall Study||1
110364|NCT01018732|255224|P3|COMPLETED|Overall Study||50
110365|NCT01018732|255225|P2|COMPLETED|Overall Study||49
110366|NCT01018732|255226|P1|COMPLETED|Overall Study||49
110367|NCT01018732|255224|P3|STARTED|Overall Study||54
110368|NCT01018732|255225|P2|STARTED|Overall Study||51
110369|NCT01018732|255226|P1|STARTED|Overall Study||50
110370|NCT01018680|255260|P2|NOT COMPLETED|Overall Study||75
110371|NCT01018680|255261|P1|NOT COMPLETED|Overall Study||61
110372|NCT01018680|255260|P2|COMPLETED|Overall Study||189
110373|NCT01018680|255261|P1|COMPLETED|Overall Study||199
110374|NCT01018680|255260|P2|STARTED|Overall Study||264
110375|NCT01018680|255261|P1|STARTED|Overall Study||260
110376|NCT01018511|255305|P4|NOT COMPLETED|Overall Study||33
110377|NCT01018511|255306|P3|NOT COMPLETED|Overall Study||40
110378|NCT01018511|255307|P2|NOT COMPLETED|Overall Study||32
110379|NCT01018511|255308|P1|NOT COMPLETED|Overall Study||26
110380|NCT01018511|255305|P4|COMPLETED|Overall Study||294
110381|NCT01018511|255306|P3|COMPLETED|Overall Study||299
110382|NCT01018511|255307|P2|COMPLETED|Overall Study||295
110383|NCT01018511|255308|P1|COMPLETED|Overall Study||315
110384|NCT01018511|255305|P4|Randomized and Treated|Overall Study||324
110385|NCT01018511|255306|P3|Randomized and Treated|Overall Study||338
110386|NCT01018511|255307|P2|Randomized and Treated|Overall Study||326
110387|NCT01018511|255308|P1|Randomized and Treated|Overall Study||341
110388|NCT01018511|255305|P4|STARTED|Overall Study||327
110389|NCT01018511|255306|P3|STARTED|Overall Study||339
110390|NCT01018511|255307|P2|STARTED|Overall Study||327
110391|NCT01018511|255308|P1|STARTED|Overall Study||341
110392|NCT01018420|255477|P2|NOT COMPLETED|Overall Study||0
110393|NCT01018420|255478|P1|NOT COMPLETED|Overall Study||0
110394|NCT01018420|255477|P2|COMPLETED|Overall Study||3
110395|NCT01018420|255478|P1|COMPLETED|Overall Study||15
110396|NCT01018420|255477|P2|STARTED|Overall Study||3
110397|NCT01018420|255478|P1|STARTED|Overall Study||15
110398|NCT01018394|255505|P2|NOT COMPLETED|Overall Study||8
110399|NCT01018394|255506|P1|NOT COMPLETED|Overall Study||9
110400|NCT01018394|255505|P2|COMPLETED|Overall Study||33
110401|NCT01018394|255506|P1|COMPLETED|Overall Study||31
110402|NCT01018394|255505|P2|STARTED|Overall Study||41
110403|NCT01018394|255506|P1|STARTED|Overall Study||40
110404|NCT01018264|255516|P2|NOT COMPLETED|Overall Study||1
110405|NCT01018264|255517|P1|NOT COMPLETED|Overall Study||1
110406|NCT01018264|255516|P2|COMPLETED|Overall Study||12
110407|NCT01018264|255517|P1|COMPLETED|Overall Study||9
110408|NCT01018264|255516|P2|STARTED|Overall Study||13
110409|NCT01018264|255517|P1|STARTED|Overall Study||10
110410|NCT01018186|255534|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
110411|NCT01018186|255535|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
110412|NCT01018186|255536|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
110413|NCT01018186|255537|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
110414|NCT01018186|255534|P4|COMPLETED|52-week Double-blind Treatment Period||71
110415|NCT01018186|255535|P3|COMPLETED|52-week Double-blind Treatment Period||161
110416|NCT01018186|255536|P2|COMPLETED|52-week Double-blind Treatment Period||161
110417|NCT01018186|255537|P1|COMPLETED|52-week Double-blind Treatment Period||0
110418|NCT01018186|255534|P4|STARTED|52-week Double-blind Treatment Period||100
110419|NCT01018186|255535|P3|STARTED|52-week Double-blind Treatment Period||202
110420|NCT01018186|255536|P2|STARTED|52-week Double-blind Treatment Period||201
110421|NCT01018186|255537|P1|STARTED|52-week Double-blind Treatment Period||0
110422|NCT01018186|255534|P4|NOT COMPLETED|2-week Run-in Period||0
110423|NCT01018186|255535|P3|NOT COMPLETED|2-week Run-in Period||0
110424|NCT01018186|255536|P2|NOT COMPLETED|2-week Run-in Period||0
110425|NCT01018186|255537|P1|NOT COMPLETED|2-week Run-in Period||114
110426|NCT01018186|255534|P4|COMPLETED|2-week Run-in Period||0
110427|NCT01018186|255535|P3|COMPLETED|2-week Run-in Period||0
110428|NCT01018186|255536|P2|COMPLETED|2-week Run-in Period||0
110429|NCT01018186|255537|P1|COMPLETED|2-week Run-in Period||503
110430|NCT01018186|255534|P4|STARTED|2-week Run-in Period||0
110431|NCT01018186|255535|P3|STARTED|2-week Run-in Period||0
110432|NCT01018186|255536|P2|STARTED|2-week Run-in Period||0
110433|NCT01018186|255537|P1|STARTED|2-week Run-in Period||617
110434|NCT01018134|255629|P6|NOT COMPLETED|Overall Study||0
110435|NCT01018134|255630|P5|NOT COMPLETED|Overall Study||0
110436|NCT01018134|255631|P4|NOT COMPLETED|Overall Study||0
110437|NCT01018134|255632|P3|NOT COMPLETED|Overall Study||1
110438|NCT01018134|255633|P2|NOT COMPLETED|Overall Study||1
110439|NCT01018134|255634|P1|NOT COMPLETED|Overall Study||0
110440|NCT01018134|255629|P6|COMPLETED|Overall Study||15
110441|NCT01018134|255630|P5|COMPLETED|Overall Study||15
110442|NCT01018134|255631|P4|COMPLETED|Overall Study||29
110443|NCT01018134|255632|P3|COMPLETED|Overall Study||29
110444|NCT01018134|255633|P2|COMPLETED|Overall Study||30
110445|NCT01018134|255634|P1|COMPLETED|Overall Study||30
110446|NCT01018134|255629|P6|STARTED|Overall Study||15
110447|NCT01018134|255630|P5|STARTED|Overall Study||15
110448|NCT01018134|255631|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
110449|NCT01018134|255632|P3|STARTED|Overall Study||30
110450|NCT01018134|255633|P2|STARTED|Overall Study||31
110451|NCT01018134|255634|P1|STARTED|Overall Study||30
110452|NCT01018095|255674|P2|NOT COMPLETED|Overall Study||62
110453|NCT01018095|255675|P1|NOT COMPLETED|Overall Study||56
110454|NCT01018095|255674|P2|COMPLETED|Overall Study||73
110455|NCT01018095|255675|P1|COMPLETED|Overall Study||79
110456|NCT01018095|255674|P2|STARTED|Overall Study||135
110457|NCT01018095|255675|P1|STARTED|Overall Study||135
110458|NCT01018056|255686|P3|NOT COMPLETED|Overall Study||1
110459|NCT01018056|255687|P2|NOT COMPLETED|Overall Study||2
110460|NCT01018056|255688|P1|NOT COMPLETED|Overall Study||3
110461|NCT01018056|255686|P3|COMPLETED|Overall Study||5
110462|NCT01018056|255687|P2|COMPLETED|Overall Study||10
110463|NCT01018056|255688|P1|COMPLETED|Overall Study||9
110464|NCT01018056|255686|P3|STARTED|Overall Study||6
110465|NCT01018056|255687|P2|STARTED|Overall Study||12
110466|NCT01018056|255688|P1|STARTED|Overall Study||12
110467|NCT01018030|255723|P3|NOT COMPLETED|Overall Study||13
110468|NCT01018030|255724|P2|NOT COMPLETED|Overall Study||11
110469|NCT01018030|255725|P1|NOT COMPLETED|Overall Study||19
110470|NCT01018030|255723|P3|COMPLETED|Overall Study||239
110471|NCT01018030|255724|P2|COMPLETED|Overall Study||232
110472|NCT01018030|255725|P1|COMPLETED|Overall Study||227
110473|NCT01018030|255723|P3|STARTED|Overall Study||252
110474|NCT01018030|255724|P2|STARTED|Overall Study||243
110475|NCT01018030|255725|P1|STARTED|Overall Study||246
110476|NCT01017952|255776|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
110477|NCT01017952|255777|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
110478|NCT01017952|255778|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
110479|NCT01017952|255779|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
110480|NCT01017952|255780|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
110481|NCT01017952|255776|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
110482|NCT01017952|255777|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
110483|NCT01017952|255778|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
110484|NCT01017952|255779|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
110485|NCT01017952|255780|P1|COMPLETED|52-week, Double-blind Treatment Period||0
110486|NCT01017952|255776|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
110487|NCT01017952|255777|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
110488|NCT01017952|255778|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
110489|NCT01017952|255779|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
110490|NCT01017952|255780|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
110491|NCT01017952|255776|P5|STARTED|52-week, Double-blind Treatment Period||409
110492|NCT01017952|255777|P4|STARTED|52-week, Double-blind Treatment Period||403
110493|NCT01017952|255778|P3|STARTED|52-week, Double-blind Treatment Period||412
110494|NCT01017952|255779|P2|STARTED|52-week, Double-blind Treatment Period||409
110495|NCT01017952|255780|P1|STARTED|52-week, Double-blind Treatment Period||0
110496|NCT01017952|255776|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
110497|NCT01017952|255777|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
110498|NCT01017952|255778|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
110499|NCT01017952|255779|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
110500|NCT01017952|255780|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
110501|NCT01017952|255776|P5|COMPLETED|4-week, Open-label Run-In Period||0
110502|NCT01017952|255777|P4|COMPLETED|4-week, Open-label Run-In Period||0
110503|NCT01017952|255778|P3|COMPLETED|4-week, Open-label Run-In Period||0
110504|NCT01017952|255779|P2|COMPLETED|4-week, Open-label Run-In Period||0
110505|NCT01017952|255780|P1|COMPLETED|4-week, Open-label Run-In Period||1633
110506|NCT01017952|255776|P5|STARTED|4-week, Open-label Run-In Period||0
110507|NCT01017952|255777|P4|STARTED|4-week, Open-label Run-In Period||0
110508|NCT01017952|255778|P3|STARTED|4-week, Open-label Run-In Period||0
110509|NCT01017952|255779|P2|STARTED|4-week, Open-label Run-In Period||0
110510|NCT01017952|255780|P1|STARTED|4-week, Open-label Run-In Period||2092
110511|NCT01017874|255804|P2|NOT COMPLETED|Overall Study||26
110512|NCT01017874|255805|P1|NOT COMPLETED|Overall Study||30
110513|NCT01017874|255804|P2|COMPLETED|Overall Study||92
110514|NCT01017874|255805|P1|COMPLETED|Overall Study||88
110515|NCT01017874|255804|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
110516|NCT01017874|255805|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
110517|NCT01017874|255804|P2|STARTED|Overall Study||118
110518|NCT01017874|255805|P1|STARTED|Overall Study||118
110519|NCT01017731|255823|P1|NOT COMPLETED|Overall Study||8
110520|NCT01017731|255823|P1|COMPLETED|Overall Study||60
110521|NCT01017731|255823|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
110522|NCT01017731|255823|P1|STARTED|Overall Study||68
110523|NCT01017653|255840|P1|NOT COMPLETED|Overall Study||0
110524|NCT01017653|255840|P1|COMPLETED|Overall Study||16
110525|NCT01017653|255840|P1|STARTED|Overall Study||16
110526|NCT01017575|255855|P5|NOT COMPLETED|Overall Study||3
110527|NCT01017575|255856|P4|NOT COMPLETED|Overall Study||1
110528|NCT01017575|255857|P3|NOT COMPLETED|Overall Study||0
110529|NCT01017575|255858|P2|NOT COMPLETED|Overall Study||2
110530|NCT01017575|255859|P1|NOT COMPLETED|Overall Study||1
110531|NCT01017575|255855|P5|COMPLETED|Overall Study||6
110532|NCT01017575|255856|P4|COMPLETED|Overall Study||7
110533|NCT01017575|255857|P3|COMPLETED|Overall Study||8
110534|NCT01017575|255858|P2|COMPLETED|Overall Study||7
110535|NCT01017575|255859|P1|COMPLETED|Overall Study||7
110536|NCT01017575|255855|P5|STARTED|Overall Study||9
110537|NCT01017575|255856|P4|STARTED|Overall Study||8
110538|NCT01017575|255857|P3|STARTED|Overall Study||8
110539|NCT01017575|255858|P2|STARTED|Overall Study||9
110540|NCT01017575|255859|P1|STARTED|Overall Study||8
110541|NCT01017549|255896|P1|NOT COMPLETED|One-year Follow-up||7
110542|NCT01017549|255896|P1|COMPLETED|One-year Follow-up||36
110543|NCT01017549|255896|P1|STARTED|One-year Follow-up||43
110544|NCT01017549|255896|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
110545|NCT01017549|255896|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
110546|NCT01017549|255896|P1|STARTED|Eligibility Through 6 Month Follow-up||44
110547|NCT01017536|255903|P2|NOT COMPLETED|Overall Study||0
110548|NCT01017536|255904|P1|NOT COMPLETED|Overall Study||0
110549|NCT01017536|255903|P2|COMPLETED|Overall Study||13
110550|NCT01017536|255904|P1|COMPLETED|Overall Study||13
110551|NCT01017536|255903|P2|STARTED|Overall Study||13
110552|NCT01017536|255904|P1|STARTED|Overall Study||13
110553|NCT01017497|255914|P1|NOT COMPLETED|Overall Study||0
110554|NCT01017497|255914|P1|COMPLETED|Overall Study||49
110555|NCT01017497|255914|P1|STARTED|Overall Study||49
110556|NCT01017263|255927|P1|NOT COMPLETED|Overall Study||12
110557|NCT01017263|255927|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
110558|NCT01017263|255927|P1|STARTED|Overall Study||14
110559|NCT01017250|255931|P1|NOT COMPLETED|Overall Study||0
110560|NCT01017250|255931|P1|COMPLETED|Overall Study||15
110561|NCT01017250|255931|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
110562|NCT01017250|255931|P1|STARTED|Overall Study||15
110563|NCT01017237|255953|P2|NOT COMPLETED|Overall Study||2
110564|NCT01017237|255954|P1|NOT COMPLETED|Overall Study||5
110565|NCT01017237|255953|P2|COMPLETED|Overall Study||6
110566|NCT01017237|255954|P1|COMPLETED|Overall Study||5
110567|NCT01017237|255953|P2|STARTED|Overall Study||8
110568|NCT01017237|255954|P1|STARTED|Overall Study||10
110569|NCT01017146|256008|P2|NOT COMPLETED|Overall Study||39
110570|NCT01017146|256009|P1|NOT COMPLETED|Overall Study||66
110571|NCT01017146|256008|P2|COMPLETED|Overall Study||333
110572|NCT01017146|256009|P1|COMPLETED|Overall Study||306
110573|NCT01017146|256008|P2|STARTED|Overall Study||372
110574|NCT01017146|256009|P1|STARTED|Overall Study||372
110575|NCT01017120|256047|P2|NOT COMPLETED|Overall Study||35
110576|NCT01017120|256048|P1|NOT COMPLETED|Overall Study||66
110577|NCT01017120|256047|P2|COMPLETED|Overall Study||334
110578|NCT01017120|256048|P1|COMPLETED|Overall Study||307
110579|NCT01017120|256047|P2|STARTED|Overall Study||369
110580|NCT01017120|256048|P1|STARTED|Overall Study||373
110581|NCT01017042|256096|P1|NOT COMPLETED|Overall Study||0
110582|NCT01017042|256096|P1|COMPLETED|Overall Study||13
110583|NCT01017042|256096|P1|STARTED|Overall Study||13
110584|NCT01017029|256109|P2|NOT COMPLETED|Overall Study||2
110585|NCT01017029|256110|P1|NOT COMPLETED|Overall Study||4
110586|NCT01017029|256109|P2|COMPLETED|Overall Study||90
110587|NCT01017029|256110|P1|COMPLETED|Overall Study||85
110588|NCT01017029|256109|P2|STARTED|Overall Study||92
110589|NCT01017029|256110|P1|STARTED|Overall Study||89
110590|NCT01017003|256126|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
110591|NCT01017003|256126|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
110592|NCT01017003|256126|P1|STARTED|Colchicine 0.6 mg Final Dose||13
110593|NCT01017003|256126|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
110594|NCT01017003|256126|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
110595|NCT01017003|256126|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
110596|NCT01017003|256126|P1|NOT COMPLETED|14 Day Washout Period||0
110597|NCT01017003|256126|P1|COMPLETED|14 Day Washout Period||13
110598|NCT01017003|256126|P1|STARTED|14 Day Washout Period||13
110599|NCT01017003|256126|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
110600|NCT01017003|256126|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
110601|NCT01017003|256126|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
110602|NCT01016977|256138|P2|NOT COMPLETED|Overall Study||2
110603|NCT01016977|256139|P1|NOT COMPLETED|Overall Study||3
110604|NCT01016977|256138|P2|COMPLETED|Overall Study||18
110605|NCT01016977|256139|P1|COMPLETED|Overall Study||17
110606|NCT01016977|256138|P2|STARTED|Overall Study||20
110607|NCT01016977|256139|P1|STARTED|Overall Study||20
110608|NCT01016964|256175|P2|NOT COMPLETED|Overall Study||3
110609|NCT01016964|256176|P1|NOT COMPLETED|Overall Study||3
110610|NCT01016964|256175|P2|COMPLETED|Overall Study||39
110611|NCT01016964|256176|P1|COMPLETED|Overall Study||18
110612|NCT01016964|256175|P2|STARTED|Overall Study||42
110613|NCT01016964|256176|P1|STARTED|Overall Study||21
110614|NCT01016938|256182|P1|NOT COMPLETED|Overall Study||9
110615|NCT01016938|256182|P1|COMPLETED|Overall Study||7
110616|NCT01016938|256182|P1|STARTED|Overall Study||16
110617|NCT01016912|256192|P5|NOT COMPLETED|Follow-up Period||0
110618|NCT01016912|256193|P4|NOT COMPLETED|Follow-up Period||1
110619|NCT01016912|256194|P3|NOT COMPLETED|Follow-up Period||1
110620|NCT01016912|256195|P2|NOT COMPLETED|Follow-up Period||0
110621|NCT01016912|256196|P1|NOT COMPLETED|Follow-up Period||0
110622|NCT01016912|256192|P5|COMPLETED|Follow-up Period||9
110623|NCT01016912|256193|P4|COMPLETED|Follow-up Period||8
110624|NCT01016912|256194|P3|COMPLETED|Follow-up Period||9
110625|NCT01016912|256195|P2|COMPLETED|Follow-up Period||9
110626|NCT01016912|256196|P1|COMPLETED|Follow-up Period||8
110627|NCT01016912|256192|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
110718|NCT01016652|256336|P2|NOT COMPLETED|Period 1||0
110628|NCT01016912|256193|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
110629|NCT01016912|256194|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
110630|NCT01016912|256195|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
110631|NCT01016912|256196|P1|STARTED|Follow-up Period||8
110632|NCT01016912|256192|P5|NOT COMPLETED|End of Treatment Period||4
110633|NCT01016912|256193|P4|NOT COMPLETED|End of Treatment Period||4
110634|NCT01016912|256194|P3|NOT COMPLETED|End of Treatment Period||1
110635|NCT01016912|256195|P2|NOT COMPLETED|End of Treatment Period||3
110636|NCT01016912|256196|P1|NOT COMPLETED|End of Treatment Period||0
110637|NCT01016912|256192|P5|COMPLETED|End of Treatment Period||5
110638|NCT01016912|256193|P4|COMPLETED|End of Treatment Period||5
110639|NCT01016912|256194|P3|COMPLETED|End of Treatment Period||9
110640|NCT01016912|256195|P2|COMPLETED|End of Treatment Period||6
110641|NCT01016912|256196|P1|COMPLETED|End of Treatment Period||8
110642|NCT01016912|256192|P5|Received Treatment|End of Treatment Period||9
110643|NCT01016912|256193|P4|Received Treatment|End of Treatment Period||9
110644|NCT01016912|256194|P3|Received Treatment|End of Treatment Period||10
110645|NCT01016912|256195|P2|Received Treatment|End of Treatment Period||9
110646|NCT01016912|256196|P1|Received Treatment|End of Treatment Period||8
110647|NCT01016912|256192|P5|STARTED|End of Treatment Period||9
110648|NCT01016912|256193|P4|STARTED|End of Treatment Period||9
110649|NCT01016912|256194|P3|STARTED|End of Treatment Period||10
110650|NCT01016912|256195|P2|STARTED|End of Treatment Period||9
110651|NCT01016912|256196|P1|STARTED|End of Treatment Period||8
110652|NCT01016873|256241|P3|NOT COMPLETED|36 Months||6
110653|NCT01016873|256242|P2|NOT COMPLETED|36 Months||4
110654|NCT01016873|256243|P1|NOT COMPLETED|36 Months||11
110655|NCT01016873|256241|P3|COMPLETED|36 Months||67
110656|NCT01016873|256242|P2|COMPLETED|36 Months||64
110657|NCT01016873|256243|P1|COMPLETED|36 Months||58
110658|NCT01016873|256241|P3|STARTED|36 Months||73
110659|NCT01016873|256242|P2|STARTED|36 Months||68
110660|NCT01016873|256243|P1|STARTED|36 Months||69
110661|NCT01016873|256241|P3|NOT COMPLETED|24 Months||6
110662|NCT01016873|256242|P2|NOT COMPLETED|24 Months||4
110663|NCT01016873|256243|P1|NOT COMPLETED|24 Months||5
110664|NCT01016873|256241|P3|COMPLETED|24 Months||73
110665|NCT01016873|256242|P2|COMPLETED|24 Months||68
110666|NCT01016873|256243|P1|COMPLETED|24 Months||69
110667|NCT01016873|256241|P3|STARTED|24 Months||79
110668|NCT01016873|256242|P2|STARTED|24 Months||72
110669|NCT01016873|256243|P1|STARTED|24 Months||74
110670|NCT01016873|256241|P3|NOT COMPLETED|12 Months||1
110671|NCT01016873|256242|P2|NOT COMPLETED|12 Months||3
110672|NCT01016873|256243|P1|NOT COMPLETED|12 Months||1
110673|NCT01016873|256241|P3|COMPLETED|12 Months||79
110674|NCT01016873|256242|P2|COMPLETED|12 Months||72
110675|NCT01016873|256243|P1|COMPLETED|12 Months||74
110676|NCT01016873|256241|P3|STARTED|12 Months||80
110677|NCT01016873|256242|P2|STARTED|12 Months||75
110678|NCT01016873|256243|P1|STARTED|12 Months||75
110679|NCT01016847|256274|P2|NOT COMPLETED|Overall Study||0
110680|NCT01016847|256275|P1|NOT COMPLETED|Overall Study||0
110681|NCT01016847|256274|P2|COMPLETED|Overall Study||2
110682|NCT01016847|256275|P1|COMPLETED|Overall Study||1
110683|NCT01016847|256274|P2|STARTED|Overall Study||2
110684|NCT01016847|256275|P1|STARTED|Overall Study||1
110685|NCT01016834|256291|P1|NOT COMPLETED|Overall Study||22
110686|NCT01016834|256291|P1|COMPLETED|Overall Study||220
110687|NCT01016834|256291|P1|STARTED|Overall Study||242
110688|NCT01016691|256300|P3|NOT COMPLETED|Overall Study||0
110689|NCT01016691|256301|P2|NOT COMPLETED|Overall Study||0
110690|NCT01016691|256302|P1|NOT COMPLETED|Overall Study||0
110691|NCT01016691|256300|P3|COMPLETED|Overall Study||18
110692|NCT01016691|256301|P2|COMPLETED|Overall Study||12
110693|NCT01016691|256302|P1|COMPLETED|Overall Study||17
110694|NCT01016691|256300|P3|STARTED|Overall Study||18
110695|NCT01016691|256301|P2|STARTED|Overall Study||12
110696|NCT01016691|256302|P1|STARTED|Overall Study||17
110697|NCT01016678|256310|P5|NOT COMPLETED|Overall Study||6
110698|NCT01016678|256311|P4|NOT COMPLETED|Overall Study||0
110699|NCT01016678|256312|P3|NOT COMPLETED|Overall Study||4
110700|NCT01016678|256313|P2|NOT COMPLETED|Overall Study||3
110701|NCT01016678|256314|P1|NOT COMPLETED|Overall Study||2
110702|NCT01016678|256310|P5|COMPLETED|Overall Study||13
110703|NCT01016678|256311|P4|COMPLETED|Overall Study||19
110704|NCT01016678|256312|P3|COMPLETED|Overall Study||15
110705|NCT01016678|256313|P2|COMPLETED|Overall Study||14
110706|NCT01016678|256314|P1|COMPLETED|Overall Study||18
110707|NCT01016678|256310|P5|STARTED|Overall Study||19
110708|NCT01016678|256311|P4|STARTED|Overall Study||19
110709|NCT01016678|256312|P3|STARTED|Overall Study||19
110710|NCT01016678|256313|P2|STARTED|Overall Study||17
110711|NCT01016678|256314|P1|STARTED|Overall Study||20
110712|NCT01016652|256336|P2|NOT COMPLETED|Period 2||0
110713|NCT01016652|256337|P1|NOT COMPLETED|Period 2||0
110714|NCT01016652|256336|P2|COMPLETED|Period 2||24
110715|NCT01016652|256337|P1|COMPLETED|Period 2||25
110716|NCT01016652|256336|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
110717|NCT01016652|256337|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
110719|NCT01016652|256337|P1|NOT COMPLETED|Period 1||0
110720|NCT01016652|256336|P2|COMPLETED|Period 1||24
110721|NCT01016652|256337|P1|COMPLETED|Period 1||25
110722|NCT01016652|256336|P2|STARTED|Period 1||24
110723|NCT01016652|256337|P1|STARTED|Period 1||25
110724|NCT01016600|256357|P4|NOT COMPLETED|Overall Study||0
110725|NCT01016600|256358|P3|NOT COMPLETED|Overall Study||0
110726|NCT01016600|256359|P2|NOT COMPLETED|Overall Study||0
110727|NCT01016600|256360|P1|NOT COMPLETED|Overall Study||1
110728|NCT01016600|256357|P4|COMPLETED|Overall Study||12
110729|NCT01016600|256358|P3|COMPLETED|Overall Study||6
110730|NCT01016600|256359|P2|COMPLETED|Overall Study||4
110731|NCT01016600|256360|P1|COMPLETED|Overall Study||8
110732|NCT01016600|256357|P4|STARTED|Overall Study||12
110733|NCT01016600|256358|P3|STARTED|Overall Study||6
110734|NCT01016600|256359|P2|STARTED|Overall Study||4
110735|NCT01016600|256360|P1|STARTED|Overall Study||9
110736|NCT01016132|256423|P1|NOT COMPLETED|Overall Study||1
110737|NCT01016132|256423|P1|COMPLETED|Overall Study||151
110738|NCT01016132|256423|P1|STARTED|Overall Study||152
110739|NCT01016106|256429|P2|NOT COMPLETED|Overall Study||0
110740|NCT01016106|256430|P1|NOT COMPLETED|Overall Study||0
110741|NCT01016106|256429|P2|COMPLETED|Overall Study||18
110742|NCT01016106|256430|P1|COMPLETED|Overall Study||17
110743|NCT01016106|256429|P2|STARTED|Overall Study||18
110744|NCT01016106|256430|P1|STARTED|Overall Study||17
110745|NCT01016067|256438|P2|NOT COMPLETED|Overall Study||4
110746|NCT01016067|256439|P1|NOT COMPLETED|Overall Study||2
110747|NCT01016067|256438|P2|COMPLETED|Overall Study||8
110748|NCT01016067|256439|P1|COMPLETED|Overall Study||9
110749|NCT01016067|256438|P2|STARTED|Overall Study||12
110750|NCT01016067|256439|P1|STARTED|Overall Study||11
110751|NCT01016015|256457|P1|NOT COMPLETED|Overall Study||19
110752|NCT01016015|256457|P1|COMPLETED|Overall Study||159
110753|NCT01016015|256457|P1|STARTED|Overall Study||178
110754|NCT01015976|256461|P2|NOT COMPLETED|Overall Study||0
110755|NCT01015976|256462|P1|NOT COMPLETED|Overall Study||0
110756|NCT01015976|256461|P2|COMPLETED|Overall Study||5
110757|NCT01015976|256462|P1|COMPLETED|Overall Study||5
110758|NCT01015976|256461|P2|STARTED|Overall Study||5
110759|NCT01015976|256462|P1|STARTED|Overall Study||5
110760|NCT01015820|256468|P2|NOT COMPLETED|Overall Study||0
110761|NCT01015820|256469|P1|NOT COMPLETED|Overall Study||1
110762|NCT01015820|256468|P2|COMPLETED|Overall Study||15
110763|NCT01015820|256469|P1|COMPLETED|Overall Study||14
110764|NCT01015820|256468|P2|STARTED|Overall Study||15
110765|NCT01015820|256469|P1|STARTED|Overall Study||15
110766|NCT01015781|256479|P2|NOT COMPLETED|Overall Study||29
110767|NCT01015781|256480|P1|NOT COMPLETED|Overall Study||37
110768|NCT01015781|256479|P2|COMPLETED|Overall Study||121
110769|NCT01015781|256480|P1|COMPLETED|Overall Study||113
110770|NCT01015781|256479|P2|STARTED|Overall Study||150
110771|NCT01015781|256480|P1|STARTED|Overall Study||150
110772|NCT01015703|256491|P5|NOT COMPLETED|Overall Study||0
110773|NCT01015703|256492|P4|NOT COMPLETED|Overall Study||0
110774|NCT01015703|256493|P3|NOT COMPLETED|Overall Study||0
110775|NCT01015703|256494|P2|NOT COMPLETED|Overall Study||1
110776|NCT01015703|256495|P1|NOT COMPLETED|Overall Study||2
110777|NCT01015703|256491|P5|COMPLETED|Overall Study||10
110778|NCT01015703|256492|P4|COMPLETED|Overall Study||10
110779|NCT01015703|256493|P3|COMPLETED|Overall Study||10
110780|NCT01015703|256494|P2|COMPLETED|Overall Study||9
110781|NCT01015703|256495|P1|COMPLETED|Overall Study||8
110782|NCT01015703|256491|P5|STARTED|Overall Study||10
110783|NCT01015703|256492|P4|STARTED|Overall Study||10
110784|NCT01015703|256493|P3|STARTED|Overall Study||10
110785|NCT01015703|256494|P2|STARTED|Overall Study||10
110786|NCT01015703|256495|P1|STARTED|Overall Study||10
110787|NCT01015677|256510|P3|NOT COMPLETED|Overall Study||0
110788|NCT01015677|256511|P2|NOT COMPLETED|Overall Study||4
110789|NCT01015677|256512|P1|NOT COMPLETED|Overall Study||1
110790|NCT01015677|256510|P3|COMPLETED|Overall Study||33
110791|NCT01015677|256511|P2|COMPLETED|Overall Study||28
110792|NCT01015677|256512|P1|COMPLETED|Overall Study||33
110793|NCT01015677|256510|P3|STARTED|Overall Study||33
110794|NCT01015677|256511|P2|STARTED|Overall Study||32
110795|NCT01015677|256512|P1|STARTED|Overall Study||34
110796|NCT01015638|256534|P2|NOT COMPLETED|Overall Study||0
110797|NCT01015638|256535|P1|NOT COMPLETED|Overall Study||1
110798|NCT01015638|256534|P2|COMPLETED|Overall Study||19
110799|NCT01015638|256535|P1|COMPLETED|Overall Study||16
110800|NCT01015638|256534|P2|STARTED|Overall Study||19
110801|NCT01015638|256535|P1|STARTED|Overall Study||17
110802|NCT01015560|256563|P1|NOT COMPLETED|Overall Study||3
110803|NCT01015560|256563|P1|COMPLETED|Overall Study||41
110804|NCT01015560|256563|P1|Eligible and Analyzable|Overall Study||43
110805|NCT01015560|256563|P1|STARTED|Overall Study||44
110806|NCT01015534|256569|P2|NOT COMPLETED|Overall Study||0
110807|NCT01015534|256570|P1|NOT COMPLETED|Overall Study||1
110808|NCT01015534|256569|P2|COMPLETED|Overall Study||27
110809|NCT01015534|256570|P1|COMPLETED|Overall Study||27
110810|NCT01015534|256569|P2|STARTED|Overall Study||27
110811|NCT01015534|256570|P1|STARTED|Overall Study||28
110812|NCT01015443|256584|P2|NOT COMPLETED|Overall Study||0
110813|NCT01015443|256585|P1|NOT COMPLETED|Overall Study||0
110814|NCT01015443|256584|P2|COMPLETED|Overall Study||94
110815|NCT01015443|256585|P1|COMPLETED|Overall Study||191
110816|NCT01015443|256584|P2|Treated|Overall Study||93
110817|NCT01015443|256585|P1|Treated|Overall Study||191
110818|NCT01015443|256584|P2|STARTED|Overall Study||94
110819|NCT01015443|256585|P1|STARTED|Overall Study||191
110820|NCT01015326|256603|P2|NOT COMPLETED|Overall Study||2
110821|NCT01015326|256604|P1|NOT COMPLETED|Overall Study||1
110822|NCT01015326|256603|P2|COMPLETED|Overall Study||18
110823|NCT01015326|256604|P1|COMPLETED|Overall Study||11
110824|NCT01015326|256603|P2|STARTED|Overall Study||20
110825|NCT01015326|256604|P1|STARTED|Overall Study||12
110826|NCT01015287|256612|P2|NOT COMPLETED|Overall Study||79
110827|NCT01015287|256613|P1|NOT COMPLETED|Overall Study||72
110828|NCT01015287|256612|P2|COMPLETED|Overall Study||1958
110829|NCT01015287|256613|P1|COMPLETED|Overall Study||1924
110830|NCT01015287|256612|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
110831|NCT01015287|256613|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
110832|NCT01015287|256612|P2|STARTED|Overall Study||2037
110833|NCT01015287|256613|P1|STARTED|Overall Study||1996
110834|NCT01015131|256639|P1|NOT COMPLETED|Overall Study||8
110835|NCT01015131|256639|P1|COMPLETED|Overall Study||36
110836|NCT01015131|256639|P1|STARTED|Overall Study||44
110837|NCT01015118|256655|P2|NOT COMPLETED|Overall Study||314
110838|NCT01015118|256656|P1|NOT COMPLETED|Overall Study||641
110839|NCT01015118|256655|P2|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|141
110840|NCT01015118|256656|P1|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|270
110841|NCT01015118|256655|P2|STARTED|Overall Study||455
110842|NCT01015118|256656|P1|STARTED|Overall Study||911
110843|NCT01014975|256674|P3|NOT COMPLETED|Overall Study||6
110844|NCT01014975|256675|P2|NOT COMPLETED|Overall Study||3
110845|NCT01014975|256676|P1|NOT COMPLETED|Overall Study||4
110846|NCT01014975|256674|P3|COMPLETED|Overall Study||10
110847|NCT01014975|256675|P2|COMPLETED|Overall Study||13
110848|NCT01014975|256676|P1|COMPLETED|Overall Study||4
110849|NCT01014975|256674|P3|STARTED|Overall Study||16
110850|NCT01014975|256675|P2|STARTED|Overall Study||16
110851|NCT01014975|256676|P1|STARTED|Overall Study||8
110852|NCT01014910|256686|P2|NOT COMPLETED|Overall Study||2
110853|NCT01014910|256687|P1|NOT COMPLETED|Overall Study||0
110854|NCT01014910|256686|P2|COMPLETED|Overall Study||79
110855|NCT01014910|256687|P1|COMPLETED|Overall Study||80
110856|NCT01014910|256686|P2|STARTED|Overall Study||81
110857|NCT01014910|256687|P1|STARTED|Overall Study||80
110858|NCT01014871|256695|P1|NOT COMPLETED|Overall Study||0
110859|NCT01014871|256695|P1|COMPLETED|Overall Study||30
110860|NCT01014871|256695|P1|STARTED|Overall Study||30
110861|NCT01014728|256703|P2|NOT COMPLETED|Overall Study||0
110862|NCT01014728|256704|P1|NOT COMPLETED|Overall Study||0
110863|NCT01014728|256703|P2|COMPLETED|Overall Study||15
110864|NCT01014728|256704|P1|COMPLETED|Overall Study||18
110865|NCT01014728|256703|P2|STARTED|Overall Study||15
110866|NCT01014728|256704|P1|STARTED|Overall Study||18
110867|NCT01014689|256716|P2|NOT COMPLETED|Overall Study||13
110868|NCT01014689|256717|P1|NOT COMPLETED|Overall Study||13
110869|NCT01014689|256716|P2|COMPLETED|Overall Study||174
110870|NCT01014689|256717|P1|COMPLETED|Overall Study||178
110871|NCT01014689|256716|P2|STARTED|Overall Study||187
110872|NCT01014689|256717|P1|STARTED|Overall Study||191
110873|NCT01014624|256727|P2|NOT COMPLETED|Overall Study||1
110874|NCT01014624|256728|P1|NOT COMPLETED|Overall Study||2
110875|NCT01014624|256727|P2|COMPLETED|Overall Study||26
110876|NCT01014624|256728|P1|COMPLETED|Overall Study||27
110877|NCT01014624|256727|P2|STARTED|Overall Study||27
110878|NCT01014624|256728|P1|STARTED|Overall Study||29
110879|NCT01014585|256752|P4|NOT COMPLETED|Overall Study||30
110880|NCT01014585|256753|P3|NOT COMPLETED|Overall Study||23
110881|NCT01014585|256754|P2|NOT COMPLETED|Overall Study||25
110882|NCT01014585|256755|P1|NOT COMPLETED|Overall Study||20
110883|NCT01014585|256752|P4|COMPLETED|Overall Study||99
110884|NCT01014585|256753|P3|COMPLETED|Overall Study||37
110885|NCT01014585|256754|P2|COMPLETED|Overall Study||75
110886|NCT01014585|256755|P1|COMPLETED|Overall Study||31
110887|NCT01014585|256752|P4|STARTED|Overall Study||129
110888|NCT01014585|256753|P3|STARTED|Overall Study||60
110889|NCT01014585|256754|P2|STARTED|Overall Study||100
110890|NCT01014585|256755|P1|STARTED|Overall Study||51
110891|NCT01014455|256775|P2|NOT COMPLETED|Overall Study||0
110892|NCT01014455|256776|P1|NOT COMPLETED|Overall Study||0
110893|NCT01014455|256775|P2|COMPLETED|Overall Study||87
110894|NCT01014455|256776|P1|COMPLETED|Overall Study||82
110895|NCT01014455|256775|P2|STARTED|Overall Study||87
110896|NCT01014455|256776|P1|STARTED|Overall Study||82
110897|NCT01014442|256784|P2|NOT COMPLETED|Overall Study||19
110898|NCT01014442|256785|P1|NOT COMPLETED|Overall Study||7
110899|NCT01014442|256784|P2|COMPLETED|Overall Study||16
110900|NCT01014442|256785|P1|COMPLETED|Overall Study||26
110901|NCT01014442|256784|P2|STARTED|Overall Study||35
110902|NCT01014442|256785|P1|STARTED|Overall Study||33
110903|NCT01014351|256897|P1|NOT COMPLETED|Overall Study||37
110904|NCT01014351|256897|P1|COMPLETED|Overall Study||33
110905|NCT01014351|256897|P1|STARTED|Overall Study||70
110906|NCT01014208|256905|P2|NOT COMPLETED|Overall Study||100
110907|NCT01014208|256906|P1|NOT COMPLETED|Overall Study||94
110908|NCT01014208|256905|P2|COMPLETED|Overall Study||122
110909|NCT01014208|256906|P1|COMPLETED|Overall Study||131
110910|NCT01014208|256905|P2|Intent-to-Treat Population|Overall Study||222
110911|NCT01014208|256906|P1|Intent-to-Treat Population|Overall Study||223
110912|NCT01014208|256905|P2|STARTED|Overall Study||222
110913|NCT01014208|256906|P1|STARTED|Overall Study||225
110914|NCT01014169|256934|P2|NOT COMPLETED|Overall Study||13
110915|NCT01014169|256935|P1|NOT COMPLETED|Overall Study||7
110916|NCT01014169|256934|P2|COMPLETED|Overall Study||48
110917|NCT01014169|256935|P1|COMPLETED|Overall Study||58
110918|NCT01014169|256934|P2|STARTED|Overall Study||61
110919|NCT01014169|256935|P1|STARTED|Overall Study||65
110920|NCT01014143|256948|P3|NOT COMPLETED|Third Intervention||0
110921|NCT01014143|256949|P2|NOT COMPLETED|Third Intervention||0
110922|NCT01014143|256950|P1|NOT COMPLETED|Third Intervention||0
110923|NCT01014143|256948|P3|COMPLETED|Third Intervention||9
110924|NCT01014143|256949|P2|COMPLETED|Third Intervention||9
110925|NCT01014143|256950|P1|COMPLETED|Third Intervention||8
110926|NCT01014143|256948|P3|STARTED|Third Intervention||9
110927|NCT01014143|256949|P2|STARTED|Third Intervention||9
110928|NCT01014143|256950|P1|STARTED|Third Intervention||8
110929|NCT01014143|256948|P3|NOT COMPLETED|Washout After 2nd Intervention||0
110930|NCT01014143|256949|P2|NOT COMPLETED|Washout After 2nd Intervention||0
110931|NCT01014143|256950|P1|NOT COMPLETED|Washout After 2nd Intervention||0
110932|NCT01014143|256948|P3|COMPLETED|Washout After 2nd Intervention||9
110933|NCT01014143|256949|P2|COMPLETED|Washout After 2nd Intervention||9
110934|NCT01014143|256950|P1|COMPLETED|Washout After 2nd Intervention||8
110935|NCT01014143|256948|P3|STARTED|Washout After 2nd Intervention||9
110936|NCT01014143|256949|P2|STARTED|Washout After 2nd Intervention||9
110937|NCT01014143|256950|P1|STARTED|Washout After 2nd Intervention||8
110938|NCT01014143|256948|P3|NOT COMPLETED|Second Intervention||0
110939|NCT01014143|256949|P2|NOT COMPLETED|Second Intervention||0
110940|NCT01014143|256950|P1|NOT COMPLETED|Second Intervention||2
110941|NCT01014143|256948|P3|COMPLETED|Second Intervention||9
110942|NCT01014143|256949|P2|COMPLETED|Second Intervention||9
110943|NCT01014143|256950|P1|COMPLETED|Second Intervention||8
110944|NCT01014143|256948|P3|STARTED|Second Intervention||9
110945|NCT01014143|256949|P2|STARTED|Second Intervention||9
110946|NCT01014143|256950|P1|STARTED|Second Intervention||10
110947|NCT01014143|256948|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
110948|NCT01014143|256949|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
110949|NCT01014143|256950|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
110950|NCT01014143|256948|P3|COMPLETED|Washout Period After 1st Intervention||9
110951|NCT01014143|256949|P2|COMPLETED|Washout Period After 1st Intervention||9
110952|NCT01014143|256950|P1|COMPLETED|Washout Period After 1st Intervention||10
110953|NCT01014143|256948|P3|STARTED|Washout Period After 1st Intervention||9
110954|NCT01014143|256949|P2|STARTED|Washout Period After 1st Intervention||9
110955|NCT01014143|256950|P1|STARTED|Washout Period After 1st Intervention||10
110956|NCT01014143|256948|P3|NOT COMPLETED|First Intervention||0
110957|NCT01014143|256949|P2|NOT COMPLETED|First Intervention||0
110958|NCT01014143|256950|P1|NOT COMPLETED|First Intervention||0
110959|NCT01014143|256948|P3|COMPLETED|First Intervention||9
110960|NCT01014143|256949|P2|COMPLETED|First Intervention||9
110961|NCT01014143|256950|P1|COMPLETED|First Intervention||10
110962|NCT01014143|256948|P3|STARTED|First Intervention||9
110963|NCT01014143|256949|P2|STARTED|First Intervention||9
110964|NCT01014143|256950|P1|STARTED|First Intervention||10
110965|NCT01014013|256960|P2|NOT COMPLETED|Overall Study||56
110966|NCT01014013|256961|P1|NOT COMPLETED|Overall Study||51
110967|NCT01014013|256960|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
110968|NCT01014013|256961|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
110969|NCT01014013|256960|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
110970|NCT01014013|256961|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
110971|NCT01014013|256960|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
110972|NCT01014013|256961|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
110973|NCT01014013|256960|P2|STARTED|Overall Study||136
110974|NCT01014013|256961|P1|STARTED|Overall Study||135
110975|NCT01013961|256973|P2|NOT COMPLETED|Overall Study||3
110976|NCT01013961|256974|P1|NOT COMPLETED|Overall Study||3
110977|NCT01013961|256973|P2|COMPLETED|Overall Study||12
110978|NCT01013961|256974|P1|COMPLETED|Overall Study||13
110979|NCT01013961|256973|P2|STARTED|Overall Study||15
110980|NCT01013961|256974|P1|STARTED|Overall Study||16
110981|NCT01013883|256992|P2|NOT COMPLETED|Overall Study||2
110982|NCT01013883|256993|P1|NOT COMPLETED|Overall Study||2
110983|NCT01013883|256992|P2|COMPLETED|Overall Study||241
110984|NCT01013883|256993|P1|COMPLETED|Overall Study||268
110985|NCT01013883|256992|P2|STARTED|Overall Study||243
110986|NCT01013883|256993|P1|STARTED|Overall Study||270
110987|NCT01013870|257005|P2|NOT COMPLETED|Overall Study||3
110988|NCT01013870|257006|P1|NOT COMPLETED|Overall Study||1
110989|NCT01013870|257005|P2|COMPLETED|Overall Study||21
110990|NCT01013870|257006|P1|COMPLETED|Overall Study||27
110991|NCT01013870|257005|P2|STARTED|Overall Study||24
110992|NCT01013870|257006|P1|STARTED|Overall Study||28
110993|NCT01013844|257030|P2|NOT COMPLETED|Overall Study||0
110994|NCT01013844|257031|P1|NOT COMPLETED|Overall Study||0
110995|NCT01013844|257030|P2|COMPLETED|Overall Study||65
110996|NCT01013844|257031|P1|COMPLETED|Overall Study||65
110997|NCT01013844|257030|P2|STARTED|Overall Study||65
110998|NCT01013844|257031|P1|STARTED|Overall Study||65
110999|NCT01013792|257055|P2|NOT COMPLETED|Overall Study||5
111000|NCT01013792|257056|P1|NOT COMPLETED|Overall Study||2
111001|NCT01013792|257055|P2|COMPLETED|Overall Study||11
111002|NCT01013792|257056|P1|COMPLETED|Overall Study||12
111003|NCT01013792|257055|P2|STARTED|Overall Study||16
111004|NCT01013792|257056|P1|STARTED|Overall Study||14
111005|NCT01013753|257062|P1|NOT COMPLETED|Overall Study||16
111006|NCT01013753|257062|P1|COMPLETED|Overall Study||182
111007|NCT01013753|257062|P1|Received Form 12 mcg Bid|Overall Study||125
111008|NCT01013753|257062|P1|Received Olo 20 mcg qd|Overall Study||124
111009|NCT01013753|257062|P1|Received Olo 10 mcg qd|Overall Study||127
111010|NCT01013753|257062|P1|Received Olo 5 mcg qd|Overall Study||130
111011|NCT01013753|257062|P1|Received Olo 2 mcg qd|Overall Study||121
111012|NCT01013753|257062|P1|Received Placebo|Overall Study||125
111013|NCT01013753|257062|P1|STARTED|Overall Study|Entered and treated|198
111014|NCT01013740|257258|P2|NOT COMPLETED|Overall Study||53
111015|NCT01013740|257259|P1|NOT COMPLETED|Overall Study||25
111016|NCT01013740|257258|P2|COMPLETED|Overall Study|It is not known if par. withdrew during the RP or the CP. These par. completed the entire study.|22
111017|NCT01013740|257259|P1|COMPLETED|Overall Study|It is not known if par. withdrew during the RP or the CP. These par. completed the entire study.|12
111018|NCT01013740|257258|P2|Ongoing|Overall Study||45
111019|NCT01013740|257259|P1|Ongoing|Overall Study||24
111020|NCT01013740|257258|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
111021|NCT01013740|257259|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
111022|NCT01013597|257283|P1|NOT COMPLETED|Overall Study||1
111023|NCT01013597|257283|P1|COMPLETED|Overall Study||12
111024|NCT01013597|257283|P1|STARTED|Overall Study||13
111025|NCT01013207|257293|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
111026|NCT01013207|257293|P1|COMPLETED|CPAP Post Nexus (S9)||44
111027|NCT01013207|257293|P1|STARTED|CPAP Post Nexus (S9)||50
111028|NCT01013207|257293|P1|NOT COMPLETED|Nexus (S9)||0
111029|NCT01013207|257293|P1|COMPLETED|Nexus (S9)||50
111030|NCT01013207|257293|P1|STARTED|Nexus (S9)||50
111031|NCT01013207|257293|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
111032|NCT01013207|257293|P1|COMPLETED|CPAP Pre Nexus (S9)||50
111033|NCT01013207|257293|P1|STARTED|CPAP Pre Nexus (S9)||50
111034|NCT01013194|257300|P2|NOT COMPLETED|Overall Study||0
111035|NCT01013194|257301|P1|NOT COMPLETED|Overall Study||0
111036|NCT01013194|257300|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
111037|NCT01013194|257301|P1|COMPLETED|Overall Study|Consecutive patients|9
111038|NCT01013194|257300|P2|STARTED|Overall Study||16
111039|NCT01013194|257301|P1|STARTED|Overall Study||9
111040|NCT01012973|257313|P2|NOT COMPLETED|Overall Study||19
111041|NCT01012973|257314|P1|NOT COMPLETED|Overall Study||16
111042|NCT01012973|257313|P2|COMPLETED|Overall Study||52
111043|NCT01012973|257314|P1|COMPLETED|Overall Study||90
111044|NCT01012973|257313|P2|Completed Week 52, From FAS|Overall Study||52
111045|NCT01012973|257314|P1|Completed Week 52, From FAS|Overall Study||91
111046|NCT01012973|257313|P2|Completed Week 24, From FAS|Overall Study||57
111047|NCT01012973|257314|P1|Completed Week 24, From FAS|Overall Study||97
111048|NCT01012973|257313|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
111049|NCT01012973|257314|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
111050|NCT01012973|257313|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
111051|NCT01012973|257314|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
111052|NCT01012973|257313|P2|STARTED|Overall Study||71
111053|NCT01012973|257314|P1|STARTED|Overall Study||106
111054|NCT01012947|257339|P5|NOT COMPLETED|Overall Study||142
111055|NCT01012947|257340|P4|NOT COMPLETED|Overall Study||118
111056|NCT01012947|257341|P3|NOT COMPLETED|Overall Study||130
111057|NCT01012947|257342|P2|NOT COMPLETED|Overall Study||135
111058|NCT01012947|257343|P1|NOT COMPLETED|Overall Study||131
111059|NCT01012947|257339|P5|COMPLETED|Overall Study||94
111060|NCT01012947|257340|P4|COMPLETED|Overall Study||93
111061|NCT01012947|257341|P3|COMPLETED|Overall Study||111
111062|NCT01012947|257342|P2|COMPLETED|Overall Study||80
111063|NCT01012947|257343|P1|COMPLETED|Overall Study||81
111064|NCT01012947|257339|P5|STARTED|Overall Study||236
111065|NCT01012947|257340|P4|STARTED|Overall Study||211
111066|NCT01012947|257341|P3|STARTED|Overall Study||241
111067|NCT01012947|257342|P2|STARTED|Overall Study||215
111068|NCT01012947|257343|P1|STARTED|Overall Study||212
111069|NCT01012765|257355|P6|NOT COMPLETED|Treatment Period 3||0
111070|NCT01012765|257356|P5|NOT COMPLETED|Treatment Period 3||0
111071|NCT01012765|257357|P4|NOT COMPLETED|Treatment Period 3||0
111072|NCT01012765|257358|P3|NOT COMPLETED|Treatment Period 3||0
111073|NCT01012765|257359|P2|NOT COMPLETED|Treatment Period 3||0
111074|NCT01012765|257360|P1|NOT COMPLETED|Treatment Period 3||0
111075|NCT01012765|257355|P6|COMPLETED|Treatment Period 3||24
111076|NCT01012765|257356|P5|COMPLETED|Treatment Period 3||18
111077|NCT01012765|257357|P4|COMPLETED|Treatment Period 3||15
111078|NCT01012765|257358|P3|COMPLETED|Treatment Period 3||18
111079|NCT01012765|257359|P2|COMPLETED|Treatment Period 3||19
111080|NCT01012765|257360|P1|COMPLETED|Treatment Period 3||16
111081|NCT01012765|257355|P6|STARTED|Treatment Period 3||24
111082|NCT01012765|257356|P5|STARTED|Treatment Period 3||18
111083|NCT01012765|257357|P4|STARTED|Treatment Period 3||15
111084|NCT01012765|257358|P3|STARTED|Treatment Period 3||18
111085|NCT01012765|257359|P2|STARTED|Treatment Period 3||19
111086|NCT01012765|257360|P1|STARTED|Treatment Period 3||16
111087|NCT01012765|257355|P6|NOT COMPLETED|Treatment Period 2||1
111088|NCT01012765|257356|P5|NOT COMPLETED|Treatment Period 2||1
111089|NCT01012765|257357|P4|NOT COMPLETED|Treatment Period 2||0
111090|NCT01012765|257358|P3|NOT COMPLETED|Treatment Period 2||3
111091|NCT01012765|257359|P2|NOT COMPLETED|Treatment Period 2||2
111092|NCT01012765|257360|P1|NOT COMPLETED|Treatment Period 2||1
111093|NCT01012765|257355|P6|COMPLETED|Treatment Period 2||24
111094|NCT01012765|257356|P5|COMPLETED|Treatment Period 2||18
111095|NCT01012765|257357|P4|COMPLETED|Treatment Period 2||15
111096|NCT01012765|257358|P3|COMPLETED|Treatment Period 2||18
111097|NCT01012765|257359|P2|COMPLETED|Treatment Period 2||19
111098|NCT01012765|257360|P1|COMPLETED|Treatment Period 2||16
111099|NCT01012765|257355|P6|STARTED|Treatment Period 2||25
111100|NCT01012765|257356|P5|STARTED|Treatment Period 2||19
111101|NCT01012765|257357|P4|STARTED|Treatment Period 2||15
111102|NCT01012765|257358|P3|STARTED|Treatment Period 2||21
111103|NCT01012765|257359|P2|STARTED|Treatment Period 2||21
111104|NCT01012765|257360|P1|STARTED|Treatment Period 2||17
111105|NCT01012765|257355|P6|NOT COMPLETED|Treatment Period 1||0
111106|NCT01012765|257356|P5|NOT COMPLETED|Treatment Period 1||3
111107|NCT01012765|257357|P4|NOT COMPLETED|Treatment Period 1||3
111108|NCT01012765|257358|P3|NOT COMPLETED|Treatment Period 1||2
111109|NCT01012765|257359|P2|NOT COMPLETED|Treatment Period 1||0
111110|NCT01012765|257360|P1|NOT COMPLETED|Treatment Period 1||3
111111|NCT01012765|257355|P6|COMPLETED|Treatment Period 1||25
111112|NCT01012765|257356|P5|COMPLETED|Treatment Period 1||19
111113|NCT01012765|257357|P4|COMPLETED|Treatment Period 1||15
111114|NCT01012765|257358|P3|COMPLETED|Treatment Period 1||21
111115|NCT01012765|257359|P2|COMPLETED|Treatment Period 1||21
111116|NCT01012765|257360|P1|COMPLETED|Treatment Period 1||17
111117|NCT01012765|257355|P6|STARTED|Treatment Period 1||25
111118|NCT01012765|257356|P5|STARTED|Treatment Period 1||22
111119|NCT01012765|257357|P4|STARTED|Treatment Period 1||18
111120|NCT01012765|257358|P3|STARTED|Treatment Period 1||23
111121|NCT01012765|257359|P2|STARTED|Treatment Period 1||21
111122|NCT01012765|257360|P1|STARTED|Treatment Period 1||20
111123|NCT01012739|257389|P4|NOT COMPLETED|Treatment Period 4||0
111124|NCT01012739|257390|P3|NOT COMPLETED|Treatment Period 4||0
111125|NCT01012739|257391|P2|NOT COMPLETED|Treatment Period 4||0
111126|NCT01012739|257392|P1|NOT COMPLETED|Treatment Period 4||0
111127|NCT01012739|257389|P4|COMPLETED|Treatment Period 4||7
111128|NCT01012739|257390|P3|COMPLETED|Treatment Period 4||9
111129|NCT01012739|257391|P2|COMPLETED|Treatment Period 4||8
111130|NCT01012739|257392|P1|COMPLETED|Treatment Period 4||9
111131|NCT01012739|257389|P4|STARTED|Treatment Period 4||7
111132|NCT01012739|257390|P3|STARTED|Treatment Period 4||9
111133|NCT01012739|257391|P2|STARTED|Treatment Period 4||8
111134|NCT01012739|257392|P1|STARTED|Treatment Period 4||9
111135|NCT01012739|257389|P4|NOT COMPLETED|Treatment Period 3||0
111136|NCT01012739|257390|P3|NOT COMPLETED|Treatment Period 3||0
111137|NCT01012739|257391|P2|NOT COMPLETED|Treatment Period 3||0
111138|NCT01012739|257392|P1|NOT COMPLETED|Treatment Period 3||0
111139|NCT01012739|257389|P4|COMPLETED|Treatment Period 3||7
111140|NCT01012739|257390|P3|COMPLETED|Treatment Period 3||9
111141|NCT01012739|257391|P2|COMPLETED|Treatment Period 3||8
111142|NCT01012739|257392|P1|COMPLETED|Treatment Period 3||9
111143|NCT01012739|257389|P4|STARTED|Treatment Period 3||7
111144|NCT01012739|257390|P3|STARTED|Treatment Period 3||9
111145|NCT01012739|257391|P2|STARTED|Treatment Period 3||8
111146|NCT01012739|257392|P1|STARTED|Treatment Period 3||9
111147|NCT01012739|257389|P4|NOT COMPLETED|Treatment Period 2||1
111148|NCT01012739|257390|P3|NOT COMPLETED|Treatment Period 2||0
111149|NCT01012739|257391|P2|NOT COMPLETED|Treatment Period 2||0
111150|NCT01012739|257392|P1|NOT COMPLETED|Treatment Period 2||0
111151|NCT01012739|257389|P4|COMPLETED|Treatment Period 2||7
111152|NCT01012739|257390|P3|COMPLETED|Treatment Period 2||9
111153|NCT01012739|257391|P2|COMPLETED|Treatment Period 2||8
111154|NCT01012739|257392|P1|COMPLETED|Treatment Period 2||9
111155|NCT01012739|257389|P4|STARTED|Treatment Period 2||8
111156|NCT01012739|257390|P3|STARTED|Treatment Period 2||9
111157|NCT01012739|257391|P2|STARTED|Treatment Period 2||8
111158|NCT01012739|257392|P1|STARTED|Treatment Period 2||9
111159|NCT01012739|257389|P4|NOT COMPLETED|Treatment Period 1||1
111160|NCT01012739|257390|P3|NOT COMPLETED|Treatment Period 1||0
111161|NCT01012739|257391|P2|NOT COMPLETED|Treatment Period 1||0
111162|NCT01012739|257392|P1|NOT COMPLETED|Treatment Period 1||0
111163|NCT01012739|257389|P4|COMPLETED|Treatment Period 1||8
111164|NCT01012739|257390|P3|COMPLETED|Treatment Period 1||9
111165|NCT01012739|257391|P2|COMPLETED|Treatment Period 1||8
111166|NCT01012739|257392|P1|COMPLETED|Treatment Period 1||9
111167|NCT01012739|257389|P4|STARTED|Treatment Period 1||9
111168|NCT01012739|257390|P3|STARTED|Treatment Period 1||9
111169|NCT01012739|257391|P2|STARTED|Treatment Period 1||8
111170|NCT01012739|257392|P1|STARTED|Treatment Period 1||9
111171|NCT01012713|257420|P1|NOT COMPLETED|Overall Study||3
111172|NCT01012713|257420|P1|COMPLETED|Overall Study||27
111173|NCT01012713|257420|P1|STARTED|Overall Study||30
111174|NCT01012674|257426|P1|NOT COMPLETED|Overall Study||24
111175|NCT01012674|257426|P1|COMPLETED|Overall Study||187
111176|NCT01012674|257426|P1|STARTED|Overall Study||211
111177|NCT01012661|257438|P1|NOT COMPLETED|Overall Study||0
111178|NCT01012661|257438|P1|COMPLETED|Overall Study||50
111179|NCT01012661|257438|P1|STARTED|Overall Study||50
111180|NCT01012622|257446|P1|NOT COMPLETED|Overall Study||31
111181|NCT01012622|257446|P1|COMPLETED|Overall Study||111
111182|NCT01012622|257446|P1|STARTED|Overall Study||142
111183|NCT01012440|257465|P1|NOT COMPLETED|Overall Study||2
111184|NCT01012440|257465|P1|COMPLETED|Overall Study||3
111185|NCT01012440|257465|P1|STARTED|Overall Study||5
111186|NCT01012414|257469|P1|NOT COMPLETED|Overall Study||10
111187|NCT01012414|257469|P1|COMPLETED|Overall Study|No subjects completed the study.|0
111188|NCT01012414|257469|P1|STARTED|Overall Study||10
111189|NCT01012388|257476|P1|NOT COMPLETED|Overall Study||0
111190|NCT01012388|257476|P1|COMPLETED|Overall Study||100
111191|NCT01012388|257476|P1|STARTED|Overall Study||100
111192|NCT01012336|257481|P1|NOT COMPLETED|Overall Study||0
111193|NCT01012336|257481|P1|COMPLETED|Overall Study||85
111194|NCT01012336|257481|P1|STARTED|Overall Study||85
111195|NCT01012258|257485|P1|NOT COMPLETED|Overall Study||66
111196|NCT01012258|257485|P1|COMPLETED|Overall Study||0
111197|NCT01012258|257485|P1|STARTED|Overall Study||66
111198|NCT01012245|257495|P1|NOT COMPLETED|Overall Study||2427
111199|NCT01012245|257495|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
111200|NCT01012245|257495|P1|STARTED|Overall Study||28812
111201|NCT01012219|257532|P1|NOT COMPLETED|Period 3||0
111202|NCT01012219|257532|P1|COMPLETED|Period 3||20
111203|NCT01012219|257532|P1|STARTED|Period 3|of the 36 who started Period 1|20
111204|NCT01012219|257532|P1|NOT COMPLETED|Period 2||1
111205|NCT01012219|257532|P1|COMPLETED|Period 2||34
111206|NCT01012219|257532|P1|STARTED|Period 2|Number who completed Period 1|35
111207|NCT01012219|257532|P1|NOT COMPLETED|Period 1||1
111208|NCT01012219|257532|P1|COMPLETED|Period 1||35
111209|NCT01012219|257532|P1|STARTED|Period 1|Number randomized|36
111210|NCT01012037|257542|P3|NOT COMPLETED|Overall Study||10
111211|NCT01012037|257543|P2|NOT COMPLETED|Overall Study||16
111212|NCT01012037|257544|P1|NOT COMPLETED|Overall Study||1
111213|NCT01012037|257542|P3|COMPLETED|Overall Study||214
111214|NCT01012037|257543|P2|COMPLETED|Overall Study||207
111215|NCT01012037|257544|P1|COMPLETED|Overall Study||43
111216|NCT01012037|257542|P3|STARTED|Overall Study||224
111217|NCT01012037|257543|P2|STARTED|Overall Study||223
111218|NCT01012037|257544|P1|STARTED|Overall Study||44
111219|NCT01011946|257579|P1|NOT COMPLETED|Overall Study||3
111220|NCT01011946|257579|P1|COMPLETED|Overall Study||33
111221|NCT01011946|257579|P1|STARTED|Overall Study||36
111222|NCT01011933|257583|P1|NOT COMPLETED|Overall Study||4
111223|NCT01011933|257583|P1|COMPLETED|Overall Study|total eligible and evaluable|50
111224|NCT01011933|257583|P1|STARTED|Overall Study|total enrolled|54
111225|NCT01011907|257592|P2|NOT COMPLETED|Overall Study||15
111226|NCT01011907|257593|P1|NOT COMPLETED|Overall Study||14
111227|NCT01011907|257592|P2|COMPLETED|Overall Study||18
111228|NCT01011907|257593|P1|COMPLETED|Overall Study||17
111229|NCT01011907|257592|P2|STARTED|Overall Study||33
111230|NCT01011907|257593|P1|STARTED|Overall Study||31
111231|NCT01011868|257606|P3|NOT COMPLETED|After Week 78 Follow-up||44
111232|NCT01011868|257607|P2|NOT COMPLETED|After Week 78 Follow-up||38
111233|NCT01011868|257608|P1|NOT COMPLETED|After Week 78 Follow-up||52
111234|NCT01011868|257606|P3|COMPLETED|After Week 78 Follow-up||111
111235|NCT01011868|257607|P2|COMPLETED|After Week 78 Follow-up||131
111236|NCT01011868|257608|P1|COMPLETED|After Week 78 Follow-up||118
111237|NCT01011868|257606|P3|STARTED|After Week 78 Follow-up||155
111238|NCT01011868|257607|P2|STARTED|After Week 78 Follow-up||169
111239|NCT01011868|257608|P1|STARTED|After Week 78 Follow-up||170
111240|NCT01011868|257606|P3|NOT COMPLETED|After Week 18 Follow-up||26
111241|NCT01011868|257607|P2|NOT COMPLETED|After Week 18 Follow-up||16
111242|NCT01011868|257608|P1|NOT COMPLETED|After Week 18 Follow-up||23
111243|NCT01011868|257606|P3|COMPLETED|After Week 18 Follow-up||129
111244|NCT01011868|257607|P2|COMPLETED|After Week 18 Follow-up||153
111245|NCT01011868|257608|P1|COMPLETED|After Week 18 Follow-up||147
111246|NCT01011868|257606|P3|STARTED|After Week 18 Follow-up||155
111247|NCT01011868|257607|P2|STARTED|After Week 18 Follow-up||169
111248|NCT01011868|257608|P1|STARTED|After Week 18 Follow-up||170
111249|NCT01011829|257645|P2|NOT COMPLETED|Overall Study||9
111250|NCT01011829|257646|P1|NOT COMPLETED|Overall Study||4
111251|NCT01011829|257645|P2|COMPLETED|Overall Study||1
111252|NCT01011829|257646|P1|COMPLETED|Overall Study||6
111253|NCT01011829|257645|P2|STARTED|Overall Study||10
111254|NCT01011829|257646|P1|STARTED|Overall Study||10
111255|NCT01011816|257656|P2|NOT COMPLETED|78-Week Extended Follow-up||28
111256|NCT01011816|257657|P1|NOT COMPLETED|78-Week Extended Follow-up||72
111257|NCT01011816|257656|P2|COMPLETED|78-Week Extended Follow-up||26
111258|NCT01011816|257657|P1|COMPLETED|78-Week Extended Follow-up||85
111259|NCT01011816|257656|P2|STARTED|78-Week Extended Follow-up||54
111260|NCT01011816|257657|P1|STARTED|78-Week Extended Follow-up||157
111261|NCT01011816|257656|P2|NOT COMPLETED|26-Week Primary Endpoint||2
111262|NCT01011816|257657|P1|NOT COMPLETED|26-Week Primary Endpoint||7
111263|NCT01011816|257656|P2|COMPLETED|26-Week Primary Endpoint||54
111264|NCT01011816|257657|P1|COMPLETED|26-Week Primary Endpoint||157
111265|NCT01011816|257656|P2|STARTED|26-Week Primary Endpoint||56
111266|NCT01011816|257657|P1|STARTED|26-Week Primary Endpoint||164
111267|NCT01011738|257670|P3|NOT COMPLETED|Overall Study||17
111268|NCT01011738|257671|P2|NOT COMPLETED|Overall Study||294
111269|NCT01011738|257672|P1|NOT COMPLETED|Overall Study||324
111270|NCT01011738|257670|P3|COMPLETED|Overall Study||36
111271|NCT01011738|257671|P2|COMPLETED|Overall Study||618
111272|NCT01011738|257672|P1|COMPLETED|Overall Study||553
111273|NCT01011738|257670|P3|STARTED|Overall Study||53
111274|NCT01011738|257671|P2|STARTED|Overall Study||912
111275|NCT01011738|257672|P1|STARTED|Overall Study||877
111276|NCT01011673|257712|P2|NOT COMPLETED|24 Hour Follow-up||3
111277|NCT01011673|257713|P1|NOT COMPLETED|24 Hour Follow-up||3
111278|NCT01011673|257712|P2|COMPLETED|24 Hour Follow-up||57
111279|NCT01011673|257713|P1|COMPLETED|24 Hour Follow-up||57
111280|NCT01011673|257712|P2|STARTED|24 Hour Follow-up||60
111281|NCT01011673|257713|P1|STARTED|24 Hour Follow-up||60
111282|NCT01011673|257712|P2|NOT COMPLETED|Emergency Department Portion||0
111283|NCT01011673|257713|P1|NOT COMPLETED|Emergency Department Portion||0
111284|NCT01011673|257712|P2|COMPLETED|Emergency Department Portion||60
111285|NCT01011673|257713|P1|COMPLETED|Emergency Department Portion||60
111286|NCT01011673|257712|P2|STARTED|Emergency Department Portion||60
111287|NCT01011673|257713|P1|STARTED|Emergency Department Portion||60
111288|NCT01011673|257712|P2|NOT COMPLETED|Randomized||1
111289|NCT01011673|257713|P1|NOT COMPLETED|Randomized||2
111290|NCT01011673|257712|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
111291|NCT01011673|257713|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
111292|NCT01011673|257712|P2|STARTED|Randomized||61
111293|NCT01011673|257713|P1|STARTED|Randomized||62
111294|NCT01011634|257723|P2|NOT COMPLETED|Overall Study||1
111295|NCT01011634|257724|P1|NOT COMPLETED|Overall Study||0
111296|NCT01011634|257723|P2|COMPLETED|Overall Study||8
111297|NCT01011634|257724|P1|COMPLETED|Overall Study||9
111298|NCT01011634|257723|P2|STARTED|Overall Study||9
111299|NCT01011634|257724|P1|STARTED|Overall Study||9
111300|NCT01011556|257736|P4|NOT COMPLETED|Overall Study||13
111301|NCT01011556|257737|P3|NOT COMPLETED|Overall Study||10
111302|NCT01011556|257738|P2|NOT COMPLETED|Overall Study||8
111303|NCT01011556|257739|P1|NOT COMPLETED|Overall Study||6
111304|NCT01011556|257736|P4|COMPLETED|Overall Study||51
111305|NCT01011556|257737|P3|COMPLETED|Overall Study||45
111306|NCT01011556|257738|P2|COMPLETED|Overall Study||48
111307|NCT01011556|257739|P1|COMPLETED|Overall Study||52
111308|NCT01011556|257736|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
111309|NCT01011556|257737|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
111310|NCT01011556|257738|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
111311|NCT01011556|257739|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
111312|NCT01011556|257736|P4|STARTED|Overall Study||64
111313|NCT01011556|257737|P3|STARTED|Overall Study||55
111314|NCT01011556|257738|P2|STARTED|Overall Study||56
111315|NCT01011556|257739|P1|STARTED|Overall Study||58
111316|NCT01011465|257817|P8|NOT COMPLETED|Overall Study||0
111317|NCT01011465|257818|P7|NOT COMPLETED|Overall Study||1
111318|NCT01011465|257819|P6|NOT COMPLETED|Overall Study||0
111319|NCT01011465|257820|P5|NOT COMPLETED|Overall Study||1
111320|NCT01011465|257821|P4|NOT COMPLETED|Overall Study||0
111321|NCT01011465|257822|P3|NOT COMPLETED|Overall Study||0
111322|NCT01011465|257823|P2|NOT COMPLETED|Overall Study||1
111323|NCT01011465|257824|P1|NOT COMPLETED|Overall Study||2
111324|NCT01011465|257817|P8|COMPLETED|Overall Study||32
111325|NCT01011465|257818|P7|COMPLETED|Overall Study||51
111326|NCT01011465|257819|P6|COMPLETED|Overall Study||29
111327|NCT01011465|257820|P5|COMPLETED|Overall Study||46
111328|NCT01011465|257821|P4|COMPLETED|Overall Study||18
111329|NCT01011465|257822|P3|COMPLETED|Overall Study||36
111330|NCT01011465|257823|P2|COMPLETED|Overall Study||19
111331|NCT01011465|257824|P1|COMPLETED|Overall Study||34
111332|NCT01011465|257817|P8|STARTED|Overall Study||32
111333|NCT01011465|257818|P7|STARTED|Overall Study||52
111334|NCT01011465|257819|P6|STARTED|Overall Study||29
111335|NCT01011465|257820|P5|STARTED|Overall Study||47
111336|NCT01011465|257821|P4|STARTED|Overall Study||18
111337|NCT01011465|257822|P3|STARTED|Overall Study||36
111338|NCT01011465|257823|P2|STARTED|Overall Study||20
111339|NCT01011465|257824|P1|STARTED|Overall Study||36
111340|NCT01011387|257852|P1|NOT COMPLETED|Overall Study||6
111341|NCT01011387|257852|P1|COMPLETED|Overall Study||10
111342|NCT01011387|257852|P1|STARTED|Overall Study||16
111343|NCT01011309|257859|P3|NOT COMPLETED|Overall Study||5
111344|NCT01011309|257860|P2|NOT COMPLETED|Overall Study||3
111345|NCT01011309|257861|P1|NOT COMPLETED|Overall Study||2
111346|NCT01011309|257859|P3|COMPLETED|Overall Study||16
111347|NCT01011309|257860|P2|COMPLETED|Overall Study||7
111348|NCT01011309|257861|P1|COMPLETED|Overall Study||12
111349|NCT01011309|257859|P3|STARTED|Overall Study||21
111350|NCT01011309|257860|P2|STARTED|Overall Study||10
111351|NCT01011309|257861|P1|STARTED|Overall Study||14
111352|NCT01011283|257877|P2|NOT COMPLETED|Overall Study||11
111353|NCT01011283|257878|P1|NOT COMPLETED|Overall Study||11
111354|NCT01011283|257877|P2|COMPLETED|Overall Study||2
111355|NCT01011283|257878|P1|COMPLETED|Overall Study||2
111356|NCT01011283|257877|P2|STARTED|Overall Study||13
111357|NCT01011283|257878|P1|STARTED|Overall Study||13
111358|NCT01011179|257888|P2|NOT COMPLETED|Overall Study||2
111359|NCT01011179|257889|P1|NOT COMPLETED|Overall Study||4
111360|NCT01011179|257888|P2|COMPLETED|Overall Study||20
111361|NCT01011179|257889|P1|COMPLETED|Overall Study||20
111362|NCT01011179|257888|P2|STARTED|Overall Study||22
111363|NCT01011179|257889|P1|STARTED|Overall Study||24
111364|NCT01011153|257898|P3|NOT COMPLETED|Overall Study||9
111365|NCT01011153|257899|P2|NOT COMPLETED|Overall Study||11
111366|NCT01011153|257900|P1|NOT COMPLETED|Overall Study||8
111367|NCT01011153|257898|P3|COMPLETED|Overall Study||45
111368|NCT01011153|257899|P2|COMPLETED|Overall Study||64
111369|NCT01011153|257900|P1|COMPLETED|Overall Study||46
111370|NCT01011153|257898|P3|STARTED|Overall Study||54
111371|NCT01011153|257899|P2|STARTED|Overall Study||75
111372|NCT01011153|257900|P1|STARTED|Overall Study||54
111373|NCT01011075|257918|P1|NOT COMPLETED|Overall Study||0
111374|NCT01011075|257918|P1|COMPLETED|Overall Study||34
111375|NCT01011075|257918|P1|STARTED|Overall Study||34
111376|NCT01011049|257929|P4|NOT COMPLETED|Overall Study||0
111377|NCT01011049|257930|P3|NOT COMPLETED|Overall Study||4
111378|NCT01011049|257931|P2|NOT COMPLETED|Overall Study||2
111379|NCT01011049|257932|P1|NOT COMPLETED|Overall Study||1
111380|NCT01011049|257929|P4|COMPLETED|Overall Study||246
111381|NCT01011049|257930|P3|COMPLETED|Overall Study||239
111382|NCT01011049|257931|P2|COMPLETED|Overall Study||250
111383|NCT01011049|257932|P1|COMPLETED|Overall Study||506
111384|NCT01011049|257929|P4|STARTED|Overall Study||246
111385|NCT01011049|257930|P3|STARTED|Overall Study||243
111386|NCT01011049|257931|P2|STARTED|Overall Study||252
111387|NCT01011049|257932|P1|STARTED|Overall Study||507
111388|NCT01010971|257957|P3|NOT COMPLETED|Overall Study||13
111389|NCT01010971|257958|P2|NOT COMPLETED|Overall Study||8
111390|NCT01010971|257959|P1|NOT COMPLETED|Overall Study||3
111391|NCT01010971|257957|P3|COMPLETED|Overall Study||207
111392|NCT01010971|257958|P2|COMPLETED|Overall Study||218
111393|NCT01010971|257959|P1|COMPLETED|Overall Study||222
111394|NCT01010971|257957|P3|STARTED|Overall Study||220
111395|NCT01010971|257958|P2|STARTED|Overall Study||226
111396|NCT01010971|257959|P1|STARTED|Overall Study||225
111397|NCT01010932|258044|P1|NOT COMPLETED|Overall Study||22
111398|NCT01010932|258044|P1|COMPLETED|Overall Study||200
111399|NCT01010932|258044|P1|STARTED|Overall Study||222
111400|NCT01010906|258062|P6|NOT COMPLETED|Overall Study||0
111401|NCT01010906|258063|P5|NOT COMPLETED|Overall Study||0
111402|NCT01010906|258064|P4|NOT COMPLETED|Overall Study||0
111403|NCT01010906|258065|P3|NOT COMPLETED|Overall Study||0
111404|NCT01010906|258066|P2|NOT COMPLETED|Overall Study||0
111405|NCT01010906|258067|P1|NOT COMPLETED|Overall Study||0
111406|NCT01010906|258062|P6|COMPLETED|Overall Study||10
111407|NCT01010906|258063|P5|COMPLETED|Overall Study||10
111408|NCT01010906|258064|P4|COMPLETED|Overall Study||10
111409|NCT01010906|258065|P3|COMPLETED|Overall Study||10
111410|NCT01010906|258066|P2|COMPLETED|Overall Study||10
111411|NCT01010906|258067|P1|COMPLETED|Overall Study||10
111412|NCT01010906|258062|P6|STARTED|Overall Study||10
111413|NCT01010906|258063|P5|STARTED|Overall Study||10
111414|NCT01010906|258064|P4|STARTED|Overall Study||10
111415|NCT01010906|258065|P3|STARTED|Overall Study||10
111416|NCT01010906|258066|P2|STARTED|Overall Study||10
111417|NCT01010906|258067|P1|STARTED|Overall Study||10
111418|NCT01010776|258087|P1|NOT COMPLETED|Extension Phase||3
111419|NCT01010776|258087|P1|COMPLETED|Extension Phase||156
111420|NCT01010776|258087|P1|STARTED|Extension Phase||159
111421|NCT01010776|258087|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
111422|NCT01010776|258087|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
111423|NCT01010776|258087|P1|STARTED|In-Between Main Phase & Extension Phase||174
111424|NCT01010776|258087|P1|NOT COMPLETED|Main Phase||49
111425|NCT01010776|258087|P1|COMPLETED|Main Phase||174
111426|NCT01010776|258087|P1|Treated|Main Phase||218
111427|NCT01010776|258087|P1|STARTED|Main Phase||223
111428|NCT01010750|258115|P6|NOT COMPLETED|Third Intervention||0
111429|NCT01010750|258116|P5|NOT COMPLETED|Third Intervention||0
111430|NCT01010750|258117|P4|NOT COMPLETED|Third Intervention||0
111431|NCT01010750|258118|P3|NOT COMPLETED|Third Intervention||0
111432|NCT01010750|258119|P2|NOT COMPLETED|Third Intervention||0
111433|NCT01010750|258120|P1|NOT COMPLETED|Third Intervention||0
111434|NCT01010750|258115|P6|COMPLETED|Third Intervention||3
111435|NCT01010750|258116|P5|COMPLETED|Third Intervention||2
111436|NCT01010750|258117|P4|COMPLETED|Third Intervention||3
111437|NCT01010750|258118|P3|COMPLETED|Third Intervention||3
111438|NCT01010750|258119|P2|COMPLETED|Third Intervention||3
111439|NCT01010750|258120|P1|COMPLETED|Third Intervention||3
111440|NCT01010750|258115|P6|STARTED|Third Intervention||3
111441|NCT01010750|258116|P5|STARTED|Third Intervention||2
111442|NCT01010750|258117|P4|STARTED|Third Intervention||3
111443|NCT01010750|258118|P3|STARTED|Third Intervention||3
111444|NCT01010750|258119|P2|STARTED|Third Intervention||3
111445|NCT01010750|258120|P1|STARTED|Third Intervention||3
111446|NCT01010750|258115|P6|NOT COMPLETED|Second Intervention||0
111447|NCT01010750|258116|P5|NOT COMPLETED|Second Intervention||0
111448|NCT01010750|258117|P4|NOT COMPLETED|Second Intervention||0
111449|NCT01010750|258118|P3|NOT COMPLETED|Second Intervention||0
111450|NCT01010750|258119|P2|NOT COMPLETED|Second Intervention||1
111451|NCT01010750|258120|P1|NOT COMPLETED|Second Intervention||0
111452|NCT01010750|258115|P6|COMPLETED|Second Intervention||3
111453|NCT01010750|258116|P5|COMPLETED|Second Intervention||2
111454|NCT01010750|258117|P4|COMPLETED|Second Intervention||3
111455|NCT01010750|258118|P3|COMPLETED|Second Intervention||3
111456|NCT01010750|258119|P2|COMPLETED|Second Intervention||3
111457|NCT01010750|258120|P1|COMPLETED|Second Intervention||3
111458|NCT01010750|258115|P6|STARTED|Second Intervention||3
111459|NCT01010750|258116|P5|STARTED|Second Intervention||2
111460|NCT01010750|258117|P4|STARTED|Second Intervention||3
111461|NCT01010750|258118|P3|STARTED|Second Intervention||3
111462|NCT01010750|258119|P2|STARTED|Second Intervention||4
111463|NCT01010750|258120|P1|STARTED|Second Intervention||3
111464|NCT01010750|258115|P6|NOT COMPLETED|First Intervention||0
111465|NCT01010750|258116|P5|NOT COMPLETED|First Intervention||0
111466|NCT01010750|258117|P4|NOT COMPLETED|First Intervention||0
111467|NCT01010750|258118|P3|NOT COMPLETED|First Intervention||0
111468|NCT01010750|258119|P2|NOT COMPLETED|First Intervention||0
111469|NCT01010750|258120|P1|NOT COMPLETED|First Intervention||0
111470|NCT01010750|258115|P6|COMPLETED|First Intervention||3
111471|NCT01010750|258116|P5|COMPLETED|First Intervention||2
111472|NCT01010750|258117|P4|COMPLETED|First Intervention||3
111473|NCT01010750|258118|P3|COMPLETED|First Intervention||3
111474|NCT01010750|258119|P2|COMPLETED|First Intervention||4
111475|NCT01010750|258120|P1|COMPLETED|First Intervention||3
111476|NCT01010750|258115|P6|STARTED|First Intervention||3
111477|NCT01010750|258116|P5|STARTED|First Intervention||2
111478|NCT01010750|258117|P4|STARTED|First Intervention||3
111479|NCT01010750|258118|P3|STARTED|First Intervention||3
111480|NCT01010750|258119|P2|STARTED|First Intervention||4
111481|NCT01010750|258120|P1|STARTED|First Intervention||3
111482|NCT01010633|258145|P2|NOT COMPLETED|Overall Study||5
111483|NCT01010633|258146|P1|NOT COMPLETED|Overall Study||4
111484|NCT01010633|258145|P2|COMPLETED|Overall Study||198
111485|NCT01010633|258146|P1|COMPLETED|Overall Study||199
111486|NCT01010633|258145|P2|STARTED|Overall Study||203
111487|NCT01010633|258146|P1|STARTED|Overall Study||203
111488|NCT01010568|258156|P1|NOT COMPLETED|Overall Study||5
111489|NCT01010568|258156|P1|COMPLETED|Overall Study||5
111490|NCT01010568|258156|P1|STARTED|Overall Study||10
111491|NCT01010555|258162|P2|NOT COMPLETED|Second Four Weeks of Wear||0
111492|NCT01010555|258163|P1|NOT COMPLETED|Second Four Weeks of Wear||0
111493|NCT01010555|258162|P2|COMPLETED|Second Four Weeks of Wear||9
111494|NCT01010555|258163|P1|COMPLETED|Second Four Weeks of Wear||10
111495|NCT01010555|258162|P2|STARTED|Second Four Weeks of Wear||9
111496|NCT01010555|258163|P1|STARTED|Second Four Weeks of Wear||10
111497|NCT01010555|258162|P2|NOT COMPLETED|First Four Weeks of Wear||0
111498|NCT01010555|258163|P1|NOT COMPLETED|First Four Weeks of Wear||0
111499|NCT01010555|258162|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
111500|NCT01010555|258163|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
111501|NCT01010555|258162|P2|STARTED|First Four Weeks of Wear||10
111502|NCT01010555|258163|P1|STARTED|First Four Weeks of Wear||11
111503|NCT01010503|258173|P1|NOT COMPLETED|Overall Study||2
111504|NCT01010503|258173|P1|COMPLETED|Overall Study||30
111505|NCT01010503|258173|P1|STARTED|Overall Study||32
111506|NCT01010477|258193|P2|NOT COMPLETED|Overall Study||3
111507|NCT01010477|258194|P1|NOT COMPLETED|Overall Study||6
111508|NCT01010477|258193|P2|COMPLETED|Overall Study||22
111509|NCT01010477|258194|P1|COMPLETED|Overall Study||21
111510|NCT01010477|258193|P2|STARTED|Overall Study||25
111511|NCT01010477|258194|P1|STARTED|Overall Study||27
111512|NCT01010399|258200|P1|NOT COMPLETED|Overall Study||5
111513|NCT01010399|258200|P1|COMPLETED|Overall Study||31
111514|NCT01010399|258200|P1|STARTED|Overall Study||36
111515|NCT01010282|258208|P3|NOT COMPLETED|Overall Study||19
111516|NCT01010282|258209|P2|NOT COMPLETED|Overall Study||7
111517|NCT01010282|258210|P1|NOT COMPLETED|Overall Study||6
111518|NCT01010282|258208|P3|COMPLETED|Overall Study||77
111519|NCT01010282|258209|P2|COMPLETED|Overall Study||88
111520|NCT01010282|258210|P1|COMPLETED|Overall Study||91
111521|NCT01010282|258208|P3|STARTED|Overall Study||96
111522|NCT01010282|258209|P2|STARTED|Overall Study||95
111523|NCT01010282|258210|P1|STARTED|Overall Study||97
111524|NCT01010230|258232|P2|NOT COMPLETED|Overall Study||7
111525|NCT01010230|258233|P1|NOT COMPLETED|Overall Study||10
111526|NCT01010230|258232|P2|COMPLETED|Overall Study||26
111527|NCT01010230|258233|P1|COMPLETED|Overall Study||22
111528|NCT01010230|258232|P2|STARTED|Overall Study||33
111529|NCT01010230|258233|P1|STARTED|Overall Study||32
111530|NCT01010204|258265|P2|NOT COMPLETED|Overall Study||9
111531|NCT01010204|258266|P1|NOT COMPLETED|Overall Study||7
111532|NCT01010204|258265|P2|COMPLETED|Overall Study||20
111533|NCT01010204|258266|P1|COMPLETED|Overall Study||24
111534|NCT01010204|258265|P2|STARTED|Overall Study||29
111535|NCT01010204|258266|P1|STARTED|Overall Study||31
111536|NCT01010061|258276|P2|NOT COMPLETED|Overall Study||95
111537|NCT01010061|258277|P1|NOT COMPLETED|Overall Study||133
111538|NCT01010061|258276|P2|COMPLETED|Overall Study||23
111539|NCT01010061|258277|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
111540|NCT01010061|258276|P2|Received Study Drug|Overall Study||116
111541|NCT01010061|258277|P1|Received Study Drug|Overall Study||236
111542|NCT01010061|258276|P2|STARTED|Overall Study||118
111543|NCT01010061|258277|P1|STARTED|Overall Study||238
111544|NCT01010009|258311|P3|NOT COMPLETED|Overall Study||0
111545|NCT01010009|258312|P2|NOT COMPLETED|Overall Study||0
111546|NCT01010009|258313|P1|NOT COMPLETED|Overall Study||0
111547|NCT01010009|258311|P3|COMPLETED|Overall Study||8
111548|NCT01010009|258312|P2|COMPLETED|Overall Study||8
111549|NCT01010009|258313|P1|COMPLETED|Overall Study||8
111550|NCT01010009|258311|P3|STARTED|Overall Study||8
111551|NCT01010009|258312|P2|STARTED|Overall Study||8
111552|NCT01010009|258313|P1|STARTED|Overall Study||8
111553|NCT01009983|258327|P1|NOT COMPLETED|Overall Study||1
111554|NCT01009983|258327|P1|COMPLETED|Overall Study||13
111555|NCT01009983|258327|P1|STARTED|Overall Study||14
111556|NCT01009931|258331|P1|NOT COMPLETED|Overall Study||1
111557|NCT01009931|258331|P1|COMPLETED|Overall Study||0
111558|NCT01009931|258331|P1|STARTED|Overall Study||1
111559|NCT01009840|258337|P1|NOT COMPLETED|Overall Study||14
111560|NCT01009840|258337|P1|COMPLETED|Overall Study||16
111561|NCT01009840|258337|P1|STARTED|Overall Study||30
111562|NCT01009762|258352|P2|NOT COMPLETED|Overall Study||0
111563|NCT01009762|258353|P1|NOT COMPLETED|Overall Study||0
111564|NCT01009762|258352|P2|COMPLETED|Overall Study|10 participants received vaccine|10
111565|NCT01009762|258353|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
111566|NCT01009762|258352|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
111567|NCT01009762|258353|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
111568|NCT01009762|258352|P2|STARTED|Overall Study||10
111569|NCT01009762|258353|P1|STARTED|Overall Study||1
111570|NCT01009645|258367|P4|NOT COMPLETED|Overall Study||5
111571|NCT01009645|258368|P3|NOT COMPLETED|Overall Study||4
111572|NCT01009645|258369|P2|NOT COMPLETED|Overall Study||8
111573|NCT01009645|258370|P1|NOT COMPLETED|Overall Study||2
111574|NCT01009645|258367|P4|COMPLETED|Overall Study||26
111575|NCT01009645|258368|P3|COMPLETED|Overall Study||28
111576|NCT01009645|258369|P2|COMPLETED|Overall Study||23
111577|NCT01009645|258370|P1|COMPLETED|Overall Study||29
111578|NCT01009645|258367|P4|STARTED|Overall Study||31
111579|NCT01009645|258368|P3|STARTED|Overall Study||32
111580|NCT01009645|258369|P2|STARTED|Overall Study||31
111581|NCT01009645|258370|P1|STARTED|Overall Study||31
111582|NCT01009619|258386|P2|NOT COMPLETED|Overall Study||0
111583|NCT01009619|258387|P1|NOT COMPLETED|Overall Study||0
111584|NCT01009619|258386|P2|COMPLETED|Overall Study||43
111585|NCT01009619|258387|P1|COMPLETED|Overall Study||40
111586|NCT01009619|258386|P2|STARTED|Overall Study||43
111587|NCT01009619|258387|P1|STARTED|Overall Study||40
111588|NCT01009580|258407|P2|NOT COMPLETED|Overall Study||35
111589|NCT01009580|258408|P1|NOT COMPLETED|Overall Study||27
111590|NCT01009580|258407|P2|COMPLETED|Overall Study||188
111591|NCT01009580|258408|P1|COMPLETED|Overall Study||197
111592|NCT01009580|258407|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
111593|NCT01009580|258408|P1|Exposed|Overall Study||224
111594|NCT01009580|258407|P2|STARTED|Overall Study||223
111595|NCT01009580|258408|P1|STARTED|Overall Study||224
111596|NCT01009554|258422|P2|NOT COMPLETED|Overall Study||7
111597|NCT01009554|258423|P1|NOT COMPLETED|Overall Study||2
111598|NCT01009554|258422|P2|COMPLETED|Overall Study||41
111599|NCT01009554|258423|P1|COMPLETED|Overall Study||46
111600|NCT01009554|258422|P2|STARTED|Overall Study||48
111601|NCT01009554|258423|P1|STARTED|Overall Study||48
111602|NCT01009515|258555|P1|NOT COMPLETED|Overall Study||3
111603|NCT01009515|258555|P1|COMPLETED|Overall Study||16
111604|NCT01009515|258555|P1|STARTED|Overall Study||19
111605|NCT01009463|258566|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
111606|NCT01009463|258567|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
111607|NCT01009463|258568|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
111608|NCT01009463|258569|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
111609|NCT01009463|258570|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
111610|NCT01009463|258566|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
111611|NCT01009463|258567|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
111612|NCT01009463|258568|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
111613|NCT01009463|258569|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
111614|NCT01009463|258570|P1|COMPLETED|52-week, Double-blind Treatment Period||0
111615|NCT01009463|258566|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
111616|NCT01009463|258567|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
111617|NCT01009463|258568|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
111618|NCT01009463|258569|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
111619|NCT01009463|258570|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
111620|NCT01009463|258566|P5|STARTED|52-week, Double-blind Treatment Period||402
111621|NCT01009463|258567|P4|STARTED|52-week, Double-blind Treatment Period||403
111622|NCT01009463|258568|P3|STARTED|52-week, Double-blind Treatment Period||408
111623|NCT01009463|258569|P2|STARTED|52-week, Double-blind Treatment Period||409
111624|NCT01009463|258570|P1|STARTED|52-week, Double-blind Treatment Period||0
111625|NCT01009463|258566|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
111626|NCT01009463|258567|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
111627|NCT01009463|258568|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
111628|NCT01009463|258569|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
111629|NCT01009463|258570|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
111630|NCT01009463|258566|P5|COMPLETED|4-week, Open-label Run-In Period||0
111631|NCT01009463|258567|P4|COMPLETED|4-week, Open-label Run-In Period||0
111632|NCT01009463|258568|P3|COMPLETED|4-week, Open-label Run-In Period||0
111633|NCT01009463|258569|P2|COMPLETED|4-week, Open-label Run-In Period||0
111634|NCT01009463|258570|P1|COMPLETED|4-week, Open-label Run-In Period||1622
111635|NCT01009463|258566|P5|STARTED|4-week, Open-label Run-In Period||0
111636|NCT01009463|258567|P4|STARTED|4-week, Open-label Run-In Period||0
111637|NCT01009463|258568|P3|STARTED|4-week, Open-label Run-In Period||0
111638|NCT01009463|258569|P2|STARTED|4-week, Open-label Run-In Period||0
111639|NCT01009463|258570|P1|STARTED|4-week, Open-label Run-In Period||2071
111640|NCT01009346|258592|P1|NOT COMPLETED|Overall Study||4
111641|NCT01009346|258592|P1|COMPLETED|Overall Study||5
111642|NCT01009346|258592|P1|Toxicity|Overall Study||8
111643|NCT01009346|258592|P1|STARTED|Overall Study||9
111644|NCT01009333|258596|P6|NOT COMPLETED|Week 3||0
111645|NCT01009333|258597|P5|NOT COMPLETED|Week 3||0
111646|NCT01009333|258598|P4|NOT COMPLETED|Week 3||0
111647|NCT01009333|258599|P3|NOT COMPLETED|Week 3||0
111648|NCT01009333|258600|P2|NOT COMPLETED|Week 3||0
111649|NCT01009333|258601|P1|NOT COMPLETED|Week 3||0
111650|NCT01009333|258596|P6|COMPLETED|Week 3||2
111651|NCT01009333|258597|P5|COMPLETED|Week 3||2
111652|NCT01009333|258598|P4|COMPLETED|Week 3||2
111653|NCT01009333|258599|P3|COMPLETED|Week 3||2
111654|NCT01009333|258600|P2|COMPLETED|Week 3||2
111655|NCT01009333|258601|P1|COMPLETED|Week 3||2
111656|NCT01009333|258596|P6|STARTED|Week 3||2
111657|NCT01009333|258597|P5|STARTED|Week 3||2
111658|NCT01009333|258598|P4|STARTED|Week 3||2
111659|NCT01009333|258599|P3|STARTED|Week 3||2
111660|NCT01009333|258600|P2|STARTED|Week 3||2
111661|NCT01009333|258601|P1|STARTED|Week 3||2
111662|NCT01009333|258596|P6|NOT COMPLETED|Week 2||0
111663|NCT01009333|258597|P5|NOT COMPLETED|Week 2||0
111664|NCT01009333|258598|P4|NOT COMPLETED|Week 2||0
111665|NCT01009333|258599|P3|NOT COMPLETED|Week 2||0
111666|NCT01009333|258600|P2|NOT COMPLETED|Week 2||0
111667|NCT01009333|258601|P1|NOT COMPLETED|Week 2||0
111668|NCT01009333|258596|P6|COMPLETED|Week 2||2
111669|NCT01009333|258597|P5|COMPLETED|Week 2||2
111670|NCT01009333|258598|P4|COMPLETED|Week 2||2
111671|NCT01009333|258599|P3|COMPLETED|Week 2||2
111672|NCT01009333|258600|P2|COMPLETED|Week 2||2
111673|NCT01009333|258601|P1|COMPLETED|Week 2||2
111674|NCT01009333|258596|P6|STARTED|Week 2||2
111675|NCT01009333|258597|P5|STARTED|Week 2||2
111676|NCT01009333|258598|P4|STARTED|Week 2||2
111677|NCT01009333|258599|P3|STARTED|Week 2||2
111678|NCT01009333|258600|P2|STARTED|Week 2||2
111679|NCT01009333|258601|P1|STARTED|Week 2||2
111680|NCT01009333|258596|P6|NOT COMPLETED|Week 1||0
111681|NCT01009333|258597|P5|NOT COMPLETED|Week 1||0
111682|NCT01009333|258598|P4|NOT COMPLETED|Week 1||0
111683|NCT01009333|258599|P3|NOT COMPLETED|Week 1||0
111684|NCT01009333|258600|P2|NOT COMPLETED|Week 1||0
111685|NCT01009333|258601|P1|NOT COMPLETED|Week 1||0
111686|NCT01009333|258596|P6|COMPLETED|Week 1||2
111687|NCT01009333|258597|P5|COMPLETED|Week 1||2
111688|NCT01009333|258598|P4|COMPLETED|Week 1||2
111689|NCT01009333|258599|P3|COMPLETED|Week 1||2
111690|NCT01009333|258600|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
111691|NCT01009333|258601|P1|COMPLETED|Week 1||2
111692|NCT01009333|258596|P6|STARTED|Week 1||2
111693|NCT01009333|258597|P5|STARTED|Week 1||2
111694|NCT01009333|258598|P4|STARTED|Week 1||2
111695|NCT01009333|258599|P3|STARTED|Week 1||2
111696|NCT01009333|258600|P2|STARTED|Week 1||3
111697|NCT01009333|258601|P1|STARTED|Week 1||2
111698|NCT01009203|258615|P1|NOT COMPLETED|Overall Study||7
111699|NCT01009203|258615|P1|COMPLETED|Overall Study||6
111700|NCT01009203|258615|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
111701|NCT01009203|258615|P1|STARTED|Overall Study||13
111702|NCT01009138|258624|P2|NOT COMPLETED|Overall Study||20
111703|NCT01009138|258625|P1|NOT COMPLETED|Overall Study||13
111704|NCT01009138|258624|P2|COMPLETED|Overall Study||88
111705|NCT01009138|258625|P1|COMPLETED|Overall Study||93
111706|NCT01009138|258624|P2|STARTED|Overall Study||108
111707|NCT01009138|258625|P1|STARTED|Overall Study||106
111708|NCT01009099|258655|P2|NOT COMPLETED|Overall Study||4
111709|NCT01009099|258656|P1|NOT COMPLETED|Overall Study||5
111710|NCT01009099|258655|P2|COMPLETED|Overall Study||57
111711|NCT01009099|258656|P1|COMPLETED|Overall Study||53
111712|NCT01009099|258655|P2|STARTED|Overall Study||61
111713|NCT01009099|258656|P1|STARTED|Overall Study||58
111714|NCT01009086|258665|P3|NOT COMPLETED|Overall Study||34
111715|NCT01009086|258666|P2|NOT COMPLETED|Overall Study||47
111716|NCT01009086|258667|P1|NOT COMPLETED|Overall Study||44
111717|NCT01009086|258665|P3|COMPLETED|Overall Study||170
111718|NCT01009086|258666|P2|COMPLETED|Overall Study||158
111719|NCT01009086|258667|P1|COMPLETED|Overall Study||162
111720|NCT01009086|258665|P3|STARTED|Overall Study||204
111721|NCT01009086|258666|P2|STARTED|Overall Study||205
111722|NCT01009086|258667|P1|STARTED|Overall Study||206
111723|NCT01009047|258702|P2|NOT COMPLETED|Overall Study||26
111724|NCT01009047|258703|P1|NOT COMPLETED|Overall Study||28
111725|NCT01009047|258702|P2|COMPLETED|Overall Study||89
111726|NCT01009047|258703|P1|COMPLETED|Overall Study||85
111727|NCT01009047|258702|P2|STARTED|Overall Study||115
111728|NCT01009047|258703|P1|STARTED|Overall Study||113
111729|NCT01009034|258725|P1|NOT COMPLETED|Overall Study||4
111730|NCT01009034|258725|P1|COMPLETED|Overall Study||10
111731|NCT01009034|258725|P1|STARTED|Overall Study||14
111732|NCT01008995|258733|P4|NOT COMPLETED|After Controlled Period||1
111733|NCT01008995|258734|P3|NOT COMPLETED|After Controlled Period||2
111734|NCT01008995|258735|P2|NOT COMPLETED|After Controlled Period||0
111735|NCT01008995|258736|P1|NOT COMPLETED|After Controlled Period||0
111736|NCT01008995|258733|P4|COMPLETED|After Controlled Period||156
111737|NCT01008995|258734|P3|COMPLETED|After Controlled Period||156
111738|NCT01008995|258735|P2|COMPLETED|After Controlled Period||0
111739|NCT01008995|258736|P1|COMPLETED|After Controlled Period||0
111740|NCT01008995|258733|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
111741|NCT01008995|258734|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
111742|NCT01008995|258735|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
111743|NCT01008995|258736|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
111744|NCT01008995|258733|P4|NOT COMPLETED|Controlled Period||0
111745|NCT01008995|258734|P3|NOT COMPLETED|Controlled Period||0
111746|NCT01008995|258735|P2|NOT COMPLETED|Controlled Period||3
111747|NCT01008995|258736|P1|NOT COMPLETED|Controlled Period||3
111748|NCT01008995|258733|P4|COMPLETED|Controlled Period||0
111749|NCT01008995|258734|P3|COMPLETED|Controlled Period||0
111750|NCT01008995|258735|P2|COMPLETED|Controlled Period||157
111751|NCT01008995|258736|P1|COMPLETED|Controlled Period||159
111752|NCT01008995|258733|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
111753|NCT01008995|258734|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
111754|NCT01008995|258735|P2|STARTED|Controlled Period||160
111755|NCT01008995|258736|P1|STARTED|Controlled Period||162
111756|NCT01008969|258748|P1|NOT COMPLETED|Overall Study||0
111757|NCT01008969|258748|P1|COMPLETED|Overall Study||10
111758|NCT01008969|258748|P1|STARTED|Overall Study||10
111759|NCT01008943|258753|P1|NOT COMPLETED|Overall Study||1
111760|NCT01008943|258753|P1|COMPLETED|Overall Study||15
111761|NCT01008943|258753|P1|STARTED|Overall Study||16
111762|NCT01008904|258760|P1|NOT COMPLETED|Overall Study||4
111763|NCT01008904|258760|P1|COMPLETED|Overall Study||25
111764|NCT01008904|258760|P1|STARTED|Overall Study||29
111765|NCT01008722|258767|P2|NOT COMPLETED|Overall Study||0
111766|NCT01008722|258768|P1|NOT COMPLETED|Overall Study||0
111767|NCT01008722|258767|P2|COMPLETED|Overall Study||71
111768|NCT01008722|258768|P1|COMPLETED|Overall Study||36
111769|NCT01008722|258767|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
111770|NCT01008722|258768|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
111771|NCT01008696|258778|P2|NOT COMPLETED|Overall Study||17
111772|NCT01008696|258779|P1|NOT COMPLETED|Overall Study||17
111773|NCT01008696|258778|P2|COMPLETED|Overall Study||92
111774|NCT01008696|258779|P1|COMPLETED|Overall Study||91
111775|NCT01008696|258778|P2|STARTED|Overall Study||109
111776|NCT01008696|258779|P1|STARTED|Overall Study||108
111777|NCT01008618|258789|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
111778|NCT01008618|258790|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
111779|NCT01008618|258791|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
111780|NCT01008618|258789|P3|COMPLETED|Period 2 (Double-Blind Period)||39
111781|NCT01008618|258790|P2|COMPLETED|Period 2 (Double-Blind Period)||37
111782|NCT01008618|258791|P1|COMPLETED|Period 2 (Double-Blind Period)||0
111783|NCT01008618|258789|P3|STARTED|Period 2 (Double-Blind Period)||77
111784|NCT01008618|258790|P2|STARTED|Period 2 (Double-Blind Period)||73
111785|NCT01008618|258791|P1|STARTED|Period 2 (Double-Blind Period)||0
111786|NCT01008618|258789|P3|NOT COMPLETED|Period 1 (Titration Period)||0
111787|NCT01008618|258790|P2|NOT COMPLETED|Period 1 (Titration Period)||0
111788|NCT01008618|258791|P1|NOT COMPLETED|Period 1 (Titration Period)||68
111789|NCT01008618|258789|P3|COMPLETED|Period 1 (Titration Period)||0
111790|NCT01008618|258790|P2|COMPLETED|Period 1 (Titration Period)||0
111791|NCT01008618|258791|P1|COMPLETED|Period 1 (Titration Period)||150
111792|NCT01008618|258789|P3|STARTED|Period 1 (Titration Period)||0
111793|NCT01008618|258790|P2|STARTED|Period 1 (Titration Period)||0
111794|NCT01008618|258791|P1|STARTED|Period 1 (Titration Period)||218
111795|NCT01008605|258816|P1|NOT COMPLETED|Overall Study||0
111796|NCT01008605|258816|P1|COMPLETED|Overall Study||48
111797|NCT01008605|258816|P1|STARTED|Overall Study||48
111798|NCT01008553|258840|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
111799|NCT01008553|258841|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
111800|NCT01008553|258842|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
111801|NCT01008553|258840|P3|COMPLETED|Period 2 (Double-Blind Period)||28
111802|NCT01008553|258841|P2|COMPLETED|Period 2 (Double-Blind Period)||47
111803|NCT01008553|258842|P1|COMPLETED|Period 2 (Double-Blind Period)||0
111804|NCT01008553|258840|P3|STARTED|Period 2 (Double-Blind Period)||79
111805|NCT01008553|258841|P2|STARTED|Period 2 (Double-Blind Period)||84
111806|NCT01008553|258842|P1|STARTED|Period 2 (Double-Blind Period)||0
111807|NCT01008553|258840|P3|NOT COMPLETED|Period 1 (Titration Period)||0
111808|NCT01008553|258841|P2|NOT COMPLETED|Period 1 (Titration Period)||0
111809|NCT01008553|258842|P1|NOT COMPLETED|Period 1 (Titration Period)||95
111810|NCT01008553|258840|P3|COMPLETED|Period 1 (Titration Period)||0
111811|NCT01008553|258841|P2|COMPLETED|Period 1 (Titration Period)||0
111812|NCT01008553|258842|P1|COMPLETED|Period 1 (Titration Period)||163
111813|NCT01008553|258840|P3|STARTED|Period 1 (Titration Period)||0
111814|NCT01008553|258841|P2|STARTED|Period 1 (Titration Period)||0
111815|NCT01008553|258842|P1|STARTED|Period 1 (Titration Period)||258
111816|NCT01008475|258874|P7|NOT COMPLETED|Overall Study||4
111817|NCT01008475|258875|P6|NOT COMPLETED|Overall Study||6
111818|NCT01008475|258876|P5|NOT COMPLETED|Overall Study||5
111819|NCT01008475|258877|P4|NOT COMPLETED|Overall Study||0
111820|NCT01008475|258878|P3|NOT COMPLETED|Overall Study||0
111821|NCT01008475|258879|P2|NOT COMPLETED|Overall Study||0
111822|NCT01008475|258880|P1|NOT COMPLETED|Overall Study||0
111823|NCT01008475|258874|P7|COMPLETED|Overall Study||67
111824|NCT01008475|258875|P6|COMPLETED|Overall Study||67
111825|NCT01008475|258876|P5|COMPLETED|Overall Study||67
111826|NCT01008475|258877|P4|COMPLETED|Overall Study||3
111827|NCT01008475|258878|P3|COMPLETED|Overall Study||7
111828|NCT01008475|258879|P2|COMPLETED|Overall Study||3
111829|NCT01008475|258880|P1|COMPLETED|Overall Study||3
111830|NCT01008475|258874|P7|Safety Analysis Set|Overall Study||69
111831|NCT01008475|258875|P6|Safety Analysis Set|Overall Study||72
111832|NCT01008475|258876|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
111833|NCT01008475|258877|P4|Safety Analysis Set|Overall Study||3
111834|NCT01008475|258878|P3|Safety Analysis Set|Overall Study||7
111835|NCT01008475|258879|P2|Safety Analysis Set|Overall Study||3
111836|NCT01008475|258880|P1|Safety Analysis Set|Overall Study||3
111837|NCT01008475|258874|P7|STARTED|Overall Study||71
111838|NCT01008475|258875|P6|STARTED|Overall Study||73
111839|NCT01008475|258876|P5|STARTED|Overall Study||72
111840|NCT01008475|258877|P4|STARTED|Overall Study||3
111841|NCT01008475|258878|P3|STARTED|Overall Study||7
111842|NCT01008475|258879|P2|STARTED|Overall Study||3
111843|NCT01008475|258880|P1|STARTED|Overall Study||3
111844|NCT01008449|258910|P2|NOT COMPLETED|Overall Study||19
111845|NCT01008449|258911|P1|NOT COMPLETED|Overall Study||29
111846|NCT01008449|258910|P2|COMPLETED|Overall Study||179
111847|NCT01008449|258911|P1|COMPLETED|Overall Study||171
111848|NCT01008449|258910|P2|STARTED|Overall Study||198
111849|NCT01008449|258911|P1|STARTED|Overall Study||200
111850|NCT01008280|258933|P2|NOT COMPLETED|Overall Study||19
111851|NCT01008280|258934|P1|NOT COMPLETED|Overall Study||21
111852|NCT01008280|258933|P2|COMPLETED|Overall Study||73
111853|NCT01008280|258934|P1|COMPLETED|Overall Study||67
111854|NCT01008280|258933|P2|STARTED|Overall Study||92
111855|NCT01008280|258934|P1|STARTED|Overall Study||88
111856|NCT01007916|258944|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
111857|NCT01007916|258945|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
111858|NCT01007916|258944|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
111859|NCT01007916|258945|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
111860|NCT01007916|258944|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
111861|NCT01007916|258945|P1|STARTED|Period 2, 4 Weeks of Wear||22
111862|NCT01007916|258944|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
111863|NCT01007916|258945|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
111864|NCT01007916|258944|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
111865|NCT01007916|258945|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
111866|NCT01007916|258944|P2|STARTED|Period 1, 4 Weeks of Wear||26
111867|NCT01007916|258945|P1|STARTED|Period 1, 4 Weeks of Wear||23
111868|NCT01007838|258955|P4|NOT COMPLETED|Overall Study||0
111869|NCT01007838|258956|P3|NOT COMPLETED|Overall Study||0
111870|NCT01007838|258957|P2|NOT COMPLETED|Overall Study||0
111871|NCT01007838|258958|P1|NOT COMPLETED|Overall Study||3
111872|NCT01007838|258955|P4|COMPLETED|Overall Study||4
111873|NCT01007838|258956|P3|COMPLETED|Overall Study||5
111874|NCT01007838|258957|P2|COMPLETED|Overall Study||11
111875|NCT01007838|258958|P1|COMPLETED|Overall Study||9
111876|NCT01007838|258955|P4|STARTED|Overall Study||4
111877|NCT01007838|258956|P3|STARTED|Overall Study||5
111878|NCT01007838|258957|P2|STARTED|Overall Study||11
111879|NCT01007838|258958|P1|STARTED|Overall Study||12
111880|NCT01007812|258968|P2|NOT COMPLETED|Period 2, One Week||0
111881|NCT01007812|258969|P1|NOT COMPLETED|Period 2, One Week||0
111882|NCT01007812|258968|P2|COMPLETED|Period 2, One Week||24
111883|NCT01007812|258969|P1|COMPLETED|Period 2, One Week||24
111884|NCT01007812|258968|P2|STARTED|Period 2, One Week||24
111885|NCT01007812|258969|P1|STARTED|Period 2, One Week||24
111886|NCT01007812|258968|P2|NOT COMPLETED|Period 1, One Week||1
111887|NCT01007812|258969|P1|NOT COMPLETED|Period 1, One Week||1
111888|NCT01007812|258968|P2|COMPLETED|Period 1, One Week||24
111889|NCT01007812|258969|P1|COMPLETED|Period 1, One Week||24
111890|NCT01007812|258968|P2|STARTED|Period 1, One Week||25
111891|NCT01007812|258969|P1|STARTED|Period 1, One Week||25
111892|NCT01007656|258975|P1|NOT COMPLETED|Overall Study||0
111893|NCT01007656|258975|P1|COMPLETED|Overall Study||31
111894|NCT01007656|258975|P1|STARTED|Overall Study||31
111895|NCT01007643|258995|P2|NOT COMPLETED|Overall Study||0
111896|NCT01007643|258996|P1|NOT COMPLETED|Overall Study||0
111897|NCT01007643|258995|P2|COMPLETED|Overall Study||14
111898|NCT01007643|258996|P1|COMPLETED|Overall Study||8
111899|NCT01007643|258995|P2|STARTED|Overall Study||14
111900|NCT01007643|258996|P1|STARTED|Overall Study||8
111901|NCT01007435|259006|P4|NOT COMPLETED|Overall Study||56
111902|NCT01007435|259007|P3|NOT COMPLETED|Overall Study||64
111903|NCT01007435|259008|P2|NOT COMPLETED|Overall Study||59
111904|NCT01007435|259009|P1|NOT COMPLETED|Overall Study||63
111905|NCT01007435|259006|P4|COMPLETED|Overall Study||236
111906|NCT01007435|259007|P3|COMPLETED|Overall Study||227
111907|NCT01007435|259008|P2|COMPLETED|Overall Study||231
111908|NCT01007435|259009|P1|COMPLETED|Overall Study||226
111909|NCT01007435|259006|P4|STARTED|Overall Study||292
111910|NCT01007435|259007|P3|STARTED|Overall Study||291
111911|NCT01007435|259008|P2|STARTED|Overall Study||290
111912|NCT01007435|259009|P1|STARTED|Overall Study||289
111913|NCT01007396|259051|P1|NOT COMPLETED|Overall Study||47
111914|NCT01007396|259051|P1|COMPLETED|Overall Study||275
111915|NCT01007396|259051|P1|STARTED|Overall Study||322
111916|NCT01007253|259056|P4|NOT COMPLETED|Fourth Intervention||0
111917|NCT01007253|259057|P3|NOT COMPLETED|Fourth Intervention||0
111918|NCT01007253|259058|P2|NOT COMPLETED|Fourth Intervention||0
111919|NCT01007253|259059|P1|NOT COMPLETED|Fourth Intervention||0
111920|NCT01007253|259056|P4|COMPLETED|Fourth Intervention||5
111921|NCT01007253|259057|P3|COMPLETED|Fourth Intervention||5
111922|NCT01007253|259058|P2|COMPLETED|Fourth Intervention||5
111923|NCT01007253|259059|P1|COMPLETED|Fourth Intervention||5
111924|NCT01007253|259056|P4|STARTED|Fourth Intervention||5
111925|NCT01007253|259057|P3|STARTED|Fourth Intervention||5
111926|NCT01007253|259058|P2|STARTED|Fourth Intervention||5
111927|NCT01007253|259059|P1|STARTED|Fourth Intervention||5
111928|NCT01007253|259056|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
111929|NCT01007253|259057|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
111930|NCT01007253|259058|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
111931|NCT01007253|259059|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
111932|NCT01007253|259056|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
111933|NCT01007253|259057|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
111934|NCT01007253|259058|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
111935|NCT01007253|259059|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
111936|NCT01007253|259056|P4|STARTED|Washout Period (2 Weeks) # 3||5
111937|NCT01007253|259057|P3|STARTED|Washout Period (2 Weeks) # 3||5
111938|NCT01007253|259058|P2|STARTED|Washout Period (2 Weeks) # 3||5
111939|NCT01007253|259059|P1|STARTED|Washout Period (2 Weeks) # 3||6
111940|NCT01007253|259056|P4|NOT COMPLETED|Third Intervention||0
111941|NCT01007253|259057|P3|NOT COMPLETED|Third Intervention||0
111942|NCT01007253|259058|P2|NOT COMPLETED|Third Intervention||0
111943|NCT01007253|259059|P1|NOT COMPLETED|Third Intervention||0
111944|NCT01007253|259056|P4|COMPLETED|Third Intervention||5
111945|NCT01007253|259057|P3|COMPLETED|Third Intervention||5
111946|NCT01007253|259058|P2|COMPLETED|Third Intervention||5
111947|NCT01007253|259059|P1|COMPLETED|Third Intervention||6
111948|NCT01007253|259056|P4|STARTED|Third Intervention||5
111949|NCT01007253|259057|P3|STARTED|Third Intervention||5
111950|NCT01007253|259058|P2|STARTED|Third Intervention||5
111951|NCT01007253|259059|P1|STARTED|Third Intervention||6
111952|NCT01007253|259056|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
111953|NCT01007253|259057|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
111954|NCT01007253|259058|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
111955|NCT01007253|259059|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
111956|NCT01007253|259056|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
111957|NCT01007253|259057|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
111958|NCT01007253|259058|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
111959|NCT01007253|259059|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
111960|NCT01007253|259056|P4|STARTED|Washout Period (2 Weeks) # 2||5
111961|NCT01007253|259057|P3|STARTED|Washout Period (2 Weeks) # 2||5
111962|NCT01007253|259058|P2|STARTED|Washout Period (2 Weeks) # 2||5
111963|NCT01007253|259059|P1|STARTED|Washout Period (2 Weeks) # 2||6
111964|NCT01007253|259056|P4|NOT COMPLETED|Second Intervention||0
111965|NCT01007253|259057|P3|NOT COMPLETED|Second Intervention||0
111966|NCT01007253|259058|P2|NOT COMPLETED|Second Intervention||0
111967|NCT01007253|259059|P1|NOT COMPLETED|Second Intervention||0
111968|NCT01007253|259056|P4|COMPLETED|Second Intervention||5
111969|NCT01007253|259057|P3|COMPLETED|Second Intervention||5
111970|NCT01007253|259058|P2|COMPLETED|Second Intervention||5
111971|NCT01007253|259059|P1|COMPLETED|Second Intervention||6
111972|NCT01007253|259056|P4|STARTED|Second Intervention||5
111973|NCT01007253|259057|P3|STARTED|Second Intervention||5
111974|NCT01007253|259058|P2|STARTED|Second Intervention||5
111975|NCT01007253|259059|P1|STARTED|Second Intervention||6
111976|NCT01007253|259056|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
111977|NCT01007253|259057|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
111978|NCT01007253|259058|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
111979|NCT01007253|259059|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
111980|NCT01007253|259056|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
111981|NCT01007253|259057|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
111982|NCT01007253|259058|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
111983|NCT01007253|259059|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
111984|NCT01007253|259056|P4|STARTED|Washout Period (2 Weeks) # 1||5
111985|NCT01007253|259057|P3|STARTED|Washout Period (2 Weeks) # 1||5
111986|NCT01007253|259058|P2|STARTED|Washout Period (2 Weeks) # 1||5
111987|NCT01007253|259059|P1|STARTED|Washout Period (2 Weeks) # 1||6
111988|NCT01007253|259056|P4|NOT COMPLETED|First Intervention||0
111989|NCT01007253|259057|P3|NOT COMPLETED|First Intervention||0
111990|NCT01007253|259058|P2|NOT COMPLETED|First Intervention||0
111991|NCT01007253|259059|P1|NOT COMPLETED|First Intervention||0
111992|NCT01007253|259056|P4|COMPLETED|First Intervention||5
111993|NCT01007253|259057|P3|COMPLETED|First Intervention||5
111994|NCT01007253|259058|P2|COMPLETED|First Intervention||5
111995|NCT01007253|259059|P1|COMPLETED|First Intervention||6
111996|NCT01007253|259056|P4|STARTED|First Intervention||5
111997|NCT01007253|259057|P3|STARTED|First Intervention||5
111998|NCT01007253|259058|P2|STARTED|First Intervention||5
111999|NCT01007253|259059|P1|STARTED|First Intervention||6
112000|NCT01007149|259091|P2|NOT COMPLETED|Overall Study||1
112001|NCT01007149|259092|P1|NOT COMPLETED|Overall Study||0
112002|NCT01007149|259091|P2|COMPLETED|Overall Study||20
112003|NCT01007149|259092|P1|COMPLETED|Overall Study||20
112004|NCT01007149|259091|P2|STARTED|Overall Study||21
112005|NCT01007149|259092|P1|STARTED|Overall Study||20
112006|NCT01007110|259116|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
112007|NCT01007110|259117|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
112008|NCT01007110|259116|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
112009|NCT01007110|259117|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
112010|NCT01007110|259116|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
112011|NCT01007110|259117|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
112012|NCT01007110|259116|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
112013|NCT01007110|259117|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
112014|NCT01007110|259116|P2|COMPLETED|Follow-Up at 36 Weeks||20
112015|NCT01007110|259117|P1|COMPLETED|Follow-Up at 36 Weeks||24
112016|NCT01007110|259116|P2|STARTED|Follow-Up at 36 Weeks||22
112017|NCT01007110|259117|P1|STARTED|Follow-Up at 36 Weeks||24
112018|NCT01007110|259116|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
112019|NCT01007110|259117|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
112020|NCT01007110|259116|P2|COMPLETED|Follow-Up at 32 Weeks||22
112021|NCT01007110|259117|P1|COMPLETED|Follow-Up at 32 Weeks||24
112022|NCT01007110|259116|P2|STARTED|Follow-Up at 32 Weeks||23
112023|NCT01007110|259117|P1|STARTED|Follow-Up at 32 Weeks||25
112024|NCT01007110|259116|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
112025|NCT01007110|259117|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
112026|NCT01007110|259116|P2|COMPLETED|Follow-Up at 24 Weeks||23
112027|NCT01007110|259117|P1|COMPLETED|Follow-Up at 24 Weeks||25
112028|NCT01007110|259116|P2|STARTED|Follow-Up at 24 Weeks||27
112029|NCT01007110|259117|P1|STARTED|Follow-Up at 24 Weeks||25
112030|NCT01007110|259116|P2|NOT COMPLETED|Allocation||8
112031|NCT01007110|259117|P1|NOT COMPLETED|Allocation||7
112032|NCT01007110|259116|P2|COMPLETED|Allocation||27
112033|NCT01007110|259117|P1|COMPLETED|Allocation||25
112034|NCT01007110|259116|P2|STARTED|Allocation||35
112035|NCT01007110|259117|P1|STARTED|Allocation||32
112036|NCT01006980|259133|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
112037|NCT01006980|259134|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
112038|NCT01006980|259133|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
112039|NCT01006980|259134|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
112040|NCT01006980|259133|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
112041|NCT01006980|259134|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
112042|NCT01006980|259133|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
112043|NCT01006980|259134|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
112044|NCT01006980|259133|P2|COMPLETED|Vemurafenib and Dacarbazine||0
112045|NCT01006980|259134|P1|COMPLETED|Vemurafenib and Dacarbazine||0
112046|NCT01006980|259133|P2|Treated|Vemurafenib and Dacarbazine||293
112047|NCT01006980|259134|P1|Treated|Vemurafenib and Dacarbazine||336
112048|NCT01006980|259133|P2|STARTED|Vemurafenib and Dacarbazine||338
112049|NCT01006980|259134|P1|STARTED|Vemurafenib and Dacarbazine||337
112050|NCT01006889|259154|P1|NOT COMPLETED|Overall Study||3
112051|NCT01006889|259154|P1|COMPLETED|Overall Study||17
112052|NCT01006889|259154|P1|STARTED|Overall Study||20
112053|NCT01006655|259167|P2|NOT COMPLETED|Second Intervention||0
112054|NCT01006655|259168|P1|NOT COMPLETED|Second Intervention||0
112055|NCT01006655|259167|P2|COMPLETED|Second Intervention||10
112056|NCT01006655|259168|P1|COMPLETED|Second Intervention||11
112057|NCT01006655|259167|P2|STARTED|Second Intervention||10
112058|NCT01006655|259168|P1|STARTED|Second Intervention||11
112059|NCT01006655|259167|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
112060|NCT01006655|259168|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
112061|NCT01006655|259167|P2|COMPLETED|Washout Period of 2 Weeks||10
112062|NCT01006655|259168|P1|COMPLETED|Washout Period of 2 Weeks||11
112063|NCT01006655|259167|P2|STARTED|Washout Period of 2 Weeks||10
112064|NCT01006655|259168|P1|STARTED|Washout Period of 2 Weeks||11
112065|NCT01006655|259167|P2|NOT COMPLETED|First Intervention||0
112066|NCT01006655|259168|P1|NOT COMPLETED|First Intervention||0
112067|NCT01006655|259167|P2|COMPLETED|First Intervention||10
112068|NCT01006655|259168|P1|COMPLETED|First Intervention||11
112069|NCT01006655|259167|P2|STARTED|First Intervention||10
112070|NCT01006655|259168|P1|STARTED|First Intervention||11
112071|NCT01006629|259174|P1|NOT COMPLETED|Overall Study||6
112072|NCT01006629|259174|P1|COMPLETED|Overall Study||94
112073|NCT01006629|259174|P1|STARTED|Overall Study||100
112074|NCT01006616|259189|P4|NOT COMPLETED|Period 2 (18 Months)||82
112075|NCT01006616|259190|P3|NOT COMPLETED|Period 2 (18 Months)||55
112076|NCT01006616|259191|P2|NOT COMPLETED|Period 2 (18 Months)||63
112077|NCT01006616|259192|P1|NOT COMPLETED|Period 2 (18 Months)||75
112078|NCT01006616|259189|P4|COMPLETED|Period 2 (18 Months)||0
112079|NCT01006616|259190|P3|COMPLETED|Period 2 (18 Months)||0
112080|NCT01006616|259191|P2|COMPLETED|Period 2 (18 Months)||0
112081|NCT01006616|259192|P1|COMPLETED|Period 2 (18 Months)||0
112082|NCT01006616|259189|P4|Treated|Period 2 (18 Months)||82
112083|NCT01006616|259190|P3|Treated|Period 2 (18 Months)||55
112084|NCT01006616|259191|P2|Treated|Period 2 (18 Months)||63
112085|NCT01006616|259192|P1|Treated|Period 2 (18 Months)||75
112086|NCT01006616|259189|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
112087|NCT01006616|259190|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
112088|NCT01006616|259191|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
112089|NCT01006616|259192|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
112090|NCT01006616|259189|P4|NOT COMPLETED|Period 1 (6 Months)||27
112091|NCT01006616|259190|P3|NOT COMPLETED|Period 1 (6 Months)||51
112092|NCT01006616|259191|P2|NOT COMPLETED|Period 1 (6 Months)||54
112093|NCT01006616|259192|P1|NOT COMPLETED|Period 1 (6 Months)||26
112094|NCT01006616|259189|P4|COMPLETED|Period 1 (6 Months)||128
112095|NCT01006616|259190|P3|COMPLETED|Period 1 (6 Months)||102
112096|NCT01006616|259191|P2|COMPLETED|Period 1 (6 Months)||102
112097|NCT01006616|259192|P1|COMPLETED|Period 1 (6 Months)||126
112098|NCT01006616|259189|P4|Treated|Period 1 (6 Months)||154
112099|NCT01006616|259190|P3|Treated|Period 1 (6 Months)||152
112100|NCT01006616|259191|P2|Treated|Period 1 (6 Months)||156
112101|NCT01006616|259192|P1|Treated|Period 1 (6 Months)||152
112102|NCT01006616|259189|P4|STARTED|Period 1 (6 Months)||155
112103|NCT01006616|259190|P3|STARTED|Period 1 (6 Months)||153
112104|NCT01006616|259191|P2|STARTED|Period 1 (6 Months)||156
112105|NCT01006616|259192|P1|STARTED|Period 1 (6 Months)||152
112106|NCT01006603|259328|P2|NOT COMPLETED|Overall Study||75
112107|NCT01006603|259329|P1|NOT COMPLETED|Overall Study||71
112108|NCT01006603|259328|P2|COMPLETED|Overall Study||285
112109|NCT01006603|259329|P1|COMPLETED|Overall Study||289
112110|NCT01006603|259328|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
112111|NCT01006603|259329|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
112112|NCT01006590|259349|P2|NOT COMPLETED|Overall Study||32
112113|NCT01006590|259350|P1|NOT COMPLETED|Overall Study||28
112114|NCT01006590|259349|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
112115|NCT01006590|259350|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
112116|NCT01006590|259349|P2|STARTED|Overall Study|Randomised and treated|139
112117|NCT01006590|259350|P1|STARTED|Overall Study|Randomised and treated|147
112118|NCT01006356|259366|P1|NOT COMPLETED|Overall Study||42
112119|NCT01006356|259366|P1|COMPLETED|Overall Study||99
112120|NCT01006356|259366|P1|STARTED|Overall Study||141
112121|NCT01006291|259381|P3|NOT COMPLETED|Overall Study||27
112122|NCT01006291|259382|P2|NOT COMPLETED|Overall Study||24
112123|NCT01006291|259383|P1|NOT COMPLETED|Overall Study||26
112124|NCT01006291|259381|P3|COMPLETED|Overall Study||203
112125|NCT01006291|259382|P2|COMPLETED|Overall Study||204
112126|NCT01006291|259383|P1|COMPLETED|Overall Study||203
112127|NCT01006291|259381|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
112128|NCT01006291|259382|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
112129|NCT01006291|259383|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
112130|NCT01006291|259381|P3|STARTED|Overall Study||230
112131|NCT01006291|259382|P2|STARTED|Overall Study||228
112132|NCT01006291|259383|P1|STARTED|Overall Study||229
112133|NCT01006135|259400|P1|NOT COMPLETED|Overall Study||140
112134|NCT01006135|259400|P1|COMPLETED|Overall Study||4712
112135|NCT01006135|259400|P1|STARTED|Overall Study||4852
112136|NCT01006122|259407|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
112137|NCT01006122|259408|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
112138|NCT01006122|259407|P2|COMPLETED|Second Double-blind Intervention Period||24
112139|NCT01006122|259408|P1|COMPLETED|Second Double-blind Intervention Period||29
112140|NCT01006122|259407|P2|STARTED|Second Double-blind Intervention Period||31
112141|NCT01006122|259408|P1|STARTED|Second Double-blind Intervention Period||31
112142|NCT01006122|259407|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
112143|NCT01006122|259408|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
112144|NCT01006122|259407|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
112145|NCT01006122|259408|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
112146|NCT01006122|259407|P2|STARTED|Wash-out Period (at Least 7 Days)||31
112147|NCT01006122|259408|P1|STARTED|Wash-out Period (at Least 7 Days)||31
112148|NCT01006122|259407|P2|NOT COMPLETED|First Double-blind Intervention Period||17
112149|NCT01006122|259408|P1|NOT COMPLETED|First Double-blind Intervention Period||16
112150|NCT01006122|259407|P2|COMPLETED|First Double-blind Intervention Period||31
112151|NCT01006122|259408|P1|COMPLETED|First Double-blind Intervention Period||31
112152|NCT01006122|259407|P2|STARTED|First Double-blind Intervention Period||48
112153|NCT01006122|259408|P1|STARTED|First Double-blind Intervention Period||47
112154|NCT01006018|259449|P3|NOT COMPLETED|Overall Study||0
112155|NCT01006018|259450|P2|NOT COMPLETED|Overall Study||0
112156|NCT01006018|259451|P1|NOT COMPLETED|Overall Study||0
112157|NCT01006018|259449|P3|COMPLETED|Overall Study||0
112158|NCT01006018|259450|P2|COMPLETED|Overall Study||0
112159|NCT01006018|259451|P1|COMPLETED|Overall Study||0
112160|NCT01006018|259449|P3|STARTED|Overall Study||0
112161|NCT01006018|259450|P2|STARTED|Overall Study||0
112162|NCT01006018|259451|P1|STARTED|Overall Study||0
112163|NCT01005966|259459|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
112164|NCT01005966|259460|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
112165|NCT01005966|259461|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
112166|NCT01005966|259462|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
112167|NCT01005966|259463|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
112168|NCT01005966|259459|P5|COMPLETED|Treatment Period 5 (14 Days)||10
112169|NCT01005966|259460|P4|COMPLETED|Treatment Period 5 (14 Days)||11
112170|NCT01005966|259461|P3|COMPLETED|Treatment Period 5 (14 Days)||11
112171|NCT01005966|259462|P2|COMPLETED|Treatment Period 5 (14 Days)||12
112172|NCT01005966|259463|P1|COMPLETED|Treatment Period 5 (14 Days)||9
112173|NCT01005966|259459|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
112174|NCT01005966|259460|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
112175|NCT01005966|259461|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
112176|NCT01005966|259462|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
112177|NCT01005966|259463|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
112178|NCT01005966|259459|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
112179|NCT01005966|259460|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
112180|NCT01005966|259461|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
112181|NCT01005966|259462|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
112182|NCT01005966|259463|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
112183|NCT01005966|259459|P5|COMPLETED|Washout Period 4 (4 Days)||12
112184|NCT01005966|259460|P4|COMPLETED|Washout Period 4 (4 Days)||10
112185|NCT01005966|259461|P3|COMPLETED|Washout Period 4 (4 Days)||11
112186|NCT01005966|259462|P2|COMPLETED|Washout Period 4 (4 Days)||10
112187|NCT01005966|259463|P1|COMPLETED|Washout Period 4 (4 Days)||10
112188|NCT01005966|259459|P5|STARTED|Washout Period 4 (4 Days)||12
112189|NCT01005966|259460|P4|STARTED|Washout Period 4 (4 Days)||10
112190|NCT01005966|259461|P3|STARTED|Washout Period 4 (4 Days)||11
112191|NCT01005966|259462|P2|STARTED|Washout Period 4 (4 Days)||10
112192|NCT01005966|259463|P1|STARTED|Washout Period 4 (4 Days)||10
112193|NCT01005966|259459|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
112194|NCT01005966|259460|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
112195|NCT01005966|259461|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
112196|NCT01005966|259462|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
112197|NCT01005966|259463|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
112198|NCT01005966|259459|P5|COMPLETED|Treatment Period 4 (14 Days)||12
112199|NCT01005966|259460|P4|COMPLETED|Treatment Period 4 (14 Days)||10
112200|NCT01005966|259461|P3|COMPLETED|Treatment Period 4 (14 Days)||11
112201|NCT01005966|259462|P2|COMPLETED|Treatment Period 4 (14 Days)||10
112202|NCT01005966|259463|P1|COMPLETED|Treatment Period 4 (14 Days)||10
112203|NCT01005966|259459|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
112204|NCT01005966|259460|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
112205|NCT01005966|259461|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
112206|NCT01005966|259462|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
112207|NCT01005966|259463|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
112208|NCT01005966|259459|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
112209|NCT01005966|259460|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
112210|NCT01005966|259461|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
112211|NCT01005966|259462|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
112212|NCT01005966|259463|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
112213|NCT01005966|259459|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
112214|NCT01005966|259460|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
112215|NCT01005966|259461|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
112216|NCT01005966|259462|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
112217|NCT01005966|259463|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
112218|NCT01005966|259459|P5|STARTED|Washout Period 3 ( 4 Days)||11
112219|NCT01005966|259460|P4|STARTED|Washout Period 3 ( 4 Days)||13
112220|NCT01005966|259461|P3|STARTED|Washout Period 3 ( 4 Days)||12
112221|NCT01005966|259462|P2|STARTED|Washout Period 3 ( 4 Days)||7
112222|NCT01005966|259463|P1|STARTED|Washout Period 3 ( 4 Days)||12
112223|NCT01005966|259459|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
112224|NCT01005966|259460|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
112225|NCT01005966|259461|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
112226|NCT01005966|259462|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
112227|NCT01005966|259463|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
112228|NCT01005966|259459|P5|COMPLETED|Treatment Period 3 (14 Days)||11
112229|NCT01005966|259460|P4|COMPLETED|Treatment Period 3 (14 Days)||13
112230|NCT01005966|259461|P3|COMPLETED|Treatment Period 3 (14 Days)||12
112231|NCT01005966|259462|P2|COMPLETED|Treatment Period 3 (14 Days)||7
112232|NCT01005966|259463|P1|COMPLETED|Treatment Period 3 (14 Days)||12
112233|NCT01005966|259459|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
112234|NCT01005966|259460|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
112235|NCT01005966|259461|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
112236|NCT01005966|259462|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
112237|NCT01005966|259463|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
112238|NCT01005966|259459|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
112239|NCT01005966|259460|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
112240|NCT01005966|259461|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
112241|NCT01005966|259462|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
112242|NCT01005966|259463|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
112243|NCT01005966|259459|P5|COMPLETED|Washout Period 2 (4 Days)||11
112244|NCT01005966|259460|P4|COMPLETED|Washout Period 2 (4 Days)||11
112245|NCT01005966|259461|P3|COMPLETED|Washout Period 2 (4 Days)||10
112246|NCT01005966|259462|P2|COMPLETED|Washout Period 2 (4 Days)||12
112247|NCT01005966|259463|P1|COMPLETED|Washout Period 2 (4 Days)||13
112248|NCT01005966|259459|P5|STARTED|Washout Period 2 (4 Days)||11
112249|NCT01005966|259460|P4|STARTED|Washout Period 2 (4 Days)||11
112250|NCT01005966|259461|P3|STARTED|Washout Period 2 (4 Days)||10
112251|NCT01005966|259462|P2|STARTED|Washout Period 2 (4 Days)||12
112252|NCT01005966|259463|P1|STARTED|Washout Period 2 (4 Days)||13
112253|NCT01005966|259459|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
112254|NCT01005966|259460|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
112255|NCT01005966|259461|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
112256|NCT01005966|259462|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
112257|NCT01005966|259463|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
112258|NCT01005966|259459|P5|COMPLETED|Treatment Period 2 (14 Days)||11
112259|NCT01005966|259460|P4|COMPLETED|Treatment Period 2 (14 Days)||11
112260|NCT01005966|259461|P3|COMPLETED|Treatment Period 2 (14 Days)||10
112261|NCT01005966|259462|P2|COMPLETED|Treatment Period 2 (14 Days)||12
112262|NCT01005966|259463|P1|COMPLETED|Treatment Period 2 (14 Days)||13
112263|NCT01005966|259459|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
112264|NCT01005966|259460|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
112265|NCT01005966|259461|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
112266|NCT01005966|259462|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
112267|NCT01005966|259463|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
112268|NCT01005966|259459|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
112269|NCT01005966|259460|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
112270|NCT01005966|259461|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
112271|NCT01005966|259462|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
112272|NCT01005966|259463|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
112273|NCT01005966|259459|P5|COMPLETED|Washout Period 1 (4 Days)||13
112274|NCT01005966|259460|P4|COMPLETED|Washout Period 1 (4 Days)||12
112275|NCT01005966|259461|P3|COMPLETED|Washout Period 1 (4 Days)||12
112276|NCT01005966|259462|P2|COMPLETED|Washout Period 1 (4 Days)||13
112277|NCT01005966|259463|P1|COMPLETED|Washout Period 1 (4 Days)||11
112278|NCT01005966|259459|P5|STARTED|Washout Period 1 (4 Days)||13
112279|NCT01005966|259460|P4|STARTED|Washout Period 1 (4 Days)||13
112280|NCT01005966|259461|P3|STARTED|Washout Period 1 (4 Days)||12
112281|NCT01005966|259462|P2|STARTED|Washout Period 1 (4 Days)||13
112282|NCT01005966|259463|P1|STARTED|Washout Period 1 (4 Days)||11
112283|NCT01005966|259459|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
112284|NCT01005966|259460|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
112285|NCT01005966|259461|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
112286|NCT01005966|259462|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
112287|NCT01005966|259463|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
112288|NCT01005966|259459|P5|COMPLETED|Treatment Period 1 (14 Days)||13
112289|NCT01005966|259460|P4|COMPLETED|Treatment Period 1 (14 Days)||13
112290|NCT01005966|259461|P3|COMPLETED|Treatment Period 1 (14 Days)||12
112291|NCT01005966|259462|P2|COMPLETED|Treatment Period 1 (14 Days)||13
112292|NCT01005966|259463|P1|COMPLETED|Treatment Period 1 (14 Days)||11
112293|NCT01005966|259459|P5|STARTED|Treatment Period 1 (14 Days)||13
112294|NCT01005966|259460|P4|STARTED|Treatment Period 1 (14 Days)||13
112295|NCT01005966|259461|P3|STARTED|Treatment Period 1 (14 Days)||13
112296|NCT01005966|259462|P2|STARTED|Treatment Period 1 (14 Days)||13
112297|NCT01005966|259463|P1|STARTED|Treatment Period 1 (14 Days)||13
112298|NCT01005914|259483|P1|NOT COMPLETED|Overall Study||10
112299|NCT01005914|259483|P1|COMPLETED|Overall Study||1
112300|NCT01005914|259483|P1|STARTED|Overall Study||11
112301|NCT01005901|259489|P2|NOT COMPLETED|Overall Study||58
112302|NCT01005901|259490|P1|NOT COMPLETED|Overall Study||102
112303|NCT01005901|259489|P2|COMPLETED|Overall Study||212
112304|NCT01005901|259490|P1|COMPLETED|Overall Study||450
112305|NCT01005901|259489|P2|Full Analysis Set|Overall Study||260
112306|NCT01005901|259490|P1|Full Analysis Set|Overall Study||534
112307|NCT01005901|259489|P2|Safety Population|Overall Study||267
112308|NCT01005901|259490|P1|Safety Population|Overall Study||550
112309|NCT01005901|259489|P2|STARTED|Overall Study||270
112310|NCT01005901|259490|P1|STARTED|Overall Study||552
112311|NCT01005888|259532|P2|NOT COMPLETED|Second Intervention||1
112312|NCT01005888|259533|P1|NOT COMPLETED|Second Intervention||1
112313|NCT01005888|259532|P2|COMPLETED|Second Intervention||10
112314|NCT01005888|259533|P1|COMPLETED|Second Intervention||10
112315|NCT01005888|259532|P2|STARTED|Second Intervention||11
112316|NCT01005888|259533|P1|STARTED|Second Intervention||11
112317|NCT01005888|259532|P2|NOT COMPLETED|First Intervention||1
112318|NCT01005888|259533|P1|NOT COMPLETED|First Intervention||1
112319|NCT01005888|259532|P2|COMPLETED|First Intervention||11
112320|NCT01005888|259533|P1|COMPLETED|First Intervention||11
112321|NCT01005888|259532|P2|STARTED|First Intervention||12
112322|NCT01005888|259533|P1|STARTED|First Intervention||12
112323|NCT01005875|259553|P1|NOT COMPLETED|Overall Study||3
112324|NCT01005875|259553|P1|COMPLETED|Overall Study||2
112325|NCT01005875|259553|P1|STARTED|Overall Study||5
112326|NCT01005745|259561|P1|NOT COMPLETED|Overall Study||6
112327|NCT01005745|259561|P1|COMPLETED|Overall Study||13
112328|NCT01005745|259561|P1|STARTED|Overall Study||19
112329|NCT01005732|259566|P1|NOT COMPLETED|Overall Study||11
112330|NCT01005732|259566|P1|COMPLETED|Overall Study||43
112331|NCT01005732|259566|P1|STARTED|Overall Study||54
112332|NCT01005719|259582|P6|NOT COMPLETED|Period 3||0
112333|NCT01005719|259583|P5|NOT COMPLETED|Period 3||0
112334|NCT01005719|259584|P4|NOT COMPLETED|Period 3||0
112335|NCT01005719|259585|P3|NOT COMPLETED|Period 3||0
112336|NCT01005719|259586|P2|NOT COMPLETED|Period 3||0
112337|NCT01005719|259587|P1|NOT COMPLETED|Period 3||0
112338|NCT01005719|259582|P6|COMPLETED|Period 3||9
112339|NCT01005719|259583|P5|COMPLETED|Period 3||10
112340|NCT01005719|259584|P4|COMPLETED|Period 3||10
112341|NCT01005719|259585|P3|COMPLETED|Period 3||10
112342|NCT01005719|259586|P2|COMPLETED|Period 3||10
112343|NCT01005719|259587|P1|COMPLETED|Period 3||10
112344|NCT01005719|259582|P6|STARTED|Period 3||9
112345|NCT01005719|259583|P5|STARTED|Period 3||10
112346|NCT01005719|259584|P4|STARTED|Period 3||10
112347|NCT01005719|259585|P3|STARTED|Period 3||10
112348|NCT01005719|259586|P2|STARTED|Period 3||10
112349|NCT01005719|259587|P1|STARTED|Period 3||10
112350|NCT01005719|259582|P6|NOT COMPLETED|Period 2||1
112351|NCT01005719|259583|P5|NOT COMPLETED|Period 2||1
112352|NCT01005719|259584|P4|NOT COMPLETED|Period 2||0
112353|NCT01005719|259585|P3|NOT COMPLETED|Period 2||0
112354|NCT01005719|259586|P2|NOT COMPLETED|Period 2||0
112355|NCT01005719|259587|P1|NOT COMPLETED|Period 2||0
112356|NCT01005719|259582|P6|COMPLETED|Period 2||9
112357|NCT01005719|259583|P5|COMPLETED|Period 2||10
112358|NCT01005719|259584|P4|COMPLETED|Period 2||10
112359|NCT01005719|259585|P3|COMPLETED|Period 2||10
112360|NCT01005719|259586|P2|COMPLETED|Period 2||10
112361|NCT01005719|259587|P1|COMPLETED|Period 2||10
112362|NCT01005719|259582|P6|STARTED|Period 2||10
112363|NCT01005719|259583|P5|STARTED|Period 2||11
112364|NCT01005719|259584|P4|STARTED|Period 2||10
112365|NCT01005719|259585|P3|STARTED|Period 2||10
112366|NCT01005719|259586|P2|STARTED|Period 2||10
112367|NCT01005719|259587|P1|STARTED|Period 2||10
112368|NCT01005719|259582|P6|NOT COMPLETED|Period 1||1
112369|NCT01005719|259583|P5|NOT COMPLETED|Period 1||0
112370|NCT01005719|259584|P4|NOT COMPLETED|Period 1||1
112371|NCT01005719|259585|P3|NOT COMPLETED|Period 1||0
112372|NCT01005719|259586|P2|NOT COMPLETED|Period 1||0
112373|NCT01005719|259587|P1|NOT COMPLETED|Period 1||0
112374|NCT01005719|259582|P6|COMPLETED|Period 1||10
112375|NCT01005719|259583|P5|COMPLETED|Period 1||11
112376|NCT01005719|259584|P4|COMPLETED|Period 1||10
112377|NCT01005719|259585|P3|COMPLETED|Period 1||10
112378|NCT01005719|259586|P2|COMPLETED|Period 1||10
112379|NCT01005719|259587|P1|COMPLETED|Period 1||10
112380|NCT01005719|259582|P6|STARTED|Period 1||11
112381|NCT01005719|259583|P5|STARTED|Period 1||11
112382|NCT01005719|259584|P4|STARTED|Period 1||11
112383|NCT01005719|259585|P3|STARTED|Period 1||10
112384|NCT01005719|259586|P2|STARTED|Period 1||10
112385|NCT01005719|259587|P1|STARTED|Period 1||10
112386|NCT01005706|259645|P2|NOT COMPLETED|Overall Study||0
112387|NCT01005706|259646|P1|NOT COMPLETED|Overall Study||0
112388|NCT01005706|259645|P2|COMPLETED|Overall Study||17
112389|NCT01005706|259646|P1|COMPLETED|Overall Study||23
112390|NCT01005706|259645|P2|STARTED|Overall Study||17
112391|NCT01005706|259646|P1|STARTED|Overall Study||23
112392|NCT01005680|259654|P2|NOT COMPLETED|Overall Study||11
112393|NCT01005680|259655|P1|NOT COMPLETED|Overall Study||6
112394|NCT01005680|259654|P2|COMPLETED|Overall Study||119
112395|NCT01005680|259655|P1|COMPLETED|Overall Study||120
112396|NCT01005680|259654|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
112397|NCT01005680|259655|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
112398|NCT01005680|259654|P2|STARTED|Overall Study||130
112399|NCT01005680|259655|P1|STARTED|Overall Study||126
112400|NCT01005602|259679|P2|NOT COMPLETED|Overall Study||0
112401|NCT01005602|259680|P1|NOT COMPLETED|Overall Study||1
112402|NCT01005602|259679|P2|COMPLETED|Overall Study||66
112403|NCT01005602|259680|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
112404|NCT01005602|259679|P2|STARTED|Overall Study||66
112405|NCT01005602|259680|P1|STARTED|Overall Study||66
112406|NCT01005355|259703|P3|NOT COMPLETED|Overall Study||0
112407|NCT01005355|259704|P2|NOT COMPLETED|Overall Study||0
112408|NCT01005355|259705|P1|NOT COMPLETED|Overall Study||0
112409|NCT01005355|259703|P3|COMPLETED|Overall Study||6
112410|NCT01005355|259704|P2|COMPLETED|Overall Study||6
112411|NCT01005355|259705|P1|COMPLETED|Overall Study||3
112412|NCT01005355|259703|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
112413|NCT01005355|259704|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
112414|NCT01005355|259705|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
112415|NCT01005355|259703|P3|STARTED|Overall Study||6
112416|NCT01005355|259704|P2|STARTED|Overall Study||6
112417|NCT01005355|259705|P1|STARTED|Overall Study||3
112418|NCT01005329|259740|P1|NOT COMPLETED|Overall Study||4
112419|NCT01005329|259740|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
112420|NCT01005329|259740|P1|STARTED|Overall Study||34
112421|NCT01005290|259744|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
112422|NCT01005290|259745|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
112423|NCT01005290|259746|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
112424|NCT01005290|259744|P3|COMPLETED|Period 2 (5 Weeks)||7
112425|NCT01005290|259745|P2|COMPLETED|Period 2 (5 Weeks)||13
112426|NCT01005290|259746|P1|COMPLETED|Period 2 (5 Weeks)||0
112427|NCT01005290|259744|P3|STARTED|Period 2 (5 Weeks)||9
112428|NCT01005290|259745|P2|STARTED|Period 2 (5 Weeks)||13
112429|NCT01005290|259746|P1|STARTED|Period 2 (5 Weeks)||0
112430|NCT01005290|259744|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
112431|NCT01005290|259745|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
112432|NCT01005290|259746|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
112433|NCT01005290|259744|P3|COMPLETED|Washout Period (2 Weeks)||9
112434|NCT01005290|259745|P2|COMPLETED|Washout Period (2 Weeks)||13
112435|NCT01005290|259746|P1|COMPLETED|Washout Period (2 Weeks)||0
112436|NCT01005290|259744|P3|STARTED|Washout Period (2 Weeks)||9
112437|NCT01005290|259745|P2|STARTED|Washout Period (2 Weeks)||13
112438|NCT01005290|259746|P1|STARTED|Washout Period (2 Weeks)||0
112439|NCT01005290|259744|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
112440|NCT01005290|259745|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
112441|NCT01005290|259746|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
112442|NCT01005290|259744|P3|COMPLETED|Period 1 (5 Weeks)||9
112443|NCT01005290|259745|P2|COMPLETED|Period 1 (5 Weeks)||13
112444|NCT01005290|259746|P1|COMPLETED|Period 1 (5 Weeks)||0
112445|NCT01005290|259744|P3|STARTED|Period 1 (5 Weeks)||18
112446|NCT01005290|259745|P2|STARTED|Period 1 (5 Weeks)||20
112447|NCT01005290|259746|P1|STARTED|Period 1 (5 Weeks)||0
112448|NCT01005290|259744|P3|NOT COMPLETED|Run-In||0
112449|NCT01005290|259745|P2|NOT COMPLETED|Run-In||0
112450|NCT01005290|259746|P1|NOT COMPLETED|Run-In||14
112451|NCT01005290|259744|P3|COMPLETED|Run-In||0
112452|NCT01005290|259745|P2|COMPLETED|Run-In||0
112453|NCT01005290|259746|P1|COMPLETED|Run-In||38
112454|NCT01005290|259744|P3|STARTED|Run-In||0
112455|NCT01005290|259745|P2|STARTED|Run-In||0
112456|NCT01005290|259746|P1|STARTED|Run-In||52
112457|NCT01005251|259759|P5|NOT COMPLETED|Overall Study||18
112458|NCT01005251|259760|P4|NOT COMPLETED|Overall Study||12
112459|NCT01005251|259761|P3|NOT COMPLETED|Overall Study||22
112460|NCT01005251|259762|P2|NOT COMPLETED|Overall Study||16
112461|NCT01005251|259763|P1|NOT COMPLETED|Overall Study||13
112462|NCT01005251|259759|P5|COMPLETED|Overall Study||122
112463|NCT01005251|259760|P4|COMPLETED|Overall Study||114
112464|NCT01005251|259761|P3|COMPLETED|Overall Study||114
112465|NCT01005251|259762|P2|COMPLETED|Overall Study||109
112466|NCT01005251|259763|P1|COMPLETED|Overall Study||121
112467|NCT01005251|259759|P5|STARTED|Overall Study||140
112468|NCT01005251|259760|P4|STARTED|Overall Study||126
112469|NCT01005251|259761|P3|STARTED|Overall Study||136
112470|NCT01005251|259762|P2|STARTED|Overall Study||125
112471|NCT01005251|259763|P1|STARTED|Overall Study||134
112472|NCT01004939|259780|P1|NOT COMPLETED|Overall Study||0
112473|NCT01004939|259780|P1|COMPLETED|Overall Study||120
112474|NCT01004939|259780|P1|STARTED|Overall Study||120
112475|NCT01004874|259821|P1|NOT COMPLETED|Overall Study||0
112476|NCT01004874|259821|P1|COMPLETED|Overall Study||80
112477|NCT01004874|259821|P1|STARTED|Overall Study||80
112478|NCT01004848|259832|P2|NOT COMPLETED|Overall Study||45
112479|NCT01004848|259833|P1|NOT COMPLETED|Overall Study||55
112480|NCT01004848|259832|P2|COMPLETED|Overall Study||147
112481|NCT01004848|259833|P1|COMPLETED|Overall Study||155
112482|NCT01004848|259832|P2|STARTED|Overall Study||192
112483|NCT01004848|259833|P1|STARTED|Overall Study||210
112484|NCT01004822|259871|P8|NOT COMPLETED|Overall Study||5
112485|NCT01004822|259872|P7|NOT COMPLETED|Overall Study||4
112486|NCT01004822|259873|P6|NOT COMPLETED|Overall Study||4
112487|NCT01004822|259874|P5|NOT COMPLETED|Overall Study||4
112488|NCT01004822|259875|P4|NOT COMPLETED|Overall Study||4
112489|NCT01004822|259876|P3|NOT COMPLETED|Overall Study||4
112490|NCT01004822|259877|P2|NOT COMPLETED|Overall Study||3
112491|NCT01004822|259878|P1|NOT COMPLETED|Overall Study||3
112492|NCT01004822|259871|P8|COMPLETED|Overall Study||0
112493|NCT01004822|259872|P7|COMPLETED|Overall Study||0
112494|NCT01004822|259873|P6|COMPLETED|Overall Study||0
112495|NCT01004822|259874|P5|COMPLETED|Overall Study||0
112496|NCT01004822|259875|P4|COMPLETED|Overall Study||0
112497|NCT01004822|259876|P3|COMPLETED|Overall Study||0
112498|NCT01004822|259877|P2|COMPLETED|Overall Study||0
112499|NCT01004822|259878|P1|COMPLETED|Overall Study||0
112500|NCT01004822|259871|P8|Treated|Overall Study||5
112501|NCT01004822|259872|P7|Treated|Overall Study||4
112502|NCT01004822|259873|P6|Treated|Overall Study||4
112503|NCT01004822|259874|P5|Treated|Overall Study||4
112504|NCT01004822|259875|P4|Treated|Overall Study||4
112505|NCT01004822|259876|P3|Treated|Overall Study||3
112506|NCT01004822|259877|P2|Treated|Overall Study||3
112507|NCT01004822|259878|P1|Treated|Overall Study||3
112508|NCT01004822|259871|P8|STARTED|Overall Study||5
112509|NCT01004822|259872|P7|STARTED|Overall Study||4
112510|NCT01004822|259873|P6|STARTED|Overall Study||4
112511|NCT01004822|259874|P5|STARTED|Overall Study||4
112512|NCT01004822|259875|P4|STARTED|Overall Study||4
112513|NCT01004822|259876|P3|STARTED|Overall Study||4
112514|NCT01004822|259877|P2|STARTED|Overall Study||3
112515|NCT01004822|259878|P1|STARTED|Overall Study||3
112516|NCT01004770|259992|P5|NOT COMPLETED|Overall Study||0
112517|NCT01004770|259993|P4|NOT COMPLETED|Overall Study||0
112518|NCT01004770|259994|P3|NOT COMPLETED|Overall Study||0
112519|NCT01004770|259995|P2|NOT COMPLETED|Overall Study||0
112520|NCT01004770|259996|P1|NOT COMPLETED|Overall Study||0
112521|NCT01004770|259992|P5|COMPLETED|Overall Study||10
112522|NCT01004770|259993|P4|COMPLETED|Overall Study||10
112523|NCT01004770|259994|P3|COMPLETED|Overall Study||10
112524|NCT01004770|259995|P2|COMPLETED|Overall Study||10
112525|NCT01004770|259996|P1|COMPLETED|Overall Study||10
112526|NCT01004770|259992|P5|STARTED|Overall Study||10
112527|NCT01004770|259993|P4|STARTED|Overall Study||10
112528|NCT01004770|259994|P3|STARTED|Overall Study||10
112529|NCT01004770|259995|P2|STARTED|Overall Study||10
112530|NCT01004770|259996|P1|STARTED|Overall Study||10
112531|NCT01004705|260028|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
112532|NCT01004705|260029|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
112533|NCT01004705|260030|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
112534|NCT01004705|260028|P3|COMPLETED|Period 2 (12 Weeks)||9
112535|NCT01004705|260029|P2|COMPLETED|Period 2 (12 Weeks)||13
112536|NCT01004705|260030|P1|COMPLETED|Period 2 (12 Weeks)||0
112537|NCT01004705|260028|P3|STARTED|Period 2 (12 Weeks)||13
112538|NCT01004705|260029|P2|STARTED|Period 2 (12 Weeks)||13
112539|NCT01004705|260030|P1|STARTED|Period 2 (12 Weeks)||0
112540|NCT01004705|260028|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
112541|NCT01004705|260029|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
112542|NCT01004705|260030|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
112543|NCT01004705|260028|P3|COMPLETED|Washout Period (6 Weeks)||13
112544|NCT01004705|260029|P2|COMPLETED|Washout Period (6 Weeks)||13
112545|NCT01004705|260030|P1|COMPLETED|Washout Period (6 Weeks)||0
112546|NCT01004705|260028|P3|STARTED|Washout Period (6 Weeks)||13
112547|NCT01004705|260029|P2|STARTED|Washout Period (6 Weeks)||13
112548|NCT01004705|260030|P1|STARTED|Washout Period (6 Weeks)||0
112549|NCT01004705|260028|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
112550|NCT01004705|260029|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
112551|NCT01004705|260030|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
112552|NCT01004705|260028|P3|COMPLETED|Period 1 (12 Weeks)||13
112553|NCT01004705|260029|P2|COMPLETED|Period 1 (12 Weeks)||13
112554|NCT01004705|260030|P1|COMPLETED|Period 1 (12 Weeks)||0
112555|NCT01004705|260028|P3|STARTED|Period 1 (12 Weeks)||18
112556|NCT01004705|260029|P2|STARTED|Period 1 (12 Weeks)||18
112557|NCT01004705|260030|P1|STARTED|Period 1 (12 Weeks)||0
112558|NCT01004705|260028|P3|NOT COMPLETED|Run-In||0
112559|NCT01004705|260029|P2|NOT COMPLETED|Run-In||0
112560|NCT01004705|260030|P1|NOT COMPLETED|Run-In||8
112561|NCT01004705|260028|P3|COMPLETED|Run-In||0
112562|NCT01004705|260029|P2|COMPLETED|Run-In||0
112563|NCT01004705|260030|P1|COMPLETED|Run-In||36
112564|NCT01004705|260028|P3|STARTED|Run-In||0
112565|NCT01004705|260029|P2|STARTED|Run-In||0
112566|NCT01004705|260030|P1|STARTED|Run-In||44
112567|NCT01004614|260043|P4|NOT COMPLETED|Second Intervention||0
112568|NCT01004614|260044|P3|NOT COMPLETED|Second Intervention||0
112569|NCT01004614|260045|P2|NOT COMPLETED|Second Intervention||0
112570|NCT01004614|260046|P1|NOT COMPLETED|Second Intervention||0
112571|NCT01004614|260043|P4|COMPLETED|Second Intervention||12
112572|NCT01004614|260044|P3|COMPLETED|Second Intervention||12
112573|NCT01004614|260045|P2|COMPLETED|Second Intervention||11
112574|NCT01004614|260046|P1|COMPLETED|Second Intervention||12
112575|NCT01004614|260043|P4|STARTED|Second Intervention||12
112576|NCT01004614|260044|P3|STARTED|Second Intervention||12
112577|NCT01004614|260045|P2|STARTED|Second Intervention||11
112578|NCT01004614|260046|P1|STARTED|Second Intervention||12
112579|NCT01004614|260043|P4|NOT COMPLETED|Washout||0
112580|NCT01004614|260044|P3|NOT COMPLETED|Washout||0
112581|NCT01004614|260045|P2|NOT COMPLETED|Washout||1
112582|NCT01004614|260046|P1|NOT COMPLETED|Washout||0
112583|NCT01004614|260043|P4|COMPLETED|Washout||12
112584|NCT01004614|260044|P3|COMPLETED|Washout||12
112585|NCT01004614|260045|P2|COMPLETED|Washout||11
112586|NCT01004614|260046|P1|COMPLETED|Washout||12
112587|NCT01004614|260043|P4|STARTED|Washout||12
112588|NCT01004614|260044|P3|STARTED|Washout||12
112589|NCT01004614|260045|P2|STARTED|Washout||12
112590|NCT01004614|260046|P1|STARTED|Washout||12
112591|NCT01004614|260043|P4|NOT COMPLETED|First Intervention||0
112592|NCT01004614|260044|P3|NOT COMPLETED|First Intervention||0
112593|NCT01004614|260045|P2|NOT COMPLETED|First Intervention||0
112594|NCT01004614|260046|P1|NOT COMPLETED|First Intervention||0
112595|NCT01004614|260043|P4|COMPLETED|First Intervention||12
112596|NCT01004614|260044|P3|COMPLETED|First Intervention||12
112597|NCT01004614|260045|P2|COMPLETED|First Intervention||12
112598|NCT01004614|260046|P1|COMPLETED|First Intervention||12
112599|NCT01004614|260043|P4|STARTED|First Intervention||12
112600|NCT01004614|260044|P3|STARTED|First Intervention||12
112601|NCT01004614|260045|P2|STARTED|First Intervention||12
112602|NCT01004614|260046|P1|STARTED|First Intervention||12
112603|NCT01004510|260080|P1|NOT COMPLETED|Overall Study||1
112604|NCT01004510|260080|P1|COMPLETED|Overall Study||2
112605|NCT01004510|260080|P1|STARTED|Overall Study||3
112606|NCT01004432|260084|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
112607|NCT01004432|260085|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
112608|NCT01004432|260086|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
112609|NCT01004432|260087|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
112610|NCT01004432|260088|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
112611|NCT01004432|260084|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
112612|NCT01004432|260085|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
112613|NCT01004432|260086|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
112614|NCT01004432|260087|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
112615|NCT01004432|260088|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
112616|NCT01004432|260084|P5|STARTED|OL Study Extension (Week 52 - 76)||212
112617|NCT01004432|260085|P4|STARTED|OL Study Extension (Week 52 - 76)||0
112618|NCT01004432|260086|P3|STARTED|OL Study Extension (Week 52 - 76)||0
112619|NCT01004432|260087|P2|STARTED|OL Study Extension (Week 52 - 76)||0
112620|NCT01004432|260088|P1|STARTED|OL Study Extension (Week 52 - 76)||0
112621|NCT01004432|260084|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
112622|NCT01004432|260085|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
112623|NCT01004432|260086|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
112624|NCT01004432|260087|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
112625|NCT01004432|260088|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
112626|NCT01004432|260084|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
112627|NCT01004432|260085|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
112628|NCT01004432|260086|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
112629|NCT01004432|260087|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
112630|NCT01004432|260088|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
112631|NCT01004432|260084|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
112632|NCT01004432|260085|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
112633|NCT01004432|260086|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
112634|NCT01004432|260087|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
112635|NCT01004432|260088|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
112636|NCT01004432|260084|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112637|NCT01004432|260085|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112638|NCT01004432|260086|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112639|NCT01004432|260087|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112640|NCT01004432|260088|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
112641|NCT01004432|260084|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112642|NCT01004432|260085|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112643|NCT01004432|260086|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112644|NCT01004432|260087|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
112645|NCT01004432|260088|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
112646|NCT01004432|260084|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
112647|NCT01004432|260085|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
112648|NCT01004432|260086|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
112649|NCT01004432|260087|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
112650|NCT01004432|260088|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
112651|NCT01004393|260108|P1|NOT COMPLETED|Overall Study||0
112652|NCT01004393|260108|P1|COMPLETED|Overall Study||12
112653|NCT01004393|260108|P1|STARTED|Overall Study||12
112654|NCT01004354|260119|P1|NOT COMPLETED|Overall Study||0
112655|NCT01004354|260119|P1|COMPLETED|Overall Study||12
112656|NCT01004354|260119|P1|STARTED|Overall Study||12
112657|NCT01004263|260123|P1|NOT COMPLETED|Overall Study||179
112658|NCT01004263|260123|P1|COMPLETED|Overall Study||427
112659|NCT01004263|260123|P1|STARTED|Overall Study|Participants who took study drug|606
112660|NCT01004250|260131|P1|NOT COMPLETED|Follow-Up (FU) Period||1
112661|NCT01004250|260131|P1|COMPLETED|Follow-Up (FU) Period||100
112662|NCT01004250|260131|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
112663|NCT01004250|260131|P1|NOT COMPLETED|Maintenance Therapy Period||26
112664|NCT01004250|260131|P1|COMPLETED|Maintenance Therapy Period||46
112665|NCT01004250|260131|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
112666|NCT01004250|260131|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
112667|NCT01004250|260131|P1|NOT COMPLETED|Induction Therapy Period||15
112668|NCT01004250|260131|P1|COMPLETED|Induction Therapy Period||94
112669|NCT01004250|260131|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
112670|NCT01004250|260131|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
112671|NCT01004250|260131|P1|STARTED|Induction Therapy Period||109
112672|NCT01004185|260143|P2|NOT COMPLETED|Overall Study||9
112673|NCT01004185|260144|P1|NOT COMPLETED|Overall Study||9
112674|NCT01004185|260143|P2|COMPLETED|Overall Study||11
112675|NCT01004185|260144|P1|COMPLETED|Overall Study||10
112676|NCT01004185|260143|P2|STARTED|Overall Study||20
112677|NCT01004185|260144|P1|STARTED|Overall Study||19
112678|NCT01004159|260152|P1|NOT COMPLETED|Overall Study||20
112679|NCT01004159|260152|P1|COMPLETED|Overall Study||0
112680|NCT01004159|260152|P1|STARTED|Overall Study||20
112681|NCT01004146|260159|P2|NOT COMPLETED|Overall Study||5
112682|NCT01004146|260160|P1|NOT COMPLETED|Overall Study||4
112683|NCT01004146|260159|P2|COMPLETED|Overall Study||20
112684|NCT01004146|260160|P1|COMPLETED|Overall Study||21
112685|NCT01004146|260159|P2|Have Incentive Spirometry Data|Overall Study||20
112686|NCT01004146|260160|P1|Have Incentive Spirometry Data|Overall Study||21
112687|NCT01004146|260159|P2|STARTED|Overall Study||25
112688|NCT01004146|260160|P1|STARTED|Overall Study||25
112689|NCT01004003|260175|P9|NOT COMPLETED|Overall Study||30
112690|NCT01004003|260176|P8|NOT COMPLETED|Overall Study||60
112691|NCT01004003|260177|P7|NOT COMPLETED|Overall Study||8
112692|NCT01004003|260178|P6|NOT COMPLETED|Overall Study||4
112693|NCT01004003|260179|P5|NOT COMPLETED|Overall Study||4
112694|NCT01004003|260180|P4|NOT COMPLETED|Overall Study||3
112695|NCT01004003|260181|P3|NOT COMPLETED|Overall Study||4
112696|NCT01004003|260182|P2|NOT COMPLETED|Overall Study||3
112697|NCT01004003|260183|P1|NOT COMPLETED|Overall Study||6
112698|NCT01004003|260175|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
112699|NCT01004003|260176|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
112700|NCT01004003|260177|P7|COMPLETED|Overall Study||0
112701|NCT01004003|260178|P6|COMPLETED|Overall Study||0
112702|NCT01004003|260179|P5|COMPLETED|Overall Study||0
112703|NCT01004003|260180|P4|COMPLETED|Overall Study||0
112704|NCT01004003|260181|P3|COMPLETED|Overall Study||0
112705|NCT01004003|260182|P2|COMPLETED|Overall Study||0
112706|NCT01004003|260183|P1|COMPLETED|Overall Study||0
112707|NCT01004003|260175|P9|STARTED|Overall Study||31
112708|NCT01004003|260176|P8|STARTED|Overall Study||62
112709|NCT01004003|260177|P7|STARTED|Overall Study||8
112710|NCT01004003|260178|P6|STARTED|Overall Study||4
112711|NCT01004003|260179|P5|STARTED|Overall Study||4
112712|NCT01004003|260180|P4|STARTED|Overall Study||3
112713|NCT01004003|260181|P3|STARTED|Overall Study||4
112714|NCT01004003|260182|P2|STARTED|Overall Study||3
112715|NCT01004003|260183|P1|STARTED|Overall Study||6
112716|NCT01003938|260211|P1|NOT COMPLETED|Overall Study||0
112717|NCT01003938|260211|P1|COMPLETED|Overall Study||6
112718|NCT01003938|260211|P1|STARTED|Overall Study||6
112719|NCT01003899|260220|P1|NOT COMPLETED|Overall Study||47
112720|NCT01003899|260220|P1|COMPLETED|Overall Study||0
112721|NCT01003899|260220|P1|STARTED|Overall Study|enrolled|47
112722|NCT01003886|260229|P1|NOT COMPLETED|Overall Study||230
112723|NCT01003886|260229|P1|COMPLETED|Overall Study||759
112724|NCT01003886|260229|P1|STARTED|Overall Study||989
112725|NCT01002742|260240|P2|NOT COMPLETED|Overall Study||1
112726|NCT01002742|260241|P1|NOT COMPLETED|Overall Study||0
112727|NCT01002742|260240|P2|COMPLETED|Overall Study||116
112728|NCT01002742|260241|P1|COMPLETED|Overall Study||119
112729|NCT01002742|260240|P2|STARTED|Overall Study||117
112730|NCT01002742|260241|P1|STARTED|Overall Study||119
112731|NCT01003301|260277|P2|NOT COMPLETED|Overall Study||0
112732|NCT01003301|260278|P1|NOT COMPLETED|Overall Study||0
112733|NCT01003301|260277|P2|COMPLETED|Overall Study||9
112734|NCT01003301|260278|P1|COMPLETED|Overall Study||10
112735|NCT01003301|260277|P2|STARTED|Overall Study||9
112736|NCT01003301|260278|P1|STARTED|Overall Study||10
112737|NCT01003288|260286|P1|NOT COMPLETED|Overall Study||0
112738|NCT01003288|260286|P1|COMPLETED|Overall Study||255
112739|NCT01003288|260286|P1|STARTED|Overall Study||255
112740|NCT01003275|260293|P2|NOT COMPLETED|Overall Study||0
112741|NCT01003275|260294|P1|NOT COMPLETED|Overall Study||1
112742|NCT01003275|260293|P2|COMPLETED|Overall Study||11
112743|NCT01003275|260294|P1|COMPLETED|Overall Study||10
112744|NCT01003275|260293|P2|STARTED|Overall Study||11
112745|NCT01003275|260294|P1|STARTED|Overall Study||11
112746|NCT01003210|260302|P2|NOT COMPLETED|Overall Study||3
112747|NCT01003210|260303|P1|NOT COMPLETED|Overall Study||1
112748|NCT01003210|260302|P2|COMPLETED|Overall Study||102
112749|NCT01003210|260303|P1|COMPLETED|Overall Study||104
112750|NCT01003210|260302|P2|STARTED|Overall Study||105
112751|NCT01003210|260303|P1|STARTED|Overall Study||105
112752|NCT01003184|260313|P2|NOT COMPLETED|Overall Study||12
112753|NCT01003184|260314|P1|NOT COMPLETED|Overall Study||19
112754|NCT01003184|260313|P2|COMPLETED|Overall Study||99
112755|NCT01003184|260314|P1|COMPLETED|Overall Study||92
112756|NCT01003184|260313|P2|Full Analysis Set (FAS)|Overall Study||105
112757|NCT01003184|260314|P1|Full Analysis Set (FAS)|Overall Study||111
112758|NCT01003184|260313|P2|STARTED|Overall Study||111
112759|NCT01003184|260314|P1|STARTED|Overall Study||111
112760|NCT01003106|260350|P8|NOT COMPLETED|Month 6-Month 36||0
112761|NCT01003106|260351|P7|NOT COMPLETED|Month 6-Month 36||1
112762|NCT01003106|260352|P6|NOT COMPLETED|Month 6-Month 36||0
112763|NCT01003106|260353|P5|NOT COMPLETED|Month 6-Month 36||0
112764|NCT01003106|260354|P4|NOT COMPLETED|Month 6-Month 36||0
112765|NCT01003106|260355|P3|NOT COMPLETED|Month 6-Month 36||1
112766|NCT01003106|260356|P2|NOT COMPLETED|Month 6-Month 36||0
112767|NCT01003106|260357|P1|NOT COMPLETED|Month 6-Month 36||0
112768|NCT01003106|260350|P8|COMPLETED|Month 6-Month 36||18
112769|NCT01003106|260351|P7|COMPLETED|Month 6-Month 36||19
112770|NCT01003106|260352|P6|COMPLETED|Month 6-Month 36||0
112771|NCT01003106|260353|P5|COMPLETED|Month 6-Month 36||0
112772|NCT01003106|260354|P4|COMPLETED|Month 6-Month 36||20
112773|NCT01003106|260355|P3|COMPLETED|Month 6-Month 36||18
112774|NCT01003106|260356|P2|COMPLETED|Month 6-Month 36||0
112775|NCT01003106|260357|P1|COMPLETED|Month 6-Month 36||0
112776|NCT01003106|260350|P8|STARTED|Month 6-Month 36||18
112777|NCT01003106|260351|P7|STARTED|Month 6-Month 36||20
112778|NCT01003106|260352|P6|STARTED|Month 6-Month 36||0
112779|NCT01003106|260353|P5|STARTED|Month 6-Month 36||0
112780|NCT01003106|260354|P4|STARTED|Month 6-Month 36||20
112781|NCT01003106|260355|P3|STARTED|Month 6-Month 36||19
112782|NCT01003106|260356|P2|STARTED|Month 6-Month 36||0
112783|NCT01003106|260357|P1|STARTED|Month 6-Month 36||0
112784|NCT01003106|260350|P8|NOT COMPLETED|Baseline to Month 6||0
112785|NCT01003106|260351|P7|NOT COMPLETED|Baseline to Month 6||0
112786|NCT01003106|260352|P6|NOT COMPLETED|Baseline to Month 6||0
112787|NCT01003106|260353|P5|NOT COMPLETED|Baseline to Month 6||0
112788|NCT01003106|260354|P4|NOT COMPLETED|Baseline to Month 6||0
112789|NCT01003106|260355|P3|NOT COMPLETED|Baseline to Month 6||0
112790|NCT01003106|260356|P2|NOT COMPLETED|Baseline to Month 6||0
112791|NCT01003106|260357|P1|NOT COMPLETED|Baseline to Month 6||0
112792|NCT01003106|260350|P8|COMPLETED|Baseline to Month 6||0
112793|NCT01003106|260351|P7|COMPLETED|Baseline to Month 6||0
112794|NCT01003106|260352|P6|COMPLETED|Baseline to Month 6||20
112795|NCT01003106|260353|P5|COMPLETED|Baseline to Month 6||19
112796|NCT01003106|260354|P4|COMPLETED|Baseline to Month 6||0
112797|NCT01003106|260355|P3|COMPLETED|Baseline to Month 6||0
112798|NCT01003106|260356|P2|COMPLETED|Baseline to Month 6||20
112799|NCT01003106|260357|P1|COMPLETED|Baseline to Month 6||22
112800|NCT01003106|260350|P8|STARTED|Baseline to Month 6||0
112801|NCT01003106|260351|P7|STARTED|Baseline to Month 6||0
112802|NCT01003106|260352|P6|STARTED|Baseline to Month 6||20
112803|NCT01003106|260353|P5|STARTED|Baseline to Month 6||19
112804|NCT01003106|260354|P4|STARTED|Baseline to Month 6||0
112805|NCT01003106|260355|P3|STARTED|Baseline to Month 6||0
112806|NCT01003106|260356|P2|STARTED|Baseline to Month 6||20
112807|NCT01003106|260357|P1|STARTED|Baseline to Month 6||22
112808|NCT01003080|260381|P2|NOT COMPLETED|Overall Study||0
112809|NCT01003080|260382|P1|NOT COMPLETED|Overall Study||0
112810|NCT01003080|260381|P2|COMPLETED|Overall Study||61
112811|NCT01003080|260382|P1|COMPLETED|Overall Study||50
112812|NCT01003080|260381|P2|STARTED|Overall Study||61
112813|NCT01003080|260382|P1|STARTED|Overall Study||50
112814|NCT01002989|260388|P1|NOT COMPLETED|Overall Study||5
112815|NCT01002989|260388|P1|COMPLETED|Overall Study||93
112816|NCT01002989|260388|P1|STARTED|Overall Study||98
112817|NCT01002573|260397|P2|NOT COMPLETED|Overall Study||7
112818|NCT01002573|260398|P1|NOT COMPLETED|Overall Study||11
112819|NCT01002573|260397|P2|COMPLETED|Overall Study||53
112820|NCT01002573|260398|P1|COMPLETED|Overall Study||47
112821|NCT01002573|260397|P2|STARTED|Overall Study||60
112822|NCT01002573|260398|P1|STARTED|Overall Study||58
112823|NCT01002482|260418|P2|NOT COMPLETED|Overall Study||21
112824|NCT01002482|260419|P1|NOT COMPLETED|Overall Study||15
112825|NCT01002482|260418|P2|COMPLETED|Overall Study||1312
112826|NCT01002482|260419|P1|COMPLETED|Overall Study||1336
112827|NCT01002482|260418|P2|STARTED|Overall Study||1333
112828|NCT01002482|260419|P1|STARTED|Overall Study||1351
112829|NCT01002456|260441|P2|NOT COMPLETED|Overall Study||0
112830|NCT01002456|260442|P1|NOT COMPLETED|Overall Study||0
112831|NCT01002456|260441|P2|COMPLETED|Overall Study||122
112832|NCT01002456|260442|P1|COMPLETED|Overall Study||98
112833|NCT01002456|260441|P2|STARTED|Overall Study||122
112834|NCT01002456|260442|P1|STARTED|Overall Study||98
112835|NCT01002339|260453|P3|NOT COMPLETED|Overall Study||5
112836|NCT01002339|260454|P2|NOT COMPLETED|Overall Study||1
112837|NCT01002339|260455|P1|NOT COMPLETED|Overall Study||0
112838|NCT01002339|260453|P3|COMPLETED|Overall Study||42
112839|NCT01002339|260454|P2|COMPLETED|Overall Study||42
112840|NCT01002339|260455|P1|COMPLETED|Overall Study||44
112841|NCT01002339|260453|P3|STARTED|Overall Study||47
112842|NCT01002339|260454|P2|STARTED|Overall Study||43
112843|NCT01002339|260455|P1|STARTED|Overall Study||44
112844|NCT01002287|260510|P2|NOT COMPLETED|Overall Study||0
112845|NCT01002287|260511|P1|NOT COMPLETED|Overall Study||0
112846|NCT01002287|260510|P2|COMPLETED|Overall Study||3
112847|NCT01002287|260511|P1|COMPLETED|Overall Study||8
112848|NCT01002287|260510|P2|STARTED|Overall Study||3
112849|NCT01002287|260511|P1|STARTED|Overall Study||8
112850|NCT01002105|260525|P2|NOT COMPLETED|Overall Study||21
112851|NCT01002105|260526|P1|NOT COMPLETED|Overall Study||19
112852|NCT01002105|260525|P2|COMPLETED|Overall Study||11
112853|NCT01002105|260526|P1|COMPLETED|Overall Study||13
112854|NCT01002105|260525|P2|STARTED|Overall Study||32
112855|NCT01002105|260526|P1|STARTED|Overall Study||32
112856|NCT01001975|260544|P2|NOT COMPLETED|Overall Study||0
112857|NCT01001975|260545|P1|NOT COMPLETED|Overall Study||0
112858|NCT01001975|260544|P2|COMPLETED|Overall Study||5
112859|NCT01001975|260545|P1|COMPLETED|Overall Study||5
112860|NCT01001975|260544|P2|STARTED|Overall Study||5
112861|NCT01001975|260545|P1|STARTED|Overall Study||5
112862|NCT01001832|260555|P2|NOT COMPLETED|Follow-up Period||21
112863|NCT01001832|260556|P1|NOT COMPLETED|Follow-up Period||18
112864|NCT01001832|260555|P2|COMPLETED|Follow-up Period||30
112865|NCT01001832|260556|P1|COMPLETED|Follow-up Period||34
112866|NCT01001832|260555|P2|STARTED|Follow-up Period||51
112867|NCT01001832|260556|P1|STARTED|Follow-up Period||52
112868|NCT01001832|260555|P2|NOT COMPLETED|Long-term Period||5
112869|NCT01001832|260556|P1|NOT COMPLETED|Long-term Period||4
112870|NCT01001832|260555|P2|COMPLETED|Long-term Period||51
112871|NCT01001832|260556|P1|COMPLETED|Long-term Period||52
112872|NCT01001832|260555|P2|STARTED|Long-term Period||56
112873|NCT01001832|260556|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
112874|NCT01001832|260555|P2|NOT COMPLETED|Short-term Period||3
112875|NCT01001832|260556|P1|NOT COMPLETED|Short-term Period||2
112876|NCT01001832|260555|P2|COMPLETED|Short-term Period||56
112877|NCT01001832|260556|P1|COMPLETED|Short-term Period||57
112878|NCT01001832|260555|P2|STARTED|Short-term Period||59
112879|NCT01001832|260556|P1|STARTED|Short-term Period||59
112880|NCT01001806|260602|P3|NOT COMPLETED|Overall Study||4
112881|NCT01001806|260603|P2|NOT COMPLETED|Overall Study||1
112882|NCT01001806|260604|P1|NOT COMPLETED|Overall Study||0
112883|NCT01001806|260602|P3|COMPLETED|Overall Study||38
112884|NCT01001806|260603|P2|COMPLETED|Overall Study||41
112885|NCT01001806|260604|P1|COMPLETED|Overall Study||42
112886|NCT01001806|260602|P3|STARTED|Overall Study||42
112887|NCT01001806|260603|P2|STARTED|Overall Study||42
112888|NCT01001806|260604|P1|STARTED|Overall Study||42
112889|NCT01001767|260614|P2|NOT COMPLETED|Overall Study||0
112890|NCT01001767|260615|P1|NOT COMPLETED|Overall Study||4
112891|NCT01001767|260614|P2|COMPLETED|Overall Study||17
112892|NCT01001767|260615|P1|COMPLETED|Overall Study||14
112893|NCT01001767|260614|P2|STARTED|Overall Study||17
112894|NCT01001767|260615|P1|STARTED|Overall Study||18
112895|NCT01001702|260621|P1|NOT COMPLETED|Overall Study||72
112896|NCT01001702|260621|P1|COMPLETED|Overall Study||13
112897|NCT01001702|260621|P1|STARTED|Overall Study||85
112898|NCT01001572|260634|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
112899|NCT01001572|260635|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
112900|NCT01001572|260636|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
112901|NCT01001572|260634|P3|COMPLETED|Double-Blind Treatment Phase||306
112902|NCT01001572|260635|P2|COMPLETED|Double-Blind Treatment Phase||319
112903|NCT01001572|260636|P1|COMPLETED|Double-Blind Treatment Phase||0
112904|NCT01001572|260634|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
112905|NCT01001572|260635|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
112906|NCT01001572|260636|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
112907|NCT01001572|260634|P3|STARTED|Double-Blind Treatment Phase||325
112908|NCT01001572|260635|P2|STARTED|Double-Blind Treatment Phase||329
112909|NCT01001572|260636|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
112910|NCT01001572|260634|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
112911|NCT01001572|260635|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
112912|NCT01001572|260636|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
112913|NCT01001572|260634|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
112914|NCT01001572|260635|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
112915|NCT01001572|260636|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
112916|NCT01001572|260634|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
112917|NCT01001572|260635|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
112918|NCT01001572|260636|P1|STARTED|Single-Blind Valsartan 160 mg||932
112919|NCT01001559|260652|P2|NOT COMPLETED|Overall Study||0
112920|NCT01001559|260653|P1|NOT COMPLETED|Overall Study||0
112921|NCT01001559|260652|P2|COMPLETED|Overall Study||147
112922|NCT01001559|260653|P1|COMPLETED|Overall Study||95
112923|NCT01001559|260652|P2|STARTED|Overall Study||147
112924|NCT01001559|260653|P1|STARTED|Overall Study||95
112925|NCT01001546|260667|P2|NOT COMPLETED|Overall Study||0
112926|NCT01001546|260668|P1|NOT COMPLETED|Overall Study||0
112927|NCT01001546|260667|P2|COMPLETED|Overall Study||207
112928|NCT01001546|260668|P1|COMPLETED|Overall Study||206
112929|NCT01001546|260667|P2|STARTED|Overall Study||207
112930|NCT01001546|260668|P1|STARTED|Overall Study||206
112931|NCT01001520|260674|P2|NOT COMPLETED|Medication Period 2||3
112932|NCT01001520|260675|P1|NOT COMPLETED|Medication Period 2||0
112933|NCT01001520|260674|P2|COMPLETED|Medication Period 2||13
112934|NCT01001520|260675|P1|COMPLETED|Medication Period 2||16
112935|NCT01001520|260674|P2|STARTED|Medication Period 2||16
112936|NCT01001520|260675|P1|STARTED|Medication Period 2||16
112937|NCT01001520|260674|P2|NOT COMPLETED|Washout Period||1
112938|NCT01001520|260675|P1|NOT COMPLETED|Washout Period||2
112939|NCT01001520|260674|P2|COMPLETED|Washout Period||16
112940|NCT01001520|260675|P1|COMPLETED|Washout Period||16
112941|NCT01001520|260674|P2|STARTED|Washout Period||17
112942|NCT01001520|260675|P1|STARTED|Washout Period||18
112943|NCT01001520|260674|P2|NOT COMPLETED|Medication Period 1||7
112944|NCT01001520|260675|P1|NOT COMPLETED|Medication Period 1||4
112945|NCT01001520|260674|P2|COMPLETED|Medication Period 1||17
112946|NCT01001520|260675|P1|COMPLETED|Medication Period 1||18
112947|NCT01001520|260674|P2|STARTED|Medication Period 1||24
112948|NCT01001520|260675|P1|STARTED|Medication Period 1||22
112949|NCT01001494|260702|P3|NOT COMPLETED|Overall Study||41
112950|NCT01001494|260703|P2|NOT COMPLETED|Overall Study||17
112951|NCT01001494|260704|P1|NOT COMPLETED|Overall Study||24
112952|NCT01001494|260702|P3|COMPLETED|Overall Study||232
112953|NCT01001494|260703|P2|COMPLETED|Overall Study||252
112954|NCT01001494|260704|P1|COMPLETED|Overall Study||253
112955|NCT01001494|260702|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
112956|NCT01001494|260703|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
112957|NCT01001494|260704|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
112958|NCT01001403|260726|P2|NOT COMPLETED|Overall Study||0
112959|NCT01001403|260727|P1|NOT COMPLETED|Overall Study||0
112960|NCT01001403|260726|P2|COMPLETED|Overall Study||31
112961|NCT01001403|260727|P1|COMPLETED|Overall Study||31
112962|NCT01001403|260726|P2|STARTED|Overall Study||31
112963|NCT01001403|260727|P1|STARTED|Overall Study||31
112964|NCT01001390|260733|P2|NOT COMPLETED|Overall Study||0
112965|NCT01001390|260734|P1|NOT COMPLETED|Overall Study||2
112966|NCT01001390|260733|P2|COMPLETED|Overall Study||0
112967|NCT01001390|260734|P1|COMPLETED|Overall Study||0
112968|NCT01001390|260733|P2|STARTED|Overall Study||0
112969|NCT01001390|260734|P1|STARTED|Overall Study||2
112970|NCT01001377|260742|P2|NOT COMPLETED|Overall Study||421
112971|NCT01001377|260743|P1|NOT COMPLETED|Overall Study||426
112972|NCT01001377|260742|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
112973|NCT01001377|260743|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
112974|NCT01001377|260742|P2|Received Treatment|Overall Study||499
112975|NCT01001377|260743|P1|Received Treatment|Overall Study||500
112976|NCT01001377|260742|P2|STARTED|Overall Study||506
112977|NCT01001377|260743|P1|STARTED|Overall Study||504
112978|NCT01001325|260773|P2|NOT COMPLETED|Overall Study||10
112979|NCT01001325|260774|P1|NOT COMPLETED|Overall Study||18
112980|NCT01001325|260773|P2|COMPLETED|Overall Study||224
112981|NCT01001325|260774|P1|COMPLETED|Overall Study||216
112982|NCT01001325|260773|P2|STARTED|Overall Study||234
112983|NCT01001325|260774|P1|STARTED|Overall Study||234
112984|NCT01001299|260780|P1|NOT COMPLETED|Overall Study||25
112985|NCT01001299|260780|P1|COMPLETED|Overall Study||0
112986|NCT01001299|260780|P1|STARTED|Overall Study||25
112987|NCT01001234|260809|P5|NOT COMPLETED|Overall Study||0
112988|NCT01001234|260810|P4|NOT COMPLETED|Overall Study||25
112989|NCT01001234|260811|P3|NOT COMPLETED|Overall Study||32
112990|NCT01001234|260812|P2|NOT COMPLETED|Overall Study||26
112991|NCT01001234|260813|P1|NOT COMPLETED|Overall Study||405
112992|NCT01001234|260809|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
112993|NCT01001234|260810|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
112994|NCT01001234|260811|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
112995|NCT01001234|260812|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
112996|NCT01001234|260813|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
112997|NCT01001234|260809|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
112998|NCT01001234|260810|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
112999|NCT01001234|260811|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
113000|NCT01001234|260812|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
113001|NCT01001234|260813|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
113002|NCT01001234|260809|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
113003|NCT01001234|260810|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
113004|NCT01001234|260811|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
113005|NCT01001234|260812|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
113006|NCT01001234|260813|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
113007|NCT01001234|260809|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
113008|NCT01001234|260810|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
113009|NCT01001234|260811|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
113010|NCT01001234|260812|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
113011|NCT01001234|260813|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
113012|NCT01001221|260829|P5|NOT COMPLETED|Overall Study||0
113013|NCT01001221|260830|P4|NOT COMPLETED|Overall Study||6
113014|NCT01001221|260831|P3|NOT COMPLETED|Overall Study||3
113015|NCT01001221|260832|P2|NOT COMPLETED|Overall Study||5
113016|NCT01001221|260833|P1|NOT COMPLETED|Overall Study||5
113017|NCT01001221|260829|P5|COMPLETED|Overall Study||0
113018|NCT01001221|260830|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
113019|NCT01001221|260831|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
113020|NCT01001221|260832|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
113021|NCT01001221|260833|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
113022|NCT01001221|260829|P5|Completed 1st Treatment Cycle|Overall Study||0
113023|NCT01001221|260830|P4|Completed 1st Treatment Cycle|Overall Study||6
113024|NCT01001221|260831|P3|Completed 1st Treatment Cycle|Overall Study||2
113025|NCT01001221|260832|P2|Completed 1st Treatment Cycle|Overall Study||5
113026|NCT01001221|260833|P1|Completed 1st Treatment Cycle|Overall Study||5
113027|NCT01001221|260829|P5|Treated|Overall Study||0
113028|NCT01001221|260830|P4|Treated|Overall Study||6
113029|NCT01001221|260831|P3|Treated|Overall Study||2
113030|NCT01001221|260832|P2|Treated|Overall Study||5
113031|NCT01001221|260833|P1|Treated|Overall Study||5
113032|NCT01001221|260829|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
113033|NCT01001221|260830|P4|STARTED|Overall Study||6
113034|NCT01001221|260831|P3|STARTED|Overall Study||3
113035|NCT01001221|260832|P2|STARTED|Overall Study||5
113036|NCT01001221|260833|P1|STARTED|Overall Study||5
113037|NCT01001208|261008|P2|NOT COMPLETED|Overall Study||33
113038|NCT01001208|261009|P1|NOT COMPLETED|Overall Study||28
113039|NCT01001208|261008|P2|COMPLETED|Overall Study||206
113040|NCT01001208|261009|P1|COMPLETED|Overall Study||211
113041|NCT01001208|261008|P2|STARTED|Overall Study||239
113042|NCT01001208|261009|P1|STARTED|Overall Study||239
113043|NCT01001195|261037|P4|NOT COMPLETED|Overall Study||0
113044|NCT01001195|261038|P3|NOT COMPLETED|Overall Study||0
113045|NCT01001195|261039|P2|NOT COMPLETED|Overall Study||2
113046|NCT01001195|261040|P1|NOT COMPLETED|Overall Study||2
113047|NCT01001195|261037|P4|COMPLETED|Overall Study||41
113048|NCT01001195|261038|P3|COMPLETED|Overall Study||44
113049|NCT01001195|261039|P2|COMPLETED|Overall Study||39
113050|NCT01001195|261040|P1|COMPLETED|Overall Study||37
113051|NCT01001195|261037|P4|STARTED|Overall Study||41
113052|NCT01001195|261038|P3|STARTED|Overall Study||44
113053|NCT01001195|261039|P2|STARTED|Overall Study||41
113054|NCT01001195|261040|P1|STARTED|Overall Study||39
113055|NCT01001104|261054|P4|NOT COMPLETED|Overall Study||3
113056|NCT01001104|261055|P3|NOT COMPLETED|Overall Study||1
113057|NCT01001104|261056|P2|NOT COMPLETED|Overall Study||1
113058|NCT01001104|261057|P1|NOT COMPLETED|Overall Study||2
113059|NCT01001104|261054|P4|COMPLETED|Overall Study||34
113060|NCT01001104|261055|P3|COMPLETED|Overall Study||35
113061|NCT01001104|261056|P2|COMPLETED|Overall Study||36
113062|NCT01001104|261057|P1|COMPLETED|Overall Study||33
113063|NCT01001104|261054|P4|STARTED|Overall Study||37
113064|NCT01001104|261055|P3|STARTED|Overall Study||36
113065|NCT01001104|261056|P2|STARTED|Overall Study||37
113066|NCT01001104|261057|P1|STARTED|Overall Study||35
113067|NCT01001078|261104|P2|NOT COMPLETED|Overall Study||0
113068|NCT01001078|261105|P1|NOT COMPLETED|Overall Study||0
113069|NCT01001078|261104|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
113070|NCT01001078|261105|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
113071|NCT01001078|261104|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
113072|NCT01001078|261105|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
113073|NCT01001078|261104|P2|Intubated|Overall Study||1
113074|NCT01001078|261105|P1|Intubated|Overall Study||2
113075|NCT01001078|261104|P2|Received Crossover|Overall Study||3
113076|NCT01001078|261105|P1|Received Crossover|Overall Study||2
113077|NCT01001078|261104|P2|Received Allocated Intervention|Overall Study||46
113078|NCT01001078|261105|P1|Received Allocated Intervention|Overall Study||46
113079|NCT01001078|261104|P2|STARTED|Overall Study||50
113080|NCT01001078|261105|P1|STARTED|Overall Study||50
113081|NCT01001052|261121|P2|NOT COMPLETED|Overall Study||0
113082|NCT01001052|261122|P1|NOT COMPLETED|Overall Study||0
113083|NCT01001052|261121|P2|COMPLETED|Overall Study||18
113084|NCT01001052|261122|P1|COMPLETED|Overall Study||20
113085|NCT01001052|261121|P2|STARTED|Overall Study||18
113086|NCT01001052|261122|P1|STARTED|Overall Study||20
113087|NCT01000974|261135|P3|NOT COMPLETED|Booster Vaccination Phase||14
113088|NCT01000974|261136|P2|NOT COMPLETED|Booster Vaccination Phase||12
113089|NCT01000974|261137|P1|NOT COMPLETED|Booster Vaccination Phase||67
113090|NCT01000974|261135|P3|COMPLETED|Booster Vaccination Phase||386
113091|NCT01000974|261136|P2|COMPLETED|Booster Vaccination Phase||423
113092|NCT01000974|261137|P1|COMPLETED|Booster Vaccination Phase||2270
113093|NCT01000974|261135|P3|STARTED|Booster Vaccination Phase||400
113094|NCT01000974|261136|P2|STARTED|Booster Vaccination Phase||435
113095|NCT01000974|261137|P1|STARTED|Booster Vaccination Phase||2337
113096|NCT01000974|261135|P3|NOT COMPLETED|Primary Vaccination Phase||63
113097|NCT01000974|261136|P2|NOT COMPLETED|Primary Vaccination Phase||50
113098|NCT01000974|261137|P1|NOT COMPLETED|Primary Vaccination Phase||338
113099|NCT01000974|261135|P3|COMPLETED|Primary Vaccination Phase||457
113100|NCT01000974|261136|P2|COMPLETED|Primary Vaccination Phase||470
113101|NCT01000974|261137|P1|COMPLETED|Primary Vaccination Phase||2625
113102|NCT01000974|261135|P3|STARTED|Primary Vaccination Phase||520
113103|NCT01000974|261136|P2|STARTED|Primary Vaccination Phase||520
113104|NCT01000974|261137|P1|STARTED|Primary Vaccination Phase||2963
113105|NCT01000961|261214|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
113106|NCT01000961|261215|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
113107|NCT01000961|261214|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
113108|NCT01000961|261215|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
113109|NCT01000961|261214|P2|STARTED|Second Intervention (3 Weeks)||20
113110|NCT01000961|261215|P1|STARTED|Second Intervention (3 Weeks)||21
113111|NCT01000961|261214|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
113112|NCT01000961|261215|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
113113|NCT01000961|261214|P2|COMPLETED|First Intervention (3 Weeks)||20
113114|NCT01000961|261215|P1|COMPLETED|First Intervention (3 Weeks)||21
113115|NCT01000961|261214|P2|STARTED|First Intervention (3 Weeks)||22
113116|NCT01000961|261215|P1|STARTED|First Intervention (3 Weeks)||21
113117|NCT01000961|261214|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
113118|NCT01000961|261215|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
113119|NCT01000961|261214|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
113120|NCT01000961|261215|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
113121|NCT01000961|261214|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
113122|NCT01000961|261215|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
113123|NCT01000818|261227|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
113124|NCT01000818|261227|P1|COMPLETED|Omeprazole + Raltegravir||18
113125|NCT01000818|261227|P1|STARTED|Omeprazole + Raltegravir||18
113126|NCT01000818|261227|P1|NOT COMPLETED|Famotidine + Raltegravir||0
113127|NCT01000818|261227|P1|COMPLETED|Famotidine + Raltegravir||18
113128|NCT01000818|261227|P1|STARTED|Famotidine + Raltegravir||18
113129|NCT01000818|261227|P1|NOT COMPLETED|Raltegravir||0
113130|NCT01000818|261227|P1|COMPLETED|Raltegravir||18
113131|NCT01000818|261227|P1|STARTED|Raltegravir||18
113132|NCT01000805|261238|P2|NOT COMPLETED|Overall Study||62
113133|NCT01000805|261239|P1|NOT COMPLETED|Overall Study||70
113134|NCT01000805|261238|P2|COMPLETED|Overall Study||204
113135|NCT01000805|261239|P1|COMPLETED|Overall Study||192
113136|NCT01000805|261238|P2|STARTED|Overall Study||266
113137|NCT01000805|261239|P1|STARTED|Overall Study||262
113138|NCT01000662|261273|P2|NOT COMPLETED|Overall Study||8
113139|NCT01000662|261274|P1|NOT COMPLETED|Overall Study||4
113140|NCT01000662|261273|P2|COMPLETED|Overall Study||198
113141|NCT01000662|261274|P1|COMPLETED|Overall Study||202
113142|NCT01000662|261273|P2|STARTED|Overall Study||206
113143|NCT01000662|261274|P1|STARTED|Overall Study||206
113144|NCT01000610|261280|P1|NOT COMPLETED|Overall Study||6
113145|NCT01000610|261280|P1|COMPLETED|Overall Study||12
113146|NCT01000610|261280|P1|STARTED|Overall Study||18
113147|NCT01000506|261291|P4|NOT COMPLETED|Overall Study||23
113148|NCT01000506|261292|P3|NOT COMPLETED|Overall Study||21
113149|NCT01000506|261293|P2|NOT COMPLETED|Overall Study||24
113150|NCT01000506|261294|P1|NOT COMPLETED|Overall Study||28
113151|NCT01000506|261291|P4|COMPLETED|Overall Study||133
113152|NCT01000506|261292|P3|COMPLETED|Overall Study||131
113153|NCT01000506|261293|P2|COMPLETED|Overall Study||129
113154|NCT01000506|261294|P1|COMPLETED|Overall Study||127
113155|NCT01000506|261291|P4|STARTED|Overall Study||156
113156|NCT01000506|261292|P3|STARTED|Overall Study||152
113157|NCT01000506|261293|P2|STARTED|Overall Study||153
113158|NCT01000506|261294|P1|STARTED|Overall Study||155
113159|NCT01000480|261336|P1|NOT COMPLETED|Follow-Up Period||0
113160|NCT01000480|261336|P1|COMPLETED|Follow-Up Period||88
113161|NCT01000480|261336|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
113162|NCT01000480|261336|P1|NOT COMPLETED|Concurrent Therapy Phase||10
113163|NCT01000480|261336|P1|COMPLETED|Concurrent Therapy Phase||65
113164|NCT01000480|261336|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
113258|NCT00999830|261480|P1|COMPLETED|Overall Study||14
113165|NCT01000480|261336|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
113166|NCT01000480|261336|P1|NOT COMPLETED|Induction Phase||7
113167|NCT01000480|261336|P1|COMPLETED|Induction Phase||83
113168|NCT01000480|261336|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
113169|NCT01000480|261336|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
113170|NCT01000480|261336|P1|STARTED|Induction Phase||90
113171|NCT01000376|261344|P2|NOT COMPLETED|Cycle 1 Day 15||0
113172|NCT01000376|261345|P1|NOT COMPLETED|Cycle 1 Day 15||0
113173|NCT01000376|261344|P2|COMPLETED|Cycle 1 Day 15||6
113174|NCT01000376|261345|P1|COMPLETED|Cycle 1 Day 15||4
113175|NCT01000376|261344|P2|STARTED|Cycle 1 Day 15||6
113176|NCT01000376|261345|P1|STARTED|Cycle 1 Day 15||4
113177|NCT01000376|261344|P2|NOT COMPLETED|Cycle 1 Day 1||0
113178|NCT01000376|261345|P1|NOT COMPLETED|Cycle 1 Day 1||2
113179|NCT01000376|261344|P2|COMPLETED|Cycle 1 Day 1||6
113180|NCT01000376|261345|P1|COMPLETED|Cycle 1 Day 1||4
113181|NCT01000376|261344|P2|STARTED|Cycle 1 Day 1||6
113182|NCT01000376|261345|P1|STARTED|Cycle 1 Day 1||6
113183|NCT01000337|261355|P2|NOT COMPLETED|Overall Study||3
113184|NCT01000337|261356|P1|NOT COMPLETED|Overall Study||4
113185|NCT01000337|261355|P2|COMPLETED|Overall Study||30
113186|NCT01000337|261356|P1|COMPLETED|Overall Study||30
113187|NCT01000337|261355|P2|STARTED|Overall Study||33
113188|NCT01000337|261356|P1|STARTED|Overall Study||34
113189|NCT01000324|261362|P1|NOT COMPLETED|Year 20||0
113190|NCT01000324|261362|P1|COMPLETED|Year 20||28
113191|NCT01000324|261362|P1|STARTED|Year 20||28
113192|NCT01000324|261362|P1|NOT COMPLETED|Year 19||0
113193|NCT01000324|261362|P1|COMPLETED|Year 19||28
113194|NCT01000324|261362|P1|STARTED|Year 19||28
113195|NCT01000324|261362|P1|NOT COMPLETED|Year 18||0
113196|NCT01000324|261362|P1|COMPLETED|Year 18||29
113197|NCT01000324|261362|P1|STARTED|Year 18||29
113198|NCT01000324|261362|P1|NOT COMPLETED|Year 17||0
113199|NCT01000324|261362|P1|COMPLETED|Year 17||32
113200|NCT01000324|261362|P1|STARTED|Year 17||32
113201|NCT01000324|261362|P1|NOT COMPLETED|Year 16||0
113202|NCT01000324|261362|P1|COMPLETED|Year 16||40
113203|NCT01000324|261362|P1|STARTED|Year 16||40
113204|NCT01000311|261374|P2|NOT COMPLETED|Overall Study||70
113205|NCT01000311|261375|P1|NOT COMPLETED|Overall Study||45
113206|NCT01000311|261374|P2|COMPLETED|Overall Study||201
113207|NCT01000311|261375|P1|COMPLETED|Overall Study||213
113208|NCT01000311|261374|P2|STARTED|Overall Study||271
113209|NCT01000311|261375|P1|STARTED|Overall Study||258
113210|NCT01000285|261405|P1|NOT COMPLETED|Overall Study||0
113211|NCT01000285|261405|P1|COMPLETED|Overall Study||18
113212|NCT01000285|261405|P1|STARTED|Overall Study||18
113213|NCT01000155|261425|P1|NOT COMPLETED|Overall Study||2
113214|NCT01000155|261425|P1|COMPLETED|Overall Study||3
113215|NCT01000155|261425|P1|STARTED|Overall Study||5
113216|NCT01000025|261431|P2|NOT COMPLETED|Overall Study||238
113217|NCT01000025|261432|P1|NOT COMPLETED|Overall Study||468
113218|NCT01000025|261431|P2|COMPLETED|Overall Study||2
113219|NCT01000025|261432|P1|COMPLETED|Overall Study||12
113220|NCT01000025|261431|P2|STARTED|Overall Study||240
113221|NCT01000025|261432|P1|STARTED|Overall Study||480
113222|NCT00999921|261450|P2|NOT COMPLETED|Overall Study||19
113223|NCT00999921|261451|P1|NOT COMPLETED|Overall Study||10
113224|NCT00999921|261450|P2|COMPLETED|Overall Study||110
113225|NCT00999921|261451|P1|COMPLETED|Overall Study||117
113226|NCT00999921|261450|P2|STARTED|Overall Study||129
113227|NCT00999921|261451|P1|STARTED|Overall Study||127
113228|NCT00999908|261461|P3|NOT COMPLETED|Treatment Period 3||0
113229|NCT00999908|261462|P2|NOT COMPLETED|Treatment Period 3||0
113230|NCT00999908|261463|P1|NOT COMPLETED|Treatment Period 3||0
113231|NCT00999908|261461|P3|COMPLETED|Treatment Period 3||19
113232|NCT00999908|261462|P2|COMPLETED|Treatment Period 3||16
113233|NCT00999908|261463|P1|COMPLETED|Treatment Period 3||16
113234|NCT00999908|261461|P3|STARTED|Treatment Period 3||19
113235|NCT00999908|261462|P2|STARTED|Treatment Period 3||16
113236|NCT00999908|261463|P1|STARTED|Treatment Period 3||16
113237|NCT00999908|261461|P3|NOT COMPLETED|Treatment Period 2||0
113238|NCT00999908|261462|P2|NOT COMPLETED|Treatment Period 2||0
113239|NCT00999908|261463|P1|NOT COMPLETED|Treatment Period 2||1
113240|NCT00999908|261461|P3|COMPLETED|Treatment Period 2||19
113241|NCT00999908|261462|P2|COMPLETED|Treatment Period 2||16
113242|NCT00999908|261463|P1|COMPLETED|Treatment Period 2||16
113243|NCT00999908|261461|P3|STARTED|Treatment Period 2||19
113244|NCT00999908|261462|P2|STARTED|Treatment Period 2||16
113245|NCT00999908|261463|P1|STARTED|Treatment Period 2||17
113246|NCT00999908|261461|P3|NOT COMPLETED|Treatment Period 1||0
113247|NCT00999908|261462|P2|NOT COMPLETED|Treatment Period 1||0
113248|NCT00999908|261463|P1|NOT COMPLETED|Treatment Period 1||2
113249|NCT00999908|261461|P3|COMPLETED|Treatment Period 1||19
113250|NCT00999908|261462|P2|COMPLETED|Treatment Period 1||16
113251|NCT00999908|261463|P1|COMPLETED|Treatment Period 1||17
113252|NCT00999908|261461|P3|STARTED|Treatment Period 1||19
113253|NCT00999908|261462|P2|STARTED|Treatment Period 1||16
113254|NCT00999908|261463|P1|STARTED|Treatment Period 1||19
113255|NCT00999830|261479|P2|NOT COMPLETED|Overall Study||0
113256|NCT00999830|261480|P1|NOT COMPLETED|Overall Study||0
113257|NCT00999830|261479|P2|COMPLETED|Overall Study||13
113259|NCT00999830|261479|P2|STARTED|Overall Study||13
113260|NCT00999830|261480|P1|STARTED|Overall Study||14
113261|NCT00999804|261492|P2|NOT COMPLETED|Overall Study||5
113262|NCT00999804|261493|P1|NOT COMPLETED|Overall Study||21
113263|NCT00999804|261492|P2|COMPLETED|Overall Study||38
113264|NCT00999804|261493|P1|COMPLETED|Overall Study||64
113265|NCT00999804|261492|P2|STARTED|Overall Study||43
113266|NCT00999804|261493|P1|STARTED|Overall Study||85
113267|NCT00999687|261505|P1|NOT COMPLETED|Second Intervention||3
113268|NCT00999687|261505|P1|COMPLETED|Second Intervention||27
113269|NCT00999687|261505|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
113270|NCT00999687|261505|P1|NOT COMPLETED|First Intervention||1
113271|NCT00999687|261505|P1|COMPLETED|First Intervention||30
113272|NCT00999687|261505|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
113273|NCT00999661|261512|P1|NOT COMPLETED|Overall Study||70
113274|NCT00999661|261512|P1|COMPLETED|Overall Study||161
113275|NCT00999661|261512|P1|STARTED|Overall Study||231
113276|NCT00999596|261518|P1|NOT COMPLETED|Overall Study||101
113277|NCT00999596|261518|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
113278|NCT00999596|261518|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
113279|NCT00999596|261518|P1|STARTED|Overall Study||107
113280|NCT00999544|261523|P1|NOT COMPLETED|Overall Study||1
113281|NCT00999544|261523|P1|COMPLETED|Overall Study||8
113282|NCT00999544|261523|P1|STARTED|Overall Study||9
113283|NCT00999466|261544|P3|NOT COMPLETED|Main Part||4
113284|NCT00999466|261545|P2|NOT COMPLETED|Main Part||4
113285|NCT00999466|261546|P1|NOT COMPLETED|Main Part||0
113286|NCT00999466|261544|P3|COMPLETED|Main Part||21
113287|NCT00999466|261545|P2|COMPLETED|Main Part||22
113288|NCT00999466|261546|P1|COMPLETED|Main Part||0
113289|NCT00999466|261544|P3|STARTED|Main Part||25
113290|NCT00999466|261545|P2|STARTED|Main Part||26
113291|NCT00999466|261546|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
113292|NCT00999466|261544|P3|NOT COMPLETED|Pilot Part||0
113293|NCT00999466|261545|P2|NOT COMPLETED|Pilot Part||0
113294|NCT00999466|261546|P1|NOT COMPLETED|Pilot Part||0
113295|NCT00999466|261544|P3|COMPLETED|Pilot Part||3
113296|NCT00999466|261545|P2|COMPLETED|Pilot Part||0
113297|NCT00999466|261546|P1|COMPLETED|Pilot Part||6
113298|NCT00999466|261544|P3|STARTED|Pilot Part||3
113299|NCT00999466|261545|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
113300|NCT00999466|261546|P1|STARTED|Pilot Part||6
113301|NCT00999167|261823|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
113302|NCT00999167|261824|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
113303|NCT00999167|261825|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
113304|NCT00999167|261823|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
113305|NCT00999167|261824|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
113306|NCT00999167|261825|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
113307|NCT00999167|261823|P3|STARTED|Part B: Randomized, Placebo Controlled||88
113308|NCT00999167|261824|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
113309|NCT00999167|261825|P1|STARTED|Part B: Randomized, Placebo Controlled||0
113310|NCT00999167|261823|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
113311|NCT00999167|261824|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
113312|NCT00999167|261825|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
113313|NCT00999167|261823|P3|COMPLETED|Part A: Open Label Safety run-in||0
113314|NCT00999167|261824|P2|COMPLETED|Part A: Open Label Safety run-in||0
113315|NCT00999167|261825|P1|COMPLETED|Part A: Open Label Safety run-in||8
113316|NCT00999167|261823|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
113317|NCT00999167|261824|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
113318|NCT00999167|261825|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
113319|NCT00999167|261823|P3|STARTED|Part A: Open Label Safety run-in||0
113320|NCT00999167|261824|P2|STARTED|Part A: Open Label Safety run-in||0
113321|NCT00999167|261825|P1|STARTED|Part A: Open Label Safety run-in||15
113322|NCT00999141|261839|P1|NOT COMPLETED|Overall Study||0
113323|NCT00999141|261839|P1|COMPLETED|Overall Study||75
113324|NCT00999141|261839|P1|STARTED|Overall Study|Randomized and treated|75
113325|NCT00998985|261935|P14|NOT COMPLETED|Overall Study||0
113326|NCT00998985|261936|P13|NOT COMPLETED|Overall Study||0
113327|NCT00998985|261937|P12|NOT COMPLETED|Overall Study||0
113328|NCT00998985|261938|P11|NOT COMPLETED|Overall Study||0
113329|NCT00998985|261939|P10|NOT COMPLETED|Overall Study||0
113330|NCT00998985|261940|P9|NOT COMPLETED|Overall Study||1
113331|NCT00998985|261941|P8|NOT COMPLETED|Overall Study||0
113332|NCT00998985|261942|P7|NOT COMPLETED|Overall Study||0
113333|NCT00998985|261943|P6|NOT COMPLETED|Overall Study||1
113334|NCT00998985|261944|P5|NOT COMPLETED|Overall Study||0
113335|NCT00998985|261945|P4|NOT COMPLETED|Overall Study||0
113336|NCT00998985|261946|P3|NOT COMPLETED|Overall Study||0
113337|NCT00998985|261947|P2|NOT COMPLETED|Overall Study||0
113338|NCT00998985|261948|P1|NOT COMPLETED|Overall Study||0
113339|NCT00998985|261935|P14|COMPLETED|Overall Study||15
113340|NCT00998985|261936|P13|COMPLETED|Overall Study||5
113341|NCT00998985|261937|P12|COMPLETED|Overall Study||5
113342|NCT00998985|261938|P11|COMPLETED|Overall Study||5
113343|NCT00998985|261939|P10|COMPLETED|Overall Study||5
113344|NCT00998985|261940|P9|COMPLETED|Overall Study||5
113345|NCT00998985|261941|P8|COMPLETED|Overall Study||5
113346|NCT00998985|261942|P7|COMPLETED|Overall Study||5
113347|NCT00998985|261943|P6|COMPLETED|Overall Study||4
113348|NCT00998985|261944|P5|COMPLETED|Overall Study||5
113349|NCT00998985|261945|P4|COMPLETED|Overall Study||5
113350|NCT00998985|261946|P3|COMPLETED|Overall Study||15
113351|NCT00998985|261947|P2|COMPLETED|Overall Study||5
113352|NCT00998985|261948|P1|COMPLETED|Overall Study||5
113353|NCT00998985|261935|P14|STARTED|Overall Study||15
113354|NCT00998985|261936|P13|STARTED|Overall Study||5
113355|NCT00998985|261937|P12|STARTED|Overall Study||5
113356|NCT00998985|261938|P11|STARTED|Overall Study||5
113357|NCT00998985|261939|P10|STARTED|Overall Study||5
113358|NCT00998985|261940|P9|STARTED|Overall Study||6
113359|NCT00998985|261941|P8|STARTED|Overall Study||5
113360|NCT00998985|261942|P7|STARTED|Overall Study||5
113361|NCT00998985|261943|P6|STARTED|Overall Study||5
113362|NCT00998985|261944|P5|STARTED|Overall Study||5
113363|NCT00998985|261945|P4|STARTED|Overall Study||5
113364|NCT00998985|261946|P3|STARTED|Overall Study||15
113365|NCT00998985|261947|P2|STARTED|Overall Study||5
113366|NCT00998985|261948|P1|STARTED|Overall Study||5
113367|NCT00998881|262016|P2|NOT COMPLETED|Overall Study||2
113368|NCT00998881|262017|P1|NOT COMPLETED|Overall Study||8
113369|NCT00998881|262016|P2|COMPLETED|Overall Study||97
113370|NCT00998881|262017|P1|COMPLETED|Overall Study||96
113371|NCT00998881|262016|P2|STARTED|Overall Study||99
113372|NCT00998881|262017|P1|STARTED|Overall Study||104
113373|NCT00998868|262029|P1|NOT COMPLETED|Overall Study||0
113374|NCT00998868|262029|P1|COMPLETED|Overall Study||51
113375|NCT00998868|262029|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
113376|NCT00998764|262038|P2|NOT COMPLETED|Overall Study||274
113377|NCT00998764|262039|P1|NOT COMPLETED|Overall Study||216
113378|NCT00998764|262038|P2|COMPLETED|Overall Study||2
113379|NCT00998764|262039|P1|COMPLETED|Overall Study||0
113380|NCT00998764|262038|P2|Treated|Overall Study||275
113381|NCT00998764|262039|P1|Treated|Overall Study||215
113382|NCT00998764|262038|P2|STARTED|Overall Study||276
113383|NCT00998764|262039|P1|STARTED|Overall Study||216
113384|NCT00998738|262061|P1|NOT COMPLETED|Overall Study||1
113385|NCT00998738|262061|P1|COMPLETED|Overall Study||0
113386|NCT00998738|262061|P1|STARTED|Overall Study||1
113387|NCT00998660|262076|P1|NOT COMPLETED|Overall Study||13
113388|NCT00998660|262076|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
113389|NCT00998660|262076|P1|Month 3 Visit|Overall Study||87
113390|NCT00998660|262076|P1|Implanted|Overall Study||93
113391|NCT00998660|262076|P1|STARTED|Overall Study||100
113392|NCT00998582|262082|P2|NOT COMPLETED|Overall Study||0
113393|NCT00998582|262083|P1|NOT COMPLETED|Overall Study||0
113394|NCT00998582|262082|P2|COMPLETED|Overall Study||14
113395|NCT00998582|262083|P1|COMPLETED|Overall Study||13
113396|NCT00998582|262082|P2|STARTED|Overall Study||14
113397|NCT00998582|262083|P1|STARTED|Overall Study||13
113398|NCT00998517|262094|P3|NOT COMPLETED|Overall Study||0
113399|NCT00998517|262095|P2|NOT COMPLETED|Overall Study||0
113400|NCT00998517|262096|P1|NOT COMPLETED|Overall Study||0
113401|NCT00998517|262094|P3|COMPLETED|Overall Study||918
113402|NCT00998517|262095|P2|COMPLETED|Overall Study||906
113403|NCT00998517|262096|P1|COMPLETED|Overall Study||888
113404|NCT00998517|262094|P3|STARTED|Overall Study||918
113405|NCT00998517|262095|P2|STARTED|Overall Study||906
113406|NCT00998517|262096|P1|STARTED|Overall Study||888
113407|NCT00998426|262122|P1|NOT COMPLETED|Overall Study||0
113408|NCT00998426|262122|P1|COMPLETED|Overall Study||5
113409|NCT00998426|262122|P1|Blood Glucose Monitoring|Overall Study||5
113410|NCT00998426|262122|P1|STARTED|Overall Study||5
113411|NCT00998374|262129|P2|NOT COMPLETED|Overall Study||11
113412|NCT00998374|262130|P1|NOT COMPLETED|Overall Study||12
113413|NCT00998374|262129|P2|COMPLETED|Overall Study||12
113414|NCT00998374|262130|P1|COMPLETED|Overall Study||27
113415|NCT00998374|262129|P2|STARTED|Overall Study||23
113416|NCT00998374|262130|P1|STARTED|Overall Study||39
113417|NCT00998335|262144|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
113418|NCT00998335|262145|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
113419|NCT00998335|262144|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
113420|NCT00998335|262145|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
113421|NCT00998335|262144|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
113422|NCT00998335|262145|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
113423|NCT00998335|262144|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
113424|NCT00998335|262145|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
113425|NCT00998335|262144|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
113426|NCT00998335|262145|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
113427|NCT00998335|262144|P2|STARTED|Initial Treatment (Months 0 - 3)||0
113428|NCT00998335|262145|P1|STARTED|Initial Treatment (Months 0 - 3)||30
113429|NCT00998309|262173|P1|NOT COMPLETED|Overall Study||4
113430|NCT00998309|262173|P1|COMPLETED|Overall Study||498
113431|NCT00998309|262173|P1|STARTED|Overall Study||502
113432|NCT00998296|262240|P11|NOT COMPLETED|Overall Study||7
113433|NCT00998296|262241|P10|NOT COMPLETED|Overall Study||18
113434|NCT00998296|262242|P9|NOT COMPLETED|Overall Study||2
113435|NCT00998296|262243|P8|NOT COMPLETED|Overall Study||2
113436|NCT00998296|262244|P7|NOT COMPLETED|Overall Study||1
113437|NCT00998296|262245|P6|NOT COMPLETED|Overall Study||0
113438|NCT00998296|262246|P5|NOT COMPLETED|Overall Study||2
113439|NCT00998296|262247|P4|NOT COMPLETED|Overall Study||0
113440|NCT00998296|262248|P3|NOT COMPLETED|Overall Study||0
113441|NCT00998296|262249|P2|NOT COMPLETED|Overall Study||1
113442|NCT00998296|262250|P1|NOT COMPLETED|Overall Study||0
113443|NCT00998296|262240|P11|COMPLETED|Overall Study||0
113444|NCT00998296|262241|P10|COMPLETED|Overall Study||0
113445|NCT00998296|262242|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
113446|NCT00998296|262243|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
113447|NCT00998296|262244|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
113448|NCT00998296|262245|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
113449|NCT00998296|262246|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
113450|NCT00998296|262247|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
113451|NCT00998296|262248|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
113452|NCT00998296|262249|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
113453|NCT00998296|262250|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
113454|NCT00998296|262240|P11|STARTED|Overall Study||7
113455|NCT00998296|262241|P10|STARTED|Overall Study||18
113456|NCT00998296|262242|P9|STARTED|Overall Study||6
113457|NCT00998296|262243|P8|STARTED|Overall Study||6
113458|NCT00998296|262244|P7|STARTED|Overall Study||7
113459|NCT00998296|262245|P6|STARTED|Overall Study||3
113460|NCT00998296|262246|P5|STARTED|Overall Study||8
113461|NCT00998296|262247|P4|STARTED|Overall Study||3
113462|NCT00998296|262248|P3|STARTED|Overall Study||3
113463|NCT00998296|262249|P2|STARTED|Overall Study||3
113464|NCT00998296|262250|P1|STARTED|Overall Study||6
113465|NCT00998049|262317|P1|NOT COMPLETED|Overall Study||0
113466|NCT00998049|262317|P1|COMPLETED|Overall Study||39
113467|NCT00998049|262317|P1|STARTED|Overall Study||39
113468|NCT00998023|262328|P2|NOT COMPLETED|Overall Study||0
113469|NCT00998023|262329|P1|NOT COMPLETED|Overall Study||0
113470|NCT00998023|262328|P2|COMPLETED|Overall Study||32
113471|NCT00998023|262329|P1|COMPLETED|Overall Study||32
113472|NCT00998023|262328|P2|STARTED|Overall Study||32
113473|NCT00998023|262329|P1|STARTED|Overall Study||32
113474|NCT00997984|262340|P3|NOT COMPLETED|Overall Study||26
113475|NCT00997984|262341|P2|NOT COMPLETED|Overall Study||34
113476|NCT00997984|262342|P1|NOT COMPLETED|Overall Study||37
113477|NCT00997984|262340|P3|COMPLETED|Overall Study||88
113478|NCT00997984|262341|P2|COMPLETED|Overall Study||79
113479|NCT00997984|262342|P1|COMPLETED|Overall Study||76
113480|NCT00997984|262340|P3|STARTED|Overall Study||114
113481|NCT00997984|262341|P2|STARTED|Overall Study||113
113482|NCT00997984|262342|P1|STARTED|Overall Study||113
113483|NCT00997672|262410|P2|NOT COMPLETED|Overall Study||4
113484|NCT00997672|262411|P1|NOT COMPLETED|Overall Study||4
113485|NCT00997672|262410|P2|COMPLETED|Overall Study||1
113486|NCT00997672|262411|P1|COMPLETED|Overall Study||0
113487|NCT00997672|262410|P2|STARTED|Overall Study||5
113488|NCT00997672|262411|P1|STARTED|Overall Study||4
113489|NCT00997594|262419|P2|NOT COMPLETED|Overall Study||0
113490|NCT00997594|262420|P1|NOT COMPLETED|Overall Study||0
113491|NCT00997594|262419|P2|COMPLETED|Overall Study||9
113492|NCT00997594|262420|P1|COMPLETED|Overall Study||9
113493|NCT00997594|262419|P2|Completion of Ablation Procedure|Overall Study||9
113494|NCT00997594|262420|P1|Completion of Ablation Procedure|Overall Study||9
113495|NCT00997594|262419|P2|STARTED|Overall Study||9
113496|NCT00997594|262420|P1|STARTED|Overall Study||9
113497|NCT00997555|262428|P2|NOT COMPLETED|Overall Study||0
113498|NCT00997555|262429|P1|NOT COMPLETED|Overall Study||0
113499|NCT00997555|262428|P2|COMPLETED|Overall Study||15
113500|NCT00997555|262429|P1|COMPLETED|Overall Study||13
113501|NCT00997555|262428|P2|STARTED|Overall Study||15
113502|NCT00997555|262429|P1|STARTED|Overall Study||13
113503|NCT00997516|262447|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
113504|NCT00997516|262448|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
113505|NCT00997516|262447|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
113506|NCT00997516|262448|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
113507|NCT00997516|262447|P2|STARTED|Long-term Follow-up (After 6 Months)||38
113508|NCT00997516|262448|P1|STARTED|Long-term Follow-up (After 6 Months)||37
113509|NCT00997516|262447|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
113510|NCT00997516|262448|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
113511|NCT00997516|262447|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
113512|NCT00997516|262448|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
113513|NCT00997516|262447|P2|STARTED|Short-term Follow-up (Post Operative)||38
113514|NCT00997516|262448|P1|STARTED|Short-term Follow-up (Post Operative)||37
113515|NCT00997503|262476|P1|NOT COMPLETED|Overall Study||273
113516|NCT00997503|262476|P1|COMPLETED|Overall Study||3926
113517|NCT00997503|262476|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
113518|NCT00997503|262476|P1|STARTED|Overall Study||4199
113519|NCT00997438|262519|P3|NOT COMPLETED|Overall Study||4
113520|NCT00997438|262520|P2|NOT COMPLETED|Overall Study||3
113521|NCT00997438|262521|P1|NOT COMPLETED|Overall Study||5
113522|NCT00997438|262519|P3|COMPLETED|Overall Study||20
113523|NCT00997438|262520|P2|COMPLETED|Overall Study||21
113524|NCT00997438|262521|P1|COMPLETED|Overall Study||16
113525|NCT00997438|262519|P3|STARTED|Overall Study||24
113526|NCT00997438|262520|P2|STARTED|Overall Study||24
113527|NCT00997438|262521|P1|STARTED|Overall Study||21
113528|NCT00997425|262556|P1|NOT COMPLETED|Overall Study||0
113529|NCT00997425|262556|P1|COMPLETED|Overall Study||19
113530|NCT00997425|262556|P1|STARTED|Overall Study||19
113531|NCT00997373|262563|P2|NOT COMPLETED|Overall Study||0
113532|NCT00997373|262564|P1|NOT COMPLETED|Overall Study||15
113533|NCT00997373|262563|P2|COMPLETED|Overall Study||15
113534|NCT00997373|262564|P1|COMPLETED|Overall Study||13
113535|NCT00997373|262563|P2|Completed Hysterectomy|Overall Study||15
113536|NCT00997373|262564|P1|Completed Hysterectomy|Overall Study||17
113537|NCT00997373|262563|P2|Received Letrozole|Overall Study||0
113538|NCT00997373|262564|P1|Received Letrozole|Overall Study||23
113539|NCT00997373|262563|P2|STARTED|Overall Study||15
113540|NCT00997373|262564|P1|STARTED|Overall Study||28
113541|NCT00997321|262572|P2|NOT COMPLETED|Overall Study||3
113542|NCT00997321|262573|P1|NOT COMPLETED|Overall Study||0
113543|NCT00997321|262572|P2|COMPLETED|Overall Study||47
113544|NCT00997321|262573|P1|COMPLETED|Overall Study||50
113545|NCT00997321|262572|P2|STARTED|Overall Study||50
113546|NCT00997321|262573|P1|STARTED|Overall Study||50
113547|NCT00997243|262585|P1|NOT COMPLETED|Overall Study||7
113548|NCT00997243|262585|P1|COMPLETED|Overall Study||0
113549|NCT00997243|262585|P1|STARTED|Overall Study||7
113550|NCT00997204|262597|P2|NOT COMPLETED|Self-administration Phase||1
113551|NCT00997204|262598|P1|NOT COMPLETED|Self-administration Phase||0
113552|NCT00997204|262597|P2|COMPLETED|Self-administration Phase||77
113553|NCT00997204|262598|P1|COMPLETED|Self-administration Phase||19
113554|NCT00997204|262597|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
113555|NCT00997204|262598|P1|STARTED|Self-administration Phase||19
113556|NCT00997204|262597|P2|NOT COMPLETED|Naive Treatment Phase||79
113557|NCT00997204|262598|P1|NOT COMPLETED|Naive Treatment Phase||6
113558|NCT00997204|262597|P2|COMPLETED|Naive Treatment Phase||0
113559|NCT00997204|262598|P1|COMPLETED|Naive Treatment Phase||19
113560|NCT00997204|262597|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
113561|NCT00997204|262598|P1|STARTED|Naive Treatment Phase||25
113562|NCT00997139|262609|P1|NOT COMPLETED|Overall Study||186
113563|NCT00997139|262609|P1|COMPLETED|Overall Study||30
113564|NCT00997139|262609|P1|Treated for Positive Baseline Culture|Overall Study||30
113565|NCT00997139|262609|P1|STARTED|Overall Study||216
113566|NCT00997126|262617|P2|NOT COMPLETED|Overall Study||11
113567|NCT00997126|262618|P1|NOT COMPLETED|Overall Study||7
113568|NCT00997126|262617|P2|COMPLETED|Overall Study||52
113569|NCT00997126|262618|P1|COMPLETED|Overall Study||56
113570|NCT00997126|262617|P2|STARTED|Overall Study||63
113571|NCT00997126|262618|P1|STARTED|Overall Study||63
113572|NCT00997113|262634|P2|NOT COMPLETED|Overall Study||0
113573|NCT00997113|262635|P1|NOT COMPLETED|Overall Study||0
113574|NCT00997113|262634|P2|COMPLETED|Overall Study||10
113575|NCT00997113|262635|P1|COMPLETED|Overall Study||10
113576|NCT00997113|262634|P2|STARTED|Overall Study||10
113577|NCT00997113|262635|P1|STARTED|Overall Study||10
113578|NCT00996996|262645|P1|NOT COMPLETED|Overall Study||33
113579|NCT00996996|262645|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
113580|NCT00996996|262645|P1|STARTED|Overall Study||77
113581|NCT00996944|262679|P2|NOT COMPLETED|Long-term Treatment Period||5
113582|NCT00996944|262680|P1|NOT COMPLETED|Long-term Treatment Period||12
113583|NCT00996944|262679|P2|COMPLETED|Long-term Treatment Period||0
113584|NCT00996944|262680|P1|COMPLETED|Long-term Treatment Period||0
113585|NCT00996944|262679|P2|STARTED|Long-term Treatment Period||5
113586|NCT00996944|262680|P1|STARTED|Long-term Treatment Period||12
113587|NCT00996944|262679|P2|NOT COMPLETED|Double-blind Treatment Period||7
113588|NCT00996944|262680|P1|NOT COMPLETED|Double-blind Treatment Period||10
113589|NCT00996944|262679|P2|COMPLETED|Double-blind Treatment Period||5
113590|NCT00996944|262680|P1|COMPLETED|Double-blind Treatment Period||12
113591|NCT00996944|262679|P2|STARTED|Double-blind Treatment Period||12
113592|NCT00996944|262680|P1|STARTED|Double-blind Treatment Period||22
113593|NCT00996931|262722|P1|NOT COMPLETED|Overall Study||0
113594|NCT00996931|262722|P1|COMPLETED|Overall Study||6
113595|NCT00996931|262722|P1|STARTED|Overall Study||6
113596|NCT00996918|262732|P5|NOT COMPLETED|Overall Study||4
113597|NCT00996918|262733|P4|NOT COMPLETED|Overall Study||56
113598|NCT00996918|262734|P3|NOT COMPLETED|Overall Study||37
113599|NCT00996918|262735|P2|NOT COMPLETED|Overall Study||66
113600|NCT00996918|262736|P1|NOT COMPLETED|Overall Study||39
113601|NCT00996918|262732|P5|COMPLETED|Overall Study||0
113602|NCT00996918|262733|P4|COMPLETED|Overall Study||0
113603|NCT00996918|262734|P3|COMPLETED|Overall Study||0
113604|NCT00996918|262735|P2|COMPLETED|Overall Study||0
113605|NCT00996918|262736|P1|COMPLETED|Overall Study||0
113606|NCT00996918|262732|P5|Treated|Overall Study||4
113607|NCT00996918|262733|P4|Treated|Overall Study||56
113608|NCT00996918|262734|P3|Treated|Overall Study||37
113609|NCT00996918|262735|P2|Treated|Overall Study||66
113610|NCT00996918|262736|P1|Treated|Overall Study||39
113611|NCT00996918|262732|P5|STARTED|Overall Study||4
113612|NCT00996918|262733|P4|STARTED|Overall Study||56
113613|NCT00996918|262734|P3|STARTED|Overall Study||37
113614|NCT00996918|262735|P2|STARTED|Overall Study||66
113615|NCT00996918|262736|P1|STARTED|Overall Study||39
113616|NCT00996892|262780|P20|NOT COMPLETED|Expansion Stage 2A||45
113617|NCT00996892|262781|P19|NOT COMPLETED|Expansion Stage 2A||0
113618|NCT00996892|262782|P18|NOT COMPLETED|Expansion Stage 2A||0
113619|NCT00996892|262783|P17|NOT COMPLETED|Expansion Stage 2A||0
113620|NCT00996892|262784|P16|NOT COMPLETED|Expansion Stage 2A||0
113621|NCT00996892|262785|P15|NOT COMPLETED|Expansion Stage 2A||0
113622|NCT00996892|262786|P14|NOT COMPLETED|Expansion Stage 2A||0
113623|NCT00996892|262787|P13|NOT COMPLETED|Expansion Stage 2A||0
113624|NCT00996892|262788|P12|NOT COMPLETED|Expansion Stage 2A||0
113625|NCT00996892|262789|P11|NOT COMPLETED|Expansion Stage 2A||0
113626|NCT00996892|262790|P10|NOT COMPLETED|Expansion Stage 2A||0
113627|NCT00996892|262791|P9|NOT COMPLETED|Expansion Stage 2A||0
113628|NCT00996892|262792|P8|NOT COMPLETED|Expansion Stage 2A||0
113629|NCT00996892|262793|P7|NOT COMPLETED|Expansion Stage 2A||0
113630|NCT00996892|262794|P6|NOT COMPLETED|Expansion Stage 2A||0
113631|NCT00996892|262795|P5|NOT COMPLETED|Expansion Stage 2A||0
113632|NCT00996892|262796|P4|NOT COMPLETED|Expansion Stage 2A||0
113633|NCT00996892|262797|P3|NOT COMPLETED|Expansion Stage 2A||0
113634|NCT00996892|262798|P2|NOT COMPLETED|Expansion Stage 2A||0
113635|NCT00996892|262799|P1|NOT COMPLETED|Expansion Stage 2A||0
113636|NCT00996892|262780|P20|COMPLETED|Expansion Stage 2A||0
113637|NCT00996892|262781|P19|COMPLETED|Expansion Stage 2A||0
113638|NCT00996892|262782|P18|COMPLETED|Expansion Stage 2A||0
113639|NCT00996892|262783|P17|COMPLETED|Expansion Stage 2A||0
113640|NCT00996892|262784|P16|COMPLETED|Expansion Stage 2A||0
113641|NCT00996892|262785|P15|COMPLETED|Expansion Stage 2A||0
113642|NCT00996892|262786|P14|COMPLETED|Expansion Stage 2A||0
113643|NCT00996892|262787|P13|COMPLETED|Expansion Stage 2A||0
113644|NCT00996892|262788|P12|COMPLETED|Expansion Stage 2A||0
113645|NCT00996892|262789|P11|COMPLETED|Expansion Stage 2A||0
113646|NCT00996892|262790|P10|COMPLETED|Expansion Stage 2A||0
113647|NCT00996892|262791|P9|COMPLETED|Expansion Stage 2A||0
113648|NCT00996892|262792|P8|COMPLETED|Expansion Stage 2A||0
113649|NCT00996892|262793|P7|COMPLETED|Expansion Stage 2A||0
113650|NCT00996892|262794|P6|COMPLETED|Expansion Stage 2A||0
113651|NCT00996892|262795|P5|COMPLETED|Expansion Stage 2A||0
113652|NCT00996892|262796|P4|COMPLETED|Expansion Stage 2A||0
113653|NCT00996892|262797|P3|COMPLETED|Expansion Stage 2A||0
113654|NCT00996892|262798|P2|COMPLETED|Expansion Stage 2A||0
113655|NCT00996892|262799|P1|COMPLETED|Expansion Stage 2A||0
113656|NCT00996892|262780|P20|STARTED|Expansion Stage 2A||45
113657|NCT00996892|262781|P19|STARTED|Expansion Stage 2A||0
113658|NCT00996892|262782|P18|STARTED|Expansion Stage 2A||0
113659|NCT00996892|262783|P17|STARTED|Expansion Stage 2A||0
113660|NCT00996892|262784|P16|STARTED|Expansion Stage 2A||0
113661|NCT00996892|262785|P15|STARTED|Expansion Stage 2A||0
113662|NCT00996892|262786|P14|STARTED|Expansion Stage 2A||0
113663|NCT00996892|262787|P13|STARTED|Expansion Stage 2A||0
113664|NCT00996892|262788|P12|STARTED|Expansion Stage 2A||0
113665|NCT00996892|262789|P11|STARTED|Expansion Stage 2A||0
113666|NCT00996892|262790|P10|STARTED|Expansion Stage 2A||0
113667|NCT00996892|262791|P9|STARTED|Expansion Stage 2A||0
113668|NCT00996892|262792|P8|STARTED|Expansion Stage 2A||0
113669|NCT00996892|262793|P7|STARTED|Expansion Stage 2A||0
113670|NCT00996892|262794|P6|STARTED|Expansion Stage 2A||0
113671|NCT00996892|262795|P5|STARTED|Expansion Stage 2A||0
113672|NCT00996892|262796|P4|STARTED|Expansion Stage 2A||0
113673|NCT00996892|262797|P3|STARTED|Expansion Stage 2A||0
113674|NCT00996892|262798|P2|STARTED|Expansion Stage 2A||0
113675|NCT00996892|262799|P1|STARTED|Expansion Stage 2A||0
113676|NCT00996892|262780|P20|NOT COMPLETED|Expansion Stage 2||0
113677|NCT00996892|262781|P19|NOT COMPLETED|Expansion Stage 2||35
113678|NCT00996892|262782|P18|NOT COMPLETED|Expansion Stage 2||0
113679|NCT00996892|262783|P17|NOT COMPLETED|Expansion Stage 2||0
113680|NCT00996892|262784|P16|NOT COMPLETED|Expansion Stage 2||0
113681|NCT00996892|262785|P15|NOT COMPLETED|Expansion Stage 2||0
113682|NCT00996892|262786|P14|NOT COMPLETED|Expansion Stage 2||0
113683|NCT00996892|262787|P13|NOT COMPLETED|Expansion Stage 2||0
113684|NCT00996892|262788|P12|NOT COMPLETED|Expansion Stage 2||0
113685|NCT00996892|262789|P11|NOT COMPLETED|Expansion Stage 2||0
113686|NCT00996892|262790|P10|NOT COMPLETED|Expansion Stage 2||0
113687|NCT00996892|262791|P9|NOT COMPLETED|Expansion Stage 2||0
113688|NCT00996892|262792|P8|NOT COMPLETED|Expansion Stage 2||0
113689|NCT00996892|262793|P7|NOT COMPLETED|Expansion Stage 2||0
113690|NCT00996892|262794|P6|NOT COMPLETED|Expansion Stage 2||0
113691|NCT00996892|262795|P5|NOT COMPLETED|Expansion Stage 2||0
113692|NCT00996892|262796|P4|NOT COMPLETED|Expansion Stage 2||0
113693|NCT00996892|262797|P3|NOT COMPLETED|Expansion Stage 2||0
113694|NCT00996892|262798|P2|NOT COMPLETED|Expansion Stage 2||0
113695|NCT00996892|262799|P1|NOT COMPLETED|Expansion Stage 2||0
113696|NCT00996892|262780|P20|COMPLETED|Expansion Stage 2||0
113697|NCT00996892|262781|P19|COMPLETED|Expansion Stage 2||0
113698|NCT00996892|262782|P18|COMPLETED|Expansion Stage 2||0
113699|NCT00996892|262783|P17|COMPLETED|Expansion Stage 2||0
113700|NCT00996892|262784|P16|COMPLETED|Expansion Stage 2||0
113701|NCT00996892|262785|P15|COMPLETED|Expansion Stage 2||0
113702|NCT00996892|262786|P14|COMPLETED|Expansion Stage 2||0
113703|NCT00996892|262787|P13|COMPLETED|Expansion Stage 2||0
113704|NCT00996892|262788|P12|COMPLETED|Expansion Stage 2||0
113705|NCT00996892|262789|P11|COMPLETED|Expansion Stage 2||0
113706|NCT00996892|262790|P10|COMPLETED|Expansion Stage 2||0
113707|NCT00996892|262791|P9|COMPLETED|Expansion Stage 2||0
113708|NCT00996892|262792|P8|COMPLETED|Expansion Stage 2||0
113709|NCT00996892|262793|P7|COMPLETED|Expansion Stage 2||0
113710|NCT00996892|262794|P6|COMPLETED|Expansion Stage 2||0
113711|NCT00996892|262795|P5|COMPLETED|Expansion Stage 2||0
113712|NCT00996892|262796|P4|COMPLETED|Expansion Stage 2||0
113713|NCT00996892|262797|P3|COMPLETED|Expansion Stage 2||0
113714|NCT00996892|262798|P2|COMPLETED|Expansion Stage 2||0
113715|NCT00996892|262799|P1|COMPLETED|Expansion Stage 2||0
113716|NCT00996892|262780|P20|STARTED|Expansion Stage 2||0
113717|NCT00996892|262781|P19|STARTED|Expansion Stage 2||35
113718|NCT00996892|262782|P18|STARTED|Expansion Stage 2||0
113719|NCT00996892|262783|P17|STARTED|Expansion Stage 2||0
113720|NCT00996892|262784|P16|STARTED|Expansion Stage 2||0
113721|NCT00996892|262785|P15|STARTED|Expansion Stage 2||0
113722|NCT00996892|262786|P14|STARTED|Expansion Stage 2||0
113723|NCT00996892|262787|P13|STARTED|Expansion Stage 2||0
113724|NCT00996892|262788|P12|STARTED|Expansion Stage 2||0
113725|NCT00996892|262789|P11|STARTED|Expansion Stage 2||0
113726|NCT00996892|262790|P10|STARTED|Expansion Stage 2||0
113727|NCT00996892|262791|P9|STARTED|Expansion Stage 2||0
113728|NCT00996892|262792|P8|STARTED|Expansion Stage 2||0
113729|NCT00996892|262793|P7|STARTED|Expansion Stage 2||0
113730|NCT00996892|262794|P6|STARTED|Expansion Stage 2||0
113731|NCT00996892|262795|P5|STARTED|Expansion Stage 2||0
113732|NCT00996892|262796|P4|STARTED|Expansion Stage 2||0
113733|NCT00996892|262797|P3|STARTED|Expansion Stage 2||0
113734|NCT00996892|262798|P2|STARTED|Expansion Stage 2||0
113735|NCT00996892|262799|P1|STARTED|Expansion Stage 2||0
113736|NCT00996892|262780|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
113737|NCT00996892|262781|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
113738|NCT00996892|262782|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
113739|NCT00996892|262783|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
113740|NCT00996892|262784|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
113741|NCT00996892|262785|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
113742|NCT00996892|262786|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
113743|NCT00996892|262787|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
113744|NCT00996892|262788|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
113745|NCT00996892|262789|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
113746|NCT00996892|262790|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
113747|NCT00996892|262791|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
113748|NCT00996892|262792|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
113749|NCT00996892|262793|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
113750|NCT00996892|262794|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
113751|NCT00996892|262795|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
113752|NCT00996892|262796|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
113753|NCT00996892|262797|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
113754|NCT00996892|262798|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
113755|NCT00996892|262799|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
113756|NCT00996892|262780|P20|COMPLETED|Dose-Escalation Stage 1B||0
113757|NCT00996892|262781|P19|COMPLETED|Dose-Escalation Stage 1B||0
113758|NCT00996892|262782|P18|COMPLETED|Dose-Escalation Stage 1B||0
113759|NCT00996892|262783|P17|COMPLETED|Dose-Escalation Stage 1B||0
113760|NCT00996892|262784|P16|COMPLETED|Dose-Escalation Stage 1B||0
113761|NCT00996892|262785|P15|COMPLETED|Dose-Escalation Stage 1B||0
113762|NCT00996892|262786|P14|COMPLETED|Dose-Escalation Stage 1B||0
113763|NCT00996892|262787|P13|COMPLETED|Dose-Escalation Stage 1B||0
113764|NCT00996892|262788|P12|COMPLETED|Dose-Escalation Stage 1B||0
113765|NCT00996892|262789|P11|COMPLETED|Dose-Escalation Stage 1B||0
113766|NCT00996892|262790|P10|COMPLETED|Dose-Escalation Stage 1B||0
113767|NCT00996892|262791|P9|COMPLETED|Dose-Escalation Stage 1B||0
113768|NCT00996892|262792|P8|COMPLETED|Dose-Escalation Stage 1B||0
113769|NCT00996892|262793|P7|COMPLETED|Dose-Escalation Stage 1B||0
113770|NCT00996892|262794|P6|COMPLETED|Dose-Escalation Stage 1B||0
113771|NCT00996892|262795|P5|COMPLETED|Dose-Escalation Stage 1B||0
113772|NCT00996892|262796|P4|COMPLETED|Dose-Escalation Stage 1B||0
113773|NCT00996892|262797|P3|COMPLETED|Dose-Escalation Stage 1B||0
113774|NCT00996892|262798|P2|COMPLETED|Dose-Escalation Stage 1B||0
113775|NCT00996892|262799|P1|COMPLETED|Dose-Escalation Stage 1B||0
113776|NCT00996892|262780|P20|STARTED|Dose-Escalation Stage 1B||0
113777|NCT00996892|262781|P19|STARTED|Dose-Escalation Stage 1B||0
113778|NCT00996892|262782|P18|STARTED|Dose-Escalation Stage 1B||5
113779|NCT00996892|262783|P17|STARTED|Dose-Escalation Stage 1B||3
113780|NCT00996892|262784|P16|STARTED|Dose-Escalation Stage 1B||3
113781|NCT00996892|262785|P15|STARTED|Dose-Escalation Stage 1B||4
113782|NCT00996892|262786|P14|STARTED|Dose-Escalation Stage 1B||0
113783|NCT00996892|262787|P13|STARTED|Dose-Escalation Stage 1B||0
113784|NCT00996892|262788|P12|STARTED|Dose-Escalation Stage 1B||0
113785|NCT00996892|262789|P11|STARTED|Dose-Escalation Stage 1B||0
113786|NCT00996892|262790|P10|STARTED|Dose-Escalation Stage 1B||0
113787|NCT00996892|262791|P9|STARTED|Dose-Escalation Stage 1B||0
113788|NCT00996892|262792|P8|STARTED|Dose-Escalation Stage 1B||0
113789|NCT00996892|262793|P7|STARTED|Dose-Escalation Stage 1B||0
113790|NCT00996892|262794|P6|STARTED|Dose-Escalation Stage 1B||0
113791|NCT00996892|262795|P5|STARTED|Dose-Escalation Stage 1B||0
113792|NCT00996892|262796|P4|STARTED|Dose-Escalation Stage 1B||0
113793|NCT00996892|262797|P3|STARTED|Dose-Escalation Stage 1B||0
113794|NCT00996892|262798|P2|STARTED|Dose-Escalation Stage 1B||0
113795|NCT00996892|262799|P1|STARTED|Dose-Escalation Stage 1B||0
113796|NCT00996892|262780|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
113797|NCT00996892|262781|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
113798|NCT00996892|262782|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
113799|NCT00996892|262783|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
113800|NCT00996892|262784|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
113801|NCT00996892|262785|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
113802|NCT00996892|262786|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
113803|NCT00996892|262787|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
113804|NCT00996892|262788|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
113805|NCT00996892|262789|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
113806|NCT00996892|262790|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
113807|NCT00996892|262791|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
113808|NCT00996892|262792|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
113809|NCT00996892|262793|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
113810|NCT00996892|262794|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
113811|NCT00996892|262795|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
113812|NCT00996892|262796|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
113813|NCT00996892|262797|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
113814|NCT00996892|262798|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
113815|NCT00996892|262799|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
113816|NCT00996892|262780|P20|COMPLETED|Dose-Escalation Stage 1A||0
113817|NCT00996892|262781|P19|COMPLETED|Dose-Escalation Stage 1A||0
113818|NCT00996892|262782|P18|COMPLETED|Dose-Escalation Stage 1A||0
113819|NCT00996892|262783|P17|COMPLETED|Dose-Escalation Stage 1A||0
113820|NCT00996892|262784|P16|COMPLETED|Dose-Escalation Stage 1A||0
113821|NCT00996892|262785|P15|COMPLETED|Dose-Escalation Stage 1A||0
113822|NCT00996892|262786|P14|COMPLETED|Dose-Escalation Stage 1A||0
113823|NCT00996892|262787|P13|COMPLETED|Dose-Escalation Stage 1A||0
113824|NCT00996892|262788|P12|COMPLETED|Dose-Escalation Stage 1A||0
113825|NCT00996892|262789|P11|COMPLETED|Dose-Escalation Stage 1A||0
113826|NCT00996892|262790|P10|COMPLETED|Dose-Escalation Stage 1A||0
113827|NCT00996892|262791|P9|COMPLETED|Dose-Escalation Stage 1A||0
113828|NCT00996892|262792|P8|COMPLETED|Dose-Escalation Stage 1A||0
113829|NCT00996892|262793|P7|COMPLETED|Dose-Escalation Stage 1A||0
113830|NCT00996892|262794|P6|COMPLETED|Dose-Escalation Stage 1A||0
113831|NCT00996892|262795|P5|COMPLETED|Dose-Escalation Stage 1A||0
113832|NCT00996892|262796|P4|COMPLETED|Dose-Escalation Stage 1A||0
113833|NCT00996892|262797|P3|COMPLETED|Dose-Escalation Stage 1A||0
113834|NCT00996892|262798|P2|COMPLETED|Dose-Escalation Stage 1A||0
113835|NCT00996892|262799|P1|COMPLETED|Dose-Escalation Stage 1A||0
113836|NCT00996892|262780|P20|STARTED|Dose-Escalation Stage 1A||0
113837|NCT00996892|262781|P19|STARTED|Dose-Escalation Stage 1A||0
113838|NCT00996892|262782|P18|STARTED|Dose-Escalation Stage 1A||0
113839|NCT00996892|262783|P17|STARTED|Dose-Escalation Stage 1A||0
113840|NCT00996892|262784|P16|STARTED|Dose-Escalation Stage 1A||0
113841|NCT00996892|262785|P15|STARTED|Dose-Escalation Stage 1A||0
113842|NCT00996892|262786|P14|STARTED|Dose-Escalation Stage 1A||5
113843|NCT00996892|262787|P13|STARTED|Dose-Escalation Stage 1A||8
113844|NCT00996892|262788|P12|STARTED|Dose-Escalation Stage 1A||9
113845|NCT00996892|262789|P11|STARTED|Dose-Escalation Stage 1A||7
113846|NCT00996892|262790|P10|STARTED|Dose-Escalation Stage 1A||4
113847|NCT00996892|262791|P9|STARTED|Dose-Escalation Stage 1A||3
113848|NCT00996892|262792|P8|STARTED|Dose-Escalation Stage 1A||3
113849|NCT00996892|262793|P7|STARTED|Dose-Escalation Stage 1A||0
113850|NCT00996892|262794|P6|STARTED|Dose-Escalation Stage 1A||0
113851|NCT00996892|262795|P5|STARTED|Dose-Escalation Stage 1A||0
113852|NCT00996892|262796|P4|STARTED|Dose-Escalation Stage 1A||0
113853|NCT00996892|262797|P3|STARTED|Dose-Escalation Stage 1A||0
113854|NCT00996892|262798|P2|STARTED|Dose-Escalation Stage 1A||0
113855|NCT00996892|262799|P1|STARTED|Dose-Escalation Stage 1A||0
113856|NCT00996892|262780|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
113857|NCT00996892|262781|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
113858|NCT00996892|262782|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
113859|NCT00996892|262783|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
113860|NCT00996892|262784|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
113861|NCT00996892|262785|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
113862|NCT00996892|262786|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
113863|NCT00996892|262787|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
113864|NCT00996892|262788|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
113865|NCT00996892|262789|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
113866|NCT00996892|262790|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
113867|NCT00996892|262791|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
113868|NCT00996892|262792|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
113869|NCT00996892|262793|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
113870|NCT00996892|262794|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
113871|NCT00996892|262795|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
113872|NCT00996892|262796|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
113873|NCT00996892|262797|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
113874|NCT00996892|262798|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
113875|NCT00996892|262799|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
113876|NCT00996892|262780|P20|COMPLETED|Dose-Escalation Stage 1||0
113877|NCT00996892|262781|P19|COMPLETED|Dose-Escalation Stage 1||0
113878|NCT00996892|262782|P18|COMPLETED|Dose-Escalation Stage 1||0
113879|NCT00996892|262783|P17|COMPLETED|Dose-Escalation Stage 1||0
113880|NCT00996892|262784|P16|COMPLETED|Dose-Escalation Stage 1||0
113881|NCT00996892|262785|P15|COMPLETED|Dose-Escalation Stage 1||0
113882|NCT00996892|262786|P14|COMPLETED|Dose-Escalation Stage 1||0
113883|NCT00996892|262787|P13|COMPLETED|Dose-Escalation Stage 1||0
113884|NCT00996892|262788|P12|COMPLETED|Dose-Escalation Stage 1||0
113885|NCT00996892|262789|P11|COMPLETED|Dose-Escalation Stage 1||0
113886|NCT00996892|262790|P10|COMPLETED|Dose-Escalation Stage 1||0
113887|NCT00996892|262791|P9|COMPLETED|Dose-Escalation Stage 1||0
113888|NCT00996892|262792|P8|COMPLETED|Dose-Escalation Stage 1||0
113889|NCT00996892|262793|P7|COMPLETED|Dose-Escalation Stage 1||0
113890|NCT00996892|262794|P6|COMPLETED|Dose-Escalation Stage 1||0
113891|NCT00996892|262795|P5|COMPLETED|Dose-Escalation Stage 1||0
113892|NCT00996892|262796|P4|COMPLETED|Dose-Escalation Stage 1||0
113893|NCT00996892|262797|P3|COMPLETED|Dose-Escalation Stage 1||0
113894|NCT00996892|262798|P2|COMPLETED|Dose-Escalation Stage 1||0
113895|NCT00996892|262799|P1|COMPLETED|Dose-Escalation Stage 1||0
113896|NCT00996892|262780|P20|STARTED|Dose-Escalation Stage 1||0
113897|NCT00996892|262781|P19|STARTED|Dose-Escalation Stage 1||0
113898|NCT00996892|262782|P18|STARTED|Dose-Escalation Stage 1||0
113899|NCT00996892|262783|P17|STARTED|Dose-Escalation Stage 1||0
113900|NCT00996892|262784|P16|STARTED|Dose-Escalation Stage 1||0
113901|NCT00996892|262785|P15|STARTED|Dose-Escalation Stage 1||0
113902|NCT00996892|262786|P14|STARTED|Dose-Escalation Stage 1||0
113903|NCT00996892|262787|P13|STARTED|Dose-Escalation Stage 1||0
113904|NCT00996892|262788|P12|STARTED|Dose-Escalation Stage 1||0
113905|NCT00996892|262789|P11|STARTED|Dose-Escalation Stage 1||0
113906|NCT00996892|262790|P10|STARTED|Dose-Escalation Stage 1||0
113907|NCT00996892|262791|P9|STARTED|Dose-Escalation Stage 1||0
113908|NCT00996892|262792|P8|STARTED|Dose-Escalation Stage 1||0
113909|NCT00996892|262793|P7|STARTED|Dose-Escalation Stage 1||4
113910|NCT00996892|262794|P6|STARTED|Dose-Escalation Stage 1||10
113911|NCT00996892|262795|P5|STARTED|Dose-Escalation Stage 1||11
113912|NCT00996892|262796|P4|STARTED|Dose-Escalation Stage 1||9
113913|NCT00996892|262797|P3|STARTED|Dose-Escalation Stage 1||3
113914|NCT00996892|262798|P2|STARTED|Dose-Escalation Stage 1||3
113915|NCT00996892|262799|P1|STARTED|Dose-Escalation Stage 1||4
113916|NCT00996801|263394|P6|NOT COMPLETED|Overall Study||19
113917|NCT00996801|263395|P5|NOT COMPLETED|Overall Study||88
113918|NCT00996801|263396|P4|NOT COMPLETED|Overall Study||31
113919|NCT00996801|263397|P3|NOT COMPLETED|Overall Study||23
113920|NCT00996801|263398|P2|NOT COMPLETED|Overall Study||16
113921|NCT00996801|263399|P1|NOT COMPLETED|Overall Study||20
113922|NCT00996801|263394|P6|COMPLETED|Overall Study||68
113923|NCT00996801|263395|P5|COMPLETED|Overall Study||0
113924|NCT00996801|263396|P4|COMPLETED|Overall Study||56
113925|NCT00996801|263397|P3|COMPLETED|Overall Study||65
113926|NCT00996801|263398|P2|COMPLETED|Overall Study||72
113927|NCT00996801|263399|P1|COMPLETED|Overall Study||68
113928|NCT00996801|263394|P6|STARTED|Overall Study||87
113929|NCT00996801|263395|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
113930|NCT00996801|263396|P4|STARTED|Overall Study||87
113931|NCT00996801|263397|P3|STARTED|Overall Study||88
113932|NCT00996801|263398|P2|STARTED|Overall Study||88
113933|NCT00996801|263399|P1|STARTED|Overall Study||88
113934|NCT00996775|263502|P2|NOT COMPLETED|Overall Study||14
113935|NCT00996775|263503|P1|NOT COMPLETED|Overall Study||11
113936|NCT00996775|263502|P2|COMPLETED|Overall Study||75
113937|NCT00996775|263503|P1|COMPLETED|Overall Study||67
113938|NCT00996775|263502|P2|STARTED|Overall Study||89
113939|NCT00996775|263503|P1|STARTED|Overall Study||78
113940|NCT00996736|263511|P2|NOT COMPLETED|Overall Study||18
113941|NCT00996736|263512|P1|NOT COMPLETED|Overall Study||21
113942|NCT00996736|263511|P2|COMPLETED|Overall Study||143
113943|NCT00996736|263512|P1|COMPLETED|Overall Study||141
113944|NCT00996736|263511|P2|3-month Visit|Overall Study||146
113945|NCT00996736|263512|P1|3-month Visit|Overall Study||146
113946|NCT00996736|263511|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
113947|NCT00996736|263512|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
113948|NCT00996736|263511|P2|STARTED|Overall Study||161
113949|NCT00996736|263512|P1|STARTED|Overall Study||162
113950|NCT00996658|263532|P2|NOT COMPLETED|Overall Study||21
113951|NCT00996658|263533|P1|NOT COMPLETED|Overall Study||16
113952|NCT00996658|263532|P2|COMPLETED|Overall Study||165
113953|NCT00996658|263533|P1|COMPLETED|Overall Study||76
113954|NCT00996658|263532|P2|STARTED|Overall Study||186
113955|NCT00996658|263533|P1|STARTED|Overall Study||92
113956|NCT00996632|263561|P2|NOT COMPLETED|Overall Study||0
113957|NCT00996632|263562|P1|NOT COMPLETED|Overall Study||0
113958|NCT00996632|263561|P2|COMPLETED|Overall Study||56
113959|NCT00996632|263562|P1|COMPLETED|Overall Study||38
113960|NCT00996632|263561|P2|STARTED|Overall Study||56
113961|NCT00996632|263562|P1|STARTED|Overall Study||38
113962|NCT00996606|263570|P1|NOT COMPLETED|Overall Study||8
113963|NCT00996606|263570|P1|COMPLETED|Overall Study||50
113964|NCT00996606|263570|P1|STARTED|Overall Study||58
113965|NCT00996593|263664|P1|NOT COMPLETED|Long-Term Follow-Up||3
113966|NCT00996593|263664|P1|COMPLETED|Long-Term Follow-Up||6
113967|NCT00996593|263664|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
113968|NCT00996593|263664|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
113969|NCT00996593|263664|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
113970|NCT00996593|263664|P1|STARTED|Dosimetric and Therapeutic Treatment||43
113971|NCT00996580|263692|P1|NOT COMPLETED|Overall Study||1453
113972|NCT00996580|263692|P1|COMPLETED|Overall Study||2144
113973|NCT00996580|263692|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
113974|NCT00996580|263692|P1|STARTED|Overall Study||3597
113975|NCT00996502|263720|P1|NOT COMPLETED|Overall Study||0
113976|NCT00996502|263720|P1|COMPLETED|Overall Study||4
113977|NCT00996502|263720|P1|STARTED|Overall Study||4
113978|NCT00996476|263729|P5|NOT COMPLETED|Overall Study||2
113979|NCT00996476|263730|P4|NOT COMPLETED|Overall Study||0
113980|NCT00996476|263731|P3|NOT COMPLETED|Overall Study||1
113981|NCT00996476|263732|P2|NOT COMPLETED|Overall Study||3
113982|NCT00996476|263733|P1|NOT COMPLETED|Overall Study||1
113983|NCT00996476|263729|P5|COMPLETED|Overall Study||11
113984|NCT00996476|263730|P4|COMPLETED|Overall Study||13
113985|NCT00996476|263731|P3|COMPLETED|Overall Study||12
113986|NCT00996476|263732|P2|COMPLETED|Overall Study||23
113987|NCT00996476|263733|P1|COMPLETED|Overall Study||26
113988|NCT00996476|263729|P5|STARTED|Overall Study||13
113989|NCT00996476|263730|P4|STARTED|Overall Study||13
113990|NCT00996476|263731|P3|STARTED|Overall Study||13
113991|NCT00996476|263732|P2|STARTED|Overall Study||26
113992|NCT00996476|263733|P1|STARTED|Overall Study||27
113993|NCT00996437|263801|P2|NOT COMPLETED|Overall Study||7
113994|NCT00996437|263802|P1|NOT COMPLETED|Overall Study||5
113995|NCT00996437|263801|P2|COMPLETED|Overall Study||129
113996|NCT00996437|263802|P1|COMPLETED|Overall Study||120
113997|NCT00996437|263801|P2|STARTED|Overall Study||136
113998|NCT00996437|263802|P1|STARTED|Overall Study||125
113999|NCT00996372|263824|P2|NOT COMPLETED|Overall Study||84
114000|NCT00996372|263825|P1|NOT COMPLETED|Overall Study||103
114001|NCT00996372|263824|P2|COMPLETED|Overall Study||397
114002|NCT00996372|263825|P1|COMPLETED|Overall Study||365
114003|NCT00996372|263824|P2|STARTED|Overall Study||481
114004|NCT00996372|263825|P1|STARTED|Overall Study||468
114005|NCT00996346|263838|P3|NOT COMPLETED|Overall Study||0
114006|NCT00996346|263839|P2|NOT COMPLETED|Overall Study||0
114007|NCT00996346|263840|P1|NOT COMPLETED|Overall Study||0
114008|NCT00996346|263838|P3|COMPLETED|Overall Study||3
114009|NCT00996346|263839|P2|COMPLETED|Overall Study||8
114010|NCT00996346|263840|P1|COMPLETED|Overall Study||6
114011|NCT00996346|263838|P3|STARTED|Overall Study||3
114012|NCT00996346|263839|P2|STARTED|Overall Study||8
114013|NCT00996346|263840|P1|STARTED|Overall Study||6
114014|NCT00996333|263847|P1|NOT COMPLETED|Overall Study||13
114015|NCT00996333|263847|P1|COMPLETED|Overall Study||33
114016|NCT00996333|263847|P1|STARTED|Overall Study||46
114017|NCT00996307|263857|P4|NOT COMPLETED|Overall Study||21
114018|NCT00996307|263858|P3|NOT COMPLETED|Overall Study||14
114019|NCT00996307|263859|P2|NOT COMPLETED|Overall Study||17
114020|NCT00996307|263860|P1|NOT COMPLETED|Overall Study||20
114021|NCT00996307|263857|P4|COMPLETED|Overall Study||144
114022|NCT00996307|263858|P3|COMPLETED|Overall Study||146
114023|NCT00996307|263859|P2|COMPLETED|Overall Study||148
114024|NCT00996307|263860|P1|COMPLETED|Overall Study||144
114025|NCT00996307|263857|P4|STARTED|Overall Study||165
114026|NCT00996307|263858|P3|STARTED|Overall Study||160
114027|NCT00996307|263859|P2|STARTED|Overall Study||165
114028|NCT00996307|263860|P1|STARTED|Overall Study||164
114029|NCT00996281|263924|P2|NOT COMPLETED|Overall Study||89
114030|NCT00996281|263925|P1|NOT COMPLETED|Overall Study||131
114031|NCT00996281|263924|P2|COMPLETED|Overall Study||330
114032|NCT00996281|263925|P1|COMPLETED|Overall Study||287
114033|NCT00996281|263924|P2|STARTED|Overall Study||419
114034|NCT00996281|263925|P1|STARTED|Overall Study||418
114035|NCT00996216|263933|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
114036|NCT00996216|263933|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
114037|NCT00996216|263933|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
114038|NCT00996216|263933|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
114039|NCT00996216|263933|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
114040|NCT00996216|263933|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
114041|NCT00996203|263949|P1|NOT COMPLETED|Overall Study||7
114042|NCT00996203|263949|P1|COMPLETED|Overall Study||194
114043|NCT00996203|263949|P1|STARTED|Overall Study||201
114044|NCT00996164|263970|P2|NOT COMPLETED|Overall Study||101
114045|NCT00996164|263971|P1|NOT COMPLETED|Overall Study||135
114046|NCT00996164|263970|P2|COMPLETED|Overall Study||446
114047|NCT00996164|263971|P1|COMPLETED|Overall Study||408
114048|NCT00996164|263970|P2|STARTED|Overall Study||547
114049|NCT00996164|263971|P1|STARTED|Overall Study||543
114050|NCT00996125|263981|P2|NOT COMPLETED|Overall Study||11
114051|NCT00996125|263982|P1|NOT COMPLETED|Overall Study||5
114052|NCT00996125|263981|P2|COMPLETED|Overall Study||365
114053|NCT00996125|263982|P1|COMPLETED|Overall Study||369
114054|NCT00996125|263981|P2|STARTED|Overall Study||376
114055|NCT00996125|263982|P1|STARTED|Overall Study||374
114056|NCT00996034|264002|P1|NOT COMPLETED|Overall Study||3
114057|NCT00996034|264002|P1|COMPLETED|Overall Study||11
114058|NCT00996034|264002|P1|STARTED|Overall Study||14
114059|NCT00995930|264008|P2|NOT COMPLETED|Overall Study||28
114060|NCT00995930|264009|P1|NOT COMPLETED|Overall Study||21
114061|NCT00995930|264008|P2|COMPLETED|Overall Study||67
114062|NCT00995930|264009|P1|COMPLETED|Overall Study||73
114063|NCT00995930|264008|P2|Imaging Analysis Set|Overall Study||92
114064|NCT00995930|264009|P1|Imaging Analysis Set|Overall Study||92
114065|NCT00995930|264008|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
114066|NCT00995930|264009|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
114067|NCT00995930|264008|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
114068|NCT00995930|264009|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
114069|NCT00995930|264008|P2|Safety Analysis Set|Overall Study||95
114070|NCT00995930|264009|P1|Safety Analysis Set|Overall Study||94
114071|NCT00995930|264008|P2|STARTED|Overall Study||95
114072|NCT00995930|264009|P1|STARTED|Overall Study||94
114073|NCT00995904|264038|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114074|NCT00995904|264039|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114075|NCT00995904|264040|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114076|NCT00995904|264041|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114077|NCT00995904|264042|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114078|NCT00995904|264043|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
114079|NCT00995904|264038|P6|COMPLETED|Follow-up Visit (Final Visit)||3
114080|NCT00995904|264039|P5|COMPLETED|Follow-up Visit (Final Visit)||5
114081|NCT00995904|264040|P4|COMPLETED|Follow-up Visit (Final Visit)||5
114082|NCT00995904|264041|P3|COMPLETED|Follow-up Visit (Final Visit)||4
114083|NCT00995904|264042|P2|COMPLETED|Follow-up Visit (Final Visit)||3
114084|NCT00995904|264043|P1|COMPLETED|Follow-up Visit (Final Visit)||4
114085|NCT00995904|264038|P6|STARTED|Follow-up Visit (Final Visit)||3
114086|NCT00995904|264039|P5|STARTED|Follow-up Visit (Final Visit)||5
114087|NCT00995904|264040|P4|STARTED|Follow-up Visit (Final Visit)||5
114088|NCT00995904|264041|P3|STARTED|Follow-up Visit (Final Visit)||4
114089|NCT00995904|264042|P2|STARTED|Follow-up Visit (Final Visit)||3
114090|NCT00995904|264043|P1|STARTED|Follow-up Visit (Final Visit)||4
114091|NCT00995904|264038|P6|NOT COMPLETED|Visit 4||0
114092|NCT00995904|264039|P5|NOT COMPLETED|Visit 4||0
114093|NCT00995904|264040|P4|NOT COMPLETED|Visit 4||0
114094|NCT00995904|264041|P3|NOT COMPLETED|Visit 4||0
114095|NCT00995904|264042|P2|NOT COMPLETED|Visit 4||0
114096|NCT00995904|264043|P1|NOT COMPLETED|Visit 4||0
114097|NCT00995904|264038|P6|COMPLETED|Visit 4||3
114098|NCT00995904|264039|P5|COMPLETED|Visit 4||5
114099|NCT00995904|264040|P4|COMPLETED|Visit 4||5
114100|NCT00995904|264041|P3|COMPLETED|Visit 4||4
114101|NCT00995904|264042|P2|COMPLETED|Visit 4||3
114102|NCT00995904|264043|P1|COMPLETED|Visit 4||4
114103|NCT00995904|264038|P6|STARTED|Visit 4||3
114104|NCT00995904|264039|P5|STARTED|Visit 4||5
114105|NCT00995904|264040|P4|STARTED|Visit 4||5
114106|NCT00995904|264041|P3|STARTED|Visit 4||4
114107|NCT00995904|264042|P2|STARTED|Visit 4||3
114108|NCT00995904|264043|P1|STARTED|Visit 4||4
114109|NCT00995904|264038|P6|NOT COMPLETED|Visit 3||0
114110|NCT00995904|264039|P5|NOT COMPLETED|Visit 3||0
114111|NCT00995904|264040|P4|NOT COMPLETED|Visit 3||0
114112|NCT00995904|264041|P3|NOT COMPLETED|Visit 3||0
114113|NCT00995904|264042|P2|NOT COMPLETED|Visit 3||0
114114|NCT00995904|264043|P1|NOT COMPLETED|Visit 3||0
114115|NCT00995904|264038|P6|COMPLETED|Visit 3||3
114116|NCT00995904|264039|P5|COMPLETED|Visit 3||5
114117|NCT00995904|264040|P4|COMPLETED|Visit 3||5
114118|NCT00995904|264041|P3|COMPLETED|Visit 3||4
114119|NCT00995904|264042|P2|COMPLETED|Visit 3||3
114120|NCT00995904|264043|P1|COMPLETED|Visit 3||4
114121|NCT00995904|264038|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
114122|NCT00995904|264039|P5|STARTED|Visit 3||5
114123|NCT00995904|264040|P4|STARTED|Visit 3||5
114124|NCT00995904|264041|P3|STARTED|Visit 3||4
114125|NCT00995904|264042|P2|STARTED|Visit 3||3
114126|NCT00995904|264043|P1|STARTED|Visit 3||4
114127|NCT00995904|264038|P6|NOT COMPLETED|Visit 2 (Randomization)||0
114128|NCT00995904|264039|P5|NOT COMPLETED|Visit 2 (Randomization)||0
114129|NCT00995904|264040|P4|NOT COMPLETED|Visit 2 (Randomization)||0
114130|NCT00995904|264041|P3|NOT COMPLETED|Visit 2 (Randomization)||0
114131|NCT00995904|264042|P2|NOT COMPLETED|Visit 2 (Randomization)||0
114132|NCT00995904|264043|P1|NOT COMPLETED|Visit 2 (Randomization)||0
114133|NCT00995904|264038|P6|COMPLETED|Visit 2 (Randomization)||4
114134|NCT00995904|264039|P5|COMPLETED|Visit 2 (Randomization)||5
114135|NCT00995904|264040|P4|COMPLETED|Visit 2 (Randomization)||5
114136|NCT00995904|264041|P3|COMPLETED|Visit 2 (Randomization)||4
114137|NCT00995904|264042|P2|COMPLETED|Visit 2 (Randomization)||3
114138|NCT00995904|264043|P1|COMPLETED|Visit 2 (Randomization)||4
114139|NCT00995904|264038|P6|STARTED|Visit 2 (Randomization)||4
114140|NCT00995904|264039|P5|STARTED|Visit 2 (Randomization)||5
114141|NCT00995904|264040|P4|STARTED|Visit 2 (Randomization)||5
114142|NCT00995904|264041|P3|STARTED|Visit 2 (Randomization)||4
114143|NCT00995904|264042|P2|STARTED|Visit 2 (Randomization)||3
114144|NCT00995904|264043|P1|STARTED|Visit 2 (Randomization)||4
114145|NCT00995865|264060|P3|NOT COMPLETED|Overall Study||1
114146|NCT00995865|264061|P2|NOT COMPLETED|Overall Study||0
114147|NCT00995865|264062|P1|NOT COMPLETED|Overall Study||2
114148|NCT00995865|264060|P3|COMPLETED|Overall Study||11
114149|NCT00995865|264061|P2|COMPLETED|Overall Study||24
114150|NCT00995865|264062|P1|COMPLETED|Overall Study||22
114151|NCT00995865|264060|P3|STARTED|Overall Study||12
114152|NCT00995865|264061|P2|STARTED|Overall Study||24
114153|NCT00995865|264062|P1|STARTED|Overall Study||24
114154|NCT00995774|264084|P2|NOT COMPLETED|Training Period 2||0
114155|NCT00995774|264085|P1|NOT COMPLETED|Training Period 2||2
114156|NCT00995774|264084|P2|COMPLETED|Training Period 2||5
114157|NCT00995774|264085|P1|COMPLETED|Training Period 2||5
114158|NCT00995774|264084|P2|STARTED|Training Period 2||5
114159|NCT00995774|264085|P1|STARTED|Training Period 2||7
114160|NCT00995774|264084|P2|NOT COMPLETED|Washout Period||0
114161|NCT00995774|264085|P1|NOT COMPLETED|Washout Period||0
114162|NCT00995774|264084|P2|COMPLETED|Washout Period||5
114163|NCT00995774|264085|P1|COMPLETED|Washout Period||7
114164|NCT00995774|264084|P2|STARTED|Washout Period||5
114165|NCT00995774|264085|P1|STARTED|Washout Period||7
114166|NCT00995774|264084|P2|NOT COMPLETED|Training Period 1||0
114167|NCT00995774|264085|P1|NOT COMPLETED|Training Period 1||0
114168|NCT00995774|264084|P2|COMPLETED|Training Period 1||5
114169|NCT00995774|264085|P1|COMPLETED|Training Period 1||7
114170|NCT00995774|264084|P2|STARTED|Training Period 1||5
114171|NCT00995774|264085|P1|STARTED|Training Period 1||7
114172|NCT00995761|264093|P1|NOT COMPLETED|Overall Study||0
114173|NCT00995761|264093|P1|COMPLETED|Overall Study||48
114174|NCT00995761|264093|P1|STARTED|Overall Study||48
114175|NCT00995722|264099|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
114176|NCT00995722|264100|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
114177|NCT00995722|264099|P2|COMPLETED|Overall Study: 36 Weeks||2
114178|NCT00995722|264100|P1|COMPLETED|Overall Study: 36 Weeks||3
114179|NCT00995722|264099|P2|STARTED|Overall Study: 36 Weeks||4
114180|NCT00995722|264100|P1|STARTED|Overall Study: 36 Weeks||5
114181|NCT00995722|264099|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
114182|NCT00995722|264100|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
114183|NCT00995722|264099|P2|COMPLETED|Double Blinded: 16 Weeks||4
114184|NCT00995722|264100|P1|COMPLETED|Double Blinded: 16 Weeks||5
114185|NCT00995722|264099|P2|STARTED|Double Blinded: 16 Weeks||5
114186|NCT00995722|264100|P1|STARTED|Double Blinded: 16 Weeks||6
114187|NCT00995709|264117|P3|NOT COMPLETED|Overall Study||5
114188|NCT00995709|264118|P2|NOT COMPLETED|Overall Study||9
114189|NCT00995709|264119|P1|NOT COMPLETED|Overall Study||7
114190|NCT00995709|264117|P3|COMPLETED|Overall Study||34
114191|NCT00995709|264118|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
114192|NCT00995709|264119|P1|COMPLETED|Overall Study||32
114193|NCT00995709|264117|P3|STARTED|Overall Study||39
114194|NCT00995709|264118|P2|STARTED|Overall Study||40
114195|NCT00995709|264119|P1|STARTED|Overall Study||39
114196|NCT00995670|264145|P3|NOT COMPLETED|Overall Study||3
114197|NCT00995670|264146|P2|NOT COMPLETED|Overall Study||0
114198|NCT00995670|264147|P1|NOT COMPLETED|Overall Study||1
114199|NCT00995670|264145|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
114200|NCT00995670|264146|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
114201|NCT00995670|264147|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
114202|NCT00995670|264145|P3|STARTED|Overall Study||17
114203|NCT00995670|264146|P2|STARTED|Overall Study||16
114204|NCT00995670|264147|P1|STARTED|Overall Study||26
114205|NCT00995566|264155|P1|NOT COMPLETED|Overall Study||54
114206|NCT00995566|264155|P1|COMPLETED|Overall Study||0
114207|NCT00995566|264155|P1|STARTED|Overall Study||54
114208|NCT00995553|264169|P2|NOT COMPLETED|Overall Study||6
114209|NCT00995553|264170|P1|NOT COMPLETED|Overall Study||2
114210|NCT00995553|264169|P2|COMPLETED|Overall Study||35
114211|NCT00995553|264170|P1|COMPLETED|Overall Study||38
114212|NCT00995553|264169|P2|STARTED|Overall Study||41
114213|NCT00995553|264170|P1|STARTED|Overall Study||40
114214|NCT00995488|264178|P1|NOT COMPLETED|Overall Study||1
114215|NCT00995488|264178|P1|COMPLETED|Overall Study||15
114216|NCT00995488|264178|P1|STARTED|Overall Study||16
114217|NCT00995449|264187|P4|NOT COMPLETED|Overall Study||0
114218|NCT00995449|264188|P3|NOT COMPLETED|Overall Study||2
114219|NCT00995449|264189|P2|NOT COMPLETED|Overall Study||0
114220|NCT00995449|264190|P1|NOT COMPLETED|Overall Study||0
114221|NCT00995449|264187|P4|COMPLETED|Overall Study||2
114222|NCT00995449|264188|P3|COMPLETED|Overall Study||5
114223|NCT00995449|264189|P2|COMPLETED|Overall Study||0
114224|NCT00995449|264190|P1|COMPLETED|Overall Study||0
114225|NCT00995449|264187|P4|STARTED|Overall Study||2
114226|NCT00995449|264188|P3|STARTED|Overall Study||7
114227|NCT00995449|264189|P2|STARTED|Overall Study||0
114228|NCT00995449|264190|P1|STARTED|Overall Study||0
114229|NCT00995436|264201|P3|NOT COMPLETED|Overall Study||0
114230|NCT00995436|264202|P2|NOT COMPLETED|Overall Study||5
114231|NCT00995436|264203|P1|NOT COMPLETED|Overall Study||2
114232|NCT00995436|264201|P3|COMPLETED|Overall Study||26
114233|NCT00995436|264202|P2|COMPLETED|Overall Study||22
114234|NCT00995436|264203|P1|COMPLETED|Overall Study||23
114235|NCT00995436|264201|P3|STARTED|Overall Study||26
114236|NCT00995436|264202|P2|STARTED|Overall Study||27
114237|NCT00995436|264203|P1|STARTED|Overall Study|25|25
114238|NCT00995410|264211|P1|NOT COMPLETED|Overall Study||88
114239|NCT00995410|264211|P1|COMPLETED|Overall Study||292
114240|NCT00995410|264211|P1|Treated|Overall Study||379
114241|NCT00995410|264211|P1|STARTED|Overall Study||380
114242|NCT00995371|264218|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
114243|NCT00995371|264219|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
114244|NCT00995371|264218|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
114245|NCT00995371|264219|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
114246|NCT00995371|264218|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
114247|NCT00995371|264219|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
114248|NCT00995371|264218|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
114249|NCT00995371|264219|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
114250|NCT00995371|264218|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
114251|NCT00995371|264219|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
114252|NCT00995371|264218|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
114253|NCT00995371|264219|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
114254|NCT00995345|264237|P5|NOT COMPLETED|Overall Study||5
114255|NCT00995345|264238|P4|NOT COMPLETED|Overall Study||5
114256|NCT00995345|264239|P3|NOT COMPLETED|Overall Study||7
114257|NCT00995345|264240|P2|NOT COMPLETED|Overall Study||7
114258|NCT00995345|264241|P1|NOT COMPLETED|Overall Study||11
114259|NCT00995345|264237|P5|COMPLETED|Overall Study||75
114260|NCT00995345|264238|P4|COMPLETED|Overall Study||76
114261|NCT00995345|264239|P3|COMPLETED|Overall Study||73
114262|NCT00995345|264240|P2|COMPLETED|Overall Study||74
114263|NCT00995345|264241|P1|COMPLETED|Overall Study||70
114264|NCT00995345|264237|P5|STARTED|Overall Study||80
114265|NCT00995345|264238|P4|STARTED|Overall Study||81
114266|NCT00995345|264239|P3|STARTED|Overall Study||80
114267|NCT00995345|264240|P2|STARTED|Overall Study||81
114268|NCT00995345|264241|P1|STARTED|Overall Study||81
114269|NCT00995085|264268|P1|NOT COMPLETED|Overall Study||5
114270|NCT00995085|264268|P1|COMPLETED|Overall Study||38
114271|NCT00995085|264268|P1|STARTED|Overall Study||43
114272|NCT00995020|264274|P2|NOT COMPLETED|Overall Study||7
114273|NCT00995020|264275|P1|NOT COMPLETED|Overall Study||3
114274|NCT00995020|264274|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
114275|NCT00995020|264275|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
114276|NCT00995020|264274|P2|STARTED|Overall Study||52
114277|NCT00995020|264275|P1|STARTED|Overall Study||51
114278|NCT00995007|264285|P2|NOT COMPLETED|Overall Study||2
114279|NCT00995007|264286|P1|NOT COMPLETED|Overall Study||17
114280|NCT00995007|264285|P2|COMPLETED|Overall Study||54
114281|NCT00995007|264286|P1|COMPLETED|Overall Study||39
114282|NCT00995007|264285|P2|Crossover to Vandetanib|Overall Study||0
114283|NCT00995007|264286|P1|Crossover to Vandetanib|Overall Study||42
114284|NCT00995007|264285|P2|STARTED|Overall Study||56
114285|NCT00995007|264286|P1|STARTED|Overall Study||56
114286|NCT00994929|264302|P1|NOT COMPLETED|Overall Study||0
114287|NCT00994929|264302|P1|COMPLETED|Overall Study||9
114288|NCT00994929|264302|P1|STARTED|Overall Study||9
114289|NCT00994760|264308|P1|NOT COMPLETED|Overall Study||24
114290|NCT00994760|264308|P1|COMPLETED|Overall Study||107
114291|NCT00994760|264308|P1|STARTED|Overall Study||131
114292|NCT00994604|264347|P1|NOT COMPLETED|Overall Study||6
114293|NCT00994604|264347|P1|COMPLETED|Overall Study||45
114294|NCT00994604|264347|P1|STARTED|Overall Study||51
114295|NCT00994461|264357|P3|NOT COMPLETED|Overall Study||0
114296|NCT00994461|264358|P2|NOT COMPLETED|Overall Study||1
114297|NCT00994461|264359|P1|NOT COMPLETED|Overall Study||2
114298|NCT00994461|264357|P3|COMPLETED|Overall Study||37
114299|NCT00994461|264358|P2|COMPLETED|Overall Study||75
114300|NCT00994461|264359|P1|COMPLETED|Overall Study||74
114301|NCT00994461|264357|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
114302|NCT00994461|264358|P2|STARTED|Overall Study||76
114303|NCT00994461|264359|P1|STARTED|Overall Study||76
114304|NCT00994448|264387|P2|NOT COMPLETED|Overall Study||2
114305|NCT00994448|264388|P1|NOT COMPLETED|Overall Study||8
114306|NCT00994448|264387|P2|COMPLETED|Overall Study||5
114307|NCT00994448|264388|P1|COMPLETED|Overall Study||4
114308|NCT00994448|264387|P2|STARTED|Overall Study||7
114309|NCT00994448|264388|P1|STARTED|Overall Study||12
114310|NCT00994422|264396|P2|NOT COMPLETED|Overall Study||1
114311|NCT00994422|264397|P1|NOT COMPLETED|Overall Study||7
114312|NCT00994422|264396|P2|COMPLETED|Overall Study||54
114313|NCT00994422|264397|P1|COMPLETED|Overall Study||185
114314|NCT00994422|264396|P2|STARTED|Overall Study||55
114315|NCT00994422|264397|P1|STARTED|Overall Study||192
114316|NCT00994318|264410|P3|NOT COMPLETED|Overall Study||67
114317|NCT00994318|264411|P2|NOT COMPLETED|Overall Study||18
114318|NCT00994318|264412|P1|NOT COMPLETED|Overall Study||22
114319|NCT00994318|264410|P3|COMPLETED|Overall Study||250
114320|NCT00994318|264411|P2|COMPLETED|Overall Study||136
114321|NCT00994318|264412|P1|COMPLETED|Overall Study||133
114322|NCT00994318|264410|P3|STARTED|Overall Study||317
114323|NCT00994318|264411|P2|STARTED|Overall Study||154
114324|NCT00994318|264412|P1|STARTED|Overall Study||155
114325|NCT00994253|264422|P2|NOT COMPLETED|Overall Study||0
114326|NCT00994253|264423|P1|NOT COMPLETED|Overall Study||0
114327|NCT00994253|264422|P2|COMPLETED|Overall Study||0
114328|NCT00994253|264423|P1|COMPLETED|Overall Study||0
114329|NCT00994253|264422|P2|STARTED|Overall Study||0
114330|NCT00994253|264423|P1|STARTED|Overall Study||0
114331|NCT00994240|264431|P2|NOT COMPLETED|Overall Study||5
114332|NCT00994240|264432|P1|NOT COMPLETED|Overall Study||6
114333|NCT00994240|264431|P2|COMPLETED|Overall Study||39
114334|NCT00994240|264432|P1|COMPLETED|Overall Study||35
114335|NCT00994240|264431|P2|STARTED|Overall Study||44
114336|NCT00994240|264432|P1|STARTED|Overall Study||41
114337|NCT00994214|264442|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
114338|NCT00994214|264443|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
114339|NCT00994214|264444|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
114340|NCT00994214|264445|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
114341|NCT00994214|264442|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
114342|NCT00994214|264443|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
114343|NCT00994214|264444|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
114344|NCT00994214|264445|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
114345|NCT00994214|264442|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
114346|NCT00994214|264443|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
114347|NCT00994214|264444|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
114348|NCT00994214|264445|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
114349|NCT00994214|264442|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
114350|NCT00994214|264443|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
114351|NCT00994214|264444|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
114352|NCT00994214|264445|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
114353|NCT00994214|264442|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
114354|NCT00994214|264443|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
114355|NCT00994214|264444|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
114356|NCT00994214|264445|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
114357|NCT00994214|264442|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
114358|NCT00994214|264443|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
114359|NCT00994214|264444|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
114360|NCT00994214|264445|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
114361|NCT00994214|264442|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
114362|NCT00994214|264443|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
114363|NCT00994214|264444|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
114364|NCT00994214|264445|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
114365|NCT00994214|264442|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
114366|NCT00994214|264443|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
114367|NCT00994214|264444|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
114368|NCT00994214|264445|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
114369|NCT00994214|264442|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
114370|NCT00994214|264443|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
114371|NCT00994214|264444|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
114372|NCT00994214|264445|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
114373|NCT00994214|264442|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
114374|NCT00994214|264443|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
114375|NCT00994214|264444|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
114376|NCT00994214|264445|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
114377|NCT00994123|264492|P3|NOT COMPLETED|Overall Study||0
114378|NCT00994123|264493|P2|NOT COMPLETED|Overall Study||0
114379|NCT00994123|264494|P1|NOT COMPLETED|Overall Study||0
114380|NCT00994123|264492|P3|COMPLETED|Overall Study||44
114381|NCT00994123|264493|P2|COMPLETED|Overall Study||85
114382|NCT00994123|264494|P1|COMPLETED|Overall Study||33
114383|NCT00994123|264492|P3|STARTED|Overall Study||44
114384|NCT00994123|264493|P2|STARTED|Overall Study||85
114385|NCT00994123|264494|P1|STARTED|Overall Study||33
114386|NCT00994110|264515|P2|NOT COMPLETED|Overall Study||74
114387|NCT00994110|264516|P1|NOT COMPLETED|Overall Study||65
114388|NCT00994110|264515|P2|COMPLETED|Overall Study||148
114389|NCT00994110|264516|P1|COMPLETED|Overall Study||152
114390|NCT00994110|264515|P2|STARTED|Overall Study||222
114391|NCT00994110|264516|P1|STARTED|Overall Study||217
114392|NCT00993954|264524|P2|NOT COMPLETED|Overall Study||2
114393|NCT00993954|264525|P1|NOT COMPLETED|Overall Study||21
114394|NCT00993954|264524|P2|COMPLETED|Overall Study||121
114395|NCT00993954|264525|P1|COMPLETED|Overall Study||124
114396|NCT00993954|264524|P2|STARTED|Overall Study||123
114397|NCT00993954|264525|P1|STARTED|Overall Study||145
114398|NCT00993915|264536|P1|NOT COMPLETED|Overall Study||9
114399|NCT00993915|264536|P1|COMPLETED|Overall Study||678
114400|NCT00993915|264536|P1|STARTED|Overall Study||687
114401|NCT00993824|264547|P2|NOT COMPLETED|Overall Study||0
114402|NCT00993824|264548|P1|NOT COMPLETED|Overall Study||0
114403|NCT00993824|264547|P2|COMPLETED|Overall Study||10
114404|NCT00993824|264548|P1|COMPLETED|Overall Study||11
114405|NCT00993824|264547|P2|STARTED|Overall Study||10
114406|NCT00993824|264548|P1|STARTED|Overall Study||11
114407|NCT00993668|264562|P2|NOT COMPLETED|Open-Label Period||15
114408|NCT00993668|264563|P1|NOT COMPLETED|Open-Label Period||23
114409|NCT00993668|264562|P2|COMPLETED|Open-Label Period||91
114410|NCT00993668|264563|P1|COMPLETED|Open-Label Period||86
114411|NCT00993668|264562|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
114412|NCT00993668|264563|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
114413|NCT00993668|264562|P2|NOT COMPLETED|Single-Blind Period||3
114414|NCT00993668|264563|P1|NOT COMPLETED|Single-Blind Period||4
114415|NCT00993668|264562|P2|COMPLETED|Single-Blind Period||107
114416|NCT00993668|264563|P1|COMPLETED|Single-Blind Period||110
114417|NCT00993668|264562|P2|STARTED|Single-Blind Period||110
114418|NCT00993668|264563|P1|STARTED|Single-Blind Period||114
114419|NCT00993616|264588|P1|NOT COMPLETED|Overall Study||2
114420|NCT00993616|264588|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
114421|NCT00993616|264588|P1|STARTED|Overall Study||29
114422|NCT00993499|264598|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
114423|NCT00993499|264599|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
114424|NCT00993499|264600|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
114425|NCT00993499|264601|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
114426|NCT00993499|264602|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
114427|NCT00993499|264603|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
114428|NCT00993499|264598|P6|COMPLETED|Discontinued After Starting Course 3||0
114429|NCT00993499|264599|P5|COMPLETED|Discontinued After Starting Course 3||0
114430|NCT00993499|264600|P4|COMPLETED|Discontinued After Starting Course 3||1
114431|NCT00993499|264601|P3|COMPLETED|Discontinued After Starting Course 3||3
114432|NCT00993499|264602|P2|COMPLETED|Discontinued After Starting Course 3||4
114433|NCT00993499|264603|P1|COMPLETED|Discontinued After Starting Course 3||4
114434|NCT00993499|264598|P6|STARTED|Discontinued After Starting Course 3||3
114435|NCT00993499|264599|P5|STARTED|Discontinued After Starting Course 3||3
114436|NCT00993499|264600|P4|STARTED|Discontinued After Starting Course 3||3
114437|NCT00993499|264601|P3|STARTED|Discontinued After Starting Course 3||9
114438|NCT00993499|264602|P2|STARTED|Discontinued After Starting Course 3||9
114439|NCT00993499|264603|P1|STARTED|Discontinued After Starting Course 3||12
114440|NCT00993499|264598|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
114441|NCT00993499|264599|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
114442|NCT00993499|264600|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
114443|NCT00993499|264601|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
114444|NCT00993499|264602|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
114445|NCT00993499|264603|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
114446|NCT00993499|264598|P6|COMPLETED|Discontinued Before Starting Course 3||3
114447|NCT00993499|264599|P5|COMPLETED|Discontinued Before Starting Course 3||3
114448|NCT00993499|264600|P4|COMPLETED|Discontinued Before Starting Course 3||2
114449|NCT00993499|264601|P3|COMPLETED|Discontinued Before Starting Course 3||6
114450|NCT00993499|264602|P2|COMPLETED|Discontinued Before Starting Course 3||5
114451|NCT00993499|264603|P1|COMPLETED|Discontinued Before Starting Course 3||8
114452|NCT00993499|264598|P6|STARTED|Discontinued Before Starting Course 3||3
114453|NCT00993499|264599|P5|STARTED|Discontinued Before Starting Course 3||3
114454|NCT00993499|264600|P4|STARTED|Discontinued Before Starting Course 3||3
114455|NCT00993499|264601|P3|STARTED|Discontinued Before Starting Course 3||9
114456|NCT00993499|264602|P2|STARTED|Discontinued Before Starting Course 3||9
114457|NCT00993499|264603|P1|STARTED|Discontinued Before Starting Course 3||12
114458|NCT00993499|264598|P6|NOT COMPLETED|Run-in Period (8 Days)||0
114459|NCT00993499|264599|P5|NOT COMPLETED|Run-in Period (8 Days)||0
114460|NCT00993499|264600|P4|NOT COMPLETED|Run-in Period (8 Days)||0
114461|NCT00993499|264601|P3|NOT COMPLETED|Run-in Period (8 Days)||1
114462|NCT00993499|264602|P2|NOT COMPLETED|Run-in Period (8 Days)||3
114463|NCT00993499|264603|P1|NOT COMPLETED|Run-in Period (8 Days)||1
114464|NCT00993499|264598|P6|COMPLETED|Run-in Period (8 Days)||3
114465|NCT00993499|264599|P5|COMPLETED|Run-in Period (8 Days)||3
114466|NCT00993499|264600|P4|COMPLETED|Run-in Period (8 Days)||3
114467|NCT00993499|264601|P3|COMPLETED|Run-in Period (8 Days)||9
114468|NCT00993499|264602|P2|COMPLETED|Run-in Period (8 Days)||9
114469|NCT00993499|264603|P1|COMPLETED|Run-in Period (8 Days)||12
114470|NCT00993499|264598|P6|STARTED|Run-in Period (8 Days)||3
114471|NCT00993499|264599|P5|STARTED|Run-in Period (8 Days)||3
114472|NCT00993499|264600|P4|STARTED|Run-in Period (8 Days)||3
114473|NCT00993499|264601|P3|STARTED|Run-in Period (8 Days)||10
114474|NCT00993499|264602|P2|STARTED|Run-in Period (8 Days)||12
114475|NCT00993499|264603|P1|STARTED|Run-in Period (8 Days)||13
114476|NCT00993473|264685|P2|NOT COMPLETED|Overall Study||10
114477|NCT00993473|264686|P1|NOT COMPLETED|Overall Study||4
114478|NCT00993473|264685|P2|COMPLETED|Overall Study||54
114479|NCT00993473|264686|P1|COMPLETED|Overall Study||57
114480|NCT00993473|264685|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
114481|NCT00993473|264686|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
114482|NCT00993447|264724|P2|NOT COMPLETED|Overall Study||19
114483|NCT00993447|264725|P1|NOT COMPLETED|Overall Study||37
114484|NCT00993447|264724|P2|COMPLETED|Overall Study||180
114485|NCT00993447|264725|P1|COMPLETED|Overall Study||364
114486|NCT00993447|264724|P2|STARTED|Overall Study||199
114487|NCT00993447|264725|P1|STARTED|Overall Study||401
114488|NCT00993421|264762|P7|NOT COMPLETED|Overall Study||42
114489|NCT00993421|264763|P6|NOT COMPLETED|Overall Study||46
114490|NCT00993421|264764|P5|NOT COMPLETED|Overall Study||46
114491|NCT00993421|264765|P4|NOT COMPLETED|Overall Study||45
114492|NCT00993421|264766|P3|NOT COMPLETED|Overall Study||43
114493|NCT00993421|264767|P2|NOT COMPLETED|Overall Study||45
114494|NCT00993421|264768|P1|NOT COMPLETED|Overall Study||44
114495|NCT00993421|264762|P7|COMPLETED|Overall Study||4
114496|NCT00993421|264763|P6|COMPLETED|Overall Study||4
114497|NCT00993421|264764|P5|COMPLETED|Overall Study||6
114498|NCT00993421|264765|P4|COMPLETED|Overall Study||4
114499|NCT00993421|264766|P3|COMPLETED|Overall Study||5
114500|NCT00993421|264767|P2|COMPLETED|Overall Study||4
114501|NCT00993421|264768|P1|COMPLETED|Overall Study||5
114502|NCT00993421|264762|P7|STARTED|Overall Study||46
114503|NCT00993421|264763|P6|STARTED|Overall Study||50
114504|NCT00993421|264764|P5|STARTED|Overall Study||52
114505|NCT00993421|264765|P4|STARTED|Overall Study||49
114506|NCT00993421|264766|P3|STARTED|Overall Study||48
114507|NCT00993421|264767|P2|STARTED|Overall Study||49
114508|NCT00993421|264768|P1|STARTED|Overall Study||49
114509|NCT00993317|264919|P2|NOT COMPLETED|Overall Study||25
114510|NCT00993317|264920|P1|NOT COMPLETED|Overall Study||21
114511|NCT00993317|264919|P2|COMPLETED|Overall Study||60
114512|NCT00993317|264920|P1|COMPLETED|Overall Study||21
114513|NCT00993317|264919|P2|STARTED|Overall Study||85
114514|NCT00993317|264920|P1|STARTED|Overall Study||42
114515|NCT00993291|264938|P1|NOT COMPLETED|Overall Study||1
114516|NCT00993291|264938|P1|COMPLETED|Overall Study||19
114517|NCT00993291|264938|P1|STARTED|Overall Study||20
114518|NCT00993265|264944|P2|NOT COMPLETED|Overall Study||0
114519|NCT00993265|264945|P1|NOT COMPLETED|Overall Study||4
114520|NCT00993265|264944|P2|COMPLETED|Overall Study||19
114521|NCT00993265|264945|P1|COMPLETED|Overall Study||16
114522|NCT00993265|264944|P2|STARTED|Overall Study||19
114523|NCT00993265|264945|P1|STARTED|Overall Study||20
114524|NCT00993200|264965|P2|NOT COMPLETED|Overall Study||0
114525|NCT00993200|264966|P1|NOT COMPLETED|Overall Study||0
114526|NCT00993200|264965|P2|COMPLETED|Overall Study||13
114527|NCT00993200|264966|P1|COMPLETED|Overall Study||13
114528|NCT00993200|264965|P2|STARTED|Overall Study||13
114529|NCT00993200|264966|P1|STARTED|Overall Study||13
114530|NCT00993187|264978|P2|NOT COMPLETED|Overall Study||37
114531|NCT00993187|264979|P1|NOT COMPLETED|Overall Study||26
114532|NCT00993187|264978|P2|COMPLETED|Overall Study||108
114533|NCT00993187|264979|P1|COMPLETED|Overall Study||121
114534|NCT00993187|264978|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
114535|NCT00993187|264979|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
114536|NCT00993187|264978|P2|STARTED|Overall Study||145
114537|NCT00993187|264979|P1|STARTED|Overall Study||147
114538|NCT00993148|264997|P1|NOT COMPLETED|Overall Study||3
114539|NCT00993148|264997|P1|COMPLETED|Overall Study||22
114540|NCT00993148|264997|P1|STARTED|Overall Study||25
114541|NCT00993044|265009|P1|NOT COMPLETED|Irinotecan 50 mg||1
114542|NCT00993044|265009|P1|COMPLETED|Irinotecan 50 mg||6
114543|NCT00993044|265009|P1|STARTED|Irinotecan 50 mg||7
114544|NCT00993044|265009|P1|NOT COMPLETED|Irinotecan 30 mg||0
114545|NCT00993044|265009|P1|COMPLETED|Irinotecan 30 mg||6
114546|NCT00993044|265009|P1|STARTED|Irinotecan 30 mg||6
114547|NCT00992992|265014|P1|NOT COMPLETED|Overall Study||25
114548|NCT00992992|265014|P1|COMPLETED|Overall Study||0
114549|NCT00992992|265014|P1|STARTED|Overall Study||25
114550|NCT00992927|265036|P2|NOT COMPLETED|Overall Study||0
114551|NCT00992927|265037|P1|NOT COMPLETED|Overall Study||0
114552|NCT00992927|265036|P2|COMPLETED|Overall Study||22
114553|NCT00992927|265037|P1|COMPLETED|Overall Study||32
114554|NCT00992927|265036|P2|STARTED|Overall Study||22
114555|NCT00992927|265037|P1|STARTED|Overall Study||32
114556|NCT00992836|265045|P1|NOT COMPLETED|Overall Study||5
114557|NCT00992836|265045|P1|COMPLETED|Overall Study||150
114558|NCT00992836|265045|P1|Received Both Study Vaccinations|Overall Study||150
114559|NCT00992836|265045|P1|STARTED|Overall Study||155
114560|NCT00992784|265060|P3|NOT COMPLETED|Overall Study||1
114561|NCT00992784|265061|P2|NOT COMPLETED|Overall Study||2
114562|NCT00992784|265062|P1|NOT COMPLETED|Overall Study||3
114563|NCT00992784|265060|P3|COMPLETED|Overall Study||85
114564|NCT00992784|265061|P2|COMPLETED|Overall Study||102
114565|NCT00992784|265062|P1|COMPLETED|Overall Study||177
114566|NCT00992784|265060|P3|STARTED|Overall Study||86
114567|NCT00992784|265061|P2|STARTED|Overall Study||104
114568|NCT00992784|265062|P1|STARTED|Overall Study||180
114569|NCT00992719|265133|P3|NOT COMPLETED|Overall Study||0
114570|NCT00992719|265134|P2|NOT COMPLETED|Overall Study||1
114571|NCT00992719|265135|P1|NOT COMPLETED|Overall Study||1
114572|NCT00992719|265133|P3|COMPLETED|Overall Study||28
114573|NCT00992719|265134|P2|COMPLETED|Overall Study||27
114574|NCT00992719|265135|P1|COMPLETED|Overall Study||27
114575|NCT00992719|265133|P3|STARTED|Overall Study||28
114576|NCT00992719|265134|P2|STARTED|Overall Study||28
114577|NCT00992719|265135|P1|STARTED|Overall Study||28
114578|NCT00992589|265169|P4|NOT COMPLETED|Double-Blind Phase||10
114579|NCT00992589|265170|P3|NOT COMPLETED|Double-Blind Phase||13
114580|NCT00992589|265171|P2|NOT COMPLETED|Double-Blind Phase||13
114581|NCT00992589|265172|P1|NOT COMPLETED|Double-Blind Phase||0
114582|NCT00992589|265169|P4|COMPLETED|Double-Blind Phase||78
114583|NCT00992589|265170|P3|COMPLETED|Double-Blind Phase||77
114584|NCT00992589|265171|P2|COMPLETED|Double-Blind Phase||76
114585|NCT00992589|265172|P1|COMPLETED|Double-Blind Phase||0
114586|NCT00992589|265169|P4|STARTED|Double-Blind Phase||88
114587|NCT00992589|265170|P3|STARTED|Double-Blind Phase||90
114588|NCT00992589|265171|P2|STARTED|Double-Blind Phase||89
114589|NCT00992589|265172|P1|STARTED|Double-Blind Phase||0
114590|NCT00992589|265169|P4|NOT COMPLETED|Open-Label Phase||0
114591|NCT00992589|265170|P3|NOT COMPLETED|Open-Label Phase||0
114592|NCT00992589|265171|P2|NOT COMPLETED|Open-Label Phase||0
114593|NCT00992589|265172|P1|NOT COMPLETED|Open-Label Phase||77
114594|NCT00992589|265169|P4|COMPLETED|Open-Label Phase||0
114595|NCT00992589|265170|P3|COMPLETED|Open-Label Phase||0
114596|NCT00992589|265171|P2|COMPLETED|Open-Label Phase||0
114597|NCT00992589|265172|P1|COMPLETED|Open-Label Phase||267
114598|NCT00992589|265169|P4|STARTED|Open-Label Phase||0
114599|NCT00992589|265170|P3|STARTED|Open-Label Phase||0
114600|NCT00992589|265171|P2|STARTED|Open-Label Phase||0
114601|NCT00992589|265172|P1|STARTED|Open-Label Phase||344
114602|NCT00992459|265216|P2|NOT COMPLETED|Overall Study||1
114603|NCT00992459|265217|P1|NOT COMPLETED|Overall Study||1
114604|NCT00992459|265216|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
114605|NCT00992459|265217|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
114606|NCT00992459|265216|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
114607|NCT00992459|265217|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
114608|NCT00992433|265243|P2|NOT COMPLETED|Overall Study||7
114609|NCT00992433|265244|P1|NOT COMPLETED|Overall Study||4
114610|NCT00992433|265243|P2|COMPLETED|Overall Study||90
114611|NCT00992433|265244|P1|COMPLETED|Overall Study||91
114612|NCT00992433|265243|P2|STARTED|Overall Study||97
114613|NCT00992433|265244|P1|STARTED|Overall Study||95
114614|NCT00992407|265308|P2|NOT COMPLETED|Overall Study||24
114615|NCT00992407|265309|P1|NOT COMPLETED|Overall Study||31
114616|NCT00992407|265308|P2|COMPLETED|Overall Study||14
114617|NCT00992407|265309|P1|COMPLETED|Overall Study||6
114618|NCT00992407|265308|P2|Treated|Overall Study||25
114619|NCT00992407|265309|P1|Treated|Overall Study||20
114620|NCT00992407|265308|P2|STARTED|Overall Study||38
114621|NCT00992407|265309|P1|STARTED|Overall Study||37
114622|NCT00992394|265359|P2|NOT COMPLETED|Overall Study||14
114623|NCT00992394|265360|P1|NOT COMPLETED|Overall Study||24
114624|NCT00992394|265359|P2|COMPLETED|Overall Study||72
114625|NCT00992394|265360|P1|COMPLETED|Overall Study||64
114626|NCT00992394|265359|P2|mITT Population|Overall Study||84
114627|NCT00992394|265360|P1|mITT Population|Overall Study||86
114628|NCT00992394|265359|P2|Safety Population|Overall Study||84
114629|NCT00992394|265360|P1|Safety Population|Overall Study||87
114630|NCT00992394|265359|P2|STARTED|Overall Study||86
114631|NCT00992394|265360|P1|STARTED|Overall Study||88
114632|NCT00992264|265418|P16|NOT COMPLETED|Overall Study||0
114633|NCT00992264|265419|P15|NOT COMPLETED|Overall Study||0
114634|NCT00992264|265420|P14|NOT COMPLETED|Overall Study||0
114635|NCT00992264|265421|P13|NOT COMPLETED|Overall Study||0
114636|NCT00992264|265422|P12|NOT COMPLETED|Overall Study||0
114637|NCT00992264|265423|P11|NOT COMPLETED|Overall Study||0
114638|NCT00992264|265424|P10|NOT COMPLETED|Overall Study||0
114639|NCT00992264|265425|P9|NOT COMPLETED|Overall Study||0
114640|NCT00992264|265426|P8|NOT COMPLETED|Overall Study||0
114641|NCT00992264|265427|P7|NOT COMPLETED|Overall Study||0
114642|NCT00992264|265428|P6|NOT COMPLETED|Overall Study||0
114643|NCT00992264|265429|P5|NOT COMPLETED|Overall Study||0
114644|NCT00992264|265430|P4|NOT COMPLETED|Overall Study||0
114645|NCT00992264|265431|P3|NOT COMPLETED|Overall Study||0
114646|NCT00992264|265432|P2|NOT COMPLETED|Overall Study||0
114647|NCT00992264|265433|P1|NOT COMPLETED|Overall Study||0
114648|NCT00992264|265418|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114649|NCT00992264|265419|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114650|NCT00992264|265420|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114651|NCT00992264|265421|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114652|NCT00992264|265422|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114653|NCT00992264|265423|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114654|NCT00992264|265424|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114655|NCT00992264|265425|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114656|NCT00992264|265426|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114657|NCT00992264|265427|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114741|NCT00991510|265557|P1|STARTED|Period II (Days 15-28)||21
114658|NCT00992264|265428|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114659|NCT00992264|265429|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114660|NCT00992264|265430|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114661|NCT00992264|265431|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
114662|NCT00992264|265432|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114663|NCT00992264|265433|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
114664|NCT00992264|265418|P16|STARTED|Overall Study||116
114665|NCT00992264|265419|P15|STARTED|Overall Study||117
114666|NCT00992264|265420|P14|STARTED|Overall Study||117
114667|NCT00992264|265421|P13|STARTED|Overall Study||116
114668|NCT00992264|265422|P12|STARTED|Overall Study||117
114669|NCT00992264|265423|P11|STARTED|Overall Study||117
114670|NCT00992264|265424|P10|STARTED|Overall Study||116
114671|NCT00992264|265425|P9|STARTED|Overall Study||116
114672|NCT00992264|265426|P8|STARTED|Overall Study||117
114673|NCT00992264|265427|P7|STARTED|Overall Study||116
114674|NCT00992264|265428|P6|STARTED|Overall Study||117
114675|NCT00992264|265429|P5|STARTED|Overall Study||117
114676|NCT00992264|265430|P4|STARTED|Overall Study||117
114677|NCT00992264|265431|P3|STARTED|Overall Study||117
114678|NCT00992264|265432|P2|STARTED|Overall Study||116
114679|NCT00992264|265433|P1|STARTED|Overall Study||116
114680|NCT00992186|265447|P1|NOT COMPLETED|Overall Study||46
114681|NCT00992186|265447|P1|COMPLETED|Overall Study||0
114682|NCT00992186|265447|P1|STARTED|Overall Study||46
114683|NCT00992108|265466|P2|NOT COMPLETED|Overall Study||1
114684|NCT00992108|265467|P1|NOT COMPLETED|Overall Study||0
114685|NCT00992108|265466|P2|COMPLETED|Overall Study||9
114686|NCT00992108|265467|P1|COMPLETED|Overall Study||7
114687|NCT00992108|265466|P2|STARTED|Overall Study||10
114688|NCT00992108|265467|P1|STARTED|Overall Study||7
114689|NCT00992056|265481|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
114690|NCT00992056|265482|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
114691|NCT00992056|265481|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
114692|NCT00992056|265482|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
114693|NCT00992056|265481|P2|STARTED|Treatment Period 2 (6 Weeks)||10
114694|NCT00992056|265482|P1|STARTED|Treatment Period 2 (6 Weeks)||10
114695|NCT00992056|265481|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
114696|NCT00992056|265482|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
114697|NCT00992056|265481|P2|COMPLETED|Washout Period (2 Weeks)||10
114698|NCT00992056|265482|P1|COMPLETED|Washout Period (2 Weeks)||10
114699|NCT00992056|265481|P2|STARTED|Washout Period (2 Weeks)||10
114700|NCT00992056|265482|P1|STARTED|Washout Period (2 Weeks)||11
114701|NCT00992056|265481|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
114702|NCT00992056|265482|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
114703|NCT00992056|265481|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
114704|NCT00992056|265482|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
114705|NCT00992056|265481|P2|STARTED|Treatment Period 1 (6 Weeks)||12
114706|NCT00992056|265482|P1|STARTED|Treatment Period 1 (6 Weeks)||12
114707|NCT00992017|265488|P1|NOT COMPLETED|Overall Study||10
114708|NCT00992017|265488|P1|COMPLETED|Overall Study||118
114709|NCT00992017|265488|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
114710|NCT00992017|265488|P1|Received Both Study Vaccinations|Overall Study||124
114711|NCT00992017|265488|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
114712|NCT00991952|265503|P2|NOT COMPLETED|Overall Study||1
114713|NCT00991952|265504|P1|NOT COMPLETED|Overall Study||0
114714|NCT00991952|265503|P2|COMPLETED|Overall Study||5
114715|NCT00991952|265504|P1|COMPLETED|Overall Study||13
114716|NCT00991952|265503|P2|STARTED|Overall Study||6
114717|NCT00991952|265504|P1|STARTED|Overall Study||13
114718|NCT00991939|265512|P2|NOT COMPLETED|Overall Study||2
114719|NCT00991939|265513|P1|NOT COMPLETED|Overall Study||5
114720|NCT00991939|265512|P2|COMPLETED|Overall Study||1
114721|NCT00991939|265513|P1|COMPLETED|Overall Study||0
114722|NCT00991939|265512|P2|STARTED|Overall Study||3
114723|NCT00991939|265513|P1|STARTED|Overall Study||5
114724|NCT00991809|265547|P2|NOT COMPLETED|Overall Study||6
114725|NCT00991809|265548|P1|NOT COMPLETED|Overall Study||4
114726|NCT00991809|265547|P2|COMPLETED|Overall Study||4
114727|NCT00991809|265548|P1|COMPLETED|Overall Study||8
114728|NCT00991809|265547|P2|STARTED|Overall Study||10
114729|NCT00991809|265548|P1|STARTED|Overall Study||12
114730|NCT00991510|265556|P2|NOT COMPLETED|Period III (Days 29-112)||1
114731|NCT00991510|265557|P1|NOT COMPLETED|Period III (Days 29-112)||1
114732|NCT00991510|265556|P2|COMPLETED|Period III (Days 29-112)||20
114733|NCT00991510|265557|P1|COMPLETED|Period III (Days 29-112)||20
114734|NCT00991510|265556|P2|STARTED|Period III (Days 29-112)||21
114735|NCT00991510|265557|P1|STARTED|Period III (Days 29-112)||21
114736|NCT00991510|265556|P2|NOT COMPLETED|Period II (Days 15-28)||0
114737|NCT00991510|265557|P1|NOT COMPLETED|Period II (Days 15-28)||0
114738|NCT00991510|265556|P2|COMPLETED|Period II (Days 15-28)||21
114739|NCT00991510|265557|P1|COMPLETED|Period II (Days 15-28)||21
114740|NCT00991510|265556|P2|STARTED|Period II (Days 15-28)||21
114742|NCT00991510|265556|P2|NOT COMPLETED|Period I (Days 1-14)||0
114743|NCT00991510|265557|P1|NOT COMPLETED|Period I (Days 1-14)||1
114744|NCT00991510|265556|P2|COMPLETED|Period I (Days 1-14)||21
114745|NCT00991510|265557|P1|COMPLETED|Period I (Days 1-14)||21
114746|NCT00991510|265556|P2|STARTED|Period I (Days 1-14)||21
114747|NCT00991510|265557|P1|STARTED|Period I (Days 1-14)||22
114748|NCT00991458|265582|P3|NOT COMPLETED|Overall Study||25
114749|NCT00991458|265583|P2|NOT COMPLETED|Overall Study||28
114750|NCT00991458|265584|P1|NOT COMPLETED|Overall Study||20
114751|NCT00991458|265582|P3|COMPLETED|Overall Study||180
114752|NCT00991458|265583|P2|COMPLETED|Overall Study||181
114753|NCT00991458|265584|P1|COMPLETED|Overall Study||187
114754|NCT00991458|265582|P3|STARTED|Overall Study||205
114755|NCT00991458|265583|P2|STARTED|Overall Study||209
114756|NCT00991458|265584|P1|STARTED|Overall Study||207
114757|NCT00991341|265603|P2|NOT COMPLETED|Overall Study||179
114758|NCT00991341|265604|P1|NOT COMPLETED|Overall Study||204
114759|NCT00991341|265603|P2|COMPLETED|Overall Study||560
114760|NCT00991341|265604|P1|COMPLETED|Overall Study||538
114761|NCT00991341|265603|P2|STARTED|Overall Study||739
114762|NCT00991341|265604|P1|STARTED|Overall Study||742
114763|NCT00991302|265642|P2|NOT COMPLETED|Overall Study||13
114764|NCT00991302|265643|P1|NOT COMPLETED|Overall Study||14
114765|NCT00991302|265642|P2|COMPLETED|Overall Study||73
114766|NCT00991302|265643|P1|COMPLETED|Overall Study||72
114767|NCT00991302|265642|P2|STARTED|Overall Study||86
114768|NCT00991302|265643|P1|STARTED|Overall Study||86
114769|NCT00991289|265659|P1|NOT COMPLETED|Overall Study||12
114770|NCT00991289|265659|P1|COMPLETED|Overall Study|Completed study.|55
114771|NCT00991289|265659|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
114772|NCT00991289|265659|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
114773|NCT00991276|265679|P6|NOT COMPLETED|Third Intervention Period||1
114774|NCT00991276|265680|P5|NOT COMPLETED|Third Intervention Period||0
114775|NCT00991276|265681|P4|NOT COMPLETED|Third Intervention Period||1
114776|NCT00991276|265682|P3|NOT COMPLETED|Third Intervention Period||1
114777|NCT00991276|265683|P2|NOT COMPLETED|Third Intervention Period||0
114778|NCT00991276|265684|P1|NOT COMPLETED|Third Intervention Period||1
114779|NCT00991276|265679|P6|COMPLETED|Third Intervention Period||10
114780|NCT00991276|265680|P5|COMPLETED|Third Intervention Period||10
114781|NCT00991276|265681|P4|COMPLETED|Third Intervention Period||8
114782|NCT00991276|265682|P3|COMPLETED|Third Intervention Period||13
114783|NCT00991276|265683|P2|COMPLETED|Third Intervention Period||8
114784|NCT00991276|265684|P1|COMPLETED|Third Intervention Period||13
114785|NCT00991276|265679|P6|STARTED|Third Intervention Period||11
114786|NCT00991276|265680|P5|STARTED|Third Intervention Period||10
114787|NCT00991276|265681|P4|STARTED|Third Intervention Period||9
114788|NCT00991276|265682|P3|STARTED|Third Intervention Period||14
114789|NCT00991276|265683|P2|STARTED|Third Intervention Period||8
114790|NCT00991276|265684|P1|STARTED|Third Intervention Period||14
114791|NCT00991276|265679|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114792|NCT00991276|265680|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114793|NCT00991276|265681|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114794|NCT00991276|265682|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114795|NCT00991276|265683|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114796|NCT00991276|265684|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114797|NCT00991276|265679|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
114798|NCT00991276|265680|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
114799|NCT00991276|265681|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
114800|NCT00991276|265682|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
114801|NCT00991276|265683|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
114802|NCT00991276|265684|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
114803|NCT00991276|265679|P6|STARTED|Placebo Wash-out Period (7 Days)||11
114804|NCT00991276|265680|P5|STARTED|Placebo Wash-out Period (7 Days)||10
114805|NCT00991276|265681|P4|STARTED|Placebo Wash-out Period (7 Days)||9
114806|NCT00991276|265682|P3|STARTED|Placebo Wash-out Period (7 Days)||14
114807|NCT00991276|265683|P2|STARTED|Placebo Wash-out Period (7 Days)||8
114808|NCT00991276|265684|P1|STARTED|Placebo Wash-out Period (7 Days)||14
114809|NCT00991276|265679|P6|NOT COMPLETED|Second Intervention Period||1
114810|NCT00991276|265680|P5|NOT COMPLETED|Second Intervention Period||1
114811|NCT00991276|265681|P4|NOT COMPLETED|Second Intervention Period||2
114812|NCT00991276|265682|P3|NOT COMPLETED|Second Intervention Period||0
114813|NCT00991276|265683|P2|NOT COMPLETED|Second Intervention Period||2
114814|NCT00991276|265684|P1|NOT COMPLETED|Second Intervention Period||1
114815|NCT00991276|265679|P6|COMPLETED|Second Intervention Period||11
114816|NCT00991276|265680|P5|COMPLETED|Second Intervention Period||10
114817|NCT00991276|265681|P4|COMPLETED|Second Intervention Period||9
114818|NCT00991276|265682|P3|COMPLETED|Second Intervention Period||14
114819|NCT00991276|265683|P2|COMPLETED|Second Intervention Period||8
114820|NCT00991276|265684|P1|COMPLETED|Second Intervention Period||14
114821|NCT00991276|265679|P6|STARTED|Second Intervention Period||12
114822|NCT00991276|265680|P5|STARTED|Second Intervention Period||11
114823|NCT00991276|265681|P4|STARTED|Second Intervention Period||11
114824|NCT00991276|265682|P3|STARTED|Second Intervention Period||14
114825|NCT00991276|265683|P2|STARTED|Second Intervention Period||10
114826|NCT00991276|265684|P1|STARTED|Second Intervention Period||15
114827|NCT00991276|265679|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114828|NCT00991276|265680|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114829|NCT00991276|265681|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114830|NCT00991276|265682|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114831|NCT00991276|265683|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114832|NCT00991276|265684|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
114833|NCT00991276|265679|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
114834|NCT00991276|265680|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
114835|NCT00991276|265681|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
114836|NCT00991276|265682|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
114837|NCT00991276|265683|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
114838|NCT00991276|265684|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
114839|NCT00991276|265679|P6|STARTED|Placebo Wash-out Period (7 Days)||12
114840|NCT00991276|265680|P5|STARTED|Placebo Wash-out Period (7 Days)||11
114841|NCT00991276|265681|P4|STARTED|Placebo Wash-out Period (7 Days)||11
114842|NCT00991276|265682|P3|STARTED|Placebo Wash-out Period (7 Days)||14
114843|NCT00991276|265683|P2|STARTED|Placebo Wash-out Period (7 Days)||10
114844|NCT00991276|265684|P1|STARTED|Placebo Wash-out Period (7 Days)||15
114845|NCT00991276|265679|P6|NOT COMPLETED|First Intervention Period||1
114846|NCT00991276|265680|P5|NOT COMPLETED|First Intervention Period||4
114847|NCT00991276|265681|P4|NOT COMPLETED|First Intervention Period||4
114848|NCT00991276|265682|P3|NOT COMPLETED|First Intervention Period||0
114849|NCT00991276|265683|P2|NOT COMPLETED|First Intervention Period||3
114850|NCT00991276|265684|P1|NOT COMPLETED|First Intervention Period||0
114851|NCT00991276|265679|P6|COMPLETED|First Intervention Period||12
114852|NCT00991276|265680|P5|COMPLETED|First Intervention Period||11
114853|NCT00991276|265681|P4|COMPLETED|First Intervention Period||11
114854|NCT00991276|265682|P3|COMPLETED|First Intervention Period||14
114855|NCT00991276|265683|P2|COMPLETED|First Intervention Period||10
114856|NCT00991276|265684|P1|COMPLETED|First Intervention Period||15
114857|NCT00991276|265679|P6|STARTED|First Intervention Period||13
114858|NCT00991276|265680|P5|STARTED|First Intervention Period||15
114859|NCT00991276|265681|P4|STARTED|First Intervention Period||15
114860|NCT00991276|265682|P3|STARTED|First Intervention Period||14
114861|NCT00991276|265683|P2|STARTED|First Intervention Period||13
114862|NCT00991276|265684|P1|STARTED|First Intervention Period||15
114863|NCT00991185|265782|P1|NOT COMPLETED|Overall Study||0
114864|NCT00991185|265782|P1|COMPLETED|Overall Study||8
114865|NCT00991185|265782|P1|STARTED|Overall Study||8
114866|NCT00991081|265788|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
114867|NCT00991081|265789|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
114868|NCT00991081|265790|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
114869|NCT00991081|265788|P3|COMPLETED|Phase II, Randomized Control Trial||15
114870|NCT00991081|265789|P2|COMPLETED|Phase II, Randomized Control Trial||15
114871|NCT00991081|265790|P1|COMPLETED|Phase II, Randomized Control Trial||0
114872|NCT00991081|265788|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
114873|NCT00991081|265789|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
114874|NCT00991081|265790|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
114875|NCT00991081|265788|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
114876|NCT00991081|265789|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
114877|NCT00991081|265790|P1|STARTED|Phase II, Randomized Control Trial||0
114878|NCT00991081|265788|P3|NOT COMPLETED|Phase I, Formative Research||0
114879|NCT00991081|265789|P2|NOT COMPLETED|Phase I, Formative Research||0
114880|NCT00991081|265790|P1|NOT COMPLETED|Phase I, Formative Research||0
114881|NCT00991081|265788|P3|COMPLETED|Phase I, Formative Research||0
114882|NCT00991081|265789|P2|COMPLETED|Phase I, Formative Research||0
114883|NCT00991081|265790|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
114884|NCT00991081|265788|P3|STARTED|Phase I, Formative Research||0
114885|NCT00991081|265789|P2|STARTED|Phase I, Formative Research||0
114886|NCT00991081|265790|P1|STARTED|Phase I, Formative Research||20
114887|NCT00990964|265822|P1|NOT COMPLETED|Overall Study||212
114888|NCT00990964|265822|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
114889|NCT00990964|265822|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
114890|NCT00990964|265822|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
114891|NCT00990821|265841|P14|NOT COMPLETED|Overall Study||1
114892|NCT00990821|265842|P13|NOT COMPLETED|Overall Study||2
114893|NCT00990821|265843|P12|NOT COMPLETED|Overall Study||5
114894|NCT00990821|265844|P11|NOT COMPLETED|Overall Study||3
114895|NCT00990821|265845|P10|NOT COMPLETED|Overall Study||1
114896|NCT00990821|265846|P9|NOT COMPLETED|Overall Study||0
114897|NCT00990821|265847|P8|NOT COMPLETED|Overall Study||0
114898|NCT00990821|265848|P7|NOT COMPLETED|Overall Study||1
114899|NCT00990821|265849|P6|NOT COMPLETED|Overall Study||3
114900|NCT00990821|265850|P5|NOT COMPLETED|Overall Study||3
114901|NCT00990821|265851|P4|NOT COMPLETED|Overall Study||0
114902|NCT00990821|265852|P3|NOT COMPLETED|Overall Study||0
114903|NCT00990821|265853|P2|NOT COMPLETED|Overall Study||2
114904|NCT00990821|265854|P1|NOT COMPLETED|Overall Study||0
114905|NCT00990821|265841|P14|COMPLETED|Overall Study||11
114906|NCT00990821|265842|P13|COMPLETED|Overall Study||10
114907|NCT00990821|265843|P12|COMPLETED|Overall Study||9
114908|NCT00990821|265844|P11|COMPLETED|Overall Study||9
114909|NCT00990821|265845|P10|COMPLETED|Overall Study||13
114910|NCT00990821|265846|P9|COMPLETED|Overall Study||12
114911|NCT00990821|265847|P8|COMPLETED|Overall Study||14
114912|NCT00990821|265848|P7|COMPLETED|Overall Study||11
114913|NCT00990821|265849|P6|COMPLETED|Overall Study||14
114914|NCT00990821|265850|P5|COMPLETED|Overall Study||14
114915|NCT00990821|265851|P4|COMPLETED|Overall Study||8
114916|NCT00990821|265852|P3|COMPLETED|Overall Study||14
114917|NCT00990821|265853|P2|COMPLETED|Overall Study||14
114918|NCT00990821|265854|P1|COMPLETED|Overall Study||14
114919|NCT00990821|265841|P14|STARTED|Overall Study||12
114920|NCT00990821|265842|P13|STARTED|Overall Study||12
114921|NCT00990821|265843|P12|STARTED|Overall Study||14
114922|NCT00990821|265844|P11|STARTED|Overall Study||12
114923|NCT00990821|265845|P10|STARTED|Overall Study||14
114924|NCT00990821|265846|P9|STARTED|Overall Study||12
114925|NCT00990821|265847|P8|STARTED|Overall Study||14
114926|NCT00990821|265848|P7|STARTED|Overall Study||12
114927|NCT00990821|265849|P6|STARTED|Overall Study||17
114928|NCT00990821|265850|P5|STARTED|Overall Study||17
114929|NCT00990821|265851|P4|STARTED|Overall Study||8
114930|NCT00990821|265852|P3|STARTED|Overall Study||14
114931|NCT00990821|265853|P2|STARTED|Overall Study||16
114932|NCT00990821|265854|P1|STARTED|Overall Study||14
114933|NCT00990769|265873|P2|NOT COMPLETED|Overall Study||0
114934|NCT00990769|265874|P1|NOT COMPLETED|Overall Study||0
114935|NCT00990769|265873|P2|COMPLETED|Overall Study||18
114936|NCT00990769|265874|P1|COMPLETED|Overall Study||22
114937|NCT00990769|265873|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
114938|NCT00990769|265874|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
114939|NCT00990704|265886|P2|NOT COMPLETED|Overall Study||2
114940|NCT00990704|265887|P1|NOT COMPLETED|Overall Study||1
114941|NCT00990704|265886|P2|COMPLETED|Overall Study||31
114942|NCT00990704|265887|P1|COMPLETED|Overall Study||13
114943|NCT00990704|265886|P2|STARTED|Overall Study||33
114944|NCT00990704|265887|P1|STARTED|Overall Study||14
114945|NCT00990652|265907|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
114946|NCT00990652|265907|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
114947|NCT00990652|265907|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
114948|NCT00990652|265907|P1|NOT COMPLETED|Surgical Resection||0
114949|NCT00990652|265907|P1|COMPLETED|Surgical Resection||9
114950|NCT00990652|265907|P1|STARTED|Surgical Resection||9
114951|NCT00990652|265907|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
114952|NCT00990652|265907|P1|COMPLETED|Pre-surgical Bortezomib||9
114953|NCT00990652|265907|P1|STARTED|Pre-surgical Bortezomib||10
114954|NCT00990561|265917|P4|NOT COMPLETED|Period 2||2
114955|NCT00990561|265918|P3|NOT COMPLETED|Period 2||0
114956|NCT00990561|265919|P2|NOT COMPLETED|Period 2||0
114957|NCT00990561|265920|P1|NOT COMPLETED|Period 2||0
114958|NCT00990561|265917|P4|COMPLETED|Period 2||17
114959|NCT00990561|265918|P3|COMPLETED|Period 2||20
114960|NCT00990561|265919|P2|COMPLETED|Period 2||0
114961|NCT00990561|265920|P1|COMPLETED|Period 2||0
114962|NCT00990561|265917|P4|STARTED|Period 2||19
114963|NCT00990561|265918|P3|STARTED|Period 2||20
114964|NCT00990561|265919|P2|STARTED|Period 2||0
114965|NCT00990561|265920|P1|STARTED|Period 2||0
114966|NCT00990561|265917|P4|NOT COMPLETED|Period 1||0
114967|NCT00990561|265918|P3|NOT COMPLETED|Period 1||0
114968|NCT00990561|265919|P2|NOT COMPLETED|Period 1||1
114969|NCT00990561|265920|P1|NOT COMPLETED|Period 1||0
114970|NCT00990561|265917|P4|COMPLETED|Period 1||0
114971|NCT00990561|265918|P3|COMPLETED|Period 1||0
114972|NCT00990561|265919|P2|COMPLETED|Period 1||19
114973|NCT00990561|265920|P1|COMPLETED|Period 1||20
114974|NCT00990561|265917|P4|STARTED|Period 1||0
114975|NCT00990561|265918|P3|STARTED|Period 1||0
114976|NCT00990561|265919|P2|STARTED|Period 1||20
114977|NCT00990561|265920|P1|STARTED|Period 1||20
114978|NCT00990509|265928|P2|NOT COMPLETED|Overall Study||1
114979|NCT00990509|265929|P1|NOT COMPLETED|Overall Study||0
114980|NCT00990509|265928|P2|COMPLETED|Overall Study||8
114981|NCT00990509|265929|P1|COMPLETED|Overall Study||5
114982|NCT00990509|265928|P2|STARTED|Overall Study||9
114983|NCT00990509|265929|P1|STARTED|Overall Study||5
114984|NCT00990340|265941|P2|NOT COMPLETED|Second 14-day Treatment||0
114985|NCT00990340|265942|P1|NOT COMPLETED|Second 14-day Treatment||0
114986|NCT00990340|265941|P2|COMPLETED|Second 14-day Treatment||21
114987|NCT00990340|265942|P1|COMPLETED|Second 14-day Treatment||21
114988|NCT00990340|265941|P2|STARTED|Second 14-day Treatment||21
114989|NCT00990340|265942|P1|STARTED|Second 14-day Treatment||21
114990|NCT00990340|265941|P2|NOT COMPLETED|First 14-day Treatment||4
114991|NCT00990340|265942|P1|NOT COMPLETED|First 14-day Treatment||6
114992|NCT00990340|265941|P2|COMPLETED|First 14-day Treatment||21
114993|NCT00990340|265942|P1|COMPLETED|First 14-day Treatment||21
114994|NCT00990340|265941|P2|STARTED|First 14-day Treatment||25
114995|NCT00990340|265942|P1|STARTED|First 14-day Treatment||27
114996|NCT00990184|265956|P1|NOT COMPLETED|Overall Study||1
114997|NCT00990184|265956|P1|COMPLETED|Overall Study||20
114998|NCT00990184|265956|P1|STARTED|Overall Study||21
114999|NCT00990106|265964|P2|NOT COMPLETED|Overall Study||12
115000|NCT00990106|265965|P1|NOT COMPLETED|Overall Study||9
115001|NCT00990106|265964|P2|COMPLETED|Overall Study||23
115002|NCT00990106|265965|P1|COMPLETED|Overall Study||23
115003|NCT00990106|265964|P2|STARTED|Overall Study||35
115004|NCT00990106|265965|P1|STARTED|Overall Study||32
115005|NCT00990093|265975|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
115006|NCT00990093|265976|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
115007|NCT00990093|265975|P2|COMPLETED|Test Period 2 (15-28 Days)||14
115008|NCT00990093|265976|P1|COMPLETED|Test Period 2 (15-28 Days)||13
115009|NCT00990093|265975|P2|STARTED|Test Period 2 (15-28 Days)||15
115010|NCT00990093|265976|P1|STARTED|Test Period 2 (15-28 Days)||15
115011|NCT00990093|265975|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
115012|NCT00990093|265976|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
115013|NCT00990093|265975|P2|COMPLETED|Test Period 1 (1-14 Days)||15
115014|NCT00990093|265976|P1|COMPLETED|Test Period 1 (1-14 Days)||15
115015|NCT00990093|265975|P2|STARTED|Test Period 1 (1-14 Days)||17
115016|NCT00990093|265976|P1|STARTED|Test Period 1 (1-14 Days)||19
115017|NCT00989989|265985|P3|NOT COMPLETED|Overall Study||23
115018|NCT00989989|265986|P2|NOT COMPLETED|Overall Study||10
115019|NCT00989989|265987|P1|NOT COMPLETED|Overall Study||18
115020|NCT00989989|265985|P3|COMPLETED|Overall Study||108
115021|NCT00989989|265986|P2|COMPLETED|Overall Study||123
115022|NCT00989989|265987|P1|COMPLETED|Overall Study||114
115023|NCT00989989|265985|P3|STARTED|Overall Study||131
115024|NCT00989989|265986|P2|STARTED|Overall Study||133
115025|NCT00989989|265987|P1|STARTED|Overall Study||132
115026|NCT00989950|266029|P4|NOT COMPLETED|Randomized Phase||0
115027|NCT00989950|266030|P3|NOT COMPLETED|Randomized Phase||0
115028|NCT00989950|266031|P2|NOT COMPLETED|Randomized Phase||1
115029|NCT00989950|266032|P1|NOT COMPLETED|Randomized Phase||1
115030|NCT00989950|266029|P4|COMPLETED|Randomized Phase||7
115031|NCT00989950|266030|P3|COMPLETED|Randomized Phase||4
115032|NCT00989950|266031|P2|COMPLETED|Randomized Phase||8
115033|NCT00989950|266032|P1|COMPLETED|Randomized Phase||5
115034|NCT00989950|266029|P4|STARTED|Randomized Phase||7
115035|NCT00989950|266030|P3|STARTED|Randomized Phase||4
115036|NCT00989950|266031|P2|STARTED|Randomized Phase||9
115037|NCT00989950|266032|P1|STARTED|Randomized Phase||6
115038|NCT00989950|266029|P4|NOT COMPLETED|Open Label Dose Optimization||0
115039|NCT00989950|266030|P3|NOT COMPLETED|Open Label Dose Optimization||0
115040|NCT00989950|266031|P2|NOT COMPLETED|Open Label Dose Optimization||0
115041|NCT00989950|266032|P1|NOT COMPLETED|Open Label Dose Optimization||0
115042|NCT00989950|266029|P4|COMPLETED|Open Label Dose Optimization||7
115043|NCT00989950|266030|P3|COMPLETED|Open Label Dose Optimization||4
115044|NCT00989950|266031|P2|COMPLETED|Open Label Dose Optimization||9
115045|NCT00989950|266032|P1|COMPLETED|Open Label Dose Optimization||6
115046|NCT00989950|266029|P4|STARTED|Open Label Dose Optimization||7
115047|NCT00989950|266030|P3|STARTED|Open Label Dose Optimization||4
115048|NCT00989950|266031|P2|STARTED|Open Label Dose Optimization||9
115049|NCT00989950|266032|P1|STARTED|Open Label Dose Optimization||6
115050|NCT00989911|266042|P1|NOT COMPLETED|Overall Study||3
115051|NCT00989911|266042|P1|COMPLETED|Overall Study||7
115052|NCT00989911|266042|P1|STARTED|Overall Study||10
115053|NCT00989833|266049|P3|NOT COMPLETED|Overall Study||2
115054|NCT00989833|266050|P2|NOT COMPLETED|Overall Study||3
115055|NCT00989833|266051|P1|NOT COMPLETED|Overall Study||2
115056|NCT00989833|266049|P3|COMPLETED|Overall Study||21
115057|NCT00989833|266050|P2|COMPLETED|Overall Study||19
115058|NCT00989833|266051|P1|COMPLETED|Overall Study||19
115059|NCT00989833|266049|P3|STARTED|Overall Study||23
115060|NCT00989833|266050|P2|STARTED|Overall Study||22
115061|NCT00989833|266051|P1|STARTED|Overall Study||21
115062|NCT00989768|266080|P1|NOT COMPLETED|Overall Study||1
115063|NCT00989768|266080|P1|COMPLETED|Overall Study||28
115064|NCT00989768|266080|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
115065|NCT00989664|266091|P1|NOT COMPLETED|Long-Term Follow-Up||3
115066|NCT00989664|266091|P1|COMPLETED|Long-Term Follow-Up||11
115067|NCT00989664|266091|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
115068|NCT00989664|266091|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
115069|NCT00989664|266091|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
115070|NCT00989664|266091|P1|STARTED|Dosimetric and Therapeutic Treatment||61
115071|NCT00989586|266121|P2|NOT COMPLETED|Overall Study||0
115072|NCT00989586|266122|P1|NOT COMPLETED|Overall Study||0
115073|NCT00989586|266121|P2|COMPLETED|Overall Study||17
115074|NCT00989586|266122|P1|COMPLETED|Overall Study||18
115075|NCT00989586|266121|P2|STARTED|Overall Study||17
115076|NCT00989586|266122|P1|STARTED|Overall Study||18
115077|NCT00989235|266137|P2|NOT COMPLETED|Overall Study||6
115078|NCT00989235|266138|P1|NOT COMPLETED|Overall Study||3
115079|NCT00989235|266137|P2|COMPLETED|Overall Study||44
115080|NCT00989235|266138|P1|COMPLETED|Overall Study||55
115081|NCT00989235|266137|P2|Number Completing Double-Blind Treatment|Overall Study||41
115082|NCT00989235|266138|P1|Number Completing Double-Blind Treatment|Overall Study||51
115083|NCT00989235|266137|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
115084|NCT00989235|266138|P1|Number Rescued to Open-Label Treatment|Overall Study||4
115085|NCT00989235|266137|P2|STARTED|Overall Study||50
115086|NCT00989235|266138|P1|STARTED|Overall Study||58
115087|NCT00989196|266183|P2|NOT COMPLETED|Treatment Period||0
115088|NCT00989196|266184|P1|NOT COMPLETED|Treatment Period||1
115089|NCT00989196|266183|P2|COMPLETED|Treatment Period||12
115090|NCT00989196|266184|P1|COMPLETED|Treatment Period||9
115091|NCT00989196|266183|P2|STARTED|Treatment Period||12
115092|NCT00989196|266184|P1|STARTED|Treatment Period||10
115093|NCT00989196|266183|P2|NOT COMPLETED|PK Crossover Period||0
115094|NCT00989196|266184|P1|NOT COMPLETED|PK Crossover Period||0
115095|NCT00989196|266183|P2|COMPLETED|PK Crossover Period||12
115096|NCT00989196|266184|P1|COMPLETED|PK Crossover Period||10
115097|NCT00989196|266183|P2|STARTED|PK Crossover Period||12
115098|NCT00989196|266184|P1|STARTED|PK Crossover Period||10
115099|NCT00989157|266205|P2|NOT COMPLETED|Overall Study||0
115100|NCT00989157|266206|P1|NOT COMPLETED|Overall Study||0
115101|NCT00989157|266205|P2|COMPLETED|Overall Study||10
115102|NCT00989157|266206|P1|COMPLETED|Overall Study||10
115103|NCT00989157|266205|P2|STARTED|Overall Study||10
115104|NCT00989157|266206|P1|STARTED|Overall Study||10
115105|NCT00989092|266222|P2|NOT COMPLETED|Overall Study||28
115106|NCT00989092|266223|P1|NOT COMPLETED|Overall Study||90
115107|NCT00989092|266222|P2|COMPLETED|Overall Study||31
115108|NCT00989092|266223|P1|COMPLETED|Overall Study||138
115109|NCT00989092|266222|P2|Treated With Darbepoetin Alfa|Overall Study||33
115110|NCT00989092|266223|P1|Treated With Darbepoetin Alfa|Overall Study||226
115111|NCT00989092|266222|P2|STARTED|Overall Study||59
115112|NCT00989092|266223|P1|STARTED|Overall Study||228
115113|NCT00989014|266260|P4|NOT COMPLETED|Overall Study||0
115114|NCT00989014|266261|P3|NOT COMPLETED|Overall Study||0
115115|NCT00989014|266262|P2|NOT COMPLETED|Overall Study||0
115116|NCT00989014|266263|P1|NOT COMPLETED|Overall Study||0
115117|NCT00989014|266260|P4|COMPLETED|Overall Study||32
115118|NCT00989014|266261|P3|COMPLETED|Overall Study||28
115119|NCT00989014|266262|P2|COMPLETED|Overall Study||31
115120|NCT00989014|266263|P1|COMPLETED|Overall Study||31
115121|NCT00989014|266260|P4|STARTED|Overall Study||32
115122|NCT00989014|266261|P3|STARTED|Overall Study||28
115123|NCT00989014|266262|P2|STARTED|Overall Study||31
115124|NCT00989014|266263|P1|STARTED|Overall Study||31
115125|NCT00988884|266275|P2|NOT COMPLETED|Overall Study||36
115126|NCT00988884|266276|P1|NOT COMPLETED|Overall Study||35
115127|NCT00988884|266275|P2|COMPLETED|Overall Study||584
115128|NCT00988884|266276|P1|COMPLETED|Overall Study||586
115129|NCT00988884|266275|P2|STARTED|Overall Study||620
115130|NCT00988884|266276|P1|STARTED|Overall Study||621
115131|NCT00988832|266298|P1|NOT COMPLETED|Overall Study||0
115132|NCT00988832|266298|P1|COMPLETED|Overall Study||380
115133|NCT00988832|266298|P1|STARTED|Overall Study||380
115134|NCT00988637|266335|P2|NOT COMPLETED|Overall Study||3
115135|NCT00988637|266336|P1|NOT COMPLETED|Overall Study||3
115136|NCT00988637|266335|P2|COMPLETED|Overall Study||65
115137|NCT00988637|266336|P1|COMPLETED|Overall Study||67
115138|NCT00988637|266335|P2|STARTED|Overall Study||68
115139|NCT00988637|266336|P1|STARTED|Overall Study||70
115140|NCT00988533|266366|P1|NOT COMPLETED|Overall Study||3
115141|NCT00988533|266366|P1|COMPLETED|Overall Study||27
115142|NCT00988533|266366|P1|STARTED|Overall Study||30
115143|NCT00988429|266381|P3|NOT COMPLETED|Overall Study||69
115144|NCT00988429|266382|P2|NOT COMPLETED|Overall Study||43
115145|NCT00988429|266383|P1|NOT COMPLETED|Overall Study||37
115146|NCT00988429|266381|P3|COMPLETED|Overall Study||142
115147|NCT00988429|266382|P2|COMPLETED|Overall Study||173
115148|NCT00988429|266383|P1|COMPLETED|Overall Study||189
115149|NCT00988429|266381|P3|Intention-to-treat (ITT) Population|Overall Study||205
115150|NCT00988429|266382|P2|Intention-to-treat (ITT) Population|Overall Study||215
115151|NCT00988429|266383|P1|Intention-to-treat (ITT) Population|Overall Study||220
115152|NCT00988429|266381|P3|Safety Population|Overall Study||210
115153|NCT00988429|266382|P2|Safety Population|Overall Study||216
115154|NCT00988429|266383|P1|Safety Population|Overall Study||224
115155|NCT00988429|266381|P3|STARTED|Overall Study||211
115156|NCT00988429|266382|P2|STARTED|Overall Study||216
115157|NCT00988429|266383|P1|STARTED|Overall Study||226
115158|NCT00988351|266396|P2|NOT COMPLETED|Overall Study||12
115159|NCT00988351|266397|P1|NOT COMPLETED|Overall Study||19
115160|NCT00988351|266396|P2|COMPLETED|Overall Study||66
115161|NCT00988351|266397|P1|COMPLETED|Overall Study||59
115162|NCT00988351|266396|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
115163|NCT00988351|266397|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
115164|NCT00988351|266396|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
115165|NCT00988351|266397|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
115166|NCT00988351|266396|P2|PAP Setup|Overall Study|APAP treatment started|78
115167|NCT00988351|266397|P1|PAP Setup|Overall Study|CPAP treatment started|70
115168|NCT00988351|266396|P2|CPAP Titration|Overall Study|no titration needed|78
115169|NCT00988351|266397|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
115170|NCT00988351|266396|P2|STARTED|Overall Study||78
115171|NCT00988351|266397|P1|STARTED|Overall Study||78
115172|NCT00988247|266413|P2|NOT COMPLETED|Overall Study||26
115173|NCT00988247|266414|P1|NOT COMPLETED|Overall Study||83
115174|NCT00988247|266413|P2|COMPLETED|Overall Study||85
115175|NCT00988247|266414|P1|COMPLETED|Overall Study||335
115176|NCT00988247|266413|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
115262|NCT00988091|266683|P2|NOT COMPLETED|Double-blind Period||47
115177|NCT00988247|266414|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
115178|NCT00988247|266413|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
115179|NCT00988247|266414|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
115180|NCT00988247|266413|P2|STARTED|Overall Study||111
115181|NCT00988247|266414|P1|STARTED|Overall Study||418
115182|NCT00988221|266433|P4|NOT COMPLETED|Part III||0
115183|NCT00988221|266434|P3|NOT COMPLETED|Part III||3
115184|NCT00988221|266435|P2|NOT COMPLETED|Part III||1
115185|NCT00988221|266436|P1|NOT COMPLETED|Part III||1
115186|NCT00988221|266433|P4|COMPLETED|Part III||0
115187|NCT00988221|266434|P3|COMPLETED|Part III||103
115188|NCT00988221|266435|P2|COMPLETED|Part III||23
115189|NCT00988221|266436|P1|COMPLETED|Part III||29
115190|NCT00988221|266433|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
115191|NCT00988221|266434|P3|STARTED|Part III||106
115192|NCT00988221|266435|P2|STARTED|Part III||24
115193|NCT00988221|266436|P1|STARTED|Part III||30
115194|NCT00988221|266433|P4|NOT COMPLETED|Part II||3
115195|NCT00988221|266434|P3|NOT COMPLETED|Part II||3
115196|NCT00988221|266435|P2|NOT COMPLETED|Part II||0
115197|NCT00988221|266436|P1|NOT COMPLETED|Part II||1
115198|NCT00988221|266433|P4|COMPLETED|Part II||81
115199|NCT00988221|266434|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
115200|NCT00988221|266435|P2|COMPLETED|Part II||11
115201|NCT00988221|266436|P1|COMPLETED|Part II||15
115202|NCT00988221|266433|P4|STARTED|Part II||84
115203|NCT00988221|266434|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
115204|NCT00988221|266435|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
115205|NCT00988221|266436|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
115206|NCT00988221|266433|P4|NOT COMPLETED|Part I||0
115207|NCT00988221|266434|P3|NOT COMPLETED|Part I||8
115208|NCT00988221|266435|P2|NOT COMPLETED|Part I||10
115209|NCT00988221|266436|P1|NOT COMPLETED|Part I||4
115210|NCT00988221|266433|P4|COMPLETED|Part I||0
115211|NCT00988221|266434|P3|COMPLETED|Part I||111
115212|NCT00988221|266435|P2|COMPLETED|Part I||24
115213|NCT00988221|266436|P1|COMPLETED|Part I||31
115214|NCT00988221|266433|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
115215|NCT00988221|266434|P3|STARTED|Part I||119
115216|NCT00988221|266435|P2|STARTED|Part I||34
115217|NCT00988221|266436|P1|STARTED|Part I||35
115218|NCT00988208|266609|P2|NOT COMPLETED|Overall Study||438
115219|NCT00988208|266610|P1|NOT COMPLETED|Overall Study||431
115220|NCT00988208|266609|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
115221|NCT00988208|266610|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
115222|NCT00988208|266609|P2|Treated|Overall Study||525
115223|NCT00988208|266610|P1|Treated|Overall Study||521
115224|NCT00988208|266609|P2|STARTED|Overall Study||533
115225|NCT00988208|266610|P1|STARTED|Overall Study||526
115226|NCT00988169|266622|P1|NOT COMPLETED|Overall Study||1
115227|NCT00988169|266622|P1|COMPLETED|Overall Study||5
115228|NCT00988169|266622|P1|STARTED|Overall Study||6
115229|NCT00988156|266628|P2|NOT COMPLETED|Overall Study||20
115230|NCT00988156|266629|P1|NOT COMPLETED|Overall Study||17
115231|NCT00988156|266628|P2|COMPLETED|Overall Study||135
115232|NCT00988156|266629|P1|COMPLETED|Overall Study||132
115233|NCT00988156|266628|P2|Safety Set|Overall Study||134
115234|NCT00988156|266629|P1|Safety Set|Overall Study||129
115235|NCT00988156|266628|P2|Per Protocol Set (PP)|Overall Study||97
115236|NCT00988156|266629|P1|Per Protocol Set (PP)|Overall Study||101
115237|NCT00988156|266628|P2|Intention-to-Treat Set (ITT)|Overall Study||134
115238|NCT00988156|266629|P1|Intention-to-Treat Set (ITT)|Overall Study||129
115239|NCT00988156|266628|P2|STARTED|Overall Study||155
115240|NCT00988156|266629|P1|STARTED|Overall Study||149
115241|NCT00988143|266640|P3|NOT COMPLETED|Overall Study||0
115242|NCT00988143|266641|P2|NOT COMPLETED|Overall Study||0
115243|NCT00988143|266642|P1|NOT COMPLETED|Overall Study||0
115244|NCT00988143|266640|P3|COMPLETED|Overall Study||190
115245|NCT00988143|266641|P2|COMPLETED|Overall Study||190
115246|NCT00988143|266642|P1|COMPLETED|Overall Study||220
115247|NCT00988143|266640|P3|STARTED|Overall Study||190
115248|NCT00988143|266641|P2|STARTED|Overall Study||190
115249|NCT00988143|266642|P1|STARTED|Overall Study||220
115250|NCT00988117|266674|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
115251|NCT00988117|266674|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
115252|NCT00988117|266674|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
115253|NCT00988117|266674|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
115254|NCT00988117|266674|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
115255|NCT00988117|266674|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
115256|NCT00988091|266683|P2|NOT COMPLETED|Open-label Period||33
115257|NCT00988091|266684|P1|NOT COMPLETED|Open-label Period||21
115258|NCT00988091|266683|P2|COMPLETED|Open-label Period||192
115259|NCT00988091|266684|P1|COMPLETED|Open-label Period||208
115260|NCT00988091|266683|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
115261|NCT00988091|266684|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
115263|NCT00988091|266684|P1|NOT COMPLETED|Double-blind Period||43
115264|NCT00988091|266683|P2|COMPLETED|Double-blind Period||251
115265|NCT00988091|266684|P1|COMPLETED|Double-blind Period||255
115266|NCT00988091|266683|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
115267|NCT00988091|266684|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
115268|NCT00988091|266683|P2|STARTED|Double-blind Period||298
115269|NCT00988091|266684|P1|STARTED|Double-blind Period||298
115270|NCT00988065|266706|P3|NOT COMPLETED|Overall Study||15
115271|NCT00988065|266707|P2|NOT COMPLETED|Overall Study||23
115272|NCT00988065|266708|P1|NOT COMPLETED|Overall Study||13
115273|NCT00988065|266706|P3|COMPLETED|Overall Study||135
115274|NCT00988065|266707|P2|COMPLETED|Overall Study||127
115275|NCT00988065|266708|P1|COMPLETED|Overall Study||135
115276|NCT00988065|266706|P3|Received Third Randomized Dose|Overall Study||135
115277|NCT00988065|266707|P2|Received Third Randomized Dose|Overall Study||127
115278|NCT00988065|266708|P1|Received Third Randomized Dose|Overall Study||135
115279|NCT00988065|266706|P3|Received Second Randomized Dose|Overall Study||145
115280|NCT00988065|266707|P2|Received Second Randomized Dose|Overall Study||135
115281|NCT00988065|266708|P1|Received Second Randomized Dose|Overall Study||139
115282|NCT00988065|266706|P3|Received First Randomized Dose|Overall Study||150
115283|NCT00988065|266707|P2|Received First Randomized Dose|Overall Study||150
115284|NCT00988065|266708|P1|Received First Randomized Dose|Overall Study||148
115285|NCT00988065|266706|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
115286|NCT00988065|266707|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
115287|NCT00988065|266708|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
115288|NCT00987935|266737|P9|NOT COMPLETED|Overall Study||32
115289|NCT00987935|266738|P8|NOT COMPLETED|Overall Study||62
115290|NCT00987935|266739|P7|NOT COMPLETED|Overall Study||15
115291|NCT00987935|266740|P6|NOT COMPLETED|Overall Study||3
115292|NCT00987935|266741|P5|NOT COMPLETED|Overall Study||7
115293|NCT00987935|266742|P4|NOT COMPLETED|Overall Study||3
115294|NCT00987935|266743|P3|NOT COMPLETED|Overall Study||3
115295|NCT00987935|266744|P2|NOT COMPLETED|Overall Study||3
115296|NCT00987935|266745|P1|NOT COMPLETED|Overall Study||4
115297|NCT00987935|266737|P9|COMPLETED|Overall Study||0
115298|NCT00987935|266738|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
115299|NCT00987935|266739|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
115300|NCT00987935|266740|P6|COMPLETED|Overall Study||0
115301|NCT00987935|266741|P5|COMPLETED|Overall Study||0
115302|NCT00987935|266742|P4|COMPLETED|Overall Study||0
115303|NCT00987935|266743|P3|COMPLETED|Overall Study||0
115304|NCT00987935|266744|P2|COMPLETED|Overall Study||0
115305|NCT00987935|266745|P1|COMPLETED|Overall Study||0
115306|NCT00987935|266737|P9|STARTED|Overall Study||32
115307|NCT00987935|266738|P8|STARTED|Overall Study||63
115308|NCT00987935|266739|P7|STARTED|Overall Study||16
115309|NCT00987935|266740|P6|STARTED|Overall Study||3
115310|NCT00987935|266741|P5|STARTED|Overall Study||7
115311|NCT00987935|266742|P4|STARTED|Overall Study||3
115312|NCT00987935|266743|P3|STARTED|Overall Study||3
115313|NCT00987935|266744|P2|STARTED|Overall Study||3
115314|NCT00987935|266745|P1|STARTED|Overall Study||4
115315|NCT00987831|266801|P3|NOT COMPLETED|Overall Study||0
115316|NCT00987831|266802|P2|NOT COMPLETED|Overall Study||3
115317|NCT00987831|266803|P1|NOT COMPLETED|Overall Study||1
115318|NCT00987831|266801|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
115319|NCT00987831|266802|P2|COMPLETED|Overall Study|all controls returned for two visits|52
115320|NCT00987831|266803|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
115321|NCT00987831|266801|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
115322|NCT00987831|266802|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
115323|NCT00987831|266803|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
115324|NCT00987727|266814|P2|NOT COMPLETED|Overall Study||7
115325|NCT00987727|266815|P1|NOT COMPLETED|Overall Study||5
115326|NCT00987727|266814|P2|COMPLETED|Overall Study||34
115327|NCT00987727|266815|P1|COMPLETED|Overall Study||36
115328|NCT00987727|266814|P2|STARTED|Overall Study||41
115329|NCT00987727|266815|P1|STARTED|Overall Study||41
115330|NCT00987623|266825|P2|NOT COMPLETED|Overall Study||3
115331|NCT00987623|266826|P1|NOT COMPLETED|Overall Study||5
115332|NCT00987623|266825|P2|COMPLETED|Overall Study||151
115333|NCT00987623|266826|P1|COMPLETED|Overall Study||140
115334|NCT00987623|266825|P2|STARTED|Overall Study||154
115335|NCT00987623|266826|P1|STARTED|Overall Study||145
115336|NCT00987558|266832|P2|NOT COMPLETED|Overall Study||5
115337|NCT00987558|266833|P1|NOT COMPLETED|Overall Study||1
115338|NCT00987558|266832|P2|COMPLETED|Overall Study||12
115339|NCT00987558|266833|P1|COMPLETED|Overall Study||12
115340|NCT00987558|266832|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
115341|NCT00987558|266833|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
115342|NCT00987558|266832|P2|Washout|Overall Study||12
115343|NCT00987558|266833|P1|Washout|Overall Study||13
115344|NCT00987558|266832|P2|Simvastatin|Overall Study||12
115345|NCT00987558|266833|P1|Simvastatin|Overall Study||13
115346|NCT00987558|266832|P2|STARTED|Overall Study||17
115347|NCT00987558|266833|P1|STARTED|Overall Study||13
115348|NCT00987467|266846|P1|NOT COMPLETED|Overall Study||2
115349|NCT00987467|266846|P1|COMPLETED|Overall Study||10
115350|NCT00987467|266846|P1|STARTED|Overall Study||12
115351|NCT00987415|266853|P2|NOT COMPLETED|Overall Study||9
115352|NCT00987415|266854|P1|NOT COMPLETED|Overall Study||9
115353|NCT00987415|266853|P2|COMPLETED|Overall Study||116
115354|NCT00987415|266854|P1|COMPLETED|Overall Study||119
115355|NCT00987415|266853|P2|STARTED|Overall Study||125
115356|NCT00987415|266854|P1|STARTED|Overall Study||128
115357|NCT00987402|266870|P2|NOT COMPLETED|Overall Study||98
115358|NCT00987402|266871|P1|NOT COMPLETED|Overall Study||86
115359|NCT00987402|266870|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
115360|NCT00987402|266871|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
115361|NCT00987402|266870|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
115362|NCT00987402|266871|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
115363|NCT00987337|266880|P3|NOT COMPLETED|Overall Study||51
115364|NCT00987337|266881|P2|NOT COMPLETED|Overall Study||55
115365|NCT00987337|266882|P1|NOT COMPLETED|Overall Study||57
115366|NCT00987337|266880|P3|COMPLETED|Overall Study||45
115367|NCT00987337|266881|P2|COMPLETED|Overall Study||41
115368|NCT00987337|266882|P1|COMPLETED|Overall Study||39
115369|NCT00987337|266880|P3|STARTED|Overall Study||96
115370|NCT00987337|266881|P2|STARTED|Overall Study||96
115371|NCT00987337|266882|P1|STARTED|Overall Study||96
115372|NCT00986999|266926|P1|NOT COMPLETED|Overall Study||1
115373|NCT00986999|266926|P1|COMPLETED|Overall Study||6
115374|NCT00986999|266926|P1|STARTED|Overall Study||7
115375|NCT00986986|266937|P2|NOT COMPLETED|Overall Study||1
115376|NCT00986986|266938|P1|NOT COMPLETED|Overall Study||0
115377|NCT00986986|266937|P2|COMPLETED|Overall Study||9
115378|NCT00986986|266938|P1|COMPLETED|Overall Study||10
115379|NCT00986986|266937|P2|STARTED|Overall Study||10
115380|NCT00986986|266938|P1|STARTED|Overall Study||10
115381|NCT00986973|266948|P1|NOT COMPLETED|Overall Study||1
115382|NCT00986973|266948|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
115383|NCT00986973|266948|P1|STARTED|Overall Study||6
115384|NCT00986960|266960|P2|NOT COMPLETED|Overall Study||0
115385|NCT00986960|266961|P1|NOT COMPLETED|Overall Study||0
115386|NCT00986960|266960|P2|COMPLETED|Overall Study||0
115387|NCT00986960|266961|P1|COMPLETED|Overall Study||0
115388|NCT00986960|266960|P2|STARTED|Overall Study||0
115389|NCT00986960|266961|P1|STARTED|Overall Study||0
115390|NCT00986921|266969|P2|NOT COMPLETED|Overall Study||0
115391|NCT00986921|266970|P1|NOT COMPLETED|Overall Study||1
115392|NCT00986921|266969|P2|COMPLETED|Overall Study||25
115393|NCT00986921|266970|P1|COMPLETED|Overall Study||24
115394|NCT00986921|266969|P2|STARTED|Overall Study||25
115395|NCT00986921|266970|P1|STARTED|Overall Study||25
115396|NCT00986856|266982|P2|NOT COMPLETED|Overall Study||0
115397|NCT00986856|266983|P1|NOT COMPLETED|Overall Study||0
115398|NCT00986856|266982|P2|COMPLETED|Overall Study||16
115399|NCT00986856|266983|P1|COMPLETED|Overall Study||42
115400|NCT00986856|266982|P2|STARTED|Overall Study||16
115401|NCT00986856|266983|P1|STARTED|Overall Study||42
115402|NCT00986674|267006|P3|NOT COMPLETED|Overall Study||48
115403|NCT00986674|267007|P2|NOT COMPLETED|Overall Study||45
115404|NCT00986674|267008|P1|NOT COMPLETED|Overall Study||47
115405|NCT00986674|267006|P3|COMPLETED|Overall Study||0
115406|NCT00986674|267007|P2|COMPLETED|Overall Study||0
115407|NCT00986674|267008|P1|COMPLETED|Overall Study||0
115408|NCT00986674|267006|P3|Eligible and Treated|Overall Study||47
115409|NCT00986674|267007|P2|Eligible and Treated|Overall Study||41
115410|NCT00986674|267008|P1|Eligible and Treated|Overall Study||39
115411|NCT00986674|267006|P3|Treated|Overall Study||47
115412|NCT00986674|267007|P2|Treated|Overall Study||42
115413|NCT00986674|267008|P1|Treated|Overall Study||43
115414|NCT00986674|267006|P3|STARTED|Overall Study||48
115415|NCT00986674|267007|P2|STARTED|Overall Study||45
115416|NCT00986674|267008|P1|STARTED|Overall Study||47
115417|NCT00986583|267024|P2|NOT COMPLETED|Overall Study||0
115418|NCT00986583|267025|P1|NOT COMPLETED|Overall Study||0
115419|NCT00986583|267024|P2|COMPLETED|Overall Study||32
115420|NCT00986583|267025|P1|COMPLETED|Overall Study||38
115421|NCT00986583|267024|P2|STARTED|Overall Study||32
115422|NCT00986583|267025|P1|STARTED|Overall Study||38
115423|NCT00986570|267041|P1|NOT COMPLETED|Overall Study||7
115424|NCT00986570|267041|P1|COMPLETED|Overall Study||114
115425|NCT00986570|267041|P1|STARTED|Overall Study||121
115426|NCT00986544|267047|P2|NOT COMPLETED|Overall Study||0
115427|NCT00986544|267048|P1|NOT COMPLETED|Overall Study||0
115428|NCT00986544|267047|P2|COMPLETED|Overall Study||53
115429|NCT00986544|267048|P1|COMPLETED|Overall Study||53
115430|NCT00986544|267047|P2|STARTED|Overall Study||53
115431|NCT00986544|267048|P1|STARTED|Overall Study||53
115432|NCT00986479|267058|P2|NOT COMPLETED|Period 2||0
115433|NCT00986479|267059|P1|NOT COMPLETED|Period 2||0
115434|NCT00986479|267058|P2|COMPLETED|Period 2||10
115435|NCT00986479|267059|P1|COMPLETED|Period 2||10
115436|NCT00986479|267058|P2|STARTED|Period 2||10
115437|NCT00986479|267059|P1|STARTED|Period 2||10
115438|NCT00986479|267058|P2|NOT COMPLETED|Period 1||0
115439|NCT00986479|267059|P1|NOT COMPLETED|Period 1||2
115440|NCT00986479|267058|P2|COMPLETED|Period 1||10
115441|NCT00986479|267059|P1|COMPLETED|Period 1||10
115442|NCT00986479|267058|P2|STARTED|Period 1||10
115443|NCT00986479|267059|P1|STARTED|Period 1||12
115444|NCT00986453|267089|P1|NOT COMPLETED|Overall Study||2
115445|NCT00986453|267089|P1|COMPLETED|Overall Study||43
115446|NCT00986453|267089|P1|STARTED|Overall Study||45
115447|NCT00986427|267105|P2|NOT COMPLETED|Overall Study||0
115448|NCT00986427|267106|P1|NOT COMPLETED|Overall Study||4
115449|NCT00986427|267105|P2|COMPLETED|Overall Study||12
115450|NCT00986427|267106|P1|COMPLETED|Overall Study||8
115451|NCT00986427|267105|P2|STARTED|Overall Study||12
115452|NCT00986427|267106|P1|STARTED|Overall Study||12
115453|NCT00986401|267122|P2|NOT COMPLETED|Period 2||0
115454|NCT00986401|267123|P1|NOT COMPLETED|Period 2||0
115455|NCT00986401|267122|P2|COMPLETED|Period 2||21
115456|NCT00986401|267123|P1|COMPLETED|Period 2||22
115457|NCT00986401|267122|P2|STARTED|Period 2||21
115458|NCT00986401|267123|P1|STARTED|Period 2||22
115459|NCT00986401|267122|P2|NOT COMPLETED|Period 1||1
115460|NCT00986401|267123|P1|NOT COMPLETED|Period 1||0
115461|NCT00986401|267122|P2|COMPLETED|Period 1||21
115462|NCT00986401|267123|P1|COMPLETED|Period 1||22
115463|NCT00986401|267122|P2|STARTED|Period 1||22
115464|NCT00986401|267123|P1|STARTED|Period 1||22
115465|NCT00986362|267134|P2|NOT COMPLETED|Overall Study||1
115466|NCT00986362|267135|P1|NOT COMPLETED|Overall Study||2
115467|NCT00986362|267134|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
115468|NCT00986362|267135|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
115469|NCT00986362|267134|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
115470|NCT00986362|267135|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
115471|NCT00986349|267141|P1|NOT COMPLETED|Overall Study||7
115472|NCT00986349|267141|P1|COMPLETED|Overall Study||16
115473|NCT00986349|267141|P1|Early Explant|Overall Study||4
115474|NCT00986349|267141|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
115475|NCT00986349|267141|P1|STARTED|Overall Study|attempted implant procedures|23
115476|NCT00986258|267154|P1|NOT COMPLETED|Maintenance Period||9
115477|NCT00986258|267154|P1|COMPLETED|Maintenance Period||93
115478|NCT00986258|267154|P1|STARTED|Maintenance Period||102
115479|NCT00986258|267154|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
115480|NCT00986258|267154|P1|COMPLETED|Titration and Optimal Dose Period||102
115481|NCT00986258|267154|P1|STARTED|Titration and Optimal Dose Period||125
115482|NCT00986258|267154|P1|NOT COMPLETED|Observation Period||11
115483|NCT00986258|267154|P1|COMPLETED|Observation Period||125
115484|NCT00986258|267154|P1|STARTED|Observation Period||136
115485|NCT00986245|267182|P2|NOT COMPLETED|Second Intervention||1
115486|NCT00986245|267183|P1|NOT COMPLETED|Second Intervention||2
115487|NCT00986245|267182|P2|COMPLETED|Second Intervention||32
115488|NCT00986245|267183|P1|COMPLETED|Second Intervention||29
115489|NCT00986245|267182|P2|STARTED|Second Intervention||33
115490|NCT00986245|267183|P1|STARTED|Second Intervention||31
115491|NCT00986245|267182|P2|NOT COMPLETED|First Intervention||8
115492|NCT00986245|267183|P1|NOT COMPLETED|First Intervention||10
115493|NCT00986245|267182|P2|COMPLETED|First Intervention||33
115494|NCT00986245|267183|P1|COMPLETED|First Intervention||31
115495|NCT00986245|267182|P2|STARTED|First Intervention||41
115496|NCT00986245|267183|P1|STARTED|First Intervention||41
115497|NCT00986232|267220|P4|NOT COMPLETED|Overall Study||20
115498|NCT00986232|267221|P3|NOT COMPLETED|Overall Study||35
115499|NCT00986232|267222|P2|NOT COMPLETED|Overall Study||50
115500|NCT00986232|267223|P1|NOT COMPLETED|Overall Study||51
115501|NCT00986232|267220|P4|COMPLETED|Overall Study||370
115502|NCT00986232|267221|P3|COMPLETED|Overall Study||346
115503|NCT00986232|267222|P2|COMPLETED|Overall Study||343
115504|NCT00986232|267223|P1|COMPLETED|Overall Study||336
115505|NCT00986232|267220|P4|Vaccination Visit 2|Overall Study||0
115506|NCT00986232|267221|P3|Vaccination Visit 2|Overall Study||360
115507|NCT00986232|267222|P2|Vaccination Visit 2|Overall Study||365
115508|NCT00986232|267223|P1|Vaccination Visit 2|Overall Study||360
115509|NCT00986232|267220|P4|Vaccination Visit 1|Overall Study||390
115510|NCT00986232|267221|P3|Vaccination Visit 1|Overall Study||381
115511|NCT00986232|267222|P2|Vaccination Visit 1|Overall Study||393
115512|NCT00986232|267223|P1|Vaccination Visit 1|Overall Study||387
115513|NCT00986232|267220|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
115514|NCT00986232|267221|P3|STARTED|Overall Study||381
115515|NCT00986232|267222|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
115516|NCT00986232|267223|P1|STARTED|Overall Study||387
115517|NCT00986180|267297|P2|NOT COMPLETED|Overall Study||56
115518|NCT00986180|267298|P1|NOT COMPLETED|Overall Study||44
115519|NCT00986180|267297|P2|COMPLETED|Overall Study||268
115520|NCT00986180|267298|P1|COMPLETED|Overall Study||277
115521|NCT00986180|267297|P2|STARTED|Overall Study||324
115522|NCT00986180|267298|P1|STARTED|Overall Study||321
115523|NCT00986154|267376|P2|NOT COMPLETED|Overall Study||194
115524|NCT00986154|267377|P1|NOT COMPLETED|Overall Study||206
115525|NCT00986154|267376|P2|COMPLETED|Overall Study||3955
115526|NCT00986154|267377|P1|COMPLETED|Overall Study||3937
115527|NCT00986154|267376|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
115528|NCT00986154|267377|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
115529|NCT00986154|267376|P2|STARTED|Overall Study||4149
115530|NCT00986154|267377|P1|STARTED|Overall Study||4143
115531|NCT00986102|267391|P4|NOT COMPLETED|Overall Study||1
115532|NCT00986102|267392|P3|NOT COMPLETED|Overall Study||0
115533|NCT00986102|267393|P2|NOT COMPLETED|Overall Study||2
115534|NCT00986102|267394|P1|NOT COMPLETED|Overall Study||1
115535|NCT00986102|267391|P4|COMPLETED|Overall Study||66
115536|NCT00986102|267392|P3|COMPLETED|Overall Study||19
115537|NCT00986102|267393|P2|COMPLETED|Overall Study||75
115538|NCT00986102|267394|P1|COMPLETED|Overall Study||52
115539|NCT00986102|267391|P4|STARTED|Overall Study|Number of participants who received study medication|67
115540|NCT00986102|267392|P3|STARTED|Overall Study|Number of participants who received study medication|19
115541|NCT00986102|267393|P2|STARTED|Overall Study|Number of participants who received study medication|77
115542|NCT00986102|267394|P1|STARTED|Overall Study|Number of participants who received study medication|53
115543|NCT00985985|267444|P4|NOT COMPLETED|Overall Study||13
115544|NCT00985985|267445|P3|NOT COMPLETED|Overall Study||11
115545|NCT00985985|267446|P2|NOT COMPLETED|Overall Study||24
115546|NCT00985985|267447|P1|NOT COMPLETED|Overall Study||24
115547|NCT00985985|267444|P4|COMPLETED|Overall Study||107
115548|NCT00985985|267445|P3|COMPLETED|Overall Study||109
115549|NCT00985985|267446|P2|COMPLETED|Overall Study||218
115550|NCT00985985|267447|P1|COMPLETED|Overall Study||217
115551|NCT00985985|267444|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
115552|NCT00985985|267445|P3|Full Analysis Set (FAS) Population|Overall Study||120
115553|NCT00985985|267446|P2|Full Analysis Set (FAS) Population|Overall Study||242
115554|NCT00985985|267447|P1|Full Analysis Set (FAS) Population|Overall Study||241
115555|NCT00985985|267444|P4|Safety Population|Overall Study||118
115556|NCT00985985|267445|P3|Safety Population|Overall Study||119
115557|NCT00985985|267446|P2|Safety Population|Overall Study||242
115558|NCT00985985|267447|P1|Safety Population|Overall Study||241
115559|NCT00985985|267444|P4|STARTED|Overall Study||120
115560|NCT00985985|267445|P3|STARTED|Overall Study||120
115561|NCT00985985|267446|P2|STARTED|Overall Study||242
115562|NCT00985985|267447|P1|STARTED|Overall Study||241
115563|NCT00985959|267488|P3|NOT COMPLETED|Overall Study||59
115564|NCT00985959|267489|P2|NOT COMPLETED|Overall Study||3
115565|NCT00985959|267490|P1|NOT COMPLETED|Overall Study||3
115566|NCT00985959|267488|P3|COMPLETED|Overall Study||28
115567|NCT00985959|267489|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
115568|NCT00985959|267490|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
115569|NCT00985959|267488|P3|STARTED|Overall Study|Number of participants treated|87
115570|NCT00985959|267489|P2|STARTED|Overall Study|Number of participants treated|6
115571|NCT00985959|267490|P1|STARTED|Overall Study|Number of participants treated|6
115572|NCT00985829|267513|P1|NOT COMPLETED|Overall Study||0
115573|NCT00985829|267513|P1|COMPLETED|Overall Study||28
115574|NCT00985829|267513|P1|STARTED|Overall Study||28
115575|NCT00985790|267524|P2|NOT COMPLETED|Overall Study||8
115576|NCT00985790|267525|P1|NOT COMPLETED|Overall Study||7
115577|NCT00985790|267524|P2|COMPLETED|Overall Study||293
115578|NCT00985790|267525|P1|COMPLETED|Overall Study||291
115579|NCT00985790|267524|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
115580|NCT00985790|267525|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
115581|NCT00985738|267563|P2|NOT COMPLETED|Overall Study||8
115582|NCT00985738|267564|P1|NOT COMPLETED|Overall Study||8
115583|NCT00985738|267563|P2|COMPLETED|Overall Study||0
115584|NCT00985738|267564|P1|COMPLETED|Overall Study||0
115585|NCT00985738|267563|P2|STARTED|Overall Study||8
115586|NCT00985738|267564|P1|STARTED|Overall Study||8
115587|NCT00985725|267572|P2|NOT COMPLETED|Overall Study||13
115588|NCT00985725|267573|P1|NOT COMPLETED|Overall Study||11
115589|NCT00985725|267572|P2|COMPLETED|Overall Study||59
115590|NCT00985725|267573|P1|COMPLETED|Overall Study||60
115591|NCT00985725|267572|P2|STARTED|Overall Study||72
115592|NCT00985725|267573|P1|STARTED|Overall Study||71
115593|NCT00985712|267609|P2|NOT COMPLETED|Overall Study||7
115594|NCT00985712|267610|P1|NOT COMPLETED|Overall Study||6
115595|NCT00985712|267609|P2|COMPLETED|Overall Study||123
115596|NCT00985712|267610|P1|COMPLETED|Overall Study||127
115597|NCT00985712|267609|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
115598|NCT00985712|267610|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
115599|NCT00985712|267609|P2|Received at Least One Dose of Study Drug|Overall Study||130
115600|NCT00985712|267610|P1|Received at Least One Dose of Study Drug|Overall Study||131
115601|NCT00985712|267609|P2|STARTED|Overall Study||130
115602|NCT00985712|267610|P1|STARTED|Overall Study||133
115603|NCT00985686|267628|P4|NOT COMPLETED|Overall Study||2
115604|NCT00985686|267629|P3|NOT COMPLETED|Overall Study||0
115605|NCT00985686|267630|P2|NOT COMPLETED|Overall Study||1
115606|NCT00985686|267631|P1|NOT COMPLETED|Overall Study||1
115607|NCT00985686|267628|P4|COMPLETED|Overall Study||14
115608|NCT00985686|267629|P3|COMPLETED|Overall Study||13
115609|NCT00985686|267630|P2|COMPLETED|Overall Study||15
115610|NCT00985686|267631|P1|COMPLETED|Overall Study||17
115611|NCT00985686|267628|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
115612|NCT00985686|267629|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
115613|NCT00985686|267630|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
115614|NCT00985686|267631|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
115615|NCT00985686|267628|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
115616|NCT00985686|267629|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
115617|NCT00985686|267630|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
115618|NCT00985686|267631|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
115619|NCT00985686|267628|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
115620|NCT00985686|267629|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
115621|NCT00985686|267630|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
115622|NCT00985686|267631|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
115623|NCT00985686|267628|P4|Visit 1: Baseline Data Collection|Overall Study||16
115624|NCT00985686|267629|P3|Visit 1: Baseline Data Collection|Overall Study||13
115625|NCT00985686|267630|P2|Visit 1: Baseline Data Collection|Overall Study||15
115626|NCT00985686|267631|P1|Visit 1: Baseline Data Collection|Overall Study||18
115627|NCT00985686|267628|P4|STARTED|Overall Study||16
115628|NCT00985686|267629|P3|STARTED|Overall Study||13
115629|NCT00985686|267630|P2|STARTED|Overall Study||16
115630|NCT00985686|267631|P1|STARTED|Overall Study||18
115631|NCT00985673|267645|P6|NOT COMPLETED|Overall Study||6
115632|NCT00985673|267646|P5|NOT COMPLETED|Overall Study||8
115633|NCT00985673|267647|P4|NOT COMPLETED|Overall Study||12
115634|NCT00985673|267648|P3|NOT COMPLETED|Overall Study||12
115635|NCT00985673|267649|P2|NOT COMPLETED|Overall Study||11
115636|NCT00985673|267650|P1|NOT COMPLETED|Overall Study||7
115637|NCT00985673|267645|P6|COMPLETED|Overall Study||96
115638|NCT00985673|267646|P5|COMPLETED|Overall Study||93
115639|NCT00985673|267647|P4|COMPLETED|Overall Study||88
115640|NCT00985673|267648|P3|COMPLETED|Overall Study||90
115641|NCT00985673|267649|P2|COMPLETED|Overall Study||93
115642|NCT00985673|267650|P1|COMPLETED|Overall Study||95
115643|NCT00985673|267645|P6|STARTED|Overall Study||102
115644|NCT00985673|267646|P5|STARTED|Overall Study||101
115645|NCT00985673|267647|P4|STARTED|Overall Study||100
115646|NCT00985673|267648|P3|STARTED|Overall Study||102
115647|NCT00985673|267649|P2|STARTED|Overall Study||104
115648|NCT00985673|267650|P1|STARTED|Overall Study||102
115649|NCT00985543|267901|P1|NOT COMPLETED|Overall Study||0
115650|NCT00985543|267901|P1|COMPLETED|Overall Study||22
115651|NCT00985543|267901|P1|STARTED|Overall Study||22
115652|NCT00985504|267912|P2|NOT COMPLETED|Optimization Period||23
115653|NCT00985504|267913|P1|NOT COMPLETED|Optimization Period||26
115654|NCT00985504|267912|P2|COMPLETED|Optimization Period||204
115655|NCT00985504|267913|P1|COMPLETED|Optimization Period||203
115656|NCT00985504|267912|P2|STARTED|Optimization Period||227
115657|NCT00985504|267913|P1|STARTED|Optimization Period||229
115658|NCT00985504|267912|P2|NOT COMPLETED|Acute Treatment Period||12
115659|NCT00985504|267913|P1|NOT COMPLETED|Acute Treatment Period||15
115660|NCT00985504|267912|P2|COMPLETED|Acute Treatment Period||227
115661|NCT00985504|267913|P1|COMPLETED|Acute Treatment Period||229
115662|NCT00985504|267912|P2|STARTED|Acute Treatment Period||239
115663|NCT00985504|267913|P1|STARTED|Acute Treatment Period||244
115664|NCT00985491|267939|P1|NOT COMPLETED|Overall Study||19
115665|NCT00985491|267939|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
115666|NCT00985491|267939|P1|Received Device|Overall Study||43
115667|NCT00985491|267939|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
115668|NCT00985439|267948|P4|NOT COMPLETED|Overall Study||0
115669|NCT00985439|267949|P3|NOT COMPLETED|Overall Study||1
115670|NCT00985439|267950|P2|NOT COMPLETED|Overall Study||0
115671|NCT00985439|267951|P1|NOT COMPLETED|Overall Study||0
115672|NCT00985439|267948|P4|COMPLETED|Overall Study||51
115673|NCT00985439|267949|P3|COMPLETED|Overall Study||50
115674|NCT00985439|267950|P2|COMPLETED|Overall Study||51
115675|NCT00985439|267951|P1|COMPLETED|Overall Study||49
115676|NCT00985439|267948|P4|STARTED|Overall Study||51
115677|NCT00985439|267949|P3|STARTED|Overall Study||51
115678|NCT00985439|267950|P2|STARTED|Overall Study||51
115679|NCT00985439|267951|P1|STARTED|Overall Study||49
115680|NCT00985257|267961|P1|NOT COMPLETED|Overall Study||0
115681|NCT00985257|267961|P1|COMPLETED|Overall Study||123
115682|NCT00985257|267961|P1|STARTED|Overall Study||123
115683|NCT00985231|267967|P2|NOT COMPLETED|Overall Study||3
115684|NCT00985231|267968|P1|NOT COMPLETED|Overall Study||3
115685|NCT00985231|267967|P2|COMPLETED|Overall Study||129
115686|NCT00985231|267968|P1|COMPLETED|Overall Study||130
115687|NCT00985231|267967|P2|STARTED|Overall Study||132
115688|NCT00985231|267968|P1|STARTED|Overall Study||133
115689|NCT00985192|267976|P1|NOT COMPLETED|Overall Study||4
115690|NCT00985192|267976|P1|COMPLETED|Overall Study||45
115691|NCT00985192|267976|P1|STARTED|Overall Study||49
115692|NCT00985166|267988|P3|NOT COMPLETED|Overall Study||7
115693|NCT00985166|267989|P2|NOT COMPLETED|Overall Study||4
115694|NCT00985166|267990|P1|NOT COMPLETED|Overall Study||9
115695|NCT00985166|267988|P3|COMPLETED|Overall Study||188
115696|NCT00985166|267989|P2|COMPLETED|Overall Study||201
115697|NCT00985166|267990|P1|COMPLETED|Overall Study||392
115698|NCT00985166|267988|P3|Vaccinated at Visit 1|Overall Study||195
115699|NCT00985166|267989|P2|Vaccinated at Visit 1|Overall Study||205
115700|NCT00985166|267990|P1|Vaccinated at Visit 1|Overall Study||399
115701|NCT00985166|267988|P3|STARTED|Overall Study||195
115702|NCT00985166|267989|P2|STARTED|Overall Study||205
115703|NCT00985166|267990|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
115704|NCT00985153|268010|P4|NOT COMPLETED|Overall Study||47
115705|NCT00985153|268011|P3|NOT COMPLETED|Overall Study||44
115706|NCT00985153|268012|P2|NOT COMPLETED|Overall Study||44
115707|NCT00985153|268013|P1|NOT COMPLETED|Overall Study||35
115708|NCT00985153|268010|P4|COMPLETED|Overall Study||965
115709|NCT00985153|268011|P3|COMPLETED|Overall Study||918
115710|NCT00985153|268012|P2|COMPLETED|Overall Study||924
115711|NCT00985153|268013|P1|COMPLETED|Overall Study||950
115712|NCT00985153|268010|P4|Vaccinated at Visit 1|Overall Study||1012
115713|NCT00985153|268011|P3|Vaccinated at Visit 1|Overall Study||962
115714|NCT00985153|268012|P2|Vaccinated at Visit 1|Overall Study||968
115715|NCT00985153|268013|P1|Vaccinated at Visit 1|Overall Study||985
115716|NCT00985153|268010|P4|STARTED|Overall Study||1012
115717|NCT00985153|268011|P3|STARTED|Overall Study||962
115718|NCT00985153|268012|P2|STARTED|Overall Study||968
115719|NCT00985153|268013|P1|STARTED|Overall Study||985
115720|NCT00985114|268057|P2|NOT COMPLETED|Overall Study||2
115721|NCT00985114|268058|P1|NOT COMPLETED|Overall Study||1
115722|NCT00985114|268057|P2|COMPLETED|Overall Study||37
115723|NCT00985114|268058|P1|COMPLETED|Overall Study||33
115724|NCT00985114|268057|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
115725|NCT00985114|268058|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
115726|NCT00985114|268057|P2|STARTED|Overall Study||39
115727|NCT00985114|268058|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
115728|NCT00985010|268066|P2|NOT COMPLETED|Overall Study||0
115729|NCT00985010|268067|P1|NOT COMPLETED|Overall Study||0
115730|NCT00985010|268066|P2|COMPLETED|Overall Study||5
115731|NCT00985010|268067|P1|COMPLETED|Overall Study||4
115732|NCT00985010|268066|P2|STARTED|Overall Study||5
115733|NCT00985010|268067|P1|STARTED|Overall Study||4
115734|NCT00984867|268077|P2|NOT COMPLETED|Overall Study||17
115735|NCT00984867|268078|P1|NOT COMPLETED|Overall Study||23
115736|NCT00984867|268077|P2|COMPLETED|Overall Study||208
115737|NCT00984867|268078|P1|COMPLETED|Overall Study||203
115738|NCT00984867|268077|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
115739|NCT00984867|268078|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
115740|NCT00984815|268096|P1|NOT COMPLETED|Overall Study||30
115741|NCT00984815|268096|P1|COMPLETED|Overall Study||56
115742|NCT00984815|268096|P1|STARTED|Overall Study||86
115743|NCT00984698|268105|P2|NOT COMPLETED|Overall Study||8
115744|NCT00984698|268106|P1|NOT COMPLETED|Overall Study||3
115745|NCT00984698|268105|P2|COMPLETED|Overall Study||14
115746|NCT00984698|268106|P1|COMPLETED|Overall Study||18
115747|NCT00984698|268105|P2|STARTED|Overall Study||22
115748|NCT00984698|268106|P1|STARTED|Overall Study||21
115749|NCT00984659|268118|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
115750|NCT00984659|268119|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
115751|NCT00984659|268120|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
115752|NCT00984659|268121|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
115753|NCT00984659|268118|P4|COMPLETED|6-week Double-blind Treatment Period||126
115754|NCT00984659|268119|P3|COMPLETED|6-week Double-blind Treatment Period||141
115755|NCT00984659|268120|P2|COMPLETED|6-week Double-blind Treatment Period||69
115756|NCT00984659|268121|P1|COMPLETED|6-week Double-blind Treatment Period||0
115757|NCT00984659|268118|P4|STARTED|6-week Double-blind Treatment Period||139
115758|NCT00984659|268119|P3|STARTED|6-week Double-blind Treatment Period||152
115759|NCT00984659|268120|P2|STARTED|6-week Double-blind Treatment Period||75
115760|NCT00984659|268121|P1|STARTED|6-week Double-blind Treatment Period||0
115761|NCT00984659|268118|P4|NOT COMPLETED|2-week Run-in Period||0
115762|NCT00984659|268119|P3|NOT COMPLETED|2-week Run-in Period||0
115763|NCT00984659|268120|P2|NOT COMPLETED|2-week Run-in Period||0
115764|NCT00984659|268121|P1|NOT COMPLETED|2-week Run-in Period||52
115765|NCT00984659|268118|P4|COMPLETED|2-week Run-in Period||0
115766|NCT00984659|268119|P3|COMPLETED|2-week Run-in Period||0
115767|NCT00984659|268120|P2|COMPLETED|2-week Run-in Period||0
115768|NCT00984659|268121|P1|COMPLETED|2-week Run-in Period||366
115769|NCT00984659|268118|P4|STARTED|2-week Run-in Period||0
115770|NCT00984659|268119|P3|STARTED|2-week Run-in Period||0
115771|NCT00984659|268120|P2|STARTED|2-week Run-in Period||0
115772|NCT00984659|268121|P1|STARTED|2-week Run-in Period||418
115773|NCT00984620|268148|P2|NOT COMPLETED|Overall Study||12
115774|NCT00984620|268149|P1|NOT COMPLETED|Overall Study||6
115775|NCT00984620|268148|P2|COMPLETED|Overall Study||67
115776|NCT00984620|268149|P1|COMPLETED|Overall Study||75
115777|NCT00984620|268148|P2|STARTED|Overall Study||79
115778|NCT00984620|268149|P1|STARTED|Overall Study||81
115779|NCT00984594|268187|P2|NOT COMPLETED|Overall Study||1
115780|NCT00984594|268188|P1|NOT COMPLETED|Overall Study||1
115781|NCT00984594|268187|P2|COMPLETED|Overall Study||1
115782|NCT00984594|268188|P1|COMPLETED|Overall Study||1
115783|NCT00984594|268187|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
115784|NCT00984594|268188|P1|STARTED|Overall Study||2
115785|NCT00984568|268204|P2|NOT COMPLETED|Overall Study||6
115786|NCT00984568|268205|P1|NOT COMPLETED|Overall Study||8
115787|NCT00984568|268204|P2|COMPLETED|Overall Study||7
115788|NCT00984568|268205|P1|COMPLETED|Overall Study||7
115789|NCT00984568|268204|P2|STARTED|Overall Study||13
115790|NCT00984568|268205|P1|STARTED|Overall Study||15
115791|NCT00984542|268213|P1|NOT COMPLETED|Overall Study||41
115792|NCT00984542|268213|P1|COMPLETED|Overall Study||9
115793|NCT00984542|268213|P1|STARTED|Overall Study||50
115794|NCT00984490|268221|P1|NOT COMPLETED|Overall Study||0
115795|NCT00984490|268221|P1|COMPLETED|Overall Study||5
115796|NCT00984490|268221|P1|STARTED|Overall Study||5
115797|NCT00984334|268231|P5|NOT COMPLETED|Overall Study||1
115798|NCT00984334|268232|P4|NOT COMPLETED|Overall Study||1
115799|NCT00984334|268233|P3|NOT COMPLETED|Overall Study||0
115800|NCT00984334|268234|P2|NOT COMPLETED|Overall Study||1
115801|NCT00984334|268235|P1|NOT COMPLETED|Overall Study||1
115802|NCT00984334|268231|P5|COMPLETED|Overall Study||7
115803|NCT00984334|268232|P4|COMPLETED|Overall Study||7
115804|NCT00984334|268233|P3|COMPLETED|Overall Study||8
115805|NCT00984334|268234|P2|COMPLETED|Overall Study||7
115806|NCT00984334|268235|P1|COMPLETED|Overall Study||7
115807|NCT00984334|268231|P5|STARTED|Overall Study||8
115808|NCT00984334|268232|P4|STARTED|Overall Study||8
115809|NCT00984334|268233|P3|STARTED|Overall Study||8
115810|NCT00984334|268234|P2|STARTED|Overall Study||8
115811|NCT00984334|268235|P1|STARTED|Overall Study||8
115812|NCT00984308|268249|P2|NOT COMPLETED|Overall Study||6
115813|NCT00984308|268250|P1|NOT COMPLETED|Overall Study||18
115814|NCT00984308|268249|P2|COMPLETED|Overall Study||109
115815|NCT00984308|268250|P1|COMPLETED|Overall Study||92
115816|NCT00984308|268249|P2|STARTED|Overall Study||115
115817|NCT00984308|268250|P1|STARTED|Overall Study||110
115818|NCT00984295|268263|P3|NOT COMPLETED|Overall Study||37
115819|NCT00984295|268264|P2|NOT COMPLETED|Overall Study||32
115820|NCT00984295|268265|P1|NOT COMPLETED|Overall Study||65
115821|NCT00984295|268263|P3|COMPLETED|Overall Study||442
115822|NCT00984295|268264|P2|COMPLETED|Overall Study||453
115823|NCT00984295|268265|P1|COMPLETED|Overall Study||884
115824|NCT00984295|268263|P3|Visit 2|Overall Study||453
115825|NCT00984295|268264|P2|Visit 2|Overall Study||468
115826|NCT00984295|268265|P1|Visit 2|Overall Study||909
115827|NCT00984295|268263|P3|Visit 1|Overall Study||479
115828|NCT00984295|268264|P2|Visit 1|Overall Study||485
115829|NCT00984295|268265|P1|Visit 1|Overall Study||949
115830|NCT00984295|268263|P3|STARTED|Overall Study||479
115831|NCT00984295|268264|P2|STARTED|Overall Study||485
115832|NCT00984295|268265|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
115833|NCT00984282|268332|P2|NOT COMPLETED|Long Term Follow-up||91
115834|NCT00984282|268333|P1|NOT COMPLETED|Long Term Follow-up||123
115835|NCT00984282|268332|P2|COMPLETED|Long Term Follow-up||0
115836|NCT00984282|268333|P1|COMPLETED|Long Term Follow-up||0
115837|NCT00984282|268332|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|91
115838|NCT00984282|268333|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|123
115839|NCT00984282|268332|P2|NOT COMPLETED|Open-label Treatment||164
115840|NCT00984282|268333|P1|NOT COMPLETED|Open-label Treatment||89
115841|NCT00984282|268332|P2|COMPLETED|Open-label Treatment||0
115842|NCT00984282|268333|P1|COMPLETED|Open-label Treatment||0
115843|NCT00984282|268332|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|150
115844|NCT00984282|268333|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|55
115845|NCT00984282|268332|P2|STARTED|Open-label Treatment||164
115846|NCT00984282|268333|P1|STARTED|Open-label Treatment||89
115847|NCT00984282|268332|P2|NOT COMPLETED|Double Blind Treatment||46
115848|NCT00984282|268333|P1|NOT COMPLETED|Double Blind Treatment||118
115849|NCT00984282|268332|P2|COMPLETED|Double Blind Treatment||164
115850|NCT00984282|268333|P1|COMPLETED|Double Blind Treatment||89
115851|NCT00984282|268332|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
115852|NCT00984282|268333|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
115853|NCT00984282|268332|P2|STARTED|Double Blind Treatment||210
115854|NCT00984282|268333|P1|STARTED|Double Blind Treatment||207
115855|NCT00984256|268356|P2|NOT COMPLETED|Overall Study||1
115856|NCT00984256|268357|P1|NOT COMPLETED|Overall Study||0
115857|NCT00984256|268356|P2|COMPLETED|Overall Study||29
115858|NCT00984256|268357|P1|COMPLETED|Overall Study||6
115859|NCT00984256|268356|P2|STARTED|Overall Study||30
115860|NCT00984256|268357|P1|STARTED|Overall Study||6
115861|NCT00984204|268377|P1|NOT COMPLETED|Overall Study||15
115862|NCT00984204|268377|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
115863|NCT00984204|268377|P1|STARTED|Overall Study||188
115864|NCT00984165|268387|P4|NOT COMPLETED|Overall Study||4
115865|NCT00984165|268388|P3|NOT COMPLETED|Overall Study||0
115866|NCT00984165|268389|P2|NOT COMPLETED|Overall Study||1
115867|NCT00984165|268390|P1|NOT COMPLETED|Overall Study||7
115868|NCT00984165|268387|P4|COMPLETED|Overall Study||0
115869|NCT00984165|268388|P3|COMPLETED|Overall Study||4
115870|NCT00984165|268389|P2|COMPLETED|Overall Study||0
115871|NCT00984165|268390|P1|COMPLETED|Overall Study||2
115872|NCT00984165|268387|P4|STARTED|Overall Study||4
115873|NCT00984165|268388|P3|STARTED|Overall Study||4
115874|NCT00984165|268389|P2|STARTED|Overall Study||1
115875|NCT00984165|268390|P1|STARTED|Overall Study||9
115876|NCT00984139|268403|P1|NOT COMPLETED|Overall Study||0
115877|NCT00984139|268403|P1|COMPLETED|Overall Study||306
115878|NCT00984139|268403|P1|STARTED|Overall Study||306
115879|NCT00984061|268415|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
115880|NCT00984061|268415|P1|COMPLETED|Colchicine With Clarithromycin||23
115881|NCT00984061|268415|P1|STARTED|Colchicine With Clarithromycin||23
115882|NCT00984061|268415|P1|NOT COMPLETED|Clarithromycin Alone||1
115883|NCT00984061|268415|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
115884|NCT00984061|268415|P1|STARTED|Clarithromycin Alone||24
115885|NCT00984061|268415|P1|NOT COMPLETED|21 Day Washout Period||0
115886|NCT00984061|268415|P1|COMPLETED|21 Day Washout Period||24
115887|NCT00984061|268415|P1|STARTED|21 Day Washout Period||24
115888|NCT00984061|268415|P1|NOT COMPLETED|Colchicine Alone||0
115889|NCT00984061|268415|P1|COMPLETED|Colchicine Alone||24
115890|NCT00984061|268415|P1|STARTED|Colchicine Alone||24
115891|NCT00984022|268428|P2|NOT COMPLETED|Overall Study||14
115892|NCT00984022|268429|P1|NOT COMPLETED|Overall Study||10
115893|NCT00984022|268428|P2|COMPLETED|Overall Study||35
115894|NCT00984022|268429|P1|COMPLETED|Overall Study||33
115895|NCT00984022|268428|P2|STARTED|Overall Study||49
115896|NCT00984022|268429|P1|STARTED|Overall Study||43
115897|NCT00984009|268439|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
115898|NCT00984009|268439|P1|COMPLETED|Colchicine With Grapefruit Juice||21
115899|NCT00984009|268439|P1|STARTED|Colchicine With Grapefruit Juice||21
115900|NCT00984009|268439|P1|NOT COMPLETED|Grapefruit Juice Alone||1
115901|NCT00984009|268439|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
115902|NCT00984009|268439|P1|STARTED|Grapefruit Juice Alone||22
115903|NCT00984009|268439|P1|NOT COMPLETED|14 Day Washout Period||0
115904|NCT00984009|268439|P1|COMPLETED|14 Day Washout Period||22
115905|NCT00984009|268439|P1|STARTED|14 Day Washout Period||22
115906|NCT00984009|268439|P1|NOT COMPLETED|Colchicine Alone||0
115907|NCT00984009|268439|P1|COMPLETED|Colchicine Alone||22
115908|NCT00984009|268439|P1|STARTED|Colchicine Alone||22
115909|NCT00983983|268453|P3|NOT COMPLETED|Overall Study||1
115910|NCT00983983|268454|P2|NOT COMPLETED|Overall Study||1
115911|NCT00983983|268455|P1|NOT COMPLETED|Overall Study||2
115912|NCT00983983|268453|P3|COMPLETED|Overall Study||6
115913|NCT00983983|268454|P2|COMPLETED|Overall Study||8
115914|NCT00983983|268455|P1|COMPLETED|Overall Study||6
115915|NCT00983983|268453|P3|STARTED|Overall Study||7
115916|NCT00983983|268454|P2|STARTED|Overall Study||9
115917|NCT00983983|268455|P1|STARTED|Overall Study||8
115918|NCT00983957|268472|P1|NOT COMPLETED|Overall Study||2
115919|NCT00983957|268472|P1|COMPLETED|Overall Study||18
115920|NCT00983957|268472|P1|Treatment C|Overall Study||18
115921|NCT00983957|268472|P1|Treatment B|Overall Study||20
115922|NCT00983957|268472|P1|Treatment A|Overall Study||20
115923|NCT00983957|268472|P1|STARTED|Overall Study||20
115924|NCT00983931|268506|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
115925|NCT00983931|268506|P1|COMPLETED|Colchicine With Cyclosporine||23
115926|NCT00983931|268506|P1|STARTED|Colchicine With Cyclosporine||23
115927|NCT00983931|268506|P1|NOT COMPLETED|14 Day Washout Period||1
115928|NCT00983931|268506|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
115929|NCT00983931|268506|P1|STARTED|14 Day Washout Period||24
115930|NCT00983931|268506|P1|NOT COMPLETED|Colchicine Alone||0
115931|NCT00983931|268506|P1|COMPLETED|Colchicine Alone||24
115932|NCT00983931|268506|P1|STARTED|Colchicine Alone||24
115933|NCT00983918|268520|P4|NOT COMPLETED|Overall Study||2
115934|NCT00983918|268521|P3|NOT COMPLETED|Overall Study||2
115935|NCT00983918|268522|P2|NOT COMPLETED|Overall Study||2
115936|NCT00983918|268523|P1|NOT COMPLETED|Overall Study||0
115937|NCT00983918|268520|P4|COMPLETED|Overall Study||18
115938|NCT00983918|268521|P3|COMPLETED|Overall Study||18
115939|NCT00983918|268522|P2|COMPLETED|Overall Study||18
115940|NCT00983918|268523|P1|COMPLETED|Overall Study||20
115941|NCT00983918|268520|P4|STARTED|Overall Study||20
115942|NCT00983918|268521|P3|STARTED|Overall Study||20
115943|NCT00983918|268522|P2|STARTED|Overall Study||20
115944|NCT00983918|268523|P1|STARTED|Overall Study||20
115945|NCT00983905|268533|P1|NOT COMPLETED|Theophylline With Colchicine||0
115946|NCT00983905|268533|P1|COMPLETED|Theophylline With Colchicine||27
115947|NCT00983905|268533|P1|STARTED|Theophylline With Colchicine||27
115948|NCT00983905|268533|P1|NOT COMPLETED|Colchicine Alone||2
115949|NCT00983905|268533|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
115950|NCT00983905|268533|P1|STARTED|Colchicine Alone||29
115951|NCT00983905|268533|P1|NOT COMPLETED|4 Day Washout Period||0
115952|NCT00983905|268533|P1|COMPLETED|4 Day Washout Period||29
115953|NCT00983905|268533|P1|STARTED|4 Day Washout Period||29
115954|NCT00983905|268533|P1|NOT COMPLETED|Theophylline Alone||1
115955|NCT00983905|268533|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
115956|NCT00983905|268533|P1|STARTED|Theophylline Alone||30
115957|NCT00983892|268546|P2|NOT COMPLETED|Overall Study||12
115958|NCT00983892|268547|P1|NOT COMPLETED|Overall Study||10
115959|NCT00983892|268546|P2|COMPLETED|Overall Study||56
115960|NCT00983892|268547|P1|COMPLETED|Overall Study||56
115961|NCT00983892|268546|P2|STARTED|Overall Study||68
115962|NCT00983892|268547|P1|STARTED|Overall Study||66
115963|NCT00983853|268559|P6|NOT COMPLETED|Overall Study||1
115964|NCT00983853|268560|P5|NOT COMPLETED|Overall Study||3
115965|NCT00983853|268561|P4|NOT COMPLETED|Overall Study||2
115966|NCT00983853|268562|P3|NOT COMPLETED|Overall Study||3
115967|NCT00983853|268563|P2|NOT COMPLETED|Overall Study||2
115968|NCT00983853|268564|P1|NOT COMPLETED|Overall Study||1
115969|NCT00983853|268559|P6|COMPLETED|Overall Study||7
115970|NCT00983853|268560|P5|COMPLETED|Overall Study||12
115971|NCT00983853|268561|P4|COMPLETED|Overall Study||6
115972|NCT00983853|268562|P3|COMPLETED|Overall Study||14
115973|NCT00983853|268563|P2|COMPLETED|Overall Study||5
115974|NCT00983853|268564|P1|COMPLETED|Overall Study||6
115975|NCT00983853|268559|P6|STARTED|Overall Study||8
115976|NCT00983853|268560|P5|STARTED|Overall Study||15
115977|NCT00983853|268561|P4|STARTED|Overall Study||8
115978|NCT00983853|268562|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
115979|NCT00983853|268563|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
115980|NCT00983853|268564|P1|STARTED|Overall Study||7
115981|NCT00983827|268592|P1|NOT COMPLETED|Overall Study||1
115982|NCT00983827|268592|P1|COMPLETED|Overall Study||7
115983|NCT00983827|268592|P1|STARTED|Overall Study||8
115984|NCT00983801|268596|P1|NOT COMPLETED|Overall Study||0
115985|NCT00983801|268596|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
115986|NCT00983801|268596|P1|STARTED|Overall Study|Participants who received treatment.|52
115987|NCT00983749|268610|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
115988|NCT00983749|268611|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
115989|NCT00983749|268610|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
115990|NCT00983749|268611|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
115991|NCT00983749|268610|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
115992|NCT00983749|268611|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
115993|NCT00983749|268610|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
115994|NCT00983749|268611|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
115995|NCT00983749|268610|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
115996|NCT00983749|268611|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
115997|NCT00983749|268610|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
115998|NCT00983749|268611|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
115999|NCT00983645|268621|P2|NOT COMPLETED|Overall Study||0
116000|NCT00983645|268622|P1|NOT COMPLETED|Overall Study||0
116001|NCT00983645|268621|P2|COMPLETED|Overall Study||7
116002|NCT00983645|268622|P1|COMPLETED|Overall Study||8
116003|NCT00983645|268621|P2|STARTED|Overall Study||7
116004|NCT00983645|268622|P1|STARTED|Overall Study||8
116005|NCT00983541|268634|P1|NOT COMPLETED|Overall Study||0
116006|NCT00983541|268634|P1|COMPLETED|Overall Study||1
116007|NCT00983541|268634|P1|STARTED|Overall Study||1
116008|NCT00983515|268644|P1|NOT COMPLETED|Colchicine With Ritonavir||1
116009|NCT00983515|268644|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
116010|NCT00983515|268644|P1|STARTED|Colchicine With Ritonavir||18
116011|NCT00983515|268644|P1|NOT COMPLETED|Ritonavir Alone||6
116012|NCT00983515|268644|P1|COMPLETED|Ritonavir Alone||18
116013|NCT00983515|268644|P1|STARTED|Ritonavir Alone||24
116014|NCT00983515|268644|P1|NOT COMPLETED|14 Day Washout Period||0
116015|NCT00983515|268644|P1|COMPLETED|14 Day Washout Period||24
116016|NCT00983515|268644|P1|STARTED|14 Day Washout Period||24
116017|NCT00983515|268644|P1|NOT COMPLETED|Colchicine Alone||0
116018|NCT00983515|268644|P1|COMPLETED|Colchicine Alone||24
116019|NCT00983515|268644|P1|STARTED|Colchicine Alone||24
116020|NCT00983489|268658|P3|NOT COMPLETED|Overall Study||312
116021|NCT00983489|268659|P2|NOT COMPLETED|Overall Study||285
116022|NCT00983489|268660|P1|NOT COMPLETED|Overall Study||185
116023|NCT00983489|268658|P3|COMPLETED|Overall Study||135
116024|NCT00983489|268659|P2|COMPLETED|Overall Study||168
116025|NCT00983489|268660|P1|COMPLETED|Overall Study||326
116026|NCT00983489|268658|P3|STARTED|Overall Study||447
116027|NCT00983489|268659|P2|STARTED|Overall Study||453
116028|NCT00983489|268660|P1|STARTED|Overall Study||511
116029|NCT00983476|268671|P3|NOT COMPLETED|Overall Study||0
116030|NCT00983476|268672|P2|NOT COMPLETED|Overall Study||22
116031|NCT00983476|268673|P1|NOT COMPLETED|Overall Study||17
116032|NCT00983476|268671|P3|COMPLETED|Overall Study||88
116033|NCT00983476|268672|P2|COMPLETED|Overall Study||71
116034|NCT00983476|268673|P1|COMPLETED|Overall Study||78
116035|NCT00983476|268671|P3|6 Month Follow up Assessment|Overall Study||74
116036|NCT00983476|268672|P2|6 Month Follow up Assessment|Overall Study||62
116037|NCT00983476|268673|P1|6 Month Follow up Assessment|Overall Study||71
116038|NCT00983476|268671|P3|STARTED|Overall Study||88
116039|NCT00983476|268672|P2|STARTED|Overall Study||93
116040|NCT00983476|268673|P1|STARTED|Overall Study||95
116041|NCT00983437|268705|P1|NOT COMPLETED|Overall Study||47
116042|NCT00983437|268705|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
116043|NCT00983437|268705|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
116044|NCT00983437|268705|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
116045|NCT00983437|268705|P1|STARTED|Overall Study||47
116046|NCT00983385|268724|P1|NOT COMPLETED|Maintenance Period||23
116047|NCT00983385|268724|P1|COMPLETED|Maintenance Period||117
116048|NCT00983385|268724|P1|STARTED|Maintenance Period||140
116049|NCT00983385|268724|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
116050|NCT00983385|268724|P1|COMPLETED|Titration and Optimal Dose Period||140
116051|NCT00983385|268724|P1|STARTED|Titration and Optimal Dose Period||176
116052|NCT00983385|268724|P1|NOT COMPLETED|Observation Period||32
116053|NCT00983385|268724|P1|COMPLETED|Observation Period||176
116054|NCT00983385|268724|P1|STARTED|Observation Period||208
116055|NCT00983372|268769|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
116056|NCT00983372|268769|P1|COMPLETED|Colchicine With Diltiazem ER||20
116057|NCT00983372|268769|P1|STARTED|Colchicine With Diltiazem ER||20
116058|NCT00983372|268769|P1|NOT COMPLETED|Diltiazem ER Alone||3
116059|NCT00983372|268769|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
116060|NCT00983372|268769|P1|STARTED|Diltiazem ER Alone||23
116061|NCT00983372|268769|P1|NOT COMPLETED|14 Day Washout Period||1
116062|NCT00983372|268769|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
116063|NCT00983372|268769|P1|STARTED|14 Day Washout Period||24
116064|NCT00983372|268769|P1|NOT COMPLETED|Colchicine Alone||0
116065|NCT00983372|268769|P1|COMPLETED|Colchicine Alone||24
116066|NCT00983372|268769|P1|STARTED|Colchicine Alone||24
116067|NCT00983359|268780|P1|NOT COMPLETED|Overall Study||1
116068|NCT00983359|268780|P1|COMPLETED|Overall Study||39
116069|NCT00983359|268780|P1|Not Eligible for Analysis|Overall Study||1
116070|NCT00983359|268780|P1|STARTED|Overall Study||40
116071|NCT00983346|268788|P1|NOT COMPLETED|Overall Study||0
116072|NCT00983346|268788|P1|COMPLETED|Overall Study||17
116073|NCT00983346|268788|P1|STARTED|Overall Study||17
116074|NCT00983294|268792|P1|NOT COMPLETED|Colchicine With Azithromycin||1
116075|NCT00983294|268792|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
116076|NCT00983294|268792|P1|STARTED|Colchicine With Azithromycin||22
116077|NCT00983294|268792|P1|NOT COMPLETED|Azithromycin Alone||0
116078|NCT00983294|268792|P1|COMPLETED|Azithromycin Alone||22
116079|NCT00983294|268792|P1|STARTED|Azithromycin Alone||22
116080|NCT00983294|268792|P1|NOT COMPLETED|14 Day Washout Period||2
116081|NCT00983294|268792|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
116082|NCT00983294|268792|P1|STARTED|14 Day Washout Period||24
116083|NCT00983294|268792|P1|NOT COMPLETED|Colchicine Alone||0
116084|NCT00983294|268792|P1|COMPLETED|Colchicine Alone||24
116085|NCT00983294|268792|P1|STARTED|Colchicine Alone||24
116086|NCT00983281|268805|P2|NOT COMPLETED|Overall Study||0
116087|NCT00983281|268806|P1|NOT COMPLETED|Overall Study||0
116088|NCT00983281|268805|P2|COMPLETED|Overall Study||909
116089|NCT00983281|268806|P1|COMPLETED|Overall Study||805
116090|NCT00983281|268805|P2|STARTED|Overall Study||909
116091|NCT00983281|268806|P1|STARTED|Overall Study||805
116092|NCT00983242|268812|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
116093|NCT00983242|268812|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
116094|NCT00983242|268812|P1|STARTED|Colchicine With Verapamil HCl ER||24
116095|NCT00983242|268812|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
116096|NCT00983242|268812|P1|COMPLETED|Verapamil HCl ER Alone||24
116097|NCT00983242|268812|P1|STARTED|Verapamil HCl ER Alone||24
116098|NCT00983242|268812|P1|NOT COMPLETED|14 Day Washout Period||0
116099|NCT00983242|268812|P1|COMPLETED|14 Day Washout Period||24
116100|NCT00983242|268812|P1|STARTED|14 Day Washout Period||24
116101|NCT00983242|268812|P1|NOT COMPLETED|Colchicine Alone||0
116102|NCT00983242|268812|P1|COMPLETED|Colchicine Alone||24
116103|NCT00983242|268812|P1|STARTED|Colchicine Alone||24
116104|NCT00983216|268823|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
116105|NCT00983216|268823|P1|COMPLETED|Colchicine With Ketoconazole||24
116106|NCT00983216|268823|P1|STARTED|Colchicine With Ketoconazole||24
116107|NCT00983216|268823|P1|NOT COMPLETED|Ketoconazole Alone||0
116108|NCT00983216|268823|P1|COMPLETED|Ketoconazole Alone||24
116109|NCT00983216|268823|P1|STARTED|Ketoconazole Alone||24
116110|NCT00983216|268823|P1|NOT COMPLETED|14 Day Washout Period||0
116111|NCT00983216|268823|P1|COMPLETED|14 Day Washout Period||24
116112|NCT00983216|268823|P1|STARTED|14 Day Washout Period||24
116113|NCT00983216|268823|P1|NOT COMPLETED|Colchicine Alone||0
116114|NCT00983216|268823|P1|COMPLETED|Colchicine Alone||24
116115|NCT00983216|268823|P1|STARTED|Colchicine Alone||24
116116|NCT00983073|268834|P1|NOT COMPLETED|Maintenance Period||16
116117|NCT00983073|268834|P1|COMPLETED|Maintenance Period||144
116118|NCT00983073|268834|P1|STARTED|Maintenance Period||160
116119|NCT00983073|268834|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
116120|NCT00983073|268834|P1|COMPLETED|Titration and Optimal Dose Period||160
116121|NCT00983073|268834|P1|STARTED|Titration and Optimal Dose Period||200
116122|NCT00983073|268834|P1|NOT COMPLETED|Observation Period||24
116123|NCT00983073|268834|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
116124|NCT00983073|268834|P1|STARTED|Observation Period||224
116125|NCT00982995|268855|P1|NOT COMPLETED|Overall Study||0
116126|NCT00982995|268855|P1|COMPLETED|Overall Study||3
116127|NCT00982995|268855|P1|STARTED|Overall Study||3
116128|NCT00982735|268860|P1|NOT COMPLETED|Overall Study||230
116129|NCT00982735|268860|P1|COMPLETED|Overall Study||757
116130|NCT00982735|268860|P1|STARTED|Overall Study||987
116131|NCT00982657|268870|P4|NOT COMPLETED|Overall Study||9
116132|NCT00982657|268871|P3|NOT COMPLETED|Overall Study||2
116133|NCT00982657|268872|P2|NOT COMPLETED|Overall Study||0
116134|NCT00982657|268873|P1|NOT COMPLETED|Overall Study||1
116135|NCT00982657|268870|P4|COMPLETED|Overall Study||7
116136|NCT00982657|268871|P3|COMPLETED|Overall Study||1
116137|NCT00982657|268872|P2|COMPLETED|Overall Study||3
116138|NCT00982657|268873|P1|COMPLETED|Overall Study||11
116139|NCT00982657|268870|P4|STARTED|Overall Study||16
116140|NCT00982657|268871|P3|STARTED|Overall Study||3
116141|NCT00982657|268872|P2|STARTED|Overall Study||3
116142|NCT00982657|268873|P1|STARTED|Overall Study||12
116143|NCT00982644|268914|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
116144|NCT00982644|268915|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
116145|NCT00982644|268914|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
116146|NCT00982644|268915|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
116147|NCT00982644|268914|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
116148|NCT00982644|268915|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
116149|NCT00982644|268914|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
116150|NCT00982644|268915|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
116151|NCT00982644|268914|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
116152|NCT00982644|268915|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
116153|NCT00982644|268914|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
116154|NCT00982644|268915|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
116155|NCT00982644|268914|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
116156|NCT00982644|268915|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
116157|NCT00982644|268914|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
116158|NCT00982644|268915|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
116159|NCT00982592|268939|P2|NOT COMPLETED|Overall Study||33
116160|NCT00982592|268940|P1|NOT COMPLETED|Overall Study||31
116161|NCT00982592|268939|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
116162|NCT00982592|268940|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
116163|NCT00982592|268939|P2|Treatment Received|Overall Study||52
116164|NCT00982592|268940|P1|Treatment Received|Overall Study||63
116165|NCT00982592|268939|P2|STARTED|Overall Study||60
116166|NCT00982592|268940|P1|STARTED|Overall Study||64
116167|NCT00982553|268954|P1|NOT COMPLETED|Overall Study||0
116168|NCT00982553|268954|P1|COMPLETED|Overall Study||14
116169|NCT00982553|268954|P1|STARTED|Overall Study||14
116170|NCT00982488|268966|P5|NOT COMPLETED|Overall Study||1
116171|NCT00982488|268967|P4|NOT COMPLETED|Overall Study||3
116172|NCT00982488|268968|P3|NOT COMPLETED|Overall Study||34
116173|NCT00982488|268969|P2|NOT COMPLETED|Overall Study||14
116174|NCT00982488|268970|P1|NOT COMPLETED|Overall Study||185
116175|NCT00982488|268966|P5|COMPLETED|Overall Study|Still receiving treatment|0
116176|NCT00982488|268967|P4|COMPLETED|Overall Study|Still receiving treatment|0
116177|NCT00982488|268968|P3|COMPLETED|Overall Study|Still receiving treatment|0
116178|NCT00982488|268969|P2|COMPLETED|Overall Study|Still receiving treatment|0
116179|NCT00982488|268970|P1|COMPLETED|Overall Study|Still receiving treatment|0
116180|NCT00982488|268966|P5|STARTED|Overall Study|Received treatment|1
116181|NCT00982488|268967|P4|STARTED|Overall Study|Received treatment|3
116182|NCT00982488|268968|P3|STARTED|Overall Study|Received treatment|34
116183|NCT00982488|268969|P2|STARTED|Overall Study|Received treatment|14
116184|NCT00982488|268970|P1|STARTED|Overall Study|Received treatment|185
116185|NCT00982423|268984|P2|NOT COMPLETED|Overall Study||0
116186|NCT00982423|268985|P1|NOT COMPLETED|Overall Study||0
116187|NCT00982423|268984|P2|COMPLETED|Overall Study||19
116188|NCT00982423|268985|P1|COMPLETED|Overall Study||13
116189|NCT00982423|268984|P2|STARTED|Overall Study||19
116190|NCT00982423|268985|P1|STARTED|Overall Study||13
116191|NCT00982410|269003|P2|NOT COMPLETED|12-month Follow-up Assessment||9
116192|NCT00982410|269004|P1|NOT COMPLETED|12-month Follow-up Assessment||9
116193|NCT00982410|269003|P2|COMPLETED|12-month Follow-up Assessment||55
116194|NCT00982410|269004|P1|COMPLETED|12-month Follow-up Assessment||56
116195|NCT00982410|269003|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
116196|NCT00982410|269004|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
116197|NCT00982410|269003|P2|NOT COMPLETED|6-month Follow-up Assessment||11
116198|NCT00982410|269004|P1|NOT COMPLETED|6-month Follow-up Assessment||6
116199|NCT00982410|269003|P2|COMPLETED|6-month Follow-up Assessment||53
116200|NCT00982410|269004|P1|COMPLETED|6-month Follow-up Assessment||59
116201|NCT00982410|269003|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
116202|NCT00982410|269004|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
116203|NCT00982410|269003|P2|NOT COMPLETED|3-month Follow-up Assessment||13
116204|NCT00982410|269004|P1|NOT COMPLETED|3-month Follow-up Assessment||9
116205|NCT00982410|269003|P2|COMPLETED|3-month Follow-up Assessment||53
116206|NCT00982410|269004|P1|COMPLETED|3-month Follow-up Assessment||56
116207|NCT00982410|269003|P2|STARTED|3-month Follow-up Assessment||66
116208|NCT00982410|269004|P1|STARTED|3-month Follow-up Assessment||65
116209|NCT00982345|269026|P1|NOT COMPLETED|Overall Study||2
116210|NCT00982345|269026|P1|COMPLETED|Overall Study||18
116211|NCT00982345|269026|P1|STARTED|Overall Study||20
116212|NCT00982280|269030|P1|NOT COMPLETED|Maintenance Period||1
116213|NCT00982280|269030|P1|COMPLETED|Maintenance Period||54
116214|NCT00982280|269030|P1|STARTED|Maintenance Period||55
116215|NCT00982280|269030|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
116216|NCT00982280|269030|P1|COMPLETED|Titration and Optimal Dose Period||55
116217|NCT00982280|269030|P1|STARTED|Titration and Optimal Dose Period||63
116218|NCT00982280|269030|P1|NOT COMPLETED|Observation Period||19
116219|NCT00982280|269030|P1|COMPLETED|Observation Period||63
116220|NCT00982280|269030|P1|STARTED|Observation Period||82
116221|NCT00982228|269055|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
116222|NCT00982228|269056|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
116223|NCT00982228|269055|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
116224|NCT00982228|269056|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
116225|NCT00982228|269055|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
116226|NCT00982228|269056|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
116227|NCT00982228|269055|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
116228|NCT00982228|269056|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
116229|NCT00982228|269055|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
116230|NCT00982228|269056|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
116231|NCT00982228|269055|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
116232|NCT00982228|269056|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
116233|NCT00982228|269055|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
116234|NCT00982228|269056|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
116235|NCT00982228|269055|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
116236|NCT00982228|269056|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
116237|NCT00982189|269084|P4|NOT COMPLETED|Overall Study||0
116238|NCT00982189|269085|P3|NOT COMPLETED|Overall Study||0
116239|NCT00982189|269086|P2|NOT COMPLETED|Overall Study||0
116240|NCT00982189|269087|P1|NOT COMPLETED|Overall Study||0
116241|NCT00982189|269084|P4|COMPLETED|Overall Study||9
116242|NCT00982189|269085|P3|COMPLETED|Overall Study||9
116243|NCT00982189|269086|P2|COMPLETED|Overall Study||9
116244|NCT00982189|269087|P1|COMPLETED|Overall Study||10
116245|NCT00982189|269084|P4|STARTED|Overall Study||9
116246|NCT00982189|269085|P3|STARTED|Overall Study||9
116247|NCT00982189|269086|P2|STARTED|Overall Study||9
116248|NCT00982189|269087|P1|STARTED|Overall Study||10
116249|NCT00982137|269109|P4|NOT COMPLETED|Overall Study||1
116250|NCT00982137|269110|P3|NOT COMPLETED|Overall Study||0
116251|NCT00982137|269111|P2|NOT COMPLETED|Overall Study||1
116252|NCT00982137|269112|P1|NOT COMPLETED|Overall Study||0
116253|NCT00982137|269109|P4|COMPLETED|Overall Study||17
116254|NCT00982137|269110|P3|COMPLETED|Overall Study||18
116255|NCT00982137|269111|P2|COMPLETED|Overall Study||35
116256|NCT00982137|269112|P1|COMPLETED|Overall Study||36
116257|NCT00982137|269109|P4|STARTED|Overall Study||18
116258|NCT00982137|269110|P3|STARTED|Overall Study||18
116259|NCT00982137|269111|P2|STARTED|Overall Study||36
116260|NCT00982137|269112|P1|STARTED|Overall Study||36
116261|NCT00982111|269144|P2|NOT COMPLETED|Overall Study||66
116262|NCT00982111|269145|P1|NOT COMPLETED|Overall Study||75
116263|NCT00982111|269144|P2|COMPLETED|Overall Study||252
116264|NCT00982111|269145|P1|COMPLETED|Overall Study||240
116265|NCT00982111|269144|P2|On Study at Conclusion, Off Treatment|Overall Study||6
116266|NCT00982111|269145|P1|On Study at Conclusion, Off Treatment|Overall Study||4
116267|NCT00982111|269144|P2|Death Due to Any Cause|Overall Study||246
116268|NCT00982111|269145|P1|Death Due to Any Cause|Overall Study||236
116269|NCT00982111|269144|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
116270|NCT00982111|269145|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
116271|NCT00982111|269144|P2|STARTED|Overall Study||318
116272|NCT00982111|269145|P1|STARTED|Overall Study||315
116273|NCT00982020|269169|P2|NOT COMPLETED|Overall Study||64
116274|NCT00982020|269170|P1|NOT COMPLETED|Overall Study||57
116275|NCT00982020|269169|P2|COMPLETED|Overall Study||37
116276|NCT00982020|269170|P1|COMPLETED|Overall Study||45
116277|NCT00982020|269169|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
116278|NCT00982020|269170|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
116279|NCT00982020|269169|P2|STARTED|Overall Study||101
116280|NCT00982020|269170|P1|STARTED|Overall Study||102
116281|NCT00982007|269194|P4|NOT COMPLETED|Overall Study||6
116282|NCT00982007|269195|P3|NOT COMPLETED|Overall Study||0
116283|NCT00982007|269196|P2|NOT COMPLETED|Overall Study||4
116284|NCT00982007|269197|P1|NOT COMPLETED|Overall Study||4
116285|NCT00982007|269194|P4|COMPLETED|Overall Study||245
116286|NCT00982007|269195|P3|COMPLETED|Overall Study||253
116287|NCT00982007|269196|P2|COMPLETED|Overall Study||253
116288|NCT00982007|269197|P1|COMPLETED|Overall Study||246
116289|NCT00982007|269194|P4|STARTED|Overall Study||251
116290|NCT00982007|269195|P3|STARTED|Overall Study||253
116291|NCT00982007|269196|P2|STARTED|Overall Study||257
116292|NCT00982007|269197|P1|STARTED|Overall Study||250
116293|NCT00981825|269209|P2|NOT COMPLETED|Second Intervention||0
116294|NCT00981825|269210|P1|NOT COMPLETED|Second Intervention||0
116295|NCT00981825|269209|P2|COMPLETED|Second Intervention||11
116296|NCT00981825|269210|P1|COMPLETED|Second Intervention||11
116297|NCT00981825|269209|P2|STARTED|Second Intervention||11
116298|NCT00981825|269210|P1|STARTED|Second Intervention||11
116299|NCT00981825|269209|P2|NOT COMPLETED|Washout After 1st Intervention||0
116300|NCT00981825|269210|P1|NOT COMPLETED|Washout After 1st Intervention||0
116301|NCT00981825|269209|P2|COMPLETED|Washout After 1st Intervention||11
116302|NCT00981825|269210|P1|COMPLETED|Washout After 1st Intervention||11
116303|NCT00981825|269209|P2|STARTED|Washout After 1st Intervention||11
116304|NCT00981825|269210|P1|STARTED|Washout After 1st Intervention||11
116305|NCT00981825|269209|P2|NOT COMPLETED|First Intervention||0
116306|NCT00981825|269210|P1|NOT COMPLETED|First Intervention||0
116307|NCT00981825|269209|P2|COMPLETED|First Intervention||11
116308|NCT00981825|269210|P1|COMPLETED|First Intervention||11
116309|NCT00981825|269209|P2|STARTED|First Intervention||11
116310|NCT00981825|269210|P1|STARTED|First Intervention||11
116311|NCT00981812|269216|P1|NOT COMPLETED|Overall Study||0
116312|NCT00981812|269216|P1|COMPLETED|Overall Study||20
116313|NCT00981812|269216|P1|STARTED|Overall Study||20
116314|NCT00981669|269222|P2|NOT COMPLETED|Overall Study||0
116315|NCT00981669|269223|P1|NOT COMPLETED|Overall Study||1
116316|NCT00981669|269222|P2|COMPLETED|Overall Study||40
116317|NCT00981669|269223|P1|COMPLETED|Overall Study||39
116318|NCT00981669|269222|P2|STARTED|Overall Study||40
116319|NCT00981669|269223|P1|STARTED|Overall Study||40
116320|NCT00981630|269235|P4|NOT COMPLETED|Overall Study||0
116321|NCT00981630|269236|P3|NOT COMPLETED|Overall Study||0
116322|NCT00981630|269237|P2|NOT COMPLETED|Overall Study||0
116323|NCT00981630|269238|P1|NOT COMPLETED|Overall Study||0
116324|NCT00981630|269235|P4|COMPLETED|Overall Study||32
116325|NCT00981630|269236|P3|COMPLETED|Overall Study||32
116326|NCT00981630|269237|P2|COMPLETED|Overall Study||32
116327|NCT00981630|269238|P1|COMPLETED|Overall Study||32
116328|NCT00981630|269235|P4|STARTED|Overall Study||32
116329|NCT00981630|269236|P3|STARTED|Overall Study||32
116330|NCT00981630|269237|P2|STARTED|Overall Study||32
116331|NCT00981630|269238|P1|STARTED|Overall Study||32
116332|NCT00981461|269270|P2|NOT COMPLETED|Overall Study||2
116333|NCT00981461|269271|P1|NOT COMPLETED|Overall Study||5
116334|NCT00981461|269270|P2|COMPLETED|Overall Study||22
116335|NCT00981461|269271|P1|COMPLETED|Overall Study||43
116336|NCT00981461|269270|P2|STARTED|Overall Study||24
116337|NCT00981461|269271|P1|STARTED|Overall Study||48
116338|NCT00981409|269279|P2|NOT COMPLETED|Overall Study||1
116339|NCT00981409|269280|P1|NOT COMPLETED|Overall Study||6
116340|NCT00981409|269279|P2|COMPLETED|Overall Study||10
116341|NCT00981409|269280|P1|COMPLETED|Overall Study||24
116342|NCT00981409|269279|P2|STARTED|Overall Study||11
116343|NCT00981409|269280|P1|STARTED|Overall Study||30
116344|NCT00981370|269294|P1|NOT COMPLETED|Overall Study||0
116345|NCT00981370|269294|P1|COMPLETED|Overall Study||0
116346|NCT00981370|269294|P1|STARTED|Overall Study||0
116347|NCT00981305|269300|P2|NOT COMPLETED|Overall Study||10
116348|NCT00981305|269301|P1|NOT COMPLETED|Overall Study||19
116349|NCT00981305|269300|P2|COMPLETED|Overall Study||57
116350|NCT00981305|269301|P1|COMPLETED|Overall Study||50
116351|NCT00981305|269300|P2|STARTED|Overall Study||67
116352|NCT00981305|269301|P1|STARTED|Overall Study||69
116353|NCT00981292|269319|P6|NOT COMPLETED|Day 3||1
116354|NCT00981292|269320|P5|NOT COMPLETED|Day 3||0
116355|NCT00981292|269321|P4|NOT COMPLETED|Day 3||0
116356|NCT00981292|269322|P3|NOT COMPLETED|Day 3||0
116357|NCT00981292|269323|P2|NOT COMPLETED|Day 3||0
116358|NCT00981292|269324|P1|NOT COMPLETED|Day 3||0
116359|NCT00981292|269319|P6|COMPLETED|Day 3||4
116360|NCT00981292|269320|P5|COMPLETED|Day 3||4
116361|NCT00981292|269321|P4|COMPLETED|Day 3||4
116362|NCT00981292|269322|P3|COMPLETED|Day 3||6
116363|NCT00981292|269323|P2|COMPLETED|Day 3||4
116364|NCT00981292|269324|P1|COMPLETED|Day 3||4
116365|NCT00981292|269319|P6|STARTED|Day 3||5
116366|NCT00981292|269320|P5|STARTED|Day 3||4
116367|NCT00981292|269321|P4|STARTED|Day 3||4
116368|NCT00981292|269322|P3|STARTED|Day 3||6
116369|NCT00981292|269323|P2|STARTED|Day 3||4
116370|NCT00981292|269324|P1|STARTED|Day 3||4
116371|NCT00981292|269319|P6|NOT COMPLETED|Day 2||0
116372|NCT00981292|269320|P5|NOT COMPLETED|Day 2||0
116373|NCT00981292|269321|P4|NOT COMPLETED|Day 2||0
116374|NCT00981292|269322|P3|NOT COMPLETED|Day 2||0
116375|NCT00981292|269323|P2|NOT COMPLETED|Day 2||0
116376|NCT00981292|269324|P1|NOT COMPLETED|Day 2||2
116377|NCT00981292|269319|P6|COMPLETED|Day 2||5
116378|NCT00981292|269320|P5|COMPLETED|Day 2||4
116379|NCT00981292|269321|P4|COMPLETED|Day 2||4
116380|NCT00981292|269322|P3|COMPLETED|Day 2||6
116381|NCT00981292|269323|P2|COMPLETED|Day 2||4
116382|NCT00981292|269324|P1|COMPLETED|Day 2||4
116383|NCT00981292|269319|P6|STARTED|Day 2||5
116384|NCT00981292|269320|P5|STARTED|Day 2||4
116385|NCT00981292|269321|P4|STARTED|Day 2||4
116386|NCT00981292|269322|P3|STARTED|Day 2||6
116387|NCT00981292|269323|P2|STARTED|Day 2||4
116388|NCT00981292|269324|P1|STARTED|Day 2||6
116389|NCT00981292|269319|P6|NOT COMPLETED|Day 1||2
116390|NCT00981292|269320|P5|NOT COMPLETED|Day 1||0
116391|NCT00981292|269321|P4|NOT COMPLETED|Day 1||0
116392|NCT00981292|269322|P3|NOT COMPLETED|Day 1||0
116393|NCT00981292|269323|P2|NOT COMPLETED|Day 1||0
116394|NCT00981292|269324|P1|NOT COMPLETED|Day 1||1
116395|NCT00981292|269319|P6|COMPLETED|Day 1||5
116396|NCT00981292|269320|P5|COMPLETED|Day 1||4
116397|NCT00981292|269321|P4|COMPLETED|Day 1||4
116398|NCT00981292|269322|P3|COMPLETED|Day 1||6
116399|NCT00981292|269323|P2|COMPLETED|Day 1||4
116400|NCT00981292|269324|P1|COMPLETED|Day 1||6
116401|NCT00981292|269319|P6|STARTED|Day 1||7
116402|NCT00981292|269320|P5|STARTED|Day 1||4
116403|NCT00981292|269321|P4|STARTED|Day 1||4
116404|NCT00981292|269322|P3|STARTED|Day 1||6
116405|NCT00981292|269323|P2|STARTED|Day 1||4
116406|NCT00981292|269324|P1|STARTED|Day 1||7
116407|NCT00981227|269347|P6|NOT COMPLETED|Overall Study||18
116408|NCT00981227|269348|P5|NOT COMPLETED|Overall Study||30
116409|NCT00981227|269349|P4|NOT COMPLETED|Overall Study||21
116410|NCT00981227|269350|P3|NOT COMPLETED|Overall Study||21
116411|NCT00981227|269351|P2|NOT COMPLETED|Overall Study||19
116412|NCT00981227|269352|P1|NOT COMPLETED|Overall Study||22
116413|NCT00981227|269347|P6|COMPLETED|Overall Study||75
116414|NCT00981227|269348|P5|COMPLETED|Overall Study||60
116415|NCT00981227|269349|P4|COMPLETED|Overall Study||73
116416|NCT00981227|269350|P3|COMPLETED|Overall Study||73
116417|NCT00981227|269351|P2|COMPLETED|Overall Study||75
116418|NCT00981227|269352|P1|COMPLETED|Overall Study||80
116419|NCT00981227|269347|P6|Per–Protocol|Overall Study||70
116420|NCT00981227|269348|P5|Per–Protocol|Overall Study||50
116421|NCT00981227|269349|P4|Per–Protocol|Overall Study||68
116422|NCT00981227|269350|P3|Per–Protocol|Overall Study||67
116423|NCT00981227|269351|P2|Per–Protocol|Overall Study||72
116424|NCT00981227|269352|P1|Per–Protocol|Overall Study||69
116425|NCT00981227|269347|P6|Safety Population|Overall Study||93
116426|NCT00981227|269348|P5|Safety Population|Overall Study||90
116427|NCT00981227|269349|P4|Safety Population|Overall Study||94
116428|NCT00981227|269350|P3|Safety Population|Overall Study||94
116429|NCT00981227|269351|P2|Safety Population|Overall Study||94
116430|NCT00981227|269352|P1|Safety Population|Overall Study||102
116431|NCT00981227|269347|P6|Randomized|Overall Study||93
116432|NCT00981227|269348|P5|Randomized|Overall Study||90
116433|NCT00981227|269349|P4|Randomized|Overall Study||94
116434|NCT00981227|269350|P3|Randomized|Overall Study||94
116435|NCT00981227|269351|P2|Randomized|Overall Study||94
116436|NCT00981227|269352|P1|Randomized|Overall Study||102
116437|NCT00981227|269347|P6|STARTED|Overall Study||93
116438|NCT00981227|269348|P5|STARTED|Overall Study||90
116439|NCT00981227|269349|P4|STARTED|Overall Study||94
116440|NCT00981227|269350|P3|STARTED|Overall Study||94
116441|NCT00981227|269351|P2|STARTED|Overall Study||94
116442|NCT00981227|269352|P1|STARTED|Overall Study||102
116443|NCT00981214|269370|P1|NOT COMPLETED|Overall Study||0
116444|NCT00981214|269370|P1|COMPLETED|Overall Study||19
116445|NCT00981214|269370|P1|STARTED|Overall Study||19
116446|NCT00981175|269387|P2|NOT COMPLETED|Booster Dose Vaccination||3
116447|NCT00981175|269388|P1|NOT COMPLETED|Booster Dose Vaccination||2
116448|NCT00981175|269387|P2|COMPLETED|Booster Dose Vaccination||40
116449|NCT00981175|269388|P1|COMPLETED|Booster Dose Vaccination||53
116450|NCT00981175|269387|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
116451|NCT00981175|269388|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
116452|NCT00981175|269387|P2|NOT COMPLETED|Primary Dose Vaccination||2
116453|NCT00981175|269388|P1|NOT COMPLETED|Primary Dose Vaccination||3
116454|NCT00981175|269387|P2|COMPLETED|Primary Dose Vaccination||99
116455|NCT00981175|269388|P1|COMPLETED|Primary Dose Vaccination||98
116456|NCT00981175|269387|P2|STARTED|Primary Dose Vaccination||101
116457|NCT00981175|269388|P1|STARTED|Primary Dose Vaccination||101
116458|NCT00981084|269413|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
116459|NCT00981084|269414|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
116460|NCT00981084|269413|P2|COMPLETED|Post Intervention (Data Analysis)||16
116461|NCT00981084|269414|P1|COMPLETED|Post Intervention (Data Analysis)||14
116462|NCT00981084|269413|P2|STARTED|Post Intervention (Data Analysis)||17
116463|NCT00981084|269414|P1|STARTED|Post Intervention (Data Analysis)||16
116464|NCT00981084|269413|P2|NOT COMPLETED|Second Intervention (One Day)||0
116465|NCT00981084|269414|P1|NOT COMPLETED|Second Intervention (One Day)||0
116466|NCT00981084|269413|P2|COMPLETED|Second Intervention (One Day)||17
116467|NCT00981084|269414|P1|COMPLETED|Second Intervention (One Day)||16
116468|NCT00981084|269413|P2|STARTED|Second Intervention (One Day)||17
116469|NCT00981084|269414|P1|STARTED|Second Intervention (One Day)||16
116470|NCT00981084|269413|P2|NOT COMPLETED|Washout Period (7 Days)||0
116471|NCT00981084|269414|P1|NOT COMPLETED|Washout Period (7 Days)||0
116472|NCT00981084|269413|P2|COMPLETED|Washout Period (7 Days)||17
116473|NCT00981084|269414|P1|COMPLETED|Washout Period (7 Days)||16
116474|NCT00981084|269413|P2|STARTED|Washout Period (7 Days)||17
116475|NCT00981084|269414|P1|STARTED|Washout Period (7 Days)||16
116476|NCT00981084|269413|P2|NOT COMPLETED|First Intervention (One Day)||0
116477|NCT00981084|269414|P1|NOT COMPLETED|First Intervention (One Day)||0
116478|NCT00981084|269413|P2|COMPLETED|First Intervention (One Day)||17
116479|NCT00981084|269414|P1|COMPLETED|First Intervention (One Day)||16
116480|NCT00981084|269413|P2|STARTED|First Intervention (One Day)||17
116481|NCT00981084|269414|P1|STARTED|First Intervention (One Day)||16
116482|NCT00981058|269430|P2|NOT COMPLETED|Overall Study||97
116483|NCT00981058|269431|P1|NOT COMPLETED|Overall Study||120
116484|NCT00981058|269430|P2|COMPLETED|Overall Study||451
116485|NCT00981058|269431|P1|COMPLETED|Overall Study||425
116486|NCT00981058|269430|P2|Death Due to Any Cause|Overall Study||442
116487|NCT00981058|269431|P1|Death Due to Any Cause|Overall Study||418
116488|NCT00981058|269430|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
116489|NCT00981058|269431|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
116490|NCT00981058|269430|P2|STARTED|Overall Study||548
116491|NCT00981058|269431|P1|STARTED|Overall Study||545
116492|NCT00981045|269453|P2|NOT COMPLETED|Overall Study||9
116493|NCT00981045|269454|P1|NOT COMPLETED|Overall Study||14
116494|NCT00981045|269453|P2|COMPLETED|Overall Study||1285
116495|NCT00981045|269454|P1|COMPLETED|Overall Study||1276
116496|NCT00981045|269453|P2|STARTED|Overall Study||1294
116497|NCT00981045|269454|P1|STARTED|Overall Study||1290
116498|NCT00981019|269462|P1|NOT COMPLETED|Overall Study||477
116499|NCT00981019|269462|P1|COMPLETED|Overall Study||301
116500|NCT00981019|269462|P1|STARTED|Overall Study||778
116501|NCT00980980|269469|P3|NOT COMPLETED|Overall Study||0
116502|NCT00980980|269470|P2|NOT COMPLETED|Overall Study||1
116503|NCT00980980|269471|P1|NOT COMPLETED|Overall Study||0
116504|NCT00980980|269469|P3|COMPLETED|Overall Study||13
116505|NCT00980980|269470|P2|COMPLETED|Overall Study||13
116506|NCT00980980|269471|P1|COMPLETED|Overall Study||16
116507|NCT00980980|269469|P3|STARTED|Overall Study||13
116508|NCT00980980|269470|P2|STARTED|Overall Study||14
116509|NCT00980980|269471|P1|STARTED|Overall Study||16
116510|NCT00980798|269496|P2|NOT COMPLETED|Overall Study||55
116511|NCT00980798|269497|P1|NOT COMPLETED|Overall Study||33
116512|NCT00980798|269496|P2|COMPLETED|Overall Study||84
116513|NCT00980798|269497|P1|COMPLETED|Overall Study||116
116514|NCT00980798|269496|P2|STARTED|Overall Study||139
116515|NCT00980798|269497|P1|STARTED|Overall Study||149
116516|NCT00980746|269511|P6|NOT COMPLETED|Overall Study||18
116517|NCT00980746|269512|P5|NOT COMPLETED|Overall Study||17
116518|NCT00980746|269513|P4|NOT COMPLETED|Overall Study||36
116519|NCT00980746|269514|P3|NOT COMPLETED|Overall Study||20
116520|NCT00980746|269515|P2|NOT COMPLETED|Overall Study||22
116521|NCT00980746|269516|P1|NOT COMPLETED|Overall Study||27
116522|NCT00980746|269511|P6|COMPLETED|Overall Study||78
116523|NCT00980746|269512|P5|COMPLETED|Overall Study||75
116524|NCT00980746|269513|P4|COMPLETED|Overall Study||64
116525|NCT00980746|269514|P3|COMPLETED|Overall Study||75
116526|NCT00980746|269515|P2|COMPLETED|Overall Study||67
116527|NCT00980746|269516|P1|COMPLETED|Overall Study||58
116528|NCT00980746|269511|P6|Per-protocol|Overall Study||74
116529|NCT00980746|269512|P5|Per-protocol|Overall Study||73
116530|NCT00980746|269513|P4|Per-protocol|Overall Study||62
116531|NCT00980746|269514|P3|Per-protocol|Overall Study||73
116532|NCT00980746|269515|P2|Per-protocol|Overall Study||66
116533|NCT00980746|269516|P1|Per-protocol|Overall Study||55
116534|NCT00980746|269511|P6|Safety Population|Overall Study||96
116535|NCT00980746|269512|P5|Safety Population|Overall Study||92
116536|NCT00980746|269513|P4|Safety Population|Overall Study||100
116537|NCT00980746|269514|P3|Safety Population|Overall Study||95
116538|NCT00980746|269515|P2|Safety Population|Overall Study||89
116539|NCT00980746|269516|P1|Safety Population|Overall Study||85
116540|NCT00980746|269511|P6|Randomized|Overall Study||96
116541|NCT00980746|269512|P5|Randomized|Overall Study||92
116542|NCT00980746|269513|P4|Randomized|Overall Study||100
116543|NCT00980746|269514|P3|Randomized|Overall Study||95
116544|NCT00980746|269515|P2|Randomized|Overall Study||89
116545|NCT00980746|269516|P1|Randomized|Overall Study||85
116546|NCT00980746|269511|P6|STARTED|Overall Study||96
116547|NCT00980746|269512|P5|STARTED|Overall Study||92
116548|NCT00980746|269513|P4|STARTED|Overall Study||100
116549|NCT00980746|269514|P3|STARTED|Overall Study||95
116550|NCT00980746|269515|P2|STARTED|Overall Study||89
116551|NCT00980746|269516|P1|STARTED|Overall Study||85
116552|NCT00980681|269530|P1|NOT COMPLETED|Dotarem MRA||0
116553|NCT00980681|269530|P1|COMPLETED|Dotarem MRA||10
116554|NCT00980681|269530|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
116555|NCT00980681|269530|P1|NOT COMPLETED|TOF MRA||0
116556|NCT00980681|269530|P1|COMPLETED|TOF MRA||10
116557|NCT00980681|269530|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
116558|NCT00980655|269538|P2|NOT COMPLETED|Overall Study||51
116559|NCT00980655|269539|P1|NOT COMPLETED|Overall Study||16
116560|NCT00980655|269538|P2|COMPLETED|Overall Study||139
116561|NCT00980655|269539|P1|COMPLETED|Overall Study||45
116562|NCT00980655|269538|P2|Vaccinated 23vPS Dose|Overall Study||140
116563|NCT00980655|269539|P1|Vaccinated 23vPS Dose|Overall Study||45
116564|NCT00980655|269538|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
116565|NCT00980655|269539|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
116566|NCT00980655|269538|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
116567|NCT00980655|269539|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
116568|NCT00980655|269538|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
116569|NCT00980655|269539|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
116570|NCT00980655|269538|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
116571|NCT00980655|269539|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
116572|NCT00980655|269538|P2|STARTED|Overall Study||190
116573|NCT00980655|269539|P1|STARTED|Overall Study||61
116574|NCT00980590|269587|P2|NOT COMPLETED|Overall Study||0
116575|NCT00980590|269588|P1|NOT COMPLETED|Overall Study||0
116576|NCT00980590|269587|P2|COMPLETED|Overall Study||50
116577|NCT00980590|269588|P1|COMPLETED|Overall Study||50
116578|NCT00980590|269587|P2|STARTED|Overall Study||50
116579|NCT00980590|269588|P1|STARTED|Overall Study||50
116580|NCT00980330|269607|P7|NOT COMPLETED|Overall Study||7
116581|NCT00980330|269608|P6|NOT COMPLETED|Overall Study||4
116582|NCT00980330|269609|P5|NOT COMPLETED|Overall Study||5
116583|NCT00980330|269610|P4|NOT COMPLETED|Overall Study||5
116584|NCT00980330|269611|P3|NOT COMPLETED|Overall Study||8
116585|NCT00980330|269612|P2|NOT COMPLETED|Overall Study||5
116586|NCT00980330|269613|P1|NOT COMPLETED|Overall Study||5
116587|NCT00980330|269607|P7|COMPLETED|Overall Study||59
116588|NCT00980330|269608|P6|COMPLETED|Overall Study||61
116589|NCT00980330|269609|P5|COMPLETED|Overall Study||63
116590|NCT00980330|269610|P4|COMPLETED|Overall Study||61
116591|NCT00980330|269611|P3|COMPLETED|Overall Study||58
116592|NCT00980330|269612|P2|COMPLETED|Overall Study||60
116593|NCT00980330|269613|P1|COMPLETED|Overall Study||61
116594|NCT00980330|269607|P7|STARTED|Overall Study||66
116595|NCT00980330|269608|P6|STARTED|Overall Study||65
116596|NCT00980330|269609|P5|STARTED|Overall Study||68
116597|NCT00980330|269610|P4|STARTED|Overall Study||66
116598|NCT00980330|269611|P3|STARTED|Overall Study||66
116599|NCT00980330|269612|P2|STARTED|Overall Study||65
116600|NCT00980330|269613|P1|STARTED|Overall Study||66
116601|NCT00980278|269713|P2|NOT COMPLETED|Overall Study||0
116602|NCT00980278|269714|P1|NOT COMPLETED|Overall Study||2
116603|NCT00980278|269713|P2|COMPLETED|Overall Study||13
116604|NCT00980278|269714|P1|COMPLETED|Overall Study||11
116605|NCT00980278|269713|P2|STARTED|Overall Study||13
116606|NCT00980278|269714|P1|STARTED|Overall Study||13
116607|NCT00980200|269728|P5|NOT COMPLETED|7-day Treatment Period 5||0
116608|NCT00980200|269729|P4|NOT COMPLETED|7-day Treatment Period 5||0
116609|NCT00980200|269730|P3|NOT COMPLETED|7-day Treatment Period 5||0
116610|NCT00980200|269731|P2|NOT COMPLETED|7-day Treatment Period 5||0
116611|NCT00980200|269732|P1|NOT COMPLETED|7-day Treatment Period 5||0
116612|NCT00980200|269728|P5|COMPLETED|7-day Treatment Period 5||14
116613|NCT00980200|269729|P4|COMPLETED|7-day Treatment Period 5||16
116614|NCT00980200|269730|P3|COMPLETED|7-day Treatment Period 5||15
116615|NCT00980200|269731|P2|COMPLETED|7-day Treatment Period 5||12
116616|NCT00980200|269732|P1|COMPLETED|7-day Treatment Period 5||15
116617|NCT00980200|269728|P5|STARTED|7-day Treatment Period 5||14
116618|NCT00980200|269729|P4|STARTED|7-day Treatment Period 5||16
116619|NCT00980200|269730|P3|STARTED|7-day Treatment Period 5||15
116620|NCT00980200|269731|P2|STARTED|7-day Treatment Period 5||12
116621|NCT00980200|269732|P1|STARTED|7-day Treatment Period 5||15
116622|NCT00980200|269728|P5|NOT COMPLETED|7-day Washout Period 4||0
116623|NCT00980200|269729|P4|NOT COMPLETED|7-day Washout Period 4||0
116624|NCT00980200|269730|P3|NOT COMPLETED|7-day Washout Period 4||0
116625|NCT00980200|269731|P2|NOT COMPLETED|7-day Washout Period 4||0
116626|NCT00980200|269732|P1|NOT COMPLETED|7-day Washout Period 4||0
116627|NCT00980200|269728|P5|COMPLETED|7-day Washout Period 4||14
116628|NCT00980200|269729|P4|COMPLETED|7-day Washout Period 4||16
116629|NCT00980200|269730|P3|COMPLETED|7-day Washout Period 4||15
116630|NCT00980200|269731|P2|COMPLETED|7-day Washout Period 4||12
116631|NCT00980200|269732|P1|COMPLETED|7-day Washout Period 4||15
116632|NCT00980200|269728|P5|STARTED|7-day Washout Period 4||14
116633|NCT00980200|269729|P4|STARTED|7-day Washout Period 4||16
116634|NCT00980200|269730|P3|STARTED|7-day Washout Period 4||15
116635|NCT00980200|269731|P2|STARTED|7-day Washout Period 4||12
116636|NCT00980200|269732|P1|STARTED|7-day Washout Period 4||15
116637|NCT00980200|269728|P5|NOT COMPLETED|7-day Treatment Period 4||0
116638|NCT00980200|269729|P4|NOT COMPLETED|7-day Treatment Period 4||0
116639|NCT00980200|269730|P3|NOT COMPLETED|7-day Treatment Period 4||0
116640|NCT00980200|269731|P2|NOT COMPLETED|7-day Treatment Period 4||0
116641|NCT00980200|269732|P1|NOT COMPLETED|7-day Treatment Period 4||0
116642|NCT00980200|269728|P5|COMPLETED|7-day Treatment Period 4||14
116643|NCT00980200|269729|P4|COMPLETED|7-day Treatment Period 4||16
116644|NCT00980200|269730|P3|COMPLETED|7-day Treatment Period 4||15
116645|NCT00980200|269731|P2|COMPLETED|7-day Treatment Period 4||12
116646|NCT00980200|269732|P1|COMPLETED|7-day Treatment Period 4||15
116647|NCT00980200|269728|P5|STARTED|7-day Treatment Period 4||14
116648|NCT00980200|269729|P4|STARTED|7-day Treatment Period 4||16
116649|NCT00980200|269730|P3|STARTED|7-day Treatment Period 4||15
116650|NCT00980200|269731|P2|STARTED|7-day Treatment Period 4||12
116651|NCT00980200|269732|P1|STARTED|7-day Treatment Period 4||15
116652|NCT00980200|269728|P5|NOT COMPLETED|7-day Washout Period 3||0
116653|NCT00980200|269729|P4|NOT COMPLETED|7-day Washout Period 3||0
116654|NCT00980200|269730|P3|NOT COMPLETED|7-day Washout Period 3||0
116655|NCT00980200|269731|P2|NOT COMPLETED|7-day Washout Period 3||0
116656|NCT00980200|269732|P1|NOT COMPLETED|7-day Washout Period 3||0
116657|NCT00980200|269728|P5|COMPLETED|7-day Washout Period 3||14
116658|NCT00980200|269729|P4|COMPLETED|7-day Washout Period 3||16
116659|NCT00980200|269730|P3|COMPLETED|7-day Washout Period 3||15
116660|NCT00980200|269731|P2|COMPLETED|7-day Washout Period 3||12
116661|NCT00980200|269732|P1|COMPLETED|7-day Washout Period 3||15
116662|NCT00980200|269728|P5|STARTED|7-day Washout Period 3||14
116663|NCT00980200|269729|P4|STARTED|7-day Washout Period 3||16
116664|NCT00980200|269730|P3|STARTED|7-day Washout Period 3||15
116665|NCT00980200|269731|P2|STARTED|7-day Washout Period 3||12
116666|NCT00980200|269732|P1|STARTED|7-day Washout Period 3||15
116667|NCT00980200|269728|P5|NOT COMPLETED|7-day Treatment Period 3||1
116668|NCT00980200|269729|P4|NOT COMPLETED|7-day Treatment Period 3||0
116669|NCT00980200|269730|P3|NOT COMPLETED|7-day Treatment Period 3||0
116670|NCT00980200|269731|P2|NOT COMPLETED|7-day Treatment Period 3||1
116671|NCT00980200|269732|P1|NOT COMPLETED|7-day Treatment Period 3||0
116672|NCT00980200|269728|P5|COMPLETED|7-day Treatment Period 3||14
116673|NCT00980200|269729|P4|COMPLETED|7-day Treatment Period 3||16
116674|NCT00980200|269730|P3|COMPLETED|7-day Treatment Period 3||15
116675|NCT00980200|269731|P2|COMPLETED|7-day Treatment Period 3||12
116676|NCT00980200|269732|P1|COMPLETED|7-day Treatment Period 3||15
116677|NCT00980200|269728|P5|STARTED|7-day Treatment Period 3||15
116678|NCT00980200|269729|P4|STARTED|7-day Treatment Period 3||16
116679|NCT00980200|269730|P3|STARTED|7-day Treatment Period 3||15
116680|NCT00980200|269731|P2|STARTED|7-day Treatment Period 3||13
116681|NCT00980200|269732|P1|STARTED|7-day Treatment Period 3||15
116682|NCT00980200|269728|P5|NOT COMPLETED|7-day Washout Period 2||0
116683|NCT00980200|269729|P4|NOT COMPLETED|7-day Washout Period 2||0
116684|NCT00980200|269730|P3|NOT COMPLETED|7-day Washout Period 2||0
116685|NCT00980200|269731|P2|NOT COMPLETED|7-day Washout Period 2||0
116686|NCT00980200|269732|P1|NOT COMPLETED|7-day Washout Period 2||0
116687|NCT00980200|269728|P5|COMPLETED|7-day Washout Period 2||15
116688|NCT00980200|269729|P4|COMPLETED|7-day Washout Period 2||16
116689|NCT00980200|269730|P3|COMPLETED|7-day Washout Period 2||15
116690|NCT00980200|269731|P2|COMPLETED|7-day Washout Period 2||13
116691|NCT00980200|269732|P1|COMPLETED|7-day Washout Period 2||15
116692|NCT00980200|269728|P5|STARTED|7-day Washout Period 2||15
116693|NCT00980200|269729|P4|STARTED|7-day Washout Period 2||16
116694|NCT00980200|269730|P3|STARTED|7-day Washout Period 2||15
116695|NCT00980200|269731|P2|STARTED|7-day Washout Period 2||13
116696|NCT00980200|269732|P1|STARTED|7-day Washout Period 2||15
116697|NCT00980200|269728|P5|NOT COMPLETED|7-day Treatment Period 2||0
116698|NCT00980200|269729|P4|NOT COMPLETED|7-day Treatment Period 2||0
116699|NCT00980200|269730|P3|NOT COMPLETED|7-day Treatment Period 2||0
116700|NCT00980200|269731|P2|NOT COMPLETED|7-day Treatment Period 2||0
116701|NCT00980200|269732|P1|NOT COMPLETED|7-day Treatment Period 2||0
116702|NCT00980200|269728|P5|COMPLETED|7-day Treatment Period 2||15
116703|NCT00980200|269729|P4|COMPLETED|7-day Treatment Period 2||16
116704|NCT00980200|269730|P3|COMPLETED|7-day Treatment Period 2||15
116705|NCT00980200|269731|P2|COMPLETED|7-day Treatment Period 2||13
116706|NCT00980200|269732|P1|COMPLETED|7-day Treatment Period 2||15
116707|NCT00980200|269728|P5|STARTED|7-day Treatment Period 2||15
116708|NCT00980200|269729|P4|STARTED|7-day Treatment Period 2||16
116709|NCT00980200|269730|P3|STARTED|7-day Treatment Period 2||15
116710|NCT00980200|269731|P2|STARTED|7-day Treatment Period 2||13
116711|NCT00980200|269732|P1|STARTED|7-day Treatment Period 2||15
116712|NCT00980200|269728|P5|NOT COMPLETED|7-day Washout Period 1||0
116713|NCT00980200|269729|P4|NOT COMPLETED|7-day Washout Period 1||0
116714|NCT00980200|269730|P3|NOT COMPLETED|7-day Washout Period 1||0
116715|NCT00980200|269731|P2|NOT COMPLETED|7-day Washout Period 1||0
116716|NCT00980200|269732|P1|NOT COMPLETED|7-day Washout Period 1||0
116717|NCT00980200|269728|P5|COMPLETED|7-day Washout Period 1||15
116718|NCT00980200|269729|P4|COMPLETED|7-day Washout Period 1||16
116719|NCT00980200|269730|P3|COMPLETED|7-day Washout Period 1||15
116720|NCT00980200|269731|P2|COMPLETED|7-day Washout Period 1||13
116721|NCT00980200|269732|P1|COMPLETED|7-day Washout Period 1||15
116722|NCT00980200|269728|P5|STARTED|7-day Washout Period 1||15
116723|NCT00980200|269729|P4|STARTED|7-day Washout Period 1||16
116724|NCT00980200|269730|P3|STARTED|7-day Washout Period 1||15
116725|NCT00980200|269731|P2|STARTED|7-day Washout Period 1||13
116726|NCT00980200|269732|P1|STARTED|7-day Washout Period 1||15
116727|NCT00980200|269728|P5|NOT COMPLETED|7-day Treatment Period 1||0
116728|NCT00980200|269729|P4|NOT COMPLETED|7-day Treatment Period 1||0
116729|NCT00980200|269730|P3|NOT COMPLETED|7-day Treatment Period 1||0
116730|NCT00980200|269731|P2|NOT COMPLETED|7-day Treatment Period 1||1
116731|NCT00980200|269732|P1|NOT COMPLETED|7-day Treatment Period 1||0
116732|NCT00980200|269728|P5|COMPLETED|7-day Treatment Period 1||15
116733|NCT00980200|269729|P4|COMPLETED|7-day Treatment Period 1||16
116734|NCT00980200|269730|P3|COMPLETED|7-day Treatment Period 1||15
116735|NCT00980200|269731|P2|COMPLETED|7-day Treatment Period 1||13
116736|NCT00980200|269732|P1|COMPLETED|7-day Treatment Period 1||15
116737|NCT00980200|269728|P5|STARTED|7-day Treatment Period 1||15
116738|NCT00980200|269729|P4|STARTED|7-day Treatment Period 1||16
116739|NCT00980200|269730|P3|STARTED|7-day Treatment Period 1||15
116740|NCT00980200|269731|P2|STARTED|7-day Treatment Period 1||14
116741|NCT00980200|269732|P1|STARTED|7-day Treatment Period 1||15
116742|NCT00980174|269751|P2|NOT COMPLETED|Overall Study||10
116743|NCT00980174|269752|P1|NOT COMPLETED|Overall Study||4
116744|NCT00980174|269751|P2|COMPLETED|Overall Study||111
116745|NCT00980174|269752|P1|COMPLETED|Overall Study||117
116746|NCT00980174|269751|P2|STARTED|Overall Study||121
116747|NCT00980174|269752|P1|STARTED|Overall Study||121
116748|NCT00980148|269770|P2|NOT COMPLETED|Overall Study||128
116749|NCT00980148|269771|P1|NOT COMPLETED|Overall Study||129
116750|NCT00980148|269770|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
116751|NCT00980148|269771|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
116752|NCT00980148|269770|P2|STARTED|Overall Study||283
116753|NCT00980148|269771|P1|STARTED|Overall Study||284
116754|NCT00980044|269780|P3|NOT COMPLETED|Overall Study||5
116755|NCT00980044|269781|P2|NOT COMPLETED|Overall Study||7
116756|NCT00980044|269782|P1|NOT COMPLETED|Overall Study||5
116757|NCT00980044|269780|P3|COMPLETED|Overall Study||12
116758|NCT00980044|269781|P2|COMPLETED|Overall Study||12
116759|NCT00980044|269782|P1|COMPLETED|Overall Study||12
116760|NCT00980044|269780|P3|STARTED|Overall Study||17
116761|NCT00980044|269781|P2|STARTED|Overall Study||19
116762|NCT00980044|269782|P1|STARTED|Overall Study||17
116763|NCT00980005|269801|P2|NOT COMPLETED|Overall Study||63
116764|NCT00980005|269802|P1|NOT COMPLETED|Overall Study||47
116765|NCT00980005|269801|P2|COMPLETED|Overall Study||998
116766|NCT00980005|269802|P1|COMPLETED|Overall Study||1008
116767|NCT00980005|269801|P2|STARTED|Overall Study||1061
116768|NCT00980005|269802|P1|STARTED|Overall Study||1055
116769|NCT00979953|269846|P4|NOT COMPLETED|Overall Study||7
116770|NCT00979953|269847|P3|NOT COMPLETED|Overall Study||22
116771|NCT00979953|269848|P2|NOT COMPLETED|Overall Study||5
116772|NCT00979953|269849|P1|NOT COMPLETED|Overall Study||8
116773|NCT00979953|269846|P4|COMPLETED|Overall Study||97
116774|NCT00979953|269847|P3|COMPLETED|Overall Study||82
116775|NCT00979953|269848|P2|COMPLETED|Overall Study||94
116776|NCT00979953|269849|P1|COMPLETED|Overall Study||93
116777|NCT00979953|269846|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
116778|NCT00979953|269847|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
116779|NCT00979953|269848|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
116780|NCT00979953|269849|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
116781|NCT00979953|269846|P4|STARTED|Overall Study||104
116782|NCT00979953|269847|P3|STARTED|Overall Study||104
116783|NCT00979953|269848|P2|STARTED|Overall Study||99
116784|NCT00979953|269849|P1|STARTED|Overall Study||101
116785|NCT00979940|269861|P2|NOT COMPLETED|Overall Study||0
116786|NCT00979940|269862|P1|NOT COMPLETED|Overall Study||0
116787|NCT00979940|269861|P2|COMPLETED|Overall Study||28
116788|NCT00979940|269862|P1|COMPLETED|Overall Study||32
116789|NCT00979940|269861|P2|STARTED|Overall Study||28
116790|NCT00979940|269862|P1|STARTED|Overall Study||32
116791|NCT00979901|269872|P4|NOT COMPLETED|Overall Study||116
116792|NCT00979901|269873|P3|NOT COMPLETED|Overall Study||29
116793|NCT00979901|269874|P2|NOT COMPLETED|Overall Study||12
116794|NCT00979901|269875|P1|NOT COMPLETED|Overall Study||18
116795|NCT00979901|269872|P4|COMPLETED|Overall Study||159
116796|NCT00979901|269873|P3|COMPLETED|Overall Study||573
116797|NCT00979901|269874|P2|COMPLETED|Overall Study||336
116798|NCT00979901|269875|P1|COMPLETED|Overall Study||334
116799|NCT00979901|269872|P4|STARTED|Overall Study||275
116800|NCT00979901|269873|P3|STARTED|Overall Study||602
116801|NCT00979901|269874|P2|STARTED|Overall Study||348
116802|NCT00979901|269875|P1|STARTED|Overall Study||352
116803|NCT00979875|269899|P6|NOT COMPLETED|Intervention 3||0
116804|NCT00979875|269900|P5|NOT COMPLETED|Intervention 3||0
116805|NCT00979875|269901|P4|NOT COMPLETED|Intervention 3||0
116806|NCT00979875|269902|P3|NOT COMPLETED|Intervention 3||0
116807|NCT00979875|269903|P2|NOT COMPLETED|Intervention 3||0
116808|NCT00979875|269904|P1|NOT COMPLETED|Intervention 3||0
116809|NCT00979875|269899|P6|COMPLETED|Intervention 3||2
116810|NCT00979875|269900|P5|COMPLETED|Intervention 3||3
116811|NCT00979875|269901|P4|COMPLETED|Intervention 3||2
116812|NCT00979875|269902|P3|COMPLETED|Intervention 3||3
116813|NCT00979875|269903|P2|COMPLETED|Intervention 3||2
116814|NCT00979875|269904|P1|COMPLETED|Intervention 3||2
116815|NCT00979875|269899|P6|STARTED|Intervention 3||2
116816|NCT00979875|269900|P5|STARTED|Intervention 3||3
116817|NCT00979875|269901|P4|STARTED|Intervention 3||2
116818|NCT00979875|269902|P3|STARTED|Intervention 3||3
116819|NCT00979875|269903|P2|STARTED|Intervention 3||2
116820|NCT00979875|269904|P1|STARTED|Intervention 3||2
116821|NCT00979875|269899|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116822|NCT00979875|269900|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116823|NCT00979875|269901|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116824|NCT00979875|269902|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116825|NCT00979875|269903|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116826|NCT00979875|269904|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
116827|NCT00979875|269899|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
116828|NCT00979875|269900|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
116829|NCT00979875|269901|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
116830|NCT00979875|269902|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
116831|NCT00979875|269903|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
116832|NCT00979875|269904|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
116833|NCT00979875|269899|P6|STARTED|Washout 2 (3 to 14 Days)||2
116834|NCT00979875|269900|P5|STARTED|Washout 2 (3 to 14 Days)||3
116835|NCT00979875|269901|P4|STARTED|Washout 2 (3 to 14 Days)||2
116836|NCT00979875|269902|P3|STARTED|Washout 2 (3 to 14 Days)||3
116837|NCT00979875|269903|P2|STARTED|Washout 2 (3 to 14 Days)||2
116838|NCT00979875|269904|P1|STARTED|Washout 2 (3 to 14 Days)||2
116839|NCT00979875|269899|P6|NOT COMPLETED|Intervention 2||0
116840|NCT00979875|269900|P5|NOT COMPLETED|Intervention 2||0
116841|NCT00979875|269901|P4|NOT COMPLETED|Intervention 2||0
116842|NCT00979875|269902|P3|NOT COMPLETED|Intervention 2||0
116843|NCT00979875|269903|P2|NOT COMPLETED|Intervention 2||0
116844|NCT00979875|269904|P1|NOT COMPLETED|Intervention 2||0
116845|NCT00979875|269899|P6|COMPLETED|Intervention 2||2
116846|NCT00979875|269900|P5|COMPLETED|Intervention 2||3
116847|NCT00979875|269901|P4|COMPLETED|Intervention 2||2
116848|NCT00979875|269902|P3|COMPLETED|Intervention 2||3
116849|NCT00979875|269903|P2|COMPLETED|Intervention 2||2
116850|NCT00979875|269904|P1|COMPLETED|Intervention 2||2
116851|NCT00979875|269899|P6|STARTED|Intervention 2||2
116852|NCT00979875|269900|P5|STARTED|Intervention 2||3
116853|NCT00979875|269901|P4|STARTED|Intervention 2||2
116854|NCT00979875|269902|P3|STARTED|Intervention 2||3
116855|NCT00979875|269903|P2|STARTED|Intervention 2||2
116856|NCT00979875|269904|P1|STARTED|Intervention 2||2
116857|NCT00979875|269899|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116858|NCT00979875|269900|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116859|NCT00979875|269901|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116860|NCT00979875|269902|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116861|NCT00979875|269903|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116862|NCT00979875|269904|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
116863|NCT00979875|269899|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
116864|NCT00979875|269900|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
116865|NCT00979875|269901|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
116866|NCT00979875|269902|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
116867|NCT00979875|269903|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
116868|NCT00979875|269904|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
116869|NCT00979875|269899|P6|STARTED|Washout 1 (3 to 14 Days)||2
116870|NCT00979875|269900|P5|STARTED|Washout 1 (3 to 14 Days)||3
116871|NCT00979875|269901|P4|STARTED|Washout 1 (3 to 14 Days)||2
116872|NCT00979875|269902|P3|STARTED|Washout 1 (3 to 14 Days)||3
116873|NCT00979875|269903|P2|STARTED|Washout 1 (3 to 14 Days)||2
116874|NCT00979875|269904|P1|STARTED|Washout 1 (3 to 14 Days)||2
116875|NCT00979875|269899|P6|NOT COMPLETED|Intervention 1||0
116876|NCT00979875|269900|P5|NOT COMPLETED|Intervention 1||0
116877|NCT00979875|269901|P4|NOT COMPLETED|Intervention 1||0
116878|NCT00979875|269902|P3|NOT COMPLETED|Intervention 1||0
116879|NCT00979875|269903|P2|NOT COMPLETED|Intervention 1||0
116880|NCT00979875|269904|P1|NOT COMPLETED|Intervention 1||0
116881|NCT00979875|269899|P6|COMPLETED|Intervention 1||2
116882|NCT00979875|269900|P5|COMPLETED|Intervention 1||3
116883|NCT00979875|269901|P4|COMPLETED|Intervention 1||2
116884|NCT00979875|269902|P3|COMPLETED|Intervention 1||3
116885|NCT00979875|269903|P2|COMPLETED|Intervention 1||2
116886|NCT00979875|269904|P1|COMPLETED|Intervention 1||2
116887|NCT00979875|269899|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
116888|NCT00979875|269900|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
116889|NCT00979875|269901|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
116890|NCT00979875|269902|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
116891|NCT00979875|269903|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
116892|NCT00979875|269904|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
116893|NCT00979875|269899|P6|STARTED|Intervention 1||2
116894|NCT00979875|269900|P5|STARTED|Intervention 1||3
116895|NCT00979875|269901|P4|STARTED|Intervention 1||2
116896|NCT00979875|269902|P3|STARTED|Intervention 1||3
116897|NCT00979875|269903|P2|STARTED|Intervention 1||2
116898|NCT00979875|269904|P1|STARTED|Intervention 1||2
116899|NCT00979654|269948|P1|NOT COMPLETED|Overall Study||36
116900|NCT00979654|269948|P1|COMPLETED|Overall Study||67
116901|NCT00979654|269948|P1|STARTED|Overall Study||103
116902|NCT00979628|269963|P3|NOT COMPLETED|Overall Study||6
116903|NCT00979628|269964|P2|NOT COMPLETED|Overall Study||9
116904|NCT00979628|269965|P1|NOT COMPLETED|Overall Study||9
116905|NCT00979628|269963|P3|COMPLETED|Overall Study||74
116906|NCT00979628|269964|P2|COMPLETED|Overall Study||133
116907|NCT00979628|269965|P1|COMPLETED|Overall Study||144
116908|NCT00979628|269963|P3|STARTED|Overall Study||80
116909|NCT00979628|269964|P2|STARTED|Overall Study||142
116910|NCT00979628|269965|P1|STARTED|Overall Study||153
116911|NCT00979615|269975|P2|NOT COMPLETED|Overall Study||8
116912|NCT00979615|269976|P1|NOT COMPLETED|Overall Study||6
116913|NCT00979615|269975|P2|COMPLETED|Overall Study||58
116914|NCT00979615|269976|P1|COMPLETED|Overall Study||57
116915|NCT00979615|269975|P2|STARTED|Overall Study||66
116916|NCT00979615|269976|P1|STARTED|Overall Study||63
116917|NCT00979576|269993|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
116918|NCT00979576|269994|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
116919|NCT00979576|269995|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
116920|NCT00979576|269993|P3|COMPLETED|Combination Followed by Monotherapy||0
116921|NCT00979576|269994|P2|COMPLETED|Combination Followed by Monotherapy||0
116922|NCT00979576|269995|P1|COMPLETED|Combination Followed by Monotherapy||0
116923|NCT00979576|269993|P3|STARTED|Combination Followed by Monotherapy||1
116924|NCT00979576|269994|P2|STARTED|Combination Followed by Monotherapy||2
116925|NCT00979576|269995|P1|STARTED|Combination Followed by Monotherapy||0
116926|NCT00979576|269993|P3|NOT COMPLETED|Combination Treatment Phase||9
116927|NCT00979576|269994|P2|NOT COMPLETED|Combination Treatment Phase||6
116928|NCT00979576|269995|P1|NOT COMPLETED|Combination Treatment Phase||3
116929|NCT00979576|269993|P3|COMPLETED|Combination Treatment Phase||0
116930|NCT00979576|269994|P2|COMPLETED|Combination Treatment Phase||0
116931|NCT00979576|269995|P1|COMPLETED|Combination Treatment Phase||0
116932|NCT00979576|269993|P3|STARTED|Combination Treatment Phase||9
116933|NCT00979576|269994|P2|STARTED|Combination Treatment Phase||6
116934|NCT00979576|269995|P1|STARTED|Combination Treatment Phase||3
116935|NCT00978627|270028|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
116936|NCT00978627|270029|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
116937|NCT00978627|270028|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
116938|NCT00978627|270029|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
116939|NCT00978627|270028|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
116940|NCT00978627|270029|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
116941|NCT00978627|270028|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
116942|NCT00978627|270029|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
116943|NCT00978627|270028|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
116944|NCT00978627|270029|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
116945|NCT00978627|270028|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
116946|NCT00978627|270029|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
116947|NCT00978627|270028|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
116948|NCT00978627|270029|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
116949|NCT00979459|270051|P2|NOT COMPLETED|Second Intervention||0
116950|NCT00979459|270052|P1|NOT COMPLETED|Second Intervention||0
116951|NCT00979459|270051|P2|COMPLETED|Second Intervention||6
116952|NCT00979459|270052|P1|COMPLETED|Second Intervention||6
116953|NCT00979459|270051|P2|STARTED|Second Intervention||6
116954|NCT00979459|270052|P1|STARTED|Second Intervention||6
116955|NCT00979459|270051|P2|NOT COMPLETED|7-day Washout Period||0
116956|NCT00979459|270052|P1|NOT COMPLETED|7-day Washout Period||0
116957|NCT00979459|270051|P2|COMPLETED|7-day Washout Period||6
116958|NCT00979459|270052|P1|COMPLETED|7-day Washout Period||6
116959|NCT00979459|270051|P2|STARTED|7-day Washout Period||6
116960|NCT00979459|270052|P1|STARTED|7-day Washout Period||6
116961|NCT00979459|270051|P2|NOT COMPLETED|First Intervention||0
116962|NCT00979459|270052|P1|NOT COMPLETED|First Intervention||0
116963|NCT00979459|270051|P2|COMPLETED|First Intervention||6
116964|NCT00979459|270052|P1|COMPLETED|First Intervention||6
116965|NCT00979459|270051|P2|STARTED|First Intervention||6
116966|NCT00979459|270052|P1|STARTED|First Intervention||6
116967|NCT00979420|270068|P4|NOT COMPLETED|Overall Study||2
116968|NCT00979420|270069|P3|NOT COMPLETED|Overall Study||1
116969|NCT00979420|270070|P2|NOT COMPLETED|Overall Study||0
116970|NCT00979420|270071|P1|NOT COMPLETED|Overall Study||7
116971|NCT00979420|270068|P4|COMPLETED|Overall Study||59
116972|NCT00979420|270069|P3|COMPLETED|Overall Study||59
116973|NCT00979420|270070|P2|COMPLETED|Overall Study||57
116974|NCT00979420|270071|P1|COMPLETED|Overall Study||171
116975|NCT00979420|270068|P4|STARTED|Overall Study||61
116976|NCT00979420|270069|P3|STARTED|Overall Study||60
116977|NCT00979420|270070|P2|STARTED|Overall Study||57
116978|NCT00979420|270071|P1|STARTED|Overall Study||178
116979|NCT00979212|270141|P2|NOT COMPLETED|Overall Study||8
116980|NCT00979212|270142|P1|NOT COMPLETED|Overall Study||2
116981|NCT00979212|270141|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
116982|NCT00979212|270142|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
116983|NCT00979212|270141|P2|STARTED|Overall Study||47
116984|NCT00979212|270142|P1|STARTED|Overall Study||24
116985|NCT00979199|270154|P1|NOT COMPLETED|Overall Study||222
116986|NCT00979199|270154|P1|COMPLETED|Overall Study||475
116987|NCT00979199|270154|P1|STARTED|Overall Study||697
116988|NCT00979121|270160|P2|NOT COMPLETED|Overall Study||0
116989|NCT00979121|270161|P1|NOT COMPLETED|Overall Study||0
116990|NCT00979121|270160|P2|COMPLETED|Overall Study||366
116991|NCT00979121|270161|P1|COMPLETED|Overall Study||379
116992|NCT00979121|270160|P2|STARTED|Overall Study||366
116993|NCT00979121|270161|P1|STARTED|Overall Study||379
116994|NCT00979069|270179|P2|NOT COMPLETED|Overall Study||2
116995|NCT00979069|270180|P1|NOT COMPLETED|Overall Study||0
116996|NCT00979069|270179|P2|COMPLETED|Overall Study||8
116997|NCT00979069|270180|P1|COMPLETED|Overall Study||10
116998|NCT00979069|270179|P2|STARTED|Overall Study||10
116999|NCT00979069|270180|P1|STARTED|Overall Study||10
117000|NCT00979017|270186|P1|NOT COMPLETED|Overall Study||0
117001|NCT00979017|270186|P1|COMPLETED|Overall Study||41
117002|NCT00979017|270186|P1|STARTED|Overall Study||41
117003|NCT00978757|270196|P2|NOT COMPLETED|Overall Study||3
117004|NCT00978757|270197|P1|NOT COMPLETED|Overall Study||1
117005|NCT00978757|270196|P2|COMPLETED|Overall Study|Junio 2008|17
117006|NCT00978757|270197|P1|COMPLETED|Overall Study|Junio 2008|21
117007|NCT00978757|270196|P2|STARTED|Overall Study|Junio 2001|20
117008|NCT00978757|270197|P1|STARTED|Overall Study|Junio 2001|22
117009|NCT00978731|270207|P4|NOT COMPLETED|Overall Study||4
117010|NCT00978731|270208|P3|NOT COMPLETED|Overall Study||5
117011|NCT00978731|270209|P2|NOT COMPLETED|Overall Study||15
117012|NCT00978731|270210|P1|NOT COMPLETED|Overall Study||22
117013|NCT00978731|270207|P4|COMPLETED|Overall Study||0
117014|NCT00978731|270208|P3|COMPLETED|Overall Study||0
117015|NCT00978731|270209|P2|COMPLETED|Overall Study||0
117016|NCT00978731|270210|P1|COMPLETED|Overall Study||0
117017|NCT00978731|270207|P4|STARTED|Overall Study||4
117018|NCT00978731|270208|P3|STARTED|Overall Study||5
117019|NCT00978731|270209|P2|STARTED|Overall Study||15
117020|NCT00978731|270210|P1|STARTED|Overall Study||22
117021|NCT00978445|270248|P2|NOT COMPLETED|Overall Study||1
117022|NCT00978445|270249|P1|NOT COMPLETED|Overall Study||2
117023|NCT00978445|270248|P2|COMPLETED|Overall Study||12
117024|NCT00978445|270249|P1|COMPLETED|Overall Study||10
117025|NCT00978445|270248|P2|STARTED|Overall Study||13
117026|NCT00978445|270249|P1|STARTED|Overall Study||12
117027|NCT00978432|270259|P3|NOT COMPLETED|Overall Study||5
117028|NCT00978432|270260|P2|NOT COMPLETED|Overall Study||1
117029|NCT00978432|270261|P1|NOT COMPLETED|Overall Study||3
117030|NCT00978432|270259|P3|COMPLETED|Overall Study||13
117031|NCT00978432|270260|P2|COMPLETED|Overall Study||4
117032|NCT00978432|270261|P1|COMPLETED|Overall Study||7
117033|NCT00978432|270259|P3|STARTED|Overall Study||18
117034|NCT00978432|270260|P2|STARTED|Overall Study||5
117035|NCT00978432|270261|P1|STARTED|Overall Study||10
117036|NCT00978380|270281|P1|NOT COMPLETED|Overall Study||19
117037|NCT00978380|270281|P1|COMPLETED|Overall Study||44
117038|NCT00978380|270281|P1|STARTED|Overall Study||63
117039|NCT00978341|270287|P2|NOT COMPLETED|Second Intervention||0
117040|NCT00978341|270288|P1|NOT COMPLETED|Second Intervention||0
117041|NCT00978341|270287|P2|COMPLETED|Second Intervention||7
117042|NCT00978341|270288|P1|COMPLETED|Second Intervention||7
117043|NCT00978341|270287|P2|STARTED|Second Intervention||7
117044|NCT00978341|270288|P1|STARTED|Second Intervention||7
117045|NCT00978341|270287|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
117046|NCT00978341|270288|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
117047|NCT00978341|270287|P2|COMPLETED|Washout Period of 2 Weeks||7
117048|NCT00978341|270288|P1|COMPLETED|Washout Period of 2 Weeks||7
117049|NCT00978341|270287|P2|STARTED|Washout Period of 2 Weeks||7
117050|NCT00978341|270288|P1|STARTED|Washout Period of 2 Weeks||8
117051|NCT00978341|270287|P2|NOT COMPLETED|First Intervention||0
117052|NCT00978341|270288|P1|NOT COMPLETED|First Intervention||0
117053|NCT00978341|270287|P2|COMPLETED|First Intervention||7
117054|NCT00978341|270288|P1|COMPLETED|First Intervention||8
117055|NCT00978341|270287|P2|STARTED|First Intervention||7
117056|NCT00978341|270288|P1|STARTED|First Intervention||8
117057|NCT00978120|270310|P4|NOT COMPLETED|Overall Study||2
117058|NCT00978120|270311|P3|NOT COMPLETED|Overall Study||3
117059|NCT00978120|270312|P2|NOT COMPLETED|Overall Study||0
117060|NCT00978120|270313|P1|NOT COMPLETED|Overall Study||2
117061|NCT00978120|270310|P4|COMPLETED|Overall Study||84
117062|NCT00978120|270311|P3|COMPLETED|Overall Study||84
117063|NCT00978120|270312|P2|COMPLETED|Overall Study||107
117064|NCT00978120|270313|P1|COMPLETED|Overall Study||108
117065|NCT00978120|270310|P4|STARTED|Overall Study||86
117066|NCT00978120|270311|P3|STARTED|Overall Study||87
117067|NCT00978120|270312|P2|STARTED|Overall Study||107
117068|NCT00978120|270313|P1|STARTED|Overall Study||110
117069|NCT00978042|270365|P2|NOT COMPLETED|Received Repeat Treatment||3
117070|NCT00978042|270366|P1|NOT COMPLETED|Received Repeat Treatment||43
117071|NCT00978042|270365|P2|COMPLETED|Received Repeat Treatment||23
117072|NCT00978042|270366|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
117073|NCT00978042|270365|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
117074|NCT00978042|270366|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
117075|NCT00978042|270365|P2|NOT COMPLETED|Initial Treatment Period||15
117076|NCT00978042|270366|P1|NOT COMPLETED|Initial Treatment Period||61
117077|NCT00978042|270365|P2|COMPLETED|Initial Treatment Period||32
117078|NCT00978042|270366|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
117079|NCT00978042|270365|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
117080|NCT00978042|270366|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
117081|NCT00978042|270365|P2|STARTED|Initial Treatment Period||47
117082|NCT00978042|270366|P1|STARTED|Initial Treatment Period||235
117083|NCT00978029|270379|P3|NOT COMPLETED|Overall Study||6
117084|NCT00978029|270380|P2|NOT COMPLETED|Overall Study||3
117085|NCT00978029|270381|P1|NOT COMPLETED|Overall Study||1
117086|NCT00978029|270379|P3|COMPLETED|Overall Study||59
117087|NCT00978029|270380|P2|COMPLETED|Overall Study||63
117088|NCT00978029|270381|P1|COMPLETED|Overall Study||64
117089|NCT00978029|270379|P3|STARTED|Overall Study||65
117090|NCT00978029|270380|P2|STARTED|Overall Study||66
117091|NCT00978029|270381|P1|STARTED|Overall Study||65
117092|NCT00977938|270408|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
117093|NCT00977938|270409|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
117094|NCT00977938|270410|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
117095|NCT00977938|270411|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
117096|NCT00977938|270408|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
117097|NCT00977938|270409|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
117098|NCT00977938|270410|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
117099|NCT00977938|270411|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
117100|NCT00977938|270408|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
117101|NCT00977938|270409|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
117102|NCT00977938|270410|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
117103|NCT00977938|270411|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
117104|NCT00977938|270408|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
117105|NCT00977938|270409|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
117106|NCT00977938|270410|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
117107|NCT00977938|270411|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
117108|NCT00977938|270408|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
117109|NCT00977938|270409|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
117110|NCT00977938|270410|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
117111|NCT00977938|270411|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
117112|NCT00977938|270408|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
117113|NCT00977938|270409|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
117114|NCT00977938|270410|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
117115|NCT00977938|270411|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
117116|NCT00977808|270445|P1|NOT COMPLETED|Overall Study||1
117117|NCT00977808|270445|P1|COMPLETED|Overall Study||11
117118|NCT00977808|270445|P1|Completion of Closed-Loop Admission|Overall Study||11
117119|NCT00977808|270445|P1|Completion of Open-Loop Admission|Overall Study||12
117120|NCT00977808|270445|P1|STARTED|Overall Study||12
117121|NCT00977769|270453|P3|NOT COMPLETED|Overall Study||0
117122|NCT00977769|270454|P2|NOT COMPLETED|Overall Study||0
117123|NCT00977769|270455|P1|NOT COMPLETED|Overall Study||0
117124|NCT00977769|270453|P3|COMPLETED|Overall Study||25
117125|NCT00977769|270454|P2|COMPLETED|Overall Study||26
117126|NCT00977769|270455|P1|COMPLETED|Overall Study||25
117127|NCT00977769|270453|P3|STARTED|Overall Study||25
117128|NCT00977769|270454|P2|STARTED|Overall Study||26
117129|NCT00977769|270455|P1|STARTED|Overall Study||25
117130|NCT00977704|270469|P1|NOT COMPLETED|Overall Study||0
117131|NCT00977704|270469|P1|COMPLETED|Overall Study||20
117132|NCT00977704|270469|P1|STARTED|Overall Study||20
117133|NCT00977665|270475|P2|NOT COMPLETED|Overall Study||15
117134|NCT00977665|270476|P1|NOT COMPLETED|Overall Study||21
117135|NCT00977665|270475|P2|COMPLETED|Overall Study||75
117136|NCT00977665|270476|P1|COMPLETED|Overall Study||63
117137|NCT00977665|270475|P2|STARTED|Overall Study||90
117138|NCT00977665|270476|P1|STARTED|Overall Study||84
117139|NCT00977613|270508|P1|NOT COMPLETED|Overall Study||16
117140|NCT00977613|270508|P1|COMPLETED|Overall Study||34
117141|NCT00977613|270508|P1|STARTED|Overall Study||50
117142|NCT00977561|270514|P2|NOT COMPLETED|Overall Study||4
117143|NCT00977561|270515|P1|NOT COMPLETED|Overall Study||5
117144|NCT00977561|270514|P2|COMPLETED|Overall Study||0
117145|NCT00977561|270515|P1|COMPLETED|Overall Study||0
117146|NCT00977561|270514|P2|STARTED|Overall Study||4
117147|NCT00977561|270515|P1|STARTED|Overall Study||5
117148|NCT00977548|270542|P1|NOT COMPLETED|Overall Study||13
117149|NCT00977548|270542|P1|COMPLETED|Overall Study||26
117150|NCT00977548|270542|P1|STARTED|Overall Study||39
117151|NCT00977379|270551|P2|NOT COMPLETED|Overall Study||12
117152|NCT00977379|270552|P1|NOT COMPLETED|Overall Study||12
117153|NCT00977379|270551|P2|COMPLETED|Overall Study||0
117154|NCT00977379|270552|P1|COMPLETED|Overall Study||0
117155|NCT00977379|270551|P2|Treated|Overall Study||11
117156|NCT00977379|270552|P1|Treated|Overall Study||12
117157|NCT00977379|270551|P2|STARTED|Overall Study|Randomized|12
117158|NCT00977379|270552|P1|STARTED|Overall Study|Randomized|12
117159|NCT00977314|270588|P2|NOT COMPLETED|Overall Study||0
117160|NCT00977314|270589|P1|NOT COMPLETED|Overall Study||2
117161|NCT00977314|270588|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
117162|NCT00977314|270589|P1|COMPLETED|Overall Study||28
117163|NCT00977314|270588|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
117164|NCT00977314|270589|P1|STARTED|Overall Study||30
117165|NCT00977197|270597|P2|NOT COMPLETED|Overall Study||9
117166|NCT00977197|270598|P1|NOT COMPLETED|Overall Study||9
117167|NCT00977197|270597|P2|COMPLETED|Overall Study||35
117168|NCT00977197|270598|P1|COMPLETED|Overall Study||32
117169|NCT00977197|270597|P2|STARTED|Overall Study||44
117170|NCT00977197|270598|P1|STARTED|Overall Study||41
117171|NCT00977184|270628|P2|NOT COMPLETED|Overall Study||0
117172|NCT00977184|270629|P1|NOT COMPLETED|Overall Study||0
117173|NCT00977184|270628|P2|COMPLETED|Overall Study||13
117174|NCT00977184|270629|P1|COMPLETED|Overall Study||13
117175|NCT00977184|270628|P2|STARTED|Overall Study||13
117176|NCT00977184|270629|P1|STARTED|Overall Study||13
117177|NCT00977171|270655|P1|NOT COMPLETED|Overall Study||0
117178|NCT00977171|270655|P1|COMPLETED|Overall Study||3
117179|NCT00977171|270655|P1|STARTED|Overall Study||3
117180|NCT00977106|270661|P2|NOT COMPLETED|Overall Study||11
117181|NCT00977106|270662|P1|NOT COMPLETED|Overall Study||10
117182|NCT00977106|270661|P2|COMPLETED|Overall Study||45
117183|NCT00977106|270662|P1|COMPLETED|Overall Study||37
117184|NCT00977106|270661|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
117185|NCT00977106|270662|P1|STARTED|Overall Study||47
117186|NCT00977080|270754|P4|NOT COMPLETED|Overall Study||17
117187|NCT00977080|270755|P3|NOT COMPLETED|Overall Study||16
117188|NCT00977080|270756|P2|NOT COMPLETED|Overall Study||20
117189|NCT00977080|270757|P1|NOT COMPLETED|Overall Study||12
117190|NCT00977080|270754|P4|COMPLETED|Overall Study||53
117191|NCT00977080|270755|P3|COMPLETED|Overall Study||56
117192|NCT00977080|270756|P2|COMPLETED|Overall Study||44
117193|NCT00977080|270757|P1|COMPLETED|Overall Study||50
117194|NCT00977080|270754|P4|STARTED|Overall Study||70
117195|NCT00977080|270755|P3|STARTED|Overall Study||72
117196|NCT00977080|270756|P2|STARTED|Overall Study||64
117197|NCT00977080|270757|P1|STARTED|Overall Study||62
117198|NCT00976989|270790|P3|NOT COMPLETED|Overall Study||17
117199|NCT00976989|270791|P2|NOT COMPLETED|Overall Study||12
117200|NCT00976989|270792|P1|NOT COMPLETED|Overall Study||13
117201|NCT00976989|270790|P3|COMPLETED|Overall Study||60
117202|NCT00976989|270791|P2|COMPLETED|Overall Study||63
117203|NCT00976989|270792|P1|COMPLETED|Overall Study||60
117204|NCT00976989|270790|P3|STARTED|Overall Study||77
117205|NCT00976989|270791|P2|STARTED|Overall Study||75
117206|NCT00976989|270792|P1|STARTED|Overall Study||73
117207|NCT00976950|270833|P1|NOT COMPLETED|Overall Study||6
117208|NCT00976950|270833|P1|COMPLETED|Overall Study||36
117209|NCT00976950|270833|P1|STARTED|Overall Study||42
117210|NCT00976937|270841|P2|NOT COMPLETED|Overall Study||11
117211|NCT00976937|270842|P1|NOT COMPLETED|Overall Study||16
117212|NCT00976937|270841|P2|COMPLETED|Overall Study||150
117213|NCT00976937|270842|P1|COMPLETED|Overall Study||142
117214|NCT00976937|270841|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
117215|NCT00976937|270842|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
117216|NCT00976937|270841|P2|Treated/Safety Population|Overall Study||161
117217|NCT00976937|270842|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
117218|NCT00976937|270841|P2|STARTED|Overall Study||161
117219|NCT00976937|270842|P1|STARTED|Overall Study|Randomized|158
117220|NCT00976911|270884|P2|NOT COMPLETED|Overall Study||179
117221|NCT00976911|270885|P1|NOT COMPLETED|Overall Study||182
117222|NCT00976911|270884|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
117223|NCT00976911|270885|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
117224|NCT00976911|270884|P2|STARTED|Overall Study||179
117225|NCT00976911|270885|P1|STARTED|Overall Study||182
117226|NCT00976716|270903|P1|NOT COMPLETED|Overall Study||1
117227|NCT00976716|270903|P1|COMPLETED|Overall Study||79
117228|NCT00976716|270903|P1|STARTED|Overall Study||80
117229|NCT00976703|270921|P2|NOT COMPLETED|Overall Study||3
117230|NCT00976703|270922|P1|NOT COMPLETED|Overall Study||3
117231|NCT00976703|270921|P2|COMPLETED|Overall Study||95
117232|NCT00976703|270922|P1|COMPLETED|Overall Study||96
117233|NCT00976703|270921|P2|STARTED|Overall Study||98
117234|NCT00976703|270922|P1|STARTED|Overall Study||99
117235|NCT00976677|270936|P2|NOT COMPLETED|Overall Study||5
117236|NCT00976677|270937|P1|NOT COMPLETED|Overall Study||5
117237|NCT00976677|270936|P2|COMPLETED|Overall Study||0
117238|NCT00976677|270937|P1|COMPLETED|Overall Study||0
117239|NCT00976677|270936|P2|STARTED|Overall Study||5
117240|NCT00976677|270937|P1|STARTED|Overall Study||5
117241|NCT00976664|270945|P2|NOT COMPLETED|Overall Study||1
117242|NCT00976664|270946|P1|NOT COMPLETED|Overall Study||3
117243|NCT00976664|270945|P2|COMPLETED|Overall Study||24
117244|NCT00976664|270946|P1|COMPLETED|Overall Study||22
117245|NCT00976664|270945|P2|STARTED|Overall Study||25
117246|NCT00976664|270946|P1|STARTED|Overall Study||25
117247|NCT00976599|270956|P2|NOT COMPLETED|Overall Study||0
117248|NCT00976599|270957|P1|NOT COMPLETED|Overall Study||0
117249|NCT00976599|270956|P2|COMPLETED|Overall Study||14
117250|NCT00976599|270957|P1|COMPLETED|Overall Study||15
117251|NCT00976599|270956|P2|STARTED|Overall Study||14
117252|NCT00976599|270957|P1|STARTED|Overall Study||15
117253|NCT00976521|271147|P4|NOT COMPLETED|Overall Study||19
117254|NCT00976521|271148|P3|NOT COMPLETED|Overall Study||9
117255|NCT00976521|271149|P2|NOT COMPLETED|Overall Study||12
117256|NCT00976521|271150|P1|NOT COMPLETED|Overall Study||9
117257|NCT00976521|271147|P4|COMPLETED|Overall Study||93
117258|NCT00976521|271148|P3|COMPLETED|Overall Study||102
117259|NCT00976521|271149|P2|COMPLETED|Overall Study||99
117260|NCT00976521|271150|P1|COMPLETED|Overall Study||109
117261|NCT00976521|271147|P4|STARTED|Overall Study||112
117262|NCT00976521|271148|P3|STARTED|Overall Study||111
117263|NCT00976521|271149|P2|STARTED|Overall Study||111
117264|NCT00976521|271150|P1|STARTED|Overall Study||118
117265|NCT00976508|271164|P2|NOT COMPLETED|Overall Study||6
117266|NCT00976508|271165|P1|NOT COMPLETED|Overall Study||14
117267|NCT00976508|271164|P2|COMPLETED|Overall Study||0
117268|NCT00976508|271165|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
117269|NCT00976508|271164|P2|STARTED|Overall Study||6
117270|NCT00976508|271165|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
117271|NCT00976482|271195|P1|NOT COMPLETED|Overall Study||259
117272|NCT00976482|271195|P1|COMPLETED|Overall Study||1486
117273|NCT00976482|271195|P1|Eligible for Last Follow up|Overall Study||1487
117274|NCT00976482|271195|P1|STARTED|Overall Study||1745
117275|NCT00976456|271201|P2|NOT COMPLETED|Overall Study||38
117276|NCT00976456|271202|P1|NOT COMPLETED|Overall Study||43
117277|NCT00976456|271201|P2|COMPLETED|Overall Study||98
117278|NCT00976456|271202|P1|COMPLETED|Overall Study||92
117279|NCT00976456|271201|P2|STARTED|Overall Study||136
117280|NCT00976456|271202|P1|STARTED|Overall Study||135
117281|NCT00976404|271212|P2|NOT COMPLETED|Overall Study||0
117282|NCT00976404|271213|P1|NOT COMPLETED|Overall Study||0
117283|NCT00976404|271212|P2|COMPLETED|Overall Study||14
117284|NCT00976404|271213|P1|COMPLETED|Overall Study||14
117285|NCT00976404|271212|P2|STARTED|Overall Study||14
117286|NCT00976404|271213|P1|STARTED|Overall Study||14
117287|NCT00976391|271229|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
117288|NCT00976391|271230|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
117289|NCT00976391|271229|P2|COMPLETED|Follow-up Period (8 Weeks)||247
117290|NCT00976391|271230|P1|COMPLETED|Follow-up Period (8 Weeks)||256
117291|NCT00976391|271229|P2|STARTED|Follow-up Period (8 Weeks)||281
117292|NCT00976391|271230|P1|STARTED|Follow-up Period (8 Weeks)||285
117293|NCT00976391|271229|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
117294|NCT00976391|271230|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
117295|NCT00976391|271229|P2|COMPLETED|Treatment Period (52 Weeks)||242
117296|NCT00976391|271230|P1|COMPLETED|Treatment Period (52 Weeks)||243
117297|NCT00976391|271229|P2|STARTED|Treatment Period (52 Weeks)||281
117298|NCT00976391|271230|P1|STARTED|Treatment Period (52 Weeks)||285
117299|NCT00976339|271250|P1|NOT COMPLETED|Overall Study||4
117300|NCT00976339|271250|P1|COMPLETED|Overall Study||16
117301|NCT00976339|271250|P1|STARTED|Overall Study||20
117302|NCT00976274|271256|P2|NOT COMPLETED|Overall Study||8
117303|NCT00976274|271257|P1|NOT COMPLETED|Overall Study||7
117304|NCT00976274|271256|P2|COMPLETED|Overall Study||21
117305|NCT00976274|271257|P1|COMPLETED|Overall Study||24
117306|NCT00976274|271256|P2|STARTED|Overall Study||29
117307|NCT00976274|271257|P1|STARTED|Overall Study||31
117308|NCT00976248|271265|P1|NOT COMPLETED|Overall Study||0
117309|NCT00976248|271265|P1|COMPLETED|Overall Study||33
117310|NCT00976248|271265|P1|STARTED|Overall Study||33
117311|NCT00976209|271273|P2|NOT COMPLETED|Treatment Period 2||2
117312|NCT00976209|271274|P1|NOT COMPLETED|Treatment Period 2||0
117313|NCT00976209|271273|P2|COMPLETED|Treatment Period 2||161
117314|NCT00976209|271274|P1|COMPLETED|Treatment Period 2||158
117315|NCT00976209|271273|P2|STARTED|Treatment Period 2||163
117316|NCT00976209|271274|P1|STARTED|Treatment Period 2||158
117317|NCT00976209|271273|P2|NOT COMPLETED|Wash-out Period||2
117318|NCT00976209|271274|P1|NOT COMPLETED|Wash-out Period||4
117319|NCT00976209|271273|P2|COMPLETED|Wash-out Period||163
117320|NCT00976209|271274|P1|COMPLETED|Wash-out Period||158
117321|NCT00976209|271273|P2|STARTED|Wash-out Period||165
117322|NCT00976209|271274|P1|STARTED|Wash-out Period||162
117323|NCT00976209|271273|P2|NOT COMPLETED|Treatment Period 1||1
117324|NCT00976209|271274|P1|NOT COMPLETED|Treatment Period 1||3
117325|NCT00976209|271273|P2|COMPLETED|Treatment Period 1||165
117326|NCT00976209|271274|P1|COMPLETED|Treatment Period 1||162
117327|NCT00976209|271273|P2|STARTED|Treatment Period 1||166
117328|NCT00976209|271274|P1|STARTED|Treatment Period 1||165
117329|NCT00976027|271282|P2|NOT COMPLETED|Overall Study||215
117330|NCT00976027|271283|P1|NOT COMPLETED|Overall Study||411
117331|NCT00976027|271282|P2|COMPLETED|Overall Study||2835
117332|NCT00976027|271283|P1|COMPLETED|Overall Study||5697
117333|NCT00976027|271282|P2|STARTED|Overall Study||3050
117334|NCT00976027|271283|P1|STARTED|Overall Study||6108
117335|NCT00975975|271295|P1|NOT COMPLETED|Overall Study||6
117336|NCT00975975|271295|P1|COMPLETED|Overall Study||11
117337|NCT00975975|271295|P1|STARTED|Overall Study||17
117338|NCT00975923|271303|P2|NOT COMPLETED|Overall Study||1
117339|NCT00975923|271304|P1|NOT COMPLETED|Overall Study||0
117340|NCT00975923|271303|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
117341|NCT00975923|271304|P1|COMPLETED|Overall Study||30
117342|NCT00975923|271303|P2|STARTED|Overall Study||30
117343|NCT00975923|271304|P1|STARTED|Overall Study||30
117344|NCT00975806|271315|P3|NOT COMPLETED|Overall Study||4
117345|NCT00975806|271316|P2|NOT COMPLETED|Overall Study||7
117346|NCT00975806|271317|P1|NOT COMPLETED|Overall Study||5
117347|NCT00975806|271315|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
117348|NCT00975806|271316|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
117349|NCT00975806|271317|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
117350|NCT00975806|271315|P3|STARTED|Overall Study||4
117351|NCT00975806|271316|P2|STARTED|Overall Study||7
117352|NCT00975806|271317|P1|STARTED|Overall Study||5
117353|NCT00975780|271341|P2|NOT COMPLETED|Follow Up||157
117354|NCT00975780|271342|P1|NOT COMPLETED|Follow Up||102
117355|NCT00975780|271341|P2|COMPLETED|Follow Up||277
117356|NCT00975780|271342|P1|COMPLETED|Follow Up||298
117357|NCT00975780|271341|P2|STARTED|Follow Up||434
117358|NCT00975780|271342|P1|STARTED|Follow Up||400
117359|NCT00975780|271341|P2|NOT COMPLETED|Allocation||0
117360|NCT00975780|271342|P1|NOT COMPLETED|Allocation||0
117361|NCT00975780|271341|P2|COMPLETED|Allocation||434
117362|NCT00975780|271342|P1|COMPLETED|Allocation||400
117363|NCT00975780|271341|P2|STARTED|Allocation||434
117364|NCT00975780|271342|P1|STARTED|Allocation||400
117365|NCT00975715|271352|P2|NOT COMPLETED|Maintenance Period||1
117366|NCT00975715|271353|P1|NOT COMPLETED|Maintenance Period||2
117367|NCT00975715|271352|P2|COMPLETED|Maintenance Period||50
117368|NCT00975715|271353|P1|COMPLETED|Maintenance Period||39
117369|NCT00975715|271352|P2|STARTED|Maintenance Period||51
117370|NCT00975715|271353|P1|STARTED|Maintenance Period||41
117371|NCT00975715|271352|P2|NOT COMPLETED|Titration Period||0
117372|NCT00975715|271353|P1|NOT COMPLETED|Titration Period||7
117373|NCT00975715|271352|P2|COMPLETED|Titration Period||51
117374|NCT00975715|271353|P1|COMPLETED|Titration Period||41
117375|NCT00975715|271352|P2|STARTED|Titration Period||51
117376|NCT00975715|271353|P1|STARTED|Titration Period||48
117377|NCT00975689|271369|P2|NOT COMPLETED|Overall Study||3
117378|NCT00975689|271370|P1|NOT COMPLETED|Overall Study||2
117379|NCT00975689|271369|P2|COMPLETED|Overall Study||15
117380|NCT00975689|271370|P1|COMPLETED|Overall Study||15
117381|NCT00975689|271369|P2|STARTED|Overall Study||18
117382|NCT00975689|271370|P1|STARTED|Overall Study||17
117383|NCT00975637|271381|P5|NOT COMPLETED|Overall Study||2
117384|NCT00975637|271382|P4|NOT COMPLETED|Overall Study||6
117385|NCT00975637|271383|P3|NOT COMPLETED|Overall Study||2
117386|NCT00975637|271384|P2|NOT COMPLETED|Overall Study||1
117387|NCT00975637|271385|P1|NOT COMPLETED|Overall Study||3
117388|NCT00975637|271381|P5|COMPLETED|Overall Study||37
117389|NCT00975637|271382|P4|COMPLETED|Overall Study||32
117390|NCT00975637|271383|P3|COMPLETED|Overall Study||40
117391|NCT00975637|271384|P2|COMPLETED|Overall Study||38
117392|NCT00975637|271385|P1|COMPLETED|Overall Study||37
117393|NCT00975637|271381|P5|STARTED|Overall Study||39
117394|NCT00975637|271382|P4|STARTED|Overall Study||38
117395|NCT00975637|271383|P3|STARTED|Overall Study||42
117396|NCT00975637|271384|P2|STARTED|Overall Study||39
117397|NCT00975637|271385|P1|STARTED|Overall Study||40
117398|NCT00975611|271402|P1|NOT COMPLETED|Overall Study||17
117399|NCT00975611|271402|P1|COMPLETED|Overall Study||5
117400|NCT00975611|271402|P1|STARTED|Overall Study||22
117401|NCT00975585|271408|P2|NOT COMPLETED|Overall Study||12
117402|NCT00975585|271409|P1|NOT COMPLETED|Overall Study||7
117403|NCT00975585|271408|P2|COMPLETED|Overall Study||183
117404|NCT00975585|271409|P1|COMPLETED|Overall Study||177
117405|NCT00975585|271408|P2|STARTED|Overall Study||195
117406|NCT00975585|271409|P1|STARTED|Overall Study||184
117407|NCT00975507|271429|P2|NOT COMPLETED|Overall Study||4
117408|NCT00975507|271430|P1|NOT COMPLETED|Overall Study||20
117409|NCT00975507|271429|P2|COMPLETED|Overall Study||153
117410|NCT00975507|271430|P1|COMPLETED|Overall Study||303
117411|NCT00975507|271429|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
117412|NCT00975507|271430|P1|Vaccinated at Visit 2|Overall Study||310
117413|NCT00975507|271429|P2|Vaccinated at Visit 1|Overall Study||157
117414|NCT00975507|271430|P1|Vaccinated at Visit 1|Overall Study||323
117415|NCT00975507|271429|P2|STARTED|Overall Study||157
117416|NCT00975507|271430|P1|STARTED|Overall Study||323
117417|NCT00975481|271450|P6|NOT COMPLETED|Sixth Intervention Period||0
117418|NCT00975481|271451|P5|NOT COMPLETED|Sixth Intervention Period||0
117419|NCT00975481|271452|P4|NOT COMPLETED|Sixth Intervention Period||0
117420|NCT00975481|271453|P3|NOT COMPLETED|Sixth Intervention Period||0
117421|NCT00975481|271454|P2|NOT COMPLETED|Sixth Intervention Period||0
117422|NCT00975481|271455|P1|NOT COMPLETED|Sixth Intervention Period||0
117423|NCT00975481|271450|P6|COMPLETED|Sixth Intervention Period||6
117424|NCT00975481|271451|P5|COMPLETED|Sixth Intervention Period||5
117425|NCT00975481|271452|P4|COMPLETED|Sixth Intervention Period||5
117426|NCT00975481|271453|P3|COMPLETED|Sixth Intervention Period||4
117427|NCT00975481|271454|P2|COMPLETED|Sixth Intervention Period||5
117428|NCT00975481|271455|P1|COMPLETED|Sixth Intervention Period||4
117429|NCT00975481|271450|P6|STARTED|Sixth Intervention Period||6
117430|NCT00975481|271451|P5|STARTED|Sixth Intervention Period||5
117431|NCT00975481|271452|P4|STARTED|Sixth Intervention Period||5
117432|NCT00975481|271453|P3|STARTED|Sixth Intervention Period||4
117433|NCT00975481|271454|P2|STARTED|Sixth Intervention Period||5
117434|NCT00975481|271455|P1|STARTED|Sixth Intervention Period||4
117435|NCT00975481|271450|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117436|NCT00975481|271451|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117437|NCT00975481|271452|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117438|NCT00975481|271453|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117439|NCT00975481|271454|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117440|NCT00975481|271455|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117441|NCT00975481|271450|P6|COMPLETED|Washout Period (at Least 7 Days)||6
117442|NCT00975481|271451|P5|COMPLETED|Washout Period (at Least 7 Days)||5
117443|NCT00975481|271452|P4|COMPLETED|Washout Period (at Least 7 Days)||5
117444|NCT00975481|271453|P3|COMPLETED|Washout Period (at Least 7 Days)||4
117445|NCT00975481|271454|P2|COMPLETED|Washout Period (at Least 7 Days)||5
117446|NCT00975481|271455|P1|COMPLETED|Washout Period (at Least 7 Days)||4
117447|NCT00975481|271450|P6|STARTED|Washout Period (at Least 7 Days)||6
117448|NCT00975481|271451|P5|STARTED|Washout Period (at Least 7 Days)||5
117449|NCT00975481|271452|P4|STARTED|Washout Period (at Least 7 Days)||5
117450|NCT00975481|271453|P3|STARTED|Washout Period (at Least 7 Days)||4
117451|NCT00975481|271454|P2|STARTED|Washout Period (at Least 7 Days)||5
117452|NCT00975481|271455|P1|STARTED|Washout Period (at Least 7 Days)||4
117453|NCT00975481|271450|P6|NOT COMPLETED|Fifth Intervention Period||0
117454|NCT00975481|271451|P5|NOT COMPLETED|Fifth Intervention Period||1
117455|NCT00975481|271452|P4|NOT COMPLETED|Fifth Intervention Period||0
117456|NCT00975481|271453|P3|NOT COMPLETED|Fifth Intervention Period||0
117457|NCT00975481|271454|P2|NOT COMPLETED|Fifth Intervention Period||0
117458|NCT00975481|271455|P1|NOT COMPLETED|Fifth Intervention Period||0
117459|NCT00975481|271450|P6|COMPLETED|Fifth Intervention Period||6
117460|NCT00975481|271451|P5|COMPLETED|Fifth Intervention Period||5
117461|NCT00975481|271452|P4|COMPLETED|Fifth Intervention Period||5
117462|NCT00975481|271453|P3|COMPLETED|Fifth Intervention Period||4
117463|NCT00975481|271454|P2|COMPLETED|Fifth Intervention Period||5
117464|NCT00975481|271455|P1|COMPLETED|Fifth Intervention Period||4
117465|NCT00975481|271450|P6|STARTED|Fifth Intervention Period||6
117466|NCT00975481|271451|P5|STARTED|Fifth Intervention Period||6
117467|NCT00975481|271452|P4|STARTED|Fifth Intervention Period||5
117468|NCT00975481|271453|P3|STARTED|Fifth Intervention Period||4
117469|NCT00975481|271454|P2|STARTED|Fifth Intervention Period||5
117470|NCT00975481|271455|P1|STARTED|Fifth Intervention Period||4
117471|NCT00975481|271450|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117472|NCT00975481|271451|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117473|NCT00975481|271452|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117474|NCT00975481|271453|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117475|NCT00975481|271454|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117476|NCT00975481|271455|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117477|NCT00975481|271450|P6|COMPLETED|Washout Period (at Least 7 Days)||6
117478|NCT00975481|271451|P5|COMPLETED|Washout Period (at Least 7 Days)||6
117479|NCT00975481|271452|P4|COMPLETED|Washout Period (at Least 7 Days)||5
117480|NCT00975481|271453|P3|COMPLETED|Washout Period (at Least 7 Days)||4
117481|NCT00975481|271454|P2|COMPLETED|Washout Period (at Least 7 Days)||5
117482|NCT00975481|271455|P1|COMPLETED|Washout Period (at Least 7 Days)||4
117483|NCT00975481|271450|P6|STARTED|Washout Period (at Least 7 Days)||6
117484|NCT00975481|271451|P5|STARTED|Washout Period (at Least 7 Days)||6
117485|NCT00975481|271452|P4|STARTED|Washout Period (at Least 7 Days)||5
117486|NCT00975481|271453|P3|STARTED|Washout Period (at Least 7 Days)||4
117487|NCT00975481|271454|P2|STARTED|Washout Period (at Least 7 Days)||5
117488|NCT00975481|271455|P1|STARTED|Washout Period (at Least 7 Days)||4
117489|NCT00975481|271450|P6|NOT COMPLETED|Fourth Intervention Period||0
117490|NCT00975481|271451|P5|NOT COMPLETED|Fourth Intervention Period||0
117491|NCT00975481|271452|P4|NOT COMPLETED|Fourth Intervention Period||1
117492|NCT00975481|271453|P3|NOT COMPLETED|Fourth Intervention Period||1
117493|NCT00975481|271454|P2|NOT COMPLETED|Fourth Intervention Period||0
117494|NCT00975481|271455|P1|NOT COMPLETED|Fourth Intervention Period||0
117495|NCT00975481|271450|P6|COMPLETED|Fourth Intervention Period||6
117496|NCT00975481|271451|P5|COMPLETED|Fourth Intervention Period||6
117497|NCT00975481|271452|P4|COMPLETED|Fourth Intervention Period||5
117498|NCT00975481|271453|P3|COMPLETED|Fourth Intervention Period||4
117499|NCT00975481|271454|P2|COMPLETED|Fourth Intervention Period||5
117500|NCT00975481|271455|P1|COMPLETED|Fourth Intervention Period||4
117501|NCT00975481|271450|P6|STARTED|Fourth Intervention Period||6
117502|NCT00975481|271451|P5|STARTED|Fourth Intervention Period||6
117503|NCT00975481|271452|P4|STARTED|Fourth Intervention Period||6
117504|NCT00975481|271453|P3|STARTED|Fourth Intervention Period||5
117505|NCT00975481|271454|P2|STARTED|Fourth Intervention Period||5
117506|NCT00975481|271455|P1|STARTED|Fourth Intervention Period||4
117507|NCT00975481|271450|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117508|NCT00975481|271451|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117509|NCT00975481|271452|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117510|NCT00975481|271453|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117511|NCT00975481|271454|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117512|NCT00975481|271455|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117513|NCT00975481|271450|P6|COMPLETED|Washout Period (at Least 7 Days)||6
117514|NCT00975481|271451|P5|COMPLETED|Washout Period (at Least 7 Days)||6
117515|NCT00975481|271452|P4|COMPLETED|Washout Period (at Least 7 Days)||6
117516|NCT00975481|271453|P3|COMPLETED|Washout Period (at Least 7 Days)||5
117517|NCT00975481|271454|P2|COMPLETED|Washout Period (at Least 7 Days)||5
117518|NCT00975481|271455|P1|COMPLETED|Washout Period (at Least 7 Days)||4
117519|NCT00975481|271450|P6|STARTED|Washout Period (at Least 7 Days)||6
117520|NCT00975481|271451|P5|STARTED|Washout Period (at Least 7 Days)||6
117521|NCT00975481|271452|P4|STARTED|Washout Period (at Least 7 Days)||6
117522|NCT00975481|271453|P3|STARTED|Washout Period (at Least 7 Days)||5
117523|NCT00975481|271454|P2|STARTED|Washout Period (at Least 7 Days)||5
117524|NCT00975481|271455|P1|STARTED|Washout Period (at Least 7 Days)||4
117525|NCT00975481|271450|P6|NOT COMPLETED|Third Intervention Period||0
117526|NCT00975481|271451|P5|NOT COMPLETED|Third Intervention Period||0
117527|NCT00975481|271452|P4|NOT COMPLETED|Third Intervention Period||0
117528|NCT00975481|271453|P3|NOT COMPLETED|Third Intervention Period||0
117529|NCT00975481|271454|P2|NOT COMPLETED|Third Intervention Period||0
117530|NCT00975481|271455|P1|NOT COMPLETED|Third Intervention Period||0
117531|NCT00975481|271450|P6|COMPLETED|Third Intervention Period||6
117532|NCT00975481|271451|P5|COMPLETED|Third Intervention Period||6
117533|NCT00975481|271452|P4|COMPLETED|Third Intervention Period||6
117534|NCT00975481|271453|P3|COMPLETED|Third Intervention Period||5
117535|NCT00975481|271454|P2|COMPLETED|Third Intervention Period||5
117536|NCT00975481|271455|P1|COMPLETED|Third Intervention Period||4
117537|NCT00975481|271450|P6|STARTED|Third Intervention Period||6
117538|NCT00975481|271451|P5|STARTED|Third Intervention Period||6
117539|NCT00975481|271452|P4|STARTED|Third Intervention Period||6
117540|NCT00975481|271453|P3|STARTED|Third Intervention Period||5
117541|NCT00975481|271454|P2|STARTED|Third Intervention Period||5
117542|NCT00975481|271455|P1|STARTED|Third Intervention Period||4
117543|NCT00975481|271450|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117544|NCT00975481|271451|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117545|NCT00975481|271452|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117546|NCT00975481|271453|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117547|NCT00975481|271454|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117548|NCT00975481|271455|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117549|NCT00975481|271450|P6|COMPLETED|Washout Period (at Least 7 Days)||6
117550|NCT00975481|271451|P5|COMPLETED|Washout Period (at Least 7 Days)||6
117551|NCT00975481|271452|P4|COMPLETED|Washout Period (at Least 7 Days)||6
117552|NCT00975481|271453|P3|COMPLETED|Washout Period (at Least 7 Days)||5
117553|NCT00975481|271454|P2|COMPLETED|Washout Period (at Least 7 Days)||5
117554|NCT00975481|271455|P1|COMPLETED|Washout Period (at Least 7 Days)||4
117555|NCT00975481|271450|P6|STARTED|Washout Period (at Least 7 Days)||6
117556|NCT00975481|271451|P5|STARTED|Washout Period (at Least 7 Days)||6
117557|NCT00975481|271452|P4|STARTED|Washout Period (at Least 7 Days)||6
117558|NCT00975481|271453|P3|STARTED|Washout Period (at Least 7 Days)||5
117559|NCT00975481|271454|P2|STARTED|Washout Period (at Least 7 Days)||5
117560|NCT00975481|271455|P1|STARTED|Washout Period (at Least 7 Days)||4
117561|NCT00975481|271450|P6|NOT COMPLETED|Second Intervention Period||0
117562|NCT00975481|271451|P5|NOT COMPLETED|Second Intervention Period||0
117563|NCT00975481|271452|P4|NOT COMPLETED|Second Intervention Period||0
117564|NCT00975481|271453|P3|NOT COMPLETED|Second Intervention Period||1
117565|NCT00975481|271454|P2|NOT COMPLETED|Second Intervention Period||1
117566|NCT00975481|271455|P1|NOT COMPLETED|Second Intervention Period||2
117567|NCT00975481|271450|P6|COMPLETED|Second Intervention Period||6
117568|NCT00975481|271451|P5|COMPLETED|Second Intervention Period||6
117569|NCT00975481|271452|P4|COMPLETED|Second Intervention Period||6
117570|NCT00975481|271453|P3|COMPLETED|Second Intervention Period||5
117571|NCT00975481|271454|P2|COMPLETED|Second Intervention Period||5
117572|NCT00975481|271455|P1|COMPLETED|Second Intervention Period||4
117573|NCT00975481|271450|P6|STARTED|Second Intervention Period||6
117574|NCT00975481|271451|P5|STARTED|Second Intervention Period||6
117575|NCT00975481|271452|P4|STARTED|Second Intervention Period||6
117576|NCT00975481|271453|P3|STARTED|Second Intervention Period||6
117577|NCT00975481|271454|P2|STARTED|Second Intervention Period||6
117578|NCT00975481|271455|P1|STARTED|Second Intervention Period||6
117579|NCT00975481|271450|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117580|NCT00975481|271451|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117581|NCT00975481|271452|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117582|NCT00975481|271453|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117583|NCT00975481|271454|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117584|NCT00975481|271455|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
117585|NCT00975481|271450|P6|COMPLETED|Washout Period (at Least 7 Days)||6
117586|NCT00975481|271451|P5|COMPLETED|Washout Period (at Least 7 Days)||6
117587|NCT00975481|271452|P4|COMPLETED|Washout Period (at Least 7 Days)||6
117588|NCT00975481|271453|P3|COMPLETED|Washout Period (at Least 7 Days)||6
117589|NCT00975481|271454|P2|COMPLETED|Washout Period (at Least 7 Days)||6
117590|NCT00975481|271455|P1|COMPLETED|Washout Period (at Least 7 Days)||6
117591|NCT00975481|271450|P6|STARTED|Washout Period (at Least 7 Days)||6
117592|NCT00975481|271451|P5|STARTED|Washout Period (at Least 7 Days)||6
117593|NCT00975481|271452|P4|STARTED|Washout Period (at Least 7 Days)||6
117594|NCT00975481|271453|P3|STARTED|Washout Period (at Least 7 Days)||6
117595|NCT00975481|271454|P2|STARTED|Washout Period (at Least 7 Days)||6
117596|NCT00975481|271455|P1|STARTED|Washout Period (at Least 7 Days)||6
117597|NCT00975481|271450|P6|NOT COMPLETED|First Intervention Period||0
117598|NCT00975481|271451|P5|NOT COMPLETED|First Intervention Period||0
117599|NCT00975481|271452|P4|NOT COMPLETED|First Intervention Period||0
117600|NCT00975481|271453|P3|NOT COMPLETED|First Intervention Period||0
117601|NCT00975481|271454|P2|NOT COMPLETED|First Intervention Period||0
117602|NCT00975481|271455|P1|NOT COMPLETED|First Intervention Period||0
117603|NCT00975481|271450|P6|COMPLETED|First Intervention Period||6
117604|NCT00975481|271451|P5|COMPLETED|First Intervention Period||6
117605|NCT00975481|271452|P4|COMPLETED|First Intervention Period||6
117606|NCT00975481|271453|P3|COMPLETED|First Intervention Period||6
117607|NCT00975481|271454|P2|COMPLETED|First Intervention Period||6
117608|NCT00975481|271455|P1|COMPLETED|First Intervention Period||6
117609|NCT00975481|271450|P6|STARTED|First Intervention Period||6
117610|NCT00975481|271451|P5|STARTED|First Intervention Period||6
117611|NCT00975481|271452|P4|STARTED|First Intervention Period||6
117612|NCT00975481|271453|P3|STARTED|First Intervention Period||6
117613|NCT00975481|271454|P2|STARTED|First Intervention Period||6
117614|NCT00975481|271455|P1|STARTED|First Intervention Period||6
117615|NCT00975416|271555|P2|NOT COMPLETED|Overall Study||5
117616|NCT00975416|271556|P1|NOT COMPLETED|Overall Study||3
117617|NCT00975416|271555|P2|COMPLETED|Overall Study||11
117618|NCT00975416|271556|P1|COMPLETED|Overall Study||11
117619|NCT00975416|271555|P2|STARTED|Overall Study||16
117620|NCT00975416|271556|P1|STARTED|Overall Study||14
117621|NCT00975286|271565|P2|NOT COMPLETED|Overall Study||29
117622|NCT00975286|271566|P1|NOT COMPLETED|Overall Study||12
117623|NCT00975286|271565|P2|COMPLETED|Overall Study||194
117624|NCT00975286|271566|P1|COMPLETED|Overall Study||211
117625|NCT00975286|271565|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
117626|NCT00975286|271566|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
117627|NCT00975286|271565|P2|Safety Population|Overall Study||223
117628|NCT00975286|271566|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
117629|NCT00975286|271565|P2|STARTED|Overall Study||223
117630|NCT00975286|271566|P1|STARTED|Overall Study|Randomized.|223
117631|NCT00975221|271598|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
117632|NCT00975221|271599|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
117633|NCT00975221|271598|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
117634|NCT00975221|271599|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
117635|NCT00975221|271598|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
117636|NCT00975221|271599|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
117637|NCT00975221|271598|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
117638|NCT00975221|271599|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
117639|NCT00975221|271598|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
117640|NCT00975221|271599|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
117641|NCT00975221|271598|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
117642|NCT00975221|271599|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
117643|NCT00975221|271598|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
117644|NCT00975221|271599|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
117645|NCT00975221|271598|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
117646|NCT00975221|271599|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
117647|NCT00975221|271598|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
117648|NCT00975221|271599|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
117649|NCT00975221|271598|P2|STARTED|Titration Phase (Weeks 1-12)||33
117650|NCT00975221|271599|P1|STARTED|Titration Phase (Weeks 1-12)||34
117651|NCT00975195|271615|P2|NOT COMPLETED|Overall Study||233
117652|NCT00975195|271616|P1|NOT COMPLETED|Overall Study||228
117653|NCT00975195|271615|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
117654|NCT00975195|271616|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
117655|NCT00975195|271615|P2|STARTED|Overall Study||1244
117656|NCT00975195|271616|P1|STARTED|Overall Study||1244
117657|NCT00975156|271676|P2|NOT COMPLETED|Overall Study||1
117658|NCT00975156|271677|P1|NOT COMPLETED|Overall Study||0
117659|NCT00975156|271676|P2|COMPLETED|Overall Study||9
117660|NCT00975156|271677|P1|COMPLETED|Overall Study||11
117661|NCT00975156|271676|P2|STARTED|Overall Study||10
117662|NCT00975156|271677|P1|STARTED|Overall Study||11
117663|NCT00975143|271689|P2|NOT COMPLETED|Overall Study||60
117664|NCT00975143|271690|P1|NOT COMPLETED|Overall Study||70
117665|NCT00975143|271689|P2|COMPLETED|Overall Study||401
117666|NCT00975143|271690|P1|COMPLETED|Overall Study||394
117667|NCT00975143|271689|P2|Completed Treatment (Week 20)|Overall Study||410
117668|NCT00975143|271690|P1|Completed Treatment (Week 20)|Overall Study||403
117669|NCT00975143|271689|P2|STARTED|Overall Study||461
117670|NCT00975143|271690|P1|STARTED|Overall Study||464
117671|NCT00975130|271700|P3|NOT COMPLETED|Study Part 2||17
117672|NCT00975130|271701|P2|NOT COMPLETED|Study Part 2||38
117673|NCT00975130|271702|P1|NOT COMPLETED|Study Part 2||0
117674|NCT00975130|271700|P3|COMPLETED|Study Part 2||238
117675|NCT00975130|271701|P2|COMPLETED|Study Part 2||212
117676|NCT00975130|271702|P1|COMPLETED|Study Part 2||0
117677|NCT00975130|271700|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
117678|NCT00975130|271701|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
117679|NCT00975130|271702|P1|STARTED|Study Part 2||0
117680|NCT00975130|271700|P3|NOT COMPLETED|Study Part 1||0
117681|NCT00975130|271701|P2|NOT COMPLETED|Study Part 1||0
117682|NCT00975130|271702|P1|NOT COMPLETED|Study Part 1||280
117683|NCT00975130|271700|P3|COMPLETED|Study Part 1||0
117684|NCT00975130|271701|P2|COMPLETED|Study Part 1||0
117685|NCT00975130|271702|P1|COMPLETED|Study Part 1||3086
117686|NCT00975130|271700|P3|STARTED|Study Part 1||0
117687|NCT00975130|271701|P2|STARTED|Study Part 1||0
117688|NCT00975130|271702|P1|STARTED|Study Part 1||3366
117689|NCT00975000|271886|P2|NOT COMPLETED|Overall Study||5
117690|NCT00975000|271887|P1|NOT COMPLETED|Overall Study||5
117691|NCT00975000|271886|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
117692|NCT00975000|271887|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
117693|NCT00975000|271886|P2|Completed Maintenance Phase|Overall Study||52
117694|NCT00975000|271887|P1|Completed Maintenance Phase|Overall Study||52
117695|NCT00975000|271886|P2|Completed Efficacy Assessment Phase|Overall Study||54
117696|NCT00975000|271887|P1|Completed Efficacy Assessment Phase|Overall Study||54
117697|NCT00975000|271886|P2|Completed Titration Phase|Overall Study||55
117698|NCT00975000|271887|P1|Completed Titration Phase|Overall Study||54
117699|NCT00975000|271886|P2|STARTED|Overall Study||57
117700|NCT00975000|271887|P1|STARTED|Overall Study||57
117701|NCT00974974|271911|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
117702|NCT00974974|271912|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
117703|NCT00974974|271911|P2|COMPLETED|Maintenance - Double Blind Treatment||182
117704|NCT00974974|271912|P1|COMPLETED|Maintenance - Double Blind Treatment||186
117705|NCT00974974|271911|P2|STARTED|Maintenance - Double Blind Treatment||192
117706|NCT00974974|271912|P1|STARTED|Maintenance - Double Blind Treatment||201
117707|NCT00974974|271911|P2|NOT COMPLETED|IPX066 Dose Conversion||0
117708|NCT00974974|271912|P1|NOT COMPLETED|IPX066 Dose Conversion||57
117709|NCT00974974|271911|P2|COMPLETED|IPX066 Dose Conversion||0
117710|NCT00974974|271912|P1|COMPLETED|IPX066 Dose Conversion||393
117711|NCT00974974|271911|P2|STARTED|IPX066 Dose Conversion||0
117712|NCT00974974|271912|P1|STARTED|IPX066 Dose Conversion||450
117713|NCT00974974|271911|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
117714|NCT00974974|271912|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
117715|NCT00974974|271911|P2|COMPLETED|IR CD-LD Dose Adjustment||450
117716|NCT00974974|271912|P1|COMPLETED|IR CD-LD Dose Adjustment||0
117717|NCT00974974|271911|P2|STARTED|IR CD-LD Dose Adjustment||471
117718|NCT00974974|271912|P1|STARTED|IR CD-LD Dose Adjustment||0
117719|NCT00974818|271924|P2|NOT COMPLETED|Overall Study||0
117720|NCT00974818|271925|P1|NOT COMPLETED|Overall Study||0
117721|NCT00974818|271924|P2|COMPLETED|Overall Study||25
117722|NCT00974818|271925|P1|COMPLETED|Overall Study||25
117723|NCT00974818|271924|P2|STARTED|Overall Study||25
117724|NCT00974818|271925|P1|STARTED|Overall Study||25
117725|NCT00974571|271934|P3|NOT COMPLETED|Overall Study||83
117726|NCT00974571|271935|P2|NOT COMPLETED|Overall Study||16
117727|NCT00974571|271936|P1|NOT COMPLETED|Overall Study||68
117728|NCT00974571|271934|P3|COMPLETED|Overall Study||530
117729|NCT00974571|271935|P2|COMPLETED|Overall Study||106
117730|NCT00974571|271936|P1|COMPLETED|Overall Study||562
117731|NCT00974571|271934|P3|STARTED|Overall Study||613
117732|NCT00974571|271935|P2|STARTED|Overall Study||122
117733|NCT00974571|271936|P1|STARTED|Overall Study||630
117734|NCT00974480|271959|P3|NOT COMPLETED|Overall Study||10
117735|NCT00974480|271960|P2|NOT COMPLETED|Overall Study||7
117736|NCT00974480|271961|P1|NOT COMPLETED|Overall Study||11
117737|NCT00974480|271959|P3|COMPLETED|Overall Study||30
117738|NCT00974480|271960|P2|COMPLETED|Overall Study||33
117739|NCT00974480|271961|P1|COMPLETED|Overall Study||29
117740|NCT00974480|271959|P3|STARTED|Overall Study||40
117741|NCT00974480|271960|P2|STARTED|Overall Study||40
117742|NCT00974480|271961|P1|STARTED|Overall Study||40
117743|NCT00974311|272001|P2|NOT COMPLETED|Overall Study||236
117744|NCT00974311|272002|P1|NOT COMPLETED|Overall Study||546
117745|NCT00974311|272001|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
117746|NCT00974311|272002|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
117747|NCT00974311|272001|P2|STARTED|Overall Study||399
117748|NCT00974311|272002|P1|STARTED|Overall Study||800
117749|NCT00974246|272022|P1|NOT COMPLETED|Overall Study||0
117750|NCT00974246|272022|P1|COMPLETED|Overall Study||27
117751|NCT00974246|272022|P1|STARTED|Overall Study||27
117752|NCT00974220|272030|P2|NOT COMPLETED|Treatment Period 2||0
117753|NCT00974220|272031|P1|NOT COMPLETED|Treatment Period 2||0
117754|NCT00974220|272030|P2|COMPLETED|Treatment Period 2||5
117755|NCT00974220|272031|P1|COMPLETED|Treatment Period 2||7
117756|NCT00974220|272030|P2|STARTED|Treatment Period 2||5
117757|NCT00974220|272031|P1|STARTED|Treatment Period 2||7
117758|NCT00974220|272030|P2|NOT COMPLETED|Treatment Period 1||2
117759|NCT00974220|272031|P1|NOT COMPLETED|Treatment Period 1||2
117760|NCT00974220|272030|P2|COMPLETED|Treatment Period 1||5
117761|NCT00974220|272031|P1|COMPLETED|Treatment Period 1||7
117762|NCT00974220|272030|P2|STARTED|Treatment Period 1||7
117763|NCT00974220|272031|P1|STARTED|Treatment Period 1||9
117764|NCT00974090|272041|P2|NOT COMPLETED|Period 2: Open-label Period||10
117765|NCT00974090|272042|P1|NOT COMPLETED|Period 2: Open-label Period||8
117766|NCT00974090|272041|P2|COMPLETED|Period 2: Open-label Period||85
117767|NCT00974090|272042|P1|COMPLETED|Period 2: Open-label Period||87
117768|NCT00974090|272041|P2|STARTED|Period 2: Open-label Period||95
117769|NCT00974090|272042|P1|STARTED|Period 2: Open-label Period||95
117770|NCT00974090|272041|P2|NOT COMPLETED|Period 1: Double Blind Period||1
117771|NCT00974090|272042|P1|NOT COMPLETED|Period 1: Double Blind Period||3
117772|NCT00974090|272041|P2|COMPLETED|Period 1: Double Blind Period||95
117773|NCT00974090|272042|P1|COMPLETED|Period 1: Double Blind Period||95
117774|NCT00974090|272041|P2|STARTED|Period 1: Double Blind Period||96
117775|NCT00974090|272042|P1|STARTED|Period 1: Double Blind Period||98
117776|NCT00974051|272056|P3|NOT COMPLETED|Overall Study||0
117777|NCT00974051|272057|P2|NOT COMPLETED|Overall Study||0
117778|NCT00974051|272058|P1|NOT COMPLETED|Overall Study||0
117779|NCT00974051|272056|P3|COMPLETED|Overall Study||6
117780|NCT00974051|272057|P2|COMPLETED|Overall Study||4
117781|NCT00974051|272058|P1|COMPLETED|Overall Study||6
117782|NCT00974051|272056|P3|STARTED|Overall Study||6
117783|NCT00974051|272057|P2|STARTED|Overall Study||4
117784|NCT00974051|272058|P1|STARTED|Overall Study||6
117785|NCT00973921|272076|P1|NOT COMPLETED|Overall Study||9
117786|NCT00973921|272076|P1|COMPLETED|Overall Study||31
117787|NCT00973921|272076|P1|STARTED|Overall Study||40
117788|NCT00973765|272085|P2|NOT COMPLETED|Overall Study||14
117789|NCT00973765|272086|P1|NOT COMPLETED|Overall Study||8
117790|NCT00973765|272085|P2|COMPLETED|Overall Study|102|102
117791|NCT00973765|272086|P1|COMPLETED|Overall Study|88|88
117792|NCT00973765|272085|P2|STARTED|Overall Study|116|116
117793|NCT00973765|272086|P1|STARTED|Overall Study|96|96
117794|NCT00973739|272092|P1|NOT COMPLETED|Overall Study||4
117795|NCT00973739|272092|P1|COMPLETED|Overall Study||17
117796|NCT00973739|272092|P1|STARTED|Overall Study||21
117797|NCT00973700|272104|P5|NOT COMPLETED|Overall Study||10
117798|NCT00973700|272105|P4|NOT COMPLETED|Overall Study||18
117799|NCT00973700|272106|P3|NOT COMPLETED|Overall Study||10
117800|NCT00973700|272107|P2|NOT COMPLETED|Overall Study||2
117801|NCT00973700|272108|P1|NOT COMPLETED|Overall Study||7
117802|NCT00973700|272104|P5|COMPLETED|Overall Study||158
117803|NCT00973700|272105|P4|COMPLETED|Overall Study||318
117804|NCT00973700|272106|P3|COMPLETED|Overall Study||158
117805|NCT00973700|272107|P2|COMPLETED|Overall Study||54
117806|NCT00973700|272108|P1|COMPLETED|Overall Study||49
117807|NCT00973700|272104|P5|STARTED|Overall Study||168
117808|NCT00973700|272105|P4|STARTED|Overall Study||336
117809|NCT00973700|272106|P3|STARTED|Overall Study||168
117810|NCT00973700|272107|P2|STARTED|Overall Study||56
117811|NCT00973700|272108|P1|STARTED|Overall Study||56
117812|NCT00973622|272157|P2|NOT COMPLETED|Overall Study||5
117813|NCT00973622|272158|P1|NOT COMPLETED|Overall Study||31
117814|NCT00973622|272157|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
117815|NCT00973622|272158|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
117816|NCT00973622|272157|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
117817|NCT00973622|272158|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
117818|NCT00973479|272166|P2|NOT COMPLETED|Overall Study||69
117819|NCT00973479|272167|P1|NOT COMPLETED|Overall Study||37
117820|NCT00973479|272166|P2|COMPLETED|Overall Study||326
117821|NCT00973479|272167|P1|COMPLETED|Overall Study||160
117822|NCT00973479|272166|P2|STARTED|Overall Study||395
117823|NCT00973479|272167|P1|STARTED|Overall Study||197
117824|NCT00973362|272185|P2|NOT COMPLETED|3-Year Follow-up||0
117825|NCT00973362|272186|P1|NOT COMPLETED|3-Year Follow-up||17
117826|NCT00973362|272185|P2|COMPLETED|3-Year Follow-up||0
117827|NCT00973362|272186|P1|COMPLETED|3-Year Follow-up||10854
117828|NCT00973362|272185|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
117829|NCT00973362|272186|P1|STARTED|3-Year Follow-up||10871
117830|NCT00973362|272185|P2|NOT COMPLETED|Baseline Evaluation||223
117831|NCT00973362|272186|P1|NOT COMPLETED|Baseline Evaluation||773
117832|NCT00973362|272185|P2|COMPLETED|Baseline Evaluation||1029
117833|NCT00973362|272186|P1|COMPLETED|Baseline Evaluation||10871
117834|NCT00973362|272185|P2|Conclusive Disease Status|Baseline Evaluation||939
117835|NCT00973362|272186|P1|Conclusive Disease Status|Baseline Evaluation||819
117836|NCT00973362|272185|P2|Evaluable for Analysis|Baseline Evaluation||958
117837|NCT00973362|272186|P1|Evaluable for Analysis|Baseline Evaluation||10871
117838|NCT00973362|272185|P2|STARTED|Baseline Evaluation||1252
117839|NCT00973362|272186|P1|STARTED|Baseline Evaluation||11644
117840|NCT00973349|272211|P16|NOT COMPLETED|Overall Study||2
117841|NCT00973349|272212|P15|NOT COMPLETED|Overall Study||2
117842|NCT00973349|272213|P14|NOT COMPLETED|Overall Study||0
117843|NCT00973349|272214|P13|NOT COMPLETED|Overall Study||1
117844|NCT00973349|272215|P12|NOT COMPLETED|Overall Study||2
117845|NCT00973349|272216|P11|NOT COMPLETED|Overall Study||0
117846|NCT00973349|272217|P10|NOT COMPLETED|Overall Study||6
117847|NCT00973349|272218|P9|NOT COMPLETED|Overall Study||4
117848|NCT00973349|272219|P8|NOT COMPLETED|Overall Study||3
117849|NCT00973349|272220|P7|NOT COMPLETED|Overall Study||2
117850|NCT00973349|272221|P6|NOT COMPLETED|Overall Study||4
117851|NCT00973349|272222|P5|NOT COMPLETED|Overall Study||5
117852|NCT00973349|272223|P4|NOT COMPLETED|Overall Study||5
117853|NCT00973349|272224|P3|NOT COMPLETED|Overall Study||5
117854|NCT00973349|272225|P2|NOT COMPLETED|Overall Study||3
117855|NCT00973349|272226|P1|NOT COMPLETED|Overall Study||4
117856|NCT00973349|272211|P16|COMPLETED|Overall Study||165
117857|NCT00973349|272212|P15|COMPLETED|Overall Study||168
117858|NCT00973349|272213|P14|COMPLETED|Overall Study||171
117859|NCT00973349|272214|P13|COMPLETED|Overall Study||168
117860|NCT00973349|272215|P12|COMPLETED|Overall Study||167
117861|NCT00973349|272216|P11|COMPLETED|Overall Study||174
117862|NCT00973349|272217|P10|COMPLETED|Overall Study||163
117863|NCT00973349|272218|P9|COMPLETED|Overall Study||167
117864|NCT00973349|272219|P8|COMPLETED|Overall Study||166
117865|NCT00973349|272220|P7|COMPLETED|Overall Study||172
117866|NCT00973349|272221|P6|COMPLETED|Overall Study||165
117867|NCT00973349|272222|P5|COMPLETED|Overall Study||165
117868|NCT00973349|272223|P4|COMPLETED|Overall Study||163
117869|NCT00973349|272224|P3|COMPLETED|Overall Study||166
117870|NCT00973349|272225|P2|COMPLETED|Overall Study||165
117871|NCT00973349|272226|P1|COMPLETED|Overall Study||166
117872|NCT00973349|272211|P16|STARTED|Overall Study||167
117873|NCT00973349|272212|P15|STARTED|Overall Study||170
117874|NCT00973349|272213|P14|STARTED|Overall Study||171
117875|NCT00973349|272214|P13|STARTED|Overall Study||169
117876|NCT00973349|272215|P12|STARTED|Overall Study||169
117877|NCT00973349|272216|P11|STARTED|Overall Study||174
117878|NCT00973349|272217|P10|STARTED|Overall Study||169
117879|NCT00973349|272218|P9|STARTED|Overall Study||171
117880|NCT00973349|272219|P8|STARTED|Overall Study||169
117881|NCT00973349|272220|P7|STARTED|Overall Study||174
117882|NCT00973349|272221|P6|STARTED|Overall Study||169
117883|NCT00973349|272222|P5|STARTED|Overall Study||170
117884|NCT00973349|272223|P4|STARTED|Overall Study||168
117885|NCT00973349|272224|P3|STARTED|Overall Study||171
117886|NCT00973349|272225|P2|STARTED|Overall Study||168
117887|NCT00973349|272226|P1|STARTED|Overall Study||170
117888|NCT00972959|272324|P1|NOT COMPLETED|Overall Study||0
117889|NCT00972959|272324|P1|COMPLETED|Overall Study||17
117890|NCT00972959|272324|P1|STARTED|Overall Study||17
117891|NCT00972816|272347|P8|NOT COMPLETED|Overall Study||9
117892|NCT00972816|272348|P7|NOT COMPLETED|Overall Study||10
117893|NCT00972816|272349|P6|NOT COMPLETED|Overall Study||11
117894|NCT00972816|272350|P5|NOT COMPLETED|Overall Study||12
117895|NCT00972816|272351|P4|NOT COMPLETED|Overall Study||8
117896|NCT00972816|272352|P3|NOT COMPLETED|Overall Study||9
117897|NCT00972816|272353|P2|NOT COMPLETED|Overall Study||11
117898|NCT00972816|272354|P1|NOT COMPLETED|Overall Study||17
117899|NCT00972816|272347|P8|COMPLETED|Overall Study||161
117900|NCT00972816|272348|P7|COMPLETED|Overall Study||159
117901|NCT00972816|272349|P6|COMPLETED|Overall Study||158
117902|NCT00972816|272350|P5|COMPLETED|Overall Study||157
117903|NCT00972816|272351|P4|COMPLETED|Overall Study||161
117904|NCT00972816|272352|P3|COMPLETED|Overall Study||160
117905|NCT00972816|272353|P2|COMPLETED|Overall Study||158
117906|NCT00972816|272354|P1|COMPLETED|Overall Study||156
117907|NCT00972816|272347|P8|STARTED|Overall Study||170
117908|NCT00972816|272348|P7|STARTED|Overall Study||169
117909|NCT00972816|272349|P6|STARTED|Overall Study||169
117910|NCT00972816|272350|P5|STARTED|Overall Study||169
117911|NCT00972816|272351|P4|STARTED|Overall Study||169
117912|NCT00972816|272352|P3|STARTED|Overall Study||169
117913|NCT00972816|272353|P2|STARTED|Overall Study||169
117914|NCT00972816|272354|P1|STARTED|Overall Study||173
117915|NCT00972777|272438|P2|NOT COMPLETED|Overall Study||14
117916|NCT00972777|272439|P1|NOT COMPLETED|Overall Study||14
117917|NCT00972777|272438|P2|COMPLETED|Overall Study||229
117918|NCT00972777|272439|P1|COMPLETED|Overall Study||217
117919|NCT00972777|272438|P2|STARTED|Overall Study||243
117920|NCT00972777|272439|P1|STARTED|Overall Study||231
117921|NCT00972738|272454|P3|NOT COMPLETED|Overall Study||29
117922|NCT00972738|272455|P2|NOT COMPLETED|Overall Study||6
117923|NCT00972738|272456|P1|NOT COMPLETED|Overall Study||21
117924|NCT00972738|272454|P3|COMPLETED|Overall Study||492
117925|NCT00972738|272455|P2|COMPLETED|Overall Study||165
117926|NCT00972738|272456|P1|COMPLETED|Overall Study||501
117927|NCT00972738|272454|P3|STARTED|Overall Study||521
117928|NCT00972738|272455|P2|STARTED|Overall Study||171
117929|NCT00972738|272456|P1|STARTED|Overall Study||522
117930|NCT00972621|272481|P2|NOT COMPLETED|Overall Study||1
117931|NCT00972621|272482|P1|NOT COMPLETED|Overall Study||0
117932|NCT00972621|272481|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
117933|NCT00972621|272482|P1|COMPLETED|Overall Study||200
117934|NCT00972621|272481|P2|STARTED|Overall Study||200
117935|NCT00972621|272482|P1|STARTED|Overall Study||200
117936|NCT00972595|272490|P2|NOT COMPLETED|Period 2||0
117937|NCT00972595|272491|P1|NOT COMPLETED|Period 2||0
117938|NCT00972595|272490|P2|COMPLETED|Period 2||22
117939|NCT00972595|272491|P1|COMPLETED|Period 2||22
117940|NCT00972595|272490|P2|STARTED|Period 2||22
117941|NCT00972595|272491|P1|STARTED|Period 2||22
117942|NCT00972595|272490|P2|NOT COMPLETED|Period 1||0
117943|NCT00972595|272491|P1|NOT COMPLETED|Period 1||1
117944|NCT00972595|272490|P2|COMPLETED|Period 1||22
117945|NCT00972595|272491|P1|COMPLETED|Period 1||22
117946|NCT00972595|272490|P2|STARTED|Period 1||22
117947|NCT00972595|272491|P1|STARTED|Period 1||23
117948|NCT00972543|272501|P2|NOT COMPLETED|Overall Study||1
117949|NCT00972543|272502|P1|NOT COMPLETED|Overall Study||5
117950|NCT00972543|272501|P2|COMPLETED|Overall Study||0
117951|NCT00972543|272502|P1|COMPLETED|Overall Study||0
117952|NCT00972543|272501|P2|STARTED|Overall Study||1
117953|NCT00972543|272502|P1|STARTED|Overall Study||5
117954|NCT00972530|272578|P2|NOT COMPLETED|Overall Study||0
117955|NCT00972530|272579|P1|NOT COMPLETED|Overall Study||0
117956|NCT00972530|272578|P2|COMPLETED|Overall Study||46
117957|NCT00972530|272579|P1|COMPLETED|Overall Study||44
117958|NCT00972530|272578|P2|STARTED|Overall Study||46
117959|NCT00972530|272579|P1|STARTED|Overall Study||44
117960|NCT00972478|272587|P2|NOT COMPLETED|Overall Study||38
117961|NCT00972478|272588|P1|NOT COMPLETED|Overall Study||7
117962|NCT00972478|272587|P2|COMPLETED|Overall Study||34
117963|NCT00972478|272588|P1|COMPLETED|Overall Study||4
117964|NCT00972478|272587|P2|Eligible and Began Protocol Therapy|Overall Study||63
117965|NCT00972478|272588|P1|Eligible and Began Protocol Therapy|Overall Study||9
117966|NCT00972478|272587|P2|STARTED|Overall Study||72
117967|NCT00972478|272588|P1|STARTED|Overall Study||11
117968|NCT00972374|272601|P3|NOT COMPLETED|Overall Study||1
117969|NCT00972374|272602|P2|NOT COMPLETED|Overall Study||0
117970|NCT00972374|272603|P1|NOT COMPLETED|Overall Study||2
117971|NCT00972374|272601|P3|COMPLETED|Overall Study||13
117972|NCT00972374|272602|P2|COMPLETED|Overall Study||15
117973|NCT00972374|272603|P1|COMPLETED|Overall Study||13
117974|NCT00972374|272601|P3|STARTED|Overall Study||14
117975|NCT00972374|272602|P2|STARTED|Overall Study||15
117976|NCT00972374|272603|P1|STARTED|Overall Study||15
117977|NCT00972335|272617|P1|NOT COMPLETED|Overall Study||17
117978|NCT00972335|272617|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
117979|NCT00972335|272617|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
117980|NCT00972322|272624|P2|NOT COMPLETED|Overall Study||3
117981|NCT00972322|272625|P1|NOT COMPLETED|Overall Study||3
117982|NCT00972322|272624|P2|COMPLETED|Overall Study||25
117983|NCT00972322|272625|P1|COMPLETED|Overall Study||25
117984|NCT00972322|272624|P2|STARTED|Overall Study||28
117985|NCT00972322|272625|P1|STARTED|Overall Study||28
117986|NCT00972283|272637|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
118077|NCT00971633|272775|P3|COMPLETED|Period 2||2
117987|NCT00972283|272638|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
117988|NCT00972283|272637|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
117989|NCT00972283|272638|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
117990|NCT00972283|272637|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
117991|NCT00972283|272638|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
117992|NCT00972283|272637|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
117993|NCT00972283|272638|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
117994|NCT00972283|272637|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
117995|NCT00972283|272638|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
117996|NCT00972283|272637|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
117997|NCT00972283|272638|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
117998|NCT00972283|272637|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
117999|NCT00972283|272638|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
118000|NCT00972283|272637|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
118001|NCT00972283|272638|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
118002|NCT00972244|272665|P5|NOT COMPLETED|Overall Study||9
118003|NCT00972244|272666|P4|NOT COMPLETED|Overall Study||0
118004|NCT00972244|272667|P3|NOT COMPLETED|Overall Study||2
118005|NCT00972244|272668|P2|NOT COMPLETED|Overall Study||5
118006|NCT00972244|272669|P1|NOT COMPLETED|Overall Study||5
118007|NCT00972244|272665|P5|COMPLETED|Overall Study||45
118008|NCT00972244|272666|P4|COMPLETED|Overall Study||52
118009|NCT00972244|272667|P3|COMPLETED|Overall Study||56
118010|NCT00972244|272668|P2|COMPLETED|Overall Study||51
118011|NCT00972244|272669|P1|COMPLETED|Overall Study||54
118012|NCT00972244|272665|P5|STARTED|Overall Study||54
118013|NCT00972244|272666|P4|STARTED|Overall Study||52
118014|NCT00972244|272667|P3|STARTED|Overall Study||58
118015|NCT00972244|272668|P2|STARTED|Overall Study||56
118016|NCT00972244|272669|P1|STARTED|Overall Study||59
118017|NCT00972205|272691|P1|NOT COMPLETED|Overall Study||0
118018|NCT00972205|272691|P1|COMPLETED|Overall Study||12
118019|NCT00972205|272691|P1|STARTED|Overall Study||12
118020|NCT00972153|272701|P3|NOT COMPLETED|Overall Study||0
118021|NCT00972153|272702|P2|NOT COMPLETED|Overall Study||1
118022|NCT00972153|272703|P1|NOT COMPLETED|Overall Study||0
118023|NCT00972153|272701|P3|COMPLETED|Overall Study||12
118024|NCT00972153|272702|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
118025|NCT00972153|272703|P1|COMPLETED|Overall Study||12
118026|NCT00972153|272701|P3|STARTED|Overall Study||12
118027|NCT00972153|272702|P2|STARTED|Overall Study||12
118028|NCT00972153|272703|P1|STARTED|Overall Study||12
118029|NCT00972088|272714|P1|NOT COMPLETED|Overall Study||0
118030|NCT00972088|272714|P1|COMPLETED|Overall Study||26
118031|NCT00972088|272714|P1|STARTED|Overall Study||26
118032|NCT00972023|272718|P1|NOT COMPLETED|Overall Study||1
118033|NCT00972023|272718|P1|COMPLETED|Overall Study||0
118034|NCT00972023|272718|P1|STARTED|Overall Study||1
118035|NCT00971997|272725|P1|NOT COMPLETED|Overall Study||19
118036|NCT00971997|272725|P1|COMPLETED|Overall Study||116
118037|NCT00971997|272725|P1|STARTED|Overall Study||135
118038|NCT00971932|272743|P1|NOT COMPLETED|Overall Study||7
118039|NCT00971932|272743|P1|COMPLETED|Overall Study||26
118040|NCT00971932|272743|P1|STARTED|Overall Study|Number of participants treated.|33
118041|NCT00971841|272753|P1|NOT COMPLETED|Overall Study||0
118042|NCT00971841|272753|P1|COMPLETED|Overall Study||1
118043|NCT00971841|272753|P1|STARTED|Overall Study||1
118044|NCT00971789|272758|P1|NOT COMPLETED|Overall Study||0
118045|NCT00971789|272758|P1|COMPLETED|Overall Study||18
118046|NCT00971789|272758|P1|STARTED|Overall Study||18
118047|NCT00971750|272763|P1|NOT COMPLETED|Overall Study||0
118048|NCT00971750|272763|P1|COMPLETED|Overall Study||253
118049|NCT00971750|272763|P1|STARTED|Overall Study||253
118050|NCT00971633|272772|P6|NOT COMPLETED|Period 3||0
118051|NCT00971633|272773|P5|NOT COMPLETED|Period 3||0
118052|NCT00971633|272774|P4|NOT COMPLETED|Period 3||0
118053|NCT00971633|272775|P3|NOT COMPLETED|Period 3||0
118054|NCT00971633|272776|P2|NOT COMPLETED|Period 3||0
118055|NCT00971633|272777|P1|NOT COMPLETED|Period 3||0
118056|NCT00971633|272772|P6|COMPLETED|Period 3||2
118057|NCT00971633|272773|P5|COMPLETED|Period 3||2
118058|NCT00971633|272774|P4|COMPLETED|Period 3||2
118059|NCT00971633|272775|P3|COMPLETED|Period 3||2
118060|NCT00971633|272776|P2|COMPLETED|Period 3||2
118061|NCT00971633|272777|P1|COMPLETED|Period 3||2
118062|NCT00971633|272772|P6|STARTED|Period 3||2
118063|NCT00971633|272773|P5|STARTED|Period 3||2
118064|NCT00971633|272774|P4|STARTED|Period 3||2
118065|NCT00971633|272775|P3|STARTED|Period 3||2
118066|NCT00971633|272776|P2|STARTED|Period 3||2
118067|NCT00971633|272777|P1|STARTED|Period 3||2
118068|NCT00971633|272772|P6|NOT COMPLETED|Period 2||0
118069|NCT00971633|272773|P5|NOT COMPLETED|Period 2||0
118070|NCT00971633|272774|P4|NOT COMPLETED|Period 2||0
118071|NCT00971633|272775|P3|NOT COMPLETED|Period 2||0
118072|NCT00971633|272776|P2|NOT COMPLETED|Period 2||0
118073|NCT00971633|272777|P1|NOT COMPLETED|Period 2||0
118074|NCT00971633|272772|P6|COMPLETED|Period 2||2
118075|NCT00971633|272773|P5|COMPLETED|Period 2||2
118076|NCT00971633|272774|P4|COMPLETED|Period 2||2
118078|NCT00971633|272776|P2|COMPLETED|Period 2||2
118079|NCT00971633|272777|P1|COMPLETED|Period 2||2
118080|NCT00971633|272772|P6|STARTED|Period 2||2
118081|NCT00971633|272773|P5|STARTED|Period 2||2
118082|NCT00971633|272774|P4|STARTED|Period 2||2
118083|NCT00971633|272775|P3|STARTED|Period 2||2
118084|NCT00971633|272776|P2|STARTED|Period 2||2
118085|NCT00971633|272777|P1|STARTED|Period 2||2
118086|NCT00971633|272772|P6|NOT COMPLETED|Period 1||0
118087|NCT00971633|272773|P5|NOT COMPLETED|Period 1||0
118088|NCT00971633|272774|P4|NOT COMPLETED|Period 1||0
118089|NCT00971633|272775|P3|NOT COMPLETED|Period 1||0
118090|NCT00971633|272776|P2|NOT COMPLETED|Period 1||0
118091|NCT00971633|272777|P1|NOT COMPLETED|Period 1||0
118092|NCT00971633|272772|P6|COMPLETED|Period 1||2
118093|NCT00971633|272773|P5|COMPLETED|Period 1||2
118094|NCT00971633|272774|P4|COMPLETED|Period 1||2
118095|NCT00971633|272775|P3|COMPLETED|Period 1||2
118096|NCT00971633|272776|P2|COMPLETED|Period 1||2
118097|NCT00971633|272777|P1|COMPLETED|Period 1||2
118098|NCT00971633|272772|P6|STARTED|Period 1||2
118099|NCT00971633|272773|P5|STARTED|Period 1||2
118100|NCT00971633|272774|P4|STARTED|Period 1||2
118101|NCT00971633|272775|P3|STARTED|Period 1||2
118102|NCT00971633|272776|P2|STARTED|Period 1||2
118103|NCT00971633|272777|P1|STARTED|Period 1||2
118104|NCT00971620|272790|P2|NOT COMPLETED|Overall Study||1
118105|NCT00971620|272791|P1|NOT COMPLETED|Overall Study||1
118106|NCT00971620|272790|P2|COMPLETED|Overall Study||8
118107|NCT00971620|272791|P1|COMPLETED|Overall Study||8
118108|NCT00971620|272790|P2|STARTED|Overall Study||9
118109|NCT00971620|272791|P1|STARTED|Overall Study||9
118110|NCT00971425|272801|P2|NOT COMPLETED|Overall Study||2
118111|NCT00971425|272802|P1|NOT COMPLETED|Overall Study||1
118112|NCT00971425|272801|P2|COMPLETED|Overall Study||71
118113|NCT00971425|272802|P1|COMPLETED|Overall Study||71
118114|NCT00971425|272801|P2|STARTED|Overall Study||73
118115|NCT00971425|272802|P1|STARTED|Overall Study||72
118116|NCT00971295|272836|P2|NOT COMPLETED|Overall Study||1
118117|NCT00971295|272837|P1|NOT COMPLETED|Overall Study||0
118118|NCT00971295|272836|P2|COMPLETED|Overall Study||9
118119|NCT00971295|272837|P1|COMPLETED|Overall Study||10
118120|NCT00971295|272836|P2|STARTED|Overall Study||10
118121|NCT00971295|272837|P1|STARTED|Overall Study||10
118122|NCT00971282|272847|P1|NOT COMPLETED|Overall Study||0
118123|NCT00971282|272847|P1|COMPLETED|Overall Study||30
118124|NCT00971282|272847|P1|STARTED|Overall Study||30
118125|NCT00971243|272866|P5|NOT COMPLETED|Open-label Period||6
118126|NCT00971243|272867|P4|NOT COMPLETED|Open-label Period||10
118127|NCT00971243|272868|P3|NOT COMPLETED|Open-label Period||5
118128|NCT00971243|272869|P2|NOT COMPLETED|Open-label Period||10
118129|NCT00971243|272870|P1|NOT COMPLETED|Open-label Period||8
118130|NCT00971243|272866|P5|COMPLETED|Open-label Period||64
118131|NCT00971243|272867|P4|COMPLETED|Open-label Period||64
118132|NCT00971243|272868|P3|COMPLETED|Open-label Period||66
118133|NCT00971243|272869|P2|COMPLETED|Open-label Period||71
118134|NCT00971243|272870|P1|COMPLETED|Open-label Period||60
118135|NCT00971243|272866|P5|STARTED|Open-label Period||70
118136|NCT00971243|272867|P4|STARTED|Open-label Period||74
118137|NCT00971243|272868|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
118138|NCT00971243|272869|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
118139|NCT00971243|272870|P1|STARTED|Open-label Period||68
118140|NCT00971243|272866|P5|NOT COMPLETED|Double Blind Period||18
118141|NCT00971243|272867|P4|NOT COMPLETED|Double Blind Period||14
118142|NCT00971243|272868|P3|NOT COMPLETED|Double Blind Period||19
118143|NCT00971243|272869|P2|NOT COMPLETED|Double Blind Period||11
118144|NCT00971243|272870|P1|NOT COMPLETED|Double Blind Period||19
118145|NCT00971243|272866|P5|COMPLETED|Double Blind Period||70
118146|NCT00971243|272867|P4|COMPLETED|Double Blind Period||74
118147|NCT00971243|272868|P3|COMPLETED|Double Blind Period||72
118148|NCT00971243|272869|P2|COMPLETED|Double Blind Period||82
118149|NCT00971243|272870|P1|COMPLETED|Double Blind Period||68
118150|NCT00971243|272866|P5|STARTED|Double Blind Period||88
118151|NCT00971243|272867|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
118152|NCT00971243|272868|P3|STARTED|Double Blind Period||91
118153|NCT00971243|272869|P2|STARTED|Double Blind Period||93
118154|NCT00971243|272870|P1|STARTED|Double Blind Period||87
118155|NCT00971204|272887|P1|NOT COMPLETED|Overall Study||24
118156|NCT00971204|272887|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
118157|NCT00971204|272887|P1|Treated|Overall Study||86
118158|NCT00971204|272887|P1|STARTED|Overall Study|100 enrolled participants|100
118159|NCT00971048|272895|P4|NOT COMPLETED|Overall Study||2
118160|NCT00971048|272896|P3|NOT COMPLETED|Overall Study||1
118161|NCT00971048|272897|P2|NOT COMPLETED|Overall Study||2
118162|NCT00971048|272898|P1|NOT COMPLETED|Overall Study||1
118163|NCT00971048|272895|P4|COMPLETED|Overall Study||11
118164|NCT00971048|272896|P3|COMPLETED|Overall Study||11
118165|NCT00971048|272897|P2|COMPLETED|Overall Study||31
118166|NCT00971048|272898|P1|COMPLETED|Overall Study||29
118167|NCT00971048|272895|P4|STARTED|Overall Study||13
118168|NCT00971048|272896|P3|STARTED|Overall Study||12
118169|NCT00971048|272897|P2|STARTED|Overall Study||33
118170|NCT00971048|272898|P1|STARTED|Overall Study||30
118171|NCT00970944|272922|P2|NOT COMPLETED|Overall Study||2
118172|NCT00970944|272923|P1|NOT COMPLETED|Overall Study||1
118173|NCT00970944|272922|P2|COMPLETED|Overall Study||95
118174|NCT00970944|272923|P1|COMPLETED|Overall Study||86
118175|NCT00970944|272922|P2|STARTED|Overall Study||97
118176|NCT00970944|272923|P1|STARTED|Overall Study||87
118177|NCT00970853|272933|P2|NOT COMPLETED|Overall Study||0
118178|NCT00970853|272934|P1|NOT COMPLETED|Overall Study||0
118179|NCT00970853|272933|P2|COMPLETED|Overall Study||98
118180|NCT00970853|272934|P1|COMPLETED|Overall Study||89
118181|NCT00970853|272933|P2|STARTED|Overall Study||98
118182|NCT00970853|272934|P1|STARTED|Overall Study||89
118183|NCT00970814|272958|P2|NOT COMPLETED|Overall Study||14
118184|NCT00970814|272959|P1|NOT COMPLETED|Overall Study||8
118185|NCT00970814|272958|P2|COMPLETED|Overall Study||50
118186|NCT00970814|272959|P1|COMPLETED|Overall Study||58
118187|NCT00970814|272958|P2|STARTED|Overall Study||64
118188|NCT00970814|272959|P1|STARTED|Overall Study||66
118189|NCT00970736|272969|P1|NOT COMPLETED|Overall Study||2
118190|NCT00970736|272969|P1|COMPLETED|Overall Study||18
118191|NCT00970736|272969|P1|STARTED|Overall Study||20
118192|NCT00970684|272975|P1|NOT COMPLETED|Overall Study||10
118193|NCT00970684|272975|P1|COMPLETED|Overall Study||3
118194|NCT00970684|272975|P1|STARTED|Overall Study||13
118195|NCT00970632|272984|P3|NOT COMPLETED|Overall Study||18
118196|NCT00970632|272985|P2|NOT COMPLETED|Overall Study||15
118197|NCT00970632|272986|P1|NOT COMPLETED|Overall Study||24
118198|NCT00970632|272984|P3|COMPLETED|Overall Study||150
118199|NCT00970632|272985|P2|COMPLETED|Overall Study||156
118200|NCT00970632|272986|P1|COMPLETED|Overall Study||148
118201|NCT00970632|272984|P3|STARTED|Overall Study||168
118202|NCT00970632|272985|P2|STARTED|Overall Study||171
118203|NCT00970632|272986|P1|STARTED|Overall Study||172
118204|NCT00970606|273044|P2|NOT COMPLETED|Overall Study||0
118205|NCT00970606|273045|P1|NOT COMPLETED|Overall Study||0
118206|NCT00970606|273044|P2|COMPLETED|Overall Study||3
118207|NCT00970606|273045|P1|COMPLETED|Overall Study||4
118208|NCT00970606|273044|P2|STARTED|Overall Study||3
118209|NCT00970606|273045|P1|STARTED|Overall Study||4
118210|NCT00970320|273056|P5|NOT COMPLETED|Overall Study||540
118211|NCT00970320|273057|P4|NOT COMPLETED|Overall Study||14
118212|NCT00970320|273058|P3|NOT COMPLETED|Overall Study||13
118213|NCT00970320|273059|P2|NOT COMPLETED|Overall Study||11
118214|NCT00970320|273060|P1|NOT COMPLETED|Overall Study||0
118215|NCT00970320|273056|P5|COMPLETED|Overall Study||1031
118216|NCT00970320|273057|P4|COMPLETED|Overall Study||36
118217|NCT00970320|273058|P3|COMPLETED|Overall Study||35
118218|NCT00970320|273059|P2|COMPLETED|Overall Study||13
118219|NCT00970320|273060|P1|COMPLETED|Overall Study||25
118220|NCT00970320|273056|P5|STARTED|Overall Study||1571
118221|NCT00970320|273057|P4|STARTED|Overall Study||50
118222|NCT00970320|273058|P3|STARTED|Overall Study||48
118223|NCT00970320|273059|P2|STARTED|Overall Study||24
118224|NCT00970320|273060|P1|STARTED|Overall Study||25
118225|NCT00970294|273072|P1|NOT COMPLETED|Overall Study||5
118226|NCT00970294|273072|P1|COMPLETED|Overall Study||6
118227|NCT00970294|273072|P1|STARTED|Overall Study||11
118228|NCT00970281|273080|P2|NOT COMPLETED|Overall Study||16
118229|NCT00970281|273081|P1|NOT COMPLETED|Overall Study||2
118230|NCT00970281|273080|P2|COMPLETED|Overall Study||29
118231|NCT00970281|273081|P1|COMPLETED|Overall Study||44
118232|NCT00970281|273080|P2|Full Analysis Set|Overall Study||45
118233|NCT00970281|273081|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
118234|NCT00970281|273080|P2|STARTED|Overall Study||45
118235|NCT00970281|273081|P1|STARTED|Overall Study||46
118236|NCT00970268|273099|P2|NOT COMPLETED|Overall Study||49
118237|NCT00970268|273100|P1|NOT COMPLETED|Overall Study||43
118238|NCT00970268|273099|P2|COMPLETED|Overall Study||103
118239|NCT00970268|273100|P1|COMPLETED|Overall Study||96
118240|NCT00970268|273099|P2|STARTED|Overall Study||152
118241|NCT00970268|273100|P1|STARTED|Overall Study||139
118242|NCT00970216|273114|P1|NOT COMPLETED|Overall Study||80
118243|NCT00970216|273114|P1|COMPLETED|Overall Study||80
118244|NCT00970216|273114|P1|STARTED|Overall Study||160
118245|NCT00969878|273120|P2|NOT COMPLETED|Overall Study||26
118246|NCT00969878|273121|P1|NOT COMPLETED|Overall Study||30
118247|NCT00969878|273120|P2|COMPLETED|Overall Study||126
118248|NCT00969878|273121|P1|COMPLETED|Overall Study||118
118249|NCT00969878|273120|P2|STARTED|Overall Study||152
118250|NCT00969878|273121|P1|STARTED|Overall Study||148
118251|NCT00969709|273133|P4|NOT COMPLETED|Overall Study||63
118252|NCT00969709|273134|P3|NOT COMPLETED|Overall Study||58
118253|NCT00969709|273135|P2|NOT COMPLETED|Overall Study||48
118254|NCT00969709|273136|P1|NOT COMPLETED|Overall Study||38
118255|NCT00969709|273133|P4|COMPLETED|Overall Study||117
118256|NCT00969709|273134|P3|COMPLETED|Overall Study||121
118257|NCT00969709|273135|P2|COMPLETED|Overall Study||130
118258|NCT00969709|273136|P1|COMPLETED|Overall Study||138
118259|NCT00969709|273133|P4|STARTED|Overall Study||180
118260|NCT00969709|273134|P3|STARTED|Overall Study||179
118261|NCT00969709|273135|P2|STARTED|Overall Study||178
118262|NCT00969709|273136|P1|STARTED|Overall Study||176
118263|NCT00969618|273150|P1|NOT COMPLETED|Overall Study||78
118264|NCT00969618|273150|P1|COMPLETED|Overall Study||133
118265|NCT00969618|273150|P1|STARTED|Overall Study||211
118266|NCT00969540|273163|P2|NOT COMPLETED|Overall Study||1
118267|NCT00969540|273164|P1|NOT COMPLETED|Overall Study||1
118268|NCT00969540|273163|P2|COMPLETED|Overall Study||3
118269|NCT00969540|273164|P1|COMPLETED|Overall Study||3
118270|NCT00969540|273163|P2|STARTED|Overall Study||4
118271|NCT00969540|273164|P1|STARTED|Overall Study||4
118272|NCT00969501|273182|P1|NOT COMPLETED|Overall Study||5
118273|NCT00969501|273182|P1|COMPLETED|Overall Study||27
118274|NCT00969501|273182|P1|STARTED|Overall Study||32
118275|NCT00969280|273188|P2|NOT COMPLETED|Overall Study||3
118276|NCT00969280|273189|P1|NOT COMPLETED|Overall Study||2
118277|NCT00969280|273188|P2|COMPLETED|Overall Study||18
118278|NCT00969280|273189|P1|COMPLETED|Overall Study||19
118279|NCT00969280|273188|P2|STARTED|Overall Study||21
118280|NCT00969280|273189|P1|STARTED|Overall Study||21
118281|NCT00969228|273197|P2|NOT COMPLETED|Overall Study||14
118282|NCT00969228|273198|P1|NOT COMPLETED|Overall Study||43
118283|NCT00969228|273197|P2|COMPLETED|Overall Study||162
118284|NCT00969228|273198|P1|COMPLETED|Overall Study||465
118285|NCT00969228|273197|P2|STARTED|Overall Study||176
118286|NCT00969228|273198|P1|STARTED|Overall Study||508
118287|NCT00969150|273216|P2|NOT COMPLETED|Overall Study||40
118288|NCT00969150|273217|P1|NOT COMPLETED|Overall Study||33
118289|NCT00969150|273216|P2|COMPLETED|Overall Study||135
118290|NCT00969150|273217|P1|COMPLETED|Overall Study||149
118291|NCT00969150|273216|P2|STARTED|Overall Study||175
118292|NCT00969150|273217|P1|STARTED|Overall Study||182
118293|NCT00968981|273228|P3|NOT COMPLETED|Overall Study||22
118294|NCT00968981|273229|P2|NOT COMPLETED|Overall Study||22
118295|NCT00968981|273230|P1|NOT COMPLETED|Overall Study||22
118296|NCT00968981|273228|P3|COMPLETED|Overall Study||0
118297|NCT00968981|273229|P2|COMPLETED|Overall Study||0
118298|NCT00968981|273230|P1|COMPLETED|Overall Study||1
118299|NCT00968981|273228|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
118300|NCT00968981|273229|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
118301|NCT00968981|273230|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
118302|NCT00968981|273228|P3|STARTED|Overall Study||22
118303|NCT00968981|273229|P2|STARTED|Overall Study||22
118304|NCT00968981|273230|P1|STARTED|Overall Study||23
118305|NCT00968890|273268|P2|NOT COMPLETED|Overall Study||0
118306|NCT00968890|273269|P1|NOT COMPLETED|Overall Study||0
118307|NCT00968890|273268|P2|COMPLETED|Overall Study||84
118308|NCT00968890|273269|P1|COMPLETED|Overall Study||84
118309|NCT00968890|273268|P2|STARTED|Overall Study||84
118310|NCT00968890|273269|P1|STARTED|Overall Study||84
118311|NCT00968838|273299|P2|NOT COMPLETED|Overall Study||0
118312|NCT00968838|273300|P1|NOT COMPLETED|Overall Study||0
118313|NCT00968838|273299|P2|COMPLETED|Overall Study||58
118314|NCT00968838|273300|P1|COMPLETED|Overall Study||50
118315|NCT00968838|273299|P2|STARTED|Overall Study||58
118316|NCT00968838|273300|P1|STARTED|Overall Study||50
118317|NCT00968812|273309|P3|NOT COMPLETED|Overall Study||168
118318|NCT00968812|273310|P2|NOT COMPLETED|Overall Study||162
118319|NCT00968812|273311|P1|NOT COMPLETED|Overall Study||140
118320|NCT00968812|273309|P3|COMPLETED|Overall Study||314
118321|NCT00968812|273310|P2|COMPLETED|Overall Study||323
118322|NCT00968812|273311|P1|COMPLETED|Overall Study||343
118323|NCT00968812|273309|P3|STARTED|Overall Study||482
118324|NCT00968812|273310|P2|STARTED|Overall Study||485
118325|NCT00968812|273311|P1|STARTED|Overall Study||483
118326|NCT00968799|273331|P1|NOT COMPLETED|Overall Study||2
118327|NCT00968799|273331|P1|COMPLETED|Overall Study||4
118328|NCT00968799|273331|P1|STARTED|Overall Study||6
118329|NCT00968708|273341|P2|NOT COMPLETED|Overall Study||298
118330|NCT00968708|273342|P1|NOT COMPLETED|Overall Study||318
118331|NCT00968708|273341|P2|COMPLETED|Overall Study||2403
118332|NCT00968708|273342|P1|COMPLETED|Overall Study||2361
118333|NCT00968708|273341|P2|Treated|Overall Study||2698
118334|NCT00968708|273342|P1|Treated|Overall Study||2676
118335|NCT00968708|273341|P2|STARTED|Overall Study||2701
118336|NCT00968708|273342|P1|STARTED|Overall Study||2679
118337|NCT00968669|273354|P4|NOT COMPLETED|Overall Study||9
118338|NCT00968669|273355|P3|NOT COMPLETED|Overall Study||11
118339|NCT00968669|273356|P2|NOT COMPLETED|Overall Study||18
118340|NCT00968669|273357|P1|NOT COMPLETED|Overall Study||18
118341|NCT00968669|273354|P4|COMPLETED|Overall Study||72
118342|NCT00968669|273355|P3|COMPLETED|Overall Study||72
118343|NCT00968669|273356|P2|COMPLETED|Overall Study||63
118344|NCT00968669|273357|P1|COMPLETED|Overall Study||64
118345|NCT00968669|273354|P4|STARTED|Overall Study||81
118346|NCT00968669|273355|P3|STARTED|Overall Study||83
118347|NCT00968669|273356|P2|STARTED|Overall Study||81
118348|NCT00968669|273357|P1|STARTED|Overall Study||82
118349|NCT00968617|273447|P1|NOT COMPLETED|Overall Study||6
118350|NCT00968617|273447|P1|COMPLETED|Overall Study||1
118351|NCT00968617|273447|P1|STARTED|Overall Study||7
118352|NCT00968201|273461|P3|NOT COMPLETED|Extension Study - (Period III)||280
118353|NCT00968201|273462|P2|NOT COMPLETED|Extension Study - (Period III)||124
118354|NCT00968201|273463|P1|NOT COMPLETED|Extension Study - (Period III)||0
118355|NCT00968201|273461|P3|COMPLETED|Extension Study - (Period III)||84
118356|NCT00968201|273462|P2|COMPLETED|Extension Study - (Period III)||33
118357|NCT00968201|273463|P1|COMPLETED|Extension Study - (Period III)||0
118358|NCT00968201|273461|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
118359|NCT00968201|273462|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
118360|NCT00968201|273463|P1|STARTED|Extension Study - (Period III)||0
118361|NCT00968201|273461|P3|NOT COMPLETED|Base Study - (Period II)||45
118362|NCT00968201|273462|P2|NOT COMPLETED|Base Study - (Period II)||0
118363|NCT00968201|273463|P1|NOT COMPLETED|Base Study - (Period II)||26
118364|NCT00968201|273461|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
118365|NCT00968201|273462|P2|COMPLETED|Base Study - (Period II)||0
118366|NCT00968201|273463|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
118367|NCT00968201|273461|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
118368|NCT00968201|273462|P2|STARTED|Base Study - (Period II)||0
118369|NCT00968201|273463|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
118370|NCT00968149|273524|P2|NOT COMPLETED|Overall Study||6
118371|NCT00968149|273525|P1|NOT COMPLETED|Overall Study||11
118372|NCT00968149|273524|P2|COMPLETED|Overall Study||127
118373|NCT00968149|273525|P1|COMPLETED|Overall Study||269
118374|NCT00968149|273524|P2|STARTED|Overall Study||133
118375|NCT00968149|273525|P1|STARTED|Overall Study||280
118376|NCT00968071|273545|P1|NOT COMPLETED|Overall Study||0
118377|NCT00968071|273545|P1|COMPLETED|Overall Study||71
118378|NCT00968071|273545|P1|STARTED|Overall Study||71
118379|NCT00968032|273549|P1|NOT COMPLETED|Overall Study||2
118380|NCT00968032|273549|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
118381|NCT00968032|273549|P1|STARTED|Overall Study||63
118382|NCT00968019|273553|P1|NOT COMPLETED|Overall Study||15
118383|NCT00968019|273553|P1|COMPLETED|Overall Study||303
118384|NCT00968019|273553|P1|STARTED|Overall Study||318
118385|NCT00967993|273574|P1|NOT COMPLETED|Overall Study||4
118386|NCT00967993|273574|P1|COMPLETED|Overall Study||18
118387|NCT00967993|273574|P1|STARTED|Overall Study||22
118388|NCT00967694|273578|P1|NOT COMPLETED|Overall Study||6
118389|NCT00967694|273578|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
118390|NCT00967694|273578|P1|STARTED|Overall Study||26
118391|NCT00967668|273585|P3|NOT COMPLETED|Overall Study||69
118392|NCT00967668|273586|P2|NOT COMPLETED|Overall Study||56
118393|NCT00967668|273587|P1|NOT COMPLETED|Overall Study||71
118394|NCT00967668|273585|P3|COMPLETED|Overall Study||90
118395|NCT00967668|273586|P2|COMPLETED|Overall Study||104
118396|NCT00967668|273587|P1|COMPLETED|Overall Study||91
118397|NCT00967668|273585|P3|18-mo Assessment|Overall Study||92
118398|NCT00967668|273586|P2|18-mo Assessment|Overall Study||102
118399|NCT00967668|273587|P1|18-mo Assessment|Overall Study||95
118400|NCT00967668|273585|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
118401|NCT00967668|273586|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
118402|NCT00967668|273587|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
118403|NCT00967668|273585|P3|3-mo Assessment|Overall Study||115
118404|NCT00967668|273586|P2|3-mo Assessment|Overall Study||127
118405|NCT00967668|273587|P1|3-mo Assessment|Overall Study||131
118406|NCT00967668|273585|P3|STARTED|Overall Study||159
118407|NCT00967668|273586|P2|STARTED|Overall Study||160
118408|NCT00967668|273587|P1|STARTED|Overall Study||162
118409|NCT00967551|273600|P2|NOT COMPLETED|Overall Study||0
118410|NCT00967551|273601|P1|NOT COMPLETED|Overall Study||0
118411|NCT00967551|273600|P2|COMPLETED|Overall Study||75
118412|NCT00967551|273601|P1|COMPLETED|Overall Study||68
118413|NCT00967551|273600|P2|STARTED|Overall Study||75
118414|NCT00967551|273601|P1|STARTED|Overall Study||68
118415|NCT00967486|273611|P2|NOT COMPLETED|Overall Study||0
118416|NCT00967486|273612|P1|NOT COMPLETED|Overall Study||0
118417|NCT00967486|273611|P2|COMPLETED|Overall Study||102
118418|NCT00967486|273612|P1|COMPLETED|Overall Study||98
118419|NCT00967486|273611|P2|STARTED|Overall Study||102
118420|NCT00967486|273612|P1|STARTED|Overall Study||98
118421|NCT00967473|273618|P1|NOT COMPLETED|Overall Study||0
118422|NCT00967473|273618|P1|COMPLETED|Overall Study||15
118423|NCT00967473|273618|P1|STARTED|Overall Study||15
118424|NCT00967447|273624|P1|NOT COMPLETED|Overall Study||0
118425|NCT00967447|273624|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
118426|NCT00967447|273624|P1|STARTED|Overall Study|there are no collected data in CRF|2
118427|NCT00967330|273633|P2|NOT COMPLETED|Overall Study||60
118428|NCT00967330|273634|P1|NOT COMPLETED|Overall Study||122
118429|NCT00967330|273633|P2|COMPLETED|Overall Study||0
118430|NCT00967330|273634|P1|COMPLETED|Overall Study||0
118431|NCT00967330|273633|P2|STARTED|Overall Study||60
118432|NCT00967330|273634|P1|STARTED|Overall Study||122
118433|NCT00967226|273664|P2|NOT COMPLETED|Overall Study||6
118434|NCT00967226|273665|P1|NOT COMPLETED|Overall Study||2
118435|NCT00967226|273664|P2|COMPLETED|Overall Study||2
118436|NCT00967226|273665|P1|COMPLETED|Overall Study||9
118437|NCT00967226|273664|P2|STARTED|Overall Study||8
118438|NCT00967226|273665|P1|STARTED|Overall Study||11
118439|NCT00967044|273695|P1|NOT COMPLETED|Overall Study||0
118440|NCT00967044|273695|P1|COMPLETED|Overall Study||30
118441|NCT00967044|273695|P1|STARTED|Overall Study||30
118442|NCT00967018|273699|P1|NOT COMPLETED|Overall Study||21
118443|NCT00967018|273699|P1|COMPLETED|Overall Study||56
118444|NCT00967018|273699|P1|STARTED|Overall Study||77
118445|NCT00966992|273708|P2|NOT COMPLETED|Overall Study||0
118446|NCT00966992|273709|P1|NOT COMPLETED|Overall Study||0
118447|NCT00966992|273708|P2|COMPLETED|Overall Study||0
118448|NCT00966992|273709|P1|COMPLETED|Overall Study||3
118449|NCT00966992|273708|P2|STARTED|Overall Study||0
118450|NCT00966992|273709|P1|STARTED|Overall Study||3
118451|NCT00966953|273729|P4|NOT COMPLETED|4th Intervention Order||0
118452|NCT00966953|273730|P3|NOT COMPLETED|4th Intervention Order||0
118453|NCT00966953|273731|P2|NOT COMPLETED|4th Intervention Order||0
118454|NCT00966953|273732|P1|NOT COMPLETED|4th Intervention Order||0
118455|NCT00966953|273729|P4|COMPLETED|4th Intervention Order||7
118456|NCT00966953|273730|P3|COMPLETED|4th Intervention Order||6
118457|NCT00966953|273731|P2|COMPLETED|4th Intervention Order||6
118458|NCT00966953|273732|P1|COMPLETED|4th Intervention Order||6
118459|NCT00966953|273729|P4|STARTED|4th Intervention Order||7
118460|NCT00966953|273730|P3|STARTED|4th Intervention Order||6
118461|NCT00966953|273731|P2|STARTED|4th Intervention Order||6
118462|NCT00966953|273732|P1|STARTED|4th Intervention Order||6
118463|NCT00966953|273729|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
118464|NCT00966953|273730|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
118465|NCT00966953|273731|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
118466|NCT00966953|273732|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
118467|NCT00966953|273729|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
118468|NCT00966953|273730|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
118469|NCT00966953|273731|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
118470|NCT00966953|273732|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
118471|NCT00966953|273729|P4|STARTED|1 Week Washout After 3rd Intervention||7
118472|NCT00966953|273730|P3|STARTED|1 Week Washout After 3rd Intervention||6
118473|NCT00966953|273731|P2|STARTED|1 Week Washout After 3rd Intervention||6
118474|NCT00966953|273732|P1|STARTED|1 Week Washout After 3rd Intervention||6
118475|NCT00966953|273729|P4|NOT COMPLETED|3rd Intervention Order||0
118476|NCT00966953|273730|P3|NOT COMPLETED|3rd Intervention Order||0
118477|NCT00966953|273731|P2|NOT COMPLETED|3rd Intervention Order||0
118478|NCT00966953|273732|P1|NOT COMPLETED|3rd Intervention Order||0
118479|NCT00966953|273729|P4|COMPLETED|3rd Intervention Order||7
118480|NCT00966953|273730|P3|COMPLETED|3rd Intervention Order||6
118481|NCT00966953|273731|P2|COMPLETED|3rd Intervention Order||6
118482|NCT00966953|273732|P1|COMPLETED|3rd Intervention Order||6
118483|NCT00966953|273729|P4|STARTED|3rd Intervention Order||7
118484|NCT00966953|273730|P3|STARTED|3rd Intervention Order||6
118485|NCT00966953|273731|P2|STARTED|3rd Intervention Order||6
118486|NCT00966953|273732|P1|STARTED|3rd Intervention Order||6
118487|NCT00966953|273729|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
118488|NCT00966953|273730|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
118489|NCT00966953|273731|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
118490|NCT00966953|273732|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
118491|NCT00966953|273729|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
118492|NCT00966953|273730|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
118493|NCT00966953|273731|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
118494|NCT00966953|273732|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
118495|NCT00966953|273729|P4|STARTED|1 Week Washout After 2nd Intervention||7
118496|NCT00966953|273730|P3|STARTED|1 Week Washout After 2nd Intervention||6
118497|NCT00966953|273731|P2|STARTED|1 Week Washout After 2nd Intervention||6
118498|NCT00966953|273732|P1|STARTED|1 Week Washout After 2nd Intervention||6
118499|NCT00966953|273729|P4|NOT COMPLETED|2nd Intervention||0
118500|NCT00966953|273730|P3|NOT COMPLETED|2nd Intervention||0
118501|NCT00966953|273731|P2|NOT COMPLETED|2nd Intervention||0
118502|NCT00966953|273732|P1|NOT COMPLETED|2nd Intervention||0
118503|NCT00966953|273729|P4|COMPLETED|2nd Intervention||7
118504|NCT00966953|273730|P3|COMPLETED|2nd Intervention||6
118505|NCT00966953|273731|P2|COMPLETED|2nd Intervention||6
118506|NCT00966953|273732|P1|COMPLETED|2nd Intervention||6
118507|NCT00966953|273729|P4|STARTED|2nd Intervention||7
118508|NCT00966953|273730|P3|STARTED|2nd Intervention||6
118509|NCT00966953|273731|P2|STARTED|2nd Intervention||6
118510|NCT00966953|273732|P1|STARTED|2nd Intervention||6
118511|NCT00966953|273729|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
118512|NCT00966953|273730|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
118513|NCT00966953|273731|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
118514|NCT00966953|273732|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
118515|NCT00966953|273729|P4|COMPLETED|1 Week Washout After 1st Intervention||7
118516|NCT00966953|273730|P3|COMPLETED|1 Week Washout After 1st Intervention||6
118517|NCT00966953|273731|P2|COMPLETED|1 Week Washout After 1st Intervention||6
118518|NCT00966953|273732|P1|COMPLETED|1 Week Washout After 1st Intervention||6
118519|NCT00966953|273729|P4|STARTED|1 Week Washout After 1st Intervention||7
118520|NCT00966953|273730|P3|STARTED|1 Week Washout After 1st Intervention||6
118521|NCT00966953|273731|P2|STARTED|1 Week Washout After 1st Intervention||6
118522|NCT00966953|273732|P1|STARTED|1 Week Washout After 1st Intervention||6
118523|NCT00966953|273729|P4|NOT COMPLETED|1st Intervention||0
118524|NCT00966953|273730|P3|NOT COMPLETED|1st Intervention||0
118525|NCT00966953|273731|P2|NOT COMPLETED|1st Intervention||0
118526|NCT00966953|273732|P1|NOT COMPLETED|1st Intervention||0
118527|NCT00966953|273729|P4|COMPLETED|1st Intervention||7
118528|NCT00966953|273730|P3|COMPLETED|1st Intervention||6
118529|NCT00966953|273731|P2|COMPLETED|1st Intervention||6
118530|NCT00966953|273732|P1|COMPLETED|1st Intervention||6
118531|NCT00966953|273729|P4|STARTED|1st Intervention||7
118532|NCT00966953|273730|P3|STARTED|1st Intervention||6
118533|NCT00966953|273731|P2|STARTED|1st Intervention||6
118534|NCT00966953|273732|P1|STARTED|1st Intervention||6
118535|NCT00966940|273740|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
118536|NCT00966940|273741|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
118537|NCT00966940|273740|P2|COMPLETED|Period 2, Second 6 Weeks||23
118538|NCT00966940|273741|P1|COMPLETED|Period 2, Second 6 Weeks||25
118539|NCT00966940|273740|P2|STARTED|Period 2, Second 6 Weeks||23
118540|NCT00966940|273741|P1|STARTED|Period 2, Second 6 Weeks||25
118541|NCT00966940|273740|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
118542|NCT00966940|273741|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
118543|NCT00966940|273740|P2|COMPLETED|Period 1, First 6 Weeks||23
118544|NCT00966940|273741|P1|COMPLETED|Period 1, First 6 Weeks||25
118545|NCT00966940|273740|P2|STARTED|Period 1, First 6 Weeks||23
118546|NCT00966940|273741|P1|STARTED|Period 1, First 6 Weeks||28
118547|NCT00966875|273768|P9|NOT COMPLETED|Part B||18
118548|NCT00966875|273769|P8|NOT COMPLETED|Part B||19
118549|NCT00966875|273770|P7|NOT COMPLETED|Part B||22
118550|NCT00966875|273771|P6|NOT COMPLETED|Part B||6
118551|NCT00966875|273772|P5|NOT COMPLETED|Part B||7
118552|NCT00966875|273773|P4|NOT COMPLETED|Part B||3
118553|NCT00966875|273774|P3|NOT COMPLETED|Part B||6
118554|NCT00966875|273775|P2|NOT COMPLETED|Part B||3
118555|NCT00966875|273776|P1|NOT COMPLETED|Part B||5
118556|NCT00966875|273768|P9|COMPLETED|Part B||32
118557|NCT00966875|273769|P8|COMPLETED|Part B||38
118558|NCT00966875|273770|P7|COMPLETED|Part B||29
118559|NCT00966875|273771|P6|COMPLETED|Part B||26
118560|NCT00966875|273772|P5|COMPLETED|Part B||44
118561|NCT00966875|273773|P4|COMPLETED|Part B||31
118562|NCT00966875|273774|P3|COMPLETED|Part B||27
118563|NCT00966875|273775|P2|COMPLETED|Part B||33
118564|NCT00966875|273776|P1|COMPLETED|Part B||41
118565|NCT00966875|273768|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
118566|NCT00966875|273769|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
118567|NCT00966875|273770|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
118568|NCT00966875|273771|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
118569|NCT00966875|273772|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
118570|NCT00966875|273773|P4|STARTED|Part B||34
118571|NCT00966875|273774|P3|STARTED|Part B||33
118572|NCT00966875|273775|P2|STARTED|Part B||36
118573|NCT00966875|273776|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
118574|NCT00966875|273768|P9|NOT COMPLETED|Part A||8
118575|NCT00966875|273769|P8|NOT COMPLETED|Part A||7
118576|NCT00966875|273770|P7|NOT COMPLETED|Part A||12
118577|NCT00966875|273771|P6|NOT COMPLETED|Part A||4
118578|NCT00966875|273772|P5|NOT COMPLETED|Part A||5
118579|NCT00966875|273773|P4|NOT COMPLETED|Part A||3
118580|NCT00966875|273774|P3|NOT COMPLETED|Part A||2
118581|NCT00966875|273775|P2|NOT COMPLETED|Part A||4
118582|NCT00966875|273776|P1|NOT COMPLETED|Part A||6
118583|NCT00966875|273768|P9|COMPLETED|Part A||51
118584|NCT00966875|273769|P8|COMPLETED|Part A||58
118585|NCT00966875|273770|P7|COMPLETED|Part A||52
118586|NCT00966875|273771|P6|COMPLETED|Part A||33
118587|NCT00966875|273772|P5|COMPLETED|Part A||52
118588|NCT00966875|273773|P4|COMPLETED|Part A||34
118589|NCT00966875|273774|P3|COMPLETED|Part A||33
118590|NCT00966875|273775|P2|COMPLETED|Part A||36
118591|NCT00966875|273776|P1|COMPLETED|Part A||48
118592|NCT00966875|273768|P9|Received ≥1 Doses of Study Drug|Part A||59
118593|NCT00966875|273769|P8|Received ≥1 Doses of Study Drug|Part A||65
118594|NCT00966875|273770|P7|Received ≥1 Doses of Study Drug|Part A||64
118595|NCT00966875|273771|P6|Received ≥1 Doses of Study Drug|Part A||37
118596|NCT00966875|273772|P5|Received ≥1 Doses of Study Drug|Part A||57
118597|NCT00966875|273773|P4|Received ≥1 Doses of Study Drug|Part A||37
118598|NCT00966875|273774|P3|Received ≥1 Doses of Study Drug|Part A||35
118599|NCT00966875|273775|P2|Received ≥1 Doses of Study Drug|Part A||40
118600|NCT00966875|273776|P1|Received ≥1 Doses of Study Drug|Part A||54
118601|NCT00966875|273768|P9|STARTED|Part A||59
118602|NCT00966875|273769|P8|STARTED|Part A||65
118603|NCT00966875|273770|P7|STARTED|Part A||64
118604|NCT00966875|273771|P6|STARTED|Part A||37
118605|NCT00966875|273772|P5|STARTED|Part A||57
118606|NCT00966875|273773|P4|STARTED|Part A||37
118607|NCT00966875|273774|P3|STARTED|Part A||35
118608|NCT00966875|273775|P2|STARTED|Part A||40
118609|NCT00966875|273776|P1|STARTED|Part A||54
118610|NCT00966641|274095|P2|NOT COMPLETED|Second Intervention||0
118611|NCT00966641|274096|P1|NOT COMPLETED|Second Intervention||0
118612|NCT00966641|274095|P2|COMPLETED|Second Intervention||17
118613|NCT00966641|274096|P1|COMPLETED|Second Intervention||17
118614|NCT00966641|274095|P2|STARTED|Second Intervention||17
118615|NCT00966641|274096|P1|STARTED|Second Intervention||17
118616|NCT00966641|274095|P2|NOT COMPLETED|First Intervention||0
118617|NCT00966641|274096|P1|NOT COMPLETED|First Intervention||0
118618|NCT00966641|274095|P2|COMPLETED|First Intervention||17
118619|NCT00966641|274096|P1|COMPLETED|First Intervention||17
118620|NCT00966641|274095|P2|STARTED|First Intervention||17
118621|NCT00966641|274096|P1|STARTED|First Intervention||17
118622|NCT00966550|274104|P2|NOT COMPLETED|Overall Study||0
118623|NCT00966550|274105|P1|NOT COMPLETED|Overall Study||0
118624|NCT00966550|274104|P2|COMPLETED|Overall Study||12
118625|NCT00966550|274105|P1|COMPLETED|Overall Study||13
118626|NCT00966550|274104|P2|STARTED|Overall Study||12
118627|NCT00966550|274105|P1|STARTED|Overall Study||13
118628|NCT00966446|274114|P3|NOT COMPLETED|Overall Study||21
118629|NCT00966446|274115|P2|NOT COMPLETED|Overall Study||25
118630|NCT00966446|274116|P1|NOT COMPLETED|Overall Study||28
118631|NCT00966446|274114|P3|COMPLETED|Overall Study||52
118632|NCT00966446|274115|P2|COMPLETED|Overall Study||49
118633|NCT00966446|274116|P1|COMPLETED|Overall Study||48
118634|NCT00966446|274114|P3|STARTED|Overall Study||73
118635|NCT00966446|274115|P2|STARTED|Overall Study||74
118636|NCT00966446|274116|P1|STARTED|Overall Study||76
118637|NCT00966277|274132|P2|NOT COMPLETED|Overall Study||4
118638|NCT00966277|274133|P1|NOT COMPLETED|Overall Study||4
118639|NCT00966277|274132|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
118640|NCT00966277|274133|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
118641|NCT00966277|274132|P2|STARTED|Overall Study||37
118642|NCT00966277|274133|P1|STARTED|Overall Study||38
118643|NCT00966264|274141|P2|NOT COMPLETED|Overall Study||3
118644|NCT00966264|274142|P1|NOT COMPLETED|Overall Study||4
118645|NCT00966264|274141|P2|COMPLETED|Overall Study|5 years results|114
118646|NCT00966264|274142|P1|COMPLETED|Overall Study|5 years results|115
118647|NCT00966264|274141|P2|STARTED|Overall Study||117
118648|NCT00966264|274142|P1|STARTED|Overall Study||119
118649|NCT00966238|274154|P6|NOT COMPLETED|Overall Study||0
118650|NCT00966238|274155|P5|NOT COMPLETED|Overall Study||0
118651|NCT00966238|274156|P4|NOT COMPLETED|Overall Study||0
118652|NCT00966238|274157|P3|NOT COMPLETED|Overall Study||0
118653|NCT00966238|274158|P2|NOT COMPLETED|Overall Study||0
118654|NCT00966238|274159|P1|NOT COMPLETED|Overall Study||0
118655|NCT00966238|274154|P6|COMPLETED|Overall Study||20
118656|NCT00966238|274155|P5|COMPLETED|Overall Study||20
118657|NCT00966238|274156|P4|COMPLETED|Overall Study||20
118658|NCT00966238|274157|P3|COMPLETED|Overall Study||20
118659|NCT00966238|274158|P2|COMPLETED|Overall Study||20
118660|NCT00966238|274159|P1|COMPLETED|Overall Study||20
118661|NCT00966238|274154|P6|STARTED|Overall Study||20
118662|NCT00966238|274155|P5|STARTED|Overall Study||20
118663|NCT00966238|274156|P4|STARTED|Overall Study||20
118664|NCT00966238|274157|P3|STARTED|Overall Study||20
118665|NCT00966238|274158|P2|STARTED|Overall Study||20
118666|NCT00966238|274159|P1|STARTED|Overall Study||20
118667|NCT00966186|274181|P2|NOT COMPLETED|Overall Study||0
118668|NCT00966186|274182|P1|NOT COMPLETED|Overall Study||0
118669|NCT00966186|274181|P2|COMPLETED|Overall Study||60
118670|NCT00966186|274182|P1|COMPLETED|Overall Study||60
118671|NCT00966186|274181|P2|STARTED|Overall Study||60
118672|NCT00966186|274182|P1|STARTED|Overall Study||60
118673|NCT00965848|274188|P3|NOT COMPLETED|Overall Study||10
118674|NCT00965848|274189|P2|NOT COMPLETED|Overall Study||2
118675|NCT00965848|274190|P1|NOT COMPLETED|Overall Study||29
118676|NCT00965848|274188|P3|COMPLETED|Overall Study||117
118677|NCT00965848|274189|P2|COMPLETED|Overall Study||32
118678|NCT00965848|274190|P1|COMPLETED|Overall Study||78
118679|NCT00965848|274188|P3|STARTED|Overall Study||127
118680|NCT00965848|274189|P2|STARTED|Overall Study||34
118681|NCT00965848|274190|P1|STARTED|Overall Study||107
118682|NCT00965757|274209|P4|NOT COMPLETED|Extension Phase||24
118683|NCT00965757|274210|P3|NOT COMPLETED|Extension Phase||33
118684|NCT00965757|274211|P2|NOT COMPLETED|Extension Phase||0
118685|NCT00965757|274212|P1|NOT COMPLETED|Extension Phase||0
118686|NCT00965757|274209|P4|COMPLETED|Extension Phase||64
118687|NCT00965757|274210|P3|COMPLETED|Extension Phase||132
118688|NCT00965757|274211|P2|COMPLETED|Extension Phase||0
118689|NCT00965757|274212|P1|COMPLETED|Extension Phase||0
118690|NCT00965757|274209|P4|STARTED|Extension Phase||88
118691|NCT00965757|274210|P3|STARTED|Extension Phase||165
118692|NCT00965757|274211|P2|STARTED|Extension Phase||0
118693|NCT00965757|274212|P1|STARTED|Extension Phase||0
118694|NCT00965757|274209|P4|NOT COMPLETED|Double-blind Phase||0
118695|NCT00965757|274210|P3|NOT COMPLETED|Double-blind Phase||0
118696|NCT00965757|274211|P2|NOT COMPLETED|Double-blind Phase||18
118697|NCT00965757|274212|P1|NOT COMPLETED|Double-blind Phase||17
118698|NCT00965757|274209|P4|COMPLETED|Double-blind Phase||0
118699|NCT00965757|274210|P3|COMPLETED|Double-blind Phase||0
118700|NCT00965757|274211|P2|COMPLETED|Double-blind Phase||70
118701|NCT00965757|274212|P1|COMPLETED|Double-blind Phase||148
118702|NCT00965757|274209|P4|STARTED|Double-blind Phase||0
118703|NCT00965757|274210|P3|STARTED|Double-blind Phase||0
118704|NCT00965757|274211|P2|STARTED|Double-blind Phase||88
118705|NCT00965757|274212|P1|STARTED|Double-blind Phase||165
118706|NCT00965731|274246|P2|NOT COMPLETED|Overall Study||20
118707|NCT00965731|274247|P1|NOT COMPLETED|Overall Study||7
118708|NCT00965731|274246|P2|COMPLETED|Overall Study||0
118709|NCT00965731|274247|P1|COMPLETED|Overall Study||0
118710|NCT00965731|274246|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
118711|NCT00965731|274247|P1|STARTED|Overall Study||7
118712|NCT00965718|274311|P1|NOT COMPLETED|Overall Study||4
118713|NCT00965718|274311|P1|COMPLETED|Overall Study||16
118714|NCT00965718|274311|P1|STARTED|Overall Study||20
118715|NCT00965562|274324|P3|NOT COMPLETED|Overall Study||3
118716|NCT00965562|274325|P2|NOT COMPLETED|Overall Study||4
118717|NCT00965562|274326|P1|NOT COMPLETED|Overall Study||3
118718|NCT00965562|274324|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
118719|NCT00965562|274325|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
118720|NCT00965562|274326|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
118721|NCT00965562|274324|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
118722|NCT00965562|274325|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
118723|NCT00965562|274326|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
118724|NCT00965562|274324|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
118725|NCT00965562|274325|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
118726|NCT00965562|274326|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
118727|NCT00965562|274324|P3|STARTED|Overall Study||16
118728|NCT00965562|274325|P2|STARTED|Overall Study||17
118729|NCT00965562|274326|P1|STARTED|Overall Study||16
118730|NCT00965523|274364|P1|NOT COMPLETED|Study 224||6
118731|NCT00965523|274364|P1|COMPLETED|Study 224||0
118732|NCT00965523|274364|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
118733|NCT00965523|274364|P1|NOT COMPLETED|Study 221||7
118734|NCT00965523|274364|P1|COMPLETED|Study 221||74
118735|NCT00965523|274364|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
118736|NCT00965497|274369|P1|NOT COMPLETED|Overall Study||1
118737|NCT00965497|274369|P1|COMPLETED|Overall Study||13
118738|NCT00965497|274369|P1|STARTED|Overall Study||14
118739|NCT00965484|274374|P1|NOT COMPLETED|Overall Study||2
118740|NCT00965484|274374|P1|COMPLETED|Overall Study||134
118741|NCT00965484|274374|P1|STARTED|Overall Study||136
118742|NCT00965458|274383|P2|NOT COMPLETED|Overall Study||4
118743|NCT00965458|274384|P1|NOT COMPLETED|Overall Study||2
118744|NCT00965458|274383|P2|COMPLETED|Overall Study||12
118745|NCT00965458|274384|P1|COMPLETED|Overall Study||31
118746|NCT00965458|274383|P2|STARTED|Overall Study||16
118747|NCT00965458|274384|P1|STARTED|Overall Study||33
118748|NCT00965341|274402|P2|NOT COMPLETED|Overall Study||8
118749|NCT00965341|274403|P1|NOT COMPLETED|Overall Study||6
118750|NCT00965341|274402|P2|COMPLETED|Overall Study||16
118751|NCT00965341|274403|P1|COMPLETED|Overall Study||13
118752|NCT00965341|274402|P2|STARTED|Overall Study||24
118753|NCT00965341|274403|P1|STARTED|Overall Study||19
118754|NCT00965250|274413|P2|NOT COMPLETED|Overall Study||0
118755|NCT00965250|274414|P1|NOT COMPLETED|Overall Study||0
118756|NCT00965250|274413|P2|COMPLETED|Overall Study||12
118757|NCT00965250|274414|P1|COMPLETED|Overall Study||37
118758|NCT00965250|274413|P2|STARTED|Overall Study||12
118759|NCT00965250|274414|P1|STARTED|Overall Study||37
118760|NCT00965237|274432|P2|NOT COMPLETED|Period 2, One Week of Wear||0
118761|NCT00965237|274433|P1|NOT COMPLETED|Period 2, One Week of Wear||0
118762|NCT00965237|274432|P2|COMPLETED|Period 2, One Week of Wear||8
118763|NCT00965237|274433|P1|COMPLETED|Period 2, One Week of Wear||8
118764|NCT00965237|274432|P2|STARTED|Period 2, One Week of Wear||8
118765|NCT00965237|274433|P1|STARTED|Period 2, One Week of Wear||8
118766|NCT00965237|274432|P2|NOT COMPLETED|Period 1, One Week of Wear||0
118767|NCT00965237|274433|P1|NOT COMPLETED|Period 1, One Week of Wear||0
118768|NCT00965237|274432|P2|COMPLETED|Period 1, One Week of Wear||8
118769|NCT00965237|274433|P1|COMPLETED|Period 1, One Week of Wear||8
118770|NCT00965237|274432|P2|STARTED|Period 1, One Week of Wear||8
118771|NCT00965237|274433|P1|STARTED|Period 1, One Week of Wear||8
118772|NCT00965185|274441|P2|NOT COMPLETED|Overall Study||1
118773|NCT00965185|274442|P1|NOT COMPLETED|Overall Study||2
118774|NCT00965185|274441|P2|COMPLETED|Overall Study||20
118775|NCT00965185|274442|P1|COMPLETED|Overall Study||17
118776|NCT00965185|274441|P2|9 Month Visit|Overall Study||21
118777|NCT00965185|274442|P1|9 Month Visit|Overall Study||18
118778|NCT00965185|274441|P2|6 Month Visit|Overall Study||21
118779|NCT00965185|274442|P1|6 Month Visit|Overall Study||18
118780|NCT00965185|274441|P2|3 Month Visit|Overall Study||21
118781|NCT00965185|274442|P1|3 Month Visit|Overall Study||18
118782|NCT00965185|274441|P2|1 Month Visit|Overall Study||21
118783|NCT00965185|274442|P1|1 Month Visit|Overall Study||18
118784|NCT00965185|274441|P2|STARTED|Overall Study||21
118785|NCT00965185|274442|P1|STARTED|Overall Study||19
118786|NCT00965146|274458|P1|NOT COMPLETED|Overall Study||210
118787|NCT00965146|274458|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
118788|NCT00965146|274458|P1|STARTED|Overall Study||210
118789|NCT00965094|274464|P2|NOT COMPLETED|Overall Study||1
118790|NCT00965094|274465|P1|NOT COMPLETED|Overall Study||5
118791|NCT00965094|274464|P2|COMPLETED|Overall Study||16
118792|NCT00965094|274465|P1|COMPLETED|Overall Study||14
118793|NCT00965094|274464|P2|STARTED|Overall Study||17
118794|NCT00965094|274465|P1|STARTED|Overall Study||19
118795|NCT00965081|274481|P2|NOT COMPLETED|Overall Study||43
118796|NCT00965081|274482|P1|NOT COMPLETED|Overall Study||34
118797|NCT00965081|274481|P2|COMPLETED|Overall Study||110
118798|NCT00965081|274482|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
118799|NCT00965081|274481|P2|STARTED|Overall Study||153
118800|NCT00965081|274482|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
118801|NCT00964886|274509|P4|NOT COMPLETED|Overall Study||9
118802|NCT00964886|274510|P3|NOT COMPLETED|Overall Study||16
118803|NCT00964886|274511|P2|NOT COMPLETED|Overall Study||7
118804|NCT00964886|274512|P1|NOT COMPLETED|Overall Study||11
118805|NCT00964886|274509|P4|COMPLETED|Overall Study||24
118806|NCT00964886|274510|P3|COMPLETED|Overall Study||21
118807|NCT00964886|274511|P2|COMPLETED|Overall Study||27
118808|NCT00964886|274512|P1|COMPLETED|Overall Study||27
118809|NCT00964886|274509|P4|STARTED|Overall Study||33
118810|NCT00964886|274510|P3|STARTED|Overall Study||37
118811|NCT00964886|274511|P2|STARTED|Overall Study||34
118812|NCT00964886|274512|P1|STARTED|Overall Study||38
118813|NCT00964860|274528|P2|NOT COMPLETED|Overall Study||1
118814|NCT00964860|274529|P1|NOT COMPLETED|Overall Study||0
118815|NCT00964860|274528|P2|COMPLETED|Overall Study||29
118816|NCT00964860|274529|P1|COMPLETED|Overall Study||30
118817|NCT00964860|274528|P2|STARTED|Overall Study||30
118818|NCT00964860|274529|P1|STARTED|Overall Study||30
118819|NCT00964795|274537|P1|NOT COMPLETED|Overall Study||307
118820|NCT00964795|274537|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
118821|NCT00964795|274537|P1|Number of Participants Treated|Overall Study||320
118822|NCT00964795|274537|P1|STARTED|Overall Study|randomized|323
118823|NCT00964743|274544|P1|NOT COMPLETED|Overall Study||2
118824|NCT00964743|274544|P1|COMPLETED|Overall Study||0
118825|NCT00964743|274544|P1|STARTED|Overall Study||2
118826|NCT00964548|274554|P2|NOT COMPLETED|Overall Study||0
118827|NCT00964548|274555|P1|NOT COMPLETED|Overall Study||0
118828|NCT00964548|274554|P2|COMPLETED|Overall Study||5
118829|NCT00964548|274555|P1|COMPLETED|Overall Study||5
118830|NCT00964548|274554|P2|STARTED|Overall Study||5
118831|NCT00964548|274555|P1|STARTED|Overall Study||5
118832|NCT00964496|274567|P2|NOT COMPLETED|Overall Study||1
118833|NCT00964496|274568|P1|NOT COMPLETED|Overall Study||2
118834|NCT00964496|274567|P2|COMPLETED|Overall Study||26
118835|NCT00964496|274568|P1|COMPLETED|Overall Study||26
118836|NCT00964496|274567|P2|STARTED|Overall Study||27
118837|NCT00964496|274568|P1|STARTED|Overall Study||28
118838|NCT00964444|274586|P1|NOT COMPLETED|Overall Study||0
118839|NCT00964444|274586|P1|COMPLETED|Overall Study||10
118840|NCT00964444|274586|P1|STARTED|Overall Study||10
118841|NCT00964431|274594|P4|NOT COMPLETED|Overall Study||0
118842|NCT00964431|274595|P3|NOT COMPLETED|Overall Study||0
118843|NCT00964431|274596|P2|NOT COMPLETED|Overall Study||0
118844|NCT00964431|274597|P1|NOT COMPLETED|Overall Study||0
118845|NCT00964431|274594|P4|COMPLETED|Overall Study||51
118846|NCT00964431|274595|P3|COMPLETED|Overall Study||51
118847|NCT00964431|274596|P2|COMPLETED|Overall Study||51
118848|NCT00964431|274597|P1|COMPLETED|Overall Study||50
118849|NCT00964431|274594|P4|STARTED|Overall Study||51
118850|NCT00964431|274595|P3|STARTED|Overall Study||51
118851|NCT00964431|274596|P2|STARTED|Overall Study||51
118852|NCT00964431|274597|P1|STARTED|Overall Study||50
118853|NCT00963235|274607|P1|NOT COMPLETED|Overall Study||60
118854|NCT00963235|274607|P1|COMPLETED|Overall Study||271
118855|NCT00963235|274607|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
118856|NCT00963235|274607|P1|Vaccinated Dose 3|Overall Study||279
118857|NCT00963235|274607|P1|Vaccinated Dose 2|Overall Study||300
118858|NCT00963235|274607|P1|Vaccinated Dose 1|Overall Study||329
118859|NCT00963235|274607|P1|STARTED|Overall Study||331
118860|NCT00964366|274628|P2|NOT COMPLETED|Overall Study||1
118861|NCT00964366|274629|P1|NOT COMPLETED|Overall Study||1
118862|NCT00964366|274628|P2|COMPLETED|Overall Study||24
118863|NCT00964366|274629|P1|COMPLETED|Overall Study||27
118864|NCT00964366|274628|P2|STARTED|Overall Study||25
118865|NCT00964366|274629|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
118866|NCT00964223|274643|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
118867|NCT00964223|274643|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
118868|NCT00964223|274643|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
118869|NCT00964223|274643|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
118870|NCT00964223|274643|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
118871|NCT00964223|274643|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
118872|NCT00964119|274708|P1|NOT COMPLETED|Overall Study||0
118873|NCT00964119|274708|P1|COMPLETED|Overall Study||15
118874|NCT00964119|274708|P1|STARTED|Overall Study||15
118875|NCT00963937|274715|P3|NOT COMPLETED|Overall Study||4
118876|NCT00963937|274716|P2|NOT COMPLETED|Overall Study||11
118877|NCT00963937|274717|P1|NOT COMPLETED|Overall Study||19
118878|NCT00963937|274715|P3|COMPLETED|Overall Study||41
118879|NCT00963937|274716|P2|COMPLETED|Overall Study||33
118880|NCT00963937|274717|P1|COMPLETED|Overall Study||70
118881|NCT00963937|274715|P3|STARTED|Overall Study||45
118882|NCT00963937|274716|P2|STARTED|Overall Study||44
118883|NCT00963937|274717|P1|STARTED|Overall Study||89
118884|NCT00963924|274755|P2|NOT COMPLETED|Overall Study||3
118885|NCT00963924|274756|P1|NOT COMPLETED|Overall Study||1
118886|NCT00963924|274755|P2|COMPLETED|Overall Study||15
118887|NCT00963924|274756|P1|COMPLETED|Overall Study||17
118888|NCT00963924|274755|P2|STARTED|Overall Study||18
118889|NCT00963924|274756|P1|STARTED|Overall Study||18
118890|NCT00963872|274774|P2|NOT COMPLETED|Overall Study||1
118891|NCT00963872|274775|P1|NOT COMPLETED|Overall Study||1
118892|NCT00963872|274774|P2|COMPLETED|Overall Study||5
118893|NCT00963872|274775|P1|COMPLETED|Overall Study||24
118894|NCT00963872|274774|P2|STARTED|Overall Study||6
118895|NCT00963872|274775|P1|STARTED|Overall Study||25
118896|NCT00963859|274819|P1|NOT COMPLETED|Overall Study||0
118897|NCT00963859|274819|P1|COMPLETED|Overall Study||11
118898|NCT00963859|274819|P1|STARTED|Overall Study||11
118899|NCT00963820|274824|P12|NOT COMPLETED|Expansion Phase||4
118900|NCT00963820|274825|P11|NOT COMPLETED|Expansion Phase||5
118901|NCT00963820|274826|P10|NOT COMPLETED|Expansion Phase||9
118902|NCT00963820|274827|P9|NOT COMPLETED|Expansion Phase||10
118903|NCT00963820|274828|P8|NOT COMPLETED|Expansion Phase||0
118904|NCT00963820|274829|P7|NOT COMPLETED|Expansion Phase||0
118905|NCT00963820|274830|P6|NOT COMPLETED|Expansion Phase||0
118906|NCT00963820|274831|P5|NOT COMPLETED|Expansion Phase||0
118907|NCT00963820|274832|P4|NOT COMPLETED|Expansion Phase||0
118908|NCT00963820|274833|P3|NOT COMPLETED|Expansion Phase||0
118909|NCT00963820|274834|P2|NOT COMPLETED|Expansion Phase||0
118910|NCT00963820|274835|P1|NOT COMPLETED|Expansion Phase||0
118911|NCT00963820|274824|P12|COMPLETED|Expansion Phase||0
118912|NCT00963820|274825|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
118913|NCT00963820|274826|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
118914|NCT00963820|274827|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
118915|NCT00963820|274828|P8|COMPLETED|Expansion Phase||0
118916|NCT00963820|274829|P7|COMPLETED|Expansion Phase||0
118917|NCT00963820|274830|P6|COMPLETED|Expansion Phase||0
118918|NCT00963820|274831|P5|COMPLETED|Expansion Phase||0
118919|NCT00963820|274832|P4|COMPLETED|Expansion Phase||0
118920|NCT00963820|274833|P3|COMPLETED|Expansion Phase||0
118921|NCT00963820|274834|P2|COMPLETED|Expansion Phase||0
118922|NCT00963820|274835|P1|COMPLETED|Expansion Phase||0
118923|NCT00963820|274824|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
118924|NCT00963820|274825|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
118925|NCT00963820|274826|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
118926|NCT00963820|274827|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
118927|NCT00963820|274828|P8|STARTED|Expansion Phase||0
118928|NCT00963820|274829|P7|STARTED|Expansion Phase||0
118929|NCT00963820|274830|P6|STARTED|Expansion Phase||0
118930|NCT00963820|274831|P5|STARTED|Expansion Phase||0
118931|NCT00963820|274832|P4|STARTED|Expansion Phase||0
118932|NCT00963820|274833|P3|STARTED|Expansion Phase||0
118933|NCT00963820|274834|P2|STARTED|Expansion Phase||0
118934|NCT00963820|274835|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
118935|NCT00963820|274824|P12|NOT COMPLETED|Dose Escalation Phase||0
118936|NCT00963820|274825|P11|NOT COMPLETED|Dose Escalation Phase||0
118937|NCT00963820|274826|P10|NOT COMPLETED|Dose Escalation Phase||0
118938|NCT00963820|274827|P9|NOT COMPLETED|Dose Escalation Phase||0
118939|NCT00963820|274828|P8|NOT COMPLETED|Dose Escalation Phase||5
118940|NCT00963820|274829|P7|NOT COMPLETED|Dose Escalation Phase||8
118941|NCT00963820|274830|P6|NOT COMPLETED|Dose Escalation Phase||3
118942|NCT00963820|274831|P5|NOT COMPLETED|Dose Escalation Phase||4
118943|NCT00963820|274832|P4|NOT COMPLETED|Dose Escalation Phase||3
118944|NCT00963820|274833|P3|NOT COMPLETED|Dose Escalation Phase||3
118945|NCT00963820|274834|P2|NOT COMPLETED|Dose Escalation Phase||3
118946|NCT00963820|274835|P1|NOT COMPLETED|Dose Escalation Phase||3
118947|NCT00963820|274824|P12|COMPLETED|Dose Escalation Phase||0
118948|NCT00963820|274825|P11|COMPLETED|Dose Escalation Phase||0
118949|NCT00963820|274826|P10|COMPLETED|Dose Escalation Phase||0
118950|NCT00963820|274827|P9|COMPLETED|Dose Escalation Phase||0
118951|NCT00963820|274828|P8|COMPLETED|Dose Escalation Phase||0
118952|NCT00963820|274829|P7|COMPLETED|Dose Escalation Phase||0
118953|NCT00963820|274830|P6|COMPLETED|Dose Escalation Phase||0
118954|NCT00963820|274831|P5|COMPLETED|Dose Escalation Phase||0
118955|NCT00963820|274832|P4|COMPLETED|Dose Escalation Phase||0
118956|NCT00963820|274833|P3|COMPLETED|Dose Escalation Phase||0
118957|NCT00963820|274834|P2|COMPLETED|Dose Escalation Phase||0
118958|NCT00963820|274835|P1|COMPLETED|Dose Escalation Phase||0
118959|NCT00963820|274824|P12|STARTED|Dose Escalation Phase||0
118960|NCT00963820|274825|P11|STARTED|Dose Escalation Phase||0
118961|NCT00963820|274826|P10|STARTED|Dose Escalation Phase||0
118962|NCT00963820|274827|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
118963|NCT00963820|274828|P8|STARTED|Dose Escalation Phase||5
118964|NCT00963820|274829|P7|STARTED|Dose Escalation Phase||8
118965|NCT00963820|274830|P6|STARTED|Dose Escalation Phase||3
118966|NCT00963820|274831|P5|STARTED|Dose Escalation Phase||4
118967|NCT00963820|274832|P4|STARTED|Dose Escalation Phase||3
118968|NCT00963820|274833|P3|STARTED|Dose Escalation Phase||3
118969|NCT00963820|274834|P2|STARTED|Dose Escalation Phase||3
118970|NCT00963820|274835|P1|STARTED|Dose Escalation Phase||3
118971|NCT00963677|274973|P2|NOT COMPLETED|Overall Study||2
118972|NCT00963677|274974|P1|NOT COMPLETED|Overall Study||0
118973|NCT00963677|274973|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
118974|NCT00963677|274974|P1|COMPLETED|Overall Study||35
118975|NCT00963677|274973|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
118976|NCT00963677|274974|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
118977|NCT00963638|274984|P2|NOT COMPLETED|Overall Study||0
118978|NCT00963638|274985|P1|NOT COMPLETED|Overall Study||0
118979|NCT00963638|274984|P2|COMPLETED|Overall Study||20
118980|NCT00963638|274985|P1|COMPLETED|Overall Study||20
118981|NCT00963638|274984|P2|STARTED|Overall Study||20
118982|NCT00963638|274985|P1|STARTED|Overall Study||20
118983|NCT00963599|274995|P4|NOT COMPLETED|Overall Study||14
118984|NCT00963599|274996|P3|NOT COMPLETED|Overall Study||9
118985|NCT00963599|274997|P2|NOT COMPLETED|Overall Study||6
118986|NCT00963599|274998|P1|NOT COMPLETED|Overall Study||6
118987|NCT00963599|274995|P4|COMPLETED|Overall Study||288
118988|NCT00963599|274996|P3|COMPLETED|Overall Study||292
118989|NCT00963599|274997|P2|COMPLETED|Overall Study||149
118990|NCT00963599|274998|P1|COMPLETED|Overall Study||143
118991|NCT00963599|274995|P4|STARTED|Overall Study||302
118992|NCT00963599|274996|P3|STARTED|Overall Study||301
118993|NCT00963599|274997|P2|STARTED|Overall Study||155
118994|NCT00963599|274998|P1|STARTED|Overall Study||149
118995|NCT00963560|275055|P3|NOT COMPLETED|Overall Study||0
118996|NCT00963560|275056|P2|NOT COMPLETED|Overall Study||3
118997|NCT00963560|275057|P1|NOT COMPLETED|Overall Study||3
118998|NCT00963560|275055|P3|COMPLETED|Overall Study||41
118999|NCT00963560|275056|P2|COMPLETED|Overall Study||41
119000|NCT00963560|275057|P1|COMPLETED|Overall Study||44
119001|NCT00963560|275055|P3|STARTED|Overall Study||41
119002|NCT00963560|275056|P2|STARTED|Overall Study||44
119003|NCT00963560|275057|P1|STARTED|Overall Study||47
119004|NCT00963508|275067|P2|NOT COMPLETED|Overall Study||28
119005|NCT00963508|275068|P1|NOT COMPLETED|Overall Study||10
119006|NCT00963508|275067|P2|COMPLETED|Overall Study||169
119007|NCT00963508|275068|P1|COMPLETED|Overall Study||196
119008|NCT00963508|275067|P2|STARTED|Overall Study||197
119009|NCT00963508|275068|P1|STARTED|Overall Study||206
119010|NCT00963482|275078|P2|NOT COMPLETED|Overall Study||17
119011|NCT00963482|275079|P1|NOT COMPLETED|Overall Study||28
119012|NCT00963482|275078|P2|COMPLETED|Overall Study||33
119013|NCT00963482|275079|P1|COMPLETED|Overall Study||25
119014|NCT00963482|275078|P2|STARTED|Overall Study||50
119015|NCT00963482|275079|P1|STARTED|Overall Study||53
119016|NCT00963469|275088|P3|NOT COMPLETED|Overall Study||10
119017|NCT00963469|275089|P2|NOT COMPLETED|Overall Study||28
119018|NCT00963469|275090|P1|NOT COMPLETED|Overall Study||41
119019|NCT00963469|275088|P3|COMPLETED|Overall Study||170
119020|NCT00963469|275089|P2|COMPLETED|Overall Study||420
119021|NCT00963469|275090|P1|COMPLETED|Overall Study||410
119022|NCT00963469|275088|P3|STARTED|Overall Study||180
119023|NCT00963469|275089|P2|STARTED|Overall Study||448
119024|NCT00963469|275090|P1|STARTED|Overall Study||451
119025|NCT00963430|275118|P2|NOT COMPLETED|Overall Study||3
119026|NCT00963430|275119|P1|NOT COMPLETED|Overall Study||1
119027|NCT00963430|275118|P2|COMPLETED|Overall Study||57
119028|NCT00963430|275119|P1|COMPLETED|Overall Study||59
119029|NCT00963430|275118|P2|STARTED|Overall Study||60
119030|NCT00963430|275119|P1|STARTED|Overall Study||60
119031|NCT00963157|275162|P5|NOT COMPLETED|Overall Study||2
119032|NCT00963157|275163|P4|NOT COMPLETED|Overall Study||7
119033|NCT00963157|275164|P3|NOT COMPLETED|Overall Study||5
119034|NCT00963157|275165|P2|NOT COMPLETED|Overall Study||4
119035|NCT00963157|275166|P1|NOT COMPLETED|Overall Study||5
119036|NCT00963157|275162|P5|COMPLETED|Overall Study||151
119037|NCT00963157|275163|P4|COMPLETED|Overall Study||150
119038|NCT00963157|275164|P3|COMPLETED|Overall Study||155
119039|NCT00963157|275165|P2|COMPLETED|Overall Study||159
119040|NCT00963157|275166|P1|COMPLETED|Overall Study||151
119041|NCT00963157|275162|P5|STARTED|Overall Study||153
119042|NCT00963157|275163|P4|STARTED|Overall Study||157
119043|NCT00963157|275164|P3|STARTED|Overall Study||160
119044|NCT00963157|275165|P2|STARTED|Overall Study||163
119045|NCT00963157|275166|P1|STARTED|Overall Study||156
119046|NCT00962871|275362|P4|NOT COMPLETED|Overall Study||0
119047|NCT00962871|275363|P3|NOT COMPLETED|Overall Study||0
119048|NCT00962871|275364|P2|NOT COMPLETED|Overall Study||0
119049|NCT00962871|275365|P1|NOT COMPLETED|Overall Study||0
119050|NCT00962871|275362|P4|COMPLETED|Overall Study||6
119051|NCT00962871|275363|P3|COMPLETED|Overall Study||12
119052|NCT00962871|275364|P2|COMPLETED|Overall Study||6
119053|NCT00962871|275365|P1|COMPLETED|Overall Study||6
119054|NCT00962871|275362|P4|STARTED|Overall Study||6
119055|NCT00962871|275363|P3|STARTED|Overall Study||12
119056|NCT00962871|275364|P2|STARTED|Overall Study||6
119057|NCT00962871|275365|P1|STARTED|Overall Study||6
119058|NCT00962780|275381|P2|NOT COMPLETED|Overall Study||14
119059|NCT00962780|275382|P1|NOT COMPLETED|Overall Study||10
119060|NCT00962780|275381|P2|COMPLETED|Overall Study||138
119061|NCT00962780|275382|P1|COMPLETED|Overall Study||141
119062|NCT00962780|275381|P2|Vaccinated 23vPS Dose|Overall Study||139
119063|NCT00962780|275382|P1|Vaccinated 23vPS Dose|Overall Study||143
119064|NCT00962780|275381|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
119065|NCT00962780|275382|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
119066|NCT00962780|275381|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
119067|NCT00962780|275382|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
119068|NCT00962780|275381|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
119069|NCT00962780|275382|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
119070|NCT00962780|275381|P2|STARTED|Overall Study||152
119071|NCT00962780|275382|P1|STARTED|Overall Study||151
119072|NCT00962754|275446|P2|NOT COMPLETED|Overall Study||0
119073|NCT00962754|275447|P1|NOT COMPLETED|Overall Study||0
119074|NCT00962754|275446|P2|COMPLETED|Overall Study||84
119075|NCT00962754|275447|P1|COMPLETED|Overall Study||86
119076|NCT00962754|275446|P2|STARTED|Overall Study||84
119077|NCT00962754|275447|P1|STARTED|Overall Study||86
119078|NCT00962741|275457|P1|NOT COMPLETED|Overall Study||8
119079|NCT00962741|275457|P1|COMPLETED|Overall Study||119
119080|NCT00962741|275457|P1|STARTED|Overall Study||127
119081|NCT00962650|275548|P1|NOT COMPLETED|Overall Study||2
119082|NCT00962650|275548|P1|COMPLETED|Overall Study||8
119083|NCT00962650|275548|P1|STARTED|Overall Study||10
119084|NCT00962585|275556|P4|NOT COMPLETED|Overall Study||0
119085|NCT00962585|275557|P3|NOT COMPLETED|Overall Study||3
119086|NCT00962585|275558|P2|NOT COMPLETED|Overall Study||2
119087|NCT00962585|275559|P1|NOT COMPLETED|Overall Study||6
119088|NCT00962585|275556|P4|COMPLETED|Overall Study||42
119089|NCT00962585|275557|P3|COMPLETED|Overall Study||39
119090|NCT00962585|275558|P2|COMPLETED|Overall Study||40
119091|NCT00962585|275559|P1|COMPLETED|Overall Study||37
119092|NCT00962585|275556|P4|STARTED|Overall Study||42
119093|NCT00962585|275557|P3|STARTED|Overall Study||42
119094|NCT00962585|275558|P2|STARTED|Overall Study||42
119095|NCT00962585|275559|P1|STARTED|Overall Study||43
119096|NCT00962208|275619|P2|NOT COMPLETED|Overall Study||10
119097|NCT00962208|275620|P1|NOT COMPLETED|Overall Study||14
119098|NCT00962208|275619|P2|COMPLETED|Overall Study||41
119099|NCT00962208|275620|P1|COMPLETED|Overall Study||37
119100|NCT00962208|275619|P2|STARTED|Overall Study||51
119101|NCT00962208|275620|P1|STARTED|Overall Study||51
119102|NCT00962104|275628|P2|NOT COMPLETED|Overall Study||25
119103|NCT00962104|275629|P1|NOT COMPLETED|Overall Study||40
119104|NCT00962104|275628|P2|COMPLETED|Overall Study||171
119105|NCT00962104|275629|P1|COMPLETED|Overall Study||155
119106|NCT00962104|275628|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
119107|NCT00962104|275629|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
119108|NCT00962104|275628|P2|STARTED|Overall Study||196
119109|NCT00962104|275629|P1|STARTED|Overall Study||195
119110|NCT00962065|275658|P3|NOT COMPLETED|Overall Study||0
119111|NCT00962065|275659|P2|NOT COMPLETED|Overall Study||0
119112|NCT00962065|275660|P1|NOT COMPLETED|Overall Study||0
119113|NCT00962065|275658|P3|COMPLETED|Overall Study||12
119114|NCT00962065|275659|P2|COMPLETED|Overall Study||12
119115|NCT00962065|275660|P1|COMPLETED|Overall Study||12
119116|NCT00962065|275658|P3|STARTED|Overall Study||12
119117|NCT00962065|275659|P2|STARTED|Overall Study||12
119118|NCT00962065|275660|P1|STARTED|Overall Study||12
119119|NCT00962013|275683|P1|NOT COMPLETED|Overall Study||68
119120|NCT00962013|275683|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
119121|NCT00962013|275683|P1|STARTED|Overall Study||120
119122|NCT00962000|275692|P2|NOT COMPLETED|Period 4 - 1 Week||0
119123|NCT00962000|275693|P1|NOT COMPLETED|Period 4 - 1 Week||0
119124|NCT00962000|275692|P2|COMPLETED|Period 4 - 1 Week||21
119125|NCT00962000|275693|P1|COMPLETED|Period 4 - 1 Week||21
119126|NCT00962000|275692|P2|STARTED|Period 4 - 1 Week||21
119127|NCT00962000|275693|P1|STARTED|Period 4 - 1 Week||21
119128|NCT00962000|275692|P2|NOT COMPLETED|Period 3 - 1 Week||0
119129|NCT00962000|275693|P1|NOT COMPLETED|Period 3 - 1 Week||0
119130|NCT00962000|275692|P2|COMPLETED|Period 3 - 1 Week||21
119131|NCT00962000|275693|P1|COMPLETED|Period 3 - 1 Week||21
119132|NCT00962000|275692|P2|STARTED|Period 3 - 1 Week||21
119133|NCT00962000|275693|P1|STARTED|Period 3 - 1 Week||21
119134|NCT00962000|275692|P2|NOT COMPLETED|Period 2 - 1 Week||0
119135|NCT00962000|275693|P1|NOT COMPLETED|Period 2 - 1 Week||0
119136|NCT00962000|275692|P2|COMPLETED|Period 2 - 1 Week||21
119137|NCT00962000|275693|P1|COMPLETED|Period 2 - 1 Week||21
119138|NCT00962000|275692|P2|STARTED|Period 2 - 1 Week||21
119139|NCT00962000|275693|P1|STARTED|Period 2 - 1 Week||21
119140|NCT00962000|275692|P2|NOT COMPLETED|Period 1 - 1 Week||0
119141|NCT00962000|275693|P1|NOT COMPLETED|Period 1 - 1 Week||0
119142|NCT00962000|275692|P2|COMPLETED|Period 1 - 1 Week||21
119143|NCT00962000|275693|P1|COMPLETED|Period 1 - 1 Week||21
119144|NCT00962000|275692|P2|STARTED|Period 1 - 1 Week||21
119145|NCT00962000|275693|P1|STARTED|Period 1 - 1 Week||21
119146|NCT00961896|275706|P3|NOT COMPLETED|Overall Study||1
119147|NCT00961896|275707|P2|NOT COMPLETED|Overall Study||0
119148|NCT00961896|275708|P1|NOT COMPLETED|Overall Study||0
119149|NCT00961896|275706|P3|COMPLETED|Overall Study||6
119150|NCT00961896|275707|P2|COMPLETED|Overall Study||3
119151|NCT00961896|275708|P1|COMPLETED|Overall Study||8
119152|NCT00961896|275706|P3|STARTED|Overall Study||7
119153|NCT00961896|275707|P2|STARTED|Overall Study||3
119154|NCT00961896|275708|P1|STARTED|Overall Study||8
119155|NCT00961805|275729|P2|NOT COMPLETED|Overall Study||0
119156|NCT00961805|275730|P1|NOT COMPLETED|Overall Study||0
119157|NCT00961805|275729|P2|COMPLETED|Overall Study||40
119158|NCT00961805|275730|P1|COMPLETED|Overall Study||40
119159|NCT00961805|275729|P2|STARTED|Overall Study||40
119160|NCT00961805|275730|P1|STARTED|Overall Study||40
119161|NCT00961662|275761|P3|NOT COMPLETED|Overall Study||19
119162|NCT00961662|275762|P2|NOT COMPLETED|Overall Study||19
119163|NCT00961662|275763|P1|NOT COMPLETED|Overall Study||22
119164|NCT00961662|275761|P3|COMPLETED|Overall Study||34
119165|NCT00961662|275762|P2|COMPLETED|Overall Study||32
119166|NCT00961662|275763|P1|COMPLETED|Overall Study||35
119167|NCT00961662|275761|P3|STARTED|Overall Study||53
119168|NCT00961662|275762|P2|STARTED|Overall Study||51
119169|NCT00961662|275763|P1|STARTED|Overall Study||57
119170|NCT00961649|275775|P4|NOT COMPLETED|Overall Study||4
119171|NCT00961649|275776|P3|NOT COMPLETED|Overall Study||5
119172|NCT00961649|275777|P2|NOT COMPLETED|Overall Study||4
119173|NCT00961649|275778|P1|NOT COMPLETED|Overall Study||9
119174|NCT00961649|275775|P4|COMPLETED|Overall Study||37
119175|NCT00961649|275776|P3|COMPLETED|Overall Study||39
119176|NCT00961649|275777|P2|COMPLETED|Overall Study||40
119177|NCT00961649|275778|P1|COMPLETED|Overall Study||32
119178|NCT00961649|275775|P4|STARTED|Overall Study||41
119179|NCT00961649|275776|P3|STARTED|Overall Study||44
119180|NCT00961649|275777|P2|STARTED|Overall Study||44
119181|NCT00961649|275778|P1|STARTED|Overall Study||41
119182|NCT00961636|275792|P3|NOT COMPLETED|Overall Study||32
119183|NCT00961636|275793|P2|NOT COMPLETED|Overall Study||131
119184|NCT00961636|275794|P1|NOT COMPLETED|Overall Study||107
119185|NCT00961636|275792|P3|COMPLETED|Overall Study||201
119186|NCT00961636|275793|P2|COMPLETED|Overall Study||325
119187|NCT00961636|275794|P1|COMPLETED|Overall Study||356
119188|NCT00961636|275792|P3|STARTED|Overall Study||233
119189|NCT00961636|275793|P2|STARTED|Overall Study||456
119190|NCT00961636|275794|P1|STARTED|Overall Study||463
119191|NCT00961532|275805|P1|NOT COMPLETED|Overall Study||0
119192|NCT00961532|275805|P1|COMPLETED|Overall Study||14
119193|NCT00961532|275805|P1|STARTED|Overall Study||14
119194|NCT00961441|275812|P2|NOT COMPLETED|Overall Study||0
119195|NCT00961441|275813|P1|NOT COMPLETED|Overall Study||0
119196|NCT00961441|275812|P2|COMPLETED|Overall Study||13
119197|NCT00961441|275813|P1|COMPLETED|Overall Study||12
119198|NCT00961441|275812|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
119199|NCT00961441|275813|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
119200|NCT00961441|275812|P2|STARTED|Overall Study||13
119201|NCT00961441|275813|P1|STARTED|Overall Study||12
119202|NCT00961415|275829|P3|NOT COMPLETED|Maintenance Treatment Phase||45
119203|NCT00961415|275830|P2|NOT COMPLETED|Maintenance Treatment Phase||48
119204|NCT00961415|275831|P1|NOT COMPLETED|Maintenance Treatment Phase||0
119205|NCT00961415|275829|P3|COMPLETED|Maintenance Treatment Phase||83
119206|NCT00961415|275830|P2|COMPLETED|Maintenance Treatment Phase||77
119207|NCT00961415|275831|P1|COMPLETED|Maintenance Treatment Phase||0
119208|NCT00961415|275829|P3|STARTED|Maintenance Treatment Phase||128
119209|NCT00961415|275830|P2|STARTED|Maintenance Treatment Phase||125
119210|NCT00961415|275831|P1|STARTED|Maintenance Treatment Phase||0
119211|NCT00961415|275829|P3|NOT COMPLETED|Induction Treatment Phase||0
119212|NCT00961415|275830|P2|NOT COMPLETED|Induction Treatment Phase||0
119213|NCT00961415|275831|P1|NOT COMPLETED|Induction Treatment Phase||123
119214|NCT00961415|275829|P3|COMPLETED|Induction Treatment Phase||0
119215|NCT00961415|275830|P2|COMPLETED|Induction Treatment Phase||0
119216|NCT00961415|275831|P1|COMPLETED|Induction Treatment Phase||253
119217|NCT00961415|275829|P3|STARTED|Induction Treatment Phase||0
119218|NCT00961415|275830|P2|STARTED|Induction Treatment Phase||0
119219|NCT00961415|275831|P1|STARTED|Induction Treatment Phase||376
119220|NCT00961402|275856|P2|NOT COMPLETED|Overall Study||5
119221|NCT00961402|275857|P1|NOT COMPLETED|Overall Study||1
119222|NCT00961402|275856|P2|COMPLETED|Overall Study||61
119223|NCT00961402|275857|P1|COMPLETED|Overall Study||63
119224|NCT00961402|275856|P2|Randomized|Overall Study||66
119225|NCT00961402|275857|P1|Randomized|Overall Study||64
119226|NCT00961402|275856|P2|STARTED|Overall Study||66
119227|NCT00961402|275857|P1|STARTED|Overall Study||64
119228|NCT00961350|275871|P2|NOT COMPLETED|Overall Study||67
119229|NCT00961350|275872|P1|NOT COMPLETED|Overall Study||47
119230|NCT00961350|275871|P2|COMPLETED|Overall Study||198
119231|NCT00961350|275872|P1|COMPLETED|Overall Study||218
119232|NCT00961350|275871|P2|Safety Population|Overall Study||265
119233|NCT00961350|275872|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
119234|NCT00961350|275871|P2|Intent-to-Treat Population (ITT)|Overall Study||265
119235|NCT00961350|275872|P1|Intent-to-Treat Population (ITT)|Overall Study||265
119236|NCT00961350|275871|P2|STARTED|Overall Study||265
119237|NCT00961350|275872|P1|STARTED|Overall Study||265
119238|NCT00961311|275886|P1|NOT COMPLETED|Overall Study||0
119239|NCT00961311|275886|P1|COMPLETED|Overall Study||51
119240|NCT00961311|275886|P1|STARTED|Overall Study||51
119241|NCT00961298|275893|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
119242|NCT00961298|275893|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
119243|NCT00961298|275893|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
119244|NCT00961298|275893|P1|NOT COMPLETED|Two Week Placebo Run in||1
119245|NCT00961298|275893|P1|COMPLETED|Two Week Placebo Run in||14
119246|NCT00961298|275893|P1|STARTED|Two Week Placebo Run in||15
119247|NCT00961259|275900|P3|NOT COMPLETED|Third Intervention||0
119248|NCT00961259|275901|P2|NOT COMPLETED|Third Intervention||0
119249|NCT00961259|275902|P1|NOT COMPLETED|Third Intervention||0
119250|NCT00961259|275900|P3|COMPLETED|Third Intervention||18
119251|NCT00961259|275901|P2|COMPLETED|Third Intervention||17
119252|NCT00961259|275902|P1|COMPLETED|Third Intervention||18
119253|NCT00961259|275900|P3|STARTED|Third Intervention||18
119254|NCT00961259|275901|P2|STARTED|Third Intervention||17
119255|NCT00961259|275902|P1|STARTED|Third Intervention||18
119256|NCT00961259|275900|P3|NOT COMPLETED|Washout Period of 7 Days||0
119257|NCT00961259|275901|P2|NOT COMPLETED|Washout Period of 7 Days||0
119258|NCT00961259|275902|P1|NOT COMPLETED|Washout Period of 7 Days||0
119259|NCT00961259|275900|P3|COMPLETED|Washout Period of 7 Days||18
119260|NCT00961259|275901|P2|COMPLETED|Washout Period of 7 Days||17
119261|NCT00961259|275902|P1|COMPLETED|Washout Period of 7 Days||18
119262|NCT00961259|275900|P3|STARTED|Washout Period of 7 Days||18
119263|NCT00961259|275901|P2|STARTED|Washout Period of 7 Days||17
119264|NCT00961259|275902|P1|STARTED|Washout Period of 7 Days||18
119265|NCT00961259|275900|P3|NOT COMPLETED|Second Intervention||0
119266|NCT00961259|275901|P2|NOT COMPLETED|Second Intervention||0
119267|NCT00961259|275902|P1|NOT COMPLETED|Second Intervention||0
119268|NCT00961259|275900|P3|COMPLETED|Second Intervention||18
119269|NCT00961259|275901|P2|COMPLETED|Second Intervention||17
119270|NCT00961259|275902|P1|COMPLETED|Second Intervention||18
119271|NCT00961259|275900|P3|STARTED|Second Intervention||18
119272|NCT00961259|275901|P2|STARTED|Second Intervention||17
119273|NCT00961259|275902|P1|STARTED|Second Intervention||18
119274|NCT00961259|275900|P3|NOT COMPLETED|Washout Period of 7 Days||0
119275|NCT00961259|275901|P2|NOT COMPLETED|Washout Period of 7 Days||1
119276|NCT00961259|275902|P1|NOT COMPLETED|Washout Period of 7 Days||0
119277|NCT00961259|275900|P3|COMPLETED|Washout Period of 7 Days||18
119278|NCT00961259|275901|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
119279|NCT00961259|275902|P1|COMPLETED|Washout Period of 7 Days||18
119280|NCT00961259|275900|P3|STARTED|Washout Period of 7 Days||18
119281|NCT00961259|275901|P2|STARTED|Washout Period of 7 Days||18
119282|NCT00961259|275902|P1|STARTED|Washout Period of 7 Days||18
119283|NCT00961259|275900|P3|NOT COMPLETED|First Intervention||0
119284|NCT00961259|275901|P2|NOT COMPLETED|First Intervention||0
119285|NCT00961259|275902|P1|NOT COMPLETED|First Intervention||0
119286|NCT00961259|275900|P3|COMPLETED|First Intervention||18
119287|NCT00961259|275901|P2|COMPLETED|First Intervention||18
119288|NCT00961259|275902|P1|COMPLETED|First Intervention||18
119289|NCT00961259|275900|P3|STARTED|First Intervention||18
119290|NCT00961259|275901|P2|STARTED|First Intervention||18
119291|NCT00961259|275902|P1|STARTED|First Intervention||18
119292|NCT00961233|275921|P2|NOT COMPLETED|Overall Study||1
119293|NCT00961233|275922|P1|NOT COMPLETED|Overall Study||2
119294|NCT00961233|275921|P2|COMPLETED|Overall Study||11
119295|NCT00961233|275922|P1|COMPLETED|Overall Study||11
119296|NCT00961233|275921|P2|STARTED|Overall Study||12
119297|NCT00961233|275922|P1|STARTED|Overall Study||13
119298|NCT00961220|275930|P1|NOT COMPLETED|Overall Study||7
119299|NCT00961220|275930|P1|COMPLETED|Overall Study||10
119300|NCT00961220|275930|P1|STARTED|Overall Study||17
119301|NCT00961181|275946|P1|NOT COMPLETED|Overall Study||5
119302|NCT00961181|275946|P1|COMPLETED|Overall Study||76
119303|NCT00961181|275946|P1|STARTED|Overall Study||81
119304|NCT00961116|275959|P2|NOT COMPLETED|Second Intervention||0
119305|NCT00961116|275960|P1|NOT COMPLETED|Second Intervention||0
119306|NCT00961116|275959|P2|COMPLETED|Second Intervention||24
119307|NCT00961116|275960|P1|COMPLETED|Second Intervention||25
119308|NCT00961116|275959|P2|STARTED|Second Intervention||24
119309|NCT00961116|275960|P1|STARTED|Second Intervention||25
119310|NCT00961116|275959|P2|NOT COMPLETED|Washout Period of 7 Days||3
119311|NCT00961116|275960|P1|NOT COMPLETED|Washout Period of 7 Days||2
119312|NCT00961116|275959|P2|COMPLETED|Washout Period of 7 Days||24
119313|NCT00961116|275960|P1|COMPLETED|Washout Period of 7 Days||25
119314|NCT00961116|275959|P2|STARTED|Washout Period of 7 Days||27
119315|NCT00961116|275960|P1|STARTED|Washout Period of 7 Days||27
119316|NCT00961116|275959|P2|NOT COMPLETED|First Intervention||0
119317|NCT00961116|275960|P1|NOT COMPLETED|First Intervention||0
119318|NCT00961116|275959|P2|COMPLETED|First Intervention||27
119319|NCT00961116|275960|P1|COMPLETED|First Intervention||27
119320|NCT00961116|275959|P2|STARTED|First Intervention||27
119321|NCT00961116|275960|P1|STARTED|First Intervention||27
119322|NCT00961051|275972|P2|NOT COMPLETED|Overall Study||14
119323|NCT00961051|275973|P1|NOT COMPLETED|Overall Study||12
119324|NCT00961051|275972|P2|COMPLETED|Overall Study||79
119325|NCT00961051|275973|P1|COMPLETED|Overall Study||165
119326|NCT00961051|275972|P2|STARTED|Overall Study||93
119327|NCT00961051|275973|P1|STARTED|Overall Study||177
119328|NCT00960999|275983|P2|NOT COMPLETED|Overall Study||2
119329|NCT00960999|275984|P1|NOT COMPLETED|Overall Study||8
119330|NCT00960999|275983|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
119413|NCT00960856|276206|P3|STARTED|Period IV||8
119331|NCT00960999|275984|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
119332|NCT00960999|275983|P2|STARTED|Overall Study||47
119333|NCT00960999|275984|P1|STARTED|Overall Study||47
119334|NCT00960986|275994|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
119335|NCT00960986|275995|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
119336|NCT00960986|275996|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
119337|NCT00960986|275997|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
119338|NCT00960986|275994|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
119339|NCT00960986|275995|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
119340|NCT00960986|275996|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
119341|NCT00960986|275997|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
119342|NCT00960986|275994|P4|STARTED|Period 3 (7-week Therapy Period)||61
119343|NCT00960986|275995|P3|STARTED|Period 3 (7-week Therapy Period)||59
119344|NCT00960986|275996|P2|STARTED|Period 3 (7-week Therapy Period)||59
119345|NCT00960986|275997|P1|STARTED|Period 3 (7-week Therapy Period)||56
119346|NCT00960986|275994|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
119347|NCT00960986|275995|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
119348|NCT00960986|275996|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
119349|NCT00960986|275997|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
119350|NCT00960986|275994|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
119351|NCT00960986|275995|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
119352|NCT00960986|275996|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
119353|NCT00960986|275997|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
119354|NCT00960986|275994|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
119355|NCT00960986|275995|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
119356|NCT00960986|275996|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
119357|NCT00960986|275997|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
119358|NCT00960986|275994|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
119359|NCT00960986|275995|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
119360|NCT00960986|275996|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
119361|NCT00960986|275997|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
119362|NCT00960986|275994|P4|COMPLETED|Period 1 (Screening and Washout)||61
119363|NCT00960986|275995|P3|COMPLETED|Period 1 (Screening and Washout)||59
119364|NCT00960986|275996|P2|COMPLETED|Period 1 (Screening and Washout)||59
119365|NCT00960986|275997|P1|COMPLETED|Period 1 (Screening and Washout)||56
119366|NCT00960986|275994|P4|STARTED|Period 1 (Screening and Washout)||64
119367|NCT00960986|275995|P3|STARTED|Period 1 (Screening and Washout)||63
119368|NCT00960986|275996|P2|STARTED|Period 1 (Screening and Washout)||63
119369|NCT00960986|275997|P1|STARTED|Period 1 (Screening and Washout)||59
119370|NCT00960934|276073|P6|NOT COMPLETED|Overall Study||64
119371|NCT00960934|276074|P5|NOT COMPLETED|Overall Study||64
119372|NCT00960934|276075|P4|NOT COMPLETED|Overall Study||64
119373|NCT00960934|276076|P3|NOT COMPLETED|Overall Study||64
119374|NCT00960934|276077|P2|NOT COMPLETED|Overall Study||63
119375|NCT00960934|276078|P1|NOT COMPLETED|Overall Study||64
119376|NCT00960934|276073|P6|COMPLETED|Overall Study||0
119377|NCT00960934|276074|P5|COMPLETED|Overall Study||0
119378|NCT00960934|276075|P4|COMPLETED|Overall Study||0
119379|NCT00960934|276076|P3|COMPLETED|Overall Study||0
119380|NCT00960934|276077|P2|COMPLETED|Overall Study||0
119381|NCT00960934|276078|P1|COMPLETED|Overall Study||0
119382|NCT00960934|276073|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
119383|NCT00960934|276074|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
119384|NCT00960934|276075|P4|Number Treated|Overall Study||64
119385|NCT00960934|276076|P3|Number Treated|Overall Study||64
119386|NCT00960934|276077|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
119387|NCT00960934|276078|P1|Number Treated|Overall Study||64
119388|NCT00960934|276073|P6|STARTED|Overall Study||64
119389|NCT00960934|276074|P5|STARTED|Overall Study||64
119390|NCT00960934|276075|P4|STARTED|Overall Study||64
119391|NCT00960934|276076|P3|STARTED|Overall Study||64
119392|NCT00960934|276077|P2|STARTED|Overall Study||63
119393|NCT00960934|276078|P1|STARTED|Overall Study||64
119394|NCT00960869|276190|P2|NOT COMPLETED|Overall Study||62
119395|NCT00960869|276191|P1|NOT COMPLETED|Overall Study||53
119396|NCT00960869|276190|P2|COMPLETED|Overall Study||198
119397|NCT00960869|276191|P1|COMPLETED|Overall Study||206
119398|NCT00960869|276190|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
119399|NCT00960869|276191|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
119400|NCT00960869|276190|P2|Intent-to-Treat Population (ITT)|Overall Study||260
119401|NCT00960869|276191|P1|Intent-to-Treat Population (ITT)|Overall Study||259
119402|NCT00960869|276190|P2|STARTED|Overall Study||260
119403|NCT00960869|276191|P1|STARTED|Overall Study||259
119404|NCT00960856|276205|P4|NOT COMPLETED|Period IV||0
119405|NCT00960856|276206|P3|NOT COMPLETED|Period IV||0
119406|NCT00960856|276207|P2|NOT COMPLETED|Period IV||0
119407|NCT00960856|276208|P1|NOT COMPLETED|Period IV||0
119408|NCT00960856|276205|P4|COMPLETED|Period IV||9
119409|NCT00960856|276206|P3|COMPLETED|Period IV||8
119410|NCT00960856|276207|P2|COMPLETED|Period IV||7
119411|NCT00960856|276208|P1|COMPLETED|Period IV||10
119412|NCT00960856|276205|P4|STARTED|Period IV||9
119414|NCT00960856|276207|P2|STARTED|Period IV||7
119415|NCT00960856|276208|P1|STARTED|Period IV||10
119416|NCT00960856|276205|P4|NOT COMPLETED|Washout Period of 7 Days||0
119417|NCT00960856|276206|P3|NOT COMPLETED|Washout Period of 7 Days||1
119418|NCT00960856|276207|P2|NOT COMPLETED|Washout Period of 7 Days||0
119419|NCT00960856|276208|P1|NOT COMPLETED|Washout Period of 7 Days||0
119420|NCT00960856|276205|P4|COMPLETED|Washout Period of 7 Days||9
119421|NCT00960856|276206|P3|COMPLETED|Washout Period of 7 Days||8
119422|NCT00960856|276207|P2|COMPLETED|Washout Period of 7 Days||7
119423|NCT00960856|276208|P1|COMPLETED|Washout Period of 7 Days||10
119424|NCT00960856|276205|P4|STARTED|Washout Period of 7 Days||9
119425|NCT00960856|276206|P3|STARTED|Washout Period of 7 Days||9
119426|NCT00960856|276207|P2|STARTED|Washout Period of 7 Days||7
119427|NCT00960856|276208|P1|STARTED|Washout Period of 7 Days||10
119428|NCT00960856|276205|P4|NOT COMPLETED|Period III||0
119429|NCT00960856|276206|P3|NOT COMPLETED|Period III||0
119430|NCT00960856|276207|P2|NOT COMPLETED|Period III||0
119431|NCT00960856|276208|P1|NOT COMPLETED|Period III||0
119432|NCT00960856|276205|P4|COMPLETED|Period III||9
119433|NCT00960856|276206|P3|COMPLETED|Period III||9
119434|NCT00960856|276207|P2|COMPLETED|Period III||7
119435|NCT00960856|276208|P1|COMPLETED|Period III||10
119436|NCT00960856|276205|P4|STARTED|Period III||9
119437|NCT00960856|276206|P3|STARTED|Period III||9
119438|NCT00960856|276207|P2|STARTED|Period III||7
119439|NCT00960856|276208|P1|STARTED|Period III||10
119440|NCT00960856|276205|P4|NOT COMPLETED|Washout Period of 7 Days||0
119441|NCT00960856|276206|P3|NOT COMPLETED|Washout Period of 7 Days||0
119442|NCT00960856|276207|P2|NOT COMPLETED|Washout Period of 7 Days||0
119443|NCT00960856|276208|P1|NOT COMPLETED|Washout Period of 7 Days||0
119444|NCT00960856|276205|P4|COMPLETED|Washout Period of 7 Days||9
119445|NCT00960856|276206|P3|COMPLETED|Washout Period of 7 Days||9
119446|NCT00960856|276207|P2|COMPLETED|Washout Period of 7 Days||7
119447|NCT00960856|276208|P1|COMPLETED|Washout Period of 7 Days||10
119448|NCT00960856|276205|P4|STARTED|Washout Period of 7 Days||9
119449|NCT00960856|276206|P3|STARTED|Washout Period of 7 Days||9
119450|NCT00960856|276207|P2|STARTED|Washout Period of 7 Days||7
119451|NCT00960856|276208|P1|STARTED|Washout Period of 7 Days||10
119452|NCT00960856|276205|P4|NOT COMPLETED|Period II||0
119453|NCT00960856|276206|P3|NOT COMPLETED|Period II||0
119454|NCT00960856|276207|P2|NOT COMPLETED|Period II||0
119455|NCT00960856|276208|P1|NOT COMPLETED|Period II||0
119456|NCT00960856|276205|P4|COMPLETED|Period II||9
119457|NCT00960856|276206|P3|COMPLETED|Period II||9
119458|NCT00960856|276207|P2|COMPLETED|Period II||7
119459|NCT00960856|276208|P1|COMPLETED|Period II||10
119460|NCT00960856|276205|P4|STARTED|Period II||9
119461|NCT00960856|276206|P3|STARTED|Period II||9
119462|NCT00960856|276207|P2|STARTED|Period II||7
119463|NCT00960856|276208|P1|STARTED|Period II||10
119464|NCT00960856|276205|P4|NOT COMPLETED|Washout Period of 7 Days||0
119465|NCT00960856|276206|P3|NOT COMPLETED|Washout Period of 7 Days||0
119466|NCT00960856|276207|P2|NOT COMPLETED|Washout Period of 7 Days||2
119467|NCT00960856|276208|P1|NOT COMPLETED|Washout Period of 7 Days||0
119468|NCT00960856|276205|P4|COMPLETED|Washout Period of 7 Days||9
119469|NCT00960856|276206|P3|COMPLETED|Washout Period of 7 Days||9
119470|NCT00960856|276207|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
119471|NCT00960856|276208|P1|COMPLETED|Washout Period of 7 Days||10
119472|NCT00960856|276205|P4|STARTED|Washout Period of 7 Days||9
119473|NCT00960856|276206|P3|STARTED|Washout Period of 7 Days||9
119474|NCT00960856|276207|P2|STARTED|Washout Period of 7 Days||9
119475|NCT00960856|276208|P1|STARTED|Washout Period of 7 Days||10
119476|NCT00960856|276205|P4|NOT COMPLETED|Period I||0
119477|NCT00960856|276206|P3|NOT COMPLETED|Period I||0
119478|NCT00960856|276207|P2|NOT COMPLETED|Period I||0
119479|NCT00960856|276208|P1|NOT COMPLETED|Period I||0
119480|NCT00960856|276205|P4|COMPLETED|Period I||9
119481|NCT00960856|276206|P3|COMPLETED|Period I||9
119482|NCT00960856|276207|P2|COMPLETED|Period I||9
119483|NCT00960856|276208|P1|COMPLETED|Period I||10
119484|NCT00960856|276205|P4|STARTED|Period I||9
119485|NCT00960856|276206|P3|STARTED|Period I||9
119486|NCT00960856|276207|P2|STARTED|Period I||9
119487|NCT00960856|276208|P1|STARTED|Period I||10
119488|NCT00960843|276228|P2|NOT COMPLETED|Overall Study||5
119489|NCT00960843|276229|P1|NOT COMPLETED|Overall Study||2
119490|NCT00960843|276228|P2|COMPLETED|Overall Study||21
119491|NCT00960843|276229|P1|COMPLETED|Overall Study||23
119492|NCT00960843|276228|P2|STARTED|Overall Study||26
119493|NCT00960843|276229|P1|STARTED|Overall Study||25
119494|NCT00960687|276239|P2|NOT COMPLETED|Second Intervention||0
119495|NCT00960687|276240|P1|NOT COMPLETED|Second Intervention||0
119496|NCT00960687|276239|P2|COMPLETED|Second Intervention||24
119497|NCT00960687|276240|P1|COMPLETED|Second Intervention||23
119498|NCT00960687|276239|P2|STARTED|Second Intervention||24
119499|NCT00960687|276240|P1|STARTED|Second Intervention||23
119500|NCT00960687|276239|P2|NOT COMPLETED|Washout Period of 7 Days||3
119501|NCT00960687|276240|P1|NOT COMPLETED|Washout Period of 7 Days||4
119502|NCT00960687|276239|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
119503|NCT00960687|276240|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
119504|NCT00960687|276239|P2|STARTED|Washout Period of 7 Days||27
119505|NCT00960687|276240|P1|STARTED|Washout Period of 7 Days||27
119506|NCT00960687|276239|P2|NOT COMPLETED|First Intervention||0
119507|NCT00960687|276240|P1|NOT COMPLETED|First Intervention||0
119508|NCT00960687|276239|P2|COMPLETED|First Intervention||27
119509|NCT00960687|276240|P1|COMPLETED|First Intervention||27
119510|NCT00960687|276239|P2|STARTED|First Intervention||27
119511|NCT00960687|276240|P1|STARTED|First Intervention||27
119512|NCT00960661|276252|P3|NOT COMPLETED|Interventional Phase||46
119513|NCT00960661|276253|P2|NOT COMPLETED|Interventional Phase||52
119514|NCT00960661|276254|P1|NOT COMPLETED|Interventional Phase||0
119515|NCT00960661|276252|P3|COMPLETED|Interventional Phase||275
119516|NCT00960661|276253|P2|COMPLETED|Interventional Phase||264
119517|NCT00960661|276254|P1|COMPLETED|Interventional Phase||0
119518|NCT00960661|276252|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
119519|NCT00960661|276253|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
119520|NCT00960661|276254|P1|Per Protocol Population|Interventional Phase||0
119521|NCT00960661|276252|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
119522|NCT00960661|276253|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
119523|NCT00960661|276254|P1|Intent to Treat Population|Interventional Phase||0
119524|NCT00960661|276252|P3|STARTED|Interventional Phase||321
119525|NCT00960661|276253|P2|STARTED|Interventional Phase||316
119526|NCT00960661|276254|P1|STARTED|Interventional Phase||0
119527|NCT00960661|276252|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
119528|NCT00960661|276253|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
119529|NCT00960661|276254|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
119530|NCT00960661|276252|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
119531|NCT00960661|276253|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
119532|NCT00960661|276254|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
119533|NCT00960661|276252|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
119534|NCT00960661|276253|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
119535|NCT00960661|276254|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
119536|NCT00960622|276286|P2|NOT COMPLETED|Overall Study||3
119537|NCT00960622|276287|P1|NOT COMPLETED|Overall Study||0
119538|NCT00960622|276286|P2|COMPLETED|Overall Study||7
119539|NCT00960622|276287|P1|COMPLETED|Overall Study||10
119540|NCT00960622|276286|P2|STARTED|Overall Study||10
119541|NCT00960622|276287|P1|STARTED|Overall Study||10
119542|NCT00960570|276293|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
119543|NCT00960570|276293|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
119544|NCT00960570|276293|P1|STARTED|Efavirenz and Fenofibric Acid||25
119545|NCT00960570|276293|P1|NOT COMPLETED|1 Day Period Between Dosing||3
119546|NCT00960570|276293|P1|COMPLETED|1 Day Period Between Dosing||25
119547|NCT00960570|276293|P1|STARTED|1 Day Period Between Dosing||28
119548|NCT00960570|276293|P1|NOT COMPLETED|Fenofibric Acid Alone||0
119549|NCT00960570|276293|P1|COMPLETED|Fenofibric Acid Alone||28
119550|NCT00960570|276293|P1|STARTED|Fenofibric Acid Alone||28
119551|NCT00960570|276293|P1|NOT COMPLETED|21 Day Washout Period||2
119552|NCT00960570|276293|P1|COMPLETED|21 Day Washout Period||28
119553|NCT00960570|276293|P1|STARTED|21 Day Washout Period||30
119554|NCT00960570|276293|P1|NOT COMPLETED|Efavirenz Alone||0
119555|NCT00960570|276293|P1|COMPLETED|Efavirenz Alone||30
119556|NCT00960570|276293|P1|STARTED|Efavirenz Alone||30
119557|NCT00960531|276314|P10|NOT COMPLETED|Overall Study||1
119558|NCT00960531|276315|P9|NOT COMPLETED|Overall Study||14
119559|NCT00960531|276316|P8|NOT COMPLETED|Overall Study||4
119560|NCT00960531|276317|P7|NOT COMPLETED|Overall Study||24
119561|NCT00960531|276318|P6|NOT COMPLETED|Overall Study||3
119562|NCT00960531|276319|P5|NOT COMPLETED|Overall Study||2
119563|NCT00960531|276320|P4|NOT COMPLETED|Overall Study||8
119564|NCT00960531|276321|P3|NOT COMPLETED|Overall Study||26
119565|NCT00960531|276322|P2|NOT COMPLETED|Overall Study||1
119566|NCT00960531|276323|P1|NOT COMPLETED|Overall Study||10
119567|NCT00960531|276314|P10|COMPLETED|Overall Study|Completed study|3
119568|NCT00960531|276315|P9|COMPLETED|Overall Study|Completed study|2
119569|NCT00960531|276316|P8|COMPLETED|Overall Study|Completed study|2
119570|NCT00960531|276317|P7|COMPLETED|Overall Study|Completed study|3
119571|NCT00960531|276318|P6|COMPLETED|Overall Study|Completed study|6
119572|NCT00960531|276319|P5|COMPLETED|Overall Study|Completed study|3
119573|NCT00960531|276320|P4|COMPLETED|Overall Study|Completed study|17
119574|NCT00960531|276321|P3|COMPLETED|Overall Study|Completed study|15
119575|NCT00960531|276322|P2|COMPLETED|Overall Study|Completed study|5
119576|NCT00960531|276323|P1|COMPLETED|Overall Study|Completed study|11
119577|NCT00960531|276314|P10|Completed Treatment|Overall Study||4
119578|NCT00960531|276315|P9|Completed Treatment|Overall Study||2
119579|NCT00960531|276316|P8|Completed Treatment|Overall Study||3
119580|NCT00960531|276317|P7|Completed Treatment|Overall Study||4
119581|NCT00960531|276318|P6|Completed Treatment|Overall Study||7
119582|NCT00960531|276319|P5|Completed Treatment|Overall Study||3
119583|NCT00960531|276320|P4|Completed Treatment|Overall Study||17
119584|NCT00960531|276321|P3|Completed Treatment|Overall Study||15
119585|NCT00960531|276322|P2|Completed Treatment|Overall Study||5
119586|NCT00960531|276323|P1|Completed Treatment|Overall Study||12
119587|NCT00960531|276314|P10|Treated|Overall Study||4
119588|NCT00960531|276315|P9|Treated|Overall Study||16
119589|NCT00960531|276316|P8|Treated|Overall Study||6
119590|NCT00960531|276317|P7|Treated|Overall Study||27
119591|NCT00960531|276318|P6|Treated|Overall Study||9
119592|NCT00960531|276319|P5|Treated|Overall Study||5
119593|NCT00960531|276320|P4|Treated|Overall Study||24
119594|NCT00960531|276321|P3|Treated|Overall Study||41
119595|NCT00960531|276322|P2|Treated|Overall Study||6
119596|NCT00960531|276323|P1|Treated|Overall Study||21
119597|NCT00960531|276314|P10|STARTED|Overall Study|Started=Randomized|4
119598|NCT00960531|276315|P9|STARTED|Overall Study|Started=Randomized|16
119599|NCT00960531|276316|P8|STARTED|Overall Study|Started=Randomized|6
119600|NCT00960531|276317|P7|STARTED|Overall Study|Started=Randomized|27
119601|NCT00960531|276318|P6|STARTED|Overall Study|Started=Randomized|9
119602|NCT00960531|276319|P5|STARTED|Overall Study|Started=Randomized|5
119603|NCT00960531|276320|P4|STARTED|Overall Study|Started=Randomized.|25
119604|NCT00960531|276321|P3|STARTED|Overall Study|Started=Randomized|41
119605|NCT00960531|276322|P2|STARTED|Overall Study|Started=Randomized|6
119606|NCT00960531|276323|P1|STARTED|Overall Study|Started=Randomized|21
119607|NCT00960440|276371|P4|NOT COMPLETED|Overall Study||18
119608|NCT00960440|276372|P3|NOT COMPLETED|Overall Study||13
119609|NCT00960440|276373|P2|NOT COMPLETED|Overall Study||31
119610|NCT00960440|276374|P1|NOT COMPLETED|Overall Study||26
119611|NCT00960440|276371|P4|COMPLETED|Overall Study||48
119612|NCT00960440|276372|P3|COMPLETED|Overall Study||53
119613|NCT00960440|276373|P2|COMPLETED|Overall Study||103
119614|NCT00960440|276374|P1|COMPLETED|Overall Study||107
119615|NCT00960440|276371|P4|STARTED|Overall Study||66
119616|NCT00960440|276372|P3|STARTED|Overall Study||66
119617|NCT00960440|276373|P2|STARTED|Overall Study||134
119618|NCT00960440|276374|P1|STARTED|Overall Study||133
119619|NCT00960375|276546|P2|NOT COMPLETED|Overall Study||22
119620|NCT00960375|276547|P1|NOT COMPLETED|Overall Study||20
119621|NCT00960375|276546|P2|COMPLETED|Overall Study||65
119622|NCT00960375|276547|P1|COMPLETED|Overall Study||72
119623|NCT00960375|276546|P2|STARTED|Overall Study||87
119624|NCT00960375|276547|P1|STARTED|Overall Study||92
119625|NCT00960323|276555|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
119626|NCT00960323|276555|P1|COMPLETED|Colchicine and Atorvastatin||23
119627|NCT00960323|276555|P1|STARTED|Colchicine and Atorvastatin||23
119628|NCT00960323|276555|P1|NOT COMPLETED|Atorvastatin Alone||1
119629|NCT00960323|276555|P1|COMPLETED|Atorvastatin Alone||23
119630|NCT00960323|276555|P1|STARTED|Atorvastatin Alone||24
119631|NCT00960323|276555|P1|NOT COMPLETED|14 Day Washout Period||0
119632|NCT00960323|276555|P1|COMPLETED|14 Day Washout Period||24
119633|NCT00960323|276555|P1|STARTED|14 Day Washout Period||24
119634|NCT00960323|276555|P1|NOT COMPLETED|Colchicine Alone||0
119635|NCT00960323|276555|P1|COMPLETED|Colchicine Alone||24
119636|NCT00960323|276555|P1|STARTED|Colchicine Alone||24
119637|NCT00960297|276566|P1|NOT COMPLETED|Overall Study||3
119638|NCT00960297|276566|P1|COMPLETED|Overall Study||1
119639|NCT00960297|276566|P1|STARTED|Overall Study||4
119640|NCT00960206|276573|P3|NOT COMPLETED|Overall Study||12
119641|NCT00960206|276574|P2|NOT COMPLETED|Overall Study||27
119642|NCT00960206|276575|P1|NOT COMPLETED|Overall Study||40
119643|NCT00960206|276573|P3|COMPLETED|Overall Study||77
119644|NCT00960206|276574|P2|COMPLETED|Overall Study||158
119645|NCT00960206|276575|P1|COMPLETED|Overall Study||150
119646|NCT00960206|276573|P3|STARTED|Overall Study||89
119647|NCT00960206|276574|P2|STARTED|Overall Study||185
119648|NCT00960206|276575|P1|STARTED|Overall Study||190
119649|NCT00960193|276593|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
119650|NCT00960193|276593|P1|COMPLETED|Colchicine With Seville Orange Juice||23
119651|NCT00960193|276593|P1|STARTED|Colchicine With Seville Orange Juice||23
119652|NCT00960193|276593|P1|NOT COMPLETED|Seville Orange Juice Alone||0
119653|NCT00960193|276593|P1|COMPLETED|Seville Orange Juice Alone||23
119654|NCT00960193|276593|P1|STARTED|Seville Orange Juice Alone||23
119655|NCT00960193|276593|P1|NOT COMPLETED|14 Day Washout Period||1
119656|NCT00960193|276593|P1|COMPLETED|14 Day Washout Period||23
119657|NCT00960193|276593|P1|STARTED|14 Day Washout Period||24
119658|NCT00960193|276593|P1|NOT COMPLETED|Colchicine Alone||0
119659|NCT00960193|276593|P1|COMPLETED|Colchicine Alone||24
119660|NCT00960193|276593|P1|STARTED|Colchicine Alone||24
119661|NCT00960154|276606|P2|NOT COMPLETED|Overall Study||25
119662|NCT00960154|276607|P1|NOT COMPLETED|Overall Study||25
119663|NCT00960154|276606|P2|COMPLETED|Overall Study||0
119664|NCT00960154|276607|P1|COMPLETED|Overall Study||0
119665|NCT00960154|276606|P2|STARTED|Overall Study||25
119666|NCT00960154|276607|P1|STARTED|Overall Study||25
119667|NCT00960141|276618|P3|NOT COMPLETED|Overall Study||7
119668|NCT00960141|276619|P2|NOT COMPLETED|Overall Study||17
119669|NCT00960141|276620|P1|NOT COMPLETED|Overall Study||10
119670|NCT00960141|276618|P3|COMPLETED|Overall Study||163
119671|NCT00960141|276619|P2|COMPLETED|Overall Study||309
119672|NCT00960141|276620|P1|COMPLETED|Overall Study||323
119673|NCT00960141|276618|P3|STARTED|Overall Study||170
119674|NCT00960141|276619|P2|STARTED|Overall Study||326
119675|NCT00960141|276620|P1|STARTED|Overall Study||333
119676|NCT00960115|276645|P2|NOT COMPLETED|Overall Study||15
119677|NCT00960115|276646|P1|NOT COMPLETED|Overall Study||19
119678|NCT00960115|276645|P2|COMPLETED|Overall Study||43
119679|NCT00960115|276646|P1|COMPLETED|Overall Study||95
119680|NCT00960115|276645|P2|STARTED|Overall Study||58
119681|NCT00960115|276646|P1|STARTED|Overall Study||114
119682|NCT00960076|276660|P2|NOT COMPLETED|Overall Study||25
119683|NCT00960076|276661|P1|NOT COMPLETED|Overall Study||8
119684|NCT00960076|276660|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
119685|NCT00960076|276661|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
119686|NCT00960076|276660|P2|STARTED|Overall Study|Randomized and treated|144
119687|NCT00960076|276661|P1|STARTED|Overall Study|Randomized and treated|138
119688|NCT00960063|276676|P3|NOT COMPLETED|Overall Study||3
119689|NCT00960063|276677|P2|NOT COMPLETED|Overall Study||0
119690|NCT00960063|276678|P1|NOT COMPLETED|Overall Study||1
119691|NCT00960063|276676|P3|COMPLETED|Overall Study||0
119692|NCT00960063|276677|P2|COMPLETED|Overall Study||0
119693|NCT00960063|276678|P1|COMPLETED|Overall Study||0
119694|NCT00960063|276676|P3|STARTED|Overall Study||3
119695|NCT00960063|276677|P2|STARTED|Overall Study||0
119696|NCT00960063|276678|P1|STARTED|Overall Study||1
119697|NCT00959946|276724|P8|NOT COMPLETED|Overall Study||2
119698|NCT00959946|276725|P7|NOT COMPLETED|Overall Study||2
119699|NCT00959946|276726|P6|NOT COMPLETED|Overall Study||9
119700|NCT00959946|276727|P5|NOT COMPLETED|Overall Study||4
119701|NCT00959946|276728|P4|NOT COMPLETED|Overall Study||5
119702|NCT00959946|276729|P3|NOT COMPLETED|Overall Study||4
119703|NCT00959946|276730|P2|NOT COMPLETED|Overall Study||4
119704|NCT00959946|276731|P1|NOT COMPLETED|Overall Study||2
119705|NCT00959946|276724|P8|COMPLETED|Overall Study||0
119706|NCT00959946|276725|P7|COMPLETED|Overall Study||0
119707|NCT00959946|276726|P6|COMPLETED|Overall Study||0
119708|NCT00959946|276727|P5|COMPLETED|Overall Study||0
119709|NCT00959946|276728|P4|COMPLETED|Overall Study||0
119710|NCT00959946|276729|P3|COMPLETED|Overall Study||0
119711|NCT00959946|276730|P2|COMPLETED|Overall Study||0
119712|NCT00959946|276731|P1|COMPLETED|Overall Study||0
119713|NCT00959946|276724|P8|STARTED|Overall Study||2
119714|NCT00959946|276725|P7|STARTED|Overall Study||2
119715|NCT00959946|276726|P6|STARTED|Overall Study||9
119716|NCT00959946|276727|P5|STARTED|Overall Study||4
119717|NCT00959946|276728|P4|STARTED|Overall Study||5
119718|NCT00959946|276729|P3|STARTED|Overall Study||4
119719|NCT00959946|276730|P2|STARTED|Overall Study||4
119720|NCT00959946|276731|P1|STARTED|Overall Study||2
119721|NCT00959920|276784|P2|NOT COMPLETED|Overall Study||1
119722|NCT00959920|276785|P1|NOT COMPLETED|Overall Study||0
119723|NCT00959920|276784|P2|COMPLETED|Overall Study||66
119724|NCT00959920|276785|P1|COMPLETED|Overall Study||72
119725|NCT00959920|276784|P2|STARTED|Overall Study||67
119726|NCT00959920|276785|P1|STARTED|Overall Study||72
119727|NCT00959907|276793|P2|NOT COMPLETED|Overall Study||1
119728|NCT00959907|276794|P1|NOT COMPLETED|Overall Study||3
119729|NCT00959907|276793|P2|COMPLETED|Overall Study||28
119730|NCT00959907|276794|P1|COMPLETED|Overall Study||27
119731|NCT00959907|276793|P2|STARTED|Overall Study||29
119732|NCT00959907|276794|P1|STARTED|Overall Study||30
119733|NCT00959894|276804|P1|NOT COMPLETED|Overall Study||16
119734|NCT00959894|276804|P1|COMPLETED|Overall Study||63
119735|NCT00959894|276804|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
119736|NCT00959764|276835|P3|NOT COMPLETED|Overall Study||36
119737|NCT00959764|276836|P2|NOT COMPLETED|Overall Study||57
119738|NCT00959764|276837|P1|NOT COMPLETED|Overall Study||95
119739|NCT00959764|276835|P3|COMPLETED|Overall Study||73
119740|NCT00959764|276836|P2|COMPLETED|Overall Study||128
119741|NCT00959764|276837|P1|COMPLETED|Overall Study||176
119742|NCT00959764|276835|P3|STARTED|Overall Study||109
119743|NCT00959764|276836|P2|STARTED|Overall Study||185
119744|NCT00959764|276837|P1|STARTED|Overall Study||271
119745|NCT00959751|276853|P2|NOT COMPLETED|Overall Study||12
119746|NCT00959751|276854|P1|NOT COMPLETED|Overall Study||9
119747|NCT00959751|276853|P2|COMPLETED|Overall Study||86
119748|NCT00959751|276854|P1|COMPLETED|Overall Study||88
119749|NCT00959751|276853|P2|STARTED|Overall Study||98
119750|NCT00959751|276854|P1|STARTED|Overall Study||97
119751|NCT00959699|276876|P2|NOT COMPLETED|Follow-up Period||6
119752|NCT00959699|276877|P1|NOT COMPLETED|Follow-up Period||6
119753|NCT00959699|276876|P2|COMPLETED|Follow-up Period||56
119754|NCT00959699|276877|P1|COMPLETED|Follow-up Period||27
119755|NCT00959699|276876|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
119756|NCT00959699|276877|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
119757|NCT00959699|276876|P2|NOT COMPLETED|Treatment Period||25
119758|NCT00959699|276877|P1|NOT COMPLETED|Treatment Period||23
119759|NCT00959699|276876|P2|COMPLETED|Treatment Period||40
119760|NCT00959699|276877|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
119761|NCT00959699|276876|P2|Treated|Treatment Period||64
119762|NCT00959699|276877|P1|Treated|Treatment Period||34
119763|NCT00959699|276876|P2|STARTED|Treatment Period||65
119764|NCT00959699|276877|P1|STARTED|Treatment Period||34
119765|NCT00959647|276894|P1|NOT COMPLETED|Overall Study||19
119766|NCT00959647|276894|P1|COMPLETED|Overall Study||0
119767|NCT00959647|276894|P1|STARTED|Overall Study||19
119768|NCT00959374|276899|P1|NOT COMPLETED|Overall Study||23
119769|NCT00959374|276899|P1|COMPLETED|Overall Study||218
119770|NCT00959374|276899|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
119771|NCT00959192|276913|P4|NOT COMPLETED|Overall Study||1
119772|NCT00959192|276914|P3|NOT COMPLETED|Overall Study||3
119773|NCT00959192|276915|P2|NOT COMPLETED|Overall Study||1
119774|NCT00959192|276916|P1|NOT COMPLETED|Overall Study||2
119775|NCT00959192|276913|P4|COMPLETED|Overall Study||7
119776|NCT00959192|276914|P3|COMPLETED|Overall Study||6
119777|NCT00959192|276915|P2|COMPLETED|Overall Study||8
119778|NCT00959192|276916|P1|COMPLETED|Overall Study||4
119779|NCT00959192|276913|P4|STARTED|Overall Study||8
119780|NCT00959192|276914|P3|STARTED|Overall Study||9
119781|NCT00959192|276915|P2|STARTED|Overall Study||9
119782|NCT00959192|276916|P1|STARTED|Overall Study||6
119783|NCT00959049|276964|P6|NOT COMPLETED|Overall Study||1
119784|NCT00959049|276965|P5|NOT COMPLETED|Overall Study||9
119785|NCT00959049|276966|P4|NOT COMPLETED|Overall Study||11
119786|NCT00959049|276967|P3|NOT COMPLETED|Overall Study||1
119787|NCT00959049|276968|P2|NOT COMPLETED|Overall Study||7
119788|NCT00959049|276969|P1|NOT COMPLETED|Overall Study||18
119789|NCT00959049|276964|P6|COMPLETED|Overall Study||249
119790|NCT00959049|276965|P5|COMPLETED|Overall Study||248
119791|NCT00959049|276966|P4|COMPLETED|Overall Study||217
119792|NCT00959049|276967|P3|COMPLETED|Overall Study||253
119793|NCT00959049|276968|P2|COMPLETED|Overall Study||247
119794|NCT00959049|276969|P1|COMPLETED|Overall Study||213
119795|NCT00959049|276964|P6|STARTED|Overall Study||250
119796|NCT00959049|276965|P5|STARTED|Overall Study||257
119797|NCT00959049|276966|P4|STARTED|Overall Study||228
119798|NCT00959049|276967|P3|STARTED|Overall Study||254
119799|NCT00959049|276968|P2|STARTED|Overall Study||254
119800|NCT00959049|276969|P1|STARTED|Overall Study||231
119801|NCT00958919|277019|P2|NOT COMPLETED|Second Intervention||0
119802|NCT00958919|277020|P1|NOT COMPLETED|Second Intervention||0
119803|NCT00958919|277019|P2|COMPLETED|Second Intervention||7
119804|NCT00958919|277020|P1|COMPLETED|Second Intervention||7
119805|NCT00958919|277019|P2|STARTED|Second Intervention||7
119806|NCT00958919|277020|P1|STARTED|Second Intervention||7
119807|NCT00958919|277019|P2|NOT COMPLETED|First Intervention||0
119808|NCT00958919|277020|P1|NOT COMPLETED|First Intervention||0
119809|NCT00958919|277019|P2|COMPLETED|First Intervention||7
119810|NCT00958919|277020|P1|COMPLETED|First Intervention||7
119811|NCT00958919|277019|P2|STARTED|First Intervention||7
119812|NCT00958919|277020|P1|STARTED|First Intervention||7
119813|NCT00958893|277034|P1|NOT COMPLETED|Overall Study||4
119814|NCT00958893|277034|P1|COMPLETED|Overall Study||0
119815|NCT00958893|277034|P1|STARTED|Overall Study||4
119816|NCT00958880|277040|P2|NOT COMPLETED|Overall Study||2
119817|NCT00958880|277041|P1|NOT COMPLETED|Overall Study||2
119818|NCT00958880|277040|P2|COMPLETED|Overall Study||18
119819|NCT00958880|277041|P1|COMPLETED|Overall Study||18
119820|NCT00958880|277040|P2|STARTED|Overall Study||20
119821|NCT00958880|277041|P1|STARTED|Overall Study||20
119822|NCT00958841|277049|P1|NOT COMPLETED|Overall Study||96
119823|NCT00958841|277049|P1|COMPLETED|Overall Study|Completed = Completed extension|22
119824|NCT00958841|277049|P1|Entered in Extension|Overall Study||63
119825|NCT00958841|277049|P1|Completed Month 6 (M6)|Overall Study||90
119826|NCT00958841|277049|P1|STARTED|Overall Study||118
119827|NCT00958828|277067|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
119828|NCT00958828|277068|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
119829|NCT00958828|277067|P2|COMPLETED|Period 2, 1 Week of Wear||87
119830|NCT00958828|277068|P1|COMPLETED|Period 2, 1 Week of Wear||89
119831|NCT00958828|277067|P2|STARTED|Period 2, 1 Week of Wear||88
119832|NCT00958828|277068|P1|STARTED|Period 2, 1 Week of Wear||89
119833|NCT00958828|277067|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
119834|NCT00958828|277068|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
119835|NCT00958828|277067|P2|COMPLETED|Period 1, 1 Week of Wear||88
119836|NCT00958828|277068|P1|COMPLETED|Period 1, 1 Week of Wear||89
119837|NCT00958828|277067|P2|STARTED|Period 1, 1 Week of Wear||89
119838|NCT00958828|277068|P1|STARTED|Period 1, 1 Week of Wear||89
119839|NCT00958776|277076|P2|NOT COMPLETED|Overall Study||29
119840|NCT00958776|277077|P1|NOT COMPLETED|Overall Study||16
119841|NCT00958776|277076|P2|COMPLETED|Overall Study||239
119842|NCT00958776|277077|P1|COMPLETED|Overall Study||121
119843|NCT00958776|277076|P2|STARTED|Overall Study||268
119844|NCT00958776|277077|P1|STARTED|Overall Study||137
119845|NCT00958568|277107|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
119846|NCT00958568|277108|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
119847|NCT00958568|277109|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119848|NCT00958568|277110|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119849|NCT00958568|277107|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
119850|NCT00958568|277108|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
119851|NCT00958568|277109|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119852|NCT00958568|277110|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119853|NCT00958568|277107|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
119854|NCT00958568|277108|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
119855|NCT00958568|277109|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119856|NCT00958568|277110|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
119857|NCT00958568|277107|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119858|NCT00958568|277108|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119859|NCT00958568|277109|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
119860|NCT00958568|277110|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119861|NCT00958568|277107|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119862|NCT00958568|277108|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119863|NCT00958568|277109|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
119864|NCT00958568|277110|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
119865|NCT00958568|277107|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
119866|NCT00958568|277108|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
119867|NCT00958568|277109|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
119868|NCT00958568|277110|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
119869|NCT00958568|277107|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119870|NCT00958568|277108|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119871|NCT00958568|277109|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119872|NCT00958568|277110|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
119873|NCT00958568|277107|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119874|NCT00958568|277108|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119875|NCT00958568|277109|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
119876|NCT00958568|277110|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
119877|NCT00958568|277107|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
119878|NCT00958568|277108|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
119879|NCT00958568|277109|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
119880|NCT00958568|277110|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
119881|NCT00958360|277193|P2|NOT COMPLETED|Overall Study||10
119882|NCT00958360|277194|P1|NOT COMPLETED|Overall Study||11
119883|NCT00958360|277193|P2|COMPLETED|Overall Study||150
119884|NCT00958360|277194|P1|COMPLETED|Overall Study||152
119885|NCT00958360|277193|P2|STARTED|Overall Study||160
119886|NCT00958360|277194|P1|STARTED|Overall Study||163
119887|NCT00958347|277208|P1|NOT COMPLETED|Overall Study||226
119888|NCT00958347|277208|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
119889|NCT00958347|277208|P1|STARTED|Overall Study||226
119890|NCT00958334|277215|P3|NOT COMPLETED|Overall Study||13
119891|NCT00958334|277216|P2|NOT COMPLETED|Overall Study||17
119892|NCT00958334|277217|P1|NOT COMPLETED|Overall Study||14
119893|NCT00958334|277215|P3|COMPLETED|Overall Study||8
119894|NCT00958334|277216|P2|COMPLETED|Overall Study||5
119895|NCT00958334|277217|P1|COMPLETED|Overall Study||8
119896|NCT00958334|277215|P3|STARTED|Overall Study||21
119897|NCT00958334|277216|P2|STARTED|Overall Study||22
119898|NCT00958334|277217|P1|STARTED|Overall Study||22
119899|NCT00958308|277228|P3|NOT COMPLETED|Overall Study||0
119900|NCT00958308|277229|P2|NOT COMPLETED|Overall Study||0
119901|NCT00958308|277230|P1|NOT COMPLETED|Overall Study||0
119902|NCT00958308|277228|P3|COMPLETED|Overall Study||86
119903|NCT00958308|277229|P2|COMPLETED|Overall Study||85
119904|NCT00958308|277230|P1|COMPLETED|Overall Study||84
119905|NCT00958308|277228|P3|STARTED|Overall Study||86
119906|NCT00958308|277229|P2|STARTED|Overall Study||85
119907|NCT00958308|277230|P1|STARTED|Overall Study||84
119908|NCT00958282|277240|P2|NOT COMPLETED|Overall Study||6
119909|NCT00958282|277241|P1|NOT COMPLETED|Overall Study||10
119910|NCT00958282|277240|P2|COMPLETED|Overall Study||15
119911|NCT00958282|277241|P1|COMPLETED|Overall Study||12
119912|NCT00958282|277240|P2|STARTED|Overall Study||21
119913|NCT00958282|277241|P1|STARTED|Overall Study||22
119914|NCT00958256|277249|P1|NOT COMPLETED|Overall Study||3
119915|NCT00958256|277249|P1|COMPLETED|Overall Study||18
119916|NCT00958256|277249|P1|STARTED|Overall Study||21
119917|NCT00958243|277259|P6|NOT COMPLETED|Overall Study||10
119918|NCT00958243|277260|P5|NOT COMPLETED|Overall Study||9
119919|NCT00958243|277261|P4|NOT COMPLETED|Overall Study||3
119920|NCT00958243|277262|P3|NOT COMPLETED|Overall Study||14
119921|NCT00958243|277263|P2|NOT COMPLETED|Overall Study||6
119922|NCT00958243|277264|P1|NOT COMPLETED|Overall Study||2
119923|NCT00958243|277259|P6|COMPLETED|Overall Study||99
119924|NCT00958243|277260|P5|COMPLETED|Overall Study||100
119925|NCT00958243|277261|P4|COMPLETED|Overall Study||25
119926|NCT00958243|277262|P3|COMPLETED|Overall Study||82
119927|NCT00958243|277263|P2|COMPLETED|Overall Study||99
119928|NCT00958243|277264|P1|COMPLETED|Overall Study||24
119929|NCT00958243|277259|P6|STARTED|Overall Study||109
119930|NCT00958243|277260|P5|STARTED|Overall Study||109
119931|NCT00958243|277261|P4|STARTED|Overall Study||28
119932|NCT00958243|277262|P3|STARTED|Overall Study||96
119933|NCT00958243|277263|P2|STARTED|Overall Study||105
119934|NCT00958243|277264|P1|STARTED|Overall Study||26
119935|NCT00958217|277322|P2|NOT COMPLETED|Overall Study||25
119936|NCT00958217|277323|P1|NOT COMPLETED|Overall Study||24
119937|NCT00958217|277322|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
119938|NCT00958217|277323|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
119939|NCT00958217|277322|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
119940|NCT00958217|277323|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
119941|NCT00958217|277322|P2|STARTED|Overall Study||62
119942|NCT00958217|277323|P1|STARTED|Overall Study||61
119943|NCT00958191|277334|P1|NOT COMPLETED|Overall Study||112
120032|NCT00957684|277548|P1|Patients Entered Part II|PART II||0
119944|NCT00958191|277334|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|110
119945|NCT00958191|277334|P1|STARTED|Overall Study||222
119946|NCT00958165|277347|P1|NOT COMPLETED|Overall Study||14
119947|NCT00958165|277347|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
119948|NCT00958165|277347|P1|Treated|Overall Study||72
119949|NCT00958165|277347|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
119950|NCT00958126|277359|P8|NOT COMPLETED|Overall Study||0
119951|NCT00958126|277360|P7|NOT COMPLETED|Overall Study||1
119952|NCT00958126|277361|P6|NOT COMPLETED|Overall Study||1
119953|NCT00958126|277362|P5|NOT COMPLETED|Overall Study||0
119954|NCT00958126|277363|P4|NOT COMPLETED|Overall Study||11
119955|NCT00958126|277364|P3|NOT COMPLETED|Overall Study||10
119956|NCT00958126|277365|P2|NOT COMPLETED|Overall Study||9
119957|NCT00958126|277366|P1|NOT COMPLETED|Overall Study||1
119958|NCT00958126|277359|P8|COMPLETED|Overall Study||202
119959|NCT00958126|277360|P7|COMPLETED|Overall Study||199
119960|NCT00958126|277361|P6|COMPLETED|Overall Study||202
119961|NCT00958126|277362|P5|COMPLETED|Overall Study||50
119962|NCT00958126|277363|P4|COMPLETED|Overall Study||192
119963|NCT00958126|277364|P3|COMPLETED|Overall Study||191
119964|NCT00958126|277365|P2|COMPLETED|Overall Study||196
119965|NCT00958126|277366|P1|COMPLETED|Overall Study||48
119966|NCT00958126|277359|P8|STARTED|Overall Study||202
119967|NCT00958126|277360|P7|STARTED|Overall Study||200
119968|NCT00958126|277361|P6|STARTED|Overall Study||203
119969|NCT00958126|277362|P5|STARTED|Overall Study||50
119970|NCT00958126|277363|P4|STARTED|Overall Study||203
119971|NCT00958126|277364|P3|STARTED|Overall Study||201
119972|NCT00958126|277365|P2|STARTED|Overall Study||205
119973|NCT00958126|277366|P1|STARTED|Overall Study||49
119974|NCT00958074|277438|P2|NOT COMPLETED|Overall Study||1
119975|NCT00958074|277439|P1|NOT COMPLETED|Overall Study||0
119976|NCT00958074|277438|P2|COMPLETED|Overall Study||6
119977|NCT00958074|277439|P1|COMPLETED|Overall Study||4
119978|NCT00958074|277438|P2|STARTED|Overall Study||7
119979|NCT00958074|277439|P1|STARTED|Overall Study||4
119980|NCT00958035|277447|P2|NOT COMPLETED|Overall Study||4
119981|NCT00958035|277448|P1|NOT COMPLETED|Overall Study||3
119982|NCT00958035|277447|P2|COMPLETED|Overall Study||39
119983|NCT00958035|277448|P1|COMPLETED|Overall Study||43
119984|NCT00958035|277447|P2|STARTED|Overall Study||43
119985|NCT00958035|277448|P1|STARTED|Overall Study||46
119986|NCT00958009|277454|P1|NOT COMPLETED|Overall Study||2
119987|NCT00958009|277454|P1|COMPLETED|Overall Study||107
119988|NCT00958009|277454|P1|STARTED|Overall Study||109
119989|NCT00957996|277461|P2|NOT COMPLETED|Overall Study||28
119990|NCT00957996|277462|P1|NOT COMPLETED|Overall Study||26
119991|NCT00957996|277461|P2|COMPLETED|Overall Study||89
119992|NCT00957996|277462|P1|COMPLETED|Overall Study||91
119993|NCT00957996|277461|P2|STARTED|Overall Study||117
119994|NCT00957996|277462|P1|STARTED|Overall Study||117
119995|NCT00957944|277494|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
119996|NCT00957944|277495|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
119997|NCT00957944|277494|P2|COMPLETED|Second Intervention- 24 Hours||19
119998|NCT00957944|277495|P1|COMPLETED|Second Intervention- 24 Hours||20
119999|NCT00957944|277494|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
120000|NCT00957944|277495|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
120001|NCT00957944|277494|P2|STARTED|Second Intervention- 24 Hours||19
120002|NCT00957944|277495|P1|STARTED|Second Intervention- 24 Hours||20
120003|NCT00957944|277494|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
120004|NCT00957944|277495|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
120005|NCT00957944|277494|P2|COMPLETED|Washout Period of at Least 5 Days||19
120006|NCT00957944|277495|P1|COMPLETED|Washout Period of at Least 5 Days||20
120007|NCT00957944|277494|P2|STARTED|Washout Period of at Least 5 Days||19
120008|NCT00957944|277495|P1|STARTED|Washout Period of at Least 5 Days||20
120009|NCT00957944|277494|P2|NOT COMPLETED|First Intervention- 24 Hours||1
120010|NCT00957944|277495|P1|NOT COMPLETED|First Intervention- 24 Hours||0
120011|NCT00957944|277494|P2|COMPLETED|First Intervention- 24 Hours||19
120012|NCT00957944|277495|P1|COMPLETED|First Intervention- 24 Hours||20
120013|NCT00957944|277494|P2|STARTED|First Intervention- 24 Hours||20
120014|NCT00957944|277495|P1|STARTED|First Intervention- 24 Hours||20
120015|NCT00957723|277529|P1|NOT COMPLETED|Overall Study||121
120016|NCT00957723|277529|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
120017|NCT00957723|277529|P1|STARTED|Overall Study||419
120018|NCT00957684|277544|P5|NOT COMPLETED|PART II||75
120019|NCT00957684|277545|P4|NOT COMPLETED|PART II||0
120020|NCT00957684|277546|P3|NOT COMPLETED|PART II||0
120021|NCT00957684|277547|P2|NOT COMPLETED|PART II||0
120022|NCT00957684|277548|P1|NOT COMPLETED|PART II||0
120023|NCT00957684|277544|P5|COMPLETED|PART II||239
120024|NCT00957684|277545|P4|COMPLETED|PART II||0
120025|NCT00957684|277546|P3|COMPLETED|PART II||0
120026|NCT00957684|277547|P2|COMPLETED|PART II||0
120027|NCT00957684|277548|P1|COMPLETED|PART II||0
120028|NCT00957684|277544|P5|Patients Entered Part II|PART II||314
120029|NCT00957684|277545|P4|Patients Entered Part II|PART II||0
120030|NCT00957684|277546|P3|Patients Entered Part II|PART II||0
120031|NCT00957684|277547|P2|Patients Entered Part II|PART II||0
120033|NCT00957684|277544|P5|STARTED|PART II||314
120034|NCT00957684|277545|P4|STARTED|PART II||0
120035|NCT00957684|277546|P3|STARTED|PART II||0
120036|NCT00957684|277547|P2|STARTED|PART II||0
120037|NCT00957684|277548|P1|STARTED|PART II||0
120038|NCT00957684|277544|P5|NOT COMPLETED|PART I||0
120039|NCT00957684|277545|P4|NOT COMPLETED|PART I||18
120040|NCT00957684|277546|P3|NOT COMPLETED|PART I||10
120041|NCT00957684|277547|P2|NOT COMPLETED|PART I||13
120042|NCT00957684|277548|P1|NOT COMPLETED|PART I||31
120043|NCT00957684|277544|P5|COMPLETED|PART I||0
120044|NCT00957684|277545|P4|COMPLETED|PART I||84
120045|NCT00957684|277546|P3|COMPLETED|PART I||90
120046|NCT00957684|277547|P2|COMPLETED|PART I||85
120047|NCT00957684|277548|P1|COMPLETED|PART I||71
120048|NCT00957684|277544|P5|Per-protocol (PP)Population|PART I||0
120049|NCT00957684|277545|P4|Per-protocol (PP)Population|PART I||91
120050|NCT00957684|277546|P3|Per-protocol (PP)Population|PART I||94
120051|NCT00957684|277547|P2|Per-protocol (PP)Population|PART I||86
120052|NCT00957684|277548|P1|Per-protocol (PP)Population|PART I||72
120053|NCT00957684|277544|P5|Intention-to-treat (ITT) Population|PART I||0
120054|NCT00957684|277545|P4|Intention-to-treat (ITT) Population|PART I||102
120055|NCT00957684|277546|P3|Intention-to-treat (ITT) Population|PART I||99
120056|NCT00957684|277547|P2|Intention-to-treat (ITT) Population|PART I||98
120057|NCT00957684|277548|P1|Intention-to-treat (ITT) Population|PART I||98
120058|NCT00957684|277544|P5|Randomised (Safety Population)|PART I||0
120059|NCT00957684|277545|P4|Randomised (Safety Population)|PART I||102
120060|NCT00957684|277546|P3|Randomised (Safety Population)|PART I||100
120061|NCT00957684|277547|P2|Randomised (Safety Population)|PART I||98
120062|NCT00957684|277548|P1|Randomised (Safety Population)|PART I||102
120063|NCT00957684|277544|P5|STARTED|PART I||0
120064|NCT00957684|277545|P4|STARTED|PART I||102
120065|NCT00957684|277546|P3|STARTED|PART I||100
120066|NCT00957684|277547|P2|STARTED|PART I||98
120067|NCT00957684|277548|P1|STARTED|PART I||102
120068|NCT00957658|277558|P1|NOT COMPLETED|Overall Study||65
120069|NCT00957658|277558|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
120070|NCT00957658|277558|P1|STARTED|Overall Study||234
120071|NCT00956761|277571|P1|NOT COMPLETED|Overall Study||0
120072|NCT00956761|277571|P1|COMPLETED|Overall Study||63
120073|NCT00956761|277571|P1|STARTED|Overall Study||63
120074|NCT00956709|277580|P2|NOT COMPLETED|Overall Study||0
120075|NCT00956709|277581|P1|NOT COMPLETED|Overall Study||0
120076|NCT00956709|277580|P2|COMPLETED|Overall Study||19
120077|NCT00956709|277581|P1|COMPLETED|Overall Study||16
120078|NCT00956709|277580|P2|STARTED|Overall Study||19
120079|NCT00956709|277581|P1|STARTED|Overall Study||16
120080|NCT00956657|277593|P2|NOT COMPLETED|Overall Study||0
120081|NCT00956657|277594|P1|NOT COMPLETED|Overall Study||0
120082|NCT00956657|277593|P2|COMPLETED|Overall Study||13
120083|NCT00956657|277594|P1|COMPLETED|Overall Study||18
120084|NCT00956657|277593|P2|STARTED|Overall Study||13
120085|NCT00956657|277594|P1|STARTED|Overall Study||18
120086|NCT00957593|277602|P2|NOT COMPLETED|Overall Study||0
120087|NCT00957593|277603|P1|NOT COMPLETED|Overall Study||0
120088|NCT00957593|277602|P2|COMPLETED|Overall Study||125
120089|NCT00957593|277603|P1|COMPLETED|Overall Study||127
120090|NCT00957593|277602|P2|STARTED|Overall Study||125
120091|NCT00957593|277603|P1|STARTED|Overall Study||127
120092|NCT00957528|277612|P3|NOT COMPLETED|Overall Study||1
120093|NCT00957528|277613|P2|NOT COMPLETED|Overall Study||1
120094|NCT00957528|277614|P1|NOT COMPLETED|Overall Study||0
120095|NCT00957528|277612|P3|COMPLETED|Overall Study||8
120096|NCT00957528|277613|P2|COMPLETED|Overall Study||8
120097|NCT00957528|277614|P1|COMPLETED|Overall Study||8
120098|NCT00957528|277612|P3|STARTED|Overall Study||9
120099|NCT00957528|277613|P2|STARTED|Overall Study||9
120100|NCT00957528|277614|P1|STARTED|Overall Study||8
120101|NCT00957424|277637|P1|NOT COMPLETED|Overall Study||23
120102|NCT00957424|277637|P1|COMPLETED|Overall Study||44
120103|NCT00957424|277637|P1|Follow-up #2|Overall Study||50
120104|NCT00957424|277637|P1|Follow-up #1|Overall Study||59
120105|NCT00957424|277637|P1|STARTED|Overall Study||67
120106|NCT00957372|277647|P4|NOT COMPLETED|PART II||44
120107|NCT00957372|277648|P3|NOT COMPLETED|PART II||0
120108|NCT00957372|277649|P2|NOT COMPLETED|PART II||0
120109|NCT00957372|277650|P1|NOT COMPLETED|PART II||0
120110|NCT00957372|277647|P4|COMPLETED|PART II||150
120111|NCT00957372|277648|P3|COMPLETED|PART II||0
120112|NCT00957372|277649|P2|COMPLETED|PART II||0
120113|NCT00957372|277650|P1|COMPLETED|PART II||0
120114|NCT00957372|277647|P4|Per-Protocol Population|PART II||108
120115|NCT00957372|277648|P3|Per-Protocol Population|PART II||0
120116|NCT00957372|277649|P2|Per-Protocol Population|PART II||0
120117|NCT00957372|277650|P1|Per-Protocol Population|PART II||0
120118|NCT00957372|277647|P4|Intention-to-treat (ITT) Population|PART II||191
120119|NCT00957372|277648|P3|Intention-to-treat (ITT) Population|PART II||0
120120|NCT00957372|277649|P2|Intention-to-treat (ITT) Population|PART II||0
120121|NCT00957372|277650|P1|Intention-to-treat (ITT) Population|PART II||0
120122|NCT00957372|277647|P4|Safety Population|PART II||194
120123|NCT00957372|277648|P3|Safety Population|PART II||0
120124|NCT00957372|277649|P2|Safety Population|PART II||0
120125|NCT00957372|277650|P1|Safety Population|PART II||0
120126|NCT00957372|277647|P4|STARTED|PART II||194
120127|NCT00957372|277648|P3|STARTED|PART II||0
120128|NCT00957372|277649|P2|STARTED|PART II||0
120129|NCT00957372|277650|P1|STARTED|PART II||0
120130|NCT00957372|277647|P4|NOT COMPLETED|PART I||0
120131|NCT00957372|277648|P3|NOT COMPLETED|PART I||1
120132|NCT00957372|277649|P2|NOT COMPLETED|PART I||0
120133|NCT00957372|277650|P1|NOT COMPLETED|PART I||0
120134|NCT00957372|277647|P4|COMPLETED|PART I||0
120135|NCT00957372|277648|P3|COMPLETED|PART I||87
120136|NCT00957372|277649|P2|COMPLETED|PART I||85
120137|NCT00957372|277650|P1|COMPLETED|PART I||80
120138|NCT00957372|277647|P4|Randomized But Not Treated|PART I||0
120139|NCT00957372|277648|P3|Randomized But Not Treated|PART I||1
120140|NCT00957372|277649|P2|Randomized But Not Treated|PART I||0
120141|NCT00957372|277650|P1|Randomized But Not Treated|PART I||0
120142|NCT00957372|277647|P4|Per-Protocol Population|PART I||0
120143|NCT00957372|277648|P3|Per-Protocol Population|PART I||51
120144|NCT00957372|277649|P2|Per-Protocol Population|PART I||47
120145|NCT00957372|277650|P1|Per-Protocol Population|PART I||35
120146|NCT00957372|277647|P4|Intention-to-Treat Population|PART I||0
120147|NCT00957372|277648|P3|Intention-to-Treat Population|PART I||84
120148|NCT00957372|277649|P2|Intention-to-Treat Population|PART I||84
120149|NCT00957372|277650|P1|Intention-to-Treat Population|PART I||77
120150|NCT00957372|277647|P4|Safety Population|PART I||0
120151|NCT00957372|277648|P3|Safety Population|PART I||87
120152|NCT00957372|277649|P2|Safety Population|PART I||85
120153|NCT00957372|277650|P1|Safety Population|PART I||80
120154|NCT00957372|277647|P4|STARTED|PART I||0
120155|NCT00957372|277648|P3|STARTED|PART I||88
120156|NCT00957372|277649|P2|STARTED|PART I||85
120157|NCT00957372|277650|P1|STARTED|PART I||80
120158|NCT00957333|277666|P1|NOT COMPLETED|Overall Study||0
120159|NCT00957333|277666|P1|COMPLETED|Overall Study||44
120160|NCT00957333|277666|P1|STARTED|Overall Study||44
120161|NCT00957268|277675|P5|NOT COMPLETED|Overall Study||0
120162|NCT00957268|277676|P4|NOT COMPLETED|Overall Study||0
120163|NCT00957268|277677|P3|NOT COMPLETED|Overall Study||1
120164|NCT00957268|277678|P2|NOT COMPLETED|Overall Study||0
120165|NCT00957268|277679|P1|NOT COMPLETED|Overall Study||0
120166|NCT00957268|277675|P5|COMPLETED|Overall Study||22
120167|NCT00957268|277676|P4|COMPLETED|Overall Study||7
120168|NCT00957268|277677|P3|COMPLETED|Overall Study||7
120169|NCT00957268|277678|P2|COMPLETED|Overall Study||4
120170|NCT00957268|277679|P1|COMPLETED|Overall Study||5
120171|NCT00957268|277675|P5|STARTED|Overall Study||22
120172|NCT00957268|277676|P4|STARTED|Overall Study||7
120173|NCT00957268|277677|P3|STARTED|Overall Study||8
120174|NCT00957268|277678|P2|STARTED|Overall Study||4
120175|NCT00957268|277679|P1|STARTED|Overall Study||5
120176|NCT00957242|277743|P2|NOT COMPLETED|Overall Study||0
120177|NCT00957242|277744|P1|NOT COMPLETED|Overall Study||0
120178|NCT00957242|277743|P2|COMPLETED|Overall Study||72
120179|NCT00957242|277744|P1|COMPLETED|Overall Study||73
120180|NCT00957242|277743|P2|STARTED|Overall Study||72
120181|NCT00957242|277744|P1|STARTED|Overall Study||73
120182|NCT00957047|277776|P5|NOT COMPLETED|PART II||102
120183|NCT00957047|277777|P4|NOT COMPLETED|PART II||0
120184|NCT00957047|277778|P3|NOT COMPLETED|PART II||0
120185|NCT00957047|277779|P2|NOT COMPLETED|PART II||0
120186|NCT00957047|277780|P1|NOT COMPLETED|PART II||0
120187|NCT00957047|277776|P5|COMPLETED|PART II||223
120188|NCT00957047|277777|P4|COMPLETED|PART II||0
120189|NCT00957047|277778|P3|COMPLETED|PART II||0
120190|NCT00957047|277779|P2|COMPLETED|PART II||0
120191|NCT00957047|277780|P1|COMPLETED|PART II||0
120192|NCT00957047|277776|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
120193|NCT00957047|277777|P4|Terminated Prematurely|PART II||0
120194|NCT00957047|277778|P3|Terminated Prematurely|PART II||0
120195|NCT00957047|277779|P2|Terminated Prematurely|PART II||0
120196|NCT00957047|277780|P1|Terminated Prematurely|PART II||0
120197|NCT00957047|277776|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
120198|NCT00957047|277777|P4|STARTED|PART II||0
120199|NCT00957047|277778|P3|STARTED|PART II||0
120200|NCT00957047|277779|P2|STARTED|PART II||0
120201|NCT00957047|277780|P1|STARTED|PART II||0
120202|NCT00957047|277776|P5|NOT COMPLETED|PART I||0
120203|NCT00957047|277777|P4|NOT COMPLETED|PART I||30
120204|NCT00957047|277778|P3|NOT COMPLETED|PART I||21
120205|NCT00957047|277779|P2|NOT COMPLETED|PART I||13
120206|NCT00957047|277780|P1|NOT COMPLETED|PART I||6
120207|NCT00957047|277776|P5|COMPLETED|PART I||0
120208|NCT00957047|277777|P4|COMPLETED|PART I||68
120209|NCT00957047|277778|P3|COMPLETED|PART I||80
120210|NCT00957047|277779|P2|COMPLETED|PART I||83
120211|NCT00957047|277780|P1|COMPLETED|PART I||94
120212|NCT00957047|277776|P5|Per-Protocol Population|PART I||0
120213|NCT00957047|277777|P4|Per-Protocol Population|PART I||54
120214|NCT00957047|277778|P3|Per-Protocol Population|PART I||75
120215|NCT00957047|277779|P2|Per-Protocol Population|PART I||70
120216|NCT00957047|277780|P1|Per-Protocol Population|PART I||81
120217|NCT00957047|277776|P5|Intention-to-treat (ITT) Population|PART I||0
120218|NCT00957047|277777|P4|Intention-to-treat (ITT) Population|PART I||97
120219|NCT00957047|277778|P3|Intention-to-treat (ITT) Population|PART I||100
120220|NCT00957047|277779|P2|Intention-to-treat (ITT) Population|PART I||96
120221|NCT00957047|277780|P1|Intention-to-treat (ITT) Population|PART I||100
120222|NCT00957047|277776|P5|Randomized/Safety Population|PART I||0
120223|NCT00957047|277777|P4|Randomized/Safety Population|PART I||98
120224|NCT00957047|277778|P3|Randomized/Safety Population|PART I||101
120225|NCT00957047|277779|P2|Randomized/Safety Population|PART I||96
120226|NCT00957047|277780|P1|Randomized/Safety Population|PART I||100
120227|NCT00957047|277776|P5|STARTED|PART I||0
120228|NCT00957047|277777|P4|STARTED|PART I||98
120229|NCT00957047|277778|P3|STARTED|PART I||101
120230|NCT00957047|277779|P2|STARTED|PART I||96
120231|NCT00957047|277780|P1|STARTED|PART I||100
120232|NCT00957034|277801|P3|NOT COMPLETED|Overall Study||6
120233|NCT00957034|277802|P2|NOT COMPLETED|Overall Study||4
120234|NCT00957034|277803|P1|NOT COMPLETED|Overall Study||6
120235|NCT00957034|277801|P3|COMPLETED|Overall Study||1
120236|NCT00957034|277802|P2|COMPLETED|Overall Study||0
120237|NCT00957034|277803|P1|COMPLETED|Overall Study||0
120238|NCT00957034|277801|P3|STARTED|Overall Study||7
120239|NCT00957034|277802|P2|STARTED|Overall Study||4
120240|NCT00957034|277803|P1|STARTED|Overall Study||6
120241|NCT00957021|277826|P1|NOT COMPLETED|Overall Study||117
120242|NCT00957021|277826|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
120243|NCT00957021|277826|P1|STARTED|Overall Study||354
120244|NCT00957008|277839|P4|NOT COMPLETED|Overall Study||24
120245|NCT00957008|277840|P3|NOT COMPLETED|Overall Study||17
120246|NCT00957008|277841|P2|NOT COMPLETED|Overall Study||12
120247|NCT00957008|277842|P1|NOT COMPLETED|Overall Study||21
120248|NCT00957008|277839|P4|COMPLETED|Overall Study||26
120249|NCT00957008|277840|P3|COMPLETED|Overall Study||32
120250|NCT00957008|277841|P2|COMPLETED|Overall Study||37
120251|NCT00957008|277842|P1|COMPLETED|Overall Study||28
120252|NCT00957008|277839|P4|STARTED|Overall Study||50
120253|NCT00957008|277840|P3|STARTED|Overall Study||49
120254|NCT00957008|277841|P2|STARTED|Overall Study||49
120255|NCT00957008|277842|P1|STARTED|Overall Study||49
120256|NCT00956943|277858|P2|NOT COMPLETED|Overall Study||10
120257|NCT00956943|277859|P1|NOT COMPLETED|Overall Study||9
120258|NCT00956943|277858|P2|COMPLETED|Overall Study||34
120259|NCT00956943|277859|P1|COMPLETED|Overall Study||34
120260|NCT00956943|277858|P2|Baseline|Overall Study||44
120261|NCT00956943|277859|P1|Baseline|Overall Study||43
120262|NCT00956943|277858|P2|STARTED|Overall Study||44
120263|NCT00956943|277859|P1|STARTED|Overall Study||43
120264|NCT00956839|277870|P3|NOT COMPLETED|Overall Study||3
120265|NCT00956839|277871|P2|NOT COMPLETED|Overall Study||0
120266|NCT00956839|277872|P1|NOT COMPLETED|Overall Study||3
120267|NCT00956839|277870|P3|COMPLETED|Overall Study||10
120268|NCT00956839|277871|P2|COMPLETED|Overall Study||13
120269|NCT00956839|277872|P1|COMPLETED|Overall Study||11
120270|NCT00956839|277870|P3|STARTED|Overall Study||13
120271|NCT00956839|277871|P2|STARTED|Overall Study||13
120272|NCT00956839|277872|P1|STARTED|Overall Study||14
120273|NCT00956631|277883|P1|NOT COMPLETED|Overall Study||16
120274|NCT00956631|277883|P1|COMPLETED|Overall Study||62
120275|NCT00956631|277883|P1|STARTED|Overall Study||78
120276|NCT00956592|277891|P2|NOT COMPLETED|Overall Study||3
120277|NCT00956592|277892|P1|NOT COMPLETED|Overall Study||1
120278|NCT00956592|277891|P2|COMPLETED|Overall Study||147
120279|NCT00956592|277892|P1|COMPLETED|Overall Study||149
120280|NCT00956592|277891|P2|STARTED|Overall Study||150
120281|NCT00956592|277892|P1|STARTED|Overall Study||150
120282|NCT00956540|277902|P4|NOT COMPLETED|Overall Study||4
120283|NCT00956540|277903|P3|NOT COMPLETED|Overall Study||3
120284|NCT00956540|277904|P2|NOT COMPLETED|Overall Study||4
120285|NCT00956540|277905|P1|NOT COMPLETED|Overall Study||3
120286|NCT00956540|277902|P4|COMPLETED|Overall Study||41
120287|NCT00956540|277903|P3|COMPLETED|Overall Study||43
120288|NCT00956540|277904|P2|COMPLETED|Overall Study||46
120289|NCT00956540|277905|P1|COMPLETED|Overall Study||51
120290|NCT00956540|277902|P4|STARTED|Overall Study||45
120291|NCT00956540|277903|P3|STARTED|Overall Study||46
120292|NCT00956540|277904|P2|STARTED|Overall Study||50
120293|NCT00956540|277905|P1|STARTED|Overall Study||54
120294|NCT00956293|277917|P3|NOT COMPLETED|Follow-up Period||0
120295|NCT00956293|277918|P2|NOT COMPLETED|Follow-up Period||32
120296|NCT00956293|277919|P1|NOT COMPLETED|Follow-up Period||20
120297|NCT00956293|277917|P3|COMPLETED|Follow-up Period||0
120298|NCT00956293|277918|P2|COMPLETED|Follow-up Period||0
120299|NCT00956293|277919|P1|COMPLETED|Follow-up Period||0
120300|NCT00956293|277917|P3|STARTED|Follow-up Period||0
120301|NCT00956293|277918|P2|STARTED|Follow-up Period||32
120302|NCT00956293|277919|P1|STARTED|Follow-up Period||20
120303|NCT00956293|277917|P3|NOT COMPLETED|Main Period (Randomization)||0
120304|NCT00956293|277918|P2|NOT COMPLETED|Main Period (Randomization)||27
120305|NCT00956293|277919|P1|NOT COMPLETED|Main Period (Randomization)||1
120306|NCT00956293|277917|P3|COMPLETED|Main Period (Randomization)||0
120307|NCT00956293|277918|P2|COMPLETED|Main Period (Randomization)||26
120308|NCT00956293|277919|P1|COMPLETED|Main Period (Randomization)||23
120309|NCT00956293|277917|P3|Randomized Safety Set|Main Period (Randomization)||0
120310|NCT00956293|277918|P2|Randomized Safety Set|Main Period (Randomization)||51
120311|NCT00956293|277919|P1|Randomized Safety Set|Main Period (Randomization)||24
120312|NCT00956293|277917|P3|Full Analysis Set|Main Period (Randomization)||0
120402|NCT00955357|278060|P1|COMPLETED|Titration Phase||80
120313|NCT00956293|277918|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
120314|NCT00956293|277919|P1|Full Analysis Set|Main Period (Randomization)||24
120315|NCT00956293|277917|P3|STARTED|Main Period (Randomization)||0
120316|NCT00956293|277918|P2|STARTED|Main Period (Randomization)||53
120317|NCT00956293|277919|P1|STARTED|Main Period (Randomization)||24
120318|NCT00956293|277917|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
120319|NCT00956293|277918|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
120320|NCT00956293|277919|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
120321|NCT00956293|277917|P3|COMPLETED|Main Period (Pre-randomization)||77
120322|NCT00956293|277918|P2|COMPLETED|Main Period (Pre-randomization)||0
120323|NCT00956293|277919|P1|COMPLETED|Main Period (Pre-randomization)||0
120324|NCT00956293|277917|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
120325|NCT00956293|277918|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
120326|NCT00956293|277919|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
120327|NCT00956293|277917|P3|STARTED|Main Period (Pre-randomization)||207
120328|NCT00956293|277918|P2|STARTED|Main Period (Pre-randomization)||0
120329|NCT00956293|277919|P1|STARTED|Main Period (Pre-randomization)||0
120330|NCT00956254|277943|P1|NOT COMPLETED|Overall Study||0
120331|NCT00956254|277943|P1|COMPLETED|Overall Study||18
120332|NCT00956254|277943|P1|STARTED|Overall Study||18
120333|NCT00956020|277953|P1|NOT COMPLETED|Overall Study||0
120334|NCT00956020|277953|P1|COMPLETED|Overall Study||4
120335|NCT00956020|277953|P1|STARTED|Overall Study||4
120336|NCT00955955|277971|P3|NOT COMPLETED|Overall Study||0
120337|NCT00955955|277972|P2|NOT COMPLETED|Overall Study||0
120338|NCT00955955|277973|P1|NOT COMPLETED|Overall Study||2
120339|NCT00955955|277971|P3|COMPLETED|Overall Study||28
120340|NCT00955955|277972|P2|COMPLETED|Overall Study||28
120341|NCT00955955|277973|P1|COMPLETED|Overall Study||17
120342|NCT00955955|277971|P3|STARTED|Overall Study||28
120343|NCT00955955|277972|P2|STARTED|Overall Study||28
120344|NCT00955955|277973|P1|STARTED|Overall Study||19
120345|NCT00955916|277987|P1|NOT COMPLETED|Overall Study||0
120346|NCT00955916|277987|P1|COMPLETED|Overall Study||38
120347|NCT00955916|277987|P1|STARTED|Overall Study||38
120348|NCT00955825|277995|P2|NOT COMPLETED|Overall Study||17
120349|NCT00955825|277996|P1|NOT COMPLETED|Overall Study||26
120350|NCT00955825|277995|P2|COMPLETED|Overall Study||223
120351|NCT00955825|277996|P1|COMPLETED|Overall Study||207
120352|NCT00955825|277995|P2|STARTED|Overall Study||240
120353|NCT00955825|277996|P1|STARTED|Overall Study||233
120354|NCT00955747|278004|P2|NOT COMPLETED|Overall Study||69
120355|NCT00955747|278005|P1|NOT COMPLETED|Overall Study||69
120356|NCT00955747|278004|P2|COMPLETED|Overall Study||172
120357|NCT00955747|278005|P1|COMPLETED|Overall Study||184
120358|NCT00955747|278004|P2|STARTED|Overall Study||241
120359|NCT00955747|278005|P1|STARTED|Overall Study||253
120360|NCT00955721|278013|P2|NOT COMPLETED|Overall Study||0
120361|NCT00955721|278014|P1|NOT COMPLETED|Overall Study||3
120362|NCT00955721|278013|P2|COMPLETED|Overall Study||0
120363|NCT00955721|278014|P1|COMPLETED|Overall Study||6
120364|NCT00955721|278013|P2|STARTED|Overall Study||0
120365|NCT00955721|278014|P1|STARTED|Overall Study||9
120366|NCT00955617|278022|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
120367|NCT00955617|278023|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
120368|NCT00955617|278022|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
120369|NCT00955617|278023|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
120370|NCT00955617|278022|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
120371|NCT00955617|278023|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
120372|NCT00955617|278022|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
120373|NCT00955617|278023|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
120374|NCT00955617|278022|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
120375|NCT00955617|278023|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
120376|NCT00955617|278022|P2|STARTED|First MRA (Between Day0 and Day21)||10
120377|NCT00955617|278023|P1|STARTED|First MRA (Between Day0 and Day21)||10
120378|NCT00955513|278036|P3|NOT COMPLETED|Overall Study||3
120379|NCT00955513|278037|P2|NOT COMPLETED|Overall Study||2
120380|NCT00955513|278038|P1|NOT COMPLETED|Overall Study||1
120381|NCT00955513|278036|P3|COMPLETED|Overall Study||79
120382|NCT00955513|278037|P2|COMPLETED|Overall Study||78
120383|NCT00955513|278038|P1|COMPLETED|Overall Study||79
120384|NCT00955513|278036|P3|STARTED|Overall Study||82
120385|NCT00955513|278037|P2|STARTED|Overall Study||80
120386|NCT00955513|278038|P1|STARTED|Overall Study||80
120387|NCT00955474|278048|P2|NOT COMPLETED|Overall Study||13
120388|NCT00955474|278049|P1|NOT COMPLETED|Overall Study||12
120389|NCT00955474|278048|P2|COMPLETED|Overall Study||0
120390|NCT00955474|278049|P1|COMPLETED|Overall Study||0
120391|NCT00955474|278048|P2|STARTED|Overall Study||13
120392|NCT00955474|278049|P1|STARTED|Overall Study||12
120393|NCT00955357|278059|P2|NOT COMPLETED|Maintenance Phase||45
120394|NCT00955357|278060|P1|NOT COMPLETED|Maintenance Phase||12
120395|NCT00955357|278059|P2|COMPLETED|Maintenance Phase||249
120396|NCT00955357|278060|P1|COMPLETED|Maintenance Phase||68
120397|NCT00955357|278059|P2|STARTED|Maintenance Phase||294
120398|NCT00955357|278060|P1|STARTED|Maintenance Phase||80
120399|NCT00955357|278059|P2|NOT COMPLETED|Titration Phase||66
120400|NCT00955357|278060|P1|NOT COMPLETED|Titration Phase||16
120401|NCT00955357|278059|P2|COMPLETED|Titration Phase||294
120403|NCT00955357|278059|P2|STARTED|Titration Phase||360
120404|NCT00955357|278060|P1|STARTED|Titration Phase||96
120405|NCT00955305|278068|P2|NOT COMPLETED|Overall Study||87
120406|NCT00955305|278069|P1|NOT COMPLETED|Overall Study||88
120407|NCT00955305|278068|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
120408|NCT00955305|278069|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
120409|NCT00955305|278068|P2|Eligible and Treated|Overall Study||75
120410|NCT00955305|278069|P1|Eligible and Treated|Overall Study||78
120411|NCT00955305|278068|P2|Treated|Overall Study||82
120412|NCT00955305|278069|P1|Treated|Overall Study||83
120413|NCT00955305|278068|P2|STARTED|Overall Study||87
120414|NCT00955305|278069|P1|STARTED|Overall Study||88
120415|NCT00955279|278082|P3|NOT COMPLETED|Overall Study||8
120416|NCT00955279|278083|P2|NOT COMPLETED|Overall Study||4
120417|NCT00955279|278084|P1|NOT COMPLETED|Overall Study||3
120418|NCT00955279|278082|P3|COMPLETED|Overall Study||52
120419|NCT00955279|278083|P2|COMPLETED|Overall Study||51
120420|NCT00955279|278084|P1|COMPLETED|Overall Study||55
120421|NCT00955279|278082|P3|STARTED|Overall Study||60
120422|NCT00955279|278083|P2|STARTED|Overall Study||55
120423|NCT00955279|278084|P1|STARTED|Overall Study||58
120424|NCT00955110|278104|P1|NOT COMPLETED|Treatment Phase||6
120425|NCT00955110|278104|P1|COMPLETED|Treatment Phase||35
120426|NCT00955110|278104|P1|Oxycodone CR 60 mg|Treatment Phase||40
120427|NCT00955110|278104|P1|Oxycodone CR 30 mg|Treatment Phase||40
120428|NCT00955110|278104|P1|Oxymorphone ER 30 mg|Treatment Phase||38
120429|NCT00955110|278104|P1|Oxymorphone ER 15 mg|Treatment Phase||37
120430|NCT00955110|278104|P1|Placebo|Treatment Phase||38
120431|NCT00955110|278104|P1|STARTED|Treatment Phase||41
120432|NCT00955110|278104|P1|NOT COMPLETED|Qualification Phase||24
120433|NCT00955110|278104|P1|COMPLETED|Qualification Phase||54
120434|NCT00955110|278104|P1|STARTED|Qualification Phase||78
120435|NCT00955032|278118|P2|NOT COMPLETED|Overall Study||0
120436|NCT00955032|278119|P1|NOT COMPLETED|Overall Study||0
120437|NCT00955032|278118|P2|COMPLETED|Overall Study||8
120438|NCT00955032|278119|P1|COMPLETED|Overall Study||16
120439|NCT00955032|278118|P2|STARTED|Overall Study||8
120440|NCT00955032|278119|P1|STARTED|Overall Study||16
120441|NCT00954993|278139|P1|NOT COMPLETED|Period 2||0
120442|NCT00954993|278139|P1|COMPLETED|Period 2||3
120443|NCT00954993|278139|P1|STARTED|Period 2||3
120444|NCT00954993|278139|P1|NOT COMPLETED|Washout||0
120445|NCT00954993|278139|P1|COMPLETED|Washout||3
120446|NCT00954993|278139|P1|STARTED|Washout||3
120447|NCT00954993|278139|P1|NOT COMPLETED|Period 1||0
120448|NCT00954993|278139|P1|COMPLETED|Period 1||3
120449|NCT00954993|278139|P1|STARTED|Period 1||3
120450|NCT00954941|278151|P2|NOT COMPLETED|Overall Study||7
120451|NCT00954941|278152|P1|NOT COMPLETED|Overall Study||8
120452|NCT00954941|278151|P2|COMPLETED|Overall Study||41
120453|NCT00954941|278152|P1|COMPLETED|Overall Study||42
120454|NCT00954941|278151|P2|STARTED|Overall Study||48
120455|NCT00954941|278152|P1|STARTED|Overall Study||50
120456|NCT00954915|278160|P1|NOT COMPLETED|Overall Study||0
120457|NCT00954915|278160|P1|COMPLETED|Overall Study||1
120458|NCT00954915|278160|P1|STARTED|Overall Study||1
120459|NCT00954824|278164|P1|NOT COMPLETED|Overall Study||50
120460|NCT00954824|278164|P1|COMPLETED|Overall Study||50
120461|NCT00954824|278164|P1|STARTED|Overall Study||100
120462|NCT00954733|278168|P1|NOT COMPLETED|Overall Study||1
120463|NCT00954733|278168|P1|COMPLETED|Overall Study||39
120464|NCT00954733|278168|P1|STARTED|Overall Study||40
120465|NCT00954707|278172|P1|NOT COMPLETED|Overall Study||167
120466|NCT00954707|278172|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
120467|NCT00954707|278172|P1|STARTED|Overall Study||2509
120468|NCT00954538|278190|P6|NOT COMPLETED|Part III||0
120469|NCT00954538|278191|P5|NOT COMPLETED|Part III||1
120470|NCT00954538|278192|P4|NOT COMPLETED|Part III||0
120471|NCT00954538|278193|P3|NOT COMPLETED|Part III||0
120472|NCT00954538|278194|P2|NOT COMPLETED|Part III||0
120473|NCT00954538|278195|P1|NOT COMPLETED|Part III||0
120474|NCT00954538|278190|P6|COMPLETED|Part III||2
120475|NCT00954538|278191|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
120476|NCT00954538|278192|P4|COMPLETED|Part III||4
120477|NCT00954538|278193|P3|COMPLETED|Part III||0
120478|NCT00954538|278194|P2|COMPLETED|Part III||0
120479|NCT00954538|278195|P1|COMPLETED|Part III||0
120480|NCT00954538|278190|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
120481|NCT00954538|278191|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
120482|NCT00954538|278192|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
120483|NCT00954538|278193|P3|STARTED|Part III||0
120484|NCT00954538|278194|P2|STARTED|Part III||0
120485|NCT00954538|278195|P1|STARTED|Part III||0
120486|NCT00954538|278190|P6|NOT COMPLETED|Part II||0
120487|NCT00954538|278191|P5|NOT COMPLETED|Part II||0
120488|NCT00954538|278192|P4|NOT COMPLETED|Part II||0
120489|NCT00954538|278193|P3|NOT COMPLETED|Part II||0
120490|NCT00954538|278194|P2|NOT COMPLETED|Part II||0
120491|NCT00954538|278195|P1|NOT COMPLETED|Part II||0
120492|NCT00954538|278190|P6|COMPLETED|Part II||2
120493|NCT00954538|278191|P5|COMPLETED|Part II||0
120494|NCT00954538|278192|P4|COMPLETED|Part II||0
120495|NCT00954538|278193|P3|COMPLETED|Part II||3
120496|NCT00954538|278194|P2|COMPLETED|Part II||1
120497|NCT00954538|278195|P1|COMPLETED|Part II||0
120498|NCT00954538|278190|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
120499|NCT00954538|278191|P5|STARTED|Part II||0
120500|NCT00954538|278192|P4|STARTED|Part II||0
120501|NCT00954538|278193|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
120502|NCT00954538|278194|P2|STARTED|Part II|This subject did not participate in Part I or III|1
120503|NCT00954538|278195|P1|STARTED|Part II||0
120504|NCT00954538|278190|P6|NOT COMPLETED|Part I||0
120505|NCT00954538|278191|P5|NOT COMPLETED|Part I||0
120506|NCT00954538|278192|P4|NOT COMPLETED|Part I||0
120507|NCT00954538|278193|P3|NOT COMPLETED|Part I||0
120508|NCT00954538|278194|P2|NOT COMPLETED|Part I||0
120509|NCT00954538|278195|P1|NOT COMPLETED|Part I||0
120510|NCT00954538|278190|P6|COMPLETED|Part I||0
120511|NCT00954538|278191|P5|COMPLETED|Part I||0
120512|NCT00954538|278192|P4|COMPLETED|Part I||0
120513|NCT00954538|278193|P3|COMPLETED|Part I||0
120514|NCT00954538|278194|P2|COMPLETED|Part I||0
120515|NCT00954538|278195|P1|COMPLETED|Part I||3
120516|NCT00954538|278190|P6|STARTED|Part I||0
120517|NCT00954538|278191|P5|STARTED|Part I||0
120518|NCT00954538|278192|P4|STARTED|Part I||0
120519|NCT00954538|278193|P3|STARTED|Part I||0
120520|NCT00954538|278194|P2|STARTED|Part I||0
120521|NCT00954538|278195|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
120522|NCT00954512|278212|P6|NOT COMPLETED|Overall Study||4
120523|NCT00954512|278213|P5|NOT COMPLETED|Overall Study||4
120524|NCT00954512|278214|P4|NOT COMPLETED|Overall Study||2
120525|NCT00954512|278215|P3|NOT COMPLETED|Overall Study||0
120526|NCT00954512|278216|P2|NOT COMPLETED|Overall Study||3
120527|NCT00954512|278217|P1|NOT COMPLETED|Overall Study||2
120528|NCT00954512|278212|P6|COMPLETED|Overall Study||0
120529|NCT00954512|278213|P5|COMPLETED|Overall Study||0
120530|NCT00954512|278214|P4|COMPLETED|Overall Study||0
120531|NCT00954512|278215|P3|COMPLETED|Overall Study||0
120532|NCT00954512|278216|P2|COMPLETED|Overall Study||0
120533|NCT00954512|278217|P1|COMPLETED|Overall Study||0
120534|NCT00954512|278212|P6|STARTED|Overall Study||4
120535|NCT00954512|278213|P5|STARTED|Overall Study||4
120536|NCT00954512|278214|P4|STARTED|Overall Study||2
120537|NCT00954512|278215|P3|STARTED|Overall Study||0
120538|NCT00954512|278216|P2|STARTED|Overall Study||3
120539|NCT00954512|278217|P1|STARTED|Overall Study||2
120540|NCT00954447|278238|P2|NOT COMPLETED|Overall Study||88
120541|NCT00954447|278239|P1|NOT COMPLETED|Overall Study||110
120542|NCT00954447|278238|P2|COMPLETED|Overall Study||543
120543|NCT00954447|278239|P1|COMPLETED|Overall Study||520
120544|NCT00954447|278238|P2|STARTED|Overall Study||631
120545|NCT00954447|278239|P1|STARTED|Overall Study||630
120546|NCT00954421|278275|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
120547|NCT00954421|278275|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
120548|NCT00954421|278275|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
120549|NCT00954421|278275|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
120550|NCT00954421|278275|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
120551|NCT00954421|278275|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
120552|NCT00954421|278275|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
120553|NCT00954421|278275|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
120554|NCT00954421|278275|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
120555|NCT00954421|278275|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
120556|NCT00954421|278275|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
120557|NCT00954421|278275|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
120558|NCT00954421|278275|P1|NOT COMPLETED|6 Months of DBS||1
120559|NCT00954421|278275|P1|COMPLETED|6 Months of DBS||12
120560|NCT00954421|278275|P1|STARTED|6 Months of DBS||13
120561|NCT00954421|278275|P1|NOT COMPLETED|Baseline||0
120562|NCT00954421|278275|P1|COMPLETED|Baseline||13
120563|NCT00954421|278275|P1|STARTED|Baseline||13
120564|NCT00954421|278275|P1|NOT COMPLETED|Screening||3
120565|NCT00954421|278275|P1|COMPLETED|Screening||13
120566|NCT00954421|278275|P1|STARTED|Screening||16
120567|NCT00954356|278283|P2|NOT COMPLETED|Overall Study||0
120568|NCT00954356|278284|P1|NOT COMPLETED|Overall Study||0
120569|NCT00954356|278283|P2|COMPLETED|Overall Study||20
120570|NCT00954356|278284|P1|COMPLETED|Overall Study||41
120571|NCT00954356|278283|P2|STARTED|Overall Study||20
120572|NCT00954356|278284|P1|STARTED|Overall Study||41
120573|NCT00954187|278314|P2|NOT COMPLETED|Overall Study||0
120574|NCT00954187|278315|P1|NOT COMPLETED|Overall Study||0
120575|NCT00954187|278314|P2|COMPLETED|Overall Study||0
120576|NCT00954187|278315|P1|COMPLETED|Overall Study||0
120577|NCT00954187|278314|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
120578|NCT00954187|278315|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
120579|NCT00954122|278321|P1|NOT COMPLETED|Overall Study||7
120580|NCT00954122|278321|P1|COMPLETED|Overall Study||28
120581|NCT00954122|278321|P1|STARTED|Overall Study||35
120582|NCT00954109|278331|P1|NOT COMPLETED|Overall Study||0
120583|NCT00954109|278331|P1|COMPLETED|Overall Study||11
120584|NCT00954109|278331|P1|STARTED|Overall Study||11
120585|NCT00953927|278338|P2|NOT COMPLETED|Overall Study||95
120586|NCT00953927|278339|P1|NOT COMPLETED|Overall Study||105
120587|NCT00953927|278338|P2|COMPLETED|Overall Study||1303
120588|NCT00953927|278339|P1|COMPLETED|Overall Study||1294
120589|NCT00953927|278338|P2|STARTED|Overall Study||1398
120590|NCT00953927|278339|P1|STARTED|Overall Study||1399
120591|NCT00953862|278357|P1|NOT COMPLETED|Overall Study||6
120592|NCT00953862|278357|P1|COMPLETED|Overall Study||12
120593|NCT00953862|278357|P1|STARTED|Overall Study||18
120594|NCT00953849|278367|P4|NOT COMPLETED|Overall Study||0
120595|NCT00953849|278368|P3|NOT COMPLETED|Overall Study||0
120596|NCT00953849|278369|P2|NOT COMPLETED|Overall Study||0
120597|NCT00953849|278370|P1|NOT COMPLETED|Overall Study||0
120598|NCT00953849|278367|P4|COMPLETED|Overall Study||5
120599|NCT00953849|278368|P3|COMPLETED|Overall Study||4
120600|NCT00953849|278369|P2|COMPLETED|Overall Study||6
120601|NCT00953849|278370|P1|COMPLETED|Overall Study||6
120602|NCT00953849|278367|P4|STARTED|Overall Study||5
120603|NCT00953849|278368|P3|STARTED|Overall Study||4
120604|NCT00953849|278369|P2|STARTED|Overall Study||6
120605|NCT00953849|278370|P1|STARTED|Overall Study||6
120606|NCT00953719|278394|P2|NOT COMPLETED|Overall Study||5
120607|NCT00953719|278395|P1|NOT COMPLETED|Overall Study||19
120608|NCT00953719|278394|P2|COMPLETED|Overall Study||69
120609|NCT00953719|278395|P1|COMPLETED|Overall Study||150
120610|NCT00953719|278394|P2|STARTED|Overall Study||74
120611|NCT00953719|278395|P1|STARTED|Overall Study||169
120612|NCT00953706|278417|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
120613|NCT00953706|278418|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
120614|NCT00953706|278419|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
120615|NCT00953706|278420|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
120616|NCT00953706|278417|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
120617|NCT00953706|278418|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
120618|NCT00953706|278419|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
120619|NCT00953706|278420|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
120620|NCT00953706|278417|P4|STARTED|Part B (96-Week Open-Label Extension)||33
120621|NCT00953706|278418|P3|STARTED|Part B (96-Week Open-Label Extension)||5
120622|NCT00953706|278419|P2|STARTED|Part B (96-Week Open-Label Extension)||0
120623|NCT00953706|278420|P1|STARTED|Part B (96-Week Open-Label Extension)||0
120624|NCT00953706|278417|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
120625|NCT00953706|278418|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
120626|NCT00953706|278419|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
120627|NCT00953706|278420|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
120628|NCT00953706|278417|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
120629|NCT00953706|278418|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
120630|NCT00953706|278419|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
120631|NCT00953706|278420|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
120632|NCT00953706|278417|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
120633|NCT00953706|278418|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
120634|NCT00953706|278419|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
120635|NCT00953706|278420|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
120636|NCT00953680|278452|P2|NOT COMPLETED|Period 2||0
120637|NCT00953680|278453|P1|NOT COMPLETED|Period 2||0
120638|NCT00953680|278452|P2|COMPLETED|Period 2||38
120639|NCT00953680|278453|P1|COMPLETED|Period 2||38
120640|NCT00953680|278452|P2|STARTED|Period 2||38
120641|NCT00953680|278453|P1|STARTED|Period 2||38
120642|NCT00953680|278452|P2|NOT COMPLETED|Period 1||1
120643|NCT00953680|278453|P1|NOT COMPLETED|Period 1||0
120644|NCT00953680|278452|P2|COMPLETED|Period 1||38
120645|NCT00953680|278453|P1|COMPLETED|Period 1||38
120646|NCT00953680|278452|P2|STARTED|Period 1||39
120647|NCT00953680|278453|P1|STARTED|Period 1||38
120648|NCT00953667|278465|P1|NOT COMPLETED|Overall Study||123
120649|NCT00953667|278465|P1|COMPLETED|Overall Study||277
120650|NCT00953667|278465|P1|STARTED|Overall Study||400
120651|NCT00953654|278473|P3|NOT COMPLETED|Overall Study||0
120652|NCT00953654|278474|P2|NOT COMPLETED|Overall Study||0
120653|NCT00953654|278475|P1|NOT COMPLETED|Overall Study||0
120654|NCT00953654|278473|P3|COMPLETED|Overall Study||10
120655|NCT00953654|278474|P2|COMPLETED|Overall Study||10
120656|NCT00953654|278475|P1|COMPLETED|Overall Study||10
120657|NCT00953654|278473|P3|STARTED|Overall Study||10
120658|NCT00953654|278474|P2|STARTED|Overall Study||10
120659|NCT00953654|278475|P1|STARTED|Overall Study||10
120660|NCT00953615|278486|P1|NOT COMPLETED|Overall Study||1
120661|NCT00953615|278486|P1|COMPLETED|Overall Study||0
120662|NCT00953615|278486|P1|STARTED|Overall Study||1
120663|NCT00953524|278497|P4|NOT COMPLETED|Overall Study||8
120664|NCT00953524|278498|P3|NOT COMPLETED|Overall Study||14
120665|NCT00953524|278499|P2|NOT COMPLETED|Overall Study||15
120666|NCT00953524|278500|P1|NOT COMPLETED|Overall Study||22
120667|NCT00953524|278497|P4|COMPLETED|Overall Study||91
120668|NCT00953524|278498|P3|COMPLETED|Overall Study||233
120669|NCT00953524|278499|P2|COMPLETED|Overall Study||239
120670|NCT00953524|278500|P1|COMPLETED|Overall Study||227
120671|NCT00953524|278497|P4|STARTED|Overall Study||99
120672|NCT00953524|278498|P3|STARTED|Overall Study||247
120673|NCT00953524|278499|P2|STARTED|Overall Study||254
120674|NCT00953524|278500|P1|STARTED|Overall Study||249
120675|NCT00953407|278543|P5|NOT COMPLETED|Overall Study||1
120676|NCT00953407|278544|P4|NOT COMPLETED|Overall Study||2
120677|NCT00953407|278545|P3|NOT COMPLETED|Overall Study||1
120678|NCT00953407|278546|P2|NOT COMPLETED|Overall Study||1
120679|NCT00953407|278547|P1|NOT COMPLETED|Overall Study||1
120680|NCT00953407|278543|P5|COMPLETED|Overall Study||23
120681|NCT00953407|278544|P4|COMPLETED|Overall Study||23
120682|NCT00953407|278545|P3|COMPLETED|Overall Study||25
120683|NCT00953407|278546|P2|COMPLETED|Overall Study||24
120684|NCT00953407|278547|P1|COMPLETED|Overall Study||25
120685|NCT00953407|278543|P5|STARTED|Overall Study||24
120686|NCT00953407|278544|P4|STARTED|Overall Study||25
120687|NCT00953407|278545|P3|STARTED|Overall Study||26
120688|NCT00953407|278546|P2|STARTED|Overall Study||25
120689|NCT00953407|278547|P1|STARTED|Overall Study||26
120690|NCT00953329|278559|P1|NOT COMPLETED|Overall Study||1
120691|NCT00953329|278559|P1|COMPLETED|Overall Study||0
120692|NCT00953329|278559|P1|STARTED|Overall Study||1
120693|NCT00953290|278563|P1|NOT COMPLETED|Overall Study||0
120694|NCT00953290|278563|P1|COMPLETED|Overall Study||4
120695|NCT00953290|278563|P1|STARTED|Overall Study||4
120696|NCT00953225|278572|P2|NOT COMPLETED|Overall Study||0
120697|NCT00953225|278573|P1|NOT COMPLETED|Overall Study||2
120698|NCT00953225|278572|P2|COMPLETED|Overall Study||37
120699|NCT00953225|278573|P1|COMPLETED|Overall Study||44
120700|NCT00953225|278572|P2|STARTED|Overall Study||37
120701|NCT00953225|278573|P1|STARTED|Overall Study||46
120702|NCT00953160|278581|P1|NOT COMPLETED|Overall Study||27
120703|NCT00953160|278581|P1|COMPLETED|Overall Study||49
120704|NCT00953160|278581|P1|STARTED|Overall Study||76
120705|NCT00953147|278590|P3|NOT COMPLETED|Overall Study||42
120706|NCT00953147|278591|P2|NOT COMPLETED|Overall Study||66
120707|NCT00953147|278592|P1|NOT COMPLETED|Overall Study||37
120708|NCT00953147|278590|P3|COMPLETED|Overall Study||265
120709|NCT00953147|278591|P2|COMPLETED|Overall Study||439
120710|NCT00953147|278592|P1|COMPLETED|Overall Study||261
120711|NCT00953147|278590|P3|STARTED|Overall Study||307
120712|NCT00953147|278591|P2|STARTED|Overall Study||505
120713|NCT00953147|278592|P1|STARTED|Overall Study||298
120714|NCT00953121|278642|P3|NOT COMPLETED|Overall Study||0
120715|NCT00953121|278643|P2|NOT COMPLETED|Overall Study||0
120716|NCT00953121|278644|P1|NOT COMPLETED|Overall Study||0
120717|NCT00953121|278642|P3|COMPLETED|Overall Study||25
120718|NCT00953121|278643|P2|COMPLETED|Overall Study||39
120719|NCT00953121|278644|P1|COMPLETED|Overall Study||40
120720|NCT00953121|278642|P3|STARTED|Overall Study||25
120721|NCT00953121|278643|P2|STARTED|Overall Study||39
120722|NCT00953121|278644|P1|STARTED|Overall Study||40
120723|NCT00953056|278670|P6|NOT COMPLETED|Overall Study||4
120724|NCT00953056|278671|P5|NOT COMPLETED|Overall Study||2
120725|NCT00953056|278672|P4|NOT COMPLETED|Overall Study||0
120726|NCT00953056|278673|P3|NOT COMPLETED|Overall Study||0
120727|NCT00953056|278674|P2|NOT COMPLETED|Overall Study||0
120728|NCT00953056|278675|P1|NOT COMPLETED|Overall Study||0
120729|NCT00953056|278670|P6|COMPLETED|Overall Study||20
120730|NCT00953056|278671|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
120731|NCT00953056|278672|P4|COMPLETED|Overall Study||24
120732|NCT00953056|278673|P3|COMPLETED|Overall Study||24
120733|NCT00953056|278674|P2|COMPLETED|Overall Study||24
120734|NCT00953056|278675|P1|COMPLETED|Overall Study||24
120735|NCT00953056|278670|P6|STARTED|Overall Study||24
120736|NCT00953056|278671|P5|STARTED|Overall Study||24
120737|NCT00953056|278672|P4|STARTED|Overall Study||24
120738|NCT00953056|278673|P3|STARTED|Overall Study||24
120739|NCT00953056|278674|P2|STARTED|Overall Study||24
120740|NCT00953056|278675|P1|STARTED|Overall Study||24
120741|NCT00953043|278699|P2|NOT COMPLETED|Overall Study||2
120742|NCT00953043|278700|P1|NOT COMPLETED|Overall Study||4
120743|NCT00953043|278699|P2|COMPLETED|Overall Study||28
120744|NCT00953043|278700|P1|COMPLETED|Overall Study||26
120745|NCT00953043|278699|P2|STARTED|Overall Study||30
120746|NCT00953043|278700|P1|STARTED|Overall Study||30
120747|NCT00953017|278724|P4|NOT COMPLETED|Overall Study||5
120748|NCT00953017|278725|P3|NOT COMPLETED|Overall Study||6
120749|NCT00953017|278726|P2|NOT COMPLETED|Overall Study||6
120750|NCT00953017|278727|P1|NOT COMPLETED|Overall Study||5
120751|NCT00953017|278724|P4|COMPLETED|Overall Study||101
120752|NCT00953017|278725|P3|COMPLETED|Overall Study||100
120753|NCT00953017|278726|P2|COMPLETED|Overall Study||101
120754|NCT00953017|278727|P1|COMPLETED|Overall Study||101
120755|NCT00953017|278724|P4|STARTED|Overall Study||106
120756|NCT00953017|278725|P3|STARTED|Overall Study||106
120757|NCT00953017|278726|P2|STARTED|Overall Study||107
120758|NCT00953017|278727|P1|STARTED|Overall Study||106
120759|NCT00952848|278749|P1|NOT COMPLETED|Overall Study||4
120760|NCT00952848|278749|P1|COMPLETED|Overall Study||14
120761|NCT00952848|278749|P1|STARTED|Overall Study||18
120762|NCT00952822|278756|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
120763|NCT00952822|278757|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
120764|NCT00952822|278758|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
120765|NCT00952822|278759|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
120766|NCT00952822|278756|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
120767|NCT00952822|278757|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
120768|NCT00952822|278758|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
120769|NCT00952822|278759|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
120770|NCT00952822|278756|P4|STARTED|2nd Pharmacokinetic Evaluation||4
120771|NCT00952822|278757|P3|STARTED|2nd Pharmacokinetic Evaluation||11
120772|NCT00952822|278758|P2|STARTED|2nd Pharmacokinetic Evaluation||17
120773|NCT00952822|278759|P1|STARTED|2nd Pharmacokinetic Evaluation||9
120774|NCT00952822|278756|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
120775|NCT00952822|278757|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
120776|NCT00952822|278758|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
120777|NCT00952822|278759|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
120778|NCT00952822|278756|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
120779|NCT00952822|278757|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
120780|NCT00952822|278758|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
120781|NCT00952822|278759|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
120782|NCT00952822|278756|P4|STARTED|1st Pharmacokinetic Evaluation||4
120783|NCT00952822|278757|P3|STARTED|1st Pharmacokinetic Evaluation||11
120784|NCT00952822|278758|P2|STARTED|1st Pharmacokinetic Evaluation||18
120785|NCT00952822|278759|P1|STARTED|1st Pharmacokinetic Evaluation||9
120786|NCT00952731|278791|P2|NOT COMPLETED|Overall Study||0
120787|NCT00952731|278792|P1|NOT COMPLETED|Overall Study||1
120788|NCT00952731|278791|P2|COMPLETED|Overall Study||14
120789|NCT00952731|278792|P1|COMPLETED|Overall Study||12
120790|NCT00952731|278791|P2|Follow-up|Overall Study||14
120791|NCT00952731|278792|P1|Follow-up|Overall Study||12
120792|NCT00952731|278791|P2|Surgery|Overall Study||14
120793|NCT00952731|278792|P1|Surgery|Overall Study||12
120794|NCT00952731|278791|P2|Treatment & Pre-Surgery|Overall Study||14
120795|NCT00952731|278792|P1|Treatment & Pre-Surgery|Overall Study||12
120796|NCT00952731|278791|P2|Randomization|Overall Study||14
120797|NCT00952731|278792|P1|Randomization|Overall Study||13
120798|NCT00952731|278791|P2|STARTED|Overall Study||14
120799|NCT00952731|278792|P1|STARTED|Overall Study||13
120800|NCT00952705|278811|P3|NOT COMPLETED|Overall Study||10
120801|NCT00952705|278812|P2|NOT COMPLETED|Overall Study||10
120802|NCT00952705|278813|P1|NOT COMPLETED|Overall Study||33
120803|NCT00952705|278811|P3|COMPLETED|Overall Study||288
120804|NCT00952705|278812|P2|COMPLETED|Overall Study||290
120805|NCT00952705|278813|P1|COMPLETED|Overall Study||1169
120806|NCT00952705|278811|P3|STARTED|Overall Study||298
120807|NCT00952705|278812|P2|STARTED|Overall Study||300
120808|NCT00952705|278813|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
120809|NCT00952653|278875|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
120810|NCT00952653|278875|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
120811|NCT00952653|278875|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
120812|NCT00952653|278875|P1|NOT COMPLETED|Period 1: MDZ Alone||0
120813|NCT00952653|278875|P1|COMPLETED|Period 1: MDZ Alone||28
120814|NCT00952653|278875|P1|STARTED|Period 1: MDZ Alone||28
120815|NCT00952614|278900|P1|NOT COMPLETED|Overall Study||7
120816|NCT00952614|278900|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
120817|NCT00952614|278900|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
120818|NCT00952614|278900|P1|STARTED|Overall Study||30
120819|NCT00952588|278907|P2|NOT COMPLETED|Overall Study||24
120820|NCT00952588|278908|P1|NOT COMPLETED|Overall Study||36
120821|NCT00952588|278907|P2|COMPLETED|Overall Study||2
120822|NCT00952588|278908|P1|COMPLETED|Overall Study||12
120823|NCT00952588|278907|P2|STARTED|Overall Study||26
120824|NCT00952588|278908|P1|STARTED|Overall Study||48
120825|NCT00952523|278926|P1|NOT COMPLETED|Overall Study||7
120826|NCT00952523|278926|P1|COMPLETED|Overall Study||155
120827|NCT00952523|278926|P1|STARTED|Overall Study||162
120828|NCT00952484|278935|P3|NOT COMPLETED|Overall Study||0
120829|NCT00952484|278936|P2|NOT COMPLETED|Overall Study||1
120830|NCT00952484|278937|P1|NOT COMPLETED|Overall Study||0
120831|NCT00952484|278935|P3|COMPLETED|Overall Study||16
120832|NCT00952484|278936|P2|COMPLETED|Overall Study||6
120833|NCT00952484|278937|P1|COMPLETED|Overall Study||6
120834|NCT00952484|278935|P3|STARTED|Overall Study||16
120835|NCT00952484|278936|P2|STARTED|Overall Study||7
120836|NCT00952484|278937|P1|STARTED|Overall Study||6
120837|NCT00952419|278964|P3|NOT COMPLETED|Overall Study||0
120838|NCT00952419|278965|P2|NOT COMPLETED|Overall Study||10
120839|NCT00952419|278966|P1|NOT COMPLETED|Overall Study||6
120840|NCT00952419|278964|P3|COMPLETED|Overall Study||51
120841|NCT00952419|278965|P2|COMPLETED|Overall Study||198
120842|NCT00952419|278966|P1|COMPLETED|Overall Study||209
120843|NCT00952419|278964|P3|STARTED|Overall Study||51
120844|NCT00952419|278965|P2|STARTED|Overall Study||208
120845|NCT00952419|278966|P1|STARTED|Overall Study||215
120846|NCT00952393|278998|P1|NOT COMPLETED|Overall Study||0
120847|NCT00952393|278998|P1|COMPLETED|Overall Study||10
120848|NCT00952393|278998|P1|STARTED|Overall Study|10|10
120849|NCT00952367|279002|P1|NOT COMPLETED|Overall Study||6
120850|NCT00952367|279002|P1|COMPLETED|Overall Study||3635
120851|NCT00952367|279002|P1|STARTED|Overall Study||3641
120852|NCT00952341|279017|P2|NOT COMPLETED|Cycle 2||12
120853|NCT00952341|279018|P1|NOT COMPLETED|Cycle 2||9
120854|NCT00952341|279017|P2|COMPLETED|Cycle 2||118
120855|NCT00952341|279018|P1|COMPLETED|Cycle 2||101
120856|NCT00952341|279017|P2|STARTED|Cycle 2||130
120857|NCT00952341|279018|P1|STARTED|Cycle 2||110
120858|NCT00952341|279017|P2|NOT COMPLETED|Cycle 1||13
120859|NCT00952341|279018|P1|NOT COMPLETED|Cycle 1||20
120860|NCT00952341|279017|P2|COMPLETED|Cycle 1||199
120861|NCT00952341|279018|P1|COMPLETED|Cycle 1||189
120862|NCT00952341|279017|P2|STARTED|Cycle 1||212
120863|NCT00952341|279018|P1|STARTED|Cycle 1||209
120864|NCT00952289|279040|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
120865|NCT00952289|279041|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
120866|NCT00952289|279040|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
120867|NCT00952289|279041|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
120868|NCT00952289|279040|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
120869|NCT00952289|279041|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
120870|NCT00952289|279040|P2|NOT COMPLETED|All Participants||40
120871|NCT00952289|279041|P1|NOT COMPLETED|All Participants||21
120872|NCT00952289|279040|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
120873|NCT00952289|279041|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
120874|NCT00952289|279040|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
120875|NCT00952289|279041|P1|Safety Population|All Participants||155
120876|NCT00952289|279040|P2|STARTED|All Participants||154
120877|NCT00952289|279041|P1|STARTED|All Participants||155
120878|NCT00952276|279070|P5|NOT COMPLETED|Overall Study||0
120879|NCT00952276|279071|P4|NOT COMPLETED|Overall Study||1
120880|NCT00952276|279072|P3|NOT COMPLETED|Overall Study||0
120881|NCT00952276|279073|P2|NOT COMPLETED|Overall Study||0
120882|NCT00952276|279074|P1|NOT COMPLETED|Overall Study||1
120883|NCT00952276|279070|P5|COMPLETED|Overall Study||63
120884|NCT00952276|279071|P4|COMPLETED|Overall Study||120
120885|NCT00952276|279072|P3|COMPLETED|Overall Study||122
120886|NCT00952276|279073|P2|COMPLETED|Overall Study||115
120887|NCT00952276|279074|P1|COMPLETED|Overall Study||126
120888|NCT00952276|279070|P5|STARTED|Overall Study||63
120889|NCT00952276|279071|P4|STARTED|Overall Study||121
120890|NCT00952276|279072|P3|STARTED|Overall Study||122
120891|NCT00952276|279073|P2|STARTED|Overall Study||115
120892|NCT00952276|279074|P1|STARTED|Overall Study||127
120893|NCT00952211|279123|P2|NOT COMPLETED|Overall Study||0
120894|NCT00952211|279124|P1|NOT COMPLETED|Overall Study||0
120895|NCT00952211|279123|P2|COMPLETED|Overall Study||0
120896|NCT00952211|279124|P1|COMPLETED|Overall Study||3
120897|NCT00952211|279123|P2|STARTED|Overall Study||0
120898|NCT00952211|279124|P1|STARTED|Overall Study||3
120899|NCT00952133|279134|P2|NOT COMPLETED|Overall Study||0
120900|NCT00952133|279135|P1|NOT COMPLETED|Overall Study||0
120901|NCT00952133|279134|P2|COMPLETED|Overall Study||59
120902|NCT00952133|279135|P1|COMPLETED|Overall Study||59
120903|NCT00952133|279134|P2|STARTED|Overall Study||59
120904|NCT00952133|279135|P1|STARTED|Overall Study||59
120905|NCT00952120|279146|P3|NOT COMPLETED|Overall Study||0
120906|NCT00952120|279147|P2|NOT COMPLETED|Overall Study||0
120907|NCT00952120|279148|P1|NOT COMPLETED|Overall Study||0
120908|NCT00952120|279146|P3|COMPLETED|Overall Study||5
120909|NCT00952120|279147|P2|COMPLETED|Overall Study||47
120910|NCT00952120|279148|P1|COMPLETED|Overall Study||52
120911|NCT00952120|279146|P3|STARTED|Overall Study||5
120912|NCT00952120|279147|P2|STARTED|Overall Study||47
120913|NCT00952120|279148|P1|STARTED|Overall Study||52
120914|NCT00952081|279156|P1|NOT COMPLETED|Overall Study||0
120915|NCT00952081|279156|P1|COMPLETED|Overall Study||22
120916|NCT00952081|279156|P1|STARTED|Overall Study||22
120917|NCT00952068|279160|P1|NOT COMPLETED|Overall Study||7
120918|NCT00952068|279160|P1|COMPLETED|Overall Study||40
120919|NCT00952068|279160|P1|STARTED|Overall Study||47
120920|NCT00951912|279171|P3|NOT COMPLETED|Overall Study||2
120921|NCT00951912|279172|P2|NOT COMPLETED|Overall Study||5
120922|NCT00951912|279173|P1|NOT COMPLETED|Overall Study||7
120923|NCT00951912|279171|P3|COMPLETED|Overall Study||54
120924|NCT00951912|279172|P2|COMPLETED|Overall Study||50
120925|NCT00951912|279173|P1|COMPLETED|Overall Study||47
120926|NCT00951912|279171|P3|STARTED|Overall Study||56
120927|NCT00951912|279172|P2|STARTED|Overall Study||55
120928|NCT00951912|279173|P1|STARTED|Overall Study||54
120929|NCT00951899|279225|P2|NOT COMPLETED|Overall Study||0
120930|NCT00951899|279226|P1|NOT COMPLETED|Overall Study||0
120931|NCT00951899|279225|P2|COMPLETED|Overall Study||19
120932|NCT00951899|279226|P1|COMPLETED|Overall Study||19
120933|NCT00951899|279225|P2|STARTED|Overall Study||19
120934|NCT00951899|279226|P1|STARTED|Overall Study||19
120935|NCT00951821|279250|P2|NOT COMPLETED|Overall Study||0
120936|NCT00951821|279251|P1|NOT COMPLETED|Overall Study||0
120937|NCT00951821|279250|P2|COMPLETED|Overall Study||8
120938|NCT00951821|279251|P1|COMPLETED|Overall Study||16
120939|NCT00951821|279250|P2|STARTED|Overall Study||8
120940|NCT00951821|279251|P1|STARTED|Overall Study||16
120941|NCT00951808|279259|P3|NOT COMPLETED|Overall Study||4
120942|NCT00951808|279260|P2|NOT COMPLETED|Overall Study||0
120943|NCT00951808|279261|P1|NOT COMPLETED|Overall Study||0
120944|NCT00951808|279259|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
120945|NCT00951808|279260|P2|COMPLETED|Overall Study||6
120946|NCT00951808|279261|P1|COMPLETED|Overall Study||4
120947|NCT00951808|279259|P3|STARTED|Overall Study||227
120948|NCT00951808|279260|P2|STARTED|Overall Study||6
120949|NCT00951808|279261|P1|STARTED|Overall Study||4
120950|NCT00951665|279273|P6|NOT COMPLETED|Phase 2a||7
120951|NCT00951665|279274|P5|NOT COMPLETED|Phase 2a||12
120952|NCT00951665|279275|P4|NOT COMPLETED|Phase 2a||0
120953|NCT00951665|279276|P3|NOT COMPLETED|Phase 2a||0
120954|NCT00951665|279277|P2|NOT COMPLETED|Phase 2a||0
120955|NCT00951665|279278|P1|NOT COMPLETED|Phase 2a||0
120956|NCT00951665|279273|P6|COMPLETED|Phase 2a||15
120957|NCT00951665|279274|P5|COMPLETED|Phase 2a||10
120958|NCT00951665|279275|P4|COMPLETED|Phase 2a||0
120959|NCT00951665|279276|P3|COMPLETED|Phase 2a||0
120960|NCT00951665|279277|P2|COMPLETED|Phase 2a||0
120961|NCT00951665|279278|P1|COMPLETED|Phase 2a||0
120962|NCT00951665|279273|P6|STARTED|Phase 2a||22
120963|NCT00951665|279274|P5|STARTED|Phase 2a||22
120964|NCT00951665|279275|P4|STARTED|Phase 2a||0
120965|NCT00951665|279276|P3|STARTED|Phase 2a||0
120966|NCT00951665|279277|P2|STARTED|Phase 2a||0
120967|NCT00951665|279278|P1|STARTED|Phase 2a||0
120968|NCT00951665|279273|P6|NOT COMPLETED|Phase 1b||0
120969|NCT00951665|279274|P5|NOT COMPLETED|Phase 1b||0
120970|NCT00951665|279275|P4|NOT COMPLETED|Phase 1b||1
120971|NCT00951665|279276|P3|NOT COMPLETED|Phase 1b||17
120972|NCT00951665|279277|P2|NOT COMPLETED|Phase 1b||4
120973|NCT00951665|279278|P1|NOT COMPLETED|Phase 1b||22
120974|NCT00951665|279273|P6|COMPLETED|Phase 1b||0
120975|NCT00951665|279274|P5|COMPLETED|Phase 1b||0
120976|NCT00951665|279275|P4|COMPLETED|Phase 1b||2
120977|NCT00951665|279276|P3|COMPLETED|Phase 1b||4
120978|NCT00951665|279277|P2|COMPLETED|Phase 1b||6
120979|NCT00951665|279278|P1|COMPLETED|Phase 1b||7
120980|NCT00951665|279273|P6|Started Treatment|Phase 1b||0
120981|NCT00951665|279274|P5|Started Treatment|Phase 1b||0
120982|NCT00951665|279275|P4|Started Treatment|Phase 1b||3
120983|NCT00951665|279276|P3|Started Treatment|Phase 1b||21
120984|NCT00951665|279277|P2|Started Treatment|Phase 1b||10
120985|NCT00951665|279278|P1|Started Treatment|Phase 1b||26
120986|NCT00951665|279273|P6|STARTED|Phase 1b||0
120987|NCT00951665|279274|P5|STARTED|Phase 1b||0
120988|NCT00951665|279275|P4|STARTED|Phase 1b||3
120989|NCT00951665|279276|P3|STARTED|Phase 1b||21
120990|NCT00951665|279277|P2|STARTED|Phase 1b||10
120991|NCT00951665|279278|P1|STARTED|Phase 1b||29
120992|NCT00951561|279379|P4|NOT COMPLETED|Overall Study||1
120993|NCT00951561|279380|P3|NOT COMPLETED|Overall Study||3
120994|NCT00951561|279381|P2|NOT COMPLETED|Overall Study||0
120995|NCT00951561|279382|P1|NOT COMPLETED|Overall Study||0
120996|NCT00951561|279379|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
120997|NCT00951561|279380|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
120998|NCT00951561|279381|P2|COMPLETED|Overall Study||29
120999|NCT00951561|279382|P1|COMPLETED|Overall Study||25
121000|NCT00951561|279379|P4|STARTED|Overall Study||27
121001|NCT00951561|279380|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
121002|NCT00951561|279381|P2|STARTED|Overall Study||29
121003|NCT00951561|279382|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
121004|NCT00951509|279387|P1|NOT COMPLETED|Overall Study||2
121005|NCT00951509|279387|P1|COMPLETED|Overall Study||29
121006|NCT00951509|279387|P1|Driving Condition 5|Overall Study||30
121007|NCT00951509|279387|P1|Driving Condition 4|Overall Study||28
121008|NCT00951509|279387|P1|Driving Condition 3|Overall Study||25
121009|NCT00951509|279387|P1|Driving Condition 2|Overall Study||29
121010|NCT00951509|279387|P1|Driving Condition 1|Overall Study||29
121011|NCT00951509|279387|P1|STARTED|Overall Study||31
121012|NCT00951483|279397|P2|NOT COMPLETED|Overall Study||0
121013|NCT00951483|279398|P1|NOT COMPLETED|Overall Study||19
121014|NCT00951483|279397|P2|COMPLETED|Overall Study||44
121015|NCT00951483|279398|P1|COMPLETED|Overall Study||28
121016|NCT00951483|279397|P2|STARTED|Overall Study||44
121017|NCT00951483|279398|P1|STARTED|Overall Study||47
121018|NCT00951379|279418|P2|NOT COMPLETED|Overall Study||2
121019|NCT00951379|279419|P1|NOT COMPLETED|Overall Study||6
121020|NCT00951379|279418|P2|COMPLETED|Overall Study||23
121021|NCT00951379|279419|P1|COMPLETED|Overall Study||21
121022|NCT00951379|279418|P2|STARTED|Overall Study||25
121023|NCT00951379|279419|P1|STARTED|Overall Study||27
121024|NCT00951275|279461|P1|NOT COMPLETED|Overall Study||13
121025|NCT00951275|279461|P1|COMPLETED|Overall Study||92
121026|NCT00951275|279461|P1|STARTED|Overall Study||105
121027|NCT00951171|279493|P2|NOT COMPLETED|Overall Study||0
121028|NCT00951171|279494|P1|NOT COMPLETED|Overall Study||2
121029|NCT00951171|279493|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
121030|NCT00951171|279494|P1|COMPLETED|Overall Study||38
121031|NCT00951171|279493|P2|Pregnancy|Overall Study||7
121032|NCT00951171|279494|P1|Pregnancy|Overall Study||1
121033|NCT00951171|279493|P2|STARTED|Overall Study||55
121034|NCT00951171|279494|P1|STARTED|Overall Study||40
121035|NCT00951093|279500|P1|NOT COMPLETED|6 Months After GBP||0
121036|NCT00951093|279500|P1|COMPLETED|6 Months After GBP||53
121037|NCT00951093|279500|P1|STARTED|6 Months After GBP||53
121038|NCT00951093|279500|P1|NOT COMPLETED|Before GBP||0
121039|NCT00951093|279500|P1|COMPLETED|Before GBP||53
121040|NCT00951093|279500|P1|STARTED|Before GBP||53
121041|NCT00951015|279528|P4|NOT COMPLETED|Overall Study||18
121042|NCT00951015|279529|P3|NOT COMPLETED|Overall Study||51
121043|NCT00951015|279530|P2|NOT COMPLETED|Overall Study||51
121044|NCT00951015|279531|P1|NOT COMPLETED|Overall Study||53
121045|NCT00951015|279528|P4|COMPLETED|Overall Study||32
121046|NCT00951015|279529|P3|COMPLETED|Overall Study||0
121047|NCT00951015|279530|P2|COMPLETED|Overall Study||0
121048|NCT00951015|279531|P1|COMPLETED|Overall Study||0
121049|NCT00951015|279528|P4|Ongoing|Overall Study||8
121050|NCT00951015|279529|P3|Ongoing|Overall Study||46
121051|NCT00951015|279530|P2|Ongoing|Overall Study||45
121052|NCT00951015|279531|P1|Ongoing|Overall Study||47
121053|NCT00951015|279528|P4|STARTED|Overall Study||50
121054|NCT00951015|279529|P3|STARTED|Overall Study||51
121055|NCT00951015|279530|P2|STARTED|Overall Study||51
121056|NCT00951015|279531|P1|STARTED|Overall Study||53
121057|NCT00950963|279627|P2|NOT COMPLETED|Overall Study||24
121058|NCT00950963|279628|P1|NOT COMPLETED|Overall Study||29
121059|NCT00950963|279627|P2|COMPLETED|Overall Study||357
121060|NCT00950963|279628|P1|COMPLETED|Overall Study||352
121061|NCT00950963|279627|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
121062|NCT00950963|279628|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
121063|NCT00950937|279644|P2|NOT COMPLETED|Overall Study||0
121064|NCT00950937|279645|P1|NOT COMPLETED|Overall Study||0
121065|NCT00950937|279644|P2|COMPLETED|Overall Study||14
121066|NCT00950937|279645|P1|COMPLETED|Overall Study||14
121067|NCT00950937|279644|P2|STARTED|Overall Study||14
121068|NCT00950937|279645|P1|STARTED|Overall Study||14
121069|NCT00950911|279663|P2|NOT COMPLETED|Overall Study||15
121070|NCT00950911|279664|P1|NOT COMPLETED|Overall Study||12
121071|NCT00950911|279663|P2|COMPLETED|Overall Study||3
121072|NCT00950911|279664|P1|COMPLETED|Overall Study||5
121073|NCT00950911|279663|P2|STARTED|Overall Study||18
121074|NCT00950911|279664|P1|STARTED|Overall Study||17
121075|NCT00950872|279670|P1|NOT COMPLETED|Overall Study||3
121076|NCT00950872|279670|P1|COMPLETED|Overall Study||26
121077|NCT00950872|279670|P1|STARTED|Overall Study||29
121078|NCT00950859|279679|P2|NOT COMPLETED|Overall Study||10
121079|NCT00950859|279680|P1|NOT COMPLETED|Overall Study||16
121080|NCT00950859|279679|P2|COMPLETED|Overall Study||14
121081|NCT00950859|279680|P1|COMPLETED|Overall Study||11
121082|NCT00950859|279679|P2|STARTED|Overall Study||24
121083|NCT00950859|279680|P1|STARTED|Overall Study||27
121084|NCT00950807|279720|P10|NOT COMPLETED|Treatment Period 3||1
121085|NCT00950807|279721|P9|NOT COMPLETED|Treatment Period 3||0
121086|NCT00950807|279722|P8|NOT COMPLETED|Treatment Period 3||1
121087|NCT00950807|279723|P7|NOT COMPLETED|Treatment Period 3||1
121088|NCT00950807|279724|P6|NOT COMPLETED|Treatment Period 3||0
121089|NCT00950807|279725|P5|NOT COMPLETED|Treatment Period 3||0
121090|NCT00950807|279726|P4|NOT COMPLETED|Treatment Period 3||0
121091|NCT00950807|279727|P3|NOT COMPLETED|Treatment Period 3||0
121092|NCT00950807|279728|P2|NOT COMPLETED|Treatment Period 3||0
121093|NCT00950807|279729|P1|NOT COMPLETED|Treatment Period 3||1
121094|NCT00950807|279720|P10|COMPLETED|Treatment Period 3||10
121095|NCT00950807|279721|P9|COMPLETED|Treatment Period 3||9
121096|NCT00950807|279722|P8|COMPLETED|Treatment Period 3||9
121097|NCT00950807|279723|P7|COMPLETED|Treatment Period 3||11
121098|NCT00950807|279724|P6|COMPLETED|Treatment Period 3||9
121099|NCT00950807|279725|P5|COMPLETED|Treatment Period 3||12
121100|NCT00950807|279726|P4|COMPLETED|Treatment Period 3||11
121101|NCT00950807|279727|P3|COMPLETED|Treatment Period 3||10
121102|NCT00950807|279728|P2|COMPLETED|Treatment Period 3||9
121103|NCT00950807|279729|P1|COMPLETED|Treatment Period 3||45
121104|NCT00950807|279720|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
121105|NCT00950807|279721|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
121106|NCT00950807|279722|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
121107|NCT00950807|279723|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
121108|NCT00950807|279724|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
121109|NCT00950807|279725|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
121110|NCT00950807|279726|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
121111|NCT00950807|279727|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
121112|NCT00950807|279728|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
121113|NCT00950807|279729|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
121114|NCT00950807|279720|P10|NOT COMPLETED|Washout Period 2||0
121115|NCT00950807|279721|P9|NOT COMPLETED|Washout Period 2||0
121116|NCT00950807|279722|P8|NOT COMPLETED|Washout Period 2||1
121117|NCT00950807|279723|P7|NOT COMPLETED|Washout Period 2||1
121118|NCT00950807|279724|P6|NOT COMPLETED|Washout Period 2||0
121119|NCT00950807|279725|P5|NOT COMPLETED|Washout Period 2||1
121120|NCT00950807|279726|P4|NOT COMPLETED|Washout Period 2||1
121121|NCT00950807|279727|P3|NOT COMPLETED|Washout Period 2||0
121122|NCT00950807|279728|P2|NOT COMPLETED|Washout Period 2||1
121123|NCT00950807|279729|P1|NOT COMPLETED|Washout Period 2||4
121124|NCT00950807|279720|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
121125|NCT00950807|279721|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
121126|NCT00950807|279722|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
121127|NCT00950807|279723|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
121128|NCT00950807|279724|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
121129|NCT00950807|279725|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
121130|NCT00950807|279726|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
121131|NCT00950807|279727|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
121132|NCT00950807|279728|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
121133|NCT00950807|279729|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
121134|NCT00950807|279720|P10|STARTED|Washout Period 2||11
121135|NCT00950807|279721|P9|STARTED|Washout Period 2||11
121136|NCT00950807|279722|P8|STARTED|Washout Period 2||10
121137|NCT00950807|279723|P7|STARTED|Washout Period 2||9
121138|NCT00950807|279724|P6|STARTED|Washout Period 2||9
121139|NCT00950807|279725|P5|STARTED|Washout Period 2||13
121140|NCT00950807|279726|P4|STARTED|Washout Period 2||12
121141|NCT00950807|279727|P3|STARTED|Washout Period 2||10
121142|NCT00950807|279728|P2|STARTED|Washout Period 2||12
121143|NCT00950807|279729|P1|STARTED|Washout Period 2||51
121144|NCT00950807|279720|P10|NOT COMPLETED|Treatment Period 2||0
121145|NCT00950807|279721|P9|NOT COMPLETED|Treatment Period 2||0
121146|NCT00950807|279722|P8|NOT COMPLETED|Treatment Period 2||3
121147|NCT00950807|279723|P7|NOT COMPLETED|Treatment Period 2||1
121148|NCT00950807|279724|P6|NOT COMPLETED|Treatment Period 2||1
121149|NCT00950807|279725|P5|NOT COMPLETED|Treatment Period 2||0
121150|NCT00950807|279726|P4|NOT COMPLETED|Treatment Period 2||1
121151|NCT00950807|279727|P3|NOT COMPLETED|Treatment Period 2||0
121152|NCT00950807|279728|P2|NOT COMPLETED|Treatment Period 2||1
121153|NCT00950807|279729|P1|NOT COMPLETED|Treatment Period 2||2
121154|NCT00950807|279720|P10|COMPLETED|Treatment Period 2||11
121155|NCT00950807|279721|P9|COMPLETED|Treatment Period 2||11
121156|NCT00950807|279722|P8|COMPLETED|Treatment Period 2||10
121157|NCT00950807|279723|P7|COMPLETED|Treatment Period 2||9
121158|NCT00950807|279724|P6|COMPLETED|Treatment Period 2||9
121159|NCT00950807|279725|P5|COMPLETED|Treatment Period 2||13
121160|NCT00950807|279726|P4|COMPLETED|Treatment Period 2||12
121161|NCT00950807|279727|P3|COMPLETED|Treatment Period 2||10
121162|NCT00950807|279728|P2|COMPLETED|Treatment Period 2||12
121163|NCT00950807|279729|P1|COMPLETED|Treatment Period 2||51
121164|NCT00950807|279720|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
121165|NCT00950807|279721|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
121166|NCT00950807|279722|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
121167|NCT00950807|279723|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
121168|NCT00950807|279724|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
121169|NCT00950807|279725|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
121170|NCT00950807|279726|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
121171|NCT00950807|279727|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
121172|NCT00950807|279728|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
121173|NCT00950807|279729|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
121174|NCT00950807|279720|P10|NOT COMPLETED|Washout Period 1||0
121175|NCT00950807|279721|P9|NOT COMPLETED|Washout Period 1||1
121176|NCT00950807|279722|P8|NOT COMPLETED|Washout Period 1||1
121177|NCT00950807|279723|P7|NOT COMPLETED|Washout Period 1||2
121178|NCT00950807|279724|P6|NOT COMPLETED|Washout Period 1||0
121179|NCT00950807|279725|P5|NOT COMPLETED|Washout Period 1||1
121180|NCT00950807|279726|P4|NOT COMPLETED|Washout Period 1||1
121181|NCT00950807|279727|P3|NOT COMPLETED|Washout Period 1||0
121182|NCT00950807|279728|P2|NOT COMPLETED|Washout Period 1||0
121183|NCT00950807|279729|P1|NOT COMPLETED|Washout Period 1||5
121184|NCT00950807|279720|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
121185|NCT00950807|279721|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
121186|NCT00950807|279722|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
121187|NCT00950807|279723|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
121188|NCT00950807|279724|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
121189|NCT00950807|279725|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
121190|NCT00950807|279726|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
121191|NCT00950807|279727|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
121192|NCT00950807|279728|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
121193|NCT00950807|279729|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
121194|NCT00950807|279720|P10|STARTED|Washout Period 1||13
121195|NCT00950807|279721|P9|STARTED|Washout Period 1||12
121196|NCT00950807|279722|P8|STARTED|Washout Period 1||14
121197|NCT00950807|279723|P7|STARTED|Washout Period 1||12
121198|NCT00950807|279724|P6|STARTED|Washout Period 1||11
121199|NCT00950807|279725|P5|STARTED|Washout Period 1||12
121200|NCT00950807|279726|P4|STARTED|Washout Period 1||12
121201|NCT00950807|279727|P3|STARTED|Washout Period 1||13
121202|NCT00950807|279728|P2|STARTED|Washout Period 1||13
121203|NCT00950807|279729|P1|STARTED|Washout Period 1||56
121204|NCT00950807|279720|P10|NOT COMPLETED|Treatment Period 1||0
121205|NCT00950807|279721|P9|NOT COMPLETED|Treatment Period 1||1
121206|NCT00950807|279722|P8|NOT COMPLETED|Treatment Period 1||0
121207|NCT00950807|279723|P7|NOT COMPLETED|Treatment Period 1||0
121208|NCT00950807|279724|P6|NOT COMPLETED|Treatment Period 1||2
121209|NCT00950807|279725|P5|NOT COMPLETED|Treatment Period 1||1
121210|NCT00950807|279726|P4|NOT COMPLETED|Treatment Period 1||0
121211|NCT00950807|279727|P3|NOT COMPLETED|Treatment Period 1||1
121212|NCT00950807|279728|P2|NOT COMPLETED|Treatment Period 1||0
121213|NCT00950807|279729|P1|NOT COMPLETED|Treatment Period 1||3
121214|NCT00950807|279720|P10|COMPLETED|Treatment Period 1||13
121215|NCT00950807|279721|P9|COMPLETED|Treatment Period 1||12
121216|NCT00950807|279722|P8|COMPLETED|Treatment Period 1||14
121217|NCT00950807|279723|P7|COMPLETED|Treatment Period 1||12
121218|NCT00950807|279724|P6|COMPLETED|Treatment Period 1||11
121219|NCT00950807|279725|P5|COMPLETED|Treatment Period 1||12
121220|NCT00950807|279726|P4|COMPLETED|Treatment Period 1||12
121221|NCT00950807|279727|P3|COMPLETED|Treatment Period 1||13
121222|NCT00950807|279728|P2|COMPLETED|Treatment Period 1||13
121223|NCT00950807|279729|P1|COMPLETED|Treatment Period 1||56
121224|NCT00950807|279720|P10|STARTED|Treatment Period 1||13
121225|NCT00950807|279721|P9|STARTED|Treatment Period 1||13
121226|NCT00950807|279722|P8|STARTED|Treatment Period 1||14
121227|NCT00950807|279723|P7|STARTED|Treatment Period 1||12
121228|NCT00950807|279724|P6|STARTED|Treatment Period 1||13
121229|NCT00950807|279725|P5|STARTED|Treatment Period 1||13
121230|NCT00950807|279726|P4|STARTED|Treatment Period 1||12
121231|NCT00950807|279727|P3|STARTED|Treatment Period 1||14
121232|NCT00950807|279728|P2|STARTED|Treatment Period 1||13
121233|NCT00950807|279729|P1|STARTED|Treatment Period 1||59
121234|NCT00950755|279771|P1|NOT COMPLETED|Long-Term Follow-Up||9
121235|NCT00950755|279771|P1|COMPLETED|Long-Term Follow-Up||9
121236|NCT00950755|279771|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
121237|NCT00950755|279771|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
121238|NCT00950755|279771|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
121239|NCT00950755|279771|P1|STARTED|Dosimetric and Therapeutic Treatment||41
121240|NCT00950742|279797|P2|NOT COMPLETED|Overall Study||2
121241|NCT00950742|279798|P1|NOT COMPLETED|Overall Study||16
121242|NCT00950742|279797|P2|COMPLETED|Overall Study||0
121243|NCT00950742|279798|P1|COMPLETED|Overall Study||0
121244|NCT00950742|279797|P2|STARTED|Overall Study|entered and treated|2
121245|NCT00950742|279798|P1|STARTED|Overall Study|entered and treated|16
121246|NCT00950729|279814|P1|NOT COMPLETED|Driving With Aircast||0
121247|NCT00950729|279814|P1|COMPLETED|Driving With Aircast||48
121248|NCT00950729|279814|P1|STARTED|Driving With Aircast||48
121249|NCT00950729|279814|P1|NOT COMPLETED|Driving With Plaster Cast||0
121250|NCT00950729|279814|P1|COMPLETED|Driving With Plaster Cast||48
121251|NCT00950729|279814|P1|STARTED|Driving With Plaster Cast||48
121252|NCT00950729|279814|P1|NOT COMPLETED|Driving With Running Shoes||0
121253|NCT00950729|279814|P1|COMPLETED|Driving With Running Shoes|June 2007|48
121254|NCT00950729|279814|P1|STARTED|Driving With Running Shoes|March 2007|48
121255|NCT00950690|279819|P1|NOT COMPLETED|Overall Study||244
121256|NCT00950690|279819|P1|COMPLETED|Overall Study||1105
121257|NCT00950690|279819|P1|STARTED|Overall Study||1349
121258|NCT00950664|279826|P2|NOT COMPLETED|Second Intervention||48
121259|NCT00950664|279827|P1|NOT COMPLETED|Second Intervention||46
121260|NCT00950664|279826|P2|COMPLETED|Second Intervention||0
121261|NCT00950664|279827|P1|COMPLETED|Second Intervention||0
121262|NCT00950664|279826|P2|STARTED|Second Intervention||48
121263|NCT00950664|279827|P1|STARTED|Second Intervention||46
121264|NCT00950664|279826|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
121265|NCT00950664|279827|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
121266|NCT00950664|279826|P2|COMPLETED|Washout Period of 4 Weeks||48
121267|NCT00950664|279827|P1|COMPLETED|Washout Period of 4 Weeks||46
121268|NCT00950664|279826|P2|STARTED|Washout Period of 4 Weeks||48
121269|NCT00950664|279827|P1|STARTED|Washout Period of 4 Weeks||46
121270|NCT00950664|279826|P2|NOT COMPLETED|First Intervention||5
121271|NCT00950664|279827|P1|NOT COMPLETED|First Intervention||3
121272|NCT00950664|279826|P2|COMPLETED|First Intervention||48
121273|NCT00950664|279827|P1|COMPLETED|First Intervention||46
121274|NCT00950664|279826|P2|STARTED|First Intervention||53
121275|NCT00950664|279827|P1|STARTED|First Intervention||49
121276|NCT00950651|279847|P2|NOT COMPLETED|Overall Study||35
121277|NCT00950651|279848|P1|NOT COMPLETED|Overall Study||31
121278|NCT00950651|279847|P2|COMPLETED|Overall Study||181
121279|NCT00950651|279848|P1|COMPLETED|Overall Study||184
121280|NCT00950651|279847|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
121281|NCT00950651|279848|P1|STARTED|Overall Study||215
121282|NCT00950612|279896|P2|NOT COMPLETED|Overall Study||0
121283|NCT00950612|279897|P1|NOT COMPLETED|Overall Study||0
121284|NCT00950612|279896|P2|COMPLETED|Overall Study||20
121285|NCT00950612|279897|P1|COMPLETED|Overall Study||40
121286|NCT00950612|279896|P2|STARTED|Overall Study||20
121287|NCT00950612|279897|P1|STARTED|Overall Study||40
121288|NCT00950599|279941|P10|NOT COMPLETED|Follow-Up Period||2
121289|NCT00950599|279942|P9|NOT COMPLETED|Follow-Up Period||13
121290|NCT00950599|279943|P8|NOT COMPLETED|Follow-Up Period||0
121291|NCT00950599|279944|P7|NOT COMPLETED|Follow-Up Period||0
121292|NCT00950599|279945|P6|NOT COMPLETED|Follow-Up Period||0
121293|NCT00950599|279946|P5|NOT COMPLETED|Follow-Up Period||0
121294|NCT00950599|279947|P4|NOT COMPLETED|Follow-Up Period||0
121295|NCT00950599|279948|P3|NOT COMPLETED|Follow-Up Period||0
121296|NCT00950599|279949|P2|NOT COMPLETED|Follow-Up Period||0
121297|NCT00950599|279950|P1|NOT COMPLETED|Follow-Up Period||0
121298|NCT00950599|279941|P10|COMPLETED|Follow-Up Period||78
121299|NCT00950599|279942|P9|COMPLETED|Follow-Up Period||296
121300|NCT00950599|279943|P8|COMPLETED|Follow-Up Period||0
121301|NCT00950599|279944|P7|COMPLETED|Follow-Up Period||0
121302|NCT00950599|279945|P6|COMPLETED|Follow-Up Period||0
121303|NCT00950599|279946|P5|COMPLETED|Follow-Up Period||0
121304|NCT00950599|279947|P4|COMPLETED|Follow-Up Period||0
121305|NCT00950599|279948|P3|COMPLETED|Follow-Up Period||0
121306|NCT00950599|279949|P2|COMPLETED|Follow-Up Period||0
121307|NCT00950599|279950|P1|COMPLETED|Follow-Up Period||0
121308|NCT00950599|279941|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
121309|NCT00950599|279942|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
121310|NCT00950599|279943|P8|STARTED|Follow-Up Period||0
121311|NCT00950599|279944|P7|STARTED|Follow-Up Period||0
121312|NCT00950599|279945|P6|STARTED|Follow-Up Period||0
121313|NCT00950599|279946|P5|STARTED|Follow-Up Period||0
121314|NCT00950599|279947|P4|STARTED|Follow-Up Period||0
121315|NCT00950599|279948|P3|STARTED|Follow-Up Period||0
121316|NCT00950599|279949|P2|STARTED|Follow-Up Period||0
121317|NCT00950599|279950|P1|STARTED|Follow-Up Period||0
121318|NCT00950599|279941|P10|NOT COMPLETED|Double-Blind Treatment Period||0
121319|NCT00950599|279942|P9|NOT COMPLETED|Double-Blind Treatment Period||0
121320|NCT00950599|279943|P8|NOT COMPLETED|Double-Blind Treatment Period||6
121321|NCT00950599|279944|P7|NOT COMPLETED|Double-Blind Treatment Period||0
121322|NCT00950599|279945|P6|NOT COMPLETED|Double-Blind Treatment Period||12
121323|NCT00950599|279946|P5|NOT COMPLETED|Double-Blind Treatment Period||7
121324|NCT00950599|279947|P4|NOT COMPLETED|Double-Blind Treatment Period||11
121325|NCT00950599|279948|P3|NOT COMPLETED|Double-Blind Treatment Period||9
121326|NCT00950599|279949|P2|NOT COMPLETED|Double-Blind Treatment Period||10
121327|NCT00950599|279950|P1|NOT COMPLETED|Double-Blind Treatment Period||7
121328|NCT00950599|279941|P10|COMPLETED|Double-Blind Treatment Period||0
121329|NCT00950599|279942|P9|COMPLETED|Double-Blind Treatment Period||0
121330|NCT00950599|279943|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
121331|NCT00950599|279944|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
121332|NCT00950599|279945|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
121333|NCT00950599|279946|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
121334|NCT00950599|279947|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
121335|NCT00950599|279948|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
121336|NCT00950599|279949|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
121337|NCT00950599|279950|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
121338|NCT00950599|279941|P10|STARTED|Double-Blind Treatment Period||0
121339|NCT00950599|279942|P9|STARTED|Double-Blind Treatment Period||0
121340|NCT00950599|279943|P8|STARTED|Double-Blind Treatment Period||41
121341|NCT00950599|279944|P7|STARTED|Double-Blind Treatment Period||44
121342|NCT00950599|279945|P6|STARTED|Double-Blind Treatment Period||67
121343|NCT00950599|279946|P5|STARTED|Double-Blind Treatment Period||52
121344|NCT00950599|279947|P4|STARTED|Double-Blind Treatment Period||54
121345|NCT00950599|279948|P3|STARTED|Double-Blind Treatment Period||63
121346|NCT00950599|279949|P2|STARTED|Double-Blind Treatment Period||47
121347|NCT00950599|279950|P1|STARTED|Double-Blind Treatment Period||55
121348|NCT00950352|280514|P2|NOT COMPLETED|Overall Study||11
121349|NCT00950352|280515|P1|NOT COMPLETED|Overall Study||42
121350|NCT00950352|280514|P2|COMPLETED|Overall Study||21
121351|NCT00950352|280515|P1|COMPLETED|Overall Study||30
121352|NCT00950352|280514|P2|STARTED|Overall Study||32
121353|NCT00950352|280515|P1|STARTED|Overall Study||72
121354|NCT00950300|280523|P2|NOT COMPLETED|SFU Period||54
121355|NCT00950300|280524|P1|NOT COMPLETED|SFU Period||53
121522|NCT00948506|281036|P1|NOT COMPLETED|Overall Study||3
121356|NCT00950300|280523|P2|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
121357|NCT00950300|280524|P1|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
121358|NCT00950300|280523|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|76
121359|NCT00950300|280524|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|75
121360|NCT00950300|280523|P2|NOT COMPLETED|TFFU Period||252
121361|NCT00950300|280524|P1|NOT COMPLETED|TFFU Period||254
121362|NCT00950300|280523|P2|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 7 participants with missing data.|16
121363|NCT00950300|280524|P1|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 3 participants with missing data.|11
121364|NCT00950300|280523|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
121365|NCT00950300|280524|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
121366|NCT00950300|280523|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
121367|NCT00950300|280524|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
121368|NCT00950300|280523|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
121369|NCT00950300|280524|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
121370|NCT00950300|280523|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
121371|NCT00950300|280524|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
121372|NCT00950300|280523|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
121373|NCT00950300|280524|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||278
121374|NCT00950300|280523|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
121375|NCT00950300|280524|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
121376|NCT00950235|280579|P2|NOT COMPLETED|Overall Study||4
121377|NCT00950235|280580|P1|NOT COMPLETED|Overall Study||2
121378|NCT00950235|280579|P2|COMPLETED|Overall Study||54
121379|NCT00950235|280580|P1|COMPLETED|Overall Study||58
121380|NCT00950235|280579|P2|STARTED|Overall Study||58
121381|NCT00950235|280580|P1|STARTED|Overall Study||60
121382|NCT00950183|280590|P1|NOT COMPLETED|Overall Study||36
121383|NCT00950183|280590|P1|COMPLETED|Overall Study||0
121384|NCT00950183|280590|P1|STARTED|Overall Study||36
121385|NCT00949975|280602|P4|NOT COMPLETED|Overall Study||28
121386|NCT00949975|280603|P3|NOT COMPLETED|Overall Study||19
121387|NCT00949975|280604|P2|NOT COMPLETED|Overall Study||29
121388|NCT00949975|280605|P1|NOT COMPLETED|Overall Study||27
121389|NCT00949975|280602|P4|COMPLETED|Overall Study||190
121390|NCT00949975|280603|P3|COMPLETED|Overall Study||183
121391|NCT00949975|280604|P2|COMPLETED|Overall Study||177
121392|NCT00949975|280605|P1|COMPLETED|Overall Study||185
121393|NCT00949975|280602|P4|STARTED|Overall Study||218
121394|NCT00949975|280603|P3|STARTED|Overall Study||202
121395|NCT00949975|280604|P2|STARTED|Overall Study||206
121396|NCT00949975|280605|P1|STARTED|Overall Study||212
121397|NCT00949910|280723|P1|NOT COMPLETED|Overall Study||6576
121398|NCT00949910|280723|P1|COMPLETED|Overall Study||10
121399|NCT00949910|280723|P1|STARTED|Overall Study||6586
121400|NCT00949884|280736|P3|NOT COMPLETED|Overall Study||58
121401|NCT00949884|280737|P2|NOT COMPLETED|Overall Study||15
121402|NCT00949884|280738|P1|NOT COMPLETED|Overall Study||50
121403|NCT00949884|280736|P3|COMPLETED|Overall Study||411
121404|NCT00949884|280737|P2|COMPLETED|Overall Study||37
121405|NCT00949884|280738|P1|COMPLETED|Overall Study||370
121406|NCT00949884|280736|P3|STARTED|Overall Study||469
121407|NCT00949884|280737|P2|STARTED|Overall Study||52
121408|NCT00949884|280738|P1|STARTED|Overall Study||420
121409|NCT00949715|280793|P2|NOT COMPLETED|Overall Study||0
121410|NCT00949715|280794|P1|NOT COMPLETED|Overall Study||4
121411|NCT00949715|280793|P2|COMPLETED|Overall Study||33
121412|NCT00949715|280794|P1|COMPLETED|Overall Study||28
121413|NCT00949715|280793|P2|STARTED|Overall Study||33
121414|NCT00949715|280794|P1|STARTED|Overall Study||32
121415|NCT00949702|280805|P1|NOT COMPLETED|Overall Study||48
121416|NCT00949702|280805|P1|COMPLETED|Overall Study||84
121417|NCT00949702|280805|P1|STARTED|Overall Study||132
121418|NCT00949650|280822|P2|NOT COMPLETED|Overall Study||55
121419|NCT00949650|280823|P1|NOT COMPLETED|Overall Study||165
121420|NCT00949650|280822|P2|COMPLETED|Overall Study|6 courses of chemotherapy completed|60
121421|NCT00949650|280823|P1|COMPLETED|Overall Study|On-treatment at primary endpoint analysis cut-off date (09 February 2012).|65
121422|NCT00949650|280822|P2|STARTED|Overall Study|Randomized patients|115
121423|NCT00949650|280823|P1|STARTED|Overall Study|Randomized patients|230
121424|NCT00949533|280861|P2|NOT COMPLETED|Overall Study||1
121425|NCT00949533|280862|P1|NOT COMPLETED|Overall Study||0
121426|NCT00949533|280861|P2|COMPLETED|Overall Study||17
121427|NCT00949533|280862|P1|COMPLETED|Overall Study||19
121428|NCT00949533|280861|P2|STARTED|Overall Study||18
121429|NCT00949533|280862|P1|STARTED|Overall Study||19
121430|NCT00949117|280876|P2|NOT COMPLETED|Overall Study||5
121431|NCT00949117|280877|P1|NOT COMPLETED|Overall Study||3
121432|NCT00949117|280876|P2|COMPLETED|Overall Study||0
121433|NCT00949117|280877|P1|COMPLETED|Overall Study||1
121434|NCT00949117|280876|P2|STARTED|Overall Study||5
121435|NCT00949117|280877|P1|STARTED|Overall Study||4
121436|NCT00948896|280899|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
121437|NCT00948896|280900|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
121438|NCT00948896|280901|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
121439|NCT00948896|280902|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
121440|NCT00948896|280903|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
121441|NCT00948896|280904|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
121442|NCT00948896|280905|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
121443|NCT00948896|280906|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
121444|NCT00948896|280899|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
121445|NCT00948896|280900|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
121446|NCT00948896|280901|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
121447|NCT00948896|280902|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
121448|NCT00948896|280903|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
121449|NCT00948896|280904|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
121450|NCT00948896|280905|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
121451|NCT00948896|280906|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
121452|NCT00948896|280899|P8|STARTED|24 Months of Age to 36 Months of Age||45
121453|NCT00948896|280900|P7|STARTED|24 Months of Age to 36 Months of Age||43
121454|NCT00948896|280901|P6|STARTED|24 Months of Age to 36 Months of Age||42
121455|NCT00948896|280902|P5|STARTED|24 Months of Age to 36 Months of Age||44
121456|NCT00948896|280903|P4|STARTED|24 Months of Age to 36 Months of Age||87
121457|NCT00948896|280904|P3|STARTED|24 Months of Age to 36 Months of Age||90
121458|NCT00948896|280905|P2|STARTED|24 Months of Age to 36 Months of Age||85
121459|NCT00948896|280906|P1|STARTED|24 Months of Age to 36 Months of Age||90
121460|NCT00948896|280899|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
121461|NCT00948896|280900|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
121462|NCT00948896|280901|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
121463|NCT00948896|280902|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
121464|NCT00948896|280903|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
121465|NCT00948896|280904|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
121466|NCT00948896|280905|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
121467|NCT00948896|280906|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
121468|NCT00948896|280899|P8|COMPLETED|Randomization to 24 Months of Age||45
121469|NCT00948896|280900|P7|COMPLETED|Randomization to 24 Months of Age||43
121470|NCT00948896|280901|P6|COMPLETED|Randomization to 24 Months of Age||42
121471|NCT00948896|280902|P5|COMPLETED|Randomization to 24 Months of Age||44
121472|NCT00948896|280903|P4|COMPLETED|Randomization to 24 Months of Age||87
121473|NCT00948896|280904|P3|COMPLETED|Randomization to 24 Months of Age||90
121474|NCT00948896|280905|P2|COMPLETED|Randomization to 24 Months of Age||85
121475|NCT00948896|280906|P1|COMPLETED|Randomization to 24 Months of Age||90
121476|NCT00948896|280899|P8|STARTED|Randomization to 24 Months of Age||47
121477|NCT00948896|280900|P7|STARTED|Randomization to 24 Months of Age||47
121478|NCT00948896|280901|P6|STARTED|Randomization to 24 Months of Age||46
121479|NCT00948896|280902|P5|STARTED|Randomization to 24 Months of Age||46
121480|NCT00948896|280903|P4|STARTED|Randomization to 24 Months of Age||98
121481|NCT00948896|280904|P3|STARTED|Randomization to 24 Months of Age||99
121482|NCT00948896|280905|P2|STARTED|Randomization to 24 Months of Age||98
121483|NCT00948896|280906|P1|STARTED|Randomization to 24 Months of Age||98
121484|NCT00948857|280942|P2|NOT COMPLETED|Overall Study||0
121485|NCT00948857|280943|P1|NOT COMPLETED|Overall Study||1
121486|NCT00948857|280942|P2|COMPLETED|Overall Study||2
121487|NCT00948857|280943|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
121488|NCT00948857|280942|P2|STARTED|Overall Study||2
121489|NCT00948857|280943|P1|STARTED|Overall Study||3
121490|NCT00948818|280951|P2|NOT COMPLETED|Overall Study||94
121491|NCT00948818|280952|P1|NOT COMPLETED|Overall Study||62
121492|NCT00948818|280951|P2|COMPLETED|Overall Study||312
121493|NCT00948818|280952|P1|COMPLETED|Overall Study||335
121494|NCT00948818|280951|P2|STARTED|Overall Study||406
121495|NCT00948818|280952|P1|STARTED|Overall Study||397
121496|NCT00948792|280987|P1|NOT COMPLETED|Overall Study||0
121497|NCT00948792|280987|P1|COMPLETED|Overall Study||21
121498|NCT00948792|280987|P1|STARTED|Overall Study||21
121499|NCT00948766|280999|P2|NOT COMPLETED|Extension Study||0
121500|NCT00948766|281000|P1|NOT COMPLETED|Extension Study||91
121501|NCT00948766|280999|P2|COMPLETED|Extension Study||0
121502|NCT00948766|281000|P1|COMPLETED|Extension Study||306
121503|NCT00948766|280999|P2|Exposed to Study Medication|Extension Study||0
121504|NCT00948766|281000|P1|Exposed to Study Medication|Extension Study||396
121505|NCT00948766|280999|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
121506|NCT00948766|281000|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
121507|NCT00948766|280999|P2|NOT COMPLETED|Core Study||126
121508|NCT00948766|281000|P1|NOT COMPLETED|Core Study||127
121509|NCT00948766|280999|P2|COMPLETED|Core Study||234
121510|NCT00948766|281000|P1|COMPLETED|Core Study||229
121511|NCT00948766|280999|P2|Exposed to Study Medication|Core Study||359
121512|NCT00948766|281000|P1|Exposed to Study Medication|Core Study||355
121513|NCT00948766|280999|P2|STARTED|Core Study||360
121514|NCT00948766|281000|P1|STARTED|Core Study||356
121515|NCT00948675|281018|P2|NOT COMPLETED|Overall Study||4
121516|NCT00948675|281019|P1|NOT COMPLETED|Overall Study||7
121517|NCT00948675|281018|P2|COMPLETED|Overall Study||175
121518|NCT00948675|281019|P1|COMPLETED|Overall Study||175
121519|NCT00948675|281018|P2|STARTED|Overall Study||179
121520|NCT00948675|281019|P1|STARTED|Overall Study||182
121521|NCT00948506|281035|P2|NOT COMPLETED|Overall Study||1
121523|NCT00948506|281035|P2|COMPLETED|Overall Study||8
121524|NCT00948506|281036|P1|COMPLETED|Overall Study||8
121525|NCT00948506|281035|P2|STARTED|Overall Study||9
121526|NCT00948506|281036|P1|STARTED|Overall Study||11
121527|NCT00947505|281047|P2|NOT COMPLETED|Overall Study||2
121528|NCT00947505|281048|P1|NOT COMPLETED|Overall Study||9
121529|NCT00947505|281047|P2|COMPLETED|Overall Study||14
121530|NCT00947505|281048|P1|COMPLETED|Overall Study||24
121531|NCT00947505|281047|P2|STARTED|Overall Study||16
121532|NCT00947505|281048|P1|STARTED|Overall Study||33
121533|NCT00948441|281056|P2|NOT COMPLETED|Overall Study||4
121534|NCT00948441|281057|P1|NOT COMPLETED|Overall Study||1
121535|NCT00948441|281056|P2|COMPLETED|Overall Study||4
121536|NCT00948441|281057|P1|COMPLETED|Overall Study||7
121537|NCT00948441|281056|P2|STARTED|Overall Study||8
121538|NCT00948441|281057|P1|STARTED|Overall Study||8
121539|NCT00948389|281070|P5|NOT COMPLETED|Overall Study||1
121540|NCT00948389|281071|P4|NOT COMPLETED|Overall Study||9
121541|NCT00948389|281072|P3|NOT COMPLETED|Overall Study||7
121542|NCT00948389|281073|P2|NOT COMPLETED|Overall Study||3
121543|NCT00948389|281074|P1|NOT COMPLETED|Overall Study||6
121544|NCT00948389|281070|P5|COMPLETED|Overall Study||0
121545|NCT00948389|281071|P4|COMPLETED|Overall Study||0
121546|NCT00948389|281072|P3|COMPLETED|Overall Study||0
121547|NCT00948389|281073|P2|COMPLETED|Overall Study||0
121548|NCT00948389|281074|P1|COMPLETED|Overall Study||0
121549|NCT00948389|281070|P5|STARTED|Overall Study||1
121550|NCT00948389|281071|P4|STARTED|Overall Study||9
121551|NCT00948389|281072|P3|STARTED|Overall Study||7
121552|NCT00948389|281073|P2|STARTED|Overall Study||3
121553|NCT00948389|281074|P1|STARTED|Overall Study||6
121554|NCT00948246|281111|P1|NOT COMPLETED|Overall Study||24
121555|NCT00948246|281111|P1|COMPLETED|Overall Study||86
121556|NCT00948246|281111|P1|STARTED|Overall Study||110
121557|NCT00948155|281120|P2|NOT COMPLETED|Second Intervention 21 Days||3
121558|NCT00948155|281121|P1|NOT COMPLETED|Second Intervention 21 Days||2
121559|NCT00948155|281120|P2|COMPLETED|Second Intervention 21 Days||8
121560|NCT00948155|281121|P1|COMPLETED|Second Intervention 21 Days||9
121561|NCT00948155|281120|P2|STARTED|Second Intervention 21 Days||11
121562|NCT00948155|281121|P1|STARTED|Second Intervention 21 Days||11
121563|NCT00948155|281120|P2|NOT COMPLETED|Washout 14 Days||2
121564|NCT00948155|281121|P1|NOT COMPLETED|Washout 14 Days||1
121565|NCT00948155|281120|P2|COMPLETED|Washout 14 Days||11
121566|NCT00948155|281121|P1|COMPLETED|Washout 14 Days||11
121567|NCT00948155|281120|P2|STARTED|Washout 14 Days||13
121568|NCT00948155|281121|P1|STARTED|Washout 14 Days||12
121569|NCT00948155|281120|P2|NOT COMPLETED|First Intervention 21 Days||2
121570|NCT00948155|281121|P1|NOT COMPLETED|First Intervention 21 Days||2
121571|NCT00948155|281120|P2|COMPLETED|First Intervention 21 Days||13
121572|NCT00948155|281121|P1|COMPLETED|First Intervention 21 Days||12
121573|NCT00948155|281120|P2|STARTED|First Intervention 21 Days||15
121574|NCT00948155|281121|P1|STARTED|First Intervention 21 Days||14
121575|NCT00948090|281143|P4|NOT COMPLETED|Overall Study||11
121576|NCT00948090|281144|P3|NOT COMPLETED|Overall Study||56
121577|NCT00948090|281145|P2|NOT COMPLETED|Overall Study||1
121578|NCT00948090|281146|P1|NOT COMPLETED|Overall Study||43
121579|NCT00948090|281143|P4|COMPLETED|Overall Study||7
121580|NCT00948090|281144|P3|COMPLETED|Overall Study||67
121581|NCT00948090|281145|P2|COMPLETED|Overall Study||0
121582|NCT00948090|281146|P1|COMPLETED|Overall Study||22
121583|NCT00948090|281143|P4|STARTED|Overall Study||18
121584|NCT00948090|281144|P3|STARTED|Overall Study||123
121585|NCT00948090|281145|P2|STARTED|Overall Study||1
121586|NCT00948090|281146|P1|STARTED|Overall Study||65
121587|NCT00948064|281168|P3|NOT COMPLETED|Phase II||1
121588|NCT00948064|281169|P2|NOT COMPLETED|Phase II||1
121589|NCT00948064|281170|P1|NOT COMPLETED|Phase II||0
121590|NCT00948064|281168|P3|COMPLETED|Phase II||26
121591|NCT00948064|281169|P2|COMPLETED|Phase II||51
121592|NCT00948064|281170|P1|COMPLETED|Phase II||0
121593|NCT00948064|281168|P3|STARTED|Phase II||27
121594|NCT00948064|281169|P2|STARTED|Phase II||52
121595|NCT00948064|281170|P1|STARTED|Phase II||0
121596|NCT00948064|281168|P3|NOT COMPLETED|Phase I||0
121597|NCT00948064|281169|P2|NOT COMPLETED|Phase I||0
121598|NCT00948064|281170|P1|NOT COMPLETED|Phase I||1
121599|NCT00948064|281168|P3|COMPLETED|Phase I||0
121600|NCT00948064|281169|P2|COMPLETED|Phase I||0
121601|NCT00948064|281170|P1|COMPLETED|Phase I||30
121602|NCT00948064|281168|P3|STARTED|Phase I||0
121603|NCT00948064|281169|P2|STARTED|Phase I||0
121604|NCT00948064|281170|P1|STARTED|Phase I||31
121605|NCT00947882|281185|P4|NOT COMPLETED|Overall Study||82
121606|NCT00947882|281186|P3|NOT COMPLETED|Overall Study||79
121607|NCT00947882|281187|P2|NOT COMPLETED|Overall Study||77
121608|NCT00947882|281188|P1|NOT COMPLETED|Overall Study||74
121609|NCT00947882|281185|P4|COMPLETED|Overall Study||20
121610|NCT00947882|281186|P3|COMPLETED|Overall Study||22
121611|NCT00947882|281187|P2|COMPLETED|Overall Study||24
121612|NCT00947882|281188|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
121613|NCT00947882|281185|P4|Visit 12, Month 6|Overall Study||95
121614|NCT00947882|281186|P3|Visit 12, Month 6|Overall Study||90
121615|NCT00947882|281187|P2|Visit 12, Month 6|Overall Study||91
121693|NCT00947518|281324|P3|NOT COMPLETED|Overall Study||0
121616|NCT00947882|281188|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
121617|NCT00947882|281185|P4|Safety Analysis Set|Overall Study||105
121618|NCT00947882|281186|P3|Safety Analysis Set|Overall Study||100
121619|NCT00947882|281187|P2|Safety Analysis Set|Overall Study||101
121620|NCT00947882|281188|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
121621|NCT00947882|281185|P4|Actual Treatment|Overall Study||105
121622|NCT00947882|281186|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
121623|NCT00947882|281187|P2|Actual Treatment|Overall Study||101
121624|NCT00947882|281188|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
121625|NCT00947882|281185|P4|Full Analysis Set (FAS)|Overall Study||102
121626|NCT00947882|281186|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
121627|NCT00947882|281187|P2|Full Analysis Set (FAS)|Overall Study||101
121628|NCT00947882|281188|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
121629|NCT00947882|281185|P4|STARTED|Overall Study||102
121630|NCT00947882|281186|P3|STARTED|Overall Study||101
121631|NCT00947882|281187|P2|STARTED|Overall Study||101
121632|NCT00947882|281188|P1|STARTED|Overall Study|Started: Randomised.|100
121633|NCT00947856|281216|P2|NOT COMPLETED|Follow-up Period||23
121634|NCT00947856|281217|P1|NOT COMPLETED|Follow-up Period||51
121635|NCT00947856|281216|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
121636|NCT00947856|281217|P1|COMPLETED|Follow-up Period||27
121637|NCT00947856|281216|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
121638|NCT00947856|281217|P1|STARTED|Follow-up Period||78
121639|NCT00947856|281216|P2|NOT COMPLETED|Treatment Period||32
121640|NCT00947856|281217|P1|NOT COMPLETED|Treatment Period||78
121641|NCT00947856|281216|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
121642|NCT00947856|281217|P1|COMPLETED|Treatment Period||0
121643|NCT00947856|281216|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
121644|NCT00947856|281217|P1|STARTED|Treatment Period||78
121645|NCT00947765|281246|P2|NOT COMPLETED|Overall Study||0
121646|NCT00947765|281247|P1|NOT COMPLETED|Overall Study||0
121647|NCT00947765|281246|P2|COMPLETED|Overall Study||30
121648|NCT00947765|281247|P1|COMPLETED|Overall Study||30
121649|NCT00947765|281246|P2|STARTED|Overall Study||30
121650|NCT00947765|281247|P1|STARTED|Overall Study||30
121651|NCT00947752|281269|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
121652|NCT00947752|281270|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
121653|NCT00947752|281269|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
121654|NCT00947752|281270|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
121655|NCT00947752|281269|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
121656|NCT00947752|281270|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
121657|NCT00947752|281269|P2|NOT COMPLETED|1st 14-day Treatment Period||0
121658|NCT00947752|281270|P1|NOT COMPLETED|1st 14-day Treatment Period||0
121659|NCT00947752|281269|P2|COMPLETED|1st 14-day Treatment Period||71
121660|NCT00947752|281270|P1|COMPLETED|1st 14-day Treatment Period||76
121661|NCT00947752|281269|P2|STARTED|1st 14-day Treatment Period||71
121662|NCT00947752|281270|P1|STARTED|1st 14-day Treatment Period||76
121663|NCT00947752|281269|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
121664|NCT00947752|281270|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
121665|NCT00947752|281269|P2|COMPLETED|7-Day Run-in Treatment Period||0
121666|NCT00947752|281270|P1|COMPLETED|7-Day Run-in Treatment Period||147
121667|NCT00947752|281269|P2|STARTED|7-Day Run-in Treatment Period||0
121668|NCT00947752|281270|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
121669|NCT00947661|281280|P2|NOT COMPLETED|Overall Study||15
121670|NCT00947661|281281|P1|NOT COMPLETED|Overall Study||13
121671|NCT00947661|281280|P2|COMPLETED|Overall Study||274
121672|NCT00947661|281281|P1|COMPLETED|Overall Study||276
121673|NCT00947661|281280|P2|STARTED|Overall Study||289
121674|NCT00947661|281281|P1|STARTED|Overall Study||289
121675|NCT00947544|281287|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
121676|NCT00947544|281288|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
121677|NCT00947544|281287|P2|COMPLETED|Safety-Extension Period (12 Months)||6
121678|NCT00947544|281288|P1|COMPLETED|Safety-Extension Period (12 Months)||10
121679|NCT00947544|281287|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
121680|NCT00947544|281288|P1|STARTED|Safety-Extension Period (12 Months)||11
121681|NCT00947544|281287|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
121682|NCT00947544|281288|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
121683|NCT00947544|281287|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
121684|NCT00947544|281288|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
121685|NCT00947544|281287|P2|STARTED|Switch-Over Period (2 Weeks)||0
121686|NCT00947544|281288|P1|STARTED|Switch-Over Period (2 Weeks)||11
121687|NCT00947531|281314|P2|NOT COMPLETED|Overall Study||11
121688|NCT00947531|281315|P1|NOT COMPLETED|Overall Study||14
121689|NCT00947531|281314|P2|COMPLETED|Overall Study||110
121690|NCT00947531|281315|P1|COMPLETED|Overall Study||107
121691|NCT00947531|281314|P2|STARTED|Overall Study||121
121692|NCT00947531|281315|P1|STARTED|Overall Study||121
121694|NCT00947518|281325|P2|NOT COMPLETED|Overall Study||0
121695|NCT00947518|281326|P1|NOT COMPLETED|Overall Study||0
121696|NCT00947518|281324|P3|COMPLETED|Overall Study||20
121697|NCT00947518|281325|P2|COMPLETED|Overall Study||20
121698|NCT00947518|281326|P1|COMPLETED|Overall Study||20
121699|NCT00947518|281324|P3|STARTED|Overall Study||20
121700|NCT00947518|281325|P2|STARTED|Overall Study||20
121701|NCT00947518|281326|P1|STARTED|Overall Study||20
121702|NCT00947427|281339|P2|NOT COMPLETED|Overall Study||4
121703|NCT00947427|281340|P1|NOT COMPLETED|Overall Study||1
121704|NCT00947427|281339|P2|COMPLETED|Overall Study||45
121705|NCT00947427|281340|P1|COMPLETED|Overall Study||21
121706|NCT00947427|281339|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
121707|NCT00947427|281340|P1|STARTED|Overall Study||22
121708|NCT00947349|281350|P4|NOT COMPLETED|Overall Study Standard of Care||2
121709|NCT00947349|281351|P3|NOT COMPLETED|Overall Study Standard of Care||2
121710|NCT00947349|281352|P2|NOT COMPLETED|Overall Study Standard of Care||0
121711|NCT00947349|281353|P1|NOT COMPLETED|Overall Study Standard of Care||0
121712|NCT00947349|281350|P4|COMPLETED|Overall Study Standard of Care||4
121713|NCT00947349|281351|P3|COMPLETED|Overall Study Standard of Care||4
121714|NCT00947349|281352|P2|COMPLETED|Overall Study Standard of Care||5
121715|NCT00947349|281353|P1|COMPLETED|Overall Study Standard of Care||4
121716|NCT00947349|281350|P4|STARTED|Overall Study Standard of Care||6
121717|NCT00947349|281351|P3|STARTED|Overall Study Standard of Care||6
121718|NCT00947349|281352|P2|STARTED|Overall Study Standard of Care||5
121719|NCT00947349|281353|P1|STARTED|Overall Study Standard of Care||4
121720|NCT00947349|281350|P4|NOT COMPLETED|Triple Treatment Combination Period||0
121721|NCT00947349|281351|P3|NOT COMPLETED|Triple Treatment Combination Period||0
121722|NCT00947349|281352|P2|NOT COMPLETED|Triple Treatment Combination Period||1
121723|NCT00947349|281353|P1|NOT COMPLETED|Triple Treatment Combination Period||0
121724|NCT00947349|281350|P4|COMPLETED|Triple Treatment Combination Period||6
121725|NCT00947349|281351|P3|COMPLETED|Triple Treatment Combination Period||6
121726|NCT00947349|281352|P2|COMPLETED|Triple Treatment Combination Period||5
121727|NCT00947349|281353|P1|COMPLETED|Triple Treatment Combination Period||4
121728|NCT00947349|281350|P4|STARTED|Triple Treatment Combination Period||6
121729|NCT00947349|281351|P3|STARTED|Triple Treatment Combination Period||6
121730|NCT00947349|281352|P2|STARTED|Triple Treatment Combination Period||6
121731|NCT00947349|281353|P1|STARTED|Triple Treatment Combination Period||4
121732|NCT00947310|281488|P3|NOT COMPLETED|Overall Study||0
121733|NCT00947310|281489|P2|NOT COMPLETED|Overall Study||0
121734|NCT00947310|281490|P1|NOT COMPLETED|Overall Study||0
121735|NCT00947310|281488|P3|COMPLETED|Overall Study||486
121736|NCT00947310|281489|P2|COMPLETED|Overall Study||500
121737|NCT00947310|281490|P1|COMPLETED|Overall Study||514
121738|NCT00947310|281488|P3|STARTED|Overall Study||486
121739|NCT00947310|281489|P2|STARTED|Overall Study||500
121740|NCT00947310|281490|P1|STARTED|Overall Study||514
121741|NCT00947297|281504|P1|NOT COMPLETED|Overall Study||7
121742|NCT00947297|281504|P1|COMPLETED|Overall Study||53
121743|NCT00947297|281504|P1|STARTED|Overall Study||60
121744|NCT00947284|281511|P2|NOT COMPLETED|Overall Study||3
121745|NCT00947284|281512|P1|NOT COMPLETED|Overall Study||0
121746|NCT00947284|281511|P2|COMPLETED|Overall Study||0
121747|NCT00947284|281512|P1|COMPLETED|Overall Study||0
121748|NCT00947284|281511|P2|STARTED|Overall Study||3
121749|NCT00947284|281512|P1|STARTED|Overall Study||0
121750|NCT00947271|281520|P4|NOT COMPLETED|12 Months Post Intervention||62
121751|NCT00947271|281521|P3|NOT COMPLETED|12 Months Post Intervention||59
121752|NCT00947271|281522|P2|NOT COMPLETED|12 Months Post Intervention||60
121753|NCT00947271|281523|P1|NOT COMPLETED|12 Months Post Intervention||71
121754|NCT00947271|281520|P4|COMPLETED|12 Months Post Intervention||188
121755|NCT00947271|281521|P3|COMPLETED|12 Months Post Intervention||195
121756|NCT00947271|281522|P2|COMPLETED|12 Months Post Intervention||192
121757|NCT00947271|281523|P1|COMPLETED|12 Months Post Intervention||183
121758|NCT00947271|281520|P4|STARTED|12 Months Post Intervention||250
121759|NCT00947271|281521|P3|STARTED|12 Months Post Intervention||254
121760|NCT00947271|281522|P2|STARTED|12 Months Post Intervention||252
121761|NCT00947271|281523|P1|STARTED|12 Months Post Intervention||254
121762|NCT00947271|281520|P4|NOT COMPLETED|9 Months Post Intervention||59
121763|NCT00947271|281521|P3|NOT COMPLETED|9 Months Post Intervention||61
121764|NCT00947271|281522|P2|NOT COMPLETED|9 Months Post Intervention||60
121765|NCT00947271|281523|P1|NOT COMPLETED|9 Months Post Intervention||70
121766|NCT00947271|281520|P4|COMPLETED|9 Months Post Intervention||191
121767|NCT00947271|281521|P3|COMPLETED|9 Months Post Intervention||193
121768|NCT00947271|281522|P2|COMPLETED|9 Months Post Intervention||192
121769|NCT00947271|281523|P1|COMPLETED|9 Months Post Intervention||184
121770|NCT00947271|281520|P4|STARTED|9 Months Post Intervention||250
121771|NCT00947271|281521|P3|STARTED|9 Months Post Intervention||254
121772|NCT00947271|281522|P2|STARTED|9 Months Post Intervention||252
121773|NCT00947271|281523|P1|STARTED|9 Months Post Intervention||254
121774|NCT00947271|281520|P4|NOT COMPLETED|6 Months Post Intervention||54
121775|NCT00947271|281521|P3|NOT COMPLETED|6 Months Post Intervention||58
121776|NCT00947271|281522|P2|NOT COMPLETED|6 Months Post Intervention||53
121777|NCT00947271|281523|P1|NOT COMPLETED|6 Months Post Intervention||55
121778|NCT00947271|281520|P4|COMPLETED|6 Months Post Intervention||196
121779|NCT00947271|281521|P3|COMPLETED|6 Months Post Intervention||196
121780|NCT00947271|281522|P2|COMPLETED|6 Months Post Intervention||199
121781|NCT00947271|281523|P1|COMPLETED|6 Months Post Intervention||199
121782|NCT00947271|281520|P4|STARTED|6 Months Post Intervention||250
121783|NCT00947271|281521|P3|STARTED|6 Months Post Intervention||254
121784|NCT00947271|281522|P2|STARTED|6 Months Post Intervention||252
121785|NCT00947271|281523|P1|STARTED|6 Months Post Intervention||254
121786|NCT00947271|281520|P4|NOT COMPLETED|3 Months Post Intervention||44
121787|NCT00947271|281521|P3|NOT COMPLETED|3 Months Post Intervention||36
121788|NCT00947271|281522|P2|NOT COMPLETED|3 Months Post Intervention||48
121789|NCT00947271|281523|P1|NOT COMPLETED|3 Months Post Intervention||52
121790|NCT00947271|281520|P4|COMPLETED|3 Months Post Intervention||206
121791|NCT00947271|281521|P3|COMPLETED|3 Months Post Intervention||218
121792|NCT00947271|281522|P2|COMPLETED|3 Months Post Intervention||204
121793|NCT00947271|281523|P1|COMPLETED|3 Months Post Intervention||202
121794|NCT00947271|281520|P4|STARTED|3 Months Post Intervention||250
121795|NCT00947271|281521|P3|STARTED|3 Months Post Intervention||254
121796|NCT00947271|281522|P2|STARTED|3 Months Post Intervention||252
121797|NCT00947271|281523|P1|STARTED|3 Months Post Intervention||254
121798|NCT00947219|281552|P3|NOT COMPLETED|Overall Study||4
121799|NCT00947219|281553|P2|NOT COMPLETED|Overall Study||4
121800|NCT00947219|281554|P1|NOT COMPLETED|Overall Study||6
121801|NCT00947219|281552|P3|COMPLETED|Overall Study||22
121802|NCT00947219|281553|P2|COMPLETED|Overall Study||21
121803|NCT00947219|281554|P1|COMPLETED|Overall Study||22
121804|NCT00947219|281552|P3|STARTED|Overall Study||26
121805|NCT00947219|281553|P2|STARTED|Overall Study||25
121806|NCT00947219|281554|P1|STARTED|Overall Study||28
121807|NCT00947154|281562|P1|NOT COMPLETED|Overall Study||1
121808|NCT00947154|281562|P1|COMPLETED|Overall Study||11
121809|NCT00947154|281562|P1|STARTED|Overall Study||12
121810|NCT00947115|281572|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
121811|NCT00947115|281573|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
121812|NCT00947115|281574|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
121813|NCT00947115|281572|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
121814|NCT00947115|281573|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
121815|NCT00947115|281574|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
121816|NCT00947115|281572|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
121817|NCT00947115|281573|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
121818|NCT00947115|281574|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
121819|NCT00947115|281572|P3|NOT COMPLETED|Year 10 (Month 120)||0
121820|NCT00947115|281573|P2|NOT COMPLETED|Year 10 (Month 120)||0
121821|NCT00947115|281574|P1|NOT COMPLETED|Year 10 (Month 120)||0
121822|NCT00947115|281572|P3|COMPLETED|Year 10 (Month 120)||156
121823|NCT00947115|281573|P2|COMPLETED|Year 10 (Month 120)||172
121824|NCT00947115|281574|P1|COMPLETED|Year 10 (Month 120)||142
121825|NCT00947115|281572|P3|STARTED|Year 10 (Month 120)||156
121826|NCT00947115|281573|P2|STARTED|Year 10 (Month 120)||172
121827|NCT00947115|281574|P1|STARTED|Year 10 (Month 120)||142
121828|NCT00947115|281572|P3|NOT COMPLETED|Year 9 (Month 108)||0
121829|NCT00947115|281573|P2|NOT COMPLETED|Year 9 (Month 108)||0
121830|NCT00947115|281574|P1|NOT COMPLETED|Year 9 (Month 108)||0
121831|NCT00947115|281572|P3|COMPLETED|Year 9 (Month 108)||157
121832|NCT00947115|281573|P2|COMPLETED|Year 9 (Month 108)||180
121833|NCT00947115|281574|P1|COMPLETED|Year 9 (Month 108)||146
121834|NCT00947115|281572|P3|STARTED|Year 9 (Month 108)||157
121835|NCT00947115|281573|P2|STARTED|Year 9 (Month 108)||180
121836|NCT00947115|281574|P1|STARTED|Year 9 (Month 108)||146
121837|NCT00947115|281572|P3|NOT COMPLETED|Year 8 (Month 96)||0
121838|NCT00947115|281573|P2|NOT COMPLETED|Year 8 (Month 96)||0
121839|NCT00947115|281574|P1|NOT COMPLETED|Year 8 (Month 96)||0
121840|NCT00947115|281572|P3|COMPLETED|Year 8 (Month 96)||141
121841|NCT00947115|281573|P2|COMPLETED|Year 8 (Month 96)||152
121842|NCT00947115|281574|P1|COMPLETED|Year 8 (Month 96)||137
121843|NCT00947115|281572|P3|STARTED|Year 8 (Month 96)||141
121844|NCT00947115|281573|P2|STARTED|Year 8 (Month 96)||152
121845|NCT00947115|281574|P1|STARTED|Year 8 (Month 96)||137
121846|NCT00947115|281572|P3|NOT COMPLETED|Year 7 (Month 84)||0
121847|NCT00947115|281573|P2|NOT COMPLETED|Year 7 (Month 84)||0
121848|NCT00947115|281574|P1|NOT COMPLETED|Year 7 (Month 84)||0
121849|NCT00947115|281572|P3|COMPLETED|Year 7 (Month 84)||160
121850|NCT00947115|281573|P2|COMPLETED|Year 7 (Month 84)||165
121851|NCT00947115|281574|P1|COMPLETED|Year 7 (Month 84)||149
121852|NCT00947115|281572|P3|STARTED|Year 7 (Month 84)||160
121853|NCT00947115|281573|P2|STARTED|Year 7 (Month 84)||165
121854|NCT00947115|281574|P1|STARTED|Year 7 (Month 84)||149
121855|NCT00947115|281572|P3|NOT COMPLETED|Year 6 (Month 72)||0
121856|NCT00947115|281573|P2|NOT COMPLETED|Year 6 (Month 72)||0
121857|NCT00947115|281574|P1|NOT COMPLETED|Year 6 (Month 72)||0
121858|NCT00947115|281572|P3|COMPLETED|Year 6 (Month 72)||164
121859|NCT00947115|281573|P2|COMPLETED|Year 6 (Month 72)||177
121860|NCT00947115|281574|P1|COMPLETED|Year 6 (Month 72)||147
121861|NCT00947115|281572|P3|STARTED|Year 6 (Month 72)||164
121862|NCT00947115|281573|P2|STARTED|Year 6 (Month 72)||177
121863|NCT00947115|281574|P1|STARTED|Year 6 (Month 72)||147
121864|NCT00947115|281572|P3|NOT COMPLETED|Year 5 (Month 60)||0
121865|NCT00947115|281573|P2|NOT COMPLETED|Year 5 (Month 60)||0
121866|NCT00947115|281574|P1|NOT COMPLETED|Year 5 (Month 60)||0
121867|NCT00947115|281572|P3|COMPLETED|Year 5 (Month 60)||170
121868|NCT00947115|281573|P2|COMPLETED|Year 5 (Month 60)||184
121869|NCT00947115|281574|P1|COMPLETED|Year 5 (Month 60)||153
121870|NCT00947115|281572|P3|STARTED|Year 5 (Month 60)||170
121871|NCT00947115|281573|P2|STARTED|Year 5 (Month 60)||184
121872|NCT00947115|281574|P1|STARTED|Year 5 (Month 60)||153
121873|NCT00946985|281636|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
121874|NCT00946985|281636|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
121875|NCT00946985|281636|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
121876|NCT00946985|281636|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
121877|NCT00946985|281636|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
121878|NCT00946985|281636|P1|STARTED|Stabilization Phase (25 Weeks)||162
121879|NCT00946920|281642|P2|NOT COMPLETED|Overall Study||44
121880|NCT00946920|281643|P1|NOT COMPLETED|Overall Study||110
121881|NCT00946920|281642|P2|COMPLETED|Overall Study||239
121882|NCT00946920|281643|P1|COMPLETED|Overall Study||455
121883|NCT00946920|281642|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
121884|NCT00946920|281643|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
121885|NCT00946920|281642|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
121886|NCT00946920|281643|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
121887|NCT00946478|281660|P2|NOT COMPLETED|Overall Study||0
121888|NCT00946478|281661|P1|NOT COMPLETED|Overall Study||0
121889|NCT00946478|281660|P2|COMPLETED|Overall Study||20
121890|NCT00946478|281661|P1|COMPLETED|Overall Study||20
121891|NCT00946478|281660|P2|STARTED|Overall Study||20
121892|NCT00946478|281661|P1|STARTED|Overall Study||20
121893|NCT00946348|281669|P2|NOT COMPLETED|Overall Study||0
121894|NCT00946348|281670|P1|NOT COMPLETED|Overall Study||0
121895|NCT00946348|281669|P2|COMPLETED|Overall Study||6
121896|NCT00946348|281670|P1|COMPLETED|Overall Study||6
121897|NCT00946348|281669|P2|STARTED|Overall Study||6
121898|NCT00946348|281670|P1|STARTED|Overall Study||6
121899|NCT00946322|281676|P1|NOT COMPLETED|Post-treatment||2
121900|NCT00946322|281676|P1|COMPLETED|Post-treatment||9
121901|NCT00946322|281676|P1|STARTED|Post-treatment||11
121902|NCT00946322|281676|P1|NOT COMPLETED|Pre-treatment||1
121903|NCT00946322|281676|P1|COMPLETED|Pre-treatment||11
121904|NCT00946322|281676|P1|STARTED|Pre-treatment||12
121905|NCT00946309|281689|P2|NOT COMPLETED|Overall Study||4
121906|NCT00946309|281690|P1|NOT COMPLETED|Overall Study||1
121907|NCT00946309|281689|P2|COMPLETED|Overall Study||19
121908|NCT00946309|281690|P1|COMPLETED|Overall Study||21
121909|NCT00946309|281689|P2|STARTED|Overall Study||23
121910|NCT00946309|281690|P1|STARTED|Overall Study||22
121911|NCT00946296|281708|P2|NOT COMPLETED|Overall Study||0
121912|NCT00946296|281709|P1|NOT COMPLETED|Overall Study||3
121913|NCT00946296|281708|P2|COMPLETED|Overall Study||15
121914|NCT00946296|281709|P1|COMPLETED|Overall Study||18
121915|NCT00946296|281708|P2|STARTED|Overall Study||15
121916|NCT00946296|281709|P1|STARTED|Overall Study||21
121917|NCT00946114|281717|P2|NOT COMPLETED|Overall Study||2
121918|NCT00946114|281718|P1|NOT COMPLETED|Overall Study||8
121919|NCT00946114|281717|P2|COMPLETED|Overall Study||10
121920|NCT00946114|281718|P1|COMPLETED|Overall Study||12
121921|NCT00946114|281717|P2|STARTED|Overall Study||12
121922|NCT00946114|281718|P1|STARTED|Overall Study||20
121923|NCT00946101|281726|P2|NOT COMPLETED|Overall Study||2
121924|NCT00946101|281727|P1|NOT COMPLETED|Overall Study||4
121925|NCT00946101|281726|P2|COMPLETED|Overall Study||63
121926|NCT00946101|281727|P1|COMPLETED|Overall Study||257
121927|NCT00946101|281726|P2|Day 15 Post Dose 2|Overall Study||63
121928|NCT00946101|281727|P1|Day 15 Post Dose 2|Overall Study||254
121929|NCT00946101|281726|P2|Day 15 Post Dose 1|Overall Study||64
121930|NCT00946101|281727|P1|Day 15 Post Dose 1|Overall Study||260
121931|NCT00946101|281726|P2|STARTED|Overall Study||65
121932|NCT00946101|281727|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
121933|NCT00946088|281793|P2|NOT COMPLETED|Overall Study||1
121934|NCT00946088|281794|P1|NOT COMPLETED|Overall Study||0
121935|NCT00946088|281793|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
121936|NCT00946088|281794|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
121937|NCT00946088|281793|P2|STARTED|Overall Study||3
121938|NCT00946088|281794|P1|STARTED|Overall Study||4
121939|NCT00945958|281816|P1|NOT COMPLETED|Overall Study||12
121940|NCT00945958|281816|P1|COMPLETED|Overall Study||149
121941|NCT00945958|281816|P1|STARTED|Overall Study||161
121942|NCT00945945|281823|P2|NOT COMPLETED|Overall Study||55
121943|NCT00945945|281824|P1|NOT COMPLETED|Overall Study||36
121944|NCT00945945|281823|P2|COMPLETED|Overall Study||162
121945|NCT00945945|281824|P1|COMPLETED|Overall Study||171
121946|NCT00945945|281823|P2|STARTED|Overall Study||217
121947|NCT00945945|281824|P1|STARTED|Overall Study||207
121948|NCT00945906|281850|P1|NOT COMPLETED|Overall Study||7
121949|NCT00945906|281850|P1|COMPLETED|Overall Study||54
121950|NCT00945906|281850|P1|STARTED|Overall Study||61
121951|NCT00945893|281861|P2|NOT COMPLETED|Overall Study||10
121952|NCT00945893|281862|P1|NOT COMPLETED|Overall Study||3
121953|NCT00945893|281861|P2|COMPLETED|Overall Study||230
121954|NCT00945893|281862|P1|COMPLETED|Overall Study||57
121955|NCT00945893|281861|P2|Day 15 Post Dose 2|Overall Study||226
121956|NCT00945893|281862|P1|Day 15 Post Dose 2|Overall Study||54
121957|NCT00945893|281861|P2|Day 15 Post Dose 1|Overall Study||238
121958|NCT00945893|281862|P1|Day 15 Post Dose 1|Overall Study||60
121959|NCT00945893|281861|P2|STARTED|Overall Study||240
121960|NCT00945893|281862|P1|STARTED|Overall Study||60
121961|NCT00945854|281928|P2|NOT COMPLETED|Overall Study||4
121962|NCT00945854|281929|P1|NOT COMPLETED|Overall Study||2
121963|NCT00945854|281928|P2|COMPLETED|Overall Study||26
121964|NCT00945854|281929|P1|COMPLETED|Overall Study||28
121965|NCT00945854|281928|P2|STARTED|Overall Study||30
121966|NCT00945854|281929|P1|STARTED|Overall Study||30
121967|NCT00945815|281939|P1|NOT COMPLETED|Overall Study||8
121968|NCT00945815|281939|P1|COMPLETED|Overall Study||27
121969|NCT00945815|281939|P1|Eligible and Began Protocol Therapy|Overall Study||31
121970|NCT00945815|281939|P1|Eligible|Overall Study||32
121971|NCT00945815|281939|P1|STARTED|Overall Study||35
121972|NCT00945750|281950|P6|NOT COMPLETED|Period III||0
121973|NCT00945750|281951|P5|NOT COMPLETED|Period III||0
121974|NCT00945750|281952|P4|NOT COMPLETED|Period III||0
121975|NCT00945750|281953|P3|NOT COMPLETED|Period III||0
121976|NCT00945750|281954|P2|NOT COMPLETED|Period III||0
121977|NCT00945750|281955|P1|NOT COMPLETED|Period III||0
121978|NCT00945750|281950|P6|COMPLETED|Period III||5
121979|NCT00945750|281951|P5|COMPLETED|Period III||5
121980|NCT00945750|281952|P4|COMPLETED|Period III||5
121981|NCT00945750|281953|P3|COMPLETED|Period III||5
121982|NCT00945750|281954|P2|COMPLETED|Period III||5
121983|NCT00945750|281955|P1|COMPLETED|Period III||5
121984|NCT00945750|281950|P6|STARTED|Period III||5
121985|NCT00945750|281951|P5|STARTED|Period III||5
121986|NCT00945750|281952|P4|STARTED|Period III||5
121987|NCT00945750|281953|P3|STARTED|Period III||5
121988|NCT00945750|281954|P2|STARTED|Period III||5
121989|NCT00945750|281955|P1|STARTED|Period III||5
121990|NCT00945750|281950|P6|NOT COMPLETED|Period II||0
121991|NCT00945750|281951|P5|NOT COMPLETED|Period II||0
121992|NCT00945750|281952|P4|NOT COMPLETED|Period II||0
121993|NCT00945750|281953|P3|NOT COMPLETED|Period II||0
121994|NCT00945750|281954|P2|NOT COMPLETED|Period II||0
121995|NCT00945750|281955|P1|NOT COMPLETED|Period II||0
121996|NCT00945750|281950|P6|COMPLETED|Period II||5
121997|NCT00945750|281951|P5|COMPLETED|Period II||5
121998|NCT00945750|281952|P4|COMPLETED|Period II||5
121999|NCT00945750|281953|P3|COMPLETED|Period II||5
122000|NCT00945750|281954|P2|COMPLETED|Period II||5
122001|NCT00945750|281955|P1|COMPLETED|Period II||5
122002|NCT00945750|281950|P6|STARTED|Period II||5
122003|NCT00945750|281951|P5|STARTED|Period II||5
122004|NCT00945750|281952|P4|STARTED|Period II||5
122005|NCT00945750|281953|P3|STARTED|Period II||5
122006|NCT00945750|281954|P2|STARTED|Period II||5
122007|NCT00945750|281955|P1|STARTED|Period II||5
122008|NCT00945750|281950|P6|NOT COMPLETED|Period I||0
122009|NCT00945750|281951|P5|NOT COMPLETED|Period I||0
122010|NCT00945750|281952|P4|NOT COMPLETED|Period I||0
122011|NCT00945750|281953|P3|NOT COMPLETED|Period I||0
122012|NCT00945750|281954|P2|NOT COMPLETED|Period I||0
122013|NCT00945750|281955|P1|NOT COMPLETED|Period I||0
122014|NCT00945750|281950|P6|COMPLETED|Period I||5
122015|NCT00945750|281951|P5|COMPLETED|Period I||5
122016|NCT00945750|281952|P4|COMPLETED|Period I||5
122017|NCT00945750|281953|P3|COMPLETED|Period I||5
122018|NCT00945750|281954|P2|COMPLETED|Period I||5
122019|NCT00945750|281955|P1|COMPLETED|Period I||5
122020|NCT00945750|281950|P6|STARTED|Period I||5
122021|NCT00945750|281951|P5|STARTED|Period I||5
122022|NCT00945750|281952|P4|STARTED|Period I||5
122023|NCT00945750|281953|P3|STARTED|Period I||5
122024|NCT00945750|281954|P2|STARTED|Period I||5
122025|NCT00945750|281955|P1|STARTED|Period I||5
122026|NCT00945555|281968|P1|NOT COMPLETED|Overall Study||28
122027|NCT00945555|281968|P1|COMPLETED|Overall Study||236
122028|NCT00945555|281968|P1|STARTED|Overall Study||264
122029|NCT00945477|281979|P1|NOT COMPLETED|Overall Study||6
122030|NCT00945477|281979|P1|COMPLETED|Overall Study||5
122031|NCT00945477|281979|P1|STARTED|Overall Study||11
122032|NCT00945334|281986|P2|NOT COMPLETED|Overall Study||3
122033|NCT00945334|281987|P1|NOT COMPLETED|Overall Study||3
122034|NCT00945334|281986|P2|COMPLETED|Overall Study||15
122035|NCT00945334|281987|P1|COMPLETED|Overall Study||16
122036|NCT00945334|281986|P2|STARTED|Overall Study||18
122037|NCT00945334|281987|P1|STARTED|Overall Study||19
122038|NCT00945321|281995|P6|NOT COMPLETED|Period 4||1
122039|NCT00945321|281996|P5|NOT COMPLETED|Period 4||0
122040|NCT00945321|281997|P4|NOT COMPLETED|Period 4||0
122041|NCT00945321|281998|P3|NOT COMPLETED|Period 4||0
122042|NCT00945321|281999|P2|NOT COMPLETED|Period 4||0
122043|NCT00945321|282000|P1|NOT COMPLETED|Period 4||0
122044|NCT00945321|281995|P6|COMPLETED|Period 4||6
122045|NCT00945321|281996|P5|COMPLETED|Period 4||6
122046|NCT00945321|281997|P4|COMPLETED|Period 4||7
122047|NCT00945321|281998|P3|COMPLETED|Period 4||7
122048|NCT00945321|281999|P2|COMPLETED|Period 4||7
122049|NCT00945321|282000|P1|COMPLETED|Period 4||7
122050|NCT00945321|281995|P6|STARTED|Period 4||7
122051|NCT00945321|281996|P5|STARTED|Period 4||6
122052|NCT00945321|281997|P4|STARTED|Period 4||7
122053|NCT00945321|281998|P3|STARTED|Period 4||7
122054|NCT00945321|281999|P2|STARTED|Period 4||7
122055|NCT00945321|282000|P1|STARTED|Period 4||7
122056|NCT00945321|281995|P6|NOT COMPLETED|Period 3||0
122057|NCT00945321|281996|P5|NOT COMPLETED|Period 3||0
122058|NCT00945321|281997|P4|NOT COMPLETED|Period 3||0
122059|NCT00945321|281998|P3|NOT COMPLETED|Period 3||0
122060|NCT00945321|281999|P2|NOT COMPLETED|Period 3||0
122061|NCT00945321|282000|P1|NOT COMPLETED|Period 3||0
122062|NCT00945321|281995|P6|COMPLETED|Period 3||7
122063|NCT00945321|281996|P5|COMPLETED|Period 3||6
122064|NCT00945321|281997|P4|COMPLETED|Period 3||7
122065|NCT00945321|281998|P3|COMPLETED|Period 3||7
122066|NCT00945321|281999|P2|COMPLETED|Period 3||7
122067|NCT00945321|282000|P1|COMPLETED|Period 3||7
122068|NCT00945321|281995|P6|STARTED|Period 3||7
122069|NCT00945321|281996|P5|STARTED|Period 3||6
122070|NCT00945321|281997|P4|STARTED|Period 3||7
122071|NCT00945321|281998|P3|STARTED|Period 3||7
122072|NCT00945321|281999|P2|STARTED|Period 3||7
122073|NCT00945321|282000|P1|STARTED|Period 3||7
122074|NCT00945321|281995|P6|NOT COMPLETED|Period 2||0
122075|NCT00945321|281996|P5|NOT COMPLETED|Period 2||0
122076|NCT00945321|281997|P4|NOT COMPLETED|Period 2||0
122077|NCT00945321|281998|P3|NOT COMPLETED|Period 2||0
122078|NCT00945321|281999|P2|NOT COMPLETED|Period 2||0
122079|NCT00945321|282000|P1|NOT COMPLETED|Period 2||0
122080|NCT00945321|281995|P6|COMPLETED|Period 2||7
122081|NCT00945321|281996|P5|COMPLETED|Period 2||6
122082|NCT00945321|281997|P4|COMPLETED|Period 2||7
122083|NCT00945321|281998|P3|COMPLETED|Period 2||7
122084|NCT00945321|281999|P2|COMPLETED|Period 2||7
122085|NCT00945321|282000|P1|COMPLETED|Period 2||7
122086|NCT00945321|281995|P6|STARTED|Period 2||7
122087|NCT00945321|281996|P5|STARTED|Period 2||6
122088|NCT00945321|281997|P4|STARTED|Period 2||7
122089|NCT00945321|281998|P3|STARTED|Period 2||7
122090|NCT00945321|281999|P2|STARTED|Period 2||7
122091|NCT00945321|282000|P1|STARTED|Period 2||7
122092|NCT00945321|281995|P6|NOT COMPLETED|Period 1||0
122093|NCT00945321|281996|P5|NOT COMPLETED|Period 1||1
122094|NCT00945321|281997|P4|NOT COMPLETED|Period 1||0
122095|NCT00945321|281998|P3|NOT COMPLETED|Period 1||0
122096|NCT00945321|281999|P2|NOT COMPLETED|Period 1||0
122097|NCT00945321|282000|P1|NOT COMPLETED|Period 1||0
122098|NCT00945321|281995|P6|COMPLETED|Period 1||7
122099|NCT00945321|281996|P5|COMPLETED|Period 1||6
122100|NCT00945321|281997|P4|COMPLETED|Period 1||7
122101|NCT00945321|281998|P3|COMPLETED|Period 1||7
122102|NCT00945321|281999|P2|COMPLETED|Period 1||7
122103|NCT00945321|282000|P1|COMPLETED|Period 1||7
122104|NCT00945321|281995|P6|STARTED|Period 1||7
122105|NCT00945321|281996|P5|STARTED|Period 1||7
122106|NCT00945321|281997|P4|STARTED|Period 1||7
122107|NCT00945321|281998|P3|STARTED|Period 1||7
122108|NCT00945321|281999|P2|STARTED|Period 1||7
122109|NCT00945321|282000|P1|STARTED|Period 1||7
122110|NCT00945295|282022|P2|NOT COMPLETED|Overall Study||2
122111|NCT00945295|282023|P1|NOT COMPLETED|Overall Study||0
122112|NCT00945295|282022|P2|COMPLETED|Overall Study||14
122113|NCT00945295|282023|P1|COMPLETED|Overall Study||15
122114|NCT00945295|282022|P2|STARTED|Overall Study||16
122115|NCT00945295|282023|P1|STARTED|Overall Study||15
122116|NCT00945256|282036|P5|NOT COMPLETED|Overall Study||1
122117|NCT00945256|282037|P4|NOT COMPLETED|Overall Study||9
122118|NCT00945256|282038|P3|NOT COMPLETED|Overall Study||8
122119|NCT00945256|282039|P2|NOT COMPLETED|Overall Study||2
122120|NCT00945256|282040|P1|NOT COMPLETED|Overall Study||4
122121|NCT00945256|282036|P5|COMPLETED|Overall Study||7
122122|NCT00945256|282037|P4|COMPLETED|Overall Study||7
122123|NCT00945256|282038|P3|COMPLETED|Overall Study||7
122124|NCT00945256|282039|P2|COMPLETED|Overall Study||8
122125|NCT00945256|282040|P1|COMPLETED|Overall Study||9
122126|NCT00945256|282036|P5|STARTED|Overall Study||8
122127|NCT00945256|282037|P4|STARTED|Overall Study||16
122128|NCT00945256|282038|P3|STARTED|Overall Study||15
122129|NCT00945256|282039|P2|STARTED|Overall Study||10
122130|NCT00945256|282040|P1|STARTED|Overall Study||13
122131|NCT00945243|282052|P1|NOT COMPLETED|Overall Study||3
122132|NCT00945243|282052|P1|COMPLETED|Overall Study||8
122133|NCT00945243|282052|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
122134|NCT00945139|282058|P1|NOT COMPLETED|Overall Study||0
122135|NCT00945139|282058|P1|COMPLETED|Overall Study||46
122136|NCT00945139|282058|P1|STARTED|Overall Study||46
122137|NCT00945100|282069|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
122138|NCT00945100|282070|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
122139|NCT00945100|282069|P2|COMPLETED|Post-10 Week Primary Outcome||56
122140|NCT00945100|282070|P1|COMPLETED|Post-10 Week Primary Outcome||51
122141|NCT00945100|282069|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
122142|NCT00945100|282070|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
122143|NCT00945100|282069|P2|NOT COMPLETED|10-week Primary Outcome||3
122144|NCT00945100|282070|P1|NOT COMPLETED|10-week Primary Outcome||1
122145|NCT00945100|282069|P2|COMPLETED|10-week Primary Outcome||83
122146|NCT00945100|282070|P1|COMPLETED|10-week Primary Outcome||82
122147|NCT00945100|282069|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
122148|NCT00945100|282070|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
122149|NCT00945100|282069|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
122150|NCT00945100|282070|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
122151|NCT00945100|282069|P2|STARTED|10-week Primary Outcome||86
122152|NCT00945100|282070|P1|STARTED|10-week Primary Outcome||83
122153|NCT00945035|282134|P2|NOT COMPLETED|Period 2||0
122154|NCT00945035|282135|P1|NOT COMPLETED|Period 2||0
122155|NCT00945035|282134|P2|COMPLETED|Period 2||18
122156|NCT00945035|282135|P1|COMPLETED|Period 2||18
122157|NCT00945035|282134|P2|STARTED|Period 2||18
122158|NCT00945035|282135|P1|STARTED|Period 2||18
122159|NCT00945035|282134|P2|NOT COMPLETED|Period 1||0
122160|NCT00945035|282135|P1|NOT COMPLETED|Period 1||0
122161|NCT00945035|282134|P2|COMPLETED|Period 1||18
122162|NCT00945035|282135|P1|COMPLETED|Period 1||18
122163|NCT00945035|282134|P2|STARTED|Period 1||18
122164|NCT00945035|282135|P1|STARTED|Period 1||18
122165|NCT00944710|282145|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
122166|NCT00944710|282146|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
122167|NCT00944710|282145|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
122168|NCT00944710|282146|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
122169|NCT00944710|282145|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
122170|NCT00944710|282146|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
122171|NCT00944710|282145|P2|STARTED|Additional Post 10-week Primary Outcome||33
122172|NCT00944710|282146|P1|STARTED|Additional Post 10-week Primary Outcome||40
122173|NCT00944710|282145|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
122174|NCT00944710|282146|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
122175|NCT00944710|282145|P2|COMPLETED|12-week Visit (Off-treatment)||33
122176|NCT00944710|282146|P1|COMPLETED|12-week Visit (Off-treatment)||40
122177|NCT00944710|282145|P2|STARTED|12-week Visit (Off-treatment)||33
122178|NCT00944710|282146|P1|STARTED|12-week Visit (Off-treatment)||40
122179|NCT00944710|282145|P2|NOT COMPLETED|10-week Primary Outcome||0
122180|NCT00944710|282146|P1|NOT COMPLETED|10-week Primary Outcome||0
122181|NCT00944710|282145|P2|COMPLETED|10-week Primary Outcome||33
122182|NCT00944710|282146|P1|COMPLETED|10-week Primary Outcome||40
122183|NCT00944710|282145|P2|STARTED|10-week Primary Outcome||33
122184|NCT00944710|282146|P1|STARTED|10-week Primary Outcome||40
122185|NCT00944697|282204|P2|NOT COMPLETED|Overall Study||5
122186|NCT00944697|282205|P1|NOT COMPLETED|Overall Study||2
122187|NCT00944697|282204|P2|COMPLETED|Overall Study||43
122188|NCT00944697|282205|P1|COMPLETED|Overall Study||48
122189|NCT00944697|282204|P2|STARTED|Overall Study||48
122190|NCT00944697|282205|P1|STARTED|Overall Study||50
122191|NCT00944671|282217|P6|NOT COMPLETED|Period III||0
122192|NCT00944671|282218|P5|NOT COMPLETED|Period III||0
122193|NCT00944671|282219|P4|NOT COMPLETED|Period III||0
122194|NCT00944671|282220|P3|NOT COMPLETED|Period III||0
122195|NCT00944671|282221|P2|NOT COMPLETED|Period III||0
122196|NCT00944671|282222|P1|NOT COMPLETED|Period III||0
122197|NCT00944671|282217|P6|COMPLETED|Period III||4
122198|NCT00944671|282218|P5|COMPLETED|Period III||4
122199|NCT00944671|282219|P4|COMPLETED|Period III||4
122200|NCT00944671|282220|P3|COMPLETED|Period III||4
122201|NCT00944671|282221|P2|COMPLETED|Period III||4
122202|NCT00944671|282222|P1|COMPLETED|Period III||4
122203|NCT00944671|282217|P6|STARTED|Period III||4
122204|NCT00944671|282218|P5|STARTED|Period III||4
122205|NCT00944671|282219|P4|STARTED|Period III||4
122206|NCT00944671|282220|P3|STARTED|Period III||4
122207|NCT00944671|282221|P2|STARTED|Period III||4
122208|NCT00944671|282222|P1|STARTED|Period III||4
122209|NCT00944671|282217|P6|NOT COMPLETED|Period II||0
122210|NCT00944671|282218|P5|NOT COMPLETED|Period II||0
122211|NCT00944671|282219|P4|NOT COMPLETED|Period II||0
122212|NCT00944671|282220|P3|NOT COMPLETED|Period II||0
122213|NCT00944671|282221|P2|NOT COMPLETED|Period II||0
122214|NCT00944671|282222|P1|NOT COMPLETED|Period II||0
122215|NCT00944671|282217|P6|COMPLETED|Period II||4
122216|NCT00944671|282218|P5|COMPLETED|Period II||4
122217|NCT00944671|282219|P4|COMPLETED|Period II||4
122218|NCT00944671|282220|P3|COMPLETED|Period II||4
122219|NCT00944671|282221|P2|COMPLETED|Period II||4
122220|NCT00944671|282222|P1|COMPLETED|Period II||4
122221|NCT00944671|282217|P6|STARTED|Period II||4
122222|NCT00944671|282218|P5|STARTED|Period II||4
122223|NCT00944671|282219|P4|STARTED|Period II||4
122224|NCT00944671|282220|P3|STARTED|Period II||4
122225|NCT00944671|282221|P2|STARTED|Period II||4
122226|NCT00944671|282222|P1|STARTED|Period II||4
122227|NCT00944671|282217|P6|NOT COMPLETED|Period I||0
122228|NCT00944671|282218|P5|NOT COMPLETED|Period I||0
122229|NCT00944671|282219|P4|NOT COMPLETED|Period I||0
122230|NCT00944671|282220|P3|NOT COMPLETED|Period I||0
122231|NCT00944671|282221|P2|NOT COMPLETED|Period I||0
122232|NCT00944671|282222|P1|NOT COMPLETED|Period I||0
122233|NCT00944671|282217|P6|COMPLETED|Period I||4
122234|NCT00944671|282218|P5|COMPLETED|Period I||4
122235|NCT00944671|282219|P4|COMPLETED|Period I||4
122236|NCT00944671|282220|P3|COMPLETED|Period I||4
122237|NCT00944671|282221|P2|COMPLETED|Period I||4
122238|NCT00944671|282222|P1|COMPLETED|Period I||4
122239|NCT00944671|282217|P6|STARTED|Period I||4
122240|NCT00944671|282218|P5|STARTED|Period I||4
122241|NCT00944671|282219|P4|STARTED|Period I||4
122242|NCT00944671|282220|P3|STARTED|Period I||4
122243|NCT00944671|282221|P2|STARTED|Period I||4
122244|NCT00944671|282222|P1|STARTED|Period I||4
122245|NCT00944645|282235|P2|NOT COMPLETED|Period 2||9
122246|NCT00944645|282236|P1|NOT COMPLETED|Period 2||8
122247|NCT00944645|282235|P2|COMPLETED|Period 2||85
122248|NCT00944645|282236|P1|COMPLETED|Period 2||86
122249|NCT00944645|282235|P2|STARTED|Period 2||94
122250|NCT00944645|282236|P1|STARTED|Period 2||94
122251|NCT00944645|282235|P2|NOT COMPLETED|Period 1||0
122252|NCT00944645|282236|P1|NOT COMPLETED|Period 1||0
122253|NCT00944645|282235|P2|COMPLETED|Period 1||94
122254|NCT00944645|282236|P1|COMPLETED|Period 1||94
122255|NCT00944645|282235|P2|STARTED|Period 1||94
122256|NCT00944645|282236|P1|STARTED|Period 1||94
122257|NCT00944450|282248|P2|NOT COMPLETED|Period 2||0
122258|NCT00944450|282249|P1|NOT COMPLETED|Period 2||0
122259|NCT00944450|282248|P2|COMPLETED|Period 2||6
122260|NCT00944450|282249|P1|COMPLETED|Period 2||6
122261|NCT00944450|282248|P2|STARTED|Period 2||6
122262|NCT00944450|282249|P1|STARTED|Period 2||6
122263|NCT00944450|282248|P2|NOT COMPLETED|Period 1||0
122264|NCT00944450|282249|P1|NOT COMPLETED|Period 1||0
122265|NCT00944450|282248|P2|COMPLETED|Period 1||6
122266|NCT00944450|282249|P1|COMPLETED|Period 1||6
122267|NCT00944450|282248|P2|STARTED|Period 1||6
122268|NCT00944450|282249|P1|STARTED|Period 1||6
122269|NCT00944229|282257|P1|NOT COMPLETED|Overall Study||25
122270|NCT00944229|282257|P1|COMPLETED|Overall Study||33
122271|NCT00944229|282257|P1|STARTED|Overall Study||58
122272|NCT00944125|282263|P2|NOT COMPLETED|6 Months to Study Completion||2
122273|NCT00944125|282264|P1|NOT COMPLETED|6 Months to Study Completion||0
122274|NCT00944125|282263|P2|COMPLETED|6 Months to Study Completion||18
122275|NCT00944125|282264|P1|COMPLETED|6 Months to Study Completion||19
122276|NCT00944125|282263|P2|STARTED|6 Months to Study Completion||20
122277|NCT00944125|282264|P1|STARTED|6 Months to Study Completion||19
122278|NCT00944125|282263|P2|NOT COMPLETED|3 to 6 Months||2
122279|NCT00944125|282264|P1|NOT COMPLETED|3 to 6 Months||0
122280|NCT00944125|282263|P2|COMPLETED|3 to 6 Months||20
122281|NCT00944125|282264|P1|COMPLETED|3 to 6 Months||19
122282|NCT00944125|282263|P2|STARTED|3 to 6 Months||22
122283|NCT00944125|282264|P1|STARTED|3 to 6 Months||19
122284|NCT00944125|282263|P2|NOT COMPLETED|Baseline to 3 Months||0
122285|NCT00944125|282264|P1|NOT COMPLETED|Baseline to 3 Months||0
122286|NCT00944125|282263|P2|COMPLETED|Baseline to 3 Months||22
122287|NCT00944125|282264|P1|COMPLETED|Baseline to 3 Months||19
122288|NCT00944125|282263|P2|STARTED|Baseline to 3 Months||22
122289|NCT00944125|282264|P1|STARTED|Baseline to 3 Months||19
122290|NCT00944073|282272|P2|NOT COMPLETED|Overall Study||4
122291|NCT00944073|282273|P1|NOT COMPLETED|Overall Study||5
122292|NCT00944073|282272|P2|COMPLETED|Overall Study||287
122293|NCT00944073|282273|P1|COMPLETED|Overall Study||287
122294|NCT00944073|282272|P2|STARTED|Overall Study||291
122295|NCT00944073|282273|P1|STARTED|Overall Study||292
122296|NCT00944034|282363|P12|NOT COMPLETED|Overall Study||4
122297|NCT00944034|282364|P11|NOT COMPLETED|Overall Study||1
122298|NCT00944034|282365|P10|NOT COMPLETED|Overall Study||10
122299|NCT00944034|282366|P9|NOT COMPLETED|Overall Study||10
122300|NCT00944034|282367|P8|NOT COMPLETED|Overall Study||5
122301|NCT00944034|282368|P7|NOT COMPLETED|Overall Study||4
122302|NCT00944034|282369|P6|NOT COMPLETED|Overall Study||20
122303|NCT00944034|282370|P5|NOT COMPLETED|Overall Study||14
122304|NCT00944034|282371|P4|NOT COMPLETED|Overall Study||4
122305|NCT00944034|282372|P3|NOT COMPLETED|Overall Study||9
122306|NCT00944034|282373|P2|NOT COMPLETED|Overall Study||7
122307|NCT00944034|282374|P1|NOT COMPLETED|Overall Study||5
122308|NCT00944034|282363|P12|COMPLETED|Overall Study||52
122309|NCT00944034|282364|P11|COMPLETED|Overall Study||50
122310|NCT00944034|282365|P10|COMPLETED|Overall Study||236
122311|NCT00944034|282366|P9|COMPLETED|Overall Study||63
122312|NCT00944034|282367|P8|COMPLETED|Overall Study||73
122313|NCT00944034|282368|P7|COMPLETED|Overall Study||102
122314|NCT00944034|282369|P6|COMPLETED|Overall Study||123
122315|NCT00944034|282370|P5|COMPLETED|Overall Study||150
122316|NCT00944034|282371|P4|COMPLETED|Overall Study||170
122317|NCT00944034|282372|P3|COMPLETED|Overall Study||143
122318|NCT00944034|282373|P2|COMPLETED|Overall Study||150
122319|NCT00944034|282374|P1|COMPLETED|Overall Study||183
122320|NCT00944034|282363|P12|STARTED|Overall Study||56
122321|NCT00944034|282364|P11|STARTED|Overall Study||51
122322|NCT00944034|282365|P10|STARTED|Overall Study||246
122323|NCT00944034|282366|P9|STARTED|Overall Study||73
122324|NCT00944034|282367|P8|STARTED|Overall Study||78
122325|NCT00944034|282368|P7|STARTED|Overall Study||106
122326|NCT00944034|282369|P6|STARTED|Overall Study||143
122327|NCT00944034|282370|P5|STARTED|Overall Study||164
122328|NCT00944034|282371|P4|STARTED|Overall Study||174
122329|NCT00944034|282372|P3|STARTED|Overall Study||152
122330|NCT00944034|282373|P2|STARTED|Overall Study||157
122331|NCT00944034|282374|P1|STARTED|Overall Study||188
122332|NCT00944021|282444|P5|NOT COMPLETED|Overall Study||0
122333|NCT00944021|282445|P4|NOT COMPLETED|Overall Study||0
122334|NCT00944021|282446|P3|NOT COMPLETED|Overall Study||0
122335|NCT00944021|282447|P2|NOT COMPLETED|Overall Study||0
122336|NCT00944021|282448|P1|NOT COMPLETED|Overall Study||1
122337|NCT00944021|282444|P5|COMPLETED|Overall Study||8
122338|NCT00944021|282445|P4|COMPLETED|Overall Study||16
122339|NCT00944021|282446|P3|COMPLETED|Overall Study||15
122340|NCT00944021|282447|P2|COMPLETED|Overall Study||15
122341|NCT00944021|282448|P1|COMPLETED|Overall Study||14
122342|NCT00944021|282444|P5|STARTED|Overall Study||8
122343|NCT00944021|282445|P4|STARTED|Overall Study||16
122344|NCT00944021|282446|P3|STARTED|Overall Study||15
122345|NCT00944021|282447|P2|STARTED|Overall Study||15
122346|NCT00944021|282448|P1|STARTED|Overall Study||15
122347|NCT00943917|282520|P15|NOT COMPLETED|Stage II Continuation||4
122348|NCT00943917|282521|P14|NOT COMPLETED|Stage II Continuation||3
122349|NCT00943917|282522|P13|NOT COMPLETED|Stage II Continuation||3
122350|NCT00943917|282523|P12|NOT COMPLETED|Stage II Continuation||2
122351|NCT00943917|282524|P11|NOT COMPLETED|Stage II Continuation||0
122352|NCT00943917|282525|P10|NOT COMPLETED|Stage II Continuation||1
122353|NCT00943917|282526|P9|NOT COMPLETED|Stage II Continuation||0
122354|NCT00943917|282527|P8|NOT COMPLETED|Stage II Continuation||0
122355|NCT00943917|282528|P7|NOT COMPLETED|Stage II Continuation||0
122356|NCT00943917|282529|P6|NOT COMPLETED|Stage II Continuation||0
122357|NCT00943917|282530|P5|NOT COMPLETED|Stage II Continuation||0
122358|NCT00943917|282531|P4|NOT COMPLETED|Stage II Continuation||0
122359|NCT00943917|282532|P3|NOT COMPLETED|Stage II Continuation||0
122360|NCT00943917|282533|P2|NOT COMPLETED|Stage II Continuation||0
122361|NCT00943917|282534|P1|NOT COMPLETED|Stage II Continuation||0
122362|NCT00943917|282520|P15|COMPLETED|Stage II Continuation||8
122363|NCT00943917|282521|P14|COMPLETED|Stage II Continuation||12
122364|NCT00943917|282522|P13|COMPLETED|Stage II Continuation||13
122365|NCT00943917|282523|P12|COMPLETED|Stage II Continuation||11
122366|NCT00943917|282524|P11|COMPLETED|Stage II Continuation||15
122367|NCT00943917|282525|P10|COMPLETED|Stage II Continuation||14
122368|NCT00943917|282526|P9|COMPLETED|Stage II Continuation||0
122369|NCT00943917|282527|P8|COMPLETED|Stage II Continuation||0
122370|NCT00943917|282528|P7|COMPLETED|Stage II Continuation||0
122371|NCT00943917|282529|P6|COMPLETED|Stage II Continuation||0
122372|NCT00943917|282530|P5|COMPLETED|Stage II Continuation||0
122373|NCT00943917|282531|P4|COMPLETED|Stage II Continuation||0
122374|NCT00943917|282532|P3|COMPLETED|Stage II Continuation||0
122375|NCT00943917|282533|P2|COMPLETED|Stage II Continuation||0
122376|NCT00943917|282534|P1|COMPLETED|Stage II Continuation||0
122377|NCT00943917|282520|P15|STARTED|Stage II Continuation||12
122378|NCT00943917|282521|P14|STARTED|Stage II Continuation||15
122379|NCT00943917|282522|P13|STARTED|Stage II Continuation||16
122380|NCT00943917|282523|P12|STARTED|Stage II Continuation||13
122381|NCT00943917|282524|P11|STARTED|Stage II Continuation||15
122382|NCT00943917|282525|P10|STARTED|Stage II Continuation||15
122383|NCT00943917|282526|P9|STARTED|Stage II Continuation||0
122384|NCT00943917|282527|P8|STARTED|Stage II Continuation||0
122385|NCT00943917|282528|P7|STARTED|Stage II Continuation||0
122386|NCT00943917|282529|P6|STARTED|Stage II Continuation||0
122387|NCT00943917|282530|P5|STARTED|Stage II Continuation||0
122388|NCT00943917|282531|P4|STARTED|Stage II Continuation||0
122389|NCT00943917|282532|P3|STARTED|Stage II Continuation||0
122390|NCT00943917|282533|P2|STARTED|Stage II Continuation||0
122391|NCT00943917|282534|P1|STARTED|Stage II Continuation||0
122392|NCT00943917|282520|P15|NOT COMPLETED|Stage II||0
122393|NCT00943917|282521|P14|NOT COMPLETED|Stage II||0
122394|NCT00943917|282522|P13|NOT COMPLETED|Stage II||0
122395|NCT00943917|282523|P12|NOT COMPLETED|Stage II||0
122396|NCT00943917|282524|P11|NOT COMPLETED|Stage II||0
122397|NCT00943917|282525|P10|NOT COMPLETED|Stage II||0
122398|NCT00943917|282526|P9|NOT COMPLETED|Stage II||1
122399|NCT00943917|282527|P8|NOT COMPLETED|Stage II||0
122400|NCT00943917|282528|P7|NOT COMPLETED|Stage II||3
122401|NCT00943917|282529|P6|NOT COMPLETED|Stage II||3
122402|NCT00943917|282530|P5|NOT COMPLETED|Stage II||0
122403|NCT00943917|282531|P4|NOT COMPLETED|Stage II||0
122404|NCT00943917|282532|P3|NOT COMPLETED|Stage II||0
122405|NCT00943917|282533|P2|NOT COMPLETED|Stage II||0
122406|NCT00943917|282534|P1|NOT COMPLETED|Stage II||0
122407|NCT00943917|282520|P15|COMPLETED|Stage II||0
122408|NCT00943917|282521|P14|COMPLETED|Stage II||0
122409|NCT00943917|282522|P13|COMPLETED|Stage II||0
122410|NCT00943917|282523|P12|COMPLETED|Stage II||0
122411|NCT00943917|282524|P11|COMPLETED|Stage II||0
122412|NCT00943917|282525|P10|COMPLETED|Stage II||0
122413|NCT00943917|282526|P9|COMPLETED|Stage II||20
122414|NCT00943917|282527|P8|COMPLETED|Stage II||23
122415|NCT00943917|282528|P7|COMPLETED|Stage II||20
122416|NCT00943917|282529|P6|COMPLETED|Stage II||20
122417|NCT00943917|282530|P5|COMPLETED|Stage II||21
122418|NCT00943917|282531|P4|COMPLETED|Stage II||20
122419|NCT00943917|282532|P3|COMPLETED|Stage II||0
122420|NCT00943917|282533|P2|COMPLETED|Stage II||0
122421|NCT00943917|282534|P1|COMPLETED|Stage II||0
122422|NCT00943917|282520|P15|STARTED|Stage II||0
122423|NCT00943917|282521|P14|STARTED|Stage II||0
122424|NCT00943917|282522|P13|STARTED|Stage II||0
122425|NCT00943917|282523|P12|STARTED|Stage II||0
122426|NCT00943917|282524|P11|STARTED|Stage II||0
122427|NCT00943917|282525|P10|STARTED|Stage II||0
122428|NCT00943917|282526|P9|STARTED|Stage II||21
122429|NCT00943917|282527|P8|STARTED|Stage II||23
122430|NCT00943917|282528|P7|STARTED|Stage II||23
122431|NCT00943917|282529|P6|STARTED|Stage II||23
122432|NCT00943917|282530|P5|STARTED|Stage II||21
122433|NCT00943917|282531|P4|STARTED|Stage II||20
122434|NCT00943917|282532|P3|STARTED|Stage II||0
122435|NCT00943917|282533|P2|STARTED|Stage II||0
122436|NCT00943917|282534|P1|STARTED|Stage II||0
122437|NCT00943917|282520|P15|NOT COMPLETED|Stage I||0
122438|NCT00943917|282521|P14|NOT COMPLETED|Stage I||0
122439|NCT00943917|282522|P13|NOT COMPLETED|Stage I||0
122440|NCT00943917|282523|P12|NOT COMPLETED|Stage I||0
122441|NCT00943917|282524|P11|NOT COMPLETED|Stage I||0
122442|NCT00943917|282525|P10|NOT COMPLETED|Stage I||0
122443|NCT00943917|282526|P9|NOT COMPLETED|Stage I||0
122444|NCT00943917|282527|P8|NOT COMPLETED|Stage I||0
122445|NCT00943917|282528|P7|NOT COMPLETED|Stage I||0
122446|NCT00943917|282529|P6|NOT COMPLETED|Stage I||0
122447|NCT00943917|282530|P5|NOT COMPLETED|Stage I||0
122448|NCT00943917|282531|P4|NOT COMPLETED|Stage I||0
122449|NCT00943917|282532|P3|NOT COMPLETED|Stage I||6
122450|NCT00943917|282533|P2|NOT COMPLETED|Stage I||3
122451|NCT00943917|282534|P1|NOT COMPLETED|Stage I||4
122452|NCT00943917|282520|P15|COMPLETED|Stage I||0
122453|NCT00943917|282521|P14|COMPLETED|Stage I||0
122454|NCT00943917|282522|P13|COMPLETED|Stage I||0
122455|NCT00943917|282523|P12|COMPLETED|Stage I||0
122456|NCT00943917|282524|P11|COMPLETED|Stage I||0
122457|NCT00943917|282525|P10|COMPLETED|Stage I||0
122458|NCT00943917|282526|P9|COMPLETED|Stage I||0
122459|NCT00943917|282527|P8|COMPLETED|Stage I||0
122460|NCT00943917|282528|P7|COMPLETED|Stage I||0
122461|NCT00943917|282529|P6|COMPLETED|Stage I||0
122462|NCT00943917|282530|P5|COMPLETED|Stage I||0
122463|NCT00943917|282531|P4|COMPLETED|Stage I||0
122464|NCT00943917|282532|P3|COMPLETED|Stage I||47
122465|NCT00943917|282533|P2|COMPLETED|Stage I||48
122466|NCT00943917|282534|P1|COMPLETED|Stage I||47
122467|NCT00943917|282520|P15|STARTED|Stage I||0
122468|NCT00943917|282521|P14|STARTED|Stage I||0
122469|NCT00943917|282522|P13|STARTED|Stage I||0
122470|NCT00943917|282523|P12|STARTED|Stage I||0
122471|NCT00943917|282524|P11|STARTED|Stage I||0
122472|NCT00943917|282525|P10|STARTED|Stage I||0
122473|NCT00943917|282526|P9|STARTED|Stage I||0
122474|NCT00943917|282527|P8|STARTED|Stage I||0
122475|NCT00943917|282528|P7|STARTED|Stage I||0
122476|NCT00943917|282529|P6|STARTED|Stage I||0
122477|NCT00943917|282530|P5|STARTED|Stage I||0
122478|NCT00943917|282531|P4|STARTED|Stage I||0
122479|NCT00943917|282532|P3|STARTED|Stage I||53
122480|NCT00943917|282533|P2|STARTED|Stage I||51
122481|NCT00943917|282534|P1|STARTED|Stage I||51
122482|NCT00943878|282585|P4|NOT COMPLETED|Overall Study||2
122483|NCT00943878|282586|P3|NOT COMPLETED|Overall Study||6
122484|NCT00943878|282587|P2|NOT COMPLETED|Overall Study||2
122485|NCT00943878|282588|P1|NOT COMPLETED|Overall Study||2
122486|NCT00943878|282585|P4|COMPLETED|Overall Study||198
122487|NCT00943878|282586|P3|COMPLETED|Overall Study||197
122488|NCT00943878|282587|P2|COMPLETED|Overall Study||198
122489|NCT00943878|282588|P1|COMPLETED|Overall Study||200
122490|NCT00943878|282585|P4|STARTED|Overall Study||200
122491|NCT00943878|282586|P3|STARTED|Overall Study||203
122492|NCT00943878|282587|P2|STARTED|Overall Study||200
122493|NCT00943878|282588|P1|STARTED|Overall Study||202
122494|NCT00943852|282710|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122495|NCT00943852|282711|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122496|NCT00943852|282712|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122497|NCT00943852|282713|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122498|NCT00943852|282714|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122499|NCT00943852|282715|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122500|NCT00943852|282716|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122501|NCT00943852|282717|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122502|NCT00943852|282718|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122503|NCT00943852|282719|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
122504|NCT00943852|282710|P10|COMPLETED|Fifth Period of Treatment Intervention||1
122505|NCT00943852|282711|P9|COMPLETED|Fifth Period of Treatment Intervention||1
122506|NCT00943852|282712|P8|COMPLETED|Fifth Period of Treatment Intervention||0
122507|NCT00943852|282713|P7|COMPLETED|Fifth Period of Treatment Intervention||0
122508|NCT00943852|282714|P6|COMPLETED|Fifth Period of Treatment Intervention||0
122509|NCT00943852|282715|P5|COMPLETED|Fifth Period of Treatment Intervention||1
122510|NCT00943852|282716|P4|COMPLETED|Fifth Period of Treatment Intervention||0
122511|NCT00943852|282717|P3|COMPLETED|Fifth Period of Treatment Intervention||0
122512|NCT00943852|282718|P2|COMPLETED|Fifth Period of Treatment Intervention||1
122513|NCT00943852|282719|P1|COMPLETED|Fifth Period of Treatment Intervention||1
122514|NCT00943852|282710|P10|STARTED|Fifth Period of Treatment Intervention||1
122515|NCT00943852|282711|P9|STARTED|Fifth Period of Treatment Intervention||1
122516|NCT00943852|282712|P8|STARTED|Fifth Period of Treatment Intervention||0
122517|NCT00943852|282713|P7|STARTED|Fifth Period of Treatment Intervention||0
122518|NCT00943852|282714|P6|STARTED|Fifth Period of Treatment Intervention||0
122519|NCT00943852|282715|P5|STARTED|Fifth Period of Treatment Intervention||1
122520|NCT00943852|282716|P4|STARTED|Fifth Period of Treatment Intervention||0
122521|NCT00943852|282717|P3|STARTED|Fifth Period of Treatment Intervention||0
122522|NCT00943852|282718|P2|STARTED|Fifth Period of Treatment Intervention||1
122523|NCT00943852|282719|P1|STARTED|Fifth Period of Treatment Intervention||1
122524|NCT00943852|282710|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
122525|NCT00943852|282711|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
122526|NCT00943852|282712|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
122527|NCT00943852|282713|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
122528|NCT00943852|282714|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
122529|NCT00943852|282715|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
122530|NCT00943852|282716|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
122531|NCT00943852|282717|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
122532|NCT00943852|282718|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
122533|NCT00943852|282719|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
122534|NCT00943852|282710|P10|COMPLETED|Washout Period After Period 4 Treatment||1
122535|NCT00943852|282711|P9|COMPLETED|Washout Period After Period 4 Treatment||1
122536|NCT00943852|282712|P8|COMPLETED|Washout Period After Period 4 Treatment||0
122537|NCT00943852|282713|P7|COMPLETED|Washout Period After Period 4 Treatment||0
122538|NCT00943852|282714|P6|COMPLETED|Washout Period After Period 4 Treatment||0
122539|NCT00943852|282715|P5|COMPLETED|Washout Period After Period 4 Treatment||1
122540|NCT00943852|282716|P4|COMPLETED|Washout Period After Period 4 Treatment||0
122541|NCT00943852|282717|P3|COMPLETED|Washout Period After Period 4 Treatment||0
122542|NCT00943852|282718|P2|COMPLETED|Washout Period After Period 4 Treatment||1
122543|NCT00943852|282719|P1|COMPLETED|Washout Period After Period 4 Treatment||1
122544|NCT00943852|282710|P10|STARTED|Washout Period After Period 4 Treatment||1
122545|NCT00943852|282711|P9|STARTED|Washout Period After Period 4 Treatment||1
122546|NCT00943852|282712|P8|STARTED|Washout Period After Period 4 Treatment||1
122547|NCT00943852|282713|P7|STARTED|Washout Period After Period 4 Treatment||1
122548|NCT00943852|282714|P6|STARTED|Washout Period After Period 4 Treatment||0
122549|NCT00943852|282715|P5|STARTED|Washout Period After Period 4 Treatment||1
122550|NCT00943852|282716|P4|STARTED|Washout Period After Period 4 Treatment||1
122551|NCT00943852|282717|P3|STARTED|Washout Period After Period 4 Treatment||1
122552|NCT00943852|282718|P2|STARTED|Washout Period After Period 4 Treatment||1
122553|NCT00943852|282719|P1|STARTED|Washout Period After Period 4 Treatment||2
122554|NCT00943852|282710|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122555|NCT00943852|282711|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122556|NCT00943852|282712|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122557|NCT00943852|282713|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122558|NCT00943852|282714|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122559|NCT00943852|282715|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122560|NCT00943852|282716|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122561|NCT00943852|282717|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122562|NCT00943852|282718|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122563|NCT00943852|282719|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
122564|NCT00943852|282710|P10|COMPLETED|Fourth Period of Treatment Intervention||1
122565|NCT00943852|282711|P9|COMPLETED|Fourth Period of Treatment Intervention||1
122566|NCT00943852|282712|P8|COMPLETED|Fourth Period of Treatment Intervention||1
122567|NCT00943852|282713|P7|COMPLETED|Fourth Period of Treatment Intervention||1
122568|NCT00943852|282714|P6|COMPLETED|Fourth Period of Treatment Intervention||0
122569|NCT00943852|282715|P5|COMPLETED|Fourth Period of Treatment Intervention||1
122570|NCT00943852|282716|P4|COMPLETED|Fourth Period of Treatment Intervention||1
122571|NCT00943852|282717|P3|COMPLETED|Fourth Period of Treatment Intervention||1
122572|NCT00943852|282718|P2|COMPLETED|Fourth Period of Treatment Intervention||1
122573|NCT00943852|282719|P1|COMPLETED|Fourth Period of Treatment Intervention||2
122574|NCT00943852|282710|P10|STARTED|Fourth Period of Treatment Intervention||1
122575|NCT00943852|282711|P9|STARTED|Fourth Period of Treatment Intervention||1
122576|NCT00943852|282712|P8|STARTED|Fourth Period of Treatment Intervention||1
122577|NCT00943852|282713|P7|STARTED|Fourth Period of Treatment Intervention||1
122578|NCT00943852|282714|P6|STARTED|Fourth Period of Treatment Intervention||0
122579|NCT00943852|282715|P5|STARTED|Fourth Period of Treatment Intervention||1
122580|NCT00943852|282716|P4|STARTED|Fourth Period of Treatment Intervention||1
122581|NCT00943852|282717|P3|STARTED|Fourth Period of Treatment Intervention||1
122582|NCT00943852|282718|P2|STARTED|Fourth Period of Treatment Intervention||1
122583|NCT00943852|282719|P1|STARTED|Fourth Period of Treatment Intervention||2
122584|NCT00943852|282710|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122585|NCT00943852|282711|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122586|NCT00943852|282712|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122587|NCT00943852|282713|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
122588|NCT00943852|282714|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122589|NCT00943852|282715|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122590|NCT00943852|282716|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122591|NCT00943852|282717|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122592|NCT00943852|282718|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122593|NCT00943852|282719|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
122594|NCT00943852|282710|P10|COMPLETED|Washout Period After Period 3 Treatment||1
122595|NCT00943852|282711|P9|COMPLETED|Washout Period After Period 3 Treatment||1
122596|NCT00943852|282712|P8|COMPLETED|Washout Period After Period 3 Treatment||1
122597|NCT00943852|282713|P7|COMPLETED|Washout Period After Period 3 Treatment||1
122598|NCT00943852|282714|P6|COMPLETED|Washout Period After Period 3 Treatment||0
122599|NCT00943852|282715|P5|COMPLETED|Washout Period After Period 3 Treatment||1
122600|NCT00943852|282716|P4|COMPLETED|Washout Period After Period 3 Treatment||1
122601|NCT00943852|282717|P3|COMPLETED|Washout Period After Period 3 Treatment||1
122602|NCT00943852|282718|P2|COMPLETED|Washout Period After Period 3 Treatment||1
122603|NCT00943852|282719|P1|COMPLETED|Washout Period After Period 3 Treatment||2
122604|NCT00943852|282710|P10|STARTED|Washout Period After Period 3 Treatment||1
122605|NCT00943852|282711|P9|STARTED|Washout Period After Period 3 Treatment||1
122606|NCT00943852|282712|P8|STARTED|Washout Period After Period 3 Treatment||1
122607|NCT00943852|282713|P7|STARTED|Washout Period After Period 3 Treatment||2
122608|NCT00943852|282714|P6|STARTED|Washout Period After Period 3 Treatment||0
122609|NCT00943852|282715|P5|STARTED|Washout Period After Period 3 Treatment||1
122610|NCT00943852|282716|P4|STARTED|Washout Period After Period 3 Treatment||1
122611|NCT00943852|282717|P3|STARTED|Washout Period After Period 3 Treatment||1
122612|NCT00943852|282718|P2|STARTED|Washout Period After Period 3 Treatment||1
122613|NCT00943852|282719|P1|STARTED|Washout Period After Period 3 Treatment||2
122614|NCT00943852|282710|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
122615|NCT00943852|282711|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
122616|NCT00943852|282712|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
122617|NCT00943852|282713|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
122618|NCT00943852|282714|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
122619|NCT00943852|282715|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
122620|NCT00943852|282716|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
122621|NCT00943852|282717|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
122622|NCT00943852|282718|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
122623|NCT00943852|282719|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
122624|NCT00943852|282710|P10|COMPLETED|Third Period of Treatment Intervention||1
122625|NCT00943852|282711|P9|COMPLETED|Third Period of Treatment Intervention||1
122626|NCT00943852|282712|P8|COMPLETED|Third Period of Treatment Intervention||1
122627|NCT00943852|282713|P7|COMPLETED|Third Period of Treatment Intervention||2
122628|NCT00943852|282714|P6|COMPLETED|Third Period of Treatment Intervention||0
122629|NCT00943852|282715|P5|COMPLETED|Third Period of Treatment Intervention||1
122630|NCT00943852|282716|P4|COMPLETED|Third Period of Treatment Intervention||1
122631|NCT00943852|282717|P3|COMPLETED|Third Period of Treatment Intervention||1
122632|NCT00943852|282718|P2|COMPLETED|Third Period of Treatment Intervention||1
122633|NCT00943852|282719|P1|COMPLETED|Third Period of Treatment Intervention||2
122634|NCT00943852|282710|P10|STARTED|Third Period of Treatment Intervention||1
122635|NCT00943852|282711|P9|STARTED|Third Period of Treatment Intervention||1
122636|NCT00943852|282712|P8|STARTED|Third Period of Treatment Intervention||1
122637|NCT00943852|282713|P7|STARTED|Third Period of Treatment Intervention||2
122638|NCT00943852|282714|P6|STARTED|Third Period of Treatment Intervention||0
122639|NCT00943852|282715|P5|STARTED|Third Period of Treatment Intervention||1
122640|NCT00943852|282716|P4|STARTED|Third Period of Treatment Intervention||1
122641|NCT00943852|282717|P3|STARTED|Third Period of Treatment Intervention||1
122642|NCT00943852|282718|P2|STARTED|Third Period of Treatment Intervention||1
122643|NCT00943852|282719|P1|STARTED|Third Period of Treatment Intervention||2
122644|NCT00943852|282710|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122645|NCT00943852|282711|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122646|NCT00943852|282712|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122647|NCT00943852|282713|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122648|NCT00943852|282714|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
122649|NCT00943852|282715|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122650|NCT00943852|282716|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122651|NCT00943852|282717|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122652|NCT00943852|282718|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122653|NCT00943852|282719|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
122654|NCT00943852|282710|P10|COMPLETED|Washout Period After Period 2 Treatment||1
122655|NCT00943852|282711|P9|COMPLETED|Washout Period After Period 2 Treatment||1
122656|NCT00943852|282712|P8|COMPLETED|Washout Period After Period 2 Treatment||1
122657|NCT00943852|282713|P7|COMPLETED|Washout Period After Period 2 Treatment||2
122658|NCT00943852|282714|P6|COMPLETED|Washout Period After Period 2 Treatment||0
122659|NCT00943852|282715|P5|COMPLETED|Washout Period After Period 2 Treatment||1
122660|NCT00943852|282716|P4|COMPLETED|Washout Period After Period 2 Treatment||1
122661|NCT00943852|282717|P3|COMPLETED|Washout Period After Period 2 Treatment||1
122662|NCT00943852|282718|P2|COMPLETED|Washout Period After Period 2 Treatment||1
122663|NCT00943852|282719|P1|COMPLETED|Washout Period After Period 2 Treatment||2
122664|NCT00943852|282710|P10|STARTED|Washout Period After Period 2 Treatment||1
122665|NCT00943852|282711|P9|STARTED|Washout Period After Period 2 Treatment||1
122666|NCT00943852|282712|P8|STARTED|Washout Period After Period 2 Treatment||1
122667|NCT00943852|282713|P7|STARTED|Washout Period After Period 2 Treatment||2
122668|NCT00943852|282714|P6|STARTED|Washout Period After Period 2 Treatment||1
122669|NCT00943852|282715|P5|STARTED|Washout Period After Period 2 Treatment||1
122670|NCT00943852|282716|P4|STARTED|Washout Period After Period 2 Treatment||1
122671|NCT00943852|282717|P3|STARTED|Washout Period After Period 2 Treatment||1
122672|NCT00943852|282718|P2|STARTED|Washout Period After Period 2 Treatment||1
122673|NCT00943852|282719|P1|STARTED|Washout Period After Period 2 Treatment||2
122674|NCT00943852|282710|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
122675|NCT00943852|282711|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
122676|NCT00943852|282712|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
122677|NCT00943852|282713|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
122678|NCT00943852|282714|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
122679|NCT00943852|282715|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
122680|NCT00943852|282716|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
122681|NCT00943852|282717|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
122682|NCT00943852|282718|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
122683|NCT00943852|282719|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
122684|NCT00943852|282710|P10|COMPLETED|Second Period of Treatment Intervention||1
122685|NCT00943852|282711|P9|COMPLETED|Second Period of Treatment Intervention||1
122686|NCT00943852|282712|P8|COMPLETED|Second Period of Treatment Intervention||1
122687|NCT00943852|282713|P7|COMPLETED|Second Period of Treatment Intervention||2
122688|NCT00943852|282714|P6|COMPLETED|Second Period of Treatment Intervention||1
122689|NCT00943852|282715|P5|COMPLETED|Second Period of Treatment Intervention||1
122690|NCT00943852|282716|P4|COMPLETED|Second Period of Treatment Intervention||1
122691|NCT00943852|282717|P3|COMPLETED|Second Period of Treatment Intervention||1
122692|NCT00943852|282718|P2|COMPLETED|Second Period of Treatment Intervention||1
122693|NCT00943852|282719|P1|COMPLETED|Second Period of Treatment Intervention||2
122694|NCT00943852|282710|P10|STARTED|Second Period of Treatment Intervention||1
122695|NCT00943852|282711|P9|STARTED|Second Period of Treatment Intervention||1
122696|NCT00943852|282712|P8|STARTED|Second Period of Treatment Intervention||1
122697|NCT00943852|282713|P7|STARTED|Second Period of Treatment Intervention||2
122698|NCT00943852|282714|P6|STARTED|Second Period of Treatment Intervention||1
122699|NCT00943852|282715|P5|STARTED|Second Period of Treatment Intervention||1
122700|NCT00943852|282716|P4|STARTED|Second Period of Treatment Intervention||1
122701|NCT00943852|282717|P3|STARTED|Second Period of Treatment Intervention||1
122702|NCT00943852|282718|P2|STARTED|Second Period of Treatment Intervention||1
122703|NCT00943852|282719|P1|STARTED|Second Period of Treatment Intervention||2
122704|NCT00943852|282710|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122705|NCT00943852|282711|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122706|NCT00943852|282712|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122707|NCT00943852|282713|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122708|NCT00943852|282714|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122709|NCT00943852|282715|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122710|NCT00943852|282716|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
122711|NCT00943852|282717|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122712|NCT00943852|282718|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122713|NCT00943852|282719|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
122714|NCT00943852|282710|P10|COMPLETED|Washout Period After Period 1 Treatment||1
122715|NCT00943852|282711|P9|COMPLETED|Washout Period After Period 1 Treatment||1
122716|NCT00943852|282712|P8|COMPLETED|Washout Period After Period 1 Treatment||1
122717|NCT00943852|282713|P7|COMPLETED|Washout Period After Period 1 Treatment||2
122718|NCT00943852|282714|P6|COMPLETED|Washout Period After Period 1 Treatment||1
122719|NCT00943852|282715|P5|COMPLETED|Washout Period After Period 1 Treatment||1
122720|NCT00943852|282716|P4|COMPLETED|Washout Period After Period 1 Treatment||1
122721|NCT00943852|282717|P3|COMPLETED|Washout Period After Period 1 Treatment||1
122722|NCT00943852|282718|P2|COMPLETED|Washout Period After Period 1 Treatment||1
122723|NCT00943852|282719|P1|COMPLETED|Washout Period After Period 1 Treatment||2
122724|NCT00943852|282710|P10|STARTED|Washout Period After Period 1 Treatment||1
122725|NCT00943852|282711|P9|STARTED|Washout Period After Period 1 Treatment||1
122726|NCT00943852|282712|P8|STARTED|Washout Period After Period 1 Treatment||1
122727|NCT00943852|282713|P7|STARTED|Washout Period After Period 1 Treatment||2
122728|NCT00943852|282714|P6|STARTED|Washout Period After Period 1 Treatment||1
122729|NCT00943852|282715|P5|STARTED|Washout Period After Period 1 Treatment||1
122730|NCT00943852|282716|P4|STARTED|Washout Period After Period 1 Treatment||2
122731|NCT00943852|282717|P3|STARTED|Washout Period After Period 1 Treatment||1
122732|NCT00943852|282718|P2|STARTED|Washout Period After Period 1 Treatment||1
122733|NCT00943852|282719|P1|STARTED|Washout Period After Period 1 Treatment||2
122734|NCT00943852|282710|P10|NOT COMPLETED|First Period of Treatment Intervention||0
122735|NCT00943852|282711|P9|NOT COMPLETED|First Period of Treatment Intervention||0
122736|NCT00943852|282712|P8|NOT COMPLETED|First Period of Treatment Intervention||0
122737|NCT00943852|282713|P7|NOT COMPLETED|First Period of Treatment Intervention||0
122738|NCT00943852|282714|P6|NOT COMPLETED|First Period of Treatment Intervention||0
122739|NCT00943852|282715|P5|NOT COMPLETED|First Period of Treatment Intervention||0
122740|NCT00943852|282716|P4|NOT COMPLETED|First Period of Treatment Intervention||0
122741|NCT00943852|282717|P3|NOT COMPLETED|First Period of Treatment Intervention||0
122742|NCT00943852|282718|P2|NOT COMPLETED|First Period of Treatment Intervention||0
122743|NCT00943852|282719|P1|NOT COMPLETED|First Period of Treatment Intervention||0
122744|NCT00943852|282710|P10|COMPLETED|First Period of Treatment Intervention||1
122745|NCT00943852|282711|P9|COMPLETED|First Period of Treatment Intervention||1
122746|NCT00943852|282712|P8|COMPLETED|First Period of Treatment Intervention||1
122747|NCT00943852|282713|P7|COMPLETED|First Period of Treatment Intervention||2
122748|NCT00943852|282714|P6|COMPLETED|First Period of Treatment Intervention||1
122749|NCT00943852|282715|P5|COMPLETED|First Period of Treatment Intervention||1
122750|NCT00943852|282716|P4|COMPLETED|First Period of Treatment Intervention||2
122751|NCT00943852|282717|P3|COMPLETED|First Period of Treatment Intervention||1
122752|NCT00943852|282718|P2|COMPLETED|First Period of Treatment Intervention||1
122753|NCT00943852|282719|P1|COMPLETED|First Period of Treatment Intervention||2
122754|NCT00943852|282710|P10|STARTED|First Period of Treatment Intervention||1
122755|NCT00943852|282711|P9|STARTED|First Period of Treatment Intervention||1
122756|NCT00943852|282712|P8|STARTED|First Period of Treatment Intervention||1
122757|NCT00943852|282713|P7|STARTED|First Period of Treatment Intervention||2
122758|NCT00943852|282714|P6|STARTED|First Period of Treatment Intervention||1
122759|NCT00943852|282715|P5|STARTED|First Period of Treatment Intervention||1
122760|NCT00943852|282716|P4|STARTED|First Period of Treatment Intervention||2
122761|NCT00943852|282717|P3|STARTED|First Period of Treatment Intervention||1
122762|NCT00943852|282718|P2|STARTED|First Period of Treatment Intervention||1
122763|NCT00943852|282719|P1|STARTED|First Period of Treatment Intervention||2
122764|NCT00943826|282732|P2|NOT COMPLETED|Monotherapy Phase||13
122765|NCT00943826|282733|P1|NOT COMPLETED|Monotherapy Phase||51
122766|NCT00943826|282732|P2|COMPLETED|Monotherapy Phase||146
122767|NCT00943826|282733|P1|COMPLETED|Monotherapy Phase||218
122768|NCT00943826|282732|P2|STARTED|Monotherapy Phase||159
122769|NCT00943826|282733|P1|STARTED|Monotherapy Phase||269
122770|NCT00943826|282732|P2|NOT COMPLETED|Maintenance Phase||41
122771|NCT00943826|282733|P1|NOT COMPLETED|Maintenance Phase||43
122772|NCT00943826|282732|P2|COMPLETED|Maintenance Phase||329
122773|NCT00943826|282733|P1|COMPLETED|Maintenance Phase||353
122774|NCT00943826|282732|P2|STARTED|Maintenance Phase||370
122775|NCT00943826|282733|P1|STARTED|Maintenance Phase||396
122776|NCT00943826|282732|P2|NOT COMPLETED|Concurrent Phase||42
122777|NCT00943826|282733|P1|NOT COMPLETED|Concurrent Phase||61
122778|NCT00943826|282732|P2|COMPLETED|Concurrent Phase||421
122779|NCT00943826|282733|P1|COMPLETED|Concurrent Phase||397
122780|NCT00943826|282732|P2|Received Randomized Treatment|Concurrent Phase||459
122781|NCT00943826|282733|P1|Received Randomized Treatment|Concurrent Phase||452
122782|NCT00943826|282732|P2|STARTED|Concurrent Phase||463
122783|NCT00943826|282733|P1|STARTED|Concurrent Phase||458
122784|NCT00943787|282747|P1|NOT COMPLETED|Overall Study||7
122785|NCT00943787|282747|P1|COMPLETED|Overall Study||34
122786|NCT00943787|282747|P1|STARTED|Overall Study||41
122787|NCT00943761|282754|P2|NOT COMPLETED|Overall Study||1
122788|NCT00943761|282755|P1|NOT COMPLETED|Overall Study||4
122789|NCT00943761|282754|P2|COMPLETED|Overall Study||23
122790|NCT00943761|282755|P1|COMPLETED|Overall Study||17
122791|NCT00943761|282754|P2|STARTED|Overall Study||24
122792|NCT00943761|282755|P1|STARTED|Overall Study||21
122793|NCT00943735|282767|P1|NOT COMPLETED|Overall Study||32
122794|NCT00943735|282767|P1|COMPLETED|Overall Study||742
122795|NCT00943735|282767|P1|Per Protocol Population|Overall Study||500
122796|NCT00943735|282767|P1|STARTED|Overall Study||774
122797|NCT00943722|282805|P5|NOT COMPLETED|Overall Study||22
122798|NCT00943722|282806|P4|NOT COMPLETED|Overall Study||22
122799|NCT00943722|282807|P3|NOT COMPLETED|Overall Study||13
122800|NCT00943722|282808|P2|NOT COMPLETED|Overall Study||22
122801|NCT00943722|282809|P1|NOT COMPLETED|Overall Study||25
122802|NCT00943722|282805|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
122803|NCT00943722|282806|P4|COMPLETED|Overall Study||647
122804|NCT00943722|282807|P3|COMPLETED|Overall Study||631
122805|NCT00943722|282808|P2|COMPLETED|Overall Study||621
122806|NCT00943722|282809|P1|COMPLETED|Overall Study||623
122807|NCT00943722|282805|P5|Vaccination 3|Overall Study||455
122808|NCT00943722|282806|P4|Vaccination 3|Overall Study||653
122809|NCT00943722|282807|P3|Vaccination 3|Overall Study||637
122810|NCT00943722|282808|P2|Vaccination 3|Overall Study||627
122811|NCT00943722|282809|P1|Vaccination 3|Overall Study||635
122812|NCT00943722|282805|P5|Vaccination 2|Overall Study||462
122813|NCT00943722|282806|P4|Vaccination 2|Overall Study||658
122814|NCT00943722|282807|P3|Vaccination 2|Overall Study||638
122815|NCT00943722|282808|P2|Vaccination 2|Overall Study||633
122816|NCT00943722|282809|P1|Vaccination 2|Overall Study||637
122817|NCT00943722|282805|P5|Vaccination 1|Overall Study||468
122818|NCT00943722|282806|P4|Vaccination 1|Overall Study||666
122819|NCT00943722|282807|P3|Vaccination 1|Overall Study||644
122820|NCT00943722|282808|P2|Vaccination 1|Overall Study||642
122821|NCT00943722|282809|P1|Vaccination 1|Overall Study||646
122822|NCT00943722|282805|P5|STARTED|Overall Study||470
122823|NCT00943722|282806|P4|STARTED|Overall Study||669
122824|NCT00943722|282807|P3|STARTED|Overall Study||644
122825|NCT00943722|282808|P2|STARTED|Overall Study||643
122826|NCT00943722|282809|P1|STARTED|Overall Study||648
122827|NCT00943683|282839|P2|NOT COMPLETED|Overall Study||6
122828|NCT00943683|282840|P1|NOT COMPLETED|Overall Study||7
122829|NCT00943683|282839|P2|COMPLETED|Overall Study||169
122830|NCT00943683|282840|P1|COMPLETED|Overall Study||74
122831|NCT00943683|282839|P2|STARTED|Overall Study||175
122832|NCT00943683|282840|P1|STARTED|Overall Study||81
122833|NCT00943670|282846|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
122834|NCT00943670|282846|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
122835|NCT00943670|282846|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
122836|NCT00943670|282846|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
122837|NCT00943670|282846|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
122838|NCT00943670|282846|P1|Treated|Single-agent Trastuzumab Emtansine||51
122839|NCT00943670|282846|P1|STARTED|Single-agent Trastuzumab Emtansine||51
122840|NCT00943631|282882|P2|NOT COMPLETED|Overall Study||2
122841|NCT00943631|282883|P1|NOT COMPLETED|Overall Study||4
122842|NCT00943631|282882|P2|COMPLETED|Overall Study||202
122843|NCT00943631|282883|P1|COMPLETED|Overall Study||198
122844|NCT00943631|282882|P2|STARTED|Overall Study||204
122845|NCT00943631|282883|P1|STARTED|Overall Study||202
122846|NCT00943605|282935|P2|NOT COMPLETED|Overall Study||30
122847|NCT00943605|282936|P1|NOT COMPLETED|Overall Study||30
122848|NCT00943605|282935|P2|COMPLETED|Overall Study||0
122849|NCT00943605|282936|P1|COMPLETED|Overall Study||0
122850|NCT00943605|282935|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
122851|NCT00943605|282936|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
122852|NCT00943592|282946|P1|NOT COMPLETED|Overall Study||3
122853|NCT00943592|282946|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
122854|NCT00943592|282946|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
122855|NCT00943592|282946|P1|STARTED|Overall Study||82
122856|NCT00943579|282959|P2|NOT COMPLETED|Overall Study||5
122857|NCT00943579|282960|P1|NOT COMPLETED|Overall Study||6
122858|NCT00943579|282959|P2|COMPLETED|Overall Study||15
122859|NCT00943579|282960|P1|COMPLETED|Overall Study||15
122860|NCT00943579|282959|P2|STARTED|Overall Study||20
122861|NCT00943579|282960|P1|STARTED|Overall Study||21
122862|NCT00943488|282974|P2|NOT COMPLETED|Overall Study||2
122863|NCT00943488|282975|P1|NOT COMPLETED|Overall Study||1
122864|NCT00943488|282974|P2|COMPLETED|Overall Study||202
122865|NCT00943488|282975|P1|COMPLETED|Overall Study||203
122866|NCT00943488|282974|P2|STARTED|Overall Study||204
122867|NCT00943488|282975|P1|STARTED|Overall Study||204
122868|NCT00943436|283031|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
122869|NCT00943436|283032|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
122870|NCT00943436|283031|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
122871|NCT00943436|283032|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
122872|NCT00943436|283031|P2|STARTED|Rest Session: 45 Minutes of Reading||10
122873|NCT00943436|283032|P1|STARTED|Rest Session: 45 Minutes of Reading||10
122874|NCT00943436|283031|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
122875|NCT00943436|283032|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
122876|NCT00943436|283031|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
122877|NCT00943436|283032|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
122878|NCT00943436|283031|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
122879|NCT00943436|283032|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
122880|NCT00943397|283054|P2|NOT COMPLETED|Overall Study||72
122881|NCT00943397|283055|P1|NOT COMPLETED|Overall Study||15
122882|NCT00943397|283054|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
122883|NCT00943397|283055|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
122884|NCT00943397|283054|P2|STARTED|Overall Study||158
122885|NCT00943397|283055|P1|STARTED|Overall Study||32
122886|NCT00943384|283061|P1|NOT COMPLETED|Overall Study||49
122887|NCT00943384|283061|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
122888|NCT00943384|283061|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
122889|NCT00943384|283061|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
122890|NCT00943384|283061|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
122891|NCT00943202|283079|P4|NOT COMPLETED|Overall Study||1
122892|NCT00943202|283080|P3|NOT COMPLETED|Overall Study||0
122893|NCT00943202|283081|P2|NOT COMPLETED|Overall Study||2
122894|NCT00943202|283082|P1|NOT COMPLETED|Overall Study||1
122895|NCT00943202|283079|P4|COMPLETED|Overall Study||131
122896|NCT00943202|283080|P3|COMPLETED|Overall Study||133
122897|NCT00943202|283081|P2|COMPLETED|Overall Study||131
122898|NCT00943202|283082|P1|COMPLETED|Overall Study||132
122899|NCT00943202|283079|P4|STARTED|Overall Study||132
122900|NCT00943202|283080|P3|STARTED|Overall Study||133
122901|NCT00943202|283081|P2|STARTED|Overall Study||133
122902|NCT00943202|283082|P1|STARTED|Overall Study||133
122903|NCT00943150|283298|P2|NOT COMPLETED|Overall Study||0
122904|NCT00943150|283299|P1|NOT COMPLETED|Overall Study||0
122905|NCT00943150|283298|P2|COMPLETED|Overall Study||10
122906|NCT00943150|283299|P1|COMPLETED|Overall Study||10
122907|NCT00943150|283298|P2|STARTED|Overall Study||10
122908|NCT00943150|283299|P1|STARTED|Overall Study||10
122909|NCT00943124|283320|P2|NOT COMPLETED|Period 2||0
122910|NCT00943124|283321|P1|NOT COMPLETED|Period 2||0
122911|NCT00943124|283320|P2|COMPLETED|Period 2||108
122912|NCT00943124|283321|P1|COMPLETED|Period 2||108
122913|NCT00943124|283320|P2|STARTED|Period 2||108
122914|NCT00943124|283321|P1|STARTED|Period 2||108
122915|NCT00943124|283320|P2|NOT COMPLETED|Period 1||2
122916|NCT00943124|283321|P1|NOT COMPLETED|Period 1||2
122917|NCT00943124|283320|P2|COMPLETED|Period 1||108
122918|NCT00943124|283321|P1|COMPLETED|Period 1||108
122919|NCT00943124|283320|P2|STARTED|Period 1||110
122920|NCT00943124|283321|P1|STARTED|Period 1||110
122921|NCT00943111|283343|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
122922|NCT00943111|283344|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
122923|NCT00943111|283345|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
122924|NCT00943111|283343|P3|COMPLETED|5 Years Long-term Treatment Period||77
122925|NCT00943111|283344|P2|COMPLETED|5 Years Long-term Treatment Period||0
122926|NCT00943111|283345|P1|COMPLETED|5 Years Long-term Treatment Period||0
122927|NCT00943111|283343|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
122928|NCT00943111|283344|P2|STARTED|5 Years Long-term Treatment Period||0
122929|NCT00943111|283345|P1|STARTED|5 Years Long-term Treatment Period||0
122930|NCT00943111|283343|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
122931|NCT00943111|283344|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
122932|NCT00943111|283345|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
122933|NCT00943111|283343|P3|COMPLETED|52-Weeks Primary Analysis Period||0
122934|NCT00943111|283344|P2|COMPLETED|52-Weeks Primary Analysis Period||52
122935|NCT00943111|283345|P1|COMPLETED|52-Weeks Primary Analysis Period||104
122936|NCT00943111|283343|P3|Treated|52-Weeks Primary Analysis Period||0
122937|NCT00943111|283344|P2|Treated|52-Weeks Primary Analysis Period||53
122938|NCT00943111|283345|P1|Treated|52-Weeks Primary Analysis Period||106
122939|NCT00943111|283343|P3|STARTED|52-Weeks Primary Analysis Period||0
122940|NCT00943111|283344|P2|STARTED|52-Weeks Primary Analysis Period||54
122941|NCT00943111|283345|P1|STARTED|52-Weeks Primary Analysis Period||106
122942|NCT00943098|283378|P2|NOT COMPLETED|Overall Study||0
122943|NCT00943098|283379|P1|NOT COMPLETED|Overall Study||0
122944|NCT00943098|283378|P2|COMPLETED|Overall Study||72
122945|NCT00943098|283379|P1|COMPLETED|Overall Study||70
122946|NCT00943098|283378|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
122947|NCT00943098|283379|P1|STARTED|Overall Study||70
122948|NCT00943072|283413|P2|NOT COMPLETED|Overall Study||14
122949|NCT00943072|283414|P1|NOT COMPLETED|Overall Study||5
122950|NCT00943072|283413|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
122951|NCT00943072|283414|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
122952|NCT00943072|283413|P2|Full Analysis Set (FAS) Population|Overall Study||73
122953|NCT00943072|283414|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
122954|NCT00943072|283413|P2|Participants Received Treatment|Overall Study||74
122955|NCT00943072|283414|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
122956|NCT00943072|283413|P2|STARTED|Overall Study||74
122957|NCT00943072|283414|P1|STARTED|Overall Study||115
122958|NCT00942994|283432|P2|NOT COMPLETED|Overall Study||19
122959|NCT00942994|283433|P1|NOT COMPLETED|Overall Study||16
122960|NCT00942994|283432|P2|COMPLETED|Overall Study||190
122961|NCT00942994|283433|P1|COMPLETED|Overall Study||187
122962|NCT00942994|283432|P2|STARTED|Overall Study||209
122963|NCT00942994|283433|P1|STARTED|Overall Study||203
122964|NCT00941889|283451|P2|NOT COMPLETED|Overall Study||12
122965|NCT00941889|283452|P1|NOT COMPLETED|Overall Study||12
122966|NCT00941889|283451|P2|COMPLETED|Overall Study||3
122967|NCT00941889|283452|P1|COMPLETED|Overall Study||5
122968|NCT00941889|283451|P2|STARTED|Overall Study||15
122969|NCT00941889|283452|P1|STARTED|Overall Study||17
122970|NCT00941863|283463|P5|NOT COMPLETED|Continued After PCD||19
122971|NCT00941863|283464|P4|NOT COMPLETED|Continued After PCD||0
122972|NCT00941863|283465|P3|NOT COMPLETED|Continued After PCD||0
122973|NCT00941863|283466|P2|NOT COMPLETED|Continued After PCD||0
122974|NCT00941863|283467|P1|NOT COMPLETED|Continued After PCD||0
122975|NCT00941863|283463|P5|COMPLETED|Continued After PCD||6
122976|NCT00941863|283464|P4|COMPLETED|Continued After PCD||0
122977|NCT00941863|283465|P3|COMPLETED|Continued After PCD||0
122978|NCT00941863|283466|P2|COMPLETED|Continued After PCD||0
122979|NCT00941863|283467|P1|COMPLETED|Continued After PCD||0
122980|NCT00941863|283463|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
122981|NCT00941863|283464|P4|STARTED|Continued After PCD||0
122982|NCT00941863|283465|P3|STARTED|Continued After PCD||0
122983|NCT00941863|283466|P2|STARTED|Continued After PCD||0
122984|NCT00941863|283467|P1|STARTED|Continued After PCD||0
122985|NCT00941863|283463|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
122986|NCT00941863|283464|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
122987|NCT00941863|283465|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
122988|NCT00941863|283466|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
122989|NCT00941863|283467|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
122990|NCT00941863|283463|P5|COMPLETED|Until Primary Completion Date (PCD)||25
122991|NCT00941863|283464|P4|COMPLETED|Until Primary Completion Date (PCD)||0
122992|NCT00941863|283465|P3|COMPLETED|Until Primary Completion Date (PCD)||0
122993|NCT00941863|283466|P2|COMPLETED|Until Primary Completion Date (PCD)||0
122994|NCT00941863|283467|P1|COMPLETED|Until Primary Completion Date (PCD)||0
122995|NCT00941863|283463|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
122996|NCT00941863|283464|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
122997|NCT00941863|283465|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
122998|NCT00941863|283466|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
122999|NCT00941863|283467|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
123000|NCT00941863|283463|P5|STARTED|Until Primary Completion Date (PCD)||119
123001|NCT00941863|283464|P4|STARTED|Until Primary Completion Date (PCD)||17
123002|NCT00941863|283465|P3|STARTED|Until Primary Completion Date (PCD)||12
123003|NCT00941863|283466|P2|STARTED|Until Primary Completion Date (PCD)||3
123004|NCT00941863|283467|P1|STARTED|Until Primary Completion Date (PCD)||7
123005|NCT00942903|283492|P1|NOT COMPLETED|Overall Study||0
123006|NCT00942903|283492|P1|COMPLETED|Overall Study||20
123007|NCT00942903|283492|P1|STARTED|Overall Study||20
123008|NCT00942851|283499|P2|NOT COMPLETED|Overall Study||1
123009|NCT00942851|283500|P1|NOT COMPLETED|Overall Study||0
123010|NCT00942851|283499|P2|COMPLETED|Overall Study||11
123011|NCT00942851|283500|P1|COMPLETED|Overall Study||12
123012|NCT00942851|283499|P2|STARTED|Overall Study||12
123013|NCT00942851|283500|P1|STARTED|Overall Study||12
123014|NCT00942786|283510|P1|NOT COMPLETED|Overall Study||0
123015|NCT00942786|283510|P1|COMPLETED|Overall Study|date of last follow-up|297
123016|NCT00942786|283510|P1|STARTED|Overall Study||297
123017|NCT00942734|283517|P1|NOT COMPLETED|Overall Study||8
123018|NCT00942734|283517|P1|COMPLETED|Overall Study||35
123019|NCT00942734|283517|P1|STARTED|Overall Study||43
123020|NCT00942604|283523|P2|NOT COMPLETED|Overall Study||4
123021|NCT00942604|283524|P1|NOT COMPLETED|Overall Study||2
123022|NCT00942604|283523|P2|COMPLETED|Overall Study||99
123023|NCT00942604|283524|P1|COMPLETED|Overall Study||98
123024|NCT00942604|283523|P2|STARTED|Overall Study||103
123025|NCT00942604|283524|P1|STARTED|Overall Study||100
123026|NCT00942448|283536|P4|NOT COMPLETED|Overall Study||0
123027|NCT00942448|283537|P3|NOT COMPLETED|Overall Study||0
123028|NCT00942448|283538|P2|NOT COMPLETED|Overall Study||0
123029|NCT00942448|283539|P1|NOT COMPLETED|Overall Study||0
123030|NCT00942448|283536|P4|COMPLETED|Overall Study||75
123031|NCT00942448|283537|P3|COMPLETED|Overall Study||78
123032|NCT00942448|283538|P2|COMPLETED|Overall Study||76
123033|NCT00942448|283539|P1|COMPLETED|Overall Study||77
123034|NCT00942448|283536|P4|STARTED|Overall Study||75
123035|NCT00942448|283537|P3|STARTED|Overall Study||78
123036|NCT00942448|283538|P2|STARTED|Overall Study||76
123037|NCT00942448|283539|P1|STARTED|Overall Study||77
123038|NCT00942422|283601|P1|NOT COMPLETED|Overall Study||3
123039|NCT00942422|283601|P1|COMPLETED|Overall Study||5
123040|NCT00942422|283601|P1|STARTED|Overall Study||8
123041|NCT00942409|283605|P1|NOT COMPLETED|Overall Study||3
123042|NCT00942409|283605|P1|COMPLETED|Overall Study||2
123043|NCT00942409|283605|P1|STARTED|Overall Study||5
123044|NCT00942266|283611|P2|NOT COMPLETED|Overall Study||15
123045|NCT00942266|283612|P1|NOT COMPLETED|Overall Study||43
123046|NCT00942266|283611|P2|COMPLETED|Overall Study||0
123047|NCT00942266|283612|P1|COMPLETED|Overall Study||0
123048|NCT00942266|283611|P2|STARTED|Overall Study||15
123049|NCT00942266|283612|P1|STARTED|Overall Study||43
123050|NCT00942175|283634|P4|NOT COMPLETED|Overall Study||2
123051|NCT00942175|283635|P3|NOT COMPLETED|Overall Study||2
123052|NCT00942175|283636|P2|NOT COMPLETED|Overall Study||4
123053|NCT00942175|283637|P1|NOT COMPLETED|Overall Study||2
123054|NCT00942175|283634|P4|COMPLETED|Overall Study||38
123055|NCT00942175|283635|P3|COMPLETED|Overall Study||38
123056|NCT00942175|283636|P2|COMPLETED|Overall Study||36
123057|NCT00942175|283637|P1|COMPLETED|Overall Study||38
123058|NCT00942175|283634|P4|STARTED|Overall Study||40
123059|NCT00942175|283635|P3|STARTED|Overall Study||40
123060|NCT00942175|283636|P2|STARTED|Overall Study||40
123061|NCT00942175|283637|P1|STARTED|Overall Study||40
123062|NCT00942149|283687|P1|NOT COMPLETED|Overall Study||0
123063|NCT00942149|283687|P1|COMPLETED|Overall Study||20
123064|NCT00942149|283687|P1|STARTED|Overall Study||20
123065|NCT00942084|283691|P1|NOT COMPLETED|Overall Study||2
123066|NCT00942084|283691|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
123067|NCT00942084|283691|P1|STARTED|Overall Study||32
123068|NCT00941993|283700|P1|NOT COMPLETED|Overall Study||0
123069|NCT00941993|283700|P1|COMPLETED|Overall Study||109
123070|NCT00941993|283700|P1|STARTED|Overall Study||109
123071|NCT00941928|283708|P1|NOT COMPLETED|Overall Study||2
123072|NCT00941928|283708|P1|COMPLETED|Overall Study||0
123073|NCT00941928|283708|P1|STARTED|Overall Study||2
123074|NCT00941798|283714|P2|NOT COMPLETED|Overall Study||185
123075|NCT00941798|283715|P1|NOT COMPLETED|Overall Study||194
123076|NCT00941798|283714|P2|COMPLETED|Overall Study||578
123077|NCT00941798|283715|P1|COMPLETED|Overall Study||561
123078|NCT00941798|283714|P2|Full Analysis Set|Overall Study||759
123079|NCT00941798|283715|P1|Full Analysis Set|Overall Study||749
123080|NCT00941798|283714|P2|STARTED|Overall Study||763
123081|NCT00941798|283715|P1|STARTED|Overall Study||755
123082|NCT00941733|283745|P2|NOT COMPLETED|Overall Study||28
123083|NCT00941733|283746|P1|NOT COMPLETED|Overall Study||74
123084|NCT00941733|283745|P2|COMPLETED|Overall Study|1 year follow-up|91
123085|NCT00941733|283746|P1|COMPLETED|Overall Study|1 year follow-up|165
123086|NCT00941733|283745|P2|STARTED|Overall Study||119
123087|NCT00941733|283746|P1|STARTED|Overall Study||239
123088|NCT00941720|283786|P1|NOT COMPLETED|Overall Study||14
123089|NCT00941720|283786|P1|COMPLETED|Overall Study||57
123090|NCT00941720|283786|P1|STARTED|Overall Study||71
123091|NCT00941681|283795|P3|NOT COMPLETED|Overall Study||0
123092|NCT00941681|283796|P2|NOT COMPLETED|Overall Study||1
123093|NCT00941681|283797|P1|NOT COMPLETED|Overall Study||0
123094|NCT00941681|283795|P3|COMPLETED|Overall Study||12
123095|NCT00941681|283796|P2|COMPLETED|Overall Study||10
123096|NCT00941681|283797|P1|COMPLETED|Overall Study||12
123097|NCT00941681|283795|P3|STARTED|Overall Study||12
123098|NCT00941681|283796|P2|STARTED|Overall Study||11
123099|NCT00941681|283797|P1|STARTED|Overall Study||12
123100|NCT00941668|283822|P2|NOT COMPLETED|Overall Study||25
123101|NCT00941668|283823|P1|NOT COMPLETED|Overall Study||24
123102|NCT00941668|283822|P2|COMPLETED|Overall Study||0
123103|NCT00941668|283823|P1|COMPLETED|Overall Study||0
123104|NCT00941668|283822|P2|STARTED|Overall Study||25
123105|NCT00941668|283823|P1|STARTED|Overall Study||24
123106|NCT00941655|283833|P2|NOT COMPLETED|Overall Study||7
123107|NCT00941655|283834|P1|NOT COMPLETED|Overall Study||6
123108|NCT00941655|283833|P2|COMPLETED|Overall Study||1
123109|NCT00941655|283834|P1|COMPLETED|Overall Study||2
123110|NCT00941655|283833|P2|STARTED|Overall Study||8
123111|NCT00941655|283834|P1|STARTED|Overall Study||8
123112|NCT00941603|283848|P6|NOT COMPLETED|Overall Study||3
123113|NCT00941603|283849|P5|NOT COMPLETED|Overall Study||4
123114|NCT00941603|283850|P4|NOT COMPLETED|Overall Study||4
123115|NCT00941603|283851|P3|NOT COMPLETED|Overall Study||5
123116|NCT00941603|283852|P2|NOT COMPLETED|Overall Study||16
123117|NCT00941603|283853|P1|NOT COMPLETED|Overall Study||11
123118|NCT00941603|283848|P6|COMPLETED|Overall Study||94
123119|NCT00941603|283849|P5|COMPLETED|Overall Study||101
123120|NCT00941603|283850|P4|COMPLETED|Overall Study||100
123121|NCT00941603|283851|P3|COMPLETED|Overall Study||99
123122|NCT00941603|283852|P2|COMPLETED|Overall Study||89
123123|NCT00941603|283853|P1|COMPLETED|Overall Study||93
123124|NCT00941603|283848|P6|STARTED|Overall Study||97
123125|NCT00941603|283849|P5|STARTED|Overall Study||105
123126|NCT00941603|283850|P4|STARTED|Overall Study||104
123127|NCT00941603|283851|P3|STARTED|Overall Study||104
123128|NCT00941603|283852|P2|STARTED|Overall Study||105
123129|NCT00941603|283853|P1|STARTED|Overall Study||104
123130|NCT00941304|283878|P5|NOT COMPLETED|Overall Study||0
123131|NCT00941304|283879|P4|NOT COMPLETED|Overall Study||0
123132|NCT00941304|283880|P3|NOT COMPLETED|Overall Study||0
123133|NCT00941304|283881|P2|NOT COMPLETED|Overall Study||0
123134|NCT00941304|283882|P1|NOT COMPLETED|Overall Study||1
123135|NCT00941304|283878|P5|COMPLETED|Overall Study||31
123136|NCT00941304|283879|P4|COMPLETED|Overall Study||30
123137|NCT00941304|283880|P3|COMPLETED|Overall Study||31
123138|NCT00941304|283881|P2|COMPLETED|Overall Study||30
123139|NCT00941304|283882|P1|COMPLETED|Overall Study||30
123140|NCT00941304|283878|P5|STARTED|Overall Study||31
123141|NCT00941304|283879|P4|STARTED|Overall Study||30
123142|NCT00941304|283880|P3|STARTED|Overall Study||31
123143|NCT00941304|283881|P2|STARTED|Overall Study||30
123144|NCT00941304|283882|P1|STARTED|Overall Study||31
123145|NCT00941070|283944|P1|NOT COMPLETED|Overall Study||1
123146|NCT00941070|283944|P1|COMPLETED|Overall Study||25
123147|NCT00941070|283944|P1|STARTED|Overall Study||26
123148|NCT00941031|283962|P7|NOT COMPLETED|Maintenance Period||43
123149|NCT00941031|283963|P6|NOT COMPLETED|Maintenance Period||6
123150|NCT00941031|283964|P5|NOT COMPLETED|Maintenance Period||9
123151|NCT00941031|283965|P4|NOT COMPLETED|Maintenance Period||0
123152|NCT00941031|283966|P3|NOT COMPLETED|Maintenance Period||0
123153|NCT00941031|283967|P2|NOT COMPLETED|Maintenance Period||0
123154|NCT00941031|283968|P1|NOT COMPLETED|Maintenance Period||0
123155|NCT00941031|283962|P7|COMPLETED|Maintenance Period||204
123156|NCT00941031|283963|P6|COMPLETED|Maintenance Period||61
123157|NCT00941031|283964|P5|COMPLETED|Maintenance Period||56
123158|NCT00941031|283965|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
123159|NCT00941031|283966|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123160|NCT00941031|283967|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123161|NCT00941031|283968|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123162|NCT00941031|283962|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
123163|NCT00941031|283963|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
123164|NCT00941031|283964|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
123165|NCT00941031|283965|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
123166|NCT00941031|283966|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123167|NCT00941031|283967|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123168|NCT00941031|283968|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
123169|NCT00941031|283962|P7|NOT COMPLETED|Induction Period||0
123170|NCT00941031|283963|P6|NOT COMPLETED|Induction Period||0
123171|NCT00941031|283964|P5|NOT COMPLETED|Induction Period||0
123172|NCT00941031|283965|P4|NOT COMPLETED|Induction Period||9
123173|NCT00941031|283966|P3|NOT COMPLETED|Induction Period||6
123174|NCT00941031|283967|P2|NOT COMPLETED|Induction Period||4
123175|NCT00941031|283968|P1|NOT COMPLETED|Induction Period||5
123176|NCT00941031|283962|P7|COMPLETED|Induction Period||0
123177|NCT00941031|283963|P6|COMPLETED|Induction Period||0
123178|NCT00941031|283964|P5|COMPLETED|Induction Period||0
123179|NCT00941031|283965|P4|COMPLETED|Induction Period||58
123180|NCT00941031|283966|P3|COMPLETED|Induction Period||127
123181|NCT00941031|283967|P2|COMPLETED|Induction Period||134
123182|NCT00941031|283968|P1|COMPLETED|Induction Period||61
123183|NCT00941031|283962|P7|STARTED|Induction Period||0
123184|NCT00941031|283963|P6|STARTED|Induction Period||0
123185|NCT00941031|283964|P5|STARTED|Induction Period||0
123186|NCT00941031|283965|P4|STARTED|Induction Period||67
123187|NCT00941031|283966|P3|STARTED|Induction Period||133
123188|NCT00941031|283967|P2|STARTED|Induction Period||138
123189|NCT00941031|283968|P1|STARTED|Induction Period||66
123190|NCT00940992|283994|P3|NOT COMPLETED|Overall Study||2
123191|NCT00940992|283995|P2|NOT COMPLETED|Overall Study||2
123192|NCT00940992|283996|P1|NOT COMPLETED|Overall Study||4
123193|NCT00940992|283994|P3|COMPLETED|Overall Study||28
123194|NCT00940992|283995|P2|COMPLETED|Overall Study||28
123195|NCT00940992|283996|P1|COMPLETED|Overall Study||28
123196|NCT00940992|283994|P3|STARTED|Overall Study||30
123197|NCT00940992|283995|P2|STARTED|Overall Study||30
123198|NCT00940992|283996|P1|STARTED|Overall Study||32
123199|NCT00940927|284007|P1|NOT COMPLETED|Overall Study||0
123200|NCT00940927|284007|P1|COMPLETED|Overall Study||81
123201|NCT00940927|284007|P1|STARTED|Overall Study||81
123202|NCT00940875|284014|P2|NOT COMPLETED|Post-Study Treatment||3
123203|NCT00940875|284015|P1|NOT COMPLETED|Post-Study Treatment||0
123204|NCT00940875|284014|P2|COMPLETED|Post-Study Treatment||1
123205|NCT00940875|284015|P1|COMPLETED|Post-Study Treatment||0
123206|NCT00940875|284014|P2|STARTED|Post-Study Treatment||4
123207|NCT00940875|284015|P1|STARTED|Post-Study Treatment||0
123208|NCT00940875|284014|P2|NOT COMPLETED|Treatment Phase||19
123209|NCT00940875|284015|P1|NOT COMPLETED|Treatment Phase||26
123210|NCT00940875|284014|P2|COMPLETED|Treatment Phase||4
123211|NCT00940875|284015|P1|COMPLETED|Treatment Phase||5
123212|NCT00940875|284014|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
123213|NCT00940875|284015|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
123214|NCT00940576|284033|P2|NOT COMPLETED|Overall Study||0
123215|NCT00940576|284034|P1|NOT COMPLETED|Overall Study||0
123216|NCT00940576|284033|P2|COMPLETED|Overall Study||9
123217|NCT00940576|284034|P1|COMPLETED|Overall Study||8
123218|NCT00940576|284033|P2|STARTED|Overall Study||9
123219|NCT00940576|284034|P1|STARTED|Overall Study||8
123220|NCT00940537|284043|P2|NOT COMPLETED|Overall Study||0
123221|NCT00940537|284044|P1|NOT COMPLETED|Overall Study||0
123222|NCT00940537|284043|P2|COMPLETED|Overall Study||9
123223|NCT00940537|284044|P1|COMPLETED|Overall Study||5
123224|NCT00940537|284043|P2|STARTED|Overall Study||9
123225|NCT00940537|284044|P1|STARTED|Overall Study||5
123226|NCT00940485|284055|P2|NOT COMPLETED|Overall Study||7
123227|NCT00940485|284056|P1|NOT COMPLETED|Overall Study||15
123228|NCT00940485|284055|P2|COMPLETED|Overall Study||93
123229|NCT00940485|284056|P1|COMPLETED|Overall Study||82
123230|NCT00940485|284055|P2|STARTED|Overall Study||100
123231|NCT00940485|284056|P1|STARTED|Overall Study||97
123232|NCT00940290|284084|P4|NOT COMPLETED|Overall Study||0
123233|NCT00940290|284085|P3|NOT COMPLETED|Overall Study||0
123234|NCT00940290|284086|P2|NOT COMPLETED|Overall Study||0
123235|NCT00940290|284087|P1|NOT COMPLETED|Overall Study||0
123236|NCT00940290|284084|P4|COMPLETED|Overall Study||54
123237|NCT00940290|284085|P3|COMPLETED|Overall Study||55
123238|NCT00940290|284086|P2|COMPLETED|Overall Study||53
123239|NCT00940290|284087|P1|COMPLETED|Overall Study||54
123240|NCT00940290|284084|P4|STARTED|Overall Study||54
123241|NCT00940290|284085|P3|STARTED|Overall Study||55
123242|NCT00940290|284086|P2|STARTED|Overall Study||53
123243|NCT00940290|284087|P1|STARTED|Overall Study||54
123244|NCT00940108|284101|P4|NOT COMPLETED|Overall Study||5
123245|NCT00940108|284102|P3|NOT COMPLETED|Overall Study||3
123246|NCT00940108|284103|P2|NOT COMPLETED|Overall Study||9
123247|NCT00940108|284104|P1|NOT COMPLETED|Overall Study||5
123248|NCT00940108|284101|P4|COMPLETED|Overall Study||99
123249|NCT00940108|284102|P3|COMPLETED|Overall Study||100
123250|NCT00940108|284103|P2|COMPLETED|Overall Study||71
123251|NCT00940108|284104|P1|COMPLETED|Overall Study||77
123252|NCT00940108|284101|P4|STARTED|Overall Study||104
123253|NCT00940108|284102|P3|STARTED|Overall Study||103
123254|NCT00940108|284103|P2|STARTED|Overall Study||80
123255|NCT00940108|284104|P1|STARTED|Overall Study||82
123256|NCT00940017|284154|P1|NOT COMPLETED|Overall Study||4
123257|NCT00940017|284154|P1|COMPLETED|Overall Study||20
123258|NCT00940017|284154|P1|Subjects Treated|Overall Study||21
123259|NCT00940017|284154|P1|STARTED|Overall Study||24
123260|NCT00939991|284175|P2|NOT COMPLETED|Overall Study||0
123261|NCT00939991|284176|P1|NOT COMPLETED|Overall Study||0
123262|NCT00939991|284175|P2|COMPLETED|Overall Study||39
123263|NCT00939991|284176|P1|COMPLETED|Overall Study||9
123264|NCT00939991|284175|P2|STARTED|Overall Study||39
123265|NCT00939991|284176|P1|STARTED|Overall Study||9
123266|NCT00939952|284186|P1|NOT COMPLETED|Overall Study||0
123267|NCT00939952|284186|P1|COMPLETED|Overall Study||7
123268|NCT00939952|284186|P1|STARTED|Overall Study||7
123269|NCT00939900|284198|P2|NOT COMPLETED|Overall Study||7
123270|NCT00939900|284199|P1|NOT COMPLETED|Overall Study||2
123271|NCT00939900|284198|P2|COMPLETED|Overall Study||48
123272|NCT00939900|284199|P1|COMPLETED|Overall Study||53
123273|NCT00939900|284198|P2|STARTED|Overall Study||55
123274|NCT00939900|284199|P1|STARTED|Overall Study||55
123275|NCT00939874|284205|P1|NOT COMPLETED|Overall Study||20
123276|NCT00939874|284205|P1|COMPLETED|Overall Study||32
123277|NCT00939874|284205|P1|Completed Week 48|Overall Study||37
123278|NCT00939874|284205|P1|STARTED|Overall Study||52
123279|NCT00939809|284210|P1|NOT COMPLETED|Overall Study||3
123280|NCT00939809|284210|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
123281|NCT00939809|284210|P1|STARTED|Overall Study||31
123282|NCT00939796|284218|P1|NOT COMPLETED|Overall Study||0
123283|NCT00939796|284218|P1|COMPLETED|Overall Study||16
123284|NCT00939796|284218|P1|STARTED|Overall Study||16
123285|NCT00939783|284224|P1|NOT COMPLETED|Overall Study||649
123286|NCT00939783|284224|P1|COMPLETED|Overall Study||0
123287|NCT00939783|284224|P1|Treated|Overall Study||648
123288|NCT00939783|284224|P1|STARTED|Overall Study||649
123289|NCT00939731|284231|P2|NOT COMPLETED|Second Intervention Period||0
123290|NCT00939731|284232|P1|NOT COMPLETED|Second Intervention Period||0
123291|NCT00939731|284231|P2|COMPLETED|Second Intervention Period||12
123292|NCT00939731|284232|P1|COMPLETED|Second Intervention Period||12
123293|NCT00939731|284231|P2|STARTED|Second Intervention Period||12
123294|NCT00939731|284232|P1|STARTED|Second Intervention Period||12
123295|NCT00939731|284231|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
123296|NCT00939731|284232|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
123297|NCT00939731|284231|P2|COMPLETED|Washout Period (at Least 14 Days)||12
123298|NCT00939731|284232|P1|COMPLETED|Washout Period (at Least 14 Days)||12
123299|NCT00939731|284231|P2|STARTED|Washout Period (at Least 14 Days)||12
123300|NCT00939731|284232|P1|STARTED|Washout Period (at Least 14 Days)||12
123301|NCT00939731|284231|P2|NOT COMPLETED|First Intervention Period||0
123302|NCT00939731|284232|P1|NOT COMPLETED|First Intervention Period||0
123303|NCT00939731|284231|P2|COMPLETED|First Intervention Period||12
123304|NCT00939731|284232|P1|COMPLETED|First Intervention Period||12
123305|NCT00939731|284231|P2|STARTED|First Intervention Period||12
123306|NCT00939731|284232|P1|STARTED|First Intervention Period||12
123307|NCT00939705|284252|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
123308|NCT00939705|284253|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
123309|NCT00939705|284252|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
123310|NCT00939705|284253|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
123311|NCT00939705|284252|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
123312|NCT00939705|284253|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
123313|NCT00939705|284252|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
123314|NCT00939705|284253|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
123315|NCT00939705|284252|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
123316|NCT00939705|284253|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
123317|NCT00939705|284252|P2|STARTED|Period 2 - Washout Period - 21 Days||9
123318|NCT00939705|284253|P1|STARTED|Period 2 - Washout Period - 21 Days||9
123319|NCT00939705|284252|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
123320|NCT00939705|284253|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
123321|NCT00939705|284252|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
123322|NCT00939705|284253|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
123323|NCT00939705|284252|P2|STARTED|Period 1 - First Intervention - 5 Days||9
123324|NCT00939705|284253|P1|STARTED|Period 1 - First Intervention - 5 Days||9
123325|NCT00939692|284265|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
123326|NCT00939692|284266|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
123327|NCT00939692|284265|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
123328|NCT00939692|284266|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
123329|NCT00939692|284265|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
123330|NCT00939692|284266|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
123331|NCT00939692|284265|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
123332|NCT00939692|284266|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
123333|NCT00939692|284265|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
123334|NCT00939692|284266|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
123335|NCT00939692|284265|P2|STARTED|Period 1 - First Intervention - 5 Days||13
123336|NCT00939692|284266|P1|STARTED|Period 1 - First Intervention - 5 Days||13
123337|NCT00939627|284278|P3|NOT COMPLETED|Overall Study||0
123338|NCT00939627|284279|P2|NOT COMPLETED|Overall Study||28
123339|NCT00939627|284280|P1|NOT COMPLETED|Overall Study||27
123340|NCT00939627|284278|P3|COMPLETED|Overall Study||0
123341|NCT00939627|284279|P2|COMPLETED|Overall Study||0
123342|NCT00939627|284280|P1|COMPLETED|Overall Study||0
123343|NCT00939627|284278|P3|STARTED|Overall Study||0
123344|NCT00939627|284279|P2|STARTED|Overall Study||28
123345|NCT00939627|284280|P1|STARTED|Overall Study||27
123346|NCT00939562|284294|P2|NOT COMPLETED|Period 2||0
123347|NCT00939562|284295|P1|NOT COMPLETED|Period 2||0
123348|NCT00939562|284294|P2|COMPLETED|Period 2||12
123349|NCT00939562|284295|P1|COMPLETED|Period 2||12
123350|NCT00939562|284294|P2|STARTED|Period 2||12
123351|NCT00939562|284295|P1|STARTED|Period 2||12
123352|NCT00939562|284294|P2|NOT COMPLETED|Period 1||0
123353|NCT00939562|284295|P1|NOT COMPLETED|Period 1||0
123354|NCT00939562|284294|P2|COMPLETED|Period 1||12
123355|NCT00939562|284295|P1|COMPLETED|Period 1||12
123356|NCT00939562|284294|P2|STARTED|Period 1||12
123357|NCT00939562|284295|P1|STARTED|Period 1||12
123358|NCT00939536|284305|P2|NOT COMPLETED|Second Intervention||0
123359|NCT00939536|284306|P1|NOT COMPLETED|Second Intervention||0
123360|NCT00939536|284305|P2|COMPLETED|Second Intervention||12
123361|NCT00939536|284306|P1|COMPLETED|Second Intervention||12
123362|NCT00939536|284305|P2|STARTED|Second Intervention||12
123363|NCT00939536|284306|P1|STARTED|Second Intervention||12
123364|NCT00939536|284305|P2|NOT COMPLETED|First Intervention||0
123365|NCT00939536|284306|P1|NOT COMPLETED|First Intervention||0
123366|NCT00939536|284305|P2|COMPLETED|First Intervention||12
123367|NCT00939536|284306|P1|COMPLETED|First Intervention||12
123368|NCT00939536|284305|P2|STARTED|First Intervention||12
123369|NCT00939536|284306|P1|STARTED|First Intervention||12
123370|NCT00939510|284316|P1|NOT COMPLETED|Overall Study||1
123371|NCT00939510|284316|P1|COMPLETED|Overall Study||31
123372|NCT00939510|284316|P1|STARTED|Overall Study||32
123373|NCT00939484|284325|P3|NOT COMPLETED|Overall Study||3
123374|NCT00939484|284326|P2|NOT COMPLETED|Overall Study||20
123375|NCT00939484|284327|P1|NOT COMPLETED|Overall Study||8
123376|NCT00939484|284325|P3|COMPLETED|Overall Study||0
123377|NCT00939484|284326|P2|COMPLETED|Overall Study||0
123378|NCT00939484|284327|P1|COMPLETED|Overall Study||0
123379|NCT00939484|284325|P3|STARTED|Overall Study||3
123380|NCT00939484|284326|P2|STARTED|Overall Study||20
123381|NCT00939484|284327|P1|STARTED|Overall Study||8
123382|NCT00939471|284340|P1|NOT COMPLETED|Overall Study||11
123383|NCT00939471|284340|P1|COMPLETED|Overall Study||33
123384|NCT00939471|284340|P1|STARTED|Overall Study||44
123385|NCT00939393|284353|P2|NOT COMPLETED|Overall Study||0
123386|NCT00939393|284354|P1|NOT COMPLETED|Overall Study||4
123387|NCT00939393|284353|P2|COMPLETED|Overall Study||35
123388|NCT00939393|284354|P1|COMPLETED|Overall Study||33
123389|NCT00939393|284353|P2|STARTED|Overall Study||35
123390|NCT00939393|284354|P1|STARTED|Overall Study||37
123391|NCT00939367|284374|P2|NOT COMPLETED|Second Intervention||0
123392|NCT00939367|284375|P1|NOT COMPLETED|Second Intervention||0
123393|NCT00939367|284374|P2|COMPLETED|Second Intervention||15
123394|NCT00939367|284375|P1|COMPLETED|Second Intervention||15
123395|NCT00939367|284374|P2|STARTED|Second Intervention||15
123396|NCT00939367|284375|P1|STARTED|Second Intervention||15
123397|NCT00939367|284374|P2|NOT COMPLETED|First Intervention||0
123398|NCT00939367|284375|P1|NOT COMPLETED|First Intervention||0
123399|NCT00939367|284374|P2|COMPLETED|First Intervention||15
123400|NCT00939367|284375|P1|COMPLETED|First Intervention||15
123401|NCT00939367|284374|P2|STARTED|First Intervention||15
123402|NCT00939367|284375|P1|STARTED|First Intervention||15
123403|NCT00939341|284385|P1|NOT COMPLETED|Overall Study||66
123404|NCT00939341|284385|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
123405|NCT00939341|284385|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
123406|NCT00939211|284405|P1|NOT COMPLETED|Placebo||0
123407|NCT00939211|284405|P1|COMPLETED|Placebo||28
123408|NCT00939211|284405|P1|STARTED|Placebo||28
123409|NCT00939211|284405|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
123410|NCT00939211|284405|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
123411|NCT00939211|284405|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
123412|NCT00939211|284405|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
123413|NCT00939211|284405|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
123414|NCT00939211|284405|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
123415|NCT00939211|284405|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
123416|NCT00939211|284405|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
123417|NCT00939211|284405|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
123418|NCT00939211|284405|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
123419|NCT00939211|284405|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
123420|NCT00939211|284405|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
123421|NCT00939185|284467|P1|NOT COMPLETED|Overall Study||25
123422|NCT00939185|284467|P1|COMPLETED|Overall Study||375
123423|NCT00939185|284467|P1|Received Treatment|Overall Study||390
123424|NCT00939185|284467|P1|STARTED|Overall Study||400
123425|NCT00939159|284474|P1|NOT COMPLETED|Overall Study||0
123426|NCT00939159|284474|P1|COMPLETED|Overall Study||13
123427|NCT00939159|284474|P1|STARTED|Overall Study||13
123428|NCT00939120|284480|P2|NOT COMPLETED|Overall Study||5
123429|NCT00939120|284481|P1|NOT COMPLETED|Overall Study||8
123430|NCT00939120|284480|P2|COMPLETED|Overall Study||18
123431|NCT00939120|284481|P1|COMPLETED|Overall Study||15
123432|NCT00939120|284480|P2|STARTED|Overall Study||23
123433|NCT00939120|284481|P1|STARTED|Overall Study||23
123434|NCT00939107|284505|P2|NOT COMPLETED|Overall Study||12
123435|NCT00939107|284506|P1|NOT COMPLETED|Overall Study||14
123436|NCT00939107|284505|P2|COMPLETED|Overall Study||163
123437|NCT00939107|284506|P1|COMPLETED|Overall Study||161
123438|NCT00939107|284505|P2|12 Months Follow-up|Overall Study||163
123439|NCT00939107|284506|P1|12 Months Follow-up|Overall Study||161
123440|NCT00939107|284505|P2|STARTED|Overall Study||175
123441|NCT00939107|284506|P1|STARTED|Overall Study||175
123442|NCT00939094|284520|P2|NOT COMPLETED|Overall Study||10
123443|NCT00939094|284521|P1|NOT COMPLETED|Overall Study||14
123444|NCT00939094|284520|P2|COMPLETED|Overall Study||35
123445|NCT00939094|284521|P1|COMPLETED|Overall Study||28
123446|NCT00939094|284520|P2|STARTED|Overall Study||45
123447|NCT00939094|284521|P1|STARTED|Overall Study||42
123448|NCT00939055|284543|P2|NOT COMPLETED|Overall Study||0
123449|NCT00939055|284544|P1|NOT COMPLETED|Overall Study||4
123450|NCT00939055|284543|P2|COMPLETED|Overall Study||39
123451|NCT00939055|284544|P1|COMPLETED|Overall Study||69
123452|NCT00939055|284543|P2|STARTED|Overall Study||39
123453|NCT00939055|284544|P1|STARTED|Overall Study||73
123454|NCT00939029|284554|P2|NOT COMPLETED|Overall Study||12
123455|NCT00939029|284555|P1|NOT COMPLETED|Overall Study||6
123456|NCT00939029|284554|P2|COMPLETED|Overall Study||15
123457|NCT00939029|284555|P1|COMPLETED|Overall Study||19
123458|NCT00939029|284554|P2|STARTED|Overall Study||27
123459|NCT00939029|284555|P1|STARTED|Overall Study||25
123460|NCT00939003|284567|P2|NOT COMPLETED|Open-label Treatment Period||29
123461|NCT00939003|284568|P1|NOT COMPLETED|Open-label Treatment Period||29
123462|NCT00939003|284567|P2|COMPLETED|Open-label Treatment Period||62
123463|NCT00939003|284568|P1|COMPLETED|Open-label Treatment Period||66
123464|NCT00939003|284567|P2|STARTED|Open-label Treatment Period||91
123465|NCT00939003|284568|P1|STARTED|Open-label Treatment Period||95
123466|NCT00939003|284567|P2|NOT COMPLETED|Double-blind Treatment Period||4
123467|NCT00939003|284568|P1|NOT COMPLETED|Double-blind Treatment Period||2
123468|NCT00939003|284567|P2|COMPLETED|Double-blind Treatment Period||91
123469|NCT00939003|284568|P1|COMPLETED|Double-blind Treatment Period||95
123470|NCT00939003|284567|P2|STARTED|Double-blind Treatment Period||95
123471|NCT00939003|284568|P1|STARTED|Double-blind Treatment Period||97
123472|NCT00938860|284605|P2|NOT COMPLETED|Overall Study||17
123473|NCT00938860|284606|P1|NOT COMPLETED|Overall Study||25
123474|NCT00938860|284605|P2|COMPLETED|Overall Study||25
123475|NCT00938860|284606|P1|COMPLETED|Overall Study||25
123476|NCT00938860|284605|P2|Efficacy Population|Overall Study||41
123477|NCT00938860|284606|P1|Efficacy Population|Overall Study||40
123478|NCT00938860|284605|P2|STARTED|Overall Study||42
123479|NCT00938860|284606|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
123480|NCT00938782|284630|P2|NOT COMPLETED|Overall Study||0
123481|NCT00938782|284631|P1|NOT COMPLETED|Overall Study||0
123482|NCT00938782|284630|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
123483|NCT00938782|284631|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
123484|NCT00938782|284630|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
123485|NCT00938782|284631|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
123486|NCT00938717|284639|P2|NOT COMPLETED|Overall Study||108
123487|NCT00938717|284640|P1|NOT COMPLETED|Overall Study||98
123488|NCT00938717|284639|P2|COMPLETED|Overall Study||294
123489|NCT00938717|284640|P1|COMPLETED|Overall Study||305
123490|NCT00938717|284639|P2|STARTED|Overall Study||402
123491|NCT00938717|284640|P1|STARTED|Overall Study||403
123492|NCT00938704|284674|P2|NOT COMPLETED|Overall Study||0
123493|NCT00938704|284675|P1|NOT COMPLETED|Overall Study||0
123494|NCT00938704|284674|P2|COMPLETED|Overall Study||37
123495|NCT00938704|284675|P1|COMPLETED|Overall Study||33
123496|NCT00938704|284674|P2|STARTED|Overall Study||37
123497|NCT00938704|284675|P1|STARTED|Overall Study||33
123498|NCT00938639|284691|P2|NOT COMPLETED|Overall Study||4
123499|NCT00938639|284692|P1|NOT COMPLETED|Overall Study||3
123500|NCT00938639|284691|P2|COMPLETED|Overall Study||116
123501|NCT00938639|284692|P1|COMPLETED|Overall Study||117
123502|NCT00938639|284691|P2|STARTED|Overall Study||120
123503|NCT00938639|284692|P1|STARTED|Overall Study||120
123504|NCT00938548|284762|P2|NOT COMPLETED|Overall Study||0
123505|NCT00938548|284763|P1|NOT COMPLETED|Overall Study||0
123506|NCT00938548|284762|P2|COMPLETED|Overall Study||35
123507|NCT00938548|284763|P1|COMPLETED|Overall Study||35
123508|NCT00938548|284762|P2|STARTED|Overall Study||35
123509|NCT00938548|284763|P1|STARTED|Overall Study||35
123510|NCT00938457|284773|P1|NOT COMPLETED|Overall Study||0
123511|NCT00938457|284773|P1|COMPLETED|Overall Study||3
123512|NCT00938457|284773|P1|STARTED|Overall Study||3
123513|NCT00938431|284789|P3|NOT COMPLETED|Overall Study||8
123514|NCT00938431|284790|P2|NOT COMPLETED|Overall Study||9
123515|NCT00938431|284791|P1|NOT COMPLETED|Overall Study||6
123516|NCT00938431|284789|P3|COMPLETED|Overall Study||1
123517|NCT00938431|284790|P2|COMPLETED|Overall Study||14
123518|NCT00938431|284791|P1|COMPLETED|Overall Study||9
123519|NCT00938431|284789|P3|STARTED|Overall Study||9
123520|NCT00938431|284790|P2|STARTED|Overall Study||23
123521|NCT00938431|284791|P1|STARTED|Overall Study||15
123522|NCT00938392|284818|P2|NOT COMPLETED|Overall Study||4
123523|NCT00938392|284819|P1|NOT COMPLETED|Overall Study||2
123524|NCT00938392|284818|P2|COMPLETED|Overall Study||358
123525|NCT00938392|284819|P1|COMPLETED|Overall Study||360
123526|NCT00938392|284818|P2|STARTED|Overall Study||362
123527|NCT00938392|284819|P1|STARTED|Overall Study||362
123528|NCT00938366|284845|P2|NOT COMPLETED|Overall Study||0
123529|NCT00938366|284846|P1|NOT COMPLETED|Overall Study||1
123530|NCT00938366|284845|P2|COMPLETED|Overall Study||9
123531|NCT00938366|284846|P1|COMPLETED|Overall Study||8
123532|NCT00938366|284845|P2|STARTED|Overall Study||9
123533|NCT00938366|284846|P1|STARTED|Overall Study||9
123534|NCT00938327|284866|P1|NOT COMPLETED|Overall Study||60
123535|NCT00938327|284866|P1|COMPLETED|Overall Study||272
123536|NCT00938327|284866|P1|STARTED|Overall Study||332
123537|NCT00938314|284877|P4|NOT COMPLETED|Cohort 3||1
123538|NCT00938314|284878|P3|NOT COMPLETED|Cohort 3||4
123539|NCT00938314|284879|P2|NOT COMPLETED|Cohort 3||0
123540|NCT00938314|284880|P1|NOT COMPLETED|Cohort 3||0
123541|NCT00938314|284877|P4|COMPLETED|Cohort 3||7
123542|NCT00938314|284878|P3|COMPLETED|Cohort 3||20
123543|NCT00938314|284879|P2|COMPLETED|Cohort 3||0
123544|NCT00938314|284880|P1|COMPLETED|Cohort 3||0
123545|NCT00938314|284877|P4|STARTED|Cohort 3||8
123546|NCT00938314|284878|P3|STARTED|Cohort 3||24
123547|NCT00938314|284879|P2|STARTED|Cohort 3||0
123548|NCT00938314|284880|P1|STARTED|Cohort 3||0
123549|NCT00938314|284877|P4|NOT COMPLETED|Cohort 2||2
123550|NCT00938314|284878|P3|NOT COMPLETED|Cohort 2||0
123551|NCT00938314|284879|P2|NOT COMPLETED|Cohort 2||6
123552|NCT00938314|284880|P1|NOT COMPLETED|Cohort 2||0
123553|NCT00938314|284877|P4|COMPLETED|Cohort 2||6
123554|NCT00938314|284878|P3|COMPLETED|Cohort 2||0
123555|NCT00938314|284879|P2|COMPLETED|Cohort 2||18
123556|NCT00938314|284880|P1|COMPLETED|Cohort 2||0
123557|NCT00938314|284877|P4|STARTED|Cohort 2||8
123558|NCT00938314|284878|P3|STARTED|Cohort 2||0
123559|NCT00938314|284879|P2|STARTED|Cohort 2||24
123560|NCT00938314|284880|P1|STARTED|Cohort 2||0
123561|NCT00938314|284877|P4|NOT COMPLETED|Cohort 1||2
123562|NCT00938314|284878|P3|NOT COMPLETED|Cohort 1||0
123563|NCT00938314|284879|P2|NOT COMPLETED|Cohort 1||0
123564|NCT00938314|284880|P1|NOT COMPLETED|Cohort 1||2
123565|NCT00938314|284877|P4|COMPLETED|Cohort 1||6
123566|NCT00938314|284878|P3|COMPLETED|Cohort 1||0
123567|NCT00938314|284879|P2|COMPLETED|Cohort 1||0
123568|NCT00938314|284880|P1|COMPLETED|Cohort 1||22
123569|NCT00938314|284877|P4|STARTED|Cohort 1||8
123570|NCT00938314|284878|P3|STARTED|Cohort 1||0
123571|NCT00938314|284879|P2|STARTED|Cohort 1||0
123572|NCT00938314|284880|P1|STARTED|Cohort 1||24
123573|NCT00938041|284934|P1|NOT COMPLETED|Overall Study||27
123574|NCT00938041|284934|P1|COMPLETED|Overall Study||5
123575|NCT00938041|284934|P1|STARTED|Overall Study||32
123576|NCT00938015|284943|P1|NOT COMPLETED|Overall Study||147
123577|NCT00938015|284943|P1|COMPLETED|Overall Study||156
123578|NCT00938015|284943|P1|STARTED|Overall Study||303
123579|NCT00937950|284959|P1|NOT COMPLETED|Overall Study||216
123580|NCT00937950|284959|P1|COMPLETED|Overall Study||1787
123581|NCT00937950|284959|P1|STARTED|Overall Study||2003
123582|NCT00937937|284975|P1|NOT COMPLETED|Overall Study||72
123583|NCT00937937|284975|P1|COMPLETED|Overall Study||0
123584|NCT00937937|284975|P1|STARTED|Overall Study||72
123585|NCT00937833|284984|P2|NOT COMPLETED|Overall Study||17
123586|NCT00937833|284985|P1|NOT COMPLETED|Overall Study||15
123587|NCT00937833|284984|P2|COMPLETED|Overall Study||60
123588|NCT00937833|284985|P1|COMPLETED|Overall Study||58
123589|NCT00937833|284984|P2|STARTED|Overall Study||77
123590|NCT00937833|284985|P1|STARTED|Overall Study||73
123591|NCT00937794|284991|P1|NOT COMPLETED|Overall Study||0
123592|NCT00937794|284991|P1|COMPLETED|Overall Study||33
123593|NCT00937794|284991|P1|STARTED|Overall Study||33
123594|NCT00937768|284998|P2|NOT COMPLETED|Overall Study||8
123595|NCT00937768|284999|P1|NOT COMPLETED|Overall Study||8
123596|NCT00937768|284998|P2|COMPLETED|Overall Study||0
123597|NCT00937768|284999|P1|COMPLETED|Overall Study||0
123598|NCT00937768|284998|P2|STARTED|Overall Study||8
123599|NCT00937768|284999|P1|STARTED|Overall Study||8
123600|NCT00937560|285005|P1|NOT COMPLETED|Maintenance Treatment||18
123601|NCT00937560|285005|P1|COMPLETED|Maintenance Treatment||150
123602|NCT00937560|285005|P1|STARTED|Maintenance Treatment||168
123603|NCT00937560|285005|P1|NOT COMPLETED|Initial Treatment||21
123604|NCT00937560|285005|P1|COMPLETED|Initial Treatment||169
123605|NCT00937560|285005|P1|Received Treatment|Initial Treatment||189
123606|NCT00937560|285005|P1|STARTED|Initial Treatment||190
123607|NCT00937547|285016|P3|NOT COMPLETED|Overall Study||7
123608|NCT00937547|285017|P2|NOT COMPLETED|Overall Study||6
123609|NCT00937547|285018|P1|NOT COMPLETED|Overall Study||1
123610|NCT00937547|285016|P3|COMPLETED|Overall Study||142
123611|NCT00937547|285017|P2|COMPLETED|Overall Study||78
123612|NCT00937547|285018|P1|COMPLETED|Overall Study||95
123613|NCT00937547|285016|P3|Histological Samples|Overall Study||142
123614|NCT00937547|285017|P2|Histological Samples|Overall Study||78
123615|NCT00937547|285018|P1|Histological Samples|Overall Study||95
123616|NCT00937547|285016|P3|STARTED|Overall Study||149
123617|NCT00937547|285017|P2|STARTED|Overall Study||84
123618|NCT00937547|285018|P1|STARTED|Overall Study||96
123619|NCT00937521|285055|P8|NOT COMPLETED|Booster Phase||2
123620|NCT00937521|285056|P7|NOT COMPLETED|Booster Phase||5
123621|NCT00937521|285057|P6|NOT COMPLETED|Booster Phase||5
123622|NCT00937521|285058|P5|NOT COMPLETED|Booster Phase||5
123623|NCT00937521|285059|P4|NOT COMPLETED|Booster Phase||3
123624|NCT00937521|285060|P3|NOT COMPLETED|Booster Phase||5
123625|NCT00937521|285061|P2|NOT COMPLETED|Booster Phase||2
123626|NCT00937521|285062|P1|NOT COMPLETED|Booster Phase||3
123627|NCT00937521|285055|P8|COMPLETED|Booster Phase||159
123628|NCT00937521|285056|P7|COMPLETED|Booster Phase||160
123629|NCT00937521|285057|P6|COMPLETED|Booster Phase||160
123630|NCT00937521|285058|P5|COMPLETED|Booster Phase||163
123631|NCT00937521|285059|P4|COMPLETED|Booster Phase||167
123632|NCT00937521|285060|P3|COMPLETED|Booster Phase||164
123633|NCT00937521|285061|P2|COMPLETED|Booster Phase||161
123634|NCT00937521|285062|P1|COMPLETED|Booster Phase||152
123635|NCT00937521|285055|P8|Premature Withdrawal|Booster Phase||2
123636|NCT00937521|285056|P7|Premature Withdrawal|Booster Phase||5
123637|NCT00937521|285057|P6|Premature Withdrawal|Booster Phase||5
123638|NCT00937521|285058|P5|Premature Withdrawal|Booster Phase||5
123639|NCT00937521|285059|P4|Premature Withdrawal|Booster Phase||3
123640|NCT00937521|285060|P3|Premature Withdrawal|Booster Phase||5
123641|NCT00937521|285061|P2|Premature Withdrawal|Booster Phase||2
123642|NCT00937521|285062|P1|Premature Withdrawal|Booster Phase||3
123643|NCT00937521|285055|P8|STARTED|Booster Phase||161
123644|NCT00937521|285056|P7|STARTED|Booster Phase||165
123645|NCT00937521|285057|P6|STARTED|Booster Phase||165
123646|NCT00937521|285058|P5|STARTED|Booster Phase||168
123647|NCT00937521|285059|P4|STARTED|Booster Phase||170
123648|NCT00937521|285060|P3|STARTED|Booster Phase||169
123649|NCT00937521|285061|P2|STARTED|Booster Phase||163
123650|NCT00937521|285062|P1|STARTED|Booster Phase||155
123651|NCT00937521|285055|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
123652|NCT00937521|285056|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
123653|NCT00937521|285057|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
123654|NCT00937521|285058|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
123655|NCT00937521|285059|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
123656|NCT00937521|285060|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
123657|NCT00937521|285061|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
123658|NCT00937521|285062|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
123659|NCT00937521|285055|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
123660|NCT00937521|285056|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
123661|NCT00937521|285057|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
123662|NCT00937521|285058|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
123663|NCT00937521|285059|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
123664|NCT00937521|285060|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
123665|NCT00937521|285061|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
123666|NCT00937521|285062|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
123667|NCT00937521|285055|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
123668|NCT00937521|285056|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
123669|NCT00937521|285057|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
123670|NCT00937521|285058|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
123671|NCT00937521|285059|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
123672|NCT00937521|285060|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
123673|NCT00937521|285061|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
123674|NCT00937521|285062|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
123675|NCT00937521|285055|P8|STARTED|Overall Study - Prior to Booster Dose||184
123676|NCT00937521|285056|P7|STARTED|Overall Study - Prior to Booster Dose||186
123677|NCT00937521|285057|P6|STARTED|Overall Study - Prior to Booster Dose||188
123678|NCT00937521|285058|P5|STARTED|Overall Study - Prior to Booster Dose||191
123679|NCT00937521|285059|P4|STARTED|Overall Study - Prior to Booster Dose||188
123680|NCT00937521|285060|P3|STARTED|Overall Study - Prior to Booster Dose||192
123681|NCT00937521|285061|P2|STARTED|Overall Study - Prior to Booster Dose||190
123682|NCT00937521|285062|P1|STARTED|Overall Study - Prior to Booster Dose||188
123683|NCT00937495|285168|P1|NOT COMPLETED|Overall Study||2
123684|NCT00937495|285168|P1|COMPLETED|Overall Study||14
123685|NCT00937495|285168|P1|STARTED|Overall Study||16
123686|NCT00937391|285176|P1|NOT COMPLETED|Stage 2||1
123687|NCT00937391|285176|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
123688|NCT00937391|285176|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
123689|NCT00937391|285176|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
123690|NCT00937391|285176|P1|NOT COMPLETED|Stage 1||0
123691|NCT00937391|285176|P1|COMPLETED|Stage 1||20
123692|NCT00937391|285176|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
123693|NCT00937391|285176|P1|STARTED|Stage 1||20
123694|NCT00937157|285227|P1|NOT COMPLETED|Overall Study||4
123695|NCT00937157|285227|P1|COMPLETED|Overall Study||8
123696|NCT00937157|285227|P1|STARTED|Overall Study||12
123697|NCT00937118|285231|P1|NOT COMPLETED|Overall Study||0
123698|NCT00937118|285231|P1|COMPLETED|Overall Study||41
123699|NCT00937118|285231|P1|STARTED|Overall Study||41
123700|NCT00937105|285240|P2|NOT COMPLETED|Overall Study||39
123701|NCT00937105|285241|P1|NOT COMPLETED|Overall Study||40
123702|NCT00937105|285240|P2|COMPLETED|Overall Study||70
123703|NCT00937105|285241|P1|COMPLETED|Overall Study||69
123704|NCT00937105|285240|P2|STARTED|Overall Study||109
123705|NCT00937105|285241|P1|STARTED|Overall Study||109
123706|NCT00937040|285258|P2|NOT COMPLETED|Overall Study||37
123707|NCT00937040|285259|P1|NOT COMPLETED|Overall Study||41
123708|NCT00937040|285258|P2|COMPLETED|Overall Study||141
123709|NCT00937040|285259|P1|COMPLETED|Overall Study||138
123710|NCT00937040|285258|P2|STARTED|Overall Study||178
123711|NCT00937040|285259|P1|STARTED|Overall Study||179
123712|NCT00936975|285301|P1|NOT COMPLETED|Overall Study||6
123713|NCT00936975|285301|P1|COMPLETED|Overall Study||12
123714|NCT00936975|285301|P1|STARTED|Overall Study||18
123715|NCT00936897|285312|P2|NOT COMPLETED|Overall Study||60
123716|NCT00936897|285313|P1|NOT COMPLETED|Overall Study||19
123717|NCT00936897|285312|P2|COMPLETED|Overall Study||356
123718|NCT00936897|285313|P1|COMPLETED|Overall Study||398
123719|NCT00936897|285312|P2|STARTED|Overall Study|Randomized|416
123720|NCT00936897|285313|P1|STARTED|Overall Study|Randomized|417
123721|NCT00936741|285325|P1|NOT COMPLETED|Overall Study||9
123722|NCT00936741|285325|P1|COMPLETED|Overall Study||21
123723|NCT00936741|285325|P1|STARTED|Overall Study||30
123724|NCT00936702|285330|P1|NOT COMPLETED|Overall Study||46
123725|NCT00936702|285330|P1|COMPLETED|Overall Study||0
123726|NCT00936702|285330|P1|STARTED|Overall Study||46
123727|NCT00936598|285340|P2|NOT COMPLETED|Overall Study||0
123728|NCT00936598|285341|P1|NOT COMPLETED|Overall Study||2
123729|NCT00936598|285340|P2|COMPLETED|Overall Study||1
123730|NCT00936598|285341|P1|COMPLETED|Overall Study||2
123731|NCT00936598|285340|P2|STARTED|Overall Study||1
123732|NCT00936598|285341|P1|STARTED|Overall Study||4
123733|NCT00936585|285351|P1|NOT COMPLETED|Overall Study||0
123734|NCT00936585|285351|P1|COMPLETED|Overall Study||2
123735|NCT00936585|285351|P1|STARTED|Overall Study||2
123736|NCT00936481|285357|P2|NOT COMPLETED|Overall Study||0
123737|NCT00936481|285358|P1|NOT COMPLETED|Overall Study||0
123738|NCT00936481|285357|P2|COMPLETED|Overall Study||17
123739|NCT00936481|285358|P1|COMPLETED|Overall Study||17
123740|NCT00936481|285357|P2|STARTED|Overall Study||17
123741|NCT00936481|285358|P1|STARTED|Overall Study||17
123742|NCT00936455|285368|P2|NOT COMPLETED|Overall Study||0
123743|NCT00936455|285369|P1|NOT COMPLETED|Overall Study||0
123744|NCT00936455|285368|P2|COMPLETED|Overall Study||38
123745|NCT00936455|285369|P1|COMPLETED|Overall Study||37
123746|NCT00936455|285368|P2|STARTED|Overall Study||38
123747|NCT00936455|285369|P1|STARTED|Overall Study||37
123748|NCT00936377|285384|P3|NOT COMPLETED|Overall Study||0
123749|NCT00936377|285385|P2|NOT COMPLETED|Overall Study||0
123750|NCT00936377|285386|P1|NOT COMPLETED|Overall Study||0
123751|NCT00936377|285384|P3|COMPLETED|Overall Study||8
123752|NCT00936377|285385|P2|COMPLETED|Overall Study||8
123753|NCT00936377|285386|P1|COMPLETED|Overall Study||8
123754|NCT00936377|285384|P3|STARTED|Overall Study||8
123755|NCT00936377|285385|P2|STARTED|Overall Study||8
123756|NCT00936377|285386|P1|STARTED|Overall Study||8
123757|NCT00936351|285417|P2|NOT COMPLETED|Overall Study||2
123758|NCT00936351|285418|P1|NOT COMPLETED|Overall Study||3
123759|NCT00936351|285417|P2|COMPLETED|Overall Study||14
123760|NCT00936351|285418|P1|COMPLETED|Overall Study||15
123761|NCT00936351|285417|P2|STARTED|Overall Study||16
123762|NCT00936351|285418|P1|STARTED|Overall Study||18
123763|NCT00936221|285430|P2|NOT COMPLETED|Overall Study||1
123764|NCT00936221|285431|P1|NOT COMPLETED|Overall Study||1
123765|NCT00936221|285430|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
123766|NCT00936221|285431|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
123767|NCT00936221|285430|P2|Received Treatment|Overall Study||45
123768|NCT00936221|285431|P1|Received Treatment|Overall Study||44
123769|NCT00936221|285430|P2|STARTED|Overall Study||46
123770|NCT00936221|285431|P1|STARTED|Overall Study||45
123771|NCT00936208|285445|P2|NOT COMPLETED|Overall Study||22
123772|NCT00936208|285446|P1|NOT COMPLETED|Overall Study||37
123773|NCT00936208|285445|P2|COMPLETED|Overall Study||1574
123774|NCT00936208|285446|P1|COMPLETED|Overall Study||1462
123775|NCT00936208|285445|P2|STARTED|Overall Study||1596
123776|NCT00936208|285446|P1|STARTED|Overall Study||1499
123777|NCT00936117|285464|P1|NOT COMPLETED|Overall Study||10
123778|NCT00936117|285464|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
123779|NCT00936117|285464|P1|STARTED|Overall Study||20
123780|NCT00936065|285472|P3|NOT COMPLETED|Overall Study||7
123781|NCT00936065|285473|P2|NOT COMPLETED|Overall Study||4
123782|NCT00936065|285474|P1|NOT COMPLETED|Overall Study||4
123783|NCT00936065|285472|P3|COMPLETED|Overall Study||12
123784|NCT00936065|285473|P2|COMPLETED|Overall Study||16
123785|NCT00936065|285474|P1|COMPLETED|Overall Study||17
123786|NCT00936065|285472|P3|Study Assessments Performed|Overall Study||18
123787|NCT00936065|285473|P2|Study Assessments Performed|Overall Study||19
123788|NCT00936065|285474|P1|Study Assessments Performed|Overall Study||21
123789|NCT00936065|285472|P3|Received Treatment|Overall Study||18
123790|NCT00936065|285473|P2|Received Treatment|Overall Study||20
123791|NCT00936065|285474|P1|Received Treatment|Overall Study||21
123792|NCT00936065|285472|P3|STARTED|Overall Study||19
123793|NCT00936065|285473|P2|STARTED|Overall Study||20
123794|NCT00936065|285474|P1|STARTED|Overall Study||21
123795|NCT00935883|285580|P2|NOT COMPLETED|Follow-Up Period||0
123796|NCT00935883|285581|P1|NOT COMPLETED|Follow-Up Period||0
123797|NCT00935883|285580|P2|COMPLETED|Follow-Up Period||38
123798|NCT00935883|285581|P1|COMPLETED|Follow-Up Period||19
123799|NCT00935883|285580|P2|STARTED|Follow-Up Period||38
123800|NCT00935883|285581|P1|STARTED|Follow-Up Period||19
123801|NCT00935883|285580|P2|NOT COMPLETED|Treatment Period||2
123802|NCT00935883|285581|P1|NOT COMPLETED|Treatment Period||1
123803|NCT00935883|285580|P2|COMPLETED|Treatment Period||38
123804|NCT00935883|285581|P1|COMPLETED|Treatment Period||19
123805|NCT00935883|285580|P2|STARTED|Treatment Period||40
123806|NCT00935883|285581|P1|STARTED|Treatment Period||20
123807|NCT00935857|285595|P2|NOT COMPLETED|Overall Study||0
123808|NCT00935857|285596|P1|NOT COMPLETED|Overall Study||0
123809|NCT00935857|285595|P2|COMPLETED|Overall Study||16
123810|NCT00935857|285596|P1|COMPLETED|Overall Study||14
123811|NCT00935857|285595|P2|STARTED|Overall Study||16
123812|NCT00935857|285596|P1|STARTED|Overall Study||14
123813|NCT00935818|285608|P2|NOT COMPLETED|Overall Study||100
123814|NCT00935818|285609|P1|NOT COMPLETED|Overall Study||91
123815|NCT00935818|285608|P2|COMPLETED|Overall Study||157
123816|NCT00935818|285609|P1|COMPLETED|Overall Study||158
123817|NCT00935818|285608|P2|End of Medication Phase|Overall Study||184
123818|NCT00935818|285609|P1|End of Medication Phase|Overall Study||182
123819|NCT00935818|285608|P2|STARTED|Overall Study||257
123820|NCT00935818|285609|P1|STARTED|Overall Study||249
123821|NCT00935792|285630|P3|NOT COMPLETED|Overall Study||0
123822|NCT00935792|285631|P2|NOT COMPLETED|Overall Study||3
123823|NCT00935792|285632|P1|NOT COMPLETED|Overall Study||1
123824|NCT00935792|285630|P3|COMPLETED|Overall Study||12
123825|NCT00935792|285631|P2|COMPLETED|Overall Study||6
123826|NCT00935792|285632|P1|COMPLETED|Overall Study||6
123827|NCT00935792|285630|P3|STARTED|Overall Study||12
123828|NCT00935792|285631|P2|STARTED|Overall Study||9
123829|NCT00935792|285632|P1|STARTED|Overall Study||7
123830|NCT00935766|285649|P2|NOT COMPLETED|Overall Study||7
123831|NCT00935766|285650|P1|NOT COMPLETED|Overall Study||7
123832|NCT00935766|285649|P2|COMPLETED|Overall Study||27
123833|NCT00935766|285650|P1|COMPLETED|Overall Study||35
123834|NCT00935766|285649|P2|STARTED|Overall Study||34
123835|NCT00935766|285650|P1|STARTED|Overall Study||42
123836|NCT00935701|285660|P1|NOT COMPLETED|Overall Study||1
123837|NCT00935701|285660|P1|COMPLETED|Overall Study||9
123838|NCT00935701|285660|P1|Transition Acupressure to Acupuncture|Overall Study||9
123839|NCT00935701|285660|P1|STARTED|Overall Study||10
123840|NCT00935649|285667|P1|NOT COMPLETED|Overall Study||5
123841|NCT00935649|285667|P1|COMPLETED|Overall Study||134
123842|NCT00935649|285667|P1|STARTED|Overall Study||139
123843|NCT00935584|285677|P2|NOT COMPLETED|Overall Study||4
123844|NCT00935584|285678|P1|NOT COMPLETED|Overall Study||49
123845|NCT00935584|285677|P2|COMPLETED|Overall Study||19
123846|NCT00935584|285678|P1|COMPLETED|Overall Study||77
123847|NCT00935584|285677|P2|STARTED|Overall Study||23
123848|NCT00935584|285678|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
123849|NCT00935532|285690|P2|NOT COMPLETED|Overall Study||11
123850|NCT00935532|285691|P1|NOT COMPLETED|Overall Study||22
123851|NCT00935532|285690|P2|COMPLETED|Overall Study||201
123852|NCT00935532|285691|P1|COMPLETED|Overall Study||193
123853|NCT00935532|285690|P2|STARTED|Overall Study||212
123854|NCT00935532|285691|P1|STARTED|Overall Study||215
123855|NCT00935493|285720|P3|NOT COMPLETED|Overall Study||1
123856|NCT00935493|285721|P2|NOT COMPLETED|Overall Study||2
123857|NCT00935493|285722|P1|NOT COMPLETED|Overall Study||1
123858|NCT00935493|285720|P3|COMPLETED|Overall Study||40
123859|NCT00935493|285721|P2|COMPLETED|Overall Study||39
123860|NCT00935493|285722|P1|COMPLETED|Overall Study||40
123861|NCT00935493|285720|P3|STARTED|Overall Study||41
123862|NCT00935493|285721|P2|STARTED|Overall Study||41
123863|NCT00935493|285722|P1|STARTED|Overall Study||41
123864|NCT00935311|285739|P3|NOT COMPLETED|Overall Study||0
123865|NCT00935311|285740|P2|NOT COMPLETED|Overall Study||0
123866|NCT00935311|285741|P1|NOT COMPLETED|Overall Study||0
123867|NCT00935311|285739|P3|COMPLETED|Overall Study||40
123868|NCT00935311|285740|P2|COMPLETED|Overall Study||39
123869|NCT00935311|285741|P1|COMPLETED|Overall Study||43
123870|NCT00935311|285739|P3|STARTED|Overall Study||40
123871|NCT00935311|285740|P2|STARTED|Overall Study||39
123872|NCT00935311|285741|P1|STARTED|Overall Study||43
123873|NCT00935272|285760|P2|NOT COMPLETED|Overall Study||6
123874|NCT00935272|285761|P1|NOT COMPLETED|Overall Study||19
123875|NCT00935272|285760|P2|COMPLETED|Overall Study||39
123876|NCT00935272|285761|P1|COMPLETED|Overall Study||116
123877|NCT00935272|285760|P2|STARTED|Overall Study||45
123878|NCT00935272|285761|P1|STARTED|Overall Study||135
123879|NCT00935259|285770|P2|NOT COMPLETED|Period 2||0
123880|NCT00935259|285771|P1|NOT COMPLETED|Period 2||0
123881|NCT00935259|285770|P2|COMPLETED|Period 2||14
123882|NCT00935259|285771|P1|COMPLETED|Period 2||15
123883|NCT00935259|285770|P2|STARTED|Period 2||14
123884|NCT00935259|285771|P1|STARTED|Period 2||15
123885|NCT00935259|285770|P2|NOT COMPLETED|Period 1||1
123886|NCT00935259|285771|P1|NOT COMPLETED|Period 1||1
123887|NCT00935259|285770|P2|COMPLETED|Period 1||14
123888|NCT00935259|285771|P1|COMPLETED|Period 1||15
123889|NCT00935259|285770|P2|STARTED|Period 1||15
123890|NCT00935259|285771|P1|STARTED|Period 1||16
123891|NCT00935220|285785|P1|NOT COMPLETED|Overall Study||2
123892|NCT00935220|285785|P1|COMPLETED|Overall Study||39
123893|NCT00935220|285785|P1|STARTED|Overall Study||41
123894|NCT00935064|285799|P2|NOT COMPLETED|Overall Study||0
123895|NCT00935064|285800|P1|NOT COMPLETED|Overall Study||0
123896|NCT00935064|285799|P2|COMPLETED|Overall Study||30
123897|NCT00935064|285800|P1|COMPLETED|Overall Study||30
123898|NCT00935064|285799|P2|STARTED|Overall Study||30
123899|NCT00935064|285800|P1|STARTED|Overall Study||30
123900|NCT00934947|285816|P2|NOT COMPLETED|Overall Study||2
123901|NCT00934947|285817|P1|NOT COMPLETED|Overall Study||0
123902|NCT00934947|285816|P2|COMPLETED|Overall Study||20
123903|NCT00934947|285817|P1|COMPLETED|Overall Study||23
123904|NCT00934947|285816|P2|STARTED|Overall Study||22
123905|NCT00934947|285817|P1|STARTED|Overall Study||23
123906|NCT00934921|285825|P2|NOT COMPLETED|Second Intervention||0
123907|NCT00934921|285826|P1|NOT COMPLETED|Second Intervention||0
123908|NCT00934921|285825|P2|COMPLETED|Second Intervention||12
123909|NCT00934921|285826|P1|COMPLETED|Second Intervention||12
123910|NCT00934921|285825|P2|STARTED|Second Intervention||12
123911|NCT00934921|285826|P1|STARTED|Second Intervention||12
123912|NCT00934921|285825|P2|NOT COMPLETED|First Intervention||0
123913|NCT00934921|285826|P1|NOT COMPLETED|First Intervention||0
123914|NCT00934921|285825|P2|COMPLETED|First Intervention||12
123915|NCT00934921|285826|P1|COMPLETED|First Intervention||12
123916|NCT00934921|285825|P2|STARTED|First Intervention||12
123917|NCT00934921|285826|P1|STARTED|First Intervention||12
123918|NCT00934843|285836|P2|NOT COMPLETED|Overall Study||1
123919|NCT00934843|285837|P1|NOT COMPLETED|Overall Study||0
123920|NCT00934843|285836|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
123921|NCT00934843|285837|P1|COMPLETED|Overall Study||37
123922|NCT00934843|285836|P2|STARTED|Overall Study||40
123923|NCT00934843|285837|P1|STARTED|Overall Study||37
123924|NCT00934791|285853|P2|NOT COMPLETED|Overall Study||0
123925|NCT00934791|285854|P1|NOT COMPLETED|Overall Study||1
123926|NCT00934791|285853|P2|COMPLETED|Overall Study||0
123927|NCT00934791|285854|P1|COMPLETED|Overall Study||0
123928|NCT00934791|285853|P2|STARTED|Overall Study||0
123929|NCT00934791|285854|P1|STARTED|Overall Study||1
123930|NCT00934648|285860|P1|NOT COMPLETED|Overall Study||9
123931|NCT00934648|285860|P1|COMPLETED|Overall Study||6
123932|NCT00934648|285860|P1|STARTED|Overall Study||15
123933|NCT00934635|285876|P9|NOT COMPLETED|Overall Study||0
123934|NCT00934635|285877|P8|NOT COMPLETED|Overall Study||0
123935|NCT00934635|285878|P7|NOT COMPLETED|Overall Study||0
123936|NCT00934635|285879|P6|NOT COMPLETED|Overall Study||0
123937|NCT00934635|285880|P5|NOT COMPLETED|Overall Study||0
123938|NCT00934635|285881|P4|NOT COMPLETED|Overall Study||0
123939|NCT00934635|285882|P3|NOT COMPLETED|Overall Study||0
123940|NCT00934635|285883|P2|NOT COMPLETED|Overall Study||0
123941|NCT00934635|285884|P1|NOT COMPLETED|Overall Study||0
123942|NCT00934635|285876|P9|COMPLETED|Overall Study||1
123943|NCT00934635|285877|P8|COMPLETED|Overall Study||0
123944|NCT00934635|285878|P7|COMPLETED|Overall Study||0
123945|NCT00934635|285879|P6|COMPLETED|Overall Study||0
123946|NCT00934635|285880|P5|COMPLETED|Overall Study||0
123947|NCT00934635|285881|P4|COMPLETED|Overall Study||0
123948|NCT00934635|285882|P3|COMPLETED|Overall Study||0
123949|NCT00934635|285883|P2|COMPLETED|Overall Study||1
123950|NCT00934635|285884|P1|COMPLETED|Overall Study||0
123951|NCT00934635|285876|P9|STARTED|Overall Study||1
123952|NCT00934635|285877|P8|STARTED|Overall Study||0
123953|NCT00934635|285878|P7|STARTED|Overall Study||0
123954|NCT00934635|285879|P6|STARTED|Overall Study||0
123955|NCT00934635|285880|P5|STARTED|Overall Study||0
123956|NCT00934635|285881|P4|STARTED|Overall Study||0
123957|NCT00934635|285882|P3|STARTED|Overall Study||0
123958|NCT00934635|285883|P2|STARTED|Overall Study||1
123959|NCT00934635|285884|P1|STARTED|Overall Study||0
123960|NCT00934622|285904|P1|NOT COMPLETED|Overall Study||8
123961|NCT00934622|285904|P1|COMPLETED|Overall Study||68
123962|NCT00934622|285904|P1|STARTED|Overall Study||76
123963|NCT00934596|285911|P2|NOT COMPLETED|Overall Study||0
123964|NCT00934596|285912|P1|NOT COMPLETED|Overall Study||0
123965|NCT00934596|285911|P2|COMPLETED|Overall Study||10
123966|NCT00934596|285912|P1|COMPLETED|Overall Study||10
123967|NCT00934596|285911|P2|STARTED|Overall Study||10
123968|NCT00934596|285912|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
123969|NCT00934544|285942|P2|NOT COMPLETED|Overall Study||42
123970|NCT00934544|285943|P1|NOT COMPLETED|Overall Study||55
123971|NCT00934544|285942|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
123972|NCT00934544|285943|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
123973|NCT00934544|285942|P2|STARTED|Overall Study||73
123974|NCT00934544|285943|P1|STARTED|Overall Study||146
123975|NCT00934375|285959|P2|NOT COMPLETED|Overall Study||22
123976|NCT00934375|285960|P1|NOT COMPLETED|Overall Study||13
123977|NCT00934375|285959|P2|COMPLETED|Overall Study||55
123978|NCT00934375|285960|P1|COMPLETED|Overall Study||55
123979|NCT00934375|285959|P2|STARTED|Overall Study||77
123980|NCT00934375|285960|P1|STARTED|Overall Study||68
123981|NCT00934362|285968|P2|NOT COMPLETED|Overall Study||0
123982|NCT00934362|285969|P1|NOT COMPLETED|Overall Study||1
123983|NCT00934362|285968|P2|COMPLETED|Overall Study||8
123984|NCT00934362|285969|P1|COMPLETED|Overall Study||7
123985|NCT00934362|285968|P2|STARTED|Overall Study||8
123986|NCT00934362|285969|P1|STARTED|Overall Study||8
123987|NCT00934180|285979|P2|NOT COMPLETED|Second Intervention||0
123988|NCT00934180|285980|P1|NOT COMPLETED|Second Intervention||0
123989|NCT00934180|285979|P2|COMPLETED|Second Intervention||12
123990|NCT00934180|285980|P1|COMPLETED|Second Intervention||12
123991|NCT00934180|285979|P2|STARTED|Second Intervention||12
123992|NCT00934180|285980|P1|STARTED|Second Intervention||12
123993|NCT00934180|285979|P2|NOT COMPLETED|First Intervention||0
123994|NCT00934180|285980|P1|NOT COMPLETED|First Intervention||0
123995|NCT00934180|285979|P2|COMPLETED|First Intervention||12
123996|NCT00934180|285980|P1|COMPLETED|First Intervention||12
123997|NCT00934180|285979|P2|STARTED|First Intervention||12
123998|NCT00934180|285980|P1|STARTED|First Intervention||12
123999|NCT00934141|285992|P4|NOT COMPLETED|Overall Study||3
124000|NCT00934141|285993|P3|NOT COMPLETED|Overall Study||0
124001|NCT00934141|285994|P2|NOT COMPLETED|Overall Study||3
124002|NCT00934141|285995|P1|NOT COMPLETED|Overall Study||4
124003|NCT00934141|285992|P4|COMPLETED|Overall Study||51
124004|NCT00934141|285993|P3|COMPLETED|Overall Study||48
124005|NCT00934141|285994|P2|COMPLETED|Overall Study||47
124006|NCT00934141|285995|P1|COMPLETED|Overall Study||45
124007|NCT00934141|285992|P4|STARTED|Overall Study||54
124008|NCT00934141|285993|P3|STARTED|Overall Study||48
124009|NCT00934141|285994|P2|STARTED|Overall Study||50
124010|NCT00934141|285995|P1|STARTED|Overall Study||49
124011|NCT00934128|286019|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
124012|NCT00934128|286020|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
124013|NCT00934128|286019|P2|COMPLETED|Second Intervention (2 Hours)||5
124014|NCT00934128|286020|P1|COMPLETED|Second Intervention (2 Hours)||3
124015|NCT00934128|286019|P2|STARTED|Second Intervention (2 Hours)||8
124016|NCT00934128|286020|P1|STARTED|Second Intervention (2 Hours)||3
124017|NCT00934128|286019|P2|NOT COMPLETED|Washout Period (1 Hour)||5
124018|NCT00934128|286020|P1|NOT COMPLETED|Washout Period (1 Hour)||7
124019|NCT00934128|286019|P2|COMPLETED|Washout Period (1 Hour)||8
124020|NCT00934128|286020|P1|COMPLETED|Washout Period (1 Hour)||3
124021|NCT00934128|286019|P2|STARTED|Washout Period (1 Hour)||13
124022|NCT00934128|286020|P1|STARTED|Washout Period (1 Hour)||10
124023|NCT00934128|286019|P2|NOT COMPLETED|First Intervention (2 Hours)||2
124024|NCT00934128|286020|P1|NOT COMPLETED|First Intervention (2 Hours)||5
124025|NCT00934128|286019|P2|COMPLETED|First Intervention (2 Hours)||13
124026|NCT00934128|286020|P1|COMPLETED|First Intervention (2 Hours)||10
124027|NCT00934128|286019|P2|STARTED|First Intervention (2 Hours)||15
124028|NCT00934128|286020|P1|STARTED|First Intervention (2 Hours)||15
124029|NCT00934102|286028|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
124030|NCT00934102|286029|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
124031|NCT00934102|286030|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
124032|NCT00934102|286028|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
124033|NCT00934102|286029|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
124034|NCT00934102|286030|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
124035|NCT00934102|286028|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
124036|NCT00934102|286029|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
124037|NCT00934102|286030|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
124038|NCT00934102|286028|P3|NOT COMPLETED|Period 1, One Night of Wear||0
124039|NCT00934102|286029|P2|NOT COMPLETED|Period 1, One Night of Wear||0
124040|NCT00934102|286030|P1|NOT COMPLETED|Period 1, One Night of Wear||1
124041|NCT00934102|286028|P3|COMPLETED|Period 1, One Night of Wear||15
124042|NCT00934102|286029|P2|COMPLETED|Period 1, One Night of Wear||15
124043|NCT00934102|286030|P1|COMPLETED|Period 1, One Night of Wear||15
124044|NCT00934102|286028|P3|STARTED|Period 1, One Night of Wear||15
124045|NCT00934102|286029|P2|STARTED|Period 1, One Night of Wear||15
124046|NCT00934102|286030|P1|STARTED|Period 1, One Night of Wear||16
124047|NCT00934050|286044|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
124048|NCT00934050|286045|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
124049|NCT00934050|286046|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
124050|NCT00934050|286047|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
124051|NCT00934050|286048|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
124052|NCT00934050|286049|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
124053|NCT00934050|286044|P6|COMPLETED|Enrolled After 15 Dec 2009||23
124054|NCT00934050|286045|P5|COMPLETED|Enrolled After 15 Dec 2009||19
124055|NCT00934050|286046|P4|COMPLETED|Enrolled After 15 Dec 2009||0
124056|NCT00934050|286047|P3|COMPLETED|Enrolled After 15 Dec 2009||0
124057|NCT00934050|286048|P2|COMPLETED|Enrolled After 15 Dec 2009||0
124058|NCT00934050|286049|P1|COMPLETED|Enrolled After 15 Dec 2009||0
124059|NCT00934050|286044|P6|STARTED|Enrolled After 15 Dec 2009||27
124060|NCT00934050|286045|P5|STARTED|Enrolled After 15 Dec 2009||26
124061|NCT00934050|286046|P4|STARTED|Enrolled After 15 Dec 2009||0
124062|NCT00934050|286047|P3|STARTED|Enrolled After 15 Dec 2009||0
124063|NCT00934050|286048|P2|STARTED|Enrolled After 15 Dec 2009||0
124064|NCT00934050|286049|P1|STARTED|Enrolled After 15 Dec 2009||0
124065|NCT00934050|286044|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
124066|NCT00934050|286045|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
124067|NCT00934050|286046|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
124068|NCT00934050|286047|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
124069|NCT00934050|286048|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
124070|NCT00934050|286049|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
124071|NCT00934050|286044|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124072|NCT00934050|286045|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124073|NCT00934050|286046|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124074|NCT00934050|286047|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124075|NCT00934050|286048|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124076|NCT00934050|286049|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
124077|NCT00934050|286044|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
124078|NCT00934050|286045|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
124079|NCT00934050|286046|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
124080|NCT00934050|286047|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
124081|NCT00934050|286048|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
124082|NCT00934050|286049|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
124083|NCT00933933|286064|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
124084|NCT00933933|286065|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
124085|NCT00933933|286066|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
124086|NCT00933933|286064|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
124087|NCT00933933|286065|P2|COMPLETED|Pediatric From 2 to 21 Years||64
124088|NCT00933933|286066|P1|COMPLETED|Pediatric From 2 to 21 Years||588
124089|NCT00933933|286064|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
124090|NCT00933933|286065|P2|STARTED|Pediatric From 2 to 21 Years||64
124091|NCT00933933|286066|P1|STARTED|Pediatric From 2 to 21 Years||588
124092|NCT00933933|286064|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
124093|NCT00933933|286065|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
124094|NCT00933933|286066|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
124095|NCT00933933|286064|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
124096|NCT00933933|286065|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
124097|NCT00933933|286066|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
124098|NCT00933933|286064|P3|STARTED|Pregnant Females Between 16-44 Years||203
124099|NCT00933933|286065|P2|STARTED|Pregnant Females Between 16-44 Years||67
124100|NCT00933933|286066|P1|STARTED|Pregnant Females Between 16-44 Years||448
124101|NCT00933933|286064|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
124102|NCT00933933|286065|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
124103|NCT00933933|286066|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
124104|NCT00933933|286064|P3|COMPLETED|General Population From 16 to 89 Years||1206
124105|NCT00933933|286065|P2|COMPLETED|General Population From 16 to 89 Years||1267
124106|NCT00933933|286066|P1|COMPLETED|General Population From 16 to 89 Years||6164
124107|NCT00933933|286064|P3|STARTED|General Population From 16 to 89 Years||1206
124108|NCT00933933|286065|P2|STARTED|General Population From 16 to 89 Years||1287
124109|NCT00933933|286066|P1|STARTED|General Population From 16 to 89 Years||6164
124110|NCT00933686|286084|P2|NOT COMPLETED|Overall Study||11
124111|NCT00933686|286085|P1|NOT COMPLETED|Overall Study||10
124112|NCT00933686|286084|P2|COMPLETED|Overall Study||47
124113|NCT00933686|286085|P1|COMPLETED|Overall Study||45
124114|NCT00933686|286084|P2|STARTED|Overall Study||58
124115|NCT00933686|286085|P1|STARTED|Overall Study||55
124116|NCT00933608|286105|P2|NOT COMPLETED|Overall Study||2
124117|NCT00933608|286106|P1|NOT COMPLETED|Overall Study||5
124118|NCT00933608|286105|P2|COMPLETED|Overall Study||8
124119|NCT00933608|286106|P1|COMPLETED|Overall Study||2
124120|NCT00933608|286105|P2|STARTED|Overall Study||10
124121|NCT00933608|286106|P1|STARTED|Overall Study||7
124122|NCT00933543|286114|P2|NOT COMPLETED|Overall Study||7
124123|NCT00933543|286115|P1|NOT COMPLETED|Overall Study||3
124124|NCT00933543|286114|P2|COMPLETED|Overall Study||46
124125|NCT00933543|286115|P1|COMPLETED|Overall Study||51
124126|NCT00933543|286114|P2|STARTED|Overall Study||53
124127|NCT00933543|286115|P1|STARTED|Overall Study||54
124128|NCT00933491|286173|P2|NOT COMPLETED|Overall Study||0
124129|NCT00933491|286174|P1|NOT COMPLETED|Overall Study||0
124130|NCT00933491|286173|P2|COMPLETED|Overall Study||18
124131|NCT00933491|286174|P1|COMPLETED|Overall Study||14
124132|NCT00933491|286173|P2|STARTED|Overall Study||18
124133|NCT00933491|286174|P1|STARTED|Overall Study||14
124134|NCT00933335|286184|P2|NOT COMPLETED|Overall Study||16
124135|NCT00933335|286185|P1|NOT COMPLETED|Overall Study||2
124136|NCT00933335|286184|P2|COMPLETED|Overall Study||20
124137|NCT00933335|286185|P1|COMPLETED|Overall Study||0
124138|NCT00933335|286184|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
124139|NCT00933335|286185|P1|STARTED|Overall Study||2
124140|NCT00933270|286255|P1|NOT COMPLETED|Overall Study||87
124141|NCT00933270|286255|P1|COMPLETED|Overall Study||177
124142|NCT00933270|286255|P1|STARTED|Overall Study|ITT population|264
124143|NCT00933244|286349|P3|NOT COMPLETED|Overall Study||3
124144|NCT00933244|286350|P2|NOT COMPLETED|Overall Study||1
124145|NCT00933244|286351|P1|NOT COMPLETED|Overall Study||5
124146|NCT00933244|286349|P3|COMPLETED|Overall Study||73
124147|NCT00933244|286350|P2|COMPLETED|Overall Study||74
124148|NCT00933244|286351|P1|COMPLETED|Overall Study||74
124149|NCT00933244|286349|P3|STARTED|Overall Study||76
124150|NCT00933244|286350|P2|STARTED|Overall Study||75
124151|NCT00933244|286351|P1|STARTED|Overall Study||79
124152|NCT00933166|286368|P1|NOT COMPLETED|Overall Study||18
124153|NCT00933166|286368|P1|COMPLETED|Overall Study||151
124154|NCT00933166|286368|P1|STARTED|Overall Study||169
124155|NCT00932893|286374|P2|NOT COMPLETED|Overall Study||170
124156|NCT00932893|286375|P1|NOT COMPLETED|Overall Study||133
124157|NCT00932893|286374|P2|COMPLETED|Overall Study||4
124158|NCT00932893|286375|P1|COMPLETED|Overall Study||40
124159|NCT00932893|286374|P2|Treated|Overall Study||171
124160|NCT00932893|286375|P1|Treated|Overall Study||172
124161|NCT00932893|286374|P2|STARTED|Overall Study||174
124162|NCT00932893|286375|P1|STARTED|Overall Study||173
124163|NCT00932659|286406|P1|NOT COMPLETED|Overall Study||0
124164|NCT00932659|286406|P1|COMPLETED|Overall Study||8
124165|NCT00932659|286406|P1|STARTED|Overall Study||8
124166|NCT00932646|286411|P4|NOT COMPLETED|Overall Study||1
124167|NCT00932646|286412|P3|NOT COMPLETED|Overall Study||4
124168|NCT00932646|286413|P2|NOT COMPLETED|Overall Study||3
124169|NCT00932646|286414|P1|NOT COMPLETED|Overall Study||5
124170|NCT00932646|286411|P4|COMPLETED|Overall Study||24
124171|NCT00932646|286412|P3|COMPLETED|Overall Study||21
124172|NCT00932646|286413|P2|COMPLETED|Overall Study||22
124173|NCT00932646|286414|P1|COMPLETED|Overall Study||20
124174|NCT00932646|286411|P4|STARTED|Overall Study||25
124175|NCT00932646|286412|P3|STARTED|Overall Study||25
124176|NCT00932646|286413|P2|STARTED|Overall Study||25
124177|NCT00932646|286414|P1|STARTED|Overall Study||25
124178|NCT00932620|286470|P2|NOT COMPLETED|Overall Study||0
124179|NCT00932620|286471|P1|NOT COMPLETED|Overall Study||0
124180|NCT00932620|286470|P2|COMPLETED|Overall Study||50
124181|NCT00932620|286471|P1|COMPLETED|Overall Study||50
124182|NCT00932620|286470|P2|STARTED|Overall Study||50
124183|NCT00932620|286471|P1|STARTED|Overall Study||50
124184|NCT00932477|286479|P6|NOT COMPLETED|Treatment 3||0
124185|NCT00932477|286480|P5|NOT COMPLETED|Treatment 3||0
124186|NCT00932477|286481|P4|NOT COMPLETED|Treatment 3||0
124187|NCT00932477|286482|P3|NOT COMPLETED|Treatment 3||0
124188|NCT00932477|286483|P2|NOT COMPLETED|Treatment 3||0
124189|NCT00932477|286484|P1|NOT COMPLETED|Treatment 3||0
124190|NCT00932477|286479|P6|COMPLETED|Treatment 3||8
124191|NCT00932477|286480|P5|COMPLETED|Treatment 3||8
124192|NCT00932477|286481|P4|COMPLETED|Treatment 3||7
124193|NCT00932477|286482|P3|COMPLETED|Treatment 3||9
124194|NCT00932477|286483|P2|COMPLETED|Treatment 3||8
124195|NCT00932477|286484|P1|COMPLETED|Treatment 3||7
124196|NCT00932477|286479|P6|STARTED|Treatment 3||8
124197|NCT00932477|286480|P5|STARTED|Treatment 3||8
124198|NCT00932477|286481|P4|STARTED|Treatment 3||7
124199|NCT00932477|286482|P3|STARTED|Treatment 3||9
124200|NCT00932477|286483|P2|STARTED|Treatment 3||8
124201|NCT00932477|286484|P1|STARTED|Treatment 3||7
124202|NCT00932477|286479|P6|NOT COMPLETED|Treatment 2||0
124203|NCT00932477|286480|P5|NOT COMPLETED|Treatment 2||0
124204|NCT00932477|286481|P4|NOT COMPLETED|Treatment 2||0
124205|NCT00932477|286482|P3|NOT COMPLETED|Treatment 2||0
124206|NCT00932477|286483|P2|NOT COMPLETED|Treatment 2||0
124207|NCT00932477|286484|P1|NOT COMPLETED|Treatment 2||0
124208|NCT00932477|286479|P6|COMPLETED|Treatment 2||8
124209|NCT00932477|286480|P5|COMPLETED|Treatment 2||8
124210|NCT00932477|286481|P4|COMPLETED|Treatment 2||7
124211|NCT00932477|286482|P3|COMPLETED|Treatment 2||9
124212|NCT00932477|286483|P2|COMPLETED|Treatment 2||8
124213|NCT00932477|286484|P1|COMPLETED|Treatment 2||7
124214|NCT00932477|286479|P6|STARTED|Treatment 2||8
124215|NCT00932477|286480|P5|STARTED|Treatment 2||8
124216|NCT00932477|286481|P4|STARTED|Treatment 2||7
124217|NCT00932477|286482|P3|STARTED|Treatment 2||9
124218|NCT00932477|286483|P2|STARTED|Treatment 2||8
124219|NCT00932477|286484|P1|STARTED|Treatment 2||7
124220|NCT00932477|286479|P6|NOT COMPLETED|Treatment 1||0
124221|NCT00932477|286480|P5|NOT COMPLETED|Treatment 1||0
124222|NCT00932477|286481|P4|NOT COMPLETED|Treatment 1||0
124223|NCT00932477|286482|P3|NOT COMPLETED|Treatment 1||0
124224|NCT00932477|286483|P2|NOT COMPLETED|Treatment 1||0
124225|NCT00932477|286484|P1|NOT COMPLETED|Treatment 1||0
124226|NCT00932477|286479|P6|COMPLETED|Treatment 1||8
124227|NCT00932477|286480|P5|COMPLETED|Treatment 1||8
124228|NCT00932477|286481|P4|COMPLETED|Treatment 1||7
124229|NCT00932477|286482|P3|COMPLETED|Treatment 1||9
124230|NCT00932477|286483|P2|COMPLETED|Treatment 1||8
124231|NCT00932477|286484|P1|COMPLETED|Treatment 1||7
124232|NCT00932477|286479|P6|STARTED|Treatment 1||8
124233|NCT00932477|286480|P5|STARTED|Treatment 1||8
124234|NCT00932477|286481|P4|STARTED|Treatment 1||7
124235|NCT00932477|286482|P3|STARTED|Treatment 1||9
124236|NCT00932477|286483|P2|STARTED|Treatment 1||8
124237|NCT00932477|286484|P1|STARTED|Treatment 1||7
124238|NCT00932451|286501|P1|NOT COMPLETED|Overall Study||822
124239|NCT00932451|286501|P1|COMPLETED|Overall Study||244
124240|NCT00932451|286501|P1|STARTED|Overall Study||1066
124241|NCT00932425|286525|P2|NOT COMPLETED|Overall Study||2
124242|NCT00932425|286526|P1|NOT COMPLETED|Overall Study||0
124243|NCT00932425|286525|P2|COMPLETED|Overall Study||18
124244|NCT00932425|286526|P1|COMPLETED|Overall Study||20
124245|NCT00932425|286525|P2|STARTED|Overall Study||20
124246|NCT00932425|286526|P1|STARTED|Overall Study||20
124247|NCT00932399|286541|P2|NOT COMPLETED|Overall Study||0
124248|NCT00932399|286542|P1|NOT COMPLETED|Overall Study||0
124249|NCT00932399|286541|P2|COMPLETED|Overall Study||3790
124250|NCT00932399|286542|P1|COMPLETED|Overall Study||759
124251|NCT00932399|286541|P2|STARTED|Overall Study||3790
124252|NCT00932399|286542|P1|STARTED|Overall Study||759
124253|NCT00932373|286559|P11|NOT COMPLETED|Overall Study||3
124254|NCT00932373|286560|P10|NOT COMPLETED|Overall Study||13
124255|NCT00932373|286561|P9|NOT COMPLETED|Overall Study||2
124256|NCT00932373|286562|P8|NOT COMPLETED|Overall Study||3
124257|NCT00932373|286563|P7|NOT COMPLETED|Overall Study||1
124258|NCT00932373|286564|P6|NOT COMPLETED|Overall Study||3
124259|NCT00932373|286565|P5|NOT COMPLETED|Overall Study||14
124260|NCT00932373|286566|P4|NOT COMPLETED|Overall Study||0
124261|NCT00932373|286567|P3|NOT COMPLETED|Overall Study||1
124262|NCT00932373|286568|P2|NOT COMPLETED|Overall Study||1
124263|NCT00932373|286569|P1|NOT COMPLETED|Overall Study||3
124264|NCT00932373|286559|P11|COMPLETED|Overall Study||0
124265|NCT00932373|286560|P10|COMPLETED|Overall Study||3
124266|NCT00932373|286561|P9|COMPLETED|Overall Study||1
124267|NCT00932373|286562|P8|COMPLETED|Overall Study||0
124268|NCT00932373|286563|P7|COMPLETED|Overall Study||2
124269|NCT00932373|286564|P6|COMPLETED|Overall Study||0
124270|NCT00932373|286565|P5|COMPLETED|Overall Study||1
124271|NCT00932373|286566|P4|COMPLETED|Overall Study||1
124272|NCT00932373|286567|P3|COMPLETED|Overall Study||0
124273|NCT00932373|286568|P2|COMPLETED|Overall Study||0
124274|NCT00932373|286569|P1|COMPLETED|Overall Study||0
124275|NCT00932373|286559|P11|STARTED|Overall Study||3
124276|NCT00932373|286560|P10|STARTED|Overall Study||16
124277|NCT00932373|286561|P9|STARTED|Overall Study||3
124278|NCT00932373|286562|P8|STARTED|Overall Study||3
124279|NCT00932373|286563|P7|STARTED|Overall Study||3
124280|NCT00932373|286564|P6|STARTED|Overall Study||3
124281|NCT00932373|286565|P5|STARTED|Overall Study||15
124282|NCT00932373|286566|P4|STARTED|Overall Study||1
124283|NCT00932373|286567|P3|STARTED|Overall Study||1
124284|NCT00932373|286568|P2|STARTED|Overall Study||1
124285|NCT00932373|286569|P1|STARTED|Overall Study||3
124286|NCT00932321|286671|P2|NOT COMPLETED|Overall Study||46
124287|NCT00932321|286672|P1|NOT COMPLETED|Overall Study||171
124288|NCT00932321|286671|P2|COMPLETED|Overall Study||141
124289|NCT00932321|286672|P1|COMPLETED|Overall Study||580
124290|NCT00932321|286671|P2|MITT Population|Overall Study||181
124291|NCT00932321|286672|P1|MITT Population|Overall Study||705
124292|NCT00932321|286671|P2|STARTED|Overall Study||187
124293|NCT00932321|286672|P1|STARTED|Overall Study||751
124294|NCT00932165|286680|P1|NOT COMPLETED|Overall Study||1
124295|NCT00932165|286680|P1|COMPLETED|Overall Study||450
124296|NCT00932165|286680|P1|STARTED|Overall Study||451
124297|NCT00932152|286693|P2|NOT COMPLETED|Overall Study||2
124298|NCT00932152|286694|P1|NOT COMPLETED|Overall Study||1
124299|NCT00932152|286693|P2|COMPLETED|Overall Study||0
124300|NCT00932152|286694|P1|COMPLETED|Overall Study||0
124301|NCT00932152|286693|P2|STARTED|Overall Study||2
124302|NCT00932152|286694|P1|STARTED|Overall Study||1
124303|NCT00932126|286698|P8|NOT COMPLETED|Overall Study||10
124304|NCT00932126|286699|P7|NOT COMPLETED|Overall Study||5
124305|NCT00932126|286700|P6|NOT COMPLETED|Overall Study||3
124306|NCT00932126|286701|P5|NOT COMPLETED|Overall Study||5
124307|NCT00932126|286702|P4|NOT COMPLETED|Overall Study||3
124308|NCT00932126|286703|P3|NOT COMPLETED|Overall Study||3
124309|NCT00932126|286704|P2|NOT COMPLETED|Overall Study||3
124310|NCT00932126|286705|P1|NOT COMPLETED|Overall Study||3
124311|NCT00932126|286698|P8|COMPLETED|Overall Study||0
124312|NCT00932126|286699|P7|COMPLETED|Overall Study||0
124313|NCT00932126|286700|P6|COMPLETED|Overall Study||0
124314|NCT00932126|286701|P5|COMPLETED|Overall Study||0
124315|NCT00932126|286702|P4|COMPLETED|Overall Study||0
124316|NCT00932126|286703|P3|COMPLETED|Overall Study||0
124317|NCT00932126|286704|P2|COMPLETED|Overall Study||0
124318|NCT00932126|286705|P1|COMPLETED|Overall Study||0
124319|NCT00932126|286698|P8|STARTED|Overall Study||10
124320|NCT00932126|286699|P7|STARTED|Overall Study||5
124321|NCT00932126|286700|P6|STARTED|Overall Study||3
124322|NCT00932126|286701|P5|STARTED|Overall Study||5
124323|NCT00932126|286702|P4|STARTED|Overall Study||3
124324|NCT00932126|286703|P3|STARTED|Overall Study||3
124325|NCT00932126|286704|P2|STARTED|Overall Study||3
124326|NCT00932126|286705|P1|STARTED|Overall Study||3
124327|NCT00932022|286743|P2|NOT COMPLETED|Overall Study||4
124328|NCT00932022|286744|P1|NOT COMPLETED|Overall Study||5
124329|NCT00932022|286743|P2|COMPLETED|Overall Study||59
124330|NCT00932022|286744|P1|COMPLETED|Overall Study||59
124331|NCT00932022|286743|P2|STARTED|Overall Study||63
124332|NCT00932022|286744|P1|STARTED|Overall Study||64
124333|NCT00931996|286758|P1|NOT COMPLETED|Overall Study||7
124334|NCT00931996|286758|P1|COMPLETED|Overall Study||5
124335|NCT00931996|286758|P1|STARTED|Overall Study||12
124336|NCT00931918|286764|P2|NOT COMPLETED|Overall Study||17
124337|NCT00931918|286765|P1|NOT COMPLETED|Overall Study||17
124338|NCT00931918|286764|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
124339|NCT00931918|286765|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
124340|NCT00931918|286764|P2|Safety Population: Received Study Drug|Overall Study||101
124341|NCT00931918|286765|P1|Safety Population: Received Study Drug|Overall Study||100
124342|NCT00931918|286764|P2|STARTED|Overall Study||103
124343|NCT00931918|286765|P1|STARTED|Overall Study||103
124344|NCT00931801|286792|P3|NOT COMPLETED|Overall Study||4
124345|NCT00931801|286793|P2|NOT COMPLETED|Overall Study||1
124346|NCT00931801|286794|P1|NOT COMPLETED|Overall Study||1
124347|NCT00931801|286792|P3|COMPLETED|Overall Study||10
124348|NCT00931801|286793|P2|COMPLETED|Overall Study||14
124349|NCT00931801|286794|P1|COMPLETED|Overall Study||13
124350|NCT00931801|286792|P3|STARTED|Overall Study||14
124351|NCT00931801|286793|P2|STARTED|Overall Study||15
124352|NCT00931801|286794|P1|STARTED|Overall Study||14
124353|NCT00931723|286817|P2|NOT COMPLETED|Overall Study||39
124354|NCT00931723|286818|P1|NOT COMPLETED|Overall Study||26
124355|NCT00931723|286817|P2|COMPLETED|Overall Study||144
124356|NCT00931723|286818|P1|COMPLETED|Overall Study||147
124357|NCT00931723|286817|P2|STARTED|Overall Study||183
124358|NCT00931723|286818|P1|STARTED|Overall Study||173
124359|NCT00931710|286866|P2|NOT COMPLETED|Overall Study||38
124360|NCT00931710|286867|P1|NOT COMPLETED|Overall Study||34
124361|NCT00931710|286866|P2|COMPLETED|Overall Study||209
124362|NCT00931710|286867|P1|COMPLETED|Overall Study||207
124363|NCT00931710|286866|P2|STARTED|Overall Study||247
124364|NCT00931710|286867|P1|STARTED|Overall Study||241
124365|NCT00931632|286885|P2|NOT COMPLETED|Overall Study||18
124366|NCT00931632|286886|P1|NOT COMPLETED|Overall Study||21
124367|NCT00931632|286885|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
124368|NCT00931632|286886|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
124369|NCT00931632|286885|P2|STARTED|Overall Study|Randomized|222
124370|NCT00931632|286886|P1|STARTED|Overall Study|Randomized|229
124371|NCT00931528|286894|P2|NOT COMPLETED|Overall Study||60
124372|NCT00931528|286895|P1|NOT COMPLETED|Overall Study||41
124373|NCT00931528|286894|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
124374|NCT00931528|286895|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
124375|NCT00931528|286894|P2|STARTED|Overall Study||121
124376|NCT00931528|286895|P1|STARTED|Overall Study||121
124377|NCT00931515|286903|P2|NOT COMPLETED|Overall Study||5
124378|NCT00931515|286904|P1|NOT COMPLETED|Overall Study||2
124379|NCT00931515|286903|P2|COMPLETED|Overall Study||10
124380|NCT00931515|286904|P1|COMPLETED|Overall Study||13
124381|NCT00931515|286903|P2|STARTED|Overall Study||15
124382|NCT00931515|286904|P1|STARTED|Overall Study||15
124383|NCT00931463|286912|P2|NOT COMPLETED|Overall Study||5
124384|NCT00931463|286913|P1|NOT COMPLETED|Overall Study||17
124385|NCT00931463|286912|P2|COMPLETED|Overall Study||265
124386|NCT00931463|286913|P1|COMPLETED|Overall Study||254
124387|NCT00931463|286912|P2|STARTED|Overall Study||270
124388|NCT00931463|286913|P1|STARTED|Overall Study||271
124389|NCT00931411|286929|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
124390|NCT00931411|286930|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
124391|NCT00931411|286929|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
124392|NCT00931411|286930|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
124393|NCT00931411|286929|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
124394|NCT00931411|286930|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
124395|NCT00931411|286929|P2|NOT COMPLETED|First Intervention - 42 Days||3
124396|NCT00931411|286930|P1|NOT COMPLETED|First Intervention - 42 Days||4
124397|NCT00931411|286929|P2|COMPLETED|First Intervention - 42 Days||35
124398|NCT00931411|286930|P1|COMPLETED|First Intervention - 42 Days||31
124399|NCT00931411|286929|P2|STARTED|First Intervention - 42 Days||38
124400|NCT00931411|286930|P1|STARTED|First Intervention - 42 Days||35
124401|NCT00931385|286951|P4|NOT COMPLETED|Overall Study||5
124402|NCT00931385|286952|P3|NOT COMPLETED|Overall Study||1
124403|NCT00931385|286953|P2|NOT COMPLETED|Overall Study||2
124404|NCT00931385|286954|P1|NOT COMPLETED|Overall Study||2
124405|NCT00931385|286951|P4|COMPLETED|Overall Study||21
124406|NCT00931385|286952|P3|COMPLETED|Overall Study||24
124407|NCT00931385|286953|P2|COMPLETED|Overall Study||21
124408|NCT00931385|286954|P1|COMPLETED|Overall Study||23
124409|NCT00931385|286951|P4|STARTED|Overall Study||26
124410|NCT00931385|286952|P3|STARTED|Overall Study||25
124411|NCT00931385|286953|P2|STARTED|Overall Study||23
124412|NCT00931385|286954|P1|STARTED|Overall Study||25
124413|NCT00931359|287010|P2|NOT COMPLETED|Overall Study||13
124414|NCT00931359|287011|P1|NOT COMPLETED|Overall Study||6
124415|NCT00931359|287010|P2|COMPLETED|Overall Study||68
124416|NCT00931359|287011|P1|COMPLETED|Overall Study||33
124417|NCT00931359|287010|P2|STARTED|Overall Study||81
124418|NCT00931359|287011|P1|STARTED|Overall Study||39
124419|NCT00931307|287023|P1|NOT COMPLETED|Overall Study||13
124420|NCT00931307|287023|P1|COMPLETED|Overall Study||9
124421|NCT00931307|287023|P1|STARTED|Overall Study||22
124422|NCT00931268|287027|P1|NOT COMPLETED|Overall Study||6
124423|NCT00931268|287027|P1|COMPLETED|Overall Study||4
124424|NCT00931268|287027|P1|STARTED|Overall Study||10
124425|NCT00931242|287039|P2|NOT COMPLETED|Overall Study||2
124426|NCT00931242|287040|P1|NOT COMPLETED|Overall Study||5
124427|NCT00931242|287039|P2|COMPLETED|Overall Study||0
124428|NCT00931242|287040|P1|COMPLETED|Overall Study||5
124429|NCT00931242|287039|P2|STARTED|Overall Study||2
124430|NCT00931242|287040|P1|STARTED|Overall Study||10
124431|NCT00931164|287046|P1|NOT COMPLETED|Overall Study||0
124432|NCT00931164|287046|P1|COMPLETED|Overall Study||6
124433|NCT00931164|287046|P1|STARTED|Overall Study||6
124434|NCT00930982|287052|P2|NOT COMPLETED|Overall Study||29
124435|NCT00930982|287053|P1|NOT COMPLETED|Overall Study||21
124436|NCT00930982|287052|P2|COMPLETED|Overall Study||35
124437|NCT00930982|287053|P1|COMPLETED|Overall Study||39
124438|NCT00930982|287052|P2|STARTED|Overall Study||64
124439|NCT00930982|287053|P1|STARTED|Overall Study||60
124440|NCT00930969|287087|P1|NOT COMPLETED|Overall Study||38
124441|NCT00930969|287087|P1|COMPLETED|Overall Study||137
124442|NCT00930969|287087|P1|STARTED|Overall Study||175
124443|NCT00930930|287097|P2|NOT COMPLETED|Overall Study||9
124444|NCT00930930|287098|P1|NOT COMPLETED|Overall Study||21
124445|NCT00930930|287097|P2|COMPLETED|Overall Study||40
124446|NCT00930930|287098|P1|COMPLETED|Overall Study||75
124447|NCT00930930|287097|P2|STARTED|Overall Study||49
124448|NCT00930930|287098|P1|STARTED|Overall Study||96
124449|NCT00930813|287112|P2|NOT COMPLETED|Overall Study||14
124450|NCT00930813|287113|P1|NOT COMPLETED|Overall Study||8
124451|NCT00930813|287112|P2|COMPLETED|Overall Study||38
124452|NCT00930813|287113|P1|COMPLETED|Overall Study||41
124453|NCT00930813|287112|P2|STARTED|Overall Study||52
124454|NCT00930813|287113|P1|STARTED|Overall Study||49
124455|NCT00930787|287123|P2|NOT COMPLETED|Overall Study||0
124456|NCT00930787|287124|P1|NOT COMPLETED|Overall Study||0
124457|NCT00930787|287123|P2|COMPLETED|Overall Study||9
124458|NCT00930787|287124|P1|COMPLETED|Overall Study||14
124459|NCT00930787|287123|P2|STARTED|Overall Study||9
124460|NCT00930787|287124|P1|STARTED|Overall Study||14
124461|NCT00930774|287134|P4|NOT COMPLETED|Overall Study||0
124462|NCT00930774|287135|P3|NOT COMPLETED|Overall Study||2
124463|NCT00930774|287136|P2|NOT COMPLETED|Overall Study||9
124464|NCT00930774|287137|P1|NOT COMPLETED|Overall Study||1
124465|NCT00930774|287134|P4|COMPLETED|Overall Study||25
124466|NCT00930774|287135|P3|COMPLETED|Overall Study||22
124467|NCT00930774|287136|P2|COMPLETED|Overall Study||16
124468|NCT00930774|287137|P1|COMPLETED|Overall Study||24
124469|NCT00930774|287134|P4|STARTED|Overall Study||25
124470|NCT00930774|287135|P3|STARTED|Overall Study||24
124471|NCT00930774|287136|P2|STARTED|Overall Study||25
124472|NCT00930774|287137|P1|STARTED|Overall Study||25
124473|NCT00930761|287177|P2|NOT COMPLETED|Overall Study||3
124474|NCT00930761|287178|P1|NOT COMPLETED|Overall Study||4
124475|NCT00930761|287177|P2|COMPLETED|Overall Study||48
124476|NCT00930761|287178|P1|COMPLETED|Overall Study||46
124477|NCT00930761|287177|P2|STARTED|Overall Study||51
124478|NCT00930761|287178|P1|STARTED|Overall Study||50
124479|NCT00930722|287190|P1|NOT COMPLETED|Overall Study||27
124480|NCT00930722|287190|P1|COMPLETED|Overall Study||302
124481|NCT00930722|287190|P1|STARTED|Overall Study||329
124482|NCT00930644|287205|P1|NOT COMPLETED|Overall Study||23
124483|NCT00930644|287205|P1|COMPLETED|Overall Study||65
124484|NCT00930644|287205|P1|STARTED|Overall Study||88
124485|NCT00930293|287220|P2|NOT COMPLETED|Overall Study||7
124486|NCT00930293|287221|P1|NOT COMPLETED|Overall Study||7
124487|NCT00930293|287220|P2|COMPLETED|Overall Study||19
124488|NCT00930293|287221|P1|COMPLETED|Overall Study||17
124489|NCT00930293|287220|P2|STARTED|Overall Study||26
124490|NCT00930293|287221|P1|STARTED|Overall Study||24
124491|NCT00930176|287229|P1|NOT COMPLETED|Overall Study||1
124492|NCT00930176|287229|P1|COMPLETED|Overall Study||15
124493|NCT00930176|287229|P1|STARTED|Overall Study||16
124494|NCT00929981|287234|P1|NOT COMPLETED|Overall Study||0
124495|NCT00929981|287234|P1|COMPLETED|Overall Study||80
124496|NCT00929981|287234|P1|STARTED|Overall Study||80
124497|NCT00929864|287246|P2|NOT COMPLETED|Overall Study||83
124498|NCT00929864|287247|P1|NOT COMPLETED|Overall Study||66
124499|NCT00929864|287246|P2|COMPLETED|Overall Study||245
124500|NCT00929864|287247|P1|COMPLETED|Overall Study||252
124501|NCT00929864|287246|P2|STARTED|Overall Study||328
124502|NCT00929864|287247|P1|STARTED|Overall Study||318
124503|NCT00929773|287267|P2|NOT COMPLETED|Overall Study||0
124504|NCT00929773|287268|P1|NOT COMPLETED|Overall Study||0
124505|NCT00929773|287267|P2|COMPLETED|Overall Study||50
124506|NCT00929773|287268|P1|COMPLETED|Overall Study||50
124507|NCT00929773|287267|P2|STARTED|Overall Study||50
124508|NCT00929773|287268|P1|STARTED|Overall Study||50
124509|NCT00929734|287286|P2|NOT COMPLETED|Overall Study||3
124510|NCT00929734|287287|P1|NOT COMPLETED|Overall Study||2
124511|NCT00929734|287286|P2|COMPLETED|Overall Study||47
124512|NCT00929734|287287|P1|COMPLETED|Overall Study||47
124513|NCT00929734|287286|P2|STARTED|Overall Study||50
124514|NCT00929734|287287|P1|STARTED|Overall Study||49
124515|NCT00929708|287304|P5|NOT COMPLETED|Overall Study||6
124516|NCT00929708|287305|P4|NOT COMPLETED|Overall Study||6
124517|NCT00929708|287306|P3|NOT COMPLETED|Overall Study||3
124518|NCT00929708|287307|P2|NOT COMPLETED|Overall Study||3
124519|NCT00929708|287308|P1|NOT COMPLETED|Overall Study||4
124520|NCT00929708|287304|P5|COMPLETED|Overall Study||57
124521|NCT00929708|287305|P4|COMPLETED|Overall Study||61
124522|NCT00929708|287306|P3|COMPLETED|Overall Study||62
124523|NCT00929708|287307|P2|COMPLETED|Overall Study||66
124524|NCT00929708|287308|P1|COMPLETED|Overall Study||61
124525|NCT00929708|287304|P5|STARTED|Overall Study||63
124526|NCT00929708|287305|P4|STARTED|Overall Study||67
124527|NCT00929708|287306|P3|STARTED|Overall Study||65
124528|NCT00929708|287307|P2|STARTED|Overall Study||69
124529|NCT00929708|287308|P1|STARTED|Overall Study||65
124530|NCT00929695|287362|P2|NOT COMPLETED|Overall Study||6
124531|NCT00929695|287363|P1|NOT COMPLETED|Overall Study||8
124532|NCT00929695|287362|P2|COMPLETED|Overall Study||77
124533|NCT00929695|287363|P1|COMPLETED|Overall Study||73
124534|NCT00929695|287362|P2|STARTED|Overall Study||83
124535|NCT00929695|287363|P1|STARTED|Overall Study||81
124536|NCT00929643|287393|P1|NOT COMPLETED|Overall Study||2
124537|NCT00929643|287393|P1|COMPLETED|Overall Study||201
124538|NCT00929643|287393|P1|STARTED|Overall Study||203
124539|NCT00929578|287402|P1|NOT COMPLETED|Overall Study||0
124540|NCT00929578|287402|P1|COMPLETED|Overall Study||15
124541|NCT00929578|287402|P1|STARTED|Overall Study||15
124542|NCT00929526|287415|P2|NOT COMPLETED|Overall Study||29
124543|NCT00929526|287416|P1|NOT COMPLETED|Overall Study||17
124544|NCT00929526|287415|P2|COMPLETED|Overall Study||348
124545|NCT00929526|287416|P1|COMPLETED|Overall Study||358
124546|NCT00929526|287415|P2|STARTED|Overall Study||377
124547|NCT00929526|287416|P1|STARTED|Overall Study||375
124548|NCT00929474|287452|P2|NOT COMPLETED|Overall Study||9
124549|NCT00929474|287453|P1|NOT COMPLETED|Overall Study||8
124550|NCT00929474|287452|P2|COMPLETED|Overall Study||0
124551|NCT00929474|287453|P1|COMPLETED|Overall Study||0
124552|NCT00929474|287452|P2|STARTED|Overall Study||9
124553|NCT00929474|287453|P1|STARTED|Overall Study||8
124554|NCT00929383|287459|P1|NOT COMPLETED|Overall Study||15
124555|NCT00929383|287459|P1|COMPLETED|Overall Study||67
124556|NCT00929383|287459|P1|STARTED|Overall Study||82
124557|NCT00929357|287469|P2|NOT COMPLETED|Overall Study||0
124558|NCT00929357|287470|P1|NOT COMPLETED|Overall Study||0
124559|NCT00929357|287469|P2|COMPLETED|Overall Study||64
124560|NCT00929357|287470|P1|COMPLETED|Overall Study||92
124561|NCT00929357|287469|P2|STARTED|Overall Study||64
124562|NCT00929357|287470|P1|STARTED|Overall Study||92
124563|NCT00929331|287492|P2|NOT COMPLETED|Overall Study||0
124564|NCT00929331|287493|P1|NOT COMPLETED|Overall Study||0
124565|NCT00929331|287492|P2|COMPLETED|Overall Study||55
124566|NCT00929331|287493|P1|COMPLETED|Overall Study||55
124567|NCT00929331|287492|P2|STARTED|Overall Study||55
124568|NCT00929331|287493|P1|STARTED|Overall Study||55
124569|NCT00929305|287527|P2|NOT COMPLETED|Overall Study||0
124570|NCT00929305|287528|P1|NOT COMPLETED|Overall Study||0
124571|NCT00929305|287527|P2|COMPLETED|Overall Study||43
124572|NCT00929305|287528|P1|COMPLETED|Overall Study||43
124573|NCT00929305|287527|P2|STARTED|Overall Study||43
124574|NCT00929305|287528|P1|STARTED|Overall Study||43
124575|NCT00929240|287536|P3|NOT COMPLETED|Maintenance Phase||91
124576|NCT00929240|287537|P2|NOT COMPLETED|Maintenance Phase||94
124577|NCT00929240|287538|P1|NOT COMPLETED|Maintenance Phase||0
124578|NCT00929240|287536|P3|COMPLETED|Maintenance Phase||0
124579|NCT00929240|287537|P2|COMPLETED|Maintenance Phase||0
124580|NCT00929240|287538|P1|COMPLETED|Maintenance Phase||0
124581|NCT00929240|287536|P3|STARTED|Maintenance Phase||91
124582|NCT00929240|287537|P2|STARTED|Maintenance Phase||94
124583|NCT00929240|287538|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
124584|NCT00929240|287536|P3|NOT COMPLETED|Initial Treatment Phase||0
124585|NCT00929240|287537|P2|NOT COMPLETED|Initial Treatment Phase||0
124586|NCT00929240|287538|P1|NOT COMPLETED|Initial Treatment Phase||99
124587|NCT00929240|287536|P3|COMPLETED|Initial Treatment Phase||0
124588|NCT00929240|287537|P2|COMPLETED|Initial Treatment Phase||0
124589|NCT00929240|287538|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
124590|NCT00929240|287536|P3|STARTED|Initial Treatment Phase||0
124591|NCT00929240|287537|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
124592|NCT00929240|287538|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
124593|NCT00929201|287565|P2|NOT COMPLETED|Period 2||0
124594|NCT00929201|287566|P1|NOT COMPLETED|Period 2||0
124595|NCT00929201|287565|P2|COMPLETED|Period 2||30
124596|NCT00929201|287566|P1|COMPLETED|Period 2||30
124597|NCT00929201|287565|P2|STARTED|Period 2||30
124598|NCT00929201|287566|P1|STARTED|Period 2||30
124599|NCT00929201|287565|P2|NOT COMPLETED|7-day Washout||0
124600|NCT00929201|287566|P1|NOT COMPLETED|7-day Washout||0
124601|NCT00929201|287565|P2|COMPLETED|7-day Washout||30
124602|NCT00929201|287566|P1|COMPLETED|7-day Washout||30
124603|NCT00929201|287565|P2|STARTED|7-day Washout||30
124604|NCT00929201|287566|P1|STARTED|7-day Washout||30
124605|NCT00929201|287565|P2|NOT COMPLETED|Period 1||1
124606|NCT00929201|287566|P1|NOT COMPLETED|Period 1||0
124607|NCT00929201|287565|P2|COMPLETED|Period 1||30
124608|NCT00929201|287566|P1|COMPLETED|Period 1||30
124609|NCT00929201|287565|P2|STARTED|Period 1||31
124610|NCT00929201|287566|P1|STARTED|Period 1||30
124611|NCT00929162|287576|P2|NOT COMPLETED|Overall Study||42
124612|NCT00929162|287577|P1|NOT COMPLETED|Overall Study||48
124613|NCT00929162|287576|P2|COMPLETED|Overall Study||19
124614|NCT00929162|287577|P1|COMPLETED|Overall Study||11
124615|NCT00929162|287576|P2|Patients Who Received Treatment|Overall Study||58
124616|NCT00929162|287577|P1|Patients Who Received Treatment|Overall Study||58
124617|NCT00929162|287576|P2|STARTED|Overall Study||61
124618|NCT00929162|287577|P1|STARTED|Overall Study||59
124619|NCT00929110|287590|P3|NOT COMPLETED|Overall Study||62
124620|NCT00929110|287591|P2|NOT COMPLETED|Overall Study||76
124621|NCT00929110|287592|P1|NOT COMPLETED|Overall Study||118
124622|NCT00929110|287590|P3|COMPLETED|Overall Study||206
124623|NCT00929110|287591|P2|COMPLETED|Overall Study||193
124624|NCT00929110|287592|P1|COMPLETED|Overall Study||411
124625|NCT00929110|287590|P3|STARTED|Overall Study||268
124626|NCT00929110|287591|P2|STARTED|Overall Study||269
124627|NCT00929110|287592|P1|STARTED|Overall Study||529
124628|NCT00929071|287657|P1|NOT COMPLETED|Overall Study||0
124629|NCT00929071|287657|P1|COMPLETED|Overall Study||10
124630|NCT00929071|287657|P1|STARTED|Overall Study||10
124631|NCT00928954|287664|P2|NOT COMPLETED|Overall Study||0
124632|NCT00928954|287665|P1|NOT COMPLETED|Overall Study||0
124633|NCT00928954|287664|P2|COMPLETED|Overall Study||6
124634|NCT00928954|287665|P1|COMPLETED|Overall Study||4
124635|NCT00928954|287664|P2|STARTED|Overall Study||6
124636|NCT00928954|287665|P1|STARTED|Overall Study||4
124637|NCT00928889|287675|P2|NOT COMPLETED|Overall Study||2
124638|NCT00928889|287676|P1|NOT COMPLETED|Overall Study||5
124639|NCT00928889|287675|P2|COMPLETED|Overall Study||78
124640|NCT00928889|287676|P1|COMPLETED|Overall Study||75
124641|NCT00928889|287675|P2|STARTED|Overall Study||80
124642|NCT00928889|287676|P1|STARTED|Overall Study||80
124643|NCT00928746|287700|P1|NOT COMPLETED|Overall Study||6
124644|NCT00928746|287700|P1|COMPLETED|Overall Study||136
124645|NCT00928746|287700|P1|STARTED|Overall Study||142
124646|NCT00928720|287723|P3|NOT COMPLETED|Overall Study||3
124647|NCT00928720|287724|P2|NOT COMPLETED|Overall Study||6
124648|NCT00928720|287725|P1|NOT COMPLETED|Overall Study||2
124649|NCT00928720|287723|P3|COMPLETED|Overall Study||15
124650|NCT00928720|287724|P2|COMPLETED|Overall Study||14
124651|NCT00928720|287725|P1|COMPLETED|Overall Study||17
124652|NCT00928720|287723|P3|STARTED|Overall Study||18
124653|NCT00928720|287724|P2|STARTED|Overall Study||20
124654|NCT00928720|287725|P1|STARTED|Overall Study||19
124655|NCT00928694|287733|P2|NOT COMPLETED|Second Intervention||0
124656|NCT00928694|287734|P1|NOT COMPLETED|Second Intervention||0
124657|NCT00928694|287733|P2|COMPLETED|Second Intervention||7
124658|NCT00928694|287734|P1|COMPLETED|Second Intervention||7
124659|NCT00928694|287733|P2|STARTED|Second Intervention||7
124660|NCT00928694|287734|P1|STARTED|Second Intervention||7
124661|NCT00928694|287733|P2|NOT COMPLETED|First Intervention||0
124662|NCT00928694|287734|P1|NOT COMPLETED|First Intervention||0
124663|NCT00928694|287733|P2|COMPLETED|First Intervention||7
124664|NCT00928694|287734|P1|COMPLETED|First Intervention||7
124665|NCT00928694|287733|P2|STARTED|First Intervention||7
124666|NCT00928694|287734|P1|STARTED|First Intervention||7
124667|NCT00928668|287742|P5|NOT COMPLETED|Overall Study||1
124668|NCT00928668|287743|P4|NOT COMPLETED|Overall Study||1
124669|NCT00928668|287744|P3|NOT COMPLETED|Overall Study||1
124670|NCT00928668|287745|P2|NOT COMPLETED|Overall Study||1
124671|NCT00928668|287746|P1|NOT COMPLETED|Overall Study||1
124672|NCT00928668|287742|P5|COMPLETED|Overall Study||5
124673|NCT00928668|287743|P4|COMPLETED|Overall Study||3
124674|NCT00928668|287744|P3|COMPLETED|Overall Study||6
124675|NCT00928668|287745|P2|COMPLETED|Overall Study||6
124676|NCT00928668|287746|P1|COMPLETED|Overall Study||6
124677|NCT00928668|287742|P5|STARTED|Overall Study||6
124678|NCT00928668|287743|P4|STARTED|Overall Study||4
124679|NCT00928668|287744|P3|STARTED|Overall Study||7
124680|NCT00928668|287745|P2|STARTED|Overall Study||7
124681|NCT00928668|287746|P1|STARTED|Overall Study||7
124682|NCT00928642|287788|P1|NOT COMPLETED|Overall Study||0
124683|NCT00928642|287788|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
124684|NCT00928642|287788|P1|STARTED|Overall Study||8
124685|NCT00928512|287802|P5|NOT COMPLETED|Overall Study||15
124686|NCT00928512|287803|P4|NOT COMPLETED|Overall Study||21
124687|NCT00928512|287804|P3|NOT COMPLETED|Overall Study||11
124688|NCT00928512|287805|P2|NOT COMPLETED|Overall Study||6
124689|NCT00928512|287806|P1|NOT COMPLETED|Overall Study||10
124690|NCT00928512|287802|P5|COMPLETED|Overall Study||35
124691|NCT00928512|287803|P4|COMPLETED|Overall Study||33
124692|NCT00928512|287804|P3|COMPLETED|Overall Study||38
124693|NCT00928512|287805|P2|COMPLETED|Overall Study||37
124694|NCT00928512|287806|P1|COMPLETED|Overall Study||31
124695|NCT00928512|287802|P5|Entered/Continued to Week 20 (All)|Overall Study||45
124696|NCT00928512|287803|P4|Entered/Continued to Week 20 (All)|Overall Study||45
124697|NCT00928512|287804|P3|Entered/Continued to Week 20 (All)|Overall Study||46
124698|NCT00928512|287805|P2|Entered/Continued to Week 20 (All)|Overall Study||43
124699|NCT00928512|287806|P1|Entered/Continued to Week 20 (All)|Overall Study||37
124700|NCT00928512|287802|P5|Completed Week 16|Overall Study||45
124701|NCT00928512|287803|P4|Completed Week 16|Overall Study||48
124702|NCT00928512|287804|P3|Completed Week 16|Overall Study||47
124703|NCT00928512|287805|P2|Completed Week 16|Overall Study||43
124704|NCT00928512|287806|P1|Completed Week 16|Overall Study||38
124705|NCT00928512|287802|P5|New Groups After Reassignment|Overall Study||0
124706|NCT00928512|287803|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
124707|NCT00928512|287804|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
124708|NCT00928512|287805|P2|New Groups After Reassignment|Overall Study||115
124709|NCT00928512|287806|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
124710|NCT00928512|287802|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
124711|NCT00928512|287803|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
124712|NCT00928512|287804|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
124713|NCT00928512|287805|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
124714|NCT00928512|287806|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
124715|NCT00928512|287802|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
124716|NCT00928512|287803|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
124717|NCT00928512|287804|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
124718|NCT00928512|287805|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
124719|NCT00928512|287806|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
124720|NCT00928512|287802|P5|Discontinued Prior to Week 16|Overall Study||5
124721|NCT00928512|287803|P4|Discontinued Prior to Week 16|Overall Study||6
124722|NCT00928512|287804|P3|Discontinued Prior to Week 16|Overall Study||2
124723|NCT00928512|287805|P2|Discontinued Prior to Week 16|Overall Study||0
124724|NCT00928512|287806|P1|Discontinued Prior to Week 16|Overall Study||3
124725|NCT00928512|287802|P5|STARTED|Overall Study||50
124726|NCT00928512|287803|P4|STARTED|Overall Study||54
124727|NCT00928512|287804|P3|STARTED|Overall Study||49
124728|NCT00928512|287805|P2|STARTED|Overall Study||43
124729|NCT00928512|287806|P1|STARTED|Overall Study||41
124730|NCT00928486|287907|P1|NOT COMPLETED|Overall Study||10
124731|NCT00928486|287907|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
124732|NCT00928486|287907|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
124733|NCT00928486|287907|P1|STARTED|Overall Study||25
124734|NCT00928434|287916|P3|NOT COMPLETED|Overall Study||44
124735|NCT00928434|287917|P2|NOT COMPLETED|Overall Study||14
124736|NCT00928434|287918|P1|NOT COMPLETED|Overall Study||44
124737|NCT00928434|287916|P3|COMPLETED|Overall Study||134
124738|NCT00928434|287917|P2|COMPLETED|Overall Study||36
124739|NCT00928434|287918|P1|COMPLETED|Overall Study||131
124740|NCT00928434|287916|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
124741|NCT00928434|287917|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
124742|NCT00928434|287918|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
124743|NCT00928434|287916|P3|STARTED|Overall Study|Full Analysis Set Patients|178
124744|NCT00928434|287917|P2|STARTED|Overall Study|Full Analysis Set Patients|50
124745|NCT00928434|287918|P1|STARTED|Overall Study|Full Analysis Set Patients|175
124746|NCT00928421|287990|P1|NOT COMPLETED|Overall Study||0
124747|NCT00928421|287990|P1|COMPLETED|Overall Study||16
124748|NCT00928421|287990|P1|Treated With Study Drug|Overall Study||16
124749|NCT00928421|287990|P1|STARTED|Overall Study||16
124750|NCT00928408|287994|P1|NOT COMPLETED|Overall Study||23
124751|NCT00928408|287994|P1|COMPLETED|Overall Study||282
124752|NCT00928408|287994|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
124753|NCT00928408|287994|P1|STARTED|Overall Study|Number Enrolled|305
124754|NCT00928395|288023|P1|NOT COMPLETED|Overall Study||21
124755|NCT00928395|288023|P1|COMPLETED|Overall Study||29
124756|NCT00928395|288023|P1|STARTED|Overall Study||50
124757|NCT00928304|288027|P2|NOT COMPLETED|Overall Study||0
124758|NCT00928304|288028|P1|NOT COMPLETED|Overall Study||0
124759|NCT00928304|288027|P2|COMPLETED|Overall Study||70
124760|NCT00928304|288028|P1|COMPLETED|Overall Study||39
124761|NCT00928304|288027|P2|STARTED|Overall Study||70
124762|NCT00928304|288028|P1|STARTED|Overall Study||39
124763|NCT00928187|288043|P3|NOT COMPLETED|Overall Study||5
124764|NCT00928187|288044|P2|NOT COMPLETED|Overall Study||6
124765|NCT00928187|288045|P1|NOT COMPLETED|Overall Study||2
124766|NCT00928187|288043|P3|COMPLETED|Overall Study||150
124767|NCT00928187|288044|P2|COMPLETED|Overall Study||141
124768|NCT00928187|288045|P1|COMPLETED|Overall Study||150
124769|NCT00928187|288043|P3|Analysed|Overall Study||154
124770|NCT00928187|288044|P2|Analysed|Overall Study||145
124771|NCT00928187|288045|P1|Analysed|Overall Study||152
124772|NCT00928187|288043|P3|STARTED|Overall Study||155
124773|NCT00928187|288044|P2|STARTED|Overall Study||147
124774|NCT00928187|288045|P1|STARTED|Overall Study||152
124775|NCT00928174|288089|P1|NOT COMPLETED|Overall Study||5
124776|NCT00928174|288089|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
124777|NCT00928174|288089|P1|STARTED|Overall Study||27
124778|NCT00928083|288096|P9|NOT COMPLETED|Overall Study||0
124779|NCT00928083|288097|P8|NOT COMPLETED|Overall Study||0
124780|NCT00928083|288098|P7|NOT COMPLETED|Overall Study||0
124781|NCT00928083|288099|P6|NOT COMPLETED|Overall Study||0
124782|NCT00928083|288100|P5|NOT COMPLETED|Overall Study||1
124783|NCT00928083|288101|P4|NOT COMPLETED|Overall Study||1
124784|NCT00928083|288102|P3|NOT COMPLETED|Overall Study||0
124785|NCT00928083|288103|P2|NOT COMPLETED|Overall Study||0
124786|NCT00928083|288104|P1|NOT COMPLETED|Overall Study||4
124787|NCT00928083|288096|P9|COMPLETED|Overall Study||6
124788|NCT00928083|288097|P8|COMPLETED|Overall Study||6
124789|NCT00928083|288098|P7|COMPLETED|Overall Study||6
124790|NCT00928083|288099|P6|COMPLETED|Overall Study||6
124791|NCT00928083|288100|P5|COMPLETED|Overall Study||6
124792|NCT00928083|288101|P4|COMPLETED|Overall Study||5
124793|NCT00928083|288102|P3|COMPLETED|Overall Study||8
124794|NCT00928083|288103|P2|COMPLETED|Overall Study||8
124795|NCT00928083|288104|P1|COMPLETED|Overall Study||6
124796|NCT00928083|288096|P9|STARTED|Overall Study||6
124797|NCT00928083|288097|P8|STARTED|Overall Study||6
124798|NCT00928083|288098|P7|STARTED|Overall Study||6
124799|NCT00928083|288099|P6|STARTED|Overall Study||6
124800|NCT00928083|288100|P5|STARTED|Overall Study||7
124801|NCT00928083|288101|P4|STARTED|Overall Study||6
124802|NCT00928083|288102|P3|STARTED|Overall Study||8
124803|NCT00928083|288103|P2|STARTED|Overall Study||8
124804|NCT00928083|288104|P1|STARTED|Overall Study||10
124805|NCT00928070|288215|P2|NOT COMPLETED|Overall Study||57
124806|NCT00928070|288216|P1|NOT COMPLETED|Overall Study||63
124807|NCT00928070|288215|P2|COMPLETED|Overall Study||226
124808|NCT00928070|288216|P1|COMPLETED|Overall Study||220
124809|NCT00928070|288215|P2|Treated|Overall Study||281
124810|NCT00928070|288216|P1|Treated|Overall Study||281
124811|NCT00928070|288215|P2|STARTED|Overall Study||283
124812|NCT00928070|288216|P1|STARTED|Overall Study||283
124813|NCT00928057|288274|P2|NOT COMPLETED|Overall Study||4
124814|NCT00928057|288275|P1|NOT COMPLETED|Overall Study||2
124815|NCT00928057|288274|P2|COMPLETED|Overall Study||85
124816|NCT00928057|288275|P1|COMPLETED|Overall Study||82
124817|NCT00928057|288274|P2|STARTED|Overall Study||89
124818|NCT00928057|288275|P1|STARTED|Overall Study||84
124819|NCT00928018|288300|P2|NOT COMPLETED|Overall Study||0
124820|NCT00928018|288301|P1|NOT COMPLETED|Overall Study||1
124821|NCT00928018|288300|P2|COMPLETED|Overall Study||73
124822|NCT00928018|288301|P1|COMPLETED|Overall Study||65
124823|NCT00928018|288300|P2|STARTED|Overall Study||73
124824|NCT00928018|288301|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
124825|NCT00927992|288319|P1|NOT COMPLETED|Overall Study||0
124826|NCT00927992|288319|P1|COMPLETED|Overall Study||11
124827|NCT00927992|288319|P1|STARTED|Overall Study||11
124828|NCT00927953|288331|P2|NOT COMPLETED|Overall Study||1
124829|NCT00927953|288332|P1|NOT COMPLETED|Overall Study||2
124830|NCT00927953|288331|P2|COMPLETED|Overall Study||6
124831|NCT00927953|288332|P1|COMPLETED|Overall Study||4
124832|NCT00927953|288331|P2|STARTED|Overall Study||7
124833|NCT00927953|288332|P1|STARTED|Overall Study||6
124834|NCT00927940|288346|P1|NOT COMPLETED|Overall Study||1
124835|NCT00927940|288346|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
124836|NCT00927940|288346|P1|STARTED|Overall Study||100
124837|NCT00927927|288366|P15|NOT COMPLETED|Overall Study||0
124838|NCT00927927|288367|P14|NOT COMPLETED|Overall Study||0
124839|NCT00927927|288368|P13|NOT COMPLETED|Overall Study||0
124840|NCT00927927|288369|P12|NOT COMPLETED|Overall Study||2
124841|NCT00927927|288370|P11|NOT COMPLETED|Overall Study||0
124842|NCT00927927|288371|P10|NOT COMPLETED|Overall Study||0
124843|NCT00927927|288372|P9|NOT COMPLETED|Overall Study||0
124844|NCT00927927|288373|P8|NOT COMPLETED|Overall Study||2
124845|NCT00927927|288374|P7|NOT COMPLETED|Overall Study||0
124846|NCT00927927|288375|P6|NOT COMPLETED|Overall Study||0
124847|NCT00927927|288376|P5|NOT COMPLETED|Overall Study||0
124848|NCT00927927|288377|P4|NOT COMPLETED|Overall Study||0
124849|NCT00927927|288378|P3|NOT COMPLETED|Overall Study||0
124850|NCT00927927|288379|P2|NOT COMPLETED|Overall Study||0
124851|NCT00927927|288380|P1|NOT COMPLETED|Overall Study||0
124852|NCT00927927|288366|P15|COMPLETED|Overall Study||9
124853|NCT00927927|288367|P14|COMPLETED|Overall Study||5
124854|NCT00927927|288368|P13|COMPLETED|Overall Study||5
124855|NCT00927927|288369|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
124856|NCT00927927|288370|P11|COMPLETED|Overall Study||5
124857|NCT00927927|288371|P10|COMPLETED|Overall Study||3
124858|NCT00927927|288372|P9|COMPLETED|Overall Study||8
124859|NCT00927927|288373|P8|COMPLETED|Overall Study||1
124860|NCT00927927|288374|P7|COMPLETED|Overall Study||3
124861|NCT00927927|288375|P6|COMPLETED|Overall Study||3
124862|NCT00927927|288376|P5|COMPLETED|Overall Study||3
124863|NCT00927927|288377|P4|COMPLETED|Overall Study||3
124864|NCT00927927|288378|P3|COMPLETED|Overall Study||3
124865|NCT00927927|288379|P2|COMPLETED|Overall Study||3
124866|NCT00927927|288380|P1|COMPLETED|Overall Study||3
124867|NCT00927927|288366|P15|Exposed|Overall Study||9
124868|NCT00927927|288367|P14|Exposed|Overall Study||5
124869|NCT00927927|288368|P13|Exposed|Overall Study||5
124870|NCT00927927|288369|P12|Exposed|Overall Study||5
124871|NCT00927927|288370|P11|Exposed|Overall Study||5
124872|NCT00927927|288371|P10|Exposed|Overall Study||3
124873|NCT00927927|288372|P9|Exposed|Overall Study||8
124874|NCT00927927|288373|P8|Exposed|Overall Study||3
124875|NCT00927927|288374|P7|Exposed|Overall Study||3
124876|NCT00927927|288375|P6|Exposed|Overall Study||3
124877|NCT00927927|288376|P5|Exposed|Overall Study||3
124878|NCT00927927|288377|P4|Exposed|Overall Study||3
124879|NCT00927927|288378|P3|Exposed|Overall Study||3
124880|NCT00927927|288379|P2|Exposed|Overall Study||3
124881|NCT00927927|288380|P1|Exposed|Overall Study||3
124882|NCT00927927|288366|P15|STARTED|Overall Study||9
124883|NCT00927927|288367|P14|STARTED|Overall Study||5
124884|NCT00927927|288368|P13|STARTED|Overall Study||5
124885|NCT00927927|288369|P12|STARTED|Overall Study||6
124886|NCT00927927|288370|P11|STARTED|Overall Study||5
124887|NCT00927927|288371|P10|STARTED|Overall Study||3
124888|NCT00927927|288372|P9|STARTED|Overall Study||8
124889|NCT00927927|288373|P8|STARTED|Overall Study||3
124890|NCT00927927|288374|P7|STARTED|Overall Study||3
124891|NCT00927927|288375|P6|STARTED|Overall Study||3
124892|NCT00927927|288376|P5|STARTED|Overall Study||3
124893|NCT00927927|288377|P4|STARTED|Overall Study||3
124894|NCT00927927|288378|P3|STARTED|Overall Study||3
124895|NCT00927927|288379|P2|STARTED|Overall Study||3
124896|NCT00927927|288380|P1|STARTED|Overall Study||3
124897|NCT00927901|288427|P4|NOT COMPLETED|Treatment Period 4||1
124898|NCT00927901|288428|P3|NOT COMPLETED|Treatment Period 4||1
124899|NCT00927901|288429|P2|NOT COMPLETED|Treatment Period 4||0
124900|NCT00927901|288430|P1|NOT COMPLETED|Treatment Period 4||0
124901|NCT00927901|288427|P4|COMPLETED|Treatment Period 4||8
124902|NCT00927901|288428|P3|COMPLETED|Treatment Period 4||5
124903|NCT00927901|288429|P2|COMPLETED|Treatment Period 4||7
124904|NCT00927901|288430|P1|COMPLETED|Treatment Period 4||7
124905|NCT00927901|288427|P4|STARTED|Treatment Period 4||9
124906|NCT00927901|288428|P3|STARTED|Treatment Period 4||6
124907|NCT00927901|288429|P2|STARTED|Treatment Period 4||7
124908|NCT00927901|288430|P1|STARTED|Treatment Period 4||7
124909|NCT00927901|288427|P4|NOT COMPLETED|Treatment Period 3||0
124910|NCT00927901|288428|P3|NOT COMPLETED|Treatment Period 3||0
124911|NCT00927901|288429|P2|NOT COMPLETED|Treatment Period 3||0
124912|NCT00927901|288430|P1|NOT COMPLETED|Treatment Period 3||0
124913|NCT00927901|288427|P4|COMPLETED|Treatment Period 3||9
124914|NCT00927901|288428|P3|COMPLETED|Treatment Period 3||6
124915|NCT00927901|288429|P2|COMPLETED|Treatment Period 3||7
124916|NCT00927901|288430|P1|COMPLETED|Treatment Period 3||7
124917|NCT00927901|288427|P4|STARTED|Treatment Period 3||9
124918|NCT00927901|288428|P3|STARTED|Treatment Period 3||6
124919|NCT00927901|288429|P2|STARTED|Treatment Period 3||7
124920|NCT00927901|288430|P1|STARTED|Treatment Period 3||7
124921|NCT00927901|288427|P4|NOT COMPLETED|Treatment Period 2||0
124922|NCT00927901|288428|P3|NOT COMPLETED|Treatment Period 2||0
124923|NCT00927901|288429|P2|NOT COMPLETED|Treatment Period 2||0
124924|NCT00927901|288430|P1|NOT COMPLETED|Treatment Period 2||0
124925|NCT00927901|288427|P4|COMPLETED|Treatment Period 2||9
124926|NCT00927901|288428|P3|COMPLETED|Treatment Period 2||6
124927|NCT00927901|288429|P2|COMPLETED|Treatment Period 2||7
124928|NCT00927901|288430|P1|COMPLETED|Treatment Period 2||7
124929|NCT00927901|288427|P4|STARTED|Treatment Period 2||9
124930|NCT00927901|288428|P3|STARTED|Treatment Period 2||6
124931|NCT00927901|288429|P2|STARTED|Treatment Period 2||7
124932|NCT00927901|288430|P1|STARTED|Treatment Period 2||7
124933|NCT00927901|288427|P4|NOT COMPLETED|Treatment Period 1||0
124934|NCT00927901|288428|P3|NOT COMPLETED|Treatment Period 1||1
124935|NCT00927901|288429|P2|NOT COMPLETED|Treatment Period 1||0
124936|NCT00927901|288430|P1|NOT COMPLETED|Treatment Period 1||0
124937|NCT00927901|288427|P4|COMPLETED|Treatment Period 1||9
124938|NCT00927901|288428|P3|COMPLETED|Treatment Period 1||6
124939|NCT00927901|288429|P2|COMPLETED|Treatment Period 1||7
124940|NCT00927901|288430|P1|COMPLETED|Treatment Period 1||7
124941|NCT00927901|288427|P4|STARTED|Treatment Period 1||9
124942|NCT00927901|288428|P3|STARTED|Treatment Period 1||7
124943|NCT00927901|288429|P2|STARTED|Treatment Period 1||7
124944|NCT00927901|288430|P1|STARTED|Treatment Period 1||7
124945|NCT00927888|288460|P2|NOT COMPLETED|Overall Study||0
124946|NCT00927888|288461|P1|NOT COMPLETED|Overall Study||0
124947|NCT00927888|288460|P2|COMPLETED|Overall Study||27
124948|NCT00927888|288461|P1|COMPLETED|Overall Study||29
124949|NCT00927888|288460|P2|STARTED|Overall Study||27
124950|NCT00927888|288461|P1|STARTED|Overall Study||29
124951|NCT00927862|288471|P2|NOT COMPLETED|Overall Study||45
124952|NCT00927862|288472|P1|NOT COMPLETED|Overall Study||27
124953|NCT00927862|288471|P2|COMPLETED|Overall Study||1866
124954|NCT00927862|288472|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
124955|NCT00927862|288471|P2|STARTED|Overall Study||1911
124956|NCT00927862|288472|P1|STARTED|Overall Study||504
124957|NCT00927849|288497|P3|NOT COMPLETED|Overall Study||0
124958|NCT00927849|288498|P2|NOT COMPLETED|Overall Study||0
124959|NCT00927849|288499|P1|NOT COMPLETED|Overall Study||0
124960|NCT00927849|288497|P3|COMPLETED|Overall Study||21
124961|NCT00927849|288498|P2|COMPLETED|Overall Study||21
124962|NCT00927849|288499|P1|COMPLETED|Overall Study||21
124963|NCT00927849|288497|P3|STARTED|Overall Study||21
124964|NCT00927849|288498|P2|STARTED|Overall Study||21
124965|NCT00927849|288499|P1|STARTED|Overall Study||21
124966|NCT00927823|288507|P4|NOT COMPLETED|Continuous Dosing Period||5
124967|NCT00927823|288508|P3|NOT COMPLETED|Continuous Dosing Period||26
124968|NCT00927823|288509|P2|NOT COMPLETED|Continuous Dosing Period||3
124969|NCT00927823|288510|P1|NOT COMPLETED|Continuous Dosing Period||3
124970|NCT00927823|288507|P4|COMPLETED|Continuous Dosing Period||0
124971|NCT00927823|288508|P3|COMPLETED|Continuous Dosing Period||0
124972|NCT00927823|288509|P2|COMPLETED|Continuous Dosing Period||0
124973|NCT00927823|288510|P1|COMPLETED|Continuous Dosing Period||0
124974|NCT00927823|288507|P4|Treated|Continuous Dosing Period||5
124975|NCT00927823|288508|P3|Treated|Continuous Dosing Period||23
124976|NCT00927823|288509|P2|Treated|Continuous Dosing Period||3
124977|NCT00927823|288510|P1|Treated|Continuous Dosing Period||3
124978|NCT00927823|288507|P4|STARTED|Continuous Dosing Period||5
124979|NCT00927823|288508|P3|STARTED|Continuous Dosing Period||26
124980|NCT00927823|288509|P2|STARTED|Continuous Dosing Period||3
124981|NCT00927823|288510|P1|STARTED|Continuous Dosing Period||3
124982|NCT00927823|288507|P4|NOT COMPLETED|Lead-In Period||0
124983|NCT00927823|288508|P3|NOT COMPLETED|Lead-In Period||0
124984|NCT00927823|288509|P2|NOT COMPLETED|Lead-In Period||0
124985|NCT00927823|288510|P1|NOT COMPLETED|Lead-In Period||0
124986|NCT00927823|288507|P4|COMPLETED|Lead-In Period||5
124987|NCT00927823|288508|P3|COMPLETED|Lead-In Period||26
124988|NCT00927823|288509|P2|COMPLETED|Lead-In Period||3
124989|NCT00927823|288510|P1|COMPLETED|Lead-In Period||3
124990|NCT00927823|288507|P4|STARTED|Lead-In Period||5
124991|NCT00927823|288508|P3|STARTED|Lead-In Period||26
124992|NCT00927823|288509|P2|STARTED|Lead-In Period||3
124993|NCT00927823|288510|P1|STARTED|Lead-In Period||3
124994|NCT00927758|288574|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
124995|NCT00927758|288575|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
124996|NCT00927758|288576|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
124997|NCT00927758|288577|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
124998|NCT00927758|288578|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
124999|NCT00927758|288579|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
125000|NCT00927758|288574|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
125001|NCT00927758|288575|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
125002|NCT00927758|288576|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
125003|NCT00927758|288577|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
125004|NCT00927758|288578|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
125005|NCT00927758|288579|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
125006|NCT00927758|288574|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
125007|NCT00927758|288575|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
125008|NCT00927758|288576|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
125009|NCT00927758|288577|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
125010|NCT00927758|288578|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
125011|NCT00927758|288579|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
125012|NCT00927758|288574|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
125013|NCT00927758|288575|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
125014|NCT00927758|288576|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
125015|NCT00927758|288577|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
125016|NCT00927758|288578|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
125017|NCT00927758|288579|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
125018|NCT00927758|288574|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
125019|NCT00927758|288575|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
125020|NCT00927758|288576|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
125021|NCT00927758|288577|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
125022|NCT00927758|288578|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
125023|NCT00927758|288579|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
125024|NCT00927758|288574|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
125025|NCT00927758|288575|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
125026|NCT00927758|288576|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
125027|NCT00927758|288577|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
125028|NCT00927758|288578|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
125029|NCT00927758|288579|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
125030|NCT00927758|288574|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
125031|NCT00927758|288575|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
125032|NCT00927758|288576|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
125033|NCT00927758|288577|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
125034|NCT00927758|288578|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
125035|NCT00927758|288579|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
125036|NCT00927758|288574|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
125037|NCT00927758|288575|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
125038|NCT00927758|288576|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
125039|NCT00927758|288577|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
125040|NCT00927758|288578|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
125041|NCT00927758|288579|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
125042|NCT00927758|288574|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
125043|NCT00927758|288575|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
125044|NCT00927758|288576|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
125045|NCT00927758|288577|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
125046|NCT00927758|288578|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
125047|NCT00927758|288579|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
125048|NCT00927758|288574|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
125049|NCT00927758|288575|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
125050|NCT00927758|288576|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
125051|NCT00927758|288577|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
125052|NCT00927758|288578|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
125053|NCT00927758|288579|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
125054|NCT00927758|288574|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
125055|NCT00927758|288575|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
125056|NCT00927758|288576|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
125057|NCT00927758|288577|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
125058|NCT00927758|288578|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
125138|NCT00927095|288858|P3|NOT COMPLETED|Overall Study||2
125059|NCT00927758|288579|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
125060|NCT00927589|288587|P1|NOT COMPLETED|Overall Study||16
125061|NCT00927589|288587|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
125062|NCT00927589|288587|P1|STARTED|Overall Study||59
125063|NCT00927576|288611|P2|NOT COMPLETED|Overall Study||0
125064|NCT00927576|288612|P1|NOT COMPLETED|Overall Study||0
125065|NCT00927576|288611|P2|COMPLETED|Overall Study||28
125066|NCT00927576|288612|P1|COMPLETED|Overall Study||237
125067|NCT00927576|288611|P2|Cognitive Testing|Overall Study||28
125068|NCT00927576|288612|P1|Cognitive Testing|Overall Study||237
125069|NCT00927576|288611|P2|STARTED|Overall Study||28
125070|NCT00927576|288612|P1|STARTED|Overall Study||237
125071|NCT00927563|288617|P1|NOT COMPLETED|Overall Study||2
125072|NCT00927563|288617|P1|COMPLETED|Overall Study||22
125073|NCT00927563|288617|P1|STARTED|Overall Study||24
125074|NCT00927472|288625|P2|NOT COMPLETED|Overall Study||22
125075|NCT00927472|288626|P1|NOT COMPLETED|Overall Study||11
125076|NCT00927472|288625|P2|COMPLETED|Overall Study||106
125077|NCT00927472|288626|P1|COMPLETED|Overall Study||115
125078|NCT00927472|288625|P2|STARTED|Overall Study||128
125079|NCT00927472|288626|P1|STARTED|Overall Study||126
125080|NCT00927394|288652|P2|NOT COMPLETED|Overall Study||85
125081|NCT00927394|288653|P1|NOT COMPLETED|Overall Study||77
125082|NCT00927394|288652|P2|COMPLETED|Overall Study||483
125083|NCT00927394|288653|P1|COMPLETED|Overall Study||498
125084|NCT00927394|288652|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
125085|NCT00927394|288653|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
125086|NCT00927394|288652|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
125087|NCT00927394|288653|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
125088|NCT00927394|288652|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
125089|NCT00927394|288653|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
125090|NCT00927394|288652|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
125091|NCT00927394|288653|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
125092|NCT00927394|288652|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
125093|NCT00927394|288653|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
125094|NCT00927394|288652|P2|Cohort 2 (Randomized)|Overall Study||403
125095|NCT00927394|288653|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
125096|NCT00927394|288652|P2|Cohort 1 (Randomized)|Overall Study||165
125097|NCT00927394|288653|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
125098|NCT00927394|288652|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
125099|NCT00927394|288653|P1|STARTED|Overall Study||575
125100|NCT00927368|288684|P3|NOT COMPLETED|Overall Study||5
125101|NCT00927368|288685|P2|NOT COMPLETED|Overall Study||5
125102|NCT00927368|288686|P1|NOT COMPLETED|Overall Study||6
125103|NCT00927368|288684|P3|COMPLETED|Overall Study||138
125104|NCT00927368|288685|P2|COMPLETED|Overall Study||152
125105|NCT00927368|288686|P1|COMPLETED|Overall Study||147
125106|NCT00927368|288684|P3|STARTED|Overall Study||143
125107|NCT00927368|288685|P2|STARTED|Overall Study||157
125108|NCT00927368|288686|P1|STARTED|Overall Study||153
125109|NCT00927355|288702|P2|NOT COMPLETED|Overall Study||1
125110|NCT00927355|288703|P1|NOT COMPLETED|Overall Study||1
125111|NCT00927355|288702|P2|COMPLETED|Overall Study||4
125112|NCT00927355|288703|P1|COMPLETED|Overall Study||4
125113|NCT00927355|288702|P2|STARTED|Overall Study||5
125114|NCT00927355|288703|P1|STARTED|Overall Study||5
125115|NCT00927251|288721|P1|NOT COMPLETED|Overall Study||8
125116|NCT00927251|288721|P1|COMPLETED|Overall Study||82
125117|NCT00927251|288721|P1|STARTED|Overall Study||90
125118|NCT00927186|288727|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
125119|NCT00927186|288728|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
125120|NCT00927186|288727|P2|COMPLETED|12 - 24 Months Extension Treatment||11
125121|NCT00927186|288728|P1|COMPLETED|12 - 24 Months Extension Treatment||10
125122|NCT00927186|288727|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
125123|NCT00927186|288728|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
125124|NCT00927186|288727|P2|NOT COMPLETED|12 Months Primary Study||4
125125|NCT00927186|288728|P1|NOT COMPLETED|12 Months Primary Study||7
125126|NCT00927186|288727|P2|COMPLETED|12 Months Primary Study||31
125127|NCT00927186|288728|P1|COMPLETED|12 Months Primary Study||27
125128|NCT00927186|288727|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
125129|NCT00927186|288728|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
125130|NCT00927186|288727|P2|STARTED|12 Months Primary Study||35
125131|NCT00927186|288728|P1|STARTED|12 Months Primary Study||34
125132|NCT00927160|288846|P2|NOT COMPLETED|Overall Study||0
125133|NCT00927160|288847|P1|NOT COMPLETED|Overall Study||0
125134|NCT00927160|288846|P2|COMPLETED|Overall Study||173
125135|NCT00927160|288847|P1|COMPLETED|Overall Study||173
125136|NCT00927160|288846|P2|STARTED|Overall Study||173
125137|NCT00927160|288847|P1|STARTED|Overall Study||173
125139|NCT00927095|288859|P2|NOT COMPLETED|Overall Study||4
125140|NCT00927095|288860|P1|NOT COMPLETED|Overall Study||6
125141|NCT00927095|288858|P3|COMPLETED|Overall Study||22
125142|NCT00927095|288859|P2|COMPLETED|Overall Study||17
125143|NCT00927095|288860|P1|COMPLETED|Overall Study||16
125144|NCT00927095|288858|P3|STARTED|Overall Study||24
125145|NCT00927095|288859|P2|STARTED|Overall Study||21
125146|NCT00927095|288860|P1|STARTED|Overall Study||22
125147|NCT00927082|288872|P4|NOT COMPLETED|Overall Study||19
125148|NCT00927082|288873|P3|NOT COMPLETED|Overall Study||22
125149|NCT00927082|288874|P2|NOT COMPLETED|Overall Study||10
125150|NCT00927082|288875|P1|NOT COMPLETED|Overall Study||12
125151|NCT00927082|288872|P4|COMPLETED|Overall Study||78
125152|NCT00927082|288873|P3|COMPLETED|Overall Study||86
125153|NCT00927082|288874|P2|COMPLETED|Overall Study||77
125154|NCT00927082|288875|P1|COMPLETED|Overall Study||79
125155|NCT00927082|288872|P4|STARTED|Overall Study||97
125156|NCT00927082|288873|P3|STARTED|Overall Study||108
125157|NCT00927082|288874|P2|STARTED|Overall Study||87
125158|NCT00927082|288875|P1|STARTED|Overall Study||91
125159|NCT00927069|288939|P4|NOT COMPLETED|Week 12 to Week 24||3
125160|NCT00927069|288940|P3|NOT COMPLETED|Week 12 to Week 24||3
125161|NCT00927069|288941|P2|NOT COMPLETED|Week 12 to Week 24||0
125162|NCT00927069|288942|P1|NOT COMPLETED|Week 12 to Week 24||2
125163|NCT00927069|288939|P4|COMPLETED|Week 12 to Week 24||20
125164|NCT00927069|288940|P3|COMPLETED|Week 12 to Week 24||28
125165|NCT00927069|288941|P2|COMPLETED|Week 12 to Week 24||11
125166|NCT00927069|288942|P1|COMPLETED|Week 12 to Week 24||16
125167|NCT00927069|288939|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
125168|NCT00927069|288940|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
125169|NCT00927069|288941|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
125170|NCT00927069|288942|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
125171|NCT00927069|288939|P4|NOT COMPLETED|Week 0 to Week 12||0
125172|NCT00927069|288940|P3|NOT COMPLETED|Week 0 to Week 12||0
125173|NCT00927069|288941|P2|NOT COMPLETED|Week 0 to Week 12||1
125174|NCT00927069|288942|P1|NOT COMPLETED|Week 0 to Week 12||1
125175|NCT00927069|288939|P4|COMPLETED|Week 0 to Week 12||0
125176|NCT00927069|288940|P3|COMPLETED|Week 0 to Week 12||0
125177|NCT00927069|288941|P2|COMPLETED|Week 0 to Week 12||34
125178|NCT00927069|288942|P1|COMPLETED|Week 0 to Week 12||49
125179|NCT00927069|288939|P4|STARTED|Week 0 to Week 12||0
125180|NCT00927069|288940|P3|STARTED|Week 0 to Week 12||0
125181|NCT00927069|288941|P2|STARTED|Week 0 to Week 12||35
125182|NCT00927069|288942|P1|STARTED|Week 0 to Week 12||50
125183|NCT00926952|288952|P1|NOT COMPLETED|Overall Study||0
125184|NCT00926952|288952|P1|COMPLETED|Overall Study||20
125185|NCT00926952|288952|P1|STARTED|Overall Study||20
125186|NCT00926887|288966|P2|NOT COMPLETED|Overall Study||0
125187|NCT00926887|288967|P1|NOT COMPLETED|Overall Study||0
125188|NCT00926887|288966|P2|COMPLETED|Overall Study||50
125189|NCT00926887|288967|P1|COMPLETED|Overall Study||54
125190|NCT00926887|288966|P2|STARTED|Overall Study||50
125191|NCT00926887|288967|P1|STARTED|Overall Study||54
125192|NCT00926796|288979|P2|NOT COMPLETED|Overall Study||106
125193|NCT00926796|288980|P1|NOT COMPLETED|Overall Study||107
125194|NCT00926796|288979|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
125195|NCT00926796|288980|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
125196|NCT00926796|288979|P2|STARTED|Overall Study|Number randomized|305
125197|NCT00926796|288980|P1|STARTED|Overall Study|Number randomized|309
125198|NCT00926783|289001|P2|NOT COMPLETED|Overall Study||3
125199|NCT00926783|289002|P1|NOT COMPLETED|Overall Study||3
125200|NCT00926783|289001|P2|COMPLETED|Overall Study||38
125201|NCT00926783|289002|P1|COMPLETED|Overall Study||39
125202|NCT00926783|289001|P2|STARTED|Overall Study||41
125203|NCT00926783|289002|P1|STARTED|Overall Study||42
125204|NCT00926588|289020|P2|NOT COMPLETED|Overall Study||4
125205|NCT00926588|289021|P1|NOT COMPLETED|Overall Study||8
125206|NCT00926588|289020|P2|COMPLETED|Overall Study||122
125207|NCT00926588|289021|P1|COMPLETED|Overall Study||116
125208|NCT00926588|289020|P2|STARTED|Overall Study||126
125209|NCT00926588|289021|P1|STARTED|Overall Study||124
125210|NCT00926575|289029|P2|NOT COMPLETED|Overall Study||17
125211|NCT00926575|289030|P1|NOT COMPLETED|Overall Study||16
125212|NCT00926575|289029|P2|COMPLETED|Overall Study||53
125213|NCT00926575|289030|P1|COMPLETED|Overall Study||54
125214|NCT00926575|289029|P2|STARTED|Overall Study||70
125215|NCT00926575|289030|P1|STARTED|Overall Study||70
125216|NCT00926536|289042|P2|NOT COMPLETED|Overall Study||2
125217|NCT00926536|289043|P1|NOT COMPLETED|Overall Study||1
125218|NCT00926536|289042|P2|COMPLETED|Overall Study||41
125219|NCT00926536|289043|P1|COMPLETED|Overall Study||43
125220|NCT00926536|289042|P2|STARTED|Overall Study||43
125221|NCT00926536|289043|P1|STARTED|Overall Study||44
125222|NCT00926497|289053|P2|NOT COMPLETED|Overall Study||0
125223|NCT00926497|289054|P1|NOT COMPLETED|Overall Study||0
125224|NCT00926497|289053|P2|COMPLETED|Overall Study||61
125225|NCT00926497|289054|P1|COMPLETED|Overall Study||60
125226|NCT00926497|289053|P2|STARTED|Overall Study||61
125227|NCT00926497|289054|P1|STARTED|Overall Study||60
125228|NCT00926393|289064|P2|NOT COMPLETED|Overall Study||3
125229|NCT00926393|289065|P1|NOT COMPLETED|Overall Study||2
125230|NCT00926393|289064|P2|COMPLETED|Overall Study||67
125231|NCT00926393|289065|P1|COMPLETED|Overall Study||67
125232|NCT00926393|289064|P2|STARTED|Overall Study||70
125233|NCT00926393|289065|P1|STARTED|Overall Study||69
125234|NCT00926367|289097|P2|NOT COMPLETED|Overall Study||3
125235|NCT00926367|289098|P1|NOT COMPLETED|Overall Study||2
125236|NCT00926367|289097|P2|COMPLETED|Overall Study||24
125237|NCT00926367|289098|P1|COMPLETED|Overall Study||23
125238|NCT00926367|289097|P2|STARTED|Overall Study||27
125239|NCT00926367|289098|P1|STARTED|Overall Study||25
125240|NCT00926328|289140|P2|NOT COMPLETED|Overall Study||14
125241|NCT00926328|289141|P1|NOT COMPLETED|Overall Study||12
125242|NCT00926328|289140|P2|COMPLETED|Overall Study||46
125243|NCT00926328|289141|P1|COMPLETED|Overall Study||48
125244|NCT00926328|289140|P2|STARTED|Overall Study||60
125245|NCT00926328|289141|P1|STARTED|Overall Study||60
125246|NCT00926289|289151|P2|NOT COMPLETED|Overall Study||36
125247|NCT00926289|289152|P1|NOT COMPLETED|Overall Study||25
125248|NCT00926289|289151|P2|COMPLETED|Overall Study||558
125249|NCT00926289|289152|P1|COMPLETED|Overall Study||269
125250|NCT00926289|289151|P2|STARTED|Overall Study|Number of treated patients|594
125251|NCT00926289|289152|P1|STARTED|Overall Study|Number of treated patients|294
125252|NCT00926263|289188|P2|NOT COMPLETED|Overall Study||0
125253|NCT00926263|289189|P1|NOT COMPLETED|Overall Study||0
125254|NCT00926263|289188|P2|COMPLETED|Overall Study||12
125255|NCT00926263|289189|P1|COMPLETED|Overall Study||16
125256|NCT00926263|289188|P2|STARTED|Overall Study||12
125257|NCT00926263|289189|P1|STARTED|Overall Study||16
125258|NCT00926211|289220|P1|NOT COMPLETED|Overall Study||1
125259|NCT00926211|289220|P1|COMPLETED|Overall Study||35
125260|NCT00926211|289220|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
125261|NCT00926029|289230|P3|NOT COMPLETED|Overall Study||1
125262|NCT00926029|289231|P2|NOT COMPLETED|Overall Study||1
125263|NCT00926029|289232|P1|NOT COMPLETED|Overall Study||2
125264|NCT00926029|289230|P3|COMPLETED|Overall Study||33
125265|NCT00926029|289231|P2|COMPLETED|Overall Study||33
125266|NCT00926029|289232|P1|COMPLETED|Overall Study||32
125267|NCT00926029|289230|P3|STARTED|Overall Study||34
125268|NCT00926029|289231|P2|STARTED|Overall Study||34
125269|NCT00926029|289232|P1|STARTED|Overall Study||34
125270|NCT00925990|289245|P2|NOT COMPLETED|Overall Study||11
125271|NCT00925990|289246|P1|NOT COMPLETED|Overall Study||5
125272|NCT00925990|289245|P2|COMPLETED|Overall Study||24
125273|NCT00925990|289246|P1|COMPLETED|Overall Study||30
125274|NCT00925990|289245|P2|STARTED|Overall Study||35
125275|NCT00925990|289246|P1|STARTED|Overall Study||35
125276|NCT00925938|289257|P3|NOT COMPLETED|Overall Study||0
125277|NCT00925938|289258|P2|NOT COMPLETED|Overall Study||0
125278|NCT00925938|289259|P1|NOT COMPLETED|Overall Study||0
125279|NCT00925938|289257|P3|COMPLETED|Overall Study||17
125280|NCT00925938|289258|P2|COMPLETED|Overall Study||25
125281|NCT00925938|289259|P1|COMPLETED|Overall Study||9
125282|NCT00925938|289257|P3|STARTED|Overall Study||17
125283|NCT00925938|289258|P2|STARTED|Overall Study||25
125284|NCT00925938|289259|P1|STARTED|Overall Study||9
125285|NCT00925782|289279|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
125286|NCT00925782|289280|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
125287|NCT00925782|289279|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
125288|NCT00925782|289280|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
125289|NCT00925782|289279|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
125290|NCT00925782|289280|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
125291|NCT00925782|289279|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
125292|NCT00925782|289280|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
125293|NCT00925782|289279|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
125294|NCT00925782|289280|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
125295|NCT00925782|289279|P2|STARTED|Study Period (Day -3 to Day 0)||12
125296|NCT00925782|289280|P1|STARTED|Study Period (Day -3 to Day 0)||12
125297|NCT00925782|289279|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
125298|NCT00925782|289280|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
125299|NCT00925782|289279|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
125300|NCT00925782|289280|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
125301|NCT00925782|289279|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
125302|NCT00925782|289280|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
125303|NCT00925769|289289|P6|NOT COMPLETED|Overall Study||3
125304|NCT00925769|289290|P5|NOT COMPLETED|Overall Study||3
125305|NCT00925769|289291|P4|NOT COMPLETED|Overall Study||6
125306|NCT00925769|289292|P3|NOT COMPLETED|Overall Study||6
125307|NCT00925769|289293|P2|NOT COMPLETED|Overall Study||6
125308|NCT00925769|289294|P1|NOT COMPLETED|Overall Study||6
125309|NCT00925769|289289|P6|COMPLETED|Overall Study||0
125310|NCT00925769|289290|P5|COMPLETED|Overall Study||0
125311|NCT00925769|289291|P4|COMPLETED|Overall Study||0
125312|NCT00925769|289292|P3|COMPLETED|Overall Study||0
125313|NCT00925769|289293|P2|COMPLETED|Overall Study||0
125314|NCT00925769|289294|P1|COMPLETED|Overall Study||0
125315|NCT00925769|289289|P6|STARTED|Overall Study||3
125316|NCT00925769|289290|P5|STARTED|Overall Study||3
125317|NCT00925769|289291|P4|STARTED|Overall Study||6
125318|NCT00925769|289292|P3|STARTED|Overall Study||6
125319|NCT00925769|289293|P2|STARTED|Overall Study||6
125320|NCT00925769|289294|P1|STARTED|Overall Study||6
125321|NCT00925704|289362|P6|NOT COMPLETED|Third Intervention||1
125322|NCT00925704|289363|P5|NOT COMPLETED|Third Intervention||0
125323|NCT00925704|289364|P4|NOT COMPLETED|Third Intervention||0
125324|NCT00925704|289365|P3|NOT COMPLETED|Third Intervention||0
125325|NCT00925704|289366|P2|NOT COMPLETED|Third Intervention||0
125326|NCT00925704|289367|P1|NOT COMPLETED|Third Intervention||0
125327|NCT00925704|289362|P6|COMPLETED|Third Intervention||6
125328|NCT00925704|289363|P5|COMPLETED|Third Intervention||5
125329|NCT00925704|289364|P4|COMPLETED|Third Intervention||6
125330|NCT00925704|289365|P3|COMPLETED|Third Intervention||7
125331|NCT00925704|289366|P2|COMPLETED|Third Intervention||7
125332|NCT00925704|289367|P1|COMPLETED|Third Intervention||5
125333|NCT00925704|289362|P6|STARTED|Third Intervention||7
125334|NCT00925704|289363|P5|STARTED|Third Intervention||5
125335|NCT00925704|289364|P4|STARTED|Third Intervention||6
125336|NCT00925704|289365|P3|STARTED|Third Intervention||7
125337|NCT00925704|289366|P2|STARTED|Third Intervention||7
125338|NCT00925704|289367|P1|STARTED|Third Intervention||5
125339|NCT00925704|289362|P6|NOT COMPLETED|Washout||0
125340|NCT00925704|289363|P5|NOT COMPLETED|Washout||0
125341|NCT00925704|289364|P4|NOT COMPLETED|Washout||0
125342|NCT00925704|289365|P3|NOT COMPLETED|Washout||0
125343|NCT00925704|289366|P2|NOT COMPLETED|Washout||0
125344|NCT00925704|289367|P1|NOT COMPLETED|Washout||0
125345|NCT00925704|289362|P6|COMPLETED|Washout||7
125346|NCT00925704|289363|P5|COMPLETED|Washout||5
125347|NCT00925704|289364|P4|COMPLETED|Washout||6
125348|NCT00925704|289365|P3|COMPLETED|Washout||7
125349|NCT00925704|289366|P2|COMPLETED|Washout||7
125350|NCT00925704|289367|P1|COMPLETED|Washout||5
125351|NCT00925704|289362|P6|STARTED|Washout||7
125352|NCT00925704|289363|P5|STARTED|Washout||5
125353|NCT00925704|289364|P4|STARTED|Washout||6
125354|NCT00925704|289365|P3|STARTED|Washout||7
125355|NCT00925704|289366|P2|STARTED|Washout||7
125356|NCT00925704|289367|P1|STARTED|Washout||5
125357|NCT00925704|289362|P6|NOT COMPLETED|Second Intervention||0
125358|NCT00925704|289363|P5|NOT COMPLETED|Second Intervention||1
125359|NCT00925704|289364|P4|NOT COMPLETED|Second Intervention||0
125360|NCT00925704|289365|P3|NOT COMPLETED|Second Intervention||0
125361|NCT00925704|289366|P2|NOT COMPLETED|Second Intervention||0
125362|NCT00925704|289367|P1|NOT COMPLETED|Second Intervention||1
125363|NCT00925704|289362|P6|COMPLETED|Second Intervention||7
125364|NCT00925704|289363|P5|COMPLETED|Second Intervention||5
125365|NCT00925704|289364|P4|COMPLETED|Second Intervention||6
125366|NCT00925704|289365|P3|COMPLETED|Second Intervention||7
125367|NCT00925704|289366|P2|COMPLETED|Second Intervention||7
125368|NCT00925704|289367|P1|COMPLETED|Second Intervention||5
125369|NCT00925704|289362|P6|STARTED|Second Intervention||7
125370|NCT00925704|289363|P5|STARTED|Second Intervention||6
125371|NCT00925704|289364|P4|STARTED|Second Intervention||6
125372|NCT00925704|289365|P3|STARTED|Second Intervention||7
125373|NCT00925704|289366|P2|STARTED|Second Intervention||7
125374|NCT00925704|289367|P1|STARTED|Second Intervention||6
125375|NCT00925704|289362|P6|NOT COMPLETED|Washout||0
125376|NCT00925704|289363|P5|NOT COMPLETED|Washout||0
125377|NCT00925704|289364|P4|NOT COMPLETED|Washout||0
125378|NCT00925704|289365|P3|NOT COMPLETED|Washout||0
125379|NCT00925704|289366|P2|NOT COMPLETED|Washout||0
125380|NCT00925704|289367|P1|NOT COMPLETED|Washout||0
125381|NCT00925704|289362|P6|COMPLETED|Washout||7
125382|NCT00925704|289363|P5|COMPLETED|Washout||6
125383|NCT00925704|289364|P4|COMPLETED|Washout||6
125384|NCT00925704|289365|P3|COMPLETED|Washout||7
125385|NCT00925704|289366|P2|COMPLETED|Washout||7
125386|NCT00925704|289367|P1|COMPLETED|Washout||6
125387|NCT00925704|289362|P6|STARTED|Washout||7
125388|NCT00925704|289363|P5|STARTED|Washout||6
125389|NCT00925704|289364|P4|STARTED|Washout||6
125390|NCT00925704|289365|P3|STARTED|Washout||7
125391|NCT00925704|289366|P2|STARTED|Washout||7
125392|NCT00925704|289367|P1|STARTED|Washout||6
125393|NCT00925704|289362|P6|NOT COMPLETED|First Intervention||0
125394|NCT00925704|289363|P5|NOT COMPLETED|First Intervention||1
125395|NCT00925704|289364|P4|NOT COMPLETED|First Intervention||1
125396|NCT00925704|289365|P3|NOT COMPLETED|First Intervention||0
125397|NCT00925704|289366|P2|NOT COMPLETED|First Intervention||0
125398|NCT00925704|289367|P1|NOT COMPLETED|First Intervention||0
125399|NCT00925704|289362|P6|COMPLETED|First Intervention||7
125400|NCT00925704|289363|P5|COMPLETED|First Intervention||6
125401|NCT00925704|289364|P4|COMPLETED|First Intervention||6
125402|NCT00925704|289365|P3|COMPLETED|First Intervention||7
125403|NCT00925704|289366|P2|COMPLETED|First Intervention||7
125404|NCT00925704|289367|P1|COMPLETED|First Intervention||6
125405|NCT00925704|289362|P6|STARTED|First Intervention||7
125406|NCT00925704|289363|P5|STARTED|First Intervention||7
125407|NCT00925704|289364|P4|STARTED|First Intervention||7
125408|NCT00925704|289365|P3|STARTED|First Intervention||7
125409|NCT00925704|289366|P2|STARTED|First Intervention||7
125410|NCT00925704|289367|P1|STARTED|First Intervention||6
125411|NCT00925587|289380|P2|NOT COMPLETED|Overall Study||25
125412|NCT00925587|289381|P1|NOT COMPLETED|Overall Study||36
125413|NCT00925587|289380|P2|COMPLETED|Overall Study||155
125414|NCT00925587|289381|P1|COMPLETED|Overall Study||142
125415|NCT00925587|289380|P2|STARTED|Overall Study||180
125416|NCT00925587|289381|P1|STARTED|Overall Study||178
125417|NCT00925548|289495|P2|NOT COMPLETED|Overall Study||5
125418|NCT00925548|289496|P1|NOT COMPLETED|Overall Study||10
125419|NCT00925548|289495|P2|COMPLETED|Overall Study||0
125420|NCT00925548|289496|P1|COMPLETED|Overall Study||1
125421|NCT00925548|289495|P2|STARTED|Overall Study||5
125422|NCT00925548|289496|P1|STARTED|Overall Study||11
125423|NCT00925522|289522|P1|NOT COMPLETED|Overall Study||0
125424|NCT00925522|289522|P1|COMPLETED|Overall Study||20
125425|NCT00925522|289522|P1|STARTED|Overall Study||20
125426|NCT00925353|289526|P1|NOT COMPLETED|Overall Study||3
125427|NCT00925353|289526|P1|COMPLETED|Overall Study||10
125428|NCT00925353|289526|P1|STARTED|Overall Study||13
125429|NCT00925288|289532|P2|NOT COMPLETED|Overall Study||7
125430|NCT00925288|289533|P1|NOT COMPLETED|Overall Study||9
125431|NCT00925288|289532|P2|COMPLETED|Overall Study||93
125432|NCT00925288|289533|P1|COMPLETED|Overall Study||91
125433|NCT00925288|289532|P2|STARTED|Overall Study||100
125434|NCT00925288|289533|P1|STARTED|Overall Study||100
125435|NCT00924950|289545|P1|NOT COMPLETED|Overall Study||2
125436|NCT00924950|289545|P1|COMPLETED|Overall Study||28
125437|NCT00924950|289545|P1|STARTED|Overall Study||30
125438|NCT00924833|289553|P3|NOT COMPLETED|Overall Study||0
125439|NCT00924833|289554|P2|NOT COMPLETED|Overall Study||0
125440|NCT00924833|289555|P1|NOT COMPLETED|Overall Study||0
125441|NCT00924833|289553|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
125442|NCT00924833|289554|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
125443|NCT00924833|289555|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
125444|NCT00924833|289553|P3|STARTED|Overall Study||9
125445|NCT00924833|289554|P2|STARTED|Overall Study||9
125446|NCT00924833|289555|P1|STARTED|Overall Study||9
125447|NCT00924807|289569|P1|NOT COMPLETED|Overall Study||0
125448|NCT00924807|289569|P1|COMPLETED|Overall Study||4
125449|NCT00924807|289569|P1|STARTED|Overall Study||4
125450|NCT00924781|289577|P2|NOT COMPLETED|Overall Study||10
125451|NCT00924781|289578|P1|NOT COMPLETED|Overall Study||12
125452|NCT00924781|289577|P2|COMPLETED|Overall Study||9
125453|NCT00924781|289578|P1|COMPLETED|Overall Study||8
125454|NCT00924781|289577|P2|STARTED|Overall Study||19
125455|NCT00924781|289578|P1|STARTED|Overall Study||20
125456|NCT00924729|289612|P2|NOT COMPLETED|Overall Study||0
125457|NCT00924729|289613|P1|NOT COMPLETED|Overall Study||2
125458|NCT00924729|289612|P2|COMPLETED|Overall Study||25
125459|NCT00924729|289613|P1|COMPLETED|Overall Study||23
125460|NCT00924729|289612|P2|STARTED|Overall Study||25
125461|NCT00924729|289613|P1|STARTED|Overall Study||25
125462|NCT00924638|289621|P2|NOT COMPLETED|Overall Study||13
125463|NCT00924638|289622|P1|NOT COMPLETED|Overall Study||12
125464|NCT00924638|289621|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
125465|NCT00924638|289622|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
125466|NCT00924638|289621|P2|STARTED|Overall Study|Randomized to Control Arm|220
125467|NCT00924638|289622|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
125468|NCT00924560|289644|P3|NOT COMPLETED|Overall Study||83
125469|NCT00924560|289645|P2|NOT COMPLETED|Overall Study||208
125470|NCT00924560|289646|P1|NOT COMPLETED|Overall Study||211
125471|NCT00924560|289644|P3|COMPLETED|Overall Study||372
125472|NCT00924560|289645|P2|COMPLETED|Overall Study||240
125473|NCT00924560|289646|P1|COMPLETED|Overall Study||247
125474|NCT00924560|289644|P3|Received Treatment|Overall Study||0
125475|NCT00924560|289645|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
125476|NCT00924560|289646|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
125477|NCT00924560|289644|P3|STARTED|Overall Study||455
125478|NCT00924560|289645|P2|STARTED|Overall Study||448
125479|NCT00924560|289646|P1|STARTED|Overall Study||458
125480|NCT00924508|289690|P1|NOT COMPLETED|Overall Study||3
125481|NCT00924508|289690|P1|COMPLETED|Overall Study||20
125482|NCT00924508|289690|P1|STARTED|Overall Study||23
125483|NCT00924482|289697|P1|NOT COMPLETED|Overall Study||0
125484|NCT00924482|289697|P1|COMPLETED|Overall Study||261
125485|NCT00924482|289697|P1|STARTED|Overall Study||261
125486|NCT00924469|289704|P2|NOT COMPLETED|Overall Study||2
125487|NCT00924469|289705|P1|NOT COMPLETED|Overall Study||2
125488|NCT00924469|289704|P2|COMPLETED|Overall Study||26
125489|NCT00924469|289705|P1|COMPLETED|Overall Study||28
125490|NCT00924469|289704|P2|STARTED|Overall Study||28
125491|NCT00924469|289705|P1|STARTED|Overall Study||30
125492|NCT00924443|289727|P1|NOT COMPLETED|Overall Study||3
125493|NCT00924443|289727|P1|COMPLETED|Overall Study||66
125494|NCT00924443|289727|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
125495|NCT00924443|289727|P1|STARTED|Overall Study||69
125496|NCT00924352|289735|P2|NOT COMPLETED|Overall Study||0
125497|NCT00924352|289736|P1|NOT COMPLETED|Overall Study||0
125498|NCT00924352|289735|P2|COMPLETED|Overall Study||44
125499|NCT00924352|289736|P1|COMPLETED|Overall Study||12
125500|NCT00924352|289735|P2|STARTED|Overall Study||44
125501|NCT00924352|289736|P1|STARTED|Overall Study||12
125502|NCT00924313|289749|P1|NOT COMPLETED|Overall Study||1
125503|NCT00924313|289749|P1|COMPLETED|Overall Study||39
125504|NCT00924313|289749|P1|STARTED|Overall Study||40
125505|NCT00924287|289754|P1|NOT COMPLETED|Overall Study||1
125506|NCT00924287|289754|P1|COMPLETED|Overall Study||0
125507|NCT00924287|289754|P1|STARTED|Overall Study||1
125508|NCT00924209|289760|P1|NOT COMPLETED|Overall Study||0
125509|NCT00924209|289760|P1|COMPLETED|Overall Study||7
125510|NCT00924209|289760|P1|STARTED|Overall Study||7
125511|NCT00924066|289765|P1|NOT COMPLETED|Overall Study||0
125512|NCT00924066|289765|P1|COMPLETED|Overall Study||41
125513|NCT00924066|289765|P1|STARTED|Overall Study||41
125514|NCT00924053|289774|P4|NOT COMPLETED|Overall Study||0
125515|NCT00924053|289775|P3|NOT COMPLETED|Overall Study||0
125516|NCT00924053|289776|P2|NOT COMPLETED|Overall Study||0
125517|NCT00924053|289777|P1|NOT COMPLETED|Overall Study||0
125518|NCT00924053|289774|P4|COMPLETED|Overall Study||6
125519|NCT00924053|289775|P3|COMPLETED|Overall Study||6
125520|NCT00924053|289776|P2|COMPLETED|Overall Study||6
125521|NCT00924053|289777|P1|COMPLETED|Overall Study||6
125522|NCT00924053|289774|P4|STARTED|Overall Study||6
125523|NCT00924053|289775|P3|STARTED|Overall Study||6
125524|NCT00924053|289776|P2|STARTED|Overall Study||6
125525|NCT00924053|289777|P1|STARTED|Overall Study||6
125526|NCT00924040|289823|P1|NOT COMPLETED|Overall Study||0
125527|NCT00924040|289823|P1|COMPLETED|Overall Study||1
125528|NCT00924040|289823|P1|STARTED|Overall Study||1
125529|NCT00924001|289835|P1|NOT COMPLETED|Overall Study||0
125530|NCT00924001|289835|P1|COMPLETED|Overall Study||1
125531|NCT00924001|289835|P1|STARTED|Overall Study||1
125532|NCT00923975|289841|P1|NOT COMPLETED|Overall Study||1
125533|NCT00923975|289841|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
125534|NCT00923975|289841|P1|STARTED|Overall Study||51
125535|NCT00923949|289848|P1|NOT COMPLETED|Overall Study||0
125536|NCT00923949|289848|P1|COMPLETED|Overall Study||1
125537|NCT00923949|289848|P1|STARTED|Overall Study||1
125538|NCT00923910|289860|P2|NOT COMPLETED|Period 2||0
125539|NCT00923910|289861|P1|NOT COMPLETED|Period 2||0
125540|NCT00923910|289860|P2|COMPLETED|Period 2||5
125541|NCT00923910|289861|P1|COMPLETED|Period 2||5
125542|NCT00923910|289860|P2|STARTED|Period 2||5
125543|NCT00923910|289861|P1|STARTED|Period 2||5
125544|NCT00923910|289860|P2|NOT COMPLETED|Period 1||0
125545|NCT00923910|289861|P1|NOT COMPLETED|Period 1||0
125546|NCT00923910|289860|P2|COMPLETED|Period 1||5
125547|NCT00923910|289861|P1|COMPLETED|Period 1||5
125548|NCT00923910|289860|P2|STARTED|Period 1||5
125549|NCT00923910|289861|P1|STARTED|Period 1||5
125550|NCT00923845|289868|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
125551|NCT00923845|289869|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
125552|NCT00923845|289868|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
125553|NCT00923845|289869|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
125554|NCT00923845|289868|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
125555|NCT00923845|289869|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
125556|NCT00923845|289868|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
125557|NCT00923845|289869|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
125558|NCT00923845|289868|P2|STARTED|Allogeneic Stem Cell Therapy||10
125559|NCT00923845|289869|P1|STARTED|Allogeneic Stem Cell Therapy||0
125560|NCT00923845|289868|P2|NOT COMPLETED|Induction Therapy||2
125561|NCT00923845|289869|P1|NOT COMPLETED|Induction Therapy||0
125562|NCT00923845|289868|P2|COMPLETED|Induction Therapy||10
125563|NCT00923845|289869|P1|COMPLETED|Induction Therapy||0
125564|NCT00923845|289868|P2|STARTED|Induction Therapy||12
125565|NCT00923845|289869|P1|STARTED|Induction Therapy||0
125566|NCT00923845|289868|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
125567|NCT00923845|289869|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
125568|NCT00923845|289868|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
125569|NCT00923845|289869|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
125570|NCT00923845|289868|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
125571|NCT00923845|289869|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
125572|NCT00923845|289868|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
125573|NCT00923845|289869|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
125574|NCT00923845|289868|P2|COMPLETED|Donor Lymphocyte Harvest||0
125575|NCT00923845|289869|P1|COMPLETED|Donor Lymphocyte Harvest||13
125576|NCT00923845|289868|P2|STARTED|Donor Lymphocyte Harvest||0
125577|NCT00923845|289869|P1|STARTED|Donor Lymphocyte Harvest||13
125578|NCT00923481|289876|P1|NOT COMPLETED|Overall Study||0
125579|NCT00923481|289876|P1|COMPLETED|Overall Study||37
125580|NCT00923481|289876|P1|STARTED|Overall Study||37
125581|NCT00923351|289883|P3|NOT COMPLETED|Overall Study||12
125582|NCT00923351|289884|P2|NOT COMPLETED|Overall Study||0
125583|NCT00923351|289885|P1|NOT COMPLETED|Overall Study||0
125584|NCT00923351|289883|P3|COMPLETED|Overall Study||0
125585|NCT00923351|289884|P2|COMPLETED|Overall Study||26
125586|NCT00923351|289885|P1|COMPLETED|Overall Study||6
125587|NCT00923351|289883|P3|STARTED|Overall Study||12
125588|NCT00923351|289884|P2|STARTED|Overall Study||26
125589|NCT00923351|289885|P1|STARTED|Overall Study||6
125590|NCT00923273|289898|P5|NOT COMPLETED|Phase II Treatment Period||0
125591|NCT00923273|289899|P4|NOT COMPLETED|Phase II Treatment Period||7
125592|NCT00923273|289900|P3|NOT COMPLETED|Phase II Treatment Period||0
125593|NCT00923273|289901|P2|NOT COMPLETED|Phase II Treatment Period||0
125594|NCT00923273|289902|P1|NOT COMPLETED|Phase II Treatment Period||0
125595|NCT00923273|289898|P5|COMPLETED|Phase II Treatment Period||0
125596|NCT00923273|289899|P4|COMPLETED|Phase II Treatment Period||20
125597|NCT00923273|289900|P3|COMPLETED|Phase II Treatment Period||0
125598|NCT00923273|289901|P2|COMPLETED|Phase II Treatment Period||0
125599|NCT00923273|289902|P1|COMPLETED|Phase II Treatment Period||0
125600|NCT00923273|289898|P5|STARTED|Phase II Treatment Period||0
125601|NCT00923273|289899|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
125602|NCT00923273|289900|P3|STARTED|Phase II Treatment Period||0
125603|NCT00923273|289901|P2|STARTED|Phase II Treatment Period||0
125604|NCT00923273|289902|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
125605|NCT00923273|289898|P5|NOT COMPLETED|Phase I Treatment Period||0
125606|NCT00923273|289899|P4|NOT COMPLETED|Phase I Treatment Period||0
125607|NCT00923273|289900|P3|NOT COMPLETED|Phase I Treatment Period||0
125608|NCT00923273|289901|P2|NOT COMPLETED|Phase I Treatment Period||0
125609|NCT00923273|289902|P1|NOT COMPLETED|Phase I Treatment Period||0
125610|NCT00923273|289898|P5|COMPLETED|Phase I Treatment Period||5
125611|NCT00923273|289899|P4|COMPLETED|Phase I Treatment Period||7
125612|NCT00923273|289900|P3|COMPLETED|Phase I Treatment Period||3
125613|NCT00923273|289901|P2|COMPLETED|Phase I Treatment Period||3
125614|NCT00923273|289902|P1|COMPLETED|Phase I Treatment Period||4
125615|NCT00923273|289898|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
125616|NCT00923273|289899|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
125617|NCT00923273|289900|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
125618|NCT00923273|289901|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
125619|NCT00923273|289902|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
125620|NCT00923260|289927|P2|NOT COMPLETED|Overall Study||1
125621|NCT00923260|289928|P1|NOT COMPLETED|Overall Study||1
125622|NCT00923260|289927|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
125623|NCT00923260|289928|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
125624|NCT00923260|289927|P2|STARTED|Overall Study||12
125625|NCT00923260|289928|P1|STARTED|Overall Study||12
125626|NCT00923195|290062|P2|NOT COMPLETED|Overall Study||1
125627|NCT00923195|290063|P1|NOT COMPLETED|Overall Study||0
125628|NCT00923195|290062|P2|COMPLETED|Overall Study||1
125629|NCT00923195|290063|P1|COMPLETED|Overall Study||2
125630|NCT00923195|290062|P2|STARTED|Overall Study||2
125631|NCT00923195|290063|P1|STARTED|Overall Study||2
125632|NCT00923156|290074|P3|NOT COMPLETED|Overall Study||3
125633|NCT00923156|290075|P2|NOT COMPLETED|Overall Study||4
125634|NCT00923156|290076|P1|NOT COMPLETED|Overall Study||0
125635|NCT00923156|290074|P3|COMPLETED|Overall Study||38
125636|NCT00923156|290075|P2|COMPLETED|Overall Study||38
125637|NCT00923156|290076|P1|COMPLETED|Overall Study||40
125638|NCT00923156|290074|P3|STARTED|Overall Study||41
125639|NCT00923156|290075|P2|STARTED|Overall Study||42
125640|NCT00923156|290076|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
125641|NCT00923117|290104|P2|NOT COMPLETED|Overall Study||0
125642|NCT00923117|290105|P1|NOT COMPLETED|Overall Study||0
125643|NCT00923117|290104|P2|COMPLETED|Overall Study||43
125644|NCT00923117|290105|P1|COMPLETED|Overall Study||44
125645|NCT00923117|290104|P2|STARTED|Overall Study||43
125646|NCT00923117|290105|P1|STARTED|Overall Study||44
125647|NCT00923091|290121|P13|NOT COMPLETED|Period VI (Open-Label)||0
125648|NCT00923091|290122|P12|NOT COMPLETED|Period VI (Open-Label)||0
125649|NCT00923091|290123|P11|NOT COMPLETED|Period VI (Open-Label)||0
125650|NCT00923091|290124|P10|NOT COMPLETED|Period VI (Open-Label)||0
125651|NCT00923091|290125|P9|NOT COMPLETED|Period VI (Open-Label)||0
125652|NCT00923091|290126|P8|NOT COMPLETED|Period VI (Open-Label)||0
125653|NCT00923091|290127|P7|NOT COMPLETED|Period VI (Open-Label)||0
125654|NCT00923091|290128|P6|NOT COMPLETED|Period VI (Open-Label)||0
125655|NCT00923091|290129|P5|NOT COMPLETED|Period VI (Open-Label)||7
125656|NCT00923091|290130|P4|NOT COMPLETED|Period VI (Open-Label)||3
125657|NCT00923091|290131|P3|NOT COMPLETED|Period VI (Open-Label)||13
125658|NCT00923091|290132|P2|NOT COMPLETED|Period VI (Open-Label)||8
125659|NCT00923091|290133|P1|NOT COMPLETED|Period VI (Open-Label)||39
125660|NCT00923091|290121|P13|COMPLETED|Period VI (Open-Label)||0
125661|NCT00923091|290122|P12|COMPLETED|Period VI (Open-Label)||0
125662|NCT00923091|290123|P11|COMPLETED|Period VI (Open-Label)||0
125663|NCT00923091|290124|P10|COMPLETED|Period VI (Open-Label)||0
125664|NCT00923091|290125|P9|COMPLETED|Period VI (Open-Label)||0
125665|NCT00923091|290126|P8|COMPLETED|Period VI (Open-Label)||0
125666|NCT00923091|290127|P7|COMPLETED|Period VI (Open-Label)||0
125667|NCT00923091|290128|P6|COMPLETED|Period VI (Open-Label)||0
125668|NCT00923091|290129|P5|COMPLETED|Period VI (Open-Label)||157
125669|NCT00923091|290130|P4|COMPLETED|Period VI (Open-Label)||143
125670|NCT00923091|290131|P3|COMPLETED|Period VI (Open-Label)||467
125671|NCT00923091|290132|P2|COMPLETED|Period VI (Open-Label)||264
125672|NCT00923091|290133|P1|COMPLETED|Period VI (Open-Label)||1408
125673|NCT00923091|290121|P13|STARTED|Period VI (Open-Label)||0
125674|NCT00923091|290122|P12|STARTED|Period VI (Open-Label)||0
125675|NCT00923091|290123|P11|STARTED|Period VI (Open-Label)||0
125676|NCT00923091|290124|P10|STARTED|Period VI (Open-Label)||0
125677|NCT00923091|290125|P9|STARTED|Period VI (Open-Label)||0
125678|NCT00923091|290126|P8|STARTED|Period VI (Open-Label)||0
125679|NCT00923091|290127|P7|STARTED|Period VI (Open-Label)||0
125680|NCT00923091|290128|P6|STARTED|Period VI (Open-Label)||0
125681|NCT00923091|290129|P5|STARTED|Period VI (Open-Label)||164
125682|NCT00923091|290130|P4|STARTED|Period VI (Open-Label)||146
125683|NCT00923091|290131|P3|STARTED|Period VI (Open-Label)||480
125684|NCT00923091|290132|P2|STARTED|Period VI (Open-Label)||272
125685|NCT00923091|290133|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
125686|NCT00923091|290121|P13|NOT COMPLETED|Period V (Double -Blind)||2
125687|NCT00923091|290122|P12|NOT COMPLETED|Period V (Double -Blind)||0
125688|NCT00923091|290123|P11|NOT COMPLETED|Period V (Double -Blind)||1
125689|NCT00923091|290124|P10|NOT COMPLETED|Period V (Double -Blind)||0
125690|NCT00923091|290125|P9|NOT COMPLETED|Period V (Double -Blind)||1
125691|NCT00923091|290126|P8|NOT COMPLETED|Period V (Double -Blind)||0
125692|NCT00923091|290127|P7|NOT COMPLETED|Period V (Double -Blind)||0
125693|NCT00923091|290128|P6|NOT COMPLETED|Period V (Double -Blind)||0
125694|NCT00923091|290129|P5|NOT COMPLETED|Period V (Double -Blind)||0
125695|NCT00923091|290130|P4|NOT COMPLETED|Period V (Double -Blind)||0
125696|NCT00923091|290131|P3|NOT COMPLETED|Period V (Double -Blind)||0
125697|NCT00923091|290132|P2|NOT COMPLETED|Period V (Double -Blind)||0
125698|NCT00923091|290133|P1|NOT COMPLETED|Period V (Double -Blind)||0
125699|NCT00923091|290121|P13|COMPLETED|Period V (Double -Blind)||73
125700|NCT00923091|290122|P12|COMPLETED|Period V (Double -Blind)||151
125701|NCT00923091|290123|P11|COMPLETED|Period V (Double -Blind)||193
125702|NCT00923091|290124|P10|COMPLETED|Period V (Double -Blind)||119
125703|NCT00923091|290125|P9|COMPLETED|Period V (Double -Blind)||134
125704|NCT00923091|290126|P8|COMPLETED|Period V (Double -Blind)||0
125705|NCT00923091|290127|P7|COMPLETED|Period V (Double -Blind)||0
125706|NCT00923091|290128|P6|COMPLETED|Period V (Double -Blind)||0
125707|NCT00923091|290129|P5|COMPLETED|Period V (Double -Blind)||0
125708|NCT00923091|290130|P4|COMPLETED|Period V (Double -Blind)||0
125709|NCT00923091|290131|P3|COMPLETED|Period V (Double -Blind)||0
125710|NCT00923091|290132|P2|COMPLETED|Period V (Double -Blind)||0
125711|NCT00923091|290133|P1|COMPLETED|Period V (Double -Blind)||0
125712|NCT00923091|290121|P13|STARTED|Period V (Double -Blind)||75
125713|NCT00923091|290122|P12|STARTED|Period V (Double -Blind)||151
125714|NCT00923091|290123|P11|STARTED|Period V (Double -Blind)||194
125715|NCT00923091|290124|P10|STARTED|Period V (Double -Blind)||119
125716|NCT00923091|290125|P9|STARTED|Period V (Double -Blind)||135
125717|NCT00923091|290126|P8|STARTED|Period V (Double -Blind)||0
125718|NCT00923091|290127|P7|STARTED|Period V (Double -Blind)||0
125719|NCT00923091|290128|P6|STARTED|Period V (Double -Blind)||0
125720|NCT00923091|290129|P5|STARTED|Period V (Double -Blind)||0
125721|NCT00923091|290130|P4|STARTED|Period V (Double -Blind)||0
125722|NCT00923091|290131|P3|STARTED|Period V (Double -Blind)||0
125723|NCT00923091|290132|P2|STARTED|Period V (Double -Blind)||0
125724|NCT00923091|290133|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
125725|NCT00923091|290121|P13|NOT COMPLETED|Period IV (Double-Blind)||0
125726|NCT00923091|290122|P12|NOT COMPLETED|Period IV (Double-Blind)||0
125727|NCT00923091|290123|P11|NOT COMPLETED|Period IV (Double-Blind)||0
125728|NCT00923091|290124|P10|NOT COMPLETED|Period IV (Double-Blind)||0
125729|NCT00923091|290125|P9|NOT COMPLETED|Period IV (Double-Blind)||0
125730|NCT00923091|290126|P8|NOT COMPLETED|Period IV (Double-Blind)||0
125731|NCT00923091|290127|P7|NOT COMPLETED|Period IV (Double-Blind)||0
125732|NCT00923091|290128|P6|NOT COMPLETED|Period IV (Double-Blind)||0
125733|NCT00923091|290129|P5|NOT COMPLETED|Period IV (Double-Blind)||0
125734|NCT00923091|290130|P4|NOT COMPLETED|Period IV (Double-Blind)||0
125735|NCT00923091|290131|P3|NOT COMPLETED|Period IV (Double-Blind)||0
125736|NCT00923091|290132|P2|NOT COMPLETED|Period IV (Double-Blind)||2
125737|NCT00923091|290133|P1|NOT COMPLETED|Period IV (Double-Blind)||2
125738|NCT00923091|290121|P13|COMPLETED|Period IV (Double-Blind)||0
125739|NCT00923091|290122|P12|COMPLETED|Period IV (Double-Blind)||0
125740|NCT00923091|290123|P11|COMPLETED|Period IV (Double-Blind)||0
125741|NCT00923091|290124|P10|COMPLETED|Period IV (Double-Blind)||0
125742|NCT00923091|290125|P9|COMPLETED|Period IV (Double-Blind)||0
125743|NCT00923091|290126|P8|COMPLETED|Period IV (Double-Blind)||0
125744|NCT00923091|290127|P7|COMPLETED|Period IV (Double-Blind)||0
125745|NCT00923091|290128|P6|COMPLETED|Period IV (Double-Blind)||0
125746|NCT00923091|290129|P5|COMPLETED|Period IV (Double-Blind)||0
125747|NCT00923091|290130|P4|COMPLETED|Period IV (Double-Blind)||0
125748|NCT00923091|290131|P3|COMPLETED|Period IV (Double-Blind)||0
125749|NCT00923091|290132|P2|COMPLETED|Period IV (Double-Blind)||451
125750|NCT00923091|290133|P1|COMPLETED|Period IV (Double-Blind)||226
125751|NCT00923091|290121|P13|STARTED|Period IV (Double-Blind)||0
125752|NCT00923091|290122|P12|STARTED|Period IV (Double-Blind)||0
125753|NCT00923091|290123|P11|STARTED|Period IV (Double-Blind)||0
125754|NCT00923091|290124|P10|STARTED|Period IV (Double-Blind)||0
125755|NCT00923091|290125|P9|STARTED|Period IV (Double-Blind)||0
125756|NCT00923091|290126|P8|STARTED|Period IV (Double-Blind)||0
125757|NCT00923091|290127|P7|STARTED|Period IV (Double-Blind)||0
125758|NCT00923091|290128|P6|STARTED|Period IV (Double-Blind)||0
125759|NCT00923091|290129|P5|STARTED|Period IV (Double-Blind)||0
125760|NCT00923091|290130|P4|STARTED|Period IV (Double-Blind)||0
125761|NCT00923091|290131|P3|STARTED|Period IV (Double-Blind)||0
125762|NCT00923091|290132|P2|STARTED|Period IV (Double-Blind)||453
125763|NCT00923091|290133|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
125764|NCT00923091|290121|P13|NOT COMPLETED|Period III (Single-Blind)||0
125765|NCT00923091|290122|P12|NOT COMPLETED|Period III (Single-Blind)||0
125766|NCT00923091|290123|P11|NOT COMPLETED|Period III (Single-Blind)||0
125767|NCT00923091|290124|P10|NOT COMPLETED|Period III (Single-Blind)||0
125768|NCT00923091|290125|P9|NOT COMPLETED|Period III (Single-Blind)||0
125769|NCT00923091|290126|P8|NOT COMPLETED|Period III (Single-Blind)||0
125770|NCT00923091|290127|P7|NOT COMPLETED|Period III (Single-Blind)||0
125771|NCT00923091|290128|P6|NOT COMPLETED|Period III (Single-Blind)||0
125772|NCT00923091|290129|P5|NOT COMPLETED|Period III (Single-Blind)||0
125773|NCT00923091|290130|P4|NOT COMPLETED|Period III (Single-Blind)||0
125774|NCT00923091|290131|P3|NOT COMPLETED|Period III (Single-Blind)||0
125775|NCT00923091|290132|P2|NOT COMPLETED|Period III (Single-Blind)||0
125776|NCT00923091|290133|P1|NOT COMPLETED|Period III (Single-Blind)||20
125777|NCT00923091|290121|P13|COMPLETED|Period III (Single-Blind)||0
125778|NCT00923091|290122|P12|COMPLETED|Period III (Single-Blind)||0
125779|NCT00923091|290123|P11|COMPLETED|Period III (Single-Blind)||0
125780|NCT00923091|290124|P10|COMPLETED|Period III (Single-Blind)||0
125781|NCT00923091|290125|P9|COMPLETED|Period III (Single-Blind)||0
125782|NCT00923091|290126|P8|COMPLETED|Period III (Single-Blind)||0
125783|NCT00923091|290127|P7|COMPLETED|Period III (Single-Blind)||0
125784|NCT00923091|290128|P6|COMPLETED|Period III (Single-Blind)||0
125785|NCT00923091|290129|P5|COMPLETED|Period III (Single-Blind)||0
125786|NCT00923091|290130|P4|COMPLETED|Period III (Single-Blind)||0
125787|NCT00923091|290131|P3|COMPLETED|Period III (Single-Blind)||0
125788|NCT00923091|290132|P2|COMPLETED|Period III (Single-Blind)||0
125789|NCT00923091|290133|P1|COMPLETED|Period III (Single-Blind)||2520
125790|NCT00923091|290121|P13|STARTED|Period III (Single-Blind)||0
125791|NCT00923091|290122|P12|STARTED|Period III (Single-Blind)||0
125792|NCT00923091|290123|P11|STARTED|Period III (Single-Blind)||0
125793|NCT00923091|290124|P10|STARTED|Period III (Single-Blind)||0
125794|NCT00923091|290125|P9|STARTED|Period III (Single-Blind)||0
125795|NCT00923091|290126|P8|STARTED|Period III (Single-Blind)||0
125796|NCT00923091|290127|P7|STARTED|Period III (Single-Blind)||0
125797|NCT00923091|290128|P6|STARTED|Period III (Single-Blind)||0
125798|NCT00923091|290129|P5|STARTED|Period III (Single-Blind)||0
125799|NCT00923091|290130|P4|STARTED|Period III (Single-Blind)||0
125800|NCT00923091|290131|P3|STARTED|Period III (Single-Blind)||0
125801|NCT00923091|290132|P2|STARTED|Period III (Single-Blind)||0
125802|NCT00923091|290133|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
125803|NCT00923091|290121|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125804|NCT00923091|290122|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125805|NCT00923091|290123|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125806|NCT00923091|290124|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125807|NCT00923091|290125|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125808|NCT00923091|290126|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
125809|NCT00923091|290127|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
125810|NCT00923091|290128|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
125811|NCT00923091|290129|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
125812|NCT00923091|290130|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
125813|NCT00923091|290131|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
125814|NCT00923091|290132|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
125815|NCT00923091|290133|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
125816|NCT00923091|290121|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125817|NCT00923091|290122|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125818|NCT00923091|290123|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125819|NCT00923091|290124|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125820|NCT00923091|290125|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
125821|NCT00923091|290126|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
125822|NCT00923091|290127|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
125823|NCT00923091|290128|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
125824|NCT00923091|290129|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
125825|NCT00923091|290130|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
125826|NCT00923091|290131|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
125827|NCT00923091|290132|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
125828|NCT00923091|290133|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
125829|NCT00923091|290121|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
125830|NCT00923091|290122|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
125831|NCT00923091|290123|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
125832|NCT00923091|290124|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
125833|NCT00923091|290125|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
125834|NCT00923091|290126|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
125835|NCT00923091|290127|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
125836|NCT00923091|290128|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
125837|NCT00923091|290129|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
125838|NCT00923091|290130|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
125839|NCT00923091|290131|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
125840|NCT00923091|290132|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
125841|NCT00923091|290133|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
125842|NCT00922987|290180|P1|NOT COMPLETED|Overall Study||4
125843|NCT00922987|290180|P1|COMPLETED|Overall Study||277
125844|NCT00922987|290180|P1|STARTED|Overall Study||281
125845|NCT00922935|290195|P3|NOT COMPLETED|Overall Study||0
125846|NCT00922935|290196|P2|NOT COMPLETED|Overall Study||5
125847|NCT00922935|290197|P1|NOT COMPLETED|Overall Study||1
125848|NCT00922935|290195|P3|COMPLETED|Overall Study||10
125849|NCT00922935|290196|P2|COMPLETED|Overall Study||11
125850|NCT00922935|290197|P1|COMPLETED|Overall Study||9
125851|NCT00922935|290195|P3|STARTED|Overall Study||10
125852|NCT00922935|290196|P2|STARTED|Overall Study||16
125853|NCT00922935|290197|P1|STARTED|Overall Study||10
125854|NCT00922779|290205|P1|NOT COMPLETED|Overall Study||2327
125855|NCT00922779|290205|P1|COMPLETED|Overall Study||4334
125856|NCT00922779|290205|P1|STARTED|Overall Study||6661
125857|NCT00922766|290212|P1|NOT COMPLETED|Overall Study||7
125858|NCT00922766|290212|P1|COMPLETED|Overall Study||610
125859|NCT00922766|290212|P1|STARTED|Overall Study||617
125860|NCT00922701|290221|P1|NOT COMPLETED|Overall Study||0
125861|NCT00922701|290221|P1|COMPLETED|Overall Study||4
125862|NCT00922701|290221|P1|STARTED|Overall Study||4
125863|NCT00922636|290230|P5|NOT COMPLETED|Overall Study||16
125864|NCT00922636|290231|P4|NOT COMPLETED|Overall Study||17
125865|NCT00922636|290232|P3|NOT COMPLETED|Overall Study||20
125866|NCT00922636|290233|P2|NOT COMPLETED|Overall Study||16
125867|NCT00922636|290234|P1|NOT COMPLETED|Overall Study||7
125868|NCT00922636|290230|P5|COMPLETED|Overall Study||59
125869|NCT00922636|290231|P4|COMPLETED|Overall Study||58
125870|NCT00922636|290232|P3|COMPLETED|Overall Study||56
125871|NCT00922636|290233|P2|COMPLETED|Overall Study||62
125872|NCT00922636|290234|P1|COMPLETED|Overall Study||29
125873|NCT00922636|290230|P5|Entered Optional Taper Phase|Overall Study||12
125874|NCT00922636|290231|P4|Entered Optional Taper Phase|Overall Study||7
125875|NCT00922636|290232|P3|Entered Optional Taper Phase|Overall Study||15
125876|NCT00922636|290233|P2|Entered Optional Taper Phase|Overall Study||10
125877|NCT00922636|290234|P1|Entered Optional Taper Phase|Overall Study||4
125878|NCT00922636|290230|P5|STARTED|Overall Study||75
125879|NCT00922636|290231|P4|STARTED|Overall Study||75
125880|NCT00922636|290232|P3|STARTED|Overall Study||76
125881|NCT00922636|290233|P2|STARTED|Overall Study||78
125882|NCT00922636|290234|P1|STARTED|Overall Study||36
125883|NCT00922623|290381|P1|NOT COMPLETED|Overall Study||5
125884|NCT00922623|290381|P1|COMPLETED|Overall Study||88
125885|NCT00922623|290381|P1|STARTED|Overall Study||93
125886|NCT00922428|290387|P1|NOT COMPLETED|Overall Study||15
125887|NCT00922428|290387|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
125888|NCT00922428|290387|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
125889|NCT00922272|290416|P2|NOT COMPLETED|Double-blind Phase||6
125890|NCT00922272|290417|P1|NOT COMPLETED|Double-blind Phase||7
125891|NCT00922272|290416|P2|COMPLETED|Double-blind Phase||29
125892|NCT00922272|290417|P1|COMPLETED|Double-blind Phase||27
125893|NCT00922272|290416|P2|STARTED|Double-blind Phase||35
125894|NCT00922272|290417|P1|STARTED|Double-blind Phase||34
125895|NCT00922272|290416|P2|NOT COMPLETED|Open-label Phase||0
125896|NCT00922272|290417|P1|NOT COMPLETED|Open-label Phase||23
125897|NCT00922272|290416|P2|COMPLETED|Open-label Phase||0
125898|NCT00922272|290417|P1|COMPLETED|Open-label Phase||69
125899|NCT00922272|290416|P2|STARTED|Open-label Phase||0
125900|NCT00922272|290417|P1|STARTED|Open-label Phase||92
125901|NCT00922233|290473|P1|NOT COMPLETED|Overall Study||4
125902|NCT00922233|290473|P1|COMPLETED|Overall Study||68
125903|NCT00922233|290473|P1|STARTED|Overall Study||72
125904|NCT00922207|290482|P3|NOT COMPLETED|Overall Study||4
125905|NCT00922207|290483|P2|NOT COMPLETED|Overall Study||7
125906|NCT00922207|290484|P1|NOT COMPLETED|Overall Study||6
125907|NCT00922207|290482|P3|COMPLETED|Overall Study||90
125908|NCT00922207|290483|P2|COMPLETED|Overall Study||88
125909|NCT00922207|290484|P1|COMPLETED|Overall Study||85
125910|NCT00922207|290482|P3|STARTED|Overall Study||94
125911|NCT00922207|290483|P2|STARTED|Overall Study||95
125912|NCT00922207|290484|P1|STARTED|Overall Study||91
125913|NCT00922194|290510|P1|NOT COMPLETED|Metformin for 12 Months or More||0
125914|NCT00922194|290510|P1|COMPLETED|Metformin for 12 Months or More||102
125915|NCT00922194|290510|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
125916|NCT00922194|290510|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
125917|NCT00922194|290510|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
125918|NCT00922194|290510|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
125919|NCT00922116|290520|P1|NOT COMPLETED|Overall Study||15
125920|NCT00922116|290520|P1|COMPLETED|Overall Study||176
125921|NCT00922116|290520|P1|STARTED|Overall Study||191
125922|NCT00921947|290531|P2|NOT COMPLETED|Day 28||0
125923|NCT00921947|290532|P1|NOT COMPLETED|Day 28||0
125924|NCT00921947|290531|P2|COMPLETED|Day 28||30
125925|NCT00921947|290532|P1|COMPLETED|Day 28||28
125926|NCT00921947|290531|P2|STARTED|Day 28||30
125927|NCT00921947|290532|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
125928|NCT00921947|290531|P2|NOT COMPLETED|Day 0||0
125929|NCT00921947|290532|P1|NOT COMPLETED|Day 0||0
125930|NCT00921947|290531|P2|COMPLETED|Day 0||30
125931|NCT00921947|290532|P1|COMPLETED|Day 0||30
125932|NCT00921947|290531|P2|STARTED|Day 0||30
125933|NCT00921947|290532|P1|STARTED|Day 0||30
125934|NCT00921934|290542|P1|NOT COMPLETED|Overall Study||0
125935|NCT00921934|290542|P1|COMPLETED|Overall Study||68
125936|NCT00921934|290542|P1|STARTED|Overall Study||68
125937|NCT00921895|290546|P1|NOT COMPLETED|Overall Study||0
125938|NCT00921895|290546|P1|COMPLETED|Overall Study||128
125939|NCT00921895|290546|P1|STARTED|Overall Study||128
125940|NCT00921687|290553|P2|NOT COMPLETED|Overall Study||0
125941|NCT00921687|290554|P1|NOT COMPLETED|Overall Study||0
125942|NCT00921687|290553|P2|COMPLETED|Overall Study||363
125943|NCT00921687|290554|P1|COMPLETED|Overall Study||418
125944|NCT00921687|290553|P2|STARTED|Overall Study||363
125945|NCT00921687|290554|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
125946|NCT00921518|290564|P2|NOT COMPLETED|Overall Study||0
125947|NCT00921518|290565|P1|NOT COMPLETED|Overall Study||0
125948|NCT00921518|290564|P2|COMPLETED|Overall Study||44
125949|NCT00921518|290565|P1|COMPLETED|Overall Study||48
125950|NCT00921518|290564|P2|STARTED|Overall Study||44
125951|NCT00921518|290565|P1|STARTED|Overall Study||48
125952|NCT00921310|290573|P3|NOT COMPLETED|Overall Study||0
125953|NCT00921310|290574|P2|NOT COMPLETED|Overall Study||0
125954|NCT00921310|290575|P1|NOT COMPLETED|Overall Study||0
125955|NCT00921310|290573|P3|COMPLETED|Overall Study||4
125956|NCT00921310|290574|P2|COMPLETED|Overall Study||6
125957|NCT00921310|290575|P1|COMPLETED|Overall Study||2
125958|NCT00921310|290573|P3|STARTED|Overall Study||4
125959|NCT00921310|290574|P2|STARTED|Overall Study||6
125960|NCT00921310|290575|P1|STARTED|Overall Study||2
125961|NCT00921024|290602|P2|NOT COMPLETED|Overall Study||3
125962|NCT00921024|290603|P1|NOT COMPLETED|Overall Study||4
125963|NCT00921024|290602|P2|COMPLETED|Overall Study||39
125964|NCT00921024|290603|P1|COMPLETED|Overall Study||81
125965|NCT00921024|290602|P2|STARTED|Overall Study||42
125966|NCT00921024|290603|P1|STARTED|Overall Study||85
125967|NCT00920907|290613|P2|NOT COMPLETED|Maintenance Period||13
125968|NCT00920907|290614|P1|NOT COMPLETED|Maintenance Period||12
125969|NCT00920907|290613|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
125970|NCT00920907|290614|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
125971|NCT00920907|290613|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
125972|NCT00920907|290614|P1|STARTED|Maintenance Period||15
125973|NCT00920907|290613|P2|NOT COMPLETED|Induction Period||22
125974|NCT00920907|290614|P1|NOT COMPLETED|Induction Period||22
125975|NCT00920907|290613|P2|COMPLETED|Induction Period||16
125976|NCT00920907|290614|P1|COMPLETED|Induction Period||15
125977|NCT00920907|290613|P2|STARTED|Induction Period||38
125978|NCT00920907|290614|P1|STARTED|Induction Period||37
125979|NCT00920855|290655|P3|NOT COMPLETED|Overall Study||22
125980|NCT00920855|290656|P2|NOT COMPLETED|Overall Study||3
125981|NCT00920855|290657|P1|NOT COMPLETED|Overall Study||5
125982|NCT00920855|290655|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
125983|NCT00920855|290656|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
125984|NCT00920855|290657|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
125985|NCT00920855|290655|P3|Safety and Efficacy Populations|Overall Study||31
125986|NCT00920855|290656|P2|Safety and Efficacy Populations|Overall Study||4
125987|NCT00920855|290657|P1|Safety and Efficacy Populations|Overall Study||5
125988|NCT00920855|290655|P3|STARTED|Overall Study||31
125989|NCT00920855|290656|P2|STARTED|Overall Study||4
125990|NCT00920855|290657|P1|STARTED|Overall Study||5
125991|NCT00920816|290683|P4|NOT COMPLETED|Overall Study||69
125992|NCT00920816|290684|P3|NOT COMPLETED|Overall Study||135
125993|NCT00920816|290685|P2|NOT COMPLETED|Overall Study||96
125994|NCT00920816|290686|P1|NOT COMPLETED|Overall Study||192
125995|NCT00920816|290683|P4|COMPLETED|Overall Study||0
125996|NCT00920816|290684|P3|COMPLETED|Overall Study||0
125997|NCT00920816|290685|P2|COMPLETED|Overall Study||0
125998|NCT00920816|290686|P1|COMPLETED|Overall Study||0
125999|NCT00920816|290683|P4|Treated|Overall Study||69
126000|NCT00920816|290684|P3|Treated|Overall Study||135
126001|NCT00920816|290685|P2|Treated|Overall Study||96
126002|NCT00920816|290686|P1|Treated|Overall Study||189
126003|NCT00920816|290683|P4|STARTED|Overall Study||69
126004|NCT00920816|290684|P3|STARTED|Overall Study||135
126005|NCT00920816|290685|P2|STARTED|Overall Study||96
126006|NCT00920816|290686|P1|STARTED|Overall Study||192
126007|NCT00920790|290724|P1|NOT COMPLETED|Overall Study||14
126008|NCT00920790|290724|P1|COMPLETED|Overall Study||13
126009|NCT00920790|290724|P1|STARTED|Overall Study||27
126010|NCT00920686|290736|P3|NOT COMPLETED|Overall Study||13
126011|NCT00920686|290737|P2|NOT COMPLETED|Overall Study||22
126012|NCT00920686|290738|P1|NOT COMPLETED|Overall Study||19
126013|NCT00920686|290736|P3|COMPLETED|Overall Study||62
126014|NCT00920686|290737|P2|COMPLETED|Overall Study||60
126015|NCT00920686|290738|P1|COMPLETED|Overall Study||63
126016|NCT00920686|290736|P3|STARTED|Overall Study||75
126017|NCT00920686|290737|P2|STARTED|Overall Study||82
126018|NCT00920686|290738|P1|STARTED|Overall Study||82
126019|NCT00920647|290762|P4|NOT COMPLETED|Overall Study||0
126020|NCT00920647|290763|P3|NOT COMPLETED|Overall Study||0
126021|NCT00920647|290764|P2|NOT COMPLETED|Overall Study||0
126022|NCT00920647|290765|P1|NOT COMPLETED|Overall Study||0
126023|NCT00920647|290762|P4|COMPLETED|Overall Study||4
126024|NCT00920647|290763|P3|COMPLETED|Overall Study||4
126025|NCT00920647|290764|P2|COMPLETED|Overall Study||4
126026|NCT00920647|290765|P1|COMPLETED|Overall Study||4
126027|NCT00920647|290762|P4|STARTED|Overall Study||4
126028|NCT00920647|290763|P3|STARTED|Overall Study||4
126029|NCT00920647|290764|P2|STARTED|Overall Study||4
126030|NCT00920647|290765|P1|STARTED|Overall Study||4
126031|NCT00920374|290815|P2|NOT COMPLETED|Overall Study||0
126032|NCT00920374|290816|P1|NOT COMPLETED|Overall Study||0
126033|NCT00920374|290815|P2|COMPLETED|Overall Study||57
126034|NCT00920374|290816|P1|COMPLETED|Overall Study||61
126035|NCT00920374|290815|P2|STARTED|Overall Study||57
126036|NCT00920374|290816|P1|STARTED|Overall Study||61
126037|NCT00920309|290842|P2|NOT COMPLETED|Overall Study||0
126038|NCT00920309|290843|P1|NOT COMPLETED|Overall Study||0
126039|NCT00920309|290842|P2|COMPLETED|Overall Study||7
126040|NCT00920309|290843|P1|COMPLETED|Overall Study||14
126041|NCT00920309|290842|P2|STARTED|Overall Study||7
126042|NCT00920309|290843|P1|STARTED|Overall Study||14
126043|NCT00920231|290853|P2|NOT COMPLETED|Overall Study||0
126044|NCT00920231|290854|P1|NOT COMPLETED|Overall Study||0
126045|NCT00920231|290853|P2|COMPLETED|Overall Study||8
126046|NCT00920231|290854|P1|COMPLETED|Overall Study||8
126047|NCT00920231|290853|P2|STARTED|Overall Study||8
126048|NCT00920231|290854|P1|STARTED|Overall Study||8
126049|NCT00920140|290867|P5|NOT COMPLETED|Phase 2||11
126050|NCT00920140|290868|P4|NOT COMPLETED|Phase 2||22
126051|NCT00920140|290869|P3|NOT COMPLETED|Phase 2||50
126052|NCT00920140|290870|P2|NOT COMPLETED|Phase 2||0
126053|NCT00920140|290871|P1|NOT COMPLETED|Phase 2||0
126054|NCT00920140|290867|P5|COMPLETED|Phase 2||0
126055|NCT00920140|290868|P4|COMPLETED|Phase 2||0
126056|NCT00920140|290869|P3|COMPLETED|Phase 2||0
126057|NCT00920140|290870|P2|COMPLETED|Phase 2||0
126058|NCT00920140|290871|P1|COMPLETED|Phase 2||0
126059|NCT00920140|290867|P5|STARTED|Phase 2||11
126060|NCT00920140|290868|P4|STARTED|Phase 2||22
126061|NCT00920140|290869|P3|STARTED|Phase 2||50
126062|NCT00920140|290870|P2|STARTED|Phase 2||0
126063|NCT00920140|290871|P1|STARTED|Phase 2||0
126064|NCT00920140|290867|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
126065|NCT00920140|290868|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
126066|NCT00920140|290869|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
126067|NCT00920140|290870|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
126068|NCT00920140|290871|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
126069|NCT00920140|290867|P5|COMPLETED|Phase 1 (Dose Escalation)||0
126070|NCT00920140|290868|P4|COMPLETED|Phase 1 (Dose Escalation)||0
126071|NCT00920140|290869|P3|COMPLETED|Phase 1 (Dose Escalation)||0
126072|NCT00920140|290870|P2|COMPLETED|Phase 1 (Dose Escalation)||0
126073|NCT00920140|290871|P1|COMPLETED|Phase 1 (Dose Escalation)||0
126074|NCT00920140|290867|P5|STARTED|Phase 1 (Dose Escalation)||0
126075|NCT00920140|290868|P4|STARTED|Phase 1 (Dose Escalation)||0
126076|NCT00920140|290869|P3|STARTED|Phase 1 (Dose Escalation)||0
126077|NCT00920140|290870|P2|STARTED|Phase 1 (Dose Escalation)||9
126078|NCT00920140|290871|P1|STARTED|Phase 1 (Dose Escalation)||5
126079|NCT00920075|290909|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
126080|NCT00920075|290909|P1|COMPLETED|Post Study, 11 Pts Responded||11
126081|NCT00920075|290909|P1|STARTED|Post Study, 11 Pts Responded||11
126082|NCT00920075|290909|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
126083|NCT00920075|290909|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
126084|NCT00920075|290909|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
126085|NCT00919932|290917|P2|NOT COMPLETED|Overall Study||0
126086|NCT00919932|290918|P1|NOT COMPLETED|Overall Study||0
126087|NCT00919932|290917|P2|COMPLETED|Overall Study||5
126088|NCT00919932|290918|P1|COMPLETED|Overall Study||4
126089|NCT00919932|290917|P2|STARTED|Overall Study||5
126090|NCT00919932|290918|P1|STARTED|Overall Study||4
126091|NCT00919893|290928|P2|NOT COMPLETED|Overall Study||9
126092|NCT00919893|290929|P1|NOT COMPLETED|Overall Study||19
126093|NCT00919893|290928|P2|COMPLETED|Overall Study||60
126094|NCT00919893|290929|P1|COMPLETED|Overall Study||51
126095|NCT00919893|290928|P2|STARTED|Overall Study||69
126096|NCT00919893|290929|P1|STARTED|Overall Study||70
126097|NCT00919867|290941|P6|NOT COMPLETED|Third Intervention||0
126098|NCT00919867|290942|P5|NOT COMPLETED|Third Intervention||0
126099|NCT00919867|290943|P4|NOT COMPLETED|Third Intervention||0
126100|NCT00919867|290944|P3|NOT COMPLETED|Third Intervention||0
126101|NCT00919867|290945|P2|NOT COMPLETED|Third Intervention||0
126102|NCT00919867|290946|P1|NOT COMPLETED|Third Intervention||0
126103|NCT00919867|290941|P6|COMPLETED|Third Intervention||6
126104|NCT00919867|290942|P5|COMPLETED|Third Intervention||7
126105|NCT00919867|290943|P4|COMPLETED|Third Intervention||7
126106|NCT00919867|290944|P3|COMPLETED|Third Intervention||6
126107|NCT00919867|290945|P2|COMPLETED|Third Intervention||7
126108|NCT00919867|290946|P1|COMPLETED|Third Intervention||7
126109|NCT00919867|290941|P6|STARTED|Third Intervention||6
126110|NCT00919867|290942|P5|STARTED|Third Intervention||7
126111|NCT00919867|290943|P4|STARTED|Third Intervention||7
126112|NCT00919867|290944|P3|STARTED|Third Intervention||6
126113|NCT00919867|290945|P2|STARTED|Third Intervention||7
126114|NCT00919867|290946|P1|STARTED|Third Intervention||7
126115|NCT00919867|290941|P6|NOT COMPLETED|Washout||0
126116|NCT00919867|290942|P5|NOT COMPLETED|Washout||0
126117|NCT00919867|290943|P4|NOT COMPLETED|Washout||0
126118|NCT00919867|290944|P3|NOT COMPLETED|Washout||0
126119|NCT00919867|290945|P2|NOT COMPLETED|Washout||0
126120|NCT00919867|290946|P1|NOT COMPLETED|Washout||0
126121|NCT00919867|290941|P6|COMPLETED|Washout||6
126122|NCT00919867|290942|P5|COMPLETED|Washout||7
126123|NCT00919867|290943|P4|COMPLETED|Washout||7
126124|NCT00919867|290944|P3|COMPLETED|Washout||6
126125|NCT00919867|290945|P2|COMPLETED|Washout||7
126126|NCT00919867|290946|P1|COMPLETED|Washout||7
126127|NCT00919867|290941|P6|STARTED|Washout||6
126128|NCT00919867|290942|P5|STARTED|Washout||7
126129|NCT00919867|290943|P4|STARTED|Washout||7
126130|NCT00919867|290944|P3|STARTED|Washout||6
126131|NCT00919867|290945|P2|STARTED|Washout||7
126132|NCT00919867|290946|P1|STARTED|Washout||7
126133|NCT00919867|290941|P6|NOT COMPLETED|Second Intervention||0
126134|NCT00919867|290942|P5|NOT COMPLETED|Second Intervention||0
126135|NCT00919867|290943|P4|NOT COMPLETED|Second Intervention||0
126136|NCT00919867|290944|P3|NOT COMPLETED|Second Intervention||0
126137|NCT00919867|290945|P2|NOT COMPLETED|Second Intervention||0
126138|NCT00919867|290946|P1|NOT COMPLETED|Second Intervention||0
126139|NCT00919867|290941|P6|COMPLETED|Second Intervention||6
126140|NCT00919867|290942|P5|COMPLETED|Second Intervention||7
126141|NCT00919867|290943|P4|COMPLETED|Second Intervention||7
126142|NCT00919867|290944|P3|COMPLETED|Second Intervention||6
126143|NCT00919867|290945|P2|COMPLETED|Second Intervention||7
126144|NCT00919867|290946|P1|COMPLETED|Second Intervention||7
126145|NCT00919867|290941|P6|STARTED|Second Intervention||6
126146|NCT00919867|290942|P5|STARTED|Second Intervention||7
126147|NCT00919867|290943|P4|STARTED|Second Intervention||7
126148|NCT00919867|290944|P3|STARTED|Second Intervention||6
126149|NCT00919867|290945|P2|STARTED|Second Intervention||7
126150|NCT00919867|290946|P1|STARTED|Second Intervention||7
126151|NCT00919867|290941|P6|NOT COMPLETED|Washout||0
126152|NCT00919867|290942|P5|NOT COMPLETED|Washout||0
126153|NCT00919867|290943|P4|NOT COMPLETED|Washout||0
126154|NCT00919867|290944|P3|NOT COMPLETED|Washout||0
126155|NCT00919867|290945|P2|NOT COMPLETED|Washout||0
126156|NCT00919867|290946|P1|NOT COMPLETED|Washout||0
126157|NCT00919867|290941|P6|COMPLETED|Washout||6
126158|NCT00919867|290942|P5|COMPLETED|Washout||7
126159|NCT00919867|290943|P4|COMPLETED|Washout||7
126160|NCT00919867|290944|P3|COMPLETED|Washout||6
126161|NCT00919867|290945|P2|COMPLETED|Washout||7
126162|NCT00919867|290946|P1|COMPLETED|Washout||7
126163|NCT00919867|290941|P6|STARTED|Washout||6
126164|NCT00919867|290942|P5|STARTED|Washout||7
126165|NCT00919867|290943|P4|STARTED|Washout||7
126166|NCT00919867|290944|P3|STARTED|Washout||6
126167|NCT00919867|290945|P2|STARTED|Washout||7
126168|NCT00919867|290946|P1|STARTED|Washout||7
126169|NCT00919867|290941|P6|NOT COMPLETED|First Intervention||1
126170|NCT00919867|290942|P5|NOT COMPLETED|First Intervention||0
126171|NCT00919867|290943|P4|NOT COMPLETED|First Intervention||0
126172|NCT00919867|290944|P3|NOT COMPLETED|First Intervention||1
126173|NCT00919867|290945|P2|NOT COMPLETED|First Intervention||0
126174|NCT00919867|290946|P1|NOT COMPLETED|First Intervention||0
126175|NCT00919867|290941|P6|COMPLETED|First Intervention||6
126176|NCT00919867|290942|P5|COMPLETED|First Intervention||7
126177|NCT00919867|290943|P4|COMPLETED|First Intervention||7
126178|NCT00919867|290944|P3|COMPLETED|First Intervention||6
126179|NCT00919867|290945|P2|COMPLETED|First Intervention||7
126180|NCT00919867|290946|P1|COMPLETED|First Intervention||7
126181|NCT00919867|290941|P6|STARTED|First Intervention||7
126182|NCT00919867|290942|P5|STARTED|First Intervention||7
126183|NCT00919867|290943|P4|STARTED|First Intervention||7
126184|NCT00919867|290944|P3|STARTED|First Intervention||7
126185|NCT00919867|290945|P2|STARTED|First Intervention||7
126186|NCT00919867|290946|P1|STARTED|First Intervention||7
126187|NCT00919854|290967|P1|NOT COMPLETED|Overall Study||1
126188|NCT00919854|290967|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
126189|NCT00919854|290967|P1|STARTED|Overall Study||21
126190|NCT00919763|290978|P2|NOT COMPLETED|Overall Study||4
126191|NCT00919763|290979|P1|NOT COMPLETED|Overall Study||12
126192|NCT00919763|290978|P2|COMPLETED|Overall Study||45
126193|NCT00919763|290979|P1|COMPLETED|Overall Study||41
126194|NCT00919763|290978|P2|STARTED|Overall Study||49
126195|NCT00919763|290979|P1|STARTED|Overall Study||53
126196|NCT00919724|290987|P2|NOT COMPLETED|Overall Study||0
126197|NCT00919724|290988|P1|NOT COMPLETED|Overall Study||0
126198|NCT00919724|290987|P2|COMPLETED|Overall Study||44
126199|NCT00919724|290988|P1|COMPLETED|Overall Study||45
126200|NCT00919724|290987|P2|STARTED|Overall Study||44
126201|NCT00919724|290988|P1|STARTED|Overall Study||45
126202|NCT00919711|290996|P2|NOT COMPLETED|Overall Study||13
126203|NCT00919711|290997|P1|NOT COMPLETED|Overall Study||33
126204|NCT00919711|290996|P2|COMPLETED|Overall Study||422
126205|NCT00919711|290997|P1|COMPLETED|Overall Study||402
126206|NCT00919711|290996|P2|STARTED|Overall Study||435
126207|NCT00919711|290997|P1|STARTED|Overall Study||435
126208|NCT00919633|291013|P4|NOT COMPLETED|Overall Study||21
126209|NCT00919633|291014|P3|NOT COMPLETED|Overall Study||23
126210|NCT00919633|291015|P2|NOT COMPLETED|Overall Study||15
126211|NCT00919633|291016|P1|NOT COMPLETED|Overall Study||22
126212|NCT00919633|291013|P4|COMPLETED|Overall Study||5
126213|NCT00919633|291014|P3|COMPLETED|Overall Study||4
126214|NCT00919633|291015|P2|COMPLETED|Overall Study||10
126215|NCT00919633|291016|P1|COMPLETED|Overall Study||6
126216|NCT00919633|291013|P4|STARTED|Overall Study||26
126217|NCT00919633|291014|P3|STARTED|Overall Study||27
126218|NCT00919633|291015|P2|STARTED|Overall Study||25
126219|NCT00919633|291016|P1|STARTED|Overall Study||28
126220|NCT00919191|291034|P1|NOT COMPLETED|Overall Study||0
126221|NCT00919191|291034|P1|COMPLETED|Overall Study||26
126222|NCT00919191|291034|P1|STARTED|Overall Study||26
126223|NCT00919126|291044|P3|NOT COMPLETED|Overall Study||1
126224|NCT00919126|291045|P2|NOT COMPLETED|Overall Study||5
126225|NCT00919126|291046|P1|NOT COMPLETED|Overall Study||1
126226|NCT00919126|291044|P3|COMPLETED|Overall Study||32
126227|NCT00919126|291045|P2|COMPLETED|Overall Study||32
126228|NCT00919126|291046|P1|COMPLETED|Overall Study||31
126229|NCT00919126|291044|P3|STARTED|Overall Study||33
126230|NCT00919126|291045|P2|STARTED|Overall Study||37
126231|NCT00919126|291046|P1|STARTED|Overall Study||32
126232|NCT00919113|291092|P2|NOT COMPLETED|Overall Study||8
126233|NCT00919113|291093|P1|NOT COMPLETED|Overall Study||9
126234|NCT00919113|291092|P2|COMPLETED|Overall Study||40
126235|NCT00919113|291093|P1|COMPLETED|Overall Study||41
126236|NCT00919113|291092|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
126237|NCT00919113|291093|P1|Received Placebo|Overall Study||0
126238|NCT00919113|291092|P2|Received Uracyst|Overall Study||0
126239|NCT00919113|291093|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
126240|NCT00919113|291092|P2|STARTED|Overall Study||48
126241|NCT00919113|291093|P1|STARTED|Overall Study||50
126242|NCT00919061|291101|P1|NOT COMPLETED|Overall Study||2
126243|NCT00919061|291101|P1|COMPLETED|Overall Study||37
126244|NCT00919061|291101|P1|STARTED|Overall Study||39
126245|NCT00919035|291106|P1|NOT COMPLETED|Overall Study||0
126246|NCT00919035|291106|P1|COMPLETED|Overall Study||21
126247|NCT00919035|291106|P1|STARTED|Overall Study||21
126248|NCT00918957|291114|P2|NOT COMPLETED|Overall Study||0
126249|NCT00918957|291115|P1|NOT COMPLETED|Overall Study||3
126250|NCT00918957|291114|P2|COMPLETED|Overall Study||30
126251|NCT00918957|291115|P1|COMPLETED|Overall Study||29
126252|NCT00918957|291114|P2|STARTED|Overall Study||30
126253|NCT00918957|291115|P1|STARTED|Overall Study||32
126254|NCT00918931|291142|P1|NOT COMPLETED|Overall Study||0
126255|NCT00918931|291142|P1|COMPLETED|Overall Study||3
126256|NCT00918931|291142|P1|STARTED|Overall Study||3
126257|NCT00918879|291148|P2|NOT COMPLETED|Overall Study||6
126258|NCT00918879|291149|P1|NOT COMPLETED|Overall Study||6
126259|NCT00918879|291148|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
126260|NCT00918879|291149|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
126261|NCT00918879|291148|P2|STARTED|Overall Study|Randomized and treated|106
126262|NCT00918879|291149|P1|STARTED|Overall Study|Randomized and treated|107
126263|NCT00918866|291163|P2|NOT COMPLETED|Overall Study||0
126264|NCT00918866|291164|P1|NOT COMPLETED|Overall Study||0
126265|NCT00918866|291163|P2|COMPLETED|Overall Study||16
126266|NCT00918866|291164|P1|COMPLETED|Overall Study||16
126267|NCT00918866|291163|P2|STARTED|Overall Study||16
126268|NCT00918866|291164|P1|STARTED|Overall Study||16
126269|NCT00918749|291181|P3|NOT COMPLETED|Overall Study||7
126270|NCT00918749|291182|P2|NOT COMPLETED|Overall Study||3
126271|NCT00918749|291183|P1|NOT COMPLETED|Overall Study||7
126272|NCT00918749|291181|P3|COMPLETED|Overall Study||62
126273|NCT00918749|291182|P2|COMPLETED|Overall Study||63
126274|NCT00918749|291183|P1|COMPLETED|Overall Study||63
126275|NCT00918749|291181|P3|ITT (Intent to Treat) Population|Overall Study||69
126276|NCT00918749|291182|P2|ITT (Intent to Treat) Population|Overall Study||66
126277|NCT00918749|291183|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
126278|NCT00918749|291181|P3|STARTED|Overall Study||69
126279|NCT00918749|291182|P2|STARTED|Overall Study||66
126280|NCT00918749|291183|P1|STARTED|Overall Study||70
126281|NCT00918736|291215|P1|NOT COMPLETED|Overall Study||4
126282|NCT00918736|291215|P1|COMPLETED|Overall Study|October, 2008|46
126283|NCT00918736|291215|P1|STARTED|Overall Study|October, 2007|50
126284|NCT00918671|291219|P1|NOT COMPLETED|Overall Study||0
126285|NCT00918671|291219|P1|COMPLETED|Overall Study||60
126286|NCT00918671|291219|P1|STARTED|Overall Study||60
126287|NCT00918580|291224|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
126288|NCT00918580|291224|P1|COMPLETED|After 6-month FU to 1-year FU||87
126289|NCT00918580|291224|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
126290|NCT00918580|291224|P1|STARTED|After 6-month FU to 1-year FU||147
126291|NCT00918580|291224|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
126292|NCT00918580|291224|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
126293|NCT00918580|291224|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
126294|NCT00918580|291224|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
126295|NCT00918580|291224|P1|STARTED|Up to 6-month Follow-up(FU)||158
126296|NCT00918385|291244|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
126297|NCT00918385|291245|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
126298|NCT00918385|291244|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
126299|NCT00918385|291245|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
126300|NCT00918385|291244|P2|STARTED|Combination Nilutamide and Dasatinib||11
126301|NCT00918385|291245|P1|STARTED|Combination Nilutamide and Dasatinib||12
126302|NCT00918385|291244|P2|NOT COMPLETED|Monotherapy||6
126303|NCT00918385|291245|P1|NOT COMPLETED|Monotherapy||2
126304|NCT00918385|291244|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
126305|NCT00918385|291245|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
126306|NCT00918385|291244|P2|STARTED|Monotherapy||17
126307|NCT00918385|291245|P1|STARTED|Monotherapy||14
126308|NCT00918346|291254|P2|NOT COMPLETED|Post Study Period||0
126309|NCT00918346|291255|P1|NOT COMPLETED|Post Study Period||0
126310|NCT00918346|291254|P2|COMPLETED|Post Study Period||21
126311|NCT00918346|291255|P1|COMPLETED|Post Study Period||21
126312|NCT00918346|291254|P2|STARTED|Post Study Period||21
126313|NCT00918346|291255|P1|STARTED|Post Study Period||21
126314|NCT00918346|291254|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
126315|NCT00918346|291255|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
126316|NCT00918346|291254|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
126317|NCT00918346|291255|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
126318|NCT00918346|291254|P2|STARTED|Second Treatment Period (4 Weeks)||21
126319|NCT00918346|291255|P1|STARTED|Second Treatment Period (4 Weeks)||21
126320|NCT00918346|291254|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
126321|NCT00918346|291255|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
126322|NCT00918346|291254|P2|COMPLETED|Washout (at Least 4 Weeks)||21
126323|NCT00918346|291255|P1|COMPLETED|Washout (at Least 4 Weeks)||21
126324|NCT00918346|291254|P2|STARTED|Washout (at Least 4 Weeks)||21
126325|NCT00918346|291255|P1|STARTED|Washout (at Least 4 Weeks)||21
126326|NCT00918346|291254|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
126327|NCT00918346|291255|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
126328|NCT00918346|291254|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
126329|NCT00918346|291255|P1|COMPLETED|First Treatment Period (4 Weeks)||21
126330|NCT00918346|291254|P2|STARTED|First Treatment Period (4 Weeks)||22
126331|NCT00918346|291255|P1|STARTED|First Treatment Period (4 Weeks)||21
126332|NCT00918281|291269|P1|NOT COMPLETED|Overall Study||29
126333|NCT00918281|291269|P1|COMPLETED|Overall Study||41
126334|NCT00918281|291269|P1|STARTED|Overall Study||70
126335|NCT00918255|291279|P3|NOT COMPLETED|Overall Study||5
126336|NCT00918255|291280|P2|NOT COMPLETED|Overall Study||0
126337|NCT00918255|291281|P1|NOT COMPLETED|Overall Study||6
126338|NCT00918255|291279|P3|COMPLETED|Overall Study||46
126339|NCT00918255|291280|P2|COMPLETED|Overall Study||52
126340|NCT00918255|291281|P1|COMPLETED|Overall Study||45
126341|NCT00918255|291279|P3|STARTED|Overall Study||51
126342|NCT00918255|291280|P2|STARTED|Overall Study||52
126343|NCT00918255|291281|P1|STARTED|Overall Study||51
126344|NCT00918203|291309|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
126345|NCT00918203|291310|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
126346|NCT00918203|291311|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
126347|NCT00918203|291309|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
126348|NCT00918203|291310|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
126349|NCT00918203|291311|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
126350|NCT00918203|291309|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
126351|NCT00918203|291310|P2|STARTED|Crossover to Olaratumab Monotherapy||0
126352|NCT00918203|291311|P1|STARTED|Crossover to Olaratumab Monotherapy||0
126353|NCT00918203|291309|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
126354|NCT00918203|291310|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
126355|NCT00918203|291311|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
126356|NCT00918203|291309|P3|COMPLETED|Treatment With or Without Olaratumab||0
126357|NCT00918203|291310|P2|COMPLETED|Treatment With or Without Olaratumab||53
126358|NCT00918203|291311|P1|COMPLETED|Treatment With or Without Olaratumab||63
126359|NCT00918203|291309|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
126360|NCT00918203|291310|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
126361|NCT00918203|291311|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
126362|NCT00918203|291309|P3|STARTED|Treatment With or Without Olaratumab||0
126363|NCT00918203|291310|P2|STARTED|Treatment With or Without Olaratumab||67
126364|NCT00918203|291311|P1|STARTED|Treatment With or Without Olaratumab||70
126365|NCT00918138|291342|P2|NOT COMPLETED|Overall Study||1
126366|NCT00918138|291343|P1|NOT COMPLETED|Overall Study||2
126367|NCT00918138|291342|P2|COMPLETED|Overall Study||46
126368|NCT00918138|291343|P1|COMPLETED|Overall Study||44
126369|NCT00918138|291342|P2|STARTED|Overall Study||47
126370|NCT00918138|291343|P1|STARTED|Overall Study||46
126371|NCT00918125|291359|P2|NOT COMPLETED|Overall Study||0
126372|NCT00918125|291360|P1|NOT COMPLETED|Overall Study||0
126373|NCT00918125|291359|P2|COMPLETED|Overall Study||39
126374|NCT00918125|291360|P1|COMPLETED|Overall Study||20
126375|NCT00918125|291359|P2|STARTED|Overall Study||39
126376|NCT00918125|291360|P1|STARTED|Overall Study||20
126377|NCT00917865|291371|P1|NOT COMPLETED|Overall Study||0
126378|NCT00917865|291371|P1|COMPLETED|Overall Study||11
126379|NCT00917865|291371|P1|STARTED|Overall Study||11
126380|NCT00917852|291382|P1|NOT COMPLETED|Overall Study||6
126381|NCT00917852|291382|P1|COMPLETED|Overall Study||45
126382|NCT00917852|291382|P1|STARTED|Overall Study||51
126383|NCT00917735|291388|P2|NOT COMPLETED|Overall Study||63
126384|NCT00917735|291389|P1|NOT COMPLETED|Overall Study||75
126385|NCT00917735|291388|P2|COMPLETED|Overall Study||474
126386|NCT00917735|291389|P1|COMPLETED|Overall Study||463
126387|NCT00917735|291388|P2|STARTED|Overall Study||537
126388|NCT00917735|291389|P1|STARTED|Overall Study||538
126389|NCT00917644|291399|P2|NOT COMPLETED|Period 2: Second Intervention||0
126390|NCT00917644|291400|P1|NOT COMPLETED|Period 2: Second Intervention||1
126391|NCT00917644|291399|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
126392|NCT00917644|291400|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
126393|NCT00917644|291399|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
126394|NCT00917644|291400|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
126395|NCT00917644|291399|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
126396|NCT00917644|291400|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
126397|NCT00917644|291399|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
126398|NCT00917644|291400|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
126399|NCT00917644|291399|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
126400|NCT00917644|291400|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
126401|NCT00917644|291399|P2|NOT COMPLETED|Period 1: First Intervention||0
126402|NCT00917644|291400|P1|NOT COMPLETED|Period 1: First Intervention||0
126403|NCT00917644|291399|P2|COMPLETED|Period 1: First Intervention||37
126404|NCT00917644|291400|P1|COMPLETED|Period 1: First Intervention||39
126405|NCT00917644|291399|P2|STARTED|Period 1: First Intervention||37
126406|NCT00917644|291400|P1|STARTED|Period 1: First Intervention||39
126407|NCT00917579|291414|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
126408|NCT00917579|291415|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
126409|NCT00917579|291414|P2|COMPLETED|Period 2: 2nd Intervention||37
126410|NCT00917579|291415|P1|COMPLETED|Period 2: 2nd Intervention||37
126411|NCT00917579|291414|P2|STARTED|Period 2: 2nd Intervention||37
126412|NCT00917579|291415|P1|STARTED|Period 2: 2nd Intervention||37
126413|NCT00917579|291414|P2|NOT COMPLETED|Washout >= 2 Weeks||0
126414|NCT00917579|291415|P1|NOT COMPLETED|Washout >= 2 Weeks||2
126415|NCT00917579|291414|P2|COMPLETED|Washout >= 2 Weeks||37
126416|NCT00917579|291415|P1|COMPLETED|Washout >= 2 Weeks||37
126417|NCT00917579|291414|P2|STARTED|Washout >= 2 Weeks||37
126418|NCT00917579|291415|P1|STARTED|Washout >= 2 Weeks||39
126419|NCT00917579|291414|P2|NOT COMPLETED|Period 1: 1st Intervention||0
126420|NCT00917579|291415|P1|NOT COMPLETED|Period 1: 1st Intervention||0
126421|NCT00917579|291414|P2|COMPLETED|Period 1: 1st Intervention||37
126422|NCT00917579|291415|P1|COMPLETED|Period 1: 1st Intervention||39
126423|NCT00917579|291414|P2|STARTED|Period 1: 1st Intervention||37
126424|NCT00917579|291415|P1|STARTED|Period 1: 1st Intervention||39
126425|NCT00917501|291431|P2|NOT COMPLETED|Overall Study||5
126426|NCT00917501|291432|P1|NOT COMPLETED|Overall Study||8
126427|NCT00917501|291431|P2|COMPLETED|Overall Study||21
126428|NCT00917501|291432|P1|COMPLETED|Overall Study||21
126429|NCT00917501|291431|P2|STARTED|Overall Study||26
126430|NCT00917501|291432|P1|STARTED|Overall Study||29
126431|NCT00917384|291440|P2|NOT COMPLETED|Overall Study||4
126432|NCT00917384|291441|P1|NOT COMPLETED|Overall Study||14
126433|NCT00917384|291440|P2|COMPLETED|Overall Study||113
126434|NCT00917384|291441|P1|COMPLETED|Overall Study||224
126435|NCT00917384|291440|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
126436|NCT00917384|291441|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
126437|NCT00917384|291440|P2|STARTED|Overall Study||117
126438|NCT00917384|291441|P1|STARTED|Overall Study||238
126439|NCT00917267|291465|P2|NOT COMPLETED|Overall Study||79
126440|NCT00917267|291466|P1|NOT COMPLETED|Overall Study||39
126441|NCT00917267|291465|P2|COMPLETED|Overall Study||266
126442|NCT00917267|291466|P1|COMPLETED|Overall Study||307
126443|NCT00917267|291465|P2|Intent to Treat (ITT)|Overall Study||338
126444|NCT00917267|291466|P1|Intent to Treat (ITT)|Overall Study||340
126445|NCT00917267|291465|P2|STARTED|Overall Study||345
126446|NCT00917267|291466|P1|STARTED|Overall Study||346
126447|NCT00917124|291494|P2|NOT COMPLETED|Overall Study||6
126448|NCT00917124|291495|P1|NOT COMPLETED|Overall Study||4
126449|NCT00917124|291494|P2|COMPLETED|Overall Study||94
126450|NCT00917124|291495|P1|COMPLETED|Overall Study||96
126451|NCT00917124|291494|P2|STARTED|Overall Study||100
126452|NCT00917124|291495|P1|STARTED|Overall Study||100
126453|NCT00916929|291505|P2|NOT COMPLETED|Overall Study||29
126454|NCT00916929|291506|P1|NOT COMPLETED|Overall Study||10
126455|NCT00916929|291505|P2|COMPLETED|Overall Study||53
126456|NCT00916929|291506|P1|COMPLETED|Overall Study||70
126457|NCT00916929|291505|P2|STARTED|Overall Study||82
126458|NCT00916929|291506|P1|STARTED|Overall Study||80
126459|NCT00916721|291516|P2|NOT COMPLETED|Overall Study||10
126460|NCT00916721|291517|P1|NOT COMPLETED|Overall Study||10
126461|NCT00916721|291516|P2|COMPLETED|Overall Study||29
126462|NCT00916721|291517|P1|COMPLETED|Overall Study||25
126463|NCT00916721|291516|P2|STARTED|Overall Study||39
126464|NCT00916721|291517|P1|STARTED|Overall Study||35
126465|NCT00916643|291529|P1|NOT COMPLETED|Overall Study||0
126466|NCT00916643|291529|P1|COMPLETED|Overall Study||113
126467|NCT00916643|291529|P1|STARTED|Overall Study||113
126468|NCT00916383|291536|P1|NOT COMPLETED|Overall Study||3
126469|NCT00916383|291536|P1|COMPLETED|Overall Study||46
126470|NCT00916383|291536|P1|STARTED|Overall Study||49
126471|NCT00916370|291564|P2|NOT COMPLETED|Overall Study||2
126472|NCT00916370|291565|P1|NOT COMPLETED|Overall Study||5
126473|NCT00916370|291564|P2|COMPLETED|Overall Study||102
126474|NCT00916370|291565|P1|COMPLETED|Overall Study||396
126475|NCT00916370|291564|P2|STARTED|Overall Study||104
126476|NCT00916370|291565|P1|STARTED|Overall Study||401
126477|NCT00916357|291739|P6|NOT COMPLETED|Period 3||0
126478|NCT00916357|291740|P5|NOT COMPLETED|Period 3||0
126479|NCT00916357|291741|P4|NOT COMPLETED|Period 3||0
126480|NCT00916357|291742|P3|NOT COMPLETED|Period 3||0
126481|NCT00916357|291743|P2|NOT COMPLETED|Period 3||0
126482|NCT00916357|291744|P1|NOT COMPLETED|Period 3||0
126483|NCT00916357|291739|P6|COMPLETED|Period 3||4
126484|NCT00916357|291740|P5|COMPLETED|Period 3||3
126485|NCT00916357|291741|P4|COMPLETED|Period 3||3
126486|NCT00916357|291742|P3|COMPLETED|Period 3||4
126487|NCT00916357|291743|P2|COMPLETED|Period 3||4
126488|NCT00916357|291744|P1|COMPLETED|Period 3||3
126489|NCT00916357|291739|P6|STARTED|Period 3||4
126490|NCT00916357|291740|P5|STARTED|Period 3||3
126491|NCT00916357|291741|P4|STARTED|Period 3||3
126492|NCT00916357|291742|P3|STARTED|Period 3||4
126493|NCT00916357|291743|P2|STARTED|Period 3||4
126494|NCT00916357|291744|P1|STARTED|Period 3||3
126495|NCT00916357|291739|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
126496|NCT00916357|291740|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
126497|NCT00916357|291741|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
126498|NCT00916357|291742|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
126499|NCT00916357|291743|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
126500|NCT00916357|291744|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
126501|NCT00916357|291739|P6|COMPLETED|Washout (3 to 14 Days)||4
126502|NCT00916357|291740|P5|COMPLETED|Washout (3 to 14 Days)||3
126503|NCT00916357|291741|P4|COMPLETED|Washout (3 to 14 Days)||3
126504|NCT00916357|291742|P3|COMPLETED|Washout (3 to 14 Days)||4
126505|NCT00916357|291743|P2|COMPLETED|Washout (3 to 14 Days)||4
126506|NCT00916357|291744|P1|COMPLETED|Washout (3 to 14 Days)||3
126507|NCT00916357|291739|P6|STARTED|Washout (3 to 14 Days)||4
126508|NCT00916357|291740|P5|STARTED|Washout (3 to 14 Days)||3
126509|NCT00916357|291741|P4|STARTED|Washout (3 to 14 Days)||3
126510|NCT00916357|291742|P3|STARTED|Washout (3 to 14 Days)||4
126511|NCT00916357|291743|P2|STARTED|Washout (3 to 14 Days)||4
126512|NCT00916357|291744|P1|STARTED|Washout (3 to 14 Days)||3
126513|NCT00916357|291739|P6|NOT COMPLETED|Period 2||0
126514|NCT00916357|291740|P5|NOT COMPLETED|Period 2||0
126515|NCT00916357|291741|P4|NOT COMPLETED|Period 2||1
126516|NCT00916357|291742|P3|NOT COMPLETED|Period 2||0
126517|NCT00916357|291743|P2|NOT COMPLETED|Period 2||0
126518|NCT00916357|291744|P1|NOT COMPLETED|Period 2||0
126519|NCT00916357|291739|P6|COMPLETED|Period 2||4
126520|NCT00916357|291740|P5|COMPLETED|Period 2||3
126521|NCT00916357|291741|P4|COMPLETED|Period 2||3
126522|NCT00916357|291742|P3|COMPLETED|Period 2||4
126523|NCT00916357|291743|P2|COMPLETED|Period 2||4
126524|NCT00916357|291744|P1|COMPLETED|Period 2||3
126525|NCT00916357|291739|P6|STARTED|Period 2||4
126526|NCT00916357|291740|P5|STARTED|Period 2||3
126527|NCT00916357|291741|P4|STARTED|Period 2||4
126528|NCT00916357|291742|P3|STARTED|Period 2||4
126529|NCT00916357|291743|P2|STARTED|Period 2||4
126530|NCT00916357|291744|P1|STARTED|Period 2||3
126531|NCT00916357|291739|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
126532|NCT00916357|291740|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
126533|NCT00916357|291741|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
126534|NCT00916357|291742|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
126535|NCT00916357|291743|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
126536|NCT00916357|291744|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
126537|NCT00916357|291739|P6|COMPLETED|Washout (3 to 14 Days)||4
126538|NCT00916357|291740|P5|COMPLETED|Washout (3 to 14 Days)||3
126539|NCT00916357|291741|P4|COMPLETED|Washout (3 to 14 Days)||4
126540|NCT00916357|291742|P3|COMPLETED|Washout (3 to 14 Days)||4
126541|NCT00916357|291743|P2|COMPLETED|Washout (3 to 14 Days)||4
126542|NCT00916357|291744|P1|COMPLETED|Washout (3 to 14 Days)||3
126543|NCT00916357|291739|P6|STARTED|Washout (3 to 14 Days)||4
126544|NCT00916357|291740|P5|STARTED|Washout (3 to 14 Days)||3
126545|NCT00916357|291741|P4|STARTED|Washout (3 to 14 Days)||4
126546|NCT00916357|291742|P3|STARTED|Washout (3 to 14 Days)||4
126547|NCT00916357|291743|P2|STARTED|Washout (3 to 14 Days)||4
126548|NCT00916357|291744|P1|STARTED|Washout (3 to 14 Days)||3
126549|NCT00916357|291739|P6|NOT COMPLETED|Period 1||0
126550|NCT00916357|291740|P5|NOT COMPLETED|Period 1||0
126551|NCT00916357|291741|P4|NOT COMPLETED|Period 1||0
126552|NCT00916357|291742|P3|NOT COMPLETED|Period 1||0
126553|NCT00916357|291743|P2|NOT COMPLETED|Period 1||0
126554|NCT00916357|291744|P1|NOT COMPLETED|Period 1||1
126555|NCT00916357|291739|P6|COMPLETED|Period 1||4
126556|NCT00916357|291740|P5|COMPLETED|Period 1||3
126557|NCT00916357|291741|P4|COMPLETED|Period 1||4
126558|NCT00916357|291742|P3|COMPLETED|Period 1||4
126559|NCT00916357|291743|P2|COMPLETED|Period 1||4
126560|NCT00916357|291744|P1|COMPLETED|Period 1||3
126561|NCT00916357|291739|P6|Received at Least 1 Dose of Study Drug|Period 1||4
126562|NCT00916357|291740|P5|Received at Least 1 Dose of Study Drug|Period 1||3
126563|NCT00916357|291741|P4|Received at Least 1 Dose of Study Drug|Period 1||4
126564|NCT00916357|291742|P3|Received at Least 1 Dose of Study Drug|Period 1||4
126565|NCT00916357|291743|P2|Received at Least 1 Dose of Study Drug|Period 1||4
126566|NCT00916357|291744|P1|Received at Least 1 Dose of Study Drug|Period 1||4
126567|NCT00916357|291739|P6|STARTED|Period 1||4
126568|NCT00916357|291740|P5|STARTED|Period 1||3
126569|NCT00916357|291741|P4|STARTED|Period 1||4
126570|NCT00916357|291742|P3|STARTED|Period 1||4
126571|NCT00916357|291743|P2|STARTED|Period 1||4
126572|NCT00916357|291744|P1|STARTED|Period 1||4
126573|NCT00916344|291782|P1|NOT COMPLETED|Overall Study||8
126574|NCT00916344|291782|P1|COMPLETED|Overall Study||167
126575|NCT00916344|291782|P1|STARTED|Overall Study||175
126576|NCT00916305|291789|P2|NOT COMPLETED|Overall Study||28
126577|NCT00916305|291790|P1|NOT COMPLETED|Overall Study||21
126578|NCT00916305|291789|P2|COMPLETED|Overall Study||9
126579|NCT00916305|291790|P1|COMPLETED|Overall Study||7
126580|NCT00916305|291789|P2|STARTED|Overall Study||37
126581|NCT00916305|291790|P1|STARTED|Overall Study||28
126582|NCT00916279|291798|P1|NOT COMPLETED|Overall Study||4
126583|NCT00916279|291798|P1|COMPLETED|Overall Study||37
126584|NCT00916279|291798|P1|24 Months|Overall Study||37
126585|NCT00916279|291798|P1|6 Months|Overall Study||41
126586|NCT00916279|291798|P1|30 Days|Overall Study||41
126587|NCT00916279|291798|P1|STARTED|Overall Study||41
126588|NCT00916136|291808|P2|NOT COMPLETED|Overall Study||0
126589|NCT00916136|291809|P1|NOT COMPLETED|Overall Study||0
126590|NCT00916136|291808|P2|COMPLETED|Overall Study||29
126591|NCT00916136|291809|P1|COMPLETED|Overall Study||37
126592|NCT00916136|291808|P2|STARTED|Overall Study||29
126593|NCT00916136|291809|P1|STARTED|Overall Study||37
126594|NCT00916032|291817|P2|NOT COMPLETED|Overall Study||0
126595|NCT00916032|291818|P1|NOT COMPLETED|Overall Study||0
126596|NCT00916032|291817|P2|COMPLETED|Overall Study||11
126597|NCT00916032|291818|P1|COMPLETED|Overall Study||12
126598|NCT00916032|291817|P2|STARTED|Overall Study||11
126599|NCT00916032|291818|P1|STARTED|Overall Study||12
126600|NCT00916006|291860|P2|NOT COMPLETED|Overall Study||7
126601|NCT00916006|291861|P1|NOT COMPLETED|Overall Study||3
126602|NCT00916006|291860|P2|COMPLETED|Overall Study||127
126603|NCT00916006|291861|P1|COMPLETED|Overall Study||132
126604|NCT00916006|291860|P2|STARTED|Overall Study||134
126605|NCT00916006|291861|P1|STARTED|Overall Study||135
126606|NCT00915902|291871|P2|NOT COMPLETED|2nd Treatment Period||1
126607|NCT00915902|291872|P1|NOT COMPLETED|2nd Treatment Period||0
126608|NCT00915902|291871|P2|COMPLETED|2nd Treatment Period||20
126609|NCT00915902|291872|P1|COMPLETED|2nd Treatment Period||19
126610|NCT00915902|291871|P2|STARTED|2nd Treatment Period||21
126611|NCT00915902|291872|P1|STARTED|2nd Treatment Period||19
126612|NCT00915902|291871|P2|NOT COMPLETED|Washout (4 Weeks)||1
126613|NCT00915902|291872|P1|NOT COMPLETED|Washout (4 Weeks)||0
126614|NCT00915902|291871|P2|COMPLETED|Washout (4 Weeks)||21
126615|NCT00915902|291872|P1|COMPLETED|Washout (4 Weeks)||19
126616|NCT00915902|291871|P2|STARTED|Washout (4 Weeks)||22
126617|NCT00915902|291872|P1|STARTED|Washout (4 Weeks)||19
126618|NCT00915902|291871|P2|NOT COMPLETED|1st Treatment Period||0
126619|NCT00915902|291872|P1|NOT COMPLETED|1st Treatment Period||1
126620|NCT00915902|291871|P2|COMPLETED|1st Treatment Period||22
126621|NCT00915902|291872|P1|COMPLETED|1st Treatment Period||19
126622|NCT00915902|291871|P2|STARTED|1st Treatment Period||22
126623|NCT00915902|291872|P1|STARTED|1st Treatment Period||20
126624|NCT00915876|291882|P2|NOT COMPLETED|Overall Study||1
126625|NCT00915876|291883|P1|NOT COMPLETED|Overall Study||0
126626|NCT00915876|291882|P2|COMPLETED|Overall Study||20
126627|NCT00915876|291883|P1|COMPLETED|Overall Study||20
126628|NCT00915876|291882|P2|Moving Beyond First Dose|Overall Study||20
126629|NCT00915876|291883|P1|Moving Beyond First Dose|Overall Study||20
126630|NCT00915876|291882|P2|STARTED|Overall Study||21
126631|NCT00915876|291883|P1|STARTED|Overall Study||20
126632|NCT00915798|291893|P4|NOT COMPLETED|Overall Study||0
126633|NCT00915798|291894|P3|NOT COMPLETED|Overall Study||0
126634|NCT00915798|291895|P2|NOT COMPLETED|Overall Study||0
126635|NCT00915798|291896|P1|NOT COMPLETED|Overall Study||0
126636|NCT00915798|291893|P4|COMPLETED|Overall Study||26
126637|NCT00915798|291894|P3|COMPLETED|Overall Study||23
126638|NCT00915798|291895|P2|COMPLETED|Overall Study||21
126639|NCT00915798|291896|P1|COMPLETED|Overall Study||19
126640|NCT00915798|291893|P4|STARTED|Overall Study||26
126641|NCT00915798|291894|P3|STARTED|Overall Study||23
126642|NCT00915798|291895|P2|STARTED|Overall Study||21
126643|NCT00915798|291896|P1|STARTED|Overall Study||19
126644|NCT00915772|291919|P3|NOT COMPLETED|Overall Study||29
126645|NCT00915772|291920|P2|NOT COMPLETED|Overall Study||46
126646|NCT00915772|291921|P1|NOT COMPLETED|Overall Study||36
126647|NCT00915772|291919|P3|COMPLETED|Overall Study||142
126648|NCT00915772|291920|P2|COMPLETED|Overall Study||179
126649|NCT00915772|291921|P1|COMPLETED|Overall Study||134
126650|NCT00915772|291919|P3|STARTED|Overall Study||171
126651|NCT00915772|291920|P2|STARTED|Overall Study||225
126652|NCT00915772|291921|P1|STARTED|Overall Study||170
126653|NCT00915759|291966|P1|NOT COMPLETED|Overall Study||0
126654|NCT00915759|291966|P1|COMPLETED|Overall Study|number of participants|40
126655|NCT00915759|291966|P1|STARTED|Overall Study|number of participants|40
126656|NCT00915655|291976|P1|NOT COMPLETED|Overall Study||0
126657|NCT00915655|291976|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
126658|NCT00915655|291976|P1|STARTED|Overall Study||12
126659|NCT00915603|291983|P2|NOT COMPLETED|Overall Study||55
126660|NCT00915603|291984|P1|NOT COMPLETED|Overall Study||56
126661|NCT00915603|291983|P2|COMPLETED|Overall Study||0
126662|NCT00915603|291984|P1|COMPLETED|Overall Study||0
126663|NCT00915603|291983|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
126664|NCT00915603|291984|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
126665|NCT00915551|292000|P2|NOT COMPLETED|Overall Study||1
126666|NCT00915551|292001|P1|NOT COMPLETED|Overall Study||0
126667|NCT00915551|292000|P2|COMPLETED|Overall Study||135
126668|NCT00915551|292001|P1|COMPLETED|Overall Study||142
126669|NCT00915551|292000|P2|STARTED|Overall Study||136
126670|NCT00915551|292001|P1|STARTED|Overall Study||142
126671|NCT00915525|292011|P2|NOT COMPLETED|Overall Study||135
126672|NCT00915525|292012|P1|NOT COMPLETED|Overall Study||265
126673|NCT00915525|292011|P2|COMPLETED|Overall Study||151
126674|NCT00915525|292012|P1|COMPLETED|Overall Study||278
126675|NCT00915525|292011|P2|STARTED|Overall Study||286
126676|NCT00915525|292012|P1|STARTED|Overall Study||543
126677|NCT00915499|292115|P2|NOT COMPLETED|Overall Study||2
126678|NCT00915499|292116|P1|NOT COMPLETED|Overall Study||4
126679|NCT00915499|292115|P2|COMPLETED|Overall Study||31
126680|NCT00915499|292116|P1|COMPLETED|Overall Study||29
126681|NCT00915499|292115|P2|STARTED|Overall Study||33
126682|NCT00915499|292116|P1|STARTED|Overall Study||33
126683|NCT00915473|292126|P2|NOT COMPLETED|4-week Follow Up||5
126684|NCT00915473|292127|P1|NOT COMPLETED|4-week Follow Up||1
126685|NCT00915473|292126|P2|COMPLETED|4-week Follow Up||30
126686|NCT00915473|292127|P1|COMPLETED|4-week Follow Up||33
126687|NCT00915473|292126|P2|STARTED|4-week Follow Up||35
126688|NCT00915473|292127|P1|STARTED|4-week Follow Up||34
126689|NCT00915473|292126|P2|NOT COMPLETED|Injection||0
126690|NCT00915473|292127|P1|NOT COMPLETED|Injection||0
126691|NCT00915473|292126|P2|COMPLETED|Injection||35
126692|NCT00915473|292127|P1|COMPLETED|Injection||34
126693|NCT00915473|292126|P2|STARTED|Injection||35
126694|NCT00915473|292127|P1|STARTED|Injection||34
126695|NCT00915473|292126|P2|NOT COMPLETED|Screening||0
126696|NCT00915473|292127|P1|NOT COMPLETED|Screening||1
126697|NCT00915473|292126|P2|COMPLETED|Screening||35
126698|NCT00915473|292127|P1|COMPLETED|Screening||34
126699|NCT00915473|292126|P2|STARTED|Screening||35
126700|NCT00915473|292127|P1|STARTED|Screening||35
126701|NCT00915356|292144|P5|NOT COMPLETED|Overall Study||0
126702|NCT00915356|292145|P4|NOT COMPLETED|Overall Study||0
126703|NCT00915356|292146|P3|NOT COMPLETED|Overall Study||0
126704|NCT00915356|292147|P2|NOT COMPLETED|Overall Study||0
126705|NCT00915356|292148|P1|NOT COMPLETED|Overall Study||1
126706|NCT00915356|292144|P5|COMPLETED|Overall Study||43
126707|NCT00915356|292145|P4|COMPLETED|Overall Study||12
126708|NCT00915356|292146|P3|COMPLETED|Overall Study||45
126709|NCT00915356|292147|P2|COMPLETED|Overall Study||45
126710|NCT00915356|292148|P1|COMPLETED|Overall Study||25
126711|NCT00915356|292144|P5|STARTED|Overall Study||43
126712|NCT00915356|292145|P4|STARTED|Overall Study||12
126713|NCT00915356|292146|P3|STARTED|Overall Study||45
126714|NCT00915356|292147|P2|STARTED|Overall Study||45
126715|NCT00915356|292148|P1|STARTED|Overall Study||26
126716|NCT00915343|292210|P3|NOT COMPLETED|Part B - Open Label Period||2
126717|NCT00915343|292211|P2|NOT COMPLETED|Part B - Open Label Period||0
126718|NCT00915343|292212|P1|NOT COMPLETED|Part B - Open Label Period||0
126719|NCT00915343|292210|P3|COMPLETED|Part B - Open Label Period||57
126720|NCT00915343|292211|P2|COMPLETED|Part B - Open Label Period||0
126721|NCT00915343|292212|P1|COMPLETED|Part B - Open Label Period||0
126722|NCT00915343|292210|P3|STARTED|Part B - Open Label Period||59
126723|NCT00915343|292211|P2|STARTED|Part B - Open Label Period||0
126724|NCT00915343|292212|P1|STARTED|Part B - Open Label Period||0
126725|NCT00915343|292210|P3|NOT COMPLETED|Part A - Second Intervention Period||0
126726|NCT00915343|292211|P2|NOT COMPLETED|Part A - Second Intervention Period||0
126727|NCT00915343|292212|P1|NOT COMPLETED|Part A - Second Intervention Period||0
126728|NCT00915343|292210|P3|COMPLETED|Part A - Second Intervention Period||0
126729|NCT00915343|292211|P2|COMPLETED|Part A - Second Intervention Period||32
126730|NCT00915343|292212|P1|COMPLETED|Part A - Second Intervention Period||32
126731|NCT00915343|292210|P3|STARTED|Part A - Second Intervention Period||0
126732|NCT00915343|292211|P2|STARTED|Part A - Second Intervention Period||32
126733|NCT00915343|292212|P1|STARTED|Part A - Second Intervention Period||32
126734|NCT00915343|292210|P3|NOT COMPLETED|Part A - First Intervention Period||0
126735|NCT00915343|292211|P2|NOT COMPLETED|Part A - First Intervention Period||0
126736|NCT00915343|292212|P1|NOT COMPLETED|Part A - First Intervention Period||0
126737|NCT00915343|292210|P3|COMPLETED|Part A - First Intervention Period||0
126738|NCT00915343|292211|P2|COMPLETED|Part A - First Intervention Period||32
126739|NCT00915343|292212|P1|COMPLETED|Part A - First Intervention Period||32
126740|NCT00915343|292210|P3|STARTED|Part A - First Intervention Period||0
126741|NCT00915343|292211|P2|STARTED|Part A - First Intervention Period||32
126742|NCT00915343|292212|P1|STARTED|Part A - First Intervention Period||32
126743|NCT00915278|292297|P6|NOT COMPLETED|Overall Study||8
126744|NCT00915278|292298|P5|NOT COMPLETED|Overall Study||2
126745|NCT00915278|292299|P4|NOT COMPLETED|Overall Study||3
126746|NCT00915278|292300|P3|NOT COMPLETED|Overall Study||1
126747|NCT00915278|292301|P2|NOT COMPLETED|Overall Study||3
126748|NCT00915278|292302|P1|NOT COMPLETED|Overall Study||5
126749|NCT00915278|292297|P6|COMPLETED|Overall Study||1
126750|NCT00915278|292298|P5|COMPLETED|Overall Study||1
126751|NCT00915278|292299|P4|COMPLETED|Overall Study||2
126752|NCT00915278|292300|P3|COMPLETED|Overall Study||2
126753|NCT00915278|292301|P2|COMPLETED|Overall Study||2
126754|NCT00915278|292302|P1|COMPLETED|Overall Study||3
126755|NCT00915278|292297|P6|STARTED|Overall Study||9
126756|NCT00915278|292298|P5|STARTED|Overall Study||3
126757|NCT00915278|292299|P4|STARTED|Overall Study||5
126758|NCT00915278|292300|P3|STARTED|Overall Study||3
126759|NCT00915278|292301|P2|STARTED|Overall Study||5
126760|NCT00915278|292302|P1|STARTED|Overall Study||8
126761|NCT00915148|292448|P1|NOT COMPLETED|Overall Study||0
126762|NCT00915148|292448|P1|COMPLETED|Overall Study|August 2010|110
126763|NCT00915148|292448|P1|STARTED|Overall Study|October 2009|110
126764|NCT00914966|292453|P1|NOT COMPLETED|Step 3: 2500 Units||0
126765|NCT00914966|292453|P1|COMPLETED|Step 3: 2500 Units||12
126766|NCT00914966|292453|P1|STARTED|Step 3: 2500 Units||12
126767|NCT00914966|292453|P1|NOT COMPLETED|Step 2: 2000 Units||1
126768|NCT00914966|292453|P1|COMPLETED|Step 2: 2000 Units||12
126769|NCT00914966|292453|P1|STARTED|Step 2: 2000 Units||13
126770|NCT00914966|292453|P1|NOT COMPLETED|Step 1: 1500 Units||2
126771|NCT00914966|292453|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
126772|NCT00914966|292453|P1|STARTED|Step 1: 1500 Units||20
126773|NCT00914862|292470|P5|NOT COMPLETED|Overall Study||0
126774|NCT00914862|292471|P4|NOT COMPLETED|Overall Study||0
126775|NCT00914862|292472|P3|NOT COMPLETED|Overall Study||0
126776|NCT00914862|292473|P2|NOT COMPLETED|Overall Study||0
126777|NCT00914862|292474|P1|NOT COMPLETED|Overall Study||0
126778|NCT00914862|292470|P5|COMPLETED|Overall Study||28
126779|NCT00914862|292471|P4|COMPLETED|Overall Study||8
126780|NCT00914862|292472|P3|COMPLETED|Overall Study||8
126781|NCT00914862|292473|P2|COMPLETED|Overall Study||6
126782|NCT00914862|292474|P1|COMPLETED|Overall Study||6
126783|NCT00914862|292470|P5|STARTED|Overall Study||28
126784|NCT00914862|292471|P4|STARTED|Overall Study||8
126785|NCT00914862|292472|P3|STARTED|Overall Study||8
126786|NCT00914862|292473|P2|STARTED|Overall Study||6
126787|NCT00914862|292474|P1|STARTED|Overall Study||6
126788|NCT00914849|292548|P2|NOT COMPLETED|Overall Study||1
126789|NCT00914849|292549|P1|NOT COMPLETED|Overall Study||1
126790|NCT00914849|292548|P2|COMPLETED|Overall Study||33
126791|NCT00914849|292549|P1|COMPLETED|Overall Study||33
126792|NCT00914849|292548|P2|STARTED|Overall Study||34
126793|NCT00914849|292549|P1|STARTED|Overall Study||34
126794|NCT00914810|292581|P2|NOT COMPLETED|Overall Study||1
126795|NCT00914810|292582|P1|NOT COMPLETED|Overall Study||2
126796|NCT00914810|292581|P2|COMPLETED|Overall Study||18
126797|NCT00914810|292582|P1|COMPLETED|Overall Study||18
126798|NCT00914810|292581|P2|STARTED|Overall Study||19
126799|NCT00914810|292582|P1|STARTED|Overall Study||20
126800|NCT00914589|292593|P3|NOT COMPLETED|Overall Study||12
126801|NCT00914589|292594|P2|NOT COMPLETED|Overall Study||16
126802|NCT00914589|292595|P1|NOT COMPLETED|Overall Study||25
126803|NCT00914589|292593|P3|COMPLETED|Overall Study||126
126804|NCT00914589|292594|P2|COMPLETED|Overall Study||127
126805|NCT00914589|292595|P1|COMPLETED|Overall Study||103
126806|NCT00914589|292593|P3|STARTED|Overall Study||138
126807|NCT00914589|292594|P2|STARTED|Overall Study||143
126808|NCT00914589|292595|P1|STARTED|Overall Study||128
126809|NCT00914485|292615|P1|NOT COMPLETED|Overall Study||0
126810|NCT00914485|292615|P1|COMPLETED|Overall Study||369
126811|NCT00914485|292615|P1|STARTED|Overall Study||369
126812|NCT00914459|292621|P2|NOT COMPLETED|Overall Study||1
126813|NCT00914459|292622|P1|NOT COMPLETED|Overall Study||1
126814|NCT00914459|292621|P2|COMPLETED|Overall Study||18
126815|NCT00914459|292622|P1|COMPLETED|Overall Study||17
126816|NCT00914459|292621|P2|STARTED|Overall Study||19
126817|NCT00914459|292622|P1|STARTED|Overall Study||18
126818|NCT00914186|292652|P4|NOT COMPLETED|Overall Study||10
126819|NCT00914186|292653|P3|NOT COMPLETED|Overall Study||2
126820|NCT00914186|292654|P2|NOT COMPLETED|Overall Study||2
126821|NCT00914186|292655|P1|NOT COMPLETED|Overall Study||3
126822|NCT00914186|292652|P4|COMPLETED|Overall Study||20
126823|NCT00914186|292653|P3|COMPLETED|Overall Study||29
126824|NCT00914186|292654|P2|COMPLETED|Overall Study||28
126825|NCT00914186|292655|P1|COMPLETED|Overall Study||28
126826|NCT00914186|292652|P4|STARTED|Overall Study||30
126827|NCT00914186|292653|P3|STARTED|Overall Study||31
126828|NCT00914186|292654|P2|STARTED|Overall Study||30
126829|NCT00914186|292655|P1|STARTED|Overall Study||31
126830|NCT00913913|292687|P1|NOT COMPLETED|Overall Study||8
126831|NCT00913913|292687|P1|COMPLETED|Overall Study||0
126832|NCT00913913|292687|P1|STARTED|Overall Study||8
126833|NCT00913770|292697|P3|NOT COMPLETED|Overall Study||21
126834|NCT00913770|292698|P2|NOT COMPLETED|Overall Study||29
126835|NCT00913770|292699|P1|NOT COMPLETED|Overall Study||35
126836|NCT00913770|292697|P3|COMPLETED|Overall Study||93
126837|NCT00913770|292698|P2|COMPLETED|Overall Study||82
126838|NCT00913770|292699|P1|COMPLETED|Overall Study||69
126839|NCT00913770|292697|P3|STARTED|Overall Study||114
126840|NCT00913770|292698|P2|STARTED|Overall Study||111
126841|NCT00913770|292699|P1|STARTED|Overall Study||104
126842|NCT00913744|292712|P2|NOT COMPLETED|Overall Study||1
126843|NCT00913744|292713|P1|NOT COMPLETED|Overall Study||5
126844|NCT00913744|292712|P2|COMPLETED|Overall Study||24
126845|NCT00913744|292713|P1|COMPLETED|Overall Study||70
126846|NCT00913744|292712|P2|STARTED|Overall Study||25
126847|NCT00913744|292713|P1|STARTED|Overall Study||75
126848|NCT00913692|292719|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
126849|NCT00913692|292719|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
126850|NCT00913692|292719|P1|STARTED|Treatment Phase 2 (5 Months)||1
126851|NCT00913692|292719|P1|NOT COMPLETED|Washout (2 Weeks)||0
126852|NCT00913692|292719|P1|COMPLETED|Washout (2 Weeks)||1
126853|NCT00913692|292719|P1|STARTED|Washout (2 Weeks)||1
126854|NCT00913692|292719|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
126855|NCT00913692|292719|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
126856|NCT00913692|292719|P1|STARTED|Treatment Phase 1 (5 Months)||2
126857|NCT00913692|292719|P1|NOT COMPLETED|Screening (4 Months)||9
126858|NCT00913692|292719|P1|COMPLETED|Screening (4 Months)||2
126859|NCT00913692|292719|P1|STARTED|Screening (4 Months)||11
126860|NCT00913523|292732|P3|NOT COMPLETED|Overall Study||14
126861|NCT00913523|292733|P2|NOT COMPLETED|Overall Study||16
126862|NCT00913523|292734|P1|NOT COMPLETED|Overall Study||18
126863|NCT00913523|292732|P3|COMPLETED|Overall Study||147
126864|NCT00913523|292733|P2|COMPLETED|Overall Study||143
126865|NCT00913523|292734|P1|COMPLETED|Overall Study||144
126866|NCT00913523|292732|P3|STARTED|Overall Study||161
126867|NCT00913523|292733|P2|STARTED|Overall Study||159
126868|NCT00913523|292734|P1|STARTED|Overall Study||162
126869|NCT00913510|292759|P2|NOT COMPLETED|Overall Study||4
126870|NCT00913510|292760|P1|NOT COMPLETED|Overall Study||8
126871|NCT00913510|292759|P2|COMPLETED|Overall Study||3
126872|NCT00913510|292760|P1|COMPLETED|Overall Study||5
126873|NCT00913510|292759|P2|STARTED|Overall Study||7
126874|NCT00913510|292760|P1|STARTED|Overall Study||13
126875|NCT00913458|292766|P7|NOT COMPLETED|Phase 3||8
126876|NCT00913458|292767|P6|NOT COMPLETED|Phase 3||18
126877|NCT00913458|292768|P5|NOT COMPLETED|Phase 3||22
126878|NCT00913458|292769|P4|NOT COMPLETED|Phase 3||0
126879|NCT00913458|292770|P3|NOT COMPLETED|Phase 3||0
126880|NCT00913458|292771|P2|NOT COMPLETED|Phase 3||0
126881|NCT00913458|292772|P1|NOT COMPLETED|Phase 3||0
126882|NCT00913458|292766|P7|COMPLETED|Phase 3||24
126883|NCT00913458|292767|P6|COMPLETED|Phase 3||28
126884|NCT00913458|292768|P5|COMPLETED|Phase 3||31
126885|NCT00913458|292769|P4|COMPLETED|Phase 3||0
126886|NCT00913458|292770|P3|COMPLETED|Phase 3||0
126887|NCT00913458|292771|P2|COMPLETED|Phase 3||0
126888|NCT00913458|292772|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
126889|NCT00913458|292766|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
126890|NCT00913458|292767|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
126891|NCT00913458|292768|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
126892|NCT00913458|292769|P4|STARTED|Phase 3||0
126893|NCT00913458|292770|P3|STARTED|Phase 3||0
126894|NCT00913458|292771|P2|STARTED|Phase 3||0
126895|NCT00913458|292772|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
126896|NCT00913458|292766|P7|NOT COMPLETED|Phase 2||0
126897|NCT00913458|292767|P6|NOT COMPLETED|Phase 2||0
126898|NCT00913458|292768|P5|NOT COMPLETED|Phase 2||0
126899|NCT00913458|292769|P4|NOT COMPLETED|Phase 2||33
126900|NCT00913458|292770|P3|NOT COMPLETED|Phase 2||19
126901|NCT00913458|292771|P2|NOT COMPLETED|Phase 2||10
126902|NCT00913458|292772|P1|NOT COMPLETED|Phase 2||0
126903|NCT00913458|292766|P7|COMPLETED|Phase 2||0
126904|NCT00913458|292767|P6|COMPLETED|Phase 2||0
126905|NCT00913458|292768|P5|COMPLETED|Phase 2||0
126906|NCT00913458|292769|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
126907|NCT00913458|292770|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
126908|NCT00913458|292771|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
126909|NCT00913458|292772|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
126910|NCT00913458|292766|P7|STARTED|Phase 2||0
126911|NCT00913458|292767|P6|STARTED|Phase 2||0
126912|NCT00913458|292768|P5|STARTED|Phase 2||0
126913|NCT00913458|292769|P4|STARTED|Phase 2||65
126914|NCT00913458|292770|P3|STARTED|Phase 2||65
126915|NCT00913458|292771|P2|STARTED|Phase 2||63
126916|NCT00913458|292772|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
126917|NCT00913458|292766|P7|NOT COMPLETED|Phase 1||0
126918|NCT00913458|292767|P6|NOT COMPLETED|Phase 1||0
126919|NCT00913458|292768|P5|NOT COMPLETED|Phase 1||0
126920|NCT00913458|292769|P4|NOT COMPLETED|Phase 1||0
126921|NCT00913458|292770|P3|NOT COMPLETED|Phase 1||0
126922|NCT00913458|292771|P2|NOT COMPLETED|Phase 1||0
126923|NCT00913458|292772|P1|NOT COMPLETED|Phase 1||112
126924|NCT00913458|292766|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
126925|NCT00913458|292767|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
126926|NCT00913458|292768|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
126927|NCT00913458|292769|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
126928|NCT00913458|292770|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
126929|NCT00913458|292771|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
126930|NCT00913458|292772|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
126931|NCT00913458|292766|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
126932|NCT00913458|292767|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
126933|NCT00913458|292768|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
126934|NCT00913458|292769|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
126935|NCT00913458|292770|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
126936|NCT00913458|292771|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
126937|NCT00913458|292772|P1|STARTED|Phase 1||306
126938|NCT00913380|292865|P2|NOT COMPLETED|Clinical Outcomes||6
126939|NCT00913380|292866|P1|NOT COMPLETED|Clinical Outcomes||6
126940|NCT00913380|292865|P2|COMPLETED|Clinical Outcomes||441
126941|NCT00913380|292866|P1|COMPLETED|Clinical Outcomes||438
126942|NCT00913380|292865|P2|STARTED|Clinical Outcomes||447
126943|NCT00913380|292866|P1|STARTED|Clinical Outcomes||444
126944|NCT00913380|292865|P2|NOT COMPLETED|CT Examination||0
126945|NCT00913380|292866|P1|NOT COMPLETED|CT Examination||0
126946|NCT00913380|292865|P2|COMPLETED|CT Examination||447
126947|NCT00913380|292866|P1|COMPLETED|CT Examination||444
126948|NCT00913380|292865|P2|STARTED|CT Examination||447
126949|NCT00913380|292866|P1|STARTED|CT Examination||444
126950|NCT00913263|292892|P1|NOT COMPLETED|Overall Study||0
126951|NCT00913263|292892|P1|COMPLETED|Overall Study||24
126952|NCT00913263|292892|P1|STARTED|Overall Study||24
126953|NCT00913133|292901|P1|NOT COMPLETED|Overall Study||0
126954|NCT00913133|292901|P1|COMPLETED|Overall Study||516
126955|NCT00913133|292901|P1|STARTED|Overall Study||516
126956|NCT00913081|292906|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
126957|NCT00913081|292906|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
126958|NCT00913081|292906|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
126959|NCT00913081|292906|P1|NOT COMPLETED|Washout #3 (7days)||0
126960|NCT00913081|292906|P1|COMPLETED|Washout #3 (7days)||17
126961|NCT00913081|292906|P1|STARTED|Washout #3 (7days)||17
126962|NCT00913081|292906|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
126963|NCT00913081|292906|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
126964|NCT00913081|292906|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
126965|NCT00913081|292906|P1|NOT COMPLETED|Washout #2 (7 Days)||0
126966|NCT00913081|292906|P1|COMPLETED|Washout #2 (7 Days)||17
126967|NCT00913081|292906|P1|STARTED|Washout #2 (7 Days)||17
126968|NCT00913081|292906|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
126969|NCT00913081|292906|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
126970|NCT00913081|292906|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
126971|NCT00913081|292906|P1|NOT COMPLETED|Washout #1 (7 Days)||0
126972|NCT00913081|292906|P1|COMPLETED|Washout #1 (7 Days)||17
126973|NCT00913081|292906|P1|STARTED|Washout #1 (7 Days)||17
126974|NCT00913081|292906|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
126975|NCT00913081|292906|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
126976|NCT00913081|292906|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
126977|NCT00913003|292918|P2|NOT COMPLETED|Overall Study||0
126978|NCT00913003|292919|P1|NOT COMPLETED|Overall Study||0
126979|NCT00913003|292918|P2|COMPLETED|Overall Study||11
126980|NCT00913003|292919|P1|COMPLETED|Overall Study||11
126981|NCT00913003|292918|P2|STARTED|Overall Study||11
126982|NCT00913003|292919|P1|STARTED|Overall Study||11
126983|NCT00912964|292932|P3|NOT COMPLETED|Overall Study||54
126984|NCT00912964|292933|P2|NOT COMPLETED|Overall Study||46
126985|NCT00912964|292934|P1|NOT COMPLETED|Overall Study||66
126986|NCT00912964|292932|P3|COMPLETED|Overall Study||386
126987|NCT00912964|292933|P2|COMPLETED|Overall Study||387
126988|NCT00912964|292934|P1|COMPLETED|Overall Study||367
126989|NCT00912964|292932|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
126990|NCT00912964|292933|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
126991|NCT00912964|292934|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
126992|NCT00912964|292932|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
126993|NCT00912964|292933|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
126994|NCT00912964|292934|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
126995|NCT00912964|292932|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
126996|NCT00912964|292933|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
126997|NCT00912964|292934|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
126998|NCT00912964|292932|P3|STARTED|Overall Study||440
126999|NCT00912964|292933|P2|STARTED|Overall Study||433
127000|NCT00912964|292934|P1|STARTED|Overall Study||433
127001|NCT00912925|293058|P2|NOT COMPLETED|Overall Study||0
127002|NCT00912925|293059|P1|NOT COMPLETED|Overall Study||0
127003|NCT00912925|293058|P2|COMPLETED|Overall Study||22
127004|NCT00912925|293059|P1|COMPLETED|Overall Study||23
127005|NCT00912925|293058|P2|STARTED|Overall Study||22
127006|NCT00912925|293059|P1|STARTED|Overall Study||23
127007|NCT00912912|293077|P1|NOT COMPLETED|Overall Study||4
127008|NCT00912912|293077|P1|COMPLETED|Overall Study||1
127009|NCT00912912|293077|P1|STARTED|Overall Study||5
127010|NCT00912808|293083|P2|NOT COMPLETED|Overall Study||1
127011|NCT00912808|293084|P1|NOT COMPLETED|Overall Study||3
127012|NCT00912808|293083|P2|COMPLETED|Overall Study||11
127013|NCT00912808|293084|P1|COMPLETED|Overall Study||8
127014|NCT00912808|293083|P2|STARTED|Overall Study||12
127015|NCT00912808|293084|P1|STARTED|Overall Study||11
127016|NCT00912795|293094|P2|NOT COMPLETED|Overall Study||58
127017|NCT00912795|293095|P1|NOT COMPLETED|Overall Study||47
127018|NCT00912795|293094|P2|COMPLETED|Overall Study||17
127019|NCT00912795|293095|P1|COMPLETED|Overall Study||29
127020|NCT00912795|293094|P2|STARTED|Overall Study||75
127021|NCT00912795|293095|P1|STARTED|Overall Study||76
127022|NCT00912782|293109|P2|NOT COMPLETED|Overall Study||5
127023|NCT00912782|293110|P1|NOT COMPLETED|Overall Study||3
127024|NCT00912782|293109|P2|COMPLETED|Overall Study||20
127025|NCT00912782|293110|P1|COMPLETED|Overall Study||24
127026|NCT00912782|293109|P2|STARTED|Overall Study||25
127027|NCT00912782|293110|P1|STARTED|Overall Study||27
127028|NCT00912743|293120|P2|NOT COMPLETED|Overall Study||20
127029|NCT00912743|293121|P1|NOT COMPLETED|Overall Study||13
127030|NCT00912743|293120|P2|COMPLETED|Overall Study||0
127031|NCT00912743|293121|P1|COMPLETED|Overall Study||0
127032|NCT00912743|293120|P2|STARTED|Overall Study||20
127033|NCT00912743|293121|P1|STARTED|Overall Study||13
127034|NCT00912509|293133|P2|NOT COMPLETED|Overall Study||3
127035|NCT00912509|293134|P1|NOT COMPLETED|Overall Study||5
127036|NCT00912509|293133|P2|COMPLETED|Overall Study||7
127037|NCT00912509|293134|P1|COMPLETED|Overall Study||15
127038|NCT00912509|293133|P2|STARTED|Overall Study||10
127039|NCT00912509|293134|P1|STARTED|Overall Study||20
127040|NCT00912405|293140|P1|NOT COMPLETED|Overall Study||5
127041|NCT00912405|293140|P1|COMPLETED|Overall Study||45
127042|NCT00912405|293140|P1|STARTED|Overall Study||50
127043|NCT00912301|293150|P3|NOT COMPLETED|Overall Study||0
127044|NCT00912301|293151|P2|NOT COMPLETED|Overall Study||0
127045|NCT00912301|293152|P1|NOT COMPLETED|Overall Study||0
127046|NCT00912301|293150|P3|COMPLETED|Overall Study||13
127047|NCT00912301|293151|P2|COMPLETED|Overall Study||12
127048|NCT00912301|293152|P1|COMPLETED|Overall Study||11
127049|NCT00912301|293150|P3|STARTED|Overall Study||13
127050|NCT00912301|293151|P2|STARTED|Overall Study||12
127051|NCT00912301|293152|P1|STARTED|Overall Study||11
127052|NCT00912288|293174|P2|NOT COMPLETED|Overall Study||40
127053|NCT00912288|293175|P1|NOT COMPLETED|Overall Study||41
127054|NCT00912288|293174|P2|COMPLETED|Overall Study||2
127055|NCT00912288|293175|P1|COMPLETED|Overall Study||3
127056|NCT00912288|293174|P2|STARTED|Overall Study||42
127057|NCT00912288|293175|P1|STARTED|Overall Study||44
127058|NCT00912223|293197|P1|NOT COMPLETED|Overall Study||3
127059|NCT00912223|293197|P1|COMPLETED|Overall Study||62
127060|NCT00912223|293197|P1|STARTED|Overall Study||65
127061|NCT00912158|293216|P3|NOT COMPLETED|Overall Study||0
127062|NCT00912158|293217|P2|NOT COMPLETED|Overall Study||0
127063|NCT00912158|293218|P1|NOT COMPLETED|Overall Study||0
127064|NCT00912158|293216|P3|COMPLETED|Overall Study||41
127065|NCT00912158|293217|P2|COMPLETED|Overall Study||44
127066|NCT00912158|293218|P1|COMPLETED|Overall Study||44
127067|NCT00912158|293216|P3|STARTED|Overall Study||41
127068|NCT00912158|293217|P2|STARTED|Overall Study||44
127069|NCT00912158|293218|P1|STARTED|Overall Study||44
127070|NCT00912093|293228|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
127071|NCT00912093|293229|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
127072|NCT00912093|293230|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
127073|NCT00912093|293231|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
127074|NCT00912093|293232|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
127075|NCT00912093|293228|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
127076|NCT00912093|293229|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
127077|NCT00912093|293230|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
127078|NCT00912093|293231|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
127079|NCT00912093|293232|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
127080|NCT00912093|293228|P5|STARTED|The Open Label Extension (OLE) Phase||4
127081|NCT00912093|293229|P4|STARTED|The Open Label Extension (OLE) Phase||2
127082|NCT00912093|293230|P3|STARTED|The Open Label Extension (OLE) Phase||3
127083|NCT00912093|293231|P2|STARTED|The Open Label Extension (OLE) Phase||35
127084|NCT00912093|293232|P1|STARTED|The Open Label Extension (OLE) Phase||38
127085|NCT00912093|293228|P5|NOT COMPLETED|The Controlled Phase||1
127086|NCT00912093|293229|P4|NOT COMPLETED|The Controlled Phase||0
127087|NCT00912093|293230|P3|NOT COMPLETED|The Controlled Phase||0
127088|NCT00912093|293231|P2|NOT COMPLETED|The Controlled Phase||2
127089|NCT00912093|293232|P1|NOT COMPLETED|The Controlled Phase||0
127090|NCT00912093|293228|P5|COMPLETED|The Controlled Phase||4
127091|NCT00912093|293229|P4|COMPLETED|The Controlled Phase||2
127092|NCT00912093|293230|P3|COMPLETED|The Controlled Phase||3
127093|NCT00912093|293231|P2|COMPLETED|The Controlled Phase||43
127094|NCT00912093|293232|P1|COMPLETED|The Controlled Phase||43
127095|NCT00912093|293228|P5|STARTED|The Controlled Phase||5
127096|NCT00912093|293229|P4|STARTED|The Controlled Phase||2
127097|NCT00912093|293230|P3|STARTED|The Controlled Phase||3
127098|NCT00912093|293231|P2|STARTED|The Controlled Phase||45
127099|NCT00912093|293232|P1|STARTED|The Controlled Phase||43
127100|NCT00912028|293251|P5|NOT COMPLETED|Overall Study||3
127101|NCT00912028|293252|P4|NOT COMPLETED|Overall Study||1
127102|NCT00912028|293253|P3|NOT COMPLETED|Overall Study||0
127103|NCT00912028|293254|P2|NOT COMPLETED|Overall Study||3
127104|NCT00912028|293255|P1|NOT COMPLETED|Overall Study||5
127105|NCT00912028|293251|P5|COMPLETED|Overall Study||0
127106|NCT00912028|293252|P4|COMPLETED|Overall Study||16
127107|NCT00912028|293253|P3|COMPLETED|Overall Study||13
127108|NCT00912028|293254|P2|COMPLETED|Overall Study||0
127109|NCT00912028|293255|P1|COMPLETED|Overall Study||30
127110|NCT00912028|293251|P5|STARTED|Overall Study||3
127111|NCT00912028|293252|P4|STARTED|Overall Study||17
127112|NCT00912028|293253|P3|STARTED|Overall Study||13
127113|NCT00912028|293254|P2|STARTED|Overall Study||3
127114|NCT00912028|293255|P1|STARTED|Overall Study||35
127115|NCT00912015|293284|P4|NOT COMPLETED|Overall Study||2
127116|NCT00912015|293285|P3|NOT COMPLETED|Overall Study||3
127117|NCT00912015|293286|P2|NOT COMPLETED|Overall Study||8
127118|NCT00912015|293287|P1|NOT COMPLETED|Overall Study||16
127119|NCT00912015|293284|P4|COMPLETED|Overall Study||0
127120|NCT00912015|293285|P3|COMPLETED|Overall Study||22
127121|NCT00912015|293286|P2|COMPLETED|Overall Study||62
127122|NCT00912015|293287|P1|COMPLETED|Overall Study||125
127123|NCT00912015|293284|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
127124|NCT00912015|293285|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
127125|NCT00912015|293286|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
127126|NCT00912015|293287|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
127127|NCT00912002|293297|P1|NOT COMPLETED|Overall Study||0
127128|NCT00912002|293297|P1|COMPLETED|Overall Study||6
127129|NCT00912002|293297|P1|STARTED|Overall Study||6
127130|NCT00911989|293303|P1|NOT COMPLETED|Overall Study||1
127131|NCT00911989|293303|P1|COMPLETED|Overall Study||3
127132|NCT00911989|293303|P1|STARTED|Overall Study||4
127133|NCT00911937|293309|P2|NOT COMPLETED|Overall Study||95
127134|NCT00911937|293310|P1|NOT COMPLETED|Overall Study||87
127135|NCT00911937|293309|P2|COMPLETED|Overall Study||381
127136|NCT00911937|293310|P1|COMPLETED|Overall Study||400
127137|NCT00911937|293309|P2|Treated|Overall Study||463
127138|NCT00911937|293310|P1|Treated|Overall Study||474
127139|NCT00911937|293309|P2|STARTED|Overall Study||476
127140|NCT00911937|293310|P1|STARTED|Overall Study||487
127141|NCT00911898|293370|P1|NOT COMPLETED|Overall Study||0
127142|NCT00911898|293370|P1|COMPLETED|Overall Study||20
127143|NCT00911898|293370|P1|STARTED|Overall Study||20
127144|NCT00911859|293377|P3|NOT COMPLETED|Follow-up Period||41
127145|NCT00911859|293378|P2|NOT COMPLETED|Follow-up Period||46
127146|NCT00911859|293379|P1|NOT COMPLETED|Follow-up Period||11
127147|NCT00911859|293377|P3|COMPLETED|Follow-up Period||11
127148|NCT00911859|293378|P2|COMPLETED|Follow-up Period||7
127149|NCT00911859|293379|P1|COMPLETED|Follow-up Period||1
127150|NCT00911859|293377|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
127151|NCT00911859|293378|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
127152|NCT00911859|293379|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
127153|NCT00911859|293377|P3|NOT COMPLETED|Maintainance Period||21
127154|NCT00911859|293378|P2|NOT COMPLETED|Maintainance Period||0
127155|NCT00911859|293379|P1|NOT COMPLETED|Maintainance Period||0
127156|NCT00911859|293377|P3|COMPLETED|Maintainance Period||0
127157|NCT00911859|293378|P2|COMPLETED|Maintainance Period||0
127158|NCT00911859|293379|P1|COMPLETED|Maintainance Period||0
127159|NCT00911859|293377|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
127160|NCT00911859|293378|P2|STARTED|Maintainance Period||0
127161|NCT00911859|293379|P1|STARTED|Maintainance Period||0
127162|NCT00911859|293377|P3|NOT COMPLETED|Treatment Period||25
127163|NCT00911859|293378|P2|NOT COMPLETED|Treatment Period||21
127164|NCT00911859|293379|P1|NOT COMPLETED|Treatment Period||8
127165|NCT00911859|293377|P3|COMPLETED|Treatment Period||27
127166|NCT00911859|293378|P2|COMPLETED|Treatment Period||33
127167|NCT00911859|293379|P1|COMPLETED|Treatment Period||4
127168|NCT00911859|293377|P3|Received Treatment|Treatment Period||52
127169|NCT00911859|293378|P2|Received Treatment|Treatment Period||53
127170|NCT00911859|293379|P1|Received Treatment|Treatment Period||12
127171|NCT00911859|293377|P3|STARTED|Treatment Period||52
127172|NCT00911859|293378|P2|STARTED|Treatment Period||54
127173|NCT00911859|293379|P1|STARTED|Treatment Period||12
127174|NCT00911807|293406|P3|NOT COMPLETED|Overall Study||23
127175|NCT00911807|293407|P2|NOT COMPLETED|Overall Study||18
127176|NCT00911807|293408|P1|NOT COMPLETED|Overall Study||17
127177|NCT00911807|293406|P3|COMPLETED|Overall Study||52
127178|NCT00911807|293407|P2|COMPLETED|Overall Study||52
127179|NCT00911807|293408|P1|COMPLETED|Overall Study||55
127180|NCT00911807|293406|P3|STARTED|Overall Study||75
127181|NCT00911807|293407|P2|STARTED|Overall Study||70
127182|NCT00911807|293408|P1|STARTED|Overall Study||72
127183|NCT00911768|293418|P2|NOT COMPLETED|Overall Study||4
127184|NCT00911768|293419|P1|NOT COMPLETED|Overall Study||6
127185|NCT00911768|293418|P2|COMPLETED|Overall Study||46
127186|NCT00911768|293419|P1|COMPLETED|Overall Study||44
127187|NCT00911768|293418|P2|STARTED|Overall Study||50
127188|NCT00911768|293419|P1|STARTED|Overall Study||50
127189|NCT00911742|293431|P2|NOT COMPLETED|Treatment Phase II||0
127190|NCT00911742|293432|P1|NOT COMPLETED|Treatment Phase II||0
127191|NCT00911742|293431|P2|COMPLETED|Treatment Phase II||13
127192|NCT00911742|293432|P1|COMPLETED|Treatment Phase II||13
127193|NCT00911742|293431|P2|STARTED|Treatment Phase II||13
127194|NCT00911742|293432|P1|STARTED|Treatment Phase II||13
127195|NCT00911742|293431|P2|NOT COMPLETED|Treatment Phase I||0
127196|NCT00911742|293432|P1|NOT COMPLETED|Treatment Phase I||0
127197|NCT00911742|293431|P2|COMPLETED|Treatment Phase I||13
127198|NCT00911742|293432|P1|COMPLETED|Treatment Phase I||13
127199|NCT00911742|293431|P2|STARTED|Treatment Phase I||13
127200|NCT00911742|293432|P1|STARTED|Treatment Phase I||13
127201|NCT00911612|293448|P2|NOT COMPLETED|Overall Study||0
127202|NCT00911612|293449|P1|NOT COMPLETED|Overall Study||0
127203|NCT00911612|293448|P2|COMPLETED|Overall Study||12
127204|NCT00911612|293449|P1|COMPLETED|Overall Study||12
127205|NCT00911612|293448|P2|STARTED|Overall Study||12
127206|NCT00911612|293449|P1|STARTED|Overall Study||12
127207|NCT00911547|293467|P4|NOT COMPLETED|Overall Study||16
127208|NCT00911547|293468|P3|NOT COMPLETED|Overall Study||22
127209|NCT00911547|293469|P2|NOT COMPLETED|Overall Study||42
127210|NCT00911547|293470|P1|NOT COMPLETED|Overall Study||11
127211|NCT00911547|293467|P4|COMPLETED|Overall Study||177
127212|NCT00911547|293468|P3|COMPLETED|Overall Study||178
127213|NCT00911547|293469|P2|COMPLETED|Overall Study||159
127214|NCT00911547|293470|P1|COMPLETED|Overall Study||37
127215|NCT00911547|293467|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
127216|NCT00911547|293468|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
127217|NCT00911547|293469|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
127218|NCT00911547|293470|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
127219|NCT00911534|293498|P2|NOT COMPLETED|Overall Study||16
127220|NCT00911534|293499|P1|NOT COMPLETED|Overall Study||15
127221|NCT00911534|293498|P2|COMPLETED|Overall Study||137
127222|NCT00911534|293499|P1|COMPLETED|Overall Study||132
127223|NCT00911534|293498|P2|STARTED|Overall Study|Randomized (treated)|153
127224|NCT00911534|293499|P1|STARTED|Overall Study|Randomized (treated)|147
127225|NCT00911495|293511|P1|NOT COMPLETED|Overall Study||1
127226|NCT00911495|293511|P1|COMPLETED|Overall Study||14
127227|NCT00911495|293511|P1|STARTED|Overall Study||15
127228|NCT00911443|293524|P5|NOT COMPLETED|Overall Study||0
127229|NCT00911443|293525|P4|NOT COMPLETED|Overall Study||0
127230|NCT00911443|293526|P3|NOT COMPLETED|Overall Study||0
127231|NCT00911443|293527|P2|NOT COMPLETED|Overall Study||0
127232|NCT00911443|293528|P1|NOT COMPLETED|Overall Study||0
127233|NCT00911443|293524|P5|COMPLETED|Overall Study||97
127234|NCT00911443|293525|P4|COMPLETED|Overall Study||99
127235|NCT00911443|293526|P3|COMPLETED|Overall Study||98
127236|NCT00911443|293527|P2|COMPLETED|Overall Study||97
127237|NCT00911443|293528|P1|COMPLETED|Overall Study||97
127238|NCT00911443|293524|P5|STARTED|Overall Study||97
127239|NCT00911443|293525|P4|STARTED|Overall Study||99
127240|NCT00911443|293526|P3|STARTED|Overall Study||98
127241|NCT00911443|293527|P2|STARTED|Overall Study||97
127242|NCT00911443|293528|P1|STARTED|Overall Study||97
127243|NCT00911326|293545|P1|NOT COMPLETED|Overall Study||16
127244|NCT00911326|293545|P1|COMPLETED|Overall Study||85
127245|NCT00911326|293545|P1|STARTED|Overall Study||101
127246|NCT00911300|293554|P2|NOT COMPLETED|Overall Study||43
127247|NCT00911300|293555|P1|NOT COMPLETED|Overall Study||35
127248|NCT00911300|293554|P2|COMPLETED|Overall Study||131
127249|NCT00911300|293555|P1|COMPLETED|Overall Study||140
127250|NCT00911300|293554|P2|STARTED|Overall Study||174
127251|NCT00911300|293555|P1|STARTED|Overall Study||175
127252|NCT00911274|293581|P2|NOT COMPLETED|Period 2||0
127253|NCT00911274|293582|P1|NOT COMPLETED|Period 2||0
127254|NCT00911274|293581|P2|COMPLETED|Period 2||26
127255|NCT00911274|293582|P1|COMPLETED|Period 2||27
127256|NCT00911274|293581|P2|STARTED|Period 2||26
127257|NCT00911274|293582|P1|STARTED|Period 2||27
127258|NCT00911274|293581|P2|NOT COMPLETED|Period 1||0
127259|NCT00911274|293582|P1|NOT COMPLETED|Period 1||0
127260|NCT00911274|293581|P2|COMPLETED|Period 1||26
127261|NCT00911274|293582|P1|COMPLETED|Period 1||27
127262|NCT00911274|293581|P2|STARTED|Period 1||26
127263|NCT00911274|293582|P1|STARTED|Period 1||27
127264|NCT00911170|293592|P2|NOT COMPLETED|Long Term Follow-Up||422
127265|NCT00911170|293593|P1|NOT COMPLETED|Long Term Follow-Up||423
127266|NCT00911170|293592|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
127267|NCT00911170|293593|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
127268|NCT00911170|293592|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
127269|NCT00911170|293593|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
127270|NCT00911170|293592|P2|NOT COMPLETED|Treatment Period||37
127271|NCT00911170|293593|P1|NOT COMPLETED|Treatment Period||27
127272|NCT00911170|293592|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
127273|NCT00911170|293593|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
127274|NCT00911170|293592|P2|Received Investigational Product|Treatment Period||419
127275|NCT00911170|293593|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
127276|NCT00911170|293592|P2|Received Bevacizumab|Treatment Period||420
127277|NCT00911170|293593|P1|Received Bevacizumab|Treatment Period||423
127278|NCT00911170|293592|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
127279|NCT00911170|293593|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
127280|NCT00911170|293592|P2|STARTED|Treatment Period||423
127281|NCT00911170|293593|P1|STARTED|Treatment Period||424
127282|NCT00911157|293617|P2|NOT COMPLETED|Overall Study||2
127283|NCT00911157|293618|P1|NOT COMPLETED|Overall Study||7
127284|NCT00911157|293617|P2|COMPLETED|Overall Study||8
127285|NCT00911157|293618|P1|COMPLETED|Overall Study||22
127286|NCT00911157|293617|P2|STARTED|Overall Study||10
127287|NCT00911157|293618|P1|STARTED|Overall Study||29
127288|NCT00911144|293634|P2|NOT COMPLETED|Overall Study||5
127289|NCT00911144|293635|P1|NOT COMPLETED|Overall Study||16
127290|NCT00911144|293634|P2|COMPLETED|Overall Study||108
127291|NCT00911144|293635|P1|COMPLETED|Overall Study||319
127292|NCT00911144|293634|P2|STARTED|Overall Study||113
127293|NCT00911144|293635|P1|STARTED|Overall Study||335
127294|NCT00910988|293663|P4|NOT COMPLETED|Overall Study||0
127295|NCT00910988|293664|P3|NOT COMPLETED|Overall Study||3
127296|NCT00910988|293665|P2|NOT COMPLETED|Overall Study||4
127297|NCT00910988|293666|P1|NOT COMPLETED|Overall Study||2
127298|NCT00910988|293663|P4|COMPLETED|Overall Study||6
127299|NCT00910988|293664|P3|COMPLETED|Overall Study||5
127300|NCT00910988|293665|P2|COMPLETED|Overall Study||12
127301|NCT00910988|293666|P1|COMPLETED|Overall Study||14
127302|NCT00910988|293663|P4|STARTED|Overall Study||6
127303|NCT00910988|293664|P3|STARTED|Overall Study||8
127304|NCT00910988|293665|P2|STARTED|Overall Study||16
127305|NCT00910988|293666|P1|STARTED|Overall Study||16
127306|NCT00910910|293710|P2|NOT COMPLETED|Overall Study||224
127307|NCT00910910|293711|P1|NOT COMPLETED|Overall Study||225
127308|NCT00910910|293710|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
127309|NCT00910910|293711|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
127310|NCT00910910|293710|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
127311|NCT00910910|293711|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
127312|NCT00910910|293710|P2|STARTED|Overall Study||225
127313|NCT00910910|293711|P1|STARTED|Overall Study||225
127314|NCT00910871|293745|P1|NOT COMPLETED|Overall Study||54
127315|NCT00910871|293745|P1|COMPLETED|Overall Study||179
127316|NCT00910871|293745|P1|STARTED|Overall Study||233
127317|NCT00910858|293753|P3|NOT COMPLETED|Combined Treatment Phase||4
127318|NCT00910858|293754|P2|NOT COMPLETED|Combined Treatment Phase||10
127319|NCT00910858|293755|P1|NOT COMPLETED|Combined Treatment Phase||9
127320|NCT00910858|293753|P3|COMPLETED|Combined Treatment Phase||0
127321|NCT00910858|293754|P2|COMPLETED|Combined Treatment Phase||0
127322|NCT00910858|293755|P1|COMPLETED|Combined Treatment Phase||0
127323|NCT00910858|293753|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
127324|NCT00910858|293754|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
127325|NCT00910858|293755|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
127326|NCT00910858|293753|P3|NOT COMPLETED|Monotherapy Phase||7
127327|NCT00910858|293754|P2|NOT COMPLETED|Monotherapy Phase||15
127328|NCT00910858|293755|P1|NOT COMPLETED|Monotherapy Phase||17
127329|NCT00910858|293753|P3|COMPLETED|Monotherapy Phase||0
127330|NCT00910858|293754|P2|COMPLETED|Monotherapy Phase||0
127331|NCT00910858|293755|P1|COMPLETED|Monotherapy Phase||0
127332|NCT00910858|293753|P3|Pharmacokinetic Population|Monotherapy Phase||7
127333|NCT00910858|293754|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
127334|NCT00910858|293755|P1|Pharmacokinetic Population|Monotherapy Phase||17
127335|NCT00910858|293753|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
127336|NCT00910858|293754|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
127337|NCT00910858|293755|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
127338|NCT00910858|293753|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
127339|NCT00910858|293754|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
127340|NCT00910858|293755|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
127341|NCT00910858|293753|P3|NOT COMPLETED|Pharmacokinetic Phase||0
127342|NCT00910858|293754|P2|NOT COMPLETED|Pharmacokinetic Phase||0
127343|NCT00910858|293755|P1|NOT COMPLETED|Pharmacokinetic Phase||1
127344|NCT00910858|293753|P3|COMPLETED|Pharmacokinetic Phase||3
127345|NCT00910858|293754|P2|COMPLETED|Pharmacokinetic Phase||0
127346|NCT00910858|293755|P1|COMPLETED|Pharmacokinetic Phase||8
127347|NCT00910858|293753|P3|STARTED|Pharmacokinetic Phase||3
127348|NCT00910858|293754|P2|STARTED|Pharmacokinetic Phase||0
127349|NCT00910858|293755|P1|STARTED|Pharmacokinetic Phase||9
127350|NCT00910845|293780|P2|NOT COMPLETED|Treatment Cycle 2||9
127351|NCT00910845|293781|P1|NOT COMPLETED|Treatment Cycle 2||5
127352|NCT00910845|293780|P2|COMPLETED|Treatment Cycle 2||203
127353|NCT00910845|293781|P1|COMPLETED|Treatment Cycle 2||136
127354|NCT00910845|293780|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
127355|NCT00910845|293781|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
127356|NCT00910845|293780|P2|NOT COMPLETED|Treatment Cycle 1||34
127357|NCT00910845|293781|P1|NOT COMPLETED|Treatment Cycle 1||31
127358|NCT00910845|293780|P2|COMPLETED|Treatment Cycle 1||243
127359|NCT00910845|293781|P1|COMPLETED|Treatment Cycle 1||249
127360|NCT00910845|293780|P2|STARTED|Treatment Cycle 1||277
127361|NCT00910845|293781|P1|STARTED|Treatment Cycle 1||280
127362|NCT00910715|293794|P3|NOT COMPLETED|Overall Study||0
127363|NCT00910715|293795|P2|NOT COMPLETED|Overall Study||26
127364|NCT00910715|293796|P1|NOT COMPLETED|Overall Study||22
127365|NCT00910715|293794|P3|COMPLETED|Overall Study||81
127366|NCT00910715|293795|P2|COMPLETED|Overall Study||91
127367|NCT00910715|293796|P1|COMPLETED|Overall Study||86
127368|NCT00910715|293794|P3|STARTED|Overall Study||81
127369|NCT00910715|293795|P2|STARTED|Overall Study||117
127370|NCT00910715|293796|P1|STARTED|Overall Study||108
127371|NCT00910689|293810|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
127372|NCT00910689|293811|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
127373|NCT00910689|293812|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
127374|NCT00910689|293813|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
127375|NCT00910689|293810|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
127376|NCT00910689|293811|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
127377|NCT00910689|293812|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
127378|NCT00910689|293813|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
127379|NCT00910689|293810|P4|STARTED|Months 11- 16: Evaluation Period II||41
127380|NCT00910689|293811|P3|STARTED|Months 11- 16: Evaluation Period II||35
127381|NCT00910689|293812|P2|STARTED|Months 11- 16: Evaluation Period II||35
127382|NCT00910689|293813|P1|STARTED|Months 11- 16: Evaluation Period II||40
127383|NCT00910689|293810|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
127384|NCT00910689|293811|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
127385|NCT00910689|293812|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
127386|NCT00910689|293813|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
127387|NCT00910689|293810|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
127388|NCT00910689|293811|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
127389|NCT00910689|293812|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
127390|NCT00910689|293813|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
127391|NCT00910689|293810|P4|STARTED|Months 5 - 10: Evaluation Period I||48
127392|NCT00910689|293811|P3|STARTED|Months 5 - 10: Evaluation Period I||42
127393|NCT00910689|293812|P2|STARTED|Months 5 - 10: Evaluation Period I||42
127394|NCT00910689|293813|P1|STARTED|Months 5 - 10: Evaluation Period I||44
127395|NCT00910689|293810|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
127396|NCT00910689|293811|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
127397|NCT00910689|293812|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
127398|NCT00910689|293813|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
127399|NCT00910689|293810|P4|COMPLETED|Month 2- 4: Treatment Period||48
127400|NCT00910689|293811|P3|COMPLETED|Month 2- 4: Treatment Period||42
127401|NCT00910689|293812|P2|COMPLETED|Month 2- 4: Treatment Period||42
127402|NCT00910689|293813|P1|COMPLETED|Month 2- 4: Treatment Period||44
127403|NCT00910689|293810|P4|STARTED|Month 2- 4: Treatment Period||59
127404|NCT00910689|293811|P3|STARTED|Month 2- 4: Treatment Period||50
127405|NCT00910689|293812|P2|STARTED|Month 2- 4: Treatment Period||52
127406|NCT00910689|293813|P1|STARTED|Month 2- 4: Treatment Period||53
127407|NCT00910689|293810|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
127408|NCT00910689|293811|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
127409|NCT00910689|293812|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
127410|NCT00910689|293813|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
127411|NCT00910689|293810|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
127412|NCT00910689|293811|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
127413|NCT00910689|293812|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
127414|NCT00910689|293813|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
127415|NCT00910689|293810|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
127416|NCT00910689|293811|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
127417|NCT00910689|293812|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
127418|NCT00910689|293813|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
127419|NCT00910663|293845|P2|NOT COMPLETED|Period 2||0
127420|NCT00910663|293846|P1|NOT COMPLETED|Period 2||0
127421|NCT00910663|293845|P2|COMPLETED|Period 2||29
127422|NCT00910663|293846|P1|COMPLETED|Period 2||30
127423|NCT00910663|293845|P2|STARTED|Period 2||29
127424|NCT00910663|293846|P1|STARTED|Period 2||30
127425|NCT00910663|293845|P2|NOT COMPLETED|Period 1||1
127426|NCT00910663|293846|P1|NOT COMPLETED|Period 1||0
127427|NCT00910663|293845|P2|COMPLETED|Period 1||29
127428|NCT00910663|293846|P1|COMPLETED|Period 1||30
127429|NCT00910663|293845|P2|STARTED|Period 1||30
127430|NCT00910663|293846|P1|STARTED|Period 1||30
127431|NCT00910624|293860|P4|NOT COMPLETED|Follow-Up Phase||0
127432|NCT00910624|293861|P3|NOT COMPLETED|Follow-Up Phase||4
127433|NCT00910624|293862|P2|NOT COMPLETED|Follow-Up Phase||4
127434|NCT00910624|293863|P1|NOT COMPLETED|Follow-Up Phase||6
127435|NCT00910624|293860|P4|COMPLETED|Follow-Up Phase||2
127436|NCT00910624|293861|P3|COMPLETED|Follow-Up Phase||25
127437|NCT00910624|293862|P2|COMPLETED|Follow-Up Phase||76
127438|NCT00910624|293863|P1|COMPLETED|Follow-Up Phase||42
127439|NCT00910624|293860|P4|STARTED|Follow-Up Phase||2
127440|NCT00910624|293861|P3|STARTED|Follow-Up Phase||29
127441|NCT00910624|293862|P2|STARTED|Follow-Up Phase||80
127442|NCT00910624|293863|P1|STARTED|Follow-Up Phase||48
127443|NCT00910624|293860|P4|NOT COMPLETED|Treatment Phase||0
127444|NCT00910624|293861|P3|NOT COMPLETED|Treatment Phase||9
127445|NCT00910624|293862|P2|NOT COMPLETED|Treatment Phase||21
127446|NCT00910624|293863|P1|NOT COMPLETED|Treatment Phase||30
127447|NCT00910624|293860|P4|COMPLETED|Treatment Phase||2
127448|NCT00910624|293861|P3|COMPLETED|Treatment Phase||20
127449|NCT00910624|293862|P2|COMPLETED|Treatment Phase||64
127450|NCT00910624|293863|P1|COMPLETED|Treatment Phase||22
127451|NCT00910624|293860|P4|STARTED|Treatment Phase||2
127452|NCT00910624|293861|P3|STARTED|Treatment Phase||29
127453|NCT00910624|293862|P2|STARTED|Treatment Phase||85
127454|NCT00910624|293863|P1|STARTED|Treatment Phase||52
127455|NCT00910520|293877|P2|NOT COMPLETED|Treatment Cycle 2||8
127456|NCT00910520|293878|P1|NOT COMPLETED|Treatment Cycle 2||7
127457|NCT00910520|293877|P2|COMPLETED|Treatment Cycle 2||215
127458|NCT00910520|293878|P1|COMPLETED|Treatment Cycle 2||156
127459|NCT00910520|293877|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
127460|NCT00910520|293878|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
127461|NCT00910520|293877|P2|NOT COMPLETED|Treatment Cycle 1||24
127462|NCT00910520|293878|P1|NOT COMPLETED|Treatment Cycle 1||20
127463|NCT00910520|293877|P2|COMPLETED|Treatment Cycle 1||247
127464|NCT00910520|293878|P1|COMPLETED|Treatment Cycle 1||257
127465|NCT00910520|293877|P2|STARTED|Treatment Cycle 1||271
127466|NCT00910520|293878|P1|STARTED|Treatment Cycle 1||277
127467|NCT00910299|293890|P2|NOT COMPLETED|Overall Study||74
127468|NCT00910299|293891|P1|NOT COMPLETED|Overall Study||76
127469|NCT00910299|293890|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
127470|NCT00910299|293891|P1|COMPLETED|Overall Study||136
127471|NCT00910299|293890|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
127472|NCT00910299|293891|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
127473|NCT00910299|293890|P2|STARTED|Overall Study||211
127474|NCT00910299|293891|P1|STARTED|Overall Study||212
127475|NCT00910273|293903|P2|NOT COMPLETED|Overall Study||13
127476|NCT00910273|293904|P1|NOT COMPLETED|Overall Study||18
127477|NCT00910273|293903|P2|COMPLETED|Overall Study||3
127478|NCT00910273|293904|P1|COMPLETED|Overall Study||0
127479|NCT00910273|293903|P2|STARTED|Overall Study||16
127480|NCT00910273|293904|P1|STARTED|Overall Study||18
127481|NCT00910091|293956|P2|NOT COMPLETED|Treatment and Survival||4
127482|NCT00910091|293957|P1|NOT COMPLETED|Treatment and Survival||4
127483|NCT00910091|293956|P2|COMPLETED|Treatment and Survival||31
127484|NCT00910091|293957|P1|COMPLETED|Treatment and Survival||32
127485|NCT00910091|293956|P2|STARTED|Treatment and Survival||35
127486|NCT00910091|293957|P1|STARTED|Treatment and Survival||36
127487|NCT00910091|293956|P2|NOT COMPLETED|Pre-assignment||2
127488|NCT00910091|293957|P1|NOT COMPLETED|Pre-assignment||0
127489|NCT00910091|293956|P2|COMPLETED|Pre-assignment||35
127490|NCT00910091|293957|P1|COMPLETED|Pre-assignment||36
127491|NCT00910091|293956|P2|STARTED|Pre-assignment||37
127492|NCT00910091|293957|P1|STARTED|Pre-assignment||36
127493|NCT00910039|293985|P1|NOT COMPLETED|Overall Study||1
127494|NCT00910039|293985|P1|COMPLETED|Overall Study||13
127495|NCT00910039|293985|P1|STARTED|Overall Study||14
127496|NCT00910000|294002|P6|NOT COMPLETED|Overall Study||1
127497|NCT00910000|294003|P5|NOT COMPLETED|Overall Study||1
127498|NCT00910000|294004|P4|NOT COMPLETED|Overall Study||2
127499|NCT00910000|294005|P3|NOT COMPLETED|Overall Study||3
127500|NCT00910000|294006|P2|NOT COMPLETED|Overall Study||3
127501|NCT00910000|294007|P1|NOT COMPLETED|Overall Study||0
127502|NCT00910000|294002|P6|COMPLETED|Overall Study||0
127503|NCT00910000|294003|P5|COMPLETED|Overall Study||2
127504|NCT00910000|294004|P4|COMPLETED|Overall Study||0
127505|NCT00910000|294005|P3|COMPLETED|Overall Study||0
127506|NCT00910000|294006|P2|COMPLETED|Overall Study||0
127507|NCT00910000|294007|P1|COMPLETED|Overall Study||3
127508|NCT00910000|294002|P6|STARTED|Overall Study||1
127509|NCT00910000|294003|P5|STARTED|Overall Study||3
127510|NCT00910000|294004|P4|STARTED|Overall Study||2
127511|NCT00910000|294005|P3|STARTED|Overall Study||3
127512|NCT00910000|294006|P2|STARTED|Overall Study||3
127513|NCT00910000|294007|P1|STARTED|Overall Study||3
127514|NCT00909870|294025|P2|NOT COMPLETED|Overall Study||27
127515|NCT00909870|294026|P1|NOT COMPLETED|Overall Study||23
127516|NCT00909870|294025|P2|COMPLETED|Overall Study||236
127517|NCT00909870|294026|P1|COMPLETED|Overall Study||251
127518|NCT00909870|294025|P2|STARTED|Overall Study||263
127519|NCT00909870|294026|P1|STARTED|Overall Study||274
127520|NCT00909857|294038|P2|NOT COMPLETED|Overall Study||45
127521|NCT00909857|294039|P1|NOT COMPLETED|Overall Study||36
127522|NCT00909857|294038|P2|COMPLETED|Overall Study||209
127523|NCT00909857|294039|P1|COMPLETED|Overall Study||217
127524|NCT00909857|294038|P2|Treated|Overall Study||230
127525|NCT00909857|294039|P1|Treated|Overall Study||234
127526|NCT00909857|294038|P2|STARTED|Overall Study||254
127527|NCT00909857|294039|P1|STARTED|Overall Study||253
127528|NCT00909792|294179|P2|NOT COMPLETED|Period 2||1
127529|NCT00909792|294180|P1|NOT COMPLETED|Period 2||1
127530|NCT00909792|294179|P2|COMPLETED|Period 2||124
127531|NCT00909792|294180|P1|COMPLETED|Period 2||128
127532|NCT00909792|294179|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
127533|NCT00909792|294180|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
127534|NCT00909792|294179|P2|NOT COMPLETED|Period 1||1
127535|NCT00909792|294180|P1|NOT COMPLETED|Period 1||0
127536|NCT00909792|294179|P2|COMPLETED|Period 1||127
127537|NCT00909792|294180|P1|COMPLETED|Period 1||130
127538|NCT00909792|294179|P2|STARTED|Period 1||128
127539|NCT00909792|294180|P1|STARTED|Period 1||130
127540|NCT00909779|294188|P2|NOT COMPLETED|Overall Study||165
127541|NCT00909779|294189|P1|NOT COMPLETED|Overall Study||210
127542|NCT00909779|294188|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
127543|NCT00909779|294189|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
127544|NCT00909779|294188|P2|STARTED|Overall Study||420
127545|NCT00909779|294189|P1|STARTED|Overall Study||421
127546|NCT00909753|294213|P2|NOT COMPLETED|Period: Second Intervention||0
127547|NCT00909753|294214|P1|NOT COMPLETED|Period: Second Intervention||1
127548|NCT00909753|294213|P2|COMPLETED|Period: Second Intervention||43
127549|NCT00909753|294214|P1|COMPLETED|Period: Second Intervention||43
127550|NCT00909753|294213|P2|STARTED|Period: Second Intervention||43
127551|NCT00909753|294214|P1|STARTED|Period: Second Intervention||44
127552|NCT00909753|294213|P2|NOT COMPLETED|Period: Washout of 28 Days||3
127553|NCT00909753|294214|P1|NOT COMPLETED|Period: Washout of 28 Days||2
127554|NCT00909753|294213|P2|COMPLETED|Period: Washout of 28 Days||43
127555|NCT00909753|294214|P1|COMPLETED|Period: Washout of 28 Days||44
127556|NCT00909753|294213|P2|STARTED|Period: Washout of 28 Days||46
127557|NCT00909753|294214|P1|STARTED|Period: Washout of 28 Days||46
127558|NCT00909753|294213|P2|NOT COMPLETED|Period: First Intervention||0
127559|NCT00909753|294214|P1|NOT COMPLETED|Period: First Intervention||0
127560|NCT00909753|294213|P2|COMPLETED|Period: First Intervention||46
127561|NCT00909753|294214|P1|COMPLETED|Period: First Intervention||46
127562|NCT00909753|294213|P2|STARTED|Period: First Intervention||46
127563|NCT00909753|294214|P1|STARTED|Period: First Intervention||46
127564|NCT00909727|294234|P2|NOT COMPLETED|Overall Study||0
127565|NCT00909727|294235|P1|NOT COMPLETED|Overall Study||4
127566|NCT00909727|294234|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
127567|NCT00909727|294235|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
127568|NCT00909727|294234|P2|Completed Treatment Period, Week 24|Overall Study||26
127569|NCT00909727|294235|P1|Completed Treatment Period, Week 24|Overall Study||23
127570|NCT00909727|294234|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
127571|NCT00909727|294235|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
127572|NCT00909649|294251|P2|NOT COMPLETED|Overall Study||0
127573|NCT00909649|294252|P1|NOT COMPLETED|Overall Study||0
127574|NCT00909649|294251|P2|COMPLETED|Overall Study||25
127575|NCT00909649|294252|P1|COMPLETED|Overall Study||25
127576|NCT00909649|294251|P2|STARTED|Overall Study||25
127577|NCT00909649|294252|P1|STARTED|Overall Study||25
127578|NCT00909610|294258|P2|NOT COMPLETED|Period: Second Intervention||0
127579|NCT00909610|294259|P1|NOT COMPLETED|Period: Second Intervention||1
127580|NCT00909610|294258|P2|COMPLETED|Period: Second Intervention||33
127581|NCT00909610|294259|P1|COMPLETED|Period: Second Intervention||36
127582|NCT00909610|294258|P2|STARTED|Period: Second Intervention||33
127583|NCT00909610|294259|P1|STARTED|Period: Second Intervention||37
127584|NCT00909610|294258|P2|NOT COMPLETED|Period: Washout of 28 Days||6
127585|NCT00909610|294259|P1|NOT COMPLETED|Period: Washout of 28 Days||3
127586|NCT00909610|294258|P2|COMPLETED|Period: Washout of 28 Days||33
127587|NCT00909610|294259|P1|COMPLETED|Period: Washout of 28 Days||37
127588|NCT00909610|294258|P2|STARTED|Period: Washout of 28 Days||39
127589|NCT00909610|294259|P1|STARTED|Period: Washout of 28 Days||40
127590|NCT00909610|294258|P2|NOT COMPLETED|Period: First Intervention||1
127591|NCT00909610|294259|P1|NOT COMPLETED|Period: First Intervention||0
127592|NCT00909610|294258|P2|COMPLETED|Period: First Intervention||39
127593|NCT00909610|294259|P1|COMPLETED|Period: First Intervention||40
127594|NCT00909610|294258|P2|STARTED|Period: First Intervention||40
127595|NCT00909610|294259|P1|STARTED|Period: First Intervention||40
127596|NCT00909545|294281|P4|NOT COMPLETED|Overall Study||5
127597|NCT00909545|294282|P3|NOT COMPLETED|Overall Study||1
127598|NCT00909545|294283|P2|NOT COMPLETED|Overall Study||1
127599|NCT00909545|294284|P1|NOT COMPLETED|Overall Study||1
127600|NCT00909545|294281|P4|COMPLETED|Overall Study||19
127601|NCT00909545|294282|P3|COMPLETED|Overall Study||25
127602|NCT00909545|294283|P2|COMPLETED|Overall Study||22
127603|NCT00909545|294284|P1|COMPLETED|Overall Study||25
127604|NCT00909545|294281|P4|STARTED|Overall Study||24
127605|NCT00909545|294282|P3|STARTED|Overall Study||26
127606|NCT00909545|294283|P2|STARTED|Overall Study||23
127607|NCT00909545|294284|P1|STARTED|Overall Study||26
127608|NCT00909532|294420|P2|NOT COMPLETED|Overall Study||6
127609|NCT00909532|294421|P1|NOT COMPLETED|Overall Study||10
127610|NCT00909532|294420|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
127611|NCT00909532|294421|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
127612|NCT00909532|294420|P2|Completed Treatment Period, Week 24|Overall Study||80
127613|NCT00909532|294421|P1|Completed Treatment Period, Week 24|Overall Study||71
127614|NCT00909532|294420|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
127615|NCT00909532|294421|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
127616|NCT00909480|294439|P2|NOT COMPLETED|Overall Study||41
127617|NCT00909480|294440|P1|NOT COMPLETED|Overall Study||38
127618|NCT00909480|294439|P2|COMPLETED|Overall Study||188
127619|NCT00909480|294440|P1|COMPLETED|Overall Study||190
127620|NCT00909480|294439|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
127621|NCT00909480|294440|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
127622|NCT00909480|294439|P2|STARTED|Overall Study||229
127623|NCT00909480|294440|P1|STARTED|Overall Study||228
127624|NCT00909389|294472|P1|NOT COMPLETED|Overall Study||133
127625|NCT00909389|294472|P1|COMPLETED|Overall Study||4615
127626|NCT00909389|294472|P1|STARTED|Overall Study||4748
127627|NCT00909324|294478|P2|NOT COMPLETED|Overall Study||0
127628|NCT00909324|294479|P1|NOT COMPLETED|Overall Study||0
127629|NCT00909324|294478|P2|COMPLETED|Overall Study||90
127630|NCT00909324|294479|P1|COMPLETED|Overall Study||72
127631|NCT00909324|294478|P2|STARTED|Overall Study||90
127632|NCT00909324|294479|P1|STARTED|Overall Study||72
127633|NCT00909181|294492|P3|NOT COMPLETED|Overall Study||33
127634|NCT00909181|294493|P2|NOT COMPLETED|Overall Study||18
127635|NCT00909181|294494|P1|NOT COMPLETED|Overall Study||39
127636|NCT00909181|294492|P3|COMPLETED|Overall Study||169
127637|NCT00909181|294493|P2|COMPLETED|Overall Study||196
127638|NCT00909181|294494|P1|COMPLETED|Overall Study||171
127639|NCT00909181|294492|P3|STARTED|Overall Study||202
127640|NCT00909181|294493|P2|STARTED|Overall Study||214
127641|NCT00909181|294494|P1|STARTED|Overall Study||210
127642|NCT00909155|294505|P3|NOT COMPLETED|Overall Study||7
127643|NCT00909155|294506|P2|NOT COMPLETED|Overall Study||5
127644|NCT00909155|294507|P1|NOT COMPLETED|Overall Study||3
127645|NCT00909155|294505|P3|COMPLETED|Overall Study||14
127646|NCT00909155|294506|P2|COMPLETED|Overall Study||9
127647|NCT00909155|294507|P1|COMPLETED|Overall Study||12
127648|NCT00909155|294505|P3|STARTED|Overall Study||21
127649|NCT00909155|294506|P2|STARTED|Overall Study||14
127650|NCT00909155|294507|P1|STARTED|Overall Study||15
127651|NCT00909038|294515|P1|NOT COMPLETED|Overall Study||417
127652|NCT00909038|294515|P1|COMPLETED|Overall Study||1994
127653|NCT00909038|294515|P1|STARTED|Overall Study||2411
127654|NCT00908960|294527|P3|NOT COMPLETED|Overall Study||2
127655|NCT00908960|294528|P2|NOT COMPLETED|Overall Study||1
127656|NCT00908960|294529|P1|NOT COMPLETED|Overall Study||1
127657|NCT00908960|294527|P3|COMPLETED|Overall Study||32
127658|NCT00908960|294528|P2|COMPLETED|Overall Study||11
127659|NCT00908960|294529|P1|COMPLETED|Overall Study||23
127660|NCT00908960|294527|P3|STARTED|Overall Study||34
127661|NCT00908960|294528|P2|STARTED|Overall Study||12
127662|NCT00908960|294529|P1|STARTED|Overall Study||24
127663|NCT00908908|294537|P1|NOT COMPLETED|Overall Study||0
127664|NCT00908908|294537|P1|COMPLETED|Overall Study||6
127665|NCT00908908|294537|P1|Physician Decision|Overall Study||0
127666|NCT00908908|294537|P1|Administrative/Other|Overall Study||0
127667|NCT00908908|294537|P1|Withdrawl by Subject|Overall Study||0
127668|NCT00908908|294537|P1|Adverse Event|Overall Study||0
127669|NCT00908908|294537|P1|STARTED|Overall Study||6
127670|NCT00908895|294545|P2|NOT COMPLETED|Overall Study||6
127671|NCT00908895|294546|P1|NOT COMPLETED|Overall Study||4
127672|NCT00908895|294545|P2|COMPLETED|Overall Study||57
127673|NCT00908895|294546|P1|COMPLETED|Overall Study||53
127674|NCT00908895|294545|P2|STARTED|Overall Study||63
127675|NCT00908895|294546|P1|STARTED|Overall Study||57
127676|NCT00908882|294556|P2|NOT COMPLETED|Overall Study||30
127677|NCT00908882|294557|P1|NOT COMPLETED|Overall Study||28
127678|NCT00908882|294556|P2|COMPLETED|Overall Study||59
127679|NCT00908882|294557|P1|COMPLETED|Overall Study||61
127680|NCT00908882|294556|P2|STARTED|Overall Study||89
127681|NCT00908882|294557|P1|STARTED|Overall Study||89
127682|NCT00908687|294587|P6|NOT COMPLETED|Overall Study||6
127683|NCT00908687|294588|P5|NOT COMPLETED|Overall Study||4
127684|NCT00908687|294589|P4|NOT COMPLETED|Overall Study||3
127685|NCT00908687|294590|P3|NOT COMPLETED|Overall Study||3
127686|NCT00908687|294591|P2|NOT COMPLETED|Overall Study||1
127687|NCT00908687|294592|P1|NOT COMPLETED|Overall Study||1
127688|NCT00908687|294587|P6|COMPLETED|Overall Study||94
127689|NCT00908687|294588|P5|COMPLETED|Overall Study||94
127690|NCT00908687|294589|P4|COMPLETED|Overall Study||47
127691|NCT00908687|294590|P3|COMPLETED|Overall Study||99
127692|NCT00908687|294591|P2|COMPLETED|Overall Study||99
127693|NCT00908687|294592|P1|COMPLETED|Overall Study||49
127694|NCT00908687|294587|P6|STARTED|Overall Study||100
127695|NCT00908687|294588|P5|STARTED|Overall Study||98
127696|NCT00908687|294589|P4|STARTED|Overall Study||50
127697|NCT00908687|294590|P3|STARTED|Overall Study||102
127698|NCT00908687|294591|P2|STARTED|Overall Study||100
127699|NCT00908687|294592|P1|STARTED|Overall Study||50
127700|NCT00908648|294608|P2|NOT COMPLETED|Overall Study||0
127701|NCT00908648|294609|P1|NOT COMPLETED|Overall Study||0
127702|NCT00908648|294608|P2|COMPLETED|Overall Study||103
127703|NCT00908648|294609|P1|COMPLETED|Overall Study||108
127704|NCT00908648|294608|P2|STARTED|Overall Study||103
127705|NCT00908648|294609|P1|STARTED|Overall Study||108
127706|NCT00908596|294619|P4|NOT COMPLETED|Overall Study||37
127707|NCT00908596|294620|P3|NOT COMPLETED|Overall Study||74
127708|NCT00908596|294621|P2|NOT COMPLETED|Overall Study||13
127709|NCT00908596|294622|P1|NOT COMPLETED|Overall Study||47
127710|NCT00908596|294619|P4|COMPLETED|Overall Study||48
127711|NCT00908596|294620|P3|COMPLETED|Overall Study||119
127712|NCT00908596|294621|P2|COMPLETED|Overall Study||19
127713|NCT00908596|294622|P1|COMPLETED|Overall Study||0
127714|NCT00908596|294619|P4|STARTED|Overall Study||85
127715|NCT00908596|294620|P3|STARTED|Overall Study||193
127716|NCT00908596|294621|P2|STARTED|Overall Study||32
127717|NCT00908596|294622|P1|STARTED|Overall Study||47
127718|NCT00908583|294652|P1|NOT COMPLETED|Phase 5||3
127719|NCT00908583|294652|P1|COMPLETED|Phase 5||2
127720|NCT00908583|294652|P1|STARTED|Phase 5||5
127721|NCT00908583|294652|P1|NOT COMPLETED|Phase 4||2
127722|NCT00908583|294652|P1|COMPLETED|Phase 4||3
127723|NCT00908583|294652|P1|STARTED|Phase 4||5
127724|NCT00908583|294652|P1|NOT COMPLETED|Phase 3||2
127725|NCT00908583|294652|P1|COMPLETED|Phase 3||8
127726|NCT00908583|294652|P1|STARTED|Phase 3||10
127727|NCT00908583|294652|P1|NOT COMPLETED|Phase 2||2
127728|NCT00908583|294652|P1|COMPLETED|Phase 2||10
127729|NCT00908583|294652|P1|STARTED|Phase 2||12
127730|NCT00908583|294652|P1|NOT COMPLETED|Phase 1||5
127731|NCT00908583|294652|P1|COMPLETED|Phase 1||15
127732|NCT00908583|294652|P1|STARTED|Phase 1||20
127733|NCT00908388|294670|P1|NOT COMPLETED|Overall Study||10
127734|NCT00908388|294670|P1|COMPLETED|Overall Study||40
127735|NCT00908388|294670|P1|STARTED|Overall Study||50
127736|NCT00908375|294680|P2|NOT COMPLETED|Overall Study||10
127737|NCT00908375|294681|P1|NOT COMPLETED|Overall Study||10
127738|NCT00908375|294680|P2|COMPLETED|Overall Study||9
127739|NCT00908375|294681|P1|COMPLETED|Overall Study||10
127740|NCT00908375|294680|P2|STARTED|Overall Study||19
127741|NCT00908375|294681|P1|STARTED|Overall Study||20
127742|NCT00908310|294691|P1|NOT COMPLETED|Overall Study||60
127743|NCT00908310|294691|P1|COMPLETED|Overall Study||153
127744|NCT00908310|294691|P1|STARTED|Overall Study||213
127745|NCT00908232|294695|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
127746|NCT00908232|294696|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
127747|NCT00908232|294697|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
127748|NCT00908232|294698|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
127749|NCT00908232|294695|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
127750|NCT00908232|294696|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
127751|NCT00908232|294697|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
127752|NCT00908232|294698|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
127753|NCT00908232|294695|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
127754|NCT00908232|294696|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
127755|NCT00908232|294697|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
127756|NCT00908232|294698|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
127757|NCT00908232|294695|P4|NOT COMPLETED|Cycle 1 to 4||0
127758|NCT00908232|294696|P3|NOT COMPLETED|Cycle 1 to 4||0
127759|NCT00908232|294697|P2|NOT COMPLETED|Cycle 1 to 4||0
127760|NCT00908232|294698|P1|NOT COMPLETED|Cycle 1 to 4||28
127761|NCT00908232|294695|P4|COMPLETED|Cycle 1 to 4||0
127762|NCT00908232|294696|P3|COMPLETED|Cycle 1 to 4||0
127763|NCT00908232|294697|P2|COMPLETED|Cycle 1 to 4||0
127764|NCT00908232|294698|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
127765|NCT00908232|294695|P4|STARTED|Cycle 1 to 4||0
127766|NCT00908232|294696|P3|STARTED|Cycle 1 to 4||0
127767|NCT00908232|294697|P2|STARTED|Cycle 1 to 4||0
127768|NCT00908232|294698|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
127769|NCT00908141|294716|P2|NOT COMPLETED|Overall Study||1
127770|NCT00908141|294717|P1|NOT COMPLETED|Overall Study||0
127771|NCT00908141|294716|P2|COMPLETED|Overall Study||8
127772|NCT00908141|294717|P1|COMPLETED|Overall Study||8
127773|NCT00908141|294716|P2|STARTED|Overall Study||9
127774|NCT00908141|294717|P1|STARTED|Overall Study||8
127775|NCT00908128|294725|P2|NOT COMPLETED|Period 4||0
127776|NCT00908128|294726|P1|NOT COMPLETED|Period 4||0
127777|NCT00908128|294725|P2|COMPLETED|Period 4||19
127778|NCT00908128|294726|P1|COMPLETED|Period 4||20
127779|NCT00908128|294725|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
127780|NCT00908128|294726|P1|STARTED|Period 4||20
127781|NCT00908128|294725|P2|NOT COMPLETED|Period 3||0
127782|NCT00908128|294726|P1|NOT COMPLETED|Period 3||0
127783|NCT00908128|294725|P2|COMPLETED|Period 3||20
127784|NCT00908128|294726|P1|COMPLETED|Period 3||20
127785|NCT00908128|294725|P2|STARTED|Period 3||20
127786|NCT00908128|294726|P1|STARTED|Period 3||20
127787|NCT00908128|294725|P2|NOT COMPLETED|Period 2||0
127788|NCT00908128|294726|P1|NOT COMPLETED|Period 2||0
127789|NCT00908128|294725|P2|COMPLETED|Period 2||20
127790|NCT00908128|294726|P1|COMPLETED|Period 2||20
127791|NCT00908128|294725|P2|STARTED|Period 2||20
127792|NCT00908128|294726|P1|STARTED|Period 2||20
127793|NCT00908128|294725|P2|NOT COMPLETED|Period 1||0
127794|NCT00908128|294726|P1|NOT COMPLETED|Period 1||0
127795|NCT00908128|294725|P2|COMPLETED|Period 1||20
127796|NCT00908128|294726|P1|COMPLETED|Period 1||20
127797|NCT00908128|294725|P2|STARTED|Period 1||20
127798|NCT00908128|294726|P1|STARTED|Period 1||20
127799|NCT00908115|294734|P1|NOT COMPLETED|Overall Study||14
127800|NCT00908115|294734|P1|COMPLETED|Overall Study||1244
127801|NCT00908115|294734|P1|STARTED|Overall Study||1258
127802|NCT00908076|294742|P2|NOT COMPLETED|Overall Study||1
127803|NCT00908076|294743|P1|NOT COMPLETED|Overall Study||1
127804|NCT00908076|294742|P2|COMPLETED|Overall Study||26
127805|NCT00908076|294743|P1|COMPLETED|Overall Study||26
127806|NCT00908076|294742|P2|STARTED|Overall Study||27
127807|NCT00908076|294743|P1|STARTED|Overall Study||27
127808|NCT00908037|294756|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
127809|NCT00908037|294757|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
127810|NCT00908037|294758|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
127811|NCT00908037|294759|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127812|NCT00908037|294760|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127813|NCT00908037|294761|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127814|NCT00908037|294762|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127815|NCT00908037|294763|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127816|NCT00908037|294764|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127817|NCT00908037|294765|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127818|NCT00908037|294766|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127819|NCT00908037|294767|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127820|NCT00908037|294756|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
127821|NCT00908037|294757|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
127822|NCT00908037|294758|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
127823|NCT00908037|294759|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127824|NCT00908037|294760|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127825|NCT00908037|294761|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127826|NCT00908037|294762|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127827|NCT00908037|294763|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127828|NCT00908037|294764|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127829|NCT00908037|294765|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127830|NCT00908037|294766|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127831|NCT00908037|294767|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
127832|NCT00908037|294756|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
127833|NCT00908037|294757|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
127834|NCT00908037|294758|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
127835|NCT00908037|294759|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127836|NCT00908037|294760|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127837|NCT00908037|294761|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127838|NCT00908037|294762|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127839|NCT00908037|294763|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127840|NCT00908037|294764|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127841|NCT00908037|294765|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127842|NCT00908037|294766|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127843|NCT00908037|294767|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
127844|NCT00908037|294756|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127845|NCT00908037|294757|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127846|NCT00908037|294758|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127847|NCT00908037|294759|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
127848|NCT00908037|294760|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127849|NCT00908037|294761|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
127850|NCT00908037|294762|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127851|NCT00908037|294763|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
127852|NCT00908037|294764|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
127853|NCT00908037|294765|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127854|NCT00908037|294766|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127855|NCT00908037|294767|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
127856|NCT00908037|294756|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
127857|NCT00908037|294757|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
127858|NCT00908037|294758|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
127859|NCT00908037|294759|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
127860|NCT00908037|294760|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
127861|NCT00908037|294761|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
127862|NCT00908037|294762|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
127863|NCT00908037|294763|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
127864|NCT00908037|294764|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
127865|NCT00908037|294765|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
127866|NCT00908037|294766|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
127867|NCT00908037|294767|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
127868|NCT00908037|294756|P12|STARTED|Part 2 (7 Week Randomized Period)||0
127869|NCT00908037|294757|P11|STARTED|Part 2 (7 Week Randomized Period)||0
127870|NCT00908037|294758|P10|STARTED|Part 2 (7 Week Randomized Period)||0
127871|NCT00908037|294759|P9|STARTED|Part 2 (7 Week Randomized Period)||10
127872|NCT00908037|294760|P8|STARTED|Part 2 (7 Week Randomized Period)||5
127873|NCT00908037|294761|P7|STARTED|Part 2 (7 Week Randomized Period)||19
127874|NCT00908037|294762|P6|STARTED|Part 2 (7 Week Randomized Period)||9
127875|NCT00908037|294763|P5|STARTED|Part 2 (7 Week Randomized Period)||16
127876|NCT00908037|294764|P4|STARTED|Part 2 (7 Week Randomized Period)||8
127877|NCT00908037|294765|P3|STARTED|Part 2 (7 Week Randomized Period)||0
127878|NCT00908037|294766|P2|STARTED|Part 2 (7 Week Randomized Period)||0
127879|NCT00908037|294767|P1|STARTED|Part 2 (7 Week Randomized Period)||0
127880|NCT00908037|294756|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127881|NCT00908037|294757|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127882|NCT00908037|294758|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127883|NCT00908037|294759|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127884|NCT00908037|294760|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127885|NCT00908037|294761|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127886|NCT00908037|294762|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127887|NCT00908037|294763|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127888|NCT00908037|294764|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127889|NCT00908037|294765|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127890|NCT00908037|294766|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127891|NCT00908037|294767|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127892|NCT00908037|294756|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127893|NCT00908037|294757|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127894|NCT00908037|294758|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127895|NCT00908037|294759|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127896|NCT00908037|294760|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127897|NCT00908037|294761|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127898|NCT00908037|294762|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127899|NCT00908037|294763|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127900|NCT00908037|294764|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
127901|NCT00908037|294765|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
127902|NCT00908037|294766|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
127903|NCT00908037|294767|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
127904|NCT00908037|294756|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
127905|NCT00908037|294757|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
127906|NCT00908037|294758|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
127907|NCT00908037|294759|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
127908|NCT00908037|294760|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
127909|NCT00908037|294761|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
127910|NCT00908037|294762|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
127911|NCT00908037|294763|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
127912|NCT00908037|294764|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
127913|NCT00908037|294765|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
127914|NCT00908037|294766|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
127915|NCT00908037|294767|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
127916|NCT00908011|294916|P2|NOT COMPLETED|Overall Study||2
127917|NCT00908011|294917|P1|NOT COMPLETED|Overall Study||2
127918|NCT00908011|294916|P2|COMPLETED|Overall Study||18
127919|NCT00908011|294917|P1|COMPLETED|Overall Study||21
127920|NCT00908011|294916|P2|STARTED|Overall Study||20
127921|NCT00908011|294917|P1|STARTED|Overall Study||23
127922|NCT00907907|294925|P2|NOT COMPLETED|Period 4||0
127923|NCT00907907|294926|P1|NOT COMPLETED|Period 4||0
127924|NCT00907907|294925|P2|COMPLETED|Period 4||18
127925|NCT00907907|294926|P1|COMPLETED|Period 4||19
127926|NCT00907907|294925|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
127927|NCT00907907|294926|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
127928|NCT00907907|294925|P2|NOT COMPLETED|Period 3||0
127929|NCT00907907|294926|P1|NOT COMPLETED|Period 3||0
127930|NCT00907907|294925|P2|COMPLETED|Period 3||20
127931|NCT00907907|294926|P1|COMPLETED|Period 3||20
127932|NCT00907907|294925|P2|STARTED|Period 3||20
127933|NCT00907907|294926|P1|STARTED|Period 3||20
127934|NCT00907907|294925|P2|NOT COMPLETED|Period 2||0
127935|NCT00907907|294926|P1|NOT COMPLETED|Period 2||0
127936|NCT00907907|294925|P2|COMPLETED|Period 2||20
127937|NCT00907907|294926|P1|COMPLETED|Period 2||20
127938|NCT00907907|294925|P2|STARTED|Period 2||20
127939|NCT00907907|294926|P1|STARTED|Period 2||20
127940|NCT00907907|294925|P2|NOT COMPLETED|Period 1||0
127941|NCT00907907|294926|P1|NOT COMPLETED|Period 1||0
127942|NCT00907907|294925|P2|COMPLETED|Period 1||20
127943|NCT00907907|294926|P1|COMPLETED|Period 1||20
127944|NCT00907907|294925|P2|STARTED|Period 1||20
127945|NCT00907907|294926|P1|STARTED|Period 1||20
127946|NCT00907881|294934|P1|NOT COMPLETED|Overall Study||85
127947|NCT00907881|294934|P1|COMPLETED|Overall Study||984
127948|NCT00907881|294934|P1|STARTED|Overall Study||1069
127949|NCT00907803|294944|P3|NOT COMPLETED|Overall Study||0
127950|NCT00907803|294945|P2|NOT COMPLETED|Overall Study||3
127951|NCT00907803|294946|P1|NOT COMPLETED|Overall Study||3
127952|NCT00907803|294944|P3|COMPLETED|Overall Study||16
127953|NCT00907803|294945|P2|COMPLETED|Overall Study||43
127954|NCT00907803|294946|P1|COMPLETED|Overall Study||42
127955|NCT00907803|294944|P3|STARTED|Overall Study||16
127956|NCT00907803|294945|P2|STARTED|Overall Study||46
127957|NCT00907803|294946|P1|STARTED|Overall Study||45
127958|NCT00907777|294977|P2|NOT COMPLETED|Overall Study||1
127959|NCT00907777|294978|P1|NOT COMPLETED|Overall Study||0
127960|NCT00907777|294977|P2|COMPLETED|Overall Study||26
127961|NCT00907777|294978|P1|COMPLETED|Overall Study||25
127962|NCT00907777|294977|P2|STARTED|Overall Study||27
127963|NCT00907777|294978|P1|STARTED|Overall Study||25
127964|NCT00907738|295005|P5|NOT COMPLETED|Overall Study||2
127965|NCT00907738|295006|P4|NOT COMPLETED|Overall Study||4
127966|NCT00907738|295007|P3|NOT COMPLETED|Overall Study||7
127967|NCT00907738|295008|P2|NOT COMPLETED|Overall Study||1
127968|NCT00907738|295009|P1|NOT COMPLETED|Overall Study||13
127969|NCT00907738|295005|P5|COMPLETED|Overall Study||0
127970|NCT00907738|295006|P4|COMPLETED|Overall Study||0
127971|NCT00907738|295007|P3|COMPLETED|Overall Study||0
127972|NCT00907738|295008|P2|COMPLETED|Overall Study||0
127973|NCT00907738|295009|P1|COMPLETED|Overall Study||0
127974|NCT00907738|295005|P5|STARTED|Overall Study||2
127975|NCT00907738|295006|P4|STARTED|Overall Study||4
127976|NCT00907738|295007|P3|STARTED|Overall Study||7
127977|NCT00907738|295008|P2|STARTED|Overall Study||1
127978|NCT00907738|295009|P1|STARTED|Overall Study||13
127979|NCT00907621|295027|P2|NOT COMPLETED|Overall Study||4
127980|NCT00907621|295028|P1|NOT COMPLETED|Overall Study||7
127981|NCT00907621|295027|P2|COMPLETED|Overall Study||41
127982|NCT00907621|295028|P1|COMPLETED|Overall Study||38
127983|NCT00907621|295027|P2|STARTED|Overall Study||45
127984|NCT00907621|295028|P1|STARTED|Overall Study||45
127985|NCT00907517|295041|P5|NOT COMPLETED|Overall Study||5
127986|NCT00907517|295042|P4|NOT COMPLETED|Overall Study||4
127987|NCT00907517|295043|P3|NOT COMPLETED|Overall Study||4
127988|NCT00907517|295044|P2|NOT COMPLETED|Overall Study||3
127989|NCT00907517|295045|P1|NOT COMPLETED|Overall Study||3
127990|NCT00907517|295041|P5|COMPLETED|Overall Study||1
127991|NCT00907517|295042|P4|COMPLETED|Overall Study||2
127992|NCT00907517|295043|P3|COMPLETED|Overall Study||2
127993|NCT00907517|295044|P2|COMPLETED|Overall Study||0
127994|NCT00907517|295045|P1|COMPLETED|Overall Study||0
127995|NCT00907517|295041|P5|STARTED|Overall Study||6
127996|NCT00907517|295042|P4|STARTED|Overall Study||6
127997|NCT00907517|295043|P3|STARTED|Overall Study||6
127998|NCT00907517|295044|P2|STARTED|Overall Study||3
127999|NCT00907517|295045|P1|STARTED|Overall Study||3
128000|NCT00907478|295070|P3|NOT COMPLETED|Overall Study||22
128001|NCT00907478|295071|P2|NOT COMPLETED|Overall Study||17
128002|NCT00907478|295072|P1|NOT COMPLETED|Overall Study||27
128003|NCT00907478|295070|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
128004|NCT00907478|295071|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
128005|NCT00907478|295072|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
128006|NCT00907478|295070|P3|STARTED|Overall Study||69
128007|NCT00907478|295071|P2|STARTED|Overall Study||50
128008|NCT00907478|295072|P1|STARTED|Overall Study||50
128009|NCT00907426|295103|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
128010|NCT00907426|295104|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
128011|NCT00907426|295105|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
128012|NCT00907426|295103|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
128013|NCT00907426|295104|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
128014|NCT00907426|295105|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
128015|NCT00907426|295103|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
128016|NCT00907426|295104|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
128017|NCT00907426|295105|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
128018|NCT00907426|295103|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
128019|NCT00907426|295104|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
128020|NCT00907426|295105|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
128021|NCT00907426|295103|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
128022|NCT00907426|295104|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
128023|NCT00907426|295105|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
128024|NCT00907426|295103|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
128025|NCT00907426|295104|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
128026|NCT00907426|295105|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
128027|NCT00907374|295122|P2|NOT COMPLETED|Overall Study||2
128028|NCT00907374|295123|P1|NOT COMPLETED|Overall Study||2
128029|NCT00907374|295122|P2|COMPLETED|Overall Study||11
128030|NCT00907374|295123|P1|COMPLETED|Overall Study||12
128031|NCT00907374|295122|P2|STARTED|Overall Study||13
128032|NCT00907374|295123|P1|STARTED|Overall Study||14
128033|NCT00907335|295137|P2|NOT COMPLETED|Overall Study||1
128034|NCT00907335|295138|P1|NOT COMPLETED|Overall Study||8
128035|NCT00907335|295137|P2|COMPLETED|Overall Study||54
128036|NCT00907335|295138|P1|COMPLETED|Overall Study||47
128037|NCT00907335|295137|P2|STARTED|Overall Study||55
128038|NCT00907335|295138|P1|STARTED|Overall Study||55
128039|NCT00907257|295156|P2|NOT COMPLETED|Overall Study||12
128040|NCT00907257|295157|P1|NOT COMPLETED|Overall Study||13
128041|NCT00907257|295156|P2|COMPLETED|Overall Study||112
128042|NCT00907257|295157|P1|COMPLETED|Overall Study||110
128043|NCT00907257|295156|P2|STARTED|Overall Study||124
128044|NCT00907257|295157|P1|STARTED|Overall Study||123
128045|NCT00907218|295167|P1|NOT COMPLETED|Overall Study||0
128046|NCT00907218|295167|P1|COMPLETED|Overall Study||2
128047|NCT00907218|295167|P1|STARTED|Overall Study||2
128048|NCT00907101|295171|P1|NOT COMPLETED|Overall Study||0
128049|NCT00907101|295171|P1|COMPLETED|Overall Study||30
128050|NCT00907101|295171|P1|STARTED|Overall Study||30
128051|NCT00907088|295181|P2|NOT COMPLETED|Overall Study||30
128052|NCT00907088|295182|P1|NOT COMPLETED|Overall Study||20
128053|NCT00907088|295181|P2|COMPLETED|Overall Study||99
128054|NCT00907088|295182|P1|COMPLETED|Overall Study||102
128055|NCT00907088|295181|P2|STARTED|Overall Study||129
128056|NCT00907088|295182|P1|STARTED|Overall Study||122
128057|NCT00906971|295190|P2|NOT COMPLETED|Overall Study||3
128058|NCT00906971|295191|P1|NOT COMPLETED|Overall Study||8
128059|NCT00906971|295190|P2|COMPLETED|Overall Study||33
128060|NCT00906971|295191|P1|COMPLETED|Overall Study||28
128061|NCT00906971|295190|P2|STARTED|Overall Study||36
128062|NCT00906971|295191|P1|STARTED|Overall Study||36
128063|NCT00906789|295199|P1|NOT COMPLETED|Overall Study||0
128064|NCT00906789|295199|P1|COMPLETED|Overall Study||15
128065|NCT00906789|295199|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
128066|NCT00906776|295209|P2|NOT COMPLETED|Overall Study||0
128067|NCT00906776|295210|P1|NOT COMPLETED|Overall Study||0
128068|NCT00906776|295209|P2|COMPLETED|Overall Study||8
128069|NCT00906776|295210|P1|COMPLETED|Overall Study||11
128070|NCT00906776|295209|P2|STARTED|Overall Study||8
128071|NCT00906776|295210|P1|STARTED|Overall Study||11
128072|NCT00906698|295232|P6|NOT COMPLETED|Overall Study||5
128073|NCT00906698|295233|P5|NOT COMPLETED|Overall Study||18
128074|NCT00906698|295234|P4|NOT COMPLETED|Overall Study||4
128075|NCT00906698|295235|P3|NOT COMPLETED|Overall Study||6
128076|NCT00906698|295236|P2|NOT COMPLETED|Overall Study||19
128077|NCT00906698|295237|P1|NOT COMPLETED|Overall Study||3
128078|NCT00906698|295232|P6|COMPLETED|Overall Study||0
128079|NCT00906698|295233|P5|COMPLETED|Overall Study||0
128080|NCT00906698|295234|P4|COMPLETED|Overall Study||0
128081|NCT00906698|295235|P3|COMPLETED|Overall Study||0
128082|NCT00906698|295236|P2|COMPLETED|Overall Study||0
128083|NCT00906698|295237|P1|COMPLETED|Overall Study||0
128084|NCT00906698|295232|P6|STARTED|Overall Study||5
128085|NCT00906698|295233|P5|STARTED|Overall Study||18
128086|NCT00906698|295234|P4|STARTED|Overall Study||4
128087|NCT00906698|295235|P3|STARTED|Overall Study||6
128088|NCT00906698|295236|P2|STARTED|Overall Study||19
128089|NCT00906698|295237|P1|STARTED|Overall Study||3
128090|NCT00906503|295319|P1|NOT COMPLETED|Overall Study||0
128091|NCT00906503|295319|P1|COMPLETED|Overall Study||9
128092|NCT00906503|295319|P1|STARTED|Overall Study||9
128093|NCT00906425|295325|P2|NOT COMPLETED|Overall Study||72
128094|NCT00906425|295326|P1|NOT COMPLETED|Overall Study||73
128095|NCT00906425|295325|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
128096|NCT00906425|295326|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
128097|NCT00906425|295325|P2|2 Year|Overall Study|ITT population|58
128098|NCT00906425|295326|P1|2 Year|Overall Study|ITT population|62
128099|NCT00906425|295325|P2|1 Year|Overall Study|ITT population|60
128100|NCT00906425|295326|P1|1 Year|Overall Study|ITT population|67
128101|NCT00906425|295325|P2|6 Months|Overall Study|ITT population|64
128102|NCT00906425|295326|P1|6 Months|Overall Study|ITT population|69
128103|NCT00906425|295325|P2|STARTED|Overall Study||72
128104|NCT00906425|295326|P1|STARTED|Overall Study||73
128105|NCT00906399|295339|P7|NOT COMPLETED|Year 2||29
128106|NCT00906399|295340|P6|NOT COMPLETED|Year 2||47
128107|NCT00906399|295341|P5|NOT COMPLETED|Year 2||35
128108|NCT00906399|295342|P4|NOT COMPLETED|Year 2||30
128109|NCT00906399|295343|P3|NOT COMPLETED|Year 2||0
128110|NCT00906399|295344|P2|NOT COMPLETED|Year 2||0
128111|NCT00906399|295345|P1|NOT COMPLETED|Year 2||0
128112|NCT00906399|295339|P7|COMPLETED|Year 2||409
128113|NCT00906399|295340|P6|COMPLETED|Year 2||391
128114|NCT00906399|295341|P5|COMPLETED|Year 2||193
128115|NCT00906399|295342|P4|COMPLETED|Year 2||198
128116|NCT00906399|295343|P3|COMPLETED|Year 2||0
128117|NCT00906399|295344|P2|COMPLETED|Year 2||0
128118|NCT00906399|295345|P1|COMPLETED|Year 2||0
128119|NCT00906399|295339|P7|Completed Year 2 Study Treatment|Year 2||411
128120|NCT00906399|295340|P6|Completed Year 2 Study Treatment|Year 2||391
128121|NCT00906399|295341|P5|Completed Year 2 Study Treatment|Year 2||196
128122|NCT00906399|295342|P4|Completed Year 2 Study Treatment|Year 2||200
128123|NCT00906399|295343|P3|Completed Year 2 Study Treatment|Year 2||0
128124|NCT00906399|295344|P2|Completed Year 2 Study Treatment|Year 2||0
128125|NCT00906399|295345|P1|Completed Year 2 Study Treatment|Year 2||0
128126|NCT00906399|295339|P7|STARTED|Year 2||438
128127|NCT00906399|295340|P6|STARTED|Year 2||438
128128|NCT00906399|295341|P5|STARTED|Year 2||228
128129|NCT00906399|295342|P4|STARTED|Year 2||228
128130|NCT00906399|295343|P3|STARTED|Year 2||0
128131|NCT00906399|295344|P2|STARTED|Year 2||0
128132|NCT00906399|295345|P1|STARTED|Year 2||0
128133|NCT00906399|295339|P7|NOT COMPLETED|Year 1||0
128134|NCT00906399|295340|P6|NOT COMPLETED|Year 1||0
128135|NCT00906399|295341|P5|NOT COMPLETED|Year 1||0
128136|NCT00906399|295342|P4|NOT COMPLETED|Year 1||0
128137|NCT00906399|295343|P3|NOT COMPLETED|Year 1||76
128138|NCT00906399|295344|P2|NOT COMPLETED|Year 1||63
128139|NCT00906399|295345|P1|NOT COMPLETED|Year 1||44
128140|NCT00906399|295339|P7|COMPLETED|Year 1||0
128141|NCT00906399|295340|P6|COMPLETED|Year 1||0
128142|NCT00906399|295341|P5|COMPLETED|Year 1||0
128143|NCT00906399|295342|P4|COMPLETED|Year 1||0
128144|NCT00906399|295343|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
128145|NCT00906399|295344|P2|COMPLETED|Year 1||438
128146|NCT00906399|295345|P1|COMPLETED|Year 1||456
128147|NCT00906399|295339|P7|Completed Year 1 Study Treatment|Year 1||0
128148|NCT00906399|295340|P6|Completed Year 1 Study Treatment|Year 1||0
128149|NCT00906399|295341|P5|Completed Year 1 Study Treatment|Year 1||0
128150|NCT00906399|295342|P4|Completed Year 1 Study Treatment|Year 1||0
128151|NCT00906399|295343|P3|Completed Year 1 Study Treatment|Year 1||438
128152|NCT00906399|295344|P2|Completed Year 1 Study Treatment|Year 1||438
128153|NCT00906399|295345|P1|Completed Year 1 Study Treatment|Year 1||456
128154|NCT00906399|295339|P7|STARTED|Year 1||0
128155|NCT00906399|295340|P6|STARTED|Year 1||0
128156|NCT00906399|295341|P5|STARTED|Year 1||0
128157|NCT00906399|295342|P4|STARTED|Year 1||0
128158|NCT00906399|295343|P3|STARTED|Year 1||515
128159|NCT00906399|295344|P2|STARTED|Year 1||501
128160|NCT00906399|295345|P1|STARTED|Year 1||500
128161|NCT00906347|295368|P2|NOT COMPLETED|Received Study Drug||31
128162|NCT00906347|295369|P1|NOT COMPLETED|Received Study Drug||40
128163|NCT00906347|295368|P2|COMPLETED|Received Study Drug||143
128164|NCT00906347|295369|P1|COMPLETED|Received Study Drug||136
128165|NCT00906347|295368|P2|STARTED|Received Study Drug||174
128166|NCT00906347|295369|P1|STARTED|Received Study Drug||176
128167|NCT00906347|295368|P2|NOT COMPLETED|Randomized||0
128168|NCT00906347|295369|P1|NOT COMPLETED|Randomized||0
128169|NCT00906347|295368|P2|COMPLETED|Randomized||174
128170|NCT00906347|295369|P1|COMPLETED|Randomized||176
128171|NCT00906347|295368|P2|STARTED|Randomized||174
128172|NCT00906347|295369|P1|STARTED|Randomized||176
128173|NCT00906243|295389|P1|NOT COMPLETED|Overall Study||0
128174|NCT00906243|295389|P1|COMPLETED|Overall Study||6
128175|NCT00906243|295389|P1|STARTED|Overall Study||6
128176|NCT00906204|295395|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
128177|NCT00906204|295396|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
128178|NCT00906204|295395|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
128179|NCT00906204|295396|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
128180|NCT00906204|295395|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
128181|NCT00906204|295396|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
128182|NCT00906204|295395|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
128183|NCT00906204|295396|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
128184|NCT00906204|295395|P2|COMPLETED|Primary Endpoint (Early Safety)||51
128185|NCT00906204|295396|P1|COMPLETED|Primary Endpoint (Early Safety)||43
128186|NCT00906204|295395|P2|STARTED|Primary Endpoint (Early Safety)||52
128187|NCT00906204|295396|P1|STARTED|Primary Endpoint (Early Safety)||45
128188|NCT00906178|295414|P2|NOT COMPLETED|Overall Study||16
128189|NCT00906178|295415|P1|NOT COMPLETED|Overall Study||15
128190|NCT00906178|295414|P2|COMPLETED|Overall Study||167
128191|NCT00906178|295415|P1|COMPLETED|Overall Study||168
128192|NCT00906178|295414|P2|STARTED|Overall Study||183
128193|NCT00906178|295415|P1|STARTED|Overall Study||183
128194|NCT00906074|295429|P2|NOT COMPLETED|Overall Study||0
128195|NCT00906074|295430|P1|NOT COMPLETED|Overall Study||0
128196|NCT00906074|295429|P2|COMPLETED|Overall Study||90
128197|NCT00906074|295430|P1|COMPLETED|Overall Study||90
128198|NCT00906074|295429|P2|STARTED|Overall Study||90
128199|NCT00906074|295430|P1|STARTED|Overall Study||90
128200|NCT00905840|295454|P1|NOT COMPLETED|Overall Study||16
128201|NCT00905840|295454|P1|COMPLETED|Overall Study||75
128202|NCT00905840|295454|P1|STARTED|Overall Study||91
128203|NCT00905827|295466|P3|NOT COMPLETED|Overall Study||0
128204|NCT00905827|295467|P2|NOT COMPLETED|Overall Study||0
128205|NCT00905827|295468|P1|NOT COMPLETED|Overall Study||0
128206|NCT00905827|295466|P3|COMPLETED|Overall Study||73
128207|NCT00905827|295467|P2|COMPLETED|Overall Study||69
128208|NCT00905827|295468|P1|COMPLETED|Overall Study||70
128209|NCT00905827|295466|P3|STARTED|Overall Study||73
128210|NCT00905827|295467|P2|STARTED|Overall Study||69
128211|NCT00905827|295468|P1|STARTED|Overall Study||70
128212|NCT00905632|295485|P7|NOT COMPLETED|Overall Study||4
128213|NCT00905632|295486|P6|NOT COMPLETED|Overall Study||1
128214|NCT00905632|295487|P5|NOT COMPLETED|Overall Study||0
128215|NCT00905632|295488|P4|NOT COMPLETED|Overall Study||0
128216|NCT00905632|295489|P3|NOT COMPLETED|Overall Study||0
128217|NCT00905632|295490|P2|NOT COMPLETED|Overall Study||0
128218|NCT00905632|295491|P1|NOT COMPLETED|Overall Study||0
128219|NCT00905632|295485|P7|COMPLETED|Overall Study||7
128220|NCT00905632|295486|P6|COMPLETED|Overall Study||8
128221|NCT00905632|295487|P5|COMPLETED|Overall Study||10
128222|NCT00905632|295488|P4|COMPLETED|Overall Study||6
128223|NCT00905632|295489|P3|COMPLETED|Overall Study||7
128224|NCT00905632|295490|P2|COMPLETED|Overall Study||6
128225|NCT00905632|295491|P1|COMPLETED|Overall Study||8
128226|NCT00905632|295485|P7|STARTED|Overall Study||11
128227|NCT00905632|295486|P6|STARTED|Overall Study||9
128228|NCT00905632|295487|P5|STARTED|Overall Study||10
128229|NCT00905632|295488|P4|STARTED|Overall Study||6
128230|NCT00905632|295489|P3|STARTED|Overall Study||7
128231|NCT00905632|295490|P2|STARTED|Overall Study||6
128232|NCT00905632|295491|P1|STARTED|Overall Study||8
128233|NCT00905606|295629|P2|NOT COMPLETED|Period 2||0
128234|NCT00905606|295630|P1|NOT COMPLETED|Period 2||0
128235|NCT00905606|295629|P2|COMPLETED|Period 2||14
128236|NCT00905606|295630|P1|COMPLETED|Period 2||14
128237|NCT00905606|295629|P2|STARTED|Period 2||14
128238|NCT00905606|295630|P1|STARTED|Period 2||14
128239|NCT00905606|295629|P2|NOT COMPLETED|Washout||0
128240|NCT00905606|295630|P1|NOT COMPLETED|Washout||1
128241|NCT00905606|295629|P2|COMPLETED|Washout||14
128242|NCT00905606|295630|P1|COMPLETED|Washout||14
128243|NCT00905606|295629|P2|STARTED|Washout||14
128244|NCT00905606|295630|P1|STARTED|Washout||15
128245|NCT00905606|295629|P2|NOT COMPLETED|Period 1||1
128246|NCT00905606|295630|P1|NOT COMPLETED|Period 1||0
128247|NCT00905606|295629|P2|COMPLETED|Period 1||14
128248|NCT00905606|295630|P1|COMPLETED|Period 1||15
128249|NCT00905606|295629|P2|STARTED|Period 1||15
128250|NCT00905606|295630|P1|STARTED|Period 1||15
128251|NCT00905580|295640|P2|NOT COMPLETED|Overall Study||3
128252|NCT00905580|295641|P1|NOT COMPLETED|Overall Study||2
128253|NCT00905580|295640|P2|COMPLETED|Overall Study||47
128254|NCT00905580|295641|P1|COMPLETED|Overall Study||47
128255|NCT00905580|295640|P2|STARTED|Overall Study||50
128256|NCT00905580|295641|P1|STARTED|Overall Study||49
128257|NCT00905567|295655|P2|NOT COMPLETED|Period 2||0
128258|NCT00905567|295656|P1|NOT COMPLETED|Period 2||0
128259|NCT00905567|295655|P2|COMPLETED|Period 2||11
128260|NCT00905567|295656|P1|COMPLETED|Period 2||12
128261|NCT00905567|295655|P2|STARTED|Period 2||11
128262|NCT00905567|295656|P1|STARTED|Period 2||12
128263|NCT00905567|295655|P2|NOT COMPLETED|Washout||1
128264|NCT00905567|295656|P1|NOT COMPLETED|Washout||0
128265|NCT00905567|295655|P2|COMPLETED|Washout||11
128266|NCT00905567|295656|P1|COMPLETED|Washout||12
128267|NCT00905567|295655|P2|STARTED|Washout||12
128268|NCT00905567|295656|P1|STARTED|Washout||12
128269|NCT00905567|295655|P2|NOT COMPLETED|Period 1||0
128270|NCT00905567|295656|P1|NOT COMPLETED|Period 1||0
128271|NCT00905567|295655|P2|COMPLETED|Period 1||12
128272|NCT00905567|295656|P1|COMPLETED|Period 1||12
128273|NCT00905567|295655|P2|STARTED|Period 1||12
128274|NCT00905567|295656|P1|STARTED|Period 1||12
128275|NCT00905554|295666|P2|NOT COMPLETED|Overall Study||0
128276|NCT00905554|295667|P1|NOT COMPLETED|Overall Study||0
128277|NCT00905554|295666|P2|COMPLETED|Overall Study||114
128278|NCT00905554|295667|P1|COMPLETED|Overall Study||116
128279|NCT00905554|295666|P2|STARTED|Overall Study||114
128280|NCT00905554|295667|P1|STARTED|Overall Study||116
128281|NCT00905515|295678|P3|NOT COMPLETED|Overall Study||2
128282|NCT00905515|295679|P2|NOT COMPLETED|Overall Study||0
128283|NCT00905515|295680|P1|NOT COMPLETED|Overall Study||2
128284|NCT00905515|295678|P3|COMPLETED|Overall Study||20
128285|NCT00905515|295679|P2|COMPLETED|Overall Study||20
128286|NCT00905515|295680|P1|COMPLETED|Overall Study||19
128287|NCT00905515|295678|P3|STARTED|Overall Study||22
128288|NCT00905515|295679|P2|STARTED|Overall Study||20
128289|NCT00905515|295680|P1|STARTED|Overall Study||21
128290|NCT00905489|295688|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
128291|NCT00905489|295688|P1|COMPLETED|Optional Extension Phase (OEP)||39
128292|NCT00905489|295688|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
128293|NCT00905489|295688|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
128294|NCT00905489|295688|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
128295|NCT00905489|295688|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
128296|NCT00905437|295737|P2|NOT COMPLETED|Overall Study||10
128297|NCT00905437|295738|P1|NOT COMPLETED|Overall Study||8
128298|NCT00905437|295737|P2|COMPLETED|Overall Study||27
128299|NCT00905437|295738|P1|COMPLETED|Overall Study||27
128300|NCT00905437|295737|P2|STARTED|Overall Study||37
128301|NCT00905437|295738|P1|STARTED|Overall Study||35
128302|NCT00905424|295758|P2|NOT COMPLETED|Overall Study||9
128303|NCT00905424|295759|P1|NOT COMPLETED|Overall Study||11
128304|NCT00905424|295758|P2|COMPLETED|Overall Study||79
128305|NCT00905424|295759|P1|COMPLETED|Overall Study||78
128306|NCT00905424|295758|P2|STARTED|Overall Study||88
128307|NCT00905424|295759|P1|STARTED|Overall Study||89
128308|NCT00905359|295801|P2|NOT COMPLETED|Overall Study||16
128309|NCT00905359|295802|P1|NOT COMPLETED|Overall Study||24
128310|NCT00905359|295801|P2|COMPLETED|Overall Study||65
128311|NCT00905359|295802|P1|COMPLETED|Overall Study||58
128312|NCT00905359|295801|P2|24 Months Follow up|Overall Study||65
128313|NCT00905359|295802|P1|24 Months Follow up|Overall Study||58
128314|NCT00905359|295801|P2|12 Months Follow up|Overall Study||72
128315|NCT00905359|295802|P1|12 Months Follow up|Overall Study||68
128316|NCT00905359|295801|P2|STARTED|Overall Study||81
128317|NCT00905359|295802|P1|STARTED|Overall Study||82
128318|NCT00905346|295838|P2|NOT COMPLETED|Period 2||0
128319|NCT00905346|295839|P1|NOT COMPLETED|Period 2||0
128320|NCT00905346|295838|P2|COMPLETED|Period 2||11
128321|NCT00905346|295839|P1|COMPLETED|Period 2||10
128322|NCT00905346|295838|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
128323|NCT00905346|295839|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
128324|NCT00905346|295838|P2|NOT COMPLETED|Period 1||0
128325|NCT00905346|295839|P1|NOT COMPLETED|Period 1||1
128326|NCT00905346|295838|P2|COMPLETED|Period 1||12
128327|NCT00905346|295839|P1|COMPLETED|Period 1||11
128328|NCT00905346|295838|P2|STARTED|Period 1||12
128329|NCT00905346|295839|P1|STARTED|Period 1||12
128330|NCT00905307|295853|P6|NOT COMPLETED|Overall Study||42
128331|NCT00905307|295854|P5|NOT COMPLETED|Overall Study||16
128332|NCT00905307|295855|P4|NOT COMPLETED|Overall Study||37
128333|NCT00905307|295856|P3|NOT COMPLETED|Overall Study||37
128334|NCT00905307|295857|P2|NOT COMPLETED|Overall Study||37
128335|NCT00905307|295858|P1|NOT COMPLETED|Overall Study||22
128336|NCT00905307|295853|P6|COMPLETED|Overall Study||53
128337|NCT00905307|295854|P5|COMPLETED|Overall Study||34
128338|NCT00905307|295855|P4|COMPLETED|Overall Study||56
128339|NCT00905307|295856|P3|COMPLETED|Overall Study||53
128340|NCT00905307|295857|P2|COMPLETED|Overall Study||52
128341|NCT00905307|295858|P1|COMPLETED|Overall Study||20
128342|NCT00905307|295853|P6|STARTED|Overall Study||95
128343|NCT00905307|295854|P5|STARTED|Overall Study||50
128344|NCT00905307|295855|P4|STARTED|Overall Study||93
128345|NCT00905307|295856|P3|STARTED|Overall Study||90
128346|NCT00905307|295857|P2|STARTED|Overall Study||89
128347|NCT00905307|295858|P1|STARTED|Overall Study||42
128348|NCT00905268|295918|P4|NOT COMPLETED|Overall Study||2
128349|NCT00905268|295919|P3|NOT COMPLETED|Overall Study||0
128350|NCT00905268|295920|P2|NOT COMPLETED|Overall Study||1
128351|NCT00905268|295921|P1|NOT COMPLETED|Overall Study||4
128352|NCT00905268|295918|P4|COMPLETED|Overall Study||57
128353|NCT00905268|295919|P3|COMPLETED|Overall Study||59
128354|NCT00905268|295920|P2|COMPLETED|Overall Study||56
128355|NCT00905268|295921|P1|COMPLETED|Overall Study||53
128356|NCT00905268|295918|P4|STARTED|Overall Study||59
128357|NCT00905268|295919|P3|STARTED|Overall Study||59
128358|NCT00905268|295920|P2|STARTED|Overall Study||57
128359|NCT00905268|295921|P1|STARTED|Overall Study||57
128360|NCT00905255|295953|P2|NOT COMPLETED|Overall Study||9
128361|NCT00905255|295954|P1|NOT COMPLETED|Overall Study||13
128362|NCT00905255|295953|P2|COMPLETED|Overall Study||27
128363|NCT00905255|295954|P1|COMPLETED|Overall Study||20
128364|NCT00905255|295953|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
128365|NCT00905255|295954|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
128366|NCT00905255|295953|P2|Safety Population|Overall Study||36
128367|NCT00905255|295954|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
128368|NCT00905255|295953|P2|STARTED|Overall Study||36
128369|NCT00905255|295954|P1|STARTED|Overall Study|Randomized.|33
128370|NCT00905164|295972|P2|NOT COMPLETED|Period 2||0
128371|NCT00905164|295973|P1|NOT COMPLETED|Period 2||0
128372|NCT00905164|295972|P2|COMPLETED|Period 2||11
128373|NCT00905164|295973|P1|COMPLETED|Period 2||12
128374|NCT00905164|295972|P2|STARTED|Period 2||11
128375|NCT00905164|295973|P1|STARTED|Period 2||12
128376|NCT00905164|295972|P2|NOT COMPLETED|Period 1||1
128377|NCT00905164|295973|P1|NOT COMPLETED|Period 1||0
128378|NCT00905164|295972|P2|COMPLETED|Period 1||11
128379|NCT00905164|295973|P1|COMPLETED|Period 1||12
128380|NCT00905164|295972|P2|STARTED|Period 1||12
128381|NCT00905164|295973|P1|STARTED|Period 1||12
128382|NCT00905151|295981|P1|NOT COMPLETED|Overall Study||6
128383|NCT00905151|295981|P1|COMPLETED|Overall Study||200
128384|NCT00905151|295981|P1|STARTED|Overall Study||206
128385|NCT00905125|295987|P2|NOT COMPLETED|Overall Study||3
128386|NCT00905125|295988|P1|NOT COMPLETED|Overall Study||4
128387|NCT00905125|295987|P2|COMPLETED|Overall Study||53
128388|NCT00905125|295988|P1|COMPLETED|Overall Study||42
128389|NCT00905125|295987|P2|STARTED|Overall Study||56
128390|NCT00905125|295988|P1|STARTED|Overall Study||46
128391|NCT00905034|296020|P1|NOT COMPLETED|Overall Study||1
128392|NCT00905034|296020|P1|COMPLETED|Overall Study||36
128393|NCT00905034|296020|P1|STARTED|Overall Study||37
128394|NCT00905021|296024|P1|NOT COMPLETED|Overall Study||2
128395|NCT00905021|296024|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
128396|NCT00905021|296024|P1|STARTED|Overall Study||4
128397|NCT00904995|296031|P2|NOT COMPLETED|Overall Study||0
128398|NCT00904995|296032|P1|NOT COMPLETED|Overall Study||0
128399|NCT00904995|296031|P2|COMPLETED|Overall Study||11
128400|NCT00904995|296032|P1|COMPLETED|Overall Study||10
128401|NCT00904995|296031|P2|STARTED|Overall Study||11
128402|NCT00904995|296032|P1|STARTED|Overall Study||10
128403|NCT00904943|296040|P2|NOT COMPLETED|Period 2||0
128404|NCT00904943|296041|P1|NOT COMPLETED|Period 2||0
128405|NCT00904943|296040|P2|COMPLETED|Period 2||8
128406|NCT00904943|296041|P1|COMPLETED|Period 2||9
128407|NCT00904943|296040|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
128408|NCT00904943|296041|P1|STARTED|Period 2||9
128409|NCT00904943|296040|P2|NOT COMPLETED|Period 1||0
128410|NCT00904943|296041|P1|NOT COMPLETED|Period 1||0
128411|NCT00904943|296040|P2|COMPLETED|Period 1||9
128412|NCT00904943|296041|P1|COMPLETED|Period 1||9
128413|NCT00904943|296040|P2|STARTED|Period 1||9
128414|NCT00904943|296041|P1|STARTED|Period 1||9
128415|NCT00904917|296053|P4|NOT COMPLETED|Overall Study||2
128416|NCT00904917|296054|P3|NOT COMPLETED|Overall Study||2
128417|NCT00904917|296055|P2|NOT COMPLETED|Overall Study||2
128418|NCT00904917|296056|P1|NOT COMPLETED|Overall Study||2
128419|NCT00904917|296053|P4|COMPLETED|Overall Study||6
128420|NCT00904917|296054|P3|COMPLETED|Overall Study||6
128421|NCT00904917|296055|P2|COMPLETED|Overall Study||9
128422|NCT00904917|296056|P1|COMPLETED|Overall Study||5
128423|NCT00904917|296053|P4|STARTED|Overall Study||8
128424|NCT00904917|296054|P3|STARTED|Overall Study||8
128425|NCT00904917|296055|P2|STARTED|Overall Study||11
128426|NCT00904917|296056|P1|STARTED|Overall Study||7
128427|NCT00904839|296074|P3|NOT COMPLETED|Overall Study||15
128428|NCT00904839|296075|P2|NOT COMPLETED|Overall Study||18
128429|NCT00904839|296076|P1|NOT COMPLETED|Overall Study||1
128430|NCT00904839|296074|P3|COMPLETED|Overall Study||27
128431|NCT00904839|296075|P2|COMPLETED|Overall Study||64
128432|NCT00904839|296076|P1|COMPLETED|Overall Study||3
128433|NCT00904839|296074|P3|STARTED|Overall Study|Randomised|42
128434|NCT00904839|296075|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
128435|NCT00904839|296076|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
128436|NCT00904826|296110|P1|NOT COMPLETED|Overall Study||0
128437|NCT00904826|296110|P1|COMPLETED|Overall Study||14
128438|NCT00904826|296110|P1|STARTED|Overall Study||14
128439|NCT00904748|296122|P6|NOT COMPLETED|Overall Study||0
128440|NCT00904748|296123|P5|NOT COMPLETED|Overall Study||1
128441|NCT00904748|296124|P4|NOT COMPLETED|Overall Study||2
128442|NCT00904748|296125|P3|NOT COMPLETED|Overall Study||1
128443|NCT00904748|296126|P2|NOT COMPLETED|Overall Study||1
128444|NCT00904748|296127|P1|NOT COMPLETED|Overall Study||1
128445|NCT00904748|296122|P6|COMPLETED|Overall Study||8
128446|NCT00904748|296123|P5|COMPLETED|Overall Study||7
128447|NCT00904748|296124|P4|COMPLETED|Overall Study||6
128448|NCT00904748|296125|P3|COMPLETED|Overall Study||7
128449|NCT00904748|296126|P2|COMPLETED|Overall Study||7
128450|NCT00904748|296127|P1|COMPLETED|Overall Study||7
128451|NCT00904748|296122|P6|Received Treatment|Overall Study||8
128452|NCT00904748|296123|P5|Received Treatment|Overall Study||7
128453|NCT00904748|296124|P4|Received Treatment|Overall Study||8
128454|NCT00904748|296125|P3|Received Treatment|Overall Study||8
128455|NCT00904748|296126|P2|Received Treatment|Overall Study||8
128456|NCT00904748|296127|P1|Received Treatment|Overall Study||8
128457|NCT00904748|296122|P6|STARTED|Overall Study||8
128458|NCT00904748|296123|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
128459|NCT00904748|296124|P4|STARTED|Overall Study||8
128460|NCT00904748|296125|P3|STARTED|Overall Study||8
128461|NCT00904748|296126|P2|STARTED|Overall Study||8
128462|NCT00904748|296127|P1|STARTED|Overall Study||8
128463|NCT00904722|296151|P1|NOT COMPLETED|Overall Study||1
128464|NCT00904722|296151|P1|COMPLETED|Overall Study||29
128465|NCT00904722|296151|P1|STARTED|Overall Study||30
128466|NCT00904670|296156|P2|NOT COMPLETED|Second Intervention Period||0
128467|NCT00904670|296157|P1|NOT COMPLETED|Second Intervention Period||0
128468|NCT00904670|296156|P2|COMPLETED|Second Intervention Period||22
128469|NCT00904670|296157|P1|COMPLETED|Second Intervention Period||17
128470|NCT00904670|296156|P2|STARTED|Second Intervention Period||22
128471|NCT00904670|296157|P1|STARTED|Second Intervention Period||17
128472|NCT00904670|296156|P2|NOT COMPLETED|First Intervention Period||0
128473|NCT00904670|296157|P1|NOT COMPLETED|First Intervention Period||0
128474|NCT00904670|296156|P2|COMPLETED|First Intervention Period||22
128475|NCT00904670|296157|P1|COMPLETED|First Intervention Period||17
128476|NCT00904670|296156|P2|STARTED|First Intervention Period||22
128477|NCT00904670|296157|P1|STARTED|First Intervention Period||17
128478|NCT00904670|296156|P2|NOT COMPLETED|Open Label Phase||0
128479|NCT00904670|296157|P1|NOT COMPLETED|Open Label Phase||6
128480|NCT00904670|296156|P2|COMPLETED|Open Label Phase||22
128481|NCT00904670|296157|P1|COMPLETED|Open Label Phase||17
128482|NCT00904670|296156|P2|STARTED|Open Label Phase||22
128483|NCT00904670|296157|P1|STARTED|Open Label Phase||23
128484|NCT00904618|296178|P1|NOT COMPLETED|Overall Study||0
128485|NCT00904618|296178|P1|COMPLETED|Overall Study||48
128486|NCT00904618|296178|P1|STARTED|Overall Study||48
128487|NCT00904423|296186|P1|NOT COMPLETED|Overall Study||0
128488|NCT00904423|296186|P1|COMPLETED|Overall Study||8
128489|NCT00904423|296186|P1|STARTED|Overall Study||8
128490|NCT00904371|296194|P1|NOT COMPLETED|Overall Study||9
128491|NCT00904371|296194|P1|COMPLETED|Overall Study||202
128492|NCT00904371|296194|P1|STARTED|Overall Study||211
128493|NCT00904215|296208|P1|NOT COMPLETED|Overall Study||135
128494|NCT00904215|296208|P1|COMPLETED|Overall Study||960
128495|NCT00904215|296208|P1|STARTED|Overall Study||1095
128496|NCT00904189|296215|P1|NOT COMPLETED|Overall Study||0
128497|NCT00904189|296215|P1|COMPLETED|Overall Study||2
128498|NCT00904189|296215|P1|STARTED|Overall Study||2
128499|NCT00904150|296222|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
128500|NCT00904150|296223|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
128501|NCT00904150|296222|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
128502|NCT00904150|296223|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
128503|NCT00904150|296222|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
128504|NCT00904150|296223|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
128505|NCT00904150|296222|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
128506|NCT00904150|296223|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
128507|NCT00904150|296222|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
128508|NCT00904150|296223|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
128509|NCT00904150|296222|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
128510|NCT00904150|296223|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
128511|NCT00904150|296222|P2|NOT COMPLETED|Saliva Samples (DNA)||145
128512|NCT00904150|296223|P1|NOT COMPLETED|Saliva Samples (DNA)||3
128513|NCT00904150|296222|P2|COMPLETED|Saliva Samples (DNA)||155
128514|NCT00904150|296223|P1|COMPLETED|Saliva Samples (DNA)||282
128515|NCT00904150|296222|P2|STARTED|Saliva Samples (DNA)||300
128516|NCT00904150|296223|P1|STARTED|Saliva Samples (DNA)||285
128517|NCT00904007|296243|P2|NOT COMPLETED|Overall Study||0
128518|NCT00904007|296244|P1|NOT COMPLETED|Overall Study||0
128519|NCT00904007|296243|P2|COMPLETED|Overall Study||56
128520|NCT00904007|296244|P1|COMPLETED|Overall Study||55
128521|NCT00904007|296243|P2|STARTED|Overall Study||56
128522|NCT00904007|296244|P1|STARTED|Overall Study||55
128523|NCT00903929|296250|P4|NOT COMPLETED|Overall Study||3
128524|NCT00903929|296251|P3|NOT COMPLETED|Overall Study||1
128525|NCT00903929|296252|P2|NOT COMPLETED|Overall Study||0
128526|NCT00903929|296253|P1|NOT COMPLETED|Overall Study||0
128527|NCT00903929|296250|P4|COMPLETED|Overall Study||6
128528|NCT00903929|296251|P3|COMPLETED|Overall Study||3
128529|NCT00903929|296252|P2|COMPLETED|Overall Study||3
128530|NCT00903929|296253|P1|COMPLETED|Overall Study||3
128531|NCT00903929|296250|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
128532|NCT00903929|296251|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
128533|NCT00903929|296252|P2|STARTED|Overall Study||3
128534|NCT00903929|296253|P1|STARTED|Overall Study||3
128535|NCT00903695|296261|P2|NOT COMPLETED|Overall Study||0
128536|NCT00903695|296262|P1|NOT COMPLETED|Overall Study||2
128537|NCT00903695|296261|P2|COMPLETED|Overall Study||2
128538|NCT00903695|296262|P1|COMPLETED|Overall Study||6
128539|NCT00903695|296261|P2|STARTED|Overall Study||2
128540|NCT00903695|296262|P1|STARTED|Overall Study||8
128541|NCT00903682|296284|P2|NOT COMPLETED|Overall Study||15
128542|NCT00903682|296285|P1|NOT COMPLETED|Overall Study||16
128543|NCT00903682|296284|P2|COMPLETED|Overall Study||63
128544|NCT00903682|296285|P1|COMPLETED|Overall Study||63
128545|NCT00903682|296284|P2|STARTED|Overall Study||78
128546|NCT00903682|296285|P1|STARTED|Overall Study||79
128547|NCT00903630|296306|P3|NOT COMPLETED|Phase 2||1
128548|NCT00903630|296307|P2|NOT COMPLETED|Phase 2||0
128549|NCT00903630|296308|P1|NOT COMPLETED|Phase 2||0
128550|NCT00903630|296306|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
128551|NCT00903630|296307|P2|COMPLETED|Phase 2||0
128552|NCT00903630|296308|P1|COMPLETED|Phase 2||6
128553|NCT00903630|296306|P3|STARTED|Phase 2||4
128554|NCT00903630|296307|P2|STARTED|Phase 2||0
128555|NCT00903630|296308|P1|STARTED|Phase 2||6
128556|NCT00903630|296306|P3|NOT COMPLETED|Phase l||0
128557|NCT00903630|296307|P2|NOT COMPLETED|Phase l||0
128558|NCT00903630|296308|P1|NOT COMPLETED|Phase l||0
128559|NCT00903630|296306|P3|COMPLETED|Phase l||0
128560|NCT00903630|296307|P2|COMPLETED|Phase l||5
128561|NCT00903630|296308|P1|COMPLETED|Phase l||6
128562|NCT00903630|296306|P3|STARTED|Phase l||0
128563|NCT00903630|296307|P2|STARTED|Phase l||5
128564|NCT00903630|296308|P1|STARTED|Phase l||6
128565|NCT00903448|296322|P2|NOT COMPLETED|Period 3: 5 Days||0
128566|NCT00903448|296323|P1|NOT COMPLETED|Period 3: 5 Days||0
128567|NCT00903448|296322|P2|COMPLETED|Period 3: 5 Days||20
128568|NCT00903448|296323|P1|COMPLETED|Period 3: 5 Days||20
128569|NCT00903448|296322|P2|STARTED|Period 3: 5 Days||20
128570|NCT00903448|296323|P1|STARTED|Period 3: 5 Days||20
128571|NCT00903448|296322|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
128572|NCT00903448|296323|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
128573|NCT00903448|296322|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
128574|NCT00903448|296323|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
128575|NCT00903448|296322|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
128576|NCT00903448|296323|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
128577|NCT00903448|296322|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
128578|NCT00903448|296323|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
128579|NCT00903448|296322|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
128580|NCT00903448|296323|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
128581|NCT00903448|296322|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
128582|NCT00903448|296323|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
128583|NCT00903409|296331|P2|NOT COMPLETED|Overall Study||27
128584|NCT00903409|296332|P1|NOT COMPLETED|Overall Study||26
128585|NCT00903409|296331|P2|COMPLETED|Overall Study||73
128586|NCT00903409|296332|P1|COMPLETED|Overall Study||62
128587|NCT00903409|296331|P2|STARTED|Overall Study||100
128588|NCT00903409|296332|P1|STARTED|Overall Study||88
128589|NCT00903396|296350|P4|NOT COMPLETED|Overall Study||0
128590|NCT00903396|296351|P3|NOT COMPLETED|Overall Study||0
128591|NCT00903396|296352|P2|NOT COMPLETED|Overall Study||0
128592|NCT00903396|296353|P1|NOT COMPLETED|Overall Study||0
128593|NCT00903396|296350|P4|COMPLETED|Overall Study||1
128594|NCT00903396|296351|P3|COMPLETED|Overall Study||3
128595|NCT00903396|296352|P2|COMPLETED|Overall Study||1
128596|NCT00903396|296353|P1|COMPLETED|Overall Study||2
128597|NCT00903396|296350|P4|STARTED|Overall Study||1
128598|NCT00903396|296351|P3|STARTED|Overall Study||3
128599|NCT00903396|296352|P2|STARTED|Overall Study||1
128600|NCT00903396|296353|P1|STARTED|Overall Study||2
128601|NCT00903383|296383|P4|NOT COMPLETED|Overall Study||5
128602|NCT00903383|296384|P3|NOT COMPLETED|Overall Study||3
128603|NCT00903383|296385|P2|NOT COMPLETED|Overall Study||6
128604|NCT00903383|296386|P1|NOT COMPLETED|Overall Study||7
128605|NCT00903383|296383|P4|COMPLETED|Overall Study||44
128606|NCT00903383|296384|P3|COMPLETED|Overall Study||47
128607|NCT00903383|296385|P2|COMPLETED|Overall Study||48
128608|NCT00903383|296386|P1|COMPLETED|Overall Study||48
128609|NCT00903383|296383|P4|STARTED|Overall Study||49
128610|NCT00903383|296384|P3|STARTED|Overall Study||50
128611|NCT00903383|296385|P2|STARTED|Overall Study||54
128612|NCT00903383|296386|P1|STARTED|Overall Study||55
128613|NCT00903370|296418|P2|NOT COMPLETED|Overall Study||24
128614|NCT00903370|296419|P1|NOT COMPLETED|Overall Study||28
128615|NCT00903370|296418|P2|COMPLETED|Overall Study||109
128616|NCT00903370|296419|P1|COMPLETED|Overall Study||99
128617|NCT00903370|296418|P2|STARTED|Overall Study||133
128618|NCT00903370|296419|P1|STARTED|Overall Study||127
128619|NCT00903357|296427|P2|NOT COMPLETED|Second Intervention||0
128620|NCT00903357|296428|P1|NOT COMPLETED|Second Intervention||1
128621|NCT00903357|296427|P2|COMPLETED|Second Intervention||22
128622|NCT00903357|296428|P1|COMPLETED|Second Intervention||21
128623|NCT00903357|296427|P2|STARTED|Second Intervention||22
128624|NCT00903357|296428|P1|STARTED|Second Intervention||22
128625|NCT00903357|296427|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
128626|NCT00903357|296428|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
128627|NCT00903357|296427|P2|COMPLETED|Wash Out Period of 2 Weeks||22
128628|NCT00903357|296428|P1|COMPLETED|Wash Out Period of 2 Weeks||22
128629|NCT00903357|296427|P2|STARTED|Wash Out Period of 2 Weeks||23
128630|NCT00903357|296428|P1|STARTED|Wash Out Period of 2 Weeks||22
128631|NCT00903357|296427|P2|NOT COMPLETED|First Intervention||4
128632|NCT00903357|296428|P1|NOT COMPLETED|First Intervention||5
128633|NCT00903357|296427|P2|COMPLETED|First Intervention||23
128634|NCT00903357|296428|P1|COMPLETED|First Intervention||22
128635|NCT00903357|296427|P2|STARTED|First Intervention||27
128636|NCT00903357|296428|P1|STARTED|First Intervention||27
128637|NCT00903344|296440|P2|NOT COMPLETED|Overall Study||3
128638|NCT00903344|296441|P1|NOT COMPLETED|Overall Study||5
128639|NCT00903344|296440|P2|COMPLETED|Overall Study||7
128640|NCT00903344|296441|P1|COMPLETED|Overall Study||7
128641|NCT00903344|296440|P2|6 Month Visit|Overall Study||10
128642|NCT00903344|296441|P1|6 Month Visit|Overall Study||9
128643|NCT00903344|296440|P2|3 Month Visit|Overall Study||10
128644|NCT00903344|296441|P1|3 Month Visit|Overall Study||10
128645|NCT00903344|296440|P2|STARTED|Overall Study||10
128646|NCT00903344|296441|P1|STARTED|Overall Study||12
128647|NCT00903331|296459|P2|NOT COMPLETED|Overall Study||18
128648|NCT00903331|296460|P1|NOT COMPLETED|Overall Study||5
128649|NCT00903331|296459|P2|COMPLETED|Overall Study||101
128650|NCT00903331|296460|P1|COMPLETED|Overall Study||54
128651|NCT00903331|296459|P2|STARTED|Overall Study||119
128652|NCT00903331|296460|P1|STARTED|Overall Study||59
128653|NCT00903175|296470|P2|NOT COMPLETED|Period 2 - Second Line||36
128654|NCT00903175|296471|P1|NOT COMPLETED|Period 2 - Second Line||49
128655|NCT00903175|296470|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
128656|NCT00903175|296471|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
128657|NCT00903175|296470|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
128658|NCT00903175|296471|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
128659|NCT00903175|296470|P2|NOT COMPLETED|Period 1 - First Line||89
128660|NCT00903175|296471|P1|NOT COMPLETED|Period 1 - First Line||77
128661|NCT00903175|296470|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
128662|NCT00903175|296471|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
128663|NCT00903175|296470|P2|STARTED|Period 1 - First Line||231
128664|NCT00903175|296471|P1|STARTED|Period 1 - First Line||238
128665|NCT00903162|296501|P1|NOT COMPLETED|Overall Study||4
128666|NCT00903162|296501|P1|COMPLETED|Overall Study||12
128667|NCT00903162|296501|P1|STARTED|Overall Study||16
128668|NCT00903032|296509|P2|NOT COMPLETED|Overall Study||5
128669|NCT00903032|296510|P1|NOT COMPLETED|Overall Study||7
128670|NCT00903032|296509|P2|COMPLETED|Overall Study||119
128671|NCT00903032|296510|P1|COMPLETED|Overall Study||122
128672|NCT00903032|296509|P2|STARTED|Overall Study||124
128673|NCT00903032|296510|P1|STARTED|Overall Study||129
128674|NCT00903006|296520|P4|NOT COMPLETED|Overall Study||0
128675|NCT00903006|296521|P3|NOT COMPLETED|Overall Study||1
128676|NCT00903006|296522|P2|NOT COMPLETED|Overall Study||3
128677|NCT00903006|296523|P1|NOT COMPLETED|Overall Study||2
128678|NCT00903006|296520|P4|COMPLETED|Overall Study||0
128679|NCT00903006|296521|P3|COMPLETED|Overall Study||0
128680|NCT00903006|296522|P2|COMPLETED|Overall Study||0
128681|NCT00903006|296523|P1|COMPLETED|Overall Study||0
128682|NCT00903006|296520|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
128683|NCT00903006|296521|P3|STARTED|Overall Study||1
128684|NCT00903006|296522|P2|STARTED|Overall Study||3
128685|NCT00903006|296523|P1|STARTED|Overall Study||2
128686|NCT00902850|296535|P2|NOT COMPLETED|Overall Study||2
128687|NCT00902850|296536|P1|NOT COMPLETED|Overall Study||2
128688|NCT00902850|296535|P2|COMPLETED|Overall Study||12
128689|NCT00902850|296536|P1|COMPLETED|Overall Study||12
128690|NCT00902850|296535|P2|STARTED|Overall Study||14
128691|NCT00902850|296536|P1|STARTED|Overall Study||14
128692|NCT00902746|296542|P1|NOT COMPLETED|Overall Study||36
128693|NCT00902746|296542|P1|COMPLETED|Overall Study||113
128694|NCT00902746|296542|P1|Transfer to Step 2|Overall Study||133
128695|NCT00902746|296542|P1|Initiation of Study Drug Administration|Overall Study||148
128696|NCT00902746|296542|P1|STARTED|Overall Study||149
128697|NCT00902668|296547|P1|NOT COMPLETED|Overall Study||3
128698|NCT00902668|296547|P1|COMPLETED|Overall Study||0
128699|NCT00902668|296547|P1|STARTED|Overall Study||3
128700|NCT00902564|296551|P1|NOT COMPLETED|Overall Study||2
128701|NCT00902564|296551|P1|COMPLETED|Overall Study||28
128702|NCT00902564|296551|P1|STARTED|Overall Study||30
128703|NCT00902538|296566|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
128704|NCT00902538|296567|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
128705|NCT00902538|296568|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
128706|NCT00902538|296569|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
128707|NCT00902538|296570|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
128708|NCT00902538|296571|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
128709|NCT00902538|296566|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
128710|NCT00902538|296567|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
128711|NCT00902538|296568|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
128712|NCT00902538|296569|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
128713|NCT00902538|296570|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
128714|NCT00902538|296571|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
128715|NCT00902538|296566|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
128716|NCT00902538|296567|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
128717|NCT00902538|296568|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
128718|NCT00902538|296569|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
128719|NCT00902538|296570|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
128720|NCT00902538|296571|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
128721|NCT00902538|296566|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
128722|NCT00902538|296567|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
128723|NCT00902538|296568|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
128724|NCT00902538|296569|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
128725|NCT00902538|296570|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
128726|NCT00902538|296571|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
128727|NCT00902538|296566|P6|COMPLETED|3-Single-blind, Single Treatment||0
128728|NCT00902538|296567|P5|COMPLETED|3-Single-blind, Single Treatment||0
128729|NCT00902538|296568|P4|COMPLETED|3-Single-blind, Single Treatment||0
128730|NCT00902538|296569|P3|COMPLETED|3-Single-blind, Single Treatment||0
128731|NCT00902538|296570|P2|COMPLETED|3-Single-blind, Single Treatment||767
128732|NCT00902538|296571|P1|COMPLETED|3-Single-blind, Single Treatment||0
128733|NCT00902538|296566|P6|STARTED|3-Single-blind, Single Treatment||0
128734|NCT00902538|296567|P5|STARTED|3-Single-blind, Single Treatment||0
128735|NCT00902538|296568|P4|STARTED|3-Single-blind, Single Treatment||0
128736|NCT00902538|296569|P3|STARTED|3-Single-blind, Single Treatment||0
128737|NCT00902538|296570|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
128738|NCT00902538|296571|P1|STARTED|3-Single-blind, Single Treatment||0
128739|NCT00902538|296566|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
128740|NCT00902538|296567|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
128741|NCT00902538|296568|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
128742|NCT00902538|296569|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
128743|NCT00902538|296570|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
128744|NCT00902538|296571|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
128745|NCT00902538|296566|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
128746|NCT00902538|296567|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
128747|NCT00902538|296568|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
128748|NCT00902538|296569|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
128749|NCT00902538|296570|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
128750|NCT00902538|296571|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
128751|NCT00902538|296566|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
128752|NCT00902538|296567|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
128753|NCT00902538|296568|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
128754|NCT00902538|296569|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
128755|NCT00902538|296570|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
128756|NCT00902538|296571|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
128757|NCT00902538|296566|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128758|NCT00902538|296567|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128759|NCT00902538|296568|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128760|NCT00902538|296569|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128761|NCT00902538|296570|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128944|NCT00901576|296817|P5|STARTED|First Intervention||6
128762|NCT00902538|296571|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
128763|NCT00902538|296566|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128764|NCT00902538|296567|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128765|NCT00902538|296568|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128766|NCT00902538|296569|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128767|NCT00902538|296570|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
128768|NCT00902538|296571|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
128769|NCT00902538|296566|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
128770|NCT00902538|296567|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
128771|NCT00902538|296568|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
128772|NCT00902538|296569|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
128773|NCT00902538|296570|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
128774|NCT00902538|296571|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
128775|NCT00902330|296603|P2|NOT COMPLETED|Overall Study||5
128776|NCT00902330|296604|P1|NOT COMPLETED|Overall Study||4
128777|NCT00902330|296603|P2|COMPLETED|Overall Study||75
128778|NCT00902330|296604|P1|COMPLETED|Overall Study||77
128779|NCT00902330|296603|P2|STARTED|Overall Study||80
128780|NCT00902330|296604|P1|STARTED|Overall Study||81
128781|NCT00902304|296641|P3|NOT COMPLETED|Overall Study||110
128782|NCT00902304|296642|P2|NOT COMPLETED|Overall Study||71
128783|NCT00902304|296643|P1|NOT COMPLETED|Overall Study||58
128784|NCT00902304|296641|P3|COMPLETED|Overall Study||568
128785|NCT00902304|296642|P2|COMPLETED|Overall Study||289
128786|NCT00902304|296643|P1|COMPLETED|Overall Study||466
128787|NCT00902304|296641|P3|STARTED|Overall Study||678
128788|NCT00902304|296642|P2|STARTED|Overall Study||360
128789|NCT00902304|296643|P1|STARTED|Overall Study||524
128790|NCT00902265|296688|P1|NOT COMPLETED|Overall Study||6
128791|NCT00902265|296688|P1|COMPLETED|Overall Study||132
128792|NCT00902265|296688|P1|Participants Who Received Treatment|Overall Study||137
128793|NCT00902265|296688|P1|STARTED|Overall Study||138
128794|NCT00902226|296700|P1|NOT COMPLETED|Overall Study||0
128795|NCT00902226|296700|P1|COMPLETED|Overall Study||30
128796|NCT00902226|296700|P1|STARTED|Overall Study||30
128797|NCT00902174|296712|P2|NOT COMPLETED|Overall Study||18
128798|NCT00902174|296713|P1|NOT COMPLETED|Overall Study||34
128799|NCT00902174|296712|P2|COMPLETED|Overall Study||81
128800|NCT00902174|296713|P1|COMPLETED|Overall Study||69
128801|NCT00902174|296712|P2|STARTED|Overall Study||99
128802|NCT00902174|296713|P1|STARTED|Overall Study||103
128803|NCT00902161|296751|P3|NOT COMPLETED|Period 2||0
128804|NCT00902161|296752|P2|NOT COMPLETED|Period 2||0
128805|NCT00902161|296753|P1|NOT COMPLETED|Period 2||0
128806|NCT00902161|296751|P3|COMPLETED|Period 2||0
128807|NCT00902161|296752|P2|COMPLETED|Period 2||9
128808|NCT00902161|296753|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
128809|NCT00902161|296751|P3|STARTED|Period 2||0
128810|NCT00902161|296752|P2|STARTED|Period 2||9
128811|NCT00902161|296753|P1|STARTED|Period 2||8
128812|NCT00902161|296751|P3|NOT COMPLETED|Post-clamp Washout||0
128813|NCT00902161|296752|P2|NOT COMPLETED|Post-clamp Washout||0
128814|NCT00902161|296753|P1|NOT COMPLETED|Post-clamp Washout||0
128815|NCT00902161|296751|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
128816|NCT00902161|296752|P2|COMPLETED|Post-clamp Washout||0
128817|NCT00902161|296753|P1|COMPLETED|Post-clamp Washout||0
128818|NCT00902161|296751|P3|STARTED|Post-clamp Washout||22
128819|NCT00902161|296752|P2|STARTED|Post-clamp Washout||0
128820|NCT00902161|296753|P1|STARTED|Post-clamp Washout||0
128821|NCT00902161|296751|P3|NOT COMPLETED|Period 1||0
128822|NCT00902161|296752|P2|NOT COMPLETED|Period 1||0
128823|NCT00902161|296753|P1|NOT COMPLETED|Period 1||0
128824|NCT00902161|296751|P3|COMPLETED|Period 1||0
128825|NCT00902161|296752|P2|COMPLETED|Period 1||10
128826|NCT00902161|296753|P1|COMPLETED|Period 1||12
128827|NCT00902161|296751|P3|STARTED|Period 1||0
128828|NCT00902161|296752|P2|STARTED|Period 1||10
128829|NCT00902161|296753|P1|STARTED|Period 1||12
128830|NCT00902161|296751|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
128831|NCT00902161|296752|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
128832|NCT00902161|296753|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
128833|NCT00902161|296751|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
128834|NCT00902161|296752|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
128835|NCT00902161|296753|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
128836|NCT00902161|296751|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
128837|NCT00902161|296752|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
128838|NCT00902161|296753|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
128839|NCT00901901|296770|P2|NOT COMPLETED|Follow-up Period||259
128840|NCT00901901|296771|P1|NOT COMPLETED|Follow-up Period||246
128841|NCT00901901|296770|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
128842|NCT00901901|296771|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
128843|NCT00901901|296770|P2|STARTED|Follow-up Period||324
128844|NCT00901901|296771|P1|STARTED|Follow-up Period||322
128845|NCT00901901|296770|P2|NOT COMPLETED|Treatment Period||168
128846|NCT00901901|296771|P1|NOT COMPLETED|Treatment Period||157
128847|NCT00901901|296770|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
128848|NCT00901901|296771|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
128849|NCT00901901|296770|P2|Participants Received Treatment|Treatment Period||355
128850|NCT00901901|296771|P1|Participants Received Treatment|Treatment Period||362
128851|NCT00901901|296770|P2|STARTED|Treatment Period||358
128852|NCT00901901|296771|P1|STARTED|Treatment Period||362
128853|NCT00901628|296793|P2|NOT COMPLETED|Overall Study||10
128854|NCT00901628|296794|P1|NOT COMPLETED|Overall Study||4
128855|NCT00901628|296793|P2|COMPLETED|Overall Study||42
128856|NCT00901628|296794|P1|COMPLETED|Overall Study||45
128857|NCT00901628|296793|P2|STARTED|Overall Study||52
128858|NCT00901628|296794|P1|STARTED|Overall Study||49
128859|NCT00901576|296816|P6|NOT COMPLETED|Third Intervention||0
128860|NCT00901576|296817|P5|NOT COMPLETED|Third Intervention||0
128861|NCT00901576|296818|P4|NOT COMPLETED|Third Intervention||0
128862|NCT00901576|296819|P3|NOT COMPLETED|Third Intervention||0
128863|NCT00901576|296820|P2|NOT COMPLETED|Third Intervention||0
128864|NCT00901576|296821|P1|NOT COMPLETED|Third Intervention||0
128865|NCT00901576|296816|P6|COMPLETED|Third Intervention||5
128866|NCT00901576|296817|P5|COMPLETED|Third Intervention||6
128867|NCT00901576|296818|P4|COMPLETED|Third Intervention||5
128868|NCT00901576|296819|P3|COMPLETED|Third Intervention||7
128869|NCT00901576|296820|P2|COMPLETED|Third Intervention||7
128870|NCT00901576|296821|P1|COMPLETED|Third Intervention||5
128871|NCT00901576|296816|P6|STARTED|Third Intervention||5
128872|NCT00901576|296817|P5|STARTED|Third Intervention||6
128873|NCT00901576|296818|P4|STARTED|Third Intervention||5
128874|NCT00901576|296819|P3|STARTED|Third Intervention||7
128875|NCT00901576|296820|P2|STARTED|Third Intervention||7
128876|NCT00901576|296821|P1|STARTED|Third Intervention||5
128877|NCT00901576|296816|P6|NOT COMPLETED|Washout||0
128878|NCT00901576|296817|P5|NOT COMPLETED|Washout||0
128879|NCT00901576|296818|P4|NOT COMPLETED|Washout||0
128880|NCT00901576|296819|P3|NOT COMPLETED|Washout||0
128881|NCT00901576|296820|P2|NOT COMPLETED|Washout||0
128882|NCT00901576|296821|P1|NOT COMPLETED|Washout||0
128883|NCT00901576|296816|P6|COMPLETED|Washout||5
128884|NCT00901576|296817|P5|COMPLETED|Washout||6
128885|NCT00901576|296818|P4|COMPLETED|Washout||5
128886|NCT00901576|296819|P3|COMPLETED|Washout||7
128887|NCT00901576|296820|P2|COMPLETED|Washout||7
128888|NCT00901576|296821|P1|COMPLETED|Washout||5
128889|NCT00901576|296816|P6|STARTED|Washout||5
128890|NCT00901576|296817|P5|STARTED|Washout||6
128891|NCT00901576|296818|P4|STARTED|Washout||5
128892|NCT00901576|296819|P3|STARTED|Washout||7
128893|NCT00901576|296820|P2|STARTED|Washout||7
128894|NCT00901576|296821|P1|STARTED|Washout||5
128895|NCT00901576|296816|P6|NOT COMPLETED|Second Intervention||1
128896|NCT00901576|296817|P5|NOT COMPLETED|Second Intervention||0
128897|NCT00901576|296818|P4|NOT COMPLETED|Second Intervention||1
128898|NCT00901576|296819|P3|NOT COMPLETED|Second Intervention||0
128899|NCT00901576|296820|P2|NOT COMPLETED|Second Intervention||0
128900|NCT00901576|296821|P1|NOT COMPLETED|Second Intervention||1
128901|NCT00901576|296816|P6|COMPLETED|Second Intervention||5
128902|NCT00901576|296817|P5|COMPLETED|Second Intervention||6
128903|NCT00901576|296818|P4|COMPLETED|Second Intervention||5
128904|NCT00901576|296819|P3|COMPLETED|Second Intervention||7
128905|NCT00901576|296820|P2|COMPLETED|Second Intervention||7
128906|NCT00901576|296821|P1|COMPLETED|Second Intervention||5
128907|NCT00901576|296816|P6|STARTED|Second Intervention||6
128908|NCT00901576|296817|P5|STARTED|Second Intervention||6
128909|NCT00901576|296818|P4|STARTED|Second Intervention||6
128910|NCT00901576|296819|P3|STARTED|Second Intervention||7
128911|NCT00901576|296820|P2|STARTED|Second Intervention||7
128912|NCT00901576|296821|P1|STARTED|Second Intervention||6
128913|NCT00901576|296816|P6|NOT COMPLETED|Washout||0
128914|NCT00901576|296817|P5|NOT COMPLETED|Washout||0
128915|NCT00901576|296818|P4|NOT COMPLETED|Washout||0
128916|NCT00901576|296819|P3|NOT COMPLETED|Washout||0
128917|NCT00901576|296820|P2|NOT COMPLETED|Washout||0
128918|NCT00901576|296821|P1|NOT COMPLETED|Washout||0
128919|NCT00901576|296816|P6|COMPLETED|Washout||6
128920|NCT00901576|296817|P5|COMPLETED|Washout||6
128921|NCT00901576|296818|P4|COMPLETED|Washout||6
128922|NCT00901576|296819|P3|COMPLETED|Washout||7
128923|NCT00901576|296820|P2|COMPLETED|Washout||7
128924|NCT00901576|296821|P1|COMPLETED|Washout||6
128925|NCT00901576|296816|P6|STARTED|Washout||6
128926|NCT00901576|296817|P5|STARTED|Washout||6
128927|NCT00901576|296818|P4|STARTED|Washout||6
128928|NCT00901576|296819|P3|STARTED|Washout||7
128929|NCT00901576|296820|P2|STARTED|Washout||7
128930|NCT00901576|296821|P1|STARTED|Washout||6
128931|NCT00901576|296816|P6|NOT COMPLETED|First Intervention||0
128932|NCT00901576|296817|P5|NOT COMPLETED|First Intervention||0
128933|NCT00901576|296818|P4|NOT COMPLETED|First Intervention||0
128934|NCT00901576|296819|P3|NOT COMPLETED|First Intervention||0
128935|NCT00901576|296820|P2|NOT COMPLETED|First Intervention||0
128936|NCT00901576|296821|P1|NOT COMPLETED|First Intervention||0
128937|NCT00901576|296816|P6|COMPLETED|First Intervention||6
128938|NCT00901576|296817|P5|COMPLETED|First Intervention||6
128939|NCT00901576|296818|P4|COMPLETED|First Intervention||6
128940|NCT00901576|296819|P3|COMPLETED|First Intervention||7
128941|NCT00901576|296820|P2|COMPLETED|First Intervention||7
128942|NCT00901576|296821|P1|COMPLETED|First Intervention||6
128943|NCT00901576|296816|P6|STARTED|First Intervention||6
128945|NCT00901576|296818|P4|STARTED|First Intervention||6
128946|NCT00901576|296819|P3|STARTED|First Intervention||7
128947|NCT00901576|296820|P2|STARTED|First Intervention||7
128948|NCT00901576|296821|P1|STARTED|First Intervention||6
128949|NCT00901459|296842|P1|NOT COMPLETED|Overall Study||6
128950|NCT00901459|296842|P1|COMPLETED|Overall Study||15
128951|NCT00901459|296842|P1|STARTED|Overall Study||21
128952|NCT00901316|296855|P2|NOT COMPLETED|Overall Study||0
128953|NCT00901316|296856|P1|NOT COMPLETED|Overall Study||0
128954|NCT00901316|296855|P2|COMPLETED|Overall Study||495
128955|NCT00901316|296856|P1|COMPLETED|Overall Study||492
128956|NCT00901316|296855|P2|STARTED|Overall Study||495
128957|NCT00901316|296856|P1|STARTED|Overall Study||492
128958|NCT00901225|296862|P1|NOT COMPLETED|Overall Study||1
128959|NCT00901225|296862|P1|COMPLETED|Overall Study||20
128960|NCT00901225|296862|P1|STARTED|Overall Study||21
128961|NCT00901186|296873|P2|NOT COMPLETED|Overall Study||11
128962|NCT00901186|296874|P1|NOT COMPLETED|Overall Study||9
128963|NCT00901186|296873|P2|COMPLETED|Overall Study||32
128964|NCT00901186|296874|P1|COMPLETED|Overall Study||31
128965|NCT00901186|296873|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
128966|NCT00901186|296874|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
128967|NCT00901186|296873|P2|Safety Set|Overall Study||43
128968|NCT00901186|296874|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
128969|NCT00901186|296873|P2|STARTED|Overall Study||43
128970|NCT00901186|296874|P1|STARTED|Overall Study||40
128971|NCT00901017|296890|P1|NOT COMPLETED|Overall Study||0
128972|NCT00901017|296890|P1|COMPLETED|Overall Study||14
128973|NCT00901017|296890|P1|STARTED|Overall Study||14
128974|NCT00900822|296904|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
128975|NCT00900822|296904|P1|COMPLETED|12 Months Clinical Evaluation||11
128976|NCT00900822|296904|P1|STARTED|12 Months Clinical Evaluation||11
128977|NCT00900822|296904|P1|NOT COMPLETED|9 Months Histological Evaluation||0
128978|NCT00900822|296904|P1|COMPLETED|9 Months Histological Evaluation||11
128979|NCT00900822|296904|P1|STARTED|9 Months Histological Evaluation||11
128980|NCT00900796|296914|P1|NOT COMPLETED|Phase 2||5
128981|NCT00900796|296914|P1|COMPLETED|Phase 2||6
128982|NCT00900796|296914|P1|STARTED|Phase 2||11
128983|NCT00900796|296914|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
128984|NCT00900796|296914|P1|COMPLETED|Between Phase 1 and Phase 2||11
128985|NCT00900796|296914|P1|STARTED|Between Phase 1 and Phase 2||121
128986|NCT00900796|296914|P1|NOT COMPLETED|Phase 1||11
128987|NCT00900796|296914|P1|COMPLETED|Phase 1||121
128988|NCT00900796|296914|P1|STARTED|Phase 1||132
128989|NCT00900757|296924|P1|NOT COMPLETED|Overall Study||19
128990|NCT00900757|296924|P1|COMPLETED|Overall Study||38
128991|NCT00900757|296924|P1|STARTED|Overall Study||57
128992|NCT00900731|296934|P2|NOT COMPLETED|Overall Study||61
128993|NCT00900731|296935|P1|NOT COMPLETED|Overall Study||60
128994|NCT00900731|296934|P2|COMPLETED|Overall Study||740
128995|NCT00900731|296935|P1|COMPLETED|Overall Study||737
128996|NCT00900731|296934|P2|Safety Set: Received Study Drug|Overall Study||799
128997|NCT00900731|296935|P1|Safety Set: Received Study Drug|Overall Study||794
128998|NCT00900731|296934|P2|STARTED|Overall Study||801
128999|NCT00900731|296935|P1|STARTED|Overall Study|Randomized participants|797
129000|NCT00900666|296957|P2|NOT COMPLETED|Overall Study||0
129001|NCT00900666|296958|P1|NOT COMPLETED|Overall Study||0
129002|NCT00900666|296957|P2|COMPLETED|Overall Study||9
129003|NCT00900666|296958|P1|COMPLETED|Overall Study||10
129004|NCT00900666|296957|P2|STARTED|Overall Study||9
129005|NCT00900666|296958|P1|STARTED|Overall Study||10
129006|NCT00900627|296972|P6|NOT COMPLETED|Overall Study||26
129007|NCT00900627|296973|P5|NOT COMPLETED|Overall Study||29
129008|NCT00900627|296974|P4|NOT COMPLETED|Overall Study||6
129009|NCT00900627|296975|P3|NOT COMPLETED|Overall Study||6
129010|NCT00900627|296976|P2|NOT COMPLETED|Overall Study||2
129011|NCT00900627|296977|P1|NOT COMPLETED|Overall Study||6
129012|NCT00900627|296972|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
129013|NCT00900627|296973|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
129014|NCT00900627|296974|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
129015|NCT00900627|296975|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
129016|NCT00900627|296976|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
129017|NCT00900627|296977|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
129018|NCT00900627|296972|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
129019|NCT00900627|296973|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
129020|NCT00900627|296974|P4|STARTED|Overall Study||6
129021|NCT00900627|296975|P3|STARTED|Overall Study||6
129022|NCT00900627|296976|P2|STARTED|Overall Study||2
129023|NCT00900627|296977|P1|STARTED|Overall Study||6
129024|NCT00900237|296997|P2|NOT COMPLETED|Overall Study||0
129025|NCT00900237|296998|P1|NOT COMPLETED|Overall Study||0
129026|NCT00900237|296997|P2|COMPLETED|Overall Study||7
129027|NCT00900237|296998|P1|COMPLETED|Overall Study||7
129028|NCT00900237|296997|P2|STARTED|Overall Study||7
129029|NCT00900237|296998|P1|STARTED|Overall Study||7
129030|NCT00900146|297011|P5|NOT COMPLETED|Intermediate: Period III||167
129031|NCT00900146|297012|P4|NOT COMPLETED|Intermediate: Period III||90
129032|NCT00900146|297013|P3|NOT COMPLETED|Intermediate: Period III||84
129033|NCT00900146|297014|P2|NOT COMPLETED|Intermediate: Period III||93
129034|NCT00900146|297015|P1|NOT COMPLETED|Intermediate: Period III||87
129035|NCT00900146|297011|P5|COMPLETED|Intermediate: Period III||0
129036|NCT00900146|297012|P4|COMPLETED|Intermediate: Period III||0
129037|NCT00900146|297013|P3|COMPLETED|Intermediate: Period III||0
129038|NCT00900146|297014|P2|COMPLETED|Intermediate: Period III||0
129039|NCT00900146|297015|P1|COMPLETED|Intermediate: Period III||0
129040|NCT00900146|297011|P5|Safety Set|Intermediate: Period III||166
129041|NCT00900146|297012|P4|Safety Set|Intermediate: Period III||90
129042|NCT00900146|297013|P3|Safety Set|Intermediate: Period III||84
129043|NCT00900146|297014|P2|Safety Set|Intermediate: Period III||92
129044|NCT00900146|297015|P1|Safety Set|Intermediate: Period III||86
129045|NCT00900146|297011|P5|STARTED|Intermediate: Period III||167
129046|NCT00900146|297012|P4|STARTED|Intermediate: Period III||90
129047|NCT00900146|297013|P3|STARTED|Intermediate: Period III||84
129048|NCT00900146|297014|P2|STARTED|Intermediate: Period III||93
129049|NCT00900146|297015|P1|STARTED|Intermediate: Period III||87
129050|NCT00900146|297011|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
129051|NCT00900146|297012|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
129052|NCT00900146|297013|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
129053|NCT00900146|297014|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
129054|NCT00900146|297015|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
129055|NCT00900146|297011|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
129056|NCT00900146|297012|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
129057|NCT00900146|297013|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
129058|NCT00900146|297014|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
129059|NCT00900146|297015|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
129060|NCT00900146|297011|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
129061|NCT00900146|297012|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
129062|NCT00900146|297013|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
129063|NCT00900146|297014|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
129064|NCT00900146|297015|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
129065|NCT00900146|297011|P5|STARTED|Dose Finding: Period II (4 Months)||179
129066|NCT00900146|297012|P4|STARTED|Dose Finding: Period II (4 Months)||92
129067|NCT00900146|297013|P3|STARTED|Dose Finding: Period II (4 Months)||92
129068|NCT00900146|297014|P2|STARTED|Dose Finding: Period II (4 Months)||95
129069|NCT00900146|297015|P1|STARTED|Dose Finding: Period II (4 Months)||93
129070|NCT00900029|297132|P5|NOT COMPLETED|Overall Study||6
129071|NCT00900029|297133|P4|NOT COMPLETED|Overall Study||7
129072|NCT00900029|297134|P3|NOT COMPLETED|Overall Study||3
129073|NCT00900029|297135|P2|NOT COMPLETED|Overall Study||4
129074|NCT00900029|297136|P1|NOT COMPLETED|Overall Study||3
129075|NCT00900029|297132|P5|COMPLETED|Overall Study||38
129076|NCT00900029|297133|P4|COMPLETED|Overall Study||35
129077|NCT00900029|297134|P3|COMPLETED|Overall Study||38
129078|NCT00900029|297135|P2|COMPLETED|Overall Study||37
129079|NCT00900029|297136|P1|COMPLETED|Overall Study||35
129080|NCT00900029|297132|P5|STARTED|Overall Study||44
129081|NCT00900029|297133|P4|STARTED|Overall Study||42
129082|NCT00900029|297134|P3|STARTED|Overall Study||41
129083|NCT00900029|297135|P2|STARTED|Overall Study||41
129084|NCT00900029|297136|P1|STARTED|Overall Study||38
129085|NCT00899717|297155|P2|NOT COMPLETED|Overall Study||0
129086|NCT00899717|297156|P1|NOT COMPLETED|Overall Study||0
129087|NCT00899717|297155|P2|COMPLETED|Overall Study||11
129088|NCT00899717|297156|P1|COMPLETED|Overall Study||10
129089|NCT00899717|297155|P2|STARTED|Overall Study||11
129090|NCT00899717|297156|P1|STARTED|Overall Study||10
129091|NCT00899678|297173|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
129092|NCT00899678|297174|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
129093|NCT00899678|297175|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
129094|NCT00899678|297173|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
129095|NCT00899678|297174|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
129096|NCT00899678|297175|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
129097|NCT00899678|297173|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
129098|NCT00899678|297174|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
129099|NCT00899678|297175|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
129100|NCT00899678|297173|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
129101|NCT00899678|297174|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
129102|NCT00899678|297175|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
129103|NCT00899678|297173|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
129104|NCT00899678|297174|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
129105|NCT00899678|297175|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
129106|NCT00899678|297173|P3|STARTED|Induction Period (Weeks 0 to 6)||35
129107|NCT00899678|297174|P2|STARTED|Induction Period (Weeks 0 to 6)||37
129108|NCT00899678|297175|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
129109|NCT00899600|297205|P2|NOT COMPLETED|Overall Study||0
129110|NCT00899600|297206|P1|NOT COMPLETED|Overall Study||0
129111|NCT00899600|297205|P2|COMPLETED|Overall Study||52
129112|NCT00899600|297206|P1|COMPLETED|Overall Study||50
129113|NCT00899600|297205|P2|STARTED|Overall Study||52
129114|NCT00899600|297206|P1|STARTED|Overall Study||50
129115|NCT00899574|297212|P1|NOT COMPLETED|Overall Study||0
129116|NCT00899574|297212|P1|COMPLETED|Overall Study||10
129117|NCT00899574|297212|P1|STARTED|Overall Study||10
129118|NCT00899470|297217|P4|NOT COMPLETED|Fourth Therapy||0
129119|NCT00899470|297218|P3|NOT COMPLETED|Fourth Therapy||0
129120|NCT00899470|297219|P2|NOT COMPLETED|Fourth Therapy||0
129121|NCT00899470|297220|P1|NOT COMPLETED|Fourth Therapy||0
129122|NCT00899470|297217|P4|COMPLETED|Fourth Therapy||6
129123|NCT00899470|297218|P3|COMPLETED|Fourth Therapy||6
129124|NCT00899470|297219|P2|COMPLETED|Fourth Therapy||6
129125|NCT00899470|297220|P1|COMPLETED|Fourth Therapy||6
129126|NCT00899470|297217|P4|STARTED|Fourth Therapy||6
129127|NCT00899470|297218|P3|STARTED|Fourth Therapy||6
129128|NCT00899470|297219|P2|STARTED|Fourth Therapy||6
129129|NCT00899470|297220|P1|STARTED|Fourth Therapy||6
129130|NCT00899470|297217|P4|NOT COMPLETED|Third Washout||0
129131|NCT00899470|297218|P3|NOT COMPLETED|Third Washout||0
129132|NCT00899470|297219|P2|NOT COMPLETED|Third Washout||0
129133|NCT00899470|297220|P1|NOT COMPLETED|Third Washout||0
129134|NCT00899470|297217|P4|COMPLETED|Third Washout||6
129135|NCT00899470|297218|P3|COMPLETED|Third Washout||6
129136|NCT00899470|297219|P2|COMPLETED|Third Washout||6
129137|NCT00899470|297220|P1|COMPLETED|Third Washout||6
129138|NCT00899470|297217|P4|STARTED|Third Washout||6
129139|NCT00899470|297218|P3|STARTED|Third Washout||6
129140|NCT00899470|297219|P2|STARTED|Third Washout||6
129141|NCT00899470|297220|P1|STARTED|Third Washout||6
129142|NCT00899470|297217|P4|NOT COMPLETED|Third Therapy||0
129143|NCT00899470|297218|P3|NOT COMPLETED|Third Therapy||0
129144|NCT00899470|297219|P2|NOT COMPLETED|Third Therapy||0
129145|NCT00899470|297220|P1|NOT COMPLETED|Third Therapy||0
129146|NCT00899470|297217|P4|COMPLETED|Third Therapy||6
129147|NCT00899470|297218|P3|COMPLETED|Third Therapy||6
129148|NCT00899470|297219|P2|COMPLETED|Third Therapy||6
129149|NCT00899470|297220|P1|COMPLETED|Third Therapy||6
129150|NCT00899470|297217|P4|STARTED|Third Therapy||6
129151|NCT00899470|297218|P3|STARTED|Third Therapy||6
129152|NCT00899470|297219|P2|STARTED|Third Therapy||6
129153|NCT00899470|297220|P1|STARTED|Third Therapy||6
129154|NCT00899470|297217|P4|NOT COMPLETED|Second Washout||0
129155|NCT00899470|297218|P3|NOT COMPLETED|Second Washout||0
129156|NCT00899470|297219|P2|NOT COMPLETED|Second Washout||0
129157|NCT00899470|297220|P1|NOT COMPLETED|Second Washout||0
129158|NCT00899470|297217|P4|COMPLETED|Second Washout||6
129159|NCT00899470|297218|P3|COMPLETED|Second Washout||6
129160|NCT00899470|297219|P2|COMPLETED|Second Washout||6
129161|NCT00899470|297220|P1|COMPLETED|Second Washout||6
129162|NCT00899470|297217|P4|STARTED|Second Washout||6
129163|NCT00899470|297218|P3|STARTED|Second Washout||6
129164|NCT00899470|297219|P2|STARTED|Second Washout||6
129165|NCT00899470|297220|P1|STARTED|Second Washout||6
129166|NCT00899470|297217|P4|NOT COMPLETED|Second Therapy||0
129167|NCT00899470|297218|P3|NOT COMPLETED|Second Therapy||0
129168|NCT00899470|297219|P2|NOT COMPLETED|Second Therapy||0
129169|NCT00899470|297220|P1|NOT COMPLETED|Second Therapy||0
129170|NCT00899470|297217|P4|COMPLETED|Second Therapy||6
129171|NCT00899470|297218|P3|COMPLETED|Second Therapy||6
129172|NCT00899470|297219|P2|COMPLETED|Second Therapy||6
129173|NCT00899470|297220|P1|COMPLETED|Second Therapy||6
129174|NCT00899470|297217|P4|STARTED|Second Therapy||6
129175|NCT00899470|297218|P3|STARTED|Second Therapy||6
129176|NCT00899470|297219|P2|STARTED|Second Therapy||6
129177|NCT00899470|297220|P1|STARTED|Second Therapy||6
129178|NCT00899470|297217|P4|NOT COMPLETED|First Washout Period||0
129179|NCT00899470|297218|P3|NOT COMPLETED|First Washout Period||0
129180|NCT00899470|297219|P2|NOT COMPLETED|First Washout Period||0
129181|NCT00899470|297220|P1|NOT COMPLETED|First Washout Period||0
129182|NCT00899470|297217|P4|COMPLETED|First Washout Period||6
129183|NCT00899470|297218|P3|COMPLETED|First Washout Period||6
129184|NCT00899470|297219|P2|COMPLETED|First Washout Period||6
129185|NCT00899470|297220|P1|COMPLETED|First Washout Period||6
129186|NCT00899470|297217|P4|STARTED|First Washout Period||6
129187|NCT00899470|297218|P3|STARTED|First Washout Period||6
129188|NCT00899470|297219|P2|STARTED|First Washout Period||6
129189|NCT00899470|297220|P1|STARTED|First Washout Period||6
129190|NCT00899470|297217|P4|NOT COMPLETED|First Therapy||0
129191|NCT00899470|297218|P3|NOT COMPLETED|First Therapy||0
129192|NCT00899470|297219|P2|NOT COMPLETED|First Therapy||0
129193|NCT00899470|297220|P1|NOT COMPLETED|First Therapy||0
129194|NCT00899470|297217|P4|COMPLETED|First Therapy||6
129195|NCT00899470|297218|P3|COMPLETED|First Therapy||6
129196|NCT00899470|297219|P2|COMPLETED|First Therapy||6
129197|NCT00899470|297220|P1|COMPLETED|First Therapy||6
129198|NCT00899470|297217|P4|STARTED|First Therapy||6
129199|NCT00899470|297218|P3|STARTED|First Therapy||6
129200|NCT00899470|297219|P2|STARTED|First Therapy||6
129201|NCT00899470|297220|P1|STARTED|First Therapy||6
129202|NCT00899392|297298|P2|NOT COMPLETED|Overall Study||24
129203|NCT00899392|297299|P1|NOT COMPLETED|Overall Study||21
129204|NCT00899392|297298|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
129205|NCT00899392|297299|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
129206|NCT00899392|297298|P2|STARTED|Overall Study||74
129207|NCT00899392|297299|P1|STARTED|Overall Study||68
129208|NCT00899379|297316|P5|NOT COMPLETED|Overall Study||31
129209|NCT00899379|297317|P4|NOT COMPLETED|Overall Study||37
129210|NCT00899379|297318|P3|NOT COMPLETED|Overall Study||29
129211|NCT00899379|297319|P2|NOT COMPLETED|Overall Study||29
129212|NCT00899379|297320|P1|NOT COMPLETED|Overall Study||34
129213|NCT00899379|297316|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
129214|NCT00899379|297317|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
129215|NCT00899379|297318|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
129216|NCT00899379|297319|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
129217|NCT00899379|297320|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
129218|NCT00899379|297316|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
129219|NCT00899379|297317|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
129220|NCT00899379|297318|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
129221|NCT00899379|297319|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
129222|NCT00899379|297320|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
129223|NCT00899379|297316|P5|Patients Treated|Overall Study|Patients who took study drug|81
129224|NCT00899379|297317|P4|Patients Treated|Overall Study|Patients who took study drug|77
129225|NCT00899379|297318|P3|Patients Treated|Overall Study|Patients who took study drug|84
129226|NCT00899379|297319|P2|Patients Treated|Overall Study|Patients who took study drug|82
129227|NCT00899379|297320|P1|Patients Treated|Overall Study|Patients who took study drug|83
129228|NCT00899379|297316|P5|STARTED|Overall Study|Patients who were allocated study drug|94
129229|NCT00899379|297317|P4|STARTED|Overall Study|Patients who were allocated study drug|94
129230|NCT00899379|297318|P3|STARTED|Overall Study|Patients who were allocated study drug|95
129231|NCT00899379|297319|P2|STARTED|Overall Study|Patients who were allocated study drug|95
129232|NCT00899379|297320|P1|STARTED|Overall Study|Patients who were allocated study drug|95
129233|NCT00899353|297332|P1|NOT COMPLETED|Overall Study||5
129234|NCT00899353|297332|P1|COMPLETED|Overall Study||11
129235|NCT00899353|297332|P1|STARTED|Overall Study||16
129236|NCT00898807|297355|P2|NOT COMPLETED|Overall Study||9
129237|NCT00898807|297356|P1|NOT COMPLETED|Overall Study||8
129238|NCT00898807|297355|P2|COMPLETED|Overall Study||83
129239|NCT00898807|297356|P1|COMPLETED|Overall Study||86
129240|NCT00898807|297355|P2|STARTED|Overall Study||92
129241|NCT00898807|297356|P1|STARTED|Overall Study||94
129242|NCT00898677|297372|P4|NOT COMPLETED|Overall Study||19
129243|NCT00898677|297373|P3|NOT COMPLETED|Overall Study||72
129244|NCT00898677|297374|P2|NOT COMPLETED|Overall Study||69
129245|NCT00898677|297375|P1|NOT COMPLETED|Overall Study||17
129246|NCT00898677|297372|P4|COMPLETED|Overall Study||159
129247|NCT00898677|297373|P3|COMPLETED|Overall Study||383
129248|NCT00898677|297374|P2|COMPLETED|Overall Study||386
129249|NCT00898677|297375|P1|COMPLETED|Overall Study||163
129250|NCT00898677|297372|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
129251|NCT00898677|297373|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
129252|NCT00898677|297374|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
129253|NCT00898677|297375|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
129254|NCT00898677|297372|P4|STARTED|Overall Study||178
129255|NCT00898677|297373|P3|STARTED|Overall Study||455
129256|NCT00898677|297374|P2|STARTED|Overall Study||455
129257|NCT00898677|297375|P1|STARTED|Overall Study||180
129258|NCT00898560|297401|P1|NOT COMPLETED|Overall Study||1
129259|NCT00898560|297401|P1|COMPLETED|Overall Study||19
129260|NCT00898560|297401|P1|STARTED|Overall Study||20
129261|NCT00898443|297413|P2|NOT COMPLETED|Overall Study||0
129262|NCT00898443|297414|P1|NOT COMPLETED|Overall Study||1
129263|NCT00898443|297413|P2|COMPLETED|Overall Study||8
129264|NCT00898443|297414|P1|COMPLETED|Overall Study||9
129265|NCT00898443|297413|P2|STARTED|Overall Study||8
129266|NCT00898443|297414|P1|STARTED|Overall Study||10
129267|NCT00898222|297422|P1|NOT COMPLETED|Overall Study||0
129268|NCT00898222|297422|P1|COMPLETED|Overall Study||4
129269|NCT00898222|297422|P1|STARTED|Overall Study||4
129270|NCT00897949|297429|P3|NOT COMPLETED|Overall Study||69
129271|NCT00897949|297430|P2|NOT COMPLETED|Overall Study||103
129272|NCT00897949|297431|P1|NOT COMPLETED|Overall Study||104
129273|NCT00897949|297429|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
129274|NCT00897949|297430|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
129275|NCT00897949|297431|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
129276|NCT00897949|297429|P3|Patients Treated|Overall Study|Patients who took study drug|304
129277|NCT00897949|297430|P2|Patients Treated|Overall Study|Patients who took study drug|456
129278|NCT00897949|297431|P1|Patients Treated|Overall Study|Patients who took study drug|458
129279|NCT00897949|297429|P3|STARTED|Overall Study|Patients who were allocated study drug|370
129280|NCT00897949|297430|P2|STARTED|Overall Study|Patients who were allocated study drug|549
129281|NCT00897949|297431|P1|STARTED|Overall Study|Patients who were allocated study drug|554
129282|NCT00897910|297454|P1|NOT COMPLETED|Overall Study||0
129283|NCT00897910|297454|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
129284|NCT00897910|297454|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
129285|NCT00897897|297458|P1|NOT COMPLETED|Overall Study||0
129286|NCT00897897|297458|P1|COMPLETED|Overall Study||33
129287|NCT00897897|297458|P1|STARTED|Overall Study||33
129288|NCT00897715|297465|P2|NOT COMPLETED|Overall Study||1
129289|NCT00897715|297466|P1|NOT COMPLETED|Overall Study||2
129290|NCT00897715|297465|P2|COMPLETED|Overall Study||6
129291|NCT00897715|297466|P1|COMPLETED|Overall Study||6
129292|NCT00897715|297465|P2|STARTED|Overall Study||7
129293|NCT00897715|297466|P1|STARTED|Overall Study||8
129294|NCT00897390|297474|P1|NOT COMPLETED|Overall Study||6
129295|NCT00897390|297474|P1|COMPLETED|Overall Study||18
129296|NCT00897390|297474|P1|STARTED|Overall Study||24
129297|NCT00897104|297564|P3|NOT COMPLETED|Overall Study||8
129298|NCT00897104|297565|P2|NOT COMPLETED|Overall Study||71
129299|NCT00897104|297566|P1|NOT COMPLETED|Overall Study||64
129300|NCT00897104|297564|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
129301|NCT00897104|297565|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
129302|NCT00897104|297566|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
129303|NCT00897104|297564|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
129304|NCT00897104|297565|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
129305|NCT00897104|297566|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
129306|NCT00897104|297564|P3|Participants Treated|Overall Study|Participants who took study drug|80
129307|NCT00897104|297565|P2|Participants Treated|Overall Study|Participants who took study drug|357
129308|NCT00897104|297566|P1|Participants Treated|Overall Study|Participants who took study drug|355
129309|NCT00897104|297564|P3|STARTED|Overall Study|Participants who were allocated study drug|87
129310|NCT00897104|297565|P2|STARTED|Overall Study|Participants who were allocated study drug|428
129311|NCT00897104|297566|P1|STARTED|Overall Study|Participants who were allocated study drug|418
129312|NCT00896779|297594|P2|NOT COMPLETED|Overall Study||1
129313|NCT00896779|297595|P1|NOT COMPLETED|Overall Study||0
129314|NCT00896779|297594|P2|COMPLETED|Overall Study||11
129315|NCT00896779|297595|P1|COMPLETED|Overall Study||8
129316|NCT00896779|297594|P2|STARTED|Overall Study||12
129317|NCT00896779|297595|P1|STARTED|Overall Study||8
129318|NCT00896649|297601|P1|NOT COMPLETED|Overall Study||5
129319|NCT00896649|297601|P1|COMPLETED|Overall Study||188
129320|NCT00896649|297601|P1|STARTED|Overall Study||193
129321|NCT00896454|297606|P1|NOT COMPLETED|Overall Study||33
129322|NCT00896454|297606|P1|COMPLETED|Overall Study||0
129323|NCT00896454|297606|P1|STARTED|Overall Study||33
129324|NCT00896337|297618|P1|NOT COMPLETED|Overall Study||25
129325|NCT00896337|297618|P1|COMPLETED|Overall Study||100
129326|NCT00896337|297618|P1|STARTED|Overall Study||125
129327|NCT00896233|297685|P1|NOT COMPLETED|Overall Study||1
129328|NCT00896233|297685|P1|COMPLETED|Overall Study||9
129329|NCT00896233|297685|P1|STARTED|Overall Study||10
129330|NCT00896168|297698|P2|NOT COMPLETED|Overall Study||19
129331|NCT00896168|297699|P1|NOT COMPLETED|Overall Study||14
129332|NCT00896168|297698|P2|COMPLETED|Overall Study||111
129333|NCT00896168|297699|P1|COMPLETED|Overall Study||90
129334|NCT00896168|297698|P2|STARTED|Overall Study||130
129335|NCT00896168|297699|P1|STARTED|Overall Study||104
129336|NCT00896051|297729|P2|NOT COMPLETED|Overall Study||9
129337|NCT00896051|297730|P1|NOT COMPLETED|Overall Study||10
129338|NCT00896051|297729|P2|COMPLETED|Overall Study||16
129339|NCT00896051|297730|P1|COMPLETED|Overall Study||15
129340|NCT00896051|297729|P2|STARTED|Overall Study||25
129341|NCT00896051|297730|P1|STARTED|Overall Study||25
129342|NCT00896038|297772|P2|NOT COMPLETED|Overall Study||1
129343|NCT00896038|297773|P1|NOT COMPLETED|Overall Study||4
129344|NCT00896038|297772|P2|COMPLETED|Overall Study||27
129345|NCT00896038|297773|P1|COMPLETED|Overall Study||26
129346|NCT00896038|297772|P2|STARTED|Overall Study||28
129347|NCT00896038|297773|P1|STARTED|Overall Study||30
129348|NCT00896025|297811|P1|NOT COMPLETED|Overall Study||0
129349|NCT00896025|297811|P1|COMPLETED|Overall Study||8
129350|NCT00896025|297811|P1|STARTED|Overall Study||8
129351|NCT00895947|297817|P2|NOT COMPLETED|Overall Study||10
129352|NCT00895947|297818|P1|NOT COMPLETED|Overall Study||12
129353|NCT00895947|297817|P2|COMPLETED|Overall Study||90
129354|NCT00895947|297818|P1|COMPLETED|Overall Study||88
129355|NCT00895947|297817|P2|STARTED|Overall Study||100
129356|NCT00895947|297818|P1|STARTED|Overall Study||100
129357|NCT00895934|297836|P2|NOT COMPLETED|Overall Study||25
129358|NCT00895934|297837|P1|NOT COMPLETED|Overall Study||6
129359|NCT00895934|297836|P2|COMPLETED|Overall Study||18
129360|NCT00895934|297837|P1|COMPLETED|Overall Study||4
129361|NCT00895934|297836|P2|STARTED|Overall Study||43
129362|NCT00895934|297837|P1|STARTED|Overall Study||10
129363|NCT00895895|297848|P5|NOT COMPLETED|Period 2||49
129364|NCT00895895|297849|P4|NOT COMPLETED|Period 2||54
129365|NCT00895895|297850|P3|NOT COMPLETED|Period 2||49
129366|NCT00895895|297851|P2|NOT COMPLETED|Period 2||53
129367|NCT00895895|297852|P1|NOT COMPLETED|Period 2||56
129368|NCT00895895|297848|P5|COMPLETED|Period 2||35
129369|NCT00895895|297849|P4|COMPLETED|Period 2||37
129370|NCT00895895|297850|P3|COMPLETED|Period 2||33
129371|NCT00895895|297851|P2|COMPLETED|Period 2||31
129372|NCT00895895|297852|P1|COMPLETED|Period 2||30
129373|NCT00895895|297848|P5|STARTED|Period 2||84
129374|NCT00895895|297849|P4|STARTED|Period 2||91
129375|NCT00895895|297850|P3|STARTED|Period 2||82
129376|NCT00895895|297851|P2|STARTED|Period 2||84
129377|NCT00895895|297852|P1|STARTED|Period 2||86
129378|NCT00895895|297848|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
129379|NCT00895895|297849|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
129380|NCT00895895|297850|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
129381|NCT00895895|297851|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
129382|NCT00895895|297852|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
129383|NCT00895895|297848|P5|COMPLETED|After Period 1, Prior to Period 2||84
129384|NCT00895895|297849|P4|COMPLETED|After Period 1, Prior to Period 2||91
129385|NCT00895895|297850|P3|COMPLETED|After Period 1, Prior to Period 2||82
129386|NCT00895895|297851|P2|COMPLETED|After Period 1, Prior to Period 2||84
129387|NCT00895895|297852|P1|COMPLETED|After Period 1, Prior to Period 2||86
129388|NCT00895895|297848|P5|STARTED|After Period 1, Prior to Period 2||86
129389|NCT00895895|297849|P4|STARTED|After Period 1, Prior to Period 2||91
129390|NCT00895895|297850|P3|STARTED|After Period 1, Prior to Period 2||84
129391|NCT00895895|297851|P2|STARTED|After Period 1, Prior to Period 2||84
129392|NCT00895895|297852|P1|STARTED|After Period 1, Prior to Period 2||86
129393|NCT00895895|297848|P5|NOT COMPLETED|Period 1||20
129394|NCT00895895|297849|P4|NOT COMPLETED|Period 1||13
129395|NCT00895895|297850|P3|NOT COMPLETED|Period 1||20
129396|NCT00895895|297851|P2|NOT COMPLETED|Period 1||21
129397|NCT00895895|297852|P1|NOT COMPLETED|Period 1||21
129398|NCT00895895|297848|P5|COMPLETED|Period 1||86
129399|NCT00895895|297849|P4|COMPLETED|Period 1||91
129400|NCT00895895|297850|P3|COMPLETED|Period 1||84
129401|NCT00895895|297851|P2|COMPLETED|Period 1||84
129402|NCT00895895|297852|P1|COMPLETED|Period 1||86
129403|NCT00895895|297848|P5|Randomized But Not Treated|Period 1||2
129404|NCT00895895|297849|P4|Randomized But Not Treated|Period 1||1
129405|NCT00895895|297850|P3|Randomized But Not Treated|Period 1||1
129406|NCT00895895|297851|P2|Randomized But Not Treated|Period 1||3
129407|NCT00895895|297852|P1|Randomized But Not Treated|Period 1||1
129408|NCT00895895|297848|P5|STARTED|Period 1||106
129409|NCT00895895|297849|P4|STARTED|Period 1||104
129410|NCT00895895|297850|P3|STARTED|Period 1||104
129411|NCT00895895|297851|P2|STARTED|Period 1||105
129412|NCT00895895|297852|P1|STARTED|Period 1||107
129413|NCT00895843|297966|P2|NOT COMPLETED|Overall Study||12
129414|NCT00895843|297967|P1|NOT COMPLETED|Overall Study||12
129415|NCT00895843|297966|P2|COMPLETED|Overall Study||50
129416|NCT00895843|297967|P1|COMPLETED|Overall Study||48
129417|NCT00895843|297966|P2|STARTED|Overall Study||62
129418|NCT00895843|297967|P1|STARTED|Overall Study||60
129419|NCT00895830|297978|P5|NOT COMPLETED|Overall Study||0
129420|NCT00895830|297979|P4|NOT COMPLETED|Overall Study||0
129421|NCT00895830|297980|P3|NOT COMPLETED|Overall Study||0
129422|NCT00895830|297981|P2|NOT COMPLETED|Overall Study||0
129423|NCT00895830|297982|P1|NOT COMPLETED|Overall Study||0
129424|NCT00895830|297978|P5|COMPLETED|Overall Study||55
129425|NCT00895830|297979|P4|COMPLETED|Overall Study||52
129426|NCT00895830|297980|P3|COMPLETED|Overall Study||49
129427|NCT00895830|297981|P2|COMPLETED|Overall Study||50
129428|NCT00895830|297982|P1|COMPLETED|Overall Study||51
129429|NCT00895830|297978|P5|STARTED|Overall Study||55
129430|NCT00895830|297979|P4|STARTED|Overall Study||52
129431|NCT00895830|297980|P3|STARTED|Overall Study||49
129432|NCT00895830|297981|P2|STARTED|Overall Study||50
129433|NCT00895830|297982|P1|STARTED|Overall Study||51
129434|NCT00895817|297996|P2|NOT COMPLETED|Overall Study||0
129435|NCT00895817|297997|P1|NOT COMPLETED|Overall Study||0
129436|NCT00895817|297996|P2|COMPLETED|Overall Study||21
129437|NCT00895817|297997|P1|COMPLETED|Overall Study||21
129438|NCT00895817|297996|P2|STARTED|Overall Study||21
129439|NCT00895817|297997|P1|STARTED|Overall Study||21
129440|NCT00895583|298005|P2|NOT COMPLETED|Overall Study||12
129441|NCT00895583|298006|P1|NOT COMPLETED|Overall Study||44
129442|NCT00895583|298005|P2|COMPLETED|Overall Study||111
129443|NCT00895583|298006|P1|COMPLETED|Overall Study||87
129444|NCT00895583|298005|P2|STARTED|Overall Study||123
129445|NCT00895583|298006|P1|STARTED|Overall Study||131
129446|NCT00895453|298087|P3|NOT COMPLETED|Overall Study||23
129447|NCT00895453|298088|P2|NOT COMPLETED|Overall Study||25
129448|NCT00895453|298089|P1|NOT COMPLETED|Overall Study||25
129449|NCT00895453|298087|P3|COMPLETED|Overall Study||23
129450|NCT00895453|298088|P2|COMPLETED|Overall Study||25
129451|NCT00895453|298089|P1|COMPLETED|Overall Study||23
129452|NCT00895453|298087|P3|STARTED|Overall Study||46
129453|NCT00895453|298088|P2|STARTED|Overall Study||50
129454|NCT00895453|298089|P1|STARTED|Overall Study||48
129455|NCT00895310|298097|P1|NOT COMPLETED|Overall Study||1
129456|NCT00895310|298097|P1|COMPLETED|Overall Study||29
129457|NCT00895310|298097|P1|STARTED|Overall Study||30
129458|NCT00895284|298106|P2|NOT COMPLETED|Overall Study||0
129459|NCT00895284|298107|P1|NOT COMPLETED|Overall Study||0
129460|NCT00895284|298106|P2|COMPLETED|Overall Study||0
129461|NCT00895284|298107|P1|COMPLETED|Overall Study||3
129462|NCT00895284|298106|P2|STARTED|Overall Study||0
129463|NCT00895284|298107|P1|STARTED|Overall Study||3
129464|NCT00895232|298116|P3|NOT COMPLETED|Overall Study||5
129465|NCT00895232|298117|P2|NOT COMPLETED|Overall Study||4
129466|NCT00895232|298118|P1|NOT COMPLETED|Overall Study||3
129467|NCT00895232|298116|P3|COMPLETED|Overall Study||3
129468|NCT00895232|298117|P2|COMPLETED|Overall Study||2
129469|NCT00895232|298118|P1|COMPLETED|Overall Study||4
129470|NCT00895232|298116|P3|STARTED|Overall Study||8
129471|NCT00895232|298117|P2|STARTED|Overall Study||6
129472|NCT00895232|298118|P1|STARTED|Overall Study||7
129473|NCT00895193|298136|P4|NOT COMPLETED|Overall Study||0
129474|NCT00895193|298137|P3|NOT COMPLETED|Overall Study||0
129475|NCT00895193|298138|P2|NOT COMPLETED|Overall Study||0
129476|NCT00895193|298139|P1|NOT COMPLETED|Overall Study||0
129477|NCT00895193|298136|P4|COMPLETED|Overall Study||25
129478|NCT00895193|298137|P3|COMPLETED|Overall Study||25
129479|NCT00895193|298138|P2|COMPLETED|Overall Study||25
129480|NCT00895193|298139|P1|COMPLETED|Overall Study||25
129481|NCT00895193|298136|P4|STARTED|Overall Study||25
129482|NCT00895193|298137|P3|STARTED|Overall Study||25
129483|NCT00895193|298138|P2|STARTED|Overall Study||25
129484|NCT00895193|298139|P1|STARTED|Overall Study||25
129485|NCT00895011|298164|P3|NOT COMPLETED|Overall Study||8
129486|NCT00895011|298165|P2|NOT COMPLETED|Overall Study||14
129487|NCT00895011|298166|P1|NOT COMPLETED|Overall Study||24
129488|NCT00895011|298164|P3|COMPLETED|Overall Study||91
129489|NCT00895011|298165|P2|COMPLETED|Overall Study||85
129490|NCT00895011|298166|P1|COMPLETED|Overall Study||76
129491|NCT00895011|298164|P3|STARTED|Overall Study||99
129492|NCT00895011|298165|P2|STARTED|Overall Study||99
129493|NCT00895011|298166|P1|STARTED|Overall Study||100
129494|NCT00894803|298182|P2|NOT COMPLETED|Overall Study||5
129495|NCT00894803|298183|P1|NOT COMPLETED|Overall Study||20
129496|NCT00894803|298182|P2|COMPLETED|Overall Study||20
129497|NCT00894803|298183|P1|COMPLETED|Overall Study||81
129498|NCT00894803|298182|P2|STARTED|Overall Study||25
129499|NCT00894803|298183|P1|STARTED|Overall Study||101
129500|NCT00894790|298219|P2|NOT COMPLETED|Overall Study||2
129501|NCT00894790|298220|P1|NOT COMPLETED|Overall Study||1
129502|NCT00894790|298219|P2|COMPLETED|Overall Study||2
129503|NCT00894790|298220|P1|COMPLETED|Overall Study||3
129504|NCT00894790|298219|P2|STARTED|Overall Study||4
129505|NCT00894790|298220|P1|STARTED|Overall Study||4
129506|NCT00894699|298244|P2|NOT COMPLETED|Overall Study||0
129507|NCT00894699|298245|P1|NOT COMPLETED|Overall Study||0
129508|NCT00894699|298244|P2|COMPLETED|Overall Study||19
129509|NCT00894699|298245|P1|COMPLETED|Overall Study||21
129510|NCT00894699|298244|P2|STARTED|Overall Study||19
129511|NCT00894699|298245|P1|STARTED|Overall Study||21
129512|NCT00894647|298253|P2|NOT COMPLETED|Overall Study||14
129513|NCT00894647|298254|P1|NOT COMPLETED|Overall Study||10
129514|NCT00894647|298253|P2|COMPLETED|Overall Study||112
129515|NCT00894647|298254|P1|COMPLETED|Overall Study||111
129516|NCT00894647|298253|P2|STARTED|Overall Study||126
129517|NCT00894647|298254|P1|STARTED|Overall Study||121
129518|NCT00894556|298267|P4|NOT COMPLETED|Treatment Phase||0
129519|NCT00894556|298268|P3|NOT COMPLETED|Treatment Phase||1
129520|NCT00894556|298269|P2|NOT COMPLETED|Treatment Phase||4
129521|NCT00894556|298270|P1|NOT COMPLETED|Treatment Phase||4
129522|NCT00894556|298267|P4|COMPLETED|Treatment Phase||0
129523|NCT00894556|298268|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
129524|NCT00894556|298269|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
129525|NCT00894556|298270|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
129526|NCT00894556|298267|P4|STARTED|Treatment Phase||0
129527|NCT00894556|298268|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
129528|NCT00894556|298269|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
129529|NCT00894556|298270|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
129530|NCT00894556|298267|P4|NOT COMPLETED|Baseline Phase||85
129531|NCT00894556|298268|P3|NOT COMPLETED|Baseline Phase||0
129532|NCT00894556|298269|P2|NOT COMPLETED|Baseline Phase||0
129533|NCT00894556|298270|P1|NOT COMPLETED|Baseline Phase||0
129534|NCT00894556|298267|P4|COMPLETED|Baseline Phase||109
129535|NCT00894556|298268|P3|COMPLETED|Baseline Phase||0
129536|NCT00894556|298269|P2|COMPLETED|Baseline Phase||0
129537|NCT00894556|298270|P1|COMPLETED|Baseline Phase||0
129538|NCT00894556|298267|P4|STARTED|Baseline Phase||194
129539|NCT00894556|298268|P3|STARTED|Baseline Phase||0
129540|NCT00894556|298269|P2|STARTED|Baseline Phase||0
129541|NCT00894556|298270|P1|STARTED|Baseline Phase||0
129542|NCT00894543|298281|P2|NOT COMPLETED|Week 4 to Week 8||2
129543|NCT00894543|298282|P1|NOT COMPLETED|Week 4 to Week 8||4
129544|NCT00894543|298281|P2|COMPLETED|Week 4 to Week 8||97
129545|NCT00894543|298282|P1|COMPLETED|Week 4 to Week 8||97
129546|NCT00894543|298281|P2|STARTED|Week 4 to Week 8||99
129547|NCT00894543|298282|P1|STARTED|Week 4 to Week 8||101
129548|NCT00894543|298281|P2|NOT COMPLETED|Baseline to Week 4||2
129549|NCT00894543|298282|P1|NOT COMPLETED|Baseline to Week 4||3
129550|NCT00894543|298281|P2|COMPLETED|Baseline to Week 4||99
129551|NCT00894543|298282|P1|COMPLETED|Baseline to Week 4||101
129552|NCT00894543|298281|P2|STARTED|Baseline to Week 4||101
129553|NCT00894543|298282|P1|STARTED|Baseline to Week 4||104
129554|NCT00894543|298281|P2|NOT COMPLETED|Baseline||0
129555|NCT00894543|298282|P1|NOT COMPLETED|Baseline||0
129556|NCT00894543|298281|P2|COMPLETED|Baseline||101
129557|NCT00894543|298282|P1|COMPLETED|Baseline||104
129558|NCT00894543|298281|P2|STARTED|Baseline||101
129559|NCT00894543|298282|P1|STARTED|Baseline||104
129560|NCT00894517|298306|P2|NOT COMPLETED|Overall Study||5
129561|NCT00894517|298307|P1|NOT COMPLETED|Overall Study||2
129562|NCT00894517|298306|P2|COMPLETED|Overall Study||26
129563|NCT00894517|298307|P1|COMPLETED|Overall Study||28
129564|NCT00894517|298306|P2|STARTED|Overall Study||31
129565|NCT00894517|298307|P1|STARTED|Overall Study||30
129566|NCT00894504|298321|P1|NOT COMPLETED|Overall Study||71
129567|NCT00894504|298321|P1|COMPLETED|Overall Study||0
129568|NCT00894504|298321|P1|STARTED|Overall Study||71
129569|NCT00894465|298337|P2|NOT COMPLETED|Overall Study||0
129570|NCT00894465|298338|P1|NOT COMPLETED|Overall Study||0
129571|NCT00894465|298337|P2|COMPLETED|Overall Study||22
129572|NCT00894465|298338|P1|COMPLETED|Overall Study||22
129573|NCT00894465|298337|P2|STARTED|Overall Study||22
129574|NCT00894465|298338|P1|STARTED|Overall Study||22
129575|NCT00894387|298348|P2|NOT COMPLETED|Overall Study||175
129576|NCT00894387|298349|P1|NOT COMPLETED|Overall Study||175
129577|NCT00894387|298348|P2|COMPLETED|Overall Study||643
129578|NCT00894387|298349|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
129579|NCT00894387|298348|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
129580|NCT00894387|298349|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
129581|NCT00894387|298348|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
129582|NCT00894387|298349|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
129583|NCT00894387|298348|P2|Full Analysis Set|Overall Study||807
129584|NCT00894387|298349|P1|Full Analysis Set|Overall Study||808
129585|NCT00894387|298348|P2|Safety Set|Overall Study||810
129586|NCT00894387|298349|P1|Safety Set|Overall Study||808
129587|NCT00894387|298348|P2|STARTED|Overall Study||818
129588|NCT00894387|298349|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
129589|NCT00894361|298369|P2|NOT COMPLETED|Overall Study||64
129590|NCT00894361|298370|P1|NOT COMPLETED|Overall Study||24
129591|NCT00894361|298369|P2|COMPLETED|Overall Study||136
129592|NCT00894361|298370|P1|COMPLETED|Overall Study||176
129593|NCT00894361|298369|P2|STARTED|Overall Study||200
129594|NCT00894361|298370|P1|STARTED|Overall Study||200
129595|NCT00894322|298379|P3|NOT COMPLETED|Overall Study||0
129596|NCT00894322|298380|P2|NOT COMPLETED|Overall Study||0
129597|NCT00894322|298381|P1|NOT COMPLETED|Overall Study||1
129598|NCT00894322|298379|P3|COMPLETED|Overall Study||12
129599|NCT00894322|298380|P2|COMPLETED|Overall Study||23
129600|NCT00894322|298381|P1|COMPLETED|Overall Study||29
129601|NCT00894322|298379|P3|STARTED|Overall Study||12
129602|NCT00894322|298380|P2|STARTED|Overall Study||23
129603|NCT00894322|298381|P1|STARTED|Overall Study||30
129604|NCT00894244|298420|P1|NOT COMPLETED|Overall Study||1
129605|NCT00894244|298420|P1|COMPLETED|Overall Study||24
129606|NCT00894244|298420|P1|STARTED|Overall Study||25
129607|NCT00894166|298432|P8|NOT COMPLETED|Overall Study||34
129608|NCT00894166|298433|P7|NOT COMPLETED|Overall Study||16
129609|NCT00894166|298434|P6|NOT COMPLETED|Overall Study||16
129610|NCT00894166|298435|P5|NOT COMPLETED|Overall Study||24
129611|NCT00894166|298436|P4|NOT COMPLETED|Overall Study||69
129612|NCT00894166|298437|P3|NOT COMPLETED|Overall Study||62
129613|NCT00894166|298438|P2|NOT COMPLETED|Overall Study||63
129614|NCT00894166|298439|P1|NOT COMPLETED|Overall Study||61
129615|NCT00894166|298432|P8|COMPLETED|Overall Study||0
129616|NCT00894166|298433|P7|COMPLETED|Overall Study||19
129617|NCT00894166|298434|P6|COMPLETED|Overall Study||20
129618|NCT00894166|298435|P5|COMPLETED|Overall Study||10
129619|NCT00894166|298436|P4|COMPLETED|Overall Study||45
129620|NCT00894166|298437|P3|COMPLETED|Overall Study||50
129621|NCT00894166|298438|P2|COMPLETED|Overall Study||46
129622|NCT00894166|298439|P1|COMPLETED|Overall Study||71
129623|NCT00894166|298432|P8|STARTED|Overall Study||34
129624|NCT00894166|298433|P7|STARTED|Overall Study||35
129625|NCT00894166|298434|P6|STARTED|Overall Study||36
129626|NCT00894166|298435|P5|STARTED|Overall Study||34
129627|NCT00894166|298436|P4|STARTED|Overall Study||114
129628|NCT00894166|298437|P3|STARTED|Overall Study||112
129629|NCT00894166|298438|P2|STARTED|Overall Study||109
129630|NCT00894166|298439|P1|STARTED|Overall Study||132
129631|NCT00894127|298469|P1|NOT COMPLETED|Overall Study||0
129632|NCT00894127|298469|P1|COMPLETED|Overall Study||128
129633|NCT00894127|298469|P1|STARTED|Overall Study||128
129634|NCT00893997|298473|P1|NOT COMPLETED|Overall Study||0
129635|NCT00893997|298473|P1|COMPLETED|Overall Study||10
129636|NCT00893997|298473|P1|STARTED|Overall Study||10
129637|NCT00893789|298482|P4|NOT COMPLETED|Overall Study||13
129638|NCT00893789|298483|P3|NOT COMPLETED|Overall Study||7
129639|NCT00893789|298484|P2|NOT COMPLETED|Overall Study||4
129640|NCT00893789|298485|P1|NOT COMPLETED|Overall Study||6
129641|NCT00893789|298482|P4|COMPLETED|Overall Study||16
129642|NCT00893789|298483|P3|COMPLETED|Overall Study||22
129643|NCT00893789|298484|P2|COMPLETED|Overall Study||26
129644|NCT00893789|298485|P1|COMPLETED|Overall Study||23
129645|NCT00893789|298482|P4|Full Analysis Set (FAS)|Overall Study||27
129646|NCT00893789|298483|P3|Full Analysis Set (FAS)|Overall Study||28
129647|NCT00893789|298484|P2|Full Analysis Set (FAS)|Overall Study||29
129732|NCT00892957|298759|P2|STARTED|Between Postoperative Day 1 and Day 14||70
129648|NCT00893789|298485|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
129649|NCT00893789|298482|P4|Safety Analysis Set (SAS)|Overall Study||29
129650|NCT00893789|298483|P3|Safety Analysis Set (SAS)|Overall Study||29
129651|NCT00893789|298484|P2|Safety Analysis Set (SAS)|Overall Study||30
129652|NCT00893789|298485|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
129653|NCT00893789|298482|P4|STARTED|Overall Study||29
129654|NCT00893789|298483|P3|STARTED|Overall Study||29
129655|NCT00893789|298484|P2|STARTED|Overall Study||30
129656|NCT00893789|298485|P1|STARTED|Overall Study||29
129657|NCT00893763|298569|P2|NOT COMPLETED|Overall Study||110
129658|NCT00893763|298570|P1|NOT COMPLETED|Overall Study||110
129659|NCT00893763|298569|P2|COMPLETED|Overall Study||47
129660|NCT00893763|298570|P1|COMPLETED|Overall Study||47
129661|NCT00893763|298569|P2|STARTED|Overall Study||157
129662|NCT00893763|298570|P1|STARTED|Overall Study||157
129663|NCT00893737|298578|P1|NOT COMPLETED|Overall Study||12
129664|NCT00893737|298578|P1|COMPLETED|Overall Study||135
129665|NCT00893737|298578|P1|STARTED|Overall Study||147
129666|NCT00893464|298592|P8|NOT COMPLETED|Overall Study||2
129667|NCT00893464|298593|P7|NOT COMPLETED|Overall Study||2
129668|NCT00893464|298594|P6|NOT COMPLETED|Overall Study||0
129669|NCT00893464|298595|P5|NOT COMPLETED|Overall Study||0
129670|NCT00893464|298596|P4|NOT COMPLETED|Overall Study||0
129671|NCT00893464|298597|P3|NOT COMPLETED|Overall Study||0
129672|NCT00893464|298598|P2|NOT COMPLETED|Overall Study||0
129673|NCT00893464|298599|P1|NOT COMPLETED|Overall Study||0
129674|NCT00893464|298592|P8|COMPLETED|Overall Study||3
129675|NCT00893464|298593|P7|COMPLETED|Overall Study||8
129676|NCT00893464|298594|P6|COMPLETED|Overall Study||7
129677|NCT00893464|298595|P5|COMPLETED|Overall Study||4
129678|NCT00893464|298596|P4|COMPLETED|Overall Study||1
129679|NCT00893464|298597|P3|COMPLETED|Overall Study||1
129680|NCT00893464|298598|P2|COMPLETED|Overall Study||1
129681|NCT00893464|298599|P1|COMPLETED|Overall Study||1
129682|NCT00893464|298592|P8|STARTED|Overall Study||5
129683|NCT00893464|298593|P7|STARTED|Overall Study||10
129684|NCT00893464|298594|P6|STARTED|Overall Study||7
129685|NCT00893464|298595|P5|STARTED|Overall Study||4
129686|NCT00893464|298596|P4|STARTED|Overall Study||1
129687|NCT00893464|298597|P3|STARTED|Overall Study||1
129688|NCT00893464|298598|P2|STARTED|Overall Study||1
129689|NCT00893464|298599|P1|STARTED|Overall Study||1
129690|NCT00892437|298717|P2|NOT COMPLETED|Open-Label Extension Phase||4
129691|NCT00892437|298718|P1|NOT COMPLETED|Open-Label Extension Phase||12
129692|NCT00892437|298717|P2|COMPLETED|Open-Label Extension Phase||15
129693|NCT00892437|298718|P1|COMPLETED|Open-Label Extension Phase||32
129694|NCT00892437|298717|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
129695|NCT00892437|298718|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
129696|NCT00892437|298717|P2|NOT COMPLETED|Randomized Phase||5
129697|NCT00892437|298718|P1|NOT COMPLETED|Randomized Phase||11
129698|NCT00892437|298717|P2|COMPLETED|Randomized Phase||24
129699|NCT00892437|298718|P1|COMPLETED|Randomized Phase||45
129700|NCT00892437|298717|P2|Randomized and Treated|Randomized Phase||29
129701|NCT00892437|298718|P1|Randomized and Treated|Randomized Phase||50
129702|NCT00892437|298717|P2|STARTED|Randomized Phase||29
129703|NCT00892437|298718|P1|STARTED|Randomized Phase||56
129704|NCT00893152|298737|P2|NOT COMPLETED|Overall Study||0
129705|NCT00893152|298738|P1|NOT COMPLETED|Overall Study||0
129706|NCT00893152|298737|P2|COMPLETED|Overall Study||36
129707|NCT00893152|298738|P1|COMPLETED|Overall Study||47
129708|NCT00893152|298737|P2|STARTED|Overall Study||36
129709|NCT00893152|298738|P1|STARTED|Overall Study||47
129710|NCT00893113|298746|P2|NOT COMPLETED|Overall Study||16
129711|NCT00893113|298747|P1|NOT COMPLETED|Overall Study||13
129712|NCT00893113|298746|P2|COMPLETED|Overall Study||22
129713|NCT00893113|298747|P1|COMPLETED|Overall Study||23
129714|NCT00893113|298746|P2|STARTED|Overall Study||38
129715|NCT00893113|298747|P1|STARTED|Overall Study||36
129716|NCT00892957|298759|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
129717|NCT00892957|298760|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
129718|NCT00892957|298759|P2|COMPLETED|Postoperative Day 30 Assessment||66
129719|NCT00892957|298760|P1|COMPLETED|Postoperative Day 30 Assessment||70
129720|NCT00892957|298759|P2|STARTED|Postoperative Day 30 Assessment||66
129721|NCT00892957|298760|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
129722|NCT00892957|298759|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
129723|NCT00892957|298760|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
129724|NCT00892957|298759|P2|COMPLETED|Postoperative Day 14 Assessment||66
129725|NCT00892957|298760|P1|COMPLETED|Postoperative Day 14 Assessment||68
129726|NCT00892957|298759|P2|STARTED|Postoperative Day 14 Assessment||66
129727|NCT00892957|298760|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
129728|NCT00892957|298759|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
129729|NCT00892957|298760|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
129730|NCT00892957|298759|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
129731|NCT00892957|298760|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
129733|NCT00892957|298760|P1|STARTED|Between Postoperative Day 1 and Day 14||70
129734|NCT00892957|298759|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
129735|NCT00892957|298760|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
129736|NCT00892957|298759|P2|COMPLETED|Postoperative Day 1 Assessment||70
129737|NCT00892957|298760|P1|COMPLETED|Postoperative Day 1 Assessment||70
129738|NCT00892957|298759|P2|STARTED|Postoperative Day 1 Assessment||70
129739|NCT00892957|298760|P1|STARTED|Postoperative Day 1 Assessment||70
129740|NCT00892957|298759|P2|NOT COMPLETED|Intraoperative Day 0||0
129741|NCT00892957|298760|P1|NOT COMPLETED|Intraoperative Day 0||0
129742|NCT00892957|298759|P2|COMPLETED|Intraoperative Day 0||70
129743|NCT00892957|298760|P1|COMPLETED|Intraoperative Day 0||70
129744|NCT00892957|298759|P2|STARTED|Intraoperative Day 0||70
129745|NCT00892957|298760|P1|STARTED|Intraoperative Day 0||70
129746|NCT00892723|298849|P3|NOT COMPLETED|Overall Study||2
129747|NCT00892723|298850|P2|NOT COMPLETED|Overall Study||4
129748|NCT00892723|298851|P1|NOT COMPLETED|Overall Study||2
129749|NCT00892723|298849|P3|COMPLETED|Overall Study||17
129750|NCT00892723|298850|P2|COMPLETED|Overall Study||15
129751|NCT00892723|298851|P1|COMPLETED|Overall Study||19
129752|NCT00892723|298849|P3|STARTED|Overall Study||19
129753|NCT00892723|298850|P2|STARTED|Overall Study||19
129754|NCT00892723|298851|P1|STARTED|Overall Study||21
129755|NCT00892710|298895|P3|NOT COMPLETED|Overall Study||55
129756|NCT00892710|298896|P2|NOT COMPLETED|Overall Study||59
129757|NCT00892710|298897|P1|NOT COMPLETED|Overall Study||48
129758|NCT00892710|298895|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
129759|NCT00892710|298896|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
129760|NCT00892710|298897|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
129761|NCT00892710|298895|P3|STARTED|Overall Study||55
129762|NCT00892710|298896|P2|STARTED|Overall Study||59
129763|NCT00892710|298897|P1|STARTED|Overall Study||48
129764|NCT00892697|298920|P1|NOT COMPLETED|Overall Study||0
129765|NCT00892697|298920|P1|COMPLETED|Overall Study||15
129766|NCT00892697|298920|P1|STARTED|Overall Study||15
129767|NCT00892281|298927|P2|NOT COMPLETED|Overall Study||37
129768|NCT00892281|298928|P1|NOT COMPLETED|Overall Study||267
129769|NCT00892281|298927|P2|COMPLETED|Overall Study||187
129770|NCT00892281|298928|P1|COMPLETED|Overall Study||930
129771|NCT00892281|298927|P2|STARTED|Overall Study||224
129772|NCT00892281|298928|P1|STARTED|Overall Study||1197
129773|NCT00892151|298938|P1|NOT COMPLETED|Overall Study||1
129774|NCT00892151|298938|P1|COMPLETED|Overall Study||50
129775|NCT00892151|298938|P1|STARTED|Overall Study||51
129776|NCT00892099|298947|P3|NOT COMPLETED|Overall Study||7
129777|NCT00892099|298948|P2|NOT COMPLETED|Overall Study||1
129778|NCT00892099|298949|P1|NOT COMPLETED|Overall Study||5
129779|NCT00892099|298947|P3|COMPLETED|Overall Study||29
129780|NCT00892099|298948|P2|COMPLETED|Overall Study||32
129781|NCT00892099|298949|P1|COMPLETED|Overall Study||31
129782|NCT00892099|298947|P3|STARTED|Overall Study||36
129783|NCT00892099|298948|P2|STARTED|Overall Study||33
129784|NCT00892099|298949|P1|STARTED|Overall Study||36
129785|NCT00892047|298959|P2|NOT COMPLETED|Overall Study||7
129786|NCT00892047|298960|P1|NOT COMPLETED|Overall Study||4
129787|NCT00892047|298959|P2|COMPLETED|Overall Study||83
129788|NCT00892047|298960|P1|COMPLETED|Overall Study||87
129789|NCT00892047|298959|P2|STARTED|Overall Study||90
129790|NCT00892047|298960|P1|STARTED|Overall Study||91
129791|NCT00892008|298976|P1|NOT COMPLETED|Overall Study||565
129792|NCT00892008|298976|P1|COMPLETED|Overall Study||1713
129793|NCT00892008|298976|P1|STARTED|Overall Study||2278
129794|NCT00891995|298992|P2|NOT COMPLETED|Overall Study||0
129795|NCT00891995|298993|P1|NOT COMPLETED|Overall Study||0
129796|NCT00891995|298992|P2|COMPLETED|Overall Study||21
129797|NCT00891995|298993|P1|COMPLETED|Overall Study||50
129798|NCT00891995|298992|P2|STARTED|Overall Study||21
129799|NCT00891995|298993|P1|STARTED|Overall Study||50
129800|NCT00891982|299017|P2|NOT COMPLETED|Overall Study||1
129801|NCT00891982|299018|P1|NOT COMPLETED|Overall Study||2
129802|NCT00891982|299017|P2|COMPLETED|Overall Study||30
129803|NCT00891982|299018|P1|COMPLETED|Overall Study||28
129804|NCT00891982|299017|P2|STARTED|Overall Study||31
129805|NCT00891982|299018|P1|STARTED|Overall Study||30
129806|NCT00891930|299062|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
129807|NCT00891930|299062|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
129808|NCT00891930|299062|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
129809|NCT00891930|299062|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
129810|NCT00891930|299062|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
129811|NCT00891930|299062|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
129812|NCT00891930|299062|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
129813|NCT00891904|299083|P1|NOT COMPLETED|Overall Study||2
129814|NCT00891904|299083|P1|COMPLETED|Overall Study||0
129815|NCT00891904|299083|P1|STARTED|Overall Study||2
129816|NCT00891839|299090|P1|NOT COMPLETED|Overall Study||7
129817|NCT00891839|299090|P1|COMPLETED|Overall Study|completed treatment|38
129818|NCT00891839|299090|P1|STARTED|Overall Study||45
129819|NCT00891813|299099|P1|NOT COMPLETED|Overall Study||12
129820|NCT00891813|299099|P1|COMPLETED|Overall Study||88
129821|NCT00891813|299099|P1|STARTED|Overall Study||100
129822|NCT00891774|299105|P1|NOT COMPLETED|Overall Study||14
129823|NCT00891774|299105|P1|COMPLETED|Overall Study||158
129824|NCT00891774|299105|P1|STARTED|Overall Study||172
129825|NCT00891735|299113|P4|NOT COMPLETED|Overall Study||15
129826|NCT00891735|299114|P3|NOT COMPLETED|Overall Study||12
129827|NCT00891735|299115|P2|NOT COMPLETED|Overall Study||16
129828|NCT00891735|299116|P1|NOT COMPLETED|Overall Study||17
129829|NCT00891735|299113|P4|COMPLETED|Overall Study||258
129830|NCT00891735|299114|P3|COMPLETED|Overall Study||263
129831|NCT00891735|299115|P2|COMPLETED|Overall Study||258
129832|NCT00891735|299116|P1|COMPLETED|Overall Study||258
129833|NCT00891735|299113|P4|STARTED|Overall Study||273
129834|NCT00891735|299114|P3|STARTED|Overall Study||275
129835|NCT00891735|299115|P2|STARTED|Overall Study||274
129836|NCT00891735|299116|P1|STARTED|Overall Study||275
129837|NCT00891657|299156|P2|NOT COMPLETED|Overall Study||1
129838|NCT00891657|299157|P1|NOT COMPLETED|Overall Study||1
129839|NCT00891657|299156|P2|COMPLETED|Overall Study||5
129840|NCT00891657|299157|P1|COMPLETED|Overall Study||8
129841|NCT00891657|299156|P2|STARTED|Overall Study||6
129842|NCT00891657|299157|P1|STARTED|Overall Study||9
129843|NCT00891618|299169|P1|NOT COMPLETED|Overall Study||1
129844|NCT00891618|299169|P1|COMPLETED|Overall Study||20
129845|NCT00891618|299169|P1|STARTED|Overall Study||21
129846|NCT00891462|299176|P3|NOT COMPLETED|Overall Study||24
129847|NCT00891462|299177|P2|NOT COMPLETED|Overall Study||33
129848|NCT00891462|299178|P1|NOT COMPLETED|Overall Study||37
129849|NCT00891462|299176|P3|COMPLETED|Overall Study||166
129850|NCT00891462|299177|P2|COMPLETED|Overall Study||152
129851|NCT00891462|299178|P1|COMPLETED|Overall Study||149
129852|NCT00891462|299176|P3|STARTED|Overall Study||190
129853|NCT00891462|299177|P2|STARTED|Overall Study||185
129854|NCT00891462|299178|P1|STARTED|Overall Study||186
129855|NCT00891436|299191|P2|NOT COMPLETED|Overall Study||0
129856|NCT00891436|299192|P1|NOT COMPLETED|Overall Study||0
129857|NCT00891436|299191|P2|COMPLETED|Overall Study||10
129858|NCT00891436|299192|P1|COMPLETED|Overall Study||10
129859|NCT00891436|299191|P2|STARTED|Overall Study||10
129860|NCT00891436|299192|P1|STARTED|Overall Study||10
129861|NCT00891371|299200|P1|NOT COMPLETED|Treatment||9
129862|NCT00891371|299200|P1|COMPLETED|Treatment||27
129863|NCT00891371|299200|P1|STARTED|Treatment||36
129864|NCT00891371|299200|P1|NOT COMPLETED|Pre-assignment||6
129865|NCT00891371|299200|P1|COMPLETED|Pre-assignment||36
129866|NCT00891371|299200|P1|STARTED|Pre-assignment||42
129867|NCT00891293|299209|P1|NOT COMPLETED|Overall Study||84
129868|NCT00891293|299209|P1|COMPLETED|Overall Study||9
129869|NCT00891293|299209|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
129870|NCT00891202|299223|P2|NOT COMPLETED|Overall Study||0
129871|NCT00891202|299224|P1|NOT COMPLETED|Overall Study||1
129872|NCT00891202|299223|P2|COMPLETED|Overall Study||20
129873|NCT00891202|299224|P1|COMPLETED|Overall Study||19
129874|NCT00891202|299223|P2|STARTED|Overall Study||20
129875|NCT00891202|299224|P1|STARTED|Overall Study||20
129876|NCT00891176|299242|P4|NOT COMPLETED|At 6 Years of Age||0
129877|NCT00891176|299243|P3|NOT COMPLETED|At 6 Years of Age||0
129878|NCT00891176|299244|P2|NOT COMPLETED|At 6 Years of Age||0
129879|NCT00891176|299245|P1|NOT COMPLETED|At 6 Years of Age||0
129880|NCT00891176|299242|P4|COMPLETED|At 6 Years of Age||135
129881|NCT00891176|299243|P3|COMPLETED|At 6 Years of Age||135
129882|NCT00891176|299244|P2|COMPLETED|At 6 Years of Age||138
129883|NCT00891176|299245|P1|COMPLETED|At 6 Years of Age||131
129884|NCT00891176|299242|P4|STARTED|At 6 Years of Age||135
129885|NCT00891176|299243|P3|STARTED|At 6 Years of Age||135
129886|NCT00891176|299244|P2|STARTED|At 6 Years of Age||138
129887|NCT00891176|299245|P1|STARTED|At 6 Years of Age||131
129888|NCT00891176|299242|P4|NOT COMPLETED|At 4 Years of Age||0
129889|NCT00891176|299243|P3|NOT COMPLETED|At 4 Years of Age||0
129890|NCT00891176|299244|P2|NOT COMPLETED|At 4 Years of Age||0
129891|NCT00891176|299245|P1|NOT COMPLETED|At 4 Years of Age||0
129892|NCT00891176|299242|P4|COMPLETED|At 4 Years of Age||137
129893|NCT00891176|299243|P3|COMPLETED|At 4 Years of Age||142
129894|NCT00891176|299244|P2|COMPLETED|At 4 Years of Age||142
129895|NCT00891176|299245|P1|COMPLETED|At 4 Years of Age||140
129896|NCT00891176|299242|P4|STARTED|At 4 Years of Age||137
129897|NCT00891176|299243|P3|STARTED|At 4 Years of Age||142
129898|NCT00891176|299244|P2|STARTED|At 4 Years of Age||142
129899|NCT00891176|299245|P1|STARTED|At 4 Years of Age||140
129900|NCT00891176|299242|P4|NOT COMPLETED|At 3 Years of Age||0
129901|NCT00891176|299243|P3|NOT COMPLETED|At 3 Years of Age||0
129902|NCT00891176|299244|P2|NOT COMPLETED|At 3 Years of Age||0
129903|NCT00891176|299245|P1|NOT COMPLETED|At 3 Years of Age||0
129904|NCT00891176|299242|P4|COMPLETED|At 3 Years of Age||141
129905|NCT00891176|299243|P3|COMPLETED|At 3 Years of Age||149
129906|NCT00891176|299244|P2|COMPLETED|At 3 Years of Age||147
129907|NCT00891176|299245|P1|COMPLETED|At 3 Years of Age||144
129908|NCT00891176|299242|P4|STARTED|At 3 Years of Age||141
129909|NCT00891176|299243|P3|STARTED|At 3 Years of Age||149
129910|NCT00891176|299244|P2|STARTED|At 3 Years of Age||147
129911|NCT00891176|299245|P1|STARTED|At 3 Years of Age||144
129912|NCT00891020|299374|P3|NOT COMPLETED|Long-term Extension Period||23
129913|NCT00891020|299375|P2|NOT COMPLETED|Long-term Extension Period||24
129914|NCT00891020|299376|P1|NOT COMPLETED|Long-term Extension Period||6
129915|NCT00891020|299374|P3|COMPLETED|Long-term Extension Period||170
129916|NCT00891020|299375|P2|COMPLETED|Long-term Extension Period||172
129917|NCT00891020|299376|P1|COMPLETED|Long-term Extension Period||49
129918|NCT00891020|299374|P3|STARTED|Long-term Extension Period||193
129919|NCT00891020|299375|P2|STARTED|Long-term Extension Period||196
129920|NCT00891020|299376|P1|STARTED|Long-term Extension Period||55
129921|NCT00891020|299374|P3|NOT COMPLETED|24 Week Treatment Period||58
129922|NCT00891020|299375|P2|NOT COMPLETED|24 Week Treatment Period||60
129923|NCT00891020|299376|P1|NOT COMPLETED|24 Week Treatment Period||37
129924|NCT00891020|299374|P3|COMPLETED|24 Week Treatment Period||302
129925|NCT00891020|299375|P2|COMPLETED|24 Week Treatment Period||303
129926|NCT00891020|299376|P1|COMPLETED|24 Week Treatment Period||126
129927|NCT00891020|299374|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
129928|NCT00891020|299375|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
129929|NCT00891020|299376|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
129930|NCT00891020|299374|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
129931|NCT00891020|299375|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
129932|NCT00891020|299376|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
129933|NCT00891020|299374|P3|STARTED|24 Week Treatment Period||360
129934|NCT00891020|299375|P2|STARTED|24 Week Treatment Period||363
129935|NCT00891020|299376|P1|STARTED|24 Week Treatment Period||163
129936|NCT00890981|299409|P2|NOT COMPLETED|Overall Study||0
129937|NCT00890981|299410|P1|NOT COMPLETED|Overall Study||0
129938|NCT00890981|299409|P2|COMPLETED|Overall Study||40
129939|NCT00890981|299410|P1|COMPLETED|Overall Study||39
129940|NCT00890981|299409|P2|STARTED|Overall Study||40
129941|NCT00890981|299410|P1|STARTED|Overall Study||39
129942|NCT00890929|299440|P1|NOT COMPLETED|Overall Study||6
129943|NCT00890929|299440|P1|COMPLETED|Overall Study||39
129944|NCT00890929|299440|P1|Initiated Treatment|Overall Study||43
129945|NCT00890929|299440|P1|Consented & Enrolled|Overall Study||45
129946|NCT00890929|299440|P1|STARTED|Overall Study||45
129947|NCT00890916|299452|P1|NOT COMPLETED|"Rehab - NP OFF"||0
129948|NCT00890916|299452|P1|COMPLETED|"Rehab - NP OFF"||10
129949|NCT00890916|299452|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP OFF"||10
129950|NCT00890916|299452|P1|STARTED|"Rehab - NP OFF"||10
129951|NCT00890916|299452|P1|NOT COMPLETED|"Rehab - NP ON"||0
129952|NCT00890916|299452|P1|COMPLETED|"Rehab - NP ON"||10
129953|NCT00890916|299452|P1|"Grasp Release Pre-Test ON"|"Rehab - NP ON"||10
129954|NCT00890916|299452|P1|STARTED|"Rehab - NP ON"|First IST-12 Implant.|10
129955|NCT00890721|299458|P2|NOT COMPLETED|Overall Study||1
129956|NCT00890721|299459|P1|NOT COMPLETED|Overall Study||1
129957|NCT00890721|299458|P2|COMPLETED|Overall Study||93
129958|NCT00890721|299459|P1|COMPLETED|Overall Study||94
129959|NCT00890721|299458|P2|STARTED|Overall Study||94
129960|NCT00890721|299459|P1|STARTED|Overall Study||95
129961|NCT00890695|299467|P2|NOT COMPLETED|Overall Study||0
129962|NCT00890695|299468|P1|NOT COMPLETED|Overall Study||1
129963|NCT00890695|299467|P2|COMPLETED|Overall Study||33
129964|NCT00890695|299468|P1|COMPLETED|Overall Study||31
129965|NCT00890695|299467|P2|STARTED|Overall Study||33
129966|NCT00890695|299468|P1|STARTED|Overall Study||32
129967|NCT00890682|299486|P2|NOT COMPLETED|Overall Study||2
129968|NCT00890682|299487|P1|NOT COMPLETED|Overall Study||4
129969|NCT00890682|299486|P2|COMPLETED|Overall Study||94
129970|NCT00890682|299487|P1|COMPLETED|Overall Study||93
129971|NCT00890682|299486|P2|STARTED|Overall Study||96
129972|NCT00890682|299487|P1|STARTED|Overall Study||97
129973|NCT00890656|299493|P1|NOT COMPLETED|Overall Study||0
129974|NCT00890656|299493|P1|COMPLETED|Overall Study||90
129975|NCT00890656|299493|P1|STARTED|Overall Study||90
129976|NCT00890591|299497|P1|NOT COMPLETED|Overall Study||20
129977|NCT00890591|299497|P1|COMPLETED|Overall Study||124
129978|NCT00890591|299497|P1|STARTED|Overall Study||144
129979|NCT00890409|299505|P2|NOT COMPLETED|Overall Study||21
129980|NCT00890409|299506|P1|NOT COMPLETED|Overall Study||20
129981|NCT00890409|299505|P2|COMPLETED|Overall Study||119
129982|NCT00890409|299506|P1|COMPLETED|Overall Study||96
129983|NCT00890409|299505|P2|STARTED|Overall Study||140
129984|NCT00890409|299506|P1|STARTED|Overall Study||116
129985|NCT00890201|299516|P2|NOT COMPLETED|Overall Study||56
129986|NCT00890201|299517|P1|NOT COMPLETED|Overall Study||5
129987|NCT00890201|299516|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
129988|NCT00890201|299517|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
129989|NCT00890201|299516|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
129990|NCT00890201|299517|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
129991|NCT00890097|299526|P3|NOT COMPLETED|Overall Study||77
129992|NCT00890097|299527|P2|NOT COMPLETED|Overall Study||86
129993|NCT00890097|299528|P1|NOT COMPLETED|Overall Study||68
129994|NCT00890097|299526|P3|COMPLETED|Overall Study||184
129995|NCT00890097|299527|P2|COMPLETED|Overall Study||173
129996|NCT00890097|299528|P1|COMPLETED|Overall Study||184
129997|NCT00890097|299526|P3|STARTED|Overall Study||261
129998|NCT00890097|299527|P2|STARTED|Overall Study||259
129999|NCT00890097|299528|P1|STARTED|Overall Study||252
130000|NCT00890084|299536|P1|NOT COMPLETED|Overall Study||142
130001|NCT00890084|299536|P1|COMPLETED|Overall Study||2771
130002|NCT00890084|299536|P1|STARTED|Overall Study||2913
130003|NCT00889928|299547|P1|NOT COMPLETED|Overall Study||0
130004|NCT00889928|299547|P1|COMPLETED|Overall Study||7
130005|NCT00889928|299547|P1|STARTED|Overall Study||7
130006|NCT00889915|299555|P4|NOT COMPLETED|Overall Study||8
130007|NCT00889915|299556|P3|NOT COMPLETED|Overall Study||13
130008|NCT00889915|299557|P2|NOT COMPLETED|Overall Study||5
130009|NCT00889915|299558|P1|NOT COMPLETED|Overall Study||2
130010|NCT00889915|299555|P4|COMPLETED|Overall Study||40
130011|NCT00889915|299556|P3|COMPLETED|Overall Study||54
130012|NCT00889915|299557|P2|COMPLETED|Overall Study||71
130013|NCT00889915|299558|P1|COMPLETED|Overall Study||35
130014|NCT00889915|299555|P4|STARTED|Overall Study||48
130015|NCT00889915|299556|P3|STARTED|Overall Study||67
130016|NCT00889915|299557|P2|STARTED|Overall Study||76
130017|NCT00889915|299558|P1|STARTED|Overall Study||37
130018|NCT00889863|299576|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
130019|NCT00889863|299577|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
130020|NCT00889863|299576|P2|COMPLETED|Part II: Randomized Double Blind||24
130021|NCT00889863|299577|P1|COMPLETED|Part II: Randomized Double Blind||39
130022|NCT00889863|299576|P2|STARTED|Part II: Randomized Double Blind||50
130023|NCT00889863|299577|P1|STARTED|Part II: Randomized Double Blind||50
130024|NCT00889863|299576|P2|NOT COMPLETED|Part I: Open Label||0
130025|NCT00889863|299577|P1|NOT COMPLETED|Part I: Open Label||77
130026|NCT00889863|299576|P2|COMPLETED|Part I: Open Label||0
130027|NCT00889863|299577|P1|COMPLETED|Part I: Open Label||100
130028|NCT00889863|299576|P2|Entered Part 1d|Part I: Open Label||0
130029|NCT00889863|299577|P1|Entered Part 1d|Part I: Open Label||103
130030|NCT00889863|299576|P2|Entered Part Ic|Part I: Open Label||0
130031|NCT00889863|299577|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
130032|NCT00889863|299576|P2|Entered Part Ib|Part I: Open Label||0
130033|NCT00889863|299577|P1|Entered Part Ib|Part I: Open Label||142
130034|NCT00889863|299576|P2|Entered Part Ia|Part I: Open Label||0
130035|NCT00889863|299577|P1|Entered Part Ia|Part I: Open Label||145
130036|NCT00889863|299576|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
130037|NCT00889863|299577|P1|STARTED|Part I: Open Label||177
130038|NCT00889824|299599|P1|NOT COMPLETED|Overall Study||0
130039|NCT00889824|299599|P1|COMPLETED|Overall Study||5
130040|NCT00889824|299599|P1|STARTED|Overall Study||5
130041|NCT00889720|299603|P1|NOT COMPLETED|Overall Study||8
130042|NCT00889720|299603|P1|COMPLETED|Overall Study||8
130043|NCT00889720|299603|P1|Surgical Population|Overall Study||12
130044|NCT00889720|299603|P1|STARTED|Overall Study||16
130045|NCT00889707|299630|P2|NOT COMPLETED|Overall Study||10
130046|NCT00889707|299631|P1|NOT COMPLETED|Overall Study||7
130047|NCT00889707|299630|P2|COMPLETED|Overall Study||21
130048|NCT00889707|299631|P1|COMPLETED|Overall Study||54
130049|NCT00889707|299630|P2|STARTED|Overall Study||31
130050|NCT00889707|299631|P1|STARTED|Overall Study||61
130051|NCT00889681|299639|P1|NOT COMPLETED|Overall Study||3
130052|NCT00889681|299639|P1|COMPLETED|Overall Study||78
130053|NCT00889681|299639|P1|Received Treatment|Overall Study||78
130054|NCT00889681|299639|P1|STARTED|Overall Study||81
130055|NCT00889603|299646|P1|NOT COMPLETED|Overall Study||37
130056|NCT00889603|299646|P1|COMPLETED|Overall Study||333
130057|NCT00889603|299646|P1|STARTED|Overall Study||370
130058|NCT00889512|299661|P2|NOT COMPLETED|Overall Study||0
130059|NCT00889512|299662|P1|NOT COMPLETED|Overall Study||0
130060|NCT00889512|299661|P2|COMPLETED|Overall Study||9
130061|NCT00889512|299662|P1|COMPLETED|Overall Study||5
130062|NCT00889512|299661|P2|STARTED|Overall Study||9
130063|NCT00889512|299662|P1|STARTED|Overall Study||5
130064|NCT00889421|299668|P1|NOT COMPLETED|Overall Study||3
130065|NCT00889421|299668|P1|COMPLETED|Overall Study||0
130066|NCT00889421|299668|P1|STARTED|Overall Study||3
130067|NCT00889330|299678|P2|NOT COMPLETED|Overall Study||0
130068|NCT00889330|299679|P1|NOT COMPLETED|Overall Study||0
130069|NCT00889330|299678|P2|COMPLETED|Overall Study||30
130070|NCT00889330|299679|P1|COMPLETED|Overall Study||30
130071|NCT00889330|299678|P2|STARTED|Overall Study||30
130072|NCT00889330|299679|P1|STARTED|Overall Study||30
130073|NCT00889265|299709|P1|NOT COMPLETED|Overall Study||7
130074|NCT00889265|299709|P1|COMPLETED|Overall Study||44
130075|NCT00889265|299709|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
130076|NCT00889252|299716|P2|NOT COMPLETED|Overall Study||4
130077|NCT00889252|299717|P1|NOT COMPLETED|Overall Study||7
130078|NCT00889252|299716|P2|COMPLETED|Overall Study||78
130079|NCT00889252|299717|P1|COMPLETED|Overall Study||161
130080|NCT00889252|299716|P2|STARTED|Overall Study||82
130081|NCT00889252|299717|P1|STARTED|Overall Study||168
130082|NCT00889200|299759|P1|NOT COMPLETED|Overall Study||0
130083|NCT00889200|299759|P1|COMPLETED|Overall Study||12
130084|NCT00889200|299759|P1|STARTED|Overall Study||12
130085|NCT00888979|299763|P1|NOT COMPLETED|Overall Study||4
130086|NCT00888979|299763|P1|COMPLETED|Overall Study||6
130087|NCT00888979|299763|P1|Received the Inhaler/Counseling|Overall Study||8
130088|NCT00888979|299763|P1|STARTED|Overall Study||10
130089|NCT00888940|299771|P2|NOT COMPLETED|Overall Study||21
130090|NCT00888940|299772|P1|NOT COMPLETED|Overall Study||28
130091|NCT00888940|299771|P2|COMPLETED|Overall Study||101
130092|NCT00888940|299772|P1|COMPLETED|Overall Study||92
130093|NCT00888940|299771|P2|Completed Therapy|Overall Study||106
130094|NCT00888940|299772|P1|Completed Therapy|Overall Study||107
130095|NCT00888940|299771|P2|STARTED|Overall Study||122
130096|NCT00888940|299772|P1|STARTED|Overall Study||120
130097|NCT00888849|299782|P2|NOT COMPLETED|Overall Study||9
130098|NCT00888849|299783|P1|NOT COMPLETED|Overall Study||5
130099|NCT00888849|299782|P2|COMPLETED|Overall Study||129
130100|NCT00888849|299783|P1|COMPLETED|Overall Study||137
130101|NCT00888849|299782|P2|STARTED|Overall Study||138
130102|NCT00888849|299783|P1|STARTED|Overall Study||142
130103|NCT00888654|299793|P1|NOT COMPLETED|Overall Study||10
130104|NCT00888654|299793|P1|COMPLETED|Overall Study||31
130105|NCT00888654|299793|P1|STARTED|Overall Study||41
130106|NCT00888628|299797|P1|NOT COMPLETED|Overall Study||3
130107|NCT00888628|299797|P1|COMPLETED|Overall Study||4
130108|NCT00888628|299797|P1|Transplanted|Overall Study||4
130109|NCT00888628|299797|P1|Withdrawn|Overall Study||1
130110|NCT00888628|299797|P1|Screen Failure|Overall Study||2
130111|NCT00888628|299797|P1|Enrolled|Overall Study||7
130112|NCT00888628|299797|P1|STARTED|Overall Study||7
130113|NCT00888459|299803|P2|NOT COMPLETED|Overall Study||0
130114|NCT00888459|299804|P1|NOT COMPLETED|Overall Study||0
130115|NCT00888459|299803|P2|COMPLETED|Overall Study||30
130116|NCT00888459|299804|P1|COMPLETED|Overall Study||30
130117|NCT00888459|299803|P2|STARTED|Overall Study||30
130118|NCT00888459|299804|P1|STARTED|Overall Study||30
130119|NCT00888433|299812|P2|NOT COMPLETED|Overall Study||3
130120|NCT00888433|299813|P1|NOT COMPLETED|Overall Study||3
130121|NCT00888433|299812|P2|COMPLETED|Overall Study||51
130122|NCT00888433|299813|P1|COMPLETED|Overall Study||49
130123|NCT00888433|299812|P2|STARTED|Overall Study||54
130124|NCT00888433|299813|P1|STARTED|Overall Study||52
130125|NCT00888381|299821|P2|NOT COMPLETED|Overall Study||1
130126|NCT00888381|299822|P1|NOT COMPLETED|Overall Study||0
130127|NCT00888381|299821|P2|COMPLETED|Overall Study||59
130128|NCT00888381|299822|P1|COMPLETED|Overall Study||60
130129|NCT00888381|299821|P2|STARTED|Overall Study||60
130130|NCT00888381|299822|P1|STARTED|Overall Study||60
130131|NCT00888355|299842|P4|NOT COMPLETED|Overall Study||10
130132|NCT00888355|299843|P3|NOT COMPLETED|Overall Study||12
130133|NCT00888355|299844|P2|NOT COMPLETED|Overall Study||9
130134|NCT00888355|299845|P1|NOT COMPLETED|Overall Study||22
130135|NCT00888355|299842|P4|COMPLETED|Overall Study||96
130136|NCT00888355|299843|P3|COMPLETED|Overall Study||94
130137|NCT00888355|299844|P2|COMPLETED|Overall Study||99
130138|NCT00888355|299845|P1|COMPLETED|Overall Study||86
130139|NCT00888355|299842|P4|STARTED|Overall Study||106
130140|NCT00888355|299843|P3|STARTED|Overall Study||106
130141|NCT00888355|299844|P2|STARTED|Overall Study||108
130142|NCT00888355|299845|P1|STARTED|Overall Study||108
130143|NCT00888329|299901|P2|NOT COMPLETED|Overall Study||9
130144|NCT00888329|299902|P1|NOT COMPLETED|Overall Study||6
130145|NCT00888329|299901|P2|COMPLETED|Overall Study||122
130146|NCT00888329|299902|P1|COMPLETED|Overall Study||119
130147|NCT00888329|299901|P2|STARTED|Overall Study||131
130148|NCT00888329|299902|P1|STARTED|Overall Study||125
130149|NCT00888238|299908|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
130150|NCT00888238|299909|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
130151|NCT00888238|299910|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
130152|NCT00888238|299908|P3|COMPLETED|Third Period of Treatment Intervention||3
130153|NCT00888238|299909|P2|COMPLETED|Third Period of Treatment Intervention||4
130154|NCT00888238|299910|P1|COMPLETED|Third Period of Treatment Intervention||4
130155|NCT00888238|299908|P3|STARTED|Third Period of Treatment Intervention||3
130156|NCT00888238|299909|P2|STARTED|Third Period of Treatment Intervention||4
130157|NCT00888238|299910|P1|STARTED|Third Period of Treatment Intervention||4
130158|NCT00888238|299908|P3|NOT COMPLETED|Washout Period After Period 2||1
130159|NCT00888238|299909|P2|NOT COMPLETED|Washout Period After Period 2||0
130160|NCT00888238|299910|P1|NOT COMPLETED|Washout Period After Period 2||0
130161|NCT00888238|299908|P3|COMPLETED|Washout Period After Period 2||3
130162|NCT00888238|299909|P2|COMPLETED|Washout Period After Period 2||4
130163|NCT00888238|299910|P1|COMPLETED|Washout Period After Period 2||4
130164|NCT00888238|299908|P3|STARTED|Washout Period After Period 2||4
130165|NCT00888238|299909|P2|STARTED|Washout Period After Period 2||4
130166|NCT00888238|299910|P1|STARTED|Washout Period After Period 2||4
130167|NCT00888238|299908|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
130168|NCT00888238|299909|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
130169|NCT00888238|299910|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
130170|NCT00888238|299908|P3|COMPLETED|Second Period of Treatment Intervention||4
130171|NCT00888238|299909|P2|COMPLETED|Second Period of Treatment Intervention||4
130172|NCT00888238|299910|P1|COMPLETED|Second Period of Treatment Intervention||4
130173|NCT00888238|299908|P3|STARTED|Second Period of Treatment Intervention||4
130174|NCT00888238|299909|P2|STARTED|Second Period of Treatment Intervention||4
130175|NCT00888238|299910|P1|STARTED|Second Period of Treatment Intervention||4
130176|NCT00888238|299908|P3|NOT COMPLETED|Washout Period After Period 1||0
130177|NCT00888238|299909|P2|NOT COMPLETED|Washout Period After Period 1||0
130178|NCT00888238|299910|P1|NOT COMPLETED|Washout Period After Period 1||0
130179|NCT00888238|299908|P3|COMPLETED|Washout Period After Period 1||4
130180|NCT00888238|299909|P2|COMPLETED|Washout Period After Period 1||4
130181|NCT00888238|299910|P1|COMPLETED|Washout Period After Period 1||4
130182|NCT00888238|299908|P3|STARTED|Washout Period After Period 1||4
130183|NCT00888238|299909|P2|STARTED|Washout Period After Period 1||4
130184|NCT00888238|299910|P1|STARTED|Washout Period After Period 1||4
130185|NCT00888238|299908|P3|NOT COMPLETED|First Period of Treatment Intervention||0
130186|NCT00888238|299909|P2|NOT COMPLETED|First Period of Treatment Intervention||0
130187|NCT00888238|299910|P1|NOT COMPLETED|First Period of Treatment Intervention||0
130188|NCT00888238|299908|P3|COMPLETED|First Period of Treatment Intervention||4
130189|NCT00888238|299909|P2|COMPLETED|First Period of Treatment Intervention||4
130190|NCT00888238|299910|P1|COMPLETED|First Period of Treatment Intervention||4
130191|NCT00888238|299908|P3|STARTED|First Period of Treatment Intervention||4
130192|NCT00888238|299909|P2|STARTED|First Period of Treatment Intervention||4
130193|NCT00888238|299910|P1|STARTED|First Period of Treatment Intervention||4
130194|NCT00888134|299918|P1|NOT COMPLETED|Follow-up||1
130195|NCT00888134|299918|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
130196|NCT00888134|299918|P1|STARTED|Follow-up||27
130197|NCT00888134|299918|P1|NOT COMPLETED|Treatment With Study Drug||1
130198|NCT00888134|299918|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
130199|NCT00888134|299918|P1|STARTED|Treatment With Study Drug||28
130200|NCT00887978|299928|P2|NOT COMPLETED|Overall Study||15
130201|NCT00887978|299929|P1|NOT COMPLETED|Overall Study||25
130202|NCT00887978|299928|P2|COMPLETED|Overall Study||138
130203|NCT00887978|299929|P1|COMPLETED|Overall Study||132
130204|NCT00887978|299928|P2|STARTED|Overall Study||153
130205|NCT00887978|299929|P1|STARTED|Overall Study||157
130206|NCT00887965|299965|P1|NOT COMPLETED|Overall Study||0
130207|NCT00887965|299965|P1|COMPLETED|Overall Study||15
130208|NCT00887965|299965|P1|STARTED|Overall Study||15
130209|NCT00887913|299995|P1|NOT COMPLETED|Overall Study||6
130210|NCT00887913|299995|P1|COMPLETED|Overall Study||63
130211|NCT00887913|299995|P1|STARTED|Overall Study||69
130212|NCT00887809|300003|P2|NOT COMPLETED|Overall Study||0
130213|NCT00887809|300004|P1|NOT COMPLETED|Overall Study||4
130214|NCT00887809|300003|P2|COMPLETED|Overall Study||10
130215|NCT00887809|300004|P1|COMPLETED|Overall Study||33
130216|NCT00887809|300003|P2|STARTED|Overall Study||10
130217|NCT00887809|300004|P1|STARTED|Overall Study||37
130218|NCT00887744|300010|P1|NOT COMPLETED|Overall Study||34
130219|NCT00887744|300010|P1|COMPLETED|Overall Study||128
130220|NCT00887744|300010|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
130221|NCT00887679|300019|P1|NOT COMPLETED|Overall Study||10
130222|NCT00887679|300019|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
130223|NCT00887679|300019|P1|STARTED|Overall Study||30
130224|NCT00887653|300028|P1|NOT COMPLETED|Overall Study||0
130225|NCT00887653|300028|P1|COMPLETED|Overall Study||20
130226|NCT00887653|300028|P1|STARTED|Overall Study||20
130227|NCT00887640|300034|P1|NOT COMPLETED|Overall Study||0
130228|NCT00887640|300034|P1|COMPLETED|Overall Study||11
130229|NCT00887640|300034|P1|STARTED|Overall Study||11
130230|NCT00887588|300049|P2|NOT COMPLETED|Extension Period||5
130231|NCT00887588|300050|P1|NOT COMPLETED|Extension Period||6
130232|NCT00887588|300049|P2|COMPLETED|Extension Period||120
130233|NCT00887588|300050|P1|COMPLETED|Extension Period||121
130234|NCT00887588|300049|P2|Arterial Stiffness Set|Extension Period||94
130235|NCT00887588|300050|P1|Arterial Stiffness Set|Extension Period||86
130236|NCT00887588|300049|P2|STARTED|Extension Period||125
130237|NCT00887588|300050|P1|STARTED|Extension Period||127
130238|NCT00887588|300049|P2|NOT COMPLETED|Core Period||21
130239|NCT00887588|300050|P1|NOT COMPLETED|Core Period||19
130240|NCT00887588|300049|P2|COMPLETED|Core Period||131
130241|NCT00887588|300050|P1|COMPLETED|Core Period||130
130242|NCT00887588|300049|P2|Arterial Stiffness Set|Core Period||94
130243|NCT00887588|300050|P1|Arterial Stiffness Set|Core Period||86
130244|NCT00887588|300049|P2|Full Analysis Set|Core Period||146
130245|NCT00887588|300050|P1|Full Analysis Set|Core Period||148
130246|NCT00887588|300049|P2|Extension Efficacy Set|Core Period||125
130247|NCT00887588|300050|P1|Extension Efficacy Set|Core Period||127
130248|NCT00887588|300049|P2|STARTED|Core Period||152
130249|NCT00887588|300050|P1|STARTED|Core Period||149
130250|NCT00887575|300102|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
130251|NCT00887575|300103|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
130252|NCT00887575|300104|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
130253|NCT00887575|300102|P3|COMPLETED|Phase II - Maintenance Therapy||0
130254|NCT00887575|300103|P2|COMPLETED|Phase II - Maintenance Therapy||0
130255|NCT00887575|300104|P1|COMPLETED|Phase II - Maintenance Therapy||6
130256|NCT00887575|300102|P3|STARTED|Phase II - Maintenance Therapy||0
130257|NCT00887575|300103|P2|STARTED|Phase II - Maintenance Therapy||0
130258|NCT00887575|300104|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
130259|NCT00887575|300102|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
130260|NCT00887575|300103|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
130261|NCT00887575|300104|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
130262|NCT00887575|300102|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
130263|NCT00887575|300103|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
130264|NCT00887575|300104|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
130265|NCT00887575|300102|P3|STARTED|Phase II - Neoadjuvant Therapy||0
130266|NCT00887575|300103|P2|STARTED|Phase II - Neoadjuvant Therapy||0
130267|NCT00887575|300104|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
130268|NCT00887575|300102|P3|NOT COMPLETED|Phase I||3
130269|NCT00887575|300103|P2|NOT COMPLETED|Phase I||6
130270|NCT00887575|300104|P1|NOT COMPLETED|Phase I||0
130271|NCT00887575|300102|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
130272|NCT00887575|300103|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
130273|NCT00887575|300104|P1|COMPLETED|Phase I||6
130274|NCT00887575|300102|P3|STARTED|Phase I||3
130275|NCT00887575|300103|P2|STARTED|Phase I||6
130276|NCT00887575|300104|P1|STARTED|Phase I||6
130277|NCT00887562|300115|P3|NOT COMPLETED|Overall Study||1
130278|NCT00887562|300116|P2|NOT COMPLETED|Overall Study||2
130279|NCT00887562|300117|P1|NOT COMPLETED|Overall Study||3
130280|NCT00887562|300115|P3|COMPLETED|Overall Study||7
130281|NCT00887562|300116|P2|COMPLETED|Overall Study||7
130282|NCT00887562|300117|P1|COMPLETED|Overall Study||7
130283|NCT00887562|300115|P3|STARTED|Overall Study||8
130284|NCT00887562|300116|P2|STARTED|Overall Study||9
130285|NCT00887562|300117|P1|STARTED|Overall Study||10
130286|NCT00887549|300131|P1|NOT COMPLETED|Maintenance Therapy||43
130287|NCT00887549|300131|P1|COMPLETED|Maintenance Therapy||0
130288|NCT00887549|300131|P1|STARTED|Maintenance Therapy||43
130289|NCT00887549|300131|P1|NOT COMPLETED|Induction Therapy||27
130290|NCT00887549|300131|P1|COMPLETED|Induction Therapy||43
130291|NCT00887549|300131|P1|STARTED|Induction Therapy||70
130292|NCT00887510|300140|P2|NOT COMPLETED|Overall Study||0
130293|NCT00887510|300141|P1|NOT COMPLETED|Overall Study||0
130294|NCT00887510|300140|P2|COMPLETED|Overall Study||12
130295|NCT00887510|300141|P1|COMPLETED|Overall Study||12
130296|NCT00887510|300140|P2|STARTED|Overall Study||12
130297|NCT00887510|300141|P1|STARTED|Overall Study||12
130298|NCT00887484|300149|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
130299|NCT00887484|300149|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
130300|NCT00887484|300149|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
130301|NCT00887484|300149|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
130302|NCT00887484|300149|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
130303|NCT00887484|300149|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
130304|NCT00887471|300215|P2|NOT COMPLETED|Overall Study||0
130305|NCT00887471|300216|P1|NOT COMPLETED|Overall Study||0
130306|NCT00887471|300215|P2|COMPLETED|Overall Study||15
130307|NCT00887471|300216|P1|COMPLETED|Overall Study||15
130308|NCT00887471|300215|P2|STARTED|Overall Study||15
130309|NCT00887471|300216|P1|STARTED|Overall Study||15
130310|NCT00887458|300226|P2|NOT COMPLETED|Overall Study||4
130311|NCT00887458|300227|P1|NOT COMPLETED|Overall Study||0
130312|NCT00887458|300226|P2|COMPLETED|Overall Study||25
130313|NCT00887458|300227|P1|COMPLETED|Overall Study||17
130314|NCT00887458|300226|P2|STARTED|Overall Study||29
130315|NCT00887458|300227|P1|STARTED|Overall Study||17
130316|NCT00887354|300235|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
130317|NCT00887354|300236|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
130318|NCT00887354|300235|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
130319|NCT00887354|300236|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
130320|NCT00887354|300235|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
130321|NCT00887354|300236|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
130322|NCT00887354|300235|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
130323|NCT00887354|300236|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
130324|NCT00887354|300235|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
130325|NCT00887354|300236|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
130326|NCT00887354|300235|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
130327|NCT00887354|300236|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
130328|NCT00887354|300235|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
130329|NCT00887354|300236|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
130330|NCT00887354|300235|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
130331|NCT00887354|300236|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
130332|NCT00887341|300256|P2|NOT COMPLETED|Overall Study||3
130333|NCT00887341|300257|P1|NOT COMPLETED|Overall Study||2
130334|NCT00887341|300256|P2|COMPLETED|Overall Study||36
130335|NCT00887341|300257|P1|COMPLETED|Overall Study||35
130336|NCT00887341|300256|P2|STARTED|Overall Study||39
130337|NCT00887341|300257|P1|STARTED|Overall Study||37
130338|NCT00887315|300293|P2|NOT COMPLETED|Overall Study||4
130339|NCT00887315|300294|P1|NOT COMPLETED|Overall Study||7
130340|NCT00887315|300293|P2|COMPLETED|Overall Study||0
130341|NCT00887315|300294|P1|COMPLETED|Overall Study||0
130342|NCT00887315|300293|P2|STARTED|Overall Study||4
130343|NCT00887315|300294|P1|STARTED|Overall Study||7
130344|NCT00887289|300302|P1|NOT COMPLETED|Overall Study||95
130345|NCT00887289|300302|P1|COMPLETED|Overall Study||1409
130346|NCT00887289|300302|P1|STARTED|Overall Study||1504
130347|NCT00887250|300314|P3|NOT COMPLETED|Overall Study||13
130348|NCT00887250|300315|P2|NOT COMPLETED|Overall Study||12
130349|NCT00887250|300316|P1|NOT COMPLETED|Overall Study||18
130350|NCT00887250|300314|P3|COMPLETED|Overall Study||110
130351|NCT00887250|300315|P2|COMPLETED|Overall Study||115
130352|NCT00887250|300316|P1|COMPLETED|Overall Study||98
130353|NCT00887250|300314|P3|STARTED|Overall Study||123
130354|NCT00887250|300315|P2|STARTED|Overall Study||127
130355|NCT00887250|300316|P1|STARTED|Overall Study||116
130356|NCT00887224|300339|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
130357|NCT00887224|300340|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
130358|NCT00887224|300341|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
130359|NCT00887224|300339|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
130360|NCT00887224|300340|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
130361|NCT00887224|300341|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
130362|NCT00887224|300339|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
130363|NCT00887224|300340|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
130364|NCT00887224|300341|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
130365|NCT00887224|300339|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
130366|NCT00887224|300340|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
130367|NCT00887224|300341|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
130368|NCT00887224|300339|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
130369|NCT00887224|300340|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
130370|NCT00887224|300341|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
130371|NCT00887224|300339|P3|NOT COMPLETED|Double-blind (DB) Phase||62
130372|NCT00887224|300340|P2|NOT COMPLETED|Double-blind (DB) Phase||100
130373|NCT00887224|300341|P1|NOT COMPLETED|Double-blind (DB) Phase||0
130374|NCT00887224|300339|P3|COMPLETED|Double-blind (DB) Phase||210
130375|NCT00887224|300340|P2|COMPLETED|Double-blind (DB) Phase||176
130376|NCT00887224|300341|P1|COMPLETED|Double-blind (DB) Phase||0
130377|NCT00887224|300339|P3|STARTED|Double-blind (DB) Phase||272
130378|NCT00887224|300340|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
130379|NCT00887224|300341|P1|STARTED|Double-blind (DB) Phase||0
130380|NCT00887224|300339|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
130381|NCT00887224|300340|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
130382|NCT00887224|300341|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
130383|NCT00887224|300339|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
130384|NCT00887224|300340|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
130385|NCT00887224|300341|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
130386|NCT00887224|300339|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
130387|NCT00887224|300340|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
130388|NCT00887224|300341|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
130389|NCT00887224|300339|P3|STARTED|OL Taper Phase / OL Follow Up||0
130390|NCT00887224|300340|P2|STARTED|OL Taper Phase / OL Follow Up||0
130391|NCT00887224|300341|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
130392|NCT00887224|300339|P3|NOT COMPLETED|Between OLS and DB Phases||0
130393|NCT00887224|300340|P2|NOT COMPLETED|Between OLS and DB Phases||0
130394|NCT00887224|300341|P1|NOT COMPLETED|Between OLS and DB Phases||28
130395|NCT00887224|300339|P3|COMPLETED|Between OLS and DB Phases||0
130396|NCT00887224|300340|P2|COMPLETED|Between OLS and DB Phases||0
130397|NCT00887224|300341|P1|COMPLETED|Between OLS and DB Phases||548
130398|NCT00887224|300339|P3|STARTED|Between OLS and DB Phases||0
130399|NCT00887224|300340|P2|STARTED|Between OLS and DB Phases||0
130400|NCT00887224|300341|P1|STARTED|Between OLS and DB Phases||576
130401|NCT00887224|300339|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
130402|NCT00887224|300340|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
130403|NCT00887224|300341|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
130404|NCT00887224|300339|P3|COMPLETED|Open-label Stability (OLS) Phase||0
130405|NCT00887224|300340|P2|COMPLETED|Open-label Stability (OLS) Phase||0
130406|NCT00887224|300341|P1|COMPLETED|Open-label Stability (OLS) Phase||576
130407|NCT00887224|300339|P3|STARTED|Open-label Stability (OLS) Phase||0
130408|NCT00887224|300340|P2|STARTED|Open-label Stability (OLS) Phase||0
130409|NCT00887224|300341|P1|STARTED|Open-label Stability (OLS) Phase||659
130410|NCT00887224|300339|P3|NOT COMPLETED|Between OLR and OLS Phases||0
130411|NCT00887224|300340|P2|NOT COMPLETED|Between OLR and OLS Phases||0
130412|NCT00887224|300341|P1|NOT COMPLETED|Between OLR and OLS Phases||93
130413|NCT00887224|300339|P3|COMPLETED|Between OLR and OLS Phases||0
130414|NCT00887224|300340|P2|COMPLETED|Between OLR and OLS Phases||0
130415|NCT00887224|300341|P1|COMPLETED|Between OLR and OLS Phases||659
130416|NCT00887224|300339|P3|STARTED|Between OLR and OLS Phases||0
130417|NCT00887224|300340|P2|STARTED|Between OLR and OLS Phases||0
130418|NCT00887224|300341|P1|STARTED|Between OLR and OLS Phases||752
130419|NCT00887224|300339|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
130420|NCT00887224|300340|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
130421|NCT00887224|300341|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
130422|NCT00887224|300339|P3|COMPLETED|Open-label Response (OLR) Phase||0
130423|NCT00887224|300340|P2|COMPLETED|Open-label Response (OLR) Phase||0
130424|NCT00887224|300341|P1|COMPLETED|Open-label Response (OLR) Phase||752
130425|NCT00887224|300339|P3|STARTED|Open-label Response (OLR) Phase||0
130426|NCT00887224|300340|P2|STARTED|Open-label Response (OLR) Phase||0
130427|NCT00887224|300341|P1|STARTED|Open-label Response (OLR) Phase||874
130428|NCT00887198|300368|P2|NOT COMPLETED|Overall Study||431
130429|NCT00887198|300369|P1|NOT COMPLETED|Overall Study||384
130430|NCT00887198|300368|P2|COMPLETED|Overall Study||111
130431|NCT00887198|300369|P1|COMPLETED|Overall Study||162
130432|NCT00887198|300368|P2|STARTED|Overall Study||542
130433|NCT00887198|300369|P1|STARTED|Overall Study||546
130434|NCT00887159|300400|P3|NOT COMPLETED|Overall Study||56
130435|NCT00887159|300401|P2|NOT COMPLETED|Overall Study||56
130436|NCT00887159|300402|P1|NOT COMPLETED|Overall Study||29
130437|NCT00887159|300400|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
130438|NCT00887159|300401|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
130439|NCT00887159|300402|P1|COMPLETED|Overall Study||27
130440|NCT00887159|300400|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
130441|NCT00887159|300401|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
130442|NCT00887159|300402|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
130443|NCT00887159|300400|P3|Eligible and Treated Patients|Overall Study||52
130444|NCT00887159|300401|P2|Eligible and Treated Patients|Overall Study||52
130445|NCT00887159|300402|P1|Eligible and Treated Patients|Overall Study||48
130446|NCT00887159|300400|P3|Patients Who Started Assigned Treatment|Overall Study||52
130447|NCT00887159|300401|P2|Patients Who Started Assigned Treatment|Overall Study||53
130448|NCT00887159|300402|P1|Patients Who Started Assigned Treatment|Overall Study||53
130449|NCT00887159|300400|P3|STARTED|Overall Study||56
130450|NCT00887159|300401|P2|STARTED|Overall Study||56
130451|NCT00887159|300402|P1|STARTED|Overall Study||56
130452|NCT00886938|300418|P1|NOT COMPLETED|Overall Study||2
130453|NCT00886938|300418|P1|COMPLETED|Overall Study||10
130454|NCT00886938|300418|P1|STARTED|Overall Study||12
130455|NCT00886899|300422|P1|NOT COMPLETED|Overall Study||0
130456|NCT00886899|300422|P1|COMPLETED|Overall Study||147
130457|NCT00886899|300422|P1|STARTED|Overall Study||147
130458|NCT00886834|300431|P2|NOT COMPLETED|Overall Study||3
130459|NCT00886834|300432|P1|NOT COMPLETED|Overall Study||0
130460|NCT00886834|300431|P2|COMPLETED|Overall Study||51
130461|NCT00886834|300432|P1|COMPLETED|Overall Study||54
130462|NCT00886834|300431|P2|STARTED|Overall Study||54
130463|NCT00886834|300432|P1|STARTED|Overall Study||54
130464|NCT00886795|300440|P1|NOT COMPLETED|Overall Study||1
130465|NCT00886795|300440|P1|COMPLETED|Overall Study||3
130466|NCT00886795|300440|P1|STARTED|Overall Study||4
130467|NCT00886769|300447|P2|NOT COMPLETED|Overall Study||37
130468|NCT00886769|300448|P1|NOT COMPLETED|Overall Study||6
130469|NCT00886769|300447|P2|COMPLETED|Overall Study||4
130470|NCT00886769|300448|P1|COMPLETED|Overall Study||37
130471|NCT00886769|300447|P2|STARTED|Overall Study||41
130472|NCT00886769|300448|P1|STARTED|Overall Study||43
130473|NCT00886704|300474|P2|NOT COMPLETED|Overall Study||0
130474|NCT00886704|300475|P1|NOT COMPLETED|Overall Study||0
130475|NCT00886704|300474|P2|COMPLETED|Overall Study||10
130476|NCT00886704|300475|P1|COMPLETED|Overall Study||40
130477|NCT00886704|300474|P2|STARTED|Overall Study||10
130478|NCT00886704|300475|P1|STARTED|Overall Study||40
130479|NCT00886639|300483|P1|NOT COMPLETED|Overall Study||16
130480|NCT00886639|300483|P1|COMPLETED|Overall Study||111
130481|NCT00886639|300483|P1|STARTED|Overall Study||127
130482|NCT00886626|300487|P2|NOT COMPLETED|Period 2 (90 Days)||0
130483|NCT00886626|300488|P1|NOT COMPLETED|Period 2 (90 Days)||0
130484|NCT00886626|300487|P2|COMPLETED|Period 2 (90 Days)||6
130485|NCT00886626|300488|P1|COMPLETED|Period 2 (90 Days)||5
130486|NCT00886626|300487|P2|STARTED|Period 2 (90 Days)||6
130487|NCT00886626|300488|P1|STARTED|Period 2 (90 Days)||5
130488|NCT00886626|300487|P2|NOT COMPLETED|Period 1 (90 Days)||0
130489|NCT00886626|300488|P1|NOT COMPLETED|Period 1 (90 Days)||1
130490|NCT00886626|300487|P2|COMPLETED|Period 1 (90 Days)||6
130491|NCT00886626|300488|P1|COMPLETED|Period 1 (90 Days)||5
130492|NCT00886626|300487|P2|STARTED|Period 1 (90 Days)||6
130493|NCT00886626|300488|P1|STARTED|Period 1 (90 Days)||6
130494|NCT00886613|300497|P3|NOT COMPLETED|Overall Study||3
130495|NCT00886613|300498|P2|NOT COMPLETED|Overall Study||0
130496|NCT00886613|300499|P1|NOT COMPLETED|Overall Study||2
130497|NCT00886613|300497|P3|COMPLETED|Overall Study||37
130498|NCT00886613|300498|P2|COMPLETED|Overall Study||39
130499|NCT00886613|300499|P1|COMPLETED|Overall Study||39
130500|NCT00886613|300497|P3|STARTED|Overall Study||40
130501|NCT00886613|300498|P2|STARTED|Overall Study||39
130502|NCT00886613|300499|P1|STARTED|Overall Study||41
130503|NCT00886600|300521|P4|NOT COMPLETED|Combination Therapy Period||0
130504|NCT00886600|300522|P3|NOT COMPLETED|Combination Therapy Period||2
130505|NCT00886600|300523|P2|NOT COMPLETED|Combination Therapy Period||0
130506|NCT00886600|300524|P1|NOT COMPLETED|Combination Therapy Period||0
130507|NCT00886600|300521|P4|COMPLETED|Combination Therapy Period||23
130508|NCT00886600|300522|P3|COMPLETED|Combination Therapy Period||19
130509|NCT00886600|300523|P2|COMPLETED|Combination Therapy Period||21
130510|NCT00886600|300524|P1|COMPLETED|Combination Therapy Period||28
130511|NCT00886600|300521|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
130512|NCT00886600|300522|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
130513|NCT00886600|300523|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
130514|NCT00886600|300524|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
130515|NCT00886600|300521|P4|NOT COMPLETED|Double-blind Monotherapy||2
130516|NCT00886600|300522|P3|NOT COMPLETED|Double-blind Monotherapy||1
130517|NCT00886600|300523|P2|NOT COMPLETED|Double-blind Monotherapy||1
130518|NCT00886600|300524|P1|NOT COMPLETED|Double-blind Monotherapy||2
130519|NCT00886600|300521|P4|COMPLETED|Double-blind Monotherapy||29
130520|NCT00886600|300522|P3|COMPLETED|Double-blind Monotherapy||29
130521|NCT00886600|300523|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
130522|NCT00886600|300524|P1|COMPLETED|Double-blind Monotherapy||30
130523|NCT00886600|300521|P4|STARTED|Double-blind Monotherapy||31
130524|NCT00886600|300522|P3|STARTED|Double-blind Monotherapy||30
130525|NCT00886600|300523|P2|STARTED|Double-blind Monotherapy||29
130526|NCT00886600|300524|P1|STARTED|Double-blind Monotherapy||32
130527|NCT00886483|300548|P2|NOT COMPLETED|Overall Study||3
130528|NCT00886483|300549|P1|NOT COMPLETED|Overall Study||2
130529|NCT00886483|300548|P2|COMPLETED|Overall Study||10
130530|NCT00886483|300549|P1|COMPLETED|Overall Study||24
130531|NCT00886483|300548|P2|Completed 20 Treatments|Overall Study||11
130532|NCT00886483|300549|P1|Completed 20 Treatments|Overall Study||25
130533|NCT00886483|300548|P2|STARTED|Overall Study||13
130534|NCT00886483|300549|P1|STARTED|Overall Study||26
130535|NCT00886340|300567|P2|NOT COMPLETED|Overall Study||7
130536|NCT00886340|300568|P1|NOT COMPLETED|Overall Study||0
130537|NCT00886340|300567|P2|COMPLETED|Overall Study||24
130538|NCT00886340|300568|P1|COMPLETED|Overall Study||27
130539|NCT00886340|300567|P2|STARTED|Overall Study||31
130540|NCT00886340|300568|P1|STARTED|Overall Study||27
130541|NCT00886288|300576|P2|NOT COMPLETED|Overall Study||227
130542|NCT00886288|300577|P1|NOT COMPLETED|Overall Study||743
130543|NCT00886288|300576|P2|COMPLETED|Overall Study||457
130544|NCT00886288|300577|P1|COMPLETED|Overall Study||1284
130545|NCT00886288|300576|P2|STARTED|Overall Study|Baseline Population|684
130546|NCT00886288|300577|P1|STARTED|Overall Study|Baseline Population|2027
130547|NCT00886145|300593|P1|NOT COMPLETED|Overall Study||0
130548|NCT00886145|300593|P1|COMPLETED|Overall Study||1
130549|NCT00886145|300593|P1|STARTED|Overall Study||1
130550|NCT00886119|300599|P2|NOT COMPLETED|Period 2||0
130551|NCT00886119|300600|P1|NOT COMPLETED|Period 2||0
130552|NCT00886119|300599|P2|COMPLETED|Period 2||22
130553|NCT00886119|300600|P1|COMPLETED|Period 2||23
130554|NCT00886119|300599|P2|STARTED|Period 2||22
130555|NCT00886119|300600|P1|STARTED|Period 2||23
130556|NCT00886119|300599|P2|NOT COMPLETED|Period 1||0
130557|NCT00886119|300600|P1|NOT COMPLETED|Period 1||1
130558|NCT00886119|300599|P2|COMPLETED|Period 1||22
130559|NCT00886119|300600|P1|COMPLETED|Period 1||23
130560|NCT00886119|300599|P2|STARTED|Period 1||22
130561|NCT00886119|300600|P1|STARTED|Period 1||24
130562|NCT00885846|300609|P3|NOT COMPLETED|Overall Study||2
130563|NCT00885846|300610|P2|NOT COMPLETED|Overall Study||5
130564|NCT00885846|300611|P1|NOT COMPLETED|Overall Study||2
130565|NCT00885846|300609|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
130566|NCT00885846|300610|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
130567|NCT00885846|300611|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
130568|NCT00885846|300609|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
130569|NCT00885846|300610|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
130570|NCT00885846|300611|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
130571|NCT00885768|300619|P1|NOT COMPLETED|Overall Study||0
130572|NCT00885768|300619|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
130573|NCT00885768|300619|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
130574|NCT00885755|300626|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
130575|NCT00885755|300627|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
130576|NCT00885755|300628|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
130577|NCT00885755|300626|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
130578|NCT00885755|300627|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
130579|NCT00885755|300628|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
130580|NCT00885755|300626|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
130581|NCT00885755|300627|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
130582|NCT00885755|300628|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
130583|NCT00885755|300626|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
130584|NCT00885755|300627|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
130585|NCT00885755|300628|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
130586|NCT00885755|300626|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
130587|NCT00885755|300627|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
130588|NCT00885755|300628|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
130589|NCT00885755|300626|P3|STARTED|Part I: Trastuzumab+Taxane||1
130590|NCT00885755|300627|P2|STARTED|Part I: Trastuzumab+Taxane||1
130591|NCT00885755|300628|P1|STARTED|Part I: Trastuzumab+Taxane||31
130592|NCT00885742|300653|P1|NOT COMPLETED|Overall Study||0
130593|NCT00885742|300653|P1|COMPLETED|Overall Study||41
130594|NCT00885742|300653|P1|STARTED|Overall Study||41
130595|NCT00885638|300664|P2|NOT COMPLETED|Overall Study||0
130596|NCT00885638|300665|P1|NOT COMPLETED|Overall Study||0
130597|NCT00885638|300664|P2|COMPLETED|Overall Study||6
130598|NCT00885638|300665|P1|COMPLETED|Overall Study||6
130599|NCT00885638|300664|P2|STARTED|Overall Study||6
130600|NCT00885638|300665|P1|STARTED|Overall Study||6
130601|NCT00885534|300672|P1|NOT COMPLETED|Overall Study||1
130602|NCT00885534|300672|P1|COMPLETED|Overall Study||6
130603|NCT00885534|300672|P1|STARTED|Overall Study||7
130604|NCT00885482|300676|P1|NOT COMPLETED|Overall Study||4
130605|NCT00885482|300676|P1|COMPLETED|Overall Study||36
130606|NCT00885482|300676|P1|STARTED|Overall Study||40
130607|NCT00885378|300682|P2|NOT COMPLETED|Overall Study||8
130608|NCT00885378|300683|P1|NOT COMPLETED|Overall Study||8
130609|NCT00885378|300682|P2|COMPLETED|Overall Study||78
130610|NCT00885378|300683|P1|COMPLETED|Overall Study||66
130611|NCT00885378|300682|P2|STARTED|Overall Study|Number randomized.|86
130612|NCT00885378|300683|P1|STARTED|Overall Study|Number randomized.|74
130613|NCT00885365|300713|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
130614|NCT00885365|300714|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
130615|NCT00885365|300713|P2|COMPLETED|4 Weeks OFF Treatment||159
130616|NCT00885365|300714|P1|COMPLETED|4 Weeks OFF Treatment||155
130617|NCT00885365|300713|P2|STARTED|4 Weeks OFF Treatment||159
130618|NCT00885365|300714|P1|STARTED|4 Weeks OFF Treatment||155
130619|NCT00885365|300713|P2|NOT COMPLETED|4 Weeks ON Treatment||6
130620|NCT00885365|300714|P1|NOT COMPLETED|4 Weeks ON Treatment||4
130621|NCT00885365|300713|P2|COMPLETED|4 Weeks ON Treatment||159
130622|NCT00885365|300714|P1|COMPLETED|4 Weeks ON Treatment||155
130623|NCT00885365|300713|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
130624|NCT00885365|300714|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
130625|NCT00885365|300713|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
130626|NCT00885365|300714|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
130627|NCT00885365|300713|P2|STARTED|4 Weeks ON Treatment||165
130628|NCT00885365|300714|P1|STARTED|4 Weeks ON Treatment||159
130629|NCT00885352|300750|P2|NOT COMPLETED|Overall Study||20
130630|NCT00885352|300751|P1|NOT COMPLETED|Overall Study||8
130631|NCT00885352|300750|P2|COMPLETED|Overall Study||136
130632|NCT00885352|300751|P1|COMPLETED|Overall Study||149
130633|NCT00885352|300750|P2|STARTED|Overall Study||156
130634|NCT00885352|300751|P1|STARTED|Overall Study||157
130635|NCT00885118|300766|P5|NOT COMPLETED|Overall Study||1
130636|NCT00885118|300767|P4|NOT COMPLETED|Overall Study||0
130637|NCT00885118|300768|P3|NOT COMPLETED|Overall Study||1
130638|NCT00885118|300769|P2|NOT COMPLETED|Overall Study||0
130639|NCT00885118|300770|P1|NOT COMPLETED|Overall Study||1
130640|NCT00885118|300766|P5|COMPLETED|Overall Study||18
130641|NCT00885118|300767|P4|COMPLETED|Overall Study||20
130642|NCT00885118|300768|P3|COMPLETED|Overall Study||20
130643|NCT00885118|300769|P2|COMPLETED|Overall Study||19
130644|NCT00885118|300770|P1|COMPLETED|Overall Study||20
130645|NCT00885118|300766|P5|STARTED|Overall Study||19
130646|NCT00885118|300767|P4|STARTED|Overall Study||20
130647|NCT00885118|300768|P3|STARTED|Overall Study||21
130648|NCT00885118|300769|P2|STARTED|Overall Study||19
130649|NCT00885118|300770|P1|STARTED|Overall Study||21
130650|NCT00885105|300909|P2|NOT COMPLETED|Overall Study||10
130651|NCT00885105|300910|P1|NOT COMPLETED|Overall Study||1
130652|NCT00885105|300909|P2|COMPLETED|Overall Study||120
130653|NCT00885105|300910|P1|COMPLETED|Overall Study||111
130654|NCT00885105|300909|P2|STARTED|Overall Study||130
130655|NCT00885105|300910|P1|STARTED|Overall Study||112
130656|NCT00885092|300928|P2|NOT COMPLETED|Period 2, 7 Days||0
130657|NCT00885092|300929|P1|NOT COMPLETED|Period 2, 7 Days||0
130658|NCT00885092|300928|P2|COMPLETED|Period 2, 7 Days||20
130659|NCT00885092|300929|P1|COMPLETED|Period 2, 7 Days||20
130660|NCT00885092|300928|P2|STARTED|Period 2, 7 Days||20
130661|NCT00885092|300929|P1|STARTED|Period 2, 7 Days||20
130662|NCT00885092|300928|P2|NOT COMPLETED|Period 1, 7 Days||0
130663|NCT00885092|300929|P1|NOT COMPLETED|Period 1, 7 Days||0
130664|NCT00885092|300928|P2|COMPLETED|Period 1, 7 Days||20
130665|NCT00885092|300929|P1|COMPLETED|Period 1, 7 Days||20
130666|NCT00885092|300928|P2|STARTED|Period 1, 7 Days||20
130667|NCT00885092|300929|P1|STARTED|Period 1, 7 Days||20
130668|NCT00885079|300941|P2|NOT COMPLETED|Overall Study||4
130669|NCT00885079|300942|P1|NOT COMPLETED|Overall Study||2
130670|NCT00885079|300941|P2|COMPLETED|Overall Study||91
130671|NCT00885079|300942|P1|COMPLETED|Overall Study||91
130672|NCT00885079|300941|P2|STARTED|Overall Study||95
130673|NCT00885079|300942|P1|STARTED|Overall Study||93
130674|NCT00884949|300950|P1|NOT COMPLETED|Continuation Period||0
130675|NCT00884949|300950|P1|COMPLETED|Continuation Period||18
130676|NCT00884949|300950|P1|STARTED|Continuation Period||18
130677|NCT00884949|300950|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
130678|NCT00884949|300950|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
130679|NCT00884949|300950|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
130680|NCT00884949|300950|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
130681|NCT00884949|300950|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
130682|NCT00884949|300950|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
130683|NCT00884949|300950|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
130684|NCT00884949|300950|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
130685|NCT00884949|300950|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
130686|NCT00884910|300967|P1|NOT COMPLETED|Overall Study||1
130687|NCT00884910|300967|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
130688|NCT00884910|300967|P1|STARTED|Overall Study||33
130689|NCT00884832|300974|P2|NOT COMPLETED|Overall Study||1
130690|NCT00884832|300975|P1|NOT COMPLETED|Overall Study||0
130691|NCT00884832|300974|P2|COMPLETED|Overall Study||21
130692|NCT00884832|300975|P1|COMPLETED|Overall Study||22
130693|NCT00884832|300974|P2|STARTED|Overall Study||22
130694|NCT00884832|300975|P1|STARTED|Overall Study||22
130695|NCT00884806|301005|P1|NOT COMPLETED|Overall Study||0
130696|NCT00884806|301005|P1|COMPLETED|Overall Study||110
130697|NCT00884806|301005|P1|STARTED|Overall Study||110
130698|NCT00884793|301010|P1|NOT COMPLETED|Overall Study||1
130699|NCT00884793|301010|P1|COMPLETED|Overall Study||7
130700|NCT00884793|301010|P1|STARTED|Overall Study||8
130701|NCT00884754|301019|P2|NOT COMPLETED|Overall Study||0
130702|NCT00884754|301020|P1|NOT COMPLETED|Overall Study||0
130703|NCT00884754|301019|P2|COMPLETED|Overall Study||30
130704|NCT00884754|301020|P1|COMPLETED|Overall Study||30
130705|NCT00884754|301019|P2|STARTED|Overall Study||30
130706|NCT00884754|301020|P1|STARTED|Overall Study||30
130707|NCT00884741|301029|P4|NOT COMPLETED|Randomization||8
130708|NCT00884741|301030|P3|NOT COMPLETED|Randomization||8
130709|NCT00884741|301031|P2|NOT COMPLETED|Randomization||0
130710|NCT00884741|301032|P1|NOT COMPLETED|Randomization||0
130711|NCT00884741|301029|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
130712|NCT00884741|301030|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
130713|NCT00884741|301031|P2|COMPLETED|Randomization||0
130714|NCT00884741|301032|P1|COMPLETED|Randomization||0
130715|NCT00884741|301029|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
130716|NCT00884741|301030|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
130717|NCT00884741|301031|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
130718|NCT00884741|301032|P1|STARTED|Randomization||0
130719|NCT00884741|301029|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
130720|NCT00884741|301030|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
130721|NCT00884741|301031|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
130722|NCT00884741|301032|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
130723|NCT00884741|301029|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
130724|NCT00884741|301030|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
130725|NCT00884741|301031|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
130726|NCT00884741|301032|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
130727|NCT00884741|301029|P4|STARTED|Step 2 Registration: Tissue Analysis||0
130728|NCT00884741|301030|P3|STARTED|Step 2 Registration: Tissue Analysis||0
130729|NCT00884741|301031|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
130730|NCT00884741|301032|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
130731|NCT00884741|301029|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
130732|NCT00884741|301030|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
130733|NCT00884741|301031|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
130734|NCT00884741|301032|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
130735|NCT00884741|301029|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
130736|NCT00884741|301030|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
130737|NCT00884741|301031|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
130738|NCT00884741|301032|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
130739|NCT00884741|301029|P4|STARTED|Step 1 Registration: Tissue Screening||0
130740|NCT00884741|301030|P3|STARTED|Step 1 Registration: Tissue Screening||0
130741|NCT00884741|301031|P2|STARTED|Step 1 Registration: Tissue Screening||0
130742|NCT00884741|301032|P1|STARTED|Step 1 Registration: Tissue Screening||978
130743|NCT00884585|301045|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
130744|NCT00884585|301046|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
130745|NCT00884585|301045|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
130746|NCT00884585|301046|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
130747|NCT00884585|301045|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
130748|NCT00884585|301046|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
130749|NCT00884585|301045|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
130750|NCT00884585|301046|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
130751|NCT00884585|301045|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
130752|NCT00884585|301046|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
130753|NCT00884585|301045|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
130754|NCT00884585|301046|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
130755|NCT00884585|301045|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
130756|NCT00884585|301046|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
130757|NCT00884585|301045|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
130758|NCT00884585|301046|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
130759|NCT00884585|301045|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
130760|NCT00884585|301046|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
130761|NCT00884390|301060|P2|NOT COMPLETED|Overall Study||8
130762|NCT00884390|301061|P1|NOT COMPLETED|Overall Study||23
130763|NCT00884390|301060|P2|COMPLETED|Overall Study||54
130764|NCT00884390|301061|P1|COMPLETED|Overall Study||123
130765|NCT00884390|301060|P2|STARTED|Overall Study||62
130766|NCT00884390|301061|P1|STARTED|Overall Study||146
130767|NCT00884325|301079|P2|NOT COMPLETED|Overall Study||4
130768|NCT00884325|301080|P1|NOT COMPLETED|Overall Study||3
130769|NCT00884325|301079|P2|COMPLETED|Overall Study||16
130770|NCT00884325|301080|P1|COMPLETED|Overall Study||17
130771|NCT00884325|301079|P2|STARTED|Overall Study||20
130772|NCT00884325|301080|P1|STARTED|Overall Study||20
130773|NCT00884273|301090|P2|NOT COMPLETED|Overall Study||5
130774|NCT00884273|301091|P1|NOT COMPLETED|Overall Study||2
130775|NCT00884273|301090|P2|COMPLETED|Overall Study||93
130776|NCT00884273|301091|P1|COMPLETED|Overall Study||82
130777|NCT00884273|301090|P2|Safety Analysis Set|Overall Study||98
130778|NCT00884273|301091|P1|Safety Analysis Set|Overall Study||84
130779|NCT00884273|301090|P2|Per Protocol (PP) Analysis Set|Overall Study||92
130780|NCT00884273|301091|P1|Per Protocol (PP) Analysis Set|Overall Study||81
130781|NCT00884273|301090|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
130782|NCT00884273|301091|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
130783|NCT00884273|301090|P2|STARTED|Overall Study|ITT population.|98
130784|NCT00884273|301091|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
130785|NCT00884221|301117|P2|NOT COMPLETED|Overall Study||32
130786|NCT00884221|301118|P1|NOT COMPLETED|Overall Study||34
130787|NCT00884221|301117|P2|COMPLETED|Overall Study||343
130788|NCT00884221|301118|P1|COMPLETED|Overall Study||340
130789|NCT00884221|301117|P2|STARTED|Overall Study||375
130790|NCT00884221|301118|P1|STARTED|Overall Study||374
130791|NCT00884117|301154|P1|NOT COMPLETED|Overall Study||249
130792|NCT00884117|301154|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
130793|NCT00884117|301154|P1|STARTED|Overall Study||4561
130794|NCT00884065|301198|P2|NOT COMPLETED|Overall Study||0
130795|NCT00884065|301199|P1|NOT COMPLETED|Overall Study||0
130796|NCT00884065|301198|P2|COMPLETED|Overall Study||25
130797|NCT00884065|301199|P1|COMPLETED|Overall Study||25
130798|NCT00884065|301198|P2|STARTED|Overall Study||25
130799|NCT00884065|301199|P1|STARTED|Overall Study||25
130800|NCT00884039|301217|P2|NOT COMPLETED|Overall Study||1
130801|NCT00884039|301218|P1|NOT COMPLETED|Overall Study||2
130802|NCT00884039|301217|P2|COMPLETED|Overall Study||1
130803|NCT00884039|301218|P1|COMPLETED|Overall Study||3
130804|NCT00884039|301217|P2|STARTED|Overall Study||2
130805|NCT00884039|301218|P1|STARTED|Overall Study||5
130806|NCT00883779|301226|P2|NOT COMPLETED|Off-study Phase||202
130807|NCT00883779|301227|P1|NOT COMPLETED|Off-study Phase||209
130808|NCT00883779|301226|P2|COMPLETED|Off-study Phase||0
130809|NCT00883779|301227|P1|COMPLETED|Off-study Phase||0
130810|NCT00883779|301226|P2|STARTED|Off-study Phase||202
130811|NCT00883779|301227|P1|STARTED|Off-study Phase||209
130812|NCT00883779|301226|P2|NOT COMPLETED|Post-Study Treatment Phase||135
130813|NCT00883779|301227|P1|NOT COMPLETED|Post-Study Treatment Phase||112
130814|NCT00883779|301226|P2|COMPLETED|Post-Study Treatment Phase||0
130815|NCT00883779|301227|P1|COMPLETED|Post-Study Treatment Phase||0
130816|NCT00883779|301226|P2|STARTED|Post-Study Treatment Phase||135
130817|NCT00883779|301227|P1|STARTED|Post-Study Treatment Phase||112
130818|NCT00883779|301226|P2|NOT COMPLETED|Primary Study Treatment Phase||86
130819|NCT00883779|301227|P1|NOT COMPLETED|Primary Study Treatment Phase||105
130820|NCT00883779|301226|P2|COMPLETED|Primary Study Treatment Phase||140
130821|NCT00883779|301227|P1|COMPLETED|Primary Study Treatment Phase||120
130822|NCT00883779|301226|P2|STARTED|Primary Study Treatment Phase||226
130823|NCT00883779|301227|P1|STARTED|Primary Study Treatment Phase||225
130824|NCT00883753|301263|P1|NOT COMPLETED|Overall Study||107
130825|NCT00883753|301263|P1|COMPLETED|Overall Study||827
130826|NCT00883753|301263|P1|STARTED|Overall Study||934
130827|NCT00883740|301303|P2|NOT COMPLETED|Second Intervention||1
130828|NCT00883740|301304|P1|NOT COMPLETED|Second Intervention||1
130829|NCT00883740|301303|P2|COMPLETED|Second Intervention||50
130830|NCT00883740|301304|P1|COMPLETED|Second Intervention||52
130831|NCT00883740|301303|P2|STARTED|Second Intervention||51
130832|NCT00883740|301304|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
130833|NCT00883740|301303|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
130834|NCT00883740|301304|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
130835|NCT00883740|301303|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
130836|NCT00883740|301304|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
130837|NCT00883740|301303|P2|STARTED|Taper and Washout Period (2 Weeks)||51
130838|NCT00883740|301304|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
130839|NCT00883740|301303|P2|NOT COMPLETED|First Intervention||8
130840|NCT00883740|301304|P1|NOT COMPLETED|First Intervention||7
130841|NCT00883740|301303|P2|COMPLETED|First Intervention||51
130842|NCT00883740|301304|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
130843|NCT00883740|301303|P2|STARTED|First Intervention||59
130844|NCT00883740|301304|P1|STARTED|First Intervention||60
130845|NCT00883675|301344|P1|NOT COMPLETED|Overall Study||0
130846|NCT00883675|301344|P1|COMPLETED|Overall Study||133
130847|NCT00883675|301344|P1|STARTED|Overall Study||133
130848|NCT00883558|301348|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
130849|NCT00883558|301349|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
130850|NCT00883558|301350|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
130851|NCT00883558|301348|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
130852|NCT00883558|301349|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
130853|NCT00883558|301350|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
130854|NCT00883558|301348|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
130855|NCT00883558|301349|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
130856|NCT00883558|301350|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
130857|NCT00883558|301348|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
130858|NCT00883558|301349|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
130859|NCT00883558|301350|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
130860|NCT00883558|301348|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
130861|NCT00883558|301349|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
130862|NCT00883558|301350|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
130863|NCT00883558|301348|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
130864|NCT00883558|301349|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
130865|NCT00883558|301350|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
130866|NCT00883558|301348|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
130867|NCT00883558|301349|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
130868|NCT00883558|301350|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
130869|NCT00883558|301348|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
130870|NCT00883558|301349|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
130871|NCT00883558|301350|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
130872|NCT00883558|301348|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
130873|NCT00883558|301349|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
130874|NCT00883558|301350|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
130875|NCT00883558|301348|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
130876|NCT00883558|301349|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
130877|NCT00883558|301350|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
130878|NCT00883558|301348|P3|STARTED|Titration Period (Weeks 0 to 4)||0
130879|NCT00883558|301349|P2|STARTED|Titration Period (Weeks 0 to 4)||0
130880|NCT00883558|301350|P1|STARTED|Titration Period (Weeks 0 to 4)||48
130881|NCT00883493|301362|P2|NOT COMPLETED|Overall Study||50
130882|NCT00883493|301363|P1|NOT COMPLETED|Overall Study||46
130883|NCT00883493|301362|P2|COMPLETED|Overall Study||159
130884|NCT00883493|301363|P1|COMPLETED|Overall Study||166
130885|NCT00883493|301362|P2|Per Protocol Analysis Population|Overall Study||155
130886|NCT00883493|301363|P1|Per Protocol Analysis Population|Overall Study||162
130887|NCT00883493|301362|P2|Intention To Treat Analysis Population|Overall Study||195
130888|NCT00883493|301363|P1|Intention To Treat Analysis Population|Overall Study||204
130889|NCT00883493|301362|P2|STARTED|Overall Study||209
130890|NCT00883493|301363|P1|STARTED|Overall Study||212
130891|NCT00883389|301387|P1|NOT COMPLETED|Overall Study||0
130892|NCT00883389|301387|P1|COMPLETED|Overall Study||26
130893|NCT00883389|301387|P1|STARTED|Overall Study||26
130894|NCT00883337|301394|P3|NOT COMPLETED|Extension Treatment Period||19
130895|NCT00883337|301395|P2|NOT COMPLETED|Extension Treatment Period||23
130896|NCT00883337|301396|P1|NOT COMPLETED|Extension Treatment Period||28
130897|NCT00883337|301394|P3|COMPLETED|Extension Treatment Period||40
130898|NCT00883337|301395|P2|COMPLETED|Extension Treatment Period||66
130899|NCT00883337|301396|P1|COMPLETED|Extension Treatment Period||61
130900|NCT00883337|301394|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
130901|NCT00883337|301395|P2|STARTED|Extension Treatment Period||89
130902|NCT00883337|301396|P1|STARTED|Extension Treatment Period||89
130903|NCT00883337|301394|P3|NOT COMPLETED|Core Treatment Period||33
130904|NCT00883337|301395|P2|NOT COMPLETED|Core Treatment Period||22
130905|NCT00883337|301396|P1|NOT COMPLETED|Core Treatment Period||20
130906|NCT00883337|301394|P3|COMPLETED|Core Treatment Period||71
130907|NCT00883337|301395|P2|COMPLETED|Core Treatment Period||89
130908|NCT00883337|301396|P1|COMPLETED|Core Treatment Period||89
130909|NCT00883337|301394|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
130910|NCT00883337|301395|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
130911|NCT00883337|301396|P1|Treated|Core Treatment Period||109
130912|NCT00883337|301394|P3|STARTED|Core Treatment Period||104
130913|NCT00883337|301395|P2|STARTED|Core Treatment Period||111
130914|NCT00883337|301396|P1|STARTED|Core Treatment Period||109
130915|NCT00883246|301428|P1|NOT COMPLETED|Overall Study||173
130916|NCT00883246|301428|P1|COMPLETED|Overall Study||626
130917|NCT00883246|301428|P1|STARTED|Overall Study||799
130918|NCT00883233|301450|P4|NOT COMPLETED|Overall Study||5
130919|NCT00883233|301451|P3|NOT COMPLETED|Overall Study||4
130920|NCT00883233|301452|P2|NOT COMPLETED|Overall Study||4
130921|NCT00883233|301453|P1|NOT COMPLETED|Overall Study||5
130922|NCT00883233|301450|P4|COMPLETED|Overall Study||25
130923|NCT00883233|301451|P3|COMPLETED|Overall Study||25
130924|NCT00883233|301452|P2|COMPLETED|Overall Study||28
130925|NCT00883233|301453|P1|COMPLETED|Overall Study||27
130926|NCT00883233|301450|P4|STARTED|Overall Study||30
130927|NCT00883233|301451|P3|STARTED|Overall Study||29
130928|NCT00883233|301452|P2|STARTED|Overall Study||32
130929|NCT00883233|301453|P1|STARTED|Overall Study||32
130930|NCT00883181|301463|P1|NOT COMPLETED|Overall Study||278
130931|NCT00883181|301463|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
130932|NCT00883181|301463|P1|STARTED|Overall Study|Full analysis set|1347
130933|NCT00883168|301676|P4|NOT COMPLETED|Overall Study||15
130934|NCT00883168|301677|P3|NOT COMPLETED|Overall Study||19
130935|NCT00883168|301678|P2|NOT COMPLETED|Overall Study||15
130936|NCT00883168|301679|P1|NOT COMPLETED|Overall Study||14
130937|NCT00883168|301676|P4|COMPLETED|Overall Study||433
130938|NCT00883168|301677|P3|COMPLETED|Overall Study||431
130939|NCT00883168|301678|P2|COMPLETED|Overall Study||430
130940|NCT00883168|301679|P1|COMPLETED|Overall Study||434
130941|NCT00883168|301676|P4|STARTED|Overall Study||448
130942|NCT00883168|301677|P3|STARTED|Overall Study||450
130943|NCT00883168|301678|P2|STARTED|Overall Study||445
130944|NCT00883168|301679|P1|STARTED|Overall Study||448
130945|NCT00883129|301699|P2|NOT COMPLETED|Overall Study||36
130946|NCT00883129|301700|P1|NOT COMPLETED|Overall Study||20
130947|NCT00883129|301699|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
130948|NCT00883129|301700|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
130949|NCT00883129|301699|P2|STARTED|Overall Study||73
130950|NCT00883129|301700|P1|STARTED|Overall Study||69
130951|NCT00883116|301724|P2|NOT COMPLETED|Overall Study||219
130952|NCT00883116|301725|P1|NOT COMPLETED|Overall Study||209
130953|NCT00883116|301724|P2|COMPLETED|Overall Study||29
130954|NCT00883116|301725|P1|COMPLETED|Overall Study||39
130955|NCT00883116|301724|P2|Received Treatment|Overall Study||239
130956|NCT00883116|301725|P1|Received Treatment|Overall Study||248
130957|NCT00883116|301724|P2|STARTED|Overall Study||248
130958|NCT00883116|301725|P1|STARTED|Overall Study||248
130959|NCT00883103|301740|P2|NOT COMPLETED|Overall Study||0
130960|NCT00883103|301741|P1|NOT COMPLETED|Overall Study||0
130961|NCT00883103|301740|P2|COMPLETED|Overall Study||68
130962|NCT00883103|301741|P1|COMPLETED|Overall Study||69
130963|NCT00883103|301740|P2|STARTED|Overall Study||68
130964|NCT00883103|301741|P1|STARTED|Overall Study||69
130965|NCT00883090|301747|P1|NOT COMPLETED|Overall Study||2
130966|NCT00883090|301747|P1|COMPLETED|Overall Study||13
130967|NCT00883090|301747|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
130968|NCT00882921|301762|P1|NOT COMPLETED|Overall Study||11
130969|NCT00882921|301762|P1|COMPLETED|Overall Study||15
130970|NCT00882921|301762|P1|STARTED|Overall Study||26
130971|NCT00882908|301772|P5|NOT COMPLETED|Overall Study||6
130972|NCT00882908|301773|P4|NOT COMPLETED|Overall Study||7
130973|NCT00882908|301774|P3|NOT COMPLETED|Overall Study||7
130974|NCT00882908|301775|P2|NOT COMPLETED|Overall Study||6
130975|NCT00882908|301776|P1|NOT COMPLETED|Overall Study||3
130976|NCT00882908|301772|P5|COMPLETED|Overall Study||71
130977|NCT00882908|301773|P4|COMPLETED|Overall Study||72
130978|NCT00882908|301774|P3|COMPLETED|Overall Study||70
130979|NCT00882908|301775|P2|COMPLETED|Overall Study||69
130980|NCT00882908|301776|P1|COMPLETED|Overall Study||75
130981|NCT00882908|301772|P5|STARTED|Overall Study||77
130982|NCT00882908|301773|P4|STARTED|Overall Study||79
130983|NCT00882908|301774|P3|STARTED|Overall Study||77
130984|NCT00882908|301775|P2|STARTED|Overall Study||75
130985|NCT00882908|301776|P1|STARTED|Overall Study||78
130986|NCT00882778|301851|P1|NOT COMPLETED|Overall Study||0
130987|NCT00882778|301851|P1|COMPLETED|Overall Study||86
130988|NCT00882778|301851|P1|STARTED|Overall Study||86
130989|NCT00882713|301882|P1|NOT COMPLETED|Overall Study||22
130990|NCT00882713|301882|P1|COMPLETED|Overall Study||172
130991|NCT00882713|301882|P1|STARTED|Overall Study||194
130992|NCT00882557|301906|P2|NOT COMPLETED|Overall Study||1
130993|NCT00882557|301907|P1|NOT COMPLETED|Overall Study||2
130994|NCT00882557|301906|P2|COMPLETED|Overall Study||7
130995|NCT00882557|301907|P1|COMPLETED|Overall Study||6
130996|NCT00882557|301906|P2|Completed Dose 2|Overall Study||7
130997|NCT00882557|301907|P1|Completed Dose 2|Overall Study||6
130998|NCT00882557|301906|P2|Completed Dose 1|Overall Study||7
130999|NCT00882557|301907|P1|Completed Dose 1|Overall Study||8
131000|NCT00882557|301906|P2|STARTED|Overall Study||8
131001|NCT00882557|301907|P1|STARTED|Overall Study||8
131002|NCT00882518|301927|P2|NOT COMPLETED|Overall Study||44
131003|NCT00882518|301928|P1|NOT COMPLETED|Overall Study||38
131004|NCT00882518|301927|P2|COMPLETED|Overall Study||148
131005|NCT00882518|301928|P1|COMPLETED|Overall Study||158
131006|NCT00882518|301927|P2|STARTED|Overall Study||192
131007|NCT00882518|301928|P1|STARTED|Overall Study||196
131008|NCT00882440|301957|P7|NOT COMPLETED|Overall Study||4
131009|NCT00882440|301958|P6|NOT COMPLETED|Overall Study||7
131010|NCT00882440|301959|P5|NOT COMPLETED|Overall Study||10
131011|NCT00882440|301960|P4|NOT COMPLETED|Overall Study||3
131012|NCT00882440|301961|P3|NOT COMPLETED|Overall Study||7
131013|NCT00882440|301962|P2|NOT COMPLETED|Overall Study||8
131014|NCT00882440|301963|P1|NOT COMPLETED|Overall Study||11
131015|NCT00882440|301957|P7|COMPLETED|Overall Study||79
131016|NCT00882440|301958|P6|COMPLETED|Overall Study||77
131017|NCT00882440|301959|P5|COMPLETED|Overall Study||80
131018|NCT00882440|301960|P4|COMPLETED|Overall Study||76
131019|NCT00882440|301961|P3|COMPLETED|Overall Study||75
131020|NCT00882440|301962|P2|COMPLETED|Overall Study||72
131021|NCT00882440|301963|P1|COMPLETED|Overall Study||67
131022|NCT00882440|301957|P7|STARTED|Overall Study||83
131023|NCT00882440|301958|P6|STARTED|Overall Study||84
131024|NCT00882440|301959|P5|STARTED|Overall Study||90
131025|NCT00882440|301960|P4|STARTED|Overall Study||79
131026|NCT00882440|301961|P3|STARTED|Overall Study||82
131027|NCT00882440|301962|P2|STARTED|Overall Study||80
131028|NCT00882440|301963|P1|STARTED|Overall Study||78
131029|NCT00882362|301988|P2|NOT COMPLETED|Overall Study||23
131030|NCT00882362|301989|P1|NOT COMPLETED|Overall Study||49
131031|NCT00882362|301988|P2|COMPLETED|Overall Study||10
131032|NCT00882362|301989|P1|COMPLETED|Overall Study||73
131033|NCT00882362|301988|P2|STARTED|Overall Study||33
131034|NCT00882362|301989|P1|STARTED|Overall Study||122
131035|NCT00882310|301995|P1|NOT COMPLETED|Overall Study||22
131036|NCT00882310|301995|P1|COMPLETED|Overall Study||15
131037|NCT00882310|301995|P1|STARTED|Overall Study||37
131038|NCT00882206|302001|P1|NOT COMPLETED|Overall Study||0
131039|NCT00882206|302001|P1|COMPLETED|Overall Study||13
131040|NCT00882206|302001|P1|STARTED|Overall Study||13
131041|NCT00882102|302008|P1|NOT COMPLETED|Overall Study||0
131042|NCT00882102|302008|P1|COMPLETED|Overall Study||40
131043|NCT00882102|302008|P1|STARTED|Overall Study||40
131044|NCT00881959|302014|P2|NOT COMPLETED|Overall Study||4
131045|NCT00881959|302015|P1|NOT COMPLETED|Overall Study||2
131046|NCT00881959|302014|P2|COMPLETED|Overall Study||38
131047|NCT00881959|302015|P1|COMPLETED|Overall Study||36
131048|NCT00881959|302014|P2|STARTED|Overall Study||42
131049|NCT00881959|302015|P1|STARTED|Overall Study||38
131050|NCT00881894|302023|P2|NOT COMPLETED|Overall Study||3
131051|NCT00881894|302024|P1|NOT COMPLETED|Overall Study||1
131052|NCT00881894|302023|P2|COMPLETED|Overall Study||23
131053|NCT00881894|302024|P1|COMPLETED|Overall Study||25
131054|NCT00881894|302023|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
131055|NCT00881894|302024|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
131056|NCT00881894|302023|P2|STARTED|Overall Study||26
131057|NCT00881894|302024|P1|STARTED|Overall Study||26
131058|NCT00881868|302056|P2|NOT COMPLETED|Overall Study||2
131059|NCT00881868|302057|P1|NOT COMPLETED|Overall Study||8
131060|NCT00881868|302056|P2|COMPLETED|Overall Study||38
131061|NCT00881868|302057|P1|COMPLETED|Overall Study||33
131062|NCT00881868|302056|P2|STARTED|Overall Study||40
131063|NCT00881868|302057|P1|STARTED|Overall Study||41
131064|NCT00881712|302072|P3|NOT COMPLETED|Overall Study||0
131065|NCT00881712|302073|P2|NOT COMPLETED|Overall Study||0
131066|NCT00881712|302074|P1|NOT COMPLETED|Overall Study||2
131067|NCT00881712|302072|P3|COMPLETED|Overall Study||0
131068|NCT00881712|302073|P2|COMPLETED|Overall Study||0
131069|NCT00881712|302074|P1|COMPLETED|Overall Study||13
131070|NCT00881712|302072|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
131071|NCT00881712|302073|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
131072|NCT00881712|302074|P1|STARTED|Overall Study||15
131073|NCT00881647|302096|P2|NOT COMPLETED|Overall Study||1
131074|NCT00881647|302097|P1|NOT COMPLETED|Overall Study||2
131075|NCT00881647|302096|P2|COMPLETED|Overall Study||15
131076|NCT00881647|302097|P1|COMPLETED|Overall Study||27
131077|NCT00881647|302096|P2|STARTED|Overall Study||16
131078|NCT00881647|302097|P1|STARTED|Overall Study||29
131079|NCT00881608|302112|P1|NOT COMPLETED|Overall Study||11
131080|NCT00881608|302112|P1|COMPLETED|Overall Study||0
131081|NCT00881608|302112|P1|STARTED|Overall Study||11
131082|NCT00881530|302135|P6|NOT COMPLETED|Overall Study||5
131083|NCT00881530|302136|P5|NOT COMPLETED|Overall Study||14
131084|NCT00881530|302137|P4|NOT COMPLETED|Overall Study||9
131085|NCT00881530|302138|P3|NOT COMPLETED|Overall Study||5
131086|NCT00881530|302139|P2|NOT COMPLETED|Overall Study||5
131087|NCT00881530|302140|P1|NOT COMPLETED|Overall Study||14
131088|NCT00881530|302135|P6|COMPLETED|Overall Study||51
131089|NCT00881530|302136|P5|COMPLETED|Overall Study||152
131090|NCT00881530|302137|P4|COMPLETED|Overall Study||157
131091|NCT00881530|302138|P3|COMPLETED|Overall Study||51
131092|NCT00881530|302139|P2|COMPLETED|Overall Study||104
131093|NCT00881530|302140|P1|COMPLETED|Overall Study||92
131094|NCT00881530|302135|P6|STARTED|Overall Study||56
131095|NCT00881530|302136|P5|STARTED|Overall Study||166
131096|NCT00881530|302137|P4|STARTED|Overall Study||166
131097|NCT00881530|302138|P3|STARTED|Overall Study||56
131098|NCT00881530|302139|P2|STARTED|Overall Study||109
131099|NCT00881530|302140|P1|STARTED|Overall Study||106
131100|NCT00881504|302196|P1|NOT COMPLETED|Overall Study||1
131101|NCT00881504|302196|P1|COMPLETED|Overall Study||8
131102|NCT00881504|302196|P1|STARTED|Overall Study||9
131103|NCT00881465|302203|P2|NOT COMPLETED|Overall Study||0
131104|NCT00881465|302204|P1|NOT COMPLETED|Overall Study||2
131105|NCT00881465|302203|P2|COMPLETED|Overall Study||15
131106|NCT00881465|302204|P1|COMPLETED|Overall Study||14
131107|NCT00881465|302203|P2|STARTED|Overall Study||15
131108|NCT00881465|302204|P1|STARTED|Overall Study||16
131109|NCT00881335|302216|P2|NOT COMPLETED|Overall Study||2
131110|NCT00881335|302217|P1|NOT COMPLETED|Overall Study||3
131111|NCT00881335|302216|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
131112|NCT00881335|302217|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
131113|NCT00881335|302216|P2|STARTED|Overall Study||30
131114|NCT00881335|302217|P1|STARTED|Overall Study||30
131115|NCT00881205|302237|P2|NOT COMPLETED|Overall Study||7
131116|NCT00881205|302238|P1|NOT COMPLETED|Overall Study||11
131117|NCT00881205|302237|P2|COMPLETED|Overall Study||34
131118|NCT00881205|302238|P1|COMPLETED|Overall Study||34
131119|NCT00881205|302237|P2|STARTED|Overall Study||41
131120|NCT00881205|302238|P1|STARTED|Overall Study||45
131121|NCT00880919|302248|P3|NOT COMPLETED|Overall Study||6
131122|NCT00880919|302249|P2|NOT COMPLETED|Overall Study||14
131123|NCT00880919|302250|P1|NOT COMPLETED|Overall Study||15
131124|NCT00880919|302248|P3|COMPLETED|Overall Study||23
131125|NCT00880919|302249|P2|COMPLETED|Overall Study||19
131126|NCT00880919|302250|P1|COMPLETED|Overall Study||18
131127|NCT00880919|302248|P3|STARTED|Overall Study||29
131128|NCT00880919|302249|P2|STARTED|Overall Study||33
131129|NCT00880919|302250|P1|STARTED|Overall Study||33
131130|NCT00880906|302284|P2|NOT COMPLETED|Overall Study||7
131131|NCT00880906|302285|P1|NOT COMPLETED|Overall Study||12
131132|NCT00880906|302284|P2|COMPLETED|Overall Study||14
131133|NCT00880906|302285|P1|COMPLETED|Overall Study||17
131134|NCT00880906|302284|P2|STARTED|Overall Study||21
131135|NCT00880906|302285|P1|STARTED|Overall Study||29
131136|NCT00880763|302295|P4|NOT COMPLETED|Extension Period (Part 2)||3
131137|NCT00880763|302296|P3|NOT COMPLETED|Extension Period (Part 2)||3
131138|NCT00880763|302297|P2|NOT COMPLETED|Extension Period (Part 2)||3
131139|NCT00880763|302298|P1|NOT COMPLETED|Extension Period (Part 2)||0
131140|NCT00880763|302295|P4|COMPLETED|Extension Period (Part 2)||19
131141|NCT00880763|302296|P3|COMPLETED|Extension Period (Part 2)||20
131142|NCT00880763|302297|P2|COMPLETED|Extension Period (Part 2)||19
131143|NCT00880763|302298|P1|COMPLETED|Extension Period (Part 2)||23
131144|NCT00880763|302295|P4|STARTED|Extension Period (Part 2)||22
131145|NCT00880763|302296|P3|STARTED|Extension Period (Part 2)||23
131146|NCT00880763|302297|P2|STARTED|Extension Period (Part 2)||22
131147|NCT00880763|302298|P1|STARTED|Extension Period (Part 2)||23
131148|NCT00880763|302295|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
131149|NCT00880763|302296|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
131150|NCT00880763|302297|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
131151|NCT00880763|302298|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
131152|NCT00880763|302295|P4|COMPLETED|Initial Treatment Period (Part 1)||22
131153|NCT00880763|302296|P3|COMPLETED|Initial Treatment Period (Part 1)||23
131154|NCT00880763|302297|P2|COMPLETED|Initial Treatment Period (Part 1)||22
131155|NCT00880763|302298|P1|COMPLETED|Initial Treatment Period (Part 1)||23
131156|NCT00880763|302295|P4|STARTED|Initial Treatment Period (Part 1)||22
131157|NCT00880763|302296|P3|STARTED|Initial Treatment Period (Part 1)||23
131158|NCT00880763|302297|P2|STARTED|Initial Treatment Period (Part 1)||22
131159|NCT00880763|302298|P1|STARTED|Initial Treatment Period (Part 1)||23
131160|NCT00880750|302330|P2|NOT COMPLETED|Second Intervention||2
131161|NCT00880750|302331|P1|NOT COMPLETED|Second Intervention||4
131162|NCT00880750|302330|P2|COMPLETED|Second Intervention||30
131163|NCT00880750|302331|P1|COMPLETED|Second Intervention||26
131164|NCT00880750|302330|P2|STARTED|Second Intervention||32
131165|NCT00880750|302331|P1|STARTED|Second Intervention||30
131166|NCT00880750|302330|P2|NOT COMPLETED|Washout Period||0
131167|NCT00880750|302331|P1|NOT COMPLETED|Washout Period||0
131168|NCT00880750|302330|P2|COMPLETED|Washout Period||32
131169|NCT00880750|302331|P1|COMPLETED|Washout Period||30
131170|NCT00880750|302330|P2|STARTED|Washout Period||32
131171|NCT00880750|302331|P1|STARTED|Washout Period||30
131172|NCT00880750|302330|P2|NOT COMPLETED|First Intervention||1
131173|NCT00880750|302331|P1|NOT COMPLETED|First Intervention||9
131174|NCT00880750|302330|P2|COMPLETED|First Intervention||32
131175|NCT00880750|302331|P1|COMPLETED|First Intervention||30
131176|NCT00880750|302330|P2|STARTED|First Intervention||33
131177|NCT00880750|302331|P1|STARTED|First Intervention||39
131178|NCT00880698|302349|P4|NOT COMPLETED|Overall Study||3
131179|NCT00880698|302350|P3|NOT COMPLETED|Overall Study||1
131180|NCT00880698|302351|P2|NOT COMPLETED|Overall Study||3
131181|NCT00880698|302352|P1|NOT COMPLETED|Overall Study||1
131182|NCT00880698|302349|P4|COMPLETED|Overall Study||36
131183|NCT00880698|302350|P3|COMPLETED|Overall Study||36
131184|NCT00880698|302351|P2|COMPLETED|Overall Study||61
131185|NCT00880698|302352|P1|COMPLETED|Overall Study||61
131186|NCT00880698|302349|P4|STARTED|Overall Study||39
131187|NCT00880698|302350|P3|STARTED|Overall Study||37
131188|NCT00880698|302351|P2|STARTED|Overall Study||64
131189|NCT00880698|302352|P1|STARTED|Overall Study||62
131190|NCT00880685|302378|P1|NOT COMPLETED|Memantine 30mg||0
131191|NCT00880685|302378|P1|COMPLETED|Memantine 30mg||9
131192|NCT00880685|302378|P1|STARTED|Memantine 30mg||9
131193|NCT00880685|302378|P1|NOT COMPLETED|Memantine 20mg||1
131194|NCT00880685|302378|P1|COMPLETED|Memantine 20mg||9
131195|NCT00880685|302378|P1|STARTED|Memantine 20mg||10
131196|NCT00880685|302378|P1|NOT COMPLETED|Memantine 10mg||2
131197|NCT00880685|302378|P1|COMPLETED|Memantine 10mg||10
131198|NCT00880685|302378|P1|STARTED|Memantine 10mg||12
131199|NCT00880620|302390|P4|NOT COMPLETED|Overall Study||24
131200|NCT00880620|302391|P3|NOT COMPLETED|Overall Study||21
131201|NCT00880620|302392|P2|NOT COMPLETED|Overall Study||15
131202|NCT00880620|302393|P1|NOT COMPLETED|Overall Study||21
131203|NCT00880620|302390|P4|COMPLETED|Overall Study||74
131204|NCT00880620|302391|P3|COMPLETED|Overall Study||83
131205|NCT00880620|302392|P2|COMPLETED|Overall Study||72
131206|NCT00880620|302393|P1|COMPLETED|Overall Study||71
131207|NCT00880620|302390|P4|STARTED|Overall Study||98
131208|NCT00880620|302391|P3|STARTED|Overall Study||104
131209|NCT00880620|302392|P2|STARTED|Overall Study||87
131210|NCT00880620|302393|P1|STARTED|Overall Study||92
131211|NCT00880568|302412|P9|NOT COMPLETED|Overall Study||3
131212|NCT00880568|302413|P8|NOT COMPLETED|Overall Study||2
131213|NCT00880568|302414|P7|NOT COMPLETED|Overall Study||6
131214|NCT00880568|302415|P6|NOT COMPLETED|Overall Study||3
131215|NCT00880568|302416|P5|NOT COMPLETED|Overall Study||3
131216|NCT00880568|302417|P4|NOT COMPLETED|Overall Study||1
131217|NCT00880568|302418|P3|NOT COMPLETED|Overall Study||3
131218|NCT00880568|302419|P2|NOT COMPLETED|Overall Study||3
131219|NCT00880568|302420|P1|NOT COMPLETED|Overall Study||3
131220|NCT00880568|302412|P9|COMPLETED|Overall Study||0
131221|NCT00880568|302413|P8|COMPLETED|Overall Study||0
131222|NCT00880568|302414|P7|COMPLETED|Overall Study||0
131223|NCT00880568|302415|P6|COMPLETED|Overall Study||0
131224|NCT00880568|302416|P5|COMPLETED|Overall Study||0
131225|NCT00880568|302417|P4|COMPLETED|Overall Study||0
131226|NCT00880568|302418|P3|COMPLETED|Overall Study||0
131227|NCT00880568|302419|P2|COMPLETED|Overall Study||0
131228|NCT00880568|302420|P1|COMPLETED|Overall Study||0
131229|NCT00880568|302412|P9|STARTED|Overall Study||3
131230|NCT00880568|302413|P8|STARTED|Overall Study||2
131231|NCT00880568|302414|P7|STARTED|Overall Study||6
131232|NCT00880568|302415|P6|STARTED|Overall Study||3
131233|NCT00880568|302416|P5|STARTED|Overall Study||3
131234|NCT00880568|302417|P4|STARTED|Overall Study||1
131235|NCT00880568|302418|P3|STARTED|Overall Study||3
131236|NCT00880568|302419|P2|STARTED|Overall Study||3
131237|NCT00880568|302420|P1|STARTED|Overall Study||3
131238|NCT00880555|302466|P6|NOT COMPLETED|Overall Study||1
131239|NCT00880555|302467|P5|NOT COMPLETED|Overall Study||1
131240|NCT00880555|302468|P4|NOT COMPLETED|Overall Study||2
131241|NCT00880555|302469|P3|NOT COMPLETED|Overall Study||5
131242|NCT00880555|302470|P2|NOT COMPLETED|Overall Study||17
131243|NCT00880555|302471|P1|NOT COMPLETED|Overall Study||10
131244|NCT00880555|302466|P6|COMPLETED|Overall Study||0
131245|NCT00880555|302467|P5|COMPLETED|Overall Study||0
131246|NCT00880555|302468|P4|COMPLETED|Overall Study||0
131247|NCT00880555|302469|P3|COMPLETED|Overall Study||6
131248|NCT00880555|302470|P2|COMPLETED|Overall Study||23
131249|NCT00880555|302471|P1|COMPLETED|Overall Study||13
131250|NCT00880555|302466|P6|STARTED|Overall Study||1
131251|NCT00880555|302467|P5|STARTED|Overall Study||1
131252|NCT00880555|302468|P4|STARTED|Overall Study||2
131253|NCT00880555|302469|P3|STARTED|Overall Study||11
131254|NCT00880555|302470|P2|STARTED|Overall Study||40
131255|NCT00880555|302471|P1|STARTED|Overall Study||23
131256|NCT00880542|302482|P1|NOT COMPLETED|Follow-up Period||0
131257|NCT00880542|302482|P1|COMPLETED|Follow-up Period||7
131258|NCT00880542|302482|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
131259|NCT00880542|302482|P1|NOT COMPLETED|Continued Treatment Period||0
131260|NCT00880542|302482|P1|COMPLETED|Continued Treatment Period||0
131261|NCT00880542|302482|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
131262|NCT00880542|302482|P1|NOT COMPLETED|Post Surgical Evaluation||0
131263|NCT00880542|302482|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
131264|NCT00880542|302482|P1|STARTED|Post Surgical Evaluation||3
131265|NCT00880542|302482|P1|NOT COMPLETED|REP: Surgical Resection||1
131266|NCT00880542|302482|P1|COMPLETED|REP: Surgical Resection||3
131267|NCT00880542|302482|P1|STARTED|REP: Surgical Resection||4
131268|NCT00880542|302482|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
131269|NCT00880542|302482|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
131270|NCT00880542|302482|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
131271|NCT00880542|302482|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
131272|NCT00880542|302482|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
131273|NCT00880542|302482|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
131274|NCT00880425|302487|P2|NOT COMPLETED|Overall Study||0
131275|NCT00880425|302488|P1|NOT COMPLETED|Overall Study||0
131276|NCT00880425|302487|P2|COMPLETED|Overall Study||27
131277|NCT00880425|302488|P1|COMPLETED|Overall Study||18
131278|NCT00880425|302487|P2|STARTED|Overall Study||27
131279|NCT00880425|302488|P1|STARTED|Overall Study||18
131280|NCT00880360|302496|P1|NOT COMPLETED|Overall Study||0
131281|NCT00880360|302496|P1|COMPLETED|Overall Study||19
131282|NCT00880360|302496|P1|STARTED|Overall Study||19
131283|NCT00880334|302502|P2|NOT COMPLETED|Overall Study||3
131284|NCT00880334|302503|P1|NOT COMPLETED|Overall Study||4
131285|NCT00880334|302502|P2|COMPLETED|Overall Study||72
131286|NCT00880334|302503|P1|COMPLETED|Overall Study||70
131287|NCT00880334|302502|P2|Eligible & Treated|Overall Study||72
131288|NCT00880334|302503|P1|Eligible & Treated|Overall Study||70
131289|NCT00880334|302502|P2|STARTED|Overall Study||75
131290|NCT00880334|302503|P1|STARTED|Overall Study||74
131291|NCT00880269|302519|P2|NOT COMPLETED|Overall Study||27
131292|NCT00880269|302520|P1|NOT COMPLETED|Overall Study||32
131293|NCT00880269|302519|P2|COMPLETED|Overall Study||0
131294|NCT00880269|302520|P1|COMPLETED|Overall Study||0
131295|NCT00880269|302519|P2|Discontinued Treatment|Overall Study||27
131296|NCT00880269|302520|P1|Discontinued Treatment|Overall Study||32
131297|NCT00880269|302519|P2|STARTED|Overall Study||27
131298|NCT00880269|302520|P1|STARTED|Overall Study||32
131299|NCT00880256|302536|P1|NOT COMPLETED|Overall Study||28
131300|NCT00880256|302536|P1|COMPLETED|Overall Study||65
131301|NCT00880256|302536|P1|STARTED|Overall Study||93
131302|NCT00880230|302541|P1|NOT COMPLETED|Overall Study||7
131303|NCT00880230|302541|P1|COMPLETED|Overall Study||134
131304|NCT00880230|302541|P1|STARTED|Overall Study||141
131305|NCT00880191|302563|P2|NOT COMPLETED|Overall Study||8
131306|NCT00880191|302564|P1|NOT COMPLETED|Overall Study||13
131307|NCT00880191|302563|P2|COMPLETED|Overall Study||198
131308|NCT00880191|302564|P1|COMPLETED|Overall Study||194
131309|NCT00880191|302563|P2|Available for Primary Endpoint Analysis|Overall Study||206
131310|NCT00880191|302564|P1|Available for Primary Endpoint Analysis|Overall Study||207
131311|NCT00880191|302563|P2|STARTED|Overall Study||206
131312|NCT00880191|302564|P1|STARTED|Overall Study||207
131313|NCT00880165|302584|P2|NOT COMPLETED|Overall Study||50
131314|NCT00880165|302585|P1|NOT COMPLETED|Overall Study||62
131315|NCT00880165|302584|P2|COMPLETED|Overall Study||98
131316|NCT00880165|302585|P1|COMPLETED|Overall Study||86
131317|NCT00880165|302584|P2|STARTED|Overall Study||148
131318|NCT00880165|302585|P1|STARTED|Overall Study||148
131319|NCT00880100|302595|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
131320|NCT00880100|302595|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
131321|NCT00880100|302595|P1|STARTED|Treatment Phase With Ultrase® MT12||48
131322|NCT00880100|302595|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
131323|NCT00880100|302595|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
131324|NCT00880100|302595|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
131325|NCT00880022|302608|P2|NOT COMPLETED|Overall Study||3
131326|NCT00880022|302609|P1|NOT COMPLETED|Overall Study||2
131327|NCT00880022|302608|P2|COMPLETED|Overall Study||21
131328|NCT00880022|302609|P1|COMPLETED|Overall Study||21
131329|NCT00880022|302608|P2|STARTED|Overall Study||24
131330|NCT00880022|302609|P1|STARTED|Overall Study||23
131331|NCT00880009|302615|P1|NOT COMPLETED|Overall Study||16
131332|NCT00880009|302615|P1|COMPLETED|Overall Study||0
131333|NCT00880009|302615|P1|STARTED|Overall Study||16
131334|NCT00879996|302639|P2|NOT COMPLETED|Overall Study||13
131335|NCT00879996|302640|P1|NOT COMPLETED|Overall Study||15
131336|NCT00879996|302639|P2|COMPLETED|Overall Study||13
131337|NCT00879996|302640|P1|COMPLETED|Overall Study||13
131338|NCT00879996|302639|P2|STARTED|Overall Study||26
131339|NCT00879996|302640|P1|STARTED|Overall Study||28
131340|NCT00879970|302655|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
131341|NCT00879970|302656|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
131342|NCT00879970|302657|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
131343|NCT00879970|302658|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
131344|NCT00879970|302659|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
131345|NCT00879970|302655|P5|COMPLETED|Period 2 Vitamin D Randomization||600
131346|NCT00879970|302656|P4|COMPLETED|Period 2 Vitamin D Randomization||610
131347|NCT00879970|302657|P3|COMPLETED|Period 2 Vitamin D Randomization||0
131348|NCT00879970|302658|P2|COMPLETED|Period 2 Vitamin D Randomization||0
131349|NCT00879970|302659|P1|COMPLETED|Period 2 Vitamin D Randomization||0
131350|NCT00879970|302655|P5|STARTED|Period 2 Vitamin D Randomization||607
131351|NCT00879970|302656|P4|STARTED|Period 2 Vitamin D Randomization||614
131352|NCT00879970|302657|P3|STARTED|Period 2 Vitamin D Randomization||0
131353|NCT00879970|302658|P2|STARTED|Period 2 Vitamin D Randomization||0
131354|NCT00879970|302659|P1|STARTED|Period 2 Vitamin D Randomization||0
131355|NCT00879970|302655|P5|NOT COMPLETED|Period 1 TZD Randomization||0
131356|NCT00879970|302656|P4|NOT COMPLETED|Period 1 TZD Randomization||0
131357|NCT00879970|302657|P3|NOT COMPLETED|Period 1 TZD Randomization||6
131358|NCT00879970|302658|P2|NOT COMPLETED|Period 1 TZD Randomization||4
131359|NCT00879970|302659|P1|NOT COMPLETED|Period 1 TZD Randomization||8
131360|NCT00879970|302655|P5|COMPLETED|Period 1 TZD Randomization||0
131361|NCT00879970|302656|P4|COMPLETED|Period 1 TZD Randomization||0
131362|NCT00879970|302657|P3|COMPLETED|Period 1 TZD Randomization||393
131363|NCT00879970|302658|P2|COMPLETED|Period 1 TZD Randomization||388
131364|NCT00879970|302659|P1|COMPLETED|Period 1 TZD Randomization||533
131365|NCT00879970|302655|P5|STARTED|Period 1 TZD Randomization||0
131366|NCT00879970|302656|P4|STARTED|Period 1 TZD Randomization||0
131367|NCT00879970|302657|P3|STARTED|Period 1 TZD Randomization||399
131368|NCT00879970|302658|P2|STARTED|Period 1 TZD Randomization||392
131369|NCT00879970|302659|P1|STARTED|Period 1 TZD Randomization||541
131370|NCT00879879|302741|P1|NOT COMPLETED|Overall Study||3
131371|NCT00879879|302741|P1|COMPLETED|Overall Study||17
131372|NCT00879879|302741|P1|STARTED|Overall Study||20
131373|NCT00879814|302749|P4|NOT COMPLETED|Overall Study||5
131374|NCT00879814|302750|P3|NOT COMPLETED|Overall Study||3
131375|NCT00879814|302751|P2|NOT COMPLETED|Overall Study||2
131376|NCT00879814|302752|P1|NOT COMPLETED|Overall Study||4
131377|NCT00879814|302749|P4|COMPLETED|Overall Study||7
131378|NCT00879814|302750|P3|COMPLETED|Overall Study||9
131379|NCT00879814|302751|P2|COMPLETED|Overall Study||10
131380|NCT00879814|302752|P1|COMPLETED|Overall Study||8
131381|NCT00879814|302749|P4|STARTED|Overall Study||12
131382|NCT00879814|302750|P3|STARTED|Overall Study||12
131383|NCT00879814|302751|P2|STARTED|Overall Study||12
131384|NCT00879814|302752|P1|STARTED|Overall Study||12
131385|NCT00879775|302860|P2|NOT COMPLETED|Overall Study||1
131386|NCT00879775|302861|P1|NOT COMPLETED|Overall Study||2
131387|NCT00879775|302860|P2|COMPLETED|Overall Study||20
131388|NCT00879775|302861|P1|COMPLETED|Overall Study||18
131389|NCT00879775|302860|P2|STARTED|Overall Study||21
131390|NCT00879775|302861|P1|STARTED|Overall Study||20
131391|NCT00879710|302877|P4|NOT COMPLETED|Phase 2 6 Weeks||0
131392|NCT00879710|302878|P3|NOT COMPLETED|Phase 2 6 Weeks||0
131393|NCT00879710|302879|P2|NOT COMPLETED|Phase 2 6 Weeks||0
131394|NCT00879710|302880|P1|NOT COMPLETED|Phase 2 6 Weeks||0
131395|NCT00879710|302877|P4|COMPLETED|Phase 2 6 Weeks||13
131396|NCT00879710|302878|P3|COMPLETED|Phase 2 6 Weeks||10
131397|NCT00879710|302879|P2|COMPLETED|Phase 2 6 Weeks||14
131398|NCT00879710|302880|P1|COMPLETED|Phase 2 6 Weeks||10
131399|NCT00879710|302877|P4|STARTED|Phase 2 6 Weeks||13
131400|NCT00879710|302878|P3|STARTED|Phase 2 6 Weeks||10
131401|NCT00879710|302879|P2|STARTED|Phase 2 6 Weeks||14
131402|NCT00879710|302880|P1|STARTED|Phase 2 6 Weeks||10
131403|NCT00879710|302877|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
131404|NCT00879710|302878|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
131405|NCT00879710|302879|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
131406|NCT00879710|302880|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
131407|NCT00879710|302877|P4|COMPLETED|Wash Out Period of 4 Weeks||13
131408|NCT00879710|302878|P3|COMPLETED|Wash Out Period of 4 Weeks||10
131409|NCT00879710|302879|P2|COMPLETED|Wash Out Period of 4 Weeks||14
131410|NCT00879710|302880|P1|COMPLETED|Wash Out Period of 4 Weeks||10
131411|NCT00879710|302877|P4|STARTED|Wash Out Period of 4 Weeks||13
131412|NCT00879710|302878|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
131413|NCT00879710|302879|P2|STARTED|Wash Out Period of 4 Weeks||14
131414|NCT00879710|302880|P1|STARTED|Wash Out Period of 4 Weeks||10
131415|NCT00879710|302877|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
131416|NCT00879710|302878|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
131417|NCT00879710|302879|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
131418|NCT00879710|302880|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
131419|NCT00879710|302877|P4|COMPLETED|Phase 1 - 6 Weeks||13
131420|NCT00879710|302878|P3|COMPLETED|Phase 1 - 6 Weeks||9
131421|NCT00879710|302879|P2|COMPLETED|Phase 1 - 6 Weeks||14
131422|NCT00879710|302880|P1|COMPLETED|Phase 1 - 6 Weeks||10
131423|NCT00879710|302877|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
131424|NCT00879710|302878|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
131425|NCT00879710|302879|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
131426|NCT00879710|302880|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
131427|NCT00879697|302890|P2|NOT COMPLETED|Overall Study||2
131428|NCT00879697|302891|P1|NOT COMPLETED|Overall Study||2
131429|NCT00879697|302890|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
131430|NCT00879697|302891|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
131431|NCT00879697|302890|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
131432|NCT00879697|302891|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
131433|NCT00879684|302897|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
131434|NCT00879684|302898|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
131435|NCT00879684|302899|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
131436|NCT00879684|302900|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
131437|NCT00879684|302901|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
131438|NCT00879684|302902|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
131439|NCT00879684|302903|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
131440|NCT00879684|302897|P7|COMPLETED|Stage 2: Expanded Cohort||0
131441|NCT00879684|302898|P6|COMPLETED|Stage 2: Expanded Cohort||0
131442|NCT00879684|302899|P5|COMPLETED|Stage 2: Expanded Cohort||0
131443|NCT00879684|302900|P4|COMPLETED|Stage 2: Expanded Cohort||0
131444|NCT00879684|302901|P3|COMPLETED|Stage 2: Expanded Cohort||0
131445|NCT00879684|302902|P2|COMPLETED|Stage 2: Expanded Cohort||0
131446|NCT00879684|302903|P1|COMPLETED|Stage 2: Expanded Cohort||0
131447|NCT00879684|302897|P7|STARTED|Stage 2: Expanded Cohort||13
131448|NCT00879684|302898|P6|STARTED|Stage 2: Expanded Cohort||0
131449|NCT00879684|302899|P5|STARTED|Stage 2: Expanded Cohort||0
131450|NCT00879684|302900|P4|STARTED|Stage 2: Expanded Cohort||0
131451|NCT00879684|302901|P3|STARTED|Stage 2: Expanded Cohort||0
131452|NCT00879684|302902|P2|STARTED|Stage 2: Expanded Cohort||0
131453|NCT00879684|302903|P1|STARTED|Stage 2: Expanded Cohort||0
131454|NCT00879684|302897|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
131455|NCT00879684|302898|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
131456|NCT00879684|302899|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
131457|NCT00879684|302900|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
131458|NCT00879684|302901|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
131459|NCT00879684|302902|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
131460|NCT00879684|302903|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
131461|NCT00879684|302897|P7|COMPLETED|Stage 1: Dose Escalation||0
131462|NCT00879684|302898|P6|COMPLETED|Stage 1: Dose Escalation||0
131463|NCT00879684|302899|P5|COMPLETED|Stage 1: Dose Escalation||0
131464|NCT00879684|302900|P4|COMPLETED|Stage 1: Dose Escalation||0
131465|NCT00879684|302901|P3|COMPLETED|Stage 1: Dose Escalation||0
131466|NCT00879684|302902|P2|COMPLETED|Stage 1: Dose Escalation||0
131467|NCT00879684|302903|P1|COMPLETED|Stage 1: Dose Escalation||0
131468|NCT00879684|302897|P7|STARTED|Stage 1: Dose Escalation||0
131469|NCT00879684|302898|P6|STARTED|Stage 1: Dose Escalation||3
131470|NCT00879684|302899|P5|STARTED|Stage 1: Dose Escalation||3
131471|NCT00879684|302900|P4|STARTED|Stage 1: Dose Escalation||6
131472|NCT00879684|302901|P3|STARTED|Stage 1: Dose Escalation||3
131473|NCT00879684|302902|P2|STARTED|Stage 1: Dose Escalation||3
131474|NCT00879684|302903|P1|STARTED|Stage 1: Dose Escalation||3
131475|NCT00879645|302969|P4|NOT COMPLETED|Overall Study||0
131476|NCT00879645|302970|P3|NOT COMPLETED|Overall Study||0
131477|NCT00879645|302971|P2|NOT COMPLETED|Overall Study||0
131478|NCT00879645|302972|P1|NOT COMPLETED|Overall Study||1
131479|NCT00879645|302969|P4|COMPLETED|Overall Study||7
131480|NCT00879645|302970|P3|COMPLETED|Overall Study||6
131481|NCT00879645|302971|P2|COMPLETED|Overall Study||6
131482|NCT00879645|302972|P1|COMPLETED|Overall Study||8
131483|NCT00879645|302969|P4|STARTED|Overall Study||7
131484|NCT00879645|302970|P3|STARTED|Overall Study||6
131485|NCT00879645|302971|P2|STARTED|Overall Study||6
131486|NCT00879645|302972|P1|STARTED|Overall Study||9
131487|NCT00879619|302990|P1|NOT COMPLETED|Overall Study||0
131488|NCT00879619|302990|P1|COMPLETED|Overall Study||4
131489|NCT00879619|302990|P1|STARTED|Overall Study||4
131490|NCT00879411|302999|P1|NOT COMPLETED|Overall Study||162
131491|NCT00879411|302999|P1|COMPLETED|Overall Study||539
131492|NCT00879411|302999|P1|STARTED|Overall Study||701
131493|NCT00879398|303005|P1|NOT COMPLETED|Overall Study||675
131494|NCT00879398|303005|P1|COMPLETED|Overall Study||2434
131495|NCT00879398|303005|P1|STARTED|Overall Study||3109
131496|NCT00879333|303017|P2|NOT COMPLETED|Overall Study||217
131497|NCT00879333|303018|P1|NOT COMPLETED|Overall Study||428
131498|NCT00879333|303017|P2|COMPLETED|Overall Study||0
131499|NCT00879333|303018|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
131500|NCT00879333|303017|P2|Discontinued Study Treatment|Overall Study||217
131501|NCT00879333|303018|P1|Discontinued Study Treatment|Overall Study||428
131502|NCT00879333|303017|P2|STARTED|Overall Study||217
131503|NCT00879333|303018|P1|STARTED|Overall Study||439
131504|NCT00879255|303038|P2|NOT COMPLETED|Overall Study||19
131505|NCT00879255|303039|P1|NOT COMPLETED|Overall Study||16
131506|NCT00879255|303038|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
131507|NCT00879255|303039|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
131508|NCT00879255|303038|P2|Completed 3-mo Follow-up|Overall Study||49
131509|NCT00879255|303039|P1|Completed 3-mo Follow-up|Overall Study||48
131510|NCT00879255|303038|P2|Completed Posttreatment Follow-up|Overall Study||55
131511|NCT00879255|303039|P1|Completed Posttreatment Follow-up|Overall Study||50
131512|NCT00879255|303038|P2|Received Allocated Intervention:|Overall Study||56
131513|NCT00879255|303039|P1|Received Allocated Intervention:|Overall Study||51
131514|NCT00879255|303038|P2|STARTED|Overall Study||64
131515|NCT00879255|303039|P1|STARTED|Overall Study||61
131516|NCT00879229|303051|P2|NOT COMPLETED|Overall Study||14
131517|NCT00879229|303052|P1|NOT COMPLETED|Overall Study||22
131518|NCT00879229|303051|P2|COMPLETED|Overall Study||1
131519|NCT00879229|303052|P1|COMPLETED|Overall Study||3
131520|NCT00879229|303051|P2|STARTED|Overall Study||15
131521|NCT00879229|303052|P1|STARTED|Overall Study||25
131522|NCT00878969|303079|P3|NOT COMPLETED|Overall Study||11
131523|NCT00878969|303080|P2|NOT COMPLETED|Overall Study||15
131524|NCT00878969|303081|P1|NOT COMPLETED|Overall Study||15
131525|NCT00878969|303079|P3|COMPLETED|Overall Study||15
131526|NCT00878969|303080|P2|COMPLETED|Overall Study||12
131527|NCT00878969|303081|P1|COMPLETED|Overall Study||10
131528|NCT00878969|303079|P3|STARTED|Overall Study||26
131529|NCT00878969|303080|P2|STARTED|Overall Study||27
131530|NCT00878969|303081|P1|STARTED|Overall Study||25
131531|NCT00878878|303091|P2|NOT COMPLETED|Overall Study||0
131532|NCT00878878|303092|P1|NOT COMPLETED|Overall Study||0
131533|NCT00878878|303091|P2|COMPLETED|Overall Study||15
131534|NCT00878878|303092|P1|COMPLETED|Overall Study||15
131535|NCT00878878|303091|P2|STARTED|Overall Study||15
131536|NCT00878878|303092|P1|STARTED|Overall Study||15
131537|NCT00878826|303105|P3|NOT COMPLETED|Overall Study||0
131538|NCT00878826|303106|P2|NOT COMPLETED|Overall Study||0
131539|NCT00878826|303107|P1|NOT COMPLETED|Overall Study||0
131540|NCT00878826|303105|P3|COMPLETED|Overall Study||2
131541|NCT00878826|303106|P2|COMPLETED|Overall Study||6
131542|NCT00878826|303107|P1|COMPLETED|Overall Study||3
131543|NCT00878826|303105|P3|STARTED|Overall Study||2
131544|NCT00878826|303106|P2|STARTED|Overall Study||6
131545|NCT00878826|303107|P1|STARTED|Overall Study||3
131546|NCT00878800|303129|P5|NOT COMPLETED|Overall Study||16
131547|NCT00878800|303130|P4|NOT COMPLETED|Overall Study||6
131548|NCT00878800|303131|P3|NOT COMPLETED|Overall Study||9
131549|NCT00878800|303132|P2|NOT COMPLETED|Overall Study||7
131550|NCT00878800|303133|P1|NOT COMPLETED|Overall Study||3
131551|NCT00878800|303129|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
131552|NCT00878800|303130|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
131553|NCT00878800|303131|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
131554|NCT00878800|303132|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
131555|NCT00878800|303133|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
131556|NCT00878800|303129|P5|STARTED|Overall Study||16
131557|NCT00878800|303130|P4|STARTED|Overall Study||6
131558|NCT00878800|303131|P3|STARTED|Overall Study||9
131559|NCT00878800|303132|P2|STARTED|Overall Study||7
131560|NCT00878800|303133|P1|STARTED|Overall Study||3
131561|NCT00878722|303168|P8|NOT COMPLETED|Overall Study||7
131562|NCT00878722|303169|P7|NOT COMPLETED|Overall Study||6
131563|NCT00878722|303170|P6|NOT COMPLETED|Overall Study||2
131564|NCT00878722|303171|P5|NOT COMPLETED|Overall Study||7
131565|NCT00878722|303172|P4|NOT COMPLETED|Overall Study||9
131566|NCT00878722|303173|P3|NOT COMPLETED|Overall Study||3
131567|NCT00878722|303174|P2|NOT COMPLETED|Overall Study||3
131568|NCT00878722|303175|P1|NOT COMPLETED|Overall Study||3
131569|NCT00878722|303168|P8|COMPLETED|Overall Study||0
131570|NCT00878722|303169|P7|COMPLETED|Overall Study||0
131571|NCT00878722|303170|P6|COMPLETED|Overall Study||1
131572|NCT00878722|303171|P5|COMPLETED|Overall Study||0
131573|NCT00878722|303172|P4|COMPLETED|Overall Study||0
131574|NCT00878722|303173|P3|COMPLETED|Overall Study||0
131575|NCT00878722|303174|P2|COMPLETED|Overall Study||0
131576|NCT00878722|303175|P1|COMPLETED|Overall Study||0
131577|NCT00878722|303168|P8|STARTED|Overall Study||7
131578|NCT00878722|303169|P7|STARTED|Overall Study||6
131579|NCT00878722|303170|P6|STARTED|Overall Study||3
131580|NCT00878722|303171|P5|STARTED|Overall Study||7
131581|NCT00878722|303172|P4|STARTED|Overall Study||9
131582|NCT00878722|303173|P3|STARTED|Overall Study||3
131583|NCT00878722|303174|P2|STARTED|Overall Study||3
131584|NCT00878722|303175|P1|STARTED|Overall Study||3
131585|NCT00878605|303262|P4|NOT COMPLETED|Overall Study||3
131586|NCT00878605|303263|P3|NOT COMPLETED|Overall Study||1
131587|NCT00878605|303264|P2|NOT COMPLETED|Overall Study||3
131588|NCT00878605|303265|P1|NOT COMPLETED|Overall Study||3
131589|NCT00878605|303262|P4|COMPLETED|Overall Study||6
131590|NCT00878605|303263|P3|COMPLETED|Overall Study||8
131591|NCT00878605|303264|P2|COMPLETED|Overall Study||7
131592|NCT00878605|303265|P1|COMPLETED|Overall Study||7
131593|NCT00878605|303262|P4|STARTED|Overall Study||9
131594|NCT00878605|303263|P3|STARTED|Overall Study||9
131595|NCT00878605|303264|P2|STARTED|Overall Study||10
131596|NCT00878605|303265|P1|STARTED|Overall Study||10
131597|NCT00878553|303279|P5|NOT COMPLETED|PK Study||0
131598|NCT00878553|303280|P4|NOT COMPLETED|PK Study||1
131599|NCT00878553|303281|P3|NOT COMPLETED|PK Study||0
131600|NCT00878553|303282|P2|NOT COMPLETED|PK Study||0
131601|NCT00878553|303283|P1|NOT COMPLETED|PK Study||0
131602|NCT00878553|303279|P5|COMPLETED|PK Study||15
131603|NCT00878553|303280|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
131604|NCT00878553|303281|P3|COMPLETED|PK Study||17
131605|NCT00878553|303282|P2|COMPLETED|PK Study||16
131606|NCT00878553|303283|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
131607|NCT00878553|303279|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
131608|NCT00878553|303280|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
131609|NCT00878553|303281|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
131610|NCT00878553|303282|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
131611|NCT00878553|303283|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
131612|NCT00878553|303279|P5|NOT COMPLETED|Sleep Study||0
131613|NCT00878553|303280|P4|NOT COMPLETED|Sleep Study||0
131614|NCT00878553|303281|P3|NOT COMPLETED|Sleep Study||0
131615|NCT00878553|303282|P2|NOT COMPLETED|Sleep Study||0
131616|NCT00878553|303283|P1|NOT COMPLETED|Sleep Study||5
131617|NCT00878553|303279|P5|COMPLETED|Sleep Study||0
131618|NCT00878553|303280|P4|COMPLETED|Sleep Study||0
131619|NCT00878553|303281|P3|COMPLETED|Sleep Study||0
131620|NCT00878553|303282|P2|COMPLETED|Sleep Study||0
131621|NCT00878553|303283|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
131622|NCT00878553|303279|P5|Number of Patients Receiving 20mg|Sleep Study||0
131623|NCT00878553|303280|P4|Number of Patients Receiving 20mg|Sleep Study||0
131624|NCT00878553|303281|P3|Number of Patients Receiving 20mg|Sleep Study||0
131625|NCT00878553|303282|P2|Number of Patients Receiving 20mg|Sleep Study||0
131626|NCT00878553|303283|P1|Number of Patients Receiving 20mg|Sleep Study||65
131627|NCT00878553|303279|P5|Number of Patients Receiving 15mg|Sleep Study||0
131628|NCT00878553|303280|P4|Number of Patients Receiving 15mg|Sleep Study||0
131629|NCT00878553|303281|P3|Number of Patients Receiving 15mg|Sleep Study||0
131630|NCT00878553|303282|P2|Number of Patients Receiving 15mg|Sleep Study||0
131631|NCT00878553|303283|P1|Number of Patients Receiving 15mg|Sleep Study||65
131632|NCT00878553|303279|P5|Number of Patients Receiving 10mg|Sleep Study||0
131633|NCT00878553|303280|P4|Number of Patients Receiving 10mg|Sleep Study||0
131634|NCT00878553|303281|P3|Number of Patients Receiving 10mg|Sleep Study||0
131635|NCT00878553|303282|P2|Number of Patients Receiving 10mg|Sleep Study||0
131636|NCT00878553|303283|P1|Number of Patients Receiving 10mg|Sleep Study||65
131637|NCT00878553|303279|P5|Number of Patients Receiving Placebo|Sleep Study||0
131638|NCT00878553|303280|P4|Number of Patients Receiving Placebo|Sleep Study||0
131639|NCT00878553|303281|P3|Number of Patients Receiving Placebo|Sleep Study||0
131640|NCT00878553|303282|P2|Number of Patients Receiving Placebo|Sleep Study||0
131641|NCT00878553|303283|P1|Number of Patients Receiving Placebo|Sleep Study||66
131642|NCT00878553|303279|P5|STARTED|Sleep Study||0
131643|NCT00878553|303280|P4|STARTED|Sleep Study||0
131644|NCT00878553|303281|P3|STARTED|Sleep Study||0
131645|NCT00878553|303282|P2|STARTED|Sleep Study||0
131646|NCT00878553|303283|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
131647|NCT00878501|303342|P3|NOT COMPLETED|Overall Study||8
131648|NCT00878501|303343|P2|NOT COMPLETED|Overall Study||7
131649|NCT00878501|303344|P1|NOT COMPLETED|Overall Study||17
131650|NCT00878501|303342|P3|COMPLETED|Overall Study||85
131651|NCT00878501|303343|P2|COMPLETED|Overall Study||37
131652|NCT00878501|303344|P1|COMPLETED|Overall Study||87
131653|NCT00878501|303342|P3|Interim Analysis|Overall Study||81
131654|NCT00878501|303343|P2|Interim Analysis|Overall Study||37
131655|NCT00878501|303344|P1|Interim Analysis|Overall Study||83
131656|NCT00878501|303342|P3|STARTED|Overall Study||93
131657|NCT00878501|303343|P2|STARTED|Overall Study||44
131658|NCT00878501|303344|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
131659|NCT00878228|303363|P2|NOT COMPLETED|Overall Study||12
131660|NCT00878228|303364|P1|NOT COMPLETED|Overall Study||10
131661|NCT00878228|303363|P2|COMPLETED|Overall Study||37
131662|NCT00878228|303364|P1|COMPLETED|Overall Study||39
131663|NCT00878228|303363|P2|STARTED|Overall Study||49
131664|NCT00878228|303364|P1|STARTED|Overall Study||49
131665|NCT00877929|303376|P2|NOT COMPLETED|Overall Study||35
131666|NCT00877929|303377|P1|NOT COMPLETED|Overall Study||20
131667|NCT00877929|303376|P2|COMPLETED|Overall Study||319
131668|NCT00877929|303377|P1|COMPLETED|Overall Study||332
131669|NCT00877929|303376|P2|STARTED|Overall Study||354
131670|NCT00877929|303377|P1|STARTED|Overall Study||352
131671|NCT00877890|303465|P2|NOT COMPLETED|Overall Study||30
131672|NCT00877890|303466|P1|NOT COMPLETED|Overall Study||20
131673|NCT00877890|303465|P2|COMPLETED|Overall Study||95
131674|NCT00877890|303466|P1|COMPLETED|Overall Study||109
131675|NCT00877890|303465|P2|Intent to Treat (ITT)|Overall Study||123
131676|NCT00877890|303466|P1|Intent to Treat (ITT)|Overall Study||129
131677|NCT00877890|303465|P2|STARTED|Overall Study||125
131678|NCT00877890|303466|P1|STARTED|Overall Study||129
131679|NCT00877877|303500|P1|NOT COMPLETED|Year 10||0
131680|NCT00877877|303500|P1|COMPLETED|Year 10||495
131681|NCT00877877|303500|P1|STARTED|Year 10||495
131682|NCT00877877|303500|P1|NOT COMPLETED|Year 9||0
131683|NCT00877877|303500|P1|COMPLETED|Year 9||507
131684|NCT00877877|303500|P1|STARTED|Year 9||507
131685|NCT00877877|303500|P1|NOT COMPLETED|Year 8||0
131686|NCT00877877|303500|P1|COMPLETED|Year 8||522
131687|NCT00877877|303500|P1|STARTED|Year 8||522
131688|NCT00877877|303500|P1|NOT COMPLETED|Year 7||0
131689|NCT00877877|303500|P1|COMPLETED|Year 7||523
131690|NCT00877877|303500|P1|STARTED|Year 7||523
131691|NCT00877877|303500|P1|NOT COMPLETED|Year 6||0
131692|NCT00877877|303500|P1|COMPLETED|Year 6||529
131693|NCT00877877|303500|P1|STARTED|Year 6||529
131694|NCT00877877|303500|P1|NOT COMPLETED|Year 5||0
131695|NCT00877877|303500|P1|COMPLETED|Year 5||397
131696|NCT00877877|303500|P1|STARTED|Year 5||397
131697|NCT00877799|303531|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
131698|NCT00877799|303532|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
131699|NCT00877799|303533|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131700|NCT00877799|303534|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131701|NCT00877799|303535|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131702|NCT00877799|303531|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
131703|NCT00877799|303532|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
131704|NCT00877799|303533|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131705|NCT00877799|303534|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131706|NCT00877799|303535|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
131707|NCT00877799|303531|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
131708|NCT00877799|303532|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
131709|NCT00877799|303533|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
131710|NCT00877799|303534|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
131711|NCT00877799|303535|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
131712|NCT00877799|303531|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131713|NCT00877799|303532|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131714|NCT00877799|303533|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
131715|NCT00877799|303534|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
131716|NCT00877799|303535|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
131717|NCT00877799|303531|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131718|NCT00877799|303532|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131719|NCT00877799|303533|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
131720|NCT00877799|303534|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
131721|NCT00877799|303535|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
131722|NCT00877799|303531|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131723|NCT00877799|303532|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
131724|NCT00877799|303533|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
131725|NCT00877799|303534|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
131726|NCT00877799|303535|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
131727|NCT00877773|303550|P1|NOT COMPLETED|Overall Study||44
131728|NCT00877773|303550|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
131729|NCT00877773|303550|P1|STARTED|Overall Study||44
131730|NCT00877604|303556|P2|NOT COMPLETED|Overall Study||3
131731|NCT00877604|303557|P1|NOT COMPLETED|Overall Study||2
131732|NCT00877604|303556|P2|COMPLETED|Overall Study||14
131733|NCT00877604|303557|P1|COMPLETED|Overall Study||15
131734|NCT00877604|303556|P2|STARTED|Overall Study||17
131735|NCT00877604|303557|P1|STARTED|Overall Study||17
131736|NCT00877487|303563|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
131737|NCT00877487|303564|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
131738|NCT00877487|303563|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
131739|NCT00877487|303564|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
131740|NCT00877487|303563|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
131741|NCT00877487|303564|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
131742|NCT00877487|303563|P2|NOT COMPLETED|Open-label Treatment Phase||0
131743|NCT00877487|303564|P1|NOT COMPLETED|Open-label Treatment Phase||7
131744|NCT00877487|303563|P2|COMPLETED|Open-label Treatment Phase||0
131745|NCT00877487|303564|P1|COMPLETED|Open-label Treatment Phase||116
131746|NCT00877487|303563|P2|STARTED|Open-label Treatment Phase||0
131747|NCT00877487|303564|P1|STARTED|Open-label Treatment Phase||123
131748|NCT00877448|303581|P7|NOT COMPLETED|Overall Study||0
131749|NCT00877448|303582|P6|NOT COMPLETED|Overall Study||1
131750|NCT00877448|303583|P5|NOT COMPLETED|Overall Study||0
131751|NCT00877448|303584|P4|NOT COMPLETED|Overall Study||1
131752|NCT00877448|303585|P3|NOT COMPLETED|Overall Study||0
131753|NCT00877448|303586|P2|NOT COMPLETED|Overall Study||1
131754|NCT00877448|303587|P1|NOT COMPLETED|Overall Study||0
131755|NCT00877448|303581|P7|COMPLETED|Overall Study||3
131756|NCT00877448|303582|P6|COMPLETED|Overall Study||9
131757|NCT00877448|303583|P5|COMPLETED|Overall Study||10
131758|NCT00877448|303584|P4|COMPLETED|Overall Study||9
131759|NCT00877448|303585|P3|COMPLETED|Overall Study||10
131760|NCT00877448|303586|P2|COMPLETED|Overall Study||9
131761|NCT00877448|303587|P1|COMPLETED|Overall Study||10
131762|NCT00877448|303581|P7|STARTED|Overall Study||3
131763|NCT00877448|303582|P6|STARTED|Overall Study||10
131764|NCT00877448|303583|P5|STARTED|Overall Study||10
131765|NCT00877448|303584|P4|STARTED|Overall Study||10
131766|NCT00877448|303585|P3|STARTED|Overall Study||10
131767|NCT00877448|303586|P2|STARTED|Overall Study||10
131768|NCT00877448|303587|P1|STARTED|Overall Study||10
131769|NCT00877383|303612|P2|NOT COMPLETED|Overall Study||37
131770|NCT00877383|303613|P1|NOT COMPLETED|Overall Study||29
131771|NCT00877383|303612|P2|COMPLETED|Overall Study||533
131772|NCT00877383|303613|P1|COMPLETED|Overall Study||543
131773|NCT00877383|303612|P2|STARTED|Overall Study||570
131774|NCT00877383|303613|P1|STARTED|Overall Study||572
131775|NCT00877370|303629|P1|NOT COMPLETED|Overall Study||0
131776|NCT00877370|303629|P1|COMPLETED|Overall Study||8
131777|NCT00877370|303629|P1|STARTED|Overall Study||8
131778|NCT00875017|303639|P6|NOT COMPLETED|Fourth Intervention||1
131779|NCT00875017|303640|P5|NOT COMPLETED|Fourth Intervention||0
131780|NCT00875017|303641|P4|NOT COMPLETED|Fourth Intervention||0
131781|NCT00875017|303642|P3|NOT COMPLETED|Fourth Intervention||0
131782|NCT00875017|303643|P2|NOT COMPLETED|Fourth Intervention||0
131783|NCT00875017|303644|P1|NOT COMPLETED|Fourth Intervention||0
131784|NCT00875017|303639|P6|COMPLETED|Fourth Intervention||4
131785|NCT00875017|303640|P5|COMPLETED|Fourth Intervention||3
131786|NCT00875017|303641|P4|COMPLETED|Fourth Intervention||4
131787|NCT00875017|303642|P3|COMPLETED|Fourth Intervention||2
131788|NCT00875017|303643|P2|COMPLETED|Fourth Intervention||3
131789|NCT00875017|303644|P1|COMPLETED|Fourth Intervention||3
131790|NCT00875017|303639|P6|STARTED|Fourth Intervention||5
131791|NCT00875017|303640|P5|STARTED|Fourth Intervention||3
131792|NCT00875017|303641|P4|STARTED|Fourth Intervention||4
131793|NCT00875017|303642|P3|STARTED|Fourth Intervention||2
131794|NCT00875017|303643|P2|STARTED|Fourth Intervention||3
131795|NCT00875017|303644|P1|STARTED|Fourth Intervention||3
131796|NCT00875017|303639|P6|NOT COMPLETED|Washout||0
131797|NCT00875017|303640|P5|NOT COMPLETED|Washout||1
131798|NCT00875017|303641|P4|NOT COMPLETED|Washout||0
131799|NCT00875017|303642|P3|NOT COMPLETED|Washout||0
131800|NCT00875017|303643|P2|NOT COMPLETED|Washout||0
131801|NCT00875017|303644|P1|NOT COMPLETED|Washout||0
131802|NCT00875017|303639|P6|COMPLETED|Washout||5
131803|NCT00875017|303640|P5|COMPLETED|Washout||3
131804|NCT00875017|303641|P4|COMPLETED|Washout||4
131805|NCT00875017|303642|P3|COMPLETED|Washout||2
131806|NCT00875017|303643|P2|COMPLETED|Washout||3
131807|NCT00875017|303644|P1|COMPLETED|Washout||3
131808|NCT00875017|303639|P6|STARTED|Washout||5
131809|NCT00875017|303640|P5|STARTED|Washout||4
131810|NCT00875017|303641|P4|STARTED|Washout||4
131811|NCT00875017|303642|P3|STARTED|Washout||2
131812|NCT00875017|303643|P2|STARTED|Washout||3
131813|NCT00875017|303644|P1|STARTED|Washout||3
131814|NCT00875017|303639|P6|NOT COMPLETED|Third Intervention||0
131815|NCT00875017|303640|P5|NOT COMPLETED|Third Intervention||0
131816|NCT00875017|303641|P4|NOT COMPLETED|Third Intervention||0
131817|NCT00875017|303642|P3|NOT COMPLETED|Third Intervention||1
131818|NCT00875017|303643|P2|NOT COMPLETED|Third Intervention||1
131819|NCT00875017|303644|P1|NOT COMPLETED|Third Intervention||0
131820|NCT00875017|303639|P6|COMPLETED|Third Intervention||5
131821|NCT00875017|303640|P5|COMPLETED|Third Intervention||4
131822|NCT00875017|303641|P4|COMPLETED|Third Intervention||4
131823|NCT00875017|303642|P3|COMPLETED|Third Intervention||2
131824|NCT00875017|303643|P2|COMPLETED|Third Intervention||3
131825|NCT00875017|303644|P1|COMPLETED|Third Intervention||3
131826|NCT00875017|303639|P6|STARTED|Third Intervention||5
131827|NCT00875017|303640|P5|STARTED|Third Intervention||4
131828|NCT00875017|303641|P4|STARTED|Third Intervention||4
131829|NCT00875017|303642|P3|STARTED|Third Intervention||3
131830|NCT00875017|303643|P2|STARTED|Third Intervention||4
131831|NCT00875017|303644|P1|STARTED|Third Intervention||3
131832|NCT00875017|303639|P6|NOT COMPLETED|Washout||0
131833|NCT00875017|303640|P5|NOT COMPLETED|Washout||0
131834|NCT00875017|303641|P4|NOT COMPLETED|Washout||0
131835|NCT00875017|303642|P3|NOT COMPLETED|Washout||0
131836|NCT00875017|303643|P2|NOT COMPLETED|Washout||1
131837|NCT00875017|303644|P1|NOT COMPLETED|Washout||0
131838|NCT00875017|303639|P6|COMPLETED|Washout||5
131839|NCT00875017|303640|P5|COMPLETED|Washout||4
131840|NCT00875017|303641|P4|COMPLETED|Washout||4
131841|NCT00875017|303642|P3|COMPLETED|Washout||3
131842|NCT00875017|303643|P2|COMPLETED|Washout||4
131843|NCT00875017|303644|P1|COMPLETED|Washout||3
131844|NCT00875017|303639|P6|STARTED|Washout||5
131845|NCT00875017|303640|P5|STARTED|Washout||4
131846|NCT00875017|303641|P4|STARTED|Washout||4
131847|NCT00875017|303642|P3|STARTED|Washout||3
131848|NCT00875017|303643|P2|STARTED|Washout||5
131849|NCT00875017|303644|P1|STARTED|Washout||3
131850|NCT00875017|303639|P6|NOT COMPLETED|Second Intervention||0
131851|NCT00875017|303640|P5|NOT COMPLETED|Second Intervention||0
131852|NCT00875017|303641|P4|NOT COMPLETED|Second Intervention||1
131853|NCT00875017|303642|P3|NOT COMPLETED|Second Intervention||0
131854|NCT00875017|303643|P2|NOT COMPLETED|Second Intervention||0
131855|NCT00875017|303644|P1|NOT COMPLETED|Second Intervention||0
131856|NCT00875017|303639|P6|COMPLETED|Second Intervention||5
131857|NCT00875017|303640|P5|COMPLETED|Second Intervention||4
131858|NCT00875017|303641|P4|COMPLETED|Second Intervention||4
131859|NCT00875017|303642|P3|COMPLETED|Second Intervention||3
131860|NCT00875017|303643|P2|COMPLETED|Second Intervention||5
131861|NCT00875017|303644|P1|COMPLETED|Second Intervention||3
131862|NCT00875017|303639|P6|STARTED|Second Intervention||5
131863|NCT00875017|303640|P5|STARTED|Second Intervention||4
131864|NCT00875017|303641|P4|STARTED|Second Intervention||5
131865|NCT00875017|303642|P3|STARTED|Second Intervention||3
131866|NCT00875017|303643|P2|STARTED|Second Intervention||5
131867|NCT00875017|303644|P1|STARTED|Second Intervention||3
131868|NCT00875017|303639|P6|NOT COMPLETED|Washout||0
131869|NCT00875017|303640|P5|NOT COMPLETED|Washout||0
131870|NCT00875017|303641|P4|NOT COMPLETED|Washout||0
131871|NCT00875017|303642|P3|NOT COMPLETED|Washout||1
131872|NCT00875017|303643|P2|NOT COMPLETED|Washout||0
131873|NCT00875017|303644|P1|NOT COMPLETED|Washout||0
131874|NCT00875017|303639|P6|COMPLETED|Washout||5
131875|NCT00875017|303640|P5|COMPLETED|Washout||4
131876|NCT00875017|303641|P4|COMPLETED|Washout||5
131877|NCT00875017|303642|P3|COMPLETED|Washout||3
131878|NCT00875017|303643|P2|COMPLETED|Washout||5
131879|NCT00875017|303644|P1|COMPLETED|Washout||3
131880|NCT00875017|303639|P6|STARTED|Washout||5
131881|NCT00875017|303640|P5|STARTED|Washout||4
131882|NCT00875017|303641|P4|STARTED|Washout||5
131883|NCT00875017|303642|P3|STARTED|Washout||4
131884|NCT00875017|303643|P2|STARTED|Washout||5
131885|NCT00875017|303644|P1|STARTED|Washout||3
131886|NCT00875017|303639|P6|NOT COMPLETED|First Intervention||0
131887|NCT00875017|303640|P5|NOT COMPLETED|First Intervention||1
131888|NCT00875017|303641|P4|NOT COMPLETED|First Intervention||1
131889|NCT00875017|303642|P3|NOT COMPLETED|First Intervention||1
131890|NCT00875017|303643|P2|NOT COMPLETED|First Intervention||0
131891|NCT00875017|303644|P1|NOT COMPLETED|First Intervention||2
131892|NCT00875017|303639|P6|COMPLETED|First Intervention||5
131893|NCT00875017|303640|P5|COMPLETED|First Intervention||4
131894|NCT00875017|303641|P4|COMPLETED|First Intervention||5
131895|NCT00875017|303642|P3|COMPLETED|First Intervention||4
131896|NCT00875017|303643|P2|COMPLETED|First Intervention||5
131897|NCT00875017|303644|P1|COMPLETED|First Intervention||3
131898|NCT00875017|303639|P6|STARTED|First Intervention||5
131899|NCT00875017|303640|P5|STARTED|First Intervention||5
131900|NCT00875017|303641|P4|STARTED|First Intervention||6
131901|NCT00875017|303642|P3|STARTED|First Intervention||5
131902|NCT00875017|303643|P2|STARTED|First Intervention||5
131903|NCT00875017|303644|P1|STARTED|First Intervention||5
131904|NCT00877071|303658|P1|NOT COMPLETED|Overall Study||2
131905|NCT00877071|303658|P1|COMPLETED|Overall Study||0
131906|NCT00877071|303658|P1|STARTED|Overall Study||2
131907|NCT00877058|303668|P3|NOT COMPLETED|Overall Study||39
131908|NCT00877058|303669|P2|NOT COMPLETED|Overall Study||40
131909|NCT00877058|303670|P1|NOT COMPLETED|Overall Study||37
131910|NCT00877058|303668|P3|COMPLETED|Overall Study||75
131911|NCT00877058|303669|P2|COMPLETED|Overall Study||131
131912|NCT00877058|303670|P1|COMPLETED|Overall Study||137
131913|NCT00877058|303668|P3|STARTED|Overall Study||114
131914|NCT00877058|303669|P2|STARTED|Overall Study||171
131915|NCT00877058|303670|P1|STARTED|Overall Study||174
131916|NCT00877032|303691|P7|NOT COMPLETED|Overall Study||2
131917|NCT00877032|303692|P6|NOT COMPLETED|Overall Study||0
131918|NCT00877032|303693|P5|NOT COMPLETED|Overall Study||0
131919|NCT00877032|303694|P4|NOT COMPLETED|Overall Study||1
131920|NCT00877032|303695|P3|NOT COMPLETED|Overall Study||0
131921|NCT00877032|303696|P2|NOT COMPLETED|Overall Study||0
131922|NCT00877032|303697|P1|NOT COMPLETED|Overall Study||0
131923|NCT00877032|303691|P7|COMPLETED|Overall Study||18
131924|NCT00877032|303692|P6|COMPLETED|Overall Study||6
131925|NCT00877032|303693|P5|COMPLETED|Overall Study||6
131926|NCT00877032|303694|P4|COMPLETED|Overall Study||6
131927|NCT00877032|303695|P3|COMPLETED|Overall Study||6
131928|NCT00877032|303696|P2|COMPLETED|Overall Study||6
131929|NCT00877032|303697|P1|COMPLETED|Overall Study||6
131930|NCT00877032|303691|P7|Treated|Overall Study||18
131931|NCT00877032|303692|P6|Treated|Overall Study||6
131932|NCT00877032|303693|P5|Treated|Overall Study||6
131933|NCT00877032|303694|P4|Treated|Overall Study||6
131934|NCT00877032|303695|P3|Treated|Overall Study||6
131935|NCT00877032|303696|P2|Treated|Overall Study||6
131936|NCT00877032|303697|P1|Treated|Overall Study||6
131937|NCT00877032|303691|P7|STARTED|Overall Study||20
131938|NCT00877032|303692|P6|STARTED|Overall Study||6
131939|NCT00877032|303693|P5|STARTED|Overall Study||6
131940|NCT00877032|303694|P4|STARTED|Overall Study||7
131941|NCT00877032|303695|P3|STARTED|Overall Study||6
131942|NCT00877032|303696|P2|STARTED|Overall Study||6
131943|NCT00877032|303697|P1|STARTED|Overall Study||6
131944|NCT00877006|303798|P2|NOT COMPLETED|Long-Term Follow-up Period||210
131945|NCT00877006|303799|P1|NOT COMPLETED|Long-Term Follow-up Period||210
131946|NCT00877006|303798|P2|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
131947|NCT00877006|303799|P1|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
131948|NCT00877006|303798|P2|STARTED|Long-Term Follow-up Period||210
131949|NCT00877006|303799|P1|STARTED|Long-Term Follow-up Period||210
131950|NCT00877006|303798|P2|NOT COMPLETED|Treatment Period||27
131951|NCT00877006|303799|P1|NOT COMPLETED|Treatment Period||21
131952|NCT00877006|303798|P2|COMPLETED|Treatment Period||196
131953|NCT00877006|303799|P1|COMPLETED|Treatment Period|treated for >=6 cycles|203
131954|NCT00877006|303798|P2|STARTED|Treatment Period||223
131955|NCT00877006|303799|P1|STARTED|Treatment Period||224
131956|NCT00876928|303827|P2|NOT COMPLETED|Overall Study||5
131957|NCT00876928|303828|P1|NOT COMPLETED|Overall Study||3
131958|NCT00876928|303827|P2|COMPLETED|Overall Study||56
131959|NCT00876928|303828|P1|COMPLETED|Overall Study||53
131960|NCT00876928|303827|P2|STARTED|Overall Study||61
131961|NCT00876928|303828|P1|STARTED|Overall Study||56
131962|NCT00876915|303839|P3|NOT COMPLETED|Overall Study||0
131963|NCT00876915|303840|P2|NOT COMPLETED|Overall Study||14
131964|NCT00876915|303841|P1|NOT COMPLETED|Overall Study||19
131965|NCT00876915|303839|P3|COMPLETED|Overall Study||101
131966|NCT00876915|303840|P2|COMPLETED|Overall Study||34
131967|NCT00876915|303841|P1|COMPLETED|Overall Study||31
131968|NCT00876915|303839|P3|Week 8|Overall Study||0
131969|NCT00876915|303840|P2|Week 8|Overall Study||36
131970|NCT00876915|303841|P1|Week 8|Overall Study||33
131971|NCT00876915|303839|P3|Week 4|Overall Study||0
131972|NCT00876915|303840|P2|Week 4|Overall Study||45
131973|NCT00876915|303841|P1|Week 4|Overall Study||38
131974|NCT00876915|303839|P3|STARTED|Overall Study||101
131975|NCT00876915|303840|P2|STARTED|Overall Study||48
131976|NCT00876915|303841|P1|STARTED|Overall Study||50
131977|NCT00876733|303865|P4|NOT COMPLETED|Overall Study||7
131978|NCT00876733|303866|P3|NOT COMPLETED|Overall Study||30
131979|NCT00876733|303867|P2|NOT COMPLETED|Overall Study||42
131980|NCT00876733|303868|P1|NOT COMPLETED|Overall Study||91
131981|NCT00876733|303865|P4|COMPLETED|Overall Study||14
131982|NCT00876733|303866|P3|COMPLETED|Overall Study||63
131983|NCT00876733|303867|P2|COMPLETED|Overall Study||161
131984|NCT00876733|303868|P1|COMPLETED|Overall Study||197
131985|NCT00876733|303865|P4|STARTED|Overall Study||21
131986|NCT00876733|303866|P3|STARTED|Overall Study||93
131987|NCT00876733|303867|P2|STARTED|Overall Study||203
131988|NCT00876733|303868|P1|STARTED|Overall Study||288
131989|NCT00876694|303976|P2|NOT COMPLETED|Overall Study||12
131990|NCT00876694|303977|P1|NOT COMPLETED|Overall Study||21
131991|NCT00876694|303976|P2|COMPLETED|Overall Study||49
131992|NCT00876694|303977|P1|COMPLETED|Overall Study||104
131993|NCT00876694|303976|P2|STARTED|Overall Study||61
131994|NCT00876694|303977|P1|STARTED|Overall Study||125
131995|NCT00876460|304003|P8|NOT COMPLETED|Mono Therapy Phase||3
131996|NCT00876460|304004|P7|NOT COMPLETED|Mono Therapy Phase||1
131997|NCT00876460|304005|P6|NOT COMPLETED|Mono Therapy Phase||0
131998|NCT00876460|304006|P5|NOT COMPLETED|Mono Therapy Phase||2
131999|NCT00876460|304007|P4|NOT COMPLETED|Mono Therapy Phase||1
132000|NCT00876460|304008|P3|NOT COMPLETED|Mono Therapy Phase||0
132001|NCT00876460|304009|P2|NOT COMPLETED|Mono Therapy Phase||1
132002|NCT00876460|304010|P1|NOT COMPLETED|Mono Therapy Phase||0
132003|NCT00876460|304003|P8|COMPLETED|Mono Therapy Phase||0
132004|NCT00876460|304004|P7|COMPLETED|Mono Therapy Phase||0
132005|NCT00876460|304005|P6|COMPLETED|Mono Therapy Phase||0
132006|NCT00876460|304006|P5|COMPLETED|Mono Therapy Phase||0
132007|NCT00876460|304007|P4|COMPLETED|Mono Therapy Phase||0
132008|NCT00876460|304008|P3|COMPLETED|Mono Therapy Phase||0
132009|NCT00876460|304009|P2|COMPLETED|Mono Therapy Phase||0
132010|NCT00876460|304010|P1|COMPLETED|Mono Therapy Phase||0
132011|NCT00876460|304003|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
132012|NCT00876460|304004|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
132013|NCT00876460|304005|P6|STARTED|Mono Therapy Phase||0
132014|NCT00876460|304006|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
132015|NCT00876460|304007|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
132016|NCT00876460|304008|P3|STARTED|Mono Therapy Phase||0
132017|NCT00876460|304009|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
132018|NCT00876460|304010|P1|STARTED|Mono Therapy Phase||0
132019|NCT00876460|304003|P8|NOT COMPLETED|Combination Therapy Phase||6
132020|NCT00876460|304004|P7|NOT COMPLETED|Combination Therapy Phase||8
132021|NCT00876460|304005|P6|NOT COMPLETED|Combination Therapy Phase||3
132022|NCT00876460|304006|P5|NOT COMPLETED|Combination Therapy Phase||7
132023|NCT00876460|304007|P4|NOT COMPLETED|Combination Therapy Phase||6
132024|NCT00876460|304008|P3|NOT COMPLETED|Combination Therapy Phase||3
132025|NCT00876460|304009|P2|NOT COMPLETED|Combination Therapy Phase||7
132026|NCT00876460|304010|P1|NOT COMPLETED|Combination Therapy Phase||3
132027|NCT00876460|304003|P8|COMPLETED|Combination Therapy Phase||0
132028|NCT00876460|304004|P7|COMPLETED|Combination Therapy Phase||0
132029|NCT00876460|304005|P6|COMPLETED|Combination Therapy Phase||0
132030|NCT00876460|304006|P5|COMPLETED|Combination Therapy Phase||0
132031|NCT00876460|304007|P4|COMPLETED|Combination Therapy Phase||0
132032|NCT00876460|304008|P3|COMPLETED|Combination Therapy Phase||0
132033|NCT00876460|304009|P2|COMPLETED|Combination Therapy Phase||0
132034|NCT00876460|304010|P1|COMPLETED|Combination Therapy Phase||0
132035|NCT00876460|304003|P8|STARTED|Combination Therapy Phase||6
132036|NCT00876460|304004|P7|STARTED|Combination Therapy Phase||8
132037|NCT00876460|304005|P6|STARTED|Combination Therapy Phase||3
132038|NCT00876460|304006|P5|STARTED|Combination Therapy Phase||7
132039|NCT00876460|304007|P4|STARTED|Combination Therapy Phase||6
132040|NCT00876460|304008|P3|STARTED|Combination Therapy Phase||3
132041|NCT00876460|304009|P2|STARTED|Combination Therapy Phase||7
132042|NCT00876460|304010|P1|STARTED|Combination Therapy Phase||3
132043|NCT00876447|304082|P2|NOT COMPLETED|Overall Study||81
132044|NCT00876447|304083|P1|NOT COMPLETED|Overall Study||80
132045|NCT00876447|304082|P2|COMPLETED|Overall Study||122
132046|NCT00876447|304083|P1|COMPLETED|Overall Study||105
132047|NCT00876447|304082|P2|STARTED|Overall Study||203
132048|NCT00876447|304083|P1|STARTED|Overall Study||185
132049|NCT00876343|304144|P3|NOT COMPLETED|Overall Study||12
132050|NCT00876343|304145|P2|NOT COMPLETED|Overall Study||17
132051|NCT00876343|304146|P1|NOT COMPLETED|Overall Study||17
132052|NCT00876343|304144|P3|COMPLETED|Overall Study||183
132053|NCT00876343|304145|P2|COMPLETED|Overall Study||180
132054|NCT00876343|304146|P1|COMPLETED|Overall Study||177
132055|NCT00876343|304144|P3|STARTED|Overall Study||195
132056|NCT00876343|304145|P2|STARTED|Overall Study||197
132057|NCT00876343|304146|P1|STARTED|Overall Study||194
132058|NCT00876265|304160|P1|NOT COMPLETED|Overall Study||12
132059|NCT00876265|304160|P1|COMPLETED|Overall Study||106
132060|NCT00876265|304160|P1|STARTED|Overall Study||118
132061|NCT00875979|304168|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
132062|NCT00875979|304169|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
132063|NCT00875979|304168|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
132064|NCT00875979|304169|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
132065|NCT00875979|304168|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
132066|NCT00875979|304169|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
132067|NCT00875979|304168|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
132068|NCT00875979|304169|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
132069|NCT00875979|304168|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
132070|NCT00875979|304169|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
132071|NCT00875979|304168|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
132072|NCT00875979|304169|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
132073|NCT00875979|304168|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
132074|NCT00875979|304169|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
132075|NCT00875979|304168|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
132076|NCT00875979|304169|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
132077|NCT00875979|304168|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
132078|NCT00875979|304169|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
132079|NCT00875836|304181|P2|NOT COMPLETED|Overall Study||40
132080|NCT00875836|304182|P1|NOT COMPLETED|Overall Study||43
132081|NCT00875836|304181|P2|COMPLETED|Overall Study||47
132082|NCT00875836|304182|P1|COMPLETED|Overall Study||45
132083|NCT00875836|304181|P2|STARTED|Overall Study||87
132084|NCT00875836|304182|P1|STARTED|Overall Study||88
132085|NCT00875810|304192|P1|NOT COMPLETED|Overall Study||46
132086|NCT00875810|304192|P1|COMPLETED|Overall Study||148
132087|NCT00875810|304192|P1|24 Months Follow up|Overall Study||148
132088|NCT00875810|304192|P1|12 Months Follow up|Overall Study||112
132089|NCT00875810|304192|P1|6 Months Follow up|Overall Study||80
132090|NCT00875810|304192|P1|3 Months Follow up|Overall Study||175
132091|NCT00875810|304192|P1|Discharged|Overall Study||177
132092|NCT00875810|304192|P1|Implanted|Overall Study||190
132093|NCT00875810|304192|P1|STARTED|Overall Study||194
132094|NCT00875797|304201|P2|NOT COMPLETED|Overall Study||3
132095|NCT00875797|304202|P1|NOT COMPLETED|Overall Study||6
132096|NCT00875797|304201|P2|COMPLETED|Overall Study||42
132097|NCT00875797|304202|P1|COMPLETED|Overall Study||39
132098|NCT00875797|304201|P2|STARTED|Overall Study||45
132099|NCT00875797|304202|P1|STARTED|Overall Study||45
132100|NCT00875706|304215|P3|NOT COMPLETED|Overall Study||0
132101|NCT00875706|304216|P2|NOT COMPLETED|Overall Study||0
132102|NCT00875706|304217|P1|NOT COMPLETED|Overall Study||1
132103|NCT00875706|304215|P3|COMPLETED|Overall Study||13
132104|NCT00875706|304216|P2|COMPLETED|Overall Study||24
132105|NCT00875706|304217|P1|COMPLETED|Overall Study||7
132106|NCT00875706|304215|P3|STARTED|Overall Study||13
132107|NCT00875706|304216|P2|STARTED|Overall Study||24
132108|NCT00875706|304217|P1|STARTED|Overall Study||8
132109|NCT00875615|304234|P1|NOT COMPLETED|Overall Study||1
132110|NCT00875615|304234|P1|COMPLETED|Overall Study||10
132111|NCT00875615|304234|P1|STARTED|Overall Study||11
132112|NCT00875589|304241|P2|NOT COMPLETED|Overall Study||0
132113|NCT00875589|304242|P1|NOT COMPLETED|Overall Study||0
132114|NCT00875589|304241|P2|COMPLETED|Overall Study||11
132115|NCT00875589|304242|P1|COMPLETED|Overall Study||15
132116|NCT00875589|304241|P2|STARTED|Overall Study||11
132117|NCT00875589|304242|P1|STARTED|Overall Study||15
132118|NCT00875563|304248|P1|NOT COMPLETED|Overall Study||24
132119|NCT00875563|304248|P1|COMPLETED|Overall Study||18
132120|NCT00875563|304248|P1|STARTED|Overall Study||42
132121|NCT00875550|304254|P2|NOT COMPLETED|Overall Study||10
132122|NCT00875550|304255|P1|NOT COMPLETED|Overall Study||12
132123|NCT00875550|304254|P2|COMPLETED|Overall Study||76
132124|NCT00875550|304255|P1|COMPLETED|Overall Study||77
132125|NCT00875550|304254|P2|STARTED|Overall Study||86
132126|NCT00875550|304255|P1|STARTED|Overall Study||89
132127|NCT00875485|304273|P2|NOT COMPLETED|Challenge Dose Epoch||0
132128|NCT00875485|304274|P1|NOT COMPLETED|Challenge Dose Epoch||1
132129|NCT00875485|304273|P2|COMPLETED|Challenge Dose Epoch||11
132130|NCT00875485|304274|P1|COMPLETED|Challenge Dose Epoch||7
132131|NCT00875485|304273|P2|STARTED|Challenge Dose Epoch||11
132132|NCT00875485|304274|P1|STARTED|Challenge Dose Epoch||8
132133|NCT00875485|304273|P2|NOT COMPLETED|Year 15||0
132134|NCT00875485|304274|P1|NOT COMPLETED|Year 15||0
132135|NCT00875485|304273|P2|COMPLETED|Year 15||111
132136|NCT00875485|304274|P1|COMPLETED|Year 15||98
132137|NCT00875485|304273|P2|STARTED|Year 15||111
132138|NCT00875485|304274|P1|STARTED|Year 15||98
132139|NCT00875485|304273|P2|NOT COMPLETED|Year 14||0
132140|NCT00875485|304274|P1|NOT COMPLETED|Year 14||0
132141|NCT00875485|304273|P2|COMPLETED|Year 14||113
132142|NCT00875485|304274|P1|COMPLETED|Year 14||100
132143|NCT00875485|304273|P2|STARTED|Year 14||113
132144|NCT00875485|304274|P1|STARTED|Year 14||100
132145|NCT00875485|304273|P2|NOT COMPLETED|Year 13||0
132146|NCT00875485|304274|P1|NOT COMPLETED|Year 13||0
132147|NCT00875485|304273|P2|COMPLETED|Year 13||113
132148|NCT00875485|304274|P1|COMPLETED|Year 13||102
132149|NCT00875485|304273|P2|STARTED|Year 13||113
132150|NCT00875485|304274|P1|STARTED|Year 13||102
132151|NCT00875485|304273|P2|NOT COMPLETED|Year 12||0
132152|NCT00875485|304274|P1|NOT COMPLETED|Year 12||0
132153|NCT00875485|304273|P2|COMPLETED|Year 12||109
132154|NCT00875485|304274|P1|COMPLETED|Year 12||101
132155|NCT00875485|304273|P2|STARTED|Year 12||109
132156|NCT00875485|304274|P1|STARTED|Year 12||101
132157|NCT00875485|304273|P2|NOT COMPLETED|Year 11||0
132158|NCT00875485|304274|P1|NOT COMPLETED|Year 11||0
132159|NCT00875485|304273|P2|COMPLETED|Year 11||111
132160|NCT00875485|304274|P1|COMPLETED|Year 11||99
132161|NCT00875485|304273|P2|STARTED|Year 11||111
132162|NCT00875485|304274|P1|STARTED|Year 11||99
132163|NCT00875433|304314|P1|NOT COMPLETED|Overall Study||60
132164|NCT00875433|304314|P1|COMPLETED|Overall Study||0
132165|NCT00875433|304314|P1|STARTED|Overall Study|Treated|60
132166|NCT00875420|304344|P5|NOT COMPLETED|Overall Study||2
132167|NCT00875420|304345|P4|NOT COMPLETED|Overall Study||2
132168|NCT00875420|304346|P3|NOT COMPLETED|Overall Study||3
132169|NCT00875420|304347|P2|NOT COMPLETED|Overall Study||2
132170|NCT00875420|304348|P1|NOT COMPLETED|Overall Study||2
132171|NCT00875420|304344|P5|COMPLETED|Overall Study||17
132172|NCT00875420|304345|P4|COMPLETED|Overall Study||16
132173|NCT00875420|304346|P3|COMPLETED|Overall Study||18
132174|NCT00875420|304347|P2|COMPLETED|Overall Study||18
132175|NCT00875420|304348|P1|COMPLETED|Overall Study||20
132176|NCT00875420|304344|P5|STARTED|Overall Study||19
132177|NCT00875420|304345|P4|STARTED|Overall Study||18
132178|NCT00875420|304346|P3|STARTED|Overall Study||21
132179|NCT00875420|304347|P2|STARTED|Overall Study||20
132180|NCT00875420|304348|P1|STARTED|Overall Study||22
132181|NCT00875394|304378|P3|NOT COMPLETED|Overall Study||0
132182|NCT00875394|304379|P2|NOT COMPLETED|Overall Study||0
132183|NCT00875394|304380|P1|NOT COMPLETED|Overall Study||0
132184|NCT00875394|304378|P3|COMPLETED|Overall Study||9
132185|NCT00875394|304379|P2|COMPLETED|Overall Study||23
132186|NCT00875394|304380|P1|COMPLETED|Overall Study||36
132187|NCT00875394|304378|P3|STARTED|Overall Study||9
132188|NCT00875394|304379|P2|STARTED|Overall Study||23
132189|NCT00875394|304380|P1|STARTED|Overall Study||36
132190|NCT00875329|304388|P1|NOT COMPLETED|Overall Study||0
132191|NCT00875329|304388|P1|COMPLETED|Overall Study||97
132192|NCT00875329|304388|P1|STARTED|Overall Study||97
132193|NCT00875212|304392|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
132194|NCT00875212|304392|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
132195|NCT00875212|304392|P1|STARTED|CaGP and Fluoride Dentifrice||12
132196|NCT00875212|304392|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
132197|NCT00875212|304392|P1|COMPLETED|Fluoride Only Dentifrice||12
132198|NCT00875212|304392|P1|STARTED|Fluoride Only Dentifrice||12
132199|NCT00875212|304392|P1|NOT COMPLETED|CaGP Only Dentifrice||0
132200|NCT00875212|304392|P1|COMPLETED|CaGP Only Dentifrice||12
132201|NCT00875212|304392|P1|STARTED|CaGP Only Dentifrice||12
132202|NCT00875212|304392|P1|NOT COMPLETED|Placebo Dentifrice||0
132203|NCT00875212|304392|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
132204|NCT00875212|304392|P1|STARTED|Placebo Dentifrice||12
132205|NCT00874939|304403|P1|NOT COMPLETED|Overall Study||4
132206|NCT00874939|304403|P1|COMPLETED|Overall Study||0
132207|NCT00874939|304403|P1|Treated|Overall Study||0
132208|NCT00874939|304403|P1|STARTED|Overall Study||4
132209|NCT00874887|304419|P2|NOT COMPLETED|Overall Study||0
132210|NCT00874887|304420|P1|NOT COMPLETED|Overall Study||0
132211|NCT00874887|304419|P2|COMPLETED|Overall Study||34
132212|NCT00874887|304420|P1|COMPLETED|Overall Study||32
132213|NCT00874887|304419|P2|STARTED|Overall Study||34
132214|NCT00874887|304420|P1|STARTED|Overall Study||32
132215|NCT00874848|304436|P2|NOT COMPLETED|Overall Study||28
132216|NCT00874848|304437|P1|NOT COMPLETED|Overall Study||59
132217|NCT00874848|304436|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
132218|NCT00874848|304437|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
132219|NCT00874848|304436|P2|Discontinued|Overall Study||28
132220|NCT00874848|304437|P1|Discontinued|Overall Study||59
132221|NCT00874848|304436|P2|STARTED|Overall Study||29
132222|NCT00874848|304437|P1|STARTED|Overall Study||59
132223|NCT00874822|304453|P1|NOT COMPLETED|Overall Study||8
132224|NCT00874822|304453|P1|COMPLETED|Overall Study||208
132225|NCT00874822|304453|P1|STARTED|Overall Study||216
132226|NCT00874770|304461|P4|NOT COMPLETED|Overall Study||5
132227|NCT00874770|304462|P3|NOT COMPLETED|Overall Study||4
132228|NCT00874770|304463|P2|NOT COMPLETED|Overall Study||1
132229|NCT00874770|304464|P1|NOT COMPLETED|Overall Study||5
132230|NCT00874770|304461|P4|COMPLETED|Overall Study||7
132231|NCT00874770|304462|P3|COMPLETED|Overall Study||8
132232|NCT00874770|304463|P2|COMPLETED|Overall Study||11
132233|NCT00874770|304464|P1|COMPLETED|Overall Study||7
132234|NCT00874770|304461|P4|STARTED|Overall Study||12
132235|NCT00874770|304462|P3|STARTED|Overall Study||12
132236|NCT00874770|304463|P2|STARTED|Overall Study||12
132237|NCT00874770|304464|P1|STARTED|Overall Study||12
132238|NCT00874549|304502|P4|NOT COMPLETED|Overall Study||2
132239|NCT00874549|304503|P3|NOT COMPLETED|Overall Study||4
132240|NCT00874549|304504|P2|NOT COMPLETED|Overall Study||1
132241|NCT00874549|304505|P1|NOT COMPLETED|Overall Study||1
132242|NCT00874549|304502|P4|COMPLETED|Overall Study||56
132243|NCT00874549|304503|P3|COMPLETED|Overall Study||47
132244|NCT00874549|304504|P2|COMPLETED|Overall Study||55
132245|NCT00874549|304505|P1|COMPLETED|Overall Study||50
132246|NCT00874549|304502|P4|STARTED|Overall Study||58
132247|NCT00874549|304503|P3|STARTED|Overall Study||51
132248|NCT00874549|304504|P2|STARTED|Overall Study||56
132249|NCT00874549|304505|P1|STARTED|Overall Study||51
132250|NCT00874510|304573|P2|NOT COMPLETED|Year 2||0
132251|NCT00874510|304574|P1|NOT COMPLETED|Year 2||0
132252|NCT00874510|304573|P2|COMPLETED|Year 2||87
132253|NCT00874510|304574|P1|COMPLETED|Year 2||92
132254|NCT00874510|304573|P2|STARTED|Year 2||87
132255|NCT00874510|304574|P1|STARTED|Year 2||92
132256|NCT00874510|304573|P2|NOT COMPLETED|Year 1||0
132257|NCT00874510|304574|P1|NOT COMPLETED|Year 1||0
132258|NCT00874510|304573|P2|COMPLETED|Year 1||85
132259|NCT00874510|304574|P1|COMPLETED|Year 1||88
132260|NCT00874510|304573|P2|STARTED|Year 1||85
132261|NCT00874510|304574|P1|STARTED|Year 1||88
132262|NCT00874276|304582|P2|NOT COMPLETED|Overall Study||1
132263|NCT00874276|304583|P1|NOT COMPLETED|Overall Study||1
132264|NCT00874276|304582|P2|COMPLETED|Overall Study||7
132265|NCT00874276|304583|P1|COMPLETED|Overall Study||5
132266|NCT00874276|304582|P2|STARTED|Overall Study||8
132267|NCT00874276|304583|P1|STARTED|Overall Study||6
132268|NCT00874250|304591|P1|NOT COMPLETED|Overall Study||51
132269|NCT00874250|304591|P1|COMPLETED|Overall Study||0
132270|NCT00874250|304591|P1|STARTED|Overall Study||51
132271|NCT00874120|304603|P2|NOT COMPLETED|Second Intervention||0
132272|NCT00874120|304604|P1|NOT COMPLETED|Second Intervention||2
132273|NCT00874120|304603|P2|COMPLETED|Second Intervention||56
132274|NCT00874120|304604|P1|COMPLETED|Second Intervention||50
132275|NCT00874120|304603|P2|STARTED|Second Intervention||56
132276|NCT00874120|304604|P1|STARTED|Second Intervention||52
132277|NCT00874120|304603|P2|NOT COMPLETED|Wash-out Period||0
132278|NCT00874120|304604|P1|NOT COMPLETED|Wash-out Period||0
132279|NCT00874120|304603|P2|COMPLETED|Wash-out Period||56
132280|NCT00874120|304604|P1|COMPLETED|Wash-out Period||52
132281|NCT00874120|304603|P2|STARTED|Wash-out Period||56
132282|NCT00874120|304604|P1|STARTED|Wash-out Period||52
132283|NCT00874120|304603|P2|NOT COMPLETED|First Intervention||2
132284|NCT00874120|304604|P1|NOT COMPLETED|First Intervention||6
132285|NCT00874120|304603|P2|COMPLETED|First Intervention||56
132286|NCT00874120|304604|P1|COMPLETED|First Intervention||52
132287|NCT00874120|304603|P2|STARTED|First Intervention||58
132288|NCT00874120|304604|P1|STARTED|First Intervention||58
132289|NCT00874094|304610|P1|NOT COMPLETED|Overall Study||0
132290|NCT00874094|304610|P1|COMPLETED|Overall Study||15
132291|NCT00874094|304610|P1|STARTED|Overall Study||15
132292|NCT00874029|304617|P1|NOT COMPLETED|Overall Study||21
132293|NCT00874029|304617|P1|COMPLETED|Overall Study||116
132294|NCT00874029|304617|P1|STARTED|Overall Study||137
132295|NCT00873912|304633|P2|NOT COMPLETED|Overall Study||0
132296|NCT00873912|304634|P1|NOT COMPLETED|Overall Study||3
132297|NCT00873912|304633|P2|COMPLETED|Overall Study||60
132298|NCT00873912|304634|P1|COMPLETED|Overall Study||237
132299|NCT00873912|304633|P2|STARTED|Overall Study||60
132300|NCT00873912|304634|P1|STARTED|Overall Study||240
132301|NCT00873873|304652|P4|NOT COMPLETED|Overall Study||0
132302|NCT00873873|304653|P3|NOT COMPLETED|Overall Study||0
132303|NCT00873873|304654|P2|NOT COMPLETED|Overall Study||0
132304|NCT00873873|304655|P1|NOT COMPLETED|Overall Study||0
132305|NCT00873873|304652|P4|COMPLETED|Overall Study||18
132306|NCT00873873|304653|P3|COMPLETED|Overall Study||9
132307|NCT00873873|304654|P2|COMPLETED|Overall Study||8
132308|NCT00873873|304655|P1|COMPLETED|Overall Study||20
132309|NCT00873873|304652|P4|STARTED|Overall Study||18
132310|NCT00873873|304653|P3|STARTED|Overall Study||9
132311|NCT00873873|304654|P2|STARTED|Overall Study||8
132312|NCT00873873|304655|P1|STARTED|Overall Study||20
132313|NCT00873821|304671|P2|NOT COMPLETED|Overall Study||0
132314|NCT00873821|304672|P1|NOT COMPLETED|Overall Study||0
132315|NCT00873821|304671|P2|COMPLETED|Overall Study||22
132316|NCT00873821|304672|P1|COMPLETED|Overall Study||22
132317|NCT00873821|304671|P2|STARTED|Overall Study||22
132318|NCT00873821|304672|P1|STARTED|Overall Study||22
132319|NCT00873782|304682|P1|NOT COMPLETED|Overall Study||0
132320|NCT00873782|304682|P1|COMPLETED|Overall Study||16
132321|NCT00873782|304682|P1|STARTED|Overall Study||16
132322|NCT00873730|304688|P2|NOT COMPLETED|Overall Study||5
132323|NCT00873730|304689|P1|NOT COMPLETED|Overall Study||6
132324|NCT00873730|304688|P2|COMPLETED|Overall Study||49
132325|NCT00873730|304689|P1|COMPLETED|Overall Study||48
132326|NCT00873730|304688|P2|STARTED|Overall Study||54
132327|NCT00873730|304689|P1|STARTED|Overall Study||54
132328|NCT00873457|304725|P1|NOT COMPLETED|Overall Study||0
132329|NCT00873457|304725|P1|COMPLETED|Overall Study||16
132330|NCT00873457|304725|P1|STARTED|Overall Study||16
132331|NCT00873327|304732|P1|NOT COMPLETED|Overall Study||0
132332|NCT00873327|304732|P1|COMPLETED|Overall Study||32
132333|NCT00873327|304732|P1|STARTED|Overall Study||32
132334|NCT00873119|304738|P2|NOT COMPLETED|Overall Study||26
132335|NCT00873119|304739|P1|NOT COMPLETED|Overall Study||44
132336|NCT00873119|304738|P2|COMPLETED|Overall Study||19
132337|NCT00873119|304739|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
132338|NCT00873119|304738|P2|STARTED|Overall Study||45
132339|NCT00873119|304739|P1|STARTED|Overall Study||44
132340|NCT00873093|304760|P5|NOT COMPLETED|Overall Study||2
132341|NCT00873093|304761|P4|NOT COMPLETED|Overall Study||11
132342|NCT00873093|304762|P3|NOT COMPLETED|Overall Study||16
132343|NCT00873093|304763|P2|NOT COMPLETED|Overall Study||27
132344|NCT00873093|304764|P1|NOT COMPLETED|Overall Study||1
132345|NCT00873093|304760|P5|COMPLETED|Overall Study||8
132346|NCT00873093|304761|P4|COMPLETED|Overall Study||12
132347|NCT00873093|304762|P3|COMPLETED|Overall Study||33
132348|NCT00873093|304763|P2|COMPLETED|Overall Study||35
132349|NCT00873093|304764|P1|COMPLETED|Overall Study||3
132350|NCT00873093|304760|P5|STARTED|Overall Study||10
132351|NCT00873093|304761|P4|STARTED|Overall Study||23
132352|NCT00873093|304762|P3|STARTED|Overall Study||49
132353|NCT00873093|304763|P2|STARTED|Overall Study||62
132354|NCT00873093|304764|P1|STARTED|Overall Study||4
132355|NCT00873041|304821|P3|NOT COMPLETED|Extension Study||2
132356|NCT00873041|304822|P2|NOT COMPLETED|Extension Study||0
132357|NCT00873041|304823|P1|NOT COMPLETED|Extension Study||1
132358|NCT00873041|304821|P3|COMPLETED|Extension Study||46
132359|NCT00873041|304822|P2|COMPLETED|Extension Study||44
132360|NCT00873041|304823|P1|COMPLETED|Extension Study||40
132361|NCT00873041|304821|P3|STARTED|Extension Study||48
132362|NCT00873041|304822|P2|STARTED|Extension Study||44
132363|NCT00873041|304823|P1|STARTED|Extension Study||41
132364|NCT00873041|304821|P3|NOT COMPLETED|Core Study||5
132365|NCT00873041|304822|P2|NOT COMPLETED|Core Study||6
132366|NCT00873041|304823|P1|NOT COMPLETED|Core Study||7
132367|NCT00873041|304821|P3|COMPLETED|Core Study||51
132368|NCT00873041|304822|P2|COMPLETED|Core Study||49
132369|NCT00873041|304823|P1|COMPLETED|Core Study||48
132370|NCT00873041|304821|P3|STARTED|Core Study||56
132371|NCT00873041|304822|P2|STARTED|Core Study||55
132372|NCT00873041|304823|P1|STARTED|Core Study||55
132373|NCT00873015|304881|P4|NOT COMPLETED|Overall Study||0
132374|NCT00873015|304882|P3|NOT COMPLETED|Overall Study||0
132375|NCT00873015|304883|P2|NOT COMPLETED|Overall Study||1
132376|NCT00873015|304884|P1|NOT COMPLETED|Overall Study||0
132377|NCT00873015|304881|P4|COMPLETED|Overall Study||3
132378|NCT00873015|304882|P3|COMPLETED|Overall Study||3
132379|NCT00873015|304883|P2|COMPLETED|Overall Study||3
132380|NCT00873015|304884|P1|COMPLETED|Overall Study||9
132381|NCT00873015|304881|P4|STARTED|Overall Study||3
132382|NCT00873015|304882|P3|STARTED|Overall Study||3
132383|NCT00873015|304883|P2|STARTED|Overall Study||4
132384|NCT00873015|304884|P1|STARTED|Overall Study||9
132385|NCT00872989|304893|P2|NOT COMPLETED|Overall Study||63
132386|NCT00872989|304894|P1|NOT COMPLETED|Overall Study||65
132387|NCT00872989|304893|P2|COMPLETED|Overall Study||0
132388|NCT00872989|304894|P1|COMPLETED|Overall Study||1
132389|NCT00872989|304893|P2|STARTED|Overall Study||63
132390|NCT00872989|304894|P1|STARTED|Overall Study||66
132391|NCT00872898|304913|P2|NOT COMPLETED|Part Two - Double Blind||6
132392|NCT00872898|304914|P1|NOT COMPLETED|Part Two - Double Blind||11
132393|NCT00872898|304913|P2|COMPLETED|Part Two - Double Blind||54
132394|NCT00872898|304914|P1|COMPLETED|Part Two - Double Blind||50
132395|NCT00872898|304913|P2|STARTED|Part Two - Double Blind||60
132396|NCT00872898|304914|P1|STARTED|Part Two - Double Blind||61
132397|NCT00872898|304913|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
132398|NCT00872898|304914|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
132399|NCT00872898|304913|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
132400|NCT00872898|304914|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
132401|NCT00872898|304913|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
132402|NCT00872898|304914|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
132403|NCT00872833|304948|P2|NOT COMPLETED|Overall Study||0
132404|NCT00872833|304949|P1|NOT COMPLETED|Overall Study||0
132405|NCT00872833|304948|P2|COMPLETED|Overall Study||17
132406|NCT00872833|304949|P1|COMPLETED|Overall Study||15
132407|NCT00872833|304948|P2|STARTED|Overall Study||17
132408|NCT00872833|304949|P1|STARTED|Overall Study||15
132409|NCT00872729|304958|P1|NOT COMPLETED|Overall Study||0
132410|NCT00872729|304958|P1|COMPLETED|Overall Study||9
132411|NCT00872729|304958|P1|STARTED|Overall Study||9
132412|NCT00872599|304988|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
132413|NCT00872599|304989|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
132414|NCT00872599|304988|P2|COMPLETED|Second Drug During High Salt Intake||16
132415|NCT00872599|304989|P1|COMPLETED|Second Drug During High Salt Intake||15
132416|NCT00872599|304988|P2|STARTED|Second Drug During High Salt Intake||16
132417|NCT00872599|304989|P1|STARTED|Second Drug During High Salt Intake||15
132418|NCT00872599|304988|P2|NOT COMPLETED|Second Washout Period||1
132419|NCT00872599|304989|P1|NOT COMPLETED|Second Washout Period||1
132420|NCT00872599|304988|P2|COMPLETED|Second Washout Period||16
132421|NCT00872599|304989|P1|COMPLETED|Second Washout Period||15
132422|NCT00872599|304988|P2|STARTED|Second Washout Period||17
132423|NCT00872599|304989|P1|STARTED|Second Washout Period||16
132424|NCT00872599|304988|P2|NOT COMPLETED|First Drug During High Salt Intake||0
132425|NCT00872599|304989|P1|NOT COMPLETED|First Drug During High Salt Intake||0
132426|NCT00872599|304988|P2|COMPLETED|First Drug During High Salt Intake||17
132427|NCT00872599|304989|P1|COMPLETED|First Drug During High Salt Intake||16
132428|NCT00872599|304988|P2|STARTED|First Drug During High Salt Intake||17
132429|NCT00872599|304989|P1|STARTED|First Drug During High Salt Intake||16
132430|NCT00872599|304988|P2|NOT COMPLETED|First Washout Period After Low Salt||0
132431|NCT00872599|304989|P1|NOT COMPLETED|First Washout Period After Low Salt||0
132432|NCT00872599|304988|P2|COMPLETED|First Washout Period After Low Salt||17
132433|NCT00872599|304989|P1|COMPLETED|First Washout Period After Low Salt||16
132434|NCT00872599|304988|P2|STARTED|First Washout Period After Low Salt||17
132435|NCT00872599|304989|P1|STARTED|First Washout Period After Low Salt||16
132436|NCT00872534|304999|P2|NOT COMPLETED|Overall Study||3
132437|NCT00872534|305000|P1|NOT COMPLETED|Overall Study||3
132438|NCT00872534|304999|P2|COMPLETED|Overall Study||101
132439|NCT00872534|305000|P1|COMPLETED|Overall Study||97
132440|NCT00872534|304999|P2|STARTED|Overall Study||104
132441|NCT00872534|305000|P1|STARTED|Overall Study||100
132442|NCT00872521|305009|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
132443|NCT00872521|305010|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
132444|NCT00872521|305011|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
132445|NCT00872521|305009|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
132446|NCT00872521|305010|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
132447|NCT00872521|305011|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
132448|NCT00872521|305009|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
132449|NCT00872521|305010|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
132450|NCT00872521|305011|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
132451|NCT00872521|305009|P3|NOT COMPLETED|Completed 3-month Follow up||0
132452|NCT00872521|305010|P2|NOT COMPLETED|Completed 3-month Follow up||3
132453|NCT00872521|305011|P1|NOT COMPLETED|Completed 3-month Follow up||0
132454|NCT00872521|305009|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
132455|NCT00872521|305010|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
132456|NCT00872521|305011|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
132457|NCT00872521|305009|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
132458|NCT00872521|305010|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
132459|NCT00872521|305011|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
132460|NCT00872521|305009|P3|NOT COMPLETED|Primary Endpoint Analysis||1
132461|NCT00872521|305010|P2|NOT COMPLETED|Primary Endpoint Analysis||5
132462|NCT00872521|305011|P1|NOT COMPLETED|Primary Endpoint Analysis||1
132463|NCT00872521|305009|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
132464|NCT00872521|305010|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
132465|NCT00872521|305011|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
132466|NCT00872521|305009|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
132467|NCT00872521|305010|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
132468|NCT00872521|305011|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
132469|NCT00872521|305009|P3|NOT COMPLETED|Completed PAD Induction||0
132470|NCT00872521|305010|P2|NOT COMPLETED|Completed PAD Induction||4
132471|NCT00872521|305011|P1|NOT COMPLETED|Completed PAD Induction||5
132472|NCT00872521|305009|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
132473|NCT00872521|305010|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
132474|NCT00872521|305011|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
132475|NCT00872521|305009|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
132476|NCT00872521|305010|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
132477|NCT00872521|305011|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
132478|NCT00872430|305059|P2|NOT COMPLETED|Second Intervention||0
132479|NCT00872430|305060|P1|NOT COMPLETED|Second Intervention||0
132480|NCT00872430|305059|P2|COMPLETED|Second Intervention||10
132481|NCT00872430|305060|P1|COMPLETED|Second Intervention||10
132482|NCT00872430|305059|P2|STARTED|Second Intervention||10
132483|NCT00872430|305060|P1|STARTED|Second Intervention||10
132484|NCT00872430|305059|P2|NOT COMPLETED|Washout Period||0
132485|NCT00872430|305060|P1|NOT COMPLETED|Washout Period||0
132486|NCT00872430|305059|P2|COMPLETED|Washout Period||10
132487|NCT00872430|305060|P1|COMPLETED|Washout Period||10
132488|NCT00872430|305059|P2|STARTED|Washout Period||10
132489|NCT00872430|305060|P1|STARTED|Washout Period||10
132490|NCT00872430|305059|P2|NOT COMPLETED|First Intervention||0
132491|NCT00872430|305060|P1|NOT COMPLETED|First Intervention||0
132492|NCT00872430|305059|P2|COMPLETED|First Intervention||10
132493|NCT00872430|305060|P1|COMPLETED|First Intervention||10
132494|NCT00872430|305059|P2|STARTED|First Intervention||10
132495|NCT00872430|305060|P1|STARTED|First Intervention||10
132496|NCT00872339|305069|P3|NOT COMPLETED|Overall Study||0
132497|NCT00872339|305070|P2|NOT COMPLETED|Overall Study||0
132498|NCT00872339|305071|P1|NOT COMPLETED|Overall Study||0
132499|NCT00872339|305069|P3|COMPLETED|Overall Study||37
132500|NCT00872339|305070|P2|COMPLETED|Overall Study||14
132501|NCT00872339|305071|P1|COMPLETED|Overall Study||201
132502|NCT00872339|305069|P3|STARTED|Overall Study||37
132503|NCT00872339|305070|P2|STARTED|Overall Study||14
132504|NCT00872339|305071|P1|STARTED|Overall Study||201
132505|NCT00872170|305082|P2|NOT COMPLETED|Overall Study||0
132506|NCT00872170|305083|P1|NOT COMPLETED|Overall Study||1
132507|NCT00872170|305082|P2|COMPLETED|Overall Study||13
132508|NCT00872170|305083|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
132509|NCT00872170|305082|P2|STARTED|Overall Study||13
132510|NCT00872170|305083|P1|STARTED|Overall Study||14
132511|NCT00872079|305098|P1|NOT COMPLETED|Overall Study||0
132512|NCT00872079|305098|P1|COMPLETED|Overall Study||175
132513|NCT00872079|305098|P1|STARTED|Overall Study||175
132514|NCT00872001|305104|P2|NOT COMPLETED|Overall Study||131
132515|NCT00872001|305105|P1|NOT COMPLETED|Overall Study||136
132516|NCT00872001|305104|P2|COMPLETED|Overall Study||1413
132517|NCT00872001|305105|P1|COMPLETED|Overall Study||1400
132518|NCT00872001|305104|P2|STARTED|Overall Study||1544
132519|NCT00872001|305105|P1|STARTED|Overall Study||1536
132520|NCT00871975|305113|P1|NOT COMPLETED|Overall Study||22
132521|NCT00871975|305113|P1|COMPLETED|Overall Study||133
132522|NCT00871975|305113|P1|STARTED|Overall Study||155
132523|NCT00871871|305119|P4|NOT COMPLETED|Part II||4
132524|NCT00871871|305120|P3|NOT COMPLETED|Part II||4
132525|NCT00871871|305121|P2|NOT COMPLETED|Part II||0
132526|NCT00871871|305122|P1|NOT COMPLETED|Part II||0
132527|NCT00871871|305119|P4|COMPLETED|Part II||11
132528|NCT00871871|305120|P3|COMPLETED|Part II||9
132529|NCT00871871|305121|P2|COMPLETED|Part II||0
132530|NCT00871871|305122|P1|COMPLETED|Part II||0
132531|NCT00871871|305119|P4|STARTED|Part II||15
132532|NCT00871871|305120|P3|STARTED|Part II||13
132533|NCT00871871|305121|P2|STARTED|Part II||0
132534|NCT00871871|305122|P1|STARTED|Part II||0
132535|NCT00871871|305119|P4|NOT COMPLETED|Part I||0
132536|NCT00871871|305120|P3|NOT COMPLETED|Part I||0
132537|NCT00871871|305121|P2|NOT COMPLETED|Part I||3
132538|NCT00871871|305122|P1|NOT COMPLETED|Part I||3
132539|NCT00871871|305119|P4|COMPLETED|Part I||0
132540|NCT00871871|305120|P3|COMPLETED|Part I||0
132541|NCT00871871|305121|P2|COMPLETED|Part I||15
132542|NCT00871871|305122|P1|COMPLETED|Part I||15
132543|NCT00871871|305119|P4|STARTED|Part I||0
132544|NCT00871871|305120|P3|STARTED|Part I||0
132545|NCT00871871|305121|P2|STARTED|Part I||18
132546|NCT00871871|305122|P1|STARTED|Part I||18
132547|NCT00871819|305142|P1|NOT COMPLETED|Overall Study||0
132548|NCT00871819|305142|P1|COMPLETED|Overall Study||20
132549|NCT00871819|305142|P1|STARTED|Overall Study||20
132550|NCT00871780|305146|P1|NOT COMPLETED|Overall Study||27
132551|NCT00871780|305146|P1|COMPLETED|Overall Study||197
132552|NCT00871780|305146|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
132553|NCT00871780|305146|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
132554|NCT00871780|305146|P1|STARTED|Overall Study|number enrolled|224
132555|NCT00871728|305164|P1|NOT COMPLETED|Overall Study||20
132556|NCT00871728|305164|P1|COMPLETED|Overall Study||112
132557|NCT00871728|305164|P1|Treated|Overall Study||130
132558|NCT00871728|305164|P1|STARTED|Overall Study||132
132559|NCT00871715|305177|P3|NOT COMPLETED|Overall Study||26
132560|NCT00871715|305178|P2|NOT COMPLETED|Overall Study||16
132561|NCT00871715|305179|P1|NOT COMPLETED|Overall Study||15
132562|NCT00871715|305177|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
132563|NCT00871715|305178|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
132564|NCT00871715|305179|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
132565|NCT00871715|305177|P3|6-mo Follow-up|Overall Study||112
132566|NCT00871715|305178|P2|6-mo Follow-up|Overall Study||113
132567|NCT00871715|305179|P1|6-mo Follow-up|Overall Study||110
132568|NCT00871715|305177|P3|Post-Intervention|Overall Study||115
132569|NCT00871715|305178|P2|Post-Intervention|Overall Study||115
132570|NCT00871715|305179|P1|Post-Intervention|Overall Study||112
132571|NCT00871715|305177|P3|STARTED|Overall Study||122
132572|NCT00871715|305178|P2|STARTED|Overall Study||120
132573|NCT00871715|305179|P1|STARTED|Overall Study||119
132574|NCT00871689|305197|P1|NOT COMPLETED|Overall Study||0
132575|NCT00871689|305197|P1|COMPLETED|Overall Study||2
132576|NCT00871689|305197|P1|STARTED|Overall Study||2
132577|NCT00871624|305210|P2|NOT COMPLETED|Overall Study||1
132578|NCT00871624|305211|P1|NOT COMPLETED|Overall Study||2
132579|NCT00871624|305210|P2|COMPLETED|Overall Study||17
132580|NCT00871624|305211|P1|COMPLETED|Overall Study||16
132581|NCT00871624|305210|P2|STARTED|Overall Study||18
132582|NCT00871624|305211|P1|STARTED|Overall Study||18
132583|NCT00871494|305217|P1|NOT COMPLETED|Overall Study||14
132584|NCT00871494|305217|P1|COMPLETED|Overall Study||62
132585|NCT00871494|305217|P1|STARTED|Overall Study||76
132586|NCT00871429|305224|P1|NOT COMPLETED|Overall Study||24
132587|NCT00871429|305224|P1|COMPLETED|Overall Study||75
132588|NCT00871429|305224|P1|STARTED|Overall Study||99
132589|NCT00871403|305235|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
132590|NCT00871403|305236|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
132591|NCT00871403|305237|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
132592|NCT00871403|305235|P3|COMPLETED|Monotherapy Treatment Phase||0
132593|NCT00871403|305236|P2|COMPLETED|Monotherapy Treatment Phase||0
132594|NCT00871403|305237|P1|COMPLETED|Monotherapy Treatment Phase||0
132595|NCT00871403|305235|P3|STARTED|Monotherapy Treatment Phase||1
132596|NCT00871403|305236|P2|STARTED|Monotherapy Treatment Phase||13
132597|NCT00871403|305237|P1|STARTED|Monotherapy Treatment Phase||0
132598|NCT00871403|305235|P3|NOT COMPLETED|Combination Treatment Phase||12
132599|NCT00871403|305236|P2|NOT COMPLETED|Combination Treatment Phase||49
132600|NCT00871403|305237|P1|NOT COMPLETED|Combination Treatment Phase||9
132601|NCT00871403|305235|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
132602|NCT00871403|305236|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
132603|NCT00871403|305237|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
132604|NCT00871403|305235|P3|STARTED|Combination Treatment Phase||35
132605|NCT00871403|305236|P2|STARTED|Combination Treatment Phase||62
132606|NCT00871403|305237|P1|STARTED|Combination Treatment Phase||9
132607|NCT00871377|305250|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
132608|NCT00871377|305251|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
132609|NCT00871377|305252|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
132610|NCT00871377|305253|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
132611|NCT00871377|305254|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
132612|NCT00871377|305255|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
132613|NCT00871377|305250|P6|COMPLETED|Third Intervention (10 Weeks)||3
132614|NCT00871377|305251|P5|COMPLETED|Third Intervention (10 Weeks)||4
132615|NCT00871377|305252|P4|COMPLETED|Third Intervention (10 Weeks)||3
132616|NCT00871377|305253|P3|COMPLETED|Third Intervention (10 Weeks)||3
132617|NCT00871377|305254|P2|COMPLETED|Third Intervention (10 Weeks)||4
132618|NCT00871377|305255|P1|COMPLETED|Third Intervention (10 Weeks)||2
132619|NCT00871377|305250|P6|STARTED|Third Intervention (10 Weeks)||3
132620|NCT00871377|305251|P5|STARTED|Third Intervention (10 Weeks)||4
132621|NCT00871377|305252|P4|STARTED|Third Intervention (10 Weeks)||4
132622|NCT00871377|305253|P3|STARTED|Third Intervention (10 Weeks)||3
132623|NCT00871377|305254|P2|STARTED|Third Intervention (10 Weeks)||4
132624|NCT00871377|305255|P1|STARTED|Third Intervention (10 Weeks)||2
132625|NCT00871377|305250|P6|NOT COMPLETED|Washout (6 Weeks)||1
132626|NCT00871377|305251|P5|NOT COMPLETED|Washout (6 Weeks)||0
132627|NCT00871377|305252|P4|NOT COMPLETED|Washout (6 Weeks)||0
132628|NCT00871377|305253|P3|NOT COMPLETED|Washout (6 Weeks)||0
132629|NCT00871377|305254|P2|NOT COMPLETED|Washout (6 Weeks)||0
132630|NCT00871377|305255|P1|NOT COMPLETED|Washout (6 Weeks)||0
132631|NCT00871377|305250|P6|COMPLETED|Washout (6 Weeks)||3
132632|NCT00871377|305251|P5|COMPLETED|Washout (6 Weeks)||4
132633|NCT00871377|305252|P4|COMPLETED|Washout (6 Weeks)||4
132634|NCT00871377|305253|P3|COMPLETED|Washout (6 Weeks)||3
132635|NCT00871377|305254|P2|COMPLETED|Washout (6 Weeks)||4
132636|NCT00871377|305255|P1|COMPLETED|Washout (6 Weeks)||2
132637|NCT00871377|305250|P6|STARTED|Washout (6 Weeks)||4
132638|NCT00871377|305251|P5|STARTED|Washout (6 Weeks)||4
132639|NCT00871377|305252|P4|STARTED|Washout (6 Weeks)||4
132640|NCT00871377|305253|P3|STARTED|Washout (6 Weeks)||3
132641|NCT00871377|305254|P2|STARTED|Washout (6 Weeks)||4
132642|NCT00871377|305255|P1|STARTED|Washout (6 Weeks)||2
132643|NCT00871377|305250|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
132644|NCT00871377|305251|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
132645|NCT00871377|305252|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
132646|NCT00871377|305253|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
132647|NCT00871377|305254|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
132648|NCT00871377|305255|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
132649|NCT00871377|305250|P6|COMPLETED|Second Intervention (10 Weeks)||4
132650|NCT00871377|305251|P5|COMPLETED|Second Intervention (10 Weeks)||4
132651|NCT00871377|305252|P4|COMPLETED|Second Intervention (10 Weeks)||4
132652|NCT00871377|305253|P3|COMPLETED|Second Intervention (10 Weeks)||3
132653|NCT00871377|305254|P2|COMPLETED|Second Intervention (10 Weeks)||4
132654|NCT00871377|305255|P1|COMPLETED|Second Intervention (10 Weeks)||2
132655|NCT00871377|305250|P6|STARTED|Second Intervention (10 Weeks)||4
132656|NCT00871377|305251|P5|STARTED|Second Intervention (10 Weeks)||4
132657|NCT00871377|305252|P4|STARTED|Second Intervention (10 Weeks)||4
132658|NCT00871377|305253|P3|STARTED|Second Intervention (10 Weeks)||3
132659|NCT00871377|305254|P2|STARTED|Second Intervention (10 Weeks)||4
132660|NCT00871377|305255|P1|STARTED|Second Intervention (10 Weeks)||2
132661|NCT00871377|305250|P6|NOT COMPLETED|Washout (6 Weeks)||0
132662|NCT00871377|305251|P5|NOT COMPLETED|Washout (6 Weeks)||0
132663|NCT00871377|305252|P4|NOT COMPLETED|Washout (6 Weeks)||0
132664|NCT00871377|305253|P3|NOT COMPLETED|Washout (6 Weeks)||0
132665|NCT00871377|305254|P2|NOT COMPLETED|Washout (6 Weeks)||0
132666|NCT00871377|305255|P1|NOT COMPLETED|Washout (6 Weeks)||1
132667|NCT00871377|305250|P6|COMPLETED|Washout (6 Weeks)||4
132668|NCT00871377|305251|P5|COMPLETED|Washout (6 Weeks)||4
132669|NCT00871377|305252|P4|COMPLETED|Washout (6 Weeks)||4
132670|NCT00871377|305253|P3|COMPLETED|Washout (6 Weeks)||3
132671|NCT00871377|305254|P2|COMPLETED|Washout (6 Weeks)||4
132672|NCT00871377|305255|P1|COMPLETED|Washout (6 Weeks)||2
132673|NCT00871377|305250|P6|STARTED|Washout (6 Weeks)||4
132674|NCT00871377|305251|P5|STARTED|Washout (6 Weeks)||4
132675|NCT00871377|305252|P4|STARTED|Washout (6 Weeks)||4
132676|NCT00871377|305253|P3|STARTED|Washout (6 Weeks)||3
132677|NCT00871377|305254|P2|STARTED|Washout (6 Weeks)||4
132678|NCT00871377|305255|P1|STARTED|Washout (6 Weeks)||3
132679|NCT00871377|305250|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
132680|NCT00871377|305251|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
132681|NCT00871377|305252|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
132682|NCT00871377|305253|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
132683|NCT00871377|305254|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
132684|NCT00871377|305255|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
132685|NCT00871377|305250|P6|COMPLETED|First Intervention (10 Weeks)||4
132686|NCT00871377|305251|P5|COMPLETED|First Intervention (10 Weeks)||4
132687|NCT00871377|305252|P4|COMPLETED|First Intervention (10 Weeks)||4
132688|NCT00871377|305253|P3|COMPLETED|First Intervention (10 Weeks)||3
132689|NCT00871377|305254|P2|COMPLETED|First Intervention (10 Weeks)||4
132690|NCT00871377|305255|P1|COMPLETED|First Intervention (10 Weeks)||3
132691|NCT00871377|305250|P6|STARTED|First Intervention (10 Weeks)||5
132692|NCT00871377|305251|P5|STARTED|First Intervention (10 Weeks)||4
132693|NCT00871377|305252|P4|STARTED|First Intervention (10 Weeks)||4
132694|NCT00871377|305253|P3|STARTED|First Intervention (10 Weeks)||4
132695|NCT00871377|305254|P2|STARTED|First Intervention (10 Weeks)||4
132696|NCT00871377|305255|P1|STARTED|First Intervention (10 Weeks)||3
132697|NCT00871351|305266|P3|NOT COMPLETED|Overall Study||0
132698|NCT00871351|305267|P2|NOT COMPLETED|Overall Study||1
132699|NCT00871351|305268|P1|NOT COMPLETED|Overall Study||4
132700|NCT00871351|305266|P3|COMPLETED|Overall Study||32
132701|NCT00871351|305267|P2|COMPLETED|Overall Study||45
132702|NCT00871351|305268|P1|COMPLETED|Overall Study||43
132703|NCT00871351|305266|P3|STARTED|Overall Study||32
132704|NCT00871351|305267|P2|STARTED|Overall Study||46
132705|NCT00871351|305268|P1|STARTED|Overall Study||47
132706|NCT00871338|305290|P2|NOT COMPLETED|After Booster||0
132707|NCT00871338|305291|P1|NOT COMPLETED|After Booster||0
132708|NCT00871338|305290|P2|COMPLETED|After Booster||135
132709|NCT00871338|305291|P1|COMPLETED|After Booster||139
132710|NCT00871338|305290|P2|STARTED|After Booster||135
132711|NCT00871338|305291|P1|STARTED|After Booster||139
132712|NCT00871338|305290|P2|NOT COMPLETED|Prior to Booster||3
132713|NCT00871338|305291|P1|NOT COMPLETED|Prior to Booster||2
132714|NCT00871338|305290|P2|COMPLETED|Prior to Booster||139
132715|NCT00871338|305291|P1|COMPLETED|Prior to Booster||140
132716|NCT00871338|305290|P2|STARTED|Prior to Booster||142
132717|NCT00871338|305291|P1|STARTED|Prior to Booster||142
132718|NCT00871286|305371|P2|NOT COMPLETED|Overall Study||6
132719|NCT00871286|305372|P1|NOT COMPLETED|Overall Study||0
132720|NCT00871286|305371|P2|COMPLETED|Overall Study||14
132721|NCT00871286|305372|P1|COMPLETED|Overall Study||20
132722|NCT00871286|305371|P2|STARTED|Overall Study||20
132723|NCT00871286|305372|P1|STARTED|Overall Study||20
132724|NCT00871234|305380|P1|NOT COMPLETED|Overall Study||5
132725|NCT00871234|305380|P1|COMPLETED|Overall Study||23
132726|NCT00871234|305380|P1|STARTED|Overall Study||28
132727|NCT00871169|305384|P1|NOT COMPLETED|Overall Study||3
132728|NCT00871169|305384|P1|COMPLETED|Overall Study||58
132729|NCT00871169|305384|P1|STARTED|Overall Study||61
132730|NCT00871143|305391|P2|NOT COMPLETED|Overall Study||0
132731|NCT00871143|305392|P1|NOT COMPLETED|Overall Study||0
132732|NCT00871143|305391|P2|COMPLETED|Overall Study||25
132733|NCT00871143|305392|P1|COMPLETED|Overall Study||21
132734|NCT00871143|305391|P2|STARTED|Overall Study||25
132735|NCT00871143|305392|P1|STARTED|Overall Study||21
132736|NCT00871117|305412|P2|NOT COMPLETED|Overall Study||10
132737|NCT00871117|305413|P1|NOT COMPLETED|Overall Study||5
132738|NCT00871117|305412|P2|COMPLETED|Overall Study||227
132739|NCT00871117|305413|P1|COMPLETED|Overall Study||234
132740|NCT00871117|305412|P2|STARTED|Overall Study||237
132741|NCT00871117|305413|P1|STARTED|Overall Study||239
132742|NCT00870896|305443|P1|NOT COMPLETED|Overall Study||0
132743|NCT00870896|305443|P1|COMPLETED|Overall Study||5
132744|NCT00870896|305443|P1|STARTED|Overall Study||5
132745|NCT00870740|305455|P6|NOT COMPLETED|Overall Study||17
132746|NCT00870740|305456|P5|NOT COMPLETED|Overall Study||11
132747|NCT00870740|305457|P4|NOT COMPLETED|Overall Study||12
132748|NCT00870740|305458|P3|NOT COMPLETED|Overall Study||10
132749|NCT00870740|305459|P2|NOT COMPLETED|Overall Study||9
132750|NCT00870740|305460|P1|NOT COMPLETED|Overall Study||12
132751|NCT00870740|305455|P6|COMPLETED|Overall Study||70
132752|NCT00870740|305456|P5|COMPLETED|Overall Study||77
132753|NCT00870740|305457|P4|COMPLETED|Overall Study||74
132754|NCT00870740|305458|P3|COMPLETED|Overall Study||76
132755|NCT00870740|305459|P2|COMPLETED|Overall Study||75
132756|NCT00870740|305460|P1|COMPLETED|Overall Study||74
132757|NCT00870740|305455|P6|STARTED|Overall Study|number randomized and dosed|87
132758|NCT00870740|305456|P5|STARTED|Overall Study|number randomized and dosed|88
132759|NCT00870740|305457|P4|STARTED|Overall Study|number randomized and dosed|86
132760|NCT00870740|305458|P3|STARTED|Overall Study|number randomized and dosed|86
132761|NCT00870740|305459|P2|STARTED|Overall Study|number randomized and dosed|84
132762|NCT00870740|305460|P1|STARTED|Overall Study|number randomized and dosed|86
132763|NCT00870688|305534|P1|NOT COMPLETED|Overall Study||4
132764|NCT00870688|305534|P1|COMPLETED|Overall Study||78
132765|NCT00870688|305534|P1|STARTED|Overall Study||82
132766|NCT00870584|305539|P2|NOT COMPLETED|Overall Study||13
132767|NCT00870584|305540|P1|NOT COMPLETED|Overall Study||16
132768|NCT00870584|305539|P2|COMPLETED|Overall Study||122
132769|NCT00870584|305540|P1|COMPLETED|Overall Study||120
132770|NCT00870584|305539|P2|STARTED|Overall Study||135
132771|NCT00870584|305540|P1|STARTED|Overall Study||136
132772|NCT00870545|305548|P1|NOT COMPLETED|Overall Study||17
132773|NCT00870545|305548|P1|COMPLETED|Overall Study||69
132774|NCT00870545|305548|P1|STARTED|Overall Study||86
132775|NCT00870467|305559|P6|NOT COMPLETED|Open-label||3
132776|NCT00870467|305560|P5|NOT COMPLETED|Open-label||5
132777|NCT00870467|305561|P4|NOT COMPLETED|Open-label||7
132778|NCT00870467|305562|P3|NOT COMPLETED|Open-label||13
132779|NCT00870467|305563|P2|NOT COMPLETED|Open-label||0
132780|NCT00870467|305564|P1|NOT COMPLETED|Open-label||0
132781|NCT00870467|305559|P6|COMPLETED|Open-label||21
132782|NCT00870467|305560|P5|COMPLETED|Open-label||5
132783|NCT00870467|305561|P4|COMPLETED|Open-label||120
132784|NCT00870467|305562|P3|COMPLETED|Open-label||132
132785|NCT00870467|305563|P2|COMPLETED|Open-label||0
132786|NCT00870467|305564|P1|COMPLETED|Open-label||0
132787|NCT00870467|305559|P6|STARTED|Open-label||24
132788|NCT00870467|305560|P5|STARTED|Open-label||10
132789|NCT00870467|305561|P4|STARTED|Open-label||127
132790|NCT00870467|305562|P3|STARTED|Open-label||145
132791|NCT00870467|305563|P2|STARTED|Open-label||0
132792|NCT00870467|305564|P1|STARTED|Open-label||0
132793|NCT00870467|305559|P6|NOT COMPLETED|Double-blind||0
132794|NCT00870467|305560|P5|NOT COMPLETED|Double-blind||0
132795|NCT00870467|305561|P4|NOT COMPLETED|Double-blind||0
132796|NCT00870467|305562|P3|NOT COMPLETED|Double-blind||0
132797|NCT00870467|305563|P2|NOT COMPLETED|Double-blind||12
132798|NCT00870467|305564|P1|NOT COMPLETED|Double-blind||16
132799|NCT00870467|305559|P6|COMPLETED|Double-blind||0
132800|NCT00870467|305560|P5|COMPLETED|Double-blind||0
132801|NCT00870467|305561|P4|COMPLETED|Double-blind||0
132802|NCT00870467|305562|P3|COMPLETED|Double-blind||0
132803|NCT00870467|305563|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
132804|NCT00870467|305564|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
132805|NCT00870467|305559|P6|STARTED|Double-blind||0
132806|NCT00870467|305560|P5|STARTED|Double-blind||0
132807|NCT00870467|305561|P4|STARTED|Double-blind||0
132808|NCT00870467|305562|P3|STARTED|Double-blind||0
132809|NCT00870467|305563|P2|STARTED|Double-blind||163
132810|NCT00870467|305564|P1|STARTED|Double-blind||171
132811|NCT00870363|305612|P4|NOT COMPLETED|Overall Study||0
132812|NCT00870363|305613|P3|NOT COMPLETED|Overall Study||3
132813|NCT00870363|305614|P2|NOT COMPLETED|Overall Study||3
132814|NCT00870363|305615|P1|NOT COMPLETED|Overall Study||0
132815|NCT00870363|305612|P4|COMPLETED|Overall Study||12
132816|NCT00870363|305613|P3|COMPLETED|Overall Study||8
132817|NCT00870363|305614|P2|COMPLETED|Overall Study||8
132818|NCT00870363|305615|P1|COMPLETED|Overall Study||10
132819|NCT00870363|305612|P4|STARTED|Overall Study||12
132820|NCT00870363|305613|P3|STARTED|Overall Study||11
132821|NCT00870363|305614|P2|STARTED|Overall Study||11
132822|NCT00870363|305615|P1|STARTED|Overall Study||10
132823|NCT00870194|305651|P2|NOT COMPLETED|Overall Study||14
132824|NCT00870194|305652|P1|NOT COMPLETED|Overall Study||26
132825|NCT00870194|305651|P2|COMPLETED|Overall Study||114
132826|NCT00870194|305652|P1|COMPLETED|Overall Study||101
132827|NCT00870194|305651|P2|Per Protocol Set|Overall Study||111
132828|NCT00870194|305652|P1|Per Protocol Set|Overall Study||97
132829|NCT00870194|305651|P2|STARTED|Overall Study||128
132830|NCT00870194|305652|P1|STARTED|Overall Study||127
132831|NCT00870103|305690|P1|NOT COMPLETED|Overall Study||4
132832|NCT00870103|305690|P1|COMPLETED|Overall Study||60
132833|NCT00870103|305690|P1|STARTED|Overall Study||64
132834|NCT00869999|305695|P1|NOT COMPLETED|Overall Study||2
132835|NCT00869999|305695|P1|COMPLETED|Overall Study||24
132836|NCT00869999|305695|P1|STARTED|Overall Study||26
132837|NCT00869960|305701|P1|NOT COMPLETED|Overall Study||2
132838|NCT00869960|305701|P1|COMPLETED|Overall Study||22
132839|NCT00869960|305701|P1|STARTED|Overall Study||24
132840|NCT00869947|305714|P2|NOT COMPLETED|Overall Study||0
132841|NCT00869947|305715|P1|NOT COMPLETED|Overall Study||0
132842|NCT00869947|305714|P2|COMPLETED|Overall Study||8
132843|NCT00869947|305715|P1|COMPLETED|Overall Study||8
132844|NCT00869947|305714|P2|STARTED|Overall Study||8
132845|NCT00869947|305715|P1|STARTED|Overall Study||8
132846|NCT00869778|305731|P3|NOT COMPLETED|Overall Study||10
132847|NCT00869778|305732|P2|NOT COMPLETED|Overall Study||7
132848|NCT00869778|305733|P1|NOT COMPLETED|Overall Study||12
132849|NCT00869778|305731|P3|COMPLETED|Overall Study||110
132850|NCT00869778|305732|P2|COMPLETED|Overall Study||113
132851|NCT00869778|305733|P1|COMPLETED|Overall Study||108
132852|NCT00869778|305731|P3|STARTED|Overall Study||120
132853|NCT00869778|305732|P2|STARTED|Overall Study||120
132854|NCT00869778|305733|P1|STARTED|Overall Study||120
132855|NCT00869622|305770|P2|NOT COMPLETED|Overall Study||14
132856|NCT00869622|305771|P1|NOT COMPLETED|Overall Study||13
132857|NCT00869622|305770|P2|COMPLETED|Overall Study||26
132858|NCT00869622|305771|P1|COMPLETED|Overall Study||27
132859|NCT00869622|305770|P2|STARTED|Overall Study||40
132860|NCT00869622|305771|P1|STARTED|Overall Study||40
132861|NCT00869609|305781|P2|NOT COMPLETED|Overall Study||3
132862|NCT00869609|305782|P1|NOT COMPLETED|Overall Study||6
132863|NCT00869609|305781|P2|COMPLETED|Overall Study||26
132864|NCT00869609|305782|P1|COMPLETED|Overall Study||25
132865|NCT00869609|305781|P2|STARTED|Overall Study||29
132866|NCT00869609|305782|P1|STARTED|Overall Study||31
132867|NCT00869557|305808|P2|NOT COMPLETED|Extension Phase||3
132868|NCT00869557|305809|P1|NOT COMPLETED|Extension Phase||10
132869|NCT00869557|305808|P2|COMPLETED|Extension Phase||11
132870|NCT00869557|305809|P1|COMPLETED|Extension Phase||35
132871|NCT00869557|305808|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
132872|NCT00869557|305809|P1|STARTED|Extension Phase||45
132873|NCT00869557|305808|P2|NOT COMPLETED|Randomized Phase||2
132874|NCT00869557|305809|P1|NOT COMPLETED|Randomized Phase||3
132875|NCT00869557|305808|P2|COMPLETED|Randomized Phase||21
132876|NCT00869557|305809|P1|COMPLETED|Randomized Phase||45
132877|NCT00869557|305808|P2|STARTED|Randomized Phase||23
132878|NCT00869557|305809|P1|STARTED|Randomized Phase||48
132879|NCT00869518|305828|P2|NOT COMPLETED|Overall Study||1
132880|NCT00869518|305829|P1|NOT COMPLETED|Overall Study||1
132881|NCT00869518|305828|P2|COMPLETED|Overall Study||5
132882|NCT00869518|305829|P1|COMPLETED|Overall Study||5
132883|NCT00869518|305828|P2|STARTED|Overall Study||6
132884|NCT00869518|305829|P1|STARTED|Overall Study||6
132885|NCT00869375|305843|P2|NOT COMPLETED|Overall Study||0
132886|NCT00869375|305844|P1|NOT COMPLETED|Overall Study||0
132887|NCT00869375|305843|P2|COMPLETED|Overall Study||3
132888|NCT00869375|305844|P1|COMPLETED|Overall Study||3
132889|NCT00869375|305843|P2|STARTED|Overall Study||3
132890|NCT00869375|305844|P1|STARTED|Overall Study||3
132891|NCT00869362|305854|P2|NOT COMPLETED|Overall Study||5
132892|NCT00869362|305855|P1|NOT COMPLETED|Overall Study||1
132893|NCT00869362|305854|P2|COMPLETED|Overall Study||11
132894|NCT00869362|305855|P1|COMPLETED|Overall Study||14
132895|NCT00869362|305854|P2|STARTED|Overall Study||16
132896|NCT00869362|305855|P1|STARTED|Overall Study||15
132897|NCT00869258|305863|P1|NOT COMPLETED|Overall Study||1
132898|NCT00869258|305863|P1|COMPLETED|Overall Study||31
132899|NCT00869258|305863|P1|STARTED|Overall Study||32
132900|NCT00869167|305869|P2|NOT COMPLETED|Overall Study||1
132901|NCT00869167|305870|P1|NOT COMPLETED|Overall Study||0
132902|NCT00869167|305869|P2|COMPLETED|Overall Study||0
132903|NCT00869167|305870|P1|COMPLETED|Overall Study||2
132904|NCT00869167|305869|P2|STARTED|Overall Study||1
132905|NCT00869167|305870|P1|STARTED|Overall Study||2
132906|NCT00869141|305886|P2|NOT COMPLETED|Overall Study||0
132907|NCT00869141|305887|P1|NOT COMPLETED|Overall Study||0
132908|NCT00869141|305886|P2|COMPLETED|Overall Study||26
132909|NCT00869141|305887|P1|COMPLETED|Overall Study||26
132910|NCT00869141|305886|P2|STARTED|Overall Study||26
132911|NCT00869141|305887|P1|STARTED|Overall Study||26
132912|NCT00869128|305897|P2|NOT COMPLETED|Overall Study||6
132913|NCT00869128|305898|P1|NOT COMPLETED|Overall Study||6
132914|NCT00869128|305897|P2|COMPLETED|Overall Study||12
132915|NCT00869128|305898|P1|COMPLETED|Overall Study||12
132916|NCT00869128|305897|P2|STARTED|Overall Study||18
132917|NCT00869128|305898|P1|STARTED|Overall Study||18
132918|NCT00869089|305902|P1|NOT COMPLETED|Overall Study||3
132919|NCT00869089|305902|P1|COMPLETED|Overall Study||2
132920|NCT00869089|305902|P1|STARTED|Overall Study||5
132921|NCT00869050|305906|P1|NOT COMPLETED|Overall Study||3
132922|NCT00869050|305906|P1|COMPLETED|Overall Study||38
132923|NCT00869050|305906|P1|STARTED|Overall Study||41
132924|NCT00868998|305911|P1|NOT COMPLETED|Overall Study||5
132925|NCT00868998|305911|P1|COMPLETED|Overall Study||0
132926|NCT00868998|305911|P1|STARTED|Overall Study||5
132927|NCT00868959|305916|P1|NOT COMPLETED|Overall Study||258
132928|NCT00868959|305916|P1|COMPLETED|Overall Study||559
132929|NCT00868959|305916|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
132930|NCT00868790|305922|P14|NOT COMPLETED|Post-study||0
132931|NCT00868790|305923|P13|NOT COMPLETED|Post-study||0
132932|NCT00868790|305924|P12|NOT COMPLETED|Post-study||0
132933|NCT00868790|305925|P11|NOT COMPLETED|Post-study||0
132934|NCT00868790|305926|P10|NOT COMPLETED|Post-study||1
132935|NCT00868790|305927|P9|NOT COMPLETED|Post-study||0
132936|NCT00868790|305928|P8|NOT COMPLETED|Post-study||2
132937|NCT00868790|305929|P7|NOT COMPLETED|Post-study||0
132938|NCT00868790|305930|P6|NOT COMPLETED|Post-study||0
132939|NCT00868790|305931|P5|NOT COMPLETED|Post-study||1
132940|NCT00868790|305932|P4|NOT COMPLETED|Post-study||0
132941|NCT00868790|305933|P3|NOT COMPLETED|Post-study||0
132942|NCT00868790|305934|P2|NOT COMPLETED|Post-study||0
132943|NCT00868790|305935|P1|NOT COMPLETED|Post-study||0
132944|NCT00868790|305922|P14|COMPLETED|Post-study||7
132945|NCT00868790|305923|P13|COMPLETED|Post-study||6
132946|NCT00868790|305924|P12|COMPLETED|Post-study||3
132947|NCT00868790|305925|P11|COMPLETED|Post-study||5
132948|NCT00868790|305926|P10|COMPLETED|Post-study||1
132949|NCT00868790|305927|P9|COMPLETED|Post-study||6
132950|NCT00868790|305928|P8|COMPLETED|Post-study||12
132951|NCT00868790|305929|P7|COMPLETED|Post-study||4
132952|NCT00868790|305930|P6|COMPLETED|Post-study||1
132953|NCT00868790|305931|P5|COMPLETED|Post-study||17
132954|NCT00868790|305932|P4|COMPLETED|Post-study||3
132955|NCT00868790|305933|P3|COMPLETED|Post-study||3
132956|NCT00868790|305934|P2|COMPLETED|Post-study||6
132957|NCT00868790|305935|P1|COMPLETED|Post-study||7
132958|NCT00868790|305922|P14|STARTED|Post-study||7
132959|NCT00868790|305923|P13|STARTED|Post-study||6
132960|NCT00868790|305924|P12|STARTED|Post-study||3
132961|NCT00868790|305925|P11|STARTED|Post-study||5
132962|NCT00868790|305926|P10|STARTED|Post-study||2
132963|NCT00868790|305927|P9|STARTED|Post-study||6
132964|NCT00868790|305928|P8|STARTED|Post-study||14
132965|NCT00868790|305929|P7|STARTED|Post-study||4
132966|NCT00868790|305930|P6|STARTED|Post-study||1
132967|NCT00868790|305931|P5|STARTED|Post-study||18
132968|NCT00868790|305932|P4|STARTED|Post-study||3
132969|NCT00868790|305933|P3|STARTED|Post-study||3
132970|NCT00868790|305934|P2|STARTED|Post-study||6
132971|NCT00868790|305935|P1|STARTED|Post-study||7
132972|NCT00868790|305922|P14|NOT COMPLETED|Period 4||1
132973|NCT00868790|305923|P13|NOT COMPLETED|Period 4||1
132974|NCT00868790|305924|P12|NOT COMPLETED|Period 4||1
132975|NCT00868790|305925|P11|NOT COMPLETED|Period 4||3
132976|NCT00868790|305926|P10|NOT COMPLETED|Period 4||0
132977|NCT00868790|305927|P9|NOT COMPLETED|Period 4||2
132978|NCT00868790|305928|P8|NOT COMPLETED|Period 4||3
132979|NCT00868790|305929|P7|NOT COMPLETED|Period 4||0
132980|NCT00868790|305930|P6|NOT COMPLETED|Period 4||0
132981|NCT00868790|305931|P5|NOT COMPLETED|Period 4||0
132982|NCT00868790|305932|P4|NOT COMPLETED|Period 4||0
132983|NCT00868790|305933|P3|NOT COMPLETED|Period 4||1
132984|NCT00868790|305934|P2|NOT COMPLETED|Period 4||0
132985|NCT00868790|305935|P1|NOT COMPLETED|Period 4||2
132986|NCT00868790|305922|P14|COMPLETED|Period 4||7
132987|NCT00868790|305923|P13|COMPLETED|Period 4||6
132988|NCT00868790|305924|P12|COMPLETED|Period 4||3
132989|NCT00868790|305925|P11|COMPLETED|Period 4||5
132990|NCT00868790|305926|P10|COMPLETED|Period 4||2
132991|NCT00868790|305927|P9|COMPLETED|Period 4||6
132992|NCT00868790|305928|P8|COMPLETED|Period 4||14
132993|NCT00868790|305929|P7|COMPLETED|Period 4||4
132994|NCT00868790|305930|P6|COMPLETED|Period 4||1
132995|NCT00868790|305931|P5|COMPLETED|Period 4||18
132996|NCT00868790|305932|P4|COMPLETED|Period 4||3
132997|NCT00868790|305933|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
132998|NCT00868790|305934|P2|COMPLETED|Period 4||6
132999|NCT00868790|305935|P1|COMPLETED|Period 4||7
133000|NCT00868790|305922|P14|STARTED|Period 4||8
133001|NCT00868790|305923|P13|STARTED|Period 4||7
133002|NCT00868790|305924|P12|STARTED|Period 4||4
133003|NCT00868790|305925|P11|STARTED|Period 4||8
133004|NCT00868790|305926|P10|STARTED|Period 4||2
133005|NCT00868790|305927|P9|STARTED|Period 4||8
133006|NCT00868790|305928|P8|STARTED|Period 4||17
133007|NCT00868790|305929|P7|STARTED|Period 4||4
133008|NCT00868790|305930|P6|STARTED|Period 4||1
133009|NCT00868790|305931|P5|STARTED|Period 4||18
133010|NCT00868790|305932|P4|STARTED|Period 4||3
133011|NCT00868790|305933|P3|STARTED|Period 4||4
133012|NCT00868790|305934|P2|STARTED|Period 4||6
133013|NCT00868790|305935|P1|STARTED|Period 4||9
133014|NCT00868790|305922|P14|NOT COMPLETED|Period 3||0
133015|NCT00868790|305923|P13|NOT COMPLETED|Period 3||0
133016|NCT00868790|305924|P12|NOT COMPLETED|Period 3||0
133017|NCT00868790|305925|P11|NOT COMPLETED|Period 3||1
133018|NCT00868790|305926|P10|NOT COMPLETED|Period 3||1
133019|NCT00868790|305927|P9|NOT COMPLETED|Period 3||0
133020|NCT00868790|305928|P8|NOT COMPLETED|Period 3||0
133021|NCT00868790|305929|P7|NOT COMPLETED|Period 3||0
133022|NCT00868790|305930|P6|NOT COMPLETED|Period 3||0
133023|NCT00868790|305931|P5|NOT COMPLETED|Period 3||0
133024|NCT00868790|305932|P4|NOT COMPLETED|Period 3||1
133025|NCT00868790|305933|P3|NOT COMPLETED|Period 3||0
133026|NCT00868790|305934|P2|NOT COMPLETED|Period 3||0
133027|NCT00868790|305935|P1|NOT COMPLETED|Period 3||0
133028|NCT00868790|305922|P14|COMPLETED|Period 3||8
133029|NCT00868790|305923|P13|COMPLETED|Period 3||7
133030|NCT00868790|305924|P12|COMPLETED|Period 3||4
133031|NCT00868790|305925|P11|COMPLETED|Period 3||8
133032|NCT00868790|305926|P10|COMPLETED|Period 3||2
133033|NCT00868790|305927|P9|COMPLETED|Period 3||8
133034|NCT00868790|305928|P8|COMPLETED|Period 3||17
133035|NCT00868790|305929|P7|COMPLETED|Period 3||4
133036|NCT00868790|305930|P6|COMPLETED|Period 3||1
133037|NCT00868790|305931|P5|COMPLETED|Period 3||18
133038|NCT00868790|305932|P4|COMPLETED|Period 3||3
133039|NCT00868790|305933|P3|COMPLETED|Period 3||4
133040|NCT00868790|305934|P2|COMPLETED|Period 3||6
133041|NCT00868790|305935|P1|COMPLETED|Period 3||9
133042|NCT00868790|305922|P14|STARTED|Period 3||8
133043|NCT00868790|305923|P13|STARTED|Period 3||7
133044|NCT00868790|305924|P12|STARTED|Period 3||4
133045|NCT00868790|305925|P11|STARTED|Period 3||9
133046|NCT00868790|305926|P10|STARTED|Period 3||3
133047|NCT00868790|305927|P9|STARTED|Period 3||8
133048|NCT00868790|305928|P8|STARTED|Period 3||17
133049|NCT00868790|305929|P7|STARTED|Period 3||4
133050|NCT00868790|305930|P6|STARTED|Period 3||1
133051|NCT00868790|305931|P5|STARTED|Period 3||18
133052|NCT00868790|305932|P4|STARTED|Period 3||4
133053|NCT00868790|305933|P3|STARTED|Period 3||4
133054|NCT00868790|305934|P2|STARTED|Period 3||6
133055|NCT00868790|305935|P1|STARTED|Period 3||9
133056|NCT00868790|305922|P14|NOT COMPLETED|Period 2||1
133057|NCT00868790|305923|P13|NOT COMPLETED|Period 2||0
133058|NCT00868790|305924|P12|NOT COMPLETED|Period 2||0
133059|NCT00868790|305925|P11|NOT COMPLETED|Period 2||0
133060|NCT00868790|305926|P10|NOT COMPLETED|Period 2||0
133061|NCT00868790|305927|P9|NOT COMPLETED|Period 2||2
133062|NCT00868790|305928|P8|NOT COMPLETED|Period 2||0
133063|NCT00868790|305929|P7|NOT COMPLETED|Period 2||0
133064|NCT00868790|305930|P6|NOT COMPLETED|Period 2||1
133065|NCT00868790|305931|P5|NOT COMPLETED|Period 2||0
133066|NCT00868790|305932|P4|NOT COMPLETED|Period 2||0
133067|NCT00868790|305933|P3|NOT COMPLETED|Period 2||0
133068|NCT00868790|305934|P2|NOT COMPLETED|Period 2||1
133069|NCT00868790|305935|P1|NOT COMPLETED|Period 2||0
133070|NCT00868790|305922|P14|COMPLETED|Period 2||8
133071|NCT00868790|305923|P13|COMPLETED|Period 2||7
133072|NCT00868790|305924|P12|COMPLETED|Period 2||4
133073|NCT00868790|305925|P11|COMPLETED|Period 2||9
133074|NCT00868790|305926|P10|COMPLETED|Period 2||3
133075|NCT00868790|305927|P9|COMPLETED|Period 2||8
133076|NCT00868790|305928|P8|COMPLETED|Period 2||17
133077|NCT00868790|305929|P7|COMPLETED|Period 2||4
133078|NCT00868790|305930|P6|COMPLETED|Period 2||1
133079|NCT00868790|305931|P5|COMPLETED|Period 2||18
133080|NCT00868790|305932|P4|COMPLETED|Period 2||4
133081|NCT00868790|305933|P3|COMPLETED|Period 2||4
133082|NCT00868790|305934|P2|COMPLETED|Period 2||6
133083|NCT00868790|305935|P1|COMPLETED|Period 2||9
133084|NCT00868790|305922|P14|STARTED|Period 2||9
133085|NCT00868790|305923|P13|STARTED|Period 2||7
133086|NCT00868790|305924|P12|STARTED|Period 2||4
133087|NCT00868790|305925|P11|STARTED|Period 2||9
133088|NCT00868790|305926|P10|STARTED|Period 2||3
133089|NCT00868790|305927|P9|STARTED|Period 2||10
133090|NCT00868790|305928|P8|STARTED|Period 2||17
133091|NCT00868790|305929|P7|STARTED|Period 2||4
133092|NCT00868790|305930|P6|STARTED|Period 2||2
133093|NCT00868790|305931|P5|STARTED|Period 2||18
133094|NCT00868790|305932|P4|STARTED|Period 2||4
133095|NCT00868790|305933|P3|STARTED|Period 2||4
133096|NCT00868790|305934|P2|STARTED|Period 2||7
133097|NCT00868790|305935|P1|STARTED|Period 2||9
133098|NCT00868790|305922|P14|NOT COMPLETED|Period 1||2
133099|NCT00868790|305923|P13|NOT COMPLETED|Period 1||0
133100|NCT00868790|305924|P12|NOT COMPLETED|Period 1||0
133101|NCT00868790|305925|P11|NOT COMPLETED|Period 1||0
133102|NCT00868790|305926|P10|NOT COMPLETED|Period 1||0
133103|NCT00868790|305927|P9|NOT COMPLETED|Period 1||1
133104|NCT00868790|305928|P8|NOT COMPLETED|Period 1||3
133105|NCT00868790|305929|P7|NOT COMPLETED|Period 1||0
133106|NCT00868790|305930|P6|NOT COMPLETED|Period 1||1
133107|NCT00868790|305931|P5|NOT COMPLETED|Period 1||1
133108|NCT00868790|305932|P4|NOT COMPLETED|Period 1||0
133109|NCT00868790|305933|P3|NOT COMPLETED|Period 1||0
133110|NCT00868790|305934|P2|NOT COMPLETED|Period 1||1
133111|NCT00868790|305935|P1|NOT COMPLETED|Period 1||2
133112|NCT00868790|305922|P14|COMPLETED|Period 1||9
133113|NCT00868790|305923|P13|COMPLETED|Period 1||7
133114|NCT00868790|305924|P12|COMPLETED|Period 1||4
133115|NCT00868790|305925|P11|COMPLETED|Period 1||9
133116|NCT00868790|305926|P10|COMPLETED|Period 1||3
133117|NCT00868790|305927|P9|COMPLETED|Period 1||10
133118|NCT00868790|305928|P8|COMPLETED|Period 1||17
133119|NCT00868790|305929|P7|COMPLETED|Period 1||4
133120|NCT00868790|305930|P6|COMPLETED|Period 1||2
133121|NCT00868790|305931|P5|COMPLETED|Period 1||18
133122|NCT00868790|305932|P4|COMPLETED|Period 1||4
133123|NCT00868790|305933|P3|COMPLETED|Period 1||4
133124|NCT00868790|305934|P2|COMPLETED|Period 1||7
133125|NCT00868790|305935|P1|COMPLETED|Period 1||9
133126|NCT00868790|305922|P14|STARTED|Period 1||11
133127|NCT00868790|305923|P13|STARTED|Period 1||7
133128|NCT00868790|305924|P12|STARTED|Period 1||4
133129|NCT00868790|305925|P11|STARTED|Period 1||9
133130|NCT00868790|305926|P10|STARTED|Period 1||3
133131|NCT00868790|305927|P9|STARTED|Period 1||11
133132|NCT00868790|305928|P8|STARTED|Period 1||20
133133|NCT00868790|305929|P7|STARTED|Period 1||4
133134|NCT00868790|305930|P6|STARTED|Period 1||3
133135|NCT00868790|305931|P5|STARTED|Period 1||19
133136|NCT00868790|305932|P4|STARTED|Period 1||4
133137|NCT00868790|305933|P3|STARTED|Period 1||4
133138|NCT00868790|305934|P2|STARTED|Period 1||8
133139|NCT00868790|305935|P1|STARTED|Period 1||11
133140|NCT00868712|305975|P3|NOT COMPLETED|Overall Study||0
133141|NCT00868712|305976|P2|NOT COMPLETED|Overall Study||0
133142|NCT00868712|305977|P1|NOT COMPLETED|Overall Study||0
133143|NCT00868712|305975|P3|COMPLETED|Overall Study||28
133144|NCT00868712|305976|P2|COMPLETED|Overall Study||11
133145|NCT00868712|305977|P1|COMPLETED|Overall Study||31
133146|NCT00868712|305975|P3|STARTED|Overall Study||28
133147|NCT00868712|305976|P2|STARTED|Overall Study||11
133148|NCT00868712|305977|P1|STARTED|Overall Study||31
133149|NCT00868699|305991|P3|NOT COMPLETED|Overall Study||43
133150|NCT00868699|305992|P2|NOT COMPLETED|Overall Study||45
133151|NCT00868699|305993|P1|NOT COMPLETED|Overall Study||43
133152|NCT00868699|305991|P3|COMPLETED|Overall Study||123
133153|NCT00868699|305992|P2|COMPLETED|Overall Study||124
133154|NCT00868699|305993|P1|COMPLETED|Overall Study||127
133155|NCT00868699|305991|P3|Safety Population|Overall Study||164
133156|NCT00868699|305992|P2|Safety Population|Overall Study||167
133157|NCT00868699|305993|P1|Safety Population|Overall Study||168
133158|NCT00868699|305991|P3|Intent-to-Treat Population|Overall Study||161
133159|NCT00868699|305992|P2|Intent-to-Treat Population|Overall Study||162
133160|NCT00868699|305993|P1|Intent-to-Treat Population|Overall Study||162
133161|NCT00868699|305991|P3|STARTED|Overall Study||166
133162|NCT00868699|305992|P2|STARTED|Overall Study||169
133163|NCT00868699|305993|P1|STARTED|Overall Study||170
133164|NCT00868530|306007|P1|NOT COMPLETED|Overall Study||4
133165|NCT00868530|306007|P1|COMPLETED|Overall Study||49
133166|NCT00868530|306007|P1|STARTED|Overall Study||53
133167|NCT00868517|306022|P3|NOT COMPLETED|Overall Study||2
133168|NCT00868517|306023|P2|NOT COMPLETED|Overall Study||4
133169|NCT00868517|306024|P1|NOT COMPLETED|Overall Study||4
133170|NCT00868517|306022|P3|COMPLETED|Overall Study||9
133171|NCT00868517|306023|P2|COMPLETED|Overall Study||8
133172|NCT00868517|306024|P1|COMPLETED|Overall Study||8
133173|NCT00868517|306022|P3|STARTED|Overall Study||11
133174|NCT00868517|306023|P2|STARTED|Overall Study||12
133175|NCT00868517|306024|P1|STARTED|Overall Study||12
133176|NCT00868452|306049|P2|NOT COMPLETED|Overall Study||29
133177|NCT00868452|306050|P1|NOT COMPLETED|Overall Study||40
133178|NCT00868452|306049|P2|COMPLETED|Overall Study||136
133179|NCT00868452|306050|P1|COMPLETED|Overall Study||143
133180|NCT00868452|306049|P2|STARTED|Overall Study||165
133181|NCT00868452|306050|P1|STARTED|Overall Study||183
133182|NCT00868439|306062|P2|NOT COMPLETED|Overall Study||9
133183|NCT00868439|306063|P1|NOT COMPLETED|Overall Study||8
133184|NCT00868439|306062|P2|COMPLETED|Overall Study||40
133185|NCT00868439|306063|P1|COMPLETED|Overall Study||48
133186|NCT00868439|306062|P2|STARTED|Overall Study||49
133187|NCT00868439|306063|P1|STARTED|Overall Study||56
133188|NCT00868374|306081|P2|NOT COMPLETED|Overall Study||7
133189|NCT00868374|306082|P1|NOT COMPLETED|Overall Study||7
133190|NCT00868374|306081|P2|COMPLETED|Overall Study||4
133191|NCT00868374|306082|P1|COMPLETED|Overall Study||5
133192|NCT00868374|306081|P2|STARTED|Overall Study||11
133193|NCT00868374|306082|P1|STARTED|Overall Study||12
133194|NCT00868348|306090|P2|NOT COMPLETED|Overall Study||0
133195|NCT00868348|306091|P1|NOT COMPLETED|Overall Study||0
133196|NCT00868348|306090|P2|COMPLETED|Overall Study||30
133197|NCT00868348|306091|P1|COMPLETED|Overall Study||30
133198|NCT00868348|306090|P2|STARTED|Overall Study||30
133199|NCT00868348|306091|P1|STARTED|Overall Study||30
133200|NCT00868309|306109|P2|NOT COMPLETED|Overall Study||0
133201|NCT00868309|306110|P1|NOT COMPLETED|Overall Study||0
133202|NCT00868309|306109|P2|COMPLETED|Overall Study||6
133203|NCT00868309|306110|P1|COMPLETED|Overall Study||6
133204|NCT00868309|306109|P2|STARTED|Overall Study||6
133205|NCT00868309|306110|P1|STARTED|Overall Study||6
133206|NCT00868296|306120|P2|NOT COMPLETED|Overall Study||3
133207|NCT00868296|306121|P1|NOT COMPLETED|Overall Study||0
133208|NCT00868296|306120|P2|COMPLETED|Overall Study||43
133209|NCT00868296|306121|P1|COMPLETED|Overall Study||12
133210|NCT00868296|306120|P2|STARTED|Overall Study||46
133211|NCT00868296|306121|P1|STARTED|Overall Study||12
133212|NCT00868231|306129|P6|NOT COMPLETED|Treatment Period 3||0
133213|NCT00868231|306130|P5|NOT COMPLETED|Treatment Period 3||0
133214|NCT00868231|306131|P4|NOT COMPLETED|Treatment Period 3||0
133215|NCT00868231|306132|P3|NOT COMPLETED|Treatment Period 3||1
133216|NCT00868231|306133|P2|NOT COMPLETED|Treatment Period 3||0
133217|NCT00868231|306134|P1|NOT COMPLETED|Treatment Period 3||0
133218|NCT00868231|306129|P6|COMPLETED|Treatment Period 3||5
133219|NCT00868231|306130|P5|COMPLETED|Treatment Period 3||4
133220|NCT00868231|306131|P4|COMPLETED|Treatment Period 3||5
133221|NCT00868231|306132|P3|COMPLETED|Treatment Period 3||4
133222|NCT00868231|306133|P2|COMPLETED|Treatment Period 3||5
133223|NCT00868231|306134|P1|COMPLETED|Treatment Period 3||4
133224|NCT00868231|306129|P6|STARTED|Treatment Period 3||5
133225|NCT00868231|306130|P5|STARTED|Treatment Period 3||4
133226|NCT00868231|306131|P4|STARTED|Treatment Period 3||5
133227|NCT00868231|306132|P3|STARTED|Treatment Period 3||5
133228|NCT00868231|306133|P2|STARTED|Treatment Period 3||5
133229|NCT00868231|306134|P1|STARTED|Treatment Period 3||4
133230|NCT00868231|306129|P6|NOT COMPLETED|Treatment Period 2||0
133231|NCT00868231|306130|P5|NOT COMPLETED|Treatment Period 2||0
133232|NCT00868231|306131|P4|NOT COMPLETED|Treatment Period 2||0
133233|NCT00868231|306132|P3|NOT COMPLETED|Treatment Period 2||0
133234|NCT00868231|306133|P2|NOT COMPLETED|Treatment Period 2||0
133235|NCT00868231|306134|P1|NOT COMPLETED|Treatment Period 2||1
133236|NCT00868231|306129|P6|COMPLETED|Treatment Period 2||5
133237|NCT00868231|306130|P5|COMPLETED|Treatment Period 2||4
133238|NCT00868231|306131|P4|COMPLETED|Treatment Period 2||5
133239|NCT00868231|306132|P3|COMPLETED|Treatment Period 2||5
133240|NCT00868231|306133|P2|COMPLETED|Treatment Period 2||5
133241|NCT00868231|306134|P1|COMPLETED|Treatment Period 2||4
133242|NCT00868231|306129|P6|STARTED|Treatment Period 2||5
133243|NCT00868231|306130|P5|STARTED|Treatment Period 2||4
133244|NCT00868231|306131|P4|STARTED|Treatment Period 2||5
133245|NCT00868231|306132|P3|STARTED|Treatment Period 2||5
133246|NCT00868231|306133|P2|STARTED|Treatment Period 2||5
133247|NCT00868231|306134|P1|STARTED|Treatment Period 2||5
133248|NCT00868231|306129|P6|NOT COMPLETED|Treatment Period 1||0
133249|NCT00868231|306130|P5|NOT COMPLETED|Treatment Period 1||1
133250|NCT00868231|306131|P4|NOT COMPLETED|Treatment Period 1||0
133251|NCT00868231|306132|P3|NOT COMPLETED|Treatment Period 1||0
133252|NCT00868231|306133|P2|NOT COMPLETED|Treatment Period 1||0
133253|NCT00868231|306134|P1|NOT COMPLETED|Treatment Period 1||0
133254|NCT00868231|306129|P6|COMPLETED|Treatment Period 1||5
133255|NCT00868231|306130|P5|COMPLETED|Treatment Period 1||4
133256|NCT00868231|306131|P4|COMPLETED|Treatment Period 1||5
133257|NCT00868231|306132|P3|COMPLETED|Treatment Period 1||5
133258|NCT00868231|306133|P2|COMPLETED|Treatment Period 1||5
133259|NCT00868231|306134|P1|COMPLETED|Treatment Period 1||5
133260|NCT00868231|306129|P6|STARTED|Treatment Period 1||5
133261|NCT00868231|306130|P5|STARTED|Treatment Period 1||5
133262|NCT00868231|306131|P4|STARTED|Treatment Period 1||5
133263|NCT00868231|306132|P3|STARTED|Treatment Period 1||5
133264|NCT00868231|306133|P2|STARTED|Treatment Period 1||5
133265|NCT00868231|306134|P1|STARTED|Treatment Period 1||5
133266|NCT00868218|306179|P4|NOT COMPLETED|Overall Study||0
133267|NCT00868218|306180|P3|NOT COMPLETED|Overall Study||0
133268|NCT00868218|306181|P2|NOT COMPLETED|Overall Study||0
133269|NCT00868218|306182|P1|NOT COMPLETED|Overall Study||0
133270|NCT00868218|306179|P4|COMPLETED|Overall Study||15
133271|NCT00868218|306180|P3|COMPLETED|Overall Study||15
133272|NCT00868218|306181|P2|COMPLETED|Overall Study||15
133273|NCT00868218|306182|P1|COMPLETED|Overall Study||15
133274|NCT00868218|306179|P4|STARTED|Overall Study||15
133275|NCT00868218|306180|P3|STARTED|Overall Study||15
133276|NCT00868218|306181|P2|STARTED|Overall Study||15
133277|NCT00868218|306182|P1|STARTED|Overall Study||15
133278|NCT00868192|306200|P1|NOT COMPLETED|Overall Study||4
133279|NCT00868192|306200|P1|COMPLETED|Overall Study||34
133280|NCT00868192|306200|P1|STARTED|Overall Study||38
133281|NCT00868140|306217|P2|NOT COMPLETED|Overall Study||0
133282|NCT00868140|306218|P1|NOT COMPLETED|Overall Study||0
133283|NCT00868140|306217|P2|COMPLETED|Overall Study||25
133284|NCT00868140|306218|P1|COMPLETED|Overall Study||26
133285|NCT00868140|306217|P2|STARTED|Overall Study||25
133286|NCT00868140|306218|P1|STARTED|Overall Study||26
133287|NCT00868101|306236|P2|NOT COMPLETED|Overall Study||0
133288|NCT00868101|306237|P1|NOT COMPLETED|Overall Study||0
133289|NCT00868101|306236|P2|COMPLETED|Overall Study||10
133290|NCT00868101|306237|P1|COMPLETED|Overall Study||12
133291|NCT00868101|306236|P2|STARTED|Overall Study||10
133292|NCT00868101|306237|P1|STARTED|Overall Study||12
133293|NCT00867659|306249|P1|NOT COMPLETED|Overall Study||0
133294|NCT00867659|306249|P1|COMPLETED|Overall Study|January 2010|20
133295|NCT00867659|306249|P1|STARTED|Overall Study|October 2009|20
133296|NCT00867568|306254|P1|NOT COMPLETED|Overall Study||15
133297|NCT00867568|306254|P1|COMPLETED|Overall Study||3
133298|NCT00867568|306254|P1|STARTED|Overall Study||18
133299|NCT00867503|306263|P1|NOT COMPLETED|Overall Study||1
133300|NCT00867503|306263|P1|COMPLETED|Overall Study||9
133301|NCT00867503|306263|P1|STARTED|Overall Study||10
133302|NCT00867490|306269|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
133303|NCT00867490|306269|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
133304|NCT00867490|306269|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
133305|NCT00867490|306269|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
133306|NCT00867490|306269|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
133307|NCT00867490|306269|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
133308|NCT00867490|306269|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
133309|NCT00867490|306269|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
133310|NCT00867490|306269|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
133311|NCT00867451|306288|P2|NOT COMPLETED|Overall Study||0
133312|NCT00867451|306289|P1|NOT COMPLETED|Overall Study||0
133313|NCT00867451|306288|P2|COMPLETED|Overall Study||4
133314|NCT00867451|306289|P1|COMPLETED|Overall Study||4
133315|NCT00867451|306288|P2|STARTED|Overall Study||4
133316|NCT00867451|306289|P1|STARTED|Overall Study||4
133317|NCT00867165|306311|P2|NOT COMPLETED|Overall Study||0
133318|NCT00867165|306312|P1|NOT COMPLETED|Overall Study||4
133319|NCT00867165|306311|P2|COMPLETED|Overall Study||45
133320|NCT00867165|306312|P1|COMPLETED|Overall Study||89
133321|NCT00867165|306311|P2|STARTED|Overall Study||45
133322|NCT00867165|306312|P1|STARTED|Overall Study||93
133323|NCT00867139|306417|P3|NOT COMPLETED|Overall Study||1
133324|NCT00867139|306418|P2|NOT COMPLETED|Overall Study||0
133325|NCT00867139|306419|P1|NOT COMPLETED|Overall Study||0
133326|NCT00867139|306417|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
133327|NCT00867139|306418|P2|COMPLETED|Overall Study||1
133328|NCT00867139|306419|P1|COMPLETED|Overall Study||2
133329|NCT00867139|306417|P3|STARTED|Overall Study||4
133330|NCT00867139|306418|P2|STARTED|Overall Study||1
133331|NCT00867139|306419|P1|STARTED|Overall Study||2
133332|NCT00867035|306462|P2|NOT COMPLETED|Baseline to 1 Week||0
133333|NCT00867035|306463|P1|NOT COMPLETED|Baseline to 1 Week||1
133334|NCT00867035|306462|P2|COMPLETED|Baseline to 1 Week||8
133335|NCT00867035|306463|P1|COMPLETED|Baseline to 1 Week||11
133336|NCT00867035|306462|P2|STARTED|Baseline to 1 Week||8
133337|NCT00867035|306463|P1|STARTED|Baseline to 1 Week||12
133338|NCT00867035|306462|P2|NOT COMPLETED|Baseline to 4 Hours||0
133339|NCT00867035|306463|P1|NOT COMPLETED|Baseline to 4 Hours||0
133340|NCT00867035|306462|P2|COMPLETED|Baseline to 4 Hours||8
133341|NCT00867035|306463|P1|COMPLETED|Baseline to 4 Hours||12
133342|NCT00867035|306462|P2|STARTED|Baseline to 4 Hours||8
133343|NCT00867035|306463|P1|STARTED|Baseline to 4 Hours||12
133344|NCT00867035|306462|P2|NOT COMPLETED|Baseline to 2 Hours||0
133345|NCT00867035|306463|P1|NOT COMPLETED|Baseline to 2 Hours||0
133346|NCT00867035|306462|P2|COMPLETED|Baseline to 2 Hours||8
133347|NCT00867035|306463|P1|COMPLETED|Baseline to 2 Hours||12
133348|NCT00867035|306462|P2|STARTED|Baseline to 2 Hours||8
133349|NCT00867035|306463|P1|STARTED|Baseline to 2 Hours||12
133350|NCT00867035|306462|P2|NOT COMPLETED|Baseline to 1 Hour||1
133351|NCT00867035|306463|P1|NOT COMPLETED|Baseline to 1 Hour||1
133352|NCT00867035|306462|P2|COMPLETED|Baseline to 1 Hour||8
133353|NCT00867035|306463|P1|COMPLETED|Baseline to 1 Hour||12
133354|NCT00867035|306462|P2|STARTED|Baseline to 1 Hour||9
133355|NCT00867035|306463|P1|STARTED|Baseline to 1 Hour||13
133356|NCT00867009|306489|P1|NOT COMPLETED|Maintenance Period||4
133357|NCT00867009|306489|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
133358|NCT00867009|306489|P1|STARTED|Maintenance Period||51
133359|NCT00867009|306489|P1|NOT COMPLETED|Induction Period||62
133360|NCT00867009|306489|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
133361|NCT00867009|306489|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
133362|NCT00867009|306489|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
133363|NCT00867009|306489|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
133364|NCT00866905|306496|P1|NOT COMPLETED|Overall Study||33
133365|NCT00866905|306496|P1|COMPLETED|Overall Study||135
133366|NCT00866905|306496|P1|STARTED|Overall Study||168
133367|NCT00866814|306501|P1|NOT COMPLETED|Overall Study||20
133368|NCT00866814|306501|P1|COMPLETED|Overall Study||99
133369|NCT00866814|306501|P1|STARTED|Overall Study||119
133370|NCT00866788|306514|P4|NOT COMPLETED|Overall Study||5
133371|NCT00866788|306515|P3|NOT COMPLETED|Overall Study||2
133372|NCT00866788|306516|P2|NOT COMPLETED|Overall Study||6
133373|NCT00866788|306517|P1|NOT COMPLETED|Overall Study||6
133374|NCT00866788|306514|P4|COMPLETED|Overall Study||16
133375|NCT00866788|306515|P3|COMPLETED|Overall Study||23
133376|NCT00866788|306516|P2|COMPLETED|Overall Study||17
133377|NCT00866788|306517|P1|COMPLETED|Overall Study||15
133378|NCT00866788|306514|P4|STARTED|Overall Study||21
133379|NCT00866788|306515|P3|STARTED|Overall Study||25
133380|NCT00866788|306516|P2|STARTED|Overall Study||23
133381|NCT00866788|306517|P1|STARTED|Overall Study||21
133382|NCT00866775|306565|P2|NOT COMPLETED|Overall Study||52
133383|NCT00866775|306566|P1|NOT COMPLETED|Overall Study||36
133384|NCT00866775|306565|P2|COMPLETED|Overall Study||76
133385|NCT00866775|306566|P1|COMPLETED|Overall Study||29
133386|NCT00866775|306565|P2|STARTED|Overall Study||128
133387|NCT00866775|306566|P1|STARTED|Overall Study||65
133388|NCT00866723|306602|P1|NOT COMPLETED|Overall Study||5
133389|NCT00866723|306602|P1|COMPLETED|Overall Study||0
133390|NCT00866723|306602|P1|STARTED|Overall Study||5
133391|NCT00866697|306609|P2|NOT COMPLETED|Overall Study||377
133392|NCT00866697|306610|P1|NOT COMPLETED|Overall Study||373
133393|NCT00866697|306609|P2|COMPLETED|Overall Study||95
133394|NCT00866697|306610|P1|COMPLETED|Overall Study||95
133395|NCT00866697|306609|P2|Ongoing|Overall Study||312
133396|NCT00866697|306610|P1|Ongoing|Overall Study||335
133397|NCT00866697|306609|P2|STARTED|Overall Study||472
133398|NCT00866697|306610|P1|STARTED|Overall Study||468
133399|NCT00866658|306654|P2|NOT COMPLETED|Overall Study||21
133400|NCT00866658|306655|P1|NOT COMPLETED|Overall Study||13
133401|NCT00866658|306654|P2|COMPLETED|Overall Study||133
133402|NCT00866658|306655|P1|COMPLETED|Overall Study||144
133403|NCT00866658|306654|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
133404|NCT00866658|306655|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
133405|NCT00866658|306654|P2|Safety Population|Overall Study||154
133406|NCT00866658|306655|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
133407|NCT00866658|306654|P2|STARTED|Overall Study||154
133408|NCT00866658|306655|P1|STARTED|Overall Study|Randomized.|157
133409|NCT00866606|306683|P1|NOT COMPLETED|Overall Study||4
133410|NCT00866606|306683|P1|COMPLETED|Overall Study||31
133411|NCT00866606|306683|P1|STARTED|Overall Study||35
133412|NCT00866359|306697|P4|NOT COMPLETED|Observational Follow-Up Phase||0
133413|NCT00866359|306698|P3|NOT COMPLETED|Observational Follow-Up Phase||0
133414|NCT00866359|306699|P2|NOT COMPLETED|Observational Follow-Up Phase||0
133415|NCT00866359|306700|P1|NOT COMPLETED|Observational Follow-Up Phase||0
133416|NCT00866359|306697|P4|COMPLETED|Observational Follow-Up Phase||54
133417|NCT00866359|306698|P3|COMPLETED|Observational Follow-Up Phase||54
133418|NCT00866359|306699|P2|COMPLETED|Observational Follow-Up Phase||0
133419|NCT00866359|306700|P1|COMPLETED|Observational Follow-Up Phase||0
133420|NCT00866359|306697|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
133421|NCT00866359|306698|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
133422|NCT00866359|306699|P2|STARTED|Observational Follow-Up Phase||0
133423|NCT00866359|306700|P1|STARTED|Observational Follow-Up Phase||0
133424|NCT00866359|306697|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
133425|NCT00866359|306698|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
133426|NCT00866359|306699|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
133427|NCT00866359|306700|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
133428|NCT00866359|306697|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
133429|NCT00866359|306698|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
133430|NCT00866359|306699|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
133431|NCT00866359|306700|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
133432|NCT00866359|306697|P4|STARTED|Extension Phase (Day 86 to 169)||50
133433|NCT00866359|306698|P3|STARTED|Extension Phase (Day 86 to 169)||45
133434|NCT00866359|306699|P2|STARTED|Extension Phase (Day 86 to 169)||0
133435|NCT00866359|306700|P1|STARTED|Extension Phase (Day 86 to 169)||0
133436|NCT00866359|306697|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
133437|NCT00866359|306698|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
133438|NCT00866359|306699|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
133439|NCT00866359|306700|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
133440|NCT00866359|306697|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
133441|NCT00866359|306698|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
133442|NCT00866359|306699|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
133443|NCT00866359|306700|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
133444|NCT00866359|306697|P4|STARTED|Treatment Phase (Days 1 to 85)||0
133445|NCT00866359|306698|P3|STARTED|Treatment Phase (Days 1 to 85)||0
133446|NCT00866359|306699|P2|STARTED|Treatment Phase (Days 1 to 85)||55
133447|NCT00866359|306700|P1|STARTED|Treatment Phase (Days 1 to 85)||56
133448|NCT00866320|306753|P1|NOT COMPLETED|Overall Study||6
133449|NCT00866320|306753|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
133450|NCT00866320|306753|P1|STARTED|Overall Study||49
133451|NCT00866307|306760|P3|NOT COMPLETED|Consolidation/Maintenance||16
133452|NCT00866307|306761|P2|NOT COMPLETED|Consolidation/Maintenance||9
133453|NCT00866307|306762|P1|NOT COMPLETED|Consolidation/Maintenance||0
133454|NCT00866307|306760|P3|COMPLETED|Consolidation/Maintenance||14
133455|NCT00866307|306761|P2|COMPLETED|Consolidation/Maintenance||45
133456|NCT00866307|306762|P1|COMPLETED|Consolidation/Maintenance||0
133457|NCT00866307|306760|P3|STARTED|Consolidation/Maintenance||30
133458|NCT00866307|306761|P2|STARTED|Consolidation/Maintenance||54
133459|NCT00866307|306762|P1|STARTED|Consolidation/Maintenance||0
133460|NCT00866307|306760|P3|NOT COMPLETED|Induction||0
133461|NCT00866307|306761|P2|NOT COMPLETED|Induction||0
133462|NCT00866307|306762|P1|NOT COMPLETED|Induction||20
133463|NCT00866307|306760|P3|COMPLETED|Induction||0
133464|NCT00866307|306761|P2|COMPLETED|Induction||0
133465|NCT00866307|306762|P1|COMPLETED|Induction||84
133466|NCT00866307|306760|P3|STARTED|Induction||0
133467|NCT00866307|306761|P2|STARTED|Induction||0
133468|NCT00866307|306762|P1|STARTED|Induction||104
133469|NCT00866294|306772|P3|NOT COMPLETED|Overall Study||11
133470|NCT00866294|306773|P2|NOT COMPLETED|Overall Study||20
133471|NCT00866294|306774|P1|NOT COMPLETED|Overall Study||33
133472|NCT00866294|306772|P3|COMPLETED|Overall Study||72
133473|NCT00866294|306773|P2|COMPLETED|Overall Study||141
133474|NCT00866294|306774|P1|COMPLETED|Overall Study||139
133475|NCT00866294|306772|P3|STARTED|Overall Study||83
133476|NCT00866294|306773|P2|STARTED|Overall Study||161
133477|NCT00866294|306774|P1|STARTED|Overall Study||172
133478|NCT00866281|306803|P2|NOT COMPLETED|Overall Study||15
133479|NCT00866281|306804|P1|NOT COMPLETED|Overall Study||7
133480|NCT00866281|306803|P2|COMPLETED|Overall Study||0
133481|NCT00866281|306804|P1|COMPLETED|Overall Study||0
133482|NCT00866281|306803|P2|STARTED|Overall Study||15
133483|NCT00866281|306804|P1|STARTED|Overall Study||7
133484|NCT00866177|306820|P1|NOT COMPLETED|Overall Study||152
133485|NCT00866177|306820|P1|COMPLETED|Overall Study||15
133486|NCT00866177|306820|P1|STARTED|Overall Study||167
133487|NCT00866047|306824|P1|NOT COMPLETED|Follow-up Period||31
133488|NCT00866047|306824|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death|12
133489|NCT00866047|306824|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|43
133490|NCT00866047|306824|P1|NOT COMPLETED|Treatment Period||55
133491|NCT00866047|306824|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|3
133492|NCT00866047|306824|P1|STARTED|Treatment Period||58
133493|NCT00866034|306842|P2|NOT COMPLETED|Overall Study||8
133494|NCT00866034|306843|P1|NOT COMPLETED|Overall Study||16
133495|NCT00866034|306842|P2|COMPLETED|Overall Study||301
133496|NCT00866034|306843|P1|COMPLETED|Overall Study||292
133497|NCT00866034|306842|P2|STARTED|Overall Study||309
133498|NCT00866034|306843|P1|STARTED|Overall Study||308
133499|NCT00865904|306856|P5|NOT COMPLETED|Overall Study||1
133500|NCT00865904|306857|P4|NOT COMPLETED|Overall Study||1
133501|NCT00865904|306858|P3|NOT COMPLETED|Overall Study||0
133502|NCT00865904|306859|P2|NOT COMPLETED|Overall Study||0
133503|NCT00865904|306860|P1|NOT COMPLETED|Overall Study||2
133504|NCT00865904|306856|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
133505|NCT00865904|306857|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
133506|NCT00865904|306858|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
133507|NCT00865904|306859|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
133508|NCT00865904|306860|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
133509|NCT00865904|306856|P5|STARTED|Overall Study|Randomized.|20
133510|NCT00865904|306857|P4|STARTED|Overall Study|Randomized.|18
133511|NCT00865904|306858|P3|STARTED|Overall Study|Randomized.|18
133512|NCT00865904|306859|P2|STARTED|Overall Study|Randomized.|18
133513|NCT00865904|306860|P1|STARTED|Overall Study|Randomized.|19
133514|NCT00865709|306917|P2|NOT COMPLETED|Long Term Follow-up||49
133515|NCT00865709|306918|P1|NOT COMPLETED|Long Term Follow-up||46
133516|NCT00865709|306917|P2|COMPLETED|Long Term Follow-up||33
133517|NCT00865709|306918|P1|COMPLETED|Long Term Follow-up||24
133518|NCT00865709|306917|P2|STARTED|Long Term Follow-up||82
133519|NCT00865709|306918|P1|STARTED|Long Term Follow-up||70
133520|NCT00865709|306917|P2|NOT COMPLETED|Active Follow-up||1
133521|NCT00865709|306918|P1|NOT COMPLETED|Active Follow-up||8
133522|NCT00865709|306917|P2|COMPLETED|Active Follow-up||15
133523|NCT00865709|306918|P1|COMPLETED|Active Follow-up||17
133524|NCT00865709|306917|P2|STARTED|Active Follow-up||16
133525|NCT00865709|306918|P1|STARTED|Active Follow-up||25
133526|NCT00865709|306917|P2|NOT COMPLETED|Treatment||18
133527|NCT00865709|306918|P1|NOT COMPLETED|Treatment||30
133528|NCT00865709|306917|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
133529|NCT00865709|306918|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
133530|NCT00865709|306917|P2|Received Treatment|Treatment|Safety population|101
133531|NCT00865709|306918|P1|Received Treatment|Treatment|Safety population|97
133532|NCT00865709|306917|P2|STARTED|Treatment||101
133533|NCT00865709|306918|P1|STARTED|Treatment||97
133534|NCT00865514|306934|P1|NOT COMPLETED|Overall Study||2
133535|NCT00865514|306934|P1|COMPLETED|Overall Study||0
133536|NCT00865514|306934|P1|STARTED|Overall Study||2
133537|NCT00865345|306939|P1|NOT COMPLETED|Overall Study||2
133538|NCT00865345|306939|P1|COMPLETED|Overall Study||61
133539|NCT00865345|306939|P1|STARTED|Overall Study||63
133540|NCT00865306|306946|P2|NOT COMPLETED|One-Year Follow-Up||0
133541|NCT00865306|306947|P1|NOT COMPLETED|One-Year Follow-Up||0
133542|NCT00865306|306946|P2|COMPLETED|One-Year Follow-Up||15
133543|NCT00865306|306947|P1|COMPLETED|One-Year Follow-Up||29
133544|NCT00865306|306946|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
133545|NCT00865306|306947|P1|STARTED|One-Year Follow-Up||29
133546|NCT00865306|306946|P2|NOT COMPLETED|Controlled Trial||2
133547|NCT00865306|306947|P1|NOT COMPLETED|Controlled Trial||5
133548|NCT00865306|306946|P2|COMPLETED|Controlled Trial||28
133549|NCT00865306|306947|P1|COMPLETED|Controlled Trial||29
133550|NCT00865306|306946|P2|STARTED|Controlled Trial||30
133551|NCT00865306|306947|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
133552|NCT00865098|306957|P1|NOT COMPLETED|Overall Study||1
133641|NCT00864253|307144|P1|Treated|Overall Study||257
133553|NCT00865098|306957|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
133554|NCT00865098|306957|P1|STARTED|Overall Study||22
133555|NCT00865046|306969|P3|NOT COMPLETED|Overall Study||1
133556|NCT00865046|306970|P2|NOT COMPLETED|Overall Study||5
133557|NCT00865046|306971|P1|NOT COMPLETED|Overall Study||6
133558|NCT00865046|306969|P3|COMPLETED|Overall Study||62
133559|NCT00865046|306970|P2|COMPLETED|Overall Study||59
133560|NCT00865046|306971|P1|COMPLETED|Overall Study||57
133561|NCT00865046|306969|P3|STARTED|Overall Study||63
133562|NCT00865046|306970|P2|STARTED|Overall Study||64
133563|NCT00865046|306971|P1|STARTED|Overall Study||63
133564|NCT00865020|306981|P2|NOT COMPLETED|Overall Study||51
133565|NCT00865020|306982|P1|NOT COMPLETED|Overall Study||49
133566|NCT00865020|306981|P2|COMPLETED|Overall Study||357
133567|NCT00865020|306982|P1|COMPLETED|Overall Study||365
133568|NCT00865020|306981|P2|STARTED|Overall Study||408
133569|NCT00865020|306982|P1|STARTED|Overall Study||414
133570|NCT00864916|306998|P2|NOT COMPLETED|Overall Study||4
133571|NCT00864916|306999|P1|NOT COMPLETED|Overall Study||6
133572|NCT00864916|306998|P2|COMPLETED|Overall Study||5
133573|NCT00864916|306999|P1|COMPLETED|Overall Study||4
133574|NCT00864916|306998|P2|STARTED|Overall Study||9
133575|NCT00864916|306999|P1|STARTED|Overall Study||10
133576|NCT00864851|307008|P3|NOT COMPLETED|Overall Study||0
133577|NCT00864851|307009|P2|NOT COMPLETED|Overall Study||1
133578|NCT00864851|307010|P1|NOT COMPLETED|Overall Study||3
133579|NCT00864851|307008|P3|COMPLETED|Overall Study||5
133580|NCT00864851|307009|P2|COMPLETED|Overall Study||18
133581|NCT00864851|307010|P1|COMPLETED|Overall Study||17
133582|NCT00864851|307008|P3|STARTED|Overall Study||5
133583|NCT00864851|307009|P2|STARTED|Overall Study||19
133584|NCT00864851|307010|P1|STARTED|Overall Study||20
133585|NCT00864708|307044|P1|NOT COMPLETED|Overall Study||0
133586|NCT00864708|307044|P1|COMPLETED|Overall Study||1
133587|NCT00864708|307044|P1|STARTED|Overall Study||1
133588|NCT00864682|307056|P3|NOT COMPLETED|Overall Study||2
133589|NCT00864682|307057|P2|NOT COMPLETED|Overall Study||1
133590|NCT00864682|307058|P1|NOT COMPLETED|Overall Study||2
133591|NCT00864682|307056|P3|COMPLETED|Overall Study||51
133592|NCT00864682|307057|P2|COMPLETED|Overall Study||50
133593|NCT00864682|307058|P1|COMPLETED|Overall Study||50
133594|NCT00864682|307056|P3|STARTED|Overall Study||53
133595|NCT00864682|307057|P2|STARTED|Overall Study||51
133596|NCT00864682|307058|P1|STARTED|Overall Study||52
133597|NCT00864539|307078|P6|NOT COMPLETED|Overall Study||14
133598|NCT00864539|307079|P5|NOT COMPLETED|Overall Study||22
133599|NCT00864539|307080|P4|NOT COMPLETED|Overall Study||7
133600|NCT00864539|307081|P3|NOT COMPLETED|Overall Study||10
133601|NCT00864539|307082|P2|NOT COMPLETED|Overall Study||23
133602|NCT00864539|307083|P1|NOT COMPLETED|Overall Study||9
133603|NCT00864539|307078|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
133604|NCT00864539|307079|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
133605|NCT00864539|307080|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
133606|NCT00864539|307081|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
133607|NCT00864539|307082|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
133608|NCT00864539|307083|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
133609|NCT00864539|307078|P6|STARTED|Overall Study||85
133610|NCT00864539|307079|P5|STARTED|Overall Study||103
133611|NCT00864539|307080|P4|STARTED|Overall Study||96
133612|NCT00864539|307081|P3|STARTED|Overall Study||102
133613|NCT00864539|307082|P2|STARTED|Overall Study||95
133614|NCT00864539|307083|P1|STARTED|Overall Study||104
133615|NCT00864513|307097|P1|NOT COMPLETED|Overall Study||3
133616|NCT00864513|307097|P1|COMPLETED|Overall Study||12
133617|NCT00864513|307097|P1|STARTED|Overall Study||15
133618|NCT00864383|307107|P3|NOT COMPLETED|Modified Intent to Treat||85
133619|NCT00864383|307108|P2|NOT COMPLETED|Modified Intent to Treat||87
133620|NCT00864383|307109|P1|NOT COMPLETED|Modified Intent to Treat||85
133621|NCT00864383|307107|P3|COMPLETED|Modified Intent to Treat||551
133622|NCT00864383|307108|P2|COMPLETED|Modified Intent to Treat||568
133623|NCT00864383|307109|P1|COMPLETED|Modified Intent to Treat||555
133624|NCT00864383|307107|P3|STARTED|Modified Intent to Treat||636
133625|NCT00864383|307108|P2|STARTED|Modified Intent to Treat||655
133626|NCT00864383|307109|P1|STARTED|Modified Intent to Treat||640
133627|NCT00864383|307107|P3|NOT COMPLETED|Per- Protocol||112
133628|NCT00864383|307108|P2|NOT COMPLETED|Per- Protocol||141
133629|NCT00864383|307109|P1|NOT COMPLETED|Per- Protocol||130
133630|NCT00864383|307107|P3|COMPLETED|Per- Protocol||524
133631|NCT00864383|307108|P2|COMPLETED|Per- Protocol||514
133632|NCT00864383|307109|P1|COMPLETED|Per- Protocol||510
133633|NCT00864383|307107|P3|STARTED|Per- Protocol||636
133634|NCT00864383|307108|P2|STARTED|Per- Protocol||655
133635|NCT00864383|307109|P1|STARTED|Per- Protocol||640
133636|NCT00864253|307143|P2|NOT COMPLETED|Overall Study||58
133637|NCT00864253|307144|P1|NOT COMPLETED|Overall Study||99
133638|NCT00864253|307143|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
133639|NCT00864253|307144|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
133640|NCT00864253|307143|P2|Treated|Overall Study||258
133642|NCT00864253|307143|P2|STARTED|Overall Study||265
133643|NCT00864253|307144|P1|STARTED|Overall Study||264
133644|NCT00864227|307174|P1|NOT COMPLETED|Overall Study||4
133645|NCT00864227|307174|P1|COMPLETED|Overall Study||50
133646|NCT00864227|307174|P1|STARTED|Overall Study||54
133647|NCT00864123|307191|P2|NOT COMPLETED|Overall Study||0
133648|NCT00864123|307192|P1|NOT COMPLETED|Overall Study||0
133649|NCT00864123|307191|P2|COMPLETED|Overall Study||15
133650|NCT00864123|307192|P1|COMPLETED|Overall Study||15
133651|NCT00864123|307191|P2|STARTED|Overall Study||15
133652|NCT00864123|307192|P1|STARTED|Overall Study||15
133653|NCT00864084|307202|P1|NOT COMPLETED|Overall Study||3
133654|NCT00864084|307202|P1|COMPLETED|Overall Study||11
133655|NCT00864084|307202|P1|STARTED|Overall Study||14
133656|NCT00864032|307225|P3|NOT COMPLETED|Overall Study||0
133657|NCT00864032|307226|P2|NOT COMPLETED|Overall Study||0
133658|NCT00864032|307227|P1|NOT COMPLETED|Overall Study||0
133659|NCT00864032|307225|P3|COMPLETED|Overall Study||0
133660|NCT00864032|307226|P2|COMPLETED|Overall Study||5
133661|NCT00864032|307227|P1|COMPLETED|Overall Study||3
133662|NCT00864032|307225|P3|STARTED|Overall Study||0
133663|NCT00864032|307226|P2|STARTED|Overall Study||5
133664|NCT00864032|307227|P1|STARTED|Overall Study||3
133665|NCT00863798|307236|P3|NOT COMPLETED|Overall Study||25
133666|NCT00863798|307237|P2|NOT COMPLETED|Overall Study||30
133667|NCT00863798|307238|P1|NOT COMPLETED|Overall Study||32
133668|NCT00863798|307236|P3|COMPLETED|Overall Study||202
133669|NCT00863798|307237|P2|COMPLETED|Overall Study||198
133670|NCT00863798|307238|P1|COMPLETED|Overall Study||195
133671|NCT00863798|307236|P3|Treated|Overall Study||224
133672|NCT00863798|307237|P2|Treated|Overall Study||226
133673|NCT00863798|307238|P1|Treated|Overall Study||223
133674|NCT00863798|307236|P3|STARTED|Overall Study||227
133675|NCT00863798|307237|P2|STARTED|Overall Study||228
133676|NCT00863798|307238|P1|STARTED|Overall Study||227
133677|NCT00863746|307290|P2|NOT COMPLETED|Survival Follow up||280
133678|NCT00863746|307291|P1|NOT COMPLETED|Survival Follow up||253
133679|NCT00863746|307290|P2|COMPLETED|Survival Follow up||51
133680|NCT00863746|307291|P1|COMPLETED|Survival Follow up||45
133681|NCT00863746|307290|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
133682|NCT00863746|307291|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
133683|NCT00863746|307290|P2|NOT COMPLETED|Treatment||35
133684|NCT00863746|307291|P1|NOT COMPLETED|Treatment||71
133685|NCT00863746|307290|P2|COMPLETED|Treatment||318
133686|NCT00863746|307291|P1|COMPLETED|Treatment||279
133687|NCT00863746|307290|P2|Participants Received Treatment|Treatment|Safety population|351
133688|NCT00863746|307291|P1|Participants Received Treatment|Treatment|Safety population|346
133689|NCT00863746|307290|P2|STARTED|Treatment||353
133690|NCT00863746|307291|P1|STARTED|Treatment||350
133691|NCT00863707|307317|P2|NOT COMPLETED|Overall Study||3
133692|NCT00863707|307318|P1|NOT COMPLETED|Overall Study||4
133693|NCT00863707|307317|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
133694|NCT00863707|307318|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
133695|NCT00863707|307317|P2|STARTED|Overall Study||337
133696|NCT00863707|307318|P1|STARTED|Overall Study||174
133697|NCT00863655|307326|P2|NOT COMPLETED|Overall Study||69
133698|NCT00863655|307327|P1|NOT COMPLETED|Overall Study||227
133699|NCT00863655|307326|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|170
133700|NCT00863655|307327|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|258
133701|NCT00863655|307326|P2|STARTED|Overall Study||239
133702|NCT00863655|307327|P1|STARTED|Overall Study||485
133703|NCT00863551|307333|P1|NOT COMPLETED|Overall Study||0
133704|NCT00863551|307333|P1|COMPLETED|Overall Study||12
133705|NCT00863551|307333|P1|STARTED|Overall Study||12
133706|NCT00863356|307341|P1|NOT COMPLETED|Overall Study||0
133707|NCT00863356|307341|P1|COMPLETED|Overall Study||20
133708|NCT00863356|307341|P1|STARTED|Overall Study||20
133709|NCT00863343|307347|P2|NOT COMPLETED|Overall Study||0
133710|NCT00863343|307348|P1|NOT COMPLETED|Overall Study||0
133711|NCT00863343|307347|P2|COMPLETED|Overall Study||374
133712|NCT00863343|307348|P1|COMPLETED|Overall Study||17
133713|NCT00863343|307347|P2|STARTED|Overall Study||374
133714|NCT00863343|307348|P1|STARTED|Overall Study||17
133715|NCT00863330|307360|P1|NOT COMPLETED|Overall Study||6
133716|NCT00863330|307360|P1|COMPLETED|Overall Study||0
133717|NCT00863330|307360|P1|STARTED|Overall Study||6
133718|NCT00863317|307366|P2|NOT COMPLETED|Overall Study||9
133719|NCT00863317|307367|P1|NOT COMPLETED|Overall Study||8
133720|NCT00863317|307366|P2|COMPLETED|Overall Study||64
133721|NCT00863317|307367|P1|COMPLETED|Overall Study||60
133722|NCT00863317|307366|P2|STARTED|Overall Study||73
133723|NCT00863317|307367|P1|STARTED|Overall Study||68
133724|NCT00863109|307373|P1|NOT COMPLETED|Follow-up Period||11
133725|NCT00863109|307373|P1|COMPLETED|Follow-up Period||48
133726|NCT00863109|307373|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
133727|NCT00863109|307373|P1|NOT COMPLETED|Treatment Period||77
133728|NCT00863109|307373|P1|COMPLETED|Treatment Period||53
133729|NCT00863109|307373|P1|STARTED|Treatment Period||130
133730|NCT00863057|307390|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
133731|NCT00863057|307391|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
133732|NCT00863057|307392|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
133733|NCT00863057|307393|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
133734|NCT00863057|307390|P4|COMPLETED|Period 4 (Weeks 16-20)||2
133735|NCT00863057|307391|P3|COMPLETED|Period 4 (Weeks 16-20)||2
133736|NCT00863057|307392|P2|COMPLETED|Period 4 (Weeks 16-20)||1
133737|NCT00863057|307393|P1|COMPLETED|Period 4 (Weeks 16-20)||3
133738|NCT00863057|307390|P4|STARTED|Period 4 (Weeks 16-20)||2
133739|NCT00863057|307391|P3|STARTED|Period 4 (Weeks 16-20)||2
133740|NCT00863057|307392|P2|STARTED|Period 4 (Weeks 16-20)||1
133741|NCT00863057|307393|P1|STARTED|Period 4 (Weeks 16-20)||3
133742|NCT00863057|307390|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
133743|NCT00863057|307391|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
133744|NCT00863057|307392|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
133745|NCT00863057|307393|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
133746|NCT00863057|307390|P4|COMPLETED|Period 3 (Weeks 11-15)||2
133747|NCT00863057|307391|P3|COMPLETED|Period 3 (Weeks 11-15)||2
133748|NCT00863057|307392|P2|COMPLETED|Period 3 (Weeks 11-15)||1
133749|NCT00863057|307393|P1|COMPLETED|Period 3 (Weeks 11-15)||3
133750|NCT00863057|307390|P4|STARTED|Period 3 (Weeks 11-15)||2
133751|NCT00863057|307391|P3|STARTED|Period 3 (Weeks 11-15)||2
133752|NCT00863057|307392|P2|STARTED|Period 3 (Weeks 11-15)||1
133753|NCT00863057|307393|P1|STARTED|Period 3 (Weeks 11-15)||3
133754|NCT00863057|307390|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
133755|NCT00863057|307391|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
133756|NCT00863057|307392|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
133757|NCT00863057|307393|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
133758|NCT00863057|307390|P4|COMPLETED|Period 2 (Weeks 6-10)||2
133759|NCT00863057|307391|P3|COMPLETED|Period 2 (Weeks 6-10)||2
133760|NCT00863057|307392|P2|COMPLETED|Period 2 (Weeks 6-10)||1
133761|NCT00863057|307393|P1|COMPLETED|Period 2 (Weeks 6-10)||3
133762|NCT00863057|307390|P4|STARTED|Period 2 (Weeks 6-10)||3
133763|NCT00863057|307391|P3|STARTED|Period 2 (Weeks 6-10)||3
133764|NCT00863057|307392|P2|STARTED|Period 2 (Weeks 6-10)||2
133765|NCT00863057|307393|P1|STARTED|Period 2 (Weeks 6-10)||3
133766|NCT00863057|307390|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
133767|NCT00863057|307391|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
133768|NCT00863057|307392|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
133769|NCT00863057|307393|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
133770|NCT00863057|307390|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
133771|NCT00863057|307391|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
133772|NCT00863057|307392|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
133773|NCT00863057|307393|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
133774|NCT00863057|307390|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
133775|NCT00863057|307391|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
133776|NCT00863057|307392|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
133777|NCT00863057|307393|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
133778|NCT00862940|307435|P2|NOT COMPLETED|Overall Study||30
133779|NCT00862940|307436|P1|NOT COMPLETED|Overall Study||30
133780|NCT00862940|307435|P2|COMPLETED|Overall Study||114
133781|NCT00862940|307436|P1|COMPLETED|Overall Study||103
133782|NCT00862940|307435|P2|STARTED|Overall Study||144
133783|NCT00862940|307436|P1|STARTED|Overall Study||133
133784|NCT00862849|307448|P6|NOT COMPLETED|Intervention 6||0
133785|NCT00862849|307449|P5|NOT COMPLETED|Intervention 6||0
133786|NCT00862849|307450|P4|NOT COMPLETED|Intervention 6||0
133787|NCT00862849|307451|P3|NOT COMPLETED|Intervention 6||0
133788|NCT00862849|307452|P2|NOT COMPLETED|Intervention 6||0
133789|NCT00862849|307453|P1|NOT COMPLETED|Intervention 6||0
133790|NCT00862849|307448|P6|COMPLETED|Intervention 6||3
133791|NCT00862849|307449|P5|COMPLETED|Intervention 6||4
133792|NCT00862849|307450|P4|COMPLETED|Intervention 6||4
133793|NCT00862849|307451|P3|COMPLETED|Intervention 6||3
133794|NCT00862849|307452|P2|COMPLETED|Intervention 6||3
133795|NCT00862849|307453|P1|COMPLETED|Intervention 6||3
133796|NCT00862849|307448|P6|STARTED|Intervention 6||3
133797|NCT00862849|307449|P5|STARTED|Intervention 6||4
133798|NCT00862849|307450|P4|STARTED|Intervention 6||4
133799|NCT00862849|307451|P3|STARTED|Intervention 6||3
133800|NCT00862849|307452|P2|STARTED|Intervention 6||3
133801|NCT00862849|307453|P1|STARTED|Intervention 6||3
133802|NCT00862849|307448|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133803|NCT00862849|307449|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133804|NCT00862849|307450|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133805|NCT00862849|307451|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133806|NCT00862849|307452|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133807|NCT00862849|307453|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
133808|NCT00862849|307448|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
133809|NCT00862849|307449|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
133810|NCT00862849|307450|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
133811|NCT00862849|307451|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
133812|NCT00862849|307452|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
133813|NCT00862849|307453|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
133814|NCT00862849|307448|P6|STARTED|Washout 5 (3 to 14 Days)||3
133815|NCT00862849|307449|P5|STARTED|Washout 5 (3 to 14 Days)||4
133816|NCT00862849|307450|P4|STARTED|Washout 5 (3 to 14 Days)||4
133817|NCT00862849|307451|P3|STARTED|Washout 5 (3 to 14 Days)||3
133818|NCT00862849|307452|P2|STARTED|Washout 5 (3 to 14 Days)||3
133819|NCT00862849|307453|P1|STARTED|Washout 5 (3 to 14 Days)||3
133820|NCT00862849|307448|P6|NOT COMPLETED|Intervention 5||0
133821|NCT00862849|307449|P5|NOT COMPLETED|Intervention 5||0
133822|NCT00862849|307450|P4|NOT COMPLETED|Intervention 5||0
133823|NCT00862849|307451|P3|NOT COMPLETED|Intervention 5||0
133824|NCT00862849|307452|P2|NOT COMPLETED|Intervention 5||0
133825|NCT00862849|307453|P1|NOT COMPLETED|Intervention 5||0
133826|NCT00862849|307448|P6|COMPLETED|Intervention 5||3
133827|NCT00862849|307449|P5|COMPLETED|Intervention 5||4
133828|NCT00862849|307450|P4|COMPLETED|Intervention 5||4
133829|NCT00862849|307451|P3|COMPLETED|Intervention 5||3
133830|NCT00862849|307452|P2|COMPLETED|Intervention 5||3
133831|NCT00862849|307453|P1|COMPLETED|Intervention 5||3
133832|NCT00862849|307448|P6|STARTED|Intervention 5||3
133833|NCT00862849|307449|P5|STARTED|Intervention 5||4
133834|NCT00862849|307450|P4|STARTED|Intervention 5||4
133835|NCT00862849|307451|P3|STARTED|Intervention 5||3
133836|NCT00862849|307452|P2|STARTED|Intervention 5||3
133837|NCT00862849|307453|P1|STARTED|Intervention 5||3
133838|NCT00862849|307448|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133839|NCT00862849|307449|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133840|NCT00862849|307450|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133841|NCT00862849|307451|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133842|NCT00862849|307452|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133843|NCT00862849|307453|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
133844|NCT00862849|307448|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
133845|NCT00862849|307449|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
133846|NCT00862849|307450|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
133847|NCT00862849|307451|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
133848|NCT00862849|307452|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
133849|NCT00862849|307453|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
133850|NCT00862849|307448|P6|STARTED|Washout 4 (3 to 14 Days)||3
133851|NCT00862849|307449|P5|STARTED|Washout 4 (3 to 14 Days)||4
133852|NCT00862849|307450|P4|STARTED|Washout 4 (3 to 14 Days)||4
133853|NCT00862849|307451|P3|STARTED|Washout 4 (3 to 14 Days)||3
133854|NCT00862849|307452|P2|STARTED|Washout 4 (3 to 14 Days)||3
133855|NCT00862849|307453|P1|STARTED|Washout 4 (3 to 14 Days)||3
133856|NCT00862849|307448|P6|NOT COMPLETED|Intervention 4||0
133857|NCT00862849|307449|P5|NOT COMPLETED|Intervention 4||0
133858|NCT00862849|307450|P4|NOT COMPLETED|Intervention 4||0
133859|NCT00862849|307451|P3|NOT COMPLETED|Intervention 4||0
133860|NCT00862849|307452|P2|NOT COMPLETED|Intervention 4||0
133861|NCT00862849|307453|P1|NOT COMPLETED|Intervention 4||0
133862|NCT00862849|307448|P6|COMPLETED|Intervention 4||3
133863|NCT00862849|307449|P5|COMPLETED|Intervention 4||4
133864|NCT00862849|307450|P4|COMPLETED|Intervention 4||4
133865|NCT00862849|307451|P3|COMPLETED|Intervention 4||3
133866|NCT00862849|307452|P2|COMPLETED|Intervention 4||3
133867|NCT00862849|307453|P1|COMPLETED|Intervention 4||3
133868|NCT00862849|307448|P6|STARTED|Intervention 4||3
133869|NCT00862849|307449|P5|STARTED|Intervention 4||4
133870|NCT00862849|307450|P4|STARTED|Intervention 4||4
133871|NCT00862849|307451|P3|STARTED|Intervention 4||3
133872|NCT00862849|307452|P2|STARTED|Intervention 4||3
133873|NCT00862849|307453|P1|STARTED|Intervention 4||3
133874|NCT00862849|307448|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133875|NCT00862849|307449|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133876|NCT00862849|307450|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133877|NCT00862849|307451|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133878|NCT00862849|307452|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133879|NCT00862849|307453|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
133880|NCT00862849|307448|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
133881|NCT00862849|307449|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
133882|NCT00862849|307450|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
133883|NCT00862849|307451|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
133884|NCT00862849|307452|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
133885|NCT00862849|307453|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
133886|NCT00862849|307448|P6|STARTED|Washout 3 (3 to 14 Days)||3
133887|NCT00862849|307449|P5|STARTED|Washout 3 (3 to 14 Days)||4
133888|NCT00862849|307450|P4|STARTED|Washout 3 (3 to 14 Days)||4
133889|NCT00862849|307451|P3|STARTED|Washout 3 (3 to 14 Days)||3
133890|NCT00862849|307452|P2|STARTED|Washout 3 (3 to 14 Days)||3
133891|NCT00862849|307453|P1|STARTED|Washout 3 (3 to 14 Days)||3
133892|NCT00862849|307448|P6|NOT COMPLETED|Intervention 3||0
133893|NCT00862849|307449|P5|NOT COMPLETED|Intervention 3||0
133894|NCT00862849|307450|P4|NOT COMPLETED|Intervention 3||0
133895|NCT00862849|307451|P3|NOT COMPLETED|Intervention 3||0
133896|NCT00862849|307452|P2|NOT COMPLETED|Intervention 3||0
133897|NCT00862849|307453|P1|NOT COMPLETED|Intervention 3||0
133898|NCT00862849|307448|P6|COMPLETED|Intervention 3||3
133899|NCT00862849|307449|P5|COMPLETED|Intervention 3||4
133900|NCT00862849|307450|P4|COMPLETED|Intervention 3||4
133901|NCT00862849|307451|P3|COMPLETED|Intervention 3||3
133902|NCT00862849|307452|P2|COMPLETED|Intervention 3||3
133903|NCT00862849|307453|P1|COMPLETED|Intervention 3||3
133904|NCT00862849|307448|P6|STARTED|Intervention 3||3
133905|NCT00862849|307449|P5|STARTED|Intervention 3||4
133906|NCT00862849|307450|P4|STARTED|Intervention 3||4
133907|NCT00862849|307451|P3|STARTED|Intervention 3||3
133908|NCT00862849|307452|P2|STARTED|Intervention 3||3
133909|NCT00862849|307453|P1|STARTED|Intervention 3||3
133910|NCT00862849|307448|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
133911|NCT00862849|307449|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
133912|NCT00862849|307450|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
133913|NCT00862849|307451|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
133914|NCT00862849|307452|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
133915|NCT00862849|307453|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
133916|NCT00862849|307448|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
133917|NCT00862849|307449|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
133918|NCT00862849|307450|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
133919|NCT00862849|307451|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
133920|NCT00862849|307452|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
133921|NCT00862849|307453|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
133922|NCT00862849|307448|P6|STARTED|Washout 2 (3 to 14 Days)||3
133923|NCT00862849|307449|P5|STARTED|Washout 2 (3 to 14 Days)||4
133924|NCT00862849|307450|P4|STARTED|Washout 2 (3 to 14 Days)||4
133925|NCT00862849|307451|P3|STARTED|Washout 2 (3 to 14 Days)||3
133926|NCT00862849|307452|P2|STARTED|Washout 2 (3 to 14 Days)||4
133927|NCT00862849|307453|P1|STARTED|Washout 2 (3 to 14 Days)||3
133928|NCT00862849|307448|P6|NOT COMPLETED|Intervention 2||0
133929|NCT00862849|307449|P5|NOT COMPLETED|Intervention 2||0
133930|NCT00862849|307450|P4|NOT COMPLETED|Intervention 2||0
133931|NCT00862849|307451|P3|NOT COMPLETED|Intervention 2||0
133932|NCT00862849|307452|P2|NOT COMPLETED|Intervention 2||0
133933|NCT00862849|307453|P1|NOT COMPLETED|Intervention 2||0
133934|NCT00862849|307448|P6|COMPLETED|Intervention 2||3
133935|NCT00862849|307449|P5|COMPLETED|Intervention 2||4
133936|NCT00862849|307450|P4|COMPLETED|Intervention 2||4
133937|NCT00862849|307451|P3|COMPLETED|Intervention 2||3
133938|NCT00862849|307452|P2|COMPLETED|Intervention 2||4
133939|NCT00862849|307453|P1|COMPLETED|Intervention 2||3
133940|NCT00862849|307448|P6|STARTED|Intervention 2||3
133941|NCT00862849|307449|P5|STARTED|Intervention 2||4
133942|NCT00862849|307450|P4|STARTED|Intervention 2||4
133943|NCT00862849|307451|P3|STARTED|Intervention 2||3
133944|NCT00862849|307452|P2|STARTED|Intervention 2||4
133945|NCT00862849|307453|P1|STARTED|Intervention 2||3
133946|NCT00862849|307448|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
133947|NCT00862849|307449|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
133948|NCT00862849|307450|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
133949|NCT00862849|307451|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
133950|NCT00862849|307452|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
133951|NCT00862849|307453|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
133952|NCT00862849|307448|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
133953|NCT00862849|307449|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
133954|NCT00862849|307450|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
133955|NCT00862849|307451|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
133956|NCT00862849|307452|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
133957|NCT00862849|307453|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
133958|NCT00862849|307448|P6|STARTED|Washout 1 (3 to 14 Days)||3
133959|NCT00862849|307449|P5|STARTED|Washout 1 (3 to 14 Days)||4
133960|NCT00862849|307450|P4|STARTED|Washout 1 (3 to 14 Days)||4
133961|NCT00862849|307451|P3|STARTED|Washout 1 (3 to 14 Days)||3
133962|NCT00862849|307452|P2|STARTED|Washout 1 (3 to 14 Days)||5
133963|NCT00862849|307453|P1|STARTED|Washout 1 (3 to 14 Days)||3
133964|NCT00862849|307448|P6|NOT COMPLETED|Intervention 1||0
133965|NCT00862849|307449|P5|NOT COMPLETED|Intervention 1||0
133966|NCT00862849|307450|P4|NOT COMPLETED|Intervention 1||0
133967|NCT00862849|307451|P3|NOT COMPLETED|Intervention 1||0
133968|NCT00862849|307452|P2|NOT COMPLETED|Intervention 1||0
133969|NCT00862849|307453|P1|NOT COMPLETED|Intervention 1||0
133970|NCT00862849|307448|P6|COMPLETED|Intervention 1||3
133971|NCT00862849|307449|P5|COMPLETED|Intervention 1||4
133972|NCT00862849|307450|P4|COMPLETED|Intervention 1||4
133973|NCT00862849|307451|P3|COMPLETED|Intervention 1||3
133974|NCT00862849|307452|P2|COMPLETED|Intervention 1||5
133975|NCT00862849|307453|P1|COMPLETED|Intervention 1||3
133976|NCT00862849|307448|P6|Received at Least One Dose of Study Drug|Intervention 1||3
133977|NCT00862849|307449|P5|Received at Least One Dose of Study Drug|Intervention 1||4
133978|NCT00862849|307450|P4|Received at Least One Dose of Study Drug|Intervention 1||4
133979|NCT00862849|307451|P3|Received at Least One Dose of Study Drug|Intervention 1||3
133980|NCT00862849|307452|P2|Received at Least One Dose of Study Drug|Intervention 1||5
133981|NCT00862849|307453|P1|Received at Least One Dose of Study Drug|Intervention 1||3
133982|NCT00862849|307448|P6|STARTED|Intervention 1||3
133983|NCT00862849|307449|P5|STARTED|Intervention 1||4
133984|NCT00862849|307450|P4|STARTED|Intervention 1||4
133985|NCT00862849|307451|P3|STARTED|Intervention 1||3
133986|NCT00862849|307452|P2|STARTED|Intervention 1||5
133987|NCT00862849|307453|P1|STARTED|Intervention 1||3
133988|NCT00862836|307476|P1|NOT COMPLETED|Overall Study||1
133989|NCT00862836|307476|P1|COMPLETED|Overall Study||14
133990|NCT00862836|307476|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
133991|NCT00862836|307476|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
133992|NCT00862836|307476|P1|STARTED|Overall Study||15
133993|NCT00862823|307487|P2|NOT COMPLETED|Second Intervention||0
133994|NCT00862823|307488|P1|NOT COMPLETED|Second Intervention||0
133995|NCT00862823|307487|P2|COMPLETED|Second Intervention||9
133996|NCT00862823|307488|P1|COMPLETED|Second Intervention||5
133997|NCT00862823|307487|P2|STARTED|Second Intervention||9
133998|NCT00862823|307488|P1|STARTED|Second Intervention||5
133999|NCT00862823|307487|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
134000|NCT00862823|307488|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
134001|NCT00862823|307487|P2|COMPLETED|Washout Period of 2 Weeks||9
134002|NCT00862823|307488|P1|COMPLETED|Washout Period of 2 Weeks||5
134003|NCT00862823|307487|P2|STARTED|Washout Period of 2 Weeks||9
134004|NCT00862823|307488|P1|STARTED|Washout Period of 2 Weeks||5
134005|NCT00862823|307487|P2|NOT COMPLETED|First Intervention||1
134006|NCT00862823|307488|P1|NOT COMPLETED|First Intervention||1
134007|NCT00862823|307487|P2|COMPLETED|First Intervention||9
134008|NCT00862823|307488|P1|COMPLETED|First Intervention||5
134009|NCT00862823|307487|P2|STARTED|First Intervention||10
134010|NCT00862823|307488|P1|STARTED|First Intervention||6
134011|NCT00862810|307497|P2|NOT COMPLETED|Overall Study||4
134012|NCT00862810|307498|P1|NOT COMPLETED|Overall Study||4
134013|NCT00862810|307497|P2|COMPLETED|Overall Study||35
134014|NCT00862810|307498|P1|COMPLETED|Overall Study||29
134015|NCT00862810|307497|P2|STARTED|Overall Study||39
134016|NCT00862810|307498|P1|STARTED|Overall Study||33
134017|NCT00862784|307504|P1|NOT COMPLETED|Overall Study||0
134018|NCT00862784|307504|P1|COMPLETED|Overall Study||48
134019|NCT00862784|307504|P1|Received Any Amount of Study Drug|Overall Study||48
134020|NCT00862784|307504|P1|STARTED|Overall Study||48
134021|NCT00862745|307526|P2|NOT COMPLETED|Open-label Follow-up||49
134022|NCT00862745|307527|P1|NOT COMPLETED|Open-label Follow-up||39
134023|NCT00862745|307526|P2|COMPLETED|Open-label Follow-up||225
134024|NCT00862745|307527|P1|COMPLETED|Open-label Follow-up||229
134025|NCT00862745|307526|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
134026|NCT00862745|307527|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
134027|NCT00862745|307526|P2|NOT COMPLETED|Randomized Control Trial||39
134028|NCT00862745|307527|P1|NOT COMPLETED|Randomized Control Trial||38
134029|NCT00862745|307526|P2|COMPLETED|Randomized Control Trial||284
134030|NCT00862745|307527|P1|COMPLETED|Randomized Control Trial||284
134031|NCT00862745|307526|P2|STARTED|Randomized Control Trial||323
134032|NCT00862745|307527|P1|STARTED|Randomized Control Trial||322
134033|NCT00862719|307537|P4|NOT COMPLETED|Overall Study||1
134034|NCT00862719|307538|P3|NOT COMPLETED|Overall Study||4
134035|NCT00862719|307539|P2|NOT COMPLETED|Overall Study||6
134036|NCT00862719|307540|P1|NOT COMPLETED|Overall Study||10
134037|NCT00862719|307537|P4|COMPLETED|Overall Study||0
134038|NCT00862719|307538|P3|COMPLETED|Overall Study||0
134039|NCT00862719|307539|P2|COMPLETED|Overall Study||1
134040|NCT00862719|307540|P1|COMPLETED|Overall Study||7
134041|NCT00862719|307537|P4|STARTED|Overall Study||1
134042|NCT00862719|307538|P3|STARTED|Overall Study||4
134043|NCT00862719|307539|P2|STARTED|Overall Study||7
134044|NCT00862719|307540|P1|STARTED|Overall Study||17
134045|NCT00862654|307563|P4|NOT COMPLETED|Overall Study||6
134046|NCT00862654|307564|P3|NOT COMPLETED|Overall Study||6
134047|NCT00862654|307565|P2|NOT COMPLETED|Overall Study||8
134048|NCT00862654|307566|P1|NOT COMPLETED|Overall Study||6
134049|NCT00862654|307563|P4|COMPLETED|Overall Study||74
134050|NCT00862654|307564|P3|COMPLETED|Overall Study||76
134051|NCT00862654|307565|P2|COMPLETED|Overall Study||74
134052|NCT00862654|307566|P1|COMPLETED|Overall Study||76
134053|NCT00862654|307563|P4|STARTED|Overall Study||80
134054|NCT00862654|307564|P3|STARTED|Overall Study||82
134055|NCT00862654|307565|P2|STARTED|Overall Study||82
134056|NCT00862654|307566|P1|STARTED|Overall Study||82
134057|NCT00862641|307580|P4|NOT COMPLETED|Overall Study||4
134058|NCT00862641|307581|P3|NOT COMPLETED|Overall Study||1
134059|NCT00862641|307582|P2|NOT COMPLETED|Overall Study||4
134060|NCT00862641|307583|P1|NOT COMPLETED|Overall Study||1
134061|NCT00862641|307580|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
134062|NCT00862641|307581|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
134063|NCT00862641|307582|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
134064|NCT00862641|307583|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
134065|NCT00862641|307580|P4|STARTED|Overall Study||320
134066|NCT00862641|307581|P3|STARTED|Overall Study||152
134067|NCT00862641|307582|P2|STARTED|Overall Study||360
134068|NCT00862641|307583|P1|STARTED|Overall Study||177
134069|NCT00862563|307629|P4|NOT COMPLETED|Overall Study||5
134070|NCT00862563|307630|P3|NOT COMPLETED|Overall Study||6
134071|NCT00862563|307631|P2|NOT COMPLETED|Overall Study||4
134072|NCT00862563|307632|P1|NOT COMPLETED|Overall Study||4
134073|NCT00862563|307629|P4|COMPLETED|Overall Study||19
134074|NCT00862563|307630|P3|COMPLETED|Overall Study||15
134075|NCT00862563|307631|P2|COMPLETED|Overall Study||17
134076|NCT00862563|307632|P1|COMPLETED|Overall Study||15
134077|NCT00862563|307629|P4|STARTED|Overall Study||24
134078|NCT00862563|307630|P3|STARTED|Overall Study||21
134079|NCT00862563|307631|P2|STARTED|Overall Study||21
134080|NCT00862563|307632|P1|STARTED|Overall Study||19
134081|NCT00862537|307670|P1|NOT COMPLETED|Overall Study||7
134082|NCT00862537|307670|P1|COMPLETED|Overall Study||11
134083|NCT00862537|307670|P1|STARTED|Overall Study||18
134084|NCT00862459|307677|P3|NOT COMPLETED|Overall Study||6
134085|NCT00862459|307678|P2|NOT COMPLETED|Overall Study||8
134086|NCT00862459|307679|P1|NOT COMPLETED|Overall Study||6
134087|NCT00862459|307677|P3|COMPLETED|Overall Study||66
134088|NCT00862459|307678|P2|COMPLETED|Overall Study||85
134089|NCT00862459|307679|P1|COMPLETED|Overall Study||66
134090|NCT00862459|307677|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
134091|NCT00862459|307678|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
134092|NCT00862459|307679|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
134093|NCT00862459|307677|P3|STARTED|Overall Study||72
134094|NCT00862459|307678|P2|STARTED|Overall Study||93
134095|NCT00862459|307679|P1|STARTED|Overall Study||72
134096|NCT00862277|307826|P3|NOT COMPLETED|Overall Study||5
134097|NCT00862277|307827|P2|NOT COMPLETED|Overall Study||2
134098|NCT00862277|307828|P1|NOT COMPLETED|Overall Study||1
134099|NCT00862277|307826|P3|COMPLETED|Overall Study||100
134100|NCT00862277|307827|P2|COMPLETED|Overall Study||94
134101|NCT00862277|307828|P1|COMPLETED|Overall Study||560
134102|NCT00862277|307826|P3|STARTED|Overall Study||105
134103|NCT00862277|307827|P2|STARTED|Overall Study||96
134104|NCT00862277|307828|P1|STARTED|Overall Study||561
134105|NCT00862251|307842|P3|NOT COMPLETED|Overall Study||9
134106|NCT00862251|307843|P2|NOT COMPLETED|Overall Study||5
134107|NCT00862251|307844|P1|NOT COMPLETED|Overall Study||19
134108|NCT00862251|307842|P3|COMPLETED|Overall Study||315
134109|NCT00862251|307843|P2|COMPLETED|Overall Study||157
134110|NCT00862251|307844|P1|COMPLETED|Overall Study||303
134111|NCT00862251|307842|P3|STARTED|Overall Study||324
134112|NCT00862251|307843|P2|STARTED|Overall Study||162
134113|NCT00862251|307844|P1|STARTED|Overall Study||322
134114|NCT00862186|307897|P1|NOT COMPLETED|Overall Study||0
134115|NCT00862186|307897|P1|COMPLETED|Overall Study||15
134116|NCT00862186|307897|P1|STARTED|Overall Study||15
134117|NCT00862134|307904|P2|NOT COMPLETED|Overall Study||12
134118|NCT00862134|307905|P1|NOT COMPLETED|Overall Study||11
134119|NCT00862134|307904|P2|COMPLETED|Overall Study||11
134120|NCT00862134|307905|P1|COMPLETED|Overall Study||8
134121|NCT00862134|307904|P2|STARTED|Overall Study||23
134122|NCT00862134|307905|P1|STARTED|Overall Study||19
134123|NCT00862121|307917|P2|NOT COMPLETED|Overall Study||8
134124|NCT00862121|307918|P1|NOT COMPLETED|Overall Study||1
134125|NCT00862121|307917|P2|COMPLETED|Overall Study||4
134126|NCT00862121|307918|P1|COMPLETED|Overall Study||7
134127|NCT00862121|307917|P2|Safety Analysis Set|Overall Study||11
134128|NCT00862121|307918|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
134129|NCT00862121|307917|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
134130|NCT00862121|307918|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
134131|NCT00862121|307917|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
134132|NCT00862121|307918|P1|STARTED|Overall Study||8
134133|NCT00862082|307936|P2|NOT COMPLETED|Overall Study||1
134134|NCT00862082|307937|P1|NOT COMPLETED|Overall Study||5
134135|NCT00862082|307936|P2|COMPLETED|Overall Study||5
134136|NCT00862082|307937|P1|COMPLETED|Overall Study||3
134137|NCT00862082|307936|P2|STARTED|Overall Study||6
134138|NCT00862082|307937|P1|STARTED|Overall Study||8
134139|NCT00861913|307980|P1|NOT COMPLETED|Overall Study||0
134140|NCT00861913|307980|P1|COMPLETED|Overall Study||13
134141|NCT00861913|307980|P1|STARTED|Overall Study||13
134142|NCT00861757|307992|P4|NOT COMPLETED|Overall Study||9
134143|NCT00861757|307993|P3|NOT COMPLETED|Overall Study||18
134144|NCT00861757|307994|P2|NOT COMPLETED|Overall Study||15
134145|NCT00861757|307995|P1|NOT COMPLETED|Overall Study||9
134146|NCT00861757|307992|P4|COMPLETED|Overall Study||143
134147|NCT00861757|307993|P3|COMPLETED|Overall Study||137
134148|NCT00861757|307994|P2|COMPLETED|Overall Study||136
134149|NCT00861757|307995|P1|COMPLETED|Overall Study||145
134150|NCT00861757|307992|P4|STARTED|Overall Study||152
134151|NCT00861757|307993|P3|STARTED|Overall Study||155
134152|NCT00861757|307994|P2|STARTED|Overall Study||151
134153|NCT00861757|307995|P1|STARTED|Overall Study||154
134154|NCT00861744|308053|P4|NOT COMPLETED|Overall Study||33
134155|NCT00861744|308054|P3|NOT COMPLETED|Overall Study||24
134156|NCT00861744|308055|P2|NOT COMPLETED|Overall Study||29
134157|NCT00861744|308056|P1|NOT COMPLETED|Overall Study||17
134158|NCT00861744|308053|P4|COMPLETED|Overall Study||275
134159|NCT00861744|308054|P3|COMPLETED|Overall Study||280
134160|NCT00861744|308055|P2|COMPLETED|Overall Study||275
134161|NCT00861744|308056|P1|COMPLETED|Overall Study||287
134162|NCT00861744|308053|P4|STARTED|Overall Study||308
134163|NCT00861744|308054|P3|STARTED|Overall Study||304
134164|NCT00861744|308055|P2|STARTED|Overall Study||304
134165|NCT00861744|308056|P1|STARTED|Overall Study||304
134166|NCT00861705|308238|P4|NOT COMPLETED|Overall Study||1
134167|NCT00861705|308239|P3|NOT COMPLETED|Overall Study||0
134168|NCT00861705|308240|P2|NOT COMPLETED|Overall Study||3
134169|NCT00861705|308241|P1|NOT COMPLETED|Overall Study||7
134170|NCT00861705|308238|P4|COMPLETED|Overall Study||112
134171|NCT00861705|308239|P3|COMPLETED|Overall Study||113
134172|NCT00861705|308240|P2|COMPLETED|Overall Study||110
134173|NCT00861705|308241|P1|COMPLETED|Overall Study||108
134174|NCT00861705|308238|P4|STARTED|Overall Study||113
134175|NCT00861705|308239|P3|STARTED|Overall Study||113
134176|NCT00861705|308240|P2|STARTED|Overall Study||113
134177|NCT00861705|308241|P1|STARTED|Overall Study||115
134178|NCT00861692|308257|P1|NOT COMPLETED|Overall Study||6
134179|NCT00861692|308257|P1|COMPLETED|Overall Study||14
134180|NCT00861692|308257|P1|STARTED|Overall Study||20
134181|NCT00861614|308269|P2|NOT COMPLETED|Overall Study||368
134182|NCT00861614|308270|P1|NOT COMPLETED|Overall Study||371
134183|NCT00861614|308269|P2|COMPLETED|Overall Study||28
134184|NCT00861614|308270|P1|COMPLETED|Overall Study||22
134185|NCT00861614|308269|P2|STARTED|Overall Study||396
134186|NCT00861614|308270|P1|STARTED|Overall Study||393
134187|NCT00861601|308303|P3|NOT COMPLETED|Overall Study||0
134188|NCT00861601|308304|P2|NOT COMPLETED|Overall Study||0
134189|NCT00861601|308305|P1|NOT COMPLETED|Overall Study||0
134190|NCT00861601|308303|P3|COMPLETED|Overall Study||12
134191|NCT00861601|308304|P2|COMPLETED|Overall Study||14
134192|NCT00861601|308305|P1|COMPLETED|Overall Study||12
134193|NCT00861601|308303|P3|STARTED|Overall Study||12
134194|NCT00861601|308304|P2|STARTED|Overall Study||14
134195|NCT00861601|308305|P1|STARTED|Overall Study||12
134196|NCT00861471|308355|P1|NOT COMPLETED|Overall Study||9
134197|NCT00861471|308355|P1|COMPLETED|Overall Study||3
134198|NCT00861471|308355|P1|STARTED|Overall Study||12
134199|NCT00861341|308363|P1|NOT COMPLETED|Overall Study||2
134200|NCT00861341|308363|P1|COMPLETED|Overall Study||38
134201|NCT00861341|308363|P1|STARTED|Overall Study||40
134202|NCT00861263|308368|P1|NOT COMPLETED|Overall Study||0
134203|NCT00861263|308368|P1|COMPLETED|Overall Study||193
134204|NCT00861263|308368|P1|STARTED|Overall Study||193
134205|NCT00861198|308372|P1|NOT COMPLETED|Overall Study||5
134206|NCT00861198|308372|P1|COMPLETED|Overall Study||70
134207|NCT00861198|308372|P1|STARTED|Overall Study||75
134208|NCT00861146|308378|P2|NOT COMPLETED|Overall Study||8
134209|NCT00861146|308379|P1|NOT COMPLETED|Overall Study||20
134210|NCT00861146|308378|P2|COMPLETED|Overall Study||38
134211|NCT00861146|308379|P1|COMPLETED|Overall Study||85
134212|NCT00861146|308378|P2|Week 13 Assessment|Overall Study||38
134213|NCT00861146|308379|P1|Week 13 Assessment|Overall Study||85
134214|NCT00861146|308378|P2|Week 2 Assessment|Overall Study||45
134215|NCT00861146|308379|P1|Week 2 Assessment|Overall Study||97
134216|NCT00861146|308378|P2|STARTED|Overall Study||46
134217|NCT00861146|308379|P1|STARTED|Overall Study||105
134218|NCT00860951|308389|P1|NOT COMPLETED|Overall Study||7
134219|NCT00860951|308389|P1|COMPLETED|Overall Study||22
134220|NCT00860951|308389|P1|STARTED|Overall Study||29
134221|NCT00860847|308397|P2|NOT COMPLETED|Overall Study||5
134222|NCT00860847|308398|P1|NOT COMPLETED|Overall Study||4
134223|NCT00860847|308397|P2|COMPLETED|Overall Study||28
134224|NCT00860847|308398|P1|COMPLETED|Overall Study||28
134225|NCT00860847|308397|P2|STARTED|Overall Study||33
134226|NCT00860847|308398|P1|STARTED|Overall Study||32
134227|NCT00860795|308406|P2|NOT COMPLETED|Overall Study||0
134228|NCT00860795|308407|P1|NOT COMPLETED|Overall Study||0
134229|NCT00860795|308406|P2|COMPLETED|Overall Study||10
134230|NCT00860795|308407|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
134231|NCT00860795|308406|P2|Number to Complete Study Medication|Overall Study||10
134232|NCT00860795|308407|P1|Number to Complete Study Medication|Overall Study||9
134233|NCT00860795|308406|P2|STARTED|Overall Study||10
134234|NCT00860795|308407|P1|STARTED|Overall Study||10
134235|NCT00860743|308431|P2|NOT COMPLETED|Overall Study||0
134236|NCT00860743|308432|P1|NOT COMPLETED|Overall Study||3
134237|NCT00860743|308431|P2|COMPLETED|Overall Study||23
134238|NCT00860743|308432|P1|COMPLETED|Overall Study||37
134239|NCT00860743|308431|P2|STARTED|Overall Study||23
134240|NCT00860743|308432|P1|STARTED|Overall Study||40
134241|NCT00860535|308438|P1|NOT COMPLETED|Overall Study||1
134242|NCT00860535|308438|P1|COMPLETED|Overall Study||8
134243|NCT00860535|308438|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
134244|NCT00860535|308438|P1|STARTED|Overall Study||9
134245|NCT00860470|308445|P2|NOT COMPLETED|Overall Study||59
134246|NCT00860470|308446|P1|NOT COMPLETED|Overall Study||48
134247|NCT00860470|308445|P2|COMPLETED|Overall Study||22346
134248|NCT00860470|308446|P1|COMPLETED|Overall Study||22114
134249|NCT00860470|308445|P2|STARTED|Overall Study||22405
134250|NCT00860470|308446|P1|STARTED|Overall Study||22162
134251|NCT00860457|308470|P1|NOT COMPLETED|Overall Study||11
134252|NCT00860457|308470|P1|COMPLETED|Overall Study||11
134253|NCT00860457|308470|P1|STARTED|Overall Study||22
134254|NCT00860405|308476|P2|NOT COMPLETED|Overall Study||4
134255|NCT00860405|308477|P1|NOT COMPLETED|Overall Study||5
134256|NCT00860405|308476|P2|COMPLETED|Overall Study||26
134257|NCT00860405|308477|P1|COMPLETED|Overall Study|completed overall study|26
134258|NCT00860405|308476|P2|Day 28 Follow-up Performed|Overall Study||29
134259|NCT00860405|308477|P1|Day 28 Follow-up Performed|Overall Study||31
134260|NCT00860405|308476|P2|Completed Treatment|Overall Study||29
134261|NCT00860405|308477|P1|Completed Treatment|Overall Study||31
134262|NCT00860405|308476|P2|STARTED|Overall Study||30
134263|NCT00860405|308477|P1|STARTED|Overall Study||31
134264|NCT00860314|308501|P2|NOT COMPLETED|Overall Study||0
134265|NCT00860314|308502|P1|NOT COMPLETED|Overall Study||0
134266|NCT00860314|308501|P2|COMPLETED|Overall Study||48
134267|NCT00860314|308502|P1|COMPLETED|Overall Study||48
134268|NCT00860314|308501|P2|STARTED|Overall Study||48
134269|NCT00860314|308502|P1|STARTED|Overall Study||48
134270|NCT00860262|308517|P3|NOT COMPLETED|Overall Study||18
134271|NCT00860262|308518|P2|NOT COMPLETED|Overall Study||22
134272|NCT00860262|308519|P1|NOT COMPLETED|Overall Study||20
134273|NCT00860262|308517|P3|COMPLETED|Overall Study||202
134274|NCT00860262|308518|P2|COMPLETED|Overall Study||195
134275|NCT00860262|308519|P1|COMPLETED|Overall Study||401
134276|NCT00860262|308517|P3|STARTED|Overall Study||220
134277|NCT00860262|308518|P2|STARTED|Overall Study||217
134278|NCT00860262|308519|P1|STARTED|Overall Study||421
134279|NCT00860249|308632|P3|NOT COMPLETED|Overall Study||21
134280|NCT00860249|308633|P2|NOT COMPLETED|Overall Study||18
134281|NCT00860249|308634|P1|NOT COMPLETED|Overall Study||21
134282|NCT00860249|308632|P3|COMPLETED|Overall Study||0
134283|NCT00860249|308633|P2|COMPLETED|Overall Study||0
134284|NCT00860249|308634|P1|COMPLETED|Overall Study||0
134285|NCT00860249|308632|P3|STARTED|Overall Study||21
134286|NCT00860249|308633|P2|STARTED|Overall Study||18
134287|NCT00860249|308634|P1|STARTED|Overall Study||21
134288|NCT00860158|308645|P1|NOT COMPLETED|Overall Study||1
134289|NCT00860158|308645|P1|COMPLETED|Overall Study||0
134290|NCT00860158|308645|P1|STARTED|Overall Study||1
134291|NCT00860067|308656|P3|NOT COMPLETED|Overall Study||9
134292|NCT00860067|308657|P2|NOT COMPLETED|Overall Study||9
134293|NCT00860067|308658|P1|NOT COMPLETED|Overall Study||51
134294|NCT00860067|308656|P3|COMPLETED|Overall Study||292
134295|NCT00860067|308657|P2|COMPLETED|Overall Study||290
134296|NCT00860067|308658|P1|COMPLETED|Overall Study||1149
134297|NCT00860067|308656|P3|STARTED|Overall Study||301
134298|NCT00860067|308657|P2|STARTED|Overall Study||299
134299|NCT00860067|308658|P1|STARTED|Overall Study||1200
134300|NCT00860028|308718|P2|NOT COMPLETED|Smoking Cessation Phase||2
134301|NCT00860028|308719|P1|NOT COMPLETED|Smoking Cessation Phase||0
134302|NCT00860028|308718|P2|COMPLETED|Smoking Cessation Phase||12
134303|NCT00860028|308719|P1|COMPLETED|Smoking Cessation Phase||13
134304|NCT00860028|308718|P2|STARTED|Smoking Cessation Phase||14
134305|NCT00860028|308719|P1|STARTED|Smoking Cessation Phase||13
134306|NCT00860028|308718|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
134307|NCT00860028|308719|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
134308|NCT00860028|308718|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
134309|NCT00860028|308719|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
134310|NCT00860028|308718|P2|STARTED|Placebo Controlled Pretreatment Period||15
134311|NCT00860028|308719|P1|STARTED|Placebo Controlled Pretreatment Period||15
134312|NCT00859937|308731|P2|NOT COMPLETED|Overall Study||0
134313|NCT00859937|308732|P1|NOT COMPLETED|Overall Study||1
134314|NCT00859937|308731|P2|COMPLETED|Overall Study||14
134315|NCT00859937|308732|P1|COMPLETED|Overall Study||40
134316|NCT00859937|308731|P2|STARTED|Overall Study||14
134317|NCT00859937|308732|P1|STARTED|Overall Study||41
134318|NCT00859898|308747|P3|NOT COMPLETED|Overall Study||27
134319|NCT00859898|308748|P2|NOT COMPLETED|Overall Study||31
134320|NCT00859898|308749|P1|NOT COMPLETED|Overall Study||28
134321|NCT00859898|308747|P3|COMPLETED|Overall Study||181
134322|NCT00859898|308748|P2|COMPLETED|Overall Study||188
134323|NCT00859898|308749|P1|COMPLETED|Overall Study||183
134324|NCT00859898|308747|P3|STARTED|Overall Study||208
134325|NCT00859898|308748|P2|STARTED|Overall Study||219
134326|NCT00859898|308749|P1|STARTED|Overall Study||211
134327|NCT00859833|308790|P1|NOT COMPLETED|Overall Study||0
134328|NCT00859833|308790|P1|COMPLETED|Overall Study||30
134329|NCT00859833|308790|P1|STARTED|Overall Study||30
134330|NCT00859638|308797|P2|NOT COMPLETED|Overall Study||4
134331|NCT00859638|308798|P1|NOT COMPLETED|Overall Study||10
134332|NCT00859638|308797|P2|COMPLETED|Overall Study||55
134333|NCT00859638|308798|P1|COMPLETED|Overall Study||55
134334|NCT00859638|308797|P2|STARTED|Overall Study||59
134335|NCT00859638|308798|P1|STARTED|Overall Study||65
134336|NCT00859586|308804|P1|NOT COMPLETED|Overall Study||4
134337|NCT00859586|308804|P1|COMPLETED|Overall Study||4
134338|NCT00859586|308804|P1|STARTED|Overall Study||8
134339|NCT00859573|308810|P2|NOT COMPLETED|Overall Study||2
134340|NCT00859573|308811|P1|NOT COMPLETED|Overall Study||5
134341|NCT00859573|308810|P2|COMPLETED|Overall Study||1
134342|NCT00859573|308811|P1|COMPLETED|Overall Study||1
134343|NCT00859573|308810|P2|STARTED|Overall Study||3
134344|NCT00859573|308811|P1|STARTED|Overall Study||6
134345|NCT00859547|308817|P1|NOT COMPLETED|Overall Study||2
134346|NCT00859547|308817|P1|COMPLETED|Overall Study||28
134347|NCT00859547|308817|P1|STARTED|Overall Study||30
134348|NCT00859521|308830|P2|NOT COMPLETED|Second Intervention||0
134349|NCT00859521|308831|P1|NOT COMPLETED|Second Intervention||0
134350|NCT00859521|308830|P2|COMPLETED|Second Intervention||14
134351|NCT00859521|308831|P1|COMPLETED|Second Intervention||15
134352|NCT00859521|308830|P2|STARTED|Second Intervention||14
134353|NCT00859521|308831|P1|STARTED|Second Intervention||15
134354|NCT00859521|308830|P2|NOT COMPLETED|Washout||1
134355|NCT00859521|308831|P1|NOT COMPLETED|Washout||0
134356|NCT00859521|308830|P2|COMPLETED|Washout||14
134357|NCT00859521|308831|P1|COMPLETED|Washout||15
134358|NCT00859521|308830|P2|STARTED|Washout||15
134359|NCT00859521|308831|P1|STARTED|Washout||15
134360|NCT00859521|308830|P2|NOT COMPLETED|First Intervention||0
134361|NCT00859521|308831|P1|NOT COMPLETED|First Intervention||0
134362|NCT00859521|308830|P2|COMPLETED|First Intervention||15
134363|NCT00859521|308831|P1|COMPLETED|First Intervention||15
134364|NCT00859521|308830|P2|STARTED|First Intervention||15
134365|NCT00859521|308831|P1|STARTED|First Intervention||15
134366|NCT00859508|308841|P2|NOT COMPLETED|Overall Study||0
134367|NCT00859508|308842|P1|NOT COMPLETED|Overall Study||6
134368|NCT00859508|308841|P2|COMPLETED|Overall Study||37
134369|NCT00859508|308842|P1|COMPLETED|Overall Study||62
134370|NCT00859508|308841|P2|STARTED|Overall Study||37
134371|NCT00859508|308842|P1|STARTED|Overall Study||68
134372|NCT00859469|308848|P1|NOT COMPLETED|Overall Study||28
134373|NCT00859469|308848|P1|COMPLETED|Overall Study||1
134374|NCT00859469|308848|P1|6 Cycles|Overall Study||16
134375|NCT00859469|308848|P1|STARTED|Overall Study||29
134376|NCT00859430|308856|P2|NOT COMPLETED|Second Intervention||0
134377|NCT00859430|308857|P1|NOT COMPLETED|Second Intervention||0
134378|NCT00859430|308856|P2|COMPLETED|Second Intervention||10
134379|NCT00859430|308857|P1|COMPLETED|Second Intervention||11
134380|NCT00859430|308856|P2|STARTED|Second Intervention||10
134381|NCT00859430|308857|P1|STARTED|Second Intervention||11
134382|NCT00859430|308856|P2|NOT COMPLETED|First Intervention||1
134383|NCT00859430|308857|P1|NOT COMPLETED|First Intervention||0
134384|NCT00859430|308856|P2|COMPLETED|First Intervention||10
134385|NCT00859430|308857|P1|COMPLETED|First Intervention||11
134386|NCT00859430|308856|P2|STARTED|First Intervention||11
134387|NCT00859430|308857|P1|STARTED|First Intervention||11
134388|NCT00859339|308865|P1|NOT COMPLETED|Overall Study||0
134389|NCT00859339|308865|P1|COMPLETED|Overall Study||9
134390|NCT00859339|308865|P1|STARTED|Overall Study||9
134391|NCT00859313|308873|P1|NOT COMPLETED|Overall Study||4
134392|NCT00859313|308873|P1|COMPLETED|Overall Study||26
134393|NCT00859313|308873|P1|STARTED|Overall Study||30
134394|NCT00859222|308880|P5|NOT COMPLETED|Overall Study||15
134395|NCT00859222|308881|P4|NOT COMPLETED|Overall Study||24
134396|NCT00859222|308882|P3|NOT COMPLETED|Overall Study||6
134397|NCT00859222|308883|P2|NOT COMPLETED|Overall Study||3
134398|NCT00859222|308884|P1|NOT COMPLETED|Overall Study||3
134399|NCT00859222|308880|P5|COMPLETED|Overall Study||0
134400|NCT00859222|308881|P4|COMPLETED|Overall Study||0
134401|NCT00859222|308882|P3|COMPLETED|Overall Study||0
134402|NCT00859222|308883|P2|COMPLETED|Overall Study||0
134403|NCT00859222|308884|P1|COMPLETED|Overall Study||0
134404|NCT00859222|308880|P5|STARTED|Overall Study||15
134405|NCT00859222|308881|P4|STARTED|Overall Study||24
134406|NCT00859222|308882|P3|STARTED|Overall Study||6
134407|NCT00859222|308883|P2|STARTED|Overall Study||3
134408|NCT00859222|308884|P1|STARTED|Overall Study||3
134409|NCT00859131|308911|P2|NOT COMPLETED|Overall Study||0
134410|NCT00859131|308912|P1|NOT COMPLETED|Overall Study||0
134411|NCT00859131|308911|P2|COMPLETED|Overall Study||98
134412|NCT00859131|308912|P1|COMPLETED|Overall Study||102
134413|NCT00859131|308911|P2|STARTED|Overall Study||98
134414|NCT00859131|308912|P1|STARTED|Overall Study||102
134415|NCT00859053|308934|P4|NOT COMPLETED|Overall Study||0
134416|NCT00859053|308935|P3|NOT COMPLETED|Overall Study||0
134417|NCT00859053|308936|P2|NOT COMPLETED|Overall Study||0
134418|NCT00859053|308937|P1|NOT COMPLETED|Overall Study||0
134419|NCT00859053|308934|P4|COMPLETED|Overall Study||12
134420|NCT00859053|308935|P3|COMPLETED|Overall Study||6
134421|NCT00859053|308936|P2|COMPLETED|Overall Study||6
134422|NCT00859053|308937|P1|COMPLETED|Overall Study||6
134423|NCT00859053|308934|P4|STARTED|Overall Study||12
134424|NCT00859053|308935|P3|STARTED|Overall Study||6
134425|NCT00859053|308936|P2|STARTED|Overall Study||6
134426|NCT00859053|308937|P1|STARTED|Overall Study||6
134427|NCT00859040|308981|P2|NOT COMPLETED|Overall Study||0
134428|NCT00859040|308982|P1|NOT COMPLETED|Overall Study||0
134429|NCT00859040|308981|P2|COMPLETED|Overall Study||16
134430|NCT00859040|308982|P1|COMPLETED|Overall Study||18
134431|NCT00859040|308981|P2|STARTED|Overall Study||16
134432|NCT00859040|308982|P1|STARTED|Overall Study||18
134433|NCT00859027|308996|P2|NOT COMPLETED|Overall Study||5
134434|NCT00859027|308997|P1|NOT COMPLETED|Overall Study||5
134435|NCT00859027|308996|P2|COMPLETED|Overall Study||20
134436|NCT00859027|308997|P1|COMPLETED|Overall Study||20
134437|NCT00859027|308996|P2|STARTED|Overall Study||25
134438|NCT00859027|308997|P1|STARTED|Overall Study||25
134439|NCT00859014|309003|P1|NOT COMPLETED|Overall Study||5
134440|NCT00859014|309003|P1|COMPLETED|Overall Study||20
134441|NCT00859014|309003|P1|STARTED|Overall Study||25
134442|NCT00858962|309008|P1|NOT COMPLETED|Overall Study||0
134443|NCT00858962|309008|P1|COMPLETED|Overall Study||12
134444|NCT00858962|309008|P1|STARTED|Overall Study||12
134445|NCT00858858|309012|P1|NOT COMPLETED|Overall Study||18
134446|NCT00858858|309012|P1|COMPLETED|Overall Study||42
134447|NCT00858858|309012|P1|STARTED|Overall Study||60
134448|NCT00858845|309016|P1|NOT COMPLETED|Overall Study||1
134449|NCT00858845|309016|P1|COMPLETED|Overall Study||10
134450|NCT00858845|309016|P1|STARTED|Overall Study||11
134451|NCT00858832|309022|P2|NOT COMPLETED|Overall Study||1
134452|NCT00858832|309023|P1|NOT COMPLETED|Overall Study||1
134453|NCT00858832|309022|P2|COMPLETED|Overall Study||22
134454|NCT00858832|309023|P1|COMPLETED|Overall Study||20
134455|NCT00858832|309022|P2|STARTED|Overall Study||23
134532|NCT00858637|309129|P3|NOT COMPLETED|Active Comparison Phase||0
134456|NCT00858832|309023|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
134457|NCT00858780|309029|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
134458|NCT00858780|309030|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134459|NCT00858780|309031|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134460|NCT00858780|309032|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134461|NCT00858780|309033|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134462|NCT00858780|309029|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
134463|NCT00858780|309030|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134464|NCT00858780|309031|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134465|NCT00858780|309032|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134466|NCT00858780|309033|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
134467|NCT00858780|309029|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
134468|NCT00858780|309030|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
134469|NCT00858780|309031|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
134470|NCT00858780|309032|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
134471|NCT00858780|309033|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
134472|NCT00858780|309029|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
134473|NCT00858780|309030|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
134474|NCT00858780|309031|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
134475|NCT00858780|309032|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
134476|NCT00858780|309033|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
134477|NCT00858780|309029|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
134478|NCT00858780|309030|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
134479|NCT00858780|309031|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
134480|NCT00858780|309032|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
134481|NCT00858780|309033|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
134482|NCT00858780|309029|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
134483|NCT00858780|309030|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
134484|NCT00858780|309031|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
134485|NCT00858780|309032|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
134486|NCT00858780|309033|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
134487|NCT00858780|309029|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134488|NCT00858780|309030|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134489|NCT00858780|309031|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134490|NCT00858780|309032|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134491|NCT00858780|309033|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
134492|NCT00858780|309029|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134493|NCT00858780|309030|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134494|NCT00858780|309031|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134495|NCT00858780|309032|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134496|NCT00858780|309033|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
134497|NCT00858780|309029|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134498|NCT00858780|309030|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134499|NCT00858780|309031|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134500|NCT00858780|309032|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
134501|NCT00858780|309033|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
134502|NCT00858702|309108|P2|NOT COMPLETED|Overall Study||2
134503|NCT00858702|309109|P1|NOT COMPLETED|Overall Study||5
134504|NCT00858702|309108|P2|COMPLETED|Overall Study||50
134505|NCT00858702|309109|P1|COMPLETED|Overall Study||48
134506|NCT00858702|309108|P2|STARTED|Overall Study||52
134507|NCT00858702|309109|P1|STARTED|Overall Study||53
134508|NCT00858689|309119|P1|NOT COMPLETED|Overall Study||1
134509|NCT00858689|309119|P1|COMPLETED|Overall Study||19
134510|NCT00858689|309119|P1|STARTED|Overall Study||20
134511|NCT00858637|309126|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
134512|NCT00858637|309127|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
134513|NCT00858637|309128|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
134514|NCT00858637|309129|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
134515|NCT00858637|309130|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
134516|NCT00858637|309131|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
134517|NCT00858637|309126|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
134518|NCT00858637|309127|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
134519|NCT00858637|309128|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
134520|NCT00858637|309129|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
134521|NCT00858637|309130|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
134522|NCT00858637|309131|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
134523|NCT00858637|309126|P6|STARTED|Placebo-controlled Withdrawal Phase||59
134524|NCT00858637|309127|P5|STARTED|Placebo-controlled Withdrawal Phase||56
134525|NCT00858637|309128|P4|STARTED|Placebo-controlled Withdrawal Phase||0
134526|NCT00858637|309129|P3|STARTED|Placebo-controlled Withdrawal Phase||54
134527|NCT00858637|309130|P2|STARTED|Placebo-controlled Withdrawal Phase||49
134528|NCT00858637|309131|P1|STARTED|Placebo-controlled Withdrawal Phase||0
134529|NCT00858637|309126|P6|NOT COMPLETED|Active Comparison Phase||0
134530|NCT00858637|309127|P5|NOT COMPLETED|Active Comparison Phase||0
134531|NCT00858637|309128|P4|NOT COMPLETED|Active Comparison Phase||18
134533|NCT00858637|309130|P2|NOT COMPLETED|Active Comparison Phase||0
134534|NCT00858637|309131|P1|NOT COMPLETED|Active Comparison Phase||24
134535|NCT00858637|309126|P6|COMPLETED|Active Comparison Phase||0
134536|NCT00858637|309127|P5|COMPLETED|Active Comparison Phase||0
134537|NCT00858637|309128|P4|COMPLETED|Active Comparison Phase||115
134538|NCT00858637|309129|P3|COMPLETED|Active Comparison Phase||0
134539|NCT00858637|309130|P2|COMPLETED|Active Comparison Phase||0
134540|NCT00858637|309131|P1|COMPLETED|Active Comparison Phase||103
134541|NCT00858637|309126|P6|STARTED|Active Comparison Phase||0
134542|NCT00858637|309127|P5|STARTED|Active Comparison Phase||0
134543|NCT00858637|309128|P4|STARTED|Active Comparison Phase||133
134544|NCT00858637|309129|P3|STARTED|Active Comparison Phase||0
134545|NCT00858637|309130|P2|STARTED|Active Comparison Phase||0
134546|NCT00858637|309131|P1|STARTED|Active Comparison Phase||127
134547|NCT00858507|309143|P2|NOT COMPLETED|Overall Study||15
134548|NCT00858507|309144|P1|NOT COMPLETED|Overall Study||22
134549|NCT00858507|309143|P2|COMPLETED|Overall Study||101
134550|NCT00858507|309144|P1|COMPLETED|Overall Study||83
134551|NCT00858507|309143|P2|STARTED|Overall Study||116
134552|NCT00858507|309144|P1|STARTED|Overall Study||105
134553|NCT00858494|309150|P1|NOT COMPLETED|Overall Study||4
134554|NCT00858494|309150|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
134555|NCT00858494|309150|P1|STARTED|Overall Study||49
134556|NCT00858468|309157|P2|NOT COMPLETED|Overall Study||0
134557|NCT00858468|309158|P1|NOT COMPLETED|Overall Study||0
134558|NCT00858468|309157|P2|COMPLETED|Overall Study||192
134559|NCT00858468|309158|P1|COMPLETED|Overall Study||201
134560|NCT00858468|309157|P2|STARTED|Overall Study||192
134561|NCT00858468|309158|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
134562|NCT00858442|309172|P2|NOT COMPLETED|Compression:Start to Finish||3
134563|NCT00858442|309173|P1|NOT COMPLETED|Compression:Start to Finish||1
134564|NCT00858442|309172|P2|COMPLETED|Compression:Start to Finish||20
134565|NCT00858442|309173|P1|COMPLETED|Compression:Start to Finish||20
134566|NCT00858442|309172|P2|STARTED|Compression:Start to Finish||23
134567|NCT00858442|309173|P1|STARTED|Compression:Start to Finish||21
134568|NCT00858442|309172|P2|NOT COMPLETED|From Surgery to Start Compression;||0
134569|NCT00858442|309173|P1|NOT COMPLETED|From Surgery to Start Compression;||0
134570|NCT00858442|309172|P2|COMPLETED|From Surgery to Start Compression;||23
134571|NCT00858442|309173|P1|COMPLETED|From Surgery to Start Compression;||21
134572|NCT00858442|309172|P2|STARTED|From Surgery to Start Compression;||23
134573|NCT00858442|309173|P1|STARTED|From Surgery to Start Compression;||21
134574|NCT00858403|309183|P1|NOT COMPLETED|Overall Study||5
134575|NCT00858403|309183|P1|COMPLETED|Overall Study||2
134576|NCT00858403|309183|P1|STARTED|Overall Study||7
134577|NCT00858390|309195|P2|NOT COMPLETED|Overall Study||0
134578|NCT00858390|309196|P1|NOT COMPLETED|Overall Study||0
134579|NCT00858390|309195|P2|COMPLETED|Overall Study||18
134580|NCT00858390|309196|P1|COMPLETED|Overall Study||18
134581|NCT00858390|309195|P2|STARTED|Overall Study||18
134582|NCT00858390|309196|P1|STARTED|Overall Study||18
134583|NCT00858247|309204|P2|NOT COMPLETED|Week 12 Follow-up||1
134584|NCT00858247|309205|P1|NOT COMPLETED|Week 12 Follow-up||0
134585|NCT00858247|309204|P2|COMPLETED|Week 12 Follow-up||23
134586|NCT00858247|309205|P1|COMPLETED|Week 12 Follow-up||23
134587|NCT00858247|309204|P2|STARTED|Week 12 Follow-up||24
134588|NCT00858247|309205|P1|STARTED|Week 12 Follow-up||23
134589|NCT00858247|309204|P2|NOT COMPLETED|Baseline Assessment||2
134590|NCT00858247|309205|P1|NOT COMPLETED|Baseline Assessment||2
134591|NCT00858247|309204|P2|COMPLETED|Baseline Assessment||24
134592|NCT00858247|309205|P1|COMPLETED|Baseline Assessment||23
134593|NCT00858247|309204|P2|STARTED|Baseline Assessment||26
134594|NCT00858247|309205|P1|STARTED|Baseline Assessment||25
134595|NCT00858208|309221|P1|NOT COMPLETED|Overall Study||79
134596|NCT00858208|309221|P1|COMPLETED|Overall Study||6
134597|NCT00858208|309221|P1|STARTED|Overall Study||85
134598|NCT00858143|309238|P1|NOT COMPLETED|Overall Study||50
134599|NCT00858143|309238|P1|COMPLETED|Overall Study||261
134600|NCT00858143|309238|P1|STARTED|Overall Study|Baseline|311
134601|NCT00857961|309287|P1|NOT COMPLETED|Overall Study||0
134602|NCT00857961|309287|P1|COMPLETED|Overall Study||21
134603|NCT00857961|309287|P1|STARTED|Overall Study||21
134604|NCT00857948|309325|P4|NOT COMPLETED|Overall Study||0
134605|NCT00857948|309326|P3|NOT COMPLETED|Overall Study||1
134606|NCT00857948|309327|P2|NOT COMPLETED|Overall Study||0
134607|NCT00857948|309328|P1|NOT COMPLETED|Overall Study||3
134608|NCT00857948|309325|P4|COMPLETED|Overall Study||23
134609|NCT00857948|309326|P3|COMPLETED|Overall Study||18
134610|NCT00857948|309327|P2|COMPLETED|Overall Study||18
134611|NCT00857948|309328|P1|COMPLETED|Overall Study||15
134612|NCT00857948|309325|P4|STARTED|Overall Study||23
134613|NCT00857948|309326|P3|STARTED|Overall Study||19
134614|NCT00857948|309327|P2|STARTED|Overall Study||18
134615|NCT00857948|309328|P1|STARTED|Overall Study||18
134616|NCT00857896|309350|P1|NOT COMPLETED|Week 5 to Week 8||0
134617|NCT00857896|309350|P1|COMPLETED|Week 5 to Week 8||20
134618|NCT00857896|309350|P1|STARTED|Week 5 to Week 8||20
134619|NCT00857896|309350|P1|NOT COMPLETED|Baseline to Week 4||1
134620|NCT00857896|309350|P1|COMPLETED|Baseline to Week 4||20
134621|NCT00857896|309350|P1|STARTED|Baseline to Week 4||21
134622|NCT00857818|309364|P2|NOT COMPLETED|Overall Study||8
134623|NCT00857818|309365|P1|NOT COMPLETED|Overall Study||11
134624|NCT00857818|309364|P2|COMPLETED|Overall Study||6
134625|NCT00857818|309365|P1|COMPLETED|Overall Study||3
134626|NCT00857818|309364|P2|Received Treatment|Overall Study||12
134627|NCT00857818|309365|P1|Received Treatment|Overall Study||14
134628|NCT00857818|309364|P2|STARTED|Overall Study||14
134629|NCT00857818|309365|P1|STARTED|Overall Study||14
134630|NCT00857792|309393|P1|NOT COMPLETED|Overall Study||12
134631|NCT00857792|309393|P1|COMPLETED|Overall Study||108
134632|NCT00857792|309393|P1|STARTED|Overall Study||120
134633|NCT00857766|309399|P2|NOT COMPLETED|Overall Study||30
134634|NCT00857766|309400|P1|NOT COMPLETED|Overall Study||31
134635|NCT00857766|309399|P2|COMPLETED|Overall Study||96
134636|NCT00857766|309400|P1|COMPLETED|Overall Study||92
134637|NCT00857766|309399|P2|STARTED|Overall Study||126
134638|NCT00857766|309400|P1|STARTED|Overall Study||123
134639|NCT00857714|309410|P1|NOT COMPLETED|Overall Study||0
134640|NCT00857714|309410|P1|COMPLETED|Overall Study||1
134641|NCT00857714|309410|P1|STARTED|Overall Study||1
134642|NCT00857649|309417|P2|NOT COMPLETED|Overall Study||32
134643|NCT00857649|309418|P1|NOT COMPLETED|Overall Study||31
134644|NCT00857649|309417|P2|COMPLETED|Overall Study||155
134645|NCT00857649|309418|P1|COMPLETED|Overall Study||151
134646|NCT00857649|309417|P2|STARTED|Overall Study||187
134647|NCT00857649|309418|P1|STARTED|Overall Study||182
134648|NCT00857623|309434|P2|NOT COMPLETED|Overall Study||10
134649|NCT00857623|309435|P1|NOT COMPLETED|Overall Study||14
134650|NCT00857623|309434|P2|COMPLETED|Overall Study||55
134651|NCT00857623|309435|P1|COMPLETED|Overall Study||48
134652|NCT00857623|309434|P2|STARTED|Overall Study||65
134653|NCT00857623|309435|P1|STARTED|Overall Study||62
134654|NCT00857584|309459|P2|NOT COMPLETED|Overall Study||5
134655|NCT00857584|309460|P1|NOT COMPLETED|Overall Study||4
134656|NCT00857584|309459|P2|COMPLETED|Overall Study||8
134657|NCT00857584|309460|P1|COMPLETED|Overall Study||10
134658|NCT00857584|309459|P2|Week 8|Overall Study||8
134659|NCT00857584|309460|P1|Week 8|Overall Study||10
134660|NCT00857584|309459|P2|Week 4|Overall Study||9
134661|NCT00857584|309460|P1|Week 4|Overall Study||11
134662|NCT00857584|309459|P2|Week 2|Overall Study||11
134663|NCT00857584|309460|P1|Week 2|Overall Study||14
134664|NCT00857584|309459|P2|Week 1|Overall Study||13
134665|NCT00857584|309460|P1|Week 1|Overall Study||14
134666|NCT00857584|309459|P2|STARTED|Overall Study||13
134667|NCT00857584|309460|P1|STARTED|Overall Study||14
134668|NCT00857532|309500|P1|NOT COMPLETED|Overall Study||0
134669|NCT00857532|309500|P1|COMPLETED|Overall Study||31
134670|NCT00857532|309500|P1|STARTED|Overall Study||31
134671|NCT00857506|309511|P3|NOT COMPLETED|Overall Study||18
134672|NCT00857506|309512|P2|NOT COMPLETED|Overall Study||15
134673|NCT00857506|309513|P1|NOT COMPLETED|Overall Study||15
134674|NCT00857506|309511|P3|COMPLETED|Overall Study||51
134675|NCT00857506|309512|P2|COMPLETED|Overall Study||37
134676|NCT00857506|309513|P1|COMPLETED|Overall Study||16
134677|NCT00857506|309511|P3|STARTED|Overall Study||69
134678|NCT00857506|309512|P2|STARTED|Overall Study||52
134679|NCT00857506|309513|P1|STARTED|Overall Study||31
134680|NCT00857454|309539|P1|NOT COMPLETED|Overall Study||20
134681|NCT00857454|309539|P1|COMPLETED|Overall Study||51
134682|NCT00857454|309539|P1|STARTED|Overall Study||71
134683|NCT00857415|309552|P2|NOT COMPLETED|Overall Study||0
134684|NCT00857415|309553|P1|NOT COMPLETED|Overall Study||117
134685|NCT00857415|309552|P2|COMPLETED|Overall Study||74
134686|NCT00857415|309553|P1|COMPLETED|Overall Study||35
134687|NCT00857415|309552|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
134688|NCT00857415|309553|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
134689|NCT00857415|309552|P2|STARTED|Overall Study||74
134690|NCT00857415|309553|P1|STARTED|Overall Study||152
134691|NCT00857311|309564|P4|NOT COMPLETED|Overall Study||0
134692|NCT00857311|309565|P3|NOT COMPLETED|Overall Study||0
134693|NCT00857311|309566|P2|NOT COMPLETED|Overall Study||0
134694|NCT00857311|309567|P1|NOT COMPLETED|Overall Study||1
134695|NCT00857311|309564|P4|COMPLETED|Overall Study||0
134696|NCT00857311|309565|P3|COMPLETED|Overall Study||8
134697|NCT00857311|309566|P2|COMPLETED|Overall Study||0
134698|NCT00857311|309567|P1|COMPLETED|Overall Study||8
134699|NCT00857311|309564|P4|STARTED|Overall Study||0
134700|NCT00857311|309565|P3|STARTED|Overall Study||8
134701|NCT00857311|309566|P2|STARTED|Overall Study||0
134702|NCT00857311|309567|P1|STARTED|Overall Study||9
134703|NCT00857285|309579|P2|NOT COMPLETED|Overall Study||6
134704|NCT00857285|309580|P1|NOT COMPLETED|Overall Study||12
134705|NCT00857285|309579|P2|COMPLETED|Overall Study||59
134706|NCT00857285|309580|P1|COMPLETED|Overall Study||53
134707|NCT00857285|309579|P2|STARTED|Overall Study||65
134708|NCT00857285|309580|P1|STARTED|Overall Study||65
134709|NCT00857272|309586|P2|NOT COMPLETED|Overall Study||9
134710|NCT00857272|309587|P1|NOT COMPLETED|Overall Study||9
134711|NCT00857272|309586|P2|COMPLETED|Overall Study||145
134712|NCT00857272|309587|P1|COMPLETED|Overall Study||145
134713|NCT00857272|309586|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
134714|NCT00857272|309587|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
134715|NCT00857259|309596|P3|NOT COMPLETED|Overall Study||1
134716|NCT00857259|309597|P2|NOT COMPLETED|Overall Study||0
134717|NCT00857259|309598|P1|NOT COMPLETED|Overall Study||1
134718|NCT00857259|309596|P3|COMPLETED|Overall Study||6
134719|NCT00857259|309597|P2|COMPLETED|Overall Study||1
134720|NCT00857259|309598|P1|COMPLETED|Overall Study||7
134721|NCT00857259|309596|P3|STARTED|Overall Study||7
134722|NCT00857259|309597|P2|STARTED|Overall Study||1
134723|NCT00857259|309598|P1|STARTED|Overall Study||8
134724|NCT00857246|309608|P1|NOT COMPLETED|ChemoRT||3
134725|NCT00857246|309608|P1|COMPLETED|ChemoRT||12
134726|NCT00857246|309608|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
134727|NCT00857246|309608|P1|NOT COMPLETED|Surgery (Curative)||6
134728|NCT00857246|309608|P1|COMPLETED|Surgery (Curative)||21
134729|NCT00857246|309608|P1|STARTED|Surgery (Curative)||27
134730|NCT00857246|309608|P1|NOT COMPLETED|Induction Regimen||3
134731|NCT00857246|309608|P1|COMPLETED|Induction Regimen||27
134732|NCT00857246|309608|P1|STARTED|Induction Regimen||30
134733|NCT00857233|309618|P1|NOT COMPLETED|Overall Study||55
134734|NCT00857233|309618|P1|COMPLETED|Overall Study||242
134735|NCT00857233|309618|P1|STARTED|Overall Study||297
134736|NCT00857220|309627|P1|NOT COMPLETED|Overall Study||183
134737|NCT00857220|309627|P1|COMPLETED|Overall Study||121
134738|NCT00857220|309627|P1|STARTED|Overall Study||304
134739|NCT00856986|309649|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
134740|NCT00856986|309650|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
134741|NCT00856986|309651|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
134742|NCT00856986|309652|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
134743|NCT00856986|309653|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
134744|NCT00856986|309649|P5|COMPLETED|Extension Period, Weeks 26-52||0
134745|NCT00856986|309650|P4|COMPLETED|Extension Period, Weeks 26-52||0
134746|NCT00856986|309651|P3|COMPLETED|Extension Period, Weeks 26-52||432
134747|NCT00856986|309652|P2|COMPLETED|Extension Period, Weeks 26-52||130
134748|NCT00856986|309653|P1|COMPLETED|Extension Period, Weeks 26-52||108
134749|NCT00856986|309649|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
134750|NCT00856986|309650|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
134751|NCT00856986|309651|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
134752|NCT00856986|309652|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
134753|NCT00856986|309653|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
134754|NCT00856986|309649|P5|STARTED|Extension Period, Weeks 26-52||0
134755|NCT00856986|309650|P4|STARTED|Extension Period, Weeks 26-52||0
134756|NCT00856986|309651|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
134757|NCT00856986|309652|P2|STARTED|Extension Period, Weeks 26-52||144
134758|NCT00856986|309653|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
134759|NCT00856986|309649|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
134760|NCT00856986|309650|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
134761|NCT00856986|309651|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
134762|NCT00856986|309652|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
134763|NCT00856986|309653|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
134764|NCT00856986|309649|P5|COMPLETED|Main Period, Weeks 0-26||0
134765|NCT00856986|309650|P4|COMPLETED|Main Period, Weeks 0-26||0
134766|NCT00856986|309651|P3|COMPLETED|Main Period, Weeks 0-26||470
134767|NCT00856986|309652|P2|COMPLETED|Main Period, Weeks 0-26||144
134768|NCT00856986|309653|P1|COMPLETED|Main Period, Weeks 0-26||127
134769|NCT00856986|309649|P5|STARTED|Main Period, Weeks 0-26||0
134770|NCT00856986|309650|P4|STARTED|Main Period, Weeks 0-26||0
134771|NCT00856986|309651|P3|STARTED|Main Period, Weeks 0-26||498
134772|NCT00856986|309652|P2|STARTED|Main Period, Weeks 0-26||162
134773|NCT00856986|309653|P1|STARTED|Main Period, Weeks 0-26||161
134774|NCT00856986|309649|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
134775|NCT00856986|309650|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
134776|NCT00856986|309651|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
134777|NCT00856986|309652|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
134778|NCT00856986|309653|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
134779|NCT00856986|309649|P5|COMPLETED|Run-in Period, Weeks -12-0||0
134780|NCT00856986|309650|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
134781|NCT00856986|309651|P3|COMPLETED|Run-in Period, Weeks -12-0||498
134782|NCT00856986|309652|P2|COMPLETED|Run-in Period, Weeks -12-0||162
134783|NCT00856986|309653|P1|COMPLETED|Run-in Period, Weeks -12-0||161
134784|NCT00856986|309649|P5|STARTED|Run-in Period, Weeks -12-0||0
134785|NCT00856986|309650|P4|STARTED|Run-in Period, Weeks -12-0||167
134786|NCT00856986|309651|P3|STARTED|Run-in Period, Weeks -12-0||498
134787|NCT00856986|309652|P2|STARTED|Run-in Period, Weeks -12-0||162
134788|NCT00856986|309653|P1|STARTED|Run-in Period, Weeks -12-0||161
134789|NCT00856973|309823|P3|NOT COMPLETED|Overall Study||38
134790|NCT00856973|309824|P2|NOT COMPLETED|Overall Study||41
134791|NCT00856973|309825|P1|NOT COMPLETED|Overall Study||36
134792|NCT00856973|309823|P3|COMPLETED|Overall Study||123
134793|NCT00856973|309824|P2|COMPLETED|Overall Study||122
134794|NCT00856973|309825|P1|COMPLETED|Overall Study||126
134795|NCT00856973|309823|P3|STARTED|Overall Study||161
134796|NCT00856973|309824|P2|STARTED|Overall Study||163
134797|NCT00856973|309825|P1|STARTED|Overall Study||162
134798|NCT00856934|309893|P3|NOT COMPLETED|Overall Study||0
134799|NCT00856934|309894|P2|NOT COMPLETED|Overall Study||0
134800|NCT00856934|309895|P1|NOT COMPLETED|Overall Study||0
134801|NCT00856934|309893|P3|COMPLETED|Overall Study||15
134802|NCT00856934|309894|P2|COMPLETED|Overall Study||15
134803|NCT00856934|309895|P1|COMPLETED|Overall Study||15
134804|NCT00856934|309893|P3|STARTED|Overall Study||15
134805|NCT00856934|309894|P2|STARTED|Overall Study||15
134806|NCT00856934|309895|P1|STARTED|Overall Study||15
134807|NCT00856908|309905|P2|NOT COMPLETED|Overall Study||0
134808|NCT00856908|309906|P1|NOT COMPLETED|Overall Study||1
134809|NCT00856908|309905|P2|COMPLETED|Overall Study||5
134810|NCT00856908|309906|P1|COMPLETED|Overall Study||14
134811|NCT00856908|309905|P2|STARTED|Overall Study||5
134812|NCT00856908|309906|P1|STARTED|Overall Study||15
134813|NCT00856843|309933|P2|NOT COMPLETED|Overall Study||5
134814|NCT00856843|309934|P1|NOT COMPLETED|Overall Study||2
134815|NCT00856843|309933|P2|COMPLETED|Overall Study||63
134816|NCT00856843|309934|P1|COMPLETED|Overall Study||66
134817|NCT00856843|309933|P2|STARTED|Overall Study||68
134818|NCT00856843|309934|P1|STARTED|Overall Study||68
134819|NCT00856791|309966|P1|NOT COMPLETED|Overall Study||0
134820|NCT00856791|309966|P1|COMPLETED|Overall Study||1
134821|NCT00856791|309966|P1|STARTED|Overall Study||1
134822|NCT00856778|309971|P1|NOT COMPLETED|Overall Study||24
134823|NCT00856778|309971|P1|COMPLETED|Overall Study||74
134824|NCT00856778|309971|P1|STARTED|Overall Study||98
134825|NCT00856739|309990|P3|NOT COMPLETED|Overall Study||0
134826|NCT00856739|309991|P2|NOT COMPLETED|Overall Study||0
134827|NCT00856739|309992|P1|NOT COMPLETED|Overall Study||0
134828|NCT00856739|309990|P3|COMPLETED|Overall Study||55
134829|NCT00856739|309991|P2|COMPLETED|Overall Study||52
134830|NCT00856739|309992|P1|COMPLETED|Overall Study||70
134831|NCT00856739|309990|P3|STARTED|Overall Study||55
134832|NCT00856739|309991|P2|STARTED|Overall Study||52
134833|NCT00856739|309992|P1|STARTED|Overall Study||70
134834|NCT00856661|310005|P2|NOT COMPLETED|Overall Study||29
134835|NCT00856661|310006|P1|NOT COMPLETED|Overall Study||27
134836|NCT00856661|310005|P2|COMPLETED|Overall Study||106
134837|NCT00856661|310006|P1|COMPLETED|Overall Study||108
134838|NCT00856661|310005|P2|Randomized Not Treated|Overall Study||4
134839|NCT00856661|310006|P1|Randomized Not Treated|Overall Study||9
134840|NCT00856661|310005|P2|Treated|Overall Study||131
134841|NCT00856661|310006|P1|Treated|Overall Study||126
134842|NCT00856661|310005|P2|STARTED|Overall Study|Randomised|135
134843|NCT00856661|310006|P1|STARTED|Overall Study|Randomised|135
134844|NCT00856635|310020|P2|NOT COMPLETED|Overall Study||8
134845|NCT00856635|310021|P1|NOT COMPLETED|Overall Study||10
134846|NCT00856635|310020|P2|COMPLETED|Overall Study||14
134847|NCT00856635|310021|P1|COMPLETED|Overall Study||12
134848|NCT00856635|310020|P2|Received Study Drug|Overall Study||20
134849|NCT00856635|310021|P1|Received Study Drug|Overall Study||20
134850|NCT00856635|310020|P2|STARTED|Overall Study||22
134851|NCT00856635|310021|P1|STARTED|Overall Study||22
134852|NCT00856583|310029|P2|NOT COMPLETED|Overall Study||2597
134853|NCT00856583|310030|P1|NOT COMPLETED|Overall Study||3137
134854|NCT00856583|310029|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
134855|NCT00856583|310030|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
134856|NCT00856583|310029|P2|STARTED|Overall Study|Patients treated|4904
134857|NCT00856583|310030|P1|STARTED|Overall Study|Patients treated|4905
134858|NCT00856557|310060|P2|NOT COMPLETED|Overall Study||16
134859|NCT00856557|310061|P1|NOT COMPLETED|Overall Study||12
134860|NCT00856557|310060|P2|COMPLETED|Overall Study||60
134861|NCT00856557|310061|P1|COMPLETED|Overall Study||50
134862|NCT00856557|310060|P2|With Patients With Contextual Flags|Overall Study||60
134863|NCT00856557|310061|P1|With Patients With Contextual Flags|Overall Study||50
134864|NCT00856557|310060|P2|Tested With Standardized Patients|Overall Study||76
134865|NCT00856557|310061|P1|Tested With Standardized Patients|Overall Study||62
134866|NCT00856557|310060|P2|Received Intervention/Control|Overall Study||76
134867|NCT00856557|310061|P1|Received Intervention/Control|Overall Study||62
134868|NCT00856557|310060|P2|STARTED|Overall Study||76
134869|NCT00856557|310061|P1|STARTED|Overall Study||62
134870|NCT00856544|310075|P4|NOT COMPLETED|Overall Study||13
134871|NCT00856544|310076|P3|NOT COMPLETED|Overall Study||8
134872|NCT00856544|310077|P2|NOT COMPLETED|Overall Study||66
134873|NCT00856544|310078|P1|NOT COMPLETED|Overall Study||57
134874|NCT00856544|310075|P4|COMPLETED|Overall Study||67
134875|NCT00856544|310076|P3|COMPLETED|Overall Study||71
134876|NCT00856544|310077|P2|COMPLETED|Overall Study||252
134877|NCT00856544|310078|P1|COMPLETED|Overall Study||261
134878|NCT00856544|310075|P4|Treated|Overall Study||80
134879|NCT00856544|310076|P3|Treated|Overall Study||79
134880|NCT00856544|310077|P2|Treated|Overall Study||318
134881|NCT00856544|310078|P1|Treated|Overall Study||315
134882|NCT00856544|310075|P4|STARTED|Overall Study||80
134883|NCT00856544|310076|P3|STARTED|Overall Study||79
134884|NCT00856544|310077|P2|STARTED|Overall Study||318
134885|NCT00856544|310078|P1|STARTED|Overall Study||318
134886|NCT00856518|310257|P2|NOT COMPLETED|Overall Study||2
134887|NCT00856518|310258|P1|NOT COMPLETED|Overall Study||4
134888|NCT00856518|310257|P2|COMPLETED|Overall Study||16
134889|NCT00856518|310258|P1|COMPLETED|Overall Study||20
134890|NCT00856518|310257|P2|STARTED|Overall Study||18
134891|NCT00856518|310258|P1|STARTED|Overall Study||24
134892|NCT00856414|310268|P1|NOT COMPLETED|Overall Study||0
134893|NCT00856414|310268|P1|COMPLETED|Overall Study||45
134894|NCT00856414|310268|P1|STARTED|Overall Study||45
134895|NCT00856388|310276|P1|NOT COMPLETED|Overall Study||1
134896|NCT00856388|310276|P1|COMPLETED|Overall Study||61
134897|NCT00856388|310276|P1|STARTED|Overall Study||62
134898|NCT00856349|310287|P1|NOT COMPLETED|Overall Study||1021
134899|NCT00856349|310287|P1|COMPLETED|Overall Study||3111
134900|NCT00856349|310287|P1|24 Month Follow-up|Overall Study||1698
134901|NCT00856349|310287|P1|18 Month Follow-up|Overall Study||2467
134902|NCT00856349|310287|P1|12 Month Follow-up|Overall Study||3228
134903|NCT00856349|310287|P1|STARTED|Overall Study||4132
134904|NCT00856323|310296|P1|NOT COMPLETED|Overall Study||2
134905|NCT00856323|310296|P1|COMPLETED|Overall Study||51
134906|NCT00856323|310296|P1|STARTED|Overall Study||53
134907|NCT00856297|310308|P5|NOT COMPLETED|Overall Study||0
134908|NCT00856297|310309|P4|NOT COMPLETED|Overall Study||0
134909|NCT00856297|310310|P3|NOT COMPLETED|Overall Study||0
134910|NCT00856297|310311|P2|NOT COMPLETED|Overall Study||0
134911|NCT00856297|310312|P1|NOT COMPLETED|Overall Study||2
134912|NCT00856297|310308|P5|COMPLETED|Overall Study||31
134913|NCT00856297|310309|P4|COMPLETED|Overall Study||44
134914|NCT00856297|310310|P3|COMPLETED|Overall Study||107
134915|NCT00856297|310311|P2|COMPLETED|Overall Study||76
134916|NCT00856297|310312|P1|COMPLETED|Overall Study||129
134917|NCT00856297|310308|P5|STARTED|Overall Study||31
134918|NCT00856297|310309|P4|STARTED|Overall Study||44
134919|NCT00856297|310310|P3|STARTED|Overall Study||107
134920|NCT00856297|310311|P2|STARTED|Overall Study||76
134921|NCT00856297|310312|P1|STARTED|Overall Study||131
134922|NCT00856284|310345|P3|NOT COMPLETED|Overall Study||447
134923|NCT00856284|310346|P2|NOT COMPLETED|Overall Study||392
134924|NCT00856284|310347|P1|NOT COMPLETED|Overall Study||408
134925|NCT00856284|310345|P3|COMPLETED|Overall Study||427
134926|NCT00856284|310346|P2|COMPLETED|Overall Study||493
134927|NCT00856284|310347|P1|COMPLETED|Overall Study||472
134928|NCT00856284|310345|P3|Received Study Drug|Overall Study||869
134929|NCT00856284|310346|P2|Received Study Drug|Overall Study||878
134930|NCT00856284|310347|P1|Received Study Drug|Overall Study||873
134931|NCT00856284|310345|P3|STARTED|Overall Study||874
134932|NCT00856284|310346|P2|STARTED|Overall Study||885
134933|NCT00856284|310347|P1|STARTED|Overall Study||880
134934|NCT00856232|310376|P3|NOT COMPLETED|Overall Study||0
134935|NCT00856232|310377|P2|NOT COMPLETED|Overall Study||0
134936|NCT00856232|310378|P1|NOT COMPLETED|Overall Study||0
134937|NCT00856232|310376|P3|COMPLETED|Overall Study||36
134938|NCT00856232|310377|P2|COMPLETED|Overall Study||29
134939|NCT00856232|310378|P1|COMPLETED|Overall Study||26
134940|NCT00856232|310376|P3|STARTED|Overall Study||36
134941|NCT00856232|310377|P2|STARTED|Overall Study||29
134942|NCT00856232|310378|P1|STARTED|Overall Study||26
134943|NCT00856193|310389|P2|NOT COMPLETED|Period 2||2
134944|NCT00856193|310390|P1|NOT COMPLETED|Period 2||0
134945|NCT00856193|310389|P2|COMPLETED|Period 2||15
134946|NCT00856193|310390|P1|COMPLETED|Period 2||16
134947|NCT00856193|310389|P2|STARTED|Period 2||17
134948|NCT00856193|310390|P1|STARTED|Period 2||16
134949|NCT00856193|310389|P2|NOT COMPLETED|Period 1||0
134950|NCT00856193|310390|P1|NOT COMPLETED|Period 1||0
134951|NCT00856193|310389|P2|COMPLETED|Period 1||17
134952|NCT00856193|310390|P1|COMPLETED|Period 1||16
134953|NCT00856193|310389|P2|STARTED|Period 1||17
134954|NCT00856193|310390|P1|STARTED|Period 1||16
134955|NCT00856180|310402|P1|NOT COMPLETED|Overall Study||20
134956|NCT00856180|310402|P1|COMPLETED|Overall Study||0
134957|NCT00856180|310402|P1|STARTED|Overall Study||20
134958|NCT00856050|310411|P1|NOT COMPLETED|Overall Study||0
134959|NCT00856050|310411|P1|COMPLETED|Overall Study||26
134960|NCT00856050|310411|P1|STARTED|Overall Study||26
134961|NCT00856024|310415|P1|NOT COMPLETED|Overall Study||0
134962|NCT00856024|310415|P1|COMPLETED|Overall Study||902
134963|NCT00856024|310415|P1|STARTED|Overall Study||902
134964|NCT00855959|310427|P1|NOT COMPLETED|Overall Study||9
134965|NCT00855959|310427|P1|COMPLETED|Overall Study||99
134966|NCT00855959|310427|P1|Patients Who Received Pulmicort Respules|Overall Study||105
134967|NCT00855959|310427|P1|STARTED|Overall Study||108
134968|NCT00855933|310444|P2|NOT COMPLETED|Overall Study||1
134969|NCT00855933|310445|P1|NOT COMPLETED|Overall Study||0
134970|NCT00855933|310444|P2|COMPLETED|Overall Study||29
134971|NCT00855933|310445|P1|COMPLETED|Overall Study||30
134972|NCT00855933|310444|P2|STARTED|Overall Study||30
134973|NCT00855933|310445|P1|STARTED|Overall Study||30
134974|NCT00855894|310451|P1|NOT COMPLETED|Overall Study||33
134975|NCT00855894|310451|P1|COMPLETED|Overall Study||8
134976|NCT00855894|310451|P1|STARTED|Overall Study||41
134977|NCT00855868|310461|P2|NOT COMPLETED|Overall Study||1
134978|NCT00855868|310462|P1|NOT COMPLETED|Overall Study||1
134979|NCT00855868|310461|P2|COMPLETED|Overall Study||14
134980|NCT00855868|310462|P1|COMPLETED|Overall Study||12
134981|NCT00855868|310461|P2|STARTED|Overall Study||15
134982|NCT00855868|310462|P1|STARTED|Overall Study||13
134983|NCT00855842|310468|P1|NOT COMPLETED|Overall Study||0
134984|NCT00855842|310468|P1|COMPLETED|Overall Study||4
134985|NCT00855842|310468|P1|STARTED|Overall Study||4
134986|NCT00855816|310474|P2|NOT COMPLETED|Overall Study||21
134987|NCT00855816|310475|P1|NOT COMPLETED|Overall Study||26
134988|NCT00855816|310474|P2|COMPLETED|Overall Study||12
134989|NCT00855816|310475|P1|COMPLETED|Overall Study||21
134990|NCT00855816|310474|P2|STARTED|Overall Study||33
134991|NCT00855816|310475|P1|STARTED|Overall Study||47
134992|NCT00855738|310481|P1|NOT COMPLETED|Overall Study||5
134993|NCT00855738|310481|P1|COMPLETED|Overall Study||106
134994|NCT00855738|310481|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
134995|NCT00855738|310481|P1|STARTED|Overall Study||111
134996|NCT00855595|310509|P2|NOT COMPLETED|Overall Study||7
134997|NCT00855595|310510|P1|NOT COMPLETED|Overall Study||6
134998|NCT00855595|310509|P2|COMPLETED|Overall Study||94
134999|NCT00855595|310510|P1|COMPLETED|Overall Study||100
135000|NCT00855595|310509|P2|STARTED|Overall Study||101
135001|NCT00855595|310510|P1|STARTED|Overall Study||106
135002|NCT00855582|310549|P3|NOT COMPLETED|Overall Study||30
135003|NCT00855582|310550|P2|NOT COMPLETED|Overall Study||24
135004|NCT00855582|310551|P1|NOT COMPLETED|Overall Study||26
135005|NCT00855582|310549|P3|COMPLETED|Overall Study||170
135006|NCT00855582|310550|P2|COMPLETED|Overall Study||184
135007|NCT00855582|310551|P1|COMPLETED|Overall Study||172
135008|NCT00855582|310549|P3|STARTED|Overall Study||200
135009|NCT00855582|310550|P2|STARTED|Overall Study||208
135010|NCT00855582|310551|P1|STARTED|Overall Study||198
135011|NCT00855465|310640|P2|NOT COMPLETED|Follow-up Period (FUP)||2
135012|NCT00855465|310641|P1|NOT COMPLETED|Follow-up Period (FUP)||8
135013|NCT00855465|310640|P2|COMPLETED|Follow-up Period (FUP)||2
135014|NCT00855465|310641|P1|COMPLETED|Follow-up Period (FUP)||9
135015|NCT00855465|310640|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
135016|NCT00855465|310641|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
135017|NCT00855465|310640|P2|NOT COMPLETED|Treatment Period||5
135018|NCT00855465|310641|P1|NOT COMPLETED|Treatment Period||14
135019|NCT00855465|310640|P2|COMPLETED|Treatment Period||83
135020|NCT00855465|310641|P1|COMPLETED|Treatment Period||160
135021|NCT00855465|310640|P2|Participants Received Treatment|Treatment Period||88
135022|NCT00855465|310641|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
135023|NCT00855465|310640|P2|STARTED|Treatment Period||88
135024|NCT00855465|310641|P1|STARTED|Treatment Period||174
135025|NCT00855439|310731|P2|NOT COMPLETED|Overall Study||0
135026|NCT00855439|310732|P1|NOT COMPLETED|Overall Study||3
135027|NCT00855439|310731|P2|COMPLETED|Overall Study||24
135028|NCT00855439|310732|P1|COMPLETED|Overall Study||19
135029|NCT00855439|310731|P2|STARTED|Overall Study||24
135030|NCT00855439|310732|P1|STARTED|Overall Study||22
135031|NCT00855309|310746|P2|NOT COMPLETED|Overall Study||0
135032|NCT00855309|310747|P1|NOT COMPLETED|Overall Study||1
135033|NCT00855309|310746|P2|COMPLETED|Overall Study||55
135034|NCT00855309|310747|P1|COMPLETED|Overall Study||56
135035|NCT00855309|310746|P2|STARTED|Overall Study||55
135036|NCT00855309|310747|P1|STARTED|Overall Study||57
135037|NCT00855218|310755|P2|NOT COMPLETED|Overall Study||76
135038|NCT00855218|310756|P1|NOT COMPLETED|Overall Study||104
135039|NCT00855218|310755|P2|COMPLETED|Overall Study|progression measurement proven ; second malignancy; untreatable disease progression|77
135040|NCT00855218|310756|P1|COMPLETED|Overall Study|progression measurement proven ; second malignancy; untreatable disease progression|50
135041|NCT00855218|310755|P2|Participants Received Treatment|Overall Study||151
135042|NCT00855218|310756|P1|Participants Received Treatment|Overall Study||153
135043|NCT00855218|310755|P2|STARTED|Overall Study||153
135044|NCT00855218|310756|P1|STARTED|Overall Study||154
135045|NCT00855166|310774|P2|NOT COMPLETED|Overall Study||8
135046|NCT00855166|310775|P1|NOT COMPLETED|Overall Study||5
135047|NCT00855166|310774|P2|COMPLETED|Overall Study||83
135048|NCT00855166|310775|P1|COMPLETED|Overall Study||86
135049|NCT00855166|310774|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
135050|NCT00855166|310775|P1|STARTED|Overall Study||91
135051|NCT00855062|310795|P2|NOT COMPLETED|Step2||6
135052|NCT00855062|310796|P1|NOT COMPLETED|Step2||6
135053|NCT00855062|310795|P2|COMPLETED|Step2||15
135054|NCT00855062|310796|P1|COMPLETED|Step2||13
135055|NCT00855062|310795|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
135056|NCT00855062|310796|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
135057|NCT00855062|310795|P2|NOT COMPLETED|Step1||11
135058|NCT00855062|310796|P1|NOT COMPLETED|Step1||10
135059|NCT00855062|310795|P2|COMPLETED|Step1||26
135060|NCT00855062|310796|P1|COMPLETED|Step1||26
135061|NCT00855062|310795|P2|STARTED|Step1||37
135062|NCT00855062|310796|P1|STARTED|Step1||36
135063|NCT00854906|310820|P1|NOT COMPLETED|Overall Study||1
135064|NCT00854906|310820|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
135065|NCT00854906|310820|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
135066|NCT00854724|310829|P2|NOT COMPLETED|Second Intervention||1
135067|NCT00854724|310830|P1|NOT COMPLETED|Second Intervention||1
135068|NCT00854724|310829|P2|COMPLETED|Second Intervention||5
135069|NCT00854724|310830|P1|COMPLETED|Second Intervention||5
135070|NCT00854724|310829|P2|STARTED|Second Intervention||6
135071|NCT00854724|310830|P1|STARTED|Second Intervention||6
135072|NCT00854724|310829|P2|NOT COMPLETED|Washout||1
135073|NCT00854724|310830|P1|NOT COMPLETED|Washout||1
135074|NCT00854724|310829|P2|COMPLETED|Washout||6
135075|NCT00854724|310830|P1|COMPLETED|Washout||6
135076|NCT00854724|310829|P2|STARTED|Washout||7
135077|NCT00854724|310830|P1|STARTED|Washout||7
135078|NCT00854724|310829|P2|NOT COMPLETED|First Intervention||1
135079|NCT00854724|310830|P1|NOT COMPLETED|First Intervention||1
135080|NCT00854724|310829|P2|COMPLETED|First Intervention||7
135081|NCT00854724|310830|P1|COMPLETED|First Intervention||7
135082|NCT00854724|310829|P2|STARTED|First Intervention||8
135083|NCT00854724|310830|P1|STARTED|First Intervention||8
135084|NCT00854620|310836|P1|NOT COMPLETED|Overall Study||1
135085|NCT00854620|310836|P1|COMPLETED|Overall Study||8
135086|NCT00854620|310836|P1|STARTED|Overall Study||9
135087|NCT00854607|310840|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
135088|NCT00854607|310840|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
135089|NCT00854607|310840|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
135090|NCT00854607|310840|P1|NOT COMPLETED|Enrollment||0
135091|NCT00854607|310840|P1|COMPLETED|Enrollment||116
135092|NCT00854607|310840|P1|STARTED|Enrollment||116
135093|NCT00854594|310875|P2|NOT COMPLETED|Overall Study||0
135094|NCT00854594|310876|P1|NOT COMPLETED|Overall Study||0
135095|NCT00854594|310875|P2|COMPLETED|Overall Study||69
135096|NCT00854594|310876|P1|COMPLETED|Overall Study||48
135097|NCT00854594|310875|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
135098|NCT00854594|310876|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
135099|NCT00854581|310888|P1|NOT COMPLETED|Overall Study||2
135100|NCT00854581|310888|P1|COMPLETED|Overall Study||11
135101|NCT00854581|310888|P1|STARTED|Overall Study||13
135102|NCT00854373|310895|P2|NOT COMPLETED|Overall Study||4
135103|NCT00854373|310896|P1|NOT COMPLETED|Overall Study||2
135104|NCT00854373|310895|P2|COMPLETED|Overall Study||89
135105|NCT00854373|310896|P1|COMPLETED|Overall Study||93
135106|NCT00854373|310895|P2|STARTED|Overall Study||93
135107|NCT00854373|310896|P1|STARTED|Overall Study||95
135108|NCT00854360|310910|P4|NOT COMPLETED|Overall Study||10
135109|NCT00854360|310911|P3|NOT COMPLETED|Overall Study||2
135110|NCT00854360|310912|P2|NOT COMPLETED|Overall Study||3
135111|NCT00854360|310913|P1|NOT COMPLETED|Overall Study||2
135112|NCT00854360|310910|P4|COMPLETED|Overall Study||114
135113|NCT00854360|310911|P3|COMPLETED|Overall Study||120
135114|NCT00854360|310912|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
135115|NCT00854360|310913|P1|COMPLETED|Overall Study||116
135116|NCT00854360|310910|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
135117|NCT00854360|310911|P3|Intent to Treat / Safety Population|Overall Study||122
135118|NCT00854360|310912|P2|Intent to Treat / Safety Population|Overall Study||123
135119|NCT00854360|310913|P1|Intent to Treat / Safety Population|Overall Study||118
135120|NCT00854360|310910|P4|STARTED|Overall Study||124
135121|NCT00854360|310911|P3|STARTED|Overall Study||122
135122|NCT00854360|310912|P2|STARTED|Overall Study||123
135123|NCT00854360|310913|P1|STARTED|Overall Study||118
135124|NCT00854308|310945|P2|NOT COMPLETED|Overall Study||67
135125|NCT00854308|310946|P1|NOT COMPLETED|Overall Study||62
135126|NCT00854308|310945|P2|COMPLETED|Overall Study||1
135127|NCT00854308|310946|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
135128|NCT00854308|310945|P2|Received Study Drug|Overall Study||67
135129|NCT00854308|310946|P1|Received Study Drug|Overall Study||69
135130|NCT00854308|310945|P2|STARTED|Overall Study||68
135131|NCT00854308|310946|P1|STARTED|Overall Study||69
135132|NCT00854113|310971|P11|NOT COMPLETED|Overall Study||0
135133|NCT00854113|310972|P10|NOT COMPLETED|Overall Study||0
135134|NCT00854113|310973|P9|NOT COMPLETED|Overall Study||1
135135|NCT00854113|310974|P8|NOT COMPLETED|Overall Study||3
135136|NCT00854113|310975|P7|NOT COMPLETED|Overall Study||0
135137|NCT00854113|310976|P6|NOT COMPLETED|Overall Study||0
135138|NCT00854113|310977|P5|NOT COMPLETED|Overall Study||0
135139|NCT00854113|310978|P4|NOT COMPLETED|Overall Study||0
135140|NCT00854113|310979|P3|NOT COMPLETED|Overall Study||0
135141|NCT00854113|310980|P2|NOT COMPLETED|Overall Study||0
135142|NCT00854113|310981|P1|NOT COMPLETED|Overall Study||0
135143|NCT00854113|310971|P11|COMPLETED|Overall Study||6
135144|NCT00854113|310972|P10|COMPLETED|Overall Study||8
135145|NCT00854113|310973|P9|COMPLETED|Overall Study||7
135146|NCT00854113|310974|P8|COMPLETED|Overall Study||5
135147|NCT00854113|310975|P7|COMPLETED|Overall Study||12
135148|NCT00854113|310976|P6|COMPLETED|Overall Study||6
135149|NCT00854113|310977|P5|COMPLETED|Overall Study||6
135150|NCT00854113|310978|P4|COMPLETED|Overall Study||6
135151|NCT00854113|310979|P3|COMPLETED|Overall Study||6
135152|NCT00854113|310980|P2|COMPLETED|Overall Study||6
135153|NCT00854113|310981|P1|COMPLETED|Overall Study||6
135154|NCT00854113|310971|P11|STARTED|Overall Study||6
135155|NCT00854113|310972|P10|STARTED|Overall Study||8
135156|NCT00854113|310973|P9|STARTED|Overall Study||8
135157|NCT00854113|310974|P8|STARTED|Overall Study||8
135158|NCT00854113|310975|P7|STARTED|Overall Study||12
135159|NCT00854113|310976|P6|STARTED|Overall Study||6
135160|NCT00854113|310977|P5|STARTED|Overall Study||6
135161|NCT00854113|310978|P4|STARTED|Overall Study||6
135162|NCT00854113|310979|P3|STARTED|Overall Study||6
135163|NCT00854113|310980|P2|STARTED|Overall Study||6
135164|NCT00854113|310981|P1|STARTED|Overall Study||6
135165|NCT00854087|311084|P2|NOT COMPLETED|Overall Study||19
135166|NCT00854087|311085|P1|NOT COMPLETED|Overall Study||19
135167|NCT00854087|311084|P2|COMPLETED|Overall Study||40
135168|NCT00854087|311085|P1|COMPLETED|Overall Study||40
135169|NCT00854087|311084|P2|STARTED|Overall Study||59
135170|NCT00854087|311085|P1|STARTED|Overall Study||59
135171|NCT00853970|311093|P2|NOT COMPLETED|Overall Study||3
135172|NCT00853970|311094|P1|NOT COMPLETED|Overall Study||6
135173|NCT00853970|311093|P2|COMPLETED|Overall Study||144
135174|NCT00853970|311094|P1|COMPLETED|Overall Study||146
135175|NCT00853970|311093|P2|STARTED|Overall Study||147
135176|NCT00853970|311094|P1|STARTED|Overall Study||152
135177|NCT00853957|311104|P2|NOT COMPLETED|Overall Study||19
135178|NCT00853957|311105|P1|NOT COMPLETED|Overall Study||14
135179|NCT00853957|311104|P2|COMPLETED|Overall Study||204
135180|NCT00853957|311105|P1|COMPLETED|Overall Study||206
135181|NCT00853957|311104|P2|STARTED|Overall Study||223
135182|NCT00853957|311105|P1|STARTED|Overall Study||220
135183|NCT00853905|311123|P2|NOT COMPLETED|Overall Study||4
135184|NCT00853905|311124|P1|NOT COMPLETED|Overall Study||2
135185|NCT00853905|311123|P2|COMPLETED|Overall Study||36
135186|NCT00853905|311124|P1|COMPLETED|Overall Study||35
135187|NCT00853905|311123|P2|STARTED|Overall Study||40
135188|NCT00853905|311124|P1|STARTED|Overall Study||37
135189|NCT00853840|311130|P2|NOT COMPLETED|Period 2||0
135190|NCT00853840|311131|P1|NOT COMPLETED|Period 2||0
135191|NCT00853840|311130|P2|COMPLETED|Period 2||9
135192|NCT00853840|311131|P1|COMPLETED|Period 2||9
135193|NCT00853840|311130|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
135194|NCT00853840|311131|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
135195|NCT00853840|311130|P2|Maraviroc (Days 1 - 3)|Period 2||9
135196|NCT00853840|311131|P1|Maraviroc (Days 1 - 3)|Period 2||9
135197|NCT00853840|311130|P2|STARTED|Period 2||9
135198|NCT00853840|311131|P1|STARTED|Period 2||9
135199|NCT00853840|311130|P2|NOT COMPLETED|Period 1||0
135200|NCT00853840|311131|P1|NOT COMPLETED|Period 1||0
135201|NCT00853840|311130|P2|COMPLETED|Period 1||9
135202|NCT00853840|311131|P1|COMPLETED|Period 1||9
135203|NCT00853840|311130|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
135204|NCT00853840|311131|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
135205|NCT00853840|311130|P2|Maraviroc (Days 1 - 4)|Period 1||9
135206|NCT00853840|311131|P1|Maraviroc (Days 1 - 4)|Period 1||9
135207|NCT00853840|311130|P2|STARTED|Period 1||9
135208|NCT00853840|311131|P1|STARTED|Period 1||9
135209|NCT00853827|311148|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
135210|NCT00853827|311149|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
135211|NCT00853827|311148|P2|COMPLETED|Double Blind Period (103 Weeks)||199
135212|NCT00853827|311149|P1|COMPLETED|Double Blind Period (103 Weeks)||201
135213|NCT00853827|311148|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
135214|NCT00853827|311149|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
135215|NCT00853827|311148|P2|STARTED|Double Blind Period (103 Weeks)||308
135216|NCT00853827|311149|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
135217|NCT00853827|311148|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
135218|NCT00853827|311149|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
135219|NCT00853827|311148|P2|COMPLETED|Single Blind Period (1 Week)||0
135220|NCT00853827|311149|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
135221|NCT00853827|311148|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
135222|NCT00853827|311149|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
135223|NCT00853762|311165|P4|NOT COMPLETED|Overall Study||22
135224|NCT00853762|311166|P3|NOT COMPLETED|Overall Study||17
135225|NCT00853762|311167|P2|NOT COMPLETED|Overall Study||19
135226|NCT00853762|311168|P1|NOT COMPLETED|Overall Study||16
135227|NCT00853762|311165|P4|COMPLETED|Overall Study||0
135228|NCT00853762|311166|P3|COMPLETED|Overall Study||0
135229|NCT00853762|311167|P2|COMPLETED|Overall Study||0
135230|NCT00853762|311168|P1|COMPLETED|Overall Study||0
135231|NCT00853762|311165|P4|STARTED|Overall Study||22
135232|NCT00853762|311166|P3|STARTED|Overall Study||17
135233|NCT00853762|311167|P2|STARTED|Overall Study||19
135234|NCT00853762|311168|P1|STARTED|Overall Study||16
135235|NCT00853749|311236|P2|NOT COMPLETED|Overall Study||1
135236|NCT00853749|311237|P1|NOT COMPLETED|Overall Study||0
135237|NCT00853749|311236|P2|COMPLETED|Overall Study||38
135238|NCT00853749|311237|P1|COMPLETED|Overall Study||50
135239|NCT00853749|311236|P2|Vaccinated|Overall Study||39
135240|NCT00853749|311237|P1|Vaccinated|Overall Study||50
135241|NCT00853749|311236|P2|STARTED|Overall Study||39
135242|NCT00853749|311237|P1|STARTED|Overall Study||50
135243|NCT00853723|311258|P3|NOT COMPLETED|Overall Study||2
135244|NCT00853723|311259|P2|NOT COMPLETED|Overall Study||7
135245|NCT00853723|311260|P1|NOT COMPLETED|Overall Study||6
135246|NCT00853723|311258|P3|COMPLETED|Overall Study||33
135247|NCT00853723|311259|P2|COMPLETED|Overall Study||28
135248|NCT00853723|311260|P1|COMPLETED|Overall Study||29
135249|NCT00853723|311258|P3|STARTED|Overall Study||35
135250|NCT00853723|311259|P2|STARTED|Overall Study||35
135251|NCT00853723|311260|P1|STARTED|Overall Study||35
135252|NCT00853658|311307|P3|NOT COMPLETED|Overall Study||815
135253|NCT00853658|311308|P2|NOT COMPLETED|Overall Study||832
135254|NCT00853658|311309|P1|NOT COMPLETED|Overall Study||787
135255|NCT00853658|311307|P3|COMPLETED|Overall Study||1539
135256|NCT00853658|311308|P2|COMPLETED|Overall Study||1524
135257|NCT00853658|311309|P1|COMPLETED|Overall Study||1567
135258|NCT00853658|311307|P3|Safety Set|Overall Study||2345
135259|NCT00853658|311308|P2|Safety Set|Overall Study||2348
135260|NCT00853658|311309|P1|Safety Set|Overall Study||2347
135261|NCT00853658|311307|P3|Full Analysis Set (FAS)|Overall Study||2336
135262|NCT00853658|311308|P2|Full Analysis Set (FAS)|Overall Study||2340
135263|NCT00853658|311309|P1|Full Analysis Set (FAS)|Overall Study||2340
135264|NCT00853658|311307|P3|STARTED|Overall Study||2354
135265|NCT00853658|311308|P2|STARTED|Overall Study||2356
135266|NCT00853658|311309|P1|STARTED|Overall Study||2354
135267|NCT00853606|311323|P1|NOT COMPLETED|Overall Study||220
135268|NCT00853606|311323|P1|COMPLETED|Overall Study||492
135269|NCT00853606|311323|P1|STARTED|Overall Study||712
135270|NCT00853593|311329|P1|NOT COMPLETED|Overall Study||45
135271|NCT00853593|311329|P1|COMPLETED|Overall Study||152
135272|NCT00853593|311329|P1|Model 4396 Lead Attempted|Overall Study||164
135273|NCT00853593|311329|P1|Implant Attempted|Overall Study||193
135274|NCT00853593|311329|P1|STARTED|Overall Study||197
135275|NCT00853567|311357|P1|NOT COMPLETED|Overall Study||71
135276|NCT00853567|311357|P1|COMPLETED|Overall Study||0
135277|NCT00853567|311357|P1|STARTED|Overall Study||71
135278|NCT00853385|311370|P5|NOT COMPLETED|Overall Study||42
135279|NCT00853385|311371|P4|NOT COMPLETED|Overall Study||13
135280|NCT00853385|311372|P3|NOT COMPLETED|Overall Study||9
135281|NCT00853385|311373|P2|NOT COMPLETED|Overall Study||43
135282|NCT00853385|311374|P1|NOT COMPLETED|Overall Study||54
135283|NCT00853385|311370|P5|COMPLETED|Overall Study||162
135284|NCT00853385|311371|P4|COMPLETED|Overall Study||39
135285|NCT00853385|311372|P3|COMPLETED|Overall Study||47
135286|NCT00853385|311373|P2|COMPLETED|Overall Study||158
135287|NCT00853385|311374|P1|COMPLETED|Overall Study||150
135288|NCT00853385|311370|P5|STARTED|Overall Study||204
135289|NCT00853385|311371|P4|STARTED|Overall Study||52
135290|NCT00853385|311372|P3|STARTED|Overall Study||56
135291|NCT00853385|311373|P2|STARTED|Overall Study||201
135292|NCT00853385|311374|P1|STARTED|Overall Study||204
135293|NCT00853333|311590|P3|NOT COMPLETED|Overall Study||0
135294|NCT00853333|311591|P2|NOT COMPLETED|Overall Study||0
135295|NCT00853333|311592|P1|NOT COMPLETED|Overall Study||0
135296|NCT00853333|311590|P3|COMPLETED|Overall Study||31
135297|NCT00853333|311591|P2|COMPLETED|Overall Study||27
135298|NCT00853333|311592|P1|COMPLETED|Overall Study||28
135299|NCT00853333|311590|P3|STARTED|Overall Study||31
135300|NCT00853333|311591|P2|STARTED|Overall Study||27
135301|NCT00853333|311592|P1|STARTED|Overall Study||28
135302|NCT00853242|311607|P7|NOT COMPLETED|Overall Study||5
135303|NCT00853242|311608|P6|NOT COMPLETED|Overall Study||2
135304|NCT00853242|311609|P5|NOT COMPLETED|Overall Study||4
135305|NCT00853242|311610|P4|NOT COMPLETED|Overall Study||4
135306|NCT00853242|311611|P3|NOT COMPLETED|Overall Study||3
135307|NCT00853242|311612|P2|NOT COMPLETED|Overall Study||3
135308|NCT00853242|311613|P1|NOT COMPLETED|Overall Study||3
135309|NCT00853242|311607|P7|COMPLETED|Overall Study||44
135310|NCT00853242|311608|P6|COMPLETED|Overall Study||49
135311|NCT00853242|311609|P5|COMPLETED|Overall Study||46
135312|NCT00853242|311610|P4|COMPLETED|Overall Study||46
135313|NCT00853242|311611|P3|COMPLETED|Overall Study||46
135314|NCT00853242|311612|P2|COMPLETED|Overall Study||47
135315|NCT00853242|311613|P1|COMPLETED|Overall Study||47
135316|NCT00853242|311607|P7|Treated|Overall Study||48
135317|NCT00853242|311608|P6|Treated|Overall Study||51
135318|NCT00853242|311609|P5|Treated|Overall Study||50
135319|NCT00853242|311610|P4|Treated|Overall Study||50
135320|NCT00853242|311611|P3|Treated|Overall Study||48
135321|NCT00853242|311612|P2|Treated|Overall Study||49
135322|NCT00853242|311613|P1|Treated|Overall Study||50
135323|NCT00853242|311607|P7|STARTED|Overall Study||49
135324|NCT00853242|311608|P6|STARTED|Overall Study||51
135325|NCT00853242|311609|P5|STARTED|Overall Study||50
135326|NCT00853242|311610|P4|STARTED|Overall Study||50
135327|NCT00853242|311611|P3|STARTED|Overall Study||49
135328|NCT00853242|311612|P2|STARTED|Overall Study||50
135329|NCT00853242|311613|P1|STARTED|Overall Study||50
135330|NCT00853151|311657|P4|NOT COMPLETED|Overall Study||3
135331|NCT00853151|311658|P3|NOT COMPLETED|Overall Study||8
135332|NCT00853151|311659|P2|NOT COMPLETED|Overall Study||13
135333|NCT00853151|311660|P1|NOT COMPLETED|Overall Study||10
135334|NCT00853151|311657|P4|COMPLETED|Overall Study||15
135335|NCT00853151|311658|P3|COMPLETED|Overall Study||30
135336|NCT00853151|311659|P2|COMPLETED|Overall Study||24
135337|NCT00853151|311660|P1|COMPLETED|Overall Study||28
135338|NCT00853151|311657|P4|STARTED|Overall Study||18
135339|NCT00853151|311658|P3|STARTED|Overall Study||38
135340|NCT00853151|311659|P2|STARTED|Overall Study||37
135341|NCT00853151|311660|P1|STARTED|Overall Study||38
135342|NCT00853099|311805|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
135343|NCT00853099|311806|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
135344|NCT00853099|311807|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
135345|NCT00853099|311808|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
135346|NCT00853099|311805|P4|COMPLETED|Double-blind + Open-label Periods||119
135347|NCT00853099|311806|P3|COMPLETED|Double-blind + Open-label Periods||0
135348|NCT00853099|311807|P2|COMPLETED|Double-blind + Open-label Periods||0
135349|NCT00853099|311808|P1|COMPLETED|Double-blind + Open-label Periods||0
135350|NCT00853099|311805|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
135351|NCT00853099|311806|P3|STARTED|Double-blind + Open-label Periods||0
135352|NCT00853099|311807|P2|STARTED|Double-blind + Open-label Periods||0
135353|NCT00853099|311808|P1|STARTED|Double-blind + Open-label Periods||0
135354|NCT00853099|311805|P4|NOT COMPLETED|Double-blind Period||0
135355|NCT00853099|311806|P3|NOT COMPLETED|Double-blind Period||31
135356|NCT00853099|311807|P2|NOT COMPLETED|Double-blind Period||29
135357|NCT00853099|311808|P1|NOT COMPLETED|Double-blind Period||23
135358|NCT00853099|311805|P4|COMPLETED|Double-blind Period||0
135359|NCT00853099|311806|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
135360|NCT00853099|311807|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
135361|NCT00853099|311808|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
135362|NCT00853099|311805|P4|Completed Week 8|Double-blind Period||0
135363|NCT00853099|311806|P3|Completed Week 8|Double-blind Period||86
135364|NCT00853099|311807|P2|Completed Week 8|Double-blind Period||85
135365|NCT00853099|311808|P1|Completed Week 8|Double-blind Period||92
135366|NCT00853099|311805|P4|Treated|Double-blind Period||0
135367|NCT00853099|311806|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
135368|NCT00853099|311807|P2|Treated|Double-blind Period||87
135369|NCT00853099|311808|P1|Treated|Double-blind Period||96
135370|NCT00853099|311805|P4|STARTED|Double-blind Period||0
135371|NCT00853099|311806|P3|STARTED|Double-blind Period||91
135372|NCT00853099|311807|P2|STARTED|Double-blind Period||87
135373|NCT00853099|311808|P1|STARTED|Double-blind Period||96
135374|NCT00853073|311850|P2|NOT COMPLETED|Overall Study||2
135375|NCT00853073|311851|P1|NOT COMPLETED|Overall Study||3
135376|NCT00853073|311850|P2|COMPLETED|Overall Study||29
135377|NCT00853073|311851|P1|COMPLETED|Overall Study||29
135378|NCT00853073|311850|P2|STARTED|Overall Study||31
135379|NCT00853073|311851|P1|STARTED|Overall Study||32
135380|NCT00853021|311857|P1|NOT COMPLETED|Overall Study||5
135381|NCT00853021|311857|P1|COMPLETED|Overall Study||21
135382|NCT00853021|311857|P1|STARTED|Overall Study||26
135383|NCT00852995|311869|P5|NOT COMPLETED|Overall Study||4
135384|NCT00852995|311870|P4|NOT COMPLETED|Overall Study||5
135385|NCT00852995|311871|P3|NOT COMPLETED|Overall Study||5
135386|NCT00852995|311872|P2|NOT COMPLETED|Overall Study||1
135387|NCT00852995|311873|P1|NOT COMPLETED|Overall Study||8
135388|NCT00852995|311869|P5|COMPLETED|Overall Study||46
135389|NCT00852995|311870|P4|COMPLETED|Overall Study||40
135390|NCT00852995|311871|P3|COMPLETED|Overall Study||39
135391|NCT00852995|311872|P2|COMPLETED|Overall Study||42
135392|NCT00852995|311873|P1|COMPLETED|Overall Study||38
135393|NCT00852995|311869|P5|STARTED|Overall Study||50
135394|NCT00852995|311870|P4|STARTED|Overall Study||45
135395|NCT00852995|311871|P3|STARTED|Overall Study||44
135396|NCT00852995|311872|P2|STARTED|Overall Study||43
135397|NCT00852995|311873|P1|STARTED|Overall Study||46
135398|NCT00852969|311917|P2|NOT COMPLETED|Overall Study||2
135399|NCT00852969|311918|P1|NOT COMPLETED|Overall Study||0
135400|NCT00852969|311917|P2|COMPLETED|Overall Study||13
135401|NCT00852969|311918|P1|COMPLETED|Overall Study||15
135402|NCT00852969|311917|P2|STARTED|Overall Study||15
135403|NCT00852969|311918|P1|STARTED|Overall Study||15
135404|NCT00852930|311929|P3|NOT COMPLETED|Overall Study||2
135405|NCT00852930|311930|P2|NOT COMPLETED|Overall Study||1
135406|NCT00852930|311931|P1|NOT COMPLETED|Overall Study||1
135407|NCT00852930|311929|P3|COMPLETED|Overall Study||15
135408|NCT00852930|311930|P2|COMPLETED|Overall Study||16
135409|NCT00852930|311931|P1|COMPLETED|Overall Study||15
135410|NCT00852930|311929|P3|STARTED|Overall Study||17
135411|NCT00852930|311930|P2|STARTED|Overall Study||17
135412|NCT00852930|311931|P1|STARTED|Overall Study||16
135413|NCT00852917|311952|P4|NOT COMPLETED|Overall Study||93
135414|NCT00852917|311953|P3|NOT COMPLETED|Overall Study||58
135415|NCT00852917|311954|P2|NOT COMPLETED|Overall Study||46
135416|NCT00852917|311955|P1|NOT COMPLETED|Overall Study||44
135417|NCT00852917|311952|P4|COMPLETED|Overall Study||134
135418|NCT00852917|311953|P3|COMPLETED|Overall Study||50
135419|NCT00852917|311954|P2|COMPLETED|Overall Study||65
135420|NCT00852917|311955|P1|COMPLETED|Overall Study||62
135421|NCT00852917|311952|P4|STARTED|Overall Study||227
135422|NCT00852917|311953|P3|STARTED|Overall Study||108
135423|NCT00852917|311954|P2|STARTED|Overall Study||111
135424|NCT00852917|311955|P1|STARTED|Overall Study||106
135425|NCT00852761|311995|P2|NOT COMPLETED|Overall Study||0
135426|NCT00852761|311996|P1|NOT COMPLETED|Overall Study||0
135427|NCT00852761|311995|P2|COMPLETED|Overall Study||17
135428|NCT00852761|311996|P1|COMPLETED|Overall Study||17
135429|NCT00852761|311995|P2|STARTED|Overall Study||17
135430|NCT00852761|311996|P1|STARTED|Overall Study||17
135431|NCT00851786|312040|P2|NOT COMPLETED|Overall Study||2
135432|NCT00851786|312041|P1|NOT COMPLETED|Overall Study||5
135433|NCT00851786|312040|P2|COMPLETED|Overall Study||97
135434|NCT00851786|312041|P1|COMPLETED|Overall Study||291
135435|NCT00851786|312040|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
135436|NCT00851786|312041|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
135437|NCT00851721|312051|P2|NOT COMPLETED|Overall Study||1
135438|NCT00851721|312052|P1|NOT COMPLETED|Overall Study||2
135439|NCT00851721|312051|P2|COMPLETED|Overall Study||16
135440|NCT00851721|312052|P1|COMPLETED|Overall Study||17
135441|NCT00851721|312051|P2|STARTED|Overall Study||17
135442|NCT00851721|312052|P1|STARTED|Overall Study||19
135443|NCT00851682|312142|P2|NOT COMPLETED|Overall Study||0
135444|NCT00851682|312143|P1|NOT COMPLETED|Overall Study||5
135445|NCT00851682|312142|P2|COMPLETED|Overall Study||5
135446|NCT00851682|312143|P1|COMPLETED|Overall Study||55
135447|NCT00851682|312142|P2|STARTED|Overall Study||5
135448|NCT00851682|312143|P1|STARTED|Overall Study||60
135449|NCT00851643|312157|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
135450|NCT00851643|312158|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
135451|NCT00851643|312159|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
135452|NCT00851643|312160|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
135453|NCT00851643|312161|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
135454|NCT00851643|312162|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
135455|NCT00851643|312157|P6|COMPLETED|Extension Study (Up to 36 Months)||14
135456|NCT00851643|312158|P5|COMPLETED|Extension Study (Up to 36 Months)||19
135457|NCT00851643|312159|P4|COMPLETED|Extension Study (Up to 36 Months)||5
135458|NCT00851643|312160|P3|COMPLETED|Extension Study (Up to 36 Months)||14
135459|NCT00851643|312161|P2|COMPLETED|Extension Study (Up to 36 Months)||15
135460|NCT00851643|312162|P1|COMPLETED|Extension Study (Up to 36 Months)||6
135461|NCT00851643|312157|P6|STARTED|Extension Study (Up to 36 Months)||15
135462|NCT00851643|312158|P5|STARTED|Extension Study (Up to 36 Months)||21
135463|NCT00851643|312159|P4|STARTED|Extension Study (Up to 36 Months)||7
135464|NCT00851643|312160|P3|STARTED|Extension Study (Up to 36 Months)||19
135465|NCT00851643|312161|P2|STARTED|Extension Study (Up to 36 Months)||19
135466|NCT00851643|312162|P1|STARTED|Extension Study (Up to 36 Months)||10
135467|NCT00851643|312157|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
135468|NCT00851643|312158|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
135469|NCT00851643|312159|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
135470|NCT00851643|312160|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
135471|NCT00851643|312161|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
135472|NCT00851643|312162|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
135473|NCT00851643|312157|P6|COMPLETED|Base Study (Up to 12 Months)||29
135474|NCT00851643|312158|P5|COMPLETED|Base Study (Up to 12 Months)||30
135475|NCT00851643|312159|P4|COMPLETED|Base Study (Up to 12 Months)||15
135476|NCT00851643|312160|P3|COMPLETED|Base Study (Up to 12 Months)||30
135477|NCT00851643|312161|P2|COMPLETED|Base Study (Up to 12 Months)||30
135478|NCT00851643|312162|P1|COMPLETED|Base Study (Up to 12 Months)||14
135479|NCT00851643|312157|P6|STARTED|Base Study (Up to 12 Months)||30
135480|NCT00851643|312158|P5|STARTED|Base Study (Up to 12 Months)||30
135481|NCT00851643|312159|P4|STARTED|Base Study (Up to 12 Months)||15
135482|NCT00851643|312160|P3|STARTED|Base Study (Up to 12 Months)||30
135483|NCT00851643|312161|P2|STARTED|Base Study (Up to 12 Months)||30
135484|NCT00851643|312162|P1|STARTED|Base Study (Up to 12 Months)||15
135485|NCT00851630|312183|P2|NOT COMPLETED|Overall Study||2
135486|NCT00851630|312184|P1|NOT COMPLETED|Overall Study||2
135487|NCT00851630|312183|P2|COMPLETED|Overall Study||33
135488|NCT00851630|312184|P1|COMPLETED|Overall Study||33
135489|NCT00851630|312183|P2|STARTED|Overall Study||35
135490|NCT00851630|312184|P1|STARTED|Overall Study||35
135491|NCT00852631|312196|P1|NOT COMPLETED|Overall Study||11
135492|NCT00852631|312196|P1|COMPLETED|Overall Study||17
135493|NCT00852631|312196|P1|STARTED|Overall Study||28
135494|NCT00852592|312204|P2|NOT COMPLETED|Overall Study||4
135495|NCT00852592|312205|P1|NOT COMPLETED|Overall Study||3
135496|NCT00852592|312204|P2|COMPLETED|Overall Study||19
135497|NCT00852592|312205|P1|COMPLETED|Overall Study||20
135498|NCT00852592|312204|P2|STARTED|Overall Study||23
135499|NCT00852592|312205|P1|STARTED|Overall Study||23
135500|NCT00852540|312215|P2|NOT COMPLETED|Overall Study||18
135501|NCT00852540|312216|P1|NOT COMPLETED|Overall Study||36
135502|NCT00852540|312215|P2|COMPLETED|Overall Study||122
135503|NCT00852540|312216|P1|COMPLETED|Overall Study||234
135504|NCT00852540|312215|P2|STARTED|Overall Study||140
135505|NCT00852540|312216|P1|STARTED|Overall Study||270
135506|NCT00852527|312242|P2|NOT COMPLETED|Overall Study||0
135507|NCT00852527|312243|P1|NOT COMPLETED|Overall Study||0
135508|NCT00852527|312242|P2|COMPLETED|Overall Study||242
135509|NCT00852527|312243|P1|COMPLETED|Overall Study||196
135510|NCT00852527|312242|P2|STARTED|Overall Study||242
135511|NCT00852527|312243|P1|STARTED|Overall Study||196
135512|NCT00852475|312250|P2|NOT COMPLETED|Overall Study||4
135513|NCT00852475|312251|P1|NOT COMPLETED|Overall Study||3
135514|NCT00852475|312250|P2|COMPLETED|Overall Study||16
135515|NCT00852475|312251|P1|COMPLETED|Overall Study||23
135516|NCT00852475|312250|P2|STARTED|Overall Study||20
135517|NCT00852475|312251|P1|STARTED|Overall Study||26
135518|NCT00852397|312262|P3|NOT COMPLETED|Overall Study||14
135519|NCT00852397|312263|P2|NOT COMPLETED|Overall Study||8
135520|NCT00852397|312264|P1|NOT COMPLETED|Overall Study||11
135521|NCT00852397|312262|P3|COMPLETED|Overall Study||36
135522|NCT00852397|312263|P2|COMPLETED|Overall Study||41
135523|NCT00852397|312264|P1|COMPLETED|Overall Study||41
135524|NCT00852397|312262|P3|Treated Participants|Overall Study||49
135525|NCT00852397|312263|P2|Treated Participants|Overall Study||49
135526|NCT00852397|312264|P1|Treated Participants|Overall Study||51
135527|NCT00852397|312262|P3|STARTED|Overall Study||50
135528|NCT00852397|312263|P2|STARTED|Overall Study||49
135529|NCT00852397|312264|P1|STARTED|Overall Study||52
135530|NCT00852137|312295|P2|NOT COMPLETED|Overall Study||0
135531|NCT00852137|312296|P1|NOT COMPLETED|Overall Study||0
135532|NCT00852137|312295|P2|COMPLETED|Overall Study||3
135533|NCT00852137|312296|P1|COMPLETED|Overall Study||13
135534|NCT00852137|312295|P2|STARTED|Overall Study||3
135535|NCT00852137|312296|P1|STARTED|Overall Study||13
135536|NCT00852124|312318|P2|NOT COMPLETED|Overall Study||0
135537|NCT00852124|312319|P1|NOT COMPLETED|Overall Study||0
135538|NCT00852124|312318|P2|COMPLETED|Overall Study||0
135539|NCT00852124|312319|P1|COMPLETED|Overall Study||3
135540|NCT00852124|312318|P2|STARTED|Overall Study||0
135541|NCT00852124|312319|P1|STARTED|Overall Study||3
135542|NCT00851903|312324|P1|NOT COMPLETED|Overall Study||2
135543|NCT00851903|312324|P1|COMPLETED|Overall Study||110
135544|NCT00851903|312324|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
135545|NCT00851903|312324|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
135546|NCT00851903|312324|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
135547|NCT00851903|312324|P1|STARTED|Overall Study||112
135548|NCT00851890|312338|P4|NOT COMPLETED|Overall Study||1
135549|NCT00851890|312339|P3|NOT COMPLETED|Overall Study||0
135550|NCT00851890|312340|P2|NOT COMPLETED|Overall Study||1
135551|NCT00851890|312341|P1|NOT COMPLETED|Overall Study||0
135552|NCT00851890|312338|P4|COMPLETED|Overall Study||5
135553|NCT00851890|312339|P3|COMPLETED|Overall Study||8
135554|NCT00851890|312340|P2|COMPLETED|Overall Study||7
135555|NCT00851890|312341|P1|COMPLETED|Overall Study||8
135556|NCT00851890|312338|P4|STARTED|Overall Study||6
135557|NCT00851890|312339|P3|STARTED|Overall Study||8
135558|NCT00851890|312340|P2|STARTED|Overall Study||8
135559|NCT00851890|312341|P1|STARTED|Overall Study||8
135560|NCT00851799|312401|P3|NOT COMPLETED|Overall Study||24
135561|NCT00851799|312402|P2|NOT COMPLETED|Overall Study||13
135562|NCT00851799|312403|P1|NOT COMPLETED|Overall Study||16
135563|NCT00851799|312401|P3|COMPLETED|Overall Study||89
135564|NCT00851799|312402|P2|COMPLETED|Overall Study||93
135565|NCT00851799|312403|P1|COMPLETED|Overall Study||93
135566|NCT00851799|312401|P3|STARTED|Overall Study||113
135567|NCT00851799|312402|P2|STARTED|Overall Study||106
135568|NCT00851799|312403|P1|STARTED|Overall Study||109
135569|NCT00851591|312491|P2|NOT COMPLETED|Overall Study||0
135570|NCT00851591|312492|P1|NOT COMPLETED|Overall Study||2
135571|NCT00851591|312491|P2|COMPLETED|Overall Study||1
135572|NCT00851591|312492|P1|COMPLETED|Overall Study||0
135573|NCT00851591|312491|P2|STARTED|Overall Study|One received treatment.|1
135574|NCT00851591|312492|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
135575|NCT00851552|312498|P1|NOT COMPLETED|Overall Study||7
135576|NCT00851552|312498|P1|COMPLETED|Overall Study||2
135577|NCT00851552|312498|P1|STARTED|Overall Study||9
135578|NCT00851409|312503|P1|NOT COMPLETED|Overall Study||0
135579|NCT00851409|312503|P1|COMPLETED|Overall Study||25
135580|NCT00851409|312503|P1|STARTED|Overall Study||25
135581|NCT00851318|312512|P4|NOT COMPLETED|Overall Study||19
135582|NCT00851318|312513|P3|NOT COMPLETED|Overall Study||21
135583|NCT00851318|312514|P2|NOT COMPLETED|Overall Study||5
135584|NCT00851318|312515|P1|NOT COMPLETED|Overall Study||30
135585|NCT00851318|312512|P4|COMPLETED|Overall Study||73
135586|NCT00851318|312513|P3|COMPLETED|Overall Study||72
135587|NCT00851318|312514|P2|COMPLETED|Overall Study||14
135588|NCT00851318|312515|P1|COMPLETED|Overall Study||51
135589|NCT00851318|312512|P4|Completed Week 52|Overall Study||85
135590|NCT00851318|312513|P3|Completed Week 52|Overall Study||87
135591|NCT00851318|312514|P2|Completed Week 52|Overall Study||16
135592|NCT00851318|312515|P1|Completed Week 52|Overall Study||64
135593|NCT00851318|312512|P4|Completed Week 24|Overall Study||87
135594|NCT00851318|312513|P3|Completed Week 24|Overall Study||90
135595|NCT00851318|312514|P2|Completed Week 24|Overall Study||17
135596|NCT00851318|312515|P1|Completed Week 24|Overall Study||69
135597|NCT00851318|312512|P4|STARTED|Overall Study||92
135598|NCT00851318|312513|P3|STARTED|Overall Study||93
135599|NCT00851318|312514|P2|STARTED|Overall Study||19
135600|NCT00851318|312515|P1|STARTED|Overall Study||81
135601|NCT00851279|312545|P1|NOT COMPLETED|Overall Study||0
135602|NCT00851279|312545|P1|COMPLETED|Overall Study||53
135603|NCT00851279|312545|P1|STARTED|Overall Study||53
135604|NCT00851084|312551|P2|NOT COMPLETED|Overall Study||119
135605|NCT00851084|312552|P1|NOT COMPLETED|Overall Study||117
135606|NCT00851084|312551|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
135607|NCT00851084|312552|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
135608|NCT00851084|312551|P2|STARTED|Overall Study||119
135609|NCT00851084|312552|P1|STARTED|Overall Study||117
135610|NCT00851006|312568|P2|NOT COMPLETED|Overall Study||0
135611|NCT00851006|312569|P1|NOT COMPLETED|Overall Study||0
135612|NCT00851006|312568|P2|COMPLETED|Overall Study||6
135613|NCT00851006|312569|P1|COMPLETED|Overall Study||7
135614|NCT00851006|312568|P2|STARTED|Overall Study||6
135615|NCT00851006|312569|P1|STARTED|Overall Study||7
135616|NCT00850993|312580|P4|NOT COMPLETED|Overall Study||0
135617|NCT00850993|312581|P3|NOT COMPLETED|Overall Study||0
135618|NCT00850993|312582|P2|NOT COMPLETED|Overall Study||1
135619|NCT00850993|312583|P1|NOT COMPLETED|Overall Study||0
135620|NCT00850993|312580|P4|COMPLETED|Overall Study||8
135621|NCT00850993|312581|P3|COMPLETED|Overall Study||18
135622|NCT00850993|312582|P2|COMPLETED|Overall Study||16
135623|NCT00850993|312583|P1|COMPLETED|Overall Study||15
135624|NCT00850993|312580|P4|STARTED|Overall Study||8
135625|NCT00850993|312581|P3|STARTED|Overall Study||18
135626|NCT00850993|312582|P2|STARTED|Overall Study||17
135627|NCT00850993|312583|P1|STARTED|Overall Study||15
135628|NCT00850889|312597|P1|NOT COMPLETED|Overall Study||0
135629|NCT00850889|312597|P1|COMPLETED|Overall Study||32
135630|NCT00850889|312597|P1|STARTED|Overall Study||32
135631|NCT00850759|312612|P4|NOT COMPLETED|Overall Study||3
135632|NCT00850759|312613|P3|NOT COMPLETED|Overall Study||5
135633|NCT00850759|312614|P2|NOT COMPLETED|Overall Study||5
135634|NCT00850759|312615|P1|NOT COMPLETED|Overall Study||7
135635|NCT00850759|312612|P4|COMPLETED|Overall Study||55
135636|NCT00850759|312613|P3|COMPLETED|Overall Study||52
135637|NCT00850759|312614|P2|COMPLETED|Overall Study||52
135638|NCT00850759|312615|P1|COMPLETED|Overall Study||52
135639|NCT00850759|312612|P4|STARTED|Overall Study||58
135640|NCT00850759|312613|P3|STARTED|Overall Study||57
135641|NCT00850759|312614|P2|STARTED|Overall Study||57
135642|NCT00850759|312615|P1|STARTED|Overall Study||59
135643|NCT00850720|312625|P1|NOT COMPLETED|Overall Study||0
135644|NCT00850720|312625|P1|COMPLETED|Overall Study||0
135645|NCT00850720|312625|P1|STARTED|Overall Study||0
135646|NCT00850603|312634|P5|NOT COMPLETED|Overall Study||0
135647|NCT00850603|312635|P4|NOT COMPLETED|Overall Study||0
135648|NCT00850603|312636|P3|NOT COMPLETED|Overall Study||0
135649|NCT00850603|312637|P2|NOT COMPLETED|Overall Study||0
135650|NCT00850603|312638|P1|NOT COMPLETED|Overall Study||0
135651|NCT00850603|312634|P5|COMPLETED|Overall Study||34
135652|NCT00850603|312635|P4|COMPLETED|Overall Study||34
135653|NCT00850603|312636|P3|COMPLETED|Overall Study||34
135654|NCT00850603|312637|P2|COMPLETED|Overall Study||34
135655|NCT00850603|312638|P1|COMPLETED|Overall Study||34
135656|NCT00850603|312634|P5|STARTED|Overall Study||34
135657|NCT00850603|312635|P4|STARTED|Overall Study||34
135658|NCT00850603|312636|P3|STARTED|Overall Study||34
135659|NCT00850603|312637|P2|STARTED|Overall Study||34
135660|NCT00850603|312638|P1|STARTED|Overall Study||34
135661|NCT00850564|312660|P1|NOT COMPLETED|Overall Study||2
135662|NCT00850564|312660|P1|COMPLETED|Overall Study||13
135663|NCT00850564|312660|P1|STARTED|Overall Study||15
135664|NCT00850538|312665|P1|NOT COMPLETED|Overall Study||41
135665|NCT00850538|312665|P1|COMPLETED|Overall Study||60
135666|NCT00850538|312665|P1|STARTED|Overall Study||101
135667|NCT00850499|312671|P2|NOT COMPLETED|Overall Study||2
135668|NCT00850499|312672|P1|NOT COMPLETED|Overall Study||3
135669|NCT00850499|312671|P2|COMPLETED|Overall Study||6
135670|NCT00850499|312672|P1|COMPLETED|Overall Study||1
135671|NCT00850499|312671|P2|STARTED|Overall Study||8
135672|NCT00850499|312672|P1|STARTED|Overall Study||4
135673|NCT00850460|312682|P2|NOT COMPLETED|Overall Study||4
135674|NCT00850460|312683|P1|NOT COMPLETED|Overall Study||4
135675|NCT00850460|312682|P2|COMPLETED|Overall Study||3
135676|NCT00850460|312683|P1|COMPLETED|Overall Study||3
135677|NCT00850460|312682|P2|Completion - Week 8|Overall Study||3
135678|NCT00850460|312683|P1|Completion - Week 8|Overall Study||3
135679|NCT00850460|312682|P2|Started - Week 0|Overall Study||7
135680|NCT00850460|312683|P1|Started - Week 0|Overall Study||7
135681|NCT00850460|312682|P2|STARTED|Overall Study||7
135682|NCT00850460|312683|P1|STARTED|Overall Study||7
135683|NCT00849524|312691|P1|NOT COMPLETED|Overall Study||3
135684|NCT00849524|312691|P1|COMPLETED|Overall Study||3
135685|NCT00849524|312691|P1|STARTED|Overall Study||6
135686|NCT00849485|312699|P2|NOT COMPLETED|Second Intervention||0
135687|NCT00849485|312700|P1|NOT COMPLETED|Second Intervention||0
135688|NCT00849485|312699|P2|COMPLETED|Second Intervention||11
135689|NCT00849485|312700|P1|COMPLETED|Second Intervention||11
135690|NCT00849485|312699|P2|STARTED|Second Intervention||11
135691|NCT00849485|312700|P1|STARTED|Second Intervention||11
135692|NCT00849485|312699|P2|NOT COMPLETED|Washout: 7 Days||0
135693|NCT00849485|312700|P1|NOT COMPLETED|Washout: 7 Days||0
135694|NCT00849485|312699|P2|COMPLETED|Washout: 7 Days||11
135695|NCT00849485|312700|P1|COMPLETED|Washout: 7 Days||11
135696|NCT00849485|312699|P2|STARTED|Washout: 7 Days||11
135697|NCT00849485|312700|P1|STARTED|Washout: 7 Days||11
135698|NCT00849485|312699|P2|NOT COMPLETED|First Intervention||0
135699|NCT00849485|312700|P1|NOT COMPLETED|First Intervention||0
135700|NCT00849485|312699|P2|COMPLETED|First Intervention||11
135701|NCT00849485|312700|P1|COMPLETED|First Intervention||11
135702|NCT00849485|312699|P2|STARTED|First Intervention||11
135703|NCT00849485|312700|P1|STARTED|First Intervention||11
135704|NCT00850421|312708|P1|NOT COMPLETED|Overall Study||17
135705|NCT00850421|312708|P1|COMPLETED|Overall Study||18
135706|NCT00850421|312708|P1|STARTED|Overall Study||35
135707|NCT00850395|312712|P1|NOT COMPLETED|Overall Study||10
135708|NCT00850395|312712|P1|COMPLETED|Overall Study||69
135709|NCT00850395|312712|P1|STARTED|Overall Study||79
135710|NCT00850343|312732|P4|NOT COMPLETED|Overall Study||13
135711|NCT00850343|312733|P3|NOT COMPLETED|Overall Study||14
135712|NCT00850343|312734|P2|NOT COMPLETED|Overall Study||3
135713|NCT00850343|312735|P1|NOT COMPLETED|Overall Study||46
135714|NCT00850343|312732|P4|COMPLETED|Overall Study||30
135715|NCT00850343|312733|P3|COMPLETED|Overall Study||29
135716|NCT00850343|312734|P2|COMPLETED|Overall Study||9
135717|NCT00850343|312735|P1|COMPLETED|Overall Study||64
135718|NCT00850343|312732|P4|Completed Week 52|Overall Study||37
135719|NCT00850343|312733|P3|Completed Week 52|Overall Study||37
135720|NCT00850343|312734|P2|Completed Week 52|Overall Study||11
135721|NCT00850343|312735|P1|Completed Week 52|Overall Study||88
135722|NCT00850343|312732|P4|Completed Week 24|Overall Study||39
135723|NCT00850343|312733|P3|Completed Week 24|Overall Study||39
135724|NCT00850343|312734|P2|Completed Week 24|Overall Study||12
135725|NCT00850343|312735|P1|Completed Week 24|Overall Study||94
135726|NCT00850343|312732|P4|STARTED|Overall Study||43
135727|NCT00850343|312733|P3|STARTED|Overall Study||43
135728|NCT00850343|312734|P2|STARTED|Overall Study||12
135729|NCT00850343|312735|P1|STARTED|Overall Study||110
135730|NCT00850200|312765|P1|NOT COMPLETED|Overall Study||1
135731|NCT00850200|312765|P1|COMPLETED|Overall Study||19
135732|NCT00850200|312765|P1|STARTED|Overall Study||20
135733|NCT00850174|312773|P2|NOT COMPLETED|Second Intervention||0
135734|NCT00850174|312774|P1|NOT COMPLETED|Second Intervention||1
135735|NCT00850174|312773|P2|COMPLETED|Second Intervention||28
135736|NCT00850174|312774|P1|COMPLETED|Second Intervention||29
135737|NCT00850174|312773|P2|STARTED|Second Intervention||28
135738|NCT00850174|312774|P1|STARTED|Second Intervention||30
135739|NCT00850174|312773|P2|NOT COMPLETED|Washout: One Week||2
135740|NCT00850174|312774|P1|NOT COMPLETED|Washout: One Week||0
135741|NCT00850174|312773|P2|COMPLETED|Washout: One Week||28
135742|NCT00850174|312774|P1|COMPLETED|Washout: One Week||30
135743|NCT00850174|312773|P2|STARTED|Washout: One Week||30
135744|NCT00850174|312774|P1|STARTED|Washout: One Week||30
135745|NCT00850174|312773|P2|NOT COMPLETED|First Intervention||0
135746|NCT00850174|312774|P1|NOT COMPLETED|First Intervention||0
135747|NCT00850174|312773|P2|COMPLETED|First Intervention||30
135748|NCT00850174|312774|P1|COMPLETED|First Intervention||30
135749|NCT00850174|312773|P2|STARTED|First Intervention||30
135750|NCT00850174|312774|P1|STARTED|First Intervention||30
135751|NCT00850135|312788|P1|NOT COMPLETED|Overall Study||1
135752|NCT00850135|312788|P1|COMPLETED|Overall Study||56
135753|NCT00850135|312788|P1|STARTED|Overall Study||57
135754|NCT00850096|312796|P2|NOT COMPLETED|Overall Study||2
135755|NCT00850096|312797|P1|NOT COMPLETED|Overall Study||3
135756|NCT00850096|312796|P2|COMPLETED|Overall Study||45
135757|NCT00850096|312797|P1|COMPLETED|Overall Study||44
135758|NCT00850096|312796|P2|STARTED|Overall Study||47
135759|NCT00850096|312797|P1|STARTED|Overall Study||47
135760|NCT00850070|312807|P2|NOT COMPLETED|Overall Study||1
135761|NCT00850070|312808|P1|NOT COMPLETED|Overall Study||3
135762|NCT00850070|312807|P2|COMPLETED|Overall Study||22
135763|NCT00850070|312808|P1|COMPLETED|Overall Study||20
135764|NCT00850070|312807|P2|STARTED|Overall Study||23
135765|NCT00850070|312808|P1|STARTED|Overall Study||23
135766|NCT00850031|312824|P1|NOT COMPLETED|Overall Study||17
135767|NCT00850031|312824|P1|COMPLETED|Overall Study||101
135768|NCT00850031|312824|P1|STARTED|Overall Study||118
135769|NCT00849940|312829|P1|NOT COMPLETED|Overall Study||4
135770|NCT00849940|312829|P1|COMPLETED|Overall Study||68
135771|NCT00849940|312829|P1|STARTED|Overall Study||72
135772|NCT00849901|312840|P3|NOT COMPLETED|Extension Phase||17
135773|NCT00849901|312841|P2|NOT COMPLETED|Extension Phase||26
135774|NCT00849901|312842|P1|NOT COMPLETED|Extension Phase||27
135775|NCT00849901|312840|P3|COMPLETED|Extension Phase||69
135776|NCT00849901|312841|P2|COMPLETED|Extension Phase||65
135777|NCT00849901|312842|P1|COMPLETED|Extension Phase||56
135778|NCT00849901|312840|P3|STARTED|Extension Phase||86
135779|NCT00849901|312841|P2|STARTED|Extension Phase||91
135780|NCT00849901|312842|P1|STARTED|Extension Phase||83
135781|NCT00849901|312840|P3|NOT COMPLETED|Acute Treatment Phase||16
135782|NCT00849901|312841|P2|NOT COMPLETED|Acute Treatment Phase||26
135783|NCT00849901|312842|P1|NOT COMPLETED|Acute Treatment Phase||30
135784|NCT00849901|312840|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
135785|NCT00849901|312841|P2|COMPLETED|Acute Treatment Phase||91
135786|NCT00849901|312842|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
135787|NCT00849901|312840|P3|STARTED|Acute Treatment Phase||103
135788|NCT00849901|312841|P2|STARTED|Acute Treatment Phase||117
135789|NCT00849901|312842|P1|STARTED|Acute Treatment Phase||117
135790|NCT00849862|312888|P2|NOT COMPLETED|Second Intervention||0
135791|NCT00849862|312889|P1|NOT COMPLETED|Second Intervention||0
135792|NCT00849862|312888|P2|COMPLETED|Second Intervention||11
135793|NCT00849862|312889|P1|COMPLETED|Second Intervention||11
135794|NCT00849862|312888|P2|STARTED|Second Intervention||11
135795|NCT00849862|312889|P1|STARTED|Second Intervention||11
135796|NCT00849862|312888|P2|NOT COMPLETED|Washout: 7 Days||0
135797|NCT00849862|312889|P1|NOT COMPLETED|Washout: 7 Days||0
135798|NCT00849862|312888|P2|COMPLETED|Washout: 7 Days||11
135799|NCT00849862|312889|P1|COMPLETED|Washout: 7 Days||11
135800|NCT00849862|312888|P2|STARTED|Washout: 7 Days||11
135801|NCT00849862|312889|P1|STARTED|Washout: 7 Days||11
135802|NCT00849862|312888|P2|NOT COMPLETED|First Intervention||0
135803|NCT00849862|312889|P1|NOT COMPLETED|First Intervention||0
135804|NCT00849862|312888|P2|COMPLETED|First Intervention||11
135805|NCT00849862|312889|P1|COMPLETED|First Intervention||11
135806|NCT00849862|312888|P2|STARTED|First Intervention||11
135807|NCT00849862|312889|P1|STARTED|First Intervention||11
135808|NCT00849810|312897|P1|NOT COMPLETED|Overall Study||0
135809|NCT00849810|312897|P1|COMPLETED|Overall Study||1
135810|NCT00849810|312897|P1|STARTED|Overall Study||1
135811|NCT00849797|312903|P2|NOT COMPLETED|Second Intervention||0
135812|NCT00849797|312904|P1|NOT COMPLETED|Second Intervention||0
135813|NCT00849797|312903|P2|COMPLETED|Second Intervention||57
135814|NCT00849797|312904|P1|COMPLETED|Second Intervention||59
135815|NCT00849797|312903|P2|STARTED|Second Intervention||57
135816|NCT00849797|312904|P1|STARTED|Second Intervention||59
135817|NCT00849797|312903|P2|NOT COMPLETED|Washout: One Week||2
135818|NCT00849797|312904|P1|NOT COMPLETED|Washout: One Week||0
135819|NCT00849797|312903|P2|COMPLETED|Washout: One Week||57
135820|NCT00849797|312904|P1|COMPLETED|Washout: One Week||59
135821|NCT00849797|312903|P2|STARTED|Washout: One Week||59
135822|NCT00849797|312904|P1|STARTED|Washout: One Week||59
135823|NCT00849797|312903|P2|NOT COMPLETED|First Intervention||1
135824|NCT00849797|312904|P1|NOT COMPLETED|First Intervention||1
135825|NCT00849797|312903|P2|COMPLETED|First Intervention||59
135826|NCT00849797|312904|P1|COMPLETED|First Intervention||59
135827|NCT00849797|312903|P2|STARTED|First Intervention||60
135828|NCT00849797|312904|P1|STARTED|First Intervention||60
135829|NCT00849693|312922|P4|NOT COMPLETED|Extension Phase||38
135830|NCT00849693|312923|P3|NOT COMPLETED|Extension Phase||35
135831|NCT00849693|312924|P2|NOT COMPLETED|Extension Phase||30
135832|NCT00849693|312925|P1|NOT COMPLETED|Extension Phase||30
135833|NCT00849693|312922|P4|COMPLETED|Extension Phase||44
135834|NCT00849693|312923|P3|COMPLETED|Extension Phase||49
135835|NCT00849693|312924|P2|COMPLETED|Extension Phase||50
135836|NCT00849693|312925|P1|COMPLETED|Extension Phase||43
135837|NCT00849693|312922|P4|STARTED|Extension Phase||82
135838|NCT00849693|312923|P3|STARTED|Extension Phase||84
135839|NCT00849693|312924|P2|STARTED|Extension Phase||80
135840|NCT00849693|312925|P1|STARTED|Extension Phase||73
135841|NCT00849693|312922|P4|NOT COMPLETED|Acute Treatment Phase||37
135842|NCT00849693|312923|P3|NOT COMPLETED|Acute Treatment Phase||33
135843|NCT00849693|312924|P2|NOT COMPLETED|Acute Treatment Phase||35
135844|NCT00849693|312925|P1|NOT COMPLETED|Acute Treatment Phase||33
135845|NCT00849693|312922|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
135846|NCT00849693|312923|P3|COMPLETED|Acute Treatment Phase||84
135847|NCT00849693|312924|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
135848|NCT00849693|312925|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
135849|NCT00849693|312922|P4|STARTED|Acute Treatment Phase||122
135850|NCT00849693|312923|P3|STARTED|Acute Treatment Phase||117
135851|NCT00849693|312924|P2|STARTED|Acute Treatment Phase||116
135852|NCT00849693|312925|P1|STARTED|Acute Treatment Phase||108
135853|NCT00849680|312992|P8|NOT COMPLETED|Overall Study||8
135854|NCT00849680|312993|P7|NOT COMPLETED|Overall Study||17
135855|NCT00849680|312994|P6|NOT COMPLETED|Overall Study||15
135856|NCT00849680|312995|P5|NOT COMPLETED|Overall Study||10
135857|NCT00849680|312996|P4|NOT COMPLETED|Overall Study||14
135858|NCT00849680|312997|P3|NOT COMPLETED|Overall Study||15
135859|NCT00849680|312998|P2|NOT COMPLETED|Overall Study||3
135860|NCT00849680|312999|P1|NOT COMPLETED|Overall Study||11
135861|NCT00849680|312992|P8|COMPLETED|Overall Study||23
135862|NCT00849680|312993|P7|COMPLETED|Overall Study||61
135863|NCT00849680|312994|P6|COMPLETED|Overall Study||27
135864|NCT00849680|312995|P5|COMPLETED|Overall Study||32
135865|NCT00849680|312996|P4|COMPLETED|Overall Study||28
135866|NCT00849680|312997|P3|COMPLETED|Overall Study||27
135867|NCT00849680|312998|P2|COMPLETED|Overall Study||10
135868|NCT00849680|312999|P1|COMPLETED|Overall Study||16
135869|NCT00849680|312992|P8|STARTED|Overall Study||31
135870|NCT00849680|312993|P7|STARTED|Overall Study||78
135871|NCT00849680|312994|P6|STARTED|Overall Study||42
135872|NCT00849680|312995|P5|STARTED|Overall Study||42
135873|NCT00849680|312996|P4|STARTED|Overall Study||42
135874|NCT00849680|312997|P3|STARTED|Overall Study||42
135875|NCT00849680|312998|P2|STARTED|Overall Study||13
135876|NCT00849680|312999|P1|STARTED|Overall Study||27
135877|NCT00849472|313041|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
135878|NCT00849472|313041|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
135879|NCT00849472|313041|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
135880|NCT00849472|313041|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
135881|NCT00849472|313041|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
135882|NCT00849472|313041|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
135883|NCT00849472|313041|P1|NOT COMPLETED|Weekly Paclitaxel||16
135884|NCT00849472|313041|P1|COMPLETED|Weekly Paclitaxel||78
135885|NCT00849472|313041|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
135886|NCT00849472|313041|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
135887|NCT00849472|313041|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
135888|NCT00849472|313041|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
135889|NCT00849381|313055|P1|NOT COMPLETED|Overall Study||145
135890|NCT00849381|313055|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
135891|NCT00849381|313055|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
135892|NCT00849290|313061|P1|NOT COMPLETED|Overall Study||55
135893|NCT00849290|313061|P1|COMPLETED|Overall Study||58
135894|NCT00849290|313061|P1|STARTED|Overall Study||113
135895|NCT00849212|313065|P1|NOT COMPLETED|Overall Study||7
135896|NCT00849212|313065|P1|COMPLETED|Overall Study||23
135897|NCT00849212|313065|P1|STARTED|Overall Study||30
135898|NCT00849186|313070|P1|NOT COMPLETED|Overall Study||10
135899|NCT00849186|313070|P1|COMPLETED|Overall Study||16
135900|NCT00849186|313070|P1|STARTED|Overall Study||26
135901|NCT00849147|313076|P1|NOT COMPLETED|Overall Study||5
135902|NCT00849147|313076|P1|COMPLETED|Overall Study||50
135903|NCT00849147|313076|P1|STARTED|Overall Study||55
135904|NCT00849121|313093|P2|NOT COMPLETED|Overall Study||0
135905|NCT00849121|313094|P1|NOT COMPLETED|Overall Study||0
135906|NCT00849121|313093|P2|COMPLETED|Overall Study||9
135907|NCT00849121|313094|P1|COMPLETED|Overall Study||8
135908|NCT00849121|313093|P2|STARTED|Overall Study||9
135909|NCT00849121|313094|P1|STARTED|Overall Study||8
135910|NCT00849108|313109|P2|NOT COMPLETED|Cohort 2 Efficacy||10
135911|NCT00849108|313110|P1|NOT COMPLETED|Cohort 2 Efficacy||0
135912|NCT00849108|313109|P2|COMPLETED|Cohort 2 Efficacy||133
135913|NCT00849108|313110|P1|COMPLETED|Cohort 2 Efficacy||0
135914|NCT00849108|313109|P2|STARTED|Cohort 2 Efficacy||143
135915|NCT00849108|313110|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
135916|NCT00849108|313109|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
135917|NCT00849108|313110|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
135918|NCT00849108|313109|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
135919|NCT00849108|313110|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
135920|NCT00849108|313109|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
135921|NCT00849108|313110|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
135922|NCT00849056|313120|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
135923|NCT00849056|313121|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
135924|NCT00849056|313120|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
135925|NCT00849056|313121|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
135926|NCT00849056|313120|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
135927|NCT00849056|313121|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
135928|NCT00849056|313120|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
135929|NCT00849056|313121|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
135930|NCT00849056|313120|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
135931|NCT00849056|313121|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
135932|NCT00849056|313120|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
135933|NCT00849056|313121|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
135934|NCT00849017|313146|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
135935|NCT00849017|313147|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
135936|NCT00849017|313148|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
135937|NCT00849017|313146|P3|COMPLETED|Follow-up Period (8 Weeks)||74
135938|NCT00849017|313147|P2|COMPLETED|Follow-up Period (8 Weeks)||83
135939|NCT00849017|313148|P1|COMPLETED|Follow-up Period (8 Weeks)||76
135940|NCT00849017|313146|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
135941|NCT00849017|313147|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
135942|NCT00849017|313148|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
135943|NCT00849017|313146|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
135944|NCT00849017|313147|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
135945|NCT00849017|313148|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
135946|NCT00849017|313146|P3|COMPLETED|Treatment Period (156 Weeks)||57
135947|NCT00849017|313147|P2|COMPLETED|Treatment Period (156 Weeks)||68
135948|NCT00849017|313148|P1|COMPLETED|Treatment Period (156 Weeks)||58
135949|NCT00849017|313146|P3|STARTED|Treatment Period (156 Weeks)||99
135950|NCT00849017|313147|P2|STARTED|Treatment Period (156 Weeks)||101
135951|NCT00849017|313148|P1|STARTED|Treatment Period (156 Weeks)||101
135952|NCT00848965|313191|P1|NOT COMPLETED|Overall Study||2
135953|NCT00848965|313191|P1|COMPLETED|Overall Study||57
135954|NCT00848965|313191|P1|STARTED|Overall Study||59
135955|NCT00848926|313233|P1|NOT COMPLETED|Follow-up Period||12
135956|NCT00848926|313233|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
135957|NCT00848926|313233|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
135958|NCT00848926|313233|P1|NOT COMPLETED|Treatment Period||84
135959|NCT00848926|313233|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
135960|NCT00848926|313233|P1|STARTED|Treatment Period||102
135961|NCT00848783|313252|P3|NOT COMPLETED|Overall Study||0
135962|NCT00848783|313253|P2|NOT COMPLETED|Overall Study||2
135963|NCT00848783|313254|P1|NOT COMPLETED|Overall Study||3
135964|NCT00848783|313252|P3|COMPLETED|Overall Study||1
135965|NCT00848783|313253|P2|COMPLETED|Overall Study||1
135966|NCT00848783|313254|P1|COMPLETED|Overall Study||1
135967|NCT00848783|313252|P3|STARTED|Overall Study||1
135968|NCT00848783|313253|P2|STARTED|Overall Study||3
135969|NCT00848783|313254|P1|STARTED|Overall Study||4
135970|NCT00848744|313260|P1|NOT COMPLETED|Overall Study||0
135971|NCT00848744|313260|P1|COMPLETED|Overall Study||10
135972|NCT00848744|313260|P1|STARTED|Overall Study||10
135973|NCT00848549|313267|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
135974|NCT00848549|313268|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
135975|NCT00848549|313267|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
135976|NCT00848549|313268|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
135977|NCT00848549|313267|P2|STARTED|E2090-E044-314 (Extension Study)||158
135978|NCT00848549|313268|P1|STARTED|E2090-E044-314 (Extension Study)||137
135979|NCT00848549|313267|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
135980|NCT00848549|313268|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
135981|NCT00848549|313267|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
135982|NCT00848549|313268|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
135983|NCT00848549|313267|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
135984|NCT00848549|313268|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
135985|NCT00848549|313267|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
135986|NCT00848549|313268|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
135987|NCT00848549|313267|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
135988|NCT00848549|313268|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
135989|NCT00848549|313267|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
135990|NCT00848549|313268|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
135991|NCT00848536|313286|P2|NOT COMPLETED|Overall Study||7
135992|NCT00848536|313287|P1|NOT COMPLETED|Overall Study||4
135993|NCT00848536|313286|P2|COMPLETED|Overall Study||179
135994|NCT00848536|313287|P1|COMPLETED|Overall Study||181
135995|NCT00848536|313286|P2|STARTED|Overall Study||186
135996|NCT00848536|313287|P1|STARTED|Overall Study||185
135997|NCT00848510|313301|P4|NOT COMPLETED|Overall Study||0
135998|NCT00848510|313302|P3|NOT COMPLETED|Overall Study||0
135999|NCT00848510|313303|P2|NOT COMPLETED|Overall Study||0
136000|NCT00848510|313304|P1|NOT COMPLETED|Overall Study||0
136001|NCT00848510|313301|P4|COMPLETED|Overall Study||10
136002|NCT00848510|313302|P3|COMPLETED|Overall Study||8
136003|NCT00848510|313303|P2|COMPLETED|Overall Study||13
136004|NCT00848510|313304|P1|COMPLETED|Overall Study||10
136005|NCT00848510|313301|P4|STARTED|Overall Study||10
136006|NCT00848510|313302|P3|STARTED|Overall Study||8
136007|NCT00848510|313303|P2|STARTED|Overall Study||13
136008|NCT00848510|313304|P1|STARTED|Overall Study||10
136009|NCT00848497|313352|P2|NOT COMPLETED|Overall Study||1
136010|NCT00848497|313353|P1|NOT COMPLETED|Overall Study||2
136011|NCT00848497|313352|P2|COMPLETED|Overall Study||0
136012|NCT00848497|313353|P1|COMPLETED|Overall Study||0
136013|NCT00848497|313352|P2|STARTED|Overall Study|Completed Visit 4|1
136014|NCT00848497|313353|P1|STARTED|Overall Study||2
136015|NCT00848484|313367|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
136016|NCT00848484|313368|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
136017|NCT00848484|313367|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
136018|NCT00848484|313368|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
136019|NCT00848484|313367|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
136020|NCT00848484|313368|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
136021|NCT00848484|313367|P2|STARTED|Second Intervention (Treatment Period 2)||21
136022|NCT00848484|313368|P1|STARTED|Second Intervention (Treatment Period 2)||25
136023|NCT00848484|313367|P2|NOT COMPLETED|Washout Period of Two Weeks||3
136024|NCT00848484|313368|P1|NOT COMPLETED|Washout Period of Two Weeks||0
136025|NCT00848484|313367|P2|COMPLETED|Washout Period of Two Weeks||21
136026|NCT00848484|313368|P1|COMPLETED|Washout Period of Two Weeks||25
136027|NCT00848484|313367|P2|STARTED|Washout Period of Two Weeks||24
136028|NCT00848484|313368|P1|STARTED|Washout Period of Two Weeks||25
136029|NCT00848484|313367|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
136030|NCT00848484|313368|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
136031|NCT00848484|313367|P2|COMPLETED|First Intervention (Treatment Period 1)||24
136032|NCT00848484|313368|P1|COMPLETED|First Intervention (Treatment Period 1)||25
136033|NCT00848484|313367|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
136034|NCT00848484|313368|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
136035|NCT00848484|313367|P2|STARTED|First Intervention (Treatment Period 1)||27
136036|NCT00848484|313368|P1|STARTED|First Intervention (Treatment Period 1)||27
136037|NCT00848367|313386|P2|NOT COMPLETED|Overall Study||9
136038|NCT00848367|313387|P1|NOT COMPLETED|Overall Study||9
136039|NCT00848367|313386|P2|COMPLETED|Overall Study||41
136040|NCT00848367|313387|P1|COMPLETED|Overall Study||43
136041|NCT00848367|313386|P2|STARTED|Overall Study||50
136042|NCT00848367|313387|P1|STARTED|Overall Study||52
136043|NCT00848354|313397|P2|NOT COMPLETED|Phase 2 Year 2||7
136044|NCT00848354|313398|P1|NOT COMPLETED|Phase 2 Year 2||23
136045|NCT00848354|313397|P2|COMPLETED|Phase 2 Year 2||113
136046|NCT00848354|313398|P1|COMPLETED|Phase 2 Year 2||218
136047|NCT00848354|313397|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
136048|NCT00848354|313398|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
136049|NCT00848354|313397|P2|NOT COMPLETED|Phase 2 Year 1||6
136050|NCT00848354|313398|P1|NOT COMPLETED|Phase 2 Year 1||18
136051|NCT00848354|313397|P2|COMPLETED|Phase 2 Year 1||120
136052|NCT00848354|313398|P1|COMPLETED|Phase 2 Year 1||242
136053|NCT00848354|313397|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
136054|NCT00848354|313398|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
136055|NCT00848354|313397|P2|NOT COMPLETED|Phase 1||14
136056|NCT00848354|313398|P1|NOT COMPLETED|Phase 1||12
136057|NCT00848354|313397|P2|COMPLETED|Phase 1||129
136058|NCT00848354|313398|P1|COMPLETED|Phase 1||269
136059|NCT00848354|313397|P2|STARTED|Phase 1||143
136060|NCT00848354|313398|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
136061|NCT00848237|313548|P1|NOT COMPLETED|Overall Study||539
136062|NCT00848237|313548|P1|COMPLETED|Overall Study||4982
136063|NCT00848237|313548|P1|STARTED|Overall Study||5521
136064|NCT00848211|313561|P4|NOT COMPLETED|Overall Study||0
136065|NCT00848211|313562|P3|NOT COMPLETED|Overall Study||1
136066|NCT00848211|313563|P2|NOT COMPLETED|Overall Study||1
136067|NCT00848211|313564|P1|NOT COMPLETED|Overall Study||0
136068|NCT00848211|313561|P4|COMPLETED|Overall Study||5
136069|NCT00848211|313562|P3|COMPLETED|Overall Study||5
136070|NCT00848211|313563|P2|COMPLETED|Overall Study||6
136071|NCT00848211|313564|P1|COMPLETED|Overall Study||6
136072|NCT00848211|313561|P4|STARTED|Overall Study||5
136073|NCT00848211|313562|P3|STARTED|Overall Study||6
136074|NCT00848211|313563|P2|STARTED|Overall Study||7
136075|NCT00848211|313564|P1|STARTED|Overall Study||6
136076|NCT00848198|313582|P1|NOT COMPLETED|Overall Study||15
136077|NCT00848198|313582|P1|COMPLETED|Overall Study||299
136078|NCT00848198|313582|P1|STARTED|Overall Study||314
136079|NCT00848172|313622|P2|NOT COMPLETED|Visit 3 - Follow Up||0
136080|NCT00848172|313623|P1|NOT COMPLETED|Visit 3 - Follow Up||0
136081|NCT00848172|313622|P2|COMPLETED|Visit 3 - Follow Up||8
136082|NCT00848172|313623|P1|COMPLETED|Visit 3 - Follow Up||10
136083|NCT00848172|313622|P2|STARTED|Visit 3 - Follow Up||8
136084|NCT00848172|313623|P1|STARTED|Visit 3 - Follow Up||10
136085|NCT00848172|313622|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
136086|NCT00848172|313623|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
136087|NCT00848172|313622|P2|COMPLETED|Visit 2 - Drug Administration||8
136088|NCT00848172|313623|P1|COMPLETED|Visit 2 - Drug Administration||10
136089|NCT00848172|313622|P2|STARTED|Visit 2 - Drug Administration||9
136090|NCT00848172|313623|P1|STARTED|Visit 2 - Drug Administration||10
136091|NCT00848120|313634|P1|NOT COMPLETED|Overall Study||1
136092|NCT00848120|313634|P1|COMPLETED|Overall Study||28
136093|NCT00848120|313634|P1|STARTED|Overall Study||29
136094|NCT00848107|313646|P1|NOT COMPLETED|Overall Study||21
136095|NCT00848107|313646|P1|COMPLETED|Overall Study||94
136096|NCT00848107|313646|P1|STARTED|Overall Study||115
136097|NCT00848081|313656|P2|NOT COMPLETED|Overall Study||18
136098|NCT00848081|313657|P1|NOT COMPLETED|Overall Study||20
136099|NCT00848081|313656|P2|COMPLETED|Overall Study||140
136100|NCT00848081|313657|P1|COMPLETED|Overall Study||140
136101|NCT00848081|313656|P2|STARTED|Overall Study||158
136102|NCT00848081|313657|P1|STARTED|Overall Study||160
136103|NCT00848042|313674|P3|NOT COMPLETED|Overall Study||0
136104|NCT00848042|313675|P2|NOT COMPLETED|Overall Study||2
136105|NCT00848042|313676|P1|NOT COMPLETED|Overall Study||4
136106|NCT00848042|313674|P3|COMPLETED|Overall Study||1
136107|NCT00848042|313675|P2|COMPLETED|Overall Study||3
136108|NCT00848042|313676|P1|COMPLETED|Overall Study||1
136109|NCT00848042|313674|P3|Month 6|Overall Study||1
136110|NCT00848042|313675|P2|Month 6|Overall Study||3
136111|NCT00848042|313676|P1|Month 6|Overall Study||1
136112|NCT00848042|313674|P3|Month 5|Overall Study||1
136113|NCT00848042|313675|P2|Month 5|Overall Study||3
136114|NCT00848042|313676|P1|Month 5|Overall Study||1
136115|NCT00848042|313674|P3|Month 4|Overall Study||1
136116|NCT00848042|313675|P2|Month 4|Overall Study||4
136117|NCT00848042|313676|P1|Month 4|Overall Study||1
136118|NCT00848042|313674|P3|Month 3|Overall Study||1
136119|NCT00848042|313675|P2|Month 3|Overall Study||4
136120|NCT00848042|313676|P1|Month 3|Overall Study||1
136121|NCT00848042|313674|P3|Month 2|Overall Study||1
136122|NCT00848042|313675|P2|Month 2|Overall Study||5
136123|NCT00848042|313676|P1|Month 2|Overall Study||1
136124|NCT00848042|313674|P3|Month 1|Overall Study||1
136125|NCT00848042|313675|P2|Month 1|Overall Study||5
136126|NCT00848042|313676|P1|Month 1|Overall Study||4
136127|NCT00848042|313674|P3|Day 15|Overall Study||1
136128|NCT00848042|313675|P2|Day 15|Overall Study||5
136129|NCT00848042|313676|P1|Day 15|Overall Study||4
136130|NCT00848042|313674|P3|Day 8|Overall Study||1
136131|NCT00848042|313675|P2|Day 8|Overall Study||5
136132|NCT00848042|313676|P1|Day 8|Overall Study||5
136133|NCT00848042|313674|P3|Day 3|Overall Study||1
136134|NCT00848042|313675|P2|Day 3|Overall Study||5
136135|NCT00848042|313676|P1|Day 3|Overall Study||5
136136|NCT00848042|313674|P3|Day 2|Overall Study||1
136137|NCT00848042|313675|P2|Day 2|Overall Study||5
136138|NCT00848042|313676|P1|Day 2|Overall Study||5
136139|NCT00848042|313674|P3|Day 1|Overall Study||1
136140|NCT00848042|313675|P2|Day 1|Overall Study||5
136141|NCT00848042|313676|P1|Day 1|Overall Study||5
136142|NCT00848042|313674|P3|STARTED|Overall Study||1
136143|NCT00848042|313675|P2|STARTED|Overall Study||5
136144|NCT00848042|313676|P1|STARTED|Overall Study||5
136145|NCT00848016|313687|P1|NOT COMPLETED|Overall Study||0
136146|NCT00848016|313687|P1|COMPLETED|Overall Study||29
136147|NCT00848016|313687|P1|STARTED|Overall Study||29
136148|NCT00847886|313695|P2|NOT COMPLETED|Overall Study||1
136149|NCT00847886|313696|P1|NOT COMPLETED|Overall Study||0
136150|NCT00847886|313695|P2|COMPLETED|Overall Study||3
136151|NCT00847886|313696|P1|COMPLETED|Overall Study||12
136152|NCT00847886|313695|P2|STARTED|Overall Study||4
136153|NCT00847886|313696|P1|STARTED|Overall Study||12
136154|NCT00847808|313722|P1|NOT COMPLETED|Overall Study||15
136155|NCT00847808|313722|P1|COMPLETED|Overall Study||163
136156|NCT00847808|313722|P1|STARTED|Overall Study||178
136157|NCT00847704|313739|P1|NOT COMPLETED|Overall Study||1
136158|NCT00847704|313739|P1|COMPLETED|Overall Study||2
136159|NCT00847704|313739|P1|STARTED|Overall Study||3
136160|NCT00847665|313750|P2|NOT COMPLETED|Overall Study||0
136161|NCT00847665|313751|P1|NOT COMPLETED|Overall Study||1
136162|NCT00847665|313750|P2|COMPLETED|Overall Study||165
136163|NCT00847665|313751|P1|COMPLETED|Overall Study||164
136164|NCT00847665|313750|P2|STARTED|Overall Study||165
136165|NCT00847665|313751|P1|STARTED|Overall Study||165
136166|NCT00847626|313774|P11|NOT COMPLETED|Overall Study||20
136167|NCT00847626|313775|P10|NOT COMPLETED|Overall Study||14
136168|NCT00847626|313776|P9|NOT COMPLETED|Overall Study||14
136169|NCT00847626|313777|P8|NOT COMPLETED|Overall Study||19
136170|NCT00847626|313778|P7|NOT COMPLETED|Overall Study||22
136171|NCT00847626|313779|P6|NOT COMPLETED|Overall Study||37
136172|NCT00847626|313780|P5|NOT COMPLETED|Overall Study||28
136173|NCT00847626|313781|P4|NOT COMPLETED|Overall Study||31
136174|NCT00847626|313782|P3|NOT COMPLETED|Overall Study||16
136175|NCT00847626|313783|P2|NOT COMPLETED|Overall Study||23
136176|NCT00847626|313784|P1|NOT COMPLETED|Overall Study||21
136177|NCT00847626|313774|P11|COMPLETED|Overall Study||142
136178|NCT00847626|313775|P10|COMPLETED|Overall Study||139
136179|NCT00847626|313776|P9|COMPLETED|Overall Study||141
136180|NCT00847626|313777|P8|COMPLETED|Overall Study||141
136181|NCT00847626|313778|P7|COMPLETED|Overall Study||135
136182|NCT00847626|313779|P6|COMPLETED|Overall Study||125
136183|NCT00847626|313780|P5|COMPLETED|Overall Study||125
136184|NCT00847626|313781|P4|COMPLETED|Overall Study||125
136185|NCT00847626|313782|P3|COMPLETED|Overall Study||131
136186|NCT00847626|313783|P2|COMPLETED|Overall Study||131
136187|NCT00847626|313784|P1|COMPLETED|Overall Study||135
136188|NCT00847626|313774|P11|STARTED|Overall Study||162
136189|NCT00847626|313775|P10|STARTED|Overall Study||153
136190|NCT00847626|313776|P9|STARTED|Overall Study||155
136191|NCT00847626|313777|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
136192|NCT00847626|313778|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
136193|NCT00847626|313779|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
136194|NCT00847626|313780|P5|STARTED|Overall Study||153
136195|NCT00847626|313781|P4|STARTED|Overall Study||156
136196|NCT00847626|313782|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
136197|NCT00847626|313783|P2|STARTED|Overall Study||154
136198|NCT00847626|313784|P1|STARTED|Overall Study||156
136199|NCT00847613|313983|P4|NOT COMPLETED|Overall Study||79
136200|NCT00847613|313984|P3|NOT COMPLETED|Overall Study||81
136201|NCT00847613|313985|P2|NOT COMPLETED|Overall Study||319
136202|NCT00847613|313986|P1|NOT COMPLETED|Overall Study||321
136203|NCT00847613|313983|P4|COMPLETED|Overall Study||0
136204|NCT00847613|313984|P3|COMPLETED|Overall Study||0
136205|NCT00847613|313985|P2|COMPLETED|Overall Study||0
136206|NCT00847613|313986|P1|COMPLETED|Overall Study||0
136207|NCT00847613|313983|P4|Treated|Overall Study||79
136208|NCT00847613|313984|P3|Treated|Overall Study||81
136209|NCT00847613|313985|P2|Treated|Overall Study||316
136210|NCT00847613|313986|P1|Treated|Overall Study||321
136211|NCT00847613|313983|P4|STARTED|Overall Study||79
136212|NCT00847613|313984|P3|STARTED|Overall Study||81
136213|NCT00847613|313985|P2|STARTED|Overall Study||319
136214|NCT00847613|313986|P1|STARTED|Overall Study||321
136215|NCT00847587|314226|P2|NOT COMPLETED|Overall Study||0
136216|NCT00847587|314227|P1|NOT COMPLETED|Overall Study||1
136217|NCT00847587|314226|P2|COMPLETED|Overall Study||34
136218|NCT00847587|314227|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
136219|NCT00847587|314226|P2|STARTED|Overall Study||34
136220|NCT00847587|314227|P1|STARTED|Overall Study||35
136221|NCT00847561|314237|P2|NOT COMPLETED|Overall Study||4
136222|NCT00847561|314238|P1|NOT COMPLETED|Overall Study||13
136223|NCT00847561|314237|P2|COMPLETED|Overall Study||62
136224|NCT00847561|314238|P1|COMPLETED|Overall Study||57
136225|NCT00847561|314237|P2|STARTED|Overall Study||66
136226|NCT00847561|314238|P1|STARTED|Overall Study||70
136227|NCT00847535|314244|P3|NOT COMPLETED|Overall Study||1
136228|NCT00847535|314245|P2|NOT COMPLETED|Overall Study||2
136229|NCT00847535|314246|P1|NOT COMPLETED|Overall Study||2
136230|NCT00847535|314244|P3|COMPLETED|Overall Study||15
136231|NCT00847535|314245|P2|COMPLETED|Overall Study||22
136232|NCT00847535|314246|P1|COMPLETED|Overall Study||22
136233|NCT00847535|314244|P3|200 Million AMDC|Overall Study||8
136234|NCT00847535|314245|P2|200 Million AMDC|Overall Study||0
136235|NCT00847535|314246|P1|200 Million AMDC|Overall Study||0
136236|NCT00847535|314244|P3|100 Million AMDC|Overall Study||8
136237|NCT00847535|314245|P2|100 Million AMDC|Overall Study||8
136238|NCT00847535|314246|P1|100 Million AMDC|Overall Study||8
136239|NCT00847535|314244|P3|50 Million AMDC|Overall Study||0
136240|NCT00847535|314245|P2|50 Million AMDC|Overall Study||8
136241|NCT00847535|314246|P1|50 Million AMDC|Overall Study||8
136242|NCT00847535|314244|P3|10 Million AMDC|Overall Study||0
136243|NCT00847535|314245|P2|10 Million AMDC|Overall Study||8
136244|NCT00847535|314246|P1|10 Million AMDC|Overall Study||8
136245|NCT00847535|314244|P3|STARTED|Overall Study||16
136246|NCT00847535|314245|P2|STARTED|Overall Study||24
136247|NCT00847535|314246|P1|STARTED|Overall Study||24
136248|NCT00847509|314254|P1|NOT COMPLETED|Overall Study||11
136249|NCT00847509|314254|P1|COMPLETED|Overall Study||38
136250|NCT00847509|314254|P1|STARTED|Overall Study||49
136251|NCT00847405|314260|P2|NOT COMPLETED|Second Intervention||0
136252|NCT00847405|314261|P1|NOT COMPLETED|Second Intervention||0
136253|NCT00847405|314260|P2|COMPLETED|Second Intervention||13
136254|NCT00847405|314261|P1|COMPLETED|Second Intervention||13
136255|NCT00847405|314260|P2|STARTED|Second Intervention||13
136256|NCT00847405|314261|P1|STARTED|Second Intervention||13
136257|NCT00847405|314260|P2|NOT COMPLETED|Washout of 7 Days||0
136258|NCT00847405|314261|P1|NOT COMPLETED|Washout of 7 Days||1
136259|NCT00847405|314260|P2|COMPLETED|Washout of 7 Days||13
136260|NCT00847405|314261|P1|COMPLETED|Washout of 7 Days||13
136261|NCT00847405|314260|P2|STARTED|Washout of 7 Days||13
136262|NCT00847405|314261|P1|STARTED|Washout of 7 Days||14
136263|NCT00847405|314260|P2|NOT COMPLETED|First Intervention||1
136264|NCT00847405|314261|P1|NOT COMPLETED|First Intervention||0
136265|NCT00847405|314260|P2|COMPLETED|First Intervention||13
136266|NCT00847405|314261|P1|COMPLETED|First Intervention||14
136267|NCT00847405|314260|P2|STARTED|First Intervention||14
136268|NCT00847405|314261|P1|STARTED|First Intervention||14
136269|NCT00847301|314269|P1|NOT COMPLETED|Overall Study||54
136270|NCT00847301|314269|P1|COMPLETED|Overall Study||374
136271|NCT00847301|314269|P1|STARTED|Overall Study||428
136272|NCT00847288|314279|P2|NOT COMPLETED|Overall Study||47
136273|NCT00847288|314280|P1|NOT COMPLETED|Overall Study||30
136274|NCT00847288|314279|P2|COMPLETED|Overall Study||780
136275|NCT00847288|314280|P1|COMPLETED|Overall Study||811
136276|NCT00847288|314279|P2|STARTED|Overall Study||827
136277|NCT00847288|314280|P1|STARTED|Overall Study||841
136278|NCT00847210|314294|P2|NOT COMPLETED|Overall Study||0
136279|NCT00847210|314295|P1|NOT COMPLETED|Overall Study||0
136280|NCT00847210|314294|P2|COMPLETED|Overall Study||18
136281|NCT00847210|314295|P1|COMPLETED|Overall Study||18
136282|NCT00847210|314294|P2|STARTED|Overall Study||18
136283|NCT00847210|314295|P1|STARTED|Overall Study||18
136284|NCT00847197|314317|P2|NOT COMPLETED|Overall Study||5
136285|NCT00847197|314318|P1|NOT COMPLETED|Overall Study||24
136286|NCT00847197|314317|P2|COMPLETED|Overall Study||70
136287|NCT00847197|314318|P1|COMPLETED|Overall Study||92
136288|NCT00847197|314317|P2|STARTED|Overall Study||75
136289|NCT00847197|314318|P1|STARTED|Overall Study||116
136290|NCT00847145|314336|P8|NOT COMPLETED|Overall Study||4
136291|NCT00847145|314337|P7|NOT COMPLETED|Overall Study||9
136292|NCT00847145|314338|P6|NOT COMPLETED|Overall Study||4
136293|NCT00847145|314339|P5|NOT COMPLETED|Overall Study||6
136294|NCT00847145|314340|P4|NOT COMPLETED|Overall Study||1
136295|NCT00847145|314341|P3|NOT COMPLETED|Overall Study||11
136296|NCT00847145|314342|P2|NOT COMPLETED|Overall Study||6
136297|NCT00847145|314343|P1|NOT COMPLETED|Overall Study||6
136298|NCT00847145|314336|P8|COMPLETED|Overall Study||136
136299|NCT00847145|314337|P7|COMPLETED|Overall Study||143
136300|NCT00847145|314338|P6|COMPLETED|Overall Study||152
136301|NCT00847145|314339|P5|COMPLETED|Overall Study||131
136302|NCT00847145|314340|P4|COMPLETED|Overall Study||116
136303|NCT00847145|314341|P3|COMPLETED|Overall Study||274
136304|NCT00847145|314342|P2|COMPLETED|Overall Study||627
136305|NCT00847145|314343|P1|COMPLETED|Overall Study||623
136306|NCT00847145|314336|P8|STARTED|Overall Study||140
136307|NCT00847145|314337|P7|STARTED|Overall Study||152
136308|NCT00847145|314338|P6|STARTED|Overall Study||156
136309|NCT00847145|314339|P5|STARTED|Overall Study||137
136310|NCT00847145|314340|P4|STARTED|Overall Study||117
136311|NCT00847145|314341|P3|STARTED|Overall Study||285
136312|NCT00847145|314342|P2|STARTED|Overall Study||633
136313|NCT00847145|314343|P1|STARTED|Overall Study||629
136314|NCT00845481|314391|P1|NOT COMPLETED|Overall Study||0
136315|NCT00845481|314391|P1|COMPLETED|Overall Study||24
136316|NCT00845481|314391|P1|STARTED|Overall Study||24
136317|NCT00847015|314400|P1|NOT COMPLETED|Overall Study||3
136318|NCT00847015|314400|P1|COMPLETED|Overall Study||15
136319|NCT00847015|314400|P1|STARTED|Overall Study||18
136320|NCT00847002|314408|P2|NOT COMPLETED|Overall Study||0
136321|NCT00847002|314409|P1|NOT COMPLETED|Overall Study||0
136322|NCT00847002|314408|P2|COMPLETED|Overall Study||4
136323|NCT00847002|314409|P1|COMPLETED|Overall Study||4
136324|NCT00847002|314408|P2|STARTED|Overall Study||4
136325|NCT00847002|314409|P1|STARTED|Overall Study||4
136326|NCT00846885|314419|P2|NOT COMPLETED|Second Intervention||0
136327|NCT00846885|314420|P1|NOT COMPLETED|Second Intervention||0
136328|NCT00846885|314419|P2|COMPLETED|Second Intervention||14
136329|NCT00846885|314420|P1|COMPLETED|Second Intervention||14
136330|NCT00846885|314419|P2|STARTED|Second Intervention||14
136331|NCT00846885|314420|P1|STARTED|Second Intervention||14
136332|NCT00846885|314419|P2|NOT COMPLETED|Washout of 7 Days||0
136333|NCT00846885|314420|P1|NOT COMPLETED|Washout of 7 Days||0
136334|NCT00846885|314419|P2|COMPLETED|Washout of 7 Days||14
136335|NCT00846885|314420|P1|COMPLETED|Washout of 7 Days||14
136336|NCT00846885|314419|P2|STARTED|Washout of 7 Days||14
136337|NCT00846885|314420|P1|STARTED|Washout of 7 Days||14
136338|NCT00846885|314419|P2|NOT COMPLETED|First Intervention||0
136339|NCT00846885|314420|P1|NOT COMPLETED|First Intervention||0
136340|NCT00846885|314419|P2|COMPLETED|First Intervention||14
136341|NCT00846885|314420|P1|COMPLETED|First Intervention||14
136342|NCT00846885|314419|P2|STARTED|First Intervention||14
136343|NCT00846885|314420|P1|STARTED|First Intervention||14
136344|NCT00846846|314428|P1|NOT COMPLETED|Overall Study||75
136345|NCT00846846|314428|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
136346|NCT00846846|314428|P1|STARTED|Overall Study||1018
136347|NCT00846807|314433|P1|NOT COMPLETED|Overall Study||632
136348|NCT00846807|314433|P1|COMPLETED|Overall Study|Completed treatment.|4660
136349|NCT00846807|314433|P1|STARTED|Overall Study|Entered and treated.|5292
136350|NCT00846768|314441|P4|NOT COMPLETED|Overall Study||0
136351|NCT00846768|314442|P3|NOT COMPLETED|Overall Study||0
136352|NCT00846768|314443|P2|NOT COMPLETED|Overall Study||1
136353|NCT00846768|314444|P1|NOT COMPLETED|Overall Study||0
136354|NCT00846768|314441|P4|COMPLETED|Overall Study||12
136355|NCT00846768|314442|P3|COMPLETED|Overall Study||12
136356|NCT00846768|314443|P2|COMPLETED|Overall Study||11
136357|NCT00846768|314444|P1|COMPLETED|Overall Study||11
136358|NCT00846768|314441|P4|STARTED|Overall Study||12
136359|NCT00846768|314442|P3|STARTED|Overall Study||12
136360|NCT00846768|314443|P2|STARTED|Overall Study||12
136361|NCT00846768|314444|P1|STARTED|Overall Study||11
136362|NCT00846651|314516|P2|NOT COMPLETED|Overall Study||4
136363|NCT00846651|314517|P1|NOT COMPLETED|Overall Study||4
136364|NCT00846651|314516|P2|COMPLETED|Overall Study||37
136365|NCT00846651|314517|P1|COMPLETED|Overall Study||37
136366|NCT00846651|314516|P2|STARTED|Overall Study||41
136367|NCT00846651|314517|P1|STARTED|Overall Study||41
136368|NCT00846586|314533|P2|NOT COMPLETED|Overall Study||35
136369|NCT00846586|314534|P1|NOT COMPLETED|Overall Study||39
136370|NCT00846586|314533|P2|COMPLETED|Overall Study||529
136371|NCT00846586|314534|P1|COMPLETED|Overall Study||531
136372|NCT00846586|314533|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
136373|NCT00846586|314534|P1|Received Study Drug|Overall Study||570
136374|NCT00846586|314533|P2|STARTED|Overall Study||564
136375|NCT00846586|314534|P1|STARTED|Overall Study||570
136376|NCT00846573|314553|P4|NOT COMPLETED|Overall Study||0
136377|NCT00846573|314554|P3|NOT COMPLETED|Overall Study||0
136378|NCT00846573|314555|P2|NOT COMPLETED|Overall Study||0
136379|NCT00846573|314556|P1|NOT COMPLETED|Overall Study||0
136380|NCT00846573|314553|P4|COMPLETED|Overall Study||0
136381|NCT00846573|314554|P3|COMPLETED|Overall Study||7
136382|NCT00846573|314555|P2|COMPLETED|Overall Study||2
136383|NCT00846573|314556|P1|COMPLETED|Overall Study||5
136384|NCT00846573|314553|P4|STARTED|Overall Study||0
136385|NCT00846573|314554|P3|STARTED|Overall Study||7
136386|NCT00846573|314555|P2|STARTED|Overall Study||2
136387|NCT00846573|314556|P1|STARTED|Overall Study||5
136388|NCT00846547|314564|P1|NOT COMPLETED|Overall Study||7
136389|NCT00846547|314564|P1|COMPLETED|Overall Study||25
136390|NCT00846547|314564|P1|STARTED|Overall Study||32
136391|NCT00846521|314568|P1|NOT COMPLETED|Overall Study||11
136392|NCT00846521|314568|P1|COMPLETED|Overall Study||12
136393|NCT00846521|314568|P1|STARTED|Overall Study||23
136394|NCT00846495|314575|P2|NOT COMPLETED|Overall Study||3
136395|NCT00846495|314576|P1|NOT COMPLETED|Overall Study||8
136396|NCT00846495|314575|P2|COMPLETED|Overall Study||24
136397|NCT00846495|314576|P1|COMPLETED|Overall Study||20
136398|NCT00846495|314575|P2|STARTED|Overall Study||27
136399|NCT00846495|314576|P1|STARTED|Overall Study||28
136400|NCT00846391|314599|P3|NOT COMPLETED|Overall Study||3
136401|NCT00846391|314600|P2|NOT COMPLETED|Overall Study||2
136402|NCT00846391|314601|P1|NOT COMPLETED|Overall Study||1
136403|NCT00846391|314599|P3|COMPLETED|Overall Study||3
136404|NCT00846391|314600|P2|COMPLETED|Overall Study||2
136405|NCT00846391|314601|P1|COMPLETED|Overall Study||3
136406|NCT00846391|314599|P3|STARTED|Overall Study||6
136407|NCT00846391|314600|P2|STARTED|Overall Study||4
136408|NCT00846391|314601|P1|STARTED|Overall Study||4
136409|NCT00846365|314612|P3|NOT COMPLETED|Overall Study||33
136410|NCT00846365|314613|P2|NOT COMPLETED|Overall Study||49
136411|NCT00846365|314614|P1|NOT COMPLETED|Overall Study||55
136412|NCT00846365|314612|P3|COMPLETED|Overall Study||323
136413|NCT00846365|314613|P2|COMPLETED|Overall Study||308
136414|NCT00846365|314614|P1|COMPLETED|Overall Study||317
136415|NCT00846365|314612|P3|STARTED|Overall Study||356
136416|NCT00846365|314613|P2|STARTED|Overall Study||357
136417|NCT00846365|314614|P1|STARTED|Overall Study||372
136418|NCT00846287|314669|P2|NOT COMPLETED|Overall Study||5
136419|NCT00846287|314670|P1|NOT COMPLETED|Overall Study||10
136420|NCT00846287|314669|P2|COMPLETED|Overall Study||10
136421|NCT00846287|314670|P1|COMPLETED|Overall Study||6
136422|NCT00846287|314669|P2|STARTED|Overall Study||15
136423|NCT00846287|314670|P1|STARTED|Overall Study||16
136424|NCT00846066|314680|P2|NOT COMPLETED|Overall Study||0
136425|NCT00846066|314681|P1|NOT COMPLETED|Overall Study||0
136426|NCT00846066|314680|P2|COMPLETED|Overall Study||29
136427|NCT00846066|314681|P1|COMPLETED|Overall Study||27
136428|NCT00846066|314680|P2|STARTED|Overall Study||29
136429|NCT00846066|314681|P1|STARTED|Overall Study||27
136430|NCT00846027|314693|P1|NOT COMPLETED|Overall Study||90
136431|NCT00846027|314693|P1|COMPLETED|Overall Study||0
136432|NCT00846027|314693|P1|Received Treatment|Overall Study||83
136433|NCT00846027|314693|P1|STARTED|Overall Study||90
136434|NCT00845975|314702|P2|NOT COMPLETED|Overall Study||0
136435|NCT00845975|314703|P1|NOT COMPLETED|Overall Study||0
136436|NCT00845975|314702|P2|COMPLETED|Overall Study||9
136437|NCT00845975|314703|P1|COMPLETED|Overall Study||9
136438|NCT00845975|314702|P2|STARTED|Overall Study||9
136439|NCT00845975|314703|P1|STARTED|Overall Study||9
136440|NCT00845897|314716|P3|NOT COMPLETED|Overall Study||3
136441|NCT00845897|314717|P2|NOT COMPLETED|Overall Study||5
136442|NCT00845897|314718|P1|NOT COMPLETED|Overall Study||2
136443|NCT00845897|314716|P3|COMPLETED|Overall Study||2
136444|NCT00845897|314717|P2|COMPLETED|Overall Study||2
136445|NCT00845897|314718|P1|COMPLETED|Overall Study||3
136446|NCT00845897|314716|P3|STARTED|Overall Study||5
136447|NCT00845897|314717|P2|STARTED|Overall Study||7
136448|NCT00845897|314718|P1|STARTED|Overall Study||5
136449|NCT00845858|314732|P3|NOT COMPLETED|Overall Study||8
136450|NCT00845858|314733|P2|NOT COMPLETED|Overall Study||12
136451|NCT00845858|314734|P1|NOT COMPLETED|Overall Study||8
136452|NCT00845858|314732|P3|COMPLETED|Overall Study||87
136453|NCT00845858|314733|P2|COMPLETED|Overall Study||84
136454|NCT00845858|314734|P1|COMPLETED|Overall Study||88
136455|NCT00845858|314732|P3|STARTED|Overall Study||95
136456|NCT00845858|314733|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
136457|NCT00845858|314734|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
136458|NCT00845845|314747|P2|NOT COMPLETED|Overall Study||4
136459|NCT00845845|314748|P1|NOT COMPLETED|Overall Study||0
136460|NCT00845845|314747|P2|COMPLETED|Overall Study||2
136461|NCT00845845|314748|P1|COMPLETED|Overall Study||3
136462|NCT00845845|314747|P2|STARTED|Overall Study||6
136463|NCT00845845|314748|P1|STARTED|Overall Study||3
136464|NCT00845832|314759|P3|NOT COMPLETED|Extended Safety Follow-Up||7
136465|NCT00845832|314760|P2|NOT COMPLETED|Extended Safety Follow-Up||0
136466|NCT00845832|314761|P1|NOT COMPLETED|Extended Safety Follow-Up||0
136467|NCT00845832|314759|P3|COMPLETED|Extended Safety Follow-Up||0
136468|NCT00845832|314760|P2|COMPLETED|Extended Safety Follow-Up||5
136469|NCT00845832|314761|P1|COMPLETED|Extended Safety Follow-Up||2
136470|NCT00845832|314759|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
136471|NCT00845832|314760|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
136472|NCT00845832|314761|P1|STARTED|Extended Safety Follow-Up||2
136473|NCT00845832|314759|P3|NOT COMPLETED|Safety Follow-Up||0
136474|NCT00845832|314760|P2|NOT COMPLETED|Safety Follow-Up||0
136475|NCT00845832|314761|P1|NOT COMPLETED|Safety Follow-Up||1
136476|NCT00845832|314759|P3|COMPLETED|Safety Follow-Up||12
136477|NCT00845832|314760|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
136478|NCT00845832|314761|P1|COMPLETED|Safety Follow-Up||2
136479|NCT00845832|314759|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
136480|NCT00845832|314760|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
136481|NCT00845832|314761|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
136482|NCT00845832|314759|P3|NOT COMPLETED|Treatment Period||0
136483|NCT00845832|314760|P2|NOT COMPLETED|Treatment Period||3
136484|NCT00845832|314761|P1|NOT COMPLETED|Treatment Period||1
136485|NCT00845832|314759|P3|COMPLETED|Treatment Period||10
136486|NCT00845832|314760|P2|COMPLETED|Treatment Period||7
136487|NCT00845832|314761|P1|COMPLETED|Treatment Period||3
136488|NCT00845832|314759|P3|STARTED|Treatment Period||10
136489|NCT00845832|314760|P2|STARTED|Treatment Period||10
136490|NCT00845832|314761|P1|STARTED|Treatment Period||4
136491|NCT00845728|314807|P2|NOT COMPLETED|Overall Study||342
136492|NCT00845728|314808|P1|NOT COMPLETED|Overall Study||386
136493|NCT00845728|314807|P2|COMPLETED|Overall Study||1379
136494|NCT00845728|314808|P1|COMPLETED|Overall Study||1337
136495|NCT00845728|314807|P2|Exposed|Overall Study||1718
136496|NCT00845728|314808|P1|Exposed|Overall Study||1721
136497|NCT00845728|314807|P2|STARTED|Overall Study||1721
136498|NCT00845728|314808|P1|STARTED|Overall Study||1723
136499|NCT00845702|314816|P1|NOT COMPLETED|Dotarem MRA||0
136500|NCT00845702|314816|P1|COMPLETED|Dotarem MRA||32
136501|NCT00845702|314816|P1|STARTED|Dotarem MRA||32
136502|NCT00845702|314816|P1|NOT COMPLETED|TOF MRA||1
136503|NCT00845702|314816|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
136504|NCT00845702|314816|P1|STARTED|TOF MRA||33
136505|NCT00845676|314822|P1|NOT COMPLETED|Overall Study||2
136506|NCT00845676|314822|P1|COMPLETED|Overall Study||19
136507|NCT00845676|314822|P1|STARTED|Overall Study||21
136508|NCT00845663|314828|P2|NOT COMPLETED|Overall Study||0
136509|NCT00845663|314829|P1|NOT COMPLETED|Overall Study||0
136510|NCT00845663|314828|P2|COMPLETED|Overall Study||49
136511|NCT00845663|314829|P1|COMPLETED|Overall Study||49
136512|NCT00845663|314828|P2|STARTED|Overall Study||49
136513|NCT00845663|314829|P1|STARTED|Overall Study||49
136514|NCT00845429|314880|P3|NOT COMPLETED|Overall Study||20
136515|NCT00845429|314881|P2|NOT COMPLETED|Overall Study||15
136516|NCT00845429|314882|P1|NOT COMPLETED|Overall Study||14
136517|NCT00845429|314880|P3|COMPLETED|Overall Study||224
136518|NCT00845429|314881|P2|COMPLETED|Overall Study||226
136519|NCT00845429|314882|P1|COMPLETED|Overall Study||230
136520|NCT00845429|314880|P3|STARTED|Overall Study||244
136521|NCT00845429|314881|P2|STARTED|Overall Study||241
136522|NCT00845429|314882|P1|STARTED|Overall Study||244
136523|NCT00845195|314901|P2|NOT COMPLETED|Overall Study||0
136524|NCT00845195|314902|P1|NOT COMPLETED|Overall Study||0
136525|NCT00845195|314901|P2|COMPLETED|Overall Study||75
136526|NCT00845195|314902|P1|COMPLETED|Overall Study||75
136527|NCT00845195|314901|P2|STARTED|Overall Study||75
136528|NCT00845195|314902|P1|STARTED|Overall Study||75
136529|NCT00845182|314917|P3|NOT COMPLETED|Overall Study||6
136530|NCT00845182|314918|P2|NOT COMPLETED|Overall Study||4
136531|NCT00845182|314919|P1|NOT COMPLETED|Overall Study||3
136532|NCT00845182|314917|P3|COMPLETED|Overall Study||9
136533|NCT00845182|314918|P2|COMPLETED|Overall Study||11
136534|NCT00845182|314919|P1|COMPLETED|Overall Study||10
136535|NCT00845182|314917|P3|STARTED|Overall Study||15
136536|NCT00845182|314918|P2|STARTED|Overall Study||15
136537|NCT00845182|314919|P1|STARTED|Overall Study||13
136538|NCT00845130|314932|P2|NOT COMPLETED|Overall Study||3
136539|NCT00845130|314933|P1|NOT COMPLETED|Overall Study||4
136540|NCT00845130|314932|P2|COMPLETED|Overall Study||19
136541|NCT00845130|314933|P1|COMPLETED|Overall Study||16
136542|NCT00845130|314932|P2|STARTED|Overall Study||22
136543|NCT00845130|314933|P1|STARTED|Overall Study||20
136544|NCT00845065|314943|P2|NOT COMPLETED|Overall Study||55
136545|NCT00845065|314944|P1|NOT COMPLETED|Overall Study||47
136546|NCT00845065|314943|P2|COMPLETED|Overall Study||79
136547|NCT00845065|314944|P1|COMPLETED|Overall Study||20
136548|NCT00845065|314943|P2|STARTED|Overall Study||134
136549|NCT00845065|314944|P1|STARTED|Overall Study||67
136550|NCT00845000|314964|P6|NOT COMPLETED|Period 3||0
136551|NCT00845000|314965|P5|NOT COMPLETED|Period 3||0
136552|NCT00845000|314966|P4|NOT COMPLETED|Period 3||0
136553|NCT00845000|314967|P3|NOT COMPLETED|Period 3||0
136554|NCT00845000|314968|P2|NOT COMPLETED|Period 3||0
136555|NCT00845000|314969|P1|NOT COMPLETED|Period 3||0
136556|NCT00845000|314964|P6|COMPLETED|Period 3||2
136557|NCT00845000|314965|P5|COMPLETED|Period 3||2
136558|NCT00845000|314966|P4|COMPLETED|Period 3||2
136559|NCT00845000|314967|P3|COMPLETED|Period 3||2
136560|NCT00845000|314968|P2|COMPLETED|Period 3||2
136561|NCT00845000|314969|P1|COMPLETED|Period 3||2
136562|NCT00845000|314964|P6|STARTED|Period 3||2
136563|NCT00845000|314965|P5|STARTED|Period 3||2
136564|NCT00845000|314966|P4|STARTED|Period 3||2
136565|NCT00845000|314967|P3|STARTED|Period 3||2
136566|NCT00845000|314968|P2|STARTED|Period 3||2
136567|NCT00845000|314969|P1|STARTED|Period 3||2
136568|NCT00845000|314964|P6|NOT COMPLETED|Period 2||0
136569|NCT00845000|314965|P5|NOT COMPLETED|Period 2||0
136570|NCT00845000|314966|P4|NOT COMPLETED|Period 2||0
136571|NCT00845000|314967|P3|NOT COMPLETED|Period 2||0
136572|NCT00845000|314968|P2|NOT COMPLETED|Period 2||0
136573|NCT00845000|314969|P1|NOT COMPLETED|Period 2||0
136574|NCT00845000|314964|P6|COMPLETED|Period 2||2
136575|NCT00845000|314965|P5|COMPLETED|Period 2||2
136576|NCT00845000|314966|P4|COMPLETED|Period 2||2
136577|NCT00845000|314967|P3|COMPLETED|Period 2||2
136578|NCT00845000|314968|P2|COMPLETED|Period 2||2
136579|NCT00845000|314969|P1|COMPLETED|Period 2||2
136580|NCT00845000|314964|P6|STARTED|Period 2||2
136581|NCT00845000|314965|P5|STARTED|Period 2||2
136582|NCT00845000|314966|P4|STARTED|Period 2||2
136583|NCT00845000|314967|P3|STARTED|Period 2||2
136584|NCT00845000|314968|P2|STARTED|Period 2||2
136585|NCT00845000|314969|P1|STARTED|Period 2||2
136586|NCT00845000|314964|P6|NOT COMPLETED|Period 1||0
136587|NCT00845000|314965|P5|NOT COMPLETED|Period 1||0
136588|NCT00845000|314966|P4|NOT COMPLETED|Period 1||0
136589|NCT00845000|314967|P3|NOT COMPLETED|Period 1||0
136590|NCT00845000|314968|P2|NOT COMPLETED|Period 1||0
136591|NCT00845000|314969|P1|NOT COMPLETED|Period 1||0
136592|NCT00845000|314964|P6|COMPLETED|Period 1||2
136593|NCT00845000|314965|P5|COMPLETED|Period 1||2
136594|NCT00845000|314966|P4|COMPLETED|Period 1||2
136595|NCT00845000|314967|P3|COMPLETED|Period 1||2
136596|NCT00845000|314968|P2|COMPLETED|Period 1||2
136597|NCT00845000|314969|P1|COMPLETED|Period 1||2
136598|NCT00845000|314964|P6|STARTED|Period 1||2
136599|NCT00845000|314965|P5|STARTED|Period 1||2
136600|NCT00845000|314966|P4|STARTED|Period 1||2
136601|NCT00845000|314967|P3|STARTED|Period 1||2
136602|NCT00845000|314968|P2|STARTED|Period 1||2
136603|NCT00845000|314969|P1|STARTED|Period 1||2
136604|NCT00844896|314988|P2|NOT COMPLETED|Overall Study||17
136605|NCT00844896|314989|P1|NOT COMPLETED|Overall Study||12
136606|NCT00844896|314988|P2|COMPLETED|Overall Study||11
136607|NCT00844896|314989|P1|COMPLETED|Overall Study||17
136608|NCT00844896|314988|P2|STARTED|Overall Study||28
136609|NCT00844896|314989|P1|STARTED|Overall Study||29
136610|NCT00844857|315013|P2|NOT COMPLETED|Overall Study||37
136611|NCT00844857|315014|P1|NOT COMPLETED|Overall Study||78
136612|NCT00844857|315013|P2|COMPLETED|Overall Study||60
136613|NCT00844857|315014|P1|COMPLETED|Overall Study||116
136614|NCT00844857|315013|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
136615|NCT00844857|315014|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
136616|NCT00844857|315013|P2|STARTED|Overall Study||97
136617|NCT00844857|315014|P1|STARTED|Overall Study||194
136618|NCT00844844|315058|P1|NOT COMPLETED|Post Treatment Period||1
136619|NCT00844844|315058|P1|COMPLETED|Post Treatment Period||5
136620|NCT00844844|315058|P1|STARTED|Post Treatment Period||6
136621|NCT00844844|315058|P1|NOT COMPLETED|Extension Treatment Period||2
136622|NCT00844844|315058|P1|COMPLETED|Extension Treatment Period||11
136623|NCT00844844|315058|P1|STARTED|Extension Treatment Period||13
136624|NCT00844844|315058|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
136625|NCT00844844|315058|P1|COMPLETED|Treatment Period (26 Weeks)||15
136626|NCT00844844|315058|P1|STARTED|Treatment Period (26 Weeks)||17
136627|NCT00844844|315058|P1|NOT COMPLETED|Screening Period||0
136628|NCT00844844|315058|P1|COMPLETED|Screening Period||17
136629|NCT00844844|315058|P1|STARTED|Screening Period||17
136630|NCT00844805|315074|P4|NOT COMPLETED|Follow-Up Phase||9
136631|NCT00844805|315075|P3|NOT COMPLETED|Follow-Up Phase||9
136632|NCT00844805|315076|P2|NOT COMPLETED|Follow-Up Phase||0
136633|NCT00844805|315077|P1|NOT COMPLETED|Follow-Up Phase||0
136634|NCT00844805|315074|P4|COMPLETED|Follow-Up Phase||32
136635|NCT00844805|315075|P3|COMPLETED|Follow-Up Phase||32
136636|NCT00844805|315076|P2|COMPLETED|Follow-Up Phase||0
136637|NCT00844805|315077|P1|COMPLETED|Follow-Up Phase||0
136638|NCT00844805|315074|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
136639|NCT00844805|315075|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
136640|NCT00844805|315076|P2|STARTED|Follow-Up Phase||0
136641|NCT00844805|315077|P1|STARTED|Follow-Up Phase||0
136642|NCT00844805|315074|P4|NOT COMPLETED|Treatment Phase||0
136643|NCT00844805|315075|P3|NOT COMPLETED|Treatment Phase||0
136644|NCT00844805|315076|P2|NOT COMPLETED|Treatment Phase||7
136645|NCT00844805|315077|P1|NOT COMPLETED|Treatment Phase||10
136646|NCT00844805|315074|P4|COMPLETED|Treatment Phase||0
136647|NCT00844805|315075|P3|COMPLETED|Treatment Phase||0
136648|NCT00844805|315076|P2|COMPLETED|Treatment Phase||45
136649|NCT00844805|315077|P1|COMPLETED|Treatment Phase||96
136650|NCT00844805|315074|P4|STARTED|Treatment Phase||0
136651|NCT00844805|315075|P3|STARTED|Treatment Phase||0
136652|NCT00844805|315076|P2|STARTED|Treatment Phase||52
136653|NCT00844805|315077|P1|STARTED|Treatment Phase||106
136654|NCT00844753|315121|P4|NOT COMPLETED|Overall Study||11
136655|NCT00844753|315122|P3|NOT COMPLETED|Overall Study||7
136656|NCT00844753|315123|P2|NOT COMPLETED|Overall Study||3
136657|NCT00844753|315124|P1|NOT COMPLETED|Overall Study||8
136658|NCT00844753|315121|P4|COMPLETED|Overall Study||21
136659|NCT00844753|315122|P3|COMPLETED|Overall Study||25
136660|NCT00844753|315123|P2|COMPLETED|Overall Study||29
136661|NCT00844753|315124|P1|COMPLETED|Overall Study||24
136662|NCT00844753|315121|P4|STARTED|Overall Study||32
136663|NCT00844753|315122|P3|STARTED|Overall Study||32
136664|NCT00844753|315123|P2|STARTED|Overall Study||32
136665|NCT00844753|315124|P1|STARTED|Overall Study||32
136666|NCT00844714|315136|P1|NOT COMPLETED|Overall Study||0
136667|NCT00844714|315136|P1|COMPLETED|Overall Study||20
136668|NCT00844714|315136|P1|STARTED|Overall Study||20
136669|NCT00844649|315142|P2|NOT COMPLETED|Overall Study||418
136670|NCT00844649|315143|P1|NOT COMPLETED|Overall Study||405
136671|NCT00844649|315142|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
136672|NCT00844649|315143|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
136673|NCT00844649|315142|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
136674|NCT00844649|315143|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
136675|NCT00844649|315142|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
136676|NCT00844649|315143|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
136677|NCT00844597|315167|P6|NOT COMPLETED|Overall Study||0
136678|NCT00844597|315168|P5|NOT COMPLETED|Overall Study||0
136679|NCT00844597|315169|P4|NOT COMPLETED|Overall Study||1
136680|NCT00844597|315170|P3|NOT COMPLETED|Overall Study||0
136681|NCT00844597|315171|P2|NOT COMPLETED|Overall Study||0
136682|NCT00844597|315172|P1|NOT COMPLETED|Overall Study||0
136683|NCT00844597|315167|P6|COMPLETED|Overall Study||4
136684|NCT00844597|315168|P5|COMPLETED|Overall Study||4
136685|NCT00844597|315169|P4|COMPLETED|Overall Study||2
136686|NCT00844597|315170|P3|COMPLETED|Overall Study||2
136687|NCT00844597|315171|P2|COMPLETED|Overall Study||2
136688|NCT00844597|315172|P1|COMPLETED|Overall Study||4
136689|NCT00844597|315167|P6|STARTED|Overall Study||4
136690|NCT00844597|315168|P5|STARTED|Overall Study||4
136691|NCT00844597|315169|P4|STARTED|Overall Study||3
136692|NCT00844597|315170|P3|STARTED|Overall Study||2
136693|NCT00844597|315171|P2|STARTED|Overall Study||2
136694|NCT00844597|315172|P1|STARTED|Overall Study||4
136695|NCT00844558|315192|P2|NOT COMPLETED|Overall Study||4
136696|NCT00844558|315193|P1|NOT COMPLETED|Overall Study||12
136697|NCT00844558|315192|P2|COMPLETED|Overall Study||18
136698|NCT00844558|315193|P1|COMPLETED|Overall Study||24
136699|NCT00844558|315192|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
136700|NCT00844558|315193|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
136701|NCT00844558|315192|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
136702|NCT00844558|315193|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
136703|NCT00844558|315192|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
136704|NCT00844558|315193|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
136705|NCT00844558|315192|P2|Received Allocated Intervention|Overall Study||21
136706|NCT00844558|315193|P1|Received Allocated Intervention|Overall Study||33
136707|NCT00844558|315192|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
136708|NCT00844558|315193|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
136709|NCT00844545|315209|P1|NOT COMPLETED|Post Treatment Period||1
136710|NCT00844545|315209|P1|COMPLETED|Post Treatment Period||5
136711|NCT00844545|315209|P1|STARTED|Post Treatment Period||6
136712|NCT00844545|315209|P1|NOT COMPLETED|Extension Treatment Period||2
136713|NCT00844545|315209|P1|COMPLETED|Extension Treatment Period||11
136714|NCT00844545|315209|P1|STARTED|Extension Treatment Period||13
136715|NCT00844545|315209|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
136716|NCT00844545|315209|P1|COMPLETED|Treatment Period (26 Weeks)||15
136717|NCT00844545|315209|P1|STARTED|Treatment Period (26 Weeks)||17
136718|NCT00844545|315209|P1|NOT COMPLETED|Screening Period||0
136719|NCT00844545|315209|P1|COMPLETED|Screening Period||17
136720|NCT00844545|315209|P1|STARTED|Screening Period||17
136721|NCT00844532|315223|P1|NOT COMPLETED|Overall Study||39
136722|NCT00844532|315223|P1|COMPLETED|Overall Study||112
136723|NCT00844532|315223|P1|STARTED|Overall Study||151
136724|NCT00844519|315309|P2|NOT COMPLETED|Overall Study||1
136725|NCT00844519|315310|P1|NOT COMPLETED|Overall Study||2
136726|NCT00844519|315309|P2|COMPLETED|Overall Study||25
136727|NCT00844519|315310|P1|COMPLETED|Overall Study||24
136728|NCT00844519|315309|P2|STARTED|Overall Study||26
136729|NCT00844519|315310|P1|STARTED|Overall Study||26
136730|NCT00844428|315316|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
136731|NCT00844428|315316|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
136732|NCT00844428|315316|P1|STARTED|Post Treatment Period (Patients Who Disc||5
136733|NCT00844428|315316|P1|NOT COMPLETED|Extension Treatment Period||1
136734|NCT00844428|315316|P1|COMPLETED|Extension Treatment Period||18
136735|NCT00844428|315316|P1|STARTED|Extension Treatment Period||19
136736|NCT00844428|315316|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
136737|NCT00844428|315316|P1|COMPLETED|Treatment Period (26 Weeks)||20
136738|NCT00844428|315316|P1|STARTED|Treatment Period (26 Weeks)||20
136739|NCT00844428|315316|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
136740|NCT00844428|315316|P1|COMPLETED|Observation Period (8 Weeks)||20
136741|NCT00844428|315316|P1|STARTED|Observation Period (8 Weeks)||20
136742|NCT00844428|315316|P1|NOT COMPLETED|Screening Period||3
136743|NCT00844428|315316|P1|COMPLETED|Screening Period||20
136744|NCT00844428|315316|P1|STARTED|Screening Period||23
136745|NCT00844415|315332|P1|NOT COMPLETED|Overall Study||1
136746|NCT00844415|315332|P1|COMPLETED|Overall Study|Completed.|8
136747|NCT00844415|315332|P1|Pat. Received Single Dose 75mg|Overall Study||1
136748|NCT00844415|315332|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
136749|NCT00844415|315332|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
136750|NCT00844415|315332|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
136751|NCT00844415|315332|P1|STARTED|Overall Study|Entered and treated.|9
136752|NCT00844376|315346|P2|NOT COMPLETED|Period 2: Second Intervention||0
136753|NCT00844376|315347|P1|NOT COMPLETED|Period 2: Second Intervention||0
136754|NCT00844376|315346|P2|COMPLETED|Period 2: Second Intervention||6
136755|NCT00844376|315347|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
136756|NCT00844376|315346|P2|STARTED|Period 2: Second Intervention||6
136757|NCT00844376|315347|P1|STARTED|Period 2: Second Intervention||5
136758|NCT00844376|315346|P2|NOT COMPLETED|Period 1: First Intervention||0
136759|NCT00844376|315347|P1|NOT COMPLETED|Period 1: First Intervention||1
136760|NCT00844376|315346|P2|COMPLETED|Period 1: First Intervention||6
136761|NCT00844376|315347|P1|COMPLETED|Period 1: First Intervention||5
136762|NCT00844376|315346|P2|STARTED|Period 1: First Intervention||6
136763|NCT00844376|315347|P1|STARTED|Period 1: First Intervention||6
136764|NCT00844298|315365|P1|NOT COMPLETED|Overall Study||0
136765|NCT00844298|315365|P1|COMPLETED|Overall Study||91
136766|NCT00844298|315365|P1|STARTED|Overall Study||91
136767|NCT00844194|315371|P2|NOT COMPLETED|Overall Study||8
136768|NCT00844194|315372|P1|NOT COMPLETED|Overall Study||25
136769|NCT00844194|315371|P2|COMPLETED|Overall Study||22
136770|NCT00844194|315372|P1|COMPLETED|Overall Study||53
136771|NCT00844194|315371|P2|STARTED|Overall Study||30
136772|NCT00844194|315372|P1|STARTED|Overall Study||78
136773|NCT00844090|315578|P2|NOT COMPLETED|Overall Study||8
136774|NCT00844090|315579|P1|NOT COMPLETED|Overall Study||6
136775|NCT00844090|315578|P2|COMPLETED|Overall Study||46
136776|NCT00844090|315579|P1|COMPLETED|Overall Study||46
136777|NCT00844090|315578|P2|STARTED|Overall Study||54
136778|NCT00844090|315579|P1|STARTED|Overall Study||52
136779|NCT00844051|315587|P2|NOT COMPLETED|Overall Study||0
136780|NCT00844051|315588|P1|NOT COMPLETED|Overall Study||0
136781|NCT00844051|315587|P2|COMPLETED|Overall Study||2368
136782|NCT00844051|315588|P1|COMPLETED|Overall Study||2087
136783|NCT00844051|315587|P2|STARTED|Overall Study||2368
136784|NCT00844051|315588|P1|STARTED|Overall Study||2087
136785|NCT00843986|315598|P2|NOT COMPLETED|Overall Study||1
136786|NCT00843986|315599|P1|NOT COMPLETED|Overall Study||1
136787|NCT00843986|315598|P2|COMPLETED|Overall Study||5
136788|NCT00843986|315599|P1|COMPLETED|Overall Study||2
136789|NCT00843986|315598|P2|Completed Treatment (Infusion)|Overall Study||6
136790|NCT00843986|315599|P1|Completed Treatment (Infusion)|Overall Study||2
136791|NCT00843986|315598|P2|STARTED|Overall Study||6
136792|NCT00843986|315599|P1|STARTED|Overall Study||3
136793|NCT00843843|315627|P2|NOT COMPLETED|Overall Study||2
136794|NCT00843843|315628|P1|NOT COMPLETED|Overall Study||2
136795|NCT00843843|315627|P2|COMPLETED|Overall Study||6
136796|NCT00843843|315628|P1|COMPLETED|Overall Study||6
136797|NCT00843843|315627|P2|STARTED|Overall Study||8
136798|NCT00843843|315628|P1|STARTED|Overall Study||8
136799|NCT00843830|315636|P1|NOT COMPLETED|Overall Study||0
136800|NCT00843830|315636|P1|COMPLETED|Overall Study||4
136801|NCT00843830|315636|P1|STARTED|Overall Study||4
136802|NCT00843778|315641|P1|NOT COMPLETED|Overall Study||35
136803|NCT00843778|315641|P1|COMPLETED|Overall Study||96
136804|NCT00843778|315641|P1|STARTED|Overall Study||131
136805|NCT00843713|315676|P2|NOT COMPLETED|Overall Study||0
136806|NCT00843713|315677|P1|NOT COMPLETED|Overall Study||0
136807|NCT00843713|315676|P2|COMPLETED|Overall Study||26
136808|NCT00843713|315677|P1|COMPLETED|Overall Study||30
136809|NCT00843713|315676|P2|STARTED|Overall Study||26
136810|NCT00843713|315677|P1|STARTED|Overall Study||30
136811|NCT00843635|315686|P3|NOT COMPLETED|Overall Study||0
136812|NCT00843635|315687|P2|NOT COMPLETED|Overall Study||2
136813|NCT00843635|315688|P1|NOT COMPLETED|Overall Study||2
136814|NCT00843635|315686|P3|COMPLETED|Overall Study||5
136815|NCT00843635|315687|P2|COMPLETED|Overall Study||13
136816|NCT00843635|315688|P1|COMPLETED|Overall Study||13
136817|NCT00843635|315686|P3|STARTED|Overall Study||5
136818|NCT00843635|315687|P2|STARTED|Overall Study||15
136819|NCT00843635|315688|P1|STARTED|Overall Study||15
136820|NCT00843622|315708|P2|NOT COMPLETED|Overall Study||55
136821|NCT00843622|315709|P1|NOT COMPLETED|Overall Study||43
136822|NCT00843622|315708|P2|COMPLETED|Overall Study||70
136823|NCT00843622|315709|P1|COMPLETED|Overall Study||82
136824|NCT00843622|315708|P2|STARTED|Overall Study||125
136825|NCT00843622|315709|P1|STARTED|Overall Study||125
136826|NCT00843492|315717|P2|NOT COMPLETED|Overall Study||14
136827|NCT00843492|315718|P1|NOT COMPLETED|Overall Study||8
136828|NCT00843492|315717|P2|COMPLETED|Overall Study||607
136829|NCT00843492|315718|P1|COMPLETED|Overall Study||614
136830|NCT00843492|315717|P2|STARTED|Overall Study||621
136831|NCT00843492|315718|P1|STARTED|Overall Study||622
136832|NCT00843479|315738|P2|NOT COMPLETED|Overall Study||0
136833|NCT00843479|315739|P1|NOT COMPLETED|Overall Study||0
136834|NCT00843479|315738|P2|COMPLETED|Overall Study||12
136835|NCT00843479|315739|P1|COMPLETED|Overall Study||12
136836|NCT00843479|315738|P2|STARTED|Overall Study||12
136837|NCT00843479|315739|P1|STARTED|Overall Study||12
136838|NCT00843349|315759|P4|NOT COMPLETED|Overall Study||1
136839|NCT00843349|315760|P3|NOT COMPLETED|Overall Study||0
136840|NCT00843349|315761|P2|NOT COMPLETED|Overall Study||0
136841|NCT00843349|315762|P1|NOT COMPLETED|Overall Study||3
136842|NCT00843349|315759|P4|COMPLETED|Overall Study||10
136843|NCT00843349|315760|P3|COMPLETED|Overall Study||10
136844|NCT00843349|315761|P2|COMPLETED|Overall Study||11
136845|NCT00843349|315762|P1|COMPLETED|Overall Study||8
136846|NCT00843349|315759|P4|STARTED|Overall Study||11
136847|NCT00843349|315760|P3|STARTED|Overall Study||10
136848|NCT00843349|315761|P2|STARTED|Overall Study||11
136849|NCT00843349|315762|P1|STARTED|Overall Study||11
136850|NCT00843310|315776|P1|NOT COMPLETED|Overall Study||7
136851|NCT00843310|315776|P1|COMPLETED|Overall Study||1
136852|NCT00843310|315776|P1|STARTED|Overall Study||8
136853|NCT00843284|315783|P1|NOT COMPLETED|Overall Study||72
136854|NCT00843284|315783|P1|COMPLETED|Overall Study||619
136855|NCT00843284|315783|P1|STARTED|Overall Study||691
136856|NCT00843180|315793|P2|NOT COMPLETED|Overall Study||0
136857|NCT00843180|315794|P1|NOT COMPLETED|Overall Study||0
136858|NCT00843180|315793|P2|COMPLETED|Overall Study||7
136859|NCT00843180|315794|P1|COMPLETED|Overall Study||16
136860|NCT00843180|315793|P2|STARTED|Overall Study||7
136861|NCT00843180|315794|P1|STARTED|Overall Study||16
136862|NCT00843167|315808|P2|NOT COMPLETED|Follow-up||0
136863|NCT00843167|315809|P1|NOT COMPLETED|Follow-up||0
136864|NCT00843167|315808|P2|COMPLETED|Follow-up||24
136865|NCT00843167|315809|P1|COMPLETED|Follow-up||24
136866|NCT00843167|315808|P2|Completed Final Visit|Follow-up||24
136867|NCT00843167|315809|P1|Completed Final Visit|Follow-up||24
136868|NCT00843167|315808|P2|STARTED|Follow-up||24
136869|NCT00843167|315809|P1|STARTED|Follow-up||24
136870|NCT00843167|315808|P2|NOT COMPLETED|Treatment Period||8
136871|NCT00843167|315809|P1|NOT COMPLETED|Treatment Period||3
136872|NCT00843167|315808|P2|COMPLETED|Treatment Period||19
136873|NCT00843167|315809|P1|COMPLETED|Treatment Period||24
136874|NCT00843167|315808|P2|STARTED|Treatment Period||27
136875|NCT00843167|315809|P1|STARTED|Treatment Period||27
136876|NCT00843115|315822|P1|NOT COMPLETED|Overall Study||66
136877|NCT00843115|315822|P1|COMPLETED|Overall Study||304
136878|NCT00843115|315822|P1|STARTED|Overall Study||370
136879|NCT00843050|315868|P1|NOT COMPLETED|Overall Study||13
136880|NCT00843050|315868|P1|COMPLETED|Overall Study||0
136881|NCT00843050|315868|P1|STARTED|Overall Study||13
136882|NCT00843024|315878|P6|NOT COMPLETED|Double-blind Treatment Phase||25
136883|NCT00843024|315879|P5|NOT COMPLETED|Double-blind Treatment Phase||20
136884|NCT00843024|315880|P4|NOT COMPLETED|Double-blind Treatment Phase||23
136885|NCT00843024|315881|P3|NOT COMPLETED|Double-blind Treatment Phase||31
136886|NCT00843024|315882|P2|NOT COMPLETED|Double-blind Treatment Phase||0
136887|NCT00843024|315883|P1|NOT COMPLETED|Double-blind Treatment Phase||0
136888|NCT00843024|315878|P6|COMPLETED|Double-blind Treatment Phase||152
136889|NCT00843024|315879|P5|COMPLETED|Double-blind Treatment Phase||97
136890|NCT00843024|315880|P4|COMPLETED|Double-blind Treatment Phase||96
136891|NCT00843024|315881|P3|COMPLETED|Double-blind Treatment Phase||145
136892|NCT00843024|315882|P2|COMPLETED|Double-blind Treatment Phase||0
136893|NCT00843024|315883|P1|COMPLETED|Double-blind Treatment Phase||0
136894|NCT00843024|315878|P6|STARTED|Double-blind Treatment Phase||177
136895|NCT00843024|315879|P5|STARTED|Double-blind Treatment Phase||117
136896|NCT00843024|315880|P4|STARTED|Double-blind Treatment Phase||119
136897|NCT00843024|315881|P3|STARTED|Double-blind Treatment Phase||176
136898|NCT00843024|315882|P2|STARTED|Double-blind Treatment Phase||0
136899|NCT00843024|315883|P1|STARTED|Double-blind Treatment Phase||0
136900|NCT00843024|315878|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
136901|NCT00843024|315879|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
136902|NCT00843024|315880|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
136903|NCT00843024|315881|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
136904|NCT00843024|315882|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
136905|NCT00843024|315883|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
136906|NCT00843024|315878|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
136907|NCT00843024|315879|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
136908|NCT00843024|315880|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
136909|NCT00843024|315881|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
136910|NCT00843024|315882|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
136911|NCT00843024|315883|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
136912|NCT00843024|315878|P6|STARTED|Single-blind Placebo Run-In Phase||0
136913|NCT00843024|315879|P5|STARTED|Single-blind Placebo Run-In Phase||0
136914|NCT00843024|315880|P4|STARTED|Single-blind Placebo Run-In Phase||0
136915|NCT00843024|315881|P3|STARTED|Single-blind Placebo Run-In Phase||0
136916|NCT00843024|315882|P2|STARTED|Single-blind Placebo Run-In Phase||457
136917|NCT00843024|315883|P1|STARTED|Single-blind Placebo Run-In Phase||408
136918|NCT00842985|315948|P1|NOT COMPLETED|Fourth Intervention||0
136919|NCT00842985|315948|P1|COMPLETED|Fourth Intervention||15
136920|NCT00842985|315948|P1|STARTED|Fourth Intervention||15
136921|NCT00842985|315948|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
136922|NCT00842985|315948|P1|COMPLETED|Washout Period of GE 4 Days||15
136923|NCT00842985|315948|P1|STARTED|Washout Period of GE 4 Days||15
136924|NCT00842985|315948|P1|NOT COMPLETED|Third Intervention||0
136925|NCT00842985|315948|P1|COMPLETED|Third Intervention||15
136926|NCT00842985|315948|P1|STARTED|Third Intervention||15
136927|NCT00842985|315948|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
136928|NCT00842985|315948|P1|COMPLETED|Washout Period of GE 4 Days||15
136929|NCT00842985|315948|P1|STARTED|Washout Period of GE 4 Days||17
136930|NCT00842985|315948|P1|NOT COMPLETED|Second Intervention||1
136931|NCT00842985|315948|P1|COMPLETED|Second Intervention||17
136932|NCT00842985|315948|P1|STARTED|Second Intervention||18
136933|NCT00842985|315948|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
136934|NCT00842985|315948|P1|COMPLETED|Washout Period of GE 4 Days||18
136935|NCT00842985|315948|P1|STARTED|Washout Period of GE 4 Days||20
136936|NCT00842985|315948|P1|NOT COMPLETED|First Intervention||6
136937|NCT00842985|315948|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
136938|NCT00842985|315948|P1|STARTED|First Intervention|Signed Consent|26
136939|NCT00842985|315948|P1|NOT COMPLETED|Screening||27
136940|NCT00842985|315948|P1|COMPLETED|Screening||26
136941|NCT00842985|315948|P1|STARTED|Screening||53
136942|NCT00842946|315957|P2|NOT COMPLETED|Overall Study||5
136943|NCT00842946|315958|P1|NOT COMPLETED|Overall Study||5
136944|NCT00842946|315957|P2|COMPLETED|Overall Study||19
136945|NCT00842946|315958|P1|COMPLETED|Overall Study||16
136946|NCT00842946|315957|P2|STARTED|Overall Study||24
136947|NCT00842946|315958|P1|STARTED|Overall Study||21
136948|NCT00842829|315966|P3|NOT COMPLETED|Continuation Period||61
136949|NCT00842829|315967|P2|NOT COMPLETED|Continuation Period||0
136950|NCT00842829|315968|P1|NOT COMPLETED|Continuation Period||0
136951|NCT00842829|315966|P3|COMPLETED|Continuation Period||27
136952|NCT00842829|315967|P2|COMPLETED|Continuation Period||0
136953|NCT00842829|315968|P1|COMPLETED|Continuation Period||0
136954|NCT00842829|315966|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
136955|NCT00842829|315967|P2|Continuation Safety Analysis Set|Continuation Period||0
136956|NCT00842829|315968|P1|Continuation Safety Analysis Set|Continuation Period||0
136957|NCT00842829|315966|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
136958|NCT00842829|315967|P2|STARTED|Continuation Period||0
136959|NCT00842829|315968|P1|STARTED|Continuation Period||0
136960|NCT00842829|315966|P3|NOT COMPLETED|Treatment Period||63
136961|NCT00842829|315967|P2|NOT COMPLETED|Treatment Period||0
136962|NCT00842829|315968|P1|NOT COMPLETED|Treatment Period||0
136963|NCT00842829|315966|P3|COMPLETED|Treatment Period||218
136964|NCT00842829|315967|P2|COMPLETED|Treatment Period||0
136965|NCT00842829|315968|P1|COMPLETED|Treatment Period||0
136966|NCT00842829|315966|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
136967|NCT00842829|315967|P2|Safety Analysis Set|Treatment Period||0
136968|NCT00842829|315968|P1|Safety Analysis Set|Treatment Period||0
136969|NCT00842829|315966|P3|STARTED|Treatment Period||281
136970|NCT00842829|315967|P2|STARTED|Treatment Period||0
136971|NCT00842829|315968|P1|STARTED|Treatment Period||0
136972|NCT00842829|315966|P3|NOT COMPLETED|Dose Titration Period||0
136973|NCT00842829|315967|P2|NOT COMPLETED|Dose Titration Period||23
136974|NCT00842829|315968|P1|NOT COMPLETED|Dose Titration Period||26
136975|NCT00842829|315966|P3|COMPLETED|Dose Titration Period||0
136976|NCT00842829|315967|P2|COMPLETED|Dose Titration Period||151
136977|NCT00842829|315968|P1|COMPLETED|Dose Titration Period||130
136978|NCT00842829|315966|P3|Titration Safety Analysis Set|Dose Titration Period||0
136979|NCT00842829|315967|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
136980|NCT00842829|315968|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
136981|NCT00842829|315966|P3|STARTED|Dose Titration Period||0
136982|NCT00842829|315967|P2|STARTED|Dose Titration Period||174
136983|NCT00842829|315968|P1|STARTED|Dose Titration Period||156
136984|NCT00842751|316002|P1|NOT COMPLETED|Overall Study||0
136985|NCT00842751|316002|P1|COMPLETED|Overall Study||11
136986|NCT00842751|316002|P1|STARTED|Overall Study||11
136987|NCT00842712|316023|P7|NOT COMPLETED|Randomized Part||6
136988|NCT00842712|316024|P6|NOT COMPLETED|Randomized Part||1
136989|NCT00842712|316025|P5|NOT COMPLETED|Randomized Part||0
136990|NCT00842712|316026|P4|NOT COMPLETED|Randomized Part||0
136991|NCT00842712|316027|P3|NOT COMPLETED|Randomized Part||0
136992|NCT00842712|316028|P2|NOT COMPLETED|Randomized Part||0
136993|NCT00842712|316029|P1|NOT COMPLETED|Randomized Part||0
136994|NCT00842712|316023|P7|COMPLETED|Randomized Part||78
136995|NCT00842712|316024|P6|COMPLETED|Randomized Part||50
136996|NCT00842712|316025|P5|COMPLETED|Randomized Part||85
136997|NCT00842712|316026|P4|COMPLETED|Randomized Part||0
136998|NCT00842712|316027|P3|COMPLETED|Randomized Part||0
136999|NCT00842712|316028|P2|COMPLETED|Randomized Part||0
137000|NCT00842712|316029|P1|COMPLETED|Randomized Part||0
137001|NCT00842712|316023|P7|Treated|Randomized Part||80
137002|NCT00842712|316024|P6|Treated|Randomized Part||50
137003|NCT00842712|316025|P5|Treated|Randomized Part||85
137004|NCT00842712|316026|P4|Treated|Randomized Part||0
137005|NCT00842712|316027|P3|Treated|Randomized Part||0
137006|NCT00842712|316028|P2|Treated|Randomized Part||0
137007|NCT00842712|316029|P1|Treated|Randomized Part||0
137008|NCT00842712|316023|P7|STARTED|Randomized Part||84
137009|NCT00842712|316024|P6|STARTED|Randomized Part||51
137010|NCT00842712|316025|P5|STARTED|Randomized Part||85
137011|NCT00842712|316026|P4|STARTED|Randomized Part||0
137012|NCT00842712|316027|P3|STARTED|Randomized Part||0
137013|NCT00842712|316028|P2|STARTED|Randomized Part||0
137014|NCT00842712|316029|P1|STARTED|Randomized Part||0
137015|NCT00842712|316023|P7|NOT COMPLETED|Safety Run-in Part||0
137016|NCT00842712|316024|P6|NOT COMPLETED|Safety Run-in Part||0
137017|NCT00842712|316025|P5|NOT COMPLETED|Safety Run-in Part||0
137018|NCT00842712|316026|P4|NOT COMPLETED|Safety Run-in Part||1
137019|NCT00842712|316027|P3|NOT COMPLETED|Safety Run-in Part||0
137020|NCT00842712|316028|P2|NOT COMPLETED|Safety Run-in Part||2
137021|NCT00842712|316029|P1|NOT COMPLETED|Safety Run-in Part||3
137022|NCT00842712|316023|P7|COMPLETED|Safety Run-in Part||0
137023|NCT00842712|316024|P6|COMPLETED|Safety Run-in Part||0
137024|NCT00842712|316025|P5|COMPLETED|Safety Run-in Part||0
137025|NCT00842712|316026|P4|COMPLETED|Safety Run-in Part||2
137026|NCT00842712|316027|P3|COMPLETED|Safety Run-in Part||3
137027|NCT00842712|316028|P2|COMPLETED|Safety Run-in Part||1
137028|NCT00842712|316029|P1|COMPLETED|Safety Run-in Part||0
137029|NCT00842712|316023|P7|STARTED|Safety Run-in Part||0
137030|NCT00842712|316024|P6|STARTED|Safety Run-in Part||0
137031|NCT00842712|316025|P5|STARTED|Safety Run-in Part||0
137032|NCT00842712|316026|P4|STARTED|Safety Run-in Part||3
137033|NCT00842712|316027|P3|STARTED|Safety Run-in Part||3
137034|NCT00842712|316028|P2|STARTED|Safety Run-in Part||3
137035|NCT00842712|316029|P1|STARTED|Safety Run-in Part||3
137036|NCT00842543|316061|P4|NOT COMPLETED|Overall Study||4
137037|NCT00842543|316062|P3|NOT COMPLETED|Overall Study||3
137038|NCT00842543|316063|P2|NOT COMPLETED|Overall Study||0
137039|NCT00842543|316064|P1|NOT COMPLETED|Overall Study||2
137040|NCT00842543|316061|P4|COMPLETED|Overall Study||4
137041|NCT00842543|316062|P3|COMPLETED|Overall Study||10
137042|NCT00842543|316063|P2|COMPLETED|Overall Study||5
137043|NCT00842543|316064|P1|COMPLETED|Overall Study||11
137044|NCT00842543|316061|P4|STARTED|Overall Study||8
137045|NCT00842543|316062|P3|STARTED|Overall Study||13
137046|NCT00842543|316063|P2|STARTED|Overall Study||5
137047|NCT00842543|316064|P1|STARTED|Overall Study||13
137048|NCT00842361|316078|P2|NOT COMPLETED|Overall Study||2
137049|NCT00842361|316079|P1|NOT COMPLETED|Overall Study||1
137050|NCT00842361|316078|P2|COMPLETED|Overall Study||31
137051|NCT00842361|316079|P1|COMPLETED|Overall Study||32
137052|NCT00842361|316078|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
137053|NCT00842361|316079|P1|Exposed|Overall Study||33
137054|NCT00842361|316078|P2|STARTED|Overall Study||33
137055|NCT00842361|316079|P1|STARTED|Overall Study||33
137056|NCT00842348|316099|P2|NOT COMPLETED|Study 729||38
137057|NCT00842348|316100|P1|NOT COMPLETED|Study 729||26
137058|NCT00842348|316099|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
137059|NCT00842348|316100|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
137060|NCT00842348|316099|P2|STARTED|Study 729||47
137061|NCT00842348|316100|P1|STARTED|Study 729||42
137062|NCT00842348|316099|P2|NOT COMPLETED|Patients Randomised in Study 726||56
137063|NCT00842348|316100|P1|NOT COMPLETED|Patients Randomised in Study 726||59
137064|NCT00842348|316099|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
137065|NCT00842348|316100|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
137066|NCT00842348|316099|P2|STARTED|Patients Randomised in Study 726||103
137067|NCT00842348|316100|P1|STARTED|Patients Randomised in Study 726||101
137068|NCT00842335|316110|P1|NOT COMPLETED|Overall Study||0
137069|NCT00842335|316110|P1|COMPLETED|Overall Study||18
137070|NCT00842335|316110|P1|STARTED|Overall Study||18
137071|NCT00842244|316117|P1|NOT COMPLETED|Overall Study||21
137072|NCT00842244|316117|P1|COMPLETED|Overall Study||1
137073|NCT00842244|316117|P1|STARTED|Overall Study||22
137074|NCT00842231|316136|P1|NOT COMPLETED|Overall Study||0
137075|NCT00842231|316136|P1|COMPLETED|Overall Study||40
137076|NCT00842231|316136|P1|STARTED|Overall Study||40
137077|NCT00842153|316144|P2|NOT COMPLETED|Overall Study||3
137078|NCT00842153|316145|P1|NOT COMPLETED|Overall Study||1
137079|NCT00842153|316144|P2|COMPLETED|Overall Study||27
137080|NCT00842153|316145|P1|COMPLETED|Overall Study||27
137081|NCT00842153|316144|P2|STARTED|Overall Study||30
137082|NCT00842153|316145|P1|STARTED|Overall Study||28
137083|NCT00842075|316185|P2|NOT COMPLETED|Overall Study||0
137084|NCT00842075|316186|P1|NOT COMPLETED|Overall Study||0
137085|NCT00842075|316185|P2|COMPLETED|Overall Study||5
137086|NCT00842075|316186|P1|COMPLETED|Overall Study||5
137087|NCT00842075|316185|P2|STARTED|Overall Study||5
137088|NCT00842075|316186|P1|STARTED|Overall Study||5
137089|NCT00842023|316196|P2|NOT COMPLETED|Overall Study||0
137090|NCT00842023|316197|P1|NOT COMPLETED|Overall Study||0
137091|NCT00842023|316196|P2|COMPLETED|Overall Study||44
137092|NCT00842023|316197|P1|COMPLETED|Overall Study||45
137093|NCT00842023|316196|P2|STARTED|Overall Study||44
137094|NCT00842023|316197|P1|STARTED|Overall Study||45
137095|NCT00841971|316209|P2|NOT COMPLETED|Overall Study||1
137096|NCT00841971|316210|P1|NOT COMPLETED|Overall Study||2
137097|NCT00841971|316209|P2|COMPLETED|Overall Study||99
137098|NCT00841971|316210|P1|COMPLETED|Overall Study||98
137099|NCT00841971|316209|P2|STARTED|Overall Study||100
137100|NCT00841971|316210|P1|STARTED|Overall Study||100
137101|NCT00841906|316220|P2|NOT COMPLETED|Overall Study||0
137102|NCT00841906|316221|P1|NOT COMPLETED|Overall Study||2
137103|NCT00841906|316220|P2|COMPLETED|Overall Study||15
137104|NCT00841906|316221|P1|COMPLETED|Overall Study||15
137105|NCT00841906|316220|P2|STARTED|Overall Study||15
137106|NCT00841906|316221|P1|STARTED|Overall Study||17
137107|NCT00841815|316235|P2|NOT COMPLETED|Period 2||0
137108|NCT00841815|316236|P1|NOT COMPLETED|Period 2||0
137109|NCT00841815|316235|P2|COMPLETED|Period 2||13
137110|NCT00841815|316236|P1|COMPLETED|Period 2||14
137111|NCT00841815|316235|P2|STARTED|Period 2||13
137112|NCT00841815|316236|P1|STARTED|Period 2||14
137113|NCT00841815|316235|P2|NOT COMPLETED|Washout||1
137114|NCT00841815|316236|P1|NOT COMPLETED|Washout||0
137115|NCT00841815|316235|P2|COMPLETED|Washout||13
137116|NCT00841815|316236|P1|COMPLETED|Washout||14
137117|NCT00841815|316235|P2|STARTED|Washout||14
137118|NCT00841815|316236|P1|STARTED|Washout||14
137119|NCT00841815|316235|P2|NOT COMPLETED|Period 1||0
137120|NCT00841815|316236|P1|NOT COMPLETED|Period 1||0
137121|NCT00841815|316235|P2|COMPLETED|Period 1||14
137122|NCT00841815|316236|P1|COMPLETED|Period 1||14
137123|NCT00841815|316235|P2|STARTED|Period 1||14
137124|NCT00841815|316236|P1|STARTED|Period 1||14
137125|NCT00841776|316246|P2|NOT COMPLETED|Overall Study||3
137126|NCT00841776|316247|P1|NOT COMPLETED|Overall Study||2
137127|NCT00841776|316246|P2|COMPLETED|Overall Study||24
137128|NCT00841776|316247|P1|COMPLETED|Overall Study||25
137129|NCT00841776|316246|P2|STARTED|Overall Study||27
137130|NCT00841776|316247|P1|STARTED|Overall Study||27
137131|NCT00841763|316265|P4|NOT COMPLETED|Overall Study||3
137132|NCT00841763|316266|P3|NOT COMPLETED|Overall Study||8
137133|NCT00841763|316267|P2|NOT COMPLETED|Overall Study||57
137134|NCT00841763|316268|P1|NOT COMPLETED|Overall Study||162
137135|NCT00841763|316265|P4|COMPLETED|Overall Study||53
137136|NCT00841763|316266|P3|COMPLETED|Overall Study||211
137137|NCT00841763|316267|P2|COMPLETED|Overall Study||624
137138|NCT00841763|316268|P1|COMPLETED|Overall Study||2529
137139|NCT00841763|316265|P4|STARTED|Overall Study||56
137140|NCT00841763|316266|P3|STARTED|Overall Study||219
137141|NCT00841763|316267|P2|STARTED|Overall Study||681
137142|NCT00841763|316268|P1|STARTED|Overall Study||2691
137143|NCT00841698|316330|P2|NOT COMPLETED|Second Intervention||0
137144|NCT00841698|316331|P1|NOT COMPLETED|Second Intervention||0
137145|NCT00841698|316330|P2|COMPLETED|Second Intervention||25
137146|NCT00841698|316331|P1|COMPLETED|Second Intervention||24
137147|NCT00841698|316330|P2|STARTED|Second Intervention||25
137148|NCT00841698|316331|P1|STARTED|Second Intervention||24
137149|NCT00841698|316330|P2|NOT COMPLETED|Washout: 2 Weeks||0
137150|NCT00841698|316331|P1|NOT COMPLETED|Washout: 2 Weeks||0
137151|NCT00841698|316330|P2|COMPLETED|Washout: 2 Weeks||25
137152|NCT00841698|316331|P1|COMPLETED|Washout: 2 Weeks||24
137153|NCT00841698|316330|P2|STARTED|Washout: 2 Weeks||25
137154|NCT00841698|316331|P1|STARTED|Washout: 2 Weeks||24
137155|NCT00841698|316330|P2|NOT COMPLETED|First Intervention||0
137156|NCT00841698|316331|P1|NOT COMPLETED|First Intervention||1
137157|NCT00841698|316330|P2|COMPLETED|First Intervention||25
137158|NCT00841698|316331|P1|COMPLETED|First Intervention||24
137159|NCT00841698|316330|P2|STARTED|First Intervention||25
137160|NCT00841698|316331|P1|STARTED|First Intervention||25
137161|NCT00841672|316341|P2|NOT COMPLETED|Overall Study||32
137162|NCT00841672|316342|P1|NOT COMPLETED|Overall Study||20
137163|NCT00841672|316341|P2|COMPLETED|Overall Study||209
137164|NCT00841672|316342|P1|COMPLETED|Overall Study||224
137165|NCT00841672|316341|P2|STARTED|Overall Study||241
137166|NCT00841672|316342|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
137167|NCT00841659|316358|P2|NOT COMPLETED|Second Intervention||0
137168|NCT00841659|316359|P1|NOT COMPLETED|Second Intervention||0
137169|NCT00841659|316358|P2|COMPLETED|Second Intervention||12
137170|NCT00841659|316359|P1|COMPLETED|Second Intervention||11
137171|NCT00841659|316358|P2|STARTED|Second Intervention||12
137172|NCT00841659|316359|P1|STARTED|Second Intervention||11
137173|NCT00841659|316358|P2|NOT COMPLETED|Washout: 2 Weeks||0
137174|NCT00841659|316359|P1|NOT COMPLETED|Washout: 2 Weeks||1
137175|NCT00841659|316358|P2|COMPLETED|Washout: 2 Weeks||12
137176|NCT00841659|316359|P1|COMPLETED|Washout: 2 Weeks||11
137177|NCT00841659|316358|P2|STARTED|Washout: 2 Weeks||12
137178|NCT00841659|316359|P1|STARTED|Washout: 2 Weeks||12
137179|NCT00841659|316358|P2|NOT COMPLETED|First Intervention||0
137180|NCT00841659|316359|P1|NOT COMPLETED|First Intervention||0
137181|NCT00841659|316358|P2|COMPLETED|First Intervention||12
137182|NCT00841659|316359|P1|COMPLETED|First Intervention||12
137183|NCT00841659|316358|P2|STARTED|First Intervention||12
137184|NCT00841659|316359|P1|STARTED|First Intervention||12
137185|NCT00841555|316367|P1|NOT COMPLETED|Overall Study||0
137186|NCT00841555|316367|P1|COMPLETED|Overall Study||9
137187|NCT00841555|316367|P1|STARTED|Overall Study||9
137188|NCT00841542|316375|P2|NOT COMPLETED|Period 2||0
137189|NCT00841542|316376|P1|NOT COMPLETED|Period 2||0
137190|NCT00841542|316375|P2|COMPLETED|Period 2||14
137191|NCT00841542|316376|P1|COMPLETED|Period 2||13
137192|NCT00841542|316375|P2|STARTED|Period 2||14
137193|NCT00841542|316376|P1|STARTED|Period 2||13
137194|NCT00841542|316375|P2|NOT COMPLETED|Period 1||0
137195|NCT00841542|316376|P1|NOT COMPLETED|Period 1||1
137196|NCT00841542|316375|P2|COMPLETED|Period 1||14
137197|NCT00841542|316376|P1|COMPLETED|Period 1||13
137198|NCT00841542|316375|P2|STARTED|Period 1||14
137199|NCT00841542|316376|P1|STARTED|Period 1||14
137200|NCT00841412|316384|P2|NOT COMPLETED|Overall Study||30
137201|NCT00841412|316385|P1|NOT COMPLETED|Overall Study||40
137202|NCT00841412|316384|P2|COMPLETED|Overall Study||50
137203|NCT00841412|316385|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
137204|NCT00841412|316384|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
137205|NCT00841412|316385|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
137206|NCT00841321|316391|P2|NOT COMPLETED|Overall Study||3
137207|NCT00841321|316392|P1|NOT COMPLETED|Overall Study||1
137208|NCT00841321|316391|P2|COMPLETED|Overall Study||58
137209|NCT00841321|316392|P1|COMPLETED|Overall Study||58
137210|NCT00841321|316391|P2|STARTED|Overall Study||61
137211|NCT00841321|316392|P1|STARTED|Overall Study||59
137212|NCT00841269|316404|P1|NOT COMPLETED|Overall Study||2
137213|NCT00841269|316404|P1|COMPLETED|Overall Study||5
137214|NCT00841269|316404|P1|STARTED|Overall Study||7
137215|NCT00841204|316410|P2|NOT COMPLETED|Overall Study||0
137216|NCT00841204|316411|P1|NOT COMPLETED|Overall Study||0
137217|NCT00841204|316410|P2|COMPLETED|Overall Study||25
137218|NCT00841204|316411|P1|COMPLETED|Overall Study||25
137219|NCT00841204|316410|P2|STARTED|Overall Study||25
137220|NCT00841204|316411|P1|STARTED|Overall Study||25
137221|NCT00841087|316423|P2|NOT COMPLETED|Overall Study||0
137222|NCT00841087|316424|P1|NOT COMPLETED|Overall Study||0
137223|NCT00841087|316423|P2|COMPLETED|Overall Study||32
137224|NCT00841087|316424|P1|COMPLETED|Overall Study||33
137225|NCT00841087|316423|P2|STARTED|Overall Study||32
137226|NCT00841087|316424|P1|STARTED|Overall Study||33
137227|NCT00841035|316442|P1|NOT COMPLETED|Phase 2 of Overall Study||0
137228|NCT00841035|316442|P1|COMPLETED|Phase 2 of Overall Study||6
137229|NCT00841035|316442|P1|STARTED|Phase 2 of Overall Study||6
137230|NCT00841035|316442|P1|NOT COMPLETED|Phase 1 Overall Study||13
137231|NCT00841035|316442|P1|COMPLETED|Phase 1 Overall Study||6
137232|NCT00841035|316442|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
137233|NCT00840996|316449|P2|NOT COMPLETED|Overall Study||0
137234|NCT00840996|316450|P1|NOT COMPLETED|Overall Study||1
137235|NCT00840996|316449|P2|COMPLETED|Overall Study||58
137236|NCT00840996|316450|P1|COMPLETED|Overall Study||57
137237|NCT00840996|316449|P2|STARTED|Overall Study||58
137238|NCT00840996|316450|P1|STARTED|Overall Study||58
137239|NCT00840879|316470|P2|NOT COMPLETED|Second Intervention||0
137240|NCT00840879|316471|P1|NOT COMPLETED|Second Intervention||1
137241|NCT00840879|316470|P2|COMPLETED|Second Intervention||14
137242|NCT00840879|316471|P1|COMPLETED|Second Intervention||13
137243|NCT00840879|316470|P2|STARTED|Second Intervention||14
137244|NCT00840879|316471|P1|STARTED|Second Intervention||14
137245|NCT00840879|316470|P2|NOT COMPLETED|Washout: 14 Days||0
137246|NCT00840879|316471|P1|NOT COMPLETED|Washout: 14 Days||0
137247|NCT00840879|316470|P2|COMPLETED|Washout: 14 Days||14
137248|NCT00840879|316471|P1|COMPLETED|Washout: 14 Days||14
137249|NCT00840879|316470|P2|STARTED|Washout: 14 Days||14
137250|NCT00840879|316471|P1|STARTED|Washout: 14 Days||14
137251|NCT00840879|316470|P2|NOT COMPLETED|First Intervention||0
137252|NCT00840879|316471|P1|NOT COMPLETED|First Intervention||0
137253|NCT00840879|316470|P2|COMPLETED|First Intervention||14
137254|NCT00840879|316471|P1|COMPLETED|First Intervention||14
137255|NCT00840879|316470|P2|STARTED|First Intervention||14
137256|NCT00840879|316471|P1|STARTED|First Intervention||14
137257|NCT00840866|316481|P2|NOT COMPLETED|Second Intervention||0
137258|NCT00840866|316482|P1|NOT COMPLETED|Second Intervention||0
137259|NCT00840866|316481|P2|COMPLETED|Second Intervention||19
137260|NCT00840866|316482|P1|COMPLETED|Second Intervention||20
137261|NCT00840866|316481|P2|STARTED|Second Intervention||19
137262|NCT00840866|316482|P1|STARTED|Second Intervention||20
137263|NCT00840866|316481|P2|NOT COMPLETED|Washout of 7 Days||0
137264|NCT00840866|316482|P1|NOT COMPLETED|Washout of 7 Days||0
137265|NCT00840866|316481|P2|COMPLETED|Washout of 7 Days||19
137266|NCT00840866|316482|P1|COMPLETED|Washout of 7 Days||20
137267|NCT00840866|316481|P2|STARTED|Washout of 7 Days||19
137268|NCT00840866|316482|P1|STARTED|Washout of 7 Days||20
137269|NCT00840866|316481|P2|NOT COMPLETED|First Intervention||0
137270|NCT00840866|316482|P1|NOT COMPLETED|First Intervention||0
137271|NCT00840866|316481|P2|COMPLETED|First Intervention||19
137272|NCT00840866|316482|P1|COMPLETED|First Intervention||20
137273|NCT00840866|316481|P2|STARTED|First Intervention||19
137274|NCT00840866|316482|P1|STARTED|First Intervention||20
137275|NCT00840840|316492|P2|NOT COMPLETED|Period 2||0
137276|NCT00840840|316493|P1|NOT COMPLETED|Period 2||0
137277|NCT00840840|316492|P2|COMPLETED|Period 2||24
137278|NCT00840840|316493|P1|COMPLETED|Period 2||23
137279|NCT00840840|316492|P2|STARTED|Period 2||24
137280|NCT00840840|316493|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
137281|NCT00840840|316492|P2|NOT COMPLETED|Period 1||0
137282|NCT00840840|316493|P1|NOT COMPLETED|Period 1||0
137283|NCT00840840|316492|P2|COMPLETED|Period 1||24
137284|NCT00840840|316493|P1|COMPLETED|Period 1||24
137285|NCT00840840|316492|P2|STARTED|Period 1||24
137286|NCT00840840|316493|P1|STARTED|Period 1||24
137287|NCT00840658|316511|P4|NOT COMPLETED|Overall Study||4
137288|NCT00840658|316512|P3|NOT COMPLETED|Overall Study||5
137289|NCT00840658|316513|P2|NOT COMPLETED|Overall Study||3
137290|NCT00840658|316514|P1|NOT COMPLETED|Overall Study||5
137291|NCT00840658|316511|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
137292|NCT00840658|316512|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
137293|NCT00840658|316513|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
137294|NCT00840658|316514|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
137295|NCT00840658|316511|P4|STARTED|Overall Study||146
137296|NCT00840658|316512|P3|STARTED|Overall Study||148
137297|NCT00840658|316513|P2|STARTED|Overall Study||146
137298|NCT00840658|316514|P1|STARTED|Overall Study||144
137299|NCT00840632|316526|P2|NOT COMPLETED|Second Intervention||0
137300|NCT00840632|316527|P1|NOT COMPLETED|Second Intervention||0
137301|NCT00840632|316526|P2|COMPLETED|Second Intervention||18
137302|NCT00840632|316527|P1|COMPLETED|Second Intervention||19
137303|NCT00840632|316526|P2|STARTED|Second Intervention||18
137304|NCT00840632|316527|P1|STARTED|Second Intervention||19
137305|NCT00840632|316526|P2|NOT COMPLETED|Washout||1
137306|NCT00840632|316527|P1|NOT COMPLETED|Washout||1
137307|NCT00840632|316526|P2|COMPLETED|Washout||18
137308|NCT00840632|316527|P1|COMPLETED|Washout||19
137309|NCT00840632|316526|P2|STARTED|Washout||19
137310|NCT00840632|316527|P1|STARTED|Washout||20
137311|NCT00840632|316526|P2|NOT COMPLETED|First Intervention||1
137312|NCT00840632|316527|P1|NOT COMPLETED|First Intervention||0
137313|NCT00840632|316526|P2|COMPLETED|First Intervention||19
137314|NCT00840632|316527|P1|COMPLETED|First Intervention||20
137315|NCT00840632|316526|P2|STARTED|First Intervention||20
137316|NCT00840632|316527|P1|STARTED|First Intervention||20
137317|NCT00840476|316543|P2|NOT COMPLETED|Second Intervention||0
137318|NCT00840476|316544|P1|NOT COMPLETED|Second Intervention||0
137319|NCT00840476|316543|P2|COMPLETED|Second Intervention||14
137320|NCT00840476|316544|P1|COMPLETED|Second Intervention||14
137321|NCT00840476|316543|P2|STARTED|Second Intervention||14
137322|NCT00840476|316544|P1|STARTED|Second Intervention||14
137323|NCT00840476|316543|P2|NOT COMPLETED|Washout: 14 Days||0
137324|NCT00840476|316544|P1|NOT COMPLETED|Washout: 14 Days||0
137325|NCT00840476|316543|P2|COMPLETED|Washout: 14 Days||14
137326|NCT00840476|316544|P1|COMPLETED|Washout: 14 Days||14
137327|NCT00840476|316543|P2|STARTED|Washout: 14 Days||14
137328|NCT00840476|316544|P1|STARTED|Washout: 14 Days||14
137329|NCT00840476|316543|P2|NOT COMPLETED|First Intervention||0
137330|NCT00840476|316544|P1|NOT COMPLETED|First Intervention||0
137331|NCT00840476|316543|P2|COMPLETED|First Intervention||14
137332|NCT00840476|316544|P1|COMPLETED|First Intervention||14
137333|NCT00840476|316543|P2|STARTED|First Intervention||14
137334|NCT00840476|316544|P1|STARTED|First Intervention||14
137335|NCT00840450|316552|P1|NOT COMPLETED|Overall Study||3
137336|NCT00840450|316552|P1|COMPLETED|Overall Study||9
137337|NCT00840450|316552|P1|STARTED|Overall Study||12
137338|NCT00840411|316560|P2|NOT COMPLETED|Second Intervention||0
137339|NCT00840411|316561|P1|NOT COMPLETED|Second Intervention||0
137340|NCT00840411|316560|P2|COMPLETED|Second Intervention||33
137341|NCT00840411|316561|P1|COMPLETED|Second Intervention||31
137342|NCT00840411|316560|P2|STARTED|Second Intervention||33
137343|NCT00840411|316561|P1|STARTED|Second Intervention||31
137344|NCT00840411|316560|P2|NOT COMPLETED|Washout||0
137345|NCT00840411|316561|P1|NOT COMPLETED|Washout||1
137346|NCT00840411|316560|P2|COMPLETED|Washout||33
137347|NCT00840411|316561|P1|COMPLETED|Washout||31
137348|NCT00840411|316560|P2|STARTED|Washout||33
137349|NCT00840411|316561|P1|STARTED|Washout||32
137350|NCT00840411|316560|P2|NOT COMPLETED|First Intervention||0
137351|NCT00840411|316561|P1|NOT COMPLETED|First Intervention||1
137352|NCT00840411|316560|P2|COMPLETED|First Intervention||33
137353|NCT00840411|316561|P1|COMPLETED|First Intervention||32
137354|NCT00840411|316560|P2|STARTED|First Intervention||33
137355|NCT00840411|316561|P1|STARTED|First Intervention||33
137356|NCT00840294|316571|P2|NOT COMPLETED|Overall Study||5
137357|NCT00840294|316572|P1|NOT COMPLETED|Overall Study||3
137358|NCT00840294|316571|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
137359|NCT00840294|316572|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
137360|NCT00840294|316571|P2|STARTED|Overall Study||43
137361|NCT00840294|316572|P1|STARTED|Overall Study||42
137362|NCT00840281|316582|P2|NOT COMPLETED|Second Intervention||0
137363|NCT00840281|316583|P1|NOT COMPLETED|Second Intervention||0
137364|NCT00840281|316582|P2|COMPLETED|Second Intervention||19
137365|NCT00840281|316583|P1|COMPLETED|Second Intervention||19
137366|NCT00840281|316582|P2|STARTED|Second Intervention||19
137367|NCT00840281|316583|P1|STARTED|Second Intervention||19
137368|NCT00840281|316582|P2|NOT COMPLETED|Washout of 7 Days||0
137369|NCT00840281|316583|P1|NOT COMPLETED|Washout of 7 Days||0
137370|NCT00840281|316582|P2|COMPLETED|Washout of 7 Days||19
137371|NCT00840281|316583|P1|COMPLETED|Washout of 7 Days||19
137372|NCT00840281|316582|P2|STARTED|Washout of 7 Days||19
137373|NCT00840281|316583|P1|STARTED|Washout of 7 Days||19
137374|NCT00840281|316582|P2|NOT COMPLETED|First Intervention||0
137375|NCT00840281|316583|P1|NOT COMPLETED|First Intervention||0
137376|NCT00840281|316582|P2|COMPLETED|First Intervention||19
137377|NCT00840281|316583|P1|COMPLETED|First Intervention||19
137378|NCT00840281|316582|P2|STARTED|First Intervention||19
137379|NCT00840281|316583|P1|STARTED|First Intervention||19
137380|NCT00840216|316593|P2|NOT COMPLETED|Second Intervention||0
137381|NCT00840216|316594|P1|NOT COMPLETED|Second Intervention||0
137382|NCT00840216|316593|P2|COMPLETED|Second Intervention||11
137383|NCT00840216|316594|P1|COMPLETED|Second Intervention||10
137384|NCT00840216|316593|P2|STARTED|Second Intervention||11
137385|NCT00840216|316594|P1|STARTED|Second Intervention||10
137386|NCT00840216|316593|P2|NOT COMPLETED|Washout: 7 Days||0
137387|NCT00840216|316594|P1|NOT COMPLETED|Washout: 7 Days||1
137388|NCT00840216|316593|P2|COMPLETED|Washout: 7 Days||11
137389|NCT00840216|316594|P1|COMPLETED|Washout: 7 Days||10
137390|NCT00840216|316593|P2|STARTED|Washout: 7 Days||11
137391|NCT00840216|316594|P1|STARTED|Washout: 7 Days||11
137392|NCT00840216|316593|P2|NOT COMPLETED|First Intervention||0
137393|NCT00840216|316594|P1|NOT COMPLETED|First Intervention||0
137394|NCT00840216|316593|P2|COMPLETED|First Intervention||11
137395|NCT00840216|316594|P1|COMPLETED|First Intervention||11
137396|NCT00840216|316593|P2|STARTED|First Intervention||11
137397|NCT00840216|316594|P1|STARTED|First Intervention||11
137398|NCT00840203|316604|P2|NOT COMPLETED|Second Intervention||0
137399|NCT00840203|316605|P1|NOT COMPLETED|Second Intervention||0
137400|NCT00840203|316604|P2|COMPLETED|Second Intervention||34
137401|NCT00840203|316605|P1|COMPLETED|Second Intervention||35
137402|NCT00840203|316604|P2|STARTED|Second Intervention||34
137403|NCT00840203|316605|P1|STARTED|Second Intervention||35
137404|NCT00840203|316604|P2|NOT COMPLETED|Washout||0
137405|NCT00840203|316605|P1|NOT COMPLETED|Washout||1
137406|NCT00840203|316604|P2|COMPLETED|Washout||34
137407|NCT00840203|316605|P1|COMPLETED|Washout||35
137408|NCT00840203|316604|P2|STARTED|Washout||34
137409|NCT00840203|316605|P1|STARTED|Washout||36
137410|NCT00840203|316604|P2|NOT COMPLETED|First Intervention||1
137411|NCT00840203|316605|P1|NOT COMPLETED|First Intervention||1
137412|NCT00840203|316604|P2|COMPLETED|First Intervention||34
137413|NCT00840203|316605|P1|COMPLETED|First Intervention||36
137414|NCT00840203|316604|P2|STARTED|First Intervention||35
137415|NCT00840203|316605|P1|STARTED|First Intervention||37
137416|NCT00840099|316621|P2|NOT COMPLETED|Period 2||0
137417|NCT00840099|316622|P1|NOT COMPLETED|Period 2||0
137418|NCT00840099|316621|P2|COMPLETED|Period 2||24
137419|NCT00840099|316622|P1|COMPLETED|Period 2||21
137420|NCT00840099|316621|P2|STARTED|Period 2||24
137421|NCT00840099|316622|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
137422|NCT00840099|316621|P2|NOT COMPLETED|Period 1||0
137423|NCT00840099|316622|P1|NOT COMPLETED|Period 1||0
137424|NCT00840099|316621|P2|COMPLETED|Period 1||24
137425|NCT00840099|316622|P1|COMPLETED|Period 1||24
137426|NCT00840099|316621|P2|STARTED|Period 1||24
137427|NCT00840099|316622|P1|STARTED|Period 1||24
137428|NCT00840086|316636|P1|NOT COMPLETED|Overall Study||4
137429|NCT00840086|316636|P1|COMPLETED|Overall Study||146
137430|NCT00840086|316636|P1|STARTED|Overall Study||150
137431|NCT00840073|316645|P2|NOT COMPLETED|Second Intervention||1
137432|NCT00840073|316646|P1|NOT COMPLETED|Second Intervention||1
137433|NCT00840073|316645|P2|COMPLETED|Second Intervention||24
137434|NCT00840073|316646|P1|COMPLETED|Second Intervention||24
137435|NCT00840073|316645|P2|STARTED|Second Intervention||25
137436|NCT00840073|316646|P1|STARTED|Second Intervention||25
137437|NCT00840073|316645|P2|NOT COMPLETED|First Intervention||0
137438|NCT00840073|316646|P1|NOT COMPLETED|First Intervention||0
137439|NCT00840073|316645|P2|COMPLETED|First Intervention||25
137440|NCT00840073|316646|P1|COMPLETED|First Intervention||25
137441|NCT00840073|316645|P2|STARTED|First Intervention||25
137442|NCT00840073|316646|P1|STARTED|First Intervention||25
137443|NCT00840060|316660|P2|NOT COMPLETED|Overall Study||1
137444|NCT00840060|316661|P1|NOT COMPLETED|Overall Study||1
137445|NCT00840060|316660|P2|COMPLETED|Overall Study||19
137446|NCT00840060|316661|P1|COMPLETED|Overall Study||19
137447|NCT00840060|316660|P2|STARTED|Overall Study||20
137448|NCT00840060|316661|P1|STARTED|Overall Study||20
137449|NCT00839930|316671|P2|NOT COMPLETED|Second Intervention||0
137450|NCT00839930|316672|P1|NOT COMPLETED|Second Intervention||0
137451|NCT00839930|316671|P2|COMPLETED|Second Intervention||15
137452|NCT00839930|316672|P1|COMPLETED|Second Intervention||15
137453|NCT00839930|316671|P2|STARTED|Second Intervention||15
137454|NCT00839930|316672|P1|STARTED|Second Intervention||15
137455|NCT00839930|316671|P2|NOT COMPLETED|Washout: 7 Days||0
137456|NCT00839930|316672|P1|NOT COMPLETED|Washout: 7 Days||0
137457|NCT00839930|316671|P2|COMPLETED|Washout: 7 Days||15
137458|NCT00839930|316672|P1|COMPLETED|Washout: 7 Days||15
137459|NCT00839930|316671|P2|STARTED|Washout: 7 Days||15
137460|NCT00839930|316672|P1|STARTED|Washout: 7 Days||15
137461|NCT00839930|316671|P2|NOT COMPLETED|First Intervention||0
137462|NCT00839930|316672|P1|NOT COMPLETED|First Intervention||0
137463|NCT00839930|316671|P2|COMPLETED|First Intervention||15
137464|NCT00839930|316672|P1|COMPLETED|First Intervention||15
137465|NCT00839930|316671|P2|STARTED|First Intervention||15
137466|NCT00839930|316672|P1|STARTED|First Intervention||15
137467|NCT00839917|316682|P2|NOT COMPLETED|Overall Study||1
137468|NCT00839917|316683|P1|NOT COMPLETED|Overall Study||1
137469|NCT00839917|316682|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
137470|NCT00839917|316683|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
137471|NCT00839917|316682|P2|STARTED|Overall Study||17
137472|NCT00839917|316683|P1|STARTED|Overall Study||13
137473|NCT00839800|316721|P2|NOT COMPLETED|Overall Study||110
137474|NCT00839800|316722|P1|NOT COMPLETED|Overall Study||93
137475|NCT00839800|316721|P2|COMPLETED|Overall Study||932
137476|NCT00839800|316722|P1|COMPLETED|Overall Study||956
137477|NCT00839800|316721|P2|STARTED|Overall Study||1042
137478|NCT00839800|316722|P1|STARTED|Overall Study||1049
137479|NCT00839540|316755|P3|NOT COMPLETED|Overall Study||0
137480|NCT00839540|316756|P2|NOT COMPLETED|Overall Study||0
137481|NCT00839540|316757|P1|NOT COMPLETED|Overall Study||0
137482|NCT00839540|316755|P3|COMPLETED|Overall Study||5
137483|NCT00839540|316756|P2|COMPLETED|Overall Study||8
137484|NCT00839540|316757|P1|COMPLETED|Overall Study||8
137485|NCT00839540|316755|P3|STARTED|Overall Study||5
137486|NCT00839540|316756|P2|STARTED|Overall Study||8
137487|NCT00839540|316757|P1|STARTED|Overall Study||8
137488|NCT00839527|316768|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
137489|NCT00839527|316769|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
137490|NCT00839527|316770|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
137491|NCT00839527|316768|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
137492|NCT00839527|316769|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
137493|NCT00839527|316770|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
137494|NCT00839527|316768|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
137495|NCT00839527|316769|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
137496|NCT00839527|316770|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
137497|NCT00839527|316768|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
137498|NCT00839527|316769|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
137499|NCT00839527|316770|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
137500|NCT00839527|316768|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
137501|NCT00839527|316769|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
137502|NCT00839527|316770|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
137503|NCT00839527|316768|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
137504|NCT00839527|316769|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
137505|NCT00839527|316770|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
137506|NCT00839436|316805|P3|NOT COMPLETED|Overall Study||1
137507|NCT00839436|316806|P2|NOT COMPLETED|Overall Study||1
137508|NCT00839436|316807|P1|NOT COMPLETED|Overall Study||1
137509|NCT00839436|316805|P3|COMPLETED|Overall Study||0
137510|NCT00839436|316806|P2|COMPLETED|Overall Study||4
137511|NCT00839436|316807|P1|COMPLETED|Overall Study||2
137512|NCT00839436|316805|P3|STARTED|Overall Study||1
137513|NCT00839436|316806|P2|STARTED|Overall Study||5
137514|NCT00839436|316807|P1|STARTED|Overall Study||3
137515|NCT00839423|316819|P4|NOT COMPLETED|Overall Study||20
137516|NCT00839423|316820|P3|NOT COMPLETED|Overall Study||18
137517|NCT00839423|316821|P2|NOT COMPLETED|Overall Study||10
137518|NCT00839423|316822|P1|NOT COMPLETED|Overall Study||18
137519|NCT00839423|316819|P4|COMPLETED|Overall Study||93
137520|NCT00839423|316820|P3|COMPLETED|Overall Study||82
137521|NCT00839423|316821|P2|COMPLETED|Overall Study||98
137522|NCT00839423|316822|P1|COMPLETED|Overall Study||87
137523|NCT00839423|316819|P4|STARTED|Overall Study||113
137524|NCT00839423|316820|P3|STARTED|Overall Study||100
137525|NCT00839423|316821|P2|STARTED|Overall Study||108
137526|NCT00839423|316822|P1|STARTED|Overall Study||105
137527|NCT00839319|316865|P5|NOT COMPLETED|Overall Study||0
137528|NCT00839319|316866|P4|NOT COMPLETED|Overall Study||3
137529|NCT00839319|316867|P3|NOT COMPLETED|Overall Study||3
137530|NCT00839319|316868|P2|NOT COMPLETED|Overall Study||1
137531|NCT00839319|316869|P1|NOT COMPLETED|Overall Study||2
137532|NCT00839319|316865|P5|COMPLETED|Overall Study||8
137533|NCT00839319|316866|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
137534|NCT00839319|316867|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
137535|NCT00839319|316868|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
137536|NCT00839319|316869|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
137537|NCT00839319|316865|P5|STARTED|Overall Study||8
137538|NCT00839319|316866|P4|STARTED|Overall Study||8
137539|NCT00839319|316867|P3|STARTED|Overall Study||8
137540|NCT00839319|316868|P2|STARTED|Overall Study||8
137541|NCT00839319|316869|P1|STARTED|Overall Study||8
137542|NCT00839306|316898|P2|NOT COMPLETED|Overall Study||43
137543|NCT00839306|316899|P1|NOT COMPLETED|Overall Study||25
137544|NCT00839306|316898|P2|COMPLETED|Overall Study||134
137545|NCT00839306|316899|P1|COMPLETED|Overall Study||35
137546|NCT00839306|316898|P2|STARTED|Overall Study|Treated|177
137547|NCT00839306|316899|P1|STARTED|Overall Study|Treated|60
137548|NCT00839241|316909|P2|NOT COMPLETED|Overall Study||17
137549|NCT00839241|316910|P1|NOT COMPLETED|Overall Study||5
137550|NCT00839241|316909|P2|COMPLETED|Overall Study||8
137551|NCT00839241|316910|P1|COMPLETED|Overall Study||15
137552|NCT00839241|316909|P2|STARTED|Overall Study||25
137553|NCT00839241|316910|P1|STARTED|Overall Study||20
137554|NCT00839098|316997|P3|NOT COMPLETED|Overall Study||7
137555|NCT00839098|316998|P2|NOT COMPLETED|Overall Study||1
137556|NCT00839098|316999|P1|NOT COMPLETED|Overall Study||2
137557|NCT00839098|316997|P3|COMPLETED|Overall Study||6
137558|NCT00839098|316998|P2|COMPLETED|Overall Study||11
137559|NCT00839098|316999|P1|COMPLETED|Overall Study||1
137560|NCT00839098|316997|P3|STARTED|Overall Study||13
137561|NCT00839098|316998|P2|STARTED|Overall Study||12
137562|NCT00839098|316999|P1|STARTED|Overall Study||3
137563|NCT00839072|317025|P2|NOT COMPLETED|Second Intervention Period||0
137564|NCT00839072|317026|P1|NOT COMPLETED|Second Intervention Period||1
137565|NCT00839072|317025|P2|COMPLETED|Second Intervention Period||11
137566|NCT00839072|317026|P1|COMPLETED|Second Intervention Period||9
137567|NCT00839072|317025|P2|STARTED|Second Intervention Period||11
137568|NCT00839072|317026|P1|STARTED|Second Intervention Period||10
137569|NCT00839072|317025|P2|NOT COMPLETED|Washout Period of 7 Days||0
137570|NCT00839072|317026|P1|NOT COMPLETED|Washout Period of 7 Days||0
137571|NCT00839072|317025|P2|COMPLETED|Washout Period of 7 Days||11
137572|NCT00839072|317026|P1|COMPLETED|Washout Period of 7 Days||10
137573|NCT00839072|317025|P2|STARTED|Washout Period of 7 Days||11
137574|NCT00839072|317026|P1|STARTED|Washout Period of 7 Days||10
137575|NCT00839072|317025|P2|NOT COMPLETED|First Intervention Period||1
137576|NCT00839072|317026|P1|NOT COMPLETED|First Intervention Period||2
137577|NCT00839072|317025|P2|COMPLETED|First Intervention Period||11
137578|NCT00839072|317026|P1|COMPLETED|First Intervention Period||10
137579|NCT00839072|317025|P2|STARTED|First Intervention Period||12
137580|NCT00839072|317026|P1|STARTED|First Intervention Period||12
137581|NCT00838929|317045|P3|NOT COMPLETED|Overall Study||1
137582|NCT00838929|317046|P2|NOT COMPLETED|Overall Study||3
137583|NCT00838929|317047|P1|NOT COMPLETED|Overall Study||0
137584|NCT00838929|317045|P3|COMPLETED|Overall Study||5
137585|NCT00838929|317046|P2|COMPLETED|Overall Study||5
137586|NCT00838929|317047|P1|COMPLETED|Overall Study||3
137587|NCT00838929|317045|P3|STARTED|Overall Study||6
137588|NCT00838929|317046|P2|STARTED|Overall Study||8
137589|NCT00838929|317047|P1|STARTED|Overall Study||3
137590|NCT00838916|317055|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
137591|NCT00838916|317056|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
137592|NCT00838916|317055|P2|COMPLETED|Follow-up Period (8 Weeks)||190
137593|NCT00838916|317056|P1|COMPLETED|Follow-up Period (8 Weeks)||408
137594|NCT00838916|317055|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
137595|NCT00838916|317056|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
137596|NCT00838916|317055|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
137597|NCT00838916|317056|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
137598|NCT00838916|317055|P2|COMPLETED|Treatment Period (156 Weeks)||164
137599|NCT00838916|317056|P1|COMPLETED|Treatment Period (156 Weeks)||308
137600|NCT00838916|317055|P2|STARTED|Treatment Period (156 Weeks)||241
137601|NCT00838916|317056|P1|STARTED|Treatment Period (156 Weeks)||504
137602|NCT00838903|317085|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
137603|NCT00838903|317086|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
137604|NCT00838903|317087|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
137605|NCT00838903|317088|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
137606|NCT00838903|317085|P4|COMPLETED|Follow-up Period (8 Weeks)||244
137607|NCT00838903|317086|P3|COMPLETED|Follow-up Period (8 Weeks)||243
137608|NCT00838903|317087|P2|COMPLETED|Follow-up Period (8 Weeks)||237
137609|NCT00838903|317088|P1|COMPLETED|Follow-up Period (8 Weeks)||75
137610|NCT00838903|317085|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
137611|NCT00838903|317086|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
137612|NCT00838903|317087|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
137613|NCT00838903|317088|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
137614|NCT00838903|317085|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
137615|NCT00838903|317086|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
137616|NCT00838903|317087|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
137617|NCT00838903|317088|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
137618|NCT00838903|317085|P4|COMPLETED|Treatment Period (156 Weeks)||192
137619|NCT00838903|317086|P3|COMPLETED|Treatment Period (156 Weeks)||191
137620|NCT00838903|317087|P2|COMPLETED|Treatment Period (156 Weeks)||190
137621|NCT00838903|317088|P1|COMPLETED|Treatment Period (156 Weeks)||55
137622|NCT00838903|317085|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
137623|NCT00838903|317086|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
137624|NCT00838903|317087|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
137625|NCT00838903|317088|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
137626|NCT00838903|317085|P4|STARTED|Treatment Period (156 Weeks)||302
137627|NCT00838903|317086|P3|STARTED|Treatment Period (156 Weeks)||307
137628|NCT00838903|317087|P2|STARTED|Treatment Period (156 Weeks)||302
137629|NCT00838903|317088|P1|STARTED|Treatment Period (156 Weeks)||101
137630|NCT00838682|317132|P2|NOT COMPLETED|Overall Study||19
137631|NCT00838682|317133|P1|NOT COMPLETED|Overall Study||25
137632|NCT00838682|317132|P2|COMPLETED|Overall Study||33
137633|NCT00838682|317133|P1|COMPLETED|Overall Study||29
137634|NCT00838682|317132|P2|STARTED|Overall Study||52
137635|NCT00838682|317133|P1|STARTED|Overall Study||54
137636|NCT00838630|317151|P2|NOT COMPLETED|Second Intervention||0
137637|NCT00838630|317152|P1|NOT COMPLETED|Second Intervention||0
137638|NCT00838630|317151|P2|COMPLETED|Second Intervention||18
137639|NCT00838630|317152|P1|COMPLETED|Second Intervention||16
137640|NCT00838630|317151|P2|STARTED|Second Intervention||18
137641|NCT00838630|317152|P1|STARTED|Second Intervention||16
137642|NCT00838630|317151|P2|NOT COMPLETED|Washout: 7 Days||0
137643|NCT00838630|317152|P1|NOT COMPLETED|Washout: 7 Days||1
137644|NCT00838630|317151|P2|COMPLETED|Washout: 7 Days||18
137645|NCT00838630|317152|P1|COMPLETED|Washout: 7 Days||16
137646|NCT00838630|317151|P2|STARTED|Washout: 7 Days||18
137647|NCT00838630|317152|P1|STARTED|Washout: 7 Days||17
137648|NCT00838630|317151|P2|NOT COMPLETED|First Intervention||0
137649|NCT00838630|317152|P1|NOT COMPLETED|First Intervention||1
137650|NCT00838630|317151|P2|COMPLETED|First Intervention||18
137651|NCT00838630|317152|P1|COMPLETED|First Intervention||17
137652|NCT00838630|317151|P2|STARTED|First Intervention||18
137653|NCT00838630|317152|P1|STARTED|First Intervention||18
137654|NCT00838578|317160|P1|NOT COMPLETED|Overall Study||2
137655|NCT00838578|317160|P1|COMPLETED|Overall Study||63
137656|NCT00838578|317160|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
137657|NCT00838526|317170|P2|NOT COMPLETED|Overall Study||39
137658|NCT00838526|317171|P1|NOT COMPLETED|Overall Study||24
137659|NCT00838526|317170|P2|COMPLETED|Overall Study||137
137660|NCT00838526|317171|P1|COMPLETED|Overall Study||35
137661|NCT00838526|317170|P2|STARTED|Overall Study|Treated|176
137662|NCT00838526|317171|P1|STARTED|Overall Study|Treated|59
137663|NCT00838513|317179|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
137664|NCT00838513|317179|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
137665|NCT00838513|317179|P1|STARTED|Post Treatment Period (Patients Who Disc||5
137666|NCT00838513|317179|P1|NOT COMPLETED|Extension Treatment Period||1
137667|NCT00838513|317179|P1|COMPLETED|Extension Treatment Period||18
137668|NCT00838513|317179|P1|STARTED|Extension Treatment Period||19
137669|NCT00838513|317179|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
137670|NCT00838513|317179|P1|COMPLETED|Treatment Period (26 Weeks)||20
137671|NCT00838513|317179|P1|STARTED|Treatment Period (26 Weeks)||20
137672|NCT00838513|317179|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
137673|NCT00838513|317179|P1|COMPLETED|Observation Period (8 Weeks)||20
137674|NCT00838513|317179|P1|STARTED|Observation Period (8 Weeks)||20
137675|NCT00838513|317179|P1|NOT COMPLETED|Screening Period||3
137676|NCT00838513|317179|P1|COMPLETED|Screening Period||20
137677|NCT00838513|317179|P1|STARTED|Screening Period||23
137678|NCT00838331|317195|P1|NOT COMPLETED|Aged Blood Transfusion||9
137679|NCT00838331|317195|P1|COMPLETED|Aged Blood Transfusion||8
137680|NCT00838331|317195|P1|STARTED|Aged Blood Transfusion||17
137681|NCT00838331|317195|P1|NOT COMPLETED|Fresh Blood Transfusion||0
137682|NCT00838331|317195|P1|COMPLETED|Fresh Blood Transfusion||17
137683|NCT00838331|317195|P1|STARTED|Fresh Blood Transfusion||17
137684|NCT00838279|317201|P2|NOT COMPLETED|Second Intervention||0
137685|NCT00838279|317202|P1|NOT COMPLETED|Second Intervention||0
137686|NCT00838279|317201|P2|COMPLETED|Second Intervention||15
137687|NCT00838279|317202|P1|COMPLETED|Second Intervention||15
137688|NCT00838279|317201|P2|STARTED|Second Intervention||15
137689|NCT00838279|317202|P1|STARTED|Second Intervention||15
137690|NCT00838279|317201|P2|NOT COMPLETED|Washout||1
137691|NCT00838279|317202|P1|NOT COMPLETED|Washout||1
137692|NCT00838279|317201|P2|COMPLETED|Washout||15
137693|NCT00838279|317202|P1|COMPLETED|Washout||15
137694|NCT00838279|317201|P2|STARTED|Washout||16
137695|NCT00838279|317202|P1|STARTED|Washout||16
137696|NCT00838279|317201|P2|NOT COMPLETED|First Intervention||0
137697|NCT00838279|317202|P1|NOT COMPLETED|First Intervention||0
137698|NCT00838279|317201|P2|COMPLETED|First Intervention||16
137699|NCT00838279|317202|P1|COMPLETED|First Intervention||16
137700|NCT00838279|317201|P2|STARTED|First Intervention||16
137701|NCT00838279|317202|P1|STARTED|First Intervention||16
137702|NCT00838201|317212|P2|NOT COMPLETED|Overall Study||53
137703|NCT00838201|317213|P1|NOT COMPLETED|Overall Study||42
137704|NCT00838201|317212|P2|COMPLETED|Overall Study||145
137705|NCT00838201|317213|P1|COMPLETED|Overall Study||144
137706|NCT00838201|317212|P2|STARTED|Overall Study||198
137707|NCT00838201|317213|P1|STARTED|Overall Study||186
137708|NCT00838162|317223|P4|NOT COMPLETED|Overall Study||0
137709|NCT00838162|317224|P3|NOT COMPLETED|Overall Study||0
137710|NCT00838162|317225|P2|NOT COMPLETED|Overall Study||0
137711|NCT00838162|317226|P1|NOT COMPLETED|Overall Study||0
137712|NCT00838162|317223|P4|COMPLETED|Overall Study||8
137713|NCT00838162|317224|P3|COMPLETED|Overall Study||8
137714|NCT00838162|317225|P2|COMPLETED|Overall Study||8
137715|NCT00838162|317226|P1|COMPLETED|Overall Study||9
137716|NCT00838162|317223|P4|STARTED|Overall Study||8
137717|NCT00838162|317224|P3|STARTED|Overall Study||8
137718|NCT00838162|317225|P2|STARTED|Overall Study||8
137719|NCT00838162|317226|P1|STARTED|Overall Study||9
137720|NCT00838136|317270|P2|NOT COMPLETED|Second Intervention||1
137721|NCT00838136|317271|P1|NOT COMPLETED|Second Intervention||0
137722|NCT00838136|317270|P2|COMPLETED|Second Intervention||15
137723|NCT00838136|317271|P1|COMPLETED|Second Intervention||16
137724|NCT00838136|317270|P2|STARTED|Second Intervention||16
137725|NCT00838136|317271|P1|STARTED|Second Intervention||16
137726|NCT00838136|317270|P2|NOT COMPLETED|First Intervention||0
137727|NCT00838136|317271|P1|NOT COMPLETED|First Intervention||0
137728|NCT00838136|317270|P2|COMPLETED|First Intervention||16
137729|NCT00838136|317271|P1|COMPLETED|First Intervention||16
137730|NCT00838136|317270|P2|STARTED|First Intervention||16
137731|NCT00838136|317271|P1|STARTED|First Intervention||16
137732|NCT00838110|317281|P4|NOT COMPLETED|Overall Study||18
137733|NCT00838110|317282|P3|NOT COMPLETED|Overall Study||17
137734|NCT00838110|317283|P2|NOT COMPLETED|Overall Study||22
137735|NCT00838110|317284|P1|NOT COMPLETED|Overall Study||22
137736|NCT00838110|317281|P4|COMPLETED|Overall Study||226
137737|NCT00838110|317282|P3|COMPLETED|Overall Study||226
137738|NCT00838110|317283|P2|COMPLETED|Overall Study||106
137739|NCT00838110|317284|P1|COMPLETED|Overall Study||105
137740|NCT00838110|317281|P4|Treated|Overall Study||244
137741|NCT00838110|317282|P3|Treated|Overall Study||243
137742|NCT00838110|317283|P2|Treated|Overall Study||127
137743|NCT00838110|317284|P1|Treated|Overall Study||127
137744|NCT00838110|317281|P4|STARTED|Overall Study||244
137745|NCT00838110|317282|P3|STARTED|Overall Study||243
137746|NCT00838110|317283|P2|STARTED|Overall Study||128
137747|NCT00838110|317284|P1|STARTED|Overall Study||127
137748|NCT00838097|317304|P1|NOT COMPLETED|Overall Study||176
137749|NCT00838097|317304|P1|COMPLETED|Overall Study||145
137750|NCT00838097|317304|P1|Received Darbepoetin Alfa|Overall Study||319
137751|NCT00838097|317304|P1|STARTED|Overall Study||321
137752|NCT00837967|317312|P2|NOT COMPLETED|Second Intervention||0
137753|NCT00837967|317313|P1|NOT COMPLETED|Second Intervention||0
137754|NCT00837967|317312|P2|COMPLETED|Second Intervention||12
137755|NCT00837967|317313|P1|COMPLETED|Second Intervention||11
137756|NCT00837967|317312|P2|STARTED|Second Intervention||12
137757|NCT00837967|317313|P1|STARTED|Second Intervention||11
137758|NCT00837967|317312|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
137759|NCT00837967|317313|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
137760|NCT00837967|317312|P2|COMPLETED|Washout Period of 7 - 14 Days||12
137761|NCT00837967|317313|P1|COMPLETED|Washout Period of 7 - 14 Days||11
137762|NCT00837967|317312|P2|STARTED|Washout Period of 7 - 14 Days||12
137763|NCT00837967|317313|P1|STARTED|Washout Period of 7 - 14 Days||13
137764|NCT00837967|317312|P2|NOT COMPLETED|First Intervention||0
137765|NCT00837967|317313|P1|NOT COMPLETED|First Intervention||0
137766|NCT00837967|317312|P2|COMPLETED|First Intervention||12
137767|NCT00837967|317313|P1|COMPLETED|First Intervention||13
137768|NCT00837967|317312|P2|STARTED|First Intervention||12
137769|NCT00837967|317313|P1|STARTED|First Intervention||13
137770|NCT00837876|317329|P1|NOT COMPLETED|Overall Study||37
137771|NCT00837876|317329|P1|COMPLETED|Overall Study||0
137772|NCT00837876|317329|P1|STARTED|Overall Study||37
137773|NCT00837824|317338|P2|NOT COMPLETED|Overall Study||0
137774|NCT00837824|317339|P1|NOT COMPLETED|Overall Study||0
137775|NCT00837824|317338|P2|COMPLETED|Overall Study||9
137776|NCT00837824|317339|P1|COMPLETED|Overall Study||11
137777|NCT00837824|317338|P2|STARTED|Overall Study||9
137778|NCT00837824|317339|P1|STARTED|Overall Study||11
137779|NCT00837759|317348|P1|NOT COMPLETED|Overall Study||4
137780|NCT00837759|317348|P1|COMPLETED|Overall Study||3
137781|NCT00837759|317348|P1|STARTED|Overall Study||7
137782|NCT00837616|317359|P2|NOT COMPLETED|Overall Study||1
137783|NCT00837616|317360|P1|NOT COMPLETED|Overall Study||0
137784|NCT00837616|317359|P2|COMPLETED|Overall Study||20
137785|NCT00837616|317360|P1|COMPLETED|Overall Study||20
137786|NCT00837616|317359|P2|STARTED|Overall Study||21
137787|NCT00837616|317360|P1|STARTED|Overall Study||20
137788|NCT00837577|317386|P2|NOT COMPLETED|Open-label Period||9
137789|NCT00837577|317387|P1|NOT COMPLETED|Open-label Period||8
137790|NCT00837577|317386|P2|COMPLETED|Open-label Period||54
137791|NCT00837577|317387|P1|COMPLETED|Open-label Period||60
137792|NCT00837577|317386|P2|STARTED|Open-label Period||63
137793|NCT00837577|317387|P1|STARTED|Open-label Period||68
137794|NCT00837577|317386|P2|NOT COMPLETED|Double-blind Period||0
137795|NCT00837577|317387|P1|NOT COMPLETED|Double-blind Period||2
137796|NCT00837577|317386|P2|COMPLETED|Double-blind Period||63
137797|NCT00837577|317387|P1|COMPLETED|Double-blind Period||68
137798|NCT00837577|317386|P2|STARTED|Double-blind Period||63
137799|NCT00837577|317387|P1|STARTED|Double-blind Period||70
137800|NCT00837512|317398|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
137801|NCT00837512|317399|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
137802|NCT00837512|317398|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
137803|NCT00837512|317399|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
137804|NCT00837512|317398|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
137805|NCT00837512|317399|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
137806|NCT00837512|317398|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
137807|NCT00837512|317399|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
137808|NCT00837512|317398|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
137809|NCT00837512|317399|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
137810|NCT00837512|317398|P2|STARTED|Both Arms: Washout (7-28 Days)||8
137811|NCT00837512|317399|P1|STARTED|Both Arms: Washout (7-28 Days)||8
137812|NCT00837512|317398|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
137813|NCT00837512|317399|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
137814|NCT00837512|317398|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
137815|NCT00837512|317399|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
137816|NCT00837512|317398|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
137817|NCT00837512|317399|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
137818|NCT00837486|317407|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
137819|NCT00837486|317408|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
137820|NCT00837486|317407|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
137821|NCT00837486|317408|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
137822|NCT00837486|317407|P2|STARTED|Long-term Follow-up Phase - Open Label||0
137823|NCT00837486|317408|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
137824|NCT00837486|317407|P2|NOT COMPLETED|Blinded-treatment Phase||0
137825|NCT00837486|317408|P1|NOT COMPLETED|Blinded-treatment Phase||1
137826|NCT00837486|317407|P2|COMPLETED|Blinded-treatment Phase||14
137827|NCT00837486|317408|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
137828|NCT00837486|317407|P2|STARTED|Blinded-treatment Phase||14
137829|NCT00837486|317408|P1|STARTED|Blinded-treatment Phase||16
137830|NCT00837447|317420|P1|NOT COMPLETED|Overall Study||0
137831|NCT00837447|317420|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
137832|NCT00837447|317420|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
137833|NCT00837434|317427|P2|NOT COMPLETED|Overall Study||1
137834|NCT00837434|317428|P1|NOT COMPLETED|Overall Study||9
137835|NCT00837434|317427|P2|COMPLETED|Overall Study||19
137836|NCT00837434|317428|P1|COMPLETED|Overall Study||34
137837|NCT00837434|317427|P2|STARTED|Overall Study||20
137838|NCT00837434|317428|P1|STARTED|Overall Study||43
137839|NCT00837330|317448|P2|NOT COMPLETED|Overall Study||3
137840|NCT00837330|317449|P1|NOT COMPLETED|Overall Study||1
137841|NCT00837330|317448|P2|COMPLETED|Overall Study||7
137842|NCT00837330|317449|P1|COMPLETED|Overall Study||9
137843|NCT00837330|317448|P2|STARTED|Overall Study||10
137844|NCT00837330|317449|P1|STARTED|Overall Study||10
137845|NCT00837252|317455|P1|NOT COMPLETED|Overall Study||0
137846|NCT00837252|317455|P1|COMPLETED|Overall Study||5
137847|NCT00837252|317455|P1|STARTED|Overall Study||5
137848|NCT00837213|317472|P2|NOT COMPLETED|Overall Study||5
137849|NCT00837213|317473|P1|NOT COMPLETED|Overall Study||6
137850|NCT00837213|317472|P2|COMPLETED|Overall Study||12
137851|NCT00837213|317473|P1|COMPLETED|Overall Study||10
137852|NCT00837213|317472|P2|STARTED|Overall Study||17
137853|NCT00837213|317473|P1|STARTED|Overall Study||16
137854|NCT00837200|317493|P1|NOT COMPLETED|Overall Study||0
137855|NCT00837200|317493|P1|COMPLETED|Overall Study||13
137856|NCT00837200|317493|P1|STARTED|Overall Study||13
137857|NCT00837161|317499|P1|NOT COMPLETED|Overall Study||2
137858|NCT00837161|317499|P1|COMPLETED|Overall Study||9
137859|NCT00837161|317499|P1|STARTED|Overall Study||11
137860|NCT00837148|317507|P1|NOT COMPLETED|Overall Study||2
137861|NCT00837148|317507|P1|COMPLETED|Overall Study||35
137862|NCT00837148|317507|P1|STARTED|Overall Study||37
137863|NCT00837031|317511|P1|NOT COMPLETED|Overall Study||0
137864|NCT00837031|317511|P1|COMPLETED|Overall Study||72
137865|NCT00837031|317511|P1|STARTED|Overall Study||72
137866|NCT00836953|317517|P1|NOT COMPLETED|Overall Study||2
137867|NCT00836953|317517|P1|COMPLETED|Overall Study||31
137868|NCT00836953|317517|P1|STARTED|Overall Study||33
137869|NCT00836901|317525|P2|NOT COMPLETED|Second Intervention||0
137870|NCT00836901|317526|P1|NOT COMPLETED|Second Intervention||0
137871|NCT00836901|317525|P2|COMPLETED|Second Intervention||28
137872|NCT00836901|317526|P1|COMPLETED|Second Intervention||23
137873|NCT00836901|317525|P2|STARTED|Second Intervention||28
137874|NCT00836901|317526|P1|STARTED|Second Intervention||23
137875|NCT00836901|317525|P2|NOT COMPLETED|First Intervention||0
137876|NCT00836901|317526|P1|NOT COMPLETED|First Intervention||1
137877|NCT00836901|317525|P2|COMPLETED|First Intervention||28
137878|NCT00836901|317526|P1|COMPLETED|First Intervention||23
137879|NCT00836901|317525|P2|STARTED|First Intervention||28
137880|NCT00836901|317526|P1|STARTED|First Intervention||24
137881|NCT00836875|317542|P2|NOT COMPLETED|Overall Study||3
137882|NCT00836875|317543|P1|NOT COMPLETED|Overall Study||3
137883|NCT00836875|317542|P2|COMPLETED|Overall Study||17
137884|NCT00836875|317543|P1|COMPLETED|Overall Study||8
137885|NCT00836875|317542|P2|STARTED|Overall Study||20
137886|NCT00836875|317543|P1|STARTED|Overall Study||11
137887|NCT00836745|317557|P1|NOT COMPLETED|Overall Study||21
137888|NCT00836745|317557|P1|COMPLETED|Overall Study||15
137889|NCT00836745|317557|P1|STARTED|Overall Study||36
137890|NCT00836719|317564|P1|NOT COMPLETED|Overall Study||0
137891|NCT00836719|317564|P1|COMPLETED|Overall Study||10
137892|NCT00836719|317564|P1|STARTED|Overall Study||10
137893|NCT00836706|317571|P2|NOT COMPLETED|Second Intervention||0
137894|NCT00836706|317572|P1|NOT COMPLETED|Second Intervention||0
137895|NCT00836706|317571|P2|COMPLETED|Second Intervention||11
137896|NCT00836706|317572|P1|COMPLETED|Second Intervention||11
137897|NCT00836706|317571|P2|STARTED|Second Intervention||11
137898|NCT00836706|317572|P1|STARTED|Second Intervention||11
137899|NCT00836706|317571|P2|NOT COMPLETED|Washout: 7 Days||1
137900|NCT00836706|317572|P1|NOT COMPLETED|Washout: 7 Days||0
137901|NCT00836706|317571|P2|COMPLETED|Washout: 7 Days||11
137902|NCT00836706|317572|P1|COMPLETED|Washout: 7 Days||11
137903|NCT00836706|317571|P2|STARTED|Washout: 7 Days||12
137904|NCT00836706|317572|P1|STARTED|Washout: 7 Days||11
137905|NCT00836706|317571|P2|NOT COMPLETED|First Intervention||0
137906|NCT00836706|317572|P1|NOT COMPLETED|First Intervention||0
137907|NCT00836706|317571|P2|COMPLETED|First Intervention||12
137908|NCT00836706|317572|P1|COMPLETED|First Intervention||11
137909|NCT00836706|317571|P2|STARTED|First Intervention||12
137910|NCT00836706|317572|P1|STARTED|First Intervention||11
137911|NCT00836693|317582|P2|NOT COMPLETED|Overall Study||6
137912|NCT00836693|317583|P1|NOT COMPLETED|Overall Study||17
137913|NCT00836693|317582|P2|COMPLETED|Overall Study||64
137914|NCT00836693|317583|P1|COMPLETED|Overall Study||130
137915|NCT00836693|317582|P2|STARTED|Overall Study||70
137916|NCT00836693|317583|P1|STARTED|Overall Study||147
137917|NCT00836641|317625|P2|NOT COMPLETED|Overall Study||0
137918|NCT00836641|317626|P1|NOT COMPLETED|Overall Study||0
137919|NCT00836641|317625|P2|COMPLETED|Overall Study||34
137920|NCT00836641|317626|P1|COMPLETED|Overall Study||36
137921|NCT00836641|317625|P2|STARTED|Overall Study||34
137922|NCT00836641|317626|P1|STARTED|Overall Study||36
137923|NCT00836498|317635|P2|NOT COMPLETED|Overall Study||1
137924|NCT00836498|317636|P1|NOT COMPLETED|Overall Study||4
137925|NCT00836498|317635|P2|COMPLETED|Overall Study||21
137926|NCT00836498|317636|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
137927|NCT00836498|317635|P2|STARTED|Overall Study||22
137928|NCT00836498|317636|P1|STARTED|Overall Study||44
137929|NCT00836472|317668|P2|NOT COMPLETED|Second Intervention||0
137930|NCT00836472|317669|P1|NOT COMPLETED|Second Intervention||0
137931|NCT00836472|317668|P2|COMPLETED|Second Intervention||27
137932|NCT00836472|317669|P1|COMPLETED|Second Intervention||28
137933|NCT00836472|317668|P2|STARTED|Second Intervention||27
137934|NCT00836472|317669|P1|STARTED|Second Intervention||28
137935|NCT00836472|317668|P2|NOT COMPLETED|Washout||3
137936|NCT00836472|317669|P1|NOT COMPLETED|Washout||2
137937|NCT00836472|317668|P2|COMPLETED|Washout||27
137938|NCT00836472|317669|P1|COMPLETED|Washout||28
137939|NCT00836472|317668|P2|STARTED|Washout||30
137940|NCT00836472|317669|P1|STARTED|Washout||30
137941|NCT00836472|317668|P2|NOT COMPLETED|First Intervention||0
137942|NCT00836472|317669|P1|NOT COMPLETED|First Intervention||0
137943|NCT00836472|317668|P2|COMPLETED|First Intervention||30
137944|NCT00836472|317669|P1|COMPLETED|First Intervention||30
137945|NCT00836472|317668|P2|STARTED|First Intervention||30
137946|NCT00836472|317669|P1|STARTED|First Intervention||30
137947|NCT00836433|317685|P2|NOT COMPLETED|Overall Study||7
137948|NCT00836433|317686|P1|NOT COMPLETED|Overall Study||12
137949|NCT00836433|317685|P2|COMPLETED|Overall Study||321
137950|NCT00836433|317686|P1|COMPLETED|Overall Study||349
137951|NCT00836433|317685|P2|STARTED|Overall Study||328
137952|NCT00836433|317686|P1|STARTED|Overall Study||361
137953|NCT00836407|317696|P2|NOT COMPLETED|Overall Study||8
137954|NCT00836407|317697|P1|NOT COMPLETED|Overall Study||11
137955|NCT00836407|317696|P2|COMPLETED|Overall Study||7
137956|NCT00836407|317697|P1|COMPLETED|Overall Study||4
137957|NCT00836407|317696|P2|STARTED|Overall Study||15
137958|NCT00836407|317697|P1|STARTED|Overall Study||15
137959|NCT00836355|317709|P4|NOT COMPLETED|Overall Study||0
137960|NCT00836355|317710|P3|NOT COMPLETED|Overall Study||0
137961|NCT00836355|317711|P2|NOT COMPLETED|Overall Study||0
137962|NCT00836355|317712|P1|NOT COMPLETED|Overall Study||0
137963|NCT00836355|317709|P4|COMPLETED|Overall Study||2
137964|NCT00836355|317710|P3|COMPLETED|Overall Study||0
137965|NCT00836355|317711|P2|COMPLETED|Overall Study||4
137966|NCT00836355|317712|P1|COMPLETED|Overall Study||0
137967|NCT00836355|317709|P4|STARTED|Overall Study||2
137968|NCT00836355|317710|P3|STARTED|Overall Study||0
137969|NCT00836355|317711|P2|STARTED|Overall Study||4
137970|NCT00836355|317712|P1|STARTED|Overall Study||0
137971|NCT00836342|317733|P3|NOT COMPLETED|Overall Study||0
137972|NCT00836342|317734|P2|NOT COMPLETED|Overall Study||0
137973|NCT00836342|317735|P1|NOT COMPLETED|Overall Study||0
137974|NCT00836342|317733|P3|COMPLETED|Overall Study||36
137975|NCT00836342|317734|P2|COMPLETED|Overall Study||23
137976|NCT00836342|317735|P1|COMPLETED|Overall Study||22
137977|NCT00836342|317733|P3|STARTED|Overall Study||36
137978|NCT00836342|317734|P2|STARTED|Overall Study||23
137979|NCT00836342|317735|P1|STARTED|Overall Study||22
137980|NCT00836277|317746|P1|NOT COMPLETED|Overall Study||6
137981|NCT00836277|317746|P1|COMPLETED|Overall Study||18
137982|NCT00836277|317746|P1|STARTED|Overall Study||24
137983|NCT00836095|317756|P2|NOT COMPLETED|Overall Study||3
137984|NCT00836095|317757|P1|NOT COMPLETED|Overall Study||0
137985|NCT00836095|317756|P2|COMPLETED|Overall Study||27
137986|NCT00836095|317757|P1|COMPLETED|Overall Study||22
137987|NCT00836095|317756|P2|STARTED|Overall Study||30
137988|NCT00836095|317757|P1|STARTED|Overall Study||22
137989|NCT00836056|317767|P2|NOT COMPLETED|Second Intervention||0
137990|NCT00836056|317768|P1|NOT COMPLETED|Second Intervention||0
137991|NCT00836056|317767|P2|COMPLETED|Second Intervention||12
137992|NCT00836056|317768|P1|COMPLETED|Second Intervention||11
137993|NCT00836056|317767|P2|STARTED|Second Intervention||12
137994|NCT00836056|317768|P1|STARTED|Second Intervention||11
137995|NCT00836056|317767|P2|NOT COMPLETED|Washout: 7 Days||0
137996|NCT00836056|317768|P1|NOT COMPLETED|Washout: 7 Days||0
137997|NCT00836056|317767|P2|COMPLETED|Washout: 7 Days||12
137998|NCT00836056|317768|P1|COMPLETED|Washout: 7 Days||11
137999|NCT00836056|317767|P2|STARTED|Washout: 7 Days||12
138000|NCT00836056|317768|P1|STARTED|Washout: 7 Days||11
138001|NCT00836056|317767|P2|NOT COMPLETED|First Intervention||0
138002|NCT00836056|317768|P1|NOT COMPLETED|First Intervention||1
138003|NCT00836056|317767|P2|COMPLETED|First Intervention||12
138004|NCT00836056|317768|P1|COMPLETED|First Intervention||11
138005|NCT00836056|317767|P2|STARTED|First Intervention||12
138006|NCT00836056|317768|P1|STARTED|First Intervention||12
138007|NCT00836017|317776|P1|NOT COMPLETED|Overall Study||544
138008|NCT00836017|317776|P1|COMPLETED|Overall Study||502
138009|NCT00836017|317776|P1|STARTED|Overall Study||1046
138010|NCT00836004|317786|P2|NOT COMPLETED|Second Intervention||0
138011|NCT00836004|317787|P1|NOT COMPLETED|Second Intervention||0
138012|NCT00836004|317786|P2|COMPLETED|Second Intervention||12
138013|NCT00836004|317787|P1|COMPLETED|Second Intervention||12
138014|NCT00836004|317786|P2|STARTED|Second Intervention||12
138015|NCT00836004|317787|P1|STARTED|Second Intervention||12
138016|NCT00836004|317786|P2|NOT COMPLETED|Washout: 7 Days||0
138017|NCT00836004|317787|P1|NOT COMPLETED|Washout: 7 Days||0
138018|NCT00836004|317786|P2|COMPLETED|Washout: 7 Days||12
138019|NCT00836004|317787|P1|COMPLETED|Washout: 7 Days||12
138020|NCT00836004|317786|P2|STARTED|Washout: 7 Days||12
138021|NCT00836004|317787|P1|STARTED|Washout: 7 Days||12
138022|NCT00836004|317786|P2|NOT COMPLETED|First Intervention||0
138023|NCT00836004|317787|P1|NOT COMPLETED|First Intervention||0
138024|NCT00836004|317786|P2|COMPLETED|First Intervention||12
138025|NCT00836004|317787|P1|COMPLETED|First Intervention||12
138026|NCT00836004|317786|P2|STARTED|First Intervention||12
138027|NCT00836004|317787|P1|STARTED|First Intervention||12
138028|NCT00835991|317797|P2|NOT COMPLETED|Second Intervention||0
138029|NCT00835991|317798|P1|NOT COMPLETED|Second Intervention||0
138030|NCT00835991|317797|P2|COMPLETED|Second Intervention||26
138031|NCT00835991|317798|P1|COMPLETED|Second Intervention||27
138032|NCT00835991|317797|P2|STARTED|Second Intervention||26
138033|NCT00835991|317798|P1|STARTED|Second Intervention||27
138034|NCT00835991|317797|P2|NOT COMPLETED|Washout||3
138035|NCT00835991|317798|P1|NOT COMPLETED|Washout||3
138036|NCT00835991|317797|P2|COMPLETED|Washout||26
138037|NCT00835991|317798|P1|COMPLETED|Washout||27
138038|NCT00835991|317797|P2|STARTED|Washout||29
138039|NCT00835991|317798|P1|STARTED|Washout||30
138040|NCT00835991|317797|P2|NOT COMPLETED|First Intervention||1
138041|NCT00835991|317798|P1|NOT COMPLETED|First Intervention||0
138042|NCT00835991|317797|P2|COMPLETED|First Intervention||29
138043|NCT00835991|317798|P1|COMPLETED|First Intervention||30
138044|NCT00835991|317797|P2|STARTED|First Intervention||30
138045|NCT00835991|317798|P1|STARTED|First Intervention||30
138046|NCT00835978|317816|P4|NOT COMPLETED|Overall Study||10
138047|NCT00835978|317817|P3|NOT COMPLETED|Overall Study||91
138048|NCT00835978|317818|P2|NOT COMPLETED|Overall Study||56
138049|NCT00835978|317819|P1|NOT COMPLETED|Overall Study||56
138050|NCT00835978|317816|P4|COMPLETED|Overall Study||0
138051|NCT00835978|317817|P3|COMPLETED|Overall Study||0
138052|NCT00835978|317818|P2|COMPLETED|Overall Study||0
138053|NCT00835978|317819|P1|COMPLETED|Overall Study||0
138054|NCT00835978|317816|P4|Treated|Overall Study||10
138055|NCT00835978|317817|P3|Treated|Overall Study||91
138056|NCT00835978|317818|P2|Treated|Overall Study||56
138057|NCT00835978|317819|P1|Treated|Overall Study||56
138058|NCT00835978|317816|P4|STARTED|Overall Study||10
138059|NCT00835978|317817|P3|STARTED|Overall Study||91
138060|NCT00835978|317818|P2|STARTED|Overall Study||56
138061|NCT00835978|317819|P1|STARTED|Overall Study||56
138062|NCT00835926|317876|P2|NOT COMPLETED|Overall Study||0
138063|NCT00835926|317877|P1|NOT COMPLETED|Overall Study||0
138064|NCT00835926|317876|P2|COMPLETED|Overall Study||60
138065|NCT00835926|317877|P1|COMPLETED|Overall Study||61
138066|NCT00835926|317876|P2|STARTED|Overall Study||60
138067|NCT00835926|317877|P1|STARTED|Overall Study||61
138068|NCT00835861|317891|P2|NOT COMPLETED|Overall Study||2
138069|NCT00835861|317892|P1|NOT COMPLETED|Overall Study||1
138070|NCT00835861|317891|P2|COMPLETED|Overall Study||14
138071|NCT00835861|317892|P1|COMPLETED|Overall Study||14
138072|NCT00835861|317891|P2|STARTED|Overall Study||16
138073|NCT00835861|317892|P1|STARTED|Overall Study||15
138074|NCT00835796|317916|P2|NOT COMPLETED|Second Intervention||0
138075|NCT00835796|317917|P1|NOT COMPLETED|Second Intervention||0
138076|NCT00835796|317916|P2|COMPLETED|Second Intervention||9
138077|NCT00835796|317917|P1|COMPLETED|Second Intervention||10
138078|NCT00835796|317916|P2|STARTED|Second Intervention||9
138079|NCT00835796|317917|P1|STARTED|Second Intervention||10
138080|NCT00835796|317916|P2|NOT COMPLETED|Washout||0
138081|NCT00835796|317917|P1|NOT COMPLETED|Washout||0
138082|NCT00835796|317916|P2|COMPLETED|Washout||9
138083|NCT00835796|317917|P1|COMPLETED|Washout||10
138084|NCT00835796|317916|P2|STARTED|Washout||9
138085|NCT00835796|317917|P1|STARTED|Washout||10
138086|NCT00835796|317916|P2|NOT COMPLETED|First Intervention||1
138087|NCT00835796|317917|P1|NOT COMPLETED|First Intervention||0
138088|NCT00835796|317916|P2|COMPLETED|First Intervention||9
138089|NCT00835796|317917|P1|COMPLETED|First Intervention||10
138090|NCT00835796|317916|P2|STARTED|First Intervention||10
138091|NCT00835796|317917|P1|STARTED|First Intervention||10
138092|NCT00835731|317927|P2|NOT COMPLETED|Overall Study||1
138093|NCT00835731|317928|P1|NOT COMPLETED|Overall Study||2
138094|NCT00835731|317927|P2|COMPLETED|Overall Study||60
138095|NCT00835731|317928|P1|COMPLETED|Overall Study||62
138096|NCT00835731|317927|P2|STARTED|Overall Study||61
138097|NCT00835731|317928|P1|STARTED|Overall Study||64
138098|NCT00835705|317944|P2|NOT COMPLETED|Second Intervention||0
138099|NCT00835705|317945|P1|NOT COMPLETED|Second Intervention||1
138100|NCT00835705|317944|P2|COMPLETED|Second Intervention||28
138101|NCT00835705|317945|P1|COMPLETED|Second Intervention||22
138102|NCT00835705|317944|P2|STARTED|Second Intervention||28
138103|NCT00835705|317945|P1|STARTED|Second Intervention||23
138104|NCT00835705|317944|P2|NOT COMPLETED|First Intervention||0
138105|NCT00835705|317945|P1|NOT COMPLETED|First Intervention||1
138106|NCT00835705|317944|P2|COMPLETED|First Intervention||28
138107|NCT00835705|317945|P1|COMPLETED|First Intervention||23
138108|NCT00835705|317944|P2|STARTED|First Intervention||28
138109|NCT00835705|317945|P1|STARTED|First Intervention||24
138110|NCT00835692|317961|P2|NOT COMPLETED|Second Intervention||0
138111|NCT00835692|317962|P1|NOT COMPLETED|Second Intervention||0
138112|NCT00835692|317961|P2|COMPLETED|Second Intervention||28
138113|NCT00835692|317962|P1|COMPLETED|Second Intervention||27
138114|NCT00835692|317961|P2|STARTED|Second Intervention||28
138115|NCT00835692|317962|P1|STARTED|Second Intervention||27
138116|NCT00835692|317961|P2|NOT COMPLETED|Washout||0
138117|NCT00835692|317962|P1|NOT COMPLETED|Washout||0
138118|NCT00835692|317961|P2|COMPLETED|Washout||28
138119|NCT00835692|317962|P1|COMPLETED|Washout||27
138120|NCT00835692|317961|P2|STARTED|Washout||28
138121|NCT00835692|317962|P1|STARTED|Washout||27
138122|NCT00835692|317961|P2|NOT COMPLETED|First Intervention||0
138123|NCT00835692|317962|P1|NOT COMPLETED|First Intervention||1
138124|NCT00835692|317961|P2|COMPLETED|First Intervention||28
138125|NCT00835692|317962|P1|COMPLETED|First Intervention||27
138126|NCT00835692|317961|P2|STARTED|First Intervention||28
138127|NCT00835692|317962|P1|STARTED|First Intervention||28
138128|NCT00835679|317974|P4|NOT COMPLETED|Overall Study||0
138129|NCT00835679|317975|P3|NOT COMPLETED|Overall Study||0
138130|NCT00835679|317976|P2|NOT COMPLETED|Overall Study||0
138131|NCT00835679|317977|P1|NOT COMPLETED|Overall Study||1
138132|NCT00835679|317974|P4|COMPLETED|Overall Study||0
138133|NCT00835679|317975|P3|COMPLETED|Overall Study||0
138134|NCT00835679|317976|P2|COMPLETED|Overall Study||0
138135|NCT00835679|317977|P1|COMPLETED|Overall Study||8
138136|NCT00835679|317974|P4|STARTED|Overall Study||0
138137|NCT00835679|317975|P3|STARTED|Overall Study||0
138138|NCT00835679|317976|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
138139|NCT00835679|317977|P1|STARTED|Overall Study||9
138140|NCT00835666|318001|P2|NOT COMPLETED|Second Intervention||0
138141|NCT00835666|318002|P1|NOT COMPLETED|Second Intervention||0
138142|NCT00835666|318001|P2|COMPLETED|Second Intervention||16
138143|NCT00835666|318002|P1|COMPLETED|Second Intervention||14
138144|NCT00835666|318001|P2|STARTED|Second Intervention||16
138145|NCT00835666|318002|P1|STARTED|Second Intervention||14
138146|NCT00835666|318001|P2|NOT COMPLETED|Washout||0
138147|NCT00835666|318002|P1|NOT COMPLETED|Washout||2
138148|NCT00835666|318001|P2|COMPLETED|Washout||16
138149|NCT00835666|318002|P1|COMPLETED|Washout||14
138150|NCT00835666|318001|P2|STARTED|Washout||16
138151|NCT00835666|318002|P1|STARTED|Washout||16
138152|NCT00835666|318001|P2|NOT COMPLETED|First Intervention||0
138153|NCT00835666|318002|P1|NOT COMPLETED|First Intervention||0
138154|NCT00835666|318001|P2|COMPLETED|First Intervention||16
138155|NCT00835666|318002|P1|COMPLETED|First Intervention||16
138156|NCT00835666|318001|P2|STARTED|First Intervention||16
138157|NCT00835666|318002|P1|STARTED|First Intervention||16
138158|NCT00835640|318012|P2|NOT COMPLETED|Second Intervention||0
138159|NCT00835640|318013|P1|NOT COMPLETED|Second Intervention||1
138160|NCT00835640|318012|P2|COMPLETED|Second Intervention||12
138161|NCT00835640|318013|P1|COMPLETED|Second Intervention||11
138162|NCT00835640|318012|P2|STARTED|Second Intervention||12
138163|NCT00835640|318013|P1|STARTED|Second Intervention||12
138164|NCT00835640|318012|P2|NOT COMPLETED|Washout of 7 Days||0
138165|NCT00835640|318013|P1|NOT COMPLETED|Washout of 7 Days||0
138166|NCT00835640|318012|P2|COMPLETED|Washout of 7 Days||12
138167|NCT00835640|318013|P1|COMPLETED|Washout of 7 Days||12
138168|NCT00835640|318012|P2|STARTED|Washout of 7 Days||12
138169|NCT00835640|318013|P1|STARTED|Washout of 7 Days||12
138170|NCT00835640|318012|P2|NOT COMPLETED|First Intervention||0
138171|NCT00835640|318013|P1|NOT COMPLETED|First Intervention||0
138172|NCT00835640|318012|P2|COMPLETED|First Intervention||12
138173|NCT00835640|318013|P1|COMPLETED|First Intervention||12
138174|NCT00835640|318012|P2|STARTED|First Intervention||12
138175|NCT00835640|318013|P1|STARTED|First Intervention||12
138176|NCT00835614|318023|P2|NOT COMPLETED|Second Intervention||0
138177|NCT00835614|318024|P1|NOT COMPLETED|Second Intervention||0
138178|NCT00835614|318023|P2|COMPLETED|Second Intervention||13
138179|NCT00835614|318024|P1|COMPLETED|Second Intervention||13
138180|NCT00835614|318023|P2|STARTED|Second Intervention||13
138181|NCT00835614|318024|P1|STARTED|Second Intervention||13
138182|NCT00835614|318023|P2|NOT COMPLETED|Washout of 7 Days||0
138183|NCT00835614|318024|P1|NOT COMPLETED|Washout of 7 Days||0
138184|NCT00835614|318023|P2|COMPLETED|Washout of 7 Days||13
138185|NCT00835614|318024|P1|COMPLETED|Washout of 7 Days||13
138186|NCT00835614|318023|P2|STARTED|Washout of 7 Days||13
138187|NCT00835614|318024|P1|STARTED|Washout of 7 Days||13
138188|NCT00835614|318023|P2|NOT COMPLETED|First Intervention||0
138189|NCT00835614|318024|P1|NOT COMPLETED|First Intervention||0
138190|NCT00835614|318023|P2|COMPLETED|First Intervention||13
138191|NCT00835614|318024|P1|COMPLETED|First Intervention||13
138192|NCT00835614|318023|P2|STARTED|First Intervention||13
138193|NCT00835614|318024|P1|STARTED|First Intervention||13
138194|NCT00835588|318034|P2|NOT COMPLETED|Second Intervention||0
138195|NCT00835588|318035|P1|NOT COMPLETED|Second Intervention||0
138196|NCT00835588|318034|P2|COMPLETED|Second Intervention||50
138197|NCT00835588|318035|P1|COMPLETED|Second Intervention||50
138198|NCT00835588|318034|P2|STARTED|Second Intervention||50
138199|NCT00835588|318035|P1|STARTED|Second Intervention||50
138200|NCT00835588|318034|P2|NOT COMPLETED|Washout: 5 Days||0
138201|NCT00835588|318035|P1|NOT COMPLETED|Washout: 5 Days||0
138202|NCT00835588|318034|P2|COMPLETED|Washout: 5 Days||50
138203|NCT00835588|318035|P1|COMPLETED|Washout: 5 Days||50
138204|NCT00835588|318034|P2|STARTED|Washout: 5 Days||50
138205|NCT00835588|318035|P1|STARTED|Washout: 5 Days||50
138206|NCT00835588|318034|P2|NOT COMPLETED|First Intervention||0
138207|NCT00835588|318035|P1|NOT COMPLETED|First Intervention||0
138208|NCT00835588|318034|P2|COMPLETED|First Intervention||50
138209|NCT00835588|318035|P1|COMPLETED|First Intervention||50
138210|NCT00835588|318034|P2|STARTED|First Intervention||50
138211|NCT00835588|318035|P1|STARTED|First Intervention||50
138212|NCT00835575|318045|P2|NOT COMPLETED|Second Intervention||0
138213|NCT00835575|318046|P1|NOT COMPLETED|Second Intervention||0
138214|NCT00835575|318045|P2|COMPLETED|Second Intervention||16
138215|NCT00835575|318046|P1|COMPLETED|Second Intervention||15
138216|NCT00835575|318045|P2|STARTED|Second Intervention||16
138217|NCT00835575|318046|P1|STARTED|Second Intervention||15
138218|NCT00835575|318045|P2|NOT COMPLETED|Washout of 14 Days||0
138219|NCT00835575|318046|P1|NOT COMPLETED|Washout of 14 Days||1
138220|NCT00835575|318045|P2|COMPLETED|Washout of 14 Days||16
138221|NCT00835575|318046|P1|COMPLETED|Washout of 14 Days||15
138222|NCT00835575|318045|P2|STARTED|Washout of 14 Days||16
138223|NCT00835575|318046|P1|STARTED|Washout of 14 Days||16
138224|NCT00835575|318045|P2|NOT COMPLETED|First Intervention||0
138225|NCT00835575|318046|P1|NOT COMPLETED|First Intervention||0
138226|NCT00835575|318045|P2|COMPLETED|First Intervention||16
138227|NCT00835575|318046|P1|COMPLETED|First Intervention||16
138228|NCT00835575|318045|P2|STARTED|First Intervention||16
138229|NCT00835575|318046|P1|STARTED|First Intervention||16
138230|NCT00835549|318056|P2|NOT COMPLETED|Second Intervention||0
138231|NCT00835549|318057|P1|NOT COMPLETED|Second Intervention||0
138232|NCT00835549|318056|P2|COMPLETED|Second Intervention||16
138233|NCT00835549|318057|P1|COMPLETED|Second Intervention||14
138234|NCT00835549|318056|P2|STARTED|Second Intervention||16
138235|NCT00835549|318057|P1|STARTED|Second Intervention||14
138236|NCT00835549|318056|P2|NOT COMPLETED|Washout of 7 Days||0
138237|NCT00835549|318057|P1|NOT COMPLETED|Washout of 7 Days||2
138238|NCT00835549|318056|P2|COMPLETED|Washout of 7 Days||16
138239|NCT00835549|318057|P1|COMPLETED|Washout of 7 Days||14
138240|NCT00835549|318056|P2|STARTED|Washout of 7 Days||16
138241|NCT00835549|318057|P1|STARTED|Washout of 7 Days||16
138242|NCT00835549|318056|P2|NOT COMPLETED|First Intervention||0
138243|NCT00835549|318057|P1|NOT COMPLETED|First Intervention||0
138244|NCT00835549|318056|P2|COMPLETED|First Intervention||16
138245|NCT00835549|318057|P1|COMPLETED|First Intervention||16
138246|NCT00835549|318056|P2|STARTED|First Intervention||16
138247|NCT00835549|318057|P1|STARTED|First Intervention||16
138248|NCT00835536|318067|P2|NOT COMPLETED|Second Intervention||0
138249|NCT00835536|318068|P1|NOT COMPLETED|Second Intervention||0
138250|NCT00835536|318067|P2|COMPLETED|Second Intervention||14
138251|NCT00835536|318068|P1|COMPLETED|Second Intervention||12
138252|NCT00835536|318067|P2|STARTED|Second Intervention||14
138253|NCT00835536|318068|P1|STARTED|Second Intervention||12
138254|NCT00835536|318067|P2|NOT COMPLETED|Washout of 5 Weeks||0
138255|NCT00835536|318068|P1|NOT COMPLETED|Washout of 5 Weeks||1
138256|NCT00835536|318067|P2|COMPLETED|Washout of 5 Weeks||14
138257|NCT00835536|318068|P1|COMPLETED|Washout of 5 Weeks||12
138258|NCT00835536|318067|P2|STARTED|Washout of 5 Weeks||14
138259|NCT00835536|318068|P1|STARTED|Washout of 5 Weeks||13
138260|NCT00835536|318067|P2|NOT COMPLETED|First Intervention||0
138261|NCT00835536|318068|P1|NOT COMPLETED|First Intervention||0
138262|NCT00835536|318067|P2|COMPLETED|First Intervention||14
138263|NCT00835536|318068|P1|COMPLETED|First Intervention||13
138264|NCT00835536|318067|P2|STARTED|First Intervention||14
138265|NCT00835536|318068|P1|STARTED|First Intervention||13
138266|NCT00835510|318077|P3|NOT COMPLETED|Overall Study||38
138267|NCT00835510|318078|P2|NOT COMPLETED|Overall Study||69
138268|NCT00835510|318079|P1|NOT COMPLETED|Overall Study||76
138269|NCT00835510|318077|P3|COMPLETED|Overall Study||70
138270|NCT00835510|318078|P2|COMPLETED|Overall Study||152
138271|NCT00835510|318079|P1|COMPLETED|Overall Study||143
138272|NCT00835510|318077|P3|Positive Fungal Culture|Overall Study||71
138273|NCT00835510|318078|P2|Positive Fungal Culture|Overall Study||155
138274|NCT00835510|318079|P1|Positive Fungal Culture|Overall Study||149
138275|NCT00835510|318077|P3|STARTED|Overall Study||108
138276|NCT00835510|318078|P2|STARTED|Overall Study||221
138277|NCT00835510|318079|P1|STARTED|Overall Study||219
138278|NCT00835497|318101|P2|NOT COMPLETED|Second Intervention||0
138279|NCT00835497|318102|P1|NOT COMPLETED|Second Intervention||0
138280|NCT00835497|318101|P2|COMPLETED|Second Intervention||20
138281|NCT00835497|318102|P1|COMPLETED|Second Intervention||20
138282|NCT00835497|318101|P2|STARTED|Second Intervention||20
138283|NCT00835497|318102|P1|STARTED|Second Intervention||20
138284|NCT00835497|318101|P2|NOT COMPLETED|Washout: 7 Days||0
138285|NCT00835497|318102|P1|NOT COMPLETED|Washout: 7 Days||0
138286|NCT00835497|318101|P2|COMPLETED|Washout: 7 Days||20
138287|NCT00835497|318102|P1|COMPLETED|Washout: 7 Days||20
138288|NCT00835497|318101|P2|STARTED|Washout: 7 Days||20
138289|NCT00835497|318102|P1|STARTED|Washout: 7 Days||20
138290|NCT00835497|318101|P2|NOT COMPLETED|First Intervention||0
138291|NCT00835497|318102|P1|NOT COMPLETED|First Intervention||0
138292|NCT00835497|318101|P2|COMPLETED|First Intervention||20
138293|NCT00835497|318102|P1|COMPLETED|First Intervention||20
138294|NCT00835497|318101|P2|STARTED|First Intervention||20
138295|NCT00835497|318102|P1|STARTED|First Intervention||20
138296|NCT00835484|318118|P2|NOT COMPLETED|Second Intervention||0
138297|NCT00835484|318119|P1|NOT COMPLETED|Second Intervention||0
138298|NCT00835484|318118|P2|COMPLETED|Second Intervention||16
138299|NCT00835484|318119|P1|COMPLETED|Second Intervention||16
138300|NCT00835484|318118|P2|STARTED|Second Intervention||16
138301|NCT00835484|318119|P1|STARTED|Second Intervention||16
138302|NCT00835484|318118|P2|NOT COMPLETED|Washout of 7 Days||0
138303|NCT00835484|318119|P1|NOT COMPLETED|Washout of 7 Days||0
138304|NCT00835484|318118|P2|COMPLETED|Washout of 7 Days||16
138305|NCT00835484|318119|P1|COMPLETED|Washout of 7 Days||16
138306|NCT00835484|318118|P2|STARTED|Washout of 7 Days||16
138307|NCT00835484|318119|P1|STARTED|Washout of 7 Days||16
138308|NCT00835484|318118|P2|NOT COMPLETED|First Intervention||0
138309|NCT00835484|318119|P1|NOT COMPLETED|First Intervention||0
138310|NCT00835484|318118|P2|COMPLETED|First Intervention||16
138311|NCT00835484|318119|P1|COMPLETED|First Intervention||16
138312|NCT00835484|318118|P2|STARTED|First Intervention||16
138313|NCT00835484|318119|P1|STARTED|First Intervention||16
138314|NCT00835406|318129|P2|NOT COMPLETED|Period: Second Intervention||0
138315|NCT00835406|318130|P1|NOT COMPLETED|Period: Second Intervention||0
138316|NCT00835406|318129|P2|COMPLETED|Period: Second Intervention||67
138317|NCT00835406|318130|P1|COMPLETED|Period: Second Intervention||68
138318|NCT00835406|318129|P2|STARTED|Period: Second Intervention||67
138319|NCT00835406|318130|P1|STARTED|Period: Second Intervention||68
138320|NCT00835406|318129|P2|NOT COMPLETED|Period: Washout of 7 Days||2
138321|NCT00835406|318130|P1|NOT COMPLETED|Period: Washout of 7 Days||0
138322|NCT00835406|318129|P2|COMPLETED|Period: Washout of 7 Days||67
138323|NCT00835406|318130|P1|COMPLETED|Period: Washout of 7 Days||68
138324|NCT00835406|318129|P2|STARTED|Period: Washout of 7 Days||69
138325|NCT00835406|318130|P1|STARTED|Period: Washout of 7 Days||68
138326|NCT00835406|318129|P2|NOT COMPLETED|Period: First Intervention||1
138327|NCT00835406|318130|P1|NOT COMPLETED|Period: First Intervention||2
138328|NCT00835406|318129|P2|COMPLETED|Period: First Intervention||69
138329|NCT00835406|318130|P1|COMPLETED|Period: First Intervention||68
138330|NCT00835406|318129|P2|STARTED|Period: First Intervention||70
138331|NCT00835406|318130|P1|STARTED|Period: First Intervention||70
138332|NCT00835380|318136|P1|NOT COMPLETED|Overall Study||2
138333|NCT00835380|318136|P1|COMPLETED|Overall Study||78
138334|NCT00835380|318136|P1|STARTED|Overall Study||80
138335|NCT00835367|318143|P2|NOT COMPLETED|Second Intervention||1
138336|NCT00835367|318144|P1|NOT COMPLETED|Second Intervention||1
138337|NCT00835367|318143|P2|COMPLETED|Second Intervention||33
138338|NCT00835367|318144|P1|COMPLETED|Second Intervention||30
138339|NCT00835367|318143|P2|STARTED|Second Intervention||34
138340|NCT00835367|318144|P1|STARTED|Second Intervention||31
138341|NCT00835367|318143|P2|NOT COMPLETED|Washout||0
138342|NCT00835367|318144|P1|NOT COMPLETED|Washout||3
138343|NCT00835367|318143|P2|COMPLETED|Washout||34
138344|NCT00835367|318144|P1|COMPLETED|Washout||31
138345|NCT00835367|318143|P2|STARTED|Washout||34
138346|NCT00835367|318144|P1|STARTED|Washout||34
138347|NCT00835367|318143|P2|NOT COMPLETED|First Intervention||0
138348|NCT00835367|318144|P1|NOT COMPLETED|First Intervention||0
138349|NCT00835367|318143|P2|COMPLETED|First Intervention||34
138350|NCT00835367|318144|P1|COMPLETED|First Intervention||34
138351|NCT00835367|318143|P2|STARTED|First Intervention||34
138352|NCT00835367|318144|P1|STARTED|First Intervention||34
138353|NCT00835354|318166|P2|NOT COMPLETED|Second Intervention||0
138354|NCT00835354|318167|P1|NOT COMPLETED|Second Intervention||0
138355|NCT00835354|318166|P2|COMPLETED|Second Intervention||12
138356|NCT00835354|318167|P1|COMPLETED|Second Intervention||13
138357|NCT00835354|318166|P2|STARTED|Second Intervention||12
138358|NCT00835354|318167|P1|STARTED|Second Intervention||13
138359|NCT00835354|318166|P2|NOT COMPLETED|Washout of 7 Days||0
138360|NCT00835354|318167|P1|NOT COMPLETED|Washout of 7 Days||0
138361|NCT00835354|318166|P2|COMPLETED|Washout of 7 Days||12
138362|NCT00835354|318167|P1|COMPLETED|Washout of 7 Days||13
138363|NCT00835354|318166|P2|STARTED|Washout of 7 Days||12
138364|NCT00835354|318167|P1|STARTED|Washout of 7 Days||13
138365|NCT00835354|318166|P2|NOT COMPLETED|First Intervention||1
138366|NCT00835354|318167|P1|NOT COMPLETED|First Intervention||0
138367|NCT00835354|318166|P2|COMPLETED|First Intervention||12
138368|NCT00835354|318167|P1|COMPLETED|First Intervention||13
138369|NCT00835354|318166|P2|STARTED|First Intervention||13
138370|NCT00835354|318167|P1|STARTED|First Intervention||13
138371|NCT00835341|318177|P2|NOT COMPLETED|Overall Study||12
138372|NCT00835341|318178|P1|NOT COMPLETED|Overall Study||3
138373|NCT00835341|318177|P2|COMPLETED|Overall Study||46
138374|NCT00835341|318178|P1|COMPLETED|Overall Study||32
138375|NCT00835341|318177|P2|STARTED|Overall Study||58
138376|NCT00835341|318178|P1|STARTED|Overall Study||35
138377|NCT00835276|318186|P2|NOT COMPLETED|Second Intervention||0
138378|NCT00835276|318187|P1|NOT COMPLETED|Second Intervention||0
138379|NCT00835276|318186|P2|COMPLETED|Second Intervention||24
138380|NCT00835276|318187|P1|COMPLETED|Second Intervention||24
138381|NCT00835276|318186|P2|STARTED|Second Intervention||24
138382|NCT00835276|318187|P1|STARTED|Second Intervention||24
138383|NCT00835276|318186|P2|NOT COMPLETED|Washout of 7 Days||0
138384|NCT00835276|318187|P1|NOT COMPLETED|Washout of 7 Days||0
138385|NCT00835276|318186|P2|COMPLETED|Washout of 7 Days||24
138386|NCT00835276|318187|P1|COMPLETED|Washout of 7 Days||24
138387|NCT00835276|318186|P2|STARTED|Washout of 7 Days||24
138388|NCT00835276|318187|P1|STARTED|Washout of 7 Days||24
138389|NCT00835276|318186|P2|NOT COMPLETED|First Intervention||0
138390|NCT00835276|318187|P1|NOT COMPLETED|First Intervention||0
138391|NCT00835276|318186|P2|COMPLETED|First Intervention||24
138392|NCT00835276|318187|P1|COMPLETED|First Intervention||24
138393|NCT00835276|318186|P2|STARTED|First Intervention||24
138394|NCT00835276|318187|P1|STARTED|First Intervention||24
138395|NCT00835263|318197|P2|NOT COMPLETED|Second Intervention||0
138396|NCT00835263|318198|P1|NOT COMPLETED|Second Intervention||1
138397|NCT00835263|318197|P2|COMPLETED|Second Intervention||16
138398|NCT00835263|318198|P1|COMPLETED|Second Intervention||15
138399|NCT00835263|318197|P2|STARTED|Second Intervention||16
138400|NCT00835263|318198|P1|STARTED|Second Intervention||16
138401|NCT00835263|318197|P2|NOT COMPLETED|First Intervention||0
138402|NCT00835263|318198|P1|NOT COMPLETED|First Intervention||0
138403|NCT00835263|318197|P2|COMPLETED|First Intervention||16
138404|NCT00835263|318198|P1|COMPLETED|First Intervention||16
138405|NCT00835263|318197|P2|STARTED|First Intervention||16
138406|NCT00835263|318198|P1|STARTED|First Intervention||16
138407|NCT00835237|318208|P2|NOT COMPLETED|Overall Study||0
138408|NCT00835237|318209|P1|NOT COMPLETED|Overall Study||6
138409|NCT00835237|318208|P2|COMPLETED|Overall Study||445
138410|NCT00835237|318209|P1|COMPLETED|Overall Study||881
138411|NCT00835237|318208|P2|STARTED|Overall Study||445
138412|NCT00835237|318209|P1|STARTED|Overall Study||887
138413|NCT00835224|318233|P1|NOT COMPLETED|Overall Study||10
138414|NCT00835224|318233|P1|COMPLETED|Overall Study||24
138415|NCT00835224|318233|P1|STARTED|Overall Study||34
138416|NCT00835211|318249|P2|NOT COMPLETED|Second Intervention||0
138417|NCT00835211|318250|P1|NOT COMPLETED|Second Intervention||0
138418|NCT00835211|318249|P2|COMPLETED|Second Intervention||22
138419|NCT00835211|318250|P1|COMPLETED|Second Intervention||21
138420|NCT00835211|318249|P2|STARTED|Second Intervention||22
138421|NCT00835211|318250|P1|STARTED|Second Intervention||21
138422|NCT00835211|318249|P2|NOT COMPLETED|Washout: 7 Days||1
138423|NCT00835211|318250|P1|NOT COMPLETED|Washout: 7 Days||3
138424|NCT00835211|318249|P2|COMPLETED|Washout: 7 Days||22
138425|NCT00835211|318250|P1|COMPLETED|Washout: 7 Days||21
138426|NCT00835211|318249|P2|STARTED|Washout: 7 Days||23
138427|NCT00835211|318250|P1|STARTED|Washout: 7 Days||24
138428|NCT00835211|318249|P2|NOT COMPLETED|First Intervention||1
138429|NCT00835211|318250|P1|NOT COMPLETED|First Intervention||0
138430|NCT00835211|318249|P2|COMPLETED|First Intervention||23
138431|NCT00835211|318250|P1|COMPLETED|First Intervention||24
138432|NCT00835211|318249|P2|STARTED|First Intervention||24
138433|NCT00835211|318250|P1|STARTED|First Intervention||24
138434|NCT00835198|318260|P2|NOT COMPLETED|Overall Study||7
138435|NCT00835198|318261|P1|NOT COMPLETED|Overall Study||8
138436|NCT00835198|318260|P2|COMPLETED|Overall Study||74
138437|NCT00835198|318261|P1|COMPLETED|Overall Study||74
138438|NCT00835198|318260|P2|STARTED|Overall Study||81
138439|NCT00835198|318261|P1|STARTED|Overall Study||82
138440|NCT00835185|318273|P1|NOT COMPLETED|Overall Study||0
138441|NCT00835185|318273|P1|COMPLETED|Overall Study||44
138442|NCT00835185|318273|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
138443|NCT00835185|318273|P1|STARTED|Overall Study||44
138444|NCT00835172|318296|P2|NOT COMPLETED|Second Intervention||0
138445|NCT00835172|318297|P1|NOT COMPLETED|Second Intervention||0
138446|NCT00835172|318296|P2|COMPLETED|Second Intervention||15
138447|NCT00835172|318297|P1|COMPLETED|Second Intervention||16
138448|NCT00835172|318296|P2|STARTED|Second Intervention||15
138449|NCT00835172|318297|P1|STARTED|Second Intervention||16
138450|NCT00835172|318296|P2|NOT COMPLETED|Washout||1
138451|NCT00835172|318297|P1|NOT COMPLETED|Washout||0
138452|NCT00835172|318296|P2|COMPLETED|Washout||15
138453|NCT00835172|318297|P1|COMPLETED|Washout||16
138454|NCT00835172|318296|P2|STARTED|Washout||16
138455|NCT00835172|318297|P1|STARTED|Washout||16
138456|NCT00835172|318296|P2|NOT COMPLETED|First Intervention||0
138457|NCT00835172|318297|P1|NOT COMPLETED|First Intervention||0
138458|NCT00835172|318296|P2|COMPLETED|First Intervention||16
138459|NCT00835172|318297|P1|COMPLETED|First Intervention||16
138460|NCT00835172|318296|P2|STARTED|First Intervention||16
138461|NCT00835172|318297|P1|STARTED|First Intervention||16
138462|NCT00835159|318307|P2|NOT COMPLETED|Overall Study||0
138463|NCT00835159|318308|P1|NOT COMPLETED|Overall Study||0
138464|NCT00835159|318307|P2|COMPLETED|Overall Study||17
138465|NCT00835159|318308|P1|COMPLETED|Overall Study||11
138466|NCT00835159|318307|P2|STARTED|Overall Study||17
138467|NCT00835159|318308|P1|STARTED|Overall Study||11
138468|NCT00835146|318316|P2|NOT COMPLETED|Second Intervention||0
138469|NCT00835146|318317|P1|NOT COMPLETED|Second Intervention||0
138470|NCT00835146|318316|P2|COMPLETED|Second Intervention||14
138471|NCT00835146|318317|P1|COMPLETED|Second Intervention||14
138472|NCT00835146|318316|P2|STARTED|Second Intervention||14
138473|NCT00835146|318317|P1|STARTED|Second Intervention||14
138474|NCT00835146|318316|P2|NOT COMPLETED|Washout of 5 Weeks||0
138475|NCT00835146|318317|P1|NOT COMPLETED|Washout of 5 Weeks||0
138476|NCT00835146|318316|P2|COMPLETED|Washout of 5 Weeks||14
138477|NCT00835146|318317|P1|COMPLETED|Washout of 5 Weeks||14
138478|NCT00835146|318316|P2|STARTED|Washout of 5 Weeks||14
138479|NCT00835146|318317|P1|STARTED|Washout of 5 Weeks||14
138480|NCT00835146|318316|P2|NOT COMPLETED|First Intervention||0
138481|NCT00835146|318317|P1|NOT COMPLETED|First Intervention||0
138482|NCT00835146|318316|P2|COMPLETED|First Intervention||14
138483|NCT00835146|318317|P1|COMPLETED|First Intervention||14
138484|NCT00835146|318316|P2|STARTED|First Intervention||14
138485|NCT00835146|318317|P1|STARTED|First Intervention||14
138486|NCT00835120|318323|P1|NOT COMPLETED|Overall Study||8
138487|NCT00835120|318323|P1|COMPLETED|Overall Study||26
138488|NCT00835120|318323|P1|STARTED|Overall Study||34
138489|NCT00835081|318333|P2|NOT COMPLETED|Second Intervention||0
138490|NCT00835081|318334|P1|NOT COMPLETED|Second Intervention||0
138491|NCT00835081|318333|P2|COMPLETED|Second Intervention||13
138492|NCT00835081|318334|P1|COMPLETED|Second Intervention||12
138493|NCT00835081|318333|P2|STARTED|Second Intervention||13
138494|NCT00835081|318334|P1|STARTED|Second Intervention||12
138495|NCT00835081|318333|P2|NOT COMPLETED|Washout of 7 Days||0
138496|NCT00835081|318334|P1|NOT COMPLETED|Washout of 7 Days||1
138497|NCT00835081|318333|P2|COMPLETED|Washout of 7 Days||13
138498|NCT00835081|318334|P1|COMPLETED|Washout of 7 Days||12
138499|NCT00835081|318333|P2|STARTED|Washout of 7 Days||13
138500|NCT00835081|318334|P1|STARTED|Washout of 7 Days||13
138501|NCT00835081|318333|P2|NOT COMPLETED|First Intervention||0
138502|NCT00835081|318334|P1|NOT COMPLETED|First Intervention||0
138503|NCT00835081|318333|P2|COMPLETED|First Intervention||13
138504|NCT00835081|318334|P1|COMPLETED|First Intervention||13
138505|NCT00835081|318333|P2|STARTED|First Intervention||13
138506|NCT00835081|318334|P1|STARTED|First Intervention||13
138507|NCT00835068|318344|P2|NOT COMPLETED|Overall Study||1
138508|NCT00835068|318345|P1|NOT COMPLETED|Overall Study||10
138509|NCT00835068|318344|P2|COMPLETED|Overall Study||0
138510|NCT00835068|318345|P1|COMPLETED|Overall Study||47
138511|NCT00835068|318344|P2|STARTED|Overall Study||1
138512|NCT00835068|318345|P1|STARTED|Overall Study||57
138513|NCT00835042|318365|P2|NOT COMPLETED|Second Intervention||0
138514|NCT00835042|318366|P1|NOT COMPLETED|Second Intervention||0
138515|NCT00835042|318365|P2|COMPLETED|Second Intervention||24
138516|NCT00835042|318366|P1|COMPLETED|Second Intervention||26
138517|NCT00835042|318365|P2|STARTED|Second Intervention||24
138518|NCT00835042|318366|P1|STARTED|Second Intervention||26
138519|NCT00835042|318365|P2|NOT COMPLETED|Washout of 21 Days||2
138520|NCT00835042|318366|P1|NOT COMPLETED|Washout of 21 Days||0
138521|NCT00835042|318365|P2|COMPLETED|Washout of 21 Days||24
138522|NCT00835042|318366|P1|COMPLETED|Washout of 21 Days||26
138523|NCT00835042|318365|P2|STARTED|Washout of 21 Days||26
138524|NCT00835042|318366|P1|STARTED|Washout of 21 Days||26
138525|NCT00835042|318365|P2|NOT COMPLETED|First Intervention||2
138526|NCT00835042|318366|P1|NOT COMPLETED|First Intervention||4
138527|NCT00835042|318365|P2|COMPLETED|First Intervention||26
138528|NCT00835042|318366|P1|COMPLETED|First Intervention||26
138529|NCT00835042|318365|P2|STARTED|First Intervention||28
138530|NCT00835042|318366|P1|STARTED|First Intervention||30
138531|NCT00835003|318388|P2|NOT COMPLETED|Overall Study||0
138532|NCT00835003|318389|P1|NOT COMPLETED|Overall Study||0
138533|NCT00835003|318388|P2|COMPLETED|Overall Study||638
138534|NCT00835003|318389|P1|COMPLETED|Overall Study||636
138535|NCT00835003|318388|P2|STARTED|Overall Study||638
138536|NCT00835003|318389|P1|STARTED|Overall Study||636
138537|NCT00834990|318397|P2|NOT COMPLETED|Second Intervention||0
138538|NCT00834990|318398|P1|NOT COMPLETED|Second Intervention||0
138539|NCT00834990|318397|P2|COMPLETED|Second Intervention||11
138540|NCT00834990|318398|P1|COMPLETED|Second Intervention||12
138541|NCT00834990|318397|P2|STARTED|Second Intervention||11
138542|NCT00834990|318398|P1|STARTED|Second Intervention||12
138543|NCT00834990|318397|P2|NOT COMPLETED|Washout of 7 Days||0
138544|NCT00834990|318398|P1|NOT COMPLETED|Washout of 7 Days||0
138545|NCT00834990|318397|P2|COMPLETED|Washout of 7 Days||11
138546|NCT00834990|318398|P1|COMPLETED|Washout of 7 Days||12
138547|NCT00834990|318397|P2|STARTED|Washout of 7 Days||11
138548|NCT00834990|318398|P1|STARTED|Washout of 7 Days||12
138549|NCT00834990|318397|P2|NOT COMPLETED|First Intervention||0
138550|NCT00834990|318398|P1|NOT COMPLETED|First Intervention||0
138551|NCT00834990|318397|P2|COMPLETED|First Intervention||11
138552|NCT00834990|318398|P1|COMPLETED|First Intervention||12
138553|NCT00834990|318397|P2|STARTED|First Intervention||11
138554|NCT00834990|318398|P1|STARTED|First Intervention||12
138555|NCT00834977|318408|P2|NOT COMPLETED|Second Intervention||0
138556|NCT00834977|318409|P1|NOT COMPLETED|Second Intervention||0
138557|NCT00834977|318408|P2|COMPLETED|Second Intervention||24
138558|NCT00834977|318409|P1|COMPLETED|Second Intervention||24
138559|NCT00834977|318408|P2|STARTED|Second Intervention||24
138560|NCT00834977|318409|P1|STARTED|Second Intervention||24
138561|NCT00834977|318408|P2|NOT COMPLETED|First Intervention||0
138562|NCT00834977|318409|P1|NOT COMPLETED|First Intervention||0
138563|NCT00834977|318408|P2|COMPLETED|First Intervention||24
138564|NCT00834977|318409|P1|COMPLETED|First Intervention||24
138565|NCT00834977|318408|P2|STARTED|First Intervention||24
138566|NCT00834977|318409|P1|STARTED|First Intervention||24
138567|NCT00834964|318431|P2|NOT COMPLETED|Second Intervention||0
138568|NCT00834964|318432|P1|NOT COMPLETED|Second Intervention||0
138569|NCT00834964|318431|P2|COMPLETED|Second Intervention||15
138570|NCT00834964|318432|P1|COMPLETED|Second Intervention||15
138571|NCT00834964|318431|P2|STARTED|Second Intervention||15
138572|NCT00834964|318432|P1|STARTED|Second Intervention||15
138573|NCT00834964|318431|P2|NOT COMPLETED|Washout: 7 Days||0
138574|NCT00834964|318432|P1|NOT COMPLETED|Washout: 7 Days||0
138575|NCT00834964|318431|P2|COMPLETED|Washout: 7 Days||15
138576|NCT00834964|318432|P1|COMPLETED|Washout: 7 Days||15
138577|NCT00834964|318431|P2|STARTED|Washout: 7 Days||15
138578|NCT00834964|318432|P1|STARTED|Washout: 7 Days||15
138579|NCT00834964|318431|P2|NOT COMPLETED|First Intervention||0
138580|NCT00834964|318432|P1|NOT COMPLETED|First Intervention||0
138581|NCT00834964|318431|P2|COMPLETED|First Intervention||15
138582|NCT00834964|318432|P1|COMPLETED|First Intervention||15
138583|NCT00834964|318431|P2|STARTED|First Intervention||15
138584|NCT00834964|318432|P1|STARTED|First Intervention||15
138585|NCT00834912|318452|P6|NOT COMPLETED|Treatment Period 3||0
138586|NCT00834912|318453|P5|NOT COMPLETED|Treatment Period 3||0
138587|NCT00834912|318454|P4|NOT COMPLETED|Treatment Period 3||0
138588|NCT00834912|318455|P3|NOT COMPLETED|Treatment Period 3||0
138589|NCT00834912|318456|P2|NOT COMPLETED|Treatment Period 3||0
138590|NCT00834912|318457|P1|NOT COMPLETED|Treatment Period 3||0
138591|NCT00834912|318452|P6|COMPLETED|Treatment Period 3||6
138592|NCT00834912|318453|P5|COMPLETED|Treatment Period 3||5
138593|NCT00834912|318454|P4|COMPLETED|Treatment Period 3||5
138594|NCT00834912|318455|P3|COMPLETED|Treatment Period 3||5
138595|NCT00834912|318456|P2|COMPLETED|Treatment Period 3||5
138596|NCT00834912|318457|P1|COMPLETED|Treatment Period 3||6
138597|NCT00834912|318452|P6|STARTED|Treatment Period 3||6
138598|NCT00834912|318453|P5|STARTED|Treatment Period 3||5
138599|NCT00834912|318454|P4|STARTED|Treatment Period 3||5
138600|NCT00834912|318455|P3|STARTED|Treatment Period 3||5
138601|NCT00834912|318456|P2|STARTED|Treatment Period 3||5
138602|NCT00834912|318457|P1|STARTED|Treatment Period 3||6
138603|NCT00834912|318452|P6|NOT COMPLETED|Treatment Period 2||0
138604|NCT00834912|318453|P5|NOT COMPLETED|Treatment Period 2||1
138605|NCT00834912|318454|P4|NOT COMPLETED|Treatment Period 2||0
138606|NCT00834912|318455|P3|NOT COMPLETED|Treatment Period 2||1
138607|NCT00834912|318456|P2|NOT COMPLETED|Treatment Period 2||0
138608|NCT00834912|318457|P1|NOT COMPLETED|Treatment Period 2||0
138609|NCT00834912|318452|P6|COMPLETED|Treatment Period 2||6
138610|NCT00834912|318453|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
138611|NCT00834912|318454|P4|COMPLETED|Treatment Period 2||5
138612|NCT00834912|318455|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
138613|NCT00834912|318456|P2|COMPLETED|Treatment Period 2||5
138614|NCT00834912|318457|P1|COMPLETED|Treatment Period 2||6
138615|NCT00834912|318452|P6|STARTED|Treatment Period 2||6
138616|NCT00834912|318453|P5|STARTED|Treatment Period 2||6
138617|NCT00834912|318454|P4|STARTED|Treatment Period 2||5
138618|NCT00834912|318455|P3|STARTED|Treatment Period 2||6
138619|NCT00834912|318456|P2|STARTED|Treatment Period 2||5
138620|NCT00834912|318457|P1|STARTED|Treatment Period 2||6
138621|NCT00834912|318452|P6|NOT COMPLETED|Treatment Period 1||0
138622|NCT00834912|318453|P5|NOT COMPLETED|Treatment Period 1||0
138623|NCT00834912|318454|P4|NOT COMPLETED|Treatment Period 1||1
138624|NCT00834912|318455|P3|NOT COMPLETED|Treatment Period 1||0
138625|NCT00834912|318456|P2|NOT COMPLETED|Treatment Period 1||1
138626|NCT00834912|318457|P1|NOT COMPLETED|Treatment Period 1||0
138627|NCT00834912|318452|P6|COMPLETED|Treatment Period 1||6
138628|NCT00834912|318453|P5|COMPLETED|Treatment Period 1||6
138629|NCT00834912|318454|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
138630|NCT00834912|318455|P3|COMPLETED|Treatment Period 1||6
138631|NCT00834912|318456|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
138632|NCT00834912|318457|P1|COMPLETED|Treatment Period 1||6
138633|NCT00834912|318452|P6|STARTED|Treatment Period 1||6
138634|NCT00834912|318453|P5|STARTED|Treatment Period 1||6
138635|NCT00834912|318454|P4|STARTED|Treatment Period 1||6
138636|NCT00834912|318455|P3|STARTED|Treatment Period 1||6
138637|NCT00834912|318456|P2|STARTED|Treatment Period 1||6
138638|NCT00834912|318457|P1|STARTED|Treatment Period 1||6
138639|NCT00834899|318479|P2|NOT COMPLETED|Overall Study||1
138640|NCT00834899|318480|P1|NOT COMPLETED|Overall Study||1
138641|NCT00834899|318479|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
138642|NCT00834899|318480|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
138643|NCT00834899|318479|P2|STARTED|Overall Study||4
138644|NCT00834899|318480|P1|STARTED|Overall Study||9
138645|NCT00834886|318496|P4|NOT COMPLETED|Overall Study||0
138646|NCT00834886|318497|P3|NOT COMPLETED|Overall Study||1
138647|NCT00834886|318498|P2|NOT COMPLETED|Overall Study||1
138648|NCT00834886|318499|P1|NOT COMPLETED|Overall Study||0
138649|NCT00834886|318496|P4|COMPLETED|Overall Study||10
138650|NCT00834886|318497|P3|COMPLETED|Overall Study||9
138651|NCT00834886|318498|P2|COMPLETED|Overall Study||9
138652|NCT00834886|318499|P1|COMPLETED|Overall Study||10
138653|NCT00834886|318496|P4|STARTED|Overall Study||10
138654|NCT00834886|318497|P3|STARTED|Overall Study||10
138655|NCT00834886|318498|P2|STARTED|Overall Study||10
138656|NCT00834886|318499|P1|STARTED|Overall Study||10
138657|NCT00834873|318519|P2|NOT COMPLETED|Second Intervention||0
138658|NCT00834873|318520|P1|NOT COMPLETED|Second Intervention||0
138659|NCT00834873|318519|P2|COMPLETED|Second Intervention||11
138660|NCT00834873|318520|P1|COMPLETED|Second Intervention||12
138661|NCT00834873|318519|P2|STARTED|Second Intervention||11
138662|NCT00834873|318520|P1|STARTED|Second Intervention||12
138663|NCT00834873|318519|P2|NOT COMPLETED|Washout: 7 Days||0
138664|NCT00834873|318520|P1|NOT COMPLETED|Washout: 7 Days||0
138665|NCT00834873|318519|P2|COMPLETED|Washout: 7 Days||11
138666|NCT00834873|318520|P1|COMPLETED|Washout: 7 Days||12
138667|NCT00834873|318519|P2|STARTED|Washout: 7 Days||11
138668|NCT00834873|318520|P1|STARTED|Washout: 7 Days||12
138669|NCT00834873|318519|P2|NOT COMPLETED|First Intervention||1
138670|NCT00834873|318520|P1|NOT COMPLETED|First Intervention||0
138671|NCT00834873|318519|P2|COMPLETED|First Intervention||11
138672|NCT00834873|318520|P1|COMPLETED|First Intervention||12
138673|NCT00834873|318519|P2|STARTED|First Intervention||12
138674|NCT00834873|318520|P1|STARTED|First Intervention||12
138675|NCT00834808|318531|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
138676|NCT00834808|318532|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
138677|NCT00834808|318533|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
138678|NCT00834808|318531|P3|COMPLETED|Treatment Period 3 (Day 15)||9
138679|NCT00834808|318532|P2|COMPLETED|Treatment Period 3 (Day 15)||9
138680|NCT00834808|318533|P1|COMPLETED|Treatment Period 3 (Day 15)||9
138681|NCT00834808|318531|P3|STARTED|Treatment Period 3 (Day 15)||9
138682|NCT00834808|318532|P2|STARTED|Treatment Period 3 (Day 15)||9
138683|NCT00834808|318533|P1|STARTED|Treatment Period 3 (Day 15)||9
138684|NCT00834808|318531|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
138685|NCT00834808|318532|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
138686|NCT00834808|318533|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
138687|NCT00834808|318531|P3|COMPLETED|Treatment Period 2 (Day 8)||9
138688|NCT00834808|318532|P2|COMPLETED|Treatment Period 2 (Day 8)||9
138689|NCT00834808|318533|P1|COMPLETED|Treatment Period 2 (Day 8)||9
138690|NCT00834808|318531|P3|STARTED|Treatment Period 2 (Day 8)||9
138691|NCT00834808|318532|P2|STARTED|Treatment Period 2 (Day 8)||9
138692|NCT00834808|318533|P1|STARTED|Treatment Period 2 (Day 8)||9
138693|NCT00834808|318531|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
138694|NCT00834808|318532|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
138695|NCT00834808|318533|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
138696|NCT00834808|318531|P3|COMPLETED|Treatment Period 1 (Day 1)||9
138697|NCT00834808|318532|P2|COMPLETED|Treatment Period 1 (Day 1)||9
138698|NCT00834808|318533|P1|COMPLETED|Treatment Period 1 (Day 1)||9
138699|NCT00834808|318531|P3|STARTED|Treatment Period 1 (Day 1)||9
138700|NCT00834808|318532|P2|STARTED|Treatment Period 1 (Day 1)||9
138701|NCT00834808|318533|P1|STARTED|Treatment Period 1 (Day 1)||9
138702|NCT00834795|318555|P2|NOT COMPLETED|Second Intervention||0
138703|NCT00834795|318556|P1|NOT COMPLETED|Second Intervention||1
138704|NCT00834795|318555|P2|COMPLETED|Second Intervention||17
138705|NCT00834795|318556|P1|COMPLETED|Second Intervention||17
138706|NCT00834795|318555|P2|STARTED|Second Intervention||17
138707|NCT00834795|318556|P1|STARTED|Second Intervention||18
138708|NCT00834795|318555|P2|NOT COMPLETED|Washout: 7 Days||1
138709|NCT00834795|318556|P1|NOT COMPLETED|Washout: 7 Days||0
138710|NCT00834795|318555|P2|COMPLETED|Washout: 7 Days||17
138711|NCT00834795|318556|P1|COMPLETED|Washout: 7 Days||18
138712|NCT00834795|318555|P2|STARTED|Washout: 7 Days||18
138713|NCT00834795|318556|P1|STARTED|Washout: 7 Days||18
138714|NCT00834795|318555|P2|NOT COMPLETED|First Intervention||0
138715|NCT00834795|318556|P1|NOT COMPLETED|First Intervention||0
138716|NCT00834795|318555|P2|COMPLETED|First Intervention||18
138717|NCT00834795|318556|P1|COMPLETED|First Intervention||18
138718|NCT00834795|318555|P2|STARTED|First Intervention||18
138719|NCT00834795|318556|P1|STARTED|First Intervention||18
138720|NCT00833794|318566|P2|NOT COMPLETED|Double-blind Phase||49
138721|NCT00833794|318567|P1|NOT COMPLETED|Double-blind Phase||106
138722|NCT00833794|318566|P2|COMPLETED|Double-blind Phase||165
138723|NCT00833794|318567|P1|COMPLETED|Double-blind Phase||326
138724|NCT00833794|318566|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
138725|NCT00833794|318567|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
138726|NCT00833794|318566|P2|NOT COMPLETED|Open-label Phase||0
138727|NCT00833794|318567|P1|NOT COMPLETED|Open-label Phase||382
138728|NCT00833794|318566|P2|COMPLETED|Open-label Phase||0
138729|NCT00833794|318567|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
138730|NCT00833794|318566|P2|Received Open-Label Treatment|Open-label Phase||0
138731|NCT00833794|318567|P1|Received Open-Label Treatment|Open-label Phase||1023
138732|NCT00833794|318566|P2|Entered run-in Period|Open-label Phase||0
138733|NCT00833794|318567|P1|Entered run-in Period|Open-label Phase||1027
138734|NCT00833794|318566|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
138735|NCT00833794|318567|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
138736|NCT00833781|318595|P2|NOT COMPLETED|Overall Study||0
138737|NCT00833781|318596|P1|NOT COMPLETED|Overall Study||0
138738|NCT00833781|318595|P2|COMPLETED|Overall Study||5
138739|NCT00833781|318596|P1|COMPLETED|Overall Study||10
138740|NCT00833781|318595|P2|STARTED|Overall Study||5
138741|NCT00833781|318596|P1|STARTED|Overall Study||10
138742|NCT00833755|318611|P4|NOT COMPLETED|Overall Study||6
138743|NCT00833755|318612|P3|NOT COMPLETED|Overall Study||2
138744|NCT00833755|318613|P2|NOT COMPLETED|Overall Study||5
138745|NCT00833755|318614|P1|NOT COMPLETED|Overall Study||4
138746|NCT00833755|318611|P4|COMPLETED|Overall Study||17
138747|NCT00833755|318612|P3|COMPLETED|Overall Study||20
138748|NCT00833755|318613|P2|COMPLETED|Overall Study||13
138749|NCT00833755|318614|P1|COMPLETED|Overall Study||12
138750|NCT00833755|318611|P4|STARTED|Overall Study||23
138751|NCT00833755|318612|P3|STARTED|Overall Study||22
138752|NCT00833755|318613|P2|STARTED|Overall Study||18
138753|NCT00833755|318614|P1|STARTED|Overall Study||16
138754|NCT00833703|318634|P2|NOT COMPLETED|Overall Study||1
138755|NCT00833703|318635|P1|NOT COMPLETED|Overall Study||0
138756|NCT00833703|318634|P2|COMPLETED|Overall Study|Completed follow-up|25
138757|NCT00833703|318635|P1|COMPLETED|Overall Study|Completed follow-up|23
138758|NCT00833703|318634|P2|Completed Treatment|Overall Study||24
138759|NCT00833703|318635|P1|Completed Treatment|Overall Study||22
138760|NCT00833703|318634|P2|Treated|Overall Study||26
138761|NCT00833703|318635|P1|Treated|Overall Study||23
138762|NCT00833703|318634|P2|STARTED|Overall Study|Included|26
138763|NCT00833703|318635|P1|STARTED|Overall Study|Included|23
138764|NCT00833690|318648|P3|NOT COMPLETED|Overall Study||0
138765|NCT00833690|318649|P2|NOT COMPLETED|Overall Study||2
138766|NCT00833690|318650|P1|NOT COMPLETED|Overall Study||4
138767|NCT00833690|318648|P3|COMPLETED|Overall Study||26
138768|NCT00833690|318649|P2|COMPLETED|Overall Study||22
138769|NCT00833690|318650|P1|COMPLETED|Overall Study||21
138770|NCT00833690|318648|P3|STARTED|Overall Study||26
138771|NCT00833690|318649|P2|STARTED|Overall Study||24
138772|NCT00833690|318650|P1|STARTED|Overall Study||25
138773|NCT00833664|318774|P2|NOT COMPLETED|Second Intervention||0
138774|NCT00833664|318775|P1|NOT COMPLETED|Second Intervention||0
138775|NCT00833664|318774|P2|COMPLETED|Second Intervention||11
138776|NCT00833664|318775|P1|COMPLETED|Second Intervention||10
138777|NCT00833664|318774|P2|STARTED|Second Intervention||11
138778|NCT00833664|318775|P1|STARTED|Second Intervention||10
138779|NCT00833664|318774|P2|NOT COMPLETED|Washout: 14 Days||0
138780|NCT00833664|318775|P1|NOT COMPLETED|Washout: 14 Days||1
138781|NCT00833664|318774|P2|COMPLETED|Washout: 14 Days||11
138782|NCT00833664|318775|P1|COMPLETED|Washout: 14 Days||10
138783|NCT00833664|318774|P2|STARTED|Washout: 14 Days||11
138784|NCT00833664|318775|P1|STARTED|Washout: 14 Days||11
138785|NCT00833664|318774|P2|NOT COMPLETED|First Intervention||0
138786|NCT00833664|318775|P1|NOT COMPLETED|First Intervention||0
138787|NCT00833664|318774|P2|COMPLETED|First Intervention||11
138788|NCT00833664|318775|P1|COMPLETED|First Intervention||11
138789|NCT00833664|318774|P2|STARTED|First Intervention||11
138790|NCT00833664|318775|P1|STARTED|First Intervention||11
138791|NCT00833638|318786|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
138792|NCT00833638|318787|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
138793|NCT00833638|318788|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
138794|NCT00833638|318786|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
138795|NCT00833638|318787|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
138796|NCT00833638|318788|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
138797|NCT00833638|318786|P3|STARTED|Phase 3: Open-label Extension Phase||124
138798|NCT00833638|318787|P2|STARTED|Phase 3: Open-label Extension Phase||108
138799|NCT00833638|318788|P1|STARTED|Phase 3: Open-label Extension Phase||111
138800|NCT00833638|318786|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
138801|NCT00833638|318787|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
138802|NCT00833638|318788|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
138803|NCT00833638|318786|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
138804|NCT00833638|318787|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
138805|NCT00833638|318788|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
138806|NCT00833638|318786|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
138807|NCT00833638|318787|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
138808|NCT00833638|318788|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
138809|NCT00833586|318830|P2|NOT COMPLETED|Second Intervention||0
138810|NCT00833586|318831|P1|NOT COMPLETED|Second Intervention||0
138811|NCT00833586|318830|P2|COMPLETED|Second Intervention||14
138812|NCT00833586|318831|P1|COMPLETED|Second Intervention||14
138813|NCT00833586|318830|P2|STARTED|Second Intervention||14
138814|NCT00833586|318831|P1|STARTED|Second Intervention||14
138815|NCT00833586|318830|P2|NOT COMPLETED|Washout: 14 Days||0
138816|NCT00833586|318831|P1|NOT COMPLETED|Washout: 14 Days||0
138817|NCT00833586|318830|P2|COMPLETED|Washout: 14 Days||14
138818|NCT00833586|318831|P1|COMPLETED|Washout: 14 Days||14
138819|NCT00833586|318830|P2|STARTED|Washout: 14 Days||14
138820|NCT00833586|318831|P1|STARTED|Washout: 14 Days||14
138821|NCT00833586|318830|P2|NOT COMPLETED|First Intervention||0
138822|NCT00833586|318831|P1|NOT COMPLETED|First Intervention||0
138823|NCT00833586|318830|P2|COMPLETED|First Intervention||14
138824|NCT00833586|318831|P1|COMPLETED|First Intervention||14
138825|NCT00833586|318830|P2|STARTED|First Intervention||14
138826|NCT00833586|318831|P1|STARTED|First Intervention||14
138827|NCT00833560|318839|P1|NOT COMPLETED|Overall Study||42
138828|NCT00833560|318839|P1|COMPLETED|Overall Study||353
138829|NCT00833560|318839|P1|STARTED|Overall Study||395
138830|NCT00833547|318848|P2|NOT COMPLETED|Overall Study||2
138831|NCT00833547|318849|P1|NOT COMPLETED|Overall Study||2
138832|NCT00833547|318848|P2|COMPLETED|Overall Study||10
138833|NCT00833547|318849|P1|COMPLETED|Overall Study||11
138834|NCT00833547|318848|P2|STARTED|Overall Study||12
138835|NCT00833547|318849|P1|STARTED|Overall Study||13
138836|NCT00834756|318859|P2|NOT COMPLETED|Second Intervention||0
138837|NCT00834756|318860|P1|NOT COMPLETED|Second Intervention||0
138838|NCT00834756|318859|P2|COMPLETED|Second Intervention||18
138839|NCT00834756|318860|P1|COMPLETED|Second Intervention||16
138840|NCT00834756|318859|P2|STARTED|Second Intervention||18
138841|NCT00834756|318860|P1|STARTED|Second Intervention||16
138842|NCT00834756|318859|P2|NOT COMPLETED|Washout: 21 Days||0
138843|NCT00834756|318860|P1|NOT COMPLETED|Washout: 21 Days||1
138844|NCT00834756|318859|P2|COMPLETED|Washout: 21 Days||18
138845|NCT00834756|318860|P1|COMPLETED|Washout: 21 Days||16
138846|NCT00834756|318859|P2|STARTED|Washout: 21 Days||18
138847|NCT00834756|318860|P1|STARTED|Washout: 21 Days||17
138848|NCT00834756|318859|P2|NOT COMPLETED|First Intervention||0
138849|NCT00834756|318860|P1|NOT COMPLETED|First Intervention||1
138850|NCT00834756|318859|P2|COMPLETED|First Intervention||18
138851|NCT00834756|318860|P1|COMPLETED|First Intervention||17
138852|NCT00834756|318859|P2|STARTED|First Intervention||18
138853|NCT00834756|318860|P1|STARTED|First Intervention||18
138854|NCT00834743|318870|P2|NOT COMPLETED|Second Intervention||0
138855|NCT00834743|318871|P1|NOT COMPLETED|Second Intervention||1
138856|NCT00834743|318870|P2|COMPLETED|Second Intervention||16
138857|NCT00834743|318871|P1|COMPLETED|Second Intervention||15
138858|NCT00834743|318870|P2|STARTED|Second Intervention||16
138859|NCT00834743|318871|P1|STARTED|Second Intervention||16
138860|NCT00834743|318870|P2|NOT COMPLETED|Washout of 7 Days||0
138861|NCT00834743|318871|P1|NOT COMPLETED|Washout of 7 Days||0
138862|NCT00834743|318870|P2|COMPLETED|Washout of 7 Days||16
138863|NCT00834743|318871|P1|COMPLETED|Washout of 7 Days||16
138864|NCT00834743|318870|P2|STARTED|Washout of 7 Days||16
138865|NCT00834743|318871|P1|STARTED|Washout of 7 Days||16
138866|NCT00834743|318870|P2|NOT COMPLETED|First Intervention||0
138867|NCT00834743|318871|P1|NOT COMPLETED|First Intervention||0
138868|NCT00834743|318870|P2|COMPLETED|First Intervention||16
138869|NCT00834743|318871|P1|COMPLETED|First Intervention||16
138870|NCT00834743|318870|P2|STARTED|First Intervention||16
138871|NCT00834743|318871|P1|STARTED|First Intervention||16
138872|NCT00834717|318881|P2|NOT COMPLETED|Second Intervention||0
138873|NCT00834717|318882|P1|NOT COMPLETED|Second Intervention||0
138874|NCT00834717|318881|P2|COMPLETED|Second Intervention||19
138875|NCT00834717|318882|P1|COMPLETED|Second Intervention||19
138876|NCT00834717|318881|P2|STARTED|Second Intervention||19
138877|NCT00834717|318882|P1|STARTED|Second Intervention||19
138878|NCT00834717|318881|P2|NOT COMPLETED|First Intervention||1
138879|NCT00834717|318882|P1|NOT COMPLETED|First Intervention||1
138880|NCT00834717|318881|P2|COMPLETED|First Intervention||19
138881|NCT00834717|318882|P1|COMPLETED|First Intervention||19
138882|NCT00834717|318881|P2|STARTED|First Intervention||20
138883|NCT00834717|318882|P1|STARTED|First Intervention||20
138884|NCT00834678|318890|P1|NOT COMPLETED|Overall Study||0
138885|NCT00834678|318890|P1|COMPLETED|Overall Study||11
138886|NCT00834678|318890|P1|STARTED|Overall Study||11
138887|NCT00834639|318903|P2|NOT COMPLETED|Second Intervention||2
138888|NCT00834639|318904|P1|NOT COMPLETED|Second Intervention||0
138889|NCT00834639|318903|P2|COMPLETED|Second Intervention||10
138890|NCT00834639|318904|P1|COMPLETED|Second Intervention||12
138891|NCT00834639|318903|P2|STARTED|Second Intervention||12
138892|NCT00834639|318904|P1|STARTED|Second Intervention||12
138893|NCT00834639|318903|P2|NOT COMPLETED|Washout of 7 Days||0
138894|NCT00834639|318904|P1|NOT COMPLETED|Washout of 7 Days||0
138895|NCT00834639|318903|P2|COMPLETED|Washout of 7 Days||12
138896|NCT00834639|318904|P1|COMPLETED|Washout of 7 Days||12
138897|NCT00834639|318903|P2|STARTED|Washout of 7 Days||12
138898|NCT00834639|318904|P1|STARTED|Washout of 7 Days||12
138899|NCT00834639|318903|P2|NOT COMPLETED|First Intervention||0
138900|NCT00834639|318904|P1|NOT COMPLETED|First Intervention||0
138901|NCT00834639|318903|P2|COMPLETED|First Intervention||12
138902|NCT00834639|318904|P1|COMPLETED|First Intervention||12
138903|NCT00834639|318903|P2|STARTED|First Intervention||12
138904|NCT00834639|318904|P1|STARTED|First Intervention||12
138905|NCT00834626|318912|P1|NOT COMPLETED|Overall Study||0
138906|NCT00834626|318912|P1|COMPLETED|Overall Study||30
138907|NCT00834626|318912|P1|1 Year Follow-up|Overall Study||30
138908|NCT00834626|318912|P1|STARTED|Overall Study||30
138909|NCT00834613|318921|P2|NOT COMPLETED|Second Intervention||0
138910|NCT00834613|318922|P1|NOT COMPLETED|Second Intervention||0
138911|NCT00834613|318921|P2|COMPLETED|Second Intervention||16
138912|NCT00834613|318922|P1|COMPLETED|Second Intervention||15
138913|NCT00834613|318921|P2|STARTED|Second Intervention||16
138914|NCT00834613|318922|P1|STARTED|Second Intervention||15
138915|NCT00834613|318921|P2|NOT COMPLETED|Washout of 7 Days||0
138916|NCT00834613|318922|P1|NOT COMPLETED|Washout of 7 Days||0
138917|NCT00834613|318921|P2|COMPLETED|Washout of 7 Days||16
138918|NCT00834613|318922|P1|COMPLETED|Washout of 7 Days||15
138919|NCT00834613|318921|P2|STARTED|Washout of 7 Days||16
138920|NCT00834613|318922|P1|STARTED|Washout of 7 Days||15
138921|NCT00834613|318921|P2|NOT COMPLETED|First Intervention||0
138922|NCT00834613|318922|P1|NOT COMPLETED|First Intervention||1
138923|NCT00834613|318921|P2|COMPLETED|First Intervention||16
138924|NCT00834613|318922|P1|COMPLETED|First Intervention||15
138925|NCT00834613|318921|P2|STARTED|First Intervention||16
138926|NCT00834613|318922|P1|STARTED|First Intervention||16
138927|NCT00834587|318932|P2|NOT COMPLETED|Second Intervention||0
138928|NCT00834587|318933|P1|NOT COMPLETED|Second Intervention||0
138929|NCT00834587|318932|P2|COMPLETED|Second Intervention||20
138930|NCT00834587|318933|P1|COMPLETED|Second Intervention||19
138931|NCT00834587|318932|P2|STARTED|Second Intervention||20
138932|NCT00834587|318933|P1|STARTED|Second Intervention||19
138933|NCT00834587|318932|P2|NOT COMPLETED|Washout: 7 Days||0
138934|NCT00834587|318933|P1|NOT COMPLETED|Washout: 7 Days||1
138935|NCT00834587|318932|P2|COMPLETED|Washout: 7 Days||20
138936|NCT00834587|318933|P1|COMPLETED|Washout: 7 Days||19
138937|NCT00834587|318932|P2|STARTED|Washout: 7 Days||20
138938|NCT00834587|318933|P1|STARTED|Washout: 7 Days||20
138939|NCT00834587|318932|P2|NOT COMPLETED|First Intervention||0
138940|NCT00834587|318933|P1|NOT COMPLETED|First Intervention||0
138941|NCT00834587|318932|P2|COMPLETED|First Intervention||20
138942|NCT00834587|318933|P1|COMPLETED|First Intervention||20
138943|NCT00834587|318932|P2|STARTED|First Intervention||20
138944|NCT00834587|318933|P1|STARTED|First Intervention||20
138945|NCT00834574|318949|P2|NOT COMPLETED|Second Intervention||0
138946|NCT00834574|318950|P1|NOT COMPLETED|Second Intervention||0
138947|NCT00834574|318949|P2|COMPLETED|Second Intervention||16
138948|NCT00834574|318950|P1|COMPLETED|Second Intervention||16
138949|NCT00834574|318949|P2|STARTED|Second Intervention||16
138950|NCT00834574|318950|P1|STARTED|Second Intervention||16
138951|NCT00834574|318949|P2|NOT COMPLETED|Washout of 7 Days||0
138952|NCT00834574|318950|P1|NOT COMPLETED|Washout of 7 Days||0
138953|NCT00834574|318949|P2|COMPLETED|Washout of 7 Days||16
138954|NCT00834574|318950|P1|COMPLETED|Washout of 7 Days||16
138955|NCT00834574|318949|P2|STARTED|Washout of 7 Days||16
138956|NCT00834574|318950|P1|STARTED|Washout of 7 Days||16
138957|NCT00834574|318949|P2|NOT COMPLETED|First Intervention||0
138958|NCT00834574|318950|P1|NOT COMPLETED|First Intervention||0
138959|NCT00834574|318949|P2|COMPLETED|First Intervention||16
138960|NCT00834574|318950|P1|COMPLETED|First Intervention||16
138961|NCT00834574|318949|P2|STARTED|First Intervention||16
138962|NCT00834574|318950|P1|STARTED|First Intervention||16
138963|NCT00834561|318960|P2|NOT COMPLETED|Second Intervention||0
138964|NCT00834561|318961|P1|NOT COMPLETED|Second Intervention||0
138965|NCT00834561|318960|P2|COMPLETED|Second Intervention||16
138966|NCT00834561|318961|P1|COMPLETED|Second Intervention||16
138967|NCT00834561|318960|P2|STARTED|Second Intervention||16
138968|NCT00834561|318961|P1|STARTED|Second Intervention||16
138969|NCT00834561|318960|P2|NOT COMPLETED|First Intervention||0
138970|NCT00834561|318961|P1|NOT COMPLETED|First Intervention||0
138971|NCT00834561|318960|P2|COMPLETED|First Intervention||16
138972|NCT00834561|318961|P1|COMPLETED|First Intervention||16
138973|NCT00834561|318960|P2|STARTED|First Intervention||16
138974|NCT00834561|318961|P1|STARTED|First Intervention||16
138975|NCT00834535|318971|P2|NOT COMPLETED|Second Intervention||0
138976|NCT00834535|318972|P1|NOT COMPLETED|Second Intervention||0
138977|NCT00834535|318971|P2|COMPLETED|Second Intervention||16
138978|NCT00834535|318972|P1|COMPLETED|Second Intervention||16
138979|NCT00834535|318971|P2|STARTED|Second Intervention||16
138980|NCT00834535|318972|P1|STARTED|Second Intervention||16
138981|NCT00834535|318971|P2|NOT COMPLETED|Washout of 7 Days||0
138982|NCT00834535|318972|P1|NOT COMPLETED|Washout of 7 Days||0
138983|NCT00834535|318971|P2|COMPLETED|Washout of 7 Days||16
138984|NCT00834535|318972|P1|COMPLETED|Washout of 7 Days||16
138985|NCT00834535|318971|P2|STARTED|Washout of 7 Days||16
138986|NCT00834535|318972|P1|STARTED|Washout of 7 Days||16
138987|NCT00834535|318971|P2|NOT COMPLETED|First Intervention||0
138988|NCT00834535|318972|P1|NOT COMPLETED|First Intervention||0
138989|NCT00834535|318971|P2|COMPLETED|First Intervention||16
138990|NCT00834535|318972|P1|COMPLETED|First Intervention||16
138991|NCT00834535|318971|P2|STARTED|First Intervention||16
138992|NCT00834535|318972|P1|STARTED|First Intervention||16
138993|NCT00834522|318982|P2|NOT COMPLETED|Second Intervention||0
138994|NCT00834522|318983|P1|NOT COMPLETED|Second Intervention||0
138995|NCT00834522|318982|P2|COMPLETED|Second Intervention||39
138996|NCT00834522|318983|P1|COMPLETED|Second Intervention||37
138997|NCT00834522|318982|P2|STARTED|Second Intervention||39
138998|NCT00834522|318983|P1|STARTED|Second Intervention||37
138999|NCT00834522|318982|P2|NOT COMPLETED|Washout||1
139000|NCT00834522|318983|P1|NOT COMPLETED|Washout||3
139001|NCT00834522|318982|P2|COMPLETED|Washout||39
139002|NCT00834522|318983|P1|COMPLETED|Washout||37
139003|NCT00834522|318982|P2|STARTED|Washout||40
139004|NCT00834522|318983|P1|STARTED|Washout||40
139005|NCT00834522|318982|P2|NOT COMPLETED|First Intervention||0
139006|NCT00834522|318983|P1|NOT COMPLETED|First Intervention||0
139007|NCT00834522|318982|P2|COMPLETED|First Intervention||40
139008|NCT00834522|318983|P1|COMPLETED|First Intervention||40
139009|NCT00834522|318982|P2|STARTED|First Intervention||40
139010|NCT00834522|318983|P1|STARTED|First Intervention||40
139011|NCT00834483|318993|P2|NOT COMPLETED|Overall Study||0
139012|NCT00834483|318994|P1|NOT COMPLETED|Overall Study||0
139013|NCT00834483|318993|P2|COMPLETED|Overall Study||29
139014|NCT00834483|318994|P1|COMPLETED|Overall Study||31
139015|NCT00834483|318993|P2|STARTED|Overall Study||29
139016|NCT00834483|318994|P1|STARTED|Overall Study||31
139017|NCT00834444|319006|P2|NOT COMPLETED|Second Intervention||0
139018|NCT00834444|319007|P1|NOT COMPLETED|Second Intervention||1
139019|NCT00834444|319006|P2|COMPLETED|Second Intervention||16
139020|NCT00834444|319007|P1|COMPLETED|Second Intervention||16
139021|NCT00834444|319006|P2|STARTED|Second Intervention||16
139022|NCT00834444|319007|P1|STARTED|Second Intervention||17
139023|NCT00834444|319006|P2|NOT COMPLETED|Washout of 7 Days||1
139024|NCT00834444|319007|P1|NOT COMPLETED|Washout of 7 Days||0
139025|NCT00834444|319006|P2|COMPLETED|Washout of 7 Days||16
139026|NCT00834444|319007|P1|COMPLETED|Washout of 7 Days||17
139027|NCT00834444|319006|P2|STARTED|Washout of 7 Days||17
139028|NCT00834444|319007|P1|STARTED|Washout of 7 Days||17
139029|NCT00834444|319006|P2|NOT COMPLETED|First Intervention||1
139030|NCT00834444|319007|P1|NOT COMPLETED|First Intervention||1
139031|NCT00834444|319006|P2|COMPLETED|First Intervention||17
139032|NCT00834444|319007|P1|COMPLETED|First Intervention||17
139033|NCT00834444|319006|P2|STARTED|First Intervention||18
139034|NCT00834444|319007|P1|STARTED|First Intervention||18
139035|NCT00834431|319017|P2|NOT COMPLETED|Second Intervention||0
139036|NCT00834431|319018|P1|NOT COMPLETED|Second Intervention||0
139037|NCT00834431|319017|P2|COMPLETED|Second Intervention||16
139038|NCT00834431|319018|P1|COMPLETED|Second Intervention||18
139039|NCT00834431|319017|P2|STARTED|Second Intervention||16
139040|NCT00834431|319018|P1|STARTED|Second Intervention||18
139041|NCT00834431|319017|P2|NOT COMPLETED|Washout of 7 Days||1
139042|NCT00834431|319018|P1|NOT COMPLETED|Washout of 7 Days||0
139043|NCT00834431|319017|P2|COMPLETED|Washout of 7 Days||16
139044|NCT00834431|319018|P1|COMPLETED|Washout of 7 Days||18
139045|NCT00834431|319017|P2|STARTED|Washout of 7 Days||17
139046|NCT00834431|319018|P1|STARTED|Washout of 7 Days||18
139047|NCT00834431|319017|P2|NOT COMPLETED|First Intervention||1
139048|NCT00834431|319018|P1|NOT COMPLETED|First Intervention||0
139049|NCT00834431|319017|P2|COMPLETED|First Intervention||17
139050|NCT00834431|319018|P1|COMPLETED|First Intervention||18
139051|NCT00834431|319017|P2|STARTED|First Intervention||18
139052|NCT00834431|319018|P1|STARTED|First Intervention||18
139053|NCT00834418|319028|P2|NOT COMPLETED|Overall Study||2
139054|NCT00834418|319029|P1|NOT COMPLETED|Overall Study||0
139055|NCT00834418|319028|P2|COMPLETED|Overall Study||40
139056|NCT00834418|319029|P1|COMPLETED|Overall Study||42
139057|NCT00834418|319028|P2|STARTED|Overall Study||42
139058|NCT00834418|319029|P1|STARTED|Overall Study||42
139059|NCT00834405|319037|P2|NOT COMPLETED|Overall Study||0
139060|NCT00834405|319038|P1|NOT COMPLETED|Overall Study||0
139061|NCT00834405|319037|P2|COMPLETED|Overall Study||17
139062|NCT00834405|319038|P1|COMPLETED|Overall Study||20
139063|NCT00834405|319037|P2|STARTED|Overall Study||17
139064|NCT00834405|319038|P1|STARTED|Overall Study||20
139065|NCT00834366|319046|P2|NOT COMPLETED|Treatment Period 2||0
139066|NCT00834366|319047|P1|NOT COMPLETED|Treatment Period 2||0
139067|NCT00834366|319046|P2|COMPLETED|Treatment Period 2||12
139068|NCT00834366|319047|P1|COMPLETED|Treatment Period 2||12
139069|NCT00834366|319046|P2|STARTED|Treatment Period 2||12
139070|NCT00834366|319047|P1|STARTED|Treatment Period 2||12
139071|NCT00834366|319046|P2|NOT COMPLETED|Treatment Period 1||1
139072|NCT00834366|319047|P1|NOT COMPLETED|Treatment Period 1||1
139073|NCT00834366|319046|P2|COMPLETED|Treatment Period 1||12
139074|NCT00834366|319047|P1|COMPLETED|Treatment Period 1||12
139075|NCT00834366|319046|P2|STARTED|Treatment Period 1||13
139076|NCT00834366|319047|P1|STARTED|Treatment Period 1||13
139077|NCT00834340|319063|P2|NOT COMPLETED|Second Intervention||0
139078|NCT00834340|319064|P1|NOT COMPLETED|Second Intervention||0
139079|NCT00834340|319063|P2|COMPLETED|Second Intervention||16
139080|NCT00834340|319064|P1|COMPLETED|Second Intervention||14
139081|NCT00834340|319063|P2|STARTED|Second Intervention||16
139082|NCT00834340|319064|P1|STARTED|Second Intervention||14
139083|NCT00834340|319063|P2|NOT COMPLETED|Washout||0
139084|NCT00834340|319064|P1|NOT COMPLETED|Washout||2
139085|NCT00834340|319063|P2|COMPLETED|Washout||16
139086|NCT00834340|319064|P1|COMPLETED|Washout||14
139087|NCT00834340|319063|P2|STARTED|Washout||16
139088|NCT00834340|319064|P1|STARTED|Washout||16
139089|NCT00834340|319063|P2|NOT COMPLETED|First Intervention||0
139090|NCT00834340|319064|P1|NOT COMPLETED|First Intervention||0
139091|NCT00834340|319063|P2|COMPLETED|First Intervention||16
139092|NCT00834340|319064|P1|COMPLETED|First Intervention||16
139093|NCT00834340|319063|P2|STARTED|First Intervention||16
139094|NCT00834340|319064|P1|STARTED|First Intervention||16
139095|NCT00834288|319074|P2|NOT COMPLETED|Treatment Phase II||0
139096|NCT00834288|319075|P1|NOT COMPLETED|Treatment Phase II||0
139097|NCT00834288|319074|P2|COMPLETED|Treatment Phase II||13
139098|NCT00834288|319075|P1|COMPLETED|Treatment Phase II||13
139099|NCT00834288|319074|P2|STARTED|Treatment Phase II||13
139100|NCT00834288|319075|P1|STARTED|Treatment Phase II||13
139101|NCT00834288|319074|P2|NOT COMPLETED|Treatment Phase I||0
139102|NCT00834288|319075|P1|NOT COMPLETED|Treatment Phase I||0
139103|NCT00834288|319074|P2|COMPLETED|Treatment Phase I||13
139104|NCT00834288|319075|P1|COMPLETED|Treatment Phase I||13
139105|NCT00834288|319074|P2|STARTED|Treatment Phase I||13
139106|NCT00834288|319075|P1|STARTED|Treatment Phase I||13
139107|NCT00834275|319097|P2|NOT COMPLETED|Second Intervention||0
139108|NCT00834275|319098|P1|NOT COMPLETED|Second Intervention||0
139109|NCT00834275|319097|P2|COMPLETED|Second Intervention||13
139110|NCT00834275|319098|P1|COMPLETED|Second Intervention||13
139111|NCT00834275|319097|P2|STARTED|Second Intervention||13
139112|NCT00834275|319098|P1|STARTED|Second Intervention||13
139113|NCT00834275|319097|P2|NOT COMPLETED|Washout of 7 Days||0
139114|NCT00834275|319098|P1|NOT COMPLETED|Washout of 7 Days||0
139115|NCT00834275|319097|P2|COMPLETED|Washout of 7 Days||13
139116|NCT00834275|319098|P1|COMPLETED|Washout of 7 Days||13
139117|NCT00834275|319097|P2|STARTED|Washout of 7 Days||13
139118|NCT00834275|319098|P1|STARTED|Washout of 7 Days||13
139119|NCT00834275|319097|P2|NOT COMPLETED|First Intervention||0
139120|NCT00834275|319098|P1|NOT COMPLETED|First Intervention||0
139121|NCT00834275|319097|P2|COMPLETED|First Intervention||13
139122|NCT00834275|319098|P1|COMPLETED|First Intervention||13
139123|NCT00834275|319097|P2|STARTED|First Intervention||13
139124|NCT00834275|319098|P1|STARTED|First Intervention||13
139125|NCT00834249|319108|P2|NOT COMPLETED|Second Intervention||0
139126|NCT00834249|319109|P1|NOT COMPLETED|Second Intervention||1
139127|NCT00834249|319108|P2|COMPLETED|Second Intervention||8
139128|NCT00834249|319109|P1|COMPLETED|Second Intervention||7
139129|NCT00834249|319108|P2|STARTED|Second Intervention||8
139130|NCT00834249|319109|P1|STARTED|Second Intervention||8
139131|NCT00834249|319108|P2|NOT COMPLETED|Washout: 7 Days||1
139132|NCT00834249|319109|P1|NOT COMPLETED|Washout: 7 Days||1
139133|NCT00834249|319108|P2|COMPLETED|Washout: 7 Days||8
139134|NCT00834249|319109|P1|COMPLETED|Washout: 7 Days||8
139135|NCT00834249|319108|P2|STARTED|Washout: 7 Days||9
139136|NCT00834249|319109|P1|STARTED|Washout: 7 Days||9
139137|NCT00834249|319108|P2|NOT COMPLETED|First Intervention||0
139138|NCT00834249|319109|P1|NOT COMPLETED|First Intervention||0
139139|NCT00834249|319108|P2|COMPLETED|First Intervention||9
139140|NCT00834249|319109|P1|COMPLETED|First Intervention||9
139141|NCT00834249|319108|P2|STARTED|First Intervention||9
139142|NCT00834249|319109|P1|STARTED|First Intervention||9
139143|NCT00834236|319125|P2|NOT COMPLETED|Overall Study||0
139144|NCT00834236|319126|P1|NOT COMPLETED|Overall Study||0
139145|NCT00834236|319125|P2|COMPLETED|Overall Study||47
139146|NCT00834236|319126|P1|COMPLETED|Overall Study||29
139147|NCT00834236|319125|P2|STARTED|Overall Study||47
139148|NCT00834236|319126|P1|STARTED|Overall Study||29
139149|NCT00834210|319134|P2|NOT COMPLETED|Overall Study||8
139150|NCT00834210|319135|P1|NOT COMPLETED|Overall Study||3
139151|NCT00834210|319134|P2|COMPLETED|Overall Study||77
139152|NCT00834210|319135|P1|COMPLETED|Overall Study||83
139153|NCT00834210|319134|P2|STARTED|Overall Study||85
139154|NCT00834210|319135|P1|STARTED|Overall Study||86
139155|NCT00834197|319149|P2|NOT COMPLETED|Second Intervention||0
139156|NCT00834197|319150|P1|NOT COMPLETED|Second Intervention||0
139157|NCT00834197|319149|P2|COMPLETED|Second Intervention||16
139158|NCT00834197|319150|P1|COMPLETED|Second Intervention||16
139159|NCT00834197|319149|P2|STARTED|Second Intervention||16
139160|NCT00834197|319150|P1|STARTED|Second Intervention||16
139161|NCT00834197|319149|P2|NOT COMPLETED|Washout of 14 Days||0
139162|NCT00834197|319150|P1|NOT COMPLETED|Washout of 14 Days||0
139163|NCT00834197|319149|P2|COMPLETED|Washout of 14 Days||16
139164|NCT00834197|319150|P1|COMPLETED|Washout of 14 Days||16
139165|NCT00834197|319149|P2|STARTED|Washout of 14 Days||16
139166|NCT00834197|319150|P1|STARTED|Washout of 14 Days||16
139167|NCT00834197|319149|P2|NOT COMPLETED|First Intervention||0
139168|NCT00834197|319150|P1|NOT COMPLETED|First Intervention||0
139169|NCT00834197|319149|P2|COMPLETED|First Intervention||16
139170|NCT00834197|319150|P1|COMPLETED|First Intervention||16
139171|NCT00834197|319149|P2|STARTED|First Intervention||16
139172|NCT00834197|319150|P1|STARTED|First Intervention||16
139173|NCT00834171|319160|P2|NOT COMPLETED|Overall Study||0
139174|NCT00834171|319161|P1|NOT COMPLETED|Overall Study||0
139175|NCT00834171|319160|P2|COMPLETED|Overall Study||7
139176|NCT00834171|319161|P1|COMPLETED|Overall Study||43
139177|NCT00834171|319160|P2|STARTED|Overall Study||7
139178|NCT00834171|319161|P1|STARTED|Overall Study||43
139179|NCT00834132|319169|P2|NOT COMPLETED|Second Intervention||0
139180|NCT00834132|319170|P1|NOT COMPLETED|Second Intervention||0
139181|NCT00834132|319169|P2|COMPLETED|Second Intervention||12
139182|NCT00834132|319170|P1|COMPLETED|Second Intervention||12
139183|NCT00834132|319169|P2|STARTED|Second Intervention||12
139184|NCT00834132|319170|P1|STARTED|Second Intervention||12
139185|NCT00834132|319169|P2|NOT COMPLETED|Washout: 21 Days||0
139186|NCT00834132|319170|P1|NOT COMPLETED|Washout: 21 Days||0
139187|NCT00834132|319169|P2|COMPLETED|Washout: 21 Days||12
139188|NCT00834132|319170|P1|COMPLETED|Washout: 21 Days||12
139189|NCT00834132|319169|P2|STARTED|Washout: 21 Days||12
139190|NCT00834132|319170|P1|STARTED|Washout: 21 Days||12
139191|NCT00834132|319169|P2|NOT COMPLETED|First Intervention||0
139192|NCT00834132|319170|P1|NOT COMPLETED|First Intervention||0
139193|NCT00834132|319169|P2|COMPLETED|First Intervention||12
139194|NCT00834132|319170|P1|COMPLETED|First Intervention||12
139195|NCT00834132|319169|P2|STARTED|First Intervention||12
139196|NCT00834132|319170|P1|STARTED|First Intervention||12
139197|NCT00834080|319178|P1|NOT COMPLETED|Overall Study||23
139198|NCT00834080|319178|P1|COMPLETED|Overall Study||15
139199|NCT00834080|319178|P1|STARTED|Overall Study||38
139200|NCT00834067|319184|P2|NOT COMPLETED|Second Intervention||0
139201|NCT00834067|319185|P1|NOT COMPLETED|Second Intervention||0
139202|NCT00834067|319184|P2|COMPLETED|Second Intervention||29
139203|NCT00834067|319185|P1|COMPLETED|Second Intervention||30
139204|NCT00834067|319184|P2|STARTED|Second Intervention||29
139205|NCT00834067|319185|P1|STARTED|Second Intervention||30
139206|NCT00834067|319184|P2|NOT COMPLETED|Washout of 21 Days||1
139207|NCT00834067|319185|P1|NOT COMPLETED|Washout of 21 Days||0
139208|NCT00834067|319184|P2|COMPLETED|Washout of 21 Days||29
139209|NCT00834067|319185|P1|COMPLETED|Washout of 21 Days||30
139210|NCT00834067|319184|P2|STARTED|Washout of 21 Days||30
139211|NCT00834067|319185|P1|STARTED|Washout of 21 Days||30
139212|NCT00834067|319184|P2|NOT COMPLETED|First Intervention||0
139213|NCT00834067|319185|P1|NOT COMPLETED|First Intervention||0
139214|NCT00834067|319184|P2|COMPLETED|First Intervention||30
139215|NCT00834067|319185|P1|COMPLETED|First Intervention||30
139216|NCT00834067|319184|P2|STARTED|First Intervention||30
139217|NCT00834067|319185|P1|STARTED|First Intervention||30
139218|NCT00834041|319207|P2|NOT COMPLETED|Overall Study||1
139219|NCT00834041|319208|P1|NOT COMPLETED|Overall Study||1
139220|NCT00834041|319207|P2|COMPLETED|Overall Study||19
139221|NCT00834041|319208|P1|COMPLETED|Overall Study||18
139222|NCT00834041|319207|P2|STARTED|Overall Study||20
139223|NCT00834041|319208|P1|STARTED|Overall Study||19
139224|NCT00833976|319222|P1|NOT COMPLETED|Overall Study||51
139225|NCT00833976|319222|P1|COMPLETED|Overall Study||14
139226|NCT00833976|319222|P1|STARTED|Overall Study||65
139227|NCT00833937|319228|P2|NOT COMPLETED|Second Intervention||0
139228|NCT00833937|319229|P1|NOT COMPLETED|Second Intervention||0
139229|NCT00833937|319228|P2|COMPLETED|Second Intervention||12
139230|NCT00833937|319229|P1|COMPLETED|Second Intervention||11
139231|NCT00833937|319228|P2|STARTED|Second Intervention||12
139232|NCT00833937|319229|P1|STARTED|Second Intervention||11
139233|NCT00833937|319228|P2|NOT COMPLETED|Washout||0
139234|NCT00833937|319229|P1|NOT COMPLETED|Washout||1
139235|NCT00833937|319228|P2|COMPLETED|Washout||12
139236|NCT00833937|319229|P1|COMPLETED|Washout||11
139237|NCT00833937|319228|P2|STARTED|Washout||12
139238|NCT00833937|319229|P1|STARTED|Washout||12
139239|NCT00833937|319228|P2|NOT COMPLETED|First Intervention||0
139240|NCT00833937|319229|P1|NOT COMPLETED|First Intervention||0
139241|NCT00833937|319228|P2|COMPLETED|First Intervention||12
139242|NCT00833937|319229|P1|COMPLETED|First Intervention||12
139243|NCT00833937|319228|P2|STARTED|First Intervention||12
139244|NCT00833937|319229|P1|STARTED|First Intervention||12
139245|NCT00833924|319237|P1|NOT COMPLETED|Overall Study||109
139246|NCT00833924|319237|P1|COMPLETED|Overall Study||11
139247|NCT00833924|319237|P1|12-month|Overall Study||113
139248|NCT00833924|319237|P1|30-day|Overall Study||120
139249|NCT00833924|319237|P1|STARTED|Overall Study||120
139250|NCT00833911|319242|P1|NOT COMPLETED|Maintenance Phase II||10
139251|NCT00833911|319242|P1|COMPLETED|Maintenance Phase II||166
139252|NCT00833911|319242|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
139253|NCT00833911|319242|P1|NOT COMPLETED|Maintenance Phase I||98
139254|NCT00833911|319242|P1|COMPLETED|Maintenance Phase I||273
139255|NCT00833911|319242|P1|STARTED|Maintenance Phase I||371
139256|NCT00833911|319242|P1|NOT COMPLETED|Titration||21
139257|NCT00833911|319242|P1|COMPLETED|Titration||371
139258|NCT00833911|319242|P1|STARTED|Titration||392
139259|NCT00833898|319252|P2|NOT COMPLETED|Overall Study||36
139260|NCT00833898|319253|P1|NOT COMPLETED|Overall Study||40
139261|NCT00833898|319252|P2|COMPLETED|Overall Study||38
139262|NCT00833898|319253|P1|COMPLETED|Overall Study||34
139263|NCT00833898|319252|P2|Month 12 (Post Transplantation)|Overall Study||50
139264|NCT00833898|319253|P1|Month 12 (Post Transplantation)|Overall Study||50
139265|NCT00833898|319252|P2|Month 6 (Post Transplantation)|Overall Study||54
139266|NCT00833898|319253|P1|Month 6 (Post Transplantation)|Overall Study||59
139267|NCT00833898|319252|P2|Month 3 (Post Transplantation)|Overall Study||64
139268|NCT00833898|319253|P1|Month 3 (Post Transplantation)|Overall Study||66
139269|NCT00833898|319252|P2|Month 1 (Post Transplantation)|Overall Study||74
139270|NCT00833898|319253|P1|Month 1 (Post Transplantation)|Overall Study||72
139271|NCT00833898|319252|P2|STARTED|Overall Study||74
139272|NCT00833898|319253|P1|STARTED|Overall Study||74
139273|NCT00833859|319299|P1|NOT COMPLETED|Overall Study||0
139274|NCT00833859|319299|P1|COMPLETED|Overall Study||2
139275|NCT00833859|319299|P1|STARTED|Overall Study||2
139276|NCT00833833|319309|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
139277|NCT00833833|319310|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
139278|NCT00833833|319311|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
139279|NCT00833833|319312|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
139280|NCT00833833|319313|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
139281|NCT00833833|319314|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
139282|NCT00833833|319309|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
139283|NCT00833833|319310|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
139284|NCT00833833|319311|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
139285|NCT00833833|319312|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
139286|NCT00833833|319313|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
139287|NCT00833833|319314|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
139288|NCT00833833|319309|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
139289|NCT00833833|319310|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
139290|NCT00833833|319311|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
139291|NCT00833833|319312|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
139292|NCT00833833|319313|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
139293|NCT00833833|319314|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
139294|NCT00833833|319309|P6|STARTED|Phase 2 (as of 01 April 2011)||108
139295|NCT00833833|319310|P5|STARTED|Phase 2 (as of 01 April 2011)||113
139296|NCT00833833|319311|P4|STARTED|Phase 2 (as of 01 April 2011)||0
139297|NCT00833833|319312|P3|STARTED|Phase 2 (as of 01 April 2011)||0
139298|NCT00833833|319313|P2|STARTED|Phase 2 (as of 01 April 2011)||0
139299|NCT00833833|319314|P1|STARTED|Phase 2 (as of 01 April 2011)||0
139300|NCT00833833|319309|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
139301|NCT00833833|319310|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
139302|NCT00833833|319311|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
139303|NCT00833833|319312|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
139304|NCT00833833|319313|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
139305|NCT00833833|319314|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
139306|NCT00833833|319309|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
139307|NCT00833833|319310|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
139308|NCT00833833|319311|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
139309|NCT00833833|319312|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
139310|NCT00833833|319313|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
139311|NCT00833833|319314|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
139312|NCT00833833|319309|P6|STARTED|Phase 1 (as of 01 April 2011)||0
139313|NCT00833833|319310|P5|STARTED|Phase 1 (as of 01 April 2011)||0
139314|NCT00833833|319311|P4|STARTED|Phase 1 (as of 01 April 2011)||10
139315|NCT00833833|319312|P3|STARTED|Phase 1 (as of 01 April 2011)||14
139316|NCT00833833|319313|P2|STARTED|Phase 1 (as of 01 April 2011)||8
139317|NCT00833833|319314|P1|STARTED|Phase 1 (as of 01 April 2011)||6
139318|NCT00833521|319354|P2|NOT COMPLETED|Second Intervention||0
139319|NCT00833521|319355|P1|NOT COMPLETED|Second Intervention||0
139320|NCT00833521|319354|P2|COMPLETED|Second Intervention||19
139321|NCT00833521|319355|P1|COMPLETED|Second Intervention||19
139322|NCT00833521|319354|P2|STARTED|Second Intervention||19
139323|NCT00833521|319355|P1|STARTED|Second Intervention||19
139324|NCT00833521|319354|P2|NOT COMPLETED|First Intervention||0
139325|NCT00833521|319355|P1|NOT COMPLETED|First Intervention||0
139326|NCT00833521|319354|P2|COMPLETED|First Intervention||19
139327|NCT00833521|319355|P1|COMPLETED|First Intervention||19
139328|NCT00833521|319354|P2|STARTED|First Intervention||19
139329|NCT00833521|319355|P1|STARTED|First Intervention||19
139330|NCT00833482|319365|P6|NOT COMPLETED|Days 21-30||0
139331|NCT00833482|319366|P5|NOT COMPLETED|Days 21-30||1
139332|NCT00833482|319367|P4|NOT COMPLETED|Days 21-30||0
139333|NCT00833482|319368|P3|NOT COMPLETED|Days 21-30||1
139334|NCT00833482|319369|P2|NOT COMPLETED|Days 21-30||0
139335|NCT00833482|319370|P1|NOT COMPLETED|Days 21-30||0
139336|NCT00833482|319365|P6|COMPLETED|Days 21-30||0
139337|NCT00833482|319366|P5|COMPLETED|Days 21-30||7
139338|NCT00833482|319367|P4|COMPLETED|Days 21-30||0
139339|NCT00833482|319368|P3|COMPLETED|Days 21-30||20
139340|NCT00833482|319369|P2|COMPLETED|Days 21-30||0
139341|NCT00833482|319370|P1|COMPLETED|Days 21-30||0
139342|NCT00833482|319365|P6|STARTED|Days 21-30||0
139343|NCT00833482|319366|P5|STARTED|Days 21-30||8
139344|NCT00833482|319367|P4|STARTED|Days 21-30||0
139345|NCT00833482|319368|P3|STARTED|Days 21-30||21
139346|NCT00833482|319369|P2|STARTED|Days 21-30||0
139347|NCT00833482|319370|P1|STARTED|Days 21-30||0
139348|NCT00833482|319365|P6|NOT COMPLETED|Days 11-20||0
139349|NCT00833482|319366|P5|NOT COMPLETED|Days 11-20||0
139350|NCT00833482|319367|P4|NOT COMPLETED|Days 11-20||0
139351|NCT00833482|319368|P3|NOT COMPLETED|Days 11-20||0
139352|NCT00833482|319369|P2|NOT COMPLETED|Days 11-20||3
139353|NCT00833482|319370|P1|NOT COMPLETED|Days 11-20||0
139354|NCT00833482|319365|P6|COMPLETED|Days 11-20||8
139355|NCT00833482|319366|P5|COMPLETED|Days 11-20||0
139356|NCT00833482|319367|P4|COMPLETED|Days 11-20||0
139357|NCT00833482|319368|P3|COMPLETED|Days 11-20||0
139358|NCT00833482|319369|P2|COMPLETED|Days 11-20||21
139359|NCT00833482|319370|P1|COMPLETED|Days 11-20||0
139360|NCT00833482|319365|P6|STARTED|Days 11-20|Participants who received treatment.|8
139361|NCT00833482|319366|P5|STARTED|Days 11-20||0
139362|NCT00833482|319367|P4|STARTED|Days 11-20||0
139363|NCT00833482|319368|P3|STARTED|Days 11-20||0
139364|NCT00833482|319369|P2|STARTED|Days 11-20|Participants who received treatment.|24
139365|NCT00833482|319370|P1|STARTED|Days 11-20||0
139366|NCT00833482|319365|P6|NOT COMPLETED|Days 1-3||0
139367|NCT00833482|319366|P5|NOT COMPLETED|Days 1-3||0
139368|NCT00833482|319367|P4|NOT COMPLETED|Days 1-3||0
139369|NCT00833482|319368|P3|NOT COMPLETED|Days 1-3||0
139370|NCT00833482|319369|P2|NOT COMPLETED|Days 1-3||0
139371|NCT00833482|319370|P1|NOT COMPLETED|Days 1-3||0
139372|NCT00833482|319365|P6|COMPLETED|Days 1-3||0
139373|NCT00833482|319366|P5|COMPLETED|Days 1-3||0
139374|NCT00833482|319367|P4|COMPLETED|Days 1-3||8
139375|NCT00833482|319368|P3|COMPLETED|Days 1-3||0
139376|NCT00833482|319369|P2|COMPLETED|Days 1-3||0
139377|NCT00833482|319370|P1|COMPLETED|Days 1-3||24
139378|NCT00833482|319365|P6|STARTED|Days 1-3||0
139379|NCT00833482|319366|P5|STARTED|Days 1-3||0
139380|NCT00833482|319367|P4|STARTED|Days 1-3||8
139381|NCT00833482|319368|P3|STARTED|Days 1-3||0
139382|NCT00833482|319369|P2|STARTED|Days 1-3|Participants who received treatment|0
139383|NCT00833482|319370|P1|STARTED|Days 1-3|Participants who received treatment|24
139384|NCT00833469|319426|P1|NOT COMPLETED|Overall Study||2
139385|NCT00833469|319426|P1|COMPLETED|Overall Study||3
139386|NCT00833469|319426|P1|STARTED|Overall Study||5
139387|NCT00833443|319434|P2|NOT COMPLETED|Overall Study||28
139388|NCT00833443|319435|P1|NOT COMPLETED|Overall Study||20
139389|NCT00833443|319434|P2|COMPLETED|Overall Study||15
139390|NCT00833443|319435|P1|COMPLETED|Overall Study||21
139391|NCT00833443|319434|P2|STARTED|Overall Study||43
139392|NCT00833443|319435|P1|STARTED|Overall Study||41
139393|NCT00833417|319449|P2|NOT COMPLETED|Overall Study||71
139394|NCT00833417|319450|P1|NOT COMPLETED|Overall Study||33
139395|NCT00833417|319449|P2|COMPLETED|Overall Study||0
139396|NCT00833417|319450|P1|COMPLETED|Overall Study||0
139397|NCT00833417|319449|P2|STARTED|Overall Study||71
139398|NCT00833417|319450|P1|STARTED|Overall Study||33
139399|NCT00833365|319465|P2|NOT COMPLETED|Overall Study||0
139400|NCT00833365|319466|P1|NOT COMPLETED|Overall Study||0
139401|NCT00833365|319465|P2|COMPLETED|Overall Study||6
139402|NCT00833365|319466|P1|COMPLETED|Overall Study||9
139403|NCT00833365|319465|P2|STARTED|Overall Study||6
139404|NCT00833365|319466|P1|STARTED|Overall Study||9
139405|NCT00833248|319476|P2|NOT COMPLETED|Overall Study||3
139406|NCT00833248|319477|P1|NOT COMPLETED|Overall Study||4
139407|NCT00833248|319476|P2|COMPLETED|Overall Study||62
139408|NCT00833248|319477|P1|COMPLETED|Overall Study||177
139409|NCT00833248|319476|P2|Safety Analysis Set|Overall Study||64
139410|NCT00833248|319477|P1|Safety Analysis Set|Overall Study||181
139411|NCT00833248|319476|P2|Per Protocol (PP) Analysis Set|Overall Study||57
139412|NCT00833248|319477|P1|Per Protocol (PP) Analysis Set|Overall Study||164
139413|NCT00833248|319476|P2|Full Analysis Set (FAS)|Overall Study||64
139414|NCT00833248|319477|P1|Full Analysis Set (FAS)|Overall Study||180
139415|NCT00833248|319476|P2|STARTED|Overall Study||65
139416|NCT00833248|319477|P1|STARTED|Overall Study||181
139417|NCT00833092|319501|P2|NOT COMPLETED|Overall Study||7
139418|NCT00833092|319502|P1|NOT COMPLETED|Overall Study||4
139419|NCT00833092|319501|P2|COMPLETED|Overall Study||50
139420|NCT00833092|319502|P1|COMPLETED|Overall Study||50
139421|NCT00833092|319501|P2|STARTED|Overall Study||57
139422|NCT00833092|319502|P1|STARTED|Overall Study||54
139423|NCT00833053|319510|P2|NOT COMPLETED|Overall Study||3
139424|NCT00833053|319511|P1|NOT COMPLETED|Overall Study||9
139425|NCT00833053|319510|P2|COMPLETED|Overall Study||17
139426|NCT00833053|319511|P1|COMPLETED|Overall Study||10
139427|NCT00833053|319510|P2|STARTED|Overall Study||20
139428|NCT00833053|319511|P1|STARTED|Overall Study||19
139429|NCT00833040|319529|P6|NOT COMPLETED|Overall Study||1
139430|NCT00833040|319530|P5|NOT COMPLETED|Overall Study||0
139431|NCT00833040|319531|P4|NOT COMPLETED|Overall Study||0
139432|NCT00833040|319532|P3|NOT COMPLETED|Overall Study||0
139433|NCT00833040|319533|P2|NOT COMPLETED|Overall Study||0
139434|NCT00833040|319534|P1|NOT COMPLETED|Overall Study||0
139435|NCT00833040|319529|P6|COMPLETED|Overall Study||4
139436|NCT00833040|319530|P5|COMPLETED|Overall Study||5
139437|NCT00833040|319531|P4|COMPLETED|Overall Study||6
139438|NCT00833040|319532|P3|COMPLETED|Overall Study||6
139439|NCT00833040|319533|P2|COMPLETED|Overall Study||6
139440|NCT00833040|319534|P1|COMPLETED|Overall Study||6
139441|NCT00833040|319529|P6|STARTED|Overall Study||5
139442|NCT00833040|319530|P5|STARTED|Overall Study||5
139443|NCT00833040|319531|P4|STARTED|Overall Study||6
139444|NCT00833040|319532|P3|STARTED|Overall Study||6
139445|NCT00833040|319533|P2|STARTED|Overall Study||6
139446|NCT00833040|319534|P1|STARTED|Overall Study||6
139447|NCT00833027|319539|P1|NOT COMPLETED|Overall Study||211
139448|NCT00833027|319539|P1|COMPLETED|Overall Study||397
139449|NCT00833027|319539|P1|STARTED|Overall Study||608
139450|NCT00832975|319544|P1|NOT COMPLETED|Overall Study||39
139451|NCT00832975|319544|P1|COMPLETED|Overall Study||118
139452|NCT00832975|319544|P1|STARTED|Overall Study||157
139453|NCT00832871|319549|P1|NOT COMPLETED|Overall Study||0
139454|NCT00832871|319549|P1|COMPLETED|Overall Study||4
139455|NCT00832871|319549|P1|STARTED|Overall Study||4
139456|NCT00832819|319558|P3|NOT COMPLETED|Overall Study||1
139457|NCT00832819|319559|P2|NOT COMPLETED|Overall Study||1
139458|NCT00832819|319560|P1|NOT COMPLETED|Overall Study||0
139459|NCT00832819|319558|P3|COMPLETED|Overall Study||15
139460|NCT00832819|319559|P2|COMPLETED|Overall Study||5
139461|NCT00832819|319560|P1|COMPLETED|Overall Study||6
139462|NCT00832819|319558|P3|STARTED|Overall Study||16
139463|NCT00832819|319559|P2|STARTED|Overall Study||6
139464|NCT00832819|319560|P1|STARTED|Overall Study||6
139465|NCT00832650|319569|P3|NOT COMPLETED|Overall Study||1
139466|NCT00832650|319570|P2|NOT COMPLETED|Overall Study||0
139467|NCT00832650|319571|P1|NOT COMPLETED|Overall Study||0
139468|NCT00832650|319569|P3|COMPLETED|Overall Study||22
139469|NCT00832650|319570|P2|COMPLETED|Overall Study||12
139470|NCT00832650|319571|P1|COMPLETED|Overall Study||25
139471|NCT00832650|319569|P3|Treated|Overall Study||22
139472|NCT00832650|319570|P2|Treated|Overall Study||12
139473|NCT00832650|319571|P1|Treated|Overall Study||25
139474|NCT00832650|319569|P3|STARTED|Overall Study||23
139475|NCT00832650|319570|P2|STARTED|Overall Study||12
139476|NCT00832650|319571|P1|STARTED|Overall Study||25
139477|NCT00832637|319603|P1|NOT COMPLETED|Overall Study||0
139478|NCT00832637|319603|P1|COMPLETED|Overall Study||33
139479|NCT00832637|319603|P1|STARTED|Overall Study||33
139480|NCT00832624|319611|P1|NOT COMPLETED|Overall Study||10
139481|NCT00832624|319611|P1|COMPLETED|Overall Study||0
139482|NCT00832624|319611|P1|STARTED|Overall Study||10
139483|NCT00832585|319615|P1|NOT COMPLETED|Overall Study||2
139484|NCT00832585|319615|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
139485|NCT00832585|319615|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
139486|NCT00832572|319622|P2|NOT COMPLETED|Period 2||0
139487|NCT00832572|319623|P1|NOT COMPLETED|Period 2||0
139488|NCT00832572|319622|P2|COMPLETED|Period 2||2
139489|NCT00832572|319623|P1|COMPLETED|Period 2||3
139490|NCT00832572|319622|P2|STARTED|Period 2||2
139491|NCT00832572|319623|P1|STARTED|Period 2||3
139492|NCT00832572|319622|P2|NOT COMPLETED|Period 1||0
139493|NCT00832572|319623|P1|NOT COMPLETED|Period 1||0
139494|NCT00832572|319622|P2|COMPLETED|Period 1||2
139495|NCT00832572|319623|P1|COMPLETED|Period 1||3
139496|NCT00832572|319622|P2|STARTED|Period 1||2
139497|NCT00832572|319623|P1|STARTED|Period 1||3
139498|NCT00832520|319635|P1|NOT COMPLETED|Overall Study||0
139499|NCT00832520|319635|P1|COMPLETED|Overall Study||13
139500|NCT00832520|319635|P1|STARTED|Overall Study||13
139501|NCT00832455|319639|P1|NOT COMPLETED|Overall Study||72
139502|NCT00832455|319639|P1|COMPLETED|Overall Study||373
139503|NCT00832455|319639|P1|Week 12|Overall Study||373
139504|NCT00832455|319639|P1|Week 8 (Optional)|Overall Study||247
139505|NCT00832455|319639|P1|Week 4|Overall Study||411
139506|NCT00832455|319639|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
139507|NCT00832455|319639|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
139508|NCT00832416|319663|P4|NOT COMPLETED|Overall Study||83
139509|NCT00832416|319664|P3|NOT COMPLETED|Overall Study||61
139510|NCT00832416|319665|P2|NOT COMPLETED|Overall Study||53
139511|NCT00832416|319666|P1|NOT COMPLETED|Overall Study||46
139512|NCT00832416|319663|P4|COMPLETED|Overall Study||144
139513|NCT00832416|319664|P3|COMPLETED|Overall Study||54
139514|NCT00832416|319665|P2|COMPLETED|Overall Study||60
139515|NCT00832416|319666|P1|COMPLETED|Overall Study||64
139516|NCT00832416|319663|P4|STARTED|Overall Study||227
139517|NCT00832416|319664|P3|STARTED|Overall Study||115
139518|NCT00832416|319665|P2|STARTED|Overall Study||113
139519|NCT00832416|319666|P1|STARTED|Overall Study||110
139520|NCT00832390|319707|P3|NOT COMPLETED|Overall Study||0
139521|NCT00832390|319708|P2|NOT COMPLETED|Overall Study||0
139522|NCT00832390|319709|P1|NOT COMPLETED|Overall Study||0
139523|NCT00832390|319707|P3|COMPLETED|Overall Study||1
139524|NCT00832390|319708|P2|COMPLETED|Overall Study||16
139525|NCT00832390|319709|P1|COMPLETED|Overall Study||12
139526|NCT00832390|319707|P3|STARTED|Overall Study||1
139527|NCT00832390|319708|P2|STARTED|Overall Study||16
139528|NCT00832390|319709|P1|STARTED|Overall Study||12
139529|NCT00832377|319717|P1|NOT COMPLETED|Overall Study||1
139530|NCT00832377|319717|P1|COMPLETED|Overall Study||36
139531|NCT00832377|319717|P1|STARTED|Overall Study||37
139532|NCT00832299|319724|P1|NOT COMPLETED|Overall Study||0
139533|NCT00832299|319724|P1|COMPLETED|Overall Study||2
139534|NCT00832299|319724|P1|STARTED|Overall Study||2
139535|NCT00832260|319728|P1|NOT COMPLETED|Overall Study||0
139536|NCT00832260|319728|P1|COMPLETED|Overall Study||70
139537|NCT00832260|319728|P1|STARTED|Overall Study||70
139538|NCT00832130|319735|P2|NOT COMPLETED|Overall Study||0
139539|NCT00832130|319736|P1|NOT COMPLETED|Overall Study||0
139540|NCT00832130|319735|P2|COMPLETED|Overall Study||70
139541|NCT00832130|319736|P1|COMPLETED|Overall Study||69
139542|NCT00832130|319735|P2|STARTED|Overall Study||70
139543|NCT00832130|319736|P1|STARTED|Overall Study||69
139544|NCT00832117|319758|P1|NOT COMPLETED|Overall Study||12
139545|NCT00832117|319758|P1|COMPLETED|Overall Study||17
139546|NCT00832117|319758|P1|STARTED|Overall Study||29
139547|NCT00832091|319777|P2|NOT COMPLETED|Overall Study||2
139548|NCT00832091|319778|P1|NOT COMPLETED|Overall Study||5
139549|NCT00832091|319777|P2|COMPLETED|Overall Study||53
139550|NCT00832091|319778|P1|COMPLETED|Overall Study||12
139551|NCT00832091|319777|P2|STARTED|Overall Study||55
139552|NCT00832091|319778|P1|STARTED|Overall Study||17
139553|NCT00832078|319786|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
139554|NCT00832078|319787|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
139555|NCT00832078|319786|P2|COMPLETED|Test Day 2 - 2 Period||10
139556|NCT00832078|319787|P1|COMPLETED|Test Day 2 - 2 Period||12
139557|NCT00832078|319786|P2|STARTED|Test Day 2 - 2 Period||10
139558|NCT00832078|319787|P1|STARTED|Test Day 2 - 2 Period||13
139559|NCT00832078|319786|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
139560|NCT00832078|319787|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
139561|NCT00832078|319786|P2|COMPLETED|Test Day 2 - 1 Period||10
139562|NCT00832078|319787|P1|COMPLETED|Test Day 2 - 1 Period||13
139563|NCT00832078|319786|P2|STARTED|Test Day 2 - 1 Period||10
139564|NCT00832078|319787|P1|STARTED|Test Day 2 - 1 Period||13
139565|NCT00832078|319786|P2|NOT COMPLETED|Test Day 1-2 Period||2
139566|NCT00832078|319787|P1|NOT COMPLETED|Test Day 1-2 Period||0
139567|NCT00832078|319786|P2|COMPLETED|Test Day 1-2 Period||10
139568|NCT00832078|319787|P1|COMPLETED|Test Day 1-2 Period||13
139569|NCT00832078|319786|P2|STARTED|Test Day 1-2 Period||12
139570|NCT00832078|319787|P1|STARTED|Test Day 1-2 Period||13
139571|NCT00832078|319786|P2|NOT COMPLETED|Test Day 1- 1 Period||0
139572|NCT00832078|319787|P1|NOT COMPLETED|Test Day 1- 1 Period||0
139573|NCT00832078|319786|P2|COMPLETED|Test Day 1- 1 Period||12
139574|NCT00832078|319787|P1|COMPLETED|Test Day 1- 1 Period||13
139575|NCT00832078|319786|P2|STARTED|Test Day 1- 1 Period||12
139576|NCT00832078|319787|P1|STARTED|Test Day 1- 1 Period||13
139577|NCT00832000|319793|P2|NOT COMPLETED|Overall Study||1
139578|NCT00832000|319794|P1|NOT COMPLETED|Overall Study||6
139579|NCT00832000|319793|P2|COMPLETED|Overall Study||29
139580|NCT00832000|319794|P1|COMPLETED|Overall Study||23
139581|NCT00832000|319793|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
139582|NCT00832000|319794|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
139583|NCT00832000|319793|P2|STARTED|Overall Study|Placebo|30
139584|NCT00832000|319794|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
139585|NCT00831987|319832|P2|NOT COMPLETED|Overall Study||0
139586|NCT00831987|319833|P1|NOT COMPLETED|Overall Study||0
139587|NCT00831987|319832|P2|COMPLETED|Overall Study||60
139588|NCT00831987|319833|P1|COMPLETED|Overall Study||60
139589|NCT00831987|319832|P2|STARTED|Overall Study||60
139590|NCT00831987|319833|P1|STARTED|Overall Study||60
139591|NCT00831844|319855|P10|NOT COMPLETED|Overall Study||0
139592|NCT00831844|319856|P9|NOT COMPLETED|Overall Study||9
139593|NCT00831844|319857|P8|NOT COMPLETED|Overall Study||10
139594|NCT00831844|319858|P7|NOT COMPLETED|Overall Study||10
139595|NCT00831844|319859|P6|NOT COMPLETED|Overall Study||19
139596|NCT00831844|319860|P5|NOT COMPLETED|Overall Study||14
139597|NCT00831844|319861|P4|NOT COMPLETED|Overall Study||10
139598|NCT00831844|319862|P3|NOT COMPLETED|Overall Study||20
139599|NCT00831844|319863|P2|NOT COMPLETED|Overall Study||12
139600|NCT00831844|319864|P1|NOT COMPLETED|Overall Study||10
139601|NCT00831844|319855|P10|COMPLETED|Overall Study||0
139602|NCT00831844|319856|P9|COMPLETED|Overall Study||0
139603|NCT00831844|319857|P8|COMPLETED|Overall Study||0
139604|NCT00831844|319858|P7|COMPLETED|Overall Study||0
139605|NCT00831844|319859|P6|COMPLETED|Overall Study||1
139606|NCT00831844|319860|P5|COMPLETED|Overall Study||0
139607|NCT00831844|319861|P4|COMPLETED|Overall Study||0
139608|NCT00831844|319862|P3|COMPLETED|Overall Study||1
139609|NCT00831844|319863|P2|COMPLETED|Overall Study||0
139610|NCT00831844|319864|P1|COMPLETED|Overall Study||0
139611|NCT00831844|319855|P10|STARTED|Overall Study||0
139612|NCT00831844|319856|P9|STARTED|Overall Study||9
139613|NCT00831844|319857|P8|STARTED|Overall Study||10
139614|NCT00831844|319858|P7|STARTED|Overall Study||10
139615|NCT00831844|319859|P6|STARTED|Overall Study||20
139616|NCT00831844|319860|P5|STARTED|Overall Study||14
139617|NCT00831844|319861|P4|STARTED|Overall Study||10
139618|NCT00831844|319862|P3|STARTED|Overall Study||21
139619|NCT00831844|319863|P2|STARTED|Overall Study||12
139620|NCT00831844|319864|P1|STARTED|Overall Study||10
139621|NCT00831766|319888|P2|NOT COMPLETED|Overall Study||0
139622|NCT00831766|319889|P1|NOT COMPLETED|Overall Study||0
139623|NCT00831766|319888|P2|COMPLETED|Overall Study||28
139624|NCT00831766|319889|P1|COMPLETED|Overall Study||23
139625|NCT00831766|319888|P2|STARTED|Overall Study||28
139626|NCT00831766|319889|P1|STARTED|Overall Study||23
139627|NCT00831753|319897|P2|NOT COMPLETED|Overall Study||0
139628|NCT00831753|319898|P1|NOT COMPLETED|Overall Study||0
139629|NCT00831753|319897|P2|COMPLETED|Overall Study||131
139630|NCT00831753|319898|P1|COMPLETED|Overall Study||132
139631|NCT00831753|319897|P2|STARTED|Overall Study||131
139632|NCT00831753|319898|P1|STARTED|Overall Study||132
139633|NCT00831701|319912|P2|NOT COMPLETED|Overall Study||5
139634|NCT00831701|319913|P1|NOT COMPLETED|Overall Study||5
139635|NCT00831701|319912|P2|COMPLETED|Overall Study||45
139636|NCT00831701|319913|P1|COMPLETED|Overall Study||45
139637|NCT00831701|319912|P2|STARTED|Overall Study||50
139638|NCT00831701|319913|P1|STARTED|Overall Study||50
139639|NCT00831675|319929|P2|NOT COMPLETED|Overall Study||0
139640|NCT00831675|319930|P1|NOT COMPLETED|Overall Study||0
139641|NCT00831675|319929|P2|COMPLETED|Overall Study||18
139642|NCT00831675|319930|P1|COMPLETED|Overall Study||12
139643|NCT00831675|319929|P2|STARTED|Overall Study||18
139644|NCT00831675|319930|P1|STARTED|Overall Study||12
139645|NCT00831493|319942|P1|NOT COMPLETED|Overall Study||1
139646|NCT00831493|319942|P1|COMPLETED|Overall Study||2
139647|NCT00831493|319942|P1|STARTED|Overall Study||3
139648|NCT00831480|319946|P1|NOT COMPLETED|Overall Study||2
139649|NCT00831480|319946|P1|COMPLETED|Overall Study||7
139650|NCT00831480|319946|P1|STARTED|Overall Study||9
139651|NCT00831441|319952|P2|NOT COMPLETED|Follow Up (30 Days)||174
139652|NCT00831441|319953|P1|NOT COMPLETED|Follow Up (30 Days)||133
139653|NCT00831441|319952|P2|COMPLETED|Follow Up (30 Days)||3355
139654|NCT00831441|319953|P1|COMPLETED|Follow Up (30 Days)||3375
139655|NCT00831441|319952|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
139656|NCT00831441|319953|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
139657|NCT00831441|319952|P2|NOT COMPLETED|Randomized||3705
139658|NCT00831441|319953|P1|NOT COMPLETED|Randomized||3687
139659|NCT00831441|319952|P2|COMPLETED|Randomized||0
139660|NCT00831441|319953|P1|COMPLETED|Randomized||0
139661|NCT00831441|319952|P2|Treated|Randomized||3672
139662|NCT00831441|319953|P1|Treated|Randomized||3643
139663|NCT00831441|319952|P2|STARTED|Randomized||3705
139664|NCT00831441|319953|P1|STARTED|Randomized||3687
139665|NCT00831428|319981|P1|NOT COMPLETED|Overall Study||0
139666|NCT00831428|319981|P1|COMPLETED|Overall Study||97
139667|NCT00831428|319981|P1|STARTED|Overall Study||97
139668|NCT00831415|319985|P1|NOT COMPLETED|Overall Study||75
139669|NCT00831415|319985|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
139670|NCT00831415|319985|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
139671|NCT00831415|319985|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
139672|NCT00831415|319985|P1|STARTED|Overall Study||304
139673|NCT00831389|319992|P1|NOT COMPLETED|Overall Study||1
139674|NCT00831389|319992|P1|COMPLETED|Overall Study||12
139675|NCT00831389|319992|P1|STARTED|Overall Study||13
139676|NCT00831311|320018|P2|NOT COMPLETED|Overall Study||8
139677|NCT00831311|320019|P1|NOT COMPLETED|Overall Study||12
139678|NCT00831311|320018|P2|COMPLETED|Overall Study||304
139679|NCT00831311|320019|P1|COMPLETED|Overall Study||300
139680|NCT00831311|320018|P2|STARTED|Overall Study||312
139681|NCT00831311|320019|P1|STARTED|Overall Study||312
139682|NCT00831233|320039|P2|NOT COMPLETED|Overall Study||1
139683|NCT00831233|320040|P1|NOT COMPLETED|Overall Study||3
139684|NCT00831233|320039|P2|COMPLETED|Overall Study||12
139685|NCT00831233|320040|P1|COMPLETED|Overall Study||26
139686|NCT00831233|320039|P2|Per Protocol (PP) Analysis Set|Overall Study||11
139687|NCT00831233|320040|P1|Per Protocol (PP) Analysis Set|Overall Study||26
139688|NCT00831233|320039|P2|Full Analysis Set (FAS)|Overall Study||13
139689|NCT00831233|320040|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
139690|NCT00831233|320039|P2|STARTED|Overall Study|ITT population.|13
139691|NCT00831233|320040|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
139692|NCT00831129|320066|P2|NOT COMPLETED|Overall Study||10
139693|NCT00831129|320067|P1|NOT COMPLETED|Overall Study||0
139694|NCT00831129|320066|P2|COMPLETED|Overall Study||23
139695|NCT00831129|320067|P1|COMPLETED|Overall Study||20
139696|NCT00831129|320066|P2|STARTED|Overall Study||33
139697|NCT00831129|320067|P1|STARTED|Overall Study||20
139698|NCT00830960|320109|P6|NOT COMPLETED|Overall Study||37
139699|NCT00830960|320110|P5|NOT COMPLETED|Overall Study||32
139700|NCT00830960|320111|P4|NOT COMPLETED|Overall Study||32
139701|NCT00830960|320112|P3|NOT COMPLETED|Overall Study||29
139702|NCT00830960|320113|P2|NOT COMPLETED|Overall Study||28
139703|NCT00830960|320114|P1|NOT COMPLETED|Overall Study||33
139704|NCT00830960|320109|P6|COMPLETED|Overall Study||63
139705|NCT00830960|320110|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
139706|NCT00830960|320111|P4|COMPLETED|Overall Study||106
139707|NCT00830960|320112|P3|COMPLETED|Overall Study||108
139708|NCT00830960|320113|P2|COMPLETED|Overall Study||96
139709|NCT00830960|320114|P1|COMPLETED|Overall Study||91
139710|NCT00830960|320109|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
139711|NCT00830960|320110|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
139712|NCT00830960|320111|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
139713|NCT00830960|320112|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
139714|NCT00830960|320113|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
139715|NCT00830960|320114|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
139716|NCT00830960|320109|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
139717|NCT00830960|320110|P5|STARTED|Overall Study||96
139718|NCT00830960|320111|P4|STARTED|Overall Study||138
139719|NCT00830960|320112|P3|STARTED|Overall Study||137
139720|NCT00830960|320113|P2|STARTED|Overall Study||124
139721|NCT00830960|320114|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
139722|NCT00830947|320230|P2|NOT COMPLETED|Overall Study||4
139723|NCT00830947|320231|P1|NOT COMPLETED|Overall Study||4
139724|NCT00830947|320230|P2|COMPLETED|Overall Study||18
139725|NCT00830947|320231|P1|COMPLETED|Overall Study||19
139726|NCT00830947|320230|P2|STARTED|Overall Study||22
139727|NCT00830947|320231|P1|STARTED|Overall Study||23
139728|NCT00830804|320237|P1|NOT COMPLETED|Overall Study||15
139729|NCT00830804|320237|P1|COMPLETED|Overall Study||97
139730|NCT00830804|320237|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
139731|NCT00830791|320263|P6|NOT COMPLETED|Overall Study||0
139732|NCT00830791|320264|P5|NOT COMPLETED|Overall Study||0
139733|NCT00830791|320265|P4|NOT COMPLETED|Overall Study||0
139734|NCT00830791|320266|P3|NOT COMPLETED|Overall Study||0
139735|NCT00830791|320267|P2|NOT COMPLETED|Overall Study||0
139736|NCT00830791|320268|P1|NOT COMPLETED|Overall Study||0
139737|NCT00830791|320263|P6|COMPLETED|Overall Study||0
139738|NCT00830791|320264|P5|COMPLETED|Overall Study||0
139739|NCT00830791|320265|P4|COMPLETED|Overall Study||8
139740|NCT00830791|320266|P3|COMPLETED|Overall Study||8
139741|NCT00830791|320267|P2|COMPLETED|Overall Study||8
139742|NCT00830791|320268|P1|COMPLETED|Overall Study||8
139743|NCT00830791|320263|P6|STARTED|Overall Study||0
139744|NCT00830791|320264|P5|STARTED|Overall Study||0
139745|NCT00830791|320265|P4|STARTED|Overall Study||8
139746|NCT00830791|320266|P3|STARTED|Overall Study||8
139747|NCT00830791|320267|P2|STARTED|Overall Study||8
139748|NCT00830791|320268|P1|STARTED|Overall Study||8
139749|NCT00830765|320317|P2|NOT COMPLETED|Overall Study||2
139750|NCT00830765|320318|P1|NOT COMPLETED|Overall Study||3
139751|NCT00830765|320317|P2|COMPLETED|Overall Study||69
139752|NCT00830765|320318|P1|COMPLETED|Overall Study||70
139753|NCT00830765|320317|P2|STARTED|Overall Study||71
139754|NCT00830765|320318|P1|STARTED|Overall Study||73
139755|NCT00830388|320324|P1|NOT COMPLETED|Overall Study||0
139756|NCT00830388|320324|P1|COMPLETED|Overall Study||11
139757|NCT00830388|320324|P1|STARTED|Overall Study||11
139758|NCT00830375|320329|P1|NOT COMPLETED|Overall Study||1
139759|NCT00830375|320329|P1|COMPLETED|Overall Study||9
139760|NCT00830375|320329|P1|STARTED|Overall Study||10
139761|NCT00830362|320335|P2|NOT COMPLETED|Overall Study||4
139762|NCT00830362|320336|P1|NOT COMPLETED|Overall Study||4
139763|NCT00830362|320335|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
139764|NCT00830362|320336|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
139765|NCT00830362|320335|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
139766|NCT00830362|320336|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
139767|NCT00830362|320335|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
139768|NCT00830362|320336|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
139769|NCT00830336|320344|P2|NOT COMPLETED|Second Intervention||0
139770|NCT00830336|320345|P1|NOT COMPLETED|Second Intervention||0
139771|NCT00830336|320344|P2|COMPLETED|Second Intervention||40
139772|NCT00830336|320345|P1|COMPLETED|Second Intervention||39
139773|NCT00830336|320344|P2|STARTED|Second Intervention||40
139774|NCT00830336|320345|P1|STARTED|Second Intervention||39
139775|NCT00830336|320344|P2|NOT COMPLETED|Washout: 21 Days||0
139776|NCT00830336|320345|P1|NOT COMPLETED|Washout: 21 Days||1
139777|NCT00830336|320344|P2|COMPLETED|Washout: 21 Days||40
139778|NCT00830336|320345|P1|COMPLETED|Washout: 21 Days||39
139779|NCT00830336|320344|P2|STARTED|Washout: 21 Days||40
139780|NCT00830336|320345|P1|STARTED|Washout: 21 Days||40
139781|NCT00830336|320344|P2|NOT COMPLETED|First Intervention||0
139782|NCT00830336|320345|P1|NOT COMPLETED|First Intervention||0
139783|NCT00830336|320344|P2|COMPLETED|First Intervention||40
139784|NCT00830336|320345|P1|COMPLETED|First Intervention||40
139785|NCT00830336|320344|P2|STARTED|First Intervention||40
139786|NCT00830336|320345|P1|STARTED|First Intervention||40
139787|NCT00830310|320353|P1|NOT COMPLETED|Overall Study||13
139788|NCT00830310|320353|P1|COMPLETED|Overall Study||30
139789|NCT00830310|320353|P1|STARTED|Overall Study||43
139790|NCT00830284|320365|P1|NOT COMPLETED|Overall Study||2
139791|NCT00830284|320365|P1|COMPLETED|Overall Study||10
139792|NCT00830284|320365|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
139793|NCT00830258|320372|P2|NOT COMPLETED|Second Intervention||0
139794|NCT00830258|320373|P1|NOT COMPLETED|Second Intervention||0
139795|NCT00830258|320372|P2|COMPLETED|Second Intervention||30
139796|NCT00830258|320373|P1|COMPLETED|Second Intervention||28
139797|NCT00830258|320372|P2|STARTED|Second Intervention||30
139798|NCT00830258|320373|P1|STARTED|Second Intervention||28
139799|NCT00830258|320372|P2|NOT COMPLETED|Washout: 7 Days||0
139800|NCT00830258|320373|P1|NOT COMPLETED|Washout: 7 Days||1
139801|NCT00830258|320372|P2|COMPLETED|Washout: 7 Days||30
139802|NCT00830258|320373|P1|COMPLETED|Washout: 7 Days||28
139803|NCT00830258|320372|P2|STARTED|Washout: 7 Days||30
139804|NCT00830258|320373|P1|STARTED|Washout: 7 Days||29
139805|NCT00830258|320372|P2|NOT COMPLETED|First Intervention||0
139806|NCT00830258|320373|P1|NOT COMPLETED|First Intervention||1
139807|NCT00830258|320372|P2|COMPLETED|First Intervention||30
139808|NCT00830258|320373|P1|COMPLETED|First Intervention||29
139809|NCT00830258|320372|P2|STARTED|First Intervention||30
139810|NCT00830258|320373|P1|STARTED|First Intervention||30
139811|NCT00830232|320383|P2|NOT COMPLETED|Overall Study||0
139812|NCT00830232|320384|P1|NOT COMPLETED|Overall Study||0
139813|NCT00830232|320383|P2|COMPLETED|Overall Study||20
139814|NCT00830232|320384|P1|COMPLETED|Overall Study||20
139815|NCT00830232|320383|P2|STARTED|Overall Study||20
139816|NCT00830232|320384|P1|STARTED|Overall Study||20
139817|NCT00830219|320392|P2|NOT COMPLETED|Second Intervention||0
139818|NCT00830219|320393|P1|NOT COMPLETED|Second Intervention||0
139819|NCT00830219|320392|P2|COMPLETED|Second Intervention||22
139820|NCT00830219|320393|P1|COMPLETED|Second Intervention||22
139821|NCT00830219|320392|P2|STARTED|Second Intervention||22
139822|NCT00830219|320393|P1|STARTED|Second Intervention||22
139823|NCT00830219|320392|P2|NOT COMPLETED|Washout of 7 Days||1
139824|NCT00830219|320393|P1|NOT COMPLETED|Washout of 7 Days||1
139825|NCT00830219|320392|P2|COMPLETED|Washout of 7 Days||22
139826|NCT00830219|320393|P1|COMPLETED|Washout of 7 Days||22
139827|NCT00830219|320392|P2|STARTED|Washout of 7 Days||23
139828|NCT00830219|320393|P1|STARTED|Washout of 7 Days||23
139829|NCT00830219|320392|P2|NOT COMPLETED|First Intervention||0
139830|NCT00830219|320393|P1|NOT COMPLETED|First Intervention||0
139831|NCT00830219|320392|P2|COMPLETED|First Intervention||23
139832|NCT00830219|320393|P1|COMPLETED|First Intervention||23
139833|NCT00830219|320392|P2|STARTED|First Intervention||23
139834|NCT00830219|320393|P1|STARTED|First Intervention||23
139835|NCT00830206|320403|P2|NOT COMPLETED|Second Intervention||0
139836|NCT00830206|320404|P1|NOT COMPLETED|Second Intervention||0
139837|NCT00830206|320403|P2|COMPLETED|Second Intervention||39
139838|NCT00830206|320404|P1|COMPLETED|Second Intervention||39
139839|NCT00830206|320403|P2|STARTED|Second Intervention||39
139840|NCT00830206|320404|P1|STARTED|Second Intervention||39
139841|NCT00830206|320403|P2|NOT COMPLETED|Washout: 21 Days||1
139842|NCT00830206|320404|P1|NOT COMPLETED|Washout: 21 Days||1
139843|NCT00830206|320403|P2|COMPLETED|Washout: 21 Days||39
139844|NCT00830206|320404|P1|COMPLETED|Washout: 21 Days||39
139845|NCT00830206|320403|P2|STARTED|Washout: 21 Days||40
139846|NCT00830206|320404|P1|STARTED|Washout: 21 Days||40
139847|NCT00830206|320403|P2|NOT COMPLETED|First Intervention||0
139848|NCT00830206|320404|P1|NOT COMPLETED|First Intervention||0
139849|NCT00830206|320403|P2|COMPLETED|First Intervention||40
139850|NCT00830206|320404|P1|COMPLETED|First Intervention||40
139851|NCT00830206|320403|P2|STARTED|First Intervention||40
139852|NCT00830206|320404|P1|STARTED|First Intervention||40
139853|NCT00830167|320414|P2|NOT COMPLETED|Overall Study||43
139854|NCT00830167|320415|P1|NOT COMPLETED|Overall Study||40
139855|NCT00830167|320414|P2|COMPLETED|Overall Study||207
139856|NCT00830167|320415|P1|COMPLETED|Overall Study||208
139857|NCT00830167|320414|P2|STARTED|Overall Study|Treated|250
139858|NCT00830167|320415|P1|STARTED|Overall Study|Treated|248
139859|NCT00830128|320485|P1|NOT COMPLETED|Overall Study||19
139860|NCT00830128|320485|P1|COMPLETED|Overall Study||87
139861|NCT00830128|320485|P1|STARTED|Overall Study||106
139862|NCT00830115|320500|P1|NOT COMPLETED|Overall Study||3
139863|NCT00830115|320500|P1|COMPLETED|Overall Study||1042
139864|NCT00830115|320500|P1|STARTED|Overall Study||1045
139865|NCT00830076|320516|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
139866|NCT00830076|320516|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
139867|NCT00830076|320516|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
139868|NCT00830076|320516|P1|NOT COMPLETED|7-day Washout||0
139869|NCT00830076|320516|P1|COMPLETED|7-day Washout||18
139870|NCT00830076|320516|P1|STARTED|7-day Washout||18
139871|NCT00830076|320516|P1|NOT COMPLETED|Sitagliptin + Metformin||0
139872|NCT00830076|320516|P1|COMPLETED|Sitagliptin + Metformin||18
139873|NCT00830076|320516|P1|STARTED|Sitagliptin + Metformin||18
139874|NCT00830076|320516|P1|NOT COMPLETED|7-day Washout||0
139875|NCT00830076|320516|P1|COMPLETED|7-day Washout||18
139876|NCT00830076|320516|P1|STARTED|7-day Washout||18
139877|NCT00830076|320516|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
139878|NCT00830076|320516|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
139879|NCT00830076|320516|P1|STARTED|Metformin + Placebo Sitagliptin||18
139880|NCT00830076|320516|P1|NOT COMPLETED|7-day Washout||0
139881|NCT00830076|320516|P1|COMPLETED|7-day Washout||18
139882|NCT00830076|320516|P1|STARTED|7-day Washout||18
139883|NCT00830076|320516|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
139884|NCT00830076|320516|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
139885|NCT00830076|320516|P1|STARTED|Sitagliptin + Placebo Metformin||18
139886|NCT00830037|320527|P2|NOT COMPLETED|Overall Study||19
139887|NCT00830037|320528|P1|NOT COMPLETED|Overall Study||18
139888|NCT00830037|320527|P2|COMPLETED|Overall Study||50
139889|NCT00830037|320528|P1|COMPLETED|Overall Study||49
139890|NCT00830037|320527|P2|STARTED|Overall Study||69
139891|NCT00830037|320528|P1|STARTED|Overall Study||67
139892|NCT00830024|320538|P2|NOT COMPLETED|Second Intervention||0
139893|NCT00830024|320539|P1|NOT COMPLETED|Second Intervention||0
139894|NCT00830024|320538|P2|COMPLETED|Second Intervention||18
139895|NCT00830024|320539|P1|COMPLETED|Second Intervention||17
139896|NCT00830024|320538|P2|STARTED|Second Intervention||18
139897|NCT00830024|320539|P1|STARTED|Second Intervention||17
139898|NCT00830024|320538|P2|NOT COMPLETED|Washout: 7 Days||0
139899|NCT00830024|320539|P1|NOT COMPLETED|Washout: 7 Days||1
139900|NCT00830024|320538|P2|COMPLETED|Washout: 7 Days||18
139901|NCT00830024|320539|P1|COMPLETED|Washout: 7 Days||17
139902|NCT00830024|320538|P2|STARTED|Washout: 7 Days||18
139903|NCT00830024|320539|P1|STARTED|Washout: 7 Days||18
139904|NCT00830024|320538|P2|NOT COMPLETED|First Intervention||0
139905|NCT00830024|320539|P1|NOT COMPLETED|First Intervention||0
139906|NCT00830024|320538|P2|COMPLETED|First Intervention||18
139907|NCT00830024|320539|P1|COMPLETED|First Intervention||18
139908|NCT00830024|320538|P2|STARTED|First Intervention||18
139909|NCT00830024|320539|P1|STARTED|First Intervention||18
139910|NCT00829998|320549|P2|NOT COMPLETED|Second Intervention||0
139911|NCT00829998|320550|P1|NOT COMPLETED|Second Intervention||0
139912|NCT00829998|320549|P2|COMPLETED|Second Intervention||19
139913|NCT00829998|320550|P1|COMPLETED|Second Intervention||21
139914|NCT00829998|320549|P2|STARTED|Second Intervention||19
139915|NCT00829998|320550|P1|STARTED|Second Intervention||21
139916|NCT00829998|320549|P2|NOT COMPLETED|Washout||1
139917|NCT00829998|320550|P1|NOT COMPLETED|Washout||0
139918|NCT00829998|320549|P2|COMPLETED|Washout||19
139919|NCT00829998|320550|P1|COMPLETED|Washout||21
139920|NCT00829998|320549|P2|STARTED|Washout||20
139921|NCT00829998|320550|P1|STARTED|Washout||21
139922|NCT00829998|320549|P2|NOT COMPLETED|First Intervention||0
139923|NCT00829998|320550|P1|NOT COMPLETED|First Intervention||0
139924|NCT00829998|320549|P2|COMPLETED|First Intervention||20
139925|NCT00829998|320550|P1|COMPLETED|First Intervention||21
139926|NCT00829998|320549|P2|STARTED|First Intervention||20
139927|NCT00829998|320550|P1|STARTED|First Intervention||21
139928|NCT00829985|320560|P2|NOT COMPLETED|Overall Study||4
139929|NCT00829985|320561|P1|NOT COMPLETED|Overall Study||9
139930|NCT00829985|320560|P2|COMPLETED|Overall Study||22
139931|NCT00829985|320561|P1|COMPLETED|Overall Study||19
139932|NCT00829985|320560|P2|STARTED|Overall Study||26
139933|NCT00829985|320561|P1|STARTED|Overall Study||28
139934|NCT00829933|320579|P4|NOT COMPLETED|Overall Study||14
139935|NCT00829933|320580|P3|NOT COMPLETED|Overall Study||13
139936|NCT00829933|320581|P2|NOT COMPLETED|Overall Study||13
139937|NCT00829933|320582|P1|NOT COMPLETED|Overall Study||14
139938|NCT00829933|320579|P4|COMPLETED|Overall Study||120
139939|NCT00829933|320580|P3|COMPLETED|Overall Study||119
139940|NCT00829933|320581|P2|COMPLETED|Overall Study||122
139941|NCT00829933|320582|P1|COMPLETED|Overall Study||121
139942|NCT00829933|320579|P4|Baseline Analysis Population|Overall Study||129
139943|NCT00829933|320580|P3|Baseline Analysis Population|Overall Study||131
139944|NCT00829933|320581|P2|Baseline Analysis Population|Overall Study||134
139945|NCT00829933|320582|P1|Baseline Analysis Population|Overall Study||131
139946|NCT00829933|320579|P4|STARTED|Overall Study||134
139947|NCT00829933|320580|P3|STARTED|Overall Study||132
139948|NCT00829933|320581|P2|STARTED|Overall Study||135
139949|NCT00829933|320582|P1|STARTED|Overall Study||135
139950|NCT00829868|320594|P2|NOT COMPLETED|Second Intervention||0
139951|NCT00829868|320595|P1|NOT COMPLETED|Second Intervention||0
139952|NCT00829868|320594|P2|COMPLETED|Second Intervention||21
139953|NCT00829868|320595|P1|COMPLETED|Second Intervention||20
139954|NCT00829868|320594|P2|STARTED|Second Intervention||21
139955|NCT00829868|320595|P1|STARTED|Second Intervention||20
139956|NCT00829868|320594|P2|NOT COMPLETED|Washout||0
139957|NCT00829868|320595|P1|NOT COMPLETED|Washout||1
139958|NCT00829868|320594|P2|COMPLETED|Washout||21
139959|NCT00829868|320595|P1|COMPLETED|Washout||20
139960|NCT00829868|320594|P2|STARTED|Washout||21
139961|NCT00829868|320595|P1|STARTED|Washout||21
139962|NCT00829868|320594|P2|NOT COMPLETED|First Intervention||0
139963|NCT00829868|320595|P1|NOT COMPLETED|First Intervention||0
139964|NCT00829868|320594|P2|COMPLETED|First Intervention||21
139965|NCT00829868|320595|P1|COMPLETED|First Intervention||21
139966|NCT00829868|320594|P2|STARTED|First Intervention||21
139967|NCT00829868|320595|P1|STARTED|First Intervention||21
139968|NCT00829790|320605|P2|NOT COMPLETED|Second Intervention||0
139969|NCT00829790|320606|P1|NOT COMPLETED|Second Intervention||0
139970|NCT00829790|320605|P2|COMPLETED|Second Intervention||14
139971|NCT00829790|320606|P1|COMPLETED|Second Intervention||15
139972|NCT00829790|320605|P2|STARTED|Second Intervention||14
139973|NCT00829790|320606|P1|STARTED|Second Intervention||15
139974|NCT00829790|320605|P2|NOT COMPLETED|Washout of 14 Days||1
139975|NCT00829790|320606|P1|NOT COMPLETED|Washout of 14 Days||0
139976|NCT00829790|320605|P2|COMPLETED|Washout of 14 Days||14
139977|NCT00829790|320606|P1|COMPLETED|Washout of 14 Days||15
139978|NCT00829790|320605|P2|STARTED|Washout of 14 Days||15
139979|NCT00829790|320606|P1|STARTED|Washout of 14 Days||15
139980|NCT00829790|320605|P2|NOT COMPLETED|First Intervention||0
139981|NCT00829790|320606|P1|NOT COMPLETED|First Intervention||0
139982|NCT00829790|320605|P2|COMPLETED|First Intervention||15
139983|NCT00829790|320606|P1|COMPLETED|First Intervention||15
139984|NCT00829790|320605|P2|STARTED|First Intervention||15
139985|NCT00829790|320606|P1|STARTED|First Intervention||15
139986|NCT00829764|320616|P2|NOT COMPLETED|Second Intervention||0
139987|NCT00829764|320617|P1|NOT COMPLETED|Second Intervention||0
139988|NCT00829764|320616|P2|COMPLETED|Second Intervention||14
139989|NCT00829764|320617|P1|COMPLETED|Second Intervention||13
139990|NCT00829764|320616|P2|STARTED|Second Intervention||14
139991|NCT00829764|320617|P1|STARTED|Second Intervention||13
139992|NCT00829764|320616|P2|NOT COMPLETED|Washout of 14 Days||0
139993|NCT00829764|320617|P1|NOT COMPLETED|Washout of 14 Days||0
139994|NCT00829764|320616|P2|COMPLETED|Washout of 14 Days||14
139995|NCT00829764|320617|P1|COMPLETED|Washout of 14 Days||13
139996|NCT00829764|320616|P2|STARTED|Washout of 14 Days||14
139997|NCT00829764|320617|P1|STARTED|Washout of 14 Days||13
139998|NCT00829764|320616|P2|NOT COMPLETED|First Intervention||1
139999|NCT00829764|320617|P1|NOT COMPLETED|First Intervention||2
140000|NCT00829764|320616|P2|COMPLETED|First Intervention||14
140001|NCT00829764|320617|P1|COMPLETED|First Intervention||13
140002|NCT00829764|320616|P2|STARTED|First Intervention||15
140003|NCT00829764|320617|P1|STARTED|First Intervention||15
140004|NCT00829738|320625|P1|NOT COMPLETED|Overall Study||8
140005|NCT00829738|320625|P1|COMPLETED|Overall Study||4180
140006|NCT00829738|320625|P1|STARTED|Overall Study||4188
140007|NCT00829712|320643|P2|NOT COMPLETED|Second Intervention||0
140008|NCT00829712|320644|P1|NOT COMPLETED|Second Intervention||0
140009|NCT00829712|320643|P2|COMPLETED|Second Intervention||11
140010|NCT00829712|320644|P1|COMPLETED|Second Intervention||12
140011|NCT00829712|320643|P2|STARTED|Second Intervention||11
140012|NCT00829712|320644|P1|STARTED|Second Intervention||12
140013|NCT00829712|320643|P2|NOT COMPLETED|Washout of 7 Days||1
140014|NCT00829712|320644|P1|NOT COMPLETED|Washout of 7 Days||0
140015|NCT00829712|320643|P2|COMPLETED|Washout of 7 Days||11
140016|NCT00829712|320644|P1|COMPLETED|Washout of 7 Days||12
140017|NCT00829712|320643|P2|STARTED|Washout of 7 Days||12
140018|NCT00829712|320644|P1|STARTED|Washout of 7 Days||12
140019|NCT00829712|320643|P2|NOT COMPLETED|First Intervention||0
140020|NCT00829712|320644|P1|NOT COMPLETED|First Intervention||0
140021|NCT00829712|320643|P2|COMPLETED|First Intervention||12
140022|NCT00829712|320644|P1|COMPLETED|First Intervention||12
140023|NCT00829712|320643|P2|STARTED|First Intervention||12
140024|NCT00829712|320644|P1|STARTED|First Intervention||12
140025|NCT00829686|320654|P2|NOT COMPLETED|Overall Study||0
140026|NCT00829686|320655|P1|NOT COMPLETED|Overall Study||0
140027|NCT00829686|320654|P2|COMPLETED|Overall Study||18
140028|NCT00829686|320655|P1|COMPLETED|Overall Study||13
140029|NCT00829686|320654|P2|STARTED|Overall Study||18
140030|NCT00829686|320655|P1|STARTED|Overall Study||13
140031|NCT00829673|320663|P2|NOT COMPLETED|Second Intervention||0
140032|NCT00829673|320664|P1|NOT COMPLETED|Second Intervention||0
140033|NCT00829673|320663|P2|COMPLETED|Second Intervention||12
140034|NCT00829673|320664|P1|COMPLETED|Second Intervention||11
140035|NCT00829673|320663|P2|STARTED|Second Intervention||12
140036|NCT00829673|320664|P1|STARTED|Second Intervention||11
140037|NCT00829673|320663|P2|NOT COMPLETED|Washout of 7 Days||0
140038|NCT00829673|320664|P1|NOT COMPLETED|Washout of 7 Days||1
140039|NCT00829673|320663|P2|COMPLETED|Washout of 7 Days||12
140040|NCT00829673|320664|P1|COMPLETED|Washout of 7 Days||11
140041|NCT00829673|320663|P2|STARTED|Washout of 7 Days||12
140042|NCT00829673|320664|P1|STARTED|Washout of 7 Days||12
140043|NCT00829673|320663|P2|NOT COMPLETED|First Intervention||0
140044|NCT00829673|320664|P1|NOT COMPLETED|First Intervention||0
140045|NCT00829673|320663|P2|COMPLETED|First Intervention||12
140046|NCT00829673|320664|P1|COMPLETED|First Intervention||12
140047|NCT00829673|320663|P2|STARTED|First Intervention||12
140048|NCT00829673|320664|P1|STARTED|First Intervention||12
140049|NCT00829621|320674|P2|NOT COMPLETED|Overall Study||4
140050|NCT00829621|320675|P1|NOT COMPLETED|Overall Study||4
140051|NCT00829621|320674|P2|COMPLETED|Overall Study||8
140052|NCT00829621|320675|P1|COMPLETED|Overall Study||4
140053|NCT00829621|320674|P2|STARTED|Overall Study||12
140054|NCT00829621|320675|P1|STARTED|Overall Study||8
140055|NCT00829530|320683|P2|NOT COMPLETED|Second Intervention||0
140056|NCT00829530|320684|P1|NOT COMPLETED|Second Intervention||1
140057|NCT00829530|320683|P2|COMPLETED|Second Intervention||18
140058|NCT00829530|320684|P1|COMPLETED|Second Intervention||19
140059|NCT00829530|320683|P2|STARTED|Second Intervention||18
140060|NCT00829530|320684|P1|STARTED|Second Intervention||20
140061|NCT00829530|320683|P2|NOT COMPLETED|Washout of 42 Days||0
140062|NCT00829530|320684|P1|NOT COMPLETED|Washout of 42 Days||0
140063|NCT00829530|320683|P2|COMPLETED|Washout of 42 Days||18
140064|NCT00829530|320684|P1|COMPLETED|Washout of 42 Days||20
140065|NCT00829530|320683|P2|STARTED|Washout of 42 Days||18
140066|NCT00829530|320684|P1|STARTED|Washout of 42 Days||20
140067|NCT00829530|320683|P2|NOT COMPLETED|First Intervention||2
140068|NCT00829530|320684|P1|NOT COMPLETED|First Intervention||0
140069|NCT00829530|320683|P2|COMPLETED|First Intervention||18
140070|NCT00829530|320684|P1|COMPLETED|First Intervention||20
140071|NCT00829530|320683|P2|STARTED|First Intervention||20
140072|NCT00829530|320684|P1|STARTED|First Intervention||20
140073|NCT00829504|320698|P2|NOT COMPLETED|Second Intervention||0
140074|NCT00829504|320699|P1|NOT COMPLETED|Second Intervention||1
140075|NCT00829504|320698|P2|COMPLETED|Second Intervention||22
140076|NCT00829504|320699|P1|COMPLETED|Second Intervention||19
140077|NCT00829504|320698|P2|STARTED|Second Intervention||22
140078|NCT00829504|320699|P1|STARTED|Second Intervention||20
140079|NCT00829504|320698|P2|NOT COMPLETED|Washout of 7 Days||0
140080|NCT00829504|320699|P1|NOT COMPLETED|Washout of 7 Days||1
140081|NCT00829504|320698|P2|COMPLETED|Washout of 7 Days||22
140082|NCT00829504|320699|P1|COMPLETED|Washout of 7 Days||20
140083|NCT00829504|320698|P2|STARTED|Washout of 7 Days||22
140084|NCT00829504|320699|P1|STARTED|Washout of 7 Days||21
140085|NCT00829504|320698|P2|NOT COMPLETED|First Intervention||0
140086|NCT00829504|320699|P1|NOT COMPLETED|First Intervention||1
140087|NCT00829504|320698|P2|COMPLETED|First Intervention||22
140088|NCT00829504|320699|P1|COMPLETED|First Intervention||21
140089|NCT00829504|320698|P2|STARTED|First Intervention||22
140090|NCT00829504|320699|P1|STARTED|First Intervention||22
140091|NCT00829452|320709|P2|NOT COMPLETED|Second Intervention||1
140092|NCT00829452|320710|P1|NOT COMPLETED|Second Intervention||0
140093|NCT00829452|320709|P2|COMPLETED|Second Intervention||17
140094|NCT00829452|320710|P1|COMPLETED|Second Intervention||20
140095|NCT00829452|320709|P2|STARTED|Second Intervention||18
140096|NCT00829452|320710|P1|STARTED|Second Intervention||20
140097|NCT00829452|320709|P2|NOT COMPLETED|Washout of 42 Days||1
140098|NCT00829452|320710|P1|NOT COMPLETED|Washout of 42 Days||0
140099|NCT00829452|320709|P2|COMPLETED|Washout of 42 Days||18
140100|NCT00829452|320710|P1|COMPLETED|Washout of 42 Days||20
140101|NCT00829452|320709|P2|STARTED|Washout of 42 Days||19
140102|NCT00829452|320710|P1|STARTED|Washout of 42 Days||20
140103|NCT00829452|320709|P2|NOT COMPLETED|First Intervention||1
140104|NCT00829452|320710|P1|NOT COMPLETED|First Intervention||0
140105|NCT00829452|320709|P2|COMPLETED|First Intervention||19
140106|NCT00829452|320710|P1|COMPLETED|First Intervention||20
140107|NCT00829452|320709|P2|STARTED|First Intervention||20
140108|NCT00829452|320710|P1|STARTED|First Intervention||20
140109|NCT00829439|320722|P4|NOT COMPLETED|Overall Study||0
140110|NCT00829439|320723|P3|NOT COMPLETED|Overall Study||1
140111|NCT00829439|320724|P2|NOT COMPLETED|Overall Study||0
140112|NCT00829439|320725|P1|NOT COMPLETED|Overall Study||0
140113|NCT00829439|320722|P4|COMPLETED|Overall Study||4
140114|NCT00829439|320723|P3|COMPLETED|Overall Study||5
140115|NCT00829439|320724|P2|COMPLETED|Overall Study||3
140116|NCT00829439|320725|P1|COMPLETED|Overall Study||3
140117|NCT00829439|320722|P4|STARTED|Overall Study||4
140118|NCT00829439|320723|P3|STARTED|Overall Study||6
140119|NCT00829439|320724|P2|STARTED|Overall Study||3
140120|NCT00829439|320725|P1|STARTED|Overall Study||3
140121|NCT00829426|320731|P2|NOT COMPLETED|Second Intervention||0
140122|NCT00829426|320732|P1|NOT COMPLETED|Second Intervention||0
140123|NCT00829426|320731|P2|COMPLETED|Second Intervention||16
140124|NCT00829426|320732|P1|COMPLETED|Second Intervention||15
140125|NCT00829426|320731|P2|STARTED|Second Intervention||16
140126|NCT00829426|320732|P1|STARTED|Second Intervention||15
140127|NCT00829426|320731|P2|NOT COMPLETED|Washout: 7 Days||0
140128|NCT00829426|320732|P1|NOT COMPLETED|Washout: 7 Days||1
140129|NCT00829426|320731|P2|COMPLETED|Washout: 7 Days||16
140130|NCT00829426|320732|P1|COMPLETED|Washout: 7 Days||15
140131|NCT00829426|320731|P2|STARTED|Washout: 7 Days||16
140132|NCT00829426|320732|P1|STARTED|Washout: 7 Days||16
140133|NCT00829426|320731|P2|NOT COMPLETED|First Intervention||0
140134|NCT00829426|320732|P1|NOT COMPLETED|First Intervention||0
140135|NCT00829426|320731|P2|COMPLETED|First Intervention||16
140136|NCT00829426|320732|P1|COMPLETED|First Intervention||16
140137|NCT00829426|320731|P2|STARTED|First Intervention||16
140138|NCT00829426|320732|P1|STARTED|First Intervention||16
140139|NCT00829387|320742|P2|NOT COMPLETED|Overall Study||3
140140|NCT00829387|320743|P1|NOT COMPLETED|Overall Study||3
140141|NCT00829387|320742|P2|COMPLETED|Overall Study||21
140142|NCT00829387|320743|P1|COMPLETED|Overall Study||20
140143|NCT00829387|320742|P2|STARTED|Overall Study||24
140144|NCT00829387|320743|P1|STARTED|Overall Study||23
140145|NCT00829309|320761|P2|NOT COMPLETED|Second Intervention||0
140146|NCT00829309|320762|P1|NOT COMPLETED|Second Intervention||0
140147|NCT00829309|320761|P2|COMPLETED|Second Intervention||8
140148|NCT00829309|320762|P1|COMPLETED|Second Intervention||7
140149|NCT00829309|320761|P2|STARTED|Second Intervention||8
140150|NCT00829309|320762|P1|STARTED|Second Intervention||7
140151|NCT00829309|320761|P2|NOT COMPLETED|Washout: 7 Days||0
140152|NCT00829309|320762|P1|NOT COMPLETED|Washout: 7 Days||1
140153|NCT00829309|320761|P2|COMPLETED|Washout: 7 Days||8
140154|NCT00829309|320762|P1|COMPLETED|Washout: 7 Days||7
140155|NCT00829309|320761|P2|STARTED|Washout: 7 Days||8
140156|NCT00829309|320762|P1|STARTED|Washout: 7 Days||8
140157|NCT00829309|320761|P2|NOT COMPLETED|First Intervention||0
140158|NCT00829309|320762|P1|NOT COMPLETED|First Intervention||0
140159|NCT00829309|320761|P2|COMPLETED|First Intervention||8
140160|NCT00829309|320762|P1|COMPLETED|First Intervention||8
140161|NCT00829309|320761|P2|STARTED|First Intervention||8
140162|NCT00829309|320762|P1|STARTED|First Intervention||8
140163|NCT00829296|320772|P2|NOT COMPLETED|Overall Study||4
140164|NCT00829296|320773|P1|NOT COMPLETED|Overall Study||5
140165|NCT00829296|320772|P2|COMPLETED|Overall Study||32
140166|NCT00829296|320773|P1|COMPLETED|Overall Study||29
140167|NCT00829296|320772|P2|STARTED|Overall Study||36
140168|NCT00829296|320773|P1|STARTED|Overall Study||34
140169|NCT00829283|320787|P2|NOT COMPLETED|Overall Study||25
140170|NCT00829283|320788|P1|NOT COMPLETED|Overall Study||7
140171|NCT00829283|320787|P2|COMPLETED|Overall Study||127
140172|NCT00829283|320788|P1|COMPLETED|Overall Study||32
140173|NCT00829283|320787|P2|STARTED|Overall Study||152
140174|NCT00829283|320788|P1|STARTED|Overall Study||39
140175|NCT00829244|320798|P2|NOT COMPLETED|Overall Study||21
140176|NCT00829244|320799|P1|NOT COMPLETED|Overall Study||14
140177|NCT00829244|320798|P2|COMPLETED|Overall Study||83
140178|NCT00829244|320799|P1|COMPLETED|Overall Study||82
140179|NCT00829244|320798|P2|STARTED|Overall Study||104
140180|NCT00829244|320799|P1|STARTED|Overall Study||96
140181|NCT00829179|320829|P1|NOT COMPLETED|Overall Study||1
140182|NCT00829179|320829|P1|COMPLETED|Overall Study||19
140183|NCT00829179|320829|P1|STARTED|Overall Study||20
140184|NCT00829166|320835|P2|NOT COMPLETED|Overall Study||496
140185|NCT00829166|320836|P1|NOT COMPLETED|Overall Study||495
140186|NCT00829166|320835|P2|COMPLETED|Overall Study||0
140187|NCT00829166|320836|P1|COMPLETED|Overall Study||0
140188|NCT00829166|320835|P2|Treated|Overall Study||488
140189|NCT00829166|320836|P1|Treated|Overall Study||490
140190|NCT00829166|320835|P2|STARTED|Overall Study||496
140191|NCT00829166|320836|P1|STARTED|Overall Study||495
140192|NCT00829049|320877|P2|NOT COMPLETED|Overall Study||20
140193|NCT00829049|320878|P1|NOT COMPLETED|Overall Study||17
140194|NCT00829049|320877|P2|COMPLETED|Overall Study||68
140195|NCT00829049|320878|P1|COMPLETED|Overall Study||60
140196|NCT00829049|320877|P2|STARTED|Overall Study||88
140197|NCT00829049|320878|P1|STARTED|Overall Study||77
140198|NCT00829036|320890|P1|NOT COMPLETED|Overall Study||0
140199|NCT00829036|320890|P1|COMPLETED|Overall Study||24
140200|NCT00829036|320890|P1|STARTED|Overall Study||24
140201|NCT00829010|320899|P5|NOT COMPLETED|Overall Study||2
140202|NCT00829010|320900|P4|NOT COMPLETED|Overall Study||8
140203|NCT00829010|320901|P3|NOT COMPLETED|Overall Study||3
140204|NCT00829010|320902|P2|NOT COMPLETED|Overall Study||9
140205|NCT00829010|320903|P1|NOT COMPLETED|Overall Study||10
140206|NCT00829010|320899|P5|COMPLETED|Overall Study||98
140207|NCT00829010|320900|P4|COMPLETED|Overall Study||92
140208|NCT00829010|320901|P3|COMPLETED|Overall Study||97
140209|NCT00829010|320902|P2|COMPLETED|Overall Study||92
140210|NCT00829010|320903|P1|COMPLETED|Overall Study||73
140211|NCT00829010|320899|P5|STARTED|Overall Study||100
140212|NCT00829010|320900|P4|STARTED|Overall Study||100
140213|NCT00829010|320901|P3|STARTED|Overall Study||100
140214|NCT00829010|320902|P2|STARTED|Overall Study||101
140215|NCT00829010|320903|P1|STARTED|Overall Study||83
140216|NCT00828984|321068|P3|NOT COMPLETED|Overall Study||9
140217|NCT00828984|321069|P2|NOT COMPLETED|Overall Study||16
140218|NCT00828984|321070|P1|NOT COMPLETED|Overall Study||14
140219|NCT00828984|321068|P3|COMPLETED|Overall Study||19
140220|NCT00828984|321069|P2|COMPLETED|Overall Study||15
140221|NCT00828984|321070|P1|COMPLETED|Overall Study||14
140222|NCT00828984|321068|P3|Post Intervention Follow-Up|Overall Study||19
140223|NCT00828984|321069|P2|Post Intervention Follow-Up|Overall Study||16
140224|NCT00828984|321070|P1|Post Intervention Follow-Up|Overall Study||15
140225|NCT00828984|321068|P3|Flex Sig|Overall Study||19
140226|NCT00828984|321069|P2|Flex Sig|Overall Study||19
140227|NCT00828984|321070|P1|Flex Sig|Overall Study||20
140228|NCT00828984|321068|P3|Treatment|Overall Study||24
140229|NCT00828984|321069|P2|Treatment|Overall Study||26
140230|NCT00828984|321070|P1|Treatment|Overall Study||24
140231|NCT00828984|321068|P3|Randomization|Overall Study||28
140232|NCT00828984|321069|P2|Randomization|Overall Study||31
140233|NCT00828984|321070|P1|Randomization|Overall Study||28
140234|NCT00828984|321068|P3|STARTED|Overall Study||28
140235|NCT00828984|321069|P2|STARTED|Overall Study||31
140236|NCT00828984|321070|P1|STARTED|Overall Study||28
140237|NCT00828945|321093|P1|NOT COMPLETED|Overall Study||41
140238|NCT00828945|321093|P1|COMPLETED|Overall Study||216
140239|NCT00828945|321093|P1|STARTED|Overall Study||257
140240|NCT00828841|321110|P3|NOT COMPLETED|Overall Study||4
140241|NCT00828841|321111|P2|NOT COMPLETED|Overall Study||4
140242|NCT00828841|321112|P1|NOT COMPLETED|Overall Study||4
140243|NCT00828841|321110|P3|COMPLETED|Overall Study||126
140244|NCT00828841|321111|P2|COMPLETED|Overall Study||232
140245|NCT00828841|321112|P1|COMPLETED|Overall Study||231
140246|NCT00828841|321110|P3|STARTED|Overall Study||130
140247|NCT00828841|321111|P2|STARTED|Overall Study||236
140248|NCT00828841|321112|P1|STARTED|Overall Study||235
140249|NCT00828750|321125|P1|NOT COMPLETED|Overall Study||4
140250|NCT00828750|321125|P1|COMPLETED|Overall Study||15
140251|NCT00828750|321125|P1|STARTED|Overall Study||19
140252|NCT00828711|321139|P3|NOT COMPLETED|Overall Study||0
140253|NCT00828711|321140|P2|NOT COMPLETED|Overall Study||0
140254|NCT00828711|321141|P1|NOT COMPLETED|Overall Study||1
140255|NCT00828711|321139|P3|COMPLETED|Overall Study||131
140256|NCT00828711|321140|P2|COMPLETED|Overall Study||125
140257|NCT00828711|321141|P1|COMPLETED|Overall Study||117
140258|NCT00828711|321139|P3|STARTED|Overall Study||131
140259|NCT00828711|321140|P2|STARTED|Overall Study||125
140260|NCT00828711|321141|P1|STARTED|Overall Study||118
140261|NCT00828568|321173|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
140262|NCT00828568|321174|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
140263|NCT00828568|321175|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
140264|NCT00828568|321173|P3|COMPLETED|Treated - Received at Least One Dose||55
140265|NCT00828568|321174|P2|COMPLETED|Treated - Received at Least One Dose||150
140266|NCT00828568|321175|P1|COMPLETED|Treated - Received at Least One Dose||153
140267|NCT00828568|321173|P3|STARTED|Treated - Received at Least One Dose||60
140268|NCT00828568|321174|P2|STARTED|Treated - Received at Least One Dose||179
140269|NCT00828568|321175|P1|STARTED|Treated - Received at Least One Dose||183
140270|NCT00828568|321173|P3|NOT COMPLETED|Randomized||2
140271|NCT00828568|321174|P2|NOT COMPLETED|Randomized||0
140272|NCT00828568|321175|P1|NOT COMPLETED|Randomized||1
140273|NCT00828568|321173|P3|COMPLETED|Randomized||60
140274|NCT00828568|321174|P2|COMPLETED|Randomized||179
140275|NCT00828568|321175|P1|COMPLETED|Randomized||183
140276|NCT00828568|321173|P3|STARTED|Randomized||62
140277|NCT00828568|321174|P2|STARTED|Randomized||179
140278|NCT00828568|321175|P1|STARTED|Randomized||184
140279|NCT00828516|321188|P1|NOT COMPLETED|Clinical Phase: Series 2||0
140280|NCT00828516|321188|P1|COMPLETED|Clinical Phase: Series 2||30
140281|NCT00828516|321188|P1|STARTED|Clinical Phase: Series 2||30
140282|NCT00828516|321188|P1|NOT COMPLETED|Clinical Phase: Series 1||2
140283|NCT00828516|321188|P1|COMPLETED|Clinical Phase: Series 1||33
140284|NCT00828516|321188|P1|STARTED|Clinical Phase: Series 1||35
140285|NCT00828464|321193|P1|NOT COMPLETED|Overall Study||1
140286|NCT00828464|321193|P1|COMPLETED|Overall Study||29
140287|NCT00828464|321193|P1|STARTED|Overall Study||30
140288|NCT00828412|321212|P2|NOT COMPLETED|Overall Study||2
140289|NCT00828412|321213|P1|NOT COMPLETED|Overall Study||9
140290|NCT00828412|321212|P2|COMPLETED|Overall Study||48
140291|NCT00828412|321213|P1|COMPLETED|Overall Study||41
140292|NCT00828412|321212|P2|STARTED|Overall Study||50
140293|NCT00828412|321213|P1|STARTED|Overall Study||50
140294|NCT00828347|321221|P2|NOT COMPLETED|Overall Study||0
140295|NCT00828347|321222|P1|NOT COMPLETED|Overall Study||0
140296|NCT00828347|321221|P2|COMPLETED|Overall Study||11
140297|NCT00828347|321222|P1|COMPLETED|Overall Study||12
140298|NCT00828347|321221|P2|STARTED|Overall Study||11
140299|NCT00828347|321222|P1|STARTED|Overall Study||12
140300|NCT00828321|321230|P2|NOT COMPLETED|Second Intervention||1
140301|NCT00828321|321231|P1|NOT COMPLETED|Second Intervention||0
140302|NCT00828321|321230|P2|COMPLETED|Second Intervention||19
140303|NCT00828321|321231|P1|COMPLETED|Second Intervention||18
140304|NCT00828321|321230|P2|STARTED|Second Intervention||20
140305|NCT00828321|321231|P1|STARTED|Second Intervention||18
140306|NCT00828321|321230|P2|NOT COMPLETED|Washout of 42 Days||0
140307|NCT00828321|321231|P1|NOT COMPLETED|Washout of 42 Days||2
140308|NCT00828321|321230|P2|COMPLETED|Washout of 42 Days||20
140309|NCT00828321|321231|P1|COMPLETED|Washout of 42 Days||18
140310|NCT00828321|321230|P2|STARTED|Washout of 42 Days||20
140311|NCT00828321|321231|P1|STARTED|Washout of 42 Days||20
140312|NCT00828321|321230|P2|NOT COMPLETED|First Intervention||0
140313|NCT00828321|321231|P1|NOT COMPLETED|First Intervention||0
140314|NCT00828321|321230|P2|COMPLETED|First Intervention||20
140315|NCT00828321|321231|P1|COMPLETED|First Intervention||20
140316|NCT00828321|321230|P2|STARTED|First Intervention||20
140317|NCT00828321|321231|P1|STARTED|First Intervention||20
140318|NCT00828308|321243|P1|NOT COMPLETED|Overall Study||0
140319|NCT00828308|321243|P1|COMPLETED|Overall Study||16
140320|NCT00828308|321243|P1|STARTED|Overall Study||16
140321|NCT00828295|321249|P2|NOT COMPLETED|Overall Study||0
140322|NCT00828295|321250|P1|NOT COMPLETED|Overall Study||0
140323|NCT00828295|321249|P2|COMPLETED|Overall Study||75
140324|NCT00828295|321250|P1|COMPLETED|Overall Study||75
140325|NCT00828295|321249|P2|STARTED|Overall Study||75
140326|NCT00828295|321250|P1|STARTED|Overall Study||75
140327|NCT00828204|321260|P2|NOT COMPLETED|Extension Study||3
140328|NCT00828204|321261|P1|NOT COMPLETED|Extension Study||0
140329|NCT00828204|321260|P2|COMPLETED|Extension Study||61
140330|NCT00828204|321261|P1|COMPLETED|Extension Study||0
140331|NCT00828204|321260|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
140332|NCT00828204|321261|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
140333|NCT00828204|321260|P2|NOT COMPLETED|Main Study: After Study Restart||3
140334|NCT00828204|321261|P1|NOT COMPLETED|Main Study: After Study Restart||0
140335|NCT00828204|321260|P2|COMPLETED|Main Study: After Study Restart||71
140336|NCT00828204|321261|P1|COMPLETED|Main Study: After Study Restart||0
140337|NCT00828204|321260|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
140338|NCT00828204|321261|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
140339|NCT00828204|321260|P2|Completed Manual Injection|Main Study: After Study Restart||74
140340|NCT00828204|321261|P1|Completed Manual Injection|Main Study: After Study Restart||0
140341|NCT00828204|321260|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
140342|NCT00828204|321261|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
140343|NCT00828204|321260|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
140344|NCT00828204|321261|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
140345|NCT00828204|321260|P2|COMPLETED|Main Study: Prior to Study Suspension||0
140346|NCT00828204|321261|P1|COMPLETED|Main Study: Prior to Study Suspension||7
140347|NCT00828204|321260|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
140348|NCT00828204|321261|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
140349|NCT00828204|321260|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
140350|NCT00828204|321261|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
140351|NCT00828204|321260|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
140352|NCT00828204|321261|P1|STARTED|Main Study: Prior to Study Suspension||21
140353|NCT00828191|321280|P2|NOT COMPLETED|Overall Study||10
140354|NCT00828191|321281|P1|NOT COMPLETED|Overall Study||8
140355|NCT00828191|321280|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
140356|NCT00828191|321281|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
140357|NCT00828191|321280|P2|STARTED|Overall Study|Randomized patients|400
140358|NCT00828191|321281|P1|STARTED|Overall Study|Randomized patients|400
140359|NCT00828178|321293|P2|NOT COMPLETED|Overall Study||2
140360|NCT00828178|321294|P1|NOT COMPLETED|Overall Study||0
140361|NCT00828178|321293|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
140362|NCT00828178|321294|P1|COMPLETED|Overall Study||42
140363|NCT00828178|321293|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
140364|NCT00828178|321294|P1|STARTED|Overall Study||42
140365|NCT00828139|321308|P4|NOT COMPLETED|Overall Study||51
140366|NCT00828139|321309|P3|NOT COMPLETED|Overall Study||55
140367|NCT00828139|321310|P2|NOT COMPLETED|Overall Study||41
140368|NCT00828139|321311|P1|NOT COMPLETED|Overall Study||41
140369|NCT00828139|321308|P4|COMPLETED|Overall Study||0
140370|NCT00828139|321309|P3|COMPLETED|Overall Study||0
140371|NCT00828139|321310|P2|COMPLETED|Overall Study||0
140372|NCT00828139|321311|P1|COMPLETED|Overall Study||1
140373|NCT00828139|321308|P4|STARTED|Overall Study||51
140374|NCT00828139|321309|P3|STARTED|Overall Study||55
140375|NCT00828139|321310|P2|STARTED|Overall Study||41
140376|NCT00828139|321311|P1|STARTED|Overall Study||42
140377|NCT00828113|321331|P2|NOT COMPLETED|Overall Study||31
140378|NCT00828113|321332|P1|NOT COMPLETED|Overall Study||30
140379|NCT00828113|321331|P2|COMPLETED|Overall Study||20
140380|NCT00828113|321332|P1|COMPLETED|Overall Study||20
140381|NCT00828113|321331|P2|STARTED|Overall Study||51
140382|NCT00828113|321332|P1|STARTED|Overall Study||50
140383|NCT00828061|321338|P6|NOT COMPLETED|Period 3||0
140384|NCT00828061|321339|P5|NOT COMPLETED|Period 3||0
140385|NCT00828061|321340|P4|NOT COMPLETED|Period 3||0
140386|NCT00828061|321341|P3|NOT COMPLETED|Period 3||0
140387|NCT00828061|321342|P2|NOT COMPLETED|Period 3||0
140388|NCT00828061|321343|P1|NOT COMPLETED|Period 3||0
140389|NCT00828061|321338|P6|COMPLETED|Period 3||3
140390|NCT00828061|321339|P5|COMPLETED|Period 3||3
140391|NCT00828061|321340|P4|COMPLETED|Period 3||3
140392|NCT00828061|321341|P3|COMPLETED|Period 3||3
140393|NCT00828061|321342|P2|COMPLETED|Period 3||3
140394|NCT00828061|321343|P1|COMPLETED|Period 3||4
140395|NCT00828061|321338|P6|STARTED|Period 3||3
140396|NCT00828061|321339|P5|STARTED|Period 3||3
140397|NCT00828061|321340|P4|STARTED|Period 3||3
140398|NCT00828061|321341|P3|STARTED|Period 3||3
140399|NCT00828061|321342|P2|STARTED|Period 3||3
140400|NCT00828061|321343|P1|STARTED|Period 3||4
140401|NCT00828061|321338|P6|NOT COMPLETED|Period 2||0
140402|NCT00828061|321339|P5|NOT COMPLETED|Period 2||0
140403|NCT00828061|321340|P4|NOT COMPLETED|Period 2||0
140404|NCT00828061|321341|P3|NOT COMPLETED|Period 2||0
140405|NCT00828061|321342|P2|NOT COMPLETED|Period 2||0
140406|NCT00828061|321343|P1|NOT COMPLETED|Period 2||0
140407|NCT00828061|321338|P6|COMPLETED|Period 2||3
140408|NCT00828061|321339|P5|COMPLETED|Period 2||3
140409|NCT00828061|321340|P4|COMPLETED|Period 2||3
140410|NCT00828061|321341|P3|COMPLETED|Period 2||3
140411|NCT00828061|321342|P2|COMPLETED|Period 2||3
140412|NCT00828061|321343|P1|COMPLETED|Period 2||4
140413|NCT00828061|321338|P6|STARTED|Period 2||3
140414|NCT00828061|321339|P5|STARTED|Period 2||3
140415|NCT00828061|321340|P4|STARTED|Period 2||3
140416|NCT00828061|321341|P3|STARTED|Period 2||3
140417|NCT00828061|321342|P2|STARTED|Period 2||3
140418|NCT00828061|321343|P1|STARTED|Period 2||4
140419|NCT00828061|321338|P6|NOT COMPLETED|Period 1||0
140420|NCT00828061|321339|P5|NOT COMPLETED|Period 1||0
140421|NCT00828061|321340|P4|NOT COMPLETED|Period 1||0
140422|NCT00828061|321341|P3|NOT COMPLETED|Period 1||0
140423|NCT00828061|321342|P2|NOT COMPLETED|Period 1||0
140424|NCT00828061|321343|P1|NOT COMPLETED|Period 1||0
140425|NCT00828061|321338|P6|COMPLETED|Period 1||3
140426|NCT00828061|321339|P5|COMPLETED|Period 1||3
140427|NCT00828061|321340|P4|COMPLETED|Period 1||3
140428|NCT00828061|321341|P3|COMPLETED|Period 1||3
140429|NCT00828061|321342|P2|COMPLETED|Period 1||3
140430|NCT00828061|321343|P1|COMPLETED|Period 1||4
140431|NCT00828061|321338|P6|STARTED|Period 1||3
140432|NCT00828061|321339|P5|STARTED|Period 1||3
140433|NCT00828061|321340|P4|STARTED|Period 1||3
140434|NCT00828061|321341|P3|STARTED|Period 1||3
140435|NCT00828061|321342|P2|STARTED|Period 1||3
140436|NCT00828061|321343|P1|STARTED|Period 1||4
140437|NCT00827983|321356|P2|NOT COMPLETED|Overall Study||16
140438|NCT00827983|321357|P1|NOT COMPLETED|Overall Study||18
140439|NCT00827983|321356|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
140440|NCT00827983|321357|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
140441|NCT00827983|321356|P2|STARTED|Overall Study|all randomised patients|344
140442|NCT00827983|321357|P1|STARTED|Overall Study|All randomised patients|339
140443|NCT00827944|321369|P2|NOT COMPLETED|Overall Study||59
140444|NCT00827944|321370|P1|NOT COMPLETED|Overall Study||63
140445|NCT00827944|321369|P2|COMPLETED|Overall Study||240
140446|NCT00827944|321370|P1|COMPLETED|Overall Study||241
140447|NCT00827944|321369|P2|STARTED|Overall Study||299
140448|NCT00827944|321370|P1|STARTED|Overall Study||304
140449|NCT00827931|321390|P2|NOT COMPLETED|Overall Study||6
140450|NCT00827931|321391|P1|NOT COMPLETED|Overall Study||6
140451|NCT00827931|321390|P2|COMPLETED|Overall Study||39
140452|NCT00827931|321391|P1|COMPLETED|Overall Study||43
140453|NCT00827931|321390|P2|STARTED|Overall Study||45
140454|NCT00827931|321391|P1|STARTED|Overall Study||49
140455|NCT00827918|321412|P3|NOT COMPLETED|Overall Study||21
140456|NCT00827918|321413|P2|NOT COMPLETED|Overall Study||9
140457|NCT00827918|321414|P1|NOT COMPLETED|Overall Study||28
140458|NCT00827918|321412|P3|COMPLETED|Overall Study||62
140459|NCT00827918|321413|P2|COMPLETED|Overall Study||38
140460|NCT00827918|321414|P1|COMPLETED|Overall Study||58
140461|NCT00827918|321412|P3|STARTED|Overall Study||83
140462|NCT00827918|321413|P2|STARTED|Overall Study||47
140463|NCT00827918|321414|P1|STARTED|Overall Study||86
140464|NCT00827827|321442|P2|NOT COMPLETED|Overall Study||0
140465|NCT00827827|321443|P1|NOT COMPLETED|Overall Study||8
140466|NCT00827827|321442|P2|COMPLETED|Overall Study||16
140467|NCT00827827|321443|P1|COMPLETED|Overall Study||14
140468|NCT00827827|321442|P2|STARTED|Overall Study||16
140469|NCT00827827|321443|P1|STARTED|Overall Study||22
140470|NCT00827632|321487|P2|NOT COMPLETED|Overall Study||23
140471|NCT00827632|321488|P1|NOT COMPLETED|Overall Study||22
140472|NCT00827632|321487|P2|COMPLETED|Overall Study||75
140473|NCT00827632|321488|P1|COMPLETED|Overall Study||106
140474|NCT00827632|321487|P2|STARTED|Overall Study||98
140475|NCT00827632|321488|P1|STARTED|Overall Study||128
140476|NCT00827606|321496|P2|NOT COMPLETED|Overall Study||38
140477|NCT00827606|321497|P1|NOT COMPLETED|Overall Study||27
140478|NCT00827606|321496|P2|COMPLETED|Overall Study||94
140479|NCT00827606|321497|P1|COMPLETED|Overall Study||112
140480|NCT00827606|321496|P2|STARTED|Overall Study||132
140481|NCT00827606|321497|P1|STARTED|Overall Study||139
140482|NCT00827567|321558|P1|NOT COMPLETED|Overall Study||4
140483|NCT00827567|321558|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
140484|NCT00827567|321558|P1|STARTED|Overall Study||4
140485|NCT00827541|321564|P2|NOT COMPLETED|Overall Study||11
140486|NCT00827541|321565|P1|NOT COMPLETED|Overall Study||4
140487|NCT00827541|321564|P2|COMPLETED|Overall Study||85
140488|NCT00827541|321565|P1|COMPLETED|Overall Study||15
140489|NCT00827541|321564|P2|STARTED|Overall Study||96
140490|NCT00827541|321565|P1|STARTED|Overall Study||19
140491|NCT00827502|321577|P1|NOT COMPLETED|Overall Study||21
140492|NCT00827502|321577|P1|COMPLETED|Overall Study||400
140493|NCT00827502|321577|P1|Received Treatment (Number Treated)|Overall Study||410
140494|NCT00827502|321577|P1|STARTED|Overall Study||421
140495|NCT00827372|321583|P1|NOT COMPLETED|Overall Study||8
140496|NCT00827372|321583|P1|COMPLETED|Overall Study||2
140497|NCT00827372|321583|P1|STARTED|Overall Study||10
140498|NCT00827255|321591|P1|NOT COMPLETED|Overall Study||0
140499|NCT00827255|321591|P1|COMPLETED|Overall Study||35
140500|NCT00827255|321591|P1|STARTED|Overall Study||35
140501|NCT00827242|321598|P2|NOT COMPLETED|Overall Study||12
140502|NCT00827242|321599|P1|NOT COMPLETED|Overall Study||13
140503|NCT00827242|321598|P2|COMPLETED|Overall Study||152
140504|NCT00827242|321599|P1|COMPLETED|Overall Study||148
140505|NCT00827242|321598|P2|STARTED|Overall Study||164
140506|NCT00827242|321599|P1|STARTED|Overall Study||161
140507|NCT00827112|321637|P2|NOT COMPLETED|Overall Study||12
140508|NCT00827112|321638|P1|NOT COMPLETED|Overall Study||15
140509|NCT00827112|321637|P2|COMPLETED|Overall Study||52
140510|NCT00827112|321638|P1|COMPLETED|Overall Study||50
140511|NCT00827112|321637|P2|Treated|Overall Study||61
140512|NCT00827112|321638|P1|Treated|Overall Study||60
140513|NCT00827112|321637|P2|STARTED|Overall Study||64
140514|NCT00827112|321638|P1|STARTED|Overall Study||65
140515|NCT00827099|321671|P1|NOT COMPLETED|Overall Study||0
140516|NCT00827099|321671|P1|COMPLETED|Overall Study||5
140517|NCT00827099|321671|P1|STARTED|Overall Study||5
140518|NCT00827073|321682|P2|NOT COMPLETED|Overall Study||0
140519|NCT00827073|321683|P1|NOT COMPLETED|Overall Study||0
140520|NCT00827073|321682|P2|COMPLETED|Overall Study||20
140521|NCT00827073|321683|P1|COMPLETED|Overall Study||20
140522|NCT00827073|321682|P2|STARTED|Overall Study||20
140523|NCT00827073|321683|P1|STARTED|Overall Study||20
140524|NCT00826943|321691|P6|NOT COMPLETED|Overall Study||0
140525|NCT00826943|321692|P5|NOT COMPLETED|Overall Study||1
140526|NCT00826943|321693|P4|NOT COMPLETED|Overall Study||0
140527|NCT00826943|321694|P3|NOT COMPLETED|Overall Study||0
140528|NCT00826943|321695|P2|NOT COMPLETED|Overall Study||0
140529|NCT00826943|321696|P1|NOT COMPLETED|Overall Study||0
140530|NCT00826943|321691|P6|COMPLETED|Overall Study||2
140531|NCT00826943|321692|P5|COMPLETED|Overall Study||6
140532|NCT00826943|321693|P4|COMPLETED|Overall Study||5
140533|NCT00826943|321694|P3|COMPLETED|Overall Study||4
140534|NCT00826943|321695|P2|COMPLETED|Overall Study||6
140535|NCT00826943|321696|P1|COMPLETED|Overall Study||6
140536|NCT00826943|321691|P6|STARTED|Overall Study||2
140537|NCT00826943|321692|P5|STARTED|Overall Study||7
140538|NCT00826943|321693|P4|STARTED|Overall Study||5
140539|NCT00826943|321694|P3|STARTED|Overall Study||4
140540|NCT00826943|321695|P2|STARTED|Overall Study||6
140541|NCT00826943|321696|P1|STARTED|Overall Study||6
140542|NCT00826800|321710|P1|NOT COMPLETED|Overall Study||0
140543|NCT00826800|321710|P1|COMPLETED|Overall Study||2
140544|NCT00826800|321710|P1|STARTED|Overall Study||2
140545|NCT00826618|321714|P1|NOT COMPLETED|Overall Study||1
140546|NCT00826618|321714|P1|COMPLETED|Overall Study||5
140547|NCT00826618|321714|P1|STARTED|Overall Study||6
140548|NCT00826540|321718|P1|NOT COMPLETED|Overall Study||4
140549|NCT00826540|321718|P1|COMPLETED|Overall Study||79
140550|NCT00826540|321718|P1|STARTED|Overall Study||83
140551|NCT00826449|321724|P1|NOT COMPLETED|Overall Study||5
140552|NCT00826449|321724|P1|COMPLETED|Overall Study||42
140553|NCT00826449|321724|P1|Phase II|Overall Study||35
140554|NCT00826449|321724|P1|Phase I|Overall Study||12
140555|NCT00826449|321724|P1|STARTED|Overall Study||47
140556|NCT00826280|321733|P3|NOT COMPLETED|Overall Study||46
140557|NCT00826280|321734|P2|NOT COMPLETED|Overall Study||46
140558|NCT00826280|321735|P1|NOT COMPLETED|Overall Study||48
140559|NCT00826280|321733|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
140560|NCT00826280|321734|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
140561|NCT00826280|321735|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
140562|NCT00826280|321733|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
140563|NCT00826280|321734|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
140564|NCT00826280|321735|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
140565|NCT00826280|321733|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
140566|NCT00826280|321734|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
140567|NCT00826280|321735|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
140568|NCT00826280|321733|P3|STARTED|Overall Study||117
140569|NCT00826280|321734|P2|STARTED|Overall Study||116
140570|NCT00826280|321735|P1|STARTED|Overall Study||114
140571|NCT00826267|321764|P3|NOT COMPLETED|Overall Study||0
140572|NCT00826267|321765|P2|NOT COMPLETED|Overall Study||0
140573|NCT00826267|321766|P1|NOT COMPLETED|Overall Study||1
140574|NCT00826267|321764|P3|COMPLETED|Overall Study||11
140575|NCT00826267|321765|P2|COMPLETED|Overall Study||8
140576|NCT00826267|321766|P1|COMPLETED|Overall Study||9
140577|NCT00826267|321764|P3|STARTED|Overall Study||11
140578|NCT00826267|321765|P2|STARTED|Overall Study||8
140579|NCT00826267|321766|P1|STARTED|Overall Study||10
140580|NCT00826228|321784|P1|NOT COMPLETED|Overall Study||1
140581|NCT00826228|321784|P1|COMPLETED|Overall Study||11
140582|NCT00826228|321784|P1|STARTED|Overall Study||12
140583|NCT00826202|321791|P2|NOT COMPLETED|Overall Study||13
140584|NCT00826202|321792|P1|NOT COMPLETED|Overall Study||10
140585|NCT00826202|321791|P2|COMPLETED|Overall Study||11
140586|NCT00826202|321792|P1|COMPLETED|Overall Study||10
140587|NCT00826202|321791|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
140588|NCT00826202|321792|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
140589|NCT00826202|321791|P2|STARTED|Overall Study||24
140590|NCT00826202|321792|P1|STARTED|Overall Study||20
140591|NCT00826176|321806|P2|NOT COMPLETED|Overall Study||0
140592|NCT00826176|321807|P1|NOT COMPLETED|Overall Study||13
140593|NCT00826176|321806|P2|COMPLETED|Overall Study|treated and completed|36
140594|NCT00826176|321807|P1|COMPLETED|Overall Study|treated and completed|115
140595|NCT00826176|321806|P2|STARTED|Overall Study|enrolled|36
140596|NCT00826176|321807|P1|STARTED|Overall Study|enrolled|128
140597|NCT00826111|321819|P2|NOT COMPLETED|Overall Study||2
140598|NCT00826111|321820|P1|NOT COMPLETED|Overall Study||7
140599|NCT00826111|321819|P2|COMPLETED|Overall Study||3
140600|NCT00826111|321820|P1|COMPLETED|Overall Study||7
140601|NCT00826111|321819|P2|STARTED|Overall Study||5
140602|NCT00826111|321820|P1|STARTED|Overall Study||14
140603|NCT00826007|321844|P2|NOT COMPLETED|Overall Study||0
140604|NCT00826007|321845|P1|NOT COMPLETED|Overall Study||0
140605|NCT00826007|321844|P2|COMPLETED|Overall Study||279
140606|NCT00826007|321845|P1|COMPLETED|Overall Study|Retrospective review|308
140607|NCT00826007|321844|P2|STARTED|Overall Study||279
140608|NCT00826007|321845|P1|STARTED|Overall Study|Retrospective review|308
140609|NCT00825994|321850|P1|NOT COMPLETED|Overall Study||5
140610|NCT00825994|321850|P1|COMPLETED|Overall Study||19
140611|NCT00825994|321850|P1|STARTED|Overall Study||24
140612|NCT00825916|321858|P3|NOT COMPLETED|Overall Study||1
140613|NCT00825916|321859|P2|NOT COMPLETED|Overall Study||2
140614|NCT00825916|321860|P1|NOT COMPLETED|Overall Study||4
140615|NCT00825916|321858|P3|COMPLETED|Overall Study||19
140616|NCT00825916|321859|P2|COMPLETED|Overall Study||18
140617|NCT00825916|321860|P1|COMPLETED|Overall Study||15
140618|NCT00825916|321858|P3|STARTED|Overall Study||20
140619|NCT00825916|321859|P2|STARTED|Overall Study||20
140620|NCT00825916|321860|P1|STARTED|Overall Study||19
140621|NCT00825825|321901|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
140622|NCT00825825|321902|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
140623|NCT00825825|321903|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
140624|NCT00825825|321904|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
140625|NCT00825825|321905|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
140626|NCT00825825|321906|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
140627|NCT00825825|321901|P6|COMPLETED|Third Medication Period (14 Days)||1
140628|NCT00825825|321902|P5|COMPLETED|Third Medication Period (14 Days)||3
140629|NCT00825825|321903|P4|COMPLETED|Third Medication Period (14 Days)||3
140630|NCT00825825|321904|P3|COMPLETED|Third Medication Period (14 Days)||2
140631|NCT00825825|321905|P2|COMPLETED|Third Medication Period (14 Days)||2
140632|NCT00825825|321906|P1|COMPLETED|Third Medication Period (14 Days)||1
140633|NCT00825825|321901|P6|STARTED|Third Medication Period (14 Days)||3
140634|NCT00825825|321902|P5|STARTED|Third Medication Period (14 Days)||3
140635|NCT00825825|321903|P4|STARTED|Third Medication Period (14 Days)||3
140636|NCT00825825|321904|P3|STARTED|Third Medication Period (14 Days)||2
140637|NCT00825825|321905|P2|STARTED|Third Medication Period (14 Days)||4
140638|NCT00825825|321906|P1|STARTED|Third Medication Period (14 Days)||1
140639|NCT00825825|321901|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
140640|NCT00825825|321902|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
140641|NCT00825825|321903|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
140642|NCT00825825|321904|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
140643|NCT00825825|321905|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
140644|NCT00825825|321906|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
140645|NCT00825825|321901|P6|COMPLETED|Second Washout Period (14 Days)||3
140646|NCT00825825|321902|P5|COMPLETED|Second Washout Period (14 Days)||3
140647|NCT00825825|321903|P4|COMPLETED|Second Washout Period (14 Days)||3
140648|NCT00825825|321904|P3|COMPLETED|Second Washout Period (14 Days)||2
140649|NCT00825825|321905|P2|COMPLETED|Second Washout Period (14 Days)||4
140650|NCT00825825|321906|P1|COMPLETED|Second Washout Period (14 Days)||1
140651|NCT00825825|321901|P6|STARTED|Second Washout Period (14 Days)||3
140652|NCT00825825|321902|P5|STARTED|Second Washout Period (14 Days)||3
140653|NCT00825825|321903|P4|STARTED|Second Washout Period (14 Days)||3
140654|NCT00825825|321904|P3|STARTED|Second Washout Period (14 Days)||2
140655|NCT00825825|321905|P2|STARTED|Second Washout Period (14 Days)||4
140656|NCT00825825|321906|P1|STARTED|Second Washout Period (14 Days)||1
140657|NCT00825825|321901|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
140658|NCT00825825|321902|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
140659|NCT00825825|321903|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
140660|NCT00825825|321904|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
140661|NCT00825825|321905|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
140662|NCT00825825|321906|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
140663|NCT00825825|321901|P6|COMPLETED|Second Medication Period (14 Days)||3
140664|NCT00825825|321902|P5|COMPLETED|Second Medication Period (14 Days)||3
140665|NCT00825825|321903|P4|COMPLETED|Second Medication Period (14 Days)||3
140666|NCT00825825|321904|P3|COMPLETED|Second Medication Period (14 Days)||2
140667|NCT00825825|321905|P2|COMPLETED|Second Medication Period (14 Days)||4
140668|NCT00825825|321906|P1|COMPLETED|Second Medication Period (14 Days)||1
140669|NCT00825825|321901|P6|STARTED|Second Medication Period (14 Days)||3
140670|NCT00825825|321902|P5|STARTED|Second Medication Period (14 Days)||4
140671|NCT00825825|321903|P4|STARTED|Second Medication Period (14 Days)||5
140672|NCT00825825|321904|P3|STARTED|Second Medication Period (14 Days)||2
140673|NCT00825825|321905|P2|STARTED|Second Medication Period (14 Days)||4
140674|NCT00825825|321906|P1|STARTED|Second Medication Period (14 Days)||3
140675|NCT00825825|321901|P6|NOT COMPLETED|First Washout Period (14 Days)||0
140676|NCT00825825|321902|P5|NOT COMPLETED|First Washout Period (14 Days)||0
140677|NCT00825825|321903|P4|NOT COMPLETED|First Washout Period (14 Days)||0
140678|NCT00825825|321904|P3|NOT COMPLETED|First Washout Period (14 Days)||0
140679|NCT00825825|321905|P2|NOT COMPLETED|First Washout Period (14 Days)||0
140680|NCT00825825|321906|P1|NOT COMPLETED|First Washout Period (14 Days)||0
140681|NCT00825825|321901|P6|COMPLETED|First Washout Period (14 Days)||3
140682|NCT00825825|321902|P5|COMPLETED|First Washout Period (14 Days)||4
140683|NCT00825825|321903|P4|COMPLETED|First Washout Period (14 Days)||5
140684|NCT00825825|321904|P3|COMPLETED|First Washout Period (14 Days)||2
140685|NCT00825825|321905|P2|COMPLETED|First Washout Period (14 Days)||4
140686|NCT00825825|321906|P1|COMPLETED|First Washout Period (14 Days)||3
140687|NCT00825825|321901|P6|STARTED|First Washout Period (14 Days)||3
140688|NCT00825825|321902|P5|STARTED|First Washout Period (14 Days)||4
140689|NCT00825825|321903|P4|STARTED|First Washout Period (14 Days)||5
140690|NCT00825825|321904|P3|STARTED|First Washout Period (14 Days)||2
140691|NCT00825825|321905|P2|STARTED|First Washout Period (14 Days)||4
140692|NCT00825825|321906|P1|STARTED|First Washout Period (14 Days)||3
140693|NCT00825825|321901|P6|NOT COMPLETED|First Medication Period (14 Days)||2
140694|NCT00825825|321902|P5|NOT COMPLETED|First Medication Period (14 Days)||0
140695|NCT00825825|321903|P4|NOT COMPLETED|First Medication Period (14 Days)||0
140696|NCT00825825|321904|P3|NOT COMPLETED|First Medication Period (14 Days)||1
140697|NCT00825825|321905|P2|NOT COMPLETED|First Medication Period (14 Days)||0
140698|NCT00825825|321906|P1|NOT COMPLETED|First Medication Period (14 Days)||3
140699|NCT00825825|321901|P6|COMPLETED|First Medication Period (14 Days)||3
140700|NCT00825825|321902|P5|COMPLETED|First Medication Period (14 Days)||4
140701|NCT00825825|321903|P4|COMPLETED|First Medication Period (14 Days)||5
140702|NCT00825825|321904|P3|COMPLETED|First Medication Period (14 Days)||2
140703|NCT00825825|321905|P2|COMPLETED|First Medication Period (14 Days)||4
140704|NCT00825825|321906|P1|COMPLETED|First Medication Period (14 Days)||3
140705|NCT00825825|321901|P6|STARTED|First Medication Period (14 Days)||5
140706|NCT00825825|321902|P5|STARTED|First Medication Period (14 Days)||4
140707|NCT00825825|321903|P4|STARTED|First Medication Period (14 Days)||5
140708|NCT00825825|321904|P3|STARTED|First Medication Period (14 Days)||3
140709|NCT00825825|321905|P2|STARTED|First Medication Period (14 Days)||4
140710|NCT00825825|321906|P1|STARTED|First Medication Period (14 Days)||6
140711|NCT00825812|321922|P4|NOT COMPLETED|Overall Study||10
140712|NCT00825812|321923|P3|NOT COMPLETED|Overall Study||6
140713|NCT00825812|321924|P2|NOT COMPLETED|Overall Study||1
140714|NCT00825812|321925|P1|NOT COMPLETED|Overall Study||0
140715|NCT00825812|321922|P4|COMPLETED|Overall Study||111
140716|NCT00825812|321923|P3|COMPLETED|Overall Study||120
140717|NCT00825812|321924|P2|COMPLETED|Overall Study||31
140718|NCT00825812|321925|P1|COMPLETED|Overall Study||29
140719|NCT00825812|321922|P4|TREATED|Overall Study||111
140720|NCT00825812|321923|P3|TREATED|Overall Study||120
140721|NCT00825812|321924|P2|TREATED|Overall Study||31
140722|NCT00825812|321925|P1|TREATED|Overall Study||29
140723|NCT00825812|321922|P4|STARTED|Overall Study||121
140724|NCT00825812|321923|P3|STARTED|Overall Study||126
140725|NCT00825812|321924|P2|STARTED|Overall Study||32
140726|NCT00825812|321925|P1|STARTED|Overall Study||29
140727|NCT00825734|321939|P3|NOT COMPLETED|Phase II||76
140728|NCT00825734|321940|P2|NOT COMPLETED|Phase II||0
140729|NCT00825734|321941|P1|NOT COMPLETED|Phase II||0
140730|NCT00825734|321939|P3|COMPLETED|Phase II||0
140731|NCT00825734|321940|P2|COMPLETED|Phase II||0
140732|NCT00825734|321941|P1|COMPLETED|Phase II||0
140733|NCT00825734|321939|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
140734|NCT00825734|321940|P2|STARTED|Phase II||0
140735|NCT00825734|321941|P1|STARTED|Phase II||0
140736|NCT00825734|321939|P3|NOT COMPLETED|Phase I||0
140737|NCT00825734|321940|P2|NOT COMPLETED|Phase I||3
140738|NCT00825734|321941|P1|NOT COMPLETED|Phase I||4
140739|NCT00825734|321939|P3|COMPLETED|Phase I||3
140740|NCT00825734|321940|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
140741|NCT00825734|321941|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
140742|NCT00825734|321939|P3|STARTED|Phase I||3
140743|NCT00825734|321940|P2|STARTED|Phase I||3
140744|NCT00825734|321941|P1|STARTED|Phase I||4
140745|NCT00825682|321951|P2|NOT COMPLETED|Overall Study||5
140746|NCT00825682|321952|P1|NOT COMPLETED|Overall Study||13
140747|NCT00825682|321951|P2|COMPLETED|Overall Study||20
140748|NCT00825682|321952|P1|COMPLETED|Overall Study||34
140749|NCT00825682|321951|P2|STARTED|Overall Study||25
140750|NCT00825682|321952|P1|STARTED|Overall Study||47
140751|NCT00825630|321966|P4|NOT COMPLETED|Overall Study||0
140752|NCT00825630|321967|P3|NOT COMPLETED|Overall Study||0
140753|NCT00825630|321968|P2|NOT COMPLETED|Overall Study||0
140754|NCT00825630|321969|P1|NOT COMPLETED|Overall Study||0
140755|NCT00825630|321966|P4|COMPLETED|Overall Study||13
140756|NCT00825630|321967|P3|COMPLETED|Overall Study||19
140757|NCT00825630|321968|P2|COMPLETED|Overall Study||62
140758|NCT00825630|321969|P1|COMPLETED|Overall Study||29
140759|NCT00825630|321966|P4|STARTED|Overall Study||13
140760|NCT00825630|321967|P3|STARTED|Overall Study||19
140761|NCT00825630|321968|P2|STARTED|Overall Study||62
140762|NCT00825630|321969|P1|STARTED|Overall Study||29
140763|NCT00825565|321979|P1|NOT COMPLETED|Overall Study||0
140764|NCT00825565|321979|P1|COMPLETED|Overall Study||8
140765|NCT00825565|321979|P1|STARTED|Overall Study||8
140766|NCT00825344|321986|P2|NOT COMPLETED|Overall Study||1
140767|NCT00825344|321987|P1|NOT COMPLETED|Overall Study||1
140768|NCT00825344|321986|P2|COMPLETED|Overall Study||42
140769|NCT00825344|321987|P1|COMPLETED|Overall Study||33
140770|NCT00825344|321986|P2|STARTED|Overall Study||43
140771|NCT00825344|321987|P1|STARTED|Overall Study||34
140772|NCT00825318|321997|P1|NOT COMPLETED|Overall Study||1
140773|NCT00825318|321997|P1|COMPLETED|Overall Study||12
140774|NCT00825318|321997|P1|STARTED|Overall Study||13
140775|NCT00825305|322007|P2|NOT COMPLETED|Overall Study||23
140776|NCT00825305|322008|P1|NOT COMPLETED|Overall Study||17
140777|NCT00825305|322007|P2|COMPLETED|Overall Study||252
140778|NCT00825305|322008|P1|COMPLETED|Overall Study||533
140779|NCT00825305|322007|P2|STARTED|Overall Study||275
140780|NCT00825305|322008|P1|STARTED|Overall Study||550
140781|NCT00825227|322022|P2|NOT COMPLETED|Overall Study||0
140782|NCT00825227|322023|P1|NOT COMPLETED|Overall Study||0
140783|NCT00825227|322022|P2|COMPLETED|Overall Study||4
140784|NCT00825227|322023|P1|COMPLETED|Overall Study||6
140785|NCT00825227|322022|P2|STARTED|Overall Study||4
140786|NCT00825227|322023|P1|STARTED|Overall Study||6
140787|NCT00825175|322031|P2|NOT COMPLETED|Overall Study||5
140788|NCT00825175|322032|P1|NOT COMPLETED|Overall Study||0
140789|NCT00825175|322031|P2|COMPLETED|Overall Study||7
140790|NCT00825175|322032|P1|COMPLETED|Overall Study||10
140791|NCT00825175|322031|P2|STARTED|Overall Study||12
140792|NCT00825175|322032|P1|STARTED|Overall Study||10
140793|NCT00825162|322041|P3|NOT COMPLETED|Overall Study||6
140794|NCT00825162|322042|P2|NOT COMPLETED|Overall Study||21
140795|NCT00825162|322043|P1|NOT COMPLETED|Overall Study||28
140796|NCT00825162|322041|P3|COMPLETED|Overall Study||396
140797|NCT00825162|322042|P2|COMPLETED|Overall Study||859
140798|NCT00825162|322043|P1|COMPLETED|Overall Study||682
140799|NCT00825162|322041|P3|STARTED|Overall Study||402
140800|NCT00825162|322042|P2|STARTED|Overall Study||880
140801|NCT00825162|322043|P1|STARTED|Overall Study||710
140802|NCT00824850|322069|P2|NOT COMPLETED|Overall Study||1
140803|NCT00824850|322070|P1|NOT COMPLETED|Overall Study||0
140804|NCT00824850|322069|P2|COMPLETED|Overall Study||36
140805|NCT00824850|322070|P1|COMPLETED|Overall Study||38
140806|NCT00824850|322069|P2|Received Vaccination 13vPnC|Overall Study||36
140807|NCT00824850|322070|P1|Received Vaccination 13vPnC|Overall Study||38
140808|NCT00824850|322069|P2|STARTED|Overall Study||37
140809|NCT00824850|322070|P1|STARTED|Overall Study||38
140810|NCT00824824|322116|P2|NOT COMPLETED|Overall Study||0
140811|NCT00824824|322117|P1|NOT COMPLETED|Overall Study||0
140812|NCT00824824|322116|P2|COMPLETED|Overall Study||3
140813|NCT00824824|322117|P1|COMPLETED|Overall Study||4
140814|NCT00824824|322116|P2|STARTED|Overall Study||3
140815|NCT00824824|322117|P1|STARTED|Overall Study||4
140816|NCT00824772|322123|P1|NOT COMPLETED|Overall Study||8
140817|NCT00824772|322123|P1|COMPLETED|Overall Study||196
140818|NCT00824772|322123|P1|STARTED|Overall Study||204
140819|NCT00824746|322128|P1|NOT COMPLETED|Overall Study||0
140820|NCT00824746|322128|P1|COMPLETED|Overall Study||23
140821|NCT00824746|322128|P1|STARTED|Overall Study||23
140822|NCT00824733|322134|P1|NOT COMPLETED|Overall Study||0
140823|NCT00824733|322134|P1|COMPLETED|Overall Study||6
140824|NCT00824733|322134|P1|STARTED|Overall Study||6
140825|NCT00824720|322143|P3|NOT COMPLETED|Overall Study||1
140826|NCT00824720|322144|P2|NOT COMPLETED|Overall Study||1
140827|NCT00824720|322145|P1|NOT COMPLETED|Overall Study||3
140828|NCT00824720|322143|P3|COMPLETED|Overall Study||19
140829|NCT00824720|322144|P2|COMPLETED|Overall Study||15
140830|NCT00824720|322145|P1|COMPLETED|Overall Study||16
140831|NCT00824720|322143|P3|STARTED|Overall Study||20
140832|NCT00824720|322144|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
140833|NCT00824720|322145|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
140834|NCT00824655|322161|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
140835|NCT00824655|322162|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
140836|NCT00824655|322161|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
140837|NCT00824655|322162|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
140838|NCT00824655|322161|P2|STARTED|Toddler Dose (12 Months of Age)||116
140839|NCT00824655|322162|P1|STARTED|Toddler Dose (12 Months of Age)||118
140840|NCT00824655|322161|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
140841|NCT00824655|322162|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
140842|NCT00824655|322161|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
140843|NCT00824655|322162|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
140844|NCT00824655|322161|P2|STARTED|After Infant Dose (6 Months of Age)||0
140845|NCT00824655|322162|P1|STARTED|After Infant Dose (6 Months of Age)||118
140846|NCT00824655|322161|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
140847|NCT00824655|322162|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
140848|NCT00824655|322161|P2|COMPLETED|Infant Series (5 Months of Age)||0
140849|NCT00824655|322162|P1|COMPLETED|Infant Series (5 Months of Age)||118
140850|NCT00824655|322161|P2|STARTED|Infant Series (5 Months of Age)||0
140851|NCT00824655|322162|P1|STARTED|Infant Series (5 Months of Age)||118
140852|NCT00824616|322182|P2|NOT COMPLETED|Overall Study||7
140853|NCT00824616|322183|P1|NOT COMPLETED|Overall Study||6
140854|NCT00824616|322182|P2|COMPLETED|Overall Study||27
140855|NCT00824616|322183|P1|COMPLETED|Overall Study||28
140856|NCT00824616|322182|P2|STARTED|Overall Study||34
140857|NCT00824616|322183|P1|STARTED|Overall Study||34
140858|NCT00824564|322193|P2|NOT COMPLETED|Overall Study||10
140859|NCT00824564|322194|P1|NOT COMPLETED|Overall Study||8
140860|NCT00824564|322193|P2|COMPLETED|Overall Study||30
140861|NCT00824564|322194|P1|COMPLETED|Overall Study||34
140862|NCT00824564|322193|P2|Treated|Overall Study||40
140863|NCT00824564|322194|P1|Treated|Overall Study||41
140864|NCT00824564|322193|P2|STARTED|Overall Study||40
140865|NCT00824564|322194|P1|STARTED|Overall Study||42
140866|NCT00824538|322212|P1|NOT COMPLETED|Overall Study||2
140867|NCT00824538|322212|P1|COMPLETED|Overall Study||11
140868|NCT00824538|322212|P1|STARTED|Overall Study|13 patients entered the study|13
140869|NCT00824512|322220|P2|NOT COMPLETED|Overall Study||0
140870|NCT00824512|322221|P1|NOT COMPLETED|Overall Study||0
140871|NCT00824512|322220|P2|COMPLETED|Overall Study||11
140872|NCT00824512|322221|P1|COMPLETED|Overall Study||11
140873|NCT00824512|322220|P2|STARTED|Overall Study||11
140874|NCT00824512|322221|P1|STARTED|Overall Study||11
140875|NCT00824473|322271|P2|NOT COMPLETED|Overall Study||13
140876|NCT00824473|322272|P1|NOT COMPLETED|Overall Study||15
140877|NCT00824473|322271|P2|COMPLETED|Overall Study||238
140878|NCT00824473|322272|P1|COMPLETED|Overall Study||240
140879|NCT00824473|322271|P2|STARTED|Overall Study||251
140880|NCT00824473|322272|P1|STARTED|Overall Study|1 subject was randomized in error|255
140881|NCT00824460|322294|P6|NOT COMPLETED|Overall Study||8
140882|NCT00824460|322295|P5|NOT COMPLETED|Overall Study||9
140883|NCT00824460|322296|P4|NOT COMPLETED|Overall Study||12
140884|NCT00824460|322297|P3|NOT COMPLETED|Overall Study||5
140885|NCT00824460|322298|P2|NOT COMPLETED|Overall Study||9
140886|NCT00824460|322299|P1|NOT COMPLETED|Overall Study||8
140887|NCT00824460|322294|P6|COMPLETED|Overall Study||18
140888|NCT00824460|322295|P5|COMPLETED|Overall Study||15
140889|NCT00824460|322296|P4|COMPLETED|Overall Study||15
140890|NCT00824460|322297|P3|COMPLETED|Overall Study||20
140891|NCT00824460|322298|P2|COMPLETED|Overall Study||17
140892|NCT00824460|322299|P1|COMPLETED|Overall Study||18
140893|NCT00824460|322294|P6|STARTED|Overall Study||26
140894|NCT00824460|322295|P5|STARTED|Overall Study||24
140895|NCT00824460|322296|P4|STARTED|Overall Study||27
140896|NCT00824460|322297|P3|STARTED|Overall Study||25
140897|NCT00824460|322298|P2|STARTED|Overall Study||26
140898|NCT00824460|322299|P1|STARTED|Overall Study||26
140899|NCT00824434|322331|P1|NOT COMPLETED|Overall Study||0
140900|NCT00824434|322331|P1|COMPLETED|Overall Study||100
140901|NCT00824434|322331|P1|STARTED|Overall Study||100
140902|NCT00824421|322353|P3|NOT COMPLETED|Overall Study||14
140903|NCT00824421|322354|P2|NOT COMPLETED|Overall Study||22
140904|NCT00824421|322355|P1|NOT COMPLETED|Overall Study||17
140905|NCT00824421|322353|P3|COMPLETED|Overall Study||49
140906|NCT00824421|322354|P2|COMPLETED|Overall Study||44
140907|NCT00824421|322355|P1|COMPLETED|Overall Study||49
140908|NCT00824421|322353|P3|Treated|Overall Study||63
140909|NCT00824421|322354|P2|Treated|Overall Study||65
140910|NCT00824421|322355|P1|Treated|Overall Study||65
140911|NCT00824421|322353|P3|STARTED|Overall Study||63
140912|NCT00824421|322354|P2|STARTED|Overall Study||66
140913|NCT00824421|322355|P1|STARTED|Overall Study||66
140914|NCT00824408|322406|P5|NOT COMPLETED|Randomized Phase||46
140915|NCT00824408|322407|P4|NOT COMPLETED|Randomized Phase||46
140916|NCT00824408|322408|P3|NOT COMPLETED|Randomized Phase||36
140917|NCT00824408|322409|P2|NOT COMPLETED|Randomized Phase||0
140918|NCT00824408|322410|P1|NOT COMPLETED|Randomized Phase||0
140919|NCT00824408|322406|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
140920|NCT00824408|322407|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
140921|NCT00824408|322408|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
140922|NCT00824408|322409|P2|COMPLETED|Randomized Phase||0
140923|NCT00824408|322410|P1|COMPLETED|Randomized Phase||0
140924|NCT00824408|322406|P5|STARTED|Randomized Phase||47
140925|NCT00824408|322407|P4|STARTED|Randomized Phase||47
140926|NCT00824408|322408|P3|STARTED|Randomized Phase||37
140927|NCT00824408|322409|P2|STARTED|Randomized Phase||0
140928|NCT00824408|322410|P1|STARTED|Randomized Phase||0
140929|NCT00824408|322406|P5|NOT COMPLETED|Run-in Phase||0
140930|NCT00824408|322407|P4|NOT COMPLETED|Run-in Phase||0
140931|NCT00824408|322408|P3|NOT COMPLETED|Run-in Phase||0
140932|NCT00824408|322409|P2|NOT COMPLETED|Run-in Phase||6
140933|NCT00824408|322410|P1|NOT COMPLETED|Run-in Phase||6
140934|NCT00824408|322406|P5|COMPLETED|Run-in Phase||0
140935|NCT00824408|322407|P4|COMPLETED|Run-in Phase||0
140936|NCT00824408|322408|P3|COMPLETED|Run-in Phase||0
140937|NCT00824408|322409|P2|COMPLETED|Run-in Phase||0
140938|NCT00824408|322410|P1|COMPLETED|Run-in Phase||0
140939|NCT00824408|322406|P5|STARTED|Run-in Phase||0
140940|NCT00824408|322407|P4|STARTED|Run-in Phase||0
140941|NCT00824408|322408|P3|STARTED|Run-in Phase||0
140942|NCT00824408|322409|P2|STARTED|Run-in Phase||6
140943|NCT00824408|322410|P1|STARTED|Run-in Phase||6
140944|NCT00824382|322462|P4|NOT COMPLETED|Overall Study||5
140945|NCT00824382|322463|P3|NOT COMPLETED|Overall Study||3
140946|NCT00824382|322464|P2|NOT COMPLETED|Overall Study||2
140947|NCT00824382|322465|P1|NOT COMPLETED|Overall Study||5
140948|NCT00824382|322462|P4|COMPLETED|Overall Study||81
140949|NCT00824382|322463|P3|COMPLETED|Overall Study||76
140950|NCT00824382|322464|P2|COMPLETED|Overall Study||82
140951|NCT00824382|322465|P1|COMPLETED|Overall Study||74
140952|NCT00824382|322462|P4|STARTED|Overall Study||86
140953|NCT00824382|322463|P3|STARTED|Overall Study||79
140954|NCT00824382|322464|P2|STARTED|Overall Study||84
140955|NCT00824382|322465|P1|STARTED|Overall Study||79
140956|NCT00824369|322541|P6|NOT COMPLETED|Overall Study||1
140957|NCT00824369|322542|P5|NOT COMPLETED|Overall Study||1
140958|NCT00824369|322543|P4|NOT COMPLETED|Overall Study||2
140959|NCT00824369|322544|P3|NOT COMPLETED|Overall Study||1
140960|NCT00824369|322545|P2|NOT COMPLETED|Overall Study||0
140961|NCT00824369|322546|P1|NOT COMPLETED|Overall Study||1
140962|NCT00824369|322541|P6|COMPLETED|Overall Study||16
140963|NCT00824369|322542|P5|COMPLETED|Overall Study||11
140964|NCT00824369|322543|P4|COMPLETED|Overall Study||9
140965|NCT00824369|322544|P3|COMPLETED|Overall Study||2
140966|NCT00824369|322545|P2|COMPLETED|Overall Study||4
140967|NCT00824369|322546|P1|COMPLETED|Overall Study||4
140968|NCT00824369|322541|P6|STARTED|Overall Study||17
140969|NCT00824369|322542|P5|STARTED|Overall Study||12
140970|NCT00824369|322543|P4|STARTED|Overall Study||11
140971|NCT00824369|322544|P3|STARTED|Overall Study||3
140972|NCT00824369|322545|P2|STARTED|Overall Study||4
140973|NCT00824369|322546|P1|STARTED|Overall Study||5
140974|NCT00824291|322586|P2|NOT COMPLETED|Overall Study||35
140975|NCT00824291|322587|P1|NOT COMPLETED|Overall Study||54
140976|NCT00824291|322586|P2|COMPLETED|Overall Study||107
140977|NCT00824291|322587|P1|COMPLETED|Overall Study||231
140978|NCT00824291|322586|P2|STARTED|Overall Study||142
140979|NCT00824291|322587|P1|STARTED|Overall Study||285
140980|NCT00824265|322609|P2|NOT COMPLETED|Overall Study||80
140981|NCT00824265|322610|P1|NOT COMPLETED|Overall Study||64
140982|NCT00824265|322609|P2|COMPLETED|Overall Study||102
140983|NCT00824265|322610|P1|COMPLETED|Overall Study||119
140984|NCT00824265|322609|P2|STARTED|Overall Study||182
140985|NCT00824265|322610|P1|STARTED|Overall Study||183
140986|NCT00824161|322669|P1|NOT COMPLETED|Overall Study||2
140987|NCT00824161|322669|P1|COMPLETED|Overall Study||26
140988|NCT00824161|322669|P1|STARTED|Overall Study||28
140989|NCT00824070|322678|P3|NOT COMPLETED|Overall Study||0
140990|NCT00824070|322679|P2|NOT COMPLETED|Overall Study||0
140991|NCT00824070|322680|P1|NOT COMPLETED|Overall Study||0
140992|NCT00824070|322678|P3|COMPLETED|Overall Study||36
140993|NCT00824070|322679|P2|COMPLETED|Overall Study||35
140994|NCT00824070|322680|P1|COMPLETED|Overall Study||34
140995|NCT00824070|322678|P3|STARTED|Overall Study||36
140996|NCT00824070|322679|P2|STARTED|Overall Study||35
140997|NCT00824070|322680|P1|STARTED|Overall Study||34
140998|NCT00824044|322690|P2|NOT COMPLETED|Overall Study||6
140999|NCT00824044|322691|P1|NOT COMPLETED|Overall Study||9
141000|NCT00824044|322690|P2|COMPLETED|Overall Study||10
141001|NCT00824044|322691|P1|COMPLETED|Overall Study||14
141002|NCT00824044|322690|P2|STARTED|Overall Study||16
141003|NCT00824044|322691|P1|STARTED|Overall Study||23
141004|NCT00823264|322699|P2|NOT COMPLETED|Overall Study||0
141005|NCT00823264|322700|P1|NOT COMPLETED|Overall Study||2
141006|NCT00823264|322699|P2|COMPLETED|Overall Study||7
141007|NCT00823264|322700|P1|COMPLETED|Overall Study||8
141008|NCT00823264|322699|P2|STARTED|Overall Study||7
141009|NCT00823264|322700|P1|STARTED|Overall Study||10
141010|NCT00822185|322711|P5|NOT COMPLETED|Overall Study||0
141011|NCT00822185|322712|P4|NOT COMPLETED|Overall Study||0
141012|NCT00822185|322713|P3|NOT COMPLETED|Overall Study||0
141013|NCT00822185|322714|P2|NOT COMPLETED|Overall Study||0
141014|NCT00822185|322715|P1|NOT COMPLETED|Overall Study||0
141015|NCT00822185|322711|P5|COMPLETED|Overall Study||8
141016|NCT00822185|322712|P4|COMPLETED|Overall Study||6
141017|NCT00822185|322713|P3|COMPLETED|Overall Study||6
141018|NCT00822185|322714|P2|COMPLETED|Overall Study||6
141019|NCT00822185|322715|P1|COMPLETED|Overall Study||6
141020|NCT00822185|322711|P5|STARTED|Overall Study||8
141021|NCT00822185|322712|P4|STARTED|Overall Study||6
141022|NCT00822185|322713|P3|STARTED|Overall Study||6
141023|NCT00822185|322714|P2|STARTED|Overall Study||6
141024|NCT00822185|322715|P1|STARTED|Overall Study||6
141025|NCT00822172|322782|P2|NOT COMPLETED|Overall Study||19
141026|NCT00822172|322783|P1|NOT COMPLETED|Overall Study||15
141027|NCT00822172|322782|P2|COMPLETED|Overall Study||64
141028|NCT00822172|322783|P1|COMPLETED|Overall Study||65
141029|NCT00822172|322782|P2|STARTED|Overall Study||83
141030|NCT00822172|322783|P1|STARTED|Overall Study||80
141031|NCT00824005|322791|P2|NOT COMPLETED|Overall Study||2
141032|NCT00824005|322792|P1|NOT COMPLETED|Overall Study||0
141033|NCT00824005|322791|P2|COMPLETED|Overall Study||59
141034|NCT00824005|322792|P1|COMPLETED|Overall Study||31
141035|NCT00824005|322791|P2|STARTED|Overall Study||61
141036|NCT00824005|322792|P1|STARTED|Overall Study||31
141037|NCT00823979|322827|P3|NOT COMPLETED|Overall Study||24
141038|NCT00823979|322828|P2|NOT COMPLETED|Overall Study||32
141039|NCT00823979|322829|P1|NOT COMPLETED|Overall Study||29
141040|NCT00823979|322827|P3|COMPLETED|Overall Study||11
141041|NCT00823979|322828|P2|COMPLETED|Overall Study||3
141042|NCT00823979|322829|P1|COMPLETED|Overall Study||6
141043|NCT00823979|322827|P3|Treated|Overall Study||34
141044|NCT00823979|322828|P2|Treated|Overall Study||32
141045|NCT00823979|322829|P1|Treated|Overall Study||31
141046|NCT00823979|322827|P3|STARTED|Overall Study||35
141047|NCT00823979|322828|P2|STARTED|Overall Study||35
141048|NCT00823979|322829|P1|STARTED|Overall Study||35
141049|NCT00823966|322867|P1|NOT COMPLETED|Overall Study||0
141050|NCT00823966|322867|P1|COMPLETED|Overall Study||3
141051|NCT00823966|322867|P1|STARTED|Overall Study||3
141052|NCT00823901|322874|P2|NOT COMPLETED|Overall Study||2
141053|NCT00823901|322875|P1|NOT COMPLETED|Overall Study||4
141054|NCT00823901|322874|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
141055|NCT00823901|322875|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
141056|NCT00823901|322874|P2|STARTED|Overall Study|Randomized to placebo gel|40
141057|NCT00823901|322875|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
141058|NCT00823836|322883|P2|NOT COMPLETED|Long-term Phase||5
141059|NCT00823836|322884|P1|NOT COMPLETED|Long-term Phase||5
141060|NCT00823836|322883|P2|COMPLETED|Long-term Phase||79
141061|NCT00823836|322884|P1|COMPLETED|Long-term Phase||68
141062|NCT00823836|322883|P2|STARTED|Long-term Phase||84
141063|NCT00823836|322884|P1|STARTED|Long-term Phase||73
141064|NCT00823836|322883|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
141065|NCT00823836|322884|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
141066|NCT00823836|322883|P2|COMPLETED|NV and PR/XR Switching Phases||117
141067|NCT00823836|322884|P1|COMPLETED|NV and PR/XR Switching Phases||124
141068|NCT00823836|322883|P2|STARTED|NV and PR/XR Switching Phases||146
141069|NCT00823836|322884|P1|STARTED|NV and PR/XR Switching Phases||156
141070|NCT00823823|322990|P2|NOT COMPLETED|Overall Study||6
141071|NCT00823823|322991|P1|NOT COMPLETED|Overall Study||8
141072|NCT00823823|322990|P2|COMPLETED|Overall Study||101
141073|NCT00823823|322991|P1|COMPLETED|Overall Study||101
141074|NCT00823823|322990|P2|STARTED|Overall Study||107
141075|NCT00823823|322991|P1|STARTED|Overall Study||109
141076|NCT00823719|323001|P2|NOT COMPLETED|Overall Study||11
141077|NCT00823719|323002|P1|NOT COMPLETED|Overall Study||6
141078|NCT00823719|323001|P2|COMPLETED|Overall Study||24
141079|NCT00823719|323002|P1|COMPLETED|Overall Study||20
141080|NCT00823719|323001|P2|STARTED|Overall Study||35
141081|NCT00823719|323002|P1|STARTED|Overall Study||26
141082|NCT00823615|323055|P2|NOT COMPLETED|Period 2||2
141083|NCT00823615|323056|P1|NOT COMPLETED|Period 2||3
141084|NCT00823615|323055|P2|COMPLETED|Period 2||17
141085|NCT00823615|323056|P1|COMPLETED|Period 2||16
141086|NCT00823615|323055|P2|STARTED|Period 2||19
141087|NCT00823615|323056|P1|STARTED|Period 2||19
141088|NCT00823615|323055|P2|NOT COMPLETED|Period 1||0
141089|NCT00823615|323056|P1|NOT COMPLETED|Period 1||0
141090|NCT00823615|323055|P2|COMPLETED|Period 1||19
141091|NCT00823615|323056|P1|COMPLETED|Period 1||19
141092|NCT00823615|323055|P2|STARTED|Period 1||19
141093|NCT00823615|323056|P1|STARTED|Period 1||19
141094|NCT00823472|323066|P2|NOT COMPLETED|Overall Study||28
141095|NCT00823472|323067|P1|NOT COMPLETED|Overall Study||24
141096|NCT00823472|323066|P2|COMPLETED|Overall Study||39
141097|NCT00823472|323067|P1|COMPLETED|Overall Study||56
141098|NCT00823472|323066|P2|STARTED|Overall Study||67
141099|NCT00823472|323067|P1|STARTED|Overall Study||80
141100|NCT00823303|323077|P2|NOT COMPLETED|Overall Study||11
141101|NCT00823303|323078|P1|NOT COMPLETED|Overall Study||9
141102|NCT00823303|323077|P2|COMPLETED|Overall Study||45
141103|NCT00823303|323078|P1|COMPLETED|Overall Study||45
141104|NCT00823303|323077|P2|STARTED|Overall Study||56
141105|NCT00823303|323078|P1|STARTED|Overall Study||54
141106|NCT00823212|323086|P2|NOT COMPLETED|Overall Study||33
141107|NCT00823212|323087|P1|NOT COMPLETED|Overall Study||35
141108|NCT00823212|323086|P2|COMPLETED|Overall Study|12-month follow-up|735
141109|NCT00823212|323087|P1|COMPLETED|Overall Study|12-month follow-up|727
141110|NCT00823212|323086|P2|STARTED|Overall Study||768
141111|NCT00823212|323087|P1|STARTED|Overall Study||762
141112|NCT00823199|323169|P1|NOT COMPLETED|Overall Study||2
141113|NCT00823199|323169|P1|COMPLETED|Overall Study||8
141114|NCT00823199|323169|P1|STARTED|Overall Study||10
141115|NCT00823095|323175|P1|NOT COMPLETED|Overall Study||0
141116|NCT00823095|323175|P1|COMPLETED|Overall Study||7
141117|NCT00823095|323175|P1|STARTED|Overall Study||7
141118|NCT00823082|323182|P2|NOT COMPLETED|Overall Study||1
141119|NCT00823082|323183|P1|NOT COMPLETED|Overall Study||0
141120|NCT00823082|323182|P2|COMPLETED|Overall Study||99
141121|NCT00823082|323183|P1|COMPLETED|Overall Study||100
141122|NCT00823082|323182|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
141123|NCT00823082|323183|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
141124|NCT00823082|323182|P2|Safety Population|Overall Study||99
141125|NCT00823082|323183|P1|Safety Population|Overall Study||100
141126|NCT00823082|323182|P2|STARTED|Overall Study||100
141127|NCT00823082|323183|P1|STARTED|Overall Study||100
141128|NCT00823069|323217|P1|NOT COMPLETED|Overall Study||0
141129|NCT00823069|323217|P1|COMPLETED|Overall Study||60
141130|NCT00823069|323217|P1|STARTED|Overall Study||60
141131|NCT00823043|323224|P2|NOT COMPLETED|Overall Study||0
141132|NCT00823043|323225|P1|NOT COMPLETED|Overall Study||0
141133|NCT00823043|323224|P2|COMPLETED|Overall Study||39
141134|NCT00823043|323225|P1|COMPLETED|Overall Study||64
141135|NCT00823043|323224|P2|STARTED|Overall Study||39
141136|NCT00823043|323225|P1|STARTED|Overall Study||64
141137|NCT00822900|323238|P2|NOT COMPLETED|Overall Study||93
141138|NCT00822900|323239|P1|NOT COMPLETED|Overall Study||108
141139|NCT00822900|323238|P2|COMPLETED|Overall Study||347
141140|NCT00822900|323239|P1|COMPLETED|Overall Study||334
141141|NCT00822900|323238|P2|STARTED|Overall Study||440
141142|NCT00822900|323239|P1|STARTED|Overall Study||442
141143|NCT00822770|323267|P1|NOT COMPLETED|Overall Study||0
141144|NCT00822770|323267|P1|COMPLETED|Overall Study||47
141145|NCT00822770|323267|P1|STARTED|Overall Study||47
141146|NCT00822757|323273|P2|NOT COMPLETED|Overall Study||0
141147|NCT00822757|323274|P1|NOT COMPLETED|Overall Study||0
141148|NCT00822757|323273|P2|COMPLETED|Overall Study||10
141149|NCT00822757|323274|P1|COMPLETED|Overall Study||41
141150|NCT00822757|323273|P2|STARTED|Overall Study||10
141151|NCT00822757|323274|P1|STARTED|Overall Study||41
141152|NCT00822692|323286|P2|NOT COMPLETED|Overall Study||25
141153|NCT00822692|323287|P1|NOT COMPLETED|Overall Study||17
141154|NCT00822692|323286|P2|COMPLETED|Overall Study|June 1 , 2009|51
141155|NCT00822692|323287|P1|COMPLETED|Overall Study|June 1, 2009|46
141156|NCT00822692|323286|P2|STARTED|Overall Study|July 1, 2008|76
141157|NCT00822692|323287|P1|STARTED|Overall Study|July 1, 2008|63
141158|NCT00822679|323295|P2|NOT COMPLETED|Overall Study||0
141159|NCT00822679|323296|P1|NOT COMPLETED|Overall Study||0
141160|NCT00822679|323295|P2|COMPLETED|Overall Study||0
141161|NCT00822679|323296|P1|COMPLETED|Overall Study||0
141162|NCT00822679|323295|P2|STARTED|Overall Study||0
141163|NCT00822679|323296|P1|STARTED|Overall Study||0
141164|NCT00822588|323304|P2|NOT COMPLETED|Overall Study||4
141165|NCT00822588|323305|P1|NOT COMPLETED|Overall Study||7
141166|NCT00822588|323304|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
141167|NCT00822588|323305|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
141168|NCT00822588|323304|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
141169|NCT00822588|323305|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
141170|NCT00822523|323314|P3|NOT COMPLETED|Overall Study||0
141171|NCT00822523|323315|P2|NOT COMPLETED|Overall Study||0
141172|NCT00822523|323316|P1|NOT COMPLETED|Overall Study||0
141173|NCT00822523|323314|P3|COMPLETED|Overall Study||4
141174|NCT00822523|323315|P2|COMPLETED|Overall Study||4
141175|NCT00822523|323316|P1|COMPLETED|Overall Study||5
141176|NCT00822523|323314|P3|STARTED|Overall Study||4
141177|NCT00822523|323315|P2|STARTED|Overall Study||4
141178|NCT00822523|323316|P1|STARTED|Overall Study||5
141179|NCT00822510|323362|P2|NOT COMPLETED|Overall Study||5
141180|NCT00822510|323363|P1|NOT COMPLETED|Overall Study||3
141181|NCT00822510|323362|P2|COMPLETED|Overall Study||36
141182|NCT00822510|323363|P1|COMPLETED|Overall Study||35
141183|NCT00822510|323362|P2|STARTED|Overall Study||41
141184|NCT00822510|323363|P1|STARTED|Overall Study||38
141185|NCT00822354|323383|P2|NOT COMPLETED|Second Intervention (28 Days)||0
141186|NCT00822354|323384|P1|NOT COMPLETED|Second Intervention (28 Days)||1
141187|NCT00822354|323383|P2|COMPLETED|Second Intervention (28 Days)||5
141188|NCT00822354|323384|P1|COMPLETED|Second Intervention (28 Days)||3
141189|NCT00822354|323383|P2|STARTED|Second Intervention (28 Days)||5
141190|NCT00822354|323384|P1|STARTED|Second Intervention (28 Days)||4
141191|NCT00822354|323383|P2|NOT COMPLETED|Washout (7 Days)||0
141192|NCT00822354|323384|P1|NOT COMPLETED|Washout (7 Days)||0
141193|NCT00822354|323383|P2|COMPLETED|Washout (7 Days)||5
141194|NCT00822354|323384|P1|COMPLETED|Washout (7 Days)||4
141195|NCT00822354|323383|P2|STARTED|Washout (7 Days)||5
141196|NCT00822354|323384|P1|STARTED|Washout (7 Days)||4
141197|NCT00822354|323383|P2|NOT COMPLETED|First Intervention (28 Days)||0
141198|NCT00822354|323384|P1|NOT COMPLETED|First Intervention (28 Days)||1
141199|NCT00822354|323383|P2|COMPLETED|First Intervention (28 Days)||5
141200|NCT00822354|323384|P1|COMPLETED|First Intervention (28 Days)||4
141201|NCT00822354|323383|P2|STARTED|First Intervention (28 Days)||5
141202|NCT00822354|323384|P1|STARTED|First Intervention (28 Days)||5
141203|NCT00822328|323414|P2|NOT COMPLETED|Overall Study||0
141204|NCT00822328|323415|P1|NOT COMPLETED|Overall Study||0
141205|NCT00822328|323414|P2|COMPLETED|Overall Study||12
141206|NCT00822328|323415|P1|COMPLETED|Overall Study||12
141207|NCT00822328|323414|P2|STARTED|Overall Study||12
141208|NCT00822328|323415|P1|STARTED|Overall Study||12
141209|NCT00822237|323425|P2|NOT COMPLETED|Dose 2 Vaccination||11
141210|NCT00822237|323426|P1|NOT COMPLETED|Dose 2 Vaccination||4
141211|NCT00822237|323425|P2|COMPLETED|Dose 2 Vaccination||262
141212|NCT00822237|323426|P1|COMPLETED|Dose 2 Vaccination||270
141213|NCT00822237|323425|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
141214|NCT00822237|323426|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
141215|NCT00822237|323425|P2|NOT COMPLETED|Dose 1 Vaccination||26
141216|NCT00822237|323426|P1|NOT COMPLETED|Dose 1 Vaccination||25
141217|NCT00822237|323425|P2|COMPLETED|Dose 1 Vaccination||273
141218|NCT00822237|323426|P1|COMPLETED|Dose 1 Vaccination||274
141219|NCT00822237|323425|P2|STARTED|Dose 1 Vaccination|Number randomized|299
141220|NCT00822237|323426|P1|STARTED|Dose 1 Vaccination|Number randomized|299
141221|NCT00821951|323431|P1|NOT COMPLETED|Overall Study||5
141222|NCT00821951|323431|P1|COMPLETED|Overall Study||12
141223|NCT00821951|323431|P1|STARTED|Overall Study||17
141224|NCT00821886|323435|P1|NOT COMPLETED|Overall Study||9
141225|NCT00821886|323435|P1|COMPLETED|Overall Study||49
141226|NCT00821886|323435|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
141227|NCT00821873|323442|P1|NOT COMPLETED|Overall Study||4
141228|NCT00821873|323442|P1|COMPLETED|Overall Study||5
141229|NCT00821873|323442|P1|STARTED|Overall Study||9
141230|NCT00821821|323449|P3|NOT COMPLETED|Overall Study||0
141231|NCT00821821|323450|P2|NOT COMPLETED|Overall Study||0
141232|NCT00821821|323451|P1|NOT COMPLETED|Overall Study||0
141233|NCT00821821|323449|P3|COMPLETED|Overall Study||11
141234|NCT00821821|323450|P2|COMPLETED|Overall Study||13
141235|NCT00821821|323451|P1|COMPLETED|Overall Study||12
141236|NCT00821821|323449|P3|STARTED|Overall Study||11
141237|NCT00821821|323450|P2|STARTED|Overall Study||13
141238|NCT00821821|323451|P1|STARTED|Overall Study||12
141239|NCT00821678|323463|P2|NOT COMPLETED|Overall Study||14
141240|NCT00821678|323464|P1|NOT COMPLETED|Overall Study||21
141241|NCT00821678|323463|P2|COMPLETED|Overall Study||118
141242|NCT00821678|323464|P1|COMPLETED|Overall Study||112
141243|NCT00821678|323463|P2|STARTED|Overall Study||132
141244|NCT00821678|323464|P1|STARTED|Overall Study||133
141245|NCT00821587|323482|P2|NOT COMPLETED|Overall Study||1
141246|NCT00821587|323483|P1|NOT COMPLETED|Overall Study||0
141247|NCT00821587|323482|P2|COMPLETED|Overall Study||18
141248|NCT00821587|323483|P1|COMPLETED|Overall Study||20
141249|NCT00821587|323482|P2|STARTED|Overall Study||19
141250|NCT00821587|323483|P1|STARTED|Overall Study||20
141251|NCT00821509|323492|P3|NOT COMPLETED|Overall Study||34
141252|NCT00821509|323493|P2|NOT COMPLETED|Overall Study||11
141253|NCT00821509|323494|P1|NOT COMPLETED|Overall Study||12
141254|NCT00821509|323492|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
141255|NCT00821509|323493|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
141256|NCT00821509|323494|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
141257|NCT00821509|323492|P3|STARTED|Overall Study||224
141258|NCT00821509|323493|P2|STARTED|Overall Study||202
141259|NCT00821509|323494|P1|STARTED|Overall Study||257
141260|NCT00821431|323507|P2|NOT COMPLETED|Overall Study||5
141261|NCT00821431|323508|P1|NOT COMPLETED|Overall Study||15
141262|NCT00821431|323507|P2|COMPLETED|Overall Study||47
141263|NCT00821431|323508|P1|COMPLETED|Overall Study||23
141264|NCT00821431|323507|P2|STARTED|Overall Study||52
141265|NCT00821431|323508|P1|STARTED|Overall Study||38
141266|NCT00821327|323516|P1|NOT COMPLETED|Overall Study||35
141267|NCT00821327|323516|P1|COMPLETED|Overall Study||1
141268|NCT00821327|323516|P1|STARTED|Overall Study||36
141269|NCT00821236|323525|P1|NOT COMPLETED|Overall Study||3
141270|NCT00821236|323525|P1|COMPLETED|Overall Study||37
141271|NCT00821236|323525|P1|STARTED|Overall Study||40
141272|NCT00821184|323541|P2|NOT COMPLETED|Overall Study||0
141273|NCT00821184|323542|P1|NOT COMPLETED|Overall Study||0
141274|NCT00821184|323541|P2|COMPLETED|Overall Study||6
141275|NCT00821184|323542|P1|COMPLETED|Overall Study||6
141276|NCT00821184|323541|P2|STARTED|Overall Study||6
141277|NCT00821184|323542|P1|STARTED|Overall Study||6
141278|NCT00821119|323550|P2|NOT COMPLETED|Overall Study||0
141279|NCT00821119|323551|P1|NOT COMPLETED|Overall Study||0
141280|NCT00821119|323550|P2|COMPLETED|Overall Study||100
141281|NCT00821119|323551|P1|COMPLETED|Overall Study||100
141282|NCT00821119|323550|P2|STARTED|Overall Study||100
141283|NCT00821119|323551|P1|STARTED|Overall Study||100
141284|NCT00821093|323563|P2|NOT COMPLETED|Overall Study||40
141285|NCT00821093|323564|P1|NOT COMPLETED|Overall Study||49
141286|NCT00821093|323563|P2|COMPLETED|Overall Study||523
141287|NCT00821093|323564|P1|COMPLETED|Overall Study||511
141288|NCT00821093|323563|P2|Exposed to Drug|Overall Study||562
141289|NCT00821093|323564|P1|Exposed to Drug|Overall Study||559
141290|NCT00821093|323563|P2|STARTED|Overall Study||563
141291|NCT00821093|323564|P1|STARTED|Overall Study||560
141292|NCT00821041|323574|P2|NOT COMPLETED|Overall Study||0
141293|NCT00821041|323575|P1|NOT COMPLETED|Overall Study||0
141294|NCT00821041|323574|P2|COMPLETED|Overall Study||59
141295|NCT00821041|323575|P1|COMPLETED|Overall Study||59
141296|NCT00821041|323574|P2|STARTED|Overall Study||59
141297|NCT00821041|323575|P1|STARTED|Overall Study||59
141298|NCT00820755|323583|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
141299|NCT00820755|323584|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
141300|NCT00820755|323585|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
141301|NCT00820755|323583|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
141302|NCT00820755|323584|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
141303|NCT00820755|323585|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
141304|NCT00820755|323583|P3|STARTED|Period 2: Maintenance Therapy Phase||154
141305|NCT00820755|323584|P2|STARTED|Period 2: Maintenance Therapy Phase||157
141306|NCT00820755|323585|P1|STARTED|Period 2: Maintenance Therapy Phase||0
141307|NCT00820755|323583|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
141308|NCT00820755|323584|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
141309|NCT00820755|323585|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
141310|NCT00820755|323583|P3|COMPLETED|Period 1: Combination Therapy Phase||0
141311|NCT00820755|323584|P2|COMPLETED|Period 1: Combination Therapy Phase||0
141312|NCT00820755|323585|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
141313|NCT00820755|323583|P3|STARTED|Period 1: Combination Therapy Phase||0
141314|NCT00820755|323584|P2|STARTED|Period 1: Combination Therapy Phase||0
141315|NCT00820755|323585|P1|STARTED|Period 1: Combination Therapy Phase||583
141316|NCT00820664|323609|P3|NOT COMPLETED|Overall Study||0
141317|NCT00820664|323610|P2|NOT COMPLETED|Overall Study||0
141318|NCT00820664|323611|P1|NOT COMPLETED|Overall Study||0
141319|NCT00820664|323609|P3|COMPLETED|Overall Study||9
141320|NCT00820664|323610|P2|COMPLETED|Overall Study||11
141321|NCT00820664|323611|P1|COMPLETED|Overall Study||9
141322|NCT00820664|323609|P3|STARTED|Overall Study||9
141323|NCT00820664|323610|P2|STARTED|Overall Study||11
141324|NCT00820664|323611|P1|STARTED|Overall Study||9
141325|NCT00820612|323621|P2|NOT COMPLETED|Overall Study||0
141326|NCT00820612|323622|P1|NOT COMPLETED|Overall Study||0
141327|NCT00820612|323621|P2|COMPLETED|Overall Study||295
141328|NCT00820612|323622|P1|COMPLETED|Overall Study||307
141329|NCT00820612|323621|P2|STARTED|Overall Study||295
141330|NCT00820612|323622|P1|STARTED|Overall Study||307
141331|NCT00820573|323632|P4|NOT COMPLETED|Overall Study||0
141332|NCT00820573|323633|P3|NOT COMPLETED|Overall Study||0
141333|NCT00820573|323634|P2|NOT COMPLETED|Overall Study||0
141334|NCT00820573|323635|P1|NOT COMPLETED|Overall Study||0
141335|NCT00820573|323632|P4|COMPLETED|Overall Study||4
141336|NCT00820573|323633|P3|COMPLETED|Overall Study||4
141337|NCT00820573|323634|P2|COMPLETED|Overall Study||4
141338|NCT00820573|323635|P1|COMPLETED|Overall Study||4
141339|NCT00820573|323632|P4|STARTED|Overall Study||4
141340|NCT00820573|323633|P3|STARTED|Overall Study||4
141341|NCT00820573|323634|P2|STARTED|Overall Study||4
141342|NCT00820573|323635|P1|STARTED|Overall Study||4
141343|NCT00820534|323659|P2|NOT COMPLETED|Overall Study||0
141344|NCT00820534|323660|P1|NOT COMPLETED|Overall Study||0
141345|NCT00820534|323659|P2|COMPLETED|Overall Study||62
141346|NCT00820534|323660|P1|COMPLETED|Overall Study||64
141347|NCT00820534|323659|P2|STARTED|Overall Study||62
141348|NCT00820534|323660|P1|STARTED|Overall Study||64
141349|NCT00820443|323668|P1|NOT COMPLETED|24 Month||43
141350|NCT00820443|323668|P1|COMPLETED|24 Month||202
141351|NCT00820443|323668|P1|STARTED|24 Month||245
141352|NCT00820443|323668|P1|NOT COMPLETED|12 Month||24
141353|NCT00820443|323668|P1|COMPLETED|12 Month||226
141354|NCT00820443|323668|P1|STARTED|12 Month||250
141355|NCT00820443|323668|P1|NOT COMPLETED|6 Month||20
141356|NCT00820443|323668|P1|COMPLETED|6 Month||233
141357|NCT00820443|323668|P1|STARTED|6 Month||253
141358|NCT00820443|323668|P1|NOT COMPLETED|3 Month||9
141359|NCT00820443|323668|P1|COMPLETED|3 Month||244
141360|NCT00820443|323668|P1|STARTED|3 Month||253
141361|NCT00820443|323668|P1|NOT COMPLETED|Immediately||5
141362|NCT00820443|323668|P1|COMPLETED|Immediately||248
141363|NCT00820443|323668|P1|STARTED|Immediately||253
141364|NCT00820443|323668|P1|NOT COMPLETED|Op||0
141365|NCT00820443|323668|P1|COMPLETED|Op||253
141366|NCT00820443|323668|P1|STARTED|Op||253
141367|NCT00820443|323668|P1|NOT COMPLETED|Pre-Op||0
141368|NCT00820443|323668|P1|COMPLETED|Pre-Op||253
141369|NCT00820443|323668|P1|STARTED|Pre-Op||253
141370|NCT00820222|323678|P2|NOT COMPLETED|Overall Study||211
141371|NCT00820222|323679|P1|NOT COMPLETED|Overall Study||201
141372|NCT00820222|323678|P2|COMPLETED|Overall Study||58
141373|NCT00820222|323679|P1|COMPLETED|Overall Study||70
141374|NCT00820222|323678|P2|Ongoing|Overall Study||191
141375|NCT00820222|323679|P1|Ongoing|Overall Study||185
141376|NCT00820222|323678|P2|STARTED|Overall Study||269
141377|NCT00820222|323679|P1|STARTED|Overall Study||271
141378|NCT00819182|323708|P3|NOT COMPLETED|Overall Study||1
141379|NCT00819182|323709|P2|NOT COMPLETED|Overall Study||8
141380|NCT00819182|323710|P1|NOT COMPLETED|Overall Study||13
141381|NCT00819182|323708|P3|COMPLETED|Overall Study||43
141382|NCT00819182|323709|P2|COMPLETED|Overall Study||78
141383|NCT00819182|323710|P1|COMPLETED|Overall Study||75
141384|NCT00819182|323708|P3|Week 16 Visit|Overall Study||43
141385|NCT00819182|323709|P2|Week 16 Visit|Overall Study||78
141386|NCT00819182|323710|P1|Week 16 Visit|Overall Study||75
141387|NCT00819182|323708|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
141388|NCT00819182|323709|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
141389|NCT00819182|323710|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
141390|NCT00819156|323746|P6|NOT COMPLETED|Overall Study||8
141391|NCT00819156|323747|P5|NOT COMPLETED|Overall Study||6
141392|NCT00819156|323748|P4|NOT COMPLETED|Overall Study||2
141393|NCT00819156|323749|P3|NOT COMPLETED|Overall Study||6
141394|NCT00819156|323750|P2|NOT COMPLETED|Overall Study||10
141395|NCT00819156|323751|P1|NOT COMPLETED|Overall Study||10
141396|NCT00819156|323746|P6|COMPLETED|Overall Study||23
141397|NCT00819156|323747|P5|COMPLETED|Overall Study||27
141398|NCT00819156|323748|P4|COMPLETED|Overall Study||28
141399|NCT00819156|323749|P3|COMPLETED|Overall Study||26
141400|NCT00819156|323750|P2|COMPLETED|Overall Study||23
141401|NCT00819156|323751|P1|COMPLETED|Overall Study||20
141402|NCT00819156|323746|P6|Randomised and Treated (ITT Population)|Overall Study||30
141403|NCT00819156|323747|P5|Randomised and Treated (ITT Population)|Overall Study||33
141404|NCT00819156|323748|P4|Randomised and Treated (ITT Population)|Overall Study||30
141405|NCT00819156|323749|P3|Randomised and Treated (ITT Population)|Overall Study||32
141406|NCT00819156|323750|P2|Randomised and Treated (ITT Population)|Overall Study||32
141407|NCT00819156|323751|P1|Randomised and Treated (ITT Population)|Overall Study||30
141408|NCT00819156|323746|P6|STARTED|Overall Study||31
141409|NCT00819156|323747|P5|STARTED|Overall Study||33
141410|NCT00819156|323748|P4|STARTED|Overall Study||30
141411|NCT00819156|323749|P3|STARTED|Overall Study||32
141412|NCT00819156|323750|P2|STARTED|Overall Study||33
141413|NCT00819156|323751|P1|STARTED|Overall Study||30
141414|NCT00819910|323843|P4|NOT COMPLETED|Overall Study||1
141415|NCT00819910|323844|P3|NOT COMPLETED|Overall Study||3
141416|NCT00819910|323845|P2|NOT COMPLETED|Overall Study||1
141417|NCT00819910|323846|P1|NOT COMPLETED|Overall Study||2
141418|NCT00819910|323843|P4|COMPLETED|Overall Study||10
141419|NCT00819910|323844|P3|COMPLETED|Overall Study||7
141420|NCT00819910|323845|P2|COMPLETED|Overall Study||9
141421|NCT00819910|323846|P1|COMPLETED|Overall Study||8
141422|NCT00819910|323843|P4|STARTED|Overall Study||11
141423|NCT00819910|323844|P3|STARTED|Overall Study||10
141424|NCT00819910|323845|P2|STARTED|Overall Study||10
141425|NCT00819910|323846|P1|STARTED|Overall Study||10
141426|NCT00819832|323878|P6|NOT COMPLETED|Overall Study||0
141427|NCT00819832|323879|P5|NOT COMPLETED|Overall Study||0
141428|NCT00819832|323880|P4|NOT COMPLETED|Overall Study||0
141429|NCT00819832|323881|P3|NOT COMPLETED|Overall Study||0
141430|NCT00819832|323882|P2|NOT COMPLETED|Overall Study||0
141431|NCT00819832|323883|P1|NOT COMPLETED|Overall Study||3
141432|NCT00819832|323878|P6|COMPLETED|Overall Study||0
141433|NCT00819832|323879|P5|COMPLETED|Overall Study||0
141434|NCT00819832|323880|P4|COMPLETED|Overall Study||0
141435|NCT00819832|323881|P3|COMPLETED|Overall Study||0
141436|NCT00819832|323882|P2|COMPLETED|Overall Study||0
141437|NCT00819832|323883|P1|COMPLETED|Overall Study||0
141438|NCT00819832|323878|P6|STARTED|Overall Study||0
141439|NCT00819832|323879|P5|STARTED|Overall Study||0
141440|NCT00819832|323880|P4|STARTED|Overall Study||0
141441|NCT00819832|323881|P3|STARTED|Overall Study||0
141442|NCT00819832|323882|P2|STARTED|Overall Study||0
141443|NCT00819832|323883|P1|STARTED|Overall Study|No patient data analysis.|3
141444|NCT00819780|323899|P2|NOT COMPLETED|Overall Study||21
141445|NCT00819780|323900|P1|NOT COMPLETED|Overall Study||28
141446|NCT00819780|323899|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
141447|NCT00819780|323900|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
141448|NCT00819780|323899|P2|Received Study Treatment|Overall Study||139
141449|NCT00819780|323900|P1|Received Study Treatment|Overall Study||139
141450|NCT00819780|323899|P2|STARTED|Overall Study||143
141451|NCT00819780|323900|P1|STARTED|Overall Study||142
141452|NCT00819767|323934|P2|NOT COMPLETED|Overall Study||2
141453|NCT00819767|323935|P1|NOT COMPLETED|Overall Study||1
141454|NCT00819767|323934|P2|COMPLETED|Overall Study||33
141455|NCT00819767|323935|P1|COMPLETED|Overall Study||32
141456|NCT00819767|323934|P2|STARTED|Overall Study||35
141457|NCT00819767|323935|P1|STARTED|Overall Study||33
141458|NCT00819741|323947|P2|NOT COMPLETED|Overall Study||14
141459|NCT00819741|323948|P1|NOT COMPLETED|Overall Study||22
141460|NCT00819741|323947|P2|COMPLETED|Overall Study||201
141461|NCT00819741|323948|P1|COMPLETED|Overall Study||196
141462|NCT00819741|323947|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
141463|NCT00819741|323948|P1|Exposed to Drug|Overall Study||218
141464|NCT00819741|323947|P2|STARTED|Overall Study||215
141465|NCT00819741|323948|P1|STARTED|Overall Study||218
141466|NCT00819637|323985|P3|NOT COMPLETED|Overall Study||0
141467|NCT00819637|323986|P2|NOT COMPLETED|Overall Study||0
141468|NCT00819637|323987|P1|NOT COMPLETED|Overall Study||0
141469|NCT00819637|323985|P3|COMPLETED|Overall Study||0
141470|NCT00819637|323986|P2|COMPLETED|Overall Study||0
141471|NCT00819637|323987|P1|COMPLETED|Overall Study||2
141472|NCT00819637|323985|P3|STARTED|Overall Study||0
141473|NCT00819637|323986|P2|STARTED|Overall Study||0
141474|NCT00819637|323987|P1|STARTED|Overall Study||2
141475|NCT00819585|324002|P7|NOT COMPLETED|Overall Study||13
141476|NCT00819585|324003|P6|NOT COMPLETED|Overall Study||2
141477|NCT00819585|324004|P5|NOT COMPLETED|Overall Study||3
141478|NCT00819585|324005|P4|NOT COMPLETED|Overall Study||5
141479|NCT00819585|324006|P3|NOT COMPLETED|Overall Study||6
141480|NCT00819585|324007|P2|NOT COMPLETED|Overall Study||6
141481|NCT00819585|324008|P1|NOT COMPLETED|Overall Study||6
141482|NCT00819585|324002|P7|COMPLETED|Overall Study||95
141483|NCT00819585|324003|P6|COMPLETED|Overall Study||52
141484|NCT00819585|324004|P5|COMPLETED|Overall Study||50
141485|NCT00819585|324005|P4|COMPLETED|Overall Study||49
141486|NCT00819585|324006|P3|COMPLETED|Overall Study||48
141487|NCT00819585|324007|P2|COMPLETED|Overall Study||48
141488|NCT00819585|324008|P1|COMPLETED|Overall Study||49
141489|NCT00819585|324002|P7|Safety Population|Overall Study||108
141490|NCT00819585|324003|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
141491|NCT00819585|324004|P5|Safety Population|Overall Study||53
141492|NCT00819585|324005|P4|Safety Population|Overall Study||54
141493|NCT00819585|324006|P3|Safety Population|Overall Study||54
141494|NCT00819585|324007|P2|Safety Population|Overall Study||54
141495|NCT00819585|324008|P1|Safety Population|Overall Study||55
141496|NCT00819585|324002|P7|STARTED|Overall Study||108
141497|NCT00819585|324003|P6|STARTED|Overall Study||54
141498|NCT00819585|324004|P5|STARTED|Overall Study||53
141499|NCT00819585|324005|P4|STARTED|Overall Study||54
141500|NCT00819585|324006|P3|STARTED|Overall Study||54
141501|NCT00819585|324007|P2|STARTED|Overall Study||54
141502|NCT00819585|324008|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
141503|NCT00819403|324067|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
141504|NCT00819403|324068|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
141505|NCT00819403|324067|P2|COMPLETED|Second Intervention (6 Weeks)||8
141506|NCT00819403|324068|P1|COMPLETED|Second Intervention (6 Weeks)||7
141507|NCT00819403|324067|P2|STARTED|Second Intervention (6 Weeks)||8
141508|NCT00819403|324068|P1|STARTED|Second Intervention (6 Weeks)||7
141509|NCT00819403|324067|P2|NOT COMPLETED|Washout (14 Days)||0
141510|NCT00819403|324068|P1|NOT COMPLETED|Washout (14 Days)||0
141511|NCT00819403|324067|P2|COMPLETED|Washout (14 Days)||8
141512|NCT00819403|324068|P1|COMPLETED|Washout (14 Days)||7
141513|NCT00819403|324067|P2|STARTED|Washout (14 Days)||8
141514|NCT00819403|324068|P1|STARTED|Washout (14 Days)||7
141515|NCT00819403|324067|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
141516|NCT00819403|324068|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
141517|NCT00819403|324067|P2|COMPLETED|First Intervention (6 Weeks)||8
141518|NCT00819403|324068|P1|COMPLETED|First Intervention (6 Weeks)||7
141519|NCT00819403|324067|P2|STARTED|First Intervention (6 Weeks)||8
141520|NCT00819403|324068|P1|STARTED|First Intervention (6 Weeks)||7
141521|NCT00819390|324080|P4|NOT COMPLETED|Overall Study||0
141522|NCT00819390|324081|P3|NOT COMPLETED|Overall Study||1
141523|NCT00819390|324082|P2|NOT COMPLETED|Overall Study||1
141524|NCT00819390|324083|P1|NOT COMPLETED|Overall Study||3
141525|NCT00819390|324080|P4|COMPLETED|Overall Study||19
141526|NCT00819390|324081|P3|COMPLETED|Overall Study||17
141527|NCT00819390|324082|P2|COMPLETED|Overall Study||16
141528|NCT00819390|324083|P1|COMPLETED|Overall Study||13
141529|NCT00819390|324080|P4|STARTED|Overall Study||19
141530|NCT00819390|324081|P3|STARTED|Overall Study||18
141531|NCT00819390|324082|P2|STARTED|Overall Study||17
141532|NCT00819390|324083|P1|STARTED|Overall Study||16
141533|NCT00819286|324195|P2|NOT COMPLETED|Overall Study||25
141534|NCT00819286|324196|P1|NOT COMPLETED|Overall Study||14
141535|NCT00819286|324195|P2|COMPLETED|Overall Study||45
141536|NCT00819286|324196|P1|COMPLETED|Overall Study||56
141537|NCT00819286|324195|P2|STARTED|Overall Study||70
141538|NCT00819286|324196|P1|STARTED|Overall Study||70
141539|NCT00819260|324204|P1|NOT COMPLETED|Overall Study||0
141540|NCT00819260|324204|P1|COMPLETED|Overall Study||31
141541|NCT00819260|324204|P1|STARTED|Overall Study||31
141542|NCT00819247|324219|P3|NOT COMPLETED|Overall Study||14
141543|NCT00819247|324220|P2|NOT COMPLETED|Overall Study||16
141544|NCT00819247|324221|P1|NOT COMPLETED|Overall Study||11
141545|NCT00819247|324219|P3|COMPLETED|Overall Study||26
141546|NCT00819247|324220|P2|COMPLETED|Overall Study||30
141547|NCT00819247|324221|P1|COMPLETED|Overall Study||32
141548|NCT00819247|324219|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
141549|NCT00819247|324220|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
141550|NCT00819247|324221|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
141551|NCT00819247|324219|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
141552|NCT00819247|324220|P2|Intent-to-treat Population|Overall Study||46
141553|NCT00819247|324221|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
141554|NCT00819247|324219|P3|Randomized|Overall Study||40
141555|NCT00819247|324220|P2|Randomized|Overall Study||46
141556|NCT00819247|324221|P1|Randomized|Overall Study||43
141557|NCT00819247|324219|P3|STARTED|Overall Study||40
141558|NCT00819247|324220|P2|STARTED|Overall Study||46
141559|NCT00819247|324221|P1|STARTED|Overall Study||43
141560|NCT00819234|324247|P10|NOT COMPLETED|Overall Study||7
141561|NCT00819234|324248|P9|NOT COMPLETED|Overall Study||6
141562|NCT00819234|324249|P8|NOT COMPLETED|Overall Study||9
141563|NCT00819234|324250|P7|NOT COMPLETED|Overall Study||5
141564|NCT00819234|324251|P6|NOT COMPLETED|Overall Study||7
141565|NCT00819234|324252|P5|NOT COMPLETED|Overall Study||1
141566|NCT00819234|324253|P4|NOT COMPLETED|Overall Study||6
141567|NCT00819234|324254|P3|NOT COMPLETED|Overall Study||8
141568|NCT00819234|324255|P2|NOT COMPLETED|Overall Study||15
141569|NCT00819234|324256|P1|NOT COMPLETED|Overall Study||10
141570|NCT00819234|324247|P10|COMPLETED|Overall Study||30
141571|NCT00819234|324248|P9|COMPLETED|Overall Study||31
141572|NCT00819234|324249|P8|COMPLETED|Overall Study||20
141573|NCT00819234|324250|P7|COMPLETED|Overall Study||8
141574|NCT00819234|324251|P6|COMPLETED|Overall Study||7
141575|NCT00819234|324252|P5|COMPLETED|Overall Study||12
141576|NCT00819234|324253|P4|COMPLETED|Overall Study||22
141577|NCT00819234|324254|P3|COMPLETED|Overall Study||28
141578|NCT00819234|324255|P2|COMPLETED|Overall Study||20
141579|NCT00819234|324256|P1|COMPLETED|Overall Study||21
141580|NCT00819234|324247|P10|STARTED|Overall Study||37
141581|NCT00819234|324248|P9|STARTED|Overall Study||37
141582|NCT00819234|324249|P8|STARTED|Overall Study||29
141583|NCT00819234|324250|P7|STARTED|Overall Study||13
141584|NCT00819234|324251|P6|STARTED|Overall Study||14
141585|NCT00819234|324252|P5|STARTED|Overall Study||13
141586|NCT00819234|324253|P4|STARTED|Overall Study||28
141587|NCT00819234|324254|P3|STARTED|Overall Study||36
141588|NCT00819234|324255|P2|STARTED|Overall Study||35
141589|NCT00819234|324256|P1|STARTED|Overall Study||31
141590|NCT00819091|324416|P2|NOT COMPLETED|Overall Study||10
141591|NCT00819091|324417|P1|NOT COMPLETED|Overall Study||7
141592|NCT00819091|324416|P2|COMPLETED|Overall Study||151
141593|NCT00819091|324417|P1|COMPLETED|Overall Study||77
141594|NCT00819091|324416|P2|STARTED|Overall Study||161
141595|NCT00819091|324417|P1|STARTED|Overall Study||84
141596|NCT00819052|324443|P2|NOT COMPLETED|Overall Study||14
141597|NCT00819052|324444|P1|NOT COMPLETED|Overall Study||6
141598|NCT00819052|324443|P2|COMPLETED|Overall Study||281
141599|NCT00819052|324444|P1|COMPLETED|Overall Study||142
141600|NCT00819052|324443|P2|STARTED|Overall Study||295
141601|NCT00819052|324444|P1|STARTED|Overall Study||148
141602|NCT00819039|324559|P3|NOT COMPLETED|Overall Study||1
141603|NCT00819039|324560|P2|NOT COMPLETED|Overall Study||0
141604|NCT00819039|324561|P1|NOT COMPLETED|Overall Study||2
141605|NCT00819039|324559|P3|COMPLETED|Overall Study||24
141606|NCT00819039|324560|P2|COMPLETED|Overall Study||27
141607|NCT00819039|324561|P1|COMPLETED|Overall Study||44
141608|NCT00819039|324559|P3|STARTED|Overall Study||25
141609|NCT00819039|324560|P2|STARTED|Overall Study||27
141610|NCT00819039|324561|P1|STARTED|Overall Study||46
141611|NCT00819013|324591|P4|NOT COMPLETED|Overall Study||4
141612|NCT00819013|324592|P3|NOT COMPLETED|Overall Study||5
141613|NCT00819013|324593|P2|NOT COMPLETED|Overall Study||1
141614|NCT00819013|324594|P1|NOT COMPLETED|Overall Study||3
141615|NCT00819013|324591|P4|COMPLETED|Overall Study||17
141616|NCT00819013|324592|P3|COMPLETED|Overall Study||16
141617|NCT00819013|324593|P2|COMPLETED|Overall Study||22
141618|NCT00819013|324594|P1|COMPLETED|Overall Study||19
141619|NCT00819013|324591|P4|STARTED|Overall Study||21
141620|NCT00819013|324592|P3|STARTED|Overall Study||21
141621|NCT00819013|324593|P2|STARTED|Overall Study||23
141622|NCT00819013|324594|P1|STARTED|Overall Study||22
141623|NCT00818961|324644|P1|NOT COMPLETED|Overall Study||0
141624|NCT00818961|324644|P1|COMPLETED|Overall Study||36
141625|NCT00818961|324644|P1|STARTED|Overall Study||36
141626|NCT00818883|324660|P2|NOT COMPLETED|Overall Study||46
141627|NCT00818883|324661|P1|NOT COMPLETED|Overall Study||51
141628|NCT00818883|324660|P2|COMPLETED|Overall Study||260
141629|NCT00818883|324661|P1|COMPLETED|Overall Study||252
141630|NCT00818883|324660|P2|STARTED|Overall Study||306
141631|NCT00818883|324661|P1|STARTED|Overall Study||303
141632|NCT00818805|324695|P2|NOT COMPLETED|Second Intervention||0
141633|NCT00818805|324696|P1|NOT COMPLETED|Second Intervention||0
141634|NCT00818805|324695|P2|COMPLETED|Second Intervention||25
141635|NCT00818805|324696|P1|COMPLETED|Second Intervention||25
141636|NCT00818805|324695|P2|STARTED|Second Intervention||25
141637|NCT00818805|324696|P1|STARTED|Second Intervention||25
141638|NCT00818805|324695|P2|NOT COMPLETED|First Intervention||0
141639|NCT00818805|324696|P1|NOT COMPLETED|First Intervention||0
141640|NCT00818805|324695|P2|COMPLETED|First Intervention||25
141641|NCT00818805|324696|P1|COMPLETED|First Intervention||25
141642|NCT00818805|324695|P2|STARTED|First Intervention||25
141643|NCT00818805|324696|P1|STARTED|First Intervention||25
141644|NCT00818779|324708|P2|NOT COMPLETED|Overall Study||1
141645|NCT00818779|324709|P1|NOT COMPLETED|Overall Study||6
141646|NCT00818779|324708|P2|COMPLETED|Overall Study||15
141647|NCT00818779|324709|P1|COMPLETED|Overall Study||16
141648|NCT00818779|324708|P2|STARTED|Overall Study||16
141649|NCT00818779|324709|P1|STARTED|Overall Study||22
141650|NCT00818753|324718|P3|NOT COMPLETED|Overall Study||1
141651|NCT00818753|324719|P2|NOT COMPLETED|Overall Study||0
141652|NCT00818753|324720|P1|NOT COMPLETED|Overall Study||3
141653|NCT00818753|324718|P3|COMPLETED|Overall Study||9
141654|NCT00818753|324719|P2|COMPLETED|Overall Study||21
141655|NCT00818753|324720|P1|COMPLETED|Overall Study||19
141656|NCT00818753|324718|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
141657|NCT00818753|324719|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
141658|NCT00818753|324720|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
141659|NCT00818662|324744|P4|NOT COMPLETED|Overall Study||16
141660|NCT00818662|324745|P3|NOT COMPLETED|Overall Study||9
141661|NCT00818662|324746|P2|NOT COMPLETED|Overall Study||33
141662|NCT00818662|324747|P1|NOT COMPLETED|Overall Study||23
141663|NCT00818662|324744|P4|COMPLETED|Overall Study||47
141664|NCT00818662|324745|P3|COMPLETED|Overall Study||49
141665|NCT00818662|324746|P2|COMPLETED|Overall Study||102
141666|NCT00818662|324747|P1|COMPLETED|Overall Study||104
141667|NCT00818662|324744|P4|STARTED|Overall Study||63
141668|NCT00818662|324745|P3|STARTED|Overall Study||58
141669|NCT00818662|324746|P2|STARTED|Overall Study||135
141670|NCT00818662|324747|P1|STARTED|Overall Study||127
141671|NCT00818649|324833|P1|NOT COMPLETED|Overall Study||4
141672|NCT00818649|324833|P1|COMPLETED|Overall Study||12
141673|NCT00818649|324833|P1|STARTED|Overall Study||16
141674|NCT00818623|324845|P8|NOT COMPLETED|Overall Study||1
141675|NCT00818623|324846|P7|NOT COMPLETED|Overall Study||4
141676|NCT00818623|324847|P6|NOT COMPLETED|Overall Study||3
141677|NCT00818623|324848|P5|NOT COMPLETED|Overall Study||4
141678|NCT00818623|324849|P4|NOT COMPLETED|Overall Study||5
141679|NCT00818623|324850|P3|NOT COMPLETED|Overall Study||4
141680|NCT00818623|324851|P2|NOT COMPLETED|Overall Study||4
141681|NCT00818623|324852|P1|NOT COMPLETED|Overall Study||2
141682|NCT00818623|324845|P8|COMPLETED|Overall Study||26
141683|NCT00818623|324846|P7|COMPLETED|Overall Study||23
141684|NCT00818623|324847|P6|COMPLETED|Overall Study||21
141685|NCT00818623|324848|P5|COMPLETED|Overall Study||23
141686|NCT00818623|324849|P4|COMPLETED|Overall Study||19
141687|NCT00818623|324850|P3|COMPLETED|Overall Study||9
141688|NCT00818623|324851|P2|COMPLETED|Overall Study||8
141689|NCT00818623|324852|P1|COMPLETED|Overall Study||24
141690|NCT00818623|324845|P8|Intent-to-treat (ITT) Population|Overall Study||27
141691|NCT00818623|324846|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
141692|NCT00818623|324847|P6|Intent-to-treat (ITT) Population|Overall Study||24
141693|NCT00818623|324848|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
141694|NCT00818623|324849|P4|Intent-to-treat (ITT) Population|Overall Study||24
141695|NCT00818623|324850|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
141696|NCT00818623|324851|P2|Intent-to-treat (ITT) Population|Overall Study||12
141697|NCT00818623|324852|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
141698|NCT00818623|324845|P8|STARTED|Overall Study||27
141699|NCT00818623|324846|P7|STARTED|Overall Study||27
141700|NCT00818623|324847|P6|STARTED|Overall Study||24
141701|NCT00818623|324848|P5|STARTED|Overall Study||27
141702|NCT00818623|324849|P4|STARTED|Overall Study||24
141703|NCT00818623|324850|P3|STARTED|Overall Study||13
141704|NCT00818623|324851|P2|STARTED|Overall Study||12
141705|NCT00818623|324852|P1|STARTED|Overall Study||26
141706|NCT00818519|324928|P2|NOT COMPLETED|Overall Study||19
141707|NCT00818519|324929|P1|NOT COMPLETED|Overall Study||14
141708|NCT00818519|324928|P2|COMPLETED|Overall Study||71
141709|NCT00818519|324929|P1|COMPLETED|Overall Study||75
141710|NCT00818519|324928|P2|Participants Received Treatment|Overall Study|= Baseline|86
141711|NCT00818519|324929|P1|Participants Received Treatment|Overall Study|= Baseline|87
141712|NCT00818519|324928|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
141713|NCT00818519|324929|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
141714|NCT00818454|324959|P4|NOT COMPLETED|Treatment Period 3||1
141715|NCT00818454|324960|P3|NOT COMPLETED|Treatment Period 3||0
141716|NCT00818454|324961|P2|NOT COMPLETED|Treatment Period 3||0
141717|NCT00818454|324962|P1|NOT COMPLETED|Treatment Period 3||0
141718|NCT00818454|324959|P4|COMPLETED|Treatment Period 3||138
141719|NCT00818454|324960|P3|COMPLETED|Treatment Period 3||26
141720|NCT00818454|324961|P2|COMPLETED|Treatment Period 3||0
141721|NCT00818454|324962|P1|COMPLETED|Treatment Period 3||0
141722|NCT00818454|324959|P4|STARTED|Treatment Period 3||139
141723|NCT00818454|324960|P3|STARTED|Treatment Period 3||26
141724|NCT00818454|324961|P2|STARTED|Treatment Period 3||0
141725|NCT00818454|324962|P1|STARTED|Treatment Period 3||0
141726|NCT00818454|324959|P4|NOT COMPLETED|Treatment Period 2||0
141727|NCT00818454|324960|P3|NOT COMPLETED|Treatment Period 2||0
141728|NCT00818454|324961|P2|NOT COMPLETED|Treatment Period 2||1
141729|NCT00818454|324962|P1|NOT COMPLETED|Treatment Period 2||2
141730|NCT00818454|324959|P4|COMPLETED|Treatment Period 2||0
141731|NCT00818454|324960|P3|COMPLETED|Treatment Period 2||0
141732|NCT00818454|324961|P2|COMPLETED|Treatment Period 2||106
141733|NCT00818454|324962|P1|COMPLETED|Treatment Period 2||106
141734|NCT00818454|324959|P4|STARTED|Treatment Period 2||0
141735|NCT00818454|324960|P3|STARTED|Treatment Period 2||0
141736|NCT00818454|324961|P2|STARTED|Treatment Period 2||107
141737|NCT00818454|324962|P1|STARTED|Treatment Period 2||108
141738|NCT00818454|324959|P4|NOT COMPLETED|Washout Period of 1 Week||0
141739|NCT00818454|324960|P3|NOT COMPLETED|Washout Period of 1 Week||0
141740|NCT00818454|324961|P2|NOT COMPLETED|Washout Period of 1 Week||3
141741|NCT00818454|324962|P1|NOT COMPLETED|Washout Period of 1 Week||4
141742|NCT00818454|324959|P4|COMPLETED|Washout Period of 1 Week||0
141743|NCT00818454|324960|P3|COMPLETED|Washout Period of 1 Week||0
141744|NCT00818454|324961|P2|COMPLETED|Washout Period of 1 Week||107
141745|NCT00818454|324962|P1|COMPLETED|Washout Period of 1 Week||108
141746|NCT00818454|324959|P4|STARTED|Washout Period of 1 Week||0
141747|NCT00818454|324960|P3|STARTED|Washout Period of 1 Week||0
141748|NCT00818454|324961|P2|STARTED|Washout Period of 1 Week||110
141749|NCT00818454|324962|P1|STARTED|Washout Period of 1 Week||112
141750|NCT00818454|324959|P4|NOT COMPLETED|Treatment Period 1||0
141751|NCT00818454|324960|P3|NOT COMPLETED|Treatment Period 1||0
141752|NCT00818454|324961|P2|NOT COMPLETED|Treatment Period 1||1
141753|NCT00818454|324962|P1|NOT COMPLETED|Treatment Period 1||3
141754|NCT00818454|324959|P4|COMPLETED|Treatment Period 1||0
141755|NCT00818454|324960|P3|COMPLETED|Treatment Period 1||0
141756|NCT00818454|324961|P2|COMPLETED|Treatment Period 1||110
141757|NCT00818454|324962|P1|COMPLETED|Treatment Period 1||112
141758|NCT00818454|324959|P4|STARTED|Treatment Period 1||0
141759|NCT00818454|324960|P3|STARTED|Treatment Period 1||0
141760|NCT00818454|324961|P2|STARTED|Treatment Period 1||111
141761|NCT00818454|324962|P1|STARTED|Treatment Period 1||115
141762|NCT00818441|324990|P2|NOT COMPLETED|Overall Study||30
141763|NCT00818441|324991|P1|NOT COMPLETED|Overall Study||89
141764|NCT00818441|324990|P2|COMPLETED|Overall Study||0
141765|NCT00818441|324991|P1|COMPLETED|Overall Study||0
141766|NCT00818441|324990|P2|STARTED|Overall Study||30
141767|NCT00818441|324991|P1|STARTED|Overall Study||89
141768|NCT00818389|325013|P2|NOT COMPLETED|Overall Study||6
141769|NCT00818389|325014|P1|NOT COMPLETED|Overall Study||4
141770|NCT00818389|325013|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
141771|NCT00818389|325014|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
141772|NCT00818389|325013|P2|STARTED|Overall Study||44
141773|NCT00818389|325014|P1|STARTED|Overall Study||40
141774|NCT00818337|325024|P1|NOT COMPLETED|Overall Study||0
141775|NCT00818337|325024|P1|COMPLETED|Overall Study||36
141776|NCT00818337|325024|P1|STARTED|Overall Study||36
141777|NCT00818324|325029|P1|NOT COMPLETED|Overall Study||27
141778|NCT00818324|325029|P1|COMPLETED|Overall Study||127
141779|NCT00818324|325029|P1|STARTED|Overall Study||154
141780|NCT00818272|325034|P1|NOT COMPLETED|Overall Study||74
141781|NCT00818272|325034|P1|COMPLETED|Overall Study||74
141782|NCT00818272|325034|P1|STARTED|Overall Study||148
141783|NCT00818259|325049|P9|NOT COMPLETED|Part V||0
141784|NCT00818259|325050|P8|NOT COMPLETED|Part V||1
141785|NCT00818259|325051|P7|NOT COMPLETED|Part V||0
141786|NCT00818259|325052|P6|NOT COMPLETED|Part V||0
141787|NCT00818259|325053|P5|NOT COMPLETED|Part V||0
141788|NCT00818259|325054|P4|NOT COMPLETED|Part V||0
141789|NCT00818259|325055|P3|NOT COMPLETED|Part V||0
141790|NCT00818259|325056|P2|NOT COMPLETED|Part V||0
141791|NCT00818259|325057|P1|NOT COMPLETED|Part V||0
141792|NCT00818259|325049|P9|COMPLETED|Part V||6
141793|NCT00818259|325050|P8|COMPLETED|Part V||16
141794|NCT00818259|325051|P7|COMPLETED|Part V||0
141795|NCT00818259|325052|P6|COMPLETED|Part V||0
141796|NCT00818259|325053|P5|COMPLETED|Part V||0
141797|NCT00818259|325054|P4|COMPLETED|Part V||0
141798|NCT00818259|325055|P3|COMPLETED|Part V||0
141799|NCT00818259|325056|P2|COMPLETED|Part V||0
141800|NCT00818259|325057|P1|COMPLETED|Part V||0
141801|NCT00818259|325049|P9|STARTED|Part V|Newly enrolled participants|6
141802|NCT00818259|325050|P8|STARTED|Part V|Participants continuing from Part IV|17
141803|NCT00818259|325051|P7|STARTED|Part V||0
141804|NCT00818259|325052|P6|STARTED|Part V||0
141805|NCT00818259|325053|P5|STARTED|Part V||0
141806|NCT00818259|325054|P4|STARTED|Part V||0
141807|NCT00818259|325055|P3|STARTED|Part V||0
141808|NCT00818259|325056|P2|STARTED|Part V||0
141809|NCT00818259|325057|P1|STARTED|Part V||0
141810|NCT00818259|325049|P9|NOT COMPLETED|Part IV||0
141811|NCT00818259|325050|P8|NOT COMPLETED|Part IV||0
141812|NCT00818259|325051|P7|NOT COMPLETED|Part IV||0
141813|NCT00818259|325052|P6|NOT COMPLETED|Part IV||1
141814|NCT00818259|325053|P5|NOT COMPLETED|Part IV||0
141815|NCT00818259|325054|P4|NOT COMPLETED|Part IV||0
141816|NCT00818259|325055|P3|NOT COMPLETED|Part IV||0
141817|NCT00818259|325056|P2|NOT COMPLETED|Part IV||0
141818|NCT00818259|325057|P1|NOT COMPLETED|Part IV||0
141819|NCT00818259|325049|P9|COMPLETED|Part IV||0
141820|NCT00818259|325050|P8|COMPLETED|Part IV||0
141821|NCT00818259|325051|P7|COMPLETED|Part IV||5
141822|NCT00818259|325052|P6|COMPLETED|Part IV||14
141823|NCT00818259|325053|P5|COMPLETED|Part IV||0
141824|NCT00818259|325054|P4|COMPLETED|Part IV||0
141825|NCT00818259|325055|P3|COMPLETED|Part IV||0
141826|NCT00818259|325056|P2|COMPLETED|Part IV||0
141827|NCT00818259|325057|P1|COMPLETED|Part IV||0
141828|NCT00818259|325049|P9|STARTED|Part IV||0
141829|NCT00818259|325050|P8|STARTED|Part IV||0
141830|NCT00818259|325051|P7|STARTED|Part IV|Newly enrolled participants|5
141831|NCT00818259|325052|P6|STARTED|Part IV|Participants continuing from Part III|15
141832|NCT00818259|325053|P5|STARTED|Part IV||0
141833|NCT00818259|325054|P4|STARTED|Part IV||0
141834|NCT00818259|325055|P3|STARTED|Part IV||0
141835|NCT00818259|325056|P2|STARTED|Part IV||0
141836|NCT00818259|325057|P1|STARTED|Part IV||0
141837|NCT00818259|325049|P9|NOT COMPLETED|Part III||0
141838|NCT00818259|325050|P8|NOT COMPLETED|Part III||0
141839|NCT00818259|325051|P7|NOT COMPLETED|Part III||0
141840|NCT00818259|325052|P6|NOT COMPLETED|Part III||0
141841|NCT00818259|325053|P5|NOT COMPLETED|Part III||0
141842|NCT00818259|325054|P4|NOT COMPLETED|Part III||0
141843|NCT00818259|325055|P3|NOT COMPLETED|Part III||0
141844|NCT00818259|325056|P2|NOT COMPLETED|Part III||0
141845|NCT00818259|325057|P1|NOT COMPLETED|Part III||0
141846|NCT00818259|325049|P9|COMPLETED|Part III||0
141847|NCT00818259|325050|P8|COMPLETED|Part III||0
141848|NCT00818259|325051|P7|COMPLETED|Part III||0
141849|NCT00818259|325052|P6|COMPLETED|Part III||0
141850|NCT00818259|325053|P5|COMPLETED|Part III||19
141851|NCT00818259|325054|P4|COMPLETED|Part III||0
141852|NCT00818259|325055|P3|COMPLETED|Part III||0
141853|NCT00818259|325056|P2|COMPLETED|Part III||0
141854|NCT00818259|325057|P1|COMPLETED|Part III||0
141855|NCT00818259|325049|P9|STARTED|Part III||0
141856|NCT00818259|325050|P8|STARTED|Part III||0
141857|NCT00818259|325051|P7|STARTED|Part III||0
141858|NCT00818259|325052|P6|STARTED|Part III||0
141859|NCT00818259|325053|P5|STARTED|Part III|Newly enrolled participants|19
141860|NCT00818259|325054|P4|STARTED|Part III||0
141861|NCT00818259|325055|P3|STARTED|Part III||0
141862|NCT00818259|325056|P2|STARTED|Part III||0
141863|NCT00818259|325057|P1|STARTED|Part III||0
141864|NCT00818259|325049|P9|NOT COMPLETED|Part II||0
141865|NCT00818259|325050|P8|NOT COMPLETED|Part II||0
141866|NCT00818259|325051|P7|NOT COMPLETED|Part II||0
141867|NCT00818259|325052|P6|NOT COMPLETED|Part II||0
141868|NCT00818259|325053|P5|NOT COMPLETED|Part II||0
141869|NCT00818259|325054|P4|NOT COMPLETED|Part II||2
141870|NCT00818259|325055|P3|NOT COMPLETED|Part II||1
141871|NCT00818259|325056|P2|NOT COMPLETED|Part II||0
141872|NCT00818259|325057|P1|NOT COMPLETED|Part II||0
141873|NCT00818259|325049|P9|COMPLETED|Part II||0
141874|NCT00818259|325050|P8|COMPLETED|Part II||0
141875|NCT00818259|325051|P7|COMPLETED|Part II||0
141876|NCT00818259|325052|P6|COMPLETED|Part II||0
141877|NCT00818259|325053|P5|COMPLETED|Part II||0
141878|NCT00818259|325054|P4|COMPLETED|Part II||18
141879|NCT00818259|325055|P3|COMPLETED|Part II||18
141880|NCT00818259|325056|P2|COMPLETED|Part II||0
141881|NCT00818259|325057|P1|COMPLETED|Part II||0
141882|NCT00818259|325049|P9|Treated|Part II||0
141883|NCT00818259|325050|P8|Treated|Part II||0
141884|NCT00818259|325051|P7|Treated|Part II||0
141885|NCT00818259|325052|P6|Treated|Part II||0
141886|NCT00818259|325053|P5|Treated|Part II||0
141887|NCT00818259|325054|P4|Treated|Part II||19
141888|NCT00818259|325055|P3|Treated|Part II||19
141889|NCT00818259|325056|P2|Treated|Part II||0
141890|NCT00818259|325057|P1|Treated|Part II||0
141891|NCT00818259|325049|P9|STARTED|Part II||0
141892|NCT00818259|325050|P8|STARTED|Part II||0
141893|NCT00818259|325051|P7|STARTED|Part II||0
141894|NCT00818259|325052|P6|STARTED|Part II||0
141895|NCT00818259|325053|P5|STARTED|Part II||0
141896|NCT00818259|325054|P4|STARTED|Part II|Newly enrolled participants|20
141897|NCT00818259|325055|P3|STARTED|Part II|Newly enrolled participants|19
141898|NCT00818259|325056|P2|STARTED|Part II||0
141899|NCT00818259|325057|P1|STARTED|Part II||0
141900|NCT00818259|325049|P9|NOT COMPLETED|Part I||0
141901|NCT00818259|325050|P8|NOT COMPLETED|Part I||0
141902|NCT00818259|325051|P7|NOT COMPLETED|Part I||0
141903|NCT00818259|325052|P6|NOT COMPLETED|Part I||0
141904|NCT00818259|325053|P5|NOT COMPLETED|Part I||0
141905|NCT00818259|325054|P4|NOT COMPLETED|Part I||0
141906|NCT00818259|325055|P3|NOT COMPLETED|Part I||0
141907|NCT00818259|325056|P2|NOT COMPLETED|Part I||0
141908|NCT00818259|325057|P1|NOT COMPLETED|Part I||1
141909|NCT00818259|325049|P9|COMPLETED|Part I||0
141910|NCT00818259|325050|P8|COMPLETED|Part I||0
141911|NCT00818259|325051|P7|COMPLETED|Part I||0
141912|NCT00818259|325052|P6|COMPLETED|Part I||0
141913|NCT00818259|325053|P5|COMPLETED|Part I||0
141914|NCT00818259|325054|P4|COMPLETED|Part I||0
141915|NCT00818259|325055|P3|COMPLETED|Part I||0
141916|NCT00818259|325056|P2|COMPLETED|Part I||11
141917|NCT00818259|325057|P1|COMPLETED|Part I||11
141918|NCT00818259|325049|P9|STARTED|Part I||0
141919|NCT00818259|325050|P8|STARTED|Part I||0
141920|NCT00818259|325051|P7|STARTED|Part I||0
141921|NCT00818259|325052|P6|STARTED|Part I||0
141922|NCT00818259|325053|P5|STARTED|Part I||0
141923|NCT00818259|325054|P4|STARTED|Part I||0
141924|NCT00818259|325055|P3|STARTED|Part I||0
141925|NCT00818259|325056|P2|STARTED|Part I|Newly enrolled participants|11
141926|NCT00818259|325057|P1|STARTED|Part I|Newly enrolled participants|12
141927|NCT00818259|325049|P9|NOT COMPLETED|Randomization||0
141928|NCT00818259|325050|P8|NOT COMPLETED|Randomization||0
141929|NCT00818259|325051|P7|NOT COMPLETED|Randomization||0
141930|NCT00818259|325052|P6|NOT COMPLETED|Randomization||0
141931|NCT00818259|325053|P5|NOT COMPLETED|Randomization||0
141932|NCT00818259|325054|P4|NOT COMPLETED|Randomization||0
141933|NCT00818259|325055|P3|NOT COMPLETED|Randomization||0
141934|NCT00818259|325056|P2|NOT COMPLETED|Randomization||0
141935|NCT00818259|325057|P1|NOT COMPLETED|Randomization||0
141936|NCT00818259|325049|P9|COMPLETED|Randomization||6
141937|NCT00818259|325050|P8|COMPLETED|Randomization||0
141938|NCT00818259|325051|P7|COMPLETED|Randomization||5
141939|NCT00818259|325052|P6|COMPLETED|Randomization||0
141940|NCT00818259|325053|P5|COMPLETED|Randomization||19
141941|NCT00818259|325054|P4|COMPLETED|Randomization||20
141942|NCT00818259|325055|P3|COMPLETED|Randomization||19
141943|NCT00818259|325056|P2|COMPLETED|Randomization||11
141944|NCT00818259|325057|P1|COMPLETED|Randomization||12
141945|NCT00818259|325049|P9|STARTED|Randomization||6
141946|NCT00818259|325050|P8|STARTED|Randomization||0
141947|NCT00818259|325051|P7|STARTED|Randomization||5
141948|NCT00818259|325052|P6|STARTED|Randomization||0
141949|NCT00818259|325053|P5|STARTED|Randomization||19
141950|NCT00818259|325054|P4|STARTED|Randomization||20
141951|NCT00818259|325055|P3|STARTED|Randomization||19
141952|NCT00818259|325056|P2|STARTED|Randomization||11
141953|NCT00818259|325057|P1|STARTED|Randomization||12
141954|NCT00818246|325129|P1|NOT COMPLETED|Overall Study||5
141955|NCT00818246|325129|P1|COMPLETED|Overall Study|split-face study|35
141956|NCT00818246|325129|P1|STARTED|Overall Study||40
141957|NCT00818207|325138|P2|NOT COMPLETED|Overall Study||267
141958|NCT00818207|325139|P1|NOT COMPLETED|Overall Study||222
141959|NCT00818207|325138|P2|COMPLETED|Overall Study||417
141960|NCT00818207|325139|P1|COMPLETED|Overall Study||474
141961|NCT00818207|325138|P2|STARTED|Overall Study||684
141962|NCT00818207|325139|P1|STARTED|Overall Study||696
141963|NCT00818168|325153|P1|NOT COMPLETED|Overall Study||70
141964|NCT00818168|325153|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
141965|NCT00818168|325153|P1|STARTED|Overall Study||320
141966|NCT00818116|325161|P1|NOT COMPLETED|Overall Study||0
141967|NCT00818116|325161|P1|COMPLETED|Overall Study||34
141968|NCT00818116|325161|P1|STARTED|Overall Study||34
141969|NCT00817999|325167|P2|NOT COMPLETED|No Grapefruit Juice||0
141970|NCT00817999|325168|P1|NOT COMPLETED|No Grapefruit Juice||0
141971|NCT00817999|325167|P2|COMPLETED|No Grapefruit Juice||17
141972|NCT00817999|325168|P1|COMPLETED|No Grapefruit Juice||15
141973|NCT00817999|325167|P2|STARTED|No Grapefruit Juice||17
141974|NCT00817999|325168|P1|STARTED|No Grapefruit Juice||15
141975|NCT00817999|325167|P2|NOT COMPLETED|Grapefruit Juice||0
141976|NCT00817999|325168|P1|NOT COMPLETED|Grapefruit Juice||0
141977|NCT00817999|325167|P2|COMPLETED|Grapefruit Juice||17
141978|NCT00817999|325168|P1|COMPLETED|Grapefruit Juice||15
141979|NCT00817999|325167|P2|STARTED|Grapefruit Juice||17
141980|NCT00817999|325168|P1|STARTED|Grapefruit Juice||15
141981|NCT00817843|325176|P2|NOT COMPLETED|Second Period (6 Weeks)||1
141982|NCT00817843|325177|P1|NOT COMPLETED|Second Period (6 Weeks)||0
141983|NCT00817843|325176|P2|COMPLETED|Second Period (6 Weeks)||44
141984|NCT00817843|325177|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
141985|NCT00817843|325176|P2|STARTED|Second Period (6 Weeks)||45
141986|NCT00817843|325177|P1|STARTED|Second Period (6 Weeks)||41
141987|NCT00817843|325176|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
141988|NCT00817843|325177|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
141989|NCT00817843|325176|P2|COMPLETED|Washout Period (6 Weeks)||45
141990|NCT00817843|325177|P1|COMPLETED|Washout Period (6 Weeks)||41
141991|NCT00817843|325176|P2|STARTED|Washout Period (6 Weeks)||46
141992|NCT00817843|325177|P1|STARTED|Washout Period (6 Weeks)||42
141993|NCT00817843|325176|P2|NOT COMPLETED|First Period (6 Weeks)||4
141994|NCT00817843|325177|P1|NOT COMPLETED|First Period (6 Weeks)||8
141995|NCT00817843|325176|P2|COMPLETED|First Period (6 Weeks)||46
141996|NCT00817843|325177|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
141997|NCT00817843|325176|P2|STARTED|First Period (6 Weeks)||50
141998|NCT00817843|325177|P1|STARTED|First Period (6 Weeks)||50
141999|NCT00817804|325184|P2|NOT COMPLETED|Overall Study||0
142000|NCT00817804|325185|P1|NOT COMPLETED|Overall Study||0
142001|NCT00817804|325184|P2|COMPLETED|Overall Study||2
142002|NCT00817804|325185|P1|COMPLETED|Overall Study||1
142003|NCT00817804|325184|P2|STARTED|Overall Study||2
142004|NCT00817804|325185|P1|STARTED|Overall Study||1
142005|NCT00817778|325193|P2|NOT COMPLETED|Overall Study||3
142006|NCT00817778|325194|P1|NOT COMPLETED|Overall Study||3
142007|NCT00817778|325193|P2|COMPLETED|Overall Study||5
142008|NCT00817778|325194|P1|COMPLETED|Overall Study||16
142009|NCT00817778|325193|P2|STARTED|Overall Study||8
142010|NCT00817778|325194|P1|STARTED|Overall Study||19
142011|NCT00817596|325219|P1|NOT COMPLETED|Overall Study||48
142012|NCT00817596|325219|P1|COMPLETED|Overall Study||62
142013|NCT00817596|325219|P1|STARTED|Overall Study||110
142014|NCT00817531|325223|P1|NOT COMPLETED|Overall Study||2
142015|NCT00817531|325223|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
142016|NCT00817531|325223|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
142017|NCT00817479|325229|P2|NOT COMPLETED|Overall Study||1
142018|NCT00817479|325230|P1|NOT COMPLETED|Overall Study||1
142019|NCT00817479|325229|P2|COMPLETED|Overall Study||13
142020|NCT00817479|325230|P1|COMPLETED|Overall Study||5
142021|NCT00817479|325229|P2|STARTED|Overall Study||14
142022|NCT00817479|325230|P1|STARTED|Overall Study||6
142023|NCT00817219|325238|P1|NOT COMPLETED|Overall Study||0
142024|NCT00817219|325238|P1|COMPLETED|Overall Study||33
142025|NCT00817219|325238|P1|STARTED|Overall Study||33
142026|NCT00817206|325253|P2|NOT COMPLETED|Overall Study||9
142027|NCT00817206|325254|P1|NOT COMPLETED|Overall Study||21
142028|NCT00817206|325253|P2|COMPLETED|Overall Study||154
142029|NCT00817206|325254|P1|COMPLETED|Overall Study||142
142030|NCT00817206|325253|P2|STARTED|Overall Study||163
142031|NCT00817206|325254|P1|STARTED|Overall Study||163
142032|NCT00816907|325262|P2|NOT COMPLETED|Overall Study||17
142033|NCT00816907|325263|P1|NOT COMPLETED|Overall Study||13
142034|NCT00816907|325262|P2|COMPLETED|Overall Study||58
142035|NCT00816907|325263|P1|COMPLETED|Overall Study||58
142036|NCT00816907|325262|P2|STARTED|Overall Study||75
142037|NCT00816907|325263|P1|STARTED|Overall Study||71
142038|NCT00816829|325285|P2|NOT COMPLETED|Overall Study||0
142039|NCT00816829|325286|P1|NOT COMPLETED|Overall Study||0
142040|NCT00816829|325285|P2|COMPLETED|Overall Study||18
142041|NCT00816829|325286|P1|COMPLETED|Overall Study||16
142042|NCT00816829|325285|P2|STARTED|Overall Study||18
142043|NCT00816829|325286|P1|STARTED|Overall Study||16
142044|NCT00816777|325312|P2|NOT COMPLETED|Overall Study||0
142045|NCT00816777|325313|P1|NOT COMPLETED|Overall Study||0
142046|NCT00816777|325312|P2|COMPLETED|Overall Study||2
142047|NCT00816777|325313|P1|COMPLETED|Overall Study||2
142048|NCT00816777|325312|P2|STARTED|Overall Study||2
142049|NCT00816777|325313|P1|STARTED|Overall Study||2
142050|NCT00816595|325321|P2|NOT COMPLETED|Overall Study||0
142051|NCT00816595|325322|P1|NOT COMPLETED|Overall Study||2
142052|NCT00816595|325321|P2|COMPLETED|Overall Study||33
142053|NCT00816595|325322|P1|COMPLETED|Overall Study||33
142054|NCT00816595|325321|P2|STARTED|Overall Study||33
142055|NCT00816595|325322|P1|STARTED|Overall Study||35
142056|NCT00816556|325335|P3|NOT COMPLETED|Overall Study||3
142057|NCT00816556|325336|P2|NOT COMPLETED|Overall Study||2
142058|NCT00816556|325337|P1|NOT COMPLETED|Overall Study||2
142059|NCT00816556|325335|P3|COMPLETED|Overall Study||19
142060|NCT00816556|325336|P2|COMPLETED|Overall Study||19
142061|NCT00816556|325337|P1|COMPLETED|Overall Study||18
142062|NCT00816556|325335|P3|STARTED|Overall Study||22
142063|NCT00816556|325336|P2|STARTED|Overall Study||21
142064|NCT00816556|325337|P1|STARTED|Overall Study||20
142065|NCT00816348|325351|P1|NOT COMPLETED|Overall Study||0
142066|NCT00816348|325351|P1|COMPLETED|Overall Study||15
142067|NCT00816348|325351|P1|STARTED|Overall Study||15
142068|NCT00816166|325357|P2|NOT COMPLETED|Overall Study||12
142069|NCT00816166|325358|P1|NOT COMPLETED|Overall Study||10
142070|NCT00816166|325357|P2|COMPLETED|Overall Study||41
142071|NCT00816166|325358|P1|COMPLETED|Overall Study||49
142072|NCT00816166|325357|P2|ITT Population (Met Eligibility)|Overall Study||53
142073|NCT00816166|325358|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
142074|NCT00816166|325357|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
142075|NCT00816166|325358|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
142076|NCT00816101|325367|P3|NOT COMPLETED|Overall Study||0
142077|NCT00816101|325368|P2|NOT COMPLETED|Overall Study||0
142078|NCT00816101|325369|P1|NOT COMPLETED|Overall Study||0
142079|NCT00816101|325367|P3|COMPLETED|Overall Study||5
142080|NCT00816101|325368|P2|COMPLETED|Overall Study||8
142081|NCT00816101|325369|P1|COMPLETED|Overall Study||13
142082|NCT00816101|325367|P3|STARTED|Overall Study||5
142083|NCT00816101|325368|P2|STARTED|Overall Study||8
142084|NCT00816101|325369|P1|STARTED|Overall Study||13
142085|NCT00816036|325385|P2|NOT COMPLETED|Overall Study||108
142086|NCT00816036|325386|P1|NOT COMPLETED|Overall Study||176
142087|NCT00816036|325385|P2|COMPLETED|Overall Study||287
142088|NCT00816036|325386|P1|COMPLETED|Overall Study||327
142089|NCT00816036|325385|P2|STARTED|Overall Study||395
142090|NCT00816036|325386|P1|STARTED|Overall Study||503
142091|NCT00816023|325400|P4|NOT COMPLETED|Overall Study||12
142092|NCT00816023|325401|P3|NOT COMPLETED|Overall Study||9
142093|NCT00816023|325402|P2|NOT COMPLETED|Overall Study||6
142094|NCT00816023|325403|P1|NOT COMPLETED|Overall Study||9
142095|NCT00816023|325400|P4|COMPLETED|Overall Study||62
142096|NCT00816023|325401|P3|COMPLETED|Overall Study||60
142097|NCT00816023|325402|P2|COMPLETED|Overall Study||56
142098|NCT00816023|325403|P1|COMPLETED|Overall Study||62
142099|NCT00816023|325400|P4|Completed Therapy|Overall Study||63
142100|NCT00816023|325401|P3|Completed Therapy|Overall Study||61
142101|NCT00816023|325402|P2|Completed Therapy|Overall Study||59
142102|NCT00816023|325403|P1|Completed Therapy|Overall Study||65
142103|NCT00816023|325400|P4|STARTED|Overall Study||74
142104|NCT00816023|325401|P3|STARTED|Overall Study||69
142105|NCT00816023|325402|P2|STARTED|Overall Study||62
142106|NCT00816023|325403|P1|STARTED|Overall Study||71
142107|NCT00815919|325417|P1|NOT COMPLETED|Overall Study||4
142108|NCT00815919|325417|P1|COMPLETED|Overall Study||18
142109|NCT00815919|325417|P1|STARTED|Overall Study||22
142110|NCT00815776|325428|P3|NOT COMPLETED|Overall Study||6
142111|NCT00815776|325429|P2|NOT COMPLETED|Overall Study||8
142112|NCT00815776|325430|P1|NOT COMPLETED|Overall Study||8
142113|NCT00815776|325428|P3|COMPLETED|Overall Study||22
142114|NCT00815776|325429|P2|COMPLETED|Overall Study||56
142115|NCT00815776|325430|P1|COMPLETED|Overall Study||52
142116|NCT00815776|325428|P3|STARTED|Overall Study||28
142117|NCT00815776|325429|P2|STARTED|Overall Study||64
142118|NCT00815776|325430|P1|STARTED|Overall Study||60
142119|NCT00815698|325446|P2|NOT COMPLETED|Overall Study||0
142120|NCT00815698|325447|P1|NOT COMPLETED|Overall Study||0
142121|NCT00815698|325446|P2|COMPLETED|Overall Study||171
142122|NCT00815698|325447|P1|COMPLETED|Overall Study||163
142123|NCT00815698|325446|P2|STARTED|Overall Study||171
142124|NCT00815698|325447|P1|STARTED|Overall Study||163
142125|NCT00815685|325455|P1|NOT COMPLETED|Overall Study||22
142126|NCT00815685|325455|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
142127|NCT00815685|325455|P1|STARTED|Overall Study||36
142128|NCT00815659|325460|P1|NOT COMPLETED|Overall Study||23
142129|NCT00815659|325460|P1|COMPLETED|Overall Study||74
142130|NCT00815659|325460|P1|STARTED|Overall Study||97
142131|NCT00814892|325503|P1|NOT COMPLETED|Overall Study||2
142132|NCT00814892|325503|P1|COMPLETED|Overall Study||0
142133|NCT00814892|325503|P1|STARTED|Overall Study||2
142134|NCT00814879|325515|P2|NOT COMPLETED|By Week 48||3
142135|NCT00814879|325516|P1|NOT COMPLETED|By Week 48||2
142136|NCT00814879|325515|P2|COMPLETED|By Week 48||26
142137|NCT00814879|325516|P1|COMPLETED|By Week 48||25
142138|NCT00814879|325515|P2|STARTED|By Week 48||29
142139|NCT00814879|325516|P1|STARTED|By Week 48||27
142140|NCT00814879|325515|P2|NOT COMPLETED|By Week 24||1
142141|NCT00814879|325516|P1|NOT COMPLETED|By Week 24||1
142142|NCT00814879|325515|P2|COMPLETED|By Week 24||29
142143|NCT00814879|325516|P1|COMPLETED|By Week 24||27
142144|NCT00814879|325515|P2|STARTED|By Week 24||30
142145|NCT00814879|325516|P1|STARTED|By Week 24||28
142146|NCT00814801|325535|P3|NOT COMPLETED|Overall Study||43
142147|NCT00814801|325536|P2|NOT COMPLETED|Overall Study||38
142148|NCT00814801|325537|P1|NOT COMPLETED|Overall Study||34
142149|NCT00814801|325535|P3|COMPLETED|Overall Study||151
142150|NCT00814801|325536|P2|COMPLETED|Overall Study||154
142151|NCT00814801|325537|P1|COMPLETED|Overall Study||160
142152|NCT00814801|325535|P3|STARTED|Overall Study||194
142153|NCT00814801|325536|P2|STARTED|Overall Study||192
142154|NCT00814801|325537|P1|STARTED|Overall Study||194
142155|NCT00814775|325559|P2|NOT COMPLETED|Overall Study||0
142156|NCT00814775|325560|P1|NOT COMPLETED|Overall Study||0
142157|NCT00814775|325559|P2|COMPLETED|Overall Study||20
142158|NCT00814775|325560|P1|COMPLETED|Overall Study||23
142159|NCT00814775|325559|P2|STARTED|Overall Study||20
142160|NCT00814775|325560|P1|STARTED|Overall Study||23
142161|NCT00814710|325570|P2|NOT COMPLETED|Overall Study||3
142162|NCT00814710|325571|P1|NOT COMPLETED|Overall Study||8
142163|NCT00814710|325570|P2|COMPLETED|Overall Study||117
142164|NCT00814710|325571|P1|COMPLETED|Overall Study||232
142165|NCT00814710|325570|P2|STARTED|Overall Study||120
142166|NCT00814710|325571|P1|STARTED|Overall Study||240
142167|NCT00814697|325609|P1|NOT COMPLETED|Overall Study||0
142168|NCT00814697|325609|P1|COMPLETED|Overall Study||12
142169|NCT00814697|325609|P1|STARTED|Overall Study||12
142170|NCT00814671|325616|P3|NOT COMPLETED|Overall Study||2
142171|NCT00814671|325617|P2|NOT COMPLETED|Overall Study||4
142172|NCT00814671|325618|P1|NOT COMPLETED|Overall Study||7
142173|NCT00814671|325616|P3|COMPLETED|Overall Study||49
142174|NCT00814671|325617|P2|COMPLETED|Overall Study||44
142175|NCT00814671|325618|P1|COMPLETED|Overall Study||47
142176|NCT00814671|325616|P3|STARTED|Overall Study||51
142177|NCT00814671|325617|P2|STARTED|Overall Study||48
142178|NCT00814671|325618|P1|STARTED|Overall Study||54
142179|NCT00814658|325631|P2|NOT COMPLETED|Overall Study||4
142180|NCT00814658|325632|P1|NOT COMPLETED|Overall Study||4
142181|NCT00814658|325631|P2|COMPLETED|Overall Study||8
142182|NCT00814658|325632|P1|COMPLETED|Overall Study||5
142183|NCT00814658|325631|P2|STARTED|Overall Study||12
142184|NCT00814658|325632|P1|STARTED|Overall Study||9
142185|NCT00815516|325700|P2|NOT COMPLETED|Overall Study||1
142186|NCT00815516|325701|P1|NOT COMPLETED|Overall Study||4
142187|NCT00815516|325700|P2|COMPLETED|Overall Study||9
142188|NCT00815516|325701|P1|COMPLETED|Overall Study||16
142189|NCT00815516|325700|P2|STARTED|Overall Study||10
142190|NCT00815516|325701|P1|STARTED|Overall Study||20
142191|NCT00815490|325732|P2|NOT COMPLETED|Overall Study||0
142192|NCT00815490|325733|P1|NOT COMPLETED|Overall Study||0
142193|NCT00815490|325732|P2|COMPLETED|Overall Study||9
142194|NCT00815490|325733|P1|COMPLETED|Overall Study||9
142195|NCT00815490|325732|P2|STARTED|Overall Study||9
142196|NCT00815490|325733|P1|STARTED|Overall Study||9
142197|NCT00815360|325741|P2|NOT COMPLETED|Overall Study||0
142198|NCT00815360|325742|P1|NOT COMPLETED|Overall Study||0
142199|NCT00815360|325741|P2|COMPLETED|Overall Study||11
142200|NCT00815360|325742|P1|COMPLETED|Overall Study||11
142201|NCT00815360|325741|P2|STARTED|Overall Study||11
142202|NCT00815360|325742|P1|STARTED|Overall Study||11
142203|NCT00815347|325750|P1|NOT COMPLETED|Overall Study||4
142204|NCT00815347|325750|P1|COMPLETED|Overall Study||7
142205|NCT00815347|325750|P1|STARTED|Overall Study||11
142206|NCT00815308|325766|P1|NOT COMPLETED|Overall Study||10
142207|NCT00815308|325766|P1|COMPLETED|Overall Study||45
142208|NCT00815308|325766|P1|STARTED|Overall Study||55
142209|NCT00815295|325775|P3|NOT COMPLETED|Overall Study||3
142210|NCT00815295|325776|P2|NOT COMPLETED|Overall Study||1
142211|NCT00815295|325777|P1|NOT COMPLETED|Overall Study||0
142212|NCT00815295|325775|P3|COMPLETED|Overall Study||9
142213|NCT00815295|325776|P2|COMPLETED|Overall Study||7
142214|NCT00815295|325777|P1|COMPLETED|Overall Study||8
142215|NCT00815295|325775|P3|STARTED|Overall Study||12
142216|NCT00815295|325776|P2|STARTED|Overall Study||8
142217|NCT00815295|325777|P1|STARTED|Overall Study||8
142218|NCT00815191|325789|P2|NOT COMPLETED|Overall Study||1
142219|NCT00815191|325790|P1|NOT COMPLETED|Overall Study||1
142220|NCT00815191|325789|P2|COMPLETED|Overall Study||34
142221|NCT00815191|325790|P1|COMPLETED|Overall Study||37
142222|NCT00815191|325789|P2|STARTED|Overall Study||35
142223|NCT00815191|325790|P1|STARTED|Overall Study||38
142224|NCT00815087|325798|P2|NOT COMPLETED|Overall Study||0
142225|NCT00815087|325799|P1|NOT COMPLETED|Overall Study||0
142226|NCT00815087|325798|P2|COMPLETED|Overall Study||10
142227|NCT00815087|325799|P1|COMPLETED|Overall Study||10
142228|NCT00815087|325798|P2|STARTED|Overall Study||10
142229|NCT00815087|325799|P1|STARTED|Overall Study||10
142230|NCT00814983|325807|P2|NOT COMPLETED|Overall Study||0
142231|NCT00814983|325808|P1|NOT COMPLETED|Overall Study||3
142232|NCT00814983|325807|P2|COMPLETED|Overall Study||0
142233|NCT00814983|325808|P1|COMPLETED|Overall Study||12
142234|NCT00814983|325807|P2|STARTED|Overall Study||0
142235|NCT00814983|325808|P1|STARTED|Overall Study||15
142236|NCT00814970|325818|P1|NOT COMPLETED|Overall Study||50
142237|NCT00814970|325818|P1|COMPLETED|Overall Study||146
142238|NCT00814970|325818|P1|STARTED|Overall Study||196
142239|NCT00814632|325839|P1|NOT COMPLETED|Overall Study||2
142240|NCT00814632|325839|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
142241|NCT00814632|325839|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
142242|NCT00814580|325845|P2|NOT COMPLETED|Overall Study||47
142243|NCT00814580|325846|P1|NOT COMPLETED|Overall Study||31
142244|NCT00814580|325845|P2|COMPLETED|Overall Study||141
142245|NCT00814580|325846|P1|COMPLETED|Overall Study||163
142246|NCT00814580|325845|P2|STARTED|Overall Study||188
142247|NCT00814580|325846|P1|STARTED|Overall Study||194
142248|NCT00814489|325977|P3|NOT COMPLETED|Overall Study||1
142249|NCT00814489|325978|P2|NOT COMPLETED|Overall Study||0
142250|NCT00814489|325979|P1|NOT COMPLETED|Overall Study||2
142251|NCT00814489|325977|P3|COMPLETED|Overall Study||7
142252|NCT00814489|325978|P2|COMPLETED|Overall Study||17
142253|NCT00814489|325979|P1|COMPLETED|Overall Study||13
142254|NCT00814489|325977|P3|STARTED|Overall Study||8
142255|NCT00814489|325978|P2|STARTED|Overall Study||17
142256|NCT00814489|325979|P1|STARTED|Overall Study||15
142257|NCT00814463|326011|P1|NOT COMPLETED|Overall Study||1
142258|NCT00814463|326011|P1|COMPLETED|Overall Study||0
142259|NCT00814463|326011|P1|STARTED|Overall Study||1
142260|NCT00814346|326017|P2|NOT COMPLETED|Open Phase (17 Months)||0
142261|NCT00814346|326018|P1|NOT COMPLETED|Open Phase (17 Months)||10
142262|NCT00814346|326017|P2|COMPLETED|Open Phase (17 Months)||0
142263|NCT00814346|326018|P1|COMPLETED|Open Phase (17 Months)||31
142264|NCT00814346|326017|P2|AD|Open Phase (17 Months)||0
142265|NCT00814346|326018|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
142266|NCT00814346|326017|P2|MC|Open Phase (17 Months)||0
142267|NCT00814346|326018|P1|MC|Open Phase (17 Months)||20
142268|NCT00814346|326017|P2|CNE|Open Phase (17 Months)||0
142269|NCT00814346|326018|P1|CNE|Open Phase (17 Months)||21
142270|NCT00814346|326017|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
142271|NCT00814346|326018|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
142272|NCT00814346|326017|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
142273|NCT00814346|326018|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
142274|NCT00814346|326017|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
142275|NCT00814346|326018|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
142276|NCT00814346|326017|P2|AD|Double-blind Phase (4 Weeks)||2
142277|NCT00814346|326018|P1|AD|Double-blind Phase (4 Weeks)||3
142278|NCT00814346|326017|P2|MC|Double-blind Phase (4 Weeks)||11
142279|NCT00814346|326018|P1|MC|Double-blind Phase (4 Weeks)||10
142280|NCT00814346|326017|P2|CNE|Double-blind Phase (4 Weeks)||13
142281|NCT00814346|326018|P1|CNE|Double-blind Phase (4 Weeks)||10
142282|NCT00814346|326017|P2|STARTED|Double-blind Phase (4 Weeks)||26
142283|NCT00814346|326018|P1|STARTED|Double-blind Phase (4 Weeks)||23
142284|NCT00814333|326084|P2|NOT COMPLETED|Treatment Period||0
142285|NCT00814333|326085|P1|NOT COMPLETED|Treatment Period||0
142286|NCT00814333|326084|P2|COMPLETED|Treatment Period||0
142287|NCT00814333|326085|P1|COMPLETED|Treatment Period||0
142288|NCT00814333|326084|P2|STARTED|Treatment Period||0
142289|NCT00814333|326085|P1|STARTED|Treatment Period||0
142290|NCT00814333|326084|P2|NOT COMPLETED|Enrollment||0
142291|NCT00814333|326085|P1|NOT COMPLETED|Enrollment||1
142292|NCT00814333|326084|P2|COMPLETED|Enrollment||0
142293|NCT00814333|326085|P1|COMPLETED|Enrollment||0
142294|NCT00814333|326084|P2|STARTED|Enrollment||0
142295|NCT00814333|326085|P1|STARTED|Enrollment||1
142296|NCT00814320|326093|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
142297|NCT00814320|326094|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
142298|NCT00814320|326093|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
142299|NCT00814320|326094|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
142300|NCT00814320|326093|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
142301|NCT00814320|326094|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
142302|NCT00814320|326093|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
142303|NCT00814320|326094|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
142304|NCT00814320|326093|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
142305|NCT00814320|326094|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
142306|NCT00814320|326093|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
142307|NCT00814320|326094|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
142308|NCT00814320|326093|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
142309|NCT00814320|326094|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
142310|NCT00814320|326093|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
142311|NCT00814320|326094|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
142312|NCT00814320|326093|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
142313|NCT00814320|326094|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
142314|NCT00814320|326093|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
142315|NCT00814320|326094|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
142316|NCT00814320|326093|P2|COMPLETED|Epoch 1 (IV Treatment)||71
142317|NCT00814320|326094|P1|COMPLETED|Epoch 1 (IV Treatment)||13
142318|NCT00814320|326093|P2|STARTED|Epoch 1 (IV Treatment)||73
142319|NCT00814320|326094|P1|STARTED|Epoch 1 (IV Treatment)||14
142320|NCT00814307|326226|P4|NOT COMPLETED|Overall Study||10
142321|NCT00814307|326227|P3|NOT COMPLETED|Overall Study||7
142322|NCT00814307|326228|P2|NOT COMPLETED|Overall Study||27
142323|NCT00814307|326229|P1|NOT COMPLETED|Overall Study||12
142324|NCT00814307|326226|P4|COMPLETED|Overall Study||51
142325|NCT00814307|326227|P3|COMPLETED|Overall Study||54
142326|NCT00814307|326228|P2|COMPLETED|Overall Study||218
142327|NCT00814307|326229|P1|COMPLETED|Overall Study||232
142328|NCT00814307|326226|P4|Treated|Overall Study||61
142329|NCT00814307|326227|P3|Treated|Overall Study||61
142330|NCT00814307|326228|P2|Treated|Overall Study||245
142331|NCT00814307|326229|P1|Treated|Overall Study||243
142332|NCT00814307|326226|P4|STARTED|Overall Study||61
142333|NCT00814307|326227|P3|STARTED|Overall Study||61
142334|NCT00814307|326228|P2|STARTED|Overall Study||245
142335|NCT00814307|326229|P1|STARTED|Overall Study||244
142336|NCT00814255|326394|P3|NOT COMPLETED|Overall Study||1
142337|NCT00814255|326395|P2|NOT COMPLETED|Overall Study||0
142338|NCT00814255|326396|P1|NOT COMPLETED|Overall Study||1
142339|NCT00814255|326394|P3|COMPLETED|Overall Study||7
142340|NCT00814255|326395|P2|COMPLETED|Overall Study||7
142341|NCT00814255|326396|P1|COMPLETED|Overall Study||7
142342|NCT00814255|326394|P3|STARTED|Overall Study||8
142343|NCT00814255|326395|P2|STARTED|Overall Study||7
142344|NCT00814255|326396|P1|STARTED|Overall Study||8
142345|NCT00814177|326418|P2|NOT COMPLETED|Overall Study||0
142346|NCT00814177|326419|P1|NOT COMPLETED|Overall Study||0
142347|NCT00814177|326418|P2|COMPLETED|Overall Study||80
142348|NCT00814177|326419|P1|COMPLETED|Overall Study||80
142349|NCT00814177|326418|P2|STARTED|Overall Study||80
142350|NCT00814177|326419|P1|STARTED|Overall Study||80
142351|NCT00814164|326425|P1|NOT COMPLETED|Overall Study||19
142352|NCT00814164|326425|P1|COMPLETED|Overall Study||2
142353|NCT00814164|326425|P1|STARTED|Overall Study||21
142354|NCT00814138|326438|P2|NOT COMPLETED|Overall Study||7
142355|NCT00814138|326439|P1|NOT COMPLETED|Overall Study||1
142356|NCT00814138|326438|P2|COMPLETED|Overall Study||18
142357|NCT00814138|326439|P1|COMPLETED|Overall Study||24
142358|NCT00814138|326438|P2|STARTED|Overall Study||25
142359|NCT00814138|326439|P1|STARTED|Overall Study||25
142360|NCT00813995|326459|P2|NOT COMPLETED|Overall Study||16
142361|NCT00813995|326460|P1|NOT COMPLETED|Overall Study||23
142362|NCT00813995|326459|P2|COMPLETED|Overall Study||182
142363|NCT00813995|326460|P1|COMPLETED|Overall Study||174
142364|NCT00813995|326459|P2|STARTED|Overall Study||198
142365|NCT00813995|326460|P1|STARTED|Overall Study||197
142366|NCT00813982|326474|P1|NOT COMPLETED|Overall Study||0
142367|NCT00813982|326474|P1|COMPLETED|Overall Study||59
142368|NCT00813982|326474|P1|STARTED|Overall Study||59
142369|NCT00813943|326483|P3|NOT COMPLETED|Overall Study||3
142370|NCT00813943|326484|P2|NOT COMPLETED|Overall Study||5
142371|NCT00813943|326485|P1|NOT COMPLETED|Overall Study||5
142372|NCT00813943|326483|P3|COMPLETED|Overall Study||86
142373|NCT00813943|326484|P2|COMPLETED|Overall Study||83
142374|NCT00813943|326485|P1|COMPLETED|Overall Study||83
142375|NCT00813943|326483|P3|STARTED|Overall Study||89
142376|NCT00813943|326484|P2|STARTED|Overall Study||88
142377|NCT00813943|326485|P1|STARTED|Overall Study||88
142378|NCT00813917|326515|P2|NOT COMPLETED|Overall Study||6
142379|NCT00813917|326516|P1|NOT COMPLETED|Overall Study||6
142380|NCT00813917|326515|P2|COMPLETED|Overall Study||32
142381|NCT00813917|326516|P1|COMPLETED|Overall Study||32
142382|NCT00813917|326515|P2|STARTED|Overall Study||38
142383|NCT00813917|326516|P1|STARTED|Overall Study||38
142384|NCT00813904|326522|P1|NOT COMPLETED|Overall Study||1
142385|NCT00813904|326522|P1|COMPLETED|Overall Study||30
142386|NCT00813904|326522|P1|STARTED|Overall Study||31
142387|NCT00813813|326530|P2|NOT COMPLETED|Overall Study||9
142388|NCT00813813|326531|P1|NOT COMPLETED|Overall Study||3
142389|NCT00813813|326530|P2|COMPLETED|Overall Study||16
142390|NCT00813813|326531|P1|COMPLETED|Overall Study||4
142391|NCT00813813|326530|P2|STARTED|Overall Study||25
142392|NCT00813813|326531|P1|STARTED|Overall Study||7
142393|NCT00813800|326547|P1|NOT COMPLETED|Overall Study||6
142394|NCT00813800|326547|P1|COMPLETED|Overall Study||5
142395|NCT00813800|326547|P1|STARTED|Overall Study||11
142396|NCT00813761|326555|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
142397|NCT00813761|326556|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
142398|NCT00813761|326557|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
142399|NCT00813761|326558|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
142400|NCT00813761|326555|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
142401|NCT00813761|326556|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
142402|NCT00813761|326557|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
142403|NCT00813761|326558|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
142404|NCT00813761|326555|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
142405|NCT00813761|326556|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
142406|NCT00813761|326557|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
142407|NCT00813761|326558|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
142408|NCT00813761|326555|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
142409|NCT00813761|326556|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
142410|NCT00813761|326557|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
142411|NCT00813761|326558|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
142412|NCT00813761|326555|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
142413|NCT00813761|326556|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
142414|NCT00813761|326557|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
142415|NCT00813761|326558|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
142416|NCT00813761|326555|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
142417|NCT00813761|326556|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
142418|NCT00813761|326557|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
142419|NCT00813761|326558|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
142420|NCT00813748|326608|P2|NOT COMPLETED|Skin Test Substudy||1
142421|NCT00813748|326609|P1|NOT COMPLETED|Skin Test Substudy||0
142422|NCT00813748|326608|P2|COMPLETED|Skin Test Substudy||7
142423|NCT00813748|326609|P1|COMPLETED|Skin Test Substudy||3
142424|NCT00813748|326608|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
142425|NCT00813748|326609|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
142426|NCT00813748|326608|P2|NOT COMPLETED|Main Observational Study||0
142427|NCT00813748|326609|P1|NOT COMPLETED|Main Observational Study||0
142428|NCT00813748|326608|P2|COMPLETED|Main Observational Study||88
142429|NCT00813748|326609|P1|COMPLETED|Main Observational Study||30
142430|NCT00813748|326608|P2|STARTED|Main Observational Study||88
142431|NCT00813748|326609|P1|STARTED|Main Observational Study||30
142432|NCT00813709|326638|P6|NOT COMPLETED|Open Label Period||11
142433|NCT00813709|326639|P5|NOT COMPLETED|Open Label Period||10
142434|NCT00813709|326640|P4|NOT COMPLETED|Open Label Period||20
142435|NCT00813709|326641|P3|NOT COMPLETED|Open Label Period||0
142436|NCT00813709|326642|P2|NOT COMPLETED|Open Label Period||0
142437|NCT00813709|326643|P1|NOT COMPLETED|Open Label Period||0
142438|NCT00813709|326638|P6|COMPLETED|Open Label Period||35
142439|NCT00813709|326639|P5|COMPLETED|Open Label Period||41
142440|NCT00813709|326640|P4|COMPLETED|Open Label Period||38
142441|NCT00813709|326641|P3|COMPLETED|Open Label Period||0
142442|NCT00813709|326642|P2|COMPLETED|Open Label Period||0
142443|NCT00813709|326643|P1|COMPLETED|Open Label Period||0
142444|NCT00813709|326638|P6|Treated|Open Label Period||45
142445|NCT00813709|326639|P5|Treated|Open Label Period||51
142446|NCT00813709|326640|P4|Treated|Open Label Period||57
142447|NCT00813709|326641|P3|Treated|Open Label Period||0
142448|NCT00813709|326642|P2|Treated|Open Label Period||0
142449|NCT00813709|326643|P1|Treated|Open Label Period||0
142450|NCT00813709|326638|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
142451|NCT00813709|326639|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
142452|NCT00813709|326640|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
142453|NCT00813709|326641|P3|STARTED|Open Label Period||0
142454|NCT00813709|326642|P2|STARTED|Open Label Period||0
142455|NCT00813709|326643|P1|STARTED|Open Label Period||0
142456|NCT00813709|326638|P6|NOT COMPLETED|Double Blind Period||0
142457|NCT00813709|326639|P5|NOT COMPLETED|Double Blind Period||0
142458|NCT00813709|326640|P4|NOT COMPLETED|Double Blind Period||0
142459|NCT00813709|326641|P3|NOT COMPLETED|Double Blind Period||31
142460|NCT00813709|326642|P2|NOT COMPLETED|Double Blind Period||41
142461|NCT00813709|326643|P1|NOT COMPLETED|Double Blind Period||31
142462|NCT00813709|326638|P6|COMPLETED|Double Blind Period||0
142463|NCT00813709|326639|P5|COMPLETED|Double Blind Period||0
142464|NCT00813709|326640|P4|COMPLETED|Double Blind Period||0
142465|NCT00813709|326641|P3|COMPLETED|Double Blind Period||68
142466|NCT00813709|326642|P2|COMPLETED|Double Blind Period||76
142467|NCT00813709|326643|P1|COMPLETED|Double Blind Period||53
142468|NCT00813709|326638|P6|Treated|Double Blind Period||0
142469|NCT00813709|326639|P5|Treated|Double Blind Period||0
142470|NCT00813709|326640|P4|Treated|Double Blind Period||0
142471|NCT00813709|326641|P3|Treated|Double Blind Period||98
142472|NCT00813709|326642|P2|Treated|Double Blind Period||114
142473|NCT00813709|326643|P1|Treated|Double Blind Period||83
142474|NCT00813709|326638|P6|STARTED|Double Blind Period||0
142475|NCT00813709|326639|P5|STARTED|Double Blind Period||0
142476|NCT00813709|326640|P4|STARTED|Double Blind Period||0
142477|NCT00813709|326641|P3|STARTED|Double Blind Period||99
142478|NCT00813709|326642|P2|STARTED|Double Blind Period||117
142479|NCT00813709|326643|P1|STARTED|Double Blind Period||84
142480|NCT00813592|326723|P1|NOT COMPLETED|Overall Study||2
142481|NCT00813592|326723|P1|COMPLETED|Overall Study||0
142482|NCT00813592|326723|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
142483|NCT00813592|326723|P1|Treated|Overall Study|Two patients were treated.|2
142484|NCT00813592|326723|P1|STARTED|Overall Study||2
142485|NCT00813488|326732|P2|NOT COMPLETED|Open-label Extension||7
142486|NCT00813488|326733|P1|NOT COMPLETED|Open-label Extension||12
142487|NCT00813488|326732|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
142488|NCT00813488|326733|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
142489|NCT00813488|326732|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
142490|NCT00813488|326733|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
142491|NCT00813488|326732|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
142492|NCT00813488|326733|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
142493|NCT00813488|326732|P2|COMPLETED|Double-blind Treatment Period 2||65
142494|NCT00813488|326733|P1|COMPLETED|Double-blind Treatment Period 2||66
142495|NCT00813488|326732|P2|STARTED|Double-blind Treatment Period 2||66
142496|NCT00813488|326733|P1|STARTED|Double-blind Treatment Period 2||71
142497|NCT00813488|326732|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
142498|NCT00813488|326733|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
142499|NCT00813488|326732|P2|COMPLETED|Double-blind Treatment Period 1||66
142500|NCT00813488|326733|P1|COMPLETED|Double-blind Treatment Period 1||71
142501|NCT00813488|326732|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
142502|NCT00813488|326733|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
142503|NCT00813488|326732|P2|NOT COMPLETED|Titration Period 2||10
142504|NCT00813488|326733|P1|NOT COMPLETED|Titration Period 2||16
142505|NCT00813488|326732|P2|COMPLETED|Titration Period 2||79
142506|NCT00813488|326733|P1|COMPLETED|Titration Period 2||64
142507|NCT00813488|326732|P2|STARTED|Titration Period 2||89
142508|NCT00813488|326733|P1|STARTED|Titration Period 2||80
142509|NCT00813488|326732|P2|NOT COMPLETED|Titration Period 1||17
142510|NCT00813488|326733|P1|NOT COMPLETED|Titration Period 1||27
142511|NCT00813488|326732|P2|COMPLETED|Titration Period 1||89
142512|NCT00813488|326733|P1|COMPLETED|Titration Period 1||80
142513|NCT00813488|326732|P2|STARTED|Titration Period 1||106
142514|NCT00813488|326733|P1|STARTED|Titration Period 1||107
142515|NCT00813319|326831|P2|NOT COMPLETED|Overall Study||0
142516|NCT00813319|326832|P1|NOT COMPLETED|Overall Study||0
142517|NCT00813319|326831|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
142518|NCT00813319|326832|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
142519|NCT00813319|326831|P2|STARTED|Overall Study||108
142520|NCT00813319|326832|P1|STARTED|Overall Study||108
142521|NCT00813150|326844|P2|NOT COMPLETED|Long Term Follow-up||31
142522|NCT00813150|326845|P1|NOT COMPLETED|Long Term Follow-up||24
142523|NCT00813150|326844|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
142524|NCT00813150|326845|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
142525|NCT00813150|326844|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
142526|NCT00813150|326845|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
142527|NCT00813150|326844|P2|NOT COMPLETED|Treatment Period||32
142528|NCT00813150|326845|P1|NOT COMPLETED|Treatment Period||32
142529|NCT00813150|326844|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
142530|NCT00813150|326845|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
142531|NCT00813150|326844|P2|Intent-to-treat Participants|Treatment Period||47
142532|NCT00813150|326845|P1|Intent-to-treat Participants|Treatment Period||43
142533|NCT00813150|326844|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
142534|NCT00813150|326845|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
142535|NCT00813111|326859|P2|NOT COMPLETED|Overall Study||0
142536|NCT00813111|326860|P1|NOT COMPLETED|Overall Study||2
142537|NCT00813111|326859|P2|COMPLETED|Overall Study||70
142538|NCT00813111|326860|P1|COMPLETED|Overall Study||64
142539|NCT00813111|326859|P2|STARTED|Overall Study||70
142540|NCT00813111|326860|P1|STARTED|Overall Study||66
142541|NCT00813098|326869|P3|NOT COMPLETED|Overall Study||2
142542|NCT00813098|326870|P2|NOT COMPLETED|Overall Study||8
142543|NCT00813098|326871|P1|NOT COMPLETED|Overall Study||3
142544|NCT00813098|326869|P3|COMPLETED|Overall Study||50
142545|NCT00813098|326870|P2|COMPLETED|Overall Study||46
142546|NCT00813098|326871|P1|COMPLETED|Overall Study||46
142547|NCT00813098|326869|P3|STARTED|Overall Study||52
142548|NCT00813098|326870|P2|STARTED|Overall Study||54
142549|NCT00813098|326871|P1|STARTED|Overall Study||49
142550|NCT00812968|326894|P1|NOT COMPLETED|Overall Study||11
142551|NCT00812968|326894|P1|COMPLETED|Overall Study||0
142552|NCT00812968|326894|P1|STARTED|Overall Study||11
142553|NCT00812955|326929|P4|NOT COMPLETED|Overall Study||8
142554|NCT00812955|326930|P3|NOT COMPLETED|Overall Study||6
142555|NCT00812955|326931|P2|NOT COMPLETED|Overall Study||7
142556|NCT00812955|326932|P1|NOT COMPLETED|Overall Study||10
142557|NCT00812955|326929|P4|COMPLETED|Overall Study||110
142558|NCT00812955|326930|P3|COMPLETED|Overall Study||113
142559|NCT00812955|326931|P2|COMPLETED|Overall Study||111
142560|NCT00812955|326932|P1|COMPLETED|Overall Study||109
142561|NCT00812955|326929|P4|STARTED|Overall Study||118
142562|NCT00812955|326930|P3|STARTED|Overall Study||119
142563|NCT00812955|326931|P2|STARTED|Overall Study||118
142564|NCT00812955|326932|P1|STARTED|Overall Study||119
142565|NCT00812916|326952|P1|NOT COMPLETED|Overall Study||3
142566|NCT00812916|326952|P1|COMPLETED|Overall Study||203
142567|NCT00812916|326952|P1|CFAE - Guided Ablation|Overall Study||203
142568|NCT00812916|326952|P1|Data Available|Overall Study||205
142569|NCT00812916|326952|P1|STARTED|Overall Study|206 enrolled (consented)|206
142570|NCT00812877|326963|P2|NOT COMPLETED|Overall Study||51
142571|NCT00812877|326964|P1|NOT COMPLETED|Overall Study||37
142572|NCT00812877|326963|P2|COMPLETED|Overall Study||130
142573|NCT00812877|326964|P1|COMPLETED|Overall Study||158
142574|NCT00812877|326963|P2|STARTED|Overall Study||181
142575|NCT00812877|326964|P1|STARTED|Overall Study||195
142576|NCT00812812|326974|P2|NOT COMPLETED|Overall Study||4
142577|NCT00812812|326975|P1|NOT COMPLETED|Overall Study||3
142578|NCT00812812|326974|P2|COMPLETED|Overall Study||25
142579|NCT00812812|326975|P1|COMPLETED|Overall Study||24
142580|NCT00812812|326974|P2|STARTED|Overall Study||29
142581|NCT00812812|326975|P1|STARTED|Overall Study||27
142582|NCT00812604|326990|P2|NOT COMPLETED|Overall Study||5
142583|NCT00812604|326991|P1|NOT COMPLETED|Overall Study||5
142584|NCT00812604|326990|P2|COMPLETED|Overall Study||22
142585|NCT00812604|326991|P1|COMPLETED|Overall Study||23
142586|NCT00812604|326990|P2|STARTED|Overall Study||27
142587|NCT00812604|326991|P1|STARTED|Overall Study||28
142588|NCT00812565|327007|P8|NOT COMPLETED|Overall Study||1
142589|NCT00812565|327008|P7|NOT COMPLETED|Overall Study||0
142590|NCT00812565|327009|P6|NOT COMPLETED|Overall Study||1
142591|NCT00812565|327010|P5|NOT COMPLETED|Overall Study||1
142592|NCT00812565|327011|P4|NOT COMPLETED|Overall Study||2
142593|NCT00812565|327012|P3|NOT COMPLETED|Overall Study||0
142594|NCT00812565|327013|P2|NOT COMPLETED|Overall Study||1
142595|NCT00812565|327014|P1|NOT COMPLETED|Overall Study||3
142596|NCT00812565|327007|P8|COMPLETED|Overall Study||6
142597|NCT00812565|327008|P7|COMPLETED|Overall Study||8
142598|NCT00812565|327009|P6|COMPLETED|Overall Study||6
142599|NCT00812565|327010|P5|COMPLETED|Overall Study||6
142600|NCT00812565|327011|P4|COMPLETED|Overall Study||5
142601|NCT00812565|327012|P3|COMPLETED|Overall Study||7
142602|NCT00812565|327013|P2|COMPLETED|Overall Study||6
142603|NCT00812565|327014|P1|COMPLETED|Overall Study||5
142604|NCT00812565|327007|P8|STARTED|Overall Study||7
142605|NCT00812565|327008|P7|STARTED|Overall Study||8
142606|NCT00812565|327009|P6|STARTED|Overall Study||7
142607|NCT00812565|327010|P5|STARTED|Overall Study||7
142608|NCT00812565|327011|P4|STARTED|Overall Study||7
142609|NCT00812565|327012|P3|STARTED|Overall Study||7
142610|NCT00812565|327013|P2|STARTED|Overall Study||7
142611|NCT00812565|327014|P1|STARTED|Overall Study||8
142612|NCT00812487|327138|P2|NOT COMPLETED|Overall Study||3
142613|NCT00812487|327139|P1|NOT COMPLETED|Overall Study||6
142614|NCT00812487|327138|P2|COMPLETED|Overall Study||39
142615|NCT00812487|327139|P1|COMPLETED|Overall Study||26
142616|NCT00812487|327138|P2|STARTED|Overall Study||42
142617|NCT00812487|327139|P1|STARTED|Overall Study||32
142618|NCT00812461|327165|P2|NOT COMPLETED|All Treated Patients||147
142619|NCT00812461|327166|P1|NOT COMPLETED|All Treated Patients||132
142620|NCT00812461|327165|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
142621|NCT00812461|327166|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
142622|NCT00812461|327165|P2|STARTED|All Treated Patients||341
142623|NCT00812461|327166|P1|STARTED|All Treated Patients||337
142624|NCT00812461|327165|P2|NOT COMPLETED|All Randomised Patients||17
142625|NCT00812461|327166|P1|NOT COMPLETED|All Randomised Patients||23
142626|NCT00812461|327165|P2|COMPLETED|All Randomised Patients||341
142627|NCT00812461|327166|P1|COMPLETED|All Randomised Patients||337
142628|NCT00812461|327165|P2|STARTED|All Randomised Patients||358
142629|NCT00812461|327166|P1|STARTED|All Randomised Patients||360
142630|NCT00812331|327189|P5|NOT COMPLETED|Overall Study||0
142631|NCT00812331|327190|P4|NOT COMPLETED|Overall Study||0
142632|NCT00812331|327191|P3|NOT COMPLETED|Overall Study||0
142633|NCT00812331|327192|P2|NOT COMPLETED|Overall Study||0
142634|NCT00812331|327193|P1|NOT COMPLETED|Overall Study||1
142635|NCT00812331|327189|P5|COMPLETED|Overall Study||8
142636|NCT00812331|327190|P4|COMPLETED|Overall Study||7
142637|NCT00812331|327191|P3|COMPLETED|Overall Study||8
142638|NCT00812331|327192|P2|COMPLETED|Overall Study||8
142639|NCT00812331|327193|P1|COMPLETED|Overall Study||5
142640|NCT00812331|327189|P5|STARTED|Overall Study||8
142641|NCT00812331|327190|P4|STARTED|Overall Study||7
142642|NCT00812331|327191|P3|STARTED|Overall Study||8
142643|NCT00812331|327192|P2|STARTED|Overall Study||8
142644|NCT00812331|327193|P1|STARTED|Overall Study||6
142645|NCT00812253|327268|P2|NOT COMPLETED|Overall Study||3
142646|NCT00812253|327269|P1|NOT COMPLETED|Overall Study||6
142647|NCT00812253|327268|P2|COMPLETED|Overall Study||39
142648|NCT00812253|327269|P1|COMPLETED|Overall Study||26
142649|NCT00812253|327268|P2|STARTED|Overall Study||42
142650|NCT00812253|327269|P1|STARTED|Overall Study||32
142651|NCT00812110|327279|P1|NOT COMPLETED|Overall Study||0
142652|NCT00812110|327279|P1|COMPLETED|Overall Study||292
142653|NCT00812110|327279|P1|STARTED|Overall Study||292
142654|NCT00812097|327288|P4|NOT COMPLETED|Overall Study||35
142655|NCT00812097|327289|P3|NOT COMPLETED|Overall Study||57
142656|NCT00812097|327290|P2|NOT COMPLETED|Overall Study||89
142657|NCT00812097|327291|P1|NOT COMPLETED|Overall Study||245
142658|NCT00812097|327288|P4|COMPLETED|Overall Study||34
142659|NCT00812097|327289|P3|COMPLETED|Overall Study||67
142660|NCT00812097|327290|P2|COMPLETED|Overall Study||101
142661|NCT00812097|327291|P1|COMPLETED|Overall Study||327
142662|NCT00812097|327288|P4|STARTED|Overall Study||69
142663|NCT00812097|327289|P3|STARTED|Overall Study||124
142664|NCT00812097|327290|P2|STARTED|Overall Study||190
142665|NCT00812097|327291|P1|STARTED|Overall Study||572
142666|NCT00812006|327320|P3|NOT COMPLETED|Overall Study||6
142667|NCT00812006|327321|P2|NOT COMPLETED|Overall Study||3
142668|NCT00812006|327322|P1|NOT COMPLETED|Overall Study||6
142669|NCT00812006|327320|P3|COMPLETED|Overall Study||30
142670|NCT00812006|327321|P2|COMPLETED|Overall Study||33
142671|NCT00812006|327322|P1|COMPLETED|Overall Study||30
142672|NCT00812006|327320|P3|STARTED|Overall Study||36
142673|NCT00812006|327321|P2|STARTED|Overall Study||36
142674|NCT00812006|327322|P1|STARTED|Overall Study||36
142675|NCT00811954|327339|P3|NOT COMPLETED|Overall Study||101
142676|NCT00811954|327340|P2|NOT COMPLETED|Overall Study||72
142677|NCT00811954|327341|P1|NOT COMPLETED|Overall Study||89
142678|NCT00811954|327339|P3|COMPLETED|Overall Study||500
142679|NCT00811954|327340|P2|COMPLETED|Overall Study||531
142680|NCT00811954|327341|P1|COMPLETED|Overall Study||516
142681|NCT00811954|327339|P3|STARTED|Overall Study||601
142682|NCT00811954|327340|P2|STARTED|Overall Study||603
142683|NCT00811954|327341|P1|STARTED|Overall Study||605
142684|NCT00811941|327405|P2|NOT COMPLETED|All Treated Patients||191
142685|NCT00811941|327406|P1|NOT COMPLETED|All Treated Patients||52
142686|NCT00811941|327405|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
142687|NCT00811941|327406|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
142688|NCT00811941|327405|P2|STARTED|All Treated Patients||501
142689|NCT00811941|327406|P1|STARTED|All Treated Patients||164
142690|NCT00811941|327405|P2|NOT COMPLETED|All Randomised Patients||8
142691|NCT00811941|327406|P1|NOT COMPLETED|All Randomised Patients||2
142692|NCT00811941|327405|P2|COMPLETED|All Randomised Patients||501
142693|NCT00811941|327406|P1|COMPLETED|All Randomised Patients||164
142694|NCT00811941|327405|P2|STARTED|All Randomised Patients||509
142695|NCT00811941|327406|P1|STARTED|All Randomised Patients||166
142696|NCT00811928|327444|P2|NOT COMPLETED|Overall Study||33
142697|NCT00811928|327445|P1|NOT COMPLETED|Overall Study||39
142698|NCT00811928|327444|P2|COMPLETED|Overall Study||90
142699|NCT00811928|327445|P1|COMPLETED|Overall Study||90
142700|NCT00811928|327444|P2|STARTED|Overall Study||123
142701|NCT00811928|327445|P1|STARTED|Overall Study||129
142702|NCT00811850|327463|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
142703|NCT00811850|327463|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
142704|NCT00811850|327463|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
142705|NCT00811850|327463|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
142706|NCT00811850|327463|P1|COMPLETED|Treatment Period 2: Wash Out||15
142707|NCT00811850|327463|P1|STARTED|Treatment Period 2: Wash Out||15
142708|NCT00811850|327463|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
142709|NCT00811850|327463|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
142710|NCT00811850|327463|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
142711|NCT00811798|327483|P1|NOT COMPLETED|Overall Study||0
142712|NCT00811798|327483|P1|COMPLETED|Overall Study||92
142713|NCT00811798|327483|P1|STARTED|Overall Study||92
142714|NCT00811733|327489|P2|NOT COMPLETED|Overall Study||10
142715|NCT00811733|327490|P1|NOT COMPLETED|Overall Study||11
142716|NCT00811733|327489|P2|COMPLETED|Overall Study||12
142717|NCT00811733|327490|P1|COMPLETED|Overall Study||4
142718|NCT00811733|327489|P2|STARTED|Overall Study||22
142719|NCT00811733|327490|P1|STARTED|Overall Study||15
142720|NCT00811720|327538|P2|NOT COMPLETED|All Treated Patients||164
142721|NCT00811720|327539|P1|NOT COMPLETED|All Treated Patients||96
142722|NCT00811720|327538|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
142723|NCT00811720|327539|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
142724|NCT00811720|327538|P2|STARTED|All Treated Patients||302
142725|NCT00811720|327539|P1|STARTED|All Treated Patients||296
142726|NCT00811720|327538|P2|NOT COMPLETED|All Randomised Patients||4
142727|NCT00811720|327539|P1|NOT COMPLETED|All Randomised Patients||2
142728|NCT00811720|327538|P2|COMPLETED|All Randomised Patients||302
142729|NCT00811720|327539|P1|COMPLETED|All Randomised Patients||296
142730|NCT00811720|327538|P2|STARTED|All Randomised Patients||306
142731|NCT00811720|327539|P1|STARTED|All Randomised Patients||298
142732|NCT00811655|327557|P1|NOT COMPLETED|Overall Study||1
142733|NCT00811655|327557|P1|COMPLETED|Overall Study||5
142734|NCT00811655|327557|P1|STARTED|Overall Study||6
142735|NCT00811642|327569|P1|NOT COMPLETED|Overall Study||15
142736|NCT00811642|327569|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
142737|NCT00811642|327569|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
142738|NCT00811590|327579|P1|NOT COMPLETED|Overall Study||0
142739|NCT00811590|327579|P1|COMPLETED|Overall Study||3
142740|NCT00811590|327579|P1|STARTED|Overall Study||3
142741|NCT00811577|327585|P2|NOT COMPLETED|Overall Study||1
142742|NCT00811577|327586|P1|NOT COMPLETED|Overall Study||10
142743|NCT00811577|327585|P2|COMPLETED|Overall Study||23
142744|NCT00811577|327586|P1|COMPLETED|Overall Study||116
142745|NCT00811577|327585|P2|STARTED|Overall Study||24
142746|NCT00811577|327586|P1|STARTED|Overall Study||126
142747|NCT00811564|327637|P2|NOT COMPLETED|Overall Study||2
142748|NCT00811564|327638|P1|NOT COMPLETED|Overall Study||9
142749|NCT00811564|327637|P2|COMPLETED|Overall Study||73
142750|NCT00811564|327638|P1|COMPLETED|Overall Study||64
142751|NCT00811564|327637|P2|STARTED|Overall Study||75
142752|NCT00811564|327638|P1|STARTED|Overall Study||73
142753|NCT00811473|327646|P2|NOT COMPLETED|Overall Study||26
142754|NCT00811473|327647|P1|NOT COMPLETED|Overall Study||23
142755|NCT00811473|327646|P2|COMPLETED|Overall Study||74
142756|NCT00811473|327647|P1|COMPLETED|Overall Study||70
142757|NCT00811473|327646|P2|STARTED|Overall Study||100
142758|NCT00811473|327647|P1|STARTED|Overall Study||93
142759|NCT00811434|327663|P2|NOT COMPLETED|Second Intervention||0
142760|NCT00811434|327664|P1|NOT COMPLETED|Second Intervention||0
142761|NCT00811434|327663|P2|COMPLETED|Second Intervention||5
142762|NCT00811434|327664|P1|COMPLETED|Second Intervention||4
142763|NCT00811434|327663|P2|STARTED|Second Intervention||5
142764|NCT00811434|327664|P1|STARTED|Second Intervention||4
142765|NCT00811434|327663|P2|NOT COMPLETED|Washout (1 Month)||0
142766|NCT00811434|327664|P1|NOT COMPLETED|Washout (1 Month)||0
142767|NCT00811434|327663|P2|COMPLETED|Washout (1 Month)||5
142768|NCT00811434|327664|P1|COMPLETED|Washout (1 Month)||4
142769|NCT00811434|327663|P2|STARTED|Washout (1 Month)||5
142770|NCT00811434|327664|P1|STARTED|Washout (1 Month)||4
142771|NCT00811434|327663|P2|NOT COMPLETED|First Intervention||0
142772|NCT00811434|327664|P1|NOT COMPLETED|First Intervention||3
142773|NCT00811434|327663|P2|COMPLETED|First Intervention||5
142774|NCT00811434|327664|P1|COMPLETED|First Intervention||4
142775|NCT00811434|327663|P2|STARTED|First Intervention||5
142776|NCT00811434|327664|P1|STARTED|First Intervention||7
142777|NCT00811395|327678|P6|NOT COMPLETED|Extension Treatment||2
142778|NCT00811395|327679|P5|NOT COMPLETED|Extension Treatment||0
142779|NCT00811395|327680|P4|NOT COMPLETED|Extension Treatment||3
142780|NCT00811395|327681|P3|NOT COMPLETED|Extension Treatment||3
142781|NCT00811395|327682|P2|NOT COMPLETED|Extension Treatment||6
142782|NCT00811395|327683|P1|NOT COMPLETED|Extension Treatment||2
142783|NCT00811395|327678|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
142784|NCT00811395|327679|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
142785|NCT00811395|327680|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
142786|NCT00811395|327681|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
142787|NCT00811395|327682|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
142788|NCT00811395|327683|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
142789|NCT00811395|327678|P6|STARTED|Extension Treatment|continued initial treatment|29
142790|NCT00811395|327679|P5|STARTED|Extension Treatment|continued initial treatment|30
142791|NCT00811395|327680|P4|STARTED|Extension Treatment|continued initial treatment|37
142792|NCT00811395|327681|P3|STARTED|Extension Treatment|continued initial treatment|27
142793|NCT00811395|327682|P2|STARTED|Extension Treatment|continued initial treatment|28
142794|NCT00811395|327683|P1|STARTED|Extension Treatment|continued initial treatment|31
142795|NCT00811395|327678|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
142796|NCT00811395|327679|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
142797|NCT00811395|327680|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
142798|NCT00811395|327681|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
142799|NCT00811395|327682|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
142800|NCT00811395|327683|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
142801|NCT00811395|327678|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
142802|NCT00811395|327679|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
142803|NCT00811395|327680|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
142804|NCT00811395|327681|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
142805|NCT00811395|327682|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
142806|NCT00811395|327683|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
142807|NCT00811395|327678|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
142808|NCT00811395|327679|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
142809|NCT00811395|327680|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
142810|NCT00811395|327681|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
142811|NCT00811395|327682|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
142812|NCT00811395|327683|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
142813|NCT00811252|327748|P3|NOT COMPLETED|Overall Study||23
142814|NCT00811252|327749|P2|NOT COMPLETED|Overall Study||20
142815|NCT00811252|327750|P1|NOT COMPLETED|Overall Study||17
142816|NCT00811252|327748|P3|COMPLETED|Overall Study||128
142817|NCT00811252|327749|P2|COMPLETED|Overall Study||136
142818|NCT00811252|327750|P1|COMPLETED|Overall Study||128
142819|NCT00811252|327748|P3|STARTED|Overall Study||151
142820|NCT00811252|327749|P2|STARTED|Overall Study||156
142821|NCT00811252|327750|P1|STARTED|Overall Study||145
142822|NCT00811135|327794|P1|NOT COMPLETED|Overall Study||88
142823|NCT00811135|327794|P1|COMPLETED|Overall Study||0
142824|NCT00811135|327794|P1|STARTED|Overall Study||88
142825|NCT00811070|327812|P6|NOT COMPLETED|Overall Study||1
142826|NCT00811070|327813|P5|NOT COMPLETED|Overall Study||5
142827|NCT00811070|327814|P4|NOT COMPLETED|Overall Study||2
142828|NCT00811070|327815|P3|NOT COMPLETED|Overall Study||0
142829|NCT00811070|327816|P2|NOT COMPLETED|Overall Study||1
142830|NCT00811070|327817|P1|NOT COMPLETED|Overall Study||1
142831|NCT00811070|327812|P6|COMPLETED|Overall Study||10
142832|NCT00811070|327813|P5|COMPLETED|Overall Study||2
142833|NCT00811070|327814|P4|COMPLETED|Overall Study||26
142834|NCT00811070|327815|P3|COMPLETED|Overall Study||3
142835|NCT00811070|327816|P2|COMPLETED|Overall Study||6
142836|NCT00811070|327817|P1|COMPLETED|Overall Study||6
142837|NCT00811070|327812|P6|STARTED|Overall Study||11
142838|NCT00811070|327813|P5|STARTED|Overall Study||7
142839|NCT00811070|327814|P4|STARTED|Overall Study||28
142840|NCT00811070|327815|P3|STARTED|Overall Study||3
142841|NCT00811070|327816|P2|STARTED|Overall Study||7
142842|NCT00811070|327817|P1|STARTED|Overall Study||7
142843|NCT00811057|327877|P3|NOT COMPLETED|Overall Study||10
142844|NCT00811057|327878|P2|NOT COMPLETED|Overall Study||10
142845|NCT00811057|327879|P1|NOT COMPLETED|Overall Study||5
142846|NCT00811057|327877|P3|COMPLETED|Overall Study||87
142847|NCT00811057|327878|P2|COMPLETED|Overall Study||104
142848|NCT00811057|327879|P1|COMPLETED|Overall Study||85
142849|NCT00811057|327877|P3|STARTED|Overall Study||97
142850|NCT00811057|327878|P2|STARTED|Overall Study||114
142851|NCT00811057|327879|P1|STARTED|Overall Study||90
142852|NCT00811018|327890|P1|NOT COMPLETED|Overall Study||968
142853|NCT00811018|327890|P1|COMPLETED|Overall Study||224
142854|NCT00811018|327890|P1|STARTED|Overall Study||1192
142855|NCT00810901|327908|P2|NOT COMPLETED|Overall Study||58
142856|NCT00810901|327909|P1|NOT COMPLETED|Overall Study||88
142857|NCT00810901|327908|P2|COMPLETED|Overall Study||118
142858|NCT00810901|327909|P1|COMPLETED|Overall Study||165
142859|NCT00810901|327908|P2|6-month Follow-up|Overall Study||122
142860|NCT00810901|327909|P1|6-month Follow-up|Overall Study||181
142861|NCT00810901|327908|P2|1-month Follow up|Overall Study||146
142862|NCT00810901|327909|P1|1-month Follow up|Overall Study||242
142863|NCT00810901|327908|P2|STARTED|Overall Study||176
142864|NCT00810901|327909|P1|STARTED|Overall Study||253
142865|NCT00810771|327920|P3|NOT COMPLETED|Overall Study||0
142866|NCT00810771|327921|P2|NOT COMPLETED|Overall Study||0
142867|NCT00810771|327922|P1|NOT COMPLETED|Overall Study||0
142868|NCT00810771|327920|P3|COMPLETED|Overall Study||84
142869|NCT00810771|327921|P2|COMPLETED|Overall Study||234
142870|NCT00810771|327922|P1|COMPLETED|Overall Study||232
142871|NCT00810771|327920|P3|STARTED|Overall Study||84
142872|NCT00810771|327921|P2|STARTED|Overall Study||234
142873|NCT00810771|327922|P1|STARTED|Overall Study||232
142874|NCT00810693|327945|P3|NOT COMPLETED|Follow-up Period (FUP)||4
142875|NCT00810693|327946|P2|NOT COMPLETED|Follow-up Period (FUP)||3
142876|NCT00810693|327947|P1|NOT COMPLETED|Follow-up Period (FUP)||8
142877|NCT00810693|327945|P3|COMPLETED|Follow-up Period (FUP)||12
142878|NCT00810693|327946|P2|COMPLETED|Follow-up Period (FUP)||4
142879|NCT00810693|327947|P1|COMPLETED|Follow-up Period (FUP)||15
142880|NCT00810693|327945|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
142881|NCT00810693|327946|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
142882|NCT00810693|327947|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
142883|NCT00810693|327945|P3|NOT COMPLETED|Treatment Period||16
142884|NCT00810693|327946|P2|NOT COMPLETED|Treatment Period||7
142885|NCT00810693|327947|P1|NOT COMPLETED|Treatment Period||17
142886|NCT00810693|327945|P3|COMPLETED|Treatment Period||111
142887|NCT00810693|327946|P2|COMPLETED|Treatment Period||57
142888|NCT00810693|327947|P1|COMPLETED|Treatment Period||237
142889|NCT00810693|327945|P3|Participants Received Treatment|Treatment Period||126
142890|NCT00810693|327946|P2|Participants Received Treatment|Treatment Period||63
142891|NCT00810693|327947|P1|Participants Received Treatment|Treatment Period||254
142892|NCT00810693|327945|P3|STARTED|Treatment Period|1 randomized but not treated|127
142893|NCT00810693|327946|P2|STARTED|Treatment Period|1 randomized but not treated|64
142894|NCT00810693|327947|P1|STARTED|Treatment Period||254
142895|NCT00810641|327979|P3|NOT COMPLETED|Overall Study||2
142896|NCT00810641|327980|P2|NOT COMPLETED|Overall Study||1
142897|NCT00810641|327981|P1|NOT COMPLETED|Overall Study||0
142898|NCT00810641|327979|P3|COMPLETED|Overall Study||49
142899|NCT00810641|327980|P2|COMPLETED|Overall Study||53
142900|NCT00810641|327981|P1|COMPLETED|Overall Study||52
142901|NCT00810641|327979|P3|STARTED|Overall Study||51
142902|NCT00810641|327980|P2|STARTED|Overall Study||54
142903|NCT00810641|327981|P1|STARTED|Overall Study||52
142904|NCT00810602|327989|P2|NOT COMPLETED|Overall Study||3
142905|NCT00810602|327990|P1|NOT COMPLETED|Overall Study||8
142906|NCT00810602|327989|P2|COMPLETED|Overall Study||31
142907|NCT00810602|327990|P1|COMPLETED|Overall Study||19
142908|NCT00810602|327989|P2|STARTED|Overall Study||34
142909|NCT00810602|327990|P1|STARTED|Overall Study||27
142910|NCT00810576|327997|P1|NOT COMPLETED|Overall Study||0
142911|NCT00810576|327997|P1|COMPLETED|Overall Study||1
142912|NCT00810576|327997|P1|STARTED|Overall Study||1
142913|NCT00810511|328003|P2|NOT COMPLETED|Overall Study||4
142914|NCT00810511|328004|P1|NOT COMPLETED|Overall Study||10
142915|NCT00810511|328003|P2|COMPLETED|Overall Study||102
142916|NCT00810511|328004|P1|COMPLETED|Overall Study||97
142917|NCT00810511|328003|P2|STARTED|Overall Study||106
142918|NCT00810511|328004|P1|STARTED|Overall Study||107
142919|NCT00810368|328012|P2|NOT COMPLETED|Overall Study||2
142920|NCT00810368|328013|P1|NOT COMPLETED|Overall Study||6
142921|NCT00810368|328012|P2|COMPLETED|Overall Study||13
142922|NCT00810368|328013|P1|COMPLETED|Overall Study||12
142923|NCT00810368|328012|P2|STARTED|Overall Study||15
142924|NCT00810368|328013|P1|STARTED|Overall Study||18
142925|NCT00810355|328034|P3|NOT COMPLETED|Overall Study||11
142926|NCT00810355|328035|P2|NOT COMPLETED|Overall Study||17
142927|NCT00810355|328036|P1|NOT COMPLETED|Overall Study||14
142928|NCT00810355|328034|P3|COMPLETED|Overall Study||14
142929|NCT00810355|328035|P2|COMPLETED|Overall Study||8
142930|NCT00810355|328036|P1|COMPLETED|Overall Study||11
142931|NCT00810355|328034|P3|STARTED|Overall Study||25
142932|NCT00810355|328035|P2|STARTED|Overall Study||25
142933|NCT00810355|328036|P1|STARTED|Overall Study||25
142934|NCT00810342|328052|P2|NOT COMPLETED|12-month Followup||11
142935|NCT00810342|328053|P1|NOT COMPLETED|12-month Followup||12
142936|NCT00810342|328052|P2|COMPLETED|12-month Followup||136
142937|NCT00810342|328053|P1|COMPLETED|12-month Followup||113
142938|NCT00810342|328052|P2|STARTED|12-month Followup||147
142939|NCT00810342|328053|P1|STARTED|12-month Followup||125
142940|NCT00810342|328052|P2|NOT COMPLETED|6-month Follow-up||8
142941|NCT00810342|328053|P1|NOT COMPLETED|6-month Follow-up||24
142942|NCT00810342|328052|P2|COMPLETED|6-month Follow-up||147
142943|NCT00810342|328053|P1|COMPLETED|6-month Follow-up||125
142944|NCT00810342|328052|P2|STARTED|6-month Follow-up||155
142945|NCT00810342|328053|P1|STARTED|6-month Follow-up||149
142946|NCT00810342|328052|P2|NOT COMPLETED|Month 1 Follow-up||2
142947|NCT00810342|328053|P1|NOT COMPLETED|Month 1 Follow-up||5
142948|NCT00810342|328052|P2|COMPLETED|Month 1 Follow-up||155
142949|NCT00810342|328053|P1|COMPLETED|Month 1 Follow-up||149
142950|NCT00810342|328052|P2|STARTED|Month 1 Follow-up||157
142951|NCT00810342|328053|P1|STARTED|Month 1 Follow-up||154
142952|NCT00810303|328061|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
142953|NCT00810303|328061|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
142954|NCT00810303|328061|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
142955|NCT00810303|328061|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
142956|NCT00810303|328061|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
142957|NCT00810303|328061|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
142958|NCT00810303|328061|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
142959|NCT00810303|328061|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
142960|NCT00810303|328061|P1|STARTED|Ezetimibe Alone - Day 6-15||12
142961|NCT00810303|328061|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
142962|NCT00810303|328061|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
142963|NCT00810303|328061|P1|STARTED|Efavirenz Alone - Day 1-5||12
142964|NCT00810277|328086|P1|NOT COMPLETED|Overall Study||1
142965|NCT00810277|328086|P1|COMPLETED|Overall Study||13
142966|NCT00810277|328086|P1|STARTED|Overall Study||14
142967|NCT00810199|328101|P2|NOT COMPLETED|Overall Study||82
142968|NCT00810199|328102|P1|NOT COMPLETED|Overall Study||59
142969|NCT00810199|328101|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
142970|NCT00810199|328102|P1|COMPLETED|Overall Study||220
142971|NCT00810199|328101|P2|Completed Week 104|Overall Study||201
142972|NCT00810199|328102|P1|Completed Week 104|Overall Study||222
142973|NCT00810199|328101|P2|Completed Week 52|Overall Study||229
142974|NCT00810199|328102|P1|Completed Week 52|Overall Study||243
142975|NCT00810199|328101|P2|Completed Week 24|Overall Study||250
142976|NCT00810199|328102|P1|Completed Week 24|Overall Study||259
142977|NCT00810199|328101|P2|Received Study Drug|Overall Study||276
142978|NCT00810199|328102|P1|Received Study Drug|Overall Study||277
142979|NCT00810199|328101|P2|STARTED|Overall Study||277
142980|NCT00810199|328102|P1|STARTED|Overall Study||279
142981|NCT00810108|328180|P2|NOT COMPLETED|Overall Study||0
142982|NCT00810108|328181|P1|NOT COMPLETED|Overall Study||1
142983|NCT00810108|328180|P2|COMPLETED|Overall Study||7
142984|NCT00810108|328181|P1|COMPLETED|Overall Study||5
142985|NCT00810108|328180|P2|STARTED|Overall Study||7
142986|NCT00810108|328181|P1|STARTED|Overall Study||6
142987|NCT00810095|328186|P1|NOT COMPLETED|Overall Study||0
142988|NCT00810095|328186|P1|COMPLETED|Overall Study||40
142989|NCT00810095|328186|P1|STARTED|Overall Study||40
142990|NCT00810082|328195|P2|NOT COMPLETED|Overall Study||4
142991|NCT00810082|328196|P1|NOT COMPLETED|Overall Study||0
142992|NCT00810082|328195|P2|COMPLETED|Overall Study||27
142993|NCT00810082|328196|P1|COMPLETED|Overall Study||34
142994|NCT00810082|328195|P2|STARTED|Overall Study||31
142995|NCT00810082|328196|P1|STARTED|Overall Study||34
142996|NCT00810069|328204|P3|NOT COMPLETED|Double-Blind Period II||72
142997|NCT00810069|328205|P2|NOT COMPLETED|Double-Blind Period II||56
142998|NCT00810069|328206|P1|NOT COMPLETED|Double-Blind Period II||0
142999|NCT00810069|328204|P3|COMPLETED|Double-Blind Period II||212
143000|NCT00810069|328205|P2|COMPLETED|Double-Blind Period II||226
143001|NCT00810069|328206|P1|COMPLETED|Double-Blind Period II||0
143002|NCT00810069|328204|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
143003|NCT00810069|328205|P2|STARTED|Double-Blind Period II||282
143004|NCT00810069|328206|P1|STARTED|Double-Blind Period II||0
143005|NCT00810069|328204|P3|NOT COMPLETED|Lead-in Period I||0
143006|NCT00810069|328205|P2|NOT COMPLETED|Lead-in Period I||0
143007|NCT00810069|328206|P1|NOT COMPLETED|Lead-in Period I||274
143008|NCT00810069|328204|P3|COMPLETED|Lead-in Period I||0
143009|NCT00810069|328205|P2|COMPLETED|Lead-in Period I||0
143010|NCT00810069|328206|P1|COMPLETED|Lead-in Period I||566
143011|NCT00810069|328204|P3|STARTED|Lead-in Period I||0
143012|NCT00810069|328205|P2|STARTED|Lead-in Period I||0
143013|NCT00810069|328206|P1|STARTED|Lead-in Period I||840
143014|NCT00810043|328251|P3|NOT COMPLETED|Overall Study||8
143015|NCT00810043|328252|P2|NOT COMPLETED|Overall Study||1
143016|NCT00810043|328253|P1|NOT COMPLETED|Overall Study||4
143017|NCT00810043|328251|P3|COMPLETED|Overall Study||0
143018|NCT00810043|328252|P2|COMPLETED|Overall Study||54
143019|NCT00810043|328253|P1|COMPLETED|Overall Study||53
143020|NCT00810043|328251|P3|STARTED|Overall Study||8
143021|NCT00810043|328252|P2|STARTED|Overall Study||55
143022|NCT00810043|328253|P1|STARTED|Overall Study||57
143023|NCT00809965|328275|P3|NOT COMPLETED|Overall Study||844
143024|NCT00809965|328276|P2|NOT COMPLETED|Overall Study||775
143025|NCT00809965|328277|P1|NOT COMPLETED|Overall Study||783
143026|NCT00809965|328275|P3|COMPLETED|Overall Study||4332
143027|NCT00809965|328276|P2|COMPLETED|Overall Study||4399
143028|NCT00809965|328277|P1|COMPLETED|Overall Study||4393
143029|NCT00809965|328275|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
143030|NCT00809965|328276|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
143031|NCT00809965|328277|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
143032|NCT00809965|328275|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
143033|NCT00809965|328276|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
143034|NCT00809965|328277|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
143035|NCT00809965|328275|P3|STARTED|Overall Study||5176
143036|NCT00809965|328276|P2|STARTED|Overall Study||5174
143037|NCT00809965|328277|P1|STARTED|Overall Study||5176
143038|NCT00809926|328299|P2|NOT COMPLETED|Overall Study||23
143039|NCT00809926|328300|P1|NOT COMPLETED|Overall Study||31
143040|NCT00809926|328299|P2|COMPLETED|Overall Study||196
143041|NCT00809926|328300|P1|COMPLETED|Overall Study||201
143042|NCT00809926|328299|P2|STARTED|Overall Study||219
143043|NCT00809926|328300|P1|STARTED|Overall Study||232
143044|NCT00809848|328329|P5|NOT COMPLETED|Overall Study||3
143045|NCT00809848|328330|P4|NOT COMPLETED|Overall Study||1
143046|NCT00809848|328331|P3|NOT COMPLETED|Overall Study||0
143047|NCT00809848|328332|P2|NOT COMPLETED|Overall Study||0
143048|NCT00809848|328333|P1|NOT COMPLETED|Overall Study||0
143049|NCT00809848|328329|P5|COMPLETED|Overall Study||34
143050|NCT00809848|328330|P4|COMPLETED|Overall Study||30
143051|NCT00809848|328331|P3|COMPLETED|Overall Study||34
143052|NCT00809848|328332|P2|COMPLETED|Overall Study||34
143053|NCT00809848|328333|P1|COMPLETED|Overall Study||36
143054|NCT00809848|328329|P5|STARTED|Overall Study||37
143055|NCT00809848|328330|P4|STARTED|Overall Study||31
143056|NCT00809848|328331|P3|STARTED|Overall Study||34
143057|NCT00809848|328332|P2|STARTED|Overall Study||34
143058|NCT00809848|328333|P1|STARTED|Overall Study||36
143059|NCT00809809|328352|P2|NOT COMPLETED|Overall Study||2
143060|NCT00809809|328353|P1|NOT COMPLETED|Overall Study||3
143061|NCT00809809|328352|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
143062|NCT00809809|328353|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
143063|NCT00809809|328352|P2|STARTED|Overall Study||79
143064|NCT00809809|328353|P1|STARTED|Overall Study||78
143065|NCT00809757|328362|P3|NOT COMPLETED|Overall Study||11
143066|NCT00809757|328363|P2|NOT COMPLETED|Overall Study||5
143067|NCT00809757|328364|P1|NOT COMPLETED|Overall Study||6
143068|NCT00809757|328362|P3|COMPLETED|Overall Study||53
143069|NCT00809757|328363|P2|COMPLETED|Overall Study||60
143070|NCT00809757|328364|P1|COMPLETED|Overall Study||62
143071|NCT00809757|328362|P3|STARTED|Overall Study||64
143072|NCT00809757|328363|P2|STARTED|Overall Study||65
143073|NCT00809757|328364|P1|STARTED|Overall Study||68
143074|NCT00809614|328449|P2|NOT COMPLETED|Overall Study||4
143075|NCT00809614|328450|P1|NOT COMPLETED|Overall Study||3
143076|NCT00809614|328449|P2|COMPLETED|Overall Study||10
143077|NCT00809614|328450|P1|COMPLETED|Overall Study||25
143078|NCT00809614|328449|P2|Pharmacodynamic (PD) Set|Overall Study||13
143079|NCT00809614|328450|P1|Pharmacodynamic (PD) Set|Overall Study||24
143080|NCT00809614|328449|P2|Pharmacokinetic Safety Set|Overall Study||14
143081|NCT00809614|328450|P1|Pharmacokinetic Safety Set|Overall Study||27
143082|NCT00809614|328449|P2|STARTED|Overall Study||14
143083|NCT00809614|328450|P1|STARTED|Overall Study||28
143084|NCT00809523|328480|P2|NOT COMPLETED|Overall Study||4
143085|NCT00809523|328481|P1|NOT COMPLETED|Overall Study||7
143086|NCT00809523|328480|P2|COMPLETED|Overall Study||48
143087|NCT00809523|328481|P1|COMPLETED|Overall Study||47
143088|NCT00809523|328480|P2|STARTED|Overall Study||52
143089|NCT00809523|328481|P1|STARTED|Overall Study||54
143090|NCT00809471|328494|P3|NOT COMPLETED|Overall Study||17
143091|NCT00809471|328495|P2|NOT COMPLETED|Overall Study||20
143092|NCT00809471|328496|P1|NOT COMPLETED|Overall Study||20
143093|NCT00809471|328494|P3|COMPLETED|Overall Study||114
143094|NCT00809471|328495|P2|COMPLETED|Overall Study||109
143095|NCT00809471|328496|P1|COMPLETED|Overall Study||110
143096|NCT00809471|328494|P3|STARTED|Overall Study||131
143097|NCT00809471|328495|P2|STARTED|Overall Study||129
143098|NCT00809471|328496|P1|STARTED|Overall Study||130
143099|NCT00809458|328512|P2|NOT COMPLETED|Overall Study||1
143100|NCT00809458|328513|P1|NOT COMPLETED|Overall Study||1
143101|NCT00809458|328512|P2|COMPLETED|Overall Study||5
143102|NCT00809458|328513|P1|COMPLETED|Overall Study||8
143103|NCT00809458|328512|P2|STARTED|Overall Study||6
143104|NCT00809458|328513|P1|STARTED|Overall Study||9
143105|NCT00809445|328526|P3|NOT COMPLETED|6 Month Follow-up||24
143106|NCT00809445|328527|P2|NOT COMPLETED|6 Month Follow-up||23
143107|NCT00809445|328528|P1|NOT COMPLETED|6 Month Follow-up||24
143108|NCT00809445|328526|P3|COMPLETED|6 Month Follow-up||395
143109|NCT00809445|328527|P2|COMPLETED|6 Month Follow-up||410
143110|NCT00809445|328528|P1|COMPLETED|6 Month Follow-up||405
143111|NCT00809445|328526|P3|STARTED|6 Month Follow-up||419
143112|NCT00809445|328527|P2|STARTED|6 Month Follow-up||433
143113|NCT00809445|328528|P1|STARTED|6 Month Follow-up||429
143114|NCT00809445|328526|P3|NOT COMPLETED|1 Month Follow-up||4
143115|NCT00809445|328527|P2|NOT COMPLETED|1 Month Follow-up||4
143116|NCT00809445|328528|P1|NOT COMPLETED|1 Month Follow-up||2
143117|NCT00809445|328526|P3|COMPLETED|1 Month Follow-up||415
143118|NCT00809445|328527|P2|COMPLETED|1 Month Follow-up||429
143119|NCT00809445|328528|P1|COMPLETED|1 Month Follow-up||427
143120|NCT00809445|328526|P3|STARTED|1 Month Follow-up||419
143121|NCT00809445|328527|P2|STARTED|1 Month Follow-up||433
143122|NCT00809445|328528|P1|STARTED|1 Month Follow-up||429
143123|NCT00809328|328545|P1|NOT COMPLETED|Overall Study||29
143124|NCT00809328|328545|P1|COMPLETED|Overall Study||73
143125|NCT00809328|328545|P1|STARTED|Overall Study||102
143126|NCT00809276|328553|P1|NOT COMPLETED|Overall Study||0
143127|NCT00809276|328553|P1|COMPLETED|Overall Study||92
143128|NCT00809276|328553|P1|STARTED|Overall Study||92
143129|NCT00809185|328557|P1|NOT COMPLETED|Overall Study||0
143130|NCT00809185|328557|P1|COMPLETED|Overall Study||7
143131|NCT00809185|328557|P1|STARTED|Overall Study||7
143132|NCT00809159|328565|P6|NOT COMPLETED|Part 1 and 2||3
143133|NCT00809159|328566|P5|NOT COMPLETED|Part 1 and 2||6
143134|NCT00809159|328567|P4|NOT COMPLETED|Part 1 and 2||5
143135|NCT00809159|328568|P3|NOT COMPLETED|Part 1 and 2||10
143136|NCT00809159|328569|P2|NOT COMPLETED|Part 1 and 2||0
143137|NCT00809159|328570|P1|NOT COMPLETED|Part 1 and 2||0
143138|NCT00809159|328565|P6|COMPLETED|Part 1 and 2||3
143139|NCT00809159|328566|P5|COMPLETED|Part 1 and 2||6
143140|NCT00809159|328567|P4|COMPLETED|Part 1 and 2||7
143141|NCT00809159|328568|P3|COMPLETED|Part 1 and 2||20
143142|NCT00809159|328569|P2|COMPLETED|Part 1 and 2||0
143143|NCT00809159|328570|P1|COMPLETED|Part 1 and 2||0
143144|NCT00809159|328565|P6|PD Analysis Set|Part 1 and 2||6
143145|NCT00809159|328566|P5|PD Analysis Set|Part 1 and 2||12
143146|NCT00809159|328567|P4|PD Analysis Set|Part 1 and 2||12
143147|NCT00809159|328568|P3|PD Analysis Set|Part 1 and 2||28
143148|NCT00809159|328569|P2|PD Analysis Set|Part 1 and 2||0
143149|NCT00809159|328570|P1|PD Analysis Set|Part 1 and 2||0
143150|NCT00809159|328565|P6|PK Analysis Set|Part 1 and 2||6
143151|NCT00809159|328566|P5|PK Analysis Set|Part 1 and 2||12
143152|NCT00809159|328567|P4|PK Analysis Set|Part 1 and 2||12
143153|NCT00809159|328568|P3|PK Analysis Set|Part 1 and 2||30
143154|NCT00809159|328569|P2|PK Analysis Set|Part 1 and 2||0
143155|NCT00809159|328570|P1|PK Analysis Set|Part 1 and 2||0
143156|NCT00809159|328565|P6|STARTED|Part 1 and 2||6
143157|NCT00809159|328566|P5|STARTED|Part 1 and 2||12
143158|NCT00809159|328567|P4|STARTED|Part 1 and 2||12
143159|NCT00809159|328568|P3|STARTED|Part 1 and 2||30
143160|NCT00809159|328569|P2|STARTED|Part 1 and 2||0
143161|NCT00809159|328570|P1|STARTED|Part 1 and 2||0
143162|NCT00809159|328565|P6|NOT COMPLETED|Part 1||0
143163|NCT00809159|328566|P5|NOT COMPLETED|Part 1||0
143164|NCT00809159|328567|P4|NOT COMPLETED|Part 1||0
143165|NCT00809159|328568|P3|NOT COMPLETED|Part 1||0
143166|NCT00809159|328569|P2|NOT COMPLETED|Part 1||3
143167|NCT00809159|328570|P1|NOT COMPLETED|Part 1||8
143168|NCT00809159|328565|P6|COMPLETED|Part 1||0
143169|NCT00809159|328566|P5|COMPLETED|Part 1||0
143170|NCT00809159|328567|P4|COMPLETED|Part 1||0
143171|NCT00809159|328568|P3|COMPLETED|Part 1||0
143172|NCT00809159|328569|P2|COMPLETED|Part 1||3
143173|NCT00809159|328570|P1|COMPLETED|Part 1||16
143174|NCT00809159|328565|P6|PD Analysis Set|Part 1||0
143175|NCT00809159|328566|P5|PD Analysis Set|Part 1||0
143176|NCT00809159|328567|P4|PD Analysis Set|Part 1||0
143177|NCT00809159|328568|P3|PD Analysis Set|Part 1||0
143178|NCT00809159|328569|P2|PD Analysis Set|Part 1||6
143179|NCT00809159|328570|P1|PD Analysis Set|Part 1||23
143180|NCT00809159|328565|P6|PK Analysis Set|Part 1||0
143181|NCT00809159|328566|P5|PK Analysis Set|Part 1||0
143182|NCT00809159|328567|P4|PK Analysis Set|Part 1||0
143183|NCT00809159|328568|P3|PK Analysis Set|Part 1||0
143184|NCT00809159|328569|P2|PK Analysis Set|Part 1||6
143185|NCT00809159|328570|P1|PK Analysis Set|Part 1||24
143186|NCT00809159|328565|P6|STARTED|Part 1||0
143187|NCT00809159|328566|P5|STARTED|Part 1||0
143188|NCT00809159|328567|P4|STARTED|Part 1||0
143189|NCT00809159|328568|P3|STARTED|Part 1||0
143190|NCT00809159|328569|P2|STARTED|Part 1||6
143191|NCT00809159|328570|P1|STARTED|Part 1||24
143192|NCT00809146|328636|P2|NOT COMPLETED|Overall Study||0
143193|NCT00809146|328637|P1|NOT COMPLETED|Overall Study||0
143194|NCT00809146|328636|P2|COMPLETED|Overall Study||445
143195|NCT00809146|328637|P1|COMPLETED|Overall Study||448
143196|NCT00809146|328636|P2|STARTED|Overall Study||445
143197|NCT00809146|328637|P1|STARTED|Overall Study||448
143198|NCT00809133|328675|P14|NOT COMPLETED|Overall Study||7
143199|NCT00809133|328676|P13|NOT COMPLETED|Overall Study||5
143200|NCT00809133|328677|P12|NOT COMPLETED|Overall Study||8
143201|NCT00809133|328678|P11|NOT COMPLETED|Overall Study||6
143202|NCT00809133|328679|P10|NOT COMPLETED|Overall Study||9
143203|NCT00809133|328680|P9|NOT COMPLETED|Overall Study||3
143204|NCT00809133|328681|P8|NOT COMPLETED|Overall Study||8
143205|NCT00809133|328682|P7|NOT COMPLETED|Overall Study||6
143206|NCT00809133|328683|P6|NOT COMPLETED|Overall Study||7
143207|NCT00809133|328684|P5|NOT COMPLETED|Overall Study||5
143208|NCT00809133|328685|P4|NOT COMPLETED|Overall Study||3
143209|NCT00809133|328686|P3|NOT COMPLETED|Overall Study||6
143210|NCT00809133|328687|P2|NOT COMPLETED|Overall Study||7
143211|NCT00809133|328688|P1|NOT COMPLETED|Overall Study||3
143212|NCT00809133|328675|P14|COMPLETED|Overall Study||0
143213|NCT00809133|328676|P13|COMPLETED|Overall Study||0
143214|NCT00809133|328677|P12|COMPLETED|Overall Study||0
143215|NCT00809133|328678|P11|COMPLETED|Overall Study||0
143216|NCT00809133|328679|P10|COMPLETED|Overall Study||0
143217|NCT00809133|328680|P9|COMPLETED|Overall Study||0
143218|NCT00809133|328681|P8|COMPLETED|Overall Study||0
143219|NCT00809133|328682|P7|COMPLETED|Overall Study||0
143220|NCT00809133|328683|P6|COMPLETED|Overall Study||0
143221|NCT00809133|328684|P5|COMPLETED|Overall Study||0
143222|NCT00809133|328685|P4|COMPLETED|Overall Study||0
143223|NCT00809133|328686|P3|COMPLETED|Overall Study||0
143224|NCT00809133|328687|P2|COMPLETED|Overall Study||0
143225|NCT00809133|328688|P1|COMPLETED|Overall Study||0
143226|NCT00809133|328675|P14|STARTED|Overall Study||7
143227|NCT00809133|328676|P13|STARTED|Overall Study||5
143228|NCT00809133|328677|P12|STARTED|Overall Study||8
143229|NCT00809133|328678|P11|STARTED|Overall Study||6
143230|NCT00809133|328679|P10|STARTED|Overall Study||9
143231|NCT00809133|328680|P9|STARTED|Overall Study||3
143232|NCT00809133|328681|P8|STARTED|Overall Study||8
143233|NCT00809133|328682|P7|STARTED|Overall Study||6
143234|NCT00809133|328683|P6|STARTED|Overall Study||7
143235|NCT00809133|328684|P5|STARTED|Overall Study||5
143236|NCT00809133|328685|P4|STARTED|Overall Study||3
143237|NCT00809133|328686|P3|STARTED|Overall Study||6
143238|NCT00809133|328687|P2|STARTED|Overall Study||7
143239|NCT00809133|328688|P1|STARTED|Overall Study||3
143240|NCT00809094|328842|P2|NOT COMPLETED|Overall Study||1
143241|NCT00809094|328843|P1|NOT COMPLETED|Overall Study||0
143242|NCT00809094|328842|P2|COMPLETED|Overall Study||33
143243|NCT00809094|328843|P1|COMPLETED|Overall Study||36
143244|NCT00809094|328842|P2|STARTED|Overall Study||34
143245|NCT00809094|328843|P1|STARTED|Overall Study||36
143246|NCT00809055|328863|P2|NOT COMPLETED|Overall Study||7
143247|NCT00809055|328864|P1|NOT COMPLETED|Overall Study||9
143248|NCT00809055|328863|P2|COMPLETED|Overall Study||30
143249|NCT00809055|328864|P1|COMPLETED|Overall Study||28
143250|NCT00809055|328863|P2|STARTED|Overall Study||37
143251|NCT00809055|328864|P1|STARTED|Overall Study||37
143252|NCT00808899|328888|P1|NOT COMPLETED|Overall Study||4
143253|NCT00808899|328888|P1|COMPLETED|Overall Study||0
143254|NCT00808899|328888|P1|STARTED|Overall Study||4
143255|NCT00808834|328892|P2|NOT COMPLETED|Period 2||0
143256|NCT00808834|328893|P1|NOT COMPLETED|Period 2||0
143257|NCT00808834|328892|P2|COMPLETED|Period 2||99
143258|NCT00808834|328893|P1|COMPLETED|Period 2||97
143259|NCT00808834|328892|P2|STARTED|Period 2||99
143260|NCT00808834|328893|P1|STARTED|Period 2||97
143261|NCT00808834|328892|P2|NOT COMPLETED|Period 1||0
143262|NCT00808834|328893|P1|NOT COMPLETED|Period 1||0
143263|NCT00808834|328892|P2|COMPLETED|Period 1||99
143264|NCT00808834|328893|P1|COMPLETED|Period 1||97
143265|NCT00808834|328892|P2|STARTED|Period 1||99
143266|NCT00808834|328893|P1|STARTED|Period 1||97
143267|NCT00808808|328902|P3|NOT COMPLETED|Overall Study||2557
143268|NCT00808808|328903|P2|NOT COMPLETED|Overall Study||2437
143269|NCT00808808|328904|P1|NOT COMPLETED|Overall Study||2817
143270|NCT00808808|328902|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
143271|NCT00808808|328903|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
143272|NCT00808808|328904|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
143273|NCT00808808|328902|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
143274|NCT00808808|328903|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
143275|NCT00808808|328904|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
143276|NCT00808808|328902|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
143277|NCT00808808|328903|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
143278|NCT00808808|328904|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
143279|NCT00808769|328930|P2|NOT COMPLETED|Second Intervention||0
143280|NCT00808769|328931|P1|NOT COMPLETED|Second Intervention||0
143281|NCT00808769|328930|P2|COMPLETED|Second Intervention||15
143282|NCT00808769|328931|P1|COMPLETED|Second Intervention||15
143283|NCT00808769|328930|P2|STARTED|Second Intervention||15
143284|NCT00808769|328931|P1|STARTED|Second Intervention||15
143285|NCT00808769|328930|P2|NOT COMPLETED|First Intervention||0
143286|NCT00808769|328931|P1|NOT COMPLETED|First Intervention||0
143287|NCT00808769|328930|P2|COMPLETED|First Intervention||15
143288|NCT00808769|328931|P1|COMPLETED|First Intervention||15
143289|NCT00808769|328930|P2|STARTED|First Intervention||15
143290|NCT00808769|328931|P1|STARTED|First Intervention||15
143291|NCT00808639|328937|P1|NOT COMPLETED|Overall Study||1
143292|NCT00808639|328937|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
143293|NCT00808639|328937|P1|STARTED|Overall Study||39
143294|NCT00808509|328945|P2|NOT COMPLETED|Observation Phase||0
143295|NCT00808509|328946|P1|NOT COMPLETED|Observation Phase||0
143296|NCT00808509|328945|P2|COMPLETED|Observation Phase||15
143297|NCT00808509|328946|P1|COMPLETED|Observation Phase||16
143298|NCT00808509|328945|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
143299|NCT00808509|328946|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
143300|NCT00808509|328945|P2|NOT COMPLETED|Randomized Phase||5
143301|NCT00808509|328946|P1|NOT COMPLETED|Randomized Phase||2
143302|NCT00808509|328945|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
143303|NCT00808509|328946|P1|COMPLETED|Randomized Phase||15
143304|NCT00808509|328945|P2|Received Rescue Therapy|Randomized Phase||9
143305|NCT00808509|328946|P1|Received Rescue Therapy|Randomized Phase||0
143306|NCT00808509|328945|P2|STARTED|Randomized Phase||16
143307|NCT00808509|328946|P1|STARTED|Randomized Phase||17
143308|NCT00808483|329044|P2|NOT COMPLETED|From 5 Months to 12 Months||0
143309|NCT00808483|329045|P1|NOT COMPLETED|From 5 Months to 12 Months||1
143310|NCT00808483|329044|P2|COMPLETED|From 5 Months to 12 Months||32
143311|NCT00808483|329045|P1|COMPLETED|From 5 Months to 12 Months||32
143312|NCT00808483|329044|P2|STARTED|From 5 Months to 12 Months||32
143313|NCT00808483|329045|P1|STARTED|From 5 Months to 12 Months||33
143314|NCT00808483|329044|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
143315|NCT00808483|329045|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
143316|NCT00808483|329044|P2|COMPLETED|From 3 to 5 Months After Surgery||32
143317|NCT00808483|329045|P1|COMPLETED|From 3 to 5 Months After Surgery||33
143318|NCT00808483|329044|P2|STARTED|From 3 to 5 Months After Surgery||33
143319|NCT00808483|329045|P1|STARTED|From 3 to 5 Months After Surgery||35
143320|NCT00808444|329067|P2|NOT COMPLETED|Overall Study||1
143321|NCT00808444|329068|P1|NOT COMPLETED|Overall Study||1
143322|NCT00808444|329067|P2|COMPLETED|Overall Study||232
143323|NCT00808444|329068|P1|COMPLETED|Overall Study||232
143324|NCT00808444|329067|P2|STARTED|Overall Study||233
143325|NCT00808444|329068|P1|STARTED|Overall Study||233
143326|NCT00808405|329108|P2|NOT COMPLETED|Overall Study||0
143327|NCT00808405|329109|P1|NOT COMPLETED|Overall Study||0
143328|NCT00808405|329108|P2|COMPLETED|Overall Study||27
143329|NCT00808405|329109|P1|COMPLETED|Overall Study||61
143330|NCT00808405|329108|P2|STARTED|Overall Study||27
143331|NCT00808405|329109|P1|STARTED|Overall Study||61
143332|NCT00808340|329117|P6|NOT COMPLETED|Third Intervention||0
143333|NCT00808340|329118|P5|NOT COMPLETED|Third Intervention||0
143334|NCT00808340|329119|P4|NOT COMPLETED|Third Intervention||0
143335|NCT00808340|329120|P3|NOT COMPLETED|Third Intervention||0
143336|NCT00808340|329121|P2|NOT COMPLETED|Third Intervention||0
143337|NCT00808340|329122|P1|NOT COMPLETED|Third Intervention||0
143338|NCT00808340|329117|P6|COMPLETED|Third Intervention||6
143339|NCT00808340|329118|P5|COMPLETED|Third Intervention||5
143340|NCT00808340|329119|P4|COMPLETED|Third Intervention||3
143341|NCT00808340|329120|P3|COMPLETED|Third Intervention||7
143342|NCT00808340|329121|P2|COMPLETED|Third Intervention||9
143343|NCT00808340|329122|P1|COMPLETED|Third Intervention||4
143344|NCT00808340|329117|P6|STARTED|Third Intervention||6
143345|NCT00808340|329118|P5|STARTED|Third Intervention||5
143346|NCT00808340|329119|P4|STARTED|Third Intervention||3
143347|NCT00808340|329120|P3|STARTED|Third Intervention||7
143348|NCT00808340|329121|P2|STARTED|Third Intervention||9
143349|NCT00808340|329122|P1|STARTED|Third Intervention||4
143350|NCT00808340|329117|P6|NOT COMPLETED|Second Intervention||0
143351|NCT00808340|329118|P5|NOT COMPLETED|Second Intervention||0
143352|NCT00808340|329119|P4|NOT COMPLETED|Second Intervention||0
143353|NCT00808340|329120|P3|NOT COMPLETED|Second Intervention||0
143354|NCT00808340|329121|P2|NOT COMPLETED|Second Intervention||0
143355|NCT00808340|329122|P1|NOT COMPLETED|Second Intervention||0
143356|NCT00808340|329117|P6|COMPLETED|Second Intervention||6
143357|NCT00808340|329118|P5|COMPLETED|Second Intervention||5
143358|NCT00808340|329119|P4|COMPLETED|Second Intervention||3
143359|NCT00808340|329120|P3|COMPLETED|Second Intervention||7
143360|NCT00808340|329121|P2|COMPLETED|Second Intervention||9
143361|NCT00808340|329122|P1|COMPLETED|Second Intervention||4
143362|NCT00808340|329117|P6|STARTED|Second Intervention||6
143363|NCT00808340|329118|P5|STARTED|Second Intervention||5
143364|NCT00808340|329119|P4|STARTED|Second Intervention||3
143365|NCT00808340|329120|P3|STARTED|Second Intervention||7
143366|NCT00808340|329121|P2|STARTED|Second Intervention||9
143367|NCT00808340|329122|P1|STARTED|Second Intervention||4
143368|NCT00808340|329117|P6|NOT COMPLETED|First Intervention||0
143369|NCT00808340|329118|P5|NOT COMPLETED|First Intervention||0
143370|NCT00808340|329119|P4|NOT COMPLETED|First Intervention||0
143371|NCT00808340|329120|P3|NOT COMPLETED|First Intervention||0
143372|NCT00808340|329121|P2|NOT COMPLETED|First Intervention||0
143373|NCT00808340|329122|P1|NOT COMPLETED|First Intervention||0
143374|NCT00808340|329117|P6|COMPLETED|First Intervention||6
143375|NCT00808340|329118|P5|COMPLETED|First Intervention||5
143376|NCT00808340|329119|P4|COMPLETED|First Intervention||3
143377|NCT00808340|329120|P3|COMPLETED|First Intervention||7
143378|NCT00808340|329121|P2|COMPLETED|First Intervention||9
143379|NCT00808340|329122|P1|COMPLETED|First Intervention||4
143380|NCT00808340|329117|P6|STARTED|First Intervention||6
143381|NCT00808340|329118|P5|STARTED|First Intervention||5
143382|NCT00808340|329119|P4|STARTED|First Intervention||3
143383|NCT00808340|329120|P3|STARTED|First Intervention||7
143384|NCT00808340|329121|P2|STARTED|First Intervention||9
143385|NCT00808340|329122|P1|STARTED|First Intervention||4
143386|NCT00808249|329143|P4|NOT COMPLETED|Overall Study||16
143387|NCT00808249|329144|P3|NOT COMPLETED|Overall Study||22
143388|NCT00808249|329145|P2|NOT COMPLETED|Overall Study||15
143389|NCT00808249|329146|P1|NOT COMPLETED|Overall Study||17
143390|NCT00808249|329143|P4|COMPLETED|Overall Study||90
143391|NCT00808249|329144|P3|COMPLETED|Overall Study||83
143392|NCT00808249|329145|P2|COMPLETED|Overall Study||91
143393|NCT00808249|329146|P1|COMPLETED|Overall Study||90
143394|NCT00808249|329143|P4|STARTED|Overall Study||106
143395|NCT00808249|329144|P3|STARTED|Overall Study||105
143396|NCT00808249|329145|P2|STARTED|Overall Study||106
143397|NCT00808249|329146|P1|STARTED|Overall Study||107
143398|NCT00808236|329174|P2|NOT COMPLETED|Overall Study||91
143399|NCT00808236|329175|P1|NOT COMPLETED|Overall Study||82
143400|NCT00808236|329174|P2|COMPLETED|Overall Study||13
143401|NCT00808236|329175|P1|COMPLETED|Overall Study||14
143402|NCT00808236|329174|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
143403|NCT00808236|329175|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
143404|NCT00808236|329174|P2|Achieved ROSC|Overall Study||43
143405|NCT00808236|329175|P1|Achieved ROSC|Overall Study||33
143406|NCT00808236|329174|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
143407|NCT00808236|329175|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
143408|NCT00808236|329174|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
143409|NCT00808236|329175|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
143410|NCT00808236|329174|P2|STARTED|Overall Study||104
143411|NCT00808236|329175|P1|STARTED|Overall Study||96
143412|NCT00808132|329208|P5|NOT COMPLETED|Overall Study||100
143413|NCT00808132|329209|P4|NOT COMPLETED|Overall Study||69
143414|NCT00808132|329210|P3|NOT COMPLETED|Overall Study||54
143415|NCT00808132|329211|P2|NOT COMPLETED|Overall Study||88
143416|NCT00808132|329212|P1|NOT COMPLETED|Overall Study||98
143417|NCT00808132|329208|P5|COMPLETED|Overall Study||383
143418|NCT00808132|329209|P4|COMPLETED|Overall Study||159
143419|NCT00808132|329210|P3|COMPLETED|Overall Study||185
143420|NCT00808132|329211|P2|COMPLETED|Overall Study||393
143421|NCT00808132|329212|P1|COMPLETED|Overall Study||357
143422|NCT00808132|329208|P5|Treated|Overall Study||474
143423|NCT00808132|329209|P4|Treated|Overall Study||220
143424|NCT00808132|329210|P3|Treated|Overall Study||230
143425|NCT00808132|329211|P2|Treated|Overall Study||474
143426|NCT00808132|329212|P1|Treated|Overall Study||445
143427|NCT00808132|329208|P5|STARTED|Overall Study||483
143428|NCT00808132|329209|P4|STARTED|Overall Study||228
143429|NCT00808132|329210|P3|STARTED|Overall Study||239
143430|NCT00808132|329211|P2|STARTED|Overall Study||481
143431|NCT00808132|329212|P1|STARTED|Overall Study||455
143432|NCT00808080|329284|P1|NOT COMPLETED|Overall Study||6
143433|NCT00808080|329284|P1|COMPLETED|Overall Study||0
143434|NCT00808080|329284|P1|STARTED|Overall Study||6
143435|NCT00808067|329290|P2|NOT COMPLETED|Overall Study||518
143436|NCT00808067|329291|P1|NOT COMPLETED|Overall Study||481
143437|NCT00808067|329290|P2|COMPLETED|Overall Study||2438
143438|NCT00808067|329291|P1|COMPLETED|Overall Study||2446
143439|NCT00808067|329290|P2|STARTED|Overall Study|Number of patients which are treated.|2956
143440|NCT00808067|329291|P1|STARTED|Overall Study|Number of patients which are treated.|2927
143441|NCT00808028|329327|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
143442|NCT00808028|329328|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
143443|NCT00808028|329329|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
143444|NCT00808028|329330|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
143445|NCT00808028|329327|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
143446|NCT00808028|329328|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
143447|NCT00808028|329329|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
143448|NCT00808028|329330|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
143449|NCT00808028|329327|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
143450|NCT00808028|329328|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
143451|NCT00808028|329329|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
143452|NCT00808028|329330|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
143453|NCT00808028|329327|P4|NOT COMPLETED|Stage 1 (6 Months)||15
143454|NCT00808028|329328|P3|NOT COMPLETED|Stage 1 (6 Months)||7
143455|NCT00808028|329329|P2|NOT COMPLETED|Stage 1 (6 Months)||1
143456|NCT00808028|329330|P1|NOT COMPLETED|Stage 1 (6 Months)||5
143457|NCT00808028|329327|P4|COMPLETED|Stage 1 (6 Months)||183
143458|NCT00808028|329328|P3|COMPLETED|Stage 1 (6 Months)||191
143459|NCT00808028|329329|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
143460|NCT00808028|329330|P1|COMPLETED|Stage 1 (6 Months)||116
143461|NCT00808028|329327|P4|STARTED|Stage 1 (6 Months)||198
143462|NCT00808028|329328|P3|STARTED|Stage 1 (6 Months)||198
143463|NCT00808028|329329|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
143464|NCT00808028|329330|P1|STARTED|Stage 1 (6 Months)||121
143465|NCT00808015|329366|P1|NOT COMPLETED|Overall Study||344
143466|NCT00808015|329366|P1|COMPLETED|Overall Study||1033
143467|NCT00808015|329366|P1|Treated|Overall Study||1373
143468|NCT00808015|329366|P1|STARTED|Overall Study||1377
143469|NCT00807989|329380|P2|NOT COMPLETED|Overall Study||2
143470|NCT00807989|329381|P1|NOT COMPLETED|Overall Study||3
143471|NCT00807989|329380|P2|COMPLETED|Overall Study||98
143472|NCT00807989|329381|P1|COMPLETED|Overall Study||104
143473|NCT00807989|329380|P2|STARTED|Overall Study||100
143474|NCT00807989|329381|P1|STARTED|Overall Study||107
143475|NCT00807937|329395|P4|NOT COMPLETED|Overall Study||15
143476|NCT00807937|329396|P3|NOT COMPLETED|Overall Study||14
143477|NCT00807937|329397|P2|NOT COMPLETED|Overall Study||25
143478|NCT00807937|329398|P1|NOT COMPLETED|Overall Study||27
143479|NCT00807937|329395|P4|COMPLETED|Overall Study||77
143480|NCT00807937|329396|P3|COMPLETED|Overall Study||78
143481|NCT00807937|329397|P2|COMPLETED|Overall Study||67
143482|NCT00807937|329398|P1|COMPLETED|Overall Study||66
143483|NCT00807937|329395|P4|STARTED|Overall Study||92
143484|NCT00807937|329396|P3|STARTED|Overall Study||92
143485|NCT00807937|329397|P2|STARTED|Overall Study||92
143486|NCT00807937|329398|P1|STARTED|Overall Study||93
143487|NCT00807885|329433|P9|NOT COMPLETED|Overall Study||0
143488|NCT00807885|329434|P8|NOT COMPLETED|Overall Study||0
143489|NCT00807885|329435|P7|NOT COMPLETED|Overall Study||0
143490|NCT00807885|329436|P6|NOT COMPLETED|Overall Study||1
143491|NCT00807885|329437|P5|NOT COMPLETED|Overall Study||0
143492|NCT00807885|329438|P4|NOT COMPLETED|Overall Study||0
143493|NCT00807885|329439|P3|NOT COMPLETED|Overall Study||0
143494|NCT00807885|329440|P2|NOT COMPLETED|Overall Study||0
143495|NCT00807885|329441|P1|NOT COMPLETED|Overall Study||0
143496|NCT00807885|329433|P9|COMPLETED|Overall Study||11
143497|NCT00807885|329434|P8|COMPLETED|Overall Study||11
143498|NCT00807885|329435|P7|COMPLETED|Overall Study||12
143499|NCT00807885|329436|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
143500|NCT00807885|329437|P5|COMPLETED|Overall Study||12
143501|NCT00807885|329438|P4|COMPLETED|Overall Study||10
143502|NCT00807885|329439|P3|COMPLETED|Overall Study||11
143503|NCT00807885|329440|P2|COMPLETED|Overall Study||11
143504|NCT00807885|329441|P1|COMPLETED|Overall Study||10
143505|NCT00807885|329433|P9|STARTED|Overall Study||11
143506|NCT00807885|329434|P8|STARTED|Overall Study||11
143507|NCT00807885|329435|P7|STARTED|Overall Study||12
143508|NCT00807885|329436|P6|STARTED|Overall Study||12
143509|NCT00807885|329437|P5|STARTED|Overall Study||12
143510|NCT00807885|329438|P4|STARTED|Overall Study||10
143511|NCT00807885|329439|P3|STARTED|Overall Study||11
143512|NCT00807885|329440|P2|STARTED|Overall Study||11
143513|NCT00807885|329441|P1|STARTED|Overall Study||10
143514|NCT00807846|329490|P2|NOT COMPLETED|Overall Study||4
143515|NCT00807846|329491|P1|NOT COMPLETED|Overall Study||12
143516|NCT00807846|329490|P2|COMPLETED|Overall Study||94
143517|NCT00807846|329491|P1|COMPLETED|Overall Study||88
143518|NCT00807846|329490|P2|STARTED|Overall Study||98
143519|NCT00807846|329491|P1|STARTED|Overall Study||100
143520|NCT00807573|329523|P1|NOT COMPLETED|Overall Study||2
143521|NCT00807573|329523|P1|COMPLETED|Overall Study||42
143522|NCT00807573|329523|P1|STARTED|Overall Study||44
143523|NCT00807560|329529|P2|NOT COMPLETED|Overall Study||0
143524|NCT00807560|329530|P1|NOT COMPLETED|Overall Study||0
143525|NCT00807560|329529|P2|COMPLETED|Overall Study||39
143526|NCT00807560|329530|P1|COMPLETED|Overall Study||38
143527|NCT00807560|329529|P2|STARTED|Overall Study||39
143528|NCT00807560|329530|P1|STARTED|Overall Study||38
143529|NCT00807456|329564|P1|NOT COMPLETED|Overall Study||0
143530|NCT00807456|329564|P1|COMPLETED|Overall Study||65
143531|NCT00807456|329564|P1|STARTED|Overall Study||65
143532|NCT00807248|329572|P4|NOT COMPLETED|Overall Study||14
143533|NCT00807248|329573|P3|NOT COMPLETED|Overall Study||18
143534|NCT00807248|329574|P2|NOT COMPLETED|Overall Study||12
143535|NCT00807248|329575|P1|NOT COMPLETED|Overall Study||21
143536|NCT00807248|329572|P4|COMPLETED|Overall Study||126
143537|NCT00807248|329573|P3|COMPLETED|Overall Study||121
143538|NCT00807248|329574|P2|COMPLETED|Overall Study||128
143539|NCT00807248|329575|P1|COMPLETED|Overall Study||50
143540|NCT00807248|329572|P4|STARTED|Overall Study||140
143541|NCT00807248|329573|P3|STARTED|Overall Study||139
143542|NCT00807248|329574|P2|STARTED|Overall Study||140
143543|NCT00807248|329575|P1|STARTED|Overall Study||71
143544|NCT00807235|329619|P2|NOT COMPLETED|Overall Study||0
143545|NCT00807235|329620|P1|NOT COMPLETED|Overall Study||1
143546|NCT00807235|329619|P2|COMPLETED|Overall Study||6
143547|NCT00807235|329620|P1|COMPLETED|Overall Study||10
143548|NCT00807235|329619|P2|STARTED|Overall Study||6
143549|NCT00807235|329620|P1|STARTED|Overall Study||11
143550|NCT00807209|329653|P3|NOT COMPLETED|Overall Study||0
143551|NCT00807209|329654|P2|NOT COMPLETED|Overall Study||0
143552|NCT00807209|329655|P1|NOT COMPLETED|Overall Study||0
143553|NCT00807209|329653|P3|COMPLETED|Overall Study||1
143554|NCT00807209|329654|P2|COMPLETED|Overall Study||1
143555|NCT00807209|329655|P1|COMPLETED|Overall Study||1
143556|NCT00807209|329653|P3|STARTED|Overall Study||1
143557|NCT00807209|329654|P2|STARTED|Overall Study||1
143558|NCT00807209|329655|P1|STARTED|Overall Study||1
143559|NCT00807092|329665|P2|NOT COMPLETED|Overall Study||4
143560|NCT00807092|329666|P1|NOT COMPLETED|Overall Study||1
143561|NCT00807092|329665|P2|COMPLETED|Overall Study||69
143562|NCT00807092|329666|P1|COMPLETED|Overall Study||71
143563|NCT00807092|329665|P2|Exposed to Drug|Overall Study||73
143564|NCT00807092|329666|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
143565|NCT00807092|329665|P2|STARTED|Overall Study||73
143566|NCT00807092|329666|P1|STARTED|Overall Study||72
143567|NCT00807014|329696|P2|NOT COMPLETED|Overall Study||27
143568|NCT00807014|329697|P1|NOT COMPLETED|Overall Study||27
143569|NCT00807014|329696|P2|COMPLETED|Overall Study||58
143570|NCT00807014|329697|P1|COMPLETED|Overall Study||56
143571|NCT00807014|329696|P2|STARTED|Overall Study||85
143572|NCT00807014|329697|P1|STARTED|Overall Study||83
143573|NCT00807001|329728|P5|NOT COMPLETED|Overall Study||0
143574|NCT00807001|329729|P4|NOT COMPLETED|Overall Study||0
143575|NCT00807001|329730|P3|NOT COMPLETED|Overall Study||0
143576|NCT00807001|329731|P2|NOT COMPLETED|Overall Study||1
143577|NCT00807001|329732|P1|NOT COMPLETED|Overall Study||0
143578|NCT00807001|329728|P5|COMPLETED|Overall Study||9
143579|NCT00807001|329729|P4|COMPLETED|Overall Study||8
143580|NCT00807001|329730|P3|COMPLETED|Overall Study||8
143581|NCT00807001|329731|P2|COMPLETED|Overall Study||7
143582|NCT00807001|329732|P1|COMPLETED|Overall Study||8
143583|NCT00807001|329728|P5|STARTED|Overall Study||9
143584|NCT00807001|329729|P4|STARTED|Overall Study||8
143585|NCT00807001|329730|P3|STARTED|Overall Study||8
143586|NCT00807001|329731|P2|STARTED|Overall Study||8
143587|NCT00807001|329732|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
143588|NCT00806819|329751|P2|NOT COMPLETED|Overall Study||358
143589|NCT00806819|329752|P1|NOT COMPLETED|Overall Study||346
143590|NCT00806819|329751|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
143591|NCT00806819|329752|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
143592|NCT00806819|329751|P2|STARTED|Overall Study|randomised patients|360
143593|NCT00806819|329752|P1|STARTED|Overall Study|randomised patients|353
143594|NCT00806624|329787|P3|NOT COMPLETED|Overall Study||6
143595|NCT00806624|329788|P2|NOT COMPLETED|Overall Study||12
143596|NCT00806624|329789|P1|NOT COMPLETED|Overall Study||9
143597|NCT00806624|329787|P3|COMPLETED|Overall Study||69
143598|NCT00806624|329788|P2|COMPLETED|Overall Study||68
143599|NCT00806624|329789|P1|COMPLETED|Overall Study||70
143600|NCT00806624|329787|P3|STARTED|Overall Study||75
143601|NCT00806624|329788|P2|STARTED|Overall Study||80
143602|NCT00806624|329789|P1|STARTED|Overall Study||79
143603|NCT00806598|329797|P1|NOT COMPLETED|Overall Study||0
143604|NCT00806598|329797|P1|COMPLETED|Overall Study||48
143605|NCT00806598|329797|P1|STARTED|Overall Study||48
143606|NCT00806585|329806|P5|NOT COMPLETED|Overall Study||31
143607|NCT00806585|329807|P4|NOT COMPLETED|Overall Study||15
143608|NCT00806585|329808|P3|NOT COMPLETED|Overall Study||32
143609|NCT00806585|329809|P2|NOT COMPLETED|Overall Study||31
143610|NCT00806585|329810|P1|NOT COMPLETED|Overall Study||32
143611|NCT00806585|329806|P5|COMPLETED|Overall Study||106
143612|NCT00806585|329807|P4|COMPLETED|Overall Study||56
143613|NCT00806585|329808|P3|COMPLETED|Overall Study||109
143614|NCT00806585|329809|P2|COMPLETED|Overall Study||103
143615|NCT00806585|329810|P1|COMPLETED|Overall Study||105
143616|NCT00806585|329806|P5|STARTED|Overall Study||137
143617|NCT00806585|329807|P4|STARTED|Overall Study||71
143618|NCT00806585|329808|P3|STARTED|Overall Study||141
143619|NCT00806585|329809|P2|STARTED|Overall Study||134
143620|NCT00806585|329810|P1|STARTED|Overall Study||137
143621|NCT00806546|329842|P1|NOT COMPLETED|Overall Study||307
143622|NCT00806546|329842|P1|COMPLETED|Overall Study||207
143623|NCT00806546|329842|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
143624|NCT00806494|329846|P1|NOT COMPLETED|Overall Study||80
143625|NCT00806494|329846|P1|COMPLETED|Overall Study||251
143626|NCT00806494|329846|P1|STARTED|Overall Study||331
143627|NCT00806416|329872|P4|NOT COMPLETED|Period 2 - Part II||0
143628|NCT00806416|329873|P3|NOT COMPLETED|Period 2 - Part II||0
143629|NCT00806416|329874|P2|NOT COMPLETED|Period 2 - Part II||0
143630|NCT00806416|329875|P1|NOT COMPLETED|Period 2 - Part II||0
143631|NCT00806416|329872|P4|COMPLETED|Period 2 - Part II||14
143632|NCT00806416|329873|P3|COMPLETED|Period 2 - Part II||14
143633|NCT00806416|329874|P2|COMPLETED|Period 2 - Part II||0
143634|NCT00806416|329875|P1|COMPLETED|Period 2 - Part II||0
143635|NCT00806416|329872|P4|STARTED|Period 2 - Part II||14
143636|NCT00806416|329873|P3|STARTED|Period 2 - Part II||14
143637|NCT00806416|329874|P2|STARTED|Period 2 - Part II||0
143638|NCT00806416|329875|P1|STARTED|Period 2 - Part II||0
143639|NCT00806416|329872|P4|NOT COMPLETED|Period 1 - Part II||2
143640|NCT00806416|329873|P3|NOT COMPLETED|Period 1 - Part II||0
143641|NCT00806416|329874|P2|NOT COMPLETED|Period 1 - Part II||0
143642|NCT00806416|329875|P1|NOT COMPLETED|Period 1 - Part II||0
143643|NCT00806416|329872|P4|COMPLETED|Period 1 - Part II||14
143644|NCT00806416|329873|P3|COMPLETED|Period 1 - Part II||14
143645|NCT00806416|329874|P2|COMPLETED|Period 1 - Part II||0
143646|NCT00806416|329875|P1|COMPLETED|Period 1 - Part II||0
143647|NCT00806416|329872|P4|STARTED|Period 1 - Part II||16
143648|NCT00806416|329873|P3|STARTED|Period 1 - Part II||14
143649|NCT00806416|329874|P2|STARTED|Period 1 - Part II||0
143650|NCT00806416|329875|P1|STARTED|Period 1 - Part II||0
143651|NCT00806416|329872|P4|NOT COMPLETED|Period 2 - Part I||0
143652|NCT00806416|329873|P3|NOT COMPLETED|Period 2 - Part I||0
143653|NCT00806416|329874|P2|NOT COMPLETED|Period 2 - Part I||0
143654|NCT00806416|329875|P1|NOT COMPLETED|Period 2 - Part I||0
143655|NCT00806416|329872|P4|COMPLETED|Period 2 - Part I||0
143656|NCT00806416|329873|P3|COMPLETED|Period 2 - Part I||0
143657|NCT00806416|329874|P2|COMPLETED|Period 2 - Part I||103
143658|NCT00806416|329875|P1|COMPLETED|Period 2 - Part I||104
143659|NCT00806416|329872|P4|STARTED|Period 2 - Part I||0
143660|NCT00806416|329873|P3|STARTED|Period 2 - Part I||0
143661|NCT00806416|329874|P2|STARTED|Period 2 - Part I||103
143662|NCT00806416|329875|P1|STARTED|Period 2 - Part I||104
143663|NCT00806416|329872|P4|NOT COMPLETED|Period 1 - Part I||0
143664|NCT00806416|329873|P3|NOT COMPLETED|Period 1 - Part I||0
143665|NCT00806416|329874|P2|NOT COMPLETED|Period 1 - Part I||4
143666|NCT00806416|329875|P1|NOT COMPLETED|Period 1 - Part I||3
143667|NCT00806416|329872|P4|COMPLETED|Period 1 - Part I||0
143668|NCT00806416|329873|P3|COMPLETED|Period 1 - Part I||0
143669|NCT00806416|329874|P2|COMPLETED|Period 1 - Part I||103
143670|NCT00806416|329875|P1|COMPLETED|Period 1 - Part I||104
143671|NCT00806416|329872|P4|STARTED|Period 1 - Part I||0
143672|NCT00806416|329873|P3|STARTED|Period 1 - Part I||0
143673|NCT00806416|329874|P2|STARTED|Period 1 - Part I||107
143674|NCT00806416|329875|P1|STARTED|Period 1 - Part I||107
143675|NCT00806403|329888|P2|NOT COMPLETED|Overall Study||3
143676|NCT00806403|329889|P1|NOT COMPLETED|Overall Study||4
143677|NCT00806403|329888|P2|COMPLETED|Overall Study||98
143678|NCT00806403|329889|P1|COMPLETED|Overall Study||100
143679|NCT00806403|329888|P2|STARTED|Overall Study||101
143680|NCT00806403|329889|P1|STARTED|Overall Study||104
143681|NCT00806390|329903|P2|NOT COMPLETED|Overall Study||0
143682|NCT00806390|329904|P1|NOT COMPLETED|Overall Study||0
143683|NCT00806390|329903|P2|COMPLETED|Overall Study||8
143684|NCT00806390|329904|P1|COMPLETED|Overall Study||7
143685|NCT00806390|329903|P2|STARTED|Overall Study||8
143686|NCT00806390|329904|P1|STARTED|Overall Study||7
143687|NCT00806351|329912|P2|NOT COMPLETED|Overall Study||4
143688|NCT00806351|329913|P1|NOT COMPLETED|Overall Study||5
143689|NCT00806351|329912|P2|COMPLETED|Overall Study||2
143690|NCT00806351|329913|P1|COMPLETED|Overall Study||10
143691|NCT00806351|329912|P2|STARTED|Overall Study||6
143692|NCT00806351|329913|P1|STARTED|Overall Study||15
143693|NCT00806260|329950|P6|NOT COMPLETED|Period 3||0
143694|NCT00806260|329951|P5|NOT COMPLETED|Period 3||0
143695|NCT00806260|329952|P4|NOT COMPLETED|Period 3||0
143696|NCT00806260|329953|P3|NOT COMPLETED|Period 3||1
143697|NCT00806260|329954|P2|NOT COMPLETED|Period 3||1
143698|NCT00806260|329955|P1|NOT COMPLETED|Period 3||1
143699|NCT00806260|329950|P6|COMPLETED|Period 3||0
143700|NCT00806260|329951|P5|COMPLETED|Period 3||0
143701|NCT00806260|329952|P4|COMPLETED|Period 3||12
143702|NCT00806260|329953|P3|COMPLETED|Period 3||5
143703|NCT00806260|329954|P2|COMPLETED|Period 3||7
143704|NCT00806260|329955|P1|COMPLETED|Period 3||12
143705|NCT00806260|329950|P6|STARTED|Period 3||0
143706|NCT00806260|329951|P5|STARTED|Period 3||0
143707|NCT00806260|329952|P4|STARTED|Period 3||12
143708|NCT00806260|329953|P3|STARTED|Period 3||6
143709|NCT00806260|329954|P2|STARTED|Period 3||8
143710|NCT00806260|329955|P1|STARTED|Period 3||13
143711|NCT00806260|329950|P6|NOT COMPLETED|Period 2||0
143712|NCT00806260|329951|P5|NOT COMPLETED|Period 2||0
143713|NCT00806260|329952|P4|NOT COMPLETED|Period 2||2
143714|NCT00806260|329953|P3|NOT COMPLETED|Period 2||2
143715|NCT00806260|329954|P2|NOT COMPLETED|Period 2||0
143716|NCT00806260|329955|P1|NOT COMPLETED|Period 2||2
143717|NCT00806260|329950|P6|COMPLETED|Period 2||0
143718|NCT00806260|329951|P5|COMPLETED|Period 2||0
143719|NCT00806260|329952|P4|COMPLETED|Period 2||12
143720|NCT00806260|329953|P3|COMPLETED|Period 2||6
143721|NCT00806260|329954|P2|COMPLETED|Period 2||8
143722|NCT00806260|329955|P1|COMPLETED|Period 2||13
143723|NCT00806260|329950|P6|STARTED|Period 2||0
143724|NCT00806260|329951|P5|STARTED|Period 2||0
143725|NCT00806260|329952|P4|STARTED|Period 2||14
143726|NCT00806260|329953|P3|STARTED|Period 2||8
143727|NCT00806260|329954|P2|STARTED|Period 2||8
143728|NCT00806260|329955|P1|STARTED|Period 2||15
143729|NCT00806260|329950|P6|NOT COMPLETED|Period 1 (1 Day)||0
143730|NCT00806260|329951|P5|NOT COMPLETED|Period 1 (1 Day)||3
143731|NCT00806260|329952|P4|NOT COMPLETED|Period 1 (1 Day)||0
143732|NCT00806260|329953|P3|NOT COMPLETED|Period 1 (1 Day)||0
143733|NCT00806260|329954|P2|NOT COMPLETED|Period 1 (1 Day)||0
143734|NCT00806260|329955|P1|NOT COMPLETED|Period 1 (1 Day)||0
143828|NCT00805792|330185|P1|NOT COMPLETED|Overall Study||5
143735|NCT00806260|329950|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
143736|NCT00806260|329951|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
143737|NCT00806260|329952|P4|COMPLETED|Period 1 (1 Day)||14
143738|NCT00806260|329953|P3|COMPLETED|Period 1 (1 Day)||8
143739|NCT00806260|329954|P2|COMPLETED|Period 1 (1 Day)||8
143740|NCT00806260|329955|P1|COMPLETED|Period 1 (1 Day)||15
143741|NCT00806260|329950|P6|STARTED|Period 1 (1 Day)||17
143742|NCT00806260|329951|P5|STARTED|Period 1 (1 Day)||18
143743|NCT00806260|329952|P4|STARTED|Period 1 (1 Day)||14
143744|NCT00806260|329953|P3|STARTED|Period 1 (1 Day)||8
143745|NCT00806260|329954|P2|STARTED|Period 1 (1 Day)||8
143746|NCT00806260|329955|P1|STARTED|Period 1 (1 Day)||15
143747|NCT00806195|329971|P4|NOT COMPLETED|Overall Study||106
143748|NCT00806195|329972|P3|NOT COMPLETED|Overall Study||270
143749|NCT00806195|329973|P2|NOT COMPLETED|Overall Study||162
143750|NCT00806195|329974|P1|NOT COMPLETED|Overall Study||514
143751|NCT00806195|329971|P4|COMPLETED|Overall Study||383
143752|NCT00806195|329972|P3|COMPLETED|Overall Study||1139
143753|NCT00806195|329973|P2|COMPLETED|Overall Study||1321
143754|NCT00806195|329974|P1|COMPLETED|Overall Study||3849
143755|NCT00806195|329971|P4|STARTED|Overall Study||489
143756|NCT00806195|329972|P3|STARTED|Overall Study||1409
143757|NCT00806195|329973|P2|STARTED|Overall Study||1483
143758|NCT00806195|329974|P1|STARTED|Overall Study||4363
143759|NCT00806078|329988|P2|NOT COMPLETED|Second Intervention||0
143760|NCT00806078|329989|P1|NOT COMPLETED|Second Intervention||0
143761|NCT00806078|329988|P2|COMPLETED|Second Intervention||9
143762|NCT00806078|329989|P1|COMPLETED|Second Intervention||9
143763|NCT00806078|329988|P2|STARTED|Second Intervention||9
143764|NCT00806078|329989|P1|STARTED|Second Intervention||9
143765|NCT00806078|329988|P2|NOT COMPLETED|7 Day Washout Period||0
143766|NCT00806078|329989|P1|NOT COMPLETED|7 Day Washout Period||0
143767|NCT00806078|329988|P2|COMPLETED|7 Day Washout Period||9
143768|NCT00806078|329989|P1|COMPLETED|7 Day Washout Period||9
143769|NCT00806078|329988|P2|STARTED|7 Day Washout Period||9
143770|NCT00806078|329989|P1|STARTED|7 Day Washout Period||9
143771|NCT00806078|329988|P2|NOT COMPLETED|First Intervention||0
143772|NCT00806078|329989|P1|NOT COMPLETED|First Intervention||0
143773|NCT00806078|329988|P2|COMPLETED|First Intervention||9
143774|NCT00806078|329989|P1|COMPLETED|First Intervention||9
143775|NCT00806078|329988|P2|STARTED|First Intervention||9
143776|NCT00806078|329989|P1|STARTED|First Intervention||9
143777|NCT00806026|330005|P6|NOT COMPLETED|Overall Study||32
143778|NCT00806026|330006|P5|NOT COMPLETED|Overall Study||30
143779|NCT00806026|330007|P4|NOT COMPLETED|Overall Study||29
143780|NCT00806026|330008|P3|NOT COMPLETED|Overall Study||93
143781|NCT00806026|330009|P2|NOT COMPLETED|Overall Study||101
143782|NCT00806026|330010|P1|NOT COMPLETED|Overall Study||92
143783|NCT00806026|330005|P6|COMPLETED|Overall Study||29
143784|NCT00806026|330006|P5|COMPLETED|Overall Study||29
143785|NCT00806026|330007|P4|COMPLETED|Overall Study||32
143786|NCT00806026|330008|P3|COMPLETED|Overall Study||89
143787|NCT00806026|330009|P2|COMPLETED|Overall Study||82
143788|NCT00806026|330010|P1|COMPLETED|Overall Study||93
143789|NCT00806026|330005|P6|Treated|Overall Study||61
143790|NCT00806026|330006|P5|Treated|Overall Study||59
143791|NCT00806026|330007|P4|Treated|Overall Study||59
143792|NCT00806026|330008|P3|Treated|Overall Study||180
143793|NCT00806026|330009|P2|Treated|Overall Study||178
143794|NCT00806026|330010|P1|Treated|Overall Study||182
143795|NCT00806026|330005|P6|STARTED|Overall Study||61
143796|NCT00806026|330006|P5|STARTED|Overall Study||59
143797|NCT00806026|330007|P4|STARTED|Overall Study||61
143798|NCT00806026|330008|P3|STARTED|Overall Study||182
143799|NCT00806026|330009|P2|STARTED|Overall Study||183
143800|NCT00806026|330010|P1|STARTED|Overall Study||185
143801|NCT00805961|330105|P1|NOT COMPLETED|Maintenance Treatment||34
143802|NCT00805961|330105|P1|COMPLETED|Maintenance Treatment||23
143803|NCT00805961|330105|P1|STARTED|Maintenance Treatment||57
143804|NCT00805961|330105|P1|NOT COMPLETED|Treatment-Free Interval||7
143805|NCT00805961|330105|P1|COMPLETED|Treatment-Free Interval||57
143806|NCT00805961|330105|P1|STARTED|Treatment-Free Interval||64
143807|NCT00805961|330105|P1|NOT COMPLETED|Modality Therapy||4
143808|NCT00805961|330105|P1|COMPLETED|Modality Therapy||64
143809|NCT00805961|330105|P1|STARTED|Modality Therapy||68
143810|NCT00805935|330115|P4|NOT COMPLETED|Overall Study||11
143811|NCT00805935|330116|P3|NOT COMPLETED|Overall Study||15
143812|NCT00805935|330117|P2|NOT COMPLETED|Overall Study||19
143813|NCT00805935|330118|P1|NOT COMPLETED|Overall Study||13
143814|NCT00805935|330115|P4|COMPLETED|Overall Study||19
143815|NCT00805935|330116|P3|COMPLETED|Overall Study||13
143816|NCT00805935|330117|P2|COMPLETED|Overall Study||8
143817|NCT00805935|330118|P1|COMPLETED|Overall Study||12
143818|NCT00805935|330115|P4|STARTED|Overall Study||30
143819|NCT00805935|330116|P3|STARTED|Overall Study||28
143820|NCT00805935|330117|P2|STARTED|Overall Study||27
143821|NCT00805935|330118|P1|STARTED|Overall Study||25
143822|NCT00805870|330172|P2|NOT COMPLETED|Overall Study||0
143823|NCT00805870|330173|P1|NOT COMPLETED|Overall Study||0
143824|NCT00805870|330172|P2|COMPLETED|Overall Study||10
143825|NCT00805870|330173|P1|COMPLETED|Overall Study||10
143826|NCT00805870|330172|P2|STARTED|Overall Study||10
143827|NCT00805870|330173|P1|STARTED|Overall Study||10
143829|NCT00805792|330185|P1|COMPLETED|Overall Study||28
143830|NCT00805792|330185|P1|STARTED|Overall Study||33
143831|NCT00805766|330193|P1|NOT COMPLETED|Increased Dose Period||13
143832|NCT00805766|330193|P1|COMPLETED|Increased Dose Period||26
143833|NCT00805766|330193|P1|STARTED|Increased Dose Period||39
143834|NCT00805766|330193|P1|NOT COMPLETED|Screening Period||6
143835|NCT00805766|330193|P1|COMPLETED|Screening Period||39
143836|NCT00805766|330193|P1|STARTED|Screening Period||45
143837|NCT00805740|330202|P2|NOT COMPLETED|Overall Study||4
143838|NCT00805740|330203|P1|NOT COMPLETED|Overall Study||11
143839|NCT00805740|330202|P2|COMPLETED|Overall Study||9
143840|NCT00805740|330203|P1|COMPLETED|Overall Study||17
143841|NCT00805740|330202|P2|Treated|Overall Study||13
143842|NCT00805740|330203|P1|Treated|Overall Study||26
143843|NCT00805740|330202|P2|STARTED|Overall Study||13
143844|NCT00805740|330203|P1|STARTED|Overall Study||28
143845|NCT00805675|330228|P3|NOT COMPLETED|Overall Study||1
143846|NCT00805675|330229|P2|NOT COMPLETED|Overall Study||0
143847|NCT00805675|330230|P1|NOT COMPLETED|Overall Study||0
143848|NCT00805675|330228|P3|COMPLETED|Overall Study||15
143849|NCT00805675|330229|P2|COMPLETED|Overall Study||14
143850|NCT00805675|330230|P1|COMPLETED|Overall Study||16
143851|NCT00805675|330228|P3|STARTED|Overall Study||16
143852|NCT00805675|330229|P2|STARTED|Overall Study||14
143853|NCT00805675|330230|P1|STARTED|Overall Study||16
143854|NCT00805545|330264|P2|NOT COMPLETED|Overall Study||3
143855|NCT00805545|330265|P1|NOT COMPLETED|Overall Study||6
143856|NCT00805545|330264|P2|COMPLETED|Overall Study||197
143857|NCT00805545|330265|P1|COMPLETED|Overall Study||194
143858|NCT00805545|330264|P2|STARTED|Overall Study||200
143859|NCT00805545|330265|P1|STARTED|Overall Study||200
143860|NCT00805493|330274|P3|NOT COMPLETED|Overall Study||1
143861|NCT00805493|330275|P2|NOT COMPLETED|Overall Study||0
143862|NCT00805493|330276|P1|NOT COMPLETED|Overall Study||2
143863|NCT00805493|330274|P3|COMPLETED|Overall Study||0
143864|NCT00805493|330275|P2|COMPLETED|Overall Study||2
143865|NCT00805493|330276|P1|COMPLETED|Overall Study||1
143866|NCT00805493|330274|P3|STARTED|Overall Study||1
143867|NCT00805493|330275|P2|STARTED|Overall Study||2
143868|NCT00805493|330276|P1|STARTED|Overall Study||3
143869|NCT00805480|330291|P4|NOT COMPLETED|Overall Study||5
143870|NCT00805480|330292|P3|NOT COMPLETED|Overall Study||12
143871|NCT00805480|330293|P2|NOT COMPLETED|Overall Study||7
143872|NCT00805480|330294|P1|NOT COMPLETED|Overall Study||14
143873|NCT00805480|330291|P4|COMPLETED|Overall Study||5
143874|NCT00805480|330292|P3|COMPLETED|Overall Study||19
143875|NCT00805480|330293|P2|COMPLETED|Overall Study||22
143876|NCT00805480|330294|P1|COMPLETED|Overall Study||16
143877|NCT00805480|330291|P4|Pharmacodynamic Analysis Set|Overall Study||10
143878|NCT00805480|330292|P3|Pharmacodynamic Analysis Set|Overall Study||29
143879|NCT00805480|330293|P2|Pharmacodynamic Analysis Set|Overall Study||25
143880|NCT00805480|330294|P1|Pharmacodynamic Analysis Set|Overall Study||30
143881|NCT00805480|330291|P4|STARTED|Overall Study||10
143882|NCT00805480|330292|P3|STARTED|Overall Study||31
143883|NCT00805480|330293|P2|STARTED|Overall Study||29
143884|NCT00805480|330294|P1|STARTED|Overall Study||30
143885|NCT00805467|330323|P4|NOT COMPLETED|Overall Study||237
143886|NCT00805467|330324|P3|NOT COMPLETED|Overall Study||103
143887|NCT00805467|330325|P2|NOT COMPLETED|Overall Study||34
143888|NCT00805467|330326|P1|NOT COMPLETED|Overall Study||0
143889|NCT00805467|330323|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
143890|NCT00805467|330324|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
143891|NCT00805467|330325|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
143892|NCT00805467|330326|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
143893|NCT00805467|330323|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
143894|NCT00805467|330324|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
143895|NCT00805467|330325|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
143896|NCT00805467|330326|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
143897|NCT00805467|330323|P4|STARTED|Overall Study|Patients who received treatment|381
143898|NCT00805467|330324|P3|STARTED|Overall Study|Patients who received treatment|183
143899|NCT00805467|330325|P2|STARTED|Overall Study|Patients who received treatment|59
143900|NCT00805467|330326|P1|STARTED|Overall Study|Patients who received treatment|1
143901|NCT00804193|330347|P3|NOT COMPLETED|Overall Study||32
143902|NCT00804193|330348|P2|NOT COMPLETED|Overall Study||44
143903|NCT00804193|330349|P1|NOT COMPLETED|Overall Study||39
143904|NCT00804193|330347|P3|COMPLETED|Overall Study||77
143905|NCT00804193|330348|P2|COMPLETED|Overall Study||180
143906|NCT00804193|330349|P1|COMPLETED|Overall Study||181
143907|NCT00804193|330347|P3|STARTED|Overall Study||109
143908|NCT00804193|330348|P2|STARTED|Overall Study||224
143909|NCT00804193|330349|P1|STARTED|Overall Study||220
143910|NCT00805389|330368|P5|NOT COMPLETED|Overall Study||13
143911|NCT00805389|330369|P4|NOT COMPLETED|Overall Study||17
143912|NCT00805389|330370|P3|NOT COMPLETED|Overall Study||12
143913|NCT00805389|330371|P2|NOT COMPLETED|Overall Study||5
143914|NCT00805389|330372|P1|NOT COMPLETED|Overall Study||7
143915|NCT00805389|330368|P5|COMPLETED|Overall Study||129
143916|NCT00805389|330369|P4|COMPLETED|Overall Study||128
143917|NCT00805389|330370|P3|COMPLETED|Overall Study||129
143918|NCT00805389|330371|P2|COMPLETED|Overall Study||137
143919|NCT00805389|330372|P1|COMPLETED|Overall Study||136
143920|NCT00805389|330368|P5|STARTED|Overall Study||142
143921|NCT00805389|330369|P4|STARTED|Overall Study||145
143922|NCT00805389|330370|P3|STARTED|Overall Study||141
143923|NCT00805389|330371|P2|STARTED|Overall Study||142
143924|NCT00805389|330372|P1|STARTED|Overall Study||143
143925|NCT00805285|330614|P1|NOT COMPLETED|Overall Study||1
143926|NCT00805285|330614|P1|COMPLETED|Overall Study||0
143927|NCT00805285|330614|P1|STARTED|Overall Study||1
143928|NCT00805194|330624|P2|NOT COMPLETED|Overall Study||654
143929|NCT00805194|330625|P1|NOT COMPLETED|Overall Study||649
143930|NCT00805194|330624|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
143931|NCT00805194|330625|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
143932|NCT00805194|330624|P2|STARTED|Overall Study|randomised patients|659
143933|NCT00805194|330625|P1|STARTED|Overall Study|randomised patients|655
143934|NCT00805142|330659|P2|NOT COMPLETED|Maintenance Period||2
143935|NCT00805142|330660|P1|NOT COMPLETED|Maintenance Period||0
143936|NCT00805142|330659|P2|COMPLETED|Maintenance Period||30
143937|NCT00805142|330660|P1|COMPLETED|Maintenance Period||30
143938|NCT00805142|330659|P2|STARTED|Maintenance Period||32
143939|NCT00805142|330660|P1|STARTED|Maintenance Period||30
143940|NCT00805142|330659|P2|NOT COMPLETED|Titration Period||10
143941|NCT00805142|330660|P1|NOT COMPLETED|Titration Period||6
143942|NCT00805142|330659|P2|COMPLETED|Titration Period||32
143943|NCT00805142|330660|P1|COMPLETED|Titration Period||30
143944|NCT00805142|330659|P2|STARTED|Titration Period||42
143945|NCT00805142|330660|P1|STARTED|Titration Period||36
143946|NCT00805038|330686|P2|NOT COMPLETED|Overall Study||0
143947|NCT00805038|330687|P1|NOT COMPLETED|Overall Study||0
143948|NCT00805038|330686|P2|COMPLETED|Overall Study||92
143949|NCT00805038|330687|P1|COMPLETED|Overall Study||75
143950|NCT00805038|330686|P2|STARTED|Overall Study||92
143951|NCT00805038|330687|P1|STARTED|Overall Study||75
143952|NCT00805025|330693|P1|NOT COMPLETED|Overall Study||49
143953|NCT00805025|330693|P1|COMPLETED|Overall Study||82
143954|NCT00805025|330693|P1|Enrolled and Treated|Overall Study||89
143955|NCT00805025|330693|P1|STARTED|Overall Study||131
143956|NCT00804986|330705|P6|NOT COMPLETED|Overall Study||10
143957|NCT00804986|330706|P5|NOT COMPLETED|Overall Study||9
143958|NCT00804986|330707|P4|NOT COMPLETED|Overall Study||8
143959|NCT00804986|330708|P3|NOT COMPLETED|Overall Study||2
143960|NCT00804986|330709|P2|NOT COMPLETED|Overall Study||8
143961|NCT00804986|330710|P1|NOT COMPLETED|Overall Study||1
143962|NCT00804986|330705|P6|COMPLETED|Overall Study||31
143963|NCT00804986|330706|P5|COMPLETED|Overall Study||34
143964|NCT00804986|330707|P4|COMPLETED|Overall Study||34
143965|NCT00804986|330708|P3|COMPLETED|Overall Study||40
143966|NCT00804986|330709|P2|COMPLETED|Overall Study||35
143967|NCT00804986|330710|P1|COMPLETED|Overall Study||35
143968|NCT00804986|330705|P6|STARTED|Overall Study||41
143969|NCT00804986|330706|P5|STARTED|Overall Study||43
143970|NCT00804986|330707|P4|STARTED|Overall Study||42
143971|NCT00804986|330708|P3|STARTED|Overall Study||42
143972|NCT00804986|330709|P2|STARTED|Overall Study||43
143973|NCT00804986|330710|P1|STARTED|Overall Study||36
143974|NCT00804843|330804|P2|NOT COMPLETED|Overall Study||7
143975|NCT00804843|330805|P1|NOT COMPLETED|Overall Study||10
143976|NCT00804843|330804|P2|COMPLETED|Overall Study||43
143977|NCT00804843|330805|P1|COMPLETED|Overall Study||40
143978|NCT00804843|330804|P2|STARTED|Overall Study||50
143979|NCT00804843|330805|P1|STARTED|Overall Study||50
143980|NCT00804713|330815|P1|NOT COMPLETED|Overall Study||0
143981|NCT00804713|330815|P1|COMPLETED|Overall Study||1978
143982|NCT00804713|330815|P1|STARTED|Overall Study||1978
143983|NCT00804687|330823|P6|NOT COMPLETED|Period 5: Treatment Period||0
143984|NCT00804687|330824|P5|NOT COMPLETED|Period 5: Treatment Period||1
143985|NCT00804687|330825|P4|NOT COMPLETED|Period 5: Treatment Period||0
143986|NCT00804687|330826|P3|NOT COMPLETED|Period 5: Treatment Period||1
143987|NCT00804687|330827|P2|NOT COMPLETED|Period 5: Treatment Period||0
143988|NCT00804687|330828|P1|NOT COMPLETED|Period 5: Treatment Period||1
143989|NCT00804687|330823|P6|COMPLETED|Period 5: Treatment Period||8
143990|NCT00804687|330824|P5|COMPLETED|Period 5: Treatment Period||8
143991|NCT00804687|330825|P4|COMPLETED|Period 5: Treatment Period||8
143992|NCT00804687|330826|P3|COMPLETED|Period 5: Treatment Period||8
143993|NCT00804687|330827|P2|COMPLETED|Period 5: Treatment Period||9
143994|NCT00804687|330828|P1|COMPLETED|Period 5: Treatment Period||8
143995|NCT00804687|330823|P6|STARTED|Period 5: Treatment Period||8
143996|NCT00804687|330824|P5|STARTED|Period 5: Treatment Period||9
143997|NCT00804687|330825|P4|STARTED|Period 5: Treatment Period||8
143998|NCT00804687|330826|P3|STARTED|Period 5: Treatment Period||9
143999|NCT00804687|330827|P2|STARTED|Period 5: Treatment Period||9
144000|NCT00804687|330828|P1|STARTED|Period 5: Treatment Period||9
144001|NCT00804687|330823|P6|NOT COMPLETED|Period 4: Washout Period||0
144002|NCT00804687|330824|P5|NOT COMPLETED|Period 4: Washout Period||0
144003|NCT00804687|330825|P4|NOT COMPLETED|Period 4: Washout Period||0
144004|NCT00804687|330826|P3|NOT COMPLETED|Period 4: Washout Period||0
144005|NCT00804687|330827|P2|NOT COMPLETED|Period 4: Washout Period||0
144006|NCT00804687|330828|P1|NOT COMPLETED|Period 4: Washout Period||0
144007|NCT00804687|330823|P6|COMPLETED|Period 4: Washout Period||8
144008|NCT00804687|330824|P5|COMPLETED|Period 4: Washout Period||9
144009|NCT00804687|330825|P4|COMPLETED|Period 4: Washout Period||8
144010|NCT00804687|330826|P3|COMPLETED|Period 4: Washout Period||9
144011|NCT00804687|330827|P2|COMPLETED|Period 4: Washout Period||9
144012|NCT00804687|330828|P1|COMPLETED|Period 4: Washout Period||9
144013|NCT00804687|330823|P6|STARTED|Period 4: Washout Period||8
144014|NCT00804687|330824|P5|STARTED|Period 4: Washout Period||9
144015|NCT00804687|330825|P4|STARTED|Period 4: Washout Period||8
144016|NCT00804687|330826|P3|STARTED|Period 4: Washout Period||9
144017|NCT00804687|330827|P2|STARTED|Period 4: Washout Period||9
144018|NCT00804687|330828|P1|STARTED|Period 4: Washout Period||9
144019|NCT00804687|330823|P6|NOT COMPLETED|Period 3: Treatment Period||0
144020|NCT00804687|330824|P5|NOT COMPLETED|Period 3: Treatment Period||0
144021|NCT00804687|330825|P4|NOT COMPLETED|Period 3: Treatment Period||1
144022|NCT00804687|330826|P3|NOT COMPLETED|Period 3: Treatment Period||0
144023|NCT00804687|330827|P2|NOT COMPLETED|Period 3: Treatment Period||0
144024|NCT00804687|330828|P1|NOT COMPLETED|Period 3: Treatment Period||0
144025|NCT00804687|330823|P6|COMPLETED|Period 3: Treatment Period||8
144026|NCT00804687|330824|P5|COMPLETED|Period 3: Treatment Period||9
144027|NCT00804687|330825|P4|COMPLETED|Period 3: Treatment Period||8
144028|NCT00804687|330826|P3|COMPLETED|Period 3: Treatment Period||9
144029|NCT00804687|330827|P2|COMPLETED|Period 3: Treatment Period||9
144030|NCT00804687|330828|P1|COMPLETED|Period 3: Treatment Period||9
144031|NCT00804687|330823|P6|STARTED|Period 3: Treatment Period||8
144032|NCT00804687|330824|P5|STARTED|Period 3: Treatment Period||9
144033|NCT00804687|330825|P4|STARTED|Period 3: Treatment Period||9
144034|NCT00804687|330826|P3|STARTED|Period 3: Treatment Period||9
144035|NCT00804687|330827|P2|STARTED|Period 3: Treatment Period||9
144036|NCT00804687|330828|P1|STARTED|Period 3: Treatment Period||9
144037|NCT00804687|330823|P6|NOT COMPLETED|Period 2: Washout Period||0
144038|NCT00804687|330824|P5|NOT COMPLETED|Period 2: Washout Period||0
144039|NCT00804687|330825|P4|NOT COMPLETED|Period 2: Washout Period||0
144040|NCT00804687|330826|P3|NOT COMPLETED|Period 2: Washout Period||0
144041|NCT00804687|330827|P2|NOT COMPLETED|Period 2: Washout Period||0
144042|NCT00804687|330828|P1|NOT COMPLETED|Period 2: Washout Period||0
144043|NCT00804687|330823|P6|COMPLETED|Period 2: Washout Period||8
144044|NCT00804687|330824|P5|COMPLETED|Period 2: Washout Period||9
144045|NCT00804687|330825|P4|COMPLETED|Period 2: Washout Period||9
144046|NCT00804687|330826|P3|COMPLETED|Period 2: Washout Period||9
144047|NCT00804687|330827|P2|COMPLETED|Period 2: Washout Period||9
144048|NCT00804687|330828|P1|COMPLETED|Period 2: Washout Period||9
144049|NCT00804687|330823|P6|STARTED|Period 2: Washout Period||8
144050|NCT00804687|330824|P5|STARTED|Period 2: Washout Period||9
144051|NCT00804687|330825|P4|STARTED|Period 2: Washout Period||9
144052|NCT00804687|330826|P3|STARTED|Period 2: Washout Period||9
144053|NCT00804687|330827|P2|STARTED|Period 2: Washout Period||9
144054|NCT00804687|330828|P1|STARTED|Period 2: Washout Period||9
144055|NCT00804687|330823|P6|NOT COMPLETED|Period 1: Treatment Period||0
144056|NCT00804687|330824|P5|NOT COMPLETED|Period 1: Treatment Period||0
144057|NCT00804687|330825|P4|NOT COMPLETED|Period 1: Treatment Period||0
144058|NCT00804687|330826|P3|NOT COMPLETED|Period 1: Treatment Period||0
144059|NCT00804687|330827|P2|NOT COMPLETED|Period 1: Treatment Period||0
144060|NCT00804687|330828|P1|NOT COMPLETED|Period 1: Treatment Period||0
144061|NCT00804687|330823|P6|COMPLETED|Period 1: Treatment Period||8
144062|NCT00804687|330824|P5|COMPLETED|Period 1: Treatment Period||9
144063|NCT00804687|330825|P4|COMPLETED|Period 1: Treatment Period||9
144064|NCT00804687|330826|P3|COMPLETED|Period 1: Treatment Period||9
144065|NCT00804687|330827|P2|COMPLETED|Period 1: Treatment Period||9
144066|NCT00804687|330828|P1|COMPLETED|Period 1: Treatment Period||9
144067|NCT00804687|330823|P6|STARTED|Period 1: Treatment Period||8
144068|NCT00804687|330824|P5|STARTED|Period 1: Treatment Period||9
144069|NCT00804687|330825|P4|STARTED|Period 1: Treatment Period||9
144070|NCT00804687|330826|P3|STARTED|Period 1: Treatment Period||9
144071|NCT00804687|330827|P2|STARTED|Period 1: Treatment Period||9
144072|NCT00804687|330828|P1|STARTED|Period 1: Treatment Period||9
144073|NCT00804648|330845|P6|NOT COMPLETED|Third Invervention||0
144074|NCT00804648|330846|P5|NOT COMPLETED|Third Invervention||0
144075|NCT00804648|330847|P4|NOT COMPLETED|Third Invervention||0
144076|NCT00804648|330848|P3|NOT COMPLETED|Third Invervention||0
144077|NCT00804648|330849|P2|NOT COMPLETED|Third Invervention||0
144078|NCT00804648|330850|P1|NOT COMPLETED|Third Invervention||0
144079|NCT00804648|330845|P6|COMPLETED|Third Invervention||8
144080|NCT00804648|330846|P5|COMPLETED|Third Invervention||4
144081|NCT00804648|330847|P4|COMPLETED|Third Invervention||4
144082|NCT00804648|330848|P3|COMPLETED|Third Invervention||6
144083|NCT00804648|330849|P2|COMPLETED|Third Invervention||5
144084|NCT00804648|330850|P1|COMPLETED|Third Invervention||3
144085|NCT00804648|330845|P6|STARTED|Third Invervention||8
144086|NCT00804648|330846|P5|STARTED|Third Invervention||4
144087|NCT00804648|330847|P4|STARTED|Third Invervention||4
144088|NCT00804648|330848|P3|STARTED|Third Invervention||6
144089|NCT00804648|330849|P2|STARTED|Third Invervention||5
144090|NCT00804648|330850|P1|STARTED|Third Invervention||3
144091|NCT00804648|330845|P6|NOT COMPLETED|Second Intervention||0
144092|NCT00804648|330846|P5|NOT COMPLETED|Second Intervention||0
144093|NCT00804648|330847|P4|NOT COMPLETED|Second Intervention||0
144094|NCT00804648|330848|P3|NOT COMPLETED|Second Intervention||0
144095|NCT00804648|330849|P2|NOT COMPLETED|Second Intervention||0
144096|NCT00804648|330850|P1|NOT COMPLETED|Second Intervention||0
144097|NCT00804648|330845|P6|COMPLETED|Second Intervention||8
144098|NCT00804648|330846|P5|COMPLETED|Second Intervention||4
144099|NCT00804648|330847|P4|COMPLETED|Second Intervention||4
144100|NCT00804648|330848|P3|COMPLETED|Second Intervention||6
144101|NCT00804648|330849|P2|COMPLETED|Second Intervention||5
144102|NCT00804648|330850|P1|COMPLETED|Second Intervention||3
144103|NCT00804648|330845|P6|STARTED|Second Intervention||8
144104|NCT00804648|330846|P5|STARTED|Second Intervention||4
144105|NCT00804648|330847|P4|STARTED|Second Intervention||4
144106|NCT00804648|330848|P3|STARTED|Second Intervention||6
144107|NCT00804648|330849|P2|STARTED|Second Intervention||5
144108|NCT00804648|330850|P1|STARTED|Second Intervention||3
144109|NCT00804648|330845|P6|NOT COMPLETED|First Intervention||0
144110|NCT00804648|330846|P5|NOT COMPLETED|First Intervention||0
144111|NCT00804648|330847|P4|NOT COMPLETED|First Intervention||0
144112|NCT00804648|330848|P3|NOT COMPLETED|First Intervention||0
144113|NCT00804648|330849|P2|NOT COMPLETED|First Intervention||0
144114|NCT00804648|330850|P1|NOT COMPLETED|First Intervention||0
144115|NCT00804648|330845|P6|COMPLETED|First Intervention||8
144116|NCT00804648|330846|P5|COMPLETED|First Intervention||4
144117|NCT00804648|330847|P4|COMPLETED|First Intervention||4
144118|NCT00804648|330848|P3|COMPLETED|First Intervention||6
144119|NCT00804648|330849|P2|COMPLETED|First Intervention||5
144120|NCT00804648|330850|P1|COMPLETED|First Intervention||3
144121|NCT00804648|330845|P6|STARTED|First Intervention||8
144122|NCT00804648|330846|P5|STARTED|First Intervention||4
144123|NCT00804648|330847|P4|STARTED|First Intervention||4
144124|NCT00804648|330848|P3|STARTED|First Intervention||6
144125|NCT00804648|330849|P2|STARTED|First Intervention||5
144126|NCT00804648|330850|P1|STARTED|First Intervention||3
144127|NCT00804609|330893|P2|NOT COMPLETED|Overall Study||1
144128|NCT00804609|330894|P1|NOT COMPLETED|Overall Study||0
144129|NCT00804609|330893|P2|COMPLETED|Overall Study||14
144130|NCT00804609|330894|P1|COMPLETED|Overall Study||15
144131|NCT00804609|330893|P2|STARTED|Overall Study||15
144132|NCT00804609|330894|P1|STARTED|Overall Study||15
144133|NCT00804596|330900|P1|NOT COMPLETED|Overall Study||0
144134|NCT00804596|330900|P1|COMPLETED|Overall Study||74
144135|NCT00804596|330900|P1|STARTED|Overall Study||74
144136|NCT00804570|330907|P2|NOT COMPLETED|Overall Study||94
144137|NCT00804570|330908|P1|NOT COMPLETED|Overall Study||72
144138|NCT00804570|330907|P2|COMPLETED|Overall Study||94
144139|NCT00804570|330908|P1|COMPLETED|Overall Study||115
144140|NCT00804570|330907|P2|STARTED|Overall Study||188
144141|NCT00804570|330908|P1|STARTED|Overall Study||187
144142|NCT00803959|330966|P2|NOT COMPLETED|Overall Study||51
144143|NCT00803959|330967|P1|NOT COMPLETED|Overall Study||56
144144|NCT00803959|330966|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
144145|NCT00803959|330967|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
144146|NCT00803959|330966|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
144147|NCT00803959|330967|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
144148|NCT00803959|330966|P2|STARTED|Overall Study||315
144149|NCT00803959|330967|P1|STARTED|Overall Study||315
144150|NCT00803790|330999|P4|NOT COMPLETED|Period 2||1
144151|NCT00803790|331000|P3|NOT COMPLETED|Period 2||1
144152|NCT00803790|331001|P2|NOT COMPLETED|Period 2||0
144153|NCT00803790|331002|P1|NOT COMPLETED|Period 2||2
144154|NCT00803790|330999|P4|COMPLETED|Period 2||30
144155|NCT00803790|331000|P3|COMPLETED|Period 2||30
144156|NCT00803790|331001|P2|COMPLETED|Period 2||114
144157|NCT00803790|331002|P1|COMPLETED|Period 2||114
144158|NCT00803790|330999|P4|STARTED|Period 2||31
144159|NCT00803790|331000|P3|STARTED|Period 2||31
144160|NCT00803790|331001|P2|STARTED|Period 2||114
144161|NCT00803790|331002|P1|STARTED|Period 2||116
144162|NCT00803790|330999|P4|NOT COMPLETED|Period 1||4
144163|NCT00803790|331000|P3|NOT COMPLETED|Period 1||1
144164|NCT00803790|331001|P2|NOT COMPLETED|Period 1||12
144165|NCT00803790|331002|P1|NOT COMPLETED|Period 1||9
144166|NCT00803790|330999|P4|COMPLETED|Period 1||31
144167|NCT00803790|331000|P3|COMPLETED|Period 1||31
144168|NCT00803790|331001|P2|COMPLETED|Period 1||114
144169|NCT00803790|331002|P1|COMPLETED|Period 1||116
144170|NCT00803790|330999|P4|STARTED|Period 1||35
144171|NCT00803790|331000|P3|STARTED|Period 1||32
144172|NCT00803790|331001|P2|STARTED|Period 1||126
144173|NCT00803790|331002|P1|STARTED|Period 1||125
144174|NCT00803777|331013|P1|NOT COMPLETED|Overall Study||0
144175|NCT00803777|331013|P1|COMPLETED|Overall Study||147
144176|NCT00803777|331013|P1|STARTED|Overall Study||147
144177|NCT00803738|331023|P2|NOT COMPLETED|Overall Study||110
144178|NCT00803738|331024|P1|NOT COMPLETED|Overall Study||94
144179|NCT00803738|331023|P2|COMPLETED|Overall Study||176
144180|NCT00803738|331024|P1|COMPLETED|Overall Study||192
144181|NCT00803738|331023|P2|STARTED|Overall Study||286
144182|NCT00803738|331024|P1|STARTED|Overall Study||286
144183|NCT00803712|331036|P2|NOT COMPLETED|Overall Study||27
144184|NCT00803712|331037|P1|NOT COMPLETED|Overall Study||36
144185|NCT00803712|331036|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
144186|NCT00803712|331037|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
144187|NCT00803712|331036|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
144188|NCT00803712|331037|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
144189|NCT00803712|331036|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
144190|NCT00803712|331037|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
144191|NCT00803712|331036|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
144192|NCT00803712|331037|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
144193|NCT00803686|331105|P4|NOT COMPLETED|Part 2, Period 3||0
144194|NCT00803686|331106|P3|NOT COMPLETED|Part 2, Period 3||0
144195|NCT00803686|331107|P2|NOT COMPLETED|Part 2, Period 3||0
144196|NCT00803686|331108|P1|NOT COMPLETED|Part 2, Period 3||0
144197|NCT00803686|331105|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
144198|NCT00803686|331106|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
144199|NCT00803686|331107|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
144200|NCT00803686|331108|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
144201|NCT00803686|331105|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
144202|NCT00803686|331106|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
144203|NCT00803686|331107|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
144204|NCT00803686|331108|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
144205|NCT00803686|331105|P4|NOT COMPLETED|Part 1, Period 2||0
144206|NCT00803686|331106|P3|NOT COMPLETED|Part 1, Period 2||0
144207|NCT00803686|331107|P2|NOT COMPLETED|Part 1, Period 2||0
144208|NCT00803686|331108|P1|NOT COMPLETED|Part 1, Period 2||0
144209|NCT00803686|331105|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
144210|NCT00803686|331106|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
144211|NCT00803686|331107|P2|COMPLETED|Part 1, Period 2||6
144212|NCT00803686|331108|P1|COMPLETED|Part 1, Period 2||6
144213|NCT00803686|331105|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
144214|NCT00803686|331106|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
144215|NCT00803686|331107|P2|STARTED|Part 1, Period 2||6
144216|NCT00803686|331108|P1|STARTED|Part 1, Period 2||6
144217|NCT00803686|331105|P4|NOT COMPLETED|Part 1, Period 1||0
144218|NCT00803686|331106|P3|NOT COMPLETED|Part 1, Period 1||0
144219|NCT00803686|331107|P2|NOT COMPLETED|Part 1, Period 1||0
144220|NCT00803686|331108|P1|NOT COMPLETED|Part 1, Period 1||0
144221|NCT00803686|331105|P4|COMPLETED|Part 1, Period 1||0
144222|NCT00803686|331106|P3|COMPLETED|Part 1, Period 1||0
144223|NCT00803686|331107|P2|COMPLETED|Part 1, Period 1||6
144224|NCT00803686|331108|P1|COMPLETED|Part 1, Period 1||6
144225|NCT00803686|331105|P4|STARTED|Part 1, Period 1||0
144226|NCT00803686|331106|P3|STARTED|Part 1, Period 1||0
144227|NCT00803686|331107|P2|STARTED|Part 1, Period 1||6
144228|NCT00803686|331108|P1|STARTED|Part 1, Period 1||6
144229|NCT00803647|331126|P1|NOT COMPLETED|Overall Study||0
144230|NCT00803647|331126|P1|COMPLETED|Overall Study||20
144231|NCT00803647|331126|P1|STARTED|Overall Study||20
144232|NCT00803634|331135|P2|NOT COMPLETED|Overall Study||5
144233|NCT00803634|331136|P1|NOT COMPLETED|Overall Study||6
144234|NCT00803634|331135|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
144235|NCT00803634|331136|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
144236|NCT00803634|331135|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
144237|NCT00803634|331136|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
144238|NCT00803634|331135|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
144239|NCT00803634|331136|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
144240|NCT00803595|331165|P3|NOT COMPLETED|Overall Study||16
144241|NCT00803595|331166|P2|NOT COMPLETED|Overall Study||8
144242|NCT00803595|331167|P1|NOT COMPLETED|Overall Study||15
144243|NCT00803595|331165|P3|COMPLETED|Overall Study||322
144244|NCT00803595|331166|P2|COMPLETED|Overall Study||319
144245|NCT00803595|331167|P1|COMPLETED|Overall Study||322
144246|NCT00803595|331165|P3|STARTED|Overall Study||338
144247|NCT00803595|331166|P2|STARTED|Overall Study||327
144248|NCT00803595|331167|P1|STARTED|Overall Study||337
144249|NCT00803517|331180|P2|NOT COMPLETED|Overall Study||0
144250|NCT00803517|331181|P1|NOT COMPLETED|Overall Study||0
144251|NCT00803517|331180|P2|COMPLETED|Overall Study||12
144252|NCT00803517|331181|P1|COMPLETED|Overall Study||12
144253|NCT00803517|331180|P2|STARTED|Overall Study||12
144254|NCT00803517|331181|P1|STARTED|Overall Study||12
144255|NCT00803413|331191|P4|NOT COMPLETED|Overall Period||0
144256|NCT00803413|331192|P3|NOT COMPLETED|Overall Period||0
144257|NCT00803413|331193|P2|NOT COMPLETED|Overall Period||0
144258|NCT00803413|331194|P1|NOT COMPLETED|Overall Period||0
144259|NCT00803413|331191|P4|COMPLETED|Overall Period||30
144260|NCT00803413|331192|P3|COMPLETED|Overall Period||29
144261|NCT00803413|331193|P2|COMPLETED|Overall Period||32
144262|NCT00803413|331194|P1|COMPLETED|Overall Period||28
144263|NCT00803413|331191|P4|STARTED|Overall Period||30
144264|NCT00803413|331192|P3|STARTED|Overall Period||29
144265|NCT00803413|331193|P2|STARTED|Overall Period||32
144266|NCT00803413|331194|P1|STARTED|Overall Period||28
144267|NCT00803400|331206|P2|NOT COMPLETED|Overall Study||24
144268|NCT00803400|331207|P1|NOT COMPLETED|Overall Study||20
144269|NCT00803400|331206|P2|COMPLETED|Overall Study||51
144270|NCT00803400|331207|P1|COMPLETED|Overall Study||55
144271|NCT00803400|331206|P2|STARTED|Overall Study||75
144272|NCT00803400|331207|P1|STARTED|Overall Study||75
144273|NCT00803361|331219|P2|NOT COMPLETED|Overall Study||28
144274|NCT00803361|331220|P1|NOT COMPLETED|Overall Study||26
144275|NCT00803361|331219|P2|COMPLETED|Overall Study||74
144276|NCT00803361|331220|P1|COMPLETED|Overall Study||82
144277|NCT00803361|331219|P2|STARTED|Overall Study||102
144278|NCT00803361|331220|P1|STARTED|Overall Study||108
144279|NCT00803283|331240|P2|NOT COMPLETED|Overall Study||0
144280|NCT00803283|331241|P1|NOT COMPLETED|Overall Study||0
144281|NCT00803283|331240|P2|COMPLETED|Overall Study||1
144282|NCT00803283|331241|P1|COMPLETED|Overall Study||1
144283|NCT00803283|331240|P2|STARTED|Overall Study||1
144284|NCT00803283|331241|P1|STARTED|Overall Study||1
144285|NCT00803270|331267|P2|NOT COMPLETED|Overall Study||2
144286|NCT00803270|331268|P1|NOT COMPLETED|Overall Study||1
144287|NCT00803270|331267|P2|COMPLETED|Overall Study||12
144288|NCT00803270|331268|P1|COMPLETED|Overall Study||12
144289|NCT00803270|331267|P2|STARTED|Overall Study||14
144290|NCT00803270|331268|P1|STARTED|Overall Study||13
144291|NCT00803244|331278|P2|NOT COMPLETED|Overall Study||15
144292|NCT00803244|331279|P1|NOT COMPLETED|Overall Study||7
144293|NCT00803244|331278|P2|COMPLETED|Overall Study||178
144294|NCT00803244|331279|P1|COMPLETED|Overall Study||181
144295|NCT00803244|331278|P2|STARTED|Overall Study||193
144296|NCT00803244|331279|P1|STARTED|Overall Study||188
144297|NCT00803179|331287|P1|NOT COMPLETED|Overall Study||3
144298|NCT00803179|331287|P1|COMPLETED|Overall Study||2
144299|NCT00803179|331287|P1|STARTED|Overall Study||5
144300|NCT00803114|331293|P2|NOT COMPLETED|Overall Study||0
144301|NCT00803114|331294|P1|NOT COMPLETED|Overall Study||0
144302|NCT00803114|331293|P2|COMPLETED|Overall Study||115
144303|NCT00803114|331294|P1|COMPLETED|Overall Study||113
144304|NCT00803114|331293|P2|STARTED|Overall Study||115
144305|NCT00803114|331294|P1|STARTED|Overall Study||113
144306|NCT00803101|331306|P2|NOT COMPLETED|Overall Study||22
144307|NCT00803101|331307|P1|NOT COMPLETED|Overall Study||18
144308|NCT00803101|331306|P2|COMPLETED|Overall Study||66
144309|NCT00803101|331307|P1|COMPLETED|Overall Study||70
144310|NCT00803101|331306|P2|STARTED|Overall Study||88
144311|NCT00803101|331307|P1|STARTED|Overall Study||88
144312|NCT00803062|331329|P4|NOT COMPLETED|Overall Study||0
144313|NCT00803062|331330|P3|NOT COMPLETED|Overall Study||0
144314|NCT00803062|331331|P2|NOT COMPLETED|Overall Study||0
144315|NCT00803062|331332|P1|NOT COMPLETED|Overall Study||0
144316|NCT00803062|331329|P4|COMPLETED|Overall Study||112
144317|NCT00803062|331330|P3|COMPLETED|Overall Study||111
144318|NCT00803062|331331|P2|COMPLETED|Overall Study||115
144319|NCT00803062|331332|P1|COMPLETED|Overall Study||114
144320|NCT00803062|331329|P4|STARTED|Overall Study||112
144321|NCT00803062|331330|P3|STARTED|Overall Study||111
144322|NCT00803062|331331|P2|STARTED|Overall Study||115
144323|NCT00803062|331332|P1|STARTED|Overall Study||114
144324|NCT00803049|331354|P4|NOT COMPLETED|Overall Study||102
144325|NCT00803049|331355|P3|NOT COMPLETED|Overall Study||44
144326|NCT00803049|331356|P2|NOT COMPLETED|Overall Study||118
144327|NCT00803049|331357|P1|NOT COMPLETED|Overall Study||61
144328|NCT00803049|331354|P4|COMPLETED|Overall Study||151
144329|NCT00803049|331355|P3|COMPLETED|Overall Study||64
144330|NCT00803049|331356|P2|COMPLETED|Overall Study||134
144331|NCT00803049|331357|P1|COMPLETED|Overall Study||68
144332|NCT00803049|331354|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
144333|NCT00803049|331355|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
144334|NCT00803049|331356|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
144335|NCT00803049|331357|P1|Safety Population|Overall Study||129
144336|NCT00803049|331354|P4|Treated|Overall Study||251
144337|NCT00803049|331355|P3|Treated|Overall Study||108
144338|NCT00803049|331356|P2|Treated|Overall Study||252
144339|NCT00803049|331357|P1|Treated|Overall Study||129
144340|NCT00803049|331354|P4|STARTED|Overall Study|Randomized in extension study|253
144341|NCT00803049|331355|P3|STARTED|Overall Study|Randomized in extension study|108
144342|NCT00803049|331356|P2|STARTED|Overall Study|Randomized in extension study|252
144343|NCT00803049|331357|P1|STARTED|Overall Study|Randomized in extension study|129
144344|NCT00803023|331391|P4|NOT COMPLETED|Overall Study||8
144345|NCT00803023|331392|P3|NOT COMPLETED|Overall Study||11
144346|NCT00803023|331393|P2|NOT COMPLETED|Overall Study||8
144347|NCT00803023|331394|P1|NOT COMPLETED|Overall Study||5
144348|NCT00803023|331391|P4|COMPLETED|Overall Study||25
144349|NCT00803023|331392|P3|COMPLETED|Overall Study||20
144350|NCT00803023|331393|P2|COMPLETED|Overall Study||25
144351|NCT00803023|331394|P1|COMPLETED|Overall Study||27
144352|NCT00803023|331391|P4|STARTED|Overall Study||33
144353|NCT00803023|331392|P3|STARTED|Overall Study||31
144354|NCT00803023|331393|P2|STARTED|Overall Study||33
144355|NCT00803023|331394|P1|STARTED|Overall Study||32
144356|NCT00803010|331406|P2|NOT COMPLETED|Overall Study||0
144357|NCT00803010|331407|P1|NOT COMPLETED|Overall Study||0
144358|NCT00803010|331406|P2|COMPLETED|Overall Study||37
144359|NCT00803010|331407|P1|COMPLETED|Overall Study||37
144360|NCT00803010|331406|P2|STARTED|Overall Study||37
144361|NCT00803010|331407|P1|STARTED|Overall Study||37
144362|NCT00802997|331419|P2|NOT COMPLETED|6 Month to 9 Months||0
144363|NCT00802997|331420|P1|NOT COMPLETED|6 Month to 9 Months||2
144364|NCT00802997|331419|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
144365|NCT00802997|331420|P1|COMPLETED|6 Month to 9 Months||25
144366|NCT00802997|331419|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
144367|NCT00802997|331420|P1|STARTED|6 Month to 9 Months||27
144368|NCT00802997|331419|P2|NOT COMPLETED|3 Months to 6 Months||0
144369|NCT00802997|331420|P1|NOT COMPLETED|3 Months to 6 Months||7
144370|NCT00802997|331419|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
144371|NCT00802997|331420|P1|COMPLETED|3 Months to 6 Months||27
144372|NCT00802997|331419|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
144373|NCT00802997|331420|P1|STARTED|3 Months to 6 Months||34
144374|NCT00802997|331419|P2|NOT COMPLETED|Baseline to 3 Months||0
144375|NCT00802997|331420|P1|NOT COMPLETED|Baseline to 3 Months||0
144376|NCT00802997|331419|P2|COMPLETED|Baseline to 3 Months||17
144377|NCT00802997|331420|P1|COMPLETED|Baseline to 3 Months||34
144378|NCT00802997|331419|P2|STARTED|Baseline to 3 Months||17
144379|NCT00802997|331420|P1|STARTED|Baseline to 3 Months||34
144380|NCT00802880|331430|P1|NOT COMPLETED|Overall Study||0
144381|NCT00802880|331430|P1|COMPLETED|Overall Study||80
144382|NCT00802880|331430|P1|STARTED|Overall Study||80
144383|NCT00802867|331449|P1|NOT COMPLETED|Overall Study||13
144384|NCT00802867|331449|P1|COMPLETED|Overall Study||976
144385|NCT00802867|331449|P1|STARTED|Overall Study||989
144386|NCT00802841|331459|P2|NOT COMPLETED|Overall Study||95
144387|NCT00802841|331460|P1|NOT COMPLETED|Overall Study||96
144388|NCT00802841|331459|P2|COMPLETED|Overall Study||0
144389|NCT00802841|331460|P1|COMPLETED|Overall Study||0
144390|NCT00802841|331459|P2|Cross-over Set|Overall Study||56
144391|NCT00802841|331460|P1|Cross-over Set|Overall Study||13
144392|NCT00802841|331459|P2|Safety Set|Overall Study||93
144393|NCT00802841|331460|P1|Safety Set|Overall Study||96
144394|NCT00802841|331459|P2|Full Analysis Set|Overall Study||95
144395|NCT00802841|331460|P1|Full Analysis Set|Overall Study||96
144396|NCT00802841|331459|P2|STARTED|Overall Study||95
144397|NCT00802841|331460|P1|STARTED|Overall Study||96
144398|NCT00802737|331485|P3|NOT COMPLETED|Overall Study||1
144399|NCT00802737|331486|P2|NOT COMPLETED|Overall Study||11
144400|NCT00802737|331487|P1|NOT COMPLETED|Overall Study||17
144401|NCT00802737|331485|P3|COMPLETED|Overall Study||0
144402|NCT00802737|331486|P2|COMPLETED|Overall Study||0
144403|NCT00802737|331487|P1|COMPLETED|Overall Study||0
144404|NCT00802737|331485|P3|STARTED|Overall Study||1
144405|NCT00802737|331486|P2|STARTED|Overall Study||11
144406|NCT00802737|331487|P1|STARTED|Overall Study||17
144407|NCT00802685|331535|P2|NOT COMPLETED|Overall Study||0
144408|NCT00802685|331536|P1|NOT COMPLETED|Overall Study||0
144409|NCT00802685|331535|P2|COMPLETED|Overall Study||51
144410|NCT00802685|331536|P1|COMPLETED|Overall Study||54
144411|NCT00802685|331535|P2|STARTED|Overall Study||51
144412|NCT00802685|331536|P1|STARTED|Overall Study||54
144413|NCT00802672|331547|P3|NOT COMPLETED|Overall Study||34
144414|NCT00802672|331548|P2|NOT COMPLETED|Overall Study||52
144415|NCT00802672|331549|P1|NOT COMPLETED|Overall Study||68
144416|NCT00802672|331547|P3|COMPLETED|Overall Study||77
144417|NCT00802672|331548|P2|COMPLETED|Overall Study||174
144418|NCT00802672|331549|P1|COMPLETED|Overall Study||156
144419|NCT00802672|331547|P3|STARTED|Overall Study||111
144420|NCT00802672|331548|P2|STARTED|Overall Study||226
144421|NCT00802672|331549|P1|STARTED|Overall Study||224
144422|NCT00802659|331567|P4|NOT COMPLETED|Overall Study||0
144423|NCT00802659|331568|P3|NOT COMPLETED|Overall Study||0
144424|NCT00802659|331569|P2|NOT COMPLETED|Overall Study||1
144425|NCT00802659|331570|P1|NOT COMPLETED|Overall Study||0
144426|NCT00802659|331567|P4|COMPLETED|Overall Study||0
144427|NCT00802659|331568|P3|COMPLETED|Overall Study||0
144428|NCT00802659|331569|P2|COMPLETED|Overall Study||1
144429|NCT00802659|331570|P1|COMPLETED|Overall Study||0
144430|NCT00802659|331567|P4|STARTED|Overall Study||0
144431|NCT00802659|331568|P3|STARTED|Overall Study||0
144432|NCT00802659|331569|P2|STARTED|Overall Study||2
144433|NCT00802659|331570|P1|STARTED|Overall Study||0
144434|NCT00802633|331598|P2|NOT COMPLETED|Overall Study||0
144435|NCT00802633|331599|P1|NOT COMPLETED|Overall Study||0
144436|NCT00802633|331598|P2|COMPLETED|Overall Study||40
144437|NCT00802633|331599|P1|COMPLETED|Overall Study||40
144438|NCT00802633|331598|P2|STARTED|Overall Study||40
144439|NCT00802633|331599|P1|STARTED|Overall Study||40
144440|NCT00802529|331609|P2|NOT COMPLETED|Overall Study||1
144441|NCT00802529|331610|P1|NOT COMPLETED|Overall Study||0
144442|NCT00802529|331609|P2|COMPLETED|Overall Study||29
144443|NCT00802529|331610|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
144444|NCT00802529|331609|P2|STARTED|Overall Study||30
144445|NCT00802529|331610|P1|STARTED|Overall Study||30
144446|NCT00802503|331622|P2|NOT COMPLETED|Overall Study||20
144447|NCT00802503|331623|P1|NOT COMPLETED|Overall Study||10
144448|NCT00802503|331622|P2|COMPLETED|Overall Study||133
144449|NCT00802503|331623|P1|COMPLETED|Overall Study||142
144450|NCT00802503|331622|P2|STARTED|Overall Study||153
144451|NCT00802503|331623|P1|STARTED|Overall Study||152
144452|NCT00802412|331647|P2|NOT COMPLETED|Overall Study||1
144453|NCT00802412|331648|P1|NOT COMPLETED|Overall Study||2
144454|NCT00802412|331647|P2|COMPLETED|Overall Study||66
144455|NCT00802412|331648|P1|COMPLETED|Overall Study||63
144456|NCT00802412|331647|P2|STARTED|Overall Study||67
144457|NCT00802412|331648|P1|STARTED|Overall Study||65
144458|NCT00802360|331660|P4|NOT COMPLETED|Overall Study||22
144459|NCT00802360|331661|P3|NOT COMPLETED|Overall Study||25
144460|NCT00802360|331662|P2|NOT COMPLETED|Overall Study||26
144461|NCT00802360|331663|P1|NOT COMPLETED|Overall Study||24
144462|NCT00802360|331660|P4|COMPLETED|Overall Study||17
144463|NCT00802360|331661|P3|COMPLETED|Overall Study||17
144464|NCT00802360|331662|P2|COMPLETED|Overall Study||16
144465|NCT00802360|331663|P1|COMPLETED|Overall Study||18
144466|NCT00802360|331660|P4|STARTED|Overall Study||39
144467|NCT00802360|331661|P3|STARTED|Overall Study||42
144468|NCT00802360|331662|P2|STARTED|Overall Study||42
144469|NCT00802360|331663|P1|STARTED|Overall Study||42
144470|NCT00802178|331703|P1|NOT COMPLETED|Overall Study||113
144471|NCT00802178|331703|P1|COMPLETED|Overall Study||2335
144472|NCT00802178|331703|P1|STARTED|Overall Study||2448
144473|NCT00802100|331713|P3|NOT COMPLETED|Overall Study||4
144474|NCT00802100|331714|P2|NOT COMPLETED|Overall Study||7
144475|NCT00802100|331715|P1|NOT COMPLETED|Overall Study||6
144476|NCT00802100|331713|P3|COMPLETED|Overall Study||2
144477|NCT00802100|331714|P2|COMPLETED|Overall Study||2
144478|NCT00802100|331715|P1|COMPLETED|Overall Study||0
144479|NCT00802100|331713|P3|STARTED|Overall Study||6
144480|NCT00802100|331714|P2|STARTED|Overall Study||9
144481|NCT00802100|331715|P1|STARTED|Overall Study||6
144482|NCT00802074|331730|P6|NOT COMPLETED|Overall Study||0
144483|NCT00802074|331731|P5|NOT COMPLETED|Overall Study||0
144484|NCT00802074|331732|P4|NOT COMPLETED|Overall Study||0
144485|NCT00802074|331733|P3|NOT COMPLETED|Overall Study||1
144486|NCT00802074|331734|P2|NOT COMPLETED|Overall Study||1
144487|NCT00802074|331735|P1|NOT COMPLETED|Overall Study||2
144488|NCT00802074|331730|P6|COMPLETED|Overall Study||7
144489|NCT00802074|331731|P5|COMPLETED|Overall Study||7
144490|NCT00802074|331732|P4|COMPLETED|Overall Study||7
144491|NCT00802074|331733|P3|COMPLETED|Overall Study||6
144492|NCT00802074|331734|P2|COMPLETED|Overall Study||7
144493|NCT00802074|331735|P1|COMPLETED|Overall Study||7
144494|NCT00802074|331730|P6|STARTED|Overall Study||7
144495|NCT00802074|331731|P5|STARTED|Overall Study||7
144496|NCT00802074|331732|P4|STARTED|Overall Study||7
144497|NCT00802074|331733|P3|STARTED|Overall Study||7
144498|NCT00802074|331734|P2|STARTED|Overall Study||8
144499|NCT00802074|331735|P1|STARTED|Overall Study||9
144500|NCT00801983|331769|P2|NOT COMPLETED|Period 2||1
144501|NCT00801983|331770|P1|NOT COMPLETED|Period 2||2
144502|NCT00801983|331769|P2|COMPLETED|Period 2||32
144503|NCT00801983|331770|P1|COMPLETED|Period 2||38
144504|NCT00801983|331769|P2|STARTED|Period 2||33
144505|NCT00801983|331770|P1|STARTED|Period 2||40
144506|NCT00801983|331769|P2|NOT COMPLETED|Period 1||8
144507|NCT00801983|331770|P1|NOT COMPLETED|Period 1||4
144508|NCT00801983|331769|P2|COMPLETED|Period 1||33
144509|NCT00801983|331770|P1|COMPLETED|Period 1||40
144510|NCT00801983|331769|P2|STARTED|Period 1||41
144511|NCT00801983|331770|P1|STARTED|Period 1||44
144512|NCT00801892|331778|P2|NOT COMPLETED|Overall Study||0
144513|NCT00801892|331779|P1|NOT COMPLETED|Overall Study||0
144514|NCT00801892|331778|P2|COMPLETED|Overall Study||12
144515|NCT00801892|331779|P1|COMPLETED|Overall Study||11
144516|NCT00801892|331778|P2|STARTED|Overall Study||12
144517|NCT00801892|331779|P1|STARTED|Overall Study||11
144518|NCT00801801|331785|P1|NOT COMPLETED|Overall Study||0
144519|NCT00801801|331785|P1|COMPLETED|Overall Study||5
144520|NCT00801801|331785|P1|STARTED|Overall Study||5
144521|NCT00801684|331789|P1|NOT COMPLETED|Overall Study||0
144522|NCT00801684|331789|P1|COMPLETED|Overall Study||24
144523|NCT00801684|331789|P1|STARTED|Overall Study||24
144524|NCT00801632|331811|P1|NOT COMPLETED|Overall Study||1
144525|NCT00801632|331811|P1|COMPLETED|Overall Study||4
144526|NCT00801632|331811|P1|STARTED|Overall Study||5
144527|NCT00801242|331822|P1|NOT COMPLETED|Overall Study||52
144528|NCT00801242|331822|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
144529|NCT00801242|331822|P1|Started Cycle 3|Overall Study||2
144530|NCT00801242|331822|P1|Started Cycle 2|Overall Study||35
144531|NCT00801242|331822|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
144532|NCT00801242|331822|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
144533|NCT00801242|331822|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
144534|NCT00801242|331822|P1|STARTED|Overall Study|Randomized participants.|220
144535|NCT00801229|331835|P2|NOT COMPLETED|Received Study Drug/Placebo||4
144536|NCT00801229|331836|P1|NOT COMPLETED|Received Study Drug/Placebo||4
144537|NCT00801229|331835|P2|COMPLETED|Received Study Drug/Placebo||30
144538|NCT00801229|331836|P1|COMPLETED|Received Study Drug/Placebo||31
144539|NCT00801229|331835|P2|STARTED|Received Study Drug/Placebo||34
144540|NCT00801229|331836|P1|STARTED|Received Study Drug/Placebo||35
144541|NCT00801229|331835|P2|NOT COMPLETED|Signed Consent||3
144542|NCT00801229|331836|P1|NOT COMPLETED|Signed Consent||3
144543|NCT00801229|331835|P2|COMPLETED|Signed Consent||34
144544|NCT00801229|331836|P1|COMPLETED|Signed Consent||35
144545|NCT00801229|331835|P2|STARTED|Signed Consent||37
144546|NCT00801229|331836|P1|STARTED|Signed Consent||38
144547|NCT00801099|331842|P1|NOT COMPLETED|Overall Study||101
144548|NCT00801099|331842|P1|COMPLETED|Overall Study||175
144549|NCT00801099|331842|P1|STARTED|Overall Study||276
144550|NCT00800982|331848|P2|NOT COMPLETED|Overall Study||3
144551|NCT00800982|331849|P1|NOT COMPLETED|Overall Study||2
144552|NCT00800982|331848|P2|COMPLETED|Overall Study||12
144553|NCT00800982|331849|P1|COMPLETED|Overall Study||13
144554|NCT00800982|331848|P2|STARTED|Overall Study||15
144555|NCT00800982|331849|P1|STARTED|Overall Study||15
144556|NCT00800865|331857|P2|NOT COMPLETED|Overall Study||0
144557|NCT00800865|331858|P1|NOT COMPLETED|Overall Study||0
144558|NCT00800865|331857|P2|COMPLETED|Overall Study||16
144559|NCT00800865|331858|P1|COMPLETED|Overall Study||15
144560|NCT00800865|331857|P2|STARTED|Overall Study||16
144561|NCT00800865|331858|P1|STARTED|Overall Study||15
144562|NCT00800839|331866|P1|NOT COMPLETED|Overall Study||7
144563|NCT00800839|331866|P1|COMPLETED|Overall Study||49
144564|NCT00800839|331866|P1|STARTED|Overall Study||56
144565|NCT00800735|331875|P1|NOT COMPLETED|Overall Study||14
144566|NCT00800735|331875|P1|COMPLETED|Overall Study||16
144567|NCT00800735|331875|P1|STARTED|Overall Study||30
144568|NCT00800683|331881|P2|NOT COMPLETED|Overall Study||19
144569|NCT00800683|331882|P1|NOT COMPLETED|Overall Study||17
144570|NCT00800683|331881|P2|COMPLETED|Overall Study|Number who completed treatment|49
144571|NCT00800683|331882|P1|COMPLETED|Overall Study|Number who completed treatment|48
144572|NCT00800683|331881|P2|STARTED|Overall Study|Number who started treatment|68
144573|NCT00800683|331882|P1|STARTED|Overall Study|Number who started treatment|65
144574|NCT00800540|331928|P2|NOT COMPLETED|Period 2: 6 Weeks||1
144575|NCT00800540|331929|P1|NOT COMPLETED|Period 2: 6 Weeks||0
144576|NCT00800540|331928|P2|COMPLETED|Period 2: 6 Weeks||16
144577|NCT00800540|331929|P1|COMPLETED|Period 2: 6 Weeks||16
144578|NCT00800540|331928|P2|STARTED|Period 2: 6 Weeks||17
144579|NCT00800540|331929|P1|STARTED|Period 2: 6 Weeks||16
144580|NCT00800540|331928|P2|NOT COMPLETED|Washout: 4 Weeks||0
144581|NCT00800540|331929|P1|NOT COMPLETED|Washout: 4 Weeks||0
144582|NCT00800540|331928|P2|COMPLETED|Washout: 4 Weeks||17
144583|NCT00800540|331929|P1|COMPLETED|Washout: 4 Weeks||16
144584|NCT00800540|331928|P2|STARTED|Washout: 4 Weeks||17
144585|NCT00800540|331929|P1|STARTED|Washout: 4 Weeks||16
144586|NCT00800540|331928|P2|NOT COMPLETED|Period One: 6 Weeks||1
144587|NCT00800540|331929|P1|NOT COMPLETED|Period One: 6 Weeks||1
144588|NCT00800540|331928|P2|COMPLETED|Period One: 6 Weeks||17
144589|NCT00800540|331929|P1|COMPLETED|Period One: 6 Weeks||16
144590|NCT00800540|331928|P2|STARTED|Period One: 6 Weeks||18
144591|NCT00800540|331929|P1|STARTED|Period One: 6 Weeks||17
144592|NCT00800436|331964|P7|NOT COMPLETED|Overall Study||0
144593|NCT00800436|331965|P6|NOT COMPLETED|Overall Study||0
144594|NCT00800436|331966|P5|NOT COMPLETED|Overall Study||0
144595|NCT00800436|331967|P4|NOT COMPLETED|Overall Study||1
144596|NCT00800436|331968|P3|NOT COMPLETED|Overall Study||1
144597|NCT00800436|331969|P2|NOT COMPLETED|Overall Study||0
144598|NCT00800436|331970|P1|NOT COMPLETED|Overall Study||0
144599|NCT00800436|331964|P7|COMPLETED|Overall Study||20
144600|NCT00800436|331965|P6|COMPLETED|Overall Study||20
144601|NCT00800436|331966|P5|COMPLETED|Overall Study||6
144602|NCT00800436|331967|P4|COMPLETED|Overall Study||5
144603|NCT00800436|331968|P3|COMPLETED|Overall Study||5
144604|NCT00800436|331969|P2|COMPLETED|Overall Study||6
144605|NCT00800436|331970|P1|COMPLETED|Overall Study||6
144606|NCT00800436|331964|P7|STARTED|Overall Study||20
144607|NCT00800436|331965|P6|STARTED|Overall Study||20
144608|NCT00800436|331966|P5|STARTED|Overall Study||6
144609|NCT00800436|331967|P4|STARTED|Overall Study||6
144610|NCT00800436|331968|P3|STARTED|Overall Study||6
144611|NCT00800436|331969|P2|STARTED|Overall Study||6
144612|NCT00800436|331970|P1|STARTED|Overall Study||6
144613|NCT00800384|332016|P2|NOT COMPLETED|Overall Study||43
144614|NCT00800384|332017|P1|NOT COMPLETED|Overall Study||41
144615|NCT00800384|332016|P2|COMPLETED|Overall Study||1210
144616|NCT00800384|332017|P1|COMPLETED|Overall Study||1206
144617|NCT00800384|332016|P2|STARTED|Overall Study||1253
144618|NCT00800384|332017|P1|STARTED|Overall Study||1247
144619|NCT00800254|332027|P2|NOT COMPLETED|Overall Study||6
144620|NCT00800254|332028|P1|NOT COMPLETED|Overall Study||5
144621|NCT00800254|332027|P2|COMPLETED|Overall Study||25
144622|NCT00800254|332028|P1|COMPLETED|Overall Study||30
144623|NCT00800254|332027|P2|3.5 Weeks Post-operatively|Overall Study||31
144624|NCT00800254|332028|P1|3.5 Weeks Post-operatively|Overall Study||31
144625|NCT00800254|332027|P2|STARTED|Overall Study||31
144626|NCT00800254|332028|P1|STARTED|Overall Study||35
144627|NCT00800202|332050|P2|NOT COMPLETED|Overall Study||24
144628|NCT00800202|332051|P1|NOT COMPLETED|Overall Study||67
144629|NCT00800202|332050|P2|COMPLETED|Overall Study||0
144630|NCT00800202|332051|P1|COMPLETED|Overall Study||0
144631|NCT00800202|332050|P2|STARTED|Overall Study||24
144632|NCT00800202|332051|P1|STARTED|Overall Study||67
144633|NCT00798967|332071|P2|NOT COMPLETED|Overall Study||4
144634|NCT00798967|332072|P1|NOT COMPLETED|Overall Study||4
144635|NCT00798967|332071|P2|COMPLETED|Overall Study||39
144636|NCT00798967|332072|P1|COMPLETED|Overall Study||39
144637|NCT00798967|332071|P2|Discontinued During Dosing Period|Overall Study||4
144638|NCT00798967|332072|P1|Discontinued During Dosing Period|Overall Study||4
144639|NCT00798967|332071|P2|STARTED|Overall Study||43
144640|NCT00798967|332072|P1|STARTED|Overall Study||43
144641|NCT00798889|332080|P1|NOT COMPLETED|Overall Study||314
144642|NCT00798889|332080|P1|COMPLETED|Overall Study||0
144643|NCT00798889|332080|P1|Treated|Overall Study||311
144644|NCT00798889|332080|P1|STARTED|Overall Study||314
144645|NCT00799825|332084|P1|NOT COMPLETED|Overall Study||48
144646|NCT00799825|332084|P1|COMPLETED|Overall Study||296
144647|NCT00799825|332084|P1|STARTED|Overall Study||344
144648|NCT00799773|332092|P2|NOT COMPLETED|Overall Study||0
144649|NCT00799773|332093|P1|NOT COMPLETED|Overall Study||0
144650|NCT00799773|332092|P2|COMPLETED|Overall Study||1
144651|NCT00799773|332093|P1|COMPLETED|Overall Study||2
144652|NCT00799773|332092|P2|STARTED|Overall Study||1
144653|NCT00799773|332093|P1|STARTED|Overall Study||2
144654|NCT00799708|332124|P3|NOT COMPLETED|Overall Study||0
144655|NCT00799708|332125|P2|NOT COMPLETED|Overall Study||0
144656|NCT00799708|332126|P1|NOT COMPLETED|Overall Study||1
144657|NCT00799708|332124|P3|COMPLETED|Overall Study||11
144658|NCT00799708|332125|P2|COMPLETED|Overall Study||6
144659|NCT00799708|332126|P1|COMPLETED|Overall Study||9
144660|NCT00799708|332124|P3|STARTED|Overall Study||11
144661|NCT00799708|332125|P2|STARTED|Overall Study||6
144662|NCT00799708|332126|P1|STARTED|Overall Study||10
144663|NCT00799643|332138|P2|NOT COMPLETED|Overall Study||27
144664|NCT00799643|332139|P1|NOT COMPLETED|Overall Study||25
144665|NCT00799643|332138|P2|COMPLETED|Overall Study||119
144666|NCT00799643|332139|P1|COMPLETED|Overall Study||115
144667|NCT00799643|332138|P2|STARTED|Overall Study||146
144668|NCT00799643|332139|P1|STARTED|Overall Study||140
144669|NCT00799604|332150|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
144670|NCT00799604|332151|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
144671|NCT00799604|332152|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
144672|NCT00799604|332150|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
144673|NCT00799604|332151|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
144674|NCT00799604|332152|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
144675|NCT00799604|332150|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
144676|NCT00799604|332151|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
144677|NCT00799604|332152|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
144678|NCT00799604|332150|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
144679|NCT00799604|332151|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
144680|NCT00799604|332152|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
144681|NCT00799604|332150|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
144682|NCT00799604|332151|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
144683|NCT00799604|332152|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
144684|NCT00799604|332150|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
144685|NCT00799604|332151|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
144686|NCT00799604|332152|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
144687|NCT00799591|332176|P1|NOT COMPLETED|Overall Study||66
144688|NCT00799591|332176|P1|COMPLETED|Overall Study||90
144689|NCT00799591|332176|P1|STARTED|Overall Study||156
144690|NCT00799578|332187|P1|NOT COMPLETED|Overall Study||2
144691|NCT00799578|332187|P1|COMPLETED|Overall Study||11
144692|NCT00799578|332187|P1|STARTED|Overall Study||13
144693|NCT00799487|332194|P3|NOT COMPLETED|Double-Blind Assessment Period||2
144694|NCT00799487|332195|P2|NOT COMPLETED|Double-Blind Assessment Period||1
144695|NCT00799487|332196|P1|NOT COMPLETED|Double-Blind Assessment Period||0
144696|NCT00799487|332194|P3|COMPLETED|Double-Blind Assessment Period||32
144697|NCT00799487|332195|P2|COMPLETED|Double-Blind Assessment Period||33
144698|NCT00799487|332196|P1|COMPLETED|Double-Blind Assessment Period||0
144699|NCT00799487|332194|P3|STARTED|Double-Blind Assessment Period||34
144700|NCT00799487|332195|P2|STARTED|Double-Blind Assessment Period||34
144701|NCT00799487|332196|P1|STARTED|Double-Blind Assessment Period||0
144702|NCT00799487|332194|P3|NOT COMPLETED|Dose Adjustment Period||0
144703|NCT00799487|332195|P2|NOT COMPLETED|Dose Adjustment Period||0
144704|NCT00799487|332196|P1|NOT COMPLETED|Dose Adjustment Period||21
144705|NCT00799487|332194|P3|COMPLETED|Dose Adjustment Period||34
144706|NCT00799487|332195|P2|COMPLETED|Dose Adjustment Period||34
144707|NCT00799487|332196|P1|COMPLETED|Dose Adjustment Period||0
144708|NCT00799487|332194|P3|STARTED|Dose Adjustment Period||34
144709|NCT00799487|332195|P2|STARTED|Dose Adjustment Period||34
144710|NCT00799487|332196|P1|STARTED|Dose Adjustment Period||21
144711|NCT00799474|332276|P1|NOT COMPLETED|Overall Study||0
144712|NCT00799474|332276|P1|COMPLETED|Overall Study||609
144713|NCT00799474|332276|P1|STARTED|Overall Study||609
144714|NCT00799422|332282|P6|NOT COMPLETED|Third Week of Wear||0
144715|NCT00799422|332283|P5|NOT COMPLETED|Third Week of Wear||0
144716|NCT00799422|332284|P4|NOT COMPLETED|Third Week of Wear||0
144717|NCT00799422|332285|P3|NOT COMPLETED|Third Week of Wear||0
144718|NCT00799422|332286|P2|NOT COMPLETED|Third Week of Wear||0
144719|NCT00799422|332287|P1|NOT COMPLETED|Third Week of Wear||0
144720|NCT00799422|332282|P6|COMPLETED|Third Week of Wear||4
144721|NCT00799422|332283|P5|COMPLETED|Third Week of Wear||4
144722|NCT00799422|332284|P4|COMPLETED|Third Week of Wear||3
144723|NCT00799422|332285|P3|COMPLETED|Third Week of Wear||3
144724|NCT00799422|332286|P2|COMPLETED|Third Week of Wear||4
144725|NCT00799422|332287|P1|COMPLETED|Third Week of Wear||4
144726|NCT00799422|332282|P6|STARTED|Third Week of Wear||4
144727|NCT00799422|332283|P5|STARTED|Third Week of Wear||4
144728|NCT00799422|332284|P4|STARTED|Third Week of Wear||3
144729|NCT00799422|332285|P3|STARTED|Third Week of Wear||3
144730|NCT00799422|332286|P2|STARTED|Third Week of Wear||4
144731|NCT00799422|332287|P1|STARTED|Third Week of Wear||4
144732|NCT00799422|332282|P6|NOT COMPLETED|Second Week of Wear||0
144733|NCT00799422|332283|P5|NOT COMPLETED|Second Week of Wear||0
144734|NCT00799422|332284|P4|NOT COMPLETED|Second Week of Wear||0
144735|NCT00799422|332285|P3|NOT COMPLETED|Second Week of Wear||0
144736|NCT00799422|332286|P2|NOT COMPLETED|Second Week of Wear||0
144737|NCT00799422|332287|P1|NOT COMPLETED|Second Week of Wear||0
144738|NCT00799422|332282|P6|COMPLETED|Second Week of Wear||4
144739|NCT00799422|332283|P5|COMPLETED|Second Week of Wear||4
144740|NCT00799422|332284|P4|COMPLETED|Second Week of Wear||3
144741|NCT00799422|332285|P3|COMPLETED|Second Week of Wear||3
144742|NCT00799422|332286|P2|COMPLETED|Second Week of Wear||4
144743|NCT00799422|332287|P1|COMPLETED|Second Week of Wear||4
144744|NCT00799422|332282|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
144745|NCT00799422|332283|P5|STARTED|Second Week of Wear||4
144746|NCT00799422|332284|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
144747|NCT00799422|332285|P3|STARTED|Second Week of Wear||3
144748|NCT00799422|332286|P2|STARTED|Second Week of Wear||4
144749|NCT00799422|332287|P1|STARTED|Second Week of Wear||4
144750|NCT00799422|332282|P6|NOT COMPLETED|First Week of Wear||0
144751|NCT00799422|332283|P5|NOT COMPLETED|First Week of Wear||0
144752|NCT00799422|332284|P4|NOT COMPLETED|First Week of Wear||1
144753|NCT00799422|332285|P3|NOT COMPLETED|First Week of Wear||1
144754|NCT00799422|332286|P2|NOT COMPLETED|First Week of Wear||0
144755|NCT00799422|332287|P1|NOT COMPLETED|First Week of Wear||0
144756|NCT00799422|332282|P6|COMPLETED|First Week of Wear||5
144757|NCT00799422|332283|P5|COMPLETED|First Week of Wear||4
144758|NCT00799422|332284|P4|COMPLETED|First Week of Wear||4
144759|NCT00799422|332285|P3|COMPLETED|First Week of Wear||3
144760|NCT00799422|332286|P2|COMPLETED|First Week of Wear||4
144761|NCT00799422|332287|P1|COMPLETED|First Week of Wear||4
144762|NCT00799422|332282|P6|STARTED|First Week of Wear||5
144763|NCT00799422|332283|P5|STARTED|First Week of Wear||4
144764|NCT00799422|332284|P4|STARTED|First Week of Wear||5
144765|NCT00799422|332285|P3|STARTED|First Week of Wear||4
144766|NCT00799422|332286|P2|STARTED|First Week of Wear||4
144767|NCT00799422|332287|P1|STARTED|First Week of Wear||4
144768|NCT00799409|332304|P3|NOT COMPLETED|Overall Study||0
144769|NCT00799409|332305|P2|NOT COMPLETED|Overall Study||0
144770|NCT00799409|332306|P1|NOT COMPLETED|Overall Study||7
144771|NCT00799409|332304|P3|COMPLETED|Overall Study||35
144772|NCT00799409|332305|P2|COMPLETED|Overall Study||36
144773|NCT00799409|332306|P1|COMPLETED|Overall Study||0
144774|NCT00799409|332304|P3|STARTED|Overall Study||35
144775|NCT00799409|332305|P2|STARTED|Overall Study||36
144776|NCT00799409|332306|P1|STARTED|Overall Study||7
144777|NCT00799396|332386|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
144778|NCT00799396|332386|P1|COMPLETED|Clopidogrel Plus Aspirin||663
144779|NCT00799396|332386|P1|STARTED|Clopidogrel Plus Aspirin||669
144780|NCT00799396|332386|P1|NOT COMPLETED|Clopidogrel Treatment||13
144781|NCT00799396|332386|P1|COMPLETED|Clopidogrel Treatment||669
144782|NCT00799396|332386|P1|STARTED|Clopidogrel Treatment||682
144783|NCT00799292|332393|P2|NOT COMPLETED|Overall Study||0
144784|NCT00799292|332394|P1|NOT COMPLETED|Overall Study||0
144785|NCT00799292|332393|P2|COMPLETED|Overall Study||29
144786|NCT00799292|332394|P1|COMPLETED|Overall Study||29
144787|NCT00799292|332393|P2|STARTED|Overall Study||29
144788|NCT00799292|332394|P1|STARTED|Overall Study||29
144789|NCT00799227|332398|P1|NOT COMPLETED|Overall Study||3
144790|NCT00799227|332398|P1|COMPLETED|Overall Study||53
144791|NCT00799227|332398|P1|STARTED|Overall Study||56
144792|NCT00798759|332407|P2|NOT COMPLETED|Overall Study||13
144793|NCT00798759|332408|P1|NOT COMPLETED|Overall Study||8
144794|NCT00798759|332407|P2|COMPLETED|Overall Study||106
144795|NCT00798759|332408|P1|COMPLETED|Overall Study||109
144796|NCT00798759|332407|P2|STARTED|Overall Study||119
144797|NCT00798759|332408|P1|STARTED|Overall Study||117
144798|NCT00798720|332416|P1|NOT COMPLETED|Overall Study||0
144799|NCT00798720|332416|P1|COMPLETED|Overall Study||18
144800|NCT00798720|332416|P1|STARTED|Overall Study||18
144801|NCT00798707|332426|P3|NOT COMPLETED|Overall Study||22
144802|NCT00798707|332427|P2|NOT COMPLETED|Overall Study||33
144803|NCT00798707|332428|P1|NOT COMPLETED|Overall Study||26
144804|NCT00798707|332426|P3|COMPLETED|Overall Study||215
144805|NCT00798707|332427|P2|COMPLETED|Overall Study||204
144806|NCT00798707|332428|P1|COMPLETED|Overall Study||209
144807|NCT00798707|332426|P3|Treated|Overall Study||236
144808|NCT00798707|332427|P2|Treated|Overall Study||232
144809|NCT00798707|332428|P1|Treated|Overall Study||231
144810|NCT00798707|332426|P3|STARTED|Overall Study||237
144811|NCT00798707|332427|P2|STARTED|Overall Study||237
144812|NCT00798707|332428|P1|STARTED|Overall Study||235
144813|NCT00798655|332478|P1|NOT COMPLETED|Overall Study||2
144814|NCT00798655|332478|P1|COMPLETED|Overall Study||44
144815|NCT00798655|332478|P1|STARTED|Overall Study||46
144816|NCT00798603|332483|P1|NOT COMPLETED|Overall Study||35
144817|NCT00798603|332483|P1|COMPLETED|Overall Study||27
144818|NCT00798603|332483|P1|STARTED|Overall Study||62
144819|NCT00798577|332505|P2|NOT COMPLETED|Overall Study||0
144820|NCT00798577|332506|P1|NOT COMPLETED|Overall Study||0
144821|NCT00798577|332505|P2|COMPLETED|Overall Study||7
144822|NCT00798577|332506|P1|COMPLETED|Overall Study||17
144823|NCT00798577|332505|P2|STARTED|Overall Study||7
144824|NCT00798577|332506|P1|STARTED|Overall Study||17
144825|NCT00798486|332520|P1|NOT COMPLETED|Overall Study||0
144826|NCT00798486|332520|P1|COMPLETED|Overall Study||110
144827|NCT00798486|332520|P1|STARTED|Overall Study||110
144828|NCT00798434|332529|P2|NOT COMPLETED|Open-Label||32
144829|NCT00798434|332530|P1|NOT COMPLETED|Open-Label||42
144830|NCT00798434|332529|P2|COMPLETED|Open-Label||282
144831|NCT00798434|332530|P1|COMPLETED|Open-Label||299
144832|NCT00798434|332529|P2|Received Treatment|Open-Label||313
144833|NCT00798434|332530|P1|Received Treatment|Open-Label||341
144834|NCT00798434|332529|P2|STARTED|Open-Label||314
144835|NCT00798434|332530|P1|STARTED|Open-Label||341
144836|NCT00798434|332529|P2|NOT COMPLETED|Double-Blind||84
144837|NCT00798434|332530|P1|NOT COMPLETED|Double-Blind||55
144838|NCT00798434|332529|P2|COMPLETED|Double-Blind||314
144839|NCT00798434|332530|P1|COMPLETED|Double-Blind||341
144840|NCT00798434|332529|P2|Received Treatment|Double-Blind||392
144841|NCT00798434|332530|P1|Received Treatment|Double-Blind||393
144842|NCT00798434|332529|P2|STARTED|Double-Blind||398
144843|NCT00798434|332530|P1|STARTED|Double-Blind||396
144844|NCT00798369|332616|P6|NOT COMPLETED|Overall Study||3
144845|NCT00798369|332617|P5|NOT COMPLETED|Overall Study||1
144846|NCT00798369|332618|P4|NOT COMPLETED|Overall Study||1
144847|NCT00798369|332619|P3|NOT COMPLETED|Overall Study||2
144848|NCT00798369|332620|P2|NOT COMPLETED|Overall Study||1
144849|NCT00798369|332621|P1|NOT COMPLETED|Overall Study||1
144850|NCT00798369|332616|P6|COMPLETED|Overall Study||54
144851|NCT00798369|332617|P5|COMPLETED|Overall Study||27
144852|NCT00798369|332618|P4|COMPLETED|Overall Study||28
144853|NCT00798369|332619|P3|COMPLETED|Overall Study||27
144854|NCT00798369|332620|P2|COMPLETED|Overall Study||28
144855|NCT00798369|332621|P1|COMPLETED|Overall Study||27
144856|NCT00798369|332616|P6|STARTED|Overall Study||57
144857|NCT00798369|332617|P5|STARTED|Overall Study||28
144858|NCT00798369|332618|P4|STARTED|Overall Study||29
144859|NCT00798369|332619|P3|STARTED|Overall Study||29
144860|NCT00798369|332620|P2|STARTED|Overall Study||29
144861|NCT00798369|332621|P1|STARTED|Overall Study||28
144862|NCT00798317|332668|P2|NOT COMPLETED|Overall Study||7
144863|NCT00798317|332669|P1|NOT COMPLETED|Overall Study||10
144864|NCT00798317|332668|P2|COMPLETED|Overall Study||74
144865|NCT00798317|332669|P1|COMPLETED|Overall Study||235
144866|NCT00798317|332668|P2|STARTED|Overall Study||81
144867|NCT00798317|332669|P1|STARTED|Overall Study||245
144868|NCT00798304|332680|P3|NOT COMPLETED|Overall Study||10
144869|NCT00798304|332681|P2|NOT COMPLETED|Overall Study||22
144870|NCT00798304|332682|P1|NOT COMPLETED|Overall Study||14
144871|NCT00798304|332680|P3|COMPLETED|Overall Study||0
144872|NCT00798304|332681|P2|COMPLETED|Overall Study||0
144873|NCT00798304|332682|P1|COMPLETED|Overall Study||0
144874|NCT00798304|332680|P3|STARTED|Overall Study||10
144875|NCT00798304|332681|P2|STARTED|Overall Study||22
144876|NCT00798304|332682|P1|STARTED|Overall Study||14
144877|NCT00798161|332715|P7|NOT COMPLETED|Overall Study||10
144878|NCT00798161|332716|P6|NOT COMPLETED|Overall Study||11
144879|NCT00798161|332717|P5|NOT COMPLETED|Overall Study||16
144880|NCT00798161|332718|P4|NOT COMPLETED|Overall Study||21
144881|NCT00798161|332719|P3|NOT COMPLETED|Overall Study||21
144882|NCT00798161|332720|P2|NOT COMPLETED|Overall Study||17
144883|NCT00798161|332721|P1|NOT COMPLETED|Overall Study||18
144884|NCT00798161|332715|P7|COMPLETED|Overall Study||56
144885|NCT00798161|332716|P6|COMPLETED|Overall Study||132
144886|NCT00798161|332717|P5|COMPLETED|Overall Study||127
144887|NCT00798161|332718|P4|COMPLETED|Overall Study||121
144888|NCT00798161|332719|P3|COMPLETED|Overall Study||126
144889|NCT00798161|332720|P2|COMPLETED|Overall Study||127
144890|NCT00798161|332721|P1|COMPLETED|Overall Study||54
144891|NCT00798161|332715|P7|STARTED|Overall Study||66
144892|NCT00798161|332716|P6|STARTED|Overall Study||143
144893|NCT00798161|332717|P5|STARTED|Overall Study||143
144894|NCT00798161|332718|P4|STARTED|Overall Study||142
144895|NCT00798161|332719|P3|STARTED|Overall Study||147
144896|NCT00798161|332720|P2|STARTED|Overall Study||144
144897|NCT00798161|332721|P1|STARTED|Overall Study||72
144898|NCT00798135|332828|P1|NOT COMPLETED|Overall Study||13
144899|NCT00798135|332828|P1|COMPLETED|Overall Study||0
144900|NCT00798135|332828|P1|STARTED|Overall Study||13
144901|NCT00798096|332834|P1|NOT COMPLETED|Overall Study||2
144902|NCT00798096|332834|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
144903|NCT00798096|332834|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
144904|NCT00798018|332845|P4|NOT COMPLETED|Overall Study||0
144905|NCT00798018|332846|P3|NOT COMPLETED|Overall Study||0
144906|NCT00798018|332847|P2|NOT COMPLETED|Overall Study||0
144907|NCT00798018|332848|P1|NOT COMPLETED|Overall Study||0
144908|NCT00798018|332845|P4|COMPLETED|Overall Study||25
144909|NCT00798018|332846|P3|COMPLETED|Overall Study||25
144910|NCT00798018|332847|P2|COMPLETED|Overall Study||25
144911|NCT00798018|332848|P1|COMPLETED|Overall Study||25
144912|NCT00798018|332845|P4|STARTED|Overall Study||25
144913|NCT00798018|332846|P3|STARTED|Overall Study||25
144914|NCT00798018|332847|P2|STARTED|Overall Study||25
144915|NCT00798018|332848|P1|STARTED|Overall Study||25
144916|NCT00797966|332862|P6|NOT COMPLETED|Phase A+||28
144917|NCT00797966|332863|P5|NOT COMPLETED|Phase A+||0
144918|NCT00797966|332864|P4|NOT COMPLETED|Phase A+||0
144919|NCT00797966|332865|P3|NOT COMPLETED|Phase A+||0
144920|NCT00797966|332866|P2|NOT COMPLETED|Phase A+||0
144921|NCT00797966|332867|P1|NOT COMPLETED|Phase A+||0
144922|NCT00797966|332862|P6|COMPLETED|Phase A+||207
144923|NCT00797966|332863|P5|COMPLETED|Phase A+||0
144924|NCT00797966|332864|P4|COMPLETED|Phase A+||0
144925|NCT00797966|332865|P3|COMPLETED|Phase A+||0
144926|NCT00797966|332866|P2|COMPLETED|Phase A+||0
144927|NCT00797966|332867|P1|COMPLETED|Phase A+||0
144928|NCT00797966|332862|P6|STARTED|Phase A+||235
144929|NCT00797966|332863|P5|STARTED|Phase A+||0
144930|NCT00797966|332864|P4|STARTED|Phase A+||0
144931|NCT00797966|332865|P3|STARTED|Phase A+||0
144932|NCT00797966|332866|P2|STARTED|Phase A+||0
144933|NCT00797966|332867|P1|STARTED|Phase A+||0
144934|NCT00797966|332862|P6|NOT COMPLETED|Phase B||0
144935|NCT00797966|332863|P5|NOT COMPLETED|Phase B||0
144936|NCT00797966|332864|P4|NOT COMPLETED|Phase B||16
144937|NCT00797966|332865|P3|NOT COMPLETED|Phase B||21
144938|NCT00797966|332866|P2|NOT COMPLETED|Phase B||18
144939|NCT00797966|332867|P1|NOT COMPLETED|Phase B||11
144940|NCT00797966|332862|P6|COMPLETED|Phase B||0
144941|NCT00797966|332863|P5|COMPLETED|Phase B||0
144942|NCT00797966|332864|P4|COMPLETED|Phase B||110
144943|NCT00797966|332865|P3|COMPLETED|Phase B||100
144944|NCT00797966|332866|P2|COMPLETED|Phase B||102
144945|NCT00797966|332867|P1|COMPLETED|Phase B||51
144946|NCT00797966|332862|P6|STARTED|Phase B||0
144947|NCT00797966|332863|P5|STARTED|Phase B||0
144948|NCT00797966|332864|P4|STARTED|Phase B|Randomized participants.|126
144949|NCT00797966|332865|P3|STARTED|Phase B|Randomized participants.|121
144950|NCT00797966|332866|P2|STARTED|Phase B|Randomized participants.|120
144951|NCT00797966|332867|P1|STARTED|Phase B|Randomized participants.|62
144952|NCT00797966|332862|P6|NOT COMPLETED|Phase A||0
144953|NCT00797966|332863|P5|NOT COMPLETED|Phase A||185
144954|NCT00797966|332864|P4|NOT COMPLETED|Phase A||0
144955|NCT00797966|332865|P3|NOT COMPLETED|Phase A||0
144956|NCT00797966|332866|P2|NOT COMPLETED|Phase A||0
144957|NCT00797966|332867|P1|NOT COMPLETED|Phase A||0
144958|NCT00797966|332862|P6|COMPLETED|Phase A||0
144959|NCT00797966|332863|P5|COMPLETED|Phase A||664
144960|NCT00797966|332864|P4|COMPLETED|Phase A||0
144961|NCT00797966|332865|P3|COMPLETED|Phase A||0
144962|NCT00797966|332866|P2|COMPLETED|Phase A||0
144963|NCT00797966|332867|P1|COMPLETED|Phase A||0
144964|NCT00797966|332862|P6|STARTED|Phase A||0
144965|NCT00797966|332863|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
144966|NCT00797966|332864|P4|STARTED|Phase A||0
144967|NCT00797966|332865|P3|STARTED|Phase A||0
144968|NCT00797966|332866|P2|STARTED|Phase A||0
144969|NCT00797966|332867|P1|STARTED|Phase A||0
144970|NCT00797862|332932|P3|NOT COMPLETED|Overall Study||86
144971|NCT00797862|332933|P2|NOT COMPLETED|Overall Study||68
144972|NCT00797862|332934|P1|NOT COMPLETED|Overall Study||124
144973|NCT00797862|332932|P3|COMPLETED|Overall Study||230
144974|NCT00797862|332933|P2|COMPLETED|Overall Study||250
144975|NCT00797862|332934|P1|COMPLETED|Overall Study||496
144976|NCT00797862|332932|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
144977|NCT00797862|332933|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
144978|NCT00797862|332934|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
144979|NCT00797862|332932|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
144980|NCT00797862|332933|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
144981|NCT00797862|332934|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
144982|NCT00797823|332963|P3|NOT COMPLETED|Second Period (Crossover)||0
144983|NCT00797823|332964|P2|NOT COMPLETED|Second Period (Crossover)||0
144984|NCT00797823|332965|P1|NOT COMPLETED|Second Period (Crossover)||0
144985|NCT00797823|332963|P3|COMPLETED|Second Period (Crossover)||0
144986|NCT00797823|332964|P2|COMPLETED|Second Period (Crossover)||4
144987|NCT00797823|332965|P1|COMPLETED|Second Period (Crossover)||3
144988|NCT00797823|332963|P3|STARTED|Second Period (Crossover)||0
144989|NCT00797823|332964|P2|STARTED|Second Period (Crossover)||4
144990|NCT00797823|332965|P1|STARTED|Second Period (Crossover)||3
144991|NCT00797823|332963|P3|NOT COMPLETED|First Period (Initial Randomization)||0
144992|NCT00797823|332964|P2|NOT COMPLETED|First Period (Initial Randomization)||0
144993|NCT00797823|332965|P1|NOT COMPLETED|First Period (Initial Randomization)||1
144994|NCT00797823|332963|P3|COMPLETED|First Period (Initial Randomization)||0
144995|NCT00797823|332964|P2|COMPLETED|First Period (Initial Randomization)||4
144996|NCT00797823|332965|P1|COMPLETED|First Period (Initial Randomization)||3
144997|NCT00797823|332963|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
144998|NCT00797823|332964|P2|STARTED|First Period (Initial Randomization)||4
144999|NCT00797823|332965|P1|STARTED|First Period (Initial Randomization)||4
145000|NCT00797823|332963|P3|NOT COMPLETED|Pilot Studies||0
145001|NCT00797823|332964|P2|NOT COMPLETED|Pilot Studies||0
145002|NCT00797823|332965|P1|NOT COMPLETED|Pilot Studies||0
145003|NCT00797823|332963|P3|COMPLETED|Pilot Studies||6
145004|NCT00797823|332964|P2|COMPLETED|Pilot Studies||0
145005|NCT00797823|332965|P1|COMPLETED|Pilot Studies||0
145006|NCT00797823|332963|P3|STARTED|Pilot Studies||6
145007|NCT00797823|332964|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
145008|NCT00797823|332965|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
145009|NCT00797797|332976|P2|NOT COMPLETED|Overall Study||43
145010|NCT00797797|332977|P1|NOT COMPLETED|Overall Study||55
145011|NCT00797797|332976|P2|COMPLETED|Overall Study||141
145012|NCT00797797|332977|P1|COMPLETED|Overall Study||123
145013|NCT00797797|332976|P2|STARTED|Overall Study||184
145014|NCT00797797|332977|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
145015|NCT00797667|332988|P3|NOT COMPLETED|Overall Study||127
145016|NCT00797667|332989|P2|NOT COMPLETED|Overall Study||259
145017|NCT00797667|332990|P1|NOT COMPLETED|Overall Study||260
145018|NCT00797667|332988|P3|COMPLETED|Overall Study||4
145019|NCT00797667|332989|P2|COMPLETED|Overall Study||5
145020|NCT00797667|332990|P1|COMPLETED|Overall Study||5
145021|NCT00797667|332988|P3|Treated|Overall Study||130
145022|NCT00797667|332989|P2|Treated|Overall Study||263
145023|NCT00797667|332990|P1|Treated|Overall Study||263
145024|NCT00797667|332988|P3|STARTED|Overall Study||131
145025|NCT00797667|332989|P2|STARTED|Overall Study||264
145026|NCT00797667|332990|P1|STARTED|Overall Study||265
145027|NCT00797563|333016|P1|NOT COMPLETED|Overall Study||1
145028|NCT00797563|333016|P1|COMPLETED|Overall Study||101
145029|NCT00797563|333016|P1|STARTED|Overall Study|number of subjects|102
145030|NCT00797511|333022|P1|NOT COMPLETED|Overall Study||1
145031|NCT00797511|333022|P1|COMPLETED|Overall Study||131
145032|NCT00797511|333022|P1|STARTED|Overall Study||132
145033|NCT00797459|333030|P1|NOT COMPLETED|Overall Study||0
145034|NCT00797459|333030|P1|COMPLETED|Overall Study||60
145035|NCT00797459|333030|P1|STARTED|Overall Study||60
145036|NCT00797316|333040|P2|NOT COMPLETED|Overall Study||32
145037|NCT00797316|333041|P1|NOT COMPLETED|Overall Study||23
145038|NCT00797316|333040|P2|COMPLETED|Overall Study||233
145039|NCT00797316|333041|P1|COMPLETED|Overall Study||244
145040|NCT00797316|333040|P2|STARTED|Overall Study||265
145041|NCT00797316|333041|P1|STARTED|Overall Study||267
145042|NCT00797277|333057|P2|NOT COMPLETED|Overall Study||0
145043|NCT00797277|333058|P1|NOT COMPLETED|Overall Study||0
145044|NCT00797277|333057|P2|COMPLETED|Overall Study||30
145045|NCT00797277|333058|P1|COMPLETED|Overall Study||37
145046|NCT00797277|333057|P2|STARTED|Overall Study||30
145047|NCT00797277|333058|P1|STARTED|Overall Study||37
145048|NCT00797212|333066|P1|NOT COMPLETED|Overall Study||0
145049|NCT00797212|333066|P1|COMPLETED|Overall Study||50
145050|NCT00797212|333066|P1|STARTED|Overall Study||50
145051|NCT00797108|333075|P3|NOT COMPLETED|Overall Study||6
145052|NCT00797108|333076|P2|NOT COMPLETED|Overall Study||2
145053|NCT00797108|333077|P1|NOT COMPLETED|Overall Study||4
145054|NCT00797108|333075|P3|COMPLETED|Overall Study||6
145055|NCT00797108|333076|P2|COMPLETED|Overall Study||9
145056|NCT00797108|333077|P1|COMPLETED|Overall Study||8
145057|NCT00797108|333075|P3|Treated|Overall Study||12
145058|NCT00797108|333076|P2|Treated|Overall Study||11
145059|NCT00797108|333077|P1|Treated|Overall Study||10
145060|NCT00797108|333075|P3|STARTED|Overall Study||12
145061|NCT00797108|333076|P2|STARTED|Overall Study||11
145062|NCT00797108|333077|P1|STARTED|Overall Study||12
145063|NCT00796991|333112|P3|NOT COMPLETED|Overall Study||14
145064|NCT00796991|333113|P2|NOT COMPLETED|Overall Study||12
145065|NCT00796991|333114|P1|NOT COMPLETED|Overall Study||15
145066|NCT00796991|333112|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
145067|NCT00796991|333113|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
145068|NCT00796991|333114|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
145069|NCT00796991|333112|P3|STARTED|Overall Study||20
145070|NCT00796991|333113|P2|STARTED|Overall Study||19
145071|NCT00796991|333114|P1|STARTED|Overall Study||20
145072|NCT00796926|333214|P2|NOT COMPLETED|Overall Study||0
145073|NCT00796926|333215|P1|NOT COMPLETED|Overall Study||1
145074|NCT00796926|333214|P2|COMPLETED|Overall Study||15
145075|NCT00796926|333215|P1|COMPLETED|Overall Study||14
145076|NCT00796926|333214|P2|STARTED|Overall Study||15
145077|NCT00796926|333215|P1|STARTED|Overall Study||15
145078|NCT00796822|333223|P2|NOT COMPLETED|Overall Study||0
145079|NCT00796822|333224|P1|NOT COMPLETED|Overall Study||3
145080|NCT00796822|333223|P2|COMPLETED|Overall Study||13
145081|NCT00796822|333224|P1|COMPLETED|Overall Study||10
145082|NCT00796822|333223|P2|STARTED|Overall Study||13
145083|NCT00796822|333224|P1|STARTED|Overall Study||13
145084|NCT00796757|333230|P1|NOT COMPLETED|Overall Study||86
145085|NCT00796757|333230|P1|COMPLETED|Overall Study||60
145086|NCT00796757|333230|P1|STARTED|Overall Study||146
145087|NCT00796744|333245|P3|NOT COMPLETED|Overall Study||1
145088|NCT00796744|333246|P2|NOT COMPLETED|Overall Study||0
145089|NCT00796744|333247|P1|NOT COMPLETED|Overall Study||0
145090|NCT00796744|333245|P3|COMPLETED|Overall Study||27
145091|NCT00796744|333246|P2|COMPLETED|Overall Study||26
145092|NCT00796744|333247|P1|COMPLETED|Overall Study||24
145093|NCT00796744|333245|P3|STARTED|Overall Study||28
145094|NCT00796744|333246|P2|STARTED|Overall Study||26
145095|NCT00796744|333247|P1|STARTED|Overall Study||24
145096|NCT00796718|333264|P1|NOT COMPLETED|Overall Study||9
145097|NCT00796718|333264|P1|COMPLETED|Overall Study||53
145098|NCT00796718|333264|P1|STARTED|Overall Study||62
145099|NCT00796705|333275|P4|NOT COMPLETED|Overall Study||0
145100|NCT00796705|333276|P3|NOT COMPLETED|Overall Study||0
145101|NCT00796705|333277|P2|NOT COMPLETED|Overall Study||0
145102|NCT00796705|333278|P1|NOT COMPLETED|Overall Study||0
145103|NCT00796705|333275|P4|COMPLETED|Overall Study||2
145104|NCT00796705|333276|P3|COMPLETED|Overall Study||4
145105|NCT00796705|333277|P2|COMPLETED|Overall Study||4
145106|NCT00796705|333278|P1|COMPLETED|Overall Study||3
145107|NCT00796705|333275|P4|STARTED|Overall Study||2
145108|NCT00796705|333276|P3|STARTED|Overall Study||4
145109|NCT00796705|333277|P2|STARTED|Overall Study||4
145110|NCT00796705|333278|P1|STARTED|Overall Study||3
145111|NCT00796666|333316|P2|NOT COMPLETED|Overall Study||64
145112|NCT00796666|333317|P1|NOT COMPLETED|Overall Study||67
145113|NCT00796666|333316|P2|COMPLETED|Overall Study||0
145114|NCT00796666|333317|P1|COMPLETED|Overall Study||0
145115|NCT00796666|333316|P2|Randomized and Not Treated|Overall Study||0
145116|NCT00796666|333317|P1|Randomized and Not Treated|Overall Study||1
145117|NCT00796666|333316|P2|Treated|Overall Study||64
145118|NCT00796666|333317|P1|Treated|Overall Study||66
145119|NCT00796666|333316|P2|STARTED|Overall Study||64
145120|NCT00796666|333317|P1|STARTED|Overall Study||67
145121|NCT00796653|333351|P4|NOT COMPLETED|Overall Study||40
145122|NCT00796653|333352|P3|NOT COMPLETED|Overall Study||36
145123|NCT00796653|333353|P2|NOT COMPLETED|Overall Study||37
145124|NCT00796653|333354|P1|NOT COMPLETED|Overall Study||51
145125|NCT00796653|333351|P4|COMPLETED|Overall Study||193
145126|NCT00796653|333352|P3|COMPLETED|Overall Study||198
145127|NCT00796653|333353|P2|COMPLETED|Overall Study||195
145128|NCT00796653|333354|P1|COMPLETED|Overall Study||184
145129|NCT00796653|333351|P4|STARTED|Overall Study||233
145130|NCT00796653|333352|P3|STARTED|Overall Study||234
145131|NCT00796653|333353|P2|STARTED|Overall Study||232
145132|NCT00796653|333354|P1|STARTED|Overall Study||235
145133|NCT00796614|333624|P4|NOT COMPLETED|Overall Study||1
145134|NCT00796614|333625|P3|NOT COMPLETED|Overall Study||3
145135|NCT00796614|333626|P2|NOT COMPLETED|Overall Study||4
145136|NCT00796614|333627|P1|NOT COMPLETED|Overall Study||5
145137|NCT00796614|333624|P4|COMPLETED|Overall Study||40
145138|NCT00796614|333625|P3|COMPLETED|Overall Study||36
145139|NCT00796614|333626|P2|COMPLETED|Overall Study||36
145140|NCT00796614|333627|P1|COMPLETED|Overall Study||36
145141|NCT00796614|333624|P4|Not Treated|Overall Study||0
145142|NCT00796614|333625|P3|Not Treated|Overall Study||1
145143|NCT00796614|333626|P2|Not Treated|Overall Study||0
145144|NCT00796614|333627|P1|Not Treated|Overall Study||0
145145|NCT00796614|333624|P4|STARTED|Overall Study||41
145146|NCT00796614|333625|P3|STARTED|Overall Study||39
145147|NCT00796614|333626|P2|STARTED|Overall Study||40
145148|NCT00796614|333627|P1|STARTED|Overall Study||41
145149|NCT00796549|333669|P1|NOT COMPLETED|Overall Study||218
145150|NCT00796549|333669|P1|COMPLETED|Overall Study||0
145151|NCT00796549|333669|P1|Entered|Overall Study|entered and treated|69
145152|NCT00796549|333669|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
145153|NCT00796523|333686|P2|NOT COMPLETED|Overall Study||7
145154|NCT00796523|333687|P1|NOT COMPLETED|Overall Study||9
145155|NCT00796523|333686|P2|COMPLETED|Overall Study||17
145156|NCT00796523|333687|P1|COMPLETED|Overall Study||18
145157|NCT00796523|333686|P2|STARTED|Overall Study||24
145158|NCT00796523|333687|P1|STARTED|Overall Study||27
145159|NCT00796510|333697|P2|NOT COMPLETED|Overall Study||0
145160|NCT00796510|333698|P1|NOT COMPLETED|Overall Study||3
145161|NCT00796510|333697|P2|COMPLETED|Overall Study||0
145162|NCT00796510|333698|P1|COMPLETED|Overall Study||0
145163|NCT00796510|333697|P2|STARTED|Overall Study||0
145164|NCT00796510|333698|P1|STARTED|Overall Study||3
145165|NCT00796367|333711|P3|NOT COMPLETED|Overall Study||47
145166|NCT00796367|333712|P2|NOT COMPLETED|Overall Study||25
145167|NCT00796367|333713|P1|NOT COMPLETED|Overall Study||30
145168|NCT00796367|333711|P3|COMPLETED|Overall Study||248
145169|NCT00796367|333712|P2|COMPLETED|Overall Study||129
145170|NCT00796367|333713|P1|COMPLETED|Overall Study||197
145171|NCT00796367|333711|P3|STARTED|Overall Study||295
145172|NCT00796367|333712|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
145173|NCT00796367|333713|P1|STARTED|Overall Study||227
145174|NCT00796328|333724|P1|NOT COMPLETED|Overall Study||6
145175|NCT00796328|333724|P1|COMPLETED|Overall Study||40
145176|NCT00796328|333724|P1|STARTED|Overall Study||46
145177|NCT00796315|333728|P3|NOT COMPLETED|Overall Study||0
145178|NCT00796315|333729|P2|NOT COMPLETED|Overall Study||1
145179|NCT00796315|333730|P1|NOT COMPLETED|Overall Study||0
145180|NCT00796315|333728|P3|COMPLETED|Overall Study||15
145181|NCT00796315|333729|P2|COMPLETED|Overall Study||16
145182|NCT00796315|333730|P1|COMPLETED|Overall Study||9
145183|NCT00796315|333728|P3|STARTED|Overall Study||15
145184|NCT00796315|333729|P2|STARTED|Overall Study||17
145185|NCT00796315|333730|P1|STARTED|Overall Study||9
145186|NCT00796302|333743|P2|NOT COMPLETED|Overall Study||18
145187|NCT00796302|333744|P1|NOT COMPLETED|Overall Study||13
145188|NCT00796302|333743|P2|COMPLETED|Overall Study||66
145189|NCT00796302|333744|P1|COMPLETED|Overall Study||71
145190|NCT00796302|333743|P2|STARTED|Overall Study||84
145191|NCT00796302|333744|P1|STARTED|Overall Study||84
145192|NCT00796224|333758|P2|NOT COMPLETED|Overall Study||1
145193|NCT00796224|333759|P1|NOT COMPLETED|Overall Study||1
145194|NCT00796224|333758|P2|COMPLETED|Overall Study||18
145195|NCT00796224|333759|P1|COMPLETED|Overall Study||18
145196|NCT00796224|333758|P2|STARTED|Overall Study||19
145197|NCT00796224|333759|P1|STARTED|Overall Study||19
145198|NCT00796120|333779|P2|NOT COMPLETED|Overall Study||60
145199|NCT00796120|333780|P1|NOT COMPLETED|Overall Study||61
145200|NCT00796120|333779|P2|COMPLETED|Overall Study||0
145201|NCT00796120|333780|P1|COMPLETED|Overall Study||0
145202|NCT00796120|333779|P2|Treated|Overall Study||57
145203|NCT00796120|333780|P1|Treated|Overall Study||61
145204|NCT00796120|333779|P2|STARTED|Overall Study||60
145205|NCT00796120|333780|P1|STARTED|Overall Study||61
145206|NCT00796003|333796|P2|NOT COMPLETED|Overall Study||29
145207|NCT00796003|333797|P1|NOT COMPLETED|Overall Study||3
145208|NCT00796003|333796|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
145209|NCT00796003|333797|P1|COMPLETED|Overall Study||0
145210|NCT00796003|333796|P2|Treated|Overall Study|Number of participants treated|34
145211|NCT00796003|333797|P1|Treated|Overall Study|Number of participants treated|3
145212|NCT00796003|333796|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
145213|NCT00796003|333797|P1|STARTED|Overall Study|Number of participants enrolled|3
145214|NCT00795951|333818|P1|NOT COMPLETED|Overall Study||2
145215|NCT00795951|333818|P1|COMPLETED|Overall Study||100
145216|NCT00795951|333818|P1|STARTED|Overall Study||102
145217|NCT00795886|333855|P1|NOT COMPLETED|Overall Study||10
145218|NCT00795886|333855|P1|COMPLETED|Overall Study||53
145219|NCT00795886|333855|P1|STARTED|Overall Study||63
145220|NCT00795717|333863|P2|NOT COMPLETED|Phase II||1
145221|NCT00795717|333864|P1|NOT COMPLETED|Phase II||0
145222|NCT00795717|333863|P2|COMPLETED|Phase II||18
145223|NCT00795717|333864|P1|COMPLETED|Phase II||18
145224|NCT00795717|333863|P2|STARTED|Phase II||19
145225|NCT00795717|333864|P1|STARTED|Phase II||18
145226|NCT00795717|333863|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
145227|NCT00795717|333864|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
145228|NCT00795717|333863|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
145229|NCT00795717|333864|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
145230|NCT00795717|333863|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
145231|NCT00795717|333864|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
145232|NCT00795704|333876|P2|NOT COMPLETED|Overall Study||3
145233|NCT00795704|333877|P1|NOT COMPLETED|Overall Study||4
145234|NCT00795704|333876|P2|COMPLETED|Overall Study||9
145235|NCT00795704|333877|P1|COMPLETED|Overall Study||8
145236|NCT00795704|333876|P2|STARTED|Overall Study||12
145237|NCT00795704|333877|P1|STARTED|Overall Study||12
145238|NCT00795639|333889|P2|NOT COMPLETED|Overall Study||26
145239|NCT00795639|333890|P1|NOT COMPLETED|Overall Study||21
145240|NCT00795639|333889|P2|COMPLETED|Overall Study||66
145241|NCT00795639|333890|P1|COMPLETED|Overall Study||70
145242|NCT00795639|333889|P2|Randomized and Not Treated|Overall Study||1
145243|NCT00795639|333890|P1|Randomized and Not Treated|Overall Study||0
145244|NCT00795639|333889|P2|STARTED|Overall Study||92
145245|NCT00795639|333890|P1|STARTED|Overall Study||91
145246|NCT00795600|333902|P2|NOT COMPLETED|Overall Study||4
145247|NCT00795600|333903|P1|NOT COMPLETED|Overall Study||4
145248|NCT00795600|333902|P2|COMPLETED|Overall Study||31
145249|NCT00795600|333903|P1|COMPLETED|Overall Study||21
145250|NCT00795600|333902|P2|Exposed to Drug|Overall Study||35
145251|NCT00795600|333903|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
145252|NCT00795600|333902|P2|STARTED|Overall Study||35
145253|NCT00795600|333903|P1|STARTED|Overall Study||25
145254|NCT00795535|334023|P1|NOT COMPLETED|Overall Study||20
145255|NCT00795535|334023|P1|COMPLETED|Overall Study||75
145256|NCT00795535|334023|P1|STARTED|Overall Study||95
145257|NCT00795509|334030|P1|NOT COMPLETED|Overall Study||31
145258|NCT00795509|334030|P1|COMPLETED|Overall Study||343
145259|NCT00795509|334030|P1|STARTED|Overall Study||374
145260|NCT00795366|334037|P2|NOT COMPLETED|Overall Study||0
145261|NCT00795366|334038|P1|NOT COMPLETED|Overall Study||0
145262|NCT00795366|334037|P2|COMPLETED|Overall Study||54
145263|NCT00795366|334038|P1|COMPLETED|Overall Study||42
145264|NCT00795366|334037|P2|STARTED|Overall Study||54
145265|NCT00795366|334038|P1|STARTED|Overall Study||42
145266|NCT00795340|334046|P2|NOT COMPLETED|Overall Study||0
145267|NCT00795340|334047|P1|NOT COMPLETED|Overall Study||7
145268|NCT00795340|334046|P2|COMPLETED|Overall Study||153
145269|NCT00795340|334047|P1|COMPLETED|Overall Study||146
145270|NCT00795340|334046|P2|STARTED|Overall Study||153
145271|NCT00795340|334047|P1|STARTED|Overall Study||153
145272|NCT00795288|334059|P2|NOT COMPLETED|Overall Study||0
145273|NCT00795288|334060|P1|NOT COMPLETED|Overall Study||0
145274|NCT00795288|334059|P2|COMPLETED|Overall Study||21
145275|NCT00795288|334060|P1|COMPLETED|Overall Study||21
145276|NCT00795288|334059|P2|STARTED|Overall Study||21
145277|NCT00795288|334060|P1|STARTED|Overall Study||21
145278|NCT00795210|334073|P3|NOT COMPLETED|Overall Study||2
145279|NCT00795210|334074|P2|NOT COMPLETED|Overall Study||1
145280|NCT00795210|334075|P1|NOT COMPLETED|Overall Study||0
145281|NCT00795210|334073|P3|COMPLETED|Overall Study||3
145282|NCT00795210|334074|P2|COMPLETED|Overall Study||11
145283|NCT00795210|334075|P1|COMPLETED|Overall Study||8
145284|NCT00795210|334073|P3|STARTED|Overall Study||5
145285|NCT00795210|334074|P2|STARTED|Overall Study||12
145286|NCT00795210|334075|P1|STARTED|Overall Study||8
145287|NCT00795184|334086|P2|NOT COMPLETED|Overall Study||13
145288|NCT00795184|334087|P1|NOT COMPLETED|Overall Study||8
145289|NCT00795184|334086|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
145290|NCT00795184|334087|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
145291|NCT00795184|334086|P2|STARTED|Overall Study||57
145292|NCT00795184|334087|P1|STARTED|Overall Study||65
145293|NCT00795145|334098|P7|NOT COMPLETED|Cohort 2||0
145294|NCT00795145|334099|P6|NOT COMPLETED|Cohort 2||0
145295|NCT00795145|334100|P5|NOT COMPLETED|Cohort 2||0
145296|NCT00795145|334101|P4|NOT COMPLETED|Cohort 2||0
145297|NCT00795145|334102|P3|NOT COMPLETED|Cohort 2||0
145298|NCT00795145|334103|P2|NOT COMPLETED|Cohort 2||0
145299|NCT00795145|334104|P1|NOT COMPLETED|Cohort 2||0
145300|NCT00795145|334098|P7|COMPLETED|Cohort 2||10
145301|NCT00795145|334099|P6|COMPLETED|Cohort 2||10
145302|NCT00795145|334100|P5|COMPLETED|Cohort 2||10
145303|NCT00795145|334101|P4|COMPLETED|Cohort 2||10
145304|NCT00795145|334102|P3|COMPLETED|Cohort 2||0
145305|NCT00795145|334103|P2|COMPLETED|Cohort 2||0
145306|NCT00795145|334104|P1|COMPLETED|Cohort 2||0
145307|NCT00795145|334098|P7|STARTED|Cohort 2||10
145308|NCT00795145|334099|P6|STARTED|Cohort 2||10
145309|NCT00795145|334100|P5|STARTED|Cohort 2||10
145310|NCT00795145|334101|P4|STARTED|Cohort 2||10
145311|NCT00795145|334102|P3|STARTED|Cohort 2||0
145312|NCT00795145|334103|P2|STARTED|Cohort 2||0
145313|NCT00795145|334104|P1|STARTED|Cohort 2||0
145314|NCT00795145|334098|P7|NOT COMPLETED|Cohort 1||0
145315|NCT00795145|334099|P6|NOT COMPLETED|Cohort 1||0
145316|NCT00795145|334100|P5|NOT COMPLETED|Cohort 1||0
145317|NCT00795145|334101|P4|NOT COMPLETED|Cohort 1||0
145318|NCT00795145|334102|P3|NOT COMPLETED|Cohort 1||0
145319|NCT00795145|334103|P2|NOT COMPLETED|Cohort 1||0
145320|NCT00795145|334104|P1|NOT COMPLETED|Cohort 1||0
145321|NCT00795145|334098|P7|COMPLETED|Cohort 1||0
145322|NCT00795145|334099|P6|COMPLETED|Cohort 1||0
145323|NCT00795145|334100|P5|COMPLETED|Cohort 1||0
145324|NCT00795145|334101|P4|COMPLETED|Cohort 1||0
145325|NCT00795145|334102|P3|COMPLETED|Cohort 1||3
145326|NCT00795145|334103|P2|COMPLETED|Cohort 1||3
145327|NCT00795145|334104|P1|COMPLETED|Cohort 1||3
145328|NCT00795145|334098|P7|STARTED|Cohort 1||0
145329|NCT00795145|334099|P6|STARTED|Cohort 1||0
145330|NCT00795145|334100|P5|STARTED|Cohort 1||0
145331|NCT00795145|334101|P4|STARTED|Cohort 1||0
145332|NCT00795145|334102|P3|STARTED|Cohort 1||3
145333|NCT00795145|334103|P2|STARTED|Cohort 1||3
145334|NCT00795145|334104|P1|STARTED|Cohort 1||3
145335|NCT00795132|334148|P1|NOT COMPLETED|Overall Study||3
145336|NCT00795132|334148|P1|COMPLETED|Overall Study||44
145337|NCT00795132|334148|P1|STARTED|Overall Study||47
145338|NCT00795002|334162|P2|NOT COMPLETED|Overall Study||2
145339|NCT00795002|334163|P1|NOT COMPLETED|Overall Study||2
145340|NCT00795002|334162|P2|COMPLETED|Overall Study||37
145341|NCT00795002|334163|P1|COMPLETED|Overall Study||37
145342|NCT00795002|334162|P2|STARTED|Overall Study||39
145343|NCT00795002|334163|P1|STARTED|Overall Study||39
145344|NCT00794963|334171|P2|NOT COMPLETED|Overall Study||4
145345|NCT00794963|334172|P1|NOT COMPLETED|Overall Study||1
145346|NCT00794963|334171|P2|COMPLETED|Overall Study||0
145347|NCT00794963|334172|P1|COMPLETED|Overall Study||3
145348|NCT00794963|334171|P2|STARTED|Overall Study||4
145349|NCT00794963|334172|P1|STARTED|Overall Study||4
145350|NCT00794924|334180|P2|NOT COMPLETED|Overall Study||70
145351|NCT00794924|334181|P1|NOT COMPLETED|Overall Study||60
145352|NCT00794924|334180|P2|COMPLETED|Overall Study||101
145353|NCT00794924|334181|P1|COMPLETED|Overall Study||114
145354|NCT00794924|334180|P2|STARTED|Overall Study|14 patients refused to start the study|171
145355|NCT00794924|334181|P1|STARTED|Overall Study|14 patients refused to start the study|174
145356|NCT00794820|334185|P1|NOT COMPLETED|Overall Study||16
145357|NCT00794820|334185|P1|COMPLETED|Overall Study||50
145358|NCT00794820|334185|P1|STARTED|Overall Study||66
145359|NCT00794677|334193|P2|NOT COMPLETED|Second Intervention||0
145360|NCT00794677|334194|P1|NOT COMPLETED|Second Intervention||0
145361|NCT00794677|334193|P2|COMPLETED|Second Intervention||13
145362|NCT00794677|334194|P1|COMPLETED|Second Intervention||11
145363|NCT00794677|334193|P2|STARTED|Second Intervention||13
145364|NCT00794677|334194|P1|STARTED|Second Intervention||11
145365|NCT00794677|334193|P2|NOT COMPLETED|First Intervention||0
145366|NCT00794677|334194|P1|NOT COMPLETED|First Intervention||2
145367|NCT00794677|334193|P2|COMPLETED|First Intervention||13
145368|NCT00794677|334194|P1|COMPLETED|First Intervention||11
145369|NCT00794677|334193|P2|STARTED|First Intervention||13
145370|NCT00794677|334194|P1|STARTED|First Intervention||13
145371|NCT00794664|334216|P2|NOT COMPLETED|Follow-up Period||5
145372|NCT00794664|334217|P1|NOT COMPLETED|Follow-up Period||1
145373|NCT00794664|334216|P2|COMPLETED|Follow-up Period||28
145374|NCT00794664|334217|P1|COMPLETED|Follow-up Period||15
145375|NCT00794664|334216|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
145376|NCT00794664|334217|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
145377|NCT00794664|334216|P2|NOT COMPLETED|Treatment Period||12
145378|NCT00794664|334217|P1|NOT COMPLETED|Treatment Period||1
145379|NCT00794664|334216|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
145380|NCT00794664|334217|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
145381|NCT00794664|334216|P2|STARTED|Treatment Period||39
145382|NCT00794664|334217|P1|STARTED|Treatment Period||19
145383|NCT00794560|334265|P4|NOT COMPLETED|Overall Study||4
145384|NCT00794560|334266|P3|NOT COMPLETED|Overall Study||4
145385|NCT00794560|334267|P2|NOT COMPLETED|Overall Study||4
145386|NCT00794560|334268|P1|NOT COMPLETED|Overall Study||3
145387|NCT00794560|334265|P4|COMPLETED|Overall Study||34
145388|NCT00794560|334266|P3|COMPLETED|Overall Study||40
145389|NCT00794560|334267|P2|COMPLETED|Overall Study||32
145390|NCT00794560|334268|P1|COMPLETED|Overall Study||33
145391|NCT00794560|334265|P4|STARTED|Overall Study||38
145392|NCT00794560|334266|P3|STARTED|Overall Study||44
145393|NCT00794560|334267|P2|STARTED|Overall Study||36
145394|NCT00794560|334268|P1|STARTED|Overall Study||36
145395|NCT00794547|334282|P2|NOT COMPLETED|Overall Study||0
145396|NCT00794547|334283|P1|NOT COMPLETED|Overall Study||0
145397|NCT00794547|334282|P2|COMPLETED|Overall Study||16
145398|NCT00794547|334283|P1|COMPLETED|Overall Study||18
145399|NCT00794547|334282|P2|STARTED|Overall Study||16
145400|NCT00794547|334283|P1|STARTED|Overall Study||18
145401|NCT00794508|334290|P1|NOT COMPLETED|Overall Study||0
145402|NCT00794508|334290|P1|COMPLETED|Overall Study||10
145403|NCT00794508|334290|P1|STARTED|Overall Study||10
145404|NCT00794469|334296|P1|NOT COMPLETED|Overall Study||0
145405|NCT00794469|334296|P1|COMPLETED|Overall Study||21
145406|NCT00794469|334296|P1|STARTED|Overall Study||21
145407|NCT00794365|334301|P1|NOT COMPLETED|Overall Study||79
145408|NCT00794365|334301|P1|COMPLETED|Overall Study||251
145409|NCT00794365|334301|P1|STARTED|Overall Study||330
145410|NCT00794196|334309|P2|NOT COMPLETED|Overall Study||23
145411|NCT00794196|334310|P1|NOT COMPLETED|Overall Study||5
145412|NCT00794196|334309|P2|COMPLETED|Overall Study||64
145413|NCT00794196|334310|P1|COMPLETED|Overall Study||87
145414|NCT00794196|334309|P2|STARTED|Overall Study||87
145415|NCT00794196|334310|P1|STARTED|Overall Study||92
145416|NCT00794170|334320|P2|NOT COMPLETED|Overall Study||3
145417|NCT00794170|334321|P1|NOT COMPLETED|Overall Study||7
145418|NCT00794170|334320|P2|COMPLETED|Overall Study||152
145419|NCT00794170|334321|P1|COMPLETED|Overall Study||150
145420|NCT00794170|334320|P2|STARTED|Overall Study||155
145421|NCT00794170|334321|P1|STARTED|Overall Study||157
145422|NCT00794157|334330|P3|NOT COMPLETED|Overall Study||19
145423|NCT00794157|334331|P2|NOT COMPLETED|Overall Study||10
145424|NCT00794157|334332|P1|NOT COMPLETED|Overall Study||10
145425|NCT00794157|334330|P3|COMPLETED|Overall Study||98
145426|NCT00794157|334331|P2|COMPLETED|Overall Study||106
145427|NCT00794157|334332|P1|COMPLETED|Overall Study||104
145428|NCT00794157|334330|P3|STARTED|Overall Study||117
145429|NCT00794157|334331|P2|STARTED|Overall Study||116
145430|NCT00794157|334332|P1|STARTED|Overall Study||114
145431|NCT00794144|334354|P2|NOT COMPLETED|Overall Study||3
145432|NCT00794144|334355|P1|NOT COMPLETED|Overall Study||3
145433|NCT00794144|334354|P2|COMPLETED|Overall Study||63
145434|NCT00794144|334355|P1|COMPLETED|Overall Study||63
145435|NCT00794144|334354|P2|STARTED|Overall Study||66
145436|NCT00794144|334355|P1|STARTED|Overall Study||66
145437|NCT00794118|334361|P1|NOT COMPLETED|Overall Study||27
145438|NCT00794118|334361|P1|COMPLETED|Overall Study||272
145439|NCT00794118|334361|P1|STARTED|Overall Study||299
145440|NCT00793910|334419|P2|NOT COMPLETED|Overall Study||7
145441|NCT00793910|334420|P1|NOT COMPLETED|Overall Study||5
145442|NCT00793910|334419|P2|COMPLETED|Overall Study||46
145443|NCT00793910|334420|P1|COMPLETED|Overall Study||48
145444|NCT00793910|334419|P2|STARTED|Overall Study||53
145445|NCT00793910|334420|P1|STARTED|Overall Study||53
145446|NCT00793871|334434|P1|NOT COMPLETED|Overall Study||60
145447|NCT00793871|334434|P1|COMPLETED|Overall Study||0
145448|NCT00793871|334434|P1|Received Treatment|Overall Study||59
145449|NCT00793871|334434|P1|STARTED|Overall Study||60
145450|NCT00793819|334448|P2|NOT COMPLETED|Overall Study||9
145451|NCT00793819|334449|P1|NOT COMPLETED|Overall Study||14
145452|NCT00793819|334448|P2|COMPLETED|Overall Study||89
145453|NCT00793819|334449|P1|COMPLETED|Overall Study||97
145454|NCT00793819|334448|P2|STARTED|Overall Study||98
145455|NCT00793819|334449|P1|STARTED|Overall Study||111
145456|NCT00793793|334467|P12|NOT COMPLETED|Overall Study||6
145457|NCT00793793|334468|P11|NOT COMPLETED|Overall Study||3
145458|NCT00793793|334469|P10|NOT COMPLETED|Overall Study||9
145459|NCT00793793|334470|P9|NOT COMPLETED|Overall Study||9
145460|NCT00793793|334471|P8|NOT COMPLETED|Overall Study||0
145461|NCT00793793|334472|P7|NOT COMPLETED|Overall Study||4
145462|NCT00793793|334473|P6|NOT COMPLETED|Overall Study||2
145463|NCT00793793|334474|P5|NOT COMPLETED|Overall Study||2
145464|NCT00793793|334475|P4|NOT COMPLETED|Overall Study||3
145465|NCT00793793|334476|P3|NOT COMPLETED|Overall Study||2
145466|NCT00793793|334477|P2|NOT COMPLETED|Overall Study||1
145467|NCT00793793|334478|P1|NOT COMPLETED|Overall Study||0
145468|NCT00793793|334467|P12|COMPLETED|Overall Study||1
145469|NCT00793793|334468|P11|COMPLETED|Overall Study||3
145470|NCT00793793|334469|P10|COMPLETED|Overall Study||6
145471|NCT00793793|334470|P9|COMPLETED|Overall Study||6
145472|NCT00793793|334471|P8|COMPLETED|Overall Study||6
145473|NCT00793793|334472|P7|COMPLETED|Overall Study||3
145474|NCT00793793|334473|P6|COMPLETED|Overall Study||4
145475|NCT00793793|334474|P5|COMPLETED|Overall Study||4
145476|NCT00793793|334475|P4|COMPLETED|Overall Study||4
145477|NCT00793793|334476|P3|COMPLETED|Overall Study||5
145478|NCT00793793|334477|P2|COMPLETED|Overall Study||5
145479|NCT00793793|334478|P1|COMPLETED|Overall Study||8
145480|NCT00793793|334467|P12|STARTED|Overall Study||7
145481|NCT00793793|334468|P11|STARTED|Overall Study||6
145482|NCT00793793|334469|P10|STARTED|Overall Study||15
145483|NCT00793793|334470|P9|STARTED|Overall Study||15
145484|NCT00793793|334471|P8|STARTED|Overall Study||6
145485|NCT00793793|334472|P7|STARTED|Overall Study||7
145486|NCT00793793|334473|P6|STARTED|Overall Study||6
145487|NCT00793793|334474|P5|STARTED|Overall Study||6
145488|NCT00793793|334475|P4|STARTED|Overall Study||7
145489|NCT00793793|334476|P3|STARTED|Overall Study||7
145490|NCT00793793|334477|P2|STARTED|Overall Study||6
145491|NCT00793793|334478|P1|STARTED|Overall Study||8
145492|NCT00793780|334853|P2|NOT COMPLETED|Overall Study||1
145493|NCT00793780|334854|P1|NOT COMPLETED|Overall Study||2
145494|NCT00793780|334853|P2|COMPLETED|Overall Study||11
145495|NCT00793780|334854|P1|COMPLETED|Overall Study||10
145496|NCT00793780|334853|P2|Collected Baseline Data|Overall Study||12
145497|NCT00793780|334854|P1|Collected Baseline Data|Overall Study||11
145498|NCT00793780|334853|P2|Randomization|Overall Study||12
145499|NCT00793780|334854|P1|Randomization|Overall Study||12
145500|NCT00793780|334853|P2|STARTED|Overall Study||12
145501|NCT00793780|334854|P1|STARTED|Overall Study||12
145502|NCT00793650|334872|P2|NOT COMPLETED|Overall Study||0
145503|NCT00793650|334873|P1|NOT COMPLETED|Overall Study||0
145504|NCT00793650|334872|P2|COMPLETED|Overall Study||20
145505|NCT00793650|334873|P1|COMPLETED|Overall Study||19
145506|NCT00793650|334872|P2|STARTED|Overall Study||20
145507|NCT00793650|334873|P1|STARTED|Overall Study||19
145508|NCT00793624|334885|P4|NOT COMPLETED|Overall Study||43
145509|NCT00793624|334886|P3|NOT COMPLETED|Overall Study||39
145510|NCT00793624|334887|P2|NOT COMPLETED|Overall Study||36
145511|NCT00793624|334888|P1|NOT COMPLETED|Overall Study||57
145512|NCT00793624|334885|P4|COMPLETED|Overall Study||184
145513|NCT00793624|334886|P3|COMPLETED|Overall Study||186
145514|NCT00793624|334887|P2|COMPLETED|Overall Study||191
145515|NCT00793624|334888|P1|COMPLETED|Overall Study||168
145516|NCT00793624|334885|P4|STARTED|Overall Study||227
145517|NCT00793624|334886|P3|STARTED|Overall Study||225
145518|NCT00793624|334887|P2|STARTED|Overall Study||227
145519|NCT00793624|334888|P1|STARTED|Overall Study||225
145520|NCT00793611|335156|P2|NOT COMPLETED|Overall Study||0
145521|NCT00793611|335157|P1|NOT COMPLETED|Overall Study||0
145522|NCT00793611|335156|P2|COMPLETED|Overall Study||10
145523|NCT00793611|335157|P1|COMPLETED|Overall Study||10
145524|NCT00793611|335156|P2|STARTED|Overall Study||10
145525|NCT00793611|335157|P1|STARTED|Overall Study||10
145526|NCT00793585|335169|P2|NOT COMPLETED|Overall Study||3
145527|NCT00793585|335170|P1|NOT COMPLETED|Overall Study||2
145528|NCT00793585|335169|P2|COMPLETED|Overall Study||18
145529|NCT00793585|335170|P1|COMPLETED|Overall Study||17
145530|NCT00793585|335169|P2|STARTED|Overall Study||21
145531|NCT00793585|335170|P1|STARTED|Overall Study||19
145532|NCT00793546|335180|P2|NOT COMPLETED|Overall Study||28
145533|NCT00793546|335181|P1|NOT COMPLETED|Overall Study||14
145534|NCT00793546|335180|P2|COMPLETED|Overall Study||0
145535|NCT00793546|335181|P1|COMPLETED|Overall Study||0
145536|NCT00793546|335180|P2|STARTED|Overall Study||28
145537|NCT00793546|335181|P1|STARTED|Overall Study||14
145538|NCT00793520|335211|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
145539|NCT00793520|335212|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
145540|NCT00793520|335211|P2|COMPLETED|Placebo Crossover to Milnacipran||0
145541|NCT00793520|335212|P1|COMPLETED|Placebo Crossover to Milnacipran||0
145542|NCT00793520|335211|P2|STARTED|Placebo Crossover to Milnacipran||1
145543|NCT00793520|335212|P1|STARTED|Placebo Crossover to Milnacipran||0
145544|NCT00793520|335211|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
145545|NCT00793520|335212|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
145546|NCT00793520|335211|P2|COMPLETED|Milnacipran Crossover to Placebo||0
145547|NCT00793520|335212|P1|COMPLETED|Milnacipran Crossover to Placebo||0
145548|NCT00793520|335211|P2|STARTED|Milnacipran Crossover to Placebo||0
145549|NCT00793520|335212|P1|STARTED|Milnacipran Crossover to Placebo||1
145550|NCT00793455|335222|P2|NOT COMPLETED|Overall Study||0
145551|NCT00793455|335223|P1|NOT COMPLETED|Overall Study||0
145552|NCT00793455|335222|P2|COMPLETED|Overall Study||314
145553|NCT00793455|335223|P1|COMPLETED|Overall Study||314
145554|NCT00793455|335222|P2|STARTED|Overall Study||314
145555|NCT00793455|335223|P1|STARTED|Overall Study||314
145556|NCT00793403|335231|P1|NOT COMPLETED|Overall Study||73
145557|NCT00793403|335231|P1|COMPLETED|Overall Study||220
145558|NCT00793403|335231|P1|STARTED|Overall Study||293
145559|NCT00793325|335278|P1|NOT COMPLETED|Overall Study||19
145560|NCT00793325|335278|P1|COMPLETED|Overall Study||890
145561|NCT00793325|335278|P1|STARTED|Overall Study||909
145562|NCT00793169|335302|P1|NOT COMPLETED|Overall Study||0
145563|NCT00793169|335302|P1|COMPLETED|Overall Study||19
145564|NCT00793169|335302|P1|STARTED|Overall Study||19
145565|NCT00793104|335306|P1|NOT COMPLETED|Overall Study||1
145566|NCT00793104|335306|P1|COMPLETED|Overall Study||9
145567|NCT00793104|335306|P1|STARTED|Overall Study||10
145568|NCT00792935|335316|P2|NOT COMPLETED|Overall Study||3
145569|NCT00792935|335317|P1|NOT COMPLETED|Overall Study||4
145570|NCT00792935|335316|P2|COMPLETED|Overall Study||68
145571|NCT00792935|335317|P1|COMPLETED|Overall Study||68
145572|NCT00792935|335316|P2|STARTED|Overall Study||71
145573|NCT00792935|335317|P1|STARTED|Overall Study||72
145574|NCT00792805|335328|P3|NOT COMPLETED|Overall Study||33
145575|NCT00792805|335329|P2|NOT COMPLETED|Overall Study||26
145576|NCT00792805|335330|P1|NOT COMPLETED|Overall Study||22
145577|NCT00792805|335328|P3|COMPLETED|Overall Study||154
145578|NCT00792805|335329|P2|COMPLETED|Overall Study||162
145579|NCT00792805|335330|P1|COMPLETED|Overall Study||166
145580|NCT00792805|335328|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
145581|NCT00792805|335329|P2|Exposed to Study Medication or Placebo|Overall Study||188
145582|NCT00792805|335330|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
145583|NCT00792805|335328|P3|STARTED|Overall Study||187
145584|NCT00792805|335329|P2|STARTED|Overall Study||188
145585|NCT00792805|335330|P1|STARTED|Overall Study||188
145586|NCT00792688|335341|P3|NOT COMPLETED|Overall Study||0
145587|NCT00792688|335342|P2|NOT COMPLETED|Overall Study||0
145588|NCT00792688|335343|P1|NOT COMPLETED|Overall Study||0
145589|NCT00792688|335341|P3|COMPLETED|Overall Study||9
145590|NCT00792688|335342|P2|COMPLETED|Overall Study||8
145591|NCT00792688|335343|P1|COMPLETED|Overall Study||9
145592|NCT00792688|335341|P3|STARTED|Overall Study||9
145593|NCT00792688|335342|P2|STARTED|Overall Study||8
145594|NCT00792688|335343|P1|STARTED|Overall Study||9
145595|NCT00792636|335357|P3|NOT COMPLETED|Overall Study||81
145596|NCT00792636|335358|P2|NOT COMPLETED|Overall Study||81
145597|NCT00792636|335359|P1|NOT COMPLETED|Overall Study||68
145598|NCT00792636|335357|P3|COMPLETED|Overall Study||55
145599|NCT00792636|335358|P2|COMPLETED|Overall Study||55
145600|NCT00792636|335359|P1|COMPLETED|Overall Study||67
145601|NCT00792636|335357|P3|STARTED|Overall Study||136
145602|NCT00792636|335358|P2|STARTED|Overall Study||136
145603|NCT00792636|335359|P1|STARTED|Overall Study||135
145604|NCT00792610|335396|P1|NOT COMPLETED|Overall Study||0
145605|NCT00792610|335396|P1|COMPLETED|Overall Study||127
145606|NCT00792610|335396|P1|Youths|Overall Study||127
145607|NCT00792610|335396|P1|STARTED|Overall Study||127
145608|NCT00792298|335400|P8|NOT COMPLETED|Treatment Period 2||2
145609|NCT00792298|335401|P7|NOT COMPLETED|Treatment Period 2||1
145610|NCT00792298|335402|P6|NOT COMPLETED|Treatment Period 2||0
145611|NCT00792298|335403|P5|NOT COMPLETED|Treatment Period 2||2
145612|NCT00792298|335404|P4|NOT COMPLETED|Treatment Period 2||2
145613|NCT00792298|335405|P3|NOT COMPLETED|Treatment Period 2||1
145614|NCT00792298|335406|P2|NOT COMPLETED|Treatment Period 2||1
145615|NCT00792298|335407|P1|NOT COMPLETED|Treatment Period 2||1
145616|NCT00792298|335400|P8|COMPLETED|Treatment Period 2||28
145617|NCT00792298|335401|P7|COMPLETED|Treatment Period 2||28
145618|NCT00792298|335402|P6|COMPLETED|Treatment Period 2||27
145619|NCT00792298|335403|P5|COMPLETED|Treatment Period 2||30
145620|NCT00792298|335404|P4|COMPLETED|Treatment Period 2||26
145621|NCT00792298|335405|P3|COMPLETED|Treatment Period 2||30
145622|NCT00792298|335406|P2|COMPLETED|Treatment Period 2||30
145623|NCT00792298|335407|P1|COMPLETED|Treatment Period 2||29
145624|NCT00792298|335400|P8|STARTED|Treatment Period 2||30
145625|NCT00792298|335401|P7|STARTED|Treatment Period 2||29
145626|NCT00792298|335402|P6|STARTED|Treatment Period 2||27
145627|NCT00792298|335403|P5|STARTED|Treatment Period 2||32
145628|NCT00792298|335404|P4|STARTED|Treatment Period 2||28
145629|NCT00792298|335405|P3|STARTED|Treatment Period 2||31
145630|NCT00792298|335406|P2|STARTED|Treatment Period 2||31
145631|NCT00792298|335407|P1|STARTED|Treatment Period 2||30
145632|NCT00792298|335400|P8|NOT COMPLETED|Washout||0
145633|NCT00792298|335401|P7|NOT COMPLETED|Washout||0
145634|NCT00792298|335402|P6|NOT COMPLETED|Washout||2
145635|NCT00792298|335403|P5|NOT COMPLETED|Washout||0
145636|NCT00792298|335404|P4|NOT COMPLETED|Washout||0
145637|NCT00792298|335405|P3|NOT COMPLETED|Washout||1
145638|NCT00792298|335406|P2|NOT COMPLETED|Washout||0
145639|NCT00792298|335407|P1|NOT COMPLETED|Washout||0
145640|NCT00792298|335400|P8|COMPLETED|Washout||30
145641|NCT00792298|335401|P7|COMPLETED|Washout||29
145642|NCT00792298|335402|P6|COMPLETED|Washout||27
145643|NCT00792298|335403|P5|COMPLETED|Washout||32
145644|NCT00792298|335404|P4|COMPLETED|Washout||28
145645|NCT00792298|335405|P3|COMPLETED|Washout||31
145646|NCT00792298|335406|P2|COMPLETED|Washout||31
145647|NCT00792298|335407|P1|COMPLETED|Washout||30
145648|NCT00792298|335400|P8|STARTED|Washout||30
145649|NCT00792298|335401|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
145650|NCT00792298|335402|P6|STARTED|Washout||29
145651|NCT00792298|335403|P5|STARTED|Washout||32
145652|NCT00792298|335404|P4|STARTED|Washout||28
145653|NCT00792298|335405|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
145654|NCT00792298|335406|P2|STARTED|Washout||31
145655|NCT00792298|335407|P1|STARTED|Washout||30
145656|NCT00792298|335400|P8|NOT COMPLETED|Treatment Period 1||1
145657|NCT00792298|335401|P7|NOT COMPLETED|Treatment Period 1||4
145658|NCT00792298|335402|P6|NOT COMPLETED|Treatment Period 1||3
145659|NCT00792298|335403|P5|NOT COMPLETED|Treatment Period 1||0
145660|NCT00792298|335404|P4|NOT COMPLETED|Treatment Period 1||4
145661|NCT00792298|335405|P3|NOT COMPLETED|Treatment Period 1||2
145662|NCT00792298|335406|P2|NOT COMPLETED|Treatment Period 1||1
145663|NCT00792298|335407|P1|NOT COMPLETED|Treatment Period 1||1
145664|NCT00792298|335400|P8|COMPLETED|Treatment Period 1||30
145665|NCT00792298|335401|P7|COMPLETED|Treatment Period 1||27
145666|NCT00792298|335402|P6|COMPLETED|Treatment Period 1||29
145667|NCT00792298|335403|P5|COMPLETED|Treatment Period 1||32
145668|NCT00792298|335404|P4|COMPLETED|Treatment Period 1||28
145669|NCT00792298|335405|P3|COMPLETED|Treatment Period 1||31
145670|NCT00792298|335406|P2|COMPLETED|Treatment Period 1||31
145671|NCT00792298|335407|P1|COMPLETED|Treatment Period 1||30
145672|NCT00792298|335400|P8|STARTED|Treatment Period 1||31
145673|NCT00792298|335401|P7|STARTED|Treatment Period 1||31
145674|NCT00792298|335402|P6|STARTED|Treatment Period 1||32
145675|NCT00792298|335403|P5|STARTED|Treatment Period 1||32
145676|NCT00792298|335404|P4|STARTED|Treatment Period 1||32
145677|NCT00792298|335405|P3|STARTED|Treatment Period 1||33
145678|NCT00792298|335406|P2|STARTED|Treatment Period 1||32
145679|NCT00792298|335407|P1|STARTED|Treatment Period 1||31
145680|NCT00792259|335437|P3|NOT COMPLETED|Overall Study||0
145681|NCT00792259|335438|P2|NOT COMPLETED|Overall Study||0
145682|NCT00792259|335439|P1|NOT COMPLETED|Overall Study||1
145683|NCT00792259|335437|P3|COMPLETED|Overall Study||13
145684|NCT00792259|335438|P2|COMPLETED|Overall Study||20
145685|NCT00792259|335439|P1|COMPLETED|Overall Study||14
145686|NCT00792259|335437|P3|STARTED|Overall Study||13
145687|NCT00792259|335438|P2|STARTED|Overall Study||20
145688|NCT00792259|335439|P1|STARTED|Overall Study||15
145689|NCT00792116|335449|P2|NOT COMPLETED|Overall Study||1
145690|NCT00792116|335450|P1|NOT COMPLETED|Overall Study||1
145691|NCT00792116|335449|P2|COMPLETED|Overall Study||54
145692|NCT00792116|335450|P1|COMPLETED|Overall Study||52
145693|NCT00792116|335449|P2|STARTED|Overall Study||55
145694|NCT00792116|335450|P1|STARTED|Overall Study||53
145695|NCT00792103|335460|P1|NOT COMPLETED|Overall Study||133
145696|NCT00792103|335460|P1|COMPLETED|Overall Study||65
145697|NCT00792103|335460|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
145698|NCT00791999|335472|P4|NOT COMPLETED|Overall Study||52
145699|NCT00791999|335473|P3|NOT COMPLETED|Overall Study||20
145700|NCT00791999|335474|P2|NOT COMPLETED|Overall Study||16
145701|NCT00791999|335475|P1|NOT COMPLETED|Overall Study||21
145702|NCT00791999|335472|P4|COMPLETED|Overall Study||25
145703|NCT00791999|335473|P3|COMPLETED|Overall Study||65
145704|NCT00791999|335474|P2|COMPLETED|Overall Study||66
145705|NCT00791999|335475|P1|COMPLETED|Overall Study||51
145706|NCT00791999|335472|P4|STARTED|Overall Study||77
145707|NCT00791999|335473|P3|STARTED|Overall Study||85
145708|NCT00791999|335474|P2|STARTED|Overall Study||82
145709|NCT00791999|335475|P1|STARTED|Overall Study||72
145710|NCT00791973|335491|P2|NOT COMPLETED|Second Intervention (1 Week)||0
145711|NCT00791973|335492|P1|NOT COMPLETED|Second Intervention (1 Week)||0
145712|NCT00791973|335491|P2|COMPLETED|Second Intervention (1 Week)||7
145713|NCT00791973|335492|P1|COMPLETED|Second Intervention (1 Week)||8
145714|NCT00791973|335491|P2|STARTED|Second Intervention (1 Week)||7
145715|NCT00791973|335492|P1|STARTED|Second Intervention (1 Week)||8
145716|NCT00791973|335491|P2|NOT COMPLETED|Washout (1 Week)||0
145717|NCT00791973|335492|P1|NOT COMPLETED|Washout (1 Week)||0
145718|NCT00791973|335491|P2|COMPLETED|Washout (1 Week)||7
145719|NCT00791973|335492|P1|COMPLETED|Washout (1 Week)||8
145720|NCT00791973|335491|P2|STARTED|Washout (1 Week)||7
145721|NCT00791973|335492|P1|STARTED|Washout (1 Week)||8
145722|NCT00791973|335491|P2|NOT COMPLETED|First Intervention (1 Week)||0
145723|NCT00791973|335492|P1|NOT COMPLETED|First Intervention (1 Week)||0
145724|NCT00791973|335491|P2|COMPLETED|First Intervention (1 Week)||7
145725|NCT00791973|335492|P1|COMPLETED|First Intervention (1 Week)||8
145726|NCT00791973|335491|P2|STARTED|First Intervention (1 Week)||7
145727|NCT00791973|335492|P1|STARTED|First Intervention (1 Week)||8
145728|NCT00791934|335500|P1|NOT COMPLETED|Overall Study||15
145729|NCT00791934|335500|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
145730|NCT00791934|335500|P1|STARTED|Overall Study||63
145731|NCT00791921|335510|P2|NOT COMPLETED|Overall Study||96
145732|NCT00791921|335511|P1|NOT COMPLETED|Overall Study||34
145733|NCT00791921|335510|P2|COMPLETED|Overall Study||18
145734|NCT00791921|335511|P1|COMPLETED|Overall Study||82
145735|NCT00791921|335510|P2|STARTED|Overall Study||114
145736|NCT00791921|335511|P1|STARTED|Overall Study||116
145737|NCT00791908|335519|P1|NOT COMPLETED|Overall Study||0
145738|NCT00791908|335519|P1|COMPLETED|Overall Study||15
145739|NCT00791908|335519|P1|STARTED|Overall Study||15
145740|NCT00791817|335529|P2|NOT COMPLETED|2: Single Dose||0
145741|NCT00791817|335530|P1|NOT COMPLETED|2: Single Dose||0
145742|NCT00791817|335529|P2|COMPLETED|2: Single Dose||5
145743|NCT00791817|335530|P1|COMPLETED|2: Single Dose||5
145744|NCT00791817|335529|P2|STARTED|2: Single Dose||5
145745|NCT00791817|335530|P1|STARTED|2: Single Dose||5
145746|NCT00791817|335529|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
145747|NCT00791817|335530|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
145748|NCT00791817|335529|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
145749|NCT00791817|335530|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
145750|NCT00791817|335529|P2|STARTED|1: Single Dose Followed by Week Washout||5
145751|NCT00791817|335530|P1|STARTED|1: Single Dose Followed by Week Washout||5
145752|NCT00791778|335538|P2|NOT COMPLETED|Follow-up||1
145753|NCT00791778|335539|P1|NOT COMPLETED|Follow-up||5
145754|NCT00791778|335538|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
145755|NCT00791778|335539|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
145756|NCT00791778|335538|P2|STARTED|Follow-up||91
145757|NCT00791778|335539|P1|STARTED|Follow-up||100
145758|NCT00791778|335538|P2|NOT COMPLETED|Double-blind Treatment||48
145759|NCT00791778|335539|P1|NOT COMPLETED|Double-blind Treatment||77
145760|NCT00791778|335538|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
145761|NCT00791778|335539|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
145762|NCT00791778|335538|P2|STARTED|Double-blind Treatment||123
145763|NCT00791778|335539|P1|STARTED|Double-blind Treatment||123
145764|NCT00791765|335593|P2|NOT COMPLETED|Weeks 13 to 24||8
145765|NCT00791765|335594|P1|NOT COMPLETED|Weeks 13 to 24||5
145766|NCT00791765|335593|P2|COMPLETED|Weeks 13 to 24||49
145767|NCT00791765|335594|P1|COMPLETED|Weeks 13 to 24||49
145768|NCT00791765|335593|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
145769|NCT00791765|335594|P1|STARTED|Weeks 13 to 24||54
145770|NCT00791765|335593|P2|NOT COMPLETED|Weeks 1 to 12||4
145771|NCT00791765|335594|P1|NOT COMPLETED|Weeks 1 to 12||8
145772|NCT00791765|335593|P2|COMPLETED|Weeks 1 to 12||58
145773|NCT00791765|335594|P1|COMPLETED|Weeks 1 to 12||54
145774|NCT00791765|335593|P2|Treated|Weeks 1 to 12||59
145775|NCT00791765|335594|P1|Treated|Weeks 1 to 12||62
145776|NCT00791765|335593|P2|STARTED|Weeks 1 to 12||62
145777|NCT00791765|335594|P1|STARTED|Weeks 1 to 12||62
145778|NCT00791700|335609|P4|NOT COMPLETED|Overall Study||18
145779|NCT00791700|335610|P3|NOT COMPLETED|Overall Study||4
145780|NCT00791700|335611|P2|NOT COMPLETED|Overall Study||5
145781|NCT00791700|335612|P1|NOT COMPLETED|Overall Study||4
145782|NCT00791700|335609|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
145783|NCT00791700|335610|P3|COMPLETED|Overall Study||9
145784|NCT00791700|335611|P2|COMPLETED|Overall Study||26
145785|NCT00791700|335612|P1|COMPLETED|Overall Study||12
145786|NCT00791700|335609|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
145787|NCT00791700|335610|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
145788|NCT00791700|335611|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
145789|NCT00791700|335612|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
145790|NCT00791661|335700|P3|NOT COMPLETED|Period 3||0
145791|NCT00791661|335701|P2|NOT COMPLETED|Period 3||0
145792|NCT00791661|335702|P1|NOT COMPLETED|Period 3||0
145793|NCT00791661|335700|P3|COMPLETED|Period 3||6
145794|NCT00791661|335701|P2|COMPLETED|Period 3||8
145795|NCT00791661|335702|P1|COMPLETED|Period 3||8
145796|NCT00791661|335700|P3|Received Matching Placebo to MK-1006|Period 3||1
145797|NCT00791661|335701|P2|Received Matching Placebo to MK-1006|Period 3||2
145798|NCT00791661|335702|P1|Received Matching Placebo to MK-1006|Period 3||2
145799|NCT00791661|335700|P3|Received MK-1006|Period 3||5
145800|NCT00791661|335701|P2|Received MK-1006|Period 3||6
145801|NCT00791661|335702|P1|Received MK-1006|Period 3||6
145802|NCT00791661|335700|P3|STARTED|Period 3||6
145803|NCT00791661|335701|P2|STARTED|Period 3||8
145804|NCT00791661|335702|P1|STARTED|Period 3||8
145805|NCT00791661|335700|P3|NOT COMPLETED|7 Day Wash-out||0
145806|NCT00791661|335701|P2|NOT COMPLETED|7 Day Wash-out||0
145807|NCT00791661|335702|P1|NOT COMPLETED|7 Day Wash-out||0
145808|NCT00791661|335700|P3|COMPLETED|7 Day Wash-out||6
145809|NCT00791661|335701|P2|COMPLETED|7 Day Wash-out||8
145810|NCT00791661|335702|P1|COMPLETED|7 Day Wash-out||8
145811|NCT00791661|335700|P3|STARTED|7 Day Wash-out||6
145812|NCT00791661|335701|P2|STARTED|7 Day Wash-out||8
145813|NCT00791661|335702|P1|STARTED|7 Day Wash-out||8
145814|NCT00791661|335700|P3|NOT COMPLETED|Period 2||0
145815|NCT00791661|335701|P2|NOT COMPLETED|Period 2||0
145816|NCT00791661|335702|P1|NOT COMPLETED|Period 2||0
145817|NCT00791661|335700|P3|COMPLETED|Period 2||6
145818|NCT00791661|335701|P2|COMPLETED|Period 2||8
145819|NCT00791661|335702|P1|COMPLETED|Period 2||8
145820|NCT00791661|335700|P3|Received Matching Placebo to MK-1006|Period 2||2
145821|NCT00791661|335701|P2|Received Matching Placebo to MK-1006|Period 2||2
145822|NCT00791661|335702|P1|Received Matching Placebo to MK-1006|Period 2||2
145823|NCT00791661|335700|P3|Received MK-1006|Period 2||4
145824|NCT00791661|335701|P2|Received MK-1006|Period 2||6
145825|NCT00791661|335702|P1|Received MK-1006|Period 2||6
145826|NCT00791661|335700|P3|STARTED|Period 2||6
145827|NCT00791661|335701|P2|STARTED|Period 2||8
145828|NCT00791661|335702|P1|STARTED|Period 2||8
145829|NCT00791661|335700|P3|NOT COMPLETED|7 Day Wash-out||2
145830|NCT00791661|335701|P2|NOT COMPLETED|7 Day Wash-out||0
145831|NCT00791661|335702|P1|NOT COMPLETED|7 Day Wash-out||0
145832|NCT00791661|335700|P3|COMPLETED|7 Day Wash-out||6
145833|NCT00791661|335701|P2|COMPLETED|7 Day Wash-out||8
145834|NCT00791661|335702|P1|COMPLETED|7 Day Wash-out||8
145835|NCT00791661|335700|P3|STARTED|7 Day Wash-out||8
145836|NCT00791661|335701|P2|STARTED|7 Day Wash-out||8
145837|NCT00791661|335702|P1|STARTED|7 Day Wash-out||8
145838|NCT00791661|335700|P3|NOT COMPLETED|Period 1||0
145839|NCT00791661|335701|P2|NOT COMPLETED|Period 1||0
145840|NCT00791661|335702|P1|NOT COMPLETED|Period 1||0
145841|NCT00791661|335700|P3|COMPLETED|Period 1||8
145842|NCT00791661|335701|P2|COMPLETED|Period 1||8
145843|NCT00791661|335702|P1|COMPLETED|Period 1||8
145844|NCT00791661|335700|P3|Received Matching Placebo to MK-1006|Period 1||2
145845|NCT00791661|335701|P2|Received Matching Placebo to MK-1006|Period 1||2
145846|NCT00791661|335702|P1|Received Matching Placebo to MK-1006|Period 1||2
145847|NCT00791661|335700|P3|Received MK-1006|Period 1||6
145848|NCT00791661|335701|P2|Received MK-1006|Period 1||6
145849|NCT00791661|335702|P1|Received MK-1006|Period 1||6
145850|NCT00791661|335700|P3|STARTED|Period 1||8
145851|NCT00791661|335701|P2|STARTED|Period 1||8
145852|NCT00791661|335702|P1|STARTED|Period 1||8
145853|NCT00791557|335793|P1|NOT COMPLETED|Overall Study||1
145854|NCT00791557|335793|P1|COMPLETED|Overall Study||1
145855|NCT00791557|335793|P1|STARTED|Overall Study||2
145856|NCT00791518|335797|P1|NOT COMPLETED|Overall Study||93
145857|NCT00791518|335797|P1|COMPLETED|Overall Study||991
145858|NCT00791518|335797|P1|STARTED|Overall Study||1084
145859|NCT00791492|335825|P2|NOT COMPLETED|Overall Study||3
145860|NCT00791492|335826|P1|NOT COMPLETED|Overall Study||6
145861|NCT00791492|335825|P2|COMPLETED|Overall Study||38
145862|NCT00791492|335826|P1|COMPLETED|Overall Study||39
145863|NCT00791492|335825|P2|TREATED|Overall Study||41
145864|NCT00791492|335826|P1|TREATED|Overall Study||44
145865|NCT00791492|335825|P2|STARTED|Overall Study||41
145866|NCT00791492|335826|P1|STARTED|Overall Study||45
145867|NCT00791479|335874|P6|NOT COMPLETED|Overall Study||3
145868|NCT00791479|335875|P5|NOT COMPLETED|Overall Study||3
145869|NCT00791479|335876|P4|NOT COMPLETED|Overall Study||4
145870|NCT00791479|335877|P3|NOT COMPLETED|Overall Study||0
145871|NCT00791479|335878|P2|NOT COMPLETED|Overall Study||3
145872|NCT00791479|335879|P1|NOT COMPLETED|Overall Study||2
145873|NCT00791479|335874|P6|COMPLETED|Overall Study||29
145874|NCT00791479|335875|P5|COMPLETED|Overall Study||0
145875|NCT00791479|335876|P4|COMPLETED|Overall Study||25
145876|NCT00791479|335877|P3|COMPLETED|Overall Study||34
145877|NCT00791479|335878|P2|COMPLETED|Overall Study||31
145878|NCT00791479|335879|P1|COMPLETED|Overall Study||33
145879|NCT00791479|335874|P6|Received at Least One Dose of Study Drug|Overall Study||32
145880|NCT00791479|335875|P5|Received at Least One Dose of Study Drug|Overall Study||3
145881|NCT00791479|335876|P4|Received at Least One Dose of Study Drug|Overall Study||29
145882|NCT00791479|335877|P3|Received at Least One Dose of Study Drug|Overall Study||34
145883|NCT00791479|335878|P2|Received at Least One Dose of Study Drug|Overall Study||34
145884|NCT00791479|335879|P1|Received at Least One Dose of Study Drug|Overall Study||35
145885|NCT00791479|335874|P6|STARTED|Overall Study||32
145886|NCT00791479|335875|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
145887|NCT00791479|335876|P4|STARTED|Overall Study||29
145888|NCT00791479|335877|P3|STARTED|Overall Study||34
145889|NCT00791479|335878|P2|STARTED|Overall Study||34
145890|NCT00791479|335879|P1|STARTED|Overall Study||35
145891|NCT00790569|335976|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
145892|NCT00790569|335977|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
145893|NCT00790569|335978|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
145894|NCT00790569|335976|P3|COMPLETED|End of Study (12 Month Interview)||83
145895|NCT00790569|335977|P2|COMPLETED|End of Study (12 Month Interview)||26
145896|NCT00790569|335978|P1|COMPLETED|End of Study (12 Month Interview)||71
145897|NCT00790569|335976|P3|STARTED|End of Study (12 Month Interview)||133
145898|NCT00790569|335977|P2|STARTED|End of Study (12 Month Interview)||45
145899|NCT00790569|335978|P1|STARTED|End of Study (12 Month Interview)||137
145900|NCT00790569|335976|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
145901|NCT00790569|335977|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
145902|NCT00790569|335978|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
145903|NCT00790569|335976|P3|COMPLETED|End of Treatment (6 Month Interview)||107
145904|NCT00790569|335977|P2|COMPLETED|End of Treatment (6 Month Interview)||35
145905|NCT00790569|335978|P1|COMPLETED|End of Treatment (6 Month Interview)||115
145906|NCT00790569|335976|P3|STARTED|End of Treatment (6 Month Interview)||133
145907|NCT00790569|335977|P2|STARTED|End of Treatment (6 Month Interview)||45
145908|NCT00790569|335978|P1|STARTED|End of Treatment (6 Month Interview)||137
145909|NCT00790556|336001|P2|NOT COMPLETED|Treatment Period 2||0
145910|NCT00790556|336002|P1|NOT COMPLETED|Treatment Period 2||0
145911|NCT00790556|336001|P2|COMPLETED|Treatment Period 2||6
145912|NCT00790556|336002|P1|COMPLETED|Treatment Period 2||6
145913|NCT00790556|336001|P2|STARTED|Treatment Period 2||6
145914|NCT00790556|336002|P1|STARTED|Treatment Period 2||6
145915|NCT00790556|336001|P2|NOT COMPLETED|Washout After Period 1||0
145916|NCT00790556|336002|P1|NOT COMPLETED|Washout After Period 1||0
145917|NCT00790556|336001|P2|COMPLETED|Washout After Period 1||6
145918|NCT00790556|336002|P1|COMPLETED|Washout After Period 1||6
145919|NCT00790556|336001|P2|STARTED|Washout After Period 1||6
145920|NCT00790556|336002|P1|STARTED|Washout After Period 1||6
145921|NCT00790556|336001|P2|NOT COMPLETED|Treatment Period 1||0
145922|NCT00790556|336002|P1|NOT COMPLETED|Treatment Period 1||2
145923|NCT00790556|336001|P2|COMPLETED|Treatment Period 1||6
145924|NCT00790556|336002|P1|COMPLETED|Treatment Period 1||6
145925|NCT00790556|336001|P2|STARTED|Treatment Period 1||6
145926|NCT00790556|336002|P1|STARTED|Treatment Period 1||8
145927|NCT00791388|336017|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
145928|NCT00791388|336018|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
145929|NCT00791388|336019|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
145930|NCT00791388|336020|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
145931|NCT00791388|336021|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
145932|NCT00791388|336017|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
145933|NCT00791388|336018|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
145934|NCT00791388|336019|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
145935|NCT00791388|336020|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
145936|NCT00791388|336021|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
145937|NCT00791388|336017|P5|STARTED|Period 4 - 400 mg Dose Group||8
145938|NCT00791388|336018|P4|STARTED|Period 4 - 400 mg Dose Group||0
145939|NCT00791388|336019|P3|STARTED|Period 4 - 400 mg Dose Group||0
145940|NCT00791388|336020|P2|STARTED|Period 4 - 400 mg Dose Group||0
145941|NCT00791388|336021|P1|STARTED|Period 4 - 400 mg Dose Group||4
145942|NCT00791388|336017|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
145943|NCT00791388|336018|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
145944|NCT00791388|336019|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
145945|NCT00791388|336020|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
145946|NCT00791388|336021|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
145947|NCT00791388|336017|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
145948|NCT00791388|336018|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
145949|NCT00791388|336019|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
145950|NCT00791388|336020|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
145951|NCT00791388|336021|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
145952|NCT00791388|336017|P5|STARTED|Period 3 - 200 mg Dose Group||0
145953|NCT00791388|336018|P4|STARTED|Period 3 - 200 mg Dose Group||8
145954|NCT00791388|336019|P3|STARTED|Period 3 - 200 mg Dose Group||0
145955|NCT00791388|336020|P2|STARTED|Period 3 - 200 mg Dose Group||0
145956|NCT00791388|336021|P1|STARTED|Period 3 - 200 mg Dose Group||3
145957|NCT00791388|336017|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
145958|NCT00791388|336018|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
145959|NCT00791388|336019|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
145960|NCT00791388|336020|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
145961|NCT00791388|336021|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
145962|NCT00791388|336017|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
145963|NCT00791388|336018|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
145964|NCT00791388|336019|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
145965|NCT00791388|336020|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
145966|NCT00791388|336021|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
145967|NCT00791388|336017|P5|STARTED|Period 2 - 100 mg Dose Group||0
145968|NCT00791388|336018|P4|STARTED|Period 2 - 100 mg Dose Group||0
145969|NCT00791388|336019|P3|STARTED|Period 2 - 100 mg Dose Group||8
145970|NCT00791388|336020|P2|STARTED|Period 2 - 100 mg Dose Group||0
145971|NCT00791388|336021|P1|STARTED|Period 2 - 100 mg Dose Group||3
145972|NCT00791388|336017|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
145973|NCT00791388|336018|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
145974|NCT00791388|336019|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
145975|NCT00791388|336020|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
145976|NCT00791388|336021|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
145977|NCT00791388|336017|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
145978|NCT00791388|336018|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
145979|NCT00791388|336019|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
145980|NCT00791388|336020|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
145981|NCT00791388|336021|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
145982|NCT00791388|336017|P5|STARTED|Period 1 - 50 mg Dose Group||0
145983|NCT00791388|336018|P4|STARTED|Period 1 - 50 mg Dose Group||0
145984|NCT00791388|336019|P3|STARTED|Period 1 - 50 mg Dose Group||0
145985|NCT00791388|336020|P2|STARTED|Period 1 - 50 mg Dose Group||8
145986|NCT00791388|336021|P1|STARTED|Period 1 - 50 mg Dose Group||3
145987|NCT00791323|336050|P2|NOT COMPLETED|Overall Study||0
145988|NCT00791323|336051|P1|NOT COMPLETED|Overall Study||0
145989|NCT00791323|336050|P2|COMPLETED|Overall Study||3
145990|NCT00791323|336051|P1|COMPLETED|Overall Study||6
145991|NCT00791323|336050|P2|STARTED|Overall Study||3
145992|NCT00791323|336051|P1|STARTED|Overall Study||6
145993|NCT00791258|336057|P1|NOT COMPLETED|Overall Study||263
145994|NCT00791258|336057|P1|COMPLETED|Overall Study||736
145995|NCT00791258|336057|P1|STARTED|Overall Study||999
145996|NCT00791128|336119|P1|NOT COMPLETED|Overall Study||9
145997|NCT00791128|336119|P1|COMPLETED|Overall Study||13
145998|NCT00791128|336119|P1|STARTED|Overall Study||22
145999|NCT00791102|336124|P2|NOT COMPLETED|Period 2||0
146000|NCT00791102|336125|P1|NOT COMPLETED|Period 2||0
146001|NCT00791102|336124|P2|COMPLETED|Period 2||10
146002|NCT00791102|336125|P1|COMPLETED|Period 2||10
146003|NCT00791102|336124|P2|STARTED|Period 2||10
146004|NCT00791102|336125|P1|STARTED|Period 2||10
146005|NCT00791102|336124|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
146006|NCT00791102|336125|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
146007|NCT00791102|336124|P2|COMPLETED|Washout Period of 2 Weeks||10
146008|NCT00791102|336125|P1|COMPLETED|Washout Period of 2 Weeks||10
146009|NCT00791102|336124|P2|STARTED|Washout Period of 2 Weeks||10
146010|NCT00791102|336125|P1|STARTED|Washout Period of 2 Weeks||10
146011|NCT00791102|336124|P2|NOT COMPLETED|Period 1||0
146012|NCT00791102|336125|P1|NOT COMPLETED|Period 1||0
146013|NCT00791102|336124|P2|COMPLETED|Period 1||10
146014|NCT00791102|336125|P1|COMPLETED|Period 1||10
146015|NCT00791102|336124|P2|STARTED|Period 1||10
146016|NCT00791102|336125|P1|STARTED|Period 1||10
146017|NCT00790907|336144|P3|NOT COMPLETED|Overall Study||339
146018|NCT00790907|336145|P2|NOT COMPLETED|Overall Study||340
146019|NCT00790907|336146|P1|NOT COMPLETED|Overall Study||455
146020|NCT00790907|336144|P3|COMPLETED|Overall Study||663
146021|NCT00790907|336145|P2|COMPLETED|Overall Study||684
146022|NCT00790907|336146|P1|COMPLETED|Overall Study||754
146023|NCT00790907|336144|P3|STARTED|Overall Study||1002
146024|NCT00790907|336145|P2|STARTED|Overall Study||1024
146025|NCT00790907|336146|P1|STARTED|Overall Study||1209
146026|NCT00790855|336167|P1|NOT COMPLETED|Overall Study||0
146027|NCT00790855|336167|P1|COMPLETED|Overall Study||25
146028|NCT00790855|336167|P1|STARTED|Overall Study||25
146029|NCT00790803|336172|P1|NOT COMPLETED|Overall Study||0
146030|NCT00790803|336172|P1|COMPLETED|Overall Study||5
146031|NCT00790803|336172|P1|STARTED|Overall Study||5
146032|NCT00790790|336183|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
146033|NCT00790790|336184|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
146034|NCT00790790|336185|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
146035|NCT00790790|336183|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
146036|NCT00790790|336184|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
146037|NCT00790790|336185|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
146038|NCT00790790|336183|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
146039|NCT00790790|336184|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
146040|NCT00790790|336185|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
146041|NCT00790790|336183|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
146042|NCT00790790|336184|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
146043|NCT00790790|336185|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
146044|NCT00790790|336183|P3|COMPLETED|Study Period 2: Therapy Phase||27
146045|NCT00790790|336184|P2|COMPLETED|Study Period 2: Therapy Phase||32
146046|NCT00790790|336185|P1|COMPLETED|Study Period 2: Therapy Phase||37
146047|NCT00790790|336183|P3|STARTED|Study Period 2: Therapy Phase||48
146048|NCT00790790|336184|P2|STARTED|Study Period 2: Therapy Phase||50
146049|NCT00790790|336185|P1|STARTED|Study Period 2: Therapy Phase||49
146050|NCT00790751|336262|P4|NOT COMPLETED|Overall Study||21
146051|NCT00790751|336263|P3|NOT COMPLETED|Overall Study||20
146052|NCT00790751|336264|P2|NOT COMPLETED|Overall Study||30
146053|NCT00790751|336265|P1|NOT COMPLETED|Overall Study||25
146054|NCT00790751|336262|P4|COMPLETED|Overall Study||141
146055|NCT00790751|336263|P3|COMPLETED|Overall Study||141
146056|NCT00790751|336264|P2|COMPLETED|Overall Study||131
146057|NCT00790751|336265|P1|COMPLETED|Overall Study||137
146058|NCT00790751|336262|P4|STARTED|Overall Study||162
146059|NCT00790751|336263|P3|STARTED|Overall Study||161
146060|NCT00790751|336264|P2|STARTED|Overall Study||161
146061|NCT00790751|336265|P1|STARTED|Overall Study||162
146062|NCT00790738|336285|P2|NOT COMPLETED|Overall Study||3
146063|NCT00790738|336286|P1|NOT COMPLETED|Overall Study||2
146064|NCT00790738|336285|P2|COMPLETED|Overall Study||3
146065|NCT00790738|336286|P1|COMPLETED|Overall Study||3
146066|NCT00790738|336285|P2|STARTED|Overall Study||6
146067|NCT00790738|336286|P1|STARTED|Overall Study||5
146068|NCT00790673|336300|P4|NOT COMPLETED|Overall Study||0
146069|NCT00790673|336301|P3|NOT COMPLETED|Overall Study||0
146070|NCT00790673|336302|P2|NOT COMPLETED|Overall Study||0
146071|NCT00790673|336303|P1|NOT COMPLETED|Overall Study||0
146072|NCT00790673|336300|P4|COMPLETED|Overall Study||8
146073|NCT00790673|336301|P3|COMPLETED|Overall Study||12
146074|NCT00790673|336302|P2|COMPLETED|Overall Study||6
146075|NCT00790673|336303|P1|COMPLETED|Overall Study||6
146076|NCT00790673|336300|P4|STARTED|Overall Study||8
146077|NCT00790673|336301|P3|STARTED|Overall Study||12
146078|NCT00790673|336302|P2|STARTED|Overall Study||6
146079|NCT00790673|336303|P1|STARTED|Overall Study||6
146080|NCT00790647|336313|P1|NOT COMPLETED|Overall Study||1
146081|NCT00790647|336313|P1|COMPLETED|Overall Study||9
146082|NCT00790647|336313|P1|STARTED|Overall Study||10
146083|NCT00790452|336322|P2|NOT COMPLETED|Overall Study||0
146084|NCT00790452|336323|P1|NOT COMPLETED|Overall Study||1
146085|NCT00790452|336322|P2|COMPLETED|Overall Study||0
146086|NCT00790452|336323|P1|COMPLETED|Overall Study||0
146087|NCT00790452|336322|P2|STARTED|Overall Study||0
146088|NCT00790452|336323|P1|STARTED|Overall Study||1
146089|NCT00790400|336331|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
146090|NCT00790400|336332|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
146091|NCT00790400|336331|P2|COMPLETED|Everolimus Period (Core or Extension)||0
146092|NCT00790400|336332|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
146093|NCT00790400|336331|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
146094|NCT00790400|336332|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
146095|NCT00790400|336331|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
146096|NCT00790400|336332|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
146097|NCT00790400|336331|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
146098|NCT00790400|336332|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
146099|NCT00790400|336331|P2|STARTED|Double-blind Period (Core Phase)||39
146100|NCT00790400|336332|P1|STARTED|Double-blind Period (Core Phase)||79
146101|NCT00790296|336361|P2|NOT COMPLETED|Overall Study||2
146102|NCT00790296|336362|P1|NOT COMPLETED|Overall Study||1
146103|NCT00790296|336361|P2|COMPLETED|Overall Study||4
146104|NCT00790296|336362|P1|COMPLETED|Overall Study||4
146105|NCT00790296|336361|P2|STARTED|Overall Study||6
146106|NCT00790296|336362|P1|STARTED|Overall Study||5
146107|NCT00790270|336371|P3|NOT COMPLETED|Overall Study||0
146108|NCT00790270|336372|P2|NOT COMPLETED|Overall Study||0
146109|NCT00790270|336373|P1|NOT COMPLETED|Overall Study||0
146110|NCT00790270|336371|P3|COMPLETED|Overall Study||20
146111|NCT00790270|336372|P2|COMPLETED|Overall Study||20
146112|NCT00790270|336373|P1|COMPLETED|Overall Study||21
146113|NCT00790270|336371|P3|STARTED|Overall Study||20
146114|NCT00790270|336372|P2|STARTED|Overall Study||20
146115|NCT00790270|336373|P1|STARTED|Overall Study||21
146116|NCT00790218|336384|P3|NOT COMPLETED|Overall Study||0
146117|NCT00790218|336385|P2|NOT COMPLETED|Overall Study||0
146118|NCT00790218|336386|P1|NOT COMPLETED|Overall Study||1
146119|NCT00790218|336384|P3|COMPLETED|Overall Study||7
146120|NCT00790218|336385|P2|COMPLETED|Overall Study||6
146121|NCT00790218|336386|P1|COMPLETED|Overall Study||5
146122|NCT00790218|336384|P3|STARTED|Overall Study||7
146123|NCT00790218|336385|P2|STARTED|Overall Study||6
146124|NCT00790218|336386|P1|STARTED|Overall Study||6
146125|NCT00790205|336396|P2|NOT COMPLETED|Overall Study||434
146126|NCT00790205|336397|P1|NOT COMPLETED|Overall Study||360
146127|NCT00790205|336396|P2|COMPLETED|Overall Study||6905
146128|NCT00790205|336397|P1|COMPLETED|Overall Study||6972
146129|NCT00790205|336396|P2|Treated|Overall Study||7274
146130|NCT00790205|336397|P1|Treated|Overall Study||7266
146131|NCT00790205|336396|P2|STARTED|Overall Study||7339
146132|NCT00790205|336397|P1|STARTED|Overall Study||7332
146133|NCT00790192|336441|P4|NOT COMPLETED|Overall Study||48
146134|NCT00790192|336442|P3|NOT COMPLETED|Overall Study||23
146135|NCT00790192|336443|P2|NOT COMPLETED|Overall Study||28
146136|NCT00790192|336444|P1|NOT COMPLETED|Overall Study||36
146137|NCT00790192|336441|P4|COMPLETED|Overall Study||74
146138|NCT00790192|336442|P3|COMPLETED|Overall Study||97
146139|NCT00790192|336443|P2|COMPLETED|Overall Study||93
146140|NCT00790192|336444|P1|COMPLETED|Overall Study||89
146141|NCT00790192|336441|P4|STARTED|Overall Study||122
146142|NCT00790192|336442|P3|STARTED|Overall Study||120
146143|NCT00790192|336443|P2|STARTED|Overall Study||121
146144|NCT00790192|336444|P1|STARTED|Overall Study||125
146145|NCT00790062|336461|P3|NOT COMPLETED|Overall Study||0
146146|NCT00790062|336462|P2|NOT COMPLETED|Overall Study||0
146147|NCT00790062|336463|P1|NOT COMPLETED|Overall Study||0
146148|NCT00790062|336461|P3|COMPLETED|Overall Study||658
146149|NCT00790062|336462|P2|COMPLETED|Overall Study||481
146150|NCT00790062|336463|P1|COMPLETED|Overall Study||659
146151|NCT00790062|336461|P3|STARTED|Overall Study||658
146152|NCT00790062|336462|P2|STARTED|Overall Study||481
146153|NCT00790062|336463|P1|STARTED|Overall Study||659
146154|NCT00790023|336495|P3|NOT COMPLETED|Overall Study||21
146155|NCT00790023|336496|P2|NOT COMPLETED|Overall Study||10
146156|NCT00790023|336497|P1|NOT COMPLETED|Overall Study||11
146157|NCT00790023|336495|P3|COMPLETED|Overall Study||214
146158|NCT00790023|336496|P2|COMPLETED|Overall Study||225
146159|NCT00790023|336497|P1|COMPLETED|Overall Study||226
146160|NCT00790023|336495|P3|STARTED|Overall Study||235
146161|NCT00790023|336496|P2|STARTED|Overall Study||235
146162|NCT00790023|336497|P1|STARTED|Overall Study||237
146163|NCT00789997|336587|P2|NOT COMPLETED|Overall Study||2
146164|NCT00789997|336588|P1|NOT COMPLETED|Overall Study||1
146165|NCT00789997|336587|P2|COMPLETED|Overall Study||38
146166|NCT00789997|336588|P1|COMPLETED|Overall Study||40
146167|NCT00789997|336587|P2|STARTED|Overall Study||40
146168|NCT00789997|336588|P1|STARTED|Overall Study||41
146169|NCT00789958|336596|P1|NOT COMPLETED|Overall Study||37
146170|NCT00789958|336596|P1|COMPLETED|Overall Study||68
146171|NCT00789958|336596|P1|Eligible and Analyzable|Overall Study||79
146172|NCT00789958|336596|P1|STARTED|Overall Study||105
146173|NCT00789880|336615|P6|NOT COMPLETED|Overall Study||0
146174|NCT00789880|336616|P5|NOT COMPLETED|Overall Study||3
146175|NCT00789880|336617|P4|NOT COMPLETED|Overall Study||1
146176|NCT00789880|336618|P3|NOT COMPLETED|Overall Study||0
146177|NCT00789880|336619|P2|NOT COMPLETED|Overall Study||1
146178|NCT00789880|336620|P1|NOT COMPLETED|Overall Study||1
146179|NCT00789880|336615|P6|COMPLETED|Overall Study||8
146180|NCT00789880|336616|P5|COMPLETED|Overall Study||15
146181|NCT00789880|336617|P4|COMPLETED|Overall Study||15
146182|NCT00789880|336618|P3|COMPLETED|Overall Study||8
146183|NCT00789880|336619|P2|COMPLETED|Overall Study||15
146184|NCT00789880|336620|P1|COMPLETED|Overall Study||15
146185|NCT00789880|336615|P6|STARTED|Overall Study||8
146186|NCT00789880|336616|P5|STARTED|Overall Study||18
146187|NCT00789880|336617|P4|STARTED|Overall Study||16
146188|NCT00789880|336618|P3|STARTED|Overall Study||8
146189|NCT00789880|336619|P2|STARTED|Overall Study||16
146190|NCT00789880|336620|P1|STARTED|Overall Study||16
146191|NCT00789854|336649|P3|NOT COMPLETED|Overall Study||47
146192|NCT00789854|336650|P2|NOT COMPLETED|Overall Study||35
146193|NCT00789854|336651|P1|NOT COMPLETED|Overall Study||49
146194|NCT00789854|336649|P3|COMPLETED|Overall Study||182
146195|NCT00789854|336650|P2|COMPLETED|Overall Study||196
146196|NCT00789854|336651|P1|COMPLETED|Overall Study||179
146197|NCT00789854|336649|P3|STARTED|Overall Study||229
146198|NCT00789854|336650|P2|STARTED|Overall Study||231
146199|NCT00789854|336651|P1|STARTED|Overall Study||228
146200|NCT00789828|336748|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
146201|NCT00789828|336749|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
146202|NCT00789828|336748|P2|COMPLETED|Open-label Extension Period (4 Years)||0
146203|NCT00789828|336749|P1|COMPLETED|Open-label Extension Period (4 Years)||82
146204|NCT00789828|336748|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
146205|NCT00789828|336749|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
146206|NCT00789828|336748|P2|NOT COMPLETED|Core Period (48 Weeks)||6
146207|NCT00789828|336749|P1|NOT COMPLETED|Core Period (48 Weeks)||0
146208|NCT00789828|336748|P2|COMPLETED|Core Period (48 Weeks)||33
146209|NCT00789828|336749|P1|COMPLETED|Core Period (48 Weeks)||78
146210|NCT00789828|336748|P2|STARTED|Core Period (48 Weeks)||39
146211|NCT00789828|336749|P1|STARTED|Core Period (48 Weeks)||78
146212|NCT00789815|336783|P2|NOT COMPLETED|Overall Study||1
146213|NCT00789815|336784|P1|NOT COMPLETED|Overall Study||7
146214|NCT00789815|336783|P2|COMPLETED|Overall Study||249
146215|NCT00789815|336784|P1|COMPLETED|Overall Study||243
146216|NCT00789815|336783|P2|STARTED|Overall Study||250
146217|NCT00789815|336784|P1|STARTED|Overall Study||250
146218|NCT00789802|336807|P3|NOT COMPLETED|Overall Study||6
146219|NCT00789802|336808|P2|NOT COMPLETED|Overall Study||7
146220|NCT00789802|336809|P1|NOT COMPLETED|Overall Study||10
146221|NCT00789802|336807|P3|COMPLETED|Overall Study||37
146222|NCT00789802|336808|P2|COMPLETED|Overall Study||35
146223|NCT00789802|336809|P1|COMPLETED|Overall Study||34
146224|NCT00789802|336807|P3|STARTED|Overall Study||43
146225|NCT00789802|336808|P2|STARTED|Overall Study||42
146226|NCT00789802|336809|P1|STARTED|Overall Study||44
146227|NCT00789737|336819|P2|NOT COMPLETED|Overall Study||55
146228|NCT00789737|336820|P1|NOT COMPLETED|Overall Study||48
146229|NCT00789737|336819|P2|COMPLETED|Overall Study||126
146230|NCT00789737|336820|P1|COMPLETED|Overall Study||128
146231|NCT00789737|336819|P2|STARTED|Overall Study||181
146232|NCT00789737|336820|P1|STARTED|Overall Study||176
146233|NCT00789724|336852|P2|NOT COMPLETED|Overall Study||0
146234|NCT00789724|336853|P1|NOT COMPLETED|Overall Study||0
146235|NCT00789724|336852|P2|COMPLETED|Overall Study||5
146236|NCT00789724|336853|P1|COMPLETED|Overall Study||5
146237|NCT00789724|336852|P2|STARTED|Overall Study||5
146238|NCT00789724|336853|P1|STARTED|Overall Study||5
146239|NCT00789698|336863|P4|NOT COMPLETED|Overall Study||52
146240|NCT00789698|336864|P3|NOT COMPLETED|Overall Study||27
146241|NCT00789698|336865|P2|NOT COMPLETED|Overall Study||33
146242|NCT00789698|336866|P1|NOT COMPLETED|Overall Study||40
146243|NCT00789698|336863|P4|COMPLETED|Overall Study||33
146244|NCT00789698|336864|P3|COMPLETED|Overall Study||29
146245|NCT00789698|336865|P2|COMPLETED|Overall Study||46
146246|NCT00789698|336866|P1|COMPLETED|Overall Study||32
146247|NCT00789698|336863|P4|STARTED|Overall Study||85
146248|NCT00789698|336864|P3|STARTED|Overall Study||56
146249|NCT00789698|336865|P2|STARTED|Overall Study||79
146250|NCT00789698|336866|P1|STARTED|Overall Study||72
146251|NCT00789685|336880|P1|NOT COMPLETED|Overall Study||12
146252|NCT00789685|336880|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
146253|NCT00789685|336880|P1|STARTED|Overall Study||37
146254|NCT00789672|336888|P2|NOT COMPLETED|Overall Study||0
146255|NCT00789672|336889|P1|NOT COMPLETED|Overall Study||0
146256|NCT00789672|336888|P2|COMPLETED|Overall Study||17
146257|NCT00789672|336889|P1|COMPLETED|Overall Study||16
146258|NCT00789672|336888|P2|STARTED|Overall Study||17
146259|NCT00789672|336889|P1|STARTED|Overall Study||16
146260|NCT00789555|336922|P3|NOT COMPLETED|Overall Study||159
146261|NCT00789555|336923|P2|NOT COMPLETED|Overall Study||139
146262|NCT00789555|336924|P1|NOT COMPLETED|Overall Study||159
146263|NCT00789555|336922|P3|COMPLETED|Overall Study||263
146264|NCT00789555|336923|P2|COMPLETED|Overall Study||278
146265|NCT00789555|336924|P1|COMPLETED|Overall Study||262
146266|NCT00789555|336922|P3|STARTED|Overall Study||422
146267|NCT00789555|336923|P2|STARTED|Overall Study||417
146268|NCT00789555|336924|P1|STARTED|Overall Study||421
146269|NCT00789529|336949|P2|NOT COMPLETED|Overall Study||1
146270|NCT00789529|336950|P1|NOT COMPLETED|Overall Study||1
146271|NCT00789529|336949|P2|COMPLETED|Overall Study||15
146272|NCT00789529|336950|P1|COMPLETED|Overall Study||15
146273|NCT00789529|336949|P2|STARTED|Overall Study||16
146274|NCT00789529|336950|P1|STARTED|Overall Study||16
146275|NCT00789477|336963|P5|NOT COMPLETED|Overall Study||7
146276|NCT00789477|336964|P4|NOT COMPLETED|Overall Study||10
146277|NCT00789477|336965|P3|NOT COMPLETED|Overall Study||11
146278|NCT00789477|336966|P2|NOT COMPLETED|Overall Study||6
146279|NCT00789477|336967|P1|NOT COMPLETED|Overall Study||11
146280|NCT00789477|336963|P5|COMPLETED|Overall Study||38
146281|NCT00789477|336964|P4|COMPLETED|Overall Study||34
146282|NCT00789477|336965|P3|COMPLETED|Overall Study||33
146283|NCT00789477|336966|P2|COMPLETED|Overall Study||38
146284|NCT00789477|336967|P1|COMPLETED|Overall Study||33
146285|NCT00789477|336963|P5|Participants Received Treatment|Overall Study|SAF|45
146286|NCT00789477|336964|P4|Participants Received Treatment|Overall Study|SAF|42
146287|NCT00789477|336965|P3|Participants Received Treatment|Overall Study|SAF|44
146288|NCT00789477|336966|P2|Participants Received Treatment|Overall Study|SAF|44
146289|NCT00789477|336967|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
146290|NCT00789477|336963|P5|STARTED|Overall Study|randomized|45
146291|NCT00789477|336964|P4|STARTED|Overall Study|randomized|44
146292|NCT00789477|336965|P3|STARTED|Overall Study|randomized|44
146293|NCT00789477|336966|P2|STARTED|Overall Study|randomized|44
146294|NCT00789477|336967|P1|STARTED|Overall Study|randomized|44
146295|NCT00789438|337002|P3|NOT COMPLETED|Overall Study||0
146296|NCT00789438|337003|P2|NOT COMPLETED|Overall Study||0
146297|NCT00789438|337004|P1|NOT COMPLETED|Overall Study||0
146298|NCT00789438|337002|P3|COMPLETED|Overall Study||28
146299|NCT00789438|337003|P2|COMPLETED|Overall Study||20
146300|NCT00789438|337004|P1|COMPLETED|Overall Study||21
146301|NCT00789438|337002|P3|STARTED|Overall Study||28
146302|NCT00789438|337003|P2|STARTED|Overall Study||20
146303|NCT00789438|337004|P1|STARTED|Overall Study||21
146304|NCT00789373|337012|P3|NOT COMPLETED|Maintenance||180
146305|NCT00789373|337013|P2|NOT COMPLETED|Maintenance||359
146306|NCT00789373|337014|P1|NOT COMPLETED|Maintenance||0
146307|NCT00789373|337012|P3|COMPLETED|Maintenance||0
146308|NCT00789373|337013|P2|COMPLETED|Maintenance||0
146309|NCT00789373|337014|P1|COMPLETED|Maintenance||0
146310|NCT00789373|337012|P3|STARTED|Maintenance||180
146311|NCT00789373|337013|P2|STARTED|Maintenance||359
146312|NCT00789373|337014|P1|STARTED|Maintenance||0
146313|NCT00789373|337012|P3|NOT COMPLETED|Induction||0
146314|NCT00789373|337013|P2|NOT COMPLETED|Induction||0
146315|NCT00789373|337014|P1|NOT COMPLETED|Induction||399
146316|NCT00789373|337012|P3|COMPLETED|Induction||0
146317|NCT00789373|337013|P2|COMPLETED|Induction||0
146318|NCT00789373|337014|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
146319|NCT00789373|337012|P3|STARTED|Induction||0
146320|NCT00789373|337013|P2|STARTED|Induction||0
146321|NCT00789373|337014|P1|STARTED|Induction||939
146322|NCT00787852|337041|P2|NOT COMPLETED|Overall Study||0
146323|NCT00787852|337042|P1|NOT COMPLETED|Overall Study||1
146324|NCT00787852|337041|P2|COMPLETED|Overall Study||5
146325|NCT00787852|337042|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
146326|NCT00787852|337041|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
146327|NCT00787852|337042|P1|STARTED|Overall Study||6
146328|NCT00787839|337048|P1|NOT COMPLETED|Overall Study||404
146329|NCT00787839|337048|P1|COMPLETED|Overall Study||1535
146330|NCT00787839|337048|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
146331|NCT00787839|337048|P1|Completed GCT Screening|Overall Study||1876
146332|NCT00787839|337048|P1|Consented|Overall Study|consented|1939
146333|NCT00787839|337048|P1|STARTED|Overall Study||1939
146334|NCT00787800|337071|P2|NOT COMPLETED|Overall Study||7
146335|NCT00787800|337072|P1|NOT COMPLETED|Overall Study||3
146336|NCT00787800|337071|P2|COMPLETED|Overall Study||43
146337|NCT00787800|337072|P1|COMPLETED|Overall Study||47
146338|NCT00787800|337071|P2|STARTED|Overall Study||50
146339|NCT00787800|337072|P1|STARTED|Overall Study||50
146340|NCT00787761|337088|P1|NOT COMPLETED|Overall Study||0
146341|NCT00787761|337088|P1|COMPLETED|Overall Study||24
146342|NCT00787761|337088|P1|STARTED|Overall Study||24
146343|NCT00789321|337101|P2|NOT COMPLETED|Overall Study||1
146344|NCT00789321|337102|P1|NOT COMPLETED|Overall Study||0
146345|NCT00789321|337101|P2|COMPLETED|Overall Study||22
146346|NCT00789321|337102|P1|COMPLETED|Overall Study||24
146347|NCT00789321|337101|P2|STARTED|Overall Study||23
146348|NCT00789321|337102|P1|STARTED|Overall Study||24
146349|NCT00789256|337112|P2|NOT COMPLETED|Overall Study||0
146350|NCT00789256|337113|P1|NOT COMPLETED|Overall Study||0
146351|NCT00789256|337112|P2|COMPLETED|Overall Study||12
146352|NCT00789256|337113|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
146353|NCT00789256|337112|P2|STARTED|Overall Study||12
146354|NCT00789256|337113|P1|STARTED|Overall Study||14
146355|NCT00789191|337121|P2|NOT COMPLETED|Overall Study||19
146356|NCT00789191|337122|P1|NOT COMPLETED|Overall Study||14
146357|NCT00789191|337121|P2|COMPLETED|Overall Study||92
146358|NCT00789191|337122|P1|COMPLETED|Overall Study||97
146359|NCT00789191|337121|P2|Exposed|Overall Study|1 non-compliance|110
146360|NCT00789191|337122|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
146361|NCT00789191|337121|P2|STARTED|Overall Study||111
146362|NCT00789191|337122|P1|STARTED|Overall Study||111
146363|NCT00789113|337150|P1|NOT COMPLETED|Overall Study||0
146364|NCT00789113|337150|P1|COMPLETED|Overall Study||12
146365|NCT00789113|337150|P1|STARTED|Overall Study||12
146366|NCT00789074|337157|P2|NOT COMPLETED|Overall Study||13
146367|NCT00789074|337158|P1|NOT COMPLETED|Overall Study||11
146368|NCT00789074|337157|P2|COMPLETED|Overall Study||35
146369|NCT00789074|337158|P1|COMPLETED|Overall Study||42
146370|NCT00789074|337157|P2|STARTED|Overall Study||48
146371|NCT00789074|337158|P1|STARTED|Overall Study||53
146372|NCT00789035|337179|P5|NOT COMPLETED|Overall Study||6
146373|NCT00789035|337180|P4|NOT COMPLETED|Overall Study||1
146374|NCT00789035|337181|P3|NOT COMPLETED|Overall Study||1
146375|NCT00789035|337182|P2|NOT COMPLETED|Overall Study||7
146376|NCT00789035|337183|P1|NOT COMPLETED|Overall Study||6
146377|NCT00789035|337179|P5|COMPLETED|Overall Study||74
146378|NCT00789035|337180|P4|COMPLETED|Overall Study||81
146379|NCT00789035|337181|P3|COMPLETED|Overall Study||80
146380|NCT00789035|337182|P2|COMPLETED|Overall Study||74
146381|NCT00789035|337183|P1|COMPLETED|Overall Study||76
146382|NCT00789035|337179|P5|STARTED|Overall Study||80
146383|NCT00789035|337180|P4|STARTED|Overall Study||82
146384|NCT00789035|337181|P3|STARTED|Overall Study||81
146385|NCT00789035|337182|P2|STARTED|Overall Study||81
146386|NCT00789035|337183|P1|STARTED|Overall Study||82
146387|NCT00788957|337242|P6|NOT COMPLETED|Part 3||11
146388|NCT00788957|337243|P5|NOT COMPLETED|Part 3||9
146389|NCT00788957|337244|P4|NOT COMPLETED|Part 3||0
146390|NCT00788957|337245|P3|NOT COMPLETED|Part 3||0
146391|NCT00788957|337246|P2|NOT COMPLETED|Part 3||0
146392|NCT00788957|337247|P1|NOT COMPLETED|Part 3||0
146393|NCT00788957|337242|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
146394|NCT00788957|337243|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
146395|NCT00788957|337244|P4|COMPLETED|Part 3||0
146396|NCT00788957|337245|P3|COMPLETED|Part 3||0
146397|NCT00788957|337246|P2|COMPLETED|Part 3||0
146398|NCT00788957|337247|P1|COMPLETED|Part 3||0
146399|NCT00788957|337242|P6|STARTED|Part 3||12
146400|NCT00788957|337243|P5|STARTED|Part 3||13
146401|NCT00788957|337244|P4|STARTED|Part 3||0
146402|NCT00788957|337245|P3|STARTED|Part 3||0
146403|NCT00788957|337246|P2|STARTED|Part 3||0
146404|NCT00788957|337247|P1|STARTED|Part 3||0
146405|NCT00788957|337242|P6|NOT COMPLETED|Part 2||0
146406|NCT00788957|337243|P5|NOT COMPLETED|Part 2||0
146407|NCT00788957|337244|P4|NOT COMPLETED|Part 2||41
146408|NCT00788957|337245|P3|NOT COMPLETED|Part 2||44
146409|NCT00788957|337246|P2|NOT COMPLETED|Part 2||42
146410|NCT00788957|337247|P1|NOT COMPLETED|Part 2||0
146411|NCT00788957|337242|P6|COMPLETED|Part 2||0
146412|NCT00788957|337243|P5|COMPLETED|Part 2||0
146413|NCT00788957|337244|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
146414|NCT00788957|337245|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
146415|NCT00788957|337246|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
146416|NCT00788957|337247|P1|COMPLETED|Part 2||0
146417|NCT00788957|337242|P6|STARTED|Part 2||0
146418|NCT00788957|337243|P5|STARTED|Part 2||0
146419|NCT00788957|337244|P4|STARTED|Part 2||46
146420|NCT00788957|337245|P3|STARTED|Part 2||48
146421|NCT00788957|337246|P2|STARTED|Part 2||48
146422|NCT00788957|337247|P1|STARTED|Part 2||0
146423|NCT00788957|337242|P6|NOT COMPLETED|Part 1||0
146424|NCT00788957|337243|P5|NOT COMPLETED|Part 1||0
146425|NCT00788957|337244|P4|NOT COMPLETED|Part 1||0
146426|NCT00788957|337245|P3|NOT COMPLETED|Part 1||0
146427|NCT00788957|337246|P2|NOT COMPLETED|Part 1||0
146428|NCT00788957|337247|P1|NOT COMPLETED|Part 1||9
146429|NCT00788957|337242|P6|COMPLETED|Part 1||0
146430|NCT00788957|337243|P5|COMPLETED|Part 1||0
146431|NCT00788957|337244|P4|COMPLETED|Part 1||0
146432|NCT00788957|337245|P3|COMPLETED|Part 1||0
146433|NCT00788957|337246|P2|COMPLETED|Part 1||0
146434|NCT00788957|337247|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
146435|NCT00788957|337242|P6|STARTED|Part 1||0
146436|NCT00788957|337243|P5|STARTED|Part 1||0
146437|NCT00788957|337244|P4|STARTED|Part 1||0
146438|NCT00788957|337245|P3|STARTED|Part 1||0
146439|NCT00788957|337246|P2|STARTED|Part 1||0
146440|NCT00788957|337247|P1|STARTED|Part 1||11
146441|NCT00788775|337303|P2|NOT COMPLETED|Overall Study||8
146442|NCT00788775|337304|P1|NOT COMPLETED|Overall Study||10
146443|NCT00788775|337303|P2|COMPLETED|Overall Study||1
146444|NCT00788775|337304|P1|COMPLETED|Overall Study||1
146445|NCT00788775|337303|P2|Treated|Overall Study||8
146446|NCT00788775|337304|P1|Treated|Overall Study||11
146447|NCT00788775|337303|P2|STARTED|Overall Study||9
146448|NCT00788775|337304|P1|STARTED|Overall Study||11
146449|NCT00788710|337319|P3|NOT COMPLETED|Overall Study||6
146450|NCT00788710|337320|P2|NOT COMPLETED|Overall Study||8
146451|NCT00788710|337321|P1|NOT COMPLETED|Overall Study||5
146452|NCT00788710|337319|P3|COMPLETED|Overall Study||138
146453|NCT00788710|337320|P2|COMPLETED|Overall Study||134
146454|NCT00788710|337321|P1|COMPLETED|Overall Study||139
146455|NCT00788710|337319|P3|STARTED|Overall Study||144
146456|NCT00788710|337320|P2|STARTED|Overall Study||142
146457|NCT00788710|337321|P1|STARTED|Overall Study||144
146458|NCT00788593|337335|P3|NOT COMPLETED|Second Intervention Period||1
146459|NCT00788593|337336|P2|NOT COMPLETED|Second Intervention Period||1
146460|NCT00788593|337337|P1|NOT COMPLETED|Second Intervention Period||0
146461|NCT00788593|337335|P3|COMPLETED|Second Intervention Period||36
146462|NCT00788593|337336|P2|COMPLETED|Second Intervention Period||37
146463|NCT00788593|337337|P1|COMPLETED|Second Intervention Period||0
146464|NCT00788593|337335|P3|STARTED|Second Intervention Period||37
146465|NCT00788593|337336|P2|STARTED|Second Intervention Period||38
146466|NCT00788593|337337|P1|STARTED|Second Intervention Period||0
146467|NCT00788593|337335|P3|NOT COMPLETED|First Intervention Period||0
146468|NCT00788593|337336|P2|NOT COMPLETED|First Intervention Period||1
146469|NCT00788593|337337|P1|NOT COMPLETED|First Intervention Period||0
146470|NCT00788593|337335|P3|COMPLETED|First Intervention Period||37
146471|NCT00788593|337336|P2|COMPLETED|First Intervention Period||38
146472|NCT00788593|337337|P1|COMPLETED|First Intervention Period||0
146473|NCT00788593|337335|P3|STARTED|First Intervention Period||37
146474|NCT00788593|337336|P2|STARTED|First Intervention Period||39
146475|NCT00788593|337337|P1|STARTED|First Intervention Period||0
146476|NCT00788593|337335|P3|NOT COMPLETED|Placebo Run-in Phase||0
146477|NCT00788593|337336|P2|NOT COMPLETED|Placebo Run-in Phase||0
146478|NCT00788593|337337|P1|NOT COMPLETED|Placebo Run-in Phase||6
146479|NCT00788593|337335|P3|COMPLETED|Placebo Run-in Phase||0
146480|NCT00788593|337336|P2|COMPLETED|Placebo Run-in Phase||0
146481|NCT00788593|337337|P1|COMPLETED|Placebo Run-in Phase||76
146482|NCT00788593|337335|P3|STARTED|Placebo Run-in Phase||0
146483|NCT00788593|337336|P2|STARTED|Placebo Run-in Phase||0
146484|NCT00788593|337337|P1|STARTED|Placebo Run-in Phase||82
146485|NCT00787644|337356|P2|NOT COMPLETED|Overall Study||2
146486|NCT00787644|337357|P1|NOT COMPLETED|Overall Study||2
146487|NCT00787644|337356|P2|COMPLETED|Overall Study||9
146488|NCT00787644|337357|P1|COMPLETED|Overall Study||10
146489|NCT00787644|337356|P2|STARTED|Overall Study||11
146490|NCT00787644|337357|P1|STARTED|Overall Study||12
146491|NCT00787618|337366|P3|NOT COMPLETED|Overall Study||0
146492|NCT00787618|337367|P2|NOT COMPLETED|Overall Study||0
146493|NCT00787618|337368|P1|NOT COMPLETED|Overall Study||0
146494|NCT00787618|337366|P3|COMPLETED|Overall Study||3
146495|NCT00787618|337367|P2|COMPLETED|Overall Study||0
146496|NCT00787618|337368|P1|COMPLETED|Overall Study||3
146497|NCT00787618|337366|P3|STARTED|Overall Study||3
146498|NCT00787618|337367|P2|STARTED|Overall Study||0
146499|NCT00787618|337368|P1|STARTED|Overall Study||3
146500|NCT00787605|337378|P2|NOT COMPLETED|Overall Study||56
146501|NCT00787605|337379|P1|NOT COMPLETED|Overall Study||46
146502|NCT00787605|337378|P2|COMPLETED|Overall Study||376
146503|NCT00787605|337379|P1|COMPLETED|Overall Study||382
146504|NCT00787605|337378|P2|STARTED|Overall Study||432
146505|NCT00787605|337379|P1|STARTED|Overall Study||428
146506|NCT00788372|337395|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
146507|NCT00788372|337395|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
146508|NCT00788372|337395|P1|STARTED|Period 2 (Week 4 to Week 52)||111
146509|NCT00788372|337395|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
146510|NCT00788372|337395|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
146511|NCT00788372|337395|P1|STARTED|Period 1 (up to 4 Weeks)||142
146512|NCT00788255|337409|P1|NOT COMPLETED|Overall Study||0
146513|NCT00788255|337409|P1|COMPLETED|Overall Study||25
146514|NCT00788255|337409|P1|Oxytocin: 0 μU/mL|Overall Study||25
146515|NCT00788255|337409|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
146516|NCT00788255|337409|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
146517|NCT00788255|337409|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
146518|NCT00788255|337409|P1|STARTED|Overall Study||25
146519|NCT00788073|337424|P2|NOT COMPLETED|Placebo Then STX209||1
146520|NCT00788073|337425|P1|NOT COMPLETED|Placebo Then STX209||2
146521|NCT00788073|337424|P2|COMPLETED|Placebo Then STX209||29
146522|NCT00788073|337425|P1|COMPLETED|Placebo Then STX209||27
146523|NCT00788073|337424|P2|STARTED|Placebo Then STX209||30
146524|NCT00788073|337425|P1|STARTED|Placebo Then STX209||29
146525|NCT00788073|337424|P2|NOT COMPLETED|STX209 Then Placebo||3
146526|NCT00788073|337425|P1|NOT COMPLETED|STX209 Then Placebo||1
146527|NCT00788073|337424|P2|COMPLETED|STX209 Then Placebo||30
146528|NCT00788073|337425|P1|COMPLETED|STX209 Then Placebo||29
146529|NCT00788073|337424|P2|STARTED|STX209 Then Placebo||33
146530|NCT00788073|337425|P1|STARTED|STX209 Then Placebo||30
146531|NCT00788008|337435|P2|NOT COMPLETED|Overall Study||0
146532|NCT00788008|337436|P1|NOT COMPLETED|Overall Study||0
146533|NCT00788008|337435|P2|COMPLETED|Overall Study||101
146534|NCT00788008|337436|P1|COMPLETED|Overall Study||98
146535|NCT00788008|337435|P2|STARTED|Overall Study||101
146536|NCT00788008|337436|P1|STARTED|Overall Study||98
146537|NCT00787943|337442|P1|NOT COMPLETED|Overall Study||0
146538|NCT00787943|337442|P1|COMPLETED|Overall Study||10
146539|NCT00787943|337442|P1|STARTED|Overall Study||10
146540|NCT00787930|337450|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
146541|NCT00787930|337450|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
146542|NCT00787930|337450|P1|STARTED|Continuation Treatment -- up to 12 Month||19
146543|NCT00787930|337450|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
146544|NCT00787930|337450|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
146545|NCT00787930|337450|P1|STARTED|Acute Treatment -- 3 Weeks||19
146546|NCT00787917|337465|P2|NOT COMPLETED|Open Label||0
146547|NCT00787917|337466|P1|NOT COMPLETED|Open Label||4
146548|NCT00787917|337465|P2|COMPLETED|Open Label||0
146549|NCT00787917|337466|P1|COMPLETED|Open Label||3
146550|NCT00787917|337465|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
146551|NCT00787917|337466|P1|STARTED|Open Label||7
146552|NCT00787917|337465|P2|NOT COMPLETED|Blinded Treatment||2
146553|NCT00787917|337466|P1|NOT COMPLETED|Blinded Treatment||5
146554|NCT00787917|337465|P2|COMPLETED|Blinded Treatment||3
146555|NCT00787917|337466|P1|COMPLETED|Blinded Treatment||4
146556|NCT00787917|337465|P2|STARTED|Blinded Treatment||5
146557|NCT00787917|337466|P1|STARTED|Blinded Treatment||9
146558|NCT00787904|337485|P2|NOT COMPLETED|Overall Study||0
146559|NCT00787904|337486|P1|NOT COMPLETED|Overall Study||0
146560|NCT00787904|337485|P2|COMPLETED|Overall Study||13
146561|NCT00787904|337486|P1|COMPLETED|Overall Study||6
146562|NCT00787904|337485|P2|STARTED|Overall Study||13
146563|NCT00787904|337486|P1|STARTED|Overall Study||6
146564|NCT00787891|337496|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
146565|NCT00787891|337497|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
146566|NCT00787891|337496|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
146567|NCT00787891|337497|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
146568|NCT00787891|337496|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
146569|NCT00787891|337497|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
146570|NCT00787891|337496|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
146571|NCT00787891|337497|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
146572|NCT00787891|337496|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
146573|NCT00787891|337497|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
146574|NCT00787891|337496|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
146575|NCT00787891|337497|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
146576|NCT00787566|337518|P3|NOT COMPLETED|Overall Study||0
146577|NCT00787566|337519|P2|NOT COMPLETED|Overall Study||1
146578|NCT00787566|337520|P1|NOT COMPLETED|Overall Study||0
146579|NCT00787566|337518|P3|COMPLETED|Overall Study||22
146580|NCT00787566|337519|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
146581|NCT00787566|337520|P1|COMPLETED|Overall Study||21
146582|NCT00787566|337518|P3|STARTED|Overall Study||22
146583|NCT00787566|337519|P2|STARTED|Overall Study||25
146584|NCT00787566|337520|P1|STARTED|Overall Study||21
146585|NCT00787527|337528|P1|NOT COMPLETED|Overall Study||3
146586|NCT00787527|337528|P1|COMPLETED|Overall Study||11
146587|NCT00787527|337528|P1|STARTED|Overall Study||14
146588|NCT00787332|337538|P2|NOT COMPLETED|Overall Study||0
146589|NCT00787332|337539|P1|NOT COMPLETED|Overall Study||0
146590|NCT00787332|337538|P2|COMPLETED|Overall Study||8
146591|NCT00787332|337539|P1|COMPLETED|Overall Study||8
146592|NCT00787332|337538|P2|STARTED|Overall Study||8
146593|NCT00787332|337539|P1|STARTED|Overall Study||8
146594|NCT00787319|337545|P1|NOT COMPLETED|Overall Study||63
146595|NCT00787319|337545|P1|COMPLETED|Overall Study||45
146596|NCT00787319|337545|P1|STARTED|Overall Study||108
146597|NCT00787267|337557|P1|NOT COMPLETED|Overall Study||12
146598|NCT00787267|337557|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
146599|NCT00787267|337557|P1|STARTED|Overall Study|Signed a consent form|37
146600|NCT00787254|337567|P2|NOT COMPLETED|Overall Study||82
146601|NCT00787254|337568|P1|NOT COMPLETED|Overall Study||76
146602|NCT00787254|337567|P2|COMPLETED|Overall Study||99
146603|NCT00787254|337568|P1|COMPLETED|Overall Study||109
146604|NCT00787254|337567|P2|STARTED|Overall Study||181
146605|NCT00787254|337568|P1|STARTED|Overall Study||185
146606|NCT00787241|337671|P3|NOT COMPLETED|Overall Study||0
146607|NCT00787241|337672|P2|NOT COMPLETED|Overall Study||0
146608|NCT00787241|337673|P1|NOT COMPLETED|Overall Study||0
146609|NCT00787241|337671|P3|COMPLETED|Overall Study||41
146610|NCT00787241|337672|P2|COMPLETED|Overall Study||143
146611|NCT00787241|337673|P1|COMPLETED|Overall Study||261
146612|NCT00787241|337671|P3|STARTED|Overall Study||41
146613|NCT00787241|337672|P2|STARTED|Overall Study||143
146614|NCT00787241|337673|P1|STARTED|Overall Study||261
146615|NCT00787202|337692|P5|NOT COMPLETED|Overall Study||4
146616|NCT00787202|337693|P4|NOT COMPLETED|Overall Study||2
146617|NCT00787202|337694|P3|NOT COMPLETED|Overall Study||7
146618|NCT00787202|337695|P2|NOT COMPLETED|Overall Study||11
146619|NCT00787202|337696|P1|NOT COMPLETED|Overall Study||14
146620|NCT00787202|337692|P5|COMPLETED|Overall Study||45
146621|NCT00787202|337693|P4|COMPLETED|Overall Study||31
146622|NCT00787202|337694|P3|COMPLETED|Overall Study||26
146623|NCT00787202|337695|P2|COMPLETED|Overall Study||20
146624|NCT00787202|337696|P1|COMPLETED|Overall Study||35
146625|NCT00787202|337692|P5|Treated|Overall Study||49
146626|NCT00787202|337693|P4|Treated|Overall Study||33
146627|NCT00787202|337694|P3|Treated|Overall Study||33
146628|NCT00787202|337695|P2|Treated|Overall Study||31
146629|NCT00787202|337696|P1|Treated|Overall Study||48
146630|NCT00787202|337692|P5|STARTED|Overall Study||49
146631|NCT00787202|337693|P4|STARTED|Overall Study||33
146632|NCT00787202|337694|P3|STARTED|Overall Study||33
146633|NCT00787202|337695|P2|STARTED|Overall Study||31
146634|NCT00787202|337696|P1|STARTED|Overall Study||49
146635|NCT00787189|337749|P2|NOT COMPLETED|Overall Study||2
146636|NCT00787189|337750|P1|NOT COMPLETED|Overall Study||2
146637|NCT00787189|337749|P2|COMPLETED|Overall Study|To study end point.|30
146638|NCT00787189|337750|P1|COMPLETED|Overall Study|To study end point.|30
146639|NCT00787189|337749|P2|STARTED|Overall Study||32
146640|NCT00787189|337750|P1|STARTED|Overall Study||32
146641|NCT00787150|337759|P3|NOT COMPLETED|Overall Study||5
146642|NCT00787150|337760|P2|NOT COMPLETED|Overall Study||7
146643|NCT00787150|337761|P1|NOT COMPLETED|Overall Study||9
146644|NCT00787150|337759|P3|COMPLETED|Overall Study||66
146645|NCT00787150|337760|P2|COMPLETED|Overall Study||65
146646|NCT00787150|337761|P1|COMPLETED|Overall Study||66
146647|NCT00787150|337759|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
146648|NCT00787150|337760|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
146649|NCT00787150|337761|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
146650|NCT00787137|337806|P3|NOT COMPLETED|Overall Study||1
146651|NCT00787137|337807|P2|NOT COMPLETED|Overall Study||0
146652|NCT00787137|337808|P1|NOT COMPLETED|Overall Study||0
146653|NCT00787137|337806|P3|COMPLETED|Overall Study||4
146654|NCT00787137|337807|P2|COMPLETED|Overall Study||6
146655|NCT00787137|337808|P1|COMPLETED|Overall Study||6
146656|NCT00787137|337806|P3|STARTED|Overall Study||5
146657|NCT00787137|337807|P2|STARTED|Overall Study||6
146658|NCT00787137|337808|P1|STARTED|Overall Study||6
146659|NCT00787124|337830|P2|NOT COMPLETED|Overall Study||0
146660|NCT00787124|337831|P1|NOT COMPLETED|Overall Study||0
146661|NCT00787124|337830|P2|COMPLETED|Overall Study||4
146662|NCT00787124|337831|P1|COMPLETED|Overall Study||4
146663|NCT00787124|337830|P2|STARTED|Overall Study||4
146664|NCT00787124|337831|P1|STARTED|Overall Study||4
146665|NCT00787020|337841|P2|NOT COMPLETED|Overall Study||0
146666|NCT00787020|337842|P1|NOT COMPLETED|Overall Study||0
146667|NCT00787020|337841|P2|COMPLETED|Overall Study||13
146668|NCT00787020|337842|P1|COMPLETED|Overall Study||24
146669|NCT00787020|337841|P2|STARTED|Overall Study||13
146670|NCT00787020|337842|P1|STARTED|Overall Study||24
146671|NCT00786994|337856|P4|NOT COMPLETED|Overall Study||6
146672|NCT00786994|337857|P3|NOT COMPLETED|Overall Study||2
146673|NCT00786994|337858|P2|NOT COMPLETED|Overall Study||15
146674|NCT00786994|337859|P1|NOT COMPLETED|Overall Study||10
146675|NCT00786994|337856|P4|COMPLETED|Overall Study||22
146676|NCT00786994|337857|P3|COMPLETED|Overall Study||24
146677|NCT00786994|337858|P2|COMPLETED|Overall Study||39
146678|NCT00786994|337859|P1|COMPLETED|Overall Study||47
146679|NCT00786994|337856|P4|ITT|Overall Study||28
146680|NCT00786994|337857|P3|ITT|Overall Study||25
146681|NCT00786994|337858|P2|ITT|Overall Study||51
146682|NCT00786994|337859|P1|ITT|Overall Study||53
146683|NCT00786994|337856|P4|STARTED|Overall Study||28
146684|NCT00786994|337857|P3|STARTED|Overall Study||26
146685|NCT00786994|337858|P2|STARTED|Overall Study||54
146686|NCT00786994|337859|P1|STARTED|Overall Study||57
146687|NCT00786916|337871|P3|NOT COMPLETED|Overall Study||0
146688|NCT00786916|337872|P2|NOT COMPLETED|Overall Study||0
146689|NCT00786916|337873|P1|NOT COMPLETED|Overall Study||0
146690|NCT00786916|337871|P3|COMPLETED|Overall Study||34
146691|NCT00786916|337872|P2|COMPLETED|Overall Study||36
146692|NCT00786916|337873|P1|COMPLETED|Overall Study||39
146693|NCT00786916|337871|P3|STARTED|Overall Study||34
146694|NCT00786916|337872|P2|STARTED|Overall Study||36
146695|NCT00786916|337873|P1|STARTED|Overall Study||39
146696|NCT00786864|337883|P2|NOT COMPLETED|Overall Study||1
146697|NCT00786864|337884|P1|NOT COMPLETED|Overall Study||1
146698|NCT00786864|337883|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
146699|NCT00786864|337884|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
146700|NCT00786864|337883|P2|STARTED|Overall Study||33
146701|NCT00786864|337884|P1|STARTED|Overall Study||39
146702|NCT00786838|337896|P1|NOT COMPLETED|Overall Study||49
146703|NCT00786838|337896|P1|COMPLETED|Overall Study||26
146704|NCT00786838|337896|P1|STARTED|Overall Study||75
146705|NCT00786799|337923|P2|NOT COMPLETED|Overall Study||1
146706|NCT00786799|337924|P1|NOT COMPLETED|Overall Study||1
146707|NCT00786799|337923|P2|COMPLETED|Overall Study||12
146708|NCT00786799|337924|P1|COMPLETED|Overall Study||13
146709|NCT00786799|337923|P2|STARTED|Overall Study||13
146710|NCT00786799|337924|P1|STARTED|Overall Study||14
146711|NCT00786682|337935|P1|NOT COMPLETED|Overall Study||0
146712|NCT00786682|337935|P1|COMPLETED|Overall Study||11
146713|NCT00786682|337935|P1|STARTED|Overall Study||11
146714|NCT00786643|337943|P2|NOT COMPLETED|Overall Study||0
146715|NCT00786643|337944|P1|NOT COMPLETED|Overall Study||0
146716|NCT00786643|337943|P2|COMPLETED|Overall Study||28
146717|NCT00786643|337944|P1|COMPLETED|Overall Study||20
146718|NCT00786643|337943|P2|STARTED|Overall Study||28
146719|NCT00786643|337944|P1|STARTED|Overall Study||20
146720|NCT00786565|337954|P1|NOT COMPLETED|Post Surgery||2
146721|NCT00786565|337954|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
146722|NCT00786565|337954|P1|STARTED|Post Surgery||69
146723|NCT00786565|337954|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
146899|NCT00784875|338371|P1|COMPLETED|Period C||96
146724|NCT00786565|337954|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
146725|NCT00786565|337954|P1|STARTED|Enrollment Prior to Surgery||75
146726|NCT00786487|337996|P4|NOT COMPLETED|Overall Study||0
146727|NCT00786487|337997|P3|NOT COMPLETED|Overall Study||0
146728|NCT00786487|337998|P2|NOT COMPLETED|Overall Study||0
146729|NCT00786487|337999|P1|NOT COMPLETED|Overall Study||0
146730|NCT00786487|337996|P4|COMPLETED|Overall Study||7
146731|NCT00786487|337997|P3|COMPLETED|Overall Study||9
146732|NCT00786487|337998|P2|COMPLETED|Overall Study||7
146733|NCT00786487|337999|P1|COMPLETED|Overall Study||10
146734|NCT00786487|337996|P4|STARTED|Overall Study||7
146735|NCT00786487|337997|P3|STARTED|Overall Study||9
146736|NCT00786487|337998|P2|STARTED|Overall Study||7
146737|NCT00786487|337999|P1|STARTED|Overall Study||10
146738|NCT00786474|338011|P2|NOT COMPLETED|Overall Study||43
146739|NCT00786474|338012|P1|NOT COMPLETED|Overall Study||37
146740|NCT00786474|338011|P2|COMPLETED|Overall Study||891
146741|NCT00786474|338012|P1|COMPLETED|Overall Study||913
146742|NCT00786474|338011|P2|STARTED|Overall Study||934
146743|NCT00786474|338012|P1|STARTED|Overall Study||950
146744|NCT00786422|338024|P1|NOT COMPLETED|Follow-up Period||3
146745|NCT00786422|338024|P1|COMPLETED|Follow-up Period||17
146746|NCT00786422|338024|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
146747|NCT00786422|338024|P1|NOT COMPLETED|Rivaroxaban Treatment||11
146748|NCT00786422|338024|P1|COMPLETED|Rivaroxaban Treatment||14
146749|NCT00786422|338024|P1|STARTED|Rivaroxaban Treatment||25
146750|NCT00786188|338042|P2|NOT COMPLETED|Overall Study||1
146751|NCT00786188|338043|P1|NOT COMPLETED|Overall Study||5
146752|NCT00786188|338042|P2|COMPLETED|Overall Study||51
146753|NCT00786188|338043|P1|COMPLETED|Overall Study||45
146754|NCT00786188|338042|P2|STARTED|Overall Study||52
146755|NCT00786188|338043|P1|STARTED|Overall Study||50
146756|NCT00786032|338069|P1|NOT COMPLETED|Overall Study||24
146757|NCT00786032|338069|P1|COMPLETED|Overall Study||3
146758|NCT00786032|338069|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
146759|NCT00786032|338069|P1|STARTED|Overall Study||27
146760|NCT00785980|338079|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
146761|NCT00785980|338079|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
146762|NCT00785980|338079|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
146763|NCT00785980|338079|P1|NOT COMPLETED|Ciprofloxacin Alone||0
146764|NCT00785980|338079|P1|COMPLETED|Ciprofloxacin Alone||21
146765|NCT00785980|338079|P1|STARTED|Ciprofloxacin Alone||21
146766|NCT00785980|338079|P1|NOT COMPLETED|7 Day Washout Period||3
146767|NCT00785980|338079|P1|COMPLETED|7 Day Washout Period||21
146768|NCT00785980|338079|P1|STARTED|7 Day Washout Period||24
146769|NCT00785980|338079|P1|NOT COMPLETED|Quinine Sulfate Alone||0
146770|NCT00785980|338079|P1|COMPLETED|Quinine Sulfate Alone||24
146771|NCT00785980|338079|P1|STARTED|Quinine Sulfate Alone||24
146772|NCT00785798|338090|P1|NOT COMPLETED|Overall Study||1
146773|NCT00785798|338090|P1|COMPLETED|Overall Study||16
146774|NCT00785798|338090|P1|STARTED|Overall Study||17
146775|NCT00785785|338097|P2|NOT COMPLETED|Optional Extension Phase||125
146776|NCT00785785|338098|P1|NOT COMPLETED|Optional Extension Phase||39
146777|NCT00785785|338097|P2|COMPLETED|Optional Extension Phase||0
146778|NCT00785785|338098|P1|COMPLETED|Optional Extension Phase||0
146779|NCT00785785|338097|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
146780|NCT00785785|338098|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
146781|NCT00785785|338097|P2|NOT COMPLETED|Core Phase up to 36 Months||320
146782|NCT00785785|338098|P1|NOT COMPLETED|Core Phase up to 36 Months||324
146783|NCT00785785|338097|P2|COMPLETED|Core Phase up to 36 Months||0
146784|NCT00785785|338098|P1|COMPLETED|Core Phase up to 36 Months||0
146785|NCT00785785|338097|P2|STARTED|Core Phase up to 36 Months||320
146786|NCT00785785|338098|P1|STARTED|Core Phase up to 36 Months||324
146787|NCT00785772|338106|P1|NOT COMPLETED|Overall Study||0
146788|NCT00785772|338106|P1|COMPLETED|Overall Study||1
146789|NCT00785772|338106|P1|STARTED|Overall Study||1
146790|NCT00785629|338116|P4|NOT COMPLETED|Overall Study||16
146791|NCT00785629|338117|P3|NOT COMPLETED|Overall Study||10
146792|NCT00785629|338118|P2|NOT COMPLETED|Overall Study||5
146793|NCT00785629|338119|P1|NOT COMPLETED|Overall Study||8
146794|NCT00785629|338116|P4|COMPLETED|Overall Study|16 not completed|41
146795|NCT00785629|338117|P3|COMPLETED|Overall Study|10 not completed|18
146796|NCT00785629|338118|P2|COMPLETED|Overall Study|5 not completed|25
146797|NCT00785629|338119|P1|COMPLETED|Overall Study|8 not completed|22
146798|NCT00785629|338116|P4|STARTED|Overall Study||57
146799|NCT00785629|338117|P3|STARTED|Overall Study||28
146800|NCT00785629|338118|P2|STARTED|Overall Study||30
146801|NCT00785629|338119|P1|STARTED|Overall Study||30
146802|NCT00785577|338132|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
146803|NCT00785577|338133|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
146804|NCT00785577|338134|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
146805|NCT00785577|338135|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
146806|NCT00785577|338136|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
146807|NCT00785577|338132|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
146808|NCT00785577|338133|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
146809|NCT00785577|338134|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
146810|NCT00785577|338135|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
146811|NCT00785577|338136|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
146812|NCT00785577|338132|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
146813|NCT00785577|338133|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
146814|NCT00785577|338134|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
146815|NCT00785577|338135|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
146816|NCT00785577|338136|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
146817|NCT00785577|338132|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
146818|NCT00785577|338133|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
146819|NCT00785577|338134|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
146820|NCT00785577|338135|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
146821|NCT00785577|338136|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
146822|NCT00785577|338132|P5|COMPLETED|Study Period 2: Therapy Phase||27
146823|NCT00785577|338133|P4|COMPLETED|Study Period 2: Therapy Phase||36
146824|NCT00785577|338134|P3|COMPLETED|Study Period 2: Therapy Phase||25
146825|NCT00785577|338135|P2|COMPLETED|Study Period 2: Therapy Phase||36
146826|NCT00785577|338136|P1|COMPLETED|Study Period 2: Therapy Phase||78
146827|NCT00785577|338132|P5|STARTED|Study Period 2: Therapy Phase||47
146828|NCT00785577|338133|P4|STARTED|Study Period 2: Therapy Phase||49
146829|NCT00785577|338134|P3|STARTED|Study Period 2: Therapy Phase||43
146830|NCT00785577|338135|P2|STARTED|Study Period 2: Therapy Phase||45
146831|NCT00785577|338136|P1|STARTED|Study Period 2: Therapy Phase||89
146832|NCT00785512|338274|P2|NOT COMPLETED|Overall Study||4
146833|NCT00785512|338275|P1|NOT COMPLETED|Overall Study||3
146834|NCT00785512|338274|P2|COMPLETED|Overall Study||101
146835|NCT00785512|338275|P1|COMPLETED|Overall Study||99
146836|NCT00785512|338274|P2|STARTED|Overall Study||105
146837|NCT00785512|338275|P1|STARTED|Overall Study||102
146838|NCT00785486|338284|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
146839|NCT00785486|338284|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
146840|NCT00785486|338284|P1|STARTED|Midazolam With Qualaquin at Steady State||23
146841|NCT00785486|338284|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
146842|NCT00785486|338284|P1|COMPLETED|Qualaquin Alone at Steady State||23
146843|NCT00785486|338284|P1|STARTED|Qualaquin Alone at Steady State||23
146844|NCT00785486|338284|P1|NOT COMPLETED|3 Day Washout||0
146845|NCT00785486|338284|P1|COMPLETED|3 Day Washout||23
146846|NCT00785486|338284|P1|STARTED|3 Day Washout||23
146847|NCT00785486|338284|P1|NOT COMPLETED|Midazolam Alone||1
146848|NCT00785486|338284|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
146849|NCT00785486|338284|P1|STARTED|Midazolam Alone||24
146850|NCT00785356|338308|P1|NOT COMPLETED|Overall Study||8
146851|NCT00785356|338308|P1|COMPLETED|Overall Study||0
146852|NCT00785356|338308|P1|STARTED|Overall Study||8
146853|NCT00785291|338319|P3|NOT COMPLETED|Overall Study||106
146854|NCT00785291|338320|P2|NOT COMPLETED|Overall Study||149
146855|NCT00785291|338321|P1|NOT COMPLETED|Overall Study||136
146856|NCT00785291|338319|P3|COMPLETED|Overall Study||139
146857|NCT00785291|338320|P2|COMPLETED|Overall Study||122
146858|NCT00785291|338321|P1|COMPLETED|Overall Study||147
146859|NCT00785291|338319|P3|STARTED|Overall Study||245
146860|NCT00785291|338320|P2|STARTED|Overall Study||271
146861|NCT00785291|338321|P1|STARTED|Overall Study||283
146862|NCT00785213|338341|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
146863|NCT00785213|338341|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
146864|NCT00785213|338341|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
146865|NCT00785213|338341|P1|NOT COMPLETED|Quinine Sulfate Alone||4
146866|NCT00785213|338341|P1|COMPLETED|Quinine Sulfate Alone||19
146867|NCT00785213|338341|P1|STARTED|Quinine Sulfate Alone||23
146868|NCT00785213|338341|P1|NOT COMPLETED|2 Day Washout Period||0
146869|NCT00785213|338341|P1|COMPLETED|2 Day Washout Period||23
146870|NCT00785213|338341|P1|STARTED|2 Day Washout Period||23
146871|NCT00785213|338341|P1|NOT COMPLETED|Rosiglitazone Alone||0
146872|NCT00785213|338341|P1|COMPLETED|Rosiglitazone Alone||23
146873|NCT00785213|338341|P1|STARTED|Rosiglitazone Alone||23
146874|NCT00784979|338352|P1|NOT COMPLETED|Overall Study||6
146875|NCT00784979|338352|P1|COMPLETED|Overall Study||20
146876|NCT00784979|338352|P1|STARTED|Overall Study||26
146877|NCT00784927|338356|P1|NOT COMPLETED|Overall Study||3
146878|NCT00784927|338356|P1|COMPLETED|Overall Study||33
146879|NCT00784927|338356|P1|STARTED|Overall Study||36
146880|NCT00784875|338368|P4|NOT COMPLETED|Period D||1
146881|NCT00784875|338369|P3|NOT COMPLETED|Period D||6
146882|NCT00784875|338370|P2|NOT COMPLETED|Period D||4
146883|NCT00784875|338371|P1|NOT COMPLETED|Period D||5
146884|NCT00784875|338368|P4|COMPLETED|Period D||87
146885|NCT00784875|338369|P3|COMPLETED|Period D||88
146886|NCT00784875|338370|P2|COMPLETED|Period D||85
146887|NCT00784875|338371|P1|COMPLETED|Period D||86
146888|NCT00784875|338368|P4|STARTED|Period D||88
146889|NCT00784875|338369|P3|STARTED|Period D||94
146890|NCT00784875|338370|P2|STARTED|Period D||89
146891|NCT00784875|338371|P1|STARTED|Period D||91
146892|NCT00784875|338368|P4|NOT COMPLETED|Period C||7
146893|NCT00784875|338369|P3|NOT COMPLETED|Period C||13
146894|NCT00784875|338370|P2|NOT COMPLETED|Period C||6
146895|NCT00784875|338371|P1|NOT COMPLETED|Period C||7
146896|NCT00784875|338368|P4|COMPLETED|Period C||91
146897|NCT00784875|338369|P3|COMPLETED|Period C||84
146898|NCT00784875|338370|P2|COMPLETED|Period C||91
146900|NCT00784875|338368|P4|STARTED|Period C||98
146901|NCT00784875|338369|P3|STARTED|Period C||97
146902|NCT00784875|338370|P2|STARTED|Period C||97
146903|NCT00784875|338371|P1|STARTED|Period C||103
146904|NCT00784875|338368|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
146905|NCT00784875|338369|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
146906|NCT00784875|338370|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
146907|NCT00784875|338371|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
146908|NCT00784875|338368|P4|COMPLETED|Period B - Efficacy Endpoint||98
146909|NCT00784875|338369|P3|COMPLETED|Period B - Efficacy Endpoint||96
146910|NCT00784875|338370|P2|COMPLETED|Period B - Efficacy Endpoint||101
146911|NCT00784875|338371|P1|COMPLETED|Period B - Efficacy Endpoint||100
146912|NCT00784875|338368|P4|Cohort 2|Period B - Efficacy Endpoint||101
146913|NCT00784875|338369|P3|Cohort 2|Period B - Efficacy Endpoint||102
146914|NCT00784875|338370|P2|Cohort 2|Period B - Efficacy Endpoint||102
146915|NCT00784875|338371|P1|Cohort 2|Period B - Efficacy Endpoint||102
146916|NCT00784875|338368|P4|STARTED|Period B - Efficacy Endpoint||117
146917|NCT00784875|338369|P3|STARTED|Period B - Efficacy Endpoint||117
146918|NCT00784875|338370|P2|STARTED|Period B - Efficacy Endpoint||113
146919|NCT00784875|338371|P1|STARTED|Period B - Efficacy Endpoint||114
146920|NCT00784875|338368|P4|NOT COMPLETED|Period A - Baseline||182
146921|NCT00784875|338369|P3|NOT COMPLETED|Period A - Baseline||0
146922|NCT00784875|338370|P2|NOT COMPLETED|Period A - Baseline||0
146923|NCT00784875|338371|P1|NOT COMPLETED|Period A - Baseline||0
146924|NCT00784875|338368|P4|COMPLETED|Period A - Baseline||461
146925|NCT00784875|338369|P3|COMPLETED|Period A - Baseline||0
146926|NCT00784875|338370|P2|COMPLETED|Period A - Baseline||0
146927|NCT00784875|338371|P1|COMPLETED|Period A - Baseline||0
146928|NCT00784875|338368|P4|STARTED|Period A - Baseline||643
146929|NCT00784875|338369|P3|STARTED|Period A - Baseline||0
146930|NCT00784875|338370|P2|STARTED|Period A - Baseline||0
146931|NCT00784875|338371|P1|STARTED|Period A - Baseline||0
146932|NCT00784849|338485|P1|NOT COMPLETED|Overall Study||0
146933|NCT00784849|338485|P1|COMPLETED|Overall Study||62
146934|NCT00784849|338485|P1|STARTED|Overall Study||62
146935|NCT00784836|338491|P1|NOT COMPLETED|Overall Study||3
146936|NCT00784836|338491|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
146937|NCT00784836|338491|P1|STARTED|Overall Study||3
146938|NCT00784810|338498|P2|NOT COMPLETED|Overall Study||49
146939|NCT00784810|338499|P1|NOT COMPLETED|Overall Study||63
146940|NCT00784810|338498|P2|COMPLETED|Overall Study||74
146941|NCT00784810|338499|P1|COMPLETED|Overall Study||61
146942|NCT00784810|338498|P2|STARTED|Overall Study||123
146943|NCT00784810|338499|P1|STARTED|Overall Study||124
146944|NCT00784784|338509|P2|NOT COMPLETED|Overall Study||2
146945|NCT00784784|338510|P1|NOT COMPLETED|Overall Study||2
146946|NCT00784784|338509|P2|COMPLETED|Overall Study||40
146947|NCT00784784|338510|P1|COMPLETED|Overall Study||20
146948|NCT00784784|338509|P2|STARTED|Overall Study||42
146949|NCT00784784|338510|P1|STARTED|Overall Study||22
146950|NCT00784719|338525|P7|NOT COMPLETED|Overall Study||5
146951|NCT00784719|338526|P6|NOT COMPLETED|Overall Study||3
146952|NCT00784719|338527|P5|NOT COMPLETED|Overall Study||6
146953|NCT00784719|338528|P4|NOT COMPLETED|Overall Study||0
146954|NCT00784719|338529|P3|NOT COMPLETED|Overall Study||1
146955|NCT00784719|338530|P2|NOT COMPLETED|Overall Study||3
146956|NCT00784719|338531|P1|NOT COMPLETED|Overall Study||3
146957|NCT00784719|338525|P7|COMPLETED|Overall Study||42
146958|NCT00784719|338526|P6|COMPLETED|Overall Study||41
146959|NCT00784719|338527|P5|COMPLETED|Overall Study||42
146960|NCT00784719|338528|P4|COMPLETED|Overall Study||48
146961|NCT00784719|338529|P3|COMPLETED|Overall Study||46
146962|NCT00784719|338530|P2|COMPLETED|Overall Study||43
146963|NCT00784719|338531|P1|COMPLETED|Overall Study||44
146964|NCT00784719|338525|P7|STARTED|Overall Study||47
146965|NCT00784719|338526|P6|STARTED|Overall Study||44
146966|NCT00784719|338527|P5|STARTED|Overall Study||48
146967|NCT00784719|338528|P4|STARTED|Overall Study||48
146968|NCT00784719|338529|P3|STARTED|Overall Study||47
146969|NCT00784719|338530|P2|STARTED|Overall Study||46
146970|NCT00784719|338531|P1|STARTED|Overall Study||47
146971|NCT00784654|338701|P3|NOT COMPLETED|Randomized Withdrawal Period||63
146972|NCT00784654|338702|P2|NOT COMPLETED|Randomized Withdrawal Period||18
146973|NCT00784654|338703|P1|NOT COMPLETED|Randomized Withdrawal Period||0
146974|NCT00784654|338701|P3|COMPLETED|Randomized Withdrawal Period||16
146975|NCT00784654|338702|P2|COMPLETED|Randomized Withdrawal Period||60
146976|NCT00784654|338703|P1|COMPLETED|Randomized Withdrawal Period||0
146977|NCT00784654|338701|P3|STARTED|Randomized Withdrawal Period||79
146978|NCT00784654|338702|P2|STARTED|Randomized Withdrawal Period||78
146979|NCT00784654|338703|P1|STARTED|Randomized Withdrawal Period||0
146980|NCT00784654|338701|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
146981|NCT00784654|338702|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
146982|NCT00784654|338703|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
146983|NCT00784654|338701|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
146984|NCT00784654|338702|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
146985|NCT00784654|338703|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
146986|NCT00784654|338701|P3|STARTED|Open-Label Period (Non-Randomized)||0
146987|NCT00784654|338702|P2|STARTED|Open-Label Period (Non-Randomized)||0
146988|NCT00784654|338703|P1|STARTED|Open-Label Period (Non-Randomized)||276
146989|NCT00784563|338738|P3|NOT COMPLETED|Year 3||3
146990|NCT00784563|338739|P2|NOT COMPLETED|Year 3||0
146991|NCT00784563|338740|P1|NOT COMPLETED|Year 3||0
146992|NCT00784563|338738|P3|COMPLETED|Year 3||14
146993|NCT00784563|338739|P2|COMPLETED|Year 3||0
146994|NCT00784563|338740|P1|COMPLETED|Year 3||0
146995|NCT00784563|338738|P3|STARTED|Year 3||17
146996|NCT00784563|338739|P2|STARTED|Year 3||0
146997|NCT00784563|338740|P1|STARTED|Year 3||0
146998|NCT00784563|338738|P3|NOT COMPLETED|Years 1 & 2||0
146999|NCT00784563|338739|P2|NOT COMPLETED|Years 1 & 2||5
147000|NCT00784563|338740|P1|NOT COMPLETED|Years 1 & 2||3
147001|NCT00784563|338738|P3|COMPLETED|Years 1 & 2||0
147002|NCT00784563|338739|P2|COMPLETED|Years 1 & 2||17
147003|NCT00784563|338740|P1|COMPLETED|Years 1 & 2||18
147004|NCT00784563|338738|P3|STARTED|Years 1 & 2||0
147005|NCT00784563|338739|P2|STARTED|Years 1 & 2||22
147006|NCT00784563|338740|P1|STARTED|Years 1 & 2||21
147007|NCT00784550|338758|P2|NOT COMPLETED|Overall Study||42
147008|NCT00784550|338759|P1|NOT COMPLETED|Overall Study||36
147009|NCT00784550|338758|P2|COMPLETED|Overall Study||127
147010|NCT00784550|338759|P1|COMPLETED|Overall Study||137
147011|NCT00784550|338758|P2|STARTED|Overall Study||169
147012|NCT00784550|338759|P1|STARTED|Overall Study||173
147013|NCT00784459|338777|P2|NOT COMPLETED|Overall Study||2
147014|NCT00784459|338778|P1|NOT COMPLETED|Overall Study||0
147015|NCT00784459|338777|P2|COMPLETED|Overall Study||11
147016|NCT00784459|338778|P1|COMPLETED|Overall Study||11
147017|NCT00784459|338777|P2|STARTED|Overall Study||13
147018|NCT00784459|338778|P1|STARTED|Overall Study||11
147019|NCT00784368|338789|P3|NOT COMPLETED|Overall Study||11
147020|NCT00784368|338790|P2|NOT COMPLETED|Overall Study||11
147021|NCT00784368|338791|P1|NOT COMPLETED|Overall Study||8
147022|NCT00784368|338789|P3|COMPLETED|Overall Study||12
147023|NCT00784368|338790|P2|COMPLETED|Overall Study||5
147024|NCT00784368|338791|P1|COMPLETED|Overall Study||8
147025|NCT00784368|338789|P3|STARTED|Overall Study||23
147026|NCT00784368|338790|P2|STARTED|Overall Study||16
147027|NCT00784368|338791|P1|STARTED|Overall Study||16
147028|NCT00784277|338829|P7|NOT COMPLETED|ER Treatment||15
147029|NCT00784277|338830|P6|NOT COMPLETED|ER Treatment||24
147030|NCT00784277|338831|P5|NOT COMPLETED|ER Treatment||9
147031|NCT00784277|338832|P4|NOT COMPLETED|ER Treatment||0
147032|NCT00784277|338833|P3|NOT COMPLETED|ER Treatment||0
147033|NCT00784277|338834|P2|NOT COMPLETED|ER Treatment||0
147034|NCT00784277|338835|P1|NOT COMPLETED|ER Treatment||0
147035|NCT00784277|338829|P7|COMPLETED|ER Treatment||76
147036|NCT00784277|338830|P6|COMPLETED|ER Treatment||226
147037|NCT00784277|338831|P5|COMPLETED|ER Treatment||113
147038|NCT00784277|338832|P4|COMPLETED|ER Treatment||0
147039|NCT00784277|338833|P3|COMPLETED|ER Treatment||0
147040|NCT00784277|338834|P2|COMPLETED|ER Treatment||0
147041|NCT00784277|338835|P1|COMPLETED|ER Treatment||0
147042|NCT00784277|338829|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
147043|NCT00784277|338830|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
147044|NCT00784277|338831|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
147045|NCT00784277|338832|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
147046|NCT00784277|338833|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
147047|NCT00784277|338834|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
147048|NCT00784277|338835|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
147049|NCT00784277|338829|P7|NOT COMPLETED|IR Treatment||0
147050|NCT00784277|338830|P6|NOT COMPLETED|IR Treatment||0
147051|NCT00784277|338831|P5|NOT COMPLETED|IR Treatment||0
147052|NCT00784277|338832|P4|NOT COMPLETED|IR Treatment||43
147053|NCT00784277|338833|P3|NOT COMPLETED|IR Treatment||28
147054|NCT00784277|338834|P2|NOT COMPLETED|IR Treatment||17
147055|NCT00784277|338835|P1|NOT COMPLETED|IR Treatment||16
147056|NCT00784277|338829|P7|COMPLETED|IR Treatment||0
147057|NCT00784277|338830|P6|COMPLETED|IR Treatment||0
147058|NCT00784277|338831|P5|COMPLETED|IR Treatment||0
147059|NCT00784277|338832|P4|COMPLETED|IR Treatment||100
147060|NCT00784277|338833|P3|COMPLETED|IR Treatment||126
147061|NCT00784277|338834|P2|COMPLETED|IR Treatment||134
147062|NCT00784277|338835|P1|COMPLETED|IR Treatment||132
147063|NCT00784277|338829|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
147064|NCT00784277|338830|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
147065|NCT00784277|338831|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
147066|NCT00784277|338832|P4|STARTED|IR Treatment||143
147067|NCT00784277|338833|P3|STARTED|IR Treatment||154
147068|NCT00784277|338834|P2|STARTED|IR Treatment||151
147069|NCT00784277|338835|P1|STARTED|IR Treatment||148
147070|NCT00784238|338852|P1|NOT COMPLETED|Overall Study||119
147071|NCT00784238|338852|P1|COMPLETED|Overall Study||170
147072|NCT00784238|338852|P1|STARTED|Overall Study||289
147073|NCT00784147|338895|P2|NOT COMPLETED|Overall Study||9
147074|NCT00784147|338896|P1|NOT COMPLETED|Overall Study||8
147075|NCT00784147|338895|P2|COMPLETED|Overall Study||45
147076|NCT00784147|338896|P1|COMPLETED|Overall Study||51
147077|NCT00784147|338895|P2|STARTED|Overall Study||54
147078|NCT00784147|338896|P1|STARTED|Overall Study||59
147079|NCT00784095|338917|P3|NOT COMPLETED|Overall Study||1
147080|NCT00784095|338918|P2|NOT COMPLETED|Overall Study||1
147081|NCT00784095|338919|P1|NOT COMPLETED|Overall Study||0
147082|NCT00784095|338917|P3|COMPLETED|Overall Study||11
147083|NCT00784095|338918|P2|COMPLETED|Overall Study||11
147084|NCT00784095|338919|P1|COMPLETED|Overall Study||12
147085|NCT00784095|338917|P3|STARTED|Overall Study||12
147086|NCT00784095|338918|P2|STARTED|Overall Study||12
147087|NCT00784095|338919|P1|STARTED|Overall Study||12
147088|NCT00784030|338941|P2|NOT COMPLETED|Overall Study||0
147089|NCT00784030|338942|P1|NOT COMPLETED|Overall Study||0
147090|NCT00784030|338941|P2|COMPLETED|Overall Study||10
147091|NCT00784030|338942|P1|COMPLETED|Overall Study||13
147092|NCT00784030|338941|P2|STARTED|Overall Study||10
147093|NCT00784030|338942|P1|STARTED|Overall Study||13
147094|NCT00783965|338950|P2|NOT COMPLETED|Second Intervention (24 Months)||9
147095|NCT00783965|338951|P1|NOT COMPLETED|Second Intervention (24 Months)||0
147096|NCT00783965|338950|P2|COMPLETED|Second Intervention (24 Months)||16
147097|NCT00783965|338951|P1|COMPLETED|Second Intervention (24 Months)||2
147098|NCT00783965|338950|P2|STARTED|Second Intervention (24 Months)||25
147099|NCT00783965|338951|P1|STARTED|Second Intervention (24 Months)||2
147100|NCT00783965|338950|P2|NOT COMPLETED|First Intervention (12 Months)||4
147101|NCT00783965|338951|P1|NOT COMPLETED|First Intervention (12 Months)||3
147102|NCT00783965|338950|P2|COMPLETED|First Intervention (12 Months)||25
147103|NCT00783965|338951|P1|COMPLETED|First Intervention (12 Months)||2
147104|NCT00783965|338950|P2|STARTED|First Intervention (12 Months)||29
147105|NCT00783965|338951|P1|STARTED|First Intervention (12 Months)||5
147106|NCT00783835|338959|P1|NOT COMPLETED|Overall Study||10
147107|NCT00783835|338959|P1|COMPLETED|Overall Study||50
147108|NCT00783835|338959|P1|STARTED|Overall Study||60
147109|NCT00783796|338971|P1|NOT COMPLETED|Overall Study||6
147110|NCT00783796|338971|P1|COMPLETED|Overall Study||144
147111|NCT00783796|338971|P1|STARTED|Overall Study||150
147112|NCT00783718|339076|P7|NOT COMPLETED|Maintenance Phase||195
147113|NCT00783718|339077|P6|NOT COMPLETED|Maintenance Phase||41
147114|NCT00783718|339078|P5|NOT COMPLETED|Maintenance Phase||45
147115|NCT00783718|339079|P4|NOT COMPLETED|Maintenance Phase||78
147116|NCT00783718|339080|P3|NOT COMPLETED|Maintenance Phase||0
147117|NCT00783718|339081|P2|NOT COMPLETED|Maintenance Phase||0
147118|NCT00783718|339082|P1|NOT COMPLETED|Maintenance Phase||105
147119|NCT00783718|339076|P7|COMPLETED|Maintenance Phase||135
147120|NCT00783718|339077|P6|COMPLETED|Maintenance Phase||84
147121|NCT00783718|339078|P5|COMPLETED|Maintenance Phase||77
147122|NCT00783718|339079|P4|COMPLETED|Maintenance Phase||48
147123|NCT00783718|339080|P3|COMPLETED|Maintenance Phase||0
147124|NCT00783718|339081|P2|COMPLETED|Maintenance Phase||0
147125|NCT00783718|339082|P1|COMPLETED|Maintenance Phase||30
147126|NCT00783718|339076|P7|STARTED|Maintenance Phase||330
147127|NCT00783718|339077|P6|STARTED|Maintenance Phase||125
147128|NCT00783718|339078|P5|STARTED|Maintenance Phase||122
147129|NCT00783718|339079|P4|STARTED|Maintenance Phase||126
147130|NCT00783718|339080|P3|STARTED|Maintenance Phase||0
147131|NCT00783718|339081|P2|STARTED|Maintenance Phase||0
147132|NCT00783718|339082|P1|STARTED|Maintenance Phase||135
147133|NCT00783718|339076|P7|NOT COMPLETED|Induction Phase||0
147134|NCT00783718|339077|P6|NOT COMPLETED|Induction Phase||0
147135|NCT00783718|339078|P5|NOT COMPLETED|Induction Phase||0
147136|NCT00783718|339079|P4|NOT COMPLETED|Induction Phase||0
147137|NCT00783718|339080|P3|NOT COMPLETED|Induction Phase||36
147138|NCT00783718|339081|P2|NOT COMPLETED|Induction Phase||7
147139|NCT00783718|339082|P1|NOT COMPLETED|Induction Phase||14
147140|NCT00783718|339076|P7|COMPLETED|Induction Phase||0
147141|NCT00783718|339077|P6|COMPLETED|Induction Phase||0
147142|NCT00783718|339078|P5|COMPLETED|Induction Phase||0
147143|NCT00783718|339079|P4|COMPLETED|Induction Phase||0
147144|NCT00783718|339080|P3|COMPLETED|Induction Phase||485
147145|NCT00783718|339081|P2|COMPLETED|Induction Phase||218
147146|NCT00783718|339082|P1|COMPLETED|Induction Phase||135
147147|NCT00783718|339076|P7|STARTED|Induction Phase||0
147148|NCT00783718|339077|P6|STARTED|Induction Phase||0
147149|NCT00783718|339078|P5|STARTED|Induction Phase||0
147150|NCT00783718|339079|P4|STARTED|Induction Phase||0
147151|NCT00783718|339080|P3|STARTED|Induction Phase||521
147152|NCT00783718|339081|P2|STARTED|Induction Phase||225
147153|NCT00783718|339082|P1|STARTED|Induction Phase||149
147154|NCT00783705|339110|P2|NOT COMPLETED|Overall Study||5
147155|NCT00783705|339111|P1|NOT COMPLETED|Overall Study||6
147156|NCT00783705|339110|P2|COMPLETED|Overall Study||36
147157|NCT00783705|339111|P1|COMPLETED|Overall Study||38
147158|NCT00783705|339110|P2|STARTED|Overall Study||41
147159|NCT00783705|339111|P1|STARTED|Overall Study||44
147160|NCT00783692|339156|P7|NOT COMPLETED|Maintenance Phase||249
147161|NCT00783692|339157|P6|NOT COMPLETED|Maintenance Phase||72
147162|NCT00783692|339158|P5|NOT COMPLETED|Maintenance Phase||81
147163|NCT00783692|339159|P4|NOT COMPLETED|Maintenance Phase||89
147164|NCT00783692|339160|P3|NOT COMPLETED|Maintenance Phase||0
147165|NCT00783692|339161|P2|NOT COMPLETED|Maintenance Phase||0
147166|NCT00783692|339162|P1|NOT COMPLETED|Maintenance Phase||95
147167|NCT00783692|339156|P7|COMPLETED|Maintenance Phase||163
147168|NCT00783692|339157|P6|COMPLETED|Maintenance Phase||82
147169|NCT00783692|339158|P5|COMPLETED|Maintenance Phase||73
147170|NCT00783692|339159|P4|COMPLETED|Maintenance Phase||64
147171|NCT00783692|339160|P3|COMPLETED|Maintenance Phase||0
147172|NCT00783692|339161|P2|COMPLETED|Maintenance Phase||0
147173|NCT00783692|339162|P1|COMPLETED|Maintenance Phase||42
147174|NCT00783692|339156|P7|STARTED|Maintenance Phase||412
147175|NCT00783692|339157|P6|STARTED|Maintenance Phase||154
147176|NCT00783692|339158|P5|STARTED|Maintenance Phase||154
147177|NCT00783692|339159|P4|STARTED|Maintenance Phase||153
147178|NCT00783692|339160|P3|STARTED|Maintenance Phase||0
147179|NCT00783692|339161|P2|STARTED|Maintenance Phase||0
147180|NCT00783692|339162|P1|STARTED|Maintenance Phase||137
147181|NCT00783692|339156|P7|NOT COMPLETED|Induction Phase||0
147182|NCT00783692|339157|P6|NOT COMPLETED|Induction Phase||0
147183|NCT00783692|339158|P5|NOT COMPLETED|Induction Phase||0
147184|NCT00783692|339159|P4|NOT COMPLETED|Induction Phase||0
147185|NCT00783692|339160|P3|NOT COMPLETED|Induction Phase||74
147186|NCT00783692|339161|P2|NOT COMPLETED|Induction Phase||21
147187|NCT00783692|339162|P1|NOT COMPLETED|Induction Phase||11
147188|NCT00783692|339156|P7|COMPLETED|Induction Phase||0
147189|NCT00783692|339157|P6|COMPLETED|Induction Phase||0
147190|NCT00783692|339158|P5|COMPLETED|Induction Phase||0
147191|NCT00783692|339159|P4|COMPLETED|Induction Phase||0
147192|NCT00783692|339160|P3|COMPLETED|Induction Phase||674
147193|NCT00783692|339161|P2|COMPLETED|Induction Phase||199
147194|NCT00783692|339162|P1|COMPLETED|Induction Phase||137
147195|NCT00783692|339156|P7|Treated|Induction Phase||0
147196|NCT00783692|339157|P6|Treated|Induction Phase||0
147197|NCT00783692|339158|P5|Treated|Induction Phase||0
147198|NCT00783692|339159|P4|Treated|Induction Phase||0
147199|NCT00783692|339160|P3|Treated|Induction Phase||747
147200|NCT00783692|339161|P2|Treated|Induction Phase||220
147201|NCT00783692|339162|P1|Treated|Induction Phase||148
147202|NCT00783692|339156|P7|STARTED|Induction Phase||0
147203|NCT00783692|339157|P6|STARTED|Induction Phase||0
147204|NCT00783692|339158|P5|STARTED|Induction Phase||0
147205|NCT00783692|339159|P4|STARTED|Induction Phase||0
147206|NCT00783692|339160|P3|STARTED|Induction Phase||748
147207|NCT00783692|339161|P2|STARTED|Induction Phase||220
147208|NCT00783692|339162|P1|STARTED|Induction Phase||148
147209|NCT00783614|339189|P4|NOT COMPLETED|Overall Study||0
147210|NCT00783614|339190|P3|NOT COMPLETED|Overall Study||0
147211|NCT00783614|339191|P2|NOT COMPLETED|Overall Study||0
147212|NCT00783614|339192|P1|NOT COMPLETED|Overall Study||0
147213|NCT00783614|339189|P4|COMPLETED|Overall Study||5
147214|NCT00783614|339190|P3|COMPLETED|Overall Study||5
147215|NCT00783614|339191|P2|COMPLETED|Overall Study||6
147216|NCT00783614|339192|P1|COMPLETED|Overall Study||6
147217|NCT00783614|339189|P4|STARTED|Overall Study||5
147218|NCT00783614|339190|P3|STARTED|Overall Study||5
147219|NCT00783614|339191|P2|STARTED|Overall Study||6
147220|NCT00783614|339192|P1|STARTED|Overall Study||6
147221|NCT00783432|339204|P2|NOT COMPLETED|Overall Study||78
147222|NCT00783432|339205|P1|NOT COMPLETED|Overall Study||85
147223|NCT00783432|339204|P2|COMPLETED|Overall Study||354
147224|NCT00783432|339205|P1|COMPLETED|Overall Study||345
147225|NCT00783432|339204|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
147226|NCT00783432|339205|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
147227|NCT00783302|339215|P1|NOT COMPLETED|Overall Study||35
147228|NCT00783302|339215|P1|COMPLETED|Overall Study||850
147229|NCT00783302|339215|P1|STARTED|Overall Study||885
147230|NCT00783263|339237|P4|NOT COMPLETED|Overall Study||3
147231|NCT00783263|339238|P3|NOT COMPLETED|Overall Study||3
147232|NCT00783263|339239|P2|NOT COMPLETED|Overall Study||2
147233|NCT00783263|339240|P1|NOT COMPLETED|Overall Study||4
147234|NCT00783263|339237|P4|COMPLETED|Overall Study||118
147235|NCT00783263|339238|P3|COMPLETED|Overall Study||119
147236|NCT00783263|339239|P2|COMPLETED|Overall Study||96
147237|NCT00783263|339240|P1|COMPLETED|Overall Study||95
147238|NCT00783263|339237|P4|STARTED|Overall Study||121
147239|NCT00783263|339238|P3|STARTED|Overall Study||122
147240|NCT00783263|339239|P2|STARTED|Overall Study||98
147241|NCT00783263|339240|P1|STARTED|Overall Study||99
147242|NCT00783224|339270|P4|NOT COMPLETED|Overall Study||2
147243|NCT00783224|339271|P3|NOT COMPLETED|Overall Study||1
147244|NCT00783224|339272|P2|NOT COMPLETED|Overall Study||0
147245|NCT00783224|339273|P1|NOT COMPLETED|Overall Study||0
147246|NCT00783224|339270|P4|COMPLETED|Overall Study||140
147247|NCT00783224|339271|P3|COMPLETED|Overall Study||142
147248|NCT00783224|339272|P2|COMPLETED|Overall Study||34
147249|NCT00783224|339273|P1|COMPLETED|Overall Study||32
147250|NCT00783224|339270|P4|STARTED|Overall Study||142
147251|NCT00783224|339271|P3|STARTED|Overall Study||143
147252|NCT00783224|339272|P2|STARTED|Overall Study||34
147253|NCT00783224|339273|P1|STARTED|Overall Study||32
147254|NCT00783198|339285|P3|NOT COMPLETED|Overall Study||42
147255|NCT00783198|339286|P2|NOT COMPLETED|Overall Study||43
147256|NCT00783198|339287|P1|NOT COMPLETED|Overall Study||57
147257|NCT00783198|339285|P3|COMPLETED|Overall Study||146
147258|NCT00783198|339286|P2|COMPLETED|Overall Study||144
147259|NCT00783198|339287|P1|COMPLETED|Overall Study||133
147260|NCT00783198|339285|P3|STARTED|Overall Study||188
147261|NCT00783198|339286|P2|STARTED|Overall Study||187
147262|NCT00783198|339287|P1|STARTED|Overall Study||190
147263|NCT00783094|339310|P3|NOT COMPLETED|Open-Label Extension Period||30
147264|NCT00783094|339311|P2|NOT COMPLETED|Open-Label Extension Period||19
147265|NCT00783094|339312|P1|NOT COMPLETED|Open-Label Extension Period||22
147266|NCT00783094|339310|P3|COMPLETED|Open-Label Extension Period||101
147267|NCT00783094|339311|P2|COMPLETED|Open-Label Extension Period||109
147268|NCT00783094|339312|P1|COMPLETED|Open-Label Extension Period||113
147269|NCT00783094|339310|P3|STARTED|Open-Label Extension Period||131
147270|NCT00783094|339311|P2|STARTED|Open-Label Extension Period||128
147271|NCT00783094|339312|P1|STARTED|Open-Label Extension Period||135
147272|NCT00783094|339310|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
147273|NCT00783094|339311|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
147274|NCT00783094|339312|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
147275|NCT00783094|339310|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
147276|NCT00783094|339311|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
147277|NCT00783094|339312|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
147278|NCT00783094|339310|P3|STARTED|Randomized Double-Blind Treatment Period||140
147279|NCT00783094|339311|P2|STARTED|Randomized Double-Blind Treatment Period||140
147280|NCT00783094|339312|P1|STARTED|Randomized Double-Blind Treatment Period||142
147281|NCT00782834|339388|P1|NOT COMPLETED|Treatment Phase||1
147282|NCT00782834|339388|P1|COMPLETED|Treatment Phase||13
147283|NCT00782834|339388|P1|STARTED|Treatment Phase||14
147284|NCT00782834|339388|P1|NOT COMPLETED|Screened Patients||1
147285|NCT00782834|339388|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
147286|NCT00782834|339388|P1|STARTED|Screened Patients||15
147287|NCT00782821|339397|P4|NOT COMPLETED|Overall Study||2
147288|NCT00782821|339398|P3|NOT COMPLETED|Overall Study||1
147289|NCT00782821|339399|P2|NOT COMPLETED|Overall Study||0
147290|NCT00782821|339400|P1|NOT COMPLETED|Overall Study||0
147291|NCT00782821|339397|P4|COMPLETED|Overall Study||8
147292|NCT00782821|339398|P3|COMPLETED|Overall Study||9
147293|NCT00782821|339399|P2|COMPLETED|Overall Study||10
147294|NCT00782821|339400|P1|COMPLETED|Overall Study||10
147295|NCT00782821|339397|P4|STARTED|Overall Study||10
147296|NCT00782821|339398|P3|STARTED|Overall Study||10
147297|NCT00782821|339399|P2|STARTED|Overall Study||10
147298|NCT00782821|339400|P1|STARTED|Overall Study||10
147299|NCT00782717|339428|P2|NOT COMPLETED|Overall Study||28
147300|NCT00782717|339429|P1|NOT COMPLETED|Overall Study||15
147301|NCT00782717|339428|P2|COMPLETED|Overall Study||102
147302|NCT00782717|339429|P1|COMPLETED|Overall Study||118
147303|NCT00782717|339428|P2|STARTED|Overall Study||130
147304|NCT00782717|339429|P1|STARTED|Overall Study||133
147305|NCT00782639|339439|P2|NOT COMPLETED|Overall Study||0
147306|NCT00782639|339440|P1|NOT COMPLETED|Overall Study||0
147307|NCT00782639|339439|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
147308|NCT00782639|339440|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
147309|NCT00782639|339439|P2|STARTED|Overall Study||11
147310|NCT00782639|339440|P1|STARTED|Overall Study||12
147311|NCT00782626|339456|P1|NOT COMPLETED|Overall Study||7
147312|NCT00782626|339456|P1|COMPLETED|Overall Study||16
147313|NCT00782626|339456|P1|STARTED|Overall Study||23
147314|NCT00782509|339463|P3|NOT COMPLETED|Overall Study||36
147315|NCT00782509|339464|P2|NOT COMPLETED|Overall Study||24
147316|NCT00782509|339465|P1|NOT COMPLETED|Overall Study||41
147317|NCT00782509|339463|P3|COMPLETED|Overall Study||181
147318|NCT00782509|339464|P2|COMPLETED|Overall Study||185
147319|NCT00782509|339465|P1|COMPLETED|Overall Study||175
147320|NCT00782509|339463|P3|STARTED|Overall Study||217
147321|NCT00782509|339464|P2|STARTED|Overall Study||209
147322|NCT00782509|339465|P1|STARTED|Overall Study||216
147323|NCT00782496|339658|P2|NOT COMPLETED|Overall Study||15
147324|NCT00782496|339659|P1|NOT COMPLETED|Overall Study||14
147325|NCT00782496|339658|P2|COMPLETED|Overall Study||90
147326|NCT00782496|339659|P1|COMPLETED|Overall Study||92
147327|NCT00782496|339658|P2|STARTED|Overall Study||105
147328|NCT00782496|339659|P1|STARTED|Overall Study||106
147329|NCT00782483|339666|P1|NOT COMPLETED|Overall Study||6
147330|NCT00782483|339666|P1|COMPLETED|Overall Study||0
147331|NCT00782483|339666|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
147332|NCT00782418|339670|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147333|NCT00782418|339671|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147334|NCT00782418|339672|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147335|NCT00782418|339673|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147336|NCT00782418|339674|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147337|NCT00782418|339675|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147338|NCT00782418|339676|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
147339|NCT00782418|339670|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
147340|NCT00782418|339671|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
147341|NCT00782418|339672|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
147342|NCT00782418|339673|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
147343|NCT00782418|339674|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
147344|NCT00782418|339675|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
147345|NCT00782418|339676|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
147346|NCT00782418|339670|P7|STARTED|Period 2 Procedure/Treatment Groups||4
147347|NCT00782418|339671|P6|STARTED|Period 2 Procedure/Treatment Groups||4
147348|NCT00782418|339672|P5|STARTED|Period 2 Procedure/Treatment Groups||3
147349|NCT00782418|339673|P4|STARTED|Period 2 Procedure/Treatment Groups||1
147350|NCT00782418|339674|P3|STARTED|Period 2 Procedure/Treatment Groups||4
147351|NCT00782418|339675|P2|STARTED|Period 2 Procedure/Treatment Groups||4
147352|NCT00782418|339676|P1|STARTED|Period 2 Procedure/Treatment Groups||3
147353|NCT00782418|339670|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
147354|NCT00782418|339671|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
147355|NCT00782418|339672|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
147356|NCT00782418|339673|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
147357|NCT00782418|339674|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
147358|NCT00782418|339675|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
147359|NCT00782418|339676|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
147360|NCT00782418|339670|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
147361|NCT00782418|339671|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
147362|NCT00782418|339672|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
147363|NCT00782418|339673|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
147364|NCT00782418|339674|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
147365|NCT00782418|339675|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
147366|NCT00782418|339676|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
147367|NCT00782418|339670|P7|STARTED|Period 1 Procedure/Treatment Groups||4
147368|NCT00782418|339671|P6|STARTED|Period 1 Procedure/Treatment Groups||5
147369|NCT00782418|339672|P5|STARTED|Period 1 Procedure/Treatment Groups||5
147370|NCT00782418|339673|P4|STARTED|Period 1 Procedure/Treatment Groups||2
147371|NCT00782418|339674|P3|STARTED|Period 1 Procedure/Treatment Groups||4
147372|NCT00782418|339675|P2|STARTED|Period 1 Procedure/Treatment Groups||4
147373|NCT00782418|339676|P1|STARTED|Period 1 Procedure/Treatment Groups||3
147374|NCT00782379|339696|P1|NOT COMPLETED|Overall Study||0
147375|NCT00782379|339696|P1|COMPLETED|Overall Study||20
147376|NCT00782379|339696|P1|STARTED|Overall Study||20
147377|NCT00782340|339713|P3|NOT COMPLETED|Randomized Double Blind||0
147378|NCT00782340|339714|P2|NOT COMPLETED|Randomized Double Blind||0
147379|NCT00782340|339715|P1|NOT COMPLETED|Randomized Double Blind||0
147380|NCT00782340|339713|P3|COMPLETED|Randomized Double Blind||80
147381|NCT00782340|339714|P2|COMPLETED|Randomized Double Blind||82
147382|NCT00782340|339715|P1|COMPLETED|Randomized Double Blind||0
147383|NCT00782340|339713|P3|STARTED|Randomized Double Blind||80
147384|NCT00782340|339714|P2|STARTED|Randomized Double Blind||82
147385|NCT00782340|339715|P1|STARTED|Randomized Double Blind||0
147386|NCT00782340|339713|P3|NOT COMPLETED|Open Label Titration||0
147387|NCT00782340|339714|P2|NOT COMPLETED|Open Label Titration||0
147388|NCT00782340|339715|P1|NOT COMPLETED|Open Label Titration||101
147389|NCT00782340|339713|P3|COMPLETED|Open Label Titration||0
147390|NCT00782340|339714|P2|COMPLETED|Open Label Titration||0
147391|NCT00782340|339715|P1|COMPLETED|Open Label Titration||162
147392|NCT00782340|339713|P3|STARTED|Open Label Titration||0
147393|NCT00782340|339714|P2|STARTED|Open Label Titration||0
147394|NCT00782340|339715|P1|STARTED|Open Label Titration||263
147395|NCT00782288|339741|P3|NOT COMPLETED|Overall Study||0
147396|NCT00782288|339742|P2|NOT COMPLETED|Overall Study||0
147397|NCT00782288|339743|P1|NOT COMPLETED|Overall Study||0
147398|NCT00782288|339741|P3|COMPLETED|Overall Study||8
147399|NCT00782288|339742|P2|COMPLETED|Overall Study||8
147400|NCT00782288|339743|P1|COMPLETED|Overall Study||8
147401|NCT00782288|339741|P3|STARTED|Overall Study||8
147402|NCT00782288|339742|P2|STARTED|Overall Study||8
147403|NCT00782288|339743|P1|STARTED|Overall Study||8
147404|NCT00782210|339788|P3|NOT COMPLETED|Overall Study||35
147405|NCT00782210|339789|P2|NOT COMPLETED|Overall Study||35
147406|NCT00782210|339790|P1|NOT COMPLETED|Overall Study||50
147407|NCT00782210|339788|P3|COMPLETED|Overall Study||172
147408|NCT00782210|339789|P2|COMPLETED|Overall Study||173
147409|NCT00782210|339790|P1|COMPLETED|Overall Study||159
147410|NCT00782210|339788|P3|STARTED|Overall Study||207
147411|NCT00782210|339789|P2|STARTED|Overall Study||208
147412|NCT00782210|339790|P1|STARTED|Overall Study||209
147413|NCT00782184|339983|P2|NOT COMPLETED|Overall Study||5
147414|NCT00782184|339984|P1|NOT COMPLETED|Overall Study||4
147415|NCT00782184|339983|P2|COMPLETED|Overall Study||125
147416|NCT00782184|339984|P1|COMPLETED|Overall Study||116
147417|NCT00782184|339983|P2|STARTED|Overall Study||130
147418|NCT00782184|339984|P1|STARTED|Overall Study||120
147419|NCT00781963|340022|P3|NOT COMPLETED|Overall Study||2
147420|NCT00781963|340023|P2|NOT COMPLETED|Overall Study||9
147421|NCT00781963|340024|P1|NOT COMPLETED|Overall Study||8
147422|NCT00781963|340022|P3|COMPLETED|Overall Study||51
147423|NCT00781963|340023|P2|COMPLETED|Overall Study||43
147424|NCT00781963|340024|P1|COMPLETED|Overall Study||46
147425|NCT00781963|340022|P3|6-month Follow-up|Overall Study||52
147426|NCT00781963|340023|P2|6-month Follow-up|Overall Study||44
147427|NCT00781963|340024|P1|6-month Follow-up|Overall Study||48
147428|NCT00781963|340022|P3|Post-treatment|Overall Study||53
147429|NCT00781963|340023|P2|Post-treatment|Overall Study||45
147430|NCT00781963|340024|P1|Post-treatment|Overall Study||52
147431|NCT00781963|340022|P3|STARTED|Overall Study||53
147432|NCT00781963|340023|P2|STARTED|Overall Study||52
147433|NCT00781963|340024|P1|STARTED|Overall Study||54
147434|NCT00781950|340034|P2|NOT COMPLETED|Overall Study||13
147435|NCT00781950|340035|P1|NOT COMPLETED|Overall Study||11
147436|NCT00781950|340034|P2|COMPLETED|Overall Study||45
147437|NCT00781950|340035|P1|COMPLETED|Overall Study||41
147438|NCT00781950|340034|P2|STARTED|Overall Study||58
147439|NCT00781950|340035|P1|STARTED|Overall Study||52
147440|NCT00781937|340045|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
147441|NCT00781937|340046|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
147442|NCT00781937|340045|P2|COMPLETED|Follow up Period (Week 56-68)||141
147443|NCT00781937|340046|P1|COMPLETED|Follow up Period (Week 56-68)||153
147444|NCT00781937|340045|P2|STARTED|Follow up Period (Week 56-68)||146
147445|NCT00781937|340046|P1|STARTED|Follow up Period (Week 56-68)||159
147446|NCT00781937|340045|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
147447|NCT00781937|340046|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
147448|NCT00781937|340045|P2|COMPLETED|Main Trial Period Through Week 56||146
147449|NCT00781937|340046|P1|COMPLETED|Main Trial Period Through Week 56||159
147450|NCT00781937|340045|P2|STARTED|Main Trial Period Through Week 56||210
147451|NCT00781937|340046|P1|STARTED|Main Trial Period Through Week 56||212
147452|NCT00781859|340104|P2|NOT COMPLETED|Overall Study||9
147453|NCT00781859|340105|P1|NOT COMPLETED|Overall Study||19
147454|NCT00781859|340104|P2|COMPLETED|Overall Study||98
147455|NCT00781859|340105|P1|COMPLETED|Overall Study||200
147456|NCT00781859|340104|P2|STARTED|Overall Study||107
147457|NCT00781859|340105|P1|STARTED|Overall Study||219
147458|NCT00781599|340115|P2|NOT COMPLETED|Overall Study||4
147459|NCT00781599|340116|P1|NOT COMPLETED|Overall Study||7
147460|NCT00781599|340115|P2|COMPLETED|Overall Study||32
147461|NCT00781599|340116|P1|COMPLETED|Overall Study||29
147462|NCT00781599|340115|P2|STARTED|Overall Study||36
147463|NCT00781599|340116|P1|STARTED|Overall Study||36
147464|NCT00781508|340130|P2|NOT COMPLETED|Overall Study||0
147465|NCT00781508|340131|P1|NOT COMPLETED|Overall Study||0
147466|NCT00781508|340130|P2|COMPLETED|Overall Study||5
147467|NCT00781508|340131|P1|COMPLETED|Overall Study||5
147468|NCT00781508|340130|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
147469|NCT00781508|340131|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
147470|NCT00781456|340141|P2|NOT COMPLETED|Overall Study||16
147471|NCT00781456|340142|P1|NOT COMPLETED|Overall Study||21
147472|NCT00781456|340141|P2|COMPLETED|Overall Study||35
147473|NCT00781456|340142|P1|COMPLETED|Overall Study||37
147474|NCT00781456|340141|P2|Received Study Drug|Overall Study||49
147475|NCT00781456|340142|P1|Received Study Drug|Overall Study||57
147476|NCT00781456|340141|P2|STARTED|Overall Study||51
147477|NCT00781456|340142|P1|STARTED|Overall Study||58
147478|NCT00781391|340165|P3|NOT COMPLETED|Overall Study||784
147479|NCT00781391|340166|P2|NOT COMPLETED|Overall Study||807
147480|NCT00781391|340167|P1|NOT COMPLETED|Overall Study||879
147481|NCT00781391|340165|P3|COMPLETED|Overall Study||6250
147482|NCT00781391|340166|P2|COMPLETED|Overall Study||6228
147483|NCT00781391|340167|P1|COMPLETED|Overall Study||6157
147484|NCT00781391|340165|P3|Per Protocol Analysis Set|Overall Study||6982
147485|NCT00781391|340166|P2|Per Protocol Analysis Set|Overall Study||6995
147486|NCT00781391|340167|P1|Per Protocol Analysis Set|Overall Study||6993
147487|NCT00781391|340165|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
147488|NCT00781391|340166|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
147489|NCT00781391|340167|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
147490|NCT00781391|340165|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
147491|NCT00781391|340166|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
147492|NCT00781391|340167|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
147493|NCT00781391|340165|P3|STARTED|Overall Study||7034
147494|NCT00781391|340166|P2|STARTED|Overall Study||7035
147495|NCT00781391|340167|P1|STARTED|Overall Study||7036
147496|NCT00781365|340201|P2|NOT COMPLETED|Overall Study||40
147497|NCT00781365|340202|P1|NOT COMPLETED|Overall Study||40
147498|NCT00781365|340201|P2|COMPLETED|Overall Study||182
147499|NCT00781365|340202|P1|COMPLETED|Overall Study||188
147500|NCT00781365|340201|P2|STARTED|Overall Study||222
147501|NCT00781365|340202|P1|STARTED|Overall Study||228
147502|NCT00781326|340212|P1|NOT COMPLETED|Phase 2||0
147503|NCT00781326|340212|P1|COMPLETED|Phase 2||0
147504|NCT00781326|340212|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
147505|NCT00781326|340212|P1|NOT COMPLETED|Phase I||4
147506|NCT00781326|340212|P1|COMPLETED|Phase I||2
147507|NCT00781326|340212|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
147508|NCT00781274|340216|P1|NOT COMPLETED|Overall Study||2
147509|NCT00781274|340216|P1|COMPLETED|Overall Study||30
147510|NCT00781274|340216|P1|STARTED|Overall Study||32
147511|NCT00781079|340222|P2|NOT COMPLETED|Overall Study||17
147512|NCT00781079|340223|P1|NOT COMPLETED|Overall Study||27
147513|NCT00781079|340222|P2|COMPLETED|Overall Study||116
147514|NCT00781079|340223|P1|COMPLETED|Overall Study||122
147515|NCT00781079|340222|P2|STARTED|Overall Study||133
147516|NCT00781079|340223|P1|STARTED|Overall Study||149
147517|NCT00780910|340231|P1|NOT COMPLETED|Overall Study||2
147518|NCT00780910|340231|P1|COMPLETED|Overall Study||107
147519|NCT00780910|340231|P1|STARTED|Overall Study||109
147520|NCT00780741|340237|P2|NOT COMPLETED|Overall Study||10
147521|NCT00780741|340238|P1|NOT COMPLETED|Overall Study||7
147522|NCT00780741|340237|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
147523|NCT00780741|340238|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
147524|NCT00780741|340237|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
147525|NCT00780741|340238|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
147526|NCT00780741|340237|P2|STARTED|Overall Study|randomized|81
147527|NCT00780741|340238|P1|STARTED|Overall Study|randomized|82
147528|NCT00780676|340255|P5|NOT COMPLETED|Overall Study||0
147529|NCT00780676|340256|P4|NOT COMPLETED|Overall Study||0
147530|NCT00780676|340257|P3|NOT COMPLETED|Overall Study||0
147531|NCT00780676|340258|P2|NOT COMPLETED|Overall Study||0
147532|NCT00780676|340259|P1|NOT COMPLETED|Overall Study||0
147533|NCT00780676|340255|P5|COMPLETED|Overall Study||0
147534|NCT00780676|340256|P4|COMPLETED|Overall Study||0
147535|NCT00780676|340257|P3|COMPLETED|Overall Study||13
147536|NCT00780676|340258|P2|COMPLETED|Overall Study||8
147537|NCT00780676|340259|P1|COMPLETED|Overall Study||9
147538|NCT00780676|340255|P5|STARTED|Overall Study||0
147539|NCT00780676|340256|P4|STARTED|Overall Study||0
147540|NCT00780676|340257|P3|STARTED|Overall Study||13
147541|NCT00780676|340258|P2|STARTED|Overall Study||8
147542|NCT00780676|340259|P1|STARTED|Overall Study||9
147543|NCT00780572|340267|P2|NOT COMPLETED|Overall Study||0
147544|NCT00780572|340268|P1|NOT COMPLETED|Overall Study||0
147545|NCT00780572|340267|P2|COMPLETED|Overall Study||298
147546|NCT00780572|340268|P1|COMPLETED|Overall Study||297
147547|NCT00780572|340267|P2|STARTED|Overall Study||298
147548|NCT00780572|340268|P1|STARTED|Overall Study||297
147549|NCT00780455|340276|P2|NOT COMPLETED|Overall Study||0
147550|NCT00780455|340277|P1|NOT COMPLETED|Overall Study||0
147551|NCT00780455|340276|P2|COMPLETED|Overall Study||2
147552|NCT00780455|340277|P1|COMPLETED|Overall Study||2
147553|NCT00780455|340276|P2|STARTED|Overall Study||2
147554|NCT00780455|340277|P1|STARTED|Overall Study||2
147555|NCT00780416|340303|P2|NOT COMPLETED|Overall Study||9
147556|NCT00780416|340304|P1|NOT COMPLETED|Overall Study||12
147557|NCT00780416|340303|P2|COMPLETED|Overall Study||54
147558|NCT00780416|340304|P1|COMPLETED|Overall Study||114
147559|NCT00780416|340303|P2|STARTED|Overall Study||63
147560|NCT00780416|340304|P1|STARTED|Overall Study||126
147561|NCT00780403|340310|P2|NOT COMPLETED|Second Intervention||0
147562|NCT00780403|340311|P1|NOT COMPLETED|Second Intervention||0
147563|NCT00780403|340310|P2|COMPLETED|Second Intervention||111
147564|NCT00780403|340311|P1|COMPLETED|Second Intervention||109
147565|NCT00780403|340310|P2|STARTED|Second Intervention||111
147566|NCT00780403|340311|P1|STARTED|Second Intervention||109
147567|NCT00780403|340310|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
147568|NCT00780403|340311|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
147569|NCT00780403|340310|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
147570|NCT00780403|340311|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
147571|NCT00780403|340310|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
147572|NCT00780403|340311|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
147573|NCT00780403|340310|P2|NOT COMPLETED|First Intervention||0
147574|NCT00780403|340311|P1|NOT COMPLETED|First Intervention||0
147575|NCT00780403|340310|P2|COMPLETED|First Intervention||111
147576|NCT00780403|340311|P1|COMPLETED|First Intervention||109
147577|NCT00780403|340310|P2|STARTED|First Intervention||111
147578|NCT00780403|340311|P1|STARTED|First Intervention||109
147579|NCT00780338|340320|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
147580|NCT00780338|340321|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
147581|NCT00780338|340320|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
147582|NCT00780338|340321|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
147583|NCT00780338|340320|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
147584|NCT00780338|340321|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
147585|NCT00780338|340320|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
147586|NCT00780338|340321|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
147587|NCT00780338|340320|P2|COMPLETED|Baseline to Mid (1 Year)||164
147588|NCT00780338|340321|P1|COMPLETED|Baseline to Mid (1 Year)||169
147589|NCT00780338|340320|P2|STARTED|Baseline to Mid (1 Year)||202
147590|NCT00780338|340321|P1|STARTED|Baseline to Mid (1 Year)||174
147591|NCT00780273|340349|P1|NOT COMPLETED|Overall Study||2
147592|NCT00780273|340349|P1|COMPLETED|Overall Study||17
147593|NCT00780273|340349|P1|STARTED|Overall Study||19
147594|NCT00779246|340360|P2|NOT COMPLETED|Overall Study||53
147595|NCT00779246|340361|P1|NOT COMPLETED|Overall Study||33
147596|NCT00779246|340360|P2|COMPLETED|Overall Study||715
147597|NCT00779246|340361|P1|COMPLETED|Overall Study||717
147598|NCT00779246|340360|P2|STARTED|Overall Study||768
147599|NCT00779246|340361|P1|STARTED|Overall Study||750
147600|NCT00779857|340367|P1|NOT COMPLETED|Overall Study||6
147601|NCT00779857|340367|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
147602|NCT00779857|340367|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
147603|NCT00779857|340367|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
147604|NCT00779857|340367|P1|STARTED|Overall Study|70 patients treated|70
147605|NCT00779779|340372|P1|NOT COMPLETED|Overall Study||24
147606|NCT00779779|340372|P1|COMPLETED|Overall Study||498
147607|NCT00779779|340372|P1|STARTED|Overall Study||522
147608|NCT00779766|340381|P2|NOT COMPLETED|Overall Study||68
147609|NCT00779766|340382|P1|NOT COMPLETED|Overall Study||85
147610|NCT00779766|340381|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
147611|NCT00779766|340382|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
147612|NCT00779766|340381|P2|STARTED|Overall Study||3025
147613|NCT00779766|340382|P1|STARTED|Overall Study||3026
147614|NCT00779701|340460|P1|NOT COMPLETED|Overall Study||0
147615|NCT00779701|340460|P1|COMPLETED|Overall Study||27
147616|NCT00779701|340460|P1|STARTED|Overall Study||27
147617|NCT00779675|340464|P1|NOT COMPLETED|Extended Treatment Period||46
147618|NCT00779675|340464|P1|COMPLETED|Extended Treatment Period||147
147619|NCT00779675|340464|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
147620|NCT00779675|340464|P1|NOT COMPLETED|Treatment Period||332
147621|NCT00779675|340464|P1|COMPLETED|Treatment Period||328
147622|NCT00779675|340464|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
147623|NCT00779558|340485|P2|NOT COMPLETED|Overall Study||7
147624|NCT00779558|340486|P1|NOT COMPLETED|Overall Study||4
147625|NCT00779558|340485|P2|COMPLETED|Overall Study||37
147626|NCT00779558|340486|P1|COMPLETED|Overall Study||53
147627|NCT00779558|340485|P2|STARTED|Overall Study||44
147628|NCT00779558|340486|P1|STARTED|Overall Study||57
147629|NCT00779506|340500|P1|NOT COMPLETED|Overall Study||29
147630|NCT00779506|340500|P1|COMPLETED|Overall Study||67
147631|NCT00779506|340500|P1|Withdrawal Treatment|Overall Study||27
147632|NCT00779506|340500|P1|Treatment Complete|Overall Study||67
147633|NCT00779506|340500|P1|MITT|Overall Study||89
147634|NCT00779506|340500|P1|Assigned|Overall Study||94
147635|NCT00779506|340500|P1|Screen Failed|Overall Study||2
147636|NCT00779506|340500|P1|Enrolled|Overall Study||96
147637|NCT00779506|340500|P1|STARTED|Overall Study||96
147638|NCT00779311|340515|P5|NOT COMPLETED|Overall Study||0
147639|NCT00779311|340516|P4|NOT COMPLETED|Overall Study||0
147640|NCT00779311|340517|P3|NOT COMPLETED|Overall Study||0
147641|NCT00779311|340518|P2|NOT COMPLETED|Overall Study||0
147642|NCT00779311|340519|P1|NOT COMPLETED|Overall Study||0
147643|NCT00779311|340515|P5|COMPLETED|Overall Study||0
147644|NCT00779311|340516|P4|COMPLETED|Overall Study||0
147645|NCT00779311|340517|P3|COMPLETED|Overall Study||0
147646|NCT00779311|340518|P2|COMPLETED|Overall Study||0
147647|NCT00779311|340519|P1|COMPLETED|Overall Study||8
147648|NCT00779311|340515|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
147649|NCT00779311|340516|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
147650|NCT00779311|340517|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
147651|NCT00779311|340518|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
147652|NCT00779311|340519|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
147653|NCT00779311|340515|P5|STARTED|Overall Study||0
147654|NCT00779311|340516|P4|STARTED|Overall Study||0
147655|NCT00779311|340517|P3|STARTED|Overall Study||0
147656|NCT00779311|340518|P2|STARTED|Overall Study||0
147657|NCT00779311|340519|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
147658|NCT00779285|340541|P1|NOT COMPLETED|Overall Study||0
147659|NCT00779285|340541|P1|COMPLETED|Overall Study||1
147660|NCT00779285|340541|P1|STARTED|Overall Study||1
147661|NCT00779259|340545|P1|NOT COMPLETED|Theophylline With Quinine||0
147662|NCT00779259|340545|P1|COMPLETED|Theophylline With Quinine||22
147663|NCT00779259|340545|P1|STARTED|Theophylline With Quinine||22
147664|NCT00779259|340545|P1|NOT COMPLETED|Quinine Alone||2
147665|NCT00779259|340545|P1|COMPLETED|Quinine Alone||22
147666|NCT00779259|340545|P1|STARTED|Quinine Alone||24
147667|NCT00779259|340545|P1|NOT COMPLETED|4 Day Washout Period||0
147668|NCT00779259|340545|P1|COMPLETED|4 Day Washout Period||24
147669|NCT00779259|340545|P1|STARTED|4 Day Washout Period||24
147670|NCT00779259|340545|P1|NOT COMPLETED|Theophylline Alone||0
147671|NCT00779259|340545|P1|COMPLETED|Theophylline Alone||24
147672|NCT00779259|340545|P1|STARTED|Theophylline Alone||24
147673|NCT00779155|340566|P2|NOT COMPLETED|Overall Study||0
147674|NCT00779155|340567|P1|NOT COMPLETED|Overall Study||0
147675|NCT00779155|340566|P2|COMPLETED|Overall Study||6
147676|NCT00779155|340567|P1|COMPLETED|Overall Study||6
147677|NCT00779155|340566|P2|STARTED|Overall Study||6
147678|NCT00779155|340567|P1|STARTED|Overall Study||6
147679|NCT00779142|340573|P1|NOT COMPLETED|Overall Study||3
147680|NCT00779142|340573|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
147681|NCT00779142|340573|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
147682|NCT00779116|340577|P2|NOT COMPLETED|Second Intervention||0
147683|NCT00779116|340578|P1|NOT COMPLETED|Second Intervention||0
147684|NCT00779116|340577|P2|COMPLETED|Second Intervention||108
147685|NCT00779116|340578|P1|COMPLETED|Second Intervention||109
147686|NCT00779116|340577|P2|STARTED|Second Intervention||108
147687|NCT00779116|340578|P1|STARTED|Second Intervention||109
147688|NCT00779116|340577|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
147689|NCT00779116|340578|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
147690|NCT00779116|340577|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
147691|NCT00779116|340578|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
147692|NCT00779116|340577|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
147693|NCT00779116|340578|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
147694|NCT00779116|340577|P2|NOT COMPLETED|First Intervention||0
147695|NCT00779116|340578|P1|NOT COMPLETED|First Intervention||0
147696|NCT00779116|340577|P2|COMPLETED|First Intervention||108
147697|NCT00779116|340578|P1|COMPLETED|First Intervention||109
147698|NCT00779116|340577|P2|STARTED|First Intervention||108
147699|NCT00779116|340578|P1|STARTED|First Intervention||109
147700|NCT00779038|340585|P1|NOT COMPLETED|Overall Study||13
147701|NCT00779038|340585|P1|COMPLETED|Overall Study||0
147702|NCT00779038|340585|P1|STARTED|Overall Study||13
147703|NCT00779025|340594|P1|NOT COMPLETED|Overall Study||1
147704|NCT00779025|340594|P1|COMPLETED|Overall Study||81
147705|NCT00779025|340594|P1|STARTED|Overall Study||82
147706|NCT00778999|340605|P2|NOT COMPLETED|Overall Study||34
147707|NCT00778999|340606|P1|NOT COMPLETED|Overall Study||28
147708|NCT00778999|340605|P2|COMPLETED|Overall Study||185
147709|NCT00778999|340606|P1|COMPLETED|Overall Study||195
147710|NCT00778999|340605|P2|STARTED|Overall Study||219
147711|NCT00778999|340606|P1|STARTED|Overall Study||223
147712|NCT00778921|340615|P3|NOT COMPLETED|Overall Study||28
147713|NCT00778921|340616|P2|NOT COMPLETED|Overall Study||19
147714|NCT00778921|340617|P1|NOT COMPLETED|Overall Study||18
147715|NCT00778921|340615|P3|COMPLETED|Overall Study||255
147716|NCT00778921|340616|P2|COMPLETED|Overall Study||266
147717|NCT00778921|340617|P1|COMPLETED|Overall Study||261
147718|NCT00778921|340615|P3|STARTED|Overall Study||283
147719|NCT00778921|340616|P2|STARTED|Overall Study||285
147720|NCT00778921|340617|P1|STARTED|Overall Study||279
147721|NCT00778895|340634|P3|NOT COMPLETED|ESFU Phase||2
147722|NCT00778895|340635|P2|NOT COMPLETED|ESFU Phase||12
147723|NCT00778895|340636|P1|NOT COMPLETED|ESFU Phase||11
147724|NCT00778895|340634|P3|COMPLETED|ESFU Phase||41
147725|NCT00778895|340635|P2|COMPLETED|ESFU Phase||155
147726|NCT00778895|340636|P1|COMPLETED|ESFU Phase||153
147727|NCT00778895|340634|P3|STARTED|ESFU Phase||43
147728|NCT00778895|340635|P2|STARTED|ESFU Phase||167
147729|NCT00778895|340636|P1|STARTED|ESFU Phase||164
147730|NCT00778895|340634|P3|NOT COMPLETED|Active Phase||0
147731|NCT00778895|340635|P2|NOT COMPLETED|Active Phase||6
147732|NCT00778895|340636|P1|NOT COMPLETED|Active Phase||7
147733|NCT00778895|340634|P3|COMPLETED|Active Phase||43
147734|NCT00778895|340635|P2|COMPLETED|Active Phase||161
147735|NCT00778895|340636|P1|COMPLETED|Active Phase||157
147736|NCT00778895|340634|P3|STARTED|Active Phase||43
147737|NCT00778895|340635|P2|STARTED|Active Phase||167
147738|NCT00778895|340636|P1|STARTED|Active Phase||164
147739|NCT00778869|340674|P1|NOT COMPLETED|Overall Study||0
147740|NCT00778869|340674|P1|COMPLETED|Overall Study||10
147741|NCT00778869|340674|P1|STARTED|Overall Study||10
147742|NCT00778830|340680|P2|NOT COMPLETED|Overall Study||1
147743|NCT00778830|340681|P1|NOT COMPLETED|Overall Study||0
147744|NCT00778830|340680|P2|COMPLETED|Overall Study||187
147745|NCT00778830|340681|P1|COMPLETED|Overall Study||101
147746|NCT00778830|340680|P2|STARTED|Overall Study||188
147747|NCT00778830|340681|P1|STARTED|Overall Study||101
147748|NCT00778817|340693|P1|NOT COMPLETED|Overall Study||4
147749|NCT00778817|340693|P1|COMPLETED|Overall Study||16
147750|NCT00778817|340693|P1|STARTED|Overall Study||20
147751|NCT00778648|340710|P2|NOT COMPLETED|Overall Study||5
147752|NCT00778648|340711|P1|NOT COMPLETED|Overall Study||9
147753|NCT00778648|340710|P2|COMPLETED|Overall Study||266
147754|NCT00778648|340711|P1|COMPLETED|Overall Study||263
147755|NCT00778648|340710|P2|STARTED|Overall Study||271
147756|NCT00778648|340711|P1|STARTED|Overall Study||272
147757|NCT00778622|340720|P3|NOT COMPLETED|Overall Study||15
147758|NCT00778622|340721|P2|NOT COMPLETED|Overall Study||15
147759|NCT00778622|340722|P1|NOT COMPLETED|Overall Study||16
147760|NCT00778622|340720|P3|COMPLETED|Overall Study||109
147761|NCT00778622|340721|P2|COMPLETED|Overall Study||107
147762|NCT00778622|340722|P1|COMPLETED|Overall Study||109
147763|NCT00778622|340720|P3|STARTED|Overall Study||124
147764|NCT00778622|340721|P2|STARTED|Overall Study||122
147765|NCT00778622|340722|P1|STARTED|Overall Study||125
147766|NCT00778375|340775|P1|NOT COMPLETED|Overall Study||3
147767|NCT00778375|340775|P1|COMPLETED|Overall Study||119
147768|NCT00778375|340775|P1|STARTED|Overall Study||122
147769|NCT00778336|340789|P4|NOT COMPLETED|3 Month Follow Up||0
147770|NCT00778336|340790|P3|NOT COMPLETED|3 Month Follow Up||5
147771|NCT00778336|340791|P2|NOT COMPLETED|3 Month Follow Up||23
147772|NCT00778336|340792|P1|NOT COMPLETED|3 Month Follow Up||23
147773|NCT00778336|340789|P4|COMPLETED|3 Month Follow Up||12
147774|NCT00778336|340790|P3|COMPLETED|3 Month Follow Up||65
147775|NCT00778336|340791|P2|COMPLETED|3 Month Follow Up||144
147776|NCT00778336|340792|P1|COMPLETED|3 Month Follow Up||169
147777|NCT00778336|340789|P4|STARTED|3 Month Follow Up||12
147778|NCT00778336|340790|P3|STARTED|3 Month Follow Up||70
147779|NCT00778336|340791|P2|STARTED|3 Month Follow Up||167
147780|NCT00778336|340792|P1|STARTED|3 Month Follow Up||192
147781|NCT00778336|340789|P4|NOT COMPLETED|Index Procedure-Discharge||0
147782|NCT00778336|340790|P3|NOT COMPLETED|Index Procedure-Discharge||2
147783|NCT00778336|340791|P2|NOT COMPLETED|Index Procedure-Discharge||3
147784|NCT00778336|340792|P1|NOT COMPLETED|Index Procedure-Discharge||6
147785|NCT00778336|340789|P4|COMPLETED|Index Procedure-Discharge||12
147786|NCT00778336|340790|P3|COMPLETED|Index Procedure-Discharge||70
147787|NCT00778336|340791|P2|COMPLETED|Index Procedure-Discharge||167
147788|NCT00778336|340792|P1|COMPLETED|Index Procedure-Discharge||192
147789|NCT00778336|340789|P4|STARTED|Index Procedure-Discharge||12
147790|NCT00778336|340790|P3|STARTED|Index Procedure-Discharge||72
147791|NCT00778336|340791|P2|STARTED|Index Procedure-Discharge||170
147792|NCT00778336|340792|P1|STARTED|Index Procedure-Discharge||198
147793|NCT00778310|340812|P2|NOT COMPLETED|Overall Study||0
147794|NCT00778310|340813|P1|NOT COMPLETED|Overall Study||0
147795|NCT00778310|340812|P2|COMPLETED|Overall Study||26
147796|NCT00778310|340813|P1|COMPLETED|Overall Study||17
147797|NCT00778310|340812|P2|Usable Data|Overall Study||21
147798|NCT00778310|340813|P1|Usable Data|Overall Study||14
147799|NCT00778310|340812|P2|STARTED|Overall Study||26
147800|NCT00778310|340813|P1|STARTED|Overall Study||17
147801|NCT00778258|340830|P9|NOT COMPLETED|Overall Study||4
147802|NCT00778258|340831|P8|NOT COMPLETED|Overall Study||15
147803|NCT00778258|340832|P7|NOT COMPLETED|Overall Study||15
147804|NCT00778258|340833|P6|NOT COMPLETED|Overall Study||10
147805|NCT00778258|340834|P5|NOT COMPLETED|Overall Study||0
147806|NCT00778258|340835|P4|NOT COMPLETED|Overall Study||3
147807|NCT00778258|340836|P3|NOT COMPLETED|Overall Study||10
147808|NCT00778258|340837|P2|NOT COMPLETED|Overall Study||2
147809|NCT00778258|340838|P1|NOT COMPLETED|Overall Study||7
147810|NCT00778258|340830|P9|COMPLETED|Overall Study||6
147811|NCT00778258|340831|P8|COMPLETED|Overall Study||26
147812|NCT00778258|340832|P7|COMPLETED|Overall Study||19
147813|NCT00778258|340833|P6|COMPLETED|Overall Study||13
147814|NCT00778258|340834|P5|COMPLETED|Overall Study||6
147815|NCT00778258|340835|P4|COMPLETED|Overall Study||12
147816|NCT00778258|340836|P3|COMPLETED|Overall Study||10
147817|NCT00778258|340837|P2|COMPLETED|Overall Study||3
147818|NCT00778258|340838|P1|COMPLETED|Overall Study||9
147819|NCT00778258|340830|P9|STARTED|Overall Study||10
147820|NCT00778258|340831|P8|STARTED|Overall Study||41
147821|NCT00778258|340832|P7|STARTED|Overall Study||34
147822|NCT00778258|340833|P6|STARTED|Overall Study||23
147823|NCT00778258|340834|P5|STARTED|Overall Study||6
147824|NCT00778258|340835|P4|STARTED|Overall Study||15
147825|NCT00778258|340836|P3|STARTED|Overall Study||20
147826|NCT00778258|340837|P2|STARTED|Overall Study||5
147827|NCT00778258|340838|P1|STARTED|Overall Study||16
147828|NCT00778167|340893|P3|NOT COMPLETED|Overall Study||0
147829|NCT00778167|340894|P2|NOT COMPLETED|Overall Study||0
147830|NCT00778167|340895|P1|NOT COMPLETED|Overall Study||0
147831|NCT00778167|340893|P3|COMPLETED|Overall Study||4
147832|NCT00778167|340894|P2|COMPLETED|Overall Study||8
147833|NCT00778167|340895|P1|COMPLETED|Overall Study||6
147834|NCT00778167|340893|P3|STARTED|Overall Study||4
147835|NCT00778167|340894|P2|STARTED|Overall Study||8
147836|NCT00778167|340895|P1|STARTED|Overall Study||6
147837|NCT00778102|340905|P2|NOT COMPLETED|Overall Study||22
147838|NCT00778102|340906|P1|NOT COMPLETED|Overall Study||21
147839|NCT00778102|340905|P2|COMPLETED|Overall Study||19
147840|NCT00778102|340906|P1|COMPLETED|Overall Study||18
147841|NCT00778102|340905|P2|STARTED|Overall Study||41
147842|NCT00778102|340906|P1|STARTED|Overall Study||39
147843|NCT00777946|340941|P3|NOT COMPLETED|Overall Study||16
147844|NCT00777946|340942|P2|NOT COMPLETED|Overall Study||6
147845|NCT00777946|340943|P1|NOT COMPLETED|Overall Study||21
147846|NCT00777946|340941|P3|COMPLETED|Overall Study||244
147847|NCT00777946|340942|P2|COMPLETED|Overall Study||271
147848|NCT00777946|340943|P1|COMPLETED|Overall Study||262
147849|NCT00777946|340941|P3|Safety & Full Analysis Sets|Overall Study||260
147850|NCT00777946|340942|P2|Safety & Full Analysis Sets|Overall Study||276
147851|NCT00777946|340943|P1|Safety & Full Analysis Sets|Overall Study||282
147852|NCT00777946|340941|P3|STARTED|Overall Study||260
147853|NCT00777946|340942|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
147854|NCT00777946|340943|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
147855|NCT00777855|340966|P2|NOT COMPLETED|Second Intervention||0
147856|NCT00777855|340967|P1|NOT COMPLETED|Second Intervention||0
147857|NCT00777855|340966|P2|COMPLETED|Second Intervention||5
147858|NCT00777855|340967|P1|COMPLETED|Second Intervention||5
147859|NCT00777855|340966|P2|STARTED|Second Intervention||5
147860|NCT00777855|340967|P1|STARTED|Second Intervention||5
147861|NCT00777855|340966|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
147862|NCT00777855|340967|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
147863|NCT00777855|340966|P2|COMPLETED|Washout Period (>= 14 Days)||5
147864|NCT00777855|340967|P1|COMPLETED|Washout Period (>= 14 Days)||5
147865|NCT00777855|340966|P2|STARTED|Washout Period (>= 14 Days)||5
147866|NCT00777855|340967|P1|STARTED|Washout Period (>= 14 Days)||5
147867|NCT00777855|340966|P2|NOT COMPLETED|First Intervention||0
147868|NCT00777855|340967|P1|NOT COMPLETED|First Intervention||0
147869|NCT00777855|340966|P2|COMPLETED|First Intervention||5
147870|NCT00777855|340967|P1|COMPLETED|First Intervention||5
147871|NCT00777855|340966|P2|STARTED|First Intervention||5
147872|NCT00777855|340967|P1|STARTED|First Intervention||5
147873|NCT00777803|340978|P2|NOT COMPLETED|Overall Study||7
147874|NCT00777803|340979|P1|NOT COMPLETED|Overall Study||15
147875|NCT00777803|340978|P2|COMPLETED|Overall Study||90
147876|NCT00777803|340979|P1|COMPLETED|Overall Study||269
147877|NCT00777803|340978|P2|STARTED|Overall Study||97
147878|NCT00777803|340979|P1|STARTED|Overall Study||284
147879|NCT00777790|341014|P3|NOT COMPLETED|Overall Study||0
147880|NCT00777790|341015|P2|NOT COMPLETED|Overall Study||0
147881|NCT00777790|341016|P1|NOT COMPLETED|Overall Study||0
147882|NCT00777790|341014|P3|COMPLETED|Overall Study||88
147883|NCT00777790|341015|P2|COMPLETED|Overall Study||77
147884|NCT00777790|341016|P1|COMPLETED|Overall Study||76
147885|NCT00777790|341014|P3|STARTED|Overall Study||88
147886|NCT00777790|341015|P2|STARTED|Overall Study||77
147887|NCT00777790|341016|P1|STARTED|Overall Study||76
147888|NCT00777764|341026|P2|NOT COMPLETED|Overall Study||1
147889|NCT00777764|341027|P1|NOT COMPLETED|Overall Study||0
147890|NCT00777764|341026|P2|COMPLETED|Overall Study||29
147891|NCT00777764|341027|P1|COMPLETED|Overall Study||30
147892|NCT00777764|341026|P2|STARTED|Overall Study||30
147893|NCT00777764|341027|P1|STARTED|Overall Study||30
147894|NCT00777634|341039|P2|NOT COMPLETED|Overall Study||1
147895|NCT00777634|341040|P1|NOT COMPLETED|Overall Study||5
147896|NCT00777634|341039|P2|COMPLETED|Overall Study||133
147897|NCT00777634|341040|P1|COMPLETED|Overall Study||129
147898|NCT00777634|341039|P2|STARTED|Overall Study||134
147899|NCT00777634|341040|P1|STARTED|Overall Study||134
147900|NCT00777608|341058|P2|NOT COMPLETED|Overall Study||6
147901|NCT00777608|341059|P1|NOT COMPLETED|Overall Study||4
147902|NCT00777608|341058|P2|COMPLETED|Overall Study||47
147903|NCT00777608|341059|P1|COMPLETED|Overall Study||49
147904|NCT00777608|341058|P2|STARTED|Overall Study||53
147905|NCT00777608|341059|P1|STARTED|Overall Study||53
147906|NCT00777556|341069|P1|NOT COMPLETED|Overall Study||66
147907|NCT00777556|341069|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
147908|NCT00777556|341069|P1|Used Product|Overall Study||297
147909|NCT00777556|341069|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
147910|NCT00777556|341069|P1|Dispensed Product|Overall Study||307
147911|NCT00777556|341069|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
147912|NCT00777335|341078|P2|NOT COMPLETED|Overall Study||0
147913|NCT00777335|341079|P1|NOT COMPLETED|Overall Study||0
147914|NCT00777335|341078|P2|COMPLETED|Overall Study||2
147915|NCT00777335|341079|P1|COMPLETED|Overall Study||2
147916|NCT00777335|341078|P2|STARTED|Overall Study||2
147917|NCT00777335|341079|P1|STARTED|Overall Study||2
147918|NCT00777257|341090|P3|NOT COMPLETED|Overall Study||9
147919|NCT00777257|341091|P2|NOT COMPLETED|Overall Study||12
147920|NCT00777257|341092|P1|NOT COMPLETED|Overall Study||11
147921|NCT00777257|341090|P3|COMPLETED|Overall Study||442
147922|NCT00777257|341091|P2|COMPLETED|Overall Study||438
147923|NCT00777257|341092|P1|COMPLETED|Overall Study||433
147924|NCT00777257|341090|P3|STARTED|Overall Study||451
147925|NCT00777257|341091|P2|STARTED|Overall Study||450
147926|NCT00777257|341092|P1|STARTED|Overall Study||444
147927|NCT00777205|341111|P2|NOT COMPLETED|Overall Study||71
147928|NCT00777205|341112|P1|NOT COMPLETED|Overall Study||31
147929|NCT00777205|341111|P2|COMPLETED|Overall Study||129
147930|NCT00777205|341112|P1|COMPLETED|Overall Study||212
147931|NCT00777205|341111|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
147932|NCT00777205|341112|P1|Intervention Interruption|Overall Study||0
147933|NCT00777205|341111|P2|STARTED|Overall Study||200
147934|NCT00777205|341112|P1|STARTED|Overall Study||243
147935|NCT00777179|341128|P2|NOT COMPLETED|Overall Study||0
147936|NCT00777179|341129|P1|NOT COMPLETED|Overall Study||0
147937|NCT00777179|341128|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
147938|NCT00777179|341129|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
147939|NCT00777179|341128|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
147940|NCT00777179|341129|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
147941|NCT00777153|341146|P3|NOT COMPLETED|Overall Study||37
147942|NCT00777153|341147|P2|NOT COMPLETED|Overall Study||83
147943|NCT00777153|341148|P1|NOT COMPLETED|Overall Study||90
147944|NCT00777153|341146|P3|COMPLETED|Overall Study||28
147945|NCT00777153|341147|P2|COMPLETED|Overall Study||46
147946|NCT00777153|341148|P1|COMPLETED|Overall Study||41
147947|NCT00777153|341146|P3|STARTED|Overall Study||65
147948|NCT00777153|341147|P2|STARTED|Overall Study||129
147949|NCT00777153|341148|P1|STARTED|Overall Study||131
147950|NCT00777062|341173|P2|NOT COMPLETED|Overall Study||5
147951|NCT00777062|341174|P1|NOT COMPLETED|Overall Study||3
147952|NCT00777062|341173|P2|COMPLETED|Overall Study||36
147953|NCT00777062|341174|P1|COMPLETED|Overall Study||36
147954|NCT00777062|341173|P2|STARTED|Overall Study||41
147955|NCT00777062|341174|P1|STARTED|Overall Study||39
147956|NCT00777049|341184|P2|NOT COMPLETED|Overall Study||1
147957|NCT00777049|341185|P1|NOT COMPLETED|Overall Study||1
147958|NCT00777049|341184|P2|COMPLETED|Overall Study||20
147959|NCT00777049|341185|P1|COMPLETED|Overall Study||32
147960|NCT00777049|341184|P2|STARTED|Overall Study||21
147961|NCT00777049|341185|P1|STARTED|Overall Study||33
147962|NCT00777023|341194|P3|NOT COMPLETED|Overall Study||37
147963|NCT00777023|341195|P2|NOT COMPLETED|Overall Study||41
147964|NCT00777023|341196|P1|NOT COMPLETED|Overall Study||35
147965|NCT00777023|341194|P3|COMPLETED|Overall Study||146
147966|NCT00777023|341195|P2|COMPLETED|Overall Study||149
147967|NCT00777023|341196|P1|COMPLETED|Overall Study||151
147968|NCT00777023|341194|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
147969|NCT00777023|341195|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
147970|NCT00777023|341196|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
147971|NCT00776997|341213|P1|NOT COMPLETED|Overall Study||2
147972|NCT00776997|341213|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
147973|NCT00776997|341213|P1|STARTED|Overall Study||100
147974|NCT00776984|341222|P2|NOT COMPLETED|Overall Study||21
147975|NCT00776984|341223|P1|NOT COMPLETED|Overall Study||31
147976|NCT00776984|341222|P2|COMPLETED|Overall Study||198
147977|NCT00776984|341223|P1|COMPLETED|Overall Study||203
147978|NCT00776984|341222|P2|STARTED|Overall Study||219
147979|NCT00776984|341223|P1|STARTED|Overall Study||234
147980|NCT00776919|341297|P4|NOT COMPLETED|Overall Study||39
147981|NCT00776919|341298|P3|NOT COMPLETED|Overall Study||32
147982|NCT00776919|341299|P2|NOT COMPLETED|Overall Study||33
147983|NCT00776919|341300|P1|NOT COMPLETED|Overall Study||27
147984|NCT00776919|341297|P4|COMPLETED|Overall Study||293
147985|NCT00776919|341298|P3|COMPLETED|Overall Study||296
147986|NCT00776919|341299|P2|COMPLETED|Overall Study||295
147987|NCT00776919|341300|P1|COMPLETED|Overall Study||300
147988|NCT00776919|341297|P4|STARTED|Overall Study||332
147989|NCT00776919|341298|P3|STARTED|Overall Study||328
147990|NCT00776919|341299|P2|STARTED|Overall Study||328
147991|NCT00776919|341300|P1|STARTED|Overall Study||327
147992|NCT00776789|341364|P2|NOT COMPLETED|Overall Study||3
147993|NCT00776789|341365|P1|NOT COMPLETED|Overall Study||3
147994|NCT00776789|341364|P2|COMPLETED|Overall Study||18
147995|NCT00776789|341365|P1|COMPLETED|Overall Study||17
147996|NCT00776789|341364|P2|STARTED|Overall Study||21
147997|NCT00776789|341365|P1|STARTED|Overall Study||20
147998|NCT00776659|341377|P1|NOT COMPLETED|Overall Study||26
147999|NCT00776659|341377|P1|COMPLETED|Overall Study||13
148000|NCT00776659|341377|P1|STARTED|Overall Study||39
148001|NCT00776594|341389|P2|NOT COMPLETED|Overall Study||2
148002|NCT00776594|341390|P1|NOT COMPLETED|Overall Study||4
148003|NCT00776594|341389|P2|COMPLETED|Overall Study||34
148004|NCT00776594|341390|P1|COMPLETED|Overall Study||62
148005|NCT00776594|341389|P2|STARTED|Overall Study||36
148006|NCT00776594|341390|P1|STARTED|Overall Study||66
148007|NCT00776555|341404|P2|NOT COMPLETED|Overall Study||0
148008|NCT00776555|341405|P1|NOT COMPLETED|Overall Study||3
148009|NCT00776555|341404|P2|COMPLETED|Overall Study||0
148010|NCT00776555|341405|P1|COMPLETED|Overall Study||0
148011|NCT00776555|341404|P2|STARTED|Overall Study||0
148012|NCT00776555|341405|P1|STARTED|Overall Study||3
148013|NCT00776295|341415|P1|NOT COMPLETED|Overall Study||0
148014|NCT00776295|341415|P1|COMPLETED|Overall Study||2
148015|NCT00776295|341415|P1|STARTED|Overall Study||2
148016|NCT00776230|341423|P3|NOT COMPLETED|Overall Study||5
148017|NCT00776230|341424|P2|NOT COMPLETED|Overall Study||3
148018|NCT00776230|341425|P1|NOT COMPLETED|Overall Study||3
148019|NCT00776230|341423|P3|COMPLETED|Overall Study||97
148020|NCT00776230|341424|P2|COMPLETED|Overall Study||100
148021|NCT00776230|341425|P1|COMPLETED|Overall Study||96
148022|NCT00776230|341423|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
148023|NCT00776230|341424|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
148024|NCT00776230|341425|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
148025|NCT00776230|341423|P3|STARTED|Overall Study||102
148026|NCT00776230|341424|P2|STARTED|Overall Study||103
148027|NCT00776230|341425|P1|STARTED|Overall Study||99
148028|NCT00776009|341439|P6|NOT COMPLETED|Period 3: Third Intervention||0
148029|NCT00776009|341440|P5|NOT COMPLETED|Period 3: Third Intervention||0
148030|NCT00776009|341441|P4|NOT COMPLETED|Period 3: Third Intervention||0
148031|NCT00776009|341442|P3|NOT COMPLETED|Period 3: Third Intervention||0
148032|NCT00776009|341443|P2|NOT COMPLETED|Period 3: Third Intervention||0
148033|NCT00776009|341444|P1|NOT COMPLETED|Period 3: Third Intervention||1
148034|NCT00776009|341439|P6|COMPLETED|Period 3: Third Intervention||26
148035|NCT00776009|341440|P5|COMPLETED|Period 3: Third Intervention||26
148036|NCT00776009|341441|P4|COMPLETED|Period 3: Third Intervention||27
148037|NCT00776009|341442|P3|COMPLETED|Period 3: Third Intervention||27
148038|NCT00776009|341443|P2|COMPLETED|Period 3: Third Intervention||27
148039|NCT00776009|341444|P1|COMPLETED|Period 3: Third Intervention||24
148040|NCT00776009|341439|P6|STARTED|Period 3: Third Intervention||26
148041|NCT00776009|341440|P5|STARTED|Period 3: Third Intervention||26
148042|NCT00776009|341441|P4|STARTED|Period 3: Third Intervention||27
148043|NCT00776009|341442|P3|STARTED|Period 3: Third Intervention||27
148044|NCT00776009|341443|P2|STARTED|Period 3: Third Intervention||27
148045|NCT00776009|341444|P1|STARTED|Period 3: Third Intervention||25
148046|NCT00776009|341439|P6|NOT COMPLETED|Period 2: Second Intervention||1
148047|NCT00776009|341440|P5|NOT COMPLETED|Period 2: Second Intervention||0
148048|NCT00776009|341441|P4|NOT COMPLETED|Period 2: Second Intervention||0
148049|NCT00776009|341442|P3|NOT COMPLETED|Period 2: Second Intervention||1
148050|NCT00776009|341443|P2|NOT COMPLETED|Period 2: Second Intervention||0
148051|NCT00776009|341444|P1|NOT COMPLETED|Period 2: Second Intervention||1
148052|NCT00776009|341439|P6|COMPLETED|Period 2: Second Intervention||26
148053|NCT00776009|341440|P5|COMPLETED|Period 2: Second Intervention||26
148054|NCT00776009|341441|P4|COMPLETED|Period 2: Second Intervention||27
148055|NCT00776009|341442|P3|COMPLETED|Period 2: Second Intervention||27
148056|NCT00776009|341443|P2|COMPLETED|Period 2: Second Intervention||27
148057|NCT00776009|341444|P1|COMPLETED|Period 2: Second Intervention||25
148058|NCT00776009|341439|P6|STARTED|Period 2: Second Intervention||27
148059|NCT00776009|341440|P5|STARTED|Period 2: Second Intervention||26
148060|NCT00776009|341441|P4|STARTED|Period 2: Second Intervention||27
148061|NCT00776009|341442|P3|STARTED|Period 2: Second Intervention||28
148062|NCT00776009|341443|P2|STARTED|Period 2: Second Intervention||27
148063|NCT00776009|341444|P1|STARTED|Period 2: Second Intervention||26
148064|NCT00776009|341439|P6|NOT COMPLETED|Period 1: First Intervention||0
148065|NCT00776009|341440|P5|NOT COMPLETED|Period 1: First Intervention||2
148066|NCT00776009|341441|P4|NOT COMPLETED|Period 1: First Intervention||0
148067|NCT00776009|341442|P3|NOT COMPLETED|Period 1: First Intervention||1
148068|NCT00776009|341443|P2|NOT COMPLETED|Period 1: First Intervention||1
148069|NCT00776009|341444|P1|NOT COMPLETED|Period 1: First Intervention||0
148070|NCT00776009|341439|P6|COMPLETED|Period 1: First Intervention||27
148071|NCT00776009|341440|P5|COMPLETED|Period 1: First Intervention||26
148072|NCT00776009|341441|P4|COMPLETED|Period 1: First Intervention||27
148073|NCT00776009|341442|P3|COMPLETED|Period 1: First Intervention||28
148074|NCT00776009|341443|P2|COMPLETED|Period 1: First Intervention||27
148075|NCT00776009|341444|P1|COMPLETED|Period 1: First Intervention||26
148076|NCT00776009|341439|P6|STARTED|Period 1: First Intervention||27
148077|NCT00776009|341440|P5|STARTED|Period 1: First Intervention||28
148078|NCT00776009|341441|P4|STARTED|Period 1: First Intervention||27
148079|NCT00776009|341442|P3|STARTED|Period 1: First Intervention||29
148080|NCT00776009|341443|P2|STARTED|Period 1: First Intervention||28
148081|NCT00776009|341444|P1|STARTED|Period 1: First Intervention||26
148082|NCT00775983|341466|P2|NOT COMPLETED|Overall Study||2
148083|NCT00775983|341467|P1|NOT COMPLETED|Overall Study||1
148084|NCT00775983|341466|P2|COMPLETED|Overall Study||34
148085|NCT00775983|341467|P1|COMPLETED|Overall Study||35
148086|NCT00775983|341466|P2|STARTED|Overall Study||36
148087|NCT00775983|341467|P1|STARTED|Overall Study||36
148088|NCT00775944|341479|P4|NOT COMPLETED|Overall Study||16
148089|NCT00775944|341480|P3|NOT COMPLETED|Overall Study||16
148090|NCT00775944|341481|P2|NOT COMPLETED|Overall Study||9
148091|NCT00775944|341482|P1|NOT COMPLETED|Overall Study||15
148092|NCT00775944|341479|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
148093|NCT00775944|341480|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
148094|NCT00775944|341481|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
148095|NCT00775944|341482|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
148096|NCT00775944|341479|P4|STARTED|Overall Study||648
148097|NCT00775944|341480|P3|STARTED|Overall Study||648
148098|NCT00775944|341481|P2|STARTED|Overall Study||647
148099|NCT00775944|341482|P1|STARTED|Overall Study||648
148100|NCT00775671|341510|P2|NOT COMPLETED|Overall Study||0
148101|NCT00775671|341511|P1|NOT COMPLETED|Overall Study||0
148102|NCT00775671|341510|P2|COMPLETED|Overall Study||23
148103|NCT00775671|341511|P1|COMPLETED|Overall Study||23
148104|NCT00775671|341510|P2|STARTED|Overall Study||23
148105|NCT00775671|341511|P1|STARTED|Overall Study||23
148106|NCT00775606|341521|P2|NOT COMPLETED|Overall Study||0
148107|NCT00775606|341522|P1|NOT COMPLETED|Overall Study||3
148108|NCT00775606|341521|P2|COMPLETED|Overall Study||5
148109|NCT00775606|341522|P1|COMPLETED|Overall Study||5
148110|NCT00775606|341521|P2|STARTED|Overall Study||5
148111|NCT00775606|341522|P1|STARTED|Overall Study||8
148112|NCT00775593|341532|P1|NOT COMPLETED|Overall Study||7
148113|NCT00775593|341532|P1|COMPLETED|Overall Study||53
148114|NCT00775593|341532|P1|STARTED|Overall Study||60
148115|NCT00775528|341539|P1|NOT COMPLETED|Overall Study||1
148116|NCT00775528|341539|P1|COMPLETED|Overall Study||18
148117|NCT00775528|341539|P1|STARTED|Overall Study|Started means number of patients who consented|19
148118|NCT00775463|341548|P2|NOT COMPLETED|Overall Study||13
148119|NCT00775463|341549|P1|NOT COMPLETED|Overall Study||11
148120|NCT00775463|341548|P2|COMPLETED|Overall Study||59
148121|NCT00775463|341549|P1|COMPLETED|Overall Study||65
148122|NCT00775463|341548|P2|STARTED|Overall Study||72
148123|NCT00775463|341549|P1|STARTED|Overall Study||76
148124|NCT00775450|341586|P5|NOT COMPLETED|Overall Study||2
148125|NCT00775450|341587|P4|NOT COMPLETED|Overall Study||0
148126|NCT00775450|341588|P3|NOT COMPLETED|Overall Study||0
148127|NCT00775450|341589|P2|NOT COMPLETED|Overall Study||0
148128|NCT00775450|341590|P1|NOT COMPLETED|Overall Study||3
148129|NCT00775450|341586|P5|COMPLETED|Overall Study||199
148130|NCT00775450|341587|P4|COMPLETED|Overall Study||108
148131|NCT00775450|341588|P3|COMPLETED|Overall Study||105
148132|NCT00775450|341589|P2|COMPLETED|Overall Study||98
148133|NCT00775450|341590|P1|COMPLETED|Overall Study||292
148134|NCT00775450|341586|P5|STARTED|Overall Study||201
148135|NCT00775450|341587|P4|STARTED|Overall Study||108
148136|NCT00775450|341588|P3|STARTED|Overall Study||105
148137|NCT00775450|341589|P2|STARTED|Overall Study||98
148138|NCT00775450|341590|P1|STARTED|Overall Study||295
148139|NCT00775437|341617|P1|NOT COMPLETED|Overall Study||6
148140|NCT00775437|341617|P1|COMPLETED|Overall Study||26
148141|NCT00775437|341617|P1|STARTED|Overall Study||32
148142|NCT00775411|341667|P1|NOT COMPLETED|Overall Study||1
148143|NCT00775411|341667|P1|COMPLETED|Overall Study||43
148144|NCT00775411|341667|P1|STARTED|Overall Study||44
148145|NCT00775346|341673|P1|NOT COMPLETED|Overall Study||0
148146|NCT00775346|341673|P1|COMPLETED|Overall Study||92
148147|NCT00775346|341673|P1|STARTED|Overall Study||92
148148|NCT00775229|341679|P2|NOT COMPLETED|Overall Study||2
148149|NCT00775229|341680|P1|NOT COMPLETED|Overall Study||5
148150|NCT00775229|341679|P2|COMPLETED|Overall Study||24
148151|NCT00775229|341680|P1|COMPLETED|Overall Study||20
148152|NCT00775229|341679|P2|STARTED|Overall Study||26
148153|NCT00775229|341680|P1|STARTED|Overall Study||25
148154|NCT00775203|341692|P2|NOT COMPLETED|Overall Study||43
148155|NCT00775203|341693|P1|NOT COMPLETED|Overall Study||62
148156|NCT00775203|341692|P2|COMPLETED|Overall Study||163
148157|NCT00775203|341693|P1|COMPLETED|Overall Study||144
148158|NCT00775203|341692|P2|Received Study Medication|Overall Study||204
148159|NCT00775203|341693|P1|Received Study Medication|Overall Study||202
148160|NCT00775203|341692|P2|STARTED|Overall Study||206
148161|NCT00775203|341693|P1|STARTED|Overall Study||206
148162|NCT00775021|341725|P2|NOT COMPLETED|Second Intervention||1
148163|NCT00775021|341726|P1|NOT COMPLETED|Second Intervention||0
148164|NCT00775021|341725|P2|COMPLETED|Second Intervention||59
148165|NCT00775021|341726|P1|COMPLETED|Second Intervention||62
148166|NCT00775021|341725|P2|STARTED|Second Intervention||60
148167|NCT00775021|341726|P1|STARTED|Second Intervention||62
148168|NCT00775021|341725|P2|NOT COMPLETED|First Intervention||0
148169|NCT00775021|341726|P1|NOT COMPLETED|First Intervention||1
148170|NCT00775021|341725|P2|COMPLETED|First Intervention||60
148171|NCT00775021|341726|P1|COMPLETED|First Intervention||62
148172|NCT00775021|341725|P2|STARTED|First Intervention||60
148173|NCT00775021|341726|P1|STARTED|First Intervention||63
148174|NCT00774995|341744|P4|NOT COMPLETED|Overall Study||0
148175|NCT00774995|341745|P3|NOT COMPLETED|Overall Study||1
148176|NCT00774995|341746|P2|NOT COMPLETED|Overall Study||0
148177|NCT00774995|341747|P1|NOT COMPLETED|Overall Study||0
148178|NCT00774995|341744|P4|COMPLETED|Overall Study||16
148179|NCT00774995|341745|P3|COMPLETED|Overall Study||7
148180|NCT00774995|341746|P2|COMPLETED|Overall Study||16
148181|NCT00774995|341747|P1|COMPLETED|Overall Study||9
148182|NCT00774995|341744|P4|STARTED|Overall Study||16
148183|NCT00774995|341745|P3|STARTED|Overall Study||8
148184|NCT00774995|341746|P2|STARTED|Overall Study||16
148185|NCT00774995|341747|P1|STARTED|Overall Study||9
148186|NCT00774930|341787|P2|NOT COMPLETED|LTOLE Phase||17
148187|NCT00774930|341788|P1|NOT COMPLETED|LTOLE Phase||15
148188|NCT00774930|341787|P2|COMPLETED|LTOLE Phase||8
148189|NCT00774930|341788|P1|COMPLETED|LTOLE Phase||17
148190|NCT00774930|341787|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
148191|NCT00774930|341788|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
148192|NCT00774930|341787|P2|NOT COMPLETED|IOL Phase||9
148193|NCT00774930|341788|P1|NOT COMPLETED|IOL Phase||13
148194|NCT00774930|341787|P2|COMPLETED|IOL Phase||37
148195|NCT00774930|341788|P1|COMPLETED|IOL Phase||43
148196|NCT00774930|341787|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
148197|NCT00774930|341788|P1|STARTED|IOL Phase||56
148198|NCT00774930|341787|P2|NOT COMPLETED|DB Phase||22
148199|NCT00774930|341788|P1|NOT COMPLETED|DB Phase||14
148200|NCT00774930|341787|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
148201|NCT00774930|341788|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
148202|NCT00774930|341787|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
148203|NCT00774930|341788|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
148204|NCT00774852|341816|P2|NOT COMPLETED|Overall Study||41
148205|NCT00774852|341817|P1|NOT COMPLETED|Overall Study||45
148206|NCT00774852|341816|P2|COMPLETED|Overall Study||27
148207|NCT00774852|341817|P1|COMPLETED|Overall Study||24
148208|NCT00774852|341816|P2|STARTED|Overall Study||68
148209|NCT00774852|341817|P1|STARTED|Overall Study||69
148210|NCT00774800|341865|P1|NOT COMPLETED|Intervention 4||1
148211|NCT00774800|341865|P1|COMPLETED|Intervention 4||21
148212|NCT00774800|341865|P1|Received at Least One Dose of Study Drug|Intervention 4||21
148213|NCT00774800|341865|P1|STARTED|Intervention 4||22
148214|NCT00774800|341865|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
148215|NCT00774800|341865|P1|COMPLETED|Washout (3 to 10 Days)||22
148216|NCT00774800|341865|P1|STARTED|Washout (3 to 10 Days)||22
148217|NCT00774800|341865|P1|NOT COMPLETED|Intervention 3||0
148218|NCT00774800|341865|P1|COMPLETED|Intervention 3||22
148219|NCT00774800|341865|P1|Received at Least One Dose of Study Drug|Intervention 3||22
148220|NCT00774800|341865|P1|STARTED|Intervention 3||22
148221|NCT00774800|341865|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
148222|NCT00774800|341865|P1|COMPLETED|Washout (3 to 10 Days)||22
148223|NCT00774800|341865|P1|STARTED|Washout (3 to 10 Days)||22
148224|NCT00774800|341865|P1|NOT COMPLETED|Intervention 2||0
148225|NCT00774800|341865|P1|COMPLETED|Intervention 2||22
148226|NCT00774800|341865|P1|Received at Least One Dose of Study Drug|Intervention 2||22
148227|NCT00774800|341865|P1|STARTED|Intervention 2||22
148228|NCT00774800|341865|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
148229|NCT00774800|341865|P1|COMPLETED|Washout (3 to 10 Days)||22
148230|NCT00774800|341865|P1|STARTED|Washout (3 to 10 Days)||22
148231|NCT00774800|341865|P1|NOT COMPLETED|Intervention 1||0
148232|NCT00774800|341865|P1|COMPLETED|Intervention 1||22
148233|NCT00774800|341865|P1|Received at Least One Dose of Study Drug|Intervention 1||22
148234|NCT00774800|341865|P1|STARTED|Intervention 1||22
148235|NCT00774787|341887|P1|NOT COMPLETED|Overall Study||1
148236|NCT00774787|341887|P1|COMPLETED|Overall Study||26
148237|NCT00774787|341887|P1|STARTED|Overall Study||27
148238|NCT00774748|341894|P1|NOT COMPLETED|Overall Study||3
148239|NCT00774748|341894|P1|COMPLETED|Overall Study||18
148240|NCT00774748|341894|P1|STARTED|Overall Study||21
148241|NCT00774397|341909|P7|NOT COMPLETED|Overall Study||30
148242|NCT00774397|341910|P6|NOT COMPLETED|Overall Study||22
148243|NCT00774397|341911|P5|NOT COMPLETED|Overall Study||46
148244|NCT00774397|341912|P4|NOT COMPLETED|Overall Study||17
148245|NCT00774397|341913|P3|NOT COMPLETED|Overall Study||30
148246|NCT00774397|341914|P2|NOT COMPLETED|Overall Study||13
148247|NCT00774397|341915|P1|NOT COMPLETED|Overall Study||14
148248|NCT00774397|341909|P7|COMPLETED|Overall Study||41
148249|NCT00774397|341910|P6|COMPLETED|Overall Study||54
148250|NCT00774397|341911|P5|COMPLETED|Overall Study||97
148251|NCT00774397|341912|P4|COMPLETED|Overall Study||129
148252|NCT00774397|341913|P3|COMPLETED|Overall Study||113
148253|NCT00774397|341914|P2|COMPLETED|Overall Study||56
148254|NCT00774397|341915|P1|COMPLETED|Overall Study||57
148255|NCT00774397|341909|P7|STARTED|Overall Study||71
148256|NCT00774397|341910|P6|STARTED|Overall Study||76
148257|NCT00774397|341911|P5|STARTED|Overall Study||143
148258|NCT00774397|341912|P4|STARTED|Overall Study||146
148259|NCT00774397|341913|P3|STARTED|Overall Study||143
148260|NCT00774397|341914|P2|STARTED|Overall Study||69
148261|NCT00774397|341915|P1|STARTED|Overall Study||71
148262|NCT00774306|342151|P4|NOT COMPLETED|Overall Study||5
148263|NCT00774306|342152|P3|NOT COMPLETED|Overall Study||8
148264|NCT00774306|342153|P2|NOT COMPLETED|Overall Study||2
148265|NCT00774306|342154|P1|NOT COMPLETED|Overall Study||18
148266|NCT00774306|342151|P4|COMPLETED|Overall Study||2
148267|NCT00774306|342152|P3|COMPLETED|Overall Study||8
148268|NCT00774306|342153|P2|COMPLETED|Overall Study||3
148269|NCT00774306|342154|P1|COMPLETED|Overall Study||6
148270|NCT00774306|342151|P4|STARTED|Overall Study||7
148271|NCT00774306|342152|P3|STARTED|Overall Study||16
148272|NCT00774306|342153|P2|STARTED|Overall Study||5
148273|NCT00774306|342154|P1|STARTED|Overall Study||24
148274|NCT00774267|342168|P4|NOT COMPLETED|Overall Study||0
148275|NCT00774267|342169|P3|NOT COMPLETED|Overall Study||0
148276|NCT00774267|342170|P2|NOT COMPLETED|Overall Study||0
148277|NCT00774267|342171|P1|NOT COMPLETED|Overall Study||0
148278|NCT00774267|342168|P4|COMPLETED|Overall Study||135
148279|NCT00774267|342169|P3|COMPLETED|Overall Study||129
148280|NCT00774267|342170|P2|COMPLETED|Overall Study||111
148281|NCT00774267|342171|P1|COMPLETED|Overall Study||132
148282|NCT00774267|342168|P4|STARTED|Overall Study||135
148283|NCT00774267|342169|P3|STARTED|Overall Study||129
148284|NCT00774267|342170|P2|STARTED|Overall Study||111
148285|NCT00774267|342171|P1|STARTED|Overall Study||132
148286|NCT00774163|342183|P2|NOT COMPLETED|Overall Study||0
148287|NCT00774163|342184|P1|NOT COMPLETED|Overall Study||0
148288|NCT00774163|342183|P2|COMPLETED|Overall Study||15
148289|NCT00774163|342184|P1|COMPLETED|Overall Study||30
148290|NCT00774163|342183|P2|STARTED|Overall Study||15
148291|NCT00774163|342184|P1|STARTED|Overall Study||30
148292|NCT00774046|342222|P1|NOT COMPLETED|Autologous Transplant||0
148293|NCT00774046|342222|P1|COMPLETED|Autologous Transplant||4
148294|NCT00774046|342222|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
148295|NCT00774046|342222|P1|NOT COMPLETED|Stem Cell Mobilization||3
148296|NCT00774046|342222|P1|COMPLETED|Stem Cell Mobilization||7
148297|NCT00774046|342222|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
148298|NCT00774046|342222|P1|NOT COMPLETED|Induction Therapy||0
148299|NCT00774046|342222|P1|COMPLETED|Induction Therapy||32
148300|NCT00774046|342222|P1|STARTED|Induction Therapy||32
148301|NCT00774046|342222|P1|NOT COMPLETED|Enrollment||28
148302|NCT00774046|342222|P1|COMPLETED|Enrollment||32
148303|NCT00774046|342222|P1|STARTED|Enrollment||60
148304|NCT00774046|342222|P1|NOT COMPLETED|Screening||56
148305|NCT00774046|342222|P1|COMPLETED|Screening||60
148306|NCT00774046|342222|P1|STARTED|Screening||116
148307|NCT00773968|342232|P1|NOT COMPLETED|Overall Study||45
148308|NCT00773968|342232|P1|COMPLETED|Overall Study||95
148309|NCT00773968|342232|P1|Treated|Overall Study||111
148310|NCT00773968|342232|P1|STARTED|Overall Study||140
148311|NCT00773955|342241|P1|NOT COMPLETED|Overall Study||0
148312|NCT00773955|342241|P1|COMPLETED|Overall Study||15
148313|NCT00773955|342241|P1|STARTED|Overall Study||15
148314|NCT00773786|342248|P2|NOT COMPLETED|Second Intervention (1 Week)||0
148315|NCT00773786|342249|P1|NOT COMPLETED|Second Intervention (1 Week)||0
148316|NCT00773786|342248|P2|COMPLETED|Second Intervention (1 Week)||10
148317|NCT00773786|342249|P1|COMPLETED|Second Intervention (1 Week)||10
148318|NCT00773786|342248|P2|STARTED|Second Intervention (1 Week)||10
148319|NCT00773786|342249|P1|STARTED|Second Intervention (1 Week)||10
148320|NCT00773786|342248|P2|NOT COMPLETED|Washout (1 Week)||0
148321|NCT00773786|342249|P1|NOT COMPLETED|Washout (1 Week)||0
148322|NCT00773786|342248|P2|COMPLETED|Washout (1 Week)||10
148323|NCT00773786|342249|P1|COMPLETED|Washout (1 Week)||10
148324|NCT00773786|342248|P2|STARTED|Washout (1 Week)||10
148325|NCT00773786|342249|P1|STARTED|Washout (1 Week)||10
148326|NCT00773786|342248|P2|NOT COMPLETED|First Intervention (1 Week)||0
148327|NCT00773786|342249|P1|NOT COMPLETED|First Intervention (1 Week)||0
148328|NCT00773786|342248|P2|COMPLETED|First Intervention (1 Week)||10
148329|NCT00773786|342249|P1|COMPLETED|First Intervention (1 Week)||10
148330|NCT00773786|342248|P2|STARTED|First Intervention (1 Week)||10
148331|NCT00773786|342249|P1|STARTED|First Intervention (1 Week)||10
148332|NCT00773734|342263|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
148333|NCT00773734|342264|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
148334|NCT00773734|342265|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
148335|NCT00773734|342266|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
148336|NCT00773734|342267|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
148337|NCT00773734|342268|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
148338|NCT00773734|342263|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
148339|NCT00773734|342264|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
148340|NCT00773734|342265|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
148341|NCT00773734|342266|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
148342|NCT00773734|342267|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
148343|NCT00773734|342268|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
148344|NCT00773734|342263|P6|STARTED|LTE Period: Week 52 to 6 Years||0
148345|NCT00773734|342264|P5|STARTED|LTE Period: Week 52 to 6 Years||0
148346|NCT00773734|342265|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
148347|NCT00773734|342266|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
148348|NCT00773734|342267|P2|STARTED|LTE Period: Week 52 to 6 Years||0
148349|NCT00773734|342268|P1|STARTED|LTE Period: Week 52 to 6 Years||0
148350|NCT00773734|342263|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
148351|NCT00773734|342264|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
148352|NCT00773734|342265|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
148353|NCT00773734|342266|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
148354|NCT00773734|342267|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
148355|NCT00773734|342268|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
148356|NCT00773734|342263|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
148357|NCT00773734|342264|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
148358|NCT00773734|342265|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
148359|NCT00773734|342266|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
148360|NCT00773734|342267|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
148361|NCT00773734|342268|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
148362|NCT00773734|342263|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
148363|NCT00773734|342264|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
148364|NCT00773734|342265|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
148365|NCT00773734|342266|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
148366|NCT00773734|342267|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
148367|NCT00773734|342268|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
148368|NCT00773734|342263|P6|STARTED|Extension: Active Treatment Week 24-52||27
148369|NCT00773734|342264|P5|STARTED|Extension: Active Treatment Week 24-52||27
148370|NCT00773734|342265|P4|STARTED|Extension: Active Treatment Week 24-52||58
148371|NCT00773734|342266|P3|STARTED|Extension: Active Treatment Week 24-52||50
148372|NCT00773734|342267|P2|STARTED|Extension: Active Treatment Week 24-52||47
148373|NCT00773734|342268|P1|STARTED|Extension: Active Treatment Week 24-52||0
148374|NCT00773734|342263|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
148375|NCT00773734|342264|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
148376|NCT00773734|342265|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
148377|NCT00773734|342266|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
148378|NCT00773734|342267|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
148379|NCT00773734|342268|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
148380|NCT00773734|342263|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
148381|NCT00773734|342264|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
148382|NCT00773734|342265|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
148383|NCT00773734|342266|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
148384|NCT00773734|342267|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
148385|NCT00773734|342268|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
148386|NCT00773734|342263|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
148387|NCT00773734|342264|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
148388|NCT00773734|342265|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
148389|NCT00773734|342266|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
148390|NCT00773734|342267|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
148391|NCT00773734|342268|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
148392|NCT00773734|342263|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
148393|NCT00773734|342264|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
148394|NCT00773734|342265|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
148395|NCT00773734|342266|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
148396|NCT00773734|342267|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
148397|NCT00773734|342268|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
148398|NCT00773734|342263|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
148399|NCT00773734|342264|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
148400|NCT00773734|342265|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
148401|NCT00773734|342266|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
148402|NCT00773734|342267|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
148403|NCT00773734|342268|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
148404|NCT00773734|342263|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
148405|NCT00773734|342264|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
148406|NCT00773734|342265|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
148407|NCT00773734|342266|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
148408|NCT00773734|342267|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
148409|NCT00773734|342268|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
148410|NCT00773474|342830|P1|NOT COMPLETED|Overall Study||0
148411|NCT00773474|342830|P1|COMPLETED|Overall Study||29
148412|NCT00773474|342830|P1|STARTED|Overall Study||29
148413|NCT00773461|342839|P2|NOT COMPLETED|Overall Study||4
148414|NCT00773461|342840|P1|NOT COMPLETED|Overall Study||5
148415|NCT00773461|342839|P2|COMPLETED|Overall Study||135
148416|NCT00773461|342840|P1|COMPLETED|Overall Study||65
148417|NCT00773461|342839|P2|STARTED|Overall Study||139
148418|NCT00773461|342840|P1|STARTED|Overall Study||70
148419|NCT00773383|342878|P1|NOT COMPLETED|Overall Study||31
148420|NCT00773383|342878|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
148421|NCT00773383|342878|P1|Received Study Drug|Overall Study||34
148422|NCT00773383|342878|P1|STARTED|Overall Study||35
148423|NCT00773370|342900|P2|NOT COMPLETED|Overall Study||10
148424|NCT00773370|342901|P1|NOT COMPLETED|Overall Study||18
148425|NCT00773370|342900|P2|COMPLETED|Overall Study||23
148426|NCT00773370|342901|P1|COMPLETED|Overall Study||25
148427|NCT00773370|342900|P2|STARTED|Overall Study||33
148428|NCT00773370|342901|P1|STARTED|Overall Study||43
148429|NCT00773253|342915|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
148430|NCT00773253|342916|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
148431|NCT00773253|342915|P2|COMPLETED|Second Intervention (Week 24-48)||4
148432|NCT00773253|342916|P1|COMPLETED|Second Intervention (Week 24-48)||5
148433|NCT00773253|342915|P2|STARTED|Second Intervention (Week 24-48)||4
148434|NCT00773253|342916|P1|STARTED|Second Intervention (Week 24-48)||5
148435|NCT00773253|342915|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
148436|NCT00773253|342916|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
148437|NCT00773253|342915|P2|COMPLETED|First Intervention (Week 0-24)||4
148438|NCT00773253|342916|P1|COMPLETED|First Intervention (Week 0-24)||5
148439|NCT00773253|342915|P2|STARTED|First Intervention (Week 0-24)||5
148440|NCT00773253|342916|P1|STARTED|First Intervention (Week 0-24)||5
148441|NCT00773136|342922|P1|NOT COMPLETED|Overall Study||2
148442|NCT00773136|342922|P1|COMPLETED|Overall Study||19
148443|NCT00773136|342922|P1|STARTED|Overall Study||21
148444|NCT00773097|342927|P1|NOT COMPLETED|Overall Study||7
148445|NCT00773097|342927|P1|COMPLETED|Overall Study||39
148446|NCT00773097|342927|P1|STARTED|Overall Study||46
148447|NCT00772967|342933|P6|NOT COMPLETED|Crossover Treatment 3||0
148448|NCT00772967|342934|P5|NOT COMPLETED|Crossover Treatment 3||1
148449|NCT00772967|342935|P4|NOT COMPLETED|Crossover Treatment 3||0
148450|NCT00772967|342936|P3|NOT COMPLETED|Crossover Treatment 3||0
148451|NCT00772967|342937|P2|NOT COMPLETED|Crossover Treatment 3||0
148452|NCT00772967|342938|P1|NOT COMPLETED|Crossover Treatment 3||0
148453|NCT00772967|342933|P6|COMPLETED|Crossover Treatment 3||3
148454|NCT00772967|342934|P5|COMPLETED|Crossover Treatment 3||3
148455|NCT00772967|342935|P4|COMPLETED|Crossover Treatment 3||3
148456|NCT00772967|342936|P3|COMPLETED|Crossover Treatment 3||3
148457|NCT00772967|342937|P2|COMPLETED|Crossover Treatment 3||4
148458|NCT00772967|342938|P1|COMPLETED|Crossover Treatment 3||3
148459|NCT00772967|342933|P6|STARTED|Crossover Treatment 3||3
148460|NCT00772967|342934|P5|STARTED|Crossover Treatment 3||4
148461|NCT00772967|342935|P4|STARTED|Crossover Treatment 3||3
148462|NCT00772967|342936|P3|STARTED|Crossover Treatment 3||3
148463|NCT00772967|342937|P2|STARTED|Crossover Treatment 3||4
148464|NCT00772967|342938|P1|STARTED|Crossover Treatment 3||3
148465|NCT00772967|342933|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
148466|NCT00772967|342934|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
148467|NCT00772967|342935|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
148468|NCT00772967|342936|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
148469|NCT00772967|342937|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
148470|NCT00772967|342938|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
148471|NCT00772967|342933|P6|COMPLETED|Break 2 (4-7 Days)||3
148472|NCT00772967|342934|P5|COMPLETED|Break 2 (4-7 Days)||4
148473|NCT00772967|342935|P4|COMPLETED|Break 2 (4-7 Days)||3
148474|NCT00772967|342936|P3|COMPLETED|Break 2 (4-7 Days)||3
148475|NCT00772967|342937|P2|COMPLETED|Break 2 (4-7 Days)||4
148476|NCT00772967|342938|P1|COMPLETED|Break 2 (4-7 Days)||3
148477|NCT00772967|342933|P6|STARTED|Break 2 (4-7 Days)||3
148478|NCT00772967|342934|P5|STARTED|Break 2 (4-7 Days)||4
148479|NCT00772967|342935|P4|STARTED|Break 2 (4-7 Days)||3
148480|NCT00772967|342936|P3|STARTED|Break 2 (4-7 Days)||3
148481|NCT00772967|342937|P2|STARTED|Break 2 (4-7 Days)||4
148482|NCT00772967|342938|P1|STARTED|Break 2 (4-7 Days)||3
148483|NCT00772967|342933|P6|NOT COMPLETED|Crossover Treatment 2||0
148484|NCT00772967|342934|P5|NOT COMPLETED|Crossover Treatment 2||0
148485|NCT00772967|342935|P4|NOT COMPLETED|Crossover Treatment 2||0
148486|NCT00772967|342936|P3|NOT COMPLETED|Crossover Treatment 2||0
148487|NCT00772967|342937|P2|NOT COMPLETED|Crossover Treatment 2||0
148488|NCT00772967|342938|P1|NOT COMPLETED|Crossover Treatment 2||0
148489|NCT00772967|342933|P6|COMPLETED|Crossover Treatment 2||3
148490|NCT00772967|342934|P5|COMPLETED|Crossover Treatment 2||4
148491|NCT00772967|342935|P4|COMPLETED|Crossover Treatment 2||3
148492|NCT00772967|342936|P3|COMPLETED|Crossover Treatment 2||3
148493|NCT00772967|342937|P2|COMPLETED|Crossover Treatment 2||4
148494|NCT00772967|342938|P1|COMPLETED|Crossover Treatment 2||3
148495|NCT00772967|342933|P6|STARTED|Crossover Treatment 2||3
148496|NCT00772967|342934|P5|STARTED|Crossover Treatment 2||4
148497|NCT00772967|342935|P4|STARTED|Crossover Treatment 2||3
148498|NCT00772967|342936|P3|STARTED|Crossover Treatment 2||3
148499|NCT00772967|342937|P2|STARTED|Crossover Treatment 2||4
148500|NCT00772967|342938|P1|STARTED|Crossover Treatment 2||3
148501|NCT00772967|342933|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
148502|NCT00772967|342934|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
148503|NCT00772967|342935|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
148504|NCT00772967|342936|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
148505|NCT00772967|342937|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
148506|NCT00772967|342938|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
148507|NCT00772967|342933|P6|COMPLETED|Break 1 (4-7 Days)||3
148508|NCT00772967|342934|P5|COMPLETED|Break 1 (4-7 Days)||4
148509|NCT00772967|342935|P4|COMPLETED|Break 1 (4-7 Days)||3
148510|NCT00772967|342936|P3|COMPLETED|Break 1 (4-7 Days)||3
148511|NCT00772967|342937|P2|COMPLETED|Break 1 (4-7 Days)||4
148512|NCT00772967|342938|P1|COMPLETED|Break 1 (4-7 Days)||3
148513|NCT00772967|342933|P6|STARTED|Break 1 (4-7 Days)||3
148514|NCT00772967|342934|P5|STARTED|Break 1 (4-7 Days)||4
148515|NCT00772967|342935|P4|STARTED|Break 1 (4-7 Days)||3
148516|NCT00772967|342936|P3|STARTED|Break 1 (4-7 Days)||3
148517|NCT00772967|342937|P2|STARTED|Break 1 (4-7 Days)||5
148518|NCT00772967|342938|P1|STARTED|Break 1 (4-7 Days)||3
148519|NCT00772967|342933|P6|NOT COMPLETED|Crossover Treatment 1||0
148520|NCT00772967|342934|P5|NOT COMPLETED|Crossover Treatment 1||0
148521|NCT00772967|342935|P4|NOT COMPLETED|Crossover Treatment 1||1
148522|NCT00772967|342936|P3|NOT COMPLETED|Crossover Treatment 1||0
148523|NCT00772967|342937|P2|NOT COMPLETED|Crossover Treatment 1||0
148524|NCT00772967|342938|P1|NOT COMPLETED|Crossover Treatment 1||0
148525|NCT00772967|342933|P6|COMPLETED|Crossover Treatment 1||3
148526|NCT00772967|342934|P5|COMPLETED|Crossover Treatment 1||4
148527|NCT00772967|342935|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
148528|NCT00772967|342936|P3|COMPLETED|Crossover Treatment 1||3
148529|NCT00772967|342937|P2|COMPLETED|Crossover Treatment 1||5
148530|NCT00772967|342938|P1|COMPLETED|Crossover Treatment 1||3
148531|NCT00772967|342933|P6|STARTED|Crossover Treatment 1||3
148532|NCT00772967|342934|P5|STARTED|Crossover Treatment 1||4
148533|NCT00772967|342935|P4|STARTED|Crossover Treatment 1||4
148534|NCT00772967|342936|P3|STARTED|Crossover Treatment 1||3
148535|NCT00772967|342937|P2|STARTED|Crossover Treatment 1||5
148536|NCT00772967|342938|P1|STARTED|Crossover Treatment 1||3
148537|NCT00772954|342958|P3|NOT COMPLETED|Overall Study||1
148538|NCT00772954|342959|P2|NOT COMPLETED|Overall Study||0
148539|NCT00772954|342960|P1|NOT COMPLETED|Overall Study||0
148540|NCT00772954|342958|P3|COMPLETED|Overall Study||11
148541|NCT00772954|342959|P2|COMPLETED|Overall Study||12
148542|NCT00772954|342960|P1|COMPLETED|Overall Study||12
148543|NCT00772954|342958|P3|STARTED|Overall Study||12
148544|NCT00772954|342959|P2|STARTED|Overall Study||12
148545|NCT00772954|342960|P1|STARTED|Overall Study||12
148546|NCT00772941|342968|P1|NOT COMPLETED|Overall Study||682
148547|NCT00772941|342968|P1|COMPLETED|Overall Study||3257
148548|NCT00772941|342968|P1|STARTED|Overall Study||3939
148549|NCT00772928|342999|P2|NOT COMPLETED|Overall Study||41
148550|NCT00772928|343000|P1|NOT COMPLETED|Overall Study||44
148551|NCT00772928|342999|P2|COMPLETED|Overall Study||538
148552|NCT00772928|343000|P1|COMPLETED|Overall Study||543
148553|NCT00772928|342999|P2|STARTED|Overall Study||579
148554|NCT00772928|343000|P1|STARTED|Overall Study||587
148555|NCT00772915|343010|P1|NOT COMPLETED|Overall Study||15
148556|NCT00772915|343010|P1|COMPLETED|Overall Study||23
148557|NCT00772915|343010|P1|STARTED|Overall Study||38
148558|NCT00772889|343017|P3|NOT COMPLETED|Overall Study||16
148559|NCT00772889|343018|P2|NOT COMPLETED|Overall Study||18
148560|NCT00772889|343019|P1|NOT COMPLETED|Overall Study||22
148561|NCT00772889|343017|P3|COMPLETED|Overall Study||187
148562|NCT00772889|343018|P2|COMPLETED|Overall Study||375
148563|NCT00772889|343019|P1|COMPLETED|Overall Study||353
148564|NCT00772889|343017|P3|Completed at Day 21|Overall Study||203
148565|NCT00772889|343018|P2|Completed at Day 21|Overall Study||390
148566|NCT00772889|343019|P1|Completed at Day 21|Overall Study||374
148567|NCT00772889|343017|P3|STARTED|Overall Study||203
148568|NCT00772889|343018|P2|STARTED|Overall Study||393
148569|NCT00772889|343019|P1|STARTED|Overall Study||375
148570|NCT00772772|343072|P1|NOT COMPLETED|Overall Study||0
148571|NCT00772772|343072|P1|COMPLETED|Overall Study||12
148572|NCT00772772|343072|P1|STARTED|Overall Study||12
148573|NCT00772707|343077|P1|NOT COMPLETED|Overall Study||3
148574|NCT00772707|343077|P1|COMPLETED|Overall Study||111
148575|NCT00772707|343077|P1|STARTED|Overall Study||114
148576|NCT00772668|343082|P1|NOT COMPLETED|Overall Study||3
148577|NCT00772668|343082|P1|COMPLETED|Overall Study||0
148578|NCT00772668|343082|P1|STARTED|Overall Study||3
148579|NCT00772629|343088|P2|NOT COMPLETED|Overall Study||0
148580|NCT00772629|343089|P1|NOT COMPLETED|Overall Study||1
148581|NCT00772629|343088|P2|COMPLETED|Overall Study||1
148582|NCT00772629|343089|P1|COMPLETED|Overall Study||16
148583|NCT00772629|343088|P2|STARTED|Overall Study||1
148584|NCT00772629|343089|P1|STARTED|Overall Study||17
148585|NCT00772603|343098|P3|NOT COMPLETED|Overall Study||26
148586|NCT00772603|343099|P2|NOT COMPLETED|Overall Study||40
148587|NCT00772603|343100|P1|NOT COMPLETED|Overall Study||52
148588|NCT00772603|343098|P3|COMPLETED|Overall Study||95
148589|NCT00772603|343099|P2|COMPLETED|Overall Study||82
148590|NCT00772603|343100|P1|COMPLETED|Overall Study||71
148591|NCT00772603|343098|P3|STARTED|Overall Study||121
148592|NCT00772603|343099|P2|STARTED|Overall Study||122
148593|NCT00772603|343100|P1|STARTED|Overall Study||123
148594|NCT00772590|343124|P4|NOT COMPLETED|Overall Study||0
148595|NCT00772590|343125|P3|NOT COMPLETED|Overall Study||0
148596|NCT00772590|343126|P2|NOT COMPLETED|Overall Study||0
148597|NCT00772590|343127|P1|NOT COMPLETED|Overall Study||0
148598|NCT00772590|343124|P4|COMPLETED|Overall Study||17
148599|NCT00772590|343125|P3|COMPLETED|Overall Study||18
148600|NCT00772590|343126|P2|COMPLETED|Overall Study||19
148601|NCT00772590|343127|P1|COMPLETED|Overall Study||19
148602|NCT00772590|343124|P4|STARTED|Overall Study||17
148603|NCT00772590|343125|P3|STARTED|Overall Study||18
148604|NCT00772590|343126|P2|STARTED|Overall Study||19
148605|NCT00772590|343127|P1|STARTED|Overall Study||19
148606|NCT00772577|343139|P2|NOT COMPLETED|Overall Study||23
148607|NCT00772577|343140|P1|NOT COMPLETED|Overall Study||23
148608|NCT00772577|343139|P2|COMPLETED|Overall Study||170
148609|NCT00772577|343140|P1|COMPLETED|Overall Study||170
148610|NCT00772577|343139|P2|STARTED|Overall Study||193
148611|NCT00772577|343140|P1|STARTED|Overall Study||193
148612|NCT00772538|343156|P2|NOT COMPLETED|Overall Study||26
148613|NCT00772538|343157|P1|NOT COMPLETED|Overall Study||20
148614|NCT00772538|343156|P2|COMPLETED|Overall Study||211
148615|NCT00772538|343157|P1|COMPLETED|Overall Study||202
148616|NCT00772538|343156|P2|STARTED|Overall Study||237
148617|NCT00772538|343157|P1|STARTED|Overall Study||222
148618|NCT00772447|343229|P2|NOT COMPLETED|Overall Study||24
148619|NCT00772447|343230|P1|NOT COMPLETED|Overall Study||20
148620|NCT00772447|343229|P2|COMPLETED|Overall Study||110
148621|NCT00772447|343230|P1|COMPLETED|Overall Study||111
148622|NCT00772447|343229|P2|STARTED|Overall Study||134
148623|NCT00772447|343230|P1|STARTED|Overall Study||131
148624|NCT00772382|343258|P1|NOT COMPLETED|Overall Study||55
148625|NCT00772382|343258|P1|COMPLETED|Overall Study||61
148626|NCT00772382|343258|P1|STARTED|Overall Study||116
148627|NCT00772369|343263|P1|NOT COMPLETED|Overall Study||1
148628|NCT00772369|343263|P1|COMPLETED|Overall Study||3213
148629|NCT00772369|343263|P1|STARTED|Overall Study||3214
148630|NCT00772304|343268|P1|NOT COMPLETED|Overall Study||0
148631|NCT00772304|343268|P1|COMPLETED|Overall Study||102
148632|NCT00772304|343268|P1|STARTED|Overall Study||102
148633|NCT00772148|343274|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
148634|NCT00772148|343275|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
148635|NCT00772148|343274|P2|COMPLETED|Maintenance Phase (Week 52)||18
148636|NCT00772148|343275|P1|COMPLETED|Maintenance Phase (Week 52)||17
148637|NCT00772148|343274|P2|STARTED|Maintenance Phase (Week 52)||23
148638|NCT00772148|343275|P1|STARTED|Maintenance Phase (Week 52)||21
148639|NCT00772148|343274|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
148640|NCT00772148|343275|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
148641|NCT00772148|343274|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
148642|NCT00772148|343275|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
148643|NCT00772148|343274|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
148644|NCT00772148|343275|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
148645|NCT00772109|343295|P4|NOT COMPLETED|Overall Study||31
148646|NCT00772109|343296|P3|NOT COMPLETED|Overall Study||19
148647|NCT00772109|343297|P2|NOT COMPLETED|Overall Study||19
148648|NCT00772109|343298|P1|NOT COMPLETED|Overall Study||21
148649|NCT00772109|343295|P4|COMPLETED|Overall Study||1397
148650|NCT00772109|343296|P3|COMPLETED|Overall Study||936
148651|NCT00772109|343297|P2|COMPLETED|Overall Study||934
148652|NCT00772109|343298|P1|COMPLETED|Overall Study||935
148653|NCT00772109|343295|P4|STARTED|Overall Study||1428
148654|NCT00772109|343296|P3|STARTED|Overall Study||955
148655|NCT00772109|343297|P2|STARTED|Overall Study||953
148656|NCT00772109|343298|P1|STARTED|Overall Study||956
148657|NCT00772070|343322|P2|NOT COMPLETED|Overall Study||10
148658|NCT00772070|343323|P1|NOT COMPLETED|Overall Study||2
148659|NCT00772070|343322|P2|COMPLETED|Overall Study||61
148660|NCT00772070|343323|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
148661|NCT00772070|343322|P2|STARTED|Overall Study||71
148662|NCT00772070|343323|P1|STARTED|Overall Study||102
148663|NCT00772031|343335|P2|NOT COMPLETED|Overall Study||43
148664|NCT00772031|343336|P1|NOT COMPLETED|Overall Study||32
148665|NCT00772031|343335|P2|COMPLETED|Overall Study||52
148666|NCT00772031|343336|P1|COMPLETED|Overall Study||64
148667|NCT00772031|343335|P2|STARTED|Overall Study||95
148668|NCT00772031|343336|P1|STARTED|Overall Study||96
148669|NCT00772005|343362|P4|NOT COMPLETED|Overall Study||26
148670|NCT00772005|343363|P3|NOT COMPLETED|Overall Study||28
148671|NCT00772005|343364|P2|NOT COMPLETED|Overall Study||30
148672|NCT00772005|343365|P1|NOT COMPLETED|Overall Study||25
148673|NCT00772005|343362|P4|COMPLETED|Overall Study||46
148674|NCT00772005|343363|P3|COMPLETED|Overall Study||44
148675|NCT00772005|343364|P2|COMPLETED|Overall Study||40
148676|NCT00772005|343365|P1|COMPLETED|Overall Study||46
148677|NCT00772005|343362|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
148678|NCT00772005|343363|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
148679|NCT00772005|343364|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
148680|NCT00772005|343365|P1|STARTED|Overall Study||71
148681|NCT00771953|344053|P2|NOT COMPLETED|Overall Study||10
148682|NCT00771953|344054|P1|NOT COMPLETED|Overall Study||10
148683|NCT00771953|344053|P2|COMPLETED|Overall Study||26
148684|NCT00771953|344054|P1|COMPLETED|Overall Study||26
148685|NCT00771953|344053|P2|STARTED|Overall Study||36
148686|NCT00771953|344054|P1|STARTED|Overall Study||36
148687|NCT00771927|344064|P2|NOT COMPLETED|Overall Study||237
148688|NCT00771927|344065|P1|NOT COMPLETED|Overall Study||255
148689|NCT00771927|344064|P2|COMPLETED|Overall Study||256
148690|NCT00771927|344065|P1|COMPLETED|Overall Study||256
148691|NCT00771927|344064|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
148692|NCT00771927|344065|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
148693|NCT00771914|344077|P4|NOT COMPLETED|Overall Study||2
148694|NCT00771914|344078|P3|NOT COMPLETED|Overall Study||0
148695|NCT00771914|344079|P2|NOT COMPLETED|Overall Study||0
148696|NCT00771914|344080|P1|NOT COMPLETED|Overall Study||0
148697|NCT00771914|344077|P4|COMPLETED|Overall Study||6
148698|NCT00771914|344078|P3|COMPLETED|Overall Study||6
148699|NCT00771914|344079|P2|COMPLETED|Overall Study||6
148700|NCT00771914|344080|P1|COMPLETED|Overall Study||7
148701|NCT00771914|344077|P4|STARTED|Overall Study||8
148702|NCT00771914|344078|P3|STARTED|Overall Study||6
148703|NCT00771914|344079|P2|STARTED|Overall Study||6
148704|NCT00771914|344080|P1|STARTED|Overall Study||7
148705|NCT00771875|344093|P3|NOT COMPLETED|Overall Study||0
148706|NCT00771875|344094|P2|NOT COMPLETED|Overall Study||1
148707|NCT00771875|344095|P1|NOT COMPLETED|Overall Study||0
148708|NCT00771875|344093|P3|COMPLETED|Overall Study||10
148709|NCT00771875|344094|P2|COMPLETED|Overall Study||9
148710|NCT00771875|344095|P1|COMPLETED|Overall Study||10
148711|NCT00771875|344093|P3|STARTED|Overall Study||10
148712|NCT00771875|344094|P2|STARTED|Overall Study||10
148713|NCT00771875|344095|P1|STARTED|Overall Study||10
148714|NCT00771849|344123|P2|NOT COMPLETED|Overall Study||4
148715|NCT00771849|344124|P1|NOT COMPLETED|Overall Study||2
148716|NCT00771849|344123|P2|COMPLETED|Overall Study||47
148717|NCT00771849|344124|P1|COMPLETED|Overall Study||50
148718|NCT00771849|344123|P2|STARTED|Overall Study|One subject was not vaccinated|51
148719|NCT00771849|344124|P1|STARTED|Overall Study||52
148720|NCT00771810|344135|P3|NOT COMPLETED|Overall Study||7
148721|NCT00771810|344136|P2|NOT COMPLETED|Overall Study||5
148722|NCT00771810|344137|P1|NOT COMPLETED|Overall Study||5
148723|NCT00771810|344135|P3|COMPLETED|Overall Study||6
148724|NCT00771810|344136|P2|COMPLETED|Overall Study||6
148725|NCT00771810|344137|P1|COMPLETED|Overall Study||5
148726|NCT00771810|344135|P3|STARTED|Overall Study||13
148727|NCT00771810|344136|P2|STARTED|Overall Study||11
148728|NCT00771810|344137|P1|STARTED|Overall Study||10
148729|NCT00771758|344175|P3|NOT COMPLETED|Overall Study||2
148730|NCT00771758|344176|P2|NOT COMPLETED|Overall Study||12
148731|NCT00771758|344177|P1|NOT COMPLETED|Overall Study||8
148732|NCT00771758|344175|P3|COMPLETED|Overall Study||19
148733|NCT00771758|344176|P2|COMPLETED|Overall Study||31
148734|NCT00771758|344177|P1|COMPLETED|Overall Study||36
148735|NCT00771758|344175|P3|STARTED|Overall Study||21
148736|NCT00771758|344176|P2|STARTED|Overall Study||43
148737|NCT00771758|344177|P1|STARTED|Overall Study||44
148738|NCT00771745|344327|P2|NOT COMPLETED|Overall Study||0
148739|NCT00771745|344328|P1|NOT COMPLETED|Overall Study||0
148740|NCT00771745|344327|P2|COMPLETED|Overall Study||5
148741|NCT00771745|344328|P1|COMPLETED|Overall Study||6
148742|NCT00771745|344327|P2|STARTED|Overall Study||5
148743|NCT00771745|344328|P1|STARTED|Overall Study||6
148744|NCT00771667|344338|P10|NOT COMPLETED|Maintenance Phase||17
148745|NCT00771667|344339|P9|NOT COMPLETED|Maintenance Phase||22
148746|NCT00771667|344340|P8|NOT COMPLETED|Maintenance Phase||5
148747|NCT00771667|344341|P7|NOT COMPLETED|Maintenance Phase||10
148748|NCT00771667|344342|P6|NOT COMPLETED|Maintenance Phase||7
148749|NCT00771667|344343|P5|NOT COMPLETED|Maintenance Phase||2
148750|NCT00771667|344344|P4|NOT COMPLETED|Maintenance Phase||0
148751|NCT00771667|344345|P3|NOT COMPLETED|Maintenance Phase||0
148752|NCT00771667|344346|P2|NOT COMPLETED|Maintenance Phase||0
148753|NCT00771667|344347|P1|NOT COMPLETED|Maintenance Phase||0
148754|NCT00771667|344338|P10|COMPLETED|Maintenance Phase||92
148755|NCT00771667|344339|P9|COMPLETED|Maintenance Phase||88
148756|NCT00771667|344340|P8|COMPLETED|Maintenance Phase||67
148757|NCT00771667|344341|P7|COMPLETED|Maintenance Phase||63
148758|NCT00771667|344342|P6|COMPLETED|Maintenance Phase||78
148759|NCT00771667|344343|P5|COMPLETED|Maintenance Phase||26
148760|NCT00771667|344344|P4|COMPLETED|Maintenance Phase||0
148761|NCT00771667|344345|P3|COMPLETED|Maintenance Phase||0
148762|NCT00771667|344346|P2|COMPLETED|Maintenance Phase||0
148763|NCT00771667|344347|P1|COMPLETED|Maintenance Phase||0
148764|NCT00771667|344338|P10|STARTED|Maintenance Phase||109
148765|NCT00771667|344339|P9|STARTED|Maintenance Phase||110
148766|NCT00771667|344340|P8|STARTED|Maintenance Phase||72
148767|NCT00771667|344341|P7|STARTED|Maintenance Phase||73
148768|NCT00771667|344342|P6|STARTED|Maintenance Phase||85
148769|NCT00771667|344343|P5|STARTED|Maintenance Phase||28
148770|NCT00771667|344344|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
148771|NCT00771667|344345|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
148772|NCT00771667|344346|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
148773|NCT00771667|344347|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
148774|NCT00771667|344338|P10|NOT COMPLETED|Induction Phase||0
148775|NCT00771667|344339|P9|NOT COMPLETED|Induction Phase||0
148776|NCT00771667|344340|P8|NOT COMPLETED|Induction Phase||0
148777|NCT00771667|344341|P7|NOT COMPLETED|Induction Phase||0
148778|NCT00771667|344342|P6|NOT COMPLETED|Induction Phase||0
148779|NCT00771667|344343|P5|NOT COMPLETED|Induction Phase||0
148780|NCT00771667|344344|P4|NOT COMPLETED|Induction Phase||8
148781|NCT00771667|344345|P3|NOT COMPLETED|Induction Phase||12
148782|NCT00771667|344346|P2|NOT COMPLETED|Induction Phase||10
148783|NCT00771667|344347|P1|NOT COMPLETED|Induction Phase||19
148784|NCT00771667|344338|P10|COMPLETED|Induction Phase||0
148785|NCT00771667|344339|P9|COMPLETED|Induction Phase||0
148786|NCT00771667|344340|P8|COMPLETED|Induction Phase||0
148787|NCT00771667|344341|P7|COMPLETED|Induction Phase||0
148788|NCT00771667|344342|P6|COMPLETED|Induction Phase||0
148789|NCT00771667|344343|P5|COMPLETED|Induction Phase||0
148790|NCT00771667|344344|P4|COMPLETED|Induction Phase||123
148791|NCT00771667|344345|P3|COMPLETED|Induction Phase||120
148792|NCT00771667|344346|P2|COMPLETED|Induction Phase||121
148793|NCT00771667|344347|P1|COMPLETED|Induction Phase||113
148794|NCT00771667|344338|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148795|NCT00771667|344339|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148796|NCT00771667|344340|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148797|NCT00771667|344341|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148798|NCT00771667|344342|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148799|NCT00771667|344343|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
148800|NCT00771667|344344|P4|STARTED|Induction Phase||131
148801|NCT00771667|344345|P3|STARTED|Induction Phase||132
148802|NCT00771667|344346|P2|STARTED|Induction Phase||131
148803|NCT00771667|344347|P1|STARTED|Induction Phase||132
148804|NCT00771615|344392|P9|NOT COMPLETED|Overall Study||0
148805|NCT00771615|344393|P8|NOT COMPLETED|Overall Study||1
148806|NCT00771615|344394|P7|NOT COMPLETED|Overall Study||1
148807|NCT00771615|344395|P6|NOT COMPLETED|Overall Study||1
148808|NCT00771615|344396|P5|NOT COMPLETED|Overall Study||0
148809|NCT00771615|344397|P4|NOT COMPLETED|Overall Study||1
148810|NCT00771615|344398|P3|NOT COMPLETED|Overall Study||1
148811|NCT00771615|344399|P2|NOT COMPLETED|Overall Study||2
148812|NCT00771615|344400|P1|NOT COMPLETED|Overall Study||1
148813|NCT00771615|344392|P9|COMPLETED|Overall Study|Up to Day 364|41
148814|NCT00771615|344393|P8|COMPLETED|Overall Study|Up to Day 364|58
148815|NCT00771615|344394|P7|COMPLETED|Overall Study|Up to Day 364|45
148816|NCT00771615|344395|P6|COMPLETED|Overall Study|Up to Day 364|60
148817|NCT00771615|344396|P5|COMPLETED|Overall Study|Up to Day 364|40
148818|NCT00771615|344397|P4|COMPLETED|Overall Study|Up to Day 364|59
148819|NCT00771615|344398|P3|COMPLETED|Overall Study|Up to Day 364|40
148820|NCT00771615|344399|P2|COMPLETED|Overall Study|Up to Day 364|70
148821|NCT00771615|344400|P1|COMPLETED|Overall Study|Up to Day 364|48
148822|NCT00771615|344392|P9|STARTED|Overall Study||41
148823|NCT00771615|344393|P8|STARTED|Overall Study||59
148824|NCT00771615|344394|P7|STARTED|Overall Study||46
148825|NCT00771615|344395|P6|STARTED|Overall Study||61
148826|NCT00771615|344396|P5|STARTED|Overall Study||40
148827|NCT00771615|344397|P4|STARTED|Overall Study||60
148828|NCT00771615|344398|P3|STARTED|Overall Study||41
148829|NCT00771615|344399|P2|STARTED|Overall Study||72
148830|NCT00771615|344400|P1|STARTED|Overall Study||49
148831|NCT00771602|344594|P3|NOT COMPLETED|Overall Study||0
148832|NCT00771602|344595|P2|NOT COMPLETED|Overall Study||0
148833|NCT00771602|344596|P1|NOT COMPLETED|Overall Study||0
148834|NCT00771602|344594|P3|COMPLETED|Overall Study||0
148835|NCT00771602|344595|P2|COMPLETED|Overall Study||0
148836|NCT00771602|344596|P1|COMPLETED|Overall Study||1
148837|NCT00771602|344594|P3|STARTED|Overall Study||0
148838|NCT00771602|344595|P2|STARTED|Overall Study||0
148839|NCT00771602|344596|P1|STARTED|Overall Study||1
148840|NCT00771537|344620|P16|NOT COMPLETED|Overall Study||0
148841|NCT00771537|344621|P15|NOT COMPLETED|Overall Study||0
148842|NCT00771537|344622|P14|NOT COMPLETED|Overall Study||0
148843|NCT00771537|344623|P13|NOT COMPLETED|Overall Study||0
148844|NCT00771537|344624|P12|NOT COMPLETED|Overall Study||0
148845|NCT00771537|344625|P11|NOT COMPLETED|Overall Study||0
148846|NCT00771537|344626|P10|NOT COMPLETED|Overall Study||0
148847|NCT00771537|344627|P9|NOT COMPLETED|Overall Study||0
148848|NCT00771537|344628|P8|NOT COMPLETED|Overall Study||0
148849|NCT00771537|344629|P7|NOT COMPLETED|Overall Study||0
148850|NCT00771537|344630|P6|NOT COMPLETED|Overall Study||0
148851|NCT00771537|344631|P5|NOT COMPLETED|Overall Study||0
148852|NCT00771537|344632|P4|NOT COMPLETED|Overall Study||0
148853|NCT00771537|344633|P3|NOT COMPLETED|Overall Study||0
148854|NCT00771537|344634|P2|NOT COMPLETED|Overall Study||0
148855|NCT00771537|344635|P1|NOT COMPLETED|Overall Study||0
148856|NCT00771537|344620|P16|COMPLETED|Overall Study||122
148857|NCT00771537|344621|P15|COMPLETED|Overall Study||124
148858|NCT00771537|344622|P14|COMPLETED|Overall Study||124
148859|NCT00771537|344623|P13|COMPLETED|Overall Study||128
148860|NCT00771537|344624|P12|COMPLETED|Overall Study||137
148861|NCT00771537|344625|P11|COMPLETED|Overall Study||133
148862|NCT00771537|344626|P10|COMPLETED|Overall Study||119
148863|NCT00771537|344627|P9|COMPLETED|Overall Study||115
148864|NCT00771537|344628|P8|COMPLETED|Overall Study||132
148865|NCT00771537|344629|P7|COMPLETED|Overall Study||128
148866|NCT00771537|344630|P6|COMPLETED|Overall Study||118
148867|NCT00771537|344631|P5|COMPLETED|Overall Study||127
148868|NCT00771537|344632|P4|COMPLETED|Overall Study||114
148869|NCT00771537|344633|P3|COMPLETED|Overall Study||151
148870|NCT00771537|344634|P2|COMPLETED|Overall Study||124
148871|NCT00771537|344635|P1|COMPLETED|Overall Study||135
148872|NCT00771537|344620|P16|STARTED|Overall Study||122
148873|NCT00771537|344621|P15|STARTED|Overall Study||124
148874|NCT00771537|344622|P14|STARTED|Overall Study||124
148875|NCT00771537|344623|P13|STARTED|Overall Study||128
148876|NCT00771537|344624|P12|STARTED|Overall Study||137
148877|NCT00771537|344625|P11|STARTED|Overall Study||133
148878|NCT00771537|344626|P10|STARTED|Overall Study||119
148879|NCT00771537|344627|P9|STARTED|Overall Study||115
148880|NCT00771537|344628|P8|STARTED|Overall Study||132
148881|NCT00771537|344629|P7|STARTED|Overall Study||128
148882|NCT00771537|344630|P6|STARTED|Overall Study||118
148883|NCT00771537|344631|P5|STARTED|Overall Study||127
148884|NCT00771537|344632|P4|STARTED|Overall Study||114
148885|NCT00771537|344633|P3|STARTED|Overall Study||151
148886|NCT00771537|344634|P2|STARTED|Overall Study||124
148887|NCT00771537|344635|P1|STARTED|Overall Study||135
148888|NCT00771472|344661|P2|NOT COMPLETED|Overall Study||4
148889|NCT00771472|344662|P1|NOT COMPLETED|Overall Study||6
148890|NCT00771472|344661|P2|COMPLETED|Overall Study||0
148891|NCT00771472|344662|P1|COMPLETED|Overall Study||0
148892|NCT00771472|344661|P2|STARTED|Overall Study||4
148893|NCT00771472|344662|P1|STARTED|Overall Study||6
148894|NCT00771407|344673|P2|NOT COMPLETED|Overall Study||25
148895|NCT00771407|344674|P1|NOT COMPLETED|Overall Study||20
148896|NCT00771407|344673|P2|COMPLETED|Overall Study||35
148897|NCT00771407|344674|P1|COMPLETED|Overall Study||40
148898|NCT00771407|344673|P2|STARTED|Overall Study||60
148899|NCT00771407|344674|P1|STARTED|Overall Study||60
148900|NCT00771316|344682|P2|NOT COMPLETED|Overall Study||1
148901|NCT00771316|344683|P1|NOT COMPLETED|Overall Study||2
148902|NCT00771316|344682|P2|COMPLETED|Overall Study||1
148903|NCT00771316|344683|P1|COMPLETED|Overall Study||2
148904|NCT00771316|344682|P2|STARTED|Overall Study||2
148905|NCT00771316|344683|P1|STARTED|Overall Study||4
148906|NCT00771277|344693|P1|NOT COMPLETED|Overall Study||0
148907|NCT00771277|344693|P1|COMPLETED|Overall Study||6
148908|NCT00771277|344693|P1|STARTED|Overall Study||6
148909|NCT00771264|344701|P2|NOT COMPLETED|Overall Study||5
148910|NCT00771264|344702|P1|NOT COMPLETED|Overall Study||7
148911|NCT00771264|344701|P2|COMPLETED|Overall Study||105
148912|NCT00771264|344702|P1|COMPLETED|Overall Study||103
148913|NCT00771264|344701|P2|STARTED|Overall Study||110
148914|NCT00771264|344702|P1|STARTED|Overall Study||110
148915|NCT00771238|344710|P2|NOT COMPLETED|Overall Study||0
148916|NCT00771238|344711|P1|NOT COMPLETED|Overall Study||0
148917|NCT00771238|344710|P2|COMPLETED|Overall Study||21
148918|NCT00771238|344711|P1|COMPLETED|Overall Study||31
148919|NCT00771238|344710|P2|STARTED|Overall Study||21
148920|NCT00771238|344711|P1|STARTED|Overall Study||31
148921|NCT00771173|344721|P2|NOT COMPLETED|Overall Study||17
148922|NCT00771173|344722|P1|NOT COMPLETED|Overall Study||22
148923|NCT00771173|344721|P2|COMPLETED|Overall Study||112
148924|NCT00771173|344722|P1|COMPLETED|Overall Study||107
148925|NCT00771173|344721|P2|STARTED|Overall Study||129
148926|NCT00771173|344722|P1|STARTED|Overall Study||129
148927|NCT00771056|344728|P1|NOT COMPLETED|Overall Study||5
148928|NCT00771056|344728|P1|COMPLETED|Overall Study||18
148929|NCT00771056|344728|P1|STARTED|Overall Study||23
148930|NCT00770991|344735|P2|NOT COMPLETED|Overall Study||5
148931|NCT00770991|344736|P1|NOT COMPLETED|Overall Study||5
148932|NCT00770991|344735|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
148933|NCT00770991|344736|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
148934|NCT00770991|344735|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
148935|NCT00770991|344736|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
148936|NCT00770965|344752|P4|NOT COMPLETED|Excluded Set||13
148937|NCT00770965|344753|P3|NOT COMPLETED|Excluded Set||14
148938|NCT00770965|344754|P2|NOT COMPLETED|Excluded Set||13
148939|NCT00770965|344755|P1|NOT COMPLETED|Excluded Set||15
148940|NCT00770965|344752|P4|COMPLETED|Excluded Set||2
148941|NCT00770965|344753|P3|COMPLETED|Excluded Set||2
148942|NCT00770965|344754|P2|COMPLETED|Excluded Set||3
148943|NCT00770965|344755|P1|COMPLETED|Excluded Set||3
148944|NCT00770965|344752|P4|STARTED|Excluded Set||15
148945|NCT00770965|344753|P3|STARTED|Excluded Set||16
148946|NCT00770965|344754|P2|STARTED|Excluded Set||16
148947|NCT00770965|344755|P1|STARTED|Excluded Set||18
148948|NCT00770965|344752|P4|NOT COMPLETED|Safety Set||1
148949|NCT00770965|344753|P3|NOT COMPLETED|Safety Set||1
148950|NCT00770965|344754|P2|NOT COMPLETED|Safety Set||0
148951|NCT00770965|344755|P1|NOT COMPLETED|Safety Set||0
148952|NCT00770965|344752|P4|COMPLETED|Safety Set||4
148953|NCT00770965|344753|P3|COMPLETED|Safety Set||3
148954|NCT00770965|344754|P2|COMPLETED|Safety Set||4
148955|NCT00770965|344755|P1|COMPLETED|Safety Set||2
148956|NCT00770965|344752|P4|STARTED|Safety Set||5
148957|NCT00770965|344753|P3|STARTED|Safety Set||4
148958|NCT00770965|344754|P2|STARTED|Safety Set||4
148959|NCT00770965|344755|P1|STARTED|Safety Set||2
148960|NCT00770913|344776|P3|NOT COMPLETED|Overall Study||13
148961|NCT00770913|344777|P2|NOT COMPLETED|Overall Study||8
148962|NCT00770913|344778|P1|NOT COMPLETED|Overall Study||11
148963|NCT00770913|344776|P3|COMPLETED|Overall Study||100
148964|NCT00770913|344777|P2|COMPLETED|Overall Study||103
148965|NCT00770913|344778|P1|COMPLETED|Overall Study||102
148966|NCT00770913|344776|P3|STARTED|Overall Study||113
148967|NCT00770913|344777|P2|STARTED|Overall Study||111
148968|NCT00770913|344778|P1|STARTED|Overall Study||113
148969|NCT00770861|344788|P2|NOT COMPLETED|Overall Study||16
148970|NCT00770861|344789|P1|NOT COMPLETED|Overall Study||10
148971|NCT00770861|344788|P2|COMPLETED|Overall Study||120
148972|NCT00770861|344789|P1|COMPLETED|Overall Study||131
148973|NCT00770861|344788|P2|STARTED|Overall Study||136
148974|NCT00770861|344789|P1|STARTED|Overall Study||141
148975|NCT00770809|344800|P3|NOT COMPLETED|Overall Study||23
148976|NCT00770809|344801|P2|NOT COMPLETED|Overall Study||10
148977|NCT00770809|344802|P1|NOT COMPLETED|Overall Study||17
148978|NCT00770809|344800|P3|COMPLETED|Overall Study||44
148979|NCT00770809|344801|P2|COMPLETED|Overall Study||110
148980|NCT00770809|344802|P1|COMPLETED|Overall Study||101
148981|NCT00770809|344800|P3|STARTED|Overall Study||67
148982|NCT00770809|344801|P2|STARTED|Overall Study||120
148983|NCT00770809|344802|P1|STARTED|Overall Study||118
148984|NCT00770770|344812|P2|NOT COMPLETED|Overall Study||1
148985|NCT00770770|344813|P1|NOT COMPLETED|Overall Study||10
148986|NCT00770770|344812|P2|COMPLETED|Overall Study||5
148987|NCT00770770|344813|P1|COMPLETED|Overall Study||4
148988|NCT00770770|344812|P2|STARTED|Overall Study||6
148989|NCT00770770|344813|P1|STARTED|Overall Study||14
148990|NCT00770757|344819|P1|NOT COMPLETED|Overall Study||0
148991|NCT00770757|344819|P1|COMPLETED|Overall Study||13
148992|NCT00770757|344819|P1|STARTED|Overall Study||13
148993|NCT00770692|344831|P4|NOT COMPLETED|Overall Study||11
148994|NCT00770692|344832|P3|NOT COMPLETED|Overall Study||14
148995|NCT00770692|344833|P2|NOT COMPLETED|Overall Study||9
148996|NCT00770692|344834|P1|NOT COMPLETED|Overall Study||12
148997|NCT00770692|344831|P4|COMPLETED|Overall Study||66
148998|NCT00770692|344832|P3|COMPLETED|Overall Study||70
148999|NCT00770692|344833|P2|COMPLETED|Overall Study||74
149000|NCT00770692|344834|P1|COMPLETED|Overall Study||69
149001|NCT00770692|344831|P4|STARTED|Overall Study||77
149002|NCT00770692|344832|P3|STARTED|Overall Study||84
149003|NCT00770692|344833|P2|STARTED|Overall Study||83
149004|NCT00770692|344834|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
149005|NCT00770653|344862|P2|NOT COMPLETED|Overall Study||29
149006|NCT00770653|344863|P1|NOT COMPLETED|Overall Study||32
149007|NCT00770653|344862|P2|COMPLETED|Overall Study||121
149008|NCT00770653|344863|P1|COMPLETED|Overall Study||123
149009|NCT00770653|344862|P2|STARTED|Overall Study||150
149010|NCT00770653|344863|P1|STARTED|Overall Study||155
149011|NCT00770588|344933|P2|NOT COMPLETED|Overall Study||95
149012|NCT00770588|344934|P1|NOT COMPLETED|Overall Study||81
149013|NCT00770588|344933|P2|COMPLETED|Overall Study||53
149014|NCT00770588|344934|P1|COMPLETED|Overall Study||67
149015|NCT00770588|344933|P2|STARTED|Overall Study||148
149016|NCT00770588|344934|P1|STARTED|Overall Study||148
149017|NCT00770562|344950|P2|NOT COMPLETED|Overall Study||1
149018|NCT00770562|344951|P1|NOT COMPLETED|Overall Study||1
149019|NCT00770562|344950|P2|COMPLETED|Overall Study||49
149020|NCT00770562|344951|P1|COMPLETED|Overall Study||52
149021|NCT00770562|344950|P2|STARTED|Overall Study||50
149022|NCT00770562|344951|P1|STARTED|Overall Study||53
149023|NCT00770510|344962|P1|NOT COMPLETED|Overall Study||5
149024|NCT00770510|344962|P1|COMPLETED|Overall Study||67
149025|NCT00770510|344962|P1|STARTED|Overall Study||72
149026|NCT00770484|345001|P2|NOT COMPLETED|Overall Study||0
149027|NCT00770484|345002|P1|NOT COMPLETED|Overall Study||1
149028|NCT00770484|345001|P2|COMPLETED|Overall Study||4
149029|NCT00770484|345002|P1|COMPLETED|Overall Study||7
149030|NCT00770484|345001|P2|STARTED|Overall Study||4
149031|NCT00770484|345002|P1|STARTED|Overall Study||8
149032|NCT00770432|345010|P2|NOT COMPLETED|Overall Study||7
149033|NCT00770432|345011|P1|NOT COMPLETED|Overall Study||4
149034|NCT00770432|345010|P2|COMPLETED|Overall Study||94
149035|NCT00770432|345011|P1|COMPLETED|Overall Study||98
149036|NCT00770432|345010|P2|STARTED|Overall Study||101
149037|NCT00770432|345011|P1|STARTED|Overall Study||102
149038|NCT00770367|345019|P2|NOT COMPLETED|Second Intervention||0
149039|NCT00770367|345020|P1|NOT COMPLETED|Second Intervention||2
149040|NCT00770367|345019|P2|COMPLETED|Second Intervention||15
149041|NCT00770367|345020|P1|COMPLETED|Second Intervention||16
149042|NCT00770367|345019|P2|STARTED|Second Intervention||15
149043|NCT00770367|345020|P1|STARTED|Second Intervention||18
149044|NCT00770367|345019|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
149045|NCT00770367|345020|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
149046|NCT00770367|345019|P2|COMPLETED|Washout Period of 4 Weeks||15
149047|NCT00770367|345020|P1|COMPLETED|Washout Period of 4 Weeks||18
149048|NCT00770367|345019|P2|STARTED|Washout Period of 4 Weeks||16
149049|NCT00770367|345020|P1|STARTED|Washout Period of 4 Weeks||18
149050|NCT00770367|345019|P2|NOT COMPLETED|First Intervention||2
149051|NCT00770367|345020|P1|NOT COMPLETED|First Intervention||0
149052|NCT00770367|345019|P2|COMPLETED|First Intervention||16
149053|NCT00770367|345020|P1|COMPLETED|First Intervention||18
149054|NCT00770367|345019|P2|STARTED|First Intervention||18
149055|NCT00770367|345020|P1|STARTED|First Intervention||18
149056|NCT00770341|345029|P3|NOT COMPLETED|Overall Study||3
149057|NCT00770341|345030|P2|NOT COMPLETED|Overall Study||5
149058|NCT00770341|345031|P1|NOT COMPLETED|Overall Study||12
149059|NCT00770341|345029|P3|COMPLETED|Overall Study||8
149060|NCT00770341|345030|P2|COMPLETED|Overall Study||17
149061|NCT00770341|345031|P1|COMPLETED|Overall Study||77
149062|NCT00770341|345029|P3|STARTED|Overall Study|Number randomized|11
149063|NCT00770341|345030|P2|STARTED|Overall Study|Number randomized|22
149064|NCT00770341|345031|P1|STARTED|Overall Study|Number randomized|89
149065|NCT00770315|345059|P4|NOT COMPLETED|Overall Study||38
149066|NCT00770315|345060|P3|NOT COMPLETED|Overall Study||57
149067|NCT00770315|345061|P2|NOT COMPLETED|Overall Study||43
149068|NCT00770315|345062|P1|NOT COMPLETED|Overall Study||40
149069|NCT00770315|345059|P4|COMPLETED|Overall Study||160
149070|NCT00770315|345060|P3|COMPLETED|Overall Study||137
149071|NCT00770315|345061|P2|COMPLETED|Overall Study||152
149072|NCT00770315|345062|P1|COMPLETED|Overall Study||157
149073|NCT00770315|345059|P4|STARTED|Overall Study||198
149074|NCT00770315|345060|P3|STARTED|Overall Study||194
149075|NCT00770315|345061|P2|STARTED|Overall Study||195
149076|NCT00770315|345062|P1|STARTED|Overall Study||197
149077|NCT00770289|345088|P1|NOT COMPLETED|Overall Study||6
149078|NCT00770289|345088|P1|COMPLETED|Overall Study||845
149079|NCT00770289|345088|P1|STARTED|Overall Study||851
149080|NCT00770211|345099|P2|NOT COMPLETED|Overall Study||2
149081|NCT00770211|345100|P1|NOT COMPLETED|Overall Study||1
149082|NCT00770211|345099|P2|COMPLETED|Overall Study||87
149083|NCT00770211|345100|P1|COMPLETED|Overall Study||181
149084|NCT00770211|345099|P2|STARTED|Overall Study||89
149085|NCT00770211|345100|P1|STARTED|Overall Study||182
149086|NCT00770146|345116|P2|NOT COMPLETED|Follow-up Period||20
149087|NCT00770146|345117|P1|NOT COMPLETED|Follow-up Period||11
149088|NCT00770146|345116|P2|COMPLETED|Follow-up Period||85
149089|NCT00770146|345117|P1|COMPLETED|Follow-up Period||42
149090|NCT00770146|345116|P2|STARTED|Follow-up Period||105
149091|NCT00770146|345117|P1|STARTED|Follow-up Period||53
149092|NCT00770146|345116|P2|NOT COMPLETED|Treatment Period||45
149093|NCT00770146|345117|P1|NOT COMPLETED|Treatment Period||9
149094|NCT00770146|345116|P2|COMPLETED|Treatment Period||60
149095|NCT00770146|345117|P1|COMPLETED|Treatment Period||44
149096|NCT00770146|345116|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
149097|NCT00770146|345117|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
149098|NCT00770146|345116|P2|Treated|Treatment Period||105
149099|NCT00770146|345117|P1|Treated|Treatment Period||52
149100|NCT00770146|345116|P2|STARTED|Treatment Period||105
149101|NCT00770146|345117|P1|STARTED|Treatment Period||53
149102|NCT00770029|345163|P2|NOT COMPLETED|Overall Study||3
149103|NCT00770029|345164|P1|NOT COMPLETED|Overall Study||6
149104|NCT00770029|345163|P2|COMPLETED|Overall Study||89
149105|NCT00770029|345164|P1|COMPLETED|Overall Study||178
149106|NCT00770029|345163|P2|STARTED|Overall Study||92
149107|NCT00770029|345164|P1|STARTED|Overall Study||184
149108|NCT00769860|345180|P2|NOT COMPLETED|Overall Study||0
149109|NCT00769860|345181|P1|NOT COMPLETED|Overall Study||2
149110|NCT00769860|345180|P2|COMPLETED|Overall Study||8
149111|NCT00769860|345181|P1|COMPLETED|Overall Study||14
149112|NCT00769860|345180|P2|Month 8|Overall Study||8
149113|NCT00769860|345181|P1|Month 8|Overall Study||14
149114|NCT00769860|345180|P2|Month 4|Overall Study||8
149115|NCT00769860|345181|P1|Month 4|Overall Study||16
149116|NCT00769860|345180|P2|STARTED|Overall Study||8
149117|NCT00769860|345181|P1|STARTED|Overall Study||16
149118|NCT00769704|345209|P2|NOT COMPLETED|Overall Study||199
149119|NCT00769704|345210|P1|NOT COMPLETED|Overall Study||111
149120|NCT00769704|345209|P2|COMPLETED|Overall Study||97
149121|NCT00769704|345210|P1|COMPLETED|Overall Study||30
149122|NCT00769704|345209|P2|Received Treatment|Overall Study||292
149123|NCT00769704|345210|P1|Received Treatment|Overall Study||127
149124|NCT00769704|345209|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
149125|NCT00769704|345210|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
149126|NCT00769704|345209|P2|STARTED|Overall Study||296
149127|NCT00769704|345210|P1|STARTED|Overall Study||141
149128|NCT00769652|345230|P2|NOT COMPLETED|Overall Study||0
149129|NCT00769652|345231|P1|NOT COMPLETED|Overall Study||0
149130|NCT00769652|345230|P2|COMPLETED|Overall Study||1
149131|NCT00769652|345231|P1|COMPLETED|Overall Study||6
149132|NCT00769652|345230|P2|STARTED|Overall Study||1
149133|NCT00769652|345231|P1|STARTED|Overall Study||6
149134|NCT00769561|345243|P2|NOT COMPLETED|Overall Study||5
149135|NCT00769561|345244|P1|NOT COMPLETED|Overall Study||3
149136|NCT00769561|345243|P2|COMPLETED|Overall Study||24
149137|NCT00769561|345244|P1|COMPLETED|Overall Study||26
149138|NCT00769561|345243|P2|STARTED|Overall Study||29
149139|NCT00769561|345244|P1|STARTED|Overall Study||29
149140|NCT00769314|345266|P2|NOT COMPLETED|Overall Study||13
149141|NCT00769314|345267|P1|NOT COMPLETED|Overall Study||17
149142|NCT00769314|345266|P2|COMPLETED|Overall Study||384
149143|NCT00769314|345267|P1|COMPLETED|Overall Study||361
149144|NCT00769314|345266|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
149145|NCT00769314|345267|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
149146|NCT00769184|345293|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
149147|NCT00769184|345294|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
149148|NCT00769184|345293|P2|COMPLETED|No Treatment (6 Weeks)||6
149149|NCT00769184|345294|P1|COMPLETED|No Treatment (6 Weeks)||5
149150|NCT00769184|345293|P2|STARTED|No Treatment (6 Weeks)||7
149151|NCT00769184|345294|P1|STARTED|No Treatment (6 Weeks)||6
149152|NCT00769184|345293|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
149153|NCT00769184|345294|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
149154|NCT00769184|345293|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
149155|NCT00769184|345294|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
149156|NCT00769184|345293|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
149157|NCT00769184|345294|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
149158|NCT00769184|345293|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
149159|NCT00769184|345294|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
149160|NCT00769184|345293|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
149161|NCT00769184|345294|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
149162|NCT00769184|345293|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
149163|NCT00769184|345294|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
149164|NCT00769132|345302|P4|NOT COMPLETED|Period 4||0
149165|NCT00769132|345303|P3|NOT COMPLETED|Period 4||0
149166|NCT00769132|345304|P2|NOT COMPLETED|Period 4||1
149167|NCT00769132|345305|P1|NOT COMPLETED|Period 4||0
149168|NCT00769132|345302|P4|COMPLETED|Period 4||5
149169|NCT00769132|345303|P3|COMPLETED|Period 4||6
149170|NCT00769132|345304|P2|COMPLETED|Period 4||5
149171|NCT00769132|345305|P1|COMPLETED|Period 4||5
149172|NCT00769132|345302|P4|STARTED|Period 4||5
149173|NCT00769132|345303|P3|STARTED|Period 4||6
149174|NCT00769132|345304|P2|STARTED|Period 4||6
149175|NCT00769132|345305|P1|STARTED|Period 4||5
149176|NCT00769132|345302|P4|NOT COMPLETED|Period 3||0
149177|NCT00769132|345303|P3|NOT COMPLETED|Period 3||0
149178|NCT00769132|345304|P2|NOT COMPLETED|Period 3||0
149179|NCT00769132|345305|P1|NOT COMPLETED|Period 3||1
149180|NCT00769132|345302|P4|COMPLETED|Period 3||5
149181|NCT00769132|345303|P3|COMPLETED|Period 3||6
149182|NCT00769132|345304|P2|COMPLETED|Period 3||6
149183|NCT00769132|345305|P1|COMPLETED|Period 3||5
149184|NCT00769132|345302|P4|STARTED|Period 3||5
149185|NCT00769132|345303|P3|STARTED|Period 3||6
149186|NCT00769132|345304|P2|STARTED|Period 3||6
149187|NCT00769132|345305|P1|STARTED|Period 3||6
149188|NCT00769132|345302|P4|NOT COMPLETED|Period 2||1
149189|NCT00769132|345303|P3|NOT COMPLETED|Period 2||0
149190|NCT00769132|345304|P2|NOT COMPLETED|Period 2||0
149191|NCT00769132|345305|P1|NOT COMPLETED|Period 2||0
149192|NCT00769132|345302|P4|COMPLETED|Period 2||5
149193|NCT00769132|345303|P3|COMPLETED|Period 2||6
149194|NCT00769132|345304|P2|COMPLETED|Period 2||6
149195|NCT00769132|345305|P1|COMPLETED|Period 2||6
149196|NCT00769132|345302|P4|STARTED|Period 2||6
149197|NCT00769132|345303|P3|STARTED|Period 2||6
149198|NCT00769132|345304|P2|STARTED|Period 2||6
149199|NCT00769132|345305|P1|STARTED|Period 2||6
149200|NCT00769132|345302|P4|NOT COMPLETED|Period 1||1
149201|NCT00769132|345303|P3|NOT COMPLETED|Period 1||0
149202|NCT00769132|345304|P2|NOT COMPLETED|Period 1||0
149203|NCT00769132|345305|P1|NOT COMPLETED|Period 1||1
149204|NCT00769132|345302|P4|COMPLETED|Period 1||6
149205|NCT00769132|345303|P3|COMPLETED|Period 1||6
149206|NCT00769132|345304|P2|COMPLETED|Period 1||6
149207|NCT00769132|345305|P1|COMPLETED|Period 1||6
149208|NCT00769132|345302|P4|STARTED|Period 1||7
149209|NCT00769132|345303|P3|STARTED|Period 1||6
149210|NCT00769132|345304|P2|STARTED|Period 1||6
149211|NCT00769132|345305|P1|STARTED|Period 1||7
149212|NCT00769119|345321|P2|NOT COMPLETED|Overall Study||3
149213|NCT00769119|345322|P1|NOT COMPLETED|Overall Study||2
149214|NCT00769119|345321|P2|COMPLETED|Overall Study||13
149215|NCT00769119|345322|P1|COMPLETED|Overall Study||20
149216|NCT00769119|345321|P2|STARTED|Overall Study||16
149217|NCT00769119|345322|P1|STARTED|Overall Study||22
149218|NCT00769067|345368|P2|NOT COMPLETED|Overall Study||94
149219|NCT00769067|345369|P1|NOT COMPLETED|Overall Study||94
149220|NCT00769067|345368|P2|COMPLETED|Overall Study||0
149221|NCT00769067|345369|P1|COMPLETED|Overall Study||0
149222|NCT00769067|345368|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
149223|NCT00769067|345369|P1|Treated|Overall Study||94
149224|NCT00769067|345368|P2|STARTED|Overall Study||94
149225|NCT00769067|345369|P1|STARTED|Overall Study||94
149226|NCT00769015|345396|P2|NOT COMPLETED|Overall Study||16
149227|NCT00769015|345397|P1|NOT COMPLETED|Overall Study||9
149228|NCT00769015|345396|P2|COMPLETED|Overall Study||76
149229|NCT00769015|345397|P1|COMPLETED|Overall Study||87
149230|NCT00769015|345396|P2|STARTED|Overall Study||92
149231|NCT00769015|345397|P1|STARTED|Overall Study||96
149232|NCT00768989|345417|P2|NOT COMPLETED|On or After Week 36||27
149233|NCT00768989|345418|P1|NOT COMPLETED|On or After Week 36||51
149234|NCT00768989|345417|P2|COMPLETED|On or After Week 36||0
149235|NCT00768989|345418|P1|COMPLETED|On or After Week 36||0
149236|NCT00768989|345417|P2|STARTED|On or After Week 36||27
149237|NCT00768989|345418|P1|STARTED|On or After Week 36||51
149238|NCT00768989|345417|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
149239|NCT00768989|345418|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
149240|NCT00768989|345417|P2|COMPLETED|Week 24 to Prior to Week 36||27
149241|NCT00768989|345418|P1|COMPLETED|Week 24 to Prior to Week 36||51
149242|NCT00768989|345417|P2|STARTED|Week 24 to Prior to Week 36||27
149243|NCT00768989|345418|P1|STARTED|Week 24 to Prior to Week 36||59
149244|NCT00768989|345417|P2|NOT COMPLETED|Prior to Week 24||3
149245|NCT00768989|345418|P1|NOT COMPLETED|Prior to Week 24||4
149246|NCT00768989|345417|P2|COMPLETED|Prior to Week 24||27
149247|NCT00768989|345418|P1|COMPLETED|Prior to Week 24||59
149248|NCT00768989|345417|P2|STARTED|Prior to Week 24||30
149249|NCT00768989|345418|P1|STARTED|Prior to Week 24||63
149250|NCT00768898|345466|P1|NOT COMPLETED|Overall Study||2
149251|NCT00768898|345466|P1|COMPLETED|Overall Study||28
149252|NCT00768898|345466|P1|STARTED|Overall Study||30
149253|NCT00768755|345490|P4|NOT COMPLETED|Phase 2||57
149254|NCT00768755|345491|P3|NOT COMPLETED|Phase 2||58
149255|NCT00768755|345492|P2|NOT COMPLETED|Phase 2||55
149256|NCT00768755|345493|P1|NOT COMPLETED|Phase 2||0
149257|NCT00768755|345490|P4|COMPLETED|Phase 2||0
149258|NCT00768755|345491|P3|COMPLETED|Phase 2||0
149259|NCT00768755|345492|P2|COMPLETED|Phase 2||0
149260|NCT00768755|345493|P1|COMPLETED|Phase 2||0
149261|NCT00768755|345490|P4|Treated|Phase 2||55
149262|NCT00768755|345491|P3|Treated|Phase 2||58
149263|NCT00768755|345492|P2|Treated|Phase 2||55
149264|NCT00768755|345493|P1|Treated|Phase 2||0
149265|NCT00768755|345490|P4|STARTED|Phase 2||57
149266|NCT00768755|345491|P3|STARTED|Phase 2||58
149267|NCT00768755|345492|P2|STARTED|Phase 2||55
149268|NCT00768755|345493|P1|STARTED|Phase 2||0
149269|NCT00768755|345490|P4|NOT COMPLETED|Phase 1||0
149270|NCT00768755|345491|P3|NOT COMPLETED|Phase 1||0
149271|NCT00768755|345492|P2|NOT COMPLETED|Phase 1||0
149272|NCT00768755|345493|P1|NOT COMPLETED|Phase 1||10
149273|NCT00768755|345490|P4|COMPLETED|Phase 1||0
149274|NCT00768755|345491|P3|COMPLETED|Phase 1||0
149275|NCT00768755|345492|P2|COMPLETED|Phase 1||0
149276|NCT00768755|345493|P1|COMPLETED|Phase 1||0
149277|NCT00768755|345490|P4|STARTED|Phase 1||0
149278|NCT00768755|345491|P3|STARTED|Phase 1||0
149279|NCT00768755|345492|P2|STARTED|Phase 1||0
149280|NCT00768755|345493|P1|STARTED|Phase 1||10
149281|NCT00768651|345517|P1|NOT COMPLETED|Overall Study||1
149282|NCT00768651|345517|P1|COMPLETED|Overall Study||7
149283|NCT00768651|345517|P1|STARTED|Overall Study||8
149284|NCT00768599|345525|P3|NOT COMPLETED|Overall Study||12
149285|NCT00768599|345526|P2|NOT COMPLETED|Overall Study||16
149286|NCT00768599|345527|P1|NOT COMPLETED|Overall Study||11
149287|NCT00768599|345525|P3|COMPLETED|Overall Study||35
149288|NCT00768599|345526|P2|COMPLETED|Overall Study||27
149289|NCT00768599|345527|P1|COMPLETED|Overall Study||34
149290|NCT00768599|345525|P3|STARTED|Overall Study||47
149291|NCT00768599|345526|P2|STARTED|Overall Study||43
149292|NCT00768599|345527|P1|STARTED|Overall Study||45
149293|NCT00768560|345556|P6|NOT COMPLETED|Intervention Set 3||0
149294|NCT00768560|345557|P5|NOT COMPLETED|Intervention Set 3||0
149295|NCT00768560|345558|P4|NOT COMPLETED|Intervention Set 3||0
149296|NCT00768560|345559|P3|NOT COMPLETED|Intervention Set 3||0
149297|NCT00768560|345560|P2|NOT COMPLETED|Intervention Set 3||0
149298|NCT00768560|345561|P1|NOT COMPLETED|Intervention Set 3||0
149299|NCT00768560|345556|P6|COMPLETED|Intervention Set 3||6
149300|NCT00768560|345557|P5|COMPLETED|Intervention Set 3||6
149301|NCT00768560|345558|P4|COMPLETED|Intervention Set 3||6
149302|NCT00768560|345559|P3|COMPLETED|Intervention Set 3||6
149303|NCT00768560|345560|P2|COMPLETED|Intervention Set 3||5
149304|NCT00768560|345561|P1|COMPLETED|Intervention Set 3||5
149305|NCT00768560|345556|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
149306|NCT00768560|345557|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
149307|NCT00768560|345558|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
149308|NCT00768560|345559|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
149309|NCT00768560|345560|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
149310|NCT00768560|345561|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
149311|NCT00768560|345556|P6|NOT COMPLETED|Intervention Set 2||0
149312|NCT00768560|345557|P5|NOT COMPLETED|Intervention Set 2||0
149313|NCT00768560|345558|P4|NOT COMPLETED|Intervention Set 2||0
149314|NCT00768560|345559|P3|NOT COMPLETED|Intervention Set 2||0
149315|NCT00768560|345560|P2|NOT COMPLETED|Intervention Set 2||0
149316|NCT00768560|345561|P1|NOT COMPLETED|Intervention Set 2||0
149317|NCT00768560|345556|P6|COMPLETED|Intervention Set 2||6
149318|NCT00768560|345557|P5|COMPLETED|Intervention Set 2||6
149319|NCT00768560|345558|P4|COMPLETED|Intervention Set 2||6
149320|NCT00768560|345559|P3|COMPLETED|Intervention Set 2||6
149321|NCT00768560|345560|P2|COMPLETED|Intervention Set 2||5
149322|NCT00768560|345561|P1|COMPLETED|Intervention Set 2||5
149323|NCT00768560|345556|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
149324|NCT00768560|345557|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
149325|NCT00768560|345558|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
149326|NCT00768560|345559|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
149327|NCT00768560|345560|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
149328|NCT00768560|345561|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
149329|NCT00768560|345556|P6|NOT COMPLETED|Intervention Set 1||0
149330|NCT00768560|345557|P5|NOT COMPLETED|Intervention Set 1||0
149331|NCT00768560|345558|P4|NOT COMPLETED|Intervention Set 1||0
149332|NCT00768560|345559|P3|NOT COMPLETED|Intervention Set 1||0
149333|NCT00768560|345560|P2|NOT COMPLETED|Intervention Set 1||1
149334|NCT00768560|345561|P1|NOT COMPLETED|Intervention Set 1||0
149335|NCT00768560|345556|P6|COMPLETED|Intervention Set 1||6
149336|NCT00768560|345557|P5|COMPLETED|Intervention Set 1||6
149337|NCT00768560|345558|P4|COMPLETED|Intervention Set 1||6
149338|NCT00768560|345559|P3|COMPLETED|Intervention Set 1||6
149339|NCT00768560|345560|P2|COMPLETED|Intervention Set 1||5
149340|NCT00768560|345561|P1|COMPLETED|Intervention Set 1||5
149341|NCT00768560|345556|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
149342|NCT00768560|345557|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
149343|NCT00768560|345558|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
149344|NCT00768560|345559|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
149345|NCT00768560|345560|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
149346|NCT00768560|345561|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
149347|NCT00768560|345556|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
149348|NCT00768560|345557|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
149349|NCT00768560|345558|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
149350|NCT00768560|345559|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
149351|NCT00768560|345560|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
149352|NCT00768560|345561|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
149353|NCT00768521|345587|P2|NOT COMPLETED|Period 2||0
149354|NCT00768521|345588|P1|NOT COMPLETED|Period 2||0
149355|NCT00768521|345587|P2|COMPLETED|Period 2||11
149356|NCT00768521|345588|P1|COMPLETED|Period 2||9
149357|NCT00768521|345587|P2|STARTED|Period 2||11
149358|NCT00768521|345588|P1|STARTED|Period 2||9
149359|NCT00768521|345587|P2|NOT COMPLETED|Period 1||0
149360|NCT00768521|345588|P1|NOT COMPLETED|Period 1||0
149361|NCT00768521|345587|P2|COMPLETED|Period 1||11
149362|NCT00768521|345588|P1|COMPLETED|Period 1||9
149363|NCT00768521|345587|P2|STARTED|Period 1||11
149364|NCT00768521|345588|P1|STARTED|Period 1||9
149365|NCT00768430|345598|P2|NOT COMPLETED|7 Day Endpoint||3
149366|NCT00768430|345599|P1|NOT COMPLETED|7 Day Endpoint||2
149367|NCT00768430|345598|P2|COMPLETED|7 Day Endpoint||22
149368|NCT00768430|345599|P1|COMPLETED|7 Day Endpoint||45
149369|NCT00768430|345598|P2|STARTED|7 Day Endpoint||25
149370|NCT00768430|345599|P1|STARTED|7 Day Endpoint||47
149371|NCT00768430|345598|P2|NOT COMPLETED|24 Hour Endpoint||0
149372|NCT00768430|345599|P1|NOT COMPLETED|24 Hour Endpoint||1
149373|NCT00768430|345598|P2|COMPLETED|24 Hour Endpoint||25
149374|NCT00768430|345599|P1|COMPLETED|24 Hour Endpoint||47
149375|NCT00768430|345598|P2|STARTED|24 Hour Endpoint||25
149376|NCT00768430|345599|P1|STARTED|24 Hour Endpoint||48
149377|NCT00768300|345607|P2|NOT COMPLETED|Overall Study||163
149378|NCT00768300|345608|P1|NOT COMPLETED|Overall Study||329
149379|NCT00768300|345607|P2|COMPLETED|Overall Study||1
149380|NCT00768300|345608|P1|COMPLETED|Overall Study||1
149381|NCT00768300|345607|P2|Randomized and Treated|Overall Study||163
149382|NCT00768300|345608|P1|Randomized and Treated|Overall Study||329
149383|NCT00768300|345607|P2|STARTED|Overall Study||164
149384|NCT00768300|345608|P1|STARTED|Overall Study||330
149385|NCT00768222|345632|P2|NOT COMPLETED|Overall Study||4
149386|NCT00768222|345633|P1|NOT COMPLETED|Overall Study||4
149387|NCT00768222|345632|P2|COMPLETED|Overall Study||47
149388|NCT00768222|345633|P1|COMPLETED|Overall Study||46
149389|NCT00768222|345632|P2|STARTED|Overall Study||51
149390|NCT00768222|345633|P1|STARTED|Overall Study||50
149391|NCT00768144|345655|P1|NOT COMPLETED|Overall Study||36
149392|NCT00768144|345655|P1|COMPLETED|Overall Study||0
149393|NCT00768144|345655|P1|STARTED|Overall Study||36
149394|NCT00768118|345661|P1|NOT COMPLETED|Overall Study||0
149395|NCT00768118|345661|P1|COMPLETED|Overall Study||11
149396|NCT00768118|345661|P1|STARTED|Overall Study||11
149397|NCT00768066|345668|P3|NOT COMPLETED|Overall Study||0
149398|NCT00768066|345669|P2|NOT COMPLETED|Overall Study||3
149399|NCT00768066|345670|P1|NOT COMPLETED|Overall Study||3
149400|NCT00768066|345668|P3|COMPLETED|Overall Study||21
149401|NCT00768066|345669|P2|COMPLETED|Overall Study||19
149402|NCT00768066|345670|P1|COMPLETED|Overall Study||19
149403|NCT00768066|345668|P3|STARTED|Overall Study||21
149404|NCT00768066|345669|P2|STARTED|Overall Study||22
149405|NCT00768066|345670|P1|STARTED|Overall Study||22
149406|NCT00768053|345702|P1|NOT COMPLETED|Overall Study||11
149407|NCT00768053|345702|P1|COMPLETED|Overall Study||97
149408|NCT00768053|345702|P1|STARTED|Overall Study||108
149409|NCT00768040|345733|P2|NOT COMPLETED|Overall Study||3
149410|NCT00768040|345734|P1|NOT COMPLETED|Overall Study||4
149411|NCT00768040|345733|P2|COMPLETED|Overall Study||16
149412|NCT00768040|345734|P1|COMPLETED|Overall Study||16
149413|NCT00768040|345733|P2|STARTED|Overall Study||19
149414|NCT00768040|345734|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
149415|NCT00767806|345742|P2|NOT COMPLETED|Overall Study||47
149416|NCT00767806|345743|P1|NOT COMPLETED|Overall Study||51
149417|NCT00767806|345742|P2|COMPLETED|Overall Study||156
149418|NCT00767806|345743|P1|COMPLETED|Overall Study||147
149419|NCT00767806|345742|P2|STARTED|Overall Study||203
149420|NCT00767806|345743|P1|STARTED|Overall Study||198
149421|NCT00767676|345799|P1|NOT COMPLETED|Overall Study||54
149422|NCT00767676|345799|P1|COMPLETED|Overall Study||205
149423|NCT00767676|345799|P1|STARTED|Overall Study||259
149424|NCT00767624|345805|P2|NOT COMPLETED|Overall Study||17
149425|NCT00767624|345806|P1|NOT COMPLETED|Overall Study||24
149426|NCT00767624|345805|P2|COMPLETED|Overall Study||58
149427|NCT00767624|345806|P1|COMPLETED|Overall Study||51
149428|NCT00767624|345805|P2|STARTED|Overall Study||75
149429|NCT00767624|345806|P1|STARTED|Overall Study||75
149430|NCT00767572|345814|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
149431|NCT00767572|345814|P1|COMPLETED|Second Intervention (12 Weeks)||12
149432|NCT00767572|345814|P1|STARTED|Second Intervention (12 Weeks)||12
149433|NCT00767572|345814|P1|NOT COMPLETED|Washout (4 Weeks)||0
149434|NCT00767572|345814|P1|COMPLETED|Washout (4 Weeks)||12
149435|NCT00767572|345814|P1|STARTED|Washout (4 Weeks)||12
149436|NCT00767572|345814|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
149437|NCT00767572|345814|P1|COMPLETED|First Intervention (12 Weeks)||12
149438|NCT00767572|345814|P1|STARTED|First Intervention (12 Weeks)||12
149439|NCT00767520|345822|P2|NOT COMPLETED|Overall Study||17
149440|NCT00767520|345823|P1|NOT COMPLETED|Overall Study||11
149441|NCT00767520|345822|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
149442|NCT00767520|345823|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
149443|NCT00767520|345822|P2|STARTED|Overall Study||78
149444|NCT00767520|345823|P1|STARTED|Overall Study||79
149445|NCT00767507|345849|P4|NOT COMPLETED|Overall Study||3
149446|NCT00767507|345850|P3|NOT COMPLETED|Overall Study||0
149447|NCT00767507|345851|P2|NOT COMPLETED|Overall Study||0
149448|NCT00767507|345852|P1|NOT COMPLETED|Overall Study||0
149449|NCT00767507|345849|P4|COMPLETED|Overall Study||101
149450|NCT00767507|345850|P3|COMPLETED|Overall Study||106
149451|NCT00767507|345851|P2|COMPLETED|Overall Study||6
149452|NCT00767507|345852|P1|COMPLETED|Overall Study||5
149453|NCT00767507|345849|P4|STARTED|Overall Study||104
149454|NCT00767507|345850|P3|STARTED|Overall Study||106
149455|NCT00767507|345851|P2|STARTED|Overall Study||6
149456|NCT00767507|345852|P1|STARTED|Overall Study||5
149457|NCT00767455|345876|P1|NOT COMPLETED|Overall Study||19
149458|NCT00767455|345876|P1|COMPLETED|Overall Study||40
149459|NCT00767455|345876|P1|STARTED|Overall Study||59
149460|NCT00767364|345884|P2|NOT COMPLETED|Overall Study||0
149461|NCT00767364|345885|P1|NOT COMPLETED|Overall Study||0
149462|NCT00767364|345884|P2|COMPLETED|Overall Study||3
149463|NCT00767364|345885|P1|COMPLETED|Overall Study||5
149464|NCT00767364|345884|P2|STARTED|Overall Study||3
149465|NCT00767364|345885|P1|STARTED|Overall Study||5
149466|NCT00767338|345897|P4|NOT COMPLETED|Overall Study||0
149467|NCT00767338|345898|P3|NOT COMPLETED|Overall Study||0
149468|NCT00767338|345899|P2|NOT COMPLETED|Overall Study||2
149469|NCT00767338|345900|P1|NOT COMPLETED|Overall Study||1
149470|NCT00767338|345897|P4|COMPLETED|Overall Study||0
149471|NCT00767338|345898|P3|COMPLETED|Overall Study||0
149472|NCT00767338|345899|P2|COMPLETED|Overall Study||0
149473|NCT00767338|345900|P1|COMPLETED|Overall Study||0
149474|NCT00767338|345897|P4|STARTED|Overall Study||0
149475|NCT00767338|345898|P3|STARTED|Overall Study||0
149476|NCT00767338|345899|P2|STARTED|Overall Study||2
149477|NCT00767338|345900|P1|STARTED|Overall Study||1
149478|NCT00767325|345910|P1|NOT COMPLETED|Overall Study||15
149479|NCT00767325|345910|P1|COMPLETED|Overall Study||89
149480|NCT00767325|345910|P1|STARTED|Overall Study||104
149481|NCT00767039|345921|P2|NOT COMPLETED|Overall Study||2
149482|NCT00767039|345922|P1|NOT COMPLETED|Overall Study||5
149483|NCT00767039|345921|P2|COMPLETED|Overall Study||23
149484|NCT00767039|345922|P1|COMPLETED|Overall Study||22
149485|NCT00767039|345921|P2|STARTED|Overall Study||25
149486|NCT00767039|345922|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
149487|NCT00767000|345953|P5|NOT COMPLETED|Optional 104-week Extension||4
149488|NCT00767000|345954|P4|NOT COMPLETED|Optional 104-week Extension||2
149489|NCT00767000|345955|P3|NOT COMPLETED|Optional 104-week Extension||7
149490|NCT00767000|345956|P2|NOT COMPLETED|Optional 104-week Extension||3
149491|NCT00767000|345957|P1|NOT COMPLETED|Optional 104-week Extension||7
149492|NCT00767000|345953|P5|COMPLETED|Optional 104-week Extension||0
149493|NCT00767000|345954|P4|COMPLETED|Optional 104-week Extension||0
149494|NCT00767000|345955|P3|COMPLETED|Optional 104-week Extension||0
149495|NCT00767000|345956|P2|COMPLETED|Optional 104-week Extension||0
149496|NCT00767000|345957|P1|COMPLETED|Optional 104-week Extension||0
149497|NCT00767000|345953|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
149498|NCT00767000|345954|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
149499|NCT00767000|345955|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
149500|NCT00767000|345956|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
149501|NCT00767000|345957|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
149502|NCT00767000|345953|P5|NOT COMPLETED|54-week Study||224
149503|NCT00767000|345954|P4|NOT COMPLETED|54-week Study||225
149504|NCT00767000|345955|P3|NOT COMPLETED|54-week Study||109
149505|NCT00767000|345956|P2|NOT COMPLETED|54-week Study||113
149506|NCT00767000|345957|P1|NOT COMPLETED|54-week Study||108
149507|NCT00767000|345953|P5|COMPLETED|54-week Study||7
149508|NCT00767000|345954|P4|COMPLETED|54-week Study||4
149509|NCT00767000|345955|P3|COMPLETED|54-week Study||8
149510|NCT00767000|345956|P2|COMPLETED|54-week Study||4
149511|NCT00767000|345957|P1|COMPLETED|54-week Study||11
149512|NCT00767000|345953|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
149513|NCT00767000|345954|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
149514|NCT00767000|345955|P3|STARTED|54-week Study||117
149515|NCT00767000|345956|P2|STARTED|54-week Study||117
149516|NCT00767000|345957|P1|STARTED|54-week Study||119
149517|NCT00766831|345999|P1|NOT COMPLETED|Overall Study||115
149518|NCT00766831|345999|P1|COMPLETED|Overall Study||75
149519|NCT00766831|345999|P1|STARTED|Overall Study||190
149520|NCT00766675|346015|P1|NOT COMPLETED|Overall Study||40
149521|NCT00766675|346015|P1|COMPLETED|Overall Study||40
149522|NCT00766675|346015|P1|STARTED|Overall Study||80
149523|NCT00766649|346028|P1|NOT COMPLETED|Overall Study||10
149524|NCT00766649|346028|P1|COMPLETED|Overall Study||1
149525|NCT00766649|346028|P1|STARTED|Overall Study||11
149526|NCT00766636|346042|P2|NOT COMPLETED|Overall Study||2
149527|NCT00766636|346043|P1|NOT COMPLETED|Overall Study||3
149528|NCT00766636|346042|P2|COMPLETED|Overall Study||0
149529|NCT00766636|346043|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
149530|NCT00766636|346042|P2|STARTED|Overall Study||2
149531|NCT00766636|346043|P1|STARTED|Overall Study||3
149532|NCT00766597|346049|P1|NOT COMPLETED|Overall Study||9
149533|NCT00766597|346049|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
149534|NCT00766597|346049|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
149535|NCT00766597|346049|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
149536|NCT00766597|346049|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
149537|NCT00766597|346049|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
149538|NCT00766597|346049|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
149539|NCT00766532|346061|P1|NOT COMPLETED|Overall Study||2
149540|NCT00766532|346061|P1|COMPLETED|Overall Study||10
149541|NCT00766532|346061|P1|STARTED|Overall Study||12
149542|NCT00766506|346067|P2|NOT COMPLETED|Overall Study||2
149543|NCT00766506|346068|P1|NOT COMPLETED|Overall Study||5
149544|NCT00766506|346067|P2|COMPLETED|Overall Study||48
149545|NCT00766506|346068|P1|COMPLETED|Overall Study||53
149546|NCT00766506|346067|P2|STARTED|Overall Study||50
149547|NCT00766506|346068|P1|STARTED|Overall Study||58
149548|NCT00766493|346092|P1|NOT COMPLETED|30 Days Post-Procedure||12
149549|NCT00766493|346092|P1|COMPLETED|30 Days Post-Procedure||238
149550|NCT00766493|346092|P1|STARTED|30 Days Post-Procedure||250
149551|NCT00766493|346092|P1|NOT COMPLETED|Pre-Discharge||0
149552|NCT00766493|346092|P1|COMPLETED|Pre-Discharge||250
149553|NCT00766493|346092|P1|STARTED|Pre-Discharge||250
149554|NCT00766467|346102|P2|NOT COMPLETED|Overall Study||8
149555|NCT00766467|346103|P1|NOT COMPLETED|Overall Study||11
149556|NCT00766467|346102|P2|COMPLETED|Overall Study||31
149557|NCT00766467|346103|P1|COMPLETED|Overall Study||31
149558|NCT00766467|346102|P2|Initiated Treatment|Overall Study||38
149559|NCT00766467|346103|P1|Initiated Treatment|Overall Study||39
149560|NCT00766467|346102|P2|STARTED|Overall Study||39
149561|NCT00766467|346103|P1|STARTED|Overall Study||42
149562|NCT00766415|346115|P2|NOT COMPLETED|Overall Study||1
149563|NCT00766415|346116|P1|NOT COMPLETED|Overall Study||0
149564|NCT00766415|346115|P2|COMPLETED|Overall Study||26
149565|NCT00766415|346116|P1|COMPLETED|Overall Study||25
149566|NCT00766415|346115|P2|STARTED|Overall Study||27
149567|NCT00766415|346116|P1|STARTED|Overall Study||25
149568|NCT00766376|346164|P1|NOT COMPLETED|Overall Study||27
149569|NCT00766376|346164|P1|COMPLETED|Overall Study||124
149570|NCT00766376|346164|P1|STARTED|Overall Study||151
149571|NCT00766363|346173|P4|NOT COMPLETED|Overall Study||0
149572|NCT00766363|346174|P3|NOT COMPLETED|Overall Study||0
149573|NCT00766363|346175|P2|NOT COMPLETED|Overall Study||1
149574|NCT00766363|346176|P1|NOT COMPLETED|Overall Study||1
149575|NCT00766363|346173|P4|COMPLETED|Overall Study||12
149576|NCT00766363|346174|P3|COMPLETED|Overall Study||12
149577|NCT00766363|346175|P2|COMPLETED|Overall Study||12
149578|NCT00766363|346176|P1|COMPLETED|Overall Study||11
149579|NCT00766363|346173|P4|PK POPULATION|Overall Study||13
149580|NCT00766363|346174|P3|PK POPULATION|Overall Study||10
149581|NCT00766363|346175|P2|PK POPULATION|Overall Study||13
149582|NCT00766363|346176|P1|PK POPULATION|Overall Study||12
149583|NCT00766363|346173|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
149584|NCT00766363|346174|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
149585|NCT00766363|346175|P2|SAFETY POPULATION|Overall Study||13
149586|NCT00766363|346176|P1|SAFETY POPULATION|Overall Study||12
149587|NCT00766363|346173|P4|STARTED|Overall Study|Number randomized.|12
149588|NCT00766363|346174|P3|STARTED|Overall Study|Number randomized.|12
149589|NCT00766363|346175|P2|STARTED|Overall Study||13
149590|NCT00766363|346176|P1|STARTED|Overall Study||12
149591|NCT00766090|346215|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
149592|NCT00766090|346216|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149593|NCT00766090|346217|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149594|NCT00766090|346218|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149595|NCT00766090|346219|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149596|NCT00766090|346220|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149597|NCT00766090|346221|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
149598|NCT00766090|346222|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
149599|NCT00766090|346223|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
149600|NCT00766090|346224|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149601|NCT00766090|346225|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
149602|NCT00766090|346226|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
149603|NCT00766090|346215|P12|COMPLETED|Treatment Period 3 (28 Days)||6
149604|NCT00766090|346216|P11|COMPLETED|Treatment Period 3 (28 Days)||7
149605|NCT00766090|346217|P10|COMPLETED|Treatment Period 3 (28 Days)||8
149606|NCT00766090|346218|P9|COMPLETED|Treatment Period 3 (28 Days)||6
149607|NCT00766090|346219|P8|COMPLETED|Treatment Period 3 (28 Days)||8
149608|NCT00766090|346220|P7|COMPLETED|Treatment Period 3 (28 Days)||6
149609|NCT00766090|346221|P6|COMPLETED|Treatment Period 3 (28 Days)||22
149610|NCT00766090|346222|P5|COMPLETED|Treatment Period 3 (28 Days)||20
149611|NCT00766090|346223|P4|COMPLETED|Treatment Period 3 (28 Days)||24
149612|NCT00766090|346224|P3|COMPLETED|Treatment Period 3 (28 Days)||20
149613|NCT00766090|346225|P2|COMPLETED|Treatment Period 3 (28 Days)||26
149614|NCT00766090|346226|P1|COMPLETED|Treatment Period 3 (28 Days)||22
149615|NCT00766090|346215|P12|STARTED|Treatment Period 3 (28 Days)||7
149616|NCT00766090|346216|P11|STARTED|Treatment Period 3 (28 Days)||7
149617|NCT00766090|346217|P10|STARTED|Treatment Period 3 (28 Days)||8
149618|NCT00766090|346218|P9|STARTED|Treatment Period 3 (28 Days)||6
149619|NCT00766090|346219|P8|STARTED|Treatment Period 3 (28 Days)||8
149620|NCT00766090|346220|P7|STARTED|Treatment Period 3 (28 Days)||6
149621|NCT00766090|346221|P6|STARTED|Treatment Period 3 (28 Days)||23
149622|NCT00766090|346222|P5|STARTED|Treatment Period 3 (28 Days)||21
149623|NCT00766090|346223|P4|STARTED|Treatment Period 3 (28 Days)||25
149624|NCT00766090|346224|P3|STARTED|Treatment Period 3 (28 Days)||20
149625|NCT00766090|346225|P2|STARTED|Treatment Period 3 (28 Days)||27
149626|NCT00766090|346226|P1|STARTED|Treatment Period 3 (28 Days)||22
149627|NCT00766090|346215|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
149628|NCT00766090|346216|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
149629|NCT00766090|346217|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
149630|NCT00766090|346218|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
149631|NCT00766090|346219|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
149632|NCT00766090|346220|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
149633|NCT00766090|346221|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
149634|NCT00766090|346222|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
149635|NCT00766090|346223|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
149636|NCT00766090|346224|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
149637|NCT00766090|346225|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
149638|NCT00766090|346226|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
149639|NCT00766090|346215|P12|COMPLETED|Washout Period 2 (14 Days)||7
149640|NCT00766090|346216|P11|COMPLETED|Washout Period 2 (14 Days)||7
149641|NCT00766090|346217|P10|COMPLETED|Washout Period 2 (14 Days)||8
149642|NCT00766090|346218|P9|COMPLETED|Washout Period 2 (14 Days)||6
149643|NCT00766090|346219|P8|COMPLETED|Washout Period 2 (14 Days)||8
149644|NCT00766090|346220|P7|COMPLETED|Washout Period 2 (14 Days)||6
149645|NCT00766090|346221|P6|COMPLETED|Washout Period 2 (14 Days)||23
149646|NCT00766090|346222|P5|COMPLETED|Washout Period 2 (14 Days)||21
149647|NCT00766090|346223|P4|COMPLETED|Washout Period 2 (14 Days)||25
149648|NCT00766090|346224|P3|COMPLETED|Washout Period 2 (14 Days)||20
149649|NCT00766090|346225|P2|COMPLETED|Washout Period 2 (14 Days)||27
149650|NCT00766090|346226|P1|COMPLETED|Washout Period 2 (14 Days)||22
149651|NCT00766090|346215|P12|STARTED|Washout Period 2 (14 Days)||7
149652|NCT00766090|346216|P11|STARTED|Washout Period 2 (14 Days)||7
149653|NCT00766090|346217|P10|STARTED|Washout Period 2 (14 Days)||8
149654|NCT00766090|346218|P9|STARTED|Washout Period 2 (14 Days)||6
149655|NCT00766090|346219|P8|STARTED|Washout Period 2 (14 Days)||8
149656|NCT00766090|346220|P7|STARTED|Washout Period 2 (14 Days)||6
149657|NCT00766090|346221|P6|STARTED|Washout Period 2 (14 Days)||23
149658|NCT00766090|346222|P5|STARTED|Washout Period 2 (14 Days)||21
149659|NCT00766090|346223|P4|STARTED|Washout Period 2 (14 Days)||25
149660|NCT00766090|346224|P3|STARTED|Washout Period 2 (14 Days)||21
149661|NCT00766090|346225|P2|STARTED|Washout Period 2 (14 Days)||27
149662|NCT00766090|346226|P1|STARTED|Washout Period 2 (14 Days)||22
149663|NCT00766090|346215|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149664|NCT00766090|346216|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149665|NCT00766090|346217|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149666|NCT00766090|346218|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149667|NCT00766090|346219|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149668|NCT00766090|346220|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149669|NCT00766090|346221|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149670|NCT00766090|346222|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
149671|NCT00766090|346223|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149672|NCT00766090|346224|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
149673|NCT00766090|346225|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149674|NCT00766090|346226|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
149675|NCT00766090|346215|P12|COMPLETED|Treatment Period 2 (28 Days)||7
149676|NCT00766090|346216|P11|COMPLETED|Treatment Period 2 (28 Days)||7
149677|NCT00766090|346217|P10|COMPLETED|Treatment Period 2 (28 Days)||8
149678|NCT00766090|346218|P9|COMPLETED|Treatment Period 2 (28 Days)||6
149679|NCT00766090|346219|P8|COMPLETED|Treatment Period 2 (28 Days)||8
149680|NCT00766090|346220|P7|COMPLETED|Treatment Period 2 (28 Days)||6
149681|NCT00766090|346221|P6|COMPLETED|Treatment Period 2 (28 Days)||23
149682|NCT00766090|346222|P5|COMPLETED|Treatment Period 2 (28 Days)||21
149683|NCT00766090|346223|P4|COMPLETED|Treatment Period 2 (28 Days)||25
149684|NCT00766090|346224|P3|COMPLETED|Treatment Period 2 (28 Days)||21
149685|NCT00766090|346225|P2|COMPLETED|Treatment Period 2 (28 Days)||27
149686|NCT00766090|346226|P1|COMPLETED|Treatment Period 2 (28 Days)||22
149687|NCT00766090|346215|P12|STARTED|Treatment Period 2 (28 Days)||7
149688|NCT00766090|346216|P11|STARTED|Treatment Period 2 (28 Days)||7
149689|NCT00766090|346217|P10|STARTED|Treatment Period 2 (28 Days)||8
149690|NCT00766090|346218|P9|STARTED|Treatment Period 2 (28 Days)||6
149691|NCT00766090|346219|P8|STARTED|Treatment Period 2 (28 Days)||8
149692|NCT00766090|346220|P7|STARTED|Treatment Period 2 (28 Days)||6
149693|NCT00766090|346221|P6|STARTED|Treatment Period 2 (28 Days)||23
149694|NCT00766090|346222|P5|STARTED|Treatment Period 2 (28 Days)||23
149695|NCT00766090|346223|P4|STARTED|Treatment Period 2 (28 Days)||25
149696|NCT00766090|346224|P3|STARTED|Treatment Period 2 (28 Days)||22
149697|NCT00766090|346225|P2|STARTED|Treatment Period 2 (28 Days)||27
149698|NCT00766090|346226|P1|STARTED|Treatment Period 2 (28 Days)||22
149699|NCT00766090|346215|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
149700|NCT00766090|346216|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
149701|NCT00766090|346217|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
149702|NCT00766090|346218|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
149703|NCT00766090|346219|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
149704|NCT00766090|346220|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
149705|NCT00766090|346221|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
149706|NCT00766090|346222|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
149707|NCT00766090|346223|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
149708|NCT00766090|346224|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
149709|NCT00766090|346225|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
149710|NCT00766090|346226|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
149711|NCT00766090|346215|P12|COMPLETED|Washout Period 1 (14 Days)||7
149712|NCT00766090|346216|P11|COMPLETED|Washout Period 1 (14 Days)||7
149713|NCT00766090|346217|P10|COMPLETED|Washout Period 1 (14 Days)||8
149714|NCT00766090|346218|P9|COMPLETED|Washout Period 1 (14 Days)||6
149715|NCT00766090|346219|P8|COMPLETED|Washout Period 1 (14 Days)||8
149716|NCT00766090|346220|P7|COMPLETED|Washout Period 1 (14 Days)||6
149717|NCT00766090|346221|P6|COMPLETED|Washout Period 1 (14 Days)||23
149718|NCT00766090|346222|P5|COMPLETED|Washout Period 1 (14 Days)||23
149719|NCT00766090|346223|P4|COMPLETED|Washout Period 1 (14 Days)||25
149720|NCT00766090|346224|P3|COMPLETED|Washout Period 1 (14 Days)||22
149721|NCT00766090|346225|P2|COMPLETED|Washout Period 1 (14 Days)||27
149722|NCT00766090|346226|P1|COMPLETED|Washout Period 1 (14 Days)||22
149723|NCT00766090|346215|P12|STARTED|Washout Period 1 (14 Days)||7
149724|NCT00766090|346216|P11|STARTED|Washout Period 1 (14 Days)||7
149725|NCT00766090|346217|P10|STARTED|Washout Period 1 (14 Days)||8
149726|NCT00766090|346218|P9|STARTED|Washout Period 1 (14 Days)||6
149727|NCT00766090|346219|P8|STARTED|Washout Period 1 (14 Days)||8
149728|NCT00766090|346220|P7|STARTED|Washout Period 1 (14 Days)||6
149729|NCT00766090|346221|P6|STARTED|Washout Period 1 (14 Days)||23
149730|NCT00766090|346222|P5|STARTED|Washout Period 1 (14 Days)||23
149731|NCT00766090|346223|P4|STARTED|Washout Period 1 (14 Days)||25
149732|NCT00766090|346224|P3|STARTED|Washout Period 1 (14 Days)||23
149733|NCT00766090|346225|P2|STARTED|Washout Period 1 (14 Days)||27
149734|NCT00766090|346226|P1|STARTED|Washout Period 1 (14 Days)||22
149735|NCT00766090|346215|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149736|NCT00766090|346216|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149737|NCT00766090|346217|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149738|NCT00766090|346218|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
149739|NCT00766090|346219|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149740|NCT00766090|346220|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149741|NCT00766090|346221|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149742|NCT00766090|346222|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149743|NCT00766090|346223|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
149744|NCT00766090|346224|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149745|NCT00766090|346225|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
149746|NCT00766090|346226|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
149747|NCT00766090|346215|P12|COMPLETED|Treatment Period 1 (28 Days)||7
149748|NCT00766090|346216|P11|COMPLETED|Treatment Period 1 (28 Days)||7
149749|NCT00766090|346217|P10|COMPLETED|Treatment Period 1 (28 Days)||8
149750|NCT00766090|346218|P9|COMPLETED|Treatment Period 1 (28 Days)||6
149751|NCT00766090|346219|P8|COMPLETED|Treatment Period 1 (28 Days)||8
149752|NCT00766090|346220|P7|COMPLETED|Treatment Period 1 (28 Days)||6
149753|NCT00766090|346221|P6|COMPLETED|Treatment Period 1 (28 Days)||23
149754|NCT00766090|346222|P5|COMPLETED|Treatment Period 1 (28 Days)||23
149755|NCT00766090|346223|P4|COMPLETED|Treatment Period 1 (28 Days)||25
149756|NCT00766090|346224|P3|COMPLETED|Treatment Period 1 (28 Days)||23
149757|NCT00766090|346225|P2|COMPLETED|Treatment Period 1 (28 Days)||27
149758|NCT00766090|346226|P1|COMPLETED|Treatment Period 1 (28 Days)||22
149759|NCT00766090|346215|P12|STARTED|Treatment Period 1 (28 Days)||7
149760|NCT00766090|346216|P11|STARTED|Treatment Period 1 (28 Days)||7
149761|NCT00766090|346217|P10|STARTED|Treatment Period 1 (28 Days)||8
149762|NCT00766090|346218|P9|STARTED|Treatment Period 1 (28 Days)||7
149763|NCT00766090|346219|P8|STARTED|Treatment Period 1 (28 Days)||8
149764|NCT00766090|346220|P7|STARTED|Treatment Period 1 (28 Days)||6
149765|NCT00766090|346221|P6|STARTED|Treatment Period 1 (28 Days)||23
149766|NCT00766090|346222|P5|STARTED|Treatment Period 1 (28 Days)||23
149767|NCT00766090|346223|P4|STARTED|Treatment Period 1 (28 Days)||26
149768|NCT00766090|346224|P3|STARTED|Treatment Period 1 (28 Days)||23
149769|NCT00766090|346225|P2|STARTED|Treatment Period 1 (28 Days)||27
149770|NCT00766090|346226|P1|STARTED|Treatment Period 1 (28 Days)||25
149771|NCT00766051|346267|P2|NOT COMPLETED|Overall Study||0
149772|NCT00766051|346268|P1|NOT COMPLETED|Overall Study||2
149773|NCT00766051|346267|P2|COMPLETED|Overall Study||10
149774|NCT00766051|346268|P1|COMPLETED|Overall Study||10
149775|NCT00766051|346267|P2|STARTED|Overall Study||10
149776|NCT00766051|346268|P1|STARTED|Overall Study||12
149777|NCT00765947|346278|P1|NOT COMPLETED|Overall Study||24
149778|NCT00765947|346278|P1|COMPLETED|Overall Study||232
149779|NCT00765947|346278|P1|STARTED|Overall Study||256
149780|NCT00765895|346289|P2|NOT COMPLETED|Overall Study||0
149781|NCT00765895|346290|P1|NOT COMPLETED|Overall Study||0
149782|NCT00765895|346289|P2|COMPLETED|Overall Study||65
149783|NCT00765895|346290|P1|COMPLETED|Overall Study||65
149784|NCT00765895|346289|P2|STARTED|Overall Study||65
149785|NCT00765895|346290|P1|STARTED|Overall Study||65
149786|NCT00765882|346299|P3|NOT COMPLETED|Overall Study||36
149787|NCT00765882|346300|P2|NOT COMPLETED|Overall Study||40
149788|NCT00765882|346301|P1|NOT COMPLETED|Overall Study||24
149789|NCT00765882|346299|P3|COMPLETED|Overall Study||169
149790|NCT00765882|346300|P2|COMPLETED|Overall Study||173
149791|NCT00765882|346301|P1|COMPLETED|Overall Study||191
149792|NCT00765882|346299|P3|STARTED|Overall Study||205
149793|NCT00765882|346300|P2|STARTED|Overall Study||213
149794|NCT00765882|346301|P1|STARTED|Overall Study||215
149795|NCT00765843|346333|P3|NOT COMPLETED|Overall Study||3
149796|NCT00765843|346334|P2|NOT COMPLETED|Overall Study||4
149797|NCT00765843|346335|P1|NOT COMPLETED|Overall Study||1
149798|NCT00765843|346333|P3|COMPLETED|Overall Study||23
149799|NCT00765843|346334|P2|COMPLETED|Overall Study||21
149800|NCT00765843|346335|P1|COMPLETED|Overall Study||25
149801|NCT00765843|346333|P3|STARTED|Overall Study||26
149802|NCT00765843|346334|P2|STARTED|Overall Study||25
149803|NCT00765843|346335|P1|STARTED|Overall Study||26
149804|NCT00765817|346345|P2|NOT COMPLETED|Overall Study||22
149805|NCT00765817|346346|P1|NOT COMPLETED|Overall Study||26
149806|NCT00765817|346345|P2|COMPLETED|Overall Study||101
149807|NCT00765817|346346|P1|COMPLETED|Overall Study||112
149808|NCT00765817|346345|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
149809|NCT00765817|346346|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
149810|NCT00765765|346384|P1|NOT COMPLETED|Overall Study||0
149811|NCT00765765|346384|P1|COMPLETED|Overall Study||6
149812|NCT00765765|346384|P1|STARTED|Overall Study||6
149813|NCT00765726|346394|P1|NOT COMPLETED|Overall Study||9
149814|NCT00765726|346394|P1|COMPLETED|Overall Study||3
149815|NCT00765726|346394|P1|STARTED|Overall Study||12
149816|NCT00765674|346402|P4|NOT COMPLETED|Overall Study||25
149817|NCT00765674|346403|P3|NOT COMPLETED|Overall Study||17
149818|NCT00765674|346404|P2|NOT COMPLETED|Overall Study||22
149819|NCT00765674|346405|P1|NOT COMPLETED|Overall Study||21
149820|NCT00765674|346402|P4|COMPLETED|Overall Study||285
149821|NCT00765674|346403|P3|COMPLETED|Overall Study||279
149822|NCT00765674|346404|P2|COMPLETED|Overall Study||276
149823|NCT00765674|346405|P1|COMPLETED|Overall Study||266
149824|NCT00765674|346402|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
149825|NCT00765674|346403|P3|STARTED|Overall Study||296
149826|NCT00765674|346404|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
149827|NCT00765674|346405|P1|STARTED|Overall Study||287
149828|NCT00765661|346429|P2|NOT COMPLETED|Overall Study||0
149829|NCT00765661|346430|P1|NOT COMPLETED|Overall Study||0
149830|NCT00765661|346429|P2|COMPLETED|Overall Study||31
149831|NCT00765661|346430|P1|COMPLETED|Overall Study||32
149832|NCT00765661|346429|P2|STARTED|Overall Study||31
149833|NCT00765661|346430|P1|STARTED|Overall Study||32
149834|NCT00765648|346444|P2|NOT COMPLETED|Overall Study||2
149835|NCT00765648|346445|P1|NOT COMPLETED|Overall Study||1
149836|NCT00765648|346444|P2|COMPLETED|Overall Study||114
149837|NCT00765648|346445|P1|COMPLETED|Overall Study||109
149838|NCT00765648|346444|P2|STARTED|Overall Study||116
149839|NCT00765648|346445|P1|STARTED|Overall Study||110
149840|NCT00765570|346463|P2|NOT COMPLETED|Overall Study||0
149841|NCT00765570|346464|P1|NOT COMPLETED|Overall Study||2
149842|NCT00765570|346463|P2|COMPLETED|Overall Study||3
149843|NCT00765570|346464|P1|COMPLETED|Overall Study||7
149844|NCT00765570|346463|P2|STARTED|Overall Study||3
149845|NCT00765570|346464|P1|STARTED|Overall Study||9
149846|NCT00765388|346472|P2|NOT COMPLETED|Period 2||0
149847|NCT00765388|346473|P1|NOT COMPLETED|Period 2||0
149848|NCT00765388|346472|P2|COMPLETED|Period 2||6
149849|NCT00765388|346473|P1|COMPLETED|Period 2||15
149850|NCT00765388|346472|P2|STARTED|Period 2||6
149851|NCT00765388|346473|P1|STARTED|Period 2||15
149852|NCT00765388|346472|P2|NOT COMPLETED|Period 1||5
149853|NCT00765388|346473|P1|NOT COMPLETED|Period 1||1
149854|NCT00765388|346472|P2|COMPLETED|Period 1||6
149855|NCT00765388|346473|P1|COMPLETED|Period 1||15
149856|NCT00765388|346472|P2|STARTED|Period 1||11
149857|NCT00765388|346473|P1|STARTED|Period 1|A cross-over study|16
149858|NCT00765375|346501|P1|NOT COMPLETED|Overall Study||0
149859|NCT00765375|346501|P1|COMPLETED|Overall Study||5
149860|NCT00765375|346501|P1|STARTED|Overall Study||5
149861|NCT00765362|346507|P1|NOT COMPLETED|Overall Study||137
149862|NCT00765362|346507|P1|COMPLETED|Overall Study||282
149863|NCT00765362|346507|P1|STARTED|Overall Study||419
149864|NCT00765336|346515|P2|NOT COMPLETED|Overall Study||16
149865|NCT00765336|346516|P1|NOT COMPLETED|Overall Study||19
149866|NCT00765336|346515|P2|COMPLETED|Overall Study||73
149867|NCT00765336|346516|P1|COMPLETED|Overall Study||72
149868|NCT00765336|346515|P2|STARTED|Overall Study||89
149869|NCT00765336|346516|P1|STARTED|Overall Study||91
149870|NCT00765245|346524|P2|NOT COMPLETED|Overall Study||2
149871|NCT00765245|346525|P1|NOT COMPLETED|Overall Study||13
149872|NCT00765245|346524|P2|COMPLETED|Overall Study||20
149873|NCT00765245|346525|P1|COMPLETED|Overall Study||9
149874|NCT00765245|346524|P2|STARTED|Overall Study||22
149875|NCT00765245|346525|P1|STARTED|Overall Study||22
149876|NCT00765232|346537|P2|NOT COMPLETED|Overall Study||0
149877|NCT00765232|346538|P1|NOT COMPLETED|Overall Study||0
149878|NCT00765232|346537|P2|COMPLETED|Overall Study||54
149879|NCT00765232|346538|P1|COMPLETED|Overall Study||57
149880|NCT00765232|346537|P2|STARTED|Overall Study||54
149881|NCT00765232|346538|P1|STARTED|Overall Study||57
149882|NCT00765206|346546|P4|NOT COMPLETED|Second Intervention||0
149883|NCT00765206|346547|P3|NOT COMPLETED|Second Intervention||0
149884|NCT00765206|346548|P2|NOT COMPLETED|Second Intervention||0
149885|NCT00765206|346549|P1|NOT COMPLETED|Second Intervention||0
149886|NCT00765206|346546|P4|COMPLETED|Second Intervention||15
149887|NCT00765206|346547|P3|COMPLETED|Second Intervention||15
149888|NCT00765206|346548|P2|COMPLETED|Second Intervention||15
149889|NCT00765206|346549|P1|COMPLETED|Second Intervention||15
149890|NCT00765206|346546|P4|STARTED|Second Intervention||15
149891|NCT00765206|346547|P3|STARTED|Second Intervention||15
149892|NCT00765206|346548|P2|STARTED|Second Intervention||15
149893|NCT00765206|346549|P1|STARTED|Second Intervention||15
149894|NCT00765206|346546|P4|NOT COMPLETED|Washout Period of 14 Days||0
149895|NCT00765206|346547|P3|NOT COMPLETED|Washout Period of 14 Days||0
149896|NCT00765206|346548|P2|NOT COMPLETED|Washout Period of 14 Days||0
149897|NCT00765206|346549|P1|NOT COMPLETED|Washout Period of 14 Days||0
149898|NCT00765206|346546|P4|COMPLETED|Washout Period of 14 Days||15
149899|NCT00765206|346547|P3|COMPLETED|Washout Period of 14 Days||15
149900|NCT00765206|346548|P2|COMPLETED|Washout Period of 14 Days||15
149901|NCT00765206|346549|P1|COMPLETED|Washout Period of 14 Days||15
149902|NCT00765206|346546|P4|STARTED|Washout Period of 14 Days||15
149903|NCT00765206|346547|P3|STARTED|Washout Period of 14 Days||15
149904|NCT00765206|346548|P2|STARTED|Washout Period of 14 Days||15
149905|NCT00765206|346549|P1|STARTED|Washout Period of 14 Days||15
149906|NCT00765206|346546|P4|NOT COMPLETED|First Intervention||0
149907|NCT00765206|346547|P3|NOT COMPLETED|First Intervention||0
149908|NCT00765206|346548|P2|NOT COMPLETED|First Intervention||0
149909|NCT00765206|346549|P1|NOT COMPLETED|First Intervention||0
149910|NCT00765206|346546|P4|COMPLETED|First Intervention||15
149911|NCT00765206|346547|P3|COMPLETED|First Intervention||15
149912|NCT00765206|346548|P2|COMPLETED|First Intervention||15
149913|NCT00765206|346549|P1|COMPLETED|First Intervention||15
149914|NCT00765206|346546|P4|STARTED|First Intervention||15
149915|NCT00765206|346547|P3|STARTED|First Intervention||15
149916|NCT00765206|346548|P2|STARTED|First Intervention||15
149917|NCT00765206|346549|P1|STARTED|First Intervention||15
149918|NCT00765193|346555|P1|NOT COMPLETED|Full Body Examination||0
149919|NCT00765193|346555|P1|COMPLETED|Full Body Examination||14381
149920|NCT00765193|346555|P1|STARTED|Full Body Examination||14381
149921|NCT00765193|346555|P1|NOT COMPLETED|Problem Area Examination||0
149922|NCT00765193|346555|P1|COMPLETED|Problem Area Examination||14381
149923|NCT00765193|346555|P1|STARTED|Problem Area Examination||14381
149924|NCT00765128|346562|P2|NOT COMPLETED|Overall Study||0
149925|NCT00765128|346563|P1|NOT COMPLETED|Overall Study||0
149926|NCT00765128|346562|P2|COMPLETED|Overall Study||9
149927|NCT00765128|346563|P1|COMPLETED|Overall Study||8
149928|NCT00765128|346562|P2|STARTED|Overall Study||9
149929|NCT00765128|346563|P1|STARTED|Overall Study||8
149930|NCT00765102|346571|P1|NOT COMPLETED|Overall Study||31
149931|NCT00765102|346571|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
149932|NCT00765102|346571|P1|STARTED|Overall Study||32
149933|NCT00765076|346596|P3|NOT COMPLETED|Overall Study||1
149934|NCT00765076|346597|P2|NOT COMPLETED|Overall Study||0
149935|NCT00765076|346598|P1|NOT COMPLETED|Overall Study||1
149936|NCT00765076|346596|P3|COMPLETED|Overall Study||49
149937|NCT00765076|346597|P2|COMPLETED|Overall Study||73
149938|NCT00765076|346598|P1|COMPLETED|Overall Study||68
149939|NCT00765076|346596|P3|STARTED|Overall Study||50
149940|NCT00765076|346597|P2|STARTED|Overall Study||73
149941|NCT00765076|346598|P1|STARTED|Overall Study||69
149942|NCT00765063|346651|P1|NOT COMPLETED|Overall Study||32
149943|NCT00765063|346651|P1|COMPLETED|Overall Study||30
149944|NCT00765063|346651|P1|STARTED|Overall Study||62
149945|NCT00765037|346667|P1|NOT COMPLETED|Overall Study||6
149946|NCT00765037|346667|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
149947|NCT00765037|346667|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
149948|NCT00764946|346674|P3|NOT COMPLETED|Overall Study||4
149949|NCT00764946|346675|P2|NOT COMPLETED|Overall Study||17
149950|NCT00764946|346676|P1|NOT COMPLETED|Overall Study||13
149951|NCT00764946|346674|P3|COMPLETED|Overall Study||18
149952|NCT00764946|346675|P2|COMPLETED|Overall Study||72
149953|NCT00764946|346676|P1|COMPLETED|Overall Study||85
149954|NCT00764946|346674|P3|TREATED|Overall Study||21
149955|NCT00764946|346675|P2|TREATED|Overall Study||88
149956|NCT00764946|346676|P1|TREATED|Overall Study||97
149957|NCT00764946|346674|P3|STARTED|Overall Study||22
149958|NCT00764946|346675|P2|STARTED|Overall Study||89
149959|NCT00764946|346676|P1|STARTED|Overall Study||98
149960|NCT00764881|346704|P2|NOT COMPLETED|Overall Study||10
149961|NCT00764881|346705|P1|NOT COMPLETED|Overall Study||16
149962|NCT00764881|346704|P2|COMPLETED|Overall Study||99
149963|NCT00764881|346705|P1|COMPLETED|Overall Study||92
149964|NCT00764881|346704|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
149965|NCT00764881|346705|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
149966|NCT00764881|346704|P2|STARTED|Overall Study||109
149967|NCT00764881|346705|P1|STARTED|Overall Study||108
149968|NCT00764868|346929|P1|NOT COMPLETED|Overall Study||113
149969|NCT00764868|346929|P1|COMPLETED|Overall Study||156
149970|NCT00764868|346929|P1|STARTED|Overall Study||269
149971|NCT00764790|346938|P3|NOT COMPLETED|Overall Study||30
149972|NCT00764790|346939|P2|NOT COMPLETED|Overall Study||41
149973|NCT00764790|346940|P1|NOT COMPLETED|Overall Study||38
149974|NCT00764790|346938|P3|COMPLETED|Overall Study||1074
149975|NCT00764790|346939|P2|COMPLETED|Overall Study||1065
149976|NCT00764790|346940|P1|COMPLETED|Overall Study||1069
149977|NCT00764790|346938|P3|STARTED|Overall Study||1104
149978|NCT00764790|346939|P2|STARTED|Overall Study||1106
149979|NCT00764790|346940|P1|STARTED|Overall Study||1107
149980|NCT00764673|346972|P1|NOT COMPLETED|Overall Study||12
149981|NCT00764673|346972|P1|COMPLETED|Overall Study||59
149982|NCT00764673|346972|P1|STARTED|Overall Study||71
149983|NCT00764660|346982|P2|NOT COMPLETED|Overall Study||11
149984|NCT00764660|346983|P1|NOT COMPLETED|Overall Study||22
149985|NCT00764660|346982|P2|COMPLETED|Overall Study||55
149986|NCT00764660|346983|P1|COMPLETED|Overall Study||53
149987|NCT00764660|346982|P2|STARTED|Overall Study||66
149988|NCT00764660|346983|P1|STARTED|Overall Study||75
149989|NCT00764504|347018|P3|NOT COMPLETED|Overall Study||103
149990|NCT00764504|347019|P2|NOT COMPLETED|Overall Study||70
149991|NCT00764504|347020|P1|NOT COMPLETED|Overall Study||66
149992|NCT00764504|347018|P3|COMPLETED|Overall Study||131
149993|NCT00764504|347019|P2|COMPLETED|Overall Study||71
149994|NCT00764504|347020|P1|COMPLETED|Overall Study||75
149995|NCT00764504|347018|P3|STARTED|Overall Study||234
149996|NCT00764504|347019|P2|STARTED|Overall Study||141
149997|NCT00764504|347020|P1|STARTED|Overall Study||141
149998|NCT00764478|347049|P3|NOT COMPLETED|Overall Study||8
149999|NCT00764478|347050|P2|NOT COMPLETED|Overall Study||22
150000|NCT00764478|347051|P1|NOT COMPLETED|Overall Study||15
150001|NCT00764478|347049|P3|COMPLETED|Overall Study||118
150002|NCT00764478|347050|P2|COMPLETED|Overall Study||97
150003|NCT00764478|347051|P1|COMPLETED|Overall Study||107
150004|NCT00764478|347049|P3|STARTED|Overall Study||126
150005|NCT00764478|347050|P2|STARTED|Overall Study||119
150006|NCT00764478|347051|P1|STARTED|Overall Study||122
150007|NCT00764465|347131|P6|NOT COMPLETED|Overall Study||1
150008|NCT00764465|347132|P5|NOT COMPLETED|Overall Study||1
150009|NCT00764465|347133|P4|NOT COMPLETED|Overall Study||1
150010|NCT00764465|347134|P3|NOT COMPLETED|Overall Study||1
150011|NCT00764465|347135|P2|NOT COMPLETED|Overall Study||1
150012|NCT00764465|347136|P1|NOT COMPLETED|Overall Study||2
150013|NCT00764465|347131|P6|COMPLETED|Overall Study||7
150014|NCT00764465|347132|P5|COMPLETED|Overall Study||6
150015|NCT00764465|347133|P4|COMPLETED|Overall Study||6
150016|NCT00764465|347134|P3|COMPLETED|Overall Study||6
150017|NCT00764465|347135|P2|COMPLETED|Overall Study||6
150018|NCT00764465|347136|P1|COMPLETED|Overall Study||7
150019|NCT00764465|347131|P6|STARTED|Overall Study||8
150020|NCT00764465|347132|P5|STARTED|Overall Study||7
150021|NCT00764465|347133|P4|STARTED|Overall Study||7
150022|NCT00764465|347134|P3|STARTED|Overall Study||7
150023|NCT00764465|347135|P2|STARTED|Overall Study||7
150024|NCT00764465|347136|P1|STARTED|Overall Study||9
150025|NCT00764361|347164|P2|NOT COMPLETED|Overall Study||4
150026|NCT00764361|347165|P1|NOT COMPLETED|Overall Study||2
150027|NCT00764361|347164|P2|COMPLETED|Overall Study||3
150028|NCT00764361|347165|P1|COMPLETED|Overall Study||6
150029|NCT00764361|347164|P2|STARTED|Overall Study||7
150030|NCT00764361|347165|P1|STARTED|Overall Study||8
150031|NCT00764309|347171|P1|NOT COMPLETED|Overall Study||0
150032|NCT00764309|347171|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
150033|NCT00764309|347171|P1|STARTED|Overall Study|Number of participants treated.|31
150034|NCT00763971|347181|P3|NOT COMPLETED|Overall Study||69
150035|NCT00763971|347182|P2|NOT COMPLETED|Overall Study||38
150036|NCT00763971|347183|P1|NOT COMPLETED|Overall Study||33
150037|NCT00763971|347181|P3|COMPLETED|Overall Study||42
150038|NCT00763971|347182|P2|COMPLETED|Overall Study||74
150039|NCT00763971|347183|P1|COMPLETED|Overall Study||80
150040|NCT00763971|347181|P3|STARTED|Overall Study||111
150041|NCT00763971|347182|P2|STARTED|Overall Study||112
150042|NCT00763971|347183|P1|STARTED|Overall Study||113
150043|NCT00763958|347214|P2|NOT COMPLETED|Overall Study||11
150044|NCT00763958|347215|P1|NOT COMPLETED|Overall Study||14
150045|NCT00763958|347214|P2|COMPLETED|Overall Study||5
150046|NCT00763958|347215|P1|COMPLETED|Overall Study||14
150047|NCT00763958|347214|P2|STARTED|Overall Study||16
150048|NCT00763958|347215|P1|STARTED|Overall Study||28
150049|NCT00763919|347225|P1|NOT COMPLETED|Overall Study||13
150050|NCT00763919|347225|P1|COMPLETED|Overall Study||30
150051|NCT00763919|347225|P1|STARTED|Overall Study||43
150052|NCT00763867|347253|P2|NOT COMPLETED|Overall Study||12
150053|NCT00763867|347254|P1|NOT COMPLETED|Overall Study||5
150054|NCT00763867|347253|P2|COMPLETED|Overall Study||101
150055|NCT00763867|347254|P1|COMPLETED|Overall Study||98
150056|NCT00763867|347253|P2|STARTED|Overall Study||113
150057|NCT00763867|347254|P1|STARTED|Overall Study||103
150058|NCT00763815|347350|P2|NOT COMPLETED|Overall Study||84
150059|NCT00763815|347351|P1|NOT COMPLETED|Overall Study||52
150060|NCT00763815|347350|P2|COMPLETED|Overall Study||239
150061|NCT00763815|347351|P1|COMPLETED|Overall Study||109
150062|NCT00763815|347350|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
150063|NCT00763815|347351|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
150064|NCT00763815|347350|P2|Treated/Safety Population|Overall Study||323
150065|NCT00763815|347351|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
150066|NCT00763815|347350|P2|STARTED|Overall Study||323
150067|NCT00763815|347351|P1|STARTED|Overall Study|Randomized.|161
150068|NCT00763750|347375|P1|NOT COMPLETED|Overall Study||0
150069|NCT00763750|347375|P1|COMPLETED|Overall Study||25
150070|NCT00763750|347375|P1|STARTED|Overall Study||25
150071|NCT00763698|347379|P1|NOT COMPLETED|Overall Study||10
150072|NCT00763698|347379|P1|COMPLETED|Overall Study||76
150073|NCT00763698|347379|P1|STARTED|Overall Study||86
150074|NCT00763490|347385|P1|NOT COMPLETED|Overall Study||0
150075|NCT00763490|347385|P1|COMPLETED|Overall Study||20
150076|NCT00763490|347385|P1|STARTED|Overall Study||20
150077|NCT00763451|347396|P4|NOT COMPLETED|Overall Study||30
150078|NCT00763451|347397|P3|NOT COMPLETED|Overall Study||40
150079|NCT00763451|347398|P2|NOT COMPLETED|Overall Study||22
150080|NCT00763451|347399|P1|NOT COMPLETED|Overall Study||13
150081|NCT00763451|347396|P4|COMPLETED|Overall Study||131
150082|NCT00763451|347397|P3|COMPLETED|Overall Study||121
150083|NCT00763451|347398|P2|COMPLETED|Overall Study||60
150084|NCT00763451|347399|P1|COMPLETED|Overall Study||67
150085|NCT00763451|347396|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
150086|NCT00763451|347397|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
150087|NCT00763451|347398|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
150088|NCT00763451|347399|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
150089|NCT00763451|347396|P4|Treated/Safety Population|Overall Study||161
150090|NCT00763451|347397|P3|Treated/Safety Population|Overall Study||161
150091|NCT00763451|347398|P2|Treated/Safety Population|Overall Study||81
150092|NCT00763451|347399|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
150093|NCT00763451|347396|P4|STARTED|Overall Study||161
150094|NCT00763451|347397|P3|STARTED|Overall Study||161
150095|NCT00763451|347398|P2|STARTED|Overall Study||82
150096|NCT00763451|347399|P1|STARTED|Overall Study|Randomized.|80
150097|NCT00763386|347433|P2|NOT COMPLETED|Overall Study||40
150098|NCT00763386|347434|P1|NOT COMPLETED|Overall Study||48
150099|NCT00763386|347433|P2|COMPLETED|Overall Study||127
150100|NCT00763386|347434|P1|COMPLETED|Overall Study||116
150101|NCT00763386|347433|P2|STARTED|Overall Study||167
150102|NCT00763386|347434|P1|STARTED|Overall Study||164
150103|NCT00763360|347445|P3|NOT COMPLETED|Overall Study||0
150104|NCT00763360|347446|P2|NOT COMPLETED|Overall Study||2
150105|NCT00763360|347447|P1|NOT COMPLETED|Overall Study||0
150106|NCT00763360|347445|P3|COMPLETED|Overall Study||63
150107|NCT00763360|347446|P2|COMPLETED|Overall Study||58
150108|NCT00763360|347447|P1|COMPLETED|Overall Study||61
150109|NCT00763360|347445|P3|STARTED|Overall Study||63
150110|NCT00763360|347446|P2|STARTED|Overall Study||60
150111|NCT00763360|347447|P1|STARTED|Overall Study||61
150112|NCT00763321|347467|P3|NOT COMPLETED|Double-blind Period||29
150113|NCT00763321|347468|P2|NOT COMPLETED|Double-blind Period||21
150114|NCT00763321|347469|P1|NOT COMPLETED|Double-blind Period||0
150115|NCT00763321|347467|P3|COMPLETED|Double-blind Period||84
150116|NCT00763321|347468|P2|COMPLETED|Double-blind Period||88
150117|NCT00763321|347469|P1|COMPLETED|Double-blind Period||0
150118|NCT00763321|347467|P3|STARTED|Double-blind Period||113
150119|NCT00763321|347468|P2|STARTED|Double-blind Period||109
150120|NCT00763321|347469|P1|STARTED|Double-blind Period||0
150121|NCT00763321|347467|P3|NOT COMPLETED|Open-label Period||0
150122|NCT00763321|347468|P2|NOT COMPLETED|Open-label Period||0
150123|NCT00763321|347469|P1|NOT COMPLETED|Open-label Period||63
150124|NCT00763321|347467|P3|COMPLETED|Open-label Period||0
150125|NCT00763321|347468|P2|COMPLETED|Open-label Period||0
150126|NCT00763321|347469|P1|COMPLETED|Open-label Period||222
150127|NCT00763321|347467|P3|STARTED|Open-label Period||0
150128|NCT00763321|347468|P2|STARTED|Open-label Period||0
150129|NCT00763321|347469|P1|STARTED|Open-label Period||285
150130|NCT00763282|347480|P2|NOT COMPLETED|Overall Study||34
150131|NCT00763282|347481|P1|NOT COMPLETED|Overall Study||32
150132|NCT00763282|347480|P2|COMPLETED|Overall Study||38
150133|NCT00763282|347481|P1|COMPLETED|Overall Study||40
150134|NCT00763282|347480|P2|STARTED|Overall Study||72
150135|NCT00763282|347481|P1|STARTED|Overall Study||72
150136|NCT00763269|347497|P2|NOT COMPLETED|Overall Study||13
150137|NCT00763269|347498|P1|NOT COMPLETED|Overall Study||12
150138|NCT00763269|347497|P2|COMPLETED|Overall Study||299
150139|NCT00763269|347498|P1|COMPLETED|Overall Study||302
150140|NCT00763269|347497|P2|STARTED|Overall Study||312
150141|NCT00763269|347498|P1|STARTED|Overall Study||314
150142|NCT00763256|347512|P2|NOT COMPLETED|Overall Study||10
150143|NCT00763256|347513|P1|NOT COMPLETED|Overall Study||7
150144|NCT00763256|347512|P2|COMPLETED|Overall Study||8
150145|NCT00763256|347513|P1|COMPLETED|Overall Study||8
150146|NCT00763256|347512|P2|STARTED|Overall Study||18
150147|NCT00763256|347513|P1|STARTED|Overall Study||15
150148|NCT00763139|347527|P2|NOT COMPLETED|Overall Study||3
150149|NCT00763139|347528|P1|NOT COMPLETED|Overall Study||5
150150|NCT00763139|347527|P2|COMPLETED|Overall Study||14
150151|NCT00763139|347528|P1|COMPLETED|Overall Study||12
150152|NCT00763139|347527|P2|STARTED|Overall Study||17
150153|NCT00763139|347528|P1|STARTED|Overall Study||17
150154|NCT00763061|347550|P2|NOT COMPLETED|Overall Study||13
150155|NCT00763061|347551|P1|NOT COMPLETED|Overall Study||5
150156|NCT00763061|347550|P2|COMPLETED|Overall Study||44
150157|NCT00763061|347551|P1|COMPLETED|Overall Study||49
150158|NCT00763061|347550|P2|STARTED|Overall Study||57
150159|NCT00763061|347551|P1|STARTED|Overall Study||54
150160|NCT00763048|347565|P2|NOT COMPLETED|Overall Study||0
150161|NCT00763048|347566|P1|NOT COMPLETED|Overall Study||0
150162|NCT00763048|347565|P2|COMPLETED|Overall Study||18
150163|NCT00763048|347566|P1|COMPLETED|Overall Study||21
150164|NCT00763048|347565|P2|STARTED|Overall Study||18
150165|NCT00763048|347566|P1|STARTED|Overall Study||21
150166|NCT00762996|347590|P4|NOT COMPLETED|Period Two||0
150167|NCT00762996|347591|P3|NOT COMPLETED|Period Two||0
150168|NCT00762996|347592|P2|NOT COMPLETED|Period Two||0
150169|NCT00762996|347593|P1|NOT COMPLETED|Period Two||0
150170|NCT00762996|347590|P4|COMPLETED|Period Two||16
150171|NCT00762996|347591|P3|COMPLETED|Period Two||13
150172|NCT00762996|347592|P2|COMPLETED|Period Two||16
150173|NCT00762996|347593|P1|COMPLETED|Period Two||15
150174|NCT00762996|347590|P4|STARTED|Period Two||16
150175|NCT00762996|347591|P3|STARTED|Period Two||13
150176|NCT00762996|347592|P2|STARTED|Period Two||16
150177|NCT00762996|347593|P1|STARTED|Period Two||15
150178|NCT00762996|347590|P4|NOT COMPLETED|Period One||1
150179|NCT00762996|347591|P3|NOT COMPLETED|Period One||4
150180|NCT00762996|347592|P2|NOT COMPLETED|Period One||0
150181|NCT00762996|347593|P1|NOT COMPLETED|Period One||0
150182|NCT00762996|347590|P4|COMPLETED|Period One||16
150183|NCT00762996|347591|P3|COMPLETED|Period One||13
150184|NCT00762996|347592|P2|COMPLETED|Period One||16
150185|NCT00762996|347593|P1|COMPLETED|Period One||15
150186|NCT00762996|347590|P4|STARTED|Period One||17
150187|NCT00762996|347591|P3|STARTED|Period One||17
150188|NCT00762996|347592|P2|STARTED|Period One||16
150189|NCT00762996|347593|P1|STARTED|Period One||15
150190|NCT00762970|347606|P3|NOT COMPLETED|Overall Study||1
150191|NCT00762970|347607|P2|NOT COMPLETED|Overall Study||9
150192|NCT00762970|347608|P1|NOT COMPLETED|Overall Study||12
150193|NCT00762970|347606|P3|COMPLETED|Overall Study||46
150194|NCT00762970|347607|P2|COMPLETED|Overall Study||35
150195|NCT00762970|347608|P1|COMPLETED|Overall Study||34
150196|NCT00762970|347606|P3|STARTED|Overall Study||47
150197|NCT00762970|347607|P2|STARTED|Overall Study||44
150198|NCT00762970|347608|P1|STARTED|Overall Study||46
150199|NCT00762892|347621|P2|NOT COMPLETED|Overall Study||6
150200|NCT00762892|347622|P1|NOT COMPLETED|Overall Study||5
150201|NCT00762892|347621|P2|COMPLETED|Overall Study||8
150202|NCT00762892|347622|P1|COMPLETED|Overall Study||9
150203|NCT00762892|347621|P2|STARTED|Overall Study||14
150204|NCT00762892|347622|P1|STARTED|Overall Study||14
150205|NCT00762853|347638|P2|NOT COMPLETED|Second Treatment Period||0
150206|NCT00762853|347639|P1|NOT COMPLETED|Second Treatment Period||0
150207|NCT00762853|347638|P2|COMPLETED|Second Treatment Period||10
150208|NCT00762853|347639|P1|COMPLETED|Second Treatment Period||10
150209|NCT00762853|347638|P2|STARTED|Second Treatment Period||10
150210|NCT00762853|347639|P1|STARTED|Second Treatment Period||10
150211|NCT00762853|347638|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
150212|NCT00762853|347639|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
150213|NCT00762853|347638|P2|COMPLETED|1 Week Washout After Treatment 1||10
150214|NCT00762853|347639|P1|COMPLETED|1 Week Washout After Treatment 1||10
150215|NCT00762853|347638|P2|STARTED|1 Week Washout After Treatment 1||10
150216|NCT00762853|347639|P1|STARTED|1 Week Washout After Treatment 1||10
150217|NCT00762853|347638|P2|NOT COMPLETED|First Treatment Period||0
150218|NCT00762853|347639|P1|NOT COMPLETED|First Treatment Period||0
150219|NCT00762853|347638|P2|COMPLETED|First Treatment Period||10
150220|NCT00762853|347639|P1|COMPLETED|First Treatment Period||10
150221|NCT00762853|347638|P2|STARTED|First Treatment Period||10
150222|NCT00762853|347639|P1|STARTED|First Treatment Period||10
150223|NCT00762788|347651|P6|NOT COMPLETED|Overall Study||21
150224|NCT00762788|347652|P5|NOT COMPLETED|Overall Study||13
150225|NCT00762788|347653|P4|NOT COMPLETED|Overall Study||26
150226|NCT00762788|347654|P3|NOT COMPLETED|Overall Study||21
150227|NCT00762788|347655|P2|NOT COMPLETED|Overall Study||37
150228|NCT00762788|347656|P1|NOT COMPLETED|Overall Study||26
150229|NCT00762788|347651|P6|COMPLETED|Overall Study||31
150230|NCT00762788|347652|P5|COMPLETED|Overall Study||30
150231|NCT00762788|347653|P4|COMPLETED|Overall Study||38
150232|NCT00762788|347654|P3|COMPLETED|Overall Study||21
150233|NCT00762788|347655|P2|COMPLETED|Overall Study||21
150234|NCT00762788|347656|P1|COMPLETED|Overall Study||29
150235|NCT00762788|347651|P6|STARTED|Overall Study||52
150236|NCT00762788|347652|P5|STARTED|Overall Study||43
150237|NCT00762788|347653|P4|STARTED|Overall Study||64
150238|NCT00762788|347654|P3|STARTED|Overall Study||42
150239|NCT00762788|347655|P2|STARTED|Overall Study||58
150240|NCT00762788|347656|P1|STARTED|Overall Study||55
150241|NCT00762762|347678|P2|NOT COMPLETED|Overall Study||10
150242|NCT00762762|347679|P1|NOT COMPLETED|Overall Study||8
150243|NCT00762762|347678|P2|COMPLETED|Overall Study||20
150244|NCT00762762|347679|P1|COMPLETED|Overall Study||22
150245|NCT00762762|347678|P2|STARTED|Overall Study||30
150246|NCT00762762|347679|P1|STARTED|Overall Study||30
150247|NCT00762723|347696|P3|NOT COMPLETED|Overall Study||3
150248|NCT00762723|347697|P2|NOT COMPLETED|Overall Study||5
150249|NCT00762723|347698|P1|NOT COMPLETED|Overall Study||5
150250|NCT00762723|347696|P3|COMPLETED|Overall Study||0
150251|NCT00762723|347697|P2|COMPLETED|Overall Study||6
150252|NCT00762723|347698|P1|COMPLETED|Overall Study||0
150253|NCT00762723|347696|P3|STARTED|Overall Study||3
150254|NCT00762723|347697|P2|STARTED|Overall Study||11
150255|NCT00762723|347698|P1|STARTED|Overall Study||5
150256|NCT00762645|347708|P2|NOT COMPLETED|Overall Study||2
150257|NCT00762645|347709|P1|NOT COMPLETED|Overall Study||4
150258|NCT00762645|347708|P2|COMPLETED|Overall Study||12
150259|NCT00762645|347709|P1|COMPLETED|Overall Study||12
150260|NCT00762645|347708|P2|STARTED|Overall Study||14
150261|NCT00762645|347709|P1|STARTED|Overall Study||16
150262|NCT00762619|347719|P2|NOT COMPLETED|Overall Study||0
150263|NCT00762619|347720|P1|NOT COMPLETED|Overall Study||0
150264|NCT00762619|347719|P2|COMPLETED|Overall Study||50
150265|NCT00762619|347720|P1|COMPLETED|Overall Study||55
150266|NCT00762619|347719|P2|STARTED|Overall Study||50
150267|NCT00762619|347720|P1|STARTED|Overall Study||55
150268|NCT00762606|347862|P2|NOT COMPLETED|Overall Study||13
150269|NCT00762606|347863|P1|NOT COMPLETED|Overall Study||18
150270|NCT00762606|347862|P2|COMPLETED|Overall Study||38
150271|NCT00762606|347863|P1|COMPLETED|Overall Study||37
150272|NCT00762606|347862|P2|STARTED|Overall Study||51
150273|NCT00762606|347863|P1|STARTED|Overall Study||55
150274|NCT00762528|347873|P2|NOT COMPLETED|Overall Study||0
150275|NCT00762528|347874|P1|NOT COMPLETED|Overall Study||0
150276|NCT00762528|347873|P2|COMPLETED|Overall Study||25
150277|NCT00762528|347874|P1|COMPLETED|Overall Study||24
150278|NCT00762528|347873|P2|STARTED|Overall Study||25
150279|NCT00762528|347874|P1|STARTED|Overall Study||24
150280|NCT00762515|347896|P2|NOT COMPLETED|Overall Study||0
150281|NCT00762515|347897|P1|NOT COMPLETED|Overall Study||0
150282|NCT00762515|347896|P2|COMPLETED|Overall Study||22
150283|NCT00762515|347897|P1|COMPLETED|Overall Study||22
150284|NCT00762515|347896|P2|STARTED|Overall Study||22
150285|NCT00762515|347897|P1|STARTED|Overall Study||22
150286|NCT00762502|347908|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
150287|NCT00762502|347909|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
150288|NCT00762502|347910|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
150289|NCT00762502|347908|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
150290|NCT00762502|347909|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
150291|NCT00762502|347910|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
150292|NCT00762502|347908|P3|STARTED|Month 3 to Month 6 (Period 2)||23
150293|NCT00762502|347909|P2|STARTED|Month 3 to Month 6 (Period 2)||5
150294|NCT00762502|347910|P1|STARTED|Month 3 to Month 6 (Period 2)||9
150295|NCT00762502|347908|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
150296|NCT00762502|347909|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
150297|NCT00762502|347910|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
150298|NCT00762502|347908|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
150299|NCT00762502|347909|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
150300|NCT00762502|347910|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
150301|NCT00762502|347908|P3|STARTED|Baseline to Month 3 (Period 1)||51
150302|NCT00762502|347909|P2|STARTED|Baseline to Month 3 (Period 1)||25
150303|NCT00762502|347910|P1|STARTED|Baseline to Month 3 (Period 1)||36
150304|NCT00762476|347924|P2|NOT COMPLETED|Overall Study||36
150305|NCT00762476|347925|P1|NOT COMPLETED|Overall Study||23
150306|NCT00762476|347924|P2|COMPLETED|Overall Study||169
150307|NCT00762476|347925|P1|COMPLETED|Overall Study||183
150308|NCT00762476|347924|P2|STARTED|Overall Study||205
150309|NCT00762476|347925|P1|STARTED|Overall Study||206
150310|NCT00762463|347937|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
150311|NCT00762463|347938|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
150312|NCT00762463|347939|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
150313|NCT00762463|347940|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
150314|NCT00762463|347937|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
150315|NCT00762463|347938|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
150316|NCT00762463|347939|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
150317|NCT00762463|347940|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
150318|NCT00762463|347937|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
150319|NCT00762463|347938|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
150320|NCT00762463|347939|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
150321|NCT00762463|347940|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
150322|NCT00762463|347937|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
150323|NCT00762463|347938|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
150324|NCT00762463|347939|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
150325|NCT00762463|347940|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
150326|NCT00762463|347937|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
150327|NCT00762463|347938|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
150328|NCT00762463|347939|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
150329|NCT00762463|347940|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
150330|NCT00762463|347937|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
150331|NCT00762463|347938|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
150332|NCT00762463|347939|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
150333|NCT00762463|347940|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
150334|NCT00762463|347937|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
150335|NCT00762463|347938|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
150336|NCT00762463|347939|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
150337|NCT00762463|347940|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
150338|NCT00762463|347937|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
150339|NCT00762463|347938|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
150340|NCT00762463|347939|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
150341|NCT00762463|347940|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
150342|NCT00762463|347937|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
150343|NCT00762463|347938|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
150344|NCT00762463|347939|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
150345|NCT00762463|347940|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
150346|NCT00762450|348025|P3|NOT COMPLETED|3rd Treatment Period||0
150347|NCT00762450|348026|P2|NOT COMPLETED|3rd Treatment Period||0
150348|NCT00762450|348027|P1|NOT COMPLETED|3rd Treatment Period||0
150349|NCT00762450|348025|P3|COMPLETED|3rd Treatment Period||2
150350|NCT00762450|348026|P2|COMPLETED|3rd Treatment Period||2
150351|NCT00762450|348027|P1|COMPLETED|3rd Treatment Period||2
150352|NCT00762450|348025|P3|STARTED|3rd Treatment Period||2
150353|NCT00762450|348026|P2|STARTED|3rd Treatment Period||2
150354|NCT00762450|348027|P1|STARTED|3rd Treatment Period||2
150355|NCT00762450|348025|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
150356|NCT00762450|348026|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
150357|NCT00762450|348027|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
150358|NCT00762450|348025|P3|COMPLETED|Washout After 2nd Treatment Period||2
150359|NCT00762450|348026|P2|COMPLETED|Washout After 2nd Treatment Period||2
150360|NCT00762450|348027|P1|COMPLETED|Washout After 2nd Treatment Period||2
150361|NCT00762450|348025|P3|STARTED|Washout After 2nd Treatment Period||2
150362|NCT00762450|348026|P2|STARTED|Washout After 2nd Treatment Period||2
150363|NCT00762450|348027|P1|STARTED|Washout After 2nd Treatment Period||2
150364|NCT00762450|348025|P3|NOT COMPLETED|2nd Treatment Period||0
150365|NCT00762450|348026|P2|NOT COMPLETED|2nd Treatment Period||0
150366|NCT00762450|348027|P1|NOT COMPLETED|2nd Treatment Period||0
150367|NCT00762450|348025|P3|COMPLETED|2nd Treatment Period||2
150368|NCT00762450|348026|P2|COMPLETED|2nd Treatment Period||2
150369|NCT00762450|348027|P1|COMPLETED|2nd Treatment Period||2
150370|NCT00762450|348025|P3|STARTED|2nd Treatment Period||2
150371|NCT00762450|348026|P2|STARTED|2nd Treatment Period||2
150372|NCT00762450|348027|P1|STARTED|2nd Treatment Period||2
150373|NCT00762450|348025|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
150374|NCT00762450|348026|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
150375|NCT00762450|348027|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
150376|NCT00762450|348025|P3|COMPLETED|Washout After 1st Treatment Period||2
150377|NCT00762450|348026|P2|COMPLETED|Washout After 1st Treatment Period||2
150378|NCT00762450|348027|P1|COMPLETED|Washout After 1st Treatment Period||2
150379|NCT00762450|348025|P3|STARTED|Washout After 1st Treatment Period||2
150380|NCT00762450|348026|P2|STARTED|Washout After 1st Treatment Period||2
150381|NCT00762450|348027|P1|STARTED|Washout After 1st Treatment Period||2
150382|NCT00762450|348025|P3|NOT COMPLETED|1st Treatment Period||0
150383|NCT00762450|348026|P2|NOT COMPLETED|1st Treatment Period||0
150384|NCT00762450|348027|P1|NOT COMPLETED|1st Treatment Period||0
150385|NCT00762450|348025|P3|COMPLETED|1st Treatment Period||2
150386|NCT00762450|348026|P2|COMPLETED|1st Treatment Period||2
150387|NCT00762450|348027|P1|COMPLETED|1st Treatment Period||2
150388|NCT00762450|348025|P3|STARTED|1st Treatment Period||2
150389|NCT00762450|348026|P2|STARTED|1st Treatment Period||2
150390|NCT00762450|348027|P1|STARTED|1st Treatment Period||2
150391|NCT00762424|348037|P2|NOT COMPLETED|Overall Study||0
150392|NCT00762424|348038|P1|NOT COMPLETED|Overall Study||0
150393|NCT00762424|348037|P2|COMPLETED|Overall Study||25
150394|NCT00762424|348038|P1|COMPLETED|Overall Study||28
150395|NCT00762424|348037|P2|STARTED|Overall Study||25
150396|NCT00762424|348038|P1|STARTED|Overall Study||28
150397|NCT00762411|348046|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
150398|NCT00762411|348047|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
150399|NCT00762411|348046|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
150400|NCT00762411|348047|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
150401|NCT00762411|348046|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
150402|NCT00762411|348047|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
150403|NCT00762411|348046|P2|NOT COMPLETED|Delayed Start||26
150404|NCT00762411|348047|P1|NOT COMPLETED|Delayed Start||17
150405|NCT00762411|348046|P2|COMPLETED|Delayed Start||8
150406|NCT00762411|348047|P1|COMPLETED|Delayed Start||5
150407|NCT00762411|348046|P2|STARTED|Delayed Start||34
150408|NCT00762411|348047|P1|STARTED|Delayed Start||22
150409|NCT00762411|348046|P2|NOT COMPLETED|Initial Treatment||521
150410|NCT00762411|348047|P1|NOT COMPLETED|Initial Treatment||534
150411|NCT00762411|348046|P2|COMPLETED|Initial Treatment||34
150412|NCT00762411|348047|P1|COMPLETED|Initial Treatment||22
150413|NCT00762411|348046|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
150414|NCT00762411|348047|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
150415|NCT00762411|348046|P2|STARTED|Initial Treatment||555
150416|NCT00762411|348047|P1|STARTED|Initial Treatment||556
150417|NCT00762385|348111|P2|NOT COMPLETED|Second Intervention||3
150418|NCT00762385|348112|P1|NOT COMPLETED|Second Intervention||3
150419|NCT00762385|348111|P2|COMPLETED|Second Intervention||39
150420|NCT00762385|348112|P1|COMPLETED|Second Intervention||46
150421|NCT00762385|348111|P2|STARTED|Second Intervention||42
150422|NCT00762385|348112|P1|STARTED|Second Intervention||49
150423|NCT00762385|348111|P2|NOT COMPLETED|First Intervention||4
150424|NCT00762385|348112|P1|NOT COMPLETED|First Intervention||2
150425|NCT00762385|348111|P2|COMPLETED|First Intervention||42
150426|NCT00762385|348112|P1|COMPLETED|First Intervention||49
150427|NCT00762385|348111|P2|STARTED|First Intervention||46
150428|NCT00762385|348112|P1|STARTED|First Intervention||51
150429|NCT00762359|348124|P2|NOT COMPLETED|Overall Study||57
150430|NCT00762359|348125|P1|NOT COMPLETED|Overall Study||59
150431|NCT00762359|348124|P2|COMPLETED|Overall Study||178
150432|NCT00762359|348125|P1|COMPLETED|Overall Study||167
150433|NCT00762359|348124|P2|STARTED|Overall Study||235
150434|NCT00762359|348125|P1|STARTED|Overall Study||226
150435|NCT00762320|348225|P1|NOT COMPLETED|Overall Study||0
150436|NCT00762320|348225|P1|COMPLETED|Overall Study||8
150437|NCT00762320|348225|P1|STARTED|Overall Study||8
150438|NCT00762268|348242|P2|NOT COMPLETED|Overall Study||2
150439|NCT00762268|348243|P1|NOT COMPLETED|Overall Study||1
150440|NCT00762268|348242|P2|COMPLETED|Overall Study||8
150441|NCT00762268|348243|P1|COMPLETED|Overall Study||9
150442|NCT00762268|348242|P2|STARTED|Overall Study||10
150443|NCT00762268|348243|P1|STARTED|Overall Study||10
150444|NCT00762229|348251|P2|NOT COMPLETED|Overall Study||2
150445|NCT00762229|348252|P1|NOT COMPLETED|Overall Study||1
150446|NCT00762229|348251|P2|COMPLETED|Overall Study||22
150447|NCT00762229|348252|P1|COMPLETED|Overall Study||14
150448|NCT00762229|348251|P2|STARTED|Overall Study||24
150449|NCT00762229|348252|P1|STARTED|Overall Study||15
150450|NCT00762216|348260|P1|NOT COMPLETED|Overall Study||0
150451|NCT00762216|348260|P1|COMPLETED|Overall Study||71
150452|NCT00762216|348260|P1|STARTED|Overall Study||71
150453|NCT00762177|348268|P3|NOT COMPLETED|3rd Treatment Period||0
150454|NCT00762177|348269|P2|NOT COMPLETED|3rd Treatment Period||0
150455|NCT00762177|348270|P1|NOT COMPLETED|3rd Treatment Period||0
150456|NCT00762177|348268|P3|COMPLETED|3rd Treatment Period||8
150457|NCT00762177|348269|P2|COMPLETED|3rd Treatment Period||8
150458|NCT00762177|348270|P1|COMPLETED|3rd Treatment Period||8
150459|NCT00762177|348268|P3|STARTED|3rd Treatment Period||8
150460|NCT00762177|348269|P2|STARTED|3rd Treatment Period||8
150461|NCT00762177|348270|P1|STARTED|3rd Treatment Period||8
150462|NCT00762177|348268|P3|NOT COMPLETED|Washout After 2nd Treatment||0
150463|NCT00762177|348269|P2|NOT COMPLETED|Washout After 2nd Treatment||0
150464|NCT00762177|348270|P1|NOT COMPLETED|Washout After 2nd Treatment||0
150465|NCT00762177|348268|P3|COMPLETED|Washout After 2nd Treatment||8
150466|NCT00762177|348269|P2|COMPLETED|Washout After 2nd Treatment||8
150467|NCT00762177|348270|P1|COMPLETED|Washout After 2nd Treatment||8
150468|NCT00762177|348268|P3|STARTED|Washout After 2nd Treatment||8
150469|NCT00762177|348269|P2|STARTED|Washout After 2nd Treatment||8
150470|NCT00762177|348270|P1|STARTED|Washout After 2nd Treatment||8
150471|NCT00762177|348268|P3|NOT COMPLETED|2nd Treatment Period||0
150472|NCT00762177|348269|P2|NOT COMPLETED|2nd Treatment Period||0
150473|NCT00762177|348270|P1|NOT COMPLETED|2nd Treatment Period||0
150474|NCT00762177|348268|P3|COMPLETED|2nd Treatment Period||8
150475|NCT00762177|348269|P2|COMPLETED|2nd Treatment Period||8
150476|NCT00762177|348270|P1|COMPLETED|2nd Treatment Period||8
150477|NCT00762177|348268|P3|STARTED|2nd Treatment Period||8
150478|NCT00762177|348269|P2|STARTED|2nd Treatment Period||8
150479|NCT00762177|348270|P1|STARTED|2nd Treatment Period||8
150480|NCT00762177|348268|P3|NOT COMPLETED|Washout After 1st Treatment||0
150481|NCT00762177|348269|P2|NOT COMPLETED|Washout After 1st Treatment||0
150482|NCT00762177|348270|P1|NOT COMPLETED|Washout After 1st Treatment||0
150483|NCT00762177|348268|P3|COMPLETED|Washout After 1st Treatment||8
150484|NCT00762177|348269|P2|COMPLETED|Washout After 1st Treatment||8
150485|NCT00762177|348270|P1|COMPLETED|Washout After 1st Treatment||8
150486|NCT00762177|348268|P3|STARTED|Washout After 1st Treatment||8
150487|NCT00762177|348269|P2|STARTED|Washout After 1st Treatment||8
150488|NCT00762177|348270|P1|STARTED|Washout After 1st Treatment||8
150489|NCT00762177|348268|P3|NOT COMPLETED|1st Treatment Period||0
150490|NCT00762177|348269|P2|NOT COMPLETED|1st Treatment Period||0
150491|NCT00762177|348270|P1|NOT COMPLETED|1st Treatment Period||0
150492|NCT00762177|348268|P3|COMPLETED|1st Treatment Period||8
150493|NCT00762177|348269|P2|COMPLETED|1st Treatment Period||8
150494|NCT00762177|348270|P1|COMPLETED|1st Treatment Period||8
150495|NCT00762177|348268|P3|STARTED|1st Treatment Period||8
150496|NCT00762177|348269|P2|STARTED|1st Treatment Period||8
150497|NCT00762177|348270|P1|STARTED|1st Treatment Period||8
150498|NCT00762164|348349|P2|NOT COMPLETED|Overall Study||2
150499|NCT00762164|348350|P1|NOT COMPLETED|Overall Study||3
150500|NCT00762164|348349|P2|COMPLETED|Overall Study||15
150501|NCT00762164|348350|P1|COMPLETED|Overall Study||14
150502|NCT00762164|348349|P2|STARTED|Overall Study||17
150503|NCT00762164|348350|P1|STARTED|Overall Study||17
150504|NCT00762086|348360|P2|NOT COMPLETED|Overall Study||4
150505|NCT00762086|348361|P1|NOT COMPLETED|Overall Study||6
150506|NCT00762086|348360|P2|COMPLETED|Overall Study||24
150507|NCT00762086|348361|P1|COMPLETED|Overall Study||33
150508|NCT00762086|348360|P2|STARTED|Overall Study||28
150509|NCT00762086|348361|P1|STARTED|Overall Study||39
150510|NCT00762073|348371|P4|NOT COMPLETED|Overall Study||3
150511|NCT00762073|348372|P3|NOT COMPLETED|Overall Study||2
150512|NCT00762073|348373|P2|NOT COMPLETED|Overall Study||4
150513|NCT00762073|348374|P1|NOT COMPLETED|Overall Study||4
150514|NCT00762073|348371|P4|COMPLETED|Overall Study||17
150515|NCT00762073|348372|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
150516|NCT00762073|348373|P2|COMPLETED|Overall Study||17
150517|NCT00762073|348374|P1|COMPLETED|Overall Study||17
150518|NCT00762073|348371|P4|STARTED|Overall Study||20
150519|NCT00762073|348372|P3|STARTED|Overall Study||20
150520|NCT00762073|348373|P2|STARTED|Overall Study||21
150521|NCT00762073|348374|P1|STARTED|Overall Study||21
150522|NCT00762034|348438|P2|NOT COMPLETED|Maintenance Period||298
150523|NCT00762034|348439|P1|NOT COMPLETED|Maintenance Period||294
150524|NCT00762034|348438|P2|COMPLETED|Maintenance Period||0
150525|NCT00762034|348439|P1|COMPLETED|Maintenance Period||0
150526|NCT00762034|348438|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
150527|NCT00762034|348439|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
150528|NCT00762034|348438|P2|STARTED|Maintenance Period||298
150529|NCT00762034|348439|P1|STARTED|Maintenance Period||294
150530|NCT00762034|348438|P2|NOT COMPLETED|Induction Period||169
150531|NCT00762034|348439|P1|NOT COMPLETED|Induction Period||178
150532|NCT00762034|348438|P2|COMPLETED|Induction Period||298
150533|NCT00762034|348439|P1|COMPLETED|Induction Period||294
150534|NCT00762034|348438|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
150535|NCT00762034|348439|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
150536|NCT00762034|348438|P2|STARTED|Induction Period||467
150537|NCT00762034|348439|P1|STARTED|Induction Period||472
150538|NCT00762021|348498|P2|NOT COMPLETED|Overall Study||8
150539|NCT00762021|348499|P1|NOT COMPLETED|Overall Study||8
150540|NCT00762021|348498|P2|COMPLETED|Overall Study||44
150541|NCT00762021|348499|P1|COMPLETED|Overall Study||44
150542|NCT00762021|348498|P2|STARTED|Overall Study||52
150543|NCT00762021|348499|P1|STARTED|Overall Study||52
150544|NCT00761969|348511|P2|NOT COMPLETED|Overall Study||140
150545|NCT00761969|348512|P1|NOT COMPLETED|Overall Study||200
150546|NCT00761969|348511|P2|COMPLETED|Overall Study||573
150547|NCT00761969|348512|P1|COMPLETED|Overall Study||542
150548|NCT00761969|348511|P2|STARTED|Overall Study||713
150549|NCT00761969|348512|P1|STARTED|Overall Study||742
150550|NCT00761956|348522|P2|NOT COMPLETED|Overall Study||54
150551|NCT00761956|348523|P1|NOT COMPLETED|Overall Study||35
150552|NCT00761956|348522|P2|COMPLETED|Overall Study||48
150553|NCT00761956|348523|P1|COMPLETED|Overall Study||52
150554|NCT00761956|348522|P2|STARTED|Overall Study||102
150555|NCT00761956|348523|P1|STARTED|Overall Study||87
150556|NCT00761930|348534|P3|NOT COMPLETED|Overall Study||0
150557|NCT00761930|348535|P2|NOT COMPLETED|Overall Study||0
150558|NCT00761930|348536|P1|NOT COMPLETED|Overall Study||0
150559|NCT00761930|348534|P3|COMPLETED|Overall Study||35
150560|NCT00761930|348535|P2|COMPLETED|Overall Study||34
150561|NCT00761930|348536|P1|COMPLETED|Overall Study||34
150562|NCT00761930|348534|P3|STARTED|Overall Study||35
150563|NCT00761930|348535|P2|STARTED|Overall Study||34
150564|NCT00761930|348536|P1|STARTED|Overall Study||34
150565|NCT00761865|348552|P2|NOT COMPLETED|Overall Study||7
150566|NCT00761865|348553|P1|NOT COMPLETED|Overall Study||8
150567|NCT00761865|348552|P2|COMPLETED|Overall Study||11
150568|NCT00761865|348553|P1|COMPLETED|Overall Study||8
150569|NCT00761865|348552|P2|STARTED|Overall Study||18
150570|NCT00761865|348553|P1|STARTED|Overall Study||16
150571|NCT00761761|348563|P2|NOT COMPLETED|Overall Study||1
150572|NCT00761761|348564|P1|NOT COMPLETED|Overall Study||6
150573|NCT00761761|348563|P2|COMPLETED|Overall Study||29
150574|NCT00761761|348564|P1|COMPLETED|Overall Study||24
150575|NCT00761761|348563|P2|STARTED|Overall Study||30
150576|NCT00761761|348564|P1|STARTED|Overall Study||30
150577|NCT00761748|348576|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
150578|NCT00761748|348577|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
150579|NCT00761748|348576|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
150580|NCT00761748|348577|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
150581|NCT00761748|348576|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
150582|NCT00761748|348577|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
150583|NCT00761748|348576|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
150584|NCT00761748|348577|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
150585|NCT00761748|348576|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
150586|NCT00761748|348577|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
150587|NCT00761748|348576|P2|STARTED|First Intervention (21 +/- 3 Days)||10
150588|NCT00761748|348577|P1|STARTED|First Intervention (21 +/- 3 Days)||20
150589|NCT00761735|348583|P1|NOT COMPLETED|Overall Study||14
150590|NCT00761735|348583|P1|COMPLETED|Overall Study||80
150591|NCT00761735|348583|P1|STARTED|Overall Study||94
150592|NCT00761631|348599|P6|NOT COMPLETED|Overall Study||5
150593|NCT00761631|348600|P5|NOT COMPLETED|Overall Study||22
150594|NCT00761631|348601|P4|NOT COMPLETED|Overall Study||3
150595|NCT00761631|348602|P3|NOT COMPLETED|Overall Study||16
150596|NCT00761631|348603|P2|NOT COMPLETED|Overall Study||7
150597|NCT00761631|348604|P1|NOT COMPLETED|Overall Study||15
150598|NCT00761631|348599|P6|COMPLETED|Overall Study||294
150599|NCT00761631|348600|P5|COMPLETED|Overall Study||277
150600|NCT00761631|348601|P4|COMPLETED|Overall Study||116
150601|NCT00761631|348602|P3|COMPLETED|Overall Study||160
150602|NCT00761631|348603|P2|COMPLETED|Overall Study||174
150603|NCT00761631|348604|P1|COMPLETED|Overall Study||111
150604|NCT00761631|348599|P6|Vaccinated Dose 2|Overall Study||0
150605|NCT00761631|348600|P5|Vaccinated Dose 2|Overall Study||0
150606|NCT00761631|348601|P4|Vaccinated Dose 2|Overall Study||0
150607|NCT00761631|348602|P3|Vaccinated Dose 2|Overall Study||165
150608|NCT00761631|348603|P2|Vaccinated Dose 2|Overall Study||0
150609|NCT00761631|348604|P1|Vaccinated Dose 2|Overall Study||112
150610|NCT00761631|348599|P6|Vaccinated Dose 1|Overall Study||298
150611|NCT00761631|348600|P5|Vaccinated Dose 1|Overall Study||294
150612|NCT00761631|348601|P4|Vaccinated Dose 1|Overall Study||118
150613|NCT00761631|348602|P3|Vaccinated Dose 1|Overall Study||175
150614|NCT00761631|348603|P2|Vaccinated Dose 1|Overall Study||179
150615|NCT00761631|348604|P1|Vaccinated Dose 1|Overall Study||124
150616|NCT00761631|348599|P6|STARTED|Overall Study||299
150617|NCT00761631|348600|P5|STARTED|Overall Study||299
150618|NCT00761631|348601|P4|STARTED|Overall Study||119
150619|NCT00761631|348602|P3|STARTED|Overall Study||176
150620|NCT00761631|348603|P2|STARTED|Overall Study||181
150621|NCT00761631|348604|P1|STARTED|Overall Study||126
150622|NCT00761605|348639|P1|NOT COMPLETED|Overall Study||141
150623|NCT00761605|348639|P1|COMPLETED|Overall Study||246
150624|NCT00761605|348639|P1|STARTED|Overall Study||387
150625|NCT00761592|348668|P2|NOT COMPLETED|Overall Study||1
150626|NCT00761592|348669|P1|NOT COMPLETED|Overall Study||1
150627|NCT00761592|348668|P2|COMPLETED|Overall Study||32
150628|NCT00761592|348669|P1|COMPLETED|Overall Study||31
150629|NCT00761592|348668|P2|STARTED|Overall Study||33
150630|NCT00761592|348669|P1|STARTED|Overall Study||32
150631|NCT00761579|348683|P1|NOT COMPLETED|Overall Study||92
150632|NCT00761579|348683|P1|COMPLETED|Overall Study||98
150633|NCT00761579|348683|P1|STARTED|Overall Study||190
150634|NCT00761527|348716|P1|NOT COMPLETED|Overall Study||22
150635|NCT00761527|348716|P1|COMPLETED|Overall Study||2958
150636|NCT00761527|348716|P1|Received One Dose of Study Medication|Overall Study||2978
150637|NCT00761527|348716|P1|STARTED|Overall Study||2980
150638|NCT00761514|348723|P1|NOT COMPLETED|Overall Study||7
150639|NCT00761514|348723|P1|COMPLETED|Overall Study||7
150640|NCT00761514|348723|P1|STARTED|Overall Study||14
150641|NCT00761462|348730|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
150642|NCT00761462|348731|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
150643|NCT00761462|348730|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
150644|NCT00761462|348731|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
150645|NCT00761462|348730|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
150646|NCT00761462|348731|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
150647|NCT00761462|348730|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
150648|NCT00761462|348731|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
150649|NCT00761462|348730|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
150650|NCT00761462|348731|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
150651|NCT00761462|348730|P2|NOT COMPLETED|Treatment||12
150652|NCT00761462|348731|P1|NOT COMPLETED|Treatment||23
150653|NCT00761462|348730|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
150654|NCT00761462|348731|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
150655|NCT00761462|348730|P2|STARTED|Treatment|Patients enrolled in study group|519
150656|NCT00761462|348731|P1|STARTED|Treatment|Patients enrolled in study group|510
150657|NCT00761345|348739|P1|NOT COMPLETED|Overall Study||3
150658|NCT00761345|348739|P1|COMPLETED|Overall Study||24
150659|NCT00761345|348739|P1|STARTED|Overall Study||27
150660|NCT00761319|348745|P2|NOT COMPLETED|Overall Study||34
150661|NCT00761319|348746|P1|NOT COMPLETED|Overall Study||48
150662|NCT00761319|348745|P2|COMPLETED|Overall Study||318
150663|NCT00761319|348746|P1|COMPLETED|Overall Study||305
150664|NCT00761319|348745|P2|STARTED|Overall Study||352
150665|NCT00761319|348746|P1|STARTED|Overall Study||353
150666|NCT00761306|348754|P1|NOT COMPLETED|Overall Study||20
150667|NCT00761306|348754|P1|COMPLETED|Overall Study||54
150668|NCT00761306|348754|P1|STARTED|Overall Study||74
150669|NCT00761280|348765|P2|NOT COMPLETED|First Dose to End of Study||11
150670|NCT00761280|348766|P1|NOT COMPLETED|First Dose to End of Study||12
150671|NCT00761280|348765|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
150672|NCT00761280|348766|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
150673|NCT00761280|348765|P2|STARTED|First Dose to End of Study||11
150674|NCT00761280|348766|P1|STARTED|First Dose to End of Study||12
150675|NCT00761280|348765|P2|NOT COMPLETED|Randomization to First Dose||2
150676|NCT00761280|348766|P1|NOT COMPLETED|Randomization to First Dose||2
150677|NCT00761280|348765|P2|COMPLETED|Randomization to First Dose||11
150678|NCT00761280|348766|P1|COMPLETED|Randomization to First Dose||12
150679|NCT00761280|348765|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
150680|NCT00761280|348766|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
150681|NCT00761280|348765|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
150682|NCT00761280|348766|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
150683|NCT00761280|348765|P2|STARTED|Randomization to First Dose||13
150684|NCT00761280|348766|P1|STARTED|Randomization to First Dose||14
150685|NCT00761215|348797|P3|NOT COMPLETED|Overall Study||8
150686|NCT00761215|348798|P2|NOT COMPLETED|Overall Study||4
150687|NCT00761215|348799|P1|NOT COMPLETED|Overall Study||9
150688|NCT00761215|348797|P3|COMPLETED|Overall Study||56
150689|NCT00761215|348798|P2|COMPLETED|Overall Study||60
150690|NCT00761215|348799|P1|COMPLETED|Overall Study||55
150691|NCT00761215|348797|P3|STARTED|Overall Study||64
150692|NCT00761215|348798|P2|STARTED|Overall Study||64
150693|NCT00761215|348799|P1|STARTED|Overall Study||64
150694|NCT00761202|348824|P2|NOT COMPLETED|Overall Study||2
150695|NCT00761202|348825|P1|NOT COMPLETED|Overall Study||1
150696|NCT00761202|348824|P2|COMPLETED|Overall Study||26
150697|NCT00761202|348825|P1|COMPLETED|Overall Study||21
150698|NCT00761202|348824|P2|STARTED|Overall Study||28
150699|NCT00761202|348825|P1|STARTED|Overall Study||22
150700|NCT00761189|348841|P1|NOT COMPLETED|Overall Study||185
150701|NCT00761189|348841|P1|COMPLETED|Overall Study||306
150702|NCT00761189|348841|P1|STARTED|Overall Study||491
150703|NCT00761176|348858|P2|NOT COMPLETED|Overall Study||1
150704|NCT00761176|348859|P1|NOT COMPLETED|Overall Study||2
150705|NCT00761176|348858|P2|COMPLETED|Overall Study||3
150706|NCT00761176|348859|P1|COMPLETED|Overall Study||2
150707|NCT00761176|348858|P2|STARTED|Overall Study||4
150708|NCT00761176|348859|P1|STARTED|Overall Study||4
150709|NCT00761150|348868|P3|NOT COMPLETED|Double-blind Period||29
150710|NCT00761150|348869|P2|NOT COMPLETED|Double-blind Period||14
150711|NCT00761150|348870|P1|NOT COMPLETED|Double-blind Period||0
150712|NCT00761150|348868|P3|COMPLETED|Double-blind Period||89
150713|NCT00761150|348869|P2|COMPLETED|Double-blind Period||106
150714|NCT00761150|348870|P1|COMPLETED|Double-blind Period||0
150715|NCT00761150|348868|P3|STARTED|Double-blind Period||118
150716|NCT00761150|348869|P2|STARTED|Double-blind Period||120
150717|NCT00761150|348870|P1|STARTED|Double-blind Period||0
150718|NCT00761150|348868|P3|NOT COMPLETED|Open-label Period||0
150719|NCT00761150|348869|P2|NOT COMPLETED|Open-label Period||0
150720|NCT00761150|348870|P1|NOT COMPLETED|Open-label Period||70
150721|NCT00761150|348868|P3|COMPLETED|Open-label Period||0
150722|NCT00761150|348869|P2|COMPLETED|Open-label Period||0
150723|NCT00761150|348870|P1|COMPLETED|Open-label Period||238
150724|NCT00761150|348868|P3|STARTED|Open-label Period||0
150725|NCT00761150|348869|P2|STARTED|Open-label Period||0
150726|NCT00761150|348870|P1|STARTED|Open-label Period||308
150727|NCT00761137|348879|P1|NOT COMPLETED|Overall Study||0
150728|NCT00761137|348879|P1|COMPLETED|Overall Study||19
150729|NCT00761137|348879|P1|3 mg Tropicamide|Overall Study||19
150730|NCT00761137|348879|P1|1 mg Tropicamide|Overall Study||19
150731|NCT00761137|348879|P1|0.3 mg Tropicamide|Overall Study||19
150732|NCT00761137|348879|P1|Placebo|Overall Study||19
150733|NCT00761137|348879|P1|STARTED|Overall Study||19
150734|NCT00760266|348892|P2|NOT COMPLETED|Overall Study||18
150735|NCT00760266|348893|P1|NOT COMPLETED|Overall Study||24
150736|NCT00760266|348892|P2|COMPLETED|Overall Study||205
150737|NCT00760266|348893|P1|COMPLETED|Overall Study||204
150738|NCT00760266|348892|P2|STARTED|Overall Study||223
150739|NCT00760266|348893|P1|STARTED|Overall Study||228
150740|NCT00760214|348910|P3|NOT COMPLETED|Overall Study||41
150741|NCT00760214|348911|P2|NOT COMPLETED|Overall Study||30
150742|NCT00760214|348912|P1|NOT COMPLETED|Overall Study||30
150743|NCT00760214|348910|P3|COMPLETED|Overall Study||255
150744|NCT00760214|348911|P2|COMPLETED|Overall Study||264
150745|NCT00760214|348912|P1|COMPLETED|Overall Study||265
150746|NCT00760214|348910|P3|STARTED|Overall Study||296
150747|NCT00760214|348911|P2|STARTED|Overall Study||294
150748|NCT00760214|348912|P1|STARTED|Overall Study||295
150749|NCT00761007|348957|P4|NOT COMPLETED|Overall Study||7
150750|NCT00761007|348958|P3|NOT COMPLETED|Overall Study||18
150751|NCT00761007|348959|P2|NOT COMPLETED|Overall Study||11
150752|NCT00761007|348960|P1|NOT COMPLETED|Overall Study||13
150753|NCT00761007|348957|P4|COMPLETED|Overall Study||131
150754|NCT00761007|348958|P3|COMPLETED|Overall Study||121
150755|NCT00761007|348959|P2|COMPLETED|Overall Study||124
150756|NCT00761007|348960|P1|COMPLETED|Overall Study||129
150757|NCT00761007|348957|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
150758|NCT00761007|348958|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
150759|NCT00761007|348959|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
150760|NCT00761007|348960|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
150761|NCT00761007|348957|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
150762|NCT00761007|348958|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
150763|NCT00761007|348959|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
150764|NCT00761007|348960|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
150765|NCT00761007|348957|P4|STARTED|Overall Study||138
150766|NCT00761007|348958|P3|STARTED|Overall Study||139
150767|NCT00761007|348959|P2|STARTED|Overall Study||135
150768|NCT00761007|348960|P1|STARTED|Overall Study||142
150769|NCT00760877|348984|P2|NOT COMPLETED|Overall Study||26
150770|NCT00760877|348985|P1|NOT COMPLETED|Overall Study||45
150771|NCT00760877|348984|P2|COMPLETED|Overall Study||77
150772|NCT00760877|348985|P1|COMPLETED|Overall Study||59
150773|NCT00760877|348984|P2|Safety Set|Overall Study||103
150774|NCT00760877|348985|P1|Safety Set|Overall Study||101
150775|NCT00760877|348984|P2|Cross-over to Nilotinib|Overall Study||46
150776|NCT00760877|348985|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
150777|NCT00760877|348984|P2|STARTED|Overall Study||103
150778|NCT00760877|348985|P1|STARTED|Overall Study||104
150779|NCT00760838|349003|P2|NOT COMPLETED|Overall Study||2
150780|NCT00760838|349004|P1|NOT COMPLETED|Overall Study||5
150781|NCT00760838|349003|P2|COMPLETED|Overall Study||53
150782|NCT00760838|349004|P1|COMPLETED|Overall Study||49
150783|NCT00760838|349003|P2|STARTED|Overall Study||55
150784|NCT00760838|349004|P1|STARTED|Overall Study||54
150785|NCT00760747|349022|P2|NOT COMPLETED|Study Period III||3
150786|NCT00760747|349023|P1|NOT COMPLETED|Study Period III||3
150787|NCT00760747|349022|P2|COMPLETED|Study Period III||38
150788|NCT00760747|349023|P1|COMPLETED|Study Period III||41
150789|NCT00760747|349022|P2|STARTED|Study Period III||41
150790|NCT00760747|349023|P1|STARTED|Study Period III||44
150791|NCT00760747|349022|P2|NOT COMPLETED|Study Period II||14
150792|NCT00760747|349023|P1|NOT COMPLETED|Study Period II||13
150793|NCT00760747|349022|P2|COMPLETED|Study Period II||41
150794|NCT00760747|349023|P1|COMPLETED|Study Period II||44
150795|NCT00760747|349022|P2|Received at Least One Dose of Study Drug|Study Period II||54
150796|NCT00760747|349023|P1|Received at Least One Dose of Study Drug|Study Period II||57
150797|NCT00760747|349022|P2|STARTED|Study Period II||55
150798|NCT00760747|349023|P1|STARTED|Study Period II||57
150799|NCT00760669|349051|P1|NOT COMPLETED|Overall Study||30
150800|NCT00760669|349051|P1|COMPLETED|Overall Study||1031
150801|NCT00760669|349051|P1|STARTED|Overall Study||1061
150802|NCT00760617|349068|P3|NOT COMPLETED|Overall Study||5
150803|NCT00760617|349069|P2|NOT COMPLETED|Overall Study||2
150804|NCT00760617|349070|P1|NOT COMPLETED|Overall Study||5
150805|NCT00760617|349068|P3|COMPLETED|Overall Study||111
150806|NCT00760617|349069|P2|COMPLETED|Overall Study||142
150807|NCT00760617|349070|P1|COMPLETED|Overall Study||261
150808|NCT00760617|349068|P3|STARTED|Overall Study||116
150809|NCT00760617|349069|P2|STARTED|Overall Study||144
150810|NCT00760617|349070|P1|STARTED|Overall Study||266
150811|NCT00760578|349145|P4|NOT COMPLETED|Overall Study||4
150812|NCT00760578|349146|P3|NOT COMPLETED|Overall Study||5
150813|NCT00760578|349147|P2|NOT COMPLETED|Overall Study||2
150814|NCT00760578|349148|P1|NOT COMPLETED|Overall Study||3
150815|NCT00760578|349145|P4|COMPLETED|Overall Study||18
150816|NCT00760578|349146|P3|COMPLETED|Overall Study||16
150817|NCT00760578|349147|P2|COMPLETED|Overall Study||19
150818|NCT00760578|349148|P1|COMPLETED|Overall Study||19
150819|NCT00760578|349145|P4|Entered Drug Treatment Period|Overall Study||22
150820|NCT00760578|349146|P3|Entered Drug Treatment Period|Overall Study||19
150821|NCT00760578|349147|P2|Entered Drug Treatment Period|Overall Study||20
150822|NCT00760578|349148|P1|Entered Drug Treatment Period|Overall Study||21
150823|NCT00760578|349145|P4|STARTED|Overall Study||22
150824|NCT00760578|349146|P3|STARTED|Overall Study||21
150825|NCT00760578|349147|P2|STARTED|Overall Study||21
150826|NCT00760578|349148|P1|STARTED|Overall Study||22
150827|NCT00760552|349184|P2|NOT COMPLETED|Overall Study||10
150828|NCT00760552|349185|P1|NOT COMPLETED|Overall Study||13
150829|NCT00760552|349184|P2|COMPLETED|Overall Study||52
150830|NCT00760552|349185|P1|COMPLETED|Overall Study||48
150831|NCT00760552|349184|P2|STARTED|Overall Study||62
150832|NCT00760552|349185|P1|STARTED|Overall Study||61
150833|NCT00760526|349193|P2|NOT COMPLETED|Overall Study||4
150834|NCT00760526|349194|P1|NOT COMPLETED|Overall Study||5
150835|NCT00760526|349193|P2|COMPLETED|Overall Study||68
150836|NCT00760526|349194|P1|COMPLETED|Overall Study||69
150837|NCT00760526|349193|P2|STARTED|Overall Study||72
150838|NCT00760526|349194|P1|STARTED|Overall Study||74
150839|NCT00760487|349219|P1|NOT COMPLETED|Overall Study||3
150840|NCT00760487|349219|P1|COMPLETED|Overall Study||117
150841|NCT00760487|349219|P1|STARTED|Overall Study||120
150842|NCT00760474|349225|P2|NOT COMPLETED|Period 2 (P2)||1
150843|NCT00760474|349226|P1|NOT COMPLETED|Period 2 (P2)||1
150844|NCT00760474|349225|P2|COMPLETED|Period 2 (P2)||11
150845|NCT00760474|349226|P1|COMPLETED|Period 2 (P2)||11
150846|NCT00760474|349225|P2|STARTED|Period 2 (P2)||12
150847|NCT00760474|349226|P1|STARTED|Period 2 (P2)||12
150848|NCT00760474|349225|P2|NOT COMPLETED|Placebo Washout Period||1
150849|NCT00760474|349226|P1|NOT COMPLETED|Placebo Washout Period||0
150850|NCT00760474|349225|P2|COMPLETED|Placebo Washout Period||12
150851|NCT00760474|349226|P1|COMPLETED|Placebo Washout Period||12
150852|NCT00760474|349225|P2|STARTED|Placebo Washout Period||13
150853|NCT00760474|349226|P1|STARTED|Placebo Washout Period||12
150854|NCT00760474|349225|P2|NOT COMPLETED|Period 1 (P1)||1
150855|NCT00760474|349226|P1|NOT COMPLETED|Period 1 (P1)||1
150856|NCT00760474|349225|P2|COMPLETED|Period 1 (P1)||13
150857|NCT00760474|349226|P1|COMPLETED|Period 1 (P1)||12
150858|NCT00760474|349225|P2|Overall Number of Unique Participants|Period 1 (P1)||13
150859|NCT00760474|349226|P1|Overall Number of Unique Participants|Period 1 (P1)||12
150860|NCT00760474|349225|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
150861|NCT00760474|349226|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
150862|NCT00760474|349225|P2|STARTED|Period 1 (P1)||14
150863|NCT00760474|349226|P1|STARTED|Period 1 (P1)||13
150864|NCT00760435|349264|P2|NOT COMPLETED|Overall Study||5
150865|NCT00760435|349265|P1|NOT COMPLETED|Overall Study||4
150866|NCT00760435|349264|P2|COMPLETED|Overall Study||93
150867|NCT00760435|349265|P1|COMPLETED|Overall Study||94
150868|NCT00760435|349264|P2|STARTED|Overall Study||98
150869|NCT00760435|349265|P1|STARTED|Overall Study||98
150870|NCT00760383|349279|P2|NOT COMPLETED|Overall Study||7
150871|NCT00760383|349280|P1|NOT COMPLETED|Overall Study||5
150872|NCT00760383|349279|P2|COMPLETED|Overall Study||12
150873|NCT00760383|349280|P1|COMPLETED|Overall Study||16
150874|NCT00760383|349279|P2|STARTED|Overall Study||19
150875|NCT00760383|349280|P1|STARTED|Overall Study||21
150876|NCT00760084|349290|P1|NOT COMPLETED|Overall Study||10
150877|NCT00760084|349290|P1|COMPLETED|Overall Study||0
150878|NCT00760084|349290|P1|STARTED|Overall Study||10
150879|NCT00759954|349296|P2|NOT COMPLETED|Overall Study||2
150880|NCT00759954|349297|P1|NOT COMPLETED|Overall Study||2
150881|NCT00759954|349296|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
150882|NCT00759954|349297|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
150883|NCT00759954|349296|P2|STARTED|Overall Study|All assigned participants entered trial|18
150884|NCT00759954|349297|P1|STARTED|Overall Study|All assigned participants entered trial|18
150885|NCT00759941|349311|P2|NOT COMPLETED|Overall Study||1
150886|NCT00759941|349312|P1|NOT COMPLETED|Overall Study||3
150887|NCT00759941|349311|P2|COMPLETED|Overall Study||43
150888|NCT00759941|349312|P1|COMPLETED|Overall Study||39
150889|NCT00759941|349311|P2|STARTED|Overall Study||44
150890|NCT00759941|349312|P1|STARTED|Overall Study||42
150891|NCT00759915|349326|P2|NOT COMPLETED|Overall Study||1
150892|NCT00759915|349327|P1|NOT COMPLETED|Overall Study||1
150893|NCT00759915|349326|P2|COMPLETED|Overall Study||17
150894|NCT00759915|349327|P1|COMPLETED|Overall Study||17
150895|NCT00759915|349326|P2|STARTED|Overall Study||18
150896|NCT00759915|349327|P1|STARTED|Overall Study||18
150897|NCT00759902|349341|P2|NOT COMPLETED|Overall Study||1
150898|NCT00759902|349342|P1|NOT COMPLETED|Overall Study||0
150899|NCT00759902|349341|P2|COMPLETED|Overall Study||17
150900|NCT00759902|349342|P1|COMPLETED|Overall Study||18
150901|NCT00759902|349341|P2|STARTED|Overall Study||18
150902|NCT00759902|349342|P1|STARTED|Overall Study||18
150903|NCT00759863|349356|P2|NOT COMPLETED|Overall Study||18
150904|NCT00759863|349357|P1|NOT COMPLETED|Overall Study||20
150905|NCT00759863|349356|P2|COMPLETED|Overall Study||80
150906|NCT00759863|349357|P1|COMPLETED|Overall Study||124
150907|NCT00759863|349356|P2|STARTED|Overall Study||98
150908|NCT00759863|349357|P1|STARTED|Overall Study||144
150909|NCT00759811|349369|P2|NOT COMPLETED|Overall Study||1
150910|NCT00759811|349370|P1|NOT COMPLETED|Overall Study||2
150911|NCT00759811|349369|P2|COMPLETED|Overall Study||24
150912|NCT00759811|349370|P1|COMPLETED|Overall Study||23
150913|NCT00759811|349369|P2|STARTED|Overall Study||25
150914|NCT00759811|349370|P1|STARTED|Overall Study||25
150915|NCT00759759|349378|P2|NOT COMPLETED|Overall Study||1
150916|NCT00759759|349379|P1|NOT COMPLETED|Overall Study||4
150917|NCT00759759|349378|P2|COMPLETED|Overall Study||17
150918|NCT00759759|349379|P1|COMPLETED|Overall Study||14
150919|NCT00759759|349378|P2|STARTED|Overall Study||18
150920|NCT00759759|349379|P1|STARTED|Overall Study||18
150921|NCT00759681|349393|P2|NOT COMPLETED|Overall Study||10
150922|NCT00759681|349394|P1|NOT COMPLETED|Overall Study||10
150923|NCT00759681|349393|P2|COMPLETED|Overall Study||100
150924|NCT00759681|349394|P1|COMPLETED|Overall Study||97
150925|NCT00759681|349393|P2|STARTED|Overall Study||110
150926|NCT00759681|349394|P1|STARTED|Overall Study||107
150927|NCT00759668|349404|P2|NOT COMPLETED|Overall Study||3
150928|NCT00759668|349405|P1|NOT COMPLETED|Overall Study||1
150929|NCT00759668|349404|P2|COMPLETED|Overall Study||15
150930|NCT00759668|349405|P1|COMPLETED|Overall Study||16
150931|NCT00759668|349404|P2|STARTED|Overall Study||18
150932|NCT00759668|349405|P1|STARTED|Overall Study||17
150933|NCT00759655|349421|P1|NOT COMPLETED|Overall Study||1
150934|NCT00759655|349421|P1|COMPLETED|Overall Study||0
150935|NCT00759655|349421|P1|STARTED|Overall Study||1
150936|NCT00759603|349432|P1|NOT COMPLETED|Overall Study||0
150937|NCT00759603|349432|P1|COMPLETED|Overall Study||59
150938|NCT00759603|349432|P1|STARTED|Overall Study||59
150939|NCT00759577|349436|P1|NOT COMPLETED|Overall Study||0
150940|NCT00759577|349436|P1|COMPLETED|Overall Study||36
150941|NCT00759577|349436|P1|STARTED|Overall Study||36
150942|NCT00759564|349445|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
150943|NCT00759564|349446|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
150944|NCT00759564|349447|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
150945|NCT00759564|349448|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
150946|NCT00759564|349449|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
150947|NCT00759564|349445|P5|COMPLETED|Second Intervention Period (4 Days)||3
150948|NCT00759564|349446|P4|COMPLETED|Second Intervention Period (4 Days)||1
150949|NCT00759564|349447|P3|COMPLETED|Second Intervention Period (4 Days)||8
150950|NCT00759564|349448|P2|COMPLETED|Second Intervention Period (4 Days)||8
150951|NCT00759564|349449|P1|COMPLETED|Second Intervention Period (4 Days)||8
150952|NCT00759564|349445|P5|STARTED|Second Intervention Period (4 Days)||3
150953|NCT00759564|349446|P4|STARTED|Second Intervention Period (4 Days)||1
150954|NCT00759564|349447|P3|STARTED|Second Intervention Period (4 Days)||8
150955|NCT00759564|349448|P2|STARTED|Second Intervention Period (4 Days)||8
150956|NCT00759564|349449|P1|STARTED|Second Intervention Period (4 Days)||8
150957|NCT00759564|349445|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
150958|NCT00759564|349446|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
150959|NCT00759564|349447|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
150960|NCT00759564|349448|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
150961|NCT00759564|349449|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
150962|NCT00759564|349445|P5|COMPLETED|Washout Period (at Least 14 Days)||3
150963|NCT00759564|349446|P4|COMPLETED|Washout Period (at Least 14 Days)||1
150964|NCT00759564|349447|P3|COMPLETED|Washout Period (at Least 14 Days)||8
150965|NCT00759564|349448|P2|COMPLETED|Washout Period (at Least 14 Days)||8
150966|NCT00759564|349449|P1|COMPLETED|Washout Period (at Least 14 Days)||8
150967|NCT00759564|349445|P5|STARTED|Washout Period (at Least 14 Days)||4
150968|NCT00759564|349446|P4|STARTED|Washout Period (at Least 14 Days)||1
150969|NCT00759564|349447|P3|STARTED|Washout Period (at Least 14 Days)||8
150970|NCT00759564|349448|P2|STARTED|Washout Period (at Least 14 Days)||8
150971|NCT00759564|349449|P1|STARTED|Washout Period (at Least 14 Days)||8
150972|NCT00759564|349445|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
150973|NCT00759564|349446|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
150974|NCT00759564|349447|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
150975|NCT00759564|349448|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
150976|NCT00759564|349449|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
150977|NCT00759564|349445|P5|COMPLETED|First Intervention Period (4 Days)||4
150978|NCT00759564|349446|P4|COMPLETED|First Intervention Period (4 Days)||1
150979|NCT00759564|349447|P3|COMPLETED|First Intervention Period (4 Days)||8
150980|NCT00759564|349448|P2|COMPLETED|First Intervention Period (4 Days)||8
150981|NCT00759564|349449|P1|COMPLETED|First Intervention Period (4 Days)||8
150982|NCT00759564|349445|P5|STARTED|First Intervention Period (4 Days)||4
150983|NCT00759564|349446|P4|STARTED|First Intervention Period (4 Days)||1
150984|NCT00759564|349447|P3|STARTED|First Intervention Period (4 Days)||8
150985|NCT00759564|349448|P2|STARTED|First Intervention Period (4 Days)||8
150986|NCT00759564|349449|P1|STARTED|First Intervention Period (4 Days)||8
150987|NCT00759525|349589|P2|NOT COMPLETED|Second Intervention (14 Days)||0
150988|NCT00759525|349590|P1|NOT COMPLETED|Second Intervention (14 Days)||0
150989|NCT00759525|349589|P2|COMPLETED|Second Intervention (14 Days)||8
150990|NCT00759525|349590|P1|COMPLETED|Second Intervention (14 Days)||7
150991|NCT00759525|349589|P2|STARTED|Second Intervention (14 Days)||8
150992|NCT00759525|349590|P1|STARTED|Second Intervention (14 Days)||7
150993|NCT00759525|349589|P2|NOT COMPLETED|Washout (14 Days)||0
150994|NCT00759525|349590|P1|NOT COMPLETED|Washout (14 Days)||0
150995|NCT00759525|349589|P2|COMPLETED|Washout (14 Days)||8
150996|NCT00759525|349590|P1|COMPLETED|Washout (14 Days)||7
150997|NCT00759525|349589|P2|STARTED|Washout (14 Days)||8
150998|NCT00759525|349590|P1|STARTED|Washout (14 Days)||7
150999|NCT00759525|349589|P2|NOT COMPLETED|First Intervention (14 Days)||0
151000|NCT00759525|349590|P1|NOT COMPLETED|First Intervention (14 Days)||0
151001|NCT00759525|349589|P2|COMPLETED|First Intervention (14 Days)||8
151002|NCT00759525|349590|P1|COMPLETED|First Intervention (14 Days)||7
151003|NCT00759525|349589|P2|STARTED|First Intervention (14 Days)||8
151004|NCT00759525|349590|P1|STARTED|First Intervention (14 Days)||7
151005|NCT00759473|349601|P5|NOT COMPLETED|Overall Study||0
151006|NCT00759473|349602|P4|NOT COMPLETED|Overall Study||0
151007|NCT00759473|349603|P3|NOT COMPLETED|Overall Study||0
151008|NCT00759473|349604|P2|NOT COMPLETED|Overall Study||0
151009|NCT00759473|349605|P1|NOT COMPLETED|Overall Study||0
151010|NCT00759473|349601|P5|COMPLETED|Overall Study||24
151011|NCT00759473|349602|P4|COMPLETED|Overall Study||23
151012|NCT00759473|349603|P3|COMPLETED|Overall Study||12
151013|NCT00759473|349604|P2|COMPLETED|Overall Study||10
151014|NCT00759473|349605|P1|COMPLETED|Overall Study||10
151015|NCT00759473|349601|P5|STARTED|Overall Study||24
151016|NCT00759473|349602|P4|STARTED|Overall Study||23
151017|NCT00759473|349603|P3|STARTED|Overall Study||12
151018|NCT00759473|349604|P2|STARTED|Overall Study||10
151019|NCT00759473|349605|P1|STARTED|Overall Study||10
151020|NCT00759395|349619|P2|NOT COMPLETED|Overall Study||2
151021|NCT00759395|349620|P1|NOT COMPLETED|Overall Study||2
151022|NCT00759395|349619|P2|COMPLETED|Overall Study||7
151023|NCT00759395|349620|P1|COMPLETED|Overall Study||11
151024|NCT00759395|349619|P2|STARTED|Overall Study||9
151025|NCT00759395|349620|P1|STARTED|Overall Study||13
151026|NCT00759356|349636|P2|NOT COMPLETED|Overall Study||3
151027|NCT00759356|349637|P1|NOT COMPLETED|Overall Study||1
151028|NCT00759356|349636|P2|COMPLETED|Overall Study||15
151029|NCT00759356|349637|P1|COMPLETED|Overall Study||17
151030|NCT00759356|349636|P2|STARTED|Overall Study||18
151031|NCT00759356|349637|P1|STARTED|Overall Study||18
151032|NCT00759330|349653|P4|NOT COMPLETED|Overall Study||2
151033|NCT00759330|349654|P3|NOT COMPLETED|Overall Study||0
151034|NCT00759330|349655|P2|NOT COMPLETED|Overall Study||1
151035|NCT00759330|349656|P1|NOT COMPLETED|Overall Study||1
151036|NCT00759330|349653|P4|COMPLETED|Overall Study||41
151037|NCT00759330|349654|P3|COMPLETED|Overall Study||22
151038|NCT00759330|349655|P2|COMPLETED|Overall Study||41
151039|NCT00759330|349656|P1|COMPLETED|Overall Study||19
151040|NCT00759330|349653|P4|STARTED|Overall Study||43
151041|NCT00759330|349654|P3|STARTED|Overall Study||22
151042|NCT00759330|349655|P2|STARTED|Overall Study||42
151043|NCT00759330|349656|P1|STARTED|Overall Study||20
151044|NCT00759187|349705|P3|NOT COMPLETED|Overall Study||0
151045|NCT00759187|349706|P2|NOT COMPLETED|Overall Study||0
151046|NCT00759187|349707|P1|NOT COMPLETED|Overall Study||0
151047|NCT00759187|349705|P3|COMPLETED|Overall Study||9
151048|NCT00759187|349706|P2|COMPLETED|Overall Study||8
151049|NCT00759187|349707|P1|COMPLETED|Overall Study||8
151050|NCT00759187|349705|P3|STARTED|Overall Study||9
151051|NCT00759187|349706|P2|STARTED|Overall Study||8
151052|NCT00759187|349707|P1|STARTED|Overall Study||8
151053|NCT00759174|349717|P2|NOT COMPLETED|Overall Study||2
151054|NCT00759174|349718|P1|NOT COMPLETED|Overall Study||0
151055|NCT00759174|349717|P2|COMPLETED|Overall Study||595
151056|NCT00759174|349718|P1|COMPLETED|Overall Study||76
151057|NCT00759174|349717|P2|STARTED|Overall Study||597
151058|NCT00759174|349718|P1|STARTED|Overall Study||76
151059|NCT00759148|349729|P2|NOT COMPLETED|Overall Study||32
151060|NCT00759148|349730|P1|NOT COMPLETED|Overall Study||14
151061|NCT00759148|349729|P2|COMPLETED|Overall Study||554
151062|NCT00759148|349730|P1|COMPLETED|Overall Study||579
151063|NCT00759148|349729|P2|STARTED|Overall Study||586
151064|NCT00759148|349730|P1|STARTED|Overall Study||593
151065|NCT00759109|349740|P2|NOT COMPLETED|Overall Study||35
151066|NCT00759109|349741|P1|NOT COMPLETED|Overall Study||39
151067|NCT00759109|349740|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
151068|NCT00759109|349741|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
151069|NCT00759109|349740|P2|STARTED|Overall Study||76
151070|NCT00759109|349741|P1|STARTED|Overall Study||74
151071|NCT00759096|349757|P1|NOT COMPLETED|Overall Study||0
151072|NCT00759096|349757|P1|COMPLETED|Overall Study||30
151073|NCT00759096|349757|P1|STARTED|Overall Study||30
151074|NCT00759031|349763|P2|NOT COMPLETED|Second Intervention (1 Day)||0
151075|NCT00759031|349764|P1|NOT COMPLETED|Second Intervention (1 Day)||0
151076|NCT00759031|349763|P2|COMPLETED|Second Intervention (1 Day)||8
151077|NCT00759031|349764|P1|COMPLETED|Second Intervention (1 Day)||8
151078|NCT00759031|349763|P2|STARTED|Second Intervention (1 Day)||8
151079|NCT00759031|349764|P1|STARTED|Second Intervention (1 Day)||8
151080|NCT00759031|349763|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
151081|NCT00759031|349764|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
151082|NCT00759031|349763|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
151083|NCT00759031|349764|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
151084|NCT00759031|349763|P2|STARTED|Washout After 1st Intervention (1 Week)||8
151085|NCT00759031|349764|P1|STARTED|Washout After 1st Intervention (1 Week)||8
151086|NCT00759031|349763|P2|NOT COMPLETED|First Intervention (1 Day)||1
151087|NCT00759031|349764|P1|NOT COMPLETED|First Intervention (1 Day)||2
151088|NCT00759031|349763|P2|COMPLETED|First Intervention (1 Day)||8
151089|NCT00759031|349764|P1|COMPLETED|First Intervention (1 Day)||8
151090|NCT00759031|349763|P2|STARTED|First Intervention (1 Day)||9
151091|NCT00759031|349764|P1|STARTED|First Intervention (1 Day)||10
151092|NCT00758836|349774|P4|NOT COMPLETED|Overall Study||32
151093|NCT00758836|349775|P3|NOT COMPLETED|Overall Study||38
151094|NCT00758836|349776|P2|NOT COMPLETED|Overall Study||26
151095|NCT00758836|349777|P1|NOT COMPLETED|Overall Study||24
151096|NCT00758836|349774|P4|COMPLETED|Overall Study||138
151097|NCT00758836|349775|P3|COMPLETED|Overall Study||133
151098|NCT00758836|349776|P2|COMPLETED|Overall Study||145
151099|NCT00758836|349777|P1|COMPLETED|Overall Study||147
151100|NCT00758836|349774|P4|Treated|Overall Study||138
151101|NCT00758836|349775|P3|Treated|Overall Study||133
151102|NCT00758836|349776|P2|Treated|Overall Study||145
151103|NCT00758836|349777|P1|Treated|Overall Study||147
151104|NCT00758836|349774|P4|STARTED|Overall Study||170
151105|NCT00758836|349775|P3|STARTED|Overall Study||171
151106|NCT00758836|349776|P2|STARTED|Overall Study||171
151107|NCT00758836|349777|P1|STARTED|Overall Study||171
151108|NCT00758771|349801|P2|NOT COMPLETED|Overall Study||5
151109|NCT00758771|349802|P1|NOT COMPLETED|Overall Study||3
151110|NCT00758771|349801|P2|COMPLETED|Overall Study||15
151111|NCT00758771|349802|P1|COMPLETED|Overall Study||15
151112|NCT00758771|349801|P2|STARTED|Overall Study||20
151113|NCT00758771|349802|P1|STARTED|Overall Study||18
151114|NCT00758758|349816|P8|NOT COMPLETED|Overall Study||0
151115|NCT00758758|349817|P7|NOT COMPLETED|Overall Study||14
151116|NCT00758758|349818|P6|NOT COMPLETED|Overall Study||14
151117|NCT00758758|349819|P5|NOT COMPLETED|Overall Study||2
151118|NCT00758758|349820|P4|NOT COMPLETED|Overall Study||2
151119|NCT00758758|349821|P3|NOT COMPLETED|Overall Study||18
151120|NCT00758758|349822|P2|NOT COMPLETED|Overall Study||25
151121|NCT00758758|349823|P1|NOT COMPLETED|Overall Study||3
151122|NCT00758758|349816|P8|COMPLETED|Overall Study||0
151123|NCT00758758|349817|P7|COMPLETED|Overall Study||17
151124|NCT00758758|349818|P6|COMPLETED|Overall Study||36
151125|NCT00758758|349819|P5|COMPLETED|Overall Study||1
151126|NCT00758758|349820|P4|COMPLETED|Overall Study||4
151127|NCT00758758|349821|P3|COMPLETED|Overall Study||35
151128|NCT00758758|349822|P2|COMPLETED|Overall Study||49
151129|NCT00758758|349823|P1|COMPLETED|Overall Study||11
151130|NCT00758758|349816|P8|STARTED|Overall Study||0
151131|NCT00758758|349817|P7|STARTED|Overall Study||31
151132|NCT00758758|349818|P6|STARTED|Overall Study||50
151133|NCT00758758|349819|P5|STARTED|Overall Study||3
151134|NCT00758758|349820|P4|STARTED|Overall Study||6
151135|NCT00758758|349821|P3|STARTED|Overall Study||53
151136|NCT00758758|349822|P2|STARTED|Overall Study||74
151137|NCT00758758|349823|P1|STARTED|Overall Study||14
151138|NCT00758745|349851|P2|NOT COMPLETED|Overall Study||21
151139|NCT00758745|349852|P1|NOT COMPLETED|Overall Study||21
151140|NCT00758745|349851|P2|COMPLETED|Overall Study||60
151141|NCT00758745|349852|P1|COMPLETED|Overall Study||60
151142|NCT00758745|349851|P2|STARTED|Overall Study||81
151143|NCT00758745|349852|P1|STARTED|Overall Study||81
151144|NCT00758706|349860|P2|NOT COMPLETED|Overall Study||4
151145|NCT00758706|349861|P1|NOT COMPLETED|Overall Study||4
151146|NCT00758706|349860|P2|COMPLETED|Overall Study||25
151147|NCT00758706|349861|P1|COMPLETED|Overall Study||22
151148|NCT00758706|349860|P2|STARTED|Overall Study||29
151149|NCT00758706|349861|P1|STARTED|Overall Study||26
151150|NCT00758680|349897|P10|NOT COMPLETED|Overall Study||1
151151|NCT00758680|349898|P9|NOT COMPLETED|Overall Study||2
151152|NCT00758680|349899|P8|NOT COMPLETED|Overall Study||1
151153|NCT00758680|349900|P7|NOT COMPLETED|Overall Study||1
151154|NCT00758680|349901|P6|NOT COMPLETED|Overall Study||0
151155|NCT00758680|349902|P5|NOT COMPLETED|Overall Study||0
151156|NCT00758680|349903|P4|NOT COMPLETED|Overall Study||0
151157|NCT00758680|349904|P3|NOT COMPLETED|Overall Study||0
151158|NCT00758680|349905|P2|NOT COMPLETED|Overall Study||0
151159|NCT00758680|349906|P1|NOT COMPLETED|Overall Study||0
151160|NCT00758680|349897|P10|COMPLETED|Overall Study||28
151161|NCT00758680|349898|P9|COMPLETED|Overall Study||18
151162|NCT00758680|349899|P8|COMPLETED|Overall Study||19
151163|NCT00758680|349900|P7|COMPLETED|Overall Study||6
151164|NCT00758680|349901|P6|COMPLETED|Overall Study||6
151165|NCT00758680|349902|P5|COMPLETED|Overall Study||6
151166|NCT00758680|349903|P4|COMPLETED|Overall Study||6
151167|NCT00758680|349904|P3|COMPLETED|Overall Study||6
151168|NCT00758680|349905|P2|COMPLETED|Overall Study||6
151169|NCT00758680|349906|P1|COMPLETED|Overall Study||6
151170|NCT00758680|349897|P10|STARTED|Overall Study||29
151171|NCT00758680|349898|P9|STARTED|Overall Study||20
151172|NCT00758680|349899|P8|STARTED|Overall Study||20
151173|NCT00758680|349900|P7|STARTED|Overall Study||7
151174|NCT00758680|349901|P6|STARTED|Overall Study||6
151175|NCT00758680|349902|P5|STARTED|Overall Study||6
151176|NCT00758680|349903|P4|STARTED|Overall Study||6
151177|NCT00758680|349904|P3|STARTED|Overall Study||6
151178|NCT00758680|349905|P2|STARTED|Overall Study||6
151179|NCT00758680|349906|P1|STARTED|Overall Study||6
151180|NCT00758667|349948|P2|NOT COMPLETED|Overall Study||0
151181|NCT00758667|349949|P1|NOT COMPLETED|Overall Study||0
151182|NCT00758667|349948|P2|COMPLETED|Overall Study||11
151183|NCT00758667|349949|P1|COMPLETED|Overall Study||9
151184|NCT00758667|349948|P2|STARTED|Overall Study||11
151185|NCT00758667|349949|P1|STARTED|Overall Study||9
151186|NCT00758602|349959|P2|NOT COMPLETED|Overall Study||22
151187|NCT00758602|349960|P1|NOT COMPLETED|Overall Study||19
151188|NCT00758602|349959|P2|COMPLETED|Overall Study||84
151189|NCT00758602|349960|P1|COMPLETED|Overall Study||85
151190|NCT00758602|349959|P2|STARTED|Overall Study||106
151191|NCT00758602|349960|P1|STARTED|Overall Study||104
151192|NCT00758589|349986|P4|NOT COMPLETED|Overall Study||6
151193|NCT00758589|349987|P3|NOT COMPLETED|Overall Study||6
151194|NCT00758589|349988|P2|NOT COMPLETED|Overall Study||3
151195|NCT00758589|349989|P1|NOT COMPLETED|Overall Study||3
151196|NCT00758589|349986|P4|COMPLETED|Overall Study||85
151197|NCT00758589|349987|P3|COMPLETED|Overall Study||86
151198|NCT00758589|349988|P2|COMPLETED|Overall Study||87
151199|NCT00758589|349989|P1|COMPLETED|Overall Study||92
151200|NCT00758589|349986|P4|STARTED|Overall Study||91
151201|NCT00758589|349987|P3|STARTED|Overall Study||92
151202|NCT00758589|349988|P2|STARTED|Overall Study||90
151203|NCT00758589|349989|P1|STARTED|Overall Study||95
151204|NCT00758576|350055|P1|NOT COMPLETED|Overall Study||1
151205|NCT00758576|350055|P1|COMPLETED|Overall Study||63
151206|NCT00758576|350055|P1|STARTED|Overall Study||64
151207|NCT00758563|350063|P2|NOT COMPLETED|Overall Study||0
151208|NCT00758563|350064|P1|NOT COMPLETED|Overall Study||0
151209|NCT00758563|350063|P2|COMPLETED|Overall Study||8
151210|NCT00758563|350064|P1|COMPLETED|Overall Study||7
151211|NCT00758563|350063|P2|STARTED|Overall Study||8
151212|NCT00758563|350064|P1|STARTED|Overall Study||7
151213|NCT00758550|350070|P2|NOT COMPLETED|Overall Study||0
151214|NCT00758550|350071|P1|NOT COMPLETED|Overall Study||0
151215|NCT00758550|350070|P2|COMPLETED|Overall Study||30
151216|NCT00758550|350071|P1|COMPLETED|Overall Study||30
151217|NCT00758550|350070|P2|STARTED|Overall Study||30
151218|NCT00758550|350071|P1|STARTED|Overall Study||30
151219|NCT00758498|350082|P3|NOT COMPLETED|Overall Study||5
151220|NCT00758498|350083|P2|NOT COMPLETED|Overall Study||2
151221|NCT00758498|350084|P1|NOT COMPLETED|Overall Study||3
151222|NCT00758498|350082|P3|COMPLETED|Overall Study||137
151223|NCT00758498|350083|P2|COMPLETED|Overall Study||141
151224|NCT00758498|350084|P1|COMPLETED|Overall Study||139
151225|NCT00758498|350082|P3|STARTED|Overall Study||142
151226|NCT00758498|350083|P2|STARTED|Overall Study||143
151227|NCT00758498|350084|P1|STARTED|Overall Study||142
151228|NCT00758485|350169|P2|NOT COMPLETED|Overall Study||3
151229|NCT00758485|350170|P1|NOT COMPLETED|Overall Study||1
151230|NCT00758485|350169|P2|COMPLETED|Overall Study||67
151231|NCT00758485|350170|P1|COMPLETED|Overall Study||69
151232|NCT00758485|350169|P2|TREATED|Overall Study||68
151233|NCT00758485|350170|P1|TREATED|Overall Study||69
151234|NCT00758485|350169|P2|STARTED|Overall Study||70
151235|NCT00758485|350170|P1|STARTED|Overall Study||70
151236|NCT00758459|350182|P2|NOT COMPLETED|Overall Study||4
151237|NCT00758459|350183|P1|NOT COMPLETED|Overall Study||3
151238|NCT00758459|350182|P2|COMPLETED|Overall Study||35
151239|NCT00758459|350183|P1|COMPLETED|Overall Study||32
151240|NCT00758459|350182|P2|STARTED|Overall Study||39
151241|NCT00758459|350183|P1|STARTED|Overall Study||35
151242|NCT00758420|350217|P2|NOT COMPLETED|Overall Study||0
151243|NCT00758420|350218|P1|NOT COMPLETED|Overall Study||0
151244|NCT00758420|350217|P2|COMPLETED|Overall Study||38
151245|NCT00758420|350218|P1|COMPLETED|Overall Study||39
151246|NCT00758420|350217|P2|STARTED|Overall Study||38
151247|NCT00758420|350218|P1|STARTED|Overall Study||39
151248|NCT00758394|350228|P4|NOT COMPLETED|4th Intervention||0
151249|NCT00758394|350229|P3|NOT COMPLETED|4th Intervention||0
151250|NCT00758394|350230|P2|NOT COMPLETED|4th Intervention||0
151251|NCT00758394|350231|P1|NOT COMPLETED|4th Intervention||0
151252|NCT00758394|350228|P4|COMPLETED|4th Intervention||7
151253|NCT00758394|350229|P3|COMPLETED|4th Intervention||6
151254|NCT00758394|350230|P2|COMPLETED|4th Intervention||6
151255|NCT00758394|350231|P1|COMPLETED|4th Intervention||7
151256|NCT00758394|350228|P4|STARTED|4th Intervention||7
151257|NCT00758394|350229|P3|STARTED|4th Intervention||6
151258|NCT00758394|350230|P2|STARTED|4th Intervention||6
151259|NCT00758394|350231|P1|STARTED|4th Intervention||7
151260|NCT00758394|350228|P4|NOT COMPLETED|Washout After 3rd Intervention||0
151261|NCT00758394|350229|P3|NOT COMPLETED|Washout After 3rd Intervention||0
151262|NCT00758394|350230|P2|NOT COMPLETED|Washout After 3rd Intervention||0
151263|NCT00758394|350231|P1|NOT COMPLETED|Washout After 3rd Intervention||0
151264|NCT00758394|350228|P4|COMPLETED|Washout After 3rd Intervention||7
151265|NCT00758394|350229|P3|COMPLETED|Washout After 3rd Intervention||6
151266|NCT00758394|350230|P2|COMPLETED|Washout After 3rd Intervention||6
151267|NCT00758394|350231|P1|COMPLETED|Washout After 3rd Intervention||7
151268|NCT00758394|350228|P4|STARTED|Washout After 3rd Intervention||7
151269|NCT00758394|350229|P3|STARTED|Washout After 3rd Intervention||6
151270|NCT00758394|350230|P2|STARTED|Washout After 3rd Intervention||6
151271|NCT00758394|350231|P1|STARTED|Washout After 3rd Intervention||7
151272|NCT00758394|350228|P4|NOT COMPLETED|3rd Intervention||1
151273|NCT00758394|350229|P3|NOT COMPLETED|3rd Intervention||0
151274|NCT00758394|350230|P2|NOT COMPLETED|3rd Intervention||0
151275|NCT00758394|350231|P1|NOT COMPLETED|3rd Intervention||1
151276|NCT00758394|350228|P4|COMPLETED|3rd Intervention||7
151277|NCT00758394|350229|P3|COMPLETED|3rd Intervention||6
151278|NCT00758394|350230|P2|COMPLETED|3rd Intervention||6
151279|NCT00758394|350231|P1|COMPLETED|3rd Intervention||7
151280|NCT00758394|350228|P4|STARTED|3rd Intervention||8
151281|NCT00758394|350229|P3|STARTED|3rd Intervention||6
151282|NCT00758394|350230|P2|STARTED|3rd Intervention||6
151283|NCT00758394|350231|P1|STARTED|3rd Intervention||8
151284|NCT00758394|350228|P4|NOT COMPLETED|Washout After 2nd Intervention||0
151285|NCT00758394|350229|P3|NOT COMPLETED|Washout After 2nd Intervention||0
151286|NCT00758394|350230|P2|NOT COMPLETED|Washout After 2nd Intervention||0
151287|NCT00758394|350231|P1|NOT COMPLETED|Washout After 2nd Intervention||0
151288|NCT00758394|350228|P4|COMPLETED|Washout After 2nd Intervention||8
151289|NCT00758394|350229|P3|COMPLETED|Washout After 2nd Intervention||6
151290|NCT00758394|350230|P2|COMPLETED|Washout After 2nd Intervention||6
151291|NCT00758394|350231|P1|COMPLETED|Washout After 2nd Intervention||8
151292|NCT00758394|350228|P4|STARTED|Washout After 2nd Intervention||8
151293|NCT00758394|350229|P3|STARTED|Washout After 2nd Intervention||6
151294|NCT00758394|350230|P2|STARTED|Washout After 2nd Intervention||6
151295|NCT00758394|350231|P1|STARTED|Washout After 2nd Intervention||8
151296|NCT00758394|350228|P4|NOT COMPLETED|2nd Intervention Order||0
151297|NCT00758394|350229|P3|NOT COMPLETED|2nd Intervention Order||0
151298|NCT00758394|350230|P2|NOT COMPLETED|2nd Intervention Order||1
151299|NCT00758394|350231|P1|NOT COMPLETED|2nd Intervention Order||0
151300|NCT00758394|350228|P4|COMPLETED|2nd Intervention Order||8
151301|NCT00758394|350229|P3|COMPLETED|2nd Intervention Order||6
151302|NCT00758394|350230|P2|COMPLETED|2nd Intervention Order||6
151303|NCT00758394|350231|P1|COMPLETED|2nd Intervention Order||8
151304|NCT00758394|350228|P4|STARTED|2nd Intervention Order||8
151305|NCT00758394|350229|P3|STARTED|2nd Intervention Order||6
151306|NCT00758394|350230|P2|STARTED|2nd Intervention Order||7
151307|NCT00758394|350231|P1|STARTED|2nd Intervention Order||8
151308|NCT00758394|350228|P4|NOT COMPLETED|Washout After 1st Intervention||0
151309|NCT00758394|350229|P3|NOT COMPLETED|Washout After 1st Intervention||0
151310|NCT00758394|350230|P2|NOT COMPLETED|Washout After 1st Intervention||0
151311|NCT00758394|350231|P1|NOT COMPLETED|Washout After 1st Intervention||0
151312|NCT00758394|350228|P4|COMPLETED|Washout After 1st Intervention||8
151313|NCT00758394|350229|P3|COMPLETED|Washout After 1st Intervention||6
151314|NCT00758394|350230|P2|COMPLETED|Washout After 1st Intervention||7
151315|NCT00758394|350231|P1|COMPLETED|Washout After 1st Intervention||8
151316|NCT00758394|350228|P4|STARTED|Washout After 1st Intervention||8
151317|NCT00758394|350229|P3|STARTED|Washout After 1st Intervention||6
151318|NCT00758394|350230|P2|STARTED|Washout After 1st Intervention||7
151319|NCT00758394|350231|P1|STARTED|Washout After 1st Intervention||8
151320|NCT00758394|350228|P4|NOT COMPLETED|1st Intervention||0
151321|NCT00758394|350229|P3|NOT COMPLETED|1st Intervention||0
151322|NCT00758394|350230|P2|NOT COMPLETED|1st Intervention||0
151323|NCT00758394|350231|P1|NOT COMPLETED|1st Intervention||0
151324|NCT00758394|350228|P4|COMPLETED|1st Intervention||8
151325|NCT00758394|350229|P3|COMPLETED|1st Intervention||6
151326|NCT00758394|350230|P2|COMPLETED|1st Intervention||7
151327|NCT00758394|350231|P1|COMPLETED|1st Intervention||8
151328|NCT00758394|350228|P4|STARTED|1st Intervention||8
151329|NCT00758394|350229|P3|STARTED|1st Intervention||6
151330|NCT00758394|350230|P2|STARTED|1st Intervention||7
151331|NCT00758394|350231|P1|STARTED|1st Intervention||8
151332|NCT00758342|350243|P2|NOT COMPLETED|Overall Study||1
151333|NCT00758342|350244|P1|NOT COMPLETED|Overall Study||4
151334|NCT00758342|350243|P2|COMPLETED|Overall Study||17
151335|NCT00758342|350244|P1|COMPLETED|Overall Study||15
151336|NCT00758342|350243|P2|STARTED|Overall Study||18
151337|NCT00758342|350244|P1|STARTED|Overall Study||19
151338|NCT00758290|350252|P2|NOT COMPLETED|Overall Study||0
151339|NCT00758290|350253|P1|NOT COMPLETED|Overall Study||0
151340|NCT00758290|350252|P2|COMPLETED|Overall Study||12
151341|NCT00758290|350253|P1|COMPLETED|Overall Study||11
151342|NCT00758290|350252|P2|STARTED|Overall Study||12
151343|NCT00758290|350253|P1|STARTED|Overall Study||11
151344|NCT00758160|350257|P1|NOT COMPLETED|Overall Study||66
151345|NCT00758160|350257|P1|COMPLETED|Overall Study||230
151346|NCT00758160|350257|P1|STARTED|Overall Study||296
151347|NCT00758069|350278|P3|NOT COMPLETED|Overall Study||1
151348|NCT00758069|350279|P2|NOT COMPLETED|Overall Study||0
151349|NCT00758069|350280|P1|NOT COMPLETED|Overall Study||1
151350|NCT00758069|350278|P3|COMPLETED|Overall Study||27
151351|NCT00758069|350279|P2|COMPLETED|Overall Study||25
151352|NCT00758069|350280|P1|COMPLETED|Overall Study||26
151353|NCT00758069|350278|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
151354|NCT00758069|350279|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
151355|NCT00758069|350280|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
151356|NCT00758043|350295|P4|NOT COMPLETED|Overall Study||100
151357|NCT00758043|350296|P3|NOT COMPLETED|Overall Study||39
151358|NCT00758043|350297|P2|NOT COMPLETED|Overall Study||41
151359|NCT00758043|350298|P1|NOT COMPLETED|Overall Study||1
151360|NCT00758043|350295|P4|COMPLETED|Overall Study||0
151361|NCT00758043|350296|P3|COMPLETED|Overall Study||79
151362|NCT00758043|350297|P2|COMPLETED|Overall Study||119
151363|NCT00758043|350298|P1|COMPLETED|Overall Study||161
151364|NCT00758043|350295|P4|STARTED|Overall Study||100
151365|NCT00758043|350296|P3|STARTED|Overall Study||118
151366|NCT00758043|350297|P2|STARTED|Overall Study||160
151367|NCT00758043|350298|P1|STARTED|Overall Study||162
151368|NCT00757848|350326|P2|NOT COMPLETED|Overall Study||2
151369|NCT00757848|350327|P1|NOT COMPLETED|Overall Study||3
151370|NCT00757848|350326|P2|COMPLETED|Overall Study||27
151371|NCT00757848|350327|P1|COMPLETED|Overall Study||24
151372|NCT00757848|350326|P2|STARTED|Overall Study||29
151373|NCT00757848|350327|P1|STARTED|Overall Study||27
151374|NCT00757822|350373|P2|NOT COMPLETED|Overall Study||31
151375|NCT00757822|350374|P1|NOT COMPLETED|Overall Study||28
151376|NCT00757822|350373|P2|COMPLETED|Overall Study||57
151377|NCT00757822|350374|P1|COMPLETED|Overall Study||64
151378|NCT00757822|350373|P2|Data Lock, Unblinding Analysis|Overall Study||57
151379|NCT00757822|350374|P1|Data Lock, Unblinding Analysis|Overall Study||64
151380|NCT00757822|350373|P2|Withdrawn-protocol Deviation|Overall Study||8
151381|NCT00757822|350374|P1|Withdrawn-protocol Deviation|Overall Study||9
151382|NCT00757822|350373|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
151383|NCT00757822|350374|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
151384|NCT00757822|350373|P2|Data Entry, QC Assessment|Overall Study||74
151385|NCT00757822|350374|P1|Data Entry, QC Assessment|Overall Study||85
151386|NCT00757822|350373|P2|2-6 wk Post-op Assessment|Overall Study||74
151387|NCT00757822|350374|P1|2-6 wk Post-op Assessment|Overall Study||85
151388|NCT00757822|350373|P2|24-48 hr Telephone Assessment|Overall Study||74
151389|NCT00757822|350374|P1|24-48 hr Telephone Assessment|Overall Study||85
151390|NCT00757822|350373|P2|DOS: Post-operative Assessments|Overall Study||74
151391|NCT00757822|350374|P1|DOS: Post-operative Assessments|Overall Study||85
151392|NCT00757822|350373|P2|Received Study Intervention|Overall Study||74
151393|NCT00757822|350374|P1|Received Study Intervention|Overall Study||85
151394|NCT00757822|350373|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
151395|NCT00757822|350374|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
151396|NCT00757822|350373|P2|Withdrawal by Subject-no Intervention|Overall Study||3
151397|NCT00757822|350374|P1|Withdrawal by Subject-no Intervention|Overall Study||1
151398|NCT00757822|350373|P2|Day of Surgery (DOS) Assessment|Overall Study||88
151399|NCT00757822|350374|P1|Day of Surgery (DOS) Assessment|Overall Study||92
151400|NCT00757822|350373|P2|STARTED|Overall Study||88
151401|NCT00757822|350374|P1|STARTED|Overall Study||92
151402|NCT00757783|350396|P2|NOT COMPLETED|Overall Study||6
151403|NCT00757783|350397|P1|NOT COMPLETED|Overall Study||5
151404|NCT00757783|350396|P2|COMPLETED|Overall Study||25
151405|NCT00757783|350397|P1|COMPLETED|Overall Study||29
151406|NCT00757783|350396|P2|STARTED|Overall Study||31
151407|NCT00757783|350397|P1|STARTED|Overall Study||34
151408|NCT00757705|350433|P1|NOT COMPLETED|Overall Study||121
151409|NCT00757705|350433|P1|COMPLETED|Overall Study||178
151410|NCT00757705|350433|P1|STARTED|Overall Study||299
151411|NCT00757627|350445|P1|NOT COMPLETED|Overall Study||81
151412|NCT00757627|350445|P1|COMPLETED|Overall Study||419
151413|NCT00757627|350445|P1|STARTED|Overall Study||500
151414|NCT00757601|350458|P12|NOT COMPLETED|Period 5||0
151415|NCT00757601|350459|P11|NOT COMPLETED|Period 5||0
151416|NCT00757601|350460|P10|NOT COMPLETED|Period 5||0
151417|NCT00757601|350461|P9|NOT COMPLETED|Period 5||0
151418|NCT00757601|350462|P8|NOT COMPLETED|Period 5||0
151419|NCT00757601|350463|P7|NOT COMPLETED|Period 5||0
151420|NCT00757601|350464|P6|NOT COMPLETED|Period 5||0
151421|NCT00757601|350465|P5|NOT COMPLETED|Period 5||0
151422|NCT00757601|350466|P4|NOT COMPLETED|Period 5||0
151423|NCT00757601|350467|P3|NOT COMPLETED|Period 5||0
151424|NCT00757601|350468|P2|NOT COMPLETED|Period 5||0
151425|NCT00757601|350469|P1|NOT COMPLETED|Period 5||0
151426|NCT00757601|350458|P12|COMPLETED|Period 5||1
151427|NCT00757601|350459|P11|COMPLETED|Period 5||2
151428|NCT00757601|350460|P10|COMPLETED|Period 5||1
151429|NCT00757601|350461|P9|COMPLETED|Period 5||2
151430|NCT00757601|350462|P8|COMPLETED|Period 5||2
151431|NCT00757601|350463|P7|COMPLETED|Period 5||2
151432|NCT00757601|350464|P6|COMPLETED|Period 5||2
151433|NCT00757601|350465|P5|COMPLETED|Period 5||2
151434|NCT00757601|350466|P4|COMPLETED|Period 5||2
151435|NCT00757601|350467|P3|COMPLETED|Period 5||2
151436|NCT00757601|350468|P2|COMPLETED|Period 5||2
151437|NCT00757601|350469|P1|COMPLETED|Period 5||2
151438|NCT00757601|350458|P12|STARTED|Period 5||1
151439|NCT00757601|350459|P11|STARTED|Period 5||2
151440|NCT00757601|350460|P10|STARTED|Period 5||1
151441|NCT00757601|350461|P9|STARTED|Period 5||2
151442|NCT00757601|350462|P8|STARTED|Period 5||2
151443|NCT00757601|350463|P7|STARTED|Period 5||2
151444|NCT00757601|350464|P6|STARTED|Period 5||2
151445|NCT00757601|350465|P5|STARTED|Period 5||2
151446|NCT00757601|350466|P4|STARTED|Period 5||2
151447|NCT00757601|350467|P3|STARTED|Period 5||2
151448|NCT00757601|350468|P2|STARTED|Period 5||2
151449|NCT00757601|350469|P1|STARTED|Period 5||2
151450|NCT00757601|350458|P12|NOT COMPLETED|Period 4||1
151451|NCT00757601|350459|P11|NOT COMPLETED|Period 4||0
151452|NCT00757601|350460|P10|NOT COMPLETED|Period 4||1
151453|NCT00757601|350461|P9|NOT COMPLETED|Period 4||0
151454|NCT00757601|350462|P8|NOT COMPLETED|Period 4||0
151455|NCT00757601|350463|P7|NOT COMPLETED|Period 4||0
151456|NCT00757601|350464|P6|NOT COMPLETED|Period 4||0
151457|NCT00757601|350465|P5|NOT COMPLETED|Period 4||0
151458|NCT00757601|350466|P4|NOT COMPLETED|Period 4||0
151459|NCT00757601|350467|P3|NOT COMPLETED|Period 4||0
151460|NCT00757601|350468|P2|NOT COMPLETED|Period 4||0
151461|NCT00757601|350469|P1|NOT COMPLETED|Period 4||0
151462|NCT00757601|350458|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
151463|NCT00757601|350459|P11|COMPLETED|Period 4||2
151464|NCT00757601|350460|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
151465|NCT00757601|350461|P9|COMPLETED|Period 4||2
151466|NCT00757601|350462|P8|COMPLETED|Period 4||2
151467|NCT00757601|350463|P7|COMPLETED|Period 4||2
151468|NCT00757601|350464|P6|COMPLETED|Period 4||2
151469|NCT00757601|350465|P5|COMPLETED|Period 4||2
151470|NCT00757601|350466|P4|COMPLETED|Period 4||2
151471|NCT00757601|350467|P3|COMPLETED|Period 4||2
151472|NCT00757601|350468|P2|COMPLETED|Period 4||2
151473|NCT00757601|350469|P1|COMPLETED|Period 4||2
151474|NCT00757601|350458|P12|STARTED|Period 4||2
151475|NCT00757601|350459|P11|STARTED|Period 4||2
151476|NCT00757601|350460|P10|STARTED|Period 4||2
151477|NCT00757601|350461|P9|STARTED|Period 4||2
151478|NCT00757601|350462|P8|STARTED|Period 4||2
151479|NCT00757601|350463|P7|STARTED|Period 4||2
151480|NCT00757601|350464|P6|STARTED|Period 4||2
151481|NCT00757601|350465|P5|STARTED|Period 4||2
151482|NCT00757601|350466|P4|STARTED|Period 4||2
151483|NCT00757601|350467|P3|STARTED|Period 4||2
151484|NCT00757601|350468|P2|STARTED|Period 4||2
151485|NCT00757601|350469|P1|STARTED|Period 4||2
151486|NCT00757601|350458|P12|NOT COMPLETED|Period 3||0
151487|NCT00757601|350459|P11|NOT COMPLETED|Period 3||0
151488|NCT00757601|350460|P10|NOT COMPLETED|Period 3||0
151489|NCT00757601|350461|P9|NOT COMPLETED|Period 3||0
151490|NCT00757601|350462|P8|NOT COMPLETED|Period 3||0
151491|NCT00757601|350463|P7|NOT COMPLETED|Period 3||0
151492|NCT00757601|350464|P6|NOT COMPLETED|Period 3||0
151493|NCT00757601|350465|P5|NOT COMPLETED|Period 3||0
151494|NCT00757601|350466|P4|NOT COMPLETED|Period 3||0
151495|NCT00757601|350467|P3|NOT COMPLETED|Period 3||0
151496|NCT00757601|350468|P2|NOT COMPLETED|Period 3||0
151497|NCT00757601|350469|P1|NOT COMPLETED|Period 3||0
151498|NCT00757601|350458|P12|COMPLETED|Period 3||2
151499|NCT00757601|350459|P11|COMPLETED|Period 3||2
151500|NCT00757601|350460|P10|COMPLETED|Period 3||2
151501|NCT00757601|350461|P9|COMPLETED|Period 3||2
151502|NCT00757601|350462|P8|COMPLETED|Period 3||2
151503|NCT00757601|350463|P7|COMPLETED|Period 3||2
151504|NCT00757601|350464|P6|COMPLETED|Period 3||2
151505|NCT00757601|350465|P5|COMPLETED|Period 3||2
151506|NCT00757601|350466|P4|COMPLETED|Period 3||2
151507|NCT00757601|350467|P3|COMPLETED|Period 3||2
151508|NCT00757601|350468|P2|COMPLETED|Period 3||2
151509|NCT00757601|350469|P1|COMPLETED|Period 3||2
151510|NCT00757601|350458|P12|STARTED|Period 3||2
151511|NCT00757601|350459|P11|STARTED|Period 3||2
151512|NCT00757601|350460|P10|STARTED|Period 3||2
151513|NCT00757601|350461|P9|STARTED|Period 3||2
151514|NCT00757601|350462|P8|STARTED|Period 3||2
151515|NCT00757601|350463|P7|STARTED|Period 3||2
151516|NCT00757601|350464|P6|STARTED|Period 3||2
151517|NCT00757601|350465|P5|STARTED|Period 3||2
151518|NCT00757601|350466|P4|STARTED|Period 3||2
151519|NCT00757601|350467|P3|STARTED|Period 3||2
151520|NCT00757601|350468|P2|STARTED|Period 3||2
151521|NCT00757601|350469|P1|STARTED|Period 3||2
151522|NCT00757601|350458|P12|NOT COMPLETED|Period 2||1
151523|NCT00757601|350459|P11|NOT COMPLETED|Period 2||0
151524|NCT00757601|350460|P10|NOT COMPLETED|Period 2||0
151525|NCT00757601|350461|P9|NOT COMPLETED|Period 2||0
151526|NCT00757601|350462|P8|NOT COMPLETED|Period 2||0
151527|NCT00757601|350463|P7|NOT COMPLETED|Period 2||0
151528|NCT00757601|350464|P6|NOT COMPLETED|Period 2||0
151529|NCT00757601|350465|P5|NOT COMPLETED|Period 2||0
151530|NCT00757601|350466|P4|NOT COMPLETED|Period 2||0
151531|NCT00757601|350467|P3|NOT COMPLETED|Period 2||0
151532|NCT00757601|350468|P2|NOT COMPLETED|Period 2||0
151533|NCT00757601|350469|P1|NOT COMPLETED|Period 2||0
151534|NCT00757601|350458|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
151535|NCT00757601|350459|P11|COMPLETED|Period 2||2
151536|NCT00757601|350460|P10|COMPLETED|Period 2||2
151537|NCT00757601|350461|P9|COMPLETED|Period 2||2
151538|NCT00757601|350462|P8|COMPLETED|Period 2||2
151539|NCT00757601|350463|P7|COMPLETED|Period 2||2
151540|NCT00757601|350464|P6|COMPLETED|Period 2||2
151541|NCT00757601|350465|P5|COMPLETED|Period 2||2
151542|NCT00757601|350466|P4|COMPLETED|Period 2||2
151543|NCT00757601|350467|P3|COMPLETED|Period 2||2
151544|NCT00757601|350468|P2|COMPLETED|Period 2||2
151545|NCT00757601|350469|P1|COMPLETED|Period 2||2
151546|NCT00757601|350458|P12|STARTED|Period 2||3
151547|NCT00757601|350459|P11|STARTED|Period 2||2
151548|NCT00757601|350460|P10|STARTED|Period 2||2
151549|NCT00757601|350461|P9|STARTED|Period 2||2
151550|NCT00757601|350462|P8|STARTED|Period 2||2
151551|NCT00757601|350463|P7|STARTED|Period 2||2
151552|NCT00757601|350464|P6|STARTED|Period 2||2
151553|NCT00757601|350465|P5|STARTED|Period 2||2
151554|NCT00757601|350466|P4|STARTED|Period 2||2
151555|NCT00757601|350467|P3|STARTED|Period 2||2
151556|NCT00757601|350468|P2|STARTED|Period 2||2
151557|NCT00757601|350469|P1|STARTED|Period 2||2
151558|NCT00757601|350458|P12|NOT COMPLETED|Period 1||0
151559|NCT00757601|350459|P11|NOT COMPLETED|Period 1||0
151560|NCT00757601|350460|P10|NOT COMPLETED|Period 1||0
151561|NCT00757601|350461|P9|NOT COMPLETED|Period 1||0
151562|NCT00757601|350462|P8|NOT COMPLETED|Period 1||0
151563|NCT00757601|350463|P7|NOT COMPLETED|Period 1||0
151564|NCT00757601|350464|P6|NOT COMPLETED|Period 1||0
151565|NCT00757601|350465|P5|NOT COMPLETED|Period 1||0
151566|NCT00757601|350466|P4|NOT COMPLETED|Period 1||0
151567|NCT00757601|350467|P3|NOT COMPLETED|Period 1||0
151568|NCT00757601|350468|P2|NOT COMPLETED|Period 1||0
151569|NCT00757601|350469|P1|NOT COMPLETED|Period 1||0
151570|NCT00757601|350458|P12|COMPLETED|Period 1||3
151571|NCT00757601|350459|P11|COMPLETED|Period 1||2
151572|NCT00757601|350460|P10|COMPLETED|Period 1||2
151573|NCT00757601|350461|P9|COMPLETED|Period 1||2
151574|NCT00757601|350462|P8|COMPLETED|Period 1||2
151575|NCT00757601|350463|P7|COMPLETED|Period 1||2
151576|NCT00757601|350464|P6|COMPLETED|Period 1||2
151577|NCT00757601|350465|P5|COMPLETED|Period 1||2
151578|NCT00757601|350466|P4|COMPLETED|Period 1||2
151579|NCT00757601|350467|P3|COMPLETED|Period 1||2
151580|NCT00757601|350468|P2|COMPLETED|Period 1||2
151581|NCT00757601|350469|P1|COMPLETED|Period 1||2
151582|NCT00757601|350458|P12|STARTED|Period 1||3
151583|NCT00757601|350459|P11|STARTED|Period 1||2
151584|NCT00757601|350460|P10|STARTED|Period 1||2
151585|NCT00757601|350461|P9|STARTED|Period 1||2
151586|NCT00757601|350462|P8|STARTED|Period 1||2
151587|NCT00757601|350463|P7|STARTED|Period 1||2
151588|NCT00757601|350464|P6|STARTED|Period 1||2
151589|NCT00757601|350465|P5|STARTED|Period 1||2
151590|NCT00757601|350466|P4|STARTED|Period 1||2
151591|NCT00757601|350467|P3|STARTED|Period 1||2
151592|NCT00757601|350468|P2|STARTED|Period 1||2
151593|NCT00757601|350469|P1|STARTED|Period 1||2
151594|NCT00757588|350580|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
151595|NCT00757588|350581|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
151596|NCT00757588|350580|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
151597|NCT00757588|350581|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
151598|NCT00757588|350580|P2|STARTED|Period 2: Long-term (52-week) Phase||134
151599|NCT00757588|350581|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
151600|NCT00757588|350580|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
151601|NCT00757588|350581|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
151602|NCT00757588|350580|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
151603|NCT00757588|350581|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
151604|NCT00757588|350580|P2|STARTED|Period 1: Short-term (24-week) Phase||151
151605|NCT00757588|350581|P1|STARTED|Period 1: Short-term (24-week) Phase||304
151606|NCT00757484|350613|P1|NOT COMPLETED|Overall Study||0
151607|NCT00757484|350613|P1|COMPLETED|Overall Study||491
151608|NCT00757484|350613|P1|STARTED|Overall Study||491
151609|NCT00757237|350622|P2|NOT COMPLETED|Overall Study||25
151610|NCT00757237|350623|P1|NOT COMPLETED|Overall Study||13
151611|NCT00757237|350622|P2|COMPLETED|Overall Study||111
151612|NCT00757237|350623|P1|COMPLETED|Overall Study||124
151613|NCT00757237|350622|P2|Treated|Overall Study||132
151614|NCT00757237|350623|P1|Treated|Overall Study||136
151615|NCT00757237|350622|P2|STARTED|Overall Study||136
151616|NCT00757237|350623|P1|STARTED|Overall Study||137
151617|NCT00757172|350651|P1|NOT COMPLETED|Overall Study||11
151618|NCT00757172|350651|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
151619|NCT00757172|350651|P1|STARTED|Overall Study||65
151620|NCT00756977|350661|P2|NOT COMPLETED|Overall Study||11
151621|NCT00756977|350662|P1|NOT COMPLETED|Overall Study||21
151622|NCT00756977|350661|P2|COMPLETED|Overall Study||187
151623|NCT00756977|350662|P1|COMPLETED|Overall Study||175
151624|NCT00756977|350661|P2|STARTED|Overall Study||198
151625|NCT00756977|350662|P1|STARTED|Overall Study||196
151626|NCT00756964|350690|P2|NOT COMPLETED|Overall Study||0
151627|NCT00756964|350691|P1|NOT COMPLETED|Overall Study||0
151628|NCT00756964|350690|P2|COMPLETED|Overall Study||13
151629|NCT00756964|350691|P1|COMPLETED|Overall Study||13
151630|NCT00756964|350690|P2|STARTED|Overall Study||13
151631|NCT00756964|350691|P1|STARTED|Overall Study||13
151632|NCT00756938|350700|P4|NOT COMPLETED|Optional Extension||37
151633|NCT00756938|350701|P3|NOT COMPLETED|Optional Extension||0
151634|NCT00756938|350702|P2|NOT COMPLETED|Optional Extension||0
151635|NCT00756938|350703|P1|NOT COMPLETED|Optional Extension||0
151636|NCT00756938|350700|P4|COMPLETED|Optional Extension||53
151637|NCT00756938|350701|P3|COMPLETED|Optional Extension||0
151638|NCT00756938|350702|P2|COMPLETED|Optional Extension||0
151639|NCT00756938|350703|P1|COMPLETED|Optional Extension||0
151640|NCT00756938|350700|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
151641|NCT00756938|350701|P3|STARTED|Optional Extension||0
151642|NCT00756938|350702|P2|STARTED|Optional Extension||0
151643|NCT00756938|350703|P1|STARTED|Optional Extension||0
151644|NCT00756938|350700|P4|NOT COMPLETED|12-week Base Study||0
151645|NCT00756938|350701|P3|NOT COMPLETED|12-week Base Study||2
151646|NCT00756938|350702|P2|NOT COMPLETED|12-week Base Study||0
151647|NCT00756938|350703|P1|NOT COMPLETED|12-week Base Study||2
151648|NCT00756938|350700|P4|COMPLETED|12-week Base Study||0
151649|NCT00756938|350701|P3|COMPLETED|12-week Base Study||32
151650|NCT00756938|350702|P2|COMPLETED|12-week Base Study||34
151651|NCT00756938|350703|P1|COMPLETED|12-week Base Study||31
151652|NCT00756938|350700|P4|STARTED|12-week Base Study||0
151653|NCT00756938|350701|P3|STARTED|12-week Base Study||34
151654|NCT00756938|350702|P2|STARTED|12-week Base Study||34
151655|NCT00756938|350703|P1|STARTED|12-week Base Study||33
151656|NCT00756886|350731|P2|NOT COMPLETED|Overall Study||7
151657|NCT00756886|350732|P1|NOT COMPLETED|Overall Study||11
151658|NCT00756886|350731|P2|COMPLETED|Overall Study||25
151659|NCT00756886|350732|P1|COMPLETED|Overall Study||30
151660|NCT00756886|350731|P2|STARTED|Overall Study||32
151661|NCT00756886|350732|P1|STARTED|Overall Study||41
151662|NCT00756730|350740|P2|NOT COMPLETED|Overall Study||2
151663|NCT00756730|350741|P1|NOT COMPLETED|Overall Study||0
151664|NCT00756730|350740|P2|COMPLETED|Overall Study||22
151665|NCT00756730|350741|P1|COMPLETED|Overall Study||25
151666|NCT00756730|350740|P2|STARTED|Overall Study||24
151667|NCT00756730|350741|P1|STARTED|Overall Study||25
151668|NCT00756678|350761|P1|NOT COMPLETED|Overall Study||1
151669|NCT00756678|350761|P1|COMPLETED|Overall Study||50
151670|NCT00756678|350761|P1|STARTED|Overall Study||51
151671|NCT00756574|350774|P2|NOT COMPLETED|Overall Study||11
151672|NCT00756574|350775|P1|NOT COMPLETED|Overall Study||13
151673|NCT00756574|350774|P2|COMPLETED|Overall Study||210
151674|NCT00756574|350775|P1|COMPLETED|Overall Study||212
151675|NCT00756574|350774|P2|STARTED|Overall Study||221
151676|NCT00756574|350775|P1|STARTED|Overall Study||225
151677|NCT00756561|350785|P1|NOT COMPLETED|Overall Study||0
151678|NCT00756561|350785|P1|COMPLETED|Overall Study||10
151679|NCT00756561|350785|P1|STARTED|Overall Study||10
151680|NCT00756548|350792|P2|NOT COMPLETED|Overall Study||0
151681|NCT00756548|350793|P1|NOT COMPLETED|Overall Study||2
151682|NCT00756548|350792|P2|COMPLETED|Overall Study||185
151683|NCT00756548|350793|P1|COMPLETED|Overall Study||184
151684|NCT00756548|350792|P2|STARTED|Overall Study||185
151685|NCT00756548|350793|P1|STARTED|Overall Study||186
151686|NCT00756470|350819|P1|NOT COMPLETED|Overall Study||5
151687|NCT00756470|350819|P1|COMPLETED|Overall Study||10
151688|NCT00756470|350819|P1|STARTED|Overall Study||15
151689|NCT00756457|350826|P2|NOT COMPLETED|Overall Study||2
151690|NCT00756457|350827|P1|NOT COMPLETED|Overall Study||1
151691|NCT00756457|350826|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
151692|NCT00756457|350827|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
151693|NCT00756457|350826|P2|STARTED|Overall Study||19
151694|NCT00756457|350827|P1|STARTED|Overall Study||20
151695|NCT00756444|350857|P2|NOT COMPLETED|Overall Study||21
151696|NCT00756444|350858|P1|NOT COMPLETED|Overall Study||15
151697|NCT00756444|350857|P2|COMPLETED|Overall Study||13
151698|NCT00756444|350858|P1|COMPLETED|Overall Study||18
151699|NCT00756444|350857|P2|STARTED|Overall Study||34
151700|NCT00756444|350858|P1|STARTED|Overall Study||33
151701|NCT00756314|350869|P2|NOT COMPLETED|Overall Study||59
151702|NCT00756314|350870|P1|NOT COMPLETED|Overall Study||2
151703|NCT00756314|350869|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
151704|NCT00756314|350870|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
151705|NCT00756314|350869|P2|STARTED|Overall Study||123
151706|NCT00756314|350870|P1|STARTED|Overall Study||123
151707|NCT00756093|350884|P4|NOT COMPLETED|Fourth Intervention||0
151708|NCT00756093|350885|P3|NOT COMPLETED|Fourth Intervention||0
151709|NCT00756093|350886|P2|NOT COMPLETED|Fourth Intervention||0
151710|NCT00756093|350887|P1|NOT COMPLETED|Fourth Intervention||0
151711|NCT00756093|350884|P4|COMPLETED|Fourth Intervention||5
151712|NCT00756093|350885|P3|COMPLETED|Fourth Intervention||5
151713|NCT00756093|350886|P2|COMPLETED|Fourth Intervention||5
151714|NCT00756093|350887|P1|COMPLETED|Fourth Intervention||5
151715|NCT00756093|350884|P4|STARTED|Fourth Intervention||5
151716|NCT00756093|350885|P3|STARTED|Fourth Intervention||5
151717|NCT00756093|350886|P2|STARTED|Fourth Intervention||5
151718|NCT00756093|350887|P1|STARTED|Fourth Intervention||5
151719|NCT00756093|350884|P4|NOT COMPLETED|Third Intervention||0
151720|NCT00756093|350885|P3|NOT COMPLETED|Third Intervention||0
151721|NCT00756093|350886|P2|NOT COMPLETED|Third Intervention||0
151722|NCT00756093|350887|P1|NOT COMPLETED|Third Intervention||0
151723|NCT00756093|350884|P4|COMPLETED|Third Intervention||5
151724|NCT00756093|350885|P3|COMPLETED|Third Intervention||5
151725|NCT00756093|350886|P2|COMPLETED|Third Intervention||5
151726|NCT00756093|350887|P1|COMPLETED|Third Intervention||5
151727|NCT00756093|350884|P4|STARTED|Third Intervention||5
151728|NCT00756093|350885|P3|STARTED|Third Intervention||5
151729|NCT00756093|350886|P2|STARTED|Third Intervention||5
151730|NCT00756093|350887|P1|STARTED|Third Intervention||5
151731|NCT00756093|350884|P4|NOT COMPLETED|Second Intervention||0
151732|NCT00756093|350885|P3|NOT COMPLETED|Second Intervention||0
151733|NCT00756093|350886|P2|NOT COMPLETED|Second Intervention||0
151734|NCT00756093|350887|P1|NOT COMPLETED|Second Intervention||0
151735|NCT00756093|350884|P4|COMPLETED|Second Intervention||5
151736|NCT00756093|350885|P3|COMPLETED|Second Intervention||5
151737|NCT00756093|350886|P2|COMPLETED|Second Intervention||5
151738|NCT00756093|350887|P1|COMPLETED|Second Intervention||5
151739|NCT00756093|350884|P4|STARTED|Second Intervention||5
151740|NCT00756093|350885|P3|STARTED|Second Intervention||5
151741|NCT00756093|350886|P2|STARTED|Second Intervention||5
151742|NCT00756093|350887|P1|STARTED|Second Intervention||5
151743|NCT00756093|350884|P4|NOT COMPLETED|First Intervention||0
151744|NCT00756093|350885|P3|NOT COMPLETED|First Intervention||0
151745|NCT00756093|350886|P2|NOT COMPLETED|First Intervention||0
151746|NCT00756093|350887|P1|NOT COMPLETED|First Intervention||0
151747|NCT00756093|350884|P4|COMPLETED|First Intervention||5
151748|NCT00756093|350885|P3|COMPLETED|First Intervention||5
151749|NCT00756093|350886|P2|COMPLETED|First Intervention||5
151750|NCT00756093|350887|P1|COMPLETED|First Intervention||5
151751|NCT00756093|350884|P4|STARTED|First Intervention||5
151752|NCT00756093|350885|P3|STARTED|First Intervention||5
151753|NCT00756093|350886|P2|STARTED|First Intervention||5
151754|NCT00756093|350887|P1|STARTED|First Intervention||5
151755|NCT00756002|350899|P2|NOT COMPLETED|Placebo Run-out||0
151756|NCT00756002|350900|P1|NOT COMPLETED|Placebo Run-out||0
151757|NCT00756002|350899|P2|COMPLETED|Placebo Run-out||0
151758|NCT00756002|350900|P1|COMPLETED|Placebo Run-out||114
151759|NCT00756002|350899|P2|STARTED|Placebo Run-out||0
151760|NCT00756002|350900|P1|STARTED|Placebo Run-out||114
151761|NCT00756002|350899|P2|NOT COMPLETED|Double-Blind Treatment Period||15
151762|NCT00756002|350900|P1|NOT COMPLETED|Double-Blind Treatment Period||15
151763|NCT00756002|350899|P2|COMPLETED|Double-Blind Treatment Period||115
151764|NCT00756002|350900|P1|COMPLETED|Double-Blind Treatment Period||114
151765|NCT00756002|350899|P2|STARTED|Double-Blind Treatment Period||130
151766|NCT00756002|350900|P1|STARTED|Double-Blind Treatment Period||129
151767|NCT00756002|350899|P2|NOT COMPLETED|Placebo Run-in||0
151768|NCT00756002|350900|P1|NOT COMPLETED|Placebo Run-in||229
151769|NCT00756002|350899|P2|COMPLETED|Placebo Run-in||0
151770|NCT00756002|350900|P1|COMPLETED|Placebo Run-in||259
151771|NCT00756002|350899|P2|STARTED|Placebo Run-in||0
151772|NCT00756002|350900|P1|STARTED|Placebo Run-in||488
151773|NCT00755937|350994|P1|NOT COMPLETED|Observational Follow-up||148
151774|NCT00755937|350994|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
151775|NCT00755937|350994|P1|STARTED|Observational Follow-up||392
151776|NCT00755937|350994|P1|NOT COMPLETED|Recruitment||164
151777|NCT00755937|350994|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
151778|NCT00755937|350994|P1|STARTED|Recruitment|Subjects registered in the program|556
151779|NCT00755911|351006|P2|NOT COMPLETED|Overall Study||0
151780|NCT00755911|351007|P1|NOT COMPLETED|Overall Study||0
151781|NCT00755911|351006|P2|COMPLETED|Overall Study||12
151782|NCT00755911|351007|P1|COMPLETED|Overall Study||12
151783|NCT00755911|351006|P2|STARTED|Overall Study||12
151784|NCT00755911|351007|P1|STARTED|Overall Study||12
151785|NCT00755846|351021|P6|NOT COMPLETED|Overall Study||14
151786|NCT00755846|351022|P5|NOT COMPLETED|Overall Study||17
151787|NCT00755846|351023|P4|NOT COMPLETED|Overall Study||13
151788|NCT00755846|351024|P3|NOT COMPLETED|Overall Study||12
151789|NCT00755846|351025|P2|NOT COMPLETED|Overall Study||17
151790|NCT00755846|351026|P1|NOT COMPLETED|Overall Study||25
151791|NCT00755846|351021|P6|COMPLETED|Overall Study||31
151792|NCT00755846|351022|P5|COMPLETED|Overall Study||27
151793|NCT00755846|351023|P4|COMPLETED|Overall Study||32
151794|NCT00755846|351024|P3|COMPLETED|Overall Study||32
151795|NCT00755846|351025|P2|COMPLETED|Overall Study||27
151796|NCT00755846|351026|P1|COMPLETED|Overall Study||18
151797|NCT00755846|351021|P6|STARTED|Overall Study||45
151798|NCT00755846|351022|P5|STARTED|Overall Study||44
151799|NCT00755846|351023|P4|STARTED|Overall Study||45
151800|NCT00755846|351024|P3|STARTED|Overall Study||44
151801|NCT00755846|351025|P2|STARTED|Overall Study||44
151802|NCT00755846|351026|P1|STARTED|Overall Study||43
151803|NCT00755807|351126|P2|NOT COMPLETED|Open-label Extension Phase||16
151804|NCT00755807|351127|P1|NOT COMPLETED|Open-label Extension Phase||18
151805|NCT00755807|351126|P2|COMPLETED|Open-label Extension Phase||93
151806|NCT00755807|351127|P1|COMPLETED|Open-label Extension Phase||82
151807|NCT00755807|351126|P2|STARTED|Open-label Extension Phase||109
151808|NCT00755807|351127|P1|STARTED|Open-label Extension Phase||100
151809|NCT00755807|351126|P2|NOT COMPLETED|Acute Phase||12
151810|NCT00755807|351127|P1|NOT COMPLETED|Acute Phase||18
151811|NCT00755807|351126|P2|COMPLETED|Acute Phase||109
151812|NCT00755807|351127|P1|COMPLETED|Acute Phase||100
151813|NCT00755807|351126|P2|STARTED|Acute Phase||121
151814|NCT00755807|351127|P1|STARTED|Acute Phase||118
151815|NCT00755755|351191|P3|NOT COMPLETED|Overall Study||3
151816|NCT00755755|351192|P2|NOT COMPLETED|Overall Study||8
151817|NCT00755755|351193|P1|NOT COMPLETED|Overall Study||6
151818|NCT00755755|351191|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
151819|NCT00755755|351192|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
151820|NCT00755755|351193|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
151821|NCT00755755|351191|P3|STARTED|Overall Study|Safety population|48
151822|NCT00755755|351192|P2|STARTED|Overall Study|Safety population|98
151823|NCT00755755|351193|P1|STARTED|Overall Study|Safety population|95
151824|NCT00755417|351207|P3|NOT COMPLETED|Overall Study||42
151825|NCT00755417|351208|P2|NOT COMPLETED|Overall Study||55
151826|NCT00755417|351209|P1|NOT COMPLETED|Overall Study||62
151827|NCT00755417|351207|P3|COMPLETED|Overall Study||135
151828|NCT00755417|351208|P2|COMPLETED|Overall Study||126
151829|NCT00755417|351209|P1|COMPLETED|Overall Study||112
151830|NCT00755417|351207|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
151831|NCT00755417|351208|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
151832|NCT00755417|351209|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
151833|NCT00755274|351228|P2|NOT COMPLETED|Overall Study||0
151834|NCT00755274|351229|P1|NOT COMPLETED|Overall Study||0
151835|NCT00755274|351228|P2|COMPLETED|Overall Study||8
151836|NCT00755274|351229|P1|COMPLETED|Overall Study||24
151837|NCT00755274|351228|P2|STARTED|Overall Study||8
151838|NCT00755274|351229|P1|STARTED|Overall Study||24
151839|NCT00755261|351249|P1|NOT COMPLETED|Overall Study||2
151840|NCT00755261|351249|P1|COMPLETED|Overall Study||4
151841|NCT00755261|351249|P1|STARTED|Overall Study||6
151842|NCT00755235|351255|P2|NOT COMPLETED|Overall Study||9
151843|NCT00755235|351256|P1|NOT COMPLETED|Overall Study||2
151844|NCT00755235|351255|P2|COMPLETED|Overall Study||93
151845|NCT00755235|351256|P1|COMPLETED|Overall Study||104
151846|NCT00755235|351255|P2|STARTED|Overall Study||102
151847|NCT00755235|351256|P1|STARTED|Overall Study||106
151848|NCT00755222|351266|P2|NOT COMPLETED|Overall Study||2
151849|NCT00755222|351267|P1|NOT COMPLETED|Overall Study||8
151850|NCT00755222|351266|P2|COMPLETED|Overall Study||34
151851|NCT00755222|351267|P1|COMPLETED|Overall Study||103
151852|NCT00755222|351266|P2|STARTED|Overall Study||36
151853|NCT00755222|351267|P1|STARTED|Overall Study||111
151854|NCT00755131|351283|P2|NOT COMPLETED|Overall Study||0
151855|NCT00755131|351284|P1|NOT COMPLETED|Overall Study||0
151856|NCT00755131|351283|P2|COMPLETED|Overall Study||38
151857|NCT00755131|351284|P1|COMPLETED|Overall Study||37
151858|NCT00755131|351283|P2|STARTED|Overall Study||38
151859|NCT00755131|351284|P1|STARTED|Overall Study||37
151860|NCT00755105|351297|P3|NOT COMPLETED|Overall Study||4
151861|NCT00755105|351298|P2|NOT COMPLETED|Overall Study||11
151862|NCT00755105|351299|P1|NOT COMPLETED|Overall Study||9
151863|NCT00755105|351297|P3|COMPLETED|Overall Study||5
151864|NCT00755105|351298|P2|COMPLETED|Overall Study||19
151865|NCT00755105|351299|P1|COMPLETED|Overall Study||29
151866|NCT00755105|351297|P3|STARTED|Overall Study||9
151867|NCT00755105|351298|P2|STARTED|Overall Study||30
151868|NCT00755105|351299|P1|STARTED|Overall Study||38
151869|NCT00755079|351309|P2|NOT COMPLETED|Overall Study||6
151870|NCT00755079|351310|P1|NOT COMPLETED|Overall Study||1
151871|NCT00755079|351309|P2|COMPLETED|Overall Study||16
151872|NCT00755079|351310|P1|COMPLETED|Overall Study||17
151873|NCT00755079|351309|P2|STARTED|Overall Study||22
151874|NCT00755079|351310|P1|STARTED|Overall Study||18
151875|NCT00755040|351320|P2|NOT COMPLETED|Overall Study||34
151876|NCT00755040|351321|P1|NOT COMPLETED|Overall Study||43
151877|NCT00755040|351320|P2|COMPLETED|Overall Study||47
151878|NCT00755040|351321|P1|COMPLETED|Overall Study||40
151879|NCT00755040|351320|P2|STARTED|Overall Study||81
151880|NCT00755040|351321|P1|STARTED|Overall Study||83
151881|NCT00754923|351327|P1|NOT COMPLETED|Overall Study||0
151882|NCT00754923|351327|P1|COMPLETED|Overall Study||11
151883|NCT00754923|351327|P1|STARTED|Overall Study||11
151884|NCT00754832|351332|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
151885|NCT00754832|351333|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
151886|NCT00754832|351332|P2|COMPLETED|Second 6 Weeks Intervention||24
151887|NCT00754832|351333|P1|COMPLETED|Second 6 Weeks Intervention||17
151888|NCT00754832|351332|P2|STARTED|Second 6 Weeks Intervention||26
151889|NCT00754832|351333|P1|STARTED|Second 6 Weeks Intervention||17
151890|NCT00754832|351332|P2|NOT COMPLETED|2 Weeks Washout||2
151891|NCT00754832|351333|P1|NOT COMPLETED|2 Weeks Washout||1
151892|NCT00754832|351332|P2|COMPLETED|2 Weeks Washout||26
151893|NCT00754832|351333|P1|COMPLETED|2 Weeks Washout||17
151894|NCT00754832|351332|P2|STARTED|2 Weeks Washout||28
151895|NCT00754832|351333|P1|STARTED|2 Weeks Washout||18
151896|NCT00754832|351332|P2|NOT COMPLETED|First 6 Weeks Intervention||2
151897|NCT00754832|351333|P1|NOT COMPLETED|First 6 Weeks Intervention||8
151898|NCT00754832|351332|P2|COMPLETED|First 6 Weeks Intervention||28
151899|NCT00754832|351333|P1|COMPLETED|First 6 Weeks Intervention||18
151900|NCT00754832|351332|P2|STARTED|First 6 Weeks Intervention||30
151901|NCT00754832|351333|P1|STARTED|First 6 Weeks Intervention||26
151902|NCT00754793|351345|P2|NOT COMPLETED|Overall Study||1
151903|NCT00754793|351346|P1|NOT COMPLETED|Overall Study||0
151904|NCT00754793|351345|P2|COMPLETED|Overall Study||1
151905|NCT00754793|351346|P1|COMPLETED|Overall Study||1
151906|NCT00754793|351345|P2|STARTED|Overall Study||2
151907|NCT00754793|351346|P1|STARTED|Overall Study||1
151908|NCT00754741|351355|P3|NOT COMPLETED|Overall Study||54
151909|NCT00754741|351356|P2|NOT COMPLETED|Overall Study||69
151910|NCT00754741|351357|P1|NOT COMPLETED|Overall Study||57
151911|NCT00754741|351355|P3|COMPLETED|Overall Study||502
151912|NCT00754741|351356|P2|COMPLETED|Overall Study||500
151913|NCT00754741|351357|P1|COMPLETED|Overall Study||510
151914|NCT00754741|351355|P3|STARTED|Overall Study||556
151915|NCT00754741|351356|P2|STARTED|Overall Study||569
151916|NCT00754741|351357|P1|STARTED|Overall Study||567
151917|NCT00754650|351404|P1|NOT COMPLETED|Overall Study||2
151918|NCT00754650|351404|P1|COMPLETED|Overall Study||0
151919|NCT00754650|351404|P1|STARTED|Overall Study||2
151920|NCT00754624|351409|P1|NOT COMPLETED|Overall Study||69
151921|NCT00754624|351409|P1|COMPLETED|Overall Study||160
151922|NCT00754624|351409|P1|STARTED|Overall Study||229
151923|NCT00754572|351419|P1|NOT COMPLETED|Overall Study||71
151924|NCT00754572|351419|P1|COMPLETED|Overall Study||347
151925|NCT00754572|351419|P1|STARTED|Overall Study||418
151926|NCT00754559|351446|P1|NOT COMPLETED|Overall Study||47
151927|NCT00754559|351446|P1|COMPLETED|Overall Study||239
151928|NCT00754559|351446|P1|STARTED|Overall Study||286
151929|NCT00754546|351470|P1|NOT COMPLETED|Overall Study||0
151930|NCT00754546|351470|P1|COMPLETED|Overall Study||20
151931|NCT00754546|351470|P1|STARTED|Overall Study||20
151932|NCT00752791|351484|P1|NOT COMPLETED|Overall Study||16
151933|NCT00752791|351484|P1|COMPLETED|Overall Study||43
151934|NCT00752791|351484|P1|STARTED|Overall Study||59
151935|NCT00754494|351497|P3|NOT COMPLETED|Overall Study||1
151936|NCT00754494|351498|P2|NOT COMPLETED|Overall Study||0
151937|NCT00754494|351499|P1|NOT COMPLETED|Overall Study||2
151938|NCT00754494|351497|P3|COMPLETED|Overall Study||14
151939|NCT00754494|351498|P2|COMPLETED|Overall Study||15
151940|NCT00754494|351499|P1|COMPLETED|Overall Study||13
151941|NCT00754494|351497|P3|STARTED|Overall Study||15
151942|NCT00754494|351498|P2|STARTED|Overall Study||15
151943|NCT00754494|351499|P1|STARTED|Overall Study||15
151944|NCT00754468|351545|P2|NOT COMPLETED|Overall Study||0
151945|NCT00754468|351546|P1|NOT COMPLETED|Overall Study||0
151946|NCT00754468|351545|P2|COMPLETED|Overall Study||3
151947|NCT00754468|351546|P1|COMPLETED|Overall Study||4
151948|NCT00754468|351545|P2|STARTED|Overall Study||3
151949|NCT00754468|351546|P1|STARTED|Overall Study||4
151950|NCT00754442|351556|P2|NOT COMPLETED|Overall Study||3
151951|NCT00754442|351557|P1|NOT COMPLETED|Overall Study||5
151952|NCT00754442|351556|P2|COMPLETED|Overall Study||6
151953|NCT00754442|351557|P1|COMPLETED|Overall Study||6
151954|NCT00754442|351556|P2|STARTED|Overall Study|patients 9|9
151955|NCT00754442|351557|P1|STARTED|Overall Study|controls 11|11
151956|NCT00754390|351564|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
151957|NCT00754390|351564|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
151958|NCT00754390|351564|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
151959|NCT00754390|351564|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
151960|NCT00754390|351564|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
151961|NCT00754390|351564|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
151962|NCT00754390|351564|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
151963|NCT00754390|351564|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
151964|NCT00754390|351564|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
151965|NCT00754390|351564|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
151966|NCT00754390|351564|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
151967|NCT00754390|351564|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
151968|NCT00754377|351573|P2|NOT COMPLETED|Overall Study||0
151969|NCT00754377|351574|P1|NOT COMPLETED|Overall Study||0
151970|NCT00754377|351573|P2|COMPLETED|Overall Study||42
151971|NCT00754377|351574|P1|COMPLETED|Overall Study||50
151972|NCT00754377|351573|P2|STARTED|Overall Study||42
151973|NCT00754377|351574|P1|STARTED|Overall Study||50
151974|NCT00754338|351586|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
151975|NCT00754338|351587|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
151976|NCT00754338|351588|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
151977|NCT00754338|351589|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
151978|NCT00754338|351586|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
151979|NCT00754338|351587|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
151980|NCT00754338|351588|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
151981|NCT00754338|351589|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
151982|NCT00754338|351586|P4|STARTED|Second Intervention for Phase1&Phase2||19
151983|NCT00754338|351587|P3|STARTED|Second Intervention for Phase1&Phase2||16
151984|NCT00754338|351588|P2|STARTED|Second Intervention for Phase1&Phase2||18
151985|NCT00754338|351589|P1|STARTED|Second Intervention for Phase1&Phase2||17
151986|NCT00754338|351586|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
151987|NCT00754338|351587|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
151988|NCT00754338|351588|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
151989|NCT00754338|351589|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
151990|NCT00754338|351586|P4|COMPLETED|First Intervention for Phase1&Phase2||19
151991|NCT00754338|351587|P3|COMPLETED|First Intervention for Phase1&Phase2||16
151992|NCT00754338|351588|P2|COMPLETED|First Intervention for Phase1&Phase2||18
151993|NCT00754338|351589|P1|COMPLETED|First Intervention for Phase1&Phase2||17
151994|NCT00754338|351586|P4|STARTED|First Intervention for Phase1&Phase2||19
151995|NCT00754338|351587|P3|STARTED|First Intervention for Phase1&Phase2||19
151996|NCT00754338|351588|P2|STARTED|First Intervention for Phase1&Phase2||21
151997|NCT00754338|351589|P1|STARTED|First Intervention for Phase1&Phase2||17
151998|NCT00754325|351621|P2|NOT COMPLETED|Progression and Cross-over||21
151999|NCT00754325|351622|P1|NOT COMPLETED|Progression and Cross-over||0
152000|NCT00754325|351621|P2|COMPLETED|Progression and Cross-over||0
152001|NCT00754325|351622|P1|COMPLETED|Progression and Cross-over||0
152002|NCT00754325|351621|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
152003|NCT00754325|351622|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
152004|NCT00754325|351621|P2|NOT COMPLETED|Initial Treatment||49
152005|NCT00754325|351622|P1|NOT COMPLETED|Initial Treatment||50
152006|NCT00754325|351621|P2|COMPLETED|Initial Treatment||0
152007|NCT00754325|351622|P1|COMPLETED|Initial Treatment||0
152008|NCT00754325|351621|P2|STARTED|Initial Treatment||49
152009|NCT00754325|351622|P1|STARTED|Initial Treatment||50
152010|NCT00754234|351641|P1|NOT COMPLETED|Overall Study||3
152011|NCT00754234|351641|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
152012|NCT00754234|351641|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
152013|NCT00754156|351647|P2|NOT COMPLETED|Overall Study||0
152014|NCT00754156|351648|P1|NOT COMPLETED|Overall Study||0
152015|NCT00754156|351647|P2|COMPLETED|Overall Study||6
152016|NCT00754156|351648|P1|COMPLETED|Overall Study||8
152017|NCT00754156|351647|P2|STARTED|Overall Study||6
152018|NCT00754156|351648|P1|STARTED|Overall Study||8
152019|NCT00754130|351672|P6|NOT COMPLETED|Period 2 (5 Days)||0
152020|NCT00754130|351673|P5|NOT COMPLETED|Period 2 (5 Days)||0
152021|NCT00754130|351674|P4|NOT COMPLETED|Period 2 (5 Days)||0
152022|NCT00754130|351675|P3|NOT COMPLETED|Period 2 (5 Days)||0
152023|NCT00754130|351676|P2|NOT COMPLETED|Period 2 (5 Days)||0
152024|NCT00754130|351677|P1|NOT COMPLETED|Period 2 (5 Days)||0
152025|NCT00754130|351672|P6|COMPLETED|Period 2 (5 Days)||4
152026|NCT00754130|351673|P5|COMPLETED|Period 2 (5 Days)||2
152027|NCT00754130|351674|P4|COMPLETED|Period 2 (5 Days)||2
152028|NCT00754130|351675|P3|COMPLETED|Period 2 (5 Days)||4
152029|NCT00754130|351676|P2|COMPLETED|Period 2 (5 Days)||2
152030|NCT00754130|351677|P1|COMPLETED|Period 2 (5 Days)||2
152031|NCT00754130|351672|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
152032|NCT00754130|351673|P5|STARTED|Period 2 (5 Days)||2
152033|NCT00754130|351674|P4|STARTED|Period 2 (5 Days)||2
152034|NCT00754130|351675|P3|STARTED|Period 2 (5 Days)||4
152035|NCT00754130|351676|P2|STARTED|Period 2 (5 Days)||2
152036|NCT00754130|351677|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
152037|NCT00754130|351672|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
152038|NCT00754130|351673|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
152039|NCT00754130|351674|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
152040|NCT00754130|351675|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
152041|NCT00754130|351676|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
152042|NCT00754130|351677|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
152043|NCT00754130|351672|P6|COMPLETED|Washout Period (>=8 Days)||4
152044|NCT00754130|351673|P5|COMPLETED|Washout Period (>=8 Days)||2
152045|NCT00754130|351674|P4|COMPLETED|Washout Period (>=8 Days)||2
152046|NCT00754130|351675|P3|COMPLETED|Washout Period (>=8 Days)||4
152047|NCT00754130|351676|P2|COMPLETED|Washout Period (>=8 Days)||2
152048|NCT00754130|351677|P1|COMPLETED|Washout Period (>=8 Days)||2
152049|NCT00754130|351672|P6|STARTED|Washout Period (>=8 Days)||4
152050|NCT00754130|351673|P5|STARTED|Washout Period (>=8 Days)||2
152051|NCT00754130|351674|P4|STARTED|Washout Period (>=8 Days)||2
152052|NCT00754130|351675|P3|STARTED|Washout Period (>=8 Days)||4
152053|NCT00754130|351676|P2|STARTED|Washout Period (>=8 Days)||2
152054|NCT00754130|351677|P1|STARTED|Washout Period (>=8 Days)||2
152055|NCT00754130|351672|P6|NOT COMPLETED|Period 1 (5 Days)||0
152056|NCT00754130|351673|P5|NOT COMPLETED|Period 1 (5 Days)||0
152057|NCT00754130|351674|P4|NOT COMPLETED|Period 1 (5 Days)||0
152058|NCT00754130|351675|P3|NOT COMPLETED|Period 1 (5 Days)||0
152059|NCT00754130|351676|P2|NOT COMPLETED|Period 1 (5 Days)||0
152060|NCT00754130|351677|P1|NOT COMPLETED|Period 1 (5 Days)||0
152061|NCT00754130|351672|P6|COMPLETED|Period 1 (5 Days)||4
152062|NCT00754130|351673|P5|COMPLETED|Period 1 (5 Days)||2
152063|NCT00754130|351674|P4|COMPLETED|Period 1 (5 Days)||2
152064|NCT00754130|351675|P3|COMPLETED|Period 1 (5 Days)||4
152065|NCT00754130|351676|P2|COMPLETED|Period 1 (5 Days)||2
152066|NCT00754130|351677|P1|COMPLETED|Period 1 (5 Days)||2
152067|NCT00754130|351672|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
152068|NCT00754130|351673|P5|STARTED|Period 1 (5 Days)||2
152069|NCT00754130|351674|P4|STARTED|Period 1 (5 Days)||2
152070|NCT00754130|351675|P3|STARTED|Period 1 (5 Days)||4
152071|NCT00754130|351676|P2|STARTED|Period 1 (5 Days)||2
152072|NCT00754130|351677|P1|STARTED|Period 1 (5 Days)||2
152073|NCT00754065|351720|P2|NOT COMPLETED|Overall Study||80
152074|NCT00754065|351721|P1|NOT COMPLETED|Overall Study||81
152075|NCT00754065|351720|P2|COMPLETED|Overall Study||126
152076|NCT00754065|351721|P1|COMPLETED|Overall Study||122
152077|NCT00754065|351720|P2|Cycle 6|Overall Study||153
152078|NCT00754065|351721|P1|Cycle 6|Overall Study||141
152079|NCT00754065|351720|P2|Participants Received Treatment|Overall Study||204
152080|NCT00754065|351721|P1|Participants Received Treatment|Overall Study||191
152081|NCT00754065|351720|P2|STARTED|Overall Study||206
152082|NCT00754065|351721|P1|STARTED|Overall Study||203
152083|NCT00754013|351961|P2|NOT COMPLETED|Overall Study||5
152084|NCT00754013|351962|P1|NOT COMPLETED|Overall Study||4
152085|NCT00754013|351961|P2|COMPLETED|Overall Study||0
152086|NCT00754013|351962|P1|COMPLETED|Overall Study||0
152087|NCT00754013|351961|P2|STARTED|Overall Study||5
152088|NCT00754013|351962|P1|STARTED|Overall Study||4
152089|NCT00753948|351973|P3|NOT COMPLETED|Overall Study||0
152090|NCT00753948|351974|P2|NOT COMPLETED|Overall Study||0
152091|NCT00753948|351975|P1|NOT COMPLETED|Overall Study||0
152092|NCT00753948|351973|P3|COMPLETED|Overall Study||7
152093|NCT00753948|351974|P2|COMPLETED|Overall Study||7
152094|NCT00753948|351975|P1|COMPLETED|Overall Study||9
152095|NCT00753948|351973|P3|STARTED|Overall Study||7
152096|NCT00753948|351974|P2|STARTED|Overall Study||7
152097|NCT00753948|351975|P1|STARTED|Overall Study||9
152098|NCT00753922|351987|P4|NOT COMPLETED|Overall Study||23
152099|NCT00753922|351988|P3|NOT COMPLETED|Overall Study||63
152100|NCT00753922|351989|P2|NOT COMPLETED|Overall Study||94
152101|NCT00753922|351990|P1|NOT COMPLETED|Overall Study||246
152102|NCT00753922|351987|P4|COMPLETED|Overall Study||37
152103|NCT00753922|351988|P3|COMPLETED|Overall Study||82
152104|NCT00753922|351989|P2|COMPLETED|Overall Study||157
152105|NCT00753922|351990|P1|COMPLETED|Overall Study||306
152106|NCT00753922|351987|P4|STARTED|Overall Study||60
152107|NCT00753922|351988|P3|STARTED|Overall Study||145
152108|NCT00753922|351989|P2|STARTED|Overall Study||251
152109|NCT00753922|351990|P1|STARTED|Overall Study||552
152110|NCT00753896|352020|P1|NOT COMPLETED|Overall Study||16
152111|NCT00753896|352020|P1|COMPLETED|Overall Study||118
152112|NCT00753896|352020|P1|STARTED|Overall Study||134
152113|NCT00752726|352036|P2|NOT COMPLETED|Overall Study||13
152114|NCT00752726|352037|P1|NOT COMPLETED|Overall Study||11
152115|NCT00752726|352036|P2|COMPLETED|Overall Study||53
152116|NCT00752726|352037|P1|COMPLETED|Overall Study||54
152117|NCT00752726|352036|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
152118|NCT00752726|352037|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
152119|NCT00752726|352036|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
152120|NCT00752726|352037|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
152121|NCT00752726|352036|P2|STARTED|Overall Study||66
152122|NCT00752726|352037|P1|STARTED|Overall Study||65
152123|NCT00753766|352064|P2|NOT COMPLETED|Overall Study||0
152124|NCT00753766|352065|P1|NOT COMPLETED|Overall Study||1
152125|NCT00753766|352064|P2|COMPLETED|Overall Study||0
152126|NCT00753766|352065|P1|COMPLETED|Overall Study||0
152127|NCT00753766|352064|P2|STARTED|Overall Study||0
152128|NCT00753766|352065|P1|STARTED|Overall Study||1
152129|NCT00753714|352075|P2|NOT COMPLETED|Overall Study||62
152130|NCT00753714|352076|P1|NOT COMPLETED|Overall Study||60
152131|NCT00753714|352075|P2|COMPLETED|Overall Study||1
152132|NCT00753714|352076|P1|COMPLETED|Overall Study||1
152133|NCT00753714|352075|P2|STARTED|Overall Study||63
152134|NCT00753714|352076|P1|STARTED|Overall Study||61
152135|NCT00753688|352092|P2|NOT COMPLETED|Overall Study||246
152136|NCT00753688|352093|P1|NOT COMPLETED|Overall Study||123
152137|NCT00753688|352092|P2|COMPLETED|Overall Study||0
152138|NCT00753688|352093|P1|COMPLETED|Overall Study||0
152139|NCT00753688|352092|P2|Ongoing - in Follow-up|Overall Study||31
152140|NCT00753688|352093|P1|Ongoing - in Follow-up|Overall Study||15
152141|NCT00753688|352092|P2|STARTED|Overall Study||246
152142|NCT00753688|352093|P1|STARTED|Overall Study||123
152143|NCT00753675|352122|P3|NOT COMPLETED|Overall Study||56
152144|NCT00753675|352123|P2|NOT COMPLETED|Overall Study||59
152145|NCT00753675|352124|P1|NOT COMPLETED|Overall Study||59
152146|NCT00753675|352122|P3|COMPLETED|Overall Study||0
152147|NCT00753675|352123|P2|COMPLETED|Overall Study||0
152148|NCT00753675|352124|P1|COMPLETED|Overall Study||0
152149|NCT00753675|352122|P3|STARTED|Overall Study||56
152150|NCT00753675|352123|P2|STARTED|Overall Study||59
152151|NCT00753675|352124|P1|STARTED|Overall Study||59
152152|NCT00753649|352146|P2|NOT COMPLETED|Overall Study||0
152153|NCT00753649|352147|P1|NOT COMPLETED|Overall Study||7
152154|NCT00753649|352146|P2|COMPLETED|Overall Study||112
152155|NCT00753649|352147|P1|COMPLETED|Overall Study||105
152156|NCT00753649|352146|P2|STARTED|Overall Study||112
152157|NCT00753649|352147|P1|STARTED|Overall Study||112
152158|NCT00753636|352167|P1|NOT COMPLETED|Overall Study||6
152159|NCT00753636|352167|P1|COMPLETED|Overall Study||25
152160|NCT00753636|352167|P1|STARTED|Overall Study||31
152161|NCT00753623|352180|P2|NOT COMPLETED|Second Intervention (14 Days)||1
152162|NCT00753623|352181|P1|NOT COMPLETED|Second Intervention (14 Days)||0
152163|NCT00753623|352180|P2|COMPLETED|Second Intervention (14 Days)||7
152164|NCT00753623|352181|P1|COMPLETED|Second Intervention (14 Days)||8
152165|NCT00753623|352180|P2|STARTED|Second Intervention (14 Days)||8
152166|NCT00753623|352181|P1|STARTED|Second Intervention (14 Days)||8
152167|NCT00753623|352180|P2|NOT COMPLETED|Washout (7 Days)||0
152168|NCT00753623|352181|P1|NOT COMPLETED|Washout (7 Days)||1
152169|NCT00753623|352180|P2|COMPLETED|Washout (7 Days)||8
152170|NCT00753623|352181|P1|COMPLETED|Washout (7 Days)||8
152171|NCT00753623|352180|P2|STARTED|Washout (7 Days)||8
152172|NCT00753623|352181|P1|STARTED|Washout (7 Days)||9
152173|NCT00753623|352180|P2|NOT COMPLETED|First Intervention (14 Days)||4
152174|NCT00753623|352181|P1|NOT COMPLETED|First Intervention (14 Days)||2
152175|NCT00753623|352180|P2|COMPLETED|First Intervention (14 Days)||8
152176|NCT00753623|352181|P1|COMPLETED|First Intervention (14 Days)||9
152177|NCT00753623|352180|P2|STARTED|First Intervention (14 Days)||12
152178|NCT00753623|352181|P1|STARTED|First Intervention (14 Days)||11
152179|NCT00753545|352188|P2|NOT COMPLETED|Overall Study||108
152180|NCT00753545|352189|P1|NOT COMPLETED|Overall Study||68
152181|NCT00753545|352188|P2|COMPLETED|Overall Study|Ongoing study treatment at time of data cut-off|21
152182|NCT00753545|352189|P1|COMPLETED|Overall Study|Ongoing study treatment at time of data cut-off|68
152183|NCT00753545|352188|P2|STARTED|Overall Study|Patients randomized|129
152184|NCT00753545|352189|P1|STARTED|Overall Study|Patients randomized|136
152185|NCT00753519|352227|P2|NOT COMPLETED|Overall Study||2
152186|NCT00753519|352228|P1|NOT COMPLETED|Overall Study||0
152187|NCT00753519|352227|P2|COMPLETED|Overall Study||13
152188|NCT00753519|352228|P1|COMPLETED|Overall Study||13
152189|NCT00753519|352227|P2|STARTED|Overall Study||15
152190|NCT00753519|352228|P1|STARTED|Overall Study||13
152191|NCT00753506|352250|P2|NOT COMPLETED|Overall Study||2
152192|NCT00753506|352251|P1|NOT COMPLETED|Overall Study||7
152193|NCT00753506|352250|P2|COMPLETED|Overall Study||31
152194|NCT00753506|352251|P1|COMPLETED|Overall Study||26
152195|NCT00753506|352250|P2|STARTED|Overall Study||33
152196|NCT00753506|352251|P1|STARTED|Overall Study||33
152197|NCT00753454|352257|P1|NOT COMPLETED|Overall Study||14
152198|NCT00753454|352257|P1|COMPLETED|Overall Study||154
152199|NCT00753454|352257|P1|STARTED|Overall Study||168
152200|NCT00753415|352291|P10|NOT COMPLETED|Part B||1
152201|NCT00753415|352292|P9|NOT COMPLETED|Part B||3
152202|NCT00753415|352293|P8|NOT COMPLETED|Part B||1
152203|NCT00753415|352294|P7|NOT COMPLETED|Part B||0
152204|NCT00753415|352295|P6|NOT COMPLETED|Part B||0
152205|NCT00753415|352296|P5|NOT COMPLETED|Part B||0
152206|NCT00753415|352297|P4|NOT COMPLETED|Part B||0
152207|NCT00753415|352298|P3|NOT COMPLETED|Part B||0
152208|NCT00753415|352299|P2|NOT COMPLETED|Part B||0
152209|NCT00753415|352300|P1|NOT COMPLETED|Part B||0
152210|NCT00753415|352291|P10|COMPLETED|Part B||8
152211|NCT00753415|352292|P9|COMPLETED|Part B||6
152212|NCT00753415|352293|P8|COMPLETED|Part B||6
152213|NCT00753415|352294|P7|COMPLETED|Part B||2
152214|NCT00753415|352295|P6|COMPLETED|Part B||1
152215|NCT00753415|352296|P5|COMPLETED|Part B||0
152216|NCT00753415|352297|P4|COMPLETED|Part B||0
152217|NCT00753415|352298|P3|COMPLETED|Part B||0
152218|NCT00753415|352299|P2|COMPLETED|Part B||0
152219|NCT00753415|352300|P1|COMPLETED|Part B||0
152220|NCT00753415|352291|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
152221|NCT00753415|352292|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
152222|NCT00753415|352293|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
152223|NCT00753415|352294|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
152224|NCT00753415|352295|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
152225|NCT00753415|352296|P5|STARTED|Part B||0
152226|NCT00753415|352297|P4|STARTED|Part B||0
152227|NCT00753415|352298|P3|STARTED|Part B||0
152228|NCT00753415|352299|P2|STARTED|Part B||0
152229|NCT00753415|352300|P1|STARTED|Part B||0
152230|NCT00753415|352291|P10|NOT COMPLETED|Part A||0
152231|NCT00753415|352292|P9|NOT COMPLETED|Part A||0
152232|NCT00753415|352293|P8|NOT COMPLETED|Part A||0
152233|NCT00753415|352294|P7|NOT COMPLETED|Part A||0
152234|NCT00753415|352295|P6|NOT COMPLETED|Part A||0
152235|NCT00753415|352296|P5|NOT COMPLETED|Part A||0
152236|NCT00753415|352297|P4|NOT COMPLETED|Part A||2
152237|NCT00753415|352298|P3|NOT COMPLETED|Part A||2
152238|NCT00753415|352299|P2|NOT COMPLETED|Part A||0
152239|NCT00753415|352300|P1|NOT COMPLETED|Part A||1
152240|NCT00753415|352291|P10|COMPLETED|Part A||0
152241|NCT00753415|352292|P9|COMPLETED|Part A||0
152242|NCT00753415|352293|P8|COMPLETED|Part A||0
152243|NCT00753415|352294|P7|COMPLETED|Part A||0
152244|NCT00753415|352295|P6|COMPLETED|Part A||0
152245|NCT00753415|352296|P5|COMPLETED|Part A||10
152246|NCT00753415|352297|P4|COMPLETED|Part A||9
152247|NCT00753415|352298|P3|COMPLETED|Part A||8
152248|NCT00753415|352299|P2|COMPLETED|Part A||3
152249|NCT00753415|352300|P1|COMPLETED|Part A||2
152250|NCT00753415|352291|P10|STARTED|Part A||0
152251|NCT00753415|352292|P9|STARTED|Part A||0
152252|NCT00753415|352293|P8|STARTED|Part A||0
152253|NCT00753415|352294|P7|STARTED|Part A||0
152254|NCT00753415|352295|P6|STARTED|Part A||0
152255|NCT00753415|352296|P5|STARTED|Part A||10
152256|NCT00753415|352297|P4|STARTED|Part A||11
152257|NCT00753415|352298|P3|STARTED|Part A||10
152258|NCT00753415|352299|P2|STARTED|Part A||3
152259|NCT00753415|352300|P1|STARTED|Part A||3
152260|NCT00753363|352344|P2|NOT COMPLETED|Overall Study||39
152261|NCT00753363|352345|P1|NOT COMPLETED|Overall Study||40
152262|NCT00753363|352344|P2|COMPLETED|Overall Study||21
152263|NCT00753363|352345|P1|COMPLETED|Overall Study||19
152264|NCT00753363|352344|P2|STARTED|Overall Study||60
152265|NCT00753363|352345|P1|STARTED|Overall Study||59
152266|NCT00753337|352355|P1|NOT COMPLETED|Overall Study||0
152267|NCT00753337|352355|P1|COMPLETED|Overall Study||123
152268|NCT00753337|352355|P1|STARTED|Overall Study||123
152269|NCT00753298|352371|P2|NOT COMPLETED|Overall Study||4
152270|NCT00753298|352372|P1|NOT COMPLETED|Overall Study||8
152271|NCT00753298|352371|P2|COMPLETED|Overall Study||94
152272|NCT00753298|352372|P1|COMPLETED|Overall Study||89
152273|NCT00753298|352371|P2|STARTED|Overall Study||98
152274|NCT00753298|352372|P1|STARTED|Overall Study||97
152275|NCT00753272|352390|P2|NOT COMPLETED|Overall Study||4907
152276|NCT00753272|352391|P1|NOT COMPLETED|Overall Study||4982
152277|NCT00753272|352390|P2|COMPLETED|Overall Study||16895
152278|NCT00753272|352391|P1|COMPLETED|Overall Study||16911
152279|NCT00753272|352390|P2|STARTED|Overall Study||21802
152280|NCT00753272|352391|P1|STARTED|Overall Study||21893
152281|NCT00753220|352457|P1|NOT COMPLETED|Overall Study||5
152282|NCT00753220|352457|P1|COMPLETED|Overall Study||2
152283|NCT00753220|352457|P1|STARTED|Overall Study||7
152284|NCT00753142|352464|P3|NOT COMPLETED|Overall Study||0
152285|NCT00753142|352465|P2|NOT COMPLETED|Overall Study||0
152286|NCT00753142|352466|P1|NOT COMPLETED|Overall Study||0
152287|NCT00753142|352464|P3|COMPLETED|Overall Study||13
152288|NCT00753142|352465|P2|COMPLETED|Overall Study||7
152289|NCT00753142|352466|P1|COMPLETED|Overall Study||8
152290|NCT00753142|352464|P3|STARTED|Overall Study||13
152291|NCT00753142|352465|P2|STARTED|Overall Study||7
152292|NCT00753142|352466|P1|STARTED|Overall Study||8
152293|NCT00753012|352476|P2|NOT COMPLETED|Overall Study||1
152294|NCT00753012|352477|P1|NOT COMPLETED|Overall Study||8
152295|NCT00753012|352476|P2|COMPLETED|Overall Study||8
152296|NCT00753012|352477|P1|COMPLETED|Overall Study||7
152297|NCT00753012|352476|P2|STARTED|Overall Study||9
152298|NCT00753012|352477|P1|STARTED|Overall Study||15
152299|NCT00752986|352490|P3|NOT COMPLETED|Overall Study||2
152300|NCT00752986|352491|P2|NOT COMPLETED|Overall Study||1
152301|NCT00752986|352492|P1|NOT COMPLETED|Overall Study||5
152302|NCT00752986|352490|P3|COMPLETED|Overall Study||9
152303|NCT00752986|352491|P2|COMPLETED|Overall Study||11
152304|NCT00752986|352492|P1|COMPLETED|Overall Study||11
152305|NCT00752986|352490|P3|STARTED|Overall Study||11
152306|NCT00752986|352491|P2|STARTED|Overall Study||12
152307|NCT00752986|352492|P1|STARTED|Overall Study||16
152308|NCT00752973|352509|P1|NOT COMPLETED|Overall Study||0
152309|NCT00752973|352509|P1|COMPLETED|Overall Study||12
152310|NCT00752973|352509|P1|STARTED|Overall Study||12
152311|NCT00752895|352521|P2|NOT COMPLETED|Overall Study||3
152312|NCT00752895|352522|P1|NOT COMPLETED|Overall Study||8
152313|NCT00752895|352521|P2|COMPLETED|Overall Study||143
152314|NCT00752895|352522|P1|COMPLETED|Overall Study||139
152315|NCT00752895|352521|P2|STARTED|Overall Study||146
152316|NCT00752895|352522|P1|STARTED|Overall Study||147
152317|NCT00752622|352530|P1|NOT COMPLETED|Interventional Phase||8
152318|NCT00752622|352530|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
152319|NCT00752622|352530|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
152320|NCT00752622|352530|P1|NOT COMPLETED|Observational Phase||43
152321|NCT00752622|352530|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
152322|NCT00752622|352530|P1|STARTED|Observational Phase||65
152323|NCT00752622|352530|P1|NOT COMPLETED|Induction Phase||35
152324|NCT00752622|352530|P1|COMPLETED|Induction Phase||65
152325|NCT00752622|352530|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
152326|NCT00752609|352543|P2|NOT COMPLETED|Overall Study||2
152327|NCT00752609|352544|P1|NOT COMPLETED|Overall Study||9
152328|NCT00752609|352543|P2|COMPLETED|Overall Study||47
152329|NCT00752609|352544|P1|COMPLETED|Overall Study||44
152330|NCT00752609|352543|P2|Full Analysis Set|Overall Study||49
152331|NCT00752609|352544|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
152332|NCT00752609|352543|P2|STARTED|Overall Study||49
152333|NCT00752609|352544|P1|STARTED|Overall Study||53
152334|NCT00752232|352570|P7|NOT COMPLETED|Overall Study||0
152335|NCT00752232|352571|P6|NOT COMPLETED|Overall Study||1
152336|NCT00752232|352572|P5|NOT COMPLETED|Overall Study||3
152337|NCT00752232|352573|P4|NOT COMPLETED|Overall Study||1
152338|NCT00752232|352574|P3|NOT COMPLETED|Overall Study||1
152339|NCT00752232|352575|P2|NOT COMPLETED|Overall Study||0
152340|NCT00752232|352576|P1|NOT COMPLETED|Overall Study||2
152341|NCT00752232|352570|P7|COMPLETED|Overall Study||4
152342|NCT00752232|352571|P6|COMPLETED|Overall Study||5
152343|NCT00752232|352572|P5|COMPLETED|Overall Study||3
152344|NCT00752232|352573|P4|COMPLETED|Overall Study||5
152345|NCT00752232|352574|P3|COMPLETED|Overall Study||5
152346|NCT00752232|352575|P2|COMPLETED|Overall Study||6
152347|NCT00752232|352576|P1|COMPLETED|Overall Study||4
152348|NCT00752232|352570|P7|STARTED|Overall Study||4
152349|NCT00752232|352571|P6|STARTED|Overall Study||6
152350|NCT00752232|352572|P5|STARTED|Overall Study||6
152351|NCT00752232|352573|P4|STARTED|Overall Study||6
152352|NCT00752232|352574|P3|STARTED|Overall Study||6
152353|NCT00752232|352575|P2|STARTED|Overall Study||6
152354|NCT00752232|352576|P1|STARTED|Overall Study||6
152355|NCT00752128|352648|P1|NOT COMPLETED|Overall Study||4
152356|NCT00752128|352648|P1|COMPLETED|Overall Study||2345
152357|NCT00752128|352648|P1|STARTED|Overall Study||2349
152358|NCT00752089|352653|P1|NOT COMPLETED|Overall Study||6
152359|NCT00752089|352653|P1|COMPLETED|Overall Study||14
152360|NCT00752089|352653|P1|Received Placebo|Overall Study||18
152361|NCT00752089|352653|P1|Received NaF|Overall Study||18
152362|NCT00752089|352653|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
152363|NCT00752089|352653|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
152364|NCT00752089|352653|P1|STARTED|Overall Study||20
152365|NCT00751998|352667|P1|NOT COMPLETED|Overall Study||20
152366|NCT00751998|352667|P1|COMPLETED|Overall Study||277
152367|NCT00751998|352667|P1|STARTED|Overall Study||297
152368|NCT00751972|352673|P2|NOT COMPLETED|Overall Study||0
152369|NCT00751972|352674|P1|NOT COMPLETED|Overall Study||0
152370|NCT00751972|352673|P2|COMPLETED|Overall Study||499
152371|NCT00751972|352674|P1|COMPLETED|Overall Study||140
152372|NCT00751972|352673|P2|STARTED|Overall Study||499
152373|NCT00751972|352674|P1|STARTED|Overall Study||140
152374|NCT00751933|352686|P4|NOT COMPLETED|Overall Study||1
152375|NCT00751933|352687|P3|NOT COMPLETED|Overall Study||1
152376|NCT00751933|352688|P2|NOT COMPLETED|Overall Study||1
152377|NCT00751933|352689|P1|NOT COMPLETED|Overall Study||0
152378|NCT00751933|352686|P4|COMPLETED|Overall Study||0
152379|NCT00751933|352687|P3|COMPLETED|Overall Study||0
152380|NCT00751933|352688|P2|COMPLETED|Overall Study||0
152381|NCT00751933|352689|P1|COMPLETED|Overall Study||0
152382|NCT00751933|352686|P4|STARTED|Overall Study||1
152383|NCT00751933|352687|P3|STARTED|Overall Study||1
152384|NCT00751933|352688|P2|STARTED|Overall Study||1
152385|NCT00751933|352689|P1|STARTED|Overall Study||0
152386|NCT00751881|352697|P3|NOT COMPLETED|Extension Study Period||66
152387|NCT00751881|352698|P2|NOT COMPLETED|Extension Study Period||71
152388|NCT00751881|352699|P1|NOT COMPLETED|Extension Study Period||65
152389|NCT00751881|352697|P3|COMPLETED|Extension Study Period||167
152390|NCT00751881|352698|P2|COMPLETED|Extension Study Period||194
152391|NCT00751881|352699|P1|COMPLETED|Extension Study Period||188
152392|NCT00751881|352697|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
152393|NCT00751881|352698|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
152394|NCT00751881|352699|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
152395|NCT00751881|352697|P3|NOT COMPLETED|Core Treatment Period||128
152396|NCT00751881|352698|P2|NOT COMPLETED|Core Treatment Period||135
152397|NCT00751881|352699|P1|NOT COMPLETED|Core Treatment Period||126
152398|NCT00751881|352697|P3|COMPLETED|Core Treatment Period||244
152399|NCT00751881|352698|P2|COMPLETED|Core Treatment Period||273
152400|NCT00751881|352699|P1|COMPLETED|Core Treatment Period||263
152401|NCT00751881|352697|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
152402|NCT00751881|352698|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
152403|NCT00751881|352699|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
152404|NCT00751881|352697|P3|STARTED|Core Treatment Period|Randomized|372
152405|NCT00751881|352698|P2|STARTED|Core Treatment Period|Randomized|408
152406|NCT00751881|352699|P1|STARTED|Core Treatment Period|Randomized|389
152407|NCT00751790|352746|P1|NOT COMPLETED|Overall Study||5
152408|NCT00751790|352746|P1|COMPLETED|Overall Study||115
152409|NCT00751790|352746|P1|STARTED|Overall Study||120
152410|NCT00751777|352752|P2|NOT COMPLETED|Overall Study||3
152411|NCT00751777|352753|P1|NOT COMPLETED|Overall Study||11
152412|NCT00751777|352752|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
152413|NCT00751777|352753|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
152414|NCT00751777|352752|P2|STARTED|Overall Study||39
152415|NCT00751777|352753|P1|STARTED|Overall Study||81
152416|NCT00751634|352763|P1|NOT COMPLETED|Overall Study||0
152417|NCT00751634|352763|P1|COMPLETED|Overall Study||20
152418|NCT00751634|352763|P1|STARTED|Overall Study||20
152419|NCT00751621|352771|P1|NOT COMPLETED|Overall Study||4
152420|NCT00751621|352771|P1|COMPLETED|Overall Study||36
152421|NCT00751621|352771|P1|STARTED|Overall Study||40
152422|NCT00751530|352790|P2|NOT COMPLETED|Overall Study||0
152423|NCT00751530|352791|P1|NOT COMPLETED|Overall Study||0
152424|NCT00751530|352790|P2|COMPLETED|Overall Study||110
152425|NCT00751530|352791|P1|COMPLETED|Overall Study||332
152426|NCT00751530|352790|P2|STARTED|Overall Study||110
152427|NCT00751530|352791|P1|STARTED|Overall Study||332
152428|NCT00751400|352805|P1|NOT COMPLETED|Overall Study||10
152429|NCT00751400|352805|P1|COMPLETED|Overall Study||487
152430|NCT00751400|352805|P1|Subjects Provided Detailed Use Data|Overall Study||467
152431|NCT00751400|352805|P1|Subjects Consumed Drug|Overall Study||485
152432|NCT00751400|352805|P1|Subjects Provided Drug|Overall Study||497
152433|NCT00751400|352805|P1|STARTED|Overall Study||497
152434|NCT00751296|352818|P1|NOT COMPLETED|Overall Study||2
152435|NCT00751296|352818|P1|COMPLETED|Overall Study||25
152436|NCT00751296|352818|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
152437|NCT00751179|352825|P2|NOT COMPLETED|Overall Study||15
152438|NCT00751179|352826|P1|NOT COMPLETED|Overall Study||14
152439|NCT00751179|352825|P2|COMPLETED|Overall Study||70
152440|NCT00751179|352826|P1|COMPLETED|Overall Study||62
152441|NCT00751179|352825|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
152442|NCT00751179|352826|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
152443|NCT00751140|352846|P1|NOT COMPLETED|Overall Study||1
152444|NCT00751140|352846|P1|COMPLETED|Overall Study||19
152445|NCT00751140|352846|P1|STARTED|Overall Study||20
152446|NCT00751114|352856|P2|NOT COMPLETED|Overall Study||32
152447|NCT00751114|352857|P1|NOT COMPLETED|Overall Study||38
152448|NCT00751114|352856|P2|COMPLETED|Overall Study||233
152449|NCT00751114|352857|P1|COMPLETED|Overall Study||212
152450|NCT00751114|352856|P2|mITT Population|Overall Study||253
152451|NCT00751114|352857|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
152452|NCT00751114|352856|P2|TREATED = Safety Population|Overall Study||264
152453|NCT00751114|352857|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
152454|NCT00751114|352856|P2|STARTED|Overall Study||265
152455|NCT00751114|352857|P1|STARTED|Overall Study|randomized|250
152456|NCT00751036|352882|P2|NOT COMPLETED|Overall Study||46
152457|NCT00751036|352883|P1|NOT COMPLETED|Overall Study||48
152458|NCT00751036|352882|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
152459|NCT00751036|352883|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
152460|NCT00751036|352882|P2|STARTED|Overall Study|Started = Treated|46
152461|NCT00751036|352883|P1|STARTED|Overall Study|Started = Treated|48
152462|NCT00750919|352895|P1|NOT COMPLETED|Overall Study||58
152463|NCT00750919|352895|P1|COMPLETED|Overall Study||126
152464|NCT00750919|352895|P1|STARTED|Overall Study||184
152465|NCT00750893|352903|P1|NOT COMPLETED|Overall Study||542
152466|NCT00750893|352903|P1|COMPLETED|Overall Study||2569
152467|NCT00750893|352903|P1|STARTED|Overall Study||3111
152468|NCT00750880|352918|P1|NOT COMPLETED|Overall Study||215
152469|NCT00750880|352918|P1|COMPLETED|Overall Study||1466
152470|NCT00750880|352918|P1|STARTED|Overall Study||1681
152471|NCT00750867|352941|P1|NOT COMPLETED|Overall Study||2
152472|NCT00750867|352941|P1|COMPLETED|Overall Study||7
152473|NCT00750867|352941|P1|STARTED|Overall Study||9
152474|NCT00750815|352948|P2|NOT COMPLETED|Overall Study||0
152475|NCT00750815|352949|P1|NOT COMPLETED|Overall Study||0
152476|NCT00750815|352948|P2|COMPLETED|Overall Study||46
152477|NCT00750815|352949|P1|COMPLETED|Overall Study||12
152478|NCT00750815|352948|P2|STARTED|Overall Study||46
152479|NCT00750815|352949|P1|STARTED|Overall Study||12
152480|NCT00750737|352962|P2|NOT COMPLETED|Overall Study||3
152481|NCT00750737|352963|P1|NOT COMPLETED|Overall Study||3
152482|NCT00750737|352962|P2|COMPLETED|Overall Study||19
152483|NCT00750737|352963|P1|COMPLETED|Overall Study||21
152484|NCT00750737|352962|P2|STARTED|Overall Study||22
152485|NCT00750737|352963|P1|STARTED|Overall Study||24
152486|NCT00750373|352973|P2|NOT COMPLETED|Overall Study||0
152487|NCT00750373|352974|P1|NOT COMPLETED|Overall Study||0
152488|NCT00750373|352973|P2|COMPLETED|Overall Study||37
152489|NCT00750373|352974|P1|COMPLETED|Overall Study||39
152490|NCT00750373|352973|P2|STARTED|Overall Study||37
152491|NCT00750373|352974|P1|STARTED|Overall Study||39
152492|NCT00750360|352986|P6|NOT COMPLETED|Overall Study||0
152493|NCT00750360|352987|P5|NOT COMPLETED|Overall Study||0
152494|NCT00750360|352988|P4|NOT COMPLETED|Overall Study||0
152495|NCT00750360|352989|P3|NOT COMPLETED|Overall Study||0
152496|NCT00750360|352990|P2|NOT COMPLETED|Overall Study||0
152497|NCT00750360|352991|P1|NOT COMPLETED|Overall Study||0
152498|NCT00750360|352986|P6|COMPLETED|Overall Study||71
152499|NCT00750360|352987|P5|COMPLETED|Overall Study||46
152500|NCT00750360|352988|P4|COMPLETED|Overall Study||79
152501|NCT00750360|352989|P3|COMPLETED|Overall Study||384
152502|NCT00750360|352990|P2|COMPLETED|Overall Study||1
152503|NCT00750360|352991|P1|COMPLETED|Overall Study||294
152504|NCT00750360|352986|P6|STARTED|Overall Study||71
152505|NCT00750360|352987|P5|STARTED|Overall Study||46
152506|NCT00750360|352988|P4|STARTED|Overall Study||79
152507|NCT00750360|352989|P3|STARTED|Overall Study||384
152508|NCT00750360|352990|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
152509|NCT00750360|352991|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
152510|NCT00750308|353023|P12|NOT COMPLETED|Fourth Treatment||0
152511|NCT00750308|353024|P11|NOT COMPLETED|Fourth Treatment||0
152512|NCT00750308|353025|P10|NOT COMPLETED|Fourth Treatment||0
152513|NCT00750308|353026|P9|NOT COMPLETED|Fourth Treatment||0
152514|NCT00750308|353027|P8|NOT COMPLETED|Fourth Treatment||0
152515|NCT00750308|353028|P7|NOT COMPLETED|Fourth Treatment||0
152516|NCT00750308|353029|P6|NOT COMPLETED|Fourth Treatment||0
152517|NCT00750308|353030|P5|NOT COMPLETED|Fourth Treatment||0
152518|NCT00750308|353031|P4|NOT COMPLETED|Fourth Treatment||0
152519|NCT00750308|353032|P3|NOT COMPLETED|Fourth Treatment||0
152520|NCT00750308|353033|P2|NOT COMPLETED|Fourth Treatment||0
152521|NCT00750308|353034|P1|NOT COMPLETED|Fourth Treatment||0
152522|NCT00750308|353023|P12|COMPLETED|Fourth Treatment||1
152523|NCT00750308|353024|P11|COMPLETED|Fourth Treatment||1
152524|NCT00750308|353025|P10|COMPLETED|Fourth Treatment||2
152525|NCT00750308|353026|P9|COMPLETED|Fourth Treatment||1
152526|NCT00750308|353027|P8|COMPLETED|Fourth Treatment||2
152527|NCT00750308|353028|P7|COMPLETED|Fourth Treatment||2
152528|NCT00750308|353029|P6|COMPLETED|Fourth Treatment||2
152529|NCT00750308|353030|P5|COMPLETED|Fourth Treatment||1
152530|NCT00750308|353031|P4|COMPLETED|Fourth Treatment||1
152531|NCT00750308|353032|P3|COMPLETED|Fourth Treatment||2
152532|NCT00750308|353033|P2|COMPLETED|Fourth Treatment||1
152533|NCT00750308|353034|P1|COMPLETED|Fourth Treatment||2
152534|NCT00750308|353023|P12|STARTED|Fourth Treatment||1
152535|NCT00750308|353024|P11|STARTED|Fourth Treatment||1
152536|NCT00750308|353025|P10|STARTED|Fourth Treatment||2
152537|NCT00750308|353026|P9|STARTED|Fourth Treatment||1
152538|NCT00750308|353027|P8|STARTED|Fourth Treatment||2
152539|NCT00750308|353028|P7|STARTED|Fourth Treatment||2
152540|NCT00750308|353029|P6|STARTED|Fourth Treatment||2
152541|NCT00750308|353030|P5|STARTED|Fourth Treatment||1
152542|NCT00750308|353031|P4|STARTED|Fourth Treatment||1
152543|NCT00750308|353032|P3|STARTED|Fourth Treatment||2
152544|NCT00750308|353033|P2|STARTED|Fourth Treatment||1
152545|NCT00750308|353034|P1|STARTED|Fourth Treatment||2
152546|NCT00750308|353023|P12|NOT COMPLETED|Washout||0
152547|NCT00750308|353024|P11|NOT COMPLETED|Washout||0
152548|NCT00750308|353025|P10|NOT COMPLETED|Washout||0
152549|NCT00750308|353026|P9|NOT COMPLETED|Washout||0
152550|NCT00750308|353027|P8|NOT COMPLETED|Washout||0
152551|NCT00750308|353028|P7|NOT COMPLETED|Washout||0
152552|NCT00750308|353029|P6|NOT COMPLETED|Washout||0
152553|NCT00750308|353030|P5|NOT COMPLETED|Washout||0
152554|NCT00750308|353031|P4|NOT COMPLETED|Washout||0
152555|NCT00750308|353032|P3|NOT COMPLETED|Washout||0
152556|NCT00750308|353033|P2|NOT COMPLETED|Washout||0
152557|NCT00750308|353034|P1|NOT COMPLETED|Washout||0
152558|NCT00750308|353023|P12|COMPLETED|Washout||1
152559|NCT00750308|353024|P11|COMPLETED|Washout||1
152560|NCT00750308|353025|P10|COMPLETED|Washout||2
152561|NCT00750308|353026|P9|COMPLETED|Washout||1
152562|NCT00750308|353027|P8|COMPLETED|Washout||2
152563|NCT00750308|353028|P7|COMPLETED|Washout||2
152564|NCT00750308|353029|P6|COMPLETED|Washout||2
152565|NCT00750308|353030|P5|COMPLETED|Washout||1
152566|NCT00750308|353031|P4|COMPLETED|Washout||1
152567|NCT00750308|353032|P3|COMPLETED|Washout||2
152568|NCT00750308|353033|P2|COMPLETED|Washout||1
152569|NCT00750308|353034|P1|COMPLETED|Washout||2
152570|NCT00750308|353023|P12|STARTED|Washout||1
152571|NCT00750308|353024|P11|STARTED|Washout||1
152572|NCT00750308|353025|P10|STARTED|Washout||2
152573|NCT00750308|353026|P9|STARTED|Washout||1
152574|NCT00750308|353027|P8|STARTED|Washout||2
152575|NCT00750308|353028|P7|STARTED|Washout||2
152576|NCT00750308|353029|P6|STARTED|Washout||2
152577|NCT00750308|353030|P5|STARTED|Washout||1
152578|NCT00750308|353031|P4|STARTED|Washout||1
152579|NCT00750308|353032|P3|STARTED|Washout||2
152580|NCT00750308|353033|P2|STARTED|Washout||1
152581|NCT00750308|353034|P1|STARTED|Washout||2
152582|NCT00750308|353023|P12|NOT COMPLETED|Third Treatment||0
152583|NCT00750308|353024|P11|NOT COMPLETED|Third Treatment||0
152584|NCT00750308|353025|P10|NOT COMPLETED|Third Treatment||0
152585|NCT00750308|353026|P9|NOT COMPLETED|Third Treatment||0
152586|NCT00750308|353027|P8|NOT COMPLETED|Third Treatment||0
152587|NCT00750308|353028|P7|NOT COMPLETED|Third Treatment||0
152588|NCT00750308|353029|P6|NOT COMPLETED|Third Treatment||0
152589|NCT00750308|353030|P5|NOT COMPLETED|Third Treatment||0
152590|NCT00750308|353031|P4|NOT COMPLETED|Third Treatment||0
152591|NCT00750308|353032|P3|NOT COMPLETED|Third Treatment||0
152592|NCT00750308|353033|P2|NOT COMPLETED|Third Treatment||1
152593|NCT00750308|353034|P1|NOT COMPLETED|Third Treatment||0
152594|NCT00750308|353023|P12|COMPLETED|Third Treatment||1
152595|NCT00750308|353024|P11|COMPLETED|Third Treatment||1
152596|NCT00750308|353025|P10|COMPLETED|Third Treatment||2
152597|NCT00750308|353026|P9|COMPLETED|Third Treatment||1
152598|NCT00750308|353027|P8|COMPLETED|Third Treatment||2
152599|NCT00750308|353028|P7|COMPLETED|Third Treatment||2
152600|NCT00750308|353029|P6|COMPLETED|Third Treatment||2
152601|NCT00750308|353030|P5|COMPLETED|Third Treatment||1
152602|NCT00750308|353031|P4|COMPLETED|Third Treatment||1
152603|NCT00750308|353032|P3|COMPLETED|Third Treatment||2
152604|NCT00750308|353033|P2|COMPLETED|Third Treatment||1
152605|NCT00750308|353034|P1|COMPLETED|Third Treatment||2
152606|NCT00750308|353023|P12|STARTED|Third Treatment||1
152607|NCT00750308|353024|P11|STARTED|Third Treatment||1
152608|NCT00750308|353025|P10|STARTED|Third Treatment||2
152609|NCT00750308|353026|P9|STARTED|Third Treatment||1
152610|NCT00750308|353027|P8|STARTED|Third Treatment||2
152611|NCT00750308|353028|P7|STARTED|Third Treatment||2
152612|NCT00750308|353029|P6|STARTED|Third Treatment||2
152613|NCT00750308|353030|P5|STARTED|Third Treatment||1
152614|NCT00750308|353031|P4|STARTED|Third Treatment||1
152615|NCT00750308|353032|P3|STARTED|Third Treatment||2
152616|NCT00750308|353033|P2|STARTED|Third Treatment||2
152617|NCT00750308|353034|P1|STARTED|Third Treatment||2
152618|NCT00750308|353023|P12|NOT COMPLETED|Washout||0
152619|NCT00750308|353024|P11|NOT COMPLETED|Washout||0
152620|NCT00750308|353025|P10|NOT COMPLETED|Washout||0
152621|NCT00750308|353026|P9|NOT COMPLETED|Washout||0
152622|NCT00750308|353027|P8|NOT COMPLETED|Washout||0
152623|NCT00750308|353028|P7|NOT COMPLETED|Washout||0
152624|NCT00750308|353029|P6|NOT COMPLETED|Washout||0
152625|NCT00750308|353030|P5|NOT COMPLETED|Washout||0
152626|NCT00750308|353031|P4|NOT COMPLETED|Washout||0
152627|NCT00750308|353032|P3|NOT COMPLETED|Washout||0
152628|NCT00750308|353033|P2|NOT COMPLETED|Washout||0
152629|NCT00750308|353034|P1|NOT COMPLETED|Washout||0
152630|NCT00750308|353023|P12|COMPLETED|Washout||1
152631|NCT00750308|353024|P11|COMPLETED|Washout||1
152632|NCT00750308|353025|P10|COMPLETED|Washout||2
152633|NCT00750308|353026|P9|COMPLETED|Washout||1
152634|NCT00750308|353027|P8|COMPLETED|Washout||2
152635|NCT00750308|353028|P7|COMPLETED|Washout||2
152636|NCT00750308|353029|P6|COMPLETED|Washout||2
152637|NCT00750308|353030|P5|COMPLETED|Washout||1
152638|NCT00750308|353031|P4|COMPLETED|Washout||1
152639|NCT00750308|353032|P3|COMPLETED|Washout||2
152640|NCT00750308|353033|P2|COMPLETED|Washout||2
152641|NCT00750308|353034|P1|COMPLETED|Washout||2
152642|NCT00750308|353023|P12|STARTED|Washout||1
152643|NCT00750308|353024|P11|STARTED|Washout||1
152644|NCT00750308|353025|P10|STARTED|Washout||2
152645|NCT00750308|353026|P9|STARTED|Washout||1
152646|NCT00750308|353027|P8|STARTED|Washout||2
152647|NCT00750308|353028|P7|STARTED|Washout||2
152648|NCT00750308|353029|P6|STARTED|Washout||2
152649|NCT00750308|353030|P5|STARTED|Washout||1
152650|NCT00750308|353031|P4|STARTED|Washout||1
152651|NCT00750308|353032|P3|STARTED|Washout||2
152652|NCT00750308|353033|P2|STARTED|Washout||2
152653|NCT00750308|353034|P1|STARTED|Washout||2
152654|NCT00750308|353023|P12|NOT COMPLETED|Second Treatment||0
152655|NCT00750308|353024|P11|NOT COMPLETED|Second Treatment||0
152656|NCT00750308|353025|P10|NOT COMPLETED|Second Treatment||0
152657|NCT00750308|353026|P9|NOT COMPLETED|Second Treatment||1
152658|NCT00750308|353027|P8|NOT COMPLETED|Second Treatment||0
152659|NCT00750308|353028|P7|NOT COMPLETED|Second Treatment||0
152660|NCT00750308|353029|P6|NOT COMPLETED|Second Treatment||1
152661|NCT00750308|353030|P5|NOT COMPLETED|Second Treatment||1
152662|NCT00750308|353031|P4|NOT COMPLETED|Second Treatment||0
152663|NCT00750308|353032|P3|NOT COMPLETED|Second Treatment||0
152664|NCT00750308|353033|P2|NOT COMPLETED|Second Treatment||0
152665|NCT00750308|353034|P1|NOT COMPLETED|Second Treatment||0
152666|NCT00750308|353023|P12|COMPLETED|Second Treatment||1
152667|NCT00750308|353024|P11|COMPLETED|Second Treatment||1
152668|NCT00750308|353025|P10|COMPLETED|Second Treatment||2
152669|NCT00750308|353026|P9|COMPLETED|Second Treatment||1
152670|NCT00750308|353027|P8|COMPLETED|Second Treatment||2
152671|NCT00750308|353028|P7|COMPLETED|Second Treatment||2
152672|NCT00750308|353029|P6|COMPLETED|Second Treatment||2
152673|NCT00750308|353030|P5|COMPLETED|Second Treatment||1
152674|NCT00750308|353031|P4|COMPLETED|Second Treatment||1
152675|NCT00750308|353032|P3|COMPLETED|Second Treatment||2
152676|NCT00750308|353033|P2|COMPLETED|Second Treatment||2
152677|NCT00750308|353034|P1|COMPLETED|Second Treatment||2
152678|NCT00750308|353023|P12|STARTED|Second Treatment||1
152679|NCT00750308|353024|P11|STARTED|Second Treatment||1
152680|NCT00750308|353025|P10|STARTED|Second Treatment||2
152681|NCT00750308|353026|P9|STARTED|Second Treatment||2
152682|NCT00750308|353027|P8|STARTED|Second Treatment||2
152683|NCT00750308|353028|P7|STARTED|Second Treatment||2
152684|NCT00750308|353029|P6|STARTED|Second Treatment||3
152685|NCT00750308|353030|P5|STARTED|Second Treatment||2
152686|NCT00750308|353031|P4|STARTED|Second Treatment||1
152687|NCT00750308|353032|P3|STARTED|Second Treatment||2
152688|NCT00750308|353033|P2|STARTED|Second Treatment||2
152689|NCT00750308|353034|P1|STARTED|Second Treatment||2
152690|NCT00750308|353023|P12|NOT COMPLETED|Washout||0
152691|NCT00750308|353024|P11|NOT COMPLETED|Washout||0
152692|NCT00750308|353025|P10|NOT COMPLETED|Washout||0
152693|NCT00750308|353026|P9|NOT COMPLETED|Washout||0
152694|NCT00750308|353027|P8|NOT COMPLETED|Washout||0
152695|NCT00750308|353028|P7|NOT COMPLETED|Washout||0
152696|NCT00750308|353029|P6|NOT COMPLETED|Washout||0
152697|NCT00750308|353030|P5|NOT COMPLETED|Washout||0
152698|NCT00750308|353031|P4|NOT COMPLETED|Washout||0
152699|NCT00750308|353032|P3|NOT COMPLETED|Washout||0
152700|NCT00750308|353033|P2|NOT COMPLETED|Washout||0
152701|NCT00750308|353034|P1|NOT COMPLETED|Washout||0
152702|NCT00750308|353023|P12|COMPLETED|Washout||1
152703|NCT00750308|353024|P11|COMPLETED|Washout||1
152704|NCT00750308|353025|P10|COMPLETED|Washout||2
152705|NCT00750308|353026|P9|COMPLETED|Washout||2
152706|NCT00750308|353027|P8|COMPLETED|Washout||2
152707|NCT00750308|353028|P7|COMPLETED|Washout||2
152708|NCT00750308|353029|P6|COMPLETED|Washout||3
152709|NCT00750308|353030|P5|COMPLETED|Washout||2
152710|NCT00750308|353031|P4|COMPLETED|Washout||1
152711|NCT00750308|353032|P3|COMPLETED|Washout||2
152712|NCT00750308|353033|P2|COMPLETED|Washout||2
152713|NCT00750308|353034|P1|COMPLETED|Washout||2
152714|NCT00750308|353023|P12|STARTED|Washout||1
152715|NCT00750308|353024|P11|STARTED|Washout||1
152716|NCT00750308|353025|P10|STARTED|Washout||2
152717|NCT00750308|353026|P9|STARTED|Washout||2
152718|NCT00750308|353027|P8|STARTED|Washout||2
152719|NCT00750308|353028|P7|STARTED|Washout||2
152720|NCT00750308|353029|P6|STARTED|Washout||3
152721|NCT00750308|353030|P5|STARTED|Washout||2
152722|NCT00750308|353031|P4|STARTED|Washout||1
152723|NCT00750308|353032|P3|STARTED|Washout||2
152724|NCT00750308|353033|P2|STARTED|Washout||2
152725|NCT00750308|353034|P1|STARTED|Washout||2
152726|NCT00750308|353023|P12|NOT COMPLETED|First Treatment||1
152727|NCT00750308|353024|P11|NOT COMPLETED|First Treatment||1
152728|NCT00750308|353025|P10|NOT COMPLETED|First Treatment||0
152729|NCT00750308|353026|P9|NOT COMPLETED|First Treatment||0
152730|NCT00750308|353027|P8|NOT COMPLETED|First Treatment||1
152731|NCT00750308|353028|P7|NOT COMPLETED|First Treatment||0
152732|NCT00750308|353029|P6|NOT COMPLETED|First Treatment||0
152733|NCT00750308|353030|P5|NOT COMPLETED|First Treatment||0
152734|NCT00750308|353031|P4|NOT COMPLETED|First Treatment||1
152735|NCT00750308|353032|P3|NOT COMPLETED|First Treatment||0
152736|NCT00750308|353033|P2|NOT COMPLETED|First Treatment||1
152737|NCT00750308|353034|P1|NOT COMPLETED|First Treatment||0
152738|NCT00750308|353023|P12|COMPLETED|First Treatment||1
152739|NCT00750308|353024|P11|COMPLETED|First Treatment||1
152740|NCT00750308|353025|P10|COMPLETED|First Treatment||2
152741|NCT00750308|353026|P9|COMPLETED|First Treatment||2
152742|NCT00750308|353027|P8|COMPLETED|First Treatment||2
152743|NCT00750308|353028|P7|COMPLETED|First Treatment||2
152744|NCT00750308|353029|P6|COMPLETED|First Treatment||3
152745|NCT00750308|353030|P5|COMPLETED|First Treatment||2
152746|NCT00750308|353031|P4|COMPLETED|First Treatment||1
152747|NCT00750308|353032|P3|COMPLETED|First Treatment||2
152748|NCT00750308|353033|P2|COMPLETED|First Treatment||2
152749|NCT00750308|353034|P1|COMPLETED|First Treatment||2
152750|NCT00750308|353023|P12|STARTED|First Treatment||2
152751|NCT00750308|353024|P11|STARTED|First Treatment||2
152752|NCT00750308|353025|P10|STARTED|First Treatment||2
152753|NCT00750308|353026|P9|STARTED|First Treatment||2
152754|NCT00750308|353027|P8|STARTED|First Treatment||3
152755|NCT00750308|353028|P7|STARTED|First Treatment||2
152756|NCT00750308|353029|P6|STARTED|First Treatment||3
152757|NCT00750308|353030|P5|STARTED|First Treatment||2
152758|NCT00750308|353031|P4|STARTED|First Treatment||2
152759|NCT00750308|353032|P3|STARTED|First Treatment||2
152760|NCT00750308|353033|P2|STARTED|First Treatment||3
152761|NCT00750308|353034|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
152762|NCT00750282|353052|P4|NOT COMPLETED|Overall Study||1
152763|NCT00750282|353053|P3|NOT COMPLETED|Overall Study||1
152764|NCT00750282|353054|P2|NOT COMPLETED|Overall Study||1
152765|NCT00750282|353055|P1|NOT COMPLETED|Overall Study||0
152766|NCT00750282|353052|P4|COMPLETED|Overall Study||147
152767|NCT00750282|353053|P3|COMPLETED|Overall Study||125
152768|NCT00750282|353054|P2|COMPLETED|Overall Study||81
152769|NCT00750282|353055|P1|COMPLETED|Overall Study||69
152770|NCT00750282|353052|P4|STARTED|Overall Study||148
152771|NCT00750282|353053|P3|STARTED|Overall Study||126
152772|NCT00750282|353054|P2|STARTED|Overall Study||82
152773|NCT00750282|353055|P1|STARTED|Overall Study||69
152774|NCT00750191|353081|P2|NOT COMPLETED|Overall Study||10
152775|NCT00750191|353082|P1|NOT COMPLETED|Overall Study||5
152776|NCT00750191|353081|P2|COMPLETED|Overall Study||20
152777|NCT00750191|353082|P1|COMPLETED|Overall Study||22
152778|NCT00750191|353081|P2|STARTED|Overall Study||30
152779|NCT00750191|353082|P1|STARTED|Overall Study||27
152780|NCT00750152|353096|P2|NOT COMPLETED|Overall Study||27
152781|NCT00750152|353097|P1|NOT COMPLETED|Overall Study||22
152782|NCT00750152|353096|P2|COMPLETED|Overall Study||141
152783|NCT00750152|353097|P1|COMPLETED|Overall Study||144
152784|NCT00750152|353096|P2|STARTED|Overall Study||168
152785|NCT00750152|353097|P1|STARTED|Overall Study||166
152786|NCT00750139|353109|P4|NOT COMPLETED|Overall Study||46
152787|NCT00750139|353110|P3|NOT COMPLETED|Overall Study||101
152788|NCT00750139|353111|P2|NOT COMPLETED|Overall Study||59
152789|NCT00750139|353112|P1|NOT COMPLETED|Overall Study||89
152790|NCT00750139|353109|P4|COMPLETED|Overall Study||73
152791|NCT00750139|353110|P3|COMPLETED|Overall Study||135
152792|NCT00750139|353111|P2|COMPLETED|Overall Study||59
152793|NCT00750139|353112|P1|COMPLETED|Overall Study||145
152794|NCT00750139|353109|P4|STARTED|Overall Study||119
152795|NCT00750139|353110|P3|STARTED|Overall Study||236
152796|NCT00750139|353111|P2|STARTED|Overall Study||118
152797|NCT00750139|353112|P1|STARTED|Overall Study||234
152798|NCT00750061|353128|P2|NOT COMPLETED|Overall Study||2
152799|NCT00750061|353129|P1|NOT COMPLETED|Overall Study||2
152800|NCT00750061|353128|P2|COMPLETED|Overall Study||18
152801|NCT00750061|353129|P1|COMPLETED|Overall Study||18
152802|NCT00750061|353128|P2|STARTED|Overall Study||20
152803|NCT00750061|353129|P1|STARTED|Overall Study||20
152804|NCT00749996|353139|P2|NOT COMPLETED|Overall Study||13
152805|NCT00749996|353140|P1|NOT COMPLETED|Overall Study||18
152806|NCT00749996|353139|P2|COMPLETED|Overall Study||58
152807|NCT00749996|353140|P1|COMPLETED|Overall Study||57
152808|NCT00749996|353139|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
152809|NCT00749996|353140|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
152810|NCT00749996|353139|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
152811|NCT00749996|353140|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
152812|NCT00749996|353139|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
152813|NCT00749996|353140|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
152814|NCT00749996|353139|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
152815|NCT00749996|353140|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
152816|NCT00749996|353139|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
152817|NCT00749996|353140|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
152818|NCT00749996|353139|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
152819|NCT00749996|353140|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
152820|NCT00749957|353150|P2|NOT COMPLETED|Overall Study||0
152821|NCT00749957|353151|P1|NOT COMPLETED|Overall Study||0
152822|NCT00749957|353150|P2|COMPLETED|Overall Study||6
152823|NCT00749957|353151|P1|COMPLETED|Overall Study||6
152824|NCT00749957|353150|P2|STARTED|Overall Study||6
152825|NCT00749957|353151|P1|STARTED|Overall Study||6
152826|NCT00749944|353163|P2|NOT COMPLETED|Overall Study||1
152827|NCT00749944|353164|P1|NOT COMPLETED|Overall Study||5
152828|NCT00749944|353163|P2|COMPLETED|Overall Study||54
152829|NCT00749944|353164|P1|COMPLETED|Overall Study||50
152830|NCT00749944|353163|P2|STARTED|Overall Study||55
152831|NCT00749944|353164|P1|STARTED|Overall Study||55
152832|NCT00749931|353232|P3|NOT COMPLETED|Overall Study||0
152833|NCT00749931|353233|P2|NOT COMPLETED|Overall Study||0
152834|NCT00749931|353234|P1|NOT COMPLETED|Overall Study||0
152835|NCT00749931|353232|P3|COMPLETED|Overall Study||68
152836|NCT00749931|353233|P2|COMPLETED|Overall Study||298
152837|NCT00749931|353234|P1|COMPLETED|Overall Study||298
152838|NCT00749931|353232|P3|STARTED|Overall Study||68
152839|NCT00749931|353233|P2|STARTED|Overall Study||298
152840|NCT00749931|353234|P1|STARTED|Overall Study||298
152841|NCT00749775|353243|P1|NOT COMPLETED|Overall Study||107
152842|NCT00749775|353243|P1|COMPLETED|Overall Study||3210
152843|NCT00749775|353243|P1|STARTED|Overall Study||3317
152844|NCT00749684|353259|P1|NOT COMPLETED|Overall Study||82
152845|NCT00749684|353259|P1|COMPLETED|Overall Study||56
152846|NCT00749684|353259|P1|STARTED|Overall Study||138
152847|NCT00749671|353266|P2|NOT COMPLETED|Overall Study||0
152848|NCT00749671|353267|P1|NOT COMPLETED|Overall Study||0
152849|NCT00749671|353266|P2|COMPLETED|Overall Study||9
152850|NCT00749671|353267|P1|COMPLETED|Overall Study||11
152851|NCT00749671|353266|P2|STARTED|Overall Study||9
152852|NCT00749671|353267|P1|STARTED|Overall Study||11
152853|NCT00749580|353277|P2|NOT COMPLETED|Overall Study||9
152854|NCT00749580|353278|P1|NOT COMPLETED|Overall Study||4
152855|NCT00749580|353277|P2|COMPLETED|Overall Study||16
152856|NCT00749580|353278|P1|COMPLETED|Overall Study|December 2010|17
152857|NCT00749580|353277|P2|STARTED|Overall Study||25
152858|NCT00749580|353278|P1|STARTED|Overall Study|September 2008|21
152859|NCT00749476|353286|P1|NOT COMPLETED|Overall Study||0
152860|NCT00749476|353286|P1|COMPLETED|Overall Study||1
152861|NCT00749476|353286|P1|STARTED|Overall Study||1
152862|NCT00749463|353293|P3|NOT COMPLETED|Overall Study||1
152863|NCT00749463|353294|P2|NOT COMPLETED|Overall Study||4
152864|NCT00749463|353295|P1|NOT COMPLETED|Overall Study||1
152865|NCT00749463|353293|P3|COMPLETED|Overall Study||149
152866|NCT00749463|353294|P2|COMPLETED|Overall Study||60
152867|NCT00749463|353295|P1|COMPLETED|Overall Study||85
152868|NCT00749463|353293|P3|STARTED|Overall Study||150
152869|NCT00749463|353294|P2|STARTED|Overall Study||64
152870|NCT00749463|353295|P1|STARTED|Overall Study||86
152871|NCT00749398|353321|P1|NOT COMPLETED|Overall Study||53
152872|NCT00749398|353321|P1|COMPLETED|Overall Study||71
152873|NCT00749398|353321|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
152874|NCT00749268|353339|P2|NOT COMPLETED|Overall Study||36
152875|NCT00749268|353340|P1|NOT COMPLETED|Overall Study||34
152876|NCT00749268|353339|P2|COMPLETED|Overall Study||74
152877|NCT00749268|353340|P1|COMPLETED|Overall Study||72
152878|NCT00749268|353339|P2|STARTED|Overall Study||110
152879|NCT00749268|353340|P1|STARTED|Overall Study||106
152880|NCT00749190|353369|P7|NOT COMPLETED|Overall Study||1
152881|NCT00749190|353370|P6|NOT COMPLETED|Overall Study||5
152882|NCT00749190|353371|P5|NOT COMPLETED|Overall Study||0
152883|NCT00749190|353372|P4|NOT COMPLETED|Overall Study||5
152884|NCT00749190|353373|P3|NOT COMPLETED|Overall Study||1
152885|NCT00749190|353374|P2|NOT COMPLETED|Overall Study||5
152886|NCT00749190|353375|P1|NOT COMPLETED|Overall Study||5
152887|NCT00749190|353369|P7|COMPLETED|Overall Study||70
152888|NCT00749190|353370|P6|COMPLETED|Overall Study||65
152889|NCT00749190|353371|P5|COMPLETED|Overall Study||70
152890|NCT00749190|353372|P4|COMPLETED|Overall Study||66
152891|NCT00749190|353373|P3|COMPLETED|Overall Study||70
152892|NCT00749190|353374|P2|COMPLETED|Overall Study||66
152893|NCT00749190|353375|P1|COMPLETED|Overall Study||66
152894|NCT00749190|353369|P7|STARTED|Overall Study||71
152895|NCT00749190|353370|P6|STARTED|Overall Study||70
152896|NCT00749190|353371|P5|STARTED|Overall Study||70
152897|NCT00749190|353372|P4|STARTED|Overall Study||71
152898|NCT00749190|353373|P3|STARTED|Overall Study||71
152899|NCT00749190|353374|P2|STARTED|Overall Study||71
152900|NCT00749190|353375|P1|STARTED|Overall Study||71
152901|NCT00749073|353452|P1|NOT COMPLETED|Overall Study||0
152902|NCT00749073|353452|P1|COMPLETED|Overall Study||10
152903|NCT00749073|353452|P1|STARTED|Overall Study||10
152904|NCT00748982|353460|P2|NOT COMPLETED|Overall Study||0
152905|NCT00748982|353461|P1|NOT COMPLETED|Overall Study||0
152906|NCT00748982|353460|P2|COMPLETED|Overall Study||4
152907|NCT00748982|353461|P1|COMPLETED|Overall Study||12
152908|NCT00748982|353460|P2|STARTED|Overall Study||4
152909|NCT00748982|353461|P1|STARTED|Overall Study||12
152910|NCT00748969|353475|P2|NOT COMPLETED|Overall Study||0
152911|NCT00748969|353476|P1|NOT COMPLETED|Overall Study||0
152912|NCT00748969|353475|P2|COMPLETED|Overall Study||1
152913|NCT00748969|353476|P1|COMPLETED|Overall Study||1
152914|NCT00748969|353475|P2|STARTED|Overall Study||1
152915|NCT00748969|353476|P1|STARTED|Overall Study||1
152916|NCT00746512|353486|P4|NOT COMPLETED|Overall Study||0
152917|NCT00746512|353487|P3|NOT COMPLETED|Overall Study||0
152918|NCT00746512|353488|P2|NOT COMPLETED|Overall Study||0
152919|NCT00746512|353489|P1|NOT COMPLETED|Overall Study||0
152920|NCT00746512|353486|P4|COMPLETED|Overall Study||9
152921|NCT00746512|353487|P3|COMPLETED|Overall Study||18
152922|NCT00746512|353488|P2|COMPLETED|Overall Study||10
152923|NCT00746512|353489|P1|COMPLETED|Overall Study||8
152924|NCT00746512|353486|P4|STARTED|Overall Study||9
152925|NCT00746512|353487|P3|STARTED|Overall Study||18
152926|NCT00746512|353488|P2|STARTED|Overall Study||10
152927|NCT00746512|353489|P1|STARTED|Overall Study||8
152928|NCT00746421|353505|P2|NOT COMPLETED|Overall Study||2
152929|NCT00746421|353506|P1|NOT COMPLETED|Overall Study||7
152930|NCT00746421|353505|P2|COMPLETED|Overall Study||9
152931|NCT00746421|353506|P1|COMPLETED|Overall Study||5
152932|NCT00746421|353505|P2|STARTED|Overall Study||11
152933|NCT00746421|353506|P1|STARTED|Overall Study||12
152934|NCT00748865|353514|P2|NOT COMPLETED|Overall Study||0
152935|NCT00748865|353515|P1|NOT COMPLETED|Overall Study||0
152936|NCT00748865|353514|P2|COMPLETED|Overall Study||10
152937|NCT00748865|353515|P1|COMPLETED|Overall Study||10
152938|NCT00748865|353514|P2|STARTED|Overall Study||10
152939|NCT00748865|353515|P1|STARTED|Overall Study||10
152940|NCT00748826|353521|P1|NOT COMPLETED|Overall Study||301
152941|NCT00748826|353521|P1|COMPLETED|Overall Study||207
152942|NCT00748826|353521|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
152943|NCT00748709|353528|P1|NOT COMPLETED|Overall Study||20
152944|NCT00748709|353528|P1|COMPLETED|Overall Study||0
152945|NCT00748709|353528|P1|STARTED|Overall Study|Treated|20
152946|NCT00748657|353540|P1|NOT COMPLETED|Overall Study||0
152947|NCT00748657|353540|P1|COMPLETED|Overall Study||36
152948|NCT00748657|353540|P1|STARTED|Overall Study||36
152949|NCT00748579|353548|P2|NOT COMPLETED|Overall Study||0
152950|NCT00748579|353549|P1|NOT COMPLETED|Overall Study||0
152951|NCT00748579|353548|P2|COMPLETED|Overall Study||0
152952|NCT00748579|353549|P1|COMPLETED|Overall Study||2
152953|NCT00748579|353548|P2|STARTED|Overall Study||0
152954|NCT00748579|353549|P1|STARTED|Overall Study||2
152955|NCT00748566|353555|P1|NOT COMPLETED|Overall Study||112
152956|NCT00748566|353555|P1|COMPLETED|Overall Study||60
152957|NCT00748566|353555|P1|STARTED|Overall Study||172
152958|NCT00748241|353583|P1|NOT COMPLETED|Overall Study||8
152959|NCT00748241|353583|P1|COMPLETED|Overall Study||11
152960|NCT00748241|353583|P1|STARTED|Overall Study||19
152961|NCT00748189|353593|P2|NOT COMPLETED|Overall Study||221
152962|NCT00748189|353594|P1|NOT COMPLETED|Overall Study||225
152963|NCT00748189|353593|P2|COMPLETED|Overall Study||0
152964|NCT00748189|353594|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
152965|NCT00748189|353593|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
152966|NCT00748189|353594|P1|Ongoing|Overall Study||155
152967|NCT00748189|353593|P2|STARTED|Overall Study||221
152968|NCT00748189|353594|P1|STARTED|Overall Study||226
152969|NCT00748098|353648|P2|NOT COMPLETED|Second Taper Period||0
152970|NCT00748098|353649|P1|NOT COMPLETED|Second Taper Period||0
152971|NCT00748098|353648|P2|COMPLETED|Second Taper Period||61
152972|NCT00748098|353649|P1|COMPLETED|Second Taper Period||53
152973|NCT00748098|353648|P2|STARTED|Second Taper Period||61
152974|NCT00748098|353649|P1|STARTED|Second Taper Period||53
152975|NCT00748098|353648|P2|NOT COMPLETED|Second Treatment Intervention Period||3
152976|NCT00748098|353649|P1|NOT COMPLETED|Second Treatment Intervention Period||6
152977|NCT00748098|353648|P2|COMPLETED|Second Treatment Intervention Period||61
152978|NCT00748098|353649|P1|COMPLETED|Second Treatment Intervention Period||53
152979|NCT00748098|353648|P2|STARTED|Second Treatment Intervention Period||64
152980|NCT00748098|353649|P1|STARTED|Second Treatment Intervention Period||59
152981|NCT00748098|353648|P2|NOT COMPLETED|1-Week Washout Period||1
152982|NCT00748098|353649|P1|NOT COMPLETED|1-Week Washout Period||2
152983|NCT00748098|353648|P2|COMPLETED|1-Week Washout Period||64
152984|NCT00748098|353649|P1|COMPLETED|1-Week Washout Period||59
152985|NCT00748098|353648|P2|STARTED|1-Week Washout Period||65
152986|NCT00748098|353649|P1|STARTED|1-Week Washout Period||61
152987|NCT00748098|353648|P2|NOT COMPLETED|First Taper Period||1
152988|NCT00748098|353649|P1|NOT COMPLETED|First Taper Period||3
152989|NCT00748098|353648|P2|COMPLETED|First Taper Period||65
152990|NCT00748098|353649|P1|COMPLETED|First Taper Period||61
152991|NCT00748098|353648|P2|STARTED|First Taper Period||66
152992|NCT00748098|353649|P1|STARTED|First Taper Period||64
152993|NCT00748098|353648|P2|NOT COMPLETED|First Treatment Intervention Period||1
152994|NCT00748098|353649|P1|NOT COMPLETED|First Treatment Intervention Period||5
152995|NCT00748098|353648|P2|COMPLETED|First Treatment Intervention Period||66
152996|NCT00748098|353649|P1|COMPLETED|First Treatment Intervention Period||64
152997|NCT00748098|353648|P2|STARTED|First Treatment Intervention Period||67
152998|NCT00748098|353649|P1|STARTED|First Treatment Intervention Period||69
152999|NCT00748085|353709|P1|NOT COMPLETED|Overall Study||0
153000|NCT00748085|353709|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
153001|NCT00748085|353709|P1|STARTED|Overall Study||5
153002|NCT00748072|353716|P2|NOT COMPLETED|Overall Study||0
153003|NCT00748072|353717|P1|NOT COMPLETED|Overall Study||0
153004|NCT00748072|353716|P2|COMPLETED|Overall Study||80
153005|NCT00748072|353717|P1|COMPLETED|Overall Study||82
153006|NCT00748072|353716|P2|STARTED|Overall Study||80
153007|NCT00748072|353717|P1|STARTED|Overall Study||82
153008|NCT00746395|353725|P2|NOT COMPLETED|Overall Study||0
153009|NCT00746395|353726|P1|NOT COMPLETED|Overall Study||0
153010|NCT00746395|353725|P2|COMPLETED|Overall Study||20
153011|NCT00746395|353726|P1|COMPLETED|Overall Study||20
153012|NCT00746395|353725|P2|STARTED|Overall Study||20
153013|NCT00746395|353726|P1|STARTED|Overall Study||20
153014|NCT00746356|353734|P2|NOT COMPLETED|Overall Study||7
153015|NCT00746356|353735|P1|NOT COMPLETED|Overall Study||11
153016|NCT00746356|353734|P2|COMPLETED|Overall Study||40
153017|NCT00746356|353735|P1|COMPLETED|Overall Study||70
153018|NCT00746356|353734|P2|STARTED|Overall Study||47
153019|NCT00746356|353735|P1|STARTED|Overall Study||81
153020|NCT00746330|353747|P4|NOT COMPLETED|Period 4||0
153021|NCT00746330|353748|P3|NOT COMPLETED|Period 4||0
153022|NCT00746330|353749|P2|NOT COMPLETED|Period 4||0
153023|NCT00746330|353750|P1|NOT COMPLETED|Period 4||0
153024|NCT00746330|353747|P4|COMPLETED|Period 4||7
153025|NCT00746330|353748|P3|COMPLETED|Period 4||8
153026|NCT00746330|353749|P2|COMPLETED|Period 4||9
153027|NCT00746330|353750|P1|COMPLETED|Period 4||7
153028|NCT00746330|353747|P4|STARTED|Period 4||7
153029|NCT00746330|353748|P3|STARTED|Period 4||8
153030|NCT00746330|353749|P2|STARTED|Period 4||9
153031|NCT00746330|353750|P1|STARTED|Period 4||7
153032|NCT00746330|353747|P4|NOT COMPLETED|Period 3||0
153033|NCT00746330|353748|P3|NOT COMPLETED|Period 3||0
153034|NCT00746330|353749|P2|NOT COMPLETED|Period 3||0
153035|NCT00746330|353750|P1|NOT COMPLETED|Period 3||0
153036|NCT00746330|353747|P4|COMPLETED|Period 3||7
153037|NCT00746330|353748|P3|COMPLETED|Period 3||8
153038|NCT00746330|353749|P2|COMPLETED|Period 3||9
153039|NCT00746330|353750|P1|COMPLETED|Period 3||7
153040|NCT00746330|353747|P4|STARTED|Period 3||7
153041|NCT00746330|353748|P3|STARTED|Period 3||8
153042|NCT00746330|353749|P2|STARTED|Period 3||9
153043|NCT00746330|353750|P1|STARTED|Period 3||7
153044|NCT00746330|353747|P4|NOT COMPLETED|Period 2||0
153045|NCT00746330|353748|P3|NOT COMPLETED|Period 2||0
153046|NCT00746330|353749|P2|NOT COMPLETED|Period 2||0
153047|NCT00746330|353750|P1|NOT COMPLETED|Period 2||0
153048|NCT00746330|353747|P4|COMPLETED|Period 2||7
153049|NCT00746330|353748|P3|COMPLETED|Period 2||8
153050|NCT00746330|353749|P2|COMPLETED|Period 2||9
153051|NCT00746330|353750|P1|COMPLETED|Period 2||7
153052|NCT00746330|353747|P4|STARTED|Period 2||7
153053|NCT00746330|353748|P3|STARTED|Period 2||8
153054|NCT00746330|353749|P2|STARTED|Period 2||9
153055|NCT00746330|353750|P1|STARTED|Period 2||7
153056|NCT00746330|353747|P4|NOT COMPLETED|Period 1||0
153057|NCT00746330|353748|P3|NOT COMPLETED|Period 1||1
153058|NCT00746330|353749|P2|NOT COMPLETED|Period 1||0
153059|NCT00746330|353750|P1|NOT COMPLETED|Period 1||0
153060|NCT00746330|353747|P4|COMPLETED|Period 1||7
153061|NCT00746330|353748|P3|COMPLETED|Period 1||8
153062|NCT00746330|353749|P2|COMPLETED|Period 1||9
153063|NCT00746330|353750|P1|COMPLETED|Period 1||7
153064|NCT00746330|353747|P4|STARTED|Period 1||7
153065|NCT00746330|353748|P3|STARTED|Period 1||9
153066|NCT00746330|353749|P2|STARTED|Period 1||9
153067|NCT00746330|353750|P1|STARTED|Period 1||7
153068|NCT00747916|353778|P1|NOT COMPLETED|Overall Study||0
153069|NCT00747916|353778|P1|COMPLETED|Overall Study||3
153070|NCT00747916|353778|P1|STARTED|Overall Study||3
153071|NCT00747812|353785|P2|NOT COMPLETED|Overall Study||3
153072|NCT00747812|353786|P1|NOT COMPLETED|Overall Study||5
153073|NCT00747812|353785|P2|COMPLETED|Overall Study||0
153074|NCT00747812|353786|P1|COMPLETED|Overall Study||0
153075|NCT00747812|353785|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
153076|NCT00747812|353786|P1|STARTED|Overall Study||5
153077|NCT00747747|353797|P3|NOT COMPLETED|Overall Study||0
153078|NCT00747747|353798|P2|NOT COMPLETED|Overall Study||0
153079|NCT00747747|353799|P1|NOT COMPLETED|Overall Study||0
153080|NCT00747747|353797|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
153081|NCT00747747|353798|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
153082|NCT00747747|353799|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
153083|NCT00747747|353797|P3|STARTED|Overall Study||21
153084|NCT00747747|353798|P2|STARTED|Overall Study||14
153085|NCT00747747|353799|P1|STARTED|Overall Study||14
153086|NCT00747643|353824|P2|NOT COMPLETED|Overall Study||27
153087|NCT00747643|353825|P1|NOT COMPLETED|Overall Study||36
153088|NCT00747643|353824|P2|COMPLETED|Overall Study||54
153089|NCT00747643|353825|P1|COMPLETED|Overall Study||46
153090|NCT00747643|353824|P2|STARTED|Overall Study||81
153091|NCT00747643|353825|P1|STARTED|Overall Study||82
153092|NCT00747617|353839|P2|NOT COMPLETED|Overall Study||1
153093|NCT00747617|353840|P1|NOT COMPLETED|Overall Study||3
153094|NCT00747617|353839|P2|COMPLETED|Overall Study||11
153095|NCT00747617|353840|P1|COMPLETED|Overall Study||10
153096|NCT00747617|353839|P2|STARTED|Overall Study||12
153097|NCT00747617|353840|P1|STARTED|Overall Study||13
153098|NCT00747565|353848|P2|NOT COMPLETED|Overall Study||7
153099|NCT00747565|353849|P1|NOT COMPLETED|Overall Study||14
153100|NCT00747565|353848|P2|COMPLETED|Overall Study||116
153101|NCT00747565|353849|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
153102|NCT00747565|353848|P2|STARTED|Overall Study||123
153103|NCT00747565|353849|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
153104|NCT00747552|353857|P1|NOT COMPLETED|Overall Study||0
153105|NCT00747552|353857|P1|COMPLETED|Overall Study||30
153106|NCT00747552|353857|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
153107|NCT00747474|353862|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153108|NCT00747474|353863|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153109|NCT00747474|353864|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153110|NCT00747474|353865|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153111|NCT00747474|353866|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153112|NCT00747474|353867|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153113|NCT00747474|353868|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153114|NCT00747474|353869|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153115|NCT00747474|353870|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153116|NCT00747474|353871|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153117|NCT00747474|353872|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153118|NCT00747474|353873|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153119|NCT00747474|353862|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
153120|NCT00747474|353863|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153121|NCT00747474|353864|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153122|NCT00747474|353865|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153123|NCT00747474|353866|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153124|NCT00747474|353867|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153125|NCT00747474|353868|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153126|NCT00747474|353869|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153127|NCT00747474|353870|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153128|NCT00747474|353871|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153129|NCT00747474|353872|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153130|NCT00747474|353873|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
153131|NCT00747474|353862|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
153132|NCT00747474|353863|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
153133|NCT00747474|353864|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
153134|NCT00747474|353865|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
153135|NCT00747474|353866|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
153136|NCT00747474|353867|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
153137|NCT00747474|353868|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
153138|NCT00747474|353869|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
153139|NCT00747474|353870|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
153140|NCT00747474|353871|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
153141|NCT00747474|353872|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
153142|NCT00747474|353873|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
153143|NCT00747474|353862|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153144|NCT00747474|353863|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153145|NCT00747474|353864|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153146|NCT00747474|353865|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153147|NCT00747474|353866|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153148|NCT00747474|353867|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153149|NCT00747474|353868|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153150|NCT00747474|353869|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153151|NCT00747474|353870|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153152|NCT00747474|353871|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153153|NCT00747474|353872|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153154|NCT00747474|353873|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153155|NCT00747474|353862|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153156|NCT00747474|353863|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
153157|NCT00747474|353864|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153158|NCT00747474|353865|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153159|NCT00747474|353866|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153160|NCT00747474|353867|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153161|NCT00747474|353868|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153162|NCT00747474|353869|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153163|NCT00747474|353870|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153164|NCT00747474|353871|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153165|NCT00747474|353872|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153166|NCT00747474|353873|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
153167|NCT00747474|353862|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
153168|NCT00747474|353863|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
153169|NCT00747474|353864|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
153170|NCT00747474|353865|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
153171|NCT00747474|353866|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
153172|NCT00747474|353867|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
153173|NCT00747474|353868|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
153174|NCT00747474|353869|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
153175|NCT00747474|353870|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
153176|NCT00747474|353871|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
153177|NCT00747474|353872|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
153178|NCT00747474|353873|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
153179|NCT00747474|353862|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153180|NCT00747474|353863|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153181|NCT00747474|353864|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153182|NCT00747474|353865|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153183|NCT00747474|353866|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153184|NCT00747474|353867|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153185|NCT00747474|353868|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153186|NCT00747474|353869|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153187|NCT00747474|353870|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153188|NCT00747474|353871|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153189|NCT00747474|353872|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153190|NCT00747474|353873|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153191|NCT00747474|353862|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153192|NCT00747474|353863|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153193|NCT00747474|353864|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
153194|NCT00747474|353865|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153195|NCT00747474|353866|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153196|NCT00747474|353867|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153197|NCT00747474|353868|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153198|NCT00747474|353869|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153199|NCT00747474|353870|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153200|NCT00747474|353871|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153201|NCT00747474|353872|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153202|NCT00747474|353873|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
153203|NCT00747474|353862|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
153204|NCT00747474|353863|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
153205|NCT00747474|353864|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
153206|NCT00747474|353865|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
153207|NCT00747474|353866|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
153208|NCT00747474|353867|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
153209|NCT00747474|353868|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
153210|NCT00747474|353869|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
153211|NCT00747474|353870|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
153212|NCT00747474|353871|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
153213|NCT00747474|353872|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
153214|NCT00747474|353873|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
153215|NCT00747474|353862|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153216|NCT00747474|353863|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153217|NCT00747474|353864|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153218|NCT00747474|353865|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153219|NCT00747474|353866|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153220|NCT00747474|353867|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153221|NCT00747474|353868|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153222|NCT00747474|353869|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153223|NCT00747474|353870|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153224|NCT00747474|353871|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153225|NCT00747474|353872|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153226|NCT00747474|353873|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153227|NCT00747474|353862|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153228|NCT00747474|353863|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153229|NCT00747474|353864|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153230|NCT00747474|353865|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
153231|NCT00747474|353866|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153232|NCT00747474|353867|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153233|NCT00747474|353868|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153234|NCT00747474|353869|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153235|NCT00747474|353870|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153236|NCT00747474|353871|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153237|NCT00747474|353872|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153238|NCT00747474|353873|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
153239|NCT00747474|353862|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
153240|NCT00747474|353863|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
153241|NCT00747474|353864|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
153242|NCT00747474|353865|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
153243|NCT00747474|353866|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
153244|NCT00747474|353867|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
153245|NCT00747474|353868|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
153246|NCT00747474|353869|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
153247|NCT00747474|353870|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
153248|NCT00747474|353871|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
153249|NCT00747474|353872|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
153250|NCT00747474|353873|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
153251|NCT00747474|353862|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153252|NCT00747474|353863|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153253|NCT00747474|353864|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153254|NCT00747474|353865|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153255|NCT00747474|353866|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
153256|NCT00747474|353867|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153257|NCT00747474|353868|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153258|NCT00747474|353869|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153259|NCT00747474|353870|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153260|NCT00747474|353871|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153261|NCT00747474|353872|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153262|NCT00747474|353873|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153263|NCT00747474|353862|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153264|NCT00747474|353863|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153265|NCT00747474|353864|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153266|NCT00747474|353865|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153267|NCT00747474|353866|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
153268|NCT00747474|353867|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153269|NCT00747474|353868|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153270|NCT00747474|353869|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153271|NCT00747474|353870|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153272|NCT00747474|353871|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153273|NCT00747474|353872|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153274|NCT00747474|353873|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
153275|NCT00747474|353862|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
153276|NCT00747474|353863|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
153277|NCT00747474|353864|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
153278|NCT00747474|353865|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
153279|NCT00747474|353866|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
153280|NCT00747474|353867|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
153281|NCT00747474|353868|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
153282|NCT00747474|353869|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
153283|NCT00747474|353870|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
153284|NCT00747474|353871|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
153285|NCT00747474|353872|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
153286|NCT00747474|353873|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
153287|NCT00747474|353862|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153288|NCT00747474|353863|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153289|NCT00747474|353864|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153290|NCT00747474|353865|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153291|NCT00747474|353866|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153292|NCT00747474|353867|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153293|NCT00747474|353868|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153294|NCT00747474|353869|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153295|NCT00747474|353870|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153296|NCT00747474|353871|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153297|NCT00747474|353872|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153298|NCT00747474|353873|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153299|NCT00747474|353862|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153300|NCT00747474|353863|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153301|NCT00747474|353864|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153302|NCT00747474|353865|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153303|NCT00747474|353866|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153304|NCT00747474|353867|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
153305|NCT00747474|353868|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153306|NCT00747474|353869|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153307|NCT00747474|353870|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153308|NCT00747474|353871|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153309|NCT00747474|353872|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153310|NCT00747474|353873|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
153311|NCT00747474|353862|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
153312|NCT00747474|353863|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
153313|NCT00747474|353864|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
153314|NCT00747474|353865|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
153315|NCT00747474|353866|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
153316|NCT00747474|353867|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
153317|NCT00747474|353868|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
153318|NCT00747474|353869|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
153319|NCT00747474|353870|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
153320|NCT00747474|353871|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
153321|NCT00747474|353872|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
153322|NCT00747474|353873|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
153323|NCT00747474|353862|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153324|NCT00747474|353863|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153325|NCT00747474|353864|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153326|NCT00747474|353865|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153327|NCT00747474|353866|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153328|NCT00747474|353867|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153329|NCT00747474|353868|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153330|NCT00747474|353869|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153331|NCT00747474|353870|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153332|NCT00747474|353871|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153333|NCT00747474|353872|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153334|NCT00747474|353873|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153335|NCT00747474|353862|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153336|NCT00747474|353863|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153337|NCT00747474|353864|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153338|NCT00747474|353865|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153339|NCT00747474|353866|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153340|NCT00747474|353867|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153341|NCT00747474|353868|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
153342|NCT00747474|353869|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153343|NCT00747474|353870|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153344|NCT00747474|353871|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153345|NCT00747474|353872|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153346|NCT00747474|353873|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
153347|NCT00747474|353862|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
153348|NCT00747474|353863|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
153349|NCT00747474|353864|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
153350|NCT00747474|353865|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
153351|NCT00747474|353866|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
153352|NCT00747474|353867|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
153353|NCT00747474|353868|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
153354|NCT00747474|353869|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
153355|NCT00747474|353870|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
153356|NCT00747474|353871|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
153357|NCT00747474|353872|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
153358|NCT00747474|353873|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
153359|NCT00747474|353862|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153360|NCT00747474|353863|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153361|NCT00747474|353864|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153362|NCT00747474|353865|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153363|NCT00747474|353866|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153364|NCT00747474|353867|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153365|NCT00747474|353868|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153366|NCT00747474|353869|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153367|NCT00747474|353870|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153368|NCT00747474|353871|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153369|NCT00747474|353872|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153370|NCT00747474|353873|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153371|NCT00747474|353862|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153372|NCT00747474|353863|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153373|NCT00747474|353864|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153374|NCT00747474|353865|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153375|NCT00747474|353866|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153376|NCT00747474|353867|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153377|NCT00747474|353868|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153378|NCT00747474|353869|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
153379|NCT00747474|353870|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153380|NCT00747474|353871|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153381|NCT00747474|353872|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153382|NCT00747474|353873|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
153383|NCT00747474|353862|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153384|NCT00747474|353863|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153385|NCT00747474|353864|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153386|NCT00747474|353865|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153387|NCT00747474|353866|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153388|NCT00747474|353867|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153389|NCT00747474|353868|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153390|NCT00747474|353869|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
153391|NCT00747474|353870|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153392|NCT00747474|353871|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153393|NCT00747474|353872|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153394|NCT00747474|353873|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
153395|NCT00747474|353862|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153396|NCT00747474|353863|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153397|NCT00747474|353864|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153398|NCT00747474|353865|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153399|NCT00747474|353866|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153400|NCT00747474|353867|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153401|NCT00747474|353868|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153402|NCT00747474|353869|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153403|NCT00747474|353870|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153404|NCT00747474|353871|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153405|NCT00747474|353872|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153406|NCT00747474|353873|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153407|NCT00747474|353862|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153408|NCT00747474|353863|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153409|NCT00747474|353864|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153410|NCT00747474|353865|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153411|NCT00747474|353866|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153412|NCT00747474|353867|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153413|NCT00747474|353868|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153414|NCT00747474|353869|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153415|NCT00747474|353870|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
153416|NCT00747474|353871|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153417|NCT00747474|353872|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153418|NCT00747474|353873|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
153419|NCT00747474|353862|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
153420|NCT00747474|353863|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
153421|NCT00747474|353864|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
153422|NCT00747474|353865|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
153423|NCT00747474|353866|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
153424|NCT00747474|353867|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
153425|NCT00747474|353868|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
153426|NCT00747474|353869|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
153427|NCT00747474|353870|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
153428|NCT00747474|353871|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
153429|NCT00747474|353872|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
153430|NCT00747474|353873|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
153431|NCT00747474|353862|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153432|NCT00747474|353863|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153433|NCT00747474|353864|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153434|NCT00747474|353865|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153435|NCT00747474|353866|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153436|NCT00747474|353867|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153437|NCT00747474|353868|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153438|NCT00747474|353869|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153439|NCT00747474|353870|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153440|NCT00747474|353871|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153441|NCT00747474|353872|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153442|NCT00747474|353873|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153443|NCT00747474|353862|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153444|NCT00747474|353863|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153445|NCT00747474|353864|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153446|NCT00747474|353865|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153447|NCT00747474|353866|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153448|NCT00747474|353867|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153449|NCT00747474|353868|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153450|NCT00747474|353869|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153451|NCT00747474|353870|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153452|NCT00747474|353871|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
153453|NCT00747474|353872|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153454|NCT00747474|353873|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
153455|NCT00747474|353862|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
153456|NCT00747474|353863|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
153457|NCT00747474|353864|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
153458|NCT00747474|353865|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
153459|NCT00747474|353866|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
153460|NCT00747474|353867|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
153461|NCT00747474|353868|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
153462|NCT00747474|353869|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
153463|NCT00747474|353870|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
153464|NCT00747474|353871|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
153465|NCT00747474|353872|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
153466|NCT00747474|353873|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
153467|NCT00747474|353862|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153468|NCT00747474|353863|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153469|NCT00747474|353864|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153470|NCT00747474|353865|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153471|NCT00747474|353866|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153472|NCT00747474|353867|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153473|NCT00747474|353868|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153474|NCT00747474|353869|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153475|NCT00747474|353870|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153476|NCT00747474|353871|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153477|NCT00747474|353872|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153478|NCT00747474|353873|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153479|NCT00747474|353862|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153480|NCT00747474|353863|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153481|NCT00747474|353864|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153482|NCT00747474|353865|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153483|NCT00747474|353866|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153484|NCT00747474|353867|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153485|NCT00747474|353868|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153486|NCT00747474|353869|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153487|NCT00747474|353870|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153488|NCT00747474|353871|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153489|NCT00747474|353872|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
153490|NCT00747474|353873|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
153491|NCT00747474|353862|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
153492|NCT00747474|353863|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
153493|NCT00747474|353864|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
153494|NCT00747474|353865|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
153495|NCT00747474|353866|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
153496|NCT00747474|353867|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
153497|NCT00747474|353868|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
153498|NCT00747474|353869|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
153499|NCT00747474|353870|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
153500|NCT00747474|353871|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
153501|NCT00747474|353872|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
153502|NCT00747474|353873|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
153503|NCT00747474|353862|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153504|NCT00747474|353863|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153505|NCT00747474|353864|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153506|NCT00747474|353865|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153507|NCT00747474|353866|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153508|NCT00747474|353867|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153509|NCT00747474|353868|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153510|NCT00747474|353869|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153511|NCT00747474|353870|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153512|NCT00747474|353871|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153513|NCT00747474|353872|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153514|NCT00747474|353873|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153515|NCT00747474|353862|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153516|NCT00747474|353863|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153517|NCT00747474|353864|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153518|NCT00747474|353865|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153519|NCT00747474|353866|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153520|NCT00747474|353867|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153521|NCT00747474|353868|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153522|NCT00747474|353869|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153523|NCT00747474|353870|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153524|NCT00747474|353871|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153525|NCT00747474|353872|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
153526|NCT00747474|353873|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
153527|NCT00747474|353862|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153528|NCT00747474|353863|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153529|NCT00747474|353864|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153530|NCT00747474|353865|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153531|NCT00747474|353866|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153532|NCT00747474|353867|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153533|NCT00747474|353868|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153534|NCT00747474|353869|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153535|NCT00747474|353870|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153536|NCT00747474|353871|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153537|NCT00747474|353872|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
153538|NCT00747474|353873|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
153539|NCT00747461|353899|P1|NOT COMPLETED|Overall Study||5
153540|NCT00747461|353899|P1|COMPLETED|Overall Study||0
153541|NCT00747461|353899|P1|STARTED|Overall Study||5
153542|NCT00747344|353906|P4|NOT COMPLETED|After Controlled Period||1
153543|NCT00747344|353907|P3|NOT COMPLETED|After Controlled Period||0
153544|NCT00747344|353908|P2|NOT COMPLETED|After Controlled Period||0
153545|NCT00747344|353909|P1|NOT COMPLETED|After Controlled Period||0
153546|NCT00747344|353906|P4|COMPLETED|After Controlled Period||56
153547|NCT00747344|353907|P3|COMPLETED|After Controlled Period||55
153548|NCT00747344|353908|P2|COMPLETED|After Controlled Period||0
153549|NCT00747344|353909|P1|COMPLETED|After Controlled Period||0
153550|NCT00747344|353906|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
153551|NCT00747344|353907|P3|STARTED|After Controlled Period||55
153552|NCT00747344|353908|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
153553|NCT00747344|353909|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
153554|NCT00747344|353906|P4|NOT COMPLETED|Controlled Period||0
153555|NCT00747344|353907|P3|NOT COMPLETED|Controlled Period||0
153556|NCT00747344|353908|P2|NOT COMPLETED|Controlled Period||4
153557|NCT00747344|353909|P1|NOT COMPLETED|Controlled Period||5
153558|NCT00747344|353906|P4|COMPLETED|Controlled Period||0
153559|NCT00747344|353907|P3|COMPLETED|Controlled Period||0
153560|NCT00747344|353908|P2|COMPLETED|Controlled Period||57
153561|NCT00747344|353909|P1|COMPLETED|Controlled Period||55
153562|NCT00747344|353906|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
153563|NCT00747344|353907|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
153564|NCT00747344|353908|P2|STARTED|Controlled Period||61
153565|NCT00747344|353909|P1|STARTED|Controlled Period||60
153566|NCT00746239|353921|P1|NOT COMPLETED|Overall Study||6
153567|NCT00746239|353921|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
153568|NCT00746239|353921|P1|STARTED|Overall Study||11
153569|NCT00747227|353927|P2|NOT COMPLETED|Overall Study||4
153570|NCT00747227|353928|P1|NOT COMPLETED|Overall Study||6
153571|NCT00747227|353927|P2|COMPLETED|Overall Study||120
153572|NCT00747227|353928|P1|COMPLETED|Overall Study||120
153573|NCT00747227|353927|P2|STARTED|Overall Study||124
153574|NCT00747227|353928|P1|STARTED|Overall Study||126
153575|NCT00747214|353942|P2|NOT COMPLETED|Overall Study||3
153576|NCT00747214|353943|P1|NOT COMPLETED|Overall Study||8
153577|NCT00747214|353942|P2|COMPLETED|Overall Study||29
153578|NCT00747214|353943|P1|COMPLETED|Overall Study||19
153579|NCT00747214|353942|P2|STARTED|Overall Study||32
153580|NCT00747214|353943|P1|STARTED|Overall Study||27
153581|NCT00747149|353957|P2|NOT COMPLETED|Overall Study||43
153582|NCT00747149|353958|P1|NOT COMPLETED|Overall Study||1
153583|NCT00747149|353957|P2|COMPLETED|Overall Study||401
153584|NCT00747149|353958|P1|COMPLETED|Overall Study||153
153585|NCT00747149|353957|P2|STARTED|Overall Study||444
153586|NCT00747149|353958|P1|STARTED|Overall Study||154
153587|NCT00747006|353973|P3|NOT COMPLETED|Overall Study||1
153588|NCT00747006|353974|P2|NOT COMPLETED|Overall Study||1
153589|NCT00747006|353975|P1|NOT COMPLETED|Overall Study||3
153590|NCT00747006|353973|P3|COMPLETED|Overall Study||2
153591|NCT00747006|353974|P2|COMPLETED|Overall Study||7
153592|NCT00747006|353975|P1|COMPLETED|Overall Study||4
153593|NCT00747006|353973|P3|STARTED|Overall Study||3
153594|NCT00747006|353974|P2|STARTED|Overall Study||8
153595|NCT00747006|353975|P1|STARTED|Overall Study||7
153596|NCT00746954|354041|P3|NOT COMPLETED|Overall Study||0
153597|NCT00746954|354042|P2|NOT COMPLETED|Overall Study||0
153598|NCT00746954|354043|P1|NOT COMPLETED|Overall Study||0
153599|NCT00746954|354041|P3|COMPLETED|Overall Study||2
153600|NCT00746954|354042|P2|COMPLETED|Overall Study||3
153601|NCT00746954|354043|P1|COMPLETED|Overall Study||3
153602|NCT00746954|354041|P3|STARTED|Overall Study||2
153603|NCT00746954|354042|P2|STARTED|Overall Study||3
153604|NCT00746954|354043|P1|STARTED|Overall Study||3
153605|NCT00746941|354053|P4|NOT COMPLETED|Overall Study||13
153606|NCT00746941|354054|P3|NOT COMPLETED|Overall Study||2
153607|NCT00746941|354055|P2|NOT COMPLETED|Overall Study||4
153608|NCT00746941|354056|P1|NOT COMPLETED|Overall Study||7
153609|NCT00746941|354053|P4|COMPLETED|Overall Study||7
153610|NCT00746941|354054|P3|COMPLETED|Overall Study||3
153611|NCT00746941|354055|P2|COMPLETED|Overall Study||1
153612|NCT00746941|354056|P1|COMPLETED|Overall Study||0
153613|NCT00746941|354053|P4|STARTED|Overall Study||20
153614|NCT00746941|354054|P3|STARTED|Overall Study||5
153615|NCT00746941|354055|P2|STARTED|Overall Study||5
153616|NCT00746941|354056|P1|STARTED|Overall Study||7
153617|NCT00746889|354084|P2|NOT COMPLETED|Overall Study||4
153618|NCT00746889|354085|P1|NOT COMPLETED|Overall Study||4
153619|NCT00746889|354084|P2|COMPLETED|Overall Study||35
153620|NCT00746889|354085|P1|COMPLETED|Overall Study||36
153621|NCT00746889|354084|P2|STARTED|Overall Study||39
153622|NCT00746889|354085|P1|STARTED|Overall Study||40
153623|NCT00746863|354095|P2|NOT COMPLETED|Overall Study||0
153624|NCT00746863|354096|P1|NOT COMPLETED|Overall Study||0
153625|NCT00746863|354095|P2|COMPLETED|Overall Study||21
153626|NCT00746863|354096|P1|COMPLETED|Overall Study||21
153627|NCT00746863|354095|P2|STARTED|Overall Study||21
153628|NCT00746863|354096|P1|STARTED|Overall Study||21
153629|NCT00746798|354114|P4|NOT COMPLETED|Overall Study||0
153630|NCT00746798|354115|P3|NOT COMPLETED|Overall Study||3
153631|NCT00746798|354116|P2|NOT COMPLETED|Overall Study||2
153632|NCT00746798|354117|P1|NOT COMPLETED|Overall Study||1
153633|NCT00746798|354114|P4|COMPLETED|Overall Study||120
153634|NCT00746798|354115|P3|COMPLETED|Overall Study||110
153635|NCT00746798|354116|P2|COMPLETED|Overall Study||122
153636|NCT00746798|354117|P1|COMPLETED|Overall Study||121
153637|NCT00746798|354114|P4|STARTED|Overall Study||120
153638|NCT00746798|354115|P3|STARTED|Overall Study||113
153639|NCT00746798|354116|P2|STARTED|Overall Study||124
153640|NCT00746798|354117|P1|STARTED|Overall Study||122
153641|NCT00746785|354142|P3|NOT COMPLETED|Overall Study||27
153642|NCT00746785|354143|P2|NOT COMPLETED|Overall Study||25
153643|NCT00746785|354144|P1|NOT COMPLETED|Overall Study||29
153644|NCT00746785|354142|P3|COMPLETED|Overall Study||13
153645|NCT00746785|354143|P2|COMPLETED|Overall Study||21
153646|NCT00746785|354144|P1|COMPLETED|Overall Study||14
153647|NCT00746785|354142|P3|STARTED|Overall Study||40
153648|NCT00746785|354143|P2|STARTED|Overall Study||46
153649|NCT00746785|354144|P1|STARTED|Overall Study||43
153650|NCT00746733|354152|P2|NOT COMPLETED|Fourth Intervention||0
153651|NCT00746733|354153|P1|NOT COMPLETED|Fourth Intervention||0
153652|NCT00746733|354152|P2|COMPLETED|Fourth Intervention||11
153653|NCT00746733|354153|P1|COMPLETED|Fourth Intervention||10
153654|NCT00746733|354152|P2|STARTED|Fourth Intervention||11
153655|NCT00746733|354153|P1|STARTED|Fourth Intervention||10
153656|NCT00746733|354152|P2|NOT COMPLETED|Third Intervention||1
153657|NCT00746733|354153|P1|NOT COMPLETED|Third Intervention||1
153658|NCT00746733|354152|P2|COMPLETED|Third Intervention||11
153659|NCT00746733|354153|P1|COMPLETED|Third Intervention||10
153660|NCT00746733|354152|P2|STARTED|Third Intervention||12
153661|NCT00746733|354153|P1|STARTED|Third Intervention||11
153662|NCT00746733|354152|P2|NOT COMPLETED|Second Intervention||0
153663|NCT00746733|354153|P1|NOT COMPLETED|Second Intervention||1
153664|NCT00746733|354152|P2|COMPLETED|Second Intervention||12
153665|NCT00746733|354153|P1|COMPLETED|Second Intervention||11
153666|NCT00746733|354152|P2|STARTED|Second Intervention||12
153667|NCT00746733|354153|P1|STARTED|Second Intervention||12
153668|NCT00746733|354152|P2|NOT COMPLETED|First Intervention||0
153669|NCT00746733|354153|P1|NOT COMPLETED|First Intervention||0
153670|NCT00746733|354152|P2|COMPLETED|First Intervention||12
153671|NCT00746733|354153|P1|COMPLETED|First Intervention||12
153672|NCT00746733|354152|P2|STARTED|First Intervention||12
153673|NCT00746733|354153|P1|STARTED|First Intervention||12
153674|NCT00746694|354213|P1|NOT COMPLETED|Overall Study||0
153675|NCT00746694|354213|P1|COMPLETED|Overall Study||154
153676|NCT00746694|354213|P1|STARTED|Overall Study||154
153677|NCT00746668|354218|P7|NOT COMPLETED|Overall Study||0
153678|NCT00746668|354219|P6|NOT COMPLETED|Overall Study||0
153679|NCT00746668|354220|P5|NOT COMPLETED|Overall Study||0
153680|NCT00746668|354221|P4|NOT COMPLETED|Overall Study||0
153681|NCT00746668|354222|P3|NOT COMPLETED|Overall Study||0
153682|NCT00746668|354223|P2|NOT COMPLETED|Overall Study||0
153683|NCT00746668|354224|P1|NOT COMPLETED|Overall Study||0
153684|NCT00746668|354218|P7|COMPLETED|Overall Study||5
153685|NCT00746668|354219|P6|COMPLETED|Overall Study||5
153686|NCT00746668|354220|P5|COMPLETED|Overall Study||5
153687|NCT00746668|354221|P4|COMPLETED|Overall Study||5
153688|NCT00746668|354222|P3|COMPLETED|Overall Study||5
153689|NCT00746668|354223|P2|COMPLETED|Overall Study||5
153690|NCT00746668|354224|P1|COMPLETED|Overall Study||6
153691|NCT00746668|354218|P7|STARTED|Overall Study||5
153692|NCT00746668|354219|P6|STARTED|Overall Study||5
153693|NCT00746668|354220|P5|STARTED|Overall Study||5
153694|NCT00746668|354221|P4|STARTED|Overall Study||5
153695|NCT00746668|354222|P3|STARTED|Overall Study||5
153696|NCT00746668|354223|P2|STARTED|Overall Study||5
153697|NCT00746668|354224|P1|STARTED|Overall Study||6
153698|NCT00746590|354237|P1|NOT COMPLETED|Overall Study||1
153699|NCT00746590|354237|P1|COMPLETED|Overall Study||0
153700|NCT00746590|354237|P1|STARTED|Overall Study||1
153701|NCT00746564|354241|P1|NOT COMPLETED|Overall Study||2
153702|NCT00746564|354241|P1|COMPLETED|Overall Study||73
153703|NCT00746564|354241|P1|STARTED|Overall Study||75
153704|NCT00746551|354256|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
153705|NCT00746551|354257|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
153706|NCT00746551|354256|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
153707|NCT00746551|354257|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
153708|NCT00746551|354256|P2|STARTED|At Delivery (GA of 39 Weeks)||40
153709|NCT00746551|354257|P1|STARTED|At Delivery (GA of 39 Weeks)||40
153710|NCT00746551|354256|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
153711|NCT00746551|354257|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
153712|NCT00746551|354256|P2|COMPLETED|At Gestational Age of 36 Weeks||36
153713|NCT00746551|354257|P1|COMPLETED|At Gestational Age of 36 Weeks||38
153714|NCT00746551|354256|P2|STARTED|At Gestational Age of 36 Weeks||40
153715|NCT00746551|354257|P1|STARTED|At Gestational Age of 36 Weeks||40
153716|NCT00746187|354267|P2|NOT COMPLETED|Overall Study||2
153717|NCT00746187|354268|P1|NOT COMPLETED|Overall Study||3
153718|NCT00746187|354267|P2|COMPLETED|Overall Study||16
153719|NCT00746187|354268|P1|COMPLETED|Overall Study||15
153720|NCT00746187|354267|P2|STARTED|Overall Study||18
153721|NCT00746187|354268|P1|STARTED|Overall Study||18
153722|NCT00746096|354276|P2|NOT COMPLETED|Overall Study||3
153723|NCT00746096|354277|P1|NOT COMPLETED|Overall Study||10
153724|NCT00746096|354276|P2|COMPLETED|Overall Study||54
153725|NCT00746096|354277|P1|COMPLETED|Overall Study||48
153726|NCT00746096|354276|P2|STARTED|Overall Study||57
153727|NCT00746096|354277|P1|STARTED|Overall Study||58
153728|NCT00745940|354287|P2|NOT COMPLETED|Overall Study||10
153729|NCT00745940|354288|P1|NOT COMPLETED|Overall Study||19
153730|NCT00745940|354287|P2|COMPLETED|Overall Study||38
153731|NCT00745940|354288|P1|COMPLETED|Overall Study||38
153732|NCT00745940|354287|P2|STARTED|Overall Study||48
153733|NCT00745940|354288|P1|STARTED|Overall Study||57
153734|NCT00745901|354304|P2|NOT COMPLETED|Overall Study||21
153735|NCT00745901|354305|P1|NOT COMPLETED|Overall Study||24
153736|NCT00745901|354304|P2|COMPLETED|Overall Study||156
153737|NCT00745901|354305|P1|COMPLETED|Overall Study||154
153738|NCT00745901|354304|P2|STARTED|Overall Study|Number of Patients Randomized|177
153739|NCT00745901|354305|P1|STARTED|Overall Study|Number of Patients Randomized|178
153740|NCT00745875|354351|P2|NOT COMPLETED|Overall Study||4
153741|NCT00745875|354352|P1|NOT COMPLETED|Overall Study||4
153742|NCT00745875|354351|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
153743|NCT00745875|354352|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
153744|NCT00745875|354351|P2|STARTED|Overall Study|Started – Number of patients randomised|30
153745|NCT00745875|354352|P1|STARTED|Overall Study|Started – Number of patients randomised|36
153746|NCT00745823|354362|P2|NOT COMPLETED|Overall Study||386
153747|NCT00745823|354363|P1|NOT COMPLETED|Overall Study||385
153748|NCT00745823|354362|P2|COMPLETED|Overall Study||3
153749|NCT00745823|354363|P1|COMPLETED|Overall Study||1
153750|NCT00745823|354362|P2|TREATED Week 0 - 96|Overall Study||388
153751|NCT00745823|354363|P1|TREATED Week 0 - 96|Overall Study||382
153752|NCT00745823|354362|P2|STARTED|Overall Study||389
153753|NCT00745823|354363|P1|STARTED|Overall Study||386
153754|NCT00745498|354390|P3|NOT COMPLETED|Overall Study||8
153755|NCT00745498|354391|P2|NOT COMPLETED|Overall Study||6
153756|NCT00745498|354392|P1|NOT COMPLETED|Overall Study||5
153757|NCT00745498|354390|P3|COMPLETED|Overall Study||34
153758|NCT00745498|354391|P2|COMPLETED|Overall Study||37
153759|NCT00745498|354392|P1|COMPLETED|Overall Study||36
153760|NCT00745498|354390|P3|STARTED|Overall Study||42
153761|NCT00745498|354391|P2|STARTED|Overall Study||43
153762|NCT00745498|354392|P1|STARTED|Overall Study||41
153763|NCT00744380|354408|P2|NOT COMPLETED|Overall Study||0
153764|NCT00744380|354409|P1|NOT COMPLETED|Overall Study||0
153765|NCT00744380|354408|P2|COMPLETED|Overall Study||11
153766|NCT00744380|354409|P1|COMPLETED|Overall Study||12
153767|NCT00744380|354408|P2|STARTED|Overall Study||11
153768|NCT00744380|354409|P1|STARTED|Overall Study||12
153769|NCT00744328|354432|P3|NOT COMPLETED|Overall Study||8
153770|NCT00744328|354433|P2|NOT COMPLETED|Overall Study||8
153771|NCT00744328|354434|P1|NOT COMPLETED|Overall Study||7
153772|NCT00744328|354432|P3|COMPLETED|Overall Study||21
153773|NCT00744328|354433|P2|COMPLETED|Overall Study||22
153774|NCT00744328|354434|P1|COMPLETED|Overall Study||19
153775|NCT00744328|354432|P3|STARTED|Overall Study||29
153776|NCT00744328|354433|P2|STARTED|Overall Study||30
153777|NCT00744328|354434|P1|STARTED|Overall Study||26
153778|NCT00744263|354444|P2|NOT COMPLETED|Overall Study||5320
153779|NCT00744263|354445|P1|NOT COMPLETED|Overall Study||5236
153780|NCT00744263|354444|P2|COMPLETED|Overall Study||36936
153781|NCT00744263|354445|P1|COMPLETED|Overall Study||37004
153782|NCT00744263|354444|P2|STARTED|Overall Study||42256
153783|NCT00744263|354445|P1|STARTED|Overall Study||42240
153784|NCT00744237|354468|P3|NOT COMPLETED|Overall Study||15
153785|NCT00744237|354469|P2|NOT COMPLETED|Overall Study||27
153786|NCT00744237|354470|P1|NOT COMPLETED|Overall Study||27
153787|NCT00744237|354468|P3|COMPLETED|Overall Study||59
153788|NCT00744237|354469|P2|COMPLETED|Overall Study||46
153789|NCT00744237|354470|P1|COMPLETED|Overall Study||56
153790|NCT00744237|354468|P3|STARTED|Overall Study||74
153791|NCT00744237|354469|P2|STARTED|Overall Study||73
153792|NCT00744237|354470|P1|STARTED|Overall Study||83
153793|NCT00745368|354481|P1|NOT COMPLETED|Overall Study||3
153794|NCT00745368|354481|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
153795|NCT00745368|354481|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
153796|NCT00745290|354494|P2|NOT COMPLETED|Overall Study||0
153797|NCT00745290|354495|P1|NOT COMPLETED|Overall Study||0
153798|NCT00745290|354494|P2|COMPLETED|Overall Study||122
153799|NCT00745290|354495|P1|COMPLETED|Overall Study||123
153800|NCT00745290|354494|P2|STARTED|Overall Study||122
153801|NCT00745290|354495|P1|STARTED|Overall Study||123
153802|NCT00745251|354503|P2|NOT COMPLETED|Overall Study||3
153803|NCT00745251|354504|P1|NOT COMPLETED|Overall Study||2
153804|NCT00745251|354503|P2|COMPLETED|Overall Study||19
153805|NCT00745251|354504|P1|COMPLETED|Overall Study||21
153806|NCT00745251|354503|P2|STARTED|Overall Study||22
153807|NCT00745251|354504|P1|STARTED|Overall Study||23
153808|NCT00745095|354518|P6|NOT COMPLETED|Overall Study||123
153809|NCT00745095|354519|P5|NOT COMPLETED|Overall Study||122
153810|NCT00745095|354520|P4|NOT COMPLETED|Overall Study||3
153811|NCT00745095|354521|P3|NOT COMPLETED|Overall Study||3
153812|NCT00745095|354522|P2|NOT COMPLETED|Overall Study||2
153813|NCT00745095|354523|P1|NOT COMPLETED|Overall Study||1
153814|NCT00745095|354518|P6|COMPLETED|Overall Study||27
153815|NCT00745095|354519|P5|COMPLETED|Overall Study||28
153816|NCT00745095|354520|P4|COMPLETED|Overall Study||12
153817|NCT00745095|354521|P3|COMPLETED|Overall Study||12
153818|NCT00745095|354522|P2|COMPLETED|Overall Study||13
153819|NCT00745095|354523|P1|COMPLETED|Overall Study||14
153820|NCT00745095|354518|P6|STARTED|Overall Study||150
153821|NCT00745095|354519|P5|STARTED|Overall Study||150
153822|NCT00745095|354520|P4|STARTED|Overall Study||15
153823|NCT00745095|354521|P3|STARTED|Overall Study||15
153824|NCT00745095|354522|P2|STARTED|Overall Study||15
153825|NCT00745095|354523|P1|STARTED|Overall Study||15
153826|NCT00745030|354545|P2|NOT COMPLETED|Overall Study||0
153827|NCT00745030|354546|P1|NOT COMPLETED|Overall Study||0
153828|NCT00745030|354545|P2|COMPLETED|Overall Study||2
153829|NCT00745030|354546|P1|COMPLETED|Overall Study||1
153830|NCT00745030|354545|P2|STARTED|Overall Study||2
153831|NCT00745030|354546|P1|STARTED|Overall Study||1
153832|NCT00744978|354554|P2|NOT COMPLETED|Period 2||1
153833|NCT00744978|354555|P1|NOT COMPLETED|Period 2||0
153834|NCT00744978|354554|P2|COMPLETED|Period 2||28
153835|NCT00744978|354555|P1|COMPLETED|Period 2||26
153836|NCT00744978|354554|P2|STARTED|Period 2||29
153837|NCT00744978|354555|P1|STARTED|Period 2||26
153838|NCT00744978|354554|P2|NOT COMPLETED|Placebo Washout||0
153839|NCT00744978|354555|P1|NOT COMPLETED|Placebo Washout||0
153840|NCT00744978|354554|P2|COMPLETED|Placebo Washout||29
153841|NCT00744978|354555|P1|COMPLETED|Placebo Washout||26
153842|NCT00744978|354554|P2|STARTED|Placebo Washout||29
153843|NCT00744978|354555|P1|STARTED|Placebo Washout||26
153844|NCT00744978|354554|P2|NOT COMPLETED|Period 1||5
153845|NCT00744978|354555|P1|NOT COMPLETED|Period 1||6
153846|NCT00744978|354554|P2|COMPLETED|Period 1||29
153847|NCT00744978|354555|P1|COMPLETED|Period 1||26
153848|NCT00744978|354554|P2|Treated|Period 1||33
153849|NCT00744978|354555|P1|Treated|Period 1||31
153850|NCT00744978|354554|P2|STARTED|Period 1||34
153851|NCT00744978|354555|P1|STARTED|Period 1||32
153852|NCT00744939|354607|P1|NOT COMPLETED|Overall Study||91
153853|NCT00744939|354607|P1|COMPLETED|Overall Study||77
153854|NCT00744939|354607|P1|Treatment Received|Overall Study||141
153855|NCT00744939|354607|P1|STARTED|Overall Study||168
153856|NCT00744874|354643|P1|NOT COMPLETED|Overall Study||4
153857|NCT00744874|354643|P1|COMPLETED|Overall Study||51
153858|NCT00744874|354643|P1|STARTED|Overall Study||55
153859|NCT00744848|354661|P2|NOT COMPLETED|Overall Study||0
153860|NCT00744848|354662|P1|NOT COMPLETED|Overall Study||0
153861|NCT00744848|354661|P2|COMPLETED|Overall Study||101
153862|NCT00744848|354662|P1|COMPLETED|Overall Study||103
153863|NCT00744848|354661|P2|STARTED|Overall Study||101
153864|NCT00744848|354662|P1|STARTED|Overall Study||103
153865|NCT00744757|354668|P1|NOT COMPLETED|Overall Study||21
153866|NCT00744757|354668|P1|COMPLETED|Overall Study||16
153867|NCT00744757|354668|P1|STARTED|Overall Study||37
153868|NCT00744692|354681|P1|NOT COMPLETED|Overall Study||0
153869|NCT00744692|354681|P1|COMPLETED|Overall Study||22
153870|NCT00744692|354681|P1|STARTED|Overall Study||22
153871|NCT00744653|354693|P1|NOT COMPLETED|Overall Study||16
153872|NCT00744653|354693|P1|COMPLETED|Overall Study||1
153873|NCT00744653|354693|P1|STARTED|Overall Study||17
153874|NCT00744627|354701|P2|NOT COMPLETED|Overall Study||22
153875|NCT00744627|354702|P1|NOT COMPLETED|Overall Study||25
153876|NCT00744627|354701|P2|COMPLETED|Overall Study||128
153877|NCT00744627|354702|P1|COMPLETED|Overall Study||126
153878|NCT00744627|354701|P2|Treated|Overall Study||150
153879|NCT00744627|354702|P1|Treated|Overall Study||150
153880|NCT00744627|354701|P2|STARTED|Overall Study||150
153881|NCT00744627|354702|P1|STARTED|Overall Study||151
153882|NCT00744523|354758|P2|NOT COMPLETED|30 Days After the Procedure||5
153883|NCT00744523|354759|P1|NOT COMPLETED|30 Days After the Procedure||0
153884|NCT00744523|354758|P2|COMPLETED|30 Days After the Procedure||220
153885|NCT00744523|354759|P1|COMPLETED|30 Days After the Procedure||37
153886|NCT00744523|354758|P2|STARTED|30 Days After the Procedure||225
153887|NCT00744523|354759|P1|STARTED|30 Days After the Procedure||37
153888|NCT00744523|354758|P2|NOT COMPLETED|Procedure||0
153889|NCT00744523|354759|P1|NOT COMPLETED|Procedure||0
153890|NCT00744523|354758|P2|COMPLETED|Procedure||225
153891|NCT00744523|354759|P1|COMPLETED|Procedure||37
153892|NCT00744523|354758|P2|STARTED|Procedure||225
153893|NCT00744523|354759|P1|STARTED|Procedure||37
153894|NCT00744497|354779|P2|NOT COMPLETED|Overall Study||762
153895|NCT00744497|354780|P1|NOT COMPLETED|Overall Study||760
153896|NCT00744497|354779|P2|COMPLETED|Overall Study||0
153897|NCT00744497|354780|P1|COMPLETED|Overall Study||0
153898|NCT00744497|354779|P2|Received Treatment|Overall Study||761
153899|NCT00744497|354780|P1|Received Treatment|Overall Study||757
153900|NCT00744497|354779|P2|STARTED|Overall Study|Randomized|762
153901|NCT00744497|354780|P1|STARTED|Overall Study|Randomized|760
153902|NCT00744055|354816|P2|NOT COMPLETED|Overall Study||14
153903|NCT00744055|354817|P1|NOT COMPLETED|Overall Study||7
153904|NCT00744055|354816|P2|COMPLETED|Overall Study||32
153905|NCT00744055|354817|P1|COMPLETED|Overall Study||43
153906|NCT00744055|354816|P2|STARTED|Overall Study||46
153907|NCT00744055|354817|P1|STARTED|Overall Study||50
153908|NCT00744042|354825|P1|NOT COMPLETED|Overall Study||1
153909|NCT00744042|354825|P1|COMPLETED|Overall Study||10
153910|NCT00744042|354825|P1|STARTED|Overall Study||11
153911|NCT00743730|354841|P3|NOT COMPLETED|Overall Study||5
153912|NCT00743730|354842|P2|NOT COMPLETED|Overall Study||4
153913|NCT00743730|354843|P1|NOT COMPLETED|Overall Study||5
153914|NCT00743730|354841|P3|COMPLETED|Overall Study||28
153915|NCT00743730|354842|P2|COMPLETED|Overall Study||30
153916|NCT00743730|354843|P1|COMPLETED|Overall Study||22
153917|NCT00743730|354841|P3|STARTED|Overall Study||33
153918|NCT00743730|354842|P2|STARTED|Overall Study||34
153919|NCT00743730|354843|P1|STARTED|Overall Study||27
153920|NCT00743717|354856|P2|NOT COMPLETED|Overall Study||0
153921|NCT00743717|354857|P1|NOT COMPLETED|Overall Study||0
153922|NCT00743717|354856|P2|COMPLETED|Overall Study||2
153923|NCT00743717|354857|P1|COMPLETED|Overall Study||2
153924|NCT00743717|354856|P2|STARTED|Overall Study||2
153925|NCT00743717|354857|P1|STARTED|Overall Study||2
153926|NCT00743652|354868|P5|NOT COMPLETED|Overall Study||0
153927|NCT00743652|354869|P4|NOT COMPLETED|Overall Study||4
153928|NCT00743652|354870|P3|NOT COMPLETED|Overall Study||2
153929|NCT00743652|354871|P2|NOT COMPLETED|Overall Study||3
153930|NCT00743652|354872|P1|NOT COMPLETED|Overall Study||10
153931|NCT00743652|354868|P5|COMPLETED|Overall Study||79
153932|NCT00743652|354869|P4|COMPLETED|Overall Study||63
153933|NCT00743652|354870|P3|COMPLETED|Overall Study||23
153934|NCT00743652|354871|P2|COMPLETED|Overall Study||48
153935|NCT00743652|354872|P1|COMPLETED|Overall Study||141
153936|NCT00743652|354868|P5|Toddler Dose|Overall Study||0
153937|NCT00743652|354869|P4|Toddler Dose|Overall Study||0
153938|NCT00743652|354870|P3|Toddler Dose|Overall Study||16
153939|NCT00743652|354871|P2|Toddler Dose|Overall Study||23
153940|NCT00743652|354872|P1|Toddler Dose|Overall Study||15
153941|NCT00743652|354868|P5|Vaccinated Dose 3|Overall Study||0
153942|NCT00743652|354869|P4|Vaccinated Dose 3|Overall Study||0
153943|NCT00743652|354870|P3|Vaccinated Dose 3|Overall Study||0
153944|NCT00743652|354871|P2|Vaccinated Dose 3|Overall Study||0
153945|NCT00743652|354872|P1|Vaccinated Dose 3|Overall Study||74
153946|NCT00743652|354868|P5|Vaccinated Dose 2|Overall Study||0
153947|NCT00743652|354869|P4|Vaccinated Dose 2|Overall Study||49
153948|NCT00743652|354870|P3|Vaccinated Dose 2|Overall Study||0
153949|NCT00743652|354871|P2|Vaccinated Dose 2|Overall Study||41
153950|NCT00743652|354872|P1|Vaccinated Dose 2|Overall Study||112
153951|NCT00743652|354868|P5|Vaccinated Dose 1|Overall Study||79
153952|NCT00743652|354869|P4|Vaccinated Dose 1|Overall Study||66
153953|NCT00743652|354870|P3|Vaccinated Dose 1|Overall Study||25
153954|NCT00743652|354871|P2|Vaccinated Dose 1|Overall Study||51
153955|NCT00743652|354872|P1|Vaccinated Dose 1|Overall Study||151
153956|NCT00743652|354868|P5|STARTED|Overall Study||79
153957|NCT00743652|354869|P4|STARTED|Overall Study||67
153958|NCT00743652|354870|P3|STARTED|Overall Study||25
153959|NCT00743652|354871|P2|STARTED|Overall Study||51
153960|NCT00743652|354872|P1|STARTED|Overall Study||151
153961|NCT00743574|354947|P1|NOT COMPLETED|Overall Study||24
153962|NCT00743574|354947|P1|COMPLETED|Overall Study||12
153963|NCT00743574|354947|P1|Dropped Out After Initiating Trial|Overall Study||3
153964|NCT00743574|354947|P1|Further Exclusions|Overall Study||8
153965|NCT00743574|354947|P1|Dropped Out Before Eligibility Testing|Overall Study||13
153966|NCT00743574|354947|P1|STARTED|Overall Study||36
153967|NCT00743509|354956|P1|NOT COMPLETED|Overall Study||2
153968|NCT00743509|354956|P1|COMPLETED|Overall Study||47
153969|NCT00743509|354956|P1|STARTED|Overall Study||49
153970|NCT00743483|354961|P1|NOT COMPLETED|Treatment Period||1
153971|NCT00743483|354961|P1|COMPLETED|Treatment Period||13
153972|NCT00743483|354961|P1|STARTED|Treatment Period||14
153973|NCT00743483|354961|P1|NOT COMPLETED|Baseline Period||1
153974|NCT00743483|354961|P1|COMPLETED|Baseline Period||14
153975|NCT00743483|354961|P1|STARTED|Baseline Period||15
153976|NCT00743444|354965|P2|NOT COMPLETED|Second Intervention||0
153977|NCT00743444|354966|P1|NOT COMPLETED|Second Intervention||0
153978|NCT00743444|354965|P2|COMPLETED|Second Intervention||11
153979|NCT00743444|354966|P1|COMPLETED|Second Intervention||14
153980|NCT00743444|354965|P2|STARTED|Second Intervention||11
153981|NCT00743444|354966|P1|STARTED|Second Intervention||14
153982|NCT00743444|354965|P2|NOT COMPLETED|Washout Period||1
153983|NCT00743444|354966|P1|NOT COMPLETED|Washout Period||0
153984|NCT00743444|354965|P2|COMPLETED|Washout Period||11
153985|NCT00743444|354966|P1|COMPLETED|Washout Period||14
153986|NCT00743444|354965|P2|STARTED|Washout Period||12
153987|NCT00743444|354966|P1|STARTED|Washout Period||14
153988|NCT00743444|354965|P2|NOT COMPLETED|First Intervention||1
153989|NCT00743444|354966|P1|NOT COMPLETED|First Intervention||0
153990|NCT00743444|354965|P2|COMPLETED|First Intervention||12
153991|NCT00743444|354966|P1|COMPLETED|First Intervention||14
153992|NCT00743444|354965|P2|STARTED|First Intervention||13
153993|NCT00743444|354966|P1|STARTED|First Intervention||14
153994|NCT00743431|354975|P1|NOT COMPLETED|Overall Study||126
153995|NCT00743431|354975|P1|COMPLETED|Overall Study||98
153996|NCT00743431|354975|P1|STARTED|Overall Study||224
153997|NCT00743288|354979|P7|NOT COMPLETED|Overall Study||9
153998|NCT00743288|354980|P6|NOT COMPLETED|Overall Study||5
153999|NCT00743288|354981|P5|NOT COMPLETED|Overall Study||6
154000|NCT00743288|354982|P4|NOT COMPLETED|Overall Study||7
154001|NCT00743288|354983|P3|NOT COMPLETED|Overall Study||5
154002|NCT00743288|354984|P2|NOT COMPLETED|Overall Study||3
154003|NCT00743288|354985|P1|NOT COMPLETED|Overall Study||3
154004|NCT00743288|354979|P7|COMPLETED|Overall Study||0
154005|NCT00743288|354980|P6|COMPLETED|Overall Study||1
154006|NCT00743288|354981|P5|COMPLETED|Overall Study||0
154007|NCT00743288|354982|P4|COMPLETED|Overall Study||0
154008|NCT00743288|354983|P3|COMPLETED|Overall Study||1
154009|NCT00743288|354984|P2|COMPLETED|Overall Study||0
154010|NCT00743288|354985|P1|COMPLETED|Overall Study||0
154011|NCT00743288|354979|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
154012|NCT00743288|354980|P6|STARTED|Overall Study||6
154013|NCT00743288|354981|P5|STARTED|Overall Study||6
154014|NCT00743288|354982|P4|STARTED|Overall Study||7
154015|NCT00743288|354983|P3|STARTED|Overall Study||6
154016|NCT00743288|354984|P2|STARTED|Overall Study||3
154017|NCT00743288|354985|P1|STARTED|Overall Study||3
154018|NCT00743275|354999|P2|NOT COMPLETED|Overall Study||1
154019|NCT00743275|355000|P1|NOT COMPLETED|Overall Study||0
154020|NCT00743275|354999|P2|COMPLETED|Overall Study||60
154021|NCT00743275|355000|P1|COMPLETED|Overall Study||59
154022|NCT00743275|354999|P2|STARTED|Overall Study||61
154023|NCT00743275|355000|P1|STARTED|Overall Study||59
154024|NCT00743262|355012|P1|NOT COMPLETED|Overall Study||0
154025|NCT00743262|355012|P1|COMPLETED|Overall Study||15
154026|NCT00743262|355012|P1|STARTED|Overall Study||15
154027|NCT00743249|355020|P2|NOT COMPLETED|Overall Study||6
154028|NCT00743249|355021|P1|NOT COMPLETED|Overall Study||2
154029|NCT00743249|355020|P2|COMPLETED|Overall Study||24
154030|NCT00743249|355021|P1|COMPLETED|Overall Study||28
154031|NCT00743249|355020|P2|STARTED|Overall Study||30
154032|NCT00743249|355021|P1|STARTED|Overall Study||30
154033|NCT00743197|355031|P2|NOT COMPLETED|Overall Study||2
154034|NCT00743197|355032|P1|NOT COMPLETED|Overall Study||1
154035|NCT00743197|355031|P2|COMPLETED|Overall Study||0
154036|NCT00743197|355032|P1|COMPLETED|Overall Study||0
154037|NCT00743197|355031|P2|STARTED|Overall Study||2
154038|NCT00743197|355032|P1|STARTED|Overall Study||1
154039|NCT00742183|355040|P2|NOT COMPLETED|Overall Study||12
154040|NCT00742183|355041|P1|NOT COMPLETED|Overall Study||9
154041|NCT00742183|355040|P2|COMPLETED|Overall Study||39
154042|NCT00742183|355041|P1|COMPLETED|Overall Study||40
154043|NCT00742183|355040|P2|STARTED|Overall Study||51
154044|NCT00742183|355041|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
154045|NCT00742170|355049|P2|NOT COMPLETED|Overall Study||5
154046|NCT00742170|355050|P1|NOT COMPLETED|Overall Study||2
154047|NCT00742170|355049|P2|COMPLETED|Overall Study||24
154048|NCT00742170|355050|P1|COMPLETED|Overall Study||24
154049|NCT00742170|355049|P2|STARTED|Overall Study||29
154050|NCT00742170|355050|P1|STARTED|Overall Study||26
154051|NCT00742079|355060|P2|NOT COMPLETED|Overall Study||1
154052|NCT00742079|355061|P1|NOT COMPLETED|Overall Study||0
154053|NCT00742079|355060|P2|COMPLETED|Overall Study||9
154054|NCT00742079|355061|P1|COMPLETED|Overall Study||11
154055|NCT00742079|355060|P2|Week 2 (Received Dose 2)|Overall Study||9
154056|NCT00742079|355061|P1|Week 2 (Received Dose 2)|Overall Study||11
154057|NCT00742079|355060|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
154058|NCT00742079|355061|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
154059|NCT00742079|355060|P2|STARTED|Overall Study||10
154060|NCT00742079|355061|P1|STARTED|Overall Study||11
154061|NCT00742053|355067|P1|NOT COMPLETED|Overall Study||0
154062|NCT00742053|355067|P1|COMPLETED|Overall Study||7
154063|NCT00742053|355067|P1|STARTED|Overall Study||7
154064|NCT00741988|355073|P2|NOT COMPLETED|Overall Study||4
154065|NCT00741988|355074|P1|NOT COMPLETED|Overall Study||4
154066|NCT00741988|355073|P2|COMPLETED|Overall Study||36
154067|NCT00741988|355074|P1|COMPLETED|Overall Study||38
154068|NCT00741988|355073|P2|STARTED|Overall Study||40
154069|NCT00741988|355074|P1|STARTED|Overall Study||42
154070|NCT00741936|355086|P2|NOT COMPLETED|Overall Study||8
154071|NCT00741936|355087|P1|NOT COMPLETED|Overall Study||9
154072|NCT00741936|355086|P2|COMPLETED|Overall Study||52
154073|NCT00741936|355087|P1|COMPLETED|Overall Study||51
154074|NCT00741936|355086|P2|STARTED|Overall Study||60
154075|NCT00741936|355087|P1|STARTED|Overall Study||60
154076|NCT00743106|355115|P2|NOT COMPLETED|Overall Study||5
154077|NCT00743106|355116|P1|NOT COMPLETED|Overall Study||8
154078|NCT00743106|355115|P2|COMPLETED|Overall Study||43
154079|NCT00743106|355116|P1|COMPLETED|Overall Study||34
154080|NCT00743106|355115|P2|STARTED|Overall Study||48
154081|NCT00743106|355116|P1|STARTED|Overall Study||42
154082|NCT00743093|355124|P2|NOT COMPLETED|Extended Dosing Period||0
154083|NCT00743093|355125|P1|NOT COMPLETED|Extended Dosing Period||3
154084|NCT00743093|355124|P2|COMPLETED|Extended Dosing Period||1
154085|NCT00743093|355125|P1|COMPLETED|Extended Dosing Period||48
154086|NCT00743093|355124|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
154087|NCT00743093|355125|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
154088|NCT00743093|355124|P2|NOT COMPLETED|Base Study Period||5
154089|NCT00743093|355125|P1|NOT COMPLETED|Base Study Period||19
154090|NCT00743093|355124|P2|COMPLETED|Base Study Period||47
154091|NCT00743093|355125|P1|COMPLETED|Base Study Period||205
154092|NCT00743093|355124|P2|STARTED|Base Study Period||52
154093|NCT00743093|355125|P1|STARTED|Base Study Period||224
154094|NCT00742924|355137|P4|NOT COMPLETED|Overall Study||6
154095|NCT00742924|355138|P3|NOT COMPLETED|Overall Study||4
154096|NCT00742924|355139|P2|NOT COMPLETED|Overall Study||2
154097|NCT00742924|355140|P1|NOT COMPLETED|Overall Study||5
154098|NCT00742924|355137|P4|COMPLETED|Overall Study||0
154099|NCT00742924|355138|P3|COMPLETED|Overall Study||2
154100|NCT00742924|355139|P2|COMPLETED|Overall Study||4
154101|NCT00742924|355140|P1|COMPLETED|Overall Study||1
154102|NCT00742924|355137|P4|STARTED|Overall Study||6
154103|NCT00742924|355138|P3|STARTED|Overall Study||6
154104|NCT00742924|355139|P2|STARTED|Overall Study||6
154105|NCT00742924|355140|P1|STARTED|Overall Study||6
154106|NCT00742885|355152|P2|NOT COMPLETED|Overall Study||0
154107|NCT00742885|355153|P1|NOT COMPLETED|Overall Study||1
154108|NCT00742885|355152|P2|COMPLETED|Overall Study|to Day 182|50
154109|NCT00742885|355153|P1|COMPLETED|Overall Study|to Day 182|49
154110|NCT00742885|355152|P2|STARTED|Overall Study||50
154111|NCT00742885|355153|P1|STARTED|Overall Study||50
154112|NCT00742872|355201|P2|NOT COMPLETED|Overall Study||8
154113|NCT00742872|355202|P1|NOT COMPLETED|Overall Study||12
154114|NCT00742872|355201|P2|COMPLETED|Overall Study||12
154115|NCT00742872|355202|P1|COMPLETED|Overall Study||9
154116|NCT00742872|355201|P2|STARTED|Overall Study||20
154117|NCT00742872|355202|P1|STARTED|Overall Study||21
154118|NCT00742781|355208|P1|NOT COMPLETED|Overall Study||3
154119|NCT00742781|355208|P1|COMPLETED|Overall Study||18
154120|NCT00742781|355208|P1|STARTED|Overall Study||21
154121|NCT00742625|355217|P1|NOT COMPLETED|Consolidation||21
154122|NCT00742625|355217|P1|COMPLETED|Consolidation||20
154123|NCT00742625|355217|P1|STARTED|Consolidation||41
154124|NCT00742625|355217|P1|NOT COMPLETED|Remission Induction||54
154125|NCT00742625|355217|P1|COMPLETED|Remission Induction||41
154126|NCT00742625|355217|P1|STARTED|Remission Induction||95
154127|NCT00742508|355228|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
154128|NCT00742508|355229|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
154129|NCT00742508|355228|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
154130|NCT00742508|355229|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
154131|NCT00742508|355228|P2|STARTED|4-Week Exploratory Evaluation Period||8
154132|NCT00742508|355229|P1|STARTED|4-Week Exploratory Evaluation Period||0
154133|NCT00742508|355228|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
154134|NCT00742508|355229|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
154135|NCT00742508|355228|P2|COMPLETED|8-Week Primary Evaluation Period||8
154136|NCT00742508|355229|P1|COMPLETED|8-Week Primary Evaluation Period||11
154137|NCT00742508|355228|P2|STARTED|8-Week Primary Evaluation Period||19
154138|NCT00742508|355229|P1|STARTED|8-Week Primary Evaluation Period||22
154139|NCT00742417|355293|P2|NOT COMPLETED|Maintenance II||0
154140|NCT00742417|355294|P1|NOT COMPLETED|Maintenance II||0
154141|NCT00742417|355293|P2|COMPLETED|Maintenance II||19
154142|NCT00742417|355294|P1|COMPLETED|Maintenance II||16
154143|NCT00742417|355293|P2|STARTED|Maintenance II||19
154144|NCT00742417|355294|P1|STARTED|Maintenance II||16
154145|NCT00742417|355293|P2|NOT COMPLETED|Maintenance I||0
154146|NCT00742417|355294|P1|NOT COMPLETED|Maintenance I||0
154147|NCT00742417|355293|P2|COMPLETED|Maintenance I||19
154148|NCT00742417|355294|P1|COMPLETED|Maintenance I||16
154149|NCT00742417|355293|P2|STARTED|Maintenance I||19
154150|NCT00742417|355294|P1|STARTED|Maintenance I||16
154151|NCT00742417|355293|P2|NOT COMPLETED|Intensive Period||1
154152|NCT00742417|355294|P1|NOT COMPLETED|Intensive Period||3
154153|NCT00742417|355293|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
154154|NCT00742417|355294|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
154155|NCT00742417|355293|P2|STARTED|Intensive Period||20
154156|NCT00742417|355294|P1|STARTED|Intensive Period||19
154157|NCT00742417|355293|P2|NOT COMPLETED|Randomized||1
154158|NCT00742417|355294|P1|NOT COMPLETED|Randomized||2
154159|NCT00742417|355293|P2|COMPLETED|Randomized||20
154160|NCT00742417|355294|P1|COMPLETED|Randomized||19
154161|NCT00742417|355293|P2|STARTED|Randomized||21
154162|NCT00742417|355294|P1|STARTED|Randomized||21
154163|NCT00742391|355318|P2|NOT COMPLETED|Overall Study||1
154164|NCT00742391|355319|P1|NOT COMPLETED|Overall Study||4
154165|NCT00742391|355318|P2|COMPLETED|Overall Study||128
154166|NCT00742391|355319|P1|COMPLETED|Overall Study||122
154167|NCT00742391|355318|P2|STARTED|Overall Study||129
154168|NCT00742391|355319|P1|STARTED|Overall Study||126
154169|NCT00742326|355329|P2|NOT COMPLETED|Overall Study||1
154170|NCT00742326|355330|P1|NOT COMPLETED|Overall Study||0
154171|NCT00742326|355329|P2|COMPLETED|Overall Study||6
154172|NCT00742326|355330|P1|COMPLETED|Overall Study||6
154173|NCT00742326|355329|P2|STARTED|Overall Study||7
154174|NCT00742326|355330|P1|STARTED|Overall Study||6
154175|NCT00742313|355340|P2|NOT COMPLETED|Overall Study||0
154176|NCT00742313|355341|P1|NOT COMPLETED|Overall Study||1
154177|NCT00742313|355340|P2|COMPLETED|Overall Study||19
154178|NCT00742313|355341|P1|COMPLETED|Overall Study||24
154179|NCT00742313|355340|P2|STARTED|Overall Study||19
154180|NCT00742313|355341|P1|STARTED|Overall Study||25
154181|NCT00742274|355349|P2|NOT COMPLETED|Overall Study||3
154182|NCT00742274|355350|P1|NOT COMPLETED|Overall Study||3
154183|NCT00742274|355349|P2|COMPLETED|Overall Study||28
154184|NCT00742274|355350|P1|COMPLETED|Overall Study||27
154185|NCT00742274|355349|P2|STARTED|Overall Study||31
154186|NCT00742274|355350|P1|STARTED|Overall Study||30
154187|NCT00742235|355358|P2|NOT COMPLETED|Overall Study||31
154188|NCT00742235|355359|P1|NOT COMPLETED|Overall Study||0
154189|NCT00742235|355358|P2|COMPLETED|Overall Study||36
154190|NCT00742235|355359|P1|COMPLETED|Overall Study||32
154191|NCT00742235|355358|P2|STARTED|Overall Study||67
154192|NCT00742235|355359|P1|STARTED|Overall Study||32
154193|NCT00742209|355372|P5|NOT COMPLETED|Overall Study||25
154194|NCT00742209|355373|P4|NOT COMPLETED|Overall Study||37
154195|NCT00742209|355374|P3|NOT COMPLETED|Overall Study||46
154196|NCT00742209|355375|P2|NOT COMPLETED|Overall Study||18
154197|NCT00742209|355376|P1|NOT COMPLETED|Overall Study||34
154198|NCT00742209|355372|P5|COMPLETED|Overall Study||37
154199|NCT00742209|355373|P4|COMPLETED|Overall Study||97
154200|NCT00742209|355374|P3|COMPLETED|Overall Study||88
154201|NCT00742209|355375|P2|COMPLETED|Overall Study||49
154202|NCT00742209|355376|P1|COMPLETED|Overall Study||95
154203|NCT00742209|355372|P5|STARTED|Overall Study||62
154204|NCT00742209|355373|P4|STARTED|Overall Study||134
154205|NCT00742209|355374|P3|STARTED|Overall Study||134
154206|NCT00742209|355375|P2|STARTED|Overall Study||67
154207|NCT00742209|355376|P1|STARTED|Overall Study||129
154208|NCT00741858|355479|P2|NOT COMPLETED|Overall Study||0
154209|NCT00741858|355480|P1|NOT COMPLETED|Overall Study||0
154210|NCT00741858|355479|P2|COMPLETED|Overall Study||18
154211|NCT00741858|355480|P1|COMPLETED|Overall Study||16
154212|NCT00741858|355479|P2|STARTED|Overall Study||18
154213|NCT00741858|355480|P1|STARTED|Overall Study||16
154214|NCT00741819|355486|P1|NOT COMPLETED|Overall Study||8
154215|NCT00741819|355486|P1|COMPLETED|Overall Study||65
154216|NCT00741819|355486|P1|STARTED|Overall Study||73
154217|NCT00741611|355500|P3|NOT COMPLETED|Overall Study||3
154218|NCT00741611|355501|P2|NOT COMPLETED|Overall Study||2
154219|NCT00741611|355502|P1|NOT COMPLETED|Overall Study||0
154220|NCT00741611|355500|P3|COMPLETED|Overall Study||26
154221|NCT00741611|355501|P2|COMPLETED|Overall Study||1
154222|NCT00741611|355502|P1|COMPLETED|Overall Study||4
154223|NCT00741611|355500|P3|STARTED|Overall Study||29
154224|NCT00741611|355501|P2|STARTED|Overall Study||3
154225|NCT00741611|355502|P1|STARTED|Overall Study||4
154226|NCT00741468|355519|P1|NOT COMPLETED|Overall Study||0
154227|NCT00741468|355519|P1|COMPLETED|Overall Study||18
154228|NCT00741468|355519|P1|STARTED|Overall Study||18
154229|NCT00741390|355527|P4|NOT COMPLETED|Visit 2||1
154230|NCT00741390|355528|P3|NOT COMPLETED|Visit 2||1
154231|NCT00741390|355529|P2|NOT COMPLETED|Visit 2||0
154232|NCT00741390|355530|P1|NOT COMPLETED|Visit 2||0
154233|NCT00741390|355527|P4|COMPLETED|Visit 2||60
154234|NCT00741390|355528|P3|COMPLETED|Visit 2||54
154235|NCT00741390|355529|P2|COMPLETED|Visit 2||61
154236|NCT00741390|355530|P1|COMPLETED|Visit 2||59
154237|NCT00741390|355527|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
154238|NCT00741390|355528|P3|STARTED|Visit 2||55
154239|NCT00741390|355529|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
154240|NCT00741390|355530|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
154241|NCT00741390|355527|P4|NOT COMPLETED|Visit 1||1
154242|NCT00741390|355528|P3|NOT COMPLETED|Visit 1||7
154243|NCT00741390|355529|P2|NOT COMPLETED|Visit 1||0
154244|NCT00741390|355530|P1|NOT COMPLETED|Visit 1||2
154245|NCT00741390|355527|P4|COMPLETED|Visit 1||62
154246|NCT00741390|355528|P3|COMPLETED|Visit 1||55
154247|NCT00741390|355529|P2|COMPLETED|Visit 1||63
154248|NCT00741390|355530|P1|COMPLETED|Visit 1||60
154249|NCT00741390|355527|P4|STARTED|Visit 1||63
154250|NCT00741390|355528|P3|STARTED|Visit 1||62
154251|NCT00741390|355529|P2|STARTED|Visit 1||63
154252|NCT00741390|355530|P1|STARTED|Visit 1||62
154253|NCT00741338|355551|P2|NOT COMPLETED|Overall Study||1
154254|NCT00741338|355552|P1|NOT COMPLETED|Overall Study||0
154255|NCT00741338|355551|P2|COMPLETED|Overall Study||2
154256|NCT00741338|355552|P1|COMPLETED|Overall Study||3
154257|NCT00741338|355551|P2|STARTED|Overall Study||3
154258|NCT00741338|355552|P1|STARTED|Overall Study||3
154259|NCT00741286|355562|P2|NOT COMPLETED|Overall Study||19
154260|NCT00741286|355563|P1|NOT COMPLETED|Overall Study||20
154261|NCT00741286|355562|P2|COMPLETED|Overall Study||81
154262|NCT00741286|355563|P1|COMPLETED|Overall Study||83
154263|NCT00741286|355562|P2|STARTED|Overall Study||100
154264|NCT00741286|355563|P1|STARTED|Overall Study||103
154265|NCT00741273|355573|P2|NOT COMPLETED|Overall Study||0
154266|NCT00741273|355574|P1|NOT COMPLETED|Overall Study||0
154267|NCT00741273|355573|P2|COMPLETED|Overall Study||8
154268|NCT00741273|355574|P1|COMPLETED|Overall Study||8
154269|NCT00741273|355573|P2|STARTED|Overall Study||8
154270|NCT00741273|355574|P1|STARTED|Overall Study||8
154271|NCT00741156|355590|P1|NOT COMPLETED|Overall Study||0
154272|NCT00741156|355590|P1|COMPLETED|Overall Study||12
154273|NCT00741156|355590|P1|STARTED|Overall Study||12
154274|NCT00741104|355605|P1|NOT COMPLETED|Overall Study||0
154275|NCT00741104|355605|P1|COMPLETED|Overall Study||363
154276|NCT00741104|355605|P1|STARTED|Overall Study||363
154277|NCT00741091|355612|P1|NOT COMPLETED|Overall Study||57
154278|NCT00741091|355612|P1|COMPLETED|Overall Study||1040
154279|NCT00741091|355612|P1|STARTED|Overall Study||1097
154280|NCT00741039|355622|P2|NOT COMPLETED|Overall Study||0
154281|NCT00741039|355623|P1|NOT COMPLETED|Overall Study||2
154282|NCT00741039|355622|P2|COMPLETED|Overall Study||25
154283|NCT00741039|355623|P1|COMPLETED|Overall Study||100
154284|NCT00741039|355622|P2|STARTED|Overall Study||25
154285|NCT00741039|355623|P1|STARTED|Overall Study||102
154286|NCT00741026|355629|P1|NOT COMPLETED|Overall Study||0
154287|NCT00741026|355629|P1|COMPLETED|Overall Study||15
154288|NCT00741026|355629|P1|STARTED|Overall Study||15
154289|NCT00741013|355660|P3|NOT COMPLETED|Overall Study||1
154290|NCT00741013|355661|P2|NOT COMPLETED|Overall Study||2
154291|NCT00741013|355662|P1|NOT COMPLETED|Overall Study||1
154292|NCT00741013|355660|P3|COMPLETED|Overall Study||6
154293|NCT00741013|355661|P2|COMPLETED|Overall Study||6
154294|NCT00741013|355662|P1|COMPLETED|Overall Study||6
154295|NCT00741013|355660|P3|STARTED|Overall Study||7
154296|NCT00741013|355661|P2|STARTED|Overall Study||8
154297|NCT00741013|355662|P1|STARTED|Overall Study||7
154298|NCT00739973|355682|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
154299|NCT00739973|355683|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
154300|NCT00739973|355684|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
154301|NCT00739973|355685|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
154302|NCT00739973|355686|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
154303|NCT00739973|355687|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
154304|NCT00739973|355688|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
154305|NCT00739973|355689|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
154306|NCT00739973|355690|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
154307|NCT00739973|355682|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
154308|NCT00739973|355683|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
154309|NCT00739973|355684|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
154310|NCT00739973|355685|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
154311|NCT00739973|355686|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
154312|NCT00739973|355687|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
154313|NCT00739973|355688|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
154314|NCT00739973|355689|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
154315|NCT00739973|355690|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
154316|NCT00739973|355682|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
154317|NCT00739973|355683|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
154318|NCT00739973|355684|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
154319|NCT00739973|355685|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
154320|NCT00739973|355686|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
154321|NCT00739973|355687|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
154322|NCT00739973|355688|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
154323|NCT00739973|355689|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
154324|NCT00739973|355690|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
154325|NCT00739973|355682|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154326|NCT00739973|355683|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154327|NCT00739973|355684|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154328|NCT00739973|355685|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154329|NCT00739973|355686|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154330|NCT00739973|355687|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154331|NCT00739973|355688|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154332|NCT00739973|355689|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154333|NCT00739973|355690|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
154334|NCT00739973|355682|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154335|NCT00739973|355683|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154336|NCT00739973|355684|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154337|NCT00739973|355685|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154338|NCT00739973|355686|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154339|NCT00739973|355687|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154340|NCT00739973|355688|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154341|NCT00739973|355689|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
154342|NCT00739973|355690|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
154343|NCT00739973|355682|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
154344|NCT00739973|355683|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
154345|NCT00739973|355684|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
154346|NCT00739973|355685|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
154347|NCT00739973|355686|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
154348|NCT00739973|355687|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
154349|NCT00739973|355688|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
154350|NCT00739973|355689|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
154351|NCT00739973|355690|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
154352|NCT00740857|355779|P3|NOT COMPLETED|Overall Study||0
154353|NCT00740857|355780|P2|NOT COMPLETED|Overall Study||0
154354|NCT00740857|355781|P1|NOT COMPLETED|Overall Study||1
154355|NCT00740857|355779|P3|COMPLETED|Overall Study||90
154356|NCT00740857|355780|P2|COMPLETED|Overall Study||88
154357|NCT00740857|355781|P1|COMPLETED|Overall Study||32
154358|NCT00740857|355779|P3|STARTED|Overall Study||90
154359|NCT00740857|355780|P2|STARTED|Overall Study||88
154360|NCT00740857|355781|P1|STARTED|Overall Study||33
154361|NCT00740831|355813|P3|NOT COMPLETED|Overall Study||6
154362|NCT00740831|355814|P2|NOT COMPLETED|Overall Study||3
154363|NCT00740831|355815|P1|NOT COMPLETED|Overall Study||4
154364|NCT00740831|355813|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
154365|NCT00740831|355814|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
154366|NCT00740831|355815|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
154367|NCT00740831|355813|P3|STARTED|Overall Study|Safety population|101
154368|NCT00740831|355814|P2|STARTED|Overall Study|Safety population|103
154369|NCT00740831|355815|P1|STARTED|Overall Study|Safety population|97
154370|NCT00740792|355836|P4|NOT COMPLETED|Overall Study||10
154371|NCT00740792|355837|P3|NOT COMPLETED|Overall Study||9
154372|NCT00740792|355838|P2|NOT COMPLETED|Overall Study||8
154373|NCT00740792|355839|P1|NOT COMPLETED|Overall Study||10
154374|NCT00740792|355836|P4|COMPLETED|Overall Study||190
154375|NCT00740792|355837|P3|COMPLETED|Overall Study||180
154376|NCT00740792|355838|P2|COMPLETED|Overall Study||186
154377|NCT00740792|355839|P1|COMPLETED|Overall Study||183
154378|NCT00740792|355836|P4|STARTED|Overall Study||200
154379|NCT00740792|355837|P3|STARTED|Overall Study||189
154380|NCT00740792|355838|P2|STARTED|Overall Study||194
154381|NCT00740792|355839|P1|STARTED|Overall Study||193
154382|NCT00740779|355860|P3|NOT COMPLETED|Overall Study||13
154383|NCT00740779|355861|P2|NOT COMPLETED|Overall Study||14
154384|NCT00740779|355862|P1|NOT COMPLETED|Overall Study||9
154385|NCT00740779|355860|P3|COMPLETED|Overall Study||41
154386|NCT00740779|355861|P2|COMPLETED|Overall Study||31
154387|NCT00740779|355862|P1|COMPLETED|Overall Study||43
154388|NCT00740779|355860|P3|STARTED|Overall Study||54
154389|NCT00740779|355861|P2|STARTED|Overall Study||45
154390|NCT00740779|355862|P1|STARTED|Overall Study||52
154391|NCT00740727|355870|P1|NOT COMPLETED|Overall Study||0
154392|NCT00740727|355870|P1|COMPLETED|Overall Study||18
154393|NCT00740727|355870|P1|STARTED|Overall Study||18
154394|NCT00740714|355879|P3|NOT COMPLETED|Overall Study||29
154395|NCT00740714|355880|P2|NOT COMPLETED|Overall Study||19
154396|NCT00740714|355881|P1|NOT COMPLETED|Overall Study||17
154397|NCT00740714|355879|P3|COMPLETED|Overall Study||174
154398|NCT00740714|355880|P2|COMPLETED|Overall Study||182
154399|NCT00740714|355881|P1|COMPLETED|Overall Study||179
154400|NCT00740714|355879|P3|Active Patients at Study Termination|Overall Study||33
154401|NCT00740714|355880|P2|Active Patients at Study Termination|Overall Study||12
154402|NCT00740714|355881|P1|Active Patients at Study Termination|Overall Study||24
154403|NCT00740714|355879|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
154404|NCT00740714|355880|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
154405|NCT00740714|355881|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
154406|NCT00740714|355879|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
154407|NCT00740714|355880|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
154408|NCT00740714|355881|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
154409|NCT00740636|355957|P2|NOT COMPLETED|Overall Study||4
154410|NCT00740636|355958|P1|NOT COMPLETED|Overall Study||2
154411|NCT00740636|355957|P2|COMPLETED|Overall Study||63
154412|NCT00740636|355958|P1|COMPLETED|Overall Study||23
154413|NCT00740636|355957|P2|STARTED|Overall Study||67
154414|NCT00740636|355958|P1|STARTED|Overall Study||25
154415|NCT00740597|355964|P1|NOT COMPLETED|Overall Study||1
154416|NCT00740597|355964|P1|COMPLETED|Overall Study||0
154417|NCT00740597|355964|P1|STARTED|Overall Study||1
154418|NCT00740584|355968|P1|NOT COMPLETED|Overall Study||1
154419|NCT00740584|355968|P1|COMPLETED|Overall Study||11
154420|NCT00740584|355968|P1|STARTED|Overall Study||12
154421|NCT00740480|355972|P1|NOT COMPLETED|Overall Study||2
154422|NCT00740480|355972|P1|COMPLETED|Overall Study||23
154423|NCT00740480|355972|P1|STARTED|Overall Study||25
154424|NCT00740220|355976|P1|NOT COMPLETED|Overall Study||9
154425|NCT00740220|355976|P1|COMPLETED|Overall Study||88
154426|NCT00740220|355976|P1|STARTED|Overall Study||97
154427|NCT00740207|355982|P2|NOT COMPLETED|Overall Study||0
154428|NCT00740207|355983|P1|NOT COMPLETED|Overall Study||0
154429|NCT00740207|355982|P2|COMPLETED|Overall Study||16
154430|NCT00740207|355983|P1|COMPLETED|Overall Study||17
154431|NCT00740207|355982|P2|STARTED|Overall Study||16
154432|NCT00740207|355983|P1|STARTED|Overall Study||17
154433|NCT00740181|355995|P1|NOT COMPLETED|Overall Study||0
154434|NCT00740181|355995|P1|COMPLETED|Overall Study||9
154435|NCT00740181|355995|P1|STARTED|Overall Study||9
154436|NCT00740051|356001|P2|NOT COMPLETED|Overall Study||32
154437|NCT00740051|356002|P1|NOT COMPLETED|Overall Study||18
154438|NCT00740051|356001|P2|COMPLETED|Overall Study||119
154439|NCT00740051|356002|P1|COMPLETED|Overall Study||58
154440|NCT00740051|356001|P2|STARTED|Overall Study||151
154441|NCT00740051|356002|P1|STARTED|Overall Study||76
154442|NCT00739999|356024|P2|NOT COMPLETED|Overall Study||0
154443|NCT00739999|356025|P1|NOT COMPLETED|Overall Study||0
154444|NCT00739999|356024|P2|COMPLETED|Overall Study||24
154445|NCT00739999|356025|P1|COMPLETED|Overall Study||15
154446|NCT00739999|356024|P2|STARTED|Overall Study||24
154447|NCT00739999|356025|P1|STARTED|Overall Study||15
154448|NCT00739934|356096|P1|NOT COMPLETED|Voriconazole Oral||3
154449|NCT00739934|356096|P1|COMPLETED|Voriconazole Oral||31
154450|NCT00739934|356096|P1|STARTED|Voriconazole Oral||34
154451|NCT00739934|356096|P1|NOT COMPLETED|Voriconazole IV||6
154452|NCT00739934|356096|P1|COMPLETED|Voriconazole IV||34
154453|NCT00739934|356096|P1|STARTED|Voriconazole IV||40
154454|NCT00739908|356118|P2|NOT COMPLETED|Overall Study||25
154455|NCT00739908|356119|P1|NOT COMPLETED|Overall Study||25
154456|NCT00739908|356118|P2|COMPLETED|Overall Study||118
154457|NCT00739908|356119|P1|COMPLETED|Overall Study||117
154458|NCT00739908|356118|P2|STARTED|Overall Study||143
154459|NCT00739908|356119|P1|STARTED|Overall Study||142
154460|NCT00739882|356139|P2|NOT COMPLETED|Open-label Period||5
154461|NCT00739882|356140|P1|NOT COMPLETED|Open-label Period||10
154462|NCT00739882|356139|P2|COMPLETED|Open-label Period||9
154463|NCT00739882|356140|P1|COMPLETED|Open-label Period||7
154464|NCT00739882|356139|P2|STARTED|Open-label Period||14
154465|NCT00739882|356140|P1|STARTED|Open-label Period||17
154466|NCT00739882|356139|P2|NOT COMPLETED|Double-blind Period||11
154467|NCT00739882|356140|P1|NOT COMPLETED|Double-blind Period||19
154468|NCT00739882|356139|P2|COMPLETED|Double-blind Period||14
154469|NCT00739882|356140|P1|COMPLETED|Double-blind Period||32
154470|NCT00739882|356139|P2|STARTED|Double-blind Period||25
154471|NCT00739882|356140|P1|STARTED|Double-blind Period||51
154472|NCT00739765|356161|P3|NOT COMPLETED|Overall Study||11
154473|NCT00739765|356162|P2|NOT COMPLETED|Overall Study||11
154474|NCT00739765|356163|P1|NOT COMPLETED|Overall Study||6
154475|NCT00739765|356161|P3|COMPLETED|Overall Study||21
154476|NCT00739765|356162|P2|COMPLETED|Overall Study||27
154477|NCT00739765|356163|P1|COMPLETED|Overall Study||34
154478|NCT00739765|356161|P3|STARTED|Overall Study||32
154479|NCT00739765|356162|P2|STARTED|Overall Study||38
154480|NCT00739765|356163|P1|STARTED|Overall Study||40
154481|NCT00739674|356176|P2|NOT COMPLETED|Overall Study||122
154482|NCT00739674|356177|P1|NOT COMPLETED|Overall Study||181
154483|NCT00739674|356176|P2|COMPLETED|Overall Study||335
154484|NCT00739674|356177|P1|COMPLETED|Overall Study||354
154485|NCT00739674|356176|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
154486|NCT00739674|356177|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
154487|NCT00739674|356176|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
154488|NCT00739674|356177|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
154489|NCT00739674|356176|P2|No Follow-up Data|Overall Study||18
154490|NCT00739674|356177|P1|No Follow-up Data|Overall Study||33
154572|NCT00739297|356281|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154491|NCT00739674|356176|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
154492|NCT00739674|356177|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
154493|NCT00739674|356176|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
154494|NCT00739674|356177|P1|Screening Failures|Overall Study||19
154495|NCT00739674|356176|P2|STARTED|Overall Study||457
154496|NCT00739674|356177|P1|STARTED|Overall Study||535
154497|NCT00739661|356205|P2|NOT COMPLETED|Overall Study||42
154498|NCT00739661|356206|P1|NOT COMPLETED|Overall Study||46
154499|NCT00739661|356205|P2|COMPLETED|Overall Study||10
154500|NCT00739661|356206|P1|COMPLETED|Overall Study||6
154501|NCT00739661|356205|P2|STARTED|Overall Study||52
154502|NCT00739661|356206|P1|STARTED|Overall Study||52
154503|NCT00739648|356218|P2|NOT COMPLETED|Overall Study||53
154504|NCT00739648|356219|P1|NOT COMPLETED|Overall Study||26
154505|NCT00739648|356218|P2|COMPLETED|Overall Study||161
154506|NCT00739648|356219|P1|COMPLETED|Overall Study||82
154507|NCT00739648|356218|P2|STARTED|Overall Study||214
154508|NCT00739648|356219|P1|STARTED|Overall Study||108
154509|NCT00739596|356233|P2|NOT COMPLETED|Overall Study||17
154510|NCT00739596|356234|P1|NOT COMPLETED|Overall Study||25
154511|NCT00739596|356233|P2|COMPLETED|Overall Study||149
154512|NCT00739596|356234|P1|COMPLETED|Overall Study||141
154513|NCT00739596|356233|P2|STARTED|Overall Study||166
154514|NCT00739596|356234|P1|STARTED|Overall Study||166
154515|NCT00739583|356250|P2|NOT COMPLETED|Overall Study||0
154516|NCT00739583|356251|P1|NOT COMPLETED|Overall Study||0
154517|NCT00739583|356250|P2|COMPLETED|Overall Study||10
154518|NCT00739583|356251|P1|COMPLETED|Overall Study||10
154519|NCT00739583|356250|P2|STARTED|Overall Study||10
154520|NCT00739583|356251|P1|STARTED|Overall Study||10
154521|NCT00739336|356263|P2|NOT COMPLETED|Overall Study||0
154522|NCT00739336|356264|P1|NOT COMPLETED|Overall Study||4
154523|NCT00739336|356263|P2|COMPLETED|Overall Study||24
154524|NCT00739336|356264|P1|COMPLETED|Overall Study||17
154525|NCT00739336|356263|P2|STARTED|Overall Study||24
154526|NCT00739336|356264|P1|STARTED|Overall Study||21
154527|NCT00739310|356276|P1|NOT COMPLETED|Overall Study||7
154528|NCT00739310|356276|P1|COMPLETED|Overall Study||22
154529|NCT00739310|356276|P1|STARTED|Overall Study||29
154530|NCT00739297|356281|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
154531|NCT00739297|356282|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
154532|NCT00739297|356283|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
154533|NCT00739297|356284|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
154534|NCT00739297|356285|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
154535|NCT00739297|356286|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
154536|NCT00739297|356287|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
154537|NCT00739297|356281|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
154538|NCT00739297|356282|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
154539|NCT00739297|356283|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
154540|NCT00739297|356284|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
154541|NCT00739297|356285|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
154542|NCT00739297|356286|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
154543|NCT00739297|356287|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
154544|NCT00739297|356281|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
154545|NCT00739297|356282|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
154546|NCT00739297|356283|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
154547|NCT00739297|356284|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
154548|NCT00739297|356285|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
154549|NCT00739297|356286|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
154550|NCT00739297|356287|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
154551|NCT00739297|356281|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154552|NCT00739297|356282|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154553|NCT00739297|356283|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154554|NCT00739297|356284|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154555|NCT00739297|356285|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154556|NCT00739297|356286|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154557|NCT00739297|356287|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
154558|NCT00739297|356281|P7|COMPLETED|Third Washout Period of 4-7 Days||66
154559|NCT00739297|356282|P6|COMPLETED|Third Washout Period of 4-7 Days||8
154560|NCT00739297|356283|P5|COMPLETED|Third Washout Period of 4-7 Days||6
154561|NCT00739297|356284|P4|COMPLETED|Third Washout Period of 4-7 Days||18
154562|NCT00739297|356285|P3|COMPLETED|Third Washout Period of 4-7 Days||6
154563|NCT00739297|356286|P2|COMPLETED|Third Washout Period of 4-7 Days||12
154564|NCT00739297|356287|P1|COMPLETED|Third Washout Period of 4-7 Days||16
154565|NCT00739297|356281|P7|STARTED|Third Washout Period of 4-7 Days||66
154566|NCT00739297|356282|P6|STARTED|Third Washout Period of 4-7 Days||8
154567|NCT00739297|356283|P5|STARTED|Third Washout Period of 4-7 Days||6
154568|NCT00739297|356284|P4|STARTED|Third Washout Period of 4-7 Days||18
154569|NCT00739297|356285|P3|STARTED|Third Washout Period of 4-7 Days||6
154570|NCT00739297|356286|P2|STARTED|Third Washout Period of 4-7 Days||12
154571|NCT00739297|356287|P1|STARTED|Third Washout Period of 4-7 Days||16
154649|NCT00739297|356281|P7|STARTED|First Washout Period of 4-7 Days||68
154573|NCT00739297|356282|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154574|NCT00739297|356283|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154575|NCT00739297|356284|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154576|NCT00739297|356285|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154577|NCT00739297|356286|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154578|NCT00739297|356287|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
154579|NCT00739297|356281|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
154580|NCT00739297|356282|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
154581|NCT00739297|356283|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
154582|NCT00739297|356284|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
154583|NCT00739297|356285|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
154584|NCT00739297|356286|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
154585|NCT00739297|356287|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
154586|NCT00739297|356281|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
154587|NCT00739297|356282|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
154588|NCT00739297|356283|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
154589|NCT00739297|356284|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
154590|NCT00739297|356285|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
154591|NCT00739297|356286|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
154592|NCT00739297|356287|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
154593|NCT00739297|356281|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154594|NCT00739297|356282|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154595|NCT00739297|356283|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154596|NCT00739297|356284|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154597|NCT00739297|356285|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154598|NCT00739297|356286|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154599|NCT00739297|356287|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
154600|NCT00739297|356281|P7|COMPLETED|Second Washout Period of 4-7 Days||66
154601|NCT00739297|356282|P6|COMPLETED|Second Washout Period of 4-7 Days||10
154602|NCT00739297|356283|P5|COMPLETED|Second Washout Period of 4-7 Days||6
154603|NCT00739297|356284|P4|COMPLETED|Second Washout Period of 4-7 Days||14
154604|NCT00739297|356285|P3|COMPLETED|Second Washout Period of 4-7 Days||10
154605|NCT00739297|356286|P2|COMPLETED|Second Washout Period of 4-7 Days||8
154606|NCT00739297|356287|P1|COMPLETED|Second Washout Period of 4-7 Days||18
154607|NCT00739297|356281|P7|STARTED|Second Washout Period of 4-7 Days||66
154608|NCT00739297|356282|P6|STARTED|Second Washout Period of 4-7 Days||10
154609|NCT00739297|356283|P5|STARTED|Second Washout Period of 4-7 Days||6
154610|NCT00739297|356284|P4|STARTED|Second Washout Period of 4-7 Days||14
154611|NCT00739297|356285|P3|STARTED|Second Washout Period of 4-7 Days||10
154612|NCT00739297|356286|P2|STARTED|Second Washout Period of 4-7 Days||8
154613|NCT00739297|356287|P1|STARTED|Second Washout Period of 4-7 Days||18
154614|NCT00739297|356281|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154615|NCT00739297|356282|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154616|NCT00739297|356283|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154617|NCT00739297|356284|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154618|NCT00739297|356285|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154619|NCT00739297|356286|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154620|NCT00739297|356287|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
154621|NCT00739297|356281|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
154622|NCT00739297|356282|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
154623|NCT00739297|356283|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
154624|NCT00739297|356284|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
154625|NCT00739297|356285|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
154626|NCT00739297|356286|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
154627|NCT00739297|356287|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
154628|NCT00739297|356281|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
154629|NCT00739297|356282|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
154630|NCT00739297|356283|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
154631|NCT00739297|356284|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
154632|NCT00739297|356285|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
154633|NCT00739297|356286|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
154634|NCT00739297|356287|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
154635|NCT00739297|356281|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
154636|NCT00739297|356282|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
154637|NCT00739297|356283|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
154638|NCT00739297|356284|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
154639|NCT00739297|356285|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
154640|NCT00739297|356286|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
154641|NCT00739297|356287|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
154642|NCT00739297|356281|P7|COMPLETED|First Washout Period of 4-7 Days||66
154643|NCT00739297|356282|P6|COMPLETED|First Washout Period of 4-7 Days||9
154644|NCT00739297|356283|P5|COMPLETED|First Washout Period of 4-7 Days||6
154645|NCT00739297|356284|P4|COMPLETED|First Washout Period of 4-7 Days||17
154646|NCT00739297|356285|P3|COMPLETED|First Washout Period of 4-7 Days||6
154647|NCT00739297|356286|P2|COMPLETED|First Washout Period of 4-7 Days||11
154648|NCT00739297|356287|P1|COMPLETED|First Washout Period of 4-7 Days||17
154650|NCT00739297|356282|P6|STARTED|First Washout Period of 4-7 Days||9
154651|NCT00739297|356283|P5|STARTED|First Washout Period of 4-7 Days||6
154652|NCT00739297|356284|P4|STARTED|First Washout Period of 4-7 Days||19
154653|NCT00739297|356285|P3|STARTED|First Washout Period of 4-7 Days||6
154654|NCT00739297|356286|P2|STARTED|First Washout Period of 4-7 Days||11
154655|NCT00739297|356287|P1|STARTED|First Washout Period of 4-7 Days||17
154656|NCT00739297|356281|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154657|NCT00739297|356282|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154658|NCT00739297|356283|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154659|NCT00739297|356284|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154660|NCT00739297|356285|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154661|NCT00739297|356286|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154662|NCT00739297|356287|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
154663|NCT00739297|356281|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
154664|NCT00739297|356282|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
154665|NCT00739297|356283|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
154666|NCT00739297|356284|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
154667|NCT00739297|356285|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
154668|NCT00739297|356286|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
154669|NCT00739297|356287|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
154670|NCT00739297|356281|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
154671|NCT00739297|356282|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
154672|NCT00739297|356283|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
154673|NCT00739297|356284|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
154674|NCT00739297|356285|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
154675|NCT00739297|356286|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
154676|NCT00739297|356287|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
154677|NCT00739102|356315|P1|NOT COMPLETED|Overall Study||15
154678|NCT00739102|356315|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
154679|NCT00739102|356315|P1|STARTED|Overall Study||250
154680|NCT00739063|356331|P1|NOT COMPLETED|Overall Study||8
154681|NCT00739063|356331|P1|COMPLETED|Overall Study||3
154682|NCT00739063|356331|P1|STARTED|Overall Study||11
154683|NCT00739050|356335|P2|NOT COMPLETED|Overall Study||0
154684|NCT00739050|356336|P1|NOT COMPLETED|Overall Study||1
154685|NCT00739050|356335|P2|COMPLETED|Overall Study||0
154686|NCT00739050|356336|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
154687|NCT00739050|356335|P2|STARTED|Overall Study||0
154688|NCT00739050|356336|P1|STARTED|Overall Study||4
154689|NCT00739024|356350|P2|NOT COMPLETED|Overall Study||0
154690|NCT00739024|356351|P1|NOT COMPLETED|Overall Study||0
154691|NCT00739024|356350|P2|COMPLETED|Overall Study||6
154692|NCT00739024|356351|P1|COMPLETED|Overall Study||7
154693|NCT00739024|356350|P2|STARTED|Overall Study||6
154694|NCT00739024|356351|P1|STARTED|Overall Study||7
154695|NCT00738972|356361|P4|NOT COMPLETED|Overall Study||1
154696|NCT00738972|356362|P3|NOT COMPLETED|Overall Study||0
154697|NCT00738972|356363|P2|NOT COMPLETED|Overall Study||0
154698|NCT00738972|356364|P1|NOT COMPLETED|Overall Study||0
154699|NCT00738972|356361|P4|COMPLETED|Overall Study||2
154700|NCT00738972|356362|P3|COMPLETED|Overall Study||3
154701|NCT00738972|356363|P2|COMPLETED|Overall Study||3
154702|NCT00738972|356364|P1|COMPLETED|Overall Study||3
154703|NCT00738972|356361|P4|STARTED|Overall Study||3
154704|NCT00738972|356362|P3|STARTED|Overall Study||3
154705|NCT00738972|356363|P2|STARTED|Overall Study||3
154706|NCT00738972|356364|P1|STARTED|Overall Study||3
154707|NCT00738881|356376|P2|NOT COMPLETED|Overall Study||2
154708|NCT00738881|356377|P1|NOT COMPLETED|Overall Study||0
154709|NCT00738881|356376|P2|COMPLETED|Overall Study||10
154710|NCT00738881|356377|P1|COMPLETED|Overall Study||11
154711|NCT00738881|356376|P2|STARTED|Overall Study||12
154712|NCT00738881|356377|P1|STARTED|Overall Study||11
154713|NCT00738673|356391|P2|NOT COMPLETED|Overall Study||11
154714|NCT00738673|356392|P1|NOT COMPLETED|Overall Study||24
154715|NCT00738673|356391|P2|COMPLETED|Overall Study||1
154716|NCT00738673|356392|P1|COMPLETED|Overall Study||1
154717|NCT00738673|356391|P2|Intent to Treat Population|Overall Study||12
154718|NCT00738673|356392|P1|Intent to Treat Population|Overall Study||24
154719|NCT00738673|356391|P2|STARTED|Overall Study||12
154720|NCT00738673|356392|P1|STARTED|Overall Study||25
154721|NCT00738543|356420|P1|NOT COMPLETED|Control||0
154722|NCT00738543|356420|P1|COMPLETED|Control||48
154723|NCT00738543|356420|P1|STARTED|Control||48
154724|NCT00738543|356420|P1|NOT COMPLETED|Sodium Hypochlorite||0
154725|NCT00738543|356420|P1|COMPLETED|Sodium Hypochlorite||48
154726|NCT00738543|356420|P1|STARTED|Sodium Hypochlorite||48
154727|NCT00738543|356420|P1|NOT COMPLETED|Povidone Iodine||0
154728|NCT00738543|356420|P1|COMPLETED|Povidone Iodine||48
154729|NCT00738543|356420|P1|STARTED|Povidone Iodine||48
154730|NCT00738530|356430|P2|NOT COMPLETED|Overall Study||238
154731|NCT00738530|356431|P1|NOT COMPLETED|Overall Study||234
154732|NCT00738530|356430|P2|COMPLETED|Overall Study||84
154733|NCT00738530|356431|P1|COMPLETED|Overall Study||93
154734|NCT00738530|356430|P2|Treated|Overall Study||316
154735|NCT00738530|356431|P1|Treated|Overall Study||325
154736|NCT00738530|356430|P2|STARTED|Overall Study||322
154737|NCT00738530|356431|P1|STARTED|Overall Study||327
154738|NCT00738426|356457|P2|NOT COMPLETED|Overall Study||3
154739|NCT00738426|356458|P1|NOT COMPLETED|Overall Study||2
154740|NCT00738426|356457|P2|COMPLETED|Overall Study||32
154741|NCT00738426|356458|P1|COMPLETED|Overall Study||35
154742|NCT00738426|356457|P2|STARTED|Overall Study||35
154743|NCT00738426|356458|P1|STARTED|Overall Study||37
154744|NCT00738400|356466|P2|NOT COMPLETED|Overall Study||7
154745|NCT00738400|356467|P1|NOT COMPLETED|Overall Study||4
154746|NCT00738400|356466|P2|COMPLETED|Overall Study||67
154747|NCT00738400|356467|P1|COMPLETED|Overall Study||72
154748|NCT00738400|356466|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
154749|NCT00738400|356467|P1|ITT (Intent To Treatment) Population|Overall Study||75
154750|NCT00738400|356466|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
154751|NCT00738400|356467|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
154752|NCT00738400|356466|P2|STARTED|Overall Study||74
154753|NCT00738400|356467|P1|STARTED|Overall Study||76
154754|NCT00738374|356488|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
154755|NCT00738374|356489|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
154756|NCT00738374|356490|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
154757|NCT00738374|356491|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
154758|NCT00738374|356488|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
154759|NCT00738374|356489|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
154760|NCT00738374|356490|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
154761|NCT00738374|356491|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
154762|NCT00738374|356488|P4|STARTED|Maintenance Treatment/Observation Phase||32
154763|NCT00738374|356489|P3|STARTED|Maintenance Treatment/Observation Phase||34
154764|NCT00738374|356490|P2|STARTED|Maintenance Treatment/Observation Phase||7
154765|NCT00738374|356491|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
154766|NCT00738374|356488|P4|NOT COMPLETED|Induction Treatment Phase||0
154767|NCT00738374|356489|P3|NOT COMPLETED|Induction Treatment Phase||0
154768|NCT00738374|356490|P2|NOT COMPLETED|Induction Treatment Phase||0
154769|NCT00738374|356491|P1|NOT COMPLETED|Induction Treatment Phase||24
154770|NCT00738374|356488|P4|COMPLETED|Induction Treatment Phase||0
154771|NCT00738374|356489|P3|COMPLETED|Induction Treatment Phase||0
154772|NCT00738374|356490|P2|COMPLETED|Induction Treatment Phase||0
154773|NCT00738374|356491|P1|COMPLETED|Induction Treatment Phase||73
154774|NCT00738374|356488|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
154775|NCT00738374|356489|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
154776|NCT00738374|356490|P2|STARTED|Induction Treatment Phase||0
154777|NCT00738374|356491|P1|STARTED|Induction Treatment Phase||97
154778|NCT00738361|356523|P1|NOT COMPLETED|Overall Study||0
154779|NCT00738361|356523|P1|COMPLETED|Overall Study||4
154780|NCT00738361|356523|P1|STARTED|Overall Study||4
154781|NCT00738283|356529|P1|NOT COMPLETED|Overall Study||4
154782|NCT00738283|356529|P1|COMPLETED|Overall Study||13
154783|NCT00738283|356529|P1|STARTED|Overall Study||17
154784|NCT00738062|356536|P3|NOT COMPLETED|Open-Label Extension||0
154785|NCT00738062|356537|P2|NOT COMPLETED|Open-Label Extension||0
154786|NCT00738062|356538|P1|NOT COMPLETED|Open-Label Extension||17
154787|NCT00738062|356536|P3|COMPLETED|Open-Label Extension||0
154788|NCT00738062|356537|P2|COMPLETED|Open-Label Extension||0
154789|NCT00738062|356538|P1|COMPLETED|Open-Label Extension||57
154790|NCT00738062|356536|P3|STARTED|Open-Label Extension||0
154791|NCT00738062|356537|P2|STARTED|Open-Label Extension||0
154792|NCT00738062|356538|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
154793|NCT00738062|356536|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
154794|NCT00738062|356537|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
154795|NCT00738062|356538|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
154796|NCT00738062|356536|P3|COMPLETED|2 Week Randomized Withdrawal||37
154797|NCT00738062|356537|P2|COMPLETED|2 Week Randomized Withdrawal||38
154798|NCT00738062|356538|P1|COMPLETED|2 Week Randomized Withdrawal||0
154799|NCT00738062|356536|P3|STARTED|2 Week Randomized Withdrawal||37
154800|NCT00738062|356537|P2|STARTED|2 Week Randomized Withdrawal||38
154801|NCT00738062|356538|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
154802|NCT00738062|356536|P3|NOT COMPLETED|Open Label Treatment||0
154803|NCT00738062|356537|P2|NOT COMPLETED|Open Label Treatment||0
154804|NCT00738062|356538|P1|NOT COMPLETED|Open Label Treatment||28
154805|NCT00738062|356536|P3|COMPLETED|Open Label Treatment||0
154806|NCT00738062|356537|P2|COMPLETED|Open Label Treatment||0
154807|NCT00738062|356538|P1|COMPLETED|Open Label Treatment||75
154808|NCT00738062|356536|P3|STARTED|Open Label Treatment||0
154809|NCT00738062|356537|P2|STARTED|Open Label Treatment||0
154810|NCT00738062|356538|P1|STARTED|Open Label Treatment||103
154811|NCT00738049|356565|P2|NOT COMPLETED|Washout||0
154812|NCT00738049|356566|P1|NOT COMPLETED|Washout||0
154813|NCT00738049|356565|P2|COMPLETED|Washout||7
154814|NCT00738049|356566|P1|COMPLETED|Washout||13
154815|NCT00738049|356565|P2|STARTED|Washout||7
154816|NCT00738049|356566|P1|STARTED|Washout||13
154817|NCT00738049|356565|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
154818|NCT00738049|356566|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
154819|NCT00738049|356565|P2|COMPLETED|2nd Intervention(14 Days)||7
154820|NCT00738049|356566|P1|COMPLETED|2nd Intervention(14 Days)||13
154821|NCT00738049|356565|P2|STARTED|2nd Intervention(14 Days)||7
154822|NCT00738049|356566|P1|STARTED|2nd Intervention(14 Days)||13
154823|NCT00738049|356565|P2|NOT COMPLETED|1st Intervention(14 Days)||0
154824|NCT00738049|356566|P1|NOT COMPLETED|1st Intervention(14 Days)||0
154825|NCT00738049|356565|P2|COMPLETED|1st Intervention(14 Days)||7
154826|NCT00738049|356566|P1|COMPLETED|1st Intervention(14 Days)||13
154827|NCT00738049|356565|P2|STARTED|1st Intervention(14 Days)||7
154828|NCT00738049|356566|P1|STARTED|1st Intervention(14 Days)||13
154829|NCT00738023|356580|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
154830|NCT00738023|356581|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
154831|NCT00738023|356580|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
154832|NCT00738023|356581|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
154833|NCT00738023|356580|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
154834|NCT00738023|356581|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
154835|NCT00738023|356580|P2|NOT COMPLETED|Saline Infusion||0
154836|NCT00738023|356581|P1|NOT COMPLETED|Saline Infusion||0
154837|NCT00738023|356580|P2|COMPLETED|Saline Infusion||0
154838|NCT00738023|356581|P1|COMPLETED|Saline Infusion||19
154839|NCT00738023|356580|P2|STARTED|Saline Infusion||0
154840|NCT00738023|356581|P1|STARTED|Saline Infusion||19
154841|NCT00738023|356580|P2|NOT COMPLETED|Intralipid Infusion||0
154842|NCT00738023|356581|P1|NOT COMPLETED|Intralipid Infusion||0
154843|NCT00738023|356580|P2|COMPLETED|Intralipid Infusion||13
154844|NCT00738023|356581|P1|COMPLETED|Intralipid Infusion||19
154845|NCT00738023|356580|P2|STARTED|Intralipid Infusion||13
154846|NCT00738023|356581|P1|STARTED|Intralipid Infusion||19
154847|NCT00737737|356591|P2|NOT COMPLETED|Overall Study||0
154848|NCT00737737|356592|P1|NOT COMPLETED|Overall Study||0
154849|NCT00737737|356591|P2|COMPLETED|Overall Study||2
154850|NCT00737737|356592|P1|COMPLETED|Overall Study||2
154851|NCT00737737|356591|P2|STARTED|Overall Study||2
154852|NCT00737737|356592|P1|STARTED|Overall Study||2
154853|NCT00737711|356600|P1|NOT COMPLETED|Overall Study||31
154854|NCT00737711|356600|P1|COMPLETED|Overall Study||158
154855|NCT00737711|356600|P1|STARTED|Overall Study||189
154856|NCT00737672|356633|P2|NOT COMPLETED|Overall Study||83
154857|NCT00737672|356634|P1|NOT COMPLETED|Overall Study||80
154858|NCT00737672|356633|P2|COMPLETED|Overall Study||65
154859|NCT00737672|356634|P1|COMPLETED|Overall Study||65
154860|NCT00737672|356633|P2|Per Protocol Population|Overall Study||138
154861|NCT00737672|356634|P1|Per Protocol Population|Overall Study||131
154862|NCT00737672|356633|P2|Exclusions Due to Protocol Deviations|Overall Study||10
154863|NCT00737672|356634|P1|Exclusions Due to Protocol Deviations|Overall Study||14
154864|NCT00737672|356633|P2|STARTED|Overall Study||148
154865|NCT00737672|356634|P1|STARTED|Overall Study||145
154866|NCT00737633|356672|P2|NOT COMPLETED|Overall Study||57
154867|NCT00737633|356673|P1|NOT COMPLETED|Overall Study||44
154868|NCT00737633|356672|P2|COMPLETED|Overall Study||0
154869|NCT00737633|356673|P1|COMPLETED|Overall Study||0
154870|NCT00737633|356672|P2|STARTED|Overall Study||57
154871|NCT00737633|356673|P1|STARTED|Overall Study||44
154872|NCT00737594|356684|P3|NOT COMPLETED|Overall Study||0
154873|NCT00737594|356685|P2|NOT COMPLETED|Overall Study||0
154874|NCT00737594|356686|P1|NOT COMPLETED|Overall Study||0
154875|NCT00737594|356684|P3|COMPLETED|Overall Study||0
154876|NCT00737594|356685|P2|COMPLETED|Overall Study||0
154877|NCT00737594|356686|P1|COMPLETED|Overall Study||0
154878|NCT00737594|356684|P3|STARTED|Overall Study||0
154879|NCT00737594|356685|P2|STARTED|Overall Study||0
154880|NCT00737594|356686|P1|STARTED|Overall Study||0
154881|NCT00737568|356696|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
154882|NCT00737568|356697|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
154883|NCT00737568|356696|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
154884|NCT00737568|356697|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
154885|NCT00737568|356696|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
154886|NCT00737568|356697|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
154887|NCT00737568|356696|P2|NOT COMPLETED|Treatment Period Through Week 240||21
154888|NCT00737568|356697|P1|NOT COMPLETED|Treatment Period Through Week 240||20
154889|NCT00737568|356696|P2|COMPLETED|Treatment Period Through Week 240||118
154890|NCT00737568|356697|P1|COMPLETED|Treatment Period Through Week 240||121
154891|NCT00737568|356696|P2|STARTED|Treatment Period Through Week 240||139
154892|NCT00737568|356697|P1|STARTED|Treatment Period Through Week 240||141
154893|NCT00737529|356727|P1|NOT COMPLETED|Overall Study||112
154894|NCT00737529|356727|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
154895|NCT00737529|356727|P1|STARTED|Overall Study||134
154896|NCT00737477|356741|P1|NOT COMPLETED|Overall Study||34
154897|NCT00737477|356741|P1|COMPLETED|Overall Study||62
154898|NCT00737477|356741|P1|STARTED|Overall Study||96
154899|NCT00737464|356757|P1|NOT COMPLETED|Overall Study||18
154900|NCT00737464|356757|P1|COMPLETED|Overall Study||114
154901|NCT00737464|356757|P1|STARTED|Overall Study||132
154902|NCT00737438|356778|P1|NOT COMPLETED|Overall Study||3
154903|NCT00737438|356778|P1|COMPLETED|Overall Study||20
154904|NCT00737438|356778|P1|STARTED|Overall Study||23
154905|NCT00737360|356782|P1|NOT COMPLETED|Overall Study||0
154906|NCT00737360|356782|P1|COMPLETED|Overall Study||27
154907|NCT00737360|356782|P1|STARTED|Overall Study||27
154908|NCT00737282|356791|P1|NOT COMPLETED|Overall Study||175
154909|NCT00737282|356791|P1|COMPLETED|Overall Study||0
154910|NCT00737282|356791|P1|STARTED|Overall Study||175
154911|NCT00737243|356797|P1|NOT COMPLETED|Overall Study||95
154912|NCT00737243|356797|P1|COMPLETED|Overall Study||194
154913|NCT00737243|356797|P1|Empiric CUP Therapy|Overall Study||29
154914|NCT00737243|356797|P1|Site Specific Therapy Less Responsive|Overall Study||79
154915|NCT00737243|356797|P1|Site Specific Therapy More Responsive|Overall Study||115
154916|NCT00737243|356797|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
154917|NCT00737243|356797|P1|Treated|Overall Study||223
154918|NCT00737243|356797|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
154919|NCT00737243|356797|P1|Successful Assay Performed|Overall Study||252
154920|NCT00737243|356797|P1|STARTED|Overall Study||289
154921|NCT00737204|356805|P2|NOT COMPLETED|Overall Study||6
154922|NCT00737204|356806|P1|NOT COMPLETED|Overall Study||0
154923|NCT00737204|356805|P2|COMPLETED|Overall Study||28
154924|NCT00737204|356806|P1|COMPLETED|Overall Study||36
154925|NCT00737204|356805|P2|STARTED|Overall Study||34
154926|NCT00737204|356806|P1|STARTED|Overall Study||36
154927|NCT00737178|356820|P2|NOT COMPLETED|Overall Study||9
154928|NCT00737178|356821|P1|NOT COMPLETED|Overall Study||5
154929|NCT00737178|356820|P2|COMPLETED|Overall Study||76
154930|NCT00737178|356821|P1|COMPLETED|Overall Study||66
154931|NCT00737178|356820|P2|STARTED|Overall Study||85
154932|NCT00737178|356821|P1|STARTED|Overall Study||71
154933|NCT00737100|356834|P3|NOT COMPLETED|Overall Study||7
154934|NCT00737100|356835|P2|NOT COMPLETED|Overall Study||7
154935|NCT00737100|356836|P1|NOT COMPLETED|Overall Study||7
154936|NCT00737100|356834|P3|COMPLETED|Overall Study||169
154937|NCT00737100|356835|P2|COMPLETED|Overall Study||159
154938|NCT00737100|356836|P1|COMPLETED|Overall Study||161
154939|NCT00737100|356834|P3|STARTED|Overall Study||176
154940|NCT00737100|356835|P2|STARTED|Overall Study||166
154941|NCT00737100|356836|P1|STARTED|Overall Study||168
154942|NCT00737061|356880|P1|NOT COMPLETED|1 Year Wearing Period||17
154943|NCT00737061|356880|P1|COMPLETED|1 Year Wearing Period||553
154944|NCT00737061|356880|P1|STARTED|1 Year Wearing Period||570
154945|NCT00737061|356880|P1|NOT COMPLETED|Waiting Period||75
154946|NCT00737061|356880|P1|COMPLETED|Waiting Period||570
154947|NCT00737061|356880|P1|STARTED|Waiting Period||645
154948|NCT00737048|356897|P3|NOT COMPLETED|Overall Study||4
154949|NCT00737048|356898|P2|NOT COMPLETED|Overall Study||6
154950|NCT00737048|356899|P1|NOT COMPLETED|Overall Study||3
154951|NCT00737048|356897|P3|COMPLETED|Overall Study||126
154952|NCT00737048|356898|P2|COMPLETED|Overall Study||60
154953|NCT00737048|356899|P1|COMPLETED|Overall Study||129
154954|NCT00737048|356897|P3|STARTED|Overall Study||130
154955|NCT00737048|356898|P2|STARTED|Overall Study||66
154956|NCT00737048|356899|P1|STARTED|Overall Study||132
154957|NCT00736996|356943|P3|NOT COMPLETED|Overall Study||2
154958|NCT00736996|356944|P2|NOT COMPLETED|Overall Study||9
154959|NCT00736996|356945|P1|NOT COMPLETED|Overall Study||1
154960|NCT00736996|356943|P3|COMPLETED|Overall Study||25
154961|NCT00736996|356944|P2|COMPLETED|Overall Study||17
154962|NCT00736996|356945|P1|COMPLETED|Overall Study||24
154963|NCT00736996|356943|P3|STARTED|Overall Study||27
154964|NCT00736996|356944|P2|STARTED|Overall Study||26
154965|NCT00736996|356945|P1|STARTED|Overall Study||25
154966|NCT00736957|356959|P1|NOT COMPLETED|Overall Study||122
154967|NCT00736957|356959|P1|COMPLETED|Overall Study||97
154968|NCT00736957|356959|P1|Treated|Overall Study||190
154969|NCT00736957|356959|P1|STARTED|Overall Study||219
154970|NCT00736944|356969|P1|NOT COMPLETED|Definitive Treatment||1
154971|NCT00736944|356969|P1|COMPLETED|Definitive Treatment||28
154972|NCT00736944|356969|P1|STARTED|Definitive Treatment||29
154973|NCT00736944|356969|P1|NOT COMPLETED|Induction||1
154974|NCT00736944|356969|P1|COMPLETED|Induction||29
154975|NCT00736944|356969|P1|STARTED|Induction||30
154976|NCT00736879|357000|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
154977|NCT00736879|357001|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
154978|NCT00736879|357002|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
154979|NCT00736879|357003|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
154980|NCT00736879|357000|P4|COMPLETED|Follow up Period - No Drug Treatment||62
154981|NCT00736879|357001|P3|COMPLETED|Follow up Period - No Drug Treatment||66
154982|NCT00736879|357002|P2|COMPLETED|Follow up Period - No Drug Treatment||67
154983|NCT00736879|357003|P1|COMPLETED|Follow up Period - No Drug Treatment||65
154984|NCT00736879|357000|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
154985|NCT00736879|357001|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
154986|NCT00736879|357002|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
155080|NCT00736489|357133|P1|NOT COMPLETED|Period 4||0
154987|NCT00736879|357003|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
154988|NCT00736879|357000|P4|NOT COMPLETED|Double Blind Treatment Period||5
154989|NCT00736879|357001|P3|NOT COMPLETED|Double Blind Treatment Period||7
154990|NCT00736879|357002|P2|NOT COMPLETED|Double Blind Treatment Period||4
154991|NCT00736879|357003|P1|NOT COMPLETED|Double Blind Treatment Period||3
154992|NCT00736879|357000|P4|COMPLETED|Double Blind Treatment Period||63
154993|NCT00736879|357001|P3|COMPLETED|Double Blind Treatment Period||67
154994|NCT00736879|357002|P2|COMPLETED|Double Blind Treatment Period||68
154995|NCT00736879|357003|P1|COMPLETED|Double Blind Treatment Period||65
154996|NCT00736879|357000|P4|STARTED|Double Blind Treatment Period||68
154997|NCT00736879|357001|P3|STARTED|Double Blind Treatment Period||74
154998|NCT00736879|357002|P2|STARTED|Double Blind Treatment Period||72
154999|NCT00736879|357003|P1|STARTED|Double Blind Treatment Period||68
155000|NCT00736853|357057|P3|NOT COMPLETED|Double-Blind Period||48
155001|NCT00736853|357058|P2|NOT COMPLETED|Double-Blind Period||24
155002|NCT00736853|357059|P1|NOT COMPLETED|Double-Blind Period||0
155003|NCT00736853|357057|P3|COMPLETED|Double-Blind Period||45
155004|NCT00736853|357058|P2|COMPLETED|Double-Blind Period||70
155005|NCT00736853|357059|P1|COMPLETED|Double-Blind Period||0
155006|NCT00736853|357057|P3|STARTED|Double-Blind Period||93
155007|NCT00736853|357058|P2|STARTED|Double-Blind Period||94
155008|NCT00736853|357059|P1|STARTED|Double-Blind Period||0
155009|NCT00736853|357057|P3|NOT COMPLETED|Open-Label Period||0
155010|NCT00736853|357058|P2|NOT COMPLETED|Open-Label Period||0
155011|NCT00736853|357059|P1|NOT COMPLETED|Open-Label Period||132
155012|NCT00736853|357057|P3|COMPLETED|Open-Label Period||0
155013|NCT00736853|357058|P2|COMPLETED|Open-Label Period||0
155014|NCT00736853|357059|P1|COMPLETED|Open-Label Period||187
155015|NCT00736853|357057|P3|Treated|Open-Label Period||0
155016|NCT00736853|357058|P2|Treated|Open-Label Period||0
155017|NCT00736853|357059|P1|Treated|Open-Label Period||277
155018|NCT00736853|357057|P3|STARTED|Open-Label Period||0
155019|NCT00736853|357058|P2|STARTED|Open-Label Period||0
155020|NCT00736853|357059|P1|STARTED|Open-Label Period||319
155021|NCT00736840|357099|P1|NOT COMPLETED|Overall Study||13
155022|NCT00736840|357099|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
155023|NCT00736840|357099|P1|STARTED|Overall Study||414
155024|NCT00736723|357106|P2|NOT COMPLETED|Overall Study||3
155025|NCT00736723|357107|P1|NOT COMPLETED|Overall Study||4
155026|NCT00736723|357106|P2|COMPLETED|Overall Study||18
155027|NCT00736723|357107|P1|COMPLETED|Overall Study||26
155028|NCT00736723|357106|P2|STARTED|Overall Study||21
155029|NCT00736723|357107|P1|STARTED|Overall Study||30
155030|NCT00736580|357115|P2|NOT COMPLETED|Overall Study||0
155031|NCT00736580|357116|P1|NOT COMPLETED|Overall Study||0
155032|NCT00736580|357115|P2|COMPLETED|Overall Study||123
155033|NCT00736580|357116|P1|COMPLETED|Overall Study||117
155034|NCT00736580|357115|P2|STARTED|Overall Study||123
155035|NCT00736580|357116|P1|STARTED|Overall Study||117
155036|NCT00736502|357122|P1|NOT COMPLETED|Overall Study||65
155037|NCT00736502|357122|P1|COMPLETED|Overall Study||213
155038|NCT00736502|357122|P1|STARTED|Overall Study|Entered and treated.|278
155039|NCT00736489|357128|P6|NOT COMPLETED|Period 6||0
155040|NCT00736489|357129|P5|NOT COMPLETED|Period 6||0
155041|NCT00736489|357130|P4|NOT COMPLETED|Period 6||0
155042|NCT00736489|357131|P3|NOT COMPLETED|Period 6||0
155043|NCT00736489|357132|P2|NOT COMPLETED|Period 6||0
155044|NCT00736489|357133|P1|NOT COMPLETED|Period 6||0
155045|NCT00736489|357128|P6|COMPLETED|Period 6||5
155046|NCT00736489|357129|P5|COMPLETED|Period 6||7
155047|NCT00736489|357130|P4|COMPLETED|Period 6||7
155048|NCT00736489|357131|P3|COMPLETED|Period 6||6
155049|NCT00736489|357132|P2|COMPLETED|Period 6||5
155050|NCT00736489|357133|P1|COMPLETED|Period 6||5
155051|NCT00736489|357128|P6|STARTED|Period 6||5
155052|NCT00736489|357129|P5|STARTED|Period 6||7
155053|NCT00736489|357130|P4|STARTED|Period 6||7
155054|NCT00736489|357131|P3|STARTED|Period 6||6
155055|NCT00736489|357132|P2|STARTED|Period 6||5
155056|NCT00736489|357133|P1|STARTED|Period 6||5
155057|NCT00736489|357128|P6|NOT COMPLETED|Period 5||0
155058|NCT00736489|357129|P5|NOT COMPLETED|Period 5||0
155059|NCT00736489|357130|P4|NOT COMPLETED|Period 5||0
155060|NCT00736489|357131|P3|NOT COMPLETED|Period 5||0
155061|NCT00736489|357132|P2|NOT COMPLETED|Period 5||0
155062|NCT00736489|357133|P1|NOT COMPLETED|Period 5||0
155063|NCT00736489|357128|P6|COMPLETED|Period 5||5
155064|NCT00736489|357129|P5|COMPLETED|Period 5||7
155065|NCT00736489|357130|P4|COMPLETED|Period 5||7
155066|NCT00736489|357131|P3|COMPLETED|Period 5||6
155067|NCT00736489|357132|P2|COMPLETED|Period 5||5
155068|NCT00736489|357133|P1|COMPLETED|Period 5||5
155069|NCT00736489|357128|P6|STARTED|Period 5||5
155070|NCT00736489|357129|P5|STARTED|Period 5||7
155071|NCT00736489|357130|P4|STARTED|Period 5||7
155072|NCT00736489|357131|P3|STARTED|Period 5||6
155073|NCT00736489|357132|P2|STARTED|Period 5||5
155074|NCT00736489|357133|P1|STARTED|Period 5||5
155075|NCT00736489|357128|P6|NOT COMPLETED|Period 4||0
155076|NCT00736489|357129|P5|NOT COMPLETED|Period 4||0
155077|NCT00736489|357130|P4|NOT COMPLETED|Period 4||0
155078|NCT00736489|357131|P3|NOT COMPLETED|Period 4||0
155079|NCT00736489|357132|P2|NOT COMPLETED|Period 4||0
155081|NCT00736489|357128|P6|COMPLETED|Period 4||5
155082|NCT00736489|357129|P5|COMPLETED|Period 4||7
155083|NCT00736489|357130|P4|COMPLETED|Period 4||7
155084|NCT00736489|357131|P3|COMPLETED|Period 4||6
155085|NCT00736489|357132|P2|COMPLETED|Period 4||5
155086|NCT00736489|357133|P1|COMPLETED|Period 4||5
155087|NCT00736489|357128|P6|STARTED|Period 4||5
155088|NCT00736489|357129|P5|STARTED|Period 4||7
155089|NCT00736489|357130|P4|STARTED|Period 4||7
155090|NCT00736489|357131|P3|STARTED|Period 4||6
155091|NCT00736489|357132|P2|STARTED|Period 4||5
155092|NCT00736489|357133|P1|STARTED|Period 4||5
155093|NCT00736489|357128|P6|NOT COMPLETED|Period 3||0
155094|NCT00736489|357129|P5|NOT COMPLETED|Period 3||0
155095|NCT00736489|357130|P4|NOT COMPLETED|Period 3||0
155096|NCT00736489|357131|P3|NOT COMPLETED|Period 3||0
155097|NCT00736489|357132|P2|NOT COMPLETED|Period 3||0
155098|NCT00736489|357133|P1|NOT COMPLETED|Period 3||0
155099|NCT00736489|357128|P6|COMPLETED|Period 3||5
155100|NCT00736489|357129|P5|COMPLETED|Period 3||7
155101|NCT00736489|357130|P4|COMPLETED|Period 3||7
155102|NCT00736489|357131|P3|COMPLETED|Period 3||6
155103|NCT00736489|357132|P2|COMPLETED|Period 3||5
155104|NCT00736489|357133|P1|COMPLETED|Period 3||5
155105|NCT00736489|357128|P6|STARTED|Period 3||5
155106|NCT00736489|357129|P5|STARTED|Period 3||7
155107|NCT00736489|357130|P4|STARTED|Period 3||7
155108|NCT00736489|357131|P3|STARTED|Period 3||6
155109|NCT00736489|357132|P2|STARTED|Period 3||5
155110|NCT00736489|357133|P1|STARTED|Period 3||5
155111|NCT00736489|357128|P6|NOT COMPLETED|Period 2||0
155112|NCT00736489|357129|P5|NOT COMPLETED|Period 2||0
155113|NCT00736489|357130|P4|NOT COMPLETED|Period 2||0
155114|NCT00736489|357131|P3|NOT COMPLETED|Period 2||0
155115|NCT00736489|357132|P2|NOT COMPLETED|Period 2||0
155116|NCT00736489|357133|P1|NOT COMPLETED|Period 2||0
155117|NCT00736489|357128|P6|COMPLETED|Period 2||5
155118|NCT00736489|357129|P5|COMPLETED|Period 2||7
155119|NCT00736489|357130|P4|COMPLETED|Period 2||7
155120|NCT00736489|357131|P3|COMPLETED|Period 2||6
155121|NCT00736489|357132|P2|COMPLETED|Period 2||5
155122|NCT00736489|357133|P1|COMPLETED|Period 2||5
155123|NCT00736489|357128|P6|STARTED|Period 2||5
155124|NCT00736489|357129|P5|STARTED|Period 2||7
155125|NCT00736489|357130|P4|STARTED|Period 2||7
155126|NCT00736489|357131|P3|STARTED|Period 2||6
155127|NCT00736489|357132|P2|STARTED|Period 2||5
155128|NCT00736489|357133|P1|STARTED|Period 2||5
155129|NCT00736489|357128|P6|NOT COMPLETED|Period 1||1
155130|NCT00736489|357129|P5|NOT COMPLETED|Period 1||0
155131|NCT00736489|357130|P4|NOT COMPLETED|Period 1||0
155132|NCT00736489|357131|P3|NOT COMPLETED|Period 1||0
155133|NCT00736489|357132|P2|NOT COMPLETED|Period 1||0
155134|NCT00736489|357133|P1|NOT COMPLETED|Period 1||1
155135|NCT00736489|357128|P6|COMPLETED|Period 1||5
155136|NCT00736489|357129|P5|COMPLETED|Period 1||7
155137|NCT00736489|357130|P4|COMPLETED|Period 1||7
155138|NCT00736489|357131|P3|COMPLETED|Period 1||6
155139|NCT00736489|357132|P2|COMPLETED|Period 1||5
155140|NCT00736489|357133|P1|COMPLETED|Period 1||5
155141|NCT00736489|357128|P6|STARTED|Period 1||6
155142|NCT00736489|357129|P5|STARTED|Period 1||7
155143|NCT00736489|357130|P4|STARTED|Period 1||7
155144|NCT00736489|357131|P3|STARTED|Period 1||6
155145|NCT00736489|357132|P2|STARTED|Period 1||5
155146|NCT00736489|357133|P1|STARTED|Period 1|Cross-over study|6
155147|NCT00736385|357287|P2|NOT COMPLETED|Overall Study||3
155148|NCT00736385|357288|P1|NOT COMPLETED|Overall Study||2
155149|NCT00736385|357287|P2|COMPLETED|Overall Study||2
155150|NCT00736385|357288|P1|COMPLETED|Overall Study||2
155151|NCT00736385|357287|P2|STARTED|Overall Study||5
155152|NCT00736385|357288|P1|STARTED|Overall Study||4
155153|NCT00736333|357300|P1|NOT COMPLETED|Overall Study||111
155154|NCT00736333|357300|P1|COMPLETED|Overall Study||56
155155|NCT00736333|357300|P1|STARTED|Overall Study||167
155156|NCT00736255|357311|P2|NOT COMPLETED|Overall Study||1
155157|NCT00736255|357312|P1|NOT COMPLETED|Overall Study||3
155158|NCT00736255|357311|P2|COMPLETED|Overall Study||14
155159|NCT00736255|357312|P1|COMPLETED|Overall Study||14
155160|NCT00736255|357311|P2|STARTED|Overall Study||15
155161|NCT00736255|357312|P1|STARTED|Overall Study||17
155162|NCT00736242|357322|P1|NOT COMPLETED|Overall Study||125
155163|NCT00736242|357322|P1|COMPLETED|Overall Study||107
155164|NCT00736242|357322|P1|Participants in Safety Analysis Set|Overall Study||229
155165|NCT00736242|357322|P1|STARTED|Overall Study||232
155166|NCT00736229|357336|P3|NOT COMPLETED|Overall Study||0
155167|NCT00736229|357337|P2|NOT COMPLETED|Overall Study||0
155168|NCT00736229|357338|P1|NOT COMPLETED|Overall Study||0
155169|NCT00736229|357336|P3|COMPLETED|Overall Study||84
155170|NCT00736229|357337|P2|COMPLETED|Overall Study||71
155171|NCT00736229|357338|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
155172|NCT00736229|357336|P3|STARTED|Overall Study|Historic Control|84
155173|NCT00736229|357337|P2|STARTED|Overall Study|Historic control|71
155174|NCT00736229|357338|P1|STARTED|Overall Study|Actively Enrolled|40
155175|NCT00736190|357351|P1|NOT COMPLETED|Overall Study||3
155176|NCT00736190|357351|P1|COMPLETED|Overall Study||87
155177|NCT00736190|357351|P1|STARTED|Overall Study||90
155178|NCT00736125|357366|P2|NOT COMPLETED|Overall Study||2
155179|NCT00736125|357367|P1|NOT COMPLETED|Overall Study||1
155180|NCT00736125|357366|P2|COMPLETED|Overall Study||8
155181|NCT00736125|357367|P1|COMPLETED|Overall Study||9
155182|NCT00736125|357366|P2|STARTED|Overall Study||10
155183|NCT00736125|357367|P1|STARTED|Overall Study||10
155184|NCT00736099|357377|P2|NOT COMPLETED|Overall Study||58
155185|NCT00736099|357378|P1|NOT COMPLETED|Overall Study||183
155186|NCT00736099|357377|P2|COMPLETED|Overall Study|Number who completed treatment.|531
155187|NCT00736099|357378|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
155188|NCT00736099|357377|P2|STARTED|Overall Study|Number who started treatment.|589
155189|NCT00736099|357378|P1|STARTED|Overall Study|Number who started treatment.|1532
155190|NCT00736073|357476|P2|NOT COMPLETED|Overall Study||0
155191|NCT00736073|357477|P1|NOT COMPLETED|Overall Study||0
155192|NCT00736073|357476|P2|COMPLETED|Overall Study||39
155193|NCT00736073|357477|P1|COMPLETED|Overall Study||34
155194|NCT00736073|357476|P2|STARTED|Overall Study||39
155195|NCT00736073|357477|P1|STARTED|Overall Study||34
155196|NCT00736034|357487|P1|NOT COMPLETED|Overall Study||2
155197|NCT00736034|357487|P1|COMPLETED|Overall Study||16
155198|NCT00736034|357487|P1|STARTED|Overall Study||18
155199|NCT00735969|357491|P1|NOT COMPLETED|Overall Study||0
155200|NCT00735969|357491|P1|COMPLETED|Overall Study||21
155201|NCT00735969|357491|P1|STARTED|Overall Study||21
155202|NCT00735943|357495|P1|NOT COMPLETED|Overall Study||2
155203|NCT00735943|357495|P1|COMPLETED|Overall Study||20
155204|NCT00735943|357495|P1|STARTED|Overall Study||22
155205|NCT00735917|357512|P1|NOT COMPLETED|Overall Study||0
155206|NCT00735917|357512|P1|COMPLETED|Overall Study||19
155207|NCT00735917|357512|P1|STARTED|Overall Study||19
155208|NCT00735904|357520|P1|NOT COMPLETED|Overall Study||38
155209|NCT00735904|357520|P1|COMPLETED|Overall Study||0
155210|NCT00735904|357520|P1|STARTED|Overall Study||38
155211|NCT00735839|357529|P2|NOT COMPLETED|Overall Study||0
155212|NCT00735839|357530|P1|NOT COMPLETED|Overall Study||0
155213|NCT00735839|357529|P2|COMPLETED|Overall Study||10
155214|NCT00735839|357530|P1|COMPLETED|Overall Study||30
155215|NCT00735839|357529|P2|STARTED|Overall Study||10
155216|NCT00735839|357530|P1|STARTED|Overall Study||30
155217|NCT00735787|357540|P2|NOT COMPLETED|Period 2||1
155218|NCT00735787|357541|P1|NOT COMPLETED|Period 2||5
155219|NCT00735787|357540|P2|COMPLETED|Period 2||40
155220|NCT00735787|357541|P1|COMPLETED|Period 2||13
155221|NCT00735787|357540|P2|STARTED|Period 2||41
155222|NCT00735787|357541|P1|STARTED|Period 2||18
155223|NCT00735787|357540|P2|NOT COMPLETED|Period 1||8
155224|NCT00735787|357541|P1|NOT COMPLETED|Period 1||6
155225|NCT00735787|357540|P2|COMPLETED|Period 1||41
155226|NCT00735787|357541|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
155227|NCT00735787|357540|P2|STARTED|Period 1||49
155228|NCT00735787|357541|P1|STARTED|Period 1||23
155229|NCT00735709|357589|P4|NOT COMPLETED|Overall Study||18
155230|NCT00735709|357590|P3|NOT COMPLETED|Overall Study||11
155231|NCT00735709|357591|P2|NOT COMPLETED|Overall Study||13
155232|NCT00735709|357592|P1|NOT COMPLETED|Overall Study||13
155233|NCT00735709|357589|P4|COMPLETED|Overall Study||122
155234|NCT00735709|357590|P3|COMPLETED|Overall Study||129
155235|NCT00735709|357591|P2|COMPLETED|Overall Study||127
155236|NCT00735709|357592|P1|COMPLETED|Overall Study||127
155237|NCT00735709|357589|P4|Treated|Overall Study||139
155238|NCT00735709|357590|P3|Treated|Overall Study||140
155239|NCT00735709|357591|P2|Treated|Overall Study||140
155240|NCT00735709|357592|P1|Treated|Overall Study||140
155241|NCT00735709|357589|P4|STARTED|Overall Study||140
155242|NCT00735709|357590|P3|STARTED|Overall Study||140
155243|NCT00735709|357591|P2|STARTED|Overall Study||140
155244|NCT00735709|357592|P1|STARTED|Overall Study||140
155245|NCT00735696|357702|P1|NOT COMPLETED|Overall Study||2
155246|NCT00735696|357702|P1|COMPLETED|Overall Study||39
155247|NCT00735696|357702|P1|Received Any Quantity of Study Drug|Overall Study||40
155248|NCT00735696|357702|P1|STARTED|Overall Study||41
155249|NCT00735670|357716|P2|NOT COMPLETED|Overall Study||5
155250|NCT00735670|357717|P1|NOT COMPLETED|Overall Study||4
155251|NCT00735670|357716|P2|COMPLETED|Overall Study||6
155252|NCT00735670|357717|P1|COMPLETED|Overall Study||6
155253|NCT00735670|357716|P2|STARTED|Overall Study||11
155254|NCT00735670|357717|P1|STARTED|Overall Study||10
155255|NCT00735644|357730|P5|NOT COMPLETED|Overall Study||0
155256|NCT00735644|357731|P4|NOT COMPLETED|Overall Study||1
155257|NCT00735644|357732|P3|NOT COMPLETED|Overall Study||1
155258|NCT00735644|357733|P2|NOT COMPLETED|Overall Study||2
155259|NCT00735644|357734|P1|NOT COMPLETED|Overall Study||0
155260|NCT00735644|357730|P5|COMPLETED|Overall Study||102
155261|NCT00735644|357731|P4|COMPLETED|Overall Study||198
155262|NCT00735644|357732|P3|COMPLETED|Overall Study||295
155263|NCT00735644|357733|P2|COMPLETED|Overall Study||298
155264|NCT00735644|357734|P1|COMPLETED|Overall Study||303
155265|NCT00735644|357730|P5|STARTED|Overall Study||102
155266|NCT00735644|357731|P4|STARTED|Overall Study||199
155267|NCT00735644|357732|P3|STARTED|Overall Study||296
155268|NCT00735644|357733|P2|STARTED|Overall Study||300
155269|NCT00735644|357734|P1|STARTED|Overall Study||303
155270|NCT00735618|357771|P1|NOT COMPLETED|Overall Study||0
155271|NCT00735618|357771|P1|COMPLETED|Overall Study||19
155272|NCT00735618|357771|P1|STARTED|Overall Study||19
155273|NCT00735553|357778|P1|NOT COMPLETED|Overall Study||77
155274|NCT00735553|357778|P1|COMPLETED|Overall Study||0
155275|NCT00735553|357778|P1|STARTED|Overall Study||77
155276|NCT00735475|357788|P2|NOT COMPLETED|Overall Study||11
155277|NCT00735475|357789|P1|NOT COMPLETED|Overall Study||8
155278|NCT00735475|357788|P2|COMPLETED|Overall Study||626
155279|NCT00735475|357789|P1|COMPLETED|Overall Study||623
155280|NCT00735475|357788|P2|STARTED|Overall Study||637
155281|NCT00735475|357789|P1|STARTED|Overall Study||631
155282|NCT00735462|357810|P3|NOT COMPLETED|Overall Study||28
155283|NCT00735462|357811|P2|NOT COMPLETED|Overall Study||55
155284|NCT00735462|357812|P1|NOT COMPLETED|Overall Study||63
155285|NCT00735462|357810|P3|COMPLETED|Overall Study||77
155286|NCT00735462|357811|P2|COMPLETED|Overall Study||149
155287|NCT00735462|357812|P1|COMPLETED|Overall Study||139
155288|NCT00735462|357810|P3|STARTED|Overall Study||105
155289|NCT00735462|357811|P2|STARTED|Overall Study||204
155290|NCT00735462|357812|P1|STARTED|Overall Study||202
155291|NCT00735449|357825|P2|NOT COMPLETED|Overall Study||6
155292|NCT00735449|357826|P1|NOT COMPLETED|Overall Study||7
155293|NCT00735449|357825|P2|COMPLETED|Overall Study||96
155294|NCT00735449|357826|P1|COMPLETED|Overall Study||95
155295|NCT00735449|357825|P2|STARTED|Overall Study||102
155296|NCT00735449|357826|P1|STARTED|Overall Study||102
155297|NCT00735436|357840|P1|NOT COMPLETED|Overall Study||0
155298|NCT00735436|357840|P1|COMPLETED|Overall Study||18
155299|NCT00735436|357840|P1|STARTED|Overall Study||18
155300|NCT00735397|357849|P1|NOT COMPLETED|Overall Study||1183
155301|NCT00735397|357849|P1|COMPLETED|Overall Study||35
155302|NCT00735397|357849|P1|STARTED|Overall Study||1218
155303|NCT00735371|357863|P4|NOT COMPLETED|Overall Study||10
155304|NCT00735371|357864|P3|NOT COMPLETED|Overall Study||11
155305|NCT00735371|357865|P2|NOT COMPLETED|Overall Study||13
155306|NCT00735371|357866|P1|NOT COMPLETED|Overall Study||15
155307|NCT00735371|357863|P4|COMPLETED|Overall Study||69
155308|NCT00735371|357864|P3|COMPLETED|Overall Study||67
155309|NCT00735371|357865|P2|COMPLETED|Overall Study||66
155310|NCT00735371|357866|P1|COMPLETED|Overall Study||63
155311|NCT00735371|357863|P4|STARTED|Overall Study||79
155312|NCT00735371|357864|P3|STARTED|Overall Study||78
155313|NCT00735371|357865|P2|STARTED|Overall Study||79
155314|NCT00735371|357866|P1|STARTED|Overall Study||78
155315|NCT00735306|357884|P1|NOT COMPLETED|Overall Study||0
155316|NCT00735306|357884|P1|COMPLETED|Overall Study||12
155317|NCT00735306|357884|P1|STARTED|Overall Study||12
155318|NCT00735072|357892|P2|NOT COMPLETED|Overall Study||1
155319|NCT00735072|357893|P1|NOT COMPLETED|Overall Study||1
155320|NCT00735072|357892|P2|COMPLETED|Overall Study||21
155321|NCT00735072|357893|P1|COMPLETED|Overall Study||22
155322|NCT00735072|357892|P2|STARTED|Overall Study||22
155323|NCT00735072|357893|P1|STARTED|Overall Study||23
155324|NCT00735007|357899|P1|NOT COMPLETED|Overall Study||5
155325|NCT00735007|357899|P1|COMPLETED|Overall Study||101
155326|NCT00735007|357899|P1|STARTED|Overall Study||106
155327|NCT00734994|357924|P1|NOT COMPLETED|Overall Study||1
155328|NCT00734994|357924|P1|COMPLETED|Overall Study||14
155329|NCT00734994|357924|P1|STARTED|Overall Study||15
155330|NCT00734968|357931|P2|NOT COMPLETED|Overall Study||1
155331|NCT00734968|357932|P1|NOT COMPLETED|Overall Study||1
155332|NCT00734968|357931|P2|COMPLETED|Overall Study||75
155333|NCT00734968|357932|P1|COMPLETED|Overall Study||76
155334|NCT00734968|357931|P2|STARTED|Overall Study||76
155335|NCT00734968|357932|P1|STARTED|Overall Study||77
155336|NCT00734929|357944|P2|NOT COMPLETED|Overall Study||5
155337|NCT00734929|357945|P1|NOT COMPLETED|Overall Study||6
155338|NCT00734929|357944|P2|COMPLETED|Overall Study||53
155339|NCT00734929|357945|P1|COMPLETED|Overall Study||51
155340|NCT00734929|357944|P2|STARTED|Overall Study||58
155341|NCT00734929|357945|P1|STARTED|Overall Study||57
155342|NCT00734851|357973|P1|NOT COMPLETED|Overall Study||21
155343|NCT00734851|357973|P1|COMPLETED|Overall Study||13
155344|NCT00734851|357973|P1|STARTED|Overall Study||34
155345|NCT00734799|357985|P2|NOT COMPLETED|Overall Study||4
155346|NCT00734799|357986|P1|NOT COMPLETED|Overall Study||0
155347|NCT00734799|357985|P2|COMPLETED|Overall Study||9
155348|NCT00734799|357986|P1|COMPLETED|Overall Study||9
155349|NCT00734799|357985|P2|STARTED|Overall Study||13
155350|NCT00734799|357986|P1|STARTED|Overall Study||9
155351|NCT00734747|357994|P1|NOT COMPLETED|6 Month Follow-up||3
155352|NCT00734747|357994|P1|COMPLETED|6 Month Follow-up||66
155353|NCT00734747|357994|P1|STARTED|6 Month Follow-up||69
155354|NCT00734747|357994|P1|NOT COMPLETED|SRS Procedure||3
155355|NCT00734747|357994|P1|COMPLETED|SRS Procedure||69
155356|NCT00734747|357994|P1|STARTED|SRS Procedure||72
155357|NCT00734734|358001|P1|NOT COMPLETED|Overall Study||0
155358|NCT00734734|358001|P1|COMPLETED|Overall Study||64
155359|NCT00734734|358001|P1|STARTED|Overall Study||64
155360|NCT00734656|358008|P4|NOT COMPLETED|Lab Session 4||1
155361|NCT00734656|358009|P3|NOT COMPLETED|Lab Session 4||0
155362|NCT00734656|358010|P2|NOT COMPLETED|Lab Session 4||0
155363|NCT00734656|358011|P1|NOT COMPLETED|Lab Session 4||0
155364|NCT00734656|358008|P4|COMPLETED|Lab Session 4||19
155365|NCT00734656|358009|P3|COMPLETED|Lab Session 4||16
155366|NCT00734656|358010|P2|COMPLETED|Lab Session 4||18
155367|NCT00734656|358011|P1|COMPLETED|Lab Session 4||20
155368|NCT00734656|358008|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
155455|NCT00734617|358047|P1|STARTED|Overall Study||249
155456|NCT00734604|358059|P6|NOT COMPLETED|Overall Study||6
155369|NCT00734656|358009|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
155370|NCT00734656|358010|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
155371|NCT00734656|358011|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
155372|NCT00734656|358008|P4|NOT COMPLETED|Washout 3||1
155373|NCT00734656|358009|P3|NOT COMPLETED|Washout 3||0
155374|NCT00734656|358010|P2|NOT COMPLETED|Washout 3||0
155375|NCT00734656|358011|P1|NOT COMPLETED|Washout 3||1
155376|NCT00734656|358008|P4|COMPLETED|Washout 3||18
155377|NCT00734656|358009|P3|COMPLETED|Washout 3||20
155378|NCT00734656|358010|P2|COMPLETED|Washout 3||19
155379|NCT00734656|358011|P1|COMPLETED|Washout 3||17
155380|NCT00734656|358008|P4|STARTED|Washout 3||19
155381|NCT00734656|358009|P3|STARTED|Washout 3||20
155382|NCT00734656|358010|P2|STARTED|Washout 3||19
155383|NCT00734656|358011|P1|STARTED|Washout 3||18
155384|NCT00734656|358008|P4|NOT COMPLETED|Lab Session 3||0
155385|NCT00734656|358009|P3|NOT COMPLETED|Lab Session 3||0
155386|NCT00734656|358010|P2|NOT COMPLETED|Lab Session 3||0
155387|NCT00734656|358011|P1|NOT COMPLETED|Lab Session 3||0
155388|NCT00734656|358008|P4|COMPLETED|Lab Session 3||19
155389|NCT00734656|358009|P3|COMPLETED|Lab Session 3||20
155390|NCT00734656|358010|P2|COMPLETED|Lab Session 3||19
155391|NCT00734656|358011|P1|COMPLETED|Lab Session 3||18
155392|NCT00734656|358008|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
155393|NCT00734656|358009|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
155394|NCT00734656|358010|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
155395|NCT00734656|358011|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
155396|NCT00734656|358008|P4|NOT COMPLETED|Washout 2||0
155397|NCT00734656|358009|P3|NOT COMPLETED|Washout 2||1
155398|NCT00734656|358010|P2|NOT COMPLETED|Washout 2||1
155399|NCT00734656|358011|P1|NOT COMPLETED|Washout 2||1
155400|NCT00734656|358008|P4|COMPLETED|Washout 2||19
155401|NCT00734656|358009|P3|COMPLETED|Washout 2||20
155402|NCT00734656|358010|P2|COMPLETED|Washout 2||20
155403|NCT00734656|358011|P1|COMPLETED|Washout 2||17
155404|NCT00734656|358008|P4|STARTED|Washout 2||19
155405|NCT00734656|358009|P3|STARTED|Washout 2||21
155406|NCT00734656|358010|P2|STARTED|Washout 2||21
155407|NCT00734656|358011|P1|STARTED|Washout 2||18
155408|NCT00734656|358008|P4|NOT COMPLETED|Lab Session 2||1
155409|NCT00734656|358009|P3|NOT COMPLETED|Lab Session 2||0
155410|NCT00734656|358010|P2|NOT COMPLETED|Lab Session 2||0
155411|NCT00734656|358011|P1|NOT COMPLETED|Lab Session 2||1
155412|NCT00734656|358008|P4|COMPLETED|Lab Session 2||19
155413|NCT00734656|358009|P3|COMPLETED|Lab Session 2||21
155414|NCT00734656|358010|P2|COMPLETED|Lab Session 2||21
155415|NCT00734656|358011|P1|COMPLETED|Lab Session 2||18
155416|NCT00734656|358008|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
155417|NCT00734656|358009|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
155418|NCT00734656|358010|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
155419|NCT00734656|358011|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
155420|NCT00734656|358008|P4|NOT COMPLETED|Washout 1||3
155421|NCT00734656|358009|P3|NOT COMPLETED|Washout 1||2
155422|NCT00734656|358010|P2|NOT COMPLETED|Washout 1||5
155423|NCT00734656|358011|P1|NOT COMPLETED|Washout 1||1
155424|NCT00734656|358008|P4|COMPLETED|Washout 1||18
155425|NCT00734656|358009|P3|COMPLETED|Washout 1||24
155426|NCT00734656|358010|P2|COMPLETED|Washout 1||18
155427|NCT00734656|358011|P1|COMPLETED|Washout 1||21
155428|NCT00734656|358008|P4|STARTED|Washout 1||21
155429|NCT00734656|358009|P3|STARTED|Washout 1||26
155430|NCT00734656|358010|P2|STARTED|Washout 1||23
155431|NCT00734656|358011|P1|STARTED|Washout 1||22
155432|NCT00734656|358008|P4|NOT COMPLETED|Lab Session 1||0
155433|NCT00734656|358009|P3|NOT COMPLETED|Lab Session 1||0
155434|NCT00734656|358010|P2|NOT COMPLETED|Lab Session 1||0
155435|NCT00734656|358011|P1|NOT COMPLETED|Lab Session 1||2
155436|NCT00734656|358008|P4|COMPLETED|Lab Session 1||21
155437|NCT00734656|358009|P3|COMPLETED|Lab Session 1||26
155438|NCT00734656|358010|P2|COMPLETED|Lab Session 1||23
155439|NCT00734656|358011|P1|COMPLETED|Lab Session 1||22
155440|NCT00734656|358008|P4|STARTED|Lab Session 1||21
155441|NCT00734656|358009|P3|STARTED|Lab Session 1||26
155442|NCT00734656|358010|P2|STARTED|Lab Session 1||23
155443|NCT00734656|358011|P1|STARTED|Lab Session 1||24
155444|NCT00734630|358035|P2|NOT COMPLETED|Overall Study||33
155445|NCT00734630|358036|P1|NOT COMPLETED|Overall Study||29
155446|NCT00734630|358035|P2|COMPLETED|Overall Study||200
155447|NCT00734630|358036|P1|COMPLETED|Overall Study||229
155448|NCT00734630|358035|P2|STARTED|Overall Study||233
155449|NCT00734630|358036|P1|STARTED|Overall Study||258
155450|NCT00734617|358046|P2|NOT COMPLETED|Overall Study||102
155451|NCT00734617|358047|P1|NOT COMPLETED|Overall Study||107
155452|NCT00734617|358046|P2|COMPLETED|Overall Study||128
155453|NCT00734617|358047|P1|COMPLETED|Overall Study||142
155454|NCT00734617|358046|P2|STARTED|Overall Study||230
155457|NCT00734604|358060|P5|NOT COMPLETED|Overall Study||8
155458|NCT00734604|358061|P4|NOT COMPLETED|Overall Study||9
155459|NCT00734604|358062|P3|NOT COMPLETED|Overall Study||6
155460|NCT00734604|358063|P2|NOT COMPLETED|Overall Study||12
155461|NCT00734604|358064|P1|NOT COMPLETED|Overall Study||3
155462|NCT00734604|358059|P6|COMPLETED|Overall Study||58
155463|NCT00734604|358060|P5|COMPLETED|Overall Study||55
155464|NCT00734604|358061|P4|COMPLETED|Overall Study||54
155465|NCT00734604|358062|P3|COMPLETED|Overall Study||57
155466|NCT00734604|358063|P2|COMPLETED|Overall Study||51
155467|NCT00734604|358064|P1|COMPLETED|Overall Study||59
155468|NCT00734604|358059|P6|STARTED|Overall Study||64
155469|NCT00734604|358060|P5|STARTED|Overall Study||63
155470|NCT00734604|358061|P4|STARTED|Overall Study||63
155471|NCT00734604|358062|P3|STARTED|Overall Study||63
155472|NCT00734604|358063|P2|STARTED|Overall Study||63
155473|NCT00734604|358064|P1|STARTED|Overall Study||62
155474|NCT00734591|358114|P2|NOT COMPLETED|Prospective Period||44
155475|NCT00734591|358115|P1|NOT COMPLETED|Prospective Period||51
155476|NCT00734591|358114|P2|COMPLETED|Prospective Period||1229
155477|NCT00734591|358115|P1|COMPLETED|Prospective Period||1307
155478|NCT00734591|358114|P2|STARTED|Prospective Period||1273
155479|NCT00734591|358115|P1|STARTED|Prospective Period||1358
155480|NCT00734591|358114|P2|NOT COMPLETED|Screening for Prospective Period||2291
155481|NCT00734591|358115|P1|NOT COMPLETED|Screening for Prospective Period||2517
155482|NCT00734591|358114|P2|COMPLETED|Screening for Prospective Period||1273
155483|NCT00734591|358115|P1|COMPLETED|Screening for Prospective Period||1358
155484|NCT00734591|358114|P2|STARTED|Screening for Prospective Period||3564
155485|NCT00734591|358115|P1|STARTED|Screening for Prospective Period||3875
155486|NCT00734591|358114|P2|NOT COMPLETED|Retrospective Period||0
155487|NCT00734591|358115|P1|NOT COMPLETED|Retrospective Period||0
155488|NCT00734591|358114|P2|COMPLETED|Retrospective Period||3564
155489|NCT00734591|358115|P1|COMPLETED|Retrospective Period||3875
155490|NCT00734591|358114|P2|STARTED|Retrospective Period||3564
155491|NCT00734591|358115|P1|STARTED|Retrospective Period||3875
155492|NCT00734578|358130|P3|NOT COMPLETED|Overall Study||25
155493|NCT00734578|358131|P2|NOT COMPLETED|Overall Study||25
155494|NCT00734578|358132|P1|NOT COMPLETED|Overall Study||33
155495|NCT00734578|358130|P3|COMPLETED|Overall Study||129
155496|NCT00734578|358131|P2|COMPLETED|Overall Study||128
155497|NCT00734578|358132|P1|COMPLETED|Overall Study||121
155498|NCT00734578|358130|P3|STARTED|Overall Study||154
155499|NCT00734578|358131|P2|STARTED|Overall Study||153
155500|NCT00734578|358132|P1|STARTED|Overall Study||154
155501|NCT00734539|358166|P2|NOT COMPLETED|Long Term Follow up||31
155502|NCT00734539|358167|P1|NOT COMPLETED|Long Term Follow up||34
155503|NCT00734539|358166|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
155504|NCT00734539|358167|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
155505|NCT00734539|358166|P2|STARTED|Long Term Follow up||138
155506|NCT00734539|358167|P1|STARTED|Long Term Follow up||152
155507|NCT00734539|358166|P2|NOT COMPLETED|Main Study||35
155508|NCT00734539|358167|P1|NOT COMPLETED|Main Study||37
155509|NCT00734539|358166|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
155510|NCT00734539|358167|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
155511|NCT00734539|358166|P2|STARTED|Main Study||173
155512|NCT00734539|358167|P1|STARTED|Main Study||189
155513|NCT00734500|358195|P1|NOT COMPLETED|Overall Study||1
155514|NCT00734500|358195|P1|COMPLETED|Overall Study||14
155515|NCT00734500|358195|P1|STARTED|Overall Study||15
155516|NCT00734474|358209|P9|NOT COMPLETED|Overall Study||82
155517|NCT00734474|358210|P8|NOT COMPLETED|Overall Study||129
155518|NCT00734474|358211|P7|NOT COMPLETED|Overall Study||24
155519|NCT00734474|358212|P6|NOT COMPLETED|Overall Study||25
155520|NCT00734474|358213|P5|NOT COMPLETED|Overall Study||118
155521|NCT00734474|358214|P4|NOT COMPLETED|Overall Study||10
155522|NCT00734474|358215|P3|NOT COMPLETED|Overall Study||112
155523|NCT00734474|358216|P2|NOT COMPLETED|Overall Study||30
155524|NCT00734474|358217|P1|NOT COMPLETED|Overall Study||15
155525|NCT00734474|358209|P9|COMPLETED|Overall Study||95
155526|NCT00734474|358210|P8|COMPLETED|Overall Study||186
155527|NCT00734474|358211|P7|COMPLETED|Overall Study||0
155528|NCT00734474|358212|P6|COMPLETED|Overall Study||0
155529|NCT00734474|358213|P5|COMPLETED|Overall Study||184
155530|NCT00734474|358214|P4|COMPLETED|Overall Study||0
155531|NCT00734474|358215|P3|COMPLETED|Overall Study||192
155532|NCT00734474|358216|P2|COMPLETED|Overall Study||0
155533|NCT00734474|358217|P1|COMPLETED|Overall Study||0
155534|NCT00734474|358209|P9|Completed 52-Week Visit|Overall Study||112
155535|NCT00734474|358210|P8|Completed 52-Week Visit|Overall Study||238
155536|NCT00734474|358211|P7|Completed 52-Week Visit|Overall Study||0
155537|NCT00734474|358212|P6|Completed 52-Week Visit|Overall Study||0
155538|NCT00734474|358213|P5|Completed 52-Week Visit|Overall Study||243
155539|NCT00734474|358214|P4|Completed 52-Week Visit|Overall Study||0
155540|NCT00734474|358215|P3|Completed 52-Week Visit|Overall Study||238
155541|NCT00734474|358216|P2|Completed 52-Week Visit|Overall Study||0
155542|NCT00734474|358217|P1|Completed 52-Week Visit|Overall Study||0
155543|NCT00734474|358209|P9|Completed 26-Week Visit|Overall Study||124
155544|NCT00734474|358210|P8|Completed 26-Week Visit|Overall Study||270
155545|NCT00734474|358211|P7|Completed 26-Week Visit|Overall Study||2
155546|NCT00734474|358212|P6|Completed 26-Week Visit|Overall Study||2
155547|NCT00734474|358213|P5|Completed 26-Week Visit|Overall Study||268
155548|NCT00734474|358214|P4|Completed 26-Week Visit|Overall Study||2
155549|NCT00734474|358215|P3|Completed 26-Week Visit|Overall Study||258
155550|NCT00734474|358216|P2|Completed 26-Week Visit|Overall Study||0
155551|NCT00734474|358217|P1|Completed 26-Week Visit|Overall Study||0
155552|NCT00734474|358209|P9|Entered Study After Dose Decision Point|Overall Study||139
155553|NCT00734474|358210|P8|Entered Study After Dose Decision Point|Overall Study||273
155554|NCT00734474|358211|P7|Entered Study After Dose Decision Point|Overall Study||0
155555|NCT00734474|358212|P6|Entered Study After Dose Decision Point|Overall Study||0
155556|NCT00734474|358213|P5|Entered Study After Dose Decision Point|Overall Study||281
155557|NCT00734474|358214|P4|Entered Study After Dose Decision Point|Overall Study||0
155558|NCT00734474|358215|P3|Entered Study After Dose Decision Point|Overall Study||279
155559|NCT00734474|358216|P2|Entered Study After Dose Decision Point|Overall Study||0
155560|NCT00734474|358217|P1|Entered Study After Dose Decision Point|Overall Study||0
155561|NCT00734474|358209|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
155562|NCT00734474|358210|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
155563|NCT00734474|358211|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
155564|NCT00734474|358212|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
155565|NCT00734474|358213|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
155566|NCT00734474|358214|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
155567|NCT00734474|358215|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
155568|NCT00734474|358216|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
155569|NCT00734474|358217|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
155570|NCT00734474|358209|P9|Entered Study Before Dose Decision Point|Overall Study||38
155571|NCT00734474|358210|P8|Entered Study Before Dose Decision Point|Overall Study||42
155572|NCT00734474|358211|P7|Entered Study Before Dose Decision Point|Overall Study||24
155573|NCT00734474|358212|P6|Entered Study Before Dose Decision Point|Overall Study||25
155574|NCT00734474|358213|P5|Entered Study Before Dose Decision Point|Overall Study||21
155575|NCT00734474|358214|P4|Entered Study Before Dose Decision Point|Overall Study||10
155576|NCT00734474|358215|P3|Entered Study Before Dose Decision Point|Overall Study||25
155577|NCT00734474|358216|P2|Entered Study Before Dose Decision Point|Overall Study||30
155578|NCT00734474|358217|P1|Entered Study Before Dose Decision Point|Overall Study||15
155579|NCT00734474|358209|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
155580|NCT00734474|358210|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
155581|NCT00734474|358211|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
155582|NCT00734474|358212|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
155583|NCT00734474|358213|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
155584|NCT00734474|358214|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
155585|NCT00734474|358215|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
155586|NCT00734474|358216|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
155587|NCT00734474|358217|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
155588|NCT00734474|358209|P9|STARTED|Overall Study||177
155589|NCT00734474|358210|P8|STARTED|Overall Study||315
155590|NCT00734474|358211|P7|STARTED|Overall Study||24
155591|NCT00734474|358212|P6|STARTED|Overall Study||25
155592|NCT00734474|358213|P5|STARTED|Overall Study||302
155593|NCT00734474|358214|P4|STARTED|Overall Study||10
155594|NCT00734474|358215|P3|STARTED|Overall Study||304
155595|NCT00734474|358216|P2|STARTED|Overall Study||30
155596|NCT00734474|358217|P1|STARTED|Overall Study||15
155597|NCT00734409|358386|P2|NOT COMPLETED|Overall Study||0
155598|NCT00734409|358387|P1|NOT COMPLETED|Overall Study||0
155599|NCT00734409|358386|P2|COMPLETED|Overall Study||145
155600|NCT00734409|358387|P1|COMPLETED|Overall Study||155
155601|NCT00734409|358386|P2|STARTED|Overall Study||145
155602|NCT00734409|358387|P1|STARTED|Overall Study||155
155603|NCT00734344|358399|P2|NOT COMPLETED|Overall Study||0
155604|NCT00734344|358400|P1|NOT COMPLETED|Overall Study||0
155605|NCT00734344|358399|P2|COMPLETED|Overall Study||9
155606|NCT00734344|358400|P1|COMPLETED|Overall Study||9
155607|NCT00734344|358399|P2|STARTED|Overall Study||9
155608|NCT00734344|358400|P1|STARTED|Overall Study||9
155609|NCT00734305|358470|P7|NOT COMPLETED|Overall Study||0
155610|NCT00734305|358471|P6|NOT COMPLETED|Overall Study||0
155611|NCT00734305|358472|P5|NOT COMPLETED|Overall Study||0
155612|NCT00734305|358473|P4|NOT COMPLETED|Overall Study||0
155613|NCT00734305|358474|P3|NOT COMPLETED|Overall Study||0
155614|NCT00734305|358475|P2|NOT COMPLETED|Overall Study||0
155615|NCT00734305|358476|P1|NOT COMPLETED|Overall Study||1
155616|NCT00734305|358470|P7|COMPLETED|Overall Study||18
155617|NCT00734305|358471|P6|COMPLETED|Overall Study||4
155618|NCT00734305|358472|P5|COMPLETED|Overall Study||5
155619|NCT00734305|358473|P4|COMPLETED|Overall Study||3
155620|NCT00734305|358474|P3|COMPLETED|Overall Study||4
155621|NCT00734305|358475|P2|COMPLETED|Overall Study||3
155622|NCT00734305|358476|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
155623|NCT00734305|358470|P7|STARTED|Overall Study||18
155624|NCT00734305|358471|P6|STARTED|Overall Study||4
155625|NCT00734305|358472|P5|STARTED|Overall Study||5
155626|NCT00734305|358473|P4|STARTED|Overall Study||3
155627|NCT00734305|358474|P3|STARTED|Overall Study||4
155628|NCT00734305|358475|P2|STARTED|Overall Study||3
155629|NCT00734305|358476|P1|STARTED|Overall Study||7
155630|NCT00734214|358507|P2|NOT COMPLETED|Overall Study||4
155631|NCT00734214|358508|P1|NOT COMPLETED|Overall Study||4
155632|NCT00734214|358507|P2|COMPLETED|Overall Study||126
155633|NCT00734214|358508|P1|COMPLETED|Overall Study||124
155634|NCT00734214|358507|P2|STARTED|Overall Study||130
155635|NCT00734214|358508|P1|STARTED|Overall Study||128
155636|NCT00734162|358518|P4|NOT COMPLETED|Open-Label Phase||3
155637|NCT00734162|358519|P3|NOT COMPLETED|Open-Label Phase||1
155638|NCT00734162|358520|P2|NOT COMPLETED|Open-Label Phase||2
155639|NCT00734162|358521|P1|NOT COMPLETED|Open-Label Phase||3
155640|NCT00734162|358518|P4|COMPLETED|Open-Label Phase||36
155641|NCT00734162|358519|P3|COMPLETED|Open-Label Phase||12
155642|NCT00734162|358520|P2|COMPLETED|Open-Label Phase||39
155643|NCT00734162|358521|P1|COMPLETED|Open-Label Phase||7
155644|NCT00734162|358518|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
155645|NCT00734162|358519|P3|STARTED|Open-Label Phase||13
155646|NCT00734162|358520|P2|STARTED|Open-Label Phase||41
155647|NCT00734162|358521|P1|STARTED|Open-Label Phase||10
155648|NCT00734162|358518|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
155649|NCT00734162|358519|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
155650|NCT00734162|358520|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
155651|NCT00734162|358521|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
155652|NCT00734162|358518|P4|COMPLETED|Randomized Phase (Through Week 72)||37
155653|NCT00734162|358519|P3|COMPLETED|Randomized Phase (Through Week 72)||13
155654|NCT00734162|358520|P2|COMPLETED|Randomized Phase (Through Week 72)||41
155655|NCT00734162|358521|P1|COMPLETED|Randomized Phase (Through Week 72)||10
155656|NCT00734162|358518|P4|STARTED|Randomized Phase (Through Week 72)||41
155657|NCT00734162|358519|P3|STARTED|Randomized Phase (Through Week 72)||13
155658|NCT00734162|358520|P2|STARTED|Randomized Phase (Through Week 72)||42
155659|NCT00734162|358521|P1|STARTED|Randomized Phase (Through Week 72)||10
155660|NCT00734149|358745|P1|NOT COMPLETED|Overall Study||1
155661|NCT00734149|358745|P1|COMPLETED|Overall Study||44
155662|NCT00734149|358745|P1|STARTED|Overall Study||45
155663|NCT00734097|358752|P1|NOT COMPLETED|Open Label||16
155664|NCT00734097|358752|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
155665|NCT00734097|358752|P1|Per Protocol|Open Label||301
155666|NCT00734097|358752|P1|Full Analysis|Open Label||311
155667|NCT00734097|358752|P1|Safety Analysis|Open Label||317
155668|NCT00734097|358752|P1|STARTED|Open Label|Full analysis performed in 311|317
155669|NCT00734097|358752|P1|NOT COMPLETED|Screening||20
155670|NCT00734097|358752|P1|COMPLETED|Screening|20 participants were screening failure.|317
155671|NCT00734097|358752|P1|STARTED|Screening||337
155672|NCT00734071|358769|P2|NOT COMPLETED|Overall Study||27
155673|NCT00734071|358770|P1|NOT COMPLETED|Overall Study||38
155674|NCT00734071|358769|P2|COMPLETED|Overall Study||125
155675|NCT00734071|358770|P1|COMPLETED|Overall Study||114
155676|NCT00734071|358769|P2|Treated|Overall Study||148
155677|NCT00734071|358770|P1|Treated|Overall Study||151
155678|NCT00734071|358769|P2|STARTED|Overall Study||152
155679|NCT00734071|358770|P1|STARTED|Overall Study||152
155680|NCT00733954|358826|P2|NOT COMPLETED|Overall Study||2
155681|NCT00733954|358827|P1|NOT COMPLETED|Overall Study||8
155682|NCT00733954|358826|P2|COMPLETED|Overall Study||123
155683|NCT00733954|358827|P1|COMPLETED|Overall Study||116
155684|NCT00733954|358826|P2|STARTED|Overall Study||125
155685|NCT00733954|358827|P1|STARTED|Overall Study||124
155686|NCT00733824|358874|P5|NOT COMPLETED|Phase II||0
155687|NCT00733824|358875|P4|NOT COMPLETED|Phase II||0
155688|NCT00733824|358876|P3|NOT COMPLETED|Phase II||0
155689|NCT00733824|358877|P2|NOT COMPLETED|Phase II||0
155690|NCT00733824|358878|P1|NOT COMPLETED|Phase II||0
155691|NCT00733824|358874|P5|COMPLETED|Phase II||36
155692|NCT00733824|358875|P4|COMPLETED|Phase II||0
155693|NCT00733824|358876|P3|COMPLETED|Phase II||0
155694|NCT00733824|358877|P2|COMPLETED|Phase II||0
155695|NCT00733824|358878|P1|COMPLETED|Phase II||0
155696|NCT00733824|358874|P5|STARTED|Phase II||36
155697|NCT00733824|358875|P4|STARTED|Phase II||0
155698|NCT00733824|358876|P3|STARTED|Phase II||0
155699|NCT00733824|358877|P2|STARTED|Phase II||0
155700|NCT00733824|358878|P1|STARTED|Phase II||0
155701|NCT00733824|358874|P5|NOT COMPLETED|Phase I||0
155702|NCT00733824|358875|P4|NOT COMPLETED|Phase I||0
155703|NCT00733824|358876|P3|NOT COMPLETED|Phase I||0
155704|NCT00733824|358877|P2|NOT COMPLETED|Phase I||0
155705|NCT00733824|358878|P1|NOT COMPLETED|Phase I||1
155706|NCT00733824|358874|P5|COMPLETED|Phase I||0
155707|NCT00733824|358875|P4|COMPLETED|Phase I||6
155708|NCT00733824|358876|P3|COMPLETED|Phase I||6
155709|NCT00733824|358877|P2|COMPLETED|Phase I||3
155710|NCT00733824|358878|P1|COMPLETED|Phase I||9
155711|NCT00733824|358874|P5|STARTED|Phase I||0
155712|NCT00733824|358875|P4|STARTED|Phase I||6
155713|NCT00733824|358876|P3|STARTED|Phase I||6
155714|NCT00733824|358877|P2|STARTED|Phase I||3
155715|NCT00733824|358878|P1|STARTED|Phase I||10
155716|NCT00733512|358897|P1|NOT COMPLETED|Overall Study||0
155717|NCT00733512|358897|P1|COMPLETED|Overall Study||146
155718|NCT00733512|358897|P1|STARTED|Overall Study||146
155719|NCT00733499|358904|P2|NOT COMPLETED|24 Months Follow-up||1
155720|NCT00733499|358905|P1|NOT COMPLETED|24 Months Follow-up||0
155721|NCT00733499|358904|P2|COMPLETED|24 Months Follow-up||95
155722|NCT00733499|358905|P1|COMPLETED|24 Months Follow-up||99
155723|NCT00733499|358904|P2|STARTED|24 Months Follow-up||96
155724|NCT00733499|358905|P1|STARTED|24 Months Follow-up||99
155725|NCT00733499|358904|P2|NOT COMPLETED|12 Months Follow-up||1
155726|NCT00733499|358905|P1|NOT COMPLETED|12 Months Follow-up||2
155727|NCT00733499|358904|P2|COMPLETED|12 Months Follow-up||96
155728|NCT00733499|358905|P1|COMPLETED|12 Months Follow-up||99
155729|NCT00733499|358904|P2|STARTED|12 Months Follow-up||97
155730|NCT00733499|358905|P1|STARTED|12 Months Follow-up||101
155731|NCT00733499|358904|P2|NOT COMPLETED|6 Months Follow-up||3
155732|NCT00733499|358905|P1|NOT COMPLETED|6 Months Follow-up||0
155733|NCT00733499|358904|P2|COMPLETED|6 Months Follow-up||97
155734|NCT00733499|358905|P1|COMPLETED|6 Months Follow-up||101
155735|NCT00733499|358904|P2|STARTED|6 Months Follow-up||100
155736|NCT00733499|358905|P1|STARTED|6 Months Follow-up||101
155737|NCT00733499|358904|P2|NOT COMPLETED|3 Months Follow-up||2
155738|NCT00733499|358905|P1|NOT COMPLETED|3 Months Follow-up||1
155739|NCT00733499|358904|P2|COMPLETED|3 Months Follow-up||100
155740|NCT00733499|358905|P1|COMPLETED|3 Months Follow-up||101
155741|NCT00733499|358904|P2|STARTED|3 Months Follow-up||102
155742|NCT00733499|358905|P1|STARTED|3 Months Follow-up||102
155743|NCT00733499|358904|P2|NOT COMPLETED|Pre-operative||1
155744|NCT00733499|358905|P1|NOT COMPLETED|Pre-operative||0
155745|NCT00733499|358904|P2|COMPLETED|Pre-operative||102
155746|NCT00733499|358905|P1|COMPLETED|Pre-operative||102
155747|NCT00733499|358904|P2|STARTED|Pre-operative||103
155748|NCT00733499|358905|P1|STARTED|Pre-operative||102
155749|NCT00733421|358913|P2|NOT COMPLETED|Overall Study||1
155750|NCT00733421|358914|P1|NOT COMPLETED|Overall Study||1
155751|NCT00733421|358913|P2|COMPLETED|Overall Study|All but one randomised patient|49
155752|NCT00733421|358914|P1|COMPLETED|Overall Study|All but one randomsied patient|49
155753|NCT00733421|358913|P2|STARTED|Overall Study|November 2008|50
155754|NCT00733421|358914|P1|STARTED|Overall Study|November 2008|50
155755|NCT00733369|358938|P2|NOT COMPLETED|Overall Study||9
155756|NCT00733369|358939|P1|NOT COMPLETED|Overall Study||10
155757|NCT00733369|358938|P2|COMPLETED|Overall Study||47
155758|NCT00733369|358939|P1|COMPLETED|Overall Study||40
155759|NCT00733369|358938|P2|STARTED|Overall Study||56
155760|NCT00733369|358939|P1|STARTED|Overall Study||50
155761|NCT00733330|359057|P2|NOT COMPLETED|Overall Study||4
155762|NCT00733330|359058|P1|NOT COMPLETED|Overall Study||2
155763|NCT00733330|359057|P2|COMPLETED|Overall Study||48
155764|NCT00733330|359058|P1|COMPLETED|Overall Study||30
155765|NCT00733330|359057|P2|STARTED|Overall Study||52
155766|NCT00733330|359058|P1|STARTED|Overall Study||32
155767|NCT00733291|359142|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
155768|NCT00733291|359143|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
155769|NCT00733291|359144|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
155770|NCT00733291|359145|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
155771|NCT00733291|359142|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155772|NCT00733291|359143|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155773|NCT00733291|359144|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155774|NCT00733291|359145|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
155775|NCT00733291|359142|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155776|NCT00733291|359143|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155777|NCT00733291|359144|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
155778|NCT00733291|359145|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
155779|NCT00733291|359142|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
155780|NCT00733291|359143|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
155781|NCT00733291|359144|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
155782|NCT00733291|359145|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
155783|NCT00733291|359142|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
155784|NCT00733291|359143|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
155785|NCT00733291|359144|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
155786|NCT00733291|359145|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
155787|NCT00733291|359142|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
155788|NCT00733291|359143|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
155789|NCT00733291|359144|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
155790|NCT00733291|359145|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
155791|NCT00733291|359142|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
155792|NCT00733291|359143|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
155793|NCT00733291|359144|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
155794|NCT00733291|359145|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
155795|NCT00733291|359142|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
155796|NCT00733291|359143|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
155797|NCT00733291|359144|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
155798|NCT00733291|359145|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
155799|NCT00733291|359142|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
155800|NCT00733291|359143|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
155801|NCT00733291|359144|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
155802|NCT00733291|359145|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
155803|NCT00733278|359167|P1|NOT COMPLETED|Overall Study||0
155804|NCT00733278|359167|P1|COMPLETED|Overall Study||7
155805|NCT00733278|359167|P1|STARTED|Overall Study||7
155806|NCT00733226|359174|P2|NOT COMPLETED|Overall Study||0
155807|NCT00733226|359175|P1|NOT COMPLETED|Overall Study||5
155808|NCT00733226|359174|P2|COMPLETED|Overall Study||40
155809|NCT00733226|359175|P1|COMPLETED|Overall Study||35
155810|NCT00733226|359174|P2|STARTED|Overall Study||40
155811|NCT00733226|359175|P1|STARTED|Overall Study||40
155812|NCT00733135|359191|P1|NOT COMPLETED|Overall Study||2
155813|NCT00733135|359191|P1|COMPLETED|Overall Study||131
155814|NCT00733135|359191|P1|STARTED|Overall Study||133
155815|NCT00733096|359203|P3|NOT COMPLETED|Overall Study||0
155816|NCT00733096|359204|P2|NOT COMPLETED|Overall Study||0
155817|NCT00733096|359205|P1|NOT COMPLETED|Overall Study||0
155818|NCT00733096|359203|P3|COMPLETED|Overall Study||30
155819|NCT00733096|359204|P2|COMPLETED|Overall Study||26
155820|NCT00733096|359205|P1|COMPLETED|Overall Study||28
155821|NCT00733096|359203|P3|STARTED|Overall Study||30
155822|NCT00733096|359204|P2|STARTED|Overall Study||26
155823|NCT00733096|359205|P1|STARTED|Overall Study||28
155824|NCT00733005|359224|P2|NOT COMPLETED|Overall Study||3
155825|NCT00733005|359225|P1|NOT COMPLETED|Overall Study||2
155826|NCT00733005|359224|P2|COMPLETED|Overall Study||159
155827|NCT00733005|359225|P1|COMPLETED|Overall Study||160
155828|NCT00733005|359224|P2|STARTED|Overall Study||162
155829|NCT00733005|359225|P1|STARTED|Overall Study||162
155830|NCT00732992|359235|P2|NOT COMPLETED|Overall Study||6
155831|NCT00732992|359236|P1|NOT COMPLETED|Overall Study||6
155832|NCT00732992|359235|P2|COMPLETED|Overall Study||0
155833|NCT00732992|359236|P1|COMPLETED|Overall Study||0
155834|NCT00732992|359235|P2|STARTED|Overall Study||6
155835|NCT00732992|359236|P1|STARTED|Overall Study||6
155836|NCT00732940|359255|P2|NOT COMPLETED|Overall Study||3
155837|NCT00732940|359256|P1|NOT COMPLETED|Overall Study||2
155838|NCT00732940|359255|P2|COMPLETED|Overall Study||25
155839|NCT00732940|359256|P1|COMPLETED|Overall Study||26
155840|NCT00732940|359255|P2|STARTED|Overall Study||28
155841|NCT00732940|359256|P1|STARTED|Overall Study||28
155842|NCT00732875|359324|P1|NOT COMPLETED|Overall Study||35
155843|NCT00732875|359324|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
155844|NCT00732875|359324|P1|STARTED|Overall Study||92
155845|NCT00732758|359332|P2|NOT COMPLETED|Overall Study||16
155846|NCT00732758|359333|P1|NOT COMPLETED|Overall Study||8
155847|NCT00732758|359332|P2|COMPLETED|Overall Study||63
155848|NCT00732758|359333|P1|COMPLETED|Overall Study||70
155849|NCT00732758|359332|P2|STARTED|Overall Study||79
155850|NCT00732758|359333|P1|STARTED|Overall Study||78
155851|NCT00732680|359345|P1|NOT COMPLETED|Overall Study||0
155852|NCT00732680|359345|P1|COMPLETED|Overall Study||9
155853|NCT00732680|359345|P1|STARTED|Overall Study||9
155854|NCT00732641|359351|P2|NOT COMPLETED|Overall Study||112
155855|NCT00732641|359352|P1|NOT COMPLETED|Overall Study||106
155856|NCT00732641|359351|P2|COMPLETED|Overall Study||9
155857|NCT00732641|359352|P1|COMPLETED|Overall Study||17
155858|NCT00732641|359351|P2|STARTED|Overall Study||121
155859|NCT00732641|359352|P1|STARTED|Overall Study||123
155860|NCT00732615|359372|P2|NOT COMPLETED|Overall Study||5
155861|NCT00732615|359373|P1|NOT COMPLETED|Overall Study||7
155862|NCT00732615|359372|P2|COMPLETED|Overall Study||79
155863|NCT00732615|359373|P1|COMPLETED|Overall Study||33
155864|NCT00732615|359372|P2|STARTED|Overall Study||84
155865|NCT00732615|359373|P1|STARTED|Overall Study||40
155866|NCT00732472|359389|P4|NOT COMPLETED|Overall Study||3
155867|NCT00732472|359390|P3|NOT COMPLETED|Overall Study||1
155868|NCT00732472|359391|P2|NOT COMPLETED|Overall Study||3
155869|NCT00732472|359392|P1|NOT COMPLETED|Overall Study||0
155870|NCT00732472|359389|P4|COMPLETED|Overall Study||6
155871|NCT00732472|359390|P3|COMPLETED|Overall Study||9
155872|NCT00732472|359391|P2|COMPLETED|Overall Study||7
155873|NCT00732472|359392|P1|COMPLETED|Overall Study||9
155874|NCT00732472|359389|P4|STARTED|Overall Study||9
155875|NCT00732472|359390|P3|STARTED|Overall Study||10
155876|NCT00732472|359391|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
155877|NCT00732472|359392|P1|STARTED|Overall Study||9
155878|NCT00732381|359492|P2|NOT COMPLETED|Overall Study||1
155879|NCT00732381|359493|P1|NOT COMPLETED|Overall Study||2
155880|NCT00732381|359492|P2|COMPLETED|Overall Study||174
155881|NCT00732381|359493|P1|COMPLETED|Overall Study||174
155882|NCT00732381|359492|P2|STARTED|Overall Study||175
155883|NCT00732381|359493|P1|STARTED|Overall Study||176
155884|NCT00732303|359501|P1|NOT COMPLETED|Overall Study||2
155885|NCT00732303|359501|P1|COMPLETED|Overall Study||6
155886|NCT00732303|359501|P1|STARTED|Overall Study||8
155887|NCT00732238|359509|P2|NOT COMPLETED|Overall Study||1
155888|NCT00732238|359510|P1|NOT COMPLETED|Overall Study||5
155889|NCT00732238|359509|P2|COMPLETED|Overall Study||27
155890|NCT00732238|359510|P1|COMPLETED|Overall Study||28
155891|NCT00732238|359509|P2|STARTED|Overall Study||28
155892|NCT00732238|359510|P1|STARTED|Overall Study||33
155893|NCT00732225|359523|P5|NOT COMPLETED|Overall Study||6
155894|NCT00732225|359524|P4|NOT COMPLETED|Overall Study||4
155895|NCT00732225|359525|P3|NOT COMPLETED|Overall Study||3
155896|NCT00732225|359526|P2|NOT COMPLETED|Overall Study||8
155897|NCT00732225|359527|P1|NOT COMPLETED|Overall Study||11
155898|NCT00732225|359523|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
155899|NCT00732225|359524|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
155900|NCT00732225|359525|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
155901|NCT00732225|359526|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
155902|NCT00732225|359527|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
155903|NCT00732225|359523|P5|STARTED|Overall Study|55 eyes of 54 patients|54
155904|NCT00732225|359524|P4|STARTED|Overall Study|33 eyes of 33 patients|33
155905|NCT00732225|359525|P3|STARTED|Overall Study|26 eyes of 26 patients|26
155906|NCT00732225|359526|P2|STARTED|Overall Study|41 eyes of 40 patients|40
155907|NCT00732225|359527|P1|STARTED|Overall Study|76 eyes of 71 patients|71
155908|NCT00732069|359574|P6|NOT COMPLETED|Third Study Drug||0
155909|NCT00732069|359575|P5|NOT COMPLETED|Third Study Drug||0
155910|NCT00732069|359576|P4|NOT COMPLETED|Third Study Drug||0
155911|NCT00732069|359577|P3|NOT COMPLETED|Third Study Drug||0
155912|NCT00732069|359578|P2|NOT COMPLETED|Third Study Drug||0
155913|NCT00732069|359579|P1|NOT COMPLETED|Third Study Drug||0
155914|NCT00732069|359574|P6|COMPLETED|Third Study Drug||2
155915|NCT00732069|359575|P5|COMPLETED|Third Study Drug||3
155916|NCT00732069|359576|P4|COMPLETED|Third Study Drug||2
155917|NCT00732069|359577|P3|COMPLETED|Third Study Drug||3
155918|NCT00732069|359578|P2|COMPLETED|Third Study Drug||3
155919|NCT00732069|359579|P1|COMPLETED|Third Study Drug||2
155920|NCT00732069|359574|P6|STARTED|Third Study Drug||2
155921|NCT00732069|359575|P5|STARTED|Third Study Drug||3
155922|NCT00732069|359576|P4|STARTED|Third Study Drug||2
155923|NCT00732069|359577|P3|STARTED|Third Study Drug||3
155924|NCT00732069|359578|P2|STARTED|Third Study Drug||3
155925|NCT00732069|359579|P1|STARTED|Third Study Drug||2
155926|NCT00732069|359574|P6|NOT COMPLETED|Washout After Second Study Drug||0
155927|NCT00732069|359575|P5|NOT COMPLETED|Washout After Second Study Drug||0
155928|NCT00732069|359576|P4|NOT COMPLETED|Washout After Second Study Drug||0
155929|NCT00732069|359577|P3|NOT COMPLETED|Washout After Second Study Drug||0
155930|NCT00732069|359578|P2|NOT COMPLETED|Washout After Second Study Drug||0
155931|NCT00732069|359579|P1|NOT COMPLETED|Washout After Second Study Drug||0
155932|NCT00732069|359574|P6|COMPLETED|Washout After Second Study Drug||2
155933|NCT00732069|359575|P5|COMPLETED|Washout After Second Study Drug||3
155934|NCT00732069|359576|P4|COMPLETED|Washout After Second Study Drug||2
155935|NCT00732069|359577|P3|COMPLETED|Washout After Second Study Drug||3
155936|NCT00732069|359578|P2|COMPLETED|Washout After Second Study Drug||3
155937|NCT00732069|359579|P1|COMPLETED|Washout After Second Study Drug||2
155938|NCT00732069|359574|P6|STARTED|Washout After Second Study Drug||2
155939|NCT00732069|359575|P5|STARTED|Washout After Second Study Drug||3
155940|NCT00732069|359576|P4|STARTED|Washout After Second Study Drug||2
155941|NCT00732069|359577|P3|STARTED|Washout After Second Study Drug||3
155942|NCT00732069|359578|P2|STARTED|Washout After Second Study Drug||3
155943|NCT00732069|359579|P1|STARTED|Washout After Second Study Drug||2
155944|NCT00732069|359574|P6|NOT COMPLETED|Second Study Drug||0
155945|NCT00732069|359575|P5|NOT COMPLETED|Second Study Drug||0
155946|NCT00732069|359576|P4|NOT COMPLETED|Second Study Drug||0
155947|NCT00732069|359577|P3|NOT COMPLETED|Second Study Drug||0
155948|NCT00732069|359578|P2|NOT COMPLETED|Second Study Drug||0
155949|NCT00732069|359579|P1|NOT COMPLETED|Second Study Drug||0
155950|NCT00732069|359574|P6|COMPLETED|Second Study Drug||2
155951|NCT00732069|359575|P5|COMPLETED|Second Study Drug||3
155952|NCT00732069|359576|P4|COMPLETED|Second Study Drug||2
155953|NCT00732069|359577|P3|COMPLETED|Second Study Drug||3
155954|NCT00732069|359578|P2|COMPLETED|Second Study Drug||3
155955|NCT00732069|359579|P1|COMPLETED|Second Study Drug||2
155956|NCT00732069|359574|P6|STARTED|Second Study Drug||2
155957|NCT00732069|359575|P5|STARTED|Second Study Drug||3
155958|NCT00732069|359576|P4|STARTED|Second Study Drug||2
155959|NCT00732069|359577|P3|STARTED|Second Study Drug||3
155960|NCT00732069|359578|P2|STARTED|Second Study Drug||3
155961|NCT00732069|359579|P1|STARTED|Second Study Drug||2
155962|NCT00732069|359574|P6|NOT COMPLETED|Washout After First Study Drug||0
155963|NCT00732069|359575|P5|NOT COMPLETED|Washout After First Study Drug||0
155964|NCT00732069|359576|P4|NOT COMPLETED|Washout After First Study Drug||0
155965|NCT00732069|359577|P3|NOT COMPLETED|Washout After First Study Drug||0
155966|NCT00732069|359578|P2|NOT COMPLETED|Washout After First Study Drug||0
155967|NCT00732069|359579|P1|NOT COMPLETED|Washout After First Study Drug||1
155968|NCT00732069|359574|P6|COMPLETED|Washout After First Study Drug||2
155969|NCT00732069|359575|P5|COMPLETED|Washout After First Study Drug||3
155970|NCT00732069|359576|P4|COMPLETED|Washout After First Study Drug||2
155971|NCT00732069|359577|P3|COMPLETED|Washout After First Study Drug||3
155972|NCT00732069|359578|P2|COMPLETED|Washout After First Study Drug||3
155973|NCT00732069|359579|P1|COMPLETED|Washout After First Study Drug||2
155974|NCT00732069|359574|P6|STARTED|Washout After First Study Drug||2
155975|NCT00732069|359575|P5|STARTED|Washout After First Study Drug||3
155976|NCT00732069|359576|P4|STARTED|Washout After First Study Drug||2
155977|NCT00732069|359577|P3|STARTED|Washout After First Study Drug||3
155978|NCT00732069|359578|P2|STARTED|Washout After First Study Drug||3
155979|NCT00732069|359579|P1|STARTED|Washout After First Study Drug||3
155980|NCT00732069|359574|P6|NOT COMPLETED|First Study Drug||0
155981|NCT00732069|359575|P5|NOT COMPLETED|First Study Drug||0
155982|NCT00732069|359576|P4|NOT COMPLETED|First Study Drug||0
155983|NCT00732069|359577|P3|NOT COMPLETED|First Study Drug||0
155984|NCT00732069|359578|P2|NOT COMPLETED|First Study Drug||0
155985|NCT00732069|359579|P1|NOT COMPLETED|First Study Drug||0
155986|NCT00732069|359574|P6|COMPLETED|First Study Drug||2
155987|NCT00732069|359575|P5|COMPLETED|First Study Drug||3
155988|NCT00732069|359576|P4|COMPLETED|First Study Drug||2
155989|NCT00732069|359577|P3|COMPLETED|First Study Drug||3
155990|NCT00732069|359578|P2|COMPLETED|First Study Drug||3
155991|NCT00732069|359579|P1|COMPLETED|First Study Drug||3
155992|NCT00732069|359574|P6|STARTED|First Study Drug||2
155993|NCT00732069|359575|P5|STARTED|First Study Drug||3
155994|NCT00732069|359576|P4|STARTED|First Study Drug||2
155995|NCT00732069|359577|P3|STARTED|First Study Drug||3
155996|NCT00732069|359578|P2|STARTED|First Study Drug||3
155997|NCT00732069|359579|P1|STARTED|First Study Drug||3
155998|NCT00732030|359590|P1|NOT COMPLETED|Overall Study||2
155999|NCT00732030|359590|P1|COMPLETED|Overall Study||24
156000|NCT00732030|359590|P1|STARTED|Overall Study||26
156001|NCT00731939|359597|P1|NOT COMPLETED|Overall Study||34
156002|NCT00731939|359597|P1|COMPLETED|Overall Study||90
156003|NCT00731939|359597|P1|STARTED|Overall Study||124
156004|NCT00731874|359647|P2|NOT COMPLETED|Overall Study||0
156005|NCT00731874|359648|P1|NOT COMPLETED|Overall Study||0
156006|NCT00731874|359647|P2|COMPLETED|Overall Study||13
156007|NCT00731874|359648|P1|COMPLETED|Overall Study||10
156008|NCT00731874|359647|P2|STARTED|Overall Study||13
156009|NCT00731874|359648|P1|STARTED|Overall Study||10
156010|NCT00731822|359658|P2|NOT COMPLETED|Overall Study||1
156011|NCT00731822|359659|P1|NOT COMPLETED|Overall Study||4
156012|NCT00731822|359658|P2|COMPLETED|Overall Study||39
156013|NCT00731822|359659|P1|COMPLETED|Overall Study||16
156014|NCT00731822|359658|P2|STARTED|Overall Study||40
156015|NCT00731822|359659|P1|STARTED|Overall Study||20
156016|NCT00731783|359673|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
156017|NCT00731783|359674|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
156018|NCT00731783|359673|P2|COMPLETED|12 Month Follow-Up Visit||58
156019|NCT00731783|359674|P1|COMPLETED|12 Month Follow-Up Visit||68
156020|NCT00731783|359673|P2|STARTED|12 Month Follow-Up Visit||65
156021|NCT00731783|359674|P1|STARTED|12 Month Follow-Up Visit||74
156022|NCT00731783|359673|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
156023|NCT00731783|359674|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
156024|NCT00731783|359673|P2|COMPLETED|Six Month Follow-Up Visit||64
156025|NCT00731783|359674|P1|COMPLETED|Six Month Follow-Up Visit||71
156026|NCT00731783|359673|P2|STARTED|Six Month Follow-Up Visit||67
156027|NCT00731783|359674|P1|STARTED|Six Month Follow-Up Visit||77
156028|NCT00731783|359673|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
156029|NCT00731783|359674|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
156030|NCT00731783|359673|P2|COMPLETED|Three Month Follow-Up Visit||57
156031|NCT00731783|359674|P1|COMPLETED|Three Month Follow-Up Visit||72
156032|NCT00731783|359673|P2|STARTED|Three Month Follow-Up Visit||73
156033|NCT00731783|359674|P1|STARTED|Three Month Follow-Up Visit||79
156034|NCT00731783|359673|P2|NOT COMPLETED|One Month Follow-Up Visit||22
156035|NCT00731783|359674|P1|NOT COMPLETED|One Month Follow-Up Visit||14
156036|NCT00731783|359673|P2|COMPLETED|One Month Follow-Up Visit||69
156037|NCT00731783|359674|P1|COMPLETED|One Month Follow-Up Visit||78
156038|NCT00731783|359673|P2|STARTED|One Month Follow-Up Visit||91
156039|NCT00731783|359674|P1|STARTED|One Month Follow-Up Visit||92
156040|NCT00731731|359697|P3|NOT COMPLETED|Overall Study||3
156041|NCT00731731|359698|P2|NOT COMPLETED|Overall Study||0
156042|NCT00731731|359699|P1|NOT COMPLETED|Overall Study||0
156043|NCT00731731|359697|P3|COMPLETED|Overall Study||107
156044|NCT00731731|359698|P2|COMPLETED|Overall Study||3
156045|NCT00731731|359699|P1|COMPLETED|Overall Study||12
156046|NCT00731731|359697|P3|STARTED|Overall Study||110
156047|NCT00731731|359698|P2|STARTED|Overall Study||3
156048|NCT00731731|359699|P1|STARTED|Overall Study||12
156049|NCT00731679|359716|P2|NOT COMPLETED|Overall Study||26
156050|NCT00731679|359717|P1|NOT COMPLETED|Overall Study||22
156051|NCT00731679|359716|P2|COMPLETED|Overall Study||283
156052|NCT00731679|359717|P1|COMPLETED|Overall Study||292
156053|NCT00731679|359716|P2|STARTED|Overall Study||309
156054|NCT00731679|359717|P1|STARTED|Overall Study||314
156055|NCT00731666|359725|P1|NOT COMPLETED|Overall Study||12
156056|NCT00731666|359725|P1|COMPLETED|Overall Study||28
156057|NCT00731666|359725|P1|STARTED|Overall Study||40
156058|NCT00731653|359731|P1|NOT COMPLETED|Overall Study||9
156059|NCT00731653|359731|P1|COMPLETED|Overall Study||72
156060|NCT00731653|359731|P1|STARTED|Overall Study||81
156061|NCT00731640|359737|P2|NOT COMPLETED|Overall Study||0
156062|NCT00731640|359738|P1|NOT COMPLETED|Overall Study||0
156063|NCT00731640|359737|P2|COMPLETED|Overall Study||32
156064|NCT00731640|359738|P1|COMPLETED|Overall Study||20
156065|NCT00731640|359737|P2|STARTED|Overall Study||32
156066|NCT00731640|359738|P1|STARTED|Overall Study||20
156067|NCT00731614|359752|P2|NOT COMPLETED|Overall Study||13
156068|NCT00731614|359753|P1|NOT COMPLETED|Overall Study||7
156069|NCT00731614|359752|P2|COMPLETED|Overall Study||18
156070|NCT00731614|359753|P1|COMPLETED|Overall Study||16
156071|NCT00731614|359752|P2|12 Weeks Posttreatment|Overall Study||23
156072|NCT00731614|359753|P1|12 Weeks Posttreatment|Overall Study||18
156073|NCT00731614|359752|P2|End of Treatment|Overall Study||24
156074|NCT00731614|359753|P1|End of Treatment|Overall Study||16
156075|NCT00731614|359752|P2|STARTED|Overall Study||31
156076|NCT00731614|359753|P1|STARTED|Overall Study||23
156077|NCT00731549|359759|P1|NOT COMPLETED|Overall Study||223
156078|NCT00731549|359759|P1|COMPLETED|Overall Study||858
156079|NCT00731549|359759|P1|STARTED|Overall Study||1081
156080|NCT00731484|359772|P1|NOT COMPLETED|Overall Study||0
156081|NCT00731484|359772|P1|COMPLETED|Overall Study||233
156082|NCT00731484|359772|P1|STARTED|Overall Study||233
156083|NCT00731341|359776|P1|NOT COMPLETED|Overall Study||0
156084|NCT00731341|359776|P1|COMPLETED|Overall Study||3
156085|NCT00731341|359776|P1|STARTED|Overall Study||3
156086|NCT00731211|359785|P1|NOT COMPLETED|Overall Study||0
156087|NCT00731211|359785|P1|COMPLETED|Overall Study||55
156088|NCT00731211|359785|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
156089|NCT00731198|359792|P2|NOT COMPLETED|Overall Study||6
156090|NCT00731198|359793|P1|NOT COMPLETED|Overall Study||6
156091|NCT00731198|359792|P2|COMPLETED|Overall Study||319
156092|NCT00731198|359793|P1|COMPLETED|Overall Study||319
156093|NCT00731198|359792|P2|STARTED|Overall Study||325
156094|NCT00731198|359793|P1|STARTED|Overall Study||325
156095|NCT00731133|359799|P1|NOT COMPLETED|Overall Study||10
156096|NCT00731133|359799|P1|COMPLETED|Overall Study||5
156097|NCT00731133|359799|P1|STARTED|Overall Study||15
156098|NCT00731120|359807|P3|NOT COMPLETED|Overall Study||36
156099|NCT00731120|359808|P2|NOT COMPLETED|Overall Study||43
156100|NCT00731120|359809|P1|NOT COMPLETED|Overall Study||42
156101|NCT00731120|359807|P3|COMPLETED|Overall Study||116
156102|NCT00731120|359808|P2|COMPLETED|Overall Study||109
156103|NCT00731120|359809|P1|COMPLETED|Overall Study||111
156104|NCT00731120|359807|P3|Treated|Overall Study||152
156105|NCT00731120|359808|P2|Treated|Overall Study||151
156106|NCT00731120|359809|P1|Treated|Overall Study||153
156107|NCT00731120|359807|P3|STARTED|Overall Study||152
156108|NCT00731120|359808|P2|STARTED|Overall Study||152
156109|NCT00731120|359809|P1|STARTED|Overall Study||153
156110|NCT00731094|359846|P2|NOT COMPLETED|Overall Study||11
156111|NCT00731094|359847|P1|NOT COMPLETED|Overall Study||18
156112|NCT00731094|359846|P2|COMPLETED|Overall Study||105
156113|NCT00731094|359847|P1|COMPLETED|Overall Study||98
156114|NCT00731094|359846|P2|Month 6|Overall Study||107
156115|NCT00731094|359847|P1|Month 6|Overall Study||101
156116|NCT00731094|359846|P2|STARTED|Overall Study||116
156117|NCT00731094|359847|P1|STARTED|Overall Study||116
156118|NCT00731055|359917|P1|NOT COMPLETED|Overall Study||0
156119|NCT00731055|359917|P1|COMPLETED|Overall Study||16
156120|NCT00731055|359917|P1|Received Varenicline 2.0 mg|Overall Study||16
156121|NCT00731055|359917|P1|Received Varenicline 1.0 mg|Overall Study||16
156122|NCT00731055|359917|P1|Received Varenicline 0.5 mg|Overall Study||16
156123|NCT00731055|359917|P1|Received Placebo|Overall Study||16
156124|NCT00731055|359917|P1|STARTED|Overall Study|This is a within-subjects study design.|16
156125|NCT00731042|359926|P2|NOT COMPLETED|Second Intervention||2
156126|NCT00731042|359927|P1|NOT COMPLETED|Second Intervention||0
156127|NCT00731042|359926|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
156128|NCT00731042|359927|P1|COMPLETED|Second Intervention||16
156129|NCT00731042|359926|P2|STARTED|Second Intervention||17
156130|NCT00731042|359927|P1|STARTED|Second Intervention||16
156131|NCT00731042|359926|P2|NOT COMPLETED|Wash-out||0
156132|NCT00731042|359927|P1|NOT COMPLETED|Wash-out||0
156133|NCT00731042|359926|P2|COMPLETED|Wash-out||17
156134|NCT00731042|359927|P1|COMPLETED|Wash-out||16
156135|NCT00731042|359926|P2|STARTED|Wash-out||17
156136|NCT00731042|359927|P1|STARTED|Wash-out||16
156137|NCT00731042|359926|P2|NOT COMPLETED|First Intervention||0
156138|NCT00731042|359927|P1|NOT COMPLETED|First Intervention||0
156139|NCT00731042|359926|P2|COMPLETED|First Intervention||17
156140|NCT00731042|359927|P1|COMPLETED|First Intervention||16
156141|NCT00731042|359926|P2|STARTED|First Intervention||17
156142|NCT00731042|359927|P1|STARTED|First Intervention||16
156143|NCT00730964|359933|P1|NOT COMPLETED|Overall Study||0
156144|NCT00730964|359933|P1|COMPLETED|Overall Study||1039
156145|NCT00730964|359933|P1|STARTED|Overall Study||1039
156146|NCT00730925|359938|P1|NOT COMPLETED|Overall Study||41
156147|NCT00730925|359938|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
156148|NCT00730925|359938|P1|STARTED|Overall Study||41
156149|NCT00730912|359948|P3|NOT COMPLETED|Overall Study||1
156150|NCT00730912|359949|P2|NOT COMPLETED|Overall Study||0
156151|NCT00730912|359950|P1|NOT COMPLETED|Overall Study||0
156152|NCT00730912|359948|P3|COMPLETED|Overall Study||103
156153|NCT00730912|359949|P2|COMPLETED|Overall Study||104
156154|NCT00730912|359950|P1|COMPLETED|Overall Study||53
156155|NCT00730912|359948|P3|STARTED|Overall Study||104
156156|NCT00730912|359949|P2|STARTED|Overall Study||104
156157|NCT00730912|359950|P1|STARTED|Overall Study||53
156158|NCT00730847|359961|P1|NOT COMPLETED|Overall Study||131
156159|NCT00730847|359961|P1|COMPLETED|Overall Study||465
156160|NCT00730847|359961|P1|STARTED|Overall Study||596
156161|NCT00730756|359970|P2|NOT COMPLETED|Overall Study||5
156162|NCT00730756|359971|P1|NOT COMPLETED|Overall Study||4
156163|NCT00730756|359970|P2|COMPLETED|Overall Study||48
156164|NCT00730756|359971|P1|COMPLETED|Overall Study||45
156165|NCT00730756|359970|P2|STARTED|Overall Study||53
156166|NCT00730756|359971|P1|STARTED|Overall Study||49
156167|NCT00730730|359993|P1|NOT COMPLETED|Overall Study||0
156168|NCT00730730|359993|P1|COMPLETED|Overall Study||50
156169|NCT00730730|359993|P1|STARTED|Overall Study||50
156170|NCT00730691|360005|P5|NOT COMPLETED|Overall Study||50
156171|NCT00730691|360006|P4|NOT COMPLETED|Overall Study||45
156172|NCT00730691|360007|P3|NOT COMPLETED|Overall Study||39
156173|NCT00730691|360008|P2|NOT COMPLETED|Overall Study||36
156174|NCT00730691|360009|P1|NOT COMPLETED|Overall Study||36
156175|NCT00730691|360005|P5|COMPLETED|Overall Study||106
156176|NCT00730691|360006|P4|COMPLETED|Overall Study||111
156177|NCT00730691|360007|P3|COMPLETED|Overall Study||117
156178|NCT00730691|360008|P2|COMPLETED|Overall Study||120
156179|NCT00730691|360009|P1|COMPLETED|Overall Study||121
156180|NCT00730691|360005|P5|STARTED|Overall Study||156
156181|NCT00730691|360006|P4|STARTED|Overall Study||156
156182|NCT00730691|360007|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
156183|NCT00730691|360008|P2|STARTED|Overall Study||156
156184|NCT00730691|360009|P1|STARTED|Overall Study||157
156185|NCT00730639|360101|P5|NOT COMPLETED|Overall Study||131
156186|NCT00730639|360102|P4|NOT COMPLETED|Overall Study||54
156187|NCT00730639|360103|P3|NOT COMPLETED|Overall Study||86
156188|NCT00730639|360104|P2|NOT COMPLETED|Overall Study||18
156189|NCT00730639|360105|P1|NOT COMPLETED|Overall Study||17
156190|NCT00730639|360101|P5|COMPLETED|Overall Study||0
156191|NCT00730639|360102|P4|COMPLETED|Overall Study||0
156192|NCT00730639|360103|P3|COMPLETED|Overall Study||0
156193|NCT00730639|360104|P2|COMPLETED|Overall Study||0
156194|NCT00730639|360105|P1|COMPLETED|Overall Study||0
156195|NCT00730639|360101|P5|STARTED|Overall Study||131
156196|NCT00730639|360102|P4|STARTED|Overall Study||54
156197|NCT00730639|360103|P3|STARTED|Overall Study||86
156198|NCT00730639|360104|P2|STARTED|Overall Study||18
156199|NCT00730639|360105|P1|STARTED|Overall Study||17
156200|NCT00730327|360171|P2|NOT COMPLETED|Overall Study||37
156201|NCT00730327|360172|P1|NOT COMPLETED|Overall Study||27
156202|NCT00730327|360171|P2|COMPLETED|Overall Study||93
156203|NCT00730327|360172|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
156204|NCT00730327|360171|P2|Completed Week 26|Overall Study||99
156205|NCT00730327|360172|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
156206|NCT00730327|360171|P2|STARTED|Overall Study||130
156207|NCT00730327|360172|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
156208|NCT00730275|360197|P4|NOT COMPLETED|Overall Study||1
156209|NCT00730275|360198|P3|NOT COMPLETED|Overall Study||0
156210|NCT00730275|360199|P2|NOT COMPLETED|Overall Study||0
156211|NCT00730275|360200|P1|NOT COMPLETED|Overall Study||0
156212|NCT00730275|360197|P4|COMPLETED|Overall Study||8
156213|NCT00730275|360198|P3|COMPLETED|Overall Study||8
156214|NCT00730275|360199|P2|COMPLETED|Overall Study||9
156215|NCT00730275|360200|P1|COMPLETED|Overall Study||9
156216|NCT00730275|360197|P4|STARTED|Overall Study||9
156217|NCT00730275|360198|P3|STARTED|Overall Study||8
156218|NCT00730275|360199|P2|STARTED|Overall Study||9
156219|NCT00730275|360200|P1|STARTED|Overall Study||9
156220|NCT00730236|360226|P1|NOT COMPLETED|Overall Study||6
156221|NCT00730236|360226|P1|COMPLETED|Overall Study||23
156222|NCT00730236|360226|P1|STARTED|Overall Study||29
156223|NCT00730132|360241|P1|NOT COMPLETED|Overall Study||155
156224|NCT00730132|360241|P1|COMPLETED|Overall Study||557
156225|NCT00730132|360241|P1|STARTED|Overall Study||712
156226|NCT00730041|360259|P2|NOT COMPLETED|Overall Study||2
156227|NCT00730041|360260|P1|NOT COMPLETED|Overall Study||0
156228|NCT00730041|360259|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
156229|NCT00730041|360260|P1|COMPLETED|Overall Study||26
156230|NCT00730041|360259|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
156231|NCT00730041|360260|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
156232|NCT00730028|360283|P5|NOT COMPLETED|Overall Study||82
156233|NCT00730028|360284|P4|NOT COMPLETED|Overall Study||56
156234|NCT00730028|360285|P3|NOT COMPLETED|Overall Study||45
156235|NCT00730028|360286|P2|NOT COMPLETED|Overall Study||66
156236|NCT00730028|360287|P1|NOT COMPLETED|Overall Study||60
156237|NCT00730028|360283|P5|COMPLETED|Overall Study||175
156238|NCT00730028|360284|P4|COMPLETED|Overall Study||207
156239|NCT00730028|360285|P3|COMPLETED|Overall Study||221
156240|NCT00730028|360286|P2|COMPLETED|Overall Study||194
156241|NCT00730028|360287|P1|COMPLETED|Overall Study||204
156242|NCT00730028|360283|P5|STARTED|Overall Study||257
156243|NCT00730028|360284|P4|STARTED|Overall Study||263
156244|NCT00730028|360285|P3|STARTED|Overall Study||266
156245|NCT00730028|360286|P2|STARTED|Overall Study||260
156246|NCT00730028|360287|P1|STARTED|Overall Study||264
156247|NCT00730015|360337|P3|NOT COMPLETED|Overall Study||32
156248|NCT00730015|360338|P2|NOT COMPLETED|Overall Study||40
156249|NCT00730015|360339|P1|NOT COMPLETED|Overall Study||31
156250|NCT00730015|360337|P3|COMPLETED|Overall Study||177
156251|NCT00730015|360338|P2|COMPLETED|Overall Study||177
156252|NCT00730015|360339|P1|COMPLETED|Overall Study||186
156253|NCT00730015|360337|P3|STARTED|Overall Study||209
156254|NCT00730015|360338|P2|STARTED|Overall Study||217
156255|NCT00730015|360339|P1|STARTED|Overall Study||217
156256|NCT00729937|360379|P6|NOT COMPLETED|Overall Study||37
156257|NCT00729937|360380|P5|NOT COMPLETED|Overall Study||28
156258|NCT00729937|360381|P4|NOT COMPLETED|Overall Study||34
156259|NCT00729937|360382|P3|NOT COMPLETED|Overall Study||29
156260|NCT00729937|360383|P2|NOT COMPLETED|Overall Study||88
156261|NCT00729937|360384|P1|NOT COMPLETED|Overall Study||74
156262|NCT00729937|360379|P6|COMPLETED|Overall Study||214
156263|NCT00729937|360380|P5|COMPLETED|Overall Study||221
156264|NCT00729937|360381|P4|COMPLETED|Overall Study||215
156265|NCT00729937|360382|P3|COMPLETED|Overall Study||222
156266|NCT00729937|360383|P2|COMPLETED|Overall Study||548
156267|NCT00729937|360384|P1|COMPLETED|Overall Study||555
156268|NCT00729937|360379|P6|STARTED|Overall Study||251
156269|NCT00729937|360380|P5|STARTED|Overall Study||249
156270|NCT00729937|360381|P4|STARTED|Overall Study||249
156271|NCT00729937|360382|P3|STARTED|Overall Study||251
156272|NCT00729937|360383|P2|STARTED|Overall Study||636
156273|NCT00729937|360384|P1|STARTED|Overall Study||629
156274|NCT00729924|360578|P1|NOT COMPLETED|Overall Study||0
156275|NCT00729924|360578|P1|COMPLETED|Overall Study||40
156276|NCT00729924|360578|P1|STARTED|Overall Study||40
156277|NCT00729859|360588|P3|NOT COMPLETED|Overall Study||0
156278|NCT00729859|360589|P2|NOT COMPLETED|Overall Study||2
156279|NCT00729859|360590|P1|NOT COMPLETED|Overall Study||0
156280|NCT00729859|360588|P3|COMPLETED|Overall Study||8
156281|NCT00729859|360589|P2|COMPLETED|Overall Study||6
156282|NCT00729859|360590|P1|COMPLETED|Overall Study||8
156283|NCT00729859|360588|P3|STARTED|Overall Study||8
156284|NCT00729859|360589|P2|STARTED|Overall Study||8
156285|NCT00729859|360590|P1|STARTED|Overall Study||8
156286|NCT00729846|360627|P2|NOT COMPLETED|Overall Study||0
156287|NCT00729846|360628|P1|NOT COMPLETED|Overall Study||0
156288|NCT00729846|360627|P2|COMPLETED|Overall Study||11
156289|NCT00729846|360628|P1|COMPLETED|Overall Study||11
156290|NCT00729846|360627|P2|STARTED|Overall Study||11
156291|NCT00729846|360628|P1|STARTED|Overall Study||11
156292|NCT00729833|360634|P4|NOT COMPLETED|Overall Study||6
156293|NCT00729833|360635|P3|NOT COMPLETED|Overall Study||12
156294|NCT00729833|360636|P2|NOT COMPLETED|Overall Study||7
156295|NCT00729833|360637|P1|NOT COMPLETED|Overall Study||20
156296|NCT00729833|360634|P4|COMPLETED|Overall Study||0
156297|NCT00729833|360635|P3|COMPLETED|Overall Study||0
156298|NCT00729833|360636|P2|COMPLETED|Overall Study||0
156299|NCT00729833|360637|P1|COMPLETED|Overall Study||0
156300|NCT00729833|360634|P4|STARTED|Overall Study||6
156301|NCT00729833|360635|P3|STARTED|Overall Study||12
156302|NCT00729833|360636|P2|STARTED|Overall Study||7
156303|NCT00729833|360637|P1|STARTED|Overall Study||20
156304|NCT00729807|360676|P1|NOT COMPLETED|Overall Study||0
156305|NCT00729807|360676|P1|COMPLETED|Overall Study||6
156306|NCT00729807|360676|P1|STARTED|Overall Study||6
156307|NCT00729781|360680|P1|NOT COMPLETED|Long-term Follow-up Study||0
156308|NCT00729781|360680|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
156309|NCT00729781|360680|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
156310|NCT00729781|360680|P1|NOT COMPLETED|Original Study||0
156311|NCT00729781|360680|P1|COMPLETED|Original Study||45
156312|NCT00729781|360680|P1|STARTED|Original Study||45
156313|NCT00729690|360689|P3|NOT COMPLETED|Overall Study||2
156314|NCT00729690|360690|P2|NOT COMPLETED|Overall Study||2
156315|NCT00729690|360691|P1|NOT COMPLETED|Overall Study||0
156316|NCT00729690|360689|P3|COMPLETED|Overall Study||14
156317|NCT00729690|360690|P2|COMPLETED|Overall Study||14
156318|NCT00729690|360691|P1|COMPLETED|Overall Study||16
156319|NCT00729690|360689|P3|STARTED|Overall Study||16
156320|NCT00729690|360690|P2|STARTED|Overall Study||16
156321|NCT00729690|360691|P1|STARTED|Overall Study||16
156322|NCT00729677|360708|P1|NOT COMPLETED|Overall Study||0
156323|NCT00729677|360708|P1|COMPLETED|Overall Study||64
156324|NCT00729677|360708|P1|STARTED|Overall Study||64
156325|NCT00729651|360721|P2|NOT COMPLETED|Overall Study||18
156326|NCT00729651|360722|P1|NOT COMPLETED|Overall Study||19
156327|NCT00729651|360721|P2|COMPLETED|Overall Study||152
156328|NCT00729651|360722|P1|COMPLETED|Overall Study||154
156329|NCT00729651|360721|P2|STARTED|Overall Study||170
156330|NCT00729651|360722|P1|STARTED|Overall Study||173
156331|NCT00729612|360734|P1|NOT COMPLETED|Overall Study||10
156332|NCT00729612|360734|P1|COMPLETED|Overall Study||53
156333|NCT00729612|360734|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
156334|NCT00729612|360734|P1|Received Cycle 2|Overall Study||54
156335|NCT00729612|360734|P1|Did Not Receive Cycle 2|Overall Study||7
156336|NCT00729612|360734|P1|Received Cycle 1|Overall Study||62
156337|NCT00729612|360734|P1|Died Before Cycle 1|Overall Study||1
156338|NCT00729612|360734|P1|STARTED|Overall Study||63
156339|NCT00729560|360741|P1|NOT COMPLETED|Overall Study||3
156340|NCT00729560|360741|P1|COMPLETED|Overall Study||5
156341|NCT00729560|360741|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
156342|NCT00729521|360748|P3|NOT COMPLETED|Overall Study||0
156343|NCT00729521|360749|P2|NOT COMPLETED|Overall Study||0
156344|NCT00729521|360750|P1|NOT COMPLETED|Overall Study||0
156345|NCT00729521|360748|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
156346|NCT00729521|360749|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
156347|NCT00729521|360750|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
156348|NCT00729521|360748|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
156349|NCT00729521|360749|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
156350|NCT00729521|360750|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
156351|NCT00729482|360758|P1|NOT COMPLETED|Overall Study||0
156352|NCT00729482|360758|P1|COMPLETED|Overall Study||54
156353|NCT00729482|360758|P1|STARTED|Overall Study||54
156354|NCT00729469|360767|P2|NOT COMPLETED|Overall Study||47
156355|NCT00729469|360768|P1|NOT COMPLETED|Overall Study||53
156356|NCT00729469|360767|P2|COMPLETED|Overall Study||416
156357|NCT00729469|360768|P1|COMPLETED|Overall Study||403
156358|NCT00729469|360767|P2|STARTED|Overall Study||463
156359|NCT00729469|360768|P1|STARTED|Overall Study||456
156360|NCT00729365|360807|P3|NOT COMPLETED|Overall Study||7
156361|NCT00729365|360808|P2|NOT COMPLETED|Overall Study||6
156362|NCT00729365|360809|P1|NOT COMPLETED|Overall Study||33
156363|NCT00729365|360807|P3|COMPLETED|Overall Study|Study terminated|0
156364|NCT00729365|360808|P2|COMPLETED|Overall Study|Study Terminated|0
156365|NCT00729365|360809|P1|COMPLETED|Overall Study|Study terminated|0
156366|NCT00729365|360807|P3|STARTED|Overall Study||7
156367|NCT00729365|360808|P2|STARTED|Overall Study||6
156368|NCT00729365|360809|P1|STARTED|Overall Study||33
156369|NCT00729326|360822|P2|NOT COMPLETED|Overall Study||9
156370|NCT00729326|360823|P1|NOT COMPLETED|Overall Study||10
156371|NCT00729326|360822|P2|COMPLETED|Overall Study||33
156372|NCT00729326|360823|P1|COMPLETED|Overall Study||31
156373|NCT00729326|360822|P2|STARTED|Overall Study||42
156374|NCT00729326|360823|P1|STARTED|Overall Study||41
156375|NCT00729248|360865|P1|NOT COMPLETED|Overall Study||2
156376|NCT00729248|360865|P1|COMPLETED|Overall Study||10
156377|NCT00729248|360865|P1|STARTED|Overall Study||12
156378|NCT00728988|360872|P2|NOT COMPLETED|Overall Study||88
156379|NCT00728988|360873|P1|NOT COMPLETED|Overall Study||93
156380|NCT00728988|360872|P2|COMPLETED|Overall Study||164
156381|NCT00728988|360873|P1|COMPLETED|Overall Study||154
156382|NCT00728988|360872|P2|Full Analysis Set|Overall Study||172
156383|NCT00728988|360873|P1|Full Analysis Set|Overall Study||163
156384|NCT00728988|360872|P2|Treated|Overall Study||250
156385|NCT00728988|360873|P1|Treated|Overall Study||245
156386|NCT00728988|360872|P2|STARTED|Overall Study||252
156387|NCT00728988|360873|P1|STARTED|Overall Study||247
156388|NCT00728962|360891|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
156389|NCT00728962|360891|P1|COMPLETED|Two Year Post Placement Follow-up||59
156390|NCT00728962|360891|P1|STARTED|Two Year Post Placement Follow-up||62
156391|NCT00728962|360891|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
156392|NCT00728962|360891|P1|COMPLETED|One Year Post Placement Follow-up||62
156393|NCT00728962|360891|P1|STARTED|One Year Post Placement Follow-up||62
156394|NCT00728962|360891|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
156395|NCT00728962|360891|P1|COMPLETED|Permanent Prosthesis Placement||62
156396|NCT00728962|360891|P1|STARTED|Permanent Prosthesis Placement||65
156397|NCT00728962|360891|P1|NOT COMPLETED|Implant Placement Surgery||10
156398|NCT00728962|360891|P1|COMPLETED|Implant Placement Surgery||65
156399|NCT00728962|360891|P1|STARTED|Implant Placement Surgery||75
156400|NCT00728923|360895|P1|NOT COMPLETED|Overall Study||0
156401|NCT00728923|360895|P1|COMPLETED|Overall Study||9
156402|NCT00728923|360895|P1|STARTED|Overall Study||9
156403|NCT00728910|360900|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
156404|NCT00728910|360900|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
156405|NCT00728910|360900|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
156406|NCT00728910|360900|P1|NOT COMPLETED|Atorvastatin+ABT335||0
156407|NCT00728910|360900|P1|COMPLETED|Atorvastatin+ABT335||22
156408|NCT00728910|360900|P1|STARTED|Atorvastatin+ABT335||22
156409|NCT00728910|360900|P1|NOT COMPLETED|Atorvastatin||3
156410|NCT00728910|360900|P1|COMPLETED|Atorvastatin||22
156411|NCT00728910|360900|P1|STARTED|Atorvastatin||25
156412|NCT00728884|360912|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
156413|NCT00728884|360912|P1|COMPLETED|Two Year Post Placement Follow-up||145
156414|NCT00728884|360912|P1|STARTED|Two Year Post Placement Follow-up||145
156415|NCT00728884|360912|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
156416|NCT00728884|360912|P1|COMPLETED|One Year Post Placement Follow-up||145
156417|NCT00728884|360912|P1|STARTED|One Year Post Placement Follow-up||149
156418|NCT00728884|360912|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
156419|NCT00728884|360912|P1|COMPLETED|Permanent Prosthesis Placement||149
156420|NCT00728884|360912|P1|STARTED|Permanent Prosthesis Placement||162
156421|NCT00728884|360912|P1|NOT COMPLETED|Implant Placement Surgery||0
156422|NCT00728884|360912|P1|COMPLETED|Implant Placement Surgery||162
156423|NCT00728884|360912|P1|STARTED|Implant Placement Surgery||162
156424|NCT00728845|360918|P2|NOT COMPLETED|Overall Study||0
156425|NCT00728845|360919|P1|NOT COMPLETED|Overall Study||0
156426|NCT00728845|360918|P2|COMPLETED|Overall Study||0
156427|NCT00728845|360919|P1|COMPLETED|Overall Study||8
156428|NCT00728845|360918|P2|STARTED|Overall Study||0
156429|NCT00728845|360919|P1|STARTED|Overall Study||8
156430|NCT00728754|360935|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
156431|NCT00728754|360936|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
156432|NCT00728754|360935|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
156433|NCT00728754|360936|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
156434|NCT00728754|360935|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
156435|NCT00728754|360936|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
156436|NCT00728754|360935|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
156437|NCT00728754|360936|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
156438|NCT00728754|360935|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
156439|NCT00728754|360936|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
156440|NCT00728754|360935|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
156441|NCT00728754|360936|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
156442|NCT00728754|360935|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
156443|NCT00728754|360936|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
156444|NCT00728754|360935|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
156445|NCT00728754|360936|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
156446|NCT00728754|360935|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
156447|NCT00728754|360936|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
156448|NCT00728754|360935|P2|NOT COMPLETED|Implant Placement Surgery||0
156449|NCT00728754|360936|P1|NOT COMPLETED|Implant Placement Surgery||0
156450|NCT00728754|360935|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
156451|NCT00728754|360936|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
156452|NCT00728754|360935|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
156453|NCT00728754|360936|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
156454|NCT00728728|360944|P2|NOT COMPLETED|Overall Study||12
156455|NCT00728728|360945|P1|NOT COMPLETED|Overall Study||4
156456|NCT00728728|360944|P2|COMPLETED|Overall Study||34
156457|NCT00728728|360945|P1|COMPLETED|Overall Study||38
156458|NCT00728728|360944|P2|STARTED|Overall Study||46
156459|NCT00728728|360945|P1|STARTED|Overall Study||42
156460|NCT00728689|360965|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
156461|NCT00728689|360966|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
156462|NCT00728689|360965|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
156463|NCT00728689|360966|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
156464|NCT00728689|360965|P2|STARTED|Second Intervention (Days 11 - 13)||6
156465|NCT00728689|360966|P1|STARTED|Second Intervention (Days 11 - 13)||5
156466|NCT00728689|360965|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
156467|NCT00728689|360966|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
156468|NCT00728689|360965|P2|COMPLETED|Washout Period (Days 4 - 10)||6
156469|NCT00728689|360966|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
156470|NCT00728689|360965|P2|STARTED|Washout Period (Days 4 - 10)||6
156471|NCT00728689|360966|P1|STARTED|Washout Period (Days 4 - 10)||6
156472|NCT00728689|360965|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
156473|NCT00728689|360966|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
156474|NCT00728689|360965|P2|COMPLETED|First Intervention (Days 1 - 3)||6
156475|NCT00728689|360966|P1|COMPLETED|First Intervention (Days 1 - 3)||6
156476|NCT00728689|360965|P2|STARTED|First Intervention (Days 1 - 3)||6
156477|NCT00728689|360966|P1|STARTED|First Intervention (Days 1 - 3)||6
156478|NCT00728494|360984|P2|NOT COMPLETED|Overall Study||7
156479|NCT00728494|360985|P1|NOT COMPLETED|Overall Study||9
156480|NCT00728494|360984|P2|COMPLETED|Overall Study||32
156481|NCT00728494|360985|P1|COMPLETED|Overall Study||51
156482|NCT00728494|360984|P2|STARTED|Overall Study||39
156483|NCT00728494|360985|P1|STARTED|Overall Study||60
156484|NCT00728481|361003|P2|NOT COMPLETED|Overall Study||4
156485|NCT00728481|361004|P1|NOT COMPLETED|Overall Study||1
156486|NCT00728481|361003|P2|COMPLETED|Overall Study||28
156487|NCT00728481|361004|P1|COMPLETED|Overall Study||18
156488|NCT00728481|361003|P2|STARTED|Overall Study||32
156489|NCT00728481|361004|P1|STARTED|Overall Study||19
156490|NCT00728416|361022|P2|NOT COMPLETED|Overall Study||2
156491|NCT00728416|361023|P1|NOT COMPLETED|Overall Study||2
156492|NCT00728416|361022|P2|COMPLETED|Overall Study||163
156493|NCT00728416|361023|P1|COMPLETED|Overall Study||166
156494|NCT00728416|361022|P2|STARTED|Overall Study||165
156495|NCT00728416|361023|P1|STARTED|Overall Study||168
156496|NCT00728260|361031|P1|NOT COMPLETED|Overall Study||0
156497|NCT00728260|361031|P1|COMPLETED|Overall Study||1421
156498|NCT00728260|361031|P1|STARTED|Overall Study||1421
156499|NCT00728182|361039|P2|NOT COMPLETED|Overall Study||3
156500|NCT00728182|361040|P1|NOT COMPLETED|Overall Study||3
156501|NCT00728182|361039|P2|COMPLETED|Overall Study||90
156502|NCT00728182|361040|P1|COMPLETED|Overall Study||89
156503|NCT00728182|361039|P2|STARTED|Overall Study||93
156504|NCT00728182|361040|P1|STARTED|Overall Study||92
156505|NCT00728130|361068|P1|NOT COMPLETED|Overall Study||3
156506|NCT00728130|361068|P1|COMPLETED|Overall Study||19
156507|NCT00728130|361068|P1|STARTED|Overall Study||22
156508|NCT00727961|361073|P1|NOT COMPLETED|Overall Study||37
156509|NCT00727961|361073|P1|COMPLETED|Overall Study||21
156510|NCT00727961|361073|P1|STARTED|Overall Study||58
156511|NCT00727909|361083|P4|NOT COMPLETED|Overall Study||5
156512|NCT00727909|361084|P3|NOT COMPLETED|Overall Study||9
156513|NCT00727909|361085|P2|NOT COMPLETED|Overall Study||11
156514|NCT00727909|361086|P1|NOT COMPLETED|Overall Study||5
156515|NCT00727909|361083|P4|COMPLETED|Overall Study||70
156516|NCT00727909|361084|P3|COMPLETED|Overall Study||58
156517|NCT00727909|361085|P2|COMPLETED|Overall Study||61
156518|NCT00727909|361086|P1|COMPLETED|Overall Study||60
156519|NCT00727909|361083|P4|STARTED|Overall Study||75
156520|NCT00727909|361084|P3|STARTED|Overall Study||67
156521|NCT00727909|361085|P2|STARTED|Overall Study||72
156522|NCT00727909|361086|P1|STARTED|Overall Study||65
156523|NCT00727857|361093|P3|NOT COMPLETED|Overall Study||68
156524|NCT00727857|361094|P2|NOT COMPLETED|Overall Study||64
156525|NCT00727857|361095|P1|NOT COMPLETED|Overall Study||44
156526|NCT00727857|361093|P3|COMPLETED|Overall Study||142
156527|NCT00727857|361094|P2|COMPLETED|Overall Study||125
156528|NCT00727857|361095|P1|COMPLETED|Overall Study||157
156529|NCT00727857|361093|P3|STARTED|Overall Study||210
156530|NCT00727857|361094|P2|STARTED|Overall Study||189
156531|NCT00727857|361095|P1|STARTED|Overall Study||201
156532|NCT00727844|361183|P4|NOT COMPLETED|Second Randomization||0
156533|NCT00727844|361184|P3|NOT COMPLETED|Second Randomization||0
156534|NCT00727844|361185|P2|NOT COMPLETED|Second Randomization||0
156535|NCT00727844|361186|P1|NOT COMPLETED|Second Randomization||0
156536|NCT00727844|361183|P4|COMPLETED|Second Randomization||16
156537|NCT00727844|361184|P3|COMPLETED|Second Randomization||17
156538|NCT00727844|361185|P2|COMPLETED|Second Randomization||0
156539|NCT00727844|361186|P1|COMPLETED|Second Randomization||0
156540|NCT00727844|361183|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
156541|NCT00727844|361184|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
156542|NCT00727844|361185|P2|STARTED|Second Randomization||0
156543|NCT00727844|361186|P1|STARTED|Second Randomization||0
156544|NCT00727844|361183|P4|NOT COMPLETED|Initial Randomization||0
156545|NCT00727844|361184|P3|NOT COMPLETED|Initial Randomization||0
156546|NCT00727844|361185|P2|NOT COMPLETED|Initial Randomization||0
156547|NCT00727844|361186|P1|NOT COMPLETED|Initial Randomization||2
156548|NCT00727844|361183|P4|COMPLETED|Initial Randomization||0
156549|NCT00727844|361184|P3|COMPLETED|Initial Randomization||0
156550|NCT00727844|361185|P2|COMPLETED|Initial Randomization||20
156551|NCT00727844|361186|P1|COMPLETED|Initial Randomization||19
156552|NCT00727844|361183|P4|Included in MITT Analysis|Initial Randomization||0
156553|NCT00727844|361184|P3|Included in MITT Analysis|Initial Randomization||0
156554|NCT00727844|361185|P2|Included in MITT Analysis|Initial Randomization||20
156555|NCT00727844|361186|P1|Included in MITT Analysis|Initial Randomization||19
156556|NCT00727844|361183|P4|STARTED|Initial Randomization||0
156557|NCT00727844|361184|P3|STARTED|Initial Randomization||0
156558|NCT00727844|361185|P2|STARTED|Initial Randomization||20
156559|NCT00727844|361186|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
156560|NCT00727740|361193|P2|NOT COMPLETED|Overall Study||0
156561|NCT00727740|361194|P1|NOT COMPLETED|Overall Study||0
156562|NCT00727740|361193|P2|COMPLETED|Overall Study||61
156563|NCT00727740|361194|P1|COMPLETED|Overall Study||56
156564|NCT00727740|361193|P2|STARTED|Overall Study||61
156565|NCT00727740|361194|P1|STARTED|Overall Study||56
156566|NCT00727714|361200|P1|NOT COMPLETED|Overall Study||2
156567|NCT00727714|361200|P1|COMPLETED|Overall Study||93
156568|NCT00727714|361200|P1|STARTED|Overall Study||95
156569|NCT00726622|361210|P2|NOT COMPLETED|Overall Study||3
156570|NCT00726622|361211|P1|NOT COMPLETED|Overall Study||18
156571|NCT00726622|361210|P2|COMPLETED|Overall Study||240
156572|NCT00726622|361211|P1|COMPLETED|Overall Study||225
156573|NCT00726622|361210|P2|STARTED|Overall Study||243
156574|NCT00726622|361211|P1|STARTED|Overall Study||243
156575|NCT00726609|361229|P1|NOT COMPLETED|Overall Study||98
156576|NCT00726609|361229|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
156577|NCT00726609|361229|P1|STARTED|Overall Study||214
156578|NCT00727649|361235|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
156579|NCT00727649|361236|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
156580|NCT00727649|361235|P2|COMPLETED|Second Intervention (4-weeks)||34
156581|NCT00727649|361236|P1|COMPLETED|Second Intervention (4-weeks)||29
156582|NCT00727649|361235|P2|STARTED|Second Intervention (4-weeks)||37
156583|NCT00727649|361236|P1|STARTED|Second Intervention (4-weeks)||30
156584|NCT00727649|361235|P2|NOT COMPLETED|Wash-out (2-weeks)||3
156585|NCT00727649|361236|P1|NOT COMPLETED|Wash-out (2-weeks)||4
156586|NCT00727649|361235|P2|COMPLETED|Wash-out (2-weeks)||37
156587|NCT00727649|361236|P1|COMPLETED|Wash-out (2-weeks)||30
156588|NCT00727649|361235|P2|STARTED|Wash-out (2-weeks)||40
156589|NCT00727649|361236|P1|STARTED|Wash-out (2-weeks)||34
156590|NCT00727649|361235|P2|NOT COMPLETED|First Intervention (4-weeks)||3
156591|NCT00727649|361236|P1|NOT COMPLETED|First Intervention (4-weeks)||3
156592|NCT00727649|361235|P2|COMPLETED|First Intervention (4-weeks)||40
156593|NCT00727649|361236|P1|COMPLETED|First Intervention (4-weeks)||34
156594|NCT00727649|361235|P2|STARTED|First Intervention (4-weeks)||43
156595|NCT00727649|361236|P1|STARTED|First Intervention (4-weeks)||37
156596|NCT00727636|361250|P2|NOT COMPLETED|Overall Study||0
156597|NCT00727636|361251|P1|NOT COMPLETED|Overall Study||4
156598|NCT00727636|361250|P2|COMPLETED|Overall Study||15
156599|NCT00727636|361251|P1|COMPLETED|Overall Study||33
156600|NCT00727636|361250|P2|STARTED|Overall Study||15
156601|NCT00727636|361251|P1|STARTED|Overall Study||37
156602|NCT00727597|361265|P2|NOT COMPLETED|Overall Study||0
156603|NCT00727597|361266|P1|NOT COMPLETED|Overall Study||0
156604|NCT00727597|361265|P2|COMPLETED|Overall Study||50
156605|NCT00727597|361266|P1|COMPLETED|Overall Study||51
156606|NCT00727597|361265|P2|STARTED|Overall Study||50
156607|NCT00727597|361266|P1|STARTED|Overall Study||51
156608|NCT00727571|361278|P4|NOT COMPLETED|Overall Study||6
156609|NCT00727571|361279|P3|NOT COMPLETED|Overall Study||30
156610|NCT00727571|361280|P2|NOT COMPLETED|Overall Study||55
156611|NCT00727571|361281|P1|NOT COMPLETED|Overall Study||1
156612|NCT00727571|361278|P4|COMPLETED|Overall Study||163
156613|NCT00727571|361279|P3|COMPLETED|Overall Study||135
156614|NCT00727571|361280|P2|COMPLETED|Overall Study||173
156615|NCT00727571|361281|P1|COMPLETED|Overall Study||231
156616|NCT00727571|361278|P4|STARTED|Overall Study||169
156617|NCT00727571|361279|P3|STARTED|Overall Study||165
156618|NCT00727571|361280|P2|STARTED|Overall Study||228
156619|NCT00727571|361281|P1|STARTED|Overall Study||232
156620|NCT00727558|361308|P2|NOT COMPLETED|Overall Study||3
156621|NCT00727558|361309|P1|NOT COMPLETED|Overall Study||2
156622|NCT00727558|361308|P2|COMPLETED|Overall Study||118
156623|NCT00727558|361309|P1|COMPLETED|Overall Study||125
156624|NCT00727558|361308|P2|STARTED|Overall Study||121
156625|NCT00727558|361309|P1|STARTED|Overall Study||127
156626|NCT00727506|361333|P6|NOT COMPLETED|Overall Study||37
156627|NCT00727506|361334|P5|NOT COMPLETED|Overall Study||40
156628|NCT00727506|361335|P4|NOT COMPLETED|Overall Study||38
156629|NCT00727506|361336|P3|NOT COMPLETED|Overall Study||18
156630|NCT00727506|361337|P2|NOT COMPLETED|Overall Study||8
156631|NCT00727506|361338|P1|NOT COMPLETED|Overall Study||6
156632|NCT00727506|361333|P6|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|2
156633|NCT00727506|361334|P5|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|1
156634|NCT00727506|361335|P4|COMPLETED|Overall Study|On treatment at data cutoff May 12, 2011|1
156635|NCT00727506|361336|P3|COMPLETED|Overall Study||0
156636|NCT00727506|361337|P2|COMPLETED|Overall Study||0
156637|NCT00727506|361338|P1|COMPLETED|Overall Study||0
156638|NCT00727506|361333|P6|STARTED|Overall Study|Randomized|39
156639|NCT00727506|361334|P5|STARTED|Overall Study|Randomized|41
156640|NCT00727506|361335|P4|STARTED|Overall Study|Randomized|39
156641|NCT00727506|361336|P3|STARTED|Overall Study|Entered|18
156642|NCT00727506|361337|P2|STARTED|Overall Study|Entered|8
156643|NCT00727506|361338|P1|STARTED|Overall Study|Entered|6
156644|NCT00727402|361358|P1|NOT COMPLETED|Overall Study||116
156645|NCT00727402|361358|P1|COMPLETED|Overall Study||89
156646|NCT00727402|361358|P1|STARTED|Overall Study||205
156647|NCT00727337|361366|P4|NOT COMPLETED|Overall Study||7
156648|NCT00727337|361367|P3|NOT COMPLETED|Overall Study||9
156649|NCT00727337|361368|P2|NOT COMPLETED|Overall Study||10
156650|NCT00727337|361369|P1|NOT COMPLETED|Overall Study||10
156651|NCT00727337|361366|P4|COMPLETED|Overall Study||61
156652|NCT00727337|361367|P3|COMPLETED|Overall Study||64
156653|NCT00727337|361368|P2|COMPLETED|Overall Study||63
156654|NCT00727337|361369|P1|COMPLETED|Overall Study||55
156655|NCT00727337|361366|P4|STARTED|Overall Study||68
156656|NCT00727337|361367|P3|STARTED|Overall Study||73
156657|NCT00727337|361368|P2|STARTED|Overall Study||73
156658|NCT00727337|361369|P1|STARTED|Overall Study||65
156659|NCT00727311|361379|P1|NOT COMPLETED|Overall Study||1107
156660|NCT00727311|361379|P1|COMPLETED|Overall Study||1195
156661|NCT00727311|361379|P1|STARTED|Overall Study||2302
156662|NCT00727298|361386|P1|NOT COMPLETED|Overall Study||1257
156663|NCT00727298|361386|P1|COMPLETED|Overall Study||3228
156664|NCT00727298|361386|P1|STARTED|Overall Study||4485
156665|NCT00727272|361392|P3|NOT COMPLETED|Period III||0
156666|NCT00727272|361393|P2|NOT COMPLETED|Period III||0
156667|NCT00727272|361394|P1|NOT COMPLETED|Period III||0
156668|NCT00727272|361392|P3|COMPLETED|Period III||7
156669|NCT00727272|361393|P2|COMPLETED|Period III||9
156670|NCT00727272|361394|P1|COMPLETED|Period III||9
156671|NCT00727272|361392|P3|STARTED|Period III||7
156672|NCT00727272|361393|P2|STARTED|Period III||9
156673|NCT00727272|361394|P1|STARTED|Period III||9
156674|NCT00727272|361392|P3|NOT COMPLETED|Washout Period B||1
156675|NCT00727272|361393|P2|NOT COMPLETED|Washout Period B||0
156676|NCT00727272|361394|P1|NOT COMPLETED|Washout Period B||0
156677|NCT00727272|361392|P3|COMPLETED|Washout Period B|personal reasons|7
156678|NCT00727272|361393|P2|COMPLETED|Washout Period B||9
156679|NCT00727272|361394|P1|COMPLETED|Washout Period B||9
156680|NCT00727272|361392|P3|STARTED|Washout Period B||8
156681|NCT00727272|361393|P2|STARTED|Washout Period B||9
156682|NCT00727272|361394|P1|STARTED|Washout Period B||9
156683|NCT00727272|361392|P3|NOT COMPLETED|Period II||0
156684|NCT00727272|361393|P2|NOT COMPLETED|Period II||0
156685|NCT00727272|361394|P1|NOT COMPLETED|Period II||0
156686|NCT00727272|361392|P3|COMPLETED|Period II||8
156687|NCT00727272|361393|P2|COMPLETED|Period II||9
156688|NCT00727272|361394|P1|COMPLETED|Period II||9
156689|NCT00727272|361392|P3|STARTED|Period II||8
156690|NCT00727272|361393|P2|STARTED|Period II||9
156691|NCT00727272|361394|P1|STARTED|Period II||9
156692|NCT00727272|361392|P3|NOT COMPLETED|Washout Period A||1
156693|NCT00727272|361393|P2|NOT COMPLETED|Washout Period A||0
156694|NCT00727272|361394|P1|NOT COMPLETED|Washout Period A||0
156695|NCT00727272|361392|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
156696|NCT00727272|361393|P2|COMPLETED|Washout Period A||9
156697|NCT00727272|361394|P1|COMPLETED|Washout Period A||9
156698|NCT00727272|361392|P3|STARTED|Washout Period A||9
156699|NCT00727272|361393|P2|STARTED|Washout Period A||9
156700|NCT00727272|361394|P1|STARTED|Washout Period A||9
156701|NCT00727272|361392|P3|NOT COMPLETED|Period I||0
156702|NCT00727272|361393|P2|NOT COMPLETED|Period I||0
156703|NCT00727272|361394|P1|NOT COMPLETED|Period I||0
156704|NCT00727272|361392|P3|COMPLETED|Period I||9
156705|NCT00727272|361393|P2|COMPLETED|Period I||9
156706|NCT00727272|361394|P1|COMPLETED|Period I||9
156707|NCT00727272|361392|P3|STARTED|Period I||9
156708|NCT00727272|361393|P2|STARTED|Period I||9
156709|NCT00727272|361394|P1|STARTED|Period I||9
156710|NCT00727259|361411|P1|NOT COMPLETED|Overall Study||1055
156711|NCT00727259|361411|P1|COMPLETED|Overall Study||940
156712|NCT00727259|361411|P1|STARTED|Overall Study||1995
156713|NCT00727194|361416|P3|NOT COMPLETED|Treatment Period 2||0
156714|NCT00727194|361417|P2|NOT COMPLETED|Treatment Period 2||1
156715|NCT00727194|361418|P1|NOT COMPLETED|Treatment Period 2||0
156716|NCT00727194|361416|P3|COMPLETED|Treatment Period 2||0
156717|NCT00727194|361417|P2|COMPLETED|Treatment Period 2||5
156718|NCT00727194|361418|P1|COMPLETED|Treatment Period 2||6
156719|NCT00727194|361416|P3|STARTED|Treatment Period 2||0
156720|NCT00727194|361417|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
156721|NCT00727194|361418|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
156722|NCT00727194|361416|P3|NOT COMPLETED|Washout Period||0
156723|NCT00727194|361417|P2|NOT COMPLETED|Washout Period||0
156724|NCT00727194|361418|P1|NOT COMPLETED|Washout Period||0
156725|NCT00727194|361416|P3|COMPLETED|Washout Period||0
156726|NCT00727194|361417|P2|COMPLETED|Washout Period||7
156727|NCT00727194|361418|P1|COMPLETED|Washout Period||7
156728|NCT00727194|361416|P3|STARTED|Washout Period||0
156729|NCT00727194|361417|P2|STARTED|Washout Period||7
156730|NCT00727194|361418|P1|STARTED|Washout Period||7
156731|NCT00727194|361416|P3|NOT COMPLETED|Treatment Period 1||0
156732|NCT00727194|361417|P2|NOT COMPLETED|Treatment Period 1||0
156733|NCT00727194|361418|P1|NOT COMPLETED|Treatment Period 1||0
156734|NCT00727194|361416|P3|COMPLETED|Treatment Period 1||0
156735|NCT00727194|361417|P2|COMPLETED|Treatment Period 1||7
156736|NCT00727194|361418|P1|COMPLETED|Treatment Period 1||7
156737|NCT00727194|361416|P3|STARTED|Treatment Period 1||0
156738|NCT00727194|361417|P2|STARTED|Treatment Period 1||7
156739|NCT00727194|361418|P1|STARTED|Treatment Period 1||7
156740|NCT00727194|361416|P3|NOT COMPLETED|Screening Period||16
156741|NCT00727194|361417|P2|NOT COMPLETED|Screening Period||0
156742|NCT00727194|361418|P1|NOT COMPLETED|Screening Period||0
156743|NCT00727194|361416|P3|COMPLETED|Screening Period||0
156744|NCT00727194|361417|P2|COMPLETED|Screening Period||7
156745|NCT00727194|361418|P1|COMPLETED|Screening Period||7
156746|NCT00727194|361416|P3|STARTED|Screening Period||16
156747|NCT00727194|361417|P2|STARTED|Screening Period||7
156748|NCT00727194|361418|P1|STARTED|Screening Period||7
156749|NCT00727090|361454|P2|NOT COMPLETED|Overall Study||0
156750|NCT00727090|361455|P1|NOT COMPLETED|Overall Study||0
156751|NCT00727090|361454|P2|COMPLETED|Overall Study||3
156752|NCT00727090|361455|P1|COMPLETED|Overall Study||3
156753|NCT00727090|361454|P2|STARTED|Overall Study||3
156754|NCT00727090|361455|P1|STARTED|Overall Study||3
156755|NCT00727064|361473|P2|NOT COMPLETED|Overall Study||0
156756|NCT00727064|361474|P1|NOT COMPLETED|Overall Study||0
156757|NCT00727064|361473|P2|COMPLETED|Overall Study||7
156758|NCT00727064|361474|P1|COMPLETED|Overall Study||7
156759|NCT00727064|361473|P2|STARTED|Overall Study||7
156760|NCT00727064|361474|P1|STARTED|Overall Study||7
156761|NCT00727025|361490|P1|NOT COMPLETED|Overall Study||23
156762|NCT00727025|361490|P1|COMPLETED|Overall Study||51
156763|NCT00727025|361490|P1|STARTED|Overall Study||74
156764|NCT00726999|361502|P2|NOT COMPLETED|Overall Study||1
156765|NCT00726999|361503|P1|NOT COMPLETED|Overall Study||3
156766|NCT00726999|361502|P2|COMPLETED|Overall Study||30
156767|NCT00726999|361503|P1|COMPLETED|Overall Study||29
156768|NCT00726999|361502|P2|STARTED|Overall Study||31
156769|NCT00726999|361503|P1|STARTED|Overall Study||32
156770|NCT00726986|361513|P1|NOT COMPLETED|Maintenance Phase||3
156771|NCT00726986|361513|P1|COMPLETED|Maintenance Phase||0
156772|NCT00726986|361513|P1|STARTED|Maintenance Phase||3
156773|NCT00726986|361513|P1|NOT COMPLETED|Induction Phase||15
156774|NCT00726986|361513|P1|COMPLETED|Induction Phase||3
156775|NCT00726986|361513|P1|Maintance|Induction Phase||3
156776|NCT00726986|361513|P1|STARTED|Induction Phase||18
156777|NCT00726895|361520|P2|NOT COMPLETED|Second Intervention||0
156778|NCT00726895|361521|P1|NOT COMPLETED|Second Intervention||0
156779|NCT00726895|361520|P2|COMPLETED|Second Intervention||11
156780|NCT00726895|361521|P1|COMPLETED|Second Intervention||12
156781|NCT00726895|361520|P2|STARTED|Second Intervention||11
156782|NCT00726895|361521|P1|STARTED|Second Intervention||12
156783|NCT00726895|361520|P2|NOT COMPLETED|Washout Period of 7 Days||1
156784|NCT00726895|361521|P1|NOT COMPLETED|Washout Period of 7 Days||0
156785|NCT00726895|361520|P2|COMPLETED|Washout Period of 7 Days||11
156786|NCT00726895|361521|P1|COMPLETED|Washout Period of 7 Days||12
156787|NCT00726895|361520|P2|STARTED|Washout Period of 7 Days||12
156788|NCT00726895|361521|P1|STARTED|Washout Period of 7 Days||12
156789|NCT00726895|361520|P2|NOT COMPLETED|First Intervention||0
156790|NCT00726895|361521|P1|NOT COMPLETED|First Intervention||0
156791|NCT00726895|361520|P2|COMPLETED|First Intervention||12
156792|NCT00726895|361521|P1|COMPLETED|First Intervention||12
156793|NCT00726895|361520|P2|STARTED|First Intervention||12
156794|NCT00726895|361521|P1|STARTED|First Intervention||12
156795|NCT00726882|361534|P1|NOT COMPLETED|Overall Study||22
156796|NCT00726882|361534|P1|COMPLETED|Overall Study||13
156797|NCT00726882|361534|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
156798|NCT00726882|361534|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
156799|NCT00726882|361534|P1|STARTED|Overall Study||35
156800|NCT00726830|361542|P2|NOT COMPLETED|Overall Study||0
156801|NCT00726830|361543|P1|NOT COMPLETED|Overall Study||0
156802|NCT00726830|361542|P2|COMPLETED|Overall Study||0
156803|NCT00726830|361543|P1|COMPLETED|Overall Study||1
156804|NCT00726830|361542|P2|STARTED|Overall Study||0
156805|NCT00726830|361543|P1|STARTED|Overall Study||1
156806|NCT00726752|361549|P1|NOT COMPLETED|Overall Study||6
156807|NCT00726752|361549|P1|COMPLETED|Overall Study||0
156808|NCT00726752|361549|P1|STARTED|Overall Study||6
156809|NCT00726739|361565|P2|NOT COMPLETED|Overall Study||0
156810|NCT00726739|361566|P1|NOT COMPLETED|Overall Study||1
156811|NCT00726739|361565|P2|COMPLETED|Overall Study||10
156812|NCT00726739|361566|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
156813|NCT00726739|361565|P2|STARTED|Overall Study||10
156814|NCT00726739|361566|P1|STARTED|Overall Study||11
156815|NCT00726713|361582|P2|NOT COMPLETED|Overall Study||7
156816|NCT00726713|361583|P1|NOT COMPLETED|Overall Study||7
156817|NCT00726713|361582|P2|COMPLETED|Overall Study||101
156818|NCT00726713|361583|P1|COMPLETED|Overall Study||99
156819|NCT00726713|361582|P2|STARTED|Overall Study||108
156820|NCT00726713|361583|P1|STARTED|Overall Study||106
156821|NCT00726661|361611|P2|NOT COMPLETED|Overall Study||418
156822|NCT00726661|361612|P1|NOT COMPLETED|Overall Study||814
156823|NCT00726661|361611|P2|COMPLETED|Overall Study||17
156824|NCT00726661|361612|P1|COMPLETED|Overall Study||18
156825|NCT00726661|361611|P2|STARTED|Overall Study||435
156826|NCT00726661|361612|P1|STARTED|Overall Study||832
156827|NCT00726557|361627|P1|NOT COMPLETED|Overall Study||128
156828|NCT00726557|361627|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
156829|NCT00726557|361627|P1|STARTED|Overall Study||246
156830|NCT00726453|361634|P2|NOT COMPLETED|38 mm Length Group||3
156831|NCT00726453|361635|P1|NOT COMPLETED|38 mm Length Group||0
156832|NCT00726453|361634|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
156833|NCT00726453|361635|P1|COMPLETED|38 mm Length Group||0
156834|NCT00726453|361634|P2|STARTED|38 mm Length Group||114
156835|NCT00726453|361635|P1|STARTED|38 mm Length Group||0
156836|NCT00726453|361634|P2|NOT COMPLETED|Primary Enrollment Group||0
156837|NCT00726453|361635|P1|NOT COMPLETED|Primary Enrollment Group||31
156838|NCT00726453|361634|P2|COMPLETED|Primary Enrollment Group||0
156839|NCT00726453|361635|P1|COMPLETED|Primary Enrollment Group||1371
156840|NCT00726453|361634|P2|STARTED|Primary Enrollment Group||0
156841|NCT00726453|361635|P1|STARTED|Primary Enrollment Group||1402
156842|NCT00726414|361645|P2|NOT COMPLETED|Second Intervention||0
156843|NCT00726414|361646|P1|NOT COMPLETED|Second Intervention||0
156844|NCT00726414|361645|P2|COMPLETED|Second Intervention||11
156845|NCT00726414|361646|P1|COMPLETED|Second Intervention||11
156846|NCT00726414|361645|P2|STARTED|Second Intervention||11
156847|NCT00726414|361646|P1|STARTED|Second Intervention||11
156848|NCT00726414|361645|P2|NOT COMPLETED|Washout Period of 7 Days||0
156849|NCT00726414|361646|P1|NOT COMPLETED|Washout Period of 7 Days||0
156850|NCT00726414|361645|P2|COMPLETED|Washout Period of 7 Days||11
156851|NCT00726414|361646|P1|COMPLETED|Washout Period of 7 Days||11
156852|NCT00726414|361645|P2|STARTED|Washout Period of 7 Days||11
156853|NCT00726414|361646|P1|STARTED|Washout Period of 7 Days||11
156854|NCT00726414|361645|P2|NOT COMPLETED|First Intervention||0
156855|NCT00726414|361646|P1|NOT COMPLETED|First Intervention||0
156856|NCT00726414|361645|P2|COMPLETED|First Intervention||11
156857|NCT00726414|361646|P1|COMPLETED|First Intervention||11
156858|NCT00726414|361645|P2|STARTED|First Intervention||11
156859|NCT00726414|361646|P1|STARTED|First Intervention||11
156860|NCT00726375|361656|P1|NOT COMPLETED|Overall Study||0
156861|NCT00726375|361656|P1|COMPLETED|Overall Study||34
156862|NCT00726375|361656|P1|STARTED|Overall Study||34
156863|NCT00726232|361667|P6|NOT COMPLETED|Overall Study||4
156864|NCT00726232|361668|P5|NOT COMPLETED|Overall Study||5
156865|NCT00726232|361669|P4|NOT COMPLETED|Overall Study||1
156866|NCT00726232|361670|P3|NOT COMPLETED|Overall Study||0
156867|NCT00726232|361671|P2|NOT COMPLETED|Overall Study||1
156868|NCT00726232|361672|P1|NOT COMPLETED|Overall Study||5
156869|NCT00726232|361667|P6|COMPLETED|Overall Study||5
156870|NCT00726232|361668|P5|COMPLETED|Overall Study||17
156871|NCT00726232|361669|P4|COMPLETED|Overall Study||7
156872|NCT00726232|361670|P3|COMPLETED|Overall Study||7
156873|NCT00726232|361671|P2|COMPLETED|Overall Study||7
156874|NCT00726232|361672|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
156875|NCT00726232|361667|P6|STARTED|Overall Study||9
156876|NCT00726232|361668|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
156877|NCT00726232|361669|P4|STARTED|Overall Study||8
156878|NCT00726232|361670|P3|STARTED|Overall Study||7
156879|NCT00726232|361671|P2|STARTED|Overall Study||8
156880|NCT00726232|361672|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
156881|NCT00726180|361716|P1|NOT COMPLETED|Overall Study||0
156882|NCT00726180|361716|P1|COMPLETED|Overall Study||1
156883|NCT00726180|361716|P1|STARTED|Overall Study||1
156884|NCT00726063|361722|P2|NOT COMPLETED|Overall Study||7
156885|NCT00726063|361723|P1|NOT COMPLETED|Overall Study||9
156886|NCT00726063|361722|P2|COMPLETED|Overall Study|Number of implants = 239|112
156887|NCT00726063|361723|P1|COMPLETED|Overall Study|Number of implants =230|113
156888|NCT00726063|361722|P2|STARTED|Overall Study|Number of implants= 246|119
156889|NCT00726063|361723|P1|STARTED|Overall Study|Number of implants= 239|122
156890|NCT00726037|361729|P1|NOT COMPLETED|Overall Study||0
156891|NCT00726037|361729|P1|COMPLETED|Overall Study||7
156892|NCT00726037|361729|P1|STARTED|Overall Study||7
156893|NCT00725985|361737|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
156894|NCT00725985|361738|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
156895|NCT00725985|361739|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
156896|NCT00725985|361740|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156897|NCT00725985|361741|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156898|NCT00725985|361742|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156899|NCT00725985|361743|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156900|NCT00725985|361744|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156901|NCT00725985|361745|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156902|NCT00725985|361746|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156903|NCT00725985|361747|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156904|NCT00725985|361748|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
156905|NCT00725985|361737|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
156906|NCT00725985|361738|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
156907|NCT00725985|361739|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
156908|NCT00725985|361740|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
156909|NCT00725985|361741|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
156910|NCT00725985|361742|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
156911|NCT00725985|361743|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
156912|NCT00725985|361744|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
156913|NCT00725985|361745|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
156914|NCT00725985|361746|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
156915|NCT00725985|361747|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
156916|NCT00725985|361748|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
156917|NCT00725985|361737|P12|STARTED|LTFU (No Cladribine Treatment)||14
156918|NCT00725985|361738|P11|STARTED|LTFU (No Cladribine Treatment)||36
156919|NCT00725985|361739|P10|STARTED|LTFU (No Cladribine Treatment)||34
156920|NCT00725985|361740|P9|STARTED|LTFU (No Cladribine Treatment)||0
156921|NCT00725985|361741|P8|STARTED|LTFU (No Cladribine Treatment)||0
156922|NCT00725985|361742|P7|STARTED|LTFU (No Cladribine Treatment)||0
156923|NCT00725985|361743|P6|STARTED|LTFU (No Cladribine Treatment)||0
156924|NCT00725985|361744|P5|STARTED|LTFU (No Cladribine Treatment)||0
156925|NCT00725985|361745|P4|STARTED|LTFU (No Cladribine Treatment)||0
156926|NCT00725985|361746|P3|STARTED|LTFU (No Cladribine Treatment)||0
156927|NCT00725985|361747|P2|STARTED|LTFU (No Cladribine Treatment)||0
156928|NCT00725985|361748|P1|STARTED|LTFU (No Cladribine Treatment)||0
156929|NCT00725985|361737|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156930|NCT00725985|361738|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156931|NCT00725985|361739|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156932|NCT00725985|361740|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
156933|NCT00725985|361741|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
156934|NCT00725985|361742|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
156935|NCT00725985|361743|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156936|NCT00725985|361744|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156937|NCT00725985|361745|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156938|NCT00725985|361746|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156939|NCT00725985|361747|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156940|NCT00725985|361748|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
156941|NCT00725985|361737|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
156942|NCT00725985|361738|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
156943|NCT00725985|361739|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
156944|NCT00725985|361740|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
156945|NCT00725985|361741|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
156946|NCT00725985|361742|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
156947|NCT00725985|361743|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
156948|NCT00725985|361744|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
156949|NCT00725985|361745|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
156950|NCT00725985|361746|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
156951|NCT00725985|361747|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
156952|NCT00725985|361748|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
156953|NCT00725985|361737|P12|STARTED|LTFU (With Cladribine Treatment)||0
156954|NCT00725985|361738|P11|STARTED|LTFU (With Cladribine Treatment)||0
156955|NCT00725985|361739|P10|STARTED|LTFU (With Cladribine Treatment)||0
156956|NCT00725985|361740|P9|STARTED|LTFU (With Cladribine Treatment)||17
156957|NCT00725985|361741|P8|STARTED|LTFU (With Cladribine Treatment)||9
156958|NCT00725985|361742|P7|STARTED|LTFU (With Cladribine Treatment)||9
156959|NCT00725985|361743|P6|STARTED|LTFU (With Cladribine Treatment)||0
156960|NCT00725985|361744|P5|STARTED|LTFU (With Cladribine Treatment)||0
156961|NCT00725985|361745|P4|STARTED|LTFU (With Cladribine Treatment)||0
156962|NCT00725985|361746|P3|STARTED|LTFU (With Cladribine Treatment)||0
156963|NCT00725985|361747|P2|STARTED|LTFU (With Cladribine Treatment)||0
156964|NCT00725985|361748|P1|STARTED|LTFU (With Cladribine Treatment)||0
156965|NCT00725985|361737|P12|NOT COMPLETED|OLMP||0
156966|NCT00725985|361738|P11|NOT COMPLETED|OLMP||0
156967|NCT00725985|361739|P10|NOT COMPLETED|OLMP||0
156968|NCT00725985|361740|P9|NOT COMPLETED|OLMP||0
156969|NCT00725985|361741|P8|NOT COMPLETED|OLMP||0
156970|NCT00725985|361742|P7|NOT COMPLETED|OLMP||0
156971|NCT00725985|361743|P6|NOT COMPLETED|OLMP||53
156972|NCT00725985|361744|P5|NOT COMPLETED|OLMP||23
156973|NCT00725985|361745|P4|NOT COMPLETED|OLMP||18
156974|NCT00725985|361746|P3|NOT COMPLETED|OLMP||0
156975|NCT00725985|361747|P2|NOT COMPLETED|OLMP||0
156976|NCT00725985|361748|P1|NOT COMPLETED|OLMP||0
156977|NCT00725985|361737|P12|COMPLETED|OLMP||0
156978|NCT00725985|361738|P11|COMPLETED|OLMP||0
156979|NCT00725985|361739|P10|COMPLETED|OLMP||0
156980|NCT00725985|361740|P9|COMPLETED|OLMP||0
156981|NCT00725985|361741|P8|COMPLETED|OLMP||0
156982|NCT00725985|361742|P7|COMPLETED|OLMP||0
156983|NCT00725985|361743|P6|COMPLETED|OLMP||7
156984|NCT00725985|361744|P5|COMPLETED|OLMP||2
156985|NCT00725985|361745|P4|COMPLETED|OLMP||6
156986|NCT00725985|361746|P3|COMPLETED|OLMP||0
156987|NCT00725985|361747|P2|COMPLETED|OLMP||0
156988|NCT00725985|361748|P1|COMPLETED|OLMP||0
156989|NCT00725985|361737|P12|STARTED|OLMP||0
156990|NCT00725985|361738|P11|STARTED|OLMP||0
156991|NCT00725985|361739|P10|STARTED|OLMP||0
156992|NCT00725985|361740|P9|STARTED|OLMP||0
156993|NCT00725985|361741|P8|STARTED|OLMP||0
156994|NCT00725985|361742|P7|STARTED|OLMP||0
156995|NCT00725985|361743|P6|STARTED|OLMP||60
156996|NCT00725985|361744|P5|STARTED|OLMP||25
156997|NCT00725985|361745|P4|STARTED|OLMP||24
156998|NCT00725985|361746|P3|STARTED|OLMP||0
156999|NCT00725985|361747|P2|STARTED|OLMP||0
157000|NCT00725985|361748|P1|STARTED|OLMP||0
157001|NCT00725985|361737|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157002|NCT00725985|361738|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157003|NCT00725985|361739|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157004|NCT00725985|361740|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157005|NCT00725985|361741|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157006|NCT00725985|361742|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157007|NCT00725985|361743|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157008|NCT00725985|361744|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157009|NCT00725985|361745|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
157010|NCT00725985|361746|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
157011|NCT00725985|361747|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
157012|NCT00725985|361748|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
157013|NCT00725985|361737|P12|COMPLETED|ITP (Up to 96 Weeks)||0
157014|NCT00725985|361738|P11|COMPLETED|ITP (Up to 96 Weeks)||0
157015|NCT00725985|361739|P10|COMPLETED|ITP (Up to 96 Weeks)||0
157016|NCT00725985|361740|P9|COMPLETED|ITP (Up to 96 Weeks)||0
157017|NCT00725985|361741|P8|COMPLETED|ITP (Up to 96 Weeks)||0
157018|NCT00725985|361742|P7|COMPLETED|ITP (Up to 96 Weeks)||0
157019|NCT00725985|361743|P6|COMPLETED|ITP (Up to 96 Weeks)||0
157020|NCT00725985|361744|P5|COMPLETED|ITP (Up to 96 Weeks)||0
157021|NCT00725985|361745|P4|COMPLETED|ITP (Up to 96 Weeks)||0
157022|NCT00725985|361746|P3|COMPLETED|ITP (Up to 96 Weeks)||104
157023|NCT00725985|361747|P2|COMPLETED|ITP (Up to 96 Weeks)||131
157024|NCT00725985|361748|P1|COMPLETED|ITP (Up to 96 Weeks)||104
157025|NCT00725985|361737|P12|Treated|ITP (Up to 96 Weeks)||0
157026|NCT00725985|361738|P11|Treated|ITP (Up to 96 Weeks)||0
157027|NCT00725985|361739|P10|Treated|ITP (Up to 96 Weeks)||0
157028|NCT00725985|361740|P9|Treated|ITP (Up to 96 Weeks)||0
157029|NCT00725985|361741|P8|Treated|ITP (Up to 96 Weeks)||0
157030|NCT00725985|361742|P7|Treated|ITP (Up to 96 Weeks)||0
157031|NCT00725985|361743|P6|Treated|ITP (Up to 96 Weeks)||0
157032|NCT00725985|361744|P5|Treated|ITP (Up to 96 Weeks)||0
157033|NCT00725985|361745|P4|Treated|ITP (Up to 96 Weeks)||0
157034|NCT00725985|361746|P3|Treated|ITP (Up to 96 Weeks)||206
157035|NCT00725985|361747|P2|Treated|ITP (Up to 96 Weeks)||206
157036|NCT00725985|361748|P1|Treated|ITP (Up to 96 Weeks)||204
157037|NCT00725985|361737|P12|STARTED|ITP (Up to 96 Weeks)||0
157038|NCT00725985|361738|P11|STARTED|ITP (Up to 96 Weeks)||0
157039|NCT00725985|361739|P10|STARTED|ITP (Up to 96 Weeks)||0
157040|NCT00725985|361740|P9|STARTED|ITP (Up to 96 Weeks)||0
157041|NCT00725985|361741|P8|STARTED|ITP (Up to 96 Weeks)||0
157042|NCT00725985|361742|P7|STARTED|ITP (Up to 96 Weeks)||0
157043|NCT00725985|361743|P6|STARTED|ITP (Up to 96 Weeks)||0
157044|NCT00725985|361744|P5|STARTED|ITP (Up to 96 Weeks)||0
157045|NCT00725985|361745|P4|STARTED|ITP (Up to 96 Weeks)||0
157046|NCT00725985|361746|P3|STARTED|ITP (Up to 96 Weeks)||206
157047|NCT00725985|361747|P2|STARTED|ITP (Up to 96 Weeks)||206
157048|NCT00725985|361748|P1|STARTED|ITP (Up to 96 Weeks)||205
157049|NCT00725920|361776|P2|NOT COMPLETED|Overall Study||6
157050|NCT00725920|361777|P1|NOT COMPLETED|Overall Study||3
157051|NCT00725920|361776|P2|COMPLETED|Overall Study||12
157052|NCT00725920|361777|P1|COMPLETED|Overall Study||14
157053|NCT00725920|361776|P2|STARTED|Overall Study||18
157054|NCT00725920|361777|P1|STARTED|Overall Study||17
157055|NCT00725842|361783|P1|NOT COMPLETED|Overall Study||40
157056|NCT00725842|361783|P1|COMPLETED|Overall Study||57
157057|NCT00725842|361783|P1|Participants Eligible for Analysis|Overall Study||90
157058|NCT00725842|361783|P1|STARTED|Overall Study||97
157059|NCT00724984|361796|P6|NOT COMPLETED|Overall Study||5
157060|NCT00724984|361797|P5|NOT COMPLETED|Overall Study||4
157061|NCT00724984|361798|P4|NOT COMPLETED|Overall Study||2
157062|NCT00724984|361799|P3|NOT COMPLETED|Overall Study||0
157063|NCT00724984|361800|P2|NOT COMPLETED|Overall Study||1
157064|NCT00724984|361801|P1|NOT COMPLETED|Overall Study||1
157065|NCT00724984|361796|P6|COMPLETED|Overall Study||9
157066|NCT00724984|361797|P5|COMPLETED|Overall Study||12
157067|NCT00724984|361798|P4|COMPLETED|Overall Study||7
157068|NCT00724984|361799|P3|COMPLETED|Overall Study||3
157069|NCT00724984|361800|P2|COMPLETED|Overall Study||7
157070|NCT00724984|361801|P1|COMPLETED|Overall Study||4
157071|NCT00724984|361796|P6|STARTED|Overall Study||14
157072|NCT00724984|361797|P5|STARTED|Overall Study||16
157073|NCT00724984|361798|P4|STARTED|Overall Study||9
157074|NCT00724984|361799|P3|STARTED|Overall Study||3
157075|NCT00724984|361800|P2|STARTED|Overall Study||8
157076|NCT00724984|361801|P1|STARTED|Overall Study||5
157077|NCT00724958|361815|P1|NOT COMPLETED|Overall Study||182
157078|NCT00724958|361815|P1|COMPLETED|Overall Study||166
157079|NCT00724958|361815|P1|STARTED|Overall Study||348
157080|NCT00724945|361824|P2|NOT COMPLETED|Period 2||0
157081|NCT00724945|361825|P1|NOT COMPLETED|Period 2||4
157082|NCT00724945|361824|P2|COMPLETED|Period 2||54
157083|NCT00724945|361825|P1|COMPLETED|Period 2||51
157084|NCT00724945|361824|P2|STARTED|Period 2||54
157085|NCT00724945|361825|P1|STARTED|Period 2||55
157086|NCT00724945|361824|P2|NOT COMPLETED|Period 1||1
157087|NCT00724945|361825|P1|NOT COMPLETED|Period 1||3
157088|NCT00724945|361824|P2|COMPLETED|Period 1||54
157089|NCT00724945|361825|P1|COMPLETED|Period 1||55
157090|NCT00724945|361824|P2|STARTED|Period 1||55
157091|NCT00724945|361825|P1|STARTED|Period 1||58
157092|NCT00724932|361837|P2|NOT COMPLETED|Overall Study||3
157093|NCT00724932|361838|P1|NOT COMPLETED|Overall Study||5
157094|NCT00724932|361837|P2|COMPLETED|Overall Study||67
157095|NCT00724932|361838|P1|COMPLETED|Overall Study||65
157096|NCT00724932|361837|P2|STARTED|Overall Study||70
157097|NCT00724932|361838|P1|STARTED|Overall Study||70
157098|NCT00725751|361909|P2|NOT COMPLETED|Overall Study||108
157099|NCT00725751|361910|P1|NOT COMPLETED|Overall Study||34
157100|NCT00725751|361909|P2|COMPLETED|Overall Study||150
157101|NCT00725751|361910|P1|COMPLETED|Overall Study||56
157102|NCT00725751|361909|P2|STARTED|Overall Study||258
157103|NCT00725751|361910|P1|STARTED|Overall Study||90
157104|NCT00725725|361922|P3|NOT COMPLETED|Overall Study||5
157105|NCT00725725|361923|P2|NOT COMPLETED|Overall Study||4
157106|NCT00725725|361924|P1|NOT COMPLETED|Overall Study||4
157107|NCT00725725|361922|P3|COMPLETED|Overall Study||12
157108|NCT00725725|361923|P2|COMPLETED|Overall Study||11
157109|NCT00725725|361924|P1|COMPLETED|Overall Study||10
157110|NCT00725725|361922|P3|Treated|Overall Study||14
157111|NCT00725725|361923|P2|Treated|Overall Study||15
157112|NCT00725725|361924|P1|Treated|Overall Study||11
157113|NCT00725725|361922|P3|STARTED|Overall Study||17
157114|NCT00725725|361923|P2|STARTED|Overall Study||15
157115|NCT00725725|361924|P1|STARTED|Overall Study||14
157116|NCT00725621|361965|P1|NOT COMPLETED|Overall Study||271
157117|NCT00725621|361965|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
157118|NCT00725621|361965|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
157119|NCT00725608|361988|P1|NOT COMPLETED|Overall Study||167
157120|NCT00725608|361988|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
157121|NCT00725608|361988|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
157122|NCT00725543|361994|P1|NOT COMPLETED|Overall Study||153
157123|NCT00725543|361994|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
157124|NCT00725543|361994|P1|STARTED|Overall Study||358
157125|NCT00725530|362003|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
157126|NCT00725530|362004|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
157127|NCT00725530|362003|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
157128|NCT00725530|362004|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
157129|NCT00725530|362003|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
157130|NCT00725530|362004|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
157217|NCT00724711|362299|P2|COMPLETED|Overall Study||139
157131|NCT00725530|362003|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
157132|NCT00725530|362004|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
157133|NCT00725530|362003|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
157134|NCT00725530|362004|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
157135|NCT00725530|362003|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
157136|NCT00725530|362004|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
157137|NCT00725491|362012|P2|NOT COMPLETED|Overall Study||18
157138|NCT00725491|362013|P1|NOT COMPLETED|Overall Study||9
157139|NCT00725491|362012|P2|COMPLETED|Overall Study||102
157140|NCT00725491|362013|P1|COMPLETED|Overall Study||104
157141|NCT00725491|362012|P2|STARTED|Overall Study|Intent-to-Treat Group|120
157142|NCT00725491|362013|P1|STARTED|Overall Study|Intent-to-Treat Group|113
157143|NCT00725452|362019|P1|NOT COMPLETED|Overall Study||11
157144|NCT00725452|362019|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
157145|NCT00725452|362019|P1|STARTED|Overall Study||26
157146|NCT00725296|362028|P1|NOT COMPLETED|Overall Study||62
157147|NCT00725296|362028|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
157148|NCT00725296|362028|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
157149|NCT00725205|362037|P1|NOT COMPLETED|Overall Study||87
157150|NCT00725205|362037|P1|COMPLETED|Overall Study||207
157151|NCT00725205|362037|P1|STARTED|Overall Study||294
157152|NCT00725153|362043|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
157153|NCT00725153|362044|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
157154|NCT00725153|362043|P2|COMPLETED|Period Two, 10 Hours of Wear||28
157155|NCT00725153|362044|P1|COMPLETED|Period Two, 10 Hours of Wear||27
157156|NCT00725153|362043|P2|STARTED|Period Two, 10 Hours of Wear||28
157157|NCT00725153|362044|P1|STARTED|Period Two, 10 Hours of Wear||27
157158|NCT00725153|362043|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
157159|NCT00725153|362044|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
157160|NCT00725153|362043|P2|COMPLETED|Period One, 10 Hours of Wear||28
157161|NCT00725153|362044|P1|COMPLETED|Period One, 10 Hours of Wear||27
157162|NCT00725153|362043|P2|STARTED|Period One, 10 Hours of Wear||28
157163|NCT00725153|362044|P1|STARTED|Period One, 10 Hours of Wear||27
157164|NCT00725101|362050|P1|NOT COMPLETED|Overall Study||495
157165|NCT00725101|362050|P1|COMPLETED|Overall Study||1205
157166|NCT00725101|362050|P1|STARTED|Overall Study||1700
157167|NCT00725075|362073|P3|NOT COMPLETED|Overall Study||9
157168|NCT00725075|362074|P2|NOT COMPLETED|Overall Study||8
157169|NCT00725075|362075|P1|NOT COMPLETED|Overall Study||11
157170|NCT00725075|362073|P3|COMPLETED|Overall Study||61
157171|NCT00725075|362074|P2|COMPLETED|Overall Study||65
157172|NCT00725075|362075|P1|COMPLETED|Overall Study||61
157173|NCT00725075|362073|P3|Treated|Overall Study||70
157174|NCT00725075|362074|P2|Treated|Overall Study||73
157175|NCT00725075|362075|P1|Treated|Overall Study||71
157176|NCT00725075|362073|P3|STARTED|Overall Study||70
157177|NCT00725075|362074|P2|STARTED|Overall Study||73
157178|NCT00725075|362075|P1|STARTED|Overall Study||72
157179|NCT00725049|362121|P2|NOT COMPLETED|Overall Study||0
157180|NCT00725049|362122|P1|NOT COMPLETED|Overall Study||0
157181|NCT00725049|362121|P2|COMPLETED|Overall Study||20
157182|NCT00725049|362122|P1|COMPLETED|Overall Study||17
157183|NCT00725049|362121|P2|STARTED|Overall Study||20
157184|NCT00725049|362122|P1|STARTED|Overall Study||17
157185|NCT00725010|362128|P1|NOT COMPLETED|Overall Study||25
157186|NCT00725010|362128|P1|COMPLETED|Overall Study||25
157187|NCT00725010|362128|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
157188|NCT00724893|362138|P2|NOT COMPLETED|Overall Study||458
157189|NCT00724893|362139|P1|NOT COMPLETED|Overall Study||364
157190|NCT00724893|362138|P2|COMPLETED|Overall Study||670
157191|NCT00724893|362139|P1|COMPLETED|Overall Study||938
157192|NCT00724893|362138|P2|STARTED|Overall Study||1128
157193|NCT00724893|362139|P1|STARTED|Overall Study||1302
157194|NCT00724867|362207|P1|NOT COMPLETED|Overall Study||128
157195|NCT00724867|362207|P1|COMPLETED|Overall Study||140
157196|NCT00724867|362207|P1|STARTED|Overall Study||268
157197|NCT00724854|362247|P2|NOT COMPLETED|Overall Study||31
157198|NCT00724854|362248|P1|NOT COMPLETED|Overall Study||403
157199|NCT00724854|362247|P2|COMPLETED|Overall Study||41
157200|NCT00724854|362248|P1|COMPLETED|Overall Study||607
157201|NCT00724854|362247|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
157202|NCT00724854|362248|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
157203|NCT00724815|362265|P2|NOT COMPLETED|Overall Study||39
157204|NCT00724815|362266|P1|NOT COMPLETED|Overall Study||43
157205|NCT00724815|362265|P2|COMPLETED|Overall Study||226
157206|NCT00724815|362266|P1|COMPLETED|Overall Study||222
157207|NCT00724815|362265|P2|STARTED|Overall Study|subjects randomized|265
157208|NCT00724815|362266|P1|STARTED|Overall Study|subjects randomized|265
157209|NCT00724750|362280|P2|NOT COMPLETED|Overall Study||0
157210|NCT00724750|362281|P1|NOT COMPLETED|Overall Study||0
157211|NCT00724750|362280|P2|COMPLETED|Overall Study||42
157212|NCT00724750|362281|P1|COMPLETED|Overall Study||45
157213|NCT00724750|362280|P2|STARTED|Overall Study||42
157214|NCT00724750|362281|P1|STARTED|Overall Study||45
157215|NCT00724711|362299|P2|NOT COMPLETED|Overall Study||17
157216|NCT00724711|362300|P1|NOT COMPLETED|Overall Study||17
157218|NCT00724711|362300|P1|COMPLETED|Overall Study||138
157219|NCT00724711|362299|P2|STARTED|Overall Study||156
157220|NCT00724711|362300|P1|STARTED|Overall Study||155
157221|NCT00724698|362332|P1|NOT COMPLETED|Overall Study||90
157222|NCT00724698|362332|P1|COMPLETED|Overall Study||2921
157223|NCT00724698|362332|P1|STARTED|Overall Study||3011
157224|NCT00724594|362339|P4|NOT COMPLETED|Overall Study||1
157225|NCT00724594|362340|P3|NOT COMPLETED|Overall Study||0
157226|NCT00724594|362341|P2|NOT COMPLETED|Overall Study||0
157227|NCT00724594|362342|P1|NOT COMPLETED|Overall Study||0
157228|NCT00724594|362339|P4|COMPLETED|Overall Study||10
157229|NCT00724594|362340|P3|COMPLETED|Overall Study||11
157230|NCT00724594|362341|P2|COMPLETED|Overall Study||12
157231|NCT00724594|362342|P1|COMPLETED|Overall Study||12
157232|NCT00724594|362339|P4|STARTED|Overall Study||11
157233|NCT00724594|362340|P3|STARTED|Overall Study||11
157234|NCT00724594|362341|P2|STARTED|Overall Study||12
157235|NCT00724594|362342|P1|STARTED|Overall Study||12
157236|NCT00724568|362365|P2|NOT COMPLETED|Overall Study||0
157237|NCT00724568|362366|P1|NOT COMPLETED|Overall Study||0
157238|NCT00724568|362365|P2|COMPLETED|Overall Study||32
157239|NCT00724568|362366|P1|COMPLETED|Overall Study||42
157240|NCT00724568|362365|P2|STARTED|Overall Study||32
157241|NCT00724568|362366|P1|STARTED|Overall Study||42
157242|NCT00724477|362371|P1|NOT COMPLETED|Overall Study||0
157243|NCT00724477|362371|P1|COMPLETED|Overall Study||1663
157244|NCT00724477|362371|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
157245|NCT00724464|362375|P1|NOT COMPLETED|Overall Study||23
157246|NCT00724464|362375|P1|COMPLETED|Overall Study||309
157247|NCT00724464|362375|P1|STARTED|Overall Study||332
157248|NCT00724451|362387|P1|NOT COMPLETED|Overall Study||802
157249|NCT00724451|362387|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
157250|NCT00724451|362387|P1|Received Antiviral Treatment|Overall Study||500
157251|NCT00724451|362387|P1|STARTED|Overall Study||1128
157252|NCT00724373|362393|P1|NOT COMPLETED|Overall Study||171
157253|NCT00724373|362393|P1|COMPLETED|Overall Study||271
157254|NCT00724373|362393|P1|STARTED|Overall Study||442
157255|NCT00724347|362397|P1|NOT COMPLETED|Overall Study||2
157256|NCT00724347|362397|P1|COMPLETED|Overall Study||16
157257|NCT00724347|362397|P1|Baseline Testing|Overall Study||18
157258|NCT00724347|362397|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
157259|NCT00724308|362403|P2|NOT COMPLETED|Overall Study||97
157260|NCT00724308|362404|P1|NOT COMPLETED|Overall Study||80
157261|NCT00724308|362403|P2|COMPLETED|Overall Study||210
157262|NCT00724308|362404|P1|COMPLETED|Overall Study||190
157263|NCT00724308|362403|P2|STARTED|Overall Study||307
157264|NCT00724308|362404|P1|STARTED|Overall Study||270
157265|NCT00724282|362410|P1|NOT COMPLETED|Overall Study||4
157266|NCT00724282|362410|P1|COMPLETED|Overall Study||16
157267|NCT00724282|362410|P1|STARTED|Overall Study||20
157268|NCT00724243|362414|P1|NOT COMPLETED|Overall Study||15
157269|NCT00724243|362414|P1|COMPLETED|Overall Study||18
157270|NCT00724243|362414|P1|STARTED|Overall Study||33
157271|NCT00724152|362424|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
157272|NCT00724152|362425|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
157273|NCT00724152|362426|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
157274|NCT00724152|362424|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
157275|NCT00724152|362425|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
157276|NCT00724152|362426|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
157277|NCT00724152|362424|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
157278|NCT00724152|362425|P2|STARTED|Three-arm Study Period (+Standard Care)||2
157279|NCT00724152|362426|P1|STARTED|Three-arm Study Period (+Standard Care)||4
157280|NCT00724152|362424|P3|NOT COMPLETED|Two-arm Study Period||0
157281|NCT00724152|362425|P2|NOT COMPLETED|Two-arm Study Period||2
157282|NCT00724152|362426|P1|NOT COMPLETED|Two-arm Study Period||3
157283|NCT00724152|362424|P3|COMPLETED|Two-arm Study Period||0
157284|NCT00724152|362425|P2|COMPLETED|Two-arm Study Period||9
157285|NCT00724152|362426|P1|COMPLETED|Two-arm Study Period||11
157286|NCT00724152|362424|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
157287|NCT00724152|362425|P2|STARTED|Two-arm Study Period||11
157288|NCT00724152|362426|P1|STARTED|Two-arm Study Period||14
157289|NCT00724126|362443|P2|NOT COMPLETED|Overall Study||15
157290|NCT00724126|362444|P1|NOT COMPLETED|Overall Study||19
157291|NCT00724126|362443|P2|COMPLETED|Overall Study||301
157292|NCT00724126|362444|P1|COMPLETED|Overall Study||302
157293|NCT00724126|362443|P2|STARTED|Overall Study||316
157294|NCT00724126|362444|P1|STARTED|Overall Study||321
157295|NCT00724061|362452|P1|NOT COMPLETED|Maintenance Therapy||0
157296|NCT00724061|362452|P1|COMPLETED|Maintenance Therapy||2
157297|NCT00724061|362452|P1|STARTED|Maintenance Therapy||2
157298|NCT00724061|362452|P1|NOT COMPLETED|Dose Escalation Phase||5
157299|NCT00724061|362452|P1|COMPLETED|Dose Escalation Phase||2
157300|NCT00724061|362452|P1|STARTED|Dose Escalation Phase||7
157301|NCT00724009|362456|P1|NOT COMPLETED|Overall Study||0
157302|NCT00724009|362456|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
157303|NCT00724009|362456|P1|STARTED|Overall Study||29
157304|NCT00723957|362469|P2|NOT COMPLETED|Overall Study||53
157305|NCT00723957|362470|P1|NOT COMPLETED|Overall Study||51
157306|NCT00723957|362469|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
157307|NCT00723957|362470|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
157308|NCT00723957|362469|P2|STARTED|Overall Study|Randomized|99
157309|NCT00723957|362470|P1|STARTED|Overall Study|Randomized|98
157310|NCT00723944|362494|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
157311|NCT00723944|362495|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
157312|NCT00723944|362494|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
157313|NCT00723944|362495|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
157314|NCT00723944|362494|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
157315|NCT00723944|362495|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
157316|NCT00723944|362494|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
157317|NCT00723944|362495|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
157318|NCT00723944|362494|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
157319|NCT00723944|362495|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
157320|NCT00723944|362494|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
157321|NCT00723944|362495|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
157322|NCT00723944|362494|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
157323|NCT00723944|362495|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
157324|NCT00723944|362494|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
157325|NCT00723944|362495|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
157326|NCT00723944|362494|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
157327|NCT00723944|362495|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
157328|NCT00723944|362494|P2|NOT COMPLETED|Implant Placement Surgery||0
157329|NCT00723944|362495|P1|NOT COMPLETED|Implant Placement Surgery||0
157330|NCT00723944|362494|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
157331|NCT00723944|362495|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
157332|NCT00723944|362494|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
157333|NCT00723944|362495|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
157334|NCT00723931|362501|P1|NOT COMPLETED|Overall Study||0
157335|NCT00723931|362501|P1|COMPLETED|Overall Study||1267
157336|NCT00723931|362501|P1|STARTED|Overall Study||1267
157337|NCT00723892|362508|P2|NOT COMPLETED|Overall Study||87
157338|NCT00723892|362509|P1|NOT COMPLETED|Overall Study||107
157339|NCT00723892|362508|P2|COMPLETED|Overall Study||168
157340|NCT00723892|362509|P1|COMPLETED|Overall Study||206
157341|NCT00723892|362508|P2|STARTED|Overall Study||255
157342|NCT00723892|362509|P1|STARTED|Overall Study||313
157343|NCT00723840|362516|P1|NOT COMPLETED|Overall Study||82
157344|NCT00723840|362516|P1|COMPLETED|Overall Study||163
157345|NCT00723840|362516|P1|STARTED|Overall Study||245
157346|NCT00723827|362527|P1|NOT COMPLETED|Overall Study||0
157347|NCT00723827|362527|P1|COMPLETED|Overall Study||682
157348|NCT00723827|362527|P1|STARTED|Overall Study||682
157349|NCT00722800|362537|P2|NOT COMPLETED|Overall Study||0
157350|NCT00722800|362538|P1|NOT COMPLETED|Overall Study||2
157351|NCT00722800|362537|P2|COMPLETED|Overall Study||2
157352|NCT00722800|362538|P1|COMPLETED|Overall Study||0
157353|NCT00722800|362537|P2|STARTED|Overall Study||2
157354|NCT00722800|362538|P1|STARTED|Overall Study||2
157355|NCT00722761|362550|P2|NOT COMPLETED|Overall Study||6
157356|NCT00722761|362551|P1|NOT COMPLETED|Overall Study||6
157357|NCT00722761|362550|P2|COMPLETED|Overall Study||8
157358|NCT00722761|362551|P1|COMPLETED|Overall Study||10
157359|NCT00722761|362550|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
157360|NCT00722761|362551|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
157361|NCT00722761|362550|P2|STARTED|Overall Study||14
157362|NCT00722761|362551|P1|STARTED|Overall Study||16
157363|NCT00722722|362562|P3|NOT COMPLETED|Overall Study||0
157364|NCT00722722|362563|P2|NOT COMPLETED|Overall Study||0
157365|NCT00722722|362564|P1|NOT COMPLETED|Overall Study||0
157366|NCT00722722|362562|P3|COMPLETED|Overall Study||10
157367|NCT00722722|362563|P2|COMPLETED|Overall Study||5
157368|NCT00722722|362564|P1|COMPLETED|Overall Study||3
157369|NCT00722722|362562|P3|STARTED|Overall Study||10
157370|NCT00722722|362563|P2|STARTED|Overall Study||5
157371|NCT00722722|362564|P1|STARTED|Overall Study||3
157372|NCT00723801|362574|P2|NOT COMPLETED|Overall Study||3
157373|NCT00723801|362575|P1|NOT COMPLETED|Overall Study||3
157374|NCT00723801|362574|P2|COMPLETED|Overall Study||17
157375|NCT00723801|362575|P1|COMPLETED|Overall Study||17
157376|NCT00723801|362574|P2|STARTED|Overall Study||20
157377|NCT00723801|362575|P1|STARTED|Overall Study||20
157378|NCT00723788|362583|P1|NOT COMPLETED|Overall Study||0
157379|NCT00723788|362583|P1|COMPLETED|Overall Study||21
157380|NCT00723788|362583|P1|STARTED|Overall Study||21
157381|NCT00723749|362589|P1|NOT COMPLETED|Overall Study||163
157382|NCT00723749|362589|P1|COMPLETED|Overall Study||182
157383|NCT00723749|362589|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
157384|NCT00723736|362596|P1|NOT COMPLETED|Overall Study||1
157550|NCT00723021|362936|P1|STARTED|Intervention Period 4||3
157385|NCT00723736|362596|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
157386|NCT00723736|362596|P1|STARTED|Overall Study||100
157387|NCT00723710|362600|P1|NOT COMPLETED|Overall Study||174
157388|NCT00723710|362600|P1|COMPLETED|Overall Study||120
157389|NCT00723710|362600|P1|STARTED|Overall Study||294
157390|NCT00723697|362604|P1|NOT COMPLETED|Overall Study||18
157391|NCT00723697|362604|P1|COMPLETED|Overall Study||1289
157392|NCT00723697|362604|P1|STARTED|Overall Study||1307
157393|NCT00723645|362612|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
157394|NCT00723645|362612|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
157395|NCT00723645|362612|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
157396|NCT00723645|362612|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
157397|NCT00723645|362612|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
157398|NCT00723645|362612|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
157399|NCT00723645|362612|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
157400|NCT00723645|362612|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
157401|NCT00723645|362612|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
157402|NCT00723632|362617|P1|NOT COMPLETED|Overall Study||203
157403|NCT00723632|362617|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
157404|NCT00723632|362617|P1|STARTED|Overall Study||901
157405|NCT00723606|362625|P2|NOT COMPLETED|Overall Study||7
157406|NCT00723606|362626|P1|NOT COMPLETED|Overall Study||4
157407|NCT00723606|362625|P2|COMPLETED|Overall Study||180
157408|NCT00723606|362626|P1|COMPLETED|Overall Study||185
157409|NCT00723606|362625|P2|STARTED|Overall Study||187
157410|NCT00723606|362626|P1|STARTED|Overall Study||189
157411|NCT00723580|362642|P1|NOT COMPLETED|Overall Study||0
157412|NCT00723580|362642|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
157413|NCT00723580|362642|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
157414|NCT00723580|362642|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
157415|NCT00723554|362646|P1|NOT COMPLETED|Overall Study||29
157416|NCT00723554|362646|P1|COMPLETED|Overall Study||34
157417|NCT00723554|362646|P1|STARTED|Overall Study||63
157418|NCT00723528|362696|P7|NOT COMPLETED|Period 2: After Controlled Period||4
157419|NCT00723528|362697|P6|NOT COMPLETED|Period 2: After Controlled Period||6
157420|NCT00723528|362698|P5|NOT COMPLETED|Period 2: After Controlled Period||2
157421|NCT00723528|362699|P4|NOT COMPLETED|Period 2: After Controlled Period||1
157422|NCT00723528|362700|P3|NOT COMPLETED|Period 2: After Controlled Period||0
157423|NCT00723528|362701|P2|NOT COMPLETED|Period 2: After Controlled Period||0
157424|NCT00723528|362702|P1|NOT COMPLETED|Period 2: After Controlled Period||0
157425|NCT00723528|362696|P7|COMPLETED|Period 2: After Controlled Period||54
157426|NCT00723528|362697|P6|COMPLETED|Period 2: After Controlled Period||58
157427|NCT00723528|362698|P5|COMPLETED|Period 2: After Controlled Period||11
157428|NCT00723528|362699|P4|COMPLETED|Period 2: After Controlled Period||14
157429|NCT00723528|362700|P3|COMPLETED|Period 2: After Controlled Period||0
157430|NCT00723528|362701|P2|COMPLETED|Period 2: After Controlled Period||0
157431|NCT00723528|362702|P1|COMPLETED|Period 2: After Controlled Period||0
157432|NCT00723528|362696|P7|STARTED|Period 2: After Controlled Period||58
157433|NCT00723528|362697|P6|STARTED|Period 2: After Controlled Period||64
157434|NCT00723528|362698|P5|STARTED|Period 2: After Controlled Period||13
157435|NCT00723528|362699|P4|STARTED|Period 2: After Controlled Period||15
157436|NCT00723528|362700|P3|STARTED|Period 2: After Controlled Period||0
157437|NCT00723528|362701|P2|STARTED|Period 2: After Controlled Period||0
157438|NCT00723528|362702|P1|STARTED|Period 2: After Controlled Period||0
157439|NCT00723528|362696|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
157440|NCT00723528|362697|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
157441|NCT00723528|362698|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
157442|NCT00723528|362699|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
157443|NCT00723528|362700|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
157444|NCT00723528|362701|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
157445|NCT00723528|362702|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
157446|NCT00723528|362696|P7|COMPLETED|Period 1: Controlled Period (CP)||0
157447|NCT00723528|362697|P6|COMPLETED|Period 1: Controlled Period (CP)||0
157448|NCT00723528|362698|P5|COMPLETED|Period 1: Controlled Period (CP)||0
157449|NCT00723528|362699|P4|COMPLETED|Period 1: Controlled Period (CP)||0
157450|NCT00723528|362700|P3|COMPLETED|Period 1: Controlled Period (CP)||58
157451|NCT00723528|362701|P2|COMPLETED|Period 1: Controlled Period (CP)||64
157452|NCT00723528|362702|P1|COMPLETED|Period 1: Controlled Period (CP)||28
157453|NCT00723528|362696|P7|STARTED|Period 1: Controlled Period (CP)||0
157454|NCT00723528|362697|P6|STARTED|Period 1: Controlled Period (CP)||0
157455|NCT00723528|362698|P5|STARTED|Period 1: Controlled Period (CP)||0
157456|NCT00723528|362699|P4|STARTED|Period 1: Controlled Period (CP)||0
157457|NCT00723528|362700|P3|STARTED|Period 1: Controlled Period (CP)||62
157458|NCT00723528|362701|P2|STARTED|Period 1: Controlled Period (CP)||64
157459|NCT00723528|362702|P1|STARTED|Period 1: Controlled Period (CP)||32
157460|NCT00723489|362764|P4|NOT COMPLETED|Overall Study||3
157461|NCT00723489|362765|P3|NOT COMPLETED|Overall Study||0
157462|NCT00723489|362766|P2|NOT COMPLETED|Overall Study||4
157463|NCT00723489|362767|P1|NOT COMPLETED|Overall Study||1
157464|NCT00723489|362764|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
157465|NCT00723489|362765|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
157466|NCT00723489|362766|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
157467|NCT00723489|362767|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
157468|NCT00723489|362764|P4|STARTED|Overall Study||23
157469|NCT00723489|362765|P3|STARTED|Overall Study||19
157470|NCT00723489|362766|P2|STARTED|Overall Study||19
157471|NCT00723489|362767|P1|STARTED|Overall Study||21
157472|NCT00723450|362795|P3|NOT COMPLETED|Randomized Phase||67
157473|NCT00723450|362796|P2|NOT COMPLETED|Randomized Phase||65
157474|NCT00723450|362797|P1|NOT COMPLETED|Randomized Phase||0
157475|NCT00723450|362795|P3|COMPLETED|Randomized Phase||20
157476|NCT00723450|362796|P2|COMPLETED|Randomized Phase||21
157477|NCT00723450|362797|P1|COMPLETED|Randomized Phase||0
157478|NCT00723450|362795|P3|STARTED|Randomized Phase||87
157479|NCT00723450|362796|P2|STARTED|Randomized Phase||86
157480|NCT00723450|362797|P1|STARTED|Randomized Phase||0
157481|NCT00723450|362795|P3|NOT COMPLETED|Open-Label Phase||0
157482|NCT00723450|362796|P2|NOT COMPLETED|Open-Label Phase||0
157483|NCT00723450|362797|P1|NOT COMPLETED|Open-Label Phase||125
157484|NCT00723450|362795|P3|COMPLETED|Open-Label Phase||0
157485|NCT00723450|362796|P2|COMPLETED|Open-Label Phase||0
157486|NCT00723450|362797|P1|COMPLETED|Open-Label Phase||173
157487|NCT00723450|362795|P3|STARTED|Open-Label Phase||0
157488|NCT00723450|362796|P2|STARTED|Open-Label Phase||0
157489|NCT00723450|362797|P1|STARTED|Open-Label Phase||298
157490|NCT00723255|362838|P1|NOT COMPLETED|Overall Study||4
157491|NCT00723255|362838|P1|COMPLETED|Overall Study|Eligible and treated patients|49
157492|NCT00723255|362838|P1|STARTED|Overall Study||53
157493|NCT00723203|362857|P1|NOT COMPLETED|Overall Study||3
157494|NCT00723203|362857|P1|COMPLETED|Overall Study||13
157495|NCT00723203|362857|P1|STARTED|Overall Study||16
157496|NCT00723190|362861|P1|NOT COMPLETED|Overall Study||142
157497|NCT00723190|362861|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
157498|NCT00723190|362861|P1|SAFETY POPULATION|Overall Study||301
157499|NCT00723190|362861|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
157500|NCT00723177|362879|P3|NOT COMPLETED|Overall Study||5
157501|NCT00723177|362880|P2|NOT COMPLETED|Overall Study||4
157502|NCT00723177|362881|P1|NOT COMPLETED|Overall Study||5
157503|NCT00723177|362879|P3|COMPLETED|Overall Study||10
157504|NCT00723177|362880|P2|COMPLETED|Overall Study||10
157505|NCT00723177|362881|P1|COMPLETED|Overall Study||10
157506|NCT00723177|362879|P3|STARTED|Overall Study||15
157507|NCT00723177|362880|P2|STARTED|Overall Study||14
157508|NCT00723177|362881|P1|STARTED|Overall Study||15
157509|NCT00723125|362894|P2|NOT COMPLETED|Overall Study||6
157510|NCT00723125|362895|P1|NOT COMPLETED|Overall Study||18
157511|NCT00723125|362894|P2|COMPLETED|Overall Study||21
157512|NCT00723125|362895|P1|COMPLETED|Overall Study||15
157513|NCT00723125|362894|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
157514|NCT00723125|362895|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
157515|NCT00723073|362907|P2|NOT COMPLETED|Overall Study||0
157516|NCT00723073|362908|P1|NOT COMPLETED|Overall Study||0
157517|NCT00723073|362907|P2|COMPLETED|Overall Study||174
157518|NCT00723073|362908|P1|COMPLETED|Overall Study||149
157519|NCT00723073|362907|P2|STARTED|Overall Study||174
157520|NCT00723073|362908|P1|STARTED|Overall Study||149
157521|NCT00723021|362932|P5|NOT COMPLETED|Intervention Period 5||0
157522|NCT00723021|362933|P4|NOT COMPLETED|Intervention Period 5||0
157523|NCT00723021|362934|P3|NOT COMPLETED|Intervention Period 5||0
157524|NCT00723021|362935|P2|NOT COMPLETED|Intervention Period 5||0
157525|NCT00723021|362936|P1|NOT COMPLETED|Intervention Period 5||0
157526|NCT00723021|362932|P5|COMPLETED|Intervention Period 5||2
157527|NCT00723021|362933|P4|COMPLETED|Intervention Period 5||3
157528|NCT00723021|362934|P3|COMPLETED|Intervention Period 5||3
157529|NCT00723021|362935|P2|COMPLETED|Intervention Period 5||3
157530|NCT00723021|362936|P1|COMPLETED|Intervention Period 5||3
157531|NCT00723021|362932|P5|STARTED|Intervention Period 5||2
157532|NCT00723021|362933|P4|STARTED|Intervention Period 5||3
157533|NCT00723021|362934|P3|STARTED|Intervention Period 5||3
157534|NCT00723021|362935|P2|STARTED|Intervention Period 5||3
157535|NCT00723021|362936|P1|STARTED|Intervention Period 5||3
157536|NCT00723021|362932|P5|NOT COMPLETED|Intervention Period 4||1
157537|NCT00723021|362933|P4|NOT COMPLETED|Intervention Period 4||0
157538|NCT00723021|362934|P3|NOT COMPLETED|Intervention Period 4||0
157539|NCT00723021|362935|P2|NOT COMPLETED|Intervention Period 4||0
157540|NCT00723021|362936|P1|NOT COMPLETED|Intervention Period 4||0
157541|NCT00723021|362932|P5|COMPLETED|Intervention Period 4||2
157542|NCT00723021|362933|P4|COMPLETED|Intervention Period 4||3
157543|NCT00723021|362934|P3|COMPLETED|Intervention Period 4||3
157544|NCT00723021|362935|P2|COMPLETED|Intervention Period 4||3
157545|NCT00723021|362936|P1|COMPLETED|Intervention Period 4||3
157546|NCT00723021|362932|P5|STARTED|Intervention Period 4||3
157547|NCT00723021|362933|P4|STARTED|Intervention Period 4||3
157548|NCT00723021|362934|P3|STARTED|Intervention Period 4||3
157549|NCT00723021|362935|P2|STARTED|Intervention Period 4||3
157551|NCT00723021|362932|P5|NOT COMPLETED|Intervention Period 3||0
157552|NCT00723021|362933|P4|NOT COMPLETED|Intervention Period 3||0
157553|NCT00723021|362934|P3|NOT COMPLETED|Intervention Period 3||0
157554|NCT00723021|362935|P2|NOT COMPLETED|Intervention Period 3||0
157555|NCT00723021|362936|P1|NOT COMPLETED|Intervention Period 3||0
157556|NCT00723021|362932|P5|COMPLETED|Intervention Period 3||3
157557|NCT00723021|362933|P4|COMPLETED|Intervention Period 3||3
157558|NCT00723021|362934|P3|COMPLETED|Intervention Period 3||3
157559|NCT00723021|362935|P2|COMPLETED|Intervention Period 3||3
157560|NCT00723021|362936|P1|COMPLETED|Intervention Period 3||3
157561|NCT00723021|362932|P5|STARTED|Intervention Period 3||3
157562|NCT00723021|362933|P4|STARTED|Intervention Period 3||3
157563|NCT00723021|362934|P3|STARTED|Intervention Period 3||3
157564|NCT00723021|362935|P2|STARTED|Intervention Period 3||3
157565|NCT00723021|362936|P1|STARTED|Intervention Period 3||3
157566|NCT00723021|362932|P5|NOT COMPLETED|Intervention Period 2||0
157567|NCT00723021|362933|P4|NOT COMPLETED|Intervention Period 2||0
157568|NCT00723021|362934|P3|NOT COMPLETED|Intervention Period 2||0
157569|NCT00723021|362935|P2|NOT COMPLETED|Intervention Period 2||0
157570|NCT00723021|362936|P1|NOT COMPLETED|Intervention Period 2||0
157571|NCT00723021|362932|P5|COMPLETED|Intervention Period 2||3
157572|NCT00723021|362933|P4|COMPLETED|Intervention Period 2||3
157573|NCT00723021|362934|P3|COMPLETED|Intervention Period 2||3
157574|NCT00723021|362935|P2|COMPLETED|Intervention Period 2||3
157575|NCT00723021|362936|P1|COMPLETED|Intervention Period 2||3
157576|NCT00723021|362932|P5|STARTED|Intervention Period 2||3
157577|NCT00723021|362933|P4|STARTED|Intervention Period 2||3
157578|NCT00723021|362934|P3|STARTED|Intervention Period 2||3
157579|NCT00723021|362935|P2|STARTED|Intervention Period 2||3
157580|NCT00723021|362936|P1|STARTED|Intervention Period 2||3
157581|NCT00723021|362932|P5|NOT COMPLETED|Intervention Period 1||0
157582|NCT00723021|362933|P4|NOT COMPLETED|Intervention Period 1||0
157583|NCT00723021|362934|P3|NOT COMPLETED|Intervention Period 1||0
157584|NCT00723021|362935|P2|NOT COMPLETED|Intervention Period 1||0
157585|NCT00723021|362936|P1|NOT COMPLETED|Intervention Period 1||0
157586|NCT00723021|362932|P5|COMPLETED|Intervention Period 1||3
157587|NCT00723021|362933|P4|COMPLETED|Intervention Period 1||3
157588|NCT00723021|362934|P3|COMPLETED|Intervention Period 1||3
157589|NCT00723021|362935|P2|COMPLETED|Intervention Period 1||3
157590|NCT00723021|362936|P1|COMPLETED|Intervention Period 1||3
157591|NCT00723021|362932|P5|STARTED|Intervention Period 1||3
157592|NCT00723021|362933|P4|STARTED|Intervention Period 1||3
157593|NCT00723021|362934|P3|STARTED|Intervention Period 1||3
157594|NCT00723021|362935|P2|STARTED|Intervention Period 1||3
157595|NCT00723021|362936|P1|STARTED|Intervention Period 1||3
157596|NCT00723008|362990|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
157597|NCT00723008|362991|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
157598|NCT00723008|362990|P2|COMPLETED|4-Week Unblinded Treatment||3
157599|NCT00723008|362991|P1|COMPLETED|4-Week Unblinded Treatment||4
157600|NCT00723008|362990|P2|STARTED|4-Week Unblinded Treatment||4
157601|NCT00723008|362991|P1|STARTED|4-Week Unblinded Treatment||5
157602|NCT00723008|362990|P2|NOT COMPLETED|4-Week Double Blinded||5
157603|NCT00723008|362991|P1|NOT COMPLETED|4-Week Double Blinded||5
157604|NCT00723008|362990|P2|COMPLETED|4-Week Double Blinded||4
157605|NCT00723008|362991|P1|COMPLETED|4-Week Double Blinded||5
157606|NCT00723008|362990|P2|STARTED|4-Week Double Blinded||9
157607|NCT00723008|362991|P1|STARTED|4-Week Double Blinded||10
157608|NCT00723008|362990|P2|NOT COMPLETED|Enrollment||0
157609|NCT00723008|362991|P1|NOT COMPLETED|Enrollment||1
157610|NCT00723008|362990|P2|COMPLETED|Enrollment||9
157611|NCT00723008|362991|P1|COMPLETED|Enrollment||10
157612|NCT00723008|362990|P2|STARTED|Enrollment||9
157613|NCT00723008|362991|P1|STARTED|Enrollment||11
157614|NCT00722566|363015|P2|NOT COMPLETED|Overall Study||35
157615|NCT00722566|363016|P1|NOT COMPLETED|Overall Study||67
157616|NCT00722566|363015|P2|COMPLETED|Overall Study|Completed 8 cycles|39
157617|NCT00722566|363016|P1|COMPLETED|Overall Study|Completed 8 cycles|81
157618|NCT00722566|363015|P2|STARTED|Overall Study||74
157619|NCT00722566|363016|P1|STARTED|Overall Study|One patient randomized and not dosed|148
157620|NCT00722553|363024|P1|NOT COMPLETED|Overall Study||0
157621|NCT00722553|363024|P1|COMPLETED|Overall Study||30
157622|NCT00722553|363024|P1|STARTED|Overall Study||30
157623|NCT00722436|363034|P2|NOT COMPLETED|Overall Study||0
157624|NCT00722436|363035|P1|NOT COMPLETED|Overall Study||0
157625|NCT00722436|363034|P2|COMPLETED|Overall Study||11
157626|NCT00722436|363035|P1|COMPLETED|Overall Study||9
157627|NCT00722436|363034|P2|STARTED|Overall Study||11
157628|NCT00722436|363035|P1|STARTED|Overall Study||9
157629|NCT00722423|363049|P2|NOT COMPLETED|Overall Study||1
157630|NCT00722423|363050|P1|NOT COMPLETED|Overall Study||0
157631|NCT00722423|363049|P2|COMPLETED|Overall Study||181
157632|NCT00722423|363050|P1|COMPLETED|Overall Study||182
157633|NCT00722423|363049|P2|STARTED|Overall Study||182
157634|NCT00722423|363050|P1|STARTED|Overall Study||182
157635|NCT00722371|363065|P7|NOT COMPLETED|Overall Study||51
157636|NCT00722371|363066|P6|NOT COMPLETED|Overall Study||53
157637|NCT00722371|363067|P5|NOT COMPLETED|Overall Study||48
157638|NCT00722371|363068|P4|NOT COMPLETED|Overall Study||63
157639|NCT00722371|363069|P3|NOT COMPLETED|Overall Study||65
157640|NCT00722371|363070|P2|NOT COMPLETED|Overall Study||72
157641|NCT00722371|363071|P1|NOT COMPLETED|Overall Study||56
157642|NCT00722371|363065|P7|COMPLETED|Overall Study||179
157643|NCT00722371|363066|P6|COMPLETED|Overall Study||178
157644|NCT00722371|363067|P5|COMPLETED|Overall Study||182
157645|NCT00722371|363068|P4|COMPLETED|Overall Study||167
157646|NCT00722371|363069|P3|COMPLETED|Overall Study||168
157647|NCT00722371|363070|P2|COMPLETED|Overall Study||158
157648|NCT00722371|363071|P1|COMPLETED|Overall Study||175
157649|NCT00722371|363065|P7|STARTED|Overall Study||230
157650|NCT00722371|363066|P6|STARTED|Overall Study||231
157651|NCT00722371|363067|P5|STARTED|Overall Study||230
157652|NCT00722371|363068|P4|STARTED|Overall Study||230
157653|NCT00722371|363069|P3|STARTED|Overall Study||233
157654|NCT00722371|363070|P2|STARTED|Overall Study||230
157655|NCT00722371|363071|P1|STARTED|Overall Study||231
157656|NCT00722137|363124|P2|NOT COMPLETED|Overall Study||45
157657|NCT00722137|363125|P1|NOT COMPLETED|Overall Study||48
157658|NCT00722137|363124|P2|COMPLETED|Overall Study||199
157659|NCT00722137|363125|P1|COMPLETED|Overall Study||195
157660|NCT00722137|363124|P2|STARTED|Overall Study||244
157661|NCT00722137|363125|P1|STARTED|Overall Study||243
157662|NCT00722124|363152|P3|NOT COMPLETED|Overall Study||20
157663|NCT00722124|363153|P2|NOT COMPLETED|Overall Study||14
157664|NCT00722124|363154|P1|NOT COMPLETED|Overall Study||17
157665|NCT00722124|363152|P3|COMPLETED|Overall Study||20
157666|NCT00722124|363153|P2|COMPLETED|Overall Study||26
157667|NCT00722124|363154|P1|COMPLETED|Overall Study||23
157668|NCT00722124|363152|P3|STARTED|Overall Study||40
157669|NCT00722124|363153|P2|STARTED|Overall Study||40
157670|NCT00722124|363154|P1|STARTED|Overall Study||40
157671|NCT00722072|363162|P1|NOT COMPLETED|Overall Study||3
157672|NCT00722072|363162|P1|COMPLETED|Overall Study||9
157673|NCT00722072|363162|P1|STARTED|Overall Study||12
157674|NCT00722020|363168|P2|NOT COMPLETED|Overall Study||0
157675|NCT00722020|363169|P1|NOT COMPLETED|Overall Study||0
157676|NCT00722020|363168|P2|COMPLETED|Overall Study||24
157677|NCT00722020|363169|P1|COMPLETED|Overall Study||19
157678|NCT00722020|363168|P2|STARTED|Overall Study||24
157679|NCT00722020|363169|P1|STARTED|Overall Study||19
157680|NCT00721968|363179|P2|NOT COMPLETED|Overall Study||0
157681|NCT00721968|363180|P1|NOT COMPLETED|Overall Study||2
157682|NCT00721968|363179|P2|COMPLETED|Overall Study||17
157683|NCT00721968|363180|P1|COMPLETED|Overall Study||25
157684|NCT00721968|363179|P2|STARTED|Overall Study||17
157685|NCT00721968|363180|P1|STARTED|Overall Study||27
157686|NCT00721734|363193|P5|NOT COMPLETED|Overall Study||6
157687|NCT00721734|363194|P4|NOT COMPLETED|Overall Study||6
157688|NCT00721734|363195|P3|NOT COMPLETED|Overall Study||8
157689|NCT00721734|363196|P2|NOT COMPLETED|Overall Study||12
157690|NCT00721734|363197|P1|NOT COMPLETED|Overall Study||8
157691|NCT00721734|363193|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
157692|NCT00721734|363194|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
157693|NCT00721734|363195|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
157694|NCT00721734|363196|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
157695|NCT00721734|363197|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
157696|NCT00721734|363193|P5|STARTED|Overall Study||8
157697|NCT00721734|363194|P4|STARTED|Overall Study||8
157698|NCT00721734|363195|P3|STARTED|Overall Study||10
157699|NCT00721734|363196|P2|STARTED|Overall Study||12
157700|NCT00721734|363197|P1|STARTED|Overall Study||12
157701|NCT00721617|363309|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
157702|NCT00721617|363309|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
157703|NCT00721617|363309|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
157704|NCT00721617|363309|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
157705|NCT00721617|363309|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
157706|NCT00721617|363309|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
157707|NCT00721617|363309|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
157708|NCT00721617|363309|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
157709|NCT00721617|363309|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
157710|NCT00721617|363309|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
157711|NCT00721617|363309|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
157712|NCT00721617|363309|P1|STARTED|8 Hours Into Dextrose Infusion||12
157713|NCT00721617|363309|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
157714|NCT00721617|363309|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
157715|NCT00721617|363309|P1|STARTED|4 Hours Into Dextrose Infusion||12
157716|NCT00721617|363309|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
157717|NCT00721617|363309|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
157718|NCT00721617|363309|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
157719|NCT00721617|363309|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
157720|NCT00721617|363309|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
157721|NCT00721617|363309|P1|STARTED|8 Hours Into Intralipid Infusion||12
157722|NCT00721617|363309|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
157723|NCT00721617|363309|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
157724|NCT00721617|363309|P1|STARTED|4 Hours Into Intralipid Infusion||12
157725|NCT00721617|363309|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
157726|NCT00721617|363309|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
157727|NCT00721617|363309|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
157728|NCT00721617|363309|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
157729|NCT00721617|363309|P1|COMPLETED|8 Hours Into Saline Infusion||12
157730|NCT00721617|363309|P1|STARTED|8 Hours Into Saline Infusion||12
157731|NCT00721617|363309|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
157732|NCT00721617|363309|P1|COMPLETED|4 Hours Into Saline Infusion||12
157733|NCT00721617|363309|P1|STARTED|4 Hours Into Saline Infusion||12
157734|NCT00721617|363309|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
157735|NCT00721617|363309|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
157736|NCT00721617|363309|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
157737|NCT00721578|363333|P2|NOT COMPLETED|Overall Study||2
157738|NCT00721578|363334|P1|NOT COMPLETED|Overall Study||2
157739|NCT00721578|363333|P2|COMPLETED|Overall Study||9
157740|NCT00721578|363334|P1|COMPLETED|Overall Study||10
157741|NCT00721578|363333|P2|STARTED|Overall Study||11
157742|NCT00721578|363334|P1|STARTED|Overall Study||12
157743|NCT00721539|363346|P1|NOT COMPLETED|Overall Study||0
157744|NCT00721539|363346|P1|COMPLETED|Overall Study||9
157745|NCT00721539|363346|P1|STARTED|Overall Study||9
157746|NCT00721500|363353|P4|NOT COMPLETED|Period Three||0
157747|NCT00721500|363354|P3|NOT COMPLETED|Period Three||0
157748|NCT00721500|363355|P2|NOT COMPLETED|Period Three||0
157749|NCT00721500|363356|P1|NOT COMPLETED|Period Three||0
157750|NCT00721500|363353|P4|COMPLETED|Period Three||6
157751|NCT00721500|363354|P3|COMPLETED|Period Three||6
157752|NCT00721500|363355|P2|COMPLETED|Period Three||7
157753|NCT00721500|363356|P1|COMPLETED|Period Three||6
157754|NCT00721500|363353|P4|STARTED|Period Three||6
157755|NCT00721500|363354|P3|STARTED|Period Three||6
157756|NCT00721500|363355|P2|STARTED|Period Three||7
157757|NCT00721500|363356|P1|STARTED|Period Three||6
157758|NCT00721500|363353|P4|NOT COMPLETED|Period Two||0
157759|NCT00721500|363354|P3|NOT COMPLETED|Period Two||0
157760|NCT00721500|363355|P2|NOT COMPLETED|Period Two||0
157761|NCT00721500|363356|P1|NOT COMPLETED|Period Two||0
157762|NCT00721500|363353|P4|COMPLETED|Period Two||6
157763|NCT00721500|363354|P3|COMPLETED|Period Two||6
157764|NCT00721500|363355|P2|COMPLETED|Period Two||7
157765|NCT00721500|363356|P1|COMPLETED|Period Two||6
157766|NCT00721500|363353|P4|STARTED|Period Two||6
157767|NCT00721500|363354|P3|STARTED|Period Two||6
157768|NCT00721500|363355|P2|STARTED|Period Two||7
157769|NCT00721500|363356|P1|STARTED|Period Two||6
157770|NCT00721500|363353|P4|NOT COMPLETED|Period One||0
157771|NCT00721500|363354|P3|NOT COMPLETED|Period One||0
157772|NCT00721500|363355|P2|NOT COMPLETED|Period One||0
157773|NCT00721500|363356|P1|NOT COMPLETED|Period One||0
157774|NCT00721500|363353|P4|COMPLETED|Period One||6
157775|NCT00721500|363354|P3|COMPLETED|Period One||6
157776|NCT00721500|363355|P2|COMPLETED|Period One||7
157777|NCT00721500|363356|P1|COMPLETED|Period One||6
157778|NCT00721500|363353|P4|STARTED|Period One||6
157779|NCT00721500|363354|P3|STARTED|Period One||6
157780|NCT00721500|363355|P2|STARTED|Period One||7
157781|NCT00721500|363356|P1|STARTED|Period One||6
157782|NCT00721409|363377|P3|NOT COMPLETED|Overall Study||81
157783|NCT00721409|363378|P2|NOT COMPLETED|Overall Study||84
157784|NCT00721409|363379|P1|NOT COMPLETED|Overall Study||12
157785|NCT00721409|363377|P3|COMPLETED|Overall Study||0
157786|NCT00721409|363378|P2|COMPLETED|Overall Study||0
157787|NCT00721409|363379|P1|COMPLETED|Overall Study||0
157788|NCT00721409|363377|P3|Treated|Overall Study||77
157789|NCT00721409|363378|P2|Treated|Overall Study||83
157790|NCT00721409|363379|P1|Treated|Overall Study||12
157791|NCT00721409|363377|P3|STARTED|Overall Study||81
157792|NCT00721409|363378|P2|STARTED|Overall Study||84
157793|NCT00721409|363379|P1|STARTED|Overall Study||12
157794|NCT00721396|363506|P4|NOT COMPLETED|Overall Study||10
157795|NCT00721396|363507|P3|NOT COMPLETED|Overall Study||10
157796|NCT00721396|363508|P2|NOT COMPLETED|Overall Study||36
157797|NCT00721396|363509|P1|NOT COMPLETED|Overall Study||30
157798|NCT00721396|363506|P4|COMPLETED|Overall Study||302
157799|NCT00721396|363507|P3|COMPLETED|Overall Study||308
157800|NCT00721396|363508|P2|COMPLETED|Overall Study||592
157801|NCT00721396|363509|P1|COMPLETED|Overall Study||597
157802|NCT00721396|363506|P4|STARTED|Overall Study||312
157803|NCT00721396|363507|P3|STARTED|Overall Study||318
157804|NCT00721396|363508|P2|STARTED|Overall Study||628
157805|NCT00721396|363509|P1|STARTED|Overall Study||627
157806|NCT00721357|363547|P2|NOT COMPLETED|Overall Study||0
157807|NCT00721357|363548|P1|NOT COMPLETED|Overall Study||0
157808|NCT00721357|363547|P2|COMPLETED|Overall Study||15
157809|NCT00721357|363548|P1|COMPLETED|Overall Study||15
157810|NCT00721357|363547|P2|STARTED|Overall Study||15
157811|NCT00721357|363548|P1|STARTED|Overall Study||15
157812|NCT00721279|363556|P2|NOT COMPLETED|Overall Study||24
157813|NCT00721279|363557|P1|NOT COMPLETED|Overall Study||36
157814|NCT00721279|363556|P2|COMPLETED|Overall Study||73
157815|NCT00721279|363557|P1|COMPLETED|Overall Study||416
157816|NCT00721279|363556|P2|STARTED|Overall Study||97
157817|NCT00721279|363557|P1|STARTED|Overall Study||452
157818|NCT00721253|363571|P3|NOT COMPLETED|Overall Study||0
157819|NCT00721253|363572|P2|NOT COMPLETED|Overall Study||0
157820|NCT00721253|363573|P1|NOT COMPLETED|Overall Study||0
157821|NCT00721253|363571|P3|COMPLETED|Overall Study||0
157822|NCT00721253|363572|P2|COMPLETED|Overall Study||22
157823|NCT00721253|363573|P1|COMPLETED|Overall Study||20
157824|NCT00721253|363571|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
157825|NCT00721253|363572|P2|STARTED|Overall Study||22
157826|NCT00721253|363573|P1|STARTED|Overall Study||20
157827|NCT00721227|363585|P2|NOT COMPLETED|Overall Study||0
157828|NCT00721227|363586|P1|NOT COMPLETED|Overall Study||4
157829|NCT00721227|363585|P2|COMPLETED|Overall Study||6
157830|NCT00721227|363586|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
157831|NCT00721227|363585|P2|STARTED|Overall Study||6
157832|NCT00721227|363586|P1|STARTED|Overall Study||9
157833|NCT00721214|363596|P1|NOT COMPLETED|Overall Study||4
157834|NCT00721214|363596|P1|COMPLETED|Overall Study||12
157835|NCT00721214|363596|P1|STARTED|Overall Study||16
157836|NCT00721188|363607|P1|NOT COMPLETED|Overall Study||0
157837|NCT00721188|363607|P1|COMPLETED|Overall Study||11
157838|NCT00721188|363607|P1|STARTED|Overall Study||11
157839|NCT00721175|363624|P2|NOT COMPLETED|Overall Study||0
157840|NCT00721175|363625|P1|NOT COMPLETED|Overall Study||0
157841|NCT00721175|363624|P2|COMPLETED|Overall Study||54
157842|NCT00721175|363625|P1|COMPLETED|Overall Study||54
157843|NCT00721175|363624|P2|STARTED|Overall Study||54
157844|NCT00721175|363625|P1|STARTED|Overall Study||54
157845|NCT00721162|363637|P1|NOT COMPLETED|Overall Study||0
157846|NCT00721162|363637|P1|COMPLETED|Overall Study||60
157847|NCT00721162|363637|P1|Received Any Amount of Study Drug|Overall Study||60
157848|NCT00721162|363637|P1|STARTED|Overall Study||60
157849|NCT00721149|363646|P1|NOT COMPLETED|Overall Study||1
157850|NCT00721149|363646|P1|COMPLETED|Overall Study||9
157851|NCT00721149|363646|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
157852|NCT00721123|363655|P1|NOT COMPLETED|Overall Study||183
157853|NCT00721123|363655|P1|COMPLETED|Overall Study||355
157854|NCT00721123|363655|P1|STARTED|Overall Study||538
157855|NCT00720941|363731|P2|NOT COMPLETED|Overall Study||415
157856|NCT00720941|363732|P1|NOT COMPLETED|Overall Study||413
157857|NCT00720941|363731|P2|COMPLETED|Overall Study||138
157858|NCT00720941|363732|P1|COMPLETED|Overall Study||144
157859|NCT00720941|363731|P2|Ongoing|Overall Study||23
157860|NCT00720941|363732|P1|Ongoing|Overall Study||34
157861|NCT00720941|363731|P2|STARTED|Overall Study||553
157862|NCT00720941|363732|P1|STARTED|Overall Study||557
157863|NCT00720798|363772|P1|NOT COMPLETED|Overall Study||756
157864|NCT00720798|363772|P1|COMPLETED|Overall Study||1311
157865|NCT00720798|363772|P1|STARTED|Overall Study||2067
157866|NCT00720759|363795|P4|NOT COMPLETED|Overall Study||0
157867|NCT00720759|363796|P3|NOT COMPLETED|Overall Study||1
157868|NCT00720759|363797|P2|NOT COMPLETED|Overall Study||1
157869|NCT00720759|363798|P1|NOT COMPLETED|Overall Study||0
157870|NCT00720759|363795|P4|COMPLETED|Overall Study||6
157871|NCT00720759|363796|P3|COMPLETED|Overall Study||5
157872|NCT00720759|363797|P2|COMPLETED|Overall Study||5
157873|NCT00720759|363798|P1|COMPLETED|Overall Study||6
157874|NCT00720759|363795|P4|STARTED|Overall Study||6
157875|NCT00720759|363796|P3|STARTED|Overall Study||6
157876|NCT00720759|363797|P2|STARTED|Overall Study||6
157877|NCT00720759|363798|P1|STARTED|Overall Study||6
157878|NCT00720629|363808|P1|NOT COMPLETED|Overall Study||0
157879|NCT00720629|363808|P1|COMPLETED|Overall Study||8
157880|NCT00720629|363808|P1|STARTED|Overall Study||8
157881|NCT00720499|363818|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
157882|NCT00720499|363819|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
157883|NCT00720499|363818|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
157884|NCT00720499|363819|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
157885|NCT00720499|363818|P2|STARTED|Treatment Period 2 (4 Weeks)||70
157886|NCT00720499|363819|P1|STARTED|Treatment Period 2 (4 Weeks)||66
157887|NCT00720499|363818|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
157888|NCT00720499|363819|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
157889|NCT00720499|363818|P2|COMPLETED|Washout Period (2 Weeks)||70
157890|NCT00720499|363819|P1|COMPLETED|Washout Period (2 Weeks)||66
157891|NCT00720499|363818|P2|STARTED|Washout Period (2 Weeks)||70
157892|NCT00720499|363819|P1|STARTED|Washout Period (2 Weeks)||66
157893|NCT00720499|363818|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
157894|NCT00720499|363819|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
157895|NCT00720499|363818|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
157896|NCT00720499|363819|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
157897|NCT00720499|363818|P2|STARTED|Treatment Period 1 (4 Weeks)||72
157898|NCT00720499|363819|P1|STARTED|Treatment Period 1 (4 Weeks)||69
157899|NCT00720473|363883|P2|NOT COMPLETED|Overall Study||8
157900|NCT00720473|363884|P1|NOT COMPLETED|Overall Study||30
157901|NCT00720473|363883|P2|COMPLETED|Overall Study||16
157902|NCT00720473|363884|P1|COMPLETED|Overall Study||15
157903|NCT00720473|363883|P2|STARTED|Overall Study||24
157904|NCT00720473|363884|P1|STARTED|Overall Study||45
157905|NCT00720434|363912|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
157906|NCT00720434|363913|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
157907|NCT00720434|363914|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
157908|NCT00720434|363915|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
157909|NCT00720434|363912|P4|COMPLETED|Open-Label Period (Week 5-72)||4
157910|NCT00720434|363913|P3|COMPLETED|Open-Label Period (Week 5-72)||4
157911|NCT00720434|363914|P2|COMPLETED|Open-Label Period (Week 5-72)||5
157912|NCT00720434|363915|P1|COMPLETED|Open-Label Period (Week 5-72)||4
157913|NCT00720434|363912|P4|STARTED|Open-Label Period (Week 5-72)||8
157914|NCT00720434|363913|P3|STARTED|Open-Label Period (Week 5-72)||8
157915|NCT00720434|363914|P2|STARTED|Open-Label Period (Week 5-72)||8
157916|NCT00720434|363915|P1|STARTED|Open-Label Period (Week 5-72)||10
157917|NCT00720434|363912|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
157918|NCT00720434|363913|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
157919|NCT00720434|363914|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
157920|NCT00720434|363915|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
157921|NCT00720434|363912|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
157922|NCT00720434|363913|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
157923|NCT00720434|363914|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
157924|NCT00720434|363915|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
157925|NCT00720434|363912|P4|STARTED|Double-Blind Period (Week 1-4)||8
157926|NCT00720434|363913|P3|STARTED|Double-Blind Period (Week 1-4)||8
157927|NCT00720434|363914|P2|STARTED|Double-Blind Period (Week 1-4)||9
157928|NCT00720434|363915|P1|STARTED|Double-Blind Period (Week 1-4)||10
157929|NCT00720382|363939|P2|NOT COMPLETED|Overall Study||59
157930|NCT00720382|363940|P1|NOT COMPLETED|Overall Study||176
157931|NCT00720382|363939|P2|COMPLETED|Overall Study||178
157932|NCT00720382|363940|P1|COMPLETED|Overall Study||290
157933|NCT00720382|363939|P2|STARTED|Overall Study||237
157934|NCT00720382|363940|P1|STARTED|Overall Study||466
157935|NCT00720369|363950|P2|NOT COMPLETED|Overall Study||0
157936|NCT00720369|363951|P1|NOT COMPLETED|Overall Study||1
157937|NCT00720369|363950|P2|COMPLETED|Overall Study||8
157938|NCT00720369|363951|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
157939|NCT00720369|363950|P2|STARTED|Overall Study||8
157940|NCT00720369|363951|P1|STARTED|Overall Study||11
157941|NCT00720343|363959|P1|NOT COMPLETED|Overall Study||6
157942|NCT00720343|363959|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
157943|NCT00720343|363959|P1|STARTED|Overall Study||54
157944|NCT00720278|363968|P3|NOT COMPLETED|Overall Study||6
157945|NCT00720278|363969|P2|NOT COMPLETED|Overall Study||4
157946|NCT00720278|363970|P1|NOT COMPLETED|Overall Study||7
157947|NCT00720278|363968|P3|COMPLETED|Overall Study||172
157948|NCT00720278|363969|P2|COMPLETED|Overall Study||166
157949|NCT00720278|363970|P1|COMPLETED|Overall Study||171
157950|NCT00720278|363968|P3|STARTED|Overall Study|1 subject was randomized in error|178
157951|NCT00720278|363969|P2|STARTED|Overall Study|1 subject was randomized in error|170
157952|NCT00720278|363970|P1|STARTED|Overall Study|1 subject was randomized in error|178
157953|NCT00720122|363990|P1|NOT COMPLETED|Overall Study||9
157954|NCT00720122|363990|P1|COMPLETED|Overall Study||19
157955|NCT00720122|363990|P1|STARTED|Overall Study||28
157956|NCT00720109|363994|P3|NOT COMPLETED|Risk Stratification Period||8
157957|NCT00720109|363995|P2|NOT COMPLETED|Risk Stratification Period||15
157958|NCT00720109|363996|P1|NOT COMPLETED|Risk Stratification Period||0
157959|NCT00720109|363994|P3|COMPLETED|Risk Stratification Period||1
157960|NCT00720109|363995|P2|COMPLETED|Risk Stratification Period||33
157961|NCT00720109|363996|P1|COMPLETED|Risk Stratification Period||0
157962|NCT00720109|363994|P3|STARTED|Risk Stratification Period||9
157963|NCT00720109|363995|P2|STARTED|Risk Stratification Period||48
157964|NCT00720109|363996|P1|STARTED|Risk Stratification Period||0
157965|NCT00720109|363994|P3|NOT COMPLETED|Induction Period||0
157966|NCT00720109|363995|P2|NOT COMPLETED|Induction Period||0
157967|NCT00720109|363996|P1|NOT COMPLETED|Induction Period||6
157968|NCT00720109|363994|P3|COMPLETED|Induction Period||0
157969|NCT00720109|363995|P2|COMPLETED|Induction Period||0
157970|NCT00720109|363996|P1|COMPLETED|Induction Period||57
157971|NCT00720109|363994|P3|STARTED|Induction Period||0
157972|NCT00720109|363995|P2|STARTED|Induction Period||0
157973|NCT00720109|363996|P1|STARTED|Induction Period||63
157974|NCT00720096|364016|P2|NOT COMPLETED|Overall Study||2
157975|NCT00720096|364017|P1|NOT COMPLETED|Overall Study||0
157976|NCT00720096|364016|P2|COMPLETED|Overall Study||0
157977|NCT00720096|364017|P1|COMPLETED|Overall Study||2
157978|NCT00720096|364016|P2|STARTED|Overall Study||2
157979|NCT00720096|364017|P1|STARTED|Overall Study||2
157980|NCT00720083|364027|P2|NOT COMPLETED|Overall Study||2
157981|NCT00720083|364028|P1|NOT COMPLETED|Overall Study||1
157982|NCT00720083|364027|P2|COMPLETED|Overall Study||13
157983|NCT00720083|364028|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
157984|NCT00720083|364027|P2|STARTED|Overall Study||15
157985|NCT00720083|364028|P1|STARTED|Overall Study||17
157986|NCT00720057|364036|P2|NOT COMPLETED|Overall Study||3
157987|NCT00720057|364037|P1|NOT COMPLETED|Overall Study||1
157988|NCT00720057|364036|P2|COMPLETED|Overall Study||156
157989|NCT00720057|364037|P1|COMPLETED|Overall Study||152
157990|NCT00720057|364036|P2|STARTED|Overall Study||159
157991|NCT00720057|364037|P1|STARTED|Overall Study||153
157992|NCT00719953|364053|P1|NOT COMPLETED|Overall Study||4
157993|NCT00719953|364053|P1|COMPLETED|Overall Study||26
157994|NCT00719953|364053|P1|STARTED|Overall Study||30
157995|NCT00719914|364059|P2|NOT COMPLETED|Overall Study||0
157996|NCT00719914|364060|P1|NOT COMPLETED|Overall Study||0
157997|NCT00719914|364059|P2|COMPLETED|Overall Study||7
157998|NCT00719914|364060|P1|COMPLETED|Overall Study||10
157999|NCT00719914|364059|P2|STARTED|Overall Study||7
158000|NCT00719914|364060|P1|STARTED|Overall Study||10
158001|NCT00719901|364066|P1|NOT COMPLETED|Overall Study||11
158002|NCT00719901|364066|P1|COMPLETED|Overall Study||0
158003|NCT00719901|364066|P1|STARTED|Overall Study||11
158004|NCT00719862|364078|P2|NOT COMPLETED|Overall Study||6
158005|NCT00719862|364079|P1|NOT COMPLETED|Overall Study||8
158006|NCT00719862|364078|P2|COMPLETED|Overall Study||233
158007|NCT00719862|364079|P1|COMPLETED|Overall Study||234
158008|NCT00719862|364078|P2|STARTED|Overall Study|1 subject was randomized in error|239
158009|NCT00719862|364079|P1|STARTED|Overall Study||242
158010|NCT00719810|364098|P3|NOT COMPLETED|Overall Study||8
158011|NCT00719810|364099|P2|NOT COMPLETED|Overall Study||4
158012|NCT00719810|364100|P1|NOT COMPLETED|Overall Study||3
158013|NCT00719810|364098|P3|COMPLETED|Overall Study||42
158014|NCT00719810|364099|P2|COMPLETED|Overall Study||47
158015|NCT00719810|364100|P1|COMPLETED|Overall Study||46
158016|NCT00719810|364098|P3|STARTED|Overall Study||50
158017|NCT00719810|364099|P2|STARTED|Overall Study||51
158018|NCT00719810|364100|P1|STARTED|Overall Study||49
158019|NCT00719732|364111|P1|NOT COMPLETED|Overall Study||22
158020|NCT00719732|364111|P1|COMPLETED|Overall Study||196
158021|NCT00719732|364111|P1|STARTED|Overall Study||218
158022|NCT00719706|364117|P2|NOT COMPLETED|Overall Study||6
158023|NCT00719706|364118|P1|NOT COMPLETED|Overall Study||9
158024|NCT00719706|364117|P2|COMPLETED|Overall Study||14
158025|NCT00719706|364118|P1|COMPLETED|Overall Study||11
158026|NCT00719706|364117|P2|STARTED|Overall Study||20
158027|NCT00719706|364118|P1|STARTED|Overall Study||20
158028|NCT00719680|364132|P1|NOT COMPLETED|Overall Study||5
158029|NCT00719680|364132|P1|COMPLETED|Overall Study||16
158030|NCT00719680|364132|P1|STARTED|Overall Study||21
158031|NCT00719615|364155|P3|NOT COMPLETED|Overall Study||0
158032|NCT00719615|364156|P2|NOT COMPLETED|Overall Study||0
158033|NCT00719615|364157|P1|NOT COMPLETED|Overall Study||0
158034|NCT00719615|364155|P3|COMPLETED|Overall Study||24
158035|NCT00719615|364156|P2|COMPLETED|Overall Study||45
158036|NCT00719615|364157|P1|COMPLETED|Overall Study||42
158037|NCT00719615|364155|P3|STARTED|Overall Study||24
158038|NCT00719615|364156|P2|STARTED|Overall Study||45
158039|NCT00719615|364157|P1|STARTED|Overall Study||42
158040|NCT00719563|364167|P2|NOT COMPLETED|Overall Study||42
158041|NCT00719563|364168|P1|NOT COMPLETED|Overall Study||38
158042|NCT00719563|364167|P2|COMPLETED|Overall Study||128
158043|NCT00719563|364168|P1|COMPLETED|Overall Study||133
158044|NCT00719563|364167|P2|STARTED|Overall Study||170
158045|NCT00719563|364168|P1|STARTED|Overall Study||171
158046|NCT00719472|364198|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
158047|NCT00719472|364198|P1|COMPLETED|Received Cycle 2 Treatment||304
158048|NCT00719472|364198|P1|STARTED|Received Cycle 2 Treatment||372
158049|NCT00719472|364198|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
158050|NCT00719472|364198|P1|COMPLETED|Received Cycle 1 Treatment||372
158051|NCT00719472|364198|P1|STARTED|Received Cycle 1 Treatment||425
158052|NCT00719472|364198|P1|NOT COMPLETED|Enrolled in Study||26
158053|NCT00719472|364198|P1|COMPLETED|Enrolled in Study||425
158054|NCT00719472|364198|P1|STARTED|Enrolled in Study||451
158055|NCT00719355|364209|P2|NOT COMPLETED|Overall Study||13
158056|NCT00719355|364210|P1|NOT COMPLETED|Overall Study||18
158057|NCT00719355|364209|P2|COMPLETED|Overall Study||39
158058|NCT00719355|364210|P1|COMPLETED|Overall Study||33
158059|NCT00719355|364209|P2|Completed 32 Weeks|Overall Study||39
158060|NCT00719355|364210|P1|Completed 32 Weeks|Overall Study||33
158061|NCT00719355|364209|P2|Completed 24 Weeks|Overall Study||43
158062|NCT00719355|364210|P1|Completed 24 Weeks|Overall Study||34
158063|NCT00719355|364209|P2|Completed 12 Weeks|Overall Study||46
158064|NCT00719355|364210|P1|Completed 12 Weeks|Overall Study||43
158065|NCT00719355|364209|P2|Completed 6 Weeks|Overall Study||48
158066|NCT00719355|364210|P1|Completed 6 Weeks|Overall Study||49
158067|NCT00719355|364209|P2|STARTED|Overall Study||52
158068|NCT00719355|364210|P1|STARTED|Overall Study||51
158069|NCT00719329|364221|P3|NOT COMPLETED|Overall Study||1
158070|NCT00719329|364222|P2|NOT COMPLETED|Overall Study||2
158071|NCT00719329|364223|P1|NOT COMPLETED|Overall Study||0
158072|NCT00719329|364221|P3|COMPLETED|Overall Study||646
158073|NCT00719329|364222|P2|COMPLETED|Overall Study||569
158074|NCT00719329|364223|P1|COMPLETED|Overall Study||705
158075|NCT00719329|364221|P3|Day 7 Swab|Overall Study||561
158076|NCT00719329|364222|P2|Day 7 Swab|Overall Study||467
158077|NCT00719329|364223|P1|Day 7 Swab|Overall Study||593
158078|NCT00719329|364221|P3|Day 3 Swab|Overall Study||578
158079|NCT00719329|364222|P2|Day 3 Swab|Overall Study||501
158080|NCT00719329|364223|P1|Day 3 Swab|Overall Study||614
158081|NCT00719329|364221|P3|Day 1 Swab|Overall Study||646
158082|NCT00719329|364222|P2|Day 1 Swab|Overall Study||569
158083|NCT00719329|364223|P1|Day 1 Swab|Overall Study||705
158084|NCT00719329|364221|P3|STARTED|Overall Study||647
158085|NCT00719329|364222|P2|STARTED|Overall Study||571
158086|NCT00719329|364223|P1|STARTED|Overall Study||705
158087|NCT00719264|364239|P2|NOT COMPLETED|Overall Study||183
158088|NCT00719264|364240|P1|NOT COMPLETED|Overall Study||182
158089|NCT00719264|364239|P2|COMPLETED|Overall Study||0
158090|NCT00719264|364240|P1|COMPLETED|Overall Study||0
158091|NCT00719264|364239|P2|Safety Set|Overall Study||181
158092|NCT00719264|364240|P1|Safety Set|Overall Study||180
158093|NCT00719264|364239|P2|Full Analysis Set|Overall Study||183
158094|NCT00719264|364240|P1|Full Analysis Set|Overall Study||182
158095|NCT00719264|364239|P2|STARTED|Overall Study||183
158096|NCT00719264|364240|P1|STARTED|Overall Study||182
158097|NCT00719212|364259|P1|NOT COMPLETED|Overall Study||44
158098|NCT00719212|364259|P1|COMPLETED|Overall Study||17
158099|NCT00719212|364259|P1|STARTED|Overall Study||61
158100|NCT00719186|364271|P2|NOT COMPLETED|Overall Study||0
158101|NCT00719186|364272|P1|NOT COMPLETED|Overall Study||0
158102|NCT00719186|364271|P2|COMPLETED|Overall Study||374
158103|NCT00719186|364272|P1|COMPLETED|Overall Study||376
158104|NCT00719186|364271|P2|STARTED|Overall Study||374
158105|NCT00719186|364272|P1|STARTED|Overall Study||376
158106|NCT00719160|364284|P2|NOT COMPLETED|Overall Study||0
158107|NCT00719160|364285|P1|NOT COMPLETED|Overall Study||0
158108|NCT00719160|364284|P2|COMPLETED|Overall Study||6
158109|NCT00719160|364285|P1|COMPLETED|Overall Study||6
158110|NCT00719160|364284|P2|STARTED|Overall Study||6
158111|NCT00719160|364285|P1|STARTED|Overall Study||6
158112|NCT00719134|364292|P1|NOT COMPLETED|Overall Study||10
158113|NCT00719134|364292|P1|COMPLETED|Overall Study||66
158114|NCT00719134|364292|P1|STARTED|Overall Study||76
158115|NCT00719043|364305|P7|NOT COMPLETED|Overall Study||28
158116|NCT00719043|364306|P6|NOT COMPLETED|Overall Study||34
158117|NCT00719043|364307|P5|NOT COMPLETED|Overall Study||27
158118|NCT00719043|364308|P4|NOT COMPLETED|Overall Study||23
158119|NCT00719043|364309|P3|NOT COMPLETED|Overall Study||20
158120|NCT00719043|364310|P2|NOT COMPLETED|Overall Study||25
158121|NCT00719043|364311|P1|NOT COMPLETED|Overall Study||32
158122|NCT00719043|364305|P7|COMPLETED|Overall Study|Up to Day 909|92
158123|NCT00719043|364306|P6|COMPLETED|Overall Study|Up to Day 909|86
158124|NCT00719043|364307|P5|COMPLETED|Overall Study|Up to Day 909|95
158125|NCT00719043|364308|P4|COMPLETED|Overall Study|Up to Day 909|96
158126|NCT00719043|364309|P3|COMPLETED|Overall Study|Up to Day 909|99
158127|NCT00719043|364310|P2|COMPLETED|Overall Study|Up to Day 909|96
158128|NCT00719043|364311|P1|COMPLETED|Overall Study|Up to Day 909|88
158129|NCT00719043|364305|P7|STARTED|Overall Study||120
158130|NCT00719043|364306|P6|STARTED|Overall Study||120
158131|NCT00719043|364307|P5|STARTED|Overall Study||122
158132|NCT00719043|364308|P4|STARTED|Overall Study||119
158133|NCT00719043|364309|P3|STARTED|Overall Study||119
158134|NCT00719043|364310|P2|STARTED|Overall Study||121
158135|NCT00719043|364311|P1|STARTED|Overall Study||120
158136|NCT00718887|364435|P2|NOT COMPLETED|Overall Study||9
158137|NCT00718887|364436|P1|NOT COMPLETED|Overall Study||5
158138|NCT00718887|364435|P2|COMPLETED|Overall Study||68
158139|NCT00718887|364436|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
158140|NCT00718887|364435|P2|STARTED|Overall Study|Participants who received treatment.|77
158141|NCT00718887|364436|P1|STARTED|Overall Study|Participants who received treatment.|89
158142|NCT00718861|364460|P2|NOT COMPLETED|Overall Study||18
158143|NCT00718861|364461|P1|NOT COMPLETED|Overall Study||21
158144|NCT00718861|364460|P2|COMPLETED|Overall Study||77
158145|NCT00718861|364461|P1|COMPLETED|Overall Study||74
158146|NCT00718861|364460|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
158147|NCT00718861|364461|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
158148|NCT00718861|364460|P2|Safety Set|Overall Study||95
158149|NCT00718861|364461|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
158150|NCT00718861|364460|P2|STARTED|Overall Study||95
158151|NCT00718861|364461|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
158152|NCT00718809|364489|P2|NOT COMPLETED|Overall Study||9
158153|NCT00718809|364490|P1|NOT COMPLETED|Overall Study||12
158154|NCT00718809|364489|P2|COMPLETED|Overall Study||0
158155|NCT00718809|364490|P1|COMPLETED|Overall Study||0
158156|NCT00718809|364489|P2|STARTED|Overall Study||9
158157|NCT00718809|364490|P1|STARTED|Overall Study||12
158158|NCT00718770|364504|P1|NOT COMPLETED|Overall Study||8
158159|NCT00718770|364504|P1|COMPLETED|Overall Study||2
158160|NCT00718770|364504|P1|STARTED|Overall Study||10
158161|NCT00718640|364508|P1|NOT COMPLETED|Overall Study||7
158162|NCT00718640|364508|P1|COMPLETED|Overall Study||3
158163|NCT00718640|364508|P1|STARTED|Overall Study||10
158164|NCT00718523|364522|P2|NOT COMPLETED|Overall Study||24
158165|NCT00718523|364523|P1|NOT COMPLETED|Overall Study||18
158166|NCT00718523|364522|P2|COMPLETED|Overall Study||62
158167|NCT00718523|364523|P1|COMPLETED|Overall Study||66
158168|NCT00718523|364522|P2|STARTED|Overall Study||86
158169|NCT00718523|364523|P1|STARTED|Overall Study||84
158170|NCT00718315|364536|P3|NOT COMPLETED|Overall Study||21
158171|NCT00718315|364537|P2|NOT COMPLETED|Overall Study||22
158172|NCT00718315|364538|P1|NOT COMPLETED|Overall Study||19
158173|NCT00718315|364536|P3|COMPLETED|Overall Study||46
158174|NCT00718315|364537|P2|COMPLETED|Overall Study||45
158175|NCT00718315|364538|P1|COMPLETED|Overall Study||48
158176|NCT00718315|364536|P3|STARTED|Overall Study||67
158177|NCT00718315|364537|P2|STARTED|Overall Study||67
158178|NCT00718315|364538|P1|STARTED|Overall Study||67
158179|NCT00718237|364572|P2|NOT COMPLETED|Overall Study||15
158180|NCT00718237|364573|P1|NOT COMPLETED|Overall Study||13
158181|NCT00718237|364572|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
158182|NCT00718237|364573|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
158183|NCT00718237|364572|P2|Vaccinated at Visit 3|Overall Study||369
158184|NCT00718237|364573|P1|Vaccinated at Visit 3|Overall Study||371
158185|NCT00718237|364572|P2|Vaccinated at Visit 2|Overall Study||374
158186|NCT00718237|364573|P1|Vaccinated at Visit 2|Overall Study||373
158187|NCT00718237|364572|P2|Vaccinated at Visit 1|Overall Study||381
158188|NCT00718237|364573|P1|Vaccinated at Visit 1|Overall Study||380
158189|NCT00718237|364572|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
158190|NCT00718237|364573|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
158191|NCT00718120|364585|P2|NOT COMPLETED|Overall Study||0
158192|NCT00718120|364586|P1|NOT COMPLETED|Overall Study||0
158193|NCT00718120|364585|P2|COMPLETED|Overall Study||55
158194|NCT00718120|364586|P1|COMPLETED|Overall Study||55
158195|NCT00718120|364585|P2|STARTED|Overall Study||55
158196|NCT00718120|364586|P1|STARTED|Overall Study||55
158197|NCT00718081|364607|P3|NOT COMPLETED|Overall Study||21
158198|NCT00718081|364608|P2|NOT COMPLETED|Overall Study||4
158199|NCT00718081|364609|P1|NOT COMPLETED|Overall Study||7
158200|NCT00718081|364607|P3|COMPLETED|Overall Study||9
158201|NCT00718081|364608|P2|COMPLETED|Overall Study||25
158202|NCT00718081|364609|P1|COMPLETED|Overall Study||22
158203|NCT00718081|364607|P3|STARTED|Overall Study||30
158204|NCT00718081|364608|P2|STARTED|Overall Study||29
158205|NCT00718081|364609|P1|STARTED|Overall Study||29
158206|NCT00718042|364626|P6|NOT COMPLETED|Donor Follow-up||0
158207|NCT00718042|364627|P5|NOT COMPLETED|Donor Follow-up||19
158208|NCT00718042|364628|P4|NOT COMPLETED|Donor Follow-up||0
158209|NCT00718042|364629|P3|NOT COMPLETED|Donor Follow-up||0
158210|NCT00718042|364630|P2|NOT COMPLETED|Donor Follow-up||0
158211|NCT00718042|364631|P1|NOT COMPLETED|Donor Follow-up||13
158212|NCT00718042|364626|P6|COMPLETED|Donor Follow-up||0
158213|NCT00718042|364627|P5|COMPLETED|Donor Follow-up||24
158214|NCT00718042|364628|P4|COMPLETED|Donor Follow-up||0
158215|NCT00718042|364629|P3|COMPLETED|Donor Follow-up||0
158216|NCT00718042|364630|P2|COMPLETED|Donor Follow-up||0
158217|NCT00718042|364631|P1|COMPLETED|Donor Follow-up||23
158218|NCT00718042|364626|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
158219|NCT00718042|364627|P5|STARTED|Donor Follow-up||43
158220|NCT00718042|364628|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
158221|NCT00718042|364629|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
158222|NCT00718042|364630|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
158223|NCT00718042|364631|P1|STARTED|Donor Follow-up||36
158224|NCT00718042|364626|P6|NOT COMPLETED|ESA Chagas Testing||0
158225|NCT00718042|364627|P5|NOT COMPLETED|ESA Chagas Testing||0
158226|NCT00718042|364628|P4|NOT COMPLETED|ESA Chagas Testing||0
158227|NCT00718042|364629|P3|NOT COMPLETED|ESA Chagas Testing||0
158228|NCT00718042|364630|P2|NOT COMPLETED|ESA Chagas Testing||0
158229|NCT00718042|364631|P1|NOT COMPLETED|ESA Chagas Testing||0
158230|NCT00718042|364626|P6|COMPLETED|ESA Chagas Testing||330
158231|NCT00718042|364627|P5|COMPLETED|ESA Chagas Testing||43
158232|NCT00718042|364628|P4|COMPLETED|ESA Chagas Testing||110
158233|NCT00718042|364629|P3|COMPLETED|ESA Chagas Testing||524
158234|NCT00718042|364630|P2|COMPLETED|ESA Chagas Testing||287
158235|NCT00718042|364631|P1|COMPLETED|ESA Chagas Testing||36
158236|NCT00718042|364626|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
158237|NCT00718042|364627|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
158238|NCT00718042|364628|P4|STARTED|ESA Chagas Testing||110
158239|NCT00718042|364629|P3|STARTED|ESA Chagas Testing||524
158240|NCT00718042|364630|P2|STARTED|ESA Chagas Testing||287
158241|NCT00718042|364631|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
158242|NCT00718042|364626|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
158243|NCT00718042|364627|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
158244|NCT00718042|364628|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
158245|NCT00718042|364629|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
158246|NCT00718042|364630|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
158247|NCT00718042|364631|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
158248|NCT00718042|364626|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
158249|NCT00718042|364627|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
158250|NCT00718042|364628|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
158251|NCT00718042|364629|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
158252|NCT00718042|364630|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
158253|NCT00718042|364631|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
158254|NCT00718042|364626|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
158255|NCT00718042|364627|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
158256|NCT00718042|364628|P4|STARTED|ABBOTT PRISM Chagas Testing||110
158257|NCT00718042|364629|P3|STARTED|ABBOTT PRISM Chagas Testing||525
158258|NCT00718042|364630|P2|STARTED|ABBOTT PRISM Chagas Testing||289
158259|NCT00718042|364631|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
158260|NCT00717977|364643|P1|NOT COMPLETED|Overall Study||0
158261|NCT00717977|364643|P1|COMPLETED|Overall Study||74
158262|NCT00717977|364643|P1|STARTED|Overall Study||74
158263|NCT00717886|364671|P1|NOT COMPLETED|Overall Study||4
158264|NCT00717886|364671|P1|COMPLETED|Overall Study||9
158265|NCT00717886|364671|P1|STARTED|Overall Study||13
158266|NCT00717873|364677|P2|NOT COMPLETED|Overall Study||0
158267|NCT00717873|364678|P1|NOT COMPLETED|Overall Study||0
158268|NCT00717873|364677|P2|COMPLETED|Overall Study||59
158269|NCT00717873|364678|P1|COMPLETED|Overall Study||46
158270|NCT00717873|364677|P2|STARTED|Overall Study||59
158271|NCT00717873|364678|P1|STARTED|Overall Study||46
158272|NCT00717860|364686|P2|NOT COMPLETED|Overall Study||28
158273|NCT00717860|364687|P1|NOT COMPLETED|Overall Study||27
158274|NCT00717860|364686|P2|COMPLETED|Overall Study||32
158275|NCT00717860|364687|P1|COMPLETED|Overall Study||34
158276|NCT00717860|364686|P2|STARTED|Overall Study||60
158277|NCT00717860|364687|P1|STARTED|Overall Study||61
158278|NCT00717756|364697|P1|NOT COMPLETED|Overall Study||1
158279|NCT00717756|364697|P1|COMPLETED|Overall Study||40
158280|NCT00717756|364697|P1|STARTED|Overall Study||41
158281|NCT00717522|364701|P1|NOT COMPLETED|Overall Study||7
158282|NCT00717522|364701|P1|COMPLETED|Overall Study||0
158283|NCT00717522|364701|P1|STARTED|Overall Study||7
158284|NCT00717418|364710|P4|NOT COMPLETED|1-Year Follow-Up||4
158285|NCT00717418|364711|P3|NOT COMPLETED|1-Year Follow-Up||434
158286|NCT00717418|364712|P2|NOT COMPLETED|1-Year Follow-Up||51
158287|NCT00717418|364713|P1|NOT COMPLETED|1-Year Follow-Up||147
158288|NCT00717418|364710|P4|COMPLETED|1-Year Follow-Up||0
158289|NCT00717418|364711|P3|COMPLETED|1-Year Follow-Up||74
158290|NCT00717418|364712|P2|COMPLETED|1-Year Follow-Up||23
158291|NCT00717418|364713|P1|COMPLETED|1-Year Follow-Up||33
158292|NCT00717418|364710|P4|STARTED|1-Year Follow-Up||4
158293|NCT00717418|364711|P3|STARTED|1-Year Follow-Up||508
158294|NCT00717418|364712|P2|STARTED|1-Year Follow-Up||74
158295|NCT00717418|364713|P1|STARTED|1-Year Follow-Up||180
158296|NCT00717418|364710|P4|NOT COMPLETED|Baseline||15
158297|NCT00717418|364711|P3|NOT COMPLETED|Baseline||0
158298|NCT00717418|364712|P2|NOT COMPLETED|Baseline||0
158299|NCT00717418|364713|P1|NOT COMPLETED|Baseline||0
158300|NCT00717418|364710|P4|COMPLETED|Baseline||4
158301|NCT00717418|364711|P3|COMPLETED|Baseline||508
158302|NCT00717418|364712|P2|COMPLETED|Baseline||74
158303|NCT00717418|364713|P1|COMPLETED|Baseline||180
158304|NCT00717418|364710|P4|STARTED|Baseline||19
158305|NCT00717418|364711|P3|STARTED|Baseline||508
158306|NCT00717418|364712|P2|STARTED|Baseline||74
158307|NCT00717418|364713|P1|STARTED|Baseline||180
158308|NCT00717405|364718|P1|NOT COMPLETED|Overall Study||0
158309|NCT00717405|364718|P1|COMPLETED|Overall Study||52
158310|NCT00717405|364718|P1|STARTED|Overall Study||52
158311|NCT00717314|364737|P2|NOT COMPLETED|Overall Study||10
158312|NCT00717314|364738|P1|NOT COMPLETED|Overall Study||6
158313|NCT00717314|364737|P2|COMPLETED|Overall Study||34
158314|NCT00717314|364738|P1|COMPLETED|Overall Study||37
158315|NCT00717314|364737|P2|STARTED|Overall Study||44
158316|NCT00717314|364738|P1|STARTED|Overall Study||43
158317|NCT00717288|364759|P3|NOT COMPLETED|Overall Study||0
158318|NCT00717288|364760|P2|NOT COMPLETED|Overall Study||0
158319|NCT00717288|364761|P1|NOT COMPLETED|Overall Study||0
158320|NCT00717288|364759|P3|COMPLETED|Overall Study||25
158321|NCT00717288|364760|P2|COMPLETED|Overall Study||29
158322|NCT00717288|364761|P1|COMPLETED|Overall Study||28
158323|NCT00717288|364759|P3|STARTED|Overall Study||25
158324|NCT00717288|364760|P2|STARTED|Overall Study||29
158325|NCT00717288|364761|P1|STARTED|Overall Study||28
158326|NCT00717275|364775|P1|NOT COMPLETED|Overall Study||3
158327|NCT00717275|364775|P1|COMPLETED|Overall Study||0
158328|NCT00717275|364775|P1|STARTED|Overall Study||3
158329|NCT00717249|364781|P2|NOT COMPLETED|Overall Study||15
158330|NCT00717249|364782|P1|NOT COMPLETED|Overall Study||22
158331|NCT00717249|364781|P2|COMPLETED|Overall Study||150
158332|NCT00717249|364782|P1|COMPLETED|Overall Study||304
158333|NCT00717249|364781|P2|STARTED|Overall Study||165
158334|NCT00717249|364782|P1|STARTED|Overall Study||326
158335|NCT00717236|364796|P2|NOT COMPLETED|Open-Label Period||21
158336|NCT00717236|364797|P1|NOT COMPLETED|Open-Label Period||125
158337|NCT00717236|364796|P2|COMPLETED|Open-Label Period||163
158338|NCT00717236|364797|P1|COMPLETED|Open-Label Period||646
158339|NCT00717236|364796|P2|STARTED|Open-Label Period||184
158340|NCT00717236|364797|P1|STARTED|Open-Label Period||771
158341|NCT00717236|364796|P2|NOT COMPLETED|Double-Blind Period||28
158342|NCT00717236|364797|P1|NOT COMPLETED|Double-Blind Period||80
158343|NCT00717236|364796|P2|COMPLETED|Double-Blind Period||184
158344|NCT00717236|364797|P1|COMPLETED|Double-Blind Period||771
158345|NCT00717236|364796|P2|STARTED|Double-Blind Period||212
158346|NCT00717236|364797|P1|STARTED|Double-Blind Period||851
158347|NCT00717197|364866|P1|NOT COMPLETED|Overall Study||7
158348|NCT00717197|364866|P1|COMPLETED|Overall Study||23
158349|NCT00717197|364866|P1|STARTED|Overall Study||30
158350|NCT00717093|364872|P2|NOT COMPLETED|Overall Study||48
158351|NCT00717093|364873|P1|NOT COMPLETED|Overall Study||44
158352|NCT00717093|364872|P2|COMPLETED|Overall Study||170
158353|NCT00717093|364873|P1|COMPLETED|Overall Study||170
158354|NCT00717093|364872|P2|Received Treatment|Overall Study||218
158355|NCT00717093|364873|P1|Received Treatment|Overall Study||213
158356|NCT00717093|364872|P2|STARTED|Overall Study||218
158357|NCT00717093|364873|P1|STARTED|Overall Study||214
158358|NCT00717067|364890|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
158359|NCT00717067|364891|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
158360|NCT00717067|364892|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
158361|NCT00717067|364893|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
158362|NCT00717067|364894|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
158363|NCT00717067|364890|P5|COMPLETED|Part 2: End Stage Renal Disease||6
158364|NCT00717067|364891|P4|COMPLETED|Part 2: End Stage Renal Disease||0
158365|NCT00717067|364892|P3|COMPLETED|Part 2: End Stage Renal Disease||0
158366|NCT00717067|364893|P2|COMPLETED|Part 2: End Stage Renal Disease||0
158367|NCT00717067|364894|P1|COMPLETED|Part 2: End Stage Renal Disease||0
158368|NCT00717067|364890|P5|STARTED|Part 2: End Stage Renal Disease||6
158369|NCT00717067|364891|P4|STARTED|Part 2: End Stage Renal Disease||0
158370|NCT00717067|364892|P3|STARTED|Part 2: End Stage Renal Disease||0
158371|NCT00717067|364893|P2|STARTED|Part 2: End Stage Renal Disease||0
158372|NCT00717067|364894|P1|STARTED|Part 2: End Stage Renal Disease||0
158373|NCT00717067|364890|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
158374|NCT00717067|364891|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
158375|NCT00717067|364892|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
158376|NCT00717067|364893|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
158377|NCT00717067|364894|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
158378|NCT00717067|364890|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
158379|NCT00717067|364891|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
158380|NCT00717067|364892|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
158381|NCT00717067|364893|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
158382|NCT00717067|364894|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
158383|NCT00717067|364890|P5|STARTED|Part 1b: Severe Renal Impairment||0
158384|NCT00717067|364891|P4|STARTED|Part 1b: Severe Renal Impairment||6
158385|NCT00717067|364892|P3|STARTED|Part 1b: Severe Renal Impairment||0
158386|NCT00717067|364893|P2|STARTED|Part 1b: Severe Renal Impairment||0
158387|NCT00717067|364894|P1|STARTED|Part 1b: Severe Renal Impairment||0
158388|NCT00717067|364890|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158389|NCT00717067|364891|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158390|NCT00717067|364892|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
158391|NCT00717067|364893|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158392|NCT00717067|364894|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158393|NCT00717067|364890|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158394|NCT00717067|364891|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
158395|NCT00717067|364892|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
158396|NCT00717067|364893|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
158397|NCT00717067|364894|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
158398|NCT00717067|364890|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
158399|NCT00717067|364891|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
158400|NCT00717067|364892|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
158401|NCT00717067|364893|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
158402|NCT00717067|364894|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
158403|NCT00717054|364978|P2|NOT COMPLETED|Overall Study||0
158404|NCT00717054|364979|P1|NOT COMPLETED|Overall Study||0
158405|NCT00717054|364978|P2|COMPLETED|Overall Study||57
158406|NCT00717054|364979|P1|COMPLETED|Overall Study||58
158407|NCT00717054|364978|P2|STARTED|Overall Study||57
158408|NCT00717054|364979|P1|STARTED|Overall Study||58
158409|NCT00717041|364991|P1|NOT COMPLETED|Overall Study||0
158410|NCT00717041|364991|P1|COMPLETED|Overall Study||1206
158411|NCT00717041|364991|P1|STARTED|Overall Study||1206
158412|NCT00716963|364999|P6|NOT COMPLETED|Overall Study||0
158413|NCT00716963|365000|P5|NOT COMPLETED|Overall Study||0
158414|NCT00716963|365001|P4|NOT COMPLETED|Overall Study||0
158415|NCT00716963|365002|P3|NOT COMPLETED|Overall Study||0
158416|NCT00716963|365003|P2|NOT COMPLETED|Overall Study||0
158417|NCT00716963|365004|P1|NOT COMPLETED|Overall Study||1
158418|NCT00716963|364999|P6|COMPLETED|Overall Study||1
158419|NCT00716963|365000|P5|COMPLETED|Overall Study||1
158420|NCT00716963|365001|P4|COMPLETED|Overall Study||1
158421|NCT00716963|365002|P3|COMPLETED|Overall Study||1
158422|NCT00716963|365003|P2|COMPLETED|Overall Study||1
158423|NCT00716963|365004|P1|COMPLETED|Overall Study||1
158424|NCT00716963|364999|P6|STARTED|Overall Study||1
158425|NCT00716963|365000|P5|STARTED|Overall Study||1
158426|NCT00716963|365001|P4|STARTED|Overall Study||1
158427|NCT00716963|365002|P3|STARTED|Overall Study||1
158428|NCT00716963|365003|P2|STARTED|Overall Study||1
158429|NCT00716963|365004|P1|STARTED|Overall Study||2
158430|NCT00716859|365017|P2|NOT COMPLETED|Overall Study||5
158431|NCT00716859|365018|P1|NOT COMPLETED|Overall Study||9
158432|NCT00716859|365017|P2|COMPLETED|Overall Study||64
158433|NCT00716859|365018|P1|COMPLETED|Overall Study||61
158434|NCT00716859|365017|P2|Received Treatment|Overall Study||68
158435|NCT00716859|365018|P1|Received Treatment|Overall Study||69
158436|NCT00716859|365017|P2|STARTED|Overall Study||69
158437|NCT00716859|365018|P1|STARTED|Overall Study||70
158438|NCT00716820|365042|P1|NOT COMPLETED|Overall Study||0
158439|NCT00716820|365042|P1|COMPLETED|Overall Study||472
158440|NCT00716820|365042|P1|STARTED|Overall Study||472
158441|NCT00716807|365077|P4|NOT COMPLETED|Overall Study||0
158442|NCT00716807|365078|P3|NOT COMPLETED|Overall Study||0
158443|NCT00716807|365079|P2|NOT COMPLETED|Overall Study||0
158444|NCT00716807|365080|P1|NOT COMPLETED|Overall Study||0
158445|NCT00716807|365077|P4|COMPLETED|Overall Study||15
158446|NCT00716807|365078|P3|COMPLETED|Overall Study||18
158447|NCT00716807|365079|P2|COMPLETED|Overall Study||5
158448|NCT00716807|365080|P1|COMPLETED|Overall Study||8
158449|NCT00716807|365077|P4|STARTED|Overall Study||15
158450|NCT00716807|365078|P3|STARTED|Overall Study||18
158451|NCT00716807|365079|P2|STARTED|Overall Study||5
158452|NCT00716807|365080|P1|STARTED|Overall Study||8
158453|NCT00716742|365093|P3|NOT COMPLETED|3 Year Follow-up||21
158454|NCT00716742|365094|P2|NOT COMPLETED|3 Year Follow-up||32
158455|NCT00716742|365095|P1|NOT COMPLETED|3 Year Follow-up||30
158456|NCT00716742|365093|P3|COMPLETED|3 Year Follow-up||29
158457|NCT00716742|365094|P2|COMPLETED|3 Year Follow-up||35
158458|NCT00716742|365095|P1|COMPLETED|3 Year Follow-up||26
158459|NCT00716742|365093|P3|STARTED|3 Year Follow-up||50
158460|NCT00716742|365094|P2|STARTED|3 Year Follow-up||67
158461|NCT00716742|365095|P1|STARTED|3 Year Follow-up||56
158462|NCT00716742|365093|P3|NOT COMPLETED|2 Year Follow-up||102
158463|NCT00716742|365094|P2|NOT COMPLETED|2 Year Follow-up||96
158464|NCT00716742|365095|P1|NOT COMPLETED|2 Year Follow-up||104
158465|NCT00716742|365093|P3|COMPLETED|2 Year Follow-up||50
158466|NCT00716742|365094|P2|COMPLETED|2 Year Follow-up||67
158467|NCT00716742|365095|P1|COMPLETED|2 Year Follow-up||56
158468|NCT00716742|365093|P3|STARTED|2 Year Follow-up||152
158469|NCT00716742|365094|P2|STARTED|2 Year Follow-up||163
158470|NCT00716742|365095|P1|STARTED|2 Year Follow-up||160
158471|NCT00716742|365093|P3|NOT COMPLETED|1 Year Follow-up||200
158472|NCT00716742|365094|P2|NOT COMPLETED|1 Year Follow-up||193
158473|NCT00716742|365095|P1|NOT COMPLETED|1 Year Follow-up||187
158474|NCT00716742|365093|P3|COMPLETED|1 Year Follow-up||152
158475|NCT00716742|365094|P2|COMPLETED|1 Year Follow-up||163
158476|NCT00716742|365095|P1|COMPLETED|1 Year Follow-up||160
158477|NCT00716742|365093|P3|STARTED|1 Year Follow-up||352
158478|NCT00716742|365094|P2|STARTED|1 Year Follow-up||356
158479|NCT00716742|365095|P1|STARTED|1 Year Follow-up||347
158480|NCT00716742|365093|P3|NOT COMPLETED|Baseline||13
158481|NCT00716742|365094|P2|NOT COMPLETED|Baseline||14
158482|NCT00716742|365095|P1|NOT COMPLETED|Baseline||17
158483|NCT00716742|365093|P3|COMPLETED|Baseline||352
158484|NCT00716742|365094|P2|COMPLETED|Baseline||356
158485|NCT00716742|365095|P1|COMPLETED|Baseline||347
158486|NCT00716742|365093|P3|STARTED|Baseline||365
158487|NCT00716742|365094|P2|STARTED|Baseline||370
158488|NCT00716742|365095|P1|STARTED|Baseline||364
158489|NCT00716625|365103|P1|NOT COMPLETED|Overall Study||1
158490|NCT00716625|365103|P1|COMPLETED|Overall Study||1673
158491|NCT00716625|365103|P1|STARTED|Overall Study||1674
158492|NCT00716482|365128|P1|NOT COMPLETED|Overall Study||119
158493|NCT00716482|365128|P1|COMPLETED|Overall Study||1562
158494|NCT00716482|365128|P1|STARTED|Overall Study||1681
158495|NCT00716456|365141|P3|NOT COMPLETED|Overall Study||0
158496|NCT00716456|365142|P2|NOT COMPLETED|Overall Study||2
158497|NCT00716456|365143|P1|NOT COMPLETED|Overall Study||0
158498|NCT00716456|365141|P3|COMPLETED|Overall Study||13
158499|NCT00716456|365142|P2|COMPLETED|Overall Study||3
158500|NCT00716456|365143|P1|COMPLETED|Overall Study||3
158501|NCT00716456|365141|P3|STARTED|Overall Study||13
158502|NCT00716456|365142|P2|STARTED|Overall Study||5
158503|NCT00716456|365143|P1|STARTED|Overall Study||3
158504|NCT00716443|365151|P1|NOT COMPLETED|Overall Study||0
158505|NCT00716443|365151|P1|COMPLETED|Overall Study||51
158506|NCT00716443|365151|P1|STARTED|Overall Study||51
158507|NCT00716417|365194|P10|NOT COMPLETED|Overall Study||3
158508|NCT00716417|365195|P9|NOT COMPLETED|Overall Study||5
158509|NCT00716417|365196|P8|NOT COMPLETED|Overall Study||3
158510|NCT00716417|365197|P7|NOT COMPLETED|Overall Study||7
158511|NCT00716417|365198|P6|NOT COMPLETED|Overall Study||3
158512|NCT00716417|365199|P5|NOT COMPLETED|Overall Study||1
158513|NCT00716417|365200|P4|NOT COMPLETED|Overall Study||11
158514|NCT00716417|365201|P3|NOT COMPLETED|Overall Study||5
158515|NCT00716417|365202|P2|NOT COMPLETED|Overall Study||6
158516|NCT00716417|365203|P1|NOT COMPLETED|Overall Study||3
158517|NCT00716417|365194|P10|COMPLETED|Overall Study||0
158518|NCT00716417|365195|P9|COMPLETED|Overall Study||0
158519|NCT00716417|365196|P8|COMPLETED|Overall Study||0
158520|NCT00716417|365197|P7|COMPLETED|Overall Study||0
158521|NCT00716417|365198|P6|COMPLETED|Overall Study||0
158522|NCT00716417|365199|P5|COMPLETED|Overall Study||0
158523|NCT00716417|365200|P4|COMPLETED|Overall Study||0
158524|NCT00716417|365201|P3|COMPLETED|Overall Study||0
158525|NCT00716417|365202|P2|COMPLETED|Overall Study||0
158526|NCT00716417|365203|P1|COMPLETED|Overall Study||0
158527|NCT00716417|365194|P10|STARTED|Overall Study||3
158528|NCT00716417|365195|P9|STARTED|Overall Study||5
158529|NCT00716417|365196|P8|STARTED|Overall Study||3
158530|NCT00716417|365197|P7|STARTED|Overall Study||7
158531|NCT00716417|365198|P6|STARTED|Overall Study||3
158532|NCT00716417|365199|P5|STARTED|Overall Study||1
158533|NCT00716417|365200|P4|STARTED|Overall Study||11
158534|NCT00716417|365201|P3|STARTED|Overall Study||5
158535|NCT00716417|365202|P2|STARTED|Overall Study||6
158536|NCT00716417|365203|P1|STARTED|Overall Study||3
158537|NCT00716092|365250|P3|NOT COMPLETED|Overall Study||0
158538|NCT00716092|365251|P2|NOT COMPLETED|Overall Study||1
158539|NCT00716092|365252|P1|NOT COMPLETED|Overall Study||2
158540|NCT00716092|365250|P3|COMPLETED|Overall Study||41
158541|NCT00716092|365251|P2|COMPLETED|Overall Study||39
158542|NCT00716092|365252|P1|COMPLETED|Overall Study||38
158543|NCT00716092|365250|P3|STARTED|Overall Study||41
158544|NCT00716092|365251|P2|STARTED|Overall Study||40
158545|NCT00716092|365252|P1|STARTED|Overall Study||40
158546|NCT00716079|365283|P2|NOT COMPLETED|Overall Study||15
158547|NCT00716079|365284|P1|NOT COMPLETED|Overall Study||9
158548|NCT00716079|365283|P2|COMPLETED|Overall Study||1421
158549|NCT00716079|365284|P1|COMPLETED|Overall Study||1394
158550|NCT00716079|365283|P2|STARTED|Overall Study||1436
158551|NCT00716079|365284|P1|STARTED|Overall Study||1403
158552|NCT00715962|365294|P2|NOT COMPLETED|Overall Study||2
158553|NCT00715962|365295|P1|NOT COMPLETED|Overall Study||6
158554|NCT00715962|365294|P2|COMPLETED|Overall Study||48
158555|NCT00715962|365295|P1|COMPLETED|Overall Study||44
158556|NCT00715962|365294|P2|STARTED|Overall Study||50
158557|NCT00715962|365295|P1|STARTED|Overall Study||50
158558|NCT00715949|365305|P1|NOT COMPLETED|Overall Study||4
158559|NCT00715949|365305|P1|COMPLETED|Overall Study|116 patients completed first test|116
158560|NCT00715949|365305|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
158561|NCT00715910|365313|P6|NOT COMPLETED|Booster and ESFU Phase||13
158562|NCT00715910|365314|P5|NOT COMPLETED|Booster and ESFU Phase||2
158563|NCT00715910|365315|P4|NOT COMPLETED|Booster and ESFU Phase||11
158564|NCT00715910|365316|P3|NOT COMPLETED|Booster and ESFU Phase||0
158565|NCT00715910|365317|P2|NOT COMPLETED|Booster and ESFU Phase||0
158566|NCT00715910|365318|P1|NOT COMPLETED|Booster and ESFU Phase||0
158567|NCT00715910|365313|P6|COMPLETED|Booster and ESFU Phase||88
158568|NCT00715910|365314|P5|COMPLETED|Booster and ESFU Phase||36
158569|NCT00715910|365315|P4|COMPLETED|Booster and ESFU Phase||172
158570|NCT00715910|365316|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
158571|NCT00715910|365317|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
158572|NCT00715910|365318|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
158573|NCT00715910|365313|P6|STARTED|Booster and ESFU Phase||101
158574|NCT00715910|365314|P5|STARTED|Booster and ESFU Phase||38
158575|NCT00715910|365315|P4|STARTED|Booster and ESFU Phase||183
158576|NCT00715910|365316|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
158577|NCT00715910|365317|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
158578|NCT00715910|365318|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
158579|NCT00715910|365313|P6|NOT COMPLETED|Year 5||0
158580|NCT00715910|365314|P5|NOT COMPLETED|Year 5||0
158581|NCT00715910|365315|P4|NOT COMPLETED|Year 5||0
158582|NCT00715910|365316|P3|NOT COMPLETED|Year 5||0
158583|NCT00715910|365317|P2|NOT COMPLETED|Year 5||0
158584|NCT00715910|365318|P1|NOT COMPLETED|Year 5||0
158585|NCT00715910|365313|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
158586|NCT00715910|365314|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
158587|NCT00715910|365315|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
158588|NCT00715910|365316|P3|COMPLETED|Year 5||38
158589|NCT00715910|365317|P2|COMPLETED|Year 5||56
158590|NCT00715910|365318|P1|COMPLETED|Year 5||218
158591|NCT00715910|365313|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
158592|NCT00715910|365314|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
158593|NCT00715910|365315|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
158594|NCT00715910|365316|P3|STARTED|Year 5||38
158595|NCT00715910|365317|P2|STARTED|Year 5||56
158596|NCT00715910|365318|P1|STARTED|Year 5||218
158597|NCT00715910|365313|P6|NOT COMPLETED|Year 3||0
158598|NCT00715910|365314|P5|NOT COMPLETED|Year 3||0
158599|NCT00715910|365315|P4|NOT COMPLETED|Year 3||0
158600|NCT00715910|365316|P3|NOT COMPLETED|Year 3||0
158601|NCT00715910|365317|P2|NOT COMPLETED|Year 3||0
158602|NCT00715910|365318|P1|NOT COMPLETED|Year 3||0
158603|NCT00715910|365313|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
158604|NCT00715910|365314|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
158605|NCT00715910|365315|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
158606|NCT00715910|365316|P3|COMPLETED|Year 3||56
158607|NCT00715910|365317|P2|COMPLETED|Year 3||86
158608|NCT00715910|365318|P1|COMPLETED|Year 3||345
158609|NCT00715910|365313|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
158610|NCT00715910|365314|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
158611|NCT00715910|365315|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
158612|NCT00715910|365316|P3|STARTED|Year 3||56
158613|NCT00715910|365317|P2|STARTED|Year 3||86
158614|NCT00715910|365318|P1|STARTED|Year 3||345
158615|NCT00715910|365313|P6|NOT COMPLETED|Year 1||0
158616|NCT00715910|365314|P5|NOT COMPLETED|Year 1||0
158617|NCT00715910|365315|P4|NOT COMPLETED|Year 1||0
158618|NCT00715910|365316|P3|NOT COMPLETED|Year 1||0
158619|NCT00715910|365317|P2|NOT COMPLETED|Year 1||0
158620|NCT00715910|365318|P1|NOT COMPLETED|Year 1||0
158621|NCT00715910|365313|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
158622|NCT00715910|365314|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
158623|NCT00715910|365315|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
158624|NCT00715910|365316|P3|COMPLETED|Year 1||68
158625|NCT00715910|365317|P2|COMPLETED|Year 1||147
158626|NCT00715910|365318|P1|COMPLETED|Year 1||433
158627|NCT00715910|365313|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
158718|NCT00715403|365567|P3|STARTED|Overall Study||4
158628|NCT00715910|365314|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
158629|NCT00715910|365315|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
158630|NCT00715910|365316|P3|STARTED|Year 1||68
158631|NCT00715910|365317|P2|STARTED|Year 1||147
158632|NCT00715910|365318|P1|STARTED|Year 1||433
158633|NCT00715884|365394|P2|NOT COMPLETED|Overall Study||1
158634|NCT00715884|365395|P1|NOT COMPLETED|Overall Study||8
158635|NCT00715884|365394|P2|COMPLETED|Overall Study||225
158636|NCT00715884|365395|P1|COMPLETED|Overall Study||444
158637|NCT00715884|365394|P2|STARTED|Overall Study||226
158638|NCT00715884|365395|P1|STARTED|Overall Study||452
158639|NCT00715754|365437|P1|NOT COMPLETED|Overall Study||0
158640|NCT00715754|365437|P1|COMPLETED|Overall Study||47
158641|NCT00715754|365437|P1|STARTED|Overall Study||47
158642|NCT00715741|365447|P4|NOT COMPLETED|Overall Study||0
158643|NCT00715741|365448|P3|NOT COMPLETED|Overall Study||0
158644|NCT00715741|365449|P2|NOT COMPLETED|Overall Study||0
158645|NCT00715741|365450|P1|NOT COMPLETED|Overall Study||0
158646|NCT00715741|365447|P4|COMPLETED|Overall Study||25
158647|NCT00715741|365448|P3|COMPLETED|Overall Study||25
158648|NCT00715741|365449|P2|COMPLETED|Overall Study||25
158649|NCT00715741|365450|P1|COMPLETED|Overall Study||25
158650|NCT00715741|365447|P4|STARTED|Overall Study||25
158651|NCT00715741|365448|P3|STARTED|Overall Study||25
158652|NCT00715741|365449|P2|STARTED|Overall Study||25
158653|NCT00715741|365450|P1|STARTED|Overall Study||25
158654|NCT00715676|365475|P3|NOT COMPLETED|Overall Study||32
158655|NCT00715676|365476|P2|NOT COMPLETED|Overall Study||11
158656|NCT00715676|365477|P1|NOT COMPLETED|Overall Study||6
158657|NCT00715676|365475|P3|COMPLETED|Overall Study||21
158658|NCT00715676|365476|P2|COMPLETED|Overall Study||43
158659|NCT00715676|365477|P1|COMPLETED|Overall Study||43
158660|NCT00715676|365475|P3|STARTED|Overall Study||53
158661|NCT00715676|365476|P2|STARTED|Overall Study||54
158662|NCT00715676|365477|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
158663|NCT00715650|365505|P2|NOT COMPLETED|Follow-up||5
158664|NCT00715650|365506|P1|NOT COMPLETED|Follow-up||13
158665|NCT00715650|365505|P2|COMPLETED|Follow-up||37
158666|NCT00715650|365506|P1|COMPLETED|Follow-up||29
158667|NCT00715650|365505|P2|Completed Month 6 Follow-up|Follow-up||37
158668|NCT00715650|365506|P1|Completed Month 6 Follow-up|Follow-up||29
158669|NCT00715650|365505|P2|Completed Month 3 Follow-up|Follow-up||40
158670|NCT00715650|365506|P1|Completed Month 3 Follow-up|Follow-up||35
158671|NCT00715650|365505|P2|Completed Month 1 Follow-up|Follow-up||38
158672|NCT00715650|365506|P1|Completed Month 1 Follow-up|Follow-up||40
158673|NCT00715650|365505|P2|STARTED|Follow-up||42
158674|NCT00715650|365506|P1|STARTED|Follow-up||42
158675|NCT00715650|365505|P2|NOT COMPLETED|Intervention||3
158676|NCT00715650|365506|P1|NOT COMPLETED|Intervention||5
158677|NCT00715650|365505|P2|COMPLETED|Intervention||42
158678|NCT00715650|365506|P1|COMPLETED|Intervention||42
158679|NCT00715650|365505|P2|Attended ≥ 3 Sessions|Intervention||17
158680|NCT00715650|365506|P1|Attended ≥ 3 Sessions|Intervention||23
158681|NCT00715650|365505|P2|Attended ≥ 2 Sessions|Intervention||33
158682|NCT00715650|365506|P1|Attended ≥ 2 Sessions|Intervention||36
158683|NCT00715650|365505|P2|Received Any Session|Intervention||38
158684|NCT00715650|365506|P1|Received Any Session|Intervention||39
158685|NCT00715650|365505|P2|STARTED|Intervention||45
158686|NCT00715650|365506|P1|STARTED|Intervention||47
158687|NCT00715624|365520|P2|NOT COMPLETED|Overall Study||116
158688|NCT00715624|365521|P1|NOT COMPLETED|Overall Study||52
158689|NCT00715624|365520|P2|COMPLETED|Overall Study||213
158690|NCT00715624|365521|P1|COMPLETED|Overall Study||115
158691|NCT00715624|365520|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
158692|NCT00715624|365521|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
158693|NCT00715624|365520|P2|Treated/Safety Population|Overall Study||328
158694|NCT00715624|365521|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
158695|NCT00715624|365520|P2|STARTED|Overall Study||329
158696|NCT00715624|365521|P1|STARTED|Overall Study|Randomized|167
158697|NCT00715559|365549|P1|NOT COMPLETED|Overall Study||1
158698|NCT00715559|365549|P1|COMPLETED|Overall Study||2
158699|NCT00715559|365549|P1|STARTED|Overall Study||3
158700|NCT00715403|365563|P7|NOT COMPLETED|Overall Study||1
158701|NCT00715403|365564|P6|NOT COMPLETED|Overall Study||19
158702|NCT00715403|365565|P5|NOT COMPLETED|Overall Study||6
158703|NCT00715403|365566|P4|NOT COMPLETED|Overall Study||9
158704|NCT00715403|365567|P3|NOT COMPLETED|Overall Study||4
158705|NCT00715403|365568|P2|NOT COMPLETED|Overall Study||1
158706|NCT00715403|365569|P1|NOT COMPLETED|Overall Study||1
158707|NCT00715403|365563|P7|COMPLETED|Overall Study||0
158708|NCT00715403|365564|P6|COMPLETED|Overall Study||0
158709|NCT00715403|365565|P5|COMPLETED|Overall Study||0
158710|NCT00715403|365566|P4|COMPLETED|Overall Study||0
158711|NCT00715403|365567|P3|COMPLETED|Overall Study||0
158712|NCT00715403|365568|P2|COMPLETED|Overall Study||0
158713|NCT00715403|365569|P1|COMPLETED|Overall Study||0
158714|NCT00715403|365563|P7|STARTED|Overall Study||1
158715|NCT00715403|365564|P6|STARTED|Overall Study||19
158716|NCT00715403|365565|P5|STARTED|Overall Study||6
158717|NCT00715403|365566|P4|STARTED|Overall Study||9
158719|NCT00715403|365568|P2|STARTED|Overall Study||1
158720|NCT00715403|365569|P1|STARTED|Overall Study||1
158721|NCT00715390|365704|P1|NOT COMPLETED|Overall Study||0
158722|NCT00715390|365704|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
158723|NCT00715390|365704|P1|Eligible|Overall Study||234
158724|NCT00715390|365704|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
158725|NCT00715299|365708|P1|NOT COMPLETED|Overall Study||6
158726|NCT00715299|365708|P1|COMPLETED|Overall Study||30
158727|NCT00715299|365708|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
158728|NCT00715208|365714|P2|NOT COMPLETED|Overall Study||9
158729|NCT00715208|365715|P1|NOT COMPLETED|Overall Study||1
158730|NCT00715208|365714|P2|COMPLETED|Overall Study||39
158731|NCT00715208|365715|P1|COMPLETED|Overall Study||6
158732|NCT00715208|365714|P2|STARTED|Overall Study||48
158733|NCT00715208|365715|P1|STARTED|Overall Study||7
158734|NCT00715117|365731|P2|NOT COMPLETED|Overall Study||1
158735|NCT00715117|365732|P1|NOT COMPLETED|Overall Study||0
158736|NCT00715117|365731|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
158737|NCT00715117|365732|P1|COMPLETED|Overall Study||6
158738|NCT00715117|365731|P2|Completion fo 8 Week Study|Overall Study||6
158739|NCT00715117|365732|P1|Completion fo 8 Week Study|Overall Study||6
158740|NCT00715117|365731|P2|STARTED|Overall Study||6
158741|NCT00715117|365732|P1|STARTED|Overall Study||6
158742|NCT00715104|365746|P3|NOT COMPLETED|Overall Study||0
158743|NCT00715104|365747|P2|NOT COMPLETED|Overall Study||0
158744|NCT00715104|365748|P1|NOT COMPLETED|Overall Study||0
158745|NCT00715104|365746|P3|COMPLETED|Overall Study||8
158746|NCT00715104|365747|P2|COMPLETED|Overall Study||16
158747|NCT00715104|365748|P1|COMPLETED|Overall Study||18
158748|NCT00715104|365746|P3|STARTED|Overall Study||8
158749|NCT00715104|365747|P2|STARTED|Overall Study||16
158750|NCT00715104|365748|P1|STARTED|Overall Study||18
158751|NCT00715078|365800|P3|NOT COMPLETED|Overall Study||31
158752|NCT00715078|365801|P2|NOT COMPLETED|Overall Study||27
158753|NCT00715078|365802|P1|NOT COMPLETED|Overall Study||19
158754|NCT00715078|365800|P3|COMPLETED|Overall Study|as of 2013-10-25 data snapshot|10
158755|NCT00715078|365801|P2|COMPLETED|Overall Study|as of 2013-10-25 data snapshot|13
158756|NCT00715078|365802|P1|COMPLETED|Overall Study|as of 2013-10-25 data snapshot|22
158757|NCT00715078|365800|P3|STARTED|Overall Study||41
158758|NCT00715078|365801|P2|STARTED|Overall Study||40
158759|NCT00715078|365802|P1|STARTED|Overall Study||41
158760|NCT00715026|365810|P1|NOT COMPLETED|Overall Study||10
158761|NCT00715026|365810|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
158762|NCT00715026|365810|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
158763|NCT00715026|365810|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
158764|NCT00714948|365815|P1|NOT COMPLETED|Overall Study||2
158765|NCT00714948|365815|P1|COMPLETED|Overall Study||0
158766|NCT00714948|365815|P1|STARTED|Overall Study||2
158767|NCT00714870|365821|P2|NOT COMPLETED|Overall Study||5
158768|NCT00714870|365822|P1|NOT COMPLETED|Overall Study||27
158769|NCT00714870|365821|P2|COMPLETED|Overall Study||22
158770|NCT00714870|365822|P1|COMPLETED|Overall Study||22
158771|NCT00714870|365821|P2|STARTED|Overall Study||27
158772|NCT00714870|365822|P1|STARTED|Overall Study||49
158773|NCT00714714|365828|P1|NOT COMPLETED|Overall Study||1
158774|NCT00714714|365828|P1|COMPLETED|Overall Study||24
158775|NCT00714714|365828|P1|STARTED|Overall Study||25
158776|NCT00714688|365837|P3|NOT COMPLETED|Overall Study||37
158777|NCT00714688|365838|P2|NOT COMPLETED|Overall Study||35
158778|NCT00714688|365839|P1|NOT COMPLETED|Overall Study||29
158779|NCT00714688|365837|P3|COMPLETED|Overall Study||55
158780|NCT00714688|365838|P2|COMPLETED|Overall Study||55
158781|NCT00714688|365839|P1|COMPLETED|Overall Study||68
158782|NCT00714688|365837|P3|STARTED|Overall Study||92
158783|NCT00714688|365838|P2|STARTED|Overall Study||90
158784|NCT00714688|365839|P1|STARTED|Overall Study||97
158785|NCT00714571|365862|P6|NOT COMPLETED|Stage 2||0
158786|NCT00714571|365863|P5|NOT COMPLETED|Stage 2||0
158787|NCT00714571|365864|P4|NOT COMPLETED|Stage 2||0
158788|NCT00714571|365865|P3|NOT COMPLETED|Stage 2||0
158789|NCT00714571|365866|P2|NOT COMPLETED|Stage 2||0
158790|NCT00714571|365867|P1|NOT COMPLETED|Stage 2||0
158791|NCT00714571|365862|P6|COMPLETED|Stage 2||15
158792|NCT00714571|365863|P5|COMPLETED|Stage 2||15
158793|NCT00714571|365864|P4|COMPLETED|Stage 2||0
158794|NCT00714571|365865|P3|COMPLETED|Stage 2||0
158795|NCT00714571|365866|P2|COMPLETED|Stage 2||0
158796|NCT00714571|365867|P1|COMPLETED|Stage 2||0
158797|NCT00714571|365862|P6|STARTED|Stage 2||15
158798|NCT00714571|365863|P5|STARTED|Stage 2||15
158799|NCT00714571|365864|P4|STARTED|Stage 2||0
158800|NCT00714571|365865|P3|STARTED|Stage 2||0
158801|NCT00714571|365866|P2|STARTED|Stage 2||0
158802|NCT00714571|365867|P1|STARTED|Stage 2||0
158803|NCT00714571|365862|P6|NOT COMPLETED|Stage 1||0
158804|NCT00714571|365863|P5|NOT COMPLETED|Stage 1||0
158805|NCT00714571|365864|P4|NOT COMPLETED|Stage 1||0
158806|NCT00714571|365865|P3|NOT COMPLETED|Stage 1||1
158807|NCT00714571|365866|P2|NOT COMPLETED|Stage 1||0
158808|NCT00714571|365867|P1|NOT COMPLETED|Stage 1||0
158809|NCT00714571|365862|P6|COMPLETED|Stage 1||0
158810|NCT00714571|365863|P5|COMPLETED|Stage 1||0
158811|NCT00714571|365864|P4|COMPLETED|Stage 1||14
158812|NCT00714571|365865|P3|COMPLETED|Stage 1||10
158813|NCT00714571|365866|P2|COMPLETED|Stage 1||15
158814|NCT00714571|365867|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
158815|NCT00714571|365862|P6|STARTED|Stage 1||0
158816|NCT00714571|365863|P5|STARTED|Stage 1||0
158817|NCT00714571|365864|P4|STARTED|Stage 1||14
158818|NCT00714571|365865|P3|STARTED|Stage 1||11
158819|NCT00714571|365866|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
158820|NCT00714571|365867|P1|STARTED|Stage 1||12
158821|NCT00714493|365881|P1|NOT COMPLETED|Overall Study||49
158822|NCT00714493|365881|P1|COMPLETED|Overall Study||154
158823|NCT00714493|365881|P1|STARTED|Overall Study||203
158824|NCT00714389|365891|P1|NOT COMPLETED|Overall Study||0
158825|NCT00714389|365891|P1|COMPLETED|Overall Study||12
158826|NCT00714389|365891|P1|STARTED|Overall Study||12
158827|NCT00714311|365898|P2|NOT COMPLETED|Overall Study||22
158828|NCT00714311|365899|P1|NOT COMPLETED|Overall Study||13
158829|NCT00714311|365898|P2|COMPLETED|Overall Study||30
158830|NCT00714311|365899|P1|COMPLETED|Overall Study||39
158831|NCT00714311|365898|P2|STARTED|Overall Study||52
158832|NCT00714311|365899|P1|STARTED|Overall Study||52
158833|NCT00714285|365909|P4|NOT COMPLETED|Overall Study||1
158834|NCT00714285|365910|P3|NOT COMPLETED|Overall Study||0
158835|NCT00714285|365911|P2|NOT COMPLETED|Overall Study||3
158836|NCT00714285|365912|P1|NOT COMPLETED|Overall Study||0
158837|NCT00714285|365909|P4|COMPLETED|Overall Study|Completed upto Day 180|104
158838|NCT00714285|365910|P3|COMPLETED|Overall Study|Completed upto Day 180|105
158839|NCT00714285|365911|P2|COMPLETED|Overall Study|Completed upto Day 180|102
158840|NCT00714285|365912|P1|COMPLETED|Overall Study|Completed upto Day 180|105
158841|NCT00714285|365909|P4|STARTED|Overall Study||105
158842|NCT00714285|365910|P3|STARTED|Overall Study||105
158843|NCT00714285|365911|P2|STARTED|Overall Study||105
158844|NCT00714285|365912|P1|STARTED|Overall Study||105
158845|NCT00714233|365966|P4|NOT COMPLETED|Overall Study||4
158846|NCT00714233|365967|P3|NOT COMPLETED|Overall Study||1
158847|NCT00714233|365968|P2|NOT COMPLETED|Overall Study||1
158848|NCT00714233|365969|P1|NOT COMPLETED|Overall Study||4
158849|NCT00714233|365966|P4|COMPLETED|Overall Study||6
158850|NCT00714233|365967|P3|COMPLETED|Overall Study||10
158851|NCT00714233|365968|P2|COMPLETED|Overall Study||10
158852|NCT00714233|365969|P1|COMPLETED|Overall Study||6
158853|NCT00714233|365966|P4|STARTED|Overall Study||10
158854|NCT00714233|365967|P3|STARTED|Overall Study||11
158855|NCT00714233|365968|P2|STARTED|Overall Study||11
158856|NCT00714233|365969|P1|STARTED|Overall Study||10
158857|NCT00714168|365998|P2|NOT COMPLETED|Overall Study||59
158858|NCT00714168|365999|P1|NOT COMPLETED|Overall Study||44
158859|NCT00714168|365998|P2|COMPLETED|Overall Study||139
158860|NCT00714168|365999|P1|COMPLETED|Overall Study||121
158861|NCT00714168|365998|P2|STARTED|Overall Study||198
158862|NCT00714168|365999|P1|STARTED|Overall Study||165
158863|NCT00714051|366015|P2|NOT COMPLETED|Overall Study||1
158864|NCT00714051|366016|P1|NOT COMPLETED|Overall Study||1
158865|NCT00714051|366015|P2|COMPLETED|Overall Study||27
158866|NCT00714051|366016|P1|COMPLETED|Overall Study||26
158867|NCT00714051|366015|P2|STARTED|Overall Study||28
158868|NCT00714051|366016|P1|STARTED|Overall Study||27
158869|NCT00713830|366024|P2|NOT COMPLETED|Overall Study||177
158870|NCT00713830|366025|P1|NOT COMPLETED|Overall Study||82
158871|NCT00713830|366024|P2|COMPLETED|Overall Study||396
158872|NCT00713830|366025|P1|COMPLETED|Overall Study||204
158873|NCT00713830|366024|P2|Subgroup for Standardized Meal Test|Overall Study||313
158874|NCT00713830|366025|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
158875|NCT00713830|366024|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
158876|NCT00713830|366025|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
158877|NCT00713830|366024|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
158878|NCT00713830|366025|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
158879|NCT00713830|366024|P2|STARTED|Overall Study||573
158880|NCT00713830|366025|P1|STARTED|Overall Study|Randomized.|286
158881|NCT00713817|366063|P2|NOT COMPLETED|Overall Study||0
158882|NCT00713817|366064|P1|NOT COMPLETED|Overall Study||0
158883|NCT00713817|366063|P2|COMPLETED|Overall Study||9
158884|NCT00713817|366064|P1|COMPLETED|Overall Study||10
158885|NCT00713817|366063|P2|STARTED|Overall Study||9
158886|NCT00713817|366064|P1|STARTED|Overall Study||10
158887|NCT00713700|366082|P1|NOT COMPLETED|Overall Study||4
158888|NCT00713700|366082|P1|COMPLETED|Overall Study||188
158889|NCT00713700|366082|P1|STARTED|Overall Study||192
158890|NCT00713661|366091|P4|NOT COMPLETED|Overall Study||0
158891|NCT00713661|366092|P3|NOT COMPLETED|Overall Study||0
158892|NCT00713661|366093|P2|NOT COMPLETED|Overall Study||0
158893|NCT00713661|366094|P1|NOT COMPLETED|Overall Study||0
158894|NCT00713661|366091|P4|COMPLETED|Overall Study||5
158895|NCT00713661|366092|P3|COMPLETED|Overall Study||4
158896|NCT00713661|366093|P2|COMPLETED|Overall Study||9
158897|NCT00713661|366094|P1|COMPLETED|Overall Study||7
158898|NCT00713661|366091|P4|STARTED|Overall Study||5
158899|NCT00713661|366092|P3|STARTED|Overall Study||4
158900|NCT00713661|366093|P2|STARTED|Overall Study||9
158901|NCT00713661|366094|P1|STARTED|Overall Study||7
158902|NCT00713648|366108|P1|NOT COMPLETED|Overall Study||8
158903|NCT00713648|366108|P1|COMPLETED|Overall Study||33
158904|NCT00713648|366108|P1|STARTED|Overall Study||41
158905|NCT00713596|366118|P3|NOT COMPLETED|Overall Study||2
158906|NCT00713596|366119|P2|NOT COMPLETED|Overall Study||3
158907|NCT00713596|366120|P1|NOT COMPLETED|Overall Study||2
158908|NCT00713596|366118|P3|COMPLETED|Overall Study||6
158909|NCT00713596|366119|P2|COMPLETED|Overall Study||5
158910|NCT00713596|366120|P1|COMPLETED|Overall Study||7
158911|NCT00713596|366118|P3|STARTED|Overall Study||8
158912|NCT00713596|366119|P2|STARTED|Overall Study||8
158913|NCT00713596|366120|P1|STARTED|Overall Study||9
158914|NCT00713544|366137|P6|NOT COMPLETED|Overall Study||9
158915|NCT00713544|366138|P5|NOT COMPLETED|Overall Study||8
158916|NCT00713544|366139|P4|NOT COMPLETED|Overall Study||10
158917|NCT00713544|366140|P3|NOT COMPLETED|Overall Study||11
158918|NCT00713544|366141|P2|NOT COMPLETED|Overall Study||6
158919|NCT00713544|366142|P1|NOT COMPLETED|Overall Study||7
158920|NCT00713544|366137|P6|COMPLETED|Overall Study||67
158921|NCT00713544|366138|P5|COMPLETED|Overall Study||57
158922|NCT00713544|366139|P4|COMPLETED|Overall Study||66
158923|NCT00713544|366140|P3|COMPLETED|Overall Study||41
158924|NCT00713544|366141|P2|COMPLETED|Overall Study||46
158925|NCT00713544|366142|P1|COMPLETED|Overall Study||45
158926|NCT00713544|366137|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
158927|NCT00713544|366138|P5|STARTED|Overall Study||65
158928|NCT00713544|366139|P4|STARTED|Overall Study||76
158929|NCT00713544|366140|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
158930|NCT00713544|366141|P2|STARTED|Overall Study||52
158931|NCT00713544|366142|P1|STARTED|Overall Study||52
158932|NCT00713479|366180|P2|NOT COMPLETED|Next Medication Condition||0
158933|NCT00713479|366181|P1|NOT COMPLETED|Next Medication Condition||0
158934|NCT00713479|366180|P2|COMPLETED|Next Medication Condition||6
158935|NCT00713479|366181|P1|COMPLETED|Next Medication Condition||2
158936|NCT00713479|366180|P2|STARTED|Next Medication Condition||6
158937|NCT00713479|366181|P1|STARTED|Next Medication Condition||2
158938|NCT00713479|366180|P2|NOT COMPLETED|Washout||0
158939|NCT00713479|366181|P1|NOT COMPLETED|Washout||0
158940|NCT00713479|366180|P2|COMPLETED|Washout||6
158941|NCT00713479|366181|P1|COMPLETED|Washout||2
158942|NCT00713479|366180|P2|STARTED|Washout||6
158943|NCT00713479|366181|P1|STARTED|Washout||2
158944|NCT00713479|366180|P2|NOT COMPLETED|First Medication Condition||0
158945|NCT00713479|366181|P1|NOT COMPLETED|First Medication Condition||4
158946|NCT00713479|366180|P2|COMPLETED|First Medication Condition||6
158947|NCT00713479|366181|P1|COMPLETED|First Medication Condition||2
158948|NCT00713479|366180|P2|STARTED|First Medication Condition||6
158949|NCT00713479|366181|P1|STARTED|First Medication Condition||6
158950|NCT00713349|366193|P1|NOT COMPLETED|Overall Study||1
158951|NCT00713349|366193|P1|COMPLETED|Overall Study||24
158952|NCT00713349|366193|P1|STARTED|Overall Study||25
158953|NCT00713323|366199|P1|NOT COMPLETED|Overall Study||146
158954|NCT00713323|366199|P1|COMPLETED|Overall Study||234
158955|NCT00713323|366199|P1|STARTED|Overall Study||380
158956|NCT00713310|366212|P2|NOT COMPLETED|Overall Study||6
158957|NCT00713310|366213|P1|NOT COMPLETED|Overall Study||5
158958|NCT00713310|366212|P2|COMPLETED|Overall Study||36
158959|NCT00713310|366213|P1|COMPLETED|Overall Study||36
158960|NCT00713310|366212|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
158961|NCT00713310|366213|P1|mITT Population|Overall Study||41
158962|NCT00713310|366212|P2|STARTED|Overall Study||42
158963|NCT00713310|366213|P1|STARTED|Overall Study||41
158964|NCT00713258|366223|P2|NOT COMPLETED|Overall Study||6
158965|NCT00713258|366224|P1|NOT COMPLETED|Overall Study||5
158966|NCT00713258|366223|P2|COMPLETED|Overall Study||28
158967|NCT00713258|366224|P1|COMPLETED|Overall Study||36
158968|NCT00713258|366223|P2|STARTED|Overall Study||34
158969|NCT00713258|366224|P1|STARTED|Overall Study||41
158970|NCT00713219|366232|P1|NOT COMPLETED|Overall Study||2
158971|NCT00713219|366232|P1|COMPLETED|Overall Study||12
158972|NCT00713219|366232|P1|STARTED|Overall Study||14
158973|NCT00713206|366238|P2|NOT COMPLETED|Overall Study||3
158974|NCT00713206|366239|P1|NOT COMPLETED|Overall Study||7
158975|NCT00713206|366238|P2|COMPLETED|Overall Study||27
158976|NCT00713206|366239|P1|COMPLETED|Overall Study||55
158977|NCT00713206|366238|P2|STARTED|Overall Study||30
158978|NCT00713206|366239|P1|STARTED|Overall Study||62
158979|NCT00712985|366245|P1|NOT COMPLETED|Overall Study||5
158980|NCT00712985|366245|P1|COMPLETED|Overall Study||13
158981|NCT00712985|366245|P1|STARTED|Overall Study||18
158982|NCT00712959|366251|P2|NOT COMPLETED|Overall Study||3
158983|NCT00712959|366252|P1|NOT COMPLETED|Overall Study||19
158984|NCT00712959|366251|P2|COMPLETED|Overall Study||404
158985|NCT00712959|366252|P1|COMPLETED|Overall Study||342
158986|NCT00712959|366251|P2|STARTED|Overall Study||407
158987|NCT00712959|366252|P1|STARTED|Overall Study||361
158988|NCT00712920|366273|P3|NOT COMPLETED|Overall Study||12
158989|NCT00712920|366274|P2|NOT COMPLETED|Overall Study||17
158990|NCT00712920|366275|P1|NOT COMPLETED|Overall Study||17
158991|NCT00712920|366273|P3|COMPLETED|Overall Study||180
158992|NCT00712920|366274|P2|COMPLETED|Overall Study||180
158993|NCT00712920|366275|P1|COMPLETED|Overall Study||175
158994|NCT00712920|366273|P3|STARTED|Overall Study||192
158995|NCT00712920|366274|P2|STARTED|Overall Study|3 subjects were randomized in error|197
158996|NCT00712920|366275|P1|STARTED|Overall Study||192
158997|NCT00712725|366303|P8|NOT COMPLETED|Overall Study||11
158998|NCT00712725|366304|P7|NOT COMPLETED|Overall Study||22
158999|NCT00712725|366305|P6|NOT COMPLETED|Overall Study||16
159000|NCT00712725|366306|P5|NOT COMPLETED|Overall Study||19
159001|NCT00712725|366307|P4|NOT COMPLETED|Overall Study||17
159002|NCT00712725|366308|P3|NOT COMPLETED|Overall Study||10
159003|NCT00712725|366309|P2|NOT COMPLETED|Overall Study||6
159004|NCT00712725|366310|P1|NOT COMPLETED|Overall Study||29
159005|NCT00712725|366303|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
159006|NCT00712725|366304|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
159007|NCT00712725|366305|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
159008|NCT00712725|366306|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
159009|NCT00712725|366307|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
159010|NCT00712725|366308|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
159011|NCT00712725|366309|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
159012|NCT00712725|366310|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
159013|NCT00712725|366303|P8|STARTED|Overall Study||74
159014|NCT00712725|366304|P7|STARTED|Overall Study||83
159015|NCT00712725|366305|P6|STARTED|Overall Study||84
159016|NCT00712725|366306|P5|STARTED|Overall Study||86
159017|NCT00712725|366307|P4|STARTED|Overall Study||84
159018|NCT00712725|366308|P3|STARTED|Overall Study||57
159019|NCT00712725|366309|P2|STARTED|Overall Study||39
159020|NCT00712725|366310|P1|STARTED|Overall Study||169
159021|NCT00712673|366371|P4|NOT COMPLETED|Overall Study||70
159022|NCT00712673|366372|P3|NOT COMPLETED|Overall Study||57
159023|NCT00712673|366373|P2|NOT COMPLETED|Overall Study||21
159024|NCT00712673|366374|P1|NOT COMPLETED|Overall Study||21
159025|NCT00712673|366371|P4|COMPLETED|Overall Study||185
159026|NCT00712673|366372|P3|COMPLETED|Overall Study||198
159027|NCT00712673|366373|P2|COMPLETED|Overall Study||64
159028|NCT00712673|366374|P1|COMPLETED|Overall Study||64
159029|NCT00712673|366371|P4|Subgroup for Standardized Meal Test|Overall Study||0
159030|NCT00712673|366372|P3|Subgroup for Standardized Meal Test|Overall Study||255
159031|NCT00712673|366373|P2|Subgroup for Standardized Meal Test|Overall Study||0
159032|NCT00712673|366374|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
159033|NCT00712673|366371|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
159034|NCT00712673|366372|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
159035|NCT00712673|366373|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
159036|NCT00712673|366374|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
159037|NCT00712673|366371|P4|Safety Population|Overall Study||255
159038|NCT00712673|366372|P3|Safety Population|Overall Study||255
159039|NCT00712673|366373|P2|Safety Population|Overall Study||85
159040|NCT00712673|366374|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
159041|NCT00712673|366371|P4|STARTED|Overall Study||255
159042|NCT00712673|366372|P3|STARTED|Overall Study||255
159043|NCT00712673|366373|P2|STARTED|Overall Study||85
159044|NCT00712673|366374|P1|STARTED|Overall Study|Randomized.|85
159045|NCT00712543|366438|P2|NOT COMPLETED|Day 8-14||2
159046|NCT00712543|366439|P1|NOT COMPLETED|Day 8-14||0
159047|NCT00712543|366438|P2|COMPLETED|Day 8-14||25
159048|NCT00712543|366439|P1|COMPLETED|Day 8-14||23
159049|NCT00712543|366438|P2|STARTED|Day 8-14||27
159050|NCT00712543|366439|P1|STARTED|Day 8-14||23
159051|NCT00712543|366438|P2|NOT COMPLETED|Day 1-7||0
159052|NCT00712543|366439|P1|NOT COMPLETED|Day 1-7||0
159053|NCT00712543|366438|P2|COMPLETED|Day 1-7||27
159054|NCT00712543|366439|P1|COMPLETED|Day 1-7||23
159055|NCT00712543|366438|P2|STARTED|Day 1-7||27
159056|NCT00712543|366439|P1|STARTED|Day 1-7||23
159057|NCT00712530|366448|P3|NOT COMPLETED|Overall Study||0
159058|NCT00712530|366449|P2|NOT COMPLETED|Overall Study||0
159059|NCT00712530|366450|P1|NOT COMPLETED|Overall Study||0
159060|NCT00712530|366448|P3|COMPLETED|Overall Study||3
159061|NCT00712530|366449|P2|COMPLETED|Overall Study||3
159062|NCT00712530|366450|P1|COMPLETED|Overall Study||3
159063|NCT00712530|366448|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
159064|NCT00712530|366449|P2|STARTED|Overall Study||3
159065|NCT00712530|366450|P1|STARTED|Overall Study||3
159066|NCT00712348|366473|P1|NOT COMPLETED|Overall Study||1
159067|NCT00712348|366473|P1|COMPLETED|Overall Study||30
159068|NCT00712348|366473|P1|STARTED|Overall Study||31
159069|NCT00712335|366485|P5|NOT COMPLETED|Overall Study||0
159070|NCT00712335|366486|P4|NOT COMPLETED|Overall Study||5
159071|NCT00712335|366487|P3|NOT COMPLETED|Overall Study||5
159072|NCT00712335|366488|P2|NOT COMPLETED|Overall Study||17
159073|NCT00712335|366489|P1|NOT COMPLETED|Overall Study||3
159074|NCT00712335|366485|P5|COMPLETED|Overall Study||30
159075|NCT00712335|366486|P4|COMPLETED|Overall Study||19
159076|NCT00712335|366487|P3|COMPLETED|Overall Study||6
159077|NCT00712335|366488|P2|COMPLETED|Overall Study||15
159078|NCT00712335|366489|P1|COMPLETED|Overall Study||5
159079|NCT00712335|366485|P5|STARTED|Overall Study||30
159080|NCT00712335|366486|P4|STARTED|Overall Study||24
159081|NCT00712335|366487|P3|STARTED|Overall Study||11
159082|NCT00712335|366488|P2|STARTED|Overall Study||32
159083|NCT00712335|366489|P1|STARTED|Overall Study||8
159084|NCT00712244|366535|P4|NOT COMPLETED|Overall Study||1
159085|NCT00712244|366536|P3|NOT COMPLETED|Overall Study||2
159086|NCT00712244|366537|P2|NOT COMPLETED|Overall Study||1
159087|NCT00712244|366538|P1|NOT COMPLETED|Overall Study||4
159088|NCT00712244|366535|P4|COMPLETED|Overall Study||26
159089|NCT00712244|366536|P3|COMPLETED|Overall Study||25
159090|NCT00712244|366537|P2|COMPLETED|Overall Study||28
159091|NCT00712244|366538|P1|COMPLETED|Overall Study||25
159092|NCT00712244|366535|P4|STARTED|Overall Study||27
159093|NCT00712244|366536|P3|STARTED|Overall Study||27
159094|NCT00712244|366537|P2|STARTED|Overall Study||29
159095|NCT00712244|366538|P1|STARTED|Overall Study||29
159096|NCT00712179|366580|P1|NOT COMPLETED|Overall Study||12
159097|NCT00712179|366580|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
159098|NCT00712179|366580|P1|STARTED|Overall Study||49
159099|NCT00712166|366586|P2|NOT COMPLETED|Overall Study||1
159100|NCT00712166|366587|P1|NOT COMPLETED|Overall Study||0
159101|NCT00712166|366586|P2|COMPLETED|Overall Study||75
159102|NCT00712166|366587|P1|COMPLETED|Overall Study||81
159103|NCT00712166|366586|P2|STARTED|Overall Study||76
159104|NCT00712166|366587|P1|STARTED|Overall Study||81
159105|NCT00712075|366614|P3|NOT COMPLETED|Overall Study||11
159106|NCT00712075|366615|P2|NOT COMPLETED|Overall Study||4
159107|NCT00712075|366616|P1|NOT COMPLETED|Overall Study||5
159108|NCT00712075|366614|P3|COMPLETED|Overall Study||14
159109|NCT00712075|366615|P2|COMPLETED|Overall Study||26
159110|NCT00712075|366616|P1|COMPLETED|Overall Study||17
159111|NCT00712075|366614|P3|STARTED|Overall Study||25
159112|NCT00712075|366615|P2|STARTED|Overall Study||30
159113|NCT00712075|366616|P1|STARTED|Overall Study||22
159114|NCT00712010|366630|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
159115|NCT00712010|366630|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
159116|NCT00712010|366630|P1|STARTED|7th and Last Protein Testing (1 Day)||23
159117|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||0
159118|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||23
159119|NCT00712010|366630|P1|STARTED|Washout (7 Days)||23
159120|NCT00712010|366630|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
159121|NCT00712010|366630|P1|COMPLETED|6th Protein Testing (1 Day)||23
159122|NCT00712010|366630|P1|STARTED|6th Protein Testing (1 Day)||23
159123|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||0
159124|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||23
159125|NCT00712010|366630|P1|STARTED|Washout (7 Days)||23
159126|NCT00712010|366630|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
159127|NCT00712010|366630|P1|COMPLETED|5th Protein Testing (1 Day)||23
159128|NCT00712010|366630|P1|STARTED|5th Protein Testing (1 Day)||23
159129|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||1
159130|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||23
159131|NCT00712010|366630|P1|STARTED|Washout (7 Days)||24
159132|NCT00712010|366630|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
159133|NCT00712010|366630|P1|COMPLETED|4th Protein Testing (1 Day)||24
159134|NCT00712010|366630|P1|STARTED|4th Protein Testing (1 Day)||24
159135|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||0
159136|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||24
159137|NCT00712010|366630|P1|STARTED|Washout (7 Days)||24
159138|NCT00712010|366630|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
159139|NCT00712010|366630|P1|COMPLETED|3rd Protein Testing (1 Day)||24
159140|NCT00712010|366630|P1|STARTED|3rd Protein Testing (1 Day)||24
159141|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||0
159142|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||24
159143|NCT00712010|366630|P1|STARTED|Washout (7 Days)||24
159144|NCT00712010|366630|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
159145|NCT00712010|366630|P1|COMPLETED|2nd Protein Testing (1 Day)||24
159146|NCT00712010|366630|P1|STARTED|2nd Protein Testing (1 Day)||24
159147|NCT00712010|366630|P1|NOT COMPLETED|Washout (7 Days)||0
159148|NCT00712010|366630|P1|COMPLETED|Washout (7 Days)||24
159149|NCT00712010|366630|P1|STARTED|Washout (7 Days)||24
159150|NCT00712010|366630|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
159151|NCT00712010|366630|P1|COMPLETED|1st Protein Testing (1 Day)||24
159152|NCT00712010|366630|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
159153|NCT00711997|366655|P2|NOT COMPLETED|Overall Study||0
159154|NCT00711997|366656|P1|NOT COMPLETED|Overall Study||0
159155|NCT00711997|366655|P2|COMPLETED|Overall Study||6
159156|NCT00711997|366656|P1|COMPLETED|Overall Study||3
159157|NCT00711997|366655|P2|STARTED|Overall Study||6
159158|NCT00711997|366656|P1|STARTED|Overall Study||3
159159|NCT00711880|366668|P2|NOT COMPLETED|Overall Study||7
159160|NCT00711880|366669|P1|NOT COMPLETED|Overall Study||13
159161|NCT00711880|366668|P2|COMPLETED|Overall Study||55
159162|NCT00711880|366669|P1|COMPLETED|Overall Study||50
159163|NCT00711880|366668|P2|STARTED|Overall Study||62
159164|NCT00711880|366669|P1|STARTED|Overall Study||63
159165|NCT00711867|366707|P2|NOT COMPLETED|Overall Study||4
159166|NCT00711867|366708|P1|NOT COMPLETED|Overall Study||5
159167|NCT00711867|366707|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
159168|NCT00711867|366708|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
159169|NCT00711867|366707|P2|STARTED|Overall Study||25
159170|NCT00711867|366708|P1|STARTED|Overall Study||30
159171|NCT00711828|366714|P1|NOT COMPLETED|Overall Study||0
159172|NCT00711828|366714|P1|COMPLETED|Overall Study||21
159173|NCT00711828|366714|P1|STARTED|Overall Study||21
159174|NCT00711802|366731|P8|NOT COMPLETED|Overall Study||2
159175|NCT00711802|366732|P7|NOT COMPLETED|Overall Study||5
159176|NCT00711802|366733|P6|NOT COMPLETED|Overall Study||8
159177|NCT00711802|366734|P5|NOT COMPLETED|Overall Study||14
159178|NCT00711802|366735|P4|NOT COMPLETED|Overall Study||3
159179|NCT00711802|366736|P3|NOT COMPLETED|Overall Study||6
159180|NCT00711802|366737|P2|NOT COMPLETED|Overall Study||6
159181|NCT00711802|366738|P1|NOT COMPLETED|Overall Study||2
159182|NCT00711802|366731|P8|COMPLETED|Overall Study||13
159183|NCT00711802|366732|P7|COMPLETED|Overall Study||25
159184|NCT00711802|366733|P6|COMPLETED|Overall Study||34
159185|NCT00711802|366734|P5|COMPLETED|Overall Study||69
159186|NCT00711802|366735|P4|COMPLETED|Overall Study||35
159187|NCT00711802|366736|P3|COMPLETED|Overall Study||69
159188|NCT00711802|366737|P2|COMPLETED|Overall Study||32
159189|NCT00711802|366738|P1|COMPLETED|Overall Study||73
159190|NCT00711802|366731|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
159191|NCT00711802|366732|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
159192|NCT00711802|366733|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
159193|NCT00711802|366734|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
159194|NCT00711802|366735|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
159195|NCT00711802|366736|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
159196|NCT00711802|366737|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
159197|NCT00711802|366738|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
159198|NCT00711802|366731|P8|STARTED|Overall Study||15
159199|NCT00711802|366732|P7|STARTED|Overall Study||30
159200|NCT00711802|366733|P6|STARTED|Overall Study||42
159201|NCT00711802|366734|P5|STARTED|Overall Study||83
159202|NCT00711802|366735|P4|STARTED|Overall Study||38
159203|NCT00711802|366736|P3|STARTED|Overall Study||75
159204|NCT00711802|366737|P2|STARTED|Overall Study||38
159205|NCT00711802|366738|P1|STARTED|Overall Study||75
159206|NCT00711646|366770|P2|NOT COMPLETED|Overall Study||3
159207|NCT00711646|366771|P1|NOT COMPLETED|Overall Study||12
159208|NCT00711646|366770|P2|COMPLETED|Overall Study||62
159209|NCT00711646|366771|P1|COMPLETED|Overall Study||112
159210|NCT00711646|366770|P2|STARTED|Overall Study||65
159211|NCT00711646|366771|P1|STARTED|Overall Study||124
159212|NCT00711594|366793|P4|NOT COMPLETED|Overall Study||62
159213|NCT00711594|366794|P3|NOT COMPLETED|Overall Study||6
159214|NCT00711594|366795|P2|NOT COMPLETED|Overall Study||3
159215|NCT00711594|366796|P1|NOT COMPLETED|Overall Study||3
159216|NCT00711594|366793|P4|COMPLETED|Overall Study||0
159217|NCT00711594|366794|P3|COMPLETED|Overall Study||0
159218|NCT00711594|366795|P2|COMPLETED|Overall Study||0
159219|NCT00711594|366796|P1|COMPLETED|Overall Study||0
159220|NCT00711594|366793|P4|STARTED|Overall Study||62
159221|NCT00711594|366794|P3|STARTED|Overall Study||6
159222|NCT00711594|366795|P2|STARTED|Overall Study||3
159223|NCT00711594|366796|P1|STARTED|Overall Study||3
159224|NCT00711555|366833|P1|NOT COMPLETED|Overall Study||3
159225|NCT00711555|366833|P1|COMPLETED|Overall Study||19
159226|NCT00711555|366833|P1|STARTED|Overall Study||22
159227|NCT00711529|366842|P2|NOT COMPLETED|Overall Study||6
159228|NCT00711529|366843|P1|NOT COMPLETED|Overall Study||4
159229|NCT00711529|366842|P2|COMPLETED|Overall Study||8
159230|NCT00711529|366843|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
159231|NCT00711529|366842|P2|STARTED|Overall Study||14
159232|NCT00711529|366843|P1|STARTED|Overall Study||13
159233|NCT00711516|366867|P2|NOT COMPLETED|Overall Study||3
159234|NCT00711516|366868|P1|NOT COMPLETED|Overall Study||1
159235|NCT00711516|366867|P2|COMPLETED|Overall Study||16
159236|NCT00711516|366868|P1|COMPLETED|Overall Study||20
159237|NCT00711516|366867|P2|STARTED|Overall Study||19
159238|NCT00711516|366868|P1|STARTED|Overall Study||21
159239|NCT00711490|366962|P1|NOT COMPLETED|Overall Study||0
159240|NCT00711490|366962|P1|COMPLETED|Overall Study||5
159241|NCT00711490|366962|P1|STARTED|Overall Study||5
159242|NCT00711477|366975|P2|NOT COMPLETED|Overall Study||3
159243|NCT00711477|366976|P1|NOT COMPLETED|Overall Study||3
159244|NCT00711477|366975|P2|COMPLETED|Overall Study||20
159245|NCT00711477|366976|P1|COMPLETED|Overall Study||20
159246|NCT00711477|366975|P2|STARTED|Overall Study||23
159247|NCT00711477|366976|P1|STARTED|Overall Study||23
159248|NCT00711425|367004|P1|NOT COMPLETED|Overall Study||4
159249|NCT00711425|367004|P1|COMPLETED|Overall Study||41
159250|NCT00711425|367004|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
159251|NCT00711347|367012|P2|NOT COMPLETED|Overall Study||0
159252|NCT00711347|367013|P1|NOT COMPLETED|Overall Study||0
159253|NCT00711347|367012|P2|COMPLETED|Overall Study||14
159254|NCT00711347|367013|P1|COMPLETED|Overall Study||14
159255|NCT00711347|367012|P2|STARTED|Overall Study||14
159256|NCT00711347|367013|P1|STARTED|Overall Study||14
159257|NCT00711191|367032|P3|NOT COMPLETED|Overall Study||12
159258|NCT00711191|367033|P2|NOT COMPLETED|Overall Study||5
159259|NCT00711191|367034|P1|NOT COMPLETED|Overall Study||3
159260|NCT00711191|367032|P3|COMPLETED|Overall Study||1
159261|NCT00711191|367033|P2|COMPLETED|Overall Study||1
159262|NCT00711191|367034|P1|COMPLETED|Overall Study||0
159263|NCT00711191|367032|P3|STARTED|Overall Study||13
159264|NCT00711191|367033|P2|STARTED|Overall Study||6
159265|NCT00711191|367034|P1|STARTED|Overall Study||3
159266|NCT00711113|367071|P1|NOT COMPLETED|Overall Study||11
159267|NCT00711113|367071|P1|COMPLETED|Overall Study||36
159268|NCT00711113|367071|P1|STARTED|Overall Study||47
159269|NCT00711100|367077|P1|NOT COMPLETED|Overall Study||13
159270|NCT00711100|367077|P1|COMPLETED|Overall Study||91
159271|NCT00711100|367077|P1|STARTED|Overall Study||104
159272|NCT00711087|367095|P2|NOT COMPLETED|Overall Study||0
159273|NCT00711087|367096|P1|NOT COMPLETED|Overall Study||1
159274|NCT00711087|367095|P2|COMPLETED|Overall Study||0
159275|NCT00711087|367096|P1|COMPLETED|Overall Study||0
159276|NCT00711087|367095|P2|STARTED|Overall Study||0
159277|NCT00711087|367096|P1|STARTED|Overall Study||1
159278|NCT00711022|367102|P1|NOT COMPLETED|Overall Study||11
159279|NCT00711022|367102|P1|COMPLETED|Overall Study||40
159280|NCT00711022|367102|P1|STARTED|Overall Study||51
159281|NCT00711009|367108|P2|NOT COMPLETED|Overall Study||19
159282|NCT00711009|367109|P1|NOT COMPLETED|Overall Study||15
159283|NCT00711009|367108|P2|COMPLETED|Overall Study||82
159284|NCT00711009|367109|P1|COMPLETED|Overall Study||90
159285|NCT00711009|367108|P2|STARTED|Overall Study||101
159286|NCT00711009|367109|P1|STARTED|Overall Study||105
159287|NCT00710996|367280|P3|NOT COMPLETED|Overall Study||0
159288|NCT00710996|367281|P2|NOT COMPLETED|Overall Study||4
159289|NCT00710996|367282|P1|NOT COMPLETED|Overall Study||1
159290|NCT00710996|367280|P3|COMPLETED|Overall Study||21
159291|NCT00710996|367281|P2|COMPLETED|Overall Study||16
159292|NCT00710996|367282|P1|COMPLETED|Overall Study||16
159293|NCT00710996|367280|P3|STARTED|Overall Study||21
159294|NCT00710996|367281|P2|STARTED|Overall Study||20
159295|NCT00710996|367282|P1|STARTED|Overall Study||17
159296|NCT00710970|367290|P1|NOT COMPLETED|Overall Study||10
159297|NCT00710970|367290|P1|COMPLETED|Overall Study||18
159298|NCT00710970|367290|P1|STARTED|Overall Study||28
159299|NCT00710944|367297|P3|NOT COMPLETED|Overall Study||2
159300|NCT00710944|367298|P2|NOT COMPLETED|Overall Study||9
159301|NCT00710944|367299|P1|NOT COMPLETED|Overall Study||10
159302|NCT00710944|367297|P3|COMPLETED|Overall Study||17
159303|NCT00710944|367298|P2|COMPLETED|Overall Study||49
159304|NCT00710944|367299|P1|COMPLETED|Overall Study||45
159305|NCT00710944|367297|P3|STARTED|Overall Study||19
159306|NCT00710944|367298|P2|STARTED|Overall Study||58
159307|NCT00710944|367299|P1|STARTED|Overall Study||55
159308|NCT00710931|367307|P1|NOT COMPLETED|Overall Study||5
159309|NCT00710931|367307|P1|COMPLETED|Overall Study||29
159310|NCT00710931|367307|P1|STARTED|Overall Study||34
159311|NCT00710905|367311|P1|NOT COMPLETED|Overall Study||16
159312|NCT00710905|367311|P1|COMPLETED|Overall Study||34
159313|NCT00710905|367311|P1|STARTED|Overall Study||50
159314|NCT00710879|367317|P2|NOT COMPLETED|Overall Study||4
159315|NCT00710879|367318|P1|NOT COMPLETED|Overall Study||2
159316|NCT00710879|367317|P2|COMPLETED|Overall Study||113
159317|NCT00710879|367318|P1|COMPLETED|Overall Study||58
159318|NCT00710879|367317|P2|STARTED|Overall Study||117
159319|NCT00710879|367318|P1|STARTED|Overall Study||60
159320|NCT00710866|367330|P2|NOT COMPLETED|Overall Study||6
159321|NCT00710866|367331|P1|NOT COMPLETED|Overall Study||9
159322|NCT00710866|367330|P2|COMPLETED|Overall Study||128
159323|NCT00710866|367331|P1|COMPLETED|Overall Study||124
159324|NCT00710866|367330|P2|STARTED|Overall Study||134
159325|NCT00710866|367331|P1|STARTED|Overall Study||133
159326|NCT00710840|367353|P2|NOT COMPLETED|Overall Study||3
159327|NCT00710840|367354|P1|NOT COMPLETED|Overall Study||0
159328|NCT00710840|367353|P2|COMPLETED|Overall Study||19
159329|NCT00710840|367354|P1|COMPLETED|Overall Study||22
159330|NCT00710840|367353|P2|STARTED|Overall Study||22
159331|NCT00710840|367354|P1|STARTED|Overall Study||22
159332|NCT00710814|367368|P2|NOT COMPLETED|Overall Study||3
159333|NCT00710814|367369|P1|NOT COMPLETED|Overall Study||1
159334|NCT00710814|367368|P2|COMPLETED|Overall Study||13
159335|NCT00710814|367369|P1|COMPLETED|Overall Study||14
159336|NCT00710814|367368|P2|STARTED|Overall Study||16
159337|NCT00710814|367369|P1|STARTED|Overall Study||15
159338|NCT00710762|367377|P2|NOT COMPLETED|Overall Study||40
159339|NCT00710762|367378|P1|NOT COMPLETED|Overall Study||39
159340|NCT00710762|367377|P2|COMPLETED|Overall Study||0
159341|NCT00710762|367378|P1|COMPLETED|Overall Study||5
159342|NCT00710762|367377|P2|STARTED|Overall Study||40
159343|NCT00710762|367378|P1|STARTED|Overall Study||44
159344|NCT00710749|367394|P2|NOT COMPLETED|Second Intervention||0
159345|NCT00710749|367395|P1|NOT COMPLETED|Second Intervention||0
159346|NCT00710749|367394|P2|COMPLETED|Second Intervention||30
159347|NCT00710749|367395|P1|COMPLETED|Second Intervention||29
159348|NCT00710749|367394|P2|STARTED|Second Intervention||30
159349|NCT00710749|367395|P1|STARTED|Second Intervention||29
159350|NCT00710749|367394|P2|NOT COMPLETED|First Intervention||0
159351|NCT00710749|367395|P1|NOT COMPLETED|First Intervention||1
159352|NCT00710749|367394|P2|COMPLETED|First Intervention||30
159353|NCT00710749|367395|P1|COMPLETED|First Intervention||29
159354|NCT00710749|367394|P2|STARTED|First Intervention||30
159355|NCT00710749|367395|P1|STARTED|First Intervention||30
159356|NCT00710749|367394|P2|NOT COMPLETED|Clinic Baseline Recording||0
159357|NCT00710749|367395|P1|NOT COMPLETED|Clinic Baseline Recording||0
159358|NCT00710749|367394|P2|COMPLETED|Clinic Baseline Recording||30
159359|NCT00710749|367395|P1|COMPLETED|Clinic Baseline Recording||30
159360|NCT00710749|367394|P2|STARTED|Clinic Baseline Recording||30
159361|NCT00710749|367395|P1|STARTED|Clinic Baseline Recording||30
159362|NCT00710606|367405|P2|NOT COMPLETED|Overall Study||2
159363|NCT00710606|367406|P1|NOT COMPLETED|Overall Study||0
159364|NCT00710606|367405|P2|COMPLETED|Overall Study||18
159365|NCT00710606|367406|P1|COMPLETED|Overall Study||20
159366|NCT00710606|367405|P2|STARTED|Overall Study||20
159367|NCT00710606|367406|P1|STARTED|Overall Study||20
159368|NCT00710554|367418|P2|NOT COMPLETED|Overall Study||24
159369|NCT00710554|367419|P1|NOT COMPLETED|Overall Study||49
159370|NCT00710554|367418|P2|COMPLETED|Overall Study||94
159371|NCT00710554|367419|P1|COMPLETED|Overall Study||79
159372|NCT00710554|367418|P2|STARTED|Overall Study||118
159373|NCT00710554|367419|P1|STARTED|Overall Study||128
159374|NCT00710424|367447|P2|NOT COMPLETED|Overall Study||23
159375|NCT00710424|367448|P1|NOT COMPLETED|Overall Study||44
159376|NCT00710424|367447|P2|COMPLETED|Overall Study||125
159377|NCT00710424|367448|P1|COMPLETED|Overall Study||105
159378|NCT00710424|367447|P2|STARTED|Overall Study||148
159379|NCT00710424|367448|P1|STARTED|Overall Study||149
159380|NCT00710385|367472|P1|NOT COMPLETED|Overall Study||5
159381|NCT00710385|367472|P1|COMPLETED|Overall Study||12
159382|NCT00710385|367472|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
159383|NCT00710203|367489|P1|NOT COMPLETED|Overall Study||0
159384|NCT00710203|367489|P1|COMPLETED|Overall Study||10
159385|NCT00710203|367489|P1|STARTED|Overall Study||10
159386|NCT00710021|367518|P3|NOT COMPLETED|Overall Study||1
159387|NCT00710021|367519|P2|NOT COMPLETED|Overall Study||3
159388|NCT00710021|367520|P1|NOT COMPLETED|Overall Study||1
159389|NCT00710021|367518|P3|COMPLETED|Overall Study||18
159390|NCT00710021|367519|P2|COMPLETED|Overall Study||16
159391|NCT00710021|367520|P1|COMPLETED|Overall Study||18
159392|NCT00710021|367518|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
159393|NCT00710021|367519|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
159394|NCT00710021|367520|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
159395|NCT00710021|367518|P3|STARTED|Overall Study||19
159396|NCT00710021|367519|P2|STARTED|Overall Study||19
159397|NCT00710021|367520|P1|STARTED|Overall Study||19
159398|NCT00709956|367635|P2|NOT COMPLETED|Overall Study||4
159399|NCT00709956|367636|P1|NOT COMPLETED|Overall Study||3
159400|NCT00709956|367635|P2|COMPLETED|Overall Study||33
159401|NCT00709956|367636|P1|COMPLETED|Overall Study||30
159402|NCT00709956|367635|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
159403|NCT00709956|367636|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
159404|NCT00709956|367635|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
159405|NCT00709956|367636|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
159406|NCT00709891|367644|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
159407|NCT00709891|367644|P1|COMPLETED|Longitudinal Follow-up Phase||5020
159408|NCT00709891|367644|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
159409|NCT00709891|367644|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
159410|NCT00709891|367644|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
159411|NCT00709891|367644|P1|STARTED|Baseline, Cross-sectional Phase||47208
159412|NCT00709878|367653|P4|NOT COMPLETED|Overall Study||0
159413|NCT00709878|367654|P3|NOT COMPLETED|Overall Study||0
159414|NCT00709878|367655|P2|NOT COMPLETED|Overall Study||0
159415|NCT00709878|367656|P1|NOT COMPLETED|Overall Study||0
159416|NCT00709878|367653|P4|COMPLETED|Overall Study||8
159417|NCT00709878|367654|P3|COMPLETED|Overall Study||8
159418|NCT00709878|367655|P2|COMPLETED|Overall Study||8
159419|NCT00709878|367656|P1|COMPLETED|Overall Study||8
159420|NCT00709878|367653|P4|STARTED|Overall Study||8
159421|NCT00709878|367654|P3|STARTED|Overall Study||8
159422|NCT00709878|367655|P2|STARTED|Overall Study||8
159423|NCT00709878|367656|P1|STARTED|Overall Study||8
159424|NCT00709852|367666|P2|NOT COMPLETED|Period 2||2
159425|NCT00709852|367667|P1|NOT COMPLETED|Period 2||9
159426|NCT00709852|367666|P2|COMPLETED|Period 2||169
159427|NCT00709852|367667|P1|COMPLETED|Period 2||211
159428|NCT00709852|367666|P2|STARTED|Period 2||171
159429|NCT00709852|367667|P1|STARTED|Period 2||220
159430|NCT00709852|367666|P2|NOT COMPLETED|Period 1||3
159431|NCT00709852|367667|P1|NOT COMPLETED|Period 1||8
159432|NCT00709852|367666|P2|COMPLETED|Period 1||171
159433|NCT00709852|367667|P1|COMPLETED|Period 1||220
159434|NCT00709852|367666|P2|STARTED|Period 1||174
159435|NCT00709852|367667|P1|STARTED|Period 1||228
159436|NCT00709826|367822|P2|NOT COMPLETED|Overall Study||1
159437|NCT00709826|367823|P1|NOT COMPLETED|Overall Study||2
159438|NCT00709826|367822|P2|COMPLETED|Overall Study||38
159439|NCT00709826|367823|P1|COMPLETED|Overall Study||68
159440|NCT00709826|367822|P2|STARTED|Overall Study||39
159441|NCT00709826|367823|P1|STARTED|Overall Study||70
159442|NCT00708734|367831|P1|NOT COMPLETED|Overall Study||7
159443|NCT00708734|367831|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
159444|NCT00708734|367831|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
159445|NCT00708708|367835|P1|NOT COMPLETED|Overall Study||742
159446|NCT00708708|367835|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
159447|NCT00708708|367835|P1|STARTED|Overall Study||955
159448|NCT00708682|367883|P1|NOT COMPLETED|Toddler Dose||8
159449|NCT00708682|367883|P1|COMPLETED|Toddler Dose||183
159450|NCT00708682|367883|P1|STARTED|Toddler Dose||191
159451|NCT00708682|367883|P1|NOT COMPLETED|After Infant Series||1
159452|NCT00708682|367883|P1|COMPLETED|After Infant Series||191
159453|NCT00708682|367883|P1|STARTED|After Infant Series||192
159454|NCT00708682|367883|P1|NOT COMPLETED|Infant Series||33
159455|NCT00708682|367883|P1|COMPLETED|Infant Series||192
159456|NCT00708682|367883|P1|Vaccinated Dose 3|Infant Series||194
159457|NCT00708682|367883|P1|Vaccinated Dose 2|Infant Series||214
159458|NCT00708682|367883|P1|Vaccinated Dose 1|Infant Series||223
159459|NCT00708682|367883|P1|STARTED|Infant Series||225
159460|NCT00708643|367904|P2|NOT COMPLETED|Overall Study||1
159461|NCT00708643|367905|P1|NOT COMPLETED|Overall Study||0
159462|NCT00708643|367904|P2|COMPLETED|Overall Study||39
159463|NCT00708643|367905|P1|COMPLETED|Overall Study||40
159464|NCT00708643|367904|P2|STARTED|Overall Study||40
159465|NCT00708643|367905|P1|STARTED|Overall Study||40
159466|NCT00709761|367921|P1|NOT COMPLETED|Overall Study||47
159467|NCT00709761|367921|P1|COMPLETED|Overall Study||13
159468|NCT00709761|367921|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
159469|NCT00709761|367921|P1|STARTED|Overall Study||60
159470|NCT00709722|367930|P1|NOT COMPLETED|Overall Study||1
159471|NCT00709722|367930|P1|COMPLETED|Overall Study||20
159472|NCT00709722|367930|P1|STARTED|Overall Study||21
159473|NCT00709618|367936|P1|NOT COMPLETED|Overall Study||30
159474|NCT00709618|367936|P1|COMPLETED|Overall Study||14
159475|NCT00709618|367936|P1|STARTED|Overall Study||44
159476|NCT00709592|367948|P2|NOT COMPLETED|Overall Study||1
159477|NCT00709592|367949|P1|NOT COMPLETED|Overall Study||0
159478|NCT00709592|367948|P2|COMPLETED|Overall Study||22
159479|NCT00709592|367949|P1|COMPLETED|Overall Study||19
159480|NCT00709592|367948|P2|STARTED|Overall Study||23
159481|NCT00709592|367949|P1|STARTED|Overall Study||19
159482|NCT00709319|367969|P1|NOT COMPLETED|Overall Study||6
159483|NCT00709319|367969|P1|COMPLETED|Overall Study||81
159484|NCT00709319|367969|P1|STARTED|Overall Study||87
159485|NCT00709228|367977|P1|NOT COMPLETED|Overall Study||332
159486|NCT00709228|367977|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
159487|NCT00709228|367977|P1|STARTED|Overall Study||496
159488|NCT00709124|367983|P2|NOT COMPLETED|Overall Study||1
159489|NCT00709124|367984|P1|NOT COMPLETED|Overall Study||4
159490|NCT00709124|367983|P2|COMPLETED|Overall Study||17
159491|NCT00709124|367984|P1|COMPLETED|Overall Study||12
159492|NCT00709124|367983|P2|STARTED|Overall Study||18
159493|NCT00709124|367984|P1|STARTED|Overall Study||16
159494|NCT00709111|367990|P1|NOT COMPLETED|Overall Study||2
159495|NCT00709111|367990|P1|COMPLETED|Overall Study||32
159496|NCT00709111|367990|P1|Week 22/24|Overall Study||33
159497|NCT00709111|367990|P1|STARTED|Overall Study||34
159498|NCT00709098|368031|P3|NOT COMPLETED|Open-label Period||14
159499|NCT00709098|368032|P2|NOT COMPLETED|Open-label Period||0
159500|NCT00709098|368033|P1|NOT COMPLETED|Open-label Period||0
159501|NCT00709098|368031|P3|COMPLETED|Open-label Period||18
159502|NCT00709098|368032|P2|COMPLETED|Open-label Period||0
159503|NCT00709098|368033|P1|COMPLETED|Open-label Period||0
159504|NCT00709098|368031|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
159505|NCT00709098|368032|P2|STARTED|Open-label Period||0
159506|NCT00709098|368033|P1|STARTED|Open-label Period||0
159507|NCT00709098|368031|P3|NOT COMPLETED|Double-blind Period||0
159508|NCT00709098|368032|P2|NOT COMPLETED|Double-blind Period||8
159509|NCT00709098|368033|P1|NOT COMPLETED|Double-blind Period||6
159510|NCT00709098|368031|P3|COMPLETED|Double-blind Period||0
159511|NCT00709098|368032|P2|COMPLETED|Double-blind Period||16
159512|NCT00709098|368033|P1|COMPLETED|Double-blind Period||19
159513|NCT00709098|368031|P3|STARTED|Double-blind Period||0
159514|NCT00709098|368032|P2|STARTED|Double-blind Period||24
159515|NCT00709098|368033|P1|STARTED|Double-blind Period||25
159516|NCT00709059|368052|P1|NOT COMPLETED|Overall Study||94
159517|NCT00709059|368052|P1|COMPLETED|Overall Study||444
159518|NCT00709059|368052|P1|STARTED|Overall Study||538
159519|NCT00708942|368061|P5|NOT COMPLETED|Overall Study||1
159520|NCT00708942|368062|P4|NOT COMPLETED|Overall Study||0
159521|NCT00708942|368063|P3|NOT COMPLETED|Overall Study||2
159522|NCT00708942|368064|P2|NOT COMPLETED|Overall Study||1
159523|NCT00708942|368065|P1|NOT COMPLETED|Overall Study||7
159524|NCT00708942|368061|P5|COMPLETED|Overall Study||2
159525|NCT00708942|368062|P4|COMPLETED|Overall Study||10
159526|NCT00708942|368063|P3|COMPLETED|Overall Study||9
159527|NCT00708942|368064|P2|COMPLETED|Overall Study||11
159528|NCT00708942|368065|P1|COMPLETED|Overall Study||40
159529|NCT00708942|368061|P5|STARTED|Overall Study||3
159530|NCT00708942|368062|P4|STARTED|Overall Study||10
159531|NCT00708942|368063|P3|STARTED|Overall Study||11
159532|NCT00708942|368064|P2|STARTED|Overall Study||12
159533|NCT00708942|368065|P1|STARTED|Overall Study||47
159534|NCT00708877|368087|P1|NOT COMPLETED|Overall Study||0
159535|NCT00708877|368087|P1|COMPLETED|Overall Study||5
159536|NCT00708877|368087|P1|STARTED|Overall Study||5
159537|NCT00708851|368091|P1|NOT COMPLETED|Overall Study||0
159538|NCT00708851|368091|P1|COMPLETED|Overall Study||12
159539|NCT00708851|368091|P1|STARTED|Overall Study||12
159540|NCT00708526|368101|P2|NOT COMPLETED|Return of Cognitive Function||0
159541|NCT00708526|368102|P1|NOT COMPLETED|Return of Cognitive Function||0
159542|NCT00708526|368101|P2|COMPLETED|Return of Cognitive Function||11
159543|NCT00708526|368102|P1|COMPLETED|Return of Cognitive Function||11
159544|NCT00708526|368101|P2|STARTED|Return of Cognitive Function||11
159545|NCT00708526|368102|P1|STARTED|Return of Cognitive Function||11
159546|NCT00708526|368101|P2|NOT COMPLETED|Wake up After Anesthesia||0
159547|NCT00708526|368102|P1|NOT COMPLETED|Wake up After Anesthesia||0
159548|NCT00708526|368101|P2|COMPLETED|Wake up After Anesthesia||11
159549|NCT00708526|368102|P1|COMPLETED|Wake up After Anesthesia||11
159550|NCT00708526|368101|P2|STARTED|Wake up After Anesthesia||11
159551|NCT00708526|368102|P1|STARTED|Wake up After Anesthesia||11
159552|NCT00708500|368113|P3|NOT COMPLETED|FOLLOWUP||15
159553|NCT00708500|368114|P2|NOT COMPLETED|FOLLOWUP||15
159554|NCT00708500|368115|P1|NOT COMPLETED|FOLLOWUP||40
159555|NCT00708500|368113|P3|COMPLETED|FOLLOWUP||143
159556|NCT00708500|368114|P2|COMPLETED|FOLLOWUP||136
159557|NCT00708500|368115|P1|COMPLETED|FOLLOWUP||37
159558|NCT00708500|368113|P3|STARTED|FOLLOWUP||158
159559|NCT00708500|368114|P2|STARTED|FOLLOWUP||151
159560|NCT00708500|368115|P1|STARTED|FOLLOWUP||77
159561|NCT00708500|368113|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
159562|NCT00708500|368114|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
159563|NCT00708500|368115|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
159564|NCT00708500|368113|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
159565|NCT00708500|368114|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
159566|NCT00708500|368115|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
159567|NCT00708500|368113|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
159568|NCT00708500|368114|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
159569|NCT00708500|368115|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
159570|NCT00708500|368113|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
159571|NCT00708500|368114|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
159572|NCT00708500|368115|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
159573|NCT00708500|368113|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
159574|NCT00708500|368114|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
159575|NCT00708500|368115|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
159576|NCT00708500|368113|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
159577|NCT00708500|368114|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
159578|NCT00708500|368115|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
159579|NCT00708500|368113|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
159580|NCT00708500|368114|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
159581|NCT00708500|368115|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
159582|NCT00708461|368134|P2|NOT COMPLETED|Overall Study||200
159583|NCT00708461|368135|P1|NOT COMPLETED|Overall Study||141
159584|NCT00708461|368134|P2|COMPLETED|Overall Study||795
159585|NCT00708461|368135|P1|COMPLETED|Overall Study||611
159586|NCT00708461|368134|P2|STARTED|Overall Study||995
159587|NCT00708461|368135|P1|STARTED|Overall Study||752
159588|NCT00708435|368143|P2|NOT COMPLETED|Overall Study||17
159589|NCT00708435|368144|P1|NOT COMPLETED|Overall Study||25
159590|NCT00708435|368143|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
159591|NCT00708435|368144|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
159592|NCT00708435|368143|P2|STARTED|Overall Study||109
159593|NCT00708435|368144|P1|STARTED|Overall Study||107
159594|NCT00708422|368171|P2|NOT COMPLETED|Overall Study||1
159595|NCT00708422|368172|P1|NOT COMPLETED|Overall Study||4
159596|NCT00708422|368171|P2|COMPLETED|Overall Study||114
159597|NCT00708422|368172|P1|COMPLETED|Overall Study||112
159598|NCT00708422|368171|P2|STARTED|Overall Study||115
159599|NCT00708422|368172|P1|STARTED|Overall Study||116
159600|NCT00708305|368180|P4|NOT COMPLETED|Period 4||0
159601|NCT00708305|368181|P3|NOT COMPLETED|Period 4||0
159602|NCT00708305|368182|P2|NOT COMPLETED|Period 4||0
159603|NCT00708305|368183|P1|NOT COMPLETED|Period 4||0
159604|NCT00708305|368180|P4|COMPLETED|Period 4||14
159605|NCT00708305|368181|P3|COMPLETED|Period 4||14
159606|NCT00708305|368182|P2|COMPLETED|Period 4||14
159607|NCT00708305|368183|P1|COMPLETED|Period 4||12
159608|NCT00708305|368180|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
159609|NCT00708305|368181|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
159610|NCT00708305|368182|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
159611|NCT00708305|368183|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
159612|NCT00708305|368180|P4|NOT COMPLETED|Period 3||0
159613|NCT00708305|368181|P3|NOT COMPLETED|Period 3||0
159614|NCT00708305|368182|P2|NOT COMPLETED|Period 3||2
159615|NCT00708305|368183|P1|NOT COMPLETED|Period 3||1
159616|NCT00708305|368180|P4|COMPLETED|Period 3||14
159617|NCT00708305|368181|P3|COMPLETED|Period 3||14
159618|NCT00708305|368182|P2|COMPLETED|Period 3||12
159619|NCT00708305|368183|P1|COMPLETED|Period 3||14
159620|NCT00708305|368180|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
159621|NCT00708305|368181|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
159622|NCT00708305|368182|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
159623|NCT00708305|368183|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
159624|NCT00708305|368180|P4|NOT COMPLETED|Period 2||1
159625|NCT00708305|368181|P3|NOT COMPLETED|Period 2||0
159626|NCT00708305|368182|P2|NOT COMPLETED|Period 2||2
159627|NCT00708305|368183|P1|NOT COMPLETED|Period 2||1
159628|NCT00708305|368180|P4|COMPLETED|Period 2||14
159629|NCT00708305|368181|P3|COMPLETED|Period 2||16
159630|NCT00708305|368182|P2|COMPLETED|Period 2||13
159631|NCT00708305|368183|P1|COMPLETED|Period 2||14
159632|NCT00708305|368180|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
159633|NCT00708305|368181|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
159634|NCT00708305|368182|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
159635|NCT00708305|368183|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
159636|NCT00708305|368180|P4|NOT COMPLETED|Period 1||2
159637|NCT00708305|368181|P3|NOT COMPLETED|Period 1||1
159638|NCT00708305|368182|P2|NOT COMPLETED|Period 1||0
159639|NCT00708305|368183|P1|NOT COMPLETED|Period 1||1
159640|NCT00708305|368180|P4|COMPLETED|Period 1||14
159641|NCT00708305|368181|P3|COMPLETED|Period 1||16
159642|NCT00708305|368182|P2|COMPLETED|Period 1||16
159643|NCT00708305|368183|P1|COMPLETED|Period 1||15
159644|NCT00708305|368180|P4|STARTED|Period 1||16
159645|NCT00708305|368181|P3|STARTED|Period 1||17
159646|NCT00708305|368182|P2|STARTED|Period 1||16
159647|NCT00708305|368183|P1|STARTED|Period 1||16
159648|NCT00708214|368218|P3|NOT COMPLETED|Overall Study||8
159649|NCT00708214|368219|P2|NOT COMPLETED|Overall Study||13
159650|NCT00708214|368220|P1|NOT COMPLETED|Overall Study||7
159651|NCT00708214|368218|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
159652|NCT00708214|368219|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
159653|NCT00708214|368220|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
159654|NCT00708214|368218|P3|STARTED|Overall Study||8
159655|NCT00708214|368219|P2|STARTED|Overall Study||13
159656|NCT00708214|368220|P1|STARTED|Overall Study||7
159657|NCT00708201|368263|P2|NOT COMPLETED|Overall Study||6
159658|NCT00708201|368264|P1|NOT COMPLETED|Overall Study||7
159659|NCT00708201|368263|P2|COMPLETED|Overall Study||137
159660|NCT00708201|368264|P1|COMPLETED|Overall Study||130
159661|NCT00708201|368263|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
159662|NCT00708201|368264|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
159663|NCT00708201|368263|P2|STARTED|Overall Study||143
159664|NCT00708201|368264|P1|STARTED|Overall Study||137
159665|NCT00708175|368288|P2|NOT COMPLETED|Overall Study||21
159666|NCT00708175|368289|P1|NOT COMPLETED|Overall Study||18
159667|NCT00708175|368288|P2|COMPLETED|Overall Study||57
159668|NCT00708175|368289|P1|COMPLETED|Overall Study||60
159669|NCT00708175|368288|P2|STARTED|Overall Study||78
159670|NCT00708175|368289|P1|STARTED|Overall Study||78
159671|NCT00708162|368305|P2|NOT COMPLETED|Open-Label Phase||30
159672|NCT00708162|368306|P1|NOT COMPLETED|Open-Label Phase||44
159673|NCT00708162|368305|P2|COMPLETED|Open-Label Phase||121
159674|NCT00708162|368306|P1|COMPLETED|Open-Label Phase||152
159675|NCT00708162|368305|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
159676|NCT00708162|368306|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
159677|NCT00708162|368305|P2|NOT COMPLETED|Randomized Phase||154
159678|NCT00708162|368306|P1|NOT COMPLETED|Randomized Phase||156
159679|NCT00708162|368305|P2|COMPLETED|Randomized Phase||209
159680|NCT00708162|368306|P1|COMPLETED|Randomized Phase||205
159681|NCT00708162|368305|P2|Randomized and Treated|Randomized Phase||358
159682|NCT00708162|368306|P1|Randomized and Treated|Randomized Phase||354
159683|NCT00708162|368305|P2|STARTED|Randomized Phase||363
159684|NCT00708162|368306|P1|STARTED|Randomized Phase||361
159685|NCT00708123|368347|P5|NOT COMPLETED|Period 5||0
159686|NCT00708123|368348|P4|NOT COMPLETED|Period 5||0
159687|NCT00708123|368349|P3|NOT COMPLETED|Period 5||0
159688|NCT00708123|368350|P2|NOT COMPLETED|Period 5||0
159689|NCT00708123|368351|P1|NOT COMPLETED|Period 5||0
159690|NCT00708123|368347|P5|COMPLETED|Period 5||10
159691|NCT00708123|368348|P4|COMPLETED|Period 5||11
159692|NCT00708123|368349|P3|COMPLETED|Period 5||11
159693|NCT00708123|368350|P2|COMPLETED|Period 5||10
159694|NCT00708123|368351|P1|COMPLETED|Period 5||10
159695|NCT00708123|368347|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
159696|NCT00708123|368348|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
159697|NCT00708123|368349|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
159698|NCT00708123|368350|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
159699|NCT00708123|368351|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
159700|NCT00708123|368347|P5|NOT COMPLETED|Period 4||0
159701|NCT00708123|368348|P4|NOT COMPLETED|Period 4||0
159702|NCT00708123|368349|P3|NOT COMPLETED|Period 4||0
159703|NCT00708123|368350|P2|NOT COMPLETED|Period 4||1
159704|NCT00708123|368351|P1|NOT COMPLETED|Period 4||0
159705|NCT00708123|368347|P5|COMPLETED|Period 4||11
159706|NCT00708123|368348|P4|COMPLETED|Period 4||10
159707|NCT00708123|368349|P3|COMPLETED|Period 4||10
159708|NCT00708123|368350|P2|COMPLETED|Period 4||11
159709|NCT00708123|368351|P1|COMPLETED|Period 4||10
159710|NCT00708123|368347|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
159711|NCT00708123|368348|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
159712|NCT00708123|368349|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
159713|NCT00708123|368350|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
159714|NCT00708123|368351|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
159715|NCT00708123|368347|P5|NOT COMPLETED|Period 3||0
159716|NCT00708123|368348|P4|NOT COMPLETED|Period 3||1
159717|NCT00708123|368349|P3|NOT COMPLETED|Period 3||1
159718|NCT00708123|368350|P2|NOT COMPLETED|Period 3||0
159719|NCT00708123|368351|P1|NOT COMPLETED|Period 3||0
159720|NCT00708123|368347|P5|COMPLETED|Period 3||10
159721|NCT00708123|368348|P4|COMPLETED|Period 3||11
159722|NCT00708123|368349|P3|COMPLETED|Period 3||10
159723|NCT00708123|368350|P2|COMPLETED|Period 3||10
159724|NCT00708123|368351|P1|COMPLETED|Period 3||12
159725|NCT00708123|368347|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
159726|NCT00708123|368348|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
159727|NCT00708123|368349|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
159728|NCT00708123|368350|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
159729|NCT00708123|368351|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
159730|NCT00708123|368347|P5|NOT COMPLETED|Period 2||0
159731|NCT00708123|368348|P4|NOT COMPLETED|Period 2||1
159732|NCT00708123|368349|P3|NOT COMPLETED|Period 2||0
159733|NCT00708123|368350|P2|NOT COMPLETED|Period 2||0
159734|NCT00708123|368351|P1|NOT COMPLETED|Period 2||1
159735|NCT00708123|368347|P5|COMPLETED|Period 2||11
159736|NCT00708123|368348|P4|COMPLETED|Period 2||10
159737|NCT00708123|368349|P3|COMPLETED|Period 2||12
159738|NCT00708123|368350|P2|COMPLETED|Period 2||12
159739|NCT00708123|368351|P1|COMPLETED|Period 2||10
159740|NCT00708123|368347|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
159741|NCT00708123|368348|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
159742|NCT00708123|368349|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
159743|NCT00708123|368350|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
159744|NCT00708123|368351|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
159745|NCT00708123|368347|P5|NOT COMPLETED|Period 1||0
159746|NCT00708123|368348|P4|NOT COMPLETED|Period 1||1
159747|NCT00708123|368349|P3|NOT COMPLETED|Period 1||1
159748|NCT00708123|368350|P2|NOT COMPLETED|Period 1||1
159749|NCT00708123|368351|P1|NOT COMPLETED|Period 1||0
159750|NCT00708123|368347|P5|COMPLETED|Period 1||12
159751|NCT00708123|368348|P4|COMPLETED|Period 1||11
159752|NCT00708123|368349|P3|COMPLETED|Period 1||11
159753|NCT00708123|368350|P2|COMPLETED|Period 1||11
159754|NCT00708123|368351|P1|COMPLETED|Period 1||12
159755|NCT00708123|368347|P5|STARTED|Period 1||12
159756|NCT00708123|368348|P4|STARTED|Period 1||12
159757|NCT00708123|368349|P3|STARTED|Period 1||12
159758|NCT00708123|368350|P2|STARTED|Period 1||12
159759|NCT00708123|368351|P1|STARTED|Period 1||12
159760|NCT00708110|368375|P4|NOT COMPLETED|Overall Study||0
159761|NCT00708110|368376|P3|NOT COMPLETED|Overall Study||0
159762|NCT00708110|368377|P2|NOT COMPLETED|Overall Study||0
159763|NCT00708110|368378|P1|NOT COMPLETED|Overall Study||0
159764|NCT00708110|368375|P4|COMPLETED|Overall Study||10
159765|NCT00708110|368376|P3|COMPLETED|Overall Study||9
159766|NCT00708110|368377|P2|COMPLETED|Overall Study||9
159767|NCT00708110|368378|P1|COMPLETED|Overall Study||7
159768|NCT00708110|368375|P4|STARTED|Overall Study||10
159769|NCT00708110|368376|P3|STARTED|Overall Study||9
159770|NCT00708110|368377|P2|STARTED|Overall Study||9
159771|NCT00708110|368378|P1|STARTED|Overall Study||7
159772|NCT00708097|368484|P5|NOT COMPLETED|Period 5||0
159773|NCT00708097|368485|P4|NOT COMPLETED|Period 5||0
159774|NCT00708097|368486|P3|NOT COMPLETED|Period 5||0
159775|NCT00708097|368487|P2|NOT COMPLETED|Period 5||0
159776|NCT00708097|368488|P1|NOT COMPLETED|Period 5||0
159777|NCT00708097|368484|P5|COMPLETED|Period 5||12
159778|NCT00708097|368485|P4|COMPLETED|Period 5||10
159779|NCT00708097|368486|P3|COMPLETED|Period 5||11
159780|NCT00708097|368487|P2|COMPLETED|Period 5||9
159781|NCT00708097|368488|P1|COMPLETED|Period 5||8
159782|NCT00708097|368484|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
159783|NCT00708097|368485|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
159784|NCT00708097|368486|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
159785|NCT00708097|368487|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
159786|NCT00708097|368488|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
159787|NCT00708097|368484|P5|NOT COMPLETED|Period 4||0
159788|NCT00708097|368485|P4|NOT COMPLETED|Period 4||0
159789|NCT00708097|368486|P3|NOT COMPLETED|Period 4||0
159790|NCT00708097|368487|P2|NOT COMPLETED|Period 4||0
159791|NCT00708097|368488|P1|NOT COMPLETED|Period 4||0
159792|NCT00708097|368484|P5|COMPLETED|Period 4||8
159793|NCT00708097|368485|P4|COMPLETED|Period 4||11
159794|NCT00708097|368486|P3|COMPLETED|Period 4||10
159795|NCT00708097|368487|P2|COMPLETED|Period 4||9
159796|NCT00708097|368488|P1|COMPLETED|Period 4||12
159797|NCT00708097|368484|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
159798|NCT00708097|368485|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
159799|NCT00708097|368486|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
159800|NCT00708097|368487|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
159801|NCT00708097|368488|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
159802|NCT00708097|368484|P5|NOT COMPLETED|Period 3||0
159803|NCT00708097|368485|P4|NOT COMPLETED|Period 3||0
159804|NCT00708097|368486|P3|NOT COMPLETED|Period 3||0
159805|NCT00708097|368487|P2|NOT COMPLETED|Period 3||0
159806|NCT00708097|368488|P1|NOT COMPLETED|Period 3||0
159807|NCT00708097|368484|P5|COMPLETED|Period 3||10
159808|NCT00708097|368485|P4|COMPLETED|Period 3||10
159809|NCT00708097|368486|P3|COMPLETED|Period 3||10
159810|NCT00708097|368487|P2|COMPLETED|Period 3||11
159811|NCT00708097|368488|P1|COMPLETED|Period 3||9
159812|NCT00708097|368484|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
159813|NCT00708097|368485|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
159814|NCT00708097|368486|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
159815|NCT00708097|368487|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
159816|NCT00708097|368488|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
159817|NCT00708097|368484|P5|NOT COMPLETED|Period 2||0
159818|NCT00708097|368485|P4|NOT COMPLETED|Period 2||1
159819|NCT00708097|368486|P3|NOT COMPLETED|Period 2||1
159820|NCT00708097|368487|P2|NOT COMPLETED|Period 2||1
159821|NCT00708097|368488|P1|NOT COMPLETED|Period 2||0
159822|NCT00708097|368484|P5|COMPLETED|Period 2||10
159823|NCT00708097|368485|P4|COMPLETED|Period 2||10
159824|NCT00708097|368486|P3|COMPLETED|Period 2||9
159825|NCT00708097|368487|P2|COMPLETED|Period 2||11
159826|NCT00708097|368488|P1|COMPLETED|Period 2||10
159827|NCT00708097|368484|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
159828|NCT00708097|368485|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
159829|NCT00708097|368486|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
159830|NCT00708097|368487|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
159831|NCT00708097|368488|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
159832|NCT00708097|368484|P5|NOT COMPLETED|Period 1||1
159833|NCT00708097|368485|P4|NOT COMPLETED|Period 1||2
159834|NCT00708097|368486|P3|NOT COMPLETED|Period 1||0
159835|NCT00708097|368487|P2|NOT COMPLETED|Period 1||1
159836|NCT00708097|368488|P1|NOT COMPLETED|Period 1||0
159837|NCT00708097|368484|P5|COMPLETED|Period 1||10
159838|NCT00708097|368485|P4|COMPLETED|Period 1||9
159839|NCT00708097|368486|P3|COMPLETED|Period 1||12
159840|NCT00708097|368487|P2|COMPLETED|Period 1||11
159841|NCT00708097|368488|P1|COMPLETED|Period 1||11
159842|NCT00708097|368484|P5|STARTED|Period 1||11
159843|NCT00708097|368485|P4|STARTED|Period 1||11
159844|NCT00708097|368486|P3|STARTED|Period 1||12
159845|NCT00708097|368487|P2|STARTED|Period 1||12
159846|NCT00708097|368488|P1|STARTED|Period 1||11
159847|NCT00708071|368518|P1|NOT COMPLETED|Overall Study||0
159848|NCT00708071|368518|P1|COMPLETED|Overall Study||45
159849|NCT00708071|368518|P1|STARTED|Overall Study|Randomized and treated|45
159850|NCT00708032|368598|P2|NOT COMPLETED|Overall Study||16
159851|NCT00708032|368599|P1|NOT COMPLETED|Overall Study||10
159852|NCT00708032|368598|P2|COMPLETED|Overall Study||22
159853|NCT00708032|368599|P1|COMPLETED|Overall Study||26
159854|NCT00708032|368598|P2|STARTED|Overall Study||38
159855|NCT00708032|368599|P1|STARTED|Overall Study||36
159856|NCT00708019|368615|P2|NOT COMPLETED|Overall Study||15
159857|NCT00708019|368616|P1|NOT COMPLETED|Overall Study||15
159858|NCT00708019|368615|P2|COMPLETED|Overall Study||78
159859|NCT00708019|368616|P1|COMPLETED|Overall Study||77
159860|NCT00708019|368615|P2|STARTED|Overall Study||93
159861|NCT00708019|368616|P1|STARTED|Overall Study||92
159862|NCT00707993|368626|P2|NOT COMPLETED|Overall Study||94
159863|NCT00707993|368627|P1|NOT COMPLETED|Overall Study||89
159864|NCT00707993|368626|P2|COMPLETED|Overall Study||125
159865|NCT00707993|368627|P1|COMPLETED|Overall Study||133
159866|NCT00707993|368626|P2|STARTED|Overall Study||219
159867|NCT00707993|368627|P1|STARTED|Overall Study||222
159868|NCT00707980|368669|P1|NOT COMPLETED|Overall Study||310
159869|NCT00707980|368669|P1|COMPLETED|Overall Study||526
159870|NCT00707980|368669|P1|Received Treatment|Overall Study||834
159871|NCT00707980|368669|P1|STARTED|Overall Study||836
159872|NCT00707967|368687|P3|NOT COMPLETED|Overall Study||0
159873|NCT00707967|368688|P2|NOT COMPLETED|Overall Study||0
159874|NCT00707967|368689|P1|NOT COMPLETED|Overall Study||0
159875|NCT00707967|368687|P3|COMPLETED|Overall Study||7
159876|NCT00707967|368688|P2|COMPLETED|Overall Study||8
159877|NCT00707967|368689|P1|COMPLETED|Overall Study||22
159878|NCT00707967|368687|P3|STARTED|Overall Study||7
159879|NCT00707967|368688|P2|STARTED|Overall Study||8
159880|NCT00707967|368689|P1|STARTED|Overall Study||22
159881|NCT00707954|368753|P5|NOT COMPLETED|Overall Study||1
159882|NCT00707954|368754|P4|NOT COMPLETED|Overall Study||0
159883|NCT00707954|368755|P3|NOT COMPLETED|Overall Study||0
159884|NCT00707954|368756|P2|NOT COMPLETED|Overall Study||0
159885|NCT00707954|368757|P1|NOT COMPLETED|Overall Study||0
159886|NCT00707954|368753|P5|COMPLETED|Overall Study||9
159887|NCT00707954|368754|P4|COMPLETED|Overall Study||13
159888|NCT00707954|368755|P3|COMPLETED|Overall Study||14
159889|NCT00707954|368756|P2|COMPLETED|Overall Study||12
159890|NCT00707954|368757|P1|COMPLETED|Overall Study||12
159891|NCT00707954|368753|P5|STARTED|Overall Study||10
159892|NCT00707954|368754|P4|STARTED|Overall Study||13
159893|NCT00707954|368755|P3|STARTED|Overall Study||14
159894|NCT00707954|368756|P2|STARTED|Overall Study||12
159895|NCT00707954|368757|P1|STARTED|Overall Study||12
159896|NCT00707915|368769|P1|NOT COMPLETED|Overall Study||0
159897|NCT00707915|368769|P1|COMPLETED|Overall Study||30
159898|NCT00707915|368769|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
159899|NCT00707915|368769|P1|STARTED|Overall Study||30
159900|NCT00707863|368780|P2|NOT COMPLETED|Overall Study||3
159901|NCT00707863|368781|P1|NOT COMPLETED|Overall Study||0
159902|NCT00707863|368780|P2|COMPLETED|Overall Study||8
159903|NCT00707863|368781|P1|COMPLETED|Overall Study||6
159904|NCT00707863|368780|P2|STARTED|Overall Study||11
159905|NCT00707863|368781|P1|STARTED|Overall Study||6
159906|NCT00707759|368789|P2|NOT COMPLETED|Overall Study||2
159907|NCT00707759|368790|P1|NOT COMPLETED|Overall Study||2
159908|NCT00707759|368789|P2|COMPLETED|Overall Study||12
159909|NCT00707759|368790|P1|COMPLETED|Overall Study||12
159910|NCT00707759|368789|P2|STARTED|Overall Study||14
159911|NCT00707759|368790|P1|STARTED|Overall Study||14
159912|NCT00707746|368798|P2|NOT COMPLETED|Follow-up Period||0
159913|NCT00707746|368799|P1|NOT COMPLETED|Follow-up Period||0
159914|NCT00707746|368798|P2|COMPLETED|Follow-up Period||21
159915|NCT00707746|368799|P1|COMPLETED|Follow-up Period||12
159916|NCT00707746|368798|P2|STARTED|Follow-up Period||21
159917|NCT00707746|368799|P1|STARTED|Follow-up Period||12
159918|NCT00707746|368798|P2|NOT COMPLETED|Treatment Period||5
159919|NCT00707746|368799|P1|NOT COMPLETED|Treatment Period||2
159920|NCT00707746|368798|P2|COMPLETED|Treatment Period||17
159921|NCT00707746|368799|P1|COMPLETED|Treatment Period||10
159922|NCT00707746|368798|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
159923|NCT00707746|368799|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
159924|NCT00707746|368798|P2|STARTED|Treatment Period||22
159925|NCT00707746|368799|P1|STARTED|Treatment Period||12
159926|NCT00707655|368847|P2|NOT COMPLETED|Overall Study||2
159927|NCT00707655|368848|P1|NOT COMPLETED|Overall Study||0
159928|NCT00707655|368847|P2|COMPLETED|Overall Study||3
159929|NCT00707655|368848|P1|COMPLETED|Overall Study||3
159930|NCT00707655|368847|P2|STARTED|Overall Study||5
159931|NCT00707655|368848|P1|STARTED|Overall Study||3
159932|NCT00707486|368858|P1|NOT COMPLETED|Overall Study||1
159933|NCT00707486|368858|P1|COMPLETED|Overall Study||71
159934|NCT00707486|368858|P1|STARTED|Overall Study||72
159935|NCT00707447|368869|P2|NOT COMPLETED|Overall Study||8
159936|NCT00707447|368870|P1|NOT COMPLETED|Overall Study||8
159937|NCT00707447|368869|P2|COMPLETED|Overall Study||85
159938|NCT00707447|368870|P1|COMPLETED|Overall Study||81
159939|NCT00707447|368869|P2|STARTED|Overall Study||93
159940|NCT00707447|368870|P1|STARTED|Overall Study||89
159941|NCT00707343|368894|P1|NOT COMPLETED|Overall Study||0
159942|NCT00707343|368894|P1|COMPLETED|Overall Study||15
159943|NCT00707343|368894|P1|STARTED|Overall Study||15
159944|NCT00707239|368901|P3|NOT COMPLETED|Overall Study||14
159945|NCT00707239|368902|P2|NOT COMPLETED|Overall Study||11
159946|NCT00707239|368903|P1|NOT COMPLETED|Overall Study||19
159947|NCT00707239|368901|P3|COMPLETED|Overall Study||21
159948|NCT00707239|368902|P2|COMPLETED|Overall Study||25
159949|NCT00707239|368903|P1|COMPLETED|Overall Study||18
159950|NCT00707239|368901|P3|Treated|Overall Study||34
159951|NCT00707239|368902|P2|Treated|Overall Study||35
159952|NCT00707239|368903|P1|Treated|Overall Study||36
159953|NCT00707239|368901|P3|STARTED|Overall Study||35
159954|NCT00707239|368902|P2|STARTED|Overall Study||36
159955|NCT00707239|368903|P1|STARTED|Overall Study||37
159956|NCT00707174|368951|P2|NOT COMPLETED|Overall Study||7
159957|NCT00707174|368952|P1|NOT COMPLETED|Overall Study||5
159958|NCT00707174|368951|P2|COMPLETED|Overall Study||37
159959|NCT00707174|368952|P1|COMPLETED|Overall Study||41
159960|NCT00707174|368951|P2|STARTED|Overall Study||44
159961|NCT00707174|368952|P1|STARTED|Overall Study||46
159962|NCT00707161|368958|P1|NOT COMPLETED|Overall Study||6
159963|NCT00707161|368958|P1|COMPLETED|Overall Study||0
159964|NCT00707161|368958|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
159965|NCT00707057|368964|P2|NOT COMPLETED|Overall Study||4
159966|NCT00707057|368965|P1|NOT COMPLETED|Overall Study||8
159967|NCT00707057|368964|P2|COMPLETED|Overall Study||83
159968|NCT00707057|368965|P1|COMPLETED|Overall Study||161
159969|NCT00707057|368964|P2|STARTED|Overall Study||87
159970|NCT00707057|368965|P1|STARTED|Overall Study||169
159971|NCT00707031|368999|P2|NOT COMPLETED|Overall Study||99
159972|NCT00707031|369000|P1|NOT COMPLETED|Overall Study||104
159973|NCT00707031|368999|P2|COMPLETED|Overall Study||220
159974|NCT00707031|369000|P1|COMPLETED|Overall Study||216
159975|NCT00707031|368999|P2|Modified Intent-to-Treat Population|Overall Study||315
159976|NCT00707031|369000|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
159977|NCT00707031|368999|P2|Treated/Safety Population|Overall Study||316
159978|NCT00707031|369000|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
159979|NCT00707031|368999|P2|STARTED|Overall Study||319
159980|NCT00707031|369000|P1|STARTED|Overall Study|Randomized|320
159981|NCT00706992|369029|P7|NOT COMPLETED|Overall Study||3
159982|NCT00706992|369030|P6|NOT COMPLETED|Overall Study||2
159983|NCT00706992|369031|P5|NOT COMPLETED|Overall Study||4
159984|NCT00706992|369032|P4|NOT COMPLETED|Overall Study||2
159985|NCT00706992|369033|P3|NOT COMPLETED|Overall Study||6
159986|NCT00706992|369034|P2|NOT COMPLETED|Overall Study||5
159987|NCT00706992|369035|P1|NOT COMPLETED|Overall Study||5
159988|NCT00706992|369029|P7|COMPLETED|Overall Study||3
159989|NCT00706992|369030|P6|COMPLETED|Overall Study||3
159990|NCT00706992|369031|P5|COMPLETED|Overall Study||2
159991|NCT00706992|369032|P4|COMPLETED|Overall Study||6
159992|NCT00706992|369033|P3|COMPLETED|Overall Study||3
159993|NCT00706992|369034|P2|COMPLETED|Overall Study||3
159994|NCT00706992|369035|P1|COMPLETED|Overall Study||3
159995|NCT00706992|369029|P7|STARTED|Overall Study||6
159996|NCT00706992|369030|P6|STARTED|Overall Study||5
159997|NCT00706992|369031|P5|STARTED|Overall Study||6
159998|NCT00706992|369032|P4|STARTED|Overall Study||8
159999|NCT00706992|369033|P3|STARTED|Overall Study||9
160000|NCT00706992|369034|P2|STARTED|Overall Study||8
160001|NCT00706992|369035|P1|STARTED|Overall Study||8
160002|NCT00706979|369054|P2|NOT COMPLETED|Overall Study||0
160003|NCT00706979|369055|P1|NOT COMPLETED|Overall Study||0
160004|NCT00706979|369054|P2|COMPLETED|Overall Study||423
160005|NCT00706979|369055|P1|COMPLETED|Overall Study||426
160006|NCT00706979|369054|P2|STARTED|Overall Study||423
160007|NCT00706979|369055|P1|STARTED|Overall Study||426
160008|NCT00706966|369067|P1|NOT COMPLETED|Overall Study||1
160009|NCT00706966|369067|P1|COMPLETED|Overall Study||9
160010|NCT00706966|369067|P1|STARTED|Overall Study||10
160011|NCT00706901|369103|P3|NOT COMPLETED|Overall Study||8
160012|NCT00706901|369104|P2|NOT COMPLETED|Overall Study||5
160013|NCT00706901|369105|P1|NOT COMPLETED|Overall Study||8
160014|NCT00706901|369103|P3|COMPLETED|Overall Study||51
160015|NCT00706901|369104|P2|COMPLETED|Overall Study||57
160016|NCT00706901|369105|P1|COMPLETED|Overall Study||51
160017|NCT00706901|369103|P3|STARTED|Overall Study||59
160018|NCT00706901|369104|P2|STARTED|Overall Study||62
160019|NCT00706901|369105|P1|STARTED|Overall Study||59
160020|NCT00706849|369130|P2|NOT COMPLETED|Follow-up Period||3
160021|NCT00706849|369131|P1|NOT COMPLETED|Follow-up Period||0
160022|NCT00706849|369130|P2|COMPLETED|Follow-up Period||25
160023|NCT00706849|369131|P1|COMPLETED|Follow-up Period||3
160024|NCT00706849|369130|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
160025|NCT00706849|369131|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
160026|NCT00706849|369130|P2|NOT COMPLETED|Treatment Period||10
160027|NCT00706849|369131|P1|NOT COMPLETED|Treatment Period||0
160028|NCT00706849|369130|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
160029|NCT00706849|369131|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
160030|NCT00706849|369130|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
160031|NCT00706849|369131|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
160032|NCT00706849|369130|P2|STARTED|Treatment Period||83
160033|NCT00706849|369131|P1|STARTED|Treatment Period||41
160034|NCT00706836|369175|P1|NOT COMPLETED|Overall Study||0
160035|NCT00706836|369175|P1|COMPLETED|Overall Study||16
160036|NCT00706836|369175|P1|STARTED|Overall Study||16
160037|NCT00706823|369185|P2|NOT COMPLETED|Overall Study||0
160038|NCT00706823|369186|P1|NOT COMPLETED|Overall Study||0
160039|NCT00706823|369185|P2|COMPLETED|Overall Study||25
160040|NCT00706823|369186|P1|COMPLETED|Overall Study||25
160041|NCT00706823|369185|P2|STARTED|Overall Study||25
160042|NCT00706823|369186|P1|STARTED|Overall Study||25
160043|NCT00706797|369204|P2|NOT COMPLETED|Overall Study||71
160044|NCT00706797|369205|P1|NOT COMPLETED|Overall Study||69
160045|NCT00706797|369204|P2|COMPLETED|Overall Study||0
160046|NCT00706797|369205|P1|COMPLETED|Overall Study||1
160047|NCT00706797|369204|P2|Safety Population|Overall Study||71
160048|NCT00706797|369205|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
160049|NCT00706797|369204|P2|STARTED|Overall Study||71
160050|NCT00706797|369205|P1|STARTED|Overall Study||70
160051|NCT00706784|369247|P2|NOT COMPLETED|Overall Study||0
160052|NCT00706784|369248|P1|NOT COMPLETED|Overall Study||0
160053|NCT00706784|369247|P2|COMPLETED|Overall Study||3
160054|NCT00706784|369248|P1|COMPLETED|Overall Study||3
160055|NCT00706784|369247|P2|STARTED|Overall Study||3
160056|NCT00706784|369248|P1|STARTED|Overall Study||3
160057|NCT00706719|369257|P3|NOT COMPLETED|Overall Study||4
160058|NCT00706719|369258|P2|NOT COMPLETED|Overall Study||1
160059|NCT00706719|369259|P1|NOT COMPLETED|Overall Study||0
160060|NCT00706719|369257|P3|COMPLETED|Overall Study||1
160061|NCT00706719|369258|P2|COMPLETED|Overall Study||6
160062|NCT00706719|369259|P1|COMPLETED|Overall Study||5
160063|NCT00706719|369257|P3|STARTED|Overall Study||5
160064|NCT00706719|369258|P2|STARTED|Overall Study||7
160065|NCT00706719|369259|P1|STARTED|Overall Study||5
160066|NCT00706706|369274|P1|NOT COMPLETED|Overall Study||105
160067|NCT00706706|369274|P1|COMPLETED|Overall Study||0
160068|NCT00706706|369274|P1|STARTED|Overall Study||105
160069|NCT00706654|369284|P4|NOT COMPLETED|Depot Maintenance Phase||70
160070|NCT00706654|369285|P3|NOT COMPLETED|Depot Maintenance Phase||88
160071|NCT00706654|369286|P2|NOT COMPLETED|Depot Maintenance Phase||69
160072|NCT00706654|369287|P1|NOT COMPLETED|Depot Maintenance Phase||0
160073|NCT00706654|369284|P4|COMPLETED|Depot Maintenance Phase||61
160074|NCT00706654|369285|P3|COMPLETED|Depot Maintenance Phase||178
160075|NCT00706654|369286|P2|COMPLETED|Depot Maintenance Phase||196
160076|NCT00706654|369287|P1|COMPLETED|Depot Maintenance Phase||0
160077|NCT00706654|369284|P4|STARTED|Depot Maintenance Phase||131
160078|NCT00706654|369285|P3|STARTED|Depot Maintenance Phase||266
160079|NCT00706654|369286|P2|STARTED|Depot Maintenance Phase||265
160080|NCT00706654|369287|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
160081|NCT00706654|369284|P4|NOT COMPLETED|Oral Stabilization Phase||0
160082|NCT00706654|369285|P3|NOT COMPLETED|Oral Stabilization Phase||0
160083|NCT00706654|369286|P2|NOT COMPLETED|Oral Stabilization Phase||0
160084|NCT00706654|369287|P1|NOT COMPLETED|Oral Stabilization Phase||180
160085|NCT00706654|369284|P4|COMPLETED|Oral Stabilization Phase||0
160086|NCT00706654|369285|P3|COMPLETED|Oral Stabilization Phase||0
160087|NCT00706654|369286|P2|COMPLETED|Oral Stabilization Phase||0
160088|NCT00706654|369287|P1|COMPLETED|Oral Stabilization Phase||662
160089|NCT00706654|369284|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160090|NCT00706654|369285|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160091|NCT00706654|369286|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160092|NCT00706654|369287|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
160093|NCT00706654|369284|P4|NOT COMPLETED|Conversion Phase||0
160094|NCT00706654|369285|P3|NOT COMPLETED|Conversion Phase||0
160095|NCT00706654|369286|P2|NOT COMPLETED|Conversion Phase||0
160096|NCT00706654|369287|P1|NOT COMPLETED|Conversion Phase||95
160097|NCT00706654|369284|P4|COMPLETED|Conversion Phase||0
160098|NCT00706654|369285|P3|COMPLETED|Conversion Phase||0
160099|NCT00706654|369286|P2|COMPLETED|Conversion Phase||0
160100|NCT00706654|369287|P1|COMPLETED|Conversion Phase||614
160101|NCT00706654|369284|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
160102|NCT00706654|369285|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
160103|NCT00706654|369286|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
160104|NCT00706654|369287|P1|STARTED|Conversion Phase||709
160105|NCT00706641|369306|P1|NOT COMPLETED|Radical Cystectomy||1
160106|NCT00706641|369306|P1|COMPLETED|Radical Cystectomy||22
160107|NCT00706641|369306|P1|STARTED|Radical Cystectomy||23
160108|NCT00706641|369306|P1|NOT COMPLETED|Dasatinib Administration||2
160109|NCT00706641|369306|P1|COMPLETED|Dasatinib Administration||23
160110|NCT00706641|369306|P1|Toxicity Evaluation|Dasatinib Administration||24
160111|NCT00706641|369306|P1|STARTED|Dasatinib Administration||25
160112|NCT00706628|369320|P4|NOT COMPLETED|Overall Study||3
160113|NCT00706628|369321|P3|NOT COMPLETED|Overall Study||16
160114|NCT00706628|369322|P2|NOT COMPLETED|Overall Study||21
160115|NCT00706628|369323|P1|NOT COMPLETED|Overall Study||47
160116|NCT00706628|369320|P4|COMPLETED|Overall Study||0
160117|NCT00706628|369321|P3|COMPLETED|Overall Study||0
160118|NCT00706628|369322|P2|COMPLETED|Overall Study||0
160119|NCT00706628|369323|P1|COMPLETED|Overall Study||0
160120|NCT00706628|369320|P4|STARTED|Overall Study||3
160121|NCT00706628|369321|P3|STARTED|Overall Study||16
160122|NCT00706628|369322|P2|STARTED|Overall Study||21
160123|NCT00706628|369323|P1|STARTED|Overall Study||47
160124|NCT00706589|369373|P2|NOT COMPLETED|Overall Study||4
160125|NCT00706589|369374|P1|NOT COMPLETED|Overall Study||3
160126|NCT00706589|369373|P2|COMPLETED|Overall Study||25
160127|NCT00706589|369374|P1|COMPLETED|Overall Study||29
160128|NCT00706589|369373|P2|STARTED|Overall Study||29
160129|NCT00706589|369374|P1|STARTED|Overall Study||32
160130|NCT00706563|369382|P2|NOT COMPLETED|Overall Study||0
160131|NCT00706563|369383|P1|NOT COMPLETED|Overall Study||0
160132|NCT00706563|369382|P2|COMPLETED|Overall Study||59
160133|NCT00706563|369383|P1|COMPLETED|Overall Study||61
160134|NCT00706563|369382|P2|STARTED|Overall Study||59
160135|NCT00706563|369383|P1|STARTED|Overall Study||61
160136|NCT00706550|369407|P2|NOT COMPLETED|Overall Study||28
160137|NCT00706550|369408|P1|NOT COMPLETED|Overall Study||7
160138|NCT00706550|369407|P2|COMPLETED|Overall Study||36
160139|NCT00706550|369408|P1|COMPLETED|Overall Study||36
160140|NCT00706550|369407|P2|STARTED|Overall Study||64
160141|NCT00706550|369408|P1|STARTED|Overall Study||43
160142|NCT00706485|369424|P1|NOT COMPLETED|Overall Study||0
160143|NCT00706485|369424|P1|COMPLETED|Overall Study||5
160144|NCT00706485|369424|P1|STARTED|Overall Study||5
160145|NCT00706433|369434|P4|NOT COMPLETED|Overall Study||2
160146|NCT00706433|369435|P3|NOT COMPLETED|Overall Study||10
160147|NCT00706433|369436|P2|NOT COMPLETED|Overall Study||3
160148|NCT00706433|369437|P1|NOT COMPLETED|Overall Study||5
160149|NCT00706433|369434|P4|COMPLETED|Overall Study||64
160150|NCT00706433|369435|P3|COMPLETED|Overall Study||57
160151|NCT00706433|369436|P2|COMPLETED|Overall Study||62
160152|NCT00706433|369437|P1|COMPLETED|Overall Study||63
160153|NCT00706433|369434|P4|STARTED|Overall Study||66
160154|NCT00706433|369435|P3|STARTED|Overall Study||67
160155|NCT00706433|369436|P2|STARTED|Overall Study||65
160156|NCT00706433|369437|P1|STARTED|Overall Study||68
160157|NCT00706355|369755|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
160158|NCT00706355|369756|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
160159|NCT00706355|369757|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
160160|NCT00706355|369758|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
160161|NCT00706355|369755|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
160162|NCT00706355|369756|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
160163|NCT00706355|369757|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
160164|NCT00706355|369758|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
160165|NCT00706355|369755|P4|STARTED|Period 4: PF-04217903 150 mg||4
160166|NCT00706355|369756|P3|STARTED|Period 4: PF-04217903 150 mg||0
160167|NCT00706355|369757|P2|STARTED|Period 4: PF-04217903 150 mg||0
160168|NCT00706355|369758|P1|STARTED|Period 4: PF-04217903 150 mg||0
160169|NCT00706355|369755|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
160170|NCT00706355|369756|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
160171|NCT00706355|369757|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
160172|NCT00706355|369758|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
160173|NCT00706355|369755|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
160174|NCT00706355|369756|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
160175|NCT00706355|369757|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
160176|NCT00706355|369758|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
160177|NCT00706355|369755|P4|STARTED|Period 3: PF-04217903 200 mg||0
160178|NCT00706355|369756|P3|STARTED|Period 3: PF-04217903 200 mg||2
160179|NCT00706355|369757|P2|STARTED|Period 3: PF-04217903 200 mg||0
160180|NCT00706355|369758|P1|STARTED|Period 3: PF-04217903 200 mg||0
160181|NCT00706355|369755|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
160182|NCT00706355|369756|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
160183|NCT00706355|369757|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
160184|NCT00706355|369758|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
160185|NCT00706355|369755|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
160186|NCT00706355|369756|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
160187|NCT00706355|369757|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
160188|NCT00706355|369758|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
160189|NCT00706355|369755|P4|STARTED|Period 2: PF-04217903 100 mg||0
160190|NCT00706355|369756|P3|STARTED|Period 2: PF-04217903 100 mg||0
160191|NCT00706355|369757|P2|STARTED|Period 2: PF-04217903 100 mg||7
160192|NCT00706355|369758|P1|STARTED|Period 2: PF-04217903 100 mg||0
160193|NCT00706355|369755|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
160194|NCT00706355|369756|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
160195|NCT00706355|369757|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
160196|NCT00706355|369758|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
160197|NCT00706355|369755|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
160198|NCT00706355|369756|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
160199|NCT00706355|369757|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
160200|NCT00706355|369758|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
160201|NCT00706355|369755|P4|STARTED|Period 1: PF-04217903 50 mg||0
160202|NCT00706355|369756|P3|STARTED|Period 1: PF-04217903 50 mg||0
160203|NCT00706355|369757|P2|STARTED|Period 1: PF-04217903 50 mg||0
160204|NCT00706355|369758|P1|STARTED|Period 1: PF-04217903 50 mg||3
160205|NCT00706342|369810|P1|NOT COMPLETED|Overall Study||18
160206|NCT00706342|369810|P1|COMPLETED|Overall Study||0
160207|NCT00706342|369810|P1|STARTED|Overall Study||18
160208|NCT00706329|369819|P1|NOT COMPLETED|Overall Study||0
160209|NCT00706329|369819|P1|COMPLETED|Overall Study||25
160210|NCT00706329|369819|P1|STARTED|Overall Study||25
160211|NCT00706134|369827|P4|NOT COMPLETED|Overall Study||11
160212|NCT00706134|369828|P3|NOT COMPLETED|Overall Study||6
160213|NCT00706134|369829|P2|NOT COMPLETED|Overall Study||19
160214|NCT00706134|369830|P1|NOT COMPLETED|Overall Study||20
160215|NCT00706134|369827|P4|COMPLETED|Overall Study||175
160216|NCT00706134|369828|P3|COMPLETED|Overall Study||183
160217|NCT00706134|369829|P2|COMPLETED|Overall Study||173
160218|NCT00706134|369830|P1|COMPLETED|Overall Study||169
160219|NCT00706134|369827|P4|Entered Double-blind Period|Overall Study||186
160220|NCT00706134|369828|P3|Entered Double-blind Period|Overall Study||189
160221|NCT00706134|369829|P2|Entered Double-blind Period|Overall Study||192
160222|NCT00706134|369830|P1|Entered Double-blind Period|Overall Study||187
160223|NCT00706134|369827|P4|STARTED|Overall Study||186
160224|NCT00706134|369828|P3|STARTED|Overall Study||189
160225|NCT00706134|369829|P2|STARTED|Overall Study||192
160226|NCT00706134|369830|P1|STARTED|Overall Study||189
160227|NCT00706095|369863|P3|NOT COMPLETED|Overall Study||5
160228|NCT00706095|369864|P2|NOT COMPLETED|Overall Study||7
160229|NCT00706095|369865|P1|NOT COMPLETED|Overall Study||6
160230|NCT00706095|369863|P3|COMPLETED|Overall Study||0
160231|NCT00706095|369864|P2|COMPLETED|Overall Study||0
160232|NCT00706095|369865|P1|COMPLETED|Overall Study||0
160233|NCT00706095|369863|P3|STARTED|Overall Study||5
160234|NCT00706095|369864|P2|STARTED|Overall Study||7
160235|NCT00706095|369865|P1|STARTED|Overall Study||6
160236|NCT00706004|369879|P1|NOT COMPLETED|Overall Study||2
160237|NCT00706004|369879|P1|COMPLETED|Overall Study||7
160238|NCT00706004|369879|P1|STARTED|Overall Study||9
160239|NCT00705939|369907|P3|NOT COMPLETED|Overall Study||4
160240|NCT00705939|369908|P2|NOT COMPLETED|Overall Study||2
160241|NCT00705939|369909|P1|NOT COMPLETED|Overall Study||0
160242|NCT00705939|369907|P3|COMPLETED|Overall Study||14
160243|NCT00705939|369908|P2|COMPLETED|Overall Study||12
160244|NCT00705939|369909|P1|COMPLETED|Overall Study||12
160245|NCT00705939|369907|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
160246|NCT00705939|369908|P2|STARTED|Overall Study||14
160247|NCT00705939|369909|P1|STARTED|Overall Study||12
160248|NCT00705874|369939|P7|NOT COMPLETED|Overall Study||0
160249|NCT00705874|369940|P6|NOT COMPLETED|Overall Study||4
160250|NCT00705874|369941|P5|NOT COMPLETED|Overall Study||12
160251|NCT00705874|369942|P4|NOT COMPLETED|Overall Study||1
160252|NCT00705874|369943|P3|NOT COMPLETED|Overall Study||2
160253|NCT00705874|369944|P2|NOT COMPLETED|Overall Study||1
160254|NCT00705874|369945|P1|NOT COMPLETED|Overall Study||2
160255|NCT00705874|369939|P7|COMPLETED|Overall Study||3
160256|NCT00705874|369940|P6|COMPLETED|Overall Study||28
160257|NCT00705874|369941|P5|COMPLETED|Overall Study||36
160258|NCT00705874|369942|P4|COMPLETED|Overall Study||33
160259|NCT00705874|369943|P3|COMPLETED|Overall Study||32
160260|NCT00705874|369944|P2|COMPLETED|Overall Study||8
160261|NCT00705874|369945|P1|COMPLETED|Overall Study||10
160262|NCT00705874|369939|P7|STARTED|Overall Study||3
160263|NCT00705874|369940|P6|STARTED|Overall Study||32
160264|NCT00705874|369941|P5|STARTED|Overall Study||48
160265|NCT00705874|369942|P4|STARTED|Overall Study||34
160266|NCT00705874|369943|P3|STARTED|Overall Study||34
160267|NCT00705874|369944|P2|STARTED|Overall Study||9
160268|NCT00705874|369945|P1|STARTED|Overall Study||12
160269|NCT00705783|369963|P3|NOT COMPLETED|Depot Maintenance Phase||131
160270|NCT00705783|369964|P2|NOT COMPLETED|Depot Maintenance Phase||246
160271|NCT00705783|369965|P1|NOT COMPLETED|Depot Maintenance Phase||0
160272|NCT00705783|369963|P3|COMPLETED|Depot Maintenance Phase||3
160273|NCT00705783|369964|P2|COMPLETED|Depot Maintenance Phase||23
160274|NCT00705783|369965|P1|COMPLETED|Depot Maintenance Phase||0
160275|NCT00705783|369963|P3|STARTED|Depot Maintenance Phase||134
160276|NCT00705783|369964|P2|STARTED|Depot Maintenance Phase||269
160277|NCT00705783|369965|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
160278|NCT00705783|369963|P3|NOT COMPLETED|Depot Stabilization Phase||0
160279|NCT00705783|369964|P2|NOT COMPLETED|Depot Stabilization Phase||0
160280|NCT00705783|369965|P1|NOT COMPLETED|Depot Stabilization Phase||173
160281|NCT00705783|369963|P3|COMPLETED|Depot Stabilization Phase||0
160282|NCT00705783|369964|P2|COMPLETED|Depot Stabilization Phase||0
160283|NCT00705783|369965|P1|COMPLETED|Depot Stabilization Phase||403
160284|NCT00705783|369963|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160285|NCT00705783|369964|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160286|NCT00705783|369965|P1|STARTED|Depot Stabilization Phase||576
160287|NCT00705783|369963|P3|NOT COMPLETED|Oral Stabilization Phase||0
160288|NCT00705783|369964|P2|NOT COMPLETED|Oral Stabilization Phase||0
160289|NCT00705783|369965|P1|NOT COMPLETED|Oral Stabilization Phase||134
160290|NCT00705783|369963|P3|COMPLETED|Oral Stabilization Phase||0
160291|NCT00705783|369964|P2|COMPLETED|Oral Stabilization Phase||0
160292|NCT00705783|369965|P1|COMPLETED|Oral Stabilization Phase||576
160293|NCT00705783|369963|P3|Received Study Medication|Oral Stabilization Phase||0
160294|NCT00705783|369964|P2|Received Study Medication|Oral Stabilization Phase||0
160295|NCT00705783|369965|P1|Received Study Medication|Oral Stabilization Phase||709
160296|NCT00705783|369963|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160297|NCT00705783|369964|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
160298|NCT00705783|369965|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
160299|NCT00705783|369963|P3|NOT COMPLETED|Conversion Phase||0
160300|NCT00705783|369964|P2|NOT COMPLETED|Conversion Phase||0
160301|NCT00705783|369965|P1|NOT COMPLETED|Conversion Phase||133
160302|NCT00705783|369963|P3|COMPLETED|Conversion Phase||0
160303|NCT00705783|369964|P2|COMPLETED|Conversion Phase||0
160304|NCT00705783|369965|P1|COMPLETED|Conversion Phase||500
160305|NCT00705783|369963|P3|Received Study Medication|Conversion Phase||0
160306|NCT00705783|369964|P2|Received Study Medication|Conversion Phase||0
160307|NCT00705783|369965|P1|Received Study Medication|Conversion Phase||632
160308|NCT00705783|369963|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
160309|NCT00705783|369964|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
160310|NCT00705783|369965|P1|STARTED|Conversion Phase||633
160311|NCT00705757|369995|P3|NOT COMPLETED|Overall Study||11
160312|NCT00705757|369996|P2|NOT COMPLETED|Overall Study||8
160313|NCT00705757|369997|P1|NOT COMPLETED|Overall Study||13
160314|NCT00705757|369995|P3|COMPLETED|Overall Study||17
160315|NCT00705757|369996|P2|COMPLETED|Overall Study||21
160316|NCT00705757|369997|P1|COMPLETED|Overall Study||19
160317|NCT00705757|369995|P3|STARTED|Overall Study||28
160318|NCT00705757|369996|P2|STARTED|Overall Study||29
160319|NCT00705757|369997|P1|STARTED|Overall Study||32
160320|NCT00705718|370007|P2|NOT COMPLETED|Overall Study||22
160321|NCT00705718|370008|P1|NOT COMPLETED|Overall Study||7
160322|NCT00705718|370007|P2|COMPLETED|Overall Study||128
160323|NCT00705718|370008|P1|COMPLETED|Overall Study||37
160324|NCT00705718|370007|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
160325|NCT00705718|370008|P1|12 Month Follow up|Overall Study|2 Deaths|37
160326|NCT00705718|370007|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
160327|NCT00705718|370008|P1|6 Month Follow up|Overall Study|3 Deaths|40
160328|NCT00705718|370007|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
160329|NCT00705718|370008|P1|1 Month Follow up|Overall Study|1 Death|43
160330|NCT00705718|370007|P2|STARTED|Overall Study||150
160331|NCT00705718|370008|P1|STARTED|Overall Study||44
160332|NCT00705679|370029|P5|NOT COMPLETED|Overall Study||69
160333|NCT00705679|370030|P4|NOT COMPLETED|Overall Study||80
160334|NCT00705679|370031|P3|NOT COMPLETED|Overall Study||115
160335|NCT00705679|370032|P2|NOT COMPLETED|Overall Study||139
160336|NCT00705679|370033|P1|NOT COMPLETED|Overall Study||65
160337|NCT00705679|370029|P5|COMPLETED|Overall Study||934
160338|NCT00705679|370030|P4|COMPLETED|Overall Study||927
160339|NCT00705679|370031|P3|COMPLETED|Overall Study||894
160340|NCT00705679|370032|P2|COMPLETED|Overall Study||864
160341|NCT00705679|370033|P1|COMPLETED|Overall Study||942
160342|NCT00705679|370029|P5|STARTED|Overall Study||1003
160343|NCT00705679|370030|P4|STARTED|Overall Study||1007
160344|NCT00705679|370031|P3|STARTED|Overall Study||1009
160345|NCT00705679|370032|P2|STARTED|Overall Study||1003
160346|NCT00705679|370033|P1|STARTED|Overall Study||1007
160347|NCT00705666|370068|P1|NOT COMPLETED|Overall Study||339
160348|NCT00705666|370068|P1|COMPLETED|Overall Study||450
160349|NCT00705666|370068|P1|STARTED|Overall Study||789
160350|NCT00705653|370072|P1|NOT COMPLETED|Overall Study||0
160351|NCT00705653|370072|P1|COMPLETED|Overall Study||46
160352|NCT00705653|370072|P1|STARTED|Overall Study||46
160353|NCT00705614|370079|P2|NOT COMPLETED|Switch to Remicade||49
160354|NCT00705614|370080|P1|NOT COMPLETED|Switch to Remicade||0
160355|NCT00705614|370079|P2|COMPLETED|Switch to Remicade||249
160356|NCT00705614|370080|P1|COMPLETED|Switch to Remicade||0
160357|NCT00705614|370079|P2|STARTED|Switch to Remicade||298
160358|NCT00705614|370080|P1|STARTED|Switch to Remicade||0
160359|NCT00705614|370079|P2|NOT COMPLETED|Initial Intervention||321
160360|NCT00705614|370080|P1|NOT COMPLETED|Initial Intervention||518
160361|NCT00705614|370079|P2|COMPLETED|Initial Intervention||800
160362|NCT00705614|370080|P1|COMPLETED|Initial Intervention||1023
160363|NCT00705614|370079|P2|STARTED|Initial Intervention||1121
160364|NCT00705614|370080|P1|STARTED|Initial Intervention||1541
160365|NCT00705575|370129|P2|NOT COMPLETED|Overall Study||46
160366|NCT00705575|370130|P1|NOT COMPLETED|Overall Study||23
160367|NCT00705575|370129|P2|COMPLETED|Overall Study||293
160368|NCT00705575|370130|P1|COMPLETED|Overall Study||326
160369|NCT00705575|370129|P2|STARTED|Overall Study||339
160370|NCT00705575|370130|P1|STARTED|Overall Study||349
160371|NCT00705536|370144|P4|NOT COMPLETED|Completed Study||0
160372|NCT00705536|370145|P3|NOT COMPLETED|Completed Study||0
160373|NCT00705536|370146|P2|NOT COMPLETED|Completed Study||0
160374|NCT00705536|370147|P1|NOT COMPLETED|Completed Study||0
160375|NCT00705536|370144|P4|COMPLETED|Completed Study||6
160376|NCT00705536|370145|P3|COMPLETED|Completed Study||7
160377|NCT00705536|370146|P2|COMPLETED|Completed Study||6
160378|NCT00705536|370147|P1|COMPLETED|Completed Study||6
160379|NCT00705536|370144|P4|STARTED|Completed Study||6
160380|NCT00705536|370145|P3|STARTED|Completed Study||7
160381|NCT00705536|370146|P2|STARTED|Completed Study||6
160382|NCT00705536|370147|P1|STARTED|Completed Study||6
160383|NCT00705536|370144|P4|NOT COMPLETED|Start Period 2||0
160384|NCT00705536|370145|P3|NOT COMPLETED|Start Period 2||0
160385|NCT00705536|370146|P2|NOT COMPLETED|Start Period 2||0
160386|NCT00705536|370147|P1|NOT COMPLETED|Start Period 2||0
160387|NCT00705536|370144|P4|COMPLETED|Start Period 2||6
160388|NCT00705536|370145|P3|COMPLETED|Start Period 2||7
160389|NCT00705536|370146|P2|COMPLETED|Start Period 2||6
160390|NCT00705536|370147|P1|COMPLETED|Start Period 2||6
160391|NCT00705536|370144|P4|STARTED|Start Period 2||6
160392|NCT00705536|370145|P3|STARTED|Start Period 2||7
160393|NCT00705536|370146|P2|STARTED|Start Period 2||6
160394|NCT00705536|370147|P1|STARTED|Start Period 2||6
160395|NCT00705536|370144|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
160396|NCT00705536|370145|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
160397|NCT00705536|370146|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
160398|NCT00705536|370147|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
160399|NCT00705536|370144|P4|COMPLETED|Washout Period of at Least 6 Days||6
160400|NCT00705536|370145|P3|COMPLETED|Washout Period of at Least 6 Days||7
160401|NCT00705536|370146|P2|COMPLETED|Washout Period of at Least 6 Days||6
160402|NCT00705536|370147|P1|COMPLETED|Washout Period of at Least 6 Days||6
160403|NCT00705536|370144|P4|STARTED|Washout Period of at Least 6 Days||6
160404|NCT00705536|370145|P3|STARTED|Washout Period of at Least 6 Days||7
160405|NCT00705536|370146|P2|STARTED|Washout Period of at Least 6 Days||6
160406|NCT00705536|370147|P1|STARTED|Washout Period of at Least 6 Days||6
160407|NCT00705536|370144|P4|NOT COMPLETED|Start Period 1||1
160408|NCT00705536|370145|P3|NOT COMPLETED|Start Period 1||0
160409|NCT00705536|370146|P2|NOT COMPLETED|Start Period 1||0
160410|NCT00705536|370147|P1|NOT COMPLETED|Start Period 1||0
160411|NCT00705536|370144|P4|COMPLETED|Start Period 1||6
160412|NCT00705536|370145|P3|COMPLETED|Start Period 1||7
160413|NCT00705536|370146|P2|COMPLETED|Start Period 1||6
160414|NCT00705536|370147|P1|COMPLETED|Start Period 1||6
160415|NCT00705536|370144|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
160416|NCT00705536|370145|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
160417|NCT00705536|370146|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
160418|NCT00705536|370147|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
160419|NCT00705536|370144|P4|STARTED|Start Period 1||7
160420|NCT00705536|370145|P3|STARTED|Start Period 1||7
160421|NCT00705536|370146|P2|STARTED|Start Period 1||6
160422|NCT00705536|370147|P1|STARTED|Start Period 1||6
160423|NCT00705523|370208|P2|NOT COMPLETED|Overall Study||3
160424|NCT00705523|370209|P1|NOT COMPLETED|Overall Study||2
160425|NCT00705523|370208|P2|COMPLETED|Overall Study||18
160426|NCT00705523|370209|P1|COMPLETED|Overall Study||17
160427|NCT00705523|370208|P2|STARTED|Overall Study||21
160428|NCT00705523|370209|P1|STARTED|Overall Study||19
160429|NCT00705432|370223|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
160430|NCT00705432|370224|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
160431|NCT00705432|370225|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
160432|NCT00705432|370226|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
160433|NCT00705432|370227|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
160434|NCT00705432|370228|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
160435|NCT00705432|370223|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
160436|NCT00705432|370224|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
160437|NCT00705432|370225|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
160438|NCT00705432|370226|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
160439|NCT00705432|370227|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
160440|NCT00705432|370228|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
160441|NCT00705432|370223|P6|STARTED|Follow-up Period (Upto Week 72)||53
160442|NCT00705432|370224|P5|STARTED|Follow-up Period (Upto Week 72)||44
160443|NCT00705432|370225|P4|STARTED|Follow-up Period (Upto Week 72)||42
160444|NCT00705432|370226|P3|STARTED|Follow-up Period (Upto Week 72)||291
160445|NCT00705432|370227|P2|STARTED|Follow-up Period (Upto Week 72)||295
160446|NCT00705432|370228|P1|STARTED|Follow-up Period (Upto Week 72)||278
160447|NCT00705432|370223|P6|NOT COMPLETED|Treatment Period||30
160448|NCT00705432|370224|P5|NOT COMPLETED|Treatment Period||28
160449|NCT00705432|370225|P4|NOT COMPLETED|Treatment Period||41
160450|NCT00705432|370226|P3|NOT COMPLETED|Treatment Period||121
160451|NCT00705432|370227|P2|NOT COMPLETED|Treatment Period||111
160452|NCT00705432|370228|P1|NOT COMPLETED|Treatment Period||163
160453|NCT00705432|370223|P6|COMPLETED|Treatment Period||25
160454|NCT00705432|370224|P5|COMPLETED|Treatment Period||24
160455|NCT00705432|370225|P4|COMPLETED|Treatment Period||11
160456|NCT00705432|370226|P3|COMPLETED|Treatment Period||190
160457|NCT00705432|370227|P2|COMPLETED|Treatment Period||205
160458|NCT00705432|370228|P1|COMPLETED|Treatment Period||148
160459|NCT00705432|370223|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
160460|NCT00705432|370224|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
160461|NCT00705432|370225|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
160462|NCT00705432|370226|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
160463|NCT00705432|370227|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
160464|NCT00705432|370228|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
160465|NCT00705432|370223|P6|STARTED|Treatment Period||55
160466|NCT00705432|370224|P5|STARTED|Treatment Period||52
160467|NCT00705432|370225|P4|STARTED|Treatment Period||52
160468|NCT00705432|370226|P3|STARTED|Treatment Period||311
160469|NCT00705432|370227|P2|STARTED|Treatment Period||316
160470|NCT00705432|370228|P1|STARTED|Treatment Period||311
160471|NCT00705406|370265|P2|NOT COMPLETED|Overall Study||5
160472|NCT00705406|370266|P1|NOT COMPLETED|Overall Study||4
160473|NCT00705406|370265|P2|COMPLETED|Overall Study||197
160474|NCT00705406|370266|P1|COMPLETED|Overall Study||199
160475|NCT00705406|370265|P2|STARTED|Overall Study||202
160476|NCT00705406|370266|P1|STARTED|Overall Study||203
160477|NCT00705367|370290|P2|NOT COMPLETED|Long-term Extension Period||0
160478|NCT00705367|370291|P1|NOT COMPLETED|Long-term Extension Period||9
160479|NCT00705367|370290|P2|COMPLETED|Long-term Extension Period||0
160480|NCT00705367|370291|P1|COMPLETED|Long-term Extension Period||0
160481|NCT00705367|370290|P2|STARTED|Long-term Extension Period||0
160482|NCT00705367|370291|P1|STARTED|Long-term Extension Period||9
160483|NCT00705367|370290|P2|NOT COMPLETED|Short-term Period||0
160484|NCT00705367|370291|P1|NOT COMPLETED|Short-term Period||0
160485|NCT00705367|370290|P2|COMPLETED|Short-term Period||3
160486|NCT00705367|370291|P1|COMPLETED|Short-term Period||6
160487|NCT00705367|370290|P2|STARTED|Short-term Period||3
160488|NCT00705367|370291|P1|STARTED|Short-term Period||6
160489|NCT00705341|370318|P4|NOT COMPLETED|Phase 2: Trial||4
160490|NCT00705341|370319|P3|NOT COMPLETED|Phase 2: Trial||7
160491|NCT00705341|370320|P2|NOT COMPLETED|Phase 2: Trial||0
160492|NCT00705341|370321|P1|NOT COMPLETED|Phase 2: Trial||0
160493|NCT00705341|370318|P4|COMPLETED|Phase 2: Trial||28
160494|NCT00705341|370319|P3|COMPLETED|Phase 2: Trial||23
160495|NCT00705341|370320|P2|COMPLETED|Phase 2: Trial||0
160496|NCT00705341|370321|P1|COMPLETED|Phase 2: Trial||0
160497|NCT00705341|370318|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
160498|NCT00705341|370319|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
160499|NCT00705341|370320|P2|STARTED|Phase 2: Trial||0
160500|NCT00705341|370321|P1|STARTED|Phase 2: Trial||0
160501|NCT00705341|370318|P4|NOT COMPLETED|Phase 1:Control Challenge||0
160502|NCT00705341|370319|P3|NOT COMPLETED|Phase 1:Control Challenge||0
160503|NCT00705341|370320|P2|NOT COMPLETED|Phase 1:Control Challenge||0
160504|NCT00705341|370321|P1|NOT COMPLETED|Phase 1:Control Challenge||0
160505|NCT00705341|370318|P4|COMPLETED|Phase 1:Control Challenge||0
160506|NCT00705341|370319|P3|COMPLETED|Phase 1:Control Challenge||0
160507|NCT00705341|370320|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
160508|NCT00705341|370321|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
160509|NCT00705341|370318|P4|STARTED|Phase 1:Control Challenge||0
160510|NCT00705341|370319|P3|STARTED|Phase 1:Control Challenge||0
160511|NCT00705341|370320|P2|STARTED|Phase 1:Control Challenge||93
160512|NCT00705341|370321|P1|STARTED|Phase 1:Control Challenge||126
160513|NCT00705289|370329|P1|NOT COMPLETED|Overall Study||131
160514|NCT00705289|370329|P1|COMPLETED|Overall Study||597
160515|NCT00705289|370329|P1|STARTED|Overall Study||728
160516|NCT00705263|370353|P1|NOT COMPLETED|Overall Study||2
160517|NCT00705263|370353|P1|COMPLETED|Overall Study||108
160518|NCT00705263|370353|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
160519|NCT00705250|370357|P1|NOT COMPLETED|Overall Study||2
160520|NCT00705250|370357|P1|COMPLETED|Overall Study||34
160521|NCT00705250|370357|P1|STARTED|Overall Study||36
160522|NCT00705224|370361|P1|NOT COMPLETED|Overall Study||11
160523|NCT00705224|370361|P1|COMPLETED|Overall Study||239
160524|NCT00705224|370361|P1|STARTED|Overall Study||250
160525|NCT00705159|370377|P4|NOT COMPLETED|Overall Study||4
160526|NCT00705159|370378|P3|NOT COMPLETED|Overall Study||5
160527|NCT00705159|370379|P2|NOT COMPLETED|Overall Study||2
160528|NCT00705159|370380|P1|NOT COMPLETED|Overall Study||0
160529|NCT00705159|370377|P4|COMPLETED|Overall Study||30
160530|NCT00705159|370378|P3|COMPLETED|Overall Study||29
160531|NCT00705159|370379|P2|COMPLETED|Overall Study||33
160532|NCT00705159|370380|P1|COMPLETED|Overall Study||34
160533|NCT00705159|370377|P4|STARTED|Overall Study||34
160534|NCT00705159|370378|P3|STARTED|Overall Study||34
160535|NCT00705159|370379|P2|STARTED|Overall Study||35
160536|NCT00705159|370380|P1|STARTED|Overall Study||34
160537|NCT00705146|370400|P2|NOT COMPLETED|Overall Study||1
160538|NCT00705146|370401|P1|NOT COMPLETED|Overall Study||1
160539|NCT00705146|370400|P2|COMPLETED|Overall Study||23
160540|NCT00705146|370401|P1|COMPLETED|Overall Study||31
160541|NCT00705146|370400|P2|STARTED|Overall Study||24
160542|NCT00705146|370401|P1|STARTED|Overall Study||32
160543|NCT00705107|370409|P1|NOT COMPLETED|Overall Study||49
160544|NCT00705107|370409|P1|COMPLETED|Overall Study||218
160545|NCT00705107|370409|P1|STARTED|Overall Study||267
160546|NCT00705081|370416|P2|NOT COMPLETED|Overall Study||0
160547|NCT00705081|370417|P1|NOT COMPLETED|Overall Study||0
160548|NCT00705081|370416|P2|COMPLETED|Overall Study||198
160549|NCT00705081|370417|P1|COMPLETED|Overall Study||255
160550|NCT00705081|370416|P2|STARTED|Overall Study||198
160551|NCT00705081|370417|P1|STARTED|Overall Study||255
160552|NCT00705016|370430|P3|NOT COMPLETED|Overall Study||58
160553|NCT00705016|370431|P2|NOT COMPLETED|Overall Study||58
160554|NCT00705016|370432|P1|NOT COMPLETED|Overall Study||60
160555|NCT00705016|370430|P3|COMPLETED|Overall Study||4
160556|NCT00705016|370431|P2|COMPLETED|Overall Study||2
160557|NCT00705016|370432|P1|COMPLETED|Overall Study||2
160558|NCT00705016|370430|P3|STARTED|Overall Study||62
160559|NCT00705016|370431|P2|STARTED|Overall Study||60
160560|NCT00705016|370432|P1|STARTED|Overall Study||62
160561|NCT00705003|370461|P3|NOT COMPLETED|Treated||3
160562|NCT00705003|370462|P2|NOT COMPLETED|Treated||6
160563|NCT00705003|370463|P1|NOT COMPLETED|Treated||13
160564|NCT00705003|370461|P3|COMPLETED|Treated||30
160565|NCT00705003|370462|P2|COMPLETED|Treated||28
160566|NCT00705003|370463|P1|COMPLETED|Treated||54
160567|NCT00705003|370461|P3|STARTED|Treated||33
160568|NCT00705003|370462|P2|STARTED|Treated||34
160569|NCT00705003|370463|P1|STARTED|Treated||67
160570|NCT00705003|370461|P3|NOT COMPLETED|Enrolled||1
160571|NCT00705003|370462|P2|NOT COMPLETED|Enrolled||3
160572|NCT00705003|370463|P1|NOT COMPLETED|Enrolled||4
160573|NCT00705003|370461|P3|COMPLETED|Enrolled||33
160574|NCT00705003|370462|P2|COMPLETED|Enrolled||34
160575|NCT00705003|370463|P1|COMPLETED|Enrolled||67
160576|NCT00705003|370461|P3|STARTED|Enrolled||34
160577|NCT00705003|370462|P2|STARTED|Enrolled||37
160578|NCT00705003|370463|P1|STARTED|Enrolled||71
160579|NCT00704964|370483|P1|NOT COMPLETED|Overall Study||328
160580|NCT00704964|370483|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
160581|NCT00704964|370483|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
160582|NCT00704938|370490|P2|NOT COMPLETED|Overall Study||0
160583|NCT00704938|370491|P1|NOT COMPLETED|Overall Study||0
160584|NCT00704938|370490|P2|COMPLETED|Overall Study||1
160585|NCT00704938|370491|P1|COMPLETED|Overall Study||2
160586|NCT00704938|370490|P2|STARTED|Overall Study||1
160587|NCT00704938|370491|P1|STARTED|Overall Study||2
160588|NCT00704912|370502|P3|NOT COMPLETED|Overall Study||7
160589|NCT00704912|370503|P2|NOT COMPLETED|Overall Study||4
160590|NCT00704912|370504|P1|NOT COMPLETED|Overall Study||6
160591|NCT00704912|370502|P3|COMPLETED|Overall Study||43
160592|NCT00704912|370503|P2|COMPLETED|Overall Study||45
160593|NCT00704912|370504|P1|COMPLETED|Overall Study||44
160594|NCT00704912|370502|P3|STARTED|Overall Study||50
160595|NCT00704912|370503|P2|STARTED|Overall Study||49
160596|NCT00704912|370504|P1|STARTED|Overall Study||50
160597|NCT00704847|370523|P2|NOT COMPLETED|Overall Study||170
160598|NCT00704847|370524|P1|NOT COMPLETED|Overall Study||221
160599|NCT00704847|370523|P2|COMPLETED|Overall Study||339
160600|NCT00704847|370524|P1|COMPLETED|Overall Study||300
160601|NCT00704847|370523|P2|STARTED|Overall Study||509
160602|NCT00704847|370524|P1|STARTED|Overall Study||521
160603|NCT00704808|370532|P1|NOT COMPLETED|Overall Study||131
160604|NCT00704808|370532|P1|COMPLETED|Overall Study||49
160605|NCT00704808|370532|P1|STARTED|Overall Study||180
160606|NCT00704769|370536|P1|NOT COMPLETED|Overall Study||0
160607|NCT00704769|370536|P1|COMPLETED|Overall Study||591
160608|NCT00704769|370536|P1|STARTED|Overall Study||591
160609|NCT00704730|370543|P2|NOT COMPLETED|Overall Study||96
160610|NCT00704730|370544|P1|NOT COMPLETED|Overall Study||121
160611|NCT00704730|370543|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
160612|NCT00704730|370544|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
160613|NCT00704730|370543|P2|STARTED|Overall Study|Randomized|111
160614|NCT00704730|370544|P1|STARTED|Overall Study|Randomized|219
160615|NCT00704717|370560|P1|NOT COMPLETED|Overall Study||0
160616|NCT00704717|370560|P1|COMPLETED|Overall Study||185
160617|NCT00704717|370560|P1|STARTED|Overall Study||185
160618|NCT00704535|370564|P1|NOT COMPLETED|Overall Study||146
160619|NCT00704535|370564|P1|COMPLETED|Overall Study||3959
160620|NCT00704535|370564|P1|STARTED|Overall Study||4105
160621|NCT00704522|370577|P2|NOT COMPLETED|Overall Study||45
160622|NCT00704522|370578|P1|NOT COMPLETED|Overall Study||183
160623|NCT00704522|370577|P2|COMPLETED|Overall Study||75
160624|NCT00704522|370578|P1|COMPLETED|Overall Study||298
160625|NCT00704522|370577|P2|STARTED|Overall Study||120
160626|NCT00704522|370578|P1|STARTED|Overall Study||481
160627|NCT00704418|370587|P2|NOT COMPLETED|Overall Study||6
160628|NCT00704418|370588|P1|NOT COMPLETED|Overall Study||5
160629|NCT00704418|370587|P2|COMPLETED|Overall Study||72
160630|NCT00704418|370588|P1|COMPLETED|Overall Study||73
160631|NCT00704418|370587|P2|STARTED|Overall Study||78
160632|NCT00704418|370588|P1|STARTED|Overall Study||78
160633|NCT00704405|370601|P5|NOT COMPLETED|Overall Study (C Population)||0
160634|NCT00704405|370602|P4|NOT COMPLETED|Overall Study (C Population)||1
160635|NCT00704405|370603|P3|NOT COMPLETED|Overall Study (C Population)||1
160636|NCT00704405|370604|P2|NOT COMPLETED|Overall Study (C Population)||3
160637|NCT00704405|370605|P1|NOT COMPLETED|Overall Study (C Population)||1
160638|NCT00704405|370601|P5|COMPLETED|Overall Study (C Population)||14
160639|NCT00704405|370602|P4|COMPLETED|Overall Study (C Population)||14
160640|NCT00704405|370603|P3|COMPLETED|Overall Study (C Population)||14
160641|NCT00704405|370604|P2|COMPLETED|Overall Study (C Population)||11
160642|NCT00704405|370605|P1|COMPLETED|Overall Study (C Population)||15
160643|NCT00704405|370601|P5|STARTED|Overall Study (C Population)||14
160644|NCT00704405|370602|P4|STARTED|Overall Study (C Population)||15
160645|NCT00704405|370603|P3|STARTED|Overall Study (C Population)||15
160646|NCT00704405|370604|P2|STARTED|Overall Study (C Population)||14
160647|NCT00704405|370605|P1|STARTED|Overall Study (C Population)||16
160648|NCT00704405|370601|P5|NOT COMPLETED|Overall Study (NC Population)||5
160649|NCT00704405|370602|P4|NOT COMPLETED|Overall Study (NC Population)||4
160650|NCT00704405|370603|P3|NOT COMPLETED|Overall Study (NC Population)||3
160651|NCT00704405|370604|P2|NOT COMPLETED|Overall Study (NC Population)||4
160652|NCT00704405|370605|P1|NOT COMPLETED|Overall Study (NC Population)||5
160653|NCT00704405|370601|P5|COMPLETED|Overall Study (NC Population)||37
160654|NCT00704405|370602|P4|COMPLETED|Overall Study (NC Population)||38
160655|NCT00704405|370603|P3|COMPLETED|Overall Study (NC Population)||38
160656|NCT00704405|370604|P2|COMPLETED|Overall Study (NC Population)||40
160657|NCT00704405|370605|P1|COMPLETED|Overall Study (NC Population)||37
160658|NCT00704405|370601|P5|STARTED|Overall Study (NC Population)||42
160659|NCT00704405|370602|P4|STARTED|Overall Study (NC Population)||42
160660|NCT00704405|370603|P3|STARTED|Overall Study (NC Population)||41
160661|NCT00704405|370604|P2|STARTED|Overall Study (NC Population)||44
160662|NCT00704405|370605|P1|STARTED|Overall Study (NC Population)||42
160663|NCT00704379|370635|P2|NOT COMPLETED|Overall Study||7
160664|NCT00704379|370636|P1|NOT COMPLETED|Overall Study||7
160665|NCT00704379|370635|P2|COMPLETED|Overall Study||41
160666|NCT00704379|370636|P1|COMPLETED|Overall Study||39
160667|NCT00704379|370635|P2|STARTED|Overall Study||48
160668|NCT00704379|370636|P1|STARTED|Overall Study||46
160669|NCT00704353|370654|P2|NOT COMPLETED|Overall Study||114
160670|NCT00704353|370655|P1|NOT COMPLETED|Overall Study||98
160671|NCT00704353|370654|P2|COMPLETED|Overall Study||255
160672|NCT00704353|370655|P1|COMPLETED|Overall Study||268
160673|NCT00704353|370654|P2|STARTED|Overall Study||369
160674|NCT00704353|370655|P1|STARTED|Overall Study||366
160675|NCT00704340|370663|P2|NOT COMPLETED|Overall Study||2
160676|NCT00704340|370664|P1|NOT COMPLETED|Overall Study||2
160677|NCT00704340|370663|P2|COMPLETED|Overall Study||115
160678|NCT00704340|370664|P1|COMPLETED|Overall Study||118
160679|NCT00704340|370663|P2|STARTED|Overall Study||117
160680|NCT00704340|370664|P1|STARTED|Overall Study||120
160681|NCT00704184|370679|P5|NOT COMPLETED|Open-Label Treatment||3
160682|NCT00704184|370680|P4|NOT COMPLETED|Open-Label Treatment||5
160683|NCT00704184|370681|P3|NOT COMPLETED|Open-Label Treatment||4
160684|NCT00704184|370682|P2|NOT COMPLETED|Open-Label Treatment||2
160685|NCT00704184|370683|P1|NOT COMPLETED|Open-Label Treatment||1
160686|NCT00704184|370679|P5|COMPLETED|Open-Label Treatment||16
160687|NCT00704184|370680|P4|COMPLETED|Open-Label Treatment||13
160688|NCT00704184|370681|P3|COMPLETED|Open-Label Treatment||16
160689|NCT00704184|370682|P2|COMPLETED|Open-Label Treatment||16
160690|NCT00704184|370683|P1|COMPLETED|Open-Label Treatment||18
160691|NCT00704184|370679|P5|STARTED|Open-Label Treatment||19
160692|NCT00704184|370680|P4|STARTED|Open-Label Treatment||18
160693|NCT00704184|370681|P3|STARTED|Open-Label Treatment||20
160694|NCT00704184|370682|P2|STARTED|Open-Label Treatment||18
160695|NCT00704184|370683|P1|STARTED|Open-Label Treatment||19
160696|NCT00704184|370679|P5|NOT COMPLETED|Double-Blind Treatment||0
160697|NCT00704184|370680|P4|NOT COMPLETED|Double-Blind Treatment||0
160698|NCT00704184|370681|P3|NOT COMPLETED|Double-Blind Treatment||0
160699|NCT00704184|370682|P2|NOT COMPLETED|Double-Blind Treatment||0
160700|NCT00704184|370683|P1|NOT COMPLETED|Double-Blind Treatment||1
160701|NCT00704184|370679|P5|COMPLETED|Double-Blind Treatment||19
160702|NCT00704184|370680|P4|COMPLETED|Double-Blind Treatment||18
160703|NCT00704184|370681|P3|COMPLETED|Double-Blind Treatment||20
160704|NCT00704184|370682|P2|COMPLETED|Double-Blind Treatment||18
160705|NCT00704184|370683|P1|COMPLETED|Double-Blind Treatment||19
160706|NCT00704184|370679|P5|Treated|Double-Blind Treatment||19
160707|NCT00704184|370680|P4|Treated|Double-Blind Treatment||18
160708|NCT00704184|370681|P3|Treated|Double-Blind Treatment||20
160709|NCT00704184|370682|P2|Treated|Double-Blind Treatment||18
160710|NCT00704184|370683|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
160711|NCT00704184|370679|P5|STARTED|Double-Blind Treatment||19
160712|NCT00704184|370680|P4|STARTED|Double-Blind Treatment||18
160713|NCT00704184|370681|P3|STARTED|Double-Blind Treatment||20
160714|NCT00704184|370682|P2|STARTED|Double-Blind Treatment||18
160715|NCT00704184|370683|P1|STARTED|Double-Blind Treatment||20
160716|NCT00704171|370722|P2|NOT COMPLETED|Overall Study||0
160717|NCT00704171|370723|P1|NOT COMPLETED|Overall Study||1
160718|NCT00704171|370722|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
160719|NCT00704171|370723|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
160720|NCT00704171|370722|P2|STARTED|Overall Study||59
160721|NCT00704171|370723|P1|STARTED|Overall Study||62
160722|NCT00704132|370741|P2|NOT COMPLETED|Overall Study||2
160723|NCT00704132|370742|P1|NOT COMPLETED|Overall Study||1
160724|NCT00704132|370741|P2|COMPLETED|Overall Study||22
160725|NCT00704132|370742|P1|COMPLETED|Overall Study||25
160726|NCT00704132|370741|P2|STARTED|Overall Study||24
160727|NCT00704132|370742|P1|STARTED|Overall Study||26
160728|NCT00704028|370750|P2|NOT COMPLETED|Overall Study||21
160729|NCT00704028|370751|P1|NOT COMPLETED|Overall Study||12
160730|NCT00704028|370750|P2|COMPLETED|Overall Study||57
160731|NCT00704028|370751|P1|COMPLETED|Overall Study||70
160827|NCT00703053|371049|P8|COMPLETED|Overall Study||91
160732|NCT00704028|370750|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
160733|NCT00704028|370751|P1|STARTED|Overall Study||82
160734|NCT00703963|370759|P2|NOT COMPLETED|Overall Study||14
160735|NCT00703963|370760|P1|NOT COMPLETED|Overall Study||7
160736|NCT00703963|370759|P2|COMPLETED|Overall Study||86
160737|NCT00703963|370760|P1|COMPLETED|Overall Study||93
160738|NCT00703963|370759|P2|STARTED|Overall Study||100
160739|NCT00703963|370760|P1|STARTED|Overall Study||100
160740|NCT00703937|370772|P2|NOT COMPLETED|Overall Study||93
160741|NCT00703937|370773|P1|NOT COMPLETED|Overall Study||65
160742|NCT00703937|370772|P2|COMPLETED|Overall Study||267
160743|NCT00703937|370773|P1|COMPLETED|Overall Study||278
160744|NCT00703937|370772|P2|STARTED|Overall Study||360
160745|NCT00703937|370773|P1|STARTED|Overall Study||343
160746|NCT00703924|370781|P2|NOT COMPLETED|Overall Study||1
160747|NCT00703924|370782|P1|NOT COMPLETED|Overall Study||1
160748|NCT00703924|370781|P2|COMPLETED|Overall Study||41
160749|NCT00703924|370782|P1|COMPLETED|Overall Study||49
160750|NCT00703924|370781|P2|STARTED|Overall Study||42
160751|NCT00703924|370782|P1|STARTED|Overall Study||50
160752|NCT00703911|370798|P1|NOT COMPLETED|Overall Study||10
160753|NCT00703911|370798|P1|COMPLETED|Overall Study||92
160754|NCT00703911|370798|P1|STARTED|Overall Study||102
160755|NCT00703885|370826|P1|NOT COMPLETED|Overall Study||0
160756|NCT00703885|370826|P1|COMPLETED|Overall Study||16
160757|NCT00703885|370826|P1|STARTED|Overall Study||16
160758|NCT00703846|370831|P1|NOT COMPLETED|Overall Study||137
160759|NCT00703846|370831|P1|COMPLETED|Overall Study||363
160760|NCT00703846|370831|P1|STARTED|Overall Study||500
160761|NCT00703781|370847|P2|NOT COMPLETED|Overall Study||2
160762|NCT00703781|370848|P1|NOT COMPLETED|Overall Study||2
160763|NCT00703781|370847|P2|COMPLETED|Overall Study||61
160764|NCT00703781|370848|P1|COMPLETED|Overall Study||61
160765|NCT00703781|370847|P2|STARTED|Overall Study||63
160766|NCT00703781|370848|P1|STARTED|Overall Study||63
160767|NCT00703729|370858|P2|NOT COMPLETED|Overall Study||3
160768|NCT00703729|370859|P1|NOT COMPLETED|Overall Study||0
160769|NCT00703729|370858|P2|COMPLETED|Overall Study||21
160770|NCT00703729|370859|P1|COMPLETED|Overall Study||25
160771|NCT00703729|370858|P2|STARTED|Overall Study||24
160772|NCT00703729|370859|P1|STARTED|Overall Study||25
160773|NCT00703677|370893|P1|NOT COMPLETED|Overall Study||3
160774|NCT00703677|370893|P1|COMPLETED|Overall Study||14
160775|NCT00703677|370893|P1|STARTED|Overall Study||17
160776|NCT00703534|370908|P2|NOT COMPLETED|Overall Study||25
160777|NCT00703534|370909|P1|NOT COMPLETED|Overall Study||30
160778|NCT00703534|370908|P2|COMPLETED|Overall Study||218
160779|NCT00703534|370909|P1|COMPLETED|Overall Study||205
160780|NCT00703534|370908|P2|STARTED|Overall Study||243
160781|NCT00703534|370909|P1|STARTED|Overall Study||235
160782|NCT00703391|370917|P2|NOT COMPLETED|Overall Study||0
160783|NCT00703391|370918|P1|NOT COMPLETED|Overall Study||0
160784|NCT00703391|370917|P2|COMPLETED|Overall Study||6
160785|NCT00703391|370918|P1|COMPLETED|Overall Study||12
160786|NCT00703391|370917|P2|STARTED|Overall Study||6
160787|NCT00703391|370918|P1|STARTED|Overall Study||12
160788|NCT00703339|370962|P1|NOT COMPLETED|Overall Study||0
160789|NCT00703339|370962|P1|COMPLETED|Overall Study||1
160790|NCT00703339|370962|P1|STARTED|Overall Study||1
160791|NCT00703326|370968|P2|NOT COMPLETED|Overall Study||225
160792|NCT00703326|370969|P1|NOT COMPLETED|Overall Study||447
160793|NCT00703326|370968|P2|COMPLETED|Overall Study||160
160794|NCT00703326|370969|P1|COMPLETED|Overall Study||312
160795|NCT00703326|370968|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
160796|NCT00703326|370969|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
160797|NCT00703326|370968|P2|STARTED|Overall Study||385
160798|NCT00703326|370969|P1|STARTED|Overall Study||759
160799|NCT00703261|370991|P2|NOT COMPLETED|Overall Study||6
160800|NCT00703261|370992|P1|NOT COMPLETED|Overall Study||6
160801|NCT00703261|370991|P2|COMPLETED|Overall Study||35
160802|NCT00703261|370992|P1|COMPLETED|Overall Study||36
160803|NCT00703261|370991|P2|STARTED|Overall Study||41
160804|NCT00703261|370992|P1|STARTED|Overall Study||42
160805|NCT00703118|371002|P3|NOT COMPLETED|Overall Study||22
160806|NCT00703118|371003|P2|NOT COMPLETED|Overall Study||16
160807|NCT00703118|371004|P1|NOT COMPLETED|Overall Study||21
160808|NCT00703118|371002|P3|COMPLETED|Overall Study||110
160809|NCT00703118|371003|P2|COMPLETED|Overall Study||248
160810|NCT00703118|371004|P1|COMPLETED|Overall Study||245
160811|NCT00703118|371002|P3|STARTED|Overall Study||132
160812|NCT00703118|371003|P2|STARTED|Overall Study||264
160813|NCT00703118|371004|P1|STARTED|Overall Study||266
160814|NCT00703092|371035|P1|NOT COMPLETED|Overall Study||2
160815|NCT00703092|371035|P1|COMPLETED|Overall Study||0
160816|NCT00703092|371035|P1|STARTED|Overall Study||2
160817|NCT00703053|371048|P9|NOT COMPLETED|Overall Study||1
160818|NCT00703053|371049|P8|NOT COMPLETED|Overall Study||6
160819|NCT00703053|371050|P7|NOT COMPLETED|Overall Study||7
160820|NCT00703053|371051|P6|NOT COMPLETED|Overall Study||6
160821|NCT00703053|371052|P5|NOT COMPLETED|Overall Study||1
160822|NCT00703053|371053|P4|NOT COMPLETED|Overall Study||3
160823|NCT00703053|371054|P3|NOT COMPLETED|Overall Study||3
160824|NCT00703053|371055|P2|NOT COMPLETED|Overall Study||2
160825|NCT00703053|371056|P1|NOT COMPLETED|Overall Study||1
160826|NCT00703053|371048|P9|COMPLETED|Overall Study||102
160828|NCT00703053|371050|P7|COMPLETED|Overall Study||45
160829|NCT00703053|371051|P6|COMPLETED|Overall Study||43
160830|NCT00703053|371052|P5|COMPLETED|Overall Study||50
160831|NCT00703053|371053|P4|COMPLETED|Overall Study||46
160832|NCT00703053|371054|P3|COMPLETED|Overall Study||48
160833|NCT00703053|371055|P2|COMPLETED|Overall Study||24
160834|NCT00703053|371056|P1|COMPLETED|Overall Study||26
160835|NCT00703053|371048|P9|STARTED|Overall Study||103
160836|NCT00703053|371049|P8|STARTED|Overall Study||97
160837|NCT00703053|371050|P7|STARTED|Overall Study||52
160838|NCT00703053|371051|P6|STARTED|Overall Study||49
160839|NCT00703053|371052|P5|STARTED|Overall Study||51
160840|NCT00703053|371053|P4|STARTED|Overall Study||49
160841|NCT00703053|371054|P3|STARTED|Overall Study||51
160842|NCT00703053|371055|P2|STARTED|Overall Study||26
160843|NCT00703053|371056|P1|STARTED|Overall Study||27
160844|NCT00703014|371242|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
160845|NCT00703014|371243|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
160846|NCT00703014|371244|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
160847|NCT00703014|371245|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
160848|NCT00703014|371242|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
160849|NCT00703014|371243|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
160850|NCT00703014|371244|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
160851|NCT00703014|371245|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
160852|NCT00703014|371242|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
160853|NCT00703014|371243|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
160854|NCT00703014|371244|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
160855|NCT00703014|371245|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
160856|NCT00703014|371242|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
160857|NCT00703014|371243|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
160858|NCT00703014|371244|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
160859|NCT00703014|371245|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
160860|NCT00703014|371242|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
160861|NCT00703014|371243|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
160862|NCT00703014|371244|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
160863|NCT00703014|371245|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
160864|NCT00703014|371242|P4|COMPLETED|Mothers Follow Up Trial P05712||0
160865|NCT00703014|371243|P3|COMPLETED|Mothers Follow Up Trial P05712||0
160866|NCT00703014|371244|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
160867|NCT00703014|371245|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
160868|NCT00703014|371242|P4|STARTED|Mothers Follow Up Trial P05712||0
160869|NCT00703014|371243|P3|STARTED|Mothers Follow Up Trial P05712||0
160870|NCT00703014|371244|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
160871|NCT00703014|371245|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
160872|NCT00703014|371242|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
160873|NCT00703014|371243|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
160874|NCT00703014|371244|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
160875|NCT00703014|371245|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
160876|NCT00703014|371242|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
160877|NCT00703014|371243|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
160878|NCT00703014|371244|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
160879|NCT00703014|371245|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
160880|NCT00703014|371242|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
160881|NCT00703014|371243|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
160882|NCT00703014|371244|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
160883|NCT00703014|371245|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
160884|NCT00703014|371242|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
160885|NCT00703014|371243|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
160886|NCT00703014|371244|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
160887|NCT00703014|371245|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
160888|NCT00703014|371242|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
160889|NCT00703014|371243|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
160890|NCT00703014|371244|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
160891|NCT00703014|371245|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
160892|NCT00702949|371266|P3|NOT COMPLETED|Overall Study||8
160893|NCT00702949|371267|P2|NOT COMPLETED|Overall Study||9
160894|NCT00702949|371268|P1|NOT COMPLETED|Overall Study||5
160895|NCT00702949|371266|P3|COMPLETED|Overall Study||54
160896|NCT00702949|371267|P2|COMPLETED|Overall Study||57
160897|NCT00702949|371268|P1|COMPLETED|Overall Study||58
160898|NCT00702949|371266|P3|Evaluable for Primary Endpoint|Overall Study||51
160899|NCT00702949|371267|P2|Evaluable for Primary Endpoint|Overall Study||56
160900|NCT00702949|371268|P1|Evaluable for Primary Endpoint|Overall Study||56
160901|NCT00702949|371266|P3|STARTED|Overall Study||62
160902|NCT00702949|371267|P2|STARTED|Overall Study||66
160903|NCT00702949|371268|P1|STARTED|Overall Study||63
160904|NCT00702923|371293|P1|NOT COMPLETED|Overall Study||1
160905|NCT00702923|371293|P1|COMPLETED|Overall Study||11
160906|NCT00702923|371293|P1|STARTED|Overall Study||12
160907|NCT00702845|371304|P2|NOT COMPLETED|Overall Study||8
160908|NCT00702845|371305|P1|NOT COMPLETED|Overall Study||22
160909|NCT00702845|371304|P2|COMPLETED|Overall Study||121
160910|NCT00702845|371305|P1|COMPLETED|Overall Study||246
160911|NCT00702845|371304|P2|Randomized|Overall Study||128
160912|NCT00702845|371305|P1|Randomized|Overall Study||268
160913|NCT00702845|371304|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
160914|NCT00702845|371305|P1|STARTED|Overall Study||268
160915|NCT00702780|371345|P2|NOT COMPLETED|Overall Study||8
160916|NCT00702780|371346|P1|NOT COMPLETED|Overall Study||9
160917|NCT00702780|371345|P2|COMPLETED|Overall Study||29
160918|NCT00702780|371346|P1|COMPLETED|Overall Study||28
160919|NCT00702780|371345|P2|STARTED|Overall Study||37
160920|NCT00702780|371346|P1|STARTED|Overall Study||37
160921|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
160922|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
160923|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
160924|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
160925|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
160926|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
160927|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
160928|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
160929|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
160930|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
160931|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
160932|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
160933|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
160934|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
160935|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
160936|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
160937|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
160938|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
160939|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
160940|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
160941|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
160942|NCT00702754|371354|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
160943|NCT00702754|371354|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
160944|NCT00702754|371354|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
160945|NCT00702715|371367|P2|NOT COMPLETED|Overall Study||0
160946|NCT00702715|371368|P1|NOT COMPLETED|Overall Study||1
160947|NCT00702715|371367|P2|COMPLETED|Overall Study||33
160948|NCT00702715|371368|P1|COMPLETED|Overall Study||34
160949|NCT00702715|371367|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
160950|NCT00702715|371368|P1|STARTED|Overall Study||35
160951|NCT00702702|371381|P1|NOT COMPLETED|Overall Study||56
160952|NCT00702702|371381|P1|COMPLETED|Overall Study||0
160953|NCT00702702|371381|P1|STARTED|Overall Study||56
160954|NCT00702689|371389|P1|NOT COMPLETED|Overall Study||6
160955|NCT00702689|371389|P1|COMPLETED|Overall Study||14
160956|NCT00702689|371389|P1|STARTED|Overall Study||20
160957|NCT00702650|371394|P1|NOT COMPLETED|Overall Study||20
160958|NCT00702650|371394|P1|COMPLETED|Overall Study||135
160959|NCT00702650|371394|P1|STARTED|Overall Study||155
160960|NCT00702624|371414|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
160961|NCT00702624|371415|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
160962|NCT00702624|371416|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
160963|NCT00702624|371417|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
160964|NCT00702624|371414|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
160965|NCT00702624|371415|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
160966|NCT00702624|371416|P2|COMPLETED|Fetuses/Infant Follow-up||0
160967|NCT00702624|371417|P1|COMPLETED|Fetuses/Infant Follow-up||0
160968|NCT00702624|371414|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
160969|NCT00702624|371415|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
160970|NCT00702624|371416|P2|Live Born Infants|Fetuses/Infant Follow-up||0
160971|NCT00702624|371417|P1|Live Born Infants|Fetuses/Infant Follow-up||0
160972|NCT00702624|371414|P4|STARTED|Fetuses/Infant Follow-up||55
160973|NCT00702624|371415|P3|STARTED|Fetuses/Infant Follow-up||88
160974|NCT00702624|371416|P2|STARTED|Fetuses/Infant Follow-up||0
160975|NCT00702624|371417|P1|STARTED|Fetuses/Infant Follow-up||0
160976|NCT00702624|371414|P4|NOT COMPLETED|Expectant Mother Follow-up||0
160977|NCT00702624|371415|P3|NOT COMPLETED|Expectant Mother Follow-up||0
160978|NCT00702624|371416|P2|NOT COMPLETED|Expectant Mother Follow-up||0
160979|NCT00702624|371417|P1|NOT COMPLETED|Expectant Mother Follow-up||7
160980|NCT00702624|371414|P4|COMPLETED|Expectant Mother Follow-up||0
160981|NCT00702624|371415|P3|COMPLETED|Expectant Mother Follow-up||0
160982|NCT00702624|371416|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
160983|NCT00702624|371417|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
160984|NCT00702624|371414|P4|STARTED|Expectant Mother Follow-up||0
160985|NCT00702624|371415|P3|STARTED|Expectant Mother Follow-up||0
160986|NCT00702624|371416|P2|STARTED|Expectant Mother Follow-up||45
160987|NCT00702624|371417|P1|STARTED|Expectant Mother Follow-up||68
160988|NCT00702624|371414|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
160989|NCT00702624|371415|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
160990|NCT00702624|371416|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
160991|NCT00702624|371417|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
160992|NCT00702624|371414|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
160993|NCT00702624|371415|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
160994|NCT00702624|371416|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
160995|NCT00702624|371417|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
160996|NCT00702624|371414|P4|STARTED|Base Study P05690 (NCT00702845)||0
160997|NCT00702624|371415|P3|STARTED|Base Study P05690 (NCT00702845)||0
160998|NCT00702624|371416|P2|STARTED|Base Study P05690 (NCT00702845)||128
160999|NCT00702624|371417|P1|STARTED|Base Study P05690 (NCT00702845)||268
161000|NCT00702546|371435|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
161001|NCT00702546|371436|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
161002|NCT00702546|371435|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
161003|NCT00702546|371436|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
161004|NCT00702546|371435|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
161005|NCT00702546|371436|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
161006|NCT00702546|371435|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
161007|NCT00702546|371436|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
161008|NCT00702546|371435|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
161009|NCT00702546|371436|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
161010|NCT00702546|371435|P2|STARTED|Base Study P05690 (NCT00702845)||128
161011|NCT00702546|371436|P1|STARTED|Base Study P05690 (NCT00702845)||268
161012|NCT00702520|371456|P4|NOT COMPLETED|Follow-up Study P05783||0
161013|NCT00702520|371457|P3|NOT COMPLETED|Follow-up Study P05783||0
161014|NCT00702520|371458|P2|NOT COMPLETED|Follow-up Study P05783||0
161015|NCT00702520|371459|P1|NOT COMPLETED|Follow-up Study P05783||0
161016|NCT00702520|371456|P4|COMPLETED|Follow-up Study P05783||11
161017|NCT00702520|371457|P3|COMPLETED|Follow-up Study P05783||8
161018|NCT00702520|371458|P2|COMPLETED|Follow-up Study P05783||8
161019|NCT00702520|371459|P1|COMPLETED|Follow-up Study P05783||7
161020|NCT00702520|371456|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
161021|NCT00702520|371457|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
161022|NCT00702520|371458|P2|STARTED|Follow-up Study P05783||8
161023|NCT00702520|371459|P1|STARTED|Follow-up Study P05783||7
161024|NCT00702520|371456|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
161025|NCT00702520|371457|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
161026|NCT00702520|371458|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
161027|NCT00702520|371459|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
161028|NCT00702520|371456|P4|COMPLETED|Base Study P05788 - Follow-Up||0
161029|NCT00702520|371457|P3|COMPLETED|Base Study P05788 - Follow-Up||0
161030|NCT00702520|371458|P2|COMPLETED|Base Study P05788 - Follow-Up||8
161031|NCT00702520|371459|P1|COMPLETED|Base Study P05788 - Follow-Up||7
161032|NCT00702520|371456|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
161033|NCT00702520|371457|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
161034|NCT00702520|371458|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
161035|NCT00702520|371459|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
161036|NCT00702520|371456|P4|STARTED|Base Study P05788 - Follow-Up||0
161037|NCT00702520|371457|P3|STARTED|Base Study P05788 - Follow-Up||0
161038|NCT00702520|371458|P2|STARTED|Base Study P05788 - Follow-Up||18
161039|NCT00702520|371459|P1|STARTED|Base Study P05788 - Follow-Up||22
161040|NCT00702520|371456|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
161041|NCT00702520|371457|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
161042|NCT00702520|371458|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
161043|NCT00702520|371459|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
161044|NCT00702520|371456|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
161045|NCT00702520|371457|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
161046|NCT00702520|371458|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
161047|NCT00702520|371459|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
161048|NCT00702520|371456|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
161049|NCT00702520|371457|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
161050|NCT00702520|371458|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
161051|NCT00702520|371459|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
161052|NCT00702520|371456|P4|STARTED|Base Study P05788 - Embryo Transfer||0
161053|NCT00702520|371457|P3|STARTED|Base Study P05788 - Embryo Transfer||0
161054|NCT00702520|371458|P2|STARTED|Base Study P05788 - Embryo Transfer||24
161055|NCT00702520|371459|P1|STARTED|Base Study P05788 - Embryo Transfer||25
161056|NCT00702520|371456|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
161057|NCT00702520|371457|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
161058|NCT00702520|371458|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
161059|NCT00702520|371459|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
161060|NCT00702520|371456|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
161061|NCT00702520|371457|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
161062|NCT00702520|371458|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
161063|NCT00702520|371459|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
161064|NCT00702520|371456|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
161065|NCT00702520|371457|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
161066|NCT00702520|371458|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
161067|NCT00702520|371459|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
161068|NCT00702520|371456|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
161069|NCT00702520|371457|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
161070|NCT00702520|371458|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
161071|NCT00702520|371459|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
161072|NCT00702520|371456|P4|STARTED|Base Study P05788 - Assigned Treatment||0
161073|NCT00702520|371457|P3|STARTED|Base Study P05788 - Assigned Treatment||0
161074|NCT00702520|371458|P2|STARTED|Base Study P05788 - Assigned Treatment||25
161075|NCT00702520|371459|P1|STARTED|Base Study P05788 - Assigned Treatment||25
161076|NCT00702507|371475|P1|NOT COMPLETED|Follow-up Phase||27
161077|NCT00702507|371475|P1|COMPLETED|Follow-up Phase||132
161078|NCT00702507|371475|P1|STARTED|Follow-up Phase||159
161079|NCT00702507|371475|P1|NOT COMPLETED|Initial Treatment Phase||41
161080|NCT00702507|371475|P1|COMPLETED|Initial Treatment Phase||159
161081|NCT00702507|371475|P1|STARTED|Initial Treatment Phase||200
161082|NCT00702468|371489|P2|NOT COMPLETED|Overall Study||16
161083|NCT00702468|371490|P1|NOT COMPLETED|Overall Study||3
161084|NCT00702468|371489|P2|COMPLETED|Overall Study||2
161085|NCT00702468|371490|P1|COMPLETED|Overall Study||15
161086|NCT00702468|371489|P2|STARTED|Overall Study||18
161087|NCT00702468|371490|P1|STARTED|Overall Study||18
161088|NCT00702377|371514|P2|NOT COMPLETED|Overall Study||3
161089|NCT00702377|371515|P1|NOT COMPLETED|Overall Study||1
161090|NCT00702377|371514|P2|COMPLETED|Overall Study||53
161091|NCT00702377|371515|P1|COMPLETED|Overall Study||52
161092|NCT00702377|371514|P2|STARTED|Overall Study||56
161093|NCT00702377|371515|P1|STARTED|Overall Study||53
161094|NCT00702364|371527|P2|NOT COMPLETED|Overall Study||4
161095|NCT00702364|371528|P1|NOT COMPLETED|Overall Study||2
161096|NCT00702364|371527|P2|COMPLETED|Overall Study||25
161097|NCT00702364|371528|P1|COMPLETED|Overall Study||24
161098|NCT00702364|371527|P2|STARTED|Overall Study||29
161099|NCT00702364|371528|P1|STARTED|Overall Study||26
161100|NCT00702338|371540|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
161101|NCT00702338|371541|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
161102|NCT00702338|371542|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
161103|NCT00702338|371540|P3|COMPLETED|Follow-up Study: Infant FU||0
161104|NCT00702338|371541|P2|COMPLETED|Follow-up Study: Infant FU||0
161105|NCT00702338|371542|P1|COMPLETED|Follow-up Study: Infant FU||0
161106|NCT00702338|371540|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
161107|NCT00702338|371541|P2|STARTED|Follow-up Study: Infant FU||0
161108|NCT00702338|371542|P1|STARTED|Follow-up Study: Infant FU||0
161109|NCT00702338|371540|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
161110|NCT00702338|371541|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
161111|NCT00702338|371542|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
161112|NCT00702338|371540|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
161113|NCT00702338|371541|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
161114|NCT00702338|371542|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
161115|NCT00702338|371540|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
161116|NCT00702338|371541|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
161117|NCT00702338|371542|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
161118|NCT00702338|371540|P3|NOT COMPLETED|Base Study (NCT00697255)||0
161119|NCT00702338|371541|P2|NOT COMPLETED|Base Study (NCT00697255)||2
161120|NCT00702338|371542|P1|NOT COMPLETED|Base Study (NCT00697255)||3
161121|NCT00702338|371540|P3|COMPLETED|Base Study (NCT00697255)||0
161122|NCT00702338|371541|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
161123|NCT00702338|371542|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
161124|NCT00702338|371540|P3|STARTED|Base Study (NCT00697255)||0
161125|NCT00702338|371541|P2|STARTED|Base Study (NCT00697255)||3
161126|NCT00702338|371542|P1|STARTED|Base Study (NCT00697255)||5
161127|NCT00702325|371558|P2|NOT COMPLETED|Overall Study||53
161128|NCT00702325|371559|P1|NOT COMPLETED|Overall Study||38
161129|NCT00702325|371558|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
161130|NCT00702325|371559|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
161131|NCT00702325|371558|P2|STARTED|Overall Study|Randomized|155
161132|NCT00702325|371559|P1|STARTED|Overall Study|Randomized|156
161133|NCT00702299|371611|P1|NOT COMPLETED|Overall Study||0
161134|NCT00702299|371611|P1|COMPLETED|Overall Study||15
161135|NCT00702299|371611|P1|STARTED|Overall Study||15
161136|NCT00702273|371624|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
161137|NCT00702273|371625|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
161138|NCT00702273|371624|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
161139|NCT00702273|371625|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
161140|NCT00702273|371624|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
161141|NCT00702273|371625|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
161142|NCT00702273|371624|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
161143|NCT00702273|371625|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
161144|NCT00702273|371624|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
161145|NCT00702273|371625|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
161146|NCT00702273|371624|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
161147|NCT00702273|371625|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
161148|NCT00702273|371624|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
161149|NCT00702273|371625|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
161150|NCT00702234|371643|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
161151|NCT00702234|371644|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
161152|NCT00702234|371643|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
161153|NCT00702234|371644|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
161154|NCT00702234|371643|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
161155|NCT00702234|371644|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
161156|NCT00702234|371643|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
161157|NCT00702234|371644|P1|STARTED|Follow-up Study: Fetuses/Infants||0
161158|NCT00702234|371643|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
161159|NCT00702234|371644|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
161160|NCT00702234|371643|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
161161|NCT00702234|371644|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
161162|NCT00702234|371643|P2|STARTED|Follow-up Study: Expectant Mothers||0
161163|NCT00702234|371644|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
161164|NCT00702234|371643|P2|NOT COMPLETED|Base Study (NCT00696878)||0
161165|NCT00702234|371644|P1|NOT COMPLETED|Base Study (NCT00696878)||504
161166|NCT00702234|371643|P2|COMPLETED|Base Study (NCT00696878)||0
161167|NCT00702234|371644|P1|COMPLETED|Base Study (NCT00696878)||178
161168|NCT00702234|371643|P2|STARTED|Base Study (NCT00696878)||0
161169|NCT00702234|371644|P1|STARTED|Base Study (NCT00696878)||682
161170|NCT00702221|371655|P2|NOT COMPLETED|Overall Study||3
161171|NCT00702221|371656|P1|NOT COMPLETED|Overall Study||4
161172|NCT00702221|371655|P2|COMPLETED|Overall Study||7
161173|NCT00702221|371656|P1|COMPLETED|Overall Study||6
161174|NCT00702221|371655|P2|STARTED|Overall Study||10
161175|NCT00702221|371656|P1|STARTED|Overall Study||10
161176|NCT00702208|371662|P1|NOT COMPLETED|Overall Study||31
161177|NCT00702208|371662|P1|COMPLETED|Overall Study||167
161178|NCT00702208|371662|P1|STARTED|Overall Study||198
161179|NCT00702143|371671|P3|NOT COMPLETED|Overall Study||1
161180|NCT00702143|371672|P2|NOT COMPLETED|Overall Study||0
161181|NCT00702143|371673|P1|NOT COMPLETED|Overall Study||0
161182|NCT00702143|371671|P3|COMPLETED|Overall Study||78
161183|NCT00702143|371672|P2|COMPLETED|Overall Study||60
161184|NCT00702143|371673|P1|COMPLETED|Overall Study||45
161185|NCT00702143|371671|P3|STARTED|Overall Study||79
161186|NCT00702143|371672|P2|STARTED|Overall Study||60
161187|NCT00702143|371673|P1|STARTED|Overall Study||45
161188|NCT00701935|371687|P2|NOT COMPLETED|Overall Study||11
161189|NCT00701935|371688|P1|NOT COMPLETED|Overall Study||16
161190|NCT00701935|371687|P2|COMPLETED|Overall Study||26
161191|NCT00701935|371688|P1|COMPLETED|Overall Study||27
161192|NCT00701935|371687|P2|STARTED|Overall Study||37
161193|NCT00701935|371688|P1|STARTED|Overall Study||43
161194|NCT00701805|371722|P4|NOT COMPLETED|Overall Study||4
161195|NCT00701805|371723|P3|NOT COMPLETED|Overall Study||7
161196|NCT00701805|371724|P2|NOT COMPLETED|Overall Study||4
161197|NCT00701805|371725|P1|NOT COMPLETED|Overall Study||3
161198|NCT00701805|371722|P4|COMPLETED|Overall Study||22
161199|NCT00701805|371723|P3|COMPLETED|Overall Study||16
161200|NCT00701805|371724|P2|COMPLETED|Overall Study||25
161201|NCT00701805|371725|P1|COMPLETED|Overall Study||23
161202|NCT00701805|371722|P4|STARTED|Overall Study||26
161203|NCT00701805|371723|P3|STARTED|Overall Study||23
161204|NCT00701805|371724|P2|STARTED|Overall Study||29
161205|NCT00701805|371725|P1|STARTED|Overall Study||26
161206|NCT00701779|371775|P1|NOT COMPLETED|Overall Study||9
161207|NCT00701779|371775|P1|COMPLETED|Overall Study||54
161208|NCT00701779|371775|P1|12 Month|Overall Study||54
161209|NCT00701779|371775|P1|9 Month|Overall Study||56
161210|NCT00701779|371775|P1|6 Month|Overall Study||58
161211|NCT00701779|371775|P1|3 Month|Overall Study||60
161212|NCT00701779|371775|P1|STARTED|Overall Study||63
161213|NCT00701727|371784|P2|NOT COMPLETED|Second Treatment Period||0
161214|NCT00701727|371785|P1|NOT COMPLETED|Second Treatment Period||2
161215|NCT00701727|371784|P2|COMPLETED|Second Treatment Period||13
161216|NCT00701727|371785|P1|COMPLETED|Second Treatment Period||13
161217|NCT00701727|371784|P2|STARTED|Second Treatment Period||13
161218|NCT00701727|371785|P1|STARTED|Second Treatment Period||15
161219|NCT00701727|371784|P2|NOT COMPLETED|First Treatment Period||2
161220|NCT00701727|371785|P1|NOT COMPLETED|First Treatment Period||1
161221|NCT00701727|371784|P2|COMPLETED|First Treatment Period||13
161222|NCT00701727|371785|P1|COMPLETED|First Treatment Period||15
161223|NCT00701727|371784|P2|STARTED|First Treatment Period||15
161224|NCT00701727|371785|P1|STARTED|First Treatment Period||16
161225|NCT00701675|371806|P3|NOT COMPLETED|Overall Study||7
161226|NCT00701675|371807|P2|NOT COMPLETED|Overall Study||8
161227|NCT00701675|371808|P1|NOT COMPLETED|Overall Study||4
161228|NCT00701675|371806|P3|COMPLETED|Overall Study||7
161229|NCT00701675|371807|P2|COMPLETED|Overall Study||6
161230|NCT00701675|371808|P1|COMPLETED|Overall Study||10
161231|NCT00701675|371806|P3|STARTED|Overall Study||14
161232|NCT00701675|371807|P2|STARTED|Overall Study||14
161233|NCT00701675|371808|P1|STARTED|Overall Study||14
161234|NCT00701662|371816|P1|NOT COMPLETED|Overall Study||1
161235|NCT00701662|371816|P1|COMPLETED|Overall Study||7
161236|NCT00701662|371816|P1|STARTED|Overall Study||8
161237|NCT00701636|371835|P2|NOT COMPLETED|Overall Study||0
161238|NCT00701636|371836|P1|NOT COMPLETED|Overall Study||0
161239|NCT00701636|371835|P2|COMPLETED|Overall Study||15
161240|NCT00701636|371836|P1|COMPLETED|Overall Study||15
161241|NCT00701636|371835|P2|STARTED|Overall Study||15
161242|NCT00701636|371836|P1|STARTED|Overall Study||15
161243|NCT00701558|371841|P1|NOT COMPLETED|Overall Study||15
161244|NCT00701558|371841|P1|COMPLETED|Overall Study||4
161245|NCT00701558|371841|P1|STARTED|Overall Study||19
161246|NCT00701441|371849|P2|NOT COMPLETED|Overall Study||4
161247|NCT00701441|371850|P1|NOT COMPLETED|Overall Study||0
161248|NCT00701441|371849|P2|COMPLETED|Overall Study||12
161249|NCT00701441|371850|P1|COMPLETED|Overall Study||9
161250|NCT00701441|371849|P2|STARTED|Overall Study||16
161251|NCT00701441|371850|P1|STARTED|Overall Study||9
161252|NCT00701415|371862|P2|NOT COMPLETED|Overall Study||1
161253|NCT00701415|371863|P1|NOT COMPLETED|Overall Study||1
161254|NCT00701415|371862|P2|COMPLETED|Overall Study||14
161255|NCT00701415|371863|P1|COMPLETED|Overall Study||15
161256|NCT00701415|371862|P2|STARTED|Overall Study||15
161257|NCT00701415|371863|P1|STARTED|Overall Study||16
161258|NCT00701389|371873|P4|NOT COMPLETED|Period 4||0
161259|NCT00701389|371874|P3|NOT COMPLETED|Period 4||0
161260|NCT00701389|371875|P2|NOT COMPLETED|Period 4||0
161261|NCT00701389|371876|P1|NOT COMPLETED|Period 4||0
161262|NCT00701389|371873|P4|COMPLETED|Period 4||6
161263|NCT00701389|371874|P3|COMPLETED|Period 4||6
161264|NCT00701389|371875|P2|COMPLETED|Period 4||6
161265|NCT00701389|371876|P1|COMPLETED|Period 4||6
161266|NCT00701389|371873|P4|STARTED|Period 4||6
161267|NCT00701389|371874|P3|STARTED|Period 4||6
161268|NCT00701389|371875|P2|STARTED|Period 4||6
161269|NCT00701389|371876|P1|STARTED|Period 4||6
161270|NCT00701389|371873|P4|NOT COMPLETED|Period 3||0
161271|NCT00701389|371874|P3|NOT COMPLETED|Period 3||0
161272|NCT00701389|371875|P2|NOT COMPLETED|Period 3||0
161273|NCT00701389|371876|P1|NOT COMPLETED|Period 3||0
161274|NCT00701389|371873|P4|COMPLETED|Period 3||6
161275|NCT00701389|371874|P3|COMPLETED|Period 3||6
161276|NCT00701389|371875|P2|COMPLETED|Period 3||6
161277|NCT00701389|371876|P1|COMPLETED|Period 3||6
161278|NCT00701389|371873|P4|STARTED|Period 3||6
161279|NCT00701389|371874|P3|STARTED|Period 3||6
161280|NCT00701389|371875|P2|STARTED|Period 3||6
161281|NCT00701389|371876|P1|STARTED|Period 3||6
161282|NCT00701389|371873|P4|NOT COMPLETED|Period 2||0
161283|NCT00701389|371874|P3|NOT COMPLETED|Period 2||0
161284|NCT00701389|371875|P2|NOT COMPLETED|Period 2||0
161285|NCT00701389|371876|P1|NOT COMPLETED|Period 2||0
161286|NCT00701389|371873|P4|COMPLETED|Period 2||6
161287|NCT00701389|371874|P3|COMPLETED|Period 2||6
161288|NCT00701389|371875|P2|COMPLETED|Period 2||6
161289|NCT00701389|371876|P1|COMPLETED|Period 2||6
161290|NCT00701389|371873|P4|STARTED|Period 2||6
161291|NCT00701389|371874|P3|STARTED|Period 2||6
161292|NCT00701389|371875|P2|STARTED|Period 2||6
161293|NCT00701389|371876|P1|STARTED|Period 2||6
161294|NCT00701389|371873|P4|NOT COMPLETED|Period 1||0
161295|NCT00701389|371874|P3|NOT COMPLETED|Period 1||0
161296|NCT00701389|371875|P2|NOT COMPLETED|Period 1||0
161297|NCT00701389|371876|P1|NOT COMPLETED|Period 1||0
161298|NCT00701389|371873|P4|COMPLETED|Period 1||6
161299|NCT00701389|371874|P3|COMPLETED|Period 1||6
161300|NCT00701389|371875|P2|COMPLETED|Period 1||6
161301|NCT00701389|371876|P1|COMPLETED|Period 1||6
161302|NCT00701389|371873|P4|STARTED|Period 1||6
161303|NCT00701389|371874|P3|STARTED|Period 1||6
161304|NCT00701389|371875|P2|STARTED|Period 1||6
161305|NCT00701389|371876|P1|STARTED|Period 1||6
161306|NCT00701363|371898|P4|NOT COMPLETED|Treatment Phase 2||0
161307|NCT00701363|371899|P3|NOT COMPLETED|Treatment Phase 2||2
161308|NCT00701363|371900|P2|NOT COMPLETED|Treatment Phase 2||0
161309|NCT00701363|371901|P1|NOT COMPLETED|Treatment Phase 2||0
161310|NCT00701363|371898|P4|COMPLETED|Treatment Phase 2||26
161311|NCT00701363|371899|P3|COMPLETED|Treatment Phase 2||68
161312|NCT00701363|371900|P2|COMPLETED|Treatment Phase 2||13
161313|NCT00701363|371901|P1|COMPLETED|Treatment Phase 2||0
161314|NCT00701363|371898|P4|STARTED|Treatment Phase 2||26
161315|NCT00701363|371899|P3|STARTED|Treatment Phase 2||70
161316|NCT00701363|371900|P2|STARTED|Treatment Phase 2||13
161317|NCT00701363|371901|P1|STARTED|Treatment Phase 2||0
161318|NCT00701363|371898|P4|NOT COMPLETED|Treatment Phase 1||0
161319|NCT00701363|371899|P3|NOT COMPLETED|Treatment Phase 1||0
161320|NCT00701363|371900|P2|NOT COMPLETED|Treatment Phase 1||0
161321|NCT00701363|371901|P1|NOT COMPLETED|Treatment Phase 1||15
161322|NCT00701363|371898|P4|COMPLETED|Treatment Phase 1||0
161323|NCT00701363|371899|P3|COMPLETED|Treatment Phase 1||0
161324|NCT00701363|371900|P2|COMPLETED|Treatment Phase 1||0
161325|NCT00701363|371901|P1|COMPLETED|Treatment Phase 1||109
161326|NCT00701363|371898|P4|STARTED|Treatment Phase 1||0
161327|NCT00701363|371899|P3|STARTED|Treatment Phase 1||0
161328|NCT00701363|371900|P2|STARTED|Treatment Phase 1||0
161329|NCT00701363|371901|P1|STARTED|Treatment Phase 1||124
161330|NCT00701363|371898|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
161331|NCT00701363|371899|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
161332|NCT00701363|371900|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
161333|NCT00701363|371901|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
161334|NCT00701363|371898|P4|COMPLETED|Screening (Pre-assignment) Phase||0
161335|NCT00701363|371899|P3|COMPLETED|Screening (Pre-assignment) Phase||0
161336|NCT00701363|371900|P2|COMPLETED|Screening (Pre-assignment) Phase||0
161337|NCT00701363|371901|P1|COMPLETED|Screening (Pre-assignment) Phase||124
161338|NCT00701363|371898|P4|STARTED|Screening (Pre-assignment) Phase||0
161339|NCT00701363|371899|P3|STARTED|Screening (Pre-assignment) Phase||0
161340|NCT00701363|371900|P2|STARTED|Screening (Pre-assignment) Phase||0
161341|NCT00701363|371901|P1|STARTED|Screening (Pre-assignment) Phase||128
161342|NCT00701311|371941|P1|NOT COMPLETED|Overall Study||8
161343|NCT00701311|371941|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
161344|NCT00701311|371941|P1|STARTED|Overall Study||17
161345|NCT00701129|371945|P1|NOT COMPLETED|Overall Study||2
161346|NCT00701129|371945|P1|COMPLETED|Overall Study||2
161347|NCT00701129|371945|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
161348|NCT00701129|371945|P1|STARTED|Overall Study||4
161349|NCT00701090|371958|P2|NOT COMPLETED|Overall Study||51
161350|NCT00701090|371959|P1|NOT COMPLETED|Overall Study||48
161351|NCT00701090|371958|P2|COMPLETED|Overall Study||468
161352|NCT00701090|371959|P1|COMPLETED|Overall Study||468
161353|NCT00701090|371958|P2|STARTED|Overall Study||519
161354|NCT00701090|371959|P1|STARTED|Overall Study||516
161355|NCT00701064|371977|P2|NOT COMPLETED|Overall Study||4
161356|NCT00701064|371978|P1|NOT COMPLETED|Overall Study||4
161357|NCT00701064|371977|P2|COMPLETED|Overall Study||32
161358|NCT00701064|371978|P1|COMPLETED|Overall Study||31
161359|NCT00701064|371977|P2|STARTED|Overall Study||36
161360|NCT00701064|371978|P1|STARTED|Overall Study||35
161361|NCT00701051|371986|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
161362|NCT00701051|371987|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
161363|NCT00701051|371988|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
161364|NCT00701051|371986|P3|COMPLETED|Detraining Intervention (Optional)||6
161365|NCT00701051|371987|P2|COMPLETED|Detraining Intervention (Optional)||6
161366|NCT00701051|371988|P1|COMPLETED|Detraining Intervention (Optional)||0
161367|NCT00701051|371986|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
161368|NCT00701051|371987|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
161369|NCT00701051|371988|P1|STARTED|Detraining Intervention (Optional)||0
161370|NCT00701051|371986|P3|NOT COMPLETED|Exercise Intervention||3
161371|NCT00701051|371987|P2|NOT COMPLETED|Exercise Intervention||5
161372|NCT00701051|371988|P1|NOT COMPLETED|Exercise Intervention||0
161373|NCT00701051|371986|P3|COMPLETED|Exercise Intervention||9
161374|NCT00701051|371987|P2|COMPLETED|Exercise Intervention||14
161375|NCT00701051|371988|P1|COMPLETED|Exercise Intervention||0
161376|NCT00701051|371986|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
161377|NCT00701051|371987|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
161378|NCT00701051|371988|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
161379|NCT00701051|371986|P3|NOT COMPLETED|Screening||0
161380|NCT00701051|371987|P2|NOT COMPLETED|Screening||0
161381|NCT00701051|371988|P1|NOT COMPLETED|Screening||59
161382|NCT00701051|371986|P3|COMPLETED|Screening||0
161383|NCT00701051|371987|P2|COMPLETED|Screening||0
161384|NCT00701051|371988|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
161385|NCT00701051|371986|P3|STARTED|Screening||0
161386|NCT00701051|371987|P2|STARTED|Screening||0
161387|NCT00701051|371988|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
161388|NCT00701038|372006|P2|NOT COMPLETED|Overall Study||4
161389|NCT00701038|372007|P1|NOT COMPLETED|Overall Study||4
161390|NCT00701038|372006|P2|COMPLETED|Overall Study||23
161391|NCT00701038|372007|P1|COMPLETED|Overall Study||23
161392|NCT00701038|372006|P2|STARTED|Overall Study||27
161393|NCT00701038|372007|P1|STARTED|Overall Study||27
161394|NCT00700999|372015|P2|NOT COMPLETED|Overall Study||9
161395|NCT00700999|372016|P1|NOT COMPLETED|Overall Study||15
161396|NCT00700999|372015|P2|COMPLETED|Overall Study||20
161397|NCT00700999|372016|P1|COMPLETED|Overall Study||21
161398|NCT00700999|372015|P2|Second MRI Scan|Overall Study||18
161399|NCT00700999|372016|P1|Second MRI Scan|Overall Study||19
161400|NCT00700999|372015|P2|First MRI Scan|Overall Study||22
161401|NCT00700999|372016|P1|First MRI Scan|Overall Study||29
161402|NCT00700999|372015|P2|STARTED|Overall Study||29
161403|NCT00700999|372016|P1|STARTED|Overall Study||36
161404|NCT00700973|372024|P2|NOT COMPLETED|Overall Study||7
161405|NCT00700973|372025|P1|NOT COMPLETED|Overall Study||8
161406|NCT00700973|372024|P2|COMPLETED|Overall Study||63
161407|NCT00700973|372025|P1|COMPLETED|Overall Study||63
161408|NCT00700973|372024|P2|STARTED|Overall Study||70
161409|NCT00700973|372025|P1|STARTED|Overall Study||71
161410|NCT00700817|372036|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
161411|NCT00700817|372037|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
161412|NCT00700817|372038|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
161413|NCT00700817|372039|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
161414|NCT00700817|372040|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
161415|NCT00700817|372036|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
161416|NCT00700817|372037|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
161417|NCT00700817|372038|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
161418|NCT00700817|372039|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
161419|NCT00700817|372040|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
161420|NCT00700817|372036|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
161421|NCT00700817|372037|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
161422|NCT00700817|372038|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
161423|NCT00700817|372039|P2|STARTED|Week 52-78 (Extension Period 2)||150
161424|NCT00700817|372040|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
161425|NCT00700817|372036|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
161426|NCT00700817|372037|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
161427|NCT00700817|372038|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
161428|NCT00700817|372039|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
161429|NCT00700817|372040|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
161430|NCT00700817|372036|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
161431|NCT00700817|372037|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
161432|NCT00700817|372038|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
161433|NCT00700817|372039|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
161434|NCT00700817|372040|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
161435|NCT00700817|372036|P5|STARTED|Week 26-52 (Extension Period 1)||0
161436|NCT00700817|372037|P4|STARTED|Week 26-52 (Extension Period 1)||0
161437|NCT00700817|372038|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
161438|NCT00700817|372039|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
161439|NCT00700817|372040|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
161440|NCT00700817|372036|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
161441|NCT00700817|372037|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
161442|NCT00700817|372038|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
161443|NCT00700817|372039|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
161444|NCT00700817|372040|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
161445|NCT00700817|372036|P5|COMPLETED|Week 0-26 (Main Period)||0
161446|NCT00700817|372037|P4|COMPLETED|Week 0-26 (Main Period)||0
161447|NCT00700817|372038|P3|COMPLETED|Week 0-26 (Main Period)||194
161448|NCT00700817|372039|P2|COMPLETED|Week 0-26 (Main Period)||191
161449|NCT00700817|372040|P1|COMPLETED|Week 0-26 (Main Period)||169
161450|NCT00700817|372036|P5|Exposed|Week 0-26 (Main Period)||0
161451|NCT00700817|372037|P4|Exposed|Week 0-26 (Main Period)||0
161452|NCT00700817|372038|P3|Exposed|Week 0-26 (Main Period)||219
161453|NCT00700817|372039|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
161454|NCT00700817|372040|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
161455|NCT00700817|372036|P5|STARTED|Week 0-26 (Main Period)||0
161456|NCT00700817|372037|P4|STARTED|Week 0-26 (Main Period)||0
161457|NCT00700817|372038|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
161458|NCT00700817|372039|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
161459|NCT00700817|372040|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
161460|NCT00700804|372422|P2|NOT COMPLETED|Overall Study||4
161461|NCT00700804|372423|P1|NOT COMPLETED|Overall Study||3
161462|NCT00700804|372422|P2|COMPLETED|Overall Study||13
161463|NCT00700804|372423|P1|COMPLETED|Overall Study||14
161464|NCT00700804|372422|P2|STARTED|Overall Study||17
161465|NCT00700804|372423|P1|STARTED|Overall Study||17
161466|NCT00700752|372431|P2|NOT COMPLETED|Second Intervention||0
161467|NCT00700752|372432|P1|NOT COMPLETED|Second Intervention||0
161468|NCT00700752|372431|P2|COMPLETED|Second Intervention||18
161469|NCT00700752|372432|P1|COMPLETED|Second Intervention||20
161470|NCT00700752|372431|P2|STARTED|Second Intervention||18
161471|NCT00700752|372432|P1|STARTED|Second Intervention||20
161472|NCT00700752|372431|P2|NOT COMPLETED|First Intervention||2
161473|NCT00700752|372432|P1|NOT COMPLETED|First Intervention||0
161474|NCT00700752|372431|P2|COMPLETED|First Intervention||18
161475|NCT00700752|372432|P1|COMPLETED|First Intervention||20
161476|NCT00700752|372431|P2|STARTED|First Intervention||20
161477|NCT00700752|372432|P1|STARTED|First Intervention||20
161478|NCT00700739|372440|P2|NOT COMPLETED|Overall Study||4
161479|NCT00700739|372441|P1|NOT COMPLETED|Overall Study||4
161480|NCT00700739|372440|P2|COMPLETED|Overall Study||12
161481|NCT00700739|372441|P1|COMPLETED|Overall Study||18
161482|NCT00700739|372440|P2|STARTED|Overall Study||16
161483|NCT00700739|372441|P1|STARTED|Overall Study||22
161484|NCT00700713|372480|P3|NOT COMPLETED|Overall Study||2
161485|NCT00700713|372481|P2|NOT COMPLETED|Overall Study||0
161486|NCT00700713|372482|P1|NOT COMPLETED|Overall Study||1
161487|NCT00700713|372480|P3|COMPLETED|Overall Study||65
161488|NCT00700713|372481|P2|COMPLETED|Overall Study||66
161489|NCT00700713|372482|P1|COMPLETED|Overall Study||47
161490|NCT00700713|372480|P3|STARTED|Overall Study||67
161491|NCT00700713|372481|P2|STARTED|Overall Study||66
161492|NCT00700713|372482|P1|STARTED|Overall Study||48
161493|NCT00700635|372499|P3|NOT COMPLETED|Overall Study||1
161494|NCT00700635|372500|P2|NOT COMPLETED|Overall Study||8
161495|NCT00700635|372501|P1|NOT COMPLETED|Overall Study||11
161496|NCT00700635|372499|P3|COMPLETED|Overall Study||110
161497|NCT00700635|372500|P2|COMPLETED|Overall Study||103
161498|NCT00700635|372501|P1|COMPLETED|Overall Study||100
161499|NCT00700635|372499|P3|STARTED|Overall Study||111
161500|NCT00700635|372500|P2|STARTED|Overall Study||111
161501|NCT00700635|372501|P1|STARTED|Overall Study||111
161502|NCT00700622|372523|P2|NOT COMPLETED|Overall Study||5
161503|NCT00700622|372524|P1|NOT COMPLETED|Overall Study||13
161504|NCT00700622|372523|P2|COMPLETED|Overall Study||60
161505|NCT00700622|372524|P1|COMPLETED|Overall Study||52
161506|NCT00700622|372523|P2|STARTED|Overall Study||65
161507|NCT00700622|372524|P1|STARTED|Overall Study||65
161508|NCT00700570|372532|P2|NOT COMPLETED|Overall Study||26
161509|NCT00700570|372533|P1|NOT COMPLETED|Overall Study||11
161510|NCT00700570|372532|P2|COMPLETED|Overall Study||0
161511|NCT00700570|372533|P1|COMPLETED|Overall Study||8
161512|NCT00700570|372532|P2|STARTED|Overall Study||26
161513|NCT00700570|372533|P1|STARTED|Overall Study||19
161514|NCT00700440|372545|P1|NOT COMPLETED|Overall Study||0
161515|NCT00700440|372545|P1|COMPLETED|Overall Study||100
161516|NCT00700440|372545|P1|STARTED|Overall Study||100
161517|NCT00700427|372549|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
161518|NCT00700427|372550|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
161519|NCT00700427|372551|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
161520|NCT00700427|372552|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
161521|NCT00700427|372553|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
161522|NCT00700427|372549|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
161523|NCT00700427|372550|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
161524|NCT00700427|372551|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
161525|NCT00700427|372552|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
161526|NCT00700427|372553|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
161527|NCT00700427|372549|P5|STARTED|Study Period 4 (Open-Label Extension)||180
161528|NCT00700427|372550|P4|STARTED|Study Period 4 (Open-Label Extension)||0
161529|NCT00700427|372551|P3|STARTED|Study Period 4 (Open-Label Extension)||0
161530|NCT00700427|372552|P2|STARTED|Study Period 4 (Open-Label Extension)||0
161531|NCT00700427|372553|P1|STARTED|Study Period 4 (Open-Label Extension)||0
161532|NCT00700427|372549|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161533|NCT00700427|372550|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
161534|NCT00700427|372551|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
161535|NCT00700427|372552|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161536|NCT00700427|372553|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161537|NCT00700427|372549|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161538|NCT00700427|372550|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
161539|NCT00700427|372551|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
161540|NCT00700427|372552|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161541|NCT00700427|372553|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
161542|NCT00700427|372549|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
161543|NCT00700427|372550|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
161544|NCT00700427|372551|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
161545|NCT00700427|372552|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
161546|NCT00700427|372553|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
161547|NCT00700427|372549|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
161548|NCT00700427|372550|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
161549|NCT00700427|372551|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
161550|NCT00700427|372552|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
161551|NCT00700427|372553|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
161552|NCT00700427|372549|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
161553|NCT00700427|372550|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
161554|NCT00700427|372551|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
161555|NCT00700427|372552|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
161556|NCT00700427|372553|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
161557|NCT00700427|372549|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
161558|NCT00700427|372550|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
161559|NCT00700427|372551|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
161560|NCT00700427|372552|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
161561|NCT00700427|372553|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
161562|NCT00700427|372549|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161563|NCT00700427|372550|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161564|NCT00700427|372551|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161565|NCT00700427|372552|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161566|NCT00700427|372553|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
161567|NCT00700427|372549|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161568|NCT00700427|372550|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161569|NCT00700427|372551|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161570|NCT00700427|372552|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
161571|NCT00700427|372553|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
161572|NCT00700427|372549|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
161573|NCT00700427|372550|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
161574|NCT00700427|372551|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
161575|NCT00700427|372552|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
161576|NCT00700427|372553|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
161577|NCT00700427|372549|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
161578|NCT00700427|372550|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
161579|NCT00700427|372551|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
161580|NCT00700427|372552|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
161581|NCT00700427|372553|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
161582|NCT00700401|372575|P1|NOT COMPLETED|Overall Study||94
161583|NCT00700401|372575|P1|COMPLETED|Overall Study||168
161584|NCT00700401|372575|P1|STARTED|Overall Study||262
161585|NCT00700375|372588|P2|NOT COMPLETED|Overall Study||0
161586|NCT00700375|372589|P1|NOT COMPLETED|Overall Study||0
161587|NCT00700375|372588|P2|COMPLETED|Overall Study||29
161588|NCT00700375|372589|P1|COMPLETED|Overall Study||30
161589|NCT00700375|372588|P2|2 Days After Creatinine Mesurement|Overall Study||29
161590|NCT00700375|372589|P1|2 Days After Creatinine Mesurement|Overall Study||30
161591|NCT00700375|372588|P2|STARTED|Overall Study||29
161592|NCT00700375|372589|P1|STARTED|Overall Study||30
161593|NCT00700310|372599|P4|NOT COMPLETED|Overall Study||26
161594|NCT00700310|372600|P3|NOT COMPLETED|Overall Study||16
161595|NCT00700310|372601|P2|NOT COMPLETED|Overall Study||26
161596|NCT00700310|372602|P1|NOT COMPLETED|Overall Study||21
161597|NCT00700310|372599|P4|COMPLETED|Overall Study||145
161598|NCT00700310|372600|P3|COMPLETED|Overall Study||158
161599|NCT00700310|372601|P2|COMPLETED|Overall Study||154
161600|NCT00700310|372602|P1|COMPLETED|Overall Study||166
161601|NCT00700310|372599|P4|STARTED|Overall Study||171
161602|NCT00700310|372600|P3|STARTED|Overall Study||174
161603|NCT00700310|372601|P2|STARTED|Overall Study||180
161604|NCT00700310|372602|P1|STARTED|Overall Study||187
161605|NCT00700271|372622|P2|NOT COMPLETED|Overall Study||12
161606|NCT00700271|372623|P1|NOT COMPLETED|Overall Study||14
161607|NCT00700271|372622|P2|COMPLETED|Overall Study||256
161608|NCT00700271|372623|P1|COMPLETED|Overall Study||264
161609|NCT00700271|372622|P2|STARTED|Overall Study||268
161610|NCT00700271|372623|P1|STARTED|Overall Study||278
161611|NCT00700180|372651|P2|NOT COMPLETED|Overall Study||149
161612|NCT00700180|372652|P1|NOT COMPLETED|Overall Study||154
161613|NCT00700180|372651|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
161614|NCT00700180|372652|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
161615|NCT00700180|372651|P2|STARTED|Overall Study||149
161616|NCT00700180|372652|P1|STARTED|Overall Study||154
161617|NCT00700141|372674|P1|NOT COMPLETED|Overall Study||0
161618|NCT00700141|372674|P1|COMPLETED|Overall Study||482
161619|NCT00700141|372674|P1|STARTED|Overall Study||482
161620|NCT00700115|372681|P2|NOT COMPLETED|Overall Study||1
161621|NCT00700115|372682|P1|NOT COMPLETED|Overall Study||1
161622|NCT00700115|372681|P2|COMPLETED|Overall Study||19
161623|NCT00700115|372682|P1|COMPLETED|Overall Study||39
161624|NCT00700115|372681|P2|STARTED|Overall Study||20
161625|NCT00700115|372682|P1|STARTED|Overall Study||40
161626|NCT00700102|372692|P2|NOT COMPLETED|Overall Study||395
161627|NCT00700102|372693|P1|NOT COMPLETED|Overall Study||402
161628|NCT00700102|372692|P2|COMPLETED|Overall Study||14
161629|NCT00700102|372693|P1|COMPLETED|Overall Study||9
161630|NCT00700102|372692|P2|Received at Least One Dose|Overall Study||403
161631|NCT00700102|372693|P1|Received at Least One Dose|Overall Study||407
161632|NCT00700102|372692|P2|Intention to Treat|Overall Study||409
161633|NCT00700102|372693|P1|Intention to Treat|Overall Study||410
161634|NCT00700102|372692|P2|STARTED|Overall Study||409
161635|NCT00700102|372693|P1|STARTED|Overall Study||411
161636|NCT00700063|372717|P8|NOT COMPLETED|Overall Study||0
161637|NCT00700063|372718|P7|NOT COMPLETED|Overall Study||0
161638|NCT00700063|372719|P6|NOT COMPLETED|Overall Study||0
161639|NCT00700063|372720|P5|NOT COMPLETED|Overall Study||2
161640|NCT00700063|372721|P4|NOT COMPLETED|Overall Study||2
161641|NCT00700063|372722|P3|NOT COMPLETED|Overall Study||0
161642|NCT00700063|372723|P2|NOT COMPLETED|Overall Study||0
161643|NCT00700063|372724|P1|NOT COMPLETED|Overall Study||1
161644|NCT00700063|372717|P8|COMPLETED|Overall Study||33
161645|NCT00700063|372718|P7|COMPLETED|Overall Study||32
161646|NCT00700063|372719|P6|COMPLETED|Overall Study||34
161647|NCT00700063|372720|P5|COMPLETED|Overall Study||31
161648|NCT00700063|372721|P4|COMPLETED|Overall Study||31
161649|NCT00700063|372722|P3|COMPLETED|Overall Study||33
161650|NCT00700063|372723|P2|COMPLETED|Overall Study||34
161651|NCT00700063|372724|P1|COMPLETED|Overall Study||32
161652|NCT00700063|372717|P8|STARTED|Overall Study||33
161653|NCT00700063|372718|P7|STARTED|Overall Study||32
161654|NCT00700063|372719|P6|STARTED|Overall Study||34
161655|NCT00700063|372720|P5|STARTED|Overall Study||33
161656|NCT00700063|372721|P4|STARTED|Overall Study||33
161657|NCT00700063|372722|P3|STARTED|Overall Study||33
161658|NCT00700063|372723|P2|STARTED|Overall Study||34
161659|NCT00700063|372724|P1|STARTED|Overall Study||33
161660|NCT00700011|372832|P2|NOT COMPLETED|Overall Study||1
161661|NCT00700011|372833|P1|NOT COMPLETED|Overall Study||0
161662|NCT00700011|372832|P2|COMPLETED|Overall Study||1
161663|NCT00700011|372833|P1|COMPLETED|Overall Study||8
161664|NCT00700011|372832|P2|STARTED|Overall Study||2
161665|NCT00700011|372833|P1|STARTED|Overall Study||8
161666|NCT00699998|372849|P4|NOT COMPLETED|Overall Study||82
161667|NCT00699998|372850|P3|NOT COMPLETED|Overall Study||206
161668|NCT00699998|372851|P2|NOT COMPLETED|Overall Study||86
161669|NCT00699998|372852|P1|NOT COMPLETED|Overall Study||199
161670|NCT00699998|372849|P4|COMPLETED|Overall Study||958
161671|NCT00699998|372850|P3|COMPLETED|Overall Study||3417
161672|NCT00699998|372851|P2|COMPLETED|Overall Study||957
161673|NCT00699998|372852|P1|COMPLETED|Overall Study||3421
161674|NCT00699998|372849|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
161675|NCT00699998|372850|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
161676|NCT00699998|372851|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
161677|NCT00699998|372852|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
161678|NCT00699998|372849|P4|STARTED|Overall Study||1040
161679|NCT00699998|372850|P3|STARTED|Overall Study||3623
161680|NCT00699998|372851|P2|STARTED|Overall Study||1043
161681|NCT00699998|372852|P1|STARTED|Overall Study||3620
161682|NCT00699972|372897|P3|NOT COMPLETED|Overall Study||35
161683|NCT00699972|372898|P2|NOT COMPLETED|Overall Study||19
161684|NCT00699972|372899|P1|NOT COMPLETED|Overall Study||16
161685|NCT00699972|372897|P3|COMPLETED|Overall Study||100
161686|NCT00699972|372898|P2|COMPLETED|Overall Study||114
161687|NCT00699972|372899|P1|COMPLETED|Overall Study||106
161688|NCT00699972|372897|P3|STARTED|Overall Study||135
161689|NCT00699972|372898|P2|STARTED|Overall Study||133
161690|NCT00699972|372899|P1|STARTED|Overall Study||122
161691|NCT00699842|372916|P3|NOT COMPLETED|Overall Study||0
161692|NCT00699842|372917|P2|NOT COMPLETED|Overall Study||1
161693|NCT00699842|372918|P1|NOT COMPLETED|Overall Study||0
161694|NCT00699842|372916|P3|COMPLETED|Overall Study||0
161695|NCT00699842|372917|P2|COMPLETED|Overall Study||4
161696|NCT00699842|372918|P1|COMPLETED|Overall Study||3
161697|NCT00699842|372916|P3|STARTED|Overall Study||0
161698|NCT00699842|372917|P2|STARTED|Overall Study||5
161699|NCT00699842|372918|P1|STARTED|Overall Study||3
161700|NCT00699816|372931|P2|NOT COMPLETED|Overall Study||3
161701|NCT00699816|372932|P1|NOT COMPLETED|Overall Study||1
161702|NCT00699816|372931|P2|COMPLETED|Overall Study||112
161703|NCT00699816|372932|P1|COMPLETED|Overall Study||114
161704|NCT00699816|372931|P2|STARTED|Overall Study||115
161705|NCT00699816|372932|P1|STARTED|Overall Study||115
161706|NCT00699751|372950|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
161707|NCT00699751|372951|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
161708|NCT00699751|372950|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
161709|NCT00699751|372951|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
161710|NCT00699751|372950|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
161711|NCT00699751|372951|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
161712|NCT00699751|372950|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
161713|NCT00699751|372951|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
161714|NCT00699751|372950|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
161715|NCT00699751|372951|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
161716|NCT00699751|372950|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
161717|NCT00699751|372951|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
161718|NCT00699751|372950|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
161719|NCT00699751|372951|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
161720|NCT00699751|372950|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
161721|NCT00699751|372951|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
161722|NCT00699751|372950|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
161723|NCT00699751|372951|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
161724|NCT00699751|372950|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
161725|NCT00699751|372951|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
161726|NCT00699751|372950|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
161727|NCT00699751|372951|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
161728|NCT00699751|372950|P2|STARTED|Period 1: Without/Before Drug Switch||307
161729|NCT00699751|372951|P1|STARTED|Period 1: Without/Before Drug Switch||614
161730|NCT00699699|373036|P1|NOT COMPLETED|Overall Study||57
161731|NCT00699699|373036|P1|COMPLETED|Overall Study||1223
161732|NCT00699699|373036|P1|STARTED|Overall Study||1280
161733|NCT00699660|373045|P2|NOT COMPLETED|Overall Study||8
161734|NCT00699660|373046|P1|NOT COMPLETED|Overall Study||14
161735|NCT00699660|373045|P2|COMPLETED|Overall Study||208
161736|NCT00699660|373046|P1|COMPLETED|Overall Study||176
161737|NCT00699660|373045|P2|STARTED|Overall Study||216
161738|NCT00699660|373046|P1|STARTED|Overall Study||190
161739|NCT00699608|373058|P6|NOT COMPLETED|Third Intervention||0
161740|NCT00699608|373059|P5|NOT COMPLETED|Third Intervention||0
161741|NCT00699608|373060|P4|NOT COMPLETED|Third Intervention||0
161742|NCT00699608|373061|P3|NOT COMPLETED|Third Intervention||0
161743|NCT00699608|373062|P2|NOT COMPLETED|Third Intervention||0
161744|NCT00699608|373063|P1|NOT COMPLETED|Third Intervention||0
161745|NCT00699608|373058|P6|COMPLETED|Third Intervention||15
161746|NCT00699608|373059|P5|COMPLETED|Third Intervention||14
161747|NCT00699608|373060|P4|COMPLETED|Third Intervention||14
161748|NCT00699608|373061|P3|COMPLETED|Third Intervention||13
161749|NCT00699608|373062|P2|COMPLETED|Third Intervention||15
161750|NCT00699608|373063|P1|COMPLETED|Third Intervention||16
161751|NCT00699608|373058|P6|STARTED|Third Intervention||15
161752|NCT00699608|373059|P5|STARTED|Third Intervention||14
161753|NCT00699608|373060|P4|STARTED|Third Intervention||14
161754|NCT00699608|373061|P3|STARTED|Third Intervention||13
161755|NCT00699608|373062|P2|STARTED|Third Intervention||15
161756|NCT00699608|373063|P1|STARTED|Third Intervention||16
161757|NCT00699608|373058|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
161758|NCT00699608|373059|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
161759|NCT00699608|373060|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
161760|NCT00699608|373061|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
161761|NCT00699608|373062|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
161762|NCT00699608|373063|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
161763|NCT00699608|373058|P6|COMPLETED|Second 4-14 Day Washout Period||15
161764|NCT00699608|373059|P5|COMPLETED|Second 4-14 Day Washout Period||14
161765|NCT00699608|373060|P4|COMPLETED|Second 4-14 Day Washout Period||14
161766|NCT00699608|373061|P3|COMPLETED|Second 4-14 Day Washout Period||13
161767|NCT00699608|373062|P2|COMPLETED|Second 4-14 Day Washout Period||15
161768|NCT00699608|373063|P1|COMPLETED|Second 4-14 Day Washout Period||16
161769|NCT00699608|373058|P6|STARTED|Second 4-14 Day Washout Period||15
161770|NCT00699608|373059|P5|STARTED|Second 4-14 Day Washout Period||14
161771|NCT00699608|373060|P4|STARTED|Second 4-14 Day Washout Period||14
161772|NCT00699608|373061|P3|STARTED|Second 4-14 Day Washout Period||13
161773|NCT00699608|373062|P2|STARTED|Second 4-14 Day Washout Period||15
161774|NCT00699608|373063|P1|STARTED|Second 4-14 Day Washout Period||16
161775|NCT00699608|373058|P6|NOT COMPLETED|Second Intervention||0
161776|NCT00699608|373059|P5|NOT COMPLETED|Second Intervention||0
161777|NCT00699608|373060|P4|NOT COMPLETED|Second Intervention||1
161778|NCT00699608|373061|P3|NOT COMPLETED|Second Intervention||1
161779|NCT00699608|373062|P2|NOT COMPLETED|Second Intervention||0
161780|NCT00699608|373063|P1|NOT COMPLETED|Second Intervention||0
161781|NCT00699608|373058|P6|COMPLETED|Second Intervention||15
161782|NCT00699608|373059|P5|COMPLETED|Second Intervention||14
161783|NCT00699608|373060|P4|COMPLETED|Second Intervention||14
161784|NCT00699608|373061|P3|COMPLETED|Second Intervention||13
161785|NCT00699608|373062|P2|COMPLETED|Second Intervention||15
161786|NCT00699608|373063|P1|COMPLETED|Second Intervention||16
161787|NCT00699608|373058|P6|STARTED|Second Intervention||15
161788|NCT00699608|373059|P5|STARTED|Second Intervention||14
161789|NCT00699608|373060|P4|STARTED|Second Intervention||15
161790|NCT00699608|373061|P3|STARTED|Second Intervention||14
161791|NCT00699608|373062|P2|STARTED|Second Intervention||15
161792|NCT00699608|373063|P1|STARTED|Second Intervention||16
161793|NCT00699608|373058|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
161794|NCT00699608|373059|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
161795|NCT00699608|373060|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
161796|NCT00699608|373061|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
161797|NCT00699608|373062|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
161798|NCT00699608|373063|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
161799|NCT00699608|373058|P6|COMPLETED|First 4-14 Day Washout Period||15
161800|NCT00699608|373059|P5|COMPLETED|First 4-14 Day Washout Period||14
161801|NCT00699608|373060|P4|COMPLETED|First 4-14 Day Washout Period||15
161802|NCT00699608|373061|P3|COMPLETED|First 4-14 Day Washout Period||14
161803|NCT00699608|373062|P2|COMPLETED|First 4-14 Day Washout Period||15
161804|NCT00699608|373063|P1|COMPLETED|First 4-14 Day Washout Period||16
161805|NCT00699608|373058|P6|STARTED|First 4-14 Day Washout Period||15
161806|NCT00699608|373059|P5|STARTED|First 4-14 Day Washout Period||14
161807|NCT00699608|373060|P4|STARTED|First 4-14 Day Washout Period||15
161808|NCT00699608|373061|P3|STARTED|First 4-14 Day Washout Period||14
161809|NCT00699608|373062|P2|STARTED|First 4-14 Day Washout Period||15
161810|NCT00699608|373063|P1|STARTED|First 4-14 Day Washout Period||16
161811|NCT00699608|373058|P6|NOT COMPLETED|First Intervention||0
161812|NCT00699608|373059|P5|NOT COMPLETED|First Intervention||1
161813|NCT00699608|373060|P4|NOT COMPLETED|First Intervention||0
161814|NCT00699608|373061|P3|NOT COMPLETED|First Intervention||1
161815|NCT00699608|373062|P2|NOT COMPLETED|First Intervention||0
161816|NCT00699608|373063|P1|NOT COMPLETED|First Intervention||0
161817|NCT00699608|373058|P6|COMPLETED|First Intervention||15
161818|NCT00699608|373059|P5|COMPLETED|First Intervention||14
161819|NCT00699608|373060|P4|COMPLETED|First Intervention||15
161820|NCT00699608|373061|P3|COMPLETED|First Intervention||14
161821|NCT00699608|373062|P2|COMPLETED|First Intervention||15
161822|NCT00699608|373063|P1|COMPLETED|First Intervention||16
161823|NCT00699608|373058|P6|STARTED|First Intervention||15
161824|NCT00699608|373059|P5|STARTED|First Intervention||15
161825|NCT00699608|373060|P4|STARTED|First Intervention||15
161826|NCT00699608|373061|P3|STARTED|First Intervention||15
161827|NCT00699608|373062|P2|STARTED|First Intervention||15
161828|NCT00699608|373063|P1|STARTED|First Intervention||16
161829|NCT00699582|373116|P3|NOT COMPLETED|Overall Study||28
161830|NCT00699582|373117|P2|NOT COMPLETED|Overall Study||22
161831|NCT00699582|373118|P1|NOT COMPLETED|Overall Study||18
161832|NCT00699582|373116|P3|COMPLETED|Overall Study||93
161833|NCT00699582|373117|P2|COMPLETED|Overall Study||108
161834|NCT00699582|373118|P1|COMPLETED|Overall Study||120
161835|NCT00699582|373116|P3|STARTED|Overall Study||121
161836|NCT00699582|373117|P2|STARTED|Overall Study||130
161837|NCT00699582|373118|P1|STARTED|Overall Study||138
161838|NCT00699491|373138|P6|NOT COMPLETED|Overall Study||0
161839|NCT00699491|373139|P5|NOT COMPLETED|Overall Study||0
161840|NCT00699491|373140|P4|NOT COMPLETED|Overall Study||0
161841|NCT00699491|373141|P3|NOT COMPLETED|Overall Study||0
161842|NCT00699491|373142|P2|NOT COMPLETED|Overall Study||0
161843|NCT00699491|373143|P1|NOT COMPLETED|Overall Study||0
161844|NCT00699491|373138|P6|COMPLETED|Overall Study||22
161845|NCT00699491|373139|P5|COMPLETED|Overall Study||8
161846|NCT00699491|373140|P4|COMPLETED|Overall Study||6
161847|NCT00699491|373141|P3|COMPLETED|Overall Study||7
161848|NCT00699491|373142|P2|COMPLETED|Overall Study||2
161849|NCT00699491|373143|P1|COMPLETED|Overall Study||3
161850|NCT00699491|373138|P6|STARTED|Overall Study||22
161851|NCT00699491|373139|P5|STARTED|Overall Study||8
161852|NCT00699491|373140|P4|STARTED|Overall Study||6
161853|NCT00699491|373141|P3|STARTED|Overall Study||7
161854|NCT00699491|373142|P2|STARTED|Overall Study||2
161855|NCT00699491|373143|P1|STARTED|Overall Study||3
161856|NCT00699400|373165|P6|NOT COMPLETED|Overall Study||11
161857|NCT00699400|373166|P5|NOT COMPLETED|Overall Study||0
161858|NCT00699400|373167|P4|NOT COMPLETED|Overall Study||0
161859|NCT00699400|373168|P3|NOT COMPLETED|Overall Study||0
161860|NCT00699400|373169|P2|NOT COMPLETED|Overall Study||0
161861|NCT00699400|373170|P1|NOT COMPLETED|Overall Study||0
161862|NCT00699400|373165|P6|COMPLETED|Overall Study||0
161863|NCT00699400|373166|P5|COMPLETED|Overall Study||4
161864|NCT00699400|373167|P4|COMPLETED|Overall Study||6
161865|NCT00699400|373168|P3|COMPLETED|Overall Study||138
161866|NCT00699400|373169|P2|COMPLETED|Overall Study||3
161867|NCT00699400|373170|P1|COMPLETED|Overall Study||42
161868|NCT00699400|373165|P6|STARTED|Overall Study||11
161869|NCT00699400|373166|P5|STARTED|Overall Study||4
161870|NCT00699400|373167|P4|STARTED|Overall Study||6
161871|NCT00699400|373168|P3|STARTED|Overall Study||138
161872|NCT00699400|373169|P2|STARTED|Overall Study||3
161873|NCT00699400|373170|P1|STARTED|Overall Study||42
161874|NCT00699374|373204|P2|NOT COMPLETED|Overall Study||544
161875|NCT00699374|373205|P1|NOT COMPLETED|Overall Study||530
161876|NCT00699374|373204|P2|COMPLETED|Overall Study||0
161877|NCT00699374|373205|P1|COMPLETED|Overall Study||0
161878|NCT00699374|373204|P2|Treated|Overall Study||542
161879|NCT00699374|373205|P1|Treated|Overall Study||526
161880|NCT00699374|373204|P2|STARTED|Overall Study||544
161881|NCT00699374|373205|P1|STARTED|Overall Study||530
161882|NCT00699348|373217|P1|NOT COMPLETED|Overall Study||90
161883|NCT00699348|373217|P1|COMPLETED|Overall Study||261
161884|NCT00699348|373217|P1|STARTED|Overall Study||351
161885|NCT00699335|373226|P1|NOT COMPLETED|Overall Study||228
161886|NCT00699335|373226|P1|COMPLETED|Overall Study||5080
161887|NCT00699335|373226|P1|STARTED|Overall Study||5308
161888|NCT00699283|373259|P2|NOT COMPLETED|Overall Study||8
161889|NCT00699283|373260|P1|NOT COMPLETED|Overall Study||33
161890|NCT00699283|373259|P2|COMPLETED|Overall Study||7
161891|NCT00699283|373260|P1|COMPLETED|Overall Study||14
161892|NCT00699283|373259|P2|STARTED|Overall Study||15
161893|NCT00699283|373260|P1|STARTED|Overall Study||47
161894|NCT00699192|373268|P3|NOT COMPLETED|Overall Study||11
161895|NCT00699192|373269|P2|NOT COMPLETED|Overall Study||12
161896|NCT00699192|373270|P1|NOT COMPLETED|Overall Study||16
161897|NCT00699192|373268|P3|COMPLETED|Overall Study||261
161898|NCT00699192|373269|P2|COMPLETED|Overall Study||260
161899|NCT00699192|373270|P1|COMPLETED|Overall Study||259
161900|NCT00699192|373268|P3|STARTED|Overall Study||272
161901|NCT00699192|373269|P2|STARTED|Overall Study||272
161902|NCT00699192|373270|P1|STARTED|Overall Study||275
161903|NCT00699153|373292|P2|NOT COMPLETED|Overall Study||2
161904|NCT00699153|373293|P1|NOT COMPLETED|Overall Study||3
161905|NCT00699153|373292|P2|COMPLETED|Overall Study||200
161906|NCT00699153|373293|P1|COMPLETED|Overall Study||200
161907|NCT00699153|373292|P2|STARTED|Overall Study|Intent to treat population|202
161908|NCT00699153|373293|P1|STARTED|Overall Study|Intent to treat population|203
161909|NCT00699140|373305|P1|NOT COMPLETED|Overall Study||0
161910|NCT00699140|373305|P1|COMPLETED|Overall Study||18
161911|NCT00699140|373305|P1|STARTED|Overall Study||18
161912|NCT00698932|373319|P2|NOT COMPLETED|Overall Study||36
161913|NCT00698932|373320|P1|NOT COMPLETED|Overall Study||22
161914|NCT00698932|373319|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
161915|NCT00698932|373320|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
161916|NCT00698932|373319|P2|STARTED|Overall Study|Randomized and treated|284
161917|NCT00698932|373320|P1|STARTED|Overall Study|Randomized and treated|284
161918|NCT00698841|373336|P1|NOT COMPLETED|Overall Study||18
161919|NCT00698841|373336|P1|COMPLETED|Overall Study||33
161920|NCT00698841|373336|P1|STARTED|Overall Study||51
161921|NCT00698815|373350|P3|NOT COMPLETED|Overall Study||10
161922|NCT00698815|373351|P2|NOT COMPLETED|Overall Study||14
161923|NCT00698815|373352|P1|NOT COMPLETED|Overall Study||10
161924|NCT00698815|373350|P3|COMPLETED|Overall Study||31
161925|NCT00698815|373351|P2|COMPLETED|Overall Study||33
161926|NCT00698815|373352|P1|COMPLETED|Overall Study||32
161927|NCT00698815|373350|P3|STARTED|Overall Study||41
161928|NCT00698815|373351|P2|STARTED|Overall Study||47
161929|NCT00698815|373352|P1|STARTED|Overall Study||42
161930|NCT00698685|373369|P1|NOT COMPLETED|Overall Study||2
161931|NCT00698685|373369|P1|COMPLETED|Overall Study||12
161932|NCT00698685|373369|P1|STARTED|Overall Study||14
161933|NCT00698646|373377|P3|NOT COMPLETED|Overall Study||29
161934|NCT00698646|373378|P2|NOT COMPLETED|Overall Study||31
161935|NCT00698646|373379|P1|NOT COMPLETED|Overall Study||36
161936|NCT00698646|373377|P3|COMPLETED|Overall Study||99
161937|NCT00698646|373378|P2|COMPLETED|Overall Study||97
161938|NCT00698646|373379|P1|COMPLETED|Overall Study||92
161939|NCT00698646|373377|P3|STARTED|Overall Study||128
161940|NCT00698646|373378|P2|STARTED|Overall Study||128
161941|NCT00698646|373379|P1|STARTED|Overall Study||128
161942|NCT00698581|373404|P2|NOT COMPLETED|Overall Study||12
161943|NCT00698581|373405|P1|NOT COMPLETED|Overall Study||45
161944|NCT00698581|373404|P2|COMPLETED|Overall Study||8
161945|NCT00698581|373405|P1|COMPLETED|Overall Study||23
161946|NCT00698581|373404|P2|STARTED|Overall Study||20
161947|NCT00698581|373405|P1|STARTED|Overall Study||68
161948|NCT00698516|373416|P1|NOT COMPLETED|Overall Study||5
161949|NCT00698516|373416|P1|COMPLETED|Overall Study||45
161950|NCT00698516|373416|P1|STARTED|Overall Study||50
161951|NCT00698451|373434|P1|NOT COMPLETED|Overall Study||39
161952|NCT00698451|373434|P1|COMPLETED|Overall Study||15
161953|NCT00698451|373434|P1|STARTED|Overall Study||54
161954|NCT00698204|373441|P2|NOT COMPLETED|Overall Study||0
161955|NCT00698204|373442|P1|NOT COMPLETED|Overall Study||1
161956|NCT00698204|373441|P2|COMPLETED|Overall Study||20
161957|NCT00698204|373442|P1|COMPLETED|Overall Study||19
161958|NCT00698204|373441|P2|STARTED|Overall Study||20
161959|NCT00698204|373442|P1|STARTED|Overall Study||20
161960|NCT00698139|373453|P3|NOT COMPLETED|Overall Study||0
161961|NCT00698139|373454|P2|NOT COMPLETED|Overall Study||0
161962|NCT00698139|373455|P1|NOT COMPLETED|Overall Study||0
161963|NCT00698139|373453|P3|COMPLETED|Overall Study||1
161964|NCT00698139|373454|P2|COMPLETED|Overall Study||1
161965|NCT00698139|373455|P1|COMPLETED|Overall Study||1
161966|NCT00698139|373453|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
161967|NCT00698139|373454|P2|2nd Visit|Overall Study||1
161968|NCT00698139|373455|P1|2nd Visit|Overall Study||1
161969|NCT00698139|373453|P3|STARTED|Overall Study||1
161970|NCT00698139|373454|P2|STARTED|Overall Study||1
161971|NCT00698139|373455|P1|STARTED|Overall Study||1
161972|NCT00698035|373471|P2|NOT COMPLETED|Overall Study||2
161973|NCT00698035|373472|P1|NOT COMPLETED|Overall Study||4
161974|NCT00698035|373471|P2|COMPLETED|Overall Study||34
161975|NCT00698035|373472|P1|COMPLETED|Overall Study||35
161976|NCT00698035|373471|P2|STARTED|Overall Study||36
161977|NCT00698035|373472|P1|STARTED|Overall Study||39
161978|NCT00698022|373492|P3|NOT COMPLETED|Overall Study||2
161979|NCT00698022|373493|P2|NOT COMPLETED|Overall Study||10
161980|NCT00698022|373494|P1|NOT COMPLETED|Overall Study||16
161981|NCT00698022|373492|P3|COMPLETED|Overall Study||14
161982|NCT00698022|373493|P2|COMPLETED|Overall Study||20
161983|NCT00698022|373494|P1|COMPLETED|Overall Study||14
161984|NCT00698022|373492|P3|STARTED|Overall Study||16
161985|NCT00698022|373493|P2|STARTED|Overall Study||30
161986|NCT00698022|373494|P1|STARTED|Overall Study||30
161987|NCT00698009|373502|P1|NOT COMPLETED|Overall Study||1
161988|NCT00698009|373502|P1|COMPLETED|Overall Study||0
161989|NCT00698009|373502|P1|STARTED|Overall Study||1
161990|NCT00697827|373508|P2|NOT COMPLETED|Overall Study||1
161991|NCT00697827|373509|P1|NOT COMPLETED|Overall Study||2
161992|NCT00697827|373508|P2|COMPLETED|Overall Study||15
161993|NCT00697827|373509|P1|COMPLETED|Overall Study||26
161994|NCT00697827|373508|P2|STARTED|Overall Study||16
161995|NCT00697827|373509|P1|STARTED|Overall Study||28
161996|NCT00697801|373520|P3|NOT COMPLETED|Overall Study||24
161997|NCT00697801|373521|P2|NOT COMPLETED|Overall Study||12
161998|NCT00697801|373522|P1|NOT COMPLETED|Overall Study||12
161999|NCT00697801|373520|P3|COMPLETED|Overall Study||45
162000|NCT00697801|373521|P2|COMPLETED|Overall Study||58
162001|NCT00697801|373522|P1|COMPLETED|Overall Study||57
162002|NCT00697801|373520|P3|STARTED|Overall Study||69
162003|NCT00697801|373521|P2|STARTED|Overall Study||70
162004|NCT00697801|373522|P1|STARTED|Overall Study||69
162005|NCT00697697|373538|P2|NOT COMPLETED|Overall Study||54
162006|NCT00697697|373539|P1|NOT COMPLETED|Overall Study||49
162007|NCT00697697|373538|P2|COMPLETED|Overall Study||44
162008|NCT00697697|373539|P1|COMPLETED|Overall Study||45
162009|NCT00697697|373538|P2|STARTED|Overall Study||98
162010|NCT00697697|373539|P1|STARTED|Overall Study||94
162011|NCT00697619|373549|P2|NOT COMPLETED|Overall Study||8
162012|NCT00697619|373550|P1|NOT COMPLETED|Overall Study||6
162013|NCT00697619|373549|P2|COMPLETED|Overall Study||22
162014|NCT00697619|373550|P1|COMPLETED|Overall Study||24
162015|NCT00697619|373549|P2|STARTED|Overall Study||30
162016|NCT00697619|373550|P1|STARTED|Overall Study||30
162017|NCT00697593|373556|P1|NOT COMPLETED|Overall Study||19
162018|NCT00697593|373556|P1|COMPLETED|Overall Study||51
162019|NCT00697593|373556|P1|STARTED|Overall Study||70
162020|NCT00697541|373589|P2|NOT COMPLETED|Overall Study||1
162021|NCT00697541|373590|P1|NOT COMPLETED|Overall Study||2
162022|NCT00697541|373589|P2|COMPLETED|Overall Study||9
162023|NCT00697541|373590|P1|COMPLETED|Overall Study||8
162024|NCT00697541|373589|P2|STARTED|Overall Study||10
162025|NCT00697541|373590|P1|STARTED|Overall Study||10
162026|NCT00697515|373600|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
162027|NCT00697515|373601|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
162028|NCT00697515|373600|P2|COMPLETED|Second Intervention (Crossover Period)||51
162029|NCT00697515|373601|P1|COMPLETED|Second Intervention (Crossover Period)||52
162030|NCT00697515|373600|P2|STARTED|Second Intervention (Crossover Period)||52
162031|NCT00697515|373601|P1|STARTED|Second Intervention (Crossover Period)||53
162032|NCT00697515|373600|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
162033|NCT00697515|373601|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
162034|NCT00697515|373600|P2|COMPLETED|First Intervention (Crossover Period)||52
162035|NCT00697515|373601|P1|COMPLETED|First Intervention (Crossover Period)||53
162036|NCT00697515|373600|P2|STARTED|First Intervention (Crossover Period)||64
162037|NCT00697515|373601|P1|STARTED|First Intervention (Crossover Period)||63
162038|NCT00697515|373600|P2|NOT COMPLETED|Dose Optimization Period||0
162039|NCT00697515|373601|P1|NOT COMPLETED|Dose Optimization Period||15
162040|NCT00697515|373600|P2|COMPLETED|Dose Optimization Period||0
162041|NCT00697515|373601|P1|COMPLETED|Dose Optimization Period||127
162042|NCT00697515|373600|P2|STARTED|Dose Optimization Period||0
162043|NCT00697515|373601|P1|STARTED|Dose Optimization Period||142
162044|NCT00697255|373631|P2|NOT COMPLETED|Stage 1b||2
162045|NCT00697255|373632|P1|NOT COMPLETED|Stage 1b||0
162046|NCT00697255|373631|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
162047|NCT00697255|373632|P1|COMPLETED|Stage 1b||0
162048|NCT00697255|373631|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
162049|NCT00697255|373632|P1|STARTED|Stage 1b||0
162050|NCT00697255|373631|P2|NOT COMPLETED|Stage 1a||0
162051|NCT00697255|373632|P1|NOT COMPLETED|Stage 1a||3
162052|NCT00697255|373631|P2|COMPLETED|Stage 1a||0
162053|NCT00697255|373632|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
162054|NCT00697255|373631|P2|STARTED|Stage 1a||0
162055|NCT00697255|373632|P1|STARTED|Stage 1a||5
162056|NCT00697190|373648|P2|NOT COMPLETED|Second Intervention||0
162057|NCT00697190|373649|P1|NOT COMPLETED|Second Intervention||0
162058|NCT00697190|373648|P2|COMPLETED|Second Intervention||20
162059|NCT00697190|373649|P1|COMPLETED|Second Intervention||18
162060|NCT00697190|373648|P2|STARTED|Second Intervention||20
162061|NCT00697190|373649|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
162062|NCT00697190|373648|P2|NOT COMPLETED|First Intervention||0
162063|NCT00697190|373649|P1|NOT COMPLETED|First Intervention||0
162064|NCT00697190|373648|P2|COMPLETED|First Intervention||20
162065|NCT00697190|373649|P1|COMPLETED|First Intervention||19
162066|NCT00697190|373648|P2|STARTED|First Intervention||20
162067|NCT00697190|373649|P1|STARTED|First Intervention||19
162068|NCT00697112|373683|P1|NOT COMPLETED|Overall Study||10
162069|NCT00697112|373683|P1|COMPLETED|Overall Study||43
162070|NCT00697112|373683|P1|Met the Inclusion Criteria|Overall Study||52
162071|NCT00697112|373683|P1|STARTED|Overall Study||53
162072|NCT00697073|373707|P1|NOT COMPLETED|Overall Study||9
162073|NCT00697073|373707|P1|COMPLETED|Overall Study||59
162074|NCT00697073|373707|P1|STARTED|Overall Study||68
162075|NCT00696878|373711|P1|NOT COMPLETED|Overall Study||504
162076|NCT00696878|373711|P1|COMPLETED|Overall Study||178
162077|NCT00696878|373711|P1|STARTED|Overall Study||682
162078|NCT00696800|373785|P2|NOT COMPLETED|Overall Study||48
162079|NCT00696800|373786|P1|NOT COMPLETED|Overall Study||85
162080|NCT00696800|373785|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
162081|NCT00696800|373786|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
162082|NCT00696800|373785|P2|Treated (ITT)|Overall Study|The ITT group|750
162083|NCT00696800|373786|P1|Treated (ITT)|Overall Study|The ITT group|756
162084|NCT00696800|373785|P2|STARTED|Overall Study||752
162085|NCT00696800|373786|P1|STARTED|Overall Study||757
162086|NCT00696787|373839|P3|NOT COMPLETED|Overall Study||26
162087|NCT00696787|373840|P2|NOT COMPLETED|Overall Study||20
162088|NCT00696787|373841|P1|NOT COMPLETED|Overall Study||15
162089|NCT00696787|373839|P3|COMPLETED|Overall Study||17
162090|NCT00696787|373840|P2|COMPLETED|Overall Study||22
162091|NCT00696787|373841|P1|COMPLETED|Overall Study||25
162092|NCT00696787|373839|P3|STARTED|Overall Study||43
162093|NCT00696787|373840|P2|STARTED|Overall Study||42
162094|NCT00696787|373841|P1|STARTED|Overall Study||40
162095|NCT00696774|373855|P3|NOT COMPLETED|Period III||0
162096|NCT00696774|373856|P2|NOT COMPLETED|Period III||7
162097|NCT00696774|373857|P1|NOT COMPLETED|Period III||7
162098|NCT00696774|373855|P3|COMPLETED|Period III||0
162099|NCT00696774|373856|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
162100|NCT00696774|373857|P1|COMPLETED|Period III||106
162101|NCT00696774|373855|P3|STARTED|Period III||0
162102|NCT00696774|373856|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
162103|NCT00696774|373857|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
162104|NCT00696774|373855|P3|NOT COMPLETED|Period II||36
162105|NCT00696774|373856|P2|NOT COMPLETED|Period II||0
162106|NCT00696774|373857|P1|NOT COMPLETED|Period II||0
162107|NCT00696774|373855|P3|COMPLETED|Period II||0
162108|NCT00696774|373856|P2|COMPLETED|Period II||91
162109|NCT00696774|373857|P1|COMPLETED|Period II||115
162110|NCT00696774|373855|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
162111|NCT00696774|373856|P2|STARTED|Period II||91
162112|NCT00696774|373857|P1|STARTED|Period II||115
162113|NCT00696761|373895|P4|NOT COMPLETED|Overall Study||10
162114|NCT00696761|373896|P3|NOT COMPLETED|Overall Study||11
162115|NCT00696761|373897|P2|NOT COMPLETED|Overall Study||26
162116|NCT00696761|373898|P1|NOT COMPLETED|Overall Study||20
162117|NCT00696761|373895|P4|COMPLETED|Overall Study||44
162118|NCT00696761|373896|P3|COMPLETED|Overall Study||30
162119|NCT00696761|373897|P2|COMPLETED|Overall Study||50
162120|NCT00696761|373898|P1|COMPLETED|Overall Study||41
162121|NCT00696761|373895|P4|STARTED|Overall Study||54
162122|NCT00696761|373896|P3|STARTED|Overall Study||41
162123|NCT00696761|373897|P2|STARTED|Overall Study||76
162124|NCT00696761|373898|P1|STARTED|Overall Study||61
162125|NCT00696696|373912|P1|NOT COMPLETED|Overall Study||18
162126|NCT00696696|373912|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
162127|NCT00696696|373912|P1|STARTED|Overall Study||44
162128|NCT00696436|373923|P5|NOT COMPLETED|Overall Study||13
162129|NCT00696436|373924|P4|NOT COMPLETED|Overall Study||22
162130|NCT00696436|373925|P3|NOT COMPLETED|Overall Study||28
162131|NCT00696436|373926|P2|NOT COMPLETED|Overall Study||30
162132|NCT00696436|373927|P1|NOT COMPLETED|Overall Study||23
162133|NCT00696436|373923|P5|COMPLETED|Overall Study||141
162134|NCT00696436|373924|P4|COMPLETED|Overall Study||268
162135|NCT00696436|373925|P3|COMPLETED|Overall Study||254
162136|NCT00696436|373926|P2|COMPLETED|Overall Study||255
162137|NCT00696436|373927|P1|COMPLETED|Overall Study||257
162138|NCT00696436|373923|P5|STARTED|Overall Study|Randomized participants only.|154
162139|NCT00696436|373924|P4|STARTED|Overall Study|Randomized participants only.|290
162140|NCT00696436|373925|P3|STARTED|Overall Study|Randomized participants only.|282
162141|NCT00696436|373926|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
162142|NCT00696436|373927|P1|STARTED|Overall Study|Randomized participants only.|280
162143|NCT00696423|374011|P2|NOT COMPLETED|Overall Study||5
162144|NCT00696423|374012|P1|NOT COMPLETED|Overall Study||0
162145|NCT00696423|374011|P2|COMPLETED|Overall Study||218
162146|NCT00696423|374012|P1|COMPLETED|Overall Study||244
162147|NCT00696423|374011|P2|STARTED|Overall Study||223
162148|NCT00696423|374012|P1|STARTED|Overall Study||244
162149|NCT00696384|374042|P3|NOT COMPLETED|Double Blind Phase||6
162150|NCT00696384|374043|P2|NOT COMPLETED|Double Blind Phase||11
162151|NCT00696384|374044|P1|NOT COMPLETED|Double Blind Phase||0
162152|NCT00696384|374042|P3|COMPLETED|Double Blind Phase||145
162153|NCT00696384|374043|P2|COMPLETED|Double Blind Phase||137
162154|NCT00696384|374044|P1|COMPLETED|Double Blind Phase||0
162155|NCT00696384|374042|P3|STARTED|Double Blind Phase||151
162156|NCT00696384|374043|P2|STARTED|Double Blind Phase||148
162157|NCT00696384|374044|P1|STARTED|Double Blind Phase||0
162158|NCT00696384|374042|P3|NOT COMPLETED|Open Label Phase||0
162159|NCT00696384|374043|P2|NOT COMPLETED|Open Label Phase||0
162160|NCT00696384|374044|P1|NOT COMPLETED|Open Label Phase||119
162161|NCT00696384|374042|P3|COMPLETED|Open Label Phase||0
162162|NCT00696384|374043|P2|COMPLETED|Open Label Phase||0
162163|NCT00696384|374044|P1|COMPLETED|Open Label Phase||299
162164|NCT00696384|374042|P3|STARTED|Open Label Phase||0
162165|NCT00696384|374043|P2|STARTED|Open Label Phase||0
162166|NCT00696384|374044|P1|STARTED|Open Label Phase||418
162167|NCT00696293|374058|P1|NOT COMPLETED|Overall Study||2
162168|NCT00696293|374058|P1|COMPLETED|Overall Study||28
162169|NCT00696293|374058|P1|STARTED|Overall Study||30
162170|NCT00696241|374068|P5|NOT COMPLETED|Overall Study||12
162171|NCT00696241|374069|P4|NOT COMPLETED|Overall Study||14
162172|NCT00696241|374070|P3|NOT COMPLETED|Overall Study||24
162173|NCT00696241|374071|P2|NOT COMPLETED|Overall Study||22
162174|NCT00696241|374072|P1|NOT COMPLETED|Overall Study||24
162175|NCT00696241|374068|P5|COMPLETED|Overall Study||130
162176|NCT00696241|374069|P4|COMPLETED|Overall Study||268
162177|NCT00696241|374070|P3|COMPLETED|Overall Study||261
162178|NCT00696241|374071|P2|COMPLETED|Overall Study||261
162179|NCT00696241|374072|P1|COMPLETED|Overall Study||259
162180|NCT00696241|374068|P5|STARTED|Overall Study||142
162181|NCT00696241|374069|P4|STARTED|Overall Study||282
162182|NCT00696241|374070|P3|STARTED|Overall Study||285
162183|NCT00696241|374071|P2|STARTED|Overall Study||283
162184|NCT00696241|374072|P1|STARTED|Overall Study||283
162185|NCT00696072|374156|P2|NOT COMPLETED|Overall Study||63
162186|NCT00696072|374157|P1|NOT COMPLETED|Overall Study||57
162187|NCT00696072|374156|P2|COMPLETED|Overall Study||0
162188|NCT00696072|374157|P1|COMPLETED|Overall Study||0
162189|NCT00696072|374156|P2|STARTED|Overall Study||63
162190|NCT00696072|374157|P1|STARTED|Overall Study||57
162191|NCT00696020|374178|P4|NOT COMPLETED|Overall Study||4
162192|NCT00696020|374179|P3|NOT COMPLETED|Overall Study||3
162193|NCT00696020|374180|P2|NOT COMPLETED|Overall Study||2
162194|NCT00696020|374181|P1|NOT COMPLETED|Overall Study||4
162195|NCT00696020|374178|P4|COMPLETED|Overall Study||84
162196|NCT00696020|374179|P3|COMPLETED|Overall Study||90
162197|NCT00696020|374180|P2|COMPLETED|Overall Study||87
162198|NCT00696020|374181|P1|COMPLETED|Overall Study||86
162199|NCT00696020|374178|P4|STARTED|Overall Study||88
162200|NCT00696020|374179|P3|STARTED|Overall Study||93
162201|NCT00696020|374180|P2|STARTED|Overall Study||89
162202|NCT00696020|374181|P1|STARTED|Overall Study||90
162203|NCT00695955|374289|P1|NOT COMPLETED|Cohort 2||104
162204|NCT00695955|374289|P1|COMPLETED|Cohort 2||203
162205|NCT00695955|374289|P1|STARTED|Cohort 2||307
162206|NCT00695955|374289|P1|NOT COMPLETED|Cohort 1||102
162207|NCT00695955|374289|P1|COMPLETED|Cohort 1||260
162208|NCT00695955|374289|P1|STARTED|Cohort 1||362
162209|NCT00695903|374301|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
162210|NCT00695903|374302|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
162211|NCT00695903|374301|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
162212|NCT00695903|374302|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
162213|NCT00695903|374301|P2|STARTED|Had Test of Cure (TOC) Assessment||4
162214|NCT00695903|374302|P1|STARTED|Had Test of Cure (TOC) Assessment||7
162215|NCT00695903|374301|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
162216|NCT00695903|374302|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
162217|NCT00695903|374301|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
162218|NCT00695903|374302|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
162219|NCT00695903|374301|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
162220|NCT00695903|374302|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
162221|NCT00695903|374301|P2|STARTED|Had End of Therapy (EOT) Assessment||19
162222|NCT00695903|374302|P1|STARTED|Had End of Therapy (EOT) Assessment||19
162223|NCT00695669|374318|P4|NOT COMPLETED|Overall Study||4
162224|NCT00695669|374319|P3|NOT COMPLETED|Overall Study||3
162225|NCT00695669|374320|P2|NOT COMPLETED|Overall Study||4
162226|NCT00695669|374321|P1|NOT COMPLETED|Overall Study||4
162227|NCT00695669|374318|P4|COMPLETED|Overall Study||74
162228|NCT00695669|374319|P3|COMPLETED|Overall Study||75
162229|NCT00695669|374320|P2|COMPLETED|Overall Study||74
162230|NCT00695669|374321|P1|COMPLETED|Overall Study||74
162231|NCT00695669|374318|P4|STARTED|Overall Study||78
162232|NCT00695669|374319|P3|STARTED|Overall Study||78
162233|NCT00695669|374320|P2|STARTED|Overall Study||78
162234|NCT00695669|374321|P1|STARTED|Overall Study||78
162235|NCT00695565|374397|P2|NOT COMPLETED|Overall Study||9
162236|NCT00695565|374398|P1|NOT COMPLETED|Overall Study||13
162237|NCT00695565|374397|P2|COMPLETED|Overall Study||81
162238|NCT00695565|374398|P1|COMPLETED|Overall Study||77
162239|NCT00695565|374397|P2|STARTED|Overall Study||90
162240|NCT00695565|374398|P1|STARTED|Overall Study||90
162241|NCT00695500|374432|P2|NOT COMPLETED|Overall Study||5
162242|NCT00695500|374433|P1|NOT COMPLETED|Overall Study||3
162243|NCT00695500|374432|P2|COMPLETED|Overall Study||17
162244|NCT00695500|374433|P1|COMPLETED|Overall Study||21
162245|NCT00695500|374432|P2|STARTED|Overall Study||22
162246|NCT00695500|374433|P1|STARTED|Overall Study||24
162247|NCT00695435|374443|P3|NOT COMPLETED|Overall Study||0
162248|NCT00695435|374444|P2|NOT COMPLETED|Overall Study||0
162249|NCT00695435|374445|P1|NOT COMPLETED|Overall Study||0
162250|NCT00695435|374443|P3|COMPLETED|Overall Study||7
162251|NCT00695435|374444|P2|COMPLETED|Overall Study||7
162252|NCT00695435|374445|P1|COMPLETED|Overall Study||7
162253|NCT00695435|374443|P3|STARTED|Overall Study||7
162254|NCT00695435|374444|P2|STARTED|Overall Study||7
162255|NCT00695435|374445|P1|STARTED|Overall Study||7
162256|NCT00695396|374459|P3|NOT COMPLETED|Overall Study||8
162257|NCT00695396|374460|P2|NOT COMPLETED|Overall Study||8
162258|NCT00695396|374461|P1|NOT COMPLETED|Overall Study||7
162259|NCT00695396|374459|P3|COMPLETED|Overall Study||1
162260|NCT00695396|374460|P2|COMPLETED|Overall Study||0
162261|NCT00695396|374461|P1|COMPLETED|Overall Study||1
162262|NCT00695396|374459|P3|STARTED|Overall Study||9
162263|NCT00695396|374460|P2|STARTED|Overall Study||8
162264|NCT00695396|374461|P1|STARTED|Overall Study||8
162265|NCT00695318|374477|P2|NOT COMPLETED|Overall Study||1
162266|NCT00695318|374478|P1|NOT COMPLETED|Overall Study||5
162267|NCT00695318|374477|P2|COMPLETED|Overall Study||6
162268|NCT00695318|374478|P1|COMPLETED|Overall Study||5
162269|NCT00695318|374477|P2|STARTED|Overall Study||7
162270|NCT00695318|374478|P1|STARTED|Overall Study||10
162271|NCT00695292|374489|P1|NOT COMPLETED|Overall Study||0
162272|NCT00695292|374489|P1|COMPLETED|Overall Study||37
162273|NCT00695292|374489|P1|STARTED|Overall Study||37
162274|NCT00695188|374496|P2|NOT COMPLETED|Overall Study||0
162275|NCT00695188|374497|P1|NOT COMPLETED|Overall Study||0
162276|NCT00695188|374496|P2|COMPLETED|Overall Study||9
162277|NCT00695188|374497|P1|COMPLETED|Overall Study||10
162278|NCT00695188|374496|P2|STARTED|Overall Study||9
162279|NCT00695188|374497|P1|STARTED|Overall Study||10
162280|NCT00695136|374503|P1|NOT COMPLETED|Overall Study||2
162281|NCT00695136|374503|P1|COMPLETED|Overall Study||5
162282|NCT00695136|374503|P1|STARTED|Overall Study|7|7
162283|NCT00695097|374509|P2|NOT COMPLETED|Overall Study||0
162284|NCT00695097|374510|P1|NOT COMPLETED|Overall Study||1
162285|NCT00695097|374509|P2|COMPLETED|Overall Study||5
162286|NCT00695097|374510|P1|COMPLETED|Overall Study||9
162287|NCT00695097|374509|P2|STARTED|Overall Study||5
162288|NCT00695097|374510|P1|STARTED|Overall Study||10
162289|NCT00695019|374519|P3|NOT COMPLETED|Overall Study||10
162290|NCT00695019|374520|P2|NOT COMPLETED|Overall Study||14
162291|NCT00695019|374521|P1|NOT COMPLETED|Overall Study||13
162292|NCT00695019|374519|P3|COMPLETED|Overall Study||47
162293|NCT00695019|374520|P2|COMPLETED|Overall Study||39
162294|NCT00695019|374521|P1|COMPLETED|Overall Study||46
162295|NCT00695019|374519|P3|STARTED|Overall Study||57
162296|NCT00695019|374520|P2|STARTED|Overall Study||53
162297|NCT00695019|374521|P1|STARTED|Overall Study||59
162298|NCT00694603|374550|P1|NOT COMPLETED|Overall Study||0
162299|NCT00694603|374550|P1|COMPLETED|Overall Study||18
162300|NCT00694603|374550|P1|STARTED|Overall Study||18
162301|NCT00694564|374555|P1|NOT COMPLETED|Overall Study||2
162302|NCT00694564|374555|P1|COMPLETED|Overall Study||6
162303|NCT00694564|374555|P1|STARTED|Overall Study||8
162304|NCT00694551|374562|P3|NOT COMPLETED|Overall Study||1
162305|NCT00694551|374563|P2|NOT COMPLETED|Overall Study||0
162306|NCT00694551|374564|P1|NOT COMPLETED|Overall Study||1
162307|NCT00694551|374562|P3|COMPLETED|Overall Study||8
162308|NCT00694551|374563|P2|COMPLETED|Overall Study||10
162309|NCT00694551|374564|P1|COMPLETED|Overall Study||9
162310|NCT00694551|374562|P3|STARTED|Overall Study||9
162311|NCT00694551|374563|P2|STARTED|Overall Study||10
162312|NCT00694551|374564|P1|STARTED|Overall Study||10
162313|NCT00694369|374583|P5|NOT COMPLETED|Overall Study||6
162314|NCT00694369|374584|P4|NOT COMPLETED|Overall Study||3
162315|NCT00694369|374585|P3|NOT COMPLETED|Overall Study||2
162316|NCT00694369|374586|P2|NOT COMPLETED|Overall Study||3
162317|NCT00694369|374587|P1|NOT COMPLETED|Overall Study||1
162318|NCT00694369|374583|P5|COMPLETED|Overall Study||56
162319|NCT00694369|374584|P4|COMPLETED|Overall Study||189
162320|NCT00694369|374585|P3|COMPLETED|Overall Study||95
162321|NCT00694369|374586|P2|COMPLETED|Overall Study||188
162322|NCT00694369|374587|P1|COMPLETED|Overall Study||45
162323|NCT00694369|374583|P5|STARTED|Overall Study||62
162324|NCT00694369|374584|P4|STARTED|Overall Study||192
162325|NCT00694369|374585|P3|STARTED|Overall Study||97
162326|NCT00694369|374586|P2|STARTED|Overall Study||191
162327|NCT00694369|374587|P1|STARTED|Overall Study||46
162328|NCT00694304|374604|P1|NOT COMPLETED|Overall Study||207
162329|NCT00694304|374604|P1|COMPLETED|Overall Study||328
162330|NCT00694304|374604|P1|STARTED|Overall Study||535
162331|NCT00694161|374617|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
162332|NCT00694161|374617|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
162333|NCT00694161|374617|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
162334|NCT00694161|374617|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
162335|NCT00694161|374617|P1|COMPLETED|Part 1 (up to Week 6)||35
162336|NCT00694161|374617|P1|STARTED|Part 1 (up to Week 6)||35
162337|NCT00694122|374656|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
162338|NCT00694122|374657|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
162339|NCT00694122|374656|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
162340|NCT00694122|374657|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
162341|NCT00694122|374656|P2|STARTED|Second Intervention (3-4 Weeks)||5
162342|NCT00694122|374657|P1|STARTED|Second Intervention (3-4 Weeks)||10
162343|NCT00694122|374656|P2|NOT COMPLETED|Washout (1 Day)||0
162344|NCT00694122|374657|P1|NOT COMPLETED|Washout (1 Day)||0
162345|NCT00694122|374656|P2|COMPLETED|Washout (1 Day)||5
162346|NCT00694122|374657|P1|COMPLETED|Washout (1 Day)||10
162347|NCT00694122|374656|P2|STARTED|Washout (1 Day)||5
162348|NCT00694122|374657|P1|STARTED|Washout (1 Day)||10
162349|NCT00694122|374656|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
162350|NCT00694122|374657|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
162351|NCT00694122|374656|P2|COMPLETED|First Intervention (3-4 Weeks)||5
162352|NCT00694122|374657|P1|COMPLETED|First Intervention (3-4 Weeks)||10
162353|NCT00694122|374656|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
162354|NCT00694122|374657|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
162355|NCT00694109|374673|P1|NOT COMPLETED|Overall Study||117
162356|NCT00694109|374673|P1|COMPLETED|Overall Study||25
162357|NCT00694109|374673|P1|Completed Consented Length of Treatment|Overall Study||60
162358|NCT00694109|374673|P1|Consented 2 Years Additional Treatment|Overall Study||42
162359|NCT00694109|374673|P1|Treated|Overall Study||141
162360|NCT00694109|374673|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
162361|NCT00694096|374697|P1|NOT COMPLETED|Overall Study||5
162362|NCT00694096|374697|P1|COMPLETED|Overall Study||20
162363|NCT00694096|374697|P1|STARTED|Overall Study||25
162364|NCT00694070|374703|P1|NOT COMPLETED|Overall Study||0
162365|NCT00694070|374703|P1|COMPLETED|Overall Study||51
162366|NCT00694070|374703|P1|STARTED|Overall Study||51
162367|NCT00694018|374711|P2|NOT COMPLETED|Overall Study||9
162368|NCT00694018|374712|P1|NOT COMPLETED|Overall Study||13
162369|NCT00694018|374711|P2|COMPLETED|Overall Study||102
162370|NCT00694018|374712|P1|COMPLETED|Overall Study||105
162371|NCT00694018|374711|P2|6 Months|Overall Study||101
162372|NCT00694018|374712|P1|6 Months|Overall Study||106
162373|NCT00694018|374711|P2|STARTED|Overall Study||111
162374|NCT00694018|374712|P1|STARTED|Overall Study||118
162375|NCT00693992|374720|P2|NOT COMPLETED|Overall Study||0
162376|NCT00693992|374721|P1|NOT COMPLETED|Overall Study||0
162377|NCT00693992|374720|P2|COMPLETED|Overall Study||104
162378|NCT00693992|374721|P1|COMPLETED|Overall Study||106
162379|NCT00693992|374720|P2|STARTED|Overall Study||104
162380|NCT00693992|374721|P1|STARTED|Overall Study||106
162381|NCT00693784|374733|P1|NOT COMPLETED|Overall Study||4
162382|NCT00693784|374733|P1|COMPLETED|Overall Study||11
162383|NCT00693784|374733|P1|104-week Extended Follow-up|Overall Study||11
162384|NCT00693784|374733|P1|52-week Extended Follow-up|Overall Study||13
162385|NCT00693784|374733|P1|26-Week Primary Endpoint|Overall Study||15
162386|NCT00693784|374733|P1|STARTED|Overall Study||15
162387|NCT00693719|374739|P1|NOT COMPLETED|Overall Study||0
162388|NCT00693719|374739|P1|COMPLETED|Overall Study||31
162389|NCT00693719|374739|P1|STARTED|Overall Study||31
162390|NCT00693706|374746|P2|NOT COMPLETED|Overall Study||1
162391|NCT00693706|374747|P1|NOT COMPLETED|Overall Study||0
162392|NCT00693706|374746|P2|COMPLETED|Overall Study||98
162393|NCT00693706|374747|P1|COMPLETED|Overall Study||101
162394|NCT00693706|374746|P2|STARTED|Overall Study||99
162395|NCT00693706|374747|P1|STARTED|Overall Study||101
162396|NCT00693498|374773|P2|NOT COMPLETED|Overall Study||0
162397|NCT00693498|374774|P1|NOT COMPLETED|Overall Study||0
162398|NCT00693498|374773|P2|COMPLETED|Overall Study||81
162399|NCT00693498|374774|P1|COMPLETED|Overall Study||81
162400|NCT00693498|374773|P2|STARTED|Overall Study||81
162401|NCT00693498|374774|P1|STARTED|Overall Study||81
162402|NCT00693485|374783|P3|NOT COMPLETED|Overall Study||0
162403|NCT00693485|374784|P2|NOT COMPLETED|Overall Study||2
162404|NCT00693485|374785|P1|NOT COMPLETED|Overall Study||0
162405|NCT00693485|374783|P3|COMPLETED|Overall Study||24
162406|NCT00693485|374784|P2|COMPLETED|Overall Study||19
162407|NCT00693485|374785|P1|COMPLETED|Overall Study||25
162408|NCT00693485|374783|P3|STARTED|Overall Study||24
162409|NCT00693485|374784|P2|STARTED|Overall Study||21
162410|NCT00693485|374785|P1|STARTED|Overall Study||25
162411|NCT00693420|374798|P2|NOT COMPLETED|Overall Study||15
162412|NCT00693420|374799|P1|NOT COMPLETED|Overall Study||6
162413|NCT00693420|374798|P2|COMPLETED|Overall Study||126
162414|NCT00693420|374799|P1|COMPLETED|Overall Study||131
162415|NCT00693420|374798|P2|STARTED|Overall Study||141
162416|NCT00693420|374799|P1|STARTED|Overall Study||137
162417|NCT00693303|374823|P1|NOT COMPLETED|Overall Study||0
162418|NCT00693303|374823|P1|COMPLETED|Overall Study||21
162419|NCT00693303|374823|P1|STARTED|Overall Study||21
162420|NCT00693238|374829|P2|NOT COMPLETED|Overall Study||0
162421|NCT00693238|374830|P1|NOT COMPLETED|Overall Study||0
162422|NCT00693238|374829|P2|COMPLETED|Overall Study||106
162423|NCT00693238|374830|P1|COMPLETED|Overall Study||122
162424|NCT00693238|374829|P2|STARTED|Overall Study||106
162425|NCT00693238|374830|P1|STARTED|Overall Study||122
162426|NCT00693225|374838|P2|NOT COMPLETED|Overall Study||5
162427|NCT00693225|374839|P1|NOT COMPLETED|Overall Study||2
162428|NCT00693225|374838|P2|COMPLETED|Overall Study||43
162429|NCT00693225|374839|P1|COMPLETED|Overall Study||41
162430|NCT00693225|374838|P2|STARTED|Overall Study||48
162431|NCT00693225|374839|P1|STARTED|Overall Study||43
162432|NCT00693160|374851|P2|NOT COMPLETED|Overall Study||0
162433|NCT00693160|374852|P1|NOT COMPLETED|Overall Study||0
162434|NCT00693160|374851|P2|COMPLETED|Overall Study||16
162435|NCT00693160|374852|P1|COMPLETED|Overall Study||14
162436|NCT00693160|374851|P2|STARTED|Overall Study||16
162437|NCT00693160|374852|P1|STARTED|Overall Study||14
162438|NCT00693017|374862|P2|NOT COMPLETED|Overall Study||2
162439|NCT00693017|374863|P1|NOT COMPLETED|Overall Study||2
162440|NCT00693017|374862|P2|COMPLETED|Overall Study||0
162441|NCT00693017|374863|P1|COMPLETED|Overall Study||0
162442|NCT00693017|374862|P2|STARTED|Overall Study||2
162443|NCT00693017|374863|P1|STARTED|Overall Study||2
162444|NCT00692913|374873|P2|NOT COMPLETED|Overall Study||30
162445|NCT00692913|374874|P1|NOT COMPLETED|Overall Study||29
162446|NCT00692913|374873|P2|COMPLETED|Overall Study||228
162447|NCT00692913|374874|P1|COMPLETED|Overall Study||228
162448|NCT00692913|374873|P2|STARTED|Overall Study||258
162449|NCT00692913|374874|P1|STARTED|Overall Study||257
162450|NCT00692770|374896|P2|NOT COMPLETED|Overall Study||558
162451|NCT00692770|374897|P1|NOT COMPLETED|Overall Study||556
162452|NCT00692770|374896|P2|COMPLETED|Overall Study||0
162453|NCT00692770|374897|P1|COMPLETED|Overall Study||0
162454|NCT00692770|374896|P2|Participants Received Treatment|Overall Study||554
162455|NCT00692770|374897|P1|Participants Received Treatment|Overall Study||553
162456|NCT00692770|374896|P2|STARTED|Overall Study||558
162457|NCT00692770|374897|P1|STARTED|Overall Study||556
162458|NCT00692692|374915|P2|NOT COMPLETED|Overall Study||0
162459|NCT00692692|374916|P1|NOT COMPLETED|Overall Study||0
162460|NCT00692692|374915|P2|COMPLETED|Overall Study||16
162461|NCT00692692|374916|P1|COMPLETED|Overall Study||20
162462|NCT00692692|374915|P2|STARTED|Overall Study||16
162463|NCT00692692|374916|P1|STARTED|Overall Study||20
162464|NCT00692419|374924|P2|NOT COMPLETED|Overall Study||18
162465|NCT00692419|374925|P1|NOT COMPLETED|Overall Study||16
162466|NCT00692419|374924|P2|COMPLETED|Overall Study||102
162467|NCT00692419|374925|P1|COMPLETED|Overall Study||84
162468|NCT00692419|374924|P2|STARTED|Overall Study||120
162469|NCT00692419|374925|P1|STARTED|Overall Study||100
162470|NCT00692406|374935|P1|NOT COMPLETED|Overall Study||57
162471|NCT00692406|374935|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
162472|NCT00692406|374935|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
162473|NCT00692341|374949|P3|NOT COMPLETED|Overall Study||0
162474|NCT00692341|374950|P2|NOT COMPLETED|Overall Study||0
162475|NCT00692341|374951|P1|NOT COMPLETED|Overall Study||0
162476|NCT00692341|374949|P3|COMPLETED|Overall Study||8
162477|NCT00692341|374950|P2|COMPLETED|Overall Study||8
162478|NCT00692341|374951|P1|COMPLETED|Overall Study||8
162479|NCT00692341|374949|P3|STARTED|Overall Study||8
162480|NCT00692341|374950|P2|STARTED|Overall Study||8
162481|NCT00692341|374951|P1|STARTED|Overall Study||8
162482|NCT00692237|374997|P2|NOT COMPLETED|Overall Study||4
162483|NCT00692237|374998|P1|NOT COMPLETED|Overall Study||1
162484|NCT00692237|374997|P2|COMPLETED|Overall Study||25
162485|NCT00692237|374998|P1|COMPLETED|Overall Study||29
162486|NCT00692237|374997|P2|STARTED|Overall Study||29
162487|NCT00692237|374998|P1|STARTED|Overall Study||30
162488|NCT00692211|375008|P2|NOT COMPLETED|Overall Study||0
162489|NCT00692211|375009|P1|NOT COMPLETED|Overall Study||0
162490|NCT00692211|375008|P2|COMPLETED|Overall Study||202
162491|NCT00692211|375009|P1|COMPLETED|Overall Study||202
162492|NCT00692211|375008|P2|STARTED|Overall Study||202
162493|NCT00692211|375009|P1|STARTED|Overall Study||202
162494|NCT00692185|375017|P2|NOT COMPLETED|Overall Study||3
162495|NCT00692185|375018|P1|NOT COMPLETED|Overall Study||3
162496|NCT00692185|375017|P2|COMPLETED|Overall Study||9
162497|NCT00692185|375018|P1|COMPLETED|Overall Study||8
162498|NCT00692185|375017|P2|STARTED|Overall Study||12
162499|NCT00692185|375018|P1|STARTED|Overall Study||11
162500|NCT00692003|375026|P2|NOT COMPLETED|Overall Study||1
162501|NCT00692003|375027|P1|NOT COMPLETED|Overall Study||5
162502|NCT00692003|375026|P2|COMPLETED|Overall Study||0
162503|NCT00692003|375027|P1|COMPLETED|Overall Study||0
162504|NCT00692003|375026|P2|STARTED|Overall Study||1
162505|NCT00692003|375027|P1|STARTED|Overall Study||5
162506|NCT00691938|375042|P7|NOT COMPLETED|Overall Study||0
162507|NCT00691938|375043|P6|NOT COMPLETED|Overall Study||0
162508|NCT00691938|375044|P5|NOT COMPLETED|Overall Study||0
162509|NCT00691938|375045|P4|NOT COMPLETED|Overall Study||0
162510|NCT00691938|375046|P3|NOT COMPLETED|Overall Study||0
162511|NCT00691938|375047|P2|NOT COMPLETED|Overall Study||0
162512|NCT00691938|375048|P1|NOT COMPLETED|Overall Study||1
162513|NCT00691938|375042|P7|COMPLETED|Overall Study||14
162514|NCT00691938|375043|P6|COMPLETED|Overall Study||6
162515|NCT00691938|375044|P5|COMPLETED|Overall Study||10
162516|NCT00691938|375045|P4|COMPLETED|Overall Study||8
162517|NCT00691938|375046|P3|COMPLETED|Overall Study||6
162518|NCT00691938|375047|P2|COMPLETED|Overall Study||3
162519|NCT00691938|375048|P1|COMPLETED|Overall Study||4
162520|NCT00691938|375042|P7|STARTED|Overall Study||14
162521|NCT00691938|375043|P6|STARTED|Overall Study||6
162522|NCT00691938|375044|P5|STARTED|Overall Study||10
162523|NCT00691938|375045|P4|STARTED|Overall Study||8
162524|NCT00691938|375046|P3|STARTED|Overall Study||6
162525|NCT00691938|375047|P2|STARTED|Overall Study||3
162526|NCT00691938|375048|P1|STARTED|Overall Study||5
162527|NCT00691808|375072|P3|NOT COMPLETED|Overall Study||0
162528|NCT00691808|375073|P2|NOT COMPLETED|Overall Study||1
162529|NCT00691808|375074|P1|NOT COMPLETED|Overall Study||0
162530|NCT00691808|375072|P3|COMPLETED|Overall Study||32
162531|NCT00691808|375073|P2|COMPLETED|Overall Study||35
162532|NCT00691808|375074|P1|COMPLETED|Overall Study||35
162533|NCT00691808|375072|P3|STARTED|Overall Study||32
162534|NCT00691808|375073|P2|STARTED|Overall Study||36
162535|NCT00691808|375074|P1|STARTED|Overall Study||35
162536|NCT00691704|375115|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
162537|NCT00691704|375115|P1|COMPLETED|Two Years of Maintenance Therapy||3
162538|NCT00691704|375115|P1|STARTED|Two Years of Maintenance Therapy||16
162539|NCT00691704|375115|P1|NOT COMPLETED|Induction Therapy||2
162540|NCT00691704|375115|P1|COMPLETED|Induction Therapy||16
162541|NCT00691704|375115|P1|STARTED|Induction Therapy||18
162542|NCT00691665|375125|P2|NOT COMPLETED|Overall Study||0
162543|NCT00691665|375126|P1|NOT COMPLETED|Overall Study||0
162544|NCT00691665|375125|P2|COMPLETED|Overall Study||65
162545|NCT00691665|375126|P1|COMPLETED|Overall Study||65
162546|NCT00691665|375125|P2|STARTED|Overall Study||65
162547|NCT00691665|375126|P1|STARTED|Overall Study||65
162548|NCT00691652|375138|P1|NOT COMPLETED|Overall Study||1
162549|NCT00691652|375138|P1|COMPLETED|Overall Study||1
162550|NCT00691652|375138|P1|STARTED|Overall Study||2
162551|NCT00691483|375144|P2|NOT COMPLETED|Overall Study||25
162552|NCT00691483|375145|P1|NOT COMPLETED|Overall Study||68
162553|NCT00691483|375144|P2|COMPLETED|Overall Study||141
162554|NCT00691483|375145|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
162555|NCT00691483|375144|P2|Received Treatment|Overall Study||165
162556|NCT00691483|375145|P1|Received Treatment|Overall Study||486
162557|NCT00691483|375144|P2|STARTED|Overall Study||166
162558|NCT00691483|375145|P1|STARTED|Overall Study||493
162559|NCT00691327|375163|P2|NOT COMPLETED|Overall Study||2508
162560|NCT00691327|375164|P1|NOT COMPLETED|Overall Study||2841
162561|NCT00691327|375163|P2|COMPLETED|Overall Study||36766
162562|NCT00691327|375164|P1|COMPLETED|Overall Study||42214
162563|NCT00691327|375163|P2|STARTED|Overall Study||39274
162564|NCT00691327|375164|P1|STARTED|Overall Study||45055
162565|NCT00691210|375180|P8|NOT COMPLETED|Overall Study||0
162566|NCT00691210|375181|P7|NOT COMPLETED|Overall Study||0
162567|NCT00691210|375182|P6|NOT COMPLETED|Overall Study||1
162568|NCT00691210|375183|P5|NOT COMPLETED|Overall Study||0
162569|NCT00691210|375184|P4|NOT COMPLETED|Overall Study||3
162570|NCT00691210|375185|P3|NOT COMPLETED|Overall Study||0
162571|NCT00691210|375186|P2|NOT COMPLETED|Overall Study||0
162572|NCT00691210|375187|P1|NOT COMPLETED|Overall Study||0
162573|NCT00691210|375180|P8|COMPLETED|Overall Study||0
162574|NCT00691210|375181|P7|COMPLETED|Overall Study||6
162575|NCT00691210|375182|P6|COMPLETED|Overall Study||6
162576|NCT00691210|375183|P5|COMPLETED|Overall Study||5
162577|NCT00691210|375184|P4|COMPLETED|Overall Study||6
162578|NCT00691210|375185|P3|COMPLETED|Overall Study||3
162579|NCT00691210|375186|P2|COMPLETED|Overall Study||5
162580|NCT00691210|375187|P1|COMPLETED|Overall Study||3
162581|NCT00691210|375180|P8|STARTED|Overall Study||0
162582|NCT00691210|375181|P7|STARTED|Overall Study||6
162583|NCT00691210|375182|P6|STARTED|Overall Study||7
162584|NCT00691210|375183|P5|STARTED|Overall Study||5
162585|NCT00691210|375184|P4|STARTED|Overall Study||9
162586|NCT00691210|375185|P3|STARTED|Overall Study||3
162587|NCT00691210|375186|P2|STARTED|Overall Study||5
162588|NCT00691210|375187|P1|STARTED|Overall Study||3
162589|NCT00691197|375207|P2|NOT COMPLETED|Overall Study||5
162590|NCT00691197|375208|P1|NOT COMPLETED|Overall Study||11
162591|NCT00691197|375207|P2|COMPLETED|Overall Study||75
162592|NCT00691197|375208|P1|COMPLETED|Overall Study||155
162593|NCT00691197|375207|P2|STARTED|Overall Study||80
162594|NCT00691197|375208|P1|STARTED|Overall Study||166
162595|NCT00691093|375220|P1|NOT COMPLETED|Overall Study||7
162596|NCT00691093|375220|P1|COMPLETED|Overall Study||816
162597|NCT00691093|375220|P1|STARTED|Overall Study||823
162598|NCT00691054|375254|P1|NOT COMPLETED|Overall Study||1
162599|NCT00691054|375254|P1|COMPLETED|Overall Study||19
162600|NCT00691054|375254|P1|STARTED|Overall Study||20
162601|NCT00691028|375265|P4|NOT COMPLETED|Double-blind Period||0
162602|NCT00691028|375266|P3|NOT COMPLETED|Double-blind Period||9
162603|NCT00691028|375267|P2|NOT COMPLETED|Double-blind Period||13
162604|NCT00691028|375268|P1|NOT COMPLETED|Double-blind Period||13
162605|NCT00691028|375265|P4|COMPLETED|Double-blind Period||0
162606|NCT00691028|375266|P3|COMPLETED|Double-blind Period||95
162607|NCT00691028|375267|P2|COMPLETED|Double-blind Period||91
162608|NCT00691028|375268|P1|COMPLETED|Double-blind Period||86
162609|NCT00691028|375265|P4|STARTED|Double-blind Period||0
162610|NCT00691028|375266|P3|STARTED|Double-blind Period||104
162611|NCT00691028|375267|P2|STARTED|Double-blind Period||104
162612|NCT00691028|375268|P1|STARTED|Double-blind Period||99
162613|NCT00691028|375265|P4|NOT COMPLETED|Open-label Period||20
162614|NCT00691028|375266|P3|NOT COMPLETED|Open-label Period||0
162615|NCT00691028|375267|P2|NOT COMPLETED|Open-label Period||0
162616|NCT00691028|375268|P1|NOT COMPLETED|Open-label Period||0
162617|NCT00691028|375265|P4|COMPLETED|Open-label Period||307
162618|NCT00691028|375266|P3|COMPLETED|Open-label Period||0
162619|NCT00691028|375267|P2|COMPLETED|Open-label Period||0
162620|NCT00691028|375268|P1|COMPLETED|Open-label Period||0
162621|NCT00691028|375265|P4|STARTED|Open-label Period||327
162622|NCT00691028|375266|P3|STARTED|Open-label Period||0
162623|NCT00691028|375267|P2|STARTED|Open-label Period||0
162624|NCT00691028|375268|P1|STARTED|Open-label Period||0
162625|NCT00690898|375301|P1|NOT COMPLETED|TREATMENT||26
162626|NCT00690898|375301|P1|COMPLETED|TREATMENT||64
162627|NCT00690898|375301|P1|STARTED|TREATMENT|Total number of patients treated.|90
162628|NCT00690898|375301|P1|NOT COMPLETED|SCREENING||18
162629|NCT00690898|375301|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
162630|NCT00690898|375301|P1|STARTED|SCREENING|Total of patients screened for the study.|108
162631|NCT00690820|375317|P2|NOT COMPLETED|Period 2||0
162632|NCT00690820|375318|P1|NOT COMPLETED|Period 2||0
162633|NCT00690820|375317|P2|COMPLETED|Period 2||8
162634|NCT00690820|375318|P1|COMPLETED|Period 2||8
162635|NCT00690820|375317|P2|STARTED|Period 2||8
162636|NCT00690820|375318|P1|STARTED|Period 2||8
162637|NCT00690820|375317|P2|NOT COMPLETED|Period 1||1
162638|NCT00690820|375318|P1|NOT COMPLETED|Period 1||0
162639|NCT00690820|375317|P2|COMPLETED|Period 1||8
162640|NCT00690820|375318|P1|COMPLETED|Period 1||8
162641|NCT00690820|375317|P2|STARTED|Period 1||9
162642|NCT00690820|375318|P1|STARTED|Period 1||8
162643|NCT00690794|375340|P2|NOT COMPLETED|Overall Study||35
162644|NCT00690794|375341|P1|NOT COMPLETED|Overall Study||21
162645|NCT00690794|375340|P2|COMPLETED|Overall Study||328
162646|NCT00690794|375341|P1|COMPLETED|Overall Study||342
162647|NCT00690794|375340|P2|STARTED|Overall Study||363
162648|NCT00690794|375341|P1|STARTED|Overall Study||363
162649|NCT00690755|375356|P7|NOT COMPLETED|Overall Study||0
162650|NCT00690755|375357|P6|NOT COMPLETED|Overall Study||4
162651|NCT00690755|375358|P5|NOT COMPLETED|Overall Study||0
162652|NCT00690755|375359|P4|NOT COMPLETED|Overall Study||5
162653|NCT00690755|375360|P3|NOT COMPLETED|Overall Study||46
162654|NCT00690755|375361|P2|NOT COMPLETED|Overall Study||0
162655|NCT00690755|375362|P1|NOT COMPLETED|Overall Study||2
162656|NCT00690755|375356|P7|COMPLETED|Overall Study||0
162657|NCT00690755|375357|P6|COMPLETED|Overall Study||6
162658|NCT00690755|375358|P5|COMPLETED|Overall Study||0
162659|NCT00690755|375359|P4|COMPLETED|Overall Study||15
162660|NCT00690755|375360|P3|COMPLETED|Overall Study||51
162661|NCT00690755|375361|P2|COMPLETED|Overall Study||0
162662|NCT00690755|375362|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
162663|NCT00690755|375356|P7|STARTED|Overall Study||0
162664|NCT00690755|375357|P6|STARTED|Overall Study||10
162665|NCT00690755|375358|P5|STARTED|Overall Study||0
162666|NCT00690755|375359|P4|STARTED|Overall Study||20
162667|NCT00690755|375360|P3|STARTED|Overall Study||97
162668|NCT00690755|375361|P2|STARTED|Overall Study||0
162669|NCT00690755|375362|P1|STARTED|Overall Study||30
162670|NCT00690612|375378|P1|NOT COMPLETED|Overall Study||3
162671|NCT00690612|375378|P1|COMPLETED|Overall Study||32
162672|NCT00690612|375378|P1|STARTED|Overall Study||35
162673|NCT00690573|375383|P1|NOT COMPLETED|Overall Study||9
162674|NCT00690573|375383|P1|COMPLETED|Overall Study||16
162675|NCT00690573|375383|P1|STARTED|Overall Study||25
162676|NCT00690495|375393|P2|NOT COMPLETED|Overall Study||0
162677|NCT00690495|375394|P1|NOT COMPLETED|Overall Study||0
162678|NCT00690495|375393|P2|COMPLETED|Overall Study||50
162679|NCT00690495|375394|P1|COMPLETED|Overall Study||50
162680|NCT00690495|375393|P2|Primary Endpoint|Overall Study||50
162681|NCT00690495|375394|P1|Primary Endpoint|Overall Study||50
162682|NCT00690495|375393|P2|STARTED|Overall Study||50
162683|NCT00690495|375394|P1|STARTED|Overall Study||50
162684|NCT00690482|375402|P2|NOT COMPLETED|Overall Study||3
162685|NCT00690482|375403|P1|NOT COMPLETED|Overall Study||4
162686|NCT00690482|375402|P2|COMPLETED|Overall Study||54
162687|NCT00690482|375403|P1|COMPLETED|Overall Study||57
162688|NCT00690482|375402|P2|STARTED|Overall Study||57
162689|NCT00690482|375403|P1|STARTED|Overall Study||61
162690|NCT00690443|375437|P2|NOT COMPLETED|Overall Study||2
162691|NCT00690443|375438|P1|NOT COMPLETED|Overall Study||1
162692|NCT00690443|375437|P2|COMPLETED|Overall Study||19
162693|NCT00690443|375438|P1|COMPLETED|Overall Study||22
162694|NCT00690443|375437|P2|STARTED|Overall Study||21
162695|NCT00690443|375438|P1|STARTED|Overall Study||23
162696|NCT00690430|375448|P3|NOT COMPLETED|Extension Phase||13
162697|NCT00690430|375449|P2|NOT COMPLETED|Extension Phase||5
162698|NCT00690430|375450|P1|NOT COMPLETED|Extension Phase||18
162699|NCT00690430|375448|P3|COMPLETED|Extension Phase||2
162700|NCT00690430|375449|P2|COMPLETED|Extension Phase||1
162701|NCT00690430|375450|P1|COMPLETED|Extension Phase||2
162702|NCT00690430|375448|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
162703|NCT00690430|375449|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
162704|NCT00690430|375450|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
162705|NCT00690430|375448|P3|NOT COMPLETED|Core Phase||0
162706|NCT00690430|375449|P2|NOT COMPLETED|Core Phase||23
162707|NCT00690430|375450|P1|NOT COMPLETED|Core Phase||18
162708|NCT00690430|375448|P3|COMPLETED|Core Phase||0
162709|NCT00690430|375449|P2|COMPLETED|Core Phase||34
162710|NCT00690430|375450|P1|COMPLETED|Core Phase||35
162711|NCT00690430|375448|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
162712|NCT00690430|375449|P2|STARTED|Core Phase||57
162713|NCT00690430|375450|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
162714|NCT00690339|375481|P4|NOT COMPLETED|Overall Study||25
162715|NCT00690339|375482|P3|NOT COMPLETED|Overall Study||57
162716|NCT00690339|375483|P2|NOT COMPLETED|Overall Study||81
162717|NCT00690339|375484|P1|NOT COMPLETED|Overall Study||117
162718|NCT00690339|375481|P4|COMPLETED|Overall Study||43
162719|NCT00690339|375482|P3|COMPLETED|Overall Study||99
162720|NCT00690339|375483|P2|COMPLETED|Overall Study||144
162721|NCT00690339|375484|P1|COMPLETED|Overall Study||375
162722|NCT00690339|375481|P4|STARTED|Overall Study||68
162723|NCT00690339|375482|P3|STARTED|Overall Study||156
162724|NCT00690339|375483|P2|STARTED|Overall Study||225
162725|NCT00690339|375484|P1|STARTED|Overall Study||492
162726|NCT00690040|375500|P2|NOT COMPLETED|Overall Study||0
162727|NCT00690040|375501|P1|NOT COMPLETED|Overall Study||0
162728|NCT00690040|375500|P2|COMPLETED|Overall Study||148
162729|NCT00690040|375501|P1|COMPLETED|Overall Study||145
162730|NCT00690040|375500|P2|STARTED|Overall Study||148
162731|NCT00690040|375501|P1|STARTED|Overall Study||145
162732|NCT00689884|375507|P1|NOT COMPLETED|Overall Study||0
162733|NCT00689884|375507|P1|COMPLETED|Overall Study||7
162734|NCT00689884|375507|P1|STARTED|Overall Study||7
162735|NCT00689871|375516|P4|NOT COMPLETED|Overall Study||7
162736|NCT00689871|375517|P3|NOT COMPLETED|Overall Study||73
162737|NCT00689871|375518|P2|NOT COMPLETED|Overall Study||52
162738|NCT00689871|375519|P1|NOT COMPLETED|Overall Study||175
162739|NCT00689871|375516|P4|COMPLETED|Overall Study|4 Patients discontinued|8
162740|NCT00689871|375517|P3|COMPLETED|Overall Study|28 Patients discontinued|74
162741|NCT00689871|375518|P2|COMPLETED|Overall Study|35 Patients discontinued|46
162742|NCT00689871|375519|P1|COMPLETED|Overall Study|35 Patients discontinued|280
162743|NCT00689871|375516|P4|STARTED|Overall Study|25 Implants|15
162744|NCT00689871|375517|P3|STARTED|Overall Study|288 Implants|147
162745|NCT00689871|375518|P2|STARTED|Overall Study|127 Implants|98
162746|NCT00689871|375519|P1|STARTED|Overall Study|908 Implants|455
162747|NCT00689819|375535|P2|NOT COMPLETED|Overall Study||15
162748|NCT00689819|375536|P1|NOT COMPLETED|Overall Study||20
162749|NCT00689819|375535|P2|COMPLETED|Overall Study||43
162750|NCT00689819|375536|P1|COMPLETED|Overall Study||45
162751|NCT00689819|375535|P2|STARTED|Overall Study||58
162752|NCT00689819|375536|P1|STARTED|Overall Study||65
162753|NCT00689793|375546|P2|NOT COMPLETED|Overall Study||5
162754|NCT00689793|375547|P1|NOT COMPLETED|Overall Study||4
162755|NCT00689793|375546|P2|COMPLETED|Overall Study||71
162756|NCT00689793|375547|P1|COMPLETED|Overall Study||74
162757|NCT00689793|375546|P2|STARTED|Overall Study||76
162758|NCT00689793|375547|P1|STARTED|Overall Study||78
162759|NCT00689611|375565|P2|NOT COMPLETED|Overall Study||46
162760|NCT00689611|375566|P1|NOT COMPLETED|Overall Study||41
162761|NCT00689611|375565|P2|COMPLETED|Overall Study||146
162762|NCT00689611|375566|P1|COMPLETED|Overall Study||159
162763|NCT00689611|375565|P2|STARTED|Overall Study||192
162764|NCT00689611|375566|P1|STARTED|Overall Study||200
162765|NCT00689481|375576|P2|NOT COMPLETED|Overall Study||14
162766|NCT00689481|375577|P1|NOT COMPLETED|Overall Study||24
162767|NCT00689481|375576|P2|COMPLETED|Overall Study||95
162768|NCT00689481|375577|P1|COMPLETED|Overall Study||190
162769|NCT00689481|375576|P2|STARTED|Overall Study||109
162770|NCT00689481|375577|P1|STARTED|Overall Study||214
162771|NCT00689390|375595|P2|NOT COMPLETED|Overall Study||10
162772|NCT00689390|375596|P1|NOT COMPLETED|Overall Study||426
162773|NCT00689390|375595|P2|COMPLETED|Overall Study||37
162774|NCT00689390|375596|P1|COMPLETED|Overall Study||1481
162775|NCT00689390|375595|P2|STARTED|Overall Study||47
162776|NCT00689390|375596|P1|STARTED|Overall Study||1907
162777|NCT00689351|375614|P2|NOT COMPLETED|Toddler Dose||0
162778|NCT00689351|375615|P1|NOT COMPLETED|Toddler Dose||0
162779|NCT00689351|375614|P2|COMPLETED|Toddler Dose||88
162780|NCT00689351|375615|P1|COMPLETED|Toddler Dose||84
162781|NCT00689351|375614|P2|STARTED|Toddler Dose||88
162782|NCT00689351|375615|P1|STARTED|Toddler Dose||84
162783|NCT00689351|375614|P2|NOT COMPLETED|After Infant Series||0
162784|NCT00689351|375615|P1|NOT COMPLETED|After Infant Series||1
162785|NCT00689351|375614|P2|COMPLETED|After Infant Series||88
162786|NCT00689351|375615|P1|COMPLETED|After Infant Series||84
162787|NCT00689351|375614|P2|STARTED|After Infant Series||88
162788|NCT00689351|375615|P1|STARTED|After Infant Series||85
162789|NCT00689351|375614|P2|NOT COMPLETED|Infant Series of Dosing||1
162790|NCT00689351|375615|P1|NOT COMPLETED|Infant Series of Dosing||6
162791|NCT00689351|375614|P2|COMPLETED|Infant Series of Dosing||88
162792|NCT00689351|375615|P1|COMPLETED|Infant Series of Dosing||85
162793|NCT00689351|375614|P2|Vaccinated Dose 3|Infant Series of Dosing||88
162794|NCT00689351|375615|P1|Vaccinated Dose 3|Infant Series of Dosing||85
162795|NCT00689351|375614|P2|Vaccinated Dose 2|Infant Series of Dosing||88
162796|NCT00689351|375615|P1|Vaccinated Dose 2|Infant Series of Dosing||86
162797|NCT00689351|375614|P2|Vaccinated Dose 1|Infant Series of Dosing||89
162798|NCT00689351|375615|P1|Vaccinated Dose 1|Infant Series of Dosing||88
162799|NCT00689351|375614|P2|STARTED|Infant Series of Dosing||89
162800|NCT00689351|375615|P1|STARTED|Infant Series of Dosing||91
162801|NCT00689338|375647|P1|NOT COMPLETED|Overall Study||143
162802|NCT00689338|375647|P1|COMPLETED|Overall Study||73
162803|NCT00689338|375647|P1|STARTED|Overall Study||216
162804|NCT00689299|375660|P3|NOT COMPLETED|Overall Study||5
162805|NCT00689299|375661|P2|NOT COMPLETED|Overall Study||3
162806|NCT00689299|375662|P1|NOT COMPLETED|Overall Study||7
162807|NCT00689299|375660|P3|COMPLETED|Overall Study||49
162808|NCT00689299|375661|P2|COMPLETED|Overall Study||54
162809|NCT00689299|375662|P1|COMPLETED|Overall Study||51
162810|NCT00689299|375660|P3|STARTED|Overall Study||54
162811|NCT00689299|375661|P2|STARTED|Overall Study||57
162812|NCT00689299|375662|P1|STARTED|Overall Study||58
162813|NCT00689260|375672|P2|NOT COMPLETED|Overall Study||0
162814|NCT00689260|375673|P1|NOT COMPLETED|Overall Study||2
162815|NCT00689260|375672|P2|COMPLETED|Overall Study||21
162816|NCT00689260|375673|P1|COMPLETED|Overall Study||19
162817|NCT00689260|375672|P2|STARTED|Overall Study||21
162818|NCT00689260|375673|P1|STARTED|Overall Study||21
162819|NCT00689221|375691|P2|NOT COMPLETED|Overall Study||36
162820|NCT00689221|375692|P1|NOT COMPLETED|Overall Study||39
162821|NCT00689221|375691|P2|COMPLETED|Overall Study||237
162822|NCT00689221|375692|P1|COMPLETED|Overall Study||233
162823|NCT00689221|375691|P2|STARTED|Overall Study||273
162824|NCT00689221|375692|P1|STARTED|Overall Study||272
162825|NCT00689117|375721|P4|NOT COMPLETED|Overall Study||31
162826|NCT00689117|375722|P3|NOT COMPLETED|Overall Study||59
162827|NCT00689117|375723|P2|NOT COMPLETED|Overall Study||51
162828|NCT00689117|375724|P1|NOT COMPLETED|Overall Study||62
162829|NCT00689117|375721|P4|COMPLETED|Overall Study||211
162830|NCT00689117|375722|P3|COMPLETED|Overall Study||405
162831|NCT00689117|375723|P2|COMPLETED|Overall Study||416
162832|NCT00689117|375724|P1|COMPLETED|Overall Study||414
162833|NCT00689117|375721|P4|STARTED|Overall Study||242
162834|NCT00689117|375722|P3|STARTED|Overall Study||464
162835|NCT00689117|375723|P2|STARTED|Overall Study||467
162836|NCT00689117|375724|P1|STARTED|Overall Study||476
162837|NCT00689104|375754|P4|NOT COMPLETED|Overall Study||50
162838|NCT00689104|375755|P3|NOT COMPLETED|Overall Study||45
162839|NCT00689104|375756|P2|NOT COMPLETED|Overall Study||57
162840|NCT00689104|375757|P1|NOT COMPLETED|Overall Study||44
162841|NCT00689104|375754|P4|COMPLETED|Overall Study||445
162842|NCT00689104|375755|P3|COMPLETED|Overall Study||453
162843|NCT00689104|375756|P2|COMPLETED|Overall Study||440
162844|NCT00689104|375757|P1|COMPLETED|Overall Study||453
162845|NCT00689104|375754|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
162846|NCT00689104|375755|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
162847|NCT00689104|375756|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
162848|NCT00689104|375757|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
162849|NCT00689104|375754|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
162850|NCT00689104|375755|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
162851|NCT00689104|375756|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
162852|NCT00689104|375757|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
162853|NCT00689104|375754|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
162854|NCT00689104|375755|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
162855|NCT00689104|375756|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
162856|NCT00689104|375757|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
162857|NCT00689104|375754|P4|STARTED|Overall Study||495
162858|NCT00689104|375755|P3|STARTED|Overall Study||498
162859|NCT00689104|375756|P2|STARTED|Overall Study||497
162860|NCT00689104|375757|P1|STARTED|Overall Study||497
162861|NCT00689091|375889|P2|NOT COMPLETED|Overall Study||1394
162862|NCT00689091|375890|P1|NOT COMPLETED|Overall Study||1371
162863|NCT00689091|375889|P2|COMPLETED|Overall Study||9376
162864|NCT00689091|375890|P1|COMPLETED|Overall Study||9460
162865|NCT00689091|375889|P2|STARTED|Overall Study||10770
162866|NCT00689091|375890|P1|STARTED|Overall Study||10831
162867|NCT00689052|375898|P2|NOT COMPLETED|Overall Study||30
162868|NCT00689052|375899|P1|NOT COMPLETED|Overall Study||31
162869|NCT00689052|375898|P2|COMPLETED|Overall Study||0
162870|NCT00689052|375899|P1|COMPLETED|Overall Study||0
162871|NCT00689052|375898|P2|STARTED|Overall Study||30
162872|NCT00689052|375899|P1|STARTED|Overall Study||31
162873|NCT00689026|375931|P2|NOT COMPLETED|Overall Study||6
162874|NCT00689026|375932|P1|NOT COMPLETED|Overall Study||13
162875|NCT00689026|375931|P2|COMPLETED|Overall Study||24
162876|NCT00689026|375932|P1|COMPLETED|Overall Study||17
162877|NCT00689026|375931|P2|STARTED|Overall Study||30
162878|NCT00689026|375932|P1|STARTED|Overall Study||30
162879|NCT00688870|375940|P2|NOT COMPLETED|Toddler Dose||0
162880|NCT00688870|375941|P1|NOT COMPLETED|Toddler Dose||0
162881|NCT00688870|375940|P2|COMPLETED|Toddler Dose||84
162882|NCT00688870|375941|P1|COMPLETED|Toddler Dose||80
162883|NCT00688870|375940|P2|STARTED|Toddler Dose||84
162884|NCT00688870|375941|P1|STARTED|Toddler Dose||80
162885|NCT00688870|375940|P2|NOT COMPLETED|After Infant Series||0
162886|NCT00688870|375941|P1|NOT COMPLETED|After Infant Series||0
162887|NCT00688870|375940|P2|COMPLETED|After Infant Series||84
162888|NCT00688870|375941|P1|COMPLETED|After Infant Series||80
162889|NCT00688870|375940|P2|STARTED|After Infant Series||84
162890|NCT00688870|375941|P1|STARTED|After Infant Series||80
162891|NCT00688870|375940|P2|NOT COMPLETED|Infant Series||0
162892|NCT00688870|375941|P1|NOT COMPLETED|Infant Series||4
162893|NCT00688870|375940|P2|COMPLETED|Infant Series||84
162894|NCT00688870|375941|P1|COMPLETED|Infant Series||80
162895|NCT00688870|375940|P2|Vaccinated Dose 3|Infant Series||84
162896|NCT00688870|375941|P1|Vaccinated Dose 3|Infant Series||80
162897|NCT00688870|375940|P2|Vaccinated Dose 2|Infant Series||84
162898|NCT00688870|375941|P1|Vaccinated Dose 2|Infant Series||80
162899|NCT00688870|375940|P2|Vaccinated Dose 1|Infant Series||84
162900|NCT00688870|375941|P1|Vaccinated Dose 1|Infant Series||83
162901|NCT00688870|375940|P2|STARTED|Infant Series||84
162902|NCT00688870|375941|P1|STARTED|Infant Series||84
162903|NCT00688844|375973|P1|NOT COMPLETED|Overall Study||10
162904|NCT00688844|375973|P1|COMPLETED|Overall Study||48
162905|NCT00688844|375973|P1|STARTED|Overall Study||58
162906|NCT00688753|375983|P1|NOT COMPLETED|Overall Study||92
162907|NCT00688753|375983|P1|COMPLETED|Overall Study||0
162908|NCT00688753|375983|P1|STARTED|Overall Study||92
162909|NCT00688740|375994|P2|NOT COMPLETED|Overall Study||35
162910|NCT00688740|375995|P1|NOT COMPLETED|Overall Study||66
162911|NCT00688740|375994|P2|COMPLETED|Overall Study||711
162912|NCT00688740|375995|P1|COMPLETED|Overall Study||679
162913|NCT00688740|375994|P2|STARTED|Overall Study||746
162914|NCT00688740|375995|P1|STARTED|Overall Study||745
162915|NCT00688701|376008|P4|NOT COMPLETED|Overall Study||11
162916|NCT00688701|376009|P3|NOT COMPLETED|Overall Study||10
162917|NCT00688701|376010|P2|NOT COMPLETED|Overall Study||5
162918|NCT00688701|376011|P1|NOT COMPLETED|Overall Study||4
162919|NCT00688701|376008|P4|COMPLETED|Overall Study||108
162920|NCT00688701|376009|P3|COMPLETED|Overall Study||110
162921|NCT00688701|376010|P2|COMPLETED|Overall Study||56
162922|NCT00688701|376011|P1|COMPLETED|Overall Study||57
162923|NCT00688701|376008|P4|Subgroup for Standardized Meal Test|Overall Study||65
162924|NCT00688701|376009|P3|Subgroup for Standardized Meal Test|Overall Study||60
162925|NCT00688701|376010|P2|Subgroup for Standardized Meal Test|Overall Study||35
162926|NCT00688701|376011|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
162927|NCT00688701|376008|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
162928|NCT00688701|376009|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
162929|NCT00688701|376010|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
162930|NCT00688701|376011|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
162931|NCT00688701|376008|P4|Treated/Safety Population|Overall Study||119
162932|NCT00688701|376009|P3|Treated/Safety Population|Overall Study||120
162933|NCT00688701|376010|P2|Treated/Safety Population|Overall Study||61
162934|NCT00688701|376011|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
162935|NCT00688701|376008|P4|STARTED|Overall Study||119
162936|NCT00688701|376009|P3|STARTED|Overall Study||120
162937|NCT00688701|376010|P2|STARTED|Overall Study||61
162938|NCT00688701|376011|P1|STARTED|Overall Study|Randomized|61
162939|NCT00688688|376052|P3|NOT COMPLETED|Overall Study||192
162940|NCT00688688|376053|P2|NOT COMPLETED|Overall Study||179
162941|NCT00688688|376054|P1|NOT COMPLETED|Overall Study||186
162942|NCT00688688|376052|P3|COMPLETED|Overall Study||621
162943|NCT00688688|376053|P2|COMPLETED|Overall Study||645
162944|NCT00688688|376054|P1|COMPLETED|Overall Study||629
162945|NCT00688688|376052|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
162946|NCT00688688|376053|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
162947|NCT00688688|376054|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
162948|NCT00688688|376052|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
162949|NCT00688688|376053|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
162950|NCT00688688|376054|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
162951|NCT00688688|376052|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
162952|NCT00688688|376053|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
162953|NCT00688688|376054|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
162954|NCT00688688|376052|P3|STARTED|Overall Study||813
162955|NCT00688688|376053|P2|STARTED|Overall Study||824
162956|NCT00688688|376054|P1|STARTED|Overall Study||815
162957|NCT00688662|376145|P2|NOT COMPLETED|Overall Study||18
162958|NCT00688662|376146|P1|NOT COMPLETED|Overall Study||23
162959|NCT00688662|376145|P2|COMPLETED|Overall Study||55
162960|NCT00688662|376146|P1|COMPLETED|Overall Study||118
162961|NCT00688662|376145|P2|STARTED|Overall Study||73
162962|NCT00688662|376146|P1|STARTED|Overall Study||141
162963|NCT00688636|376156|P2|NOT COMPLETED|Overall Study||1
162964|NCT00688636|376157|P1|NOT COMPLETED|Overall Study||2
162965|NCT00688636|376156|P2|COMPLETED|Overall Study||12
162966|NCT00688636|376157|P1|COMPLETED|Overall Study||9
162967|NCT00688636|376156|P2|STARTED|Overall Study||13
162968|NCT00688636|376157|P1|STARTED|Overall Study||11
162969|NCT00688545|376173|P2|NOT COMPLETED|Overall Study||15
162970|NCT00688545|376174|P1|NOT COMPLETED|Overall Study||5
162971|NCT00688545|376173|P2|COMPLETED|Overall Study||204
162972|NCT00688545|376174|P1|COMPLETED|Overall Study||50
162973|NCT00688545|376173|P2|Switched Treatment at Least Once|Overall Study||13
162974|NCT00688545|376174|P1|Switched Treatment at Least Once|Overall Study||6
162975|NCT00688545|376173|P2|STARTED|Overall Study||219
162976|NCT00688545|376174|P1|STARTED|Overall Study||55
162977|NCT00688519|376184|P2|NOT COMPLETED|Overall Study||15
162978|NCT00688519|376185|P1|NOT COMPLETED|Overall Study||19
162979|NCT00688519|376184|P2|COMPLETED|Overall Study||98
162980|NCT00688519|376185|P1|COMPLETED|Overall Study||204
162981|NCT00688519|376184|P2|STARTED|Overall Study||113
162982|NCT00688519|376185|P1|STARTED|Overall Study||223
162983|NCT00688467|376203|P2|NOT COMPLETED|Treatment Period 2||2
162984|NCT00688467|376204|P1|NOT COMPLETED|Treatment Period 2||0
162985|NCT00688467|376203|P2|COMPLETED|Treatment Period 2||6
162986|NCT00688467|376204|P1|COMPLETED|Treatment Period 2||7
162987|NCT00688467|376203|P2|STARTED|Treatment Period 2||8
162988|NCT00688467|376204|P1|STARTED|Treatment Period 2||7
162989|NCT00688467|376203|P2|NOT COMPLETED|Treatment Period 1||2
162990|NCT00688467|376204|P1|NOT COMPLETED|Treatment Period 1||2
162991|NCT00688467|376203|P2|COMPLETED|Treatment Period 1||8
162992|NCT00688467|376204|P1|COMPLETED|Treatment Period 1||7
162993|NCT00688467|376203|P2|STARTED|Treatment Period 1||10
162994|NCT00688467|376204|P1|STARTED|Treatment Period 1||9
162995|NCT00688103|376236|P2|NOT COMPLETED|Overall Study||13
162996|NCT00688103|376237|P1|NOT COMPLETED|Overall Study||30
162997|NCT00688103|376236|P2|COMPLETED|Overall Study||64
162998|NCT00688103|376237|P1|COMPLETED|Overall Study||44
162999|NCT00688103|376236|P2|Actually Treated|Overall Study||76
163000|NCT00688103|376237|P1|Actually Treated|Overall Study||71
163001|NCT00688103|376236|P2|STARTED|Overall Study||77
163002|NCT00688103|376237|P1|STARTED|Overall Study||74
163003|NCT00688064|376249|P2|NOT COMPLETED|Overall Study||26
163004|NCT00688064|376250|P1|NOT COMPLETED|Overall Study||21
163005|NCT00688064|376249|P2|COMPLETED|Overall Study||201
163006|NCT00688064|376250|P1|COMPLETED|Overall Study||211
163007|NCT00688064|376249|P2|STARTED|Overall Study||227
163008|NCT00688064|376250|P1|STARTED|Overall Study||232
163009|NCT00687973|376266|P2|NOT COMPLETED|Overall Study||38
163010|NCT00687973|376267|P1|NOT COMPLETED|Overall Study||24
163011|NCT00687973|376266|P2|COMPLETED|Overall Study||162
163012|NCT00687973|376267|P1|COMPLETED|Overall Study||169
163013|NCT00687973|376266|P2|STARTED|Overall Study||200
163014|NCT00687973|376267|P1|STARTED|Overall Study||193
163015|NCT00687908|376296|P2|NOT COMPLETED|Overall Study||42
163016|NCT00687908|376297|P1|NOT COMPLETED|Overall Study||18
163017|NCT00687908|376296|P2|COMPLETED|Overall Study||78
163018|NCT00687908|376297|P1|COMPLETED|Overall Study||105
163019|NCT00687908|376296|P2|STARTED|Overall Study||120
163020|NCT00687908|376297|P1|STARTED|Overall Study||123
163021|NCT00687856|376311|P1|NOT COMPLETED|Overall Study||0
163022|NCT00687856|376311|P1|COMPLETED|Overall Study||211
163023|NCT00687856|376311|P1|STARTED|Overall Study||211
163024|NCT00687830|376317|P2|NOT COMPLETED|Overall Study||0
163025|NCT00687830|376318|P1|NOT COMPLETED|Overall Study||0
163026|NCT00687830|376317|P2|COMPLETED|Overall Study||68
163027|NCT00687830|376318|P1|COMPLETED|Overall Study||68
163028|NCT00687830|376317|P2|STARTED|Overall Study||68
163029|NCT00687830|376318|P1|STARTED|Overall Study||68
163030|NCT00687804|376329|P3|NOT COMPLETED|Open-Label Extension Study||11
163031|NCT00687804|376330|P2|NOT COMPLETED|Open-Label Extension Study||11
163032|NCT00687804|376331|P1|NOT COMPLETED|Open-Label Extension Study||10
163033|NCT00687804|376329|P3|COMPLETED|Open-Label Extension Study||63
163034|NCT00687804|376330|P2|COMPLETED|Open-Label Extension Study||72
163035|NCT00687804|376331|P1|COMPLETED|Open-Label Extension Study||73
163036|NCT00687804|376329|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
163037|NCT00687804|376330|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
163038|NCT00687804|376331|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
163039|NCT00687804|376329|P3|STARTED|Open-Label Extension Study||74
163040|NCT00687804|376330|P2|STARTED|Open-Label Extension Study||83
163041|NCT00687804|376331|P1|STARTED|Open-Label Extension Study||83
163042|NCT00687804|376329|P3|NOT COMPLETED|Core Study||13
163043|NCT00687804|376330|P2|NOT COMPLETED|Core Study||15
163044|NCT00687804|376331|P1|NOT COMPLETED|Core Study||14
163045|NCT00687804|376329|P3|COMPLETED|Core Study||98
163046|NCT00687804|376330|P2|COMPLETED|Core Study||103
163047|NCT00687804|376331|P1|COMPLETED|Core Study||102
163048|NCT00687804|376329|P3|STARTED|Core Study||111
163049|NCT00687804|376330|P2|STARTED|Core Study||118
163050|NCT00687804|376331|P1|STARTED|Core Study||116
163051|NCT00687713|376376|P2|NOT COMPLETED|Overall Study||40
163052|NCT00687713|376377|P1|NOT COMPLETED|Overall Study||32
163053|NCT00687713|376376|P2|COMPLETED|Overall Study||64
163054|NCT00687713|376377|P1|COMPLETED|Overall Study||68
163055|NCT00687713|376376|P2|STARTED|Overall Study||104
163056|NCT00687713|376377|P1|STARTED|Overall Study||100
163057|NCT00687674|376383|P1|NOT COMPLETED|Overall Study||2
163058|NCT00687674|376383|P1|COMPLETED|Overall Study||11
163059|NCT00687674|376383|P1|STARTED|Overall Study||13
163060|NCT00687609|376390|P1|NOT COMPLETED|Overall Study||3
163061|NCT00687609|376390|P1|COMPLETED|Overall Study||4
163062|NCT00687609|376390|P1|STARTED|Overall Study||7
163063|NCT00687544|376404|P1|NOT COMPLETED|Overall Study||11
163064|NCT00687544|376404|P1|COMPLETED|Overall Study||0
163065|NCT00687544|376404|P1|STARTED|Overall Study||11
163066|NCT00687531|376413|P1|NOT COMPLETED|Overall Study||135
163067|NCT00687531|376413|P1|COMPLETED|Overall Study||250
163068|NCT00687531|376413|P1|RECEIVED TREATMENT|Overall Study||281
163069|NCT00687531|376413|P1|STARTED|Overall Study|Completed screening procedures|385
163070|NCT00687453|376429|P2|NOT COMPLETED|Overall Study||6
163071|NCT00687453|376430|P1|NOT COMPLETED|Overall Study||3
163072|NCT00687453|376429|P2|COMPLETED|Overall Study||7
163073|NCT00687453|376430|P1|COMPLETED|Overall Study||8
163074|NCT00687453|376429|P2|STARTED|Overall Study||13
163075|NCT00687453|376430|P1|STARTED|Overall Study||11
163076|NCT00687440|376436|P1|NOT COMPLETED|Overall Study||12
163077|NCT00687440|376436|P1|COMPLETED|Overall Study||15
163078|NCT00687440|376436|P1|STARTED|Overall Study|Number of screened participants|27
163079|NCT00687401|376440|P1|NOT COMPLETED|Overall Study||30
163080|NCT00687401|376440|P1|COMPLETED|Overall Study||129
163081|NCT00687401|376440|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
163082|NCT00687362|376445|P1|NOT COMPLETED|Overall Study||3
163083|NCT00687362|376445|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
163084|NCT00687362|376445|P1|STARTED|Overall Study||22
163085|NCT00687323|376449|P1|NOT COMPLETED|Overall Study||180
163086|NCT00687323|376449|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
163087|NCT00687323|376449|P1|Received Treatment|Overall Study||47
163088|NCT00687323|376449|P1|STARTED|Overall Study|Number of screened participants|195
163089|NCT00687297|376465|P2|NOT COMPLETED|Maintenance||1
163090|NCT00687297|376466|P1|NOT COMPLETED|Maintenance||3
163091|NCT00687297|376465|P2|COMPLETED|Maintenance||25
163092|NCT00687297|376466|P1|COMPLETED|Maintenance||29
163093|NCT00687297|376465|P2|STARTED|Maintenance||26
163094|NCT00687297|376466|P1|STARTED|Maintenance||32
163095|NCT00687297|376465|P2|NOT COMPLETED|Induction||55
163096|NCT00687297|376466|P1|NOT COMPLETED|Induction||45
163097|NCT00687297|376465|P2|COMPLETED|Induction||26
163098|NCT00687297|376466|P1|COMPLETED|Induction||32
163099|NCT00687297|376465|P2|STARTED|Induction||81
163100|NCT00687297|376466|P1|STARTED|Induction||77
163101|NCT00687297|376465|P2|NOT COMPLETED|Randomization||1
163102|NCT00687297|376466|P1|NOT COMPLETED|Randomization||3
163103|NCT00687297|376465|P2|COMPLETED|Randomization||81
163104|NCT00687297|376466|P1|COMPLETED|Randomization||77
163105|NCT00687297|376465|P2|STARTED|Randomization||82
163106|NCT00687297|376466|P1|STARTED|Randomization||80
163107|NCT00687219|376476|P1|NOT COMPLETED|Overall Study||51
163108|NCT00687219|376476|P1|COMPLETED|Overall Study||51
163109|NCT00687219|376476|P1|STARTED|Overall Study||102
163110|NCT00687193|376488|P6|NOT COMPLETED|Overall Study||4
163111|NCT00687193|376489|P5|NOT COMPLETED|Overall Study||2
163112|NCT00687193|376490|P4|NOT COMPLETED|Overall Study||4
163113|NCT00687193|376491|P3|NOT COMPLETED|Overall Study||2
163114|NCT00687193|376492|P2|NOT COMPLETED|Overall Study||4
163115|NCT00687193|376493|P1|NOT COMPLETED|Overall Study||2
163116|NCT00687193|376488|P6|COMPLETED|Overall Study||48
163117|NCT00687193|376489|P5|COMPLETED|Overall Study||52
163118|NCT00687193|376490|P4|COMPLETED|Overall Study||49
163119|NCT00687193|376491|P3|COMPLETED|Overall Study||50
163120|NCT00687193|376492|P2|COMPLETED|Overall Study||49
163121|NCT00687193|376493|P1|COMPLETED|Overall Study||51
163122|NCT00687193|376488|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
163123|NCT00687193|376489|P5|STARTED|Overall Study||54
163124|NCT00687193|376490|P4|STARTED|Overall Study||53
163125|NCT00687193|376491|P3|STARTED|Overall Study||52
163126|NCT00687193|376492|P2|STARTED|Overall Study||53
163127|NCT00687193|376493|P1|STARTED|Overall Study||53
163128|NCT00687167|376657|P2|NOT COMPLETED|Second Intervention||0
163129|NCT00687167|376658|P1|NOT COMPLETED|Second Intervention||0
163130|NCT00687167|376657|P2|COMPLETED|Second Intervention||17
163131|NCT00687167|376658|P1|COMPLETED|Second Intervention||17
163132|NCT00687167|376657|P2|STARTED|Second Intervention||17
163133|NCT00687167|376658|P1|STARTED|Second Intervention||17
163134|NCT00687167|376657|P2|NOT COMPLETED|Washout Period of 28 Days||0
163135|NCT00687167|376658|P1|NOT COMPLETED|Washout Period of 28 Days||0
163136|NCT00687167|376657|P2|COMPLETED|Washout Period of 28 Days||17
163137|NCT00687167|376658|P1|COMPLETED|Washout Period of 28 Days||17
163138|NCT00687167|376657|P2|STARTED|Washout Period of 28 Days||17
163139|NCT00687167|376658|P1|STARTED|Washout Period of 28 Days||17
163140|NCT00687167|376657|P2|NOT COMPLETED|First Intervention||0
163141|NCT00687167|376658|P1|NOT COMPLETED|First Intervention||0
163142|NCT00687167|376657|P2|COMPLETED|First Intervention||17
163143|NCT00687167|376658|P1|COMPLETED|First Intervention||17
163144|NCT00687167|376657|P2|STARTED|First Intervention||17
163145|NCT00687167|376658|P1|STARTED|First Intervention||17
163146|NCT00687076|376668|P2|NOT COMPLETED|Overall Study||30
163147|NCT00687076|376669|P1|NOT COMPLETED|Overall Study||32
163148|NCT00687076|376668|P2|COMPLETED|Overall Study||21
163149|NCT00687076|376669|P1|COMPLETED|Overall Study||19
163150|NCT00687076|376668|P2|STARTED|Overall Study||51
163151|NCT00687076|376669|P1|STARTED|Overall Study||51
163152|NCT00686998|376680|P3|NOT COMPLETED|Overall Study||4
163153|NCT00686998|376681|P2|NOT COMPLETED|Overall Study||8
163154|NCT00686998|376682|P1|NOT COMPLETED|Overall Study||13
163155|NCT00686998|376680|P3|COMPLETED|Overall Study||18
163156|NCT00686998|376681|P2|COMPLETED|Overall Study||33
163157|NCT00686998|376682|P1|COMPLETED|Overall Study||30
163158|NCT00686998|376680|P3|Completed Scheduled Treatment|Overall Study||18
163159|NCT00686998|376681|P2|Completed Scheduled Treatment|Overall Study||33
163160|NCT00686998|376682|P1|Completed Scheduled Treatment|Overall Study||30
163161|NCT00686998|376680|P3|Eligible for Efficacy Analysis|Overall Study||21
163162|NCT00686998|376681|P2|Eligible for Efficacy Analysis|Overall Study||39
163163|NCT00686998|376682|P1|Eligible for Efficacy Analysis|Overall Study||42
163164|NCT00686998|376680|P3|Received Treatment|Overall Study||22
163165|NCT00686998|376681|P2|Received Treatment|Overall Study||41
163166|NCT00686998|376682|P1|Received Treatment|Overall Study||43
163167|NCT00686998|376680|P3|Randomized|Overall Study||22
163168|NCT00686998|376681|P2|Randomized|Overall Study||41
163169|NCT00686998|376682|P1|Randomized|Overall Study||43
163170|NCT00686998|376680|P3|STARTED|Overall Study|Randomized & received study medication|22
163171|NCT00686998|376681|P2|STARTED|Overall Study|Randomized & received study medication|41
163172|NCT00686998|376682|P1|STARTED|Overall Study|Randomized & received study medication|43
163173|NCT00686959|376692|P2|NOT COMPLETED|Overall Study||117
163174|NCT00686959|376693|P1|NOT COMPLETED|Overall Study||124
163175|NCT00686959|376692|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
163176|NCT00686959|376693|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
163177|NCT00686959|376692|P2|Entered Consolidation Phase|Overall Study||202
163178|NCT00686959|376693|P1|Entered Consolidation Phase|Overall Study||229
163179|NCT00686959|376692|P2|Received at Least One Dose of Study Drug|Overall Study||272
163180|NCT00686959|376693|P1|Received at Least One Dose of Study Drug|Overall Study||283
163181|NCT00686959|376692|P2|STARTED|Overall Study||297
163182|NCT00686959|376693|P1|STARTED|Overall Study||301
163183|NCT00686894|376711|P1|NOT COMPLETED|Overall Study||6
163184|NCT00686894|376711|P1|COMPLETED|Overall Study||1
163185|NCT00686894|376711|P1|STARTED|Overall Study||7
163186|NCT00686881|376717|P2|NOT COMPLETED|Overall Study||81
163187|NCT00686881|376718|P1|NOT COMPLETED|Overall Study||82
163188|NCT00686881|376717|P2|COMPLETED|Overall Study||53
163189|NCT00686881|376718|P1|COMPLETED|Overall Study||45
163190|NCT00686881|376717|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
163191|NCT00686881|376718|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
163192|NCT00686855|376730|P2|NOT COMPLETED|Overall Study||1
163193|NCT00686855|376731|P1|NOT COMPLETED|Overall Study||1
163194|NCT00686855|376730|P2|COMPLETED|Overall Study||17
163195|NCT00686855|376731|P1|COMPLETED|Overall Study||27
163196|NCT00686855|376730|P2|STARTED|Overall Study||18
163197|NCT00686855|376731|P1|STARTED|Overall Study||28
163198|NCT00686842|376737|P1|NOT COMPLETED|Overall Study||0
163199|NCT00686842|376737|P1|COMPLETED|Overall Study||17
163200|NCT00686842|376737|P1|STARTED|Overall Study||17
163201|NCT00686803|376744|P3|NOT COMPLETED|Overall Study||0
163202|NCT00686803|376745|P2|NOT COMPLETED|Overall Study||0
163203|NCT00686803|376746|P1|NOT COMPLETED|Overall Study||0
163204|NCT00686803|376744|P3|COMPLETED|Overall Study||3
163205|NCT00686803|376745|P2|COMPLETED|Overall Study||12
163206|NCT00686803|376746|P1|COMPLETED|Overall Study||6
163207|NCT00686803|376744|P3|STARTED|Overall Study||3
163208|NCT00686803|376745|P2|STARTED|Overall Study||12
163209|NCT00686803|376746|P1|STARTED|Overall Study||6
163210|NCT00686790|376757|P1|NOT COMPLETED|Overall Study||16
163211|NCT00686790|376757|P1|COMPLETED|Overall Study||32
163212|NCT00686790|376757|P1|STARTED|Overall Study||48
163213|NCT00686777|376765|P1|NOT COMPLETED|Overall Study||10
163214|NCT00686777|376765|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
163215|NCT00686777|376765|P1|Completed 24 Weeks of Follow-up|Overall Study||70
163216|NCT00686777|376765|P1|Included in Follow-up (All Treated)|Overall Study||75
163217|NCT00686777|376765|P1|Completed 48 Weeks of Treatment|Overall Study||65
163218|NCT00686777|376765|P1|Completed 24 Weeks of Treatment|Overall Study||69
163219|NCT00686777|376765|P1|STARTED|Overall Study||75
163220|NCT00686725|376773|P2|NOT COMPLETED|Overall Study||42
163221|NCT00686725|376774|P1|NOT COMPLETED|Overall Study||46
163222|NCT00686725|376773|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
163223|NCT00686725|376774|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
163224|NCT00686725|376773|P2|STARTED|Overall Study||52
163225|NCT00686725|376774|P1|STARTED|Overall Study||47
163226|NCT00686712|376799|P3|NOT COMPLETED|Overall Study||13
163227|NCT00686712|376800|P2|NOT COMPLETED|Overall Study||11
163228|NCT00686712|376801|P1|NOT COMPLETED|Overall Study||10
163229|NCT00686712|376799|P3|COMPLETED|Overall Study||17
163230|NCT00686712|376800|P2|COMPLETED|Overall Study||14
163231|NCT00686712|376801|P1|COMPLETED|Overall Study||20
163232|NCT00686712|376799|P3|STARTED|Overall Study||30
163233|NCT00686712|376800|P2|STARTED|Overall Study||25
163234|NCT00686712|376801|P1|STARTED|Overall Study||30
163235|NCT00686699|376811|P2|NOT COMPLETED|Treatment Period 2||0
163236|NCT00686699|376812|P1|NOT COMPLETED|Treatment Period 2||0
163237|NCT00686699|376811|P2|COMPLETED|Treatment Period 2||5
163238|NCT00686699|376812|P1|COMPLETED|Treatment Period 2||4
163239|NCT00686699|376811|P2|STARTED|Treatment Period 2||5
163240|NCT00686699|376812|P1|STARTED|Treatment Period 2||4
163241|NCT00686699|376811|P2|NOT COMPLETED|Treatment Period 1||2
163242|NCT00686699|376812|P1|NOT COMPLETED|Treatment Period 1||0
163243|NCT00686699|376811|P2|COMPLETED|Treatment Period 1||5
163244|NCT00686699|376812|P1|COMPLETED|Treatment Period 1||4
163245|NCT00686699|376811|P2|STARTED|Treatment Period 1||7
163246|NCT00686699|376812|P1|STARTED|Treatment Period 1||4
163247|NCT00686686|376836|P1|NOT COMPLETED|Overall Study||6
163248|NCT00686686|376836|P1|COMPLETED|Overall Study||17
163249|NCT00686686|376836|P1|STARTED|Overall Study||23
163250|NCT00686647|376844|P1|NOT COMPLETED|Overall Study||2
163251|NCT00686647|376844|P1|COMPLETED|Overall Study||91
163252|NCT00686647|376844|P1|STARTED|Overall Study||93
163253|NCT00686634|376850|P1|NOT COMPLETED|Overall Study||6
163254|NCT00686634|376850|P1|COMPLETED|Overall Study||102
163255|NCT00686634|376850|P1|STARTED|Overall Study||108
163256|NCT00686595|376857|P1|NOT COMPLETED|Overall Study||7
163257|NCT00686595|376857|P1|COMPLETED|Overall Study||31
163258|NCT00686595|376857|P1|STARTED|Overall Study||38
163259|NCT00686543|376886|P4|NOT COMPLETED|Overall Study||3
163260|NCT00686543|376887|P3|NOT COMPLETED|Overall Study||5
163261|NCT00686543|376888|P2|NOT COMPLETED|Overall Study||1
163262|NCT00686543|376889|P1|NOT COMPLETED|Overall Study||14
163263|NCT00686543|376886|P4|COMPLETED|Overall Study||17
163264|NCT00686543|376887|P3|COMPLETED|Overall Study||15
163265|NCT00686543|376888|P2|COMPLETED|Overall Study||20
163266|NCT00686543|376889|P1|COMPLETED|Overall Study||0
163267|NCT00686543|376886|P4|STARTED|Overall Study||20
163268|NCT00686543|376887|P3|STARTED|Overall Study||20
163269|NCT00686543|376888|P2|STARTED|Overall Study||21
163270|NCT00686543|376889|P1|STARTED|Overall Study||14
163271|NCT00686517|376910|P3|NOT COMPLETED|Follow-up||10
163272|NCT00686517|376911|P2|NOT COMPLETED|Follow-up||10
163273|NCT00686517|376912|P1|NOT COMPLETED|Follow-up||8
163274|NCT00686517|376910|P3|COMPLETED|Follow-up||29
163275|NCT00686517|376911|P2|COMPLETED|Follow-up||28
163276|NCT00686517|376912|P1|COMPLETED|Follow-up||29
163277|NCT00686517|376910|P3|STARTED|Follow-up||39
163278|NCT00686517|376911|P2|STARTED|Follow-up||38
163279|NCT00686517|376912|P1|STARTED|Follow-up||37
163280|NCT00686517|376910|P3|NOT COMPLETED|Treatment||1
163281|NCT00686517|376911|P2|NOT COMPLETED|Treatment||3
163282|NCT00686517|376912|P1|NOT COMPLETED|Treatment||6
163283|NCT00686517|376910|P3|COMPLETED|Treatment||42
163284|NCT00686517|376911|P2|COMPLETED|Treatment||40
163285|NCT00686517|376912|P1|COMPLETED|Treatment||38
163286|NCT00686517|376910|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
163287|NCT00686517|376911|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
163288|NCT00686517|376912|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
163289|NCT00686517|376910|P3|STARTED|Treatment||43
163290|NCT00686517|376911|P2|STARTED|Treatment||43
163291|NCT00686517|376912|P1|STARTED|Treatment||44
163292|NCT00686335|376935|P1|NOT COMPLETED|Treatment Period||0
163293|NCT00686335|376935|P1|COMPLETED|Treatment Period||7
163294|NCT00686335|376935|P1|STARTED|Treatment Period||7
163295|NCT00686335|376935|P1|NOT COMPLETED|Run-in Period||5
163296|NCT00686335|376935|P1|COMPLETED|Run-in Period||7
163297|NCT00686335|376935|P1|STARTED|Run-in Period||12
163298|NCT00686257|376943|P2|NOT COMPLETED|Overall Study||0
163299|NCT00686257|376944|P1|NOT COMPLETED|Overall Study||0
163300|NCT00686257|376943|P2|COMPLETED|Overall Study||31
163301|NCT00686257|376944|P1|COMPLETED|Overall Study||29
163302|NCT00686257|376943|P2|STARTED|Overall Study||31
163303|NCT00686257|376944|P1|STARTED|Overall Study||29
163304|NCT00686231|376953|P3|NOT COMPLETED|Overall Study||0
163305|NCT00686231|376954|P2|NOT COMPLETED|Overall Study||0
163306|NCT00686231|376955|P1|NOT COMPLETED|Overall Study||0
163307|NCT00686231|376953|P3|COMPLETED|Overall Study||20
163308|NCT00686231|376954|P2|COMPLETED|Overall Study||20
163309|NCT00686231|376955|P1|COMPLETED|Overall Study||20
163310|NCT00686231|376953|P3|STARTED|Overall Study||20
163311|NCT00686231|376954|P2|STARTED|Overall Study||20
163312|NCT00686231|376955|P1|STARTED|Overall Study||20
163313|NCT00686205|376965|P2|NOT COMPLETED|Overall Study||981
163314|NCT00686205|376966|P1|NOT COMPLETED|Overall Study||6007
163315|NCT00686205|376965|P2|COMPLETED|Overall Study||1524
163316|NCT00686205|376966|P1|COMPLETED|Overall Study||15599
163317|NCT00686205|376965|P2|STARTED|Overall Study||2505
163318|NCT00686205|376966|P1|STARTED|Overall Study||21606
163319|NCT00686166|376972|P1|NOT COMPLETED|Overall Study||20
163320|NCT00686166|376972|P1|COMPLETED|Overall Study||63
163321|NCT00686166|376972|P1|Eligible and Began Protocol Therapy|Overall Study||74
163322|NCT00686166|376972|P1|Eligible|Overall Study||78
163323|NCT00686166|376972|P1|STARTED|Overall Study||83
163324|NCT00686127|376984|P2|NOT COMPLETED|Overall Study||6
163325|NCT00686127|376985|P1|NOT COMPLETED|Overall Study||14
163326|NCT00686127|376984|P2|COMPLETED|Overall Study||1
163327|NCT00686127|376985|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
163328|NCT00686127|376984|P2|STARTED|Overall Study||7
163329|NCT00686127|376985|P1|STARTED|Overall Study||14
163330|NCT00686075|377001|P10|NOT COMPLETED|Overall Study||10
163331|NCT00686075|377002|P9|NOT COMPLETED|Overall Study||6
163332|NCT00686075|377003|P8|NOT COMPLETED|Overall Study||2
163333|NCT00686075|377004|P7|NOT COMPLETED|Overall Study||0
163334|NCT00686075|377005|P6|NOT COMPLETED|Overall Study||3
163335|NCT00686075|377006|P5|NOT COMPLETED|Overall Study||4
163336|NCT00686075|377007|P4|NOT COMPLETED|Overall Study||9
163337|NCT00686075|377008|P3|NOT COMPLETED|Overall Study||6
163338|NCT00686075|377009|P2|NOT COMPLETED|Overall Study||10
163339|NCT00686075|377010|P1|NOT COMPLETED|Overall Study||8
163340|NCT00686075|377001|P10|COMPLETED|Overall Study||69
163341|NCT00686075|377002|P9|COMPLETED|Overall Study||75
163342|NCT00686075|377003|P8|COMPLETED|Overall Study||76
163343|NCT00686075|377004|P7|COMPLETED|Overall Study||82
163344|NCT00686075|377005|P6|COMPLETED|Overall Study||37
163345|NCT00686075|377006|P5|COMPLETED|Overall Study||36
163346|NCT00686075|377007|P4|COMPLETED|Overall Study||71
163347|NCT00686075|377008|P3|COMPLETED|Overall Study||74
163348|NCT00686075|377009|P2|COMPLETED|Overall Study||71
163349|NCT00686075|377010|P1|COMPLETED|Overall Study||71
163350|NCT00686075|377001|P10|Treated|Overall Study||78
163351|NCT00686075|377002|P9|Treated|Overall Study||80
163352|NCT00686075|377003|P8|Treated|Overall Study||77
163353|NCT00686075|377004|P7|Treated|Overall Study||82
163354|NCT00686075|377005|P6|Treated|Overall Study||40
163355|NCT00686075|377006|P5|Treated|Overall Study||40
163356|NCT00686075|377007|P4|Treated|Overall Study||80
163357|NCT00686075|377008|P3|Treated|Overall Study||80
163358|NCT00686075|377009|P2|Treated|Overall Study||79
163359|NCT00686075|377010|P1|Treated|Overall Study||78
163360|NCT00686075|377001|P10|STARTED|Overall Study||79
163361|NCT00686075|377002|P9|STARTED|Overall Study||81
163362|NCT00686075|377003|P8|STARTED|Overall Study||78
163363|NCT00686075|377004|P7|STARTED|Overall Study||82
163364|NCT00686075|377005|P6|STARTED|Overall Study||40
163365|NCT00686075|377006|P5|STARTED|Overall Study||40
163366|NCT00686075|377007|P4|STARTED|Overall Study||80
163367|NCT00686075|377008|P3|STARTED|Overall Study||80
163368|NCT00686075|377009|P2|STARTED|Overall Study||81
163369|NCT00686075|377010|P1|STARTED|Overall Study||79
163370|NCT00686036|377204|P2|NOT COMPLETED|Overall Study||6
163371|NCT00686036|377205|P1|NOT COMPLETED|Overall Study||9
163372|NCT00686036|377204|P2|COMPLETED|Overall Study||2
163373|NCT00686036|377205|P1|COMPLETED|Overall Study||0
163374|NCT00686036|377204|P2|STARTED|Overall Study||8
163375|NCT00686036|377205|P1|STARTED|Overall Study||9
163376|NCT00685945|377217|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
163377|NCT00685945|377217|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
163378|NCT00685945|377217|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
163379|NCT00685945|377217|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
163380|NCT00685945|377217|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
163381|NCT00685945|377217|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
163382|NCT00685945|377217|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
163383|NCT00685945|377217|P1|COMPLETED|L-NMMA + Bradykinin||23
163384|NCT00685945|377217|P1|STARTED|L-NMMA + Bradykinin||24
163385|NCT00685945|377217|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
163386|NCT00685945|377217|P1|COMPLETED|Control (Bradykinin Infusion)||24
163387|NCT00685945|377217|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
163388|NCT00685880|377234|P2|NOT COMPLETED|Overall Study||0
163389|NCT00685880|377235|P1|NOT COMPLETED|Overall Study||0
163390|NCT00685880|377234|P2|COMPLETED|Overall Study||2
163391|NCT00685880|377235|P1|COMPLETED|Overall Study||0
163392|NCT00685880|377234|P2|STARTED|Overall Study||2
163393|NCT00685880|377235|P1|STARTED|Overall Study||0
163394|NCT00685802|377241|P2|NOT COMPLETED|Second Intervention||0
163395|NCT00685802|377242|P1|NOT COMPLETED|Second Intervention||0
163396|NCT00685802|377241|P2|COMPLETED|Second Intervention||15
163397|NCT00685802|377242|P1|COMPLETED|Second Intervention||14
163398|NCT00685802|377241|P2|STARTED|Second Intervention||15
163399|NCT00685802|377242|P1|STARTED|Second Intervention||14
163400|NCT00685802|377241|P2|NOT COMPLETED|Washout Period of 7 Days||1
163401|NCT00685802|377242|P1|NOT COMPLETED|Washout Period of 7 Days||2
163402|NCT00685802|377241|P2|COMPLETED|Washout Period of 7 Days||15
163403|NCT00685802|377242|P1|COMPLETED|Washout Period of 7 Days||14
163404|NCT00685802|377241|P2|STARTED|Washout Period of 7 Days||16
163405|NCT00685802|377242|P1|STARTED|Washout Period of 7 Days||16
163406|NCT00685802|377241|P2|NOT COMPLETED|First Intervention||0
163407|NCT00685802|377242|P1|NOT COMPLETED|First Intervention||0
163408|NCT00685802|377241|P2|COMPLETED|First Intervention||16
163409|NCT00685802|377242|P1|COMPLETED|First Intervention||16
163410|NCT00685802|377241|P2|STARTED|First Intervention||16
163411|NCT00685802|377242|P1|STARTED|First Intervention||16
163412|NCT00685763|377252|P1|NOT COMPLETED|Overall Study||2
163413|NCT00685763|377252|P1|COMPLETED|Overall Study||11
163414|NCT00685763|377252|P1|STARTED|Overall Study||13
163415|NCT00685698|377256|P1|NOT COMPLETED|Overall Study||13
163416|NCT00685698|377256|P1|COMPLETED|Overall Study||25
163417|NCT00685698|377256|P1|STARTED|Overall Study||38
163418|NCT00685685|377291|P2|NOT COMPLETED|Second Intervention||0
163419|NCT00685685|377292|P1|NOT COMPLETED|Second Intervention||0
163420|NCT00685685|377291|P2|COMPLETED|Second Intervention||26
163421|NCT00685685|377292|P1|COMPLETED|Second Intervention||25
163422|NCT00685685|377291|P2|STARTED|Second Intervention||26
163423|NCT00685685|377292|P1|STARTED|Second Intervention||25
163424|NCT00685685|377291|P2|NOT COMPLETED|Washout Period of 7 Days||1
163425|NCT00685685|377292|P1|NOT COMPLETED|Washout Period of 7 Days||2
163426|NCT00685685|377291|P2|COMPLETED|Washout Period of 7 Days||26
163427|NCT00685685|377292|P1|COMPLETED|Washout Period of 7 Days||25
163428|NCT00685685|377291|P2|STARTED|Washout Period of 7 Days||27
163429|NCT00685685|377292|P1|STARTED|Washout Period of 7 Days||27
163430|NCT00685685|377291|P2|NOT COMPLETED|First Intervention||0
163431|NCT00685685|377292|P1|NOT COMPLETED|First Intervention||0
163432|NCT00685685|377291|P2|COMPLETED|First Intervention||27
163433|NCT00685685|377292|P1|COMPLETED|First Intervention||27
163434|NCT00685685|377291|P2|STARTED|First Intervention||27
163435|NCT00685685|377292|P1|STARTED|First Intervention||27
163436|NCT00685659|377305|P3|NOT COMPLETED|Overall Study||15
163437|NCT00685659|377306|P2|NOT COMPLETED|Overall Study||25
163438|NCT00685659|377307|P1|NOT COMPLETED|Overall Study||31
163439|NCT00685659|377305|P3|COMPLETED|Overall Study||92
163440|NCT00685659|377306|P2|COMPLETED|Overall Study||81
163441|NCT00685659|377307|P1|COMPLETED|Overall Study||77
163442|NCT00685659|377305|P3|STARTED|Overall Study||107
163443|NCT00685659|377306|P2|STARTED|Overall Study||106
163444|NCT00685659|377307|P1|STARTED|Overall Study||108
163445|NCT00685516|377318|P3|NOT COMPLETED|Overall Study||7
163446|NCT00685516|377319|P2|NOT COMPLETED|Overall Study||5
163447|NCT00685516|377320|P1|NOT COMPLETED|Overall Study||8
163448|NCT00685516|377318|P3|COMPLETED|Overall Study||26
163449|NCT00685516|377319|P2|COMPLETED|Overall Study||33
163450|NCT00685516|377320|P1|COMPLETED|Overall Study||34
163451|NCT00685516|377318|P3|STARTED|Overall Study||33
163452|NCT00685516|377319|P2|STARTED|Overall Study||38
163453|NCT00685516|377320|P1|STARTED|Overall Study||42
163454|NCT00685477|377337|P6|NOT COMPLETED|Overall Study||0
163455|NCT00685477|377338|P5|NOT COMPLETED|Overall Study||0
163456|NCT00685477|377339|P4|NOT COMPLETED|Overall Study||0
163457|NCT00685477|377340|P3|NOT COMPLETED|Overall Study||0
163458|NCT00685477|377341|P2|NOT COMPLETED|Overall Study||0
163459|NCT00685477|377342|P1|NOT COMPLETED|Overall Study||0
163460|NCT00685477|377337|P6|COMPLETED|Overall Study||10
163461|NCT00685477|377338|P5|COMPLETED|Overall Study||10
163462|NCT00685477|377339|P4|COMPLETED|Overall Study||10
163463|NCT00685477|377340|P3|COMPLETED|Overall Study||10
163464|NCT00685477|377341|P2|COMPLETED|Overall Study||10
163465|NCT00685477|377342|P1|COMPLETED|Overall Study||10
163466|NCT00685477|377337|P6|STARTED|Overall Study||10
163467|NCT00685477|377338|P5|STARTED|Overall Study||10
163468|NCT00685477|377339|P4|STARTED|Overall Study||10
163469|NCT00685477|377340|P3|STARTED|Overall Study||10
163470|NCT00685477|377341|P2|STARTED|Overall Study||10
163471|NCT00685477|377342|P1|STARTED|Overall Study||10
163472|NCT00685373|377351|P1|NOT COMPLETED|Overall Study||15
163473|NCT00685373|377351|P1|COMPLETED|Overall Study||151
163474|NCT00685373|377351|P1|STARTED|Overall Study||166
163475|NCT00685334|377360|P2|NOT COMPLETED|Overall Study||7
163476|NCT00685334|377361|P1|NOT COMPLETED|Overall Study||10
163477|NCT00685334|377360|P2|COMPLETED|Overall Study||3
163478|NCT00685334|377361|P1|COMPLETED|Overall Study||2
163479|NCT00685334|377360|P2|STARTED|Overall Study||10
163480|NCT00685334|377361|P1|STARTED|Overall Study||12
163481|NCT00685295|377371|P2|NOT COMPLETED|Overall Study||0
163482|NCT00685295|377372|P1|NOT COMPLETED|Overall Study||0
163483|NCT00685295|377371|P2|COMPLETED|Overall Study||30
163484|NCT00685295|377372|P1|COMPLETED|Overall Study||30
163485|NCT00685295|377371|P2|STARTED|Overall Study||30
163486|NCT00685295|377372|P1|STARTED|Overall Study||30
163487|NCT00685165|377382|P2|NOT COMPLETED|Second Intervention||0
163488|NCT00685165|377383|P1|NOT COMPLETED|Second Intervention||0
163489|NCT00685165|377382|P2|COMPLETED|Second Intervention||11
163490|NCT00685165|377383|P1|COMPLETED|Second Intervention||10
163491|NCT00685165|377382|P2|STARTED|Second Intervention||11
163492|NCT00685165|377383|P1|STARTED|Second Intervention||10
163493|NCT00685165|377382|P2|NOT COMPLETED|Washout Period of 14 Days||0
163494|NCT00685165|377383|P1|NOT COMPLETED|Washout Period of 14 Days||1
163495|NCT00685165|377382|P2|COMPLETED|Washout Period of 14 Days||11
163496|NCT00685165|377383|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
163497|NCT00685165|377382|P2|STARTED|Washout Period of 14 Days||11
163498|NCT00685165|377383|P1|STARTED|Washout Period of 14 Days||11
163499|NCT00685165|377382|P2|NOT COMPLETED|First Intervention||0
163500|NCT00685165|377383|P1|NOT COMPLETED|First Intervention||0
163501|NCT00685165|377382|P2|COMPLETED|First Intervention||11
163502|NCT00685165|377383|P1|COMPLETED|First Intervention||11
163503|NCT00685165|377382|P2|STARTED|First Intervention||11
163504|NCT00685165|377383|P1|STARTED|First Intervention||11
163505|NCT00685139|377393|P2|NOT COMPLETED|Second Intervention||0
163506|NCT00685139|377394|P1|NOT COMPLETED|Second Intervention||0
163507|NCT00685139|377393|P2|COMPLETED|Second Intervention||17
163508|NCT00685139|377394|P1|COMPLETED|Second Intervention||17
163509|NCT00685139|377393|P2|STARTED|Second Intervention||17
163510|NCT00685139|377394|P1|STARTED|Second Intervention||17
163511|NCT00685139|377393|P2|NOT COMPLETED|Washout Period of 28 Days||0
163512|NCT00685139|377394|P1|NOT COMPLETED|Washout Period of 28 Days||0
163513|NCT00685139|377393|P2|COMPLETED|Washout Period of 28 Days||17
163514|NCT00685139|377394|P1|COMPLETED|Washout Period of 28 Days||17
163515|NCT00685139|377393|P2|STARTED|Washout Period of 28 Days||17
163516|NCT00685139|377394|P1|STARTED|Washout Period of 28 Days||17
163517|NCT00685139|377393|P2|NOT COMPLETED|First Intervention||0
163518|NCT00685139|377394|P1|NOT COMPLETED|First Intervention||0
163519|NCT00685139|377393|P2|COMPLETED|First Intervention||17
163520|NCT00685139|377394|P1|COMPLETED|First Intervention||17
163521|NCT00685139|377393|P2|STARTED|First Intervention||17
163522|NCT00685139|377394|P1|STARTED|First Intervention||17
163523|NCT00685035|377402|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
163524|NCT00685035|377403|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
163525|NCT00685035|377402|P2|COMPLETED|Period 3: 2nd Intervention||8
163526|NCT00685035|377403|P1|COMPLETED|Period 3: 2nd Intervention||8
163527|NCT00685035|377402|P2|STARTED|Period 3: 2nd Intervention||8
163528|NCT00685035|377403|P1|STARTED|Period 3: 2nd Intervention||8
163529|NCT00685035|377402|P2|NOT COMPLETED|Period 2: 2-day Washout||0
163530|NCT00685035|377403|P1|NOT COMPLETED|Period 2: 2-day Washout||0
163531|NCT00685035|377402|P2|COMPLETED|Period 2: 2-day Washout||8
163532|NCT00685035|377403|P1|COMPLETED|Period 2: 2-day Washout||8
163533|NCT00685035|377402|P2|STARTED|Period 2: 2-day Washout||8
163534|NCT00685035|377403|P1|STARTED|Period 2: 2-day Washout||8
163535|NCT00685035|377402|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
163536|NCT00685035|377403|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
163537|NCT00685035|377402|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
163538|NCT00685035|377403|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
163539|NCT00685035|377402|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
163540|NCT00685035|377403|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
163541|NCT00684996|377427|P1|NOT COMPLETED|Overall Study||5
163542|NCT00684996|377427|P1|COMPLETED|Overall Study||0
163543|NCT00684996|377427|P1|Eligible|Overall Study||5
163544|NCT00684996|377427|P1|STARTED|Overall Study||5
163545|NCT00684983|377442|P2|NOT COMPLETED|Overall Study||0
163546|NCT00684983|377443|P1|NOT COMPLETED|Overall Study||0
163547|NCT00684983|377442|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
163548|NCT00684983|377443|P1|COMPLETED|Overall Study||19
163549|NCT00684983|377442|P2|STARTED|Overall Study||45
163550|NCT00684983|377443|P1|STARTED|Overall Study||19
163551|NCT00684814|377449|P2|NOT COMPLETED|Second Intervention||0
163552|NCT00684814|377450|P1|NOT COMPLETED|Second Intervention||1
163553|NCT00684814|377449|P2|COMPLETED|Second Intervention||15
163554|NCT00684814|377450|P1|COMPLETED|Second Intervention||16
163555|NCT00684814|377449|P2|STARTED|Second Intervention||15
163556|NCT00684814|377450|P1|STARTED|Second Intervention||17
163557|NCT00684814|377449|P2|NOT COMPLETED|Washout Period of 7 Days||4
163558|NCT00684814|377450|P1|NOT COMPLETED|Washout Period of 7 Days||2
163559|NCT00684814|377449|P2|COMPLETED|Washout Period of 7 Days||15
163560|NCT00684814|377450|P1|COMPLETED|Washout Period of 7 Days||17
163561|NCT00684814|377449|P2|STARTED|Washout Period of 7 Days||19
163562|NCT00684814|377450|P1|STARTED|Washout Period of 7 Days||19
163563|NCT00684814|377449|P2|NOT COMPLETED|First Intervention||0
163564|NCT00684814|377450|P1|NOT COMPLETED|First Intervention||0
163565|NCT00684814|377449|P2|COMPLETED|First Intervention||19
163566|NCT00684814|377450|P1|COMPLETED|First Intervention||19
163567|NCT00684814|377449|P2|STARTED|First Intervention||19
163568|NCT00684814|377450|P1|STARTED|First Intervention||19
163569|NCT00684762|377460|P2|NOT COMPLETED|Second Intervention||0
163570|NCT00684762|377461|P1|NOT COMPLETED|Second Intervention||0
163571|NCT00684762|377460|P2|COMPLETED|Second Intervention||14
163572|NCT00684762|377461|P1|COMPLETED|Second Intervention||14
163573|NCT00684762|377460|P2|STARTED|Second Intervention||14
163574|NCT00684762|377461|P1|STARTED|Second Intervention||14
163575|NCT00684762|377460|P2|NOT COMPLETED|Washout Period of 7 Days||2
163576|NCT00684762|377461|P1|NOT COMPLETED|Washout Period of 7 Days||2
163577|NCT00684762|377460|P2|COMPLETED|Washout Period of 7 Days||14
163578|NCT00684762|377461|P1|COMPLETED|Washout Period of 7 Days||14
163579|NCT00684762|377460|P2|STARTED|Washout Period of 7 Days||16
163580|NCT00684762|377461|P1|STARTED|Washout Period of 7 Days||16
163581|NCT00684762|377460|P2|NOT COMPLETED|First Intervention||0
163582|NCT00684762|377461|P1|NOT COMPLETED|First Intervention||0
163583|NCT00684762|377460|P2|COMPLETED|First Intervention||16
163584|NCT00684762|377461|P1|COMPLETED|First Intervention||16
163585|NCT00684762|377460|P2|STARTED|First Intervention||16
163586|NCT00684762|377461|P1|STARTED|First Intervention||16
163587|NCT00684749|377471|P1|NOT COMPLETED|Overall Study||0
163588|NCT00684749|377471|P1|COMPLETED|Overall Study||142
163589|NCT00684749|377471|P1|STARTED|Overall Study||142
163590|NCT00684723|377475|P2|NOT COMPLETED|Second Intervention||0
163591|NCT00684723|377476|P1|NOT COMPLETED|Second Intervention||0
163592|NCT00684723|377475|P2|COMPLETED|Second Intervention||27
163593|NCT00684723|377476|P1|COMPLETED|Second Intervention||27
163594|NCT00684723|377475|P2|STARTED|Second Intervention||27
163595|NCT00684723|377476|P1|STARTED|Second Intervention||27
163596|NCT00684723|377475|P2|NOT COMPLETED|Washout Period of 7 Days||0
163597|NCT00684723|377476|P1|NOT COMPLETED|Washout Period of 7 Days||0
163598|NCT00684723|377475|P2|COMPLETED|Washout Period of 7 Days||27
163599|NCT00684723|377476|P1|COMPLETED|Washout Period of 7 Days||27
163600|NCT00684723|377475|P2|STARTED|Washout Period of 7 Days||27
163601|NCT00684723|377476|P1|STARTED|Washout Period of 7 Days||27
163602|NCT00684723|377475|P2|NOT COMPLETED|First Intervention||0
163603|NCT00684723|377476|P1|NOT COMPLETED|First Intervention||0
163604|NCT00684723|377475|P2|COMPLETED|First Intervention||27
163605|NCT00684723|377476|P1|COMPLETED|First Intervention||27
163606|NCT00684723|377475|P2|STARTED|First Intervention||27
163607|NCT00684723|377476|P1|STARTED|First Intervention||27
163608|NCT00684671|377489|P3|NOT COMPLETED|Overall Study||0
163609|NCT00684671|377490|P2|NOT COMPLETED|Overall Study||0
163610|NCT00684671|377491|P1|NOT COMPLETED|Overall Study||3
163611|NCT00684671|377489|P3|COMPLETED|Overall Study||164
163612|NCT00684671|377490|P2|COMPLETED|Overall Study||170
163613|NCT00684671|377491|P1|COMPLETED|Overall Study||169
163614|NCT00684671|377489|P3|STARTED|Overall Study||164
163615|NCT00684671|377490|P2|STARTED|Overall Study||170
163616|NCT00684671|377491|P1|STARTED|Overall Study||172
163617|NCT00684645|377520|P1|NOT COMPLETED|Overall Study||114
163618|NCT00684645|377520|P1|COMPLETED|Overall Study||72
163619|NCT00684645|377520|P1|STARTED|Overall Study||186
163620|NCT00684593|377540|P2|NOT COMPLETED|Overall Study||2
163621|NCT00684593|377541|P1|NOT COMPLETED|Overall Study||0
163622|NCT00684593|377540|P2|COMPLETED|Overall Study||8
163623|NCT00684593|377541|P1|COMPLETED|Overall Study||21
163624|NCT00684593|377540|P2|STARTED|Overall Study||10
163625|NCT00684593|377541|P1|STARTED|Overall Study||21
163626|NCT00684567|377553|P1|NOT COMPLETED|Monotherapy Period||14
163627|NCT00684567|377553|P1|COMPLETED|Monotherapy Period||9
163628|NCT00684567|377553|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
163629|NCT00684567|377553|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
163630|NCT00684567|377553|P1|COMPLETED|Concomitant Radiotherapy Period||28
163631|NCT00684567|377553|P1|STARTED|Concomitant Radiotherapy Period||30
163632|NCT00684554|377563|P2|NOT COMPLETED|Overall Study||0
163633|NCT00684554|377564|P1|NOT COMPLETED|Overall Study||0
163634|NCT00684554|377563|P2|COMPLETED|Overall Study||10
163635|NCT00684554|377564|P1|COMPLETED|Overall Study||10
163636|NCT00684554|377563|P2|STARTED|Overall Study||10
163637|NCT00684554|377564|P1|STARTED|Overall Study||10
163638|NCT00684541|377574|P2|NOT COMPLETED|Overall Study||3
163639|NCT00684541|377575|P1|NOT COMPLETED|Overall Study||3
163640|NCT00684541|377574|P2|COMPLETED|Overall Study||23
163641|NCT00684541|377575|P1|COMPLETED|Overall Study||20
163642|NCT00684541|377574|P2|STARTED|Overall Study||26
163643|NCT00684541|377575|P1|STARTED|Overall Study||23
163644|NCT00684515|377586|P3|NOT COMPLETED|Overall Study||1
163645|NCT00684515|377587|P2|NOT COMPLETED|Overall Study||3
163646|NCT00684515|377588|P1|NOT COMPLETED|Overall Study||4
163647|NCT00684515|377586|P3|COMPLETED|Overall Study||27
163648|NCT00684515|377587|P2|COMPLETED|Overall Study||26
163649|NCT00684515|377588|P1|COMPLETED|Overall Study||29
163650|NCT00684515|377586|P3|STARTED|Overall Study||28
163651|NCT00684515|377587|P2|STARTED|Overall Study||29
163652|NCT00684515|377588|P1|STARTED|Overall Study||33
163653|NCT00684424|377611|P1|NOT COMPLETED|Overall Study||5
163654|NCT00684424|377611|P1|COMPLETED|Overall Study||194
163655|NCT00684424|377611|P1|STARTED|Overall Study||199
163656|NCT00684411|377626|P1|NOT COMPLETED|Overall Study||12
163657|NCT00684411|377626|P1|COMPLETED|Overall Study||0
163658|NCT00684411|377626|P1|Disease Evaluable|Overall Study||11
163659|NCT00684411|377626|P1|STARTED|Overall Study||12
163660|NCT00684320|377634|P2|NOT COMPLETED|Overall Study||0
163661|NCT00684320|377635|P1|NOT COMPLETED|Overall Study||4
163662|NCT00684320|377634|P2|COMPLETED|Overall Study||22
163663|NCT00684320|377635|P1|COMPLETED|Overall Study||22
163664|NCT00684320|377634|P2|STARTED|Overall Study||22
163665|NCT00684320|377635|P1|STARTED|Overall Study||26
163666|NCT00684307|377648|P5|NOT COMPLETED|Overall Study||25
163667|NCT00684307|377649|P4|NOT COMPLETED|Overall Study||32
163668|NCT00684307|377650|P3|NOT COMPLETED|Overall Study||28
163669|NCT00684307|377651|P2|NOT COMPLETED|Overall Study||22
163670|NCT00684307|377652|P1|NOT COMPLETED|Overall Study||24
163671|NCT00684307|377648|P5|COMPLETED|Overall Study||293
163672|NCT00684307|377649|P4|COMPLETED|Overall Study||128
163673|NCT00684307|377650|P3|COMPLETED|Overall Study||128
163674|NCT00684307|377651|P2|COMPLETED|Overall Study||129
163675|NCT00684307|377652|P1|COMPLETED|Overall Study||140
163676|NCT00684307|377648|P5|On Treatment Period Completed|Overall Study||293
163677|NCT00684307|377649|P4|On Treatment Period Completed|Overall Study||128
163678|NCT00684307|377650|P3|On Treatment Period Completed|Overall Study||128
163679|NCT00684307|377651|P2|On Treatment Period Completed|Overall Study||129
163680|NCT00684307|377652|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
163681|NCT00684307|377648|P5|On Treatment Period Started|Overall Study||318
163682|NCT00684307|377649|P4|On Treatment Period Started|Overall Study||160
163683|NCT00684307|377650|P3|On Treatment Period Started|Overall Study||156
163684|NCT00684307|377651|P2|On Treatment Period Started|Overall Study||151
163685|NCT00684307|377652|P1|On Treatment Period Started|Overall Study||164
163686|NCT00684307|377648|P5|STARTED|Overall Study||318
163687|NCT00684307|377649|P4|STARTED|Overall Study||160
163688|NCT00684307|377650|P3|STARTED|Overall Study||156
163689|NCT00684307|377651|P2|STARTED|Overall Study||151
163690|NCT00684307|377652|P1|STARTED|Overall Study|Patients who received treatment|164
163691|NCT00684255|377719|P1|NOT COMPLETED|Overall Study||0
163692|NCT00684255|377719|P1|COMPLETED|Overall Study||1
163693|NCT00684255|377719|P1|STARTED|Overall Study||1
163694|NCT00684242|377724|P1|NOT COMPLETED|Overall Study||0
163695|NCT00684242|377724|P1|COMPLETED|Overall Study||3
163696|NCT00684242|377724|P1|STARTED|Overall Study||3
163697|NCT00684203|377734|P6|NOT COMPLETED|Overall Study||0
163698|NCT00684203|377735|P5|NOT COMPLETED|Overall Study||0
163699|NCT00684203|377736|P4|NOT COMPLETED|Overall Study||0
163700|NCT00684203|377737|P3|NOT COMPLETED|Overall Study||9
163701|NCT00684203|377738|P2|NOT COMPLETED|Overall Study||8
163702|NCT00684203|377739|P1|NOT COMPLETED|Overall Study||9
163703|NCT00684203|377734|P6|COMPLETED|Overall Study||2
163704|NCT00684203|377735|P5|COMPLETED|Overall Study||17
163705|NCT00684203|377736|P4|COMPLETED|Overall Study||6
163706|NCT00684203|377737|P3|COMPLETED|Overall Study||12
163707|NCT00684203|377738|P2|COMPLETED|Overall Study||23
163708|NCT00684203|377739|P1|COMPLETED|Overall Study||31
163709|NCT00684203|377734|P6|STARTED|Overall Study||2
163710|NCT00684203|377735|P5|STARTED|Overall Study||17
163711|NCT00684203|377736|P4|STARTED|Overall Study||6
163712|NCT00684203|377737|P3|STARTED|Overall Study||21
163713|NCT00684203|377738|P2|STARTED|Overall Study||31
163714|NCT00684203|377739|P1|STARTED|Overall Study||40
163715|NCT00684177|377800|P2|NOT COMPLETED|Overall Study||23
163716|NCT00684177|377801|P1|NOT COMPLETED|Overall Study||21
163717|NCT00684177|377800|P2|COMPLETED|Overall Study||141
163718|NCT00684177|377801|P1|COMPLETED|Overall Study||322
163719|NCT00684177|377800|P2|STARTED|Overall Study||164
163720|NCT00684177|377801|P1|STARTED|Overall Study||343
163721|NCT00684138|377819|P2|NOT COMPLETED|Overall Study||8
163722|NCT00684138|377820|P1|NOT COMPLETED|Overall Study||3
163723|NCT00684138|377819|P2|COMPLETED|Overall Study||131
163724|NCT00684138|377820|P1|COMPLETED|Overall Study||138
163725|NCT00684138|377819|P2|STARTED|Overall Study||139
163726|NCT00684138|377820|P1|STARTED|Overall Study||141
163727|NCT00684073|377836|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
163728|NCT00684073|377836|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
163729|NCT00684073|377836|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
163730|NCT00684073|377836|P1|NOT COMPLETED|Selection||7
163731|NCT00684073|377836|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
163732|NCT00684073|377836|P1|STARTED|Selection||60
163733|NCT00684060|377846|P2|NOT COMPLETED|Overall Study||3
163734|NCT00684060|377847|P1|NOT COMPLETED|Overall Study||3
163735|NCT00684060|377846|P2|COMPLETED|Overall Study||26
163736|NCT00684060|377847|P1|COMPLETED|Overall Study||55
163737|NCT00684060|377846|P2|STARTED|Overall Study||29
163738|NCT00684060|377847|P1|STARTED|Overall Study||58
163739|NCT00684047|377870|P3|NOT COMPLETED|Overall Study||5
163740|NCT00684047|377871|P2|NOT COMPLETED|Overall Study||16
163741|NCT00684047|377872|P1|NOT COMPLETED|Overall Study||13
163742|NCT00684047|377870|P3|COMPLETED|Overall Study||52
163743|NCT00684047|377871|P2|COMPLETED|Overall Study||94
163744|NCT00684047|377872|P1|COMPLETED|Overall Study||59
163745|NCT00684047|377870|P3|STARTED|Overall Study||57
163746|NCT00684047|377871|P2|STARTED|Overall Study||110
163747|NCT00684047|377872|P1|STARTED|Overall Study||72
163748|NCT00684021|377886|P4|NOT COMPLETED|Overall Study||2
163749|NCT00684021|377887|P3|NOT COMPLETED|Overall Study||2
163750|NCT00684021|377888|P2|NOT COMPLETED|Overall Study||2
163751|NCT00684021|377889|P1|NOT COMPLETED|Overall Study||2
163752|NCT00684021|377886|P4|COMPLETED|Overall Study||15
163753|NCT00684021|377887|P3|COMPLETED|Overall Study||34
163754|NCT00684021|377888|P2|COMPLETED|Overall Study||22
163755|NCT00684021|377889|P1|COMPLETED|Overall Study||41
163756|NCT00684021|377886|P4|STARTED|Overall Study||17
163757|NCT00684021|377887|P3|STARTED|Overall Study||36
163758|NCT00684021|377888|P2|STARTED|Overall Study||24
163759|NCT00684021|377889|P1|STARTED|Overall Study||43
163760|NCT00683930|377930|P3|NOT COMPLETED|Overall Study||9
163761|NCT00683930|377931|P2|NOT COMPLETED|Overall Study||3
163762|NCT00683930|377932|P1|NOT COMPLETED|Overall Study||7
163763|NCT00683930|377930|P3|COMPLETED|Overall Study||28
163764|NCT00683930|377931|P2|COMPLETED|Overall Study||18
163765|NCT00683930|377932|P1|COMPLETED|Overall Study||29
163766|NCT00683930|377930|P3|STARTED|Overall Study||37
163767|NCT00683930|377931|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
163768|NCT00683930|377932|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
163769|NCT00683917|377950|P1|NOT COMPLETED|Overall Study||10
163770|NCT00683917|377950|P1|COMPLETED|Overall Study||0
163771|NCT00683917|377950|P1|STARTED|Overall Study||10
163772|NCT00683904|377960|P2|NOT COMPLETED|Dose Level 2||2
163773|NCT00683904|377961|P1|NOT COMPLETED|Dose Level 2||0
163774|NCT00683904|377960|P2|COMPLETED|Dose Level 2||4
163775|NCT00683904|377961|P1|COMPLETED|Dose Level 2||0
163776|NCT00683904|377960|P2|STARTED|Dose Level 2||6
163777|NCT00683904|377961|P1|STARTED|Dose Level 2||0
163778|NCT00683904|377960|P2|NOT COMPLETED|Dose Level 1||0
163779|NCT00683904|377961|P1|NOT COMPLETED|Dose Level 1||3
163780|NCT00683904|377960|P2|COMPLETED|Dose Level 1||0
163781|NCT00683904|377961|P1|COMPLETED|Dose Level 1||3
163782|NCT00683904|377960|P2|STARTED|Dose Level 1||0
163783|NCT00683904|377961|P1|STARTED|Dose Level 1||6
163784|NCT00683826|377997|P1|NOT COMPLETED|Overall Study||1
163785|NCT00683826|377997|P1|COMPLETED|Overall Study||7
163786|NCT00683826|377997|P1|4g Leucine|Overall Study||7
163787|NCT00683826|377997|P1|8g Leucine|Overall Study||8
163788|NCT00683826|377997|P1|0g Leucine|Overall Study||8
163789|NCT00683826|377997|P1|STARTED|Overall Study||8
163790|NCT00683800|378007|P2|NOT COMPLETED|Overall Study||366
163791|NCT00683800|378008|P1|NOT COMPLETED|Overall Study||432
163792|NCT00683800|378007|P2|COMPLETED|Overall Study||719
163793|NCT00683800|378008|P1|COMPLETED|Overall Study||669
163794|NCT00683800|378007|P2|Treated|Overall Study||1052
163795|NCT00683800|378008|P1|Treated|Overall Study||1066
163796|NCT00683800|378007|P2|STARTED|Overall Study||1085
163797|NCT00683800|378008|P1|STARTED|Overall Study||1101
163798|NCT00683787|378075|P3|NOT COMPLETED|Overall Study||2
163799|NCT00683787|378076|P2|NOT COMPLETED|Overall Study||3
163800|NCT00683787|378077|P1|NOT COMPLETED|Overall Study||3
163801|NCT00683787|378075|P3|COMPLETED|Overall Study||0
163802|NCT00683787|378076|P2|COMPLETED|Overall Study||0
163803|NCT00683787|378077|P1|COMPLETED|Overall Study||0
163804|NCT00683787|378075|P3|STARTED|Overall Study||2
163805|NCT00683787|378076|P2|STARTED|Overall Study||3
163806|NCT00683787|378077|P1|STARTED|Overall Study||3
163807|NCT00683774|378096|P2|NOT COMPLETED|Overall Study||1
163808|NCT00683774|378097|P1|NOT COMPLETED|Overall Study||3
163809|NCT00683774|378096|P2|COMPLETED|Overall Study||9
163810|NCT00683774|378097|P1|COMPLETED|Overall Study||8
163811|NCT00683774|378096|P2|STARTED|Overall Study||10
163812|NCT00683774|378097|P1|STARTED|Overall Study||11
163813|NCT00683696|378107|P2|NOT COMPLETED|Overall Study||405
163814|NCT00683696|378108|P1|NOT COMPLETED|Overall Study||404
163815|NCT00683696|378107|P2|COMPLETED|Overall Study||0
163816|NCT00683696|378108|P1|COMPLETED|Overall Study||0
163817|NCT00683696|378107|P2|STARTED|Overall Study||405
163818|NCT00683696|378108|P1|STARTED|Overall Study||404
163819|NCT00683657|378117|P2|NOT COMPLETED|Overall Study||1
163820|NCT00683657|378118|P1|NOT COMPLETED|Overall Study||1
163821|NCT00683657|378117|P2|COMPLETED|Overall Study||46
163822|NCT00683657|378118|P1|COMPLETED|Overall Study||45
163823|NCT00683657|378117|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
163824|NCT00683657|378118|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
163825|NCT00683657|378117|P2|STARTED|Overall Study||47
163826|NCT00683657|378118|P1|STARTED|Overall Study||46
163827|NCT00683618|378135|P3|NOT COMPLETED|Extension Treatment Period||0
163828|NCT00683618|378136|P2|NOT COMPLETED|Extension Treatment Period||0
163829|NCT00683618|378137|P1|NOT COMPLETED|Extension Treatment Period||3
163830|NCT00683618|378135|P3|COMPLETED|Extension Treatment Period||0
163831|NCT00683618|378136|P2|COMPLETED|Extension Treatment Period||23
163832|NCT00683618|378137|P1|COMPLETED|Extension Treatment Period||33
163833|NCT00683618|378135|P3|STARTED|Extension Treatment Period||0
163834|NCT00683618|378136|P2|STARTED|Extension Treatment Period||23
163835|NCT00683618|378137|P1|STARTED|Extension Treatment Period||36
163836|NCT00683618|378135|P3|NOT COMPLETED|Randomised Treatment Period||6
163837|NCT00683618|378136|P2|NOT COMPLETED|Randomised Treatment Period||2
163838|NCT00683618|378137|P1|NOT COMPLETED|Randomised Treatment Period||6
163839|NCT00683618|378135|P3|COMPLETED|Randomised Treatment Period||140
163840|NCT00683618|378136|P2|COMPLETED|Randomised Treatment Period||143
163841|NCT00683618|378137|P1|COMPLETED|Randomised Treatment Period||139
163842|NCT00683618|378135|P3|STARTED|Randomised Treatment Period||146
163843|NCT00683618|378136|P2|STARTED|Randomised Treatment Period||145
163844|NCT00683618|378137|P1|STARTED|Randomised Treatment Period||145
163845|NCT00683592|378187|P2|NOT COMPLETED|Overall Study||46
163846|NCT00683592|378188|P1|NOT COMPLETED|Overall Study||47
163847|NCT00683592|378187|P2|COMPLETED|Overall Study||195
163848|NCT00683592|378188|P1|COMPLETED|Overall Study||193
163849|NCT00683592|378187|P2|Safety Population|Overall Study||233
163850|NCT00683592|378188|P1|Safety Population|Overall Study||235
163851|NCT00683592|378187|P2|Intent to Treat Population|Overall Study||232
163852|NCT00683592|378188|P1|Intent to Treat Population|Overall Study||231
163853|NCT00683592|378187|P2|STARTED|Overall Study||241
163854|NCT00683592|378188|P1|STARTED|Overall Study||240
163855|NCT00683475|378206|P2|NOT COMPLETED|Overall Study||3
163856|NCT00683475|378207|P1|NOT COMPLETED|Overall Study||4
163857|NCT00683475|378206|P2|COMPLETED|Overall Study||66
163858|NCT00683475|378207|P1|COMPLETED|Overall Study||65
163859|NCT00683475|378206|P2|Received Any Quantity of Study Drug|Overall Study||66
163860|NCT00683475|378207|P1|Received Any Quantity of Study Drug|Overall Study||66
163861|NCT00683475|378206|P2|STARTED|Overall Study||69
163862|NCT00683475|378207|P1|STARTED|Overall Study||69
163863|NCT00683449|378242|P5|NOT COMPLETED|Overall Study||0
163864|NCT00683449|378243|P4|NOT COMPLETED|Overall Study||0
163865|NCT00683449|378244|P3|NOT COMPLETED|Overall Study||0
163866|NCT00683449|378245|P2|NOT COMPLETED|Overall Study||1
163867|NCT00683449|378246|P1|NOT COMPLETED|Overall Study||0
163868|NCT00683449|378242|P5|COMPLETED|Overall Study||2
163869|NCT00683449|378243|P4|COMPLETED|Overall Study||6
163870|NCT00683449|378244|P3|COMPLETED|Overall Study||3
163871|NCT00683449|378245|P2|COMPLETED|Overall Study||12
163872|NCT00683449|378246|P1|COMPLETED|Overall Study||5
163873|NCT00683449|378242|P5|STARTED|Overall Study||2
163874|NCT00683449|378243|P4|STARTED|Overall Study||6
163875|NCT00683449|378244|P3|STARTED|Overall Study||3
163876|NCT00683449|378245|P2|STARTED|Overall Study||13
163877|NCT00683449|378246|P1|STARTED|Overall Study||5
163878|NCT00683410|378268|P1|NOT COMPLETED|Overall Study||0
163879|NCT00683410|378268|P1|COMPLETED|Overall Study||3366
163880|NCT00683410|378268|P1|Vaccinated Dose 4|Overall Study||175
163881|NCT00683410|378268|P1|Vaccinated Dose 3|Overall Study||817
163882|NCT00683410|378268|P1|Vaccinated Dose 2|Overall Study||1623
163883|NCT00683410|378268|P1|Vaccinated Dose 1|Overall Study||3240
163884|NCT00683410|378268|P1|STARTED|Overall Study||3366
163885|NCT00683384|378272|P1|NOT COMPLETED|Overall Study||2
163886|NCT00683384|378272|P1|COMPLETED|Overall Study||91
163887|NCT00683384|378272|P1|STARTED|Overall Study||93
163888|NCT00683332|378276|P1|NOT COMPLETED|Overall Study||0
163889|NCT00683332|378276|P1|COMPLETED|Overall Study||621
163890|NCT00683332|378276|P1|STARTED|Overall Study||621
163891|NCT00683293|378282|P2|NOT COMPLETED|Overall Study||3
163892|NCT00683293|378283|P1|NOT COMPLETED|Overall Study||2
163893|NCT00683293|378282|P2|COMPLETED|Overall Study||47
163894|NCT00683293|378283|P1|COMPLETED|Overall Study||48
163895|NCT00683293|378282|P2|STARTED|Overall Study||50
163896|NCT00683293|378283|P1|STARTED|Overall Study||50
163897|NCT00683163|378293|P2|NOT COMPLETED|Overall Study||0
163898|NCT00683163|378294|P1|NOT COMPLETED|Overall Study||0
163899|NCT00683163|378293|P2|COMPLETED|Overall Study||22
163900|NCT00683163|378294|P1|COMPLETED|Overall Study||22
163901|NCT00683163|378293|P2|STARTED|Overall Study||22
163902|NCT00683163|378294|P1|STARTED|Overall Study||22
163903|NCT00683085|378302|P1|NOT COMPLETED|Overall Study||0
163904|NCT00683085|378302|P1|COMPLETED|Overall Study||2
163905|NCT00683085|378302|P1|STARTED|Overall Study||2
163906|NCT00683046|378307|P1|NOT COMPLETED|Overall Study||0
163907|NCT00683046|378307|P1|COMPLETED|Overall Study||204
163908|NCT00683046|378307|P1|STARTED|Overall Study||204
163909|NCT00683020|378314|P2|NOT COMPLETED|Overall Study||55
163910|NCT00683020|378315|P1|NOT COMPLETED|Overall Study||55
163911|NCT00683020|378314|P2|COMPLETED|Overall Study||125
163912|NCT00683020|378315|P1|COMPLETED|Overall Study||127
163913|NCT00683020|378314|P2|STARTED|Overall Study||180
163914|NCT00683020|378315|P1|STARTED|Overall Study||182
163915|NCT00682890|378345|P2|NOT COMPLETED|Overall Study||2
163916|NCT00682890|378346|P1|NOT COMPLETED|Overall Study||2
163917|NCT00682890|378345|P2|COMPLETED|Overall Study||9
163918|NCT00682890|378346|P1|COMPLETED|Overall Study||10
163919|NCT00682890|378345|P2|STARTED|Overall Study||11
163920|NCT00682890|378346|P1|STARTED|Overall Study||12
163921|NCT00682851|378356|P2|NOT COMPLETED|Overall Study||0
163922|NCT00682851|378357|P1|NOT COMPLETED|Overall Study||0
163923|NCT00682851|378356|P2|COMPLETED|Overall Study||268
163924|NCT00682851|378357|P1|COMPLETED|Overall Study||251
163925|NCT00682851|378356|P2|STARTED|Overall Study||268
163926|NCT00682851|378357|P1|STARTED|Overall Study||251
163927|NCT00682838|378373|P4|NOT COMPLETED|Overall Study||0
163928|NCT00682838|378374|P3|NOT COMPLETED|Overall Study||0
163929|NCT00682838|378375|P2|NOT COMPLETED|Overall Study||0
163930|NCT00682838|378376|P1|NOT COMPLETED|Overall Study||0
163931|NCT00682838|378373|P4|COMPLETED|Overall Study||73
163932|NCT00682838|378374|P3|COMPLETED|Overall Study||75
163933|NCT00682838|378375|P2|COMPLETED|Overall Study||67
163934|NCT00682838|378376|P1|COMPLETED|Overall Study||65
163935|NCT00682838|378373|P4|STARTED|Overall Study||73
163936|NCT00682838|378374|P3|STARTED|Overall Study||75
163937|NCT00682838|378375|P2|STARTED|Overall Study||67
163938|NCT00682838|378376|P1|STARTED|Overall Study||65
163939|NCT00682786|378388|P2|NOT COMPLETED|Overall Study||3
163940|NCT00682786|378389|P1|NOT COMPLETED|Overall Study||2
163941|NCT00682786|378388|P2|COMPLETED|Overall Study||34
163942|NCT00682786|378389|P1|COMPLETED|Overall Study||96
163943|NCT00682786|378388|P2|STARTED|Overall Study||37
163944|NCT00682786|378389|P1|STARTED|Overall Study||98
163945|NCT00682734|378422|P3|NOT COMPLETED|48 Hour Follow-up||11
163946|NCT00682734|378423|P2|NOT COMPLETED|48 Hour Follow-up||6
163947|NCT00682734|378424|P1|NOT COMPLETED|48 Hour Follow-up||6
163948|NCT00682734|378422|P3|COMPLETED|48 Hour Follow-up||106
163949|NCT00682734|378423|P2|COMPLETED|48 Hour Follow-up||111
163950|NCT00682734|378424|P1|COMPLETED|48 Hour Follow-up||107
163951|NCT00682734|378422|P3|STARTED|48 Hour Follow-up||117
163952|NCT00682734|378423|P2|STARTED|48 Hour Follow-up||117
163953|NCT00682734|378424|P1|STARTED|48 Hour Follow-up||113
163954|NCT00682734|378422|P3|NOT COMPLETED|Emergency Department Portion||1
163955|NCT00682734|378423|P2|NOT COMPLETED|Emergency Department Portion||1
163956|NCT00682734|378424|P1|NOT COMPLETED|Emergency Department Portion||0
163957|NCT00682734|378422|P3|COMPLETED|Emergency Department Portion||117
163958|NCT00682734|378423|P2|COMPLETED|Emergency Department Portion||117
163959|NCT00682734|378424|P1|COMPLETED|Emergency Department Portion||113
163960|NCT00682734|378422|P3|STARTED|Emergency Department Portion||118
163961|NCT00682734|378423|P2|STARTED|Emergency Department Portion||118
163962|NCT00682734|378424|P1|STARTED|Emergency Department Portion||113
163963|NCT00682643|378434|P2|NOT COMPLETED|Overall Study||169
163964|NCT00682643|378435|P1|NOT COMPLETED|Overall Study||78
163965|NCT00682643|378434|P2|COMPLETED|Overall Study||199
163966|NCT00682643|378435|P1|COMPLETED|Overall Study||104
163967|NCT00682643|378434|P2|STARTED|Overall Study||368
163968|NCT00682643|378435|P1|STARTED|Overall Study||182
163969|NCT00682565|378470|P3|NOT COMPLETED|Overall Study||0
163970|NCT00682565|378471|P2|NOT COMPLETED|Overall Study||2
163971|NCT00682565|378472|P1|NOT COMPLETED|Overall Study||1
163972|NCT00682565|378470|P3|COMPLETED|Overall Study||29
163973|NCT00682565|378471|P2|COMPLETED|Overall Study||32
163974|NCT00682565|378472|P1|COMPLETED|Overall Study||30
163975|NCT00682565|378470|P3|STARTED|Overall Study||29
163976|NCT00682565|378471|P2|STARTED|Overall Study||34
163977|NCT00682565|378472|P1|STARTED|Overall Study||31
163978|NCT00682539|378496|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
163979|NCT00682539|378497|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
163980|NCT00682539|378498|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
163981|NCT00682539|378496|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
163982|NCT00682539|378497|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
163983|NCT00682539|378498|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
163984|NCT00682539|378496|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
163985|NCT00682539|378497|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
163986|NCT00682539|378498|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
163987|NCT00682539|378496|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
163988|NCT00682539|378497|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
163989|NCT00682539|378498|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
163990|NCT00682539|378496|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
163991|NCT00682539|378497|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
163992|NCT00682539|378498|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
163993|NCT00682539|378496|P3|STARTED|Bevacizumab vs Triamcinolone||0
163994|NCT00682539|378497|P2|STARTED|Bevacizumab vs Triamcinolone||16
163995|NCT00682539|378498|P1|STARTED|Bevacizumab vs Triamcinolone||18
163996|NCT00682461|378511|P2|NOT COMPLETED|Overall Study||31
163997|NCT00682461|378512|P1|NOT COMPLETED|Overall Study||25
163998|NCT00682461|378511|P2|COMPLETED|Overall Study||69
163999|NCT00682461|378512|P1|COMPLETED|Overall Study||75
164000|NCT00682461|378511|P2|STARTED|Overall Study||100
164001|NCT00682461|378512|P1|STARTED|Overall Study||100
164002|NCT00682357|378529|P3|NOT COMPLETED|Overall Study||0
164003|NCT00682357|378530|P2|NOT COMPLETED|Overall Study||0
164004|NCT00682357|378531|P1|NOT COMPLETED|Overall Study||0
164005|NCT00682357|378529|P3|COMPLETED|Overall Study||5
164006|NCT00682357|378530|P2|COMPLETED|Overall Study||10
164007|NCT00682357|378531|P1|COMPLETED|Overall Study||10
164008|NCT00682357|378529|P3|STARTED|Overall Study||5
164009|NCT00682357|378530|P2|STARTED|Overall Study||10
164010|NCT00682357|378531|P1|STARTED|Overall Study||10
164011|NCT00681889|378548|P1|NOT COMPLETED|Overall Study||0
164012|NCT00681889|378548|P1|COMPLETED|Overall Study||9
164013|NCT00681889|378548|P1|STARTED|Overall Study||9
164014|NCT00681863|378552|P1|NOT COMPLETED|Overall Study||23
164015|NCT00681863|378552|P1|COMPLETED|Overall Study||22
164016|NCT00681863|378552|P1|STARTED|Overall Study||45
164017|NCT00681824|378600|P3|NOT COMPLETED|Overall Study||1
164018|NCT00681824|378601|P2|NOT COMPLETED|Overall Study||1
164019|NCT00681824|378602|P1|NOT COMPLETED|Overall Study||1
164020|NCT00681824|378600|P3|COMPLETED|Overall Study||33
164021|NCT00681824|378601|P2|COMPLETED|Overall Study||12
164022|NCT00681824|378602|P1|COMPLETED|Overall Study||27
164023|NCT00681824|378600|P3|STARTED|Overall Study||34
164024|NCT00681824|378601|P2|STARTED|Overall Study||13
164025|NCT00681824|378602|P1|STARTED|Overall Study||28
164026|NCT00681811|378620|P2|NOT COMPLETED|Overall Study||4
164027|NCT00681811|378621|P1|NOT COMPLETED|Overall Study||3
164028|NCT00681811|378620|P2|COMPLETED|Overall Study||1
164029|NCT00681811|378621|P1|COMPLETED|Overall Study||3
164030|NCT00681811|378620|P2|STARTED|Overall Study||5
164031|NCT00681811|378621|P1|STARTED|Overall Study||6
164032|NCT00681668|378649|P1|NOT COMPLETED|Overall Study||2
164033|NCT00681668|378649|P1|COMPLETED|Overall Study||3
164034|NCT00681668|378649|P1|STARTED|Overall Study||5
164035|NCT00681629|378658|P2|NOT COMPLETED|Overall Study||2
164036|NCT00681629|378659|P1|NOT COMPLETED|Overall Study||5
164037|NCT00681629|378658|P2|COMPLETED|Overall Study||0
164038|NCT00681629|378659|P1|COMPLETED|Overall Study||0
164039|NCT00681629|378658|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
164040|NCT00681629|378659|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
164041|NCT00681590|378705|P2|NOT COMPLETED|Overall Study||12
164042|NCT00681590|378706|P1|NOT COMPLETED|Overall Study||2
164043|NCT00681590|378705|P2|COMPLETED|Overall Study||59
164044|NCT00681590|378706|P1|COMPLETED|Overall Study||32
164045|NCT00681590|378705|P2|STARTED|Overall Study||71
164046|NCT00681590|378706|P1|STARTED|Overall Study||34
164047|NCT00681564|378716|P2|NOT COMPLETED|Overall Study||8
164048|NCT00681564|378717|P1|NOT COMPLETED|Overall Study||6
164049|NCT00681564|378716|P2|COMPLETED|Overall Study||47
164050|NCT00681564|378717|P1|COMPLETED|Overall Study||41
164051|NCT00681564|378716|P2|STARTED|Overall Study||55
164052|NCT00681564|378717|P1|STARTED|Overall Study||47
164053|NCT00681538|378747|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
164054|NCT00681538|378748|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
164055|NCT00681538|378747|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
164056|NCT00681538|378748|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
164057|NCT00681538|378747|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
164058|NCT00681538|378748|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
164059|NCT00681538|378747|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
164060|NCT00681538|378748|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
164061|NCT00681538|378747|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
164062|NCT00681538|378748|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
164063|NCT00681538|378747|P2|STARTED|Phase A- 4 Weeks Single Blind||0
164064|NCT00681538|378748|P1|STARTED|Phase A- 4 Weeks Single Blind||572
164065|NCT00681473|378778|P1|NOT COMPLETED|Overall Study||0
164066|NCT00681473|378778|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
164067|NCT00681473|378778|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
164068|NCT00681291|378786|P2|NOT COMPLETED|Overall Study||27
164069|NCT00681291|378787|P1|NOT COMPLETED|Overall Study||13
164070|NCT00681291|378786|P2|COMPLETED|Overall Study||57
164071|NCT00681291|378787|P1|COMPLETED|Overall Study||75
164072|NCT00681291|378786|P2|STARTED|Overall Study||84
164073|NCT00681291|378787|P1|STARTED|Overall Study||88
164074|NCT00681265|378799|P1|NOT COMPLETED|Overall Study||0
164075|NCT00681265|378799|P1|COMPLETED|Overall Study||16
164076|NCT00681265|378799|P1|STARTED|Overall Study||16
164077|NCT00681187|378809|P2|NOT COMPLETED|Overall Study||2
164078|NCT00681187|378810|P1|NOT COMPLETED|Overall Study||1
164079|NCT00681187|378809|P2|COMPLETED|Overall Study||13
164080|NCT00681187|378810|P1|COMPLETED|Overall Study||10
164081|NCT00681187|378809|P2|STARTED|Overall Study||15
164082|NCT00681187|378810|P1|STARTED|Overall Study||11
164083|NCT00681109|378845|P3|NOT COMPLETED|Overall Study||0
164084|NCT00681109|378846|P2|NOT COMPLETED|Overall Study||6
164085|NCT00681109|378847|P1|NOT COMPLETED|Overall Study||2
164086|NCT00681109|378845|P3|COMPLETED|Overall Study||15
164087|NCT00681109|378846|P2|COMPLETED|Overall Study||24
164088|NCT00681109|378847|P1|COMPLETED|Overall Study||28
164089|NCT00681109|378845|P3|STARTED|Overall Study||15
164090|NCT00681109|378846|P2|STARTED|Overall Study||30
164091|NCT00681109|378847|P1|STARTED|Overall Study||30
164092|NCT00680953|378858|P3|NOT COMPLETED|Overall Study||47
164093|NCT00680953|378859|P2|NOT COMPLETED|Overall Study||95
164094|NCT00680953|378860|P1|NOT COMPLETED|Overall Study||86
164095|NCT00680953|378858|P3|COMPLETED|Overall Study||204
164096|NCT00680953|378859|P2|COMPLETED|Overall Study||416
164097|NCT00680953|378860|P1|COMPLETED|Overall Study||414
164098|NCT00680953|378858|P3|STARTED|Overall Study||251
164099|NCT00680953|378859|P2|STARTED|Overall Study||511
164100|NCT00680953|378860|P1|STARTED|Overall Study||500
164101|NCT00680914|378876|P2|NOT COMPLETED|Overall Study||4
164102|NCT00680914|378877|P1|NOT COMPLETED|Overall Study||10
164103|NCT00680914|378876|P2|COMPLETED|Overall Study||125
164104|NCT00680914|378877|P1|COMPLETED|Overall Study||364
164105|NCT00680914|378876|P2|STARTED|Overall Study||129
164106|NCT00680914|378877|P1|STARTED|Overall Study||374
164107|NCT00680901|378911|P2|NOT COMPLETED|Overall Study||76
164108|NCT00680901|378912|P1|NOT COMPLETED|Overall Study||73
164109|NCT00680901|378911|P2|COMPLETED|Overall Study||197
164110|NCT00680901|378912|P1|COMPLETED|Overall Study||199
164111|NCT00680901|378911|P2|Ongoing: In Follow Up|Overall Study||41
164112|NCT00680901|378912|P1|Ongoing: In Follow Up|Overall Study||45
164113|NCT00680901|378911|P2|Ongoing: On Study Treatment|Overall Study||13
164114|NCT00680901|378912|P1|Ongoing: On Study Treatment|Overall Study||16
164115|NCT00680901|378911|P2|STARTED|Overall Study||273
164116|NCT00680901|378912|P1|STARTED|Overall Study||272
164117|NCT00680862|378944|P1|NOT COMPLETED|Overall Study||0
164118|NCT00680862|378944|P1|COMPLETED|Overall Study||25
164119|NCT00680862|378944|P1|STARTED|Overall Study||25
164120|NCT00680836|378950|P2|NOT COMPLETED|Overall Study||2
164121|NCT00680836|378951|P1|NOT COMPLETED|Overall Study||8
164122|NCT00680836|378950|P2|COMPLETED|Overall Study||25
164123|NCT00680836|378951|P1|COMPLETED|Overall Study||19
164124|NCT00680836|378950|P2|STARTED|Overall Study||27
164125|NCT00680836|378951|P1|STARTED|Overall Study||27
164126|NCT00680797|378971|P4|NOT COMPLETED|Overall Study||0
164127|NCT00680797|378972|P3|NOT COMPLETED|Overall Study||0
164128|NCT00680797|378973|P2|NOT COMPLETED|Overall Study||0
164129|NCT00680797|378974|P1|NOT COMPLETED|Overall Study||0
164130|NCT00680797|378971|P4|COMPLETED|Overall Study||8
164131|NCT00680797|378972|P3|COMPLETED|Overall Study||8
164132|NCT00680797|378973|P2|COMPLETED|Overall Study||8
164133|NCT00680797|378974|P1|COMPLETED|Overall Study||9
164134|NCT00680797|378971|P4|STARTED|Overall Study||8
164135|NCT00680797|378972|P3|STARTED|Overall Study||8
164136|NCT00680797|378973|P2|STARTED|Overall Study||8
164137|NCT00680797|378974|P1|STARTED|Overall Study||9
164138|NCT00680771|378986|P2|NOT COMPLETED|Overall Study||2
164139|NCT00680771|378987|P1|NOT COMPLETED|Overall Study||6
164140|NCT00680771|378986|P2|COMPLETED|Overall Study||11
164141|NCT00680771|378987|P1|COMPLETED|Overall Study||9
164142|NCT00680771|378986|P2|STARTED|Overall Study||13
164143|NCT00680771|378987|P1|STARTED|Overall Study||15
164144|NCT00680745|378997|P4|NOT COMPLETED|Overall Study||13
164145|NCT00680745|378998|P3|NOT COMPLETED|Overall Study||10
164146|NCT00680745|378999|P2|NOT COMPLETED|Overall Study||13
164147|NCT00680745|379000|P1|NOT COMPLETED|Overall Study||14
164148|NCT00680745|378997|P4|COMPLETED|Overall Study||133
164149|NCT00680745|378998|P3|COMPLETED|Overall Study||141
164150|NCT00680745|378999|P2|COMPLETED|Overall Study||132
164151|NCT00680745|379000|P1|COMPLETED|Overall Study||140
164152|NCT00680745|378997|P4|STARTED|Overall Study|Safety Analysis Set|146
164153|NCT00680745|378998|P3|STARTED|Overall Study|Safety Analysis Set|151
164154|NCT00680745|378999|P2|STARTED|Overall Study|Safety Analysis Set|145
164155|NCT00680745|379000|P1|STARTED|Overall Study|Safety Analysis Set|154
164156|NCT00680706|379032|P2|NOT COMPLETED|Overall Study||5
164157|NCT00680706|379033|P1|NOT COMPLETED|Overall Study||7
164158|NCT00680706|379032|P2|COMPLETED|Overall Study||55
164159|NCT00680706|379033|P1|COMPLETED|Overall Study||63
164160|NCT00680706|379032|P2|STARTED|Overall Study||60
164161|NCT00680706|379033|P1|STARTED|Overall Study||70
164162|NCT00680628|379043|P2|NOT COMPLETED|Overall Study||0
164163|NCT00680628|379044|P1|NOT COMPLETED|Overall Study||0
164164|NCT00680628|379043|P2|COMPLETED|Overall Study||40
164165|NCT00680628|379044|P1|COMPLETED|Overall Study||43
164166|NCT00680628|379043|P2|STARTED|Overall Study||40
164167|NCT00680628|379044|P1|STARTED|Overall Study||43
164168|NCT00680524|379054|P1|NOT COMPLETED|Overall Study||3
164169|NCT00680524|379054|P1|COMPLETED|Overall Study||17
164170|NCT00680524|379054|P1|STARTED|Overall Study||20
164171|NCT00680459|379060|P2|NOT COMPLETED|Overall Study||0
164172|NCT00680459|379061|P1|NOT COMPLETED|Overall Study||0
164173|NCT00680459|379060|P2|COMPLETED|Overall Study||6
164174|NCT00680459|379061|P1|COMPLETED|Overall Study||7
164175|NCT00680459|379060|P2|STARTED|Overall Study||6
164176|NCT00680459|379061|P1|STARTED|Overall Study||7
164177|NCT00680407|379074|P3|NOT COMPLETED|Overall Study||3
164178|NCT00680407|379075|P2|NOT COMPLETED|Overall Study||5
164179|NCT00680407|379076|P1|NOT COMPLETED|Overall Study||8
164180|NCT00680407|379074|P3|COMPLETED|Overall Study||22
164181|NCT00680407|379075|P2|COMPLETED|Overall Study||22
164182|NCT00680407|379076|P1|COMPLETED|Overall Study||18
164183|NCT00680407|379074|P3|STARTED|Overall Study||25
164184|NCT00680407|379075|P2|STARTED|Overall Study||27
164185|NCT00680407|379076|P1|STARTED|Overall Study||26
164186|NCT00680368|379090|P1|NOT COMPLETED|Overall Study||15
164187|NCT00680368|379090|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
164188|NCT00680368|379090|P1|STARTED|Overall Study||112
164189|NCT00680316|379098|P2|NOT COMPLETED|Overall Study||0
164190|NCT00680316|379099|P1|NOT COMPLETED|Overall Study||0
164191|NCT00680316|379098|P2|COMPLETED|Overall Study||2
164192|NCT00680316|379099|P1|COMPLETED|Overall Study||1
164193|NCT00680316|379098|P2|STARTED|Overall Study||2
164194|NCT00680316|379099|P1|STARTED|Overall Study||1
164195|NCT00680186|379113|P2|NOT COMPLETED|Overall Study||116
164196|NCT00680186|379114|P1|NOT COMPLETED|Overall Study||125
164197|NCT00680186|379113|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
164198|NCT00680186|379114|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
164199|NCT00680186|379113|P2|STARTED|Overall Study|Started treatment.|1288
164200|NCT00680186|379114|P1|STARTED|Overall Study|Started treatment.|1280
164201|NCT00680121|379140|P2|NOT COMPLETED|Overall Study||23
164202|NCT00680121|379141|P1|NOT COMPLETED|Overall Study||27
164203|NCT00680121|379140|P2|COMPLETED|Overall Study||37
164204|NCT00680121|379141|P1|COMPLETED|Overall Study||33
164205|NCT00680121|379140|P2|STARTED|Overall Study||60
164206|NCT00680121|379141|P1|STARTED|Overall Study||60
164207|NCT00680056|379155|P2|NOT COMPLETED|Second Intervention||1
164208|NCT00680056|379156|P1|NOT COMPLETED|Second Intervention||3
164209|NCT00680056|379155|P2|COMPLETED|Second Intervention||14
164210|NCT00680056|379156|P1|COMPLETED|Second Intervention||12
164211|NCT00680056|379155|P2|STARTED|Second Intervention||15
164212|NCT00680056|379156|P1|STARTED|Second Intervention||15
164213|NCT00680056|379155|P2|NOT COMPLETED|Washout Period of One Week||0
164214|NCT00680056|379156|P1|NOT COMPLETED|Washout Period of One Week||0
164215|NCT00680056|379155|P2|COMPLETED|Washout Period of One Week||15
164216|NCT00680056|379156|P1|COMPLETED|Washout Period of One Week||15
164217|NCT00680056|379155|P2|STARTED|Washout Period of One Week||15
164218|NCT00680056|379156|P1|STARTED|Washout Period of One Week||15
164219|NCT00680056|379155|P2|NOT COMPLETED|First Intervention||2
164220|NCT00680056|379156|P1|NOT COMPLETED|First Intervention||1
164221|NCT00680056|379155|P2|COMPLETED|First Intervention||15
164222|NCT00680056|379156|P1|COMPLETED|First Intervention||15
164223|NCT00680056|379155|P2|STARTED|First Intervention||17
164224|NCT00680056|379156|P1|STARTED|First Intervention||16
164225|NCT00680043|379167|P3|NOT COMPLETED|Overall Study||4
164226|NCT00680043|379168|P2|NOT COMPLETED|Overall Study||1
164227|NCT00680043|379169|P1|NOT COMPLETED|Overall Study||2
164228|NCT00680043|379167|P3|COMPLETED|Overall Study||34
164229|NCT00680043|379168|P2|COMPLETED|Overall Study||36
164230|NCT00680043|379169|P1|COMPLETED|Overall Study||37
164231|NCT00680043|379167|P3|STARTED|Overall Study||38
164232|NCT00680043|379168|P2|STARTED|Overall Study||37
164233|NCT00680043|379169|P1|STARTED|Overall Study||39
164234|NCT00680017|379185|P2|NOT COMPLETED|Overall Study||12
164235|NCT00680017|379186|P1|NOT COMPLETED|Overall Study||17
164236|NCT00680017|379185|P2|COMPLETED|Overall Study||128
164237|NCT00680017|379186|P1|COMPLETED|Overall Study||123
164238|NCT00680017|379185|P2|STARTED|Overall Study||140
164239|NCT00680017|379186|P1|STARTED|Overall Study||140
164240|NCT00679952|379196|P2|NOT COMPLETED|Overall Study||0
164241|NCT00679952|379197|P1|NOT COMPLETED|Overall Study||0
164242|NCT00679952|379196|P2|COMPLETED|Overall Study||82
164243|NCT00679952|379197|P1|COMPLETED|Overall Study||86
164244|NCT00679952|379196|P2|STARTED|Overall Study||82
164245|NCT00679952|379197|P1|STARTED|Overall Study||86
164246|NCT00679939|379205|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
164247|NCT00679939|379206|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
164248|NCT00679939|379205|P2|COMPLETED|24-Week Open-Label (OL) Period||80
164249|NCT00679939|379206|P1|COMPLETED|24-Week Open-Label (OL) Period||69
164250|NCT00679939|379205|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
164251|NCT00679939|379206|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
164252|NCT00679939|379205|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
164253|NCT00679939|379206|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
164254|NCT00679939|379205|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
164255|NCT00679939|379206|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
164256|NCT00679939|379205|P2|STARTED|52-Week Double-Blind (DB) Period||112
164257|NCT00679939|379206|P1|STARTED|52-Week Double-Blind (DB) Period||114
164258|NCT00679913|379357|P2|NOT COMPLETED|Overall Study||13
164259|NCT00679913|379358|P1|NOT COMPLETED|Overall Study||18
164260|NCT00679913|379357|P2|COMPLETED|Overall Study||86
164261|NCT00679913|379358|P1|COMPLETED|Overall Study||83
164262|NCT00679913|379357|P2|STARTED|Overall Study||99
164263|NCT00679913|379358|P1|STARTED|Overall Study||101
164264|NCT00679783|379373|P7|NOT COMPLETED|Overall Study||1
164265|NCT00679783|379374|P6|NOT COMPLETED|Overall Study||0
164266|NCT00679783|379375|P5|NOT COMPLETED|Overall Study||1
164267|NCT00679783|379376|P4|NOT COMPLETED|Overall Study||20
164268|NCT00679783|379377|P3|NOT COMPLETED|Overall Study||1
164269|NCT00679783|379378|P2|NOT COMPLETED|Overall Study||3
164270|NCT00679783|379379|P1|NOT COMPLETED|Overall Study||2
164271|NCT00679783|379373|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
164272|NCT00679783|379374|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
164273|NCT00679783|379375|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
164274|NCT00679783|379376|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
164275|NCT00679783|379377|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
164276|NCT00679783|379378|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
164277|NCT00679783|379379|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
164278|NCT00679783|379373|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
164279|NCT00679783|379374|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
164280|NCT00679783|379375|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
164281|NCT00679783|379376|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
164282|NCT00679783|379377|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
164283|NCT00679783|379378|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
164284|NCT00679783|379379|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
164285|NCT00679627|379432|P2|NOT COMPLETED|Overall Study||685
164286|NCT00679627|379433|P1|NOT COMPLETED|Overall Study||699
164287|NCT00679627|379432|P2|COMPLETED|Overall Study||339
164288|NCT00679627|379433|P1|COMPLETED|Overall Study||322
164289|NCT00679627|379432|P2|STARTED|Overall Study||1024
164290|NCT00679627|379433|P1|STARTED|Overall Study||1021
164291|NCT00679432|379459|P4|NOT COMPLETED|Overall Study||32
164292|NCT00679432|379460|P3|NOT COMPLETED|Overall Study||53
164293|NCT00679432|379461|P2|NOT COMPLETED|Overall Study||38
164294|NCT00679432|379462|P1|NOT COMPLETED|Overall Study||37
164295|NCT00679432|379459|P4|COMPLETED|Overall Study||95
164296|NCT00679432|379460|P3|COMPLETED|Overall Study||76
164297|NCT00679432|379461|P2|COMPLETED|Overall Study||89
164298|NCT00679432|379462|P1|COMPLETED|Overall Study||89
164299|NCT00679432|379459|P4|STARTED|Overall Study||127
164300|NCT00679432|379460|P3|STARTED|Overall Study||129
164301|NCT00679432|379461|P2|STARTED|Overall Study||127
164302|NCT00679432|379462|P1|STARTED|Overall Study||126
164303|NCT00679380|379484|P4|NOT COMPLETED|Overall Study||28
164304|NCT00679380|379485|P3|NOT COMPLETED|Overall Study||35
164305|NCT00679380|379486|P2|NOT COMPLETED|Overall Study||33
164306|NCT00679380|379487|P1|NOT COMPLETED|Overall Study||42
164307|NCT00679380|379484|P4|COMPLETED|Overall Study||61
164308|NCT00679380|379485|P3|COMPLETED|Overall Study||68
164309|NCT00679380|379486|P2|COMPLETED|Overall Study||76
164310|NCT00679380|379487|P1|COMPLETED|Overall Study||67
164311|NCT00679380|379484|P4|STARTED|Overall Study||89
164312|NCT00679380|379485|P3|STARTED|Overall Study||103
164313|NCT00679380|379486|P2|STARTED|Overall Study||109
164314|NCT00679380|379487|P1|STARTED|Overall Study||109
164315|NCT00679354|379505|P1|NOT COMPLETED|Overall Study||30
164316|NCT00679354|379505|P1|COMPLETED|Overall Study||0
164317|NCT00679354|379505|P1|STARTED|Overall Study||30
164318|NCT00679341|379511|P2|NOT COMPLETED|Overall Study||51
164319|NCT00679341|379512|P1|NOT COMPLETED|Overall Study||53
164320|NCT00679341|379511|P2|COMPLETED|Overall Study||19
164321|NCT00679341|379512|P1|COMPLETED|Overall Study||14
164322|NCT00679341|379511|P2|STARTED|Overall Study||70
164323|NCT00679341|379512|P1|STARTED|Overall Study||67
164324|NCT00679302|379532|P2|NOT COMPLETED|Overall Study||4
164325|NCT00679302|379533|P1|NOT COMPLETED|Overall Study||8
164326|NCT00679302|379532|P2|COMPLETED|Overall Study||73
164327|NCT00679302|379533|P1|COMPLETED|Overall Study||76
164328|NCT00679302|379532|P2|STARTED|Overall Study||77
164329|NCT00679302|379533|P1|STARTED|Overall Study||84
164330|NCT00679263|379544|P3|NOT COMPLETED|Visit 2/Dose 1||0
164331|NCT00679263|379545|P2|NOT COMPLETED|Visit 2/Dose 1||1
164332|NCT00679263|379546|P1|NOT COMPLETED|Visit 2/Dose 1||2
164333|NCT00679263|379544|P3|COMPLETED|Visit 2/Dose 1||11
164334|NCT00679263|379545|P2|COMPLETED|Visit 2/Dose 1||5
164335|NCT00679263|379546|P1|COMPLETED|Visit 2/Dose 1||9
164336|NCT00679263|379544|P3|STARTED|Visit 2/Dose 1||11
164337|NCT00679263|379545|P2|STARTED|Visit 2/Dose 1||6
164338|NCT00679263|379546|P1|STARTED|Visit 2/Dose 1||11
164339|NCT00679263|379544|P3|NOT COMPLETED|Visit 3/Dose 2||0
164340|NCT00679263|379545|P2|NOT COMPLETED|Visit 3/Dose 2||5
164341|NCT00679263|379546|P1|NOT COMPLETED|Visit 3/Dose 2||1
164342|NCT00679263|379544|P3|COMPLETED|Visit 3/Dose 2||11
164343|NCT00679263|379545|P2|COMPLETED|Visit 3/Dose 2||6
164344|NCT00679263|379546|P1|COMPLETED|Visit 3/Dose 2||9
164345|NCT00679263|379544|P3|STARTED|Visit 3/Dose 2||11
164346|NCT00679263|379545|P2|STARTED|Visit 3/Dose 2||11
164347|NCT00679263|379546|P1|STARTED|Visit 3/Dose 2||10
164348|NCT00679211|379557|P1|NOT COMPLETED|Overall Study||110
164349|NCT00679211|379557|P1|COMPLETED|Overall Study||0
164350|NCT00679211|379557|P1|STARTED|Overall Study||110
164351|NCT00679081|379569|P1|NOT COMPLETED|Overall Study||1
164352|NCT00679081|379569|P1|COMPLETED|Overall Study||14
164353|NCT00679081|379569|P1|STARTED|Overall Study|Study design was within-subject control.|15
164354|NCT00679055|379579|P2|NOT COMPLETED|Overall Study||5
164355|NCT00679055|379580|P1|NOT COMPLETED|Overall Study||2
164356|NCT00679055|379579|P2|COMPLETED|Overall Study||1
164357|NCT00679055|379580|P1|COMPLETED|Overall Study||6
164358|NCT00679055|379579|P2|STARTED|Overall Study||6
164359|NCT00679055|379580|P1|STARTED|Overall Study||8
164360|NCT00678899|379590|P1|NOT COMPLETED|Overall Study||1
164361|NCT00678899|379590|P1|COMPLETED|Overall Study||49
164362|NCT00678899|379590|P1|STARTED|Overall Study||50
164363|NCT00678834|379600|P3|NOT COMPLETED|Overall Study||9
164364|NCT00678834|379601|P2|NOT COMPLETED|Overall Study||0
164365|NCT00678834|379602|P1|NOT COMPLETED|Overall Study||16
164366|NCT00678834|379600|P3|COMPLETED|Overall Study||16
164367|NCT00678834|379601|P2|COMPLETED|Overall Study||15
164368|NCT00678834|379602|P1|COMPLETED|Overall Study||24
164369|NCT00678834|379600|P3|STARTED|Overall Study||25
164370|NCT00678834|379601|P2|STARTED|Overall Study||15
164371|NCT00678834|379602|P1|STARTED|Overall Study||40
164372|NCT00678795|379622|P2|NOT COMPLETED|Overall Study||6
164373|NCT00678795|379623|P1|NOT COMPLETED|Overall Study||11
164374|NCT00678795|379622|P2|COMPLETED|Overall Study||62
164375|NCT00678795|379623|P1|COMPLETED|Overall Study||56
164376|NCT00678795|379622|P2|STARTED|Overall Study||68
164377|NCT00678795|379623|P1|STARTED|Overall Study||67
164378|NCT00678691|379645|P2|NOT COMPLETED|Overall Study||4
164379|NCT00678691|379646|P1|NOT COMPLETED|Overall Study||6
164380|NCT00678691|379645|P2|COMPLETED|Overall Study||24
164381|NCT00678691|379646|P1|COMPLETED|Overall Study||21
164382|NCT00678691|379645|P2|STARTED|Overall Study||28
164383|NCT00678691|379646|P1|STARTED|Overall Study||27
164384|NCT00678639|379654|P2|NOT COMPLETED|Overall Study||0
164385|NCT00678639|379655|P1|NOT COMPLETED|Overall Study||2
164386|NCT00678639|379654|P2|COMPLETED|Overall Study||57
164387|NCT00678639|379655|P1|COMPLETED|Overall Study||51
164388|NCT00678639|379654|P2|Hospital Discharge|Overall Study||57
164389|NCT00678639|379655|P1|Hospital Discharge|Overall Study||53
164390|NCT00678639|379654|P2|STARTED|Overall Study||57
164391|NCT00678639|379655|P1|STARTED|Overall Study||53
164392|NCT00678587|379670|P2|NOT COMPLETED|Overall Study||18
164393|NCT00678587|379671|P1|NOT COMPLETED|Overall Study||20
164394|NCT00678587|379670|P2|COMPLETED|Overall Study||127
164395|NCT00678587|379671|P1|COMPLETED|Overall Study||127
164396|NCT00678587|379670|P2|STARTED|Overall Study||145
164397|NCT00678587|379671|P1|STARTED|Overall Study||147
164398|NCT00678535|379705|P2|NOT COMPLETED|Overall Study||98
164399|NCT00678535|379706|P1|NOT COMPLETED|Overall Study||93
164400|NCT00678535|379705|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
164401|NCT00678535|379706|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
164402|NCT00678535|379705|P2|STARTED|Overall Study|ITT population|449
164403|NCT00678535|379706|P1|STARTED|Overall Study|ITT population|455
164404|NCT00678470|379722|P1|NOT COMPLETED|Overall Study||3
164405|NCT00678470|379722|P1|COMPLETED|Overall Study||15
164406|NCT00678470|379722|P1|STARTED|Overall Study||18
164407|NCT00678418|379728|P2|NOT COMPLETED|Part B (Open Label)||0
164408|NCT00678418|379729|P1|NOT COMPLETED|Part B (Open Label)||43
164409|NCT00678418|379728|P2|COMPLETED|Part B (Open Label)||0
164410|NCT00678418|379729|P1|COMPLETED|Part B (Open Label)||71
164411|NCT00678418|379728|P2|STARTED|Part B (Open Label)||0
164412|NCT00678418|379729|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
164413|NCT00678418|379728|P2|NOT COMPLETED|Part A (Double Blind)||77
164414|NCT00678418|379729|P1|NOT COMPLETED|Part A (Double Blind)||59
164415|NCT00678418|379728|P2|COMPLETED|Part A (Double Blind)||47
164416|NCT00678418|379729|P1|COMPLETED|Part A (Double Blind)||67
164417|NCT00678418|379728|P2|STARTED|Part A (Double Blind)||124
164418|NCT00678418|379729|P1|STARTED|Part A (Double Blind)||126
164419|NCT00678392|379745|P2|NOT COMPLETED|Overall Study||362
164420|NCT00678392|379746|P1|NOT COMPLETED|Overall Study||361
164421|NCT00678392|379745|P2|COMPLETED|Overall Study||0
164422|NCT00678392|379746|P1|COMPLETED|Overall Study||0
164423|NCT00678392|379745|P2|Treated|Overall Study||355
164424|NCT00678392|379746|P1|Treated|Overall Study||359
164425|NCT00678392|379745|P2|STARTED|Overall Study||362
164426|NCT00678392|379746|P1|STARTED|Overall Study||361
164427|NCT00678288|379754|P2|NOT COMPLETED|Overall Study||6
164428|NCT00678288|379755|P1|NOT COMPLETED|Overall Study||10
164429|NCT00678288|379754|P2|COMPLETED|Overall Study||0
164430|NCT00678288|379755|P1|COMPLETED|Overall Study||0
164431|NCT00678288|379754|P2|STARTED|Overall Study||6
164432|NCT00678288|379755|P1|STARTED|Overall Study||10
164433|NCT00678249|379772|P3|NOT COMPLETED|Overall Study||0
164434|NCT00678249|379773|P2|NOT COMPLETED|Overall Study||0
164435|NCT00678249|379774|P1|NOT COMPLETED|Overall Study||0
164436|NCT00678249|379772|P3|COMPLETED|Overall Study||37
164437|NCT00678249|379773|P2|COMPLETED|Overall Study||93
164438|NCT00678249|379774|P1|COMPLETED|Overall Study||97
164439|NCT00678249|379772|P3|STARTED|Overall Study||37
164440|NCT00678249|379773|P2|STARTED|Overall Study||93
164441|NCT00678249|379774|P1|STARTED|Overall Study||97
164442|NCT00678210|379810|P4|NOT COMPLETED|Overall Study||20
164443|NCT00678210|379811|P3|NOT COMPLETED|Overall Study||6
164444|NCT00678210|379812|P2|NOT COMPLETED|Overall Study||11
164445|NCT00678210|379813|P1|NOT COMPLETED|Overall Study||11
164446|NCT00678210|379810|P4|COMPLETED|Overall Study||30
164447|NCT00678210|379811|P3|COMPLETED|Overall Study||43
164448|NCT00678210|379812|P2|COMPLETED|Overall Study||38
164449|NCT00678210|379813|P1|COMPLETED|Overall Study||38
164450|NCT00678210|379810|P4|STARTED|Overall Study||50
164451|NCT00678210|379811|P3|STARTED|Overall Study||49
164452|NCT00678210|379812|P2|STARTED|Overall Study||49
164453|NCT00678210|379813|P1|STARTED|Overall Study||49
164454|NCT00678041|379849|P2|NOT COMPLETED|Overall Study||5
164455|NCT00678041|379850|P1|NOT COMPLETED|Overall Study||5
164456|NCT00678041|379849|P2|COMPLETED|Overall Study||0
164457|NCT00678041|379850|P1|COMPLETED|Overall Study||0
164458|NCT00678041|379849|P2|STARTED|Overall Study||5
164459|NCT00678041|379850|P1|STARTED|Overall Study||5
164460|NCT00678015|379862|P1|NOT COMPLETED|Overall Study||0
164461|NCT00678015|379862|P1|COMPLETED|Overall Study||12
164462|NCT00678015|379862|P1|STARTED|Overall Study||12
164463|NCT00677924|379871|P2|NOT COMPLETED|Overall Study||0
164464|NCT00677924|379872|P1|NOT COMPLETED|Overall Study||0
164465|NCT00677924|379871|P2|COMPLETED|Overall Study||6
164466|NCT00677924|379872|P1|COMPLETED|Overall Study||3
164467|NCT00677924|379871|P2|STARTED|Overall Study||6
164468|NCT00677924|379872|P1|STARTED|Overall Study||3
164469|NCT00677898|379882|P2|NOT COMPLETED|Overall Study||18
164470|NCT00677898|379883|P1|NOT COMPLETED|Overall Study||20
164471|NCT00677898|379882|P2|COMPLETED|Overall Study||102
164472|NCT00677898|379883|P1|COMPLETED|Overall Study||99
164473|NCT00677898|379882|P2|STARTED|Overall Study||120
164474|NCT00677898|379883|P1|STARTED|Overall Study||119
164475|NCT00677833|379903|P4|NOT COMPLETED|Overall Study||3
164476|NCT00677833|379904|P3|NOT COMPLETED|Overall Study||2
164477|NCT00677833|379905|P2|NOT COMPLETED|Overall Study||0
164478|NCT00677833|379906|P1|NOT COMPLETED|Overall Study||4
164479|NCT00677833|379903|P4|COMPLETED|Overall Study||128
164480|NCT00677833|379904|P3|COMPLETED|Overall Study||122
164481|NCT00677833|379905|P2|COMPLETED|Overall Study||51
164482|NCT00677833|379906|P1|COMPLETED|Overall Study||51
164483|NCT00677833|379903|P4|STARTED|Overall Study||131
164484|NCT00677833|379904|P3|STARTED|Overall Study||124
164485|NCT00677833|379905|P2|STARTED|Overall Study||51
164486|NCT00677833|379906|P1|STARTED|Overall Study||55
164487|NCT00677820|379956|P2|NOT COMPLETED|Overall Study||0
164488|NCT00677820|379957|P1|NOT COMPLETED|Overall Study||1
164489|NCT00677820|379956|P2|COMPLETED|Overall Study||60
164490|NCT00677820|379957|P1|COMPLETED|Overall Study||239
164491|NCT00677820|379956|P2|STARTED|Overall Study||60
164492|NCT00677820|379957|P1|STARTED|Overall Study||240
164493|NCT00677807|379978|P3|NOT COMPLETED|Overall Study||20
164494|NCT00677807|379979|P2|NOT COMPLETED|Overall Study||11
164495|NCT00677807|379980|P1|NOT COMPLETED|Overall Study||18
164496|NCT00677807|379978|P3|COMPLETED|Overall Study||105
164497|NCT00677807|379979|P2|COMPLETED|Overall Study||135
164498|NCT00677807|379980|P1|COMPLETED|Overall Study||126
164499|NCT00677807|379978|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
164500|NCT00677807|379979|P2|Safety/ITT: Received Study Drug|Overall Study||146
164501|NCT00677807|379980|P1|Safety/ITT: Received Study Drug|Overall Study||144
164502|NCT00677807|379978|P3|STARTED|Overall Study||125
164503|NCT00677807|379979|P2|STARTED|Overall Study||146
164504|NCT00677807|379980|P1|STARTED|Overall Study||144
164505|NCT00677690|380011|P2|NOT COMPLETED|Overall Study||0
164506|NCT00677690|380012|P1|NOT COMPLETED|Overall Study||0
164507|NCT00677690|380011|P2|COMPLETED|Overall Study||41
164508|NCT00677690|380012|P1|COMPLETED|Overall Study||42
164509|NCT00677690|380011|P2|STARTED|Overall Study||41
164510|NCT00677690|380012|P1|STARTED|Overall Study||42
164511|NCT00677534|380026|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
164512|NCT00677534|380026|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
164513|NCT00677534|380026|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
164514|NCT00677534|380026|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
164515|NCT00677534|380026|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
164516|NCT00677534|380026|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
164517|NCT00677534|380026|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
164518|NCT00677534|380026|P1|COMPLETED|Washout (Weeks 1-4)||7
164519|NCT00677534|380026|P1|STARTED|Washout (Weeks 1-4)||10
164520|NCT00677365|380034|P4|NOT COMPLETED|Overall Study||3
164521|NCT00677365|380035|P3|NOT COMPLETED|Overall Study||2
164522|NCT00677365|380036|P2|NOT COMPLETED|Overall Study||1
164523|NCT00677365|380037|P1|NOT COMPLETED|Overall Study||2
164524|NCT00677365|380034|P4|COMPLETED|Overall Study||36
164525|NCT00677365|380035|P3|COMPLETED|Overall Study||35
164526|NCT00677365|380036|P2|COMPLETED|Overall Study||37
164527|NCT00677365|380037|P1|COMPLETED|Overall Study||35
164528|NCT00677365|380034|P4|STARTED|Overall Study||39
164529|NCT00677365|380035|P3|STARTED|Overall Study||37
164530|NCT00677365|380036|P2|STARTED|Overall Study||38
164531|NCT00677365|380037|P1|STARTED|Overall Study||37
164532|NCT00677352|380069|P2|NOT COMPLETED|Tapering Phase||10
164533|NCT00677352|380070|P1|NOT COMPLETED|Tapering Phase||6
164534|NCT00677352|380069|P2|COMPLETED|Tapering Phase||112
164535|NCT00677352|380070|P1|COMPLETED|Tapering Phase||126
164536|NCT00677352|380069|P2|STARTED|Tapering Phase||122
164537|NCT00677352|380070|P1|STARTED|Tapering Phase||132
164538|NCT00677352|380069|P2|NOT COMPLETED|Treatment Phase||42
164539|NCT00677352|380070|P1|NOT COMPLETED|Treatment Phase||25
164540|NCT00677352|380069|P2|COMPLETED|Treatment Phase||122
164541|NCT00677352|380070|P1|COMPLETED|Treatment Phase||132
164542|NCT00677352|380069|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
164543|NCT00677352|380070|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
164544|NCT00677235|380090|P2|NOT COMPLETED|Overall Study||38
164545|NCT00677235|380091|P1|NOT COMPLETED|Overall Study||41
164546|NCT00677235|380090|P2|COMPLETED|Overall Study||94
164547|NCT00677235|380091|P1|COMPLETED|Overall Study||97
164548|NCT00677235|380090|P2|STARTED|Overall Study||132
164549|NCT00677235|380091|P1|STARTED|Overall Study||138
164550|NCT00677014|380134|P3|NOT COMPLETED|Overall Study||49
164551|NCT00677014|380135|P2|NOT COMPLETED|Overall Study||41
164552|NCT00677014|380136|P1|NOT COMPLETED|Overall Study||44
164553|NCT00677014|380134|P3|COMPLETED|Overall Study||283
164554|NCT00677014|380135|P2|COMPLETED|Overall Study||282
164555|NCT00677014|380136|P1|COMPLETED|Overall Study||281
164556|NCT00677014|380134|P3|STARTED|Overall Study||332
164557|NCT00677014|380135|P2|STARTED|Overall Study||323
164558|NCT00677014|380136|P1|STARTED|Overall Study||325
164559|NCT00676806|380146|P2|NOT COMPLETED|Overall Study||0
164560|NCT00676806|380147|P1|NOT COMPLETED|Overall Study||0
164561|NCT00676806|380146|P2|COMPLETED|Overall Study||3
164562|NCT00676806|380147|P1|COMPLETED|Overall Study||3
164563|NCT00676806|380146|P2|STARTED|Overall Study||3
164564|NCT00676806|380147|P1|STARTED|Overall Study||3
164565|NCT00676793|380161|P1|NOT COMPLETED|Overall Study||13
164566|NCT00676793|380161|P1|COMPLETED|Overall Study||19
164567|NCT00676793|380161|P1|STARTED|Overall Study||32
164568|NCT00676780|380166|P1|NOT COMPLETED|Overall Study||7
164569|NCT00676780|380166|P1|COMPLETED|Overall Study||26
164570|NCT00676780|380166|P1|STARTED|Overall Study||33
164571|NCT00676689|380172|P1|NOT COMPLETED|Overall Study||61
164572|NCT00676689|380172|P1|COMPLETED|Overall Study||20
164573|NCT00676689|380172|P1|1 Year Follow-up|Overall Study||64
164574|NCT00676689|380172|P1|30 Day Follow-up|Overall Study||78
164575|NCT00676689|380172|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
164576|NCT00676689|380172|P1|STARTED|Overall Study||81
164577|NCT00676676|380178|P1|NOT COMPLETED|Overall Study||0
164578|NCT00676676|380178|P1|COMPLETED|Overall Study||9
164579|NCT00676676|380178|P1|STARTED|Overall Study||9
164580|NCT00676650|380184|P2|NOT COMPLETED|Overall Study||289
164581|NCT00676650|380185|P1|NOT COMPLETED|Overall Study||584
164582|NCT00676650|380184|P2|COMPLETED|Overall Study||0
164583|NCT00676650|380185|P1|COMPLETED|Overall Study||0
164584|NCT00676650|380184|P2|Treated|Overall Study||285
164585|NCT00676650|380185|P1|Treated|Overall Study||581
164586|NCT00676650|380184|P2|STARTED|Overall Study||289
164587|NCT00676650|380185|P1|STARTED|Overall Study||584
164588|NCT00676520|380203|P1|NOT COMPLETED|Overall Study||731
164589|NCT00676520|380203|P1|COMPLETED|Overall Study||7309
164590|NCT00676520|380203|P1|STARTED|Overall Study||8040
164591|NCT00676494|380260|P1|NOT COMPLETED|Overall Study||14
164592|NCT00676494|380260|P1|COMPLETED|Overall Study||158
164593|NCT00676494|380260|P1|STARTED|Overall Study||172
164594|NCT00676455|380266|P1|NOT COMPLETED|Overall Study||0
164595|NCT00676455|380266|P1|COMPLETED|Overall Study||14
164596|NCT00676455|380266|P1|STARTED|Overall Study||14
164597|NCT00676403|380277|P6|NOT COMPLETED|Overall Study||5
164598|NCT00676403|380278|P5|NOT COMPLETED|Overall Study||1
164599|NCT00676403|380279|P4|NOT COMPLETED|Overall Study||5
164600|NCT00676403|380280|P3|NOT COMPLETED|Overall Study||1
164601|NCT00676403|380281|P2|NOT COMPLETED|Overall Study||2
164602|NCT00676403|380282|P1|NOT COMPLETED|Overall Study||2
164603|NCT00676403|380277|P6|COMPLETED|Overall Study||18
164604|NCT00676403|380278|P5|COMPLETED|Overall Study||23
164605|NCT00676403|380279|P4|COMPLETED|Overall Study||17
164606|NCT00676403|380280|P3|COMPLETED|Overall Study||22
164607|NCT00676403|380281|P2|COMPLETED|Overall Study||20
164608|NCT00676403|380282|P1|COMPLETED|Overall Study||21
164609|NCT00676403|380277|P6|STARTED|Overall Study||23
164610|NCT00676403|380278|P5|STARTED|Overall Study||24
164611|NCT00676403|380279|P4|STARTED|Overall Study||22
164612|NCT00676403|380280|P3|STARTED|Overall Study||23
164613|NCT00676403|380281|P2|STARTED|Overall Study||22
164614|NCT00676403|380282|P1|STARTED|Overall Study||23
164615|NCT00676364|380412|P2|NOT COMPLETED|Overall Study||0
164616|NCT00676364|380413|P1|NOT COMPLETED|Overall Study||0
164617|NCT00676364|380412|P2|COMPLETED|Overall Study||57
164618|NCT00676364|380413|P1|COMPLETED|Overall Study||57
164619|NCT00676364|380412|P2|STARTED|Overall Study||57
164620|NCT00676364|380413|P1|STARTED|Overall Study||57
164621|NCT00676338|380425|P4|NOT COMPLETED|Overall Study||23
164622|NCT00676338|380426|P3|NOT COMPLETED|Overall Study||30
164623|NCT00676338|380427|P2|NOT COMPLETED|Overall Study||33
164624|NCT00676338|380428|P1|NOT COMPLETED|Overall Study||38
164625|NCT00676338|380425|P4|COMPLETED|Overall Study||140
164626|NCT00676338|380426|P3|COMPLETED|Overall Study||133
164627|NCT00676338|380427|P2|COMPLETED|Overall Study||213
164628|NCT00676338|380428|P1|COMPLETED|Overall Study||210
164629|NCT00676338|380425|P4|STARTED|Overall Study||163
164630|NCT00676338|380426|P3|STARTED|Overall Study||163
164631|NCT00676338|380427|P2|STARTED|Overall Study||246
164632|NCT00676338|380428|P1|STARTED|Overall Study||248
164633|NCT00676208|380480|P2|NOT COMPLETED|Overall Study||6
164634|NCT00676208|380481|P1|NOT COMPLETED|Overall Study||2
164635|NCT00676208|380480|P2|COMPLETED|Overall Study||13
164636|NCT00676208|380481|P1|COMPLETED|Overall Study||12
164637|NCT00676208|380480|P2|STARTED|Overall Study||19
164638|NCT00676208|380481|P1|STARTED|Overall Study||14
164639|NCT00676182|380491|P1|NOT COMPLETED|Overall Study||0
164640|NCT00676182|380491|P1|COMPLETED|Overall Study||75
164641|NCT00676182|380491|P1|STARTED|Overall Study||75
164642|NCT00676143|380506|P2|NOT COMPLETED|Overall Study||260
164643|NCT00676143|380507|P1|NOT COMPLETED|Overall Study||156
164644|NCT00676143|380506|P2|COMPLETED|Overall Study||398
164645|NCT00676143|380507|P1|COMPLETED|Overall Study||285
164646|NCT00676143|380506|P2|Treated|Overall Study||654
164647|NCT00676143|380507|P1|Treated|Overall Study||439
164648|NCT00676143|380506|P2|STARTED|Overall Study||658
164649|NCT00676143|380507|P1|STARTED|Overall Study||441
164650|NCT00676130|380547|P2|NOT COMPLETED|Overall Study||4
164651|NCT00676130|380548|P1|NOT COMPLETED|Overall Study||3
164652|NCT00676130|380547|P2|COMPLETED|Overall Study||73
164653|NCT00676130|380548|P1|COMPLETED|Overall Study||73
164654|NCT00676130|380547|P2|STARTED|Overall Study||77
164655|NCT00676130|380548|P1|STARTED|Overall Study||76
164656|NCT00676091|380558|P2|NOT COMPLETED|Toddler Dose||0
164657|NCT00676091|380559|P1|NOT COMPLETED|Toddler Dose||3
164658|NCT00676091|380558|P2|COMPLETED|Toddler Dose||156
164659|NCT00676091|380559|P1|COMPLETED|Toddler Dose||153
164660|NCT00676091|380558|P2|STARTED|Toddler Dose||156
164661|NCT00676091|380559|P1|STARTED|Toddler Dose||156
164662|NCT00676091|380558|P2|NOT COMPLETED|After Infant Series||3
164663|NCT00676091|380559|P1|NOT COMPLETED|After Infant Series||1
164664|NCT00676091|380558|P2|COMPLETED|After Infant Series||156
164665|NCT00676091|380559|P1|COMPLETED|After Infant Series||156
164666|NCT00676091|380558|P2|STARTED|After Infant Series||159
164667|NCT00676091|380559|P1|STARTED|After Infant Series||157
164668|NCT00676091|380558|P2|NOT COMPLETED|Infant Series||18
164669|NCT00676091|380559|P1|NOT COMPLETED|Infant Series||20
164670|NCT00676091|380558|P2|COMPLETED|Infant Series||159
164671|NCT00676091|380559|P1|COMPLETED|Infant Series||157
164672|NCT00676091|380558|P2|Vaccinated Dose 3|Infant Series||161
164673|NCT00676091|380559|P1|Vaccinated Dose 3|Infant Series||158
164674|NCT00676091|380558|P2|Vaccinated Dose 2|Infant Series||162
164675|NCT00676091|380559|P1|Vaccinated Dose 2|Infant Series||159
164676|NCT00676091|380558|P2|Vaccinated Dose 1|Infant Series||162
164677|NCT00676091|380559|P1|Vaccinated Dose 1|Infant Series||163
164678|NCT00676091|380558|P2|STARTED|Infant Series||177
164679|NCT00676091|380559|P1|STARTED|Infant Series||177
164680|NCT00676065|380594|P3|NOT COMPLETED|Overall Study||0
164681|NCT00676065|380595|P2|NOT COMPLETED|Overall Study||0
164682|NCT00676065|380596|P1|NOT COMPLETED|Overall Study||0
164683|NCT00676065|380594|P3|COMPLETED|Overall Study||26341
164684|NCT00676065|380595|P2|COMPLETED|Overall Study||15428
164685|NCT00676065|380596|P1|COMPLETED|Overall Study||16534
164686|NCT00676065|380594|P3|STARTED|Overall Study||26341
164687|NCT00676065|380595|P2|STARTED|Overall Study||15428
164688|NCT00676065|380596|P1|STARTED|Overall Study||16534
164689|NCT00675987|380612|P2|NOT COMPLETED|Overall Study||0
164690|NCT00675987|380613|P1|NOT COMPLETED|Overall Study||0
164691|NCT00675987|380612|P2|COMPLETED|Overall Study||27
164692|NCT00675987|380613|P1|COMPLETED|Overall Study||26
164693|NCT00675987|380612|P2|STARTED|Overall Study||27
164694|NCT00675987|380613|P1|STARTED|Overall Study||26
164695|NCT00675948|380623|P2|NOT COMPLETED|Overall Study||3
164696|NCT00675948|380624|P1|NOT COMPLETED|Overall Study||39
164697|NCT00675948|380623|P2|COMPLETED|Overall Study||1
164698|NCT00675948|380624|P1|COMPLETED|Overall Study||0
164699|NCT00675948|380623|P2|STARTED|Overall Study||4
164700|NCT00675948|380624|P1|STARTED|Overall Study||39
164701|NCT00675922|380634|P1|NOT COMPLETED|Overall Study||0
164702|NCT00675922|380634|P1|COMPLETED|Overall Study||98
164703|NCT00675922|380634|P1|STARTED|Overall Study||98
164704|NCT00675909|380642|P3|NOT COMPLETED|Overall Study||0
164705|NCT00675909|380643|P2|NOT COMPLETED|Overall Study||0
164706|NCT00675909|380644|P1|NOT COMPLETED|Overall Study||0
164707|NCT00675909|380642|P3|COMPLETED|Overall Study||60
164708|NCT00675909|380643|P2|COMPLETED|Overall Study||60
164709|NCT00675909|380644|P1|COMPLETED|Overall Study||60
164710|NCT00675909|380642|P3|STARTED|Overall Study||60
164711|NCT00675909|380643|P2|STARTED|Overall Study||60
164712|NCT00675909|380644|P1|STARTED|Overall Study||60
164713|NCT00675792|380654|P2|NOT COMPLETED|Overall Study||0
164714|NCT00675792|380655|P1|NOT COMPLETED|Overall Study||0
164715|NCT00675792|380654|P2|COMPLETED|Overall Study||49
164716|NCT00675792|380655|P1|COMPLETED|Overall Study||51
164717|NCT00675792|380654|P2|STARTED|Overall Study||49
164718|NCT00675792|380655|P1|STARTED|Overall Study||51
164719|NCT00675766|380675|P4|NOT COMPLETED|Overall Study||26
164720|NCT00675766|380676|P3|NOT COMPLETED|Overall Study||21
164721|NCT00675766|380677|P2|NOT COMPLETED|Overall Study||5
164722|NCT00675766|380678|P1|NOT COMPLETED|Overall Study||6
164723|NCT00675766|380675|P4|COMPLETED|Overall Study||11
164724|NCT00675766|380676|P3|COMPLETED|Overall Study||29
164725|NCT00675766|380677|P2|COMPLETED|Overall Study||25
164726|NCT00675766|380678|P1|COMPLETED|Overall Study||100
164727|NCT00675766|380675|P4|Year 3|Overall Study||11
164728|NCT00675766|380676|P3|Year 3|Overall Study||29
164729|NCT00675766|380677|P2|Year 3|Overall Study||25
164730|NCT00675766|380678|P1|Year 3|Overall Study||100
164731|NCT00675766|380675|P4|Year 2|Overall Study||20
164732|NCT00675766|380676|P3|Year 2|Overall Study||34
164733|NCT00675766|380677|P2|Year 2|Overall Study||28
164734|NCT00675766|380678|P1|Year 2|Overall Study||105
164735|NCT00675766|380675|P4|STARTED|Overall Study||37
164736|NCT00675766|380676|P3|STARTED|Overall Study||50
164737|NCT00675766|380677|P2|STARTED|Overall Study||30
164738|NCT00675766|380678|P1|STARTED|Overall Study||106
164739|NCT00675597|380688|P1|NOT COMPLETED|Overall Study||3
164740|NCT00675597|380688|P1|COMPLETED|Overall Study||23
164741|NCT00675597|380688|P1|STARTED|Overall Study||26
164742|NCT00675584|380694|P2|NOT COMPLETED|Overall Study||26
164743|NCT00675584|380695|P1|NOT COMPLETED|Overall Study||39
164744|NCT00675584|380694|P2|COMPLETED|Overall Study||113
164745|NCT00675584|380695|P1|COMPLETED|Overall Study||100
164746|NCT00675584|380694|P2|STARTED|Overall Study||139
164747|NCT00675584|380695|P1|STARTED|Overall Study||139
164748|NCT00675558|380704|P3|NOT COMPLETED|Second Operation||0
164749|NCT00675558|380705|P2|NOT COMPLETED|Second Operation||0
164750|NCT00675558|380706|P1|NOT COMPLETED|Second Operation||0
164751|NCT00675558|380704|P3|COMPLETED|Second Operation||10
164752|NCT00675558|380705|P2|COMPLETED|Second Operation||0
164753|NCT00675558|380706|P1|COMPLETED|Second Operation||0
164754|NCT00675558|380704|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
164755|NCT00675558|380705|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
164756|NCT00675558|380706|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
164757|NCT00675558|380704|P3|NOT COMPLETED|Surgery||0
164758|NCT00675558|380705|P2|NOT COMPLETED|Surgery||0
164759|NCT00675558|380706|P1|NOT COMPLETED|Surgery||0
164760|NCT00675558|380704|P3|COMPLETED|Surgery||30
164761|NCT00675558|380705|P2|COMPLETED|Surgery||10
164762|NCT00675558|380706|P1|COMPLETED|Surgery||10
164763|NCT00675558|380704|P3|STARTED|Surgery||30
164764|NCT00675558|380705|P2|STARTED|Surgery||10
164765|NCT00675558|380706|P1|STARTED|Surgery||10
164766|NCT00675506|380722|P2|NOT COMPLETED|Overall Study||12
164767|NCT00675506|380723|P1|NOT COMPLETED|Overall Study||12
164768|NCT00675506|380722|P2|COMPLETED|Overall Study||17
164769|NCT00675506|380723|P1|COMPLETED|Overall Study||19
164770|NCT00675506|380722|P2|Received Intervention|Overall Study||29
164771|NCT00675506|380723|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
164772|NCT00675506|380722|P2|STARTED|Overall Study||29
164773|NCT00675506|380723|P1|STARTED|Overall Study||31
164774|NCT00675441|380735|P1|NOT COMPLETED|Overall Study||3
164775|NCT00675441|380735|P1|COMPLETED|Overall Study||2
164776|NCT00675441|380735|P1|STARTED|Overall Study||5
164777|NCT00675428|380741|P2|NOT COMPLETED|Overall Study||3
164778|NCT00675428|380742|P1|NOT COMPLETED|Overall Study||3
164779|NCT00675428|380741|P2|COMPLETED|Overall Study||0
164780|NCT00675428|380742|P1|COMPLETED|Overall Study||0
164781|NCT00675428|380741|P2|STARTED|Overall Study||3
164782|NCT00675428|380742|P1|STARTED|Overall Study||3
164783|NCT00675259|380760|P1|NOT COMPLETED|Overall Study||14
164784|NCT00675259|380760|P1|COMPLETED|Overall Study||19
164785|NCT00675259|380760|P1|STARTED|Overall Study||33
164786|NCT00675103|380769|P1|NOT COMPLETED|Overall Study||3
164787|NCT00675103|380769|P1|COMPLETED|Overall Study||4
164788|NCT00675103|380769|P1|STARTED|Overall Study||7
164789|NCT00674986|380776|P2|NOT COMPLETED|Overall Study||81
164790|NCT00674986|380777|P1|NOT COMPLETED|Overall Study||43
164791|NCT00674986|380776|P2|COMPLETED|Overall Study||188
164792|NCT00674986|380777|P1|COMPLETED|Overall Study||187
164793|NCT00674986|380776|P2|Intent to Treat Population|Overall Study||256
164794|NCT00674986|380777|P1|Intent to Treat Population|Overall Study||227
164795|NCT00674986|380776|P2|STARTED|Overall Study||269
164796|NCT00674986|380777|P1|STARTED|Overall Study||230
164797|NCT00674973|380798|P2|NOT COMPLETED|Overall Study||102
164798|NCT00674973|380799|P1|NOT COMPLETED|Overall Study||100
164799|NCT00674973|380798|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
164800|NCT00674973|380799|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
164801|NCT00674973|380798|P2|Switch to Open-Label Erlotinib|Overall Study||0
164802|NCT00674973|380799|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
164803|NCT00674973|380798|P2|STARTED|Overall Study||104
164804|NCT00674973|380799|P1|STARTED|Overall Study||103
164805|NCT00674765|380815|P2|NOT COMPLETED|Overall Study||29
164806|NCT00674765|380816|P1|NOT COMPLETED|Overall Study||36
164807|NCT00674765|380815|P2|COMPLETED|Overall Study||46
164808|NCT00674765|380816|P1|COMPLETED|Overall Study||45
164809|NCT00674765|380815|P2|STARTED|Overall Study||75
164810|NCT00674765|380816|P1|STARTED|Overall Study||81
164811|NCT00674739|380825|P3|NOT COMPLETED|Overall Study||32
164812|NCT00674739|380826|P2|NOT COMPLETED|Overall Study||59
164813|NCT00674739|380827|P1|NOT COMPLETED|Overall Study||57
164814|NCT00674739|380825|P3|COMPLETED|Overall Study||65
164815|NCT00674739|380826|P2|COMPLETED|Overall Study||136
164816|NCT00674739|380827|P1|COMPLETED|Overall Study||121
164817|NCT00674739|380825|P3|STARTED|Overall Study||97
164818|NCT00674739|380826|P2|STARTED|Overall Study||195
164819|NCT00674739|380827|P1|STARTED|Overall Study||178
164820|NCT00674700|380844|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
164821|NCT00674700|380845|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
164822|NCT00674700|380846|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
164823|NCT00674700|380844|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
164824|NCT00674700|380845|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
164825|NCT00674700|380846|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
164826|NCT00674700|380844|P3|STARTED|Year 2 Follow-up Without Treatment||153
164827|NCT00674700|380845|P2|STARTED|Year 2 Follow-up Without Treatment||135
164828|NCT00674700|380846|P1|STARTED|Year 2 Follow-up Without Treatment||139
164829|NCT00674700|380844|P3|NOT COMPLETED|Year 1||17
164830|NCT00674700|380845|P2|NOT COMPLETED|Year 1||34
164831|NCT00674700|380846|P1|NOT COMPLETED|Year 1||31
164832|NCT00674700|380844|P3|COMPLETED|Year 1||153
164833|NCT00674700|380845|P2|COMPLETED|Year 1||135
164834|NCT00674700|380846|P1|COMPLETED|Year 1||139
164835|NCT00674700|380844|P3|STARTED|Year 1||170
164836|NCT00674700|380845|P2|STARTED|Year 1||169
164837|NCT00674700|380846|P1|STARTED|Year 1||170
164838|NCT00674661|380859|P2|NOT COMPLETED|Overall Study||15
164839|NCT00674661|380860|P1|NOT COMPLETED|Overall Study||11
164840|NCT00674661|380859|P2|COMPLETED|Overall Study||48
164841|NCT00674661|380860|P1|COMPLETED|Overall Study||56
164842|NCT00674661|380859|P2|STARTED|Overall Study||63
164843|NCT00674661|380860|P1|STARTED|Overall Study||67
164844|NCT00674622|380869|P3|NOT COMPLETED|Overall Study||0
164845|NCT00674622|380870|P2|NOT COMPLETED|Overall Study||4
164846|NCT00674622|380871|P1|NOT COMPLETED|Overall Study||1
164847|NCT00674622|380869|P3|COMPLETED|Overall Study||22
164848|NCT00674622|380870|P2|COMPLETED|Overall Study||18
164849|NCT00674622|380871|P1|COMPLETED|Overall Study||21
164850|NCT00674622|380869|P3|STARTED|Overall Study||22
164851|NCT00674622|380870|P2|STARTED|Overall Study||22
164852|NCT00674622|380871|P1|STARTED|Overall Study||22
164853|NCT00674609|380894|P3|NOT COMPLETED|Overall Study||8
164854|NCT00674609|380895|P2|NOT COMPLETED|Overall Study||13
164855|NCT00674609|380896|P1|NOT COMPLETED|Overall Study||12
164856|NCT00674609|380894|P3|COMPLETED|Overall Study||51
164857|NCT00674609|380895|P2|COMPLETED|Overall Study||45
164858|NCT00674609|380896|P1|COMPLETED|Overall Study||48
164859|NCT00674609|380894|P3|STARTED|Overall Study||59
164860|NCT00674609|380895|P2|STARTED|Overall Study||58
164861|NCT00674609|380896|P1|STARTED|Overall Study||60
164862|NCT00674492|380928|P1|NOT COMPLETED|Overall Study||0
164863|NCT00674492|380928|P1|COMPLETED|Overall Study||21
164864|NCT00674492|380928|P1|STARTED|Overall Study||21
164865|NCT00674362|380934|P2|NOT COMPLETED|Open Label||0
164866|NCT00674362|380935|P1|NOT COMPLETED|Open Label||2
164867|NCT00674362|380934|P2|COMPLETED|Open Label||7
164868|NCT00674362|380935|P1|COMPLETED|Open Label||18
164869|NCT00674362|380934|P2|STARTED|Open Label||7
164870|NCT00674362|380935|P1|STARTED|Open Label||20
164871|NCT00674362|380934|P2|NOT COMPLETED|Double Blind||18
164872|NCT00674362|380935|P1|NOT COMPLETED|Double Blind||12
164873|NCT00674362|380934|P2|COMPLETED|Double Blind||80
164874|NCT00674362|380935|P1|COMPLETED|Double Blind||84
164875|NCT00674362|380934|P2|STARTED|Double Blind||98
164876|NCT00674362|380935|P1|STARTED|Double Blind||96
164877|NCT00674323|381003|P3|NOT COMPLETED|Overall Study||0
164878|NCT00674323|381004|P2|NOT COMPLETED|Overall Study||1
164879|NCT00674323|381005|P1|NOT COMPLETED|Overall Study||1
164880|NCT00674323|381003|P3|COMPLETED|Overall Study||21
164881|NCT00674323|381004|P2|COMPLETED|Overall Study||20
164882|NCT00674323|381005|P1|COMPLETED|Overall Study||18
164883|NCT00674323|381003|P3|STARTED|Overall Study||21
164884|NCT00674323|381004|P2|STARTED|Overall Study||21
164885|NCT00674323|381005|P1|STARTED|Overall Study||19
164886|NCT00674206|381022|P1|NOT COMPLETED|Overall Study||0
164887|NCT00674206|381022|P1|COMPLETED|Overall Study||6
164888|NCT00674206|381022|P1|STARTED|Overall Study||6
164889|NCT00674154|381029|P2|NOT COMPLETED|Overall Study||3
164890|NCT00674154|381030|P1|NOT COMPLETED|Overall Study||3
164891|NCT00674154|381029|P2|COMPLETED|Overall Study||20
164892|NCT00674154|381030|P1|COMPLETED|Overall Study||20
164893|NCT00674154|381029|P2|STARTED|Overall Study||23
164894|NCT00674154|381030|P1|STARTED|Overall Study||23
164895|NCT00674128|381038|P2|NOT COMPLETED|Overall Study||23
164896|NCT00674128|381039|P1|NOT COMPLETED|Overall Study||25
164897|NCT00674128|381038|P2|COMPLETED|Overall Study||21
164898|NCT00674128|381039|P1|COMPLETED|Overall Study||25
164899|NCT00674128|381038|P2|STARTED|Overall Study||44
164900|NCT00674128|381039|P1|STARTED|Overall Study||50
164901|NCT00674115|381045|P4|NOT COMPLETED|Third Intervention||0
164902|NCT00674115|381046|P3|NOT COMPLETED|Third Intervention||0
164903|NCT00674115|381047|P2|NOT COMPLETED|Third Intervention||0
164904|NCT00674115|381048|P1|NOT COMPLETED|Third Intervention||0
164905|NCT00674115|381045|P4|COMPLETED|Third Intervention||0
164906|NCT00674115|381046|P3|COMPLETED|Third Intervention||0
164907|NCT00674115|381047|P2|COMPLETED|Third Intervention||16
164908|NCT00674115|381048|P1|COMPLETED|Third Intervention||14
164909|NCT00674115|381045|P4|STARTED|Third Intervention||0
164910|NCT00674115|381046|P3|STARTED|Third Intervention||0
164911|NCT00674115|381047|P2|STARTED|Third Intervention||16
164912|NCT00674115|381048|P1|STARTED|Third Intervention||14
164913|NCT00674115|381045|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
164914|NCT00674115|381046|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
164915|NCT00674115|381047|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
164916|NCT00674115|381048|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
164917|NCT00674115|381045|P4|COMPLETED|Washout Period of 2 Weeks||0
164918|NCT00674115|381046|P3|COMPLETED|Washout Period of 2 Weeks||0
164919|NCT00674115|381047|P2|COMPLETED|Washout Period of 2 Weeks||16
164920|NCT00674115|381048|P1|COMPLETED|Washout Period of 2 Weeks||14
164921|NCT00674115|381045|P4|STARTED|Washout Period of 2 Weeks||0
164922|NCT00674115|381046|P3|STARTED|Washout Period of 2 Weeks||0
164923|NCT00674115|381047|P2|STARTED|Washout Period of 2 Weeks||16
164924|NCT00674115|381048|P1|STARTED|Washout Period of 2 Weeks||14
164925|NCT00674115|381045|P4|NOT COMPLETED|Second Intervention||0
164926|NCT00674115|381046|P3|NOT COMPLETED|Second Intervention||0
164927|NCT00674115|381047|P2|NOT COMPLETED|Second Intervention||0
164928|NCT00674115|381048|P1|NOT COMPLETED|Second Intervention||0
164929|NCT00674115|381045|P4|COMPLETED|Second Intervention||16
164930|NCT00674115|381046|P3|COMPLETED|Second Intervention||14
164931|NCT00674115|381047|P2|COMPLETED|Second Intervention||16
164932|NCT00674115|381048|P1|COMPLETED|Second Intervention||14
164933|NCT00674115|381045|P4|STARTED|Second Intervention||16
164934|NCT00674115|381046|P3|STARTED|Second Intervention||14
164935|NCT00674115|381047|P2|STARTED|Second Intervention||16
164936|NCT00674115|381048|P1|STARTED|Second Intervention||14
164937|NCT00674115|381045|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
164938|NCT00674115|381046|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
164939|NCT00674115|381047|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
164940|NCT00674115|381048|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
164941|NCT00674115|381045|P4|COMPLETED|Washout Period of 2 Weeks||16
164942|NCT00674115|381046|P3|COMPLETED|Washout Period of 2 Weeks||14
164943|NCT00674115|381047|P2|COMPLETED|Washout Period of 2 Weeks||16
164944|NCT00674115|381048|P1|COMPLETED|Washout Period of 2 Weeks||14
164945|NCT00674115|381045|P4|STARTED|Washout Period of 2 Weeks||16
164946|NCT00674115|381046|P3|STARTED|Washout Period of 2 Weeks||14
164947|NCT00674115|381047|P2|STARTED|Washout Period of 2 Weeks||16
164948|NCT00674115|381048|P1|STARTED|Washout Period of 2 Weeks||14
164949|NCT00674115|381045|P4|NOT COMPLETED|First Intervention||0
164950|NCT00674115|381046|P3|NOT COMPLETED|First Intervention||0
164951|NCT00674115|381047|P2|NOT COMPLETED|First Intervention||0
164952|NCT00674115|381048|P1|NOT COMPLETED|First Intervention||0
164953|NCT00674115|381045|P4|COMPLETED|First Intervention||16
164954|NCT00674115|381046|P3|COMPLETED|First Intervention||14
164955|NCT00674115|381047|P2|COMPLETED|First Intervention||16
164956|NCT00674115|381048|P1|COMPLETED|First Intervention||14
164957|NCT00674115|381045|P4|STARTED|First Intervention||16
164958|NCT00674115|381046|P3|STARTED|First Intervention||14
164959|NCT00674115|381047|P2|STARTED|First Intervention||16
164960|NCT00674115|381048|P1|STARTED|First Intervention||14
164961|NCT00673959|381057|P2|NOT COMPLETED|Overall Study||0
164962|NCT00673959|381058|P1|NOT COMPLETED|Overall Study||0
164963|NCT00673959|381057|P2|COMPLETED|Overall Study||10
164964|NCT00673959|381058|P1|COMPLETED|Overall Study||10
164965|NCT00673959|381057|P2|STARTED|Overall Study||10
164966|NCT00673959|381058|P1|STARTED|Overall Study||10
164967|NCT00673933|381064|P1|NOT COMPLETED|Overall Study||3
164968|NCT00673933|381064|P1|COMPLETED|Overall Study||17
164969|NCT00673933|381064|P1|STARTED|Overall Study||20
164970|NCT00673881|381080|P1|NOT COMPLETED|Overall Study||1
164971|NCT00673881|381080|P1|COMPLETED|Overall Study||24
164972|NCT00673881|381080|P1|STARTED|Overall Study||25
164973|NCT00673855|381087|P2|NOT COMPLETED|Second Intervention||0
164974|NCT00673855|381088|P1|NOT COMPLETED|Second Intervention||0
164975|NCT00673855|381087|P2|COMPLETED|Second Intervention||10
164976|NCT00673855|381088|P1|COMPLETED|Second Intervention||10
164977|NCT00673855|381087|P2|STARTED|Second Intervention||10
164978|NCT00673855|381088|P1|STARTED|Second Intervention||10
164979|NCT00673855|381087|P2|NOT COMPLETED|First Intervention||0
164980|NCT00673855|381088|P1|NOT COMPLETED|First Intervention||0
164981|NCT00673855|381087|P2|COMPLETED|First Intervention||10
164982|NCT00673855|381088|P1|COMPLETED|First Intervention||10
164983|NCT00673855|381087|P2|STARTED|First Intervention||10
164984|NCT00673855|381088|P1|STARTED|First Intervention||10
164985|NCT00673816|381094|P1|NOT COMPLETED|Overall Study||2
164986|NCT00673816|381094|P1|COMPLETED|Overall Study||0
164987|NCT00673816|381094|P1|STARTED|Overall Study||2
164988|NCT00673764|381101|P2|NOT COMPLETED|Overall Study||0
164989|NCT00673764|381102|P1|NOT COMPLETED|Overall Study||0
164990|NCT00673764|381101|P2|COMPLETED|Overall Study||24
164991|NCT00673764|381102|P1|COMPLETED|Overall Study||24
164992|NCT00673764|381101|P2|STARTED|Overall Study||24
164993|NCT00673764|381102|P1|STARTED|Overall Study||24
164994|NCT00673738|381110|P1|NOT COMPLETED|Overall Study||0
164995|NCT00673738|381110|P1|COMPLETED|Overall Study||27
164996|NCT00673738|381110|P1|STARTED|Overall Study||27
164997|NCT00673712|381118|P2|NOT COMPLETED|Overall Study||0
164998|NCT00673712|381119|P1|NOT COMPLETED|Overall Study||0
164999|NCT00673712|381118|P2|COMPLETED|Overall Study||326
165000|NCT00673712|381119|P1|COMPLETED|Overall Study||321
165001|NCT00673712|381118|P2|STARTED|Overall Study||326
165002|NCT00673712|381119|P1|STARTED|Overall Study||321
165003|NCT00673673|381129|P1|NOT COMPLETED|Overall Study||36
165004|NCT00673673|381129|P1|COMPLETED|Overall Study||3
165005|NCT00673673|381129|P1|STARTED|Overall Study||39
165006|NCT00673660|381135|P1|NOT COMPLETED|Overall Study||107
165007|NCT00673660|381135|P1|COMPLETED|Overall Study||268
165008|NCT00673660|381135|P1|STARTED|Overall Study||375
165009|NCT00673595|381148|P2|NOT COMPLETED|Overall Study||0
165010|NCT00673595|381149|P1|NOT COMPLETED|Overall Study||0
165011|NCT00673595|381148|P2|COMPLETED|Overall Study||11
165012|NCT00673595|381149|P1|COMPLETED|Overall Study||8
165013|NCT00673595|381148|P2|STARTED|Overall Study||11
165014|NCT00673595|381149|P1|STARTED|Overall Study||8
165015|NCT00673465|381157|P12|NOT COMPLETED|Part 2 (India)||0
165016|NCT00673465|381158|P11|NOT COMPLETED|Part 2 (India)||0
165017|NCT00673465|381159|P10|NOT COMPLETED|Part 2 (India)||0
165018|NCT00673465|381160|P9|NOT COMPLETED|Part 2 (India)||0
165019|NCT00673465|381161|P8|NOT COMPLETED|Part 2 (India)||0
165020|NCT00673465|381162|P7|NOT COMPLETED|Part 2 (India)||0
165021|NCT00673465|381163|P6|NOT COMPLETED|Part 2 (India)||0
165022|NCT00673465|381164|P5|NOT COMPLETED|Part 2 (India)||0
165023|NCT00673465|381165|P4|NOT COMPLETED|Part 2 (India)||0
165024|NCT00673465|381166|P3|NOT COMPLETED|Part 2 (India)||0
165025|NCT00673465|381167|P2|NOT COMPLETED|Part 2 (India)||0
165026|NCT00673465|381168|P1|NOT COMPLETED|Part 2 (India)||0
165027|NCT00673465|381157|P12|COMPLETED|Part 2 (India)||0
165028|NCT00673465|381158|P11|COMPLETED|Part 2 (India)||0
165029|NCT00673465|381159|P10|COMPLETED|Part 2 (India)||0
165030|NCT00673465|381160|P9|COMPLETED|Part 2 (India)||0
165031|NCT00673465|381161|P8|COMPLETED|Part 2 (India)||0
165032|NCT00673465|381162|P7|COMPLETED|Part 2 (India)||0
165033|NCT00673465|381163|P6|COMPLETED|Part 2 (India)||0
165034|NCT00673465|381164|P5|COMPLETED|Part 2 (India)||0
165035|NCT00673465|381165|P4|COMPLETED|Part 2 (India)||0
165036|NCT00673465|381166|P3|COMPLETED|Part 2 (India)||0
165037|NCT00673465|381167|P2|COMPLETED|Part 2 (India)||0
165038|NCT00673465|381168|P1|COMPLETED|Part 2 (India)||0
165039|NCT00673465|381157|P12|STARTED|Part 2 (India)||0
165040|NCT00673465|381158|P11|STARTED|Part 2 (India)||0
165041|NCT00673465|381159|P10|STARTED|Part 2 (India)||0
165042|NCT00673465|381160|P9|STARTED|Part 2 (India)||0
165043|NCT00673465|381161|P8|STARTED|Part 2 (India)||0
165044|NCT00673465|381162|P7|STARTED|Part 2 (India)||0
165045|NCT00673465|381163|P6|STARTED|Part 2 (India)||0
165046|NCT00673465|381164|P5|STARTED|Part 2 (India)||0
165047|NCT00673465|381165|P4|STARTED|Part 2 (India)||0
165048|NCT00673465|381166|P3|STARTED|Part 2 (India)||0
165049|NCT00673465|381167|P2|STARTED|Part 2 (India)||0
165050|NCT00673465|381168|P1|STARTED|Part 2 (India)||0
165051|NCT00673465|381157|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
165052|NCT00673465|381158|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
165053|NCT00673465|381159|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
165054|NCT00673465|381160|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
165055|NCT00673465|381161|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
165056|NCT00673465|381162|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
165057|NCT00673465|381163|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
165058|NCT00673465|381164|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
165059|NCT00673465|381165|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
165060|NCT00673465|381166|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
165061|NCT00673465|381167|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
165062|NCT00673465|381168|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
165063|NCT00673465|381157|P12|COMPLETED|Part 1/Period 3 (United States)||0
165064|NCT00673465|381158|P11|COMPLETED|Part 1/Period 3 (United States)||0
165065|NCT00673465|381159|P10|COMPLETED|Part 1/Period 3 (United States)||0
165066|NCT00673465|381160|P9|COMPLETED|Part 1/Period 3 (United States)||0
165067|NCT00673465|381161|P8|COMPLETED|Part 1/Period 3 (United States)||0
165068|NCT00673465|381162|P7|COMPLETED|Part 1/Period 3 (United States)||0
165069|NCT00673465|381163|P6|COMPLETED|Part 1/Period 3 (United States)||1
165070|NCT00673465|381164|P5|COMPLETED|Part 1/Period 3 (United States)||1
165071|NCT00673465|381165|P4|COMPLETED|Part 1/Period 3 (United States)||3
165072|NCT00673465|381166|P3|COMPLETED|Part 1/Period 3 (United States)||3
165073|NCT00673465|381167|P2|COMPLETED|Part 1/Period 3 (United States)||3
165074|NCT00673465|381168|P1|COMPLETED|Part 1/Period 3 (United States)||3
165075|NCT00673465|381157|P12|STARTED|Part 1/Period 3 (United States)||0
165076|NCT00673465|381158|P11|STARTED|Part 1/Period 3 (United States)||0
165077|NCT00673465|381159|P10|STARTED|Part 1/Period 3 (United States)||0
165078|NCT00673465|381160|P9|STARTED|Part 1/Period 3 (United States)||0
165079|NCT00673465|381161|P8|STARTED|Part 1/Period 3 (United States)||0
165080|NCT00673465|381162|P7|STARTED|Part 1/Period 3 (United States)||0
165081|NCT00673465|381163|P6|STARTED|Part 1/Period 3 (United States)||1
165082|NCT00673465|381164|P5|STARTED|Part 1/Period 3 (United States)||1
165083|NCT00673465|381165|P4|STARTED|Part 1/Period 3 (United States)||3
165084|NCT00673465|381166|P3|STARTED|Part 1/Period 3 (United States)||3
165085|NCT00673465|381167|P2|STARTED|Part 1/Period 3 (United States)||3
165086|NCT00673465|381168|P1|STARTED|Part 1/Period 3 (United States)||3
165087|NCT00673465|381157|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
165088|NCT00673465|381158|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
165089|NCT00673465|381159|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
165090|NCT00673465|381160|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
165091|NCT00673465|381161|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
165092|NCT00673465|381162|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
165093|NCT00673465|381163|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
165094|NCT00673465|381164|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
165095|NCT00673465|381165|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
165096|NCT00673465|381166|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
165097|NCT00673465|381167|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
165098|NCT00673465|381168|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
165099|NCT00673465|381157|P12|COMPLETED|Part 1/Period 2 (United States)||0
165100|NCT00673465|381158|P11|COMPLETED|Part 1/Period 2 (United States)||0
165101|NCT00673465|381159|P10|COMPLETED|Part 1/Period 2 (United States)||0
165102|NCT00673465|381160|P9|COMPLETED|Part 1/Period 2 (United States)||0
165103|NCT00673465|381161|P8|COMPLETED|Part 1/Period 2 (United States)||0
165104|NCT00673465|381162|P7|COMPLETED|Part 1/Period 2 (United States)||0
165105|NCT00673465|381163|P6|COMPLETED|Part 1/Period 2 (United States)||1
165106|NCT00673465|381164|P5|COMPLETED|Part 1/Period 2 (United States)||1
165107|NCT00673465|381165|P4|COMPLETED|Part 1/Period 2 (United States)||3
165108|NCT00673465|381166|P3|COMPLETED|Part 1/Period 2 (United States)||3
165109|NCT00673465|381167|P2|COMPLETED|Part 1/Period 2 (United States)||3
165110|NCT00673465|381168|P1|COMPLETED|Part 1/Period 2 (United States)||3
165111|NCT00673465|381157|P12|STARTED|Part 1/Period 2 (United States)||0
165112|NCT00673465|381158|P11|STARTED|Part 1/Period 2 (United States)||0
165113|NCT00673465|381159|P10|STARTED|Part 1/Period 2 (United States)||0
165114|NCT00673465|381160|P9|STARTED|Part 1/Period 2 (United States)||0
165115|NCT00673465|381161|P8|STARTED|Part 1/Period 2 (United States)||0
165116|NCT00673465|381162|P7|STARTED|Part 1/Period 2 (United States)||0
165117|NCT00673465|381163|P6|STARTED|Part 1/Period 2 (United States)||1
165118|NCT00673465|381164|P5|STARTED|Part 1/Period 2 (United States)||2
165119|NCT00673465|381165|P4|STARTED|Part 1/Period 2 (United States)||3
165120|NCT00673465|381166|P3|STARTED|Part 1/Period 2 (United States)||3
165121|NCT00673465|381167|P2|STARTED|Part 1/Period 2 (United States)||3
165122|NCT00673465|381168|P1|STARTED|Part 1/Period 2 (United States)||3
165123|NCT00673465|381157|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
165124|NCT00673465|381158|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
165125|NCT00673465|381159|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
165126|NCT00673465|381160|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
165127|NCT00673465|381161|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
165128|NCT00673465|381162|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
165129|NCT00673465|381163|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
165130|NCT00673465|381164|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
165131|NCT00673465|381165|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
165132|NCT00673465|381166|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
165133|NCT00673465|381167|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
165134|NCT00673465|381168|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
165135|NCT00673465|381157|P12|COMPLETED|Part 1/Period 1 (United States)||0
165136|NCT00673465|381158|P11|COMPLETED|Part 1/Period 1 (United States)||0
165137|NCT00673465|381159|P10|COMPLETED|Part 1/Period 1 (United States)||0
165138|NCT00673465|381160|P9|COMPLETED|Part 1/Period 1 (United States)||0
165139|NCT00673465|381161|P8|COMPLETED|Part 1/Period 1 (United States)||0
165140|NCT00673465|381162|P7|COMPLETED|Part 1/Period 1 (United States)||0
165141|NCT00673465|381163|P6|COMPLETED|Part 1/Period 1 (United States)||1
165142|NCT00673465|381164|P5|COMPLETED|Part 1/Period 1 (United States)||2
165143|NCT00673465|381165|P4|COMPLETED|Part 1/Period 1 (United States)||3
165144|NCT00673465|381166|P3|COMPLETED|Part 1/Period 1 (United States)||3
165145|NCT00673465|381167|P2|COMPLETED|Part 1/Period 1 (United States)||3
165146|NCT00673465|381168|P1|COMPLETED|Part 1/Period 1 (United States)||3
165147|NCT00673465|381157|P12|STARTED|Part 1/Period 1 (United States)||0
165148|NCT00673465|381158|P11|STARTED|Part 1/Period 1 (United States)||0
165149|NCT00673465|381159|P10|STARTED|Part 1/Period 1 (United States)||0
165150|NCT00673465|381160|P9|STARTED|Part 1/Period 1 (United States)||0
165151|NCT00673465|381161|P8|STARTED|Part 1/Period 1 (United States)||0
165152|NCT00673465|381162|P7|STARTED|Part 1/Period 1 (United States)||0
165153|NCT00673465|381163|P6|STARTED|Part 1/Period 1 (United States)||2
165154|NCT00673465|381164|P5|STARTED|Part 1/Period 1 (United States)||3
165155|NCT00673465|381165|P4|STARTED|Part 1/Period 1 (United States)||3
165156|NCT00673465|381166|P3|STARTED|Part 1/Period 1 (United States)||3
165157|NCT00673465|381167|P2|STARTED|Part 1/Period 1 (United States)||3
165158|NCT00673465|381168|P1|STARTED|Part 1/Period 1 (United States)||3
165159|NCT00673452|381217|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
165160|NCT00673452|381218|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
165161|NCT00673452|381217|P2|COMPLETED|Continuation Double-Blind Phase||153
165162|NCT00673452|381218|P1|COMPLETED|Continuation Double-Blind Phase||151
165163|NCT00673452|381217|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
165164|NCT00673452|381218|P1|STARTED|Continuation Double-Blind Phase||176
165165|NCT00673452|381217|P2|NOT COMPLETED|Acute Double-Blind Phase||80
165166|NCT00673452|381218|P1|NOT COMPLETED|Acute Double-Blind Phase||87
165167|NCT00673452|381217|P2|COMPLETED|Acute Double-Blind Phase||187
165168|NCT00673452|381218|P1|COMPLETED|Acute Double-Blind Phase||176
165169|NCT00673452|381217|P2|STARTED|Acute Double-Blind Phase||267
165170|NCT00673452|381218|P1|STARTED|Acute Double-Blind Phase||263
165171|NCT00673439|381252|P1|NOT COMPLETED|Overall Study||0
165172|NCT00673439|381252|P1|COMPLETED|Overall Study||3
165173|NCT00673439|381252|P1|STARTED|Overall Study||3
165174|NCT00673400|381256|P1|NOT COMPLETED|Overall Study||0
165175|NCT00673400|381256|P1|COMPLETED|Overall Study||52
165176|NCT00673400|381256|P1|STARTED|Overall Study||52
165177|NCT00673387|381281|P8|NOT COMPLETED|Overall Study||35
165178|NCT00673387|381282|P7|NOT COMPLETED|Overall Study||30
165179|NCT00673387|381283|P6|NOT COMPLETED|Overall Study||34
165180|NCT00673387|381284|P5|NOT COMPLETED|Overall Study||30
165181|NCT00673387|381285|P4|NOT COMPLETED|Overall Study||26
165182|NCT00673387|381286|P3|NOT COMPLETED|Overall Study||31
165183|NCT00673387|381287|P2|NOT COMPLETED|Overall Study||23
165184|NCT00673387|381288|P1|NOT COMPLETED|Overall Study||29
165185|NCT00673387|381281|P8|COMPLETED|Overall Study||40
165186|NCT00673387|381282|P7|COMPLETED|Overall Study||48
165187|NCT00673387|381283|P6|COMPLETED|Overall Study||44
165188|NCT00673387|381284|P5|COMPLETED|Overall Study||48
165189|NCT00673387|381285|P4|COMPLETED|Overall Study||49
165190|NCT00673387|381286|P3|COMPLETED|Overall Study||41
165191|NCT00673387|381287|P2|COMPLETED|Overall Study||54
165192|NCT00673387|381288|P1|COMPLETED|Overall Study||46
165193|NCT00673387|381281|P8|STARTED|Overall Study||75
165194|NCT00673387|381282|P7|STARTED|Overall Study||78
165195|NCT00673387|381283|P6|STARTED|Overall Study||78
165196|NCT00673387|381284|P5|STARTED|Overall Study||78
165197|NCT00673387|381285|P4|STARTED|Overall Study||75
165198|NCT00673387|381286|P3|STARTED|Overall Study||72
165199|NCT00673387|381287|P2|STARTED|Overall Study||77
165200|NCT00673387|381288|P1|STARTED|Overall Study||75
165201|NCT00673361|381504|P1|NOT COMPLETED|Overall Study||2
165202|NCT00673361|381504|P1|COMPLETED|Overall Study||7
165203|NCT00673361|381504|P1|STARTED|Overall Study||9
165204|NCT00673257|381508|P1|NOT COMPLETED|Overall Study||5
165205|NCT00673257|381508|P1|COMPLETED|Overall Study||102
165206|NCT00673257|381508|P1|STARTED|Overall Study||107
165207|NCT00673231|381517|P4|NOT COMPLETED|Overall Study||18
165208|NCT00673231|381518|P3|NOT COMPLETED|Overall Study||26
165209|NCT00673231|381519|P2|NOT COMPLETED|Overall Study||22
165210|NCT00673231|381520|P1|NOT COMPLETED|Overall Study||29
165211|NCT00673231|381517|P4|COMPLETED|Overall Study||178
165212|NCT00673231|381518|P3|COMPLETED|Overall Study||186
165213|NCT00673231|381519|P2|COMPLETED|Overall Study||180
165214|NCT00673231|381520|P1|COMPLETED|Overall Study||168
165215|NCT00673231|381517|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
165216|NCT00673231|381518|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
165217|NCT00673231|381519|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
165218|NCT00673231|381520|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
165219|NCT00673179|381552|P2|NOT COMPLETED|Overall Study||0
165220|NCT00673179|381553|P1|NOT COMPLETED|Overall Study||3
165221|NCT00673179|381552|P2|COMPLETED|Overall Study||0
165222|NCT00673179|381553|P1|COMPLETED|Overall Study||4
165223|NCT00673179|381552|P2|STARTED|Overall Study||0
165224|NCT00673179|381553|P1|STARTED|Overall Study||7
165225|NCT00673127|381559|P1|NOT COMPLETED|Overall Study||0
165226|NCT00673127|381559|P1|COMPLETED|Overall Study||57
165227|NCT00673127|381559|P1|STARTED|Overall Study||57
165228|NCT00673114|381564|P1|NOT COMPLETED|Overall Study||0
165229|NCT00673114|381564|P1|COMPLETED|Overall Study||3
165230|NCT00673114|381564|P1|STARTED|Overall Study||3
165231|NCT00673075|381577|P2|NOT COMPLETED|Overall Study||7
165232|NCT00673075|381578|P1|NOT COMPLETED|Overall Study||9
165233|NCT00673075|381577|P2|COMPLETED|Overall Study||11
165234|NCT00673075|381578|P1|COMPLETED|Overall Study||12
165235|NCT00673075|381577|P2|STARTED|Overall Study||18
165236|NCT00673075|381578|P1|STARTED|Overall Study||21
165237|NCT00673049|381594|P4|NOT COMPLETED|After Progression on Erlotinib||83
165238|NCT00673049|381595|P3|NOT COMPLETED|After Progression on Erlotinib||0
165239|NCT00673049|381596|P2|NOT COMPLETED|After Progression on Erlotinib||0
165240|NCT00673049|381597|P1|NOT COMPLETED|After Progression on Erlotinib||0
165241|NCT00673049|381594|P4|COMPLETED|After Progression on Erlotinib||0
165242|NCT00673049|381595|P3|COMPLETED|After Progression on Erlotinib||0
165243|NCT00673049|381596|P2|COMPLETED|After Progression on Erlotinib||0
165244|NCT00673049|381597|P1|COMPLETED|After Progression on Erlotinib||0
165245|NCT00673049|381594|P4|STARTED|After Progression on Erlotinib||83
165246|NCT00673049|381595|P3|STARTED|After Progression on Erlotinib||0
165247|NCT00673049|381596|P2|STARTED|After Progression on Erlotinib||0
165248|NCT00673049|381597|P1|STARTED|After Progression on Erlotinib||0
165249|NCT00673049|381594|P4|NOT COMPLETED|Before Progression on Erlotinib||0
165250|NCT00673049|381595|P3|NOT COMPLETED|Before Progression on Erlotinib||1
165251|NCT00673049|381596|P2|NOT COMPLETED|Before Progression on Erlotinib||290
165252|NCT00673049|381597|P1|NOT COMPLETED|Before Progression on Erlotinib||292
165253|NCT00673049|381594|P4|COMPLETED|Before Progression on Erlotinib||0
165254|NCT00673049|381595|P3|COMPLETED|Before Progression on Erlotinib||0
165255|NCT00673049|381596|P2|COMPLETED|Before Progression on Erlotinib||0
165256|NCT00673049|381597|P1|COMPLETED|Before Progression on Erlotinib||0
165257|NCT00673049|381594|P4|Treated|Before Progression on Erlotinib||0
165258|NCT00673049|381595|P3|Treated|Before Progression on Erlotinib||1
165259|NCT00673049|381596|P2|Treated|Before Progression on Erlotinib||289
165260|NCT00673049|381597|P1|Treated|Before Progression on Erlotinib||289
165261|NCT00673049|381594|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
165262|NCT00673049|381595|P3|STARTED|Before Progression on Erlotinib||1
165263|NCT00673049|381596|P2|STARTED|Before Progression on Erlotinib||290
165264|NCT00673049|381597|P1|STARTED|Before Progression on Erlotinib||292
165265|NCT00672984|381621|P3|NOT COMPLETED|Third Intervention||1
165266|NCT00672984|381622|P2|NOT COMPLETED|Third Intervention||0
165267|NCT00672984|381623|P1|NOT COMPLETED|Third Intervention||1
165268|NCT00672984|381621|P3|COMPLETED|Third Intervention||23
165269|NCT00672984|381622|P2|COMPLETED|Third Intervention||17
165270|NCT00672984|381623|P1|COMPLETED|Third Intervention||21
165271|NCT00672984|381621|P3|STARTED|Third Intervention||24
165272|NCT00672984|381622|P2|STARTED|Third Intervention||17
165273|NCT00672984|381623|P1|STARTED|Third Intervention||22
165274|NCT00672984|381621|P3|NOT COMPLETED|Second Intervention||1
165275|NCT00672984|381622|P2|NOT COMPLETED|Second Intervention||6
165276|NCT00672984|381623|P1|NOT COMPLETED|Second Intervention||0
165277|NCT00672984|381621|P3|COMPLETED|Second Intervention||24
165278|NCT00672984|381622|P2|COMPLETED|Second Intervention||17
165279|NCT00672984|381623|P1|COMPLETED|Second Intervention||22
165280|NCT00672984|381621|P3|STARTED|Second Intervention||25
165281|NCT00672984|381622|P2|STARTED|Second Intervention||23
165282|NCT00672984|381623|P1|STARTED|Second Intervention||22
165283|NCT00672984|381621|P3|NOT COMPLETED|First Intervention||2
165284|NCT00672984|381622|P2|NOT COMPLETED|First Intervention||2
165285|NCT00672984|381623|P1|NOT COMPLETED|First Intervention||9
165286|NCT00672984|381621|P3|COMPLETED|First Intervention||25
165287|NCT00672984|381622|P2|COMPLETED|First Intervention||23
165288|NCT00672984|381623|P1|COMPLETED|First Intervention||22
165289|NCT00672984|381621|P3|STARTED|First Intervention||27
165290|NCT00672984|381622|P2|STARTED|First Intervention||25
165291|NCT00672984|381623|P1|STARTED|First Intervention||31
165292|NCT00672958|381674|P2|NOT COMPLETED|Overall Study||56
165293|NCT00672958|381675|P1|NOT COMPLETED|Overall Study||64
165294|NCT00672958|381674|P2|COMPLETED|Overall Study||244
165295|NCT00672958|381675|P1|COMPLETED|Overall Study||236
165296|NCT00672958|381674|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
165297|NCT00672958|381675|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
165298|NCT00672958|381674|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
165299|NCT00672958|381675|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
165300|NCT00672958|381674|P2|STARTED|Overall Study||300
165301|NCT00672958|381675|P1|STARTED|Overall Study||300
165302|NCT00672932|381707|P2|NOT COMPLETED|Overall Study||0
165303|NCT00672932|381708|P1|NOT COMPLETED|Overall Study||0
165304|NCT00672932|381707|P2|COMPLETED|Overall Study||9
165305|NCT00672932|381708|P1|COMPLETED|Overall Study||9
165306|NCT00672932|381707|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
165307|NCT00672932|381708|P1|Rolled Over to Raltegravir|Overall Study||0
165308|NCT00672932|381707|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
165309|NCT00672932|381708|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
165310|NCT00672932|381707|P2|Completed Initial 12-week Assignment|Overall Study||9
165311|NCT00672932|381708|P1|Completed Initial 12-week Assignment|Overall Study||9
165312|NCT00672932|381707|P2|STARTED|Overall Study||9
165313|NCT00672932|381708|P1|STARTED|Overall Study||9
165314|NCT00672854|381718|P2|NOT COMPLETED|Overall Study||0
165315|NCT00672854|381719|P1|NOT COMPLETED|Overall Study||0
165316|NCT00672854|381718|P2|COMPLETED|Overall Study||51
165317|NCT00672854|381719|P1|COMPLETED|Overall Study||49
165318|NCT00672854|381718|P2|STARTED|Overall Study||51
165319|NCT00672854|381719|P1|STARTED|Overall Study||49
165320|NCT00672841|381727|P2|NOT COMPLETED|Overall Study||15
165321|NCT00672841|381728|P1|NOT COMPLETED|Overall Study||1
165322|NCT00672841|381727|P2|COMPLETED|Overall Study||32
165323|NCT00672841|381728|P1|COMPLETED|Overall Study||16
165324|NCT00672841|381727|P2|STARTED|Overall Study||47
165325|NCT00672841|381728|P1|STARTED|Overall Study||17
165326|NCT00672646|381743|P3|NOT COMPLETED|Overall Study||3
165327|NCT00672646|381744|P2|NOT COMPLETED|Overall Study||1
165328|NCT00672646|381745|P1|NOT COMPLETED|Overall Study||0
165329|NCT00672646|381743|P3|COMPLETED|Overall Study||37
165330|NCT00672646|381744|P2|COMPLETED|Overall Study||22
165331|NCT00672646|381745|P1|COMPLETED|Overall Study||40
165332|NCT00672646|381743|P3|STARTED|Overall Study||40
165333|NCT00672646|381744|P2|STARTED|Overall Study||23
165334|NCT00672646|381745|P1|STARTED|Overall Study||40
165335|NCT00672633|381770|P2|NOT COMPLETED|Overall Study||1
165336|NCT00672633|381771|P1|NOT COMPLETED|Overall Study||0
165337|NCT00672633|381770|P2|COMPLETED|Overall Study||12
165338|NCT00672633|381771|P1|COMPLETED|Overall Study||12
165339|NCT00672633|381770|P2|STARTED|Overall Study||13
165340|NCT00672633|381771|P1|STARTED|Overall Study||12
165341|NCT00672620|381785|P4|NOT COMPLETED|Overall Study||42
165342|NCT00672620|381786|P3|NOT COMPLETED|Overall Study||31
165343|NCT00672620|381787|P2|NOT COMPLETED|Overall Study||54
165344|NCT00672620|381788|P1|NOT COMPLETED|Overall Study||33
165345|NCT00672620|381785|P4|COMPLETED|Overall Study||110
165346|NCT00672620|381786|P3|COMPLETED|Overall Study||122
165347|NCT00672620|381787|P2|COMPLETED|Overall Study||99
165348|NCT00672620|381788|P1|COMPLETED|Overall Study||120
165349|NCT00672620|381785|P4|Treated|Overall Study||150
165350|NCT00672620|381786|P3|Treated|Overall Study||153
165351|NCT00672620|381787|P2|Treated|Overall Study||149
165352|NCT00672620|381788|P1|Treated|Overall Study||151
165353|NCT00672620|381785|P4|STARTED|Overall Study||152
165354|NCT00672620|381786|P3|STARTED|Overall Study||153
165355|NCT00672620|381787|P2|STARTED|Overall Study||153
165356|NCT00672620|381788|P1|STARTED|Overall Study||153
165357|NCT00672594|381842|P1|NOT COMPLETED|Overall Study||3
165358|NCT00672594|381842|P1|COMPLETED|Overall Study||27
165359|NCT00672594|381842|P1|STARTED|Overall Study||30
165360|NCT00672555|381853|P1|NOT COMPLETED|Overall Study||6
165361|NCT00672555|381853|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
165362|NCT00672555|381853|P1|STARTED|Overall Study||70
165363|NCT00672490|381864|P2|NOT COMPLETED|Overall Study||32
165364|NCT00672490|381865|P1|NOT COMPLETED|Overall Study||24
165365|NCT00672490|381864|P2|COMPLETED|Overall Study||157
165366|NCT00672490|381865|P1|COMPLETED|Overall Study||163
165367|NCT00672490|381864|P2|STARTED|Overall Study||189
165368|NCT00672490|381865|P1|STARTED|Overall Study||187
165369|NCT00672438|381889|P2|NOT COMPLETED|Infusion 2||0
165370|NCT00672438|381890|P1|NOT COMPLETED|Infusion 2||0
165371|NCT00672438|381889|P2|COMPLETED|Infusion 2||118
165372|NCT00672438|381890|P1|COMPLETED|Infusion 2||119
165373|NCT00672438|381889|P2|STARTED|Infusion 2||118
165374|NCT00672438|381890|P1|STARTED|Infusion 2||119
165375|NCT00672438|381889|P2|NOT COMPLETED|Washout||0
165376|NCT00672438|381890|P1|NOT COMPLETED|Washout||0
165377|NCT00672438|381889|P2|COMPLETED|Washout||118
165378|NCT00672438|381890|P1|COMPLETED|Washout||119
165379|NCT00672438|381889|P2|STARTED|Washout||118
165380|NCT00672438|381890|P1|STARTED|Washout||119
165381|NCT00672438|381889|P2|NOT COMPLETED|Infusion 1||0
165382|NCT00672438|381890|P1|NOT COMPLETED|Infusion 1||0
165383|NCT00672438|381889|P2|COMPLETED|Infusion 1||118
165384|NCT00672438|381890|P1|COMPLETED|Infusion 1||119
165385|NCT00672438|381889|P2|STARTED|Infusion 1||118
165386|NCT00672438|381890|P1|STARTED|Infusion 1||119
165387|NCT00672256|381921|P1|NOT COMPLETED|Overall Study||44
165388|NCT00672256|381921|P1|COMPLETED|Overall Study||18
165389|NCT00672256|381921|P1|STARTED|Overall Study|January 2007|62
165390|NCT00672243|381928|P1|NOT COMPLETED|Overall Study||0
165391|NCT00672243|381928|P1|COMPLETED|Overall Study||32
165392|NCT00672243|381928|P1|STARTED|Overall Study||32
165393|NCT00672204|381936|P1|NOT COMPLETED|Overall Study||20
165394|NCT00672204|381936|P1|COMPLETED|Overall Study||3
165395|NCT00672204|381936|P1|STARTED|Overall Study||23
165396|NCT00672178|381940|P1|NOT COMPLETED|Overall Study||0
165397|NCT00672178|381940|P1|COMPLETED|Overall Study||1
165398|NCT00672178|381940|P1|STARTED|Overall Study||1
165399|NCT00672100|381947|P3|NOT COMPLETED|Overall Study||0
165400|NCT00672100|381948|P2|NOT COMPLETED|Overall Study||0
165401|NCT00672100|381949|P1|NOT COMPLETED|Overall Study||0
165402|NCT00672100|381947|P3|COMPLETED|Overall Study||12
165403|NCT00672100|381948|P2|COMPLETED|Overall Study||12
165404|NCT00672100|381949|P1|COMPLETED|Overall Study||12
165405|NCT00672100|381947|P3|PACU (Within 8 Hours)|Overall Study||12
165406|NCT00672100|381948|P2|PACU (Within 8 Hours)|Overall Study||12
165407|NCT00672100|381949|P1|PACU (Within 8 Hours)|Overall Study||12
165408|NCT00672100|381947|P3|STARTED|Overall Study||12
165409|NCT00672100|381948|P2|STARTED|Overall Study||12
165410|NCT00672100|381949|P1|STARTED|Overall Study||12
165411|NCT00671970|381966|P2|NOT COMPLETED|Overall Study||0
165412|NCT00671970|381967|P1|NOT COMPLETED|Overall Study||0
165413|NCT00671970|381966|P2|COMPLETED|Overall Study||25
165414|NCT00671970|381967|P1|COMPLETED|Overall Study||32
165415|NCT00671970|381966|P2|STARTED|Overall Study||25
165416|NCT00671970|381967|P1|STARTED|Overall Study||32
165417|NCT00671931|381995|P5|NOT COMPLETED|Overall Study||1
165418|NCT00671931|381996|P4|NOT COMPLETED|Overall Study||2
165419|NCT00671931|381997|P3|NOT COMPLETED|Overall Study||0
165420|NCT00671931|381998|P2|NOT COMPLETED|Overall Study||0
165421|NCT00671931|381999|P1|NOT COMPLETED|Overall Study||1
165422|NCT00671931|381995|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
165423|NCT00671931|381996|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
165424|NCT00671931|381997|P3|COMPLETED|Overall Study|all completed|9
165425|NCT00671931|381998|P2|COMPLETED|Overall Study|All completed|8
165426|NCT00671931|381999|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
165427|NCT00671931|381995|P5|STARTED|Overall Study||8
165428|NCT00671931|381996|P4|STARTED|Overall Study||10
165429|NCT00671931|381997|P3|STARTED|Overall Study||9
165430|NCT00671931|381998|P2|STARTED|Overall Study||8
165431|NCT00671931|381999|P1|STARTED|Overall Study||9
165432|NCT00671918|382011|P1|NOT COMPLETED|Overall Study||17
165433|NCT00671918|382011|P1|COMPLETED|Overall Study||169
165434|NCT00671918|382011|P1|STARTED|Overall Study||186
165435|NCT00671879|382019|P3|NOT COMPLETED|Overall Study||6
165436|NCT00671879|382020|P2|NOT COMPLETED|Overall Study||4
165437|NCT00671879|382021|P1|NOT COMPLETED|Overall Study||0
165438|NCT00671879|382019|P3|COMPLETED|Overall Study||274
165439|NCT00671879|382020|P2|COMPLETED|Overall Study||275
165440|NCT00671879|382021|P1|COMPLETED|Overall Study||281
165441|NCT00671879|382019|P3|STARTED|Overall Study||280
165442|NCT00671879|382020|P2|STARTED|Overall Study||279
165443|NCT00671879|382021|P1|STARTED|Overall Study||281
165444|NCT00671853|382034|P2|NOT COMPLETED|Overall Study||27
165445|NCT00671853|382035|P1|NOT COMPLETED|Overall Study||20
165446|NCT00671853|382034|P2|COMPLETED|Overall Study||18
165447|NCT00671853|382035|P1|COMPLETED|Overall Study||26
165448|NCT00671853|382034|P2|STARTED|Overall Study||45
165449|NCT00671853|382035|P1|STARTED|Overall Study||46
165450|NCT00671788|382051|P1|NOT COMPLETED|Overall Study||14
165451|NCT00671788|382051|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
165452|NCT00671788|382051|P1|STARTED|Overall Study||35
165453|NCT00671749|382058|P1|NOT COMPLETED|Overall Study||8
165454|NCT00671749|382058|P1|COMPLETED|Overall Study||92
165455|NCT00671749|382058|P1|STARTED|Overall Study||100
165456|NCT00671671|382070|P2|NOT COMPLETED|Overall Study||0
165457|NCT00671671|382071|P1|NOT COMPLETED|Overall Study||0
165458|NCT00671671|382070|P2|COMPLETED|Overall Study||10
165459|NCT00671671|382071|P1|COMPLETED|Overall Study||10
165460|NCT00671671|382070|P2|STARTED|Overall Study||10
165461|NCT00671671|382071|P1|STARTED|Overall Study||10
165462|NCT00671606|382097|P1|NOT COMPLETED|Overall Study||0
165463|NCT00671606|382097|P1|COMPLETED|Overall Study||5
165464|NCT00671606|382097|P1|STARTED|Overall Study||5
165465|NCT00671554|382101|P1|NOT COMPLETED|Overall Study||3
165466|NCT00671554|382101|P1|COMPLETED|Overall Study||0
165467|NCT00671554|382101|P1|STARTED|Overall Study||3
165468|NCT00671528|382109|P3|NOT COMPLETED|Overall Study||0
165469|NCT00671528|382110|P2|NOT COMPLETED|Overall Study||0
165470|NCT00671528|382111|P1|NOT COMPLETED|Overall Study||0
165471|NCT00671528|382109|P3|COMPLETED|Overall Study||1
165472|NCT00671528|382110|P2|COMPLETED|Overall Study||1
165473|NCT00671528|382111|P1|COMPLETED|Overall Study||1
165474|NCT00671528|382109|P3|STARTED|Overall Study||1
165475|NCT00671528|382110|P2|STARTED|Overall Study||1
165476|NCT00671528|382111|P1|STARTED|Overall Study||1
165477|NCT00671515|382122|P1|NOT COMPLETED|Phase 2||4
165478|NCT00671515|382122|P1|COMPLETED|Phase 2||9
165479|NCT00671515|382122|P1|STARTED|Phase 2||13
165480|NCT00671515|382122|P1|NOT COMPLETED|Phase 1||3
165481|NCT00671515|382122|P1|COMPLETED|Phase 1||20
165482|NCT00671515|382122|P1|STARTED|Phase 1||23
165483|NCT00671502|382130|P3|NOT COMPLETED|Overall Study||27
165484|NCT00671502|382131|P2|NOT COMPLETED|Overall Study||39
165485|NCT00671502|382132|P1|NOT COMPLETED|Overall Study||39
165486|NCT00671502|382130|P3|COMPLETED|Overall Study||252
165487|NCT00671502|382131|P2|COMPLETED|Overall Study||241
165488|NCT00671502|382132|P1|COMPLETED|Overall Study||242
165489|NCT00671502|382130|P3|STARTED|Overall Study||279
165490|NCT00671502|382131|P2|STARTED|Overall Study||280
165491|NCT00671502|382132|P1|STARTED|Overall Study||281
165492|NCT00671437|382140|P1|NOT COMPLETED|Overall Study||15
165493|NCT00671437|382140|P1|COMPLETED|Overall Study||27
165494|NCT00671437|382140|P1|STARTED|Overall Study||42
165495|NCT00671060|382159|P2|NOT COMPLETED|Overall Study||1
165496|NCT00671060|382160|P1|NOT COMPLETED|Overall Study||1
165497|NCT00671060|382159|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
165498|NCT00671060|382160|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
165499|NCT00671060|382159|P2|STARTED|Overall Study||76
165500|NCT00671060|382160|P1|STARTED|Overall Study||77
165501|NCT00670982|382168|P2|NOT COMPLETED|Overall Study||0
165502|NCT00670982|382169|P1|NOT COMPLETED|Overall Study||0
165503|NCT00670982|382168|P2|COMPLETED|Overall Study||7
165504|NCT00670982|382169|P1|COMPLETED|Overall Study||22
165505|NCT00670982|382168|P2|STARTED|Overall Study||7
165506|NCT00670982|382169|P1|STARTED|Overall Study||22
165507|NCT00670956|382178|P1|NOT COMPLETED|Overall Study||0
165508|NCT00670956|382178|P1|COMPLETED|Overall Study||1
165509|NCT00670956|382178|P1|STARTED|Overall Study||1
165510|NCT00670930|382186|P2|NOT COMPLETED|Overall Study||1
165511|NCT00670930|382187|P1|NOT COMPLETED|Overall Study||1
165512|NCT00670930|382186|P2|COMPLETED|Overall Study||12
165513|NCT00670930|382187|P1|COMPLETED|Overall Study||22
165514|NCT00670930|382186|P2|Intent to Treat (ITT) Population|Overall Study||12
165515|NCT00670930|382187|P1|Intent to Treat (ITT) Population|Overall Study||23
165516|NCT00670930|382186|P2|STARTED|Overall Study||13
165517|NCT00670930|382187|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
165518|NCT00670800|382203|P2|NOT COMPLETED|Overall Study||2
165519|NCT00670800|382204|P1|NOT COMPLETED|Overall Study||0
165520|NCT00670800|382203|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
165521|NCT00670800|382204|P1|COMPLETED|Overall Study||7
165522|NCT00670800|382203|P2|STARTED|Overall Study||7
165523|NCT00670800|382204|P1|STARTED|Overall Study||7
165524|NCT00670748|382224|P4|NOT COMPLETED|Overall Study||1
165525|NCT00670748|382225|P3|NOT COMPLETED|Overall Study||2
165526|NCT00670748|382226|P2|NOT COMPLETED|Overall Study||2
165527|NCT00670748|382227|P1|NOT COMPLETED|Overall Study||3
165528|NCT00670748|382224|P4|COMPLETED|Overall Study||4
165529|NCT00670748|382225|P3|COMPLETED|Overall Study||5
165530|NCT00670748|382226|P2|COMPLETED|Overall Study||14
165531|NCT00670748|382227|P1|COMPLETED|Overall Study||14
165532|NCT00670748|382224|P4|STARTED|Overall Study||5
165533|NCT00670748|382225|P3|STARTED|Overall Study||7
165534|NCT00670748|382226|P2|STARTED|Overall Study||16
165535|NCT00670748|382227|P1|STARTED|Overall Study||17
165536|NCT00670709|382247|P2|NOT COMPLETED|Overall Study||0
165537|NCT00670709|382248|P1|NOT COMPLETED|Overall Study||0
165538|NCT00670709|382247|P2|COMPLETED|Overall Study||15
165539|NCT00670709|382248|P1|COMPLETED|Overall Study||27
165540|NCT00670709|382247|P2|STARTED|Overall Study||15
165541|NCT00670709|382248|P1|STARTED|Overall Study||27
165542|NCT00670540|382256|P1|NOT COMPLETED|Overall Study||3325
165543|NCT00670540|382256|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
165544|NCT00670540|382256|P1|STARTED|Overall Study||8256
165545|NCT00670462|382268|P2|NOT COMPLETED|Overall Study||31
165546|NCT00670462|382269|P1|NOT COMPLETED|Overall Study||30
165547|NCT00670462|382268|P2|COMPLETED|Overall Study||76
165548|NCT00670462|382269|P1|COMPLETED|Overall Study||76
165549|NCT00670462|382268|P2|STARTED|Overall Study||107
165550|NCT00670462|382269|P1|STARTED|Overall Study||106
165551|NCT00670449|382301|P4|NOT COMPLETED|Overall Study||8
165552|NCT00670449|382302|P3|NOT COMPLETED|Overall Study||9
165553|NCT00670449|382303|P2|NOT COMPLETED|Overall Study||10
165554|NCT00670449|382304|P1|NOT COMPLETED|Overall Study||9
165555|NCT00670449|382301|P4|COMPLETED|Overall Study||15
165556|NCT00670449|382302|P3|COMPLETED|Overall Study||18
165557|NCT00670449|382303|P2|COMPLETED|Overall Study||36
165558|NCT00670449|382304|P1|COMPLETED|Overall Study||38
165559|NCT00670449|382301|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
165560|NCT00670449|382302|P3|Switched to 0.5mg (Open Label)|Overall Study||23
165561|NCT00670449|382303|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
165562|NCT00670449|382304|P1|Switched to 0.5mg (Open Label)|Overall Study||45
165563|NCT00670449|382301|P4|STARTED|Overall Study||23
165564|NCT00670449|382302|P3|STARTED|Overall Study||27
165565|NCT00670449|382303|P2|STARTED|Overall Study||46
165566|NCT00670449|382304|P1|STARTED|Overall Study||47
165567|NCT00670306|382328|P1|NOT COMPLETED|Overall Study||55
165568|NCT00670306|382328|P1|COMPLETED|Overall Study||473
165569|NCT00670306|382328|P1|STARTED|Overall Study||528
165570|NCT00670267|382332|P1|NOT COMPLETED|Overall Study||1
165571|NCT00670267|382332|P1|COMPLETED|Overall Study||9
165572|NCT00670267|382332|P1|STARTED|Overall Study||10
165573|NCT00670241|382343|P3|NOT COMPLETED|Overall Study||27
165574|NCT00670241|382344|P2|NOT COMPLETED|Overall Study||21
165575|NCT00670241|382345|P1|NOT COMPLETED|Overall Study||12
165576|NCT00670241|382343|P3|COMPLETED|Overall Study||64
165577|NCT00670241|382344|P2|COMPLETED|Overall Study||163
165578|NCT00670241|382345|P1|COMPLETED|Overall Study||171
165579|NCT00670241|382343|P3|STARTED|Overall Study||91
165580|NCT00670241|382344|P2|STARTED|Overall Study||184
165581|NCT00670241|382345|P1|STARTED|Overall Study||183
165582|NCT00670228|382367|P2|NOT COMPLETED|Overall Study||3
165583|NCT00670228|382368|P1|NOT COMPLETED|Overall Study||5
165584|NCT00670228|382367|P2|COMPLETED|Overall Study||12
165585|NCT00670228|382368|P1|COMPLETED|Overall Study||13
165586|NCT00670228|382367|P2|STARTED|Overall Study||15
165587|NCT00670228|382368|P1|STARTED|Overall Study||18
165588|NCT00670007|382380|P1|NOT COMPLETED|Overall Study||9
165589|NCT00670007|382380|P1|COMPLETED|Overall Study||131
165590|NCT00670007|382380|P1|STARTED|Overall Study||140
165591|NCT00669955|382407|P2|NOT COMPLETED|Overall Study||27
165592|NCT00669955|382408|P1|NOT COMPLETED|Overall Study||14
165593|NCT00669955|382407|P2|COMPLETED|Overall Study||195
165594|NCT00669955|382408|P1|COMPLETED|Overall Study||204
165595|NCT00669955|382407|P2|STARTED|Overall Study||222
165596|NCT00669955|382408|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
165597|NCT00669942|382438|P12|NOT COMPLETED|Healthy Volunteers||0
165598|NCT00669942|382439|P11|NOT COMPLETED|Healthy Volunteers||1
165599|NCT00669942|382440|P10|NOT COMPLETED|Healthy Volunteers||0
165600|NCT00669942|382441|P9|NOT COMPLETED|Healthy Volunteers||0
165601|NCT00669942|382442|P8|NOT COMPLETED|Healthy Volunteers||0
165602|NCT00669942|382443|P7|NOT COMPLETED|Healthy Volunteers||0
165603|NCT00669942|382444|P6|NOT COMPLETED|Healthy Volunteers||0
165604|NCT00669942|382445|P5|NOT COMPLETED|Healthy Volunteers||0
165605|NCT00669942|382446|P4|NOT COMPLETED|Healthy Volunteers||0
165606|NCT00669942|382447|P3|NOT COMPLETED|Healthy Volunteers||0
165607|NCT00669942|382448|P2|NOT COMPLETED|Healthy Volunteers||0
165608|NCT00669942|382449|P1|NOT COMPLETED|Healthy Volunteers||0
165609|NCT00669942|382438|P12|COMPLETED|Healthy Volunteers||2
165610|NCT00669942|382439|P11|COMPLETED|Healthy Volunteers||2
165611|NCT00669942|382440|P10|COMPLETED|Healthy Volunteers||3
165612|NCT00669942|382441|P9|COMPLETED|Healthy Volunteers||0
165613|NCT00669942|382442|P8|COMPLETED|Healthy Volunteers||0
165614|NCT00669942|382443|P7|COMPLETED|Healthy Volunteers||0
165615|NCT00669942|382444|P6|COMPLETED|Healthy Volunteers||0
165616|NCT00669942|382445|P5|COMPLETED|Healthy Volunteers||0
165617|NCT00669942|382446|P4|COMPLETED|Healthy Volunteers||0
165618|NCT00669942|382447|P3|COMPLETED|Healthy Volunteers||0
165619|NCT00669942|382448|P2|COMPLETED|Healthy Volunteers||0
165620|NCT00669942|382449|P1|COMPLETED|Healthy Volunteers||0
165621|NCT00669942|382438|P12|STARTED|Healthy Volunteers||2
165622|NCT00669942|382439|P11|STARTED|Healthy Volunteers||3
165623|NCT00669942|382440|P10|STARTED|Healthy Volunteers||3
165624|NCT00669942|382441|P9|STARTED|Healthy Volunteers||0
165625|NCT00669942|382442|P8|STARTED|Healthy Volunteers||0
165626|NCT00669942|382443|P7|STARTED|Healthy Volunteers||0
165627|NCT00669942|382444|P6|STARTED|Healthy Volunteers||0
165628|NCT00669942|382445|P5|STARTED|Healthy Volunteers||0
165629|NCT00669942|382446|P4|STARTED|Healthy Volunteers||0
165630|NCT00669942|382447|P3|STARTED|Healthy Volunteers||0
165631|NCT00669942|382448|P2|STARTED|Healthy Volunteers||0
165632|NCT00669942|382449|P1|STARTED|Healthy Volunteers||0
165633|NCT00669942|382438|P12|NOT COMPLETED|Parts 2 and 3||0
165634|NCT00669942|382439|P11|NOT COMPLETED|Parts 2 and 3||0
165635|NCT00669942|382440|P10|NOT COMPLETED|Parts 2 and 3||0
165636|NCT00669942|382441|P9|NOT COMPLETED|Parts 2 and 3||3
165637|NCT00669942|382442|P8|NOT COMPLETED|Parts 2 and 3||2
165638|NCT00669942|382443|P7|NOT COMPLETED|Parts 2 and 3||0
165639|NCT00669942|382444|P6|NOT COMPLETED|Parts 2 and 3||2
165640|NCT00669942|382445|P5|NOT COMPLETED|Parts 2 and 3||0
165641|NCT00669942|382446|P4|NOT COMPLETED|Parts 2 and 3||0
165642|NCT00669942|382447|P3|NOT COMPLETED|Parts 2 and 3||0
165643|NCT00669942|382448|P2|NOT COMPLETED|Parts 2 and 3||0
165644|NCT00669942|382449|P1|NOT COMPLETED|Parts 2 and 3||0
165645|NCT00669942|382438|P12|COMPLETED|Parts 2 and 3||0
165646|NCT00669942|382439|P11|COMPLETED|Parts 2 and 3||0
165647|NCT00669942|382440|P10|COMPLETED|Parts 2 and 3||0
165648|NCT00669942|382441|P9|COMPLETED|Parts 2 and 3||23
165649|NCT00669942|382442|P8|COMPLETED|Parts 2 and 3||24
165650|NCT00669942|382443|P7|COMPLETED|Parts 2 and 3||6
165651|NCT00669942|382444|P6|COMPLETED|Parts 2 and 3||4
165652|NCT00669942|382445|P5|COMPLETED|Parts 2 and 3||0
165653|NCT00669942|382446|P4|COMPLETED|Parts 2 and 3||0
165654|NCT00669942|382447|P3|COMPLETED|Parts 2 and 3||0
165655|NCT00669942|382448|P2|COMPLETED|Parts 2 and 3||0
165656|NCT00669942|382449|P1|COMPLETED|Parts 2 and 3||0
165657|NCT00669942|382438|P12|STARTED|Parts 2 and 3||0
165658|NCT00669942|382439|P11|STARTED|Parts 2 and 3||0
165659|NCT00669942|382440|P10|STARTED|Parts 2 and 3||0
165660|NCT00669942|382441|P9|STARTED|Parts 2 and 3||26
165661|NCT00669942|382442|P8|STARTED|Parts 2 and 3||26
165662|NCT00669942|382443|P7|STARTED|Parts 2 and 3||6
165663|NCT00669942|382444|P6|STARTED|Parts 2 and 3||6
165664|NCT00669942|382445|P5|STARTED|Parts 2 and 3||0
165665|NCT00669942|382446|P4|STARTED|Parts 2 and 3||0
165666|NCT00669942|382447|P3|STARTED|Parts 2 and 3||0
165667|NCT00669942|382448|P2|STARTED|Parts 2 and 3||0
165668|NCT00669942|382449|P1|STARTED|Parts 2 and 3||0
165669|NCT00669942|382438|P12|NOT COMPLETED|Part 1||0
165670|NCT00669942|382439|P11|NOT COMPLETED|Part 1||0
165671|NCT00669942|382440|P10|NOT COMPLETED|Part 1||0
165672|NCT00669942|382441|P9|NOT COMPLETED|Part 1||0
165673|NCT00669942|382442|P8|NOT COMPLETED|Part 1||0
165674|NCT00669942|382443|P7|NOT COMPLETED|Part 1||0
165675|NCT00669942|382444|P6|NOT COMPLETED|Part 1||0
165676|NCT00669942|382445|P5|NOT COMPLETED|Part 1||0
165677|NCT00669942|382446|P4|NOT COMPLETED|Part 1||0
165678|NCT00669942|382447|P3|NOT COMPLETED|Part 1||0
165679|NCT00669942|382448|P2|NOT COMPLETED|Part 1||0
165680|NCT00669942|382449|P1|NOT COMPLETED|Part 1||0
165681|NCT00669942|382438|P12|COMPLETED|Part 1||0
165682|NCT00669942|382439|P11|COMPLETED|Part 1||0
165683|NCT00669942|382440|P10|COMPLETED|Part 1||0
165684|NCT00669942|382441|P9|COMPLETED|Part 1||0
165685|NCT00669942|382442|P8|COMPLETED|Part 1||0
165686|NCT00669942|382443|P7|COMPLETED|Part 1||0
165687|NCT00669942|382444|P6|COMPLETED|Part 1||0
165688|NCT00669942|382445|P5|COMPLETED|Part 1||8
165689|NCT00669942|382446|P4|COMPLETED|Part 1||6
165690|NCT00669942|382447|P3|COMPLETED|Part 1||6
165691|NCT00669942|382448|P2|COMPLETED|Part 1||6
165692|NCT00669942|382449|P1|COMPLETED|Part 1||6
165693|NCT00669942|382438|P12|STARTED|Part 1||0
165694|NCT00669942|382439|P11|STARTED|Part 1||0
165695|NCT00669942|382440|P10|STARTED|Part 1||0
165696|NCT00669942|382441|P9|STARTED|Part 1||0
165697|NCT00669942|382442|P8|STARTED|Part 1||0
165698|NCT00669942|382443|P7|STARTED|Part 1||0
165699|NCT00669942|382444|P6|STARTED|Part 1||0
165700|NCT00669942|382445|P5|STARTED|Part 1||8
165701|NCT00669942|382446|P4|STARTED|Part 1||6
165702|NCT00669942|382447|P3|STARTED|Part 1||6
165703|NCT00669942|382448|P2|STARTED|Part 1||6
165704|NCT00669942|382449|P1|STARTED|Part 1||6
165705|NCT00669916|382513|P2|NOT COMPLETED|Overall Study||0
165706|NCT00669916|382514|P1|NOT COMPLETED|Overall Study||0
165707|NCT00669916|382513|P2|COMPLETED|Overall Study||18
165708|NCT00669916|382514|P1|COMPLETED|Overall Study||18
165709|NCT00669916|382513|P2|STARTED|Overall Study||18
165710|NCT00669916|382514|P1|STARTED|Overall Study||18
165711|NCT00669903|382532|P4|NOT COMPLETED|Overall Study||4
165712|NCT00669903|382533|P3|NOT COMPLETED|Overall Study||5
165713|NCT00669903|382534|P2|NOT COMPLETED|Overall Study||5
165714|NCT00669903|382535|P1|NOT COMPLETED|Overall Study||1
165715|NCT00669903|382532|P4|COMPLETED|Overall Study||18
165716|NCT00669903|382533|P3|COMPLETED|Overall Study||13
165717|NCT00669903|382534|P2|COMPLETED|Overall Study||32
165718|NCT00669903|382535|P1|COMPLETED|Overall Study||22
165719|NCT00669903|382532|P4|Completed Treatment Period|Overall Study||19
165720|NCT00669903|382533|P3|Completed Treatment Period|Overall Study||13
165721|NCT00669903|382534|P2|Completed Treatment Period|Overall Study||33
165722|NCT00669903|382535|P1|Completed Treatment Period|Overall Study||23
165723|NCT00669903|382532|P4|STARTED|Overall Study||22
165724|NCT00669903|382533|P3|STARTED|Overall Study||18
165725|NCT00669903|382534|P2|STARTED|Overall Study||37
165726|NCT00669903|382535|P1|STARTED|Overall Study||23
165727|NCT00669864|382565|P1|NOT COMPLETED|Overall Study||9
165728|NCT00669864|382565|P1|COMPLETED|Overall Study||284
165729|NCT00669864|382565|P1|STARTED|Overall Study||293
165730|NCT00669682|382574|P1|NOT COMPLETED|Overall Study||0
165731|NCT00669682|382574|P1|COMPLETED|Overall Study||9
165732|NCT00669682|382574|P1|STARTED|Overall Study||9
165733|NCT00669617|382579|P5|NOT COMPLETED|Period 5||0
165734|NCT00669617|382580|P4|NOT COMPLETED|Period 5||0
165735|NCT00669617|382581|P3|NOT COMPLETED|Period 5||0
165736|NCT00669617|382582|P2|NOT COMPLETED|Period 5||0
165737|NCT00669617|382583|P1|NOT COMPLETED|Period 5||0
165738|NCT00669617|382579|P5|COMPLETED|Period 5||17
165739|NCT00669617|382580|P4|COMPLETED|Period 5||18
165740|NCT00669617|382581|P3|COMPLETED|Period 5||17
165741|NCT00669617|382582|P2|COMPLETED|Period 5||17
165742|NCT00669617|382583|P1|COMPLETED|Period 5||17
165743|NCT00669617|382579|P5|STARTED|Period 5||17
165744|NCT00669617|382580|P4|STARTED|Period 5||18
165745|NCT00669617|382581|P3|STARTED|Period 5||17
165746|NCT00669617|382582|P2|STARTED|Period 5||17
165747|NCT00669617|382583|P1|STARTED|Period 5||17
165748|NCT00669617|382579|P5|NOT COMPLETED|Period 4||0
165749|NCT00669617|382580|P4|NOT COMPLETED|Period 4||0
165750|NCT00669617|382581|P3|NOT COMPLETED|Period 4||0
165751|NCT00669617|382582|P2|NOT COMPLETED|Period 4||0
165752|NCT00669617|382583|P1|NOT COMPLETED|Period 4||0
165753|NCT00669617|382579|P5|COMPLETED|Period 4||17
165754|NCT00669617|382580|P4|COMPLETED|Period 4||18
165755|NCT00669617|382581|P3|COMPLETED|Period 4||17
165756|NCT00669617|382582|P2|COMPLETED|Period 4||17
165757|NCT00669617|382583|P1|COMPLETED|Period 4||17
165758|NCT00669617|382579|P5|STARTED|Period 4||17
165759|NCT00669617|382580|P4|STARTED|Period 4||18
165760|NCT00669617|382581|P3|STARTED|Period 4||17
165761|NCT00669617|382582|P2|STARTED|Period 4||17
165762|NCT00669617|382583|P1|STARTED|Period 4||17
165763|NCT00669617|382579|P5|NOT COMPLETED|Period 3||0
165764|NCT00669617|382580|P4|NOT COMPLETED|Period 3||0
165765|NCT00669617|382581|P3|NOT COMPLETED|Period 3||0
165766|NCT00669617|382582|P2|NOT COMPLETED|Period 3||0
165767|NCT00669617|382583|P1|NOT COMPLETED|Period 3||1
165768|NCT00669617|382579|P5|COMPLETED|Period 3||17
165769|NCT00669617|382580|P4|COMPLETED|Period 3||18
165770|NCT00669617|382581|P3|COMPLETED|Period 3||17
165771|NCT00669617|382582|P2|COMPLETED|Period 3||17
165772|NCT00669617|382583|P1|COMPLETED|Period 3||17
165773|NCT00669617|382579|P5|STARTED|Period 3||17
165774|NCT00669617|382580|P4|STARTED|Period 3||18
165775|NCT00669617|382581|P3|STARTED|Period 3||17
165776|NCT00669617|382582|P2|STARTED|Period 3||17
165777|NCT00669617|382583|P1|STARTED|Period 3||18
165778|NCT00669617|382579|P5|NOT COMPLETED|Period 2||0
165779|NCT00669617|382580|P4|NOT COMPLETED|Period 2||0
165780|NCT00669617|382581|P3|NOT COMPLETED|Period 2||0
165781|NCT00669617|382582|P2|NOT COMPLETED|Period 2||0
165782|NCT00669617|382583|P1|NOT COMPLETED|Period 2||0
165783|NCT00669617|382579|P5|COMPLETED|Period 2||17
165784|NCT00669617|382580|P4|COMPLETED|Period 2||18
165785|NCT00669617|382581|P3|COMPLETED|Period 2||17
165786|NCT00669617|382582|P2|COMPLETED|Period 2||17
165787|NCT00669617|382583|P1|COMPLETED|Period 2||18
165788|NCT00669617|382579|P5|STARTED|Period 2||17
165789|NCT00669617|382580|P4|STARTED|Period 2||18
165790|NCT00669617|382581|P3|STARTED|Period 2||17
165791|NCT00669617|382582|P2|STARTED|Period 2||17
165792|NCT00669617|382583|P1|STARTED|Period 2||18
165793|NCT00669617|382579|P5|NOT COMPLETED|Period 1||1
165794|NCT00669617|382580|P4|NOT COMPLETED|Period 1||0
165795|NCT00669617|382581|P3|NOT COMPLETED|Period 1||1
165796|NCT00669617|382582|P2|NOT COMPLETED|Period 1||0
165797|NCT00669617|382583|P1|NOT COMPLETED|Period 1||0
165798|NCT00669617|382579|P5|COMPLETED|Period 1||17
165799|NCT00669617|382580|P4|COMPLETED|Period 1||18
165800|NCT00669617|382581|P3|COMPLETED|Period 1||17
165801|NCT00669617|382582|P2|COMPLETED|Period 1||17
165802|NCT00669617|382583|P1|COMPLETED|Period 1||18
165803|NCT00669617|382579|P5|STARTED|Period 1||18
165804|NCT00669617|382580|P4|STARTED|Period 1||18
165805|NCT00669617|382581|P3|STARTED|Period 1||18
165806|NCT00669617|382582|P2|STARTED|Period 1||17
165807|NCT00669617|382583|P1|STARTED|Period 1||18
165808|NCT00669578|382597|P2|NOT COMPLETED|Overall Study||0
165809|NCT00669578|382598|P1|NOT COMPLETED|Overall Study||0
165810|NCT00669578|382597|P2|COMPLETED|Overall Study||65
165811|NCT00669578|382598|P1|COMPLETED|Overall Study||12
165812|NCT00669578|382597|P2|STARTED|Overall Study||65
165813|NCT00669578|382598|P1|STARTED|Overall Study||12
165814|NCT00669552|382611|P1|NOT COMPLETED|Overall Study||0
165815|NCT00669552|382611|P1|COMPLETED|Overall Study||11
165816|NCT00669552|382611|P1|STARTED|Overall Study||11
165817|NCT00669539|382617|P2|NOT COMPLETED|Overall Study||9
165818|NCT00669539|382618|P1|NOT COMPLETED|Overall Study||8
165819|NCT00669539|382617|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
165820|NCT00669539|382618|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
165821|NCT00669539|382617|P2|STARTED|Overall Study||52
165822|NCT00669539|382618|P1|STARTED|Overall Study||94
165823|NCT00669461|382624|P1|NOT COMPLETED|Overall Study||0
165824|NCT00669461|382624|P1|COMPLETED|Overall Study||1
165825|NCT00669461|382624|P1|STARTED|Overall Study||1
165826|NCT00669396|382631|P2|NOT COMPLETED|Overall Study||12
165827|NCT00669396|382632|P1|NOT COMPLETED|Overall Study||10
165828|NCT00669396|382631|P2|COMPLETED|Overall Study||22
165829|NCT00669396|382632|P1|COMPLETED|Overall Study||13
165830|NCT00669396|382631|P2|STARTED|Overall Study||34
165831|NCT00669396|382632|P1|STARTED|Overall Study||23
165832|NCT00669331|382646|P2|NOT COMPLETED|Blinded Treatment Period||39
165833|NCT00669331|382647|P1|NOT COMPLETED|Blinded Treatment Period||42
165834|NCT00669331|382646|P2|COMPLETED|Blinded Treatment Period||189
165835|NCT00669331|382647|P1|COMPLETED|Blinded Treatment Period||191
165836|NCT00669331|382646|P2|STARTED|Blinded Treatment Period||228
165837|NCT00669331|382647|P1|STARTED|Blinded Treatment Period||233
165838|NCT00669331|382646|P2|NOT COMPLETED|Randomisation to First Dose||13
165839|NCT00669331|382647|P1|NOT COMPLETED|Randomisation to First Dose||11
165840|NCT00669331|382646|P2|COMPLETED|Randomisation to First Dose||228
165841|NCT00669331|382647|P1|COMPLETED|Randomisation to First Dose||233
165842|NCT00669331|382646|P2|STARTED|Randomisation to First Dose||241
165843|NCT00669331|382647|P1|STARTED|Randomisation to First Dose||244
165844|NCT00669318|382689|P1|NOT COMPLETED|Overall Study||2
165845|NCT00669318|382689|P1|COMPLETED|Overall Study||39
165846|NCT00669318|382689|P1|STARTED|Overall Study||41
165847|NCT00669279|382699|P2|NOT COMPLETED|Overall Study||0
165848|NCT00669279|382700|P1|NOT COMPLETED|Overall Study||0
165849|NCT00669279|382699|P2|COMPLETED|Overall Study||19
165850|NCT00669279|382700|P1|COMPLETED|Overall Study||22
165851|NCT00669279|382699|P2|STARTED|Overall Study||19
165852|NCT00669279|382700|P1|STARTED|Overall Study||22
165853|NCT00669240|382706|P1|NOT COMPLETED|Overall Study||165
165854|NCT00669240|382706|P1|COMPLETED|Overall Study||402
165855|NCT00669240|382706|P1|Received Treatment|Overall Study||551
165856|NCT00669240|382706|P1|Assigned to Treatment|Overall Study||566
165857|NCT00669240|382706|P1|STARTED|Overall Study||567
165858|NCT00669214|382722|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
165859|NCT00669214|382723|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
165860|NCT00669214|382722|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
165861|NCT00669214|382723|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
165862|NCT00669214|382722|P2|STARTED|Open-Label Treatment Period (Week 24)||55
165863|NCT00669214|382723|P1|STARTED|Open-Label Treatment Period (Week 24)||22
165864|NCT00669214|382722|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
165865|NCT00669214|382723|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
165866|NCT00669214|382722|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
165867|NCT00669214|382723|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
165868|NCT00669214|382722|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
165869|NCT00669214|382723|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
165870|NCT00669110|382757|P2|NOT COMPLETED|Overall Study||13
165871|NCT00669110|382758|P1|NOT COMPLETED|Overall Study||8
165872|NCT00669110|382757|P2|COMPLETED|Overall Study||7
165873|NCT00669110|382758|P1|COMPLETED|Overall Study||12
165874|NCT00669110|382757|P2|STARTED|Overall Study||20
165875|NCT00669110|382758|P1|STARTED|Overall Study||20
165876|NCT00669071|382794|P1|NOT COMPLETED|Overall Study||4
165877|NCT00669071|382794|P1|COMPLETED|Overall Study||52
165878|NCT00669071|382794|P1|STARTED|Overall Study||56
165879|NCT00669032|382815|P2|NOT COMPLETED|Overall Study||59
165880|NCT00669032|382816|P1|NOT COMPLETED|Overall Study||44
165881|NCT00669032|382815|P2|COMPLETED|Overall Study||94
165882|NCT00669032|382816|P1|COMPLETED|Overall Study||109
165883|NCT00669032|382815|P2|STARTED|Overall Study||153
165884|NCT00669032|382816|P1|STARTED|Overall Study||153
165885|NCT00669019|382844|P1|NOT COMPLETED|Overall Study||0
165886|NCT00669019|382844|P1|COMPLETED|Overall Study||23
165887|NCT00669019|382844|P1|STARTED|Overall Study||23
165888|NCT00668902|382852|P3|NOT COMPLETED|Overall Study||0
165889|NCT00668902|382853|P2|NOT COMPLETED|Overall Study||0
165890|NCT00668902|382854|P1|NOT COMPLETED|Overall Study||0
165891|NCT00668902|382852|P3|COMPLETED|Overall Study||5
165892|NCT00668902|382853|P2|COMPLETED|Overall Study||10
165893|NCT00668902|382854|P1|COMPLETED|Overall Study||10
165894|NCT00668902|382852|P3|STARTED|Overall Study||5
165895|NCT00668902|382853|P2|STARTED|Overall Study||10
165896|NCT00668902|382854|P1|STARTED|Overall Study||10
165897|NCT00668863|382862|P1|NOT COMPLETED|Overall Study||71
165898|NCT00668863|382862|P1|COMPLETED|Overall Study||0
165899|NCT00668863|382862|P1|STARTED|Overall Study||71
165900|NCT00668785|382881|P1|NOT COMPLETED|Overall Study||0
165901|NCT00668785|382881|P1|COMPLETED|Overall Study||6
165902|NCT00668785|382881|P1|STARTED|Overall Study||6
165903|NCT00668746|382887|P2|NOT COMPLETED|Overall Study||1
165904|NCT00668746|382888|P1|NOT COMPLETED|Overall Study||2
165905|NCT00668746|382887|P2|COMPLETED|Overall Study||11
165906|NCT00668746|382888|P1|COMPLETED|Overall Study||21
165907|NCT00668746|382887|P2|STARTED|Overall Study||12
165908|NCT00668746|382888|P1|STARTED|Overall Study||23
165909|NCT00668733|382908|P2|NOT COMPLETED|Overall Study||7
165910|NCT00668733|382909|P1|NOT COMPLETED|Overall Study||2
165911|NCT00668733|382908|P2|COMPLETED|Overall Study||83
165912|NCT00668733|382909|P1|COMPLETED|Overall Study||87
165913|NCT00668733|382908|P2|STARTED|Overall Study||90
165914|NCT00668733|382909|P1|STARTED|Overall Study||89
165915|NCT00668564|382915|P1|NOT COMPLETED|Overall Study||0
165916|NCT00668564|382915|P1|COMPLETED|Overall Study||18
165917|NCT00668564|382915|P1|STARTED|Overall Study||18
165918|NCT00668525|382923|P3|NOT COMPLETED|Overall Study||53
165919|NCT00668525|382924|P2|NOT COMPLETED|Overall Study||93
165920|NCT00668525|382925|P1|NOT COMPLETED|Overall Study||77
165921|NCT00668525|382923|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
165922|NCT00668525|382924|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
165923|NCT00668525|382925|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
165924|NCT00668525|382923|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
165925|NCT00668525|382924|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
165926|NCT00668525|382925|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
165927|NCT00668434|382938|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
165928|NCT00668434|382939|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
165929|NCT00668434|382938|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
165930|NCT00668434|382939|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
165931|NCT00668434|382938|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
165932|NCT00668434|382939|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
165933|NCT00668434|382938|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
165934|NCT00668434|382939|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
165935|NCT00668434|382938|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
165936|NCT00668434|382939|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
165937|NCT00668434|382938|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
165938|NCT00668434|382939|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
165939|NCT00668395|382954|P3|NOT COMPLETED|Overall Study||1
165940|NCT00668395|382955|P2|NOT COMPLETED|Overall Study||6
165941|NCT00668395|382956|P1|NOT COMPLETED|Overall Study||6
165942|NCT00668395|382954|P3|COMPLETED|Overall Study||5
165943|NCT00668395|382955|P2|COMPLETED|Overall Study||16
165944|NCT00668395|382956|P1|COMPLETED|Overall Study||39
165945|NCT00668395|382954|P3|STARTED|Overall Study||6
165946|NCT00668395|382955|P2|STARTED|Overall Study||22
165947|NCT00668395|382956|P1|STARTED|Overall Study||45
165948|NCT00668382|382964|P1|NOT COMPLETED|Overall Study||0
165949|NCT00668382|382964|P1|COMPLETED|Overall Study||11
165950|NCT00668382|382964|P1|STARTED|Overall Study|beginning of trial|11
165951|NCT00668317|382968|P1|NOT COMPLETED|Overall Study||2
165952|NCT00668317|382968|P1|COMPLETED|Overall Study||3
165953|NCT00668317|382968|P1|STARTED|Overall Study||5
165954|NCT00668265|382974|P2|NOT COMPLETED|Overall Study||5
165955|NCT00668265|382975|P1|NOT COMPLETED|Overall Study||9
165956|NCT00668265|382974|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
165957|NCT00668265|382975|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
165958|NCT00668265|382974|P2|STARTED|Overall Study||5
165959|NCT00668265|382975|P1|STARTED|Overall Study||9
165960|NCT00668200|382983|P1|NOT COMPLETED|Overall Study||3
165961|NCT00668200|382983|P1|COMPLETED|Overall Study||77
165962|NCT00668200|382983|P1|Intent to Treat (ITT)|Overall Study||80
165963|NCT00668200|382983|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
165964|NCT00668200|382983|P1|STARTED|Overall Study||80
165965|NCT00667992|382991|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
165966|NCT00667992|382992|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
166051|NCT00667732|383150|P2|STARTED|Randomization (24 Weeks)||17
165967|NCT00667992|382991|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
165968|NCT00667992|382992|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
165969|NCT00667992|382991|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
165970|NCT00667992|382992|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
165971|NCT00667992|382991|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
165972|NCT00667992|382992|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
165973|NCT00667992|382991|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
165974|NCT00667992|382992|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
165975|NCT00667992|382991|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
165976|NCT00667992|382992|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
165977|NCT00667992|382991|P2|NOT COMPLETED|Wash-out||5
165978|NCT00667992|382992|P1|NOT COMPLETED|Wash-out||7
165979|NCT00667992|382991|P2|COMPLETED|Wash-out||36
165980|NCT00667992|382992|P1|COMPLETED|Wash-out||34
165981|NCT00667992|382991|P2|STARTED|Wash-out||41
165982|NCT00667992|382992|P1|STARTED|Wash-out||41
165983|NCT00667992|382991|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
165984|NCT00667992|382992|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
165985|NCT00667992|382991|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
165986|NCT00667992|382992|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
165987|NCT00667992|382991|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
165988|NCT00667992|382992|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
165989|NCT00667992|382991|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
165990|NCT00667992|382992|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
165991|NCT00667992|382991|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
165992|NCT00667992|382992|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
165993|NCT00667992|382991|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
165994|NCT00667992|382992|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
165995|NCT00667875|383049|P3|NOT COMPLETED|Overall Study||13
165996|NCT00667875|383050|P2|NOT COMPLETED|Overall Study||11
165997|NCT00667875|383051|P1|NOT COMPLETED|Overall Study||10
165998|NCT00667875|383049|P3|COMPLETED|Overall Study||8
165999|NCT00667875|383050|P2|COMPLETED|Overall Study||10
166000|NCT00667875|383051|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
166001|NCT00667875|383049|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
166002|NCT00667875|383050|P2|STARTED|Overall Study||21
166003|NCT00667875|383051|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
166004|NCT00667849|383061|P2|NOT COMPLETED|Overall Study||121
166005|NCT00667849|383062|P1|NOT COMPLETED|Overall Study||108
166006|NCT00667849|383061|P2|COMPLETED|Overall Study||130
166007|NCT00667849|383062|P1|COMPLETED|Overall Study||142
166008|NCT00667849|383061|P2|STARTED|Overall Study||251
166009|NCT00667849|383062|P1|STARTED|Overall Study||250
166010|NCT00667810|383076|P4|NOT COMPLETED|Overall Study||2
166011|NCT00667810|383077|P3|NOT COMPLETED|Overall Study||222
166012|NCT00667810|383078|P2|NOT COMPLETED|Overall Study||170
166013|NCT00667810|383079|P1|NOT COMPLETED|Overall Study||167
166014|NCT00667810|383076|P4|COMPLETED|Overall Study||9
166015|NCT00667810|383077|P3|COMPLETED|Overall Study||124
166016|NCT00667810|383078|P2|COMPLETED|Overall Study||94
166017|NCT00667810|383079|P1|COMPLETED|Overall Study||102
166018|NCT00667810|383076|P4|Treated|Overall Study||11
166019|NCT00667810|383077|P3|Treated|Overall Study||344
166020|NCT00667810|383078|P2|Treated|Overall Study||263
166021|NCT00667810|383079|P1|Treated|Overall Study||267
166022|NCT00667810|383076|P4|STARTED|Overall Study||11
166023|NCT00667810|383077|P3|STARTED|Overall Study||346
166024|NCT00667810|383078|P2|STARTED|Overall Study||264
166025|NCT00667810|383079|P1|STARTED|Overall Study||269
166026|NCT00667745|383138|P2|NOT COMPLETED|Overall Study||21
166027|NCT00667745|383139|P1|NOT COMPLETED|Overall Study||25
166028|NCT00667745|383138|P2|COMPLETED|Overall Study||121
166029|NCT00667745|383139|P1|COMPLETED|Overall Study||116
166030|NCT00667745|383138|P2|STARTED|Overall Study||142
166031|NCT00667745|383139|P1|STARTED|Overall Study||141
166032|NCT00667732|383149|P3|NOT COMPLETED|Extension (26 Weeks)||0
166033|NCT00667732|383150|P2|NOT COMPLETED|Extension (26 Weeks)||0
166034|NCT00667732|383151|P1|NOT COMPLETED|Extension (26 Weeks)||0
166035|NCT00667732|383149|P3|COMPLETED|Extension (26 Weeks)||17
166036|NCT00667732|383150|P2|COMPLETED|Extension (26 Weeks)||14
166037|NCT00667732|383151|P1|COMPLETED|Extension (26 Weeks)||0
166038|NCT00667732|383149|P3|STARTED|Extension (26 Weeks)||17
166039|NCT00667732|383150|P2|STARTED|Extension (26 Weeks)||14
166040|NCT00667732|383151|P1|STARTED|Extension (26 Weeks)||0
166041|NCT00667732|383149|P3|NOT COMPLETED|Randomization (24 Weeks)||0
166042|NCT00667732|383150|P2|NOT COMPLETED|Randomization (24 Weeks)||1
166043|NCT00667732|383151|P1|NOT COMPLETED|Randomization (24 Weeks)||0
166044|NCT00667732|383149|P3|COMPLETED|Randomization (24 Weeks)||17
166045|NCT00667732|383150|P2|COMPLETED|Randomization (24 Weeks)||16
166046|NCT00667732|383151|P1|COMPLETED|Randomization (24 Weeks)||0
166047|NCT00667732|383149|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
166048|NCT00667732|383150|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
166049|NCT00667732|383151|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
166050|NCT00667732|383149|P3|STARTED|Randomization (24 Weeks)||17
166052|NCT00667732|383151|P1|STARTED|Randomization (24 Weeks)||0
166053|NCT00667732|383149|P3|NOT COMPLETED|Run -In (8 Weeks)||0
166054|NCT00667732|383150|P2|NOT COMPLETED|Run -In (8 Weeks)||0
166055|NCT00667732|383151|P1|NOT COMPLETED|Run -In (8 Weeks)||7
166056|NCT00667732|383149|P3|COMPLETED|Run -In (8 Weeks)||0
166057|NCT00667732|383150|P2|COMPLETED|Run -In (8 Weeks)||0
166058|NCT00667732|383151|P1|COMPLETED|Run -In (8 Weeks)||34
166059|NCT00667732|383149|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
166060|NCT00667732|383150|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
166061|NCT00667732|383151|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
166062|NCT00667732|383149|P3|STARTED|Run -In (8 Weeks)||0
166063|NCT00667732|383150|P2|STARTED|Run -In (8 Weeks)||0
166064|NCT00667732|383151|P1|STARTED|Run -In (8 Weeks)||41
166065|NCT00667693|383164|P2|NOT COMPLETED|Overall Study||2
166066|NCT00667693|383165|P1|NOT COMPLETED|Overall Study||0
166067|NCT00667693|383164|P2|COMPLETED|Overall Study||50
166068|NCT00667693|383165|P1|COMPLETED|Overall Study||49
166069|NCT00667693|383164|P2|STARTED|Overall Study||52
166070|NCT00667693|383165|P1|STARTED|Overall Study||49
166071|NCT00667602|383174|P3|NOT COMPLETED|Overall Study||18
166072|NCT00667602|383175|P2|NOT COMPLETED|Overall Study||15
166073|NCT00667602|383176|P1|NOT COMPLETED|Overall Study||8
166074|NCT00667602|383174|P3|COMPLETED|Overall Study||197
166075|NCT00667602|383175|P2|COMPLETED|Overall Study||213
166076|NCT00667602|383176|P1|COMPLETED|Overall Study||211
166077|NCT00667602|383174|P3|STARTED|Overall Study||215
166078|NCT00667602|383175|P2|STARTED|Overall Study||228
166079|NCT00667602|383176|P1|STARTED|Overall Study||219
166080|NCT00667589|383226|P4|NOT COMPLETED|Overall Study||1
166081|NCT00667589|383227|P3|NOT COMPLETED|Overall Study||3
166082|NCT00667589|383228|P2|NOT COMPLETED|Overall Study||0
166083|NCT00667589|383229|P1|NOT COMPLETED|Overall Study||1
166084|NCT00667589|383226|P4|COMPLETED|Overall Study||1
166085|NCT00667589|383227|P3|COMPLETED|Overall Study||0
166086|NCT00667589|383228|P2|COMPLETED|Overall Study||0
166087|NCT00667589|383229|P1|COMPLETED|Overall Study||0
166088|NCT00667589|383226|P4|STARTED|Overall Study||2
166089|NCT00667589|383227|P3|STARTED|Overall Study||3
166090|NCT00667589|383228|P2|STARTED|Overall Study||0
166091|NCT00667589|383229|P1|STARTED|Overall Study||1
166092|NCT00667576|383244|P5|NOT COMPLETED|Overall Study||1
166093|NCT00667576|383245|P4|NOT COMPLETED|Overall Study||4
166094|NCT00667576|383246|P3|NOT COMPLETED|Overall Study||2
166095|NCT00667576|383247|P2|NOT COMPLETED|Overall Study||1
166096|NCT00667576|383248|P1|NOT COMPLETED|Overall Study||2
166097|NCT00667576|383244|P5|COMPLETED|Overall Study||29
166098|NCT00667576|383245|P4|COMPLETED|Overall Study||27
166099|NCT00667576|383246|P3|COMPLETED|Overall Study||29
166100|NCT00667576|383247|P2|COMPLETED|Overall Study||30
166101|NCT00667576|383248|P1|COMPLETED|Overall Study||28
166102|NCT00667576|383244|P5|STARTED|Overall Study||30
166103|NCT00667576|383245|P4|STARTED|Overall Study||31
166104|NCT00667576|383246|P3|STARTED|Overall Study||31
166105|NCT00667576|383247|P2|STARTED|Overall Study||31
166106|NCT00667576|383248|P1|STARTED|Overall Study||30
166107|NCT00667563|383295|P1|NOT COMPLETED|Overall Study||24
166108|NCT00667563|383295|P1|COMPLETED|Overall Study||126
166109|NCT00667563|383295|P1|STARTED|Overall Study||150
166110|NCT00667511|383305|P1|NOT COMPLETED|Intervention 2: Home NHD||4
166111|NCT00667511|383305|P1|COMPLETED|Intervention 2: Home NHD||39
166112|NCT00667511|383305|P1|STARTED|Intervention 2: Home NHD||43
166113|NCT00667511|383305|P1|NOT COMPLETED|Training/Transition Period||8
166114|NCT00667511|383305|P1|COMPLETED|Training/Transition Period||43
166115|NCT00667511|383305|P1|STARTED|Training/Transition Period||51
166116|NCT00667511|383305|P1|NOT COMPLETED|Intervention 1: Home DHD||7
166117|NCT00667511|383305|P1|COMPLETED|Intervention 1: Home DHD||51
166118|NCT00667511|383305|P1|STARTED|Intervention 1: Home DHD||58
166119|NCT00667459|383315|P2|NOT COMPLETED|Overall Study||45
166120|NCT00667459|383316|P1|NOT COMPLETED|Overall Study||8
166121|NCT00667459|383315|P2|COMPLETED|Overall Study||220
166122|NCT00667459|383316|P1|COMPLETED|Overall Study||272
166123|NCT00667459|383315|P2|STARTED|Overall Study||265
166124|NCT00667459|383316|P1|STARTED|Overall Study||280
166125|NCT00667446|383358|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
166126|NCT00667446|383359|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
166127|NCT00667446|383358|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
166128|NCT00667446|383359|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
166129|NCT00667446|383358|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
166130|NCT00667446|383359|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
166131|NCT00667446|383358|P2|NOT COMPLETED|Treatment Period (36 Months)||25
166132|NCT00667446|383359|P1|NOT COMPLETED|Treatment Period (36 Months)||23
166133|NCT00667446|383358|P2|COMPLETED|Treatment Period (36 Months)||13
166134|NCT00667446|383359|P1|COMPLETED|Treatment Period (36 Months)||11
166135|NCT00667446|383358|P2|STARTED|Treatment Period (36 Months)||38
166136|NCT00667446|383359|P1|STARTED|Treatment Period (36 Months)||34
166137|NCT00667420|383381|P1|NOT COMPLETED|Overall Study||10
166138|NCT00667420|383381|P1|COMPLETED|Overall Study||7
166139|NCT00667420|383381|P1|Completion of Surgery/Re-staging|Overall Study||11
166140|NCT00667420|383381|P1|Completion of Pre-operative EOX-P|Overall Study||15
166141|NCT00667420|383381|P1|STARTED|Overall Study||17
166142|NCT00667394|383391|P2|NOT COMPLETED|Overall Study||0
166143|NCT00667394|383392|P1|NOT COMPLETED|Overall Study||4
166144|NCT00667394|383391|P2|COMPLETED|Overall Study||1
166145|NCT00667394|383392|P1|COMPLETED|Overall Study||37
166146|NCT00667394|383391|P2|STARTED|Overall Study||1
166147|NCT00667394|383392|P1|STARTED|Overall Study||41
166148|NCT00667381|383402|P2|NOT COMPLETED|Overall Study||0
166149|NCT00667381|383403|P1|NOT COMPLETED|Overall Study||0
166150|NCT00667381|383402|P2|COMPLETED|Overall Study||503
166151|NCT00667381|383403|P1|COMPLETED|Overall Study||501
166152|NCT00667381|383402|P2|STARTED|Overall Study||503
166153|NCT00667381|383403|P1|STARTED|Overall Study||501
166154|NCT00667368|383419|P2|NOT COMPLETED|Overall Study||172
166155|NCT00667368|383420|P1|NOT COMPLETED|Overall Study||200
166156|NCT00667368|383419|P2|COMPLETED|Overall Study||511
166157|NCT00667368|383420|P1|COMPLETED|Overall Study||482
166158|NCT00667368|383419|P2|STARTED|Overall Study||683
166159|NCT00667368|383420|P1|STARTED|Overall Study||682
166160|NCT00667355|383428|P1|NOT COMPLETED|Overall Study||11
166161|NCT00667355|383428|P1|COMPLETED|Overall Study||30
166162|NCT00667355|383428|P1|STARTED|Overall Study||41
166163|NCT00667342|383453|P3|NOT COMPLETED|Overall Study||9
166164|NCT00667342|383454|P2|NOT COMPLETED|Overall Study||0
166165|NCT00667342|383455|P1|NOT COMPLETED|Overall Study||14
166166|NCT00667342|383453|P3|COMPLETED|Overall Study||3
166167|NCT00667342|383454|P2|COMPLETED|Overall Study||0
166168|NCT00667342|383455|P1|COMPLETED|Overall Study||17
166169|NCT00667342|383453|P3|STARTED|Overall Study||12
166170|NCT00667342|383454|P2|STARTED|Overall Study||0
166171|NCT00667342|383455|P1|STARTED|Overall Study||31
166172|NCT00667277|383482|P1|NOT COMPLETED|Overall Study||2
166173|NCT00667277|383482|P1|COMPLETED|Overall Study||11
166174|NCT00667277|383482|P1|STARTED|Overall Study||13
166175|NCT00667251|383489|P2|NOT COMPLETED|Overall Study||95
166176|NCT00667251|383490|P1|NOT COMPLETED|Overall Study||70
166177|NCT00667251|383489|P2|COMPLETED|Overall Study||231
166178|NCT00667251|383490|P1|COMPLETED|Overall Study||256
166179|NCT00667251|383489|P2|Not Started|Overall Study||1
166180|NCT00667251|383490|P1|Not Started|Overall Study||4
166181|NCT00667251|383489|P2|Monotherapy|Overall Study||232
166182|NCT00667251|383490|P1|Monotherapy|Overall Study||225
166183|NCT00667251|383489|P2|Combination Rx|Overall Study||325
166184|NCT00667251|383490|P1|Combination Rx|Overall Study||322
166185|NCT00667251|383489|P2|STARTED|Overall Study||326
166186|NCT00667251|383490|P1|STARTED|Overall Study||326
166187|NCT00667225|383516|P2|NOT COMPLETED|Overall Study||1
166188|NCT00667225|383517|P1|NOT COMPLETED|Overall Study||1
166189|NCT00667225|383516|P2|COMPLETED|Overall Study||12
166190|NCT00667225|383517|P1|COMPLETED|Overall Study||15
166191|NCT00667225|383516|P2|STARTED|Overall Study||13
166192|NCT00667225|383517|P1|STARTED|Overall Study||16
166193|NCT00667186|383527|P2|NOT COMPLETED|Overall Study||0
166194|NCT00667186|383528|P1|NOT COMPLETED|Overall Study||0
166195|NCT00667186|383527|P2|COMPLETED|Overall Study||4880
166196|NCT00667186|383528|P1|COMPLETED|Overall Study||4692
166197|NCT00667186|383527|P2|STARTED|Overall Study||4880
166198|NCT00667186|383528|P1|STARTED|Overall Study||4692
166199|NCT00667095|383538|P2|NOT COMPLETED|Overall Study||1
166200|NCT00667095|383539|P1|NOT COMPLETED|Overall Study||0
166201|NCT00667095|383538|P2|COMPLETED|Overall Study||9
166202|NCT00667095|383539|P1|COMPLETED|Overall Study||11
166203|NCT00667095|383538|P2|STARTED|Overall Study||10
166204|NCT00667095|383539|P1|STARTED|Overall Study||11
166205|NCT00666965|383559|P4|NOT COMPLETED|Overall Study||15
166206|NCT00666965|383560|P3|NOT COMPLETED|Overall Study||2
166207|NCT00666965|383561|P2|NOT COMPLETED|Overall Study||4
166208|NCT00666965|383562|P1|NOT COMPLETED|Overall Study||3
166209|NCT00666965|383559|P4|COMPLETED|Overall Study||42
166210|NCT00666965|383560|P3|COMPLETED|Overall Study||56
166211|NCT00666965|383561|P2|COMPLETED|Overall Study||53
166212|NCT00666965|383562|P1|COMPLETED|Overall Study||55
166213|NCT00666965|383559|P4|STARTED|Overall Study||57
166214|NCT00666965|383560|P3|STARTED|Overall Study||58
166215|NCT00666965|383561|P2|STARTED|Overall Study||57
166216|NCT00666965|383562|P1|STARTED|Overall Study||58
166217|NCT00666926|383592|P16|NOT COMPLETED|Overall Study||8
166218|NCT00666926|383593|P15|NOT COMPLETED|Overall Study||7
166219|NCT00666926|383594|P14|NOT COMPLETED|Overall Study||4
166220|NCT00666926|383595|P13|NOT COMPLETED|Overall Study||3
166221|NCT00666926|383596|P12|NOT COMPLETED|Overall Study||33
166222|NCT00666926|383597|P11|NOT COMPLETED|Overall Study||6
166223|NCT00666926|383598|P10|NOT COMPLETED|Overall Study||10
166224|NCT00666926|383599|P9|NOT COMPLETED|Overall Study||3
166225|NCT00666926|383600|P8|NOT COMPLETED|Overall Study||1
166226|NCT00666926|383601|P7|NOT COMPLETED|Overall Study||4
166227|NCT00666926|383602|P6|NOT COMPLETED|Overall Study||4
166228|NCT00666926|383603|P5|NOT COMPLETED|Overall Study||3
166229|NCT00666926|383604|P4|NOT COMPLETED|Overall Study||4
166230|NCT00666926|383605|P3|NOT COMPLETED|Overall Study||3
166231|NCT00666926|383606|P2|NOT COMPLETED|Overall Study||4
166232|NCT00666926|383607|P1|NOT COMPLETED|Overall Study||2
166233|NCT00666926|383592|P16|COMPLETED|Overall Study||0
166234|NCT00666926|383593|P15|COMPLETED|Overall Study||0
166235|NCT00666926|383594|P14|COMPLETED|Overall Study||0
166236|NCT00666926|383595|P13|COMPLETED|Overall Study||0
166237|NCT00666926|383596|P12|COMPLETED|Overall Study||0
166238|NCT00666926|383597|P11|COMPLETED|Overall Study||0
166239|NCT00666926|383598|P10|COMPLETED|Overall Study||0
166240|NCT00666926|383599|P9|COMPLETED|Overall Study||0
166241|NCT00666926|383600|P8|COMPLETED|Overall Study||0
166242|NCT00666926|383601|P7|COMPLETED|Overall Study||0
166243|NCT00666926|383602|P6|COMPLETED|Overall Study||0
166244|NCT00666926|383603|P5|COMPLETED|Overall Study||0
166245|NCT00666926|383604|P4|COMPLETED|Overall Study||0
166246|NCT00666926|383605|P3|COMPLETED|Overall Study||0
166247|NCT00666926|383606|P2|COMPLETED|Overall Study||0
166248|NCT00666926|383607|P1|COMPLETED|Overall Study||0
166249|NCT00666926|383592|P16|STARTED|Overall Study||8
166250|NCT00666926|383593|P15|STARTED|Overall Study||7
166251|NCT00666926|383594|P14|STARTED|Overall Study||4
166252|NCT00666926|383595|P13|STARTED|Overall Study||3
166253|NCT00666926|383596|P12|STARTED|Overall Study||33
166254|NCT00666926|383597|P11|STARTED|Overall Study||6
166255|NCT00666926|383598|P10|STARTED|Overall Study||10
166256|NCT00666926|383599|P9|STARTED|Overall Study||3
166257|NCT00666926|383600|P8|STARTED|Overall Study||1
166258|NCT00666926|383601|P7|STARTED|Overall Study||4
166259|NCT00666926|383602|P6|STARTED|Overall Study||4
166260|NCT00666926|383603|P5|STARTED|Overall Study||3
166261|NCT00666926|383604|P4|STARTED|Overall Study||4
166262|NCT00666926|383605|P3|STARTED|Overall Study||3
166263|NCT00666926|383606|P2|STARTED|Overall Study||4
166264|NCT00666926|383607|P1|STARTED|Overall Study||2
166265|NCT00666848|383901|P3|NOT COMPLETED|Overall Study||0
166266|NCT00666848|383902|P2|NOT COMPLETED|Overall Study||0
166267|NCT00666848|383903|P1|NOT COMPLETED|Overall Study||0
166268|NCT00666848|383901|P3|COMPLETED|Overall Study|finished Aim 3|7
166269|NCT00666848|383902|P2|COMPLETED|Overall Study|finished Aim 1|9
166270|NCT00666848|383903|P1|COMPLETED|Overall Study|finished Aim 2|8
166271|NCT00666848|383901|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
166272|NCT00666848|383902|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
166273|NCT00666848|383903|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
166274|NCT00666757|383916|P2|NOT COMPLETED|Overall Study||97
166275|NCT00666757|383917|P1|NOT COMPLETED|Overall Study||100
166276|NCT00666757|383916|P2|COMPLETED|Overall Study||281
166277|NCT00666757|383917|P1|COMPLETED|Overall Study||272
166278|NCT00666757|383916|P2|STARTED|Overall Study||378
166279|NCT00666757|383917|P1|STARTED|Overall Study||372
166280|NCT00666718|383976|P2|NOT COMPLETED|Overall Study||18
166281|NCT00666718|383977|P1|NOT COMPLETED|Overall Study||12
166282|NCT00666718|383976|P2|COMPLETED|Overall Study||169
166283|NCT00666718|383977|P1|COMPLETED|Overall Study||175
166284|NCT00666718|383976|P2|STARTED|Overall Study||187
166285|NCT00666718|383977|P1|STARTED|Overall Study||187
166286|NCT00666705|384003|P1|NOT COMPLETED|Overall Study||1
166287|NCT00666705|384003|P1|COMPLETED|Overall Study||17
166288|NCT00666705|384003|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
166289|NCT00666705|384003|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
166290|NCT00666705|384003|P1|Washout (Days 4 - 5)|Overall Study||18
166291|NCT00666705|384003|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
166292|NCT00666705|384003|P1|STARTED|Overall Study||18
166293|NCT00666679|384022|P2|NOT COMPLETED|Second Intervention||1
166294|NCT00666679|384023|P1|NOT COMPLETED|Second Intervention||1
166295|NCT00666679|384022|P2|COMPLETED|Second Intervention||64
166296|NCT00666679|384023|P1|COMPLETED|Second Intervention||61
166297|NCT00666679|384022|P2|STARTED|Second Intervention||65
166298|NCT00666679|384023|P1|STARTED|Second Intervention||62
166299|NCT00666679|384022|P2|NOT COMPLETED|Washout Period of 1 Week||2
166300|NCT00666679|384023|P1|NOT COMPLETED|Washout Period of 1 Week||0
166301|NCT00666679|384022|P2|COMPLETED|Washout Period of 1 Week||65
166302|NCT00666679|384023|P1|COMPLETED|Washout Period of 1 Week||62
166303|NCT00666679|384022|P2|STARTED|Washout Period of 1 Week||67
166304|NCT00666679|384023|P1|STARTED|Washout Period of 1 Week||62
166305|NCT00666679|384022|P2|NOT COMPLETED|First Intervention||1
166306|NCT00666679|384023|P1|NOT COMPLETED|First Intervention||4
166307|NCT00666679|384022|P2|COMPLETED|First Intervention||67
166308|NCT00666679|384023|P1|COMPLETED|First Intervention||62
166309|NCT00666679|384022|P2|STARTED|First Intervention||68
166310|NCT00666679|384023|P1|STARTED|First Intervention||66
166311|NCT00666666|384043|P1|NOT COMPLETED|Overall Study||0
166312|NCT00666666|384043|P1|COMPLETED|Overall Study||55
166313|NCT00666666|384043|P1|STARTED|Overall Study||55
166314|NCT00666588|384053|P4|NOT COMPLETED|Overall Study||2
166315|NCT00666588|384054|P3|NOT COMPLETED|Overall Study||0
166316|NCT00666588|384055|P2|NOT COMPLETED|Overall Study||0
166317|NCT00666588|384056|P1|NOT COMPLETED|Overall Study||4
166318|NCT00666588|384053|P4|COMPLETED|Overall Study||20
166319|NCT00666588|384054|P3|COMPLETED|Overall Study||6
166320|NCT00666588|384055|P2|COMPLETED|Overall Study||6
166321|NCT00666588|384056|P1|COMPLETED|Overall Study||14
166322|NCT00666588|384053|P4|STARTED|Overall Study||22
166323|NCT00666588|384054|P3|STARTED|Overall Study||6
166324|NCT00666588|384055|P2|STARTED|Overall Study||6
166325|NCT00666588|384056|P1|STARTED|Overall Study||18
166326|NCT00666562|384073|P3|NOT COMPLETED|Overall Study||0
166327|NCT00666562|384074|P2|NOT COMPLETED|Overall Study||2
166328|NCT00666562|384075|P1|NOT COMPLETED|Overall Study||0
166329|NCT00666562|384073|P3|COMPLETED|Overall Study||10
166330|NCT00666562|384074|P2|COMPLETED|Overall Study||8
166331|NCT00666562|384075|P1|COMPLETED|Overall Study||11
166332|NCT00666562|384073|P3|STARTED|Overall Study||10
166333|NCT00666562|384074|P2|STARTED|Overall Study||10
166334|NCT00666562|384075|P1|STARTED|Overall Study||11
166335|NCT00666536|384122|P2|NOT COMPLETED|Overall Study||37
166336|NCT00666536|384123|P1|NOT COMPLETED|Overall Study||33
166337|NCT00666536|384122|P2|COMPLETED|Overall Study||322
166338|NCT00666536|384123|P1|COMPLETED|Overall Study||336
166339|NCT00666536|384122|P2|STARTED|Overall Study||359
166340|NCT00666536|384123|P1|STARTED|Overall Study||369
166341|NCT00666458|384141|P2|NOT COMPLETED|Overall Study||24
166342|NCT00666458|384142|P1|NOT COMPLETED|Overall Study||38
166343|NCT00666458|384141|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
166344|NCT00666458|384142|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
166345|NCT00666458|384141|P2|STARTED|Overall Study|Randomized and treated|398
166346|NCT00666458|384142|P1|STARTED|Overall Study|Randomized and treated|403
166347|NCT00666406|384154|P2|NOT COMPLETED|Second PK Infusion||0
166348|NCT00666406|384155|P1|NOT COMPLETED|Second PK Infusion||0
166349|NCT00666406|384154|P2|COMPLETED|Second PK Infusion||3
166350|NCT00666406|384155|P1|COMPLETED|Second PK Infusion||6
166351|NCT00666406|384154|P2|STARTED|Second PK Infusion||3
166352|NCT00666406|384155|P1|STARTED|Second PK Infusion||6
166353|NCT00666406|384154|P2|NOT COMPLETED|First PK Infusion||0
166354|NCT00666406|384155|P1|NOT COMPLETED|First PK Infusion||0
166355|NCT00666406|384154|P2|COMPLETED|First PK Infusion||3
166356|NCT00666406|384155|P1|COMPLETED|First PK Infusion||6
166357|NCT00666406|384154|P2|STARTED|First PK Infusion||3
166358|NCT00666406|384155|P1|STARTED|First PK Infusion||6
166359|NCT00666328|384230|P1|NOT COMPLETED|Overall Study||5
166360|NCT00666328|384230|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
166361|NCT00666328|384230|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
166362|NCT00666328|384230|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
166363|NCT00666276|384243|P1|NOT COMPLETED|Overall Study||34
166364|NCT00666276|384243|P1|COMPLETED|Overall Study||970
166365|NCT00666276|384243|P1|STARTED|Overall Study||1004
166366|NCT00666263|384267|P2|NOT COMPLETED|End of Study Visit||0
166367|NCT00666263|384268|P1|NOT COMPLETED|End of Study Visit||0
166368|NCT00666263|384267|P2|COMPLETED|End of Study Visit||22
166369|NCT00666263|384268|P1|COMPLETED|End of Study Visit||22
166370|NCT00666263|384267|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
166371|NCT00666263|384268|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
166372|NCT00666263|384267|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
166373|NCT00666263|384268|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
166374|NCT00666263|384267|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
166375|NCT00666263|384268|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
166376|NCT00666263|384267|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
166377|NCT00666263|384268|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
166378|NCT00666263|384267|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
166379|NCT00666263|384268|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
166380|NCT00666263|384267|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
166381|NCT00666263|384268|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
166382|NCT00666263|384267|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
166383|NCT00666263|384268|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
166384|NCT00666263|384267|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
166385|NCT00666263|384268|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
166386|NCT00666263|384267|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
166387|NCT00666263|384268|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
166388|NCT00666263|384267|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
166389|NCT00666263|384268|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
166390|NCT00666263|384267|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
166391|NCT00666263|384268|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
166392|NCT00666263|384267|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
166393|NCT00666263|384268|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
166394|NCT00666263|384267|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
166395|NCT00666263|384268|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
166396|NCT00666263|384267|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
166397|NCT00666263|384268|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
166398|NCT00666263|384267|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
166399|NCT00666263|384268|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
166400|NCT00666263|384267|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
166401|NCT00666263|384268|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
166402|NCT00666224|384412|P2|NOT COMPLETED|Open-Label||85
166403|NCT00666224|384413|P1|NOT COMPLETED|Open-Label||35
166404|NCT00666224|384412|P2|COMPLETED|Open-Label||126
166405|NCT00666224|384413|P1|COMPLETED|Open-Label||163
166406|NCT00666224|384412|P2|STARTED|Open-Label||211
166495|NCT00664560|385089|P3|STARTED|Overall Study|Safety Population|124
166407|NCT00666224|384413|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
166408|NCT00666224|384412|P2|NOT COMPLETED|Double-Blind||27
166409|NCT00666224|384413|P1|NOT COMPLETED|Double-Blind||45
166410|NCT00666224|384412|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
166411|NCT00666224|384413|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
166412|NCT00666224|384412|P2|STARTED|Double-Blind||238
166413|NCT00666224|384413|P1|STARTED|Double-Blind||243
166414|NCT00666211|384432|P2|NOT COMPLETED|Overall Study||38
166415|NCT00666211|384433|P1|NOT COMPLETED|Overall Study||20
166416|NCT00666211|384432|P2|COMPLETED|Overall Study||18
166417|NCT00666211|384433|P1|COMPLETED|Overall Study||22
166418|NCT00666211|384432|P2|STARTED|Overall Study||56
166419|NCT00666211|384433|P1|STARTED|Overall Study||42
166420|NCT00666029|384453|P2|NOT COMPLETED|Overall Study||0
166421|NCT00666029|384454|P1|NOT COMPLETED|Overall Study||1
166422|NCT00666029|384453|P2|COMPLETED|Overall Study||20
166423|NCT00666029|384454|P1|COMPLETED|Overall Study||19
166424|NCT00666029|384453|P2|STARTED|Overall Study||20
166425|NCT00666029|384454|P1|STARTED|Overall Study||20
166426|NCT00665925|384466|P4|NOT COMPLETED|Overall Study||21
166427|NCT00665925|384467|P3|NOT COMPLETED|Overall Study||26
166428|NCT00665925|384468|P2|NOT COMPLETED|Overall Study||17
166429|NCT00665925|384469|P1|NOT COMPLETED|Overall Study||15
166430|NCT00665925|384466|P4|COMPLETED|Overall Study|Participants completed the study|131
166431|NCT00665925|384467|P3|COMPLETED|Overall Study|Participants completed the study|126
166432|NCT00665925|384468|P2|COMPLETED|Overall Study|Participants completed the study|59
166433|NCT00665925|384469|P1|COMPLETED|Overall Study|Participants completed the study|62
166434|NCT00665925|384466|P4|STARTED|Overall Study|Participants randomized|152
166435|NCT00665925|384467|P3|STARTED|Overall Study|Participants randomized|152
166436|NCT00665925|384468|P2|STARTED|Overall Study|Participants randomized|76
166437|NCT00665925|384469|P1|STARTED|Overall Study|Participants randomized|77
166438|NCT00665847|384880|P1|NOT COMPLETED|Overall Study||25
166439|NCT00665847|384880|P1|COMPLETED|Overall Study||76
166440|NCT00665847|384880|P1|STARTED|Overall Study||101
166441|NCT00665704|384892|P1|NOT COMPLETED|Overall Study||0
166442|NCT00665704|384892|P1|COMPLETED|Overall Study||9
166443|NCT00665704|384892|P1|STARTED|Overall Study||9
166444|NCT00665626|384899|P2|NOT COMPLETED|Overall Study||22
166445|NCT00665626|384900|P1|NOT COMPLETED|Overall Study||10
166446|NCT00665626|384899|P2|COMPLETED|Overall Study|Participants completed the study|124
166447|NCT00665626|384900|P1|COMPLETED|Overall Study|Participants completed the study|63
166448|NCT00665626|384899|P2|STARTED|Overall Study|Participants randomized|146
166449|NCT00665626|384900|P1|STARTED|Overall Study|Participants randomized|73
166450|NCT00665470|384968|P2|NOT COMPLETED|Overall Study||0
166451|NCT00665470|384969|P1|NOT COMPLETED|Overall Study||0
166452|NCT00665470|384968|P2|COMPLETED|Overall Study||0
166453|NCT00665470|384969|P1|COMPLETED|Overall Study||10
166454|NCT00665470|384968|P2|STARTED|Overall Study||0
166455|NCT00665470|384969|P1|STARTED|Overall Study||10
166456|NCT00665444|384977|P1|NOT COMPLETED|Overall Study||2
166457|NCT00665444|384977|P1|COMPLETED|Overall Study||1
166458|NCT00665444|384977|P1|STARTED|Overall Study||3
166459|NCT00665431|384985|P3|NOT COMPLETED|Overall Study||24
166460|NCT00665431|384986|P2|NOT COMPLETED|Overall Study||57
166461|NCT00665431|384987|P1|NOT COMPLETED|Overall Study||40
166462|NCT00665431|384985|P3|COMPLETED|Overall Study||98
166463|NCT00665431|384986|P2|COMPLETED|Overall Study||188
166464|NCT00665431|384987|P1|COMPLETED|Overall Study||203
166465|NCT00665431|384985|P3|STARTED|Overall Study|Safety population|122
166466|NCT00665431|384986|P2|STARTED|Overall Study|Safety population|245
166467|NCT00665431|384987|P1|STARTED|Overall Study|Safety population|243
166468|NCT00665366|385030|P2|NOT COMPLETED|Overall Study||59
166469|NCT00665366|385031|P1|NOT COMPLETED|Overall Study||58
166470|NCT00665366|385030|P2|COMPLETED|Overall Study||122
166471|NCT00665366|385031|P1|COMPLETED|Overall Study||131
166472|NCT00665366|385030|P2|STARTED|Overall Study|Participants randomized|181
166473|NCT00665366|385031|P1|STARTED|Overall Study|Participants randomized|189
166474|NCT00665353|385059|P1|NOT COMPLETED|Study Step 2||14
166475|NCT00665353|385059|P1|COMPLETED|Study Step 2||2
166476|NCT00665353|385059|P1|STARTED|Study Step 2||16
166477|NCT00665353|385059|P1|NOT COMPLETED|Study Step 1||3
166478|NCT00665353|385059|P1|COMPLETED|Study Step 1||16
166479|NCT00665353|385059|P1|STARTED|Study Step 1||19
166480|NCT00665132|385069|P1|NOT COMPLETED|Overall Study||0
166481|NCT00665132|385069|P1|COMPLETED|Overall Study||10
166482|NCT00665132|385069|P1|STARTED|Overall Study||10
166483|NCT00665002|385076|P1|NOT COMPLETED|Overall Study||12
166484|NCT00665002|385076|P1|COMPLETED|Overall Study||4
166485|NCT00665002|385076|P1|STARTED|Overall Study||16
166486|NCT00664742|385081|P1|NOT COMPLETED|Overall Study||126
166487|NCT00664742|385081|P1|COMPLETED|Overall Study||481
166488|NCT00664742|385081|P1|STARTED|Overall Study||607
166489|NCT00664560|385089|P3|NOT COMPLETED|Overall Study||19
166490|NCT00664560|385090|P2|NOT COMPLETED|Overall Study||35
166491|NCT00664560|385091|P1|NOT COMPLETED|Overall Study||39
166492|NCT00664560|385089|P3|COMPLETED|Overall Study||105
166493|NCT00664560|385090|P2|COMPLETED|Overall Study||208
166494|NCT00664560|385091|P1|COMPLETED|Overall Study||208
166496|NCT00664560|385090|P2|STARTED|Overall Study|Safety Population|243
166497|NCT00664560|385091|P1|STARTED|Overall Study|Safety Population|247
166498|NCT00664534|385134|P2|NOT COMPLETED|Overall Study||33
166499|NCT00664534|385135|P1|NOT COMPLETED|Overall Study||41
166500|NCT00664534|385134|P2|COMPLETED|Overall Study||138
166501|NCT00664534|385135|P1|COMPLETED|Overall Study||132
166502|NCT00664534|385134|P2|STARTED|Overall Study||171
166503|NCT00664534|385135|P1|STARTED|Overall Study||173
166504|NCT00664521|385163|P2|NOT COMPLETED|Overall Study||1
166505|NCT00664521|385164|P1|NOT COMPLETED|Overall Study||6
166506|NCT00664521|385163|P2|COMPLETED|Overall Study||8
166507|NCT00664521|385164|P1|COMPLETED|Overall Study||12
166508|NCT00664521|385163|P2|STARTED|Overall Study||9
166509|NCT00664521|385164|P1|STARTED|Overall Study||18
166510|NCT00664430|385184|P1|NOT COMPLETED|Overall Study||13
166511|NCT00664430|385184|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
166512|NCT00664430|385184|P1|STARTED|Overall Study||13
166513|NCT00664326|385190|P1|NOT COMPLETED|Overall Study||24
166514|NCT00664326|385190|P1|COMPLETED|Overall Study||25
166515|NCT00664326|385190|P1|STARTED|Overall Study||49
166516|NCT00664105|385209|P1|NOT COMPLETED|Overall Study||24
166517|NCT00664105|385209|P1|COMPLETED|Overall Study||39
166518|NCT00664105|385209|P1|STARTED|Overall Study||63
166519|NCT00664066|385216|P1|NOT COMPLETED|Overall Study||3
166520|NCT00664066|385216|P1|COMPLETED|Overall Study||0
166521|NCT00664066|385216|P1|STARTED|Overall Study||3
166522|NCT00663962|385222|P2|NOT COMPLETED|Overall Study||0
166523|NCT00663962|385223|P1|NOT COMPLETED|Overall Study||1
166524|NCT00663962|385222|P2|COMPLETED|Overall Study||8
166525|NCT00663962|385223|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
166526|NCT00663962|385222|P2|STARTED|Overall Study||8
166527|NCT00663962|385223|P1|STARTED|Overall Study||7
166528|NCT00663923|385229|P1|NOT COMPLETED|Overall Study||2
166529|NCT00663923|385229|P1|COMPLETED|Overall Study||48
166530|NCT00663923|385229|P1|STARTED|Overall Study||50
166531|NCT00663858|385246|P3|NOT COMPLETED|Overall Study||20
166532|NCT00663858|385247|P2|NOT COMPLETED|Overall Study||10
166533|NCT00663858|385248|P1|NOT COMPLETED|Overall Study||34
166534|NCT00663858|385246|P3|COMPLETED|Overall Study||82
166535|NCT00663858|385247|P2|COMPLETED|Overall Study||96
166536|NCT00663858|385248|P1|COMPLETED|Overall Study||178
166537|NCT00663858|385246|P3|STARTED|Overall Study||102
166538|NCT00663858|385247|P2|STARTED|Overall Study||106
166539|NCT00663858|385248|P1|STARTED|Overall Study||212
166540|NCT00663819|385258|P2|NOT COMPLETED|Overall Study||0
166541|NCT00663819|385259|P1|NOT COMPLETED|Overall Study||0
166542|NCT00663819|385258|P2|COMPLETED|Overall Study||135
166543|NCT00663819|385259|P1|COMPLETED|Overall Study||123
166544|NCT00663819|385258|P2|STARTED|Overall Study||135
166545|NCT00663819|385259|P1|STARTED|Overall Study||123
166546|NCT00663793|385267|P2|NOT COMPLETED|Overall Study||0
166547|NCT00663793|385268|P1|NOT COMPLETED|Overall Study||0
166548|NCT00663793|385267|P2|COMPLETED|Overall Study||8
166549|NCT00663793|385268|P1|COMPLETED|Overall Study||8
166550|NCT00663793|385267|P2|STARTED|Overall Study||8
166551|NCT00663793|385268|P1|STARTED|Overall Study||8
166552|NCT00663702|385280|P2|NOT COMPLETED|Overall Study||10
166553|NCT00663702|385281|P1|NOT COMPLETED|Overall Study||18
166554|NCT00663702|385280|P2|COMPLETED|Overall Study||61
166555|NCT00663702|385281|P1|COMPLETED|Overall Study||34
166556|NCT00663702|385280|P2|STARTED|Overall Study||71
166557|NCT00663702|385281|P1|STARTED|Overall Study||52
166558|NCT00663403|385304|P1|NOT COMPLETED|Overall Study||0
166559|NCT00663403|385304|P1|COMPLETED|Overall Study||8
166560|NCT00663403|385304|P1|STARTED|Overall Study||8
166561|NCT00663260|385317|P3|NOT COMPLETED|Overall Study||16
166562|NCT00663260|385318|P2|NOT COMPLETED|Overall Study||11
166563|NCT00663260|385319|P1|NOT COMPLETED|Overall Study||21
166564|NCT00663260|385317|P3|COMPLETED|Overall Study||69
166565|NCT00663260|385318|P2|COMPLETED|Overall Study||72
166566|NCT00663260|385319|P1|COMPLETED|Overall Study||63
166567|NCT00663260|385317|P3|STARTED|Overall Study||85
166568|NCT00663260|385318|P2|STARTED|Overall Study||83
166569|NCT00663260|385319|P1|STARTED|Overall Study||84
166570|NCT00663234|385333|P1|NOT COMPLETED|Overall Study||1
166571|NCT00663234|385333|P1|COMPLETED|Overall Study||27
166572|NCT00663234|385333|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
166573|NCT00663234|385333|P1|STARTED|Overall Study||28
166574|NCT00663208|385366|P7|NOT COMPLETED|Follow-up Period||1
166575|NCT00663208|385367|P6|NOT COMPLETED|Follow-up Period||0
166576|NCT00663208|385368|P5|NOT COMPLETED|Follow-up Period||0
166577|NCT00663208|385369|P4|NOT COMPLETED|Follow-up Period||2
166578|NCT00663208|385370|P3|NOT COMPLETED|Follow-up Period||3
166579|NCT00663208|385371|P2|NOT COMPLETED|Follow-up Period||0
166580|NCT00663208|385372|P1|NOT COMPLETED|Follow-up Period||3
166581|NCT00663208|385366|P7|COMPLETED|Follow-up Period||5
166582|NCT00663208|385367|P6|COMPLETED|Follow-up Period||4
166583|NCT00663208|385368|P5|COMPLETED|Follow-up Period||4
166584|NCT00663208|385369|P4|COMPLETED|Follow-up Period||2
166585|NCT00663208|385370|P3|COMPLETED|Follow-up Period||1
166586|NCT00663208|385371|P2|COMPLETED|Follow-up Period||3
166587|NCT00663208|385372|P1|COMPLETED|Follow-up Period||1
166588|NCT00663208|385366|P7|STARTED|Follow-up Period||6
166589|NCT00663208|385367|P6|STARTED|Follow-up Period||4
166590|NCT00663208|385368|P5|STARTED|Follow-up Period||4
166591|NCT00663208|385369|P4|STARTED|Follow-up Period||4
166592|NCT00663208|385370|P3|STARTED|Follow-up Period||4
166593|NCT00663208|385371|P2|STARTED|Follow-up Period||3
166594|NCT00663208|385372|P1|STARTED|Follow-up Period||4
166595|NCT00663208|385366|P7|NOT COMPLETED|Treatment Period||0
166596|NCT00663208|385367|P6|NOT COMPLETED|Treatment Period||0
166597|NCT00663208|385368|P5|NOT COMPLETED|Treatment Period||0
166598|NCT00663208|385369|P4|NOT COMPLETED|Treatment Period||0
166599|NCT00663208|385370|P3|NOT COMPLETED|Treatment Period||0
166600|NCT00663208|385371|P2|NOT COMPLETED|Treatment Period||1
166601|NCT00663208|385372|P1|NOT COMPLETED|Treatment Period||0
166602|NCT00663208|385366|P7|COMPLETED|Treatment Period||6
166603|NCT00663208|385367|P6|COMPLETED|Treatment Period||4
166604|NCT00663208|385368|P5|COMPLETED|Treatment Period||4
166605|NCT00663208|385369|P4|COMPLETED|Treatment Period||4
166606|NCT00663208|385370|P3|COMPLETED|Treatment Period||4
166607|NCT00663208|385371|P2|COMPLETED|Treatment Period||3
166608|NCT00663208|385372|P1|COMPLETED|Treatment Period||4
166609|NCT00663208|385366|P7|STARTED|Treatment Period||6
166610|NCT00663208|385367|P6|STARTED|Treatment Period||4
166611|NCT00663208|385368|P5|STARTED|Treatment Period||4
166612|NCT00663208|385369|P4|STARTED|Treatment Period||4
166613|NCT00663208|385370|P3|STARTED|Treatment Period||4
166614|NCT00663208|385371|P2|STARTED|Treatment Period||4
166615|NCT00663208|385372|P1|STARTED|Treatment Period||4
166616|NCT00663169|385524|P2|NOT COMPLETED|Overall Study||0
166617|NCT00663169|385525|P1|NOT COMPLETED|Overall Study||0
166618|NCT00663169|385524|P2|COMPLETED|Overall Study||3
166619|NCT00663169|385525|P1|COMPLETED|Overall Study||3
166620|NCT00663169|385524|P2|STARTED|Overall Study||3
166621|NCT00663169|385525|P1|STARTED|Overall Study||3
166622|NCT00663117|385550|P2|NOT COMPLETED|Overall Study||0
166623|NCT00663117|385551|P1|NOT COMPLETED|Overall Study||1
166624|NCT00663117|385550|P2|COMPLETED|Overall Study||20
166625|NCT00663117|385551|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
166626|NCT00663117|385550|P2|STARTED|Overall Study||20
166627|NCT00663117|385551|P1|STARTED|Overall Study||20
166628|NCT00663052|385565|P2|NOT COMPLETED|Overall Study||10
166629|NCT00663052|385566|P1|NOT COMPLETED|Overall Study||12
166630|NCT00663052|385565|P2|COMPLETED|Overall Study||127
166631|NCT00663052|385566|P1|COMPLETED|Overall Study||124
166632|NCT00663052|385565|P2|STARTED|Overall Study||137
166633|NCT00663052|385566|P1|STARTED|Overall Study||136
166634|NCT00663026|385649|P3|NOT COMPLETED|Overall Study||4
166635|NCT00663026|385650|P2|NOT COMPLETED|Overall Study||6
166636|NCT00663026|385651|P1|NOT COMPLETED|Overall Study||2
166637|NCT00663026|385649|P3|COMPLETED|Overall Study||27
166638|NCT00663026|385650|P2|COMPLETED|Overall Study||23
166639|NCT00663026|385651|P1|COMPLETED|Overall Study||17
166640|NCT00663026|385649|P3|STARTED|Overall Study||31
166641|NCT00663026|385650|P2|STARTED|Overall Study||29
166642|NCT00663026|385651|P1|STARTED|Overall Study||19
166643|NCT00662909|385674|P3|NOT COMPLETED|Overall Study||53
166644|NCT00662909|385675|P2|NOT COMPLETED|Overall Study||59
166645|NCT00662909|385676|P1|NOT COMPLETED|Overall Study||69
166646|NCT00662909|385674|P3|COMPLETED|Overall Study||380
166647|NCT00662909|385675|P2|COMPLETED|Overall Study||383
166648|NCT00662909|385676|P1|COMPLETED|Overall Study||385
166649|NCT00662909|385674|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
166650|NCT00662909|385675|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
166651|NCT00662909|385676|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
166652|NCT00662909|385674|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
166653|NCT00662909|385675|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
166654|NCT00662909|385676|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
166655|NCT00662909|385674|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
166656|NCT00662909|385675|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
166657|NCT00662909|385676|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
166658|NCT00662909|385674|P3|STARTED|Overall Study||433
166659|NCT00662909|385675|P2|STARTED|Overall Study||442
166660|NCT00662909|385676|P1|STARTED|Overall Study||454
166661|NCT00662857|385774|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
166662|NCT00662857|385775|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
166663|NCT00662857|385774|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
166664|NCT00662857|385775|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
166665|NCT00662857|385774|P2|STARTED|Lispro Dosing Period (1 Day)||14
166666|NCT00662857|385775|P1|STARTED|Lispro Dosing Period (1 Day)||12
166667|NCT00662857|385774|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
166668|NCT00662857|385775|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
166669|NCT00662857|385774|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
166670|NCT00662857|385775|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
166671|NCT00662857|385774|P2|STARTED|Washout 2 (3 - 14 Days)||14
166672|NCT00662857|385775|P1|STARTED|Washout 2 (3 - 14 Days)||13
166673|NCT00662857|385774|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
166674|NCT00662857|385775|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
166675|NCT00662857|385774|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
166676|NCT00662857|385775|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
166677|NCT00662857|385774|P2|STARTED|TI Dosing Period 2 (1 Day)||14
166678|NCT00662857|385775|P1|STARTED|TI Dosing Period 2 (1 Day)||13
166679|NCT00662857|385774|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
166680|NCT00662857|385775|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
166681|NCT00662857|385774|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
166682|NCT00662857|385775|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
166683|NCT00662857|385774|P2|STARTED|Washout 1 (3 - 14 Days)||16
166684|NCT00662857|385775|P1|STARTED|Washout 1 (3 - 14 Days)||13
166685|NCT00662857|385774|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
166686|NCT00662857|385775|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
166687|NCT00662857|385774|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
166688|NCT00662857|385775|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
166689|NCT00662857|385774|P2|STARTED|TI Dosing Period 1 (1 Day)||16
166690|NCT00662857|385775|P1|STARTED|TI Dosing Period 1 (1 Day)||13
166691|NCT00662831|385790|P2|NOT COMPLETED|Overall Study||59
166692|NCT00662831|385791|P1|NOT COMPLETED|Overall Study||106
166693|NCT00662831|385790|P2|COMPLETED|Overall Study||33
166694|NCT00662831|385791|P1|COMPLETED|Overall Study||78
166695|NCT00662831|385790|P2|STARTED|Overall Study||92
166696|NCT00662831|385791|P1|STARTED|Overall Study||184
166697|NCT00662818|385831|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
166698|NCT00662818|385832|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
166699|NCT00662818|385831|P2|COMPLETED|Period 2 (6 Weeks)||41
166700|NCT00662818|385832|P1|COMPLETED|Period 2 (6 Weeks)||38
166701|NCT00662818|385831|P2|STARTED|Period 2 (6 Weeks)||53
166702|NCT00662818|385832|P1|STARTED|Period 2 (6 Weeks)||51
166703|NCT00662818|385831|P2|NOT COMPLETED|Wash-Out (14 Days)||5
166704|NCT00662818|385832|P1|NOT COMPLETED|Wash-Out (14 Days)||5
166705|NCT00662818|385831|P2|COMPLETED|Wash-Out (14 Days)||53
166706|NCT00662818|385832|P1|COMPLETED|Wash-Out (14 Days)||51
166707|NCT00662818|385831|P2|STARTED|Wash-Out (14 Days)||58
166708|NCT00662818|385832|P1|STARTED|Wash-Out (14 Days)||56
166709|NCT00662818|385831|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
166710|NCT00662818|385832|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
166711|NCT00662818|385831|P2|COMPLETED|Period 1 (6 Weeks)||58
166712|NCT00662818|385832|P1|COMPLETED|Period 1 (6 Weeks)||56
166713|NCT00662818|385831|P2|Treated|Period 1 (6 Weeks)||58
166714|NCT00662818|385832|P1|Treated|Period 1 (6 Weeks)||56
166715|NCT00662818|385831|P2|STARTED|Period 1 (6 Weeks)||81
166716|NCT00662818|385832|P1|STARTED|Period 1 (6 Weeks)||84
166717|NCT00662675|385856|P2|NOT COMPLETED|Overall Study||0
166718|NCT00662675|385857|P1|NOT COMPLETED|Overall Study||0
166719|NCT00662675|385856|P2|COMPLETED|Overall Study||20
166720|NCT00662675|385857|P1|COMPLETED|Overall Study||20
166721|NCT00662675|385856|P2|STARTED|Overall Study||20
166722|NCT00662675|385857|P1|STARTED|Overall Study||20
166723|NCT00662649|385871|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
166724|NCT00662649|385872|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
166725|NCT00662649|385873|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
166726|NCT00662649|385874|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
166727|NCT00662649|385875|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
166728|NCT00662649|385871|P5|COMPLETED|Extension Study (Month 24 to 60)||126
166729|NCT00662649|385872|P4|COMPLETED|Extension Study (Month 24 to 60)||112
166730|NCT00662649|385873|P3|COMPLETED|Extension Study (Month 24 to 60)||0
166731|NCT00662649|385874|P2|COMPLETED|Extension Study (Month 24 to 60)||290
166732|NCT00662649|385875|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
166733|NCT00662649|385871|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
166734|NCT00662649|385872|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
166735|NCT00662649|385873|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
166736|NCT00662649|385874|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
166737|NCT00662649|385875|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
166738|NCT00662649|385871|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
166739|NCT00662649|385872|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
166740|NCT00662649|385873|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
166741|NCT00662649|385874|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
166742|NCT00662649|385875|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
166743|NCT00662649|385871|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
166744|NCT00662649|385872|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
166745|NCT00662649|385873|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
166746|NCT00662649|385874|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
166747|NCT00662649|385875|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
166748|NCT00662649|385871|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
166749|NCT00662649|385872|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
166750|NCT00662649|385873|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
166751|NCT00662649|385874|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
166752|NCT00662649|385875|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
166753|NCT00662649|385871|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
166754|NCT00662649|385872|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
166755|NCT00662649|385873|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
166756|NCT00662649|385874|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
166757|NCT00662649|385875|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
166758|NCT00662649|385871|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
166759|NCT00662649|385872|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
166760|NCT00662649|385873|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
166761|NCT00662649|385874|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
166762|NCT00662649|385875|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
166763|NCT00662649|385871|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
166764|NCT00662649|385872|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
166765|NCT00662649|385873|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
166766|NCT00662649|385874|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
166767|NCT00662649|385875|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
166768|NCT00662649|385871|P5|STARTED|Extension Study (Month 24 to 60)||155
166769|NCT00662649|385872|P4|STARTED|Extension Study (Month 24 to 60)||145
166770|NCT00662649|385873|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
166771|NCT00662649|385874|P2|STARTED|Extension Study (Month 24 to 60)||331
166772|NCT00662649|385875|P1|STARTED|Extension Study (Month 24 to 60)||289
166773|NCT00662649|385871|P5|NOT COMPLETED|Core Study (24 Months)||0
166774|NCT00662649|385872|P4|NOT COMPLETED|Core Study (24 Months)||0
166775|NCT00662649|385873|P3|NOT COMPLETED|Core Study (24 Months)||86
166776|NCT00662649|385874|P2|NOT COMPLETED|Core Study (24 Months)||56
166777|NCT00662649|385875|P1|NOT COMPLETED|Core Study (24 Months)||97
166778|NCT00662649|385871|P5|COMPLETED|Core Study (24 Months)||0
166779|NCT00662649|385872|P4|COMPLETED|Core Study (24 Months)||0
166780|NCT00662649|385873|P3|COMPLETED|Core Study (24 Months)||332
166781|NCT00662649|385874|P2|COMPLETED|Core Study (24 Months)||369
166782|NCT00662649|385875|P1|COMPLETED|Core Study (24 Months)||332
166783|NCT00662649|385871|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
166784|NCT00662649|385872|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
166785|NCT00662649|385873|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
166786|NCT00662649|385874|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
166787|NCT00662649|385875|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
166788|NCT00662649|385871|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
166789|NCT00662649|385872|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
166790|NCT00662649|385873|P3|STARTED|Core Study (24 Months)||418
166791|NCT00662649|385874|P2|STARTED|Core Study (24 Months)||425
166792|NCT00662649|385875|P1|STARTED|Core Study (24 Months)||429
166793|NCT00662558|385915|P2|NOT COMPLETED|Overall Study||110
166794|NCT00662558|385916|P1|NOT COMPLETED|Overall Study||56
166795|NCT00662558|385915|P2|COMPLETED|Overall Study||294
166796|NCT00662558|385916|P1|COMPLETED|Overall Study||342
166797|NCT00662558|385915|P2|Received Treatment|Overall Study||396
166798|NCT00662558|385916|P1|Received Treatment|Overall Study||396
166799|NCT00662558|385915|P2|STARTED|Overall Study||404
166800|NCT00662558|385916|P1|STARTED|Overall Study||398
166801|NCT00662545|385950|P2|NOT COMPLETED|Overall Study||0
166802|NCT00662545|385951|P1|NOT COMPLETED|Overall Study||0
166803|NCT00662545|385950|P2|COMPLETED|Overall Study||5
166804|NCT00662545|385951|P1|COMPLETED|Overall Study||5
166805|NCT00662545|385950|P2|STARTED|Overall Study||5
166806|NCT00662545|385951|P1|STARTED|Overall Study||5
166807|NCT00662532|385967|P2|NOT COMPLETED|Overall Study||2
166808|NCT00662532|385968|P1|NOT COMPLETED|Overall Study||0
166809|NCT00662532|385967|P2|COMPLETED|Overall Study||20
166810|NCT00662532|385968|P1|COMPLETED|Overall Study||22
166811|NCT00662532|385967|P2|STARTED|Overall Study||22
166812|NCT00662532|385968|P1|STARTED|Overall Study||22
166813|NCT00662389|385978|P1|NOT COMPLETED|Overall Study||0
166814|NCT00662389|385978|P1|COMPLETED|Overall Study||4
166815|NCT00662389|385978|P1|STARTED|Overall Study||4
166816|NCT00662363|385983|P2|NOT COMPLETED|Overall Study||10
166817|NCT00662363|385984|P1|NOT COMPLETED|Overall Study||11
166818|NCT00662363|385983|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
166819|NCT00662363|385984|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
166820|NCT00662363|385983|P2|STARTED|Overall Study||32
166821|NCT00662363|385984|P1|STARTED|Overall Study||32
166822|NCT00662207|385992|P1|NOT COMPLETED|Overall Study||0
166823|NCT00662207|385992|P1|COMPLETED|Overall Study||3
166824|NCT00662207|385992|P1|STARTED|Overall Study||3
166825|NCT00662025|385999|P1|NOT COMPLETED|Overall Study||63
166826|NCT00662025|385999|P1|COMPLETED|Overall Study||0
166827|NCT00662025|385999|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
166828|NCT00661999|386022|P3|NOT COMPLETED|Overall Study||57
166829|NCT00661999|386023|P2|NOT COMPLETED|Overall Study||50
166830|NCT00661999|386024|P1|NOT COMPLETED|Overall Study||59
166831|NCT00661999|386022|P3|COMPLETED|Overall Study||106
166832|NCT00661999|386023|P2|COMPLETED|Overall Study||113
166833|NCT00661999|386024|P1|COMPLETED|Overall Study||105
166834|NCT00661999|386022|P3|STARTED|Overall Study||163
166835|NCT00661999|386023|P2|STARTED|Overall Study||163
166836|NCT00661999|386024|P1|STARTED|Overall Study||164
166837|NCT00661960|386080|P3|NOT COMPLETED|Overall Study||1
166838|NCT00661960|386081|P2|NOT COMPLETED|Overall Study||3
166839|NCT00661960|386082|P1|NOT COMPLETED|Overall Study||0
166840|NCT00661960|386080|P3|COMPLETED|Overall Study||9
166841|NCT00661960|386081|P2|COMPLETED|Overall Study||7
166842|NCT00661960|386082|P1|COMPLETED|Overall Study||5
166843|NCT00661960|386080|P3|STARTED|Overall Study||10
166844|NCT00661960|386081|P2|STARTED|Overall Study||10
166845|NCT00661960|386082|P1|STARTED|Overall Study||5
166846|NCT00661895|386092|P2|NOT COMPLETED|Overall Study||0
166847|NCT00661895|386093|P1|NOT COMPLETED|Overall Study||0
166848|NCT00661895|386092|P2|COMPLETED|Overall Study||50
166849|NCT00661895|386093|P1|COMPLETED|Overall Study||49
166850|NCT00661895|386092|P2|STARTED|Overall Study||50
166851|NCT00661895|386093|P1|STARTED|Overall Study||49
166852|NCT00661830|386101|P2|NOT COMPLETED|Overall Study||42
166853|NCT00661830|386102|P1|NOT COMPLETED|Overall Study||40
166854|NCT00661830|386101|P2|COMPLETED|Overall Study||6
166855|NCT00661830|386102|P1|COMPLETED|Overall Study||9
166856|NCT00661830|386101|P2|STARTED|Overall Study||48
166857|NCT00661830|386102|P1|STARTED|Overall Study||49
166858|NCT00661778|386114|P1|NOT COMPLETED|Overall Study||50
166859|NCT00661778|386114|P1|COMPLETED|Overall Study||0
166860|NCT00661778|386114|P1|STARTED|Overall Study||50
166861|NCT00661726|386121|P1|NOT COMPLETED|Overall Study||1
166862|NCT00661726|386121|P1|COMPLETED|Overall Study||5
166863|NCT00661726|386121|P1|STARTED|Overall Study||6
166864|NCT00661713|386144|P8|NOT COMPLETED|Overall Study||11
166865|NCT00661713|386145|P7|NOT COMPLETED|Overall Study||64
166866|NCT00661713|386146|P6|NOT COMPLETED|Overall Study||37
166867|NCT00661713|386147|P5|NOT COMPLETED|Overall Study||20
166868|NCT00661713|386148|P4|NOT COMPLETED|Overall Study||28
166869|NCT00661713|386149|P3|NOT COMPLETED|Overall Study||17
166870|NCT00661713|386150|P2|NOT COMPLETED|Overall Study||39
166871|NCT00661713|386151|P1|NOT COMPLETED|Overall Study||16
166872|NCT00661713|386144|P8|COMPLETED|Overall Study||117
166873|NCT00661713|386145|P7|COMPLETED|Overall Study||309
166874|NCT00661713|386146|P6|COMPLETED|Overall Study||216
166875|NCT00661713|386147|P5|COMPLETED|Overall Study||107
166876|NCT00661713|386148|P4|COMPLETED|Overall Study||219
166877|NCT00661713|386149|P3|COMPLETED|Overall Study||111
166878|NCT00661713|386150|P2|COMPLETED|Overall Study||208
166879|NCT00661713|386151|P1|COMPLETED|Overall Study||112
166880|NCT00661713|386144|P8|STARTED|Overall Study||128
166881|NCT00661713|386145|P7|STARTED|Overall Study||373
166882|NCT00661713|386146|P6|STARTED|Overall Study||253
166883|NCT00661713|386147|P5|STARTED|Overall Study||127
166884|NCT00661713|386148|P4|STARTED|Overall Study||247
166885|NCT00661713|386149|P3|STARTED|Overall Study||128
166886|NCT00661713|386150|P2|STARTED|Overall Study||247
166887|NCT00661713|386151|P1|STARTED|Overall Study||128
166888|NCT00661687|386241|P1|NOT COMPLETED|Overall Study||15
166889|NCT00661687|386241|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
166890|NCT00661687|386241|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
166891|NCT00661661|386253|P2|NOT COMPLETED|Overall Study||39
166892|NCT00661661|386254|P1|NOT COMPLETED|Overall Study||140
166893|NCT00661661|386253|P2|COMPLETED|Overall Study||66
166894|NCT00661661|386254|P1|COMPLETED|Overall Study||242
166895|NCT00661661|386253|P2|STARTED|Overall Study||105
166896|NCT00661661|386254|P1|STARTED|Overall Study||382
166897|NCT00661622|386330|P2|NOT COMPLETED|Overall Study||0
166898|NCT00661622|386331|P1|NOT COMPLETED|Overall Study||1
166899|NCT00661622|386330|P2|COMPLETED|Overall Study||27
166900|NCT00661622|386331|P1|COMPLETED|Overall Study||25
166901|NCT00661622|386330|P2|STARTED|Overall Study||27
166902|NCT00661622|386331|P1|STARTED|Overall Study||26
166903|NCT00661609|386345|P1|NOT COMPLETED|Overall Study||41
166904|NCT00661609|386345|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
166905|NCT00661609|386345|P1|STARTED|Overall Study|All dosed patients|41
166906|NCT00661583|386355|P3|NOT COMPLETED|Overall Study||0
166907|NCT00661583|386356|P2|NOT COMPLETED|Overall Study||0
166908|NCT00661583|386357|P1|NOT COMPLETED|Overall Study||0
166909|NCT00661583|386355|P3|COMPLETED|Overall Study||10
166910|NCT00661583|386356|P2|COMPLETED|Overall Study||10
166911|NCT00661583|386357|P1|COMPLETED|Overall Study||10
166912|NCT00661583|386355|P3|STARTED|Overall Study||10
166913|NCT00661583|386356|P2|STARTED|Overall Study||10
166914|NCT00661583|386357|P1|STARTED|Overall Study||10
166915|NCT00661570|386374|P1|NOT COMPLETED|Overall Study||0
166916|NCT00661570|386374|P1|COMPLETED|Overall Study||26
166917|NCT00661570|386374|P1|STARTED|Overall Study||26
166918|NCT00661544|386381|P1|NOT COMPLETED|Overall Study||0
166919|NCT00661544|386381|P1|COMPLETED|Overall Study||48
166920|NCT00661544|386381|P1|STARTED|Overall Study||48
166921|NCT00661505|386385|P1|NOT COMPLETED|Overall Study||30
166922|NCT00661505|386385|P1|COMPLETED|Overall Study||102
166923|NCT00661505|386385|P1|STARTED|Overall Study||132
166924|NCT00661492|386413|P2|NOT COMPLETED|Overall Study||29
166925|NCT00661492|386414|P1|NOT COMPLETED|Overall Study||68
166926|NCT00661492|386413|P2|COMPLETED|Overall Study||11
166927|NCT00661492|386414|P1|COMPLETED|Overall Study||7
166928|NCT00661492|386413|P2|STARTED|Overall Study||40
166929|NCT00661492|386414|P1|STARTED|Overall Study||75
166930|NCT00661479|386438|P4|NOT COMPLETED|Overall Study||0
166931|NCT00661479|386439|P3|NOT COMPLETED|Overall Study||0
166932|NCT00661479|386440|P2|NOT COMPLETED|Overall Study||0
166933|NCT00661479|386441|P1|NOT COMPLETED|Overall Study||0
166934|NCT00661479|386438|P4|COMPLETED|Overall Study||3
166935|NCT00661479|386439|P3|COMPLETED|Overall Study||3
166936|NCT00661479|386440|P2|COMPLETED|Overall Study||3
166937|NCT00661479|386441|P1|COMPLETED|Overall Study||12
166938|NCT00661479|386438|P4|STARTED|Overall Study||3
166939|NCT00661479|386439|P3|STARTED|Overall Study||3
166940|NCT00661479|386440|P2|STARTED|Overall Study||3
166941|NCT00661479|386441|P1|STARTED|Overall Study||12
166942|NCT00661453|386454|P1|NOT COMPLETED|Overall Study||13
166943|NCT00661453|386454|P1|COMPLETED|Overall Study||25
166944|NCT00661453|386454|P1|STARTED|Overall Study||38
166945|NCT00661427|386460|P2|NOT COMPLETED|Overall Study||7
166946|NCT00661427|386461|P1|NOT COMPLETED|Overall Study||5
166947|NCT00661427|386460|P2|COMPLETED|Overall Study||19
166948|NCT00661427|386461|P1|COMPLETED|Overall Study||30
166949|NCT00661427|386460|P2|STARTED|Overall Study||26
166950|NCT00661427|386461|P1|STARTED|Overall Study||35
166951|NCT00661388|386467|P1|NOT COMPLETED|Overall Study||24
166952|NCT00661388|386467|P1|COMPLETED|Overall Study||51
166953|NCT00661388|386467|P1|STARTED|Overall Study||75
166954|NCT00661362|386490|P2|NOT COMPLETED|Overall Study||40
166955|NCT00661362|386491|P1|NOT COMPLETED|Overall Study||29
166956|NCT00661362|386490|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
166957|NCT00661362|386491|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
166958|NCT00661362|386490|P2|STARTED|Overall Study|Randomized and treated|287
166959|NCT00661362|386491|P1|STARTED|Overall Study|Randomized and treated|283
166960|NCT00661193|386509|P2|NOT COMPLETED|Overall Study||26
166961|NCT00661193|386510|P1|NOT COMPLETED|Overall Study||33
166962|NCT00661193|386509|P2|COMPLETED|Overall Study||0
166963|NCT00661193|386510|P1|COMPLETED|Overall Study||0
166964|NCT00661193|386509|P2|STARTED|Overall Study||26
166965|NCT00661193|386510|P1|STARTED|Overall Study||33
166966|NCT00661089|386520|P2|NOT COMPLETED|Overall Study||2
166967|NCT00661089|386521|P1|NOT COMPLETED|Overall Study||0
166968|NCT00661089|386520|P2|COMPLETED|Overall Study||9
166969|NCT00661089|386521|P1|COMPLETED|Overall Study||10
166970|NCT00661089|386520|P2|STARTED|Overall Study||11
166971|NCT00661089|386521|P1|STARTED|Overall Study||10
166972|NCT00660985|386531|P2|NOT COMPLETED|Overall Study||0
166973|NCT00660985|386532|P1|NOT COMPLETED|Overall Study||1
166974|NCT00660985|386531|P2|COMPLETED|Overall Study||25
166975|NCT00660985|386532|P1|COMPLETED|Overall Study||25
166976|NCT00660985|386531|P2|STARTED|Overall Study||25
166977|NCT00660985|386532|P1|STARTED|Overall Study||26
166978|NCT00660907|386556|P2|NOT COMPLETED|Overall Study||94
166979|NCT00660907|386557|P1|NOT COMPLETED|Overall Study||84
166980|NCT00660907|386556|P2|COMPLETED|Overall Study||314
166981|NCT00660907|386557|P1|COMPLETED|Overall Study||322
166982|NCT00660907|386556|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
166983|NCT00660907|386557|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
166984|NCT00660829|386571|P2|NOT COMPLETED|Overall Study||19
166985|NCT00660829|386572|P1|NOT COMPLETED|Overall Study||18
166986|NCT00660829|386571|P2|COMPLETED|Overall Study||249
166987|NCT00660829|386572|P1|COMPLETED|Overall Study||250
166988|NCT00660829|386571|P2|STARTED|Overall Study|2 subjects were randomized in error|268
166989|NCT00660829|386572|P1|STARTED|Overall Study|2 subjects were randomized in error|268
166990|NCT00660816|386590|P2|NOT COMPLETED|Overall Study||19
166991|NCT00660816|386591|P1|NOT COMPLETED|Overall Study||20
166992|NCT00660816|386590|P2|COMPLETED|Overall Study||3
166993|NCT00660816|386591|P1|COMPLETED|Overall Study||4
166994|NCT00660816|386590|P2|STARTED|Overall Study||22
166995|NCT00660816|386591|P1|STARTED|Overall Study||24
166996|NCT00660699|386603|P1|NOT COMPLETED|Overall Study||2
166997|NCT00660699|386603|P1|COMPLETED|Overall Study||48
166998|NCT00660699|386603|P1|STARTED|Overall Study||50
166999|NCT00660660|386619|P2|NOT COMPLETED|Overall Study||9
167000|NCT00660660|386620|P1|NOT COMPLETED|Overall Study||5
167001|NCT00660660|386619|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
167002|NCT00660660|386620|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
167003|NCT00660660|386619|P2|Met Criteria for MITT Population|Overall Study||125
167004|NCT00660660|386620|P1|Met Criteria for MITT Population|Overall Study||137
167005|NCT00660660|386619|P2|STARTED|Overall Study|Randomized|133
167006|NCT00660660|386620|P1|STARTED|Overall Study|Randomized|143
167007|NCT00660595|386720|P2|NOT COMPLETED|Overall Study||9
167008|NCT00660595|386721|P1|NOT COMPLETED|Overall Study||18
167009|NCT00660595|386720|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
167010|NCT00660595|386721|P1|COMPLETED|Overall Study||1
167011|NCT00660595|386720|P2|STARTED|Overall Study||10
167012|NCT00660595|386721|P1|STARTED|Overall Study||19
167013|NCT00659490|386736|P3|NOT COMPLETED|Overall Study||1
167014|NCT00659490|386737|P2|NOT COMPLETED|Overall Study||0
167015|NCT00659490|386738|P1|NOT COMPLETED|Overall Study||2
167016|NCT00659490|386736|P3|COMPLETED|Overall Study||30
167017|NCT00659490|386737|P2|COMPLETED|Overall Study||59
167018|NCT00659490|386738|P1|COMPLETED|Overall Study||59
167019|NCT00659490|386736|P3|STARTED|Overall Study||31
167020|NCT00659490|386737|P2|STARTED|Overall Study||59
167021|NCT00659490|386738|P1|STARTED|Overall Study||61
167022|NCT00659438|386811|P2|NOT COMPLETED|Overall Study||8
167023|NCT00659438|386812|P1|NOT COMPLETED|Overall Study||14
167024|NCT00659438|386811|P2|COMPLETED|Overall Study||40
167025|NCT00659438|386812|P1|COMPLETED|Overall Study||33
167026|NCT00659438|386811|P2|Safety Analysis Set|Overall Study||47
167027|NCT00659438|386812|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
167028|NCT00659438|386811|P2|Secondary Analysis Set|Overall Study||48
167029|NCT00659438|386812|P1|Secondary Analysis Set|Overall Study||47
167030|NCT00659438|386811|P2|Assessable Set : Primary Analysis|Overall Study||45
167031|NCT00659438|386812|P1|Assessable Set : Primary Analysis|Overall Study||44
167032|NCT00659438|386811|P2|STARTED|Overall Study||48
167033|NCT00659438|386812|P1|STARTED|Overall Study||47
167034|NCT00659373|386836|P2|NOT COMPLETED|Overall Study||7
167035|NCT00659373|386837|P1|NOT COMPLETED|Overall Study||5
167036|NCT00659373|386836|P2|COMPLETED|Overall Study||54
167037|NCT00659373|386837|P1|COMPLETED|Overall Study||20
167038|NCT00659373|386836|P2|STARTED|Overall Study||61
167039|NCT00659373|386837|P1|STARTED|Overall Study||25
167040|NCT00659360|386843|P1|NOT COMPLETED|Overall Study||0
167041|NCT00659360|386843|P1|COMPLETED|Overall Study||17
167042|NCT00659360|386843|P1|STARTED|Overall Study||17
167043|NCT00659334|386858|P7|NOT COMPLETED|Overall Study||1
167044|NCT00659334|386859|P6|NOT COMPLETED|Overall Study||0
167045|NCT00659334|386860|P5|NOT COMPLETED|Overall Study||0
167046|NCT00659334|386861|P4|NOT COMPLETED|Overall Study||0
167047|NCT00659334|386862|P3|NOT COMPLETED|Overall Study||0
167048|NCT00659334|386863|P2|NOT COMPLETED|Overall Study||5
167049|NCT00659334|386864|P1|NOT COMPLETED|Overall Study||8
167050|NCT00659334|386858|P7|COMPLETED|Overall Study|1 screen failure|20
167051|NCT00659334|386859|P6|COMPLETED|Overall Study||0
167052|NCT00659334|386860|P5|COMPLETED|Overall Study||1
167053|NCT00659334|386861|P4|COMPLETED|Overall Study||2
167054|NCT00659334|386862|P3|COMPLETED|Overall Study||5
167055|NCT00659334|386863|P2|COMPLETED|Overall Study|5 Screen failures|36
167056|NCT00659334|386864|P1|COMPLETED|Overall Study|8 Screen failures|38
167057|NCT00659334|386858|P7|STARTED|Overall Study||21
167058|NCT00659334|386859|P6|STARTED|Overall Study||0
167059|NCT00659334|386860|P5|STARTED|Overall Study||1
167060|NCT00659334|386861|P4|STARTED|Overall Study||2
167061|NCT00659334|386862|P3|STARTED|Overall Study||5
167062|NCT00659334|386863|P2|STARTED|Overall Study||41
167063|NCT00659334|386864|P1|STARTED|Overall Study||46
167064|NCT00660543|386880|P1|NOT COMPLETED|Overall Study||0
167065|NCT00660543|386880|P1|COMPLETED|Overall Study||14
167066|NCT00660543|386880|P1|STARTED|Overall Study||14
167067|NCT00660517|386893|P4|NOT COMPLETED|Overall Study||7
167068|NCT00660517|386894|P3|NOT COMPLETED|Overall Study||7
167069|NCT00660517|386895|P2|NOT COMPLETED|Overall Study||8
167070|NCT00660517|386896|P1|NOT COMPLETED|Overall Study||8
167071|NCT00660517|386893|P4|COMPLETED|Overall Study||144
167072|NCT00660517|386894|P3|COMPLETED|Overall Study||144
167073|NCT00660517|386895|P2|COMPLETED|Overall Study||144
167074|NCT00660517|386896|P1|COMPLETED|Overall Study||145
167075|NCT00660517|386893|P4|STARTED|Overall Study||151
167076|NCT00660517|386894|P3|STARTED|Overall Study||151
167077|NCT00660517|386895|P2|STARTED|Overall Study||152
167078|NCT00660517|386896|P1|STARTED|Overall Study||153
167079|NCT00660504|386916|P2|NOT COMPLETED|Overall Study||1
167080|NCT00660504|386917|P1|NOT COMPLETED|Overall Study||0
167081|NCT00660504|386916|P2|COMPLETED|Overall Study||150
167082|NCT00660504|386917|P1|COMPLETED|Overall Study||149
167083|NCT00660504|386916|P2|STARTED|Overall Study||151
167084|NCT00660504|386917|P1|STARTED|Overall Study||149
167085|NCT00660400|386929|P1|NOT COMPLETED|Overall Study||4
167086|NCT00660400|386929|P1|COMPLETED|Overall Study||21
167087|NCT00660400|386929|P1|STARTED|Overall Study||25
167088|NCT00660387|386938|P2|NOT COMPLETED|Overall Study||3
167089|NCT00660387|386939|P1|NOT COMPLETED|Overall Study||2
167090|NCT00660387|386938|P2|COMPLETED|Overall Study||31
167091|NCT00660387|386939|P1|COMPLETED|Overall Study||35
167092|NCT00660387|386938|P2|STARTED|Overall Study||34
167093|NCT00660387|386939|P1|STARTED|Overall Study||37
167094|NCT00660348|386993|P2|NOT COMPLETED|Overall Study||0
167095|NCT00660348|386994|P1|NOT COMPLETED|Overall Study||1
167096|NCT00660348|386993|P2|COMPLETED|Overall Study||0
167097|NCT00660348|386994|P1|COMPLETED|Overall Study||0
167098|NCT00660348|386993|P2|STARTED|Overall Study||0
167099|NCT00660348|386994|P1|STARTED|Overall Study||1
167100|NCT00660309|387002|P2|NOT COMPLETED|Overall Study||3
167101|NCT00660309|387003|P1|NOT COMPLETED|Overall Study||2
167102|NCT00660309|387002|P2|COMPLETED|Overall Study||19
167103|NCT00660309|387003|P1|COMPLETED|Overall Study||21
167104|NCT00660309|387002|P2|Pharmacodynamic Analysis Set|Overall Study||20
167105|NCT00660309|387003|P1|Pharmacodynamic Analysis Set|Overall Study||22
167106|NCT00660309|387002|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
167107|NCT00660309|387003|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
167108|NCT00660309|387002|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
167109|NCT00660309|387003|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
167110|NCT00660192|387044|P2|NOT COMPLETED|Overall Study||3
167111|NCT00660192|387045|P1|NOT COMPLETED|Overall Study||2
167112|NCT00660192|387044|P2|COMPLETED|Overall Study||10
167113|NCT00660192|387045|P1|COMPLETED|Overall Study||10
167114|NCT00660192|387044|P2|STARTED|Overall Study||13
167115|NCT00660192|387045|P1|STARTED|Overall Study||12
167116|NCT00660179|387056|P3|NOT COMPLETED|Overall Study||41
167117|NCT00660179|387057|P2|NOT COMPLETED|Overall Study||58
167118|NCT00660179|387058|P1|NOT COMPLETED|Overall Study||56
167119|NCT00660179|387056|P3|COMPLETED|Overall Study||201
167120|NCT00660179|387057|P2|COMPLETED|Overall Study||192
167121|NCT00660179|387058|P1|COMPLETED|Overall Study||194
167122|NCT00660179|387056|P3|STARTED|Overall Study||242
167123|NCT00660179|387057|P2|STARTED|Overall Study||250
167124|NCT00660179|387058|P1|STARTED|Overall Study||250
167125|NCT00660075|387092|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
167126|NCT00660075|387093|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
167127|NCT00660075|387092|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
167128|NCT00660075|387093|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
167129|NCT00660075|387092|P2|STARTED|Second Intervention (Week 11 to Week 16||18
167130|NCT00660075|387093|P1|STARTED|Second Intervention (Week 11 to Week 16||18
167131|NCT00660075|387092|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
167132|NCT00660075|387093|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
167133|NCT00660075|387092|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
167134|NCT00660075|387093|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
167135|NCT00660075|387092|P2|STARTED|Washout Period (Week 7 to Week 10)||18
167136|NCT00660075|387093|P1|STARTED|Washout Period (Week 7 to Week 10)||18
167137|NCT00660075|387092|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
167138|NCT00660075|387093|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
167139|NCT00660075|387092|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
167140|NCT00660075|387093|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
167141|NCT00660075|387092|P2|STARTED|First Intervention (Week 1 to Week 6)||18
167142|NCT00660075|387093|P1|STARTED|First Intervention (Week 1 to Week 6)||18
167143|NCT00660049|387099|P1|NOT COMPLETED|Overall Study||6
167144|NCT00660049|387099|P1|COMPLETED|Overall Study||6
167145|NCT00660049|387099|P1|STARTED|Overall Study||12
167146|NCT00660023|387103|P1|NOT COMPLETED|Overall Study||29
167147|NCT00660023|387103|P1|COMPLETED|Overall Study||95
167148|NCT00660023|387103|P1|Treated|Overall Study||114
167149|NCT00660023|387103|P1|STARTED|Overall Study||124
167150|NCT00660010|387114|P1|NOT COMPLETED|Overall Study||9
167151|NCT00660010|387114|P1|COMPLETED|Overall Study||46
167152|NCT00660010|387114|P1|STARTED|Overall Study||55
167153|NCT00659945|387130|P2|NOT COMPLETED|Overall Study||0
167154|NCT00659945|387131|P1|NOT COMPLETED|Overall Study||0
167155|NCT00659945|387130|P2|COMPLETED|Overall Study||75
167156|NCT00659945|387131|P1|COMPLETED|Overall Study||75
167157|NCT00659945|387130|P2|STARTED|Overall Study||75
167158|NCT00659945|387131|P1|STARTED|Overall Study||75
167159|NCT00659815|387139|P2|NOT COMPLETED|Overall Study||4
167160|NCT00659815|387140|P1|NOT COMPLETED|Overall Study||4
167161|NCT00659815|387139|P2|COMPLETED|Overall Study||147
167162|NCT00659815|387140|P1|COMPLETED|Overall Study||153
167163|NCT00659815|387139|P2|STARTED|Overall Study||151
167164|NCT00659815|387140|P1|STARTED|Overall Study||157
167165|NCT00659789|387152|P2|NOT COMPLETED|Overall Study||7
167166|NCT00659789|387153|P1|NOT COMPLETED|Overall Study||7
167167|NCT00659789|387152|P2|COMPLETED|Overall Study||36
167168|NCT00659789|387153|P1|COMPLETED|Overall Study||86
167169|NCT00659789|387152|P2|STARTED|Overall Study||43
167170|NCT00659789|387153|P1|STARTED|Overall Study||93
167171|NCT00659737|387171|P2|NOT COMPLETED|Overall Study||0
167172|NCT00659737|387172|P1|NOT COMPLETED|Overall Study||0
167173|NCT00659737|387171|P2|COMPLETED|Overall Study||58
167174|NCT00659737|387172|P1|COMPLETED|Overall Study||57
167175|NCT00659737|387171|P2|STARTED|Overall Study||58
167176|NCT00659737|387172|P1|STARTED|Overall Study||57
167177|NCT00659724|387178|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
167178|NCT00659724|387178|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
167179|NCT00659724|387178|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
167180|NCT00659724|387178|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
167181|NCT00659724|387178|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
167182|NCT00659724|387178|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
167183|NCT00659607|387196|P1|NOT COMPLETED|Overall Study||316
167184|NCT00659607|387196|P1|COMPLETED|Overall Study||3616
167185|NCT00659607|387196|P1|STARTED|Overall Study||3932
167186|NCT00659581|387214|P1|NOT COMPLETED|Overall Study||8582
167187|NCT00659581|387214|P1|COMPLETED|Overall Study||12412
167188|NCT00659581|387214|P1|STARTED|Overall Study||20994
167189|NCT00659529|387226|P1|NOT COMPLETED|Overall Study||16
167190|NCT00659529|387226|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
167191|NCT00659529|387226|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
167192|NCT00659529|387226|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
167193|NCT00659295|387232|P2|NOT COMPLETED|Overall Study||5603
167194|NCT00659295|387233|P1|NOT COMPLETED|Overall Study||2708
167195|NCT00659295|387232|P2|COMPLETED|Overall Study||32038
167196|NCT00659295|387233|P1|COMPLETED|Overall Study||10821
167197|NCT00659295|387232|P2|STARTED|Overall Study||37641
167198|NCT00659295|387233|P1|STARTED|Overall Study||13529
167199|NCT00659269|387241|P2|NOT COMPLETED|Overall Study||1
167200|NCT00659269|387242|P1|NOT COMPLETED|Overall Study||1
167201|NCT00659269|387241|P2|COMPLETED|Overall Study||161
167202|NCT00659269|387242|P1|COMPLETED|Overall Study||156
167203|NCT00659269|387241|P2|Group 3 (Taxanes)|Overall Study||97
167204|NCT00659269|387242|P1|Group 3 (Taxanes)|Overall Study||92
167205|NCT00659269|387241|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
167206|NCT00659269|387242|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
167207|NCT00659269|387241|P2|Group 1 (Heavy Metals)|Overall Study||52
167208|NCT00659269|387242|P1|Group 1 (Heavy Metals)|Overall Study||52
167209|NCT00659269|387241|P2|STARTED|Overall Study||162
167210|NCT00659269|387242|P1|STARTED|Overall Study||157
167211|NCT00659165|387272|P2|NOT COMPLETED|Overall Study||0
167212|NCT00659165|387273|P1|NOT COMPLETED|Overall Study||0
167213|NCT00659165|387272|P2|COMPLETED|Overall Study||5
167214|NCT00659165|387273|P1|COMPLETED|Overall Study||5
167215|NCT00659165|387272|P2|STARTED|Overall Study||5
167216|NCT00659165|387273|P1|STARTED|Overall Study||5
167217|NCT00659061|387281|P2|NOT COMPLETED|Overall Study||15
167218|NCT00659061|387282|P1|NOT COMPLETED|Overall Study||21
167219|NCT00659061|387281|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
167220|NCT00659061|387282|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
167221|NCT00659061|387281|P2|STARTED|Overall Study||302
167222|NCT00659061|387282|P1|STARTED|Overall Study||308
167223|NCT00658996|387300|P2|NOT COMPLETED|Second Intervention||1
167224|NCT00658996|387301|P1|NOT COMPLETED|Second Intervention||1
167225|NCT00658996|387300|P2|COMPLETED|Second Intervention||104
167226|NCT00658996|387301|P1|COMPLETED|Second Intervention||105
167227|NCT00658996|387300|P2|STARTED|Second Intervention||105
167228|NCT00658996|387301|P1|STARTED|Second Intervention||106
167229|NCT00658996|387300|P2|NOT COMPLETED|Crossover Period||1
167230|NCT00658996|387301|P1|NOT COMPLETED|Crossover Period||2
167231|NCT00658996|387300|P2|COMPLETED|Crossover Period||105
167232|NCT00658996|387301|P1|COMPLETED|Crossover Period||106
167233|NCT00658996|387300|P2|STARTED|Crossover Period||106
167234|NCT00658996|387301|P1|STARTED|Crossover Period||108
167235|NCT00658996|387300|P2|NOT COMPLETED|First Intervention||1
167236|NCT00658996|387301|P1|NOT COMPLETED|First Intervention||1
167237|NCT00658996|387300|P2|COMPLETED|First Intervention||106
167238|NCT00658996|387301|P1|COMPLETED|First Intervention||108
167239|NCT00658996|387300|P2|STARTED|First Intervention||107
167240|NCT00658996|387301|P1|STARTED|First Intervention||109
167241|NCT00658814|387313|P2|NOT COMPLETED|Maintenance Therapy||1
167242|NCT00658814|387314|P1|NOT COMPLETED|Maintenance Therapy||3
167243|NCT00658814|387313|P2|COMPLETED|Maintenance Therapy||7
167244|NCT00658814|387314|P1|COMPLETED|Maintenance Therapy||17
167245|NCT00658814|387313|P2|Eligible|Maintenance Therapy||8
167246|NCT00658814|387314|P1|Eligible|Maintenance Therapy||19
167247|NCT00658814|387313|P2|STARTED|Maintenance Therapy||8
167248|NCT00658814|387314|P1|STARTED|Maintenance Therapy||20
167249|NCT00658814|387313|P2|NOT COMPLETED|Consolidation Therapy||3
167250|NCT00658814|387314|P1|NOT COMPLETED|Consolidation Therapy||2
167251|NCT00658814|387313|P2|COMPLETED|Consolidation Therapy||10
167252|NCT00658814|387314|P1|COMPLETED|Consolidation Therapy||22
167253|NCT00658814|387313|P2|Eligible|Consolidation Therapy||11
167254|NCT00658814|387314|P1|Eligible|Consolidation Therapy||22
167255|NCT00658814|387313|P2|STARTED|Consolidation Therapy||13
167256|NCT00658814|387314|P1|STARTED|Consolidation Therapy||24
167257|NCT00658814|387313|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
167258|NCT00658814|387314|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
167259|NCT00658814|387313|P2|COMPLETED|Remission Induction Chemotherapy||41
167260|NCT00658814|387314|P1|COMPLETED|Remission Induction Chemotherapy||75
167261|NCT00658814|387313|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
167262|NCT00658814|387314|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
167263|NCT00658814|387313|P2|Eligible|Remission Induction Chemotherapy||57
167264|NCT00658814|387314|P1|Eligible|Remission Induction Chemotherapy||82
167265|NCT00658814|387313|P2|STARTED|Remission Induction Chemotherapy||59
167266|NCT00658814|387314|P1|STARTED|Remission Induction Chemotherapy||83
167267|NCT00658788|387328|P1|NOT COMPLETED|Overall Study||74
167268|NCT00658788|387328|P1|COMPLETED|Overall Study||231
167269|NCT00658788|387328|P1|STARTED|Overall Study||305
167270|NCT00658775|387383|P2|NOT COMPLETED|Overall Study||43
167271|NCT00658775|387384|P1|NOT COMPLETED|Overall Study||42
167272|NCT00658775|387383|P2|COMPLETED|Overall Study||485
167273|NCT00658775|387384|P1|COMPLETED|Overall Study||495
167274|NCT00658775|387383|P2|STARTED|Overall Study|Treated|528
167275|NCT00658775|387384|P1|STARTED|Overall Study|Treated|537
167276|NCT00658723|387396|P3|NOT COMPLETED|Overall Study||7
167277|NCT00658723|387397|P2|NOT COMPLETED|Overall Study||4
167278|NCT00658723|387398|P1|NOT COMPLETED|Overall Study||4
167279|NCT00658723|387396|P3|COMPLETED|Overall Study||44
167280|NCT00658723|387397|P2|COMPLETED|Overall Study||26
167281|NCT00658723|387398|P1|COMPLETED|Overall Study||56
167282|NCT00658723|387396|P3|STARTED|Overall Study||51
167283|NCT00658723|387397|P2|STARTED|Overall Study||30
167284|NCT00658723|387398|P1|STARTED|Overall Study||60
167285|NCT00658697|387425|P1|NOT COMPLETED|Overall Study||0
167286|NCT00658697|387425|P1|COMPLETED|Overall Study||41
167287|NCT00658697|387425|P1|STARTED|Overall Study||41
167288|NCT00658684|387436|P4|NOT COMPLETED|Overall Study||1
167289|NCT00658684|387437|P3|NOT COMPLETED|Overall Study||3
167290|NCT00658684|387438|P2|NOT COMPLETED|Overall Study||15
167291|NCT00658684|387439|P1|NOT COMPLETED|Overall Study||19
167292|NCT00658684|387436|P4|COMPLETED|Overall Study||27
167293|NCT00658684|387437|P3|COMPLETED|Overall Study||22
167294|NCT00658684|387438|P2|COMPLETED|Overall Study||84
167295|NCT00658684|387439|P1|COMPLETED|Overall Study||133
167296|NCT00658684|387436|P4|STARTED|Overall Study||28
167297|NCT00658684|387437|P3|STARTED|Overall Study||25
167298|NCT00658684|387438|P2|STARTED|Overall Study||99
167299|NCT00658684|387439|P1|STARTED|Overall Study||152
167300|NCT00658658|387494|P5|NOT COMPLETED|Overall Study||5
167301|NCT00658658|387495|P4|NOT COMPLETED|Overall Study||2
167302|NCT00658658|387496|P3|NOT COMPLETED|Overall Study||0
167303|NCT00658658|387497|P2|NOT COMPLETED|Overall Study||2
167304|NCT00658658|387498|P1|NOT COMPLETED|Overall Study||5
167305|NCT00658658|387494|P5|COMPLETED|Overall Study||3
167306|NCT00658658|387495|P4|COMPLETED|Overall Study||4
167307|NCT00658658|387496|P3|COMPLETED|Overall Study||4
167308|NCT00658658|387497|P2|COMPLETED|Overall Study||5
167309|NCT00658658|387498|P1|COMPLETED|Overall Study||1
167310|NCT00658658|387494|P5|STARTED|Overall Study||8
167311|NCT00658658|387495|P4|STARTED|Overall Study||6
167312|NCT00658658|387496|P3|STARTED|Overall Study||4
167313|NCT00658658|387497|P2|STARTED|Overall Study||7
167314|NCT00658658|387498|P1|STARTED|Overall Study||6
167315|NCT00658632|387557|P2|NOT COMPLETED|Overall Study||65
167316|NCT00658632|387558|P1|NOT COMPLETED|Overall Study||64
167317|NCT00658632|387557|P2|COMPLETED|Overall Study||633
167318|NCT00658632|387558|P1|COMPLETED|Overall Study||618
167319|NCT00658632|387557|P2|STARTED|Overall Study|Treated|698
167320|NCT00658632|387558|P1|STARTED|Overall Study|Treated|682
167321|NCT00658619|387573|P5|NOT COMPLETED|Overall Study||2
167322|NCT00658619|387574|P4|NOT COMPLETED|Overall Study||12
167323|NCT00658619|387575|P3|NOT COMPLETED|Overall Study||10
167324|NCT00658619|387576|P2|NOT COMPLETED|Overall Study||1
167325|NCT00658619|387577|P1|NOT COMPLETED|Overall Study||0
167326|NCT00658619|387573|P5|COMPLETED|Overall Study||21
167327|NCT00658619|387574|P4|COMPLETED|Overall Study||37
167328|NCT00658619|387575|P3|COMPLETED|Overall Study||31
167329|NCT00658619|387576|P2|COMPLETED|Overall Study||2
167330|NCT00658619|387577|P1|COMPLETED|Overall Study||3
167331|NCT00658619|387573|P5|STARTED|Overall Study||23
167332|NCT00658619|387574|P4|STARTED|Overall Study||49
167333|NCT00658619|387575|P3|STARTED|Overall Study||41
167334|NCT00658619|387576|P2|STARTED|Overall Study||3
167335|NCT00658619|387577|P1|STARTED|Overall Study||3
167336|NCT00658606|387599|P2|NOT COMPLETED|Overall Study||23
167337|NCT00658606|387600|P1|NOT COMPLETED|Overall Study||16
167338|NCT00658606|387599|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
167339|NCT00658606|387600|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
167340|NCT00658606|387599|P2|Completed Treatment|Overall Study||44
167341|NCT00658606|387600|P1|Completed Treatment|Overall Study||42
167342|NCT00658606|387599|P2|STARTED|Overall Study||49
167343|NCT00658606|387600|P1|STARTED|Overall Study||49
167344|NCT00658567|387629|P3|NOT COMPLETED|Overall Study||6
167345|NCT00658567|387630|P2|NOT COMPLETED|Overall Study||4
167346|NCT00658567|387631|P1|NOT COMPLETED|Overall Study||8
167347|NCT00658567|387629|P3|COMPLETED|Overall Study||35
167348|NCT00658567|387630|P2|COMPLETED|Overall Study||38
167349|NCT00658567|387631|P1|COMPLETED|Overall Study||32
167350|NCT00658567|387629|P3|STARTED|Overall Study||41
167351|NCT00658567|387630|P2|STARTED|Overall Study||42
167352|NCT00658567|387631|P1|STARTED|Overall Study||40
167353|NCT00658541|387642|P2|NOT COMPLETED|Second Intervention||0
167354|NCT00658541|387643|P1|NOT COMPLETED|Second Intervention||0
167355|NCT00658541|387642|P2|COMPLETED|Second Intervention||17
167356|NCT00658541|387643|P1|COMPLETED|Second Intervention||18
167357|NCT00658541|387642|P2|STARTED|Second Intervention||17
167358|NCT00658541|387643|P1|STARTED|Second Intervention||18
167359|NCT00658541|387642|P2|NOT COMPLETED|Washout Period of 7 Days||2
167360|NCT00658541|387643|P1|NOT COMPLETED|Washout Period of 7 Days||1
167361|NCT00658541|387642|P2|COMPLETED|Washout Period of 7 Days||17
167362|NCT00658541|387643|P1|COMPLETED|Washout Period of 7 Days||18
167363|NCT00658541|387642|P2|STARTED|Washout Period of 7 Days||19
167364|NCT00658541|387643|P1|STARTED|Washout Period of 7 Days||19
167365|NCT00658541|387642|P2|NOT COMPLETED|First Intervention||0
167366|NCT00658541|387643|P1|NOT COMPLETED|First Intervention||0
167367|NCT00658541|387642|P2|COMPLETED|First Intervention||19
167368|NCT00658541|387643|P1|COMPLETED|First Intervention||19
167369|NCT00658541|387642|P2|STARTED|First Intervention||19
167370|NCT00658541|387643|P1|STARTED|First Intervention||19
167371|NCT00658528|387655|P2|NOT COMPLETED|Overall Study||45
167372|NCT00658528|387656|P1|NOT COMPLETED|Overall Study||40
167373|NCT00658528|387655|P2|COMPLETED|Overall Study||479
167374|NCT00658528|387656|P1|COMPLETED|Overall Study||491
167375|NCT00658528|387655|P2|STARTED|Overall Study|Treated|524
167376|NCT00658528|387656|P1|STARTED|Overall Study|Treated|531
167377|NCT00658411|387666|P1|NOT COMPLETED|Overall Study||0
167378|NCT00658411|387666|P1|COMPLETED|Overall Study||5
167379|NCT00658411|387666|P1|STARTED|Overall Study||5
167380|NCT00658385|387674|P1|NOT COMPLETED|Overall Study||0
167381|NCT00658385|387674|P1|COMPLETED|Overall Study||5
167382|NCT00658385|387674|P1|STARTED|Overall Study||5
167383|NCT00658333|387680|P2|NOT COMPLETED|Overall Study||1
167384|NCT00658333|387681|P1|NOT COMPLETED|Overall Study||2
167385|NCT00658333|387680|P2|COMPLETED|Overall Study||14
167386|NCT00658333|387681|P1|COMPLETED|Overall Study||13
167387|NCT00658333|387680|P2|STARTED|Overall Study||15
167388|NCT00658333|387681|P1|STARTED|Overall Study||15
167389|NCT00658320|387691|P2|NOT COMPLETED|Extension Study: After Month 24||0
167390|NCT00658320|387692|P1|NOT COMPLETED|Extension Study: After Month 24||2
167391|NCT00658320|387691|P2|COMPLETED|Extension Study: After Month 24||0
167392|NCT00658320|387692|P1|COMPLETED|Extension Study: After Month 24||42
167393|NCT00658320|387691|P2|STARTED|Extension Study: After Month 24||0
167394|NCT00658320|387692|P1|STARTED|Extension Study: After Month 24||44
167395|NCT00658320|387691|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
167396|NCT00658320|387692|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
167397|NCT00658320|387691|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
167398|NCT00658320|387692|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
167399|NCT00658320|387691|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
167400|NCT00658320|387692|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
167401|NCT00658320|387691|P2|STARTED|Extension Study: Month 12 to Month 24||57
167402|NCT00658320|387692|P1|STARTED|Extension Study: Month 12 to Month 24||53
167403|NCT00658320|387691|P2|NOT COMPLETED|Core Study: 12 Months||3
167404|NCT00658320|387692|P1|NOT COMPLETED|Core Study: 12 Months||5
167405|NCT00658320|387691|P2|COMPLETED|Core Study: 12 Months||58
167406|NCT00658320|387692|P1|COMPLETED|Core Study: 12 Months||56
167407|NCT00658320|387691|P2|STARTED|Core Study: 12 Months||61
167408|NCT00658320|387692|P1|STARTED|Core Study: 12 Months||61
167409|NCT00658138|387715|P1|NOT COMPLETED|Overall Study||21
167410|NCT00658138|387715|P1|COMPLETED|Overall Study||40
167411|NCT00658138|387715|P1|STARTED|Overall Study||61
167412|NCT00657709|387725|P5|NOT COMPLETED|Overall Study||33
167413|NCT00657709|387726|P4|NOT COMPLETED|Overall Study||14
167414|NCT00657709|387727|P3|NOT COMPLETED|Overall Study||28
167415|NCT00657709|387728|P2|NOT COMPLETED|Overall Study||33
167416|NCT00657709|387729|P1|NOT COMPLETED|Overall Study||23
167417|NCT00657709|387725|P5|COMPLETED|Overall Study||457
167418|NCT00657709|387726|P4|COMPLETED|Overall Study||645
167419|NCT00657709|387727|P3|COMPLETED|Overall Study||792
167420|NCT00657709|387728|P2|COMPLETED|Overall Study||795
167421|NCT00657709|387729|P1|COMPLETED|Overall Study||810
167422|NCT00657709|387725|P5|STARTED|Overall Study||490
167423|NCT00657709|387726|P4|STARTED|Overall Study||659
167424|NCT00657709|387727|P3|STARTED|Overall Study||820
167425|NCT00657709|387728|P2|STARTED|Overall Study||828
167426|NCT00657709|387729|P1|STARTED|Overall Study||833
167427|NCT00657657|387770|P1|NOT COMPLETED|Overall Study||0
167428|NCT00657657|387770|P1|COMPLETED|Overall Study||29
167429|NCT00657657|387770|P1|STARTED|Overall Study||29
167430|NCT00657553|387780|P2|NOT COMPLETED|Overall Study||5
167431|NCT00657553|387781|P1|NOT COMPLETED|Overall Study||5
167432|NCT00657553|387780|P2|COMPLETED|Overall Study||0
167433|NCT00657553|387781|P1|COMPLETED|Overall Study||0
167434|NCT00657553|387780|P2|STARTED|Overall Study||5
167435|NCT00657553|387781|P1|STARTED|Overall Study||5
167436|NCT00657371|387787|P1|NOT COMPLETED|Overall Study||39
167437|NCT00657371|387787|P1|COMPLETED|Overall Study||249
167438|NCT00657371|387787|P1|STARTED|Overall Study||288
167439|NCT00657358|387792|P1|NOT COMPLETED|Overall Study||6
167440|NCT00657358|387792|P1|COMPLETED|Overall Study||16
167441|NCT00657358|387792|P1|STARTED|Overall Study||22
167442|NCT00657280|387800|P1|NOT COMPLETED|Overall Study||0
167443|NCT00657280|387800|P1|COMPLETED|Overall Study||16
167444|NCT00657280|387800|P1|STARTED|Overall Study||16
167445|NCT00657267|387804|P1|NOT COMPLETED|Overall Study||54
167446|NCT00657267|387804|P1|COMPLETED|Overall Study||4
167447|NCT00657267|387804|P1|STARTED|Overall Study||58
167448|NCT00657150|387814|P2|NOT COMPLETED|Treatment||97
167449|NCT00657150|387815|P1|NOT COMPLETED|Treatment||107
167450|NCT00657150|387814|P2|COMPLETED|Treatment||906
167451|NCT00657150|387815|P1|COMPLETED|Treatment||903
167452|NCT00657150|387814|P2|STARTED|Treatment||1003
167453|NCT00657150|387815|P1|STARTED|Treatment||1010
167454|NCT00657150|387814|P2|NOT COMPLETED|Overall Study||93
167455|NCT00657150|387815|P1|NOT COMPLETED|Overall Study||115
167456|NCT00657150|387814|P2|COMPLETED|Overall Study||910
167457|NCT00657150|387815|P1|COMPLETED|Overall Study||895
167458|NCT00657150|387814|P2|STARTED|Overall Study||1003
167459|NCT00657150|387815|P1|STARTED|Overall Study||1010
167460|NCT00657046|387846|P3|NOT COMPLETED|Overall Study||2
167461|NCT00657046|387847|P2|NOT COMPLETED|Overall Study||3
167462|NCT00657046|387848|P1|NOT COMPLETED|Overall Study||4
167463|NCT00657046|387846|P3|COMPLETED|Overall Study||21
167464|NCT00657046|387847|P2|COMPLETED|Overall Study||29
167465|NCT00657046|387848|P1|COMPLETED|Overall Study||26
167466|NCT00657046|387846|P3|Had Visits up to Visit 18|Overall Study||23
167467|NCT00657046|387847|P2|Had Visits up to Visit 18|Overall Study||30
167468|NCT00657046|387848|P1|Had Visits up to Visit 18|Overall Study||28
167469|NCT00657046|387846|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
167470|NCT00657046|387847|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
167471|NCT00657046|387848|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
167472|NCT00657046|387846|P3|STARTED|Overall Study||23
167473|NCT00657046|387847|P2|STARTED|Overall Study||32
167474|NCT00657046|387848|P1|STARTED|Overall Study||30
167475|NCT00657020|387880|P2|NOT COMPLETED|PERIOD 2||0
167476|NCT00657020|387881|P1|NOT COMPLETED|PERIOD 2||0
167477|NCT00657020|387880|P2|COMPLETED|PERIOD 2||11
167478|NCT00657020|387881|P1|COMPLETED|PERIOD 2||11
167479|NCT00657020|387880|P2|STARTED|PERIOD 2||11
167480|NCT00657020|387881|P1|STARTED|PERIOD 2||11
167481|NCT00657020|387880|P2|NOT COMPLETED|PERIOD 1||1
167482|NCT00657020|387881|P1|NOT COMPLETED|PERIOD 1||0
167483|NCT00657020|387880|P2|COMPLETED|PERIOD 1||11
167484|NCT00657020|387881|P1|COMPLETED|PERIOD 1||11
167485|NCT00657020|387880|P2|STARTED|PERIOD 1||12
167486|NCT00657020|387881|P1|STARTED|PERIOD 1||11
167487|NCT00656968|387911|P2|NOT COMPLETED|Overall Study||0
167488|NCT00656968|387912|P1|NOT COMPLETED|Overall Study||0
167489|NCT00656968|387911|P2|COMPLETED|Overall Study||117
167490|NCT00656968|387912|P1|COMPLETED|Overall Study||115
167491|NCT00656968|387911|P2|STARTED|Overall Study||117
167492|NCT00656968|387912|P1|STARTED|Overall Study||115
167493|NCT00656916|387922|P2|NOT COMPLETED|Overall Study||0
167494|NCT00656916|387923|P1|NOT COMPLETED|Overall Study||0
167495|NCT00656916|387922|P2|COMPLETED|Overall Study||0
167496|NCT00656916|387923|P1|COMPLETED|Overall Study||1
167497|NCT00656916|387922|P2|STARTED|Overall Study||0
167498|NCT00656916|387923|P1|STARTED|Overall Study||1
167499|NCT00656851|387931|P2|NOT COMPLETED|Overall Study||4
167500|NCT00656851|387932|P1|NOT COMPLETED|Overall Study||0
167501|NCT00656851|387931|P2|COMPLETED|Overall Study||8
167502|NCT00656851|387932|P1|COMPLETED|Overall Study||12
167503|NCT00656851|387931|P2|STARTED|Overall Study||12
167504|NCT00656851|387932|P1|STARTED|Overall Study||12
167505|NCT00656799|387954|P1|NOT COMPLETED|Overall Study||2
167506|NCT00656799|387954|P1|COMPLETED|Overall Study||4
167507|NCT00656799|387954|P1|STARTED|Overall Study||6
167508|NCT00656669|387976|P1|NOT COMPLETED|AC (Cycles 6-9)||2
167509|NCT00656669|387976|P1|COMPLETED|AC (Cycles 6-9)||15
167510|NCT00656669|387976|P1|STARTED|AC (Cycles 6-9)||17
167511|NCT00656669|387976|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
167512|NCT00656669|387976|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
167513|NCT00656669|387976|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
167514|NCT00656669|387976|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
167515|NCT00656669|387976|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
167516|NCT00656669|387976|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
167517|NCT00656656|387985|P1|NOT COMPLETED|Overall Study||0
167518|NCT00656656|387985|P1|COMPLETED|Overall Study||23
167519|NCT00656656|387985|P1|STARTED|Overall Study||23
167520|NCT00656617|387990|P1|NOT COMPLETED|Overall Study||7
167521|NCT00656617|387990|P1|COMPLETED|Overall Study||99
167522|NCT00656617|387990|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
167523|NCT00656617|387990|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
167524|NCT00656617|387990|P1|STARTED|Overall Study||106
167525|NCT00656474|387996|P1|NOT COMPLETED|Overall Study||1
167526|NCT00656474|387996|P1|COMPLETED|Overall Study||11
167527|NCT00656474|387996|P1|STARTED|Overall Study||12
167528|NCT00656448|388005|P2|NOT COMPLETED|Overall Study||0
167529|NCT00656448|388006|P1|NOT COMPLETED|Overall Study||0
167530|NCT00656448|388005|P2|COMPLETED|Overall Study||25
167531|NCT00656448|388006|P1|COMPLETED|Overall Study||25
167532|NCT00656448|388005|P2|STARTED|Overall Study||25
167533|NCT00656448|388006|P1|STARTED|Overall Study||25
167534|NCT00656370|388014|P1|NOT COMPLETED|Overall Study||10
167535|NCT00656370|388014|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
167536|NCT00656370|388014|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
167537|NCT00656201|388022|P2|NOT COMPLETED|Overall Study||32
167538|NCT00656201|388023|P1|NOT COMPLETED|Overall Study||29
167539|NCT00656201|388022|P2|COMPLETED|Overall Study||201
167540|NCT00656201|388023|P1|COMPLETED|Overall Study||206
167541|NCT00656201|388022|P2|STARTED|Overall Study||233
167542|NCT00656201|388023|P1|STARTED|Overall Study||235
167543|NCT00656175|388031|P2|NOT COMPLETED|Overall Study||1
167544|NCT00656175|388032|P1|NOT COMPLETED|Overall Study||1
167545|NCT00656175|388031|P2|COMPLETED|Overall Study||20
167546|NCT00656175|388032|P1|COMPLETED|Overall Study||17
167547|NCT00656175|388031|P2|STARTED|Overall Study||21
167548|NCT00656175|388032|P1|STARTED|Overall Study||18
167549|NCT00656136|388040|P2|NOT COMPLETED|Overall Study||390
167550|NCT00656136|388041|P1|NOT COMPLETED|Overall Study||195
167551|NCT00656136|388040|P2|COMPLETED|Overall Study||0
167552|NCT00656136|388041|P1|COMPLETED|Overall Study||0
167553|NCT00656136|388040|P2|STARTED|Overall Study|Randomised patients.|390
167554|NCT00656136|388041|P1|STARTED|Overall Study|Randomised patients.|195
167555|NCT00656084|388051|P1|NOT COMPLETED|Overall Study||7
167556|NCT00656084|388051|P1|COMPLETED|Overall Study||9
167557|NCT00656084|388051|P1|STARTED|Overall Study||16
167558|NCT00656058|388058|P1|NOT COMPLETED|Overall Study||6
167559|NCT00656058|388058|P1|COMPLETED|Overall Study||19
167560|NCT00656058|388058|P1|STARTED|Overall Study||25
167561|NCT00655889|388067|P1|NOT COMPLETED|Overall Study||2
167562|NCT00655889|388067|P1|COMPLETED|Overall Study||11
167563|NCT00655889|388067|P1|STARTED|Overall Study||13
167564|NCT00655863|388075|P3|NOT COMPLETED|Overall Study||1
167565|NCT00655863|388076|P2|NOT COMPLETED|Overall Study||0
167566|NCT00655863|388077|P1|NOT COMPLETED|Overall Study||0
167567|NCT00655863|388075|P3|COMPLETED|Overall Study||21
167568|NCT00655863|388076|P2|COMPLETED|Overall Study||25
167569|NCT00655863|388077|P1|COMPLETED|Overall Study||24
167570|NCT00655863|388075|P3|STARTED|Overall Study||22
167571|NCT00655863|388076|P2|STARTED|Overall Study||25
167572|NCT00655863|388077|P1|STARTED|Overall Study||24
167573|NCT00655824|388136|P1|NOT COMPLETED|Follow-up (FU) Period||66
167574|NCT00655824|388136|P1|COMPLETED|Follow-up (FU) Period||13
167575|NCT00655824|388136|P1|STARTED|Follow-up (FU) Period|A participant who withdrew from the Treatment Phase could still enter the Follow-up Phase.|79
167576|NCT00655824|388136|P1|NOT COMPLETED|Treatment Period||84
167577|NCT00655824|388136|P1|COMPLETED|Treatment Period||8
167578|NCT00655824|388136|P1|STARTED|Treatment Period||92
167579|NCT00655746|388180|P1|NOT COMPLETED|Overall Study||1
167580|NCT00655746|388180|P1|COMPLETED|Overall Study||13
167581|NCT00655746|388180|P1|STARTED|Overall Study||14
167582|NCT00655733|388199|P2|NOT COMPLETED|Overall Study||8
167583|NCT00655733|388200|P1|NOT COMPLETED|Overall Study||7
167584|NCT00655733|388199|P2|COMPLETED|Overall Study||42
167585|NCT00655733|388200|P1|COMPLETED|Overall Study||44
167586|NCT00655733|388199|P2|STARTED|Overall Study||50
167587|NCT00655733|388200|P1|STARTED|Overall Study||51
167588|NCT00655668|388206|P1|NOT COMPLETED|Overall Study||54
167589|NCT00655668|388206|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
167590|NCT00655668|388206|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
167591|NCT00655642|388218|P4|NOT COMPLETED|Overall Study||2
167592|NCT00655642|388219|P3|NOT COMPLETED|Overall Study||2
167593|NCT00655642|388220|P2|NOT COMPLETED|Overall Study||3
167594|NCT00655642|388221|P1|NOT COMPLETED|Overall Study||1
167595|NCT00655642|388218|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
167596|NCT00655642|388219|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
167597|NCT00655642|388220|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
167598|NCT00655642|388221|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
167599|NCT00655642|388218|P4|STARTED|Overall Study||41
167600|NCT00655642|388219|P3|STARTED|Overall Study||45
167601|NCT00655642|388220|P2|STARTED|Overall Study||43
167602|NCT00655642|388221|P1|STARTED|Overall Study||42
167603|NCT00655629|388233|P2|NOT COMPLETED|Overall Study||23
167604|NCT00655629|388234|P1|NOT COMPLETED|Overall Study||21
167605|NCT00655629|388233|P2|COMPLETED|Overall Study||144
167606|NCT00655629|388234|P1|COMPLETED|Overall Study||151
167607|NCT00655629|388233|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
167608|NCT00655629|388234|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
167609|NCT00655629|388233|P2|STARTED|Overall Study||167
167610|NCT00655629|388234|P1|STARTED|Overall Study||172
167611|NCT00655564|388270|P1|NOT COMPLETED|Overall Study||3
167612|NCT00655564|388270|P1|COMPLETED|Overall Study||12
167613|NCT00655564|388270|P1|STARTED|Overall Study||15
167614|NCT00655551|388278|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
167615|NCT00655551|388279|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
167616|NCT00655551|388280|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
167617|NCT00655551|388278|P3|COMPLETED|Period 4 (up to 7 Days)||0
167618|NCT00655551|388279|P2|COMPLETED|Period 4 (up to 7 Days)||23
167619|NCT00655551|388280|P1|COMPLETED|Period 4 (up to 7 Days)||0
167620|NCT00655551|388278|P3|STARTED|Period 4 (up to 7 Days)||0
167621|NCT00655551|388279|P2|STARTED|Period 4 (up to 7 Days)||25
167622|NCT00655551|388280|P1|STARTED|Period 4 (up to 7 Days)||0
167623|NCT00655551|388278|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
167624|NCT00655551|388279|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
167625|NCT00655551|388280|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
167626|NCT00655551|388278|P3|COMPLETED|Period 3 (up to 7 Days)||21
167627|NCT00655551|388279|P2|COMPLETED|Period 3 (up to 7 Days)||0
167628|NCT00655551|388280|P1|COMPLETED|Period 3 (up to 7 Days)||0
167629|NCT00655551|388278|P3|STARTED|Period 3 (up to 7 Days)||25
167630|NCT00655551|388279|P2|STARTED|Period 3 (up to 7 Days)||0
167631|NCT00655551|388280|P1|STARTED|Period 3 (up to 7 Days)||0
167632|NCT00655551|388278|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
167633|NCT00655551|388279|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
167634|NCT00655551|388280|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
167635|NCT00655551|388278|P3|COMPLETED|Period 2 (up to 7 Days)||0
167636|NCT00655551|388279|P2|COMPLETED|Period 2 (up to 7 Days)||24
167637|NCT00655551|388280|P1|COMPLETED|Period 2 (up to 7 Days)||0
167638|NCT00655551|388278|P3|STARTED|Period 2 (up to 7 Days)||0
167639|NCT00655551|388279|P2|STARTED|Period 2 (up to 7 Days)||25
167640|NCT00655551|388280|P1|STARTED|Period 2 (up to 7 Days)||0
167641|NCT00655551|388278|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
167642|NCT00655551|388279|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
167643|NCT00655551|388280|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
167644|NCT00655551|388278|P3|COMPLETED|Period 1 (up to 7 Days)||0
167645|NCT00655551|388279|P2|COMPLETED|Period 1 (up to 7 Days)||0
167646|NCT00655551|388280|P1|COMPLETED|Period 1 (up to 7 Days)||25
167647|NCT00655551|388278|P3|STARTED|Period 1 (up to 7 Days)||0
167648|NCT00655551|388279|P2|STARTED|Period 1 (up to 7 Days)||0
167649|NCT00655551|388280|P1|STARTED|Period 1 (up to 7 Days)||25
167650|NCT00655551|388278|P3|NOT COMPLETED|All Periods Combined||4
167651|NCT00655551|388279|P2|NOT COMPLETED|All Periods Combined||3
167652|NCT00655551|388280|P1|NOT COMPLETED|All Periods Combined||0
167653|NCT00655551|388278|P3|COMPLETED|All Periods Combined||21
167654|NCT00655551|388279|P2|COMPLETED|All Periods Combined||47
167655|NCT00655551|388280|P1|COMPLETED|All Periods Combined||25
167656|NCT00655551|388278|P3|STARTED|All Periods Combined||25
167657|NCT00655551|388279|P2|STARTED|All Periods Combined||50
167658|NCT00655551|388280|P1|STARTED|All Periods Combined||25
167659|NCT00655486|388294|P1|NOT COMPLETED|Overall Study||28
167660|NCT00655486|388294|P1|COMPLETED|Overall Study||69
167661|NCT00655486|388294|P1|STARTED|Overall Study||97
167662|NCT00655356|388301|P2|NOT COMPLETED|Overall Study||10
167663|NCT00655356|388302|P1|NOT COMPLETED|Overall Study||17
167664|NCT00655356|388301|P2|COMPLETED|Overall Study||98
167665|NCT00655356|388302|P1|COMPLETED|Overall Study||93
167666|NCT00655356|388301|P2|STARTED|Overall Study||108
167667|NCT00655356|388302|P1|STARTED|Overall Study||110
167668|NCT00655083|388316|P2|NOT COMPLETED|Overall Study||0
167669|NCT00655083|388317|P1|NOT COMPLETED|Overall Study||0
167670|NCT00655083|388316|P2|COMPLETED|Overall Study||8
167671|NCT00655083|388317|P1|COMPLETED|Overall Study||12
167672|NCT00655083|388316|P2|STARTED|Overall Study||8
167673|NCT00655083|388317|P1|STARTED|Overall Study||12
167674|NCT00654992|388331|P2|NOT COMPLETED|Overall Study||0
167675|NCT00654992|388332|P1|NOT COMPLETED|Overall Study||0
167676|NCT00654992|388331|P2|COMPLETED|Overall Study||35
167677|NCT00654992|388332|P1|COMPLETED|Overall Study||36
167678|NCT00654992|388331|P2|STARTED|Overall Study||35
167679|NCT00654992|388332|P1|STARTED|Overall Study||36
167680|NCT00654953|388341|P3|NOT COMPLETED|Overall Study||22
167681|NCT00654953|388342|P2|NOT COMPLETED|Overall Study||28
167682|NCT00654953|388343|P1|NOT COMPLETED|Overall Study||30
167683|NCT00654953|388341|P3|COMPLETED|Overall Study||8
167684|NCT00654953|388342|P2|COMPLETED|Overall Study||8
167685|NCT00654953|388343|P1|COMPLETED|Overall Study||6
167686|NCT00654953|388341|P3|STARTED|Overall Study||30
167687|NCT00654953|388342|P2|STARTED|Overall Study||36
167688|NCT00654953|388343|P1|STARTED|Overall Study||36
167689|NCT00654940|388353|P2|NOT COMPLETED|Period 2||0
167690|NCT00654940|388354|P1|NOT COMPLETED|Period 2||0
167691|NCT00654940|388353|P2|COMPLETED|Period 2||11
167692|NCT00654940|388354|P1|COMPLETED|Period 2||12
167693|NCT00654940|388353|P2|STARTED|Period 2||11
167694|NCT00654940|388354|P1|STARTED|Period 2||12
167695|NCT00654940|388353|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
167696|NCT00654940|388354|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
167697|NCT00654940|388353|P2|COMPLETED|Washout Period of 2 Weeks||11
167698|NCT00654940|388354|P1|COMPLETED|Washout Period of 2 Weeks||12
167699|NCT00654940|388353|P2|STARTED|Washout Period of 2 Weeks||11
167700|NCT00654940|388354|P1|STARTED|Washout Period of 2 Weeks||12
167701|NCT00654940|388353|P2|NOT COMPLETED|Period 1||1
167702|NCT00654940|388354|P1|NOT COMPLETED|Period 1||1
167703|NCT00654940|388353|P2|COMPLETED|Period 1||11
167704|NCT00654940|388354|P1|COMPLETED|Period 1||12
167705|NCT00654940|388353|P2|Received Study Treatment|Period 1||12
167706|NCT00654940|388354|P1|Received Study Treatment|Period 1||12
167707|NCT00654940|388353|P2|STARTED|Period 1|Assigned to study treatment.|12
167708|NCT00654940|388354|P1|STARTED|Period 1|Assigned to study treatment.|13
167709|NCT00654927|388366|P1|NOT COMPLETED|Overall Study||107
167710|NCT00654927|388366|P1|COMPLETED|Overall Study||70
167711|NCT00654927|388366|P1|STARTED|Overall Study||177
167712|NCT00654901|388378|P4|NOT COMPLETED|Overall Study||0
167713|NCT00654901|388379|P3|NOT COMPLETED|Overall Study||2
167714|NCT00654901|388380|P2|NOT COMPLETED|Overall Study||0
167715|NCT00654901|388381|P1|NOT COMPLETED|Overall Study||4
167716|NCT00654901|388378|P4|COMPLETED|Overall Study||113
167717|NCT00654901|388379|P3|COMPLETED|Overall Study||250
167718|NCT00654901|388380|P2|COMPLETED|Overall Study||262
167719|NCT00654901|388381|P1|COMPLETED|Overall Study||250
167720|NCT00654901|388378|P4|STARTED|Overall Study||113
167721|NCT00654901|388379|P3|STARTED|Overall Study||252
167722|NCT00654901|388380|P2|STARTED|Overall Study||262
167723|NCT00654901|388381|P1|STARTED|Overall Study||254
167724|NCT00654875|388401|P2|NOT COMPLETED|Overall Study||17
167725|NCT00654875|388402|P1|NOT COMPLETED|Overall Study||17
167726|NCT00654875|388401|P2|COMPLETED|Overall Study||147
167727|NCT00654875|388402|P1|COMPLETED|Overall Study||147
167728|NCT00654875|388401|P2|STARTED|Overall Study||164
167729|NCT00654875|388402|P1|STARTED|Overall Study||164
167730|NCT00654784|388422|P2|NOT COMPLETED|Overall Study||0
167731|NCT00654784|388423|P1|NOT COMPLETED|Overall Study||0
167732|NCT00654784|388422|P2|COMPLETED|Overall Study||8
167733|NCT00654784|388423|P1|COMPLETED|Overall Study||13
167734|NCT00654784|388422|P2|STARTED|Overall Study||8
167735|NCT00654784|388423|P1|STARTED|Overall Study||13
167736|NCT00654745|388429|P1|NOT COMPLETED|Overall Study||43
167737|NCT00654745|388429|P1|COMPLETED|Overall Study||164
167828|NCT00654381|388583|P4|STARTED|2nd Stage||155
167829|NCT00654381|388584|P3|STARTED|2nd Stage||156
167738|NCT00654745|388429|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
167739|NCT00654654|388467|P1|NOT COMPLETED|Overall Study||7
167740|NCT00654654|388467|P1|COMPLETED|Overall Study||43
167741|NCT00654654|388467|P1|STARTED|Overall Study||50
167742|NCT00654641|388474|P2|NOT COMPLETED|Overall Study||3
167743|NCT00654641|388475|P1|NOT COMPLETED|Overall Study||2
167744|NCT00654641|388474|P2|COMPLETED|Overall Study||23
167745|NCT00654641|388475|P1|COMPLETED|Overall Study||26
167746|NCT00654641|388474|P2|STARTED|Overall Study||26
167747|NCT00654641|388475|P1|STARTED|Overall Study||28
167748|NCT00654628|388481|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
167749|NCT00654628|388481|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
167750|NCT00654628|388481|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
167751|NCT00654628|388481|P1|NOT COMPLETED|6-week Active Treatment Period||21
167752|NCT00654628|388481|P1|COMPLETED|6-week Active Treatment Period||152
167753|NCT00654628|388481|P1|STARTED|6-week Active Treatment Period||173
167754|NCT00654511|388500|P4|NOT COMPLETED|Overall Study||0
167755|NCT00654511|388501|P3|NOT COMPLETED|Overall Study||0
167756|NCT00654511|388502|P2|NOT COMPLETED|Overall Study||0
167757|NCT00654511|388503|P1|NOT COMPLETED|Overall Study||0
167758|NCT00654511|388500|P4|COMPLETED|Overall Study||25
167759|NCT00654511|388501|P3|COMPLETED|Overall Study||25
167760|NCT00654511|388502|P2|COMPLETED|Overall Study||25
167761|NCT00654511|388503|P1|COMPLETED|Overall Study||26
167762|NCT00654511|388500|P4|STARTED|Overall Study||25
167763|NCT00654511|388501|P3|STARTED|Overall Study||25
167764|NCT00654511|388502|P2|STARTED|Overall Study||25
167765|NCT00654511|388503|P1|STARTED|Overall Study||26
167766|NCT00654498|388519|P2|NOT COMPLETED|Overall Study||12
167767|NCT00654498|388520|P1|NOT COMPLETED|Overall Study||14
167768|NCT00654498|388519|P2|COMPLETED|Overall Study||91
167769|NCT00654498|388520|P1|COMPLETED|Overall Study||189
167770|NCT00654498|388519|P2|STARTED|Overall Study||103
167771|NCT00654498|388520|P1|STARTED|Overall Study||203
167772|NCT00654420|388552|P4|NOT COMPLETED|Phase II||38
167773|NCT00654420|388553|P3|NOT COMPLETED|Phase II||37
167774|NCT00654420|388554|P2|NOT COMPLETED|Phase II||0
167775|NCT00654420|388555|P1|NOT COMPLETED|Phase II||0
167776|NCT00654420|388552|P4|COMPLETED|Phase II||0
167777|NCT00654420|388553|P3|COMPLETED|Phase II||0
167778|NCT00654420|388554|P2|COMPLETED|Phase II||0
167779|NCT00654420|388555|P1|COMPLETED|Phase II||0
167780|NCT00654420|388552|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
167781|NCT00654420|388553|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
167782|NCT00654420|388554|P2|STARTED|Phase II||0
167783|NCT00654420|388555|P1|STARTED|Phase II||0
167784|NCT00654420|388552|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
167785|NCT00654420|388553|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
167786|NCT00654420|388554|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
167787|NCT00654420|388555|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
167788|NCT00654420|388552|P4|COMPLETED|Phase I (Dose Escalation)||0
167789|NCT00654420|388553|P3|COMPLETED|Phase I (Dose Escalation)||0
167790|NCT00654420|388554|P2|COMPLETED|Phase I (Dose Escalation)||0
167791|NCT00654420|388555|P1|COMPLETED|Phase I (Dose Escalation)||0
167792|NCT00654420|388552|P4|STARTED|Phase I (Dose Escalation)||0
167793|NCT00654420|388553|P3|STARTED|Phase I (Dose Escalation)||0
167794|NCT00654420|388554|P2|STARTED|Phase I (Dose Escalation)||16
167795|NCT00654420|388555|P1|STARTED|Phase I (Dose Escalation)||4
167796|NCT00654381|388581|P6|NOT COMPLETED|Extension Stage||3
167797|NCT00654381|388582|P5|NOT COMPLETED|Extension Stage||3
167798|NCT00654381|388583|P4|NOT COMPLETED|Extension Stage||9
167799|NCT00654381|388584|P3|NOT COMPLETED|Extension Stage||11
167800|NCT00654381|388585|P2|NOT COMPLETED|Extension Stage||2
167801|NCT00654381|388586|P1|NOT COMPLETED|Extension Stage||1
167802|NCT00654381|388581|P6|COMPLETED|Extension Stage||73
167803|NCT00654381|388582|P5|COMPLETED|Extension Stage||68
167804|NCT00654381|388583|P4|COMPLETED|Extension Stage||142
167805|NCT00654381|388584|P3|COMPLETED|Extension Stage||142
167806|NCT00654381|388585|P2|COMPLETED|Extension Stage||36
167807|NCT00654381|388586|P1|COMPLETED|Extension Stage||33
167808|NCT00654381|388581|P6|STARTED|Extension Stage||76
167809|NCT00654381|388582|P5|STARTED|Extension Stage||71
167810|NCT00654381|388583|P4|STARTED|Extension Stage||151
167811|NCT00654381|388584|P3|STARTED|Extension Stage||153
167812|NCT00654381|388585|P2|STARTED|Extension Stage||38
167813|NCT00654381|388586|P1|STARTED|Extension Stage||34
167814|NCT00654381|388581|P6|NOT COMPLETED|2nd Stage||3
167815|NCT00654381|388582|P5|NOT COMPLETED|2nd Stage||8
167816|NCT00654381|388583|P4|NOT COMPLETED|2nd Stage||4
167817|NCT00654381|388584|P3|NOT COMPLETED|2nd Stage||3
167818|NCT00654381|388585|P2|NOT COMPLETED|2nd Stage||0
167819|NCT00654381|388586|P1|NOT COMPLETED|2nd Stage||2
167820|NCT00654381|388581|P6|COMPLETED|2nd Stage||76
167821|NCT00654381|388582|P5|COMPLETED|2nd Stage||71
167822|NCT00654381|388583|P4|COMPLETED|2nd Stage||151
167823|NCT00654381|388584|P3|COMPLETED|2nd Stage||153
167824|NCT00654381|388585|P2|COMPLETED|2nd Stage||38
167825|NCT00654381|388586|P1|COMPLETED|2nd Stage||34
167826|NCT00654381|388581|P6|STARTED|2nd Stage||79
167827|NCT00654381|388582|P5|STARTED|2nd Stage||79
167830|NCT00654381|388585|P2|STARTED|2nd Stage||38
167831|NCT00654381|388586|P1|STARTED|2nd Stage||36
167832|NCT00654381|388581|P6|NOT COMPLETED|1st Stage||2
167833|NCT00654381|388582|P5|NOT COMPLETED|1st Stage||2
167834|NCT00654381|388583|P4|NOT COMPLETED|1st Stage||5
167835|NCT00654381|388584|P3|NOT COMPLETED|1st Stage||3
167836|NCT00654381|388585|P2|NOT COMPLETED|1st Stage||3
167837|NCT00654381|388586|P1|NOT COMPLETED|1st Stage||3
167838|NCT00654381|388581|P6|COMPLETED|1st Stage||79
167839|NCT00654381|388582|P5|COMPLETED|1st Stage||79
167840|NCT00654381|388583|P4|COMPLETED|1st Stage||155
167841|NCT00654381|388584|P3|COMPLETED|1st Stage||156
167842|NCT00654381|388585|P2|COMPLETED|1st Stage||38
167843|NCT00654381|388586|P1|COMPLETED|1st Stage||36
167844|NCT00654381|388581|P6|STARTED|1st Stage||81
167845|NCT00654381|388582|P5|STARTED|1st Stage||81
167846|NCT00654381|388583|P4|STARTED|1st Stage||160
167847|NCT00654381|388584|P3|STARTED|1st Stage||159
167848|NCT00654381|388585|P2|STARTED|1st Stage||41
167849|NCT00654381|388586|P1|STARTED|1st Stage||39
167850|NCT00654368|388623|P3|NOT COMPLETED|Overall Study||32
167851|NCT00654368|388624|P2|NOT COMPLETED|Overall Study||48
167852|NCT00654368|388625|P1|NOT COMPLETED|Overall Study||53
167853|NCT00654368|388623|P3|COMPLETED|Overall Study||75
167854|NCT00654368|388624|P2|COMPLETED|Overall Study||50
167855|NCT00654368|388625|P1|COMPLETED|Overall Study||0
167856|NCT00654368|388623|P3|STARTED|Overall Study||107
167857|NCT00654368|388624|P2|STARTED|Overall Study||98
167858|NCT00654368|388625|P1|STARTED|Overall Study||53
167859|NCT00654329|388660|P4|NOT COMPLETED|Overall Study||0
167860|NCT00654329|388661|P3|NOT COMPLETED|Overall Study||0
167861|NCT00654329|388662|P2|NOT COMPLETED|Overall Study||0
167862|NCT00654329|388663|P1|NOT COMPLETED|Overall Study||0
167863|NCT00654329|388660|P4|COMPLETED|Overall Study||27
167864|NCT00654329|388661|P3|COMPLETED|Overall Study||23
167865|NCT00654329|388662|P2|COMPLETED|Overall Study||28
167866|NCT00654329|388663|P1|COMPLETED|Overall Study||23
167867|NCT00654329|388660|P4|STARTED|Overall Study||27
167868|NCT00654329|388661|P3|STARTED|Overall Study||23
167869|NCT00654329|388662|P2|STARTED|Overall Study||28
167870|NCT00654329|388663|P1|STARTED|Overall Study||23
167871|NCT00654186|388677|P1|NOT COMPLETED|Overall Study||5
167872|NCT00654186|388677|P1|COMPLETED|Overall Study||27
167873|NCT00654186|388677|P1|STARTED|Overall Study||32
167874|NCT00654147|388685|P2|NOT COMPLETED|Overall Study||4
167875|NCT00654147|388686|P1|NOT COMPLETED|Overall Study||2
167876|NCT00654147|388685|P2|COMPLETED|Overall Study||19
167877|NCT00654147|388686|P1|COMPLETED|Overall Study||19
167878|NCT00654147|388685|P2|STARTED|Overall Study||23
167879|NCT00654147|388686|P1|STARTED|Overall Study||21
167880|NCT00654095|388702|P1|NOT COMPLETED|Overall Study||32
167881|NCT00654095|388702|P1|COMPLETED|Overall Study||114
167882|NCT00654095|388702|P1|STARTED|Overall Study||146
167883|NCT00654030|388706|P1|NOT COMPLETED|Overall Study||2
167884|NCT00654030|388706|P1|COMPLETED|Overall Study||10
167885|NCT00654030|388706|P1|STARTED|Overall Study||12
167886|NCT00654004|388712|P2|NOT COMPLETED|Overall Study||0
167887|NCT00654004|388713|P1|NOT COMPLETED|Overall Study||1
167888|NCT00654004|388712|P2|COMPLETED|Overall Study||12
167889|NCT00654004|388713|P1|COMPLETED|Overall Study||13
167890|NCT00654004|388712|P2|STARTED|Overall Study||12
167891|NCT00654004|388713|P1|STARTED|Overall Study||14
167892|NCT00653939|388729|P2|NOT COMPLETED|Overall Study||15
167893|NCT00653939|388730|P1|NOT COMPLETED|Overall Study||12
167894|NCT00653939|388729|P2|COMPLETED|Overall Study||17
167895|NCT00653939|388730|P1|COMPLETED|Overall Study||19
167896|NCT00653939|388729|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
167897|NCT00653939|388730|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
167898|NCT00653861|388746|P1|NOT COMPLETED|Overall Study||0
167899|NCT00653861|388746|P1|COMPLETED|Overall Study||72
167900|NCT00653861|388746|P1|STARTED|Overall Study||72
167901|NCT00653523|388755|P1|NOT COMPLETED|Overall Study||19
167902|NCT00653523|388755|P1|COMPLETED|Overall Study||132
167903|NCT00653523|388755|P1|STARTED|Overall Study||151
167904|NCT00653328|388759|P1|NOT COMPLETED|Overall Study||15
167905|NCT00653328|388759|P1|COMPLETED|Overall Study||0
167906|NCT00653328|388759|P1|STARTED|Overall Study||15
167907|NCT00653263|388766|P1|NOT COMPLETED|Overall Study||2
167908|NCT00653263|388766|P1|COMPLETED|Overall Study||6
167909|NCT00653263|388766|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
167910|NCT00653224|388774|P2|NOT COMPLETED|Overall Study||7
167911|NCT00653224|388775|P1|NOT COMPLETED|Overall Study||7
167912|NCT00653224|388774|P2|COMPLETED|Overall Study||280
167913|NCT00653224|388775|P1|COMPLETED|Overall Study||286
167914|NCT00653224|388774|P2|STARTED|Overall Study||287
167915|NCT00653224|388775|P1|STARTED|Overall Study||293
167916|NCT00652145|388961|P2|NOT COMPLETED|Overall Study||0
167917|NCT00652145|388962|P1|NOT COMPLETED|Overall Study||0
167918|NCT00652145|388961|P2|COMPLETED|Overall Study||26
167919|NCT00652145|388962|P1|COMPLETED|Overall Study||26
167920|NCT00652145|388961|P2|STARTED|Overall Study||26
167921|NCT00652145|388962|P1|STARTED|Overall Study||26
167922|NCT00653159|388974|P2|NOT COMPLETED|Overall Study||3
167923|NCT00653159|388975|P1|NOT COMPLETED|Overall Study||5
167924|NCT00653159|388974|P2|COMPLETED|Overall Study||9
167925|NCT00653159|388975|P1|COMPLETED|Overall Study||6
167926|NCT00653159|388974|P2|STARTED|Overall Study||12
167927|NCT00653159|388975|P1|STARTED|Overall Study||11
167928|NCT00653133|388991|P2|NOT COMPLETED|Overall Study||0
167929|NCT00653133|388992|P1|NOT COMPLETED|Overall Study||0
167930|NCT00653133|388991|P2|COMPLETED|Overall Study||497
167931|NCT00653133|388992|P1|COMPLETED|Overall Study||1324
167932|NCT00653133|388991|P2|STARTED|Overall Study||497
167933|NCT00653133|388992|P1|STARTED|Overall Study||1324
167934|NCT00653068|389002|P1|NOT COMPLETED|Overall Study||50
167935|NCT00653068|389002|P1|COMPLETED|Overall Study||20
167936|NCT00653068|389002|P1|STARTED|Overall Study||70
167937|NCT00652938|389016|P3|NOT COMPLETED|Overall Study||5
167938|NCT00652938|389017|P2|NOT COMPLETED|Overall Study||7
167939|NCT00652938|389018|P1|NOT COMPLETED|Overall Study||1
167940|NCT00652938|389016|P3|COMPLETED|Overall Study||242
167941|NCT00652938|389017|P2|COMPLETED|Overall Study||240
167942|NCT00652938|389018|P1|COMPLETED|Overall Study||246
167943|NCT00652938|389016|P3|STARTED|Overall Study||247
167944|NCT00652938|389017|P2|STARTED|Overall Study||247
167945|NCT00652938|389018|P1|STARTED|Overall Study||247
167946|NCT00652899|389083|P1|NOT COMPLETED|Overall Study||2
167947|NCT00652899|389083|P1|COMPLETED|Overall Study||12
167948|NCT00652899|389083|P1|STARTED|Overall Study||14
167949|NCT00652834|389093|P1|NOT COMPLETED|Overall Study||5
167950|NCT00652834|389093|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
167951|NCT00652834|389093|P1|STARTED|Overall Study||23
167952|NCT00652626|389104|P7|NOT COMPLETED|Extension Phase||3
167953|NCT00652626|389105|P6|NOT COMPLETED|Extension Phase||12
167954|NCT00652626|389106|P5|NOT COMPLETED|Extension Phase||0
167955|NCT00652626|389107|P4|NOT COMPLETED|Extension Phase||0
167956|NCT00652626|389108|P3|NOT COMPLETED|Extension Phase||0
167957|NCT00652626|389109|P2|NOT COMPLETED|Extension Phase||0
167958|NCT00652626|389110|P1|NOT COMPLETED|Extension Phase||0
167959|NCT00652626|389104|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
167960|NCT00652626|389105|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
167961|NCT00652626|389106|P5|COMPLETED|Extension Phase||0
167962|NCT00652626|389107|P4|COMPLETED|Extension Phase||0
167963|NCT00652626|389108|P3|COMPLETED|Extension Phase||0
167964|NCT00652626|389109|P2|COMPLETED|Extension Phase||0
167965|NCT00652626|389110|P1|COMPLETED|Extension Phase||0
167966|NCT00652626|389104|P7|STARTED|Extension Phase||4
167967|NCT00652626|389105|P6|STARTED|Extension Phase||14
167968|NCT00652626|389106|P5|STARTED|Extension Phase||0
167969|NCT00652626|389107|P4|STARTED|Extension Phase||0
167970|NCT00652626|389108|P3|STARTED|Extension Phase||0
167971|NCT00652626|389109|P2|STARTED|Extension Phase||0
167972|NCT00652626|389110|P1|STARTED|Extension Phase||0
167973|NCT00652626|389104|P7|NOT COMPLETED|Initial Treatment Phase||0
167974|NCT00652626|389105|P6|NOT COMPLETED|Initial Treatment Phase||0
167975|NCT00652626|389106|P5|NOT COMPLETED|Initial Treatment Phase||3
167976|NCT00652626|389107|P4|NOT COMPLETED|Initial Treatment Phase||1
167977|NCT00652626|389108|P3|NOT COMPLETED|Initial Treatment Phase||1
167978|NCT00652626|389109|P2|NOT COMPLETED|Initial Treatment Phase||0
167979|NCT00652626|389110|P1|NOT COMPLETED|Initial Treatment Phase||0
167980|NCT00652626|389104|P7|COMPLETED|Initial Treatment Phase||0
167981|NCT00652626|389105|P6|COMPLETED|Initial Treatment Phase||0
167982|NCT00652626|389106|P5|COMPLETED|Initial Treatment Phase||5
167983|NCT00652626|389107|P4|COMPLETED|Initial Treatment Phase||5
167984|NCT00652626|389108|P3|COMPLETED|Initial Treatment Phase||6
167985|NCT00652626|389109|P2|COMPLETED|Initial Treatment Phase||5
167986|NCT00652626|389110|P1|COMPLETED|Initial Treatment Phase||5
167987|NCT00652626|389104|P7|Received Study Drug|Initial Treatment Phase||0
167988|NCT00652626|389105|P6|Received Study Drug|Initial Treatment Phase||0
167989|NCT00652626|389106|P5|Received Study Drug|Initial Treatment Phase||6
167990|NCT00652626|389107|P4|Received Study Drug|Initial Treatment Phase||5
167991|NCT00652626|389108|P3|Received Study Drug|Initial Treatment Phase||6
167992|NCT00652626|389109|P2|Received Study Drug|Initial Treatment Phase||5
167993|NCT00652626|389110|P1|Received Study Drug|Initial Treatment Phase||5
167994|NCT00652626|389104|P7|STARTED|Initial Treatment Phase||0
167995|NCT00652626|389105|P6|STARTED|Initial Treatment Phase||0
167996|NCT00652626|389106|P5|STARTED|Initial Treatment Phase||8
167997|NCT00652626|389107|P4|STARTED|Initial Treatment Phase||6
167998|NCT00652626|389108|P3|STARTED|Initial Treatment Phase||7
167999|NCT00652626|389109|P2|STARTED|Initial Treatment Phase||5
168000|NCT00652626|389110|P1|STARTED|Initial Treatment Phase||5
168001|NCT00652366|389179|P5|NOT COMPLETED|Overall Study||36
168002|NCT00652366|389180|P4|NOT COMPLETED|Overall Study||179
168003|NCT00652366|389181|P3|NOT COMPLETED|Overall Study||71
168004|NCT00652366|389182|P2|NOT COMPLETED|Overall Study||75
168005|NCT00652366|389183|P1|NOT COMPLETED|Overall Study||106
168006|NCT00652366|389179|P5|COMPLETED|Overall Study||0
168007|NCT00652366|389180|P4|COMPLETED|Overall Study||0
168008|NCT00652366|389181|P3|COMPLETED|Overall Study||0
168009|NCT00652366|389182|P2|COMPLETED|Overall Study||0
168010|NCT00652366|389183|P1|COMPLETED|Overall Study||0
168011|NCT00652366|389179|P5|STARTED|Overall Study||36
168012|NCT00652366|389180|P4|STARTED|Overall Study||179
168013|NCT00652366|389181|P3|STARTED|Overall Study||71
168014|NCT00652366|389182|P2|STARTED|Overall Study||75
168015|NCT00652366|389183|P1|STARTED|Overall Study||106
168016|NCT00652340|389218|P2|NOT COMPLETED|Overall Study||3
168017|NCT00652340|389219|P1|NOT COMPLETED|Overall Study||4
168018|NCT00652340|389218|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
168019|NCT00652340|389219|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
168020|NCT00652340|389218|P2|STARTED|Overall Study||42
168021|NCT00652340|389219|P1|STARTED|Overall Study||78
168022|NCT00652327|389229|P2|NOT COMPLETED|Overall Study||5
168023|NCT00652327|389230|P1|NOT COMPLETED|Overall Study||0
168024|NCT00652327|389229|P2|COMPLETED|Overall Study||36
168025|NCT00652327|389230|P1|COMPLETED|Overall Study||42
168026|NCT00652327|389229|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
168027|NCT00652327|389230|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
168028|NCT00652314|389238|P2|NOT COMPLETED|Overall Study||9
168029|NCT00652314|389239|P1|NOT COMPLETED|Overall Study||9
168030|NCT00652314|389238|P2|COMPLETED|Overall Study||26
168031|NCT00652314|389239|P1|COMPLETED|Overall Study||53
168032|NCT00652314|389238|P2|STARTED|Overall Study||35
168033|NCT00652314|389239|P1|STARTED|Overall Study||62
168034|NCT00652093|389259|P6|NOT COMPLETED|Overall Study||0
168035|NCT00652093|389260|P5|NOT COMPLETED|Overall Study||2
168036|NCT00652093|389261|P4|NOT COMPLETED|Overall Study||0
168037|NCT00652093|389262|P3|NOT COMPLETED|Overall Study||1
168038|NCT00652093|389263|P2|NOT COMPLETED|Overall Study||0
168039|NCT00652093|389264|P1|NOT COMPLETED|Overall Study||0
168040|NCT00652093|389259|P6|COMPLETED|Overall Study||4
168041|NCT00652093|389260|P5|COMPLETED|Overall Study||2
168042|NCT00652093|389261|P4|COMPLETED|Overall Study||4
168043|NCT00652093|389262|P3|COMPLETED|Overall Study||3
168044|NCT00652093|389263|P2|COMPLETED|Overall Study||4
168045|NCT00652093|389264|P1|COMPLETED|Overall Study||4
168046|NCT00652093|389259|P6|STARTED|Overall Study||4
168047|NCT00652093|389260|P5|STARTED|Overall Study||4
168048|NCT00652093|389261|P4|STARTED|Overall Study||4
168049|NCT00652093|389262|P3|STARTED|Overall Study||4
168050|NCT00652093|389263|P2|STARTED|Overall Study||4
168051|NCT00652093|389264|P1|STARTED|Overall Study||4
168052|NCT00652028|389348|P4|NOT COMPLETED|Overall Study||0
168053|NCT00652028|389349|P3|NOT COMPLETED|Overall Study||1
168054|NCT00652028|389350|P2|NOT COMPLETED|Overall Study||1
168055|NCT00652028|389351|P1|NOT COMPLETED|Overall Study||1
168056|NCT00652028|389348|P4|COMPLETED|Overall Study||14
168057|NCT00652028|389349|P3|COMPLETED|Overall Study||14
168058|NCT00652028|389350|P2|COMPLETED|Overall Study||13
168059|NCT00652028|389351|P1|COMPLETED|Overall Study||15
168060|NCT00652028|389348|P4|STARTED|Overall Study||14
168061|NCT00652028|389349|P3|STARTED|Overall Study||15
168062|NCT00652028|389350|P2|STARTED|Overall Study||14
168063|NCT00652028|389351|P1|STARTED|Overall Study||16
168064|NCT00651924|389395|P2|NOT COMPLETED|Overall Study||7
168065|NCT00651924|389396|P1|NOT COMPLETED|Overall Study||0
168066|NCT00651924|389395|P2|COMPLETED|Overall Study||2
168067|NCT00651924|389396|P1|COMPLETED|Overall Study||18
168068|NCT00651924|389395|P2|STARTED|Overall Study||9
168069|NCT00651924|389396|P1|STARTED|Overall Study||18
168070|NCT00651820|389402|P1|NOT COMPLETED|Overall Study||2
168071|NCT00651820|389402|P1|COMPLETED|Overall Study||26
168072|NCT00651820|389402|P1|STARTED|Overall Study||28
168073|NCT00651755|389409|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
168074|NCT00651755|389410|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
168075|NCT00651755|389409|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
168076|NCT00651755|389410|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
168077|NCT00651755|389409|P2|STARTED|Cycle 2 (Second 21 Days)||9
168078|NCT00651755|389410|P1|STARTED|Cycle 2 (Second 21 Days)||10
168079|NCT00651755|389409|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
168080|NCT00651755|389410|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
168081|NCT00651755|389409|P2|COMPLETED|Cycle 1 (First 21 Days)||9
168082|NCT00651755|389410|P1|COMPLETED|Cycle 1 (First 21 Days)||10
168083|NCT00651755|389409|P2|STARTED|Cycle 1 (First 21 Days)||9
168084|NCT00651755|389410|P1|STARTED|Cycle 1 (First 21 Days)||11
168085|NCT00651625|389428|P2|NOT COMPLETED|Overall Study||0
168086|NCT00651625|389429|P1|NOT COMPLETED|Overall Study||0
168087|NCT00651625|389428|P2|COMPLETED|Overall Study||218
168088|NCT00651625|389429|P1|COMPLETED|Overall Study||219
168089|NCT00651625|389428|P2|STARTED|Overall Study||218
168090|NCT00651625|389429|P1|STARTED|Overall Study||219
168091|NCT00651482|389441|P1|NOT COMPLETED|Overall Study||0
168092|NCT00651482|389441|P1|COMPLETED|Overall Study||10
168093|NCT00651482|389441|P1|STARTED|Overall Study||10
168094|NCT00651313|389455|P2|NOT COMPLETED|Overall Study||6
168095|NCT00651313|389456|P1|NOT COMPLETED|Overall Study||6
168096|NCT00651313|389455|P2|COMPLETED|Overall Study||37
168097|NCT00651313|389456|P1|COMPLETED|Overall Study||35
168098|NCT00651313|389455|P2|STARTED|Overall Study||43
168099|NCT00651313|389456|P1|STARTED|Overall Study||41
168100|NCT00651261|389464|P2|NOT COMPLETED|Overall Study||306
168101|NCT00651261|389465|P1|NOT COMPLETED|Overall Study||291
168102|NCT00651261|389464|P2|COMPLETED|Overall Study||51
168103|NCT00651261|389465|P1|COMPLETED|Overall Study||69
168104|NCT00651261|389464|P2|STARTED|Overall Study||357
168105|NCT00651261|389465|P1|STARTED|Overall Study||360
168106|NCT00651183|389481|P2|NOT COMPLETED|Overall Study||10
168107|NCT00651183|389482|P1|NOT COMPLETED|Overall Study||20
168108|NCT00651183|389481|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
168109|NCT00651183|389482|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
168110|NCT00651183|389481|P2|STARTED|Overall Study||97
168111|NCT00651183|389482|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
168112|NCT00651157|389494|P1|NOT COMPLETED|Overall Study||2
168113|NCT00651157|389494|P1|COMPLETED|Overall Study||21
168114|NCT00651157|389494|P1|STARTED|Overall Study||23
168115|NCT00651118|389504|P4|NOT COMPLETED|Overall Study||7
168116|NCT00651118|389505|P3|NOT COMPLETED|Overall Study||11
168117|NCT00651118|389506|P2|NOT COMPLETED|Overall Study||7
168118|NCT00651118|389507|P1|NOT COMPLETED|Overall Study||9
168119|NCT00651118|389504|P4|COMPLETED|Overall Study||203
168120|NCT00651118|389505|P3|COMPLETED|Overall Study||197
168121|NCT00651118|389506|P2|COMPLETED|Overall Study||200
168122|NCT00651118|389507|P1|COMPLETED|Overall Study||198
168123|NCT00651118|389504|P4|STARTED|Overall Study||210
168124|NCT00651118|389505|P3|STARTED|Overall Study||208
168125|NCT00651118|389506|P2|STARTED|Overall Study||207
168126|NCT00651118|389507|P1|STARTED|Overall Study||207
168127|NCT00651040|389527|P2|NOT COMPLETED|Overall Study||1
168128|NCT00651040|389528|P1|NOT COMPLETED|Overall Study||3
168129|NCT00651040|389527|P2|COMPLETED|Overall Study||14
168130|NCT00651040|389528|P1|COMPLETED|Overall Study||13
168131|NCT00651040|389527|P2|STARTED|Overall Study||15
168132|NCT00651040|389528|P1|STARTED|Overall Study||16
168133|NCT00650858|389537|P3|NOT COMPLETED|Overall Study||0
168134|NCT00650858|389538|P2|NOT COMPLETED|Overall Study||0
168135|NCT00650858|389539|P1|NOT COMPLETED|Overall Study||0
168136|NCT00650858|389537|P3|COMPLETED|Overall Study||36
168137|NCT00650858|389538|P2|COMPLETED|Overall Study||8
168138|NCT00650858|389539|P1|COMPLETED|Overall Study||8
168139|NCT00650858|389537|P3|STARTED|Overall Study||36
168140|NCT00650858|389538|P2|STARTED|Overall Study||8
168141|NCT00650858|389539|P1|STARTED|Overall Study||8
168142|NCT00650845|389555|P2|NOT COMPLETED|Overall Study||13
168143|NCT00650845|389556|P1|NOT COMPLETED|Overall Study||5
168144|NCT00650845|389555|P2|COMPLETED|Overall Study||44
168145|NCT00650845|389556|P1|COMPLETED|Overall Study||70
168146|NCT00650845|389555|P2|STARTED|Overall Study||57
168147|NCT00650845|389556|P1|STARTED|Overall Study||75
168148|NCT00650806|389576|P4|NOT COMPLETED|Overall Study||26
168149|NCT00650806|389577|P3|NOT COMPLETED|Overall Study||29
168150|NCT00650806|389578|P2|NOT COMPLETED|Overall Study||21
168151|NCT00650806|389579|P1|NOT COMPLETED|Overall Study||18
168152|NCT00650806|389576|P4|COMPLETED|Overall Study||70
168153|NCT00650806|389577|P3|COMPLETED|Overall Study||64
168154|NCT00650806|389578|P2|COMPLETED|Overall Study||77
168155|NCT00650806|389579|P1|COMPLETED|Overall Study||71
168156|NCT00650806|389576|P4|STARTED|Overall Study||96
168157|NCT00650806|389577|P3|STARTED|Overall Study||93
168158|NCT00650806|389578|P2|STARTED|Overall Study||98
168159|NCT00650806|389579|P1|STARTED|Overall Study||89
168160|NCT00650767|389621|P4|NOT COMPLETED|Overall Study||11
168161|NCT00650767|389622|P3|NOT COMPLETED|Overall Study||14
168162|NCT00650767|389623|P2|NOT COMPLETED|Overall Study||9
168163|NCT00650767|389624|P1|NOT COMPLETED|Overall Study||5
168164|NCT00650767|389621|P4|COMPLETED|Overall Study||39
168165|NCT00650767|389622|P3|COMPLETED|Overall Study||36
168166|NCT00650767|389623|P2|COMPLETED|Overall Study||41
168167|NCT00650767|389624|P1|COMPLETED|Overall Study||46
168168|NCT00650767|389621|P4|STARTED|Overall Study||50
168169|NCT00650767|389622|P3|STARTED|Overall Study||50
168170|NCT00650767|389623|P2|STARTED|Overall Study||50
168171|NCT00650767|389624|P1|STARTED|Overall Study||51
168172|NCT00650585|390128|P2|NOT COMPLETED|Overall Study||1477
168173|NCT00650585|390129|P1|NOT COMPLETED|Overall Study||1797
168174|NCT00650585|390128|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
168175|NCT00650585|390129|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
168176|NCT00650585|390128|P2|STARTED|Overall Study||3990
168177|NCT00650585|390129|P1|STARTED|Overall Study||4348
168178|NCT00650546|390149|P1|NOT COMPLETED|Overall Study||0
168179|NCT00650546|390149|P1|COMPLETED|Overall Study||8
168180|NCT00650546|390149|P1|STARTED|Overall Study||8
168181|NCT00650260|390156|P2|NOT COMPLETED|Overall Study||0
168182|NCT00650260|390157|P1|NOT COMPLETED|Overall Study||0
168183|NCT00650260|390156|P2|COMPLETED|Overall Study||21
168184|NCT00650260|390157|P1|COMPLETED|Overall Study||21
168185|NCT00650260|390156|P2|STARTED|Overall Study||21
168186|NCT00650260|390157|P1|STARTED|Overall Study||21
168187|NCT00650104|390173|P1|NOT COMPLETED|Overall Study||41
168188|NCT00650104|390173|P1|COMPLETED|Overall Study||42
168189|NCT00650104|390173|P1|STARTED|Overall Study||83
168190|NCT00650091|390188|P3|NOT COMPLETED|Amended Study Design||0
168191|NCT00650091|390189|P2|NOT COMPLETED|Amended Study Design||20
168192|NCT00650091|390190|P1|NOT COMPLETED|Amended Study Design||23
168193|NCT00650091|390188|P3|COMPLETED|Amended Study Design||0
168194|NCT00650091|390189|P2|COMPLETED|Amended Study Design||111
168195|NCT00650091|390190|P1|COMPLETED|Amended Study Design||110
168377|NCT00645944|390554|P2|NOT COMPLETED|Randomized||2
168196|NCT00650091|390188|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
168197|NCT00650091|390189|P2|STARTED|Amended Study Design||131
168198|NCT00650091|390190|P1|STARTED|Amended Study Design||133
168199|NCT00650091|390188|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
168200|NCT00650091|390189|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
168201|NCT00650091|390190|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
168202|NCT00650091|390188|P3|COMPLETED|Initial Study Design - Interim Analysis||77
168203|NCT00650091|390189|P2|COMPLETED|Initial Study Design - Interim Analysis||78
168204|NCT00650091|390190|P1|COMPLETED|Initial Study Design - Interim Analysis||81
168205|NCT00650091|390188|P3|STARTED|Initial Study Design - Interim Analysis||77
168206|NCT00650091|390189|P2|STARTED|Initial Study Design - Interim Analysis||78
168207|NCT00650091|390190|P1|STARTED|Initial Study Design - Interim Analysis||81
168208|NCT00650078|390210|P2|NOT COMPLETED|Overall Study||13
168209|NCT00650078|390211|P1|NOT COMPLETED|Overall Study||14
168210|NCT00650078|390210|P2|COMPLETED|Overall Study||106
168211|NCT00650078|390211|P1|COMPLETED|Overall Study||217
168212|NCT00650078|390210|P2|STARTED|Overall Study||119
168213|NCT00650078|390211|P1|STARTED|Overall Study||231
168214|NCT00649961|390219|P1|NOT COMPLETED|Overall Study||0
168215|NCT00649961|390219|P1|COMPLETED|Overall Study||18
168216|NCT00649961|390219|P1|STARTED|Overall Study||18
168217|NCT00649792|390223|P1|NOT COMPLETED|Overall Study||68
168218|NCT00649792|390223|P1|COMPLETED|Overall Study||146
168219|NCT00649792|390223|P1|STARTED|Overall Study||214
168220|NCT00649428|390233|P2|NOT COMPLETED|Overall Study||15
168221|NCT00649428|390234|P1|NOT COMPLETED|Overall Study||20
168222|NCT00649428|390233|P2|COMPLETED|Overall Study||88
168223|NCT00649428|390234|P1|COMPLETED|Overall Study||80
168224|NCT00649428|390233|P2|STARTED|Overall Study||103
168225|NCT00649428|390234|P1|STARTED|Overall Study||100
168226|NCT00649389|390250|P4|NOT COMPLETED|Overall Study||111
168227|NCT00649389|390251|P3|NOT COMPLETED|Overall Study||88
168228|NCT00649389|390252|P2|NOT COMPLETED|Overall Study||106
168229|NCT00649389|390253|P1|NOT COMPLETED|Overall Study||71
168230|NCT00649389|390250|P4|COMPLETED|Overall Study||516
168231|NCT00649389|390251|P3|COMPLETED|Overall Study||512
168232|NCT00649389|390252|P2|COMPLETED|Overall Study||531
168233|NCT00649389|390253|P1|COMPLETED|Overall Study||557
168234|NCT00649389|390250|P4|STARTED|Overall Study||627
168235|NCT00649389|390251|P3|STARTED|Overall Study||600
168236|NCT00649389|390252|P2|STARTED|Overall Study||637
168237|NCT00649389|390253|P1|STARTED|Overall Study||628
168238|NCT00649220|390275|P1|NOT COMPLETED|Overall Study||3
168239|NCT00649220|390275|P1|COMPLETED|Overall Study||16
168240|NCT00649220|390275|P1|STARTED|Overall Study||19
168241|NCT00648908|390286|P1|NOT COMPLETED|Overall Study||115
168242|NCT00648908|390286|P1|COMPLETED|Overall Study||154
168243|NCT00648908|390286|P1|STARTED|Overall Study||269
168244|NCT00648895|390296|P2|NOT COMPLETED|Overall Study||1
168245|NCT00648895|390297|P1|NOT COMPLETED|Overall Study||0
168246|NCT00648895|390296|P2|COMPLETED|Overall Study||5
168247|NCT00648895|390297|P1|COMPLETED|Overall Study||6
168248|NCT00648895|390296|P2|STARTED|Overall Study||6
168249|NCT00648895|390297|P1|STARTED|Overall Study||6
168250|NCT00648167|390303|P1|NOT COMPLETED|Overall Study||7
168251|NCT00648167|390303|P1|COMPLETED|Overall Study||48
168252|NCT00648167|390303|P1|STARTED|Overall Study||55
168253|NCT00648115|390311|P3|NOT COMPLETED|Overall Study||0
168254|NCT00648115|390312|P2|NOT COMPLETED|Overall Study||0
168255|NCT00648115|390313|P1|NOT COMPLETED|Overall Study||0
168256|NCT00648115|390311|P3|COMPLETED|Overall Study||27
168257|NCT00648115|390312|P2|COMPLETED|Overall Study||42
168258|NCT00648115|390313|P1|COMPLETED|Overall Study||42
168259|NCT00648115|390311|P3|STARTED|Overall Study||27
168260|NCT00648115|390312|P2|STARTED|Overall Study||42
168261|NCT00648115|390313|P1|STARTED|Overall Study||42
168262|NCT00648037|390324|P1|NOT COMPLETED|Overall Study||16
168263|NCT00648037|390324|P1|COMPLETED|Overall Study||10
168264|NCT00648037|390324|P1|STARTED|Overall Study||26
168265|NCT00647998|390330|P2|NOT COMPLETED|Overall Study||0
168266|NCT00647998|390331|P1|NOT COMPLETED|Overall Study||0
168267|NCT00647998|390330|P2|COMPLETED|Overall Study||9
168268|NCT00647998|390331|P1|COMPLETED|Overall Study||9
168269|NCT00647998|390330|P2|STARTED|Overall Study||9
168270|NCT00647998|390331|P1|STARTED|Overall Study||9
168271|NCT00647699|390339|P2|NOT COMPLETED|Overall Study||12
168272|NCT00647699|390340|P1|NOT COMPLETED|Overall Study||8
168273|NCT00647699|390339|P2|COMPLETED|Overall Study||62
168274|NCT00647699|390340|P1|COMPLETED|Overall Study||65
168275|NCT00647699|390339|P2|STARTED|Overall Study||74
168276|NCT00647699|390340|P1|STARTED|Overall Study||73
168277|NCT00647556|390348|P2|NOT COMPLETED|Overall Study||2
168278|NCT00647556|390349|P1|NOT COMPLETED|Overall Study||3
168279|NCT00647556|390348|P2|COMPLETED|Overall Study||13
168280|NCT00647556|390349|P1|COMPLETED|Overall Study||12
168281|NCT00647556|390348|P2|STARTED|Overall Study||15
168282|NCT00647556|390349|P1|STARTED|Overall Study||15
168283|NCT00647400|390365|P2|NOT COMPLETED|Overall Study||13
168284|NCT00647400|390366|P1|NOT COMPLETED|Overall Study||22
168285|NCT00647400|390365|P2|COMPLETED|Overall Study||45
168286|NCT00647400|390366|P1|COMPLETED|Overall Study||67
168287|NCT00647400|390365|P2|STARTED|Overall Study||58
168288|NCT00647400|390366|P1|STARTED|Overall Study||89
168289|NCT00647270|390379|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
168290|NCT00647270|390380|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
168291|NCT00647270|390381|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
168292|NCT00647270|390379|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
168293|NCT00647270|390380|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
168294|NCT00647270|390381|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
168295|NCT00647270|390379|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
168296|NCT00647270|390380|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
168297|NCT00647270|390381|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
168298|NCT00647270|390379|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
168299|NCT00647270|390380|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
168300|NCT00647270|390381|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
168301|NCT00647270|390379|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
168302|NCT00647270|390380|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
168303|NCT00647270|390381|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
168304|NCT00647270|390379|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
168305|NCT00647270|390380|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
168306|NCT00647270|390381|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
168307|NCT00646958|390407|P3|NOT COMPLETED|Overall Study||9
168308|NCT00646958|390408|P2|NOT COMPLETED|Overall Study||9
168309|NCT00646958|390409|P1|NOT COMPLETED|Overall Study||11
168310|NCT00646958|390407|P3|COMPLETED|Overall Study||40
168311|NCT00646958|390408|P2|COMPLETED|Overall Study||41
168312|NCT00646958|390409|P1|COMPLETED|Overall Study||40
168313|NCT00646958|390407|P3|STARTED|Overall Study|No. Participants Randomized|49
168314|NCT00646958|390408|P2|STARTED|Overall Study|No. Participants Randomized|50
168315|NCT00646958|390409|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
168316|NCT00646776|390422|P2|NOT COMPLETED|Overall Study||13
168317|NCT00646776|390423|P1|NOT COMPLETED|Overall Study||1
168318|NCT00646776|390422|P2|COMPLETED|Overall Study||5
168319|NCT00646776|390423|P1|COMPLETED|Overall Study||14
168320|NCT00646776|390422|P2|STARTED|Overall Study|Treated on Day 1|18
168321|NCT00646776|390423|P1|STARTED|Overall Study|Treated on Day 1|15
168322|NCT00646763|390472|P2|NOT COMPLETED|Overall Study||0
168323|NCT00646763|390473|P1|NOT COMPLETED|Overall Study||0
168324|NCT00646763|390472|P2|COMPLETED|Overall Study||17
168325|NCT00646763|390473|P1|COMPLETED|Overall Study||18
168326|NCT00646763|390472|P2|STARTED|Overall Study||17
168327|NCT00646763|390473|P1|STARTED|Overall Study||18
168328|NCT00646646|390487|P4|NOT COMPLETED|Overall Study||0
168329|NCT00646646|390488|P3|NOT COMPLETED|Overall Study||0
168330|NCT00646646|390489|P2|NOT COMPLETED|Overall Study||0
168331|NCT00646646|390490|P1|NOT COMPLETED|Overall Study||0
168332|NCT00646646|390487|P4|COMPLETED|Overall Study||20
168333|NCT00646646|390488|P3|COMPLETED|Overall Study||15
168334|NCT00646646|390489|P2|COMPLETED|Overall Study||15
168335|NCT00646646|390490|P1|COMPLETED|Overall Study||15
168336|NCT00646646|390487|P4|STARTED|Overall Study||20
168337|NCT00646646|390488|P3|STARTED|Overall Study||15
168338|NCT00646646|390489|P2|STARTED|Overall Study||15
168339|NCT00646646|390490|P1|STARTED|Overall Study||15
168340|NCT00646581|390502|P2|NOT COMPLETED|Overall Study||0
168341|NCT00646581|390503|P1|NOT COMPLETED|Overall Study||0
168342|NCT00646581|390502|P2|COMPLETED|Overall Study||15
168343|NCT00646581|390503|P1|COMPLETED|Overall Study||15
168344|NCT00646581|390502|P2|STARTED|Overall Study||15
168345|NCT00646581|390503|P1|STARTED|Overall Study||15
168346|NCT00646399|390521|P2|NOT COMPLETED|Overall Study||74
168347|NCT00646399|390522|P1|NOT COMPLETED|Overall Study||83
168348|NCT00646399|390521|P2|COMPLETED|Overall Study||713
168349|NCT00646399|390522|P1|COMPLETED|Overall Study||709
168350|NCT00646399|390521|P2|STARTED|Overall Study||787
168351|NCT00646399|390522|P1|STARTED|Overall Study||792
168352|NCT00646282|390530|P2|NOT COMPLETED|Overall Study||4
168353|NCT00646282|390531|P1|NOT COMPLETED|Overall Study||4
168354|NCT00646282|390530|P2|COMPLETED|Overall Study||0
168355|NCT00646282|390531|P1|COMPLETED|Overall Study||0
168356|NCT00646282|390530|P2|STARTED|Overall Study||4
168357|NCT00646282|390531|P1|STARTED|Overall Study||4
168358|NCT00646048|390537|P1|NOT COMPLETED|Overall Study||16
168359|NCT00646048|390537|P1|COMPLETED|Overall Study||27
168360|NCT00646048|390537|P1|STARTED|Overall Study||43
168361|NCT00645970|390545|P2|NOT COMPLETED|Overall Study||186
168362|NCT00645970|390546|P1|NOT COMPLETED|Overall Study||109
168363|NCT00645970|390545|P2|COMPLETED|Overall Study||32
168364|NCT00645970|390546|P1|COMPLETED|Overall Study||32
168365|NCT00645970|390545|P2|1 Year|Overall Study||42
168366|NCT00645970|390546|P1|1 Year|Overall Study||37
168367|NCT00645970|390545|P2|6 Months|Overall Study||97
168368|NCT00645970|390546|P1|6 Months|Overall Study||58
168369|NCT00645970|390545|P2|STARTED|Overall Study||218
168370|NCT00645970|390546|P1|STARTED|Overall Study||141
168371|NCT00645944|390554|P2|NOT COMPLETED|Received Medication||3
168372|NCT00645944|390555|P1|NOT COMPLETED|Received Medication||6
168373|NCT00645944|390554|P2|COMPLETED|Received Medication||14
168374|NCT00645944|390555|P1|COMPLETED|Received Medication||13
168375|NCT00645944|390554|P2|STARTED|Received Medication||17
168376|NCT00645944|390555|P1|STARTED|Received Medication||19
168378|NCT00645944|390555|P1|NOT COMPLETED|Randomized||1
168379|NCT00645944|390554|P2|COMPLETED|Randomized||17
168380|NCT00645944|390555|P1|COMPLETED|Randomized||19
168381|NCT00645944|390554|P2|STARTED|Randomized||19
168382|NCT00645944|390555|P1|STARTED|Randomized||20
168383|NCT00645853|390563|P2|NOT COMPLETED|Overall Study||57
168384|NCT00645853|390564|P1|NOT COMPLETED|Overall Study||92
168385|NCT00645853|390563|P2|COMPLETED|Overall Study||178
168386|NCT00645853|390564|P1|COMPLETED|Overall Study||196
168387|NCT00645853|390563|P2|AZ Study Closure in Hungary|Overall Study||40
168388|NCT00645853|390564|P1|AZ Study Closure in Hungary|Overall Study||60
168389|NCT00645853|390563|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
168390|NCT00645853|390564|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
168391|NCT00645853|390563|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
168392|NCT00645853|390564|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
168393|NCT00645853|390563|P2|STARTED|Overall Study||235
168394|NCT00645853|390564|P1|STARTED|Overall Study||288
168395|NCT00645827|390584|P2|NOT COMPLETED|Overall Study||0
168396|NCT00645827|390585|P1|NOT COMPLETED|Overall Study||0
168397|NCT00645827|390584|P2|COMPLETED|Overall Study||17
168398|NCT00645827|390585|P1|COMPLETED|Overall Study||14
168399|NCT00645827|390584|P2|STARTED|Overall Study||17
168400|NCT00645827|390585|P1|STARTED|Overall Study||14
168401|NCT00645788|390595|P4|NOT COMPLETED|Overall Study||14
168402|NCT00645788|390596|P3|NOT COMPLETED|Overall Study||18
168403|NCT00645788|390597|P2|NOT COMPLETED|Overall Study||27
168404|NCT00645788|390598|P1|NOT COMPLETED|Overall Study||20
168405|NCT00645788|390595|P4|COMPLETED|Overall Study||21
168406|NCT00645788|390596|P3|COMPLETED|Overall Study||47
168407|NCT00645788|390597|P2|COMPLETED|Overall Study||67
168408|NCT00645788|390598|P1|COMPLETED|Overall Study||74
168409|NCT00645788|390595|P4|Participants Receive Treatment|Overall Study||35
168410|NCT00645788|390596|P3|Participants Receive Treatment|Overall Study||65
168411|NCT00645788|390597|P2|Participants Receive Treatment|Overall Study||93
168412|NCT00645788|390598|P1|Participants Receive Treatment|Overall Study||93
168413|NCT00645788|390595|P4|STARTED|Overall Study||35
168414|NCT00645788|390596|P3|STARTED|Overall Study||65
168415|NCT00645788|390597|P2|STARTED|Overall Study||94
168416|NCT00645788|390598|P1|STARTED|Overall Study||94
168417|NCT00645762|390648|P1|NOT COMPLETED|Overall Study||4
168418|NCT00645762|390648|P1|COMPLETED|Overall Study||67
168419|NCT00645762|390648|P1|STARTED|Overall Study||71
168420|NCT00645671|390656|P2|NOT COMPLETED|Overall Study||6
168421|NCT00645671|390657|P1|NOT COMPLETED|Overall Study||1
168422|NCT00645671|390656|P2|COMPLETED|Overall Study||193
168423|NCT00645671|390657|P1|COMPLETED|Overall Study||200
168424|NCT00645671|390656|P2|STARTED|Overall Study||199
168425|NCT00645671|390657|P1|STARTED|Overall Study||201
168426|NCT00645593|390671|P2|NOT COMPLETED|Overall Study||0
168427|NCT00645593|390672|P1|NOT COMPLETED|Overall Study||1
168428|NCT00645593|390671|P2|COMPLETED|Overall Study||60
168429|NCT00645593|390672|P1|COMPLETED|Overall Study||28
168430|NCT00645593|390671|P2|STARTED|Overall Study||60
168431|NCT00645593|390672|P1|STARTED|Overall Study||29
168432|NCT00645528|390684|P1|NOT COMPLETED|Overall Study||7
168433|NCT00645528|390684|P1|COMPLETED|Overall Study||32
168434|NCT00645528|390684|P1|STARTED|Overall Study||39
168435|NCT00645411|390697|P4|NOT COMPLETED|Overall Study||103
168436|NCT00645411|390698|P3|NOT COMPLETED|Overall Study||151
168437|NCT00645411|390699|P2|NOT COMPLETED|Overall Study||6
168438|NCT00645411|390700|P1|NOT COMPLETED|Overall Study||13
168439|NCT00645411|390697|P4|COMPLETED|Overall Study||919
168440|NCT00645411|390698|P3|COMPLETED|Overall Study||1457
168441|NCT00645411|390699|P2|COMPLETED|Overall Study||312
168442|NCT00645411|390700|P1|COMPLETED|Overall Study||643
168443|NCT00645411|390697|P4|STARTED|Overall Study||1022
168444|NCT00645411|390698|P3|STARTED|Overall Study||1608
168445|NCT00645411|390699|P2|STARTED|Overall Study||318
168446|NCT00645411|390700|P1|STARTED|Overall Study||656
168447|NCT00645359|390732|P1|NOT COMPLETED|Overall Study||0
168448|NCT00645359|390732|P1|COMPLETED|Overall Study||9
168449|NCT00645359|390732|P1|STARTED|Overall Study||9
168450|NCT00645333|390736|P1|NOT COMPLETED|Overall Study||0
168451|NCT00645333|390736|P1|COMPLETED|Overall Study||30
168452|NCT00645333|390736|P1|STARTED|Overall Study||30
168453|NCT00645164|390741|P1|NOT COMPLETED|Overall Study||7
168454|NCT00645164|390741|P1|COMPLETED|Overall Study||52
168455|NCT00645164|390741|P1|STARTED|Overall Study||59
168456|NCT00645099|390747|P2|NOT COMPLETED|Overall Study||42
168457|NCT00645099|390748|P1|NOT COMPLETED|Overall Study||71
168458|NCT00645099|390747|P2|COMPLETED|Overall Study||178
168459|NCT00645099|390748|P1|COMPLETED|Overall Study||168
168460|NCT00645099|390747|P2|STARTED|Overall Study||220
168461|NCT00645099|390748|P1|STARTED|Overall Study||239
168462|NCT00644995|390792|P2|NOT COMPLETED|Overall Study||4
168463|NCT00644995|390793|P1|NOT COMPLETED|Overall Study||2
168464|NCT00644995|390792|P2|COMPLETED|Overall Study||23
168465|NCT00644995|390793|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
168466|NCT00644995|390792|P2|Completed 4 Month Assessment|Overall Study||24
168467|NCT00644995|390793|P1|Completed 4 Month Assessment|Overall Study||23
168468|NCT00644995|390792|P2|STARTED|Overall Study||27
168469|NCT00644995|390793|P1|STARTED|Overall Study||25
168470|NCT00644969|390813|P2|NOT COMPLETED|Post Treatment Phase||3
168471|NCT00644969|390814|P1|NOT COMPLETED|Post Treatment Phase||10
168472|NCT00644969|390813|P2|COMPLETED|Post Treatment Phase||37
168473|NCT00644969|390814|P1|COMPLETED|Post Treatment Phase||61
168474|NCT00644969|390813|P2|STARTED|Post Treatment Phase||40
168475|NCT00644969|390814|P1|STARTED|Post Treatment Phase||71
168476|NCT00644969|390813|P2|NOT COMPLETED|Treatment Phase||3
168477|NCT00644969|390814|P1|NOT COMPLETED|Treatment Phase||14
168478|NCT00644969|390813|P2|COMPLETED|Treatment Phase||40
168479|NCT00644969|390814|P1|COMPLETED|Treatment Phase||71
168480|NCT00644969|390813|P2|STARTED|Treatment Phase||43
168481|NCT00644969|390814|P1|STARTED|Treatment Phase||85
168482|NCT00644917|390860|P1|NOT COMPLETED|Overall Study||2
168483|NCT00644917|390860|P1|COMPLETED|Overall Study||36
168484|NCT00644917|390860|P1|STARTED|Overall Study||38
168485|NCT00644787|390868|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
168486|NCT00644787|390869|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
168487|NCT00644787|390870|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
168488|NCT00644787|390868|P3|COMPLETED|Period 2: Double Blind Phase||55
168489|NCT00644787|390869|P2|COMPLETED|Period 2: Double Blind Phase||49
168490|NCT00644787|390870|P1|COMPLETED|Period 2: Double Blind Phase||0
168491|NCT00644787|390868|P3|STARTED|Period 2: Double Blind Phase||62
168492|NCT00644787|390869|P2|STARTED|Period 2: Double Blind Phase||58
168493|NCT00644787|390870|P1|STARTED|Period 2: Double Blind Phase||0
168494|NCT00644787|390868|P3|NOT COMPLETED|Period 1: Titration Phase||0
168495|NCT00644787|390869|P2|NOT COMPLETED|Period 1: Titration Phase||0
168496|NCT00644787|390870|P1|NOT COMPLETED|Period 1: Titration Phase||27
168497|NCT00644787|390868|P3|COMPLETED|Period 1: Titration Phase||0
168498|NCT00644787|390869|P2|COMPLETED|Period 1: Titration Phase||0
168499|NCT00644787|390870|P1|COMPLETED|Period 1: Titration Phase||129
168500|NCT00644787|390868|P3|STARTED|Period 1: Titration Phase||0
168501|NCT00644787|390869|P2|STARTED|Period 1: Titration Phase||0
168502|NCT00644787|390870|P1|STARTED|Period 1: Titration Phase||156
168503|NCT00644657|390898|P1|NOT COMPLETED|Overall Study||0
168504|NCT00644657|390898|P1|COMPLETED|Overall Study||27
168505|NCT00644657|390898|P1|STARTED|Overall Study||27
168506|NCT00644592|390905|P2|NOT COMPLETED|Overall Study||0
168507|NCT00644592|390906|P1|NOT COMPLETED|Overall Study||0
168508|NCT00644592|390905|P2|COMPLETED|Overall Study||6
168509|NCT00644592|390906|P1|COMPLETED|Overall Study||5
168510|NCT00644592|390905|P2|STARTED|Overall Study||6
168511|NCT00644592|390906|P1|STARTED|Overall Study||5
168512|NCT00644332|390912|P1|NOT COMPLETED|Overall Study||21
168513|NCT00644332|390912|P1|COMPLETED|Overall Study||150
168514|NCT00644332|390912|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
168515|NCT00644280|390927|P2|NOT COMPLETED|Overall Study||0
168516|NCT00644280|390928|P1|NOT COMPLETED|Overall Study||0
168517|NCT00644280|390927|P2|COMPLETED|Overall Study||5
168518|NCT00644280|390928|P1|COMPLETED|Overall Study||6
168519|NCT00644280|390927|P2|STARTED|Overall Study||5
168520|NCT00644280|390928|P1|STARTED|Overall Study||6
168521|NCT00644059|390939|P3|NOT COMPLETED|Overall Study||65
168522|NCT00644059|390940|P2|NOT COMPLETED|Overall Study||123
168523|NCT00644059|390941|P1|NOT COMPLETED|Overall Study||124
168524|NCT00644059|390939|P3|COMPLETED|Overall Study||969
168525|NCT00644059|390940|P2|COMPLETED|Overall Study||1726
168526|NCT00644059|390941|P1|COMPLETED|Overall Study||1895
168527|NCT00644059|390939|P3|STARTED|Overall Study||1034
168528|NCT00644059|390940|P2|STARTED|Overall Study||1849
168529|NCT00644059|390941|P1|STARTED|Overall Study||2019
168530|NCT00643201|391027|P2|NOT COMPLETED|Completed Study Follow Up||79
168531|NCT00643201|391028|P1|NOT COMPLETED|Completed Study Follow Up||70
168532|NCT00643201|391027|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
168533|NCT00643201|391028|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
168534|NCT00643201|391027|P2|STARTED|Completed Study Follow Up||2639
168535|NCT00643201|391028|P1|STARTED|Completed Study Follow Up||2617
168536|NCT00643201|391027|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
168537|NCT00643201|391028|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
168538|NCT00643201|391027|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
168539|NCT00643201|391028|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
168540|NCT00643201|391027|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
168541|NCT00643201|391028|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
168542|NCT00643097|391077|P3|NOT COMPLETED|Overall Study||0
168543|NCT00643097|391078|P2|NOT COMPLETED|Overall Study||0
168544|NCT00643097|391079|P1|NOT COMPLETED|Overall Study||0
168545|NCT00643097|391077|P3|COMPLETED|Overall Study||10
168546|NCT00643097|391078|P2|COMPLETED|Overall Study||12
168547|NCT00643097|391079|P1|COMPLETED|Overall Study||18
168548|NCT00643097|391077|P3|STARTED|Overall Study||10
168549|NCT00643097|391078|P2|STARTED|Overall Study||12
168550|NCT00643097|391079|P1|STARTED|Overall Study||18
168551|NCT00643916|391102|P6|NOT COMPLETED|Overall Study||1
168552|NCT00643916|391103|P5|NOT COMPLETED|Overall Study||2
168553|NCT00643916|391104|P4|NOT COMPLETED|Overall Study||2
168554|NCT00643916|391105|P3|NOT COMPLETED|Overall Study||6
168555|NCT00643916|391106|P2|NOT COMPLETED|Overall Study||6
168556|NCT00643916|391107|P1|NOT COMPLETED|Overall Study||4
168557|NCT00643916|391102|P6|COMPLETED|Overall Study||66
168558|NCT00643916|391103|P5|COMPLETED|Overall Study||57
168559|NCT00643916|391104|P4|COMPLETED|Overall Study||60
168560|NCT00643916|391105|P3|COMPLETED|Overall Study||62
168561|NCT00643916|391106|P2|COMPLETED|Overall Study||61
168562|NCT00643916|391107|P1|COMPLETED|Overall Study||51
168563|NCT00643916|391102|P6|STARTED|Overall Study||67
168564|NCT00643916|391103|P5|STARTED|Overall Study||59
168565|NCT00643916|391104|P4|STARTED|Overall Study||62
168566|NCT00643916|391105|P3|STARTED|Overall Study||68
168567|NCT00643916|391106|P2|STARTED|Overall Study||67
168568|NCT00643916|391107|P1|STARTED|Overall Study||55
168569|NCT00643760|391132|P5|NOT COMPLETED|Overall Study||19
168570|NCT00643760|391133|P4|NOT COMPLETED|Overall Study||38
168571|NCT00643760|391134|P3|NOT COMPLETED|Overall Study||19
168572|NCT00643760|391135|P2|NOT COMPLETED|Overall Study||15
168573|NCT00643760|391136|P1|NOT COMPLETED|Overall Study||30
168574|NCT00643760|391132|P5|COMPLETED|Overall Study||47
168575|NCT00643760|391133|P4|COMPLETED|Overall Study||79
168576|NCT00643760|391134|P3|COMPLETED|Overall Study||37
168577|NCT00643760|391135|P2|COMPLETED|Overall Study||47
168578|NCT00643760|391136|P1|COMPLETED|Overall Study||90
168579|NCT00643760|391132|P5|ITT Population|Overall Study||66
168580|NCT00643760|391133|P4|ITT Population|Overall Study||116
168581|NCT00643760|391134|P3|ITT Population|Overall Study||56
168582|NCT00643760|391135|P2|ITT Population|Overall Study||62
168583|NCT00643760|391136|P1|ITT Population|Overall Study||120
168584|NCT00643760|391132|P5|Safety Population/Treated With Drug|Overall Study||66
168585|NCT00643760|391133|P4|Safety Population/Treated With Drug|Overall Study||116
168586|NCT00643760|391134|P3|Safety Population/Treated With Drug|Overall Study||56
168587|NCT00643760|391135|P2|Safety Population/Treated With Drug|Overall Study||62
168588|NCT00643760|391136|P1|Safety Population/Treated With Drug|Overall Study||120
168589|NCT00643760|391132|P5|STARTED|Overall Study||66
168590|NCT00643760|391133|P4|STARTED|Overall Study||117
168591|NCT00643760|391134|P3|STARTED|Overall Study||56
168592|NCT00643760|391135|P2|STARTED|Overall Study||62
168593|NCT00643760|391136|P1|STARTED|Overall Study||120
168594|NCT00643682|391240|P2|NOT COMPLETED|Overall Study||509
168595|NCT00643682|391241|P1|NOT COMPLETED|Overall Study||522
168596|NCT00643682|391240|P2|COMPLETED|Overall Study||492
168597|NCT00643682|391241|P1|COMPLETED|Overall Study||477
168598|NCT00643682|391240|P2|STARTED|Overall Study||1001
168599|NCT00643682|391241|P1|STARTED|Overall Study||999
168600|NCT00643604|391253|P1|NOT COMPLETED|Overall Study||1
168601|NCT00643604|391253|P1|COMPLETED|Overall Study||6
168602|NCT00643604|391253|P1|STARTED|Overall Study||7
168603|NCT00643578|391270|P2|NOT COMPLETED|Overall Study||0
168604|NCT00643578|391271|P1|NOT COMPLETED|Overall Study||2
168605|NCT00643578|391270|P2|COMPLETED|Overall Study||6
168606|NCT00643578|391271|P1|COMPLETED|Overall Study||4
168607|NCT00643578|391270|P2|STARTED|Overall Study||6
168608|NCT00643578|391271|P1|STARTED|Overall Study||6
168609|NCT00643565|391281|P2|NOT COMPLETED|Overall Study||74
168610|NCT00643565|391282|P1|NOT COMPLETED|Overall Study||80
168611|NCT00643565|391281|P2|COMPLETED|Overall Study||0
168612|NCT00643565|391282|P1|COMPLETED|Overall Study||0
168613|NCT00643565|391281|P2|STARTED|Overall Study||74
168614|NCT00643565|391282|P1|STARTED|Overall Study||80
168615|NCT00643487|391304|P1|NOT COMPLETED|Overall Study||3
168616|NCT00643487|391304|P1|COMPLETED|Overall Study||5
168617|NCT00643487|391304|P1|STARTED|Overall Study||8
168618|NCT00643448|391311|P3|NOT COMPLETED|Overall Study||6
168619|NCT00643448|391312|P2|NOT COMPLETED|Overall Study||5
168620|NCT00643448|391313|P1|NOT COMPLETED|Overall Study||4
168621|NCT00643448|391311|P3|COMPLETED|Overall Study||16
168622|NCT00643448|391312|P2|COMPLETED|Overall Study||17
168623|NCT00643448|391313|P1|COMPLETED|Overall Study||17
168624|NCT00643448|391311|P3|STARTED|Overall Study||22
168625|NCT00643448|391312|P2|STARTED|Overall Study||22
168626|NCT00643448|391313|P1|STARTED|Overall Study||21
168627|NCT00643006|391330|P2|NOT COMPLETED|Overall Study||4
168628|NCT00643006|391331|P1|NOT COMPLETED|Overall Study||5
168629|NCT00643006|391330|P2|COMPLETED|Overall Study||29
168630|NCT00643006|391331|P1|COMPLETED|Overall Study||29
168631|NCT00643006|391330|P2|STARTED|Overall Study||33
168632|NCT00643006|391331|P1|STARTED|Overall Study||34
168633|NCT00642993|391341|P2|NOT COMPLETED|Overall Study||16
168634|NCT00642993|391342|P1|NOT COMPLETED|Overall Study||106
168635|NCT00642993|391341|P2|COMPLETED|Overall Study||118
168636|NCT00642993|391342|P1|COMPLETED|Overall Study||161
168637|NCT00642993|391341|P2|STARTED|Overall Study||134
168638|NCT00642993|391342|P1|STARTED|Overall Study||267
168639|NCT00642902|391360|P4|NOT COMPLETED|Overall Study||40
168640|NCT00642902|391361|P3|NOT COMPLETED|Overall Study||43
168641|NCT00642902|391362|P2|NOT COMPLETED|Overall Study||42
168642|NCT00642902|391363|P1|NOT COMPLETED|Overall Study||40
168643|NCT00642902|391360|P4|COMPLETED|Overall Study||25
168644|NCT00642902|391361|P3|COMPLETED|Overall Study||21
168645|NCT00642902|391362|P2|COMPLETED|Overall Study||21
168646|NCT00642902|391363|P1|COMPLETED|Overall Study||23
168647|NCT00642902|391360|P4|Treated|Overall Study||65
168648|NCT00642902|391361|P3|Treated|Overall Study||63
168649|NCT00642902|391362|P2|Treated|Overall Study||63
168650|NCT00642902|391363|P1|Treated|Overall Study||63
168651|NCT00642902|391360|P4|STARTED|Overall Study||65
168652|NCT00642902|391361|P3|STARTED|Overall Study||64
168653|NCT00642902|391362|P2|STARTED|Overall Study||63
168654|NCT00642902|391363|P1|STARTED|Overall Study||63
168655|NCT00642850|391385|P1|NOT COMPLETED|Overall Study||33
168656|NCT00642850|391385|P1|COMPLETED|Overall Study||155
168657|NCT00642850|391385|P1|STARTED|Overall Study||188
168658|NCT00642811|391401|P6|NOT COMPLETED|Overall Study||1
168659|NCT00642811|391402|P5|NOT COMPLETED|Overall Study||1
168660|NCT00642811|391403|P4|NOT COMPLETED|Overall Study||1
168661|NCT00642811|391404|P3|NOT COMPLETED|Overall Study||0
168662|NCT00642811|391405|P2|NOT COMPLETED|Overall Study||4
168663|NCT00642811|391406|P1|NOT COMPLETED|Overall Study||3
168664|NCT00642811|391401|P6|COMPLETED|Overall Study||13
168665|NCT00642811|391402|P5|COMPLETED|Overall Study||13
168666|NCT00642811|391403|P4|COMPLETED|Overall Study||15
168667|NCT00642811|391404|P3|COMPLETED|Overall Study||13
168668|NCT00642811|391405|P2|COMPLETED|Overall Study||17
168669|NCT00642811|391406|P1|COMPLETED|Overall Study||17
168670|NCT00642811|391401|P6|STARTED|Overall Study||14
168671|NCT00642811|391402|P5|STARTED|Overall Study||14
168672|NCT00642811|391403|P4|STARTED|Overall Study||16
168673|NCT00642811|391404|P3|STARTED|Overall Study||13
168674|NCT00642811|391405|P2|STARTED|Overall Study||21
168675|NCT00642811|391406|P1|STARTED|Overall Study||20
168676|NCT00642772|391428|P1|NOT COMPLETED|Overall Study||10
168677|NCT00642772|391428|P1|COMPLETED|Overall Study||14
168678|NCT00642772|391428|P1|STARTED|Overall Study||24
168679|NCT00642759|391432|P1|NOT COMPLETED|Overall Study||1
168680|NCT00642759|391432|P1|COMPLETED|Overall Study||35
168681|NCT00642759|391432|P1|STARTED|Overall Study||36
168682|NCT00642746|391438|P2|NOT COMPLETED|Overall Study||0
168683|NCT00642746|391439|P1|NOT COMPLETED|Overall Study||1
168684|NCT00642746|391438|P2|COMPLETED|Overall Study||1
168685|NCT00642746|391439|P1|COMPLETED|Overall Study||9
168686|NCT00642746|391438|P2|STARTED|Overall Study||1
168687|NCT00642746|391439|P1|STARTED|Overall Study||10
168688|NCT00642707|391453|P4|NOT COMPLETED|Overall Study||2
168689|NCT00642707|391454|P3|NOT COMPLETED|Overall Study||0
168690|NCT00642707|391455|P2|NOT COMPLETED|Overall Study||0
168691|NCT00642707|391456|P1|NOT COMPLETED|Overall Study||1
168692|NCT00642707|391453|P4|COMPLETED|Overall Study||8
168693|NCT00642707|391454|P3|COMPLETED|Overall Study||12
168694|NCT00642707|391455|P2|COMPLETED|Overall Study||11
168695|NCT00642707|391456|P1|COMPLETED|Overall Study||10
168696|NCT00642707|391453|P4|STARTED|Overall Study||10
168697|NCT00642707|391454|P3|STARTED|Overall Study||12
168698|NCT00642707|391455|P2|STARTED|Overall Study||11
168699|NCT00642707|391456|P1|STARTED|Overall Study||11
168700|NCT00642694|391468|P2|NOT COMPLETED|Overall Study||4
168701|NCT00642694|391469|P1|NOT COMPLETED|Overall Study||6
168702|NCT00642694|391468|P2|COMPLETED|Overall Study||11
168703|NCT00642694|391469|P1|COMPLETED|Overall Study||8
168704|NCT00642694|391468|P2|STARTED|Overall Study||15
168705|NCT00642694|391469|P1|STARTED|Overall Study||14
168706|NCT00642668|391477|P1|NOT COMPLETED|Overall Study||14
168707|NCT00642668|391477|P1|COMPLETED|Overall Study||21
168708|NCT00642668|391477|P1|STARTED|Overall Study||35
168709|NCT00642642|391485|P1|NOT COMPLETED|Treatment & Follow Up||17
168710|NCT00642642|391485|P1|COMPLETED|Treatment & Follow Up||92
168711|NCT00642642|391485|P1|STARTED|Treatment & Follow Up||109
168712|NCT00642642|391485|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
168713|NCT00642642|391485|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
168714|NCT00642642|391485|P1|STARTED|Biopsy & Product Manufacture||122
168715|NCT00642616|391502|P4|NOT COMPLETED|Overall Study||7
168716|NCT00642616|391503|P3|NOT COMPLETED|Overall Study||9
168717|NCT00642616|391504|P2|NOT COMPLETED|Overall Study||7
168718|NCT00642616|391505|P1|NOT COMPLETED|Overall Study||9
168719|NCT00642616|391502|P4|COMPLETED|Overall Study||1
168720|NCT00642616|391503|P3|COMPLETED|Overall Study||0
168721|NCT00642616|391504|P2|COMPLETED|Overall Study||1
168722|NCT00642616|391505|P1|COMPLETED|Overall Study||0
168723|NCT00642616|391502|P4|STARTED|Overall Study||8
168724|NCT00642616|391503|P3|STARTED|Overall Study||9
168725|NCT00642616|391504|P2|STARTED|Overall Study||8
168726|NCT00642616|391505|P1|STARTED|Overall Study||9
168727|NCT00642603|391529|P2|NOT COMPLETED|Overall Study||18
168728|NCT00642603|391530|P1|NOT COMPLETED|Overall Study||21
168729|NCT00642603|391529|P2|COMPLETED|Overall Study||2
168730|NCT00642603|391530|P1|COMPLETED|Overall Study||0
168731|NCT00642603|391529|P2|Safety Population|Overall Study||20
168732|NCT00642603|391530|P1|Safety Population|Overall Study||19
168733|NCT00642603|391529|P2|STARTED|Overall Study||20
168734|NCT00642603|391530|P1|STARTED|Overall Study||21
168735|NCT00642473|391538|P2|NOT COMPLETED|Overall Study||11
168736|NCT00642473|391539|P1|NOT COMPLETED|Overall Study||4
168737|NCT00642473|391538|P2|COMPLETED|Overall Study||5
168738|NCT00642473|391539|P1|COMPLETED|Overall Study||14
168739|NCT00642473|391538|P2|STARTED|Overall Study||16
168740|NCT00642473|391539|P1|STARTED|Overall Study||18
168741|NCT00642460|391553|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
168742|NCT00642460|391554|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
168743|NCT00642460|391555|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
168744|NCT00642460|391556|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
168745|NCT00642460|391557|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
168746|NCT00642460|391558|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
168747|NCT00642460|391553|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
168748|NCT00642460|391554|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
168749|NCT00642460|391555|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
168750|NCT00642460|391556|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
168751|NCT00642460|391557|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
168752|NCT00642460|391558|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
168753|NCT00642460|391553|P6|STARTED|Part III: Open-Label Up to Week 260||59
168754|NCT00642460|391554|P5|STARTED|Part III: Open-Label Up to Week 260||53
168755|NCT00642460|391555|P4|STARTED|Part III: Open-Label Up to Week 260||0
168756|NCT00642460|391556|P3|STARTED|Part III: Open-Label Up to Week 260||0
168757|NCT00642460|391557|P2|STARTED|Part III: Open-Label Up to Week 260||0
168758|NCT00642460|391558|P1|STARTED|Part III: Open-Label Up to Week 260||0
168759|NCT00642460|391553|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
168760|NCT00642460|391554|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
168761|NCT00642460|391555|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
168762|NCT00642460|391556|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
168763|NCT00642460|391557|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
168764|NCT00642460|391558|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
168765|NCT00642460|391553|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
168766|NCT00642460|391554|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
168767|NCT00642460|391555|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
168768|NCT00642460|391556|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
168769|NCT00642460|391557|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
168770|NCT00642460|391558|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
168771|NCT00642460|391553|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
168772|NCT00642460|391554|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
168773|NCT00642460|391555|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
168774|NCT00642460|391556|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
168775|NCT00642460|391557|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
168776|NCT00642460|391558|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
168777|NCT00642460|391553|P6|STARTED|Part II: Open-Label Up to Week 92||0
168778|NCT00642460|391554|P5|STARTED|Part II: Open-Label Up to Week 92||0
168779|NCT00642460|391555|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
168780|NCT00642460|391556|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
168781|NCT00642460|391557|P2|STARTED|Part II: Open-Label Up to Week 92||40
168782|NCT00642460|391558|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
168783|NCT00642460|391553|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
168784|NCT00642460|391554|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
168785|NCT00642460|391555|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
168786|NCT00642460|391556|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
168787|NCT00642460|391557|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
168788|NCT00642460|391558|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
168789|NCT00642460|391553|P6|COMPLETED|Part I: 12 Week Double-Blind||0
168790|NCT00642460|391554|P5|COMPLETED|Part I: 12 Week Double-Blind||0
168791|NCT00642460|391555|P4|COMPLETED|Part I: 12 Week Double-Blind||0
168792|NCT00642460|391556|P3|COMPLETED|Part I: 12 Week Double-Blind||36
168793|NCT00642460|391557|P2|COMPLETED|Part I: 12 Week Double-Blind||37
168794|NCT00642460|391558|P1|COMPLETED|Part I: 12 Week Double-Blind||36
168795|NCT00642460|391553|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
168796|NCT00642460|391554|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
168797|NCT00642460|391555|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
168798|NCT00642460|391556|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
168799|NCT00642460|391557|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
168800|NCT00642460|391558|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
168801|NCT00642460|391553|P6|STARTED|Part I: 12 Week Double-Blind||0
168802|NCT00642460|391554|P5|STARTED|Part I: 12 Week Double-Blind||0
168803|NCT00642460|391555|P4|STARTED|Part I: 12 Week Double-Blind||0
168804|NCT00642460|391556|P3|STARTED|Part I: 12 Week Double-Blind||37
168805|NCT00642460|391557|P2|STARTED|Part I: 12 Week Double-Blind||38
168806|NCT00642460|391558|P1|STARTED|Part I: 12 Week Double-Blind||37
168807|NCT00642369|391624|P2|NOT COMPLETED|Overall Study||6
168808|NCT00642369|391625|P1|NOT COMPLETED|Overall Study||5
168809|NCT00642369|391624|P2|COMPLETED|Overall Study||24
168810|NCT00642369|391625|P1|COMPLETED|Overall Study||25
168811|NCT00642369|391624|P2|STARTED|Overall Study||30
168812|NCT00642369|391625|P1|STARTED|Overall Study||30
168813|NCT00642356|391635|P2|NOT COMPLETED|Overall Study||3
168814|NCT00642356|391636|P1|NOT COMPLETED|Overall Study||2
168815|NCT00642356|391635|P2|COMPLETED|Overall Study||4
168816|NCT00642356|391636|P1|COMPLETED|Overall Study||5
168817|NCT00642356|391635|P2|STARTED|Overall Study||7
168818|NCT00642356|391636|P1|STARTED|Overall Study||7
168819|NCT00642304|391644|P1|NOT COMPLETED|Overall Study||6
168820|NCT00642304|391644|P1|COMPLETED|Overall Study||14
168821|NCT00642304|391644|P1|STARTED|Overall Study||20
168822|NCT00642278|391660|P7|NOT COMPLETED|Overall Study||5
168823|NCT00642278|391661|P6|NOT COMPLETED|Overall Study||7
168824|NCT00642278|391662|P5|NOT COMPLETED|Overall Study||8
168825|NCT00642278|391663|P4|NOT COMPLETED|Overall Study||9
168826|NCT00642278|391664|P3|NOT COMPLETED|Overall Study||5
168827|NCT00642278|391665|P2|NOT COMPLETED|Overall Study||5
168828|NCT00642278|391666|P1|NOT COMPLETED|Overall Study||10
168829|NCT00642278|391660|P7|COMPLETED|Overall Study||60
168830|NCT00642278|391661|P6|COMPLETED|Overall Study||57
168831|NCT00642278|391662|P5|COMPLETED|Overall Study||56
168832|NCT00642278|391663|P4|COMPLETED|Overall Study||56
168833|NCT00642278|391664|P3|COMPLETED|Overall Study||59
168834|NCT00642278|391665|P2|COMPLETED|Overall Study||59
168835|NCT00642278|391666|P1|COMPLETED|Overall Study||55
168836|NCT00642278|391660|P7|STARTED|Overall Study||65
168837|NCT00642278|391661|P6|STARTED|Overall Study||64
168838|NCT00642278|391662|P5|STARTED|Overall Study||64
168839|NCT00642278|391663|P4|STARTED|Overall Study||65
168840|NCT00642278|391664|P3|STARTED|Overall Study||64
168841|NCT00642278|391665|P2|STARTED|Overall Study||64
168842|NCT00642278|391666|P1|STARTED|Overall Study||65
168843|NCT00642174|391719|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
168844|NCT00642174|391720|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
168845|NCT00642174|391719|P2|COMPLETED|Period 2 - Crossover Drug||16
168846|NCT00642174|391720|P1|COMPLETED|Period 2 - Crossover Drug||18
168847|NCT00642174|391719|P2|STARTED|Period 2 - Crossover Drug||16
168848|NCT00642174|391720|P1|STARTED|Period 2 - Crossover Drug||18
168849|NCT00642174|391719|P2|NOT COMPLETED|Period 1 - Initial Drug||1
168850|NCT00642174|391720|P1|NOT COMPLETED|Period 1 - Initial Drug||0
168851|NCT00642174|391719|P2|COMPLETED|Period 1 - Initial Drug||16
168852|NCT00642174|391720|P1|COMPLETED|Period 1 - Initial Drug||18
168853|NCT00642174|391719|P2|STARTED|Period 1 - Initial Drug||17
168854|NCT00642174|391720|P1|STARTED|Period 1 - Initial Drug||18
168855|NCT00641862|391736|P2|NOT COMPLETED|Overall Study||38
168856|NCT00641862|391737|P1|NOT COMPLETED|Overall Study||44
168857|NCT00641862|391736|P2|COMPLETED|Overall Study||145
168858|NCT00641862|391737|P1|COMPLETED|Overall Study||139
168859|NCT00641862|391736|P2|STARTED|Overall Study||183
168860|NCT00641862|391737|P1|STARTED|Overall Study||183
168861|NCT00640835|391745|P2|NOT COMPLETED|Overall Study||57
168862|NCT00640835|391746|P1|NOT COMPLETED|Overall Study||76
168863|NCT00640835|391745|P2|COMPLETED|Overall Study||131
168864|NCT00640835|391746|P1|COMPLETED|Overall Study||118
168865|NCT00640835|391745|P2|STARTED|Overall Study||188
168866|NCT00640835|391746|P1|STARTED|Overall Study||194
168867|NCT00641745|391756|P2|NOT COMPLETED|Overall Study||113
168868|NCT00641745|391757|P1|NOT COMPLETED|Overall Study||280
168869|NCT00641745|391756|P2|COMPLETED|Overall Study||89
168870|NCT00641745|391757|P1|COMPLETED|Overall Study||147
168871|NCT00641745|391756|P2|STARTED|Overall Study||202
168872|NCT00641745|391757|P1|STARTED|Overall Study||427
168873|NCT00641719|391765|P2|NOT COMPLETED|Overall Study||37
168874|NCT00641719|391766|P1|NOT COMPLETED|Overall Study||30
168875|NCT00641719|391765|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
168876|NCT00641719|391766|P1|COMPLETED|Overall Study||99
168877|NCT00641719|391765|P2|STARTED|Overall Study||129
168878|NCT00641719|391766|P1|STARTED|Overall Study||129
168879|NCT00641706|391790|P2|NOT COMPLETED|Overall Study||3
168880|NCT00641706|391791|P1|NOT COMPLETED|Overall Study||9
168881|NCT00641706|391790|P2|COMPLETED|Overall Study||4
168882|NCT00641706|391791|P1|COMPLETED|Overall Study||28
168883|NCT00641706|391790|P2|STARTED|Overall Study||7
168884|NCT00641706|391791|P1|STARTED|Overall Study||37
168885|NCT00641667|391803|P1|NOT COMPLETED|Overall Study||6
168886|NCT00641667|391803|P1|COMPLETED|Overall Study||60
168887|NCT00641667|391803|P1|STARTED|Overall Study||66
168888|NCT00641641|391813|P1|NOT COMPLETED|Overall Study||0
168889|NCT00641641|391813|P1|COMPLETED|Overall Study||16
168890|NCT00641641|391813|P1|STARTED|Overall Study||16
168891|NCT00641563|391817|P2|NOT COMPLETED|Infusion 2||0
168892|NCT00641563|391818|P1|NOT COMPLETED|Infusion 2||0
168893|NCT00641563|391817|P2|COMPLETED|Infusion 2||5
168894|NCT00641563|391818|P1|COMPLETED|Infusion 2||5
168895|NCT00641563|391817|P2|STARTED|Infusion 2||5
168896|NCT00641563|391818|P1|STARTED|Infusion 2||5
168897|NCT00641563|391817|P2|NOT COMPLETED|Infusion 1||0
168898|NCT00641563|391818|P1|NOT COMPLETED|Infusion 1||0
168899|NCT00641563|391817|P2|COMPLETED|Infusion 1||5
168900|NCT00641563|391818|P1|COMPLETED|Infusion 1||5
168901|NCT00641563|391817|P2|STARTED|Infusion 1||5
168902|NCT00641563|391818|P1|STARTED|Infusion 1||5
168903|NCT00641537|391831|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
168904|NCT00641537|391832|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
168905|NCT00641537|391833|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
168906|NCT00641537|391834|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
168907|NCT00641537|391835|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
168908|NCT00641537|391836|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
168909|NCT00641537|391837|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
168910|NCT00641537|391838|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
168911|NCT00641537|391831|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
168912|NCT00641537|391832|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
168913|NCT00641537|391833|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
168914|NCT00641537|391834|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
168915|NCT00641537|391835|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
168916|NCT00641537|391836|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
168917|NCT00641537|391837|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
168918|NCT00641537|391838|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
168919|NCT00641537|391831|P8|STARTED|24-Week Supplemental Follow-up Period||11
168920|NCT00641537|391832|P7|STARTED|24-Week Supplemental Follow-up Period||9
168921|NCT00641537|391833|P6|STARTED|24-Week Supplemental Follow-up Period||15
168922|NCT00641537|391834|P5|STARTED|24-Week Supplemental Follow-up Period||198
168923|NCT00641537|391835|P4|STARTED|24-Week Supplemental Follow-up Period||151
168924|NCT00641537|391836|P3|STARTED|24-Week Supplemental Follow-up Period||143
168925|NCT00641537|391837|P2|STARTED|24-Week Supplemental Follow-up Period||69
168926|NCT00641537|391838|P1|STARTED|24-Week Supplemental Follow-up Period||75
168927|NCT00641537|391831|P8|NOT COMPLETED|96-week Period||6
168928|NCT00641537|391832|P7|NOT COMPLETED|96-week Period||5
168929|NCT00641537|391833|P6|NOT COMPLETED|96-week Period||7
168930|NCT00641537|391834|P5|NOT COMPLETED|96-week Period||18
168931|NCT00641537|391835|P4|NOT COMPLETED|96-week Period||12
168932|NCT00641537|391836|P3|NOT COMPLETED|96-week Period||20
168933|NCT00641537|391837|P2|NOT COMPLETED|96-week Period||10
168934|NCT00641537|391838|P1|NOT COMPLETED|96-week Period||9
168935|NCT00641537|391831|P8|COMPLETED|96-week Period||16
168936|NCT00641537|391832|P7|COMPLETED|96-week Period||12
168937|NCT00641537|391833|P6|COMPLETED|96-week Period||15
168938|NCT00641537|391834|P5|COMPLETED|96-week Period||226
168939|NCT00641537|391835|P4|COMPLETED|96-week Period||174
168940|NCT00641537|391836|P3|COMPLETED|96-week Period||166
168941|NCT00641537|391837|P2|COMPLETED|96-week Period||82
168942|NCT00641537|391838|P1|COMPLETED|96-week Period||89
168943|NCT00641537|391831|P8|STARTED|96-week Period||22
168944|NCT00641537|391832|P7|STARTED|96-week Period||17
168945|NCT00641537|391833|P6|STARTED|96-week Period||22
168946|NCT00641537|391834|P5|STARTED|96-week Period||244
168947|NCT00641537|391835|P4|STARTED|96-week Period||186
168948|NCT00641537|391836|P3|STARTED|96-week Period||186
168949|NCT00641537|391837|P2|STARTED|96-week Period||92
168950|NCT00641537|391838|P1|STARTED|96-week Period||98
168951|NCT00641056|391893|P2|NOT COMPLETED|Overall Study||25
168952|NCT00641056|391894|P1|NOT COMPLETED|Overall Study||29
168953|NCT00641056|391893|P2|COMPLETED|Overall Study||209
168954|NCT00641056|391894|P1|COMPLETED|Overall Study||204
168955|NCT00641056|391893|P2|Intent to Treat (ITT)|Overall Study||223
168956|NCT00641056|391894|P1|Intent to Treat (ITT)|Overall Study||233
168957|NCT00641056|391893|P2|STARTED|Overall Study||234
168958|NCT00641056|391894|P1|STARTED|Overall Study||233
168959|NCT00641043|391922|P2|NOT COMPLETED|Overall Study||15
168960|NCT00641043|391923|P1|NOT COMPLETED|Overall Study||19
168961|NCT00641043|391922|P2|COMPLETED|Overall Study|number who completed treatment|244
168962|NCT00641043|391923|P1|COMPLETED|Overall Study|number who completed treatment|111
168963|NCT00641043|391922|P2|STARTED|Overall Study|number who started treatment|259
168964|NCT00641043|391923|P1|STARTED|Overall Study|number who started treatment|130
168965|NCT00640978|391953|P1|NOT COMPLETED|Overall Study||0
168966|NCT00640978|391953|P1|COMPLETED|Overall Study||15
168967|NCT00640978|391953|P1|STARTED|Overall Study||15
168968|NCT00640926|391960|P3|NOT COMPLETED|Overall Study||8
168969|NCT00640926|391961|P2|NOT COMPLETED|Overall Study||6
168970|NCT00640926|391962|P1|NOT COMPLETED|Overall Study||8
168971|NCT00640926|391960|P3|COMPLETED|Overall Study||45
168972|NCT00640926|391961|P2|COMPLETED|Overall Study||46
168973|NCT00640926|391962|P1|COMPLETED|Overall Study||45
168974|NCT00640926|391960|P3|STARTED|Overall Study||53
168975|NCT00640926|391961|P2|STARTED|Overall Study||52
168976|NCT00640926|391962|P1|STARTED|Overall Study||53
168977|NCT00640822|391976|P3|NOT COMPLETED|Overall Study||25
168978|NCT00640822|391977|P2|NOT COMPLETED|Overall Study||59
168979|NCT00640822|391978|P1|NOT COMPLETED|Overall Study||43
168980|NCT00640822|391976|P3|COMPLETED|Overall Study||77
168981|NCT00640822|391977|P2|COMPLETED|Overall Study||258
168982|NCT00640822|391978|P1|COMPLETED|Overall Study||279
168983|NCT00640822|391976|P3|STARTED|Overall Study||102
168984|NCT00640822|391977|P2|STARTED|Overall Study||317
168985|NCT00640822|391978|P1|STARTED|Overall Study||322
168986|NCT00640614|391988|P2|NOT COMPLETED|Overall Study||0
168987|NCT00640614|391989|P1|NOT COMPLETED|Overall Study||1
168988|NCT00640614|391988|P2|COMPLETED|Overall Study||110
168989|NCT00640614|391989|P1|COMPLETED|Overall Study||124
168990|NCT00640614|391988|P2|STARTED|Overall Study||110
168991|NCT00640614|391989|P1|STARTED|Overall Study||125
168992|NCT00640601|392031|P1|NOT COMPLETED|Overall Study||112
168993|NCT00640601|392031|P1|COMPLETED|Overall Study||183
168994|NCT00640601|392031|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
168995|NCT00640562|392047|P2|NOT COMPLETED|Overall Study||26
168996|NCT00640562|392048|P1|NOT COMPLETED|Overall Study||18
168997|NCT00640562|392047|P2|COMPLETED|Overall Study||81
168998|NCT00640562|392048|P1|COMPLETED|Overall Study||91
168999|NCT00640562|392047|P2|STARTED|Overall Study||107
169000|NCT00640562|392048|P1|STARTED|Overall Study||109
169001|NCT00640510|392076|P2|NOT COMPLETED|Overall Study||2
169002|NCT00640510|392077|P1|NOT COMPLETED|Overall Study||1
169003|NCT00640510|392076|P2|COMPLETED|Overall Study||15
169004|NCT00640510|392077|P1|COMPLETED|Overall Study||16
169005|NCT00640510|392076|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
169006|NCT00640510|392077|P1|STARTED|Overall Study||17
169007|NCT00640393|392089|P3|NOT COMPLETED|Part 2||3
169008|NCT00640393|392090|P2|NOT COMPLETED|Part 2||10
169009|NCT00640393|392091|P1|NOT COMPLETED|Part 2||0
169010|NCT00640393|392089|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
169011|NCT00640393|392090|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
169012|NCT00640393|392091|P1|COMPLETED|Part 2||0
169013|NCT00640393|392089|P3|STARTED|Part 2||38
169014|NCT00640393|392090|P2|STARTED|Part 2||37
169015|NCT00640393|392091|P1|STARTED|Part 2||0
169016|NCT00640393|392089|P3|NOT COMPLETED|Randomization||0
169017|NCT00640393|392090|P2|NOT COMPLETED|Randomization||0
169018|NCT00640393|392091|P1|NOT COMPLETED|Randomization||19
169019|NCT00640393|392089|P3|COMPLETED|Randomization||0
169020|NCT00640393|392090|P2|COMPLETED|Randomization||0
169021|NCT00640393|392091|P1|COMPLETED|Randomization||75
169022|NCT00640393|392089|P3|STARTED|Randomization||0
169023|NCT00640393|392090|P2|STARTED|Randomization||0
169024|NCT00640393|392091|P1|STARTED|Randomization||94
169025|NCT00640393|392089|P3|NOT COMPLETED|Part 1||0
169026|NCT00640393|392090|P2|NOT COMPLETED|Part 1||0
169027|NCT00640393|392091|P1|NOT COMPLETED|Part 1||5
169028|NCT00640393|392089|P3|COMPLETED|Part 1||0
169029|NCT00640393|392090|P2|COMPLETED|Part 1||0
169030|NCT00640393|392091|P1|COMPLETED|Part 1||94
169031|NCT00640393|392089|P3|STARTED|Part 1||0
169032|NCT00640393|392090|P2|STARTED|Part 1||0
169033|NCT00640393|392091|P1|STARTED|Part 1||99
169034|NCT00640341|392156|P3|NOT COMPLETED|Overall Study||7
169035|NCT00640341|392157|P2|NOT COMPLETED|Overall Study||5
169036|NCT00640341|392158|P1|NOT COMPLETED|Overall Study||21
169037|NCT00640341|392156|P3|COMPLETED|Overall Study||163
169038|NCT00640341|392157|P2|COMPLETED|Overall Study||165
169039|NCT00640341|392158|P1|COMPLETED|Overall Study||149
169040|NCT00640341|392156|P3|Eligible Participants at Baseline|Overall Study||168
169041|NCT00640341|392157|P2|Eligible Participants at Baseline|Overall Study||167
169042|NCT00640341|392158|P1|Eligible Participants at Baseline|Overall Study||165
169043|NCT00640341|392156|P3|STARTED|Overall Study||170
169044|NCT00640341|392157|P2|STARTED|Overall Study||170
169045|NCT00640341|392158|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
169046|NCT00640328|392178|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
169047|NCT00640328|392179|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
169048|NCT00640328|392180|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
169049|NCT00640328|392181|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
169050|NCT00640328|392182|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
169051|NCT00640328|392183|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
169052|NCT00640328|392178|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
169053|NCT00640328|392179|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
169054|NCT00640328|392180|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
169055|NCT00640328|392181|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
169056|NCT00640328|392182|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
169057|NCT00640328|392183|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
169058|NCT00640328|392178|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
169059|NCT00640328|392179|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
169060|NCT00640328|392180|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
169061|NCT00640328|392181|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
169062|NCT00640328|392182|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
169063|NCT00640328|392183|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
169064|NCT00640328|392178|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
169065|NCT00640328|392179|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
169066|NCT00640328|392180|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
169067|NCT00640328|392181|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
169068|NCT00640328|392182|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
169069|NCT00640328|392183|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
169070|NCT00640328|392178|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
169071|NCT00640328|392179|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
169072|NCT00640328|392180|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
169073|NCT00640328|392181|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
169074|NCT00640328|392182|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
169075|NCT00640328|392183|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
169076|NCT00640328|392178|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
169077|NCT00640328|392179|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
169078|NCT00640328|392180|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
169079|NCT00640328|392181|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
169080|NCT00640328|392182|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
169081|NCT00640328|392183|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
169082|NCT00640328|392178|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
169083|NCT00640328|392179|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
169084|NCT00640328|392180|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
169085|NCT00640328|392181|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
169086|NCT00640328|392182|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
169087|NCT00640328|392183|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
169088|NCT00640328|392178|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
169089|NCT00640328|392179|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
169090|NCT00640328|392180|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
169091|NCT00640328|392181|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
169092|NCT00640328|392182|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
169093|NCT00640328|392183|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
169094|NCT00640328|392178|P6|STARTED|First Treatment Period (Weeks 0-24)||4
169095|NCT00640328|392179|P5|STARTED|First Treatment Period (Weeks 0-24)||4
169096|NCT00640328|392180|P4|STARTED|First Treatment Period (Weeks 0-24)||4
169097|NCT00640328|392181|P3|STARTED|First Treatment Period (Weeks 0-24)||7
169098|NCT00640328|392182|P2|STARTED|First Treatment Period (Weeks 0-24)||11
169099|NCT00640328|392183|P1|STARTED|First Treatment Period (Weeks 0-24)||8
169100|NCT00640315|392349|P2|NOT COMPLETED|Overall Study||1
169101|NCT00640315|392350|P1|NOT COMPLETED|Overall Study||0
169102|NCT00640315|392349|P2|COMPLETED|Overall Study||12
169103|NCT00640315|392350|P1|COMPLETED|Overall Study||10
169104|NCT00640315|392349|P2|Participants Received Treatment|Overall Study||13
169105|NCT00640315|392350|P1|Participants Received Treatment|Overall Study||10
169106|NCT00640315|392349|P2|STARTED|Overall Study||13
169107|NCT00640315|392350|P1|STARTED|Overall Study||10
169108|NCT00640042|392476|P1|NOT COMPLETED|Treatment||926
169109|NCT00640042|392476|P1|COMPLETED|Treatment||561
169110|NCT00640042|392476|P1|STARTED|Treatment||1487
169111|NCT00640042|392476|P1|NOT COMPLETED|Enrollment||83
169112|NCT00640042|392476|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
169113|NCT00640042|392476|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
169114|NCT00640016|392492|P4|NOT COMPLETED|Overall Study||3
169115|NCT00640016|392493|P3|NOT COMPLETED|Overall Study||3
169116|NCT00640016|392494|P2|NOT COMPLETED|Overall Study||2
169117|NCT00640016|392495|P1|NOT COMPLETED|Overall Study||2
169118|NCT00640016|392492|P4|COMPLETED|Overall Study||1
169119|NCT00640016|392493|P3|COMPLETED|Overall Study||1
169120|NCT00640016|392494|P2|COMPLETED|Overall Study||1
169121|NCT00640016|392495|P1|COMPLETED|Overall Study||1
169122|NCT00640016|392492|P4|Treated|Overall Study||4
169123|NCT00640016|392493|P3|Treated|Overall Study||4
169124|NCT00640016|392494|P2|Treated|Overall Study||2
169125|NCT00640016|392495|P1|Treated|Overall Study||3
169126|NCT00640016|392492|P4|STARTED|Overall Study||4
169127|NCT00640016|392493|P3|STARTED|Overall Study||4
169128|NCT00640016|392494|P2|STARTED|Overall Study||3
169129|NCT00640016|392495|P1|STARTED|Overall Study||3
169130|NCT00639860|392539|P1|NOT COMPLETED|Overall Study||0
169131|NCT00639860|392539|P1|COMPLETED|Overall Study||10
169132|NCT00639860|392539|P1|STARTED|Overall Study||10
169133|NCT00639769|392547|P1|NOT COMPLETED|Overall Study||40
169134|NCT00639769|392547|P1|COMPLETED|Overall Study||0
169135|NCT00639769|392547|P1|STARTED|Overall Study||40
169136|NCT00639717|392552|P1|NOT COMPLETED|Overall Study||0
169137|NCT00639717|392552|P1|COMPLETED|Overall Study||48
169138|NCT00639717|392552|P1|STARTED|Overall Study||48
169139|NCT00639678|392564|P4|NOT COMPLETED|Overall Study||0
169140|NCT00639678|392565|P3|NOT COMPLETED|Overall Study||11
169141|NCT00639678|392566|P2|NOT COMPLETED|Overall Study||1
169142|NCT00639678|392567|P1|NOT COMPLETED|Overall Study||4
169143|NCT00639678|392564|P4|COMPLETED|Overall Study||23
169144|NCT00639678|392565|P3|COMPLETED|Overall Study||206
169145|NCT00639678|392566|P2|COMPLETED|Overall Study||5
169146|NCT00639678|392567|P1|COMPLETED|Overall Study||70
169147|NCT00639678|392564|P4|STARTED|Overall Study||23
169148|NCT00639678|392565|P3|STARTED|Overall Study||217
169149|NCT00639678|392566|P2|STARTED|Overall Study||6
169150|NCT00639678|392567|P1|STARTED|Overall Study||74
169151|NCT00639509|392627|P1|NOT COMPLETED|Overall Study||1
169152|NCT00639509|392627|P1|COMPLETED|Overall Study||23
169153|NCT00639509|392627|P1|STARTED|Overall Study||24
169154|NCT00639457|392635|P2|NOT COMPLETED|Overall Study||3
169155|NCT00639457|392636|P1|NOT COMPLETED|Overall Study||2
169156|NCT00639457|392635|P2|COMPLETED|Overall Study||19
169157|NCT00639457|392636|P1|COMPLETED|Overall Study||20
169158|NCT00639457|392635|P2|STARTED|Overall Study||22
169159|NCT00639457|392636|P1|STARTED|Overall Study||22
169160|NCT00639418|392674|P4|NOT COMPLETED|Overall Study||0
169161|NCT00639418|392675|P3|NOT COMPLETED|Overall Study||0
169162|NCT00639418|392676|P2|NOT COMPLETED|Overall Study||0
169163|NCT00639418|392677|P1|NOT COMPLETED|Overall Study||0
169164|NCT00639418|392674|P4|COMPLETED|Overall Study||46930
169165|NCT00639418|392675|P3|COMPLETED|Overall Study||36496
169166|NCT00639418|392676|P2|COMPLETED|Overall Study||35967
169167|NCT00639418|392677|P1|COMPLETED|Overall Study||28101
169168|NCT00639418|392674|P4|STARTED|Overall Study||46930
169169|NCT00639418|392675|P3|STARTED|Overall Study||36496
169170|NCT00639418|392676|P2|STARTED|Overall Study||35967
169171|NCT00639418|392677|P1|STARTED|Overall Study||28101
169172|NCT00639379|392695|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
169173|NCT00639379|392696|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
169174|NCT00639379|392695|P2|COMPLETED|Period 2 - 2 Weeks||45
169175|NCT00639379|392696|P1|COMPLETED|Period 2 - 2 Weeks||39
169176|NCT00639379|392695|P2|STARTED|Period 2 - 2 Weeks||45
169177|NCT00639379|392696|P1|STARTED|Period 2 - 2 Weeks||39
169178|NCT00639379|392695|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
169179|NCT00639379|392696|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
169180|NCT00639379|392695|P2|COMPLETED|Period 1 - 2 Weeks||45
169181|NCT00639379|392696|P1|COMPLETED|Period 1 - 2 Weeks||39
169182|NCT00639379|392695|P2|STARTED|Period 1 - 2 Weeks||45
169183|NCT00639379|392696|P1|STARTED|Period 1 - 2 Weeks||44
169184|NCT00639223|392712|P2|NOT COMPLETED|Overall Study||2
169185|NCT00639223|392713|P1|NOT COMPLETED|Overall Study||0
169186|NCT00639223|392712|P2|COMPLETED|Overall Study||19
169187|NCT00639223|392713|P1|COMPLETED|Overall Study||22
169188|NCT00639223|392712|P2|STARTED|Overall Study||21
169189|NCT00639223|392713|P1|STARTED|Overall Study||22
169190|NCT00639158|392723|P2|NOT COMPLETED|Overall Study||30
169191|NCT00639158|392724|P1|NOT COMPLETED|Overall Study||26
169192|NCT00639158|392723|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
169193|NCT00639158|392724|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
169194|NCT00639158|392723|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
169195|NCT00639158|392724|P1|STARTED|Overall Study|All randomized subjects were treated.|272
169196|NCT00639093|392746|P2|NOT COMPLETED|Overall Study||0
169197|NCT00639093|392747|P1|NOT COMPLETED|Overall Study||0
169198|NCT00639093|392746|P2|COMPLETED|Overall Study|46|46
169199|NCT00639093|392747|P1|COMPLETED|Overall Study|45|45
169200|NCT00639093|392746|P2|STARTED|Overall Study|46|46
169201|NCT00639093|392747|P1|STARTED|Overall Study|45|45
169202|NCT00639002|392753|P1|NOT COMPLETED|Overall Study||13
169203|NCT00639002|392753|P1|COMPLETED|Overall Study||0
169204|NCT00639002|392753|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
169205|NCT00639002|392753|P1|Received Ruxolitinib|Overall Study||13
169206|NCT00639002|392753|P1|STARTED|Overall Study||13
169207|NCT00638963|392761|P2|NOT COMPLETED|Overall Study||0
169208|NCT00638963|392762|P1|NOT COMPLETED|Overall Study||1
169209|NCT00638963|392761|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
169210|NCT00638963|392762|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
169211|NCT00638963|392761|P2|STARTED|Overall Study|Received randomized treatment assignment|3
169212|NCT00638963|392762|P1|STARTED|Overall Study|Received randomized treatment assignment|3
169213|NCT00638937|392781|P1|NOT COMPLETED|Overall Study||0
169214|NCT00638937|392781|P1|COMPLETED|Overall Study||37
169215|NCT00638937|392781|P1|STARTED|Overall Study||37
169216|NCT00638924|392791|P1|NOT COMPLETED|Overall Study||0
169217|NCT00638924|392791|P1|COMPLETED|Overall Study||40
169218|NCT00638924|392791|P1|2 Months|Overall Study||40
169219|NCT00638924|392791|P1|STARTED|Overall Study||40
169220|NCT00638885|392796|P1|NOT COMPLETED|Overall Study||0
169221|NCT00638885|392796|P1|COMPLETED|Overall Study||142
169222|NCT00638885|392796|P1|STARTED|Overall Study||142
169223|NCT00638846|392802|P2|NOT COMPLETED|Overall Study||6
169224|NCT00638846|392803|P1|NOT COMPLETED|Overall Study||4
169225|NCT00638846|392802|P2|COMPLETED|Overall Study||133
169226|NCT00638846|392803|P1|COMPLETED|Overall Study||133
169227|NCT00638846|392802|P2|STARTED|Overall Study||139
169228|NCT00638846|392803|P1|STARTED|Overall Study||137
169229|NCT00638820|392819|P1|NOT COMPLETED|Overall Study||0
169230|NCT00638820|392819|P1|COMPLETED|Overall Study||3
169231|NCT00638820|392819|P1|STARTED|Overall Study||3
169232|NCT00638690|392828|P2|NOT COMPLETED|Overall Study||342
169233|NCT00638690|392829|P1|NOT COMPLETED|Overall Study||681
169234|NCT00638690|392828|P2|COMPLETED|Overall Study||56
169235|NCT00638690|392829|P1|COMPLETED|Overall Study||116
169236|NCT00638690|392828|P2|STARTED|Overall Study||398
169237|NCT00638690|392829|P1|STARTED|Overall Study||797
169238|NCT00638651|392844|P2|NOT COMPLETED|Overall Study||0
169239|NCT00638651|392845|P1|NOT COMPLETED|Overall Study||0
169240|NCT00638651|392844|P2|COMPLETED|Overall Study||3
169241|NCT00638651|392845|P1|COMPLETED|Overall Study||3
169242|NCT00638651|392844|P2|STARTED|Overall Study||3
169243|NCT00638651|392845|P1|STARTED|Overall Study||3
169244|NCT00638443|392851|P2|NOT COMPLETED|Second Intervention||0
169245|NCT00638443|392852|P1|NOT COMPLETED|Second Intervention||0
169246|NCT00638443|392851|P2|COMPLETED|Second Intervention||14
169247|NCT00638443|392852|P1|COMPLETED|Second Intervention||12
169248|NCT00638443|392851|P2|STARTED|Second Intervention||14
169249|NCT00638443|392852|P1|STARTED|Second Intervention||12
169250|NCT00638443|392851|P2|NOT COMPLETED|Washout||0
169251|NCT00638443|392852|P1|NOT COMPLETED|Washout||0
169252|NCT00638443|392851|P2|COMPLETED|Washout||14
169253|NCT00638443|392852|P1|COMPLETED|Washout||12
169254|NCT00638443|392851|P2|STARTED|Washout||14
169255|NCT00638443|392852|P1|STARTED|Washout||12
169256|NCT00638443|392851|P2|NOT COMPLETED|First Intervention||1
169257|NCT00638443|392852|P1|NOT COMPLETED|First Intervention||2
169258|NCT00638443|392851|P2|COMPLETED|First Intervention||14
169259|NCT00638443|392852|P1|COMPLETED|First Intervention||12
169260|NCT00638443|392851|P2|STARTED|First Intervention||15
169261|NCT00638443|392852|P1|STARTED|First Intervention||14
169262|NCT00638378|392880|P1|NOT COMPLETED|Overall Study||22
169263|NCT00638378|392880|P1|COMPLETED|Overall Study||0
169264|NCT00638378|392880|P1|STARTED|Overall Study||22
169265|NCT00638365|392890|P3|NOT COMPLETED|Overall Study||0
169266|NCT00638365|392891|P2|NOT COMPLETED|Overall Study||0
169267|NCT00638365|392892|P1|NOT COMPLETED|Overall Study||0
169268|NCT00638365|392890|P3|COMPLETED|Overall Study||8
169269|NCT00638365|392891|P2|COMPLETED|Overall Study||10
169270|NCT00638365|392892|P1|COMPLETED|Overall Study||9
169271|NCT00638365|392890|P3|STARTED|Overall Study||8
169272|NCT00638365|392891|P2|STARTED|Overall Study||10
169273|NCT00638365|392892|P1|STARTED|Overall Study||9
169274|NCT00638235|392909|P9|NOT COMPLETED|Overall Study||18
169275|NCT00638235|392910|P8|NOT COMPLETED|Overall Study||1
169276|NCT00638235|392911|P7|NOT COMPLETED|Overall Study||0
169277|NCT00638235|392912|P6|NOT COMPLETED|Overall Study||26
169278|NCT00638235|392913|P5|NOT COMPLETED|Overall Study||13
169279|NCT00638235|392914|P4|NOT COMPLETED|Overall Study||10
169280|NCT00638235|392915|P3|NOT COMPLETED|Overall Study||18
169281|NCT00638235|392916|P2|NOT COMPLETED|Overall Study||3
169282|NCT00638235|392917|P1|NOT COMPLETED|Overall Study||31
169283|NCT00638235|392909|P9|COMPLETED|Overall Study||124
169284|NCT00638235|392910|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
169285|NCT00638235|392911|P7|COMPLETED|Overall Study||23
169286|NCT00638235|392912|P6|COMPLETED|Overall Study||113
169287|NCT00638235|392913|P5|COMPLETED|Overall Study||42
169288|NCT00638235|392914|P4|COMPLETED|Overall Study||46
169289|NCT00638235|392915|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
169290|NCT00638235|392916|P2|COMPLETED|Overall Study||23
169291|NCT00638235|392917|P1|COMPLETED|Overall Study||110
169292|NCT00638235|392909|P9|STARTED|Overall Study||142
169293|NCT00638235|392910|P8|STARTED|Overall Study||35
169294|NCT00638235|392911|P7|STARTED|Overall Study||23
169295|NCT00638235|392912|P6|STARTED|Overall Study||139
169296|NCT00638235|392913|P5|STARTED|Overall Study||55
169297|NCT00638235|392914|P4|STARTED|Overall Study||56
169298|NCT00638235|392915|P3|STARTED|Overall Study||81
169299|NCT00638235|392916|P2|STARTED|Overall Study||26
169300|NCT00638235|392917|P1|STARTED|Overall Study||141
169301|NCT00638222|393318|P3|NOT COMPLETED|Overall Study||0
169302|NCT00638222|393319|P2|NOT COMPLETED|Overall Study||0
169303|NCT00638222|393320|P1|NOT COMPLETED|Overall Study||0
169304|NCT00638222|393318|P3|COMPLETED|Overall Study||6
169305|NCT00638222|393319|P2|COMPLETED|Overall Study||0
169306|NCT00638222|393320|P1|COMPLETED|Overall Study||0
169307|NCT00638222|393318|P3|STARTED|Overall Study||6
169308|NCT00638222|393319|P2|STARTED|Overall Study||0
169309|NCT00638222|393320|P1|STARTED|Overall Study||0
169310|NCT00638183|393327|P1|NOT COMPLETED|Overall Study||119
169311|NCT00638183|393327|P1|COMPLETED|Overall Study||266
169312|NCT00638183|393327|P1|STARTED|Overall Study||385
169313|NCT00638157|393336|P2|NOT COMPLETED|Overall Study||4
169314|NCT00638157|393337|P1|NOT COMPLETED|Overall Study||7
169315|NCT00638157|393336|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
169316|NCT00638157|393337|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
169317|NCT00638157|393336|P2|Treated|Overall Study||12
169318|NCT00638157|393337|P1|Treated|Overall Study||10
169319|NCT00638157|393336|P2|STARTED|Overall Study||12
169320|NCT00638157|393337|P1|STARTED|Overall Study||12
169321|NCT00638027|393347|P2|NOT COMPLETED|Overall Study||2
169322|NCT00638027|393348|P1|NOT COMPLETED|Overall Study||0
169323|NCT00638027|393347|P2|COMPLETED|Overall Study|all 10 included in analyses|8
169324|NCT00638027|393348|P1|COMPLETED|Overall Study||11
169325|NCT00638027|393347|P2|STARTED|Overall Study||10
169326|NCT00638027|393348|P1|STARTED|Overall Study||11
169327|NCT00638014|393360|P2|NOT COMPLETED|Overall Study||0
169328|NCT00638014|393361|P1|NOT COMPLETED|Overall Study||0
169329|NCT00638014|393360|P2|COMPLETED|Overall Study||28
169330|NCT00638014|393361|P1|COMPLETED|Overall Study||23
169331|NCT00638014|393360|P2|STARTED|Overall Study||28
169332|NCT00638014|393361|P1|STARTED|Overall Study||23
169333|NCT00637923|393371|P2|NOT COMPLETED|Overall Study||19
169334|NCT00637923|393372|P1|NOT COMPLETED|Overall Study||30
169335|NCT00637923|393371|P2|COMPLETED|Overall Study||18
169336|NCT00637923|393372|P1|COMPLETED|Overall Study||45
169337|NCT00637923|393371|P2|STARTED|Overall Study||37
169338|NCT00637923|393372|P1|STARTED|Overall Study||75
169339|NCT00637806|393395|P4|NOT COMPLETED|Extension Phase||1
169340|NCT00637806|393396|P3|NOT COMPLETED|Extension Phase||0
169341|NCT00637806|393397|P2|NOT COMPLETED|Extension Phase||0
169342|NCT00637806|393398|P1|NOT COMPLETED|Extension Phase||0
169343|NCT00637806|393395|P4|COMPLETED|Extension Phase||0
169344|NCT00637806|393396|P3|COMPLETED|Extension Phase||0
169345|NCT00637806|393397|P2|COMPLETED|Extension Phase||0
169346|NCT00637806|393398|P1|COMPLETED|Extension Phase||0
169347|NCT00637806|393395|P4|STARTED|Extension Phase||1
169348|NCT00637806|393396|P3|STARTED|Extension Phase||0
169349|NCT00637806|393397|P2|STARTED|Extension Phase||0
169350|NCT00637806|393398|P1|STARTED|Extension Phase||0
169351|NCT00637806|393395|P4|NOT COMPLETED|Double-blind Phase||0
169352|NCT00637806|393396|P3|NOT COMPLETED|Double-blind Phase||1
169353|NCT00637806|393397|P2|NOT COMPLETED|Double-blind Phase||0
169354|NCT00637806|393398|P1|NOT COMPLETED|Double-blind Phase||2
169355|NCT00637806|393395|P4|COMPLETED|Double-blind Phase||0
169356|NCT00637806|393396|P3|COMPLETED|Double-blind Phase||1
169357|NCT00637806|393397|P2|COMPLETED|Double-blind Phase||0
169358|NCT00637806|393398|P1|COMPLETED|Double-blind Phase||0
169359|NCT00637806|393395|P4|STARTED|Double-blind Phase||0
169360|NCT00637806|393396|P3|STARTED|Double-blind Phase||2
169361|NCT00637806|393397|P2|STARTED|Double-blind Phase||0
169362|NCT00637806|393398|P1|STARTED|Double-blind Phase||2
169363|NCT00637728|393418|P3|NOT COMPLETED|Extension Phase||0
169364|NCT00637728|393419|P2|NOT COMPLETED|Extension Phase||0
169365|NCT00637728|393420|P1|NOT COMPLETED|Extension Phase||0
169366|NCT00637728|393418|P3|COMPLETED|Extension Phase||0
169367|NCT00637728|393419|P2|COMPLETED|Extension Phase||0
169368|NCT00637728|393420|P1|COMPLETED|Extension Phase||0
169369|NCT00637728|393418|P3|STARTED|Extension Phase||0
169370|NCT00637728|393419|P2|STARTED|Extension Phase||0
169371|NCT00637728|393420|P1|STARTED|Extension Phase||0
169372|NCT00637728|393418|P3|NOT COMPLETED|Double-blind Phase||0
169373|NCT00637728|393419|P2|NOT COMPLETED|Double-blind Phase||1
169374|NCT00637728|393420|P1|NOT COMPLETED|Double-blind Phase||4
169375|NCT00637728|393418|P3|COMPLETED|Double-blind Phase||0
169376|NCT00637728|393419|P2|COMPLETED|Double-blind Phase||0
169377|NCT00637728|393420|P1|COMPLETED|Double-blind Phase||0
169378|NCT00637728|393418|P3|STARTED|Double-blind Phase||0
169379|NCT00637728|393419|P2|STARTED|Double-blind Phase||1
169380|NCT00637728|393420|P1|STARTED|Double-blind Phase||4
169381|NCT00637572|393435|P2|NOT COMPLETED|Overall Study||7
169382|NCT00637572|393436|P1|NOT COMPLETED|Overall Study||3
169383|NCT00637572|393435|P2|COMPLETED|Overall Study||24
169384|NCT00637572|393436|P1|COMPLETED|Overall Study||29
169385|NCT00637572|393435|P2|STARTED|Overall Study||31
169386|NCT00637572|393436|P1|STARTED|Overall Study||32
169387|NCT00637494|393464|P2|NOT COMPLETED|Overall Study||43
169388|NCT00637494|393465|P1|NOT COMPLETED|Overall Study||32
169389|NCT00637494|393464|P2|COMPLETED|Overall Study||108
169390|NCT00637494|393465|P1|COMPLETED|Overall Study||109
169391|NCT00637494|393464|P2|STARTED|Overall Study||151
169392|NCT00637494|393465|P1|STARTED|Overall Study||141
169393|NCT00637416|393473|P2|NOT COMPLETED|Overall Study||2
169394|NCT00637416|393474|P1|NOT COMPLETED|Overall Study||1
169395|NCT00637416|393473|P2|COMPLETED|Overall Study||3
169396|NCT00637416|393474|P1|COMPLETED|Overall Study||3
169397|NCT00637416|393473|P2|STARTED|Overall Study||5
169398|NCT00637416|393474|P1|STARTED|Overall Study||4
169399|NCT00637377|393484|P4|NOT COMPLETED|Overall Study||29
169400|NCT00637377|393485|P3|NOT COMPLETED|Overall Study||37
169401|NCT00637377|393486|P2|NOT COMPLETED|Overall Study||32
169402|NCT00637377|393487|P1|NOT COMPLETED|Overall Study||27
169403|NCT00637377|393484|P4|COMPLETED|Overall Study||284
169404|NCT00637377|393485|P3|COMPLETED|Overall Study||274
169405|NCT00637377|393486|P2|COMPLETED|Overall Study||281
169406|NCT00637377|393487|P1|COMPLETED|Overall Study||276
169407|NCT00637377|393484|P4|Participants Treated (FAS)|Overall Study||306
169408|NCT00637377|393485|P3|Participants Treated (FAS)|Overall Study||296
169409|NCT00637377|393486|P2|Participants Treated (FAS)|Overall Study||309
169410|NCT00637377|393487|P1|Participants Treated (FAS)|Overall Study||291
169411|NCT00637377|393484|P4|Participants Received Treatment|Overall Study|safety population|307
169412|NCT00637377|393485|P3|Participants Received Treatment|Overall Study|safety population|297
169413|NCT00637377|393486|P2|Participants Received Treatment|Overall Study|safety population|309
169414|NCT00637377|393487|P1|Participants Received Treatment|Overall Study|safety population|291
169415|NCT00637377|393484|P4|STARTED|Overall Study||313
169416|NCT00637377|393485|P3|STARTED|Overall Study||311
169417|NCT00637377|393486|P2|STARTED|Overall Study||313
169418|NCT00637377|393487|P1|STARTED|Overall Study||303
169419|NCT00637312|393515|P2|NOT COMPLETED|Overall Study||17
169420|NCT00637312|393516|P1|NOT COMPLETED|Overall Study||42
169421|NCT00637312|393515|P2|COMPLETED|Overall Study||19
169422|NCT00637312|393516|P1|COMPLETED|Overall Study||30
169423|NCT00637312|393515|P2|STARTED|Overall Study||36
169424|NCT00637312|393516|P1|STARTED|Overall Study||72
169425|NCT00637299|393524|P2|NOT COMPLETED|Overall Study||0
169426|NCT00637299|393525|P1|NOT COMPLETED|Overall Study||0
169427|NCT00637299|393524|P2|COMPLETED|Overall Study||10
169428|NCT00637299|393525|P1|COMPLETED|Overall Study||10
169429|NCT00637299|393524|P2|STARTED|Overall Study||10
169430|NCT00637299|393525|P1|STARTED|Overall Study||10
169431|NCT00637273|393536|P3|NOT COMPLETED|Overall Study||41
169432|NCT00637273|393537|P2|NOT COMPLETED|Overall Study||28
169433|NCT00637273|393538|P1|NOT COMPLETED|Overall Study||43
169434|NCT00637273|393536|P3|COMPLETED|Overall Study||131
169435|NCT00637273|393537|P2|COMPLETED|Overall Study||144
169436|NCT00637273|393538|P1|COMPLETED|Overall Study||127
169437|NCT00637273|393536|P3|Intent to Treat (ITT)|Overall Study||165
169438|NCT00637273|393537|P2|Intent to Treat (ITT)|Overall Study||166
169439|NCT00637273|393538|P1|Intent to Treat (ITT)|Overall Study||160
169440|NCT00637273|393536|P3|STARTED|Overall Study||172
169441|NCT00637273|393537|P2|STARTED|Overall Study||172
169442|NCT00637273|393538|P1|STARTED|Overall Study||170
169443|NCT00637247|393581|P2|NOT COMPLETED|Overall Study||0
169444|NCT00637247|393582|P1|NOT COMPLETED|Overall Study||0
169445|NCT00637247|393581|P2|COMPLETED|Overall Study||70
169446|NCT00637247|393582|P1|COMPLETED|Overall Study||72
169447|NCT00637247|393581|P2|STARTED|Overall Study||70
169448|NCT00637247|393582|P1|STARTED|Overall Study||72
169449|NCT00637195|393594|P2|NOT COMPLETED|Overall Study||1
169450|NCT00637195|393595|P1|NOT COMPLETED|Overall Study||3
169451|NCT00637195|393594|P2|COMPLETED|Overall Study||75
169452|NCT00637195|393595|P1|COMPLETED|Overall Study||73
169453|NCT00637195|393594|P2|STARTED|Overall Study||76
169454|NCT00637195|393595|P1|STARTED|Overall Study||76
169455|NCT00637156|393631|P2|NOT COMPLETED|Overall Study||24
169456|NCT00637156|393632|P1|NOT COMPLETED|Overall Study||10
169457|NCT00637156|393631|P2|COMPLETED|Overall Study||164
169458|NCT00637156|393632|P1|COMPLETED|Overall Study||199
169459|NCT00637156|393631|P2|STARTED|Overall Study||188
169460|NCT00637156|393632|P1|STARTED|Overall Study||209
169461|NCT00637000|393674|P2|NOT COMPLETED|Overall Study||3
169462|NCT00637000|393675|P1|NOT COMPLETED|Overall Study||4
169463|NCT00637000|393674|P2|COMPLETED|Overall Study||15
169464|NCT00637000|393675|P1|COMPLETED|Overall Study||16
169465|NCT00637000|393674|P2|Evaluable|Overall Study||16
169466|NCT00637000|393675|P1|Evaluable|Overall Study||18
169467|NCT00637000|393674|P2|STARTED|Overall Study|Randomized and treated|18
169468|NCT00637000|393675|P1|STARTED|Overall Study|Randomized and treated|20
169469|NCT00636961|393717|P2|NOT COMPLETED|Period 2||0
169470|NCT00636961|393718|P1|NOT COMPLETED|Period 2||1
169471|NCT00636961|393717|P2|COMPLETED|Period 2||12
169472|NCT00636961|393718|P1|COMPLETED|Period 2||12
169473|NCT00636961|393717|P2|STARTED|Period 2||12
169474|NCT00636961|393718|P1|STARTED|Period 2||13
169475|NCT00636961|393717|P2|NOT COMPLETED|Period 1||1
169476|NCT00636961|393718|P1|NOT COMPLETED|Period 1||1
169477|NCT00636961|393717|P2|COMPLETED|Period 1||12
169478|NCT00636961|393718|P1|COMPLETED|Period 1||13
169479|NCT00636961|393717|P2|STARTED|Period 1||13
169480|NCT00636961|393718|P1|STARTED|Period 1||14
169481|NCT00636818|393732|P1|NOT COMPLETED|Overall Study||11
169482|NCT00636818|393732|P1|COMPLETED|Overall Study||34
169483|NCT00636818|393732|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
169484|NCT00636818|393732|P1|STARTED|Overall Study||45
169485|NCT00636805|393747|P1|NOT COMPLETED|Overall Study||0
169486|NCT00636805|393747|P1|COMPLETED|Overall Study||63
169487|NCT00636805|393747|P1|STARTED|Overall Study||63
169488|NCT00636792|393757|P1|NOT COMPLETED|Overall Study||33
169489|NCT00636792|393757|P1|COMPLETED|Overall Study||40
169490|NCT00636792|393757|P1|STARTED|Overall Study||73
169491|NCT00636701|393764|P2|NOT COMPLETED|Overall Study||0
169492|NCT00636701|393765|P1|NOT COMPLETED|Overall Study||0
169493|NCT00636701|393764|P2|COMPLETED|Overall Study||2
169494|NCT00636701|393765|P1|COMPLETED|Overall Study||2
169495|NCT00636701|393764|P2|STARTED|Overall Study||2
169496|NCT00636701|393765|P1|STARTED|Overall Study||2
169497|NCT00636649|393773|P2|NOT COMPLETED|Overall Study||0
169498|NCT00636649|393774|P1|NOT COMPLETED|Overall Study||0
169499|NCT00636649|393773|P2|COMPLETED|Overall Study||20
169500|NCT00636649|393774|P1|COMPLETED|Overall Study||20
169501|NCT00636649|393773|P2|STARTED|Overall Study||20
169502|NCT00636649|393774|P1|STARTED|Overall Study||20
169503|NCT00636636|393804|P2|NOT COMPLETED|Overall Study||39
169504|NCT00636636|393805|P1|NOT COMPLETED|Overall Study||36
169505|NCT00636636|393804|P2|COMPLETED|Overall Study||192
169506|NCT00636636|393805|P1|COMPLETED|Overall Study||185
169507|NCT00636636|393804|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
169508|NCT00636636|393805|P1|379|Overall Study||186
169509|NCT00636636|393804|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
169510|NCT00636636|393805|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
169511|NCT00636636|393804|P2|STARTED|Overall Study||231
169512|NCT00636636|393805|P1|STARTED|Overall Study||221
169513|NCT00636610|393821|P2|NOT COMPLETED|Overall Study||83
169514|NCT00636610|393822|P1|NOT COMPLETED|Overall Study||92
169515|NCT00636610|393821|P2|COMPLETED|Overall Study||18
169516|NCT00636610|393822|P1|COMPLETED|Overall Study||6
169517|NCT00636610|393821|P2|STARTED|Overall Study||101
169518|NCT00636610|393822|P1|STARTED|Overall Study||98
169519|NCT00636441|393839|P7|NOT COMPLETED|Overall Study||18
169520|NCT00636441|393840|P6|NOT COMPLETED|Overall Study||1
169521|NCT00636441|393841|P5|NOT COMPLETED|Overall Study||0
169522|NCT00636441|393842|P4|NOT COMPLETED|Overall Study||0
169523|NCT00636441|393843|P3|NOT COMPLETED|Overall Study||1
169524|NCT00636441|393844|P2|NOT COMPLETED|Overall Study||1
169525|NCT00636441|393845|P1|NOT COMPLETED|Overall Study||0
169526|NCT00636441|393839|P7|COMPLETED|Overall Study||0
169527|NCT00636441|393840|P6|COMPLETED|Overall Study||6
169528|NCT00636441|393841|P5|COMPLETED|Overall Study||6
169529|NCT00636441|393842|P4|COMPLETED|Overall Study||6
169530|NCT00636441|393843|P3|COMPLETED|Overall Study||5
169531|NCT00636441|393844|P2|COMPLETED|Overall Study||6
169532|NCT00636441|393845|P1|COMPLETED|Overall Study||6
169533|NCT00636441|393839|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
169534|NCT00636441|393840|P6|Assigned Treatment|Overall Study||7
169535|NCT00636441|393841|P5|Assigned Treatment|Overall Study||6
169536|NCT00636441|393842|P4|Assigned Treatment|Overall Study||6
169537|NCT00636441|393843|P3|Assigned Treatment|Overall Study||6
169538|NCT00636441|393844|P2|Assigned Treatment|Overall Study||7
169539|NCT00636441|393845|P1|Assigned Treatment|Overall Study||6
169540|NCT00636441|393839|P7|STARTED|Overall Study||18
169541|NCT00636441|393840|P6|STARTED|Overall Study||7
169542|NCT00636441|393841|P5|STARTED|Overall Study||6
169543|NCT00636441|393842|P4|STARTED|Overall Study||6
169544|NCT00636441|393843|P3|STARTED|Overall Study||6
169545|NCT00636441|393844|P2|STARTED|Overall Study||7
169546|NCT00636441|393845|P1|STARTED|Overall Study||6
169547|NCT00636389|393874|P2|NOT COMPLETED|Period 2 - 1 Week||0
169548|NCT00636389|393875|P1|NOT COMPLETED|Period 2 - 1 Week||0
169549|NCT00636389|393874|P2|COMPLETED|Period 2 - 1 Week||5
169550|NCT00636389|393875|P1|COMPLETED|Period 2 - 1 Week||7
169551|NCT00636389|393874|P2|STARTED|Period 2 - 1 Week||5
169552|NCT00636389|393875|P1|STARTED|Period 2 - 1 Week||7
169553|NCT00636389|393874|P2|NOT COMPLETED|Period 1 - 1 Week||0
169554|NCT00636389|393875|P1|NOT COMPLETED|Period 1 - 1 Week||0
169555|NCT00636389|393874|P2|COMPLETED|Period 1 - 1 Week||5
169556|NCT00636389|393875|P1|COMPLETED|Period 1 - 1 Week||7
169557|NCT00636389|393874|P2|STARTED|Period 1 - 1 Week||5
169558|NCT00636389|393875|P1|STARTED|Period 1 - 1 Week||7
169559|NCT00636363|393888|P3|NOT COMPLETED|Overall Study||18
169560|NCT00636363|393889|P2|NOT COMPLETED|Overall Study||20
169561|NCT00636363|393890|P1|NOT COMPLETED|Overall Study||13
169562|NCT00636363|393888|P3|COMPLETED|Overall Study||163
169563|NCT00636363|393889|P2|COMPLETED|Overall Study||156
169564|NCT00636363|393890|P1|COMPLETED|Overall Study||165
169565|NCT00636363|393888|P3|STARTED|Overall Study||181
169566|NCT00636363|393889|P2|STARTED|Overall Study||176
169567|NCT00636363|393890|P1|STARTED|Overall Study||178
169568|NCT00635232|393909|P5|NOT COMPLETED|Overall Study||8
169569|NCT00635232|393910|P4|NOT COMPLETED|Overall Study||10
169570|NCT00635232|393911|P3|NOT COMPLETED|Overall Study||3
169571|NCT00635232|393912|P2|NOT COMPLETED|Overall Study||20
169572|NCT00635232|393913|P1|NOT COMPLETED|Overall Study||14
169573|NCT00635232|393909|P5|COMPLETED|Overall Study||20
169574|NCT00635232|393910|P4|COMPLETED|Overall Study||48
169575|NCT00635232|393911|P3|COMPLETED|Overall Study||55
169576|NCT00635232|393912|P2|COMPLETED|Overall Study||39
169577|NCT00635232|393913|P1|COMPLETED|Overall Study||44
169578|NCT00635232|393909|P5|STARTED|Overall Study||28
169579|NCT00635232|393910|P4|STARTED|Overall Study||58
169580|NCT00635232|393911|P3|STARTED|Overall Study||58
169581|NCT00635232|393912|P2|STARTED|Overall Study||59
169582|NCT00635232|393913|P1|STARTED|Overall Study||58
169583|NCT00635219|393940|P5|NOT COMPLETED|Overall Study||42
169584|NCT00635219|393941|P4|NOT COMPLETED|Overall Study||34
169585|NCT00635219|393942|P3|NOT COMPLETED|Overall Study||35
169586|NCT00635219|393943|P2|NOT COMPLETED|Overall Study||25
169587|NCT00635219|393944|P1|NOT COMPLETED|Overall Study||25
169588|NCT00635219|393940|P5|COMPLETED|Overall Study||113
169589|NCT00635219|393941|P4|COMPLETED|Overall Study||117
169590|NCT00635219|393942|P3|COMPLETED|Overall Study||122
169591|NCT00635219|393943|P2|COMPLETED|Overall Study||130
169592|NCT00635219|393944|P1|COMPLETED|Overall Study||123
169593|NCT00635219|393940|P5|STARTED|Overall Study||155
169594|NCT00635219|393941|P4|STARTED|Overall Study||151
169595|NCT00635219|393942|P3|STARTED|Overall Study||157
169596|NCT00635219|393943|P2|STARTED|Overall Study||155
169597|NCT00635219|393944|P1|STARTED|Overall Study||148
169598|NCT00633477|394003|P2|NOT COMPLETED|Overall Study||0
169599|NCT00633477|394004|P1|NOT COMPLETED|Overall Study||2
169600|NCT00633477|394003|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
169601|NCT00633477|394004|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
169602|NCT00633477|394003|P2|Completed Study Through Day 28|Overall Study||8
169603|NCT00633477|394004|P1|Completed Study Through Day 28|Overall Study||4
169604|NCT00633477|394003|P2|Prematurely Discontinued Study Drug|Overall Study||0
169605|NCT00633477|394004|P1|Prematurely Discontinued Study Drug|Overall Study||1
169606|NCT00633477|394003|P2|Randomized But Not Treated|Overall Study||0
169607|NCT00633477|394004|P1|Randomized But Not Treated|Overall Study||1
169608|NCT00633477|394003|P2|STARTED|Overall Study||11
169609|NCT00633477|394004|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
169610|NCT00633464|394020|P2|NOT COMPLETED|Overall Study||2
169611|NCT00633464|394021|P1|NOT COMPLETED|Overall Study||0
169612|NCT00633464|394020|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
169613|NCT00633464|394021|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
169614|NCT00633464|394020|P2|Treated|Overall Study||37
169615|NCT00633464|394021|P1|Treated|Overall Study||40
169616|NCT00633464|394020|P2|STARTED|Overall Study||39
169617|NCT00633464|394021|P1|STARTED|Overall Study||40
169618|NCT00633399|394043|P2|NOT COMPLETED|Overall Study||15
169619|NCT00633399|394044|P1|NOT COMPLETED|Overall Study||22
169620|NCT00633399|394043|P2|COMPLETED|Overall Study||53
169621|NCT00633399|394044|P1|COMPLETED|Overall Study||49
169622|NCT00633399|394043|P2|STARTED|Overall Study||68
169623|NCT00633399|394044|P1|STARTED|Overall Study||71
169624|NCT00636220|394054|P1|NOT COMPLETED|Overall Study||0
169625|NCT00636220|394054|P1|COMPLETED|Overall Study||101
169626|NCT00636220|394054|P1|STARTED|Overall Study||101
169627|NCT00636207|394061|P7|NOT COMPLETED|Overall Study||0
169628|NCT00636207|394062|P6|NOT COMPLETED|Overall Study||0
169629|NCT00636207|394063|P5|NOT COMPLETED|Overall Study||1
169630|NCT00636207|394064|P4|NOT COMPLETED|Overall Study||0
169631|NCT00636207|394065|P3|NOT COMPLETED|Overall Study||0
169632|NCT00636207|394066|P2|NOT COMPLETED|Overall Study||1
169633|NCT00636207|394067|P1|NOT COMPLETED|Overall Study||1
169634|NCT00636207|394061|P7|COMPLETED|Overall Study||3
169635|NCT00636207|394062|P6|COMPLETED|Overall Study||1
169636|NCT00636207|394063|P5|COMPLETED|Overall Study||8
169637|NCT00636207|394064|P4|COMPLETED|Overall Study||6
169638|NCT00636207|394065|P3|COMPLETED|Overall Study||18
169639|NCT00636207|394066|P2|COMPLETED|Overall Study||7
169640|NCT00636207|394067|P1|COMPLETED|Overall Study||0
169641|NCT00636207|394061|P7|STARTED|Overall Study||3
169642|NCT00636207|394062|P6|STARTED|Overall Study||1
169643|NCT00636207|394063|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
169644|NCT00636207|394064|P4|STARTED|Overall Study||6
169645|NCT00636207|394065|P3|STARTED|Overall Study||18
169646|NCT00636207|394066|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
169647|NCT00636207|394067|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
169648|NCT00636194|394131|P2|NOT COMPLETED|Overall Study||0
169649|NCT00636194|394132|P1|NOT COMPLETED|Overall Study||3
169650|NCT00636194|394131|P2|COMPLETED|Overall Study||175
169651|NCT00636194|394132|P1|COMPLETED|Overall Study||172
169652|NCT00636194|394131|P2|STARTED|Overall Study||175
169653|NCT00636194|394132|P1|STARTED|Overall Study||175
169654|NCT00636168|394144|P2|NOT COMPLETED|Treated With Study Drug||411
169655|NCT00636168|394145|P1|NOT COMPLETED|Treated With Study Drug||447
169656|NCT00636168|394144|P2|COMPLETED|Treated With Study Drug||63
169657|NCT00636168|394145|P1|COMPLETED|Treated With Study Drug||24
169658|NCT00636168|394144|P2|STARTED|Treated With Study Drug||474
169659|NCT00636168|394145|P1|STARTED|Treated With Study Drug||471
169660|NCT00636168|394144|P2|NOT COMPLETED|Randomized to Study Drug||2
169661|NCT00636168|394145|P1|NOT COMPLETED|Randomized to Study Drug||4
169662|NCT00636168|394144|P2|COMPLETED|Randomized to Study Drug||474
169663|NCT00636168|394145|P1|COMPLETED|Randomized to Study Drug||471
169664|NCT00636168|394144|P2|STARTED|Randomized to Study Drug||476
169665|NCT00636168|394145|P1|STARTED|Randomized to Study Drug||475
169666|NCT00636155|394161|P1|NOT COMPLETED|Overall Study||18
169667|NCT00636155|394161|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
169668|NCT00636155|394161|P1|STARTED|Overall Study||20
169669|NCT00636077|394167|P4|NOT COMPLETED|Week 4||0
169670|NCT00636077|394168|P3|NOT COMPLETED|Week 4||0
169671|NCT00636077|394169|P2|NOT COMPLETED|Week 4||0
169672|NCT00636077|394170|P1|NOT COMPLETED|Week 4||0
169673|NCT00636077|394167|P4|COMPLETED|Week 4||3
169674|NCT00636077|394168|P3|COMPLETED|Week 4||3
169675|NCT00636077|394169|P2|COMPLETED|Week 4||3
169676|NCT00636077|394170|P1|COMPLETED|Week 4||3
169677|NCT00636077|394167|P4|STARTED|Week 4||3
169678|NCT00636077|394168|P3|STARTED|Week 4||3
169679|NCT00636077|394169|P2|STARTED|Week 4||3
169680|NCT00636077|394170|P1|STARTED|Week 4||3
169681|NCT00636077|394167|P4|NOT COMPLETED|Week 3||0
169682|NCT00636077|394168|P3|NOT COMPLETED|Week 3||0
169683|NCT00636077|394169|P2|NOT COMPLETED|Week 3||0
169684|NCT00636077|394170|P1|NOT COMPLETED|Week 3||0
169685|NCT00636077|394167|P4|COMPLETED|Week 3||3
169686|NCT00636077|394168|P3|COMPLETED|Week 3||3
169687|NCT00636077|394169|P2|COMPLETED|Week 3||3
169688|NCT00636077|394170|P1|COMPLETED|Week 3||3
169689|NCT00636077|394167|P4|STARTED|Week 3||3
169690|NCT00636077|394168|P3|STARTED|Week 3||3
169691|NCT00636077|394169|P2|STARTED|Week 3||3
169692|NCT00636077|394170|P1|STARTED|Week 3||3
169693|NCT00636077|394167|P4|NOT COMPLETED|Week 2||0
169694|NCT00636077|394168|P3|NOT COMPLETED|Week 2||0
169695|NCT00636077|394169|P2|NOT COMPLETED|Week 2||0
169696|NCT00636077|394170|P1|NOT COMPLETED|Week 2||0
169697|NCT00636077|394167|P4|COMPLETED|Week 2||3
169698|NCT00636077|394168|P3|COMPLETED|Week 2||3
169699|NCT00636077|394169|P2|COMPLETED|Week 2||3
169700|NCT00636077|394170|P1|COMPLETED|Week 2||3
169701|NCT00636077|394167|P4|STARTED|Week 2||3
169702|NCT00636077|394168|P3|STARTED|Week 2||3
169703|NCT00636077|394169|P2|STARTED|Week 2||3
169704|NCT00636077|394170|P1|STARTED|Week 2||3
169705|NCT00636077|394167|P4|NOT COMPLETED|Week 1||0
169706|NCT00636077|394168|P3|NOT COMPLETED|Week 1||0
169707|NCT00636077|394169|P2|NOT COMPLETED|Week 1||0
169708|NCT00636077|394170|P1|NOT COMPLETED|Week 1||0
169709|NCT00636077|394167|P4|COMPLETED|Week 1||3
169710|NCT00636077|394168|P3|COMPLETED|Week 1||3
169711|NCT00636077|394169|P2|COMPLETED|Week 1||3
169712|NCT00636077|394170|P1|COMPLETED|Week 1||3
169713|NCT00636077|394167|P4|STARTED|Week 1||3
169714|NCT00636077|394168|P3|STARTED|Week 1||3
169715|NCT00636077|394169|P2|STARTED|Week 1||3
169716|NCT00636077|394170|P1|STARTED|Week 1||3
169717|NCT00635882|394206|P6|NOT COMPLETED|Overall Study||0
169718|NCT00635882|394207|P5|NOT COMPLETED|Overall Study||0
169719|NCT00635882|394208|P4|NOT COMPLETED|Overall Study||0
169720|NCT00635882|394209|P3|NOT COMPLETED|Overall Study||0
169721|NCT00635882|394210|P2|NOT COMPLETED|Overall Study||0
169722|NCT00635882|394211|P1|NOT COMPLETED|Overall Study||1
169723|NCT00635882|394206|P6|COMPLETED|Overall Study||13
169724|NCT00635882|394207|P5|COMPLETED|Overall Study||16
169725|NCT00635882|394208|P4|COMPLETED|Overall Study||15
169726|NCT00635882|394209|P3|COMPLETED|Overall Study||12
169727|NCT00635882|394210|P2|COMPLETED|Overall Study||17
169728|NCT00635882|394211|P1|COMPLETED|Overall Study||19
169729|NCT00635882|394206|P6|STARTED|Overall Study||13
169730|NCT00635882|394207|P5|STARTED|Overall Study||16
169731|NCT00635882|394208|P4|STARTED|Overall Study||15
169732|NCT00635882|394209|P3|STARTED|Overall Study||12
169733|NCT00635882|394210|P2|STARTED|Overall Study||17
169734|NCT00635882|394211|P1|STARTED|Overall Study||20
169735|NCT00635830|394275|P2|NOT COMPLETED|Overall Study||0
169736|NCT00635830|394276|P1|NOT COMPLETED|Overall Study||0
169737|NCT00635830|394275|P2|COMPLETED|Overall Study||20
169738|NCT00635830|394276|P1|COMPLETED|Overall Study||20
169739|NCT00635830|394275|P2|STARTED|Overall Study||20
169740|NCT00635830|394276|P1|STARTED|Overall Study||20
169741|NCT00635817|394286|P4|NOT COMPLETED|Overall Study||0
169742|NCT00635817|394287|P3|NOT COMPLETED|Overall Study||2
169743|NCT00635817|394288|P2|NOT COMPLETED|Overall Study||2
169744|NCT00635817|394289|P1|NOT COMPLETED|Overall Study||6
169745|NCT00635817|394286|P4|COMPLETED|Overall Study||21
169746|NCT00635817|394287|P3|COMPLETED|Overall Study||19
169747|NCT00635817|394288|P2|COMPLETED|Overall Study||19
169748|NCT00635817|394289|P1|COMPLETED|Overall Study||15
169749|NCT00635817|394286|P4|STARTED|Overall Study||21
169750|NCT00635817|394287|P3|STARTED|Overall Study||21
169751|NCT00635817|394288|P2|STARTED|Overall Study||21
169752|NCT00635817|394289|P1|STARTED|Overall Study||21
169753|NCT00635804|394341|P8|NOT COMPLETED|Overall Study||0
169754|NCT00635804|394342|P7|NOT COMPLETED|Overall Study||0
169755|NCT00635804|394343|P6|NOT COMPLETED|Overall Study||1
169756|NCT00635804|394344|P5|NOT COMPLETED|Overall Study||0
169757|NCT00635804|394345|P4|NOT COMPLETED|Overall Study||0
169758|NCT00635804|394346|P3|NOT COMPLETED|Overall Study||0
169759|NCT00635804|394347|P2|NOT COMPLETED|Overall Study||0
169760|NCT00635804|394348|P1|NOT COMPLETED|Overall Study||1
169761|NCT00635804|394341|P8|COMPLETED|Overall Study||14
169762|NCT00635804|394342|P7|COMPLETED|Overall Study||3
169763|NCT00635804|394343|P6|COMPLETED|Overall Study||11
169764|NCT00635804|394344|P5|COMPLETED|Overall Study||6
169765|NCT00635804|394345|P4|COMPLETED|Overall Study||6
169766|NCT00635804|394346|P3|COMPLETED|Overall Study||6
169767|NCT00635804|394347|P2|COMPLETED|Overall Study||6
169768|NCT00635804|394348|P1|COMPLETED|Overall Study||6
169769|NCT00635804|394341|P8|STARTED|Overall Study||14
169770|NCT00635804|394342|P7|STARTED|Overall Study||3
169771|NCT00635804|394343|P6|STARTED|Overall Study||12
169772|NCT00635804|394344|P5|STARTED|Overall Study||6
169773|NCT00635804|394345|P4|STARTED|Overall Study||6
169774|NCT00635804|394346|P3|STARTED|Overall Study||6
169775|NCT00635804|394347|P2|STARTED|Overall Study||6
169776|NCT00635804|394348|P1|STARTED|Overall Study||7
169777|NCT00635700|394447|P2|NOT COMPLETED|Overall Study||14
169778|NCT00635700|394448|P1|NOT COMPLETED|Overall Study||15
169779|NCT00635700|394447|P2|COMPLETED|Overall Study||13
169780|NCT00635700|394448|P1|COMPLETED|Overall Study||9
169781|NCT00635700|394447|P2|STARTED|Overall Study||27
169782|NCT00635700|394448|P1|STARTED|Overall Study||24
169783|NCT00635661|394454|P1|NOT COMPLETED|Overall Study||4
169784|NCT00635661|394454|P1|COMPLETED|Overall Study||30
169785|NCT00635661|394454|P1|STARTED|Overall Study||34
169786|NCT00635648|394458|P1|NOT COMPLETED|Overall Study||37
169787|NCT00635648|394458|P1|COMPLETED|Overall Study||26
169788|NCT00635648|394458|P1|STARTED|Overall Study||63
169789|NCT00635609|394467|P2|NOT COMPLETED|Overall Study||3
169790|NCT00635609|394468|P1|NOT COMPLETED|Overall Study||7
169791|NCT00635609|394467|P2|COMPLETED|Overall Study||42
169792|NCT00635609|394468|P1|COMPLETED|Overall Study||41
169793|NCT00635609|394467|P2|STARTED|Overall Study||45
169794|NCT00635609|394468|P1|STARTED|Overall Study||48
169795|NCT00635570|394480|P2|NOT COMPLETED|Overall Study||11
169796|NCT00635570|394481|P1|NOT COMPLETED|Overall Study||15
169797|NCT00635570|394480|P2|COMPLETED|Overall Study||126
169798|NCT00635570|394481|P1|COMPLETED|Overall Study||121
169799|NCT00635570|394480|P2|STARTED|Overall Study||137
169800|NCT00635570|394481|P1|STARTED|Overall Study||136
169801|NCT00635492|394495|P2|NOT COMPLETED|Overall Study||282
169802|NCT00635492|394496|P1|NOT COMPLETED|Overall Study||279
169803|NCT00635492|394495|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
169804|NCT00635492|394496|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
169805|NCT00635492|394495|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
169806|NCT00635492|394496|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
169807|NCT00635479|394542|P2|NOT COMPLETED|Overall Study||18
169808|NCT00635479|394543|P1|NOT COMPLETED|Overall Study||6
169809|NCT00635479|394542|P2|COMPLETED|Overall Study||42
169810|NCT00635479|394543|P1|COMPLETED|Overall Study||49
169811|NCT00635479|394542|P2|STARTED|Overall Study||60
169812|NCT00635479|394543|P1|STARTED|Overall Study||55
169813|NCT00635427|394554|P5|NOT COMPLETED|Overall Study||8
169814|NCT00635427|394555|P4|NOT COMPLETED|Overall Study||9
169815|NCT00635427|394556|P3|NOT COMPLETED|Overall Study||11
169816|NCT00635427|394557|P2|NOT COMPLETED|Overall Study||6
169817|NCT00635427|394558|P1|NOT COMPLETED|Overall Study||12
169818|NCT00635427|394554|P5|COMPLETED|Overall Study||30
169819|NCT00635427|394555|P4|COMPLETED|Overall Study||7
169820|NCT00635427|394556|P3|COMPLETED|Overall Study||5
169821|NCT00635427|394557|P2|COMPLETED|Overall Study||6
169822|NCT00635427|394558|P1|COMPLETED|Overall Study||1
169823|NCT00635427|394554|P5|STARTED|Overall Study||38
169824|NCT00635427|394555|P4|STARTED|Overall Study||16
169825|NCT00635427|394556|P3|STARTED|Overall Study||16
169826|NCT00635427|394557|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
169827|NCT00635427|394558|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
169828|NCT00635362|394580|P2|NOT COMPLETED|Overall Study||8
169829|NCT00635362|394581|P1|NOT COMPLETED|Overall Study||13
169830|NCT00635362|394580|P2|COMPLETED|Overall Study||12
169831|NCT00635362|394581|P1|COMPLETED|Overall Study||9
169832|NCT00635362|394580|P2|STARTED|Overall Study||20
169833|NCT00635362|394581|P1|STARTED|Overall Study||22
169834|NCT00635349|394597|P2|NOT COMPLETED|Overall Study||48
169835|NCT00635349|394598|P1|NOT COMPLETED|Overall Study||44
169836|NCT00635349|394597|P2|COMPLETED|Overall Study||19
169837|NCT00635349|394598|P1|COMPLETED|Overall Study||29
169838|NCT00635349|394597|P2|STARTED|Overall Study||67
169839|NCT00635349|394598|P1|STARTED|Overall Study||73
169840|NCT00635154|394616|P1|NOT COMPLETED|Overall Study||33
169841|NCT00635154|394616|P1|COMPLETED|Overall Study||21
169842|NCT00635154|394616|P1|STARTED|Overall Study||54
169843|NCT00635102|394628|P2|NOT COMPLETED|Overall Study||8
169844|NCT00635102|394629|P1|NOT COMPLETED|Overall Study||7
169845|NCT00635102|394628|P2|COMPLETED|Overall Study||22
169846|NCT00635102|394629|P1|COMPLETED|Overall Study||20
169847|NCT00635102|394628|P2|STARTED|Overall Study||30
169848|NCT00635102|394629|P1|STARTED|Overall Study||27
169849|NCT00635050|394723|P1|NOT COMPLETED|Overall Study||1
169850|NCT00635050|394723|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
169851|NCT00635050|394723|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
169852|NCT00635024|394730|P1|NOT COMPLETED|Overall Study||1
169853|NCT00635024|394730|P1|COMPLETED|Overall Study||0
169854|NCT00635024|394730|P1|STARTED|Overall Study||1
169855|NCT00634933|394741|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
169856|NCT00634933|394742|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
169857|NCT00634933|394743|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
169858|NCT00634933|394744|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
169859|NCT00634933|394745|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
169860|NCT00634933|394741|P5|COMPLETED|Part B: Week 24 to Week 52||22
169861|NCT00634933|394742|P4|COMPLETED|Part B: Week 24 to Week 52||25
169862|NCT00634933|394743|P3|COMPLETED|Part B: Week 24 to Week 52||33
169863|NCT00634933|394744|P2|COMPLETED|Part B: Week 24 to Week 52||42
169864|NCT00634933|394745|P1|COMPLETED|Part B: Week 24 to Week 52||0
169865|NCT00634933|394741|P5|STARTED|Part B: Week 24 to Week 52||32
169866|NCT00634933|394742|P4|STARTED|Part B: Week 24 to Week 52||31
169867|NCT00634933|394743|P3|STARTED|Part B: Week 24 to Week 52||55
169868|NCT00634933|394744|P2|STARTED|Part B: Week 24 to Week 52||56
169869|NCT00634933|394745|P1|STARTED|Part B: Week 24 to Week 52||0
169870|NCT00634933|394741|P5|NOT COMPLETED|Between Part A and Part B||0
169871|NCT00634933|394742|P4|NOT COMPLETED|Between Part A and Part B||0
169872|NCT00634933|394743|P3|NOT COMPLETED|Between Part A and Part B||0
169873|NCT00634933|394744|P2|NOT COMPLETED|Between Part A and Part B||1
169874|NCT00634933|394745|P1|NOT COMPLETED|Between Part A and Part B||0
169875|NCT00634933|394741|P5|COMPLETED|Between Part A and Part B||32
169876|NCT00634933|394742|P4|COMPLETED|Between Part A and Part B||31
169877|NCT00634933|394743|P3|COMPLETED|Between Part A and Part B||55
169878|NCT00634933|394744|P2|COMPLETED|Between Part A and Part B||56
169879|NCT00634933|394745|P1|COMPLETED|Between Part A and Part B||0
169880|NCT00634933|394741|P5|STARTED|Between Part A and Part B||32
169881|NCT00634933|394742|P4|STARTED|Between Part A and Part B||31
169882|NCT00634933|394743|P3|STARTED|Between Part A and Part B||55
169883|NCT00634933|394744|P2|STARTED|Between Part A and Part B||57
169884|NCT00634933|394745|P1|STARTED|Between Part A and Part B||0
169885|NCT00634933|394741|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
169886|NCT00634933|394742|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
169887|NCT00634933|394743|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
169888|NCT00634933|394744|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
169889|NCT00634933|394745|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
169890|NCT00634933|394741|P5|COMPLETED|Part A: Baseline to Week 24||0
169891|NCT00634933|394742|P4|COMPLETED|Part A: Baseline to Week 24||0
169892|NCT00634933|394743|P3|COMPLETED|Part A: Baseline to Week 24||55
169893|NCT00634933|394744|P2|COMPLETED|Part A: Baseline to Week 24||57
169894|NCT00634933|394745|P1|COMPLETED|Part A: Baseline to Week 24||63
169895|NCT00634933|394741|P5|STARTED|Part A: Baseline to Week 24||0
169896|NCT00634933|394742|P4|STARTED|Part A: Baseline to Week 24||0
169897|NCT00634933|394743|P3|STARTED|Part A: Baseline to Week 24||73
169898|NCT00634933|394744|P2|STARTED|Part A: Baseline to Week 24||75
169899|NCT00634933|394745|P1|STARTED|Part A: Baseline to Week 24||74
169900|NCT00634920|394814|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
169901|NCT00634920|394815|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
169902|NCT00634920|394816|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
169903|NCT00634920|394814|P3|COMPLETED|Period 2 - Post-Randomization||0
169904|NCT00634920|394815|P2|COMPLETED|Period 2 - Post-Randomization||68
169905|NCT00634920|394816|P1|COMPLETED|Period 2 - Post-Randomization||43
169906|NCT00634920|394814|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
169907|NCT00634920|394815|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
169908|NCT00634920|394816|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
169909|NCT00634920|394814|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
169910|NCT00634920|394815|P2|STARTED|Period 2 - Post-Randomization||100
169911|NCT00634920|394816|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
169912|NCT00634920|394814|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
169913|NCT00634920|394815|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
169914|NCT00634920|394816|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
169915|NCT00634920|394814|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
169916|NCT00634920|394815|P2|COMPLETED|Period 1 - Pre-Randomization||0
169917|NCT00634920|394816|P1|COMPLETED|Period 1 - Pre-Randomization||0
169918|NCT00634920|394814|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
169919|NCT00634920|394815|P2|STARTED|Period 1 - Pre-Randomization||0
169920|NCT00634920|394816|P1|STARTED|Period 1 - Pre-Randomization||0
169921|NCT00634842|394860|P2|NOT COMPLETED|Overall Study||18
169922|NCT00634842|394861|P1|NOT COMPLETED|Overall Study||15
169923|NCT00634842|394860|P2|COMPLETED|Overall Study||104
169924|NCT00634842|394861|P1|COMPLETED|Overall Study||107
169925|NCT00634842|394860|P2|STARTED|Overall Study||122
169926|NCT00634842|394861|P1|STARTED|Overall Study||122
169927|NCT00634647|394873|P1|NOT COMPLETED|Overall Study||9
169928|NCT00634647|394873|P1|COMPLETED|Overall Study||15
169929|NCT00634647|394873|P1|STARTED|Overall Study||24
169930|NCT00634621|394878|P1|NOT COMPLETED|Overall Study||0
169931|NCT00634621|394878|P1|COMPLETED|Overall Study||283
169932|NCT00634621|394878|P1|STARTED|Overall Study||283
169933|NCT00634582|394886|P1|NOT COMPLETED|Overall Study||0
169934|NCT00634582|394886|P1|COMPLETED|Overall Study||2
169935|NCT00634582|394886|P1|STARTED|Overall Study||2
169936|NCT00634569|394892|P2|NOT COMPLETED|Overall Study||5
169937|NCT00634569|394893|P1|NOT COMPLETED|Overall Study||0
169938|NCT00634569|394892|P2|COMPLETED|Overall Study||5
169939|NCT00634569|394893|P1|COMPLETED|Overall Study||14
169940|NCT00634569|394892|P2|STARTED|Overall Study||10
169941|NCT00634569|394893|P1|STARTED|Overall Study||14
169942|NCT00634543|394907|P2|NOT COMPLETED|Overall Study||21
169943|NCT00634543|394908|P1|NOT COMPLETED|Overall Study||19
169944|NCT00634543|394907|P2|COMPLETED|Overall Study||63
169945|NCT00634543|394908|P1|COMPLETED|Overall Study||59
169946|NCT00634543|394907|P2|Treated|Overall Study||80
169947|NCT00634543|394908|P1|Treated|Overall Study||76
169948|NCT00634543|394907|P2|STARTED|Overall Study||84
169949|NCT00634543|394908|P1|STARTED|Overall Study||78
169950|NCT00634504|394926|P2|NOT COMPLETED|Overall Study||0
169951|NCT00634504|394927|P1|NOT COMPLETED|Overall Study||1
169952|NCT00634504|394926|P2|COMPLETED|Overall Study||9
169953|NCT00634504|394927|P1|COMPLETED|Overall Study||10
169954|NCT00634504|394926|P2|STARTED|Overall Study||9
169955|NCT00634504|394927|P1|STARTED|Overall Study||11
169956|NCT00633594|394936|P3|NOT COMPLETED|Overall Study||10
169957|NCT00633594|394937|P2|NOT COMPLETED|Overall Study||5
169958|NCT00633594|394938|P1|NOT COMPLETED|Overall Study||0
169959|NCT00633594|394936|P3|COMPLETED|Overall Study||16
169960|NCT00633594|394937|P2|COMPLETED|Overall Study||3
169961|NCT00633594|394938|P1|COMPLETED|Overall Study||5
169962|NCT00633594|394936|P3|STARTED|Overall Study||26
169963|NCT00633594|394937|P2|STARTED|Overall Study||8
169964|NCT00633594|394938|P1|STARTED|Overall Study||5
169965|NCT00634322|394968|P3|NOT COMPLETED|Overall Study||0
169966|NCT00634322|394969|P2|NOT COMPLETED|Overall Study||0
169967|NCT00634322|394970|P1|NOT COMPLETED|Overall Study||0
169968|NCT00634322|394968|P3|COMPLETED|Overall Study||5
169969|NCT00634322|394969|P2|COMPLETED|Overall Study||1
169970|NCT00634322|394970|P1|COMPLETED|Overall Study||1
169971|NCT00634322|394968|P3|STARTED|Overall Study||5
169972|NCT00634322|394969|P2|STARTED|Overall Study||1
169973|NCT00634322|394970|P1|STARTED|Overall Study||1
169974|NCT00634270|394980|P2|NOT COMPLETED|Overall Study||1
169975|NCT00634270|394981|P1|NOT COMPLETED|Overall Study||3
169976|NCT00634270|394980|P2|COMPLETED|Overall Study||12
169977|NCT00634270|394981|P1|COMPLETED|Overall Study||46
169978|NCT00634270|394980|P2|STARTED|Overall Study||13
169979|NCT00634270|394981|P1|STARTED|Overall Study|February 12, 2008|49
169980|NCT00634244|395008|P3|NOT COMPLETED|Overall Study||0
169981|NCT00634244|395009|P2|NOT COMPLETED|Overall Study||13
169982|NCT00634244|395010|P1|NOT COMPLETED|Overall Study||1
169983|NCT00634244|395008|P3|COMPLETED|Overall Study||20
169984|NCT00634244|395009|P2|COMPLETED|Overall Study||24
169985|NCT00634244|395010|P1|COMPLETED|Overall Study||34
169986|NCT00634244|395008|P3|Eligible and Treated|Overall Study||20
169987|NCT00634244|395009|P2|Eligible and Treated|Overall Study||36
169988|NCT00634244|395010|P1|Eligible and Treated|Overall Study||35
169989|NCT00634244|395008|P3|STARTED|Overall Study||20
169990|NCT00634244|395009|P2|STARTED|Overall Study||37
169991|NCT00634244|395010|P1|STARTED|Overall Study||35
169992|NCT00634179|395021|P1|NOT COMPLETED|Phase II: Maintenance||1
169993|NCT00634179|395021|P1|COMPLETED|Phase II: Maintenance||29
169994|NCT00634179|395021|P1|STARTED|Phase II: Maintenance||30
169995|NCT00634179|395021|P1|NOT COMPLETED|Phase I: Induction||0
169996|NCT00634179|395021|P1|COMPLETED|Phase I: Induction||19
169997|NCT00634179|395021|P1|STARTED|Phase I: Induction||19
169998|NCT00634166|395030|P2|NOT COMPLETED|Overall Study||60
169999|NCT00634166|395031|P1|NOT COMPLETED|Overall Study||60
170000|NCT00634166|395030|P2|COMPLETED|Overall Study||78
170001|NCT00634166|395031|P1|COMPLETED|Overall Study||22
170002|NCT00634166|395030|P2|STARTED|Overall Study||138
170003|NCT00634166|395031|P1|STARTED|Overall Study||82
170004|NCT00634114|395040|P3|NOT COMPLETED|Overall Study||39
170005|NCT00634114|395041|P2|NOT COMPLETED|Overall Study||35
170006|NCT00634114|395042|P1|NOT COMPLETED|Overall Study||28
170007|NCT00634114|395040|P3|COMPLETED|Overall Study|Completed|148
170008|NCT00634114|395041|P2|COMPLETED|Overall Study|Completed|154
170009|NCT00634114|395042|P1|COMPLETED|Overall Study|Completed|160
170010|NCT00634114|395040|P3|STARTED|Overall Study|Randomised|187
170011|NCT00634114|395041|P2|STARTED|Overall Study|Randomised|189
170012|NCT00634114|395042|P1|STARTED|Overall Study|Randomised|188
170013|NCT00634088|395060|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
170014|NCT00634088|395061|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
170015|NCT00634088|395062|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
170016|NCT00634088|395063|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
170017|NCT00634088|395060|P4|COMPLETED|Time Period 4: Triplet Combination||0
170018|NCT00634088|395061|P3|COMPLETED|Time Period 4: Triplet Combination||0
170019|NCT00634088|395062|P2|COMPLETED|Time Period 4: Triplet Combination||0
170020|NCT00634088|395063|P1|COMPLETED|Time Period 4: Triplet Combination||0
170021|NCT00634088|395060|P4|STARTED|Time Period 4: Triplet Combination||0
170022|NCT00634088|395061|P3|STARTED|Time Period 4: Triplet Combination||0
170023|NCT00634088|395062|P2|STARTED|Time Period 4: Triplet Combination||0
170024|NCT00634088|395063|P1|STARTED|Time Period 4: Triplet Combination||0
170025|NCT00634088|395060|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
170026|NCT00634088|395061|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
170027|NCT00634088|395062|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
170028|NCT00634088|395063|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
170029|NCT00634088|395060|P4|COMPLETED|Time Period 3: Dose Level 3||0
170030|NCT00634088|395061|P3|COMPLETED|Time Period 3: Dose Level 3||0
170031|NCT00634088|395062|P2|COMPLETED|Time Period 3: Dose Level 3||0
170032|NCT00634088|395063|P1|COMPLETED|Time Period 3: Dose Level 3||0
170033|NCT00634088|395060|P4|STARTED|Time Period 3: Dose Level 3||0
170034|NCT00634088|395061|P3|STARTED|Time Period 3: Dose Level 3||1
170035|NCT00634088|395062|P2|STARTED|Time Period 3: Dose Level 3||0
170036|NCT00634088|395063|P1|STARTED|Time Period 3: Dose Level 3||0
170037|NCT00634088|395060|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
170038|NCT00634088|395061|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
170039|NCT00634088|395062|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
170040|NCT00634088|395063|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
170041|NCT00634088|395060|P4|COMPLETED|Time Period 2: Dose Level 2||0
170042|NCT00634088|395061|P3|COMPLETED|Time Period 2: Dose Level 2||0
170043|NCT00634088|395062|P2|COMPLETED|Time Period 2: Dose Level 2||0
170044|NCT00634088|395063|P1|COMPLETED|Time Period 2: Dose Level 2||0
170045|NCT00634088|395060|P4|STARTED|Time Period 2: Dose Level 2||0
170046|NCT00634088|395061|P3|STARTED|Time Period 2: Dose Level 2||0
170047|NCT00634088|395062|P2|STARTED|Time Period 2: Dose Level 2||3
170048|NCT00634088|395063|P1|STARTED|Time Period 2: Dose Level 2||0
170049|NCT00634088|395060|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
170050|NCT00634088|395061|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
170051|NCT00634088|395062|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
170052|NCT00634088|395063|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
170053|NCT00634088|395060|P4|COMPLETED|Time Period 1: Dose Level 1||0
170054|NCT00634088|395061|P3|COMPLETED|Time Period 1: Dose Level 1||0
170055|NCT00634088|395062|P2|COMPLETED|Time Period 1: Dose Level 1||0
170056|NCT00634088|395063|P1|COMPLETED|Time Period 1: Dose Level 1||0
170057|NCT00634088|395060|P4|STARTED|Time Period 1: Dose Level 1||0
170058|NCT00634088|395061|P3|STARTED|Time Period 1: Dose Level 1||0
170059|NCT00634088|395062|P2|STARTED|Time Period 1: Dose Level 1||0
170060|NCT00634088|395063|P1|STARTED|Time Period 1: Dose Level 1||6
170061|NCT00634049|395114|P1|NOT COMPLETED|Overall Study||3
170062|NCT00634049|395114|P1|COMPLETED|Overall Study||146
170063|NCT00634049|395114|P1|STARTED|Overall Study||149
170064|NCT00634010|395193|P2|NOT COMPLETED|Overall Study||14
170065|NCT00634010|395194|P1|NOT COMPLETED|Overall Study||10
170066|NCT00634010|395193|P2|COMPLETED|Overall Study||4
170067|NCT00634010|395194|P1|COMPLETED|Overall Study||8
170068|NCT00634010|395193|P2|STARTED|Overall Study||18
170069|NCT00634010|395194|P1|STARTED|Overall Study||18
170070|NCT00633984|395202|P2|NOT COMPLETED|Overall Study||13
170071|NCT00633984|395203|P1|NOT COMPLETED|Overall Study||9
170072|NCT00633984|395202|P2|COMPLETED|Overall Study||69
170073|NCT00633984|395203|P1|COMPLETED|Overall Study||78
170074|NCT00633984|395202|P2|STARTED|Overall Study||82
170075|NCT00633984|395203|P1|STARTED|Overall Study||87
170076|NCT00633932|395214|P3|NOT COMPLETED|Overall Study||11
170077|NCT00633932|395215|P2|NOT COMPLETED|Overall Study||14
170078|NCT00633932|395216|P1|NOT COMPLETED|Overall Study||12
170079|NCT00633932|395214|P3|COMPLETED|Overall Study||180
170080|NCT00633932|395215|P2|COMPLETED|Overall Study||176
170081|NCT00633932|395216|P1|COMPLETED|Overall Study||179
170082|NCT00633932|395214|P3|STARTED|Overall Study|Randomised|191
170083|NCT00633932|395215|P2|STARTED|Overall Study|Randomised|190
170084|NCT00633932|395216|P1|STARTED|Overall Study|Randomised|191
170085|NCT00633919|395229|P2|NOT COMPLETED|Overall Study||22
170086|NCT00633919|395230|P1|NOT COMPLETED|Overall Study||27
170087|NCT00633919|395229|P2|COMPLETED|Overall Study||39
170088|NCT00633919|395230|P1|COMPLETED|Overall Study||36
170089|NCT00633919|395229|P2|STARTED|Overall Study||61
170090|NCT00633919|395230|P1|STARTED|Overall Study||63
170091|NCT00633893|395247|P3|NOT COMPLETED|Overall Study||188
170092|NCT00633893|395248|P2|NOT COMPLETED|Overall Study||129
170093|NCT00633893|395249|P1|NOT COMPLETED|Overall Study||114
170094|NCT00633893|395247|P3|COMPLETED|Overall Study||641
170095|NCT00633893|395248|P2|COMPLETED|Overall Study||684
170096|NCT00633893|395249|P1|COMPLETED|Overall Study||726
170097|NCT00633893|395247|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
170098|NCT00633893|395248|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
170099|NCT00633893|395249|P1|STARTED|Overall Study||840
170100|NCT00633880|395323|P3|NOT COMPLETED|Randomized Double Blind||0
170101|NCT00633880|395324|P2|NOT COMPLETED|Randomized Double Blind||0
170102|NCT00633880|395325|P1|NOT COMPLETED|Randomized Double Blind||0
170103|NCT00633880|395323|P3|COMPLETED|Randomized Double Blind||51
170104|NCT00633880|395324|P2|COMPLETED|Randomized Double Blind||50
170105|NCT00633880|395325|P1|COMPLETED|Randomized Double Blind||0
170106|NCT00633880|395323|P3|STARTED|Randomized Double Blind||51
170107|NCT00633880|395324|P2|STARTED|Randomized Double Blind||50
170108|NCT00633880|395325|P1|STARTED|Randomized Double Blind||0
170109|NCT00633880|395323|P3|NOT COMPLETED|Open Label Titration||0
170110|NCT00633880|395324|P2|NOT COMPLETED|Open Label Titration||0
170111|NCT00633880|395325|P1|NOT COMPLETED|Open Label Titration||80
170112|NCT00633880|395323|P3|COMPLETED|Open Label Titration||0
170113|NCT00633880|395324|P2|COMPLETED|Open Label Titration||0
170114|NCT00633880|395325|P1|COMPLETED|Open Label Titration||101
170115|NCT00633880|395323|P3|STARTED|Open Label Titration||0
170116|NCT00633880|395324|P2|STARTED|Open Label Titration||0
170117|NCT00633880|395325|P1|STARTED|Open Label Titration||181
170118|NCT00633867|395354|P2|NOT COMPLETED|Overall Study||0
170119|NCT00633867|395355|P1|NOT COMPLETED|Overall Study||0
170120|NCT00633867|395354|P2|COMPLETED|Overall Study||60
170121|NCT00633867|395355|P1|COMPLETED|Overall Study||60
170122|NCT00633867|395354|P2|STARTED|Overall Study||60
170123|NCT00633867|395355|P1|STARTED|Overall Study||60
170124|NCT00633750|395361|P1|NOT COMPLETED|Overall Study||5
170125|NCT00633750|395361|P1|COMPLETED|Overall Study||42
170126|NCT00633750|395361|P1|STARTED|Overall Study||47
170127|NCT00633256|395369|P2|NOT COMPLETED|Overall Study||3
170128|NCT00633256|395370|P1|NOT COMPLETED|Overall Study||4
170129|NCT00633256|395369|P2|COMPLETED|Overall Study||10
170130|NCT00633256|395370|P1|COMPLETED|Overall Study||8
170131|NCT00633256|395369|P2|STARTED|Overall Study||13
170132|NCT00633256|395370|P1|STARTED|Overall Study||12
170133|NCT00633243|395382|P2|NOT COMPLETED|Overall Study||7
170134|NCT00633243|395383|P1|NOT COMPLETED|Overall Study||1
170135|NCT00633243|395382|P2|COMPLETED|Overall Study||2
170136|NCT00633243|395383|P1|COMPLETED|Overall Study||11
170137|NCT00633243|395382|P2|STARTED|Overall Study||9
170138|NCT00633243|395383|P1|STARTED|Overall Study||12
170139|NCT00633217|395391|P2|NOT COMPLETED|Overall Study||23
170140|NCT00633217|395392|P1|NOT COMPLETED|Overall Study||15
170141|NCT00633217|395391|P2|COMPLETED|Overall Study||103
170142|NCT00633217|395392|P1|COMPLETED|Overall Study||106
170143|NCT00633217|395391|P2|STARTED|Overall Study||126
170144|NCT00633217|395392|P1|STARTED|Overall Study||121
170145|NCT00633152|395404|P2|NOT COMPLETED|Overall Study||6
170146|NCT00633152|395405|P1|NOT COMPLETED|Overall Study||14
170147|NCT00633152|395404|P2|COMPLETED|Overall Study||41
170148|NCT00633152|395405|P1|COMPLETED|Overall Study||89
170149|NCT00633152|395404|P2|Clinically Evaluable Population|Overall Study||39
170150|NCT00633152|395405|P1|Clinically Evaluable Population|Overall Study||86
170151|NCT00633152|395404|P2|MITT and Safety Population|Overall Study||45
170152|NCT00633152|395405|P1|MITT and Safety Population|Overall Study||98
170153|NCT00633152|395404|P2|STARTED|Overall Study||47
170154|NCT00633152|395405|P1|STARTED|Overall Study||103
170155|NCT00633139|395416|P3|NOT COMPLETED|Overall Study||1
170156|NCT00633139|395417|P2|NOT COMPLETED|Overall Study||1
170157|NCT00633139|395418|P1|NOT COMPLETED|Overall Study||0
170158|NCT00633139|395416|P3|COMPLETED|Overall Study||3
170159|NCT00633139|395417|P2|COMPLETED|Overall Study||4
170160|NCT00633139|395418|P1|COMPLETED|Overall Study||4
170161|NCT00633139|395416|P3|STARTED|Overall Study||4
170162|NCT00633139|395417|P2|STARTED|Overall Study||5
170163|NCT00633139|395418|P1|STARTED|Overall Study||4
170164|NCT00633126|395432|P1|NOT COMPLETED|Overall Study||1
170165|NCT00633126|395432|P1|COMPLETED|Overall Study||8
170166|NCT00633126|395432|P1|STARTED|Overall Study||9
170167|NCT00633087|395437|P1|NOT COMPLETED|Overall Study||0
170168|NCT00633087|395437|P1|COMPLETED|Overall Study||12
170169|NCT00633087|395437|P1|STARTED|Overall Study||12
170170|NCT00633074|395446|P2|NOT COMPLETED|Overall Study||0
170171|NCT00633074|395447|P1|NOT COMPLETED|Overall Study||1
170172|NCT00633074|395446|P2|COMPLETED|Overall Study||360
170173|NCT00633074|395447|P1|COMPLETED|Overall Study||359
170174|NCT00633074|395446|P2|STARTED|Overall Study||360
170175|NCT00633074|395447|P1|STARTED|Overall Study||360
170176|NCT00633009|395478|P3|NOT COMPLETED|Overall Study||1
170177|NCT00633009|395479|P2|NOT COMPLETED|Overall Study||4
170178|NCT00633009|395480|P1|NOT COMPLETED|Overall Study||4
170179|NCT00633009|395478|P3|COMPLETED|Overall Study||10
170180|NCT00633009|395479|P2|COMPLETED|Overall Study||23
170181|NCT00633009|395480|P1|COMPLETED|Overall Study||8
170182|NCT00633009|395478|P3|STARTED|Overall Study||11
170183|NCT00633009|395479|P2|STARTED|Overall Study||27
170184|NCT00633009|395480|P1|STARTED|Overall Study||12
170185|NCT00632931|395491|P3|NOT COMPLETED|Part 2||24
170186|NCT00632931|395492|P2|NOT COMPLETED|Part 2||0
170187|NCT00632931|395493|P1|NOT COMPLETED|Part 2||0
170188|NCT00632931|395491|P3|COMPLETED|Part 2||0
170189|NCT00632931|395492|P2|COMPLETED|Part 2||0
170190|NCT00632931|395493|P1|COMPLETED|Part 2||0
170191|NCT00632931|395491|P3|STARTED|Part 2||24
170192|NCT00632931|395492|P2|STARTED|Part 2||0
170193|NCT00632931|395493|P1|STARTED|Part 2||0
170194|NCT00632931|395491|P3|NOT COMPLETED|Post-Part 1 Washout||0
170195|NCT00632931|395492|P2|NOT COMPLETED|Post-Part 1 Washout||0
170196|NCT00632931|395493|P1|NOT COMPLETED|Post-Part 1 Washout||0
170197|NCT00632931|395491|P3|COMPLETED|Post-Part 1 Washout||0
170198|NCT00632931|395492|P2|COMPLETED|Post-Part 1 Washout||12
170199|NCT00632931|395493|P1|COMPLETED|Post-Part 1 Washout||12
170200|NCT00632931|395491|P3|STARTED|Post-Part 1 Washout||0
170201|NCT00632931|395492|P2|STARTED|Post-Part 1 Washout||12
170202|NCT00632931|395493|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
170203|NCT00632931|395491|P3|NOT COMPLETED|Part 1, Period 2||0
170204|NCT00632931|395492|P2|NOT COMPLETED|Part 1, Period 2||0
170205|NCT00632931|395493|P1|NOT COMPLETED|Part 1, Period 2||0
170206|NCT00632931|395491|P3|COMPLETED|Part 1, Period 2||0
170207|NCT00632931|395492|P2|COMPLETED|Part 1, Period 2||12
170208|NCT00632931|395493|P1|COMPLETED|Part 1, Period 2||11
170209|NCT00632931|395491|P3|STARTED|Part 1, Period 2||0
170210|NCT00632931|395492|P2|STARTED|Part 1, Period 2||12
170211|NCT00632931|395493|P1|STARTED|Part 1, Period 2||11
170212|NCT00632931|395491|P3|NOT COMPLETED|Part 1, Washout||0
170213|NCT00632931|395492|P2|NOT COMPLETED|Part 1, Washout||0
170214|NCT00632931|395493|P1|NOT COMPLETED|Part 1, Washout||0
170215|NCT00632931|395491|P3|COMPLETED|Part 1, Washout||0
170216|NCT00632931|395492|P2|COMPLETED|Part 1, Washout||12
170217|NCT00632931|395493|P1|COMPLETED|Part 1, Washout||11
170218|NCT00632931|395491|P3|STARTED|Part 1, Washout||0
170219|NCT00632931|395492|P2|STARTED|Part 1, Washout||12
170220|NCT00632931|395493|P1|STARTED|Part 1, Washout||11
170221|NCT00632931|395491|P3|NOT COMPLETED|Part 1, Period 1||0
170222|NCT00632931|395492|P2|NOT COMPLETED|Part 1, Period 1||0
170223|NCT00632931|395493|P1|NOT COMPLETED|Part 1, Period 1||2
170224|NCT00632931|395491|P3|COMPLETED|Part 1, Period 1||0
170225|NCT00632931|395492|P2|COMPLETED|Part 1, Period 1||12
170226|NCT00632931|395493|P1|COMPLETED|Part 1, Period 1||11
170227|NCT00632931|395491|P3|STARTED|Part 1, Period 1||0
170228|NCT00632931|395492|P2|STARTED|Part 1, Period 1||12
170229|NCT00632931|395493|P1|STARTED|Part 1, Period 1||13
170230|NCT00632814|395515|P3|NOT COMPLETED|Overall Study||0
170231|NCT00632814|395516|P2|NOT COMPLETED|Overall Study||0
170232|NCT00632814|395517|P1|NOT COMPLETED|Overall Study||0
170233|NCT00632814|395515|P3|COMPLETED|Overall Study||8
170234|NCT00632814|395516|P2|COMPLETED|Overall Study||13
170235|NCT00632814|395517|P1|COMPLETED|Overall Study||11
170236|NCT00632814|395515|P3|STARTED|Overall Study||8
170237|NCT00632814|395516|P2|STARTED|Overall Study||13
170238|NCT00632814|395517|P1|STARTED|Overall Study||11
170239|NCT00632749|395563|P14|NOT COMPLETED|Overall Study||6
170240|NCT00632749|395564|P13|NOT COMPLETED|Overall Study||3
170241|NCT00632749|395565|P12|NOT COMPLETED|Overall Study||4
170242|NCT00632749|395566|P11|NOT COMPLETED|Overall Study||7
170243|NCT00632749|395567|P10|NOT COMPLETED|Overall Study||3
170244|NCT00632749|395568|P9|NOT COMPLETED|Overall Study||5
170245|NCT00632749|395569|P8|NOT COMPLETED|Overall Study||4
170246|NCT00632749|395570|P7|NOT COMPLETED|Overall Study||5
170247|NCT00632749|395571|P6|NOT COMPLETED|Overall Study||8
170248|NCT00632749|395572|P5|NOT COMPLETED|Overall Study||7
170249|NCT00632749|395573|P4|NOT COMPLETED|Overall Study||4
170250|NCT00632749|395574|P3|NOT COMPLETED|Overall Study||3
170251|NCT00632749|395575|P2|NOT COMPLETED|Overall Study||5
170252|NCT00632749|395576|P1|NOT COMPLETED|Overall Study||4
170253|NCT00632749|395563|P14|COMPLETED|Overall Study||0
170254|NCT00632749|395564|P13|COMPLETED|Overall Study||0
170255|NCT00632749|395565|P12|COMPLETED|Overall Study||0
170256|NCT00632749|395566|P11|COMPLETED|Overall Study||0
170257|NCT00632749|395567|P10|COMPLETED|Overall Study||0
170258|NCT00632749|395568|P9|COMPLETED|Overall Study||0
170259|NCT00632749|395569|P8|COMPLETED|Overall Study||0
170260|NCT00632749|395570|P7|COMPLETED|Overall Study||0
170261|NCT00632749|395571|P6|COMPLETED|Overall Study||0
170262|NCT00632749|395572|P5|COMPLETED|Overall Study||0
170263|NCT00632749|395573|P4|COMPLETED|Overall Study||0
170264|NCT00632749|395574|P3|COMPLETED|Overall Study||0
170265|NCT00632749|395575|P2|COMPLETED|Overall Study||0
170266|NCT00632749|395576|P1|COMPLETED|Overall Study||0
170267|NCT00632749|395563|P14|Not Treated|Overall Study||0
170268|NCT00632749|395564|P13|Not Treated|Overall Study||0
170269|NCT00632749|395565|P12|Not Treated|Overall Study||0
170270|NCT00632749|395566|P11|Not Treated|Overall Study||0
170271|NCT00632749|395567|P10|Not Treated|Overall Study||0
170272|NCT00632749|395568|P9|Not Treated|Overall Study||0
170273|NCT00632749|395569|P8|Not Treated|Overall Study||0
170274|NCT00632749|395570|P7|Not Treated|Overall Study||1
170275|NCT00632749|395571|P6|Not Treated|Overall Study||1
170276|NCT00632749|395572|P5|Not Treated|Overall Study||0
170277|NCT00632749|395573|P4|Not Treated|Overall Study||0
170278|NCT00632749|395574|P3|Not Treated|Overall Study||0
170279|NCT00632749|395575|P2|Not Treated|Overall Study||2
170280|NCT00632749|395576|P1|Not Treated|Overall Study||0
170281|NCT00632749|395563|P14|Treated|Overall Study||6
170282|NCT00632749|395564|P13|Treated|Overall Study||3
170283|NCT00632749|395565|P12|Treated|Overall Study||4
170284|NCT00632749|395566|P11|Treated|Overall Study||7
170285|NCT00632749|395567|P10|Treated|Overall Study||3
170286|NCT00632749|395568|P9|Treated|Overall Study||5
170287|NCT00632749|395569|P8|Treated|Overall Study||4
170288|NCT00632749|395570|P7|Treated|Overall Study||4
170289|NCT00632749|395571|P6|Treated|Overall Study||7
170290|NCT00632749|395572|P5|Treated|Overall Study||7
170291|NCT00632749|395573|P4|Treated|Overall Study||4
170292|NCT00632749|395574|P3|Treated|Overall Study||3
170293|NCT00632749|395575|P2|Treated|Overall Study||3
170294|NCT00632749|395576|P1|Treated|Overall Study||4
170295|NCT00632749|395563|P14|STARTED|Overall Study||6
170296|NCT00632749|395564|P13|STARTED|Overall Study||3
170297|NCT00632749|395565|P12|STARTED|Overall Study||4
170298|NCT00632749|395566|P11|STARTED|Overall Study||7
170299|NCT00632749|395567|P10|STARTED|Overall Study||3
170300|NCT00632749|395568|P9|STARTED|Overall Study||5
170301|NCT00632749|395569|P8|STARTED|Overall Study||4
170302|NCT00632749|395570|P7|STARTED|Overall Study||5
170303|NCT00632749|395571|P6|STARTED|Overall Study||8
170304|NCT00632749|395572|P5|STARTED|Overall Study||7
170305|NCT00632749|395573|P4|STARTED|Overall Study||4
170306|NCT00632749|395574|P3|STARTED|Overall Study||3
170307|NCT00632749|395575|P2|STARTED|Overall Study||5
170308|NCT00632749|395576|P1|STARTED|Overall Study||4
170309|NCT00632736|395870|P1|NOT COMPLETED|Overall Study||268
170310|NCT00632736|395870|P1|COMPLETED|Overall Study||151
170311|NCT00632736|395870|P1|STARTED|Overall Study||419
170312|NCT00632632|395877|P2|NOT COMPLETED|Overall Study||3
170313|NCT00632632|395878|P1|NOT COMPLETED|Overall Study||0
170314|NCT00632632|395877|P2|COMPLETED|Overall Study||9
170315|NCT00632632|395878|P1|COMPLETED|Overall Study||13
170316|NCT00632632|395877|P2|STARTED|Overall Study||12
170317|NCT00632632|395878|P1|STARTED|Overall Study||13
170318|NCT00632619|395890|P2|NOT COMPLETED|Overall Study||4
170319|NCT00632619|395891|P1|NOT COMPLETED|Overall Study||8
170320|NCT00632619|395890|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
170321|NCT00632619|395891|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
170322|NCT00632619|395890|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
170323|NCT00632619|395891|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
170324|NCT00632541|395905|P1|NOT COMPLETED|Overall Study||7
170325|NCT00632541|395905|P1|COMPLETED|Overall Study||11
170326|NCT00632541|395905|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
170327|NCT00632502|395911|P2|NOT COMPLETED|Overall Study||1
170328|NCT00632502|395912|P1|NOT COMPLETED|Overall Study||3
170329|NCT00632502|395911|P2|COMPLETED|Overall Study||11
170330|NCT00632502|395912|P1|COMPLETED|Overall Study||22
170331|NCT00632502|395911|P2|Completed Treatment|Overall Study||9
170332|NCT00632502|395912|P1|Completed Treatment|Overall Study||19
170333|NCT00632502|395911|P2|Treated|Overall Study||12
170334|NCT00632502|395912|P1|Treated|Overall Study||22
170335|NCT00632502|395911|P2|STARTED|Overall Study||12
170336|NCT00632502|395912|P1|STARTED|Overall Study||25
170337|NCT00632489|395940|P3|NOT COMPLETED|Overall Study||0
170338|NCT00632489|395941|P2|NOT COMPLETED|Overall Study||5
170339|NCT00632489|395942|P1|NOT COMPLETED|Overall Study||15
170340|NCT00632489|395940|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
170341|NCT00632489|395941|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
170342|NCT00632489|395942|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
170343|NCT00632489|395940|P3|STARTED|Overall Study||0
170344|NCT00632489|395941|P2|STARTED|Overall Study||5
170345|NCT00632489|395942|P1|STARTED|Overall Study||15
170346|NCT00632463|395956|P3|NOT COMPLETED|Overall Study||0
170347|NCT00632463|395957|P2|NOT COMPLETED|Overall Study||1
170348|NCT00632463|395958|P1|NOT COMPLETED|Overall Study||0
170349|NCT00632463|395956|P3|COMPLETED|Overall Study||7
170350|NCT00632463|395957|P2|COMPLETED|Overall Study||6
170351|NCT00632463|395958|P1|COMPLETED|Overall Study||7
170352|NCT00632463|395956|P3|STARTED|Overall Study||7
170353|NCT00632463|395957|P2|STARTED|Overall Study||7
170354|NCT00632463|395958|P1|STARTED|Overall Study||7
170355|NCT00632424|395975|P1|NOT COMPLETED|Overall Study||18
170356|NCT00632424|395975|P1|COMPLETED|Overall Study||0
170357|NCT00632424|395975|P1|STARTED|Overall Study||18
170358|NCT00632281|395997|P1|NOT COMPLETED|Overall Study||0
170359|NCT00632281|395997|P1|COMPLETED|Overall Study||38
170360|NCT00632281|395997|P1|STARTED|Overall Study||38
170361|NCT00632229|396004|P2|NOT COMPLETED|Overall Study||6
170362|NCT00632229|396005|P1|NOT COMPLETED|Overall Study||6
170363|NCT00632229|396004|P2|COMPLETED|Overall Study||11
170364|NCT00632229|396005|P1|COMPLETED|Overall Study||11
170365|NCT00632229|396004|P2|STARTED|Overall Study||17
170366|NCT00632229|396005|P1|STARTED|Overall Study||17
170367|NCT00632203|396015|P2|NOT COMPLETED|Overall Study||0
170368|NCT00632203|396016|P1|NOT COMPLETED|Overall Study||1
170369|NCT00632203|396015|P2|COMPLETED|Overall Study||27
170370|NCT00632203|396016|P1|COMPLETED|Overall Study||25
170371|NCT00632203|396015|P2|STARTED|Overall Study||27
170372|NCT00632203|396016|P1|STARTED|Overall Study||26
170373|NCT00632099|396036|P2|NOT COMPLETED|Overall Study||3
170374|NCT00632099|396037|P1|NOT COMPLETED|Overall Study||3
170375|NCT00632099|396036|P2|COMPLETED|Overall Study||8
170376|NCT00632099|396037|P1|COMPLETED|Overall Study||7
170377|NCT00632099|396036|P2|STARTED|Overall Study||11
170378|NCT00632099|396037|P1|STARTED|Overall Study||10
170379|NCT00631969|396045|P2|NOT COMPLETED|Overall Study||21
170380|NCT00631969|396046|P1|NOT COMPLETED|Overall Study||15
170381|NCT00631969|396045|P2|COMPLETED|Overall Study||155
170382|NCT00631969|396046|P1|COMPLETED|Overall Study||171
170383|NCT00631969|396045|P2|Received Treatment|Overall Study|safety population|174
170384|NCT00631969|396046|P1|Received Treatment|Overall Study|safety population|184
170385|NCT00631969|396045|P2|STARTED|Overall Study||176
170386|NCT00631969|396046|P1|STARTED|Overall Study||186
170387|NCT00631917|396092|P2|NOT COMPLETED|Overall Study||108
170388|NCT00631917|396093|P1|NOT COMPLETED|Overall Study||88
170389|NCT00631917|396092|P2|COMPLETED|Overall Study||291
170390|NCT00631917|396093|P1|COMPLETED|Overall Study||287
170391|NCT00631917|396092|P2|STARTED|Overall Study||399
170392|NCT00631917|396093|P1|STARTED|Overall Study||375
170393|NCT00631748|396109|P2|NOT COMPLETED|Overall Study||22
170394|NCT00631748|396110|P1|NOT COMPLETED|Overall Study||18
170395|NCT00631748|396109|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
170396|NCT00631748|396110|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
170397|NCT00631748|396109|P2|STARTED|Overall Study||31
170398|NCT00631748|396110|P1|STARTED|Overall Study||29
170399|NCT00631696|396120|P2|NOT COMPLETED|Overall Study||40
170400|NCT00631696|396121|P1|NOT COMPLETED|Overall Study||37
170401|NCT00631696|396120|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
170402|NCT00631696|396121|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
170403|NCT00631696|396120|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
170404|NCT00631696|396121|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
170405|NCT00631696|396120|P2|Received Study Treatment (Tx)|Overall Study||109
170406|NCT00631696|396121|P1|Received Study Treatment (Tx)|Overall Study||111
170407|NCT00631696|396120|P2|STARTED|Overall Study||110
170408|NCT00631696|396121|P1|STARTED|Overall Study||112
170409|NCT00631670|396147|P2|NOT COMPLETED|Overall Study||0
170410|NCT00631670|396148|P1|NOT COMPLETED|Overall Study||0
170411|NCT00631670|396147|P2|COMPLETED|Overall Study||0
170412|NCT00631670|396148|P1|COMPLETED|Overall Study||21
170413|NCT00631670|396147|P2|STARTED|Overall Study||0
170414|NCT00631670|396148|P1|STARTED|Overall Study||21
170415|NCT00631657|396164|P3|NOT COMPLETED|7-Day Discontinuation Period||1
170416|NCT00631657|396165|P2|NOT COMPLETED|7-Day Discontinuation Period||1
170417|NCT00631657|396166|P1|NOT COMPLETED|7-Day Discontinuation Period||2
170418|NCT00631657|396164|P3|COMPLETED|7-Day Discontinuation Period||65
170419|NCT00631657|396165|P2|COMPLETED|7-Day Discontinuation Period||136
170420|NCT00631657|396166|P1|COMPLETED|7-Day Discontinuation Period||65
170421|NCT00631657|396164|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
170422|NCT00631657|396165|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
170423|NCT00631657|396166|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
170424|NCT00631657|396164|P3|STARTED|7-Day Discontinuation Period||66
170425|NCT00631657|396165|P2|STARTED|7-Day Discontinuation Period||137
170426|NCT00631657|396166|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
170427|NCT00631657|396164|P3|NOT COMPLETED|6-Month Treatment Period||50
170428|NCT00631657|396165|P2|NOT COMPLETED|6-Month Treatment Period||0
170429|NCT00631657|396166|P1|NOT COMPLETED|6-Month Treatment Period||141
170430|NCT00631657|396164|P3|COMPLETED|6-Month Treatment Period||66
170431|NCT00631657|396165|P2|COMPLETED|6-Month Treatment Period||0
170432|NCT00631657|396166|P1|COMPLETED|6-Month Treatment Period||203
170433|NCT00631657|396164|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
170434|NCT00631657|396165|P2|Treated|6-Month Treatment Period||0
170435|NCT00631657|396166|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
170436|NCT00631657|396164|P3|STARTED|6-Month Treatment Period||116
170437|NCT00631657|396165|P2|STARTED|6-Month Treatment Period||0
170438|NCT00631657|396166|P1|STARTED|6-Month Treatment Period||344
170439|NCT00631540|396193|P1|NOT COMPLETED|Overall Study||14
170440|NCT00631540|396193|P1|COMPLETED|Overall Study||86
170441|NCT00631540|396193|P1|STARTED|Overall Study||100
170442|NCT00631488|396205|P3|NOT COMPLETED|Overall Study||2
170443|NCT00631488|396206|P2|NOT COMPLETED|Overall Study||2
170444|NCT00631488|396207|P1|NOT COMPLETED|Overall Study||4
170445|NCT00631488|396205|P3|COMPLETED|Overall Study||47
170446|NCT00631488|396206|P2|COMPLETED|Overall Study||47
170447|NCT00631488|396207|P1|COMPLETED|Overall Study||44
170448|NCT00631488|396205|P3|Completed Post-Treatment Period|Overall Study||47
170449|NCT00631488|396206|P2|Completed Post-Treatment Period|Overall Study||47
170450|NCT00631488|396207|P1|Completed Post-Treatment Period|Overall Study||44
170451|NCT00631488|396205|P3|STARTED|Overall Study||49
170452|NCT00631488|396206|P2|STARTED|Overall Study||49
170453|NCT00631488|396207|P1|STARTED|Overall Study||48
170454|NCT00631475|396227|P1|NOT COMPLETED|Overall Study||45
170455|NCT00631475|396227|P1|COMPLETED|Overall Study||83
170456|NCT00631475|396227|P1|STARTED|Overall Study||128
170457|NCT00631449|396237|P2|NOT COMPLETED|Overall Study||0
170458|NCT00631449|396238|P1|NOT COMPLETED|Overall Study||0
170459|NCT00631449|396237|P2|COMPLETED|Overall Study||15
170460|NCT00631449|396238|P1|COMPLETED|Overall Study||15
170461|NCT00631449|396237|P2|STARTED|Overall Study||15
170462|NCT00631449|396238|P1|STARTED|Overall Study||15
170463|NCT00631410|396246|P2|NOT COMPLETED|Overall Study||6
170464|NCT00631410|396247|P1|NOT COMPLETED|Overall Study||6
170465|NCT00631410|396246|P2|COMPLETED|Overall Study||0
170466|NCT00631410|396247|P1|COMPLETED|Overall Study||0
170467|NCT00631410|396246|P2|STARTED|Overall Study||6
170468|NCT00631410|396247|P1|STARTED|Overall Study||6
170469|NCT00631371|396266|P2|NOT COMPLETED|Overall Study||391
170470|NCT00631371|396267|P1|NOT COMPLETED|Overall Study||400
170471|NCT00631371|396266|P2|COMPLETED|Overall Study||0
170472|NCT00631371|396267|P1|COMPLETED|Overall Study||0
170473|NCT00631371|396266|P2|Treated|Overall Study||391
170474|NCT00631371|396267|P1|Treated|Overall Study||393
170475|NCT00631371|396266|P2|STARTED|Overall Study||391
170476|NCT00631371|396267|P1|STARTED|Overall Study||400
170477|NCT00631358|396281|P2|NOT COMPLETED|Overall Study||2
170478|NCT00631358|396282|P1|NOT COMPLETED|Overall Study||6
170479|NCT00631358|396281|P2|COMPLETED|Overall Study||45
170480|NCT00631358|396282|P1|COMPLETED|Overall Study||44
170481|NCT00631358|396281|P2|STARTED|Overall Study||47
170482|NCT00631358|396282|P1|STARTED|Overall Study||50
170483|NCT00631189|396300|P4|NOT COMPLETED|Treatment Phase||7
170484|NCT00631189|396301|P3|NOT COMPLETED|Treatment Phase||11
170485|NCT00631189|396302|P2|NOT COMPLETED|Treatment Phase||7
170486|NCT00631189|396303|P1|NOT COMPLETED|Treatment Phase||0
170487|NCT00631189|396300|P4|COMPLETED|Treatment Phase||103
170488|NCT00631189|396301|P3|COMPLETED|Treatment Phase||92
170489|NCT00631189|396302|P2|COMPLETED|Treatment Phase||97
170490|NCT00631189|396303|P1|COMPLETED|Treatment Phase||0
170491|NCT00631189|396300|P4|STARTED|Treatment Phase||110
170492|NCT00631189|396301|P3|STARTED|Treatment Phase||103
170493|NCT00631189|396302|P2|STARTED|Treatment Phase||104
170494|NCT00631189|396303|P1|STARTED|Treatment Phase||0
170495|NCT00631189|396300|P4|NOT COMPLETED|Initial Phase||0
170496|NCT00631189|396301|P3|NOT COMPLETED|Initial Phase||0
170497|NCT00631189|396302|P2|NOT COMPLETED|Initial Phase||0
170498|NCT00631189|396303|P1|NOT COMPLETED|Initial Phase||351
170499|NCT00631189|396300|P4|COMPLETED|Initial Phase||0
170500|NCT00631189|396301|P3|COMPLETED|Initial Phase||0
170501|NCT00631189|396302|P2|COMPLETED|Initial Phase||0
170502|NCT00631189|396303|P1|COMPLETED|Initial Phase||317
170503|NCT00631189|396300|P4|STARTED|Initial Phase||0
170504|NCT00631189|396301|P3|STARTED|Initial Phase||0
170505|NCT00631189|396302|P2|STARTED|Initial Phase||0
170506|NCT00631189|396303|P1|STARTED|Initial Phase||668
170507|NCT00631020|396345|P1|NOT COMPLETED|Overall Study||8
170508|NCT00631020|396345|P1|COMPLETED|Overall Study||26
170509|NCT00631020|396345|P1|STARTED|Overall Study||34
170510|NCT00631007|396360|P6|NOT COMPLETED|Overall Study||15
170511|NCT00631007|396361|P5|NOT COMPLETED|Overall Study||12
170512|NCT00631007|396362|P4|NOT COMPLETED|Overall Study||9
170513|NCT00631007|396363|P3|NOT COMPLETED|Overall Study||10
170514|NCT00631007|396364|P2|NOT COMPLETED|Overall Study||11
170515|NCT00631007|396365|P1|NOT COMPLETED|Overall Study||11
170516|NCT00631007|396360|P6|COMPLETED|Overall Study||46
170517|NCT00631007|396361|P5|COMPLETED|Overall Study||48
170518|NCT00631007|396362|P4|COMPLETED|Overall Study||53
170519|NCT00631007|396363|P3|COMPLETED|Overall Study||53
170520|NCT00631007|396364|P2|COMPLETED|Overall Study||50
170521|NCT00631007|396365|P1|COMPLETED|Overall Study||49
170522|NCT00631007|396360|P6|STARTED|Overall Study||61
170523|NCT00631007|396361|P5|STARTED|Overall Study||60
170524|NCT00631007|396362|P4|STARTED|Overall Study||62
170525|NCT00631007|396363|P3|STARTED|Overall Study||63
170526|NCT00631007|396364|P2|STARTED|Overall Study||61
170527|NCT00631007|396365|P1|STARTED|Overall Study||60
170528|NCT00630994|396385|P1|NOT COMPLETED|Overall Study||4
170529|NCT00630994|396385|P1|COMPLETED|Overall Study||0
170530|NCT00630994|396385|P1|STARTED|Overall Study||4
170531|NCT00630955|396396|P3|NOT COMPLETED|Overall Study||12
170532|NCT00630955|396397|P2|NOT COMPLETED|Overall Study||6
170533|NCT00630955|396398|P1|NOT COMPLETED|Overall Study||3
170534|NCT00630955|396396|P3|COMPLETED|Overall Study||28
170535|NCT00630955|396397|P2|COMPLETED|Overall Study||31
170536|NCT00630955|396398|P1|COMPLETED|Overall Study||31
170537|NCT00630955|396396|P3|STARTED|Overall Study||40
170538|NCT00630955|396397|P2|STARTED|Overall Study||37
170539|NCT00630955|396398|P1|STARTED|Overall Study||34
170540|NCT00630916|396409|P1|NOT COMPLETED|Overall Study||210
170541|NCT00630916|396409|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
170542|NCT00630916|396409|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
170543|NCT00630916|396409|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
170544|NCT00630877|396419|P3|NOT COMPLETED|Overall Study||10
170545|NCT00630877|396420|P2|NOT COMPLETED|Overall Study||15
170546|NCT00630877|396421|P1|NOT COMPLETED|Overall Study||19
170547|NCT00630877|396419|P3|COMPLETED|Overall Study||80
170548|NCT00630877|396420|P2|COMPLETED|Overall Study||75
170549|NCT00630877|396421|P1|COMPLETED|Overall Study||72
170550|NCT00630877|396419|P3|STARTED|Overall Study||90
170551|NCT00630877|396420|P2|STARTED|Overall Study||90
170552|NCT00630877|396421|P1|STARTED|Overall Study|For all arms, started means treated.|91
170553|NCT00630864|396439|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
170554|NCT00630864|396439|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
170555|NCT00630864|396439|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
170556|NCT00630864|396439|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
170557|NCT00630864|396439|P1|COMPLETED|Part 1 (up to Week 6)||20
170558|NCT00630864|396439|P1|STARTED|Part 1 (up to Week 6)||21
170559|NCT00630838|396478|P2|NOT COMPLETED|Overall Study||2
170560|NCT00630838|396479|P1|NOT COMPLETED|Overall Study||0
170561|NCT00630838|396478|P2|COMPLETED|Overall Study||28
170562|NCT00630838|396479|P1|COMPLETED|Overall Study||32
170563|NCT00630838|396478|P2|STARTED|Overall Study||30
170564|NCT00630838|396479|P1|STARTED|Overall Study||32
170565|NCT00630825|396491|P4|NOT COMPLETED|Overall Study||6
170566|NCT00630825|396492|P3|NOT COMPLETED|Overall Study||8
170567|NCT00630825|396493|P2|NOT COMPLETED|Overall Study||7
170568|NCT00630825|396494|P1|NOT COMPLETED|Overall Study||9
170569|NCT00630825|396491|P4|COMPLETED|Overall Study||60
170570|NCT00630825|396492|P3|COMPLETED|Overall Study||58
170571|NCT00630825|396493|P2|COMPLETED|Overall Study||58
170572|NCT00630825|396494|P1|COMPLETED|Overall Study||56
170573|NCT00630825|396491|P4|Received at Least One Dose of Study Drug|Overall Study||66
170574|NCT00630825|396492|P3|Received at Least One Dose of Study Drug|Overall Study||66
170575|NCT00630825|396493|P2|Received at Least One Dose of Study Drug|Overall Study||65
170576|NCT00630825|396494|P1|Received at Least One Dose of Study Drug|Overall Study||65
170577|NCT00630825|396491|P4|STARTED|Overall Study||66
170578|NCT00630825|396492|P3|STARTED|Overall Study||66
170579|NCT00630825|396493|P2|STARTED|Overall Study||65
170580|NCT00630825|396494|P1|STARTED|Overall Study||65
170581|NCT00630786|396566|P3|NOT COMPLETED|Overall Study||2
170582|NCT00630786|396567|P2|NOT COMPLETED|Overall Study||2
170583|NCT00630786|396568|P1|NOT COMPLETED|Overall Study||1
170584|NCT00630786|396566|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
170585|NCT00630786|396567|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
170586|NCT00630786|396568|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
170587|NCT00630786|396566|P3|Received Study Medication|Overall Study||8
170588|NCT00630786|396567|P2|Received Study Medication|Overall Study||25
170589|NCT00630786|396568|P1|Received Study Medication|Overall Study||19
170590|NCT00630786|396566|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
170591|NCT00630786|396567|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
170592|NCT00630786|396568|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
170593|NCT00630747|396587|P1|NOT COMPLETED|Overall Study||9
170594|NCT00630747|396587|P1|COMPLETED|Overall Study||85
170595|NCT00630747|396587|P1|Participants Treated in Phase I of Study|Overall Study||94
170596|NCT00630747|396587|P1|STARTED|Overall Study||94
170597|NCT00630734|396599|P3|NOT COMPLETED|Overall Study||1
170598|NCT00630734|396600|P2|NOT COMPLETED|Overall Study||1
170599|NCT00630734|396601|P1|NOT COMPLETED|Overall Study||2
170600|NCT00630734|396599|P3|COMPLETED|Overall Study||7
170601|NCT00630734|396600|P2|COMPLETED|Overall Study||12
170602|NCT00630734|396601|P1|COMPLETED|Overall Study||9
170603|NCT00630734|396599|P3|STARTED|Overall Study||8
170604|NCT00630734|396600|P2|STARTED|Overall Study||13
170605|NCT00630734|396601|P1|STARTED|Overall Study||11
170606|NCT00630539|396640|P4|NOT COMPLETED|Overall Study||3
170607|NCT00630539|396641|P3|NOT COMPLETED|Overall Study||1
170608|NCT00630539|396642|P2|NOT COMPLETED|Overall Study||4
170609|NCT00630539|396643|P1|NOT COMPLETED|Overall Study||1
170610|NCT00630539|396640|P4|COMPLETED|Overall Study||27
170611|NCT00630539|396641|P3|COMPLETED|Overall Study||28
170612|NCT00630539|396642|P2|COMPLETED|Overall Study||29
170613|NCT00630539|396643|P1|COMPLETED|Overall Study||33
170614|NCT00630539|396640|P4|STARTED|Overall Study||30
170615|NCT00630539|396641|P3|STARTED|Overall Study||29
170616|NCT00630539|396642|P2|STARTED|Overall Study||33
170617|NCT00630539|396643|P1|STARTED|Overall Study||34
170618|NCT00630487|396699|P2|NOT COMPLETED|Overall Study||0
170619|NCT00630487|396700|P1|NOT COMPLETED|Overall Study||0
170620|NCT00630487|396699|P2|COMPLETED|Overall Study||0
170621|NCT00630487|396700|P1|COMPLETED|Overall Study||0
170622|NCT00630487|396699|P2|STARTED|Overall Study||0
170623|NCT00630487|396700|P1|STARTED|Overall Study||0
170624|NCT00630396|396734|P1|NOT COMPLETED|Overall Study||7
170625|NCT00630396|396734|P1|COMPLETED|Overall Study||53
170626|NCT00630396|396734|P1|STARTED|Overall Study||60
170627|NCT00630344|396740|P1|NOT COMPLETED|Overall Study||0
170628|NCT00630344|396740|P1|COMPLETED|Overall Study||36
170629|NCT00630344|396740|P1|STARTED|Overall Study||36
170630|NCT00630331|396747|P3|NOT COMPLETED|Overall Study||188
170631|NCT00630331|396748|P2|NOT COMPLETED|Overall Study||166
170632|NCT00630331|396749|P1|NOT COMPLETED|Overall Study||206
170633|NCT00630331|396747|P3|COMPLETED|Overall Study||3712
170634|NCT00630331|396748|P2|COMPLETED|Overall Study||3510
170635|NCT00630331|396749|P1|COMPLETED|Overall Study||3622
170636|NCT00630331|396747|P3|STARTED|Overall Study||3900
170637|NCT00630331|396748|P2|STARTED|Overall Study||3676
170638|NCT00630331|396749|P1|STARTED|Overall Study||3828
170639|NCT00630292|396790|P1|NOT COMPLETED|Overall Study||1
170640|NCT00630292|396790|P1|COMPLETED|Overall Study||5
170641|NCT00630292|396790|P1|STARTED|Overall Study||6
170642|NCT00630058|396796|P2|NOT COMPLETED|Overall Study||4
170643|NCT00630058|396797|P1|NOT COMPLETED|Overall Study||4
170644|NCT00630058|396796|P2|COMPLETED|Overall Study||6
170645|NCT00630058|396797|P1|COMPLETED|Overall Study||6
170646|NCT00630058|396796|P2|STARTED|Overall Study||10
170647|NCT00630058|396797|P1|STARTED|Overall Study||10
170648|NCT00629850|396815|P2|NOT COMPLETED|Overall Study||0
170649|NCT00629850|396816|P1|NOT COMPLETED|Overall Study||0
170650|NCT00629850|396815|P2|COMPLETED|Overall Study||0
170651|NCT00629850|396816|P1|COMPLETED|Overall Study||1
170652|NCT00629850|396815|P2|STARTED|Overall Study||0
170653|NCT00629850|396816|P1|STARTED|Overall Study||1
170654|NCT00629772|396828|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
170655|NCT00629772|396829|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
170656|NCT00629772|396828|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
170657|NCT00629772|396829|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
170658|NCT00629772|396828|P2|STARTED|Second Intervention Week 14 - Week 26||12
170659|NCT00629772|396829|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
170660|NCT00629772|396828|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
170661|NCT00629772|396829|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
170662|NCT00629772|396828|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
170663|NCT00629772|396829|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
170664|NCT00629772|396828|P2|STARTED|First Intervention - Day 0 - Week 14||12
170665|NCT00629772|396829|P1|STARTED|First Intervention - Day 0 - Week 14||12
170666|NCT00629707|396849|P2|NOT COMPLETED|Overall Study||2
170667|NCT00629707|396850|P1|NOT COMPLETED|Overall Study||0
170668|NCT00629707|396849|P2|COMPLETED|Overall Study||8
170669|NCT00629707|396850|P1|COMPLETED|Overall Study||10
170670|NCT00629707|396849|P2|STARTED|Overall Study||10
170671|NCT00629707|396850|P1|STARTED|Overall Study||10
170672|NCT00629525|396856|P1|NOT COMPLETED|Overall Study||3
170673|NCT00629525|396856|P1|COMPLETED|Overall Study||32
170674|NCT00629525|396856|P1|STARTED|Overall Study||35
170675|NCT00629499|396864|P1|NOT COMPLETED|Overall Study||0
170676|NCT00629499|396864|P1|COMPLETED|Overall Study||63
170677|NCT00629499|396864|P1|STARTED|Overall Study||63
170678|NCT00629265|396870|P2|NOT COMPLETED|Overall Study||20
170679|NCT00629265|396871|P1|NOT COMPLETED|Overall Study||32
170680|NCT00629265|396870|P2|COMPLETED|Overall Study||34
170681|NCT00629265|396871|P1|COMPLETED|Overall Study||84
170682|NCT00629265|396870|P2|STARTED|Overall Study||54
170683|NCT00629265|396871|P1|STARTED|Overall Study||116
170684|NCT00629239|396881|P2|NOT COMPLETED|Overall Study||4
170685|NCT00629239|396882|P1|NOT COMPLETED|Overall Study||8
170686|NCT00629239|396881|P2|COMPLETED|Overall Study||28
170687|NCT00629239|396882|P1|COMPLETED|Overall Study||26
170688|NCT00629239|396881|P2|STARTED|Overall Study||32
170689|NCT00629239|396882|P1|STARTED|Overall Study||34
170690|NCT00629018|396916|P2|NOT COMPLETED|Overall Study||0
170691|NCT00629018|396917|P1|NOT COMPLETED|Overall Study||0
170692|NCT00629018|396916|P2|COMPLETED|Overall Study||55
170693|NCT00629018|396917|P1|COMPLETED|Overall Study||55
170694|NCT00629018|396916|P2|STARTED|Overall Study||55
170695|NCT00629018|396917|P1|STARTED|Overall Study||55
170696|NCT00628927|396927|P2|NOT COMPLETED|Overall Study||0
170697|NCT00628927|396928|P1|NOT COMPLETED|Overall Study||8
170698|NCT00628927|396927|P2|COMPLETED|Overall Study||30
170699|NCT00628927|396928|P1|COMPLETED|Overall Study||175
170700|NCT00628927|396927|P2|STARTED|Overall Study||30
170701|NCT00628927|396928|P1|STARTED|Overall Study||183
170702|NCT00628901|396941|P2|NOT COMPLETED|Overall Study||1
170703|NCT00628901|396942|P1|NOT COMPLETED|Overall Study||3
170704|NCT00628901|396941|P2|COMPLETED|Overall Study||29
170705|NCT00628901|396942|P1|COMPLETED|Overall Study||27
170706|NCT00628901|396941|P2|STARTED|Overall Study||30
170707|NCT00628901|396942|P1|STARTED|Overall Study||30
170708|NCT00628862|396973|P3|NOT COMPLETED|Overall Study||22
170709|NCT00628862|396974|P2|NOT COMPLETED|Overall Study||17
170710|NCT00628862|396975|P1|NOT COMPLETED|Overall Study||11
170711|NCT00628862|396973|P3|COMPLETED|Overall Study|randomised patients|186
170712|NCT00628862|396974|P2|COMPLETED|Overall Study|randomised patients|182
170713|NCT00628862|396975|P1|COMPLETED|Overall Study|randomised patients|195
170714|NCT00628862|396973|P3|STARTED|Overall Study|randomised patients|208
170715|NCT00628862|396974|P2|STARTED|Overall Study|randomised patients|199
170716|NCT00628862|396975|P1|STARTED|Overall Study|randomised patients|206
170717|NCT00628758|397021|P2|NOT COMPLETED|Overall Study||42
170718|NCT00628758|397022|P1|NOT COMPLETED|Overall Study||44
170719|NCT00628758|397021|P2|COMPLETED|Overall Study||179
170720|NCT00628758|397022|P1|COMPLETED|Overall Study||165
170721|NCT00628758|397021|P2|STARTED|Overall Study||221
170722|NCT00628758|397022|P1|STARTED|Overall Study||209
170723|NCT00628628|397036|P2|NOT COMPLETED|Overall Study||0
170724|NCT00628628|397037|P1|NOT COMPLETED|Overall Study||0
170725|NCT00628628|397036|P2|COMPLETED|Overall Study||40
170726|NCT00628628|397037|P1|COMPLETED|Overall Study||40
170727|NCT00628628|397036|P2|STARTED|Overall Study||40
170728|NCT00628628|397037|P1|STARTED|Overall Study||40
170729|NCT00628446|397043|P1|NOT COMPLETED|Overall Study||7
170730|NCT00628446|397043|P1|COMPLETED|Overall Study||38
170731|NCT00628446|397043|P1|STARTED|Overall Study||45
170732|NCT00628407|397048|P1|NOT COMPLETED|Overall Study||0
170733|NCT00628407|397048|P1|COMPLETED|Overall Study||13
170734|NCT00628407|397048|P1|STARTED|Overall Study||13
170735|NCT00628355|397054|P2|NOT COMPLETED|Overall Study||1
170736|NCT00628355|397055|P1|NOT COMPLETED|Overall Study||1
170737|NCT00628355|397054|P2|COMPLETED|Overall Study||14
170738|NCT00628355|397055|P1|COMPLETED|Overall Study||14
170739|NCT00628355|397054|P2|STARTED|Overall Study||15
170740|NCT00628355|397055|P1|STARTED|Overall Study||15
170741|NCT00628251|397066|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
170742|NCT00628251|397067|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
170743|NCT00628251|397068|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
170744|NCT00628251|397066|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
170745|NCT00628251|397067|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
170746|NCT00628251|397068|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
170747|NCT00628251|397066|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
170748|NCT00628251|397067|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
170749|NCT00628251|397068|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
170750|NCT00628251|397066|P3|NOT COMPLETED|Randomised Part||8
170751|NCT00628251|397067|P2|NOT COMPLETED|Randomised Part||0
170752|NCT00628251|397068|P1|NOT COMPLETED|Randomised Part||0
170753|NCT00628251|397066|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
170754|NCT00628251|397067|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
170755|NCT00628251|397068|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
170756|NCT00628251|397066|P3|STARTED|Randomised Part|Patients randomised|33
170757|NCT00628251|397067|P2|STARTED|Randomised Part|Patients randomised|32
170758|NCT00628251|397068|P1|STARTED|Randomised Part|Patients randomised|32
170759|NCT00628212|397111|P4|NOT COMPLETED|Overall Study||5
170760|NCT00628212|397112|P3|NOT COMPLETED|Overall Study||3
170761|NCT00628212|397113|P2|NOT COMPLETED|Overall Study||1
170762|NCT00628212|397114|P1|NOT COMPLETED|Overall Study||3
170763|NCT00628212|397111|P4|COMPLETED|Overall Study||76
170764|NCT00628212|397112|P3|COMPLETED|Overall Study||76
170765|NCT00628212|397113|P2|COMPLETED|Overall Study||83
170766|NCT00628212|397114|P1|COMPLETED|Overall Study||77
170767|NCT00628212|397111|P4|STARTED|Overall Study||81
170768|NCT00628212|397112|P3|STARTED|Overall Study||79
170769|NCT00628212|397113|P2|STARTED|Overall Study||84
170770|NCT00628212|397114|P1|STARTED|Overall Study||80
170771|NCT00628134|397136|P2|NOT COMPLETED|Overall Study||0
170772|NCT00628134|397137|P1|NOT COMPLETED|Overall Study||0
170773|NCT00628134|397136|P2|COMPLETED|Overall Study||4
170774|NCT00628134|397137|P1|COMPLETED|Overall Study||4
170775|NCT00628134|397136|P2|STARTED|Overall Study||4
170776|NCT00628134|397137|P1|STARTED|Overall Study||4
170777|NCT00628108|397147|P2|NOT COMPLETED|Overall Study||3
170778|NCT00628108|397148|P1|NOT COMPLETED|Overall Study||1
170779|NCT00628108|397147|P2|COMPLETED|Overall Study||43
170780|NCT00628108|397148|P1|COMPLETED|Overall Study||22
170781|NCT00628108|397147|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
170782|NCT00628108|397148|P1|Safety Population|Overall Study||24
170783|NCT00628108|397147|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
170784|NCT00628108|397148|P1|STARTED|Overall Study||23
170785|NCT00628030|397180|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
170786|NCT00628030|397181|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
170787|NCT00628030|397180|P2|COMPLETED|Post to 6 Month Follow-up||33
170788|NCT00628030|397181|P1|COMPLETED|Post to 6 Month Follow-up||27
170789|NCT00628030|397180|P2|STARTED|Post to 6 Month Follow-up||63
170790|NCT00628030|397181|P1|STARTED|Post to 6 Month Follow-up||59
170791|NCT00628030|397180|P2|NOT COMPLETED|Baseline to Post-Assessment||29
170792|NCT00628030|397181|P1|NOT COMPLETED|Baseline to Post-Assessment||33
170793|NCT00628030|397180|P2|COMPLETED|Baseline to Post-Assessment||63
170794|NCT00628030|397181|P1|COMPLETED|Baseline to Post-Assessment||59
170795|NCT00628030|397180|P2|STARTED|Baseline to Post-Assessment||92
170796|NCT00628030|397181|P1|STARTED|Baseline to Post-Assessment||92
170797|NCT00627926|397198|P3|NOT COMPLETED|Overall Study||95
170798|NCT00627926|397199|P2|NOT COMPLETED|Overall Study||104
170799|NCT00627926|397200|P1|NOT COMPLETED|Overall Study||159
170800|NCT00627926|397198|P3|COMPLETED|Overall Study||268
170801|NCT00627926|397199|P2|COMPLETED|Overall Study||260
170802|NCT00627926|397200|P1|COMPLETED|Overall Study||202
170803|NCT00627926|397198|P3|STARTED|Overall Study||363
170804|NCT00627926|397199|P2|STARTED|Overall Study||364
170805|NCT00627926|397200|P1|STARTED|Overall Study||361
170806|NCT00627861|397244|P1|NOT COMPLETED|Overall Study||0
170807|NCT00627861|397244|P1|COMPLETED|Overall Study||1
170808|NCT00627861|397244|P1|STARTED|Overall Study||1
170809|NCT00627679|397250|P4|NOT COMPLETED|Overall Study||0
170810|NCT00627679|397251|P3|NOT COMPLETED|Overall Study||0
170811|NCT00627679|397252|P2|NOT COMPLETED|Overall Study||0
170812|NCT00627679|397253|P1|NOT COMPLETED|Overall Study||0
170813|NCT00627679|397250|P4|COMPLETED|Overall Study||4
170814|NCT00627679|397251|P3|COMPLETED|Overall Study||4
170815|NCT00627679|397252|P2|COMPLETED|Overall Study||4
170816|NCT00627679|397253|P1|COMPLETED|Overall Study||4
170817|NCT00627679|397250|P4|STARTED|Overall Study||4
170818|NCT00627679|397251|P3|STARTED|Overall Study||4
170819|NCT00627679|397252|P2|STARTED|Overall Study||4
170820|NCT00627679|397253|P1|STARTED|Overall Study||4
170821|NCT00627523|397281|P2|NOT COMPLETED|Overall Study||2
170822|NCT00627523|397282|P1|NOT COMPLETED|Overall Study||2
170823|NCT00627523|397281|P2|COMPLETED|Overall Study||20
170824|NCT00627523|397282|P1|COMPLETED|Overall Study||19
170825|NCT00627523|397281|P2|STARTED|Overall Study||22
170826|NCT00627523|397282|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
170827|NCT00627497|397310|P4|NOT COMPLETED|Overall Study||0
170828|NCT00627497|397311|P3|NOT COMPLETED|Overall Study||0
170829|NCT00627497|397312|P2|NOT COMPLETED|Overall Study||1
170830|NCT00627497|397313|P1|NOT COMPLETED|Overall Study||1
170831|NCT00627497|397310|P4|COMPLETED|Overall Study||2
170832|NCT00627497|397311|P3|COMPLETED|Overall Study||4
170833|NCT00627497|397312|P2|COMPLETED|Overall Study||11
170834|NCT00627497|397313|P1|COMPLETED|Overall Study||13
170835|NCT00627497|397310|P4|STARTED|Overall Study||2
170836|NCT00627497|397311|P3|STARTED|Overall Study||4
170837|NCT00627497|397312|P2|STARTED|Overall Study||12
170838|NCT00627497|397313|P1|STARTED|Overall Study||14
170839|NCT00627445|397373|P2|NOT COMPLETED|Overall Study||12
170840|NCT00627445|397374|P1|NOT COMPLETED|Overall Study||9
170841|NCT00627445|397373|P2|COMPLETED|Overall Study||210
170842|NCT00627445|397374|P1|COMPLETED|Overall Study||210
170843|NCT00627445|397373|P2|Exposed to Study Drug|Overall Study||222
170844|NCT00627445|397374|P1|Exposed to Study Drug|Overall Study||219
170845|NCT00627445|397373|P2|STARTED|Overall Study||222
170846|NCT00627445|397374|P1|STARTED|Overall Study||219
170847|NCT00627406|397398|P4|NOT COMPLETED|Overall Study||0
170848|NCT00627406|397399|P3|NOT COMPLETED|Overall Study||0
170849|NCT00627406|397400|P2|NOT COMPLETED|Overall Study||0
170850|NCT00627406|397401|P1|NOT COMPLETED|Overall Study||0
170851|NCT00627406|397398|P4|COMPLETED|Overall Study||141
170852|NCT00627406|397399|P3|COMPLETED|Overall Study||125
170853|NCT00627406|397400|P2|COMPLETED|Overall Study||58
170854|NCT00627406|397401|P1|COMPLETED|Overall Study||60
170855|NCT00627406|397398|P4|STARTED|Overall Study||141
170856|NCT00627406|397399|P3|STARTED|Overall Study||125
170857|NCT00627406|397400|P2|STARTED|Overall Study||58
170858|NCT00627406|397401|P1|STARTED|Overall Study||60
170859|NCT00627393|397417|P2|NOT COMPLETED|Per-Protocol Analysis||13
170860|NCT00627393|397418|P1|NOT COMPLETED|Per-Protocol Analysis||10
170861|NCT00627393|397417|P2|COMPLETED|Per-Protocol Analysis||35
170862|NCT00627393|397418|P1|COMPLETED|Per-Protocol Analysis||39
170863|NCT00627393|397417|P2|STARTED|Per-Protocol Analysis||48
170864|NCT00627393|397418|P1|STARTED|Per-Protocol Analysis||49
170865|NCT00627393|397417|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
170866|NCT00627393|397418|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
170867|NCT00627393|397417|P2|COMPLETED|Intention-To-Treat Analysis||48
170868|NCT00627393|397418|P1|COMPLETED|Intention-To-Treat Analysis||49
170869|NCT00627393|397417|P2|STARTED|Intention-To-Treat Analysis||56
170870|NCT00627393|397418|P1|STARTED|Intention-To-Treat Analysis||58
170871|NCT00627094|397439|P2|NOT COMPLETED|Overall Study||15
170872|NCT00627094|397440|P1|NOT COMPLETED|Overall Study||12
170873|NCT00627094|397439|P2|COMPLETED|Overall Study||45
170874|NCT00627094|397440|P1|COMPLETED|Overall Study||48
170875|NCT00627094|397439|P2|STARTED|Overall Study||60
170876|NCT00627094|397440|P1|STARTED|Overall Study||60
170877|NCT00627042|397452|P1|NOT COMPLETED|Overall Study||2
170878|NCT00627042|397452|P1|COMPLETED|Overall Study||40
170879|NCT00627042|397452|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
170880|NCT00627042|397452|P1|STARTED|Overall Study||42
170881|NCT00627016|397464|P2|NOT COMPLETED|Overall Study||6
170882|NCT00627016|397465|P1|NOT COMPLETED|Overall Study||6
170883|NCT00627016|397464|P2|COMPLETED|Overall Study||146
170884|NCT00627016|397465|P1|COMPLETED|Overall Study||147
170885|NCT00627016|397464|P2|STARTED|Overall Study||152
170886|NCT00627016|397465|P1|STARTED|Overall Study||153
170887|NCT00626925|397477|P2|NOT COMPLETED|Overall Study||9
170888|NCT00626925|397478|P1|NOT COMPLETED|Overall Study||12
170889|NCT00626925|397477|P2|COMPLETED|Overall Study||62
170890|NCT00626925|397478|P1|COMPLETED|Overall Study||55
170891|NCT00626925|397477|P2|STARTED|Overall Study||71
170892|NCT00626925|397478|P1|STARTED|Overall Study||67
170893|NCT00626821|397504|P1|NOT COMPLETED|Overall Study||221
170894|NCT00626821|397504|P1|COMPLETED|Overall Study||2796
170895|NCT00626821|397504|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
170896|NCT00626821|397504|P1|STARTED|Overall Study||3017
170897|NCT00626808|397512|P4|NOT COMPLETED|Overall Study||0
170898|NCT00626808|397513|P3|NOT COMPLETED|Overall Study||0
170899|NCT00626808|397514|P2|NOT COMPLETED|Overall Study||0
170900|NCT00626808|397515|P1|NOT COMPLETED|Overall Study||0
170901|NCT00626808|397512|P4|COMPLETED|Overall Study||2906
170902|NCT00626808|397513|P3|COMPLETED|Overall Study||30011
170903|NCT00626808|397514|P2|COMPLETED|Overall Study||34316
170904|NCT00626808|397515|P1|COMPLETED|Overall Study||254464
170905|NCT00626808|397512|P4|STARTED|Overall Study||2906
170906|NCT00626808|397513|P3|STARTED|Overall Study||30011
170907|NCT00626808|397514|P2|STARTED|Overall Study||34316
170908|NCT00626808|397515|P1|STARTED|Overall Study||254464
170909|NCT00626782|397583|P2|NOT COMPLETED|Overall Study||0
170910|NCT00626782|397584|P1|NOT COMPLETED|Overall Study||0
170911|NCT00626782|397583|P2|COMPLETED|Overall Study||12
170912|NCT00626782|397584|P1|COMPLETED|Overall Study||12
170913|NCT00626782|397583|P2|STARTED|Overall Study||12
170914|NCT00626782|397584|P1|STARTED|Overall Study||12
170915|NCT00626743|397592|P2|NOT COMPLETED|Treatment Period 2||0
170916|NCT00626743|397593|P1|NOT COMPLETED|Treatment Period 2||0
170917|NCT00626743|397592|P2|COMPLETED|Treatment Period 2||6
170918|NCT00626743|397593|P1|COMPLETED|Treatment Period 2||6
170919|NCT00626743|397592|P2|STARTED|Treatment Period 2||6
170920|NCT00626743|397593|P1|STARTED|Treatment Period 2||6
170921|NCT00626743|397592|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
170922|NCT00626743|397593|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
170923|NCT00626743|397592|P2|COMPLETED|Wash-out Period of 6 Days||6
170924|NCT00626743|397593|P1|COMPLETED|Wash-out Period of 6 Days||6
170925|NCT00626743|397592|P2|STARTED|Wash-out Period of 6 Days||6
170926|NCT00626743|397593|P1|STARTED|Wash-out Period of 6 Days||6
170927|NCT00626743|397592|P2|NOT COMPLETED|Treatment Period 1||1
170928|NCT00626743|397593|P1|NOT COMPLETED|Treatment Period 1||0
170929|NCT00626743|397592|P2|COMPLETED|Treatment Period 1||6
170930|NCT00626743|397593|P1|COMPLETED|Treatment Period 1||6
170931|NCT00626743|397592|P2|STARTED|Treatment Period 1||7
170932|NCT00626743|397593|P1|STARTED|Treatment Period 1||6
170933|NCT00626639|397603|P2|NOT COMPLETED|Overall Study||2
170934|NCT00626639|397604|P1|NOT COMPLETED|Overall Study||2
170935|NCT00626639|397603|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
170936|NCT00626639|397604|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
170937|NCT00626639|397603|P2|STARTED|Overall Study||3
170938|NCT00626639|397604|P1|STARTED|Overall Study||2
170939|NCT00626574|397622|P2|NOT COMPLETED|Overall Study||0
170940|NCT00626574|397623|P1|NOT COMPLETED|Overall Study||0
170941|NCT00626574|397622|P2|COMPLETED|Overall Study||1
170942|NCT00626574|397623|P1|COMPLETED|Overall Study||2
170943|NCT00626574|397622|P2|STARTED|Overall Study||1
170944|NCT00626574|397623|P1|STARTED|Overall Study||2
170945|NCT00626561|397629|P1|NOT COMPLETED|Overall Study||4
170946|NCT00626561|397629|P1|COMPLETED|Overall Study||0
170947|NCT00626561|397629|P1|STARTED|Overall Study||4
170948|NCT00626548|397635|P2|NOT COMPLETED|Overall Study||716
170949|NCT00626548|397636|P1|NOT COMPLETED|Overall Study||705
170950|NCT00626548|397635|P2|COMPLETED|Overall Study||0
170951|NCT00626548|397636|P1|COMPLETED|Overall Study||0
170952|NCT00626548|397635|P2|Patients Received Treatment|Overall Study||712
170953|NCT00626548|397636|P1|Patients Received Treatment|Overall Study||703
170954|NCT00626548|397635|P2|STARTED|Overall Study||716
170955|NCT00626548|397636|P1|STARTED|Overall Study||705
170956|NCT00626522|397650|P6|NOT COMPLETED|Overall Study||2
170957|NCT00626522|397651|P5|NOT COMPLETED|Overall Study||7
170958|NCT00626522|397652|P4|NOT COMPLETED|Overall Study||2
170959|NCT00626522|397653|P3|NOT COMPLETED|Overall Study||8
170960|NCT00626522|397654|P2|NOT COMPLETED|Overall Study||7
170961|NCT00626522|397655|P1|NOT COMPLETED|Overall Study||6
170962|NCT00626522|397650|P6|COMPLETED|Overall Study||57
170963|NCT00626522|397651|P5|COMPLETED|Overall Study||58
170964|NCT00626522|397652|P4|COMPLETED|Overall Study||74
170965|NCT00626522|397653|P3|COMPLETED|Overall Study||117
170966|NCT00626522|397654|P2|COMPLETED|Overall Study||113
170967|NCT00626522|397655|P1|COMPLETED|Overall Study||115
170968|NCT00626522|397650|P6|STARTED|Overall Study||59
170969|NCT00626522|397651|P5|STARTED|Overall Study||65
170970|NCT00626522|397652|P4|STARTED|Overall Study||76
170971|NCT00626522|397653|P3|STARTED|Overall Study||125
170972|NCT00626522|397654|P2|STARTED|Overall Study||120
170973|NCT00626522|397655|P1|STARTED|Overall Study||121
170974|NCT00626444|397693|P1|NOT COMPLETED|Overall Study||0
170975|NCT00626444|397693|P1|COMPLETED|Overall Study||2
170976|NCT00626444|397693|P1|STARTED|Overall Study||2
170977|NCT00626431|397700|P2|NOT COMPLETED|Overall Study||45
170978|NCT00626431|397701|P1|NOT COMPLETED|Overall Study||17
170979|NCT00626431|397700|P2|COMPLETED|Overall Study||114
170980|NCT00626431|397701|P1|COMPLETED|Overall Study||134
170981|NCT00626431|397700|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
170982|NCT00626431|397701|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
170983|NCT00626392|397722|P6|NOT COMPLETED|Coadministration Period||6
170984|NCT00626392|397723|P5|NOT COMPLETED|Coadministration Period||5
170985|NCT00626392|397724|P4|NOT COMPLETED|Coadministration Period||7
170986|NCT00626392|397725|P3|NOT COMPLETED|Coadministration Period||10
170987|NCT00626392|397726|P2|NOT COMPLETED|Coadministration Period||5
170988|NCT00626392|397727|P1|NOT COMPLETED|Coadministration Period||4
170989|NCT00626392|397722|P6|COMPLETED|Coadministration Period||38
170990|NCT00626392|397723|P5|COMPLETED|Coadministration Period||36
170991|NCT00626392|397724|P4|COMPLETED|Coadministration Period||36
170992|NCT00626392|397725|P3|COMPLETED|Coadministration Period||31
170993|NCT00626392|397726|P2|COMPLETED|Coadministration Period||38
170994|NCT00626392|397727|P1|COMPLETED|Coadministration Period||40
170995|NCT00626392|397722|P6|STARTED|Coadministration Period||44
170996|NCT00626392|397723|P5|STARTED|Coadministration Period||41
170997|NCT00626392|397724|P4|STARTED|Coadministration Period||43
170998|NCT00626392|397725|P3|STARTED|Coadministration Period||41
170999|NCT00626392|397726|P2|STARTED|Coadministration Period||43
171000|NCT00626392|397727|P1|STARTED|Coadministration Period||44
171001|NCT00626392|397722|P6|NOT COMPLETED|Run-in Period||1
171002|NCT00626392|397723|P5|NOT COMPLETED|Run-in Period||4
171003|NCT00626392|397724|P4|NOT COMPLETED|Run-in Period||1
171004|NCT00626392|397725|P3|NOT COMPLETED|Run-in Period||3
171005|NCT00626392|397726|P2|NOT COMPLETED|Run-in Period||1
171006|NCT00626392|397727|P1|NOT COMPLETED|Run-in Period||1
171007|NCT00626392|397722|P6|COMPLETED|Run-in Period||44
171008|NCT00626392|397723|P5|COMPLETED|Run-in Period||41
171009|NCT00626392|397724|P4|COMPLETED|Run-in Period||43
171010|NCT00626392|397725|P3|COMPLETED|Run-in Period||41
171011|NCT00626392|397726|P2|COMPLETED|Run-in Period||43
171012|NCT00626392|397727|P1|COMPLETED|Run-in Period||44
171013|NCT00626392|397722|P6|STARTED|Run-in Period||45
171014|NCT00626392|397723|P5|STARTED|Run-in Period||45
171015|NCT00626392|397724|P4|STARTED|Run-in Period||44
171016|NCT00626392|397725|P3|STARTED|Run-in Period||44
171017|NCT00626392|397726|P2|STARTED|Run-in Period||44
171018|NCT00626392|397727|P1|STARTED|Run-in Period||45
171019|NCT00626327|397742|P3|NOT COMPLETED|Overall Study||88
171020|NCT00626327|397743|P2|NOT COMPLETED|Overall Study||59
171021|NCT00626327|397744|P1|NOT COMPLETED|Overall Study||78
171022|NCT00626327|397742|P3|COMPLETED|Overall Study||422
171023|NCT00626327|397743|P2|COMPLETED|Overall Study||557
171024|NCT00626327|397744|P1|COMPLETED|Overall Study||426
171025|NCT00626327|397742|P3|STARTED|Overall Study||510
171026|NCT00626327|397743|P2|STARTED|Overall Study||616
171027|NCT00626327|397744|P1|STARTED|Overall Study||504
171028|NCT00626275|397770|P8|NOT COMPLETED|Part B||1
171029|NCT00626275|397771|P7|NOT COMPLETED|Part B||1
171030|NCT00626275|397772|P6|NOT COMPLETED|Part B||0
171031|NCT00626275|397773|P5|NOT COMPLETED|Part B||0
171032|NCT00626275|397774|P4|NOT COMPLETED|Part B||0
171033|NCT00626275|397775|P3|NOT COMPLETED|Part B||0
171034|NCT00626275|397776|P2|NOT COMPLETED|Part B||0
171035|NCT00626275|397777|P1|NOT COMPLETED|Part B||0
171036|NCT00626275|397770|P8|COMPLETED|Part B||23
171037|NCT00626275|397771|P7|COMPLETED|Part B||19
171038|NCT00626275|397772|P6|COMPLETED|Part B||0
171039|NCT00626275|397773|P5|COMPLETED|Part B||0
171040|NCT00626275|397774|P4|COMPLETED|Part B||0
171041|NCT00626275|397775|P3|COMPLETED|Part B||0
171042|NCT00626275|397776|P2|COMPLETED|Part B||0
171043|NCT00626275|397777|P1|COMPLETED|Part B||0
171044|NCT00626275|397770|P8|STARTED|Part B||24
171045|NCT00626275|397771|P7|STARTED|Part B||20
171046|NCT00626275|397772|P6|STARTED|Part B||0
171047|NCT00626275|397773|P5|STARTED|Part B||0
171048|NCT00626275|397774|P4|STARTED|Part B||0
171049|NCT00626275|397775|P3|STARTED|Part B||0
171050|NCT00626275|397776|P2|STARTED|Part B||0
171051|NCT00626275|397777|P1|STARTED|Part B||0
171052|NCT00626275|397770|P8|NOT COMPLETED|Re-randomization Period for Part B||0
171053|NCT00626275|397771|P7|NOT COMPLETED|Re-randomization Period for Part B||0
171054|NCT00626275|397772|P6|NOT COMPLETED|Re-randomization Period for Part B||0
171055|NCT00626275|397773|P5|NOT COMPLETED|Re-randomization Period for Part B||0
171056|NCT00626275|397774|P4|NOT COMPLETED|Re-randomization Period for Part B||0
171057|NCT00626275|397775|P3|NOT COMPLETED|Re-randomization Period for Part B||0
171058|NCT00626275|397776|P2|NOT COMPLETED|Re-randomization Period for Part B||0
171059|NCT00626275|397777|P1|NOT COMPLETED|Re-randomization Period for Part B||0
171060|NCT00626275|397770|P8|COMPLETED|Re-randomization Period for Part B||24
171061|NCT00626275|397771|P7|COMPLETED|Re-randomization Period for Part B||20
171062|NCT00626275|397772|P6|COMPLETED|Re-randomization Period for Part B||0
171063|NCT00626275|397773|P5|COMPLETED|Re-randomization Period for Part B||0
171064|NCT00626275|397774|P4|COMPLETED|Re-randomization Period for Part B||0
171065|NCT00626275|397775|P3|COMPLETED|Re-randomization Period for Part B||0
171066|NCT00626275|397776|P2|COMPLETED|Re-randomization Period for Part B||0
171067|NCT00626275|397777|P1|COMPLETED|Re-randomization Period for Part B||0
171068|NCT00626275|397770|P8|STARTED|Re-randomization Period for Part B||24
171069|NCT00626275|397771|P7|STARTED|Re-randomization Period for Part B||20
171070|NCT00626275|397772|P6|STARTED|Re-randomization Period for Part B||0
171071|NCT00626275|397773|P5|STARTED|Re-randomization Period for Part B||0
171072|NCT00626275|397774|P4|STARTED|Re-randomization Period for Part B||0
171073|NCT00626275|397775|P3|STARTED|Re-randomization Period for Part B||0
171074|NCT00626275|397776|P2|STARTED|Re-randomization Period for Part B||0
171075|NCT00626275|397777|P1|STARTED|Re-randomization Period for Part B||0
171076|NCT00626275|397770|P8|NOT COMPLETED|Part A - Treatment Period 3||0
171077|NCT00626275|397771|P7|NOT COMPLETED|Part A - Treatment Period 3||0
171078|NCT00626275|397772|P6|NOT COMPLETED|Part A - Treatment Period 3||0
171079|NCT00626275|397773|P5|NOT COMPLETED|Part A - Treatment Period 3||0
171080|NCT00626275|397774|P4|NOT COMPLETED|Part A - Treatment Period 3||0
171081|NCT00626275|397775|P3|NOT COMPLETED|Part A - Treatment Period 3||0
171082|NCT00626275|397776|P2|NOT COMPLETED|Part A - Treatment Period 3||0
171083|NCT00626275|397777|P1|NOT COMPLETED|Part A - Treatment Period 3||0
171084|NCT00626275|397770|P8|COMPLETED|Part A - Treatment Period 3||0
171085|NCT00626275|397771|P7|COMPLETED|Part A - Treatment Period 3||0
171086|NCT00626275|397772|P6|COMPLETED|Part A - Treatment Period 3||8
171087|NCT00626275|397773|P5|COMPLETED|Part A - Treatment Period 3||9
171088|NCT00626275|397774|P4|COMPLETED|Part A - Treatment Period 3||8
171089|NCT00626275|397775|P3|COMPLETED|Part A - Treatment Period 3||6
171090|NCT00626275|397776|P2|COMPLETED|Part A - Treatment Period 3||7
171091|NCT00626275|397777|P1|COMPLETED|Part A - Treatment Period 3||6
171092|NCT00626275|397770|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
171093|NCT00626275|397771|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
171094|NCT00626275|397772|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
171095|NCT00626275|397773|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
171096|NCT00626275|397774|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
171097|NCT00626275|397775|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
171098|NCT00626275|397776|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
171099|NCT00626275|397777|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
171100|NCT00626275|397770|P8|STARTED|Part A - Treatment Period 3||0
171101|NCT00626275|397771|P7|STARTED|Part A - Treatment Period 3||0
171102|NCT00626275|397772|P6|STARTED|Part A - Treatment Period 3||8
171103|NCT00626275|397773|P5|STARTED|Part A - Treatment Period 3||9
171104|NCT00626275|397774|P4|STARTED|Part A - Treatment Period 3||8
171105|NCT00626275|397775|P3|STARTED|Part A - Treatment Period 3||6
171106|NCT00626275|397776|P2|STARTED|Part A - Treatment Period 3||7
171107|NCT00626275|397777|P1|STARTED|Part A - Treatment Period 3||6
171108|NCT00626275|397770|P8|NOT COMPLETED|Part A - Washout Period 2||0
171109|NCT00626275|397771|P7|NOT COMPLETED|Part A - Washout Period 2||0
171110|NCT00626275|397772|P6|NOT COMPLETED|Part A - Washout Period 2||0
171111|NCT00626275|397773|P5|NOT COMPLETED|Part A - Washout Period 2||0
171112|NCT00626275|397774|P4|NOT COMPLETED|Part A - Washout Period 2||0
171113|NCT00626275|397775|P3|NOT COMPLETED|Part A - Washout Period 2||0
171114|NCT00626275|397776|P2|NOT COMPLETED|Part A - Washout Period 2||0
171115|NCT00626275|397777|P1|NOT COMPLETED|Part A - Washout Period 2||0
171116|NCT00626275|397770|P8|COMPLETED|Part A - Washout Period 2||0
171117|NCT00626275|397771|P7|COMPLETED|Part A - Washout Period 2||0
171118|NCT00626275|397772|P6|COMPLETED|Part A - Washout Period 2||8
171119|NCT00626275|397773|P5|COMPLETED|Part A - Washout Period 2||9
171120|NCT00626275|397774|P4|COMPLETED|Part A - Washout Period 2||8
171121|NCT00626275|397775|P3|COMPLETED|Part A - Washout Period 2||6
171122|NCT00626275|397776|P2|COMPLETED|Part A - Washout Period 2||7
171123|NCT00626275|397777|P1|COMPLETED|Part A - Washout Period 2||6
171124|NCT00626275|397770|P8|STARTED|Part A - Washout Period 2||0
171125|NCT00626275|397771|P7|STARTED|Part A - Washout Period 2||0
171126|NCT00626275|397772|P6|STARTED|Part A - Washout Period 2||8
171127|NCT00626275|397773|P5|STARTED|Part A - Washout Period 2||9
171128|NCT00626275|397774|P4|STARTED|Part A - Washout Period 2||8
171129|NCT00626275|397775|P3|STARTED|Part A - Washout Period 2||6
171130|NCT00626275|397776|P2|STARTED|Part A - Washout Period 2||7
171131|NCT00626275|397777|P1|STARTED|Part A - Washout Period 2||6
171132|NCT00626275|397770|P8|NOT COMPLETED|Part A - Treatment Period 2||0
171133|NCT00626275|397771|P7|NOT COMPLETED|Part A - Treatment Period 2||0
171134|NCT00626275|397772|P6|NOT COMPLETED|Part A - Treatment Period 2||0
171135|NCT00626275|397773|P5|NOT COMPLETED|Part A - Treatment Period 2||0
171136|NCT00626275|397774|P4|NOT COMPLETED|Part A - Treatment Period 2||0
171137|NCT00626275|397775|P3|NOT COMPLETED|Part A - Treatment Period 2||0
171138|NCT00626275|397776|P2|NOT COMPLETED|Part A - Treatment Period 2||0
171139|NCT00626275|397777|P1|NOT COMPLETED|Part A - Treatment Period 2||0
171140|NCT00626275|397770|P8|COMPLETED|Part A - Treatment Period 2||0
171141|NCT00626275|397771|P7|COMPLETED|Part A - Treatment Period 2||0
171142|NCT00626275|397772|P6|COMPLETED|Part A - Treatment Period 2||8
171143|NCT00626275|397773|P5|COMPLETED|Part A - Treatment Period 2||9
171144|NCT00626275|397774|P4|COMPLETED|Part A - Treatment Period 2||8
171145|NCT00626275|397775|P3|COMPLETED|Part A - Treatment Period 2||6
171146|NCT00626275|397776|P2|COMPLETED|Part A - Treatment Period 2||7
171147|NCT00626275|397777|P1|COMPLETED|Part A - Treatment Period 2||6
171148|NCT00626275|397770|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
171149|NCT00626275|397771|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
171150|NCT00626275|397772|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
171151|NCT00626275|397773|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
171152|NCT00626275|397774|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
171153|NCT00626275|397775|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
171154|NCT00626275|397776|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
171155|NCT00626275|397777|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
171156|NCT00626275|397770|P8|STARTED|Part A - Treatment Period 2||0
171157|NCT00626275|397771|P7|STARTED|Part A - Treatment Period 2||0
171158|NCT00626275|397772|P6|STARTED|Part A - Treatment Period 2||8
171159|NCT00626275|397773|P5|STARTED|Part A - Treatment Period 2||9
171160|NCT00626275|397774|P4|STARTED|Part A - Treatment Period 2||8
171161|NCT00626275|397775|P3|STARTED|Part A - Treatment Period 2||6
171162|NCT00626275|397776|P2|STARTED|Part A - Treatment Period 2||7
171163|NCT00626275|397777|P1|STARTED|Part A - Treatment Period 2||6
171164|NCT00626275|397770|P8|NOT COMPLETED|Part A - Washout Period 1||0
171165|NCT00626275|397771|P7|NOT COMPLETED|Part A - Washout Period 1||0
171166|NCT00626275|397772|P6|NOT COMPLETED|Part A - Washout Period 1||0
171167|NCT00626275|397773|P5|NOT COMPLETED|Part A - Washout Period 1||0
171168|NCT00626275|397774|P4|NOT COMPLETED|Part A - Washout Period 1||0
171169|NCT00626275|397775|P3|NOT COMPLETED|Part A - Washout Period 1||0
171170|NCT00626275|397776|P2|NOT COMPLETED|Part A - Washout Period 1||0
171171|NCT00626275|397777|P1|NOT COMPLETED|Part A - Washout Period 1||0
171172|NCT00626275|397770|P8|COMPLETED|Part A - Washout Period 1||0
171173|NCT00626275|397771|P7|COMPLETED|Part A - Washout Period 1||0
171174|NCT00626275|397772|P6|COMPLETED|Part A - Washout Period 1||8
171175|NCT00626275|397773|P5|COMPLETED|Part A - Washout Period 1||9
171176|NCT00626275|397774|P4|COMPLETED|Part A - Washout Period 1||8
171177|NCT00626275|397775|P3|COMPLETED|Part A - Washout Period 1||6
171178|NCT00626275|397776|P2|COMPLETED|Part A - Washout Period 1||7
171179|NCT00626275|397777|P1|COMPLETED|Part A - Washout Period 1||6
171180|NCT00626275|397770|P8|STARTED|Part A - Washout Period 1||0
171181|NCT00626275|397771|P7|STARTED|Part A - Washout Period 1||0
171182|NCT00626275|397772|P6|STARTED|Part A - Washout Period 1||8
171183|NCT00626275|397773|P5|STARTED|Part A - Washout Period 1||9
171184|NCT00626275|397774|P4|STARTED|Part A - Washout Period 1||8
171185|NCT00626275|397775|P3|STARTED|Part A - Washout Period 1||6
171186|NCT00626275|397776|P2|STARTED|Part A - Washout Period 1||7
171187|NCT00626275|397777|P1|STARTED|Part A - Washout Period 1||6
171188|NCT00626275|397770|P8|NOT COMPLETED|Part A - Treatment Period 1||0
171189|NCT00626275|397771|P7|NOT COMPLETED|Part A - Treatment Period 1||0
171190|NCT00626275|397772|P6|NOT COMPLETED|Part A - Treatment Period 1||0
171191|NCT00626275|397773|P5|NOT COMPLETED|Part A - Treatment Period 1||0
171192|NCT00626275|397774|P4|NOT COMPLETED|Part A - Treatment Period 1||0
171193|NCT00626275|397775|P3|NOT COMPLETED|Part A - Treatment Period 1||1
171194|NCT00626275|397776|P2|NOT COMPLETED|Part A - Treatment Period 1||0
171195|NCT00626275|397777|P1|NOT COMPLETED|Part A - Treatment Period 1||1
171196|NCT00626275|397770|P8|COMPLETED|Part A - Treatment Period 1||0
171197|NCT00626275|397771|P7|COMPLETED|Part A - Treatment Period 1||0
171198|NCT00626275|397772|P6|COMPLETED|Part A - Treatment Period 1||8
171199|NCT00626275|397773|P5|COMPLETED|Part A - Treatment Period 1||9
171200|NCT00626275|397774|P4|COMPLETED|Part A - Treatment Period 1||8
171201|NCT00626275|397775|P3|COMPLETED|Part A - Treatment Period 1||6
171202|NCT00626275|397776|P2|COMPLETED|Part A - Treatment Period 1||7
171203|NCT00626275|397777|P1|COMPLETED|Part A - Treatment Period 1||6
171204|NCT00626275|397770|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
171205|NCT00626275|397771|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
171206|NCT00626275|397772|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
171207|NCT00626275|397773|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
171208|NCT00626275|397774|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
171209|NCT00626275|397775|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
171210|NCT00626275|397776|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
171211|NCT00626275|397777|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
171212|NCT00626275|397770|P8|STARTED|Part A - Treatment Period 1||0
171213|NCT00626275|397771|P7|STARTED|Part A - Treatment Period 1||0
171214|NCT00626275|397772|P6|STARTED|Part A - Treatment Period 1||8
171215|NCT00626275|397773|P5|STARTED|Part A - Treatment Period 1||9
171216|NCT00626275|397774|P4|STARTED|Part A - Treatment Period 1||8
171217|NCT00626275|397775|P3|STARTED|Part A - Treatment Period 1||7
171218|NCT00626275|397776|P2|STARTED|Part A - Treatment Period 1||7
171219|NCT00626275|397777|P1|STARTED|Part A - Treatment Period 1||7
171220|NCT00626210|397817|P1|NOT COMPLETED|Overall Study||0
171221|NCT00626210|397817|P1|COMPLETED|Overall Study||2
171222|NCT00626210|397817|P1|STARTED|Overall Study||2
171223|NCT00626093|397821|P1|NOT COMPLETED|Overall Study||23
171224|NCT00626093|397821|P1|COMPLETED|Overall Study||54
171225|NCT00626093|397821|P1|STARTED|Overall Study||77
171226|NCT00626028|397828|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
171227|NCT00626028|397829|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
171228|NCT00626028|397828|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
171229|NCT00626028|397829|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
171230|NCT00626028|397828|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
171231|NCT00626028|397829|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
171232|NCT00626028|397828|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
171233|NCT00626028|397829|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
171234|NCT00626028|397828|P2|COMPLETED|Washout Period of 10 Minutes||59
171235|NCT00626028|397829|P1|COMPLETED|Washout Period of 10 Minutes||62
171236|NCT00626028|397828|P2|STARTED|Washout Period of 10 Minutes||59
171237|NCT00626028|397829|P1|STARTED|Washout Period of 10 Minutes||62
171238|NCT00626028|397828|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
171239|NCT00626028|397829|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
171240|NCT00626028|397828|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
171241|NCT00626028|397829|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
171242|NCT00626028|397828|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
171243|NCT00626028|397829|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
171244|NCT00626028|397828|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
171245|NCT00626028|397829|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
171246|NCT00626028|397828|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
171247|NCT00626028|397829|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
171248|NCT00626028|397828|P2|STARTED|Treatment 1 NO First, O2 Last||68
171249|NCT00626028|397829|P1|STARTED|Treatment 1 NO First, O2 Last||68
171250|NCT00625989|397839|P2|NOT COMPLETED|Overall Study||0
171251|NCT00625989|397840|P1|NOT COMPLETED|Overall Study||0
171252|NCT00625989|397839|P2|COMPLETED|Overall Study||6
171253|NCT00625989|397840|P1|COMPLETED|Overall Study||6
171254|NCT00625989|397839|P2|STARTED|Overall Study||6
171255|NCT00625989|397840|P1|STARTED|Overall Study||6
171256|NCT00625872|397849|P2|NOT COMPLETED|Overall Study||6
171257|NCT00625872|397850|P1|NOT COMPLETED|Overall Study||4
171258|NCT00625872|397849|P2|COMPLETED|Overall Study||5
171259|NCT00625872|397850|P1|COMPLETED|Overall Study||8
171260|NCT00625872|397849|P2|Treated|Overall Study||10
171261|NCT00625872|397850|P1|Treated|Overall Study||12
171262|NCT00625872|397849|P2|STARTED|Overall Study||11
171263|NCT00625872|397850|P1|STARTED|Overall Study||12
171264|NCT00625820|397960|P1|NOT COMPLETED|Overall Study||1
171265|NCT00625820|397960|P1|COMPLETED|Overall Study||16
171266|NCT00625820|397960|P1|STARTED|Overall Study||17
171267|NCT00625742|397966|P1|NOT COMPLETED|Overall Study||12
171268|NCT00625742|397966|P1|COMPLETED|Overall Study||3
171269|NCT00625742|397966|P1|STARTED|Overall Study||15
171270|NCT00625729|397971|P1|NOT COMPLETED|Overall Study||0
171271|NCT00625729|397971|P1|COMPLETED|Overall Study||6
171272|NCT00625729|397971|P1|STARTED|Overall Study||6
171273|NCT00625586|397980|P1|NOT COMPLETED|Overall Study||1
171274|NCT00625586|397980|P1|COMPLETED|Overall Study||1
171275|NCT00625586|397980|P1|STARTED|Overall Study||2
171276|NCT00625404|397992|P2|NOT COMPLETED|Overall Study||173
171277|NCT00625404|397993|P1|NOT COMPLETED|Overall Study||207
171278|NCT00625404|397992|P2|COMPLETED|Overall Study||885
171279|NCT00625404|397993|P1|COMPLETED|Overall Study||855
171280|NCT00625404|397992|P2|STARTED|Overall Study||1058
171281|NCT00625404|397993|P1|STARTED|Overall Study||1062
171282|NCT00625391|398023|P4|NOT COMPLETED|Overall Study||1
171283|NCT00625391|398024|P3|NOT COMPLETED|Overall Study||5
171284|NCT00625391|398025|P2|NOT COMPLETED|Overall Study||8
171285|NCT00625391|398026|P1|NOT COMPLETED|Overall Study||7
171286|NCT00625391|398023|P4|COMPLETED|Overall Study||37
171287|NCT00625391|398024|P3|COMPLETED|Overall Study||37
171288|NCT00625391|398025|P2|COMPLETED|Overall Study||39
171289|NCT00625391|398026|P1|COMPLETED|Overall Study||37
171290|NCT00625391|398023|P4|STARTED|Overall Study||38
171291|NCT00625391|398024|P3|STARTED|Overall Study||42
171292|NCT00625391|398025|P2|STARTED|Overall Study||47
171293|NCT00625391|398026|P1|STARTED|Overall Study||44
171294|NCT00625365|398040|P1|NOT COMPLETED|Overall Study||7
171295|NCT00625365|398040|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
171296|NCT00625365|398040|P1|STARTED|Overall Study||1060
171297|NCT00625183|398046|P1|NOT COMPLETED|Overall Study||1
171298|NCT00625183|398046|P1|COMPLETED|Overall Study||4
171299|NCT00625183|398046|P1|STARTED|Overall Study||5
171300|NCT00625131|398055|P3|NOT COMPLETED|Overall Study||5
171301|NCT00625131|398056|P2|NOT COMPLETED|Overall Study||2
171302|NCT00625131|398057|P1|NOT COMPLETED|Overall Study||4
171303|NCT00625131|398055|P3|COMPLETED|Overall Study||0
171304|NCT00625131|398056|P2|COMPLETED|Overall Study||42
171305|NCT00625131|398057|P1|COMPLETED|Overall Study||34
171306|NCT00625131|398055|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
171307|NCT00625131|398056|P2|STARTED|Overall Study||44
171308|NCT00625131|398057|P1|STARTED|Overall Study||38
171309|NCT00624832|398071|P4|NOT COMPLETED|Overall Study||1
171310|NCT00624832|398072|P3|NOT COMPLETED|Overall Study||0
171311|NCT00624832|398073|P2|NOT COMPLETED|Overall Study||1
171312|NCT00624832|398074|P1|NOT COMPLETED|Overall Study||2
171313|NCT00624832|398071|P4|COMPLETED|Overall Study||15
171314|NCT00624832|398072|P3|COMPLETED|Overall Study||10
171315|NCT00624832|398073|P2|COMPLETED|Overall Study||15
171316|NCT00624832|398074|P1|COMPLETED|Overall Study||16
171317|NCT00624832|398071|P4|STARTED|Overall Study||16
171318|NCT00624832|398072|P3|STARTED|Overall Study||10
171319|NCT00624832|398073|P2|STARTED|Overall Study||16
171320|NCT00624832|398074|P1|STARTED|Overall Study||18
171321|NCT00624806|398088|P2|NOT COMPLETED|Overall Study||0
171322|NCT00624806|398089|P1|NOT COMPLETED|Overall Study||0
171323|NCT00624806|398088|P2|COMPLETED|Overall Study||8
171324|NCT00624806|398089|P1|COMPLETED|Overall Study||10
171325|NCT00624806|398088|P2|STARTED|Overall Study||8
171326|NCT00624806|398089|P1|STARTED|Overall Study||10
171327|NCT00624780|398105|P6|NOT COMPLETED|Follow-up (Week 26)||0
171328|NCT00624780|398106|P5|NOT COMPLETED|Follow-up (Week 26)||2
171329|NCT00624780|398107|P4|NOT COMPLETED|Follow-up (Week 26)||0
171330|NCT00624780|398108|P3|NOT COMPLETED|Follow-up (Week 26)||2
171331|NCT00624780|398109|P2|NOT COMPLETED|Follow-up (Week 26)||1
171332|NCT00624780|398110|P1|NOT COMPLETED|Follow-up (Week 26)||2
171333|NCT00624780|398105|P6|COMPLETED|Follow-up (Week 26)||29
171334|NCT00624780|398106|P5|COMPLETED|Follow-up (Week 26)||93
171335|NCT00624780|398107|P4|COMPLETED|Follow-up (Week 26)||26
171336|NCT00624780|398108|P3|COMPLETED|Follow-up (Week 26)||89
171337|NCT00624780|398109|P2|COMPLETED|Follow-up (Week 26)||27
171338|NCT00624780|398110|P1|COMPLETED|Follow-up (Week 26)||102
171339|NCT00624780|398105|P6|STARTED|Follow-up (Week 26)||29
171340|NCT00624780|398106|P5|STARTED|Follow-up (Week 26)||95
171341|NCT00624780|398107|P4|STARTED|Follow-up (Week 26)||26
171342|NCT00624780|398108|P3|STARTED|Follow-up (Week 26)||91
171343|NCT00624780|398109|P2|STARTED|Follow-up (Week 26)||28
171344|NCT00624780|398110|P1|STARTED|Follow-up (Week 26)||104
171345|NCT00624780|398105|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
171346|NCT00624780|398106|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
171347|NCT00624780|398107|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
171348|NCT00624780|398108|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
171349|NCT00624780|398109|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
171350|NCT00624780|398110|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
171351|NCT00624780|398105|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
171352|NCT00624780|398106|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
171353|NCT00624780|398107|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
171354|NCT00624780|398108|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
171355|NCT00624780|398109|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
171356|NCT00624780|398110|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
171357|NCT00624780|398105|P6|STARTED|Treatment Discontinuation (Week 25)||30
171358|NCT00624780|398106|P5|STARTED|Treatment Discontinuation (Week 25)||95
171359|NCT00624780|398107|P4|STARTED|Treatment Discontinuation (Week 25)||27
171360|NCT00624780|398108|P3|STARTED|Treatment Discontinuation (Week 25)||94
171361|NCT00624780|398109|P2|STARTED|Treatment Discontinuation (Week 25)||28
171362|NCT00624780|398110|P1|STARTED|Treatment Discontinuation (Week 25)||106
171363|NCT00624780|398105|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
171364|NCT00624780|398106|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
171365|NCT00624780|398107|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
171366|NCT00624780|398108|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
171367|NCT00624780|398109|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
171368|NCT00624780|398110|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
171369|NCT00624780|398105|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
171370|NCT00624780|398106|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
171371|NCT00624780|398107|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
171372|NCT00624780|398108|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
171373|NCT00624780|398109|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
171374|NCT00624780|398110|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
171375|NCT00624780|398105|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
171376|NCT00624780|398106|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
171377|NCT00624780|398107|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
171378|NCT00624780|398108|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
171379|NCT00624780|398109|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
171380|NCT00624780|398110|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
171381|NCT00624780|398105|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
171382|NCT00624780|398106|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
171383|NCT00624780|398107|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
171384|NCT00624780|398108|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
171385|NCT00624780|398109|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
171386|NCT00624780|398110|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
171387|NCT00624780|398105|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
171388|NCT00624780|398106|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
171389|NCT00624780|398107|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
171390|NCT00624780|398108|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
171391|NCT00624780|398109|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
171392|NCT00624780|398110|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
171393|NCT00624780|398105|P6|STARTED|Treatment Optimization (Up to Week 12)||50
171394|NCT00624780|398106|P5|STARTED|Treatment Optimization (Up to Week 12)||153
171395|NCT00624780|398107|P4|STARTED|Treatment Optimization (Up to Week 12)||52
171396|NCT00624780|398108|P3|STARTED|Treatment Optimization (Up to Week 12)||154
171397|NCT00624780|398109|P2|STARTED|Treatment Optimization (Up to Week 12)||52
171398|NCT00624780|398110|P1|STARTED|Treatment Optimization (Up to Week 12)||154
171399|NCT00624585|398292|P1|NOT COMPLETED|Overall Study||12
171400|NCT00624585|398292|P1|COMPLETED|Overall Study||6
171401|NCT00624585|398292|P1|STARTED|Overall Study||18
171402|NCT00624559|398303|P4|NOT COMPLETED|Overall Study||0
171403|NCT00624559|398304|P3|NOT COMPLETED|Overall Study||0
171404|NCT00624559|398305|P2|NOT COMPLETED|Overall Study||0
171405|NCT00624559|398306|P1|NOT COMPLETED|Overall Study||0
171406|NCT00624559|398303|P4|COMPLETED|Overall Study||3
171407|NCT00624559|398304|P3|COMPLETED|Overall Study||3
171408|NCT00624559|398305|P2|COMPLETED|Overall Study||3
171409|NCT00624559|398306|P1|COMPLETED|Overall Study||3
171410|NCT00624559|398303|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
171411|NCT00624559|398304|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
171412|NCT00624559|398305|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
171413|NCT00624559|398306|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
171414|NCT00624520|398322|P2|NOT COMPLETED|Overall Study||8
171415|NCT00624520|398323|P1|NOT COMPLETED|Overall Study||12
171416|NCT00624520|398322|P2|COMPLETED|Overall Study||39
171417|NCT00624520|398323|P1|COMPLETED|Overall Study||44
171418|NCT00624520|398322|P2|STARTED|Overall Study||47
171419|NCT00624520|398323|P1|STARTED|Overall Study||56
171420|NCT00624468|398350|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
171421|NCT00624468|398351|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
171422|NCT00624468|398352|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
171423|NCT00624468|398353|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
171424|NCT00624468|398350|P4|COMPLETED|Safety Follow-up (SFU) Period||11
171425|NCT00624468|398351|P3|COMPLETED|Safety Follow-up (SFU) Period||11
171426|NCT00624468|398352|P2|COMPLETED|Safety Follow-up (SFU) Period||0
171427|NCT00624468|398353|P1|COMPLETED|Safety Follow-up (SFU) Period||0
171428|NCT00624468|398350|P4|STARTED|Safety Follow-up (SFU) Period||14
171429|NCT00624468|398351|P3|STARTED|Safety Follow-up (SFU) Period||13
171430|NCT00624468|398352|P2|STARTED|Safety Follow-up (SFU) Period||0
171431|NCT00624468|398353|P1|STARTED|Safety Follow-up (SFU) Period||0
171432|NCT00624468|398350|P4|NOT COMPLETED|Double-blind Period||0
171433|NCT00624468|398351|P3|NOT COMPLETED|Double-blind Period||0
171434|NCT00624468|398352|P2|NOT COMPLETED|Double-blind Period||13
171435|NCT00624468|398353|P1|NOT COMPLETED|Double-blind Period||14
171436|NCT00624468|398350|P4|COMPLETED|Double-blind Period||0
171437|NCT00624468|398351|P3|COMPLETED|Double-blind Period||0
171438|NCT00624468|398352|P2|COMPLETED|Double-blind Period||4
171439|NCT00624468|398353|P1|COMPLETED|Double-blind Period||3
171440|NCT00624468|398350|P4|STARTED|Double-blind Period||0
171441|NCT00624468|398351|P3|STARTED|Double-blind Period||0
171442|NCT00624468|398352|P2|STARTED|Double-blind Period||17
171443|NCT00624468|398353|P1|STARTED|Double-blind Period||17
171444|NCT00624442|398384|P5|NOT COMPLETED|Overall Study||2
171445|NCT00624442|398385|P4|NOT COMPLETED|Overall Study||0
171446|NCT00624442|398386|P3|NOT COMPLETED|Overall Study||2
171447|NCT00624442|398387|P2|NOT COMPLETED|Overall Study||1
171448|NCT00624442|398388|P1|NOT COMPLETED|Overall Study||0
171449|NCT00624442|398384|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
171450|NCT00624442|398385|P4|COMPLETED|Overall Study||8
171451|NCT00624442|398386|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
171452|NCT00624442|398387|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
171453|NCT00624442|398388|P1|COMPLETED|Overall Study||8
171454|NCT00624442|398384|P5|STARTED|Overall Study||10
171455|NCT00624442|398385|P4|STARTED|Overall Study||8
171456|NCT00624442|398386|P3|STARTED|Overall Study||10
171457|NCT00624442|398387|P2|STARTED|Overall Study||9
171458|NCT00624442|398388|P1|STARTED|Overall Study||8
171459|NCT00624416|398414|P1|NOT COMPLETED|Overall Study||0
171460|NCT00624416|398414|P1|COMPLETED|Overall Study||10
171461|NCT00624416|398414|P1|STARTED|Overall Study||10
171462|NCT00624377|398420|P1|NOT COMPLETED|Overall Study||644
171463|NCT00624377|398420|P1|COMPLETED|Overall Study||1387
171464|NCT00624377|398420|P1|STARTED|Overall Study||2031
171465|NCT00624338|398434|P3|NOT COMPLETED|Overall Study||46
171466|NCT00624338|398435|P2|NOT COMPLETED|Overall Study||83
171467|NCT00624338|398436|P1|NOT COMPLETED|Overall Study||47
171468|NCT00624338|398434|P3|COMPLETED|Overall Study||111
171469|NCT00624338|398435|P2|COMPLETED|Overall Study||62
171470|NCT00624338|398436|P1|COMPLETED|Overall Study||112
171471|NCT00624338|398434|P3|Treated|Overall Study||154
171472|NCT00624338|398435|P2|Treated|Overall Study||144
171473|NCT00624338|398436|P1|Treated|Overall Study||157
171474|NCT00624338|398434|P3|STARTED|Overall Study||157
171475|NCT00624338|398435|P2|STARTED|Overall Study||145
171476|NCT00624338|398436|P1|STARTED|Overall Study||159
171477|NCT00624286|398458|P2|NOT COMPLETED|Overall Study||27
171478|NCT00624286|398459|P1|NOT COMPLETED|Overall Study||25
171479|NCT00624286|398458|P2|COMPLETED|Overall Study||178
171480|NCT00624286|398459|P1|COMPLETED|Overall Study||186
171481|NCT00624286|398458|P2|STARTED|Overall Study||205
171482|NCT00624286|398459|P1|STARTED|Overall Study||211
171483|NCT00624221|398469|P2|NOT COMPLETED|Overall Study||0
171484|NCT00624221|398470|P1|NOT COMPLETED|Overall Study||0
171485|NCT00624221|398469|P2|COMPLETED|Overall Study||20
171486|NCT00624221|398470|P1|COMPLETED|Overall Study||20
171487|NCT00624221|398469|P2|STARTED|Overall Study||20
171488|NCT00624221|398470|P1|STARTED|Overall Study||20
171489|NCT00624195|398478|P2|NOT COMPLETED|Overall Study||7
171490|NCT00624195|398479|P1|NOT COMPLETED|Overall Study||3
171491|NCT00624195|398478|P2|COMPLETED|Overall Study||23
171492|NCT00624195|398479|P1|COMPLETED|Overall Study||26
171493|NCT00624195|398478|P2|STARTED|Overall Study||30
171494|NCT00624195|398479|P1|STARTED|Overall Study||29
171495|NCT00624065|398487|P2|NOT COMPLETED|Overall Study||24
171496|NCT00624065|398488|P1|NOT COMPLETED|Overall Study||19
171497|NCT00624065|398487|P2|COMPLETED|Overall Study||192
171498|NCT00624065|398488|P1|COMPLETED|Overall Study||197
171499|NCT00624065|398487|P2|STARTED|Overall Study||216
171500|NCT00624065|398488|P1|STARTED|Overall Study||216
171501|NCT00624052|398500|P4|NOT COMPLETED|Overall Study||4
171502|NCT00624052|398501|P3|NOT COMPLETED|Overall Study||3
171503|NCT00624052|398502|P2|NOT COMPLETED|Overall Study||14
171504|NCT00624052|398503|P1|NOT COMPLETED|Overall Study||15
171505|NCT00624052|398500|P4|COMPLETED|Overall Study||88
171506|NCT00624052|398501|P3|COMPLETED|Overall Study||88
171507|NCT00624052|398502|P2|COMPLETED|Overall Study||422
171508|NCT00624052|398503|P1|COMPLETED|Overall Study||204
171509|NCT00624052|398500|P4|STARTED|Overall Study||92
171510|NCT00624052|398501|P3|STARTED|Overall Study||91
171511|NCT00624052|398502|P2|STARTED|Overall Study||436
171512|NCT00624052|398503|P1|STARTED|Overall Study||219
171513|NCT00623974|398556|P4|NOT COMPLETED|Overall Study||0
171514|NCT00623974|398557|P3|NOT COMPLETED|Overall Study||0
171515|NCT00623974|398558|P2|NOT COMPLETED|Overall Study||0
171516|NCT00623974|398559|P1|NOT COMPLETED|Overall Study||0
171517|NCT00623974|398556|P4|COMPLETED|Overall Study||0
171518|NCT00623974|398557|P3|COMPLETED|Overall Study||0
171519|NCT00623974|398558|P2|COMPLETED|Overall Study||0
171520|NCT00623974|398559|P1|COMPLETED|Overall Study||0
171521|NCT00623974|398556|P4|STARTED|Overall Study||0
171522|NCT00623974|398557|P3|STARTED|Overall Study||0
171523|NCT00623974|398558|P2|STARTED|Overall Study||0
171524|NCT00623974|398559|P1|STARTED|Overall Study||0
171525|NCT00623935|398569|P1|NOT COMPLETED|Overall Study||2
171526|NCT00623935|398569|P1|COMPLETED|Overall Study||54
171527|NCT00623935|398569|P1|STARTED|Overall Study||56
171528|NCT00623831|398576|P2|NOT COMPLETED|Overall Study||1
171529|NCT00623831|398577|P1|NOT COMPLETED|Overall Study||1
171530|NCT00623831|398576|P2|COMPLETED|Overall Study||3
171531|NCT00623831|398577|P1|COMPLETED|Overall Study||12
171532|NCT00623831|398576|P2|STARTED|Overall Study||4
171533|NCT00623831|398577|P1|STARTED|Overall Study||13
171534|NCT00623805|398589|P2|NOT COMPLETED|Overall Study||22
171535|NCT00623805|398590|P1|NOT COMPLETED|Overall Study||20
171536|NCT00623805|398589|P2|COMPLETED|Overall Study||39
171537|NCT00623805|398590|P1|COMPLETED|Overall Study||42
171538|NCT00623805|398589|P2|STARTED|Overall Study||61
171539|NCT00623805|398590|P1|STARTED|Overall Study||62
171540|NCT00623779|398607|P3|NOT COMPLETED|Overall Study||1
171541|NCT00623779|398608|P2|NOT COMPLETED|Overall Study||3
171542|NCT00623779|398609|P1|NOT COMPLETED|Overall Study||3
171543|NCT00623779|398607|P3|COMPLETED|Overall Study||44
171544|NCT00623779|398608|P2|COMPLETED|Overall Study||39
171545|NCT00623779|398609|P1|COMPLETED|Overall Study||38
171546|NCT00623779|398607|P3|STARTED|Overall Study||45
171547|NCT00623779|398608|P2|STARTED|Overall Study||42
171548|NCT00623779|398609|P1|STARTED|Overall Study||41
171549|NCT00623766|398658|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
171550|NCT00623766|398659|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
171551|NCT00623766|398658|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
171552|NCT00623766|398659|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
171553|NCT00623766|398658|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
171554|NCT00623766|398659|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
171555|NCT00623766|398658|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
171556|NCT00623766|398659|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
171557|NCT00623766|398658|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
171558|NCT00623766|398659|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
171559|NCT00623766|398658|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
171560|NCT00623766|398659|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
171561|NCT00623727|398683|P2|NOT COMPLETED|Open Label Extension Period||0
171562|NCT00623727|398684|P1|NOT COMPLETED|Open Label Extension Period||0
171563|NCT00623727|398683|P2|COMPLETED|Open Label Extension Period||0
171564|NCT00623727|398684|P1|COMPLETED|Open Label Extension Period||20
171565|NCT00623727|398683|P2|STARTED|Open Label Extension Period||0
171566|NCT00623727|398684|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
171567|NCT00623727|398683|P2|NOT COMPLETED|Open Label Follow-up||8
171568|NCT00623727|398684|P1|NOT COMPLETED|Open Label Follow-up||0
171569|NCT00623727|398683|P2|COMPLETED|Open Label Follow-up||18
171570|NCT00623727|398684|P1|COMPLETED|Open Label Follow-up||0
171571|NCT00623727|398683|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
171572|NCT00623727|398684|P1|STARTED|Open Label Follow-up||0
171573|NCT00623727|398683|P2|NOT COMPLETED|Double Blind (DB)||32
171574|NCT00623727|398684|P1|NOT COMPLETED|Double Blind (DB)||36
171575|NCT00623727|398683|P2|COMPLETED|Double Blind (DB)||41
171576|NCT00623727|398684|P1|COMPLETED|Double Blind (DB)||34
171577|NCT00623727|398683|P2|Participants Received Treatment|Double Blind (DB)||72
171578|NCT00623727|398684|P1|Participants Received Treatment|Double Blind (DB)||67
171579|NCT00623727|398683|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
171580|NCT00623727|398684|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
171581|NCT00623714|398704|P2|NOT COMPLETED|Period 2||0
171582|NCT00623714|398705|P1|NOT COMPLETED|Period 2||0
171583|NCT00623714|398704|P2|COMPLETED|Period 2||7
171584|NCT00623714|398705|P1|COMPLETED|Period 2||6
171585|NCT00623714|398704|P2|STARTED|Period 2||7
171586|NCT00623714|398705|P1|STARTED|Period 2||6
171587|NCT00623714|398704|P2|NOT COMPLETED|Period 1||0
171588|NCT00623714|398705|P1|NOT COMPLETED|Period 1||0
171589|NCT00623714|398704|P2|COMPLETED|Period 1||7
171590|NCT00623714|398705|P1|COMPLETED|Period 1||6
171591|NCT00623714|398704|P2|STARTED|Period 1||7
171592|NCT00623714|398705|P1|STARTED|Period 1||6
171593|NCT00623636|398715|P2|NOT COMPLETED|Open Label||412
171594|NCT00623636|398716|P1|NOT COMPLETED|Open Label||0
171595|NCT00623636|398715|P2|COMPLETED|Open Label||263
171596|NCT00623636|398716|P1|COMPLETED|Open Label||0
171597|NCT00623636|398715|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
171598|NCT00623636|398716|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
171599|NCT00623636|398715|P2|NOT COMPLETED|Double Blind||28
171600|NCT00623636|398716|P1|NOT COMPLETED|Double Blind||33
171601|NCT00623636|398715|P2|COMPLETED|Double Blind||422
171602|NCT00623636|398716|P1|COMPLETED|Double Blind||419
171603|NCT00623636|398715|P2|STARTED|Double Blind||450
171604|NCT00623636|398716|P1|STARTED|Double Blind||452
171605|NCT00623597|398739|P2|NOT COMPLETED|Overall Study||0
171606|NCT00623597|398740|P1|NOT COMPLETED|Overall Study||1
171607|NCT00623597|398739|P2|COMPLETED|Overall Study||13
171608|NCT00623597|398740|P1|COMPLETED|Overall Study||4
171609|NCT00623597|398739|P2|STARTED|Overall Study||13
171610|NCT00623597|398740|P1|STARTED|Overall Study||5
171611|NCT00623545|398803|P1|NOT COMPLETED|Overall Study||10
171612|NCT00623545|398803|P1|COMPLETED|Overall Study||18
171613|NCT00623545|398803|P1|STARTED|Overall Study||28
171614|NCT00623506|398810|P2|NOT COMPLETED|Overall Study||4
171615|NCT00623506|398811|P1|NOT COMPLETED|Overall Study||4
171616|NCT00623506|398810|P2|COMPLETED|Overall Study||11
171617|NCT00623506|398811|P1|COMPLETED|Overall Study||11
171618|NCT00623506|398810|P2|Week 4|Overall Study||11
171619|NCT00623506|398811|P1|Week 4|Overall Study||11
171620|NCT00623506|398810|P2|STARTED|Overall Study||15
171621|NCT00623506|398811|P1|STARTED|Overall Study||15
171622|NCT00623480|398823|P2|NOT COMPLETED|Overall Study||7
171623|NCT00623480|398824|P1|NOT COMPLETED|Overall Study||7
171624|NCT00623480|398823|P2|COMPLETED|Overall Study||35
171625|NCT00623480|398824|P1|COMPLETED|Overall Study||35
171626|NCT00623480|398823|P2|STARTED|Overall Study||42
171627|NCT00623480|398824|P1|STARTED|Overall Study||42
171628|NCT00623467|398836|P1|NOT COMPLETED|Overall Study||7
171629|NCT00623467|398836|P1|COMPLETED|Overall Study||336
171630|NCT00623467|398836|P1|STARTED|Overall Study||343
171631|NCT00623441|398900|P1|NOT COMPLETED|Overall Study||0
171632|NCT00623441|398900|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
171633|NCT00623441|398900|P1|STARTED|Overall Study||8314
171634|NCT00623428|398906|P2|NOT COMPLETED|Follow-up Period||15
171635|NCT00623428|398907|P1|NOT COMPLETED|Follow-up Period||29
171636|NCT00623428|398906|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
171637|NCT00623428|398907|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
171638|NCT00623428|398906|P2|STARTED|Follow-up Period||93
171639|NCT00623428|398907|P1|STARTED|Follow-up Period||95
171640|NCT00623428|398906|P2|NOT COMPLETED|Treatment Period||27
171641|NCT00623428|398907|P1|NOT COMPLETED|Treatment Period||0
171642|NCT00623428|398906|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
171643|NCT00623428|398907|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
171644|NCT00623428|398906|P2|STARTED|Treatment Period||93
171645|NCT00623428|398907|P1|STARTED|Treatment Period||95
171646|NCT00623233|398925|P1|NOT COMPLETED|Overall Study||24
171647|NCT00623233|398925|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
171648|NCT00623233|398925|P1|STARTED|Overall Study||52
171649|NCT00623194|398932|P1|NOT COMPLETED|Overall Study||5
171650|NCT00623194|398932|P1|COMPLETED|Overall Study||141
171651|NCT00623194|398932|P1|STARTED|Overall Study||146
171652|NCT00623181|398954|P2|NOT COMPLETED|Overall Study||0
171653|NCT00623181|398955|P1|NOT COMPLETED|Overall Study||0
171654|NCT00623181|398954|P2|COMPLETED|Overall Study||54
171655|NCT00623181|398955|P1|COMPLETED|Overall Study||56
171656|NCT00623181|398954|P2|STARTED|Overall Study||54
171657|NCT00623181|398955|P1|STARTED|Overall Study||56
171658|NCT00623103|398969|P2|NOT COMPLETED|Overall Study||113
171659|NCT00623103|398970|P1|NOT COMPLETED|Overall Study||111
171660|NCT00623103|398969|P2|COMPLETED|Overall Study||175
171661|NCT00623103|398970|P1|COMPLETED|Overall Study||184
171662|NCT00623103|398969|P2|Safety Set: Received Study Drug|Overall Study||288
171663|NCT00623103|398970|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
171664|NCT00623103|398969|P2|STARTED|Overall Study||288
171665|NCT00623103|398970|P1|STARTED|Overall Study||295
171666|NCT00623012|398990|P1|NOT COMPLETED|Overall Study||0
171667|NCT00623012|398990|P1|COMPLETED|Overall Study||2
171668|NCT00623012|398990|P1|STARTED|Overall Study||2
171669|NCT00622908|398998|P2|NOT COMPLETED|Overall Study||10
171670|NCT00622908|398999|P1|NOT COMPLETED|Overall Study||3
171671|NCT00622908|398998|P2|COMPLETED|Overall Study||122
171672|NCT00622908|398999|P1|COMPLETED|Overall Study||134
171673|NCT00622908|398998|P2|STARTED|Overall Study|Intent to treat population|132
171674|NCT00622908|398999|P1|STARTED|Overall Study|Intent to treat population|137
171675|NCT00622869|399014|P3|NOT COMPLETED|Overall Study||39
171676|NCT00622869|399015|P2|NOT COMPLETED|Overall Study||57
171677|NCT00622869|399016|P1|NOT COMPLETED|Overall Study||43
171678|NCT00622869|399014|P3|COMPLETED|Overall Study||204
171679|NCT00622869|399015|P2|COMPLETED|Overall Study||174
171680|NCT00622869|399016|P1|COMPLETED|Overall Study||202
171681|NCT00622869|399014|P3|STARTED|Overall Study||243
171682|NCT00622869|399015|P2|STARTED|Overall Study||231
171683|NCT00622869|399016|P1|STARTED|Overall Study||245
171684|NCT00622739|399035|P2|NOT COMPLETED|Overall Study||6
171685|NCT00622739|399036|P1|NOT COMPLETED|Overall Study||2
171686|NCT00622739|399035|P2|COMPLETED|Overall Study||9
171687|NCT00622739|399036|P1|COMPLETED|Overall Study||11
171688|NCT00622739|399035|P2|STARTED|Overall Study||15
171689|NCT00622739|399036|P1|STARTED|Overall Study||13
171690|NCT00622726|399044|P2|NOT COMPLETED|August, 2010 to April, 2013||5
171691|NCT00622726|399045|P1|NOT COMPLETED|August, 2010 to April, 2013||1
171692|NCT00622726|399044|P2|COMPLETED|August, 2010 to April, 2013||68
171693|NCT00622726|399045|P1|COMPLETED|August, 2010 to April, 2013||69
171694|NCT00622726|399044|P2|STARTED|August, 2010 to April, 2013||73
171695|NCT00622726|399045|P1|STARTED|August, 2010 to April, 2013||70
171696|NCT00622726|399044|P2|NOT COMPLETED|March, 2008 to August, 2010||2
171697|NCT00622726|399045|P1|NOT COMPLETED|March, 2008 to August, 2010||5
171698|NCT00622726|399044|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
171699|NCT00622726|399045|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
171700|NCT00622726|399044|P2|STARTED|March, 2008 to August, 2010||75
171701|NCT00622726|399045|P1|STARTED|March, 2008 to August, 2010||75
171702|NCT00622713|399055|P1|NOT COMPLETED|Overall Study||59
171703|NCT00622713|399055|P1|COMPLETED|Overall Study||169
171704|NCT00622713|399055|P1|Intent to Treat (ITT) Population|Overall Study||218
171705|NCT00622713|399055|P1|Exposed to Study Drug|Overall Study||226
171706|NCT00622713|399055|P1|STARTED|Overall Study||228
171707|NCT00622700|399066|P3|NOT COMPLETED|Overall Study||53
171708|NCT00622700|399067|P2|NOT COMPLETED|Overall Study||55
171709|NCT00622700|399068|P1|NOT COMPLETED|Overall Study||56
171710|NCT00622700|399066|P3|COMPLETED|Overall Study|Defined as completing 108 weeks placebo-controlled period or entering the extension period.|163
171711|NCT00622700|399067|P2|COMPLETED|Overall Study|Defined as completing 108 weeks placebo-controlled period or entering the extension period.|150
171712|NCT00622700|399068|P1|COMPLETED|Overall Study|Defined as completing 108 weeks placebo-controlled period or entering the extension period.|141
171713|NCT00622700|399066|P3|STARTED|Overall Study||216
171714|NCT00622700|399067|P2|STARTED|Overall Study||205
171715|NCT00622700|399068|P1|STARTED|Overall Study|4 participants received teriflunomide 7 mg and 2 participants received teriflunomide 14 mg.|197
171716|NCT00622635|399115|P6|NOT COMPLETED|Treatment Period 3||0
171717|NCT00622635|399116|P5|NOT COMPLETED|Treatment Period 3||0
171718|NCT00622635|399117|P4|NOT COMPLETED|Treatment Period 3||3
171719|NCT00622635|399118|P3|NOT COMPLETED|Treatment Period 3||0
171720|NCT00622635|399119|P2|NOT COMPLETED|Treatment Period 3||0
171721|NCT00622635|399120|P1|NOT COMPLETED|Treatment Period 3||0
171722|NCT00622635|399115|P6|COMPLETED|Treatment Period 3||10
171723|NCT00622635|399116|P5|COMPLETED|Treatment Period 3||9
171724|NCT00622635|399117|P4|COMPLETED|Treatment Period 3||10
171725|NCT00622635|399118|P3|COMPLETED|Treatment Period 3||10
171726|NCT00622635|399119|P2|COMPLETED|Treatment Period 3||10
171727|NCT00622635|399120|P1|COMPLETED|Treatment Period 3||12
171728|NCT00622635|399115|P6|STARTED|Treatment Period 3||10
171729|NCT00622635|399116|P5|STARTED|Treatment Period 3||9
171730|NCT00622635|399117|P4|STARTED|Treatment Period 3||13
171731|NCT00622635|399118|P3|STARTED|Treatment Period 3||10
171732|NCT00622635|399119|P2|STARTED|Treatment Period 3||10
171733|NCT00622635|399120|P1|STARTED|Treatment Period 3||12
171734|NCT00622635|399115|P6|NOT COMPLETED|Treatment Period 2||0
171735|NCT00622635|399116|P5|NOT COMPLETED|Treatment Period 2||0
171736|NCT00622635|399117|P4|NOT COMPLETED|Treatment Period 2||0
171737|NCT00622635|399118|P3|NOT COMPLETED|Treatment Period 2||0
171738|NCT00622635|399119|P2|NOT COMPLETED|Treatment Period 2||0
171739|NCT00622635|399120|P1|NOT COMPLETED|Treatment Period 2||1
171740|NCT00622635|399115|P6|COMPLETED|Treatment Period 2||10
171741|NCT00622635|399116|P5|COMPLETED|Treatment Period 2||9
171742|NCT00622635|399117|P4|COMPLETED|Treatment Period 2||13
171743|NCT00622635|399118|P3|COMPLETED|Treatment Period 2||10
171744|NCT00622635|399119|P2|COMPLETED|Treatment Period 2||10
171745|NCT00622635|399120|P1|COMPLETED|Treatment Period 2||12
171746|NCT00622635|399115|P6|STARTED|Treatment Period 2||10
171747|NCT00622635|399116|P5|STARTED|Treatment Period 2||9
171748|NCT00622635|399117|P4|STARTED|Treatment Period 2||13
171749|NCT00622635|399118|P3|STARTED|Treatment Period 2||10
171750|NCT00622635|399119|P2|STARTED|Treatment Period 2||10
171751|NCT00622635|399120|P1|STARTED|Treatment Period 2||13
171752|NCT00622635|399115|P6|NOT COMPLETED|Treatment Period 1||0
171753|NCT00622635|399116|P5|NOT COMPLETED|Treatment Period 1||1
171754|NCT00622635|399117|P4|NOT COMPLETED|Treatment Period 1||0
171755|NCT00622635|399118|P3|NOT COMPLETED|Treatment Period 1||1
171756|NCT00622635|399119|P2|NOT COMPLETED|Treatment Period 1||1
171757|NCT00622635|399120|P1|NOT COMPLETED|Treatment Period 1||0
171758|NCT00622635|399115|P6|COMPLETED|Treatment Period 1||10
171759|NCT00622635|399116|P5|COMPLETED|Treatment Period 1||9
171760|NCT00622635|399117|P4|COMPLETED|Treatment Period 1||13
171761|NCT00622635|399118|P3|COMPLETED|Treatment Period 1||10
171762|NCT00622635|399119|P2|COMPLETED|Treatment Period 1||10
171763|NCT00622635|399120|P1|COMPLETED|Treatment Period 1||13
171764|NCT00622635|399115|P6|STARTED|Treatment Period 1||10
171765|NCT00622635|399116|P5|STARTED|Treatment Period 1||10
171766|NCT00622635|399117|P4|STARTED|Treatment Period 1||13
171767|NCT00622635|399118|P3|STARTED|Treatment Period 1||11
171768|NCT00622635|399119|P2|STARTED|Treatment Period 1||11
171769|NCT00622635|399120|P1|STARTED|Treatment Period 1||13
171770|NCT00622518|399187|P2|NOT COMPLETED|Overall Study||0
171771|NCT00622518|399188|P1|NOT COMPLETED|Overall Study||0
171772|NCT00622518|399187|P2|COMPLETED|Overall Study||60
171773|NCT00622518|399188|P1|COMPLETED|Overall Study||59
171774|NCT00622518|399187|P2|STARTED|Overall Study||60
171775|NCT00622518|399188|P1|STARTED|Overall Study||59
171776|NCT00622440|399198|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
171777|NCT00622440|399199|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
171778|NCT00622440|399198|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
171779|NCT00622440|399199|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
171780|NCT00622440|399198|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
171781|NCT00622440|399199|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
171782|NCT00622440|399198|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
171783|NCT00622440|399199|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
171784|NCT00622440|399198|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
171785|NCT00622440|399199|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
171786|NCT00622440|399198|P2|STARTED|Week 12 - Week 48 (Treatment)||34
171787|NCT00622440|399199|P1|STARTED|Week 12 - Week 48 (Treatment)||31
171788|NCT00622440|399198|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
171789|NCT00622440|399199|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
171790|NCT00622440|399198|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
171791|NCT00622440|399199|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
171792|NCT00622440|399198|P2|STARTED|Baseline - Week 12 (Treatment)||35
171793|NCT00622440|399199|P1|STARTED|Baseline - Week 12 (Treatment)||35
171794|NCT00622427|399213|P2|NOT COMPLETED|Overall Study||0
171795|NCT00622427|399214|P1|NOT COMPLETED|Overall Study||0
171796|NCT00622427|399213|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
171797|NCT00622427|399214|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
171798|NCT00622427|399213|P2|STARTED|Overall Study||16
171799|NCT00622427|399214|P1|STARTED|Overall Study||16
171800|NCT00622401|399225|P3|NOT COMPLETED|Overall Study||0
171801|NCT00622401|399226|P2|NOT COMPLETED|Overall Study||2
171802|NCT00622401|399227|P1|NOT COMPLETED|Overall Study||3
171803|NCT00622401|399225|P3|COMPLETED|Overall Study||0
171804|NCT00622401|399226|P2|COMPLETED|Overall Study||0
171805|NCT00622401|399227|P1|COMPLETED|Overall Study||3
171806|NCT00622401|399225|P3|STARTED|Overall Study|Never Opened|0
171807|NCT00622401|399226|P2|STARTED|Overall Study||2
171808|NCT00622401|399227|P1|STARTED|Overall Study||6
171809|NCT00622388|399231|P1|NOT COMPLETED|Overall Study||72
171810|NCT00622388|399231|P1|COMPLETED|Overall Study||9
171811|NCT00622388|399231|P1|STARTED|Overall Study||81
171812|NCT00622336|399249|P1|NOT COMPLETED|Extension Phase||21
171813|NCT00622336|399249|P1|COMPLETED|Extension Phase||0
171814|NCT00622336|399249|P1|STARTED|Extension Phase||21
171815|NCT00622336|399249|P1|NOT COMPLETED|Treatment Phase||309
171816|NCT00622336|399249|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
171817|NCT00622336|399249|P1|Safety Population|Treatment Phase||330
171818|NCT00622336|399249|P1|STARTED|Treatment Phase||330
171819|NCT00622284|399260|P2|NOT COMPLETED|Overall Study||171
171820|NCT00622284|399261|P1|NOT COMPLETED|Overall Study||189
171821|NCT00622284|399260|P2|COMPLETED|Overall Study|Number who completed treatment.|604
171822|NCT00622284|399261|P1|COMPLETED|Overall Study|Number who completed treatment.|587
171823|NCT00622284|399260|P2|STARTED|Overall Study|Number who started treatment.|775
171824|NCT00622284|399261|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
171825|NCT00622167|399323|P1|NOT COMPLETED|Overall Study||20
171826|NCT00622167|399323|P1|COMPLETED|Overall Study||4
171827|NCT00622167|399323|P1|STARTED|Overall Study||24
171828|NCT00621985|399327|P1|NOT COMPLETED|Dexamethasone Admission||1
171829|NCT00621985|399327|P1|COMPLETED|Dexamethasone Admission||4
171830|NCT00621985|399327|P1|STARTED|Dexamethasone Admission||5
171831|NCT00621985|399327|P1|NOT COMPLETED|Hydrocortisone Admission||0
171832|NCT00621985|399327|P1|COMPLETED|Hydrocortisone Admission||5
171833|NCT00621985|399327|P1|STARTED|Hydrocortisone Admission||5
171834|NCT00621959|399335|P2|NOT COMPLETED|Overall Study||9
171835|NCT00621959|399336|P1|NOT COMPLETED|Overall Study||7
171836|NCT00621959|399335|P2|COMPLETED|Overall Study||292
171837|NCT00621959|399336|P1|COMPLETED|Overall Study||288
171838|NCT00621959|399335|P2|STARTED|Overall Study||301
171839|NCT00621959|399336|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
171840|NCT00621946|399346|P2|NOT COMPLETED|Overall Study||1
171841|NCT00621946|399347|P1|NOT COMPLETED|Overall Study||0
171842|NCT00621946|399346|P2|COMPLETED|Overall Study||12
171843|NCT00621946|399347|P1|COMPLETED|Overall Study||13
171844|NCT00621946|399346|P2|STARTED|Overall Study||13
171845|NCT00621946|399347|P1|STARTED|Overall Study||13
171846|NCT00621933|399363|P1|NOT COMPLETED|Overall Study||0
171847|NCT00621933|399363|P1|COMPLETED|Overall Study||399
171848|NCT00621933|399363|P1|STARTED|Overall Study||399
171849|NCT00621855|399375|P5|NOT COMPLETED|Overall Study||55
171850|NCT00621855|399376|P4|NOT COMPLETED|Overall Study||67
171851|NCT00621855|399377|P3|NOT COMPLETED|Overall Study||81
171852|NCT00621855|399378|P2|NOT COMPLETED|Overall Study||61
171853|NCT00621855|399379|P1|NOT COMPLETED|Overall Study||76
171854|NCT00621855|399375|P5|COMPLETED|Overall Study|Completed means completed treatment|318
171855|NCT00621855|399376|P4|COMPLETED|Overall Study|Completed means completed treatment|284
171856|NCT00621855|399377|P3|COMPLETED|Overall Study|Completed means completed treatment|330
171857|NCT00621855|399378|P2|COMPLETED|Overall Study|Completed means completed treatment|310
171858|NCT00621855|399379|P1|COMPLETED|Overall Study|Completed means completed treatment|296
171859|NCT00621855|399375|P5|STARTED|Overall Study|Started means randomised to treatment|373
171860|NCT00621855|399376|P4|STARTED|Overall Study|Started means randomised to treatment|351
171861|NCT00621855|399377|P3|STARTED|Overall Study|Started means randomised to treatment|411
171862|NCT00621855|399378|P2|STARTED|Overall Study|Started means randomised to treatment|371
171863|NCT00621855|399379|P1|STARTED|Overall Study|Started means randomised to treatment|372
171864|NCT00621842|399421|P1|NOT COMPLETED|Overall Study||19
171865|NCT00621842|399421|P1|COMPLETED|Overall Study||38
171866|NCT00621842|399421|P1|STARTED|Overall Study||57
171867|NCT00621777|399438|P2|NOT COMPLETED|Randomized Phase||19
171868|NCT00621777|399439|P1|NOT COMPLETED|Randomized Phase||7
171869|NCT00621777|399438|P2|COMPLETED|Randomized Phase||28
171870|NCT00621777|399439|P1|COMPLETED|Randomized Phase||33
171871|NCT00621777|399438|P2|STARTED|Randomized Phase||47
171872|NCT00621777|399439|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
171873|NCT00621777|399438|P2|NOT COMPLETED|Open Phase||0
171874|NCT00621777|399439|P1|NOT COMPLETED|Open Phase||116
171875|NCT00621777|399438|P2|COMPLETED|Open Phase||0
171876|NCT00621777|399439|P1|COMPLETED|Open Phase||87
171877|NCT00621777|399438|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
171878|NCT00621777|399439|P1|STARTED|Open Phase||203
171879|NCT00621764|399450|P4|NOT COMPLETED|Overall Study||1
171880|NCT00621764|399451|P3|NOT COMPLETED|Overall Study||0
171881|NCT00621764|399452|P2|NOT COMPLETED|Overall Study||0
171882|NCT00621764|399453|P1|NOT COMPLETED|Overall Study||0
171883|NCT00621764|399450|P4|COMPLETED|Overall Study||98
171884|NCT00621764|399451|P3|COMPLETED|Overall Study||101
171885|NCT00621764|399452|P2|COMPLETED|Overall Study||50
171886|NCT00621764|399453|P1|COMPLETED|Overall Study||50
171887|NCT00621764|399450|P4|STARTED|Overall Study||99
171888|NCT00621764|399451|P3|STARTED|Overall Study||101
171889|NCT00621764|399452|P2|STARTED|Overall Study||50
171890|NCT00621764|399453|P1|STARTED|Overall Study||50
171891|NCT00621686|399485|P2|NOT COMPLETED|Overall Study||0
171892|NCT00621686|399486|P1|NOT COMPLETED|Overall Study||0
171893|NCT00621686|399485|P2|COMPLETED|Overall Study||35
171894|NCT00621686|399486|P1|COMPLETED|Overall Study||19
171895|NCT00621686|399485|P2|STARTED|Overall Study||35
171896|NCT00621686|399486|P1|STARTED|Overall Study||19
171897|NCT00621621|399499|P2|NOT COMPLETED|Overall Study||0
171898|NCT00621621|399500|P1|NOT COMPLETED|Overall Study||30
171899|NCT00621621|399499|P2|COMPLETED|Overall Study||705
171900|NCT00621621|399500|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
171901|NCT00621621|399499|P2|STARTED|Overall Study||705
171902|NCT00621621|399500|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
171903|NCT00621582|399508|P1|NOT COMPLETED|Overall Study||106
171904|NCT00621582|399508|P1|COMPLETED|Overall Study||4812
171905|NCT00621582|399508|P1|STARTED|Overall Study||4918
171906|NCT00621543|399515|P1|NOT COMPLETED|Overall Study||23
171907|NCT00621543|399515|P1|COMPLETED|Overall Study||97
171908|NCT00621543|399515|P1|STARTED|Overall Study||120
171909|NCT00621517|399522|P2|NOT COMPLETED|Overall Study||7
171910|NCT00621517|399523|P1|NOT COMPLETED|Overall Study||7
171911|NCT00621517|399522|P2|COMPLETED|Overall Study||24
171912|NCT00621517|399523|P1|COMPLETED|Overall Study||22
171913|NCT00621517|399522|P2|STARTED|Overall Study||31
171914|NCT00621517|399523|P1|STARTED|Overall Study||29
171915|NCT00621504|399531|P2|NOT COMPLETED|Overall Study||25
171916|NCT00621504|399532|P1|NOT COMPLETED|Overall Study||26
171917|NCT00621504|399531|P2|COMPLETED|Overall Study||282
171918|NCT00621504|399532|P1|COMPLETED|Overall Study||273
171919|NCT00621504|399531|P2|STARTED|Overall Study||307
171920|NCT00621504|399532|P1|STARTED|Overall Study||299
171921|NCT00621348|399541|P3|NOT COMPLETED|Overall Study||0
171922|NCT00621348|399542|P2|NOT COMPLETED|Overall Study||0
171923|NCT00621348|399543|P1|NOT COMPLETED|Overall Study||0
171924|NCT00621348|399541|P3|COMPLETED|Overall Study||56
171925|NCT00621348|399542|P2|COMPLETED|Overall Study||53
171926|NCT00621348|399543|P1|COMPLETED|Overall Study||58
171927|NCT00621348|399541|P3|STARTED|Overall Study||56
171928|NCT00621348|399542|P2|STARTED|Overall Study||53
171929|NCT00621348|399543|P1|STARTED|Overall Study||58
171930|NCT00621322|399566|P6|NOT COMPLETED|Overall Study||4
171931|NCT00621322|399567|P5|NOT COMPLETED|Overall Study||1
171932|NCT00621322|399568|P4|NOT COMPLETED|Overall Study||3
171933|NCT00621322|399569|P3|NOT COMPLETED|Overall Study||2
171934|NCT00621322|399570|P2|NOT COMPLETED|Overall Study||0
171935|NCT00621322|399571|P1|NOT COMPLETED|Overall Study||1
171936|NCT00621322|399566|P6|COMPLETED|Overall Study||36
171937|NCT00621322|399567|P5|COMPLETED|Overall Study||39
171938|NCT00621322|399568|P4|COMPLETED|Overall Study||37
171939|NCT00621322|399569|P3|COMPLETED|Overall Study||38
171940|NCT00621322|399570|P2|COMPLETED|Overall Study||10
171941|NCT00621322|399571|P1|COMPLETED|Overall Study||9
171942|NCT00621322|399566|P6|STARTED|Overall Study||40
171943|NCT00621322|399567|P5|STARTED|Overall Study||40
171944|NCT00621322|399568|P4|STARTED|Overall Study||40
171945|NCT00621322|399569|P3|STARTED|Overall Study||40
171946|NCT00621322|399570|P2|STARTED|Overall Study||10
171947|NCT00621322|399571|P1|STARTED|Overall Study||10
171948|NCT00621296|399651|P1|NOT COMPLETED|Overall Study||14
171949|NCT00621296|399651|P1|COMPLETED|Overall Study||1
171950|NCT00621296|399651|P1|STARTED|Overall Study||15
171951|NCT00621257|399660|P5|NOT COMPLETED|Overall Study||9
171952|NCT00621257|399661|P4|NOT COMPLETED|Overall Study||6
171953|NCT00621257|399662|P3|NOT COMPLETED|Overall Study||3
171954|NCT00621257|399663|P2|NOT COMPLETED|Overall Study||3
171955|NCT00621257|399664|P1|NOT COMPLETED|Overall Study||4
171956|NCT00621257|399660|P5|COMPLETED|Overall Study||22
171957|NCT00621257|399661|P4|COMPLETED|Overall Study||26
171958|NCT00621257|399662|P3|COMPLETED|Overall Study||20
171959|NCT00621257|399663|P2|COMPLETED|Overall Study||21
171960|NCT00621257|399664|P1|COMPLETED|Overall Study||20
171961|NCT00621257|399660|P5|STARTED|Overall Study||31
171962|NCT00621257|399661|P4|STARTED|Overall Study||32
171963|NCT00621257|399662|P3|STARTED|Overall Study||23
171964|NCT00621257|399663|P2|STARTED|Overall Study||24
171965|NCT00621257|399664|P1|STARTED|Overall Study||24
171966|NCT00621192|399680|P4|NOT COMPLETED|Overall Study||3
171967|NCT00621192|399681|P3|NOT COMPLETED|Overall Study||5
171968|NCT00621192|399682|P2|NOT COMPLETED|Overall Study||9
171969|NCT00621192|399683|P1|NOT COMPLETED|Overall Study||4
171970|NCT00621192|399680|P4|COMPLETED|Overall Study||24
171971|NCT00621192|399681|P3|COMPLETED|Overall Study||26
171972|NCT00621192|399682|P2|COMPLETED|Overall Study||94
171973|NCT00621192|399683|P1|COMPLETED|Overall Study||35
171974|NCT00621192|399680|P4|Efficacy Population|Overall Study||27
171975|NCT00621192|399681|P3|Efficacy Population|Overall Study||28
171976|NCT00621192|399682|P2|Efficacy Population|Overall Study||101
171977|NCT00621192|399683|P1|Efficacy Population|Overall Study||39
171978|NCT00621192|399680|P4|Safety Population|Overall Study||27
171979|NCT00621192|399681|P3|Safety Population|Overall Study||31
171980|NCT00621192|399682|P2|Safety Population|Overall Study||103
171981|NCT00621192|399683|P1|Safety Population|Overall Study||39
171982|NCT00621192|399680|P4|STARTED|Overall Study||27
171983|NCT00621192|399681|P3|STARTED|Overall Study||31
171984|NCT00621192|399682|P2|STARTED|Overall Study||103
171985|NCT00621192|399683|P1|STARTED|Overall Study||39
171986|NCT00621153|399707|P2|NOT COMPLETED|Overall Study||15
171987|NCT00621153|399708|P1|NOT COMPLETED|Overall Study||20
171988|NCT00621153|399707|P2|COMPLETED|Overall Study|completed|101
171989|NCT00621153|399708|P1|COMPLETED|Overall Study|completed|97
171990|NCT00621153|399707|P2|Discontinued|Overall Study||15
171991|NCT00621153|399708|P1|Discontinued|Overall Study||20
171992|NCT00621153|399707|P2|STARTED|Overall Study|randomised|116
171993|NCT00621153|399708|P1|STARTED|Overall Study|randomised|117
171994|NCT00621140|399716|P2|NOT COMPLETED|Overall Study||18
171995|NCT00621140|399717|P1|NOT COMPLETED|Overall Study||15
171996|NCT00621140|399716|P2|COMPLETED|Overall Study|number who completed treatment|318
171997|NCT00621140|399717|P1|COMPLETED|Overall Study|number who completed treatment|152
171998|NCT00621140|399716|P2|STARTED|Overall Study|number who started treatment|336
171999|NCT00621140|399717|P1|STARTED|Overall Study|number who started treatment|167
172000|NCT00621049|399751|P2|NOT COMPLETED|Maintenance Treatment||0
172001|NCT00621049|399752|P1|NOT COMPLETED|Maintenance Treatment||15
172002|NCT00621049|399751|P2|COMPLETED|Maintenance Treatment||0
172003|NCT00621049|399752|P1|COMPLETED|Maintenance Treatment||34
172004|NCT00621049|399751|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
172005|NCT00621049|399752|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
172006|NCT00621049|399751|P2|NOT COMPLETED|Adjuvant Treatment||10
172007|NCT00621049|399752|P1|NOT COMPLETED|Adjuvant Treatment||3
172008|NCT00621049|399751|P2|COMPLETED|Adjuvant Treatment||47
172009|NCT00621049|399752|P1|COMPLETED|Adjuvant Treatment||52
172010|NCT00621049|399751|P2|STARTED|Adjuvant Treatment||57
172011|NCT00621049|399752|P1|STARTED|Adjuvant Treatment||55
172012|NCT00621023|399764|P1|NOT COMPLETED|Overall Study||6
172013|NCT00621023|399764|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
172014|NCT00621023|399764|P1|STARTED|Overall Study||6
172015|NCT00620854|399776|P6|NOT COMPLETED|Period 3||0
172016|NCT00620854|399777|P5|NOT COMPLETED|Period 3||0
172017|NCT00620854|399778|P4|NOT COMPLETED|Period 3||0
172018|NCT00620854|399779|P3|NOT COMPLETED|Period 3||0
172019|NCT00620854|399780|P2|NOT COMPLETED|Period 3||0
172020|NCT00620854|399781|P1|NOT COMPLETED|Period 3||0
172021|NCT00620854|399776|P6|COMPLETED|Period 3||4
172022|NCT00620854|399777|P5|COMPLETED|Period 3||4
172023|NCT00620854|399778|P4|COMPLETED|Period 3||3
172024|NCT00620854|399779|P3|COMPLETED|Period 3||3
172025|NCT00620854|399780|P2|COMPLETED|Period 3||4
172026|NCT00620854|399781|P1|COMPLETED|Period 3||4
172027|NCT00620854|399776|P6|STARTED|Period 3||4
172028|NCT00620854|399777|P5|STARTED|Period 3||4
172029|NCT00620854|399778|P4|STARTED|Period 3||3
172030|NCT00620854|399779|P3|STARTED|Period 3||3
172031|NCT00620854|399780|P2|STARTED|Period 3||4
172032|NCT00620854|399781|P1|STARTED|Period 3||4
172033|NCT00620854|399776|P6|NOT COMPLETED|Washout 2||0
172034|NCT00620854|399777|P5|NOT COMPLETED|Washout 2||0
172035|NCT00620854|399778|P4|NOT COMPLETED|Washout 2||0
172036|NCT00620854|399779|P3|NOT COMPLETED|Washout 2||0
172037|NCT00620854|399780|P2|NOT COMPLETED|Washout 2||0
172038|NCT00620854|399781|P1|NOT COMPLETED|Washout 2||0
172039|NCT00620854|399776|P6|COMPLETED|Washout 2||4
172040|NCT00620854|399777|P5|COMPLETED|Washout 2||4
172041|NCT00620854|399778|P4|COMPLETED|Washout 2||3
172042|NCT00620854|399779|P3|COMPLETED|Washout 2||3
172043|NCT00620854|399780|P2|COMPLETED|Washout 2||4
172044|NCT00620854|399781|P1|COMPLETED|Washout 2||4
172045|NCT00620854|399776|P6|STARTED|Washout 2||4
172046|NCT00620854|399777|P5|STARTED|Washout 2||4
172047|NCT00620854|399778|P4|STARTED|Washout 2||3
172048|NCT00620854|399779|P3|STARTED|Washout 2||3
172049|NCT00620854|399780|P2|STARTED|Washout 2||4
172050|NCT00620854|399781|P1|STARTED|Washout 2||4
172051|NCT00620854|399776|P6|NOT COMPLETED|Period 2||0
172052|NCT00620854|399777|P5|NOT COMPLETED|Period 2||0
172053|NCT00620854|399778|P4|NOT COMPLETED|Period 2||0
172054|NCT00620854|399779|P3|NOT COMPLETED|Period 2||0
172055|NCT00620854|399780|P2|NOT COMPLETED|Period 2||0
172056|NCT00620854|399781|P1|NOT COMPLETED|Period 2||0
172057|NCT00620854|399776|P6|COMPLETED|Period 2||4
172058|NCT00620854|399777|P5|COMPLETED|Period 2||4
172059|NCT00620854|399778|P4|COMPLETED|Period 2||3
172060|NCT00620854|399779|P3|COMPLETED|Period 2||3
172061|NCT00620854|399780|P2|COMPLETED|Period 2||4
172062|NCT00620854|399781|P1|COMPLETED|Period 2||4
172063|NCT00620854|399776|P6|STARTED|Period 2||4
172064|NCT00620854|399777|P5|STARTED|Period 2||4
172065|NCT00620854|399778|P4|STARTED|Period 2||3
172066|NCT00620854|399779|P3|STARTED|Period 2||3
172067|NCT00620854|399780|P2|STARTED|Period 2||4
172068|NCT00620854|399781|P1|STARTED|Period 2||4
172069|NCT00620854|399776|P6|NOT COMPLETED|Washout 1||0
172070|NCT00620854|399777|P5|NOT COMPLETED|Washout 1||0
172071|NCT00620854|399778|P4|NOT COMPLETED|Washout 1||1
172072|NCT00620854|399779|P3|NOT COMPLETED|Washout 1||1
172073|NCT00620854|399780|P2|NOT COMPLETED|Washout 1||0
172074|NCT00620854|399781|P1|NOT COMPLETED|Washout 1||0
172075|NCT00620854|399776|P6|COMPLETED|Washout 1||4
172076|NCT00620854|399777|P5|COMPLETED|Washout 1||4
172077|NCT00620854|399778|P4|COMPLETED|Washout 1||3
172078|NCT00620854|399779|P3|COMPLETED|Washout 1||3
172079|NCT00620854|399780|P2|COMPLETED|Washout 1||4
172080|NCT00620854|399781|P1|COMPLETED|Washout 1||4
172081|NCT00620854|399776|P6|STARTED|Washout 1||4
172082|NCT00620854|399777|P5|STARTED|Washout 1||4
172083|NCT00620854|399778|P4|STARTED|Washout 1||4
172084|NCT00620854|399779|P3|STARTED|Washout 1||4
172085|NCT00620854|399780|P2|STARTED|Washout 1||4
172086|NCT00620854|399781|P1|STARTED|Washout 1||4
172087|NCT00620854|399776|P6|NOT COMPLETED|Period 1||0
172088|NCT00620854|399777|P5|NOT COMPLETED|Period 1||0
172089|NCT00620854|399778|P4|NOT COMPLETED|Period 1||0
172090|NCT00620854|399779|P3|NOT COMPLETED|Period 1||0
172091|NCT00620854|399780|P2|NOT COMPLETED|Period 1||0
172092|NCT00620854|399781|P1|NOT COMPLETED|Period 1||0
172093|NCT00620854|399776|P6|COMPLETED|Period 1||4
172094|NCT00620854|399777|P5|COMPLETED|Period 1||4
172095|NCT00620854|399778|P4|COMPLETED|Period 1||4
172096|NCT00620854|399779|P3|COMPLETED|Period 1||4
172097|NCT00620854|399780|P2|COMPLETED|Period 1||4
172098|NCT00620854|399781|P1|COMPLETED|Period 1||4
172099|NCT00620854|399776|P6|STARTED|Period 1||4
172100|NCT00620854|399777|P5|STARTED|Period 1||4
172101|NCT00620854|399778|P4|STARTED|Period 1||4
172102|NCT00620854|399779|P3|STARTED|Period 1||4
172103|NCT00620854|399780|P2|STARTED|Period 1||4
172104|NCT00620854|399781|P1|STARTED|Period 1||4
172105|NCT00620828|399794|P2|NOT COMPLETED|Overall Study||0
172106|NCT00620828|399795|P1|NOT COMPLETED|Overall Study||0
172107|NCT00620828|399794|P2|COMPLETED|Overall Study||35
172108|NCT00620828|399795|P1|COMPLETED|Overall Study||32
172109|NCT00620828|399794|P2|Number of Subjects Enrolled = 67|Overall Study||35
172110|NCT00620828|399795|P1|Number of Subjects Enrolled = 67|Overall Study||32
172111|NCT00620828|399794|P2|STARTED|Overall Study||35
172112|NCT00620828|399795|P1|STARTED|Overall Study||32
172113|NCT00620815|399812|P3|NOT COMPLETED|Overall Study||7
172114|NCT00620815|399813|P2|NOT COMPLETED|Overall Study||11
172115|NCT00620815|399814|P1|NOT COMPLETED|Overall Study||4
172116|NCT00620815|399812|P3|COMPLETED|Overall Study||192
172117|NCT00620815|399813|P2|COMPLETED|Overall Study||192
172118|NCT00620815|399814|P1|COMPLETED|Overall Study||195
172119|NCT00620815|399812|P3|STARTED|Overall Study||199
172120|NCT00620815|399813|P2|STARTED|Overall Study||203
172121|NCT00620815|399814|P1|STARTED|Overall Study||199
172122|NCT00620776|399854|P2|NOT COMPLETED|Overall Study||16
172123|NCT00620776|399855|P1|NOT COMPLETED|Overall Study||12
172124|NCT00620776|399854|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
172125|NCT00620776|399855|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
172126|NCT00620776|399854|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
172127|NCT00620776|399855|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
172128|NCT00620776|399854|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
172129|NCT00620776|399855|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
172130|NCT00620763|399883|P2|NOT COMPLETED|Period: Second Intervention||0
172131|NCT00620763|399884|P1|NOT COMPLETED|Period: Second Intervention||1
172132|NCT00620763|399883|P2|COMPLETED|Period: Second Intervention||7
172133|NCT00620763|399884|P1|COMPLETED|Period: Second Intervention||9
172134|NCT00620763|399883|P2|STARTED|Period: Second Intervention||7
172135|NCT00620763|399884|P1|STARTED|Period: Second Intervention||10
172136|NCT00620763|399883|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
172137|NCT00620763|399884|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
172138|NCT00620763|399883|P2|COMPLETED|Period: Washout Period of 1 Week||7
172139|NCT00620763|399884|P1|COMPLETED|Period: Washout Period of 1 Week||10
172140|NCT00620763|399883|P2|STARTED|Period: Washout Period of 1 Week||7
172141|NCT00620763|399884|P1|STARTED|Period: Washout Period of 1 Week||10
172142|NCT00620763|399883|P2|NOT COMPLETED|Period: First Intervention||5
172143|NCT00620763|399884|P1|NOT COMPLETED|Period: First Intervention||0
172144|NCT00620763|399883|P2|COMPLETED|Period: First Intervention||7
172145|NCT00620763|399884|P1|COMPLETED|Period: First Intervention||10
172146|NCT00620763|399883|P2|STARTED|Period: First Intervention||12
172147|NCT00620763|399884|P1|STARTED|Period: First Intervention||10
172148|NCT00620750|399890|P1|NOT COMPLETED|Overall Study||25
172149|NCT00620750|399890|P1|COMPLETED|Overall Study||40
172150|NCT00620750|399890|P1|STARTED|Overall Study||65
172151|NCT00620711|399894|P1|NOT COMPLETED|Overall Study||0
172152|NCT00620711|399894|P1|COMPLETED|Overall Study||4
172153|NCT00620711|399894|P1|STARTED|Overall Study||4
172154|NCT00620698|399899|P1|NOT COMPLETED|Overall Study||29
172155|NCT00620698|399899|P1|COMPLETED|Overall Study||60
172156|NCT00620698|399899|P1|STARTED|Overall Study||89
172157|NCT00620659|399905|P6|NOT COMPLETED|Treatment Period 3||0
172158|NCT00620659|399906|P5|NOT COMPLETED|Treatment Period 3||0
172159|NCT00620659|399907|P4|NOT COMPLETED|Treatment Period 3||1
172160|NCT00620659|399908|P3|NOT COMPLETED|Treatment Period 3||0
172161|NCT00620659|399909|P2|NOT COMPLETED|Treatment Period 3||2
172162|NCT00620659|399910|P1|NOT COMPLETED|Treatment Period 3||0
172163|NCT00620659|399905|P6|COMPLETED|Treatment Period 3||20
172164|NCT00620659|399906|P5|COMPLETED|Treatment Period 3||15
172165|NCT00620659|399907|P4|COMPLETED|Treatment Period 3||17
172166|NCT00620659|399908|P3|COMPLETED|Treatment Period 3||19
172167|NCT00620659|399909|P2|COMPLETED|Treatment Period 3||16
172168|NCT00620659|399910|P1|COMPLETED|Treatment Period 3||16
172169|NCT00620659|399905|P6|STARTED|Treatment Period 3||20
172170|NCT00620659|399906|P5|STARTED|Treatment Period 3||15
172171|NCT00620659|399907|P4|STARTED|Treatment Period 3||18
172172|NCT00620659|399908|P3|STARTED|Treatment Period 3||19
172173|NCT00620659|399909|P2|STARTED|Treatment Period 3||18
172174|NCT00620659|399910|P1|STARTED|Treatment Period 3||16
172175|NCT00620659|399905|P6|NOT COMPLETED|Placebo Washout Period 2||0
172176|NCT00620659|399906|P5|NOT COMPLETED|Placebo Washout Period 2||0
172177|NCT00620659|399907|P4|NOT COMPLETED|Placebo Washout Period 2||0
172178|NCT00620659|399908|P3|NOT COMPLETED|Placebo Washout Period 2||0
172179|NCT00620659|399909|P2|NOT COMPLETED|Placebo Washout Period 2||0
172180|NCT00620659|399910|P1|NOT COMPLETED|Placebo Washout Period 2||2
172181|NCT00620659|399905|P6|COMPLETED|Placebo Washout Period 2||20
172182|NCT00620659|399906|P5|COMPLETED|Placebo Washout Period 2||15
172183|NCT00620659|399907|P4|COMPLETED|Placebo Washout Period 2||18
172184|NCT00620659|399908|P3|COMPLETED|Placebo Washout Period 2||19
172185|NCT00620659|399909|P2|COMPLETED|Placebo Washout Period 2||18
172186|NCT00620659|399910|P1|COMPLETED|Placebo Washout Period 2||16
172187|NCT00620659|399905|P6|STARTED|Placebo Washout Period 2||20
172188|NCT00620659|399906|P5|STARTED|Placebo Washout Period 2||15
172189|NCT00620659|399907|P4|STARTED|Placebo Washout Period 2||18
172190|NCT00620659|399908|P3|STARTED|Placebo Washout Period 2||19
172191|NCT00620659|399909|P2|STARTED|Placebo Washout Period 2||18
172192|NCT00620659|399910|P1|STARTED|Placebo Washout Period 2||18
172193|NCT00620659|399905|P6|NOT COMPLETED|Treatment Period 2||0
172194|NCT00620659|399906|P5|NOT COMPLETED|Treatment Period 2||5
172195|NCT00620659|399907|P4|NOT COMPLETED|Treatment Period 2||0
172196|NCT00620659|399908|P3|NOT COMPLETED|Treatment Period 2||1
172197|NCT00620659|399909|P2|NOT COMPLETED|Treatment Period 2||3
172198|NCT00620659|399910|P1|NOT COMPLETED|Treatment Period 2||0
172199|NCT00620659|399905|P6|COMPLETED|Treatment Period 2||20
172200|NCT00620659|399906|P5|COMPLETED|Treatment Period 2||15
172201|NCT00620659|399907|P4|COMPLETED|Treatment Period 2||18
172202|NCT00620659|399908|P3|COMPLETED|Treatment Period 2||19
172203|NCT00620659|399909|P2|COMPLETED|Treatment Period 2||18
172204|NCT00620659|399910|P1|COMPLETED|Treatment Period 2||18
172205|NCT00620659|399905|P6|STARTED|Treatment Period 2||20
172206|NCT00620659|399906|P5|STARTED|Treatment Period 2||20
172207|NCT00620659|399907|P4|STARTED|Treatment Period 2||18
172208|NCT00620659|399908|P3|STARTED|Treatment Period 2||20
172209|NCT00620659|399909|P2|STARTED|Treatment Period 2||21
172210|NCT00620659|399910|P1|STARTED|Treatment Period 2||18
172211|NCT00620659|399905|P6|NOT COMPLETED|Placebo Washout Period 1||0
172212|NCT00620659|399906|P5|NOT COMPLETED|Placebo Washout Period 1||0
172213|NCT00620659|399907|P4|NOT COMPLETED|Placebo Washout Period 1||1
172214|NCT00620659|399908|P3|NOT COMPLETED|Placebo Washout Period 1||0
172215|NCT00620659|399909|P2|NOT COMPLETED|Placebo Washout Period 1||0
172216|NCT00620659|399910|P1|NOT COMPLETED|Placebo Washout Period 1||0
172217|NCT00620659|399905|P6|COMPLETED|Placebo Washout Period 1||20
172218|NCT00620659|399906|P5|COMPLETED|Placebo Washout Period 1||20
172219|NCT00620659|399907|P4|COMPLETED|Placebo Washout Period 1||18
172220|NCT00620659|399908|P3|COMPLETED|Placebo Washout Period 1||20
172221|NCT00620659|399909|P2|COMPLETED|Placebo Washout Period 1||21
172222|NCT00620659|399910|P1|COMPLETED|Placebo Washout Period 1||18
172223|NCT00620659|399905|P6|STARTED|Placebo Washout Period 1||20
172224|NCT00620659|399906|P5|STARTED|Placebo Washout Period 1||20
172225|NCT00620659|399907|P4|STARTED|Placebo Washout Period 1||19
172226|NCT00620659|399908|P3|STARTED|Placebo Washout Period 1||20
172227|NCT00620659|399909|P2|STARTED|Placebo Washout Period 1||21
172228|NCT00620659|399910|P1|STARTED|Placebo Washout Period 1||18
172229|NCT00620659|399905|P6|NOT COMPLETED|Treatment Period 1||0
172230|NCT00620659|399906|P5|NOT COMPLETED|Treatment Period 1||1
172231|NCT00620659|399907|P4|NOT COMPLETED|Treatment Period 1||3
172232|NCT00620659|399908|P3|NOT COMPLETED|Treatment Period 1||1
172233|NCT00620659|399909|P2|NOT COMPLETED|Treatment Period 1||0
172234|NCT00620659|399910|P1|NOT COMPLETED|Treatment Period 1||3
172235|NCT00620659|399905|P6|COMPLETED|Treatment Period 1||20
172236|NCT00620659|399906|P5|COMPLETED|Treatment Period 1||20
172237|NCT00620659|399907|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
172238|NCT00620659|399908|P3|COMPLETED|Treatment Period 1||20
172239|NCT00620659|399909|P2|COMPLETED|Treatment Period 1||21
172240|NCT00620659|399910|P1|COMPLETED|Treatment Period 1||18
172241|NCT00620659|399905|P6|STARTED|Treatment Period 1||20
172242|NCT00620659|399906|P5|STARTED|Treatment Period 1||21
172243|NCT00620659|399907|P4|STARTED|Treatment Period 1||21
172244|NCT00620659|399908|P3|STARTED|Treatment Period 1||21
172245|NCT00620659|399909|P2|STARTED|Treatment Period 1||21
172246|NCT00620659|399910|P1|STARTED|Treatment Period 1||21
172247|NCT00620555|399928|P1|NOT COMPLETED|Overall Study||21
172248|NCT00620555|399928|P1|COMPLETED|Overall Study||44
172249|NCT00620555|399928|P1|STARTED|Overall Study||65
172250|NCT00620542|399937|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
172251|NCT00620542|399938|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
172252|NCT00620542|399939|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
172253|NCT00620542|399940|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
172254|NCT00620542|399937|P4|COMPLETED|Part B (2 Year Core Study)||547
172255|NCT00620542|399938|P3|COMPLETED|Part B (2 Year Core Study)||546
172256|NCT00620542|399939|P2|COMPLETED|Part B (2 Year Core Study)||0
172257|NCT00620542|399940|P1|COMPLETED|Part B (2 Year Core Study)||0
172258|NCT00620542|399937|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
172259|NCT00620542|399938|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
172260|NCT00620542|399939|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
172261|NCT00620542|399940|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
172262|NCT00620542|399937|P4|Received Treatment|Part B (2 Year Core Study)||689
172263|NCT00620542|399938|P3|Received Treatment|Part B (2 Year Core Study)||691
172264|NCT00620542|399939|P2|Received Treatment|Part B (2 Year Core Study)||0
172265|NCT00620542|399940|P1|Received Treatment|Part B (2 Year Core Study)||0
172266|NCT00620542|399937|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
172267|NCT00620542|399938|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
172268|NCT00620542|399939|P2|STARTED|Part B (2 Year Core Study)||0
172269|NCT00620542|399940|P1|STARTED|Part B (2 Year Core Study)||0
172270|NCT00620542|399937|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
172271|NCT00620542|399938|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
172272|NCT00620542|399939|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
172273|NCT00620542|399940|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
172274|NCT00620542|399937|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
172275|NCT00620542|399938|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
172276|NCT00620542|399939|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
172277|NCT00620542|399940|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
172278|NCT00620542|399937|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
172279|NCT00620542|399938|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
172280|NCT00620542|399939|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
172281|NCT00620542|399940|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
172282|NCT00620542|399937|P4|STARTED|Part A (Run-in - 2 Weeks)||0
172283|NCT00620542|399938|P3|STARTED|Part A (Run-in - 2 Weeks)||0
172284|NCT00620542|399939|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
172285|NCT00620542|399940|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
172286|NCT00620464|399980|P2|NOT COMPLETED|Overall Study||24
172287|NCT00620464|399981|P1|NOT COMPLETED|Overall Study||20
172288|NCT00620464|399980|P2|COMPLETED|Overall Study||32
172289|NCT00620464|399981|P1|COMPLETED|Overall Study||32
172290|NCT00620464|399980|P2|STARTED|Overall Study||56
172291|NCT00620464|399981|P1|STARTED|Overall Study||52
172292|NCT00620425|399989|P1|NOT COMPLETED|Overall Study||0
172293|NCT00620425|399989|P1|COMPLETED|Overall Study||18
172294|NCT00620425|399989|P1|STARTED|Overall Study||18
172295|NCT00620373|400000|P1|NOT COMPLETED|Overall Study||33
172296|NCT00620373|400000|P1|COMPLETED|Overall Study||936
172297|NCT00620373|400000|P1|STARTED|Overall Study||969
172298|NCT00620282|400019|P3|NOT COMPLETED|Overall Study||1
172299|NCT00620282|400020|P2|NOT COMPLETED|Overall Study||2
172300|NCT00620282|400021|P1|NOT COMPLETED|Overall Study||0
172301|NCT00620282|400019|P3|COMPLETED|Overall Study||16
172302|NCT00620282|400020|P2|COMPLETED|Overall Study||14
172303|NCT00620282|400021|P1|COMPLETED|Overall Study||16
172304|NCT00620282|400019|P3|STARTED|Overall Study||17
172305|NCT00620282|400020|P2|STARTED|Overall Study||16
172306|NCT00620282|400021|P1|STARTED|Overall Study||16
172307|NCT00620126|400070|P2|NOT COMPLETED|Overall Study||5
172308|NCT00620126|400071|P1|NOT COMPLETED|Overall Study||11
172309|NCT00620126|400070|P2|COMPLETED|Overall Study||17
172310|NCT00620126|400071|P1|COMPLETED|Overall Study||14
172311|NCT00620126|400070|P2|STARTED|Overall Study||22
172312|NCT00620126|400071|P1|STARTED|Overall Study||25
172313|NCT00620074|400081|P1|NOT COMPLETED|Overall Study||1
172314|NCT00620074|400081|P1|COMPLETED|Overall Study||5
172315|NCT00620074|400081|P1|STARTED|Overall Study||6
172316|NCT00620035|400089|P1|NOT COMPLETED|Overall Study||145
172317|NCT00620035|400089|P1|COMPLETED|Overall Study||156
172318|NCT00620035|400089|P1|STARTED|Overall Study||301
172319|NCT00620022|400099|P2|NOT COMPLETED|Treatment Period 2||2
172320|NCT00620022|400100|P1|NOT COMPLETED|Treatment Period 2||2
172321|NCT00620022|400099|P2|COMPLETED|Treatment Period 2||35
172322|NCT00620022|400100|P1|COMPLETED|Treatment Period 2||39
172323|NCT00620022|400099|P2|STARTED|Treatment Period 2||37
172324|NCT00620022|400100|P1|STARTED|Treatment Period 2||41
172325|NCT00620022|400099|P2|NOT COMPLETED|Treatment Period 1||6
172326|NCT00620022|400100|P1|NOT COMPLETED|Treatment Period 1||5
172327|NCT00620022|400099|P2|COMPLETED|Treatment Period 1||37
172328|NCT00620022|400100|P1|COMPLETED|Treatment Period 1||41
172329|NCT00620022|400099|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
172330|NCT00620022|400100|P1|STARTED|Treatment Period 1||46
172331|NCT00619970|400111|P3|NOT COMPLETED|Overall Study||2
172332|NCT00619970|400112|P2|NOT COMPLETED|Overall Study||3
172333|NCT00619970|400113|P1|NOT COMPLETED|Overall Study||0
172334|NCT00619970|400111|P3|COMPLETED|Overall Study||24
172335|NCT00619970|400112|P2|COMPLETED|Overall Study||46
172336|NCT00619970|400113|P1|COMPLETED|Overall Study||40
172337|NCT00619970|400111|P3|STARTED|Overall Study||26
172338|NCT00619970|400112|P2|STARTED|Overall Study||49
172339|NCT00619970|400113|P1|STARTED|Overall Study||40
172340|NCT00619957|400125|P2|NOT COMPLETED|Month 48 Open-Label||17
172341|NCT00619957|400126|P1|NOT COMPLETED|Month 48 Open-Label||12
172342|NCT00619957|400125|P2|COMPLETED|Month 48 Open-Label||134
172343|NCT00619957|400126|P1|COMPLETED|Month 48 Open-Label||55
172344|NCT00619957|400125|P2|STARTED|Month 48 Open-Label||151
172345|NCT00619957|400126|P1|STARTED|Month 48 Open-Label||67
172346|NCT00619957|400125|P2|NOT COMPLETED|Month 24 Double-Blind||17
172347|NCT00619957|400126|P1|NOT COMPLETED|Month 24 Double-Blind||18
172348|NCT00619957|400125|P2|COMPLETED|Month 24 Double-Blind||175
172349|NCT00619957|400126|P1|COMPLETED|Month 24 Double-Blind||75
172350|NCT00619957|400125|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
172351|NCT00619957|400126|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
172352|NCT00619957|400125|P2|STARTED|Month 24 Double-Blind||192
172353|NCT00619957|400126|P1|STARTED|Month 24 Double-Blind||93
172354|NCT00619918|400208|P2|NOT COMPLETED|Overall Study||22
172355|NCT00619918|400209|P1|NOT COMPLETED|Overall Study||20
172356|NCT00619918|400208|P2|COMPLETED|Overall Study||195
172357|NCT00619918|400209|P1|COMPLETED|Overall Study||210
172358|NCT00619918|400208|P2|STARTED|Overall Study||217
172359|NCT00619918|400209|P1|STARTED|Overall Study||230
172360|NCT00619892|400219|P2|NOT COMPLETED|Overall Study||2
172361|NCT00619892|400220|P1|NOT COMPLETED|Overall Study||3
172362|NCT00619892|400219|P2|COMPLETED|Overall Study||11
172363|NCT00619892|400220|P1|COMPLETED|Overall Study||10
172364|NCT00619892|400219|P2|STARTED|Overall Study||13
172365|NCT00619892|400220|P1|STARTED|Overall Study||13
172366|NCT00619827|400230|P2|NOT COMPLETED|Overall Study||4
172367|NCT00619827|400231|P1|NOT COMPLETED|Overall Study||3
172368|NCT00619827|400230|P2|COMPLETED|Overall Study||40
172369|NCT00619827|400231|P1|COMPLETED|Overall Study||42
172370|NCT00619827|400230|P2|STARTED|Overall Study||44
172371|NCT00619827|400231|P1|STARTED|Overall Study||45
172372|NCT00619801|400239|P2|NOT COMPLETED|Overall Study||3
172373|NCT00619801|400240|P1|NOT COMPLETED|Overall Study||1
172374|NCT00619801|400239|P2|COMPLETED|Overall Study||111
172375|NCT00619801|400240|P1|COMPLETED|Overall Study||58
172376|NCT00619801|400239|P2|Safety Population|Overall Study||114
172377|NCT00619801|400240|P1|Safety Population|Overall Study||59
172378|NCT00619801|400239|P2|STARTED|Overall Study||114
172379|NCT00619801|400240|P1|STARTED|Overall Study||59
172380|NCT00619762|400270|P1|NOT COMPLETED|Overall Study||3
172381|NCT00619762|400270|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
172382|NCT00619762|400270|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
172383|NCT00619619|400283|P8|NOT COMPLETED|Overall Study||3
172384|NCT00619619|400284|P7|NOT COMPLETED|Overall Study||1
172385|NCT00619619|400285|P6|NOT COMPLETED|Overall Study||0
172386|NCT00619619|400286|P5|NOT COMPLETED|Overall Study||2
172387|NCT00619619|400287|P4|NOT COMPLETED|Overall Study||1
172388|NCT00619619|400288|P3|NOT COMPLETED|Overall Study||1
172389|NCT00619619|400289|P2|NOT COMPLETED|Overall Study||0
172390|NCT00619619|400290|P1|NOT COMPLETED|Overall Study||0
172391|NCT00619619|400283|P8|COMPLETED|Overall Study||5
172392|NCT00619619|400284|P7|COMPLETED|Overall Study||7
172393|NCT00619619|400285|P6|COMPLETED|Overall Study||7
172394|NCT00619619|400286|P5|COMPLETED|Overall Study||5
172395|NCT00619619|400287|P4|COMPLETED|Overall Study||6
172396|NCT00619619|400288|P3|COMPLETED|Overall Study||8
172397|NCT00619619|400289|P2|COMPLETED|Overall Study||7
172398|NCT00619619|400290|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
172399|NCT00619619|400283|P8|Entered the Extension Study|Overall Study||7
172400|NCT00619619|400284|P7|Entered the Extension Study|Overall Study||6
172401|NCT00619619|400285|P6|Entered the Extension Study|Overall Study||6
172402|NCT00619619|400286|P5|Entered the Extension Study|Overall Study||7
172403|NCT00619619|400287|P4|Entered the Extension Study|Overall Study||3
172404|NCT00619619|400288|P3|Entered the Extension Study|Overall Study||8
172405|NCT00619619|400289|P2|Entered the Extension Study|Overall Study||5
172406|NCT00619619|400290|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
172407|NCT00619619|400283|P8|STARTED|Overall Study||8
172408|NCT00619619|400284|P7|STARTED|Overall Study||8
172409|NCT00619619|400285|P6|STARTED|Overall Study||7
172410|NCT00619619|400286|P5|STARTED|Overall Study||7
172411|NCT00619619|400287|P4|STARTED|Overall Study||7
172412|NCT00619619|400288|P3|STARTED|Overall Study||9
172413|NCT00619619|400289|P2|STARTED|Overall Study||7
172414|NCT00619619|400290|P1|STARTED|Overall Study||6
172415|NCT00619502|400377|P2|NOT COMPLETED|Overall Study||10
172416|NCT00619502|400378|P1|NOT COMPLETED|Overall Study||8
172417|NCT00619502|400377|P2|COMPLETED|Overall Study||114
172418|NCT00619502|400378|P1|COMPLETED|Overall Study||122
172419|NCT00619502|400377|P2|STARTED|Overall Study||124
172420|NCT00619502|400378|P1|STARTED|Overall Study||130
172421|NCT00619489|400390|P2|NOT COMPLETED|Overall Study||34
172422|NCT00619489|400391|P1|NOT COMPLETED|Overall Study||23
172423|NCT00619489|400390|P2|COMPLETED|Overall Study||1
172424|NCT00619489|400391|P1|COMPLETED|Overall Study||14
172425|NCT00619489|400390|P2|STARTED|Overall Study||35
172426|NCT00619489|400391|P1|STARTED|Overall Study||37
172427|NCT00619476|400413|P4|NOT COMPLETED|Overall Study||34
172428|NCT00619476|400414|P3|NOT COMPLETED|Overall Study||24
172429|NCT00619476|400415|P2|NOT COMPLETED|Overall Study||22
172430|NCT00619476|400416|P1|NOT COMPLETED|Overall Study||31
172431|NCT00619476|400413|P4|COMPLETED|Overall Study||56
172432|NCT00619476|400414|P3|COMPLETED|Overall Study||60
172433|NCT00619476|400415|P2|COMPLETED|Overall Study||85
172434|NCT00619476|400416|P1|COMPLETED|Overall Study||64
172435|NCT00619476|400413|P4|Safety Population|Overall Study||87
172436|NCT00619476|400414|P3|Safety Population|Overall Study||82
172437|NCT00619476|400415|P2|Safety Population|Overall Study||107
172438|NCT00619476|400416|P1|Safety Population|Overall Study||95
172439|NCT00619476|400413|P4|Intent-to-Treat Population|Overall Study||87
172440|NCT00619476|400414|P3|Intent-to-Treat Population|Overall Study||82
172441|NCT00619476|400415|P2|Intent-to-Treat Population|Overall Study||107
172442|NCT00619476|400416|P1|Intent-to-Treat Population|Overall Study||95
172443|NCT00619476|400413|P4|STARTED|Overall Study||90
172444|NCT00619476|400414|P3|STARTED|Overall Study||84
172445|NCT00619476|400415|P2|STARTED|Overall Study||107
172446|NCT00619476|400416|P1|STARTED|Overall Study||95
172447|NCT00619385|400501|P3|NOT COMPLETED|Overall Study||4
172448|NCT00619385|400502|P2|NOT COMPLETED|Overall Study||2
172449|NCT00619385|400503|P1|NOT COMPLETED|Overall Study||1
172450|NCT00619385|400501|P3|COMPLETED|Overall Study||6
172451|NCT00619385|400502|P2|COMPLETED|Overall Study||6
172452|NCT00619385|400503|P1|COMPLETED|Overall Study||6
172453|NCT00619385|400501|P3|STARTED|Overall Study||10
172454|NCT00619385|400502|P2|STARTED|Overall Study||8
172455|NCT00619385|400503|P1|STARTED|Overall Study||7
172456|NCT00619359|400518|P2|NOT COMPLETED|Overall Study||81
172457|NCT00619359|400519|P1|NOT COMPLETED|Overall Study||67
172458|NCT00619359|400518|P2|COMPLETED|Overall Study||1094
172459|NCT00619359|400519|P1|COMPLETED|Overall Study||1080
172460|NCT00619359|400518|P2|STARTED|Overall Study||1175
172461|NCT00619359|400519|P1|STARTED|Overall Study||1147
172462|NCT00619307|400531|P2|NOT COMPLETED|Overall Study||4
172463|NCT00619307|400532|P1|NOT COMPLETED|Overall Study||4
172464|NCT00619307|400531|P2|COMPLETED|Overall Study||53
172465|NCT00619307|400532|P1|COMPLETED|Overall Study||56
172466|NCT00619307|400531|P2|STARTED|Overall Study||57
172467|NCT00619307|400532|P1|STARTED|Overall Study||60
172468|NCT00619242|400546|P1|NOT COMPLETED|Overall Study||0
172469|NCT00619242|400546|P1|COMPLETED|Overall Study||3
172470|NCT00619242|400546|P1|STARTED|Overall Study||3
172471|NCT00619229|400552|P2|NOT COMPLETED|Overall Study||2
172472|NCT00619229|400553|P1|NOT COMPLETED|Overall Study||4
172473|NCT00619229|400552|P2|COMPLETED|Overall Study||16
172474|NCT00619229|400553|P1|COMPLETED|Overall Study||14
172475|NCT00619229|400552|P2|Full Analysis Set (FAS)|Overall Study||17
172476|NCT00619229|400553|P1|Full Analysis Set (FAS)|Overall Study||16
172477|NCT00619229|400552|P2|STARTED|Overall Study||18
172478|NCT00619229|400553|P1|STARTED|Overall Study||18
172479|NCT00619190|400581|P2|NOT COMPLETED|Overall Study||0
172480|NCT00619190|400582|P1|NOT COMPLETED|Overall Study||1
172481|NCT00619190|400581|P2|COMPLETED|Overall Study||9
172482|NCT00619190|400582|P1|COMPLETED|Overall Study||20
172483|NCT00619190|400581|P2|STARTED|Overall Study||9
172484|NCT00619190|400582|P1|STARTED|Overall Study||21
172485|NCT00619177|400592|P1|NOT COMPLETED|Overall Study||508
172486|NCT00619177|400592|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
172487|NCT00619177|400592|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
172488|NCT00619151|400602|P2|NOT COMPLETED|Overall Study||0
172489|NCT00619151|400603|P1|NOT COMPLETED|Overall Study||1
172490|NCT00619151|400602|P2|COMPLETED|Overall Study||0
172491|NCT00619151|400603|P1|COMPLETED|Overall Study||1
172492|NCT00619151|400602|P2|STARTED|Overall Study||0
172493|NCT00619151|400603|P1|STARTED|Overall Study||2
172494|NCT00619112|400611|P1|NOT COMPLETED|Overall Study||0
172495|NCT00619112|400611|P1|COMPLETED|Overall Study|enrolled all patients from Nov 2007 to Jan 2012|60
172496|NCT00619112|400611|P1|STARTED|Overall Study||60
172497|NCT00619099|400617|P2|NOT COMPLETED|Overall Study||19
172498|NCT00619099|400618|P1|NOT COMPLETED|Overall Study||33
172499|NCT00619099|400617|P2|COMPLETED|Overall Study||4
172500|NCT00619099|400618|P1|COMPLETED|Overall Study||11
172501|NCT00619099|400617|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
172502|NCT00619099|400618|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
172503|NCT00619099|400617|P2|STARTED|Overall Study|All randomized subjects|23
172504|NCT00619099|400618|P1|STARTED|Overall Study|All randomized subjects|44
172505|NCT00619073|400624|P2|NOT COMPLETED|Second Intervention - 60 Days||0
172506|NCT00619073|400625|P1|NOT COMPLETED|Second Intervention - 60 Days||0
172507|NCT00619073|400624|P2|COMPLETED|Second Intervention - 60 Days||8
172508|NCT00619073|400625|P1|COMPLETED|Second Intervention - 60 Days||8
172509|NCT00619073|400624|P2|STARTED|Second Intervention - 60 Days||8
172510|NCT00619073|400625|P1|STARTED|Second Intervention - 60 Days||8
172511|NCT00619073|400624|P2|NOT COMPLETED|Washout Period (30 Days)||0
172512|NCT00619073|400625|P1|NOT COMPLETED|Washout Period (30 Days)||0
172513|NCT00619073|400624|P2|COMPLETED|Washout Period (30 Days)||8
172514|NCT00619073|400625|P1|COMPLETED|Washout Period (30 Days)||8
172515|NCT00619073|400624|P2|STARTED|Washout Period (30 Days)||8
172516|NCT00619073|400625|P1|STARTED|Washout Period (30 Days)||8
172517|NCT00619073|400624|P2|NOT COMPLETED|First Intervention - 60 Days||0
172518|NCT00619073|400625|P1|NOT COMPLETED|First Intervention - 60 Days||0
172519|NCT00619073|400624|P2|COMPLETED|First Intervention - 60 Days||8
172520|NCT00619073|400625|P1|COMPLETED|First Intervention - 60 Days||8
172521|NCT00619073|400624|P2|STARTED|First Intervention - 60 Days||8
172522|NCT00619073|400625|P1|STARTED|First Intervention - 60 Days||8
172523|NCT00619060|400631|P2|NOT COMPLETED|Overall Study||0
172524|NCT00619060|400632|P1|NOT COMPLETED|Overall Study||0
172525|NCT00619060|400631|P2|COMPLETED|Overall Study||12
172526|NCT00619060|400632|P1|COMPLETED|Overall Study||10
172527|NCT00619060|400631|P2|STARTED|Overall Study||12
172528|NCT00619060|400632|P1|STARTED|Overall Study||10
172529|NCT00618995|400640|P4|NOT COMPLETED|Period 4||0
172530|NCT00618995|400641|P3|NOT COMPLETED|Period 4||0
172531|NCT00618995|400642|P2|NOT COMPLETED|Period 4||0
172532|NCT00618995|400643|P1|NOT COMPLETED|Period 4||1
172533|NCT00618995|400640|P4|COMPLETED|Period 4||6
172534|NCT00618995|400641|P3|COMPLETED|Period 4||4
172535|NCT00618995|400642|P2|COMPLETED|Period 4||6
172536|NCT00618995|400643|P1|COMPLETED|Period 4||5
172537|NCT00618995|400640|P4|STARTED|Period 4||6
172538|NCT00618995|400641|P3|STARTED|Period 4||4
172539|NCT00618995|400642|P2|STARTED|Period 4||6
172540|NCT00618995|400643|P1|STARTED|Period 4||6
172541|NCT00618995|400640|P4|NOT COMPLETED|Period 3||0
172542|NCT00618995|400641|P3|NOT COMPLETED|Period 3||0
172543|NCT00618995|400642|P2|NOT COMPLETED|Period 3||0
172544|NCT00618995|400643|P1|NOT COMPLETED|Period 3||0
172545|NCT00618995|400640|P4|COMPLETED|Period 3||6
172546|NCT00618995|400641|P3|COMPLETED|Period 3||4
172547|NCT00618995|400642|P2|COMPLETED|Period 3||6
172548|NCT00618995|400643|P1|COMPLETED|Period 3||6
172549|NCT00618995|400640|P4|STARTED|Period 3||6
172550|NCT00618995|400641|P3|STARTED|Period 3||4
172551|NCT00618995|400642|P2|STARTED|Period 3||6
172552|NCT00618995|400643|P1|STARTED|Period 3||6
172553|NCT00618995|400640|P4|NOT COMPLETED|Period 2||0
172554|NCT00618995|400641|P3|NOT COMPLETED|Period 2||1
172555|NCT00618995|400642|P2|NOT COMPLETED|Period 2||0
172556|NCT00618995|400643|P1|NOT COMPLETED|Period 2||0
172557|NCT00618995|400640|P4|COMPLETED|Period 2||6
172558|NCT00618995|400641|P3|COMPLETED|Period 2||4
172559|NCT00618995|400642|P2|COMPLETED|Period 2||6
172560|NCT00618995|400643|P1|COMPLETED|Period 2||6
172561|NCT00618995|400640|P4|STARTED|Period 2||6
172562|NCT00618995|400641|P3|STARTED|Period 2||5
172563|NCT00618995|400642|P2|STARTED|Period 2||6
172564|NCT00618995|400643|P1|STARTED|Period 2||6
172565|NCT00618995|400640|P4|NOT COMPLETED|Period 1||0
172566|NCT00618995|400641|P3|NOT COMPLETED|Period 1||2
172567|NCT00618995|400642|P2|NOT COMPLETED|Period 1||1
172568|NCT00618995|400643|P1|NOT COMPLETED|Period 1||0
172569|NCT00618995|400640|P4|COMPLETED|Period 1||6
172570|NCT00618995|400641|P3|COMPLETED|Period 1||5
172571|NCT00618995|400642|P2|COMPLETED|Period 1||6
172572|NCT00618995|400643|P1|COMPLETED|Period 1||6
172573|NCT00618995|400640|P4|STARTED|Period 1||6
172574|NCT00618995|400641|P3|STARTED|Period 1||7
172575|NCT00618995|400642|P2|STARTED|Period 1||7
172576|NCT00618995|400643|P1|STARTED|Period 1||6
172577|NCT00618982|400657|P1|NOT COMPLETED|Overall Study||50
172578|NCT00618982|400657|P1|COMPLETED|Overall Study||33
172579|NCT00618982|400657|P1|STARTED|Overall Study||83
172580|NCT00618956|400680|P2|NOT COMPLETED|Overall Study||50
172581|NCT00618956|400681|P1|NOT COMPLETED|Overall Study||25
172582|NCT00618956|400680|P2|COMPLETED|Overall Study||160
172583|NCT00618956|400681|P1|COMPLETED|Overall Study||86
172584|NCT00618956|400680|P2|STARTED|Overall Study||210
172585|NCT00618956|400681|P1|STARTED|Overall Study||111
172586|NCT00618839|400697|P1|NOT COMPLETED|Overall Study||0
172587|NCT00618839|400697|P1|COMPLETED|Overall Study||15
172588|NCT00618839|400697|P1|STARTED|Overall Study||15
172589|NCT00618813|400706|P1|NOT COMPLETED|Overall Study||4
172590|NCT00618813|400706|P1|COMPLETED|Overall Study||31
172591|NCT00618813|400706|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
172592|NCT00618813|400706|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
172593|NCT00618813|400706|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
172594|NCT00618813|400706|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
172595|NCT00618813|400706|P1|STARTED|Overall Study||35
172596|NCT00618787|400716|P2|NOT COMPLETED|Overall Study||2
172597|NCT00618787|400717|P1|NOT COMPLETED|Overall Study||3
172598|NCT00618787|400716|P2|COMPLETED|Overall Study||21
172599|NCT00618787|400717|P1|COMPLETED|Overall Study||19
172600|NCT00618787|400716|P2|STARTED|Overall Study||23
172601|NCT00618787|400717|P1|STARTED|Overall Study||22
172602|NCT00618774|400725|P2|NOT COMPLETED|Overall Study||3
172603|NCT00618774|400726|P1|NOT COMPLETED|Overall Study||6
172604|NCT00618774|400725|P2|COMPLETED|Overall Study||45
172605|NCT00618774|400726|P1|COMPLETED|Overall Study||205
172606|NCT00618774|400725|P2|STARTED|Overall Study||48
172607|NCT00618774|400726|P1|STARTED|Overall Study||211
172608|NCT00618748|400759|P3|NOT COMPLETED|Overall Study||14
172609|NCT00618748|400760|P2|NOT COMPLETED|Overall Study||5
172610|NCT00618748|400761|P1|NOT COMPLETED|Overall Study||11
172611|NCT00618748|400759|P3|COMPLETED|Overall Study||6
172612|NCT00618748|400760|P2|COMPLETED|Overall Study||20
172613|NCT00618748|400761|P1|COMPLETED|Overall Study||45
172614|NCT00618748|400759|P3|STARTED|Overall Study||20
172615|NCT00618748|400760|P2|STARTED|Overall Study||25
172616|NCT00618748|400761|P1|STARTED|Overall Study||56
172617|NCT00618722|400806|P4|NOT COMPLETED|Overall Study||4
172618|NCT00618722|400807|P3|NOT COMPLETED|Overall Study||3
172619|NCT00618722|400808|P2|NOT COMPLETED|Overall Study||2
172620|NCT00618722|400809|P1|NOT COMPLETED|Overall Study||3
172621|NCT00618722|400806|P4|COMPLETED|Overall Study||18
172622|NCT00618722|400807|P3|COMPLETED|Overall Study||19
172623|NCT00618722|400808|P2|COMPLETED|Overall Study||18
172624|NCT00618722|400809|P1|COMPLETED|Overall Study||18
172625|NCT00618722|400806|P4|Received Treatment|Overall Study||22
172626|NCT00618722|400807|P3|Received Treatment|Overall Study||22
172627|NCT00618722|400808|P2|Received Treatment|Overall Study||20
172628|NCT00618722|400809|P1|Received Treatment|Overall Study||20
172629|NCT00618722|400806|P4|STARTED|Overall Study||22
172630|NCT00618722|400807|P3|STARTED|Overall Study||22
172631|NCT00618722|400808|P2|STARTED|Overall Study||20
172632|NCT00618722|400809|P1|STARTED|Overall Study||21
172633|NCT00618618|400847|P4|NOT COMPLETED|Overall Study||1
172634|NCT00618618|400848|P3|NOT COMPLETED|Overall Study||3
172635|NCT00618618|400849|P2|NOT COMPLETED|Overall Study||3
172636|NCT00618618|400850|P1|NOT COMPLETED|Overall Study||4
172637|NCT00618618|400847|P4|COMPLETED|Overall Study||13
172638|NCT00618618|400848|P3|COMPLETED|Overall Study||18
172639|NCT00618618|400849|P2|COMPLETED|Overall Study||11
172640|NCT00618618|400850|P1|COMPLETED|Overall Study||20
172641|NCT00618618|400847|P4|Received Treatment|Overall Study||14
172642|NCT00618618|400848|P3|Received Treatment|Overall Study||20
172643|NCT00618618|400849|P2|Received Treatment|Overall Study||13
172644|NCT00618618|400850|P1|Received Treatment|Overall Study||24
172645|NCT00618618|400847|P4|STARTED|Overall Study||14
172646|NCT00618618|400848|P3|STARTED|Overall Study||21
172647|NCT00618618|400849|P2|STARTED|Overall Study||14
172648|NCT00618618|400850|P1|STARTED|Overall Study||24
172649|NCT00618540|400896|P1|NOT COMPLETED|Overall Study||0
172650|NCT00618540|400896|P1|COMPLETED|Overall Study||1
172651|NCT00618540|400896|P1|STARTED|Overall Study||1
172652|NCT00618514|400909|P3|NOT COMPLETED|Overall Study||4
172653|NCT00618514|400910|P2|NOT COMPLETED|Overall Study||12
172654|NCT00618514|400911|P1|NOT COMPLETED|Overall Study||11
172655|NCT00618514|400909|P3|COMPLETED|Overall Study||12
172656|NCT00618514|400910|P2|COMPLETED|Overall Study||26
172657|NCT00618514|400911|P1|COMPLETED|Overall Study||25
172658|NCT00618514|400909|P3|STARTED|Overall Study||16
172659|NCT00618514|400910|P2|STARTED|Overall Study||38
172660|NCT00618514|400911|P1|STARTED|Overall Study||36
172661|NCT00618449|400931|P2|NOT COMPLETED|Overall Study||110
172662|NCT00618449|400932|P1|NOT COMPLETED|Overall Study||98
172663|NCT00618449|400931|P2|COMPLETED|Overall Study||558
172664|NCT00618449|400932|P1|COMPLETED|Overall Study||581
172665|NCT00618449|400931|P2|1-year, Post-treatment|Overall Study||558
172666|NCT00618449|400932|P1|1-year, Post-treatment|Overall Study||581
172667|NCT00618449|400931|P2|1-month, Post-treatment|Overall Study||656
172668|NCT00618449|400932|P1|1-month, Post-treatment|Overall Study||666
172669|NCT00618449|400931|P2|STARTED|Overall Study||668
172670|NCT00618449|400932|P1|STARTED|Overall Study||679
172671|NCT00618436|400940|P2|NOT COMPLETED|Overall Study||0
172672|NCT00618436|400941|P1|NOT COMPLETED|Overall Study||0
172673|NCT00618436|400940|P2|COMPLETED|Overall Study||18
172674|NCT00618436|400941|P1|COMPLETED|Overall Study||34
172675|NCT00618436|400940|P2|STARTED|Overall Study||18
172676|NCT00618436|400941|P1|STARTED|Overall Study||34
172677|NCT00618410|400951|P2|NOT COMPLETED|Second Intervention||0
172678|NCT00618410|400952|P1|NOT COMPLETED|Second Intervention||0
172679|NCT00618410|400951|P2|COMPLETED|Second Intervention||5
172680|NCT00618410|400952|P1|COMPLETED|Second Intervention||7
172681|NCT00618410|400951|P2|STARTED|Second Intervention||5
172682|NCT00618410|400952|P1|STARTED|Second Intervention||7
172683|NCT00618410|400951|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
172684|NCT00618410|400952|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
172685|NCT00618410|400951|P2|COMPLETED|Washout Period (2 Weeks)||5
172686|NCT00618410|400952|P1|COMPLETED|Washout Period (2 Weeks)||7
172687|NCT00618410|400951|P2|STARTED|Washout Period (2 Weeks)||6
172688|NCT00618410|400952|P1|STARTED|Washout Period (2 Weeks)||7
172689|NCT00618410|400951|P2|NOT COMPLETED|First Intervention||0
172690|NCT00618410|400952|P1|NOT COMPLETED|First Intervention||0
172691|NCT00618410|400951|P2|COMPLETED|First Intervention||6
172692|NCT00618410|400952|P1|COMPLETED|First Intervention||7
172693|NCT00618410|400951|P2|STARTED|First Intervention||6
172694|NCT00618410|400952|P1|STARTED|First Intervention||7
172695|NCT00618371|400968|P1|NOT COMPLETED|Overall Study||2
172696|NCT00618371|400968|P1|COMPLETED|Overall Study||10
172697|NCT00618371|400968|P1|STARTED|Overall Study||12
172698|NCT00618332|400975|P2|NOT COMPLETED|Overall Study||0
172699|NCT00618332|400976|P1|NOT COMPLETED|Overall Study||0
172700|NCT00618332|400975|P2|COMPLETED|Overall Study||20
172701|NCT00618332|400976|P1|COMPLETED|Overall Study||20
172702|NCT00618332|400975|P2|STARTED|Overall Study||20
172703|NCT00618332|400976|P1|STARTED|Overall Study||20
172704|NCT00618072|401001|P3|NOT COMPLETED|Overall Study||4
172705|NCT00618072|401002|P2|NOT COMPLETED|Overall Study||1
172706|NCT00618072|401003|P1|NOT COMPLETED|Overall Study||2
172707|NCT00618072|401001|P3|COMPLETED|Overall Study||11
172708|NCT00618072|401002|P2|COMPLETED|Overall Study||14
172709|NCT00618072|401003|P1|COMPLETED|Overall Study||14
172710|NCT00618072|401001|P3|STARTED|Overall Study||15
172711|NCT00618072|401002|P2|STARTED|Overall Study||15
172712|NCT00618072|401003|P1|STARTED|Overall Study||16
172713|NCT00617929|401035|P1|NOT COMPLETED|Overall Study||1
172714|NCT00617929|401035|P1|COMPLETED|Overall Study||11
172715|NCT00617929|401035|P1|STARTED|Overall Study||12
172716|NCT00617903|401047|P2|NOT COMPLETED|Overall Study||7
172717|NCT00617903|401048|P1|NOT COMPLETED|Overall Study||3
172718|NCT00617903|401047|P2|COMPLETED|Overall Study||35
172719|NCT00617903|401048|P1|COMPLETED|Overall Study||38
172720|NCT00617903|401047|P2|STARTED|Overall Study||42
172721|NCT00617903|401048|P1|STARTED|Overall Study||41
172722|NCT00617890|401094|P4|NOT COMPLETED|Overall Study||115
172723|NCT00617890|401095|P3|NOT COMPLETED|Overall Study||35
172724|NCT00617890|401096|P2|NOT COMPLETED|Overall Study||28
172725|NCT00617890|401097|P1|NOT COMPLETED|Overall Study||31
172726|NCT00617890|401094|P4|COMPLETED|Overall Study||1
172727|NCT00617890|401095|P3|COMPLETED|Overall Study||0
172728|NCT00617890|401096|P2|COMPLETED|Overall Study||5
172729|NCT00617890|401097|P1|COMPLETED|Overall Study||4
172730|NCT00617890|401094|P4|Received Treatment|Overall Study||115
172731|NCT00617890|401095|P3|Received Treatment|Overall Study||34
172732|NCT00617890|401096|P2|Received Treatment|Overall Study||33
172733|NCT00617890|401097|P1|Received Treatment|Overall Study||34
172734|NCT00617890|401094|P4|STARTED|Overall Study||116
172735|NCT00617890|401095|P3|STARTED|Overall Study||35
172736|NCT00617890|401096|P2|STARTED|Overall Study||33
172737|NCT00617890|401097|P1|STARTED|Overall Study||35
172738|NCT00617851|401133|P4|NOT COMPLETED|Overall Study||25
172739|NCT00617851|401134|P3|NOT COMPLETED|Overall Study||45
172740|NCT00617851|401135|P2|NOT COMPLETED|Overall Study||40
172741|NCT00617851|401136|P1|NOT COMPLETED|Overall Study||47
172742|NCT00617851|401133|P4|COMPLETED|Overall Study||192
172743|NCT00617851|401134|P3|COMPLETED|Overall Study||384
172744|NCT00617851|401135|P2|COMPLETED|Overall Study||391
172745|NCT00617851|401136|P1|COMPLETED|Overall Study||383
172746|NCT00617851|401133|P4|STARTED|Overall Study||217
172747|NCT00617851|401134|P3|STARTED|Overall Study||429
172748|NCT00617851|401135|P2|STARTED|Overall Study||431
172749|NCT00617851|401136|P1|STARTED|Overall Study||430
172750|NCT00617773|401174|P1|NOT COMPLETED|Overall Study||24
172751|NCT00617773|401174|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
172752|NCT00617773|401174|P1|STARTED|Overall Study||31
172753|NCT00617708|401192|P3|NOT COMPLETED|Overall Study||64
172754|NCT00617708|401193|P2|NOT COMPLETED|Overall Study||60
172755|NCT00617708|401194|P1|NOT COMPLETED|Overall Study||10
172756|NCT00617708|401192|P3|COMPLETED|Overall Study||0
172757|NCT00617708|401193|P2|COMPLETED|Overall Study||0
172758|NCT00617708|401194|P1|COMPLETED|Overall Study||0
172759|NCT00617708|401192|P3|Eligible and Began Protocol Therapy|Overall Study||59
172760|NCT00617708|401193|P2|Eligible and Began Protocol Therapy|Overall Study||57
172761|NCT00617708|401194|P1|Eligible and Began Protocol Therapy|Overall Study||9
172762|NCT00617708|401192|P3|STARTED|Overall Study||64
172763|NCT00617708|401193|P2|STARTED|Overall Study||60
172764|NCT00617708|401194|P1|STARTED|Overall Study||10
172765|NCT00617669|401211|P2|NOT COMPLETED|Overall Study||451
172766|NCT00617669|401212|P1|NOT COMPLETED|Overall Study||430
172767|NCT00617669|401211|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
172768|NCT00617669|401212|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
172769|NCT00617669|401211|P2|Patients Who Received IP|Overall Study||525
172770|NCT00617669|401212|P1|Patients Who Received IP|Overall Study||522
172771|NCT00617669|401211|P2|STARTED|Overall Study||528
172772|NCT00617669|401212|P1|STARTED|Overall Study||524
172773|NCT00617604|401234|P2|NOT COMPLETED|Overall Study||20
172774|NCT00617604|401235|P1|NOT COMPLETED|Overall Study||18
172775|NCT00617604|401234|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
172776|NCT00617604|401235|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
172777|NCT00617604|401234|P2|Completed 12 Weeks of Treatment|Overall Study||83
172778|NCT00617604|401235|P1|Completed 12 Weeks of Treatment|Overall Study||89
172779|NCT00617604|401234|P2|Received Treatment|Overall Study||105
172780|NCT00617604|401235|P1|Received Treatment|Overall Study||107
172781|NCT00617604|401234|P2|STARTED|Overall Study||108
172782|NCT00617604|401235|P1|STARTED|Overall Study||110
172783|NCT00617591|401279|P1|NOT COMPLETED|Overall Study||10
172784|NCT00617591|401279|P1|COMPLETED|Overall Study||47
172785|NCT00617591|401279|P1|STARTED|Overall Study||57
172786|NCT00617461|401287|P2|NOT COMPLETED|6-Day Down-Titration Period||2
172787|NCT00617461|401288|P1|NOT COMPLETED|6-Day Down-Titration Period||2
172788|NCT00617461|401287|P2|COMPLETED|6-Day Down-Titration Period||35
172789|NCT00617461|401288|P1|COMPLETED|6-Day Down-Titration Period||39
172790|NCT00617461|401287|P2|STARTED|6-Day Down-Titration Period||37
172791|NCT00617461|401288|P1|STARTED|6-Day Down-Titration Period||41
172792|NCT00617461|401287|P2|NOT COMPLETED|Second Treatment Intervention Period||4
172793|NCT00617461|401288|P1|NOT COMPLETED|Second Treatment Intervention Period||0
172794|NCT00617461|401287|P2|COMPLETED|Second Treatment Intervention Period||37
172795|NCT00617461|401288|P1|COMPLETED|Second Treatment Intervention Period||41
172796|NCT00617461|401287|P2|STARTED|Second Treatment Intervention Period||41
172797|NCT00617461|401288|P1|STARTED|Second Treatment Intervention Period||41
172798|NCT00617461|401287|P2|NOT COMPLETED|4-Day Crossover Period||0
172799|NCT00617461|401288|P1|NOT COMPLETED|4-Day Crossover Period||1
172800|NCT00617461|401287|P2|COMPLETED|4-Day Crossover Period||40
172801|NCT00617461|401288|P1|COMPLETED|4-Day Crossover Period||41
172802|NCT00617461|401287|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
172803|NCT00617461|401288|P1|STARTED|4-Day Crossover Period||42
172804|NCT00617461|401287|P2|NOT COMPLETED|First Treatment Intervention Period||3
172805|NCT00617461|401288|P1|NOT COMPLETED|First Treatment Intervention Period||10
172806|NCT00617461|401287|P2|COMPLETED|First Treatment Intervention Period||41
172807|NCT00617461|401288|P1|COMPLETED|First Treatment Intervention Period||42
172808|NCT00617461|401287|P2|STARTED|First Treatment Intervention Period||44
172809|NCT00617461|401288|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
172810|NCT00617409|401344|P3|NOT COMPLETED|Overall Study||27
172811|NCT00617409|401345|P2|NOT COMPLETED|Overall Study||18
172812|NCT00617409|401346|P1|NOT COMPLETED|Overall Study||16
172813|NCT00617409|401344|P3|COMPLETED|Overall Study||4
172814|NCT00617409|401345|P2|COMPLETED|Overall Study||2
172815|NCT00617409|401346|P1|COMPLETED|Overall Study||2
172816|NCT00617409|401344|P3|STARTED|Overall Study||31
172817|NCT00617409|401345|P2|STARTED|Overall Study||20
172818|NCT00617409|401346|P1|STARTED|Overall Study||18
172819|NCT00617396|401357|P1|NOT COMPLETED|Overall Study||0
172820|NCT00617396|401357|P1|COMPLETED|Overall Study||25
172821|NCT00617396|401357|P1|STARTED|Overall Study||25
172822|NCT00617357|401361|P1|NOT COMPLETED|Overall Study||16
172823|NCT00617357|401361|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
172917|NCT00616928|401641|P3|STARTED|Overall Study||1118
172824|NCT00617357|401361|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
172825|NCT00617305|401374|P3|NOT COMPLETED|Overall Study||1
172826|NCT00617305|401375|P2|NOT COMPLETED|Overall Study||0
172827|NCT00617305|401376|P1|NOT COMPLETED|Overall Study||8
172828|NCT00617305|401374|P3|COMPLETED|Overall Study||0
172829|NCT00617305|401375|P2|COMPLETED|Overall Study||4
172830|NCT00617305|401376|P1|COMPLETED|Overall Study||25
172831|NCT00617305|401374|P3|Completed 24-week Primary Analysis|Overall Study||0
172832|NCT00617305|401375|P2|Completed 24-week Primary Analysis|Overall Study||4
172833|NCT00617305|401376|P1|Completed 24-week Primary Analysis|Overall Study||31
172834|NCT00617305|401374|P3|STARTED|Overall Study||1
172835|NCT00617305|401375|P2|STARTED|Overall Study||4
172836|NCT00617305|401376|P1|STARTED|Overall Study||33
172837|NCT00617279|401432|P2|NOT COMPLETED|Overall Study||17
172838|NCT00617279|401433|P1|NOT COMPLETED|Overall Study||14
172839|NCT00617279|401432|P2|COMPLETED|Overall Study||0
172840|NCT00617279|401433|P1|COMPLETED|Overall Study||0
172841|NCT00617279|401432|P2|STARTED|Overall Study||17
172842|NCT00617279|401433|P1|STARTED|Overall Study||14
172843|NCT00617240|401489|P2|NOT COMPLETED|Overall Study||0
172844|NCT00617240|401490|P1|NOT COMPLETED|Overall Study||1
172845|NCT00617240|401489|P2|COMPLETED|Overall Study||4
172846|NCT00617240|401490|P1|COMPLETED|Overall Study||4
172847|NCT00617240|401489|P2|STARTED|Overall Study||4
172848|NCT00617240|401490|P1|STARTED|Overall Study||5
172849|NCT00617201|401510|P2|NOT COMPLETED|Overall Study||13
172850|NCT00617201|401511|P1|NOT COMPLETED|Overall Study||9
172851|NCT00617201|401510|P2|COMPLETED|Overall Study||12
172852|NCT00617201|401511|P1|COMPLETED|Overall Study||16
172853|NCT00617201|401510|P2|STARTED|Overall Study||25
172854|NCT00617201|401511|P1|STARTED|Overall Study||25
172855|NCT00617188|401519|P1|NOT COMPLETED|Overall Study||0
172856|NCT00617188|401519|P1|COMPLETED|Overall Study||26
172857|NCT00617188|401519|P1|STARTED|Overall Study||26
172858|NCT00617175|401530|P2|NOT COMPLETED|Overall Study||0
172859|NCT00617175|401531|P1|NOT COMPLETED|Overall Study||0
172860|NCT00617175|401530|P2|COMPLETED|Overall Study||948
172861|NCT00617175|401531|P1|COMPLETED|Overall Study||954
172862|NCT00617175|401530|P2|STARTED|Overall Study||948
172863|NCT00617175|401531|P1|STARTED|Overall Study||954
172864|NCT00617123|401539|P2|NOT COMPLETED|Study Treatment Period||16
172865|NCT00617123|401540|P1|NOT COMPLETED|Study Treatment Period||17
172866|NCT00617123|401539|P2|COMPLETED|Study Treatment Period||79
172867|NCT00617123|401540|P1|COMPLETED|Study Treatment Period||81
172868|NCT00617123|401539|P2|Treated|Study Treatment Period||95
172869|NCT00617123|401540|P1|Treated|Study Treatment Period|1 participant was not treated|97
172870|NCT00617123|401539|P2|STARTED|Study Treatment Period||95
172871|NCT00617123|401540|P1|STARTED|Study Treatment Period||98
172872|NCT00617123|401539|P2|NOT COMPLETED|Referral Screening Period||26
172873|NCT00617123|401540|P1|NOT COMPLETED|Referral Screening Period||39
172874|NCT00617123|401539|P2|COMPLETED|Referral Screening Period||95
172875|NCT00617123|401540|P1|COMPLETED|Referral Screening Period||98
172876|NCT00617123|401539|P2|STARTED|Referral Screening Period||121
172877|NCT00617123|401540|P1|STARTED|Referral Screening Period||137
172878|NCT00617097|401556|P2|NOT COMPLETED|Overall Study||0
172879|NCT00617097|401557|P1|NOT COMPLETED|Overall Study||0
172880|NCT00617097|401556|P2|COMPLETED|Overall Study||25
172881|NCT00617097|401557|P1|COMPLETED|Overall Study||25
172882|NCT00617097|401556|P2|STARTED|Overall Study||25
172883|NCT00617097|401557|P1|STARTED|Overall Study||25
172884|NCT00617084|401571|P2|NOT COMPLETED|Overall Study||26
172885|NCT00617084|401572|P1|NOT COMPLETED|Overall Study||21
172886|NCT00617084|401571|P2|COMPLETED|Overall Study||1126
172887|NCT00617084|401572|P1|COMPLETED|Overall Study||1119
172888|NCT00617084|401571|P2|STARTED|Overall Study||1152
172889|NCT00617084|401572|P1|STARTED|Overall Study||1140
172890|NCT00617058|401583|P3|NOT COMPLETED|Overall Study||0
172891|NCT00617058|401584|P2|NOT COMPLETED|Overall Study||0
172892|NCT00617058|401585|P1|NOT COMPLETED|Overall Study||0
172893|NCT00617058|401583|P3|COMPLETED|Overall Study||0
172894|NCT00617058|401584|P2|COMPLETED|Overall Study||0
172895|NCT00617058|401585|P1|COMPLETED|Overall Study||1
172896|NCT00617058|401583|P3|STARTED|Overall Study||0
172897|NCT00617058|401584|P2|STARTED|Overall Study||0
172898|NCT00617058|401585|P1|STARTED|Overall Study||1
172899|NCT00616967|401625|P3|NOT COMPLETED|Overall Study||1
172900|NCT00616967|401626|P2|NOT COMPLETED|Overall Study||0
172901|NCT00616967|401627|P1|NOT COMPLETED|Overall Study||0
172902|NCT00616967|401625|P3|COMPLETED|Overall Study||30
172903|NCT00616967|401626|P2|COMPLETED|Overall Study||31
172904|NCT00616967|401627|P1|COMPLETED|Overall Study||6
172905|NCT00616967|401625|P3|STARTED|Overall Study||31
172906|NCT00616967|401626|P2|STARTED|Overall Study||31
172907|NCT00616967|401627|P1|STARTED|Overall Study||6
172908|NCT00616928|401640|P4|NOT COMPLETED|Overall Study||7
172909|NCT00616928|401641|P3|NOT COMPLETED|Overall Study||17
172910|NCT00616928|401642|P2|NOT COMPLETED|Overall Study||18
172911|NCT00616928|401643|P1|NOT COMPLETED|Overall Study||62
172912|NCT00616928|401640|P4|COMPLETED|Overall Study||364
172913|NCT00616928|401641|P3|COMPLETED|Overall Study||1101
172914|NCT00616928|401642|P2|COMPLETED|Overall Study||750
172915|NCT00616928|401643|P1|COMPLETED|Overall Study||2242
172916|NCT00616928|401640|P4|STARTED|Overall Study||371
172918|NCT00616928|401642|P2|STARTED|Overall Study||768
172919|NCT00616928|401643|P1|STARTED|Overall Study||2304
172920|NCT00616902|401707|P2|NOT COMPLETED|Overall Study||6
172921|NCT00616902|401708|P1|NOT COMPLETED|Overall Study||6
172922|NCT00616902|401707|P2|COMPLETED|Overall Study||0
172923|NCT00616902|401708|P1|COMPLETED|Overall Study||0
172924|NCT00616902|401707|P2|STARTED|Overall Study||6
172925|NCT00616902|401708|P1|STARTED|Overall Study||6
172926|NCT00616772|401734|P2|NOT COMPLETED|Overall Study||102
172927|NCT00616772|401735|P1|NOT COMPLETED|Overall Study||115
172928|NCT00616772|401734|P2|COMPLETED|Overall Study||240
172929|NCT00616772|401735|P1|COMPLETED|Overall Study||225
172930|NCT00616772|401734|P2|Treated|Overall Study||339
172931|NCT00616772|401735|P1|Treated|Overall Study||337
172932|NCT00616772|401734|P2|STARTED|Overall Study||342
172933|NCT00616772|401735|P1|STARTED|Overall Study||340
172934|NCT00616759|401751|P2|NOT COMPLETED|Overall Study||2
172935|NCT00616759|401752|P1|NOT COMPLETED|Overall Study||3
172936|NCT00616759|401751|P2|COMPLETED|Overall Study||8
172937|NCT00616759|401752|P1|COMPLETED|Overall Study||7
172938|NCT00616759|401751|P2|STARTED|Overall Study||10
172939|NCT00616759|401752|P1|STARTED|Overall Study||10
172940|NCT00616655|401761|P3|NOT COMPLETED|Overall Study||48
172941|NCT00616655|401762|P2|NOT COMPLETED|Overall Study||41
172942|NCT00616655|401763|P1|NOT COMPLETED|Overall Study||35
172943|NCT00616655|401761|P3|COMPLETED|Overall Study||103
172944|NCT00616655|401762|P2|COMPLETED|Overall Study||112
172945|NCT00616655|401763|P1|COMPLETED|Overall Study||117
172946|NCT00616655|401761|P3|STARTED|Overall Study||151
172947|NCT00616655|401762|P2|STARTED|Overall Study||153
172948|NCT00616655|401763|P1|STARTED|Overall Study||152
172949|NCT00616642|401803|P2|NOT COMPLETED|Overall Study||1
172950|NCT00616642|401804|P1|NOT COMPLETED|Overall Study||0
172951|NCT00616642|401803|P2|COMPLETED|Overall Study||0
172952|NCT00616642|401804|P1|COMPLETED|Overall Study||0
172953|NCT00616642|401803|P2|STARTED|Overall Study||1
172954|NCT00616642|401804|P1|STARTED|Overall Study||0
172955|NCT00616629|401815|P5|NOT COMPLETED|Overall Study||0
172956|NCT00616629|401816|P4|NOT COMPLETED|Overall Study||0
172957|NCT00616629|401817|P3|NOT COMPLETED|Overall Study||1
172958|NCT00616629|401818|P2|NOT COMPLETED|Overall Study||2
172959|NCT00616629|401819|P1|NOT COMPLETED|Overall Study||2
172960|NCT00616629|401815|P5|COMPLETED|Overall Study||12
172961|NCT00616629|401816|P4|COMPLETED|Overall Study||2
172962|NCT00616629|401817|P3|COMPLETED|Overall Study||13
172963|NCT00616629|401818|P2|COMPLETED|Overall Study||12
172964|NCT00616629|401819|P1|COMPLETED|Overall Study||11
172965|NCT00616629|401815|P5|STARTED|Overall Study||12
172966|NCT00616629|401816|P4|STARTED|Overall Study||2
172967|NCT00616629|401817|P3|STARTED|Overall Study|One patient never received study drug|14
172968|NCT00616629|401818|P2|STARTED|Overall Study|Two patients never received study drug|14
172969|NCT00616629|401819|P1|STARTED|Overall Study|Two patients never received study drug|13
172970|NCT00616603|401864|P3|NOT COMPLETED|Overall Study||2
172971|NCT00616603|401865|P2|NOT COMPLETED|Overall Study||0
172972|NCT00616603|401866|P1|NOT COMPLETED|Overall Study||2
172973|NCT00616603|401864|P3|COMPLETED|Overall Study||13
172974|NCT00616603|401865|P2|COMPLETED|Overall Study||14
172975|NCT00616603|401866|P1|COMPLETED|Overall Study||12
172976|NCT00616603|401864|P3|STARTED|Overall Study||15
172977|NCT00616603|401865|P2|STARTED|Overall Study||14
172978|NCT00616603|401866|P1|STARTED|Overall Study||14
172979|NCT00616577|401877|P3|NOT COMPLETED|Overall Study||0
172980|NCT00616577|401878|P2|NOT COMPLETED|Overall Study||0
172981|NCT00616577|401879|P1|NOT COMPLETED|Overall Study||0
172982|NCT00616577|401877|P3|COMPLETED|Overall Study||7
172983|NCT00616577|401878|P2|COMPLETED|Overall Study||9
172984|NCT00616577|401879|P1|COMPLETED|Overall Study||6
172985|NCT00616577|401877|P3|STARTED|Overall Study||7
172986|NCT00616577|401878|P2|STARTED|Overall Study||9
172987|NCT00616577|401879|P1|STARTED|Overall Study||6
172988|NCT00616434|401889|P2|NOT COMPLETED|Overall Study||8
172989|NCT00616434|401890|P1|NOT COMPLETED|Overall Study||6
172990|NCT00616434|401889|P2|COMPLETED|Overall Study||53
172991|NCT00616434|401890|P1|COMPLETED|Overall Study||56
172992|NCT00616434|401889|P2|STARTED|Overall Study||61
172993|NCT00616434|401890|P1|STARTED|Overall Study||62
172994|NCT00616421|401903|P3|NOT COMPLETED|Overall Study||41
172995|NCT00616421|401904|P2|NOT COMPLETED|Overall Study||38
172996|NCT00616421|401905|P1|NOT COMPLETED|Overall Study||26
172997|NCT00616421|401903|P3|COMPLETED|Overall Study||1229
172998|NCT00616421|401904|P2|COMPLETED|Overall Study||1240
172999|NCT00616421|401905|P1|COMPLETED|Overall Study||333
173000|NCT00616421|401903|P3|STARTED|Overall Study||1270
173001|NCT00616421|401904|P2|STARTED|Overall Study||1278
173002|NCT00616421|401905|P1|STARTED|Overall Study||359
173003|NCT00616343|401942|P1|NOT COMPLETED|Overall Study||0
173004|NCT00616343|401942|P1|COMPLETED|Overall Study||9
173005|NCT00616343|401942|P1|STARTED|Overall Study||9
173006|NCT00616239|401946|P1|NOT COMPLETED|Overall Study||2
173007|NCT00616239|401946|P1|COMPLETED|Overall Study||18
173008|NCT00616239|401946|P1|STARTED|Overall Study||20
173009|NCT00614198|401952|P2|NOT COMPLETED|Stage 2||12
173010|NCT00614198|401953|P1|NOT COMPLETED|Stage 2||8
173011|NCT00614198|401952|P2|COMPLETED|Stage 2||17
173012|NCT00614198|401953|P1|COMPLETED|Stage 2||18
173093|NCT00615550|402099|P2|STARTED|Overall Study||236
173013|NCT00614198|401952|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
173014|NCT00614198|401953|P1|STARTED|Stage 2||26
173015|NCT00614198|401952|P2|NOT COMPLETED|Stage 1||5
173016|NCT00614198|401953|P1|NOT COMPLETED|Stage 1||12
173017|NCT00614198|401952|P2|COMPLETED|Stage 1||29
173018|NCT00614198|401953|P1|COMPLETED|Stage 1||26
173019|NCT00614198|401952|P2|STARTED|Stage 1||34
173020|NCT00614198|401953|P1|STARTED|Stage 1||38
173021|NCT00616200|401959|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
173022|NCT00616200|401959|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
173023|NCT00616200|401959|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
173024|NCT00616200|401959|P1|NOT COMPLETED|Two Week Standard Diet||1
173025|NCT00616200|401959|P1|COMPLETED|Two Week Standard Diet||16
173026|NCT00616200|401959|P1|STARTED|Two Week Standard Diet||17
173027|NCT00616122|401965|P1|NOT COMPLETED|Overall Study||7
173028|NCT00616122|401965|P1|COMPLETED|Overall Study||25
173029|NCT00616122|401965|P1|STARTED|Overall Study||32
173030|NCT00616109|401972|P1|NOT COMPLETED|Overall Study||0
173031|NCT00616109|401972|P1|COMPLETED|Overall Study||16
173032|NCT00616109|401972|P1|STARTED|Overall Study||16
173033|NCT00616018|401979|P1|NOT COMPLETED|Overall Study||3
173034|NCT00616018|401979|P1|COMPLETED|Overall Study||24
173035|NCT00616018|401979|P1|STARTED|Overall Study||27
173036|NCT00615992|401984|P1|NOT COMPLETED|Overall Study||67
173037|NCT00615992|401984|P1|COMPLETED|Overall Study||687
173038|NCT00615992|401984|P1|STARTED|Overall Study||754
173039|NCT00615927|401995|P2|NOT COMPLETED|Overall Study||0
173040|NCT00615927|401996|P1|NOT COMPLETED|Overall Study||0
173041|NCT00615927|401995|P2|COMPLETED|Overall Study||32
173042|NCT00615927|401996|P1|COMPLETED|Overall Study||32
173043|NCT00615927|401995|P2|STARTED|Overall Study||32
173044|NCT00615927|401996|P1|STARTED|Overall Study||32
173045|NCT00615914|402010|P1|NOT COMPLETED|Overall Study||637
173046|NCT00615914|402010|P1|COMPLETED|Overall Study||1008
173047|NCT00615914|402010|P1|STARTED|Overall Study|The number of patients enrolled|1645
173048|NCT00615836|402021|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
173049|NCT00615836|402022|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
173050|NCT00615836|402023|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
173051|NCT00615836|402024|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
173052|NCT00615836|402025|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
173053|NCT00615836|402021|P5|COMPLETED|Extension Study (FE992026 CS31)||0
173054|NCT00615836|402022|P4|COMPLETED|Extension Study (FE992026 CS31)||53
173055|NCT00615836|402023|P3|COMPLETED|Extension Study (FE992026 CS31)||59
173056|NCT00615836|402024|P2|COMPLETED|Extension Study (FE992026 CS31)||58
173057|NCT00615836|402025|P1|COMPLETED|Extension Study (FE992026 CS31)||0
173058|NCT00615836|402021|P5|STARTED|Extension Study (FE992026 CS31)||0
173059|NCT00615836|402022|P4|STARTED|Extension Study (FE992026 CS31)||137
173060|NCT00615836|402023|P3|STARTED|Extension Study (FE992026 CS31)||132
173061|NCT00615836|402024|P2|STARTED|Extension Study (FE992026 CS31)||144
173062|NCT00615836|402025|P1|STARTED|Extension Study (FE992026 CS31)||141
173063|NCT00615836|402021|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
173064|NCT00615836|402022|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
173065|NCT00615836|402023|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
173066|NCT00615836|402024|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
173067|NCT00615836|402025|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
173068|NCT00615836|402021|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
173069|NCT00615836|402022|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
173070|NCT00615836|402023|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
173071|NCT00615836|402024|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
173072|NCT00615836|402025|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
173073|NCT00615836|402021|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
173074|NCT00615836|402022|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
173075|NCT00615836|402023|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
173076|NCT00615836|402024|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
173077|NCT00615836|402025|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
173078|NCT00615836|402021|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
173079|NCT00615836|402022|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
173080|NCT00615836|402023|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
173081|NCT00615836|402024|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
173082|NCT00615836|402025|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
173083|NCT00615719|402085|P1|NOT COMPLETED|Overall Study||5
173084|NCT00615719|402085|P1|COMPLETED|Overall Study||30
173085|NCT00615719|402085|P1|STARTED|Overall Study||35
173086|NCT00615589|402089|P1|NOT COMPLETED|Overall Study||0
173087|NCT00615589|402089|P1|COMPLETED|Overall Study||22
173088|NCT00615589|402089|P1|STARTED|Overall Study||22
173089|NCT00615550|402099|P2|NOT COMPLETED|Overall Study||1
173090|NCT00615550|402100|P1|NOT COMPLETED|Overall Study||6
173091|NCT00615550|402099|P2|COMPLETED|Overall Study||235
173092|NCT00615550|402100|P1|COMPLETED|Overall Study||223
173094|NCT00615550|402100|P1|STARTED|Overall Study||229
173095|NCT00615472|402116|P2|NOT COMPLETED|Overall Study||0
173096|NCT00615472|402117|P1|NOT COMPLETED|Overall Study||0
173097|NCT00615472|402116|P2|COMPLETED|Overall Study||28
173098|NCT00615472|402117|P1|COMPLETED|Overall Study||30
173099|NCT00615472|402116|P2|STARTED|Overall Study||28
173100|NCT00615472|402117|P1|STARTED|Overall Study||30
173101|NCT00615459|402123|P4|NOT COMPLETED|Period III||0
173102|NCT00615459|402124|P3|NOT COMPLETED|Period III||1
173103|NCT00615459|402125|P2|NOT COMPLETED|Period III||3
173104|NCT00615459|402126|P1|NOT COMPLETED|Period III||0
173105|NCT00615459|402123|P4|COMPLETED|Period III||41
173106|NCT00615459|402124|P3|COMPLETED|Period III||39
173107|NCT00615459|402125|P2|COMPLETED|Period III||37
173108|NCT00615459|402126|P1|COMPLETED|Period III||36
173109|NCT00615459|402123|P4|STARTED|Period III||41
173110|NCT00615459|402124|P3|STARTED|Period III||40
173111|NCT00615459|402125|P2|STARTED|Period III||40
173112|NCT00615459|402126|P1|STARTED|Period III||36
173113|NCT00615459|402123|P4|NOT COMPLETED|Period II||1
173114|NCT00615459|402124|P3|NOT COMPLETED|Period II||0
173115|NCT00615459|402125|P2|NOT COMPLETED|Period II||0
173116|NCT00615459|402126|P1|NOT COMPLETED|Period II||1
173117|NCT00615459|402123|P4|COMPLETED|Period II||41
173118|NCT00615459|402124|P3|COMPLETED|Period II||40
173119|NCT00615459|402125|P2|COMPLETED|Period II||40
173120|NCT00615459|402126|P1|COMPLETED|Period II||36
173121|NCT00615459|402123|P4|STARTED|Period II||42
173122|NCT00615459|402124|P3|STARTED|Period II||40
173123|NCT00615459|402125|P2|STARTED|Period II||40
173124|NCT00615459|402126|P1|STARTED|Period II||37
173125|NCT00615459|402123|P4|NOT COMPLETED|Period I||1
173126|NCT00615459|402124|P3|NOT COMPLETED|Period I||2
173127|NCT00615459|402125|P2|NOT COMPLETED|Period I||1
173128|NCT00615459|402126|P1|NOT COMPLETED|Period I||4
173129|NCT00615459|402123|P4|COMPLETED|Period I||42
173130|NCT00615459|402124|P3|COMPLETED|Period I||40
173131|NCT00615459|402125|P2|COMPLETED|Period I||40
173132|NCT00615459|402126|P1|COMPLETED|Period I||37
173133|NCT00615459|402123|P4|STARTED|Period I||43
173134|NCT00615459|402124|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
173135|NCT00615459|402125|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
173136|NCT00615459|402126|P1|STARTED|Period I||41
173137|NCT00615433|402144|P4|NOT COMPLETED|Overall Study||45
173138|NCT00615433|402145|P3|NOT COMPLETED|Overall Study||39
173139|NCT00615433|402146|P2|NOT COMPLETED|Overall Study||53
173140|NCT00615433|402147|P1|NOT COMPLETED|Overall Study||43
173141|NCT00615433|402144|P4|COMPLETED|Overall Study||71
173142|NCT00615433|402145|P3|COMPLETED|Overall Study||84
173143|NCT00615433|402146|P2|COMPLETED|Overall Study||66
173144|NCT00615433|402147|P1|COMPLETED|Overall Study||77
173145|NCT00615433|402144|P4|STARTED|Overall Study||116
173146|NCT00615433|402145|P3|STARTED|Overall Study||123
173147|NCT00615433|402146|P2|STARTED|Overall Study||119
173148|NCT00615433|402147|P1|STARTED|Overall Study||120
173149|NCT00614120|402165|P4|NOT COMPLETED|Overall Study||16
173150|NCT00614120|402166|P3|NOT COMPLETED|Overall Study||59
173151|NCT00614120|402167|P2|NOT COMPLETED|Overall Study||46
173152|NCT00614120|402168|P1|NOT COMPLETED|Overall Study||29
173153|NCT00614120|402165|P4|COMPLETED|Overall Study||215
173154|NCT00614120|402166|P3|COMPLETED|Overall Study||175
173155|NCT00614120|402167|P2|COMPLETED|Overall Study||187
173156|NCT00614120|402168|P1|COMPLETED|Overall Study||202
173157|NCT00614120|402165|P4|Exposed to Study Drug|Overall Study||231
173158|NCT00614120|402166|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
173159|NCT00614120|402167|P2|Exposed to Study Drug|Overall Study||233
173160|NCT00614120|402168|P1|Exposed to Study Drug|Overall Study||231
173161|NCT00614120|402165|P4|STARTED|Overall Study|Randomised|231
173162|NCT00614120|402166|P3|STARTED|Overall Study|Randomised|234
173163|NCT00614120|402167|P2|STARTED|Overall Study|Randomised|233
173164|NCT00614120|402168|P1|STARTED|Overall Study|Randomised|231
173165|NCT00614055|402209|P3|NOT COMPLETED|Overall Study||5
173166|NCT00614055|402210|P2|NOT COMPLETED|Overall Study||6
173167|NCT00614055|402211|P1|NOT COMPLETED|Overall Study||4
173168|NCT00614055|402209|P3|COMPLETED|Overall Study||55
173169|NCT00614055|402210|P2|COMPLETED|Overall Study||53
173170|NCT00614055|402211|P1|COMPLETED|Overall Study||55
173171|NCT00614055|402209|P3|Exposed|Overall Study||60
173172|NCT00614055|402210|P2|Exposed|Overall Study||59
173173|NCT00614055|402211|P1|Exposed|Overall Study||59
173174|NCT00614055|402209|P3|STARTED|Overall Study||60
173175|NCT00614055|402210|P2|STARTED|Overall Study||59
173176|NCT00614055|402211|P1|STARTED|Overall Study||59
173177|NCT00613951|402258|P3|NOT COMPLETED|Overall Study||5
173178|NCT00613951|402259|P2|NOT COMPLETED|Overall Study||5
173179|NCT00613951|402260|P1|NOT COMPLETED|Overall Study||7
173180|NCT00613951|402258|P3|COMPLETED|Overall Study||57
173181|NCT00613951|402259|P2|COMPLETED|Overall Study||54
173182|NCT00613951|402260|P1|COMPLETED|Overall Study||54
173183|NCT00613951|402258|P3|Exposed|Overall Study||62
173184|NCT00613951|402259|P2|Exposed|Overall Study||59
173185|NCT00613951|402260|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
173186|NCT00613951|402258|P3|STARTED|Overall Study||62
173187|NCT00613951|402259|P2|STARTED|Overall Study||59
173188|NCT00613951|402260|P1|STARTED|Overall Study||61
173189|NCT00615290|402301|P1|NOT COMPLETED|Overall Study||8
173190|NCT00615290|402301|P1|COMPLETED|Overall Study||34
173191|NCT00615290|402301|P1|STARTED|Overall Study||42
173192|NCT00615264|402315|P2|NOT COMPLETED|Overall Study||52
173193|NCT00615264|402316|P1|NOT COMPLETED|Overall Study||50
173194|NCT00615264|402315|P2|COMPLETED|Overall Study||180
173195|NCT00615264|402316|P1|COMPLETED|Overall Study||175
173196|NCT00615264|402315|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
173197|NCT00615264|402316|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
173198|NCT00615264|402315|P2|Received at Least One Dose (ITT)|Overall Study||231
173199|NCT00615264|402316|P1|Received at Least One Dose (ITT)|Overall Study||225
173200|NCT00615264|402315|P2|STARTED|Overall Study||232
173201|NCT00615264|402316|P1|STARTED|Overall Study||225
173202|NCT00615199|402328|P4|NOT COMPLETED|Overall Study||2
173203|NCT00615199|402329|P3|NOT COMPLETED|Overall Study||1
173204|NCT00615199|402330|P2|NOT COMPLETED|Overall Study||2
173205|NCT00615199|402331|P1|NOT COMPLETED|Overall Study||8
173206|NCT00615199|402328|P4|COMPLETED|Overall Study||33
173207|NCT00615199|402329|P3|COMPLETED|Overall Study||33
173208|NCT00615199|402330|P2|COMPLETED|Overall Study||34
173209|NCT00615199|402331|P1|COMPLETED|Overall Study||26
173210|NCT00615199|402328|P4|STARTED|Overall Study||35
173211|NCT00615199|402329|P3|STARTED|Overall Study||34
173212|NCT00615199|402330|P2|STARTED|Overall Study||36
173213|NCT00615199|402331|P1|STARTED|Overall Study||34
173214|NCT00615108|402365|P1|NOT COMPLETED|Overall Study||507
173215|NCT00615108|402365|P1|COMPLETED|Overall Study||2641
173216|NCT00615108|402365|P1|STARTED|Overall Study||3148
173217|NCT00615069|402380|P1|NOT COMPLETED|Overall Study||16
173218|NCT00615069|402380|P1|COMPLETED|Overall Study||19
173219|NCT00615069|402380|P1|STARTED|Overall Study||35
173220|NCT00615056|402389|P4|NOT COMPLETED|Overall Study||35
173221|NCT00615056|402390|P3|NOT COMPLETED|Overall Study||36
173222|NCT00615056|402391|P2|NOT COMPLETED|Overall Study||51
173223|NCT00615056|402392|P1|NOT COMPLETED|Overall Study||49
173224|NCT00615056|402389|P4|COMPLETED|Overall Study||0
173225|NCT00615056|402390|P3|COMPLETED|Overall Study||0
173226|NCT00615056|402391|P2|COMPLETED|Overall Study||0
173227|NCT00615056|402392|P1|COMPLETED|Overall Study||0
173228|NCT00615056|402389|P4|Treated|Overall Study||35
173229|NCT00615056|402390|P3|Treated|Overall Study||36
173230|NCT00615056|402391|P2|Treated|Overall Study||51
173231|NCT00615056|402392|P1|Treated|Overall Study||46
173232|NCT00615056|402389|P4|STARTED|Overall Study||35
173233|NCT00615056|402390|P3|STARTED|Overall Study||36
173234|NCT00615056|402391|P2|STARTED|Overall Study||51
173235|NCT00615056|402392|P1|STARTED|Overall Study||49
173236|NCT00615030|402422|P12|NOT COMPLETED|Period III||0
173237|NCT00615030|402423|P11|NOT COMPLETED|Period III||0
173238|NCT00615030|402424|P10|NOT COMPLETED|Period III||0
173239|NCT00615030|402425|P9|NOT COMPLETED|Period III||0
173240|NCT00615030|402426|P8|NOT COMPLETED|Period III||0
173241|NCT00615030|402427|P7|NOT COMPLETED|Period III||0
173242|NCT00615030|402428|P6|NOT COMPLETED|Period III||0
173243|NCT00615030|402429|P5|NOT COMPLETED|Period III||0
173244|NCT00615030|402430|P4|NOT COMPLETED|Period III||1
173245|NCT00615030|402431|P3|NOT COMPLETED|Period III||0
173246|NCT00615030|402432|P2|NOT COMPLETED|Period III||0
173247|NCT00615030|402433|P1|NOT COMPLETED|Period III||1
173248|NCT00615030|402422|P12|COMPLETED|Period III||6
173249|NCT00615030|402423|P11|COMPLETED|Period III||7
173250|NCT00615030|402424|P10|COMPLETED|Period III||8
173251|NCT00615030|402425|P9|COMPLETED|Period III||7
173252|NCT00615030|402426|P8|COMPLETED|Period III||7
173253|NCT00615030|402427|P7|COMPLETED|Period III||6
173254|NCT00615030|402428|P6|COMPLETED|Period III||5
173255|NCT00615030|402429|P5|COMPLETED|Period III||8
173256|NCT00615030|402430|P4|COMPLETED|Period III||6
173257|NCT00615030|402431|P3|COMPLETED|Period III||8
173258|NCT00615030|402432|P2|COMPLETED|Period III||8
173259|NCT00615030|402433|P1|COMPLETED|Period III||7
173260|NCT00615030|402422|P12|STARTED|Period III||6
173261|NCT00615030|402423|P11|STARTED|Period III||7
173262|NCT00615030|402424|P10|STARTED|Period III||8
173263|NCT00615030|402425|P9|STARTED|Period III||7
173264|NCT00615030|402426|P8|STARTED|Period III||7
173265|NCT00615030|402427|P7|STARTED|Period III||6
173266|NCT00615030|402428|P6|STARTED|Period III||5
173267|NCT00615030|402429|P5|STARTED|Period III||8
173268|NCT00615030|402430|P4|STARTED|Period III||7
173269|NCT00615030|402431|P3|STARTED|Period III||8
173270|NCT00615030|402432|P2|STARTED|Period III||8
173271|NCT00615030|402433|P1|STARTED|Period III||8
173272|NCT00615030|402422|P12|NOT COMPLETED|Period II||0
173273|NCT00615030|402423|P11|NOT COMPLETED|Period II||0
173274|NCT00615030|402424|P10|NOT COMPLETED|Period II||0
173275|NCT00615030|402425|P9|NOT COMPLETED|Period II||1
173276|NCT00615030|402426|P8|NOT COMPLETED|Period II||0
173277|NCT00615030|402427|P7|NOT COMPLETED|Period II||1
173278|NCT00615030|402428|P6|NOT COMPLETED|Period II||0
173279|NCT00615030|402429|P5|NOT COMPLETED|Period II||0
173280|NCT00615030|402430|P4|NOT COMPLETED|Period II||1
173281|NCT00615030|402431|P3|NOT COMPLETED|Period II||1
173282|NCT00615030|402432|P2|NOT COMPLETED|Period II||0
173283|NCT00615030|402433|P1|NOT COMPLETED|Period II||0
173284|NCT00615030|402422|P12|COMPLETED|Period II||6
173285|NCT00615030|402423|P11|COMPLETED|Period II||7
173286|NCT00615030|402424|P10|COMPLETED|Period II||8
173287|NCT00615030|402425|P9|COMPLETED|Period II||7
173288|NCT00615030|402426|P8|COMPLETED|Period II||7
173289|NCT00615030|402427|P7|COMPLETED|Period II||6
173290|NCT00615030|402428|P6|COMPLETED|Period II||5
173291|NCT00615030|402429|P5|COMPLETED|Period II||8
173292|NCT00615030|402430|P4|COMPLETED|Period II||7
173293|NCT00615030|402431|P3|COMPLETED|Period II||8
173294|NCT00615030|402432|P2|COMPLETED|Period II||8
173295|NCT00615030|402433|P1|COMPLETED|Period II||8
173296|NCT00615030|402422|P12|STARTED|Period II||6
173297|NCT00615030|402423|P11|STARTED|Period II||7
173298|NCT00615030|402424|P10|STARTED|Period II||8
173299|NCT00615030|402425|P9|STARTED|Period II||8
173300|NCT00615030|402426|P8|STARTED|Period II||7
173301|NCT00615030|402427|P7|STARTED|Period II||7
173302|NCT00615030|402428|P6|STARTED|Period II||5
173303|NCT00615030|402429|P5|STARTED|Period II||8
173304|NCT00615030|402430|P4|STARTED|Period II||8
173305|NCT00615030|402431|P3|STARTED|Period II||9
173306|NCT00615030|402432|P2|STARTED|Period II||8
173307|NCT00615030|402433|P1|STARTED|Period II||8
173308|NCT00615030|402422|P12|NOT COMPLETED|Period I||1
173309|NCT00615030|402423|P11|NOT COMPLETED|Period I||1
173310|NCT00615030|402424|P10|NOT COMPLETED|Period I||0
173311|NCT00615030|402425|P9|NOT COMPLETED|Period I||1
173312|NCT00615030|402426|P8|NOT COMPLETED|Period I||0
173313|NCT00615030|402427|P7|NOT COMPLETED|Period I||0
173314|NCT00615030|402428|P6|NOT COMPLETED|Period I||1
173315|NCT00615030|402429|P5|NOT COMPLETED|Period I||1
173316|NCT00615030|402430|P4|NOT COMPLETED|Period I||0
173317|NCT00615030|402431|P3|NOT COMPLETED|Period I||0
173318|NCT00615030|402432|P2|NOT COMPLETED|Period I||0
173319|NCT00615030|402433|P1|NOT COMPLETED|Period I||1
173320|NCT00615030|402422|P12|COMPLETED|Period I||6
173321|NCT00615030|402423|P11|COMPLETED|Period I||7
173322|NCT00615030|402424|P10|COMPLETED|Period I||8
173323|NCT00615030|402425|P9|COMPLETED|Period I||8
173324|NCT00615030|402426|P8|COMPLETED|Period I||7
173325|NCT00615030|402427|P7|COMPLETED|Period I||7
173326|NCT00615030|402428|P6|COMPLETED|Period I||5
173327|NCT00615030|402429|P5|COMPLETED|Period I||8
173328|NCT00615030|402430|P4|COMPLETED|Period I||8
173329|NCT00615030|402431|P3|COMPLETED|Period I||9
173330|NCT00615030|402432|P2|COMPLETED|Period I||8
173331|NCT00615030|402433|P1|COMPLETED|Period I||8
173332|NCT00615030|402422|P12|STARTED|Period I||7
173333|NCT00615030|402423|P11|STARTED|Period I||8
173334|NCT00615030|402424|P10|STARTED|Period I||8
173335|NCT00615030|402425|P9|STARTED|Period I||9
173336|NCT00615030|402426|P8|STARTED|Period I||7
173337|NCT00615030|402427|P7|STARTED|Period I||7
173338|NCT00615030|402428|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
173339|NCT00615030|402429|P5|STARTED|Period I||9
173340|NCT00615030|402430|P4|STARTED|Period I||8
173341|NCT00615030|402431|P3|STARTED|Period I||9
173342|NCT00615030|402432|P2|STARTED|Period I||8
173343|NCT00615030|402433|P1|STARTED|Period I||9
173344|NCT00615017|402453|P6|NOT COMPLETED|Overall Study||3
173345|NCT00615017|402454|P5|NOT COMPLETED|Overall Study||1
173346|NCT00615017|402455|P4|NOT COMPLETED|Overall Study||1
173347|NCT00615017|402456|P3|NOT COMPLETED|Overall Study||5
173348|NCT00615017|402457|P2|NOT COMPLETED|Overall Study||1
173349|NCT00615017|402458|P1|NOT COMPLETED|Overall Study||0
173350|NCT00615017|402453|P6|COMPLETED|Overall Study|Patient completed the study drug|20
173351|NCT00615017|402454|P5|COMPLETED|Overall Study|Patient completed the study drug|7
173352|NCT00615017|402455|P4|COMPLETED|Overall Study|Patient completed the study drug|9
173353|NCT00615017|402456|P3|COMPLETED|Overall Study|Patient completed the study drug|7
173354|NCT00615017|402457|P2|COMPLETED|Overall Study|Patient completed the study drug|8
173355|NCT00615017|402458|P1|COMPLETED|Overall Study|Patient completed the study drug|8
173356|NCT00615017|402453|P6|STARTED|Overall Study|Patients received treatment|23
173357|NCT00615017|402454|P5|STARTED|Overall Study|Patients received treatment|8
173358|NCT00615017|402455|P4|STARTED|Overall Study|Patients received treatment|10
173359|NCT00615017|402456|P3|STARTED|Overall Study|Patients received treatment|12
173360|NCT00615017|402457|P2|STARTED|Overall Study|Patients received treatment|9
173361|NCT00615017|402458|P1|STARTED|Overall Study|Patients received treatment|8
173362|NCT00614991|402616|P6|NOT COMPLETED|Overall Study||0
173363|NCT00614991|402617|P5|NOT COMPLETED|Overall Study||1
173364|NCT00614991|402618|P4|NOT COMPLETED|Overall Study||0
173365|NCT00614991|402619|P3|NOT COMPLETED|Overall Study||0
173366|NCT00614991|402620|P2|NOT COMPLETED|Overall Study||3
173367|NCT00614991|402621|P1|NOT COMPLETED|Overall Study||3
173368|NCT00614991|402616|P6|COMPLETED|Overall Study||6
173369|NCT00614991|402617|P5|COMPLETED|Overall Study||6
173370|NCT00614991|402618|P4|COMPLETED|Overall Study||7
173371|NCT00614991|402619|P3|COMPLETED|Overall Study||7
173372|NCT00614991|402620|P2|COMPLETED|Overall Study||6
173373|NCT00614991|402621|P1|COMPLETED|Overall Study||5
173374|NCT00614991|402616|P6|STARTED|Overall Study||6
173375|NCT00614991|402617|P5|STARTED|Overall Study||7
173376|NCT00614991|402618|P4|STARTED|Overall Study||7
173377|NCT00614991|402619|P3|STARTED|Overall Study||7
173378|NCT00614991|402620|P2|STARTED|Overall Study||9
173379|NCT00614991|402621|P1|STARTED|Overall Study||8
173380|NCT00614939|402655|P2|NOT COMPLETED|Overall Study||43
173381|NCT00614939|402656|P1|NOT COMPLETED|Overall Study||35
173382|NCT00614939|402655|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
173383|NCT00614939|402656|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
173384|NCT00614939|402655|P2|STARTED|Overall Study|Randomized and treated|85
173385|NCT00614939|402656|P1|STARTED|Overall Study|Randomized and treated|85
173386|NCT00614926|402690|P2|NOT COMPLETED|Overall Study||0
173387|NCT00614926|402691|P1|NOT COMPLETED|Overall Study||4
173388|NCT00614926|402690|P2|COMPLETED|Overall Study||7
173389|NCT00614926|402691|P1|COMPLETED|Overall Study||21
173390|NCT00614926|402690|P2|STARTED|Overall Study||7
173391|NCT00614926|402691|P1|STARTED|Overall Study||25
173392|NCT00614913|402699|P1|NOT COMPLETED|Overall Study||0
173393|NCT00614913|402699|P1|COMPLETED|Overall Study||76
173394|NCT00614913|402699|P1|STARTED|Overall Study||76
173395|NCT00614874|402704|P1|NOT COMPLETED|Overall Study||2
173396|NCT00614874|402704|P1|COMPLETED|Overall Study||14
173397|NCT00614874|402704|P1|STARTED|Overall Study||16
173398|NCT00614614|402713|P5|NOT COMPLETED|Booster Vaccination Phase||13
173399|NCT00614614|402714|P4|NOT COMPLETED|Booster Vaccination Phase||19
173400|NCT00614614|402715|P3|NOT COMPLETED|Booster Vaccination Phase||27
173401|NCT00614614|402716|P2|NOT COMPLETED|Booster Vaccination Phase||6
173402|NCT00614614|402717|P1|NOT COMPLETED|Booster Vaccination Phase||0
173403|NCT00614614|402713|P5|COMPLETED|Booster Vaccination Phase||396
173404|NCT00614614|402714|P4|COMPLETED|Booster Vaccination Phase||210
173405|NCT00614614|402715|P3|COMPLETED|Booster Vaccination Phase||405
173406|NCT00614614|402716|P2|COMPLETED|Booster Vaccination Phase||227
173407|NCT00614614|402717|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
173408|NCT00614614|402713|P5|STARTED|Booster Vaccination Phase||409
173409|NCT00614614|402714|P4|STARTED|Booster Vaccination Phase||229
173410|NCT00614614|402715|P3|STARTED|Booster Vaccination Phase||432
173411|NCT00614614|402716|P2|STARTED|Booster Vaccination Phase||233
173412|NCT00614614|402717|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
173413|NCT00614614|402713|P5|NOT COMPLETED|Primary Vaccination Phase||0
173414|NCT00614614|402714|P4|NOT COMPLETED|Primary Vaccination Phase||0
173415|NCT00614614|402715|P3|NOT COMPLETED|Primary Vaccination Phase||0
173416|NCT00614614|402716|P2|NOT COMPLETED|Primary Vaccination Phase||17
173417|NCT00614614|402717|P1|NOT COMPLETED|Primary Vaccination Phase||90
173418|NCT00614614|402713|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173419|NCT00614614|402714|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173420|NCT00614614|402715|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173421|NCT00614614|402716|P2|COMPLETED|Primary Vaccination Phase||265
173422|NCT00614614|402717|P1|COMPLETED|Primary Vaccination Phase||1182
173423|NCT00614614|402713|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173424|NCT00614614|402714|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173425|NCT00614614|402715|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
173426|NCT00614614|402716|P2|STARTED|Primary Vaccination Phase||282
173427|NCT00614614|402717|P1|STARTED|Primary Vaccination Phase||1272
173428|NCT00614575|402840|P1|NOT COMPLETED|Overall Study||228
173429|NCT00614575|402840|P1|COMPLETED|Overall Study||861
173430|NCT00614575|402840|P1|STARTED|Overall Study|The number of patients enrolled.|1089
173431|NCT00614523|402851|P2|NOT COMPLETED|Overall Study||131
173432|NCT00614523|402852|P1|NOT COMPLETED|Overall Study||63
173433|NCT00614523|402851|P2|COMPLETED|Overall Study||36
173434|NCT00614523|402852|P1|COMPLETED|Overall Study||20
173435|NCT00614523|402851|P2|STARTED|Overall Study||167
173436|NCT00614523|402852|P1|STARTED|Overall Study||83
173437|NCT00614484|402876|P1|NOT COMPLETED|Overall Study||0
173438|NCT00614484|402876|P1|COMPLETED|Overall Study||28
173439|NCT00614484|402876|P1|STARTED|Overall Study||28
173440|NCT00614458|402881|P1|NOT COMPLETED|Overall Study||0
173441|NCT00614458|402881|P1|COMPLETED|Overall Study||6
173442|NCT00614458|402881|P1|STARTED|Overall Study||6
173443|NCT00614445|402887|P2|NOT COMPLETED|Overall Study||49
173444|NCT00614445|402888|P1|NOT COMPLETED|Overall Study||28
173445|NCT00614445|402887|P2|COMPLETED|Overall Study||91
173446|NCT00614445|402888|P1|COMPLETED|Overall Study||112
173447|NCT00614445|402887|P2|STARTED|Overall Study||140
173448|NCT00614445|402888|P1|STARTED|Overall Study||140
173449|NCT00614406|402896|P2|NOT COMPLETED|Overall Study||0
173450|NCT00614406|402897|P1|NOT COMPLETED|Overall Study||0
173451|NCT00614406|402896|P2|COMPLETED|Overall Study||4
173452|NCT00614406|402897|P1|COMPLETED|Overall Study||7
173453|NCT00614406|402896|P2|STARTED|Overall Study||4
173454|NCT00614406|402897|P1|STARTED|Overall Study||7
173455|NCT00614393|402908|P5|NOT COMPLETED|Overall Study||180
173456|NCT00614393|402909|P4|NOT COMPLETED|Overall Study||180
173457|NCT00614393|402910|P3|NOT COMPLETED|Overall Study||10
173458|NCT00614393|402911|P2|NOT COMPLETED|Overall Study||8
173459|NCT00614393|402912|P1|NOT COMPLETED|Overall Study||180
173460|NCT00614393|402908|P5|COMPLETED|Overall Study||0
173461|NCT00614393|402909|P4|COMPLETED|Overall Study||0
173462|NCT00614393|402910|P3|COMPLETED|Overall Study||0
173463|NCT00614393|402911|P2|COMPLETED|Overall Study||0
173464|NCT00614393|402912|P1|COMPLETED|Overall Study||0
173465|NCT00614393|402908|P5|Treated|Overall Study||178
173466|NCT00614393|402909|P4|Treated|Overall Study||180
173467|NCT00614393|402910|P3|Treated|Overall Study||10
173468|NCT00614393|402911|P2|Treated|Overall Study||8
173469|NCT00614393|402912|P1|Treated|Overall Study||180
173470|NCT00614393|402908|P5|STARTED|Overall Study||180
173471|NCT00614393|402909|P4|STARTED|Overall Study||180
173472|NCT00614393|402910|P3|STARTED|Overall Study||10
173473|NCT00614393|402911|P2|STARTED|Overall Study||8
173474|NCT00614393|402912|P1|STARTED|Overall Study||180
173475|NCT00614380|402958|P4|NOT COMPLETED|Overall Study||2
173476|NCT00614380|402959|P3|NOT COMPLETED|Overall Study||1
173477|NCT00614380|402960|P2|NOT COMPLETED|Overall Study||8
173478|NCT00614380|402961|P1|NOT COMPLETED|Overall Study||35
173479|NCT00614380|402958|P4|COMPLETED|Overall Study||179
173480|NCT00614380|402959|P3|COMPLETED|Overall Study||24
173481|NCT00614380|402960|P2|COMPLETED|Overall Study||198
173482|NCT00614380|402961|P1|COMPLETED|Overall Study||529
173483|NCT00614380|402958|P4|STARTED|Overall Study||181
173484|NCT00614380|402959|P3|STARTED|Overall Study||25
173485|NCT00614380|402960|P2|STARTED|Overall Study||206
173486|NCT00614380|402961|P1|STARTED|Overall Study||564
173487|NCT00614315|403010|P1|NOT COMPLETED|Overall Study||0
173488|NCT00614315|403010|P1|COMPLETED|Overall Study||30
173489|NCT00614315|403010|P1|STARTED|Overall Study||30
173490|NCT00613938|403019|P4|NOT COMPLETED|Overall Study||26
173491|NCT00613938|403020|P3|NOT COMPLETED|Overall Study||23
173492|NCT00613938|403021|P2|NOT COMPLETED|Overall Study||28
173493|NCT00613938|403022|P1|NOT COMPLETED|Overall Study||20
173494|NCT00613938|403019|P4|COMPLETED|Overall Study||253
173495|NCT00613938|403020|P3|COMPLETED|Overall Study||255
173496|NCT00613938|403021|P2|COMPLETED|Overall Study||247
173497|NCT00613938|403022|P1|COMPLETED|Overall Study||49
173498|NCT00613938|403019|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
173499|NCT00613938|403020|P3|STARTED|Overall Study||278
173500|NCT00613938|403021|P2|STARTED|Overall Study||275
173501|NCT00613938|403022|P1|STARTED|Overall Study||69
173502|NCT00613925|403054|P2|NOT COMPLETED|Overall Study||1
173503|NCT00613925|403055|P1|NOT COMPLETED|Overall Study||0
173504|NCT00613925|403054|P2|COMPLETED|Overall Study||32
173505|NCT00613925|403055|P1|COMPLETED|Overall Study||37
173506|NCT00613925|403054|P2|STARTED|Overall Study||33
173507|NCT00613925|403055|P1|STARTED|Overall Study||37
173508|NCT00613730|403063|P1|NOT COMPLETED|Overall Study||3
173509|NCT00613730|403063|P1|COMPLETED|Overall Study||0
173510|NCT00613730|403063|P1|STARTED|Overall Study||3
173511|NCT00613626|403072|P3|NOT COMPLETED|Overall Study||0
173512|NCT00613626|403073|P2|NOT COMPLETED|Overall Study||1
173513|NCT00613626|403074|P1|NOT COMPLETED|Overall Study||0
173514|NCT00613626|403072|P3|COMPLETED|Overall Study||7
173515|NCT00613626|403073|P2|COMPLETED|Overall Study||33
173516|NCT00613626|403074|P1|COMPLETED|Overall Study||33
173517|NCT00613626|403072|P3|1st Dose ZD6474|Overall Study||7
173518|NCT00613626|403073|P2|1st Dose ZD6474|Overall Study||34
173519|NCT00613626|403074|P1|1st Dose ZD6474|Overall Study||33
173520|NCT00613626|403072|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
173521|NCT00613626|403073|P2|STARTED|Overall Study||34
173522|NCT00613626|403074|P1|STARTED|Overall Study||33
173523|NCT00613574|403090|P1|NOT COMPLETED|Overall Study||6
173524|NCT00613574|403090|P1|COMPLETED|Overall Study||401
173525|NCT00613574|403090|P1|STARTED|Overall Study||407
173526|NCT00613509|403102|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
173527|NCT00613509|403103|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
173528|NCT00613509|403102|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
173529|NCT00613509|403103|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
173530|NCT00613509|403102|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
173531|NCT00613509|403103|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
173532|NCT00613509|403102|P2|NOT COMPLETED|Cycle 1||8
173533|NCT00613509|403103|P1|NOT COMPLETED|Cycle 1||5
173534|NCT00613509|403102|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
173535|NCT00613509|403103|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
173536|NCT00613509|403102|P2|STARTED|Cycle 1||12
173537|NCT00613509|403103|P1|STARTED|Cycle 1||11
173538|NCT00613405|403127|P2|NOT COMPLETED|Overall Study||0
173539|NCT00613405|403128|P1|NOT COMPLETED|Overall Study||0
173540|NCT00613405|403127|P2|COMPLETED|Overall Study||42
173541|NCT00613405|403128|P1|COMPLETED|Overall Study||45
173542|NCT00613405|403127|P2|STARTED|Overall Study||42
173543|NCT00613405|403128|P1|STARTED|Overall Study||45
173544|NCT00613379|403137|P3|NOT COMPLETED|Overall Study||0
173545|NCT00613379|403138|P2|NOT COMPLETED|Overall Study||0
173546|NCT00613379|403139|P1|NOT COMPLETED|Overall Study||0
173547|NCT00613379|403137|P3|COMPLETED|Overall Study||11
173548|NCT00613379|403138|P2|COMPLETED|Overall Study||10
173549|NCT00613379|403139|P1|COMPLETED|Overall Study||10
173550|NCT00613379|403137|P3|STARTED|Overall Study||11
173551|NCT00613379|403138|P2|STARTED|Overall Study||10
173552|NCT00613379|403139|P1|STARTED|Overall Study||10
173553|NCT00613366|403149|P2|NOT COMPLETED|Overall Study||2
173554|NCT00613366|403150|P1|NOT COMPLETED|Overall Study||3
173555|NCT00613366|403149|P2|COMPLETED|Overall Study||18
173556|NCT00613366|403150|P1|COMPLETED|Overall Study||17
173557|NCT00613366|403149|P2|STARTED|Overall Study||20
173558|NCT00613366|403150|P1|STARTED|Overall Study||20
173559|NCT00613327|403158|P1|NOT COMPLETED|Overall Study||101
173560|NCT00613327|403158|P1|COMPLETED|Overall Study||244
173561|NCT00613327|403158|P1|STARTED|Overall Study||345
173562|NCT00613314|403177|P1|NOT COMPLETED|Overall Study||155
173563|NCT00613314|403177|P1|COMPLETED|Overall Study||15113
173564|NCT00613314|403177|P1|STARTED|Overall Study||15268
173565|NCT00613301|403185|P1|NOT COMPLETED|Overall Study||228
173566|NCT00613301|403185|P1|COMPLETED|Overall Study||188
173567|NCT00613301|403185|P1|STARTED|Overall Study||416
173568|NCT00613106|403194|P2|NOT COMPLETED|Overall Study||9
173569|NCT00613106|403195|P1|NOT COMPLETED|Overall Study||20
173570|NCT00613106|403194|P2|COMPLETED|Overall Study||38
173571|NCT00613106|403195|P1|COMPLETED|Overall Study||112
173572|NCT00613106|403194|P2|STARTED|Overall Study||47
173573|NCT00613106|403195|P1|STARTED|Overall Study||132
173574|NCT00613080|403201|P1|NOT COMPLETED|Overall Study||11
173575|NCT00613080|403201|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
173576|NCT00613080|403201|P1|STARTED|Overall Study||79
173577|NCT00613028|403207|P2|NOT COMPLETED|Overall Study||1
173578|NCT00613028|403208|P1|NOT COMPLETED|Overall Study||0
173579|NCT00613028|403207|P2|COMPLETED|Overall Study||12
173580|NCT00613028|403208|P1|COMPLETED|Overall Study||10
173581|NCT00613028|403207|P2|STARTED|Overall Study||13
173582|NCT00613028|403208|P1|STARTED|Overall Study||10
173583|NCT00613015|403228|P6|NOT COMPLETED|Overall Study||3
173584|NCT00613015|403229|P5|NOT COMPLETED|Overall Study||2
173585|NCT00613015|403230|P4|NOT COMPLETED|Overall Study||3
173586|NCT00613015|403231|P3|NOT COMPLETED|Overall Study||3
173587|NCT00613015|403232|P2|NOT COMPLETED|Overall Study||1
173588|NCT00613015|403233|P1|NOT COMPLETED|Overall Study||0
173589|NCT00613015|403228|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
173590|NCT00613015|403229|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
173591|NCT00613015|403230|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
173592|NCT00613015|403231|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
173593|NCT00613015|403232|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
173594|NCT00613015|403233|P1|COMPLETED|Overall Study||13
173595|NCT00613015|403228|P6|STARTED|Overall Study||19
173596|NCT00613015|403229|P5|STARTED|Overall Study||15
173597|NCT00613015|403230|P4|STARTED|Overall Study||24
173598|NCT00613015|403231|P3|STARTED|Overall Study||26
173599|NCT00613015|403232|P2|STARTED|Overall Study||12
173600|NCT00613015|403233|P1|STARTED|Overall Study||13
173601|NCT00612924|403255|P2|NOT COMPLETED|Overall Study||9
173602|NCT00612924|403256|P1|NOT COMPLETED|Overall Study||7
173603|NCT00612924|403255|P2|COMPLETED|Overall Study||85
173604|NCT00612924|403256|P1|COMPLETED|Overall Study||94
173605|NCT00612924|403255|P2|STARTED|Overall Study||94
173606|NCT00612924|403256|P1|STARTED|Overall Study||101
173607|NCT00612807|403269|P2|NOT COMPLETED|Overall Study||0
173608|NCT00612807|403270|P1|NOT COMPLETED|Overall Study||2
173609|NCT00612807|403269|P2|COMPLETED|Overall Study||28
173610|NCT00612807|403270|P1|COMPLETED|Overall Study||12
173611|NCT00612807|403269|P2|STARTED|Overall Study||28
173612|NCT00612807|403270|P1|STARTED|Overall Study||14
173613|NCT00612690|403280|P2|NOT COMPLETED|Overall Study||118
173614|NCT00612690|403281|P1|NOT COMPLETED|Overall Study||115
173615|NCT00612690|403280|P2|COMPLETED|Overall Study||89
173616|NCT00612690|403281|P1|COMPLETED|Overall Study||160
173617|NCT00612690|403280|P2|STARTED|Overall Study||207
173618|NCT00612690|403281|P1|STARTED|Overall Study||275
173619|NCT00612677|403289|P1|NOT COMPLETED|Overall Study||1
173620|NCT00612677|403289|P1|COMPLETED|Overall Study||0
173621|NCT00612677|403289|P1|STARTED|Overall Study||1
173622|NCT00612573|403299|P4|NOT COMPLETED|Overall Study||13
173623|NCT00612573|403300|P3|NOT COMPLETED|Overall Study||9
173624|NCT00612573|403301|P2|NOT COMPLETED|Overall Study||14
173625|NCT00612573|403302|P1|NOT COMPLETED|Overall Study||12
173626|NCT00612573|403299|P4|COMPLETED|Overall Study||54
173627|NCT00612573|403300|P3|COMPLETED|Overall Study||52
173628|NCT00612573|403301|P2|COMPLETED|Overall Study||51
173629|NCT00612573|403302|P1|COMPLETED|Overall Study||52
173630|NCT00612573|403299|P4|STARTED|Overall Study||67
173631|NCT00612573|403300|P3|STARTED|Overall Study||61
173632|NCT00612573|403301|P2|STARTED|Overall Study||65
173633|NCT00612573|403302|P1|STARTED|Overall Study||64
173634|NCT00612534|403328|P4|NOT COMPLETED|Overall Study||17
173635|NCT00612534|403329|P3|NOT COMPLETED|Overall Study||7
173636|NCT00612534|403330|P2|NOT COMPLETED|Overall Study||17
173637|NCT00612534|403331|P1|NOT COMPLETED|Overall Study||13
173638|NCT00612534|403328|P4|COMPLETED|Overall Study||7
173639|NCT00612534|403329|P3|COMPLETED|Overall Study||13
173640|NCT00612534|403330|P2|COMPLETED|Overall Study||9
173641|NCT00612534|403331|P1|COMPLETED|Overall Study||11
173642|NCT00612534|403328|P4|STARTED|Overall Study||24
173643|NCT00612534|403329|P3|STARTED|Overall Study||20
173644|NCT00612534|403330|P2|STARTED|Overall Study||26
173645|NCT00612534|403331|P1|STARTED|Overall Study||24
173646|NCT00612508|403343|P2|NOT COMPLETED|Overall Study||4
173647|NCT00612508|403344|P1|NOT COMPLETED|Overall Study||3
173648|NCT00612508|403343|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
173649|NCT00612508|403344|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
173650|NCT00612508|403343|P2|STARTED|Overall Study||7
173651|NCT00612508|403344|P1|STARTED|Overall Study||7
173652|NCT00612430|403354|P2|NOT COMPLETED|Overall Study||0
173653|NCT00612430|403355|P1|NOT COMPLETED|Overall Study||0
173654|NCT00612430|403354|P2|COMPLETED|Overall Study||27
173655|NCT00612430|403355|P1|COMPLETED|Overall Study||32
173656|NCT00612430|403354|P2|STARTED|Overall Study||27
173657|NCT00612430|403355|P1|STARTED|Overall Study||32
173658|NCT00612339|403369|P1|NOT COMPLETED|Overall Study||0
173659|NCT00612339|403369|P1|COMPLETED|Overall Study||41
173660|NCT00612339|403369|P1|STARTED|Overall Study||41
173661|NCT00612313|403375|P2|NOT COMPLETED|Overall Study||13
173662|NCT00612313|403376|P1|NOT COMPLETED|Overall Study||17
173663|NCT00612313|403375|P2|COMPLETED|Overall Study||62
173664|NCT00612313|403376|P1|COMPLETED|Overall Study||52
173665|NCT00612313|403375|P2|STARTED|Overall Study||75
173666|NCT00612313|403376|P1|STARTED|Overall Study||69
173667|NCT00612222|403392|P1|NOT COMPLETED|Overall Study||0
173668|NCT00612222|403392|P1|COMPLETED|Overall Study||4
173669|NCT00612222|403392|P1|STARTED|Overall Study||4
173670|NCT00612105|403400|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
173671|NCT00612105|403401|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
173672|NCT00612105|403400|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
173673|NCT00612105|403401|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
173674|NCT00612105|403400|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
173675|NCT00612105|403401|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
173676|NCT00612105|403400|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
173677|NCT00612105|403401|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
173678|NCT00612105|403400|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
173679|NCT00612105|403401|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
173680|NCT00612105|403400|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
173681|NCT00612105|403401|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
173682|NCT00612105|403400|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
173683|NCT00612105|403401|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
173684|NCT00612105|403400|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
173685|NCT00612105|403401|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
173686|NCT00612105|403400|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
173687|NCT00612105|403401|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
173688|NCT00612066|403451|P1|NOT COMPLETED|Overall Study||1
173689|NCT00612066|403451|P1|COMPLETED|Overall Study||1
173690|NCT00612066|403451|P1|STARTED|Overall Study||2
173691|NCT00612040|403458|P3|NOT COMPLETED|Overall Study||7
173692|NCT00612040|403459|P2|NOT COMPLETED|Overall Study||7
173693|NCT00612040|403460|P1|NOT COMPLETED|Overall Study||5
173694|NCT00612040|403458|P3|COMPLETED|Overall Study||52
173695|NCT00612040|403459|P2|COMPLETED|Overall Study||52
173696|NCT00612040|403460|P1|COMPLETED|Overall Study||55
173697|NCT00612040|403458|P3|Exposed|Overall Study||59
173698|NCT00612040|403459|P2|Exposed|Overall Study||59
173699|NCT00612040|403460|P1|Exposed|Overall Study||60
173700|NCT00612040|403458|P3|STARTED|Overall Study||59
173701|NCT00612040|403459|P2|STARTED|Overall Study||59
173702|NCT00612040|403460|P1|STARTED|Overall Study||60
173703|NCT00611897|403504|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
173704|NCT00611897|403505|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
173705|NCT00611897|403504|P2|COMPLETED|Day 2: Crossover Treatment||8
173706|NCT00611897|403505|P1|COMPLETED|Day 2: Crossover Treatment||8
173707|NCT00611897|403504|P2|STARTED|Day 2: Crossover Treatment||8
173708|NCT00611897|403505|P1|STARTED|Day 2: Crossover Treatment||8
173709|NCT00611897|403504|P2|NOT COMPLETED|Day 1: Initial Treatment||0
173710|NCT00611897|403505|P1|NOT COMPLETED|Day 1: Initial Treatment||0
173711|NCT00611897|403504|P2|COMPLETED|Day 1: Initial Treatment||8
173712|NCT00611897|403505|P1|COMPLETED|Day 1: Initial Treatment||8
173713|NCT00611897|403504|P2|STARTED|Day 1: Initial Treatment||8
173714|NCT00611897|403505|P1|STARTED|Day 1: Initial Treatment||8
173715|NCT00611884|403533|P4|NOT COMPLETED|Overall Study||6
173716|NCT00611884|403534|P3|NOT COMPLETED|Overall Study||4
173717|NCT00611884|403535|P2|NOT COMPLETED|Overall Study||9
173718|NCT00611884|403536|P1|NOT COMPLETED|Overall Study||9
173719|NCT00611884|403533|P4|COMPLETED|Overall Study||56
173720|NCT00611884|403534|P3|COMPLETED|Overall Study||58
173721|NCT00611884|403535|P2|COMPLETED|Overall Study||51
173722|NCT00611884|403536|P1|COMPLETED|Overall Study||52
173723|NCT00611884|403533|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
173724|NCT00611884|403534|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
173725|NCT00611884|403535|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
173726|NCT00611884|403536|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
173727|NCT00611884|403533|P4|STARTED|Overall Study||62
173728|NCT00611884|403534|P3|STARTED|Overall Study||62
173729|NCT00611884|403535|P2|STARTED|Overall Study||60
173730|NCT00611884|403536|P1|STARTED|Overall Study||61
173731|NCT00611806|403592|P2|NOT COMPLETED|Overall Study||3
173732|NCT00611806|403593|P1|NOT COMPLETED|Overall Study||16
173733|NCT00611806|403592|P2|COMPLETED|Overall Study||43
173734|NCT00611806|403593|P1|COMPLETED|Overall Study||78
173735|NCT00611806|403592|P2|STARTED|Overall Study||46
173736|NCT00611806|403593|P1|STARTED|Overall Study||94
173737|NCT00611715|403607|P2|NOT COMPLETED|Overall Study||6
173738|NCT00611715|403608|P1|NOT COMPLETED|Overall Study||41
173739|NCT00611715|403607|P2|COMPLETED|Overall Study||0
173740|NCT00611715|403608|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
173741|NCT00611715|403607|P2|STARTED|Overall Study||6
173742|NCT00611715|403608|P1|STARTED|Overall Study||42
173743|NCT00611559|403623|P3|NOT COMPLETED|Overall Study||1
173744|NCT00611559|403624|P2|NOT COMPLETED|Overall Study||1
173745|NCT00611559|403625|P1|NOT COMPLETED|Overall Study||1
173746|NCT00611559|403623|P3|COMPLETED|Overall Study||56
173747|NCT00611559|403624|P2|COMPLETED|Overall Study||114
173748|NCT00611559|403625|P1|COMPLETED|Overall Study||110
173749|NCT00611559|403623|P3|STARTED|Overall Study||57
173750|NCT00611559|403624|P2|STARTED|Overall Study||115
173751|NCT00611559|403625|P1|STARTED|Overall Study||111
173752|NCT00611468|403684|P4|NOT COMPLETED|Overall Study||0
173753|NCT00611468|403685|P3|NOT COMPLETED|Overall Study||0
173754|NCT00611468|403686|P2|NOT COMPLETED|Overall Study||1
173755|NCT00611468|403687|P1|NOT COMPLETED|Overall Study||0
173756|NCT00611468|403684|P4|COMPLETED|Overall Study||13
173757|NCT00611468|403685|P3|COMPLETED|Overall Study||6
173758|NCT00611468|403686|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
173759|NCT00611468|403687|P1|COMPLETED|Overall Study||3
173760|NCT00611468|403684|P4|STARTED|Overall Study||13
173761|NCT00611468|403685|P3|STARTED|Overall Study||6
173762|NCT00611468|403686|P2|STARTED|Overall Study||7
173763|NCT00611468|403687|P1|STARTED|Overall Study||3
173764|NCT00611455|403699|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
173765|NCT00611455|403700|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
173766|NCT00611455|403701|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
173767|NCT00611455|403699|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
173768|NCT00611455|403700|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
173769|NCT00611455|403701|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
173770|NCT00611455|403699|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
173771|NCT00611455|403700|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
173772|NCT00611455|403701|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
173773|NCT00611455|403699|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
173774|NCT00611455|403700|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
173775|NCT00611455|403701|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
173776|NCT00611455|403699|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
173777|NCT00611455|403700|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
173778|NCT00611455|403701|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
173779|NCT00611455|403699|P3|STARTED|OL Treatment Period (120 Weeks)||0
173780|NCT00611455|403700|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
173781|NCT00611455|403701|P1|STARTED|OL Treatment Period (120 Weeks)||0
173782|NCT00611455|403699|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
173783|NCT00611455|403700|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
173784|NCT00611455|403701|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
173785|NCT00611455|403699|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
173786|NCT00611455|403700|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
173787|NCT00611455|403701|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
173788|NCT00611455|403699|P3|STARTED|DB Treatment Period (24 Weeks)||0
173789|NCT00611455|403700|P2|STARTED|DB Treatment Period (24 Weeks)||131
173790|NCT00611455|403701|P1|STARTED|DB Treatment Period (24 Weeks)||134
173791|NCT00611442|403829|P2|NOT COMPLETED|Overall Study||2
173792|NCT00611442|403830|P1|NOT COMPLETED|Overall Study||1
173793|NCT00611442|403829|P2|COMPLETED|Overall Study||94
173794|NCT00611442|403830|P1|COMPLETED|Overall Study||94
173795|NCT00611442|403829|P2|STARTED|Overall Study||96
173796|NCT00611442|403830|P1|STARTED|Overall Study||95
173797|NCT00611403|403844|P2|NOT COMPLETED|Post Treatment Extension Phase||1
173798|NCT00611403|403845|P1|NOT COMPLETED|Post Treatment Extension Phase||4
173799|NCT00611403|403844|P2|COMPLETED|Post Treatment Extension Phase||24
173800|NCT00611403|403845|P1|COMPLETED|Post Treatment Extension Phase||22
173801|NCT00611403|403844|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
173802|NCT00611403|403845|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
173803|NCT00611403|403844|P2|NOT COMPLETED|Treatment Phase||11
173804|NCT00611403|403845|P1|NOT COMPLETED|Treatment Phase||6
173805|NCT00611403|403844|P2|COMPLETED|Treatment Phase||58
173806|NCT00611403|403845|P1|COMPLETED|Treatment Phase||62
173807|NCT00611403|403844|P2|STARTED|Treatment Phase||69
173808|NCT00611403|403845|P1|STARTED|Treatment Phase||68
173809|NCT00611325|403857|P2|NOT COMPLETED|Overall Study||0
173810|NCT00611325|403858|P1|NOT COMPLETED|Overall Study||0
173811|NCT00611325|403857|P2|COMPLETED|Overall Study||28
173812|NCT00611325|403858|P1|COMPLETED|Overall Study||28
173813|NCT00611325|403857|P2|STARTED|Overall Study||28
173814|NCT00611325|403858|P1|STARTED|Overall Study||28
173815|NCT00611247|403874|P2|NOT COMPLETED|Overall Study||21
173816|NCT00611247|403875|P1|NOT COMPLETED|Overall Study||2
173817|NCT00611247|403874|P2|COMPLETED|Overall Study||10
173818|NCT00611247|403875|P1|COMPLETED|Overall Study||3
173819|NCT00611247|403874|P2|STARTED|Overall Study||31
173820|NCT00611247|403875|P1|STARTED|Overall Study||5
173821|NCT00611130|403887|P2|NOT COMPLETED|Overall Study||47
173822|NCT00611130|403888|P1|NOT COMPLETED|Overall Study||49
173823|NCT00611130|403887|P2|COMPLETED|Overall Study||47
173824|NCT00611130|403888|P1|COMPLETED|Overall Study||43
173825|NCT00611130|403887|P2|Completed 12 Week Treatment Phase|Overall Study||64
173826|NCT00611130|403888|P1|Completed 12 Week Treatment Phase|Overall Study||61
173827|NCT00611130|403887|P2|STARTED|Overall Study||94
173828|NCT00611130|403888|P1|STARTED|Overall Study||92
173829|NCT00611026|403898|P3|NOT COMPLETED|Double-blind Treatment Period||98
173830|NCT00611026|403899|P2|NOT COMPLETED|Double-blind Treatment Period||88
173831|NCT00611026|403900|P1|NOT COMPLETED|Double-blind Treatment Period||47
173832|NCT00611026|403898|P3|COMPLETED|Double-blind Treatment Period||862
173833|NCT00611026|403899|P2|COMPLETED|Double-blind Treatment Period||885
173834|NCT00611026|403900|P1|COMPLETED|Double-blind Treatment Period||431
173835|NCT00611026|403898|P3|STARTED|Double-blind Treatment Period||960
173836|NCT00611026|403899|P2|STARTED|Double-blind Treatment Period||973
173837|NCT00611026|403900|P1|STARTED|Double-blind Treatment Period||478
173838|NCT00611026|403898|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
173839|NCT00611026|403899|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
173840|NCT00611026|403900|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
173841|NCT00611026|403898|P3|COMPLETED|Randomized to Double-blind Treatment||960
173842|NCT00611026|403899|P2|COMPLETED|Randomized to Double-blind Treatment||973
173843|NCT00611026|403900|P1|COMPLETED|Randomized to Double-blind Treatment||478
173844|NCT00611026|403898|P3|STARTED|Randomized to Double-blind Treatment||963
173845|NCT00611026|403899|P2|STARTED|Randomized to Double-blind Treatment||974
173846|NCT00611026|403900|P1|STARTED|Randomized to Double-blind Treatment||480
173847|NCT00610987|403966|P2|NOT COMPLETED|Overall Study||0
173848|NCT00610987|403967|P1|NOT COMPLETED|Overall Study||0
173849|NCT00610987|403966|P2|COMPLETED|Overall Study||71
173850|NCT00610987|403967|P1|COMPLETED|Overall Study||75
173851|NCT00610987|403966|P2|STARTED|Overall Study||71
173852|NCT00610987|403967|P1|STARTED|Overall Study||75
173853|NCT00610883|403973|P1|NOT COMPLETED|Overall Study||0
173854|NCT00610883|403973|P1|COMPLETED|Overall Study||17
173855|NCT00610883|403973|P1|STARTED|Overall Study||17
173856|NCT00610857|403977|P1|NOT COMPLETED|Overall Study||2
173857|NCT00610857|403977|P1|COMPLETED|Overall Study||35
173858|NCT00610857|403977|P1|STARTED|Overall Study||37
173859|NCT00610740|403984|P1|NOT COMPLETED|Overall Study||0
173860|NCT00610740|403984|P1|COMPLETED|Overall Study||18
173861|NCT00610740|403984|P1|STARTED|Overall Study||18
173862|NCT00610714|403992|P2|NOT COMPLETED|Overall Study||24
173863|NCT00610714|403993|P1|NOT COMPLETED|Overall Study||26
173864|NCT00610714|403992|P2|COMPLETED|Overall Study||82
173865|NCT00610714|403993|P1|COMPLETED|Overall Study||79
173866|NCT00610714|403992|P2|STARTED|Overall Study||106
173867|NCT00610714|403993|P1|STARTED|Overall Study||105
173868|NCT00610701|404005|P2|NOT COMPLETED|Overall Study||11
173869|NCT00610701|404006|P1|NOT COMPLETED|Overall Study||10
173870|NCT00610701|404005|P2|COMPLETED|Overall Study||9
173871|NCT00610701|404006|P1|COMPLETED|Overall Study||5
173872|NCT00610701|404005|P2|STARTED|Overall Study||20
173873|NCT00610701|404006|P1|STARTED|Overall Study||15
173874|NCT00610688|404015|P3|NOT COMPLETED|Overall Study||8
173875|NCT00610688|404016|P2|NOT COMPLETED|Overall Study||13
173876|NCT00610688|404017|P1|NOT COMPLETED|Overall Study||9
173877|NCT00610688|404015|P3|COMPLETED|Overall Study||55
173878|NCT00610688|404016|P2|COMPLETED|Overall Study||52
173879|NCT00610688|404017|P1|COMPLETED|Overall Study||55
173880|NCT00610688|404015|P3|STARTED|Overall Study||63
173881|NCT00610688|404016|P2|STARTED|Overall Study||65
173882|NCT00610688|404017|P1|STARTED|Overall Study||64
173883|NCT00610675|404031|P1|NOT COMPLETED|Overall Study||220
173884|NCT00610675|404031|P1|COMPLETED|Overall Study||126
173885|NCT00610675|404031|P1|Treated|Overall Study||342
173886|NCT00610675|404031|P1|STARTED|Overall Study||346
173887|NCT00610649|404053|P11|NOT COMPLETED|Overall Study||1
173888|NCT00610649|404054|P10|NOT COMPLETED|Overall Study||1
173889|NCT00610649|404055|P9|NOT COMPLETED|Overall Study||0
173890|NCT00610649|404056|P8|NOT COMPLETED|Overall Study||0
173891|NCT00610649|404057|P7|NOT COMPLETED|Overall Study||0
173892|NCT00610649|404058|P6|NOT COMPLETED|Overall Study||0
173893|NCT00610649|404059|P5|NOT COMPLETED|Overall Study||0
173894|NCT00610649|404060|P4|NOT COMPLETED|Overall Study||0
173895|NCT00610649|404061|P3|NOT COMPLETED|Overall Study||0
173896|NCT00610649|404062|P2|NOT COMPLETED|Overall Study||1
173897|NCT00610649|404063|P1|NOT COMPLETED|Overall Study||1
173898|NCT00610649|404053|P11|COMPLETED|Overall Study||9
173899|NCT00610649|404054|P10|COMPLETED|Overall Study||9
173900|NCT00610649|404055|P9|COMPLETED|Overall Study||10
173901|NCT00610649|404056|P8|COMPLETED|Overall Study||2
173902|NCT00610649|404057|P7|COMPLETED|Overall Study||4
173903|NCT00610649|404058|P6|COMPLETED|Overall Study||2
173904|NCT00610649|404059|P5|COMPLETED|Overall Study||4
173905|NCT00610649|404060|P4|COMPLETED|Overall Study||2
173906|NCT00610649|404061|P3|COMPLETED|Overall Study||4
173907|NCT00610649|404062|P2|COMPLETED|Overall Study||1
173908|NCT00610649|404063|P1|COMPLETED|Overall Study||3
173909|NCT00610649|404053|P11|STARTED|Overall Study||10
173910|NCT00610649|404054|P10|STARTED|Overall Study||10
173911|NCT00610649|404055|P9|STARTED|Overall Study||10
173912|NCT00610649|404056|P8|STARTED|Overall Study||2
173913|NCT00610649|404057|P7|STARTED|Overall Study||4
173914|NCT00610649|404058|P6|STARTED|Overall Study||2
173915|NCT00610649|404059|P5|STARTED|Overall Study||4
173916|NCT00610649|404060|P4|STARTED|Overall Study||2
173917|NCT00610649|404061|P3|STARTED|Overall Study||4
173918|NCT00610649|404062|P2|STARTED|Overall Study||2
173919|NCT00610649|404063|P1|STARTED|Overall Study||4
173920|NCT00610532|404117|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
173921|NCT00610532|404117|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
173922|NCT00610532|404117|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
173923|NCT00610532|404117|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
173924|NCT00610532|404117|P1|COMPLETED|Intravenous Phenytoin Alone||8
173925|NCT00610532|404117|P1|STARTED|Intravenous Phenytoin Alone||8
173926|NCT00610441|404127|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
173927|NCT00610441|404128|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
173928|NCT00610441|404129|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
173929|NCT00610441|404130|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
173930|NCT00610441|404127|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
173931|NCT00610441|404128|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
173932|NCT00610441|404129|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
173933|NCT00610441|404130|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
173934|NCT00610441|404127|P4|STARTED|Treatment Period 2 - 3 Weeks||16
173935|NCT00610441|404128|P3|STARTED|Treatment Period 2 - 3 Weeks||9
173936|NCT00610441|404129|P2|STARTED|Treatment Period 2 - 3 Weeks||13
173937|NCT00610441|404130|P1|STARTED|Treatment Period 2 - 3 Weeks||12
173938|NCT00610441|404127|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
173939|NCT00610441|404128|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
173940|NCT00610441|404129|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
173941|NCT00610441|404130|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
173942|NCT00610441|404127|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
173943|NCT00610441|404128|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
173944|NCT00610441|404129|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
173945|NCT00610441|404130|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
173946|NCT00610441|404127|P4|STARTED|Placebo Washout Period - 2 Weeks||16
173947|NCT00610441|404128|P3|STARTED|Placebo Washout Period - 2 Weeks||11
173948|NCT00610441|404129|P2|STARTED|Placebo Washout Period - 2 Weeks||14
173949|NCT00610441|404130|P1|STARTED|Placebo Washout Period - 2 Weeks||12
173950|NCT00610441|404127|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
173951|NCT00610441|404128|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
173952|NCT00610441|404129|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
173953|NCT00610441|404130|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
173954|NCT00610441|404127|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
173955|NCT00610441|404128|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
173956|NCT00610441|404129|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
173957|NCT00610441|404130|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
173958|NCT00610441|404127|P4|STARTED|Treatment Period 1 - 3 Weeks||18
173959|NCT00610441|404128|P3|STARTED|Treatment Period 1 - 3 Weeks||18
173960|NCT00610441|404129|P2|STARTED|Treatment Period 1 - 3 Weeks||16
173961|NCT00610441|404130|P1|STARTED|Treatment Period 1 - 3 Weeks||15
173962|NCT00610311|404221|P1|NOT COMPLETED|Overall Study||0
173963|NCT00610311|404221|P1|COMPLETED|Overall Study||3
173964|NCT00610311|404221|P1|STARTED|Overall Study||3
173965|NCT00610207|404228|P1|NOT COMPLETED|Overall Study||3
173966|NCT00610207|404228|P1|COMPLETED|Overall Study||18
173967|NCT00610207|404228|P1|STARTED|Overall Study||21
173968|NCT00610155|404233|P6|NOT COMPLETED|Period 3||0
173969|NCT00610155|404234|P5|NOT COMPLETED|Period 3||0
173970|NCT00610155|404235|P4|NOT COMPLETED|Period 3||0
173971|NCT00610155|404236|P3|NOT COMPLETED|Period 3||0
173972|NCT00610155|404237|P2|NOT COMPLETED|Period 3||0
173973|NCT00610155|404238|P1|NOT COMPLETED|Period 3||1
173974|NCT00610155|404233|P6|COMPLETED|Period 3||1
173975|NCT00610155|404234|P5|COMPLETED|Period 3||3
173976|NCT00610155|404235|P4|COMPLETED|Period 3||3
173977|NCT00610155|404236|P3|COMPLETED|Period 3||3
173978|NCT00610155|404237|P2|COMPLETED|Period 3||3
173979|NCT00610155|404238|P1|COMPLETED|Period 3||3
173980|NCT00610155|404233|P6|STARTED|Period 3||1
173981|NCT00610155|404234|P5|STARTED|Period 3||3
173982|NCT00610155|404235|P4|STARTED|Period 3||3
173983|NCT00610155|404236|P3|STARTED|Period 3||3
173984|NCT00610155|404237|P2|STARTED|Period 3||3
173985|NCT00610155|404238|P1|STARTED|Period 3||4
173986|NCT00610155|404233|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
173987|NCT00610155|404234|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
173988|NCT00610155|404235|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
173989|NCT00610155|404236|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
173990|NCT00610155|404237|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
173991|NCT00610155|404238|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
173992|NCT00610155|404233|P6|COMPLETED|Washout Period 2 (7 Days)||1
173993|NCT00610155|404234|P5|COMPLETED|Washout Period 2 (7 Days)||3
173994|NCT00610155|404235|P4|COMPLETED|Washout Period 2 (7 Days)||3
173995|NCT00610155|404236|P3|COMPLETED|Washout Period 2 (7 Days)||3
173996|NCT00610155|404237|P2|COMPLETED|Washout Period 2 (7 Days)||3
173997|NCT00610155|404238|P1|COMPLETED|Washout Period 2 (7 Days)||4
173998|NCT00610155|404233|P6|STARTED|Washout Period 2 (7 Days)||1
173999|NCT00610155|404234|P5|STARTED|Washout Period 2 (7 Days)||3
174000|NCT00610155|404235|P4|STARTED|Washout Period 2 (7 Days)||3
174001|NCT00610155|404236|P3|STARTED|Washout Period 2 (7 Days)||3
174002|NCT00610155|404237|P2|STARTED|Washout Period 2 (7 Days)||3
174003|NCT00610155|404238|P1|STARTED|Washout Period 2 (7 Days)||4
174004|NCT00610155|404233|P6|NOT COMPLETED|Period 2||0
174005|NCT00610155|404234|P5|NOT COMPLETED|Period 2||0
174006|NCT00610155|404235|P4|NOT COMPLETED|Period 2||0
174007|NCT00610155|404236|P3|NOT COMPLETED|Period 2||0
174008|NCT00610155|404237|P2|NOT COMPLETED|Period 2||0
174009|NCT00610155|404238|P1|NOT COMPLETED|Period 2||0
174010|NCT00610155|404233|P6|COMPLETED|Period 2||1
174011|NCT00610155|404234|P5|COMPLETED|Period 2||3
174012|NCT00610155|404235|P4|COMPLETED|Period 2||3
174013|NCT00610155|404236|P3|COMPLETED|Period 2||3
174014|NCT00610155|404237|P2|COMPLETED|Period 2||3
174015|NCT00610155|404238|P1|COMPLETED|Period 2||4
174016|NCT00610155|404233|P6|STARTED|Period 2||1
174017|NCT00610155|404234|P5|STARTED|Period 2||3
174018|NCT00610155|404235|P4|STARTED|Period 2||3
174019|NCT00610155|404236|P3|STARTED|Period 2||3
174020|NCT00610155|404237|P2|STARTED|Period 2||3
174021|NCT00610155|404238|P1|STARTED|Period 2||4
174022|NCT00610155|404233|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
174023|NCT00610155|404234|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
174024|NCT00610155|404235|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
174025|NCT00610155|404236|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
174026|NCT00610155|404237|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
174027|NCT00610155|404238|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
174028|NCT00610155|404233|P6|COMPLETED|Washout Period 1 (7 Days)||1
174029|NCT00610155|404234|P5|COMPLETED|Washout Period 1 (7 Days)||3
174030|NCT00610155|404235|P4|COMPLETED|Washout Period 1 (7 Days)||3
174031|NCT00610155|404236|P3|COMPLETED|Washout Period 1 (7 Days)||3
174032|NCT00610155|404237|P2|COMPLETED|Washout Period 1 (7 Days)||3
174033|NCT00610155|404238|P1|COMPLETED|Washout Period 1 (7 Days)||4
174034|NCT00610155|404233|P6|STARTED|Washout Period 1 (7 Days)||1
174035|NCT00610155|404234|P5|STARTED|Washout Period 1 (7 Days)||3
174036|NCT00610155|404235|P4|STARTED|Washout Period 1 (7 Days)||3
174037|NCT00610155|404236|P3|STARTED|Washout Period 1 (7 Days)||3
174038|NCT00610155|404237|P2|STARTED|Washout Period 1 (7 Days)||3
174039|NCT00610155|404238|P1|STARTED|Washout Period 1 (7 Days)||4
174040|NCT00610155|404233|P6|NOT COMPLETED|Period 1||0
174041|NCT00610155|404234|P5|NOT COMPLETED|Period 1||0
174042|NCT00610155|404235|P4|NOT COMPLETED|Period 1||0
174043|NCT00610155|404236|P3|NOT COMPLETED|Period 1||1
174044|NCT00610155|404237|P2|NOT COMPLETED|Period 1||0
174045|NCT00610155|404238|P1|NOT COMPLETED|Period 1||0
174046|NCT00610155|404233|P6|COMPLETED|Period 1||1
174047|NCT00610155|404234|P5|COMPLETED|Period 1||3
174048|NCT00610155|404235|P4|COMPLETED|Period 1||3
174049|NCT00610155|404236|P3|COMPLETED|Period 1||3
174050|NCT00610155|404237|P2|COMPLETED|Period 1||3
174051|NCT00610155|404238|P1|COMPLETED|Period 1||4
174052|NCT00610155|404233|P6|STARTED|Period 1||1
174053|NCT00610155|404234|P5|STARTED|Period 1||3
174054|NCT00610155|404235|P4|STARTED|Period 1||3
174055|NCT00610155|404236|P3|STARTED|Period 1||4
174056|NCT00610155|404237|P2|STARTED|Period 1||3
174057|NCT00610155|404238|P1|STARTED|Period 1||4
174058|NCT00610129|404285|P1|NOT COMPLETED|Overall Study||3
174059|NCT00610129|404285|P1|COMPLETED|Overall Study||25
174060|NCT00610129|404285|P1|STARTED|Overall Study||28
174061|NCT00609986|404291|P2|NOT COMPLETED|Overall Study||3
174062|NCT00609986|404292|P1|NOT COMPLETED|Overall Study||8
174063|NCT00609986|404291|P2|COMPLETED|Overall Study||49
174064|NCT00609986|404292|P1|COMPLETED|Overall Study||44
174065|NCT00609986|404291|P2|Received Transplant|Overall Study||49
174066|NCT00609986|404292|P1|Received Transplant|Overall Study||44
174067|NCT00609986|404291|P2|STARTED|Overall Study||52
174068|NCT00609986|404292|P1|STARTED|Overall Study||52
174069|NCT00609973|404306|P2|NOT COMPLETED|Overall Study||6
174070|NCT00609973|404307|P1|NOT COMPLETED|Overall Study||8
174071|NCT00609973|404306|P2|COMPLETED|Overall Study||10
174072|NCT00609973|404307|P1|COMPLETED|Overall Study||9
174073|NCT00609973|404306|P2|STARTED|Overall Study||16
174074|NCT00609973|404307|P1|STARTED|Overall Study||17
174075|NCT00609947|404315|P1|NOT COMPLETED|Overall Study||1
174076|NCT00609947|404315|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
174077|NCT00609947|404315|P1|STARTED|Overall Study||241
174078|NCT00609869|404320|P1|NOT COMPLETED|Overall Study||11
174079|NCT00609869|404320|P1|COMPLETED|Overall Study||18
174080|NCT00609869|404320|P1|STARTED|Overall Study||29
174081|NCT00609804|404328|P2|NOT COMPLETED|Overall Study||28
174082|NCT00609804|404329|P1|NOT COMPLETED|Overall Study||25
174083|NCT00609804|404328|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
174084|NCT00609804|404329|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
174085|NCT00609804|404328|P2|STARTED|Overall Study||28
174086|NCT00609804|404329|P1|STARTED|Overall Study||25
174087|NCT00609765|404339|P1|NOT COMPLETED|Overall Study||1
174088|NCT00609765|404339|P1|COMPLETED|Overall Study||0
174089|NCT00609765|404339|P1|STARTED|Overall Study||1
174090|NCT00609739|404344|P1|NOT COMPLETED|Overall Study||0
174091|NCT00609739|404344|P1|COMPLETED|Overall Study||1
174092|NCT00609739|404344|P1|STARTED|Overall Study||1
174093|NCT00609674|404353|P2|NOT COMPLETED|Overall Study||7
174094|NCT00609674|404354|P1|NOT COMPLETED|Overall Study||7
174095|NCT00609674|404353|P2|COMPLETED|Overall Study||153
174096|NCT00609674|404354|P1|COMPLETED|Overall Study||148
174097|NCT00609674|404353|P2|STARTED|Overall Study||160
174098|NCT00609674|404354|P1|STARTED|Overall Study||155
174099|NCT00609622|404390|P2|NOT COMPLETED|Overall Study||95
174100|NCT00609622|404391|P1|NOT COMPLETED|Overall Study||96
174101|NCT00609622|404390|P2|COMPLETED|Overall Study||0
174102|NCT00609622|404391|P1|COMPLETED|Overall Study||0
174103|NCT00609622|404390|P2|STARTED|Overall Study||95
174104|NCT00609622|404391|P1|STARTED|Overall Study||96
174105|NCT00609518|404413|P2|NOT COMPLETED|Overall Study||40
174106|NCT00609518|404414|P1|NOT COMPLETED|Overall Study||43
174107|NCT00609518|404413|P2|COMPLETED|Overall Study||17
174108|NCT00609518|404414|P1|COMPLETED|Overall Study||11
174109|NCT00609518|404413|P2|Completed 6 Treatment Cycles|Overall Study||22
174110|NCT00609518|404414|P1|Completed 6 Treatment Cycles|Overall Study||19
174111|NCT00609518|404413|P2|STARTED|Overall Study||57
174112|NCT00609518|404414|P1|STARTED|Overall Study||54
174113|NCT00609466|404429|P3|NOT COMPLETED|Overall Study||4
174114|NCT00609466|404430|P2|NOT COMPLETED|Overall Study||6
174115|NCT00609466|404431|P1|NOT COMPLETED|Overall Study||2
174116|NCT00609466|404429|P3|COMPLETED|Overall Study||95
174117|NCT00609466|404430|P2|COMPLETED|Overall Study||90
174118|NCT00609466|404431|P1|COMPLETED|Overall Study||94
174119|NCT00609466|404429|P3|STARTED|Overall Study||99
174120|NCT00609466|404430|P2|STARTED|Overall Study||96
174121|NCT00609466|404431|P1|STARTED|Overall Study||96
174122|NCT00609362|404459|P2|NOT COMPLETED|Overall Study||1
174123|NCT00609362|404460|P1|NOT COMPLETED|Overall Study||3
174124|NCT00609362|404459|P2|COMPLETED|Overall Study||27
174125|NCT00609362|404460|P1|COMPLETED|Overall Study||26
174126|NCT00609362|404459|P2|STARTED|Overall Study||28
174127|NCT00609362|404460|P1|STARTED|Overall Study||29
174128|NCT00609167|404472|P2|NOT COMPLETED|Overall Study||7
174129|NCT00609167|404473|P1|NOT COMPLETED|Overall Study||8
174130|NCT00609167|404472|P2|COMPLETED|Overall Study||23
174131|NCT00609167|404473|P1|COMPLETED|Overall Study||25
174132|NCT00609167|404472|P2|STARTED|Overall Study||30
174133|NCT00609167|404473|P1|STARTED|Overall Study||33
174134|NCT00608985|404499|P4|NOT COMPLETED|Overall Study||9
174135|NCT00608985|404500|P3|NOT COMPLETED|Overall Study||6
174136|NCT00608985|404501|P2|NOT COMPLETED|Overall Study||13
174137|NCT00608985|404502|P1|NOT COMPLETED|Overall Study||16
174138|NCT00608985|404499|P4|COMPLETED|Overall Study|Completed follow-up|159
174139|NCT00608985|404500|P3|COMPLETED|Overall Study|Completed follow-up|170
174140|NCT00608985|404501|P2|COMPLETED|Overall Study|Completed follow-up|173
174141|NCT00608985|404502|P1|COMPLETED|Overall Study|Completed follow-up|161
174142|NCT00608985|404499|P4|Completed Double-blind Treatment|Overall Study||161
174143|NCT00608985|404500|P3|Completed Double-blind Treatment|Overall Study||171
174144|NCT00608985|404501|P2|Completed Double-blind Treatment|Overall Study||174
174145|NCT00608985|404502|P1|Completed Double-blind Treatment|Overall Study||163
174146|NCT00608985|404499|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
174147|NCT00608985|404500|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
174148|NCT00608985|404501|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
174149|NCT00608985|404502|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
174150|NCT00608959|404534|P1|NOT COMPLETED|Part 2||0
174151|NCT00608959|404534|P1|COMPLETED|Part 2||25
174152|NCT00608959|404534|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
174153|NCT00608959|404534|P1|NOT COMPLETED|Part 1||1
174154|NCT00608959|404534|P1|COMPLETED|Part 1||24
174155|NCT00608959|404534|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
174156|NCT00608907|404547|P3|NOT COMPLETED|Overall Study||1
174157|NCT00608907|404548|P2|NOT COMPLETED|Overall Study||0
174158|NCT00608907|404549|P1|NOT COMPLETED|Overall Study||12
174159|NCT00608907|404547|P3|COMPLETED|Overall Study||17
174160|NCT00608907|404548|P2|COMPLETED|Overall Study||13
174161|NCT00608907|404549|P1|COMPLETED|Overall Study||18
174162|NCT00608907|404547|P3|STARTED|Overall Study||18
174163|NCT00608907|404548|P2|STARTED|Overall Study||13
174164|NCT00608907|404549|P1|STARTED|Overall Study||30
174165|NCT00608881|404559|P2|NOT COMPLETED|Overall Study||66
174166|NCT00608881|404560|P1|NOT COMPLETED|Overall Study||79
174167|NCT00608881|404559|P2|COMPLETED|Overall Study||240
174168|NCT00608881|404560|P1|COMPLETED|Overall Study||224
174169|NCT00608881|404559|P2|STARTED|Overall Study||306
174170|NCT00608881|404560|P1|STARTED|Overall Study||303
174171|NCT00608868|404594|P1|NOT COMPLETED|Overall Study||15
174172|NCT00608868|404594|P1|COMPLETED|Overall Study||141
174173|NCT00608868|404594|P1|Per Protocol (PP) Population|Overall Study||121
174174|NCT00608868|404594|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
174175|NCT00608868|404594|P1|Treatment Completed|Overall Study||141
174176|NCT00608868|404594|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
174177|NCT00608868|404594|P1|Enrolled|Overall Study||156
174178|NCT00608868|404594|P1|STARTED|Overall Study||156
174179|NCT00608842|404605|P4|NOT COMPLETED|Overall Study||1
174180|NCT00608842|404606|P3|NOT COMPLETED|Overall Study||2
174181|NCT00608842|404607|P2|NOT COMPLETED|Overall Study||1
174182|NCT00608842|404608|P1|NOT COMPLETED|Overall Study||1
174183|NCT00608842|404605|P4|COMPLETED|Overall Study||16
174184|NCT00608842|404606|P3|COMPLETED|Overall Study||13
174185|NCT00608842|404607|P2|COMPLETED|Overall Study||14
174186|NCT00608842|404608|P1|COMPLETED|Overall Study||14
174187|NCT00608842|404605|P4|STARTED|Overall Study||17
174188|NCT00608842|404606|P3|STARTED|Overall Study||15
174189|NCT00608842|404607|P2|STARTED|Overall Study||15
174190|NCT00608842|404608|P1|STARTED|Overall Study||15
174191|NCT00608829|404642|P1|NOT COMPLETED|Overall Study||15
174192|NCT00608829|404642|P1|COMPLETED|Overall Study||8
174193|NCT00608829|404642|P1|STARTED|Overall Study||23
174194|NCT00608777|404646|P1|NOT COMPLETED|Overall Study||0
174195|NCT00608777|404646|P1|COMPLETED|Overall Study||6
174196|NCT00608777|404646|P1|STARTED|Overall Study||6
174197|NCT00608634|404653|P3|NOT COMPLETED|Overall Study||1
174198|NCT00608634|404654|P2|NOT COMPLETED|Overall Study||1
174199|NCT00608634|404655|P1|NOT COMPLETED|Overall Study||2
174200|NCT00608634|404653|P3|COMPLETED|Overall Study||27
174201|NCT00608634|404654|P2|COMPLETED|Overall Study||26
174202|NCT00608634|404655|P1|COMPLETED|Overall Study||26
174203|NCT00608634|404653|P3|STARTED|Overall Study||28
174204|NCT00608634|404654|P2|STARTED|Overall Study||27
174205|NCT00608634|404655|P1|STARTED|Overall Study||28
174206|NCT00608582|404668|P2|NOT COMPLETED|Overall Study||4
174207|NCT00608582|404669|P1|NOT COMPLETED|Overall Study||4
174208|NCT00608582|404668|P2|COMPLETED|Overall Study||7
174209|NCT00608582|404669|P1|COMPLETED|Overall Study||10
174210|NCT00608582|404668|P2|STARTED|Overall Study||11
174211|NCT00608582|404669|P1|STARTED|Overall Study||14
174212|NCT00608569|404679|P2|NOT COMPLETED|Overall Study||9
174213|NCT00608569|404680|P1|NOT COMPLETED|Overall Study||10
174214|NCT00608569|404679|P2|COMPLETED|Overall Study||119
174215|NCT00608569|404680|P1|COMPLETED|Overall Study||119
174216|NCT00608569|404679|P2|STARTED|Overall Study||128
174217|NCT00608569|404680|P1|STARTED|Overall Study||129
174218|NCT00608543|404700|P1|NOT COMPLETED|Overall Study||4
174219|NCT00608543|404700|P1|COMPLETED|Overall Study||13
174220|NCT00608543|404700|P1|STARTED|Overall Study||17
174221|NCT00608530|404711|P2|NOT COMPLETED|Overall Study||5
174222|NCT00608530|404712|P1|NOT COMPLETED|Overall Study||11
174223|NCT00608530|404711|P2|COMPLETED|Overall Study||28
174224|NCT00608530|404712|P1|COMPLETED|Overall Study||22
174225|NCT00608530|404711|P2|Attended > 0 Treatment Sessions|Overall Study||31
174226|NCT00608530|404712|P1|Attended > 0 Treatment Sessions|Overall Study||28
174227|NCT00608530|404711|P2|STARTED|Overall Study|Randomized|33
174228|NCT00608530|404712|P1|STARTED|Overall Study|Randomized|33
174229|NCT00608517|404725|P3|NOT COMPLETED|Overall Study||0
174230|NCT00608517|404726|P2|NOT COMPLETED|Overall Study||0
174231|NCT00608517|404727|P1|NOT COMPLETED|Overall Study||1
174232|NCT00608517|404725|P3|COMPLETED|Overall Study||1
174233|NCT00608517|404726|P2|COMPLETED|Overall Study||3
174234|NCT00608517|404727|P1|COMPLETED|Overall Study||1
174235|NCT00608517|404725|P3|STARTED|Overall Study||1
174236|NCT00608517|404726|P2|STARTED|Overall Study||3
174237|NCT00608517|404727|P1|STARTED|Overall Study||2
174238|NCT00608491|404755|P2|NOT COMPLETED|Overall Study||22
174239|NCT00608491|404756|P1|NOT COMPLETED|Overall Study||21
174240|NCT00608491|404755|P2|COMPLETED|Overall Study||72
174241|NCT00608491|404756|P1|COMPLETED|Overall Study||73
174242|NCT00608491|404755|P2|STARTED|Overall Study||94
174243|NCT00608491|404756|P1|STARTED|Overall Study||94
174244|NCT00608426|404902|P2|NOT COMPLETED|Overall Study||905
174245|NCT00608426|404903|P1|NOT COMPLETED|Overall Study||836
174246|NCT00608426|404902|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
174247|NCT00608426|404903|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
174248|NCT00608426|404902|P2|STARTED|Overall Study||2519
174249|NCT00608426|404903|P1|STARTED|Overall Study||2604
174250|NCT00608322|404915|P2|NOT COMPLETED|Overall Study||1
174251|NCT00608322|404916|P1|NOT COMPLETED|Overall Study||2
174252|NCT00608322|404915|P2|COMPLETED|Overall Study||22
174253|NCT00608322|404916|P1|COMPLETED|Overall Study||24
174254|NCT00608322|404915|P2|STARTED|Overall Study||23
174255|NCT00608322|404916|P1|STARTED|Overall Study||26
174256|NCT00608244|404922|P1|NOT COMPLETED|Overall Study||2
174257|NCT00608244|404922|P1|COMPLETED|Overall Study||57
174258|NCT00608244|404922|P1|STARTED|Overall Study||59
174259|NCT00608205|404933|P2|NOT COMPLETED|Overall Study||3
174260|NCT00608205|404934|P1|NOT COMPLETED|Overall Study||3
174261|NCT00608205|404933|P2|COMPLETED|Overall Study||31
174262|NCT00608205|404934|P1|COMPLETED|Overall Study||32
174263|NCT00608205|404933|P2|STARTED|Overall Study||34
174264|NCT00608205|404934|P1|STARTED|Overall Study||35
174265|NCT00608140|405024|P2|NOT COMPLETED|Overall Study||1
174266|NCT00608140|405025|P1|NOT COMPLETED|Overall Study||1
174267|NCT00608140|405024|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
174268|NCT00608140|405025|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
174269|NCT00608140|405024|P2|STARTED|Overall Study||1
174270|NCT00608140|405025|P1|STARTED|Overall Study||1
174271|NCT00608023|405036|P3|NOT COMPLETED|Overall Study||14
174272|NCT00608023|405037|P2|NOT COMPLETED|Overall Study||22
174273|NCT00608023|405038|P1|NOT COMPLETED|Overall Study||12
174274|NCT00608023|405036|P3|COMPLETED|Overall Study||72
174275|NCT00608023|405037|P2|COMPLETED|Overall Study||63
174276|NCT00608023|405038|P1|COMPLETED|Overall Study||80
174277|NCT00608023|405036|P3|STARTED|Overall Study||86
174278|NCT00608023|405037|P2|STARTED|Overall Study||85
174279|NCT00608023|405038|P1|STARTED|Overall Study||92
174280|NCT00607919|405060|P2|NOT COMPLETED|Open-Label Phase||12
174281|NCT00607919|405061|P1|NOT COMPLETED|Open-Label Phase||10
174282|NCT00607919|405060|P2|COMPLETED|Open-Label Phase||59
174283|NCT00607919|405061|P1|COMPLETED|Open-Label Phase||74
174284|NCT00607919|405060|P2|STARTED|Open-Label Phase||71
174285|NCT00607919|405061|P1|STARTED|Open-Label Phase||84
174286|NCT00607919|405060|P2|NOT COMPLETED|Acute Phase||16
174287|NCT00607919|405061|P1|NOT COMPLETED|Acute Phase||34
174288|NCT00607919|405060|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
174289|NCT00607919|405061|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
174290|NCT00607919|405060|P2|STARTED|Acute Phase||89
174291|NCT00607919|405061|P1|STARTED|Acute Phase||120
174292|NCT00607880|405119|P2|NOT COMPLETED|Overall Study||0
174293|NCT00607880|405120|P1|NOT COMPLETED|Overall Study||1
174294|NCT00607880|405119|P2|COMPLETED|Overall Study||50
174295|NCT00607880|405120|P1|COMPLETED|Overall Study||49
174296|NCT00607880|405119|P2|STARTED|Overall Study||50
174297|NCT00607880|405120|P1|STARTED|Overall Study||50
174298|NCT00607867|405134|P2|NOT COMPLETED|Overall Study||0
174299|NCT00607867|405135|P1|NOT COMPLETED|Overall Study||0
174300|NCT00607867|405134|P2|COMPLETED|Overall Study||7
174301|NCT00607867|405135|P1|COMPLETED|Overall Study||7
174302|NCT00607867|405134|P2|STARTED|Overall Study||7
174303|NCT00607867|405135|P1|STARTED|Overall Study||7
174304|NCT00607815|405153|P2|NOT COMPLETED|Overall Study||11
174305|NCT00607815|405154|P1|NOT COMPLETED|Overall Study||23
174306|NCT00607815|405153|P2|COMPLETED|Overall Study||25
174307|NCT00607815|405154|P1|COMPLETED|Overall Study||20
174308|NCT00607815|405153|P2|STARTED|Overall Study||36
174309|NCT00607815|405154|P1|STARTED|Overall Study||43
174310|NCT00607789|405170|P2|NOT COMPLETED|Overall Study||6
174311|NCT00607789|405171|P1|NOT COMPLETED|Overall Study||7
174312|NCT00607789|405170|P2|COMPLETED|Overall Study||14
174313|NCT00607789|405171|P1|COMPLETED|Overall Study||13
174314|NCT00607789|405170|P2|STARTED|Overall Study||20
174315|NCT00607789|405171|P1|STARTED|Overall Study|20 participants were randomized in each group|20
174316|NCT00607724|405186|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
174317|NCT00607724|405187|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
174318|NCT00607724|405188|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
174319|NCT00607724|405189|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
174320|NCT00607724|405190|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
174321|NCT00607724|405191|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
174322|NCT00607724|405192|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
174323|NCT00607724|405186|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
174324|NCT00607724|405187|P6|COMPLETED|Stage 2: Expanded Cohort||0
174325|NCT00607724|405188|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
174326|NCT00607724|405189|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
174327|NCT00607724|405190|P3|COMPLETED|Stage 2: Expanded Cohort||0
174328|NCT00607724|405191|P2|COMPLETED|Stage 2: Expanded Cohort||0
174329|NCT00607724|405192|P1|COMPLETED|Stage 2: Expanded Cohort||0
174330|NCT00607724|405186|P7|STARTED|Stage 2: Expanded Cohort||16
174331|NCT00607724|405187|P6|STARTED|Stage 2: Expanded Cohort||12
174332|NCT00607724|405188|P5|STARTED|Stage 2: Expanded Cohort||14
174333|NCT00607724|405189|P4|STARTED|Stage 2: Expanded Cohort||6
174334|NCT00607724|405190|P3|STARTED|Stage 2: Expanded Cohort||0
174335|NCT00607724|405191|P2|STARTED|Stage 2: Expanded Cohort||0
174336|NCT00607724|405192|P1|STARTED|Stage 2: Expanded Cohort||0
174337|NCT00607724|405186|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
174338|NCT00607724|405187|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
174339|NCT00607724|405188|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
174340|NCT00607724|405189|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
174341|NCT00607724|405190|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
174342|NCT00607724|405191|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
174343|NCT00607724|405192|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
174344|NCT00607724|405186|P7|COMPLETED|Stage 1: Dose Escalation||0
174345|NCT00607724|405187|P6|COMPLETED|Stage 1: Dose Escalation||0
174346|NCT00607724|405188|P5|COMPLETED|Stage 1: Dose Escalation||0
174347|NCT00607724|405189|P4|COMPLETED|Stage 1: Dose Escalation||0
174348|NCT00607724|405190|P3|COMPLETED|Stage 1: Dose Escalation||0
174349|NCT00607724|405191|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
174350|NCT00607724|405192|P1|COMPLETED|Stage 1: Dose Escalation||0
174351|NCT00607724|405186|P7|STARTED|Stage 1: Dose Escalation||0
174352|NCT00607724|405187|P6|STARTED|Stage 1: Dose Escalation||0
174353|NCT00607724|405188|P5|STARTED|Stage 1: Dose Escalation||0
174354|NCT00607724|405189|P4|STARTED|Stage 1: Dose Escalation||0
174355|NCT00607724|405190|P3|STARTED|Stage 1: Dose Escalation||4
174356|NCT00607724|405191|P2|STARTED|Stage 1: Dose Escalation||9
174357|NCT00607724|405192|P1|STARTED|Stage 1: Dose Escalation||7
174358|NCT00607672|405271|P3|NOT COMPLETED|Overall Study||5
174359|NCT00607672|405272|P2|NOT COMPLETED|Overall Study||3
174360|NCT00607672|405273|P1|NOT COMPLETED|Overall Study||4
174361|NCT00607672|405271|P3|COMPLETED|Overall Study||22
174362|NCT00607672|405272|P2|COMPLETED|Overall Study||24
174363|NCT00607672|405273|P1|COMPLETED|Overall Study||28
174364|NCT00607672|405271|P3|STARTED|Overall Study||27
174365|NCT00607672|405272|P2|STARTED|Overall Study||27
174366|NCT00607672|405273|P1|STARTED|Overall Study||32
174367|NCT00607594|405317|P1|NOT COMPLETED|Overall Study||0
174368|NCT00607594|405317|P1|COMPLETED|Overall Study||21
174369|NCT00607594|405317|P1|STARTED|Overall Study||21
174370|NCT00607477|405326|P2|NOT COMPLETED|Overall Study||0
174371|NCT00607477|405327|P1|NOT COMPLETED|Overall Study||0
174372|NCT00607477|405326|P2|COMPLETED|Overall Study||2
174373|NCT00607477|405327|P1|COMPLETED|Overall Study||0
174374|NCT00607477|405326|P2|STARTED|Overall Study||2
174375|NCT00607477|405327|P1|STARTED|Overall Study||0
174376|NCT00607386|405333|P1|NOT COMPLETED|Overall Study||1
174377|NCT00607386|405333|P1|COMPLETED|Overall Study||27
174378|NCT00607386|405333|P1|STARTED|Overall Study||28
174379|NCT00607373|405348|P2|NOT COMPLETED|Follow-up Period||5
174380|NCT00607373|405349|P1|NOT COMPLETED|Follow-up Period||1
174381|NCT00607373|405348|P2|COMPLETED|Follow-up Period||6
174382|NCT00607373|405349|P1|COMPLETED|Follow-up Period||0
174383|NCT00607373|405348|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
174384|NCT00607373|405349|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
174385|NCT00607373|405348|P2|NOT COMPLETED|Treatment Period||6
174386|NCT00607373|405349|P1|NOT COMPLETED|Treatment Period||0
174387|NCT00607373|405348|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
174388|NCT00607373|405349|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
174389|NCT00607373|405348|P2|STARTED|Treatment Period||34
174390|NCT00607373|405349|P1|STARTED|Treatment Period||17
174391|NCT00607321|405393|P1|NOT COMPLETED|Overall Study||0
174392|NCT00607321|405393|P1|COMPLETED|Overall Study||60
174393|NCT00607321|405393|P1|STARTED|Overall Study||60
174394|NCT00607269|405403|P2|NOT COMPLETED|Overall Study||0
174395|NCT00607269|405404|P1|NOT COMPLETED|Overall Study||0
174396|NCT00607269|405403|P2|COMPLETED|Overall Study||64
174397|NCT00607269|405404|P1|COMPLETED|Overall Study||67
174398|NCT00607269|405403|P2|STARTED|Overall Study||64
174399|NCT00607269|405404|P1|STARTED|Overall Study||67
174400|NCT00607243|405418|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
174401|NCT00607243|405419|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
174402|NCT00607243|405418|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
174403|NCT00607243|405419|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
174404|NCT00607243|405418|P2|STARTED|Telephone Safety Assessment Period||41
174405|NCT00607243|405419|P1|STARTED|Telephone Safety Assessment Period||82
174406|NCT00607243|405418|P2|NOT COMPLETED|Initial Post-vaccination Period||0
174407|NCT00607243|405419|P1|NOT COMPLETED|Initial Post-vaccination Period||0
174408|NCT00607243|405418|P2|COMPLETED|Initial Post-vaccination Period||41
174409|NCT00607243|405419|P1|COMPLETED|Initial Post-vaccination Period||82
174410|NCT00607243|405418|P2|STARTED|Initial Post-vaccination Period||41
174411|NCT00607243|405419|P1|STARTED|Initial Post-vaccination Period||82
174412|NCT00607126|405427|P2|NOT COMPLETED|Overall Study||0
174413|NCT00607126|405428|P1|NOT COMPLETED|Overall Study||0
174414|NCT00607126|405427|P2|COMPLETED|Overall Study||19
174415|NCT00607126|405428|P1|COMPLETED|Overall Study||17
174416|NCT00607126|405427|P2|STARTED|Overall Study||19
174417|NCT00607126|405428|P1|STARTED|Overall Study||17
174418|NCT00607113|405442|P2|NOT COMPLETED|Overall Study||0
174419|NCT00607113|405443|P1|NOT COMPLETED|Overall Study||0
174420|NCT00607113|405442|P2|COMPLETED|Overall Study||20
174421|NCT00607113|405443|P1|COMPLETED|Overall Study||19
174422|NCT00607113|405442|P2|STARTED|Overall Study||20
174423|NCT00607113|405443|P1|STARTED|Overall Study||19
174424|NCT00607087|405451|P3|NOT COMPLETED|Period 3||0
174425|NCT00607087|405452|P2|NOT COMPLETED|Period 3||2
174426|NCT00607087|405453|P1|NOT COMPLETED|Period 3||2
174427|NCT00607087|405451|P3|COMPLETED|Period 3||84
174428|NCT00607087|405452|P2|COMPLETED|Period 3||84
174429|NCT00607087|405453|P1|COMPLETED|Period 3||84
174430|NCT00607087|405451|P3|STARTED|Period 3||84
174431|NCT00607087|405452|P2|STARTED|Period 3||86
174432|NCT00607087|405453|P1|STARTED|Period 3||86
174433|NCT00607087|405451|P3|NOT COMPLETED|Period 2||5
174434|NCT00607087|405452|P2|NOT COMPLETED|Period 2||3
174435|NCT00607087|405453|P1|NOT COMPLETED|Period 2||1
174436|NCT00607087|405451|P3|COMPLETED|Period 2||84
174437|NCT00607087|405452|P2|COMPLETED|Period 2||86
174438|NCT00607087|405453|P1|COMPLETED|Period 2||86
174439|NCT00607087|405451|P3|STARTED|Period 2||89
174440|NCT00607087|405452|P2|STARTED|Period 2||89
174441|NCT00607087|405453|P1|STARTED|Period 2||87
174442|NCT00607087|405451|P3|NOT COMPLETED|Period 1||5
174443|NCT00607087|405452|P2|NOT COMPLETED|Period 1||6
174444|NCT00607087|405453|P1|NOT COMPLETED|Period 1||12
174445|NCT00607087|405451|P3|COMPLETED|Period 1||89
174446|NCT00607087|405452|P2|COMPLETED|Period 1||89
174447|NCT00607087|405453|P1|COMPLETED|Period 1||87
174448|NCT00607087|405451|P3|STARTED|Period 1||94
174449|NCT00607087|405452|P2|STARTED|Period 1||95
174450|NCT00607087|405453|P1|STARTED|Period 1||99
174451|NCT00607087|405451|P3|NOT COMPLETED|Overall Study||10
174452|NCT00607087|405452|P2|NOT COMPLETED|Overall Study||11
174453|NCT00607087|405453|P1|NOT COMPLETED|Overall Study||15
174454|NCT00607087|405451|P3|COMPLETED|Overall Study||84
174455|NCT00607087|405452|P2|COMPLETED|Overall Study||84
174456|NCT00607087|405453|P1|COMPLETED|Overall Study||84
174457|NCT00607087|405451|P3|STARTED|Overall Study||94
174458|NCT00607087|405452|P2|STARTED|Overall Study||95
174459|NCT00607087|405453|P1|STARTED|Overall Study||99
174460|NCT00607048|405511|P6|NOT COMPLETED|Overall Study||5
174461|NCT00607048|405512|P5|NOT COMPLETED|Overall Study||6
174462|NCT00607048|405513|P4|NOT COMPLETED|Overall Study||3
174463|NCT00607048|405514|P3|NOT COMPLETED|Overall Study||4
174464|NCT00607048|405515|P2|NOT COMPLETED|Overall Study||4
174465|NCT00607048|405516|P1|NOT COMPLETED|Overall Study||3
174466|NCT00607048|405511|P6|COMPLETED|Overall Study||2
174467|NCT00607048|405512|P5|COMPLETED|Overall Study||0
174468|NCT00607048|405513|P4|COMPLETED|Overall Study||0
174469|NCT00607048|405514|P3|COMPLETED|Overall Study||3
174470|NCT00607048|405515|P2|COMPLETED|Overall Study||2
174471|NCT00607048|405516|P1|COMPLETED|Overall Study||0
174472|NCT00607048|405511|P6|STARTED|Overall Study||7
174473|NCT00607048|405512|P5|STARTED|Overall Study||6
174474|NCT00607048|405513|P4|STARTED|Overall Study||3
174475|NCT00607048|405514|P3|STARTED|Overall Study||7
174476|NCT00607048|405515|P2|STARTED|Overall Study||6
174477|NCT00607048|405516|P1|STARTED|Overall Study||3
174478|NCT00606944|405600|P2|NOT COMPLETED|Overall Study||0
174479|NCT00606944|405601|P1|NOT COMPLETED|Overall Study||0
174480|NCT00606944|405600|P2|COMPLETED|Overall Study||100
174481|NCT00606944|405601|P1|COMPLETED|Overall Study||98
174482|NCT00606944|405600|P2|STARTED|Overall Study||100
174483|NCT00606944|405601|P1|STARTED|Overall Study||98
174484|NCT00606931|405607|P1|NOT COMPLETED|Overall Study||3
174485|NCT00606931|405607|P1|COMPLETED|Overall Study||19
174486|NCT00606931|405607|P1|STARTED|Overall Study||22
174487|NCT00606905|405615|P2|NOT COMPLETED|Overall Study||15
174488|NCT00606905|405616|P1|NOT COMPLETED|Overall Study||15
174489|NCT00606905|405615|P2|COMPLETED|Overall Study||24
174490|NCT00606905|405616|P1|COMPLETED|Overall Study||23
174491|NCT00606905|405615|P2|Pregnancy|Overall Study||33
174492|NCT00606905|405616|P1|Pregnancy|Overall Study||29
174493|NCT00606905|405615|P2|STARTED|Overall Study||39
174494|NCT00606905|405616|P1|STARTED|Overall Study||38
174495|NCT00606892|405622|P2|NOT COMPLETED|Second Intervention||0
174496|NCT00606892|405623|P1|NOT COMPLETED|Second Intervention||0
174497|NCT00606892|405622|P2|COMPLETED|Second Intervention||4
174498|NCT00606892|405623|P1|COMPLETED|Second Intervention||8
174499|NCT00606892|405622|P2|STARTED|Second Intervention||4
174500|NCT00606892|405623|P1|STARTED|Second Intervention||8
174501|NCT00606892|405622|P2|NOT COMPLETED|Washout Period||0
174502|NCT00606892|405623|P1|NOT COMPLETED|Washout Period||0
174503|NCT00606892|405622|P2|COMPLETED|Washout Period||4
174504|NCT00606892|405623|P1|COMPLETED|Washout Period||8
174505|NCT00606892|405622|P2|STARTED|Washout Period||4
174506|NCT00606892|405623|P1|STARTED|Washout Period||8
174507|NCT00606892|405622|P2|NOT COMPLETED|First Intervention||4
174508|NCT00606892|405623|P1|NOT COMPLETED|First Intervention||1
174509|NCT00606892|405622|P2|COMPLETED|First Intervention||4
174510|NCT00606892|405623|P1|COMPLETED|First Intervention||8
174511|NCT00606892|405622|P2|STARTED|First Intervention||8
174512|NCT00606892|405623|P1|STARTED|First Intervention||9
174513|NCT00606892|405622|P2|NOT COMPLETED|Adaptation||0
174514|NCT00606892|405623|P1|NOT COMPLETED|Adaptation||0
174515|NCT00606892|405622|P2|COMPLETED|Adaptation||8
174516|NCT00606892|405623|P1|COMPLETED|Adaptation||9
174517|NCT00606892|405622|P2|STARTED|Adaptation||8
174518|NCT00606892|405623|P1|STARTED|Adaptation||9
174519|NCT00606801|405657|P2|NOT COMPLETED|Intervention||3
174520|NCT00606801|405658|P1|NOT COMPLETED|Intervention||3
174521|NCT00606801|405657|P2|COMPLETED|Intervention||14
174522|NCT00606801|405658|P1|COMPLETED|Intervention||14
174523|NCT00606801|405657|P2|STARTED|Intervention||17
174524|NCT00606801|405658|P1|STARTED|Intervention||17
174525|NCT00606801|405657|P2|NOT COMPLETED|Adaptation||0
174526|NCT00606801|405658|P1|NOT COMPLETED|Adaptation||0
174527|NCT00606801|405657|P2|COMPLETED|Adaptation||17
174528|NCT00606801|405658|P1|COMPLETED|Adaptation||17
174529|NCT00606801|405657|P2|STARTED|Adaptation||17
174530|NCT00606801|405658|P1|STARTED|Adaptation||17
174531|NCT00606684|405686|P7|NOT COMPLETED|Double-Blind Treatment Period||8
174532|NCT00606684|405687|P6|NOT COMPLETED|Double-Blind Treatment Period||9
174533|NCT00606684|405688|P5|NOT COMPLETED|Double-Blind Treatment Period||9
174534|NCT00606684|405689|P4|NOT COMPLETED|Double-Blind Treatment Period||10
174535|NCT00606684|405690|P3|NOT COMPLETED|Double-Blind Treatment Period||11
174536|NCT00606684|405691|P2|NOT COMPLETED|Double-Blind Treatment Period||16
174537|NCT00606684|405692|P1|NOT COMPLETED|Double-Blind Treatment Period||0
174538|NCT00606684|405686|P7|COMPLETED|Double-Blind Treatment Period||91
174539|NCT00606684|405687|P6|COMPLETED|Double-Blind Treatment Period||92
174540|NCT00606684|405688|P5|COMPLETED|Double-Blind Treatment Period||92
174541|NCT00606684|405689|P4|COMPLETED|Double-Blind Treatment Period||91
174542|NCT00606684|405690|P3|COMPLETED|Double-Blind Treatment Period||88
174543|NCT00606684|405691|P2|COMPLETED|Double-Blind Treatment Period||85
174544|NCT00606684|405692|P1|COMPLETED|Double-Blind Treatment Period||0
174545|NCT00606684|405686|P7|STARTED|Double-Blind Treatment Period||99
174546|NCT00606684|405687|P6|STARTED|Double-Blind Treatment Period||101
174547|NCT00606684|405688|P5|STARTED|Double-Blind Treatment Period||101
174548|NCT00606684|405689|P4|STARTED|Double-Blind Treatment Period||101
174549|NCT00606684|405690|P3|STARTED|Double-Blind Treatment Period||99
174550|NCT00606684|405691|P2|STARTED|Double-Blind Treatment Period||101
174551|NCT00606684|405692|P1|STARTED|Double-Blind Treatment Period||0
174552|NCT00606684|405686|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174553|NCT00606684|405687|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174554|NCT00606684|405688|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174555|NCT00606684|405689|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174556|NCT00606684|405690|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174557|NCT00606684|405691|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
174558|NCT00606684|405692|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
174559|NCT00606684|405686|P7|COMPLETED|2-week Single-Blind Run-in Period||0
174560|NCT00606684|405687|P6|COMPLETED|2-week Single-Blind Run-in Period||0
174561|NCT00606684|405688|P5|COMPLETED|2-week Single-Blind Run-in Period||0
174562|NCT00606684|405689|P4|COMPLETED|2-week Single-Blind Run-in Period||0
174563|NCT00606684|405690|P3|COMPLETED|2-week Single-Blind Run-in Period||0
174564|NCT00606684|405691|P2|COMPLETED|2-week Single-Blind Run-in Period||0
174565|NCT00606684|405692|P1|COMPLETED|2-week Single-Blind Run-in Period||605
174566|NCT00606684|405686|P7|STARTED|2-week Single-Blind Run-in Period||0
174567|NCT00606684|405687|P6|STARTED|2-week Single-Blind Run-in Period||0
174568|NCT00606684|405688|P5|STARTED|2-week Single-Blind Run-in Period||0
174569|NCT00606684|405689|P4|STARTED|2-week Single-Blind Run-in Period||0
174570|NCT00606684|405690|P3|STARTED|2-week Single-Blind Run-in Period||0
174571|NCT00606684|405691|P2|STARTED|2-week Single-Blind Run-in Period||0
174572|NCT00606684|405692|P1|STARTED|2-week Single-Blind Run-in Period||851
174573|NCT00606632|405724|P1|NOT COMPLETED|Overall Study||22
174574|NCT00606632|405724|P1|COMPLETED|Overall Study||204
174575|NCT00606632|405724|P1|STARTED|Overall Study||226
174576|NCT00606593|405731|P10|NOT COMPLETED|Overall Study||0
174577|NCT00606593|405732|P9|NOT COMPLETED|Overall Study||1
174578|NCT00606593|405733|P8|NOT COMPLETED|Overall Study||2
174579|NCT00606593|405734|P7|NOT COMPLETED|Overall Study||1
174580|NCT00606593|405735|P6|NOT COMPLETED|Overall Study||0
174581|NCT00606593|405736|P5|NOT COMPLETED|Overall Study||1
174582|NCT00606593|405737|P4|NOT COMPLETED|Overall Study||1
174583|NCT00606593|405738|P3|NOT COMPLETED|Overall Study||2
174584|NCT00606593|405739|P2|NOT COMPLETED|Overall Study||0
174585|NCT00606593|405740|P1|NOT COMPLETED|Overall Study||1
174586|NCT00606593|405731|P10|COMPLETED|Overall Study||11
174587|NCT00606593|405732|P9|COMPLETED|Overall Study||11
174588|NCT00606593|405733|P8|COMPLETED|Overall Study||9
174589|NCT00606593|405734|P7|COMPLETED|Overall Study||10
174590|NCT00606593|405735|P6|COMPLETED|Overall Study||11
174591|NCT00606593|405736|P5|COMPLETED|Overall Study||11
174592|NCT00606593|405737|P4|COMPLETED|Overall Study||10
174593|NCT00606593|405738|P3|COMPLETED|Overall Study||9
174594|NCT00606593|405739|P2|COMPLETED|Overall Study||11
174595|NCT00606593|405740|P1|COMPLETED|Overall Study||10
174596|NCT00606593|405731|P10|5th Double-blind Treatment|Overall Study||11
174597|NCT00606593|405732|P9|5th Double-blind Treatment|Overall Study||11
174598|NCT00606593|405733|P8|5th Double-blind Treatment|Overall Study||9
174599|NCT00606593|405734|P7|5th Double-blind Treatment|Overall Study||10
174600|NCT00606593|405735|P6|5th Double-blind Treatment|Overall Study||11
174601|NCT00606593|405736|P5|5th Double-blind Treatment|Overall Study||11
174602|NCT00606593|405737|P4|5th Double-blind Treatment|Overall Study||10
174603|NCT00606593|405738|P3|5th Double-blind Treatment|Overall Study||9
174604|NCT00606593|405739|P2|5th Double-blind Treatment|Overall Study||11
174605|NCT00606593|405740|P1|5th Double-blind Treatment|Overall Study||10
174606|NCT00606593|405731|P10|4th Double-blind Treatment|Overall Study||11
174607|NCT00606593|405732|P9|4th Double-blind Treatment|Overall Study||11
174608|NCT00606593|405733|P8|4th Double-blind Treatment|Overall Study||9
174609|NCT00606593|405734|P7|4th Double-blind Treatment|Overall Study||10
174610|NCT00606593|405735|P6|4th Double-blind Treatment|Overall Study||11
174611|NCT00606593|405736|P5|4th Double-blind Treatment|Overall Study||11
174612|NCT00606593|405737|P4|4th Double-blind Treatment|Overall Study||10
174613|NCT00606593|405738|P3|4th Double-blind Treatment|Overall Study||10
174614|NCT00606593|405739|P2|4th Double-blind Treatment|Overall Study||11
174615|NCT00606593|405740|P1|4th Double-blind Treatment|Overall Study||10
174616|NCT00606593|405731|P10|3rd Double-blind Treatment|Overall Study||11
174617|NCT00606593|405732|P9|3rd Double-blind Treatment|Overall Study||12
174618|NCT00606593|405733|P8|3rd Double-blind Treatment|Overall Study||9
174619|NCT00606593|405734|P7|3rd Double-blind Treatment|Overall Study||10
174620|NCT00606593|405735|P6|3rd Double-blind Treatment|Overall Study||11
174621|NCT00606593|405736|P5|3rd Double-blind Treatment|Overall Study||11
174622|NCT00606593|405737|P4|3rd Double-blind Treatment|Overall Study||10
174623|NCT00606593|405738|P3|3rd Double-blind Treatment|Overall Study||10
174624|NCT00606593|405739|P2|3rd Double-blind Treatment|Overall Study||11
174625|NCT00606593|405740|P1|3rd Double-blind Treatment|Overall Study||11
174626|NCT00606593|405731|P10|2nd Double-blind Treatment|Overall Study||11
174627|NCT00606593|405732|P9|2nd Double-blind Treatment|Overall Study||12
174628|NCT00606593|405733|P8|2nd Double-blind Treatment|Overall Study||9
174629|NCT00606593|405734|P7|2nd Double-blind Treatment|Overall Study||10
174630|NCT00606593|405735|P6|2nd Double-blind Treatment|Overall Study||11
174631|NCT00606593|405736|P5|2nd Double-blind Treatment|Overall Study||12
174632|NCT00606593|405737|P4|2nd Double-blind Treatment|Overall Study||10
174633|NCT00606593|405738|P3|2nd Double-blind Treatment|Overall Study||11
174634|NCT00606593|405739|P2|2nd Double-blind Treatment|Overall Study||11
174635|NCT00606593|405740|P1|2nd Double-blind Treatment|Overall Study||11
174636|NCT00606593|405731|P10|1st Double-blind Treatment|Overall Study||11
174637|NCT00606593|405732|P9|1st Double-blind Treatment|Overall Study||12
174638|NCT00606593|405733|P8|1st Double-blind Treatment|Overall Study||11
174639|NCT00606593|405734|P7|1st Double-blind Treatment|Overall Study||11
174640|NCT00606593|405735|P6|1st Double-blind Treatment|Overall Study||11
174641|NCT00606593|405736|P5|1st Double-blind Treatment|Overall Study||12
174642|NCT00606593|405737|P4|1st Double-blind Treatment|Overall Study||11
174643|NCT00606593|405738|P3|1st Double-blind Treatment|Overall Study||11
174644|NCT00606593|405739|P2|1st Double-blind Treatment|Overall Study||11
174645|NCT00606593|405740|P1|1st Double-blind Treatment|Overall Study||11
174646|NCT00606593|405731|P10|STARTED|Overall Study|Randomized participants|11
174647|NCT00606593|405732|P9|STARTED|Overall Study|Randomized participants|12
174648|NCT00606593|405733|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
174649|NCT00606593|405734|P7|STARTED|Overall Study|Randomized participants|11
174650|NCT00606593|405735|P6|STARTED|Overall Study|Randomized participants|11
174651|NCT00606593|405736|P5|STARTED|Overall Study|Randomized participants|12
174652|NCT00606593|405737|P4|STARTED|Overall Study|Randomized participants|11
174653|NCT00606593|405738|P3|STARTED|Overall Study|Randomized participants|11
174654|NCT00606593|405739|P2|STARTED|Overall Study|Randomized participants|11
174655|NCT00606593|405740|P1|STARTED|Overall Study|Randomized participants|11
174656|NCT00606580|405761|P3|NOT COMPLETED|Overall Study||22
174657|NCT00606580|405762|P2|NOT COMPLETED|Overall Study||3
174658|NCT00606580|405763|P1|NOT COMPLETED|Overall Study||2
174659|NCT00606580|405761|P3|COMPLETED|Overall Study||103
174660|NCT00606580|405762|P2|COMPLETED|Overall Study||122
174661|NCT00606580|405763|P1|COMPLETED|Overall Study||123
174662|NCT00606580|405761|P3|STARTED|Overall Study||125
174663|NCT00606580|405762|P2|STARTED|Overall Study||125
174664|NCT00606580|405763|P1|STARTED|Overall Study||125
174665|NCT00606554|405806|P2|NOT COMPLETED|Overall Study||0
174666|NCT00606554|405807|P1|NOT COMPLETED|Overall Study||0
174667|NCT00606554|405806|P2|COMPLETED|Overall Study||18
174668|NCT00606554|405807|P1|COMPLETED|Overall Study||15
174669|NCT00606554|405806|P2|STARTED|Overall Study||18
174670|NCT00606554|405807|P1|STARTED|Overall Study||15
174671|NCT00606502|405819|P2|NOT COMPLETED|Treatment||3
174672|NCT00606502|405820|P1|NOT COMPLETED|Treatment||0
174673|NCT00606502|405819|P2|COMPLETED|Treatment||98
174674|NCT00606502|405820|P1|COMPLETED|Treatment||97
174675|NCT00606502|405819|P2|STARTED|Treatment||101
174676|NCT00606502|405820|P1|STARTED|Treatment||97
174677|NCT00606502|405819|P2|NOT COMPLETED|Randomization||0
174678|NCT00606502|405820|P1|NOT COMPLETED|Randomization||3
174679|NCT00606502|405819|P2|COMPLETED|Randomization||101
174680|NCT00606502|405820|P1|COMPLETED|Randomization||97
174681|NCT00606502|405819|P2|STARTED|Randomization||101
174682|NCT00606502|405820|P1|STARTED|Randomization||100
174683|NCT00606489|405834|P2|NOT COMPLETED|Overall Study||0
174684|NCT00606489|405835|P1|NOT COMPLETED|Overall Study||0
174685|NCT00606489|405834|P2|COMPLETED|Overall Study||40
174686|NCT00606489|405835|P1|COMPLETED|Overall Study||21
174687|NCT00606489|405834|P2|STARTED|Overall Study||40
174688|NCT00606489|405835|P1|STARTED|Overall Study||21
174689|NCT00605384|405843|P2|NOT COMPLETED|Overall Study||1
174690|NCT00605384|405844|P1|NOT COMPLETED|Overall Study||1
174691|NCT00605384|405843|P2|COMPLETED|Overall Study|study terminated early|0
174692|NCT00605384|405844|P1|COMPLETED|Overall Study|study terminated early|0
174693|NCT00605384|405843|P2|STARTED|Overall Study||1
174694|NCT00605384|405844|P1|STARTED|Overall Study||1
174695|NCT00605345|405874|P2|NOT COMPLETED|Overall Study||3
174696|NCT00605345|405875|P1|NOT COMPLETED|Overall Study||1
174697|NCT00605345|405874|P2|COMPLETED|Overall Study||22
174698|NCT00605345|405875|P1|COMPLETED|Overall Study||45
174699|NCT00605345|405874|P2|STARTED|Overall Study||25
174700|NCT00605345|405875|P1|STARTED|Overall Study||46
174701|NCT00605306|405893|P2|NOT COMPLETED|Overall Study||1
174702|NCT00605306|405894|P1|NOT COMPLETED|Overall Study||0
174703|NCT00605306|405893|P2|COMPLETED|Overall Study||13
174704|NCT00605306|405894|P1|COMPLETED|Overall Study||14
174705|NCT00605306|405893|P2|STARTED|Overall Study||14
174706|NCT00605306|405894|P1|STARTED|Overall Study||14
174707|NCT00605293|405908|P2|NOT COMPLETED|Overall Study||5
174708|NCT00605293|405909|P1|NOT COMPLETED|Overall Study||17
174709|NCT00605293|405908|P2|COMPLETED|Overall Study||31
174710|NCT00605293|405909|P1|COMPLETED|Overall Study||48
174711|NCT00605293|405908|P2|STARTED|Overall Study||36
174712|NCT00605293|405909|P1|STARTED|Overall Study||65
174713|NCT00605280|405929|P4|NOT COMPLETED|Year 3 Extension||9
174714|NCT00605280|405930|P3|NOT COMPLETED|Year 3 Extension||0
174715|NCT00605280|405931|P2|NOT COMPLETED|Year 3 Extension||0
174716|NCT00605280|405932|P1|NOT COMPLETED|Year 3 Extension||8
174717|NCT00605280|405929|P4|COMPLETED|Year 3 Extension||45
174718|NCT00605280|405930|P3|COMPLETED|Year 3 Extension||0
174719|NCT00605280|405931|P2|COMPLETED|Year 3 Extension||0
174720|NCT00605280|405932|P1|COMPLETED|Year 3 Extension||38
174721|NCT00605280|405929|P4|Received 0.3 mg Treatment|Year 3 Extension||54
174722|NCT00605280|405930|P3|Received 0.3 mg Treatment|Year 3 Extension||0
174723|NCT00605280|405931|P2|Received 0.3 mg Treatment|Year 3 Extension||0
174724|NCT00605280|405932|P1|Received 0.3 mg Treatment|Year 3 Extension||46
174725|NCT00605280|405929|P4|STARTED|Year 3 Extension||54
174726|NCT00605280|405930|P3|STARTED|Year 3 Extension||0
174727|NCT00605280|405931|P2|STARTED|Year 3 Extension||0
174728|NCT00605280|405932|P1|STARTED|Year 3 Extension||46
174729|NCT00605280|405929|P4|NOT COMPLETED|Year 2||22
174730|NCT00605280|405930|P3|NOT COMPLETED|Year 2||6
174731|NCT00605280|405931|P2|NOT COMPLETED|Year 2||6
174732|NCT00605280|405932|P1|NOT COMPLETED|Year 2||24
174733|NCT00605280|405929|P4|COMPLETED|Year 2||102
174734|NCT00605280|405930|P3|COMPLETED|Year 2||0
174735|NCT00605280|405931|P2|COMPLETED|Year 2||5
174736|NCT00605280|405932|P1|COMPLETED|Year 2||102
174737|NCT00605280|405929|P4|Received 0.3 mg Treatment|Year 2||0
174738|NCT00605280|405930|P3|Received 0.3 mg Treatment|Year 2||2
174739|NCT00605280|405931|P2|Received 0.3 mg Treatment|Year 2||3
174740|NCT00605280|405932|P1|Received 0.3 mg Treatment|Year 2||126
174741|NCT00605280|405929|P4|STARTED|Year 2||124
174742|NCT00605280|405930|P3|STARTED|Year 2||6
174743|NCT00605280|405931|P2|STARTED|Year 2||11
174744|NCT00605280|405932|P1|STARTED|Year 2||126
174745|NCT00605280|405929|P4|NOT COMPLETED|Year 1||19
174746|NCT00605280|405930|P3|NOT COMPLETED|Year 1||1
174747|NCT00605280|405931|P2|NOT COMPLETED|Year 1||11
174748|NCT00605280|405932|P1|NOT COMPLETED|Year 1||19
174749|NCT00605280|405929|P4|COMPLETED|Year 1||124
174750|NCT00605280|405930|P3|COMPLETED|Year 1||6
174751|NCT00605280|405931|P2|COMPLETED|Year 1||11
174752|NCT00605280|405932|P1|COMPLETED|Year 1||126
174753|NCT00605280|405929|P4|Received 0.3 mg Treatment|Year 1||0
174754|NCT00605280|405930|P3|Received 0.3 mg Treatment|Year 1||3
174755|NCT00605280|405931|P2|Received 0.3 mg Treatment|Year 1||13
174756|NCT00605280|405932|P1|Received 0.3 mg Treatment|Year 1||144
174757|NCT00605280|405929|P4|STARTED|Year 1||143
174758|NCT00605280|405930|P3|STARTED|Year 1||7
174759|NCT00605280|405931|P2|STARTED|Year 1||22
174760|NCT00605280|405932|P1|STARTED|Year 1||145
174761|NCT00605267|405966|P2|NOT COMPLETED|Overall Study||9
174762|NCT00605267|405967|P1|NOT COMPLETED|Overall Study||3
174763|NCT00605267|405966|P2|COMPLETED|Overall Study|Breast surgery performed|90
174764|NCT00605267|405967|P1|COMPLETED|Overall Study|Breast surgery performed|95
174765|NCT00605267|405966|P2|STARTED|Overall Study||99
174766|NCT00605267|405967|P1|STARTED|Overall Study||98
174767|NCT00606320|406005|P1|NOT COMPLETED|Overall Study||37
174768|NCT00606320|406005|P1|COMPLETED|Overall Study||22
174769|NCT00606320|406005|P1|STARTED|Overall Study||59
174770|NCT00606281|406012|P2|NOT COMPLETED|Overall Study||66
174771|NCT00606281|406013|P1|NOT COMPLETED|Overall Study||56
174772|NCT00606281|406012|P2|COMPLETED|Overall Study||64
174773|NCT00606281|406013|P1|COMPLETED|Overall Study||72
174774|NCT00606281|406012|P2|STARTED|Overall Study||130
174775|NCT00606281|406013|P1|STARTED|Overall Study||128
174776|NCT00606229|406021|P1|NOT COMPLETED|Overall Study||22
174777|NCT00606229|406021|P1|COMPLETED|Overall Study||19
174778|NCT00606229|406021|P1|STARTED|Overall Study||41
174779|NCT00606177|406028|P2|NOT COMPLETED|Overall Study||25
174780|NCT00606177|406029|P1|NOT COMPLETED|Overall Study||27
174781|NCT00606177|406028|P2|COMPLETED|Overall Study||19
174782|NCT00606177|406029|P1|COMPLETED|Overall Study||28
174783|NCT00606177|406028|P2|STARTED|Overall Study||44
174784|NCT00606177|406029|P1|STARTED|Overall Study||55
174785|NCT00606138|406039|P2|NOT COMPLETED|Overall Study||0
174786|NCT00606138|406040|P1|NOT COMPLETED|Overall Study||0
174787|NCT00606138|406039|P2|COMPLETED|Overall Study||2
174788|NCT00606138|406040|P1|COMPLETED|Overall Study||6
174789|NCT00606138|406039|P2|STARTED|Overall Study||2
174790|NCT00606138|406040|P1|STARTED|Overall Study||6
174791|NCT00606086|406056|P2|NOT COMPLETED|Overall Study||15
174792|NCT00606086|406057|P1|NOT COMPLETED|Overall Study||12
174793|NCT00606086|406056|P2|COMPLETED|Overall Study||53
174794|NCT00606086|406057|P1|COMPLETED|Overall Study||60
174795|NCT00606086|406056|P2|STARTED|Overall Study||68
174796|NCT00606086|406057|P1|STARTED|Overall Study||72
174797|NCT00606034|406063|P1|NOT COMPLETED|Overall Study||1
174798|NCT00606034|406063|P1|COMPLETED|Overall Study||20
174799|NCT00606034|406063|P1|STARTED|Overall Study||21
174800|NCT00606021|406071|P3|NOT COMPLETED|Maintenance Phase||17
174801|NCT00606021|406072|P2|NOT COMPLETED|Maintenance Phase||23
174802|NCT00606021|406073|P1|NOT COMPLETED|Maintenance Phase||0
174803|NCT00606021|406071|P3|COMPLETED|Maintenance Phase||10
174804|NCT00606021|406072|P2|COMPLETED|Maintenance Phase||5
174805|NCT00606021|406073|P1|COMPLETED|Maintenance Phase||0
174806|NCT00606021|406071|P3|STARTED|Maintenance Phase||27
174807|NCT00606021|406072|P2|STARTED|Maintenance Phase||28
174808|NCT00606021|406073|P1|STARTED|Maintenance Phase||0
174809|NCT00606021|406071|P3|NOT COMPLETED|Induction Phase||0
174810|NCT00606021|406072|P2|NOT COMPLETED|Induction Phase||0
174811|NCT00606021|406073|P1|NOT COMPLETED|Induction Phase||87
174812|NCT00606021|406071|P3|COMPLETED|Induction Phase||0
174813|NCT00606021|406072|P2|COMPLETED|Induction Phase||0
174814|NCT00606021|406073|P1|COMPLETED|Induction Phase||19
174815|NCT00606021|406071|P3|STARTED|Induction Phase||0
174816|NCT00606021|406072|P2|STARTED|Induction Phase||0
174817|NCT00606021|406073|P1|STARTED|Induction Phase||106
174818|NCT00606008|406091|P1|NOT COMPLETED|Overall Study||5
174819|NCT00606008|406091|P1|COMPLETED|Overall Study||25
174820|NCT00606008|406091|P1|STARTED|Overall Study||30
174821|NCT00605917|406105|P1|NOT COMPLETED|Overall Study||79
174822|NCT00605917|406105|P1|COMPLETED|Overall Study||908
174823|NCT00605917|406105|P1|STARTED|Overall Study||987
174824|NCT00605904|406146|P2|NOT COMPLETED|Infusion Sessions||3
174825|NCT00605904|406147|P1|NOT COMPLETED|Infusion Sessions||1
174826|NCT00605904|406146|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
174827|NCT00605904|406147|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
174828|NCT00605904|406146|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
174829|NCT00605904|406147|P1|Yohimbine Infusion|Infusion Sessions||12
174830|NCT00605904|406146|P2|mCPP Infusion|Infusion Sessions||13
174831|NCT00605904|406147|P1|mCPP Infusion|Infusion Sessions||12
174832|NCT00605904|406146|P2|Saline Infusion|Infusion Sessions||14
174833|NCT00605904|406147|P1|Saline Infusion|Infusion Sessions||13
174834|NCT00605904|406146|P2|STARTED|Infusion Sessions||16
174835|NCT00605904|406147|P1|STARTED|Infusion Sessions||13
174836|NCT00605904|406146|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
174837|NCT00605904|406147|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
174838|NCT00605904|406146|P2|COMPLETED|Baseline Data Collection and Dosing||16
174839|NCT00605904|406147|P1|COMPLETED|Baseline Data Collection and Dosing||13
174840|NCT00605904|406146|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
174841|NCT00605904|406147|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
174842|NCT00605865|406157|P1|NOT COMPLETED|Overall Study||115
174843|NCT00605865|406157|P1|COMPLETED|Overall Study||2157
174844|NCT00605865|406157|P1|STARTED|Overall Study||2272
174845|NCT00605839|406199|P3|NOT COMPLETED|Overall Study||0
174846|NCT00605839|406200|P2|NOT COMPLETED|Overall Study||0
174847|NCT00605839|406201|P1|NOT COMPLETED|Overall Study||1
174848|NCT00605839|406199|P3|COMPLETED|Overall Study||28
174849|NCT00605839|406200|P2|COMPLETED|Overall Study||37
174850|NCT00605839|406201|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
174851|NCT00605839|406199|P3|STARTED|Overall Study||28
174852|NCT00605839|406200|P2|STARTED|Overall Study||37
174853|NCT00605839|406201|P1|STARTED|Overall Study||40
174854|NCT00605813|406209|P1|NOT COMPLETED|Overall Study||25
174855|NCT00605813|406209|P1|COMPLETED|Overall Study||517
174856|NCT00605813|406209|P1|STARTED|Overall Study||542
174857|NCT00605722|406222|P1|NOT COMPLETED|Overall Study||51
174858|NCT00605722|406222|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
174859|NCT00605722|406222|P1|STARTED|Overall Study||51
174860|NCT00605657|406232|P1|NOT COMPLETED|Overall Study||2
174861|NCT00605657|406232|P1|COMPLETED|Overall Study||3
174862|NCT00605657|406232|P1|STARTED|Overall Study||5
174863|NCT00605540|406237|P1|NOT COMPLETED|Overall Study||38
174864|NCT00605540|406237|P1|COMPLETED|Overall Study||95
174865|NCT00605540|406237|P1|STARTED|Overall Study||133
174866|NCT00605475|406255|P10|NOT COMPLETED|Overall Study||2
174867|NCT00605475|406256|P9|NOT COMPLETED|Overall Study||2
174868|NCT00605475|406257|P8|NOT COMPLETED|Overall Study||0
174869|NCT00605475|406258|P7|NOT COMPLETED|Overall Study||1
174870|NCT00605475|406259|P6|NOT COMPLETED|Overall Study||2
174871|NCT00605475|406260|P5|NOT COMPLETED|Overall Study||1
174872|NCT00605475|406261|P4|NOT COMPLETED|Overall Study||0
174873|NCT00605475|406262|P3|NOT COMPLETED|Overall Study||0
174874|NCT00605475|406263|P2|NOT COMPLETED|Overall Study||0
174875|NCT00605475|406264|P1|NOT COMPLETED|Overall Study||0
174876|NCT00605475|406255|P10|COMPLETED|Overall Study||8
174877|NCT00605475|406256|P9|COMPLETED|Overall Study||18
174878|NCT00605475|406257|P8|COMPLETED|Overall Study||24
174879|NCT00605475|406258|P7|COMPLETED|Overall Study||22
174880|NCT00605475|406259|P6|COMPLETED|Overall Study||22
174881|NCT00605475|406260|P5|COMPLETED|Overall Study||24
174882|NCT00605475|406261|P4|COMPLETED|Overall Study||45
174883|NCT00605475|406262|P3|COMPLETED|Overall Study||45
174884|NCT00605475|406263|P2|COMPLETED|Overall Study||5
174885|NCT00605475|406264|P1|COMPLETED|Overall Study||10
174886|NCT00605475|406255|P10|STARTED|Overall Study||10
174887|NCT00605475|406256|P9|STARTED|Overall Study||20
174888|NCT00605475|406257|P8|STARTED|Overall Study||24
174889|NCT00605475|406258|P7|STARTED|Overall Study||23
174890|NCT00605475|406259|P6|STARTED|Overall Study||24
174891|NCT00605475|406260|P5|STARTED|Overall Study||25
174892|NCT00605475|406261|P4|STARTED|Overall Study||45
174893|NCT00605475|406262|P3|STARTED|Overall Study||45
174894|NCT00605475|406263|P2|STARTED|Overall Study||5
174895|NCT00605475|406264|P1|STARTED|Overall Study||10
174896|NCT00605423|406388|P2|NOT COMPLETED|Overall Study||0
174897|NCT00605423|406389|P1|NOT COMPLETED|Overall Study||0
174898|NCT00605423|406388|P2|COMPLETED|Overall Study||2
174899|NCT00605423|406389|P1|COMPLETED|Overall Study||4
174900|NCT00605423|406388|P2|STARTED|Overall Study||2
174901|NCT00605423|406389|P1|STARTED|Overall Study||4
174902|NCT00605202|406399|P2|NOT COMPLETED|Second Intervention||0
174903|NCT00605202|406400|P1|NOT COMPLETED|Second Intervention||0
174904|NCT00605202|406399|P2|COMPLETED|Second Intervention||5
174905|NCT00605202|406400|P1|COMPLETED|Second Intervention||5
174906|NCT00605202|406399|P2|STARTED|Second Intervention||5
174907|NCT00605202|406400|P1|STARTED|Second Intervention||5
174908|NCT00605202|406399|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
174909|NCT00605202|406400|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
174910|NCT00605202|406399|P2|COMPLETED|Washout Period of 3 Weeks||5
174911|NCT00605202|406400|P1|COMPLETED|Washout Period of 3 Weeks||5
174912|NCT00605202|406399|P2|STARTED|Washout Period of 3 Weeks||5
174913|NCT00605202|406400|P1|STARTED|Washout Period of 3 Weeks||5
174914|NCT00605202|406399|P2|NOT COMPLETED|First Intervention||0
174915|NCT00605202|406400|P1|NOT COMPLETED|First Intervention||0
174916|NCT00605202|406399|P2|COMPLETED|First Intervention||5
174917|NCT00605202|406400|P1|COMPLETED|First Intervention||5
174918|NCT00605202|406399|P2|STARTED|First Intervention||5
174919|NCT00605202|406400|P1|STARTED|First Intervention||5
174920|NCT00605176|406409|P3|NOT COMPLETED|Overall Study||9
174921|NCT00605176|406410|P2|NOT COMPLETED|Overall Study||6
174922|NCT00605176|406411|P1|NOT COMPLETED|Overall Study||11
174923|NCT00605176|406409|P3|COMPLETED|Overall Study||150
174924|NCT00605176|406410|P2|COMPLETED|Overall Study||154
174925|NCT00605176|406411|P1|COMPLETED|Overall Study||149
174926|NCT00605176|406409|P3|STARTED|Overall Study||159
174927|NCT00605176|406410|P2|STARTED|Overall Study||160
174928|NCT00605176|406411|P1|STARTED|Overall Study||160
174929|NCT00605150|406428|P1|NOT COMPLETED|Overall Study||1
174930|NCT00605150|406428|P1|COMPLETED|Overall Study||10
174931|NCT00605150|406428|P1|STARTED|Overall Study|11 started|11
174932|NCT00605085|406434|P2|NOT COMPLETED|Overall Study||25
174933|NCT00605085|406435|P1|NOT COMPLETED|Overall Study||50
174934|NCT00605085|406434|P2|COMPLETED|Overall Study||638
174935|NCT00605085|406435|P1|COMPLETED|Overall Study||1962
174936|NCT00605085|406434|P2|STARTED|Overall Study||663
174937|NCT00605085|406435|P1|STARTED|Overall Study||2012
174938|NCT00605072|406444|P3|NOT COMPLETED|Overall Study||4
174939|NCT00605072|406445|P2|NOT COMPLETED|Overall Study||11
174940|NCT00605072|406446|P1|NOT COMPLETED|Overall Study||7
174941|NCT00605072|406444|P3|COMPLETED|Overall Study||11
174942|NCT00605072|406445|P2|COMPLETED|Overall Study||9
174943|NCT00605072|406446|P1|COMPLETED|Overall Study||11
174944|NCT00605072|406444|P3|STARTED|Overall Study||15
174945|NCT00605072|406445|P2|STARTED|Overall Study||20
174946|NCT00605072|406446|P1|STARTED|Overall Study||18
174947|NCT00605033|406468|P2|NOT COMPLETED|Overall Study||8
174948|NCT00605033|406469|P1|NOT COMPLETED|Overall Study||7
174949|NCT00605033|406468|P2|COMPLETED|Overall Study||90
174950|NCT00605033|406469|P1|COMPLETED|Overall Study||136
174951|NCT00605033|406468|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
174952|NCT00605033|406469|P1|STARTED|Overall Study||143
174953|NCT00604968|406475|P1|NOT COMPLETED|Overall Study||0
174954|NCT00604968|406475|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
174955|NCT00604968|406475|P1|STARTED|Overall Study||25
174956|NCT00604851|406490|P2|NOT COMPLETED|Overall Study||26
174957|NCT00604851|406491|P1|NOT COMPLETED|Overall Study||17
174958|NCT00604851|406490|P2|COMPLETED|Overall Study||131
174959|NCT00604851|406491|P1|COMPLETED|Overall Study||132
174960|NCT00604851|406490|P2|STARTED|Overall Study||157
174961|NCT00604851|406491|P1|STARTED|Overall Study||149
174962|NCT00604812|406500|P6|NOT COMPLETED|Overall Study||0
174963|NCT00604812|406501|P5|NOT COMPLETED|Overall Study||0
174964|NCT00604812|406502|P4|NOT COMPLETED|Overall Study||0
174965|NCT00604812|406503|P3|NOT COMPLETED|Overall Study||0
174966|NCT00604812|406504|P2|NOT COMPLETED|Overall Study||0
174967|NCT00604812|406505|P1|NOT COMPLETED|Overall Study||0
174968|NCT00604812|406500|P6|COMPLETED|Overall Study||1
174969|NCT00604812|406501|P5|COMPLETED|Overall Study||5
174970|NCT00604812|406502|P4|COMPLETED|Overall Study||3
174971|NCT00604812|406503|P3|COMPLETED|Overall Study||10
174972|NCT00604812|406504|P2|COMPLETED|Overall Study||3
174973|NCT00604812|406505|P1|COMPLETED|Overall Study||9
174974|NCT00604812|406500|P6|STARTED|Overall Study||1
174975|NCT00604812|406501|P5|STARTED|Overall Study||5
174976|NCT00604812|406502|P4|STARTED|Overall Study||3
174977|NCT00604812|406503|P3|STARTED|Overall Study||10
174978|NCT00604812|406504|P2|STARTED|Overall Study||3
174979|NCT00604812|406505|P1|STARTED|Overall Study||9
174980|NCT00604721|406525|P1|NOT COMPLETED|Overall Study||2
174981|NCT00604721|406525|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
174982|NCT00604721|406525|P1|STARTED|Overall Study||19
174983|NCT00604708|406533|P2|NOT COMPLETED|Overall Study||40
174984|NCT00604708|406534|P1|NOT COMPLETED|Overall Study||31
174985|NCT00604708|406533|P2|COMPLETED|Overall Study||397
174986|NCT00604708|406534|P1|COMPLETED|Overall Study||399
174987|NCT00604708|406533|P2|STARTED|Overall Study||437
174988|NCT00604708|406534|P1|STARTED|Overall Study||430
174989|NCT00604695|406544|P2|NOT COMPLETED|Overall Study||4
174990|NCT00604695|406545|P1|NOT COMPLETED|Overall Study||0
174991|NCT00604695|406544|P2|COMPLETED|Overall Study||16
174992|NCT00604695|406545|P1|COMPLETED|Overall Study||20
174993|NCT00604695|406544|P2|STARTED|Overall Study||20
174994|NCT00604695|406545|P1|STARTED|Overall Study||20
174995|NCT00604669|406567|P1|NOT COMPLETED|Overall Study||7
174996|NCT00604669|406567|P1|COMPLETED|Overall Study||163
174997|NCT00604669|406567|P1|STARTED|Overall Study||170
174998|NCT00604565|406573|P2|NOT COMPLETED|Overall Study||3
174999|NCT00604565|406574|P1|NOT COMPLETED|Overall Study||0
175000|NCT00604565|406573|P2|COMPLETED|Overall Study||4
175001|NCT00604565|406574|P1|COMPLETED|Overall Study||4
175002|NCT00604565|406573|P2|STARTED|Overall Study||7
175003|NCT00604565|406574|P1|STARTED|Overall Study||4
175004|NCT00604552|406584|P2|NOT COMPLETED|Overall Study||0
175005|NCT00604552|406585|P1|NOT COMPLETED|Overall Study||0
175006|NCT00604552|406584|P2|COMPLETED|Overall Study||160
175007|NCT00604552|406585|P1|COMPLETED|Overall Study||189
175008|NCT00604552|406584|P2|STARTED|Overall Study||160
175009|NCT00604552|406585|P1|STARTED|Overall Study||189
175010|NCT00604500|406591|P1|NOT COMPLETED|Overall Study||11
175011|NCT00604500|406591|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
175012|NCT00604500|406591|P1|STARTED|Overall Study||272
175013|NCT00604461|406598|P1|NOT COMPLETED|Overall Study||1
175014|NCT00604461|406598|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
175015|NCT00604461|406598|P1|STARTED|Overall Study||13
175016|NCT00604383|406605|P2|NOT COMPLETED|Overall Study||84
175017|NCT00604383|406606|P1|NOT COMPLETED|Overall Study||87
175018|NCT00604383|406605|P2|COMPLETED|Overall Study||256
175019|NCT00604383|406606|P1|COMPLETED|Overall Study||258
175020|NCT00604383|406605|P2|Received Extended Treatment|Overall Study||141
175021|NCT00604383|406606|P1|Received Extended Treatment|Overall Study||136
175022|NCT00604383|406605|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
175023|NCT00604383|406606|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
175024|NCT00604383|406605|P2|STARTED|Overall Study||340
175025|NCT00604383|406606|P1|STARTED|Overall Study||345
175026|NCT00604279|406622|P2|NOT COMPLETED|Overall Study||38
175027|NCT00604279|406623|P1|NOT COMPLETED|Overall Study||64
175028|NCT00604279|406622|P2|COMPLETED|Overall Study||185
175029|NCT00604279|406623|P1|COMPLETED|Overall Study||165
175030|NCT00604279|406622|P2|STARTED|Overall Study||223
175031|NCT00604279|406623|P1|STARTED|Overall Study||229
175032|NCT00604214|406639|P2|NOT COMPLETED|Day 91 to Day 180||32
175033|NCT00604214|406640|P1|NOT COMPLETED|Day 91 to Day 180||26
175034|NCT00604214|406639|P2|COMPLETED|Day 91 to Day 180||521
175035|NCT00604214|406640|P1|COMPLETED|Day 91 to Day 180||529
175036|NCT00604214|406639|P2|STARTED|Day 91 to Day 180||553
175037|NCT00604214|406640|P1|STARTED|Day 91 to Day 180||555
175038|NCT00604214|406639|P2|NOT COMPLETED|Day 29 to Day 90||79
175039|NCT00604214|406640|P1|NOT COMPLETED|Day 29 to Day 90||68
175040|NCT00604214|406639|P2|COMPLETED|Day 29 to Day 90||553
175041|NCT00604214|406640|P1|COMPLETED|Day 29 to Day 90||555
175042|NCT00604214|406639|P2|STARTED|Day 29 to Day 90||632
175043|NCT00604214|406640|P1|STARTED|Day 29 to Day 90||623
175044|NCT00604214|406639|P2|NOT COMPLETED|Baseline to Day 28||213
175045|NCT00604214|406640|P1|NOT COMPLETED|Baseline to Day 28||228
175046|NCT00604214|406639|P2|COMPLETED|Baseline to Day 28||632
175047|NCT00604214|406640|P1|COMPLETED|Baseline to Day 28||623
175048|NCT00604214|406639|P2|Received Study Drug|Baseline to Day 28||833
175049|NCT00604214|406640|P1|Received Study Drug|Baseline to Day 28||833
175050|NCT00604214|406639|P2|STARTED|Baseline to Day 28||845
175051|NCT00604214|406640|P1|STARTED|Baseline to Day 28||851
175052|NCT00604188|406672|P2|NOT COMPLETED|Overall Study||25
175053|NCT00604188|406673|P1|NOT COMPLETED|Overall Study||27
175054|NCT00604188|406672|P2|COMPLETED|Overall Study||70
175055|NCT00604188|406673|P1|COMPLETED|Overall Study||66
175056|NCT00604188|406672|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
175057|NCT00604188|406673|P1|STARTED|Overall Study||93
175058|NCT00604175|406696|P3|NOT COMPLETED|Week 29 Through Week 72||4
175059|NCT00604175|406697|P2|NOT COMPLETED|Week 29 Through Week 72||7
175060|NCT00604175|406698|P1|NOT COMPLETED|Week 29 Through Week 72||12
175061|NCT00604175|406696|P3|COMPLETED|Week 29 Through Week 72||89
175062|NCT00604175|406697|P2|COMPLETED|Week 29 Through Week 72||85
175063|NCT00604175|406698|P1|COMPLETED|Week 29 Through Week 72||108
175064|NCT00604175|406696|P3|STARTED|Week 29 Through Week 72||93
175065|NCT00604175|406697|P2|STARTED|Week 29 Through Week 72||92
175066|NCT00604175|406698|P1|STARTED|Week 29 Through Week 72||120
175067|NCT00604175|406696|P3|NOT COMPLETED|Entry Through Week 28||1
175068|NCT00604175|406697|P2|NOT COMPLETED|Entry Through Week 28||3
175069|NCT00604175|406698|P1|NOT COMPLETED|Entry Through Week 28||10
175070|NCT00604175|406696|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
175071|NCT00604175|406697|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
175072|NCT00604175|406698|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
175073|NCT00604175|406696|P3|STARTED|Entry Through Week 28||94
175074|NCT00604175|406697|P2|STARTED|Entry Through Week 28||95
175075|NCT00604175|406698|P1|STARTED|Entry Through Week 28||130
175076|NCT00604162|406751|P1|NOT COMPLETED|Overall Study||4
175077|NCT00604162|406751|P1|COMPLETED|Overall Study||328
175078|NCT00604162|406751|P1|STARTED|Overall Study||332
175079|NCT00604045|406764|P2|NOT COMPLETED|Overall Study||1
175080|NCT00604045|406765|P1|NOT COMPLETED|Overall Study||1
175081|NCT00604045|406764|P2|COMPLETED|Overall Study||9
175082|NCT00604045|406765|P1|COMPLETED|Overall Study||14
175083|NCT00604045|406764|P2|STARTED|Overall Study||10
175084|NCT00604045|406765|P1|STARTED|Overall Study||15
175085|NCT00604019|406773|P2|NOT COMPLETED|Overall Study||0
175086|NCT00604019|406774|P1|NOT COMPLETED|Overall Study||0
175087|NCT00604019|406773|P2|COMPLETED|Overall Study||118
175088|NCT00604019|406774|P1|COMPLETED|Overall Study||134
175089|NCT00604019|406773|P2|STARTED|Overall Study||118
175090|NCT00604019|406774|P1|STARTED|Overall Study||134
175091|NCT00603993|406780|P1|NOT COMPLETED|Overall Study||20
175092|NCT00603993|406780|P1|COMPLETED|Overall Study||68
175093|NCT00603993|406780|P1|STARTED|Overall Study||88
175094|NCT00603915|406793|P1|NOT COMPLETED|Overall Study||1
175095|NCT00603915|406793|P1|COMPLETED|Overall Study||19
175096|NCT00603915|406793|P1|STARTED|Overall Study||20
175097|NCT00603902|406801|P3|NOT COMPLETED|Overall Study||769
175098|NCT00603902|406802|P2|NOT COMPLETED|Overall Study||686
175099|NCT00603902|406803|P1|NOT COMPLETED|Overall Study||329
175100|NCT00603902|406801|P3|COMPLETED|Overall Study||834
175101|NCT00603902|406802|P2|COMPLETED|Overall Study||917
175102|NCT00603902|406803|P1|COMPLETED|Overall Study||473
175103|NCT00603902|406801|P3|STARTED|Overall Study||1603
175104|NCT00603902|406802|P2|STARTED|Overall Study||1603
175105|NCT00603902|406803|P1|STARTED|Overall Study||802
175106|NCT00603889|406814|P1|NOT COMPLETED|Overall Study||0
175107|NCT00603889|406814|P1|COMPLETED|Overall Study||12
175108|NCT00603889|406814|P1|STARTED|Overall Study||12
175109|NCT00603837|406823|P2|NOT COMPLETED|Overall Study||0
175110|NCT00603837|406824|P1|NOT COMPLETED|Overall Study||3
175111|NCT00603837|406823|P2|COMPLETED|Overall Study||19
175112|NCT00603837|406824|P1|COMPLETED|Overall Study||17
175113|NCT00603837|406823|P2|STARTED|Overall Study||19
175114|NCT00603837|406824|P1|STARTED|Overall Study||20
175115|NCT00603798|406833|P3|NOT COMPLETED|Overall Study||10
175116|NCT00603798|406834|P2|NOT COMPLETED|Overall Study||7
175117|NCT00603798|406835|P1|NOT COMPLETED|Overall Study||10
175118|NCT00603798|406833|P3|COMPLETED|Overall Study||154
175119|NCT00603798|406834|P2|COMPLETED|Overall Study||157
175120|NCT00603798|406835|P1|COMPLETED|Overall Study||152
175121|NCT00603798|406833|P3|STARTED|Overall Study||164
175122|NCT00603798|406834|P2|STARTED|Overall Study||164
175123|NCT00603798|406835|P1|STARTED|Overall Study||162
175124|NCT00603746|406858|P6|NOT COMPLETED|Overall Study||13
175125|NCT00603746|406859|P5|NOT COMPLETED|Overall Study||17
175126|NCT00603746|406860|P4|NOT COMPLETED|Overall Study||13
175127|NCT00603746|406861|P3|NOT COMPLETED|Overall Study||8
175128|NCT00603746|406862|P2|NOT COMPLETED|Overall Study||18
175129|NCT00603746|406863|P1|NOT COMPLETED|Overall Study||38
175130|NCT00603746|406858|P6|COMPLETED|Overall Study||97
175131|NCT00603746|406859|P5|COMPLETED|Overall Study||85
175132|NCT00603746|406860|P4|COMPLETED|Overall Study||94
175133|NCT00603746|406861|P3|COMPLETED|Overall Study||93
175134|NCT00603746|406862|P2|COMPLETED|Overall Study||81
175135|NCT00603746|406863|P1|COMPLETED|Overall Study||65
175136|NCT00603746|406858|P6|STARTED|Overall Study||110
175137|NCT00603746|406859|P5|STARTED|Overall Study||102
175138|NCT00603746|406860|P4|STARTED|Overall Study||107
175139|NCT00603746|406861|P3|STARTED|Overall Study||101
175140|NCT00603746|406862|P2|STARTED|Overall Study||99
175141|NCT00603746|406863|P1|STARTED|Overall Study||103
175142|NCT00603733|407011|P2|NOT COMPLETED|Maintenance Phase ITT||16
175143|NCT00603733|407012|P1|NOT COMPLETED|Maintenance Phase ITT||10
175144|NCT00603733|407011|P2|COMPLETED|Maintenance Phase ITT||66
175145|NCT00603733|407012|P1|COMPLETED|Maintenance Phase ITT||61
175146|NCT00603733|407011|P2|STARTED|Maintenance Phase ITT||82
175147|NCT00603733|407012|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
175148|NCT00603733|407011|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
175149|NCT00603733|407012|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
175150|NCT00603733|407011|P2|COMPLETED|Run-In Phase - 4 Weeks||36
175151|NCT00603733|407012|P1|COMPLETED|Run-In Phase - 4 Weeks||35
175152|NCT00603733|407011|P2|STARTED|Run-In Phase - 4 Weeks||49
175153|NCT00603733|407012|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
175154|NCT00603733|407011|P2|NOT COMPLETED|Active Phase ITT||17
175155|NCT00603733|407012|P1|NOT COMPLETED|Active Phase ITT||11
175156|NCT00603733|407011|P2|COMPLETED|Active Phase ITT||78
175157|NCT00603733|407012|P1|COMPLETED|Active Phase ITT||84
175158|NCT00603733|407011|P2|STARTED|Active Phase ITT||95
175159|NCT00603733|407012|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
175160|NCT00603642|407024|P2|NOT COMPLETED|Overall Study||0
175161|NCT00603642|407025|P1|NOT COMPLETED|Overall Study||0
175162|NCT00603642|407024|P2|COMPLETED|Overall Study||22
175163|NCT00603642|407025|P1|COMPLETED|Overall Study||12
175164|NCT00603642|407024|P2|STARTED|Overall Study||22
175165|NCT00603642|407025|P1|STARTED|Overall Study||12
175166|NCT00603590|407041|P2|NOT COMPLETED|Overall Study||51
175167|NCT00603590|407042|P1|NOT COMPLETED|Overall Study||76
175168|NCT00603590|407041|P2|COMPLETED|Overall Study||183
175169|NCT00603590|407042|P1|COMPLETED|Overall Study||165
175170|NCT00603590|407041|P2|Eight Months|Overall Study||194
175171|NCT00603590|407042|P1|Eight Months|Overall Study||178
175172|NCT00603590|407041|P2|Four Months|Overall Study||200
175173|NCT00603590|407042|P1|Four Months|Overall Study||187
175174|NCT00603590|407041|P2|One Month|Overall Study||212
175175|NCT00603590|407042|P1|One Month|Overall Study||204
175176|NCT00603590|407041|P2|STARTED|Overall Study||234
175177|NCT00603590|407042|P1|STARTED|Overall Study||241
175178|NCT00603564|407054|P2|NOT COMPLETED|Overall Study||0
175179|NCT00603564|407055|P1|NOT COMPLETED|Overall Study||0
175180|NCT00603564|407054|P2|COMPLETED|Overall Study|February 2008|27
175181|NCT00603564|407055|P1|COMPLETED|Overall Study|February 2008|20
175182|NCT00603564|407054|P2|STARTED|Overall Study|January 2006|27
175183|NCT00603564|407055|P1|STARTED|Overall Study|January 2006|20
175184|NCT00603538|407066|P3|NOT COMPLETED|Overall Study||2
175185|NCT00603538|407067|P2|NOT COMPLETED|Overall Study||4
175186|NCT00603538|407068|P1|NOT COMPLETED|Overall Study||3
175187|NCT00603538|407066|P3|COMPLETED|Overall Study||4
175188|NCT00603538|407067|P2|COMPLETED|Overall Study||3
175189|NCT00603538|407068|P1|COMPLETED|Overall Study||3
175190|NCT00603538|407066|P3|STARTED|Overall Study||6
175191|NCT00603538|407067|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
175192|NCT00603538|407068|P1|STARTED|Overall Study||6
175193|NCT00603525|407108|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
175194|NCT00603525|407109|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
175195|NCT00603525|407110|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
175196|NCT00603525|407108|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
175197|NCT00603525|407109|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
175198|NCT00603525|407110|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
175199|NCT00603525|407108|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
175200|NCT00603525|407109|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
175201|NCT00603525|407110|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
175202|NCT00603525|407108|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
175203|NCT00603525|407109|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
175204|NCT00603525|407110|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
175205|NCT00603525|407108|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
175206|NCT00603525|407109|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
175207|NCT00603525|407110|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
175208|NCT00603525|407108|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
175209|NCT00603525|407109|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
175210|NCT00603525|407110|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
175211|NCT00603525|407108|P3|STARTED|OL Treatment Period (120 Weeks)||0
175212|NCT00603525|407109|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
175213|NCT00603525|407110|P1|STARTED|OL Treatment Period (120 Weeks)||0
175214|NCT00603525|407108|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
175215|NCT00603525|407109|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
175216|NCT00603525|407110|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
175217|NCT00603525|407108|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
175218|NCT00603525|407109|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
175219|NCT00603525|407110|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
175220|NCT00603525|407108|P3|STARTED|DB Treatment Period (24 Weeks)||0
175221|NCT00603525|407109|P2|STARTED|DB Treatment Period (24 Weeks)||85
175222|NCT00603525|407110|P1|STARTED|DB Treatment Period (24 Weeks)||84
175223|NCT00603512|407242|P5|NOT COMPLETED|Overall Study||5
175224|NCT00603512|407243|P4|NOT COMPLETED|Overall Study||7
175225|NCT00603512|407244|P3|NOT COMPLETED|Overall Study||5
175226|NCT00603512|407245|P2|NOT COMPLETED|Overall Study||5
175227|NCT00603512|407246|P1|NOT COMPLETED|Overall Study||2
175228|NCT00603512|407242|P5|COMPLETED|Overall Study||23
175229|NCT00603512|407243|P4|COMPLETED|Overall Study||21
175230|NCT00603512|407244|P3|COMPLETED|Overall Study||23
175231|NCT00603512|407245|P2|COMPLETED|Overall Study||23
175232|NCT00603512|407246|P1|COMPLETED|Overall Study||26
175233|NCT00603512|407242|P5|Treated|Overall Study||28
175234|NCT00603512|407243|P4|Treated|Overall Study||26
175235|NCT00603512|407244|P3|Treated|Overall Study||27
175236|NCT00603512|407245|P2|Treated|Overall Study||27
175237|NCT00603512|407246|P1|Treated|Overall Study||28
175238|NCT00603512|407242|P5|STARTED|Overall Study||28
175239|NCT00603512|407243|P4|STARTED|Overall Study||28
175240|NCT00603512|407244|P3|STARTED|Overall Study||28
175241|NCT00603512|407245|P2|STARTED|Overall Study||28
175242|NCT00603512|407246|P1|STARTED|Overall Study||28
175243|NCT00603473|407388|P1|NOT COMPLETED|Overall Study||9
175244|NCT00603473|407388|P1|COMPLETED|Overall Study||80
175245|NCT00603473|407388|P1|STARTED|Overall Study||89
175246|NCT00603447|407401|P7|NOT COMPLETED|Overall Study||24
175247|NCT00603447|407402|P6|NOT COMPLETED|Overall Study||2
175248|NCT00603447|407403|P5|NOT COMPLETED|Overall Study||5
175249|NCT00603447|407404|P4|NOT COMPLETED|Overall Study||2
175250|NCT00603447|407405|P3|NOT COMPLETED|Overall Study||2
175251|NCT00603447|407406|P2|NOT COMPLETED|Overall Study||3
175252|NCT00603447|407407|P1|NOT COMPLETED|Overall Study||0
175253|NCT00603447|407401|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
175254|NCT00603447|407402|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
175255|NCT00603447|407403|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
175256|NCT00603447|407404|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
175257|NCT00603447|407405|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
175258|NCT00603447|407406|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
175259|NCT00603447|407407|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
175260|NCT00603447|407401|P7|STARTED|Overall Study||44
175261|NCT00603447|407402|P6|STARTED|Overall Study||8
175262|NCT00603447|407403|P5|STARTED|Overall Study||6
175263|NCT00603447|407404|P4|STARTED|Overall Study||6
175264|NCT00603447|407405|P3|STARTED|Overall Study||8
175265|NCT00603447|407406|P2|STARTED|Overall Study||6
175266|NCT00603447|407407|P1|STARTED|Overall Study||6
175267|NCT00603408|407429|P1|NOT COMPLETED|Overall Study||0
175268|NCT00603408|407429|P1|COMPLETED|Overall Study||5
175269|NCT00603408|407429|P1|STARTED|Overall Study||5
175270|NCT00603382|407446|P6|NOT COMPLETED|Overall Study||18
175271|NCT00603382|407447|P5|NOT COMPLETED|Overall Study||9
175272|NCT00603382|407448|P4|NOT COMPLETED|Overall Study||12
175273|NCT00603382|407449|P3|NOT COMPLETED|Overall Study||9
175274|NCT00603382|407450|P2|NOT COMPLETED|Overall Study||14
175275|NCT00603382|407451|P1|NOT COMPLETED|Overall Study||18
175276|NCT00603382|407446|P6|COMPLETED|Overall Study||84
175277|NCT00603382|407447|P5|COMPLETED|Overall Study||86
175278|NCT00603382|407448|P4|COMPLETED|Overall Study||98
175279|NCT00603382|407449|P3|COMPLETED|Overall Study||91
175280|NCT00603382|407450|P2|COMPLETED|Overall Study||83
175281|NCT00603382|407451|P1|COMPLETED|Overall Study||76
175282|NCT00603382|407446|P6|STARTED|Overall Study||102
175283|NCT00603382|407447|P5|STARTED|Overall Study||95
175284|NCT00603382|407448|P4|STARTED|Overall Study||110
175285|NCT00603382|407449|P3|STARTED|Overall Study||100
175286|NCT00603382|407450|P2|STARTED|Overall Study||97
175287|NCT00603382|407451|P1|STARTED|Overall Study||94
175288|NCT00603304|407599|P2|NOT COMPLETED|Overall Study||31
175289|NCT00603304|407600|P1|NOT COMPLETED|Overall Study||32
175290|NCT00603304|407599|P2|COMPLETED|Overall Study||155
175291|NCT00603304|407600|P1|COMPLETED|Overall Study||151
175292|NCT00603304|407599|P2|STARTED|Overall Study||186
175293|NCT00603304|407600|P1|STARTED|Overall Study||183
175294|NCT00603291|407637|P3|NOT COMPLETED|Overall Study||96
175295|NCT00603291|407638|P2|NOT COMPLETED|Overall Study||87
175296|NCT00603291|407639|P1|NOT COMPLETED|Overall Study||20
175297|NCT00603291|407637|P3|COMPLETED|Overall Study||157
175298|NCT00603291|407638|P2|COMPLETED|Overall Study||169
175299|NCT00603291|407639|P1|COMPLETED|Overall Study||75
175300|NCT00603291|407637|P3|STARTED|Overall Study||253
175301|NCT00603291|407638|P2|STARTED|Overall Study||256
175302|NCT00603291|407639|P1|STARTED|Overall Study||95
175303|NCT00603278|407656|P6|NOT COMPLETED|Overall Study||19
175304|NCT00603278|407657|P5|NOT COMPLETED|Overall Study||13
175305|NCT00603278|407658|P4|NOT COMPLETED|Overall Study||11
175306|NCT00603278|407659|P3|NOT COMPLETED|Overall Study||14
175307|NCT00603278|407660|P2|NOT COMPLETED|Overall Study||17
175308|NCT00603278|407661|P1|NOT COMPLETED|Overall Study||41
175309|NCT00603278|407656|P6|COMPLETED|Overall Study||81
175310|NCT00603278|407657|P5|COMPLETED|Overall Study||86
175311|NCT00603278|407658|P4|COMPLETED|Overall Study||92
175312|NCT00603278|407659|P3|COMPLETED|Overall Study||87
175313|NCT00603278|407660|P2|COMPLETED|Overall Study||88
175314|NCT00603278|407661|P1|COMPLETED|Overall Study||66
175315|NCT00603278|407656|P6|STARTED|Overall Study||100
175316|NCT00603278|407657|P5|STARTED|Overall Study||99
175317|NCT00603278|407658|P4|STARTED|Overall Study||103
175318|NCT00603278|407659|P3|STARTED|Overall Study||101
175319|NCT00603278|407660|P2|STARTED|Overall Study||105
175320|NCT00603278|407661|P1|STARTED|Overall Study||107
175321|NCT00603265|407810|P3|NOT COMPLETED|Overall Study||5
175322|NCT00603265|407811|P2|NOT COMPLETED|Overall Study||16
175323|NCT00603265|407812|P1|NOT COMPLETED|Overall Study||7
175324|NCT00603265|407810|P3|COMPLETED|Overall Study||67
175325|NCT00603265|407811|P2|COMPLETED|Overall Study||62
175326|NCT00603265|407812|P1|COMPLETED|Overall Study||69
175327|NCT00603265|407810|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
175328|NCT00603265|407811|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
175329|NCT00603265|407812|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
175330|NCT00603265|407810|P3|STARTED|Overall Study||72
175331|NCT00603265|407811|P2|STARTED|Overall Study||78
175332|NCT00603265|407812|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
175333|NCT00603239|407840|P2|NOT COMPLETED|Overall Study||4
175334|NCT00603239|407841|P1|NOT COMPLETED|Overall Study||15
175335|NCT00603239|407840|P2|COMPLETED|Overall Study||50
175336|NCT00603239|407841|P1|COMPLETED|Overall Study||96
175337|NCT00603239|407840|P2|STARTED|Overall Study||54
175338|NCT00603239|407841|P1|STARTED|Overall Study||111
175339|NCT00603187|407867|P1|NOT COMPLETED|Overall Study||0
175340|NCT00603187|407867|P1|COMPLETED|Overall Study||4
175341|NCT00603187|407867|P1|STARTED|Overall Study||4
175342|NCT00603044|407875|P2|NOT COMPLETED|Overall Study||0
175343|NCT00603044|407876|P1|NOT COMPLETED|Overall Study||0
175344|NCT00603044|407875|P2|COMPLETED|Overall Study||13
175345|NCT00603044|407876|P1|COMPLETED|Overall Study||11
175346|NCT00603044|407875|P2|STARTED|Overall Study||13
175347|NCT00603044|407876|P1|STARTED|Overall Study||11
175348|NCT00603018|407892|P1|NOT COMPLETED|Overall Study||0
175349|NCT00603018|407892|P1|COMPLETED|Overall Study||23
175350|NCT00603018|407892|P1|STARTED|Overall Study||23
175351|NCT00602927|407899|P2|NOT COMPLETED|Period 3: 13 Days||3
175352|NCT00602927|407900|P1|NOT COMPLETED|Period 3: 13 Days||2
175353|NCT00602927|407899|P2|COMPLETED|Period 3: 13 Days||9
175354|NCT00602927|407900|P1|COMPLETED|Period 3: 13 Days||13
175355|NCT00602927|407899|P2|STARTED|Period 3: 13 Days||12
175356|NCT00602927|407900|P1|STARTED|Period 3: 13 Days||15
175357|NCT00602927|407899|P2|NOT COMPLETED|Period 2: 14 Days||2
175358|NCT00602927|407900|P1|NOT COMPLETED|Period 2: 14 Days||0
175359|NCT00602927|407899|P2|COMPLETED|Period 2: 14 Days||12
175360|NCT00602927|407900|P1|COMPLETED|Period 2: 14 Days||15
175361|NCT00602927|407899|P2|STARTED|Period 2: 14 Days||14
175362|NCT00602927|407900|P1|STARTED|Period 2: 14 Days||15
175363|NCT00602927|407899|P2|NOT COMPLETED|Period 1: 13 Days||5
175364|NCT00602927|407900|P1|NOT COMPLETED|Period 1: 13 Days||4
175365|NCT00602927|407899|P2|COMPLETED|Period 1: 13 Days||14
175366|NCT00602927|407900|P1|COMPLETED|Period 1: 13 Days||15
175367|NCT00602927|407899|P2|STARTED|Period 1: 13 Days||19
175368|NCT00602927|407900|P1|STARTED|Period 1: 13 Days||19
175369|NCT00602836|407908|P1|NOT COMPLETED|Overall Study||5
175370|NCT00602836|407908|P1|COMPLETED|Overall Study||39
175371|NCT00602836|407908|P1|STARTED|Overall Study||44
175372|NCT00602771|407914|P2|NOT COMPLETED|Overall Study||0
175373|NCT00602771|407915|P1|NOT COMPLETED|Overall Study||1
175374|NCT00602771|407914|P2|COMPLETED|Overall Study||21
175375|NCT00602771|407915|P1|COMPLETED|Overall Study||62
175376|NCT00602771|407914|P2|STARTED|Overall Study||21
175377|NCT00602771|407915|P1|STARTED|Overall Study||63
175378|NCT00602641|407923|P2|NOT COMPLETED|Overall Study||152
175379|NCT00602641|407924|P1|NOT COMPLETED|Overall Study||154
175380|NCT00602641|407923|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
175381|NCT00602641|407924|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
175382|NCT00602641|407923|P2|Started Protocol Therapy|Overall Study||150
175383|NCT00602641|407924|P1|Started Protocol Therapy|Overall Study||148
175384|NCT00602641|407923|P2|STARTED|Overall Study||152
175385|NCT00602641|407924|P1|STARTED|Overall Study||154
175386|NCT00602472|407938|P2|NOT COMPLETED|Overall Study||58
175387|NCT00602472|407939|P1|NOT COMPLETED|Overall Study||21
175388|NCT00602472|407938|P2|COMPLETED|Overall Study|number who completed treatment|734
175389|NCT00602472|407939|P1|COMPLETED|Overall Study|number who completed treatment|242
175390|NCT00602472|407938|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
175391|NCT00602472|407939|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
175392|NCT00602446|407969|P1|NOT COMPLETED|Overall Study||0
175393|NCT00602446|407969|P1|COMPLETED|Overall Study||3
175394|NCT00602446|407969|P1|STARTED|Overall Study||3
175395|NCT00602420|407976|P2|NOT COMPLETED|Overall Study||24
175396|NCT00602420|407977|P1|NOT COMPLETED|Overall Study||25
175397|NCT00602420|407976|P2|COMPLETED|Overall Study||229
175398|NCT00602420|407977|P1|COMPLETED|Overall Study||232
175399|NCT00602420|407976|P2|STARTED|Overall Study||253
175400|NCT00602420|407977|P1|STARTED|Overall Study||257
175401|NCT00602355|407986|P3|NOT COMPLETED|Overall Study||10
175402|NCT00602355|407987|P2|NOT COMPLETED|Overall Study||18
175403|NCT00602355|407988|P1|NOT COMPLETED|Overall Study||9
175404|NCT00602355|407986|P3|COMPLETED|Overall Study||43
175405|NCT00602355|407987|P2|COMPLETED|Overall Study||38
175406|NCT00602355|407988|P1|COMPLETED|Overall Study||44
175407|NCT00602355|407986|P3|STARTED|Overall Study||53
175408|NCT00602355|407987|P2|STARTED|Overall Study||56
175409|NCT00602355|407988|P1|STARTED|Overall Study||53
175410|NCT00602290|408011|P3|NOT COMPLETED|Overall Study||1
175411|NCT00602290|408012|P2|NOT COMPLETED|Overall Study||2
175412|NCT00602290|408013|P1|NOT COMPLETED|Overall Study||2
175413|NCT00602290|408011|P3|COMPLETED|Overall Study||46
175414|NCT00602290|408012|P2|COMPLETED|Overall Study||46
175415|NCT00602290|408013|P1|COMPLETED|Overall Study||46
175416|NCT00602290|408011|P3|STARTED|Overall Study||47
175417|NCT00602290|408012|P2|STARTED|Overall Study||48
175418|NCT00602290|408013|P1|STARTED|Overall Study||48
175419|NCT00602043|408021|P1|NOT COMPLETED|Overall Study||5
175420|NCT00602043|408021|P1|COMPLETED|Overall Study||15
175421|NCT00602043|408021|P1|STARTED|Overall Study||20
175422|NCT00601965|408030|P4|NOT COMPLETED|Overall Study||1
175423|NCT00601965|408031|P3|NOT COMPLETED|Overall Study||0
175424|NCT00601965|408032|P2|NOT COMPLETED|Overall Study||2
175425|NCT00601965|408033|P1|NOT COMPLETED|Overall Study||0
175426|NCT00601965|408030|P4|COMPLETED|Overall Study||17
175427|NCT00601965|408031|P3|COMPLETED|Overall Study||19
175428|NCT00601965|408032|P2|COMPLETED|Overall Study||16
175429|NCT00601965|408033|P1|COMPLETED|Overall Study||18
175430|NCT00601965|408030|P4|STARTED|Overall Study||18
175431|NCT00601965|408031|P3|STARTED|Overall Study||19
175432|NCT00601965|408032|P2|STARTED|Overall Study||18
175433|NCT00601965|408033|P1|STARTED|Overall Study||18
175434|NCT00601952|408049|P2|NOT COMPLETED|Overall Study||0
175435|NCT00601952|408050|P1|NOT COMPLETED|Overall Study||2
175436|NCT00601952|408049|P2|COMPLETED|Overall Study||17
175437|NCT00601952|408050|P1|COMPLETED|Overall Study||12
175438|NCT00601952|408049|P2|STARTED|Overall Study||17
175439|NCT00601952|408050|P1|STARTED|Overall Study||14
175440|NCT00601926|408056|P1|NOT COMPLETED|Overall Study||0
175441|NCT00601926|408056|P1|COMPLETED|Overall Study||5
175442|NCT00601926|408056|P1|STARTED|Overall Study||5
175443|NCT00601900|408064|P2|NOT COMPLETED|Overall Study||3
175444|NCT00601900|408065|P1|NOT COMPLETED|Overall Study||0
175445|NCT00601900|408064|P2|COMPLETED|Overall Study||196
175446|NCT00601900|408065|P1|COMPLETED|Overall Study||195
175447|NCT00601900|408064|P2|STARTED|Overall Study||199
175448|NCT00601900|408065|P1|STARTED|Overall Study||195
175449|NCT00601835|408081|P2|NOT COMPLETED|Overall Study||14
175450|NCT00601835|408082|P1|NOT COMPLETED|Overall Study||60
175451|NCT00601835|408081|P2|COMPLETED|Overall Study||686
175452|NCT00601835|408082|P1|COMPLETED|Overall Study||2890
175453|NCT00601835|408081|P2|STARTED|Overall Study||700
175454|NCT00601835|408082|P1|STARTED|Overall Study||2950
175455|NCT00601796|408092|P1|NOT COMPLETED|Overall Study||0
175456|NCT00601796|408092|P1|COMPLETED|Overall Study||24
175457|NCT00601796|408092|P1|STARTED|Overall Study||24
175458|NCT00601731|408111|P4|NOT COMPLETED|Overall Study||1
175459|NCT00601731|408112|P3|NOT COMPLETED|Overall Study||15
175460|NCT00601731|408113|P2|NOT COMPLETED|Overall Study||0
175461|NCT00601731|408114|P1|NOT COMPLETED|Overall Study||23
175462|NCT00601731|408111|P4|COMPLETED|Overall Study||29
175463|NCT00601731|408112|P3|COMPLETED|Overall Study||151
175464|NCT00601731|408113|P2|COMPLETED|Overall Study||43
175465|NCT00601731|408114|P1|COMPLETED|Overall Study||120
175466|NCT00601731|408111|P4|STARTED|Overall Study||30
175467|NCT00601731|408112|P3|STARTED|Overall Study||166
175468|NCT00601731|408113|P2|STARTED|Overall Study||43
175469|NCT00601731|408114|P1|STARTED|Overall Study||143
175470|NCT00601523|408166|P2|NOT COMPLETED|Overall Study||26
175471|NCT00601523|408167|P1|NOT COMPLETED|Overall Study||77
175472|NCT00601523|408166|P2|COMPLETED|Overall Study||117
175473|NCT00601523|408167|P1|COMPLETED|Overall Study||291
175474|NCT00601523|408166|P2|STARTED|Overall Study||143
175475|NCT00601523|408167|P1|STARTED|Overall Study||368
175476|NCT00601458|408202|P3|NOT COMPLETED|Overall Study||2
175477|NCT00601458|408203|P2|NOT COMPLETED|Overall Study||5
175478|NCT00601458|408204|P1|NOT COMPLETED|Overall Study||4
175479|NCT00601458|408202|P3|COMPLETED|Overall Study||28
175480|NCT00601458|408203|P2|COMPLETED|Overall Study||29
175481|NCT00601458|408204|P1|COMPLETED|Overall Study||32
175482|NCT00601458|408202|P3|STARTED|Overall Study||30
175483|NCT00601458|408203|P2|STARTED|Overall Study||34
175484|NCT00601458|408204|P1|STARTED|Overall Study||36
175485|NCT00601419|408215|P1|NOT COMPLETED|Overall Study||4
175486|NCT00601419|408215|P1|COMPLETED|Overall Study||226
175487|NCT00601419|408215|P1|STARTED|Overall Study||230
175488|NCT00601367|408239|P1|NOT COMPLETED|Overall Study||187
175489|NCT00601367|408239|P1|COMPLETED|Overall Study||293
175490|NCT00601367|408239|P1|STARTED|Overall Study||480
175491|NCT00601354|408245|P2|NOT COMPLETED|Overall Study||5
175492|NCT00601354|408246|P1|NOT COMPLETED|Overall Study||4
175493|NCT00601354|408245|P2|COMPLETED|Overall Study||4
175494|NCT00601354|408246|P1|COMPLETED|Overall Study||4
175495|NCT00601354|408245|P2|STARTED|Overall Study||9
175496|NCT00601354|408246|P1|STARTED|Overall Study||8
175497|NCT00601250|408258|P2|NOT COMPLETED|Overall Study||39
175498|NCT00601250|408259|P1|NOT COMPLETED|Overall Study||14
175499|NCT00601250|408258|P2|COMPLETED|Overall Study|number who completed treatment|484
175500|NCT00601250|408259|P1|COMPLETED|Overall Study|number who completed treatment|163
175501|NCT00601250|408258|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
175502|NCT00601250|408259|P1|STARTED|Overall Study|number who started treatment|177
175503|NCT00601146|408293|P1|NOT COMPLETED|Overall Study||161
175504|NCT00601146|408293|P1|COMPLETED|Overall Study||39
175505|NCT00601146|408293|P1|STARTED|Overall Study||200
175506|NCT00601107|408301|P4|NOT COMPLETED|Overall Study||12
175507|NCT00601107|408302|P3|NOT COMPLETED|Overall Study||12
175508|NCT00601107|408303|P2|NOT COMPLETED|Overall Study||9
175509|NCT00601107|408304|P1|NOT COMPLETED|Overall Study||13
175510|NCT00601107|408301|P4|COMPLETED|Overall Study||13
175511|NCT00601107|408302|P3|COMPLETED|Overall Study||16
175512|NCT00601107|408303|P2|COMPLETED|Overall Study||22
175513|NCT00601107|408304|P1|COMPLETED|Overall Study||14
175514|NCT00601107|408301|P4|Treated|Overall Study||25
175515|NCT00601107|408302|P3|Treated|Overall Study||28
175516|NCT00601107|408303|P2|Treated|Overall Study||31
175517|NCT00601107|408304|P1|Treated|Overall Study||27
175518|NCT00601107|408301|P4|STARTED|Overall Study||25
175519|NCT00601107|408302|P3|STARTED|Overall Study||28
175520|NCT00601107|408303|P2|STARTED|Overall Study||31
175521|NCT00601107|408304|P1|STARTED|Overall Study|Randomized.|27
175522|NCT00600938|408324|P4|NOT COMPLETED|Extension Study||1
175523|NCT00600938|408325|P3|NOT COMPLETED|Extension Study||9
175524|NCT00600938|408326|P2|NOT COMPLETED|Extension Study||5
175525|NCT00600938|408327|P1|NOT COMPLETED|Extension Study||9
175526|NCT00600938|408324|P4|COMPLETED|Extension Study||0
175527|NCT00600938|408325|P3|COMPLETED|Extension Study||33
175528|NCT00600938|408326|P2|COMPLETED|Extension Study||24
175529|NCT00600938|408327|P1|COMPLETED|Extension Study||65
175530|NCT00600938|408324|P4|Extension Safety Set|Extension Study||1
175531|NCT00600938|408325|P3|Extension Safety Set|Extension Study||42
175532|NCT00600938|408326|P2|Extension Safety Set|Extension Study||29
175533|NCT00600938|408327|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
175534|NCT00600938|408324|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
175535|NCT00600938|408325|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
175536|NCT00600938|408326|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
175537|NCT00600938|408327|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
175538|NCT00600938|408324|P4|NOT COMPLETED|Core Study||0
175539|NCT00600938|408325|P3|NOT COMPLETED|Core Study||0
175540|NCT00600938|408326|P2|NOT COMPLETED|Core Study||21
175541|NCT00600938|408327|P1|NOT COMPLETED|Core Study||16
175542|NCT00600938|408324|P4|COMPLETED|Core Study||0
175543|NCT00600938|408325|P3|COMPLETED|Core Study||0
175544|NCT00600938|408326|P2|COMPLETED|Core Study||78
175545|NCT00600938|408327|P1|COMPLETED|Core Study||82
175546|NCT00600938|408324|P4|Per Protocol Set (PPS)|Core Study||0
175547|NCT00600938|408325|P3|Per Protocol Set (PPS)|Core Study||0
175548|NCT00600938|408326|P2|Per Protocol Set (PPS)|Core Study||81
175549|NCT00600938|408327|P1|Per Protocol Set (PPS)|Core Study||91
175550|NCT00600938|408324|P4|Core Safety Set|Core Study||0
175551|NCT00600938|408325|P3|Core Safety Set|Core Study||0
175552|NCT00600938|408326|P2|Core Safety Set|Core Study||91
175553|NCT00600938|408327|P1|Core Safety Set|Core Study||96
175554|NCT00600938|408324|P4|STARTED|Core Study||0
175555|NCT00600938|408325|P3|STARTED|Core Study||0
175556|NCT00600938|408326|P2|STARTED|Core Study||99
175557|NCT00600938|408327|P1|STARTED|Core Study||98
175558|NCT00600886|408391|P2|NOT COMPLETED|Extension-start of Crossover to Month 26||13
175559|NCT00600886|408392|P1|NOT COMPLETED|Extension-start of Crossover to Month 26||31
175560|NCT00600886|408391|P2|COMPLETED|Extension-start of Crossover to Month 26|Completed and continued beyond month 26.|25
175561|NCT00600886|408392|P1|COMPLETED|Extension-start of Crossover to Month 26|Completed and continued beyond month 26.|50
175562|NCT00600886|408391|P2|Continued Beyond Month 26|Extension-start of Crossover to Month 26||0
175563|NCT00600886|408392|P1|Continued Beyond Month 26|Extension-start of Crossover to Month 26||50
175564|NCT00600886|408391|P2|Completed Study at Month 26|Extension-start of Crossover to Month 26||25
175565|NCT00600886|408392|P1|Completed Study at Month 26|Extension-start of Crossover to Month 26||0
175566|NCT00600886|408391|P2|STARTED|Extension-start of Crossover to Month 26||38
175567|NCT00600886|408392|P1|STARTED|Extension-start of Crossover to Month 26||81
175568|NCT00600886|408391|P2|NOT COMPLETED|Ext Month 12 - 26 Same Treatment||10
175569|NCT00600886|408392|P1|NOT COMPLETED|Ext Month 12 - 26 Same Treatment||23
175570|NCT00600886|408391|P2|COMPLETED|Ext Month 12 - 26 Same Treatment|Completed Month 12 and continued beyond Month 26.|36
175571|NCT00600886|408392|P1|COMPLETED|Ext Month 12 - 26 Same Treatment|Completed Month 12 and continued beyond Month 26.|51
175572|NCT00600886|408391|P2|Continued Beyond Month 26|Ext Month 12 - 26 Same Treatment||5
175573|NCT00600886|408392|P1|Continued Beyond Month 26|Ext Month 12 - 26 Same Treatment||51
175574|NCT00600886|408391|P2|Completed Study at Month 26|Ext Month 12 - 26 Same Treatment||31
175575|NCT00600886|408392|P1|Completed Study at Month 26|Ext Month 12 - 26 Same Treatment||0
175576|NCT00600886|408391|P2|STARTED|Ext Month 12 - 26 Same Treatment||46
175577|NCT00600886|408392|P1|STARTED|Ext Month 12 - 26 Same Treatment||74
175578|NCT00600886|408391|P2|NOT COMPLETED|Core Phase - Full Analysis Set||26
175579|NCT00600886|408392|P1|NOT COMPLETED|Core Phase - Full Analysis Set||35
175580|NCT00600886|408391|P2|COMPLETED|Core Phase - Full Analysis Set|Completed = anyone who did not discontinue prior to month 12.|156
175581|NCT00600886|408392|P1|COMPLETED|Core Phase - Full Analysis Set|Completed = anyone who did not discontinue prior to month 12.|141
175582|NCT00600886|408391|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set||46
175583|NCT00600886|408392|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set||74
175584|NCT00600886|408391|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set||81
175585|NCT00600886|408392|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set||38
175586|NCT00600886|408391|P2|Did Not Enter Extension|Core Phase - Full Analysis Set||29
175587|NCT00600886|408392|P1|Did Not Enter Extension|Core Phase - Full Analysis Set||29
175588|NCT00600886|408391|P2|STARTED|Core Phase - Full Analysis Set||182
175589|NCT00600886|408392|P1|STARTED|Core Phase - Full Analysis Set||176
175590|NCT00600821|408402|P2|NOT COMPLETED|Overall Study||60
175591|NCT00600821|408403|P1|NOT COMPLETED|Overall Study||58
175592|NCT00600821|408402|P2|COMPLETED|Overall Study||0
175593|NCT00600821|408403|P1|COMPLETED|Overall Study||0
175594|NCT00600821|408402|P2|Treated|Overall Study||59
175595|NCT00600821|408403|P1|Treated|Overall Study||58
175596|NCT00600821|408402|P2|STARTED|Overall Study||60
175597|NCT00600821|408403|P1|STARTED|Overall Study||58
175598|NCT00600756|408431|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
175599|NCT00600756|408432|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
175600|NCT00600756|408431|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
175601|NCT00600756|408432|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
175602|NCT00600756|408431|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
175603|NCT00600756|408432|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
175604|NCT00600756|408431|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
175605|NCT00600756|408432|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
175606|NCT00600756|408431|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
175607|NCT00600756|408432|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
175608|NCT00600756|408431|P2|STARTED|Overall Study Analysis After 12 Months||403
175609|NCT00600756|408432|P1|STARTED|Overall Study Analysis After 12 Months||395
175610|NCT00600756|408431|P2|NOT COMPLETED|Analysis After 6 Months||120
175611|NCT00600756|408432|P1|NOT COMPLETED|Analysis After 6 Months||131
175612|NCT00600756|408431|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
175613|NCT00600756|408432|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
175614|NCT00600756|408431|P2|STARTED|Analysis After 6 Months||403
175615|NCT00600756|408432|P1|STARTED|Analysis After 6 Months||395
175616|NCT00600704|408500|P2|NOT COMPLETED|Overall Study||0
175617|NCT00600704|408501|P1|NOT COMPLETED|Overall Study||0
175618|NCT00600704|408500|P2|COMPLETED|Overall Study||92
175619|NCT00600704|408501|P1|COMPLETED|Overall Study||100
175620|NCT00600704|408500|P2|STARTED|Overall Study||92
175621|NCT00600704|408501|P1|STARTED|Overall Study||100
175622|NCT00600613|408507|P1|NOT COMPLETED|Overall Study||1
175623|NCT00600613|408507|P1|COMPLETED|Overall Study||5
175624|NCT00600613|408507|P1|STARTED|Overall Study||6
175625|NCT00600171|408517|P6|NOT COMPLETED|Overall Study||5
175626|NCT00600171|408518|P5|NOT COMPLETED|Overall Study||8
175627|NCT00600171|408519|P4|NOT COMPLETED|Overall Study||12
175628|NCT00600171|408520|P3|NOT COMPLETED|Overall Study||10
175629|NCT00600171|408521|P2|NOT COMPLETED|Overall Study||17
175630|NCT00600171|408522|P1|NOT COMPLETED|Overall Study||16
175631|NCT00600171|408517|P6|COMPLETED|Overall Study||97
175632|NCT00600171|408518|P5|COMPLETED|Overall Study||93
175633|NCT00600171|408519|P4|COMPLETED|Overall Study||88
175634|NCT00600171|408520|P3|COMPLETED|Overall Study||91
175635|NCT00600171|408521|P2|COMPLETED|Overall Study||84
175636|NCT00600171|408522|P1|COMPLETED|Overall Study||86
175637|NCT00600171|408517|P6|STARTED|Overall Study||102
175638|NCT00600171|408518|P5|STARTED|Overall Study||101
175639|NCT00600171|408519|P4|STARTED|Overall Study||100
175640|NCT00600171|408520|P3|STARTED|Overall Study||101
175641|NCT00600171|408521|P2|STARTED|Overall Study||101
175642|NCT00600171|408522|P1|STARTED|Overall Study||102
175643|NCT00600119|408596|P6|NOT COMPLETED|Follow-up Period||1
175644|NCT00600119|408597|P5|NOT COMPLETED|Follow-up Period||0
175645|NCT00600119|408598|P4|NOT COMPLETED|Follow-up Period||0
175646|NCT00600119|408599|P3|NOT COMPLETED|Follow-up Period||0
175647|NCT00600119|408600|P2|NOT COMPLETED|Follow-up Period||0
175648|NCT00600119|408601|P1|NOT COMPLETED|Follow-up Period||1
175649|NCT00600119|408596|P6|COMPLETED|Follow-up Period||20
175650|NCT00600119|408597|P5|COMPLETED|Follow-up Period||31
175651|NCT00600119|408598|P4|COMPLETED|Follow-up Period||28
175652|NCT00600119|408599|P3|COMPLETED|Follow-up Period||27
175653|NCT00600119|408600|P2|COMPLETED|Follow-up Period||28
175654|NCT00600119|408601|P1|COMPLETED|Follow-up Period||26
175655|NCT00600119|408596|P6|STARTED|Follow-up Period||21
175656|NCT00600119|408597|P5|STARTED|Follow-up Period||31
175657|NCT00600119|408598|P4|STARTED|Follow-up Period||28
175658|NCT00600119|408599|P3|STARTED|Follow-up Period||27
175659|NCT00600119|408600|P2|STARTED|Follow-up Period||28
175660|NCT00600119|408601|P1|STARTED|Follow-up Period||27
175661|NCT00600119|408596|P6|NOT COMPLETED|Double-blind Treatment Period||14
175662|NCT00600119|408597|P5|NOT COMPLETED|Double-blind Treatment Period||6
175663|NCT00600119|408598|P4|NOT COMPLETED|Double-blind Treatment Period||2
175664|NCT00600119|408599|P3|NOT COMPLETED|Double-blind Treatment Period||0
175665|NCT00600119|408600|P2|NOT COMPLETED|Double-blind Treatment Period||5
175666|NCT00600119|408601|P1|NOT COMPLETED|Double-blind Treatment Period||5
175667|NCT00600119|408596|P6|COMPLETED|Double-blind Treatment Period||21
175668|NCT00600119|408597|P5|COMPLETED|Double-blind Treatment Period||31
175669|NCT00600119|408598|P4|COMPLETED|Double-blind Treatment Period||28
175670|NCT00600119|408599|P3|COMPLETED|Double-blind Treatment Period||27
175671|NCT00600119|408600|P2|COMPLETED|Double-blind Treatment Period||28
175672|NCT00600119|408601|P1|COMPLETED|Double-blind Treatment Period||27
175673|NCT00600119|408596|P6|STARTED|Double-blind Treatment Period||35
175674|NCT00600119|408597|P5|STARTED|Double-blind Treatment Period||37
175675|NCT00600119|408598|P4|STARTED|Double-blind Treatment Period||30
175676|NCT00600119|408599|P3|STARTED|Double-blind Treatment Period||27
175677|NCT00600119|408600|P2|STARTED|Double-blind Treatment Period||33
175678|NCT00600119|408601|P1|STARTED|Double-blind Treatment Period||32
175679|NCT00600119|408596|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
175680|NCT00600119|408597|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
175681|NCT00600119|408598|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
175682|NCT00600119|408599|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
175683|NCT00600119|408600|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
175684|NCT00600119|408601|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
175685|NCT00600119|408596|P6|COMPLETED|Single-blind Placebo run-in Period||35
175686|NCT00600119|408597|P5|COMPLETED|Single-blind Placebo run-in Period||37
175687|NCT00600119|408598|P4|COMPLETED|Single-blind Placebo run-in Period||30
175688|NCT00600119|408599|P3|COMPLETED|Single-blind Placebo run-in Period||27
175689|NCT00600119|408600|P2|COMPLETED|Single-blind Placebo run-in Period||33
175690|NCT00600119|408601|P1|COMPLETED|Single-blind Placebo run-in Period||32
175691|NCT00600119|408596|P6|STARTED|Single-blind Placebo run-in Period||37
175692|NCT00600119|408597|P5|STARTED|Single-blind Placebo run-in Period||39
175693|NCT00600119|408598|P4|STARTED|Single-blind Placebo run-in Period||31
175694|NCT00600119|408599|P3|STARTED|Single-blind Placebo run-in Period||29
175695|NCT00600119|408600|P2|STARTED|Single-blind Placebo run-in Period||35
175696|NCT00600119|408601|P1|STARTED|Single-blind Placebo run-in Period||36
175697|NCT00600080|408633|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
175698|NCT00600080|408634|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
175699|NCT00600080|408633|P2|COMPLETED|Period 2: One-week to Two-weeks||32
175700|NCT00600080|408634|P1|COMPLETED|Period 2: One-week to Two-weeks||28
175701|NCT00600080|408633|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
175702|NCT00600080|408634|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
175703|NCT00600080|408633|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
175704|NCT00600080|408634|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
175705|NCT00600080|408633|P2|COMPLETED|Period 1: Baseline to One-week||32
175706|NCT00600080|408634|P1|COMPLETED|Period 1: Baseline to One-week||28
175707|NCT00600080|408633|P2|STARTED|Period 1: Baseline to One-week||32
175708|NCT00600080|408634|P1|STARTED|Period 1: Baseline to One-week||28
175709|NCT00600067|408648|P2|NOT COMPLETED|Overall Study||7
175710|NCT00600067|408649|P1|NOT COMPLETED|Overall Study||3
175711|NCT00600067|408648|P2|COMPLETED|Overall Study||68
175712|NCT00600067|408649|P1|COMPLETED|Overall Study||52
175713|NCT00600067|408648|P2|STARTED|Overall Study||75
175714|NCT00600067|408649|P1|STARTED|Overall Study||55
175715|NCT00600015|408659|P2|NOT COMPLETED|Overall Study||35
175716|NCT00600015|408660|P1|NOT COMPLETED|Overall Study||60
175717|NCT00600015|408659|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
175718|NCT00600015|408660|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
175719|NCT00600015|408659|P2|STARTED|Overall Study||55
175720|NCT00600015|408660|P1|STARTED|Overall Study||111
175721|NCT00599924|408675|P7|NOT COMPLETED|Overall Study||5
175722|NCT00599924|408676|P6|NOT COMPLETED|Overall Study||4
175723|NCT00599924|408677|P5|NOT COMPLETED|Overall Study||6
175724|NCT00599924|408678|P4|NOT COMPLETED|Overall Study||8
175725|NCT00599924|408679|P3|NOT COMPLETED|Overall Study||2
175726|NCT00599924|408680|P2|NOT COMPLETED|Overall Study||5
175727|NCT00599924|408681|P1|NOT COMPLETED|Overall Study||3
175728|NCT00599924|408675|P7|COMPLETED|Overall Study||3
175729|NCT00599924|408676|P6|COMPLETED|Overall Study||2
175730|NCT00599924|408677|P5|COMPLETED|Overall Study||3
175731|NCT00599924|408678|P4|COMPLETED|Overall Study||4
175732|NCT00599924|408679|P3|COMPLETED|Overall Study||3
175733|NCT00599924|408680|P2|COMPLETED|Overall Study||4
175734|NCT00599924|408681|P1|COMPLETED|Overall Study||1
175735|NCT00599924|408675|P7|STARTED|Overall Study||8
175736|NCT00599924|408676|P6|STARTED|Overall Study||6
175737|NCT00599924|408677|P5|STARTED|Overall Study||9
175738|NCT00599924|408678|P4|STARTED|Overall Study||12
175739|NCT00599924|408679|P3|STARTED|Overall Study||5
175740|NCT00599924|408680|P2|STARTED|Overall Study||9
175741|NCT00599924|408681|P1|STARTED|Overall Study||4
175742|NCT00599872|408768|P2|NOT COMPLETED|Overall Study||33
175743|NCT00599872|408769|P1|NOT COMPLETED|Overall Study||49
175744|NCT00599872|408768|P2|COMPLETED|Overall Study||181
175745|NCT00599872|408769|P1|COMPLETED|Overall Study||167
175746|NCT00599872|408768|P2|STARTED|Overall Study||214
175747|NCT00599872|408769|P1|STARTED|Overall Study||216
175748|NCT00599755|408785|P1|NOT COMPLETED|Overall Study||19
175749|NCT00599755|408785|P1|COMPLETED|Overall Study||49
175750|NCT00599755|408785|P1|STARTED|Overall Study||68
175751|NCT00599521|408796|P2|NOT COMPLETED|Overall Study||69
175752|NCT00599521|408797|P1|NOT COMPLETED|Overall Study||60
175753|NCT00599521|408796|P2|COMPLETED|Overall Study||462
175754|NCT00599521|408797|P1|COMPLETED|Overall Study||475
175755|NCT00599521|408796|P2|STARTED|Overall Study||531
175756|NCT00599521|408797|P1|STARTED|Overall Study||535
175757|NCT00599339|408811|P1|NOT COMPLETED|Overall Study||664
175758|NCT00599339|408811|P1|COMPLETED|Overall Study||1531
175759|NCT00599339|408811|P1|Safety Set|Overall Study||2179
175760|NCT00599339|408811|P1|STARTED|Overall Study||2195
175761|NCT00599326|408913|P1|NOT COMPLETED|Overall Study||2
175762|NCT00599326|408913|P1|COMPLETED|Overall Study||8
175763|NCT00599326|408913|P1|STARTED|Overall Study||10
175764|NCT00599313|408918|P1|NOT COMPLETED|Overall Study||36
175765|NCT00599313|408918|P1|COMPLETED|Overall Study||0
175766|NCT00599313|408918|P1|STARTED|Overall Study||36
175767|NCT00599248|408929|P2|NOT COMPLETED|Overall Study||0
175768|NCT00599248|408930|P1|NOT COMPLETED|Overall Study||0
175769|NCT00599248|408929|P2|COMPLETED|Overall Study||3
175770|NCT00599248|408930|P1|COMPLETED|Overall Study||9
175771|NCT00599248|408929|P2|STARTED|Overall Study||3
175772|NCT00599248|408930|P1|STARTED|Overall Study||9
175773|NCT00599196|408938|P1|NOT COMPLETED|Overall Study||381
175774|NCT00599196|408938|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
175775|NCT00599196|408938|P1|STARTED|Overall Study||381
175776|NCT00599131|408944|P1|NOT COMPLETED|Overall Study||0
175777|NCT00599131|408944|P1|COMPLETED|Overall Study||4
175778|NCT00599131|408944|P1|STARTED|Overall Study||4
175779|NCT00599053|408954|P2|NOT COMPLETED|Overall Study||0
175780|NCT00599053|408955|P1|NOT COMPLETED|Overall Study||0
175781|NCT00599053|408954|P2|COMPLETED|Overall Study||2
175782|NCT00599053|408955|P1|COMPLETED|Overall Study||5
175783|NCT00599053|408954|P2|STARTED|Overall Study||2
175784|NCT00599053|408955|P1|STARTED|Overall Study||5
175785|NCT00599027|408969|P2|NOT COMPLETED|Overall Study||3
175786|NCT00599027|408970|P1|NOT COMPLETED|Overall Study||1
175787|NCT00599027|408969|P2|COMPLETED|Overall Study||22
175788|NCT00599027|408970|P1|COMPLETED|Overall Study||25
175789|NCT00599027|408969|P2|STARTED|Overall Study||25
175790|NCT00599027|408970|P1|STARTED|Overall Study||26
175791|NCT00599014|408976|P1|NOT COMPLETED|Overall Study||0
175792|NCT00599014|408976|P1|COMPLETED|Overall Study||335
175793|NCT00599014|408976|P1|STARTED|Overall Study||335
175794|NCT00598871|408983|P2|NOT COMPLETED|Overall Study||1
175795|NCT00598871|408984|P1|NOT COMPLETED|Overall Study||0
175796|NCT00598871|408983|P2|COMPLETED|Overall Study||8
175797|NCT00598871|408984|P1|COMPLETED|Overall Study||3
175798|NCT00598871|408983|P2|STARTED|Overall Study||9
175799|NCT00598871|408984|P1|STARTED|Overall Study||3
175800|NCT00598832|408994|P2|NOT COMPLETED|Overall Study||82
175801|NCT00598832|408995|P1|NOT COMPLETED|Overall Study||62
175802|NCT00598832|408994|P2|COMPLETED|Overall Study||460
175803|NCT00598832|408995|P1|COMPLETED|Overall Study||471
175804|NCT00598832|408994|P2|STARTED|Overall Study||542
175805|NCT00598832|408995|P1|STARTED|Overall Study||533
175806|NCT00598819|409009|P1|NOT COMPLETED|Overall Study||0
175807|NCT00598819|409009|P1|COMPLETED|Overall Study||14
175808|NCT00598819|409009|P1|STARTED|Overall Study||14
175809|NCT00598702|409025|P8|NOT COMPLETED|Overall Study||0
175810|NCT00598702|409026|P7|NOT COMPLETED|Overall Study||1
175811|NCT00598702|409027|P6|NOT COMPLETED|Overall Study||12
175812|NCT00598702|409028|P5|NOT COMPLETED|Overall Study||3
175813|NCT00598702|409029|P4|NOT COMPLETED|Overall Study||8
175814|NCT00598702|409030|P3|NOT COMPLETED|Overall Study||2
175815|NCT00598702|409031|P2|NOT COMPLETED|Overall Study||2
175816|NCT00598702|409032|P1|NOT COMPLETED|Overall Study||0
175817|NCT00598702|409025|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
175818|NCT00598702|409026|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
175819|NCT00598702|409027|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
175820|NCT00598702|409028|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
175821|NCT00598702|409029|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
175822|NCT00598702|409030|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
175823|NCT00598702|409031|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
175824|NCT00598702|409032|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
175825|NCT00598702|409025|P8|STARTED|Overall Study||4
175826|NCT00598702|409026|P7|STARTED|Overall Study||1
175827|NCT00598702|409027|P6|STARTED|Overall Study||42
175828|NCT00598702|409028|P5|STARTED|Overall Study||9
175829|NCT00598702|409029|P4|STARTED|Overall Study||33
175830|NCT00598702|409030|P3|STARTED|Overall Study||7
175831|NCT00598702|409031|P2|STARTED|Overall Study||3
175832|NCT00598702|409032|P1|STARTED|Overall Study||1
175833|NCT00598689|409076|P2|NOT COMPLETED|Overall Study||0
175834|NCT00598689|409077|P1|NOT COMPLETED|Overall Study||0
175835|NCT00598689|409076|P2|COMPLETED|Overall Study||40
175836|NCT00598689|409077|P1|COMPLETED|Overall Study||40
175837|NCT00598689|409076|P2|STARTED|Overall Study||40
175838|NCT00598689|409077|P1|STARTED|Overall Study||40
175839|NCT00598650|409087|P1|NOT COMPLETED|Overall Study||27
175840|NCT00598650|409087|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
175841|NCT00598650|409087|P1|STARTED|Overall Study||108
175842|NCT00598559|409097|P3|NOT COMPLETED|Overall Study||3
175843|NCT00598559|409098|P2|NOT COMPLETED|Overall Study||28
175844|NCT00598559|409099|P1|NOT COMPLETED|Overall Study||27
175845|NCT00598559|409097|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
175846|NCT00598559|409098|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
175847|NCT00598559|409099|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
175848|NCT00598559|409097|P3|STARTED|Overall Study||30
175849|NCT00598559|409098|P2|STARTED|Overall Study||91
175850|NCT00598559|409099|P1|STARTED|Overall Study||92
175851|NCT00598507|409116|P1|NOT COMPLETED|Overall Study||0
175852|NCT00598507|409116|P1|COMPLETED|Overall Study||35
175853|NCT00598507|409116|P1|STARTED|Overall Study||35
175854|NCT00598442|409126|P3|NOT COMPLETED|Overall Study||24
175855|NCT00598442|409127|P2|NOT COMPLETED|Overall Study||39
175856|NCT00598442|409128|P1|NOT COMPLETED|Overall Study||43
175857|NCT00598442|409126|P3|COMPLETED|Overall Study||139
175858|NCT00598442|409127|P2|COMPLETED|Overall Study||124
175859|NCT00598442|409128|P1|COMPLETED|Overall Study||124
175860|NCT00598442|409126|P3|STARTED|Overall Study||163
175861|NCT00598442|409127|P2|STARTED|Overall Study||163
175862|NCT00598442|409128|P1|STARTED|Overall Study||167
175863|NCT00598273|409145|P3|NOT COMPLETED|Overall Study||39
175864|NCT00598273|409146|P2|NOT COMPLETED|Overall Study||38
175865|NCT00598273|409147|P1|NOT COMPLETED|Overall Study||41
175866|NCT00598273|409145|P3|COMPLETED|Overall Study||125
175867|NCT00598273|409146|P2|COMPLETED|Overall Study||127
175868|NCT00598273|409147|P1|COMPLETED|Overall Study||120
175869|NCT00598273|409145|P3|STARTED|Overall Study||164
175870|NCT00598273|409146|P2|STARTED|Overall Study||165
175871|NCT00598273|409147|P1|STARTED|Overall Study||161
175872|NCT00598078|409161|P2|NOT COMPLETED|Period 3 (Day 3)||0
175873|NCT00598078|409162|P1|NOT COMPLETED|Period 3 (Day 3)||0
175874|NCT00598078|409161|P2|COMPLETED|Period 3 (Day 3)||10
175875|NCT00598078|409162|P1|COMPLETED|Period 3 (Day 3)||9
175876|NCT00598078|409161|P2|STARTED|Period 3 (Day 3)||10
175877|NCT00598078|409162|P1|STARTED|Period 3 (Day 3)||9
175878|NCT00598078|409161|P2|NOT COMPLETED|Period 2 (Day 2)||0
175879|NCT00598078|409162|P1|NOT COMPLETED|Period 2 (Day 2)||1
175880|NCT00598078|409161|P2|COMPLETED|Period 2 (Day 2)||10
175881|NCT00598078|409162|P1|COMPLETED|Period 2 (Day 2)||9
175882|NCT00598078|409161|P2|STARTED|Period 2 (Day 2)||10
175883|NCT00598078|409162|P1|STARTED|Period 2 (Day 2)||10
175884|NCT00598078|409161|P2|NOT COMPLETED|Period 1 (Day 1)||0
175885|NCT00598078|409162|P1|NOT COMPLETED|Period 1 (Day 1)||0
175886|NCT00598078|409161|P2|COMPLETED|Period 1 (Day 1)||10
175887|NCT00598078|409162|P1|COMPLETED|Period 1 (Day 1)||10
175888|NCT00598078|409161|P2|STARTED|Period 1 (Day 1)||10
175889|NCT00598078|409162|P1|STARTED|Period 1 (Day 1)||10
175890|NCT00597909|409173|P3|NOT COMPLETED|Overall Study||0
175891|NCT00597909|409174|P2|NOT COMPLETED|Overall Study||0
175892|NCT00597909|409175|P1|NOT COMPLETED|Overall Study||0
175893|NCT00597909|409173|P3|COMPLETED|Overall Study||0
175894|NCT00597909|409174|P2|COMPLETED|Overall Study||0
175895|NCT00597909|409175|P1|COMPLETED|Overall Study||0
175896|NCT00597909|409173|P3|STARTED|Overall Study||0
175897|NCT00597909|409174|P2|STARTED|Overall Study||0
175898|NCT00597909|409175|P1|STARTED|Overall Study||0
175899|NCT00597896|409185|P2|NOT COMPLETED|Overall Study||2
175900|NCT00597896|409186|P1|NOT COMPLETED|Overall Study||3
175901|NCT00597896|409185|P2|COMPLETED|Overall Study||24
175902|NCT00597896|409186|P1|COMPLETED|Overall Study||21
175903|NCT00597896|409185|P2|STARTED|Overall Study||26
175904|NCT00597896|409186|P1|STARTED|Overall Study||24
175905|NCT00597753|409214|P2|NOT COMPLETED|Overall Study||69
175906|NCT00597753|409215|P1|NOT COMPLETED|Overall Study||166
175907|NCT00597753|409214|P2|COMPLETED|Overall Study||202
175908|NCT00597753|409215|P1|COMPLETED|Overall Study||366
175909|NCT00597753|409214|P2|STARTED|Overall Study||271
175910|NCT00597753|409215|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
175911|NCT00597714|409227|P3|NOT COMPLETED|Overall Study||10
175912|NCT00597714|409228|P2|NOT COMPLETED|Overall Study||46
175913|NCT00597714|409229|P1|NOT COMPLETED|Overall Study||56
175914|NCT00597714|409227|P3|COMPLETED|Overall Study||84
175915|NCT00597714|409228|P2|COMPLETED|Overall Study||11
175916|NCT00597714|409229|P1|COMPLETED|Overall Study||24
175917|NCT00597714|409227|P3|STARTED|Overall Study||94
175918|NCT00597714|409228|P2|STARTED|Overall Study||57
175919|NCT00597714|409229|P1|STARTED|Overall Study||80
175920|NCT00597701|409241|P2|NOT COMPLETED|Overall Study||8
175921|NCT00597701|409242|P1|NOT COMPLETED|Overall Study||7
175922|NCT00597701|409241|P2|COMPLETED|Overall Study||13
175923|NCT00597701|409242|P1|COMPLETED|Overall Study||18
175924|NCT00597701|409241|P2|STARTED|Overall Study||21
175925|NCT00597701|409242|P1|STARTED|Overall Study||25
175926|NCT00597584|409250|P2|NOT COMPLETED|Overall Study||63
175927|NCT00597584|409251|P1|NOT COMPLETED|Overall Study||128
175928|NCT00597584|409250|P2|COMPLETED|Overall Study||211
175929|NCT00597584|409251|P1|COMPLETED|Overall Study||421
175930|NCT00597584|409250|P2|STARTED|Overall Study||274
175931|NCT00597584|409251|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
175932|NCT00596466|409261|P1|NOT COMPLETED|Overall Study||17
175933|NCT00596466|409261|P1|COMPLETED|Overall Study||58
175934|NCT00596466|409261|P1|Enrolled, Treated|Overall Study||73
175935|NCT00596466|409261|P1|STARTED|Overall Study||75
175936|NCT00596453|409269|P2|NOT COMPLETED|Overall Study||3
175937|NCT00596453|409270|P1|NOT COMPLETED|Overall Study||1
175938|NCT00596453|409269|P2|COMPLETED|Overall Study||12
175939|NCT00596453|409270|P1|COMPLETED|Overall Study||12
175940|NCT00596453|409269|P2|STARTED|Overall Study||15
175941|NCT00596453|409270|P1|STARTED|Overall Study||13
175942|NCT00596440|409278|P2|NOT COMPLETED|Overall Study||80
175943|NCT00596440|409279|P1|NOT COMPLETED|Overall Study||65
175944|NCT00596440|409278|P2|COMPLETED|Overall Study||41
175945|NCT00596440|409279|P1|COMPLETED|Overall Study||48
175946|NCT00596440|409278|P2|Showed to First Treatment Session|Overall Study||52
175947|NCT00596440|409279|P1|Showed to First Treatment Session|Overall Study||61
175948|NCT00596440|409278|P2|Showed to Eligibility Visit|Overall Study||72
175949|NCT00596440|409279|P1|Showed to Eligibility Visit|Overall Study||85
175950|NCT00596440|409278|P2|STARTED|Overall Study||121
175951|NCT00596440|409279|P1|STARTED|Overall Study||113
175952|NCT00596427|409291|P2|NOT COMPLETED|Overall Study||2
175953|NCT00596427|409292|P1|NOT COMPLETED|Overall Study||4
175954|NCT00596427|409291|P2|COMPLETED|Overall Study||28
175955|NCT00596427|409292|P1|COMPLETED|Overall Study||26
175956|NCT00596427|409291|P2|STARTED|Overall Study||30
175957|NCT00596427|409292|P1|STARTED|Overall Study||30
175958|NCT00597558|409320|P1|NOT COMPLETED|Overall Study||4
175959|NCT00597558|409320|P1|COMPLETED|Overall Study||9
175960|NCT00597558|409320|P1|STARTED|Overall Study||13
175961|NCT00597545|409326|P2|NOT COMPLETED|Overall Study||0
175962|NCT00597545|409327|P1|NOT COMPLETED|Overall Study||0
175963|NCT00597545|409326|P2|COMPLETED|Overall Study||6
175964|NCT00597545|409327|P1|COMPLETED|Overall Study||4
175965|NCT00597545|409326|P2|STARTED|Overall Study||6
175966|NCT00597545|409327|P1|STARTED|Overall Study||4
175967|NCT00597519|409333|P1|NOT COMPLETED|Overall Study||1
175968|NCT00597519|409333|P1|COMPLETED|Overall Study||27
175969|NCT00597519|409333|P1|STARTED|Overall Study||28
175970|NCT00597506|409337|P1|NOT COMPLETED|Overall Study||1
175971|NCT00597506|409337|P1|COMPLETED|Overall Study||49
175972|NCT00597506|409337|P1|STARTED|Overall Study||50
175973|NCT00597493|409342|P1|NOT COMPLETED|Overall Study||0
175974|NCT00597493|409342|P1|COMPLETED|Overall Study||32
175975|NCT00597493|409342|P1|STARTED|Overall Study||32
175976|NCT00597428|409361|P2|NOT COMPLETED|Overall Study||71
175977|NCT00597428|409362|P1|NOT COMPLETED|Overall Study||61
175978|NCT00597428|409361|P2|COMPLETED|Overall Study||152
175979|NCT00597428|409362|P1|COMPLETED|Overall Study||153
175980|NCT00597428|409361|P2|STARTED|Overall Study||223
175981|NCT00597428|409362|P1|STARTED|Overall Study||214
175982|NCT00597402|409378|P1|NOT COMPLETED|Overall Study||0
175983|NCT00597402|409378|P1|COMPLETED|Overall Study||125
175984|NCT00597402|409378|P1|STARTED|Overall Study||125
175985|NCT00597376|409387|P2|NOT COMPLETED|Overall Study||4
175986|NCT00597376|409388|P1|NOT COMPLETED|Overall Study||8
175987|NCT00597376|409387|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
175988|NCT00597376|409388|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
175989|NCT00597376|409387|P2|STARTED|Overall Study||53
175990|NCT00597376|409388|P1|STARTED|Overall Study||51
175991|NCT00597272|409405|P7|NOT COMPLETED|Overall Study||0
175992|NCT00597272|409406|P6|NOT COMPLETED|Overall Study||0
175993|NCT00597272|409407|P5|NOT COMPLETED|Overall Study||0
175994|NCT00597272|409408|P4|NOT COMPLETED|Overall Study||0
175995|NCT00597272|409409|P3|NOT COMPLETED|Overall Study||0
175996|NCT00597272|409410|P2|NOT COMPLETED|Overall Study||0
175997|NCT00597272|409411|P1|NOT COMPLETED|Overall Study||0
175998|NCT00597272|409405|P7|COMPLETED|Overall Study||10
175999|NCT00597272|409406|P6|COMPLETED|Overall Study||10
176000|NCT00597272|409407|P5|COMPLETED|Overall Study||1
176001|NCT00597272|409408|P4|COMPLETED|Overall Study||1
176002|NCT00597272|409409|P3|COMPLETED|Overall Study||10
176003|NCT00597272|409410|P2|COMPLETED|Overall Study||1
176004|NCT00597272|409411|P1|COMPLETED|Overall Study||1
176005|NCT00597272|409405|P7|STARTED|Overall Study||10
176006|NCT00597272|409406|P6|STARTED|Overall Study||10
176007|NCT00597272|409407|P5|STARTED|Overall Study||1
176008|NCT00597272|409408|P4|STARTED|Overall Study||1
176009|NCT00597272|409409|P3|STARTED|Overall Study||10
176010|NCT00597272|409410|P2|STARTED|Overall Study||1
176011|NCT00597272|409411|P1|STARTED|Overall Study||1
176012|NCT00597207|409429|P2|NOT COMPLETED|Overall Study||7
176013|NCT00597207|409430|P1|NOT COMPLETED|Overall Study||5
176014|NCT00597207|409429|P2|COMPLETED|Overall Study||2125
176015|NCT00597207|409430|P1|COMPLETED|Overall Study||2094
176016|NCT00597207|409429|P2|STARTED|Overall Study||2132
176017|NCT00597207|409430|P1|STARTED|Overall Study||2099
176018|NCT00597116|409438|P2|NOT COMPLETED|Overall Study||11
176019|NCT00597116|409439|P1|NOT COMPLETED|Overall Study||14
176020|NCT00597116|409438|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
176021|NCT00597116|409439|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
176022|NCT00597116|409438|P2|STARTED|Overall Study||11
176023|NCT00597116|409439|P1|STARTED|Overall Study||14
176024|NCT00597038|409453|P2|NOT COMPLETED|Overall Study||4
176025|NCT00597038|409454|P1|NOT COMPLETED|Overall Study||2
176026|NCT00597038|409453|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
176027|NCT00597038|409454|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
176028|NCT00597038|409453|P2|STARTED|Overall Study||34
176029|NCT00597038|409454|P1|STARTED|Overall Study||16
176030|NCT00597012|409465|P2|NOT COMPLETED|Overall Study||8
176031|NCT00597012|409466|P1|NOT COMPLETED|Overall Study||13
176032|NCT00597012|409465|P2|COMPLETED|Overall Study||169
176033|NCT00597012|409466|P1|COMPLETED|Overall Study||161
176034|NCT00597012|409465|P2|STARTED|Overall Study||177
176035|NCT00597012|409466|P1|STARTED|Overall Study||174
176036|NCT00596960|409478|P2|NOT COMPLETED|Overall Study||9
176037|NCT00596960|409479|P1|NOT COMPLETED|Overall Study||11
176038|NCT00596960|409478|P2|COMPLETED|Overall Study||60
176039|NCT00596960|409479|P1|COMPLETED|Overall Study||59
176040|NCT00596960|409478|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
176041|NCT00596960|409479|P1|STARTED|Overall Study||70
176042|NCT00596947|409491|P2|NOT COMPLETED|Overall Study||4
176043|NCT00596947|409492|P1|NOT COMPLETED|Overall Study||5
176044|NCT00596947|409491|P2|COMPLETED|Overall Study||6
176045|NCT00596947|409492|P1|COMPLETED|Overall Study||3
176046|NCT00596947|409491|P2|STARTED|Overall Study||10
176047|NCT00596947|409492|P1|STARTED|Overall Study||8
176048|NCT00596934|409532|P1|NOT COMPLETED|Overall Study||2
176049|NCT00596934|409532|P1|COMPLETED|Overall Study||7
176050|NCT00596934|409532|P1|STARTED|Overall Study||9
176051|NCT00596830|409545|P2|NOT COMPLETED|Overall Study||339
176052|NCT00596830|409546|P1|NOT COMPLETED|Overall Study||342
176053|NCT00596830|409545|P2|COMPLETED|Overall Study||0
176054|NCT00596830|409546|P1|COMPLETED|Overall Study||0
176055|NCT00596830|409545|P2|Treated|Overall Study||332
176056|NCT00596830|409546|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
176057|NCT00596830|409545|P2|STARTED|Overall Study||339
176058|NCT00596830|409546|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
176059|NCT00596817|409572|P2|NOT COMPLETED|Double-blind Period||79
176060|NCT00596817|409573|P1|NOT COMPLETED|Double-blind Period||88
176061|NCT00596817|409572|P2|COMPLETED|Double-blind Period||125
176062|NCT00596817|409573|P1|COMPLETED|Double-blind Period||104
176063|NCT00596817|409572|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
176064|NCT00596817|409573|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
176065|NCT00596817|409572|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
176066|NCT00596817|409573|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
176067|NCT00596817|409572|P2|COMPLETED|Open-label Period to Double-blind Period||400
176068|NCT00596817|409573|P1|COMPLETED|Open-label Period to Double-blind Period||0
176069|NCT00596817|409572|P2|STARTED|Open-label Period to Double-blind Period||492
176070|NCT00596817|409573|P1|STARTED|Open-label Period to Double-blind Period||0
176071|NCT00596817|409572|P2|NOT COMPLETED|Open-label Period||147
176072|NCT00596817|409573|P1|NOT COMPLETED|Open-label Period||0
176073|NCT00596817|409572|P2|COMPLETED|Open-label Period||492
176074|NCT00596817|409573|P1|COMPLETED|Open-label Period||0
176075|NCT00596817|409572|P2|STARTED|Open-label Period||639
176076|NCT00596817|409573|P1|STARTED|Open-label Period||0
176077|NCT00596752|409598|P2|NOT COMPLETED|Overall Study||143
176078|NCT00596752|409599|P1|NOT COMPLETED|Overall Study||126
176079|NCT00596752|409598|P2|COMPLETED|Overall Study||282
176080|NCT00596752|409599|P1|COMPLETED|Overall Study||289
176081|NCT00596752|409598|P2|Randomized and Treated|Overall Study||424
176082|NCT00596752|409599|P1|Randomized and Treated|Overall Study||415
176083|NCT00596752|409598|P2|STARTED|Overall Study||425
176084|NCT00596752|409599|P1|STARTED|Overall Study||415
176085|NCT00596687|409629|P2|NOT COMPLETED|Overall Study||9
176086|NCT00596687|409630|P1|NOT COMPLETED|Overall Study||14
176087|NCT00596687|409629|P2|COMPLETED|Overall Study||107
176088|NCT00596687|409630|P1|COMPLETED|Overall Study||104
176089|NCT00596687|409629|P2|STARTED|Overall Study||116
176090|NCT00596687|409630|P1|STARTED|Overall Study||118
176091|NCT00596635|409641|P3|NOT COMPLETED|Overall Study||8
176092|NCT00596635|409642|P2|NOT COMPLETED|Overall Study||13
176093|NCT00596635|409643|P1|NOT COMPLETED|Overall Study||7
176094|NCT00596635|409641|P3|COMPLETED|Overall Study||11
176095|NCT00596635|409642|P2|COMPLETED|Overall Study||7
176096|NCT00596635|409643|P1|COMPLETED|Overall Study||10
176097|NCT00596635|409641|P3|STARTED|Overall Study||19
176098|NCT00596635|409642|P2|STARTED|Overall Study||20
176099|NCT00596635|409643|P1|STARTED|Overall Study||17
176100|NCT00596622|409660|P1|NOT COMPLETED|Overall Study||13
176101|NCT00596622|409660|P1|COMPLETED|Overall Study||33
176102|NCT00596622|409660|P1|STARTED|Overall Study||46
176103|NCT00596362|409669|P1|NOT COMPLETED|Overall Study||1
176104|NCT00596362|409669|P1|COMPLETED|Overall Study||0
176105|NCT00596362|409669|P1|STARTED|Overall Study||1
176106|NCT00596271|409676|P3|NOT COMPLETED|Overall Study||1
176107|NCT00596271|409677|P2|NOT COMPLETED|Overall Study||6
176108|NCT00596271|409678|P1|NOT COMPLETED|Overall Study||5
176109|NCT00596271|409676|P3|COMPLETED|Overall Study||61
176110|NCT00596271|409677|P2|COMPLETED|Overall Study||59
176111|NCT00596271|409678|P1|COMPLETED|Overall Study||60
176112|NCT00596271|409676|P3|STARTED|Overall Study||62
176113|NCT00596271|409677|P2|STARTED|Overall Study||65
176114|NCT00596271|409678|P1|STARTED|Overall Study||65
176115|NCT00596167|409687|P1|NOT COMPLETED|Overall Study||0
176116|NCT00596167|409687|P1|COMPLETED|Overall Study||6
176117|NCT00596167|409687|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
176118|NCT00596102|409694|P3|NOT COMPLETED|Up to Month 60||637
176119|NCT00596102|409695|P2|NOT COMPLETED|Up to Month 60||338
176120|NCT00596102|409696|P1|NOT COMPLETED|Up to Month 60||2181
176121|NCT00596102|409694|P3|COMPLETED|Up to Month 60||0
176122|NCT00596102|409695|P2|COMPLETED|Up to Month 60||0
176212|NCT00595413|409871|P1|NOT COMPLETED|Overall Study||7
176123|NCT00596102|409696|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
176124|NCT00596102|409694|P3|STARTED|Up to Month 60||637
176125|NCT00596102|409695|P2|STARTED|Up to Month 60||338
176126|NCT00596102|409696|P1|STARTED|Up to Month 60||2283
176127|NCT00596102|409694|P3|NOT COMPLETED|Up to Month 6||0
176128|NCT00596102|409695|P2|NOT COMPLETED|Up to Month 6||0
176129|NCT00596102|409696|P1|NOT COMPLETED|Up to Month 6||0
176130|NCT00596102|409694|P3|COMPLETED|Up to Month 6||637
176131|NCT00596102|409695|P2|COMPLETED|Up to Month 6||338
176132|NCT00596102|409696|P1|COMPLETED|Up to Month 6||2283
176133|NCT00596102|409694|P3|STARTED|Up to Month 6||637
176134|NCT00596102|409695|P2|STARTED|Up to Month 6||338
176135|NCT00596102|409696|P1|STARTED|Up to Month 6||2283
176136|NCT00596011|409705|P2|NOT COMPLETED|Overall Study||10
176137|NCT00596011|409706|P1|NOT COMPLETED|Overall Study||13
176138|NCT00596011|409705|P2|COMPLETED|Overall Study||38
176139|NCT00596011|409706|P1|COMPLETED|Overall Study||36
176140|NCT00596011|409705|P2|STARTED|Overall Study||48
176141|NCT00596011|409706|P1|STARTED|Overall Study||49
176142|NCT00595959|409722|P1|NOT COMPLETED|Overall Study||2
176143|NCT00595959|409722|P1|COMPLETED|Overall Study||63
176144|NCT00595959|409722|P1|STARTED|Overall Study||65
176145|NCT00595946|409739|P2|NOT COMPLETED|Overall Study||69
176146|NCT00595946|409740|P1|NOT COMPLETED|Overall Study||64
176147|NCT00595946|409739|P2|COMPLETED|Overall Study||152
176148|NCT00595946|409740|P1|COMPLETED|Overall Study||154
176149|NCT00595946|409739|P2|STARTED|Overall Study||221
176150|NCT00595946|409740|P1|STARTED|Overall Study||218
176151|NCT00595920|409756|P1|NOT COMPLETED|Overall Study||116
176152|NCT00595920|409756|P1|COMPLETED|Overall Study||0
176153|NCT00595920|409756|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
176154|NCT00595920|409756|P1|STARTED|Overall Study||116
176155|NCT00595881|409760|P1|NOT COMPLETED|Overall Study||0
176156|NCT00595881|409760|P1|COMPLETED|Overall Study||420
176157|NCT00595881|409760|P1|STARTED|Overall Study||420
176158|NCT00595868|409767|P2|NOT COMPLETED|Overall Study||50
176159|NCT00595868|409768|P1|NOT COMPLETED|Overall Study||45
176160|NCT00595868|409767|P2|COMPLETED|Overall Study||61
176161|NCT00595868|409768|P1|COMPLETED|Overall Study||62
176162|NCT00595868|409767|P2|STARTED|Overall Study||111
176163|NCT00595868|409768|P1|STARTED|Overall Study||107
176164|NCT00595790|409779|P3|NOT COMPLETED|Overall Study||3
176165|NCT00595790|409780|P2|NOT COMPLETED|Overall Study||1
176166|NCT00595790|409781|P1|NOT COMPLETED|Overall Study||2
176167|NCT00595790|409779|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
176168|NCT00595790|409780|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
176169|NCT00595790|409781|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
176170|NCT00595790|409779|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
176171|NCT00595790|409780|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
176172|NCT00595790|409781|P1|STARTED|Overall Study||125
176173|NCT00595764|409791|P2|NOT COMPLETED|Overall Study||43
176174|NCT00595764|409792|P1|NOT COMPLETED|Overall Study||39
176175|NCT00595764|409791|P2|COMPLETED|Overall Study||27
176176|NCT00595764|409792|P1|COMPLETED|Overall Study||32
176177|NCT00595764|409791|P2|STARTED|Overall Study||70
176178|NCT00595764|409792|P1|STARTED|Overall Study||71
176179|NCT00595582|409806|P1|NOT COMPLETED|Overall Study||10
176180|NCT00595582|409806|P1|COMPLETED|Overall Study||0
176181|NCT00595582|409806|P1|STARTED|Overall Study||10
176182|NCT00595556|409812|P2|NOT COMPLETED|Overall Study||1
176183|NCT00595556|409813|P1|NOT COMPLETED|Overall Study||3
176184|NCT00595556|409812|P2|COMPLETED|Overall Study||19
176185|NCT00595556|409813|P1|COMPLETED|Overall Study||17
176186|NCT00595556|409812|P2|STARTED|Overall Study||20
176187|NCT00595556|409813|P1|STARTED|Overall Study||20
176188|NCT00595530|409827|P1|NOT COMPLETED|Overall Study||0
176189|NCT00595530|409827|P1|COMPLETED|Overall Study||3
176190|NCT00595530|409827|P1|STARTED|Overall Study||3
176191|NCT00595517|409831|P1|NOT COMPLETED|Overall Study||19
176192|NCT00595517|409831|P1|COMPLETED|Overall Study||111
176193|NCT00595517|409831|P1|STARTED|Overall Study||130
176194|NCT00595504|409840|P2|NOT COMPLETED|Overall Study||3
176195|NCT00595504|409841|P1|NOT COMPLETED|Overall Study||2
176196|NCT00595504|409840|P2|COMPLETED|Overall Study||6
176197|NCT00595504|409841|P1|COMPLETED|Overall Study||14
176198|NCT00595504|409840|P2|STARTED|Overall Study||9
176199|NCT00595504|409841|P1|STARTED|Overall Study||16
176200|NCT00595465|409854|P3|NOT COMPLETED|Overall Study||7
176201|NCT00595465|409855|P2|NOT COMPLETED|Overall Study||4
176202|NCT00595465|409856|P1|NOT COMPLETED|Overall Study||6
176203|NCT00595465|409854|P3|COMPLETED|Overall Study||121
176204|NCT00595465|409855|P2|COMPLETED|Overall Study||125
176205|NCT00595465|409856|P1|COMPLETED|Overall Study||124
176206|NCT00595465|409854|P3|STARTED|Overall Study||128
176207|NCT00595465|409855|P2|STARTED|Overall Study||129
176208|NCT00595465|409856|P1|STARTED|Overall Study||130
176209|NCT00595413|409868|P4|NOT COMPLETED|Overall Study||4
176210|NCT00595413|409869|P3|NOT COMPLETED|Overall Study||8
176211|NCT00595413|409870|P2|NOT COMPLETED|Overall Study||5
176213|NCT00595413|409868|P4|COMPLETED|Overall Study||75
176214|NCT00595413|409869|P3|COMPLETED|Overall Study||70
176215|NCT00595413|409870|P2|COMPLETED|Overall Study||73
176216|NCT00595413|409871|P1|COMPLETED|Overall Study||69
176217|NCT00595413|409868|P4|STARTED|Overall Study||79
176218|NCT00595413|409869|P3|STARTED|Overall Study||78
176219|NCT00595413|409870|P2|STARTED|Overall Study||78
176220|NCT00595413|409871|P1|STARTED|Overall Study||76
176221|NCT00595361|409899|P2|NOT COMPLETED|Overall Study||0
176222|NCT00595361|409900|P1|NOT COMPLETED|Overall Study||0
176223|NCT00595361|409899|P2|COMPLETED|Overall Study||18
176224|NCT00595361|409900|P1|COMPLETED|Overall Study||12
176225|NCT00595361|409899|P2|STARTED|Overall Study||18
176226|NCT00595361|409900|P1|STARTED|Overall Study||12
176227|NCT00595335|409908|P2|NOT COMPLETED|Six Months to Twelve Months||1
176228|NCT00595335|409909|P1|NOT COMPLETED|Six Months to Twelve Months||1
176229|NCT00595335|409908|P2|COMPLETED|Six Months to Twelve Months||9
176230|NCT00595335|409909|P1|COMPLETED|Six Months to Twelve Months||10
176231|NCT00595335|409908|P2|STARTED|Six Months to Twelve Months||10
176232|NCT00595335|409909|P1|STARTED|Six Months to Twelve Months||11
176233|NCT00595335|409908|P2|NOT COMPLETED|Baseline to Six Months||2
176234|NCT00595335|409909|P1|NOT COMPLETED|Baseline to Six Months||2
176235|NCT00595335|409908|P2|COMPLETED|Baseline to Six Months||10
176236|NCT00595335|409909|P1|COMPLETED|Baseline to Six Months||11
176237|NCT00595335|409908|P2|STARTED|Baseline to Six Months||12
176238|NCT00595335|409909|P1|STARTED|Baseline to Six Months||13
176239|NCT00595309|409929|P1|NOT COMPLETED|Overall Study||4
176240|NCT00595309|409929|P1|COMPLETED|Overall Study||194
176241|NCT00595309|409929|P1|STARTED|Overall Study||198
176242|NCT00595270|409936|P3|NOT COMPLETED|Overall Study||8
176243|NCT00595270|409937|P2|NOT COMPLETED|Overall Study||10
176244|NCT00595270|409938|P1|NOT COMPLETED|Overall Study||6
176245|NCT00595270|409936|P3|COMPLETED|Overall Study||108
176246|NCT00595270|409937|P2|COMPLETED|Overall Study||107
176247|NCT00595270|409938|P1|COMPLETED|Overall Study||110
176248|NCT00595270|409936|P3|STARTED|Overall Study||116
176249|NCT00595270|409937|P2|STARTED|Overall Study||117
176250|NCT00595270|409938|P1|STARTED|Overall Study||116
176251|NCT00595153|409949|P3|NOT COMPLETED|Overall Study||25
176252|NCT00595153|409950|P2|NOT COMPLETED|Overall Study||16
176253|NCT00595153|409951|P1|NOT COMPLETED|Overall Study||4
176254|NCT00595153|409949|P3|COMPLETED|Overall Study||36
176255|NCT00595153|409950|P2|COMPLETED|Overall Study||26
176256|NCT00595153|409951|P1|COMPLETED|Overall Study||20
176257|NCT00595153|409949|P3|STARTED|Overall Study||61
176258|NCT00595153|409950|P2|STARTED|Overall Study||42
176259|NCT00595153|409951|P1|STARTED|Overall Study||24
176260|NCT00595127|409959|P1|NOT COMPLETED|Overall Study||10
176261|NCT00595127|409959|P1|COMPLETED|Overall Study||11
176262|NCT00595127|409959|P1|STARTED|Overall Study||21
176263|NCT00595114|409965|P2|NOT COMPLETED|Overall Study||0
176264|NCT00595114|409966|P1|NOT COMPLETED|Overall Study||0
176265|NCT00595114|409965|P2|COMPLETED|Overall Study||19
176266|NCT00595114|409966|P1|COMPLETED|Overall Study||24
176267|NCT00595114|409965|P2|STARTED|Overall Study||19
176268|NCT00595114|409966|P1|STARTED|Overall Study||24
176269|NCT00595088|409972|P1|NOT COMPLETED|Overall Study||40
176270|NCT00595088|409972|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
176271|NCT00595088|409972|P1|STARTED|Overall Study||47
176272|NCT00595075|409981|P2|NOT COMPLETED|Overall Study||0
176273|NCT00595075|409982|P1|NOT COMPLETED|Overall Study||1
176274|NCT00595075|409981|P2|COMPLETED|Overall Study||5
176275|NCT00595075|409982|P1|COMPLETED|Overall Study||5
176276|NCT00595075|409981|P2|STARTED|Overall Study||5
176277|NCT00595075|409982|P1|STARTED|Overall Study||6
176278|NCT00594958|410003|P3|NOT COMPLETED|Overall Study||10
176279|NCT00594958|410004|P2|NOT COMPLETED|Overall Study||3
176280|NCT00594958|410005|P1|NOT COMPLETED|Overall Study||14
176281|NCT00594958|410003|P3|COMPLETED|Overall Study||202
176282|NCT00594958|410004|P2|COMPLETED|Overall Study||210
176283|NCT00594958|410005|P1|COMPLETED|Overall Study||200
176284|NCT00594958|410003|P3|Randomized and at Least 1 Vaccination|Overall Study||211
176285|NCT00594958|410004|P2|Randomized and at Least 1 Vaccination|Overall Study||213
176286|NCT00594958|410005|P1|Randomized and at Least 1 Vaccination|Overall Study||212
176287|NCT00594958|410003|P3|STARTED|Overall Study||212
176288|NCT00594958|410004|P2|STARTED|Overall Study||213
176289|NCT00594958|410005|P1|STARTED|Overall Study||214
176290|NCT00594945|410016|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
176291|NCT00594945|410017|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
176292|NCT00594945|410018|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
176293|NCT00594945|410016|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
176294|NCT00594945|410017|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
176295|NCT00594945|410018|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
176296|NCT00594945|410016|P3|STARTED|Cohort 2 / Treatment Period 2||2
176297|NCT00594945|410017|P2|STARTED|Cohort 2 / Treatment Period 2||3
176298|NCT00594945|410018|P1|STARTED|Cohort 2 / Treatment Period 2||0
176299|NCT00594945|410016|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
176300|NCT00594945|410017|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
176301|NCT00594945|410018|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
176302|NCT00594945|410016|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
176303|NCT00594945|410017|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
176304|NCT00594945|410018|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
176305|NCT00594945|410016|P3|STARTED|Cohort 1 / Treatment Period 1||2
176306|NCT00594945|410017|P2|STARTED|Cohort 1 / Treatment Period 1||0
176307|NCT00594945|410018|P1|STARTED|Cohort 1 / Treatment Period 1||4
176308|NCT00594906|410026|P2|NOT COMPLETED|Overall Study||2
176309|NCT00594906|410027|P1|NOT COMPLETED|Overall Study||1
176310|NCT00594906|410026|P2|COMPLETED|Overall Study||1
176311|NCT00594906|410027|P1|COMPLETED|Overall Study||6
176312|NCT00594906|410026|P2|STARTED|Overall Study||3
176313|NCT00594906|410027|P1|STARTED|Overall Study||7
176314|NCT00594880|410035|P2|NOT COMPLETED|Overall Study||1
176315|NCT00594880|410036|P1|NOT COMPLETED|Overall Study||2
176316|NCT00594880|410035|P2|COMPLETED|Overall Study||10
176317|NCT00594880|410036|P1|COMPLETED|Overall Study||10
176318|NCT00594880|410035|P2|STARTED|Overall Study||11
176319|NCT00594880|410036|P1|STARTED|Overall Study||12
176320|NCT00594854|410048|P2|NOT COMPLETED|Overall Study||10
176321|NCT00594854|410049|P1|NOT COMPLETED|Overall Study||7
176322|NCT00594854|410048|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
176323|NCT00594854|410049|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
176324|NCT00594854|410048|P2|STARTED|Overall Study||11
176325|NCT00594854|410049|P1|STARTED|Overall Study||9
176326|NCT00594685|410059|P1|NOT COMPLETED|Overall Study||0
176327|NCT00594685|410059|P1|COMPLETED|Overall Study||10
176328|NCT00594685|410059|P1|STARTED|Overall Study||10
176329|NCT00594659|410079|P3|NOT COMPLETED|Overall Study||7
176330|NCT00594659|410080|P2|NOT COMPLETED|Overall Study||9
176331|NCT00594659|410081|P1|NOT COMPLETED|Overall Study||13
176332|NCT00594659|410079|P3|COMPLETED|Overall Study||9
176333|NCT00594659|410080|P2|COMPLETED|Overall Study||21
176334|NCT00594659|410081|P1|COMPLETED|Overall Study||16
176335|NCT00594659|410079|P3|STARTED|Overall Study||16
176336|NCT00594659|410080|P2|STARTED|Overall Study||30
176337|NCT00594659|410081|P1|STARTED|Overall Study||29
176338|NCT00594646|410092|P1|NOT COMPLETED|Overall Study||16
176339|NCT00594646|410092|P1|COMPLETED|Overall Study||84
176340|NCT00594646|410092|P1|STARTED|Overall Study||100
176341|NCT00594568|410100|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
176342|NCT00594568|410101|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
176343|NCT00594568|410102|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
176344|NCT00594568|410100|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
176345|NCT00594568|410101|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
176346|NCT00594568|410102|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
176347|NCT00594568|410100|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
176348|NCT00594568|410101|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
176349|NCT00594568|410102|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
176350|NCT00594568|410100|P3|NOT COMPLETED|Delayed Start||66
176351|NCT00594568|410101|P2|NOT COMPLETED|Delayed Start||77
176352|NCT00594568|410102|P1|NOT COMPLETED|Delayed Start||98
176353|NCT00594568|410100|P3|COMPLETED|Delayed Start||55
176354|NCT00594568|410101|P2|COMPLETED|Delayed Start||76
176355|NCT00594568|410102|P1|COMPLETED|Delayed Start||91
176356|NCT00594568|410100|P3|STARTED|Delayed Start||121
176357|NCT00594568|410101|P2|STARTED|Delayed Start||153
176358|NCT00594568|410102|P1|STARTED|Delayed Start||189
176359|NCT00594568|410100|P3|NOT COMPLETED|Initial Treatment||408
176360|NCT00594568|410101|P2|NOT COMPLETED|Initial Treatment||354
176361|NCT00594568|410102|P1|NOT COMPLETED|Initial Treatment||312
176362|NCT00594568|410100|P3|COMPLETED|Initial Treatment||121
176363|NCT00594568|410101|P2|COMPLETED|Initial Treatment||153
176364|NCT00594568|410102|P1|COMPLETED|Initial Treatment||189
176365|NCT00594568|410100|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
176366|NCT00594568|410101|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
176367|NCT00594568|410102|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
176368|NCT00594568|410100|P3|STARTED|Initial Treatment||529
176369|NCT00594568|410101|P2|STARTED|Initial Treatment||507
176370|NCT00594568|410102|P1|STARTED|Initial Treatment||501
176371|NCT00594516|410190|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
176372|NCT00594516|410191|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
176373|NCT00594516|410192|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
176374|NCT00594516|410190|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
176375|NCT00594516|410191|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
176376|NCT00594516|410192|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
176377|NCT00594516|410190|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
176378|NCT00594516|410191|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
176379|NCT00594516|410192|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
176380|NCT00594516|410190|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
176381|NCT00594516|410191|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
176382|NCT00594516|410192|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
176383|NCT00594516|410190|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
176384|NCT00594516|410191|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
176385|NCT00594516|410192|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
176386|NCT00594516|410190|P3|STARTED|Open Label (OL): Tapentadol IR||0
176387|NCT00594516|410191|P2|STARTED|Open Label (OL): Tapentadol IR||0
176388|NCT00594516|410192|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
176389|NCT00594464|410200|P1|NOT COMPLETED|Overall Study||3
176390|NCT00594464|410200|P1|COMPLETED|Overall Study||11
176391|NCT00594464|410200|P1|STARTED|Overall Study||14
176392|NCT00594425|410215|P3|NOT COMPLETED|Overall Study||10
176393|NCT00594425|410216|P2|NOT COMPLETED|Overall Study||14
176394|NCT00594425|410217|P1|NOT COMPLETED|Overall Study||7
176395|NCT00594425|410215|P3|COMPLETED|Overall Study||42
176396|NCT00594425|410216|P2|COMPLETED|Overall Study||34
176397|NCT00594425|410217|P1|COMPLETED|Overall Study||43
176398|NCT00594425|410215|P3|STARTED|Overall Study||52
176399|NCT00594425|410216|P2|STARTED|Overall Study||48
176400|NCT00594425|410217|P1|STARTED|Overall Study||50
176401|NCT00594399|410329|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
176402|NCT00594399|410330|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
176403|NCT00594399|410331|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
176404|NCT00594399|410329|P3|COMPLETED|Rerandomization Arm 1 Only||82
176405|NCT00594399|410330|P2|COMPLETED|Rerandomization Arm 1 Only||114
176406|NCT00594399|410331|P1|COMPLETED|Rerandomization Arm 1 Only||79
176407|NCT00594399|410329|P3|Rerandomization|Rerandomization Arm 1 Only||82
176408|NCT00594399|410330|P2|Rerandomization|Rerandomization Arm 1 Only||114
176409|NCT00594399|410331|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
176410|NCT00594399|410329|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
176411|NCT00594399|410330|P2|STARTED|Rerandomization Arm 1 Only||118
176412|NCT00594399|410331|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
176413|NCT00594399|410329|P3|NOT COMPLETED|Initial 3 Month Counseling||0
176414|NCT00594399|410330|P2|NOT COMPLETED|Initial 3 Month Counseling||4
176415|NCT00594399|410331|P1|NOT COMPLETED|Initial 3 Month Counseling||17
176416|NCT00594399|410329|P3|COMPLETED|Initial 3 Month Counseling||0
176417|NCT00594399|410330|P2|COMPLETED|Initial 3 Month Counseling||118
176418|NCT00594399|410331|P1|COMPLETED|Initial 3 Month Counseling||163
176419|NCT00594399|410329|P3|STARTED|Initial 3 Month Counseling||0
176420|NCT00594399|410330|P2|STARTED|Initial 3 Month Counseling||122
176421|NCT00594399|410331|P1|STARTED|Initial 3 Month Counseling||180
176422|NCT00594386|410353|P1|NOT COMPLETED|Overall Study||258
176423|NCT00594386|410353|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
176424|NCT00594386|410353|P1|STARTED|Overall Study||258
176425|NCT00594308|410359|P1|NOT COMPLETED|Overall Study||0
176426|NCT00594308|410359|P1|COMPLETED|Overall Study||10
176427|NCT00594308|410359|P1|STARTED|Overall Study||10
176428|NCT00594256|410367|P1|NOT COMPLETED|Overall Study||0
176429|NCT00594256|410367|P1|COMPLETED|Overall Study||8
176430|NCT00594256|410367|P1|STARTED|Overall Study||8
176431|NCT00594230|410377|P2|NOT COMPLETED|Overall Study||9
176432|NCT00594230|410378|P1|NOT COMPLETED|Overall Study||15
176433|NCT00594230|410377|P2|COMPLETED|Overall Study||1
176434|NCT00594230|410378|P1|COMPLETED|Overall Study||1
176435|NCT00594230|410377|P2|STARTED|Overall Study||10
176436|NCT00594230|410378|P1|STARTED|Overall Study||16
176437|NCT00594204|410386|P2|NOT COMPLETED|Overall Study||45
176438|NCT00594204|410387|P1|NOT COMPLETED|Overall Study||58
176439|NCT00594204|410386|P2|COMPLETED|Overall Study||154
176440|NCT00594204|410387|P1|COMPLETED|Overall Study||336
176441|NCT00594204|410386|P2|Received Treatment|Overall Study||198
176442|NCT00594204|410387|P1|Received Treatment|Overall Study||390
176443|NCT00594204|410386|P2|STARTED|Overall Study||199
176444|NCT00594204|410387|P1|STARTED|Overall Study||394
176445|NCT00594178|410397|P1|NOT COMPLETED|Overall Study||5
176446|NCT00594178|410397|P1|COMPLETED|Overall Study||12
176447|NCT00594178|410397|P1|STARTED|Overall Study||17
176448|NCT00594165|410402|P1|NOT COMPLETED|Overall Study||217
176449|NCT00594165|410402|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
176450|NCT00594165|410402|P1|STARTED|Overall Study||217
176451|NCT00594100|410408|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
176452|NCT00594100|410408|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
176453|NCT00594100|410408|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
176454|NCT00594100|410408|P1|NOT COMPLETED|Procedure||9
176455|NCT00594100|410408|P1|COMPLETED|Procedure||236
176456|NCT00594100|410408|P1|STARTED|Procedure||245
176457|NCT00594035|410419|P2|NOT COMPLETED|Overall Study||3
176458|NCT00594035|410420|P1|NOT COMPLETED|Overall Study||2
176459|NCT00594035|410419|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
176460|NCT00594035|410420|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
176461|NCT00594035|410419|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
176462|NCT00594035|410420|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
176463|NCT00594022|410428|P2|NOT COMPLETED|Overall Study||0
176464|NCT00594022|410429|P1|NOT COMPLETED|Overall Study||0
176465|NCT00594022|410428|P2|COMPLETED|Overall Study||173
176466|NCT00594022|410429|P1|COMPLETED|Overall Study||176
176467|NCT00594022|410428|P2|STARTED|Overall Study||173
176468|NCT00594022|410429|P1|STARTED|Overall Study||176
176469|NCT00593957|410446|P3|NOT COMPLETED|Overall Study||2
176470|NCT00593957|410447|P2|NOT COMPLETED|Overall Study||1
176471|NCT00593957|410448|P1|NOT COMPLETED|Overall Study||0
176472|NCT00593957|410446|P3|COMPLETED|Overall Study||10
176473|NCT00593957|410447|P2|COMPLETED|Overall Study||12
176474|NCT00593957|410448|P1|COMPLETED|Overall Study||13
176475|NCT00593957|410446|P3|STARTED|Overall Study||12
176476|NCT00593957|410447|P2|STARTED|Overall Study||13
176477|NCT00593957|410448|P1|STARTED|Overall Study||13
176478|NCT00593918|410472|P2|NOT COMPLETED|Overall Study||24
176479|NCT00593918|410473|P1|NOT COMPLETED|Overall Study||5
176480|NCT00593918|410472|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
176481|NCT00593918|410473|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
176482|NCT00593918|410472|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
176483|NCT00593918|410473|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
176484|NCT00593866|410481|P1|NOT COMPLETED|Overall Study||0
176485|NCT00593866|410481|P1|COMPLETED|Overall Study||50
176486|NCT00593866|410481|P1|STARTED|Overall Study||50
176487|NCT00593827|410488|P2|NOT COMPLETED|Overall Study||2
176488|NCT00593827|410489|P1|NOT COMPLETED|Overall Study||0
176489|NCT00593827|410488|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
176490|NCT00593827|410489|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
176491|NCT00593827|410488|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
176492|NCT00593827|410489|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
176493|NCT00593827|410488|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
176494|NCT00593827|410489|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
176495|NCT00593827|410488|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
176496|NCT00593827|410489|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
176497|NCT00593814|410513|P2|NOT COMPLETED|Overall Study||0
176498|NCT00593814|410514|P1|NOT COMPLETED|Overall Study||24
176499|NCT00593814|410513|P2|COMPLETED|Overall Study||120
176500|NCT00593814|410514|P1|COMPLETED|Overall Study||115
176501|NCT00593814|410513|P2|STARTED|Overall Study||120
176502|NCT00593814|410514|P1|STARTED|Overall Study||139
176503|NCT00593736|410524|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
176504|NCT00593736|410525|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
176505|NCT00593736|410526|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
176506|NCT00593736|410527|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
176507|NCT00593736|410524|P4|COMPLETED|Treatment Period and Placebo Run-out||28
176508|NCT00593736|410525|P3|COMPLETED|Treatment Period and Placebo Run-out||30
176509|NCT00593736|410526|P2|COMPLETED|Treatment Period and Placebo Run-out||31
176510|NCT00593736|410527|P1|COMPLETED|Treatment Period and Placebo Run-out||29
176511|NCT00593736|410524|P4|STARTED|Treatment Period and Placebo Run-out||32
176512|NCT00593736|410525|P3|STARTED|Treatment Period and Placebo Run-out||35
176513|NCT00593736|410526|P2|STARTED|Treatment Period and Placebo Run-out||33
176514|NCT00593736|410527|P1|STARTED|Treatment Period and Placebo Run-out||32
176515|NCT00593736|410524|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
176516|NCT00593736|410525|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
176517|NCT00593736|410526|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
176518|NCT00593736|410527|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
176519|NCT00593736|410524|P4|COMPLETED|Screening Period and Placebo Run-in||132
176520|NCT00593736|410525|P3|COMPLETED|Screening Period and Placebo Run-in||0
176521|NCT00593736|410526|P2|COMPLETED|Screening Period and Placebo Run-in||0
176522|NCT00593736|410527|P1|COMPLETED|Screening Period and Placebo Run-in||0
176523|NCT00593736|410524|P4|STARTED|Screening Period and Placebo Run-in||549
176524|NCT00593736|410525|P3|STARTED|Screening Period and Placebo Run-in||0
176525|NCT00593736|410526|P2|STARTED|Screening Period and Placebo Run-in||0
176526|NCT00593736|410527|P1|STARTED|Screening Period and Placebo Run-in||0
176527|NCT00593684|410775|P2|NOT COMPLETED|Overall Study||1
176528|NCT00593684|410776|P1|NOT COMPLETED|Overall Study||2
176529|NCT00593684|410775|P2|COMPLETED|Overall Study||24
176530|NCT00593684|410776|P1|COMPLETED|Overall Study||23
176531|NCT00593684|410775|P2|STARTED|Overall Study||25
176532|NCT00593684|410776|P1|STARTED|Overall Study||25
176533|NCT00593645|410788|P1|NOT COMPLETED|Overall Study||0
176534|NCT00593645|410788|P1|COMPLETED|Overall Study||7
176535|NCT00593645|410788|P1|STARTED|Overall Study||7
176536|NCT00593606|410802|P1|NOT COMPLETED|Overall Study||27
176537|NCT00593606|410802|P1|COMPLETED|Overall Study||97
176538|NCT00593606|410802|P1|Treatment Period Completed|Overall Study||99
176539|NCT00593606|410802|P1|Full Analysis Set|Overall Study||114
176540|NCT00593606|410802|P1|Start of Treatment - Safety Set|Overall Study||116
176541|NCT00593606|410802|P1|STARTED|Overall Study||124
176542|NCT00593450|410902|P4|NOT COMPLETED|Overall Study||29
176543|NCT00593450|410903|P3|NOT COMPLETED|Overall Study||13
176544|NCT00593450|410904|P2|NOT COMPLETED|Overall Study||21
176545|NCT00593450|410905|P1|NOT COMPLETED|Overall Study||17
176546|NCT00593450|410902|P4|COMPLETED|Overall Study||271
176547|NCT00593450|410903|P3|COMPLETED|Overall Study||285
176548|NCT00593450|410904|P2|COMPLETED|Overall Study||265
176549|NCT00593450|410905|P1|COMPLETED|Overall Study||284
176550|NCT00593450|410902|P4|STARTED|Overall Study||300
176551|NCT00593450|410903|P3|STARTED|Overall Study||298
176552|NCT00593450|410904|P2|STARTED|Overall Study||286
176553|NCT00593450|410905|P1|STARTED|Overall Study||301
176554|NCT00593372|410977|P2|NOT COMPLETED|Overall Study||0
176555|NCT00593372|410978|P1|NOT COMPLETED|Overall Study||0
176556|NCT00593372|410977|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
176557|NCT00593372|410978|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
176558|NCT00593372|410977|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
176559|NCT00593372|410978|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
176560|NCT00593346|410984|P1|NOT COMPLETED|Overall Study||0
176561|NCT00593346|410984|P1|COMPLETED|Overall Study||151
176562|NCT00593346|410984|P1|STARTED|Overall Study||151
176563|NCT00593333|411001|P2|NOT COMPLETED|Overall Study||11
176564|NCT00593333|411002|P1|NOT COMPLETED|Overall Study||10
176565|NCT00593333|411001|P2|COMPLETED|Overall Study||45
176566|NCT00593333|411002|P1|COMPLETED|Overall Study||44
176567|NCT00593333|411001|P2|STARTED|Overall Study||56
176568|NCT00593333|411002|P1|STARTED|Overall Study||54
176569|NCT00593320|411010|P2|NOT COMPLETED|Overall Study||0
176570|NCT00593320|411011|P1|NOT COMPLETED|Overall Study||0
176571|NCT00593320|411010|P2|COMPLETED|Overall Study||1
176572|NCT00593320|411011|P1|COMPLETED|Overall Study||1
176573|NCT00593320|411010|P2|STARTED|Overall Study||1
176574|NCT00593320|411011|P1|STARTED|Overall Study||1
176575|NCT00593112|411025|P2|NOT COMPLETED|Overall Study||0
176576|NCT00593112|411026|P1|NOT COMPLETED|Overall Study||10
176577|NCT00593112|411025|P2|COMPLETED|Overall Study||12
176578|NCT00593112|411026|P1|COMPLETED|Overall Study||17
176579|NCT00593112|411025|P2|STARTED|Overall Study||12
176580|NCT00593112|411026|P1|STARTED|Overall Study||27
176581|NCT00592943|411038|P2|NOT COMPLETED|Overall Study||0
176582|NCT00592943|411039|P1|NOT COMPLETED|Overall Study||0
176583|NCT00592943|411038|P2|COMPLETED|Overall Study||6
176584|NCT00592943|411039|P1|COMPLETED|Overall Study||6
176585|NCT00592943|411038|P2|STARTED|Overall Study||6
176586|NCT00592943|411039|P1|STARTED|Overall Study||6
176587|NCT00592904|411053|P4|NOT COMPLETED|Overall Study||11
176588|NCT00592904|411054|P3|NOT COMPLETED|Overall Study||17
176589|NCT00592904|411055|P2|NOT COMPLETED|Overall Study||55
176590|NCT00592904|411056|P1|NOT COMPLETED|Overall Study||25
176591|NCT00592904|411053|P4|COMPLETED|Overall Study||19
176592|NCT00592904|411054|P3|COMPLETED|Overall Study||10
176593|NCT00592904|411055|P2|COMPLETED|Overall Study||93
176594|NCT00592904|411056|P1|COMPLETED|Overall Study||32
176595|NCT00592904|411053|P4|STARTED|Overall Study||30
176596|NCT00592904|411054|P3|STARTED|Overall Study||27
176597|NCT00592904|411055|P2|STARTED|Overall Study||148
176598|NCT00592904|411056|P1|STARTED|Overall Study||57
176599|NCT00592852|411082|P1|NOT COMPLETED|Overall Study||6
176600|NCT00592852|411082|P1|COMPLETED|Overall Study||7
176601|NCT00592852|411082|P1|STARTED|Overall Study||13
176602|NCT00592839|411090|P3|NOT COMPLETED|Overall Study||6
176603|NCT00592839|411091|P2|NOT COMPLETED|Overall Study||4
176604|NCT00592839|411092|P1|NOT COMPLETED|Overall Study||2
176605|NCT00592839|411090|P3|COMPLETED|Overall Study||46
176606|NCT00592839|411091|P2|COMPLETED|Overall Study||48
176607|NCT00592839|411092|P1|COMPLETED|Overall Study||51
176608|NCT00592839|411090|P3|STARTED|Overall Study||52
176609|NCT00592839|411091|P2|STARTED|Overall Study||52
176610|NCT00592839|411092|P1|STARTED|Overall Study||53
176611|NCT00592774|411120|P5|NOT COMPLETED|Overall Study||14
176612|NCT00592774|411121|P4|NOT COMPLETED|Overall Study||14
176613|NCT00592774|411122|P3|NOT COMPLETED|Overall Study||4
176614|NCT00592774|411123|P2|NOT COMPLETED|Overall Study||32
176615|NCT00592774|411124|P1|NOT COMPLETED|Overall Study||11
176616|NCT00592774|411120|P5|COMPLETED|Overall Study||9
176617|NCT00592774|411121|P4|COMPLETED|Overall Study||8
176618|NCT00592774|411122|P3|COMPLETED|Overall Study||18
176619|NCT00592774|411123|P2|COMPLETED|Overall Study||21
176620|NCT00592774|411124|P1|COMPLETED|Overall Study||15
176621|NCT00592774|411120|P5|STARTED|Overall Study||23
176622|NCT00592774|411121|P4|STARTED|Overall Study||22
176623|NCT00592774|411122|P3|STARTED|Overall Study||22
176624|NCT00592774|411123|P2|STARTED|Overall Study||53
176625|NCT00592774|411124|P1|STARTED|Overall Study||26
176626|NCT00592761|411181|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
176627|NCT00592761|411182|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
176628|NCT00592761|411181|P2|COMPLETED|Second Intervention (2 Weeks)||9
176629|NCT00592761|411182|P1|COMPLETED|Second Intervention (2 Weeks)||9
176630|NCT00592761|411181|P2|STARTED|Second Intervention (2 Weeks)||9
176631|NCT00592761|411182|P1|STARTED|Second Intervention (2 Weeks)||9
176632|NCT00592761|411181|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
176633|NCT00592761|411182|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
176634|NCT00592761|411181|P2|COMPLETED|First Intervention (2 Weeks)||9
176635|NCT00592761|411182|P1|COMPLETED|First Intervention (2 Weeks)||9
176636|NCT00592761|411181|P2|STARTED|First Intervention (2 Weeks)||9
176637|NCT00592761|411182|P1|STARTED|First Intervention (2 Weeks)||9
176638|NCT00592683|411196|P2|NOT COMPLETED|Overall Study||4
176639|NCT00592683|411197|P1|NOT COMPLETED|Overall Study||4
176640|NCT00592683|411196|P2|COMPLETED|Overall Study||6
176641|NCT00592683|411197|P1|COMPLETED|Overall Study||6
176642|NCT00592683|411196|P2|STARTED|Overall Study||10
176643|NCT00592683|411197|P1|STARTED|Overall Study||10
176644|NCT00592631|411207|P2|NOT COMPLETED|Overall Study||2
176645|NCT00592631|411208|P1|NOT COMPLETED|Overall Study||0
176646|NCT00592631|411207|P2|COMPLETED|Overall Study||9
176647|NCT00592631|411208|P1|COMPLETED|Overall Study||16
176648|NCT00592631|411207|P2|STARTED|Overall Study||11
176649|NCT00592631|411208|P1|STARTED|Overall Study||16
176650|NCT00592488|411216|P2|NOT COMPLETED|Overall Study||0
176651|NCT00592488|411217|P1|NOT COMPLETED|Overall Study||0
176652|NCT00592488|411216|P2|COMPLETED|Overall Study||7
176653|NCT00592488|411217|P1|COMPLETED|Overall Study||6
176654|NCT00592488|411216|P2|STARTED|Overall Study||7
176655|NCT00592488|411217|P1|STARTED|Overall Study||6
176656|NCT00592475|411226|P3|NOT COMPLETED|Overall Study||0
176657|NCT00592475|411227|P2|NOT COMPLETED|Overall Study||0
176658|NCT00592475|411228|P1|NOT COMPLETED|Overall Study||0
176659|NCT00592475|411226|P3|COMPLETED|Overall Study||5
176660|NCT00592475|411227|P2|COMPLETED|Overall Study||9
176661|NCT00592475|411228|P1|COMPLETED|Overall Study||6
176662|NCT00592475|411226|P3|STARTED|Overall Study||5
176663|NCT00592475|411227|P2|STARTED|Overall Study||9
176664|NCT00592475|411228|P1|STARTED|Overall Study||6
176665|NCT00592384|411253|P2|NOT COMPLETED|Overall Study||6
176666|NCT00592384|411254|P1|NOT COMPLETED|Overall Study||5
176667|NCT00592384|411253|P2|COMPLETED|Overall Study||63
176668|NCT00592384|411254|P1|COMPLETED|Overall Study||59
176669|NCT00592384|411253|P2|STARTED|Overall Study||69
176670|NCT00592384|411254|P1|STARTED|Overall Study||64
176671|NCT00592358|411262|P1|NOT COMPLETED|Overall Study||6
176672|NCT00592358|411262|P1|COMPLETED|Overall Study||11
176673|NCT00592358|411262|P1|STARTED|Overall Study||17
176674|NCT00592319|411269|P2|NOT COMPLETED|Overall Study||3
176675|NCT00592319|411270|P1|NOT COMPLETED|Overall Study||0
176676|NCT00592319|411269|P2|COMPLETED|Overall Study||5
176677|NCT00592319|411270|P1|COMPLETED|Overall Study||2
176678|NCT00592319|411269|P2|STARTED|Overall Study||8
176679|NCT00592319|411270|P1|STARTED|Overall Study||2
176680|NCT00592176|411278|P1|NOT COMPLETED|Overall Study||0
176681|NCT00592176|411278|P1|COMPLETED|Overall Study||5
176682|NCT00592176|411278|P1|STARTED|Overall Study||5
176683|NCT00592072|411283|P2|NOT COMPLETED|Second Sequence||0
176684|NCT00592072|411284|P1|NOT COMPLETED|Second Sequence||0
176685|NCT00592072|411283|P2|COMPLETED|Second Sequence||5
176686|NCT00592072|411284|P1|COMPLETED|Second Sequence||5
176687|NCT00592072|411283|P2|STARTED|Second Sequence||5
176688|NCT00592072|411284|P1|STARTED|Second Sequence||5
176689|NCT00592072|411283|P2|NOT COMPLETED|Wash Out Period||1
176690|NCT00592072|411284|P1|NOT COMPLETED|Wash Out Period||1
176691|NCT00592072|411283|P2|COMPLETED|Wash Out Period||5
176692|NCT00592072|411284|P1|COMPLETED|Wash Out Period||5
176693|NCT00592072|411283|P2|STARTED|Wash Out Period||6
176694|NCT00592072|411284|P1|STARTED|Wash Out Period||6
176695|NCT00592072|411283|P2|NOT COMPLETED|First Sequence||0
176696|NCT00592072|411284|P1|NOT COMPLETED|First Sequence||0
176697|NCT00592072|411283|P2|COMPLETED|First Sequence||6
176698|NCT00592072|411284|P1|COMPLETED|First Sequence||6
176699|NCT00592072|411283|P2|STARTED|First Sequence||6
176700|NCT00592072|411284|P1|STARTED|First Sequence||6
176701|NCT00591864|411306|P1|NOT COMPLETED|Overall Study||5
176702|NCT00591864|411306|P1|COMPLETED|Overall Study||84
176703|NCT00591864|411306|P1|STARTED|Overall Study||89
176704|NCT00591851|411312|P1|NOT COMPLETED|Overall Study||6
176705|NCT00591851|411312|P1|COMPLETED|Overall Study||64
176706|NCT00591851|411312|P1|STARTED|Overall Study||70
176707|NCT00591773|411319|P3|NOT COMPLETED|Overall Study||16
176708|NCT00591773|411320|P2|NOT COMPLETED|Overall Study||24
176709|NCT00591773|411321|P1|NOT COMPLETED|Overall Study||16
176710|NCT00591773|411319|P3|COMPLETED|Overall Study||168
176711|NCT00591773|411320|P2|COMPLETED|Overall Study||158
176712|NCT00591773|411321|P1|COMPLETED|Overall Study||169
176713|NCT00591773|411319|P3|STARTED|Overall Study||184
176714|NCT00591773|411320|P2|STARTED|Overall Study||182
176715|NCT00591773|411321|P1|STARTED|Overall Study||185
176716|NCT00591760|411373|P2|NOT COMPLETED|Overall Study||0
176717|NCT00591760|411374|P1|NOT COMPLETED|Overall Study||0
176718|NCT00591760|411373|P2|COMPLETED|Overall Study||28
176719|NCT00591760|411374|P1|COMPLETED|Overall Study||28
176720|NCT00591760|411373|P2|STARTED|Overall Study||28
176721|NCT00591760|411374|P1|STARTED|Overall Study||28
176722|NCT00591734|411380|P1|NOT COMPLETED|Overall Study||53
176723|NCT00591734|411380|P1|COMPLETED|Overall Study||4
176724|NCT00591734|411380|P1|STARTED|Overall Study||57
176725|NCT00591721|411386|P2|NOT COMPLETED|Overall Study||22
176726|NCT00591721|411387|P1|NOT COMPLETED|Overall Study||21
176727|NCT00591721|411386|P2|COMPLETED|Overall Study||70
176728|NCT00591721|411387|P1|COMPLETED|Overall Study||68
176729|NCT00591721|411386|P2|STARTED|Overall Study||92
176730|NCT00591721|411387|P1|STARTED|Overall Study||89
176731|NCT00591591|411395|P2|NOT COMPLETED|Overall Study||39
176732|NCT00591591|411396|P1|NOT COMPLETED|Overall Study||11
176733|NCT00591591|411395|P2|COMPLETED|Overall Study||94
176734|NCT00591591|411396|P1|COMPLETED|Overall Study||165
176735|NCT00591591|411395|P2|STARTED|Overall Study||133
176736|NCT00591591|411396|P1|STARTED|Overall Study||176
176737|NCT00591578|411413|P3|NOT COMPLETED|Open-Label Extension Phase||0
176738|NCT00591578|411414|P2|NOT COMPLETED|Open-Label Extension Phase||10
176739|NCT00591578|411415|P1|NOT COMPLETED|Open-Label Extension Phase||6
176740|NCT00591578|411413|P3|COMPLETED|Open-Label Extension Phase||0
176741|NCT00591578|411414|P2|COMPLETED|Open-Label Extension Phase||105
176742|NCT00591578|411415|P1|COMPLETED|Open-Label Extension Phase||49
176743|NCT00591578|411413|P3|STARTED|Open-Label Extension Phase||0
176744|NCT00591578|411414|P2|STARTED|Open-Label Extension Phase||115
176745|NCT00591578|411415|P1|STARTED|Open-Label Extension Phase||55
176746|NCT00591578|411413|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
176747|NCT00591578|411414|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
176748|NCT00591578|411415|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
176749|NCT00591578|411413|P3|COMPLETED|Double-Blind Treatment Phase||244
176750|NCT00591578|411414|P2|COMPLETED|Double-Blind Treatment Phase||249
176751|NCT00591578|411415|P1|COMPLETED|Double-Blind Treatment Phase||249
176752|NCT00591578|411413|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
176753|NCT00591578|411414|P2|STARTED|Double-Blind Treatment Phase||329
176754|NCT00591578|411415|P1|STARTED|Double-Blind Treatment Phase||327
176755|NCT00591565|411466|P1|NOT COMPLETED|Overall Study||5
176756|NCT00591565|411466|P1|COMPLETED|Overall Study||8
176757|NCT00591565|411466|P1|STARTED|Overall Study||13
176758|NCT00591370|411470|P1|NOT COMPLETED|Overall Study||2
176759|NCT00591370|411470|P1|COMPLETED|Overall Study||49
176760|NCT00591370|411470|P1|STARTED|Overall Study||51
176761|NCT00591344|411478|P2|NOT COMPLETED|Overall Study||8
176762|NCT00591344|411479|P1|NOT COMPLETED|Overall Study||5
176763|NCT00591344|411478|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
176764|NCT00591344|411479|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
176765|NCT00591344|411478|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
176766|NCT00591344|411479|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
176767|NCT00591344|411478|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
176768|NCT00591344|411479|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
176769|NCT00591266|411492|P3|NOT COMPLETED|Overall Study||14
176770|NCT00591266|411493|P2|NOT COMPLETED|Overall Study||11
176771|NCT00591266|411494|P1|NOT COMPLETED|Overall Study||9
176772|NCT00591266|411492|P3|COMPLETED|Overall Study||175
176773|NCT00591266|411493|P2|COMPLETED|Overall Study||177
176774|NCT00591266|411494|P1|COMPLETED|Overall Study||180
176775|NCT00591266|411492|P3|STARTED|Overall Study|Randomized only|189
176776|NCT00591266|411493|P2|STARTED|Overall Study|Randomized only|188
176777|NCT00591266|411494|P1|STARTED|Overall Study|Randomized only|189
176778|NCT00591253|411547|P3|NOT COMPLETED|Overall Study||15
176779|NCT00591253|411548|P2|NOT COMPLETED|Overall Study||21
176780|NCT00591253|411549|P1|NOT COMPLETED|Overall Study||14
176781|NCT00591253|411547|P3|COMPLETED|Overall Study||123
176782|NCT00591253|411548|P2|COMPLETED|Overall Study||116
176783|NCT00591253|411549|P1|COMPLETED|Overall Study||126
176784|NCT00591253|411547|P3|STARTED|Overall Study|Randomized or Treated|138
176785|NCT00591253|411548|P2|STARTED|Overall Study|Randomized or Treated|137
176786|NCT00591253|411549|P1|STARTED|Overall Study|Randomized or Treated|140
176787|NCT00591240|411601|P2|NOT COMPLETED|Overall Study||0
176788|NCT00591240|411602|P1|NOT COMPLETED|Overall Study||0
176789|NCT00591240|411601|P2|COMPLETED|Overall Study||222
176790|NCT00591240|411602|P1|COMPLETED|Overall Study||116
176791|NCT00591240|411601|P2|STARTED|Overall Study||222
176792|NCT00591240|411602|P1|STARTED|Overall Study||116
176793|NCT00591227|411610|P2|NOT COMPLETED|Overall Study||0
176794|NCT00591227|411611|P1|NOT COMPLETED|Overall Study||0
176795|NCT00591227|411610|P2|COMPLETED|Overall Study||87
176796|NCT00591227|411611|P1|COMPLETED|Overall Study||89
176797|NCT00591227|411610|P2|STARTED|Overall Study||87
176798|NCT00591227|411611|P1|STARTED|Overall Study||89
176799|NCT00591214|411617|P1|NOT COMPLETED|Overall Study||8
176800|NCT00591214|411617|P1|COMPLETED|Overall Study||2
176801|NCT00591214|411617|P1|STARTED|Overall Study||10
176802|NCT00591019|411626|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
176803|NCT00591019|411627|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
176804|NCT00591019|411626|P2|COMPLETED|Intevention 2 (14 Days)||3
176805|NCT00591019|411627|P1|COMPLETED|Intevention 2 (14 Days)||2
176806|NCT00591019|411626|P2|STARTED|Intevention 2 (14 Days)||3
176807|NCT00591019|411627|P1|STARTED|Intevention 2 (14 Days)||2
176808|NCT00591019|411626|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
176809|NCT00591019|411627|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
176810|NCT00591019|411626|P2|COMPLETED|Intervention 1 (14 Days)||3
176811|NCT00591019|411627|P1|COMPLETED|Intervention 1 (14 Days)||2
176812|NCT00591019|411626|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
176813|NCT00591019|411627|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
176814|NCT00591019|411626|P2|NOT COMPLETED|Baseline (1 Day)||0
176815|NCT00591019|411627|P1|NOT COMPLETED|Baseline (1 Day)||0
176816|NCT00591019|411626|P2|COMPLETED|Baseline (1 Day)||4
176817|NCT00591019|411627|P1|COMPLETED|Baseline (1 Day)||3
176818|NCT00591019|411626|P2|STARTED|Baseline (1 Day)||4
176819|NCT00591019|411627|P1|STARTED|Baseline (1 Day)||3
176820|NCT00591006|411638|P24|NOT COMPLETED|Overall Study||1
176821|NCT00591006|411639|P23|NOT COMPLETED|Overall Study||1
176822|NCT00591006|411640|P22|NOT COMPLETED|Overall Study||0
176823|NCT00591006|411641|P21|NOT COMPLETED|Overall Study||0
176824|NCT00591006|411642|P20|NOT COMPLETED|Overall Study||0
176825|NCT00591006|411643|P19|NOT COMPLETED|Overall Study||0
176826|NCT00591006|411644|P18|NOT COMPLETED|Overall Study||0
176827|NCT00591006|411645|P17|NOT COMPLETED|Overall Study||0
176828|NCT00591006|411646|P16|NOT COMPLETED|Overall Study||1
176829|NCT00591006|411647|P15|NOT COMPLETED|Overall Study||0
176830|NCT00591006|411648|P14|NOT COMPLETED|Overall Study||0
176831|NCT00591006|411649|P13|NOT COMPLETED|Overall Study||0
176832|NCT00591006|411650|P12|NOT COMPLETED|Overall Study||0
176833|NCT00591006|411651|P11|NOT COMPLETED|Overall Study||0
176834|NCT00591006|411652|P10|NOT COMPLETED|Overall Study||0
176835|NCT00591006|411653|P9|NOT COMPLETED|Overall Study||0
176836|NCT00591006|411654|P8|NOT COMPLETED|Overall Study||0
176837|NCT00591006|411655|P7|NOT COMPLETED|Overall Study||0
176838|NCT00591006|411656|P6|NOT COMPLETED|Overall Study||0
176839|NCT00591006|411657|P5|NOT COMPLETED|Overall Study||0
176840|NCT00591006|411658|P4|NOT COMPLETED|Overall Study||0
176841|NCT00591006|411659|P3|NOT COMPLETED|Overall Study||0
176842|NCT00591006|411660|P2|NOT COMPLETED|Overall Study||0
176843|NCT00591006|411661|P1|NOT COMPLETED|Overall Study||0
176844|NCT00591006|411638|P24|COMPLETED|Overall Study||0
176845|NCT00591006|411639|P23|COMPLETED|Overall Study||0
176846|NCT00591006|411640|P22|COMPLETED|Overall Study||1
176847|NCT00591006|411641|P21|COMPLETED|Overall Study||0
176848|NCT00591006|411642|P20|COMPLETED|Overall Study||1
176849|NCT00591006|411643|P19|COMPLETED|Overall Study||0
176850|NCT00591006|411644|P18|COMPLETED|Overall Study||1
176851|NCT00591006|411645|P17|COMPLETED|Overall Study||0
176852|NCT00591006|411646|P16|COMPLETED|Overall Study||0
176853|NCT00591006|411647|P15|COMPLETED|Overall Study||0
176854|NCT00591006|411648|P14|COMPLETED|Overall Study||2
176855|NCT00591006|411649|P13|COMPLETED|Overall Study||1
176856|NCT00591006|411650|P12|COMPLETED|Overall Study||1
176857|NCT00591006|411651|P11|COMPLETED|Overall Study||0
176858|NCT00591006|411652|P10|COMPLETED|Overall Study||1
176859|NCT00591006|411653|P9|COMPLETED|Overall Study||1
176860|NCT00591006|411654|P8|COMPLETED|Overall Study||0
176861|NCT00591006|411655|P7|COMPLETED|Overall Study||1
176862|NCT00591006|411656|P6|COMPLETED|Overall Study||0
176863|NCT00591006|411657|P5|COMPLETED|Overall Study||1
176864|NCT00591006|411658|P4|COMPLETED|Overall Study||1
176865|NCT00591006|411659|P3|COMPLETED|Overall Study||1
176866|NCT00591006|411660|P2|COMPLETED|Overall Study||0
176867|NCT00591006|411661|P1|COMPLETED|Overall Study||1
176868|NCT00591006|411638|P24|Treatment #4|Overall Study||0
176869|NCT00591006|411639|P23|Treatment #4|Overall Study||0
176870|NCT00591006|411640|P22|Treatment #4|Overall Study||1
176871|NCT00591006|411641|P21|Treatment #4|Overall Study||0
176872|NCT00591006|411642|P20|Treatment #4|Overall Study||1
176873|NCT00591006|411643|P19|Treatment #4|Overall Study||0
176874|NCT00591006|411644|P18|Treatment #4|Overall Study||1
176875|NCT00591006|411645|P17|Treatment #4|Overall Study||0
176876|NCT00591006|411646|P16|Treatment #4|Overall Study||0
176877|NCT00591006|411647|P15|Treatment #4|Overall Study||0
176878|NCT00591006|411648|P14|Treatment #4|Overall Study||2
176879|NCT00591006|411649|P13|Treatment #4|Overall Study||1
176880|NCT00591006|411650|P12|Treatment #4|Overall Study||1
176881|NCT00591006|411651|P11|Treatment #4|Overall Study||0
176882|NCT00591006|411652|P10|Treatment #4|Overall Study||1
176883|NCT00591006|411653|P9|Treatment #4|Overall Study||1
176884|NCT00591006|411654|P8|Treatment #4|Overall Study||0
176885|NCT00591006|411655|P7|Treatment #4|Overall Study||1
176886|NCT00591006|411656|P6|Treatment #4|Overall Study||0
176887|NCT00591006|411657|P5|Treatment #4|Overall Study||1
176888|NCT00591006|411658|P4|Treatment #4|Overall Study||1
176889|NCT00591006|411659|P3|Treatment #4|Overall Study||1
176890|NCT00591006|411660|P2|Treatment #4|Overall Study||0
176891|NCT00591006|411661|P1|Treatment #4|Overall Study||1
176892|NCT00591006|411638|P24|Treatment #3|Overall Study||1
176893|NCT00591006|411639|P23|Treatment #3|Overall Study||1
176894|NCT00591006|411640|P22|Treatment #3|Overall Study||1
176895|NCT00591006|411641|P21|Treatment #3|Overall Study||0
176896|NCT00591006|411642|P20|Treatment #3|Overall Study||1
176897|NCT00591006|411643|P19|Treatment #3|Overall Study||0
176898|NCT00591006|411644|P18|Treatment #3|Overall Study||1
176899|NCT00591006|411645|P17|Treatment #3|Overall Study||0
176900|NCT00591006|411646|P16|Treatment #3|Overall Study||0
176901|NCT00591006|411647|P15|Treatment #3|Overall Study||0
176902|NCT00591006|411648|P14|Treatment #3|Overall Study||2
176903|NCT00591006|411649|P13|Treatment #3|Overall Study||1
176904|NCT00591006|411650|P12|Treatment #3|Overall Study||1
176905|NCT00591006|411651|P11|Treatment #3|Overall Study||0
176906|NCT00591006|411652|P10|Treatment #3|Overall Study||1
176907|NCT00591006|411653|P9|Treatment #3|Overall Study||1
176908|NCT00591006|411654|P8|Treatment #3|Overall Study||0
176909|NCT00591006|411655|P7|Treatment #3|Overall Study||1
176910|NCT00591006|411656|P6|Treatment #3|Overall Study||0
176911|NCT00591006|411657|P5|Treatment #3|Overall Study||1
176912|NCT00591006|411658|P4|Treatment #3|Overall Study||1
176913|NCT00591006|411659|P3|Treatment #3|Overall Study||1
176914|NCT00591006|411660|P2|Treatment #3|Overall Study||0
176915|NCT00591006|411661|P1|Treatment #3|Overall Study||1
176916|NCT00591006|411638|P24|Treatment #2|Overall Study||1
176917|NCT00591006|411639|P23|Treatment #2|Overall Study||1
176918|NCT00591006|411640|P22|Treatment #2|Overall Study||1
176919|NCT00591006|411641|P21|Treatment #2|Overall Study||0
176920|NCT00591006|411642|P20|Treatment #2|Overall Study||1
176921|NCT00591006|411643|P19|Treatment #2|Overall Study||0
176922|NCT00591006|411644|P18|Treatment #2|Overall Study||1
176923|NCT00591006|411645|P17|Treatment #2|Overall Study||0
176924|NCT00591006|411646|P16|Treatment #2|Overall Study||0
176925|NCT00591006|411647|P15|Treatment #2|Overall Study||0
176926|NCT00591006|411648|P14|Treatment #2|Overall Study||2
176927|NCT00591006|411649|P13|Treatment #2|Overall Study||1
176928|NCT00591006|411650|P12|Treatment #2|Overall Study||1
176929|NCT00591006|411651|P11|Treatment #2|Overall Study||0
176930|NCT00591006|411652|P10|Treatment #2|Overall Study||1
176931|NCT00591006|411653|P9|Treatment #2|Overall Study||1
176932|NCT00591006|411654|P8|Treatment #2|Overall Study||0
176933|NCT00591006|411655|P7|Treatment #2|Overall Study||1
176934|NCT00591006|411656|P6|Treatment #2|Overall Study||0
176935|NCT00591006|411657|P5|Treatment #2|Overall Study||1
176936|NCT00591006|411658|P4|Treatment #2|Overall Study||1
176937|NCT00591006|411659|P3|Treatment #2|Overall Study||1
176938|NCT00591006|411660|P2|Treatment #2|Overall Study||0
176939|NCT00591006|411661|P1|Treatment #2|Overall Study||1
176940|NCT00591006|411638|P24|STARTED|Overall Study||1
176941|NCT00591006|411639|P23|STARTED|Overall Study||1
176942|NCT00591006|411640|P22|STARTED|Overall Study||1
176943|NCT00591006|411641|P21|STARTED|Overall Study||0
176944|NCT00591006|411642|P20|STARTED|Overall Study||1
176945|NCT00591006|411643|P19|STARTED|Overall Study||0
176946|NCT00591006|411644|P18|STARTED|Overall Study||1
176947|NCT00591006|411645|P17|STARTED|Overall Study||0
176948|NCT00591006|411646|P16|STARTED|Overall Study||1
176949|NCT00591006|411647|P15|STARTED|Overall Study||0
176950|NCT00591006|411648|P14|STARTED|Overall Study||2
176951|NCT00591006|411649|P13|STARTED|Overall Study||1
176952|NCT00591006|411650|P12|STARTED|Overall Study||1
176953|NCT00591006|411651|P11|STARTED|Overall Study||0
176954|NCT00591006|411652|P10|STARTED|Overall Study||1
176955|NCT00591006|411653|P9|STARTED|Overall Study||1
176956|NCT00591006|411654|P8|STARTED|Overall Study||0
176957|NCT00591006|411655|P7|STARTED|Overall Study||1
176958|NCT00591006|411656|P6|STARTED|Overall Study||0
176959|NCT00591006|411657|P5|STARTED|Overall Study||1
176960|NCT00591006|411658|P4|STARTED|Overall Study||1
176961|NCT00591006|411659|P3|STARTED|Overall Study||1
176962|NCT00591006|411660|P2|STARTED|Overall Study||0
176963|NCT00591006|411661|P1|STARTED|Overall Study||1
176964|NCT00590967|411681|P2|NOT COMPLETED|Overall Study||5
176965|NCT00590967|411682|P1|NOT COMPLETED|Overall Study||3
176966|NCT00590967|411681|P2|COMPLETED|Overall Study||20
176967|NCT00590967|411682|P1|COMPLETED|Overall Study||41
176968|NCT00590967|411681|P2|STARTED|Overall Study||25
176969|NCT00590967|411682|P1|STARTED|Overall Study||44
176970|NCT00590902|411694|P1|NOT COMPLETED|Overall Study||1
176971|NCT00590902|411694|P1|COMPLETED|Overall Study||80
176972|NCT00590902|411694|P1|STARTED|Overall Study||81
176973|NCT00590889|411700|P2|NOT COMPLETED|Overall Study||299
176974|NCT00590889|411701|P1|NOT COMPLETED|Overall Study||286
176975|NCT00590889|411700|P2|COMPLETED|Overall Study||104
176976|NCT00590889|411701|P1|COMPLETED|Overall Study||118
176977|NCT00590889|411700|P2|STARTED|Overall Study||403
176978|NCT00590889|411701|P1|STARTED|Overall Study||404
176979|NCT00590863|411710|P3|NOT COMPLETED|Overall Study||78
176980|NCT00590863|411711|P2|NOT COMPLETED|Overall Study||82
176981|NCT00590863|411712|P1|NOT COMPLETED|Overall Study||84
176982|NCT00590863|411710|P3|COMPLETED|Overall Study||146
176983|NCT00590863|411711|P2|COMPLETED|Overall Study||138
176984|NCT00590863|411712|P1|COMPLETED|Overall Study||137
176985|NCT00590863|411710|P3|STARTED|Overall Study||224
176986|NCT00590863|411711|P2|STARTED|Overall Study||220
176987|NCT00590863|411712|P1|STARTED|Overall Study||221
176988|NCT00590772|411723|P1|NOT COMPLETED|Overall Study||0
176989|NCT00590772|411723|P1|COMPLETED|Overall Study||31
176990|NCT00590772|411723|P1|STARTED|Overall Study||31
176991|NCT00590759|411729|P1|NOT COMPLETED|Overall Study||80
176992|NCT00590759|411729|P1|COMPLETED|Overall Study||70
176993|NCT00590759|411729|P1|STARTED|Overall Study||150
176994|NCT00590720|411736|P2|NOT COMPLETED|Overall Study||1
176995|NCT00590720|411737|P1|NOT COMPLETED|Overall Study||1
176996|NCT00590720|411736|P2|COMPLETED|Overall Study||6
176997|NCT00590720|411737|P1|COMPLETED|Overall Study||3
176998|NCT00590720|411736|P2|STARTED|Overall Study||7
176999|NCT00590720|411737|P1|STARTED|Overall Study||4
177000|NCT00590590|411782|P3|NOT COMPLETED|Overall Study||6
177001|NCT00590590|411783|P2|NOT COMPLETED|Overall Study||6
177002|NCT00590590|411784|P1|NOT COMPLETED|Overall Study||7
177003|NCT00590590|411782|P3|COMPLETED|Overall Study||21
177004|NCT00590590|411783|P2|COMPLETED|Overall Study||33
177005|NCT00590590|411784|P1|COMPLETED|Overall Study||32
177006|NCT00590590|411782|P3|STARTED|Overall Study||27
177007|NCT00590590|411783|P2|STARTED|Overall Study||39
177008|NCT00590590|411784|P1|STARTED|Overall Study||39
177009|NCT00590577|411811|P4|NOT COMPLETED|Overall Study||93
177010|NCT00590577|411812|P3|NOT COMPLETED|Overall Study||73
177011|NCT00590577|411813|P2|NOT COMPLETED|Overall Study||76
177012|NCT00590577|411814|P1|NOT COMPLETED|Overall Study||77
177013|NCT00590577|411811|P4|COMPLETED|Overall Study||71
177014|NCT00590577|411812|P3|COMPLETED|Overall Study||90
177015|NCT00590577|411813|P2|COMPLETED|Overall Study||89
177016|NCT00590577|411814|P1|COMPLETED|Overall Study||83
177017|NCT00590577|411811|P4|STARTED|Overall Study||164
177018|NCT00590577|411812|P3|STARTED|Overall Study||163
177019|NCT00590577|411813|P2|STARTED|Overall Study||165
177020|NCT00590577|411814|P1|STARTED|Overall Study||160
177021|NCT00590564|411832|P1|NOT COMPLETED|Overall Study||18
177022|NCT00590564|411832|P1|COMPLETED|Overall Study||24
177023|NCT00590564|411832|P1|STARTED|Overall Study||42
177024|NCT00590538|411836|P1|NOT COMPLETED|Overall Study||2
177025|NCT00590538|411836|P1|COMPLETED|Overall Study||7
177026|NCT00590538|411836|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
177027|NCT00590460|411844|P1|NOT COMPLETED|Overall Study||0
177028|NCT00590460|411844|P1|COMPLETED|Overall Study||5
177029|NCT00590460|411844|P1|STARTED|Overall Study||5
177030|NCT00590369|411858|P2|NOT COMPLETED|Overall Study||0
177031|NCT00590369|411859|P1|NOT COMPLETED|Overall Study||0
177032|NCT00590369|411858|P2|COMPLETED|Overall Study||5
177033|NCT00590369|411859|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
177034|NCT00590369|411858|P2|STARTED|Overall Study||5
177035|NCT00590369|411859|P1|STARTED|Overall Study||6
177036|NCT00590317|411877|P2|NOT COMPLETED|Overall Study||5
177037|NCT00590317|411878|P1|NOT COMPLETED|Overall Study||1
177038|NCT00590317|411877|P2|COMPLETED|Overall Study||27
177039|NCT00590317|411878|P1|COMPLETED|Overall Study||31
177040|NCT00590317|411877|P2|STARTED|Overall Study||32
177041|NCT00590317|411878|P1|STARTED|Overall Study||32
177042|NCT00590226|411890|P2|NOT COMPLETED|Overall Study||0
177043|NCT00590226|411891|P1|NOT COMPLETED|Overall Study||0
177044|NCT00590226|411890|P2|COMPLETED|Overall Study||63
177045|NCT00590226|411891|P1|COMPLETED|Overall Study||67
177046|NCT00590226|411890|P2|STARTED|Overall Study||63
177047|NCT00590226|411891|P1|STARTED|Overall Study||67
177048|NCT00590161|411901|P2|NOT COMPLETED|Overall Study||3
177049|NCT00590161|411902|P1|NOT COMPLETED|Overall Study||3
177050|NCT00590161|411901|P2|COMPLETED|Overall Study||26
177051|NCT00590161|411902|P1|COMPLETED|Overall Study||23
177052|NCT00590161|411901|P2|STARTED|Overall Study||29
177053|NCT00590161|411902|P1|STARTED|Overall Study||26
177054|NCT00590044|411910|P2|NOT COMPLETED|Overall Study||2
177055|NCT00590044|411911|P1|NOT COMPLETED|Overall Study||4
177056|NCT00590044|411910|P2|COMPLETED|Overall Study||34
177057|NCT00590044|411911|P1|COMPLETED|Overall Study||34
177058|NCT00590044|411910|P2|STARTED|Overall Study||36
177059|NCT00590044|411911|P1|STARTED|Overall Study||38
177060|NCT00590031|411917|P1|NOT COMPLETED|Overall Study||6
177061|NCT00590031|411917|P1|COMPLETED|Overall Study||55
177062|NCT00590031|411917|P1|STARTED|Overall Study||61
177063|NCT00590018|411924|P2|NOT COMPLETED|Overall Study||0
177064|NCT00590018|411925|P1|NOT COMPLETED|Overall Study||0
177065|NCT00590018|411924|P2|COMPLETED|Overall Study||9
177066|NCT00590018|411925|P1|COMPLETED|Overall Study||9
177067|NCT00590018|411924|P2|STARTED|Overall Study||9
177068|NCT00590018|411925|P1|STARTED|Overall Study||9
177069|NCT00590005|411933|P2|NOT COMPLETED|Overall Study||0
177070|NCT00590005|411934|P1|NOT COMPLETED|Overall Study||0
177071|NCT00590005|411933|P2|COMPLETED|Overall Study||119
177072|NCT00590005|411934|P1|COMPLETED|Overall Study||106
177073|NCT00590005|411933|P2|STARTED|Overall Study||119
177074|NCT00590005|411934|P1|STARTED|Overall Study||106
177075|NCT00589979|411944|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
177076|NCT00589979|411945|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
177077|NCT00589979|411946|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
177078|NCT00589979|411944|P3|COMPLETED|Double-Blind Treatment Period 3||38
177079|NCT00589979|411945|P2|COMPLETED|Double-Blind Treatment Period 3||46
177080|NCT00589979|411946|P1|COMPLETED|Double-Blind Treatment Period 3||0
177081|NCT00589979|411944|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
177082|NCT00589979|411945|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
177083|NCT00589979|411946|P1|STARTED|Double-Blind Treatment Period 3||0
177084|NCT00589979|411944|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
177085|NCT00589979|411945|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
177086|NCT00589979|411946|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
177087|NCT00589979|411944|P3|COMPLETED|Double-Blind Treatment Period 2||39
177088|NCT00589979|411945|P2|COMPLETED|Double-Blind Treatment Period 2||47
177089|NCT00589979|411946|P1|COMPLETED|Double-Blind Treatment Period 2||0
177090|NCT00589979|411944|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
177091|NCT00589979|411945|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
177092|NCT00589979|411946|P1|STARTED|Double-Blind Treatment Period 2||0
177093|NCT00589979|411944|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
177094|NCT00589979|411945|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
177095|NCT00589979|411946|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
177096|NCT00589979|411944|P3|COMPLETED|Double-Blind Treatment Period 1||41
177097|NCT00589979|411945|P2|COMPLETED|Double-Blind Treatment Period 1||48
177098|NCT00589979|411946|P1|COMPLETED|Double-Blind Treatment Period 1||0
177099|NCT00589979|411944|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
177100|NCT00589979|411945|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
177101|NCT00589979|411946|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
177102|NCT00589979|411944|P3|NOT COMPLETED|Run-In Period||0
177103|NCT00589979|411945|P2|NOT COMPLETED|Run-In Period||0
177104|NCT00589979|411946|P1|NOT COMPLETED|Run-In Period||76
177105|NCT00589979|411944|P3|COMPLETED|Run-In Period||0
177106|NCT00589979|411945|P2|COMPLETED|Run-In Period||0
177107|NCT00589979|411946|P1|COMPLETED|Run-In Period||93
177108|NCT00589979|411944|P3|STARTED|Run-In Period||0
177109|NCT00589979|411945|P2|STARTED|Run-In Period||0
177110|NCT00589979|411946|P1|STARTED|Run-In Period||169
177111|NCT00589914|411985|P2|NOT COMPLETED|Overall Study||137
177112|NCT00589914|411986|P1|NOT COMPLETED|Overall Study||150
177113|NCT00589914|411985|P2|COMPLETED|Overall Study||471
177114|NCT00589914|411986|P1|COMPLETED|Overall Study||456
177115|NCT00589914|411985|P2|STARTED|Overall Study||608
177116|NCT00589914|411986|P1|STARTED|Overall Study||606
177117|NCT00589888|411996|P5|NOT COMPLETED|64-gram Oral Fat Load||0
177118|NCT00589888|411997|P4|NOT COMPLETED|64-gram Oral Fat Load||0
177119|NCT00589888|411998|P3|NOT COMPLETED|64-gram Oral Fat Load||0
177120|NCT00589888|411999|P2|NOT COMPLETED|64-gram Oral Fat Load||0
177121|NCT00589888|412000|P1|NOT COMPLETED|64-gram Oral Fat Load||0
177122|NCT00589888|411996|P5|COMPLETED|64-gram Oral Fat Load||13
177123|NCT00589888|411997|P4|COMPLETED|64-gram Oral Fat Load||0
177124|NCT00589888|411998|P3|COMPLETED|64-gram Oral Fat Load||0
177125|NCT00589888|411999|P2|COMPLETED|64-gram Oral Fat Load||0
177126|NCT00589888|412000|P1|COMPLETED|64-gram Oral Fat Load||0
177127|NCT00589888|411996|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
177128|NCT00589888|411997|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
177129|NCT00589888|411998|P3|STARTED|64-gram Oral Fat Load||0
177130|NCT00589888|411999|P2|STARTED|64-gram Oral Fat Load||0
177131|NCT00589888|412000|P1|STARTED|64-gram Oral Fat Load||0
177132|NCT00589888|411996|P5|NOT COMPLETED|32-gram Oral Fat Load||0
177133|NCT00589888|411997|P4|NOT COMPLETED|32-gram Oral Fat Load||0
177134|NCT00589888|411998|P3|NOT COMPLETED|32-gram Oral Fat Load||0
177135|NCT00589888|411999|P2|NOT COMPLETED|32-gram Oral Fat Load||0
177136|NCT00589888|412000|P1|NOT COMPLETED|32-gram Oral Fat Load||0
177137|NCT00589888|411996|P5|COMPLETED|32-gram Oral Fat Load||0
177138|NCT00589888|411997|P4|COMPLETED|32-gram Oral Fat Load||13
177139|NCT00589888|411998|P3|COMPLETED|32-gram Oral Fat Load||0
177140|NCT00589888|411999|P2|COMPLETED|32-gram Oral Fat Load||0
177141|NCT00589888|412000|P1|COMPLETED|32-gram Oral Fat Load||0
177142|NCT00589888|411996|P5|STARTED|32-gram Oral Fat Load||0
177143|NCT00589888|411997|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
177144|NCT00589888|411998|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
177145|NCT00589888|411999|P2|STARTED|32-gram Oral Fat Load||0
177146|NCT00589888|412000|P1|STARTED|32-gram Oral Fat Load||0
177147|NCT00589888|411996|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
177148|NCT00589888|411997|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
177149|NCT00589888|411998|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
177150|NCT00589888|411999|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
177151|NCT00589888|412000|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
177152|NCT00589888|411996|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
177153|NCT00589888|411997|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
177154|NCT00589888|411998|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
177155|NCT00589888|411999|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
177156|NCT00589888|412000|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
177157|NCT00589888|411996|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
177158|NCT00589888|411997|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
177159|NCT00589888|411998|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
177160|NCT00589888|411999|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
177161|NCT00589888|412000|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
177162|NCT00589888|411996|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
177163|NCT00589888|411997|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
177164|NCT00589888|411998|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
177165|NCT00589888|411999|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
177166|NCT00589888|412000|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
177167|NCT00589888|411996|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
177168|NCT00589888|411997|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
177169|NCT00589888|411998|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
177170|NCT00589888|411999|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
177171|NCT00589888|412000|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
177172|NCT00589888|411996|P5|STARTED|Intralipid 20% @ 20cc/hr||0
177173|NCT00589888|411997|P4|STARTED|Intralipid 20% @ 20cc/hr||0
177174|NCT00589888|411998|P3|STARTED|Intralipid 20% @ 20cc/hr||0
177175|NCT00589888|411999|P2|STARTED|Intralipid 20% @ 20cc/hr||13
177176|NCT00589888|412000|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
177177|NCT00589888|411996|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
177178|NCT00589888|411997|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
177179|NCT00589888|411998|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
177180|NCT00589888|411999|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
177181|NCT00589888|412000|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
177182|NCT00589888|411996|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
177183|NCT00589888|411997|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
177184|NCT00589888|411998|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
177185|NCT00589888|411999|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
177186|NCT00589888|412000|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
177187|NCT00589888|411996|P5|STARTED|Normal Saline @ 40cc/Hour||0
177188|NCT00589888|411997|P4|STARTED|Normal Saline @ 40cc/Hour||0
177189|NCT00589888|411998|P3|STARTED|Normal Saline @ 40cc/Hour||0
177190|NCT00589888|411999|P2|STARTED|Normal Saline @ 40cc/Hour||0
177191|NCT00589888|412000|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
177192|NCT00589849|412012|P1|NOT COMPLETED|Overall Study||0
177193|NCT00589849|412012|P1|COMPLETED|Overall Study||32
177194|NCT00589849|412012|P1|STARTED|Overall Study||32
177195|NCT00589784|412018|P2|NOT COMPLETED|Overall Study||10
177196|NCT00589784|412019|P1|NOT COMPLETED|Overall Study||1
177197|NCT00589784|412018|P2|COMPLETED|Overall Study||4
177198|NCT00589784|412019|P1|COMPLETED|Overall Study||35
177199|NCT00589784|412018|P2|STARTED|Overall Study||14
177200|NCT00589784|412019|P1|STARTED|Overall Study||36
177201|NCT00589693|412026|P2|NOT COMPLETED|Overall Study||29
177202|NCT00589693|412027|P1|NOT COMPLETED|Overall Study||44
177203|NCT00589693|412026|P2|COMPLETED|Overall Study||83
177204|NCT00589693|412027|P1|COMPLETED|Overall Study||71
177205|NCT00589693|412026|P2|STARTED|Overall Study||112
177206|NCT00589693|412027|P1|STARTED|Overall Study||115
177207|NCT00589667|412041|P1|NOT COMPLETED|Overall Study||3
177208|NCT00589667|412041|P1|COMPLETED|Overall Study||23
177209|NCT00589667|412041|P1|STARTED|Overall Study||26
177210|NCT00589628|412048|P2|NOT COMPLETED|Overall Study||1
177211|NCT00589628|412049|P1|NOT COMPLETED|Overall Study||0
177212|NCT00589628|412048|P2|COMPLETED|Overall Study||5
177213|NCT00589628|412049|P1|COMPLETED|Overall Study||7
177214|NCT00589628|412048|P2|STARTED|Overall Study||6
177215|NCT00589628|412049|P1|STARTED|Overall Study||7
177216|NCT00589563|412055|P1|NOT COMPLETED|Overall Study||0
177217|NCT00589563|412055|P1|COMPLETED|Overall Study||32
177218|NCT00589563|412055|P1|STARTED|Overall Study||32
177219|NCT00589550|412072|P1|NOT COMPLETED|Overall Study||1
177220|NCT00589550|412072|P1|COMPLETED|Overall Study||0
177221|NCT00589550|412072|P1|Withdrew From Study|Overall Study||1
177222|NCT00589550|412072|P1|STARTED|Overall Study||1
177223|NCT00589303|412084|P2|NOT COMPLETED|Overall Study||1
177224|NCT00589303|412085|P1|NOT COMPLETED|Overall Study||2
177225|NCT00589303|412084|P2|COMPLETED|Overall Study||12
177226|NCT00589303|412085|P1|COMPLETED|Overall Study||12
177227|NCT00589303|412084|P2|STARTED|Overall Study||13
177228|NCT00589303|412085|P1|STARTED|Overall Study||14
177229|NCT00589290|412091|P1|NOT COMPLETED|Overall Study||1
177230|NCT00589290|412091|P1|COMPLETED|Overall Study||40
177231|NCT00589290|412091|P1|STARTED|Overall Study||41
177232|NCT00589277|412101|P2|NOT COMPLETED|Overall Study||286
177233|NCT00589277|412102|P1|NOT COMPLETED|Overall Study||460
177234|NCT00589277|412101|P2|COMPLETED|Overall Study||524
177235|NCT00589277|412102|P1|COMPLETED|Overall Study||762
177236|NCT00589277|412101|P2|Completed 3 Month Follow Up|Overall Study||524
177237|NCT00589277|412102|P1|Completed 3 Month Follow Up|Overall Study||762
177238|NCT00589277|412101|P2|Completed 2 Week Follow Up|Overall Study||424
177239|NCT00589277|412102|P1|Completed 2 Week Follow Up|Overall Study||603
177240|NCT00589277|412101|P2|STARTED|Overall Study||810
177241|NCT00589277|412102|P1|STARTED|Overall Study||1222
177242|NCT00589108|412115|P3|NOT COMPLETED|Overall Study||5
177243|NCT00589108|412116|P2|NOT COMPLETED|Overall Study||4
177244|NCT00589108|412117|P1|NOT COMPLETED|Overall Study||4
177245|NCT00589108|412115|P3|COMPLETED|Overall Study||75
177246|NCT00589108|412116|P2|COMPLETED|Overall Study||76
177247|NCT00589108|412117|P1|COMPLETED|Overall Study||76
177248|NCT00589108|412115|P3|STARTED|Overall Study||80
177249|NCT00589108|412116|P2|STARTED|Overall Study||80
177250|NCT00589108|412117|P1|STARTED|Overall Study||80
177251|NCT00588965|412137|P1|NOT COMPLETED|Overall Study||0
177252|NCT00588965|412137|P1|COMPLETED|Overall Study||35
177253|NCT00588965|412137|P1|STARTED|Overall Study||35
177254|NCT00588861|412147|P2|NOT COMPLETED|10 Years||114
177255|NCT00588861|412148|P1|NOT COMPLETED|10 Years||107
177256|NCT00588861|412147|P2|COMPLETED|10 Years||0
177257|NCT00588861|412148|P1|COMPLETED|10 Years||0
177258|NCT00588861|412147|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
177259|NCT00588861|412148|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
177260|NCT00588861|412147|P2|NOT COMPLETED|8 Years||114
177261|NCT00588861|412148|P1|NOT COMPLETED|8 Years||105
177262|NCT00588861|412147|P2|COMPLETED|8 Years||0
177263|NCT00588861|412148|P1|COMPLETED|8 Years||2
177264|NCT00588861|412147|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
177265|NCT00588861|412148|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
177266|NCT00588861|412147|P2|NOT COMPLETED|6 Years||109
177267|NCT00588861|412148|P1|NOT COMPLETED|6 Years||104
177268|NCT00588861|412147|P2|COMPLETED|6 Years||5
177269|NCT00588861|412148|P1|COMPLETED|6 Years||3
177270|NCT00588861|412147|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
177271|NCT00588861|412148|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
177272|NCT00588861|412147|P2|NOT COMPLETED|4 Years||103
177273|NCT00588861|412148|P1|NOT COMPLETED|4 Years||91
177274|NCT00588861|412147|P2|COMPLETED|4 Years||11
177275|NCT00588861|412148|P1|COMPLETED|4 Years||16
177276|NCT00588861|412147|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
177277|NCT00588861|412148|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
177278|NCT00588861|412147|P2|NOT COMPLETED|2 Years||87
177279|NCT00588861|412148|P1|NOT COMPLETED|2 Years||92
177280|NCT00588861|412147|P2|COMPLETED|2 Years||27
177281|NCT00588861|412148|P1|COMPLETED|2 Years||15
177282|NCT00588861|412147|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
177283|NCT00588861|412148|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
177284|NCT00588861|412147|P2|NOT COMPLETED|1 Year||82
177285|NCT00588861|412148|P1|NOT COMPLETED|1 Year||89
177286|NCT00588861|412147|P2|COMPLETED|1 Year||32
177287|NCT00588861|412148|P1|COMPLETED|1 Year||18
177288|NCT00588861|412147|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
177289|NCT00588861|412148|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
177290|NCT00588861|412147|P2|NOT COMPLETED|6 Months||73
177291|NCT00588861|412148|P1|NOT COMPLETED|6 Months||98
177292|NCT00588861|412147|P2|COMPLETED|6 Months||41
177293|NCT00588861|412148|P1|COMPLETED|6 Months||9
177294|NCT00588861|412147|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
177295|NCT00588861|412148|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
177296|NCT00588861|412147|P2|NOT COMPLETED|Pre-Operative||86
177297|NCT00588861|412148|P1|NOT COMPLETED|Pre-Operative||95
177298|NCT00588861|412147|P2|COMPLETED|Pre-Operative||114
177299|NCT00588861|412148|P1|COMPLETED|Pre-Operative||107
177300|NCT00588861|412147|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
177301|NCT00588861|412148|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
177302|NCT00588848|412158|P2|NOT COMPLETED|Overall Study||0
177303|NCT00588848|412159|P1|NOT COMPLETED|Overall Study||0
177304|NCT00588848|412158|P2|COMPLETED|Overall Study||8
177305|NCT00588848|412159|P1|COMPLETED|Overall Study||3
177306|NCT00588848|412158|P2|STARTED|Overall Study||8
177307|NCT00588848|412159|P1|STARTED|Overall Study||3
177308|NCT00588822|412167|P1|NOT COMPLETED|Overall Study||8
177309|NCT00588822|412167|P1|COMPLETED|Overall Study||13
177310|NCT00588822|412167|P1|STARTED|Overall Study||21
177311|NCT00588809|412176|P1|NOT COMPLETED|Overall Study||0
177312|NCT00588809|412176|P1|COMPLETED|Overall Study||47
177313|NCT00588809|412176|P1|STARTED|Overall Study||47
177314|NCT00588692|412187|P2|NOT COMPLETED|Overall Study||3
177315|NCT00588692|412188|P1|NOT COMPLETED|Overall Study||7
177316|NCT00588692|412187|P2|COMPLETED|Overall Study||27
177317|NCT00588692|412188|P1|COMPLETED|Overall Study||23
177318|NCT00588692|412187|P2|STARTED|Overall Study||30
177319|NCT00588692|412188|P1|STARTED|Overall Study||30
177320|NCT00588666|412224|P1|NOT COMPLETED|Overall Study||4
177321|NCT00588666|412224|P1|COMPLETED|Overall Study||47
177322|NCT00588666|412224|P1|STARTED|Overall Study||51
177323|NCT00588640|412229|P1|NOT COMPLETED|Overall Study||2
177324|NCT00588640|412229|P1|COMPLETED|Overall Study||8
177325|NCT00588640|412229|P1|STARTED|Overall Study||10
177326|NCT00588536|412233|P1|NOT COMPLETED|Overall Study||0
177327|NCT00588536|412233|P1|COMPLETED|Overall Study||5
177328|NCT00588536|412233|P1|STARTED|Overall Study||5
177329|NCT00588471|412239|P2|NOT COMPLETED|Overall Study||0
177330|NCT00588471|412240|P1|NOT COMPLETED|Overall Study||0
177331|NCT00588471|412239|P2|COMPLETED|Overall Study||29
177332|NCT00588471|412240|P1|COMPLETED|Overall Study||28
177333|NCT00588471|412239|P2|STARTED|Overall Study||29
177334|NCT00588471|412240|P1|STARTED|Overall Study||28
177335|NCT00588445|412248|P1|NOT COMPLETED|Overall Study||15
177336|NCT00588445|412248|P1|COMPLETED|Overall Study||50
177337|NCT00588445|412248|P1|STARTED|Overall Study||65
177338|NCT00588406|412256|P2|NOT COMPLETED|Overall Study||0
177339|NCT00588406|412257|P1|NOT COMPLETED|Overall Study||0
177340|NCT00588406|412256|P2|COMPLETED|Overall Study||49
177341|NCT00588406|412257|P1|COMPLETED|Overall Study||46
177342|NCT00588406|412256|P2|STARTED|Overall Study||49
177343|NCT00588406|412257|P1|STARTED|Overall Study||46
177344|NCT00588380|412265|P1|NOT COMPLETED|Overall Study||0
177345|NCT00588380|412265|P1|COMPLETED|Overall Study||88
177346|NCT00588380|412265|P1|STARTED|Overall Study||88
177347|NCT00588354|412272|P2|NOT COMPLETED|Baseline to 4 Weeks||1
177348|NCT00588354|412273|P1|NOT COMPLETED|Baseline to 4 Weeks||0
177349|NCT00588354|412272|P2|COMPLETED|Baseline to 4 Weeks||14
177350|NCT00588354|412273|P1|COMPLETED|Baseline to 4 Weeks||9
177351|NCT00588354|412272|P2|STARTED|Baseline to 4 Weeks||15
177352|NCT00588354|412273|P1|STARTED|Baseline to 4 Weeks||9
177353|NCT00588354|412272|P2|NOT COMPLETED|Baseline to 2 Weeks||0
177354|NCT00588354|412273|P1|NOT COMPLETED|Baseline to 2 Weeks||2
177355|NCT00588354|412272|P2|COMPLETED|Baseline to 2 Weeks||15
177356|NCT00588354|412273|P1|COMPLETED|Baseline to 2 Weeks||9
177357|NCT00588354|412272|P2|STARTED|Baseline to 2 Weeks||15
177358|NCT00588354|412273|P1|STARTED|Baseline to 2 Weeks||11
177359|NCT00588341|412293|P1|NOT COMPLETED|Overall Study||5
177360|NCT00588341|412293|P1|COMPLETED|Overall Study||19
177361|NCT00588341|412293|P1|STARTED|Overall Study||24
177362|NCT00588237|412297|P1|NOT COMPLETED|Overall Study||4
177363|NCT00588237|412297|P1|COMPLETED|Overall Study||38
177364|NCT00588237|412297|P1|STARTED|Overall Study||42
177365|NCT00588159|412303|P2|NOT COMPLETED|Overall Study||11
177366|NCT00588159|412304|P1|NOT COMPLETED|Overall Study||15
177367|NCT00588159|412303|P2|COMPLETED|Overall Study||63
177368|NCT00588159|412304|P1|COMPLETED|Overall Study||57
177369|NCT00588159|412303|P2|STARTED|Overall Study||74
177370|NCT00588159|412304|P1|STARTED|Overall Study||72
177371|NCT00588146|412320|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
177372|NCT00588146|412321|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
177373|NCT00588146|412320|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
177374|NCT00588146|412321|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
177375|NCT00588146|412320|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
177376|NCT00588146|412321|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
177377|NCT00588146|412320|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
177378|NCT00588146|412321|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
177379|NCT00588146|412320|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
177380|NCT00588146|412321|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
177381|NCT00588146|412320|P2|STARTED|First Intervention (Baseline to 6 mo)||5
177382|NCT00588146|412321|P1|STARTED|First Intervention (Baseline to 6 mo)||5
177383|NCT00588094|412327|P1|NOT COMPLETED|Overall Study||5
177384|NCT00588094|412327|P1|COMPLETED|Overall Study||15
177385|NCT00588094|412327|P1|STARTED|Overall Study||20
177386|NCT00587990|412334|P3|NOT COMPLETED|Overall Study||0
177387|NCT00587990|412335|P2|NOT COMPLETED|Overall Study||0
177388|NCT00587990|412336|P1|NOT COMPLETED|Overall Study||0
177389|NCT00587990|412334|P3|COMPLETED|Overall Study||3
177390|NCT00587990|412335|P2|COMPLETED|Overall Study||4
177391|NCT00587990|412336|P1|COMPLETED|Overall Study||2
177392|NCT00587990|412334|P3|STARTED|Overall Study||3
177393|NCT00587990|412335|P2|STARTED|Overall Study||4
177394|NCT00587990|412336|P1|STARTED|Overall Study||2
177395|NCT00587964|412344|P1|NOT COMPLETED|Overall Study||12
177396|NCT00587964|412344|P1|COMPLETED|Overall Study||39
177397|NCT00587964|412344|P1|STARTED|Overall Study||51
177398|NCT00587860|412350|P2|NOT COMPLETED|Overall Study||5
177399|NCT00587860|412351|P1|NOT COMPLETED|Overall Study||5
177400|NCT00587860|412350|P2|COMPLETED|Overall Study||30
177401|NCT00587860|412351|P1|COMPLETED|Overall Study||30
177402|NCT00587860|412350|P2|STARTED|Overall Study||35
177403|NCT00587860|412351|P1|STARTED|Overall Study||35
177404|NCT00587847|412371|P1|NOT COMPLETED|Overall Study||7
177405|NCT00587847|412371|P1|COMPLETED|Overall Study||5
177406|NCT00587847|412371|P1|STARTED|Overall Study||12
177407|NCT00587834|412376|P1|NOT COMPLETED|Overall Study||0
177408|NCT00587834|412376|P1|COMPLETED|Overall Study||96
177409|NCT00587834|412376|P1|STARTED|Overall Study||96
177410|NCT00587769|412392|P1|NOT COMPLETED|Overall Study||0
177411|NCT00587769|412392|P1|COMPLETED|Overall Study||38
177412|NCT00587769|412392|P1|STARTED|Overall Study||38
177413|NCT00587678|412400|P3|NOT COMPLETED|Overall Study||8
177414|NCT00587678|412401|P2|NOT COMPLETED|Overall Study||4
177415|NCT00587678|412402|P1|NOT COMPLETED|Overall Study||6
177416|NCT00587678|412400|P3|COMPLETED|Overall Study||33
177417|NCT00587678|412401|P2|COMPLETED|Overall Study||18
177418|NCT00587678|412402|P1|COMPLETED|Overall Study||16
177419|NCT00587678|412400|P3|STARTED|Overall Study||41
177420|NCT00587678|412401|P2|STARTED|Overall Study||22
177421|NCT00587678|412402|P1|STARTED|Overall Study||22
177422|NCT00587639|412440|P1|NOT COMPLETED|Overall Study||1
177423|NCT00587639|412440|P1|COMPLETED|Overall Study||7
177424|NCT00587639|412440|P1|STARTED|Overall Study||8
177425|NCT00586729|412447|P2|NOT COMPLETED|Overall Study||1
177426|NCT00586729|412448|P1|NOT COMPLETED|Overall Study||3
177427|NCT00586729|412447|P2|COMPLETED|Overall Study||8
177428|NCT00586729|412448|P1|COMPLETED|Overall Study||11
177429|NCT00586729|412447|P2|STARTED|Overall Study||9
177430|NCT00586729|412448|P1|STARTED|Overall Study||14
177431|NCT00586716|412460|P2|NOT COMPLETED|Overall Study||0
177432|NCT00586716|412461|P1|NOT COMPLETED|Overall Study||0
177433|NCT00586716|412460|P2|COMPLETED|Overall Study||8
177434|NCT00586716|412461|P1|COMPLETED|Overall Study||14
177435|NCT00586716|412460|P2|STARTED|Overall Study||8
177436|NCT00586716|412461|P1|STARTED|Overall Study||14
177437|NCT00587587|412470|P2|NOT COMPLETED|Overall Study||1
177438|NCT00587587|412471|P1|NOT COMPLETED|Overall Study||6
177439|NCT00587587|412470|P2|COMPLETED|Overall Study||12
177440|NCT00587587|412471|P1|COMPLETED|Overall Study||11
177441|NCT00587587|412470|P2|STARTED|Overall Study||13
177442|NCT00587587|412471|P1|STARTED|Overall Study||17
177443|NCT00587483|412494|P3|NOT COMPLETED|Overall Study||0
177444|NCT00587483|412495|P2|NOT COMPLETED|Overall Study||0
177445|NCT00587483|412496|P1|NOT COMPLETED|Overall Study||0
177446|NCT00587483|412494|P3|COMPLETED|Overall Study||112
177447|NCT00587483|412495|P2|COMPLETED|Overall Study||115
177448|NCT00587483|412496|P1|COMPLETED|Overall Study||115
177449|NCT00587483|412494|P3|STARTED|Overall Study||112
177450|NCT00587483|412495|P2|STARTED|Overall Study||115
177451|NCT00587483|412496|P1|STARTED|Overall Study||115
177452|NCT00587431|412524|P2|NOT COMPLETED|Overall Study||1
177453|NCT00587431|412525|P1|NOT COMPLETED|Overall Study||1
177454|NCT00587431|412524|P2|COMPLETED|Overall Study||38
177455|NCT00587431|412525|P1|COMPLETED|Overall Study||62
177456|NCT00587431|412524|P2|STARTED|Overall Study||39
177457|NCT00587431|412525|P1|STARTED|Overall Study||63
177458|NCT00587288|412536|P2|NOT COMPLETED|Overall Study||9
177459|NCT00587288|412537|P1|NOT COMPLETED|Overall Study||3
177460|NCT00587288|412536|P2|COMPLETED|Overall Study||44
177461|NCT00587288|412537|P1|COMPLETED|Overall Study||50
177462|NCT00587288|412536|P2|STARTED|Overall Study||53
177463|NCT00587288|412537|P1|STARTED|Overall Study||53
177464|NCT00587223|412555|P1|NOT COMPLETED|Overall Study||1
177465|NCT00587223|412555|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
177466|NCT00587223|412555|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
177467|NCT00587171|412572|P2|NOT COMPLETED|Overall Study||1
177468|NCT00587171|412573|P1|NOT COMPLETED|Overall Study||1
177469|NCT00587171|412572|P2|COMPLETED|Overall Study||9
177470|NCT00587171|412573|P1|COMPLETED|Overall Study||8
177471|NCT00587171|412572|P2|STARTED|Overall Study||10
177472|NCT00587171|412573|P1|STARTED|Overall Study||9
177473|NCT00587158|412603|P2|NOT COMPLETED|Overall Study||8
177474|NCT00587158|412604|P1|NOT COMPLETED|Overall Study||5
177475|NCT00587158|412603|P2|COMPLETED|Overall Study||43
177476|NCT00587158|412604|P1|COMPLETED|Overall Study||44
177477|NCT00587158|412603|P2|Continued in Study|Overall Study||46
177478|NCT00587158|412604|P1|Continued in Study|Overall Study||45
177479|NCT00587158|412603|P2|STARTED|Overall Study||51
177480|NCT00587158|412604|P1|STARTED|Overall Study||49
177481|NCT00587132|412638|P4|NOT COMPLETED|Overall Study||0
177482|NCT00587132|412639|P3|NOT COMPLETED|Overall Study||0
177483|NCT00587132|412640|P2|NOT COMPLETED|Overall Study||0
177484|NCT00587132|412641|P1|NOT COMPLETED|Overall Study||0
177485|NCT00587132|412638|P4|COMPLETED|Overall Study||0
177486|NCT00587132|412639|P3|COMPLETED|Overall Study||0
177487|NCT00587132|412640|P2|COMPLETED|Overall Study||0
177488|NCT00587132|412641|P1|COMPLETED|Overall Study||4
177489|NCT00587132|412638|P4|STARTED|Overall Study||0
177490|NCT00587132|412639|P3|STARTED|Overall Study||0
177491|NCT00587132|412640|P2|STARTED|Overall Study||0
177492|NCT00587132|412641|P1|STARTED|Overall Study||4
177493|NCT00587041|412654|P3|NOT COMPLETED|Overall Study||0
177494|NCT00587041|412655|P2|NOT COMPLETED|Overall Study||0
177495|NCT00587041|412656|P1|NOT COMPLETED|Overall Study||0
177496|NCT00587041|412654|P3|COMPLETED|Overall Study||14
177497|NCT00587041|412655|P2|COMPLETED|Overall Study||14
177498|NCT00587041|412656|P1|COMPLETED|Overall Study||12
177499|NCT00587041|412654|P3|STARTED|Overall Study||14
177500|NCT00587041|412655|P2|STARTED|Overall Study||14
177501|NCT00587041|412656|P1|STARTED|Overall Study||12
177502|NCT00586898|412667|P1|NOT COMPLETED|Overall Study||7
177503|NCT00586898|412667|P1|COMPLETED|Overall Study||29
177504|NCT00586898|412667|P1|STARTED|Overall Study||36
177505|NCT00586846|412671|P1|NOT COMPLETED|Overall Study||6
177506|NCT00586846|412671|P1|COMPLETED|Overall Study||34
177507|NCT00586846|412671|P1|STARTED|Overall Study||40
177508|NCT00586820|412677|P2|NOT COMPLETED|Overall Study||0
177509|NCT00586820|412678|P1|NOT COMPLETED|Overall Study||1
177510|NCT00586820|412677|P2|COMPLETED|Overall Study||11
177511|NCT00586820|412678|P1|COMPLETED|Overall Study||11
177512|NCT00586820|412677|P2|STARTED|Overall Study||11
177513|NCT00586820|412678|P1|STARTED|Overall Study||12
177514|NCT00586703|412686|P1|NOT COMPLETED|Overall Study||12
177515|NCT00586703|412686|P1|COMPLETED|Overall Study||4
177516|NCT00586703|412686|P1|STARTED|Overall Study||16
177517|NCT00586690|412693|P2|NOT COMPLETED|Overall Study||0
177518|NCT00586690|412694|P1|NOT COMPLETED|Overall Study||16
177519|NCT00586690|412693|P2|COMPLETED|Overall Study||22
177520|NCT00586690|412694|P1|COMPLETED|Overall Study||5
177521|NCT00586690|412693|P2|STARTED|Overall Study||22
177522|NCT00586690|412694|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
177523|NCT00586664|412704|P3|NOT COMPLETED|Overall Study||1
177524|NCT00586664|412705|P2|NOT COMPLETED|Overall Study||7
177525|NCT00586664|412706|P1|NOT COMPLETED|Overall Study||5
177526|NCT00586664|412704|P3|COMPLETED|Overall Study||43
177527|NCT00586664|412705|P2|COMPLETED|Overall Study||36
177528|NCT00586664|412706|P1|COMPLETED|Overall Study||38
177529|NCT00586664|412704|P3|STARTED|Overall Study||44
177530|NCT00586664|412705|P2|STARTED|Overall Study||43
177531|NCT00586664|412706|P1|STARTED|Overall Study||43
177532|NCT00586625|412752|P2|NOT COMPLETED|Overall Study||17
177533|NCT00586625|412753|P1|NOT COMPLETED|Overall Study||43
177534|NCT00586625|412752|P2|COMPLETED|Overall Study||269
177535|NCT00586625|412753|P1|COMPLETED|Overall Study||532
177536|NCT00586625|412752|P2|STARTED|Overall Study||286
177537|NCT00586625|412753|P1|STARTED|Overall Study||575
177538|NCT00586612|412761|P2|NOT COMPLETED|Booster Phase||1
177539|NCT00586612|412762|P1|NOT COMPLETED|Booster Phase||3
177540|NCT00586612|412761|P2|COMPLETED|Booster Phase||143
177541|NCT00586612|412762|P1|COMPLETED|Booster Phase||151
177542|NCT00586612|412761|P2|STARTED|Booster Phase||144
177543|NCT00586612|412762|P1|STARTED|Booster Phase||154
177544|NCT00586612|412761|P2|NOT COMPLETED|Primary Phase||3
177545|NCT00586612|412762|P1|NOT COMPLETED|Primary Phase||1
177546|NCT00586612|412761|P2|COMPLETED|Primary Phase||147
177547|NCT00586612|412762|P1|COMPLETED|Primary Phase||162
177548|NCT00586612|412761|P2|STARTED|Primary Phase||150
177549|NCT00586612|412762|P1|STARTED|Primary Phase||163
177550|NCT00586573|412828|P1|NOT COMPLETED|Overall Study||6
177551|NCT00586573|412828|P1|COMPLETED|Overall Study||28
177552|NCT00586573|412828|P1|STARTED|Overall Study||34
177553|NCT00586521|412832|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
177554|NCT00586521|412832|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
177555|NCT00586521|412832|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
177556|NCT00586521|412832|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
177557|NCT00586521|412832|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
177558|NCT00586521|412832|P1|STARTED|On Demand Treatment (Months 1-6)||20
177559|NCT00586495|412839|P1|NOT COMPLETED|Follow-up||92
177560|NCT00586495|412839|P1|COMPLETED|Follow-up||0
177561|NCT00586495|412839|P1|STARTED|Follow-up||92
177562|NCT00586495|412839|P1|NOT COMPLETED|Treatment Period||95
177563|NCT00586495|412839|P1|COMPLETED|Treatment Period||0
177564|NCT00586495|412839|P1|STARTED|Treatment Period||95
177565|NCT00586482|412851|P2|NOT COMPLETED|Overall Study||0
177566|NCT00586482|412852|P1|NOT COMPLETED|Overall Study||0
177567|NCT00586482|412851|P2|COMPLETED|Overall Study||24
177568|NCT00586482|412852|P1|COMPLETED|Overall Study||22
177569|NCT00586482|412851|P2|STARTED|Overall Study||24
177570|NCT00586482|412852|P1|STARTED|Overall Study||22
177571|NCT00586469|412868|P2|NOT COMPLETED|Overall Study||1
177572|NCT00586469|412869|P1|NOT COMPLETED|Overall Study||0
177573|NCT00586469|412868|P2|COMPLETED|Overall Study||499
177574|NCT00586469|412869|P1|COMPLETED|Overall Study||500
177575|NCT00586469|412868|P2|STARTED|Overall Study||500
177576|NCT00586469|412869|P1|STARTED|Overall Study||500
177577|NCT00586339|412896|P3|NOT COMPLETED|Overall Study||6
177578|NCT00586339|412897|P2|NOT COMPLETED|Overall Study||7
177579|NCT00586339|412898|P1|NOT COMPLETED|Overall Study||7
177580|NCT00586339|412896|P3|COMPLETED|Overall Study||24
177581|NCT00586339|412897|P2|COMPLETED|Overall Study||52
177582|NCT00586339|412898|P1|COMPLETED|Overall Study||54
177583|NCT00586339|412896|P3|STARTED|Overall Study||30
177584|NCT00586339|412897|P2|STARTED|Overall Study||59
177585|NCT00586339|412898|P1|STARTED|Overall Study||61
177586|NCT00586326|412990|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
177587|NCT00586326|412990|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
177588|NCT00586326|412990|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
177589|NCT00586326|412990|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
177590|NCT00586326|412990|P1|COMPLETED|Device Placed toTreatment-ITT||100
177591|NCT00586326|412990|P1|STARTED|Device Placed toTreatment-ITT||118
177592|NCT00586326|412990|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
177593|NCT00586326|412990|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
177594|NCT00586326|412990|P1|STARTED|Enrollment to Device Placement-Enrolled||133
177595|NCT00586313|413001|P1|NOT COMPLETED|Overall Study||2
177596|NCT00586313|413001|P1|COMPLETED|Overall Study||19
177597|NCT00586313|413001|P1|STARTED|Overall Study||21
177598|NCT00586261|413008|P2|NOT COMPLETED|Overall Study||0
177599|NCT00586261|413009|P1|NOT COMPLETED|Overall Study||0
177600|NCT00586261|413008|P2|COMPLETED|Overall Study||19
177601|NCT00586261|413009|P1|COMPLETED|Overall Study||17
177602|NCT00586261|413008|P2|STARTED|Overall Study||19
177603|NCT00586261|413009|P1|STARTED|Overall Study||17
177604|NCT00586196|413017|P2|NOT COMPLETED|Overall Study||0
177605|NCT00586196|413018|P1|NOT COMPLETED|Overall Study||0
177606|NCT00586196|413017|P2|COMPLETED|Overall Study||9
177607|NCT00586196|413018|P1|COMPLETED|Overall Study||7
177608|NCT00586196|413017|P2|STARTED|Overall Study||9
177609|NCT00586196|413018|P1|STARTED|Overall Study||7
177610|NCT00586170|413028|P2|NOT COMPLETED|Overall Study||0
177611|NCT00586170|413029|P1|NOT COMPLETED|Overall Study||0
177612|NCT00586170|413028|P2|COMPLETED|Overall Study||3
177613|NCT00586170|413029|P1|COMPLETED|Overall Study||5
177614|NCT00586170|413028|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
177615|NCT00586170|413029|P1|STARTED|Overall Study||5
177616|NCT00586157|413037|P2|NOT COMPLETED|Second Intervention||1
177617|NCT00586157|413038|P1|NOT COMPLETED|Second Intervention||2
177618|NCT00586157|413037|P2|COMPLETED|Second Intervention||14
177619|NCT00586157|413038|P1|COMPLETED|Second Intervention||12
177620|NCT00586157|413037|P2|STARTED|Second Intervention||15
177621|NCT00586157|413038|P1|STARTED|Second Intervention||14
177622|NCT00586157|413037|P2|NOT COMPLETED|First Intervention||0
177623|NCT00586157|413038|P1|NOT COMPLETED|First Intervention||1
177624|NCT00586157|413037|P2|COMPLETED|First Intervention||15
177625|NCT00586157|413038|P1|COMPLETED|First Intervention||14
177626|NCT00586157|413037|P2|STARTED|First Intervention||15
177627|NCT00586157|413038|P1|STARTED|First Intervention||15
177628|NCT00586105|413048|P1|NOT COMPLETED|Overall Study||39
177629|NCT00586105|413048|P1|COMPLETED|Overall Study||0
177630|NCT00586105|413048|P1|STARTED|Overall Study||39
177631|NCT00585975|413063|P2|NOT COMPLETED|Overall Study||13
177632|NCT00585975|413064|P1|NOT COMPLETED|Overall Study||15
177633|NCT00585975|413063|P2|COMPLETED|Overall Study||278
177634|NCT00585975|413064|P1|COMPLETED|Overall Study||262
177635|NCT00585975|413063|P2|STARTED|Overall Study||291
177636|NCT00585975|413064|P1|STARTED|Overall Study||277
177637|NCT00585923|413074|P2|NOT COMPLETED|Overall Study||33
177638|NCT00585923|413075|P1|NOT COMPLETED|Overall Study||31
177639|NCT00585923|413074|P2|COMPLETED|Overall Study||26
177640|NCT00585923|413075|P1|COMPLETED|Overall Study||25
177641|NCT00585923|413074|P2|STARTED|Overall Study||59
177642|NCT00585923|413075|P1|STARTED|Overall Study||56
177643|NCT00585910|413089|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
177644|NCT00585910|413089|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
177645|NCT00585910|413089|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
177646|NCT00585910|413089|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
177647|NCT00585910|413089|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
177648|NCT00585910|413089|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
177649|NCT00585715|413097|P2|NOT COMPLETED|Overall Study||0
177650|NCT00585715|413098|P1|NOT COMPLETED|Overall Study||3
177651|NCT00585715|413097|P2|COMPLETED|Overall Study||11
177652|NCT00585715|413098|P1|COMPLETED|Overall Study||8
177653|NCT00585715|413097|P2|STARTED|Overall Study||11
177654|NCT00585715|413098|P1|STARTED|Overall Study||11
177655|NCT00585689|413106|P1|NOT COMPLETED|Overall Study||7
177656|NCT00585689|413106|P1|COMPLETED|Overall Study||22
177657|NCT00585689|413106|P1|STARTED|Overall Study||29
177658|NCT00585650|413112|P2|NOT COMPLETED|Overall Study||0
177659|NCT00585650|413113|P1|NOT COMPLETED|Overall Study||0
177660|NCT00585650|413112|P2|COMPLETED|Overall Study||12
177661|NCT00585650|413113|P1|COMPLETED|Overall Study||8
177662|NCT00585650|413112|P2|STARTED|Overall Study||12
177663|NCT00585650|413113|P1|STARTED|Overall Study||8
177664|NCT00585637|413123|P4|NOT COMPLETED|6-month Time Point||6
177665|NCT00585637|413124|P3|NOT COMPLETED|6-month Time Point||11
177666|NCT00585637|413125|P2|NOT COMPLETED|6-month Time Point||13
177667|NCT00585637|413126|P1|NOT COMPLETED|6-month Time Point||6
177668|NCT00585637|413123|P4|COMPLETED|6-month Time Point||77
177669|NCT00585637|413124|P3|COMPLETED|6-month Time Point||72
177670|NCT00585637|413125|P2|COMPLETED|6-month Time Point||68
177671|NCT00585637|413126|P1|COMPLETED|6-month Time Point||75
177672|NCT00585637|413123|P4|STARTED|6-month Time Point||83
177673|NCT00585637|413124|P3|STARTED|6-month Time Point||83
177674|NCT00585637|413125|P2|STARTED|6-month Time Point||81
177675|NCT00585637|413126|P1|STARTED|6-month Time Point||81
177676|NCT00585637|413123|P4|NOT COMPLETED|3-month Time Point||5
177677|NCT00585637|413124|P3|NOT COMPLETED|3-month Time Point||7
177678|NCT00585637|413125|P2|NOT COMPLETED|3-month Time Point||14
177679|NCT00585637|413126|P1|NOT COMPLETED|3-month Time Point||10
177680|NCT00585637|413123|P4|COMPLETED|3-month Time Point||78
177681|NCT00585637|413124|P3|COMPLETED|3-month Time Point||76
177682|NCT00585637|413125|P2|COMPLETED|3-month Time Point||67
177683|NCT00585637|413126|P1|COMPLETED|3-month Time Point||71
177684|NCT00585637|413123|P4|STARTED|3-month Time Point||83
177685|NCT00585637|413124|P3|STARTED|3-month Time Point||83
177686|NCT00585637|413125|P2|STARTED|3-month Time Point||81
177687|NCT00585637|413126|P1|STARTED|3-month Time Point||81
177688|NCT00585637|413123|P4|NOT COMPLETED|Baseline||0
177689|NCT00585637|413124|P3|NOT COMPLETED|Baseline||0
177690|NCT00585637|413125|P2|NOT COMPLETED|Baseline||0
177691|NCT00585637|413126|P1|NOT COMPLETED|Baseline||0
177692|NCT00585637|413123|P4|COMPLETED|Baseline||83
177693|NCT00585637|413124|P3|COMPLETED|Baseline||83
177694|NCT00585637|413125|P2|COMPLETED|Baseline||81
177695|NCT00585637|413126|P1|COMPLETED|Baseline||81
177696|NCT00585637|413123|P4|STARTED|Baseline||83
177697|NCT00585637|413124|P3|STARTED|Baseline||83
177698|NCT00585637|413125|P2|STARTED|Baseline||81
177699|NCT00585637|413126|P1|STARTED|Baseline||81
177700|NCT00585533|413152|P1|NOT COMPLETED|Overall Study||9
177701|NCT00585533|413152|P1|COMPLETED|Overall Study||31
177702|NCT00585533|413152|P1|STARTED|Overall Study||40
177703|NCT00585494|413157|P1|NOT COMPLETED|Overall Study||56
177704|NCT00585494|413157|P1|COMPLETED|Overall Study||244
177705|NCT00585494|413157|P1|STARTED|Overall Study||300
177706|NCT00585468|413161|P2|NOT COMPLETED|Second Intervention||0
177707|NCT00585468|413162|P1|NOT COMPLETED|Second Intervention||0
177708|NCT00585468|413161|P2|COMPLETED|Second Intervention||10
177709|NCT00585468|413162|P1|COMPLETED|Second Intervention||9
177710|NCT00585468|413161|P2|STARTED|Second Intervention||10
177711|NCT00585468|413162|P1|STARTED|Second Intervention||9
177712|NCT00585468|413161|P2|NOT COMPLETED|First Intervention||1
177713|NCT00585468|413162|P1|NOT COMPLETED|First Intervention||1
177714|NCT00585468|413161|P2|COMPLETED|First Intervention||10
177715|NCT00585468|413162|P1|COMPLETED|First Intervention||9
177716|NCT00585468|413161|P2|STARTED|First Intervention||11
177717|NCT00585468|413162|P1|STARTED|First Intervention||10
177718|NCT00585377|413182|P1|NOT COMPLETED|Overall Study||0
177719|NCT00585377|413182|P1|COMPLETED|Overall Study||50
177720|NCT00585377|413182|P1|STARTED|Overall Study||50
177721|NCT00585351|413194|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
177722|NCT00585351|413195|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
177723|NCT00585351|413196|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
177724|NCT00585351|413197|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
177725|NCT00585351|413198|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
177726|NCT00585351|413199|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
177727|NCT00585351|413200|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
177728|NCT00585351|413201|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
177729|NCT00585351|413194|P8|COMPLETED|Enrollment Period (Intervention)||2
177730|NCT00585351|413195|P7|COMPLETED|Enrollment Period (Intervention)||5
177731|NCT00585351|413196|P6|COMPLETED|Enrollment Period (Intervention)||5
177732|NCT00585351|413197|P5|COMPLETED|Enrollment Period (Intervention)||3
177733|NCT00585351|413198|P4|COMPLETED|Enrollment Period (Intervention)||15
177734|NCT00585351|413199|P3|COMPLETED|Enrollment Period (Intervention)||15
177735|NCT00585351|413200|P2|COMPLETED|Enrollment Period (Intervention)||0
177736|NCT00585351|413201|P1|COMPLETED|Enrollment Period (Intervention)||0
177737|NCT00585351|413194|P8|STARTED|Enrollment Period (Intervention)||3
177738|NCT00585351|413195|P7|STARTED|Enrollment Period (Intervention)||7
177739|NCT00585351|413196|P6|STARTED|Enrollment Period (Intervention)||7
177740|NCT00585351|413197|P5|STARTED|Enrollment Period (Intervention)||5
177741|NCT00585351|413198|P4|STARTED|Enrollment Period (Intervention)||15
177742|NCT00585351|413199|P3|STARTED|Enrollment Period (Intervention)||15
177743|NCT00585351|413200|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
177744|NCT00585351|413201|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
177745|NCT00585351|413194|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
177746|NCT00585351|413195|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
177747|NCT00585351|413196|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
177748|NCT00585351|413197|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
177749|NCT00585351|413198|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
177750|NCT00585351|413199|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
177751|NCT00585351|413200|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
177752|NCT00585351|413201|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
177753|NCT00585351|413194|P8|COMPLETED|Notification Period (Informed Consent)||0
177754|NCT00585351|413195|P7|COMPLETED|Notification Period (Informed Consent)||0
177755|NCT00585351|413196|P6|COMPLETED|Notification Period (Informed Consent)||0
177756|NCT00585351|413197|P5|COMPLETED|Notification Period (Informed Consent)||0
177757|NCT00585351|413198|P4|COMPLETED|Notification Period (Informed Consent)||0
177758|NCT00585351|413199|P3|COMPLETED|Notification Period (Informed Consent)||0
177759|NCT00585351|413200|P2|COMPLETED|Notification Period (Informed Consent)||25
177760|NCT00585351|413201|P1|COMPLETED|Notification Period (Informed Consent)||27
177761|NCT00585351|413194|P8|STARTED|Notification Period (Informed Consent)||0
177762|NCT00585351|413195|P7|STARTED|Notification Period (Informed Consent)||0
177763|NCT00585351|413196|P6|STARTED|Notification Period (Informed Consent)||0
177764|NCT00585351|413197|P5|STARTED|Notification Period (Informed Consent)||0
177765|NCT00585351|413198|P4|STARTED|Notification Period (Informed Consent)||0
177766|NCT00585351|413199|P3|STARTED|Notification Period (Informed Consent)||0
177767|NCT00585351|413200|P2|STARTED|Notification Period (Informed Consent)||50
177768|NCT00585351|413201|P1|STARTED|Notification Period (Informed Consent)||50
177769|NCT00585312|413217|P2|NOT COMPLETED|Overall Study||44
177770|NCT00585312|413218|P1|NOT COMPLETED|Overall Study||51
177771|NCT00585312|413217|P2|COMPLETED|Overall Study||7
177772|NCT00585312|413218|P1|COMPLETED|Overall Study||4
177773|NCT00585312|413217|P2|Treated|Overall Study||48
177774|NCT00585312|413218|P1|Treated|Overall Study||53
177775|NCT00585312|413217|P2|STARTED|Overall Study|STARTED=Randomized|51
177776|NCT00585312|413218|P1|STARTED|Overall Study|STARTED=Randomized|55
177777|NCT00585286|413230|P1|NOT COMPLETED|Overall Study||1
177778|NCT00585286|413230|P1|COMPLETED|Overall Study||14
177779|NCT00585286|413230|P1|STARTED|Overall Study||15
177780|NCT00585221|413237|P1|NOT COMPLETED|Overall Study||8
177781|NCT00585221|413237|P1|COMPLETED|Overall Study||0
177782|NCT00585221|413237|P1|STARTED|Overall Study||8
177783|NCT00585182|413242|P1|NOT COMPLETED|Overall Study||0
177784|NCT00585182|413242|P1|COMPLETED|Overall Study||28
177785|NCT00585182|413242|P1|STARTED|Overall Study||28
177786|NCT00585169|413247|P1|NOT COMPLETED|Overall Study||1
177787|NCT00585169|413247|P1|COMPLETED|Overall Study||28
177788|NCT00585169|413247|P1|STARTED|Overall Study||29
177789|NCT00585104|413253|P1|NOT COMPLETED|Overall Study||4
177790|NCT00585104|413253|P1|COMPLETED|Overall Study||6
177791|NCT00585104|413253|P1|STARTED|Overall Study||10
177792|NCT00585039|413259|P2|NOT COMPLETED|Overall Study||0
177793|NCT00585039|413260|P1|NOT COMPLETED|Overall Study||2
177794|NCT00585039|413259|P2|COMPLETED|Overall Study||44
177795|NCT00585039|413260|P1|COMPLETED|Overall Study||55
177796|NCT00585039|413259|P2|STARTED|Overall Study||44
177797|NCT00585039|413260|P1|STARTED|Overall Study||57
177798|NCT00585013|413270|P2|NOT COMPLETED|Overall Study||0
177799|NCT00585013|413271|P1|NOT COMPLETED|Overall Study||0
177800|NCT00585013|413270|P2|COMPLETED|Overall Study||8
177801|NCT00585013|413271|P1|COMPLETED|Overall Study||8
177802|NCT00585013|413270|P2|STARTED|Overall Study||8
177803|NCT00585013|413271|P1|STARTED|Overall Study||8
177804|NCT00584987|413289|P4|NOT COMPLETED|Overall Study||1
177805|NCT00584987|413290|P3|NOT COMPLETED|Overall Study||1
177806|NCT00584987|413291|P2|NOT COMPLETED|Overall Study||1
177807|NCT00584987|413292|P1|NOT COMPLETED|Overall Study||1
177808|NCT00584987|413289|P4|COMPLETED|Overall Study||15
177809|NCT00584987|413290|P3|COMPLETED|Overall Study||16
177810|NCT00584987|413291|P2|COMPLETED|Overall Study||15
177811|NCT00584987|413292|P1|COMPLETED|Overall Study||14
177812|NCT00584987|413289|P4|STARTED|Overall Study||16
177813|NCT00584987|413290|P3|STARTED|Overall Study||17
177814|NCT00584987|413291|P2|STARTED|Overall Study||16
177815|NCT00584987|413292|P1|STARTED|Overall Study||15
177816|NCT00584935|413322|P1|NOT COMPLETED|Overall Study||0
177817|NCT00584935|413322|P1|COMPLETED|Overall Study||3
177818|NCT00584935|413322|P1|STARTED|Overall Study||3
177819|NCT00584909|413326|P1|NOT COMPLETED|Overall Study||4
177820|NCT00584909|413326|P1|COMPLETED|Overall Study||9
177821|NCT00584909|413326|P1|STARTED|Overall Study||13
177822|NCT00584857|413331|P1|NOT COMPLETED|Overall Study||0
177823|NCT00584857|413331|P1|COMPLETED|Overall Study||30
177824|NCT00584857|413331|P1|STARTED|Overall Study||30
177825|NCT00584831|413336|P19|NOT COMPLETED|Intervention 4||0
177826|NCT00584831|413337|P18|NOT COMPLETED|Intervention 4||0
177827|NCT00584831|413338|P17|NOT COMPLETED|Intervention 4||0
177828|NCT00584831|413339|P16|NOT COMPLETED|Intervention 4||0
177829|NCT00584831|413340|P15|NOT COMPLETED|Intervention 4||0
177830|NCT00584831|413341|P14|NOT COMPLETED|Intervention 4||0
177831|NCT00584831|413342|P13|NOT COMPLETED|Intervention 4||0
177832|NCT00584831|413343|P12|NOT COMPLETED|Intervention 4||0
177833|NCT00584831|413344|P11|NOT COMPLETED|Intervention 4||0
177834|NCT00584831|413345|P10|NOT COMPLETED|Intervention 4||0
177835|NCT00584831|413346|P9|NOT COMPLETED|Intervention 4||0
177836|NCT00584831|413347|P8|NOT COMPLETED|Intervention 4||0
177837|NCT00584831|413348|P7|NOT COMPLETED|Intervention 4||0
177838|NCT00584831|413349|P6|NOT COMPLETED|Intervention 4||0
177839|NCT00584831|413350|P5|NOT COMPLETED|Intervention 4||0
177840|NCT00584831|413351|P4|NOT COMPLETED|Intervention 4||0
177841|NCT00584831|413352|P3|NOT COMPLETED|Intervention 4||0
177842|NCT00584831|413353|P2|NOT COMPLETED|Intervention 4||0
177843|NCT00584831|413354|P1|NOT COMPLETED|Intervention 4||0
177844|NCT00584831|413336|P19|COMPLETED|Intervention 4||1
177845|NCT00584831|413337|P18|COMPLETED|Intervention 4||1
177846|NCT00584831|413338|P17|COMPLETED|Intervention 4||4
177847|NCT00584831|413339|P16|COMPLETED|Intervention 4||1
177848|NCT00584831|413340|P15|COMPLETED|Intervention 4||2
177849|NCT00584831|413341|P14|COMPLETED|Intervention 4||1
177850|NCT00584831|413342|P13|COMPLETED|Intervention 4||2
177851|NCT00584831|413343|P12|COMPLETED|Intervention 4||1
177852|NCT00584831|413344|P11|COMPLETED|Intervention 4||2
177853|NCT00584831|413345|P10|COMPLETED|Intervention 4||2
177854|NCT00584831|413346|P9|COMPLETED|Intervention 4||3
177855|NCT00584831|413347|P8|COMPLETED|Intervention 4||2
177856|NCT00584831|413348|P7|COMPLETED|Intervention 4||6
177857|NCT00584831|413349|P6|COMPLETED|Intervention 4||1
177858|NCT00584831|413350|P5|COMPLETED|Intervention 4||2
177859|NCT00584831|413351|P4|COMPLETED|Intervention 4||1
177860|NCT00584831|413352|P3|COMPLETED|Intervention 4||2
177861|NCT00584831|413353|P2|COMPLETED|Intervention 4||3
177862|NCT00584831|413354|P1|COMPLETED|Intervention 4||1
177863|NCT00584831|413336|P19|STARTED|Intervention 4||1
177864|NCT00584831|413337|P18|STARTED|Intervention 4||1
177865|NCT00584831|413338|P17|STARTED|Intervention 4||4
177866|NCT00584831|413339|P16|STARTED|Intervention 4||1
177867|NCT00584831|413340|P15|STARTED|Intervention 4||2
177868|NCT00584831|413341|P14|STARTED|Intervention 4||1
177869|NCT00584831|413342|P13|STARTED|Intervention 4||2
177870|NCT00584831|413343|P12|STARTED|Intervention 4||1
177871|NCT00584831|413344|P11|STARTED|Intervention 4||2
177872|NCT00584831|413345|P10|STARTED|Intervention 4||2
177873|NCT00584831|413346|P9|STARTED|Intervention 4||3
177874|NCT00584831|413347|P8|STARTED|Intervention 4||2
177875|NCT00584831|413348|P7|STARTED|Intervention 4||6
177876|NCT00584831|413349|P6|STARTED|Intervention 4||1
177877|NCT00584831|413350|P5|STARTED|Intervention 4||2
177878|NCT00584831|413351|P4|STARTED|Intervention 4||1
177879|NCT00584831|413352|P3|STARTED|Intervention 4||2
177880|NCT00584831|413353|P2|STARTED|Intervention 4||3
177881|NCT00584831|413354|P1|STARTED|Intervention 4||1
177882|NCT00584831|413336|P19|NOT COMPLETED|Intervention 3||0
177883|NCT00584831|413337|P18|NOT COMPLETED|Intervention 3||0
177884|NCT00584831|413338|P17|NOT COMPLETED|Intervention 3||0
177885|NCT00584831|413339|P16|NOT COMPLETED|Intervention 3||0
177886|NCT00584831|413340|P15|NOT COMPLETED|Intervention 3||0
177887|NCT00584831|413341|P14|NOT COMPLETED|Intervention 3||0
177888|NCT00584831|413342|P13|NOT COMPLETED|Intervention 3||0
177889|NCT00584831|413343|P12|NOT COMPLETED|Intervention 3||0
177890|NCT00584831|413344|P11|NOT COMPLETED|Intervention 3||0
177891|NCT00584831|413345|P10|NOT COMPLETED|Intervention 3||0
177892|NCT00584831|413346|P9|NOT COMPLETED|Intervention 3||0
177893|NCT00584831|413347|P8|NOT COMPLETED|Intervention 3||0
177894|NCT00584831|413348|P7|NOT COMPLETED|Intervention 3||0
177895|NCT00584831|413349|P6|NOT COMPLETED|Intervention 3||0
177896|NCT00584831|413350|P5|NOT COMPLETED|Intervention 3||0
177897|NCT00584831|413351|P4|NOT COMPLETED|Intervention 3||0
177898|NCT00584831|413352|P3|NOT COMPLETED|Intervention 3||0
177899|NCT00584831|413353|P2|NOT COMPLETED|Intervention 3||0
177900|NCT00584831|413354|P1|NOT COMPLETED|Intervention 3||0
177901|NCT00584831|413336|P19|COMPLETED|Intervention 3||1
177902|NCT00584831|413337|P18|COMPLETED|Intervention 3||1
177903|NCT00584831|413338|P17|COMPLETED|Intervention 3||4
177904|NCT00584831|413339|P16|COMPLETED|Intervention 3||1
177905|NCT00584831|413340|P15|COMPLETED|Intervention 3||3
177906|NCT00584831|413341|P14|COMPLETED|Intervention 3||1
177907|NCT00584831|413342|P13|COMPLETED|Intervention 3||2
177908|NCT00584831|413343|P12|COMPLETED|Intervention 3||1
177909|NCT00584831|413344|P11|COMPLETED|Intervention 3||2
177910|NCT00584831|413345|P10|COMPLETED|Intervention 3||2
177911|NCT00584831|413346|P9|COMPLETED|Intervention 3||4
177912|NCT00584831|413347|P8|COMPLETED|Intervention 3||2
177913|NCT00584831|413348|P7|COMPLETED|Intervention 3||6
177914|NCT00584831|413349|P6|COMPLETED|Intervention 3||1
177915|NCT00584831|413350|P5|COMPLETED|Intervention 3||2
177916|NCT00584831|413351|P4|COMPLETED|Intervention 3||1
177917|NCT00584831|413352|P3|COMPLETED|Intervention 3||2
177918|NCT00584831|413353|P2|COMPLETED|Intervention 3||3
177919|NCT00584831|413354|P1|COMPLETED|Intervention 3||1
177920|NCT00584831|413336|P19|STARTED|Intervention 3||1
177921|NCT00584831|413337|P18|STARTED|Intervention 3||1
177922|NCT00584831|413338|P17|STARTED|Intervention 3||4
177923|NCT00584831|413339|P16|STARTED|Intervention 3||1
177924|NCT00584831|413340|P15|STARTED|Intervention 3||3
177925|NCT00584831|413341|P14|STARTED|Intervention 3||1
177926|NCT00584831|413342|P13|STARTED|Intervention 3||2
177927|NCT00584831|413343|P12|STARTED|Intervention 3||1
177928|NCT00584831|413344|P11|STARTED|Intervention 3||2
177929|NCT00584831|413345|P10|STARTED|Intervention 3||2
177930|NCT00584831|413346|P9|STARTED|Intervention 3||4
177931|NCT00584831|413347|P8|STARTED|Intervention 3||2
177932|NCT00584831|413348|P7|STARTED|Intervention 3||6
177933|NCT00584831|413349|P6|STARTED|Intervention 3||1
177934|NCT00584831|413350|P5|STARTED|Intervention 3||2
177935|NCT00584831|413351|P4|STARTED|Intervention 3||1
177936|NCT00584831|413352|P3|STARTED|Intervention 3||2
177937|NCT00584831|413353|P2|STARTED|Intervention 3||3
177938|NCT00584831|413354|P1|STARTED|Intervention 3||1
177939|NCT00584831|413336|P19|NOT COMPLETED|Intervention 2||0
177940|NCT00584831|413337|P18|NOT COMPLETED|Intervention 2||0
177941|NCT00584831|413338|P17|NOT COMPLETED|Intervention 2||0
177942|NCT00584831|413339|P16|NOT COMPLETED|Intervention 2||0
177943|NCT00584831|413340|P15|NOT COMPLETED|Intervention 2||0
177944|NCT00584831|413341|P14|NOT COMPLETED|Intervention 2||0
177945|NCT00584831|413342|P13|NOT COMPLETED|Intervention 2||0
177946|NCT00584831|413343|P12|NOT COMPLETED|Intervention 2||0
177947|NCT00584831|413344|P11|NOT COMPLETED|Intervention 2||0
177948|NCT00584831|413345|P10|NOT COMPLETED|Intervention 2||0
177949|NCT00584831|413346|P9|NOT COMPLETED|Intervention 2||0
177950|NCT00584831|413347|P8|NOT COMPLETED|Intervention 2||0
177951|NCT00584831|413348|P7|NOT COMPLETED|Intervention 2||0
177952|NCT00584831|413349|P6|NOT COMPLETED|Intervention 2||0
177953|NCT00584831|413350|P5|NOT COMPLETED|Intervention 2||0
177954|NCT00584831|413351|P4|NOT COMPLETED|Intervention 2||0
177955|NCT00584831|413352|P3|NOT COMPLETED|Intervention 2||0
177956|NCT00584831|413353|P2|NOT COMPLETED|Intervention 2||0
177957|NCT00584831|413354|P1|NOT COMPLETED|Intervention 2||0
177958|NCT00584831|413336|P19|COMPLETED|Intervention 2||1
177959|NCT00584831|413337|P18|COMPLETED|Intervention 2||1
177960|NCT00584831|413338|P17|COMPLETED|Intervention 2||4
177961|NCT00584831|413339|P16|COMPLETED|Intervention 2||1
177962|NCT00584831|413340|P15|COMPLETED|Intervention 2||3
177963|NCT00584831|413341|P14|COMPLETED|Intervention 2||1
177964|NCT00584831|413342|P13|COMPLETED|Intervention 2||2
177965|NCT00584831|413343|P12|COMPLETED|Intervention 2||1
177966|NCT00584831|413344|P11|COMPLETED|Intervention 2||2
177967|NCT00584831|413345|P10|COMPLETED|Intervention 2||2
177968|NCT00584831|413346|P9|COMPLETED|Intervention 2||4
177969|NCT00584831|413347|P8|COMPLETED|Intervention 2||2
177970|NCT00584831|413348|P7|COMPLETED|Intervention 2||6
177971|NCT00584831|413349|P6|COMPLETED|Intervention 2||1
177972|NCT00584831|413350|P5|COMPLETED|Intervention 2||2
177973|NCT00584831|413351|P4|COMPLETED|Intervention 2||1
177974|NCT00584831|413352|P3|COMPLETED|Intervention 2||2
177975|NCT00584831|413353|P2|COMPLETED|Intervention 2||3
177976|NCT00584831|413354|P1|COMPLETED|Intervention 2||1
177977|NCT00584831|413336|P19|STARTED|Intervention 2||1
177978|NCT00584831|413337|P18|STARTED|Intervention 2||1
177979|NCT00584831|413338|P17|STARTED|Intervention 2||4
177980|NCT00584831|413339|P16|STARTED|Intervention 2||1
177981|NCT00584831|413340|P15|STARTED|Intervention 2||3
177982|NCT00584831|413341|P14|STARTED|Intervention 2||1
177983|NCT00584831|413342|P13|STARTED|Intervention 2||2
177984|NCT00584831|413343|P12|STARTED|Intervention 2||1
177985|NCT00584831|413344|P11|STARTED|Intervention 2||2
177986|NCT00584831|413345|P10|STARTED|Intervention 2||2
177987|NCT00584831|413346|P9|STARTED|Intervention 2||4
177988|NCT00584831|413347|P8|STARTED|Intervention 2||2
177989|NCT00584831|413348|P7|STARTED|Intervention 2||6
177990|NCT00584831|413349|P6|STARTED|Intervention 2||1
177991|NCT00584831|413350|P5|STARTED|Intervention 2||2
177992|NCT00584831|413351|P4|STARTED|Intervention 2||1
177993|NCT00584831|413352|P3|STARTED|Intervention 2||2
177994|NCT00584831|413353|P2|STARTED|Intervention 2||3
177995|NCT00584831|413354|P1|STARTED|Intervention 2||1
177996|NCT00584831|413336|P19|NOT COMPLETED|Intervention 1||0
177997|NCT00584831|413337|P18|NOT COMPLETED|Intervention 1||0
177998|NCT00584831|413338|P17|NOT COMPLETED|Intervention 1||0
177999|NCT00584831|413339|P16|NOT COMPLETED|Intervention 1||0
178000|NCT00584831|413340|P15|NOT COMPLETED|Intervention 1||0
178001|NCT00584831|413341|P14|NOT COMPLETED|Intervention 1||0
178002|NCT00584831|413342|P13|NOT COMPLETED|Intervention 1||0
178003|NCT00584831|413343|P12|NOT COMPLETED|Intervention 1||0
178004|NCT00584831|413344|P11|NOT COMPLETED|Intervention 1||0
178005|NCT00584831|413345|P10|NOT COMPLETED|Intervention 1||0
178006|NCT00584831|413346|P9|NOT COMPLETED|Intervention 1||0
178007|NCT00584831|413347|P8|NOT COMPLETED|Intervention 1||0
178008|NCT00584831|413348|P7|NOT COMPLETED|Intervention 1||0
178009|NCT00584831|413349|P6|NOT COMPLETED|Intervention 1||0
178010|NCT00584831|413350|P5|NOT COMPLETED|Intervention 1||0
178011|NCT00584831|413351|P4|NOT COMPLETED|Intervention 1||0
178012|NCT00584831|413352|P3|NOT COMPLETED|Intervention 1||0
178013|NCT00584831|413353|P2|NOT COMPLETED|Intervention 1||0
178014|NCT00584831|413354|P1|NOT COMPLETED|Intervention 1||0
178015|NCT00584831|413336|P19|COMPLETED|Intervention 1||1
178016|NCT00584831|413337|P18|COMPLETED|Intervention 1||1
178017|NCT00584831|413338|P17|COMPLETED|Intervention 1||4
178018|NCT00584831|413339|P16|COMPLETED|Intervention 1||1
178019|NCT00584831|413340|P15|COMPLETED|Intervention 1||3
178020|NCT00584831|413341|P14|COMPLETED|Intervention 1||1
178021|NCT00584831|413342|P13|COMPLETED|Intervention 1||2
178022|NCT00584831|413343|P12|COMPLETED|Intervention 1||1
178023|NCT00584831|413344|P11|COMPLETED|Intervention 1||2
178024|NCT00584831|413345|P10|COMPLETED|Intervention 1||2
178025|NCT00584831|413346|P9|COMPLETED|Intervention 1||4
178026|NCT00584831|413347|P8|COMPLETED|Intervention 1||2
178027|NCT00584831|413348|P7|COMPLETED|Intervention 1||6
178028|NCT00584831|413349|P6|COMPLETED|Intervention 1||1
178029|NCT00584831|413350|P5|COMPLETED|Intervention 1||2
178030|NCT00584831|413351|P4|COMPLETED|Intervention 1||1
178031|NCT00584831|413352|P3|COMPLETED|Intervention 1||2
178032|NCT00584831|413353|P2|COMPLETED|Intervention 1||3
178033|NCT00584831|413354|P1|COMPLETED|Intervention 1||1
178034|NCT00584831|413336|P19|STARTED|Intervention 1||1
178035|NCT00584831|413337|P18|STARTED|Intervention 1||1
178036|NCT00584831|413338|P17|STARTED|Intervention 1||4
178037|NCT00584831|413339|P16|STARTED|Intervention 1||1
178038|NCT00584831|413340|P15|STARTED|Intervention 1||3
178039|NCT00584831|413341|P14|STARTED|Intervention 1||1
178040|NCT00584831|413342|P13|STARTED|Intervention 1||2
178041|NCT00584831|413343|P12|STARTED|Intervention 1||1
178042|NCT00584831|413344|P11|STARTED|Intervention 1||2
178043|NCT00584831|413345|P10|STARTED|Intervention 1||2
178044|NCT00584831|413346|P9|STARTED|Intervention 1||4
178045|NCT00584831|413347|P8|STARTED|Intervention 1||2
178046|NCT00584831|413348|P7|STARTED|Intervention 1||6
178047|NCT00584831|413349|P6|STARTED|Intervention 1||1
178048|NCT00584831|413350|P5|STARTED|Intervention 1||2
178049|NCT00584831|413351|P4|STARTED|Intervention 1||1
178050|NCT00584831|413352|P3|STARTED|Intervention 1||2
178051|NCT00584831|413353|P2|STARTED|Intervention 1||3
178052|NCT00584831|413354|P1|STARTED|Intervention 1||1
178053|NCT00584740|413378|P2|NOT COMPLETED|Overall Study||6
178054|NCT00584740|413379|P1|NOT COMPLETED|Overall Study||12
178055|NCT00584740|413378|P2|COMPLETED|Overall Study||14
178056|NCT00584740|413379|P1|COMPLETED|Overall Study||27
178057|NCT00584740|413378|P2|STARTED|Overall Study||20
178058|NCT00584740|413379|P1|STARTED|Overall Study||39
178059|NCT00584727|413397|P6|NOT COMPLETED|Third Intervention||2
178060|NCT00584727|413398|P5|NOT COMPLETED|Third Intervention||4
178061|NCT00584727|413399|P4|NOT COMPLETED|Third Intervention||0
178062|NCT00584727|413400|P3|NOT COMPLETED|Third Intervention||1
178063|NCT00584727|413401|P2|NOT COMPLETED|Third Intervention||0
178064|NCT00584727|413402|P1|NOT COMPLETED|Third Intervention||0
178065|NCT00584727|413397|P6|COMPLETED|Third Intervention||14
178066|NCT00584727|413398|P5|COMPLETED|Third Intervention||12
178067|NCT00584727|413399|P4|COMPLETED|Third Intervention||14
178068|NCT00584727|413400|P3|COMPLETED|Third Intervention||14
178069|NCT00584727|413401|P2|COMPLETED|Third Intervention||17
178070|NCT00584727|413402|P1|COMPLETED|Third Intervention||17
178071|NCT00584727|413397|P6|STARTED|Third Intervention||16
178072|NCT00584727|413398|P5|STARTED|Third Intervention||16
178073|NCT00584727|413399|P4|STARTED|Third Intervention||14
178074|NCT00584727|413400|P3|STARTED|Third Intervention||15
178075|NCT00584727|413401|P2|STARTED|Third Intervention||17
178076|NCT00584727|413402|P1|STARTED|Third Intervention||17
178077|NCT00584727|413397|P6|NOT COMPLETED|Second Intervention||0
178078|NCT00584727|413398|P5|NOT COMPLETED|Second Intervention||0
178079|NCT00584727|413399|P4|NOT COMPLETED|Second Intervention||0
178080|NCT00584727|413400|P3|NOT COMPLETED|Second Intervention||0
178081|NCT00584727|413401|P2|NOT COMPLETED|Second Intervention||0
178082|NCT00584727|413402|P1|NOT COMPLETED|Second Intervention||0
178083|NCT00584727|413397|P6|COMPLETED|Second Intervention||16
178084|NCT00584727|413398|P5|COMPLETED|Second Intervention||16
178085|NCT00584727|413399|P4|COMPLETED|Second Intervention||14
178086|NCT00584727|413400|P3|COMPLETED|Second Intervention||15
178087|NCT00584727|413401|P2|COMPLETED|Second Intervention||17
178088|NCT00584727|413402|P1|COMPLETED|Second Intervention||17
178089|NCT00584727|413397|P6|STARTED|Second Intervention||16
178090|NCT00584727|413398|P5|STARTED|Second Intervention||16
178091|NCT00584727|413399|P4|STARTED|Second Intervention||14
178092|NCT00584727|413400|P3|STARTED|Second Intervention||15
178093|NCT00584727|413401|P2|STARTED|Second Intervention||17
178094|NCT00584727|413402|P1|STARTED|Second Intervention||17
178095|NCT00584727|413397|P6|NOT COMPLETED|First Intervention||0
178096|NCT00584727|413398|P5|NOT COMPLETED|First Intervention||0
178097|NCT00584727|413399|P4|NOT COMPLETED|First Intervention||0
178098|NCT00584727|413400|P3|NOT COMPLETED|First Intervention||1
178099|NCT00584727|413401|P2|NOT COMPLETED|First Intervention||0
178100|NCT00584727|413402|P1|NOT COMPLETED|First Intervention||0
178101|NCT00584727|413397|P6|COMPLETED|First Intervention||16
178102|NCT00584727|413398|P5|COMPLETED|First Intervention||16
178103|NCT00584727|413399|P4|COMPLETED|First Intervention||14
178104|NCT00584727|413400|P3|COMPLETED|First Intervention||15
178105|NCT00584727|413401|P2|COMPLETED|First Intervention||17
178106|NCT00584727|413402|P1|COMPLETED|First Intervention||17
178107|NCT00584727|413397|P6|STARTED|First Intervention||16
178108|NCT00584727|413398|P5|STARTED|First Intervention||16
178109|NCT00584727|413399|P4|STARTED|First Intervention||14
178110|NCT00584727|413400|P3|STARTED|First Intervention||16
178111|NCT00584727|413401|P2|STARTED|First Intervention||17
178112|NCT00584727|413402|P1|STARTED|First Intervention||17
178113|NCT00584701|413426|P1|NOT COMPLETED|Follow-up||12
178114|NCT00584701|413426|P1|COMPLETED|Follow-up||34
178115|NCT00584701|413426|P1|STARTED|Follow-up||46
178116|NCT00584701|413426|P1|NOT COMPLETED|Active Risperidone||3
178117|NCT00584701|413426|P1|COMPLETED|Active Risperidone||46
178118|NCT00584701|413426|P1|STARTED|Active Risperidone||49
178119|NCT00584480|413431|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
178120|NCT00584480|413431|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
178121|NCT00584480|413431|P1|STARTED|Second 8 Weeks (40 Treatments)||10
178122|NCT00584480|413431|P1|NOT COMPLETED|4-Week Break From Treatment||0
178123|NCT00584480|413431|P1|COMPLETED|4-Week Break From Treatment||10
178124|NCT00584480|413431|P1|STARTED|4-Week Break From Treatment||10
178125|NCT00584480|413431|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
178126|NCT00584480|413431|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
178127|NCT00584480|413431|P1|STARTED|First 8 Weeks (40 Treatments)||10
178128|NCT00584415|413435|P1|NOT COMPLETED|Overall Study||7
178129|NCT00584415|413435|P1|COMPLETED|Overall Study||112
178130|NCT00584415|413435|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
178131|NCT00584220|413440|P2|NOT COMPLETED|Second Period||0
178132|NCT00584220|413441|P1|NOT COMPLETED|Second Period||0
178133|NCT00584220|413440|P2|COMPLETED|Second Period||39
178134|NCT00584220|413441|P1|COMPLETED|Second Period||48
178135|NCT00584220|413440|P2|STARTED|Second Period||39
178136|NCT00584220|413441|P1|STARTED|Second Period||48
178137|NCT00584220|413440|P2|NOT COMPLETED|First Period||0
178138|NCT00584220|413441|P1|NOT COMPLETED|First Period||0
178139|NCT00584220|413440|P2|COMPLETED|First Period||39
178140|NCT00584220|413441|P1|COMPLETED|First Period||48
178141|NCT00584220|413440|P2|STARTED|First Period||39
178142|NCT00584220|413441|P1|STARTED|First Period||48
178143|NCT00584077|413449|P1|NOT COMPLETED|Overall Study||0
178144|NCT00584077|413449|P1|COMPLETED|Overall Study||15
178145|NCT00584077|413449|P1|STARTED|Overall Study||15
178146|NCT00583947|413455|P2|NOT COMPLETED|Open Label Period||0
178147|NCT00583947|413456|P1|NOT COMPLETED|Open Label Period||0
178148|NCT00583947|413455|P2|COMPLETED|Open Label Period||24
178149|NCT00583947|413456|P1|COMPLETED|Open Label Period||22
178150|NCT00583947|413455|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
178151|NCT00583947|413456|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
178152|NCT00583947|413455|P2|NOT COMPLETED|Washout||0
178153|NCT00583947|413456|P1|NOT COMPLETED|Washout||0
178154|NCT00583947|413455|P2|COMPLETED|Washout||24
178155|NCT00583947|413456|P1|COMPLETED|Washout||22
178156|NCT00583947|413455|P2|STARTED|Washout||24
178157|NCT00583947|413456|P1|STARTED|Washout||22
178158|NCT00583947|413455|P2|NOT COMPLETED|Cross-over Period||2
178159|NCT00583947|413456|P1|NOT COMPLETED|Cross-over Period||5
178160|NCT00583947|413455|P2|COMPLETED|Cross-over Period||24
178161|NCT00583947|413456|P1|COMPLETED|Cross-over Period||22
178162|NCT00583947|413455|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
178163|NCT00583947|413456|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
178164|NCT00583908|413506|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
178165|NCT00583908|413507|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
178166|NCT00583908|413508|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
178167|NCT00583908|413509|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
178168|NCT00583908|413510|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
178169|NCT00583908|413511|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
178170|NCT00583908|413512|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
178171|NCT00583908|413513|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
178172|NCT00583908|413514|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
178173|NCT00583908|413515|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
178174|NCT00583908|413516|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
178175|NCT00583908|413517|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
178176|NCT00583908|413506|P12|COMPLETED|Period 4 - Fourth Intervention||1
178177|NCT00583908|413507|P11|COMPLETED|Period 4 - Fourth Intervention||1
178178|NCT00583908|413508|P10|COMPLETED|Period 4 - Fourth Intervention||1
178179|NCT00583908|413509|P9|COMPLETED|Period 4 - Fourth Intervention||1
178180|NCT00583908|413510|P8|COMPLETED|Period 4 - Fourth Intervention||1
178181|NCT00583908|413511|P7|COMPLETED|Period 4 - Fourth Intervention||1
178182|NCT00583908|413512|P6|COMPLETED|Period 4 - Fourth Intervention||1
178183|NCT00583908|413513|P5|COMPLETED|Period 4 - Fourth Intervention||2
178184|NCT00583908|413514|P4|COMPLETED|Period 4 - Fourth Intervention||1
178185|NCT00583908|413515|P3|COMPLETED|Period 4 - Fourth Intervention||1
178186|NCT00583908|413516|P2|COMPLETED|Period 4 - Fourth Intervention||2
178187|NCT00583908|413517|P1|COMPLETED|Period 4 - Fourth Intervention||1
178188|NCT00583908|413506|P12|STARTED|Period 4 - Fourth Intervention||1
178189|NCT00583908|413507|P11|STARTED|Period 4 - Fourth Intervention||1
178190|NCT00583908|413508|P10|STARTED|Period 4 - Fourth Intervention||1
178191|NCT00583908|413509|P9|STARTED|Period 4 - Fourth Intervention||1
178192|NCT00583908|413510|P8|STARTED|Period 4 - Fourth Intervention||1
178193|NCT00583908|413511|P7|STARTED|Period 4 - Fourth Intervention||1
178194|NCT00583908|413512|P6|STARTED|Period 4 - Fourth Intervention||1
178195|NCT00583908|413513|P5|STARTED|Period 4 - Fourth Intervention||2
178196|NCT00583908|413514|P4|STARTED|Period 4 - Fourth Intervention||1
178197|NCT00583908|413515|P3|STARTED|Period 4 - Fourth Intervention||1
178198|NCT00583908|413516|P2|STARTED|Period 4 - Fourth Intervention||2
178199|NCT00583908|413517|P1|STARTED|Period 4 - Fourth Intervention||1
178200|NCT00583908|413506|P12|NOT COMPLETED|Period 3 - Third Intervention||0
178201|NCT00583908|413507|P11|NOT COMPLETED|Period 3 - Third Intervention||0
178202|NCT00583908|413508|P10|NOT COMPLETED|Period 3 - Third Intervention||0
178203|NCT00583908|413509|P9|NOT COMPLETED|Period 3 - Third Intervention||0
178204|NCT00583908|413510|P8|NOT COMPLETED|Period 3 - Third Intervention||0
178205|NCT00583908|413511|P7|NOT COMPLETED|Period 3 - Third Intervention||0
178206|NCT00583908|413512|P6|NOT COMPLETED|Period 3 - Third Intervention||0
178207|NCT00583908|413513|P5|NOT COMPLETED|Period 3 - Third Intervention||0
178208|NCT00583908|413514|P4|NOT COMPLETED|Period 3 - Third Intervention||0
178209|NCT00583908|413515|P3|NOT COMPLETED|Period 3 - Third Intervention||0
178210|NCT00583908|413516|P2|NOT COMPLETED|Period 3 - Third Intervention||0
178211|NCT00583908|413517|P1|NOT COMPLETED|Period 3 - Third Intervention||0
178212|NCT00583908|413506|P12|COMPLETED|Period 3 - Third Intervention||1
178213|NCT00583908|413507|P11|COMPLETED|Period 3 - Third Intervention||1
178214|NCT00583908|413508|P10|COMPLETED|Period 3 - Third Intervention||1
178215|NCT00583908|413509|P9|COMPLETED|Period 3 - Third Intervention||1
178216|NCT00583908|413510|P8|COMPLETED|Period 3 - Third Intervention||1
178217|NCT00583908|413511|P7|COMPLETED|Period 3 - Third Intervention||1
178218|NCT00583908|413512|P6|COMPLETED|Period 3 - Third Intervention||1
178219|NCT00583908|413513|P5|COMPLETED|Period 3 - Third Intervention||2
178220|NCT00583908|413514|P4|COMPLETED|Period 3 - Third Intervention||1
178221|NCT00583908|413515|P3|COMPLETED|Period 3 - Third Intervention||1
178222|NCT00583908|413516|P2|COMPLETED|Period 3 - Third Intervention||2
178223|NCT00583908|413517|P1|COMPLETED|Period 3 - Third Intervention||1
178224|NCT00583908|413506|P12|STARTED|Period 3 - Third Intervention||1
178225|NCT00583908|413507|P11|STARTED|Period 3 - Third Intervention||1
178226|NCT00583908|413508|P10|STARTED|Period 3 - Third Intervention||1
178227|NCT00583908|413509|P9|STARTED|Period 3 - Third Intervention||1
178228|NCT00583908|413510|P8|STARTED|Period 3 - Third Intervention||1
178229|NCT00583908|413511|P7|STARTED|Period 3 - Third Intervention||1
178230|NCT00583908|413512|P6|STARTED|Period 3 - Third Intervention||1
178231|NCT00583908|413513|P5|STARTED|Period 3 - Third Intervention||2
178232|NCT00583908|413514|P4|STARTED|Period 3 - Third Intervention||1
178233|NCT00583908|413515|P3|STARTED|Period 3 - Third Intervention||1
178234|NCT00583908|413516|P2|STARTED|Period 3 - Third Intervention||2
178235|NCT00583908|413517|P1|STARTED|Period 3 - Third Intervention||1
178236|NCT00583908|413506|P12|NOT COMPLETED|Period 2 - Second Intervention||0
178237|NCT00583908|413507|P11|NOT COMPLETED|Period 2 - Second Intervention||0
178238|NCT00583908|413508|P10|NOT COMPLETED|Period 2 - Second Intervention||0
178239|NCT00583908|413509|P9|NOT COMPLETED|Period 2 - Second Intervention||0
178240|NCT00583908|413510|P8|NOT COMPLETED|Period 2 - Second Intervention||0
178241|NCT00583908|413511|P7|NOT COMPLETED|Period 2 - Second Intervention||0
178242|NCT00583908|413512|P6|NOT COMPLETED|Period 2 - Second Intervention||0
178243|NCT00583908|413513|P5|NOT COMPLETED|Period 2 - Second Intervention||0
178244|NCT00583908|413514|P4|NOT COMPLETED|Period 2 - Second Intervention||0
178245|NCT00583908|413515|P3|NOT COMPLETED|Period 2 - Second Intervention||0
178246|NCT00583908|413516|P2|NOT COMPLETED|Period 2 - Second Intervention||0
178247|NCT00583908|413517|P1|NOT COMPLETED|Period 2 - Second Intervention||0
178248|NCT00583908|413506|P12|COMPLETED|Period 2 - Second Intervention||1
178249|NCT00583908|413507|P11|COMPLETED|Period 2 - Second Intervention||1
178250|NCT00583908|413508|P10|COMPLETED|Period 2 - Second Intervention||1
178251|NCT00583908|413509|P9|COMPLETED|Period 2 - Second Intervention||1
178252|NCT00583908|413510|P8|COMPLETED|Period 2 - Second Intervention||1
178253|NCT00583908|413511|P7|COMPLETED|Period 2 - Second Intervention||1
178254|NCT00583908|413512|P6|COMPLETED|Period 2 - Second Intervention||1
178255|NCT00583908|413513|P5|COMPLETED|Period 2 - Second Intervention||2
178256|NCT00583908|413514|P4|COMPLETED|Period 2 - Second Intervention||1
178257|NCT00583908|413515|P3|COMPLETED|Period 2 - Second Intervention||1
178258|NCT00583908|413516|P2|COMPLETED|Period 2 - Second Intervention||2
178259|NCT00583908|413517|P1|COMPLETED|Period 2 - Second Intervention||1
178260|NCT00583908|413506|P12|STARTED|Period 2 - Second Intervention||1
178261|NCT00583908|413507|P11|STARTED|Period 2 - Second Intervention||1
178262|NCT00583908|413508|P10|STARTED|Period 2 - Second Intervention||1
178263|NCT00583908|413509|P9|STARTED|Period 2 - Second Intervention||1
178264|NCT00583908|413510|P8|STARTED|Period 2 - Second Intervention||1
178265|NCT00583908|413511|P7|STARTED|Period 2 - Second Intervention||1
178266|NCT00583908|413512|P6|STARTED|Period 2 - Second Intervention||1
178267|NCT00583908|413513|P5|STARTED|Period 2 - Second Intervention||2
178268|NCT00583908|413514|P4|STARTED|Period 2 - Second Intervention||1
178269|NCT00583908|413515|P3|STARTED|Period 2 - Second Intervention||1
178270|NCT00583908|413516|P2|STARTED|Period 2 - Second Intervention||2
178271|NCT00583908|413517|P1|STARTED|Period 2 - Second Intervention||1
178272|NCT00583908|413506|P12|NOT COMPLETED|Period 1 - First Intervention||0
178273|NCT00583908|413507|P11|NOT COMPLETED|Period 1 - First Intervention||0
178274|NCT00583908|413508|P10|NOT COMPLETED|Period 1 - First Intervention||0
178275|NCT00583908|413509|P9|NOT COMPLETED|Period 1 - First Intervention||0
178276|NCT00583908|413510|P8|NOT COMPLETED|Period 1 - First Intervention||0
178277|NCT00583908|413511|P7|NOT COMPLETED|Period 1 - First Intervention||0
178278|NCT00583908|413512|P6|NOT COMPLETED|Period 1 - First Intervention||0
178279|NCT00583908|413513|P5|NOT COMPLETED|Period 1 - First Intervention||0
178280|NCT00583908|413514|P4|NOT COMPLETED|Period 1 - First Intervention||0
178281|NCT00583908|413515|P3|NOT COMPLETED|Period 1 - First Intervention||0
178282|NCT00583908|413516|P2|NOT COMPLETED|Period 1 - First Intervention||0
178283|NCT00583908|413517|P1|NOT COMPLETED|Period 1 - First Intervention||0
178284|NCT00583908|413506|P12|COMPLETED|Period 1 - First Intervention||1
178285|NCT00583908|413507|P11|COMPLETED|Period 1 - First Intervention||1
178286|NCT00583908|413508|P10|COMPLETED|Period 1 - First Intervention||1
178287|NCT00583908|413509|P9|COMPLETED|Period 1 - First Intervention||1
178288|NCT00583908|413510|P8|COMPLETED|Period 1 - First Intervention||1
178289|NCT00583908|413511|P7|COMPLETED|Period 1 - First Intervention||1
178290|NCT00583908|413512|P6|COMPLETED|Period 1 - First Intervention||1
178291|NCT00583908|413513|P5|COMPLETED|Period 1 - First Intervention||2
178292|NCT00583908|413514|P4|COMPLETED|Period 1 - First Intervention||1
178293|NCT00583908|413515|P3|COMPLETED|Period 1 - First Intervention||1
178294|NCT00583908|413516|P2|COMPLETED|Period 1 - First Intervention||2
178295|NCT00583908|413517|P1|COMPLETED|Period 1 - First Intervention||1
178296|NCT00583908|413506|P12|STARTED|Period 1 - First Intervention||1
178297|NCT00583908|413507|P11|STARTED|Period 1 - First Intervention||1
178298|NCT00583908|413508|P10|STARTED|Period 1 - First Intervention||1
178299|NCT00583908|413509|P9|STARTED|Period 1 - First Intervention||1
178300|NCT00583908|413510|P8|STARTED|Period 1 - First Intervention||1
178301|NCT00583908|413511|P7|STARTED|Period 1 - First Intervention||1
178302|NCT00583908|413512|P6|STARTED|Period 1 - First Intervention||1
178303|NCT00583908|413513|P5|STARTED|Period 1 - First Intervention||2
178304|NCT00583908|413514|P4|STARTED|Period 1 - First Intervention||1
178305|NCT00583908|413515|P3|STARTED|Period 1 - First Intervention||1
178306|NCT00583908|413516|P2|STARTED|Period 1 - First Intervention||2
178307|NCT00583908|413517|P1|STARTED|Period 1 - First Intervention||1
178308|NCT00583713|413574|P3|NOT COMPLETED|Overall Study||0
178309|NCT00583713|413575|P2|NOT COMPLETED|Overall Study||0
178310|NCT00583713|413576|P1|NOT COMPLETED|Overall Study||0
178311|NCT00583713|413574|P3|COMPLETED|Overall Study||6
178312|NCT00583713|413575|P2|COMPLETED|Overall Study||6
178313|NCT00583713|413576|P1|COMPLETED|Overall Study||6
178314|NCT00583713|413574|P3|STARTED|Overall Study||6
178315|NCT00583713|413575|P2|STARTED|Overall Study||6
178316|NCT00583713|413576|P1|STARTED|Overall Study||6
178317|NCT00583700|413601|P2|NOT COMPLETED|Overall Study||4
178318|NCT00583700|413602|P1|NOT COMPLETED|Overall Study||3
178319|NCT00583700|413601|P2|COMPLETED|Overall Study||23
178320|NCT00583700|413602|P1|COMPLETED|Overall Study||24
178321|NCT00583700|413601|P2|STARTED|Overall Study||27
178322|NCT00583700|413602|P1|STARTED|Overall Study||27
178323|NCT00583661|413610|P1|NOT COMPLETED|Overall Study||0
178324|NCT00583661|413610|P1|COMPLETED|Overall Study||48
178325|NCT00583661|413610|P1|STARTED|Overall Study||48
178326|NCT00583622|413617|P1|NOT COMPLETED|Overall Study||0
178327|NCT00583622|413617|P1|COMPLETED|Overall Study||12
178328|NCT00583622|413617|P1|STARTED|Overall Study||12
178329|NCT00583596|413622|P1|NOT COMPLETED|Overall Study||284
178330|NCT00583596|413622|P1|COMPLETED|Overall Study||152
178331|NCT00583596|413622|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
178332|NCT00583557|413627|P1|NOT COMPLETED|Overall Study||70
178333|NCT00583557|413627|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
178334|NCT00583557|413627|P1|Received at Least 1 Dose Belimumab|Overall Study||153
178335|NCT00583557|413627|P1|STARTED|Overall Study||155
178336|NCT00583492|413633|P2|NOT COMPLETED|Overall Study||0
178337|NCT00583492|413634|P1|NOT COMPLETED|Overall Study||0
178338|NCT00583492|413633|P2|COMPLETED|Overall Study||23
178339|NCT00583492|413634|P1|COMPLETED|Overall Study||21
178340|NCT00583492|413633|P2|STARTED|Overall Study||23
178341|NCT00583492|413634|P1|STARTED|Overall Study||21
178342|NCT00583219|413650|P1|NOT COMPLETED|Phase 2||1
178343|NCT00583219|413650|P1|COMPLETED|Phase 2||21
178344|NCT00583219|413650|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
178345|NCT00583219|413650|P1|NOT COMPLETED|Phase 1||0
178346|NCT00583219|413650|P1|COMPLETED|Phase 1||9
178347|NCT00583219|413650|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
178348|NCT00583115|413667|P1|NOT COMPLETED|Overall Study||1
178349|NCT00583115|413667|P1|COMPLETED|Overall Study||0
178350|NCT00583115|413667|P1|STARTED|Overall Study||1
178351|NCT00582972|413672|P1|NOT COMPLETED|Overall Study||2
178352|NCT00582972|413672|P1|COMPLETED|Overall Study||21
178353|NCT00582972|413672|P1|STARTED|Overall Study||23
178354|NCT00582946|413677|P1|NOT COMPLETED|Overall Study||0
178355|NCT00582946|413677|P1|COMPLETED|Overall Study||16
178356|NCT00582946|413677|P1|STARTED|Overall Study||16
178357|NCT00582933|413681|P1|NOT COMPLETED|Overall Study||3
178358|NCT00582933|413681|P1|COMPLETED|Overall Study||92
178359|NCT00582933|413681|P1|STARTED|Overall Study||95
178360|NCT00582907|413685|P4|NOT COMPLETED|4th Course||0
178361|NCT00582907|413686|P3|NOT COMPLETED|4th Course||0
178362|NCT00582907|413687|P2|NOT COMPLETED|4th Course||0
178363|NCT00582907|413688|P1|NOT COMPLETED|4th Course||0
178364|NCT00582907|413685|P4|COMPLETED|4th Course||3
178365|NCT00582907|413686|P3|COMPLETED|4th Course||3
178366|NCT00582907|413687|P2|COMPLETED|4th Course||3
178367|NCT00582907|413688|P1|COMPLETED|4th Course||2
178368|NCT00582907|413685|P4|STARTED|4th Course||3
178369|NCT00582907|413686|P3|STARTED|4th Course||3
178370|NCT00582907|413687|P2|STARTED|4th Course||3
178371|NCT00582907|413688|P1|STARTED|4th Course||2
178372|NCT00582907|413685|P4|NOT COMPLETED|3rd Course||0
178373|NCT00582907|413686|P3|NOT COMPLETED|3rd Course||0
178374|NCT00582907|413687|P2|NOT COMPLETED|3rd Course||0
178375|NCT00582907|413688|P1|NOT COMPLETED|3rd Course||0
178376|NCT00582907|413685|P4|COMPLETED|3rd Course||3
178377|NCT00582907|413686|P3|COMPLETED|3rd Course||3
178378|NCT00582907|413687|P2|COMPLETED|3rd Course||3
178379|NCT00582907|413688|P1|COMPLETED|3rd Course||2
178380|NCT00582907|413685|P4|STARTED|3rd Course||3
178381|NCT00582907|413686|P3|STARTED|3rd Course||3
178382|NCT00582907|413687|P2|STARTED|3rd Course||3
178383|NCT00582907|413688|P1|STARTED|3rd Course||2
178384|NCT00582907|413685|P4|NOT COMPLETED|2nd Course||0
178385|NCT00582907|413686|P3|NOT COMPLETED|2nd Course||0
178386|NCT00582907|413687|P2|NOT COMPLETED|2nd Course||0
178387|NCT00582907|413688|P1|NOT COMPLETED|2nd Course||1
178388|NCT00582907|413685|P4|COMPLETED|2nd Course||3
178389|NCT00582907|413686|P3|COMPLETED|2nd Course||3
178390|NCT00582907|413687|P2|COMPLETED|2nd Course||3
178391|NCT00582907|413688|P1|COMPLETED|2nd Course||2
178392|NCT00582907|413685|P4|STARTED|2nd Course||3
178393|NCT00582907|413686|P3|STARTED|2nd Course||3
178394|NCT00582907|413687|P2|STARTED|2nd Course||3
178395|NCT00582907|413688|P1|STARTED|2nd Course||3
178396|NCT00582907|413685|P4|NOT COMPLETED|1st Course||1
178397|NCT00582907|413686|P3|NOT COMPLETED|1st Course||0
178398|NCT00582907|413687|P2|NOT COMPLETED|1st Course||0
178399|NCT00582907|413688|P1|NOT COMPLETED|1st Course||1
178400|NCT00582907|413685|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
178401|NCT00582907|413686|P3|COMPLETED|1st Course||3
178402|NCT00582907|413687|P2|COMPLETED|1st Course||3
178403|NCT00582907|413688|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
178404|NCT00582907|413685|P4|STARTED|1st Course||4
178405|NCT00582907|413686|P3|STARTED|1st Course||3
178406|NCT00582907|413687|P2|STARTED|1st Course||3
178407|NCT00582907|413688|P1|STARTED|1st Course||4
178408|NCT00582894|413720|P1|NOT COMPLETED|Overall Study||0
178409|NCT00582894|413720|P1|COMPLETED|Overall Study||17
178410|NCT00582894|413720|P1|Day 100 Post Transplant|Overall Study||17
178411|NCT00582894|413720|P1|STARTED|Overall Study||17
178412|NCT00582790|413727|P1|NOT COMPLETED|Overall Study||1
178413|NCT00582790|413727|P1|COMPLETED|Overall Study||11
178414|NCT00582790|413727|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
178415|NCT00582738|413736|P2|NOT COMPLETED|Overall Study||18
178416|NCT00582738|413737|P1|NOT COMPLETED|Overall Study||9
178417|NCT00582738|413736|P2|COMPLETED|Overall Study||4
178418|NCT00582738|413737|P1|COMPLETED|Overall Study||12
178419|NCT00582738|413736|P2|STARTED|Overall Study||22
178420|NCT00582738|413737|P1|STARTED|Overall Study||21
178421|NCT00582712|413761|P1|NOT COMPLETED|Overall Study||4
178422|NCT00582712|413761|P1|COMPLETED|Overall Study||1
178423|NCT00582712|413761|P1|STARTED|Overall Study||5
178424|NCT00582660|413767|P2|NOT COMPLETED|Overall Study||0
178425|NCT00582660|413768|P1|NOT COMPLETED|Overall Study||0
178426|NCT00582660|413767|P2|COMPLETED|Overall Study||20
178427|NCT00582660|413768|P1|COMPLETED|Overall Study||20
178428|NCT00582660|413767|P2|STARTED|Overall Study||20
178429|NCT00582660|413768|P1|STARTED|Overall Study||20
178430|NCT00582556|413779|P3|NOT COMPLETED|Overall Study||2
178431|NCT00582556|413780|P2|NOT COMPLETED|Overall Study||1
178432|NCT00582556|413781|P1|NOT COMPLETED|Overall Study||0
178433|NCT00582556|413779|P3|COMPLETED|Overall Study||12
178434|NCT00582556|413780|P2|COMPLETED|Overall Study||14
178435|NCT00582556|413781|P1|COMPLETED|Overall Study||14
178436|NCT00582556|413779|P3|STARTED|Overall Study||14
178437|NCT00582556|413780|P2|STARTED|Overall Study||15
178438|NCT00582556|413781|P1|STARTED|Overall Study||14
178439|NCT00582517|413800|P2|NOT COMPLETED|Overall Study||0
178440|NCT00582517|413801|P1|NOT COMPLETED|Overall Study||0
178441|NCT00582517|413800|P2|COMPLETED|Overall Study||55
178442|NCT00582517|413801|P1|COMPLETED|Overall Study||45
178443|NCT00582517|413800|P2|STARTED|Overall Study||55
178444|NCT00582517|413801|P1|STARTED|Overall Study||45
178445|NCT00582491|413809|P2|NOT COMPLETED|Overall Study||0
178446|NCT00582491|413810|P1|NOT COMPLETED|Overall Study||1
178447|NCT00582491|413809|P2|COMPLETED|Overall Study||10
178448|NCT00582491|413810|P1|COMPLETED|Overall Study||10
178449|NCT00582491|413809|P2|STARTED|Overall Study||10
178450|NCT00582491|413810|P1|STARTED|Overall Study||11
178451|NCT00582426|413834|P2|NOT COMPLETED|Overall Study||13
178452|NCT00582426|413835|P1|NOT COMPLETED|Overall Study||20
178453|NCT00582426|413834|P2|COMPLETED|Overall Study||58
178454|NCT00582426|413835|P1|COMPLETED|Overall Study||48
178455|NCT00582426|413834|P2|STARTED|Overall Study||71
178456|NCT00582426|413835|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
178457|NCT00582400|413861|P1|NOT COMPLETED|Overall Study||3
178458|NCT00582400|413861|P1|COMPLETED|Overall Study||6
178459|NCT00582400|413861|P1|STARTED|Overall Study||9
178460|NCT00582361|413870|P2|NOT COMPLETED|Overall Study||0
178461|NCT00582361|413871|P1|NOT COMPLETED|Overall Study||0
178462|NCT00582361|413870|P2|COMPLETED|Overall Study||38
178463|NCT00582361|413871|P1|COMPLETED|Overall Study||25
178464|NCT00582361|413870|P2|STARTED|Overall Study||38
178465|NCT00582361|413871|P1|STARTED|Overall Study||25
178466|NCT00582309|413882|P3|NOT COMPLETED|Overall Study||2
178467|NCT00582309|413883|P2|NOT COMPLETED|Overall Study||0
178468|NCT00582309|413884|P1|NOT COMPLETED|Overall Study||0
178469|NCT00582309|413882|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
178470|NCT00582309|413883|P2|COMPLETED|Overall Study||49
178471|NCT00582309|413884|P1|COMPLETED|Overall Study||56
178472|NCT00582309|413882|P3|STARTED|Overall Study||46
178473|NCT00582309|413883|P2|STARTED|Overall Study||49
178474|NCT00582309|413884|P1|STARTED|Overall Study||56
178475|NCT00582114|413894|P2|NOT COMPLETED|Overall Study||54
178476|NCT00582114|413895|P1|NOT COMPLETED|Overall Study||42
178477|NCT00582114|413894|P2|COMPLETED|Overall Study||46
178478|NCT00582114|413895|P1|COMPLETED|Overall Study||58
178479|NCT00582114|413894|P2|STARTED|Overall Study||100
178480|NCT00582114|413895|P1|STARTED|Overall Study||100
178481|NCT00582075|413903|P1|NOT COMPLETED|Overall Study||0
178482|NCT00582075|413903|P1|COMPLETED|Overall Study||25
178483|NCT00582075|413903|P1|STARTED|Overall Study||25
178484|NCT00582036|413910|P2|NOT COMPLETED|Overall Study||1
178485|NCT00582036|413911|P1|NOT COMPLETED|Overall Study||0
178486|NCT00582036|413910|P2|COMPLETED|Overall Study|One patient withdrew consent|5
178487|NCT00582036|413911|P1|COMPLETED|Overall Study||5
178488|NCT00582036|413910|P2|STARTED|Overall Study||6
178489|NCT00582036|413911|P1|STARTED|Overall Study||5
178490|NCT00582010|413919|P2|NOT COMPLETED|Overall Study||1
178491|NCT00582010|413920|P1|NOT COMPLETED|Overall Study||0
178492|NCT00582010|413919|P2|COMPLETED|Overall Study||39
178493|NCT00582010|413920|P1|COMPLETED|Overall Study||40
178494|NCT00582010|413919|P2|STARTED|Overall Study||40
178495|NCT00582010|413920|P1|STARTED|Overall Study||40
178496|NCT00581971|413942|P1|NOT COMPLETED|Overall Study||0
178497|NCT00581971|413942|P1|COMPLETED|Overall Study||30
178498|NCT00581971|413942|P1|STARTED|Overall Study||30
178499|NCT00581945|413949|P2|NOT COMPLETED|Overall Study||10
178500|NCT00581945|413950|P1|NOT COMPLETED|Overall Study||9
178501|NCT00581945|413949|P2|COMPLETED|Overall Study||63
178502|NCT00581945|413950|P1|COMPLETED|Overall Study||65
178503|NCT00581945|413949|P2|STARTED|Overall Study||73
178504|NCT00581945|413950|P1|STARTED|Overall Study||74
178505|NCT00581919|413966|P1|NOT COMPLETED|Overall Study||24
178506|NCT00581919|413966|P1|COMPLETED|Overall Study||8
178507|NCT00581919|413966|P1|STARTED|Overall Study||32
178508|NCT00581867|413972|P2|NOT COMPLETED|Second Intervention||0
178509|NCT00581867|413973|P1|NOT COMPLETED|Second Intervention||0
178510|NCT00581867|413972|P2|COMPLETED|Second Intervention||14
178511|NCT00581867|413973|P1|COMPLETED|Second Intervention||15
178512|NCT00581867|413972|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
178513|NCT00581867|413973|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
178514|NCT00581867|413972|P2|NOT COMPLETED|First Intervention||0
178515|NCT00581867|413973|P1|NOT COMPLETED|First Intervention||0
178516|NCT00581867|413972|P2|COMPLETED|First Intervention||15
178517|NCT00581867|413973|P1|COMPLETED|First Intervention||16
178518|NCT00581867|413972|P2|STARTED|First Intervention||15
178519|NCT00581867|413973|P1|STARTED|First Intervention||16
178520|NCT00581854|413981|P1|NOT COMPLETED|Overall Study||0
178521|NCT00581854|413981|P1|COMPLETED|Overall Study||22
178522|NCT00581854|413981|P1|STARTED|Overall Study||22
178523|NCT00581828|413985|P1|NOT COMPLETED|Overall Study||1
178524|NCT00581828|413985|P1|COMPLETED|Overall Study||18
178525|NCT00581828|413985|P1|STARTED|Overall Study||19
178526|NCT00581776|413989|P1|NOT COMPLETED|Overall Study||3
178527|NCT00581776|413989|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
178528|NCT00581776|413989|P1|STARTED|Overall Study||30
178529|NCT00581581|413998|P2|NOT COMPLETED|Overall Study||0
178530|NCT00581581|413999|P1|NOT COMPLETED|Overall Study||0
178531|NCT00581581|413998|P2|COMPLETED|Overall Study||30
178532|NCT00581581|413999|P1|COMPLETED|Overall Study||32
178533|NCT00581581|413998|P2|STARTED|Overall Study||30
178534|NCT00581581|413999|P1|STARTED|Overall Study||32
178535|NCT00581555|414007|P2|NOT COMPLETED|Overall Study||20
178536|NCT00581555|414008|P1|NOT COMPLETED|Overall Study||43
178537|NCT00581555|414007|P2|COMPLETED|Overall Study||38
178538|NCT00581555|414008|P1|COMPLETED|Overall Study||19
178539|NCT00581555|414007|P2|STARTED|Overall Study||58
178540|NCT00581555|414008|P1|STARTED|Overall Study||62
178541|NCT00581542|414032|P2|NOT COMPLETED|Overall Study||23
178542|NCT00581542|414033|P1|NOT COMPLETED|Overall Study||11
178543|NCT00581542|414032|P2|COMPLETED|Overall Study||39
178544|NCT00581542|414033|P1|COMPLETED|Overall Study||51
178545|NCT00581542|414032|P2|STARTED|Overall Study||62
178546|NCT00581542|414033|P1|STARTED|Overall Study||62
178547|NCT00581529|414041|P1|NOT COMPLETED|Overall Study||0
178548|NCT00581529|414041|P1|COMPLETED|Overall Study||34
178549|NCT00581529|414041|P1|STARTED|Overall Study||34
178550|NCT00581399|414048|P2|NOT COMPLETED|Overall Study||0
178551|NCT00581399|414049|P1|NOT COMPLETED|Overall Study||0
178552|NCT00581399|414048|P2|COMPLETED|Overall Study||48
178553|NCT00581399|414049|P1|COMPLETED|Overall Study||46
178554|NCT00581399|414048|P2|STARTED|Overall Study||48
178555|NCT00581399|414049|P1|STARTED|Overall Study||46
178556|NCT00581386|414060|P3|NOT COMPLETED|Overall Study||0
178557|NCT00581386|414061|P2|NOT COMPLETED|Overall Study||0
178558|NCT00581386|414062|P1|NOT COMPLETED|Overall Study||0
178559|NCT00581386|414060|P3|COMPLETED|Overall Study|04/15/2009|72
178560|NCT00581386|414061|P2|COMPLETED|Overall Study|04/15/2009|73
178561|NCT00581386|414062|P1|COMPLETED|Overall Study|04/15/2009|73
178562|NCT00581386|414060|P3|STARTED|Overall Study|05/30/2007|72
178563|NCT00581386|414061|P2|STARTED|Overall Study|05/30/2007|73
178564|NCT00581386|414062|P1|STARTED|Overall Study|05/30/2007|73
178565|NCT00581360|414085|P1|NOT COMPLETED|Overall Study||1
178566|NCT00581360|414085|P1|COMPLETED|Overall Study||9
178567|NCT00581360|414085|P1|STARTED|Overall Study||10
178568|NCT00581347|414095|P2|NOT COMPLETED|Overall Study||0
178569|NCT00581347|414096|P1|NOT COMPLETED|Overall Study||0
178570|NCT00581347|414095|P2|COMPLETED|Overall Study||3707
178571|NCT00581347|414096|P1|COMPLETED|Overall Study||3839
178572|NCT00581347|414095|P2|STARTED|Overall Study||3707
178573|NCT00581347|414096|P1|STARTED|Overall Study||3839
178574|NCT00581308|414104|P1|NOT COMPLETED|Month 12||21
178575|NCT00581308|414104|P1|COMPLETED|Month 12||177
178576|NCT00581308|414104|P1|STARTED|Month 12||198
178577|NCT00581308|414104|P1|NOT COMPLETED|Month 6||5
178578|NCT00581308|414104|P1|COMPLETED|Month 6||198
178579|NCT00581308|414104|P1|STARTED|Month 6||203
178580|NCT00581308|414104|P1|NOT COMPLETED|Month 1||9
178581|NCT00581308|414104|P1|COMPLETED|Month 1||203
178582|NCT00581308|414104|P1|STARTED|Month 1||212
178583|NCT00581308|414104|P1|NOT COMPLETED|Pre Discharge||3
178584|NCT00581308|414104|P1|COMPLETED|Pre Discharge||212
178585|NCT00581308|414104|P1|STARTED|Pre Discharge||215
178586|NCT00581256|414114|P2|NOT COMPLETED|Overall Study||0
178587|NCT00581256|414115|P1|NOT COMPLETED|Overall Study||0
178588|NCT00581256|414114|P2|COMPLETED|Overall Study||26
178589|NCT00581256|414115|P1|COMPLETED|Overall Study||28
178590|NCT00581256|414114|P2|STARTED|Overall Study||26
178591|NCT00581256|414115|P1|STARTED|Overall Study||28
178592|NCT00581230|414127|P1|NOT COMPLETED|Overall Study||0
178593|NCT00581230|414127|P1|COMPLETED|Overall Study||51
178594|NCT00581230|414127|P1|Laryngoscopy With RAMP|Overall Study||51
178595|NCT00581230|414127|P1|Laryngoscopy Without RAMP|Overall Study||51
178596|NCT00581230|414127|P1|STARTED|Overall Study||51
178597|NCT00581113|414136|P2|NOT COMPLETED|Overall Study||1
178598|NCT00581113|414137|P1|NOT COMPLETED|Overall Study||0
178599|NCT00581113|414136|P2|COMPLETED|Overall Study||3
178600|NCT00581113|414137|P1|COMPLETED|Overall Study||4
178601|NCT00581113|414136|P2|STARTED|Overall Study||4
178602|NCT00581113|414137|P1|STARTED|Overall Study||4
178603|NCT00581100|414147|P2|NOT COMPLETED|Overall Study||5
178604|NCT00581100|414148|P1|NOT COMPLETED|Overall Study||7
178605|NCT00581100|414147|P2|COMPLETED|Overall Study||29
178606|NCT00581100|414148|P1|COMPLETED|Overall Study||31
178607|NCT00581100|414147|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
178608|NCT00581100|414148|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
178609|NCT00581100|414147|P2|STARTED|Overall Study||34
178610|NCT00581100|414148|P1|STARTED|Overall Study||38
178611|NCT00581061|414184|P1|NOT COMPLETED|Overall Study||0
178612|NCT00581061|414184|P1|COMPLETED|Overall Study||13
178613|NCT00581061|414184|P1|STARTED|Overall Study||13
178614|NCT00580983|414190|P1|NOT COMPLETED|Overall Study||7
178615|NCT00580983|414190|P1|COMPLETED|Overall Study||73
178616|NCT00580983|414190|P1|STARTED|Overall Study||80
178617|NCT00580970|414197|P1|NOT COMPLETED|Treatment (Lovastatin)||19
178618|NCT00580970|414197|P1|COMPLETED|Treatment (Lovastatin)||53
178619|NCT00580970|414197|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
178620|NCT00580970|414197|P1|STARTED|Treatment (Lovastatin)||72
178621|NCT00580970|414197|P1|NOT COMPLETED|Pre-treatment||1
178622|NCT00580970|414197|P1|COMPLETED|Pre-treatment||72
178623|NCT00580970|414197|P1|STARTED|Pre-treatment||73
178624|NCT00580957|414203|P2|NOT COMPLETED|Overall Study||7
178625|NCT00580957|414204|P1|NOT COMPLETED|Overall Study||7
178626|NCT00580957|414203|P2|COMPLETED|Overall Study||21
178627|NCT00580957|414204|P1|COMPLETED|Overall Study||21
178628|NCT00580957|414203|P2|STARTED|Overall Study||28
178629|NCT00580957|414204|P1|STARTED|Overall Study||28
178630|NCT00580866|414212|P2|NOT COMPLETED|Overall Study||2
178631|NCT00580866|414213|P1|NOT COMPLETED|Overall Study||2
178632|NCT00580866|414212|P2|COMPLETED|Overall Study||5
178633|NCT00580866|414213|P1|COMPLETED|Overall Study||8
178634|NCT00580866|414212|P2|STARTED|Overall Study||7
178635|NCT00580866|414213|P1|STARTED|Overall Study||10
178636|NCT00580840|414221|P4|NOT COMPLETED|Double-Blind||15
178637|NCT00580840|414222|P3|NOT COMPLETED|Double-Blind||9
178638|NCT00580840|414223|P2|NOT COMPLETED|Double-Blind||7
178639|NCT00580840|414224|P1|NOT COMPLETED|Double-Blind||0
178640|NCT00580840|414221|P4|COMPLETED|Double-Blind||54
178641|NCT00580840|414222|P3|COMPLETED|Double-Blind||61
178642|NCT00580840|414223|P2|COMPLETED|Double-Blind||63
178643|NCT00580840|414224|P1|COMPLETED|Double-Blind||0
178644|NCT00580840|414221|P4|STARTED|Double-Blind||69
178645|NCT00580840|414222|P3|STARTED|Double-Blind||70
178646|NCT00580840|414223|P2|STARTED|Double-Blind||70
178647|NCT00580840|414224|P1|STARTED|Double-Blind||0
178648|NCT00580840|414221|P4|NOT COMPLETED|Run-in||0
178649|NCT00580840|414222|P3|NOT COMPLETED|Run-in||0
178650|NCT00580840|414223|P2|NOT COMPLETED|Run-in||0
178651|NCT00580840|414224|P1|NOT COMPLETED|Run-in||124
178652|NCT00580840|414221|P4|COMPLETED|Run-in||0
178653|NCT00580840|414222|P3|COMPLETED|Run-in||0
178654|NCT00580840|414223|P2|COMPLETED|Run-in||0
178655|NCT00580840|414224|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
178656|NCT00580840|414221|P4|STARTED|Run-in||0
178657|NCT00580840|414222|P3|STARTED|Run-in||0
178658|NCT00580840|414223|P2|STARTED|Run-in||0
178659|NCT00580840|414224|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
178660|NCT00580801|414332|P3|NOT COMPLETED|Overall Study||3
178661|NCT00580801|414333|P2|NOT COMPLETED|Overall Study||1
178662|NCT00580801|414334|P1|NOT COMPLETED|Overall Study||6
178663|NCT00580801|414332|P3|COMPLETED|Overall Study||5
178664|NCT00580801|414333|P2|COMPLETED|Overall Study||7
178665|NCT00580801|414334|P1|COMPLETED|Overall Study||2
178666|NCT00580801|414332|P3|STARTED|Overall Study||8
178667|NCT00580801|414333|P2|STARTED|Overall Study||8
178668|NCT00580801|414334|P1|STARTED|Overall Study||8
178669|NCT00580788|414373|P4|NOT COMPLETED|Overall Study||1
178670|NCT00580788|414374|P3|NOT COMPLETED|Overall Study||0
178671|NCT00580788|414375|P2|NOT COMPLETED|Overall Study||0
178672|NCT00580788|414376|P1|NOT COMPLETED|Overall Study||0
178673|NCT00580788|414373|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
178674|NCT00580788|414374|P3|COMPLETED|Overall Study||3
178675|NCT00580788|414375|P2|COMPLETED|Overall Study||6
178676|NCT00580788|414376|P1|COMPLETED|Overall Study||3
178677|NCT00580788|414373|P4|STARTED|Overall Study||2
178678|NCT00580788|414374|P3|STARTED|Overall Study||3
178679|NCT00580788|414375|P2|STARTED|Overall Study||6
178680|NCT00580788|414376|P1|STARTED|Overall Study||3
178681|NCT00580723|414434|P1|NOT COMPLETED|Overall Study||8
178682|NCT00580723|414434|P1|COMPLETED|Overall Study||16
178683|NCT00580723|414434|P1|STARTED|Overall Study||24
178684|NCT00580671|414443|P3|NOT COMPLETED|Overall Study||17
178685|NCT00580671|414444|P2|NOT COMPLETED|Overall Study||16
178686|NCT00580671|414445|P1|NOT COMPLETED|Overall Study||16
178687|NCT00580671|414443|P3|COMPLETED|Overall Study||34
178688|NCT00580671|414444|P2|COMPLETED|Overall Study||35
178689|NCT00580671|414445|P1|COMPLETED|Overall Study||35
178690|NCT00580671|414443|P3|STARTED|Overall Study||51
178691|NCT00580671|414444|P2|STARTED|Overall Study||51
178692|NCT00580671|414445|P1|STARTED|Overall Study||51
178693|NCT00580606|414461|P2|NOT COMPLETED|Open Label (OL)||12
178694|NCT00580606|414462|P1|NOT COMPLETED|Open Label (OL)||9
178695|NCT00580606|414461|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
178696|NCT00580606|414462|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
178697|NCT00580606|414461|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
178698|NCT00580606|414462|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
178699|NCT00580606|414461|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
178700|NCT00580606|414462|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
178701|NCT00580606|414461|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
178702|NCT00580606|414462|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
178703|NCT00580606|414461|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
178704|NCT00580606|414462|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
178785|NCT00579501|414781|P1|COMPLETED|Overall Study||0
178705|NCT00580606|414461|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
178706|NCT00580606|414462|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
178707|NCT00580606|414461|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
178708|NCT00580606|414462|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
178709|NCT00580606|414461|P2|NOT COMPLETED|Double Blind (DB)||0
178710|NCT00580606|414462|P1|NOT COMPLETED|Double Blind (DB)||0
178711|NCT00580606|414461|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
178712|NCT00580606|414462|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
178713|NCT00580606|414461|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
178714|NCT00580606|414462|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
178715|NCT00580606|414461|P2|STARTED|Double Blind (DB)||20
178716|NCT00580606|414462|P1|STARTED|Double Blind (DB)||20
178717|NCT00580502|414480|P1|NOT COMPLETED|Overall Study||0
178718|NCT00580502|414480|P1|COMPLETED|Overall Study||50
178719|NCT00580502|414480|P1|STARTED|Overall Study||50
178720|NCT00580398|414489|P2|NOT COMPLETED|Overall Study||0
178721|NCT00580398|414490|P1|NOT COMPLETED|Overall Study||0
178722|NCT00580398|414489|P2|COMPLETED|Overall Study||32
178723|NCT00580398|414490|P1|COMPLETED|Overall Study||17
178724|NCT00580398|414489|P2|STARTED|Overall Study||32
178725|NCT00580398|414490|P1|STARTED|Overall Study||17
178726|NCT00580372|414498|P1|NOT COMPLETED|Overall Study||0
178727|NCT00580372|414498|P1|COMPLETED|Overall Study||231
178728|NCT00580372|414498|P1|STARTED|Overall Study||231
178729|NCT00580294|414502|P1|NOT COMPLETED|Overall Study||0
178730|NCT00580294|414502|P1|COMPLETED|Overall Study||12
178731|NCT00580294|414502|P1|STARTED|Overall Study||12
178732|NCT00580229|414506|P1|NOT COMPLETED|Overall Study||0
178733|NCT00580229|414506|P1|COMPLETED|Overall Study||50
178734|NCT00580229|414506|P1|STARTED|Overall Study||50
178735|NCT00580151|414512|P2|NOT COMPLETED|Overall Study||0
178736|NCT00580151|414513|P1|NOT COMPLETED|Overall Study||0
178737|NCT00580151|414512|P2|COMPLETED|Overall Study||0
178738|NCT00580151|414513|P1|COMPLETED|Overall Study||9
178739|NCT00580151|414512|P2|STARTED|Overall Study||0
178740|NCT00580151|414513|P1|STARTED|Overall Study||9
178741|NCT00580138|414521|P1|NOT COMPLETED|Overall Study||0
178742|NCT00580138|414521|P1|COMPLETED|Overall Study||30
178743|NCT00580138|414521|P1|STARTED|Overall Study||30
178744|NCT00580034|414525|P2|NOT COMPLETED|Overall Study||0
178745|NCT00580034|414526|P1|NOT COMPLETED|Overall Study||10
178746|NCT00580034|414525|P2|COMPLETED|Overall Study||88
178747|NCT00580034|414526|P1|COMPLETED|Overall Study||78
178748|NCT00580034|414525|P2|STARTED|Overall Study||88
178749|NCT00580034|414526|P1|STARTED|Overall Study||88
178750|NCT00579982|414532|P1|NOT COMPLETED|Overall Study||8
178751|NCT00579982|414532|P1|COMPLETED|Overall Study||89
178752|NCT00579982|414532|P1|STARTED|Overall Study||97
178753|NCT00579813|414553|P2|NOT COMPLETED|Overall Study||0
178754|NCT00579813|414554|P1|NOT COMPLETED|Overall Study||0
178755|NCT00579813|414553|P2|COMPLETED|Overall Study||10
178756|NCT00579813|414554|P1|COMPLETED|Overall Study||60
178757|NCT00579813|414553|P2|STARTED|Overall Study||10
178758|NCT00579813|414554|P1|STARTED|Overall Study||60
178759|NCT00579670|414565|P5|NOT COMPLETED|Overall Study||0
178760|NCT00579670|414566|P4|NOT COMPLETED|Overall Study||22
178761|NCT00579670|414567|P3|NOT COMPLETED|Overall Study||4
178762|NCT00579670|414568|P2|NOT COMPLETED|Overall Study||1
178763|NCT00579670|414569|P1|NOT COMPLETED|Overall Study||2
178764|NCT00579670|414565|P5|COMPLETED|Overall Study||5
178765|NCT00579670|414566|P4|COMPLETED|Overall Study||263
178766|NCT00579670|414567|P3|COMPLETED|Overall Study||84
178767|NCT00579670|414568|P2|COMPLETED|Overall Study||56
178768|NCT00579670|414569|P1|COMPLETED|Overall Study||13
178769|NCT00579670|414565|P5|Population: Within SmPC (Completed)|Overall Study||0
178770|NCT00579670|414566|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
178771|NCT00579670|414567|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
178772|NCT00579670|414568|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
178773|NCT00579670|414569|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
178774|NCT00579670|414565|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
178775|NCT00579670|414566|P4|Population: Within SmPC (Started)|Overall Study||159
178776|NCT00579670|414567|P3|Population: Within SmPC (Started)|Overall Study||83
178777|NCT00579670|414568|P2|Population: Within SmPC (Started)|Overall Study||56
178778|NCT00579670|414569|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
178779|NCT00579670|414565|P5|STARTED|Overall Study||5
178780|NCT00579670|414566|P4|STARTED|Overall Study||285
178781|NCT00579670|414567|P3|STARTED|Overall Study||88
178782|NCT00579670|414568|P2|STARTED|Overall Study||57
178783|NCT00579670|414569|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
178784|NCT00579501|414781|P1|NOT COMPLETED|Overall Study||29
178786|NCT00579501|414781|P1|STARTED|Overall Study||29
178787|NCT00579345|414794|P8|NOT COMPLETED|Overall Study||2
178788|NCT00579345|414795|P7|NOT COMPLETED|Overall Study||0
178789|NCT00579345|414796|P6|NOT COMPLETED|Overall Study||0
178790|NCT00579345|414797|P5|NOT COMPLETED|Overall Study||0
178791|NCT00579345|414798|P4|NOT COMPLETED|Overall Study||1
178792|NCT00579345|414799|P3|NOT COMPLETED|Overall Study||2
178793|NCT00579345|414800|P2|NOT COMPLETED|Overall Study||1
178794|NCT00579345|414801|P1|NOT COMPLETED|Overall Study||5
178795|NCT00579345|414794|P8|COMPLETED|Overall Study||42
178796|NCT00579345|414795|P7|COMPLETED|Overall Study||57
178797|NCT00579345|414796|P6|COMPLETED|Overall Study||78
178798|NCT00579345|414797|P5|COMPLETED|Overall Study||90
178799|NCT00579345|414798|P4|COMPLETED|Overall Study||143
178800|NCT00579345|414799|P3|COMPLETED|Overall Study||389
178801|NCT00579345|414800|P2|COMPLETED|Overall Study||168
178802|NCT00579345|414801|P1|COMPLETED|Overall Study||544
178803|NCT00579345|414794|P8|STARTED|Overall Study||44
178804|NCT00579345|414795|P7|STARTED|Overall Study||57
178805|NCT00579345|414796|P6|STARTED|Overall Study||78
178806|NCT00579345|414797|P5|STARTED|Overall Study||90
178807|NCT00579345|414798|P4|STARTED|Overall Study||144
178808|NCT00579345|414799|P3|STARTED|Overall Study||391
178809|NCT00579345|414800|P2|STARTED|Overall Study||169
178810|NCT00579345|414801|P1|STARTED|Overall Study||549
178811|NCT00579254|414833|P1|NOT COMPLETED|Overall Study||112
178812|NCT00579254|414833|P1|COMPLETED|Overall Study||0
178813|NCT00579254|414833|P1|STARTED|Overall Study||112
178814|NCT00579137|414837|P1|NOT COMPLETED|Overall Study||0
178815|NCT00579137|414837|P1|COMPLETED|Overall Study||3
178816|NCT00579137|414837|P1|STARTED|Overall Study||3
178817|NCT00579111|414846|P2|NOT COMPLETED|Overall Study||1
178818|NCT00579111|414847|P1|NOT COMPLETED|Overall Study||2
178819|NCT00579111|414846|P2|COMPLETED|Overall Study||0
178820|NCT00579111|414847|P1|COMPLETED|Overall Study||1
178821|NCT00579111|414846|P2|STARTED|Overall Study||1
178822|NCT00579111|414847|P1|STARTED|Overall Study||3
178823|NCT00579098|414857|P2|NOT COMPLETED|Overall Study||8
178824|NCT00579098|414858|P1|NOT COMPLETED|Overall Study||9
178825|NCT00579098|414857|P2|COMPLETED|Overall Study||55
178826|NCT00579098|414858|P1|COMPLETED|Overall Study||53
178827|NCT00579098|414857|P2|STARTED|Overall Study||63
178828|NCT00579098|414858|P1|STARTED|Overall Study||62
178829|NCT00579059|414874|P2|NOT COMPLETED|Overall Study||10
178830|NCT00579059|414875|P1|NOT COMPLETED|Overall Study||21
178831|NCT00579059|414874|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
178832|NCT00579059|414875|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
178833|NCT00579059|414874|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
178834|NCT00579059|414875|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
178835|NCT00579059|414874|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
178836|NCT00579059|414875|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
178837|NCT00579059|414874|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
178838|NCT00579059|414875|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
178839|NCT00579059|414874|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
178840|NCT00579059|414875|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
178841|NCT00579059|414874|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
178842|NCT00579059|414875|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
178843|NCT00579059|414874|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
178844|NCT00579059|414875|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
178845|NCT00578968|414886|P3|NOT COMPLETED|Intervention||0
178846|NCT00578968|414887|P2|NOT COMPLETED|Intervention||0
178847|NCT00578968|414888|P1|NOT COMPLETED|Intervention||0
178848|NCT00578968|414886|P3|COMPLETED|Intervention||0
178849|NCT00578968|414887|P2|COMPLETED|Intervention||12
178850|NCT00578968|414888|P1|COMPLETED|Intervention||12
178851|NCT00578968|414886|P3|STARTED|Intervention||0
178852|NCT00578968|414887|P2|STARTED|Intervention||12
178853|NCT00578968|414888|P1|STARTED|Intervention||12
178854|NCT00578968|414886|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
178855|NCT00578968|414887|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
178856|NCT00578968|414888|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
178857|NCT00578968|414886|P3|COMPLETED|Baseline (Prior to Intervention)||12
178858|NCT00578968|414887|P2|COMPLETED|Baseline (Prior to Intervention)||12
178859|NCT00578968|414888|P1|COMPLETED|Baseline (Prior to Intervention)||12
178860|NCT00578968|414886|P3|STARTED|Baseline (Prior to Intervention)||12
178861|NCT00578968|414887|P2|STARTED|Baseline (Prior to Intervention)||12
178862|NCT00578968|414888|P1|STARTED|Baseline (Prior to Intervention)||12
178863|NCT00578942|414949|P1|NOT COMPLETED|Overall Study||1
178864|NCT00578942|414949|P1|COMPLETED|Overall Study||47
178865|NCT00578942|414949|P1|STARTED|Overall Study||48
178866|NCT00578929|414959|P4|NOT COMPLETED|Randomized Period||14
178867|NCT00578929|414960|P3|NOT COMPLETED|Randomized Period||8
178868|NCT00578929|414961|P2|NOT COMPLETED|Randomized Period||14
178869|NCT00578929|414962|P1|NOT COMPLETED|Randomized Period||17
178870|NCT00578929|414959|P4|COMPLETED|Randomized Period||283
178871|NCT00578929|414960|P3|COMPLETED|Randomized Period||288
178872|NCT00578929|414961|P2|COMPLETED|Randomized Period||283
178873|NCT00578929|414962|P1|COMPLETED|Randomized Period||281
178874|NCT00578929|414959|P4|STARTED|Randomized Period||297
178875|NCT00578929|414960|P3|STARTED|Randomized Period||296
178876|NCT00578929|414961|P2|STARTED|Randomized Period||297
178877|NCT00578929|414962|P1|STARTED|Randomized Period||298
178878|NCT00578929|414959|P4|NOT COMPLETED|Vehicle Run-In Period||0
178879|NCT00578929|414960|P3|NOT COMPLETED|Vehicle Run-In Period||0
178880|NCT00578929|414961|P2|NOT COMPLETED|Vehicle Run-In Period||0
178881|NCT00578929|414962|P1|NOT COMPLETED|Vehicle Run-In Period||0
178882|NCT00578929|414959|P4|COMPLETED|Vehicle Run-In Period||0
178883|NCT00578929|414960|P3|COMPLETED|Vehicle Run-In Period||0
178884|NCT00578929|414961|P2|COMPLETED|Vehicle Run-In Period||2388
178885|NCT00578929|414962|P1|COMPLETED|Vehicle Run-In Period||0
178886|NCT00578929|414959|P4|STARTED|Vehicle Run-In Period||0
178887|NCT00578929|414960|P3|STARTED|Vehicle Run-In Period||0
178888|NCT00578929|414961|P2|STARTED|Vehicle Run-In Period||2388
178889|NCT00578929|414962|P1|STARTED|Vehicle Run-In Period||0
178890|NCT00578903|414977|P1|NOT COMPLETED|Overall Study||0
178891|NCT00578903|414977|P1|COMPLETED|Overall Study||22
178892|NCT00578903|414977|P1|STARTED|Overall Study||22
178893|NCT00578864|414988|P2|NOT COMPLETED|Overall Study||0
178894|NCT00578864|414989|P1|NOT COMPLETED|Overall Study||1
178895|NCT00578864|414988|P2|COMPLETED|Overall Study||6
178896|NCT00578864|414989|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
178897|NCT00578864|414988|P2|STARTED|Overall Study||6
178898|NCT00578864|414989|P1|STARTED|Overall Study||7
178899|NCT00578812|415005|P2|NOT COMPLETED|Overall Study||7
178900|NCT00578812|415006|P1|NOT COMPLETED|Overall Study||6
178901|NCT00578812|415005|P2|COMPLETED|Overall Study||185
178902|NCT00578812|415006|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
178903|NCT00578812|415005|P2|STARTED|Overall Study||192
178904|NCT00578812|415006|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
178905|NCT00578786|415045|P3|NOT COMPLETED|Overall Study||30
178906|NCT00578786|415046|P2|NOT COMPLETED|Overall Study||66
178907|NCT00578786|415047|P1|NOT COMPLETED|Overall Study||39
178908|NCT00578786|415045|P3|COMPLETED|Overall Study||67
178909|NCT00578786|415046|P2|COMPLETED|Overall Study||124
178910|NCT00578786|415047|P1|COMPLETED|Overall Study||57
178911|NCT00578786|415045|P3|STARTED|Overall Study||97
178912|NCT00578786|415046|P2|STARTED|Overall Study||190
178913|NCT00578786|415047|P1|STARTED|Overall Study||96
178914|NCT00578734|415128|P2|NOT COMPLETED|Overall Study||0
178915|NCT00578734|415129|P1|NOT COMPLETED|Overall Study||0
178916|NCT00578734|415128|P2|COMPLETED|Overall Study||81
178917|NCT00578734|415129|P1|COMPLETED|Overall Study||84
178918|NCT00578734|415128|P2|STARTED|Overall Study||81
178919|NCT00578734|415129|P1|STARTED|Overall Study||84
178920|NCT00578617|415139|P2|NOT COMPLETED|Overall Study||0
178921|NCT00578617|415140|P1|NOT COMPLETED|Overall Study||0
178922|NCT00578617|415139|P2|COMPLETED|Overall Study||29
178923|NCT00578617|415140|P1|COMPLETED|Overall Study||31
178924|NCT00578617|415139|P2|STARTED|Overall Study||29
178925|NCT00578617|415140|P1|STARTED|Overall Study||31
178926|NCT00578565|415146|P1|NOT COMPLETED|Overall Study||3
178927|NCT00578565|415146|P1|COMPLETED|Overall Study||7
178928|NCT00578565|415146|P1|STARTED|Overall Study||10
178929|NCT00578552|415158|P3|NOT COMPLETED|Overall Study||15
178930|NCT00578552|415159|P2|NOT COMPLETED|Overall Study||14
178931|NCT00578552|415160|P1|NOT COMPLETED|Overall Study||15
178932|NCT00578552|415158|P3|COMPLETED|Overall Study||11
178933|NCT00578552|415159|P2|COMPLETED|Overall Study||13
178934|NCT00578552|415160|P1|COMPLETED|Overall Study||12
178935|NCT00578552|415158|P3|STARTED|Overall Study||26
178936|NCT00578552|415159|P2|STARTED|Overall Study||27
178937|NCT00578552|415160|P1|STARTED|Overall Study||27
178938|NCT00578539|415168|P1|NOT COMPLETED|Overall Study||0
178939|NCT00578539|415168|P1|COMPLETED|Overall Study||24
178940|NCT00578539|415168|P1|STARTED|Overall Study||24
178941|NCT00578461|415172|P1|NOT COMPLETED|Overall Study||0
178942|NCT00578461|415172|P1|COMPLETED|Overall Study||26
178943|NCT00578461|415172|P1|STARTED|Overall Study||26
178944|NCT00578448|415176|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
178945|NCT00578448|415176|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
178946|NCT00578448|415176|P1|STARTED|1 Year Long Term Extension (LTE)||9
178947|NCT00578448|415176|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
178948|NCT00578448|415176|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
178949|NCT00578448|415176|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
178950|NCT00578383|415194|P4|NOT COMPLETED|Overall Study||6
178951|NCT00578383|415195|P3|NOT COMPLETED|Overall Study||6
178952|NCT00578383|415196|P2|NOT COMPLETED|Overall Study||16
178953|NCT00578383|415197|P1|NOT COMPLETED|Overall Study||16
178954|NCT00578383|415194|P4|COMPLETED|Overall Study||9
178955|NCT00578383|415195|P3|COMPLETED|Overall Study||13
178956|NCT00578383|415196|P2|COMPLETED|Overall Study||20
178957|NCT00578383|415197|P1|COMPLETED|Overall Study||21
178958|NCT00578383|415194|P4|STARTED|Overall Study||15
178959|NCT00578383|415195|P3|STARTED|Overall Study||19
178960|NCT00578383|415196|P2|STARTED|Overall Study||36
178961|NCT00578383|415197|P1|STARTED|Overall Study||37
178962|NCT00578331|415229|P2|NOT COMPLETED|Overall Study||125
178963|NCT00578331|415230|P1|NOT COMPLETED|Overall Study||116
178964|NCT00578331|415229|P2|COMPLETED|Overall Study||320
178965|NCT00578331|415230|P1|COMPLETED|Overall Study||329
178966|NCT00578331|415229|P2|STARTED|Overall Study||445
178967|NCT00578331|415230|P1|STARTED|Overall Study||445
178968|NCT00578318|415240|P2|NOT COMPLETED|Overall Study||0
178969|NCT00578318|415241|P1|NOT COMPLETED|Overall Study||3
178970|NCT00578318|415240|P2|COMPLETED|Overall Study||8
178971|NCT00578318|415241|P1|COMPLETED|Overall Study||5
178972|NCT00578318|415240|P2|STARTED|Overall Study||8
178973|NCT00578318|415241|P1|STARTED|Overall Study||8
178974|NCT00578305|415250|P3|NOT COMPLETED|Safety Follow-up Phase||46
178975|NCT00578305|415251|P2|NOT COMPLETED|Safety Follow-up Phase||45
178976|NCT00578305|415252|P1|NOT COMPLETED|Safety Follow-up Phase||46
178977|NCT00578305|415250|P3|COMPLETED|Safety Follow-up Phase||8
178978|NCT00578305|415251|P2|COMPLETED|Safety Follow-up Phase||9
178979|NCT00578305|415252|P1|COMPLETED|Safety Follow-up Phase||11
178980|NCT00578305|415250|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
178981|NCT00578305|415251|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
178982|NCT00578305|415252|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
178983|NCT00578305|415250|P3|NOT COMPLETED|Extension Phase||3
178984|NCT00578305|415251|P2|NOT COMPLETED|Extension Phase||1
178985|NCT00578305|415252|P1|NOT COMPLETED|Extension Phase||4
178986|NCT00578305|415250|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
178987|NCT00578305|415251|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
178988|NCT00578305|415252|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
178989|NCT00578305|415250|P3|STARTED|Extension Phase||43
178990|NCT00578305|415251|P2|STARTED|Extension Phase||50
178991|NCT00578305|415252|P1|STARTED|Extension Phase||53
178992|NCT00578305|415250|P3|NOT COMPLETED|Double-blind Treatment Phase||14
178993|NCT00578305|415251|P2|NOT COMPLETED|Double-blind Treatment Phase||4
178994|NCT00578305|415252|P1|NOT COMPLETED|Double-blind Treatment Phase||3
178995|NCT00578305|415250|P3|COMPLETED|Double-blind Treatment Phase||49
178996|NCT00578305|415251|P2|COMPLETED|Double-blind Treatment Phase||56
178997|NCT00578305|415252|P1|COMPLETED|Double-blind Treatment Phase||59
178998|NCT00578305|415250|P3|Treated|Double-blind Treatment Phase||63
178999|NCT00578305|415251|P2|Treated|Double-blind Treatment Phase||60
179000|NCT00578305|415252|P1|Treated|Double-blind Treatment Phase||62
179001|NCT00578305|415250|P3|STARTED|Double-blind Treatment Phase||63
179002|NCT00578305|415251|P2|STARTED|Double-blind Treatment Phase||60
179003|NCT00578305|415252|P1|STARTED|Double-blind Treatment Phase||62
179004|NCT00578279|415313|P2|NOT COMPLETED|Overall Study||0
179005|NCT00578279|415314|P1|NOT COMPLETED|Overall Study||0
179006|NCT00578279|415313|P2|COMPLETED|Overall Study||10
179007|NCT00578279|415314|P1|COMPLETED|Overall Study||10
179008|NCT00578279|415313|P2|STARTED|Overall Study||10
179009|NCT00578279|415314|P1|STARTED|Overall Study||10
179010|NCT00578227|415323|P3|NOT COMPLETED|Overall Study||4
179011|NCT00578227|415324|P2|NOT COMPLETED|Overall Study||2
179012|NCT00578227|415325|P1|NOT COMPLETED|Overall Study||5
179013|NCT00578227|415323|P3|COMPLETED|Overall Study||267
179014|NCT00578227|415324|P2|COMPLETED|Overall Study||268
179015|NCT00578227|415325|P1|COMPLETED|Overall Study||267
179016|NCT00578227|415323|P3|STARTED|Overall Study||271
179017|NCT00578227|415324|P2|STARTED|Overall Study||270
179018|NCT00578227|415325|P1|STARTED|Overall Study||272
179019|NCT00578214|415398|P3|NOT COMPLETED|Overall Study||0
179020|NCT00578214|415399|P2|NOT COMPLETED|Overall Study||0
179021|NCT00578214|415400|P1|NOT COMPLETED|Overall Study||0
179022|NCT00578214|415398|P3|COMPLETED|Overall Study||31
179023|NCT00578214|415399|P2|COMPLETED|Overall Study||22
179024|NCT00578214|415400|P1|COMPLETED|Overall Study||22
179025|NCT00578214|415398|P3|STARTED|Overall Study||31
179026|NCT00578214|415399|P2|STARTED|Overall Study||22
179027|NCT00578214|415400|P1|STARTED|Overall Study||22
179028|NCT00578175|415450|P3|NOT COMPLETED|Overall Study||24
179029|NCT00578175|415451|P2|NOT COMPLETED|Overall Study||43
179030|NCT00578175|415452|P1|NOT COMPLETED|Overall Study||70
179031|NCT00578175|415450|P3|COMPLETED|Overall Study||365
179032|NCT00578175|415451|P2|COMPLETED|Overall Study||646
179033|NCT00578175|415452|P1|COMPLETED|Overall Study||635
179034|NCT00578175|415450|P3|STARTED|Overall Study||389
179035|NCT00578175|415451|P2|STARTED|Overall Study||689
179036|NCT00578175|415452|P1|STARTED|Overall Study||705
179037|NCT00578136|415531|P2|NOT COMPLETED|Overall Study||1
179038|NCT00578136|415532|P1|NOT COMPLETED|Overall Study||1
179039|NCT00578136|415531|P2|COMPLETED|Overall Study||26
179040|NCT00578136|415532|P1|COMPLETED|Overall Study||26
179041|NCT00578136|415531|P2|STARTED|Overall Study||27
179042|NCT00578136|415532|P1|STARTED|Overall Study||27
179043|NCT00578071|415540|P1|NOT COMPLETED|Overall Study||0
179044|NCT00578071|415540|P1|COMPLETED|Overall Study||29
179045|NCT00578071|415540|P1|STARTED|Overall Study||29
179046|NCT00577889|415550|P3|NOT COMPLETED|Overall Study||0
179047|NCT00577889|415551|P2|NOT COMPLETED|Overall Study||0
179048|NCT00577889|415552|P1|NOT COMPLETED|Overall Study||1
179049|NCT00577889|415550|P3|COMPLETED|Overall Study||6
179050|NCT00577889|415551|P2|COMPLETED|Overall Study||6
179051|NCT00577889|415552|P1|COMPLETED|Overall Study||8
179052|NCT00577889|415550|P3|STARTED|Overall Study||6
179053|NCT00577889|415551|P2|STARTED|Overall Study||6
179054|NCT00577889|415552|P1|STARTED|Overall Study||9
179055|NCT00577863|415571|P2|NOT COMPLETED|Overall Study||14
179056|NCT00577863|415572|P1|NOT COMPLETED|Overall Study||10
179057|NCT00577863|415571|P2|COMPLETED|Overall Study||94
179058|NCT00577863|415572|P1|COMPLETED|Overall Study||82
179059|NCT00577863|415571|P2|Received at Least One Injection|Overall Study||107
179060|NCT00577863|415572|P1|Received at Least One Injection|Overall Study||92
179061|NCT00577863|415571|P2|STARTED|Overall Study||108
179062|NCT00577863|415572|P1|STARTED|Overall Study||92
179063|NCT00577824|415614|P3|NOT COMPLETED|Overall Study||2
179064|NCT00577824|415615|P2|NOT COMPLETED|Overall Study||20
179065|NCT00577824|415616|P1|NOT COMPLETED|Overall Study||7
179066|NCT00577824|415614|P3|COMPLETED|Overall Study||34
179067|NCT00577824|415615|P2|COMPLETED|Overall Study||53
179068|NCT00577824|415616|P1|COMPLETED|Overall Study||65
179069|NCT00577824|415614|P3|Full Analysis Set|Overall Study||35
179070|NCT00577824|415615|P2|Full Analysis Set|Overall Study||72
179071|NCT00577824|415616|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
179072|NCT00577824|415614|P3|STARTED|Overall Study||36
179073|NCT00577824|415615|P2|STARTED|Overall Study||73
179074|NCT00577824|415616|P1|STARTED|Overall Study|Started=Randomized|72
179075|NCT00577772|415674|P2|NOT COMPLETED|Overall Study||1
179076|NCT00577772|415675|P1|NOT COMPLETED|Overall Study||0
179077|NCT00577772|415674|P2|COMPLETED|Overall Study||6
179078|NCT00577772|415675|P1|COMPLETED|Overall Study||10
179079|NCT00577772|415674|P2|STARTED|Overall Study||7
179080|NCT00577772|415675|P1|STARTED|Overall Study||10
179081|NCT00577720|415685|P4|NOT COMPLETED|Overall Study||7
179082|NCT00577720|415686|P3|NOT COMPLETED|Overall Study||1
179083|NCT00577720|415687|P2|NOT COMPLETED|Overall Study||1
179084|NCT00577720|415688|P1|NOT COMPLETED|Overall Study||4
179085|NCT00577720|415685|P4|COMPLETED|Overall Study||65
179086|NCT00577720|415686|P3|COMPLETED|Overall Study||35
179087|NCT00577720|415687|P2|COMPLETED|Overall Study||35
179088|NCT00577720|415688|P1|COMPLETED|Overall Study||33
179089|NCT00577720|415685|P4|ITT (Intent to Treat) Population|Overall Study||65
179090|NCT00577720|415686|P3|ITT (Intent to Treat) Population|Overall Study||35
179091|NCT00577720|415687|P2|ITT (Intent to Treat) Population|Overall Study||35
179092|NCT00577720|415688|P1|ITT (Intent to Treat) Population|Overall Study||34
179093|NCT00577720|415685|P4|STARTED|Overall Study||72
179094|NCT00577720|415686|P3|STARTED|Overall Study||36
179095|NCT00577720|415687|P2|STARTED|Overall Study||36
179096|NCT00577720|415688|P1|STARTED|Overall Study||37
179097|NCT00577707|415706|P1|NOT COMPLETED|Overall Study||3
179098|NCT00577707|415706|P1|COMPLETED|Overall Study||6
179099|NCT00577707|415706|P1|STARTED|Overall Study||9
179100|NCT00577655|415712|P2|NOT COMPLETED|Overall Study||4
179101|NCT00577655|415713|P1|NOT COMPLETED|Overall Study||1
179102|NCT00577655|415712|P2|COMPLETED|Overall Study||47
179103|NCT00577655|415713|P1|COMPLETED|Overall Study||51
179104|NCT00577655|415712|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
179105|NCT00577655|415713|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
179106|NCT00577629|415751|P1|NOT COMPLETED|Overall Study||1
179107|NCT00577629|415751|P1|COMPLETED|Overall Study||38
179108|NCT00577629|415751|P1|STARTED|Overall Study||39
179109|NCT00577512|415756|P1|NOT COMPLETED|Overall Study||4
179110|NCT00577512|415756|P1|COMPLETED|Overall Study||0
179111|NCT00577512|415756|P1|STARTED|Overall Study||4
179112|NCT00577473|415762|P2|NOT COMPLETED|Overall Study||24
179113|NCT00577473|415763|P1|NOT COMPLETED|Overall Study||21
179114|NCT00577473|415762|P2|COMPLETED|Overall Study||123
179115|NCT00577473|415763|P1|COMPLETED|Overall Study||133
179116|NCT00577473|415762|P2|ITT Population|Overall Study||136
179117|NCT00577473|415763|P1|ITT Population|Overall Study||150
179118|NCT00577473|415762|P2|STARTED|Overall Study||147
179119|NCT00577473|415763|P1|STARTED|Overall Study||154
179120|NCT00577460|415794|P3|NOT COMPLETED|Overall Study||27
179121|NCT00577460|415795|P2|NOT COMPLETED|Overall Study||19
179122|NCT00577460|415796|P1|NOT COMPLETED|Overall Study||16
179123|NCT00577460|415794|P3|COMPLETED|Overall Study||112
179124|NCT00577460|415795|P2|COMPLETED|Overall Study||104
179125|NCT00577460|415796|P1|COMPLETED|Overall Study||113
179126|NCT00577460|415794|P3|STARTED|Overall Study||139
179127|NCT00577460|415795|P2|STARTED|Overall Study||123
179128|NCT00577460|415796|P1|STARTED|Overall Study||129
179129|NCT00577395|415905|P2|NOT COMPLETED|Overall Study||6
179130|NCT00577395|415906|P1|NOT COMPLETED|Overall Study||7
179131|NCT00577395|415905|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
179132|NCT00577395|415906|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
179133|NCT00577395|415905|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
179134|NCT00577395|415906|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
179135|NCT00577382|415916|P2|NOT COMPLETED|Overall Study||31
179136|NCT00577382|415917|P1|NOT COMPLETED|Overall Study||21
179220|NCT00576823|416154|P2|COMPLETED|40-week Safety Extension Phase||6
179137|NCT00577382|415916|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
179138|NCT00577382|415917|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
179139|NCT00577382|415916|P2|STARTED|Overall Study||31
179140|NCT00577382|415917|P1|STARTED|Overall Study||21
179141|NCT00577356|415929|P1|NOT COMPLETED|Overall Study||0
179142|NCT00577356|415929|P1|COMPLETED|Overall Study||6
179143|NCT00577356|415929|P1|STARTED|Overall Study||6
179144|NCT00577135|415937|P4|NOT COMPLETED|Overall Study||0
179145|NCT00577135|415938|P3|NOT COMPLETED|Overall Study||0
179146|NCT00577135|415939|P2|NOT COMPLETED|Overall Study||0
179147|NCT00577135|415940|P1|NOT COMPLETED|Overall Study||0
179148|NCT00577135|415937|P4|COMPLETED|Overall Study||75
179149|NCT00577135|415938|P3|COMPLETED|Overall Study||77
179150|NCT00577135|415939|P2|COMPLETED|Overall Study||82
179151|NCT00577135|415940|P1|COMPLETED|Overall Study||74
179152|NCT00577135|415937|P4|STARTED|Overall Study||75
179153|NCT00577135|415938|P3|STARTED|Overall Study||77
179154|NCT00577135|415939|P2|STARTED|Overall Study||82
179155|NCT00577135|415940|P1|STARTED|Overall Study||74
179156|NCT00577122|416060|P2|NOT COMPLETED|Overall Study||16
179157|NCT00577122|416061|P1|NOT COMPLETED|Overall Study||14
179158|NCT00577122|416060|P2|COMPLETED|Overall Study||0
179159|NCT00577122|416061|P1|COMPLETED|Overall Study||0
179160|NCT00577122|416060|P2|STARTED|Overall Study||16
179161|NCT00577122|416061|P1|STARTED|Overall Study||14
179162|NCT00577096|416075|P2|NOT COMPLETED|Long Term Participation||0
179163|NCT00577096|416076|P1|NOT COMPLETED|Long Term Participation||0
179164|NCT00577096|416075|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
179165|NCT00577096|416076|P1|COMPLETED|Long Term Participation||34
179166|NCT00577096|416075|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
179167|NCT00577096|416076|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
179168|NCT00577096|416075|P2|NOT COMPLETED|Short Term Participation||8
179169|NCT00577096|416076|P1|NOT COMPLETED|Short Term Participation||7
179170|NCT00577096|416075|P2|COMPLETED|Short Term Participation||58
179171|NCT00577096|416076|P1|COMPLETED|Short Term Participation||62
179172|NCT00577096|416075|P2|STARTED|Short Term Participation||66
179173|NCT00577096|416076|P1|STARTED|Short Term Participation||69
179174|NCT00577083|416102|P2|NOT COMPLETED|Second Intervention (14days)||0
179175|NCT00577083|416103|P1|NOT COMPLETED|Second Intervention (14days)||0
179176|NCT00577083|416102|P2|COMPLETED|Second Intervention (14days)||52
179177|NCT00577083|416103|P1|COMPLETED|Second Intervention (14days)||48
179178|NCT00577083|416102|P2|STARTED|Second Intervention (14days)||52
179179|NCT00577083|416103|P1|STARTED|Second Intervention (14days)||48
179180|NCT00577083|416102|P2|NOT COMPLETED|Washout (14 Days)||0
179181|NCT00577083|416103|P1|NOT COMPLETED|Washout (14 Days)||0
179182|NCT00577083|416102|P2|COMPLETED|Washout (14 Days)||52
179183|NCT00577083|416103|P1|COMPLETED|Washout (14 Days)||48
179184|NCT00577083|416102|P2|STARTED|Washout (14 Days)||52
179185|NCT00577083|416103|P1|STARTED|Washout (14 Days)||48
179186|NCT00577083|416102|P2|NOT COMPLETED|First Intervention (14 Days)||0
179187|NCT00577083|416103|P1|NOT COMPLETED|First Intervention (14 Days)||0
179188|NCT00577083|416102|P2|COMPLETED|First Intervention (14 Days)||52
179189|NCT00577083|416103|P1|COMPLETED|First Intervention (14 Days)||48
179190|NCT00577083|416102|P2|STARTED|First Intervention (14 Days)||52
179191|NCT00577083|416103|P1|STARTED|First Intervention (14 Days)||48
179192|NCT00577031|416109|P1|NOT COMPLETED|Overall Study||205
179193|NCT00577031|416109|P1|COMPLETED|Overall Study||0
179194|NCT00577031|416109|P1|STARTED|Overall Study||205
179195|NCT00576927|416130|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
179196|NCT00576927|416130|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
179197|NCT00576927|416130|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
179198|NCT00576927|416130|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
179199|NCT00576927|416130|P1|COMPLETED|Sleep Hygiene With Study Drug||22
179200|NCT00576927|416130|P1|STARTED|Sleep Hygiene With Study Drug||22
179201|NCT00576927|416130|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
179202|NCT00576927|416130|P1|COMPLETED|Sleep Hygiene With the Placebo||22
179203|NCT00576927|416130|P1|STARTED|Sleep Hygiene With the Placebo||23
179204|NCT00576927|416130|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
179205|NCT00576927|416130|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
179206|NCT00576927|416130|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
179207|NCT00576927|416130|P1|NOT COMPLETED|Baseline||13
179208|NCT00576927|416130|P1|COMPLETED|Baseline||30
179209|NCT00576927|416130|P1|STARTED|Baseline||43
179210|NCT00576927|416130|P1|NOT COMPLETED|Clinical Assessment||36
179211|NCT00576927|416130|P1|COMPLETED|Clinical Assessment||43
179212|NCT00576927|416130|P1|STARTED|Clinical Assessment||79
179213|NCT00576901|416142|P1|NOT COMPLETED|Overall Study||3
179214|NCT00576901|416142|P1|COMPLETED|Overall Study||20
179215|NCT00576901|416142|P1|STARTED|Overall Study||23
179216|NCT00576823|416153|P3|NOT COMPLETED|40-week Safety Extension Phase||0
179217|NCT00576823|416154|P2|NOT COMPLETED|40-week Safety Extension Phase||0
179218|NCT00576823|416155|P1|NOT COMPLETED|40-week Safety Extension Phase||1
179219|NCT00576823|416153|P3|COMPLETED|40-week Safety Extension Phase||6
179221|NCT00576823|416155|P1|COMPLETED|40-week Safety Extension Phase||10
179222|NCT00576823|416153|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
179223|NCT00576823|416154|P2|STARTED|40-week Safety Extension Phase||6
179224|NCT00576823|416155|P1|STARTED|40-week Safety Extension Phase||11
179225|NCT00576823|416153|P3|NOT COMPLETED|12-week Efficacy Phase||0
179226|NCT00576823|416154|P2|NOT COMPLETED|12-week Efficacy Phase||0
179227|NCT00576823|416155|P1|NOT COMPLETED|12-week Efficacy Phase||1
179228|NCT00576823|416153|P3|COMPLETED|12-week Efficacy Phase||7
179229|NCT00576823|416154|P2|COMPLETED|12-week Efficacy Phase||6
179230|NCT00576823|416155|P1|COMPLETED|12-week Efficacy Phase||11
179231|NCT00576823|416153|P3|STARTED|12-week Efficacy Phase||7
179232|NCT00576823|416154|P2|STARTED|12-week Efficacy Phase||6
179233|NCT00576823|416155|P1|STARTED|12-week Efficacy Phase||12
179234|NCT00576758|416171|P2|NOT COMPLETED|Follow-up Period||17
179235|NCT00576758|416172|P1|NOT COMPLETED|Follow-up Period||27
179236|NCT00576758|416171|P2|COMPLETED|Follow-up Period||34
179237|NCT00576758|416172|P1|COMPLETED|Follow-up Period||28
179238|NCT00576758|416171|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
179239|NCT00576758|416172|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
179240|NCT00576758|416171|P2|NOT COMPLETED|Extension Treatment Period||43
179241|NCT00576758|416172|P1|NOT COMPLETED|Extension Treatment Period||42
179242|NCT00576758|416171|P2|COMPLETED|Extension Treatment Period||30
179243|NCT00576758|416172|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
179244|NCT00576758|416171|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
179245|NCT00576758|416172|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
179246|NCT00576758|416171|P2|NOT COMPLETED|Induction Treatment Period||5
179247|NCT00576758|416172|P1|NOT COMPLETED|Induction Treatment Period||8
179248|NCT00576758|416171|P2|COMPLETED|Induction Treatment Period||83
179249|NCT00576758|416172|P1|COMPLETED|Induction Treatment Period||79
179250|NCT00576758|416171|P2|Received Treatment|Induction Treatment Period||87
179251|NCT00576758|416172|P1|Received Treatment|Induction Treatment Period||86
179252|NCT00576758|416171|P2|STARTED|Induction Treatment Period||88
179253|NCT00576758|416172|P1|STARTED|Induction Treatment Period||87
179254|NCT00576732|416218|P6|NOT COMPLETED|OPEN LABEL||8
179255|NCT00576732|416219|P5|NOT COMPLETED|OPEN LABEL||4
179256|NCT00576732|416220|P4|NOT COMPLETED|OPEN LABEL||11
179257|NCT00576732|416221|P3|NOT COMPLETED|OPEN LABEL||0
179258|NCT00576732|416222|P2|NOT COMPLETED|OPEN LABEL||0
179259|NCT00576732|416223|P1|NOT COMPLETED|OPEN LABEL||0
179260|NCT00576732|416218|P6|COMPLETED|OPEN LABEL||17
179261|NCT00576732|416219|P5|COMPLETED|OPEN LABEL||20
179262|NCT00576732|416220|P4|COMPLETED|OPEN LABEL||19
179263|NCT00576732|416221|P3|COMPLETED|OPEN LABEL||0
179264|NCT00576732|416222|P2|COMPLETED|OPEN LABEL||0
179265|NCT00576732|416223|P1|COMPLETED|OPEN LABEL||0
179266|NCT00576732|416218|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
179267|NCT00576732|416219|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
179268|NCT00576732|416220|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
179269|NCT00576732|416221|P3|STARTED|OPEN LABEL||0
179270|NCT00576732|416222|P2|STARTED|OPEN LABEL||0
179271|NCT00576732|416223|P1|STARTED|OPEN LABEL||0
179272|NCT00576732|416218|P6|NOT COMPLETED|DOUBLE BLIND||0
179273|NCT00576732|416219|P5|NOT COMPLETED|DOUBLE BLIND||0
179274|NCT00576732|416220|P4|NOT COMPLETED|DOUBLE BLIND||0
179275|NCT00576732|416221|P3|NOT COMPLETED|DOUBLE BLIND||6
179276|NCT00576732|416222|P2|NOT COMPLETED|DOUBLE BLIND||5
179277|NCT00576732|416223|P1|NOT COMPLETED|DOUBLE BLIND||8
179278|NCT00576732|416218|P6|COMPLETED|DOUBLE BLIND||0
179279|NCT00576732|416219|P5|COMPLETED|DOUBLE BLIND||0
179280|NCT00576732|416220|P4|COMPLETED|DOUBLE BLIND||0
179281|NCT00576732|416221|P3|COMPLETED|DOUBLE BLIND||25
179282|NCT00576732|416222|P2|COMPLETED|DOUBLE BLIND||25
179283|NCT00576732|416223|P1|COMPLETED|DOUBLE BLIND||27
179284|NCT00576732|416218|P6|STARTED|DOUBLE BLIND||0
179285|NCT00576732|416219|P5|STARTED|DOUBLE BLIND||0
179286|NCT00576732|416220|P4|STARTED|DOUBLE BLIND||0
179287|NCT00576732|416221|P3|STARTED|DOUBLE BLIND||31
179288|NCT00576732|416222|P2|STARTED|DOUBLE BLIND||30
179289|NCT00576732|416223|P1|STARTED|DOUBLE BLIND||35
179290|NCT00576693|416255|P2|NOT COMPLETED|Overall Study||24
179291|NCT00576693|416256|P1|NOT COMPLETED|Overall Study||10
179292|NCT00576693|416255|P2|COMPLETED|Overall Study||203
179293|NCT00576693|416256|P1|COMPLETED|Overall Study||214
179294|NCT00576693|416255|P2|STARTED|Overall Study||227
179295|NCT00576693|416256|P1|STARTED|Overall Study||224
179296|NCT00576628|416262|P1|NOT COMPLETED|Overall Study||43
179297|NCT00576628|416262|P1|COMPLETED|Overall Study||82
179298|NCT00576628|416262|P1|STARTED|Overall Study||125
179299|NCT00576576|416282|P1|NOT COMPLETED|Overall Study||7
179300|NCT00576576|416282|P1|COMPLETED|Overall Study||20
179301|NCT00576576|416282|P1|STARTED|Overall Study||27
179302|NCT00576524|416290|P2|NOT COMPLETED|Overall Study||0
179303|NCT00576524|416291|P1|NOT COMPLETED|Overall Study||0
179304|NCT00576524|416290|P2|COMPLETED|Overall Study||0
179305|NCT00576524|416291|P1|COMPLETED|Overall Study||2
179306|NCT00576524|416290|P2|STARTED|Overall Study||0
179307|NCT00576524|416291|P1|STARTED|Overall Study||2
179308|NCT00576472|416316|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
179309|NCT00576472|416317|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
179310|NCT00576472|416318|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
179311|NCT00576472|416319|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
179312|NCT00576472|416320|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
179313|NCT00576472|416321|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
179314|NCT00576472|416322|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
179315|NCT00576472|416323|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
179316|NCT00576472|416324|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
179317|NCT00576472|416325|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
179318|NCT00576472|416326|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
179319|NCT00576472|416327|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
179320|NCT00576472|416328|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
179321|NCT00576472|416329|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
179322|NCT00576472|416330|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
179323|NCT00576472|416316|P15|COMPLETED|MPH Home Maintenance Phase||68
179324|NCT00576472|416317|P14|COMPLETED|MPH Home Maintenance Phase||0
179325|NCT00576472|416318|P13|COMPLETED|MPH Home Maintenance Phase||0
179326|NCT00576472|416319|P12|COMPLETED|MPH Home Maintenance Phase||0
179327|NCT00576472|416320|P11|COMPLETED|MPH Home Maintenance Phase||0
179328|NCT00576472|416321|P10|COMPLETED|MPH Home Maintenance Phase||0
179329|NCT00576472|416322|P9|COMPLETED|MPH Home Maintenance Phase||0
179330|NCT00576472|416323|P8|COMPLETED|MPH Home Maintenance Phase||0
179331|NCT00576472|416324|P7|COMPLETED|MPH Home Maintenance Phase||0
179332|NCT00576472|416325|P6|COMPLETED|MPH Home Maintenance Phase||0
179333|NCT00576472|416326|P5|COMPLETED|MPH Home Maintenance Phase||0
179334|NCT00576472|416327|P4|COMPLETED|MPH Home Maintenance Phase||0
179335|NCT00576472|416328|P3|COMPLETED|MPH Home Maintenance Phase||0
179336|NCT00576472|416329|P2|COMPLETED|MPH Home Maintenance Phase||0
179337|NCT00576472|416330|P1|COMPLETED|MPH Home Maintenance Phase||0
179338|NCT00576472|416316|P15|STARTED|MPH Home Maintenance Phase||91
179339|NCT00576472|416317|P14|STARTED|MPH Home Maintenance Phase||27
179340|NCT00576472|416318|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179341|NCT00576472|416319|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179342|NCT00576472|416320|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179343|NCT00576472|416321|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179344|NCT00576472|416322|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179345|NCT00576472|416323|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179346|NCT00576472|416324|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179347|NCT00576472|416325|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179348|NCT00576472|416326|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179349|NCT00576472|416327|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179350|NCT00576472|416328|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179351|NCT00576472|416329|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179352|NCT00576472|416330|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179353|NCT00576472|416316|P15|NOT COMPLETED|MPH Cross Over Phase||0
179354|NCT00576472|416317|P14|NOT COMPLETED|MPH Cross Over Phase||0
179355|NCT00576472|416318|P13|NOT COMPLETED|MPH Cross Over Phase||0
179356|NCT00576472|416319|P12|NOT COMPLETED|MPH Cross Over Phase||1
179357|NCT00576472|416320|P11|NOT COMPLETED|MPH Cross Over Phase||1
179358|NCT00576472|416321|P10|NOT COMPLETED|MPH Cross Over Phase||0
179359|NCT00576472|416322|P9|NOT COMPLETED|MPH Cross Over Phase||2
179360|NCT00576472|416323|P8|NOT COMPLETED|MPH Cross Over Phase||0
179361|NCT00576472|416324|P7|NOT COMPLETED|MPH Cross Over Phase||12
179362|NCT00576472|416325|P6|NOT COMPLETED|MPH Cross Over Phase||0
179363|NCT00576472|416326|P5|NOT COMPLETED|MPH Cross Over Phase||0
179364|NCT00576472|416327|P4|NOT COMPLETED|MPH Cross Over Phase||0
179365|NCT00576472|416328|P3|NOT COMPLETED|MPH Cross Over Phase||0
179366|NCT00576472|416329|P2|NOT COMPLETED|MPH Cross Over Phase||0
179367|NCT00576472|416330|P1|NOT COMPLETED|MPH Cross Over Phase||0
179368|NCT00576472|416316|P15|COMPLETED|MPH Cross Over Phase||0
179369|NCT00576472|416317|P14|COMPLETED|MPH Cross Over Phase||0
179370|NCT00576472|416318|P13|COMPLETED|MPH Cross Over Phase||21
179371|NCT00576472|416319|P12|COMPLETED|MPH Cross Over Phase||17
179372|NCT00576472|416320|P11|COMPLETED|MPH Cross Over Phase||22
179373|NCT00576472|416321|P10|COMPLETED|MPH Cross Over Phase||22
179374|NCT00576472|416322|P9|COMPLETED|MPH Cross Over Phase||16
179375|NCT00576472|416323|P8|COMPLETED|MPH Cross Over Phase||20
179376|NCT00576472|416324|P7|COMPLETED|MPH Cross Over Phase||0
179377|NCT00576472|416325|P6|COMPLETED|MPH Cross Over Phase||0
179378|NCT00576472|416326|P5|COMPLETED|MPH Cross Over Phase||0
179379|NCT00576472|416327|P4|COMPLETED|MPH Cross Over Phase||0
179380|NCT00576472|416328|P3|COMPLETED|MPH Cross Over Phase||0
179381|NCT00576472|416329|P2|COMPLETED|MPH Cross Over Phase||0
179382|NCT00576472|416330|P1|COMPLETED|MPH Cross Over Phase||0
179383|NCT00576472|416316|P15|STARTED|MPH Cross Over Phase||0
179384|NCT00576472|416317|P14|STARTED|MPH Cross Over Phase||0
179385|NCT00576472|416318|P13|STARTED|MPH Cross Over Phase||21
179386|NCT00576472|416319|P12|STARTED|MPH Cross Over Phase||18
179387|NCT00576472|416320|P11|STARTED|MPH Cross Over Phase||23
179388|NCT00576472|416321|P10|STARTED|MPH Cross Over Phase||22
179389|NCT00576472|416322|P9|STARTED|MPH Cross Over Phase||18
179390|NCT00576472|416323|P8|STARTED|MPH Cross Over Phase||20
179391|NCT00576472|416324|P7|STARTED|MPH Cross Over Phase||12
179392|NCT00576472|416325|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179393|NCT00576472|416326|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179394|NCT00576472|416327|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179395|NCT00576472|416328|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179396|NCT00576472|416329|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179397|NCT00576472|416330|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179398|NCT00576472|416316|P15|NOT COMPLETED|MPH In-Lab Phase||0
179399|NCT00576472|416317|P14|NOT COMPLETED|MPH In-Lab Phase||0
179400|NCT00576472|416318|P13|NOT COMPLETED|MPH In-Lab Phase||0
179401|NCT00576472|416319|P12|NOT COMPLETED|MPH In-Lab Phase||0
179402|NCT00576472|416320|P11|NOT COMPLETED|MPH In-Lab Phase||0
179403|NCT00576472|416321|P10|NOT COMPLETED|MPH In-Lab Phase||0
179404|NCT00576472|416322|P9|NOT COMPLETED|MPH In-Lab Phase||0
179405|NCT00576472|416323|P8|NOT COMPLETED|MPH In-Lab Phase||0
179406|NCT00576472|416324|P7|NOT COMPLETED|MPH In-Lab Phase||0
179407|NCT00576472|416325|P6|NOT COMPLETED|MPH In-Lab Phase||0
179408|NCT00576472|416326|P5|NOT COMPLETED|MPH In-Lab Phase||0
179409|NCT00576472|416327|P4|NOT COMPLETED|MPH In-Lab Phase||335
179410|NCT00576472|416328|P3|NOT COMPLETED|MPH In-Lab Phase||0
179411|NCT00576472|416329|P2|NOT COMPLETED|MPH In-Lab Phase||0
179412|NCT00576472|416330|P1|NOT COMPLETED|MPH In-Lab Phase||0
179413|NCT00576472|416316|P15|COMPLETED|MPH In-Lab Phase||0
179414|NCT00576472|416317|P14|COMPLETED|MPH In-Lab Phase||0
179415|NCT00576472|416318|P13|COMPLETED|MPH In-Lab Phase||0
179416|NCT00576472|416319|P12|COMPLETED|MPH In-Lab Phase||0
179417|NCT00576472|416320|P11|COMPLETED|MPH In-Lab Phase||0
179418|NCT00576472|416321|P10|COMPLETED|MPH In-Lab Phase||0
179419|NCT00576472|416322|P9|COMPLETED|MPH In-Lab Phase||0
179420|NCT00576472|416323|P8|COMPLETED|MPH In-Lab Phase||0
179421|NCT00576472|416324|P7|COMPLETED|MPH In-Lab Phase||0
179422|NCT00576472|416325|P6|COMPLETED|MPH In-Lab Phase||67
179423|NCT00576472|416326|P5|COMPLETED|MPH In-Lab Phase||67
179424|NCT00576472|416327|P4|COMPLETED|MPH In-Lab Phase||0
179425|NCT00576472|416328|P3|COMPLETED|MPH In-Lab Phase||0
179426|NCT00576472|416329|P2|COMPLETED|MPH In-Lab Phase||0
179427|NCT00576472|416330|P1|COMPLETED|MPH In-Lab Phase||0
179428|NCT00576472|416316|P15|STARTED|MPH In-Lab Phase||0
179429|NCT00576472|416317|P14|STARTED|MPH In-Lab Phase||0
179430|NCT00576472|416318|P13|STARTED|MPH In-Lab Phase||0
179431|NCT00576472|416319|P12|STARTED|MPH In-Lab Phase||0
179432|NCT00576472|416320|P11|STARTED|MPH In-Lab Phase||0
179433|NCT00576472|416321|P10|STARTED|MPH In-Lab Phase||0
179434|NCT00576472|416322|P9|STARTED|MPH In-Lab Phase||0
179435|NCT00576472|416323|P8|STARTED|MPH In-Lab Phase||0
179436|NCT00576472|416324|P7|STARTED|MPH In-Lab Phase||0
179437|NCT00576472|416325|P6|STARTED|MPH In-Lab Phase||67
179438|NCT00576472|416326|P5|STARTED|MPH In-Lab Phase||67
179439|NCT00576472|416327|P4|STARTED|MPH In-Lab Phase||335
179440|NCT00576472|416328|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179441|NCT00576472|416329|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179442|NCT00576472|416330|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179443|NCT00576472|416316|P15|NOT COMPLETED|Initial Screening||0
179444|NCT00576472|416317|P14|NOT COMPLETED|Initial Screening||0
179445|NCT00576472|416318|P13|NOT COMPLETED|Initial Screening||0
179446|NCT00576472|416319|P12|NOT COMPLETED|Initial Screening||0
179447|NCT00576472|416320|P11|NOT COMPLETED|Initial Screening||0
179448|NCT00576472|416321|P10|NOT COMPLETED|Initial Screening||0
179449|NCT00576472|416322|P9|NOT COMPLETED|Initial Screening||0
179450|NCT00576472|416323|P8|NOT COMPLETED|Initial Screening||0
179451|NCT00576472|416324|P7|NOT COMPLETED|Initial Screening||0
179452|NCT00576472|416325|P6|NOT COMPLETED|Initial Screening||0
179453|NCT00576472|416326|P5|NOT COMPLETED|Initial Screening||0
179454|NCT00576472|416327|P4|NOT COMPLETED|Initial Screening||0
179455|NCT00576472|416328|P3|NOT COMPLETED|Initial Screening||0
179456|NCT00576472|416329|P2|NOT COMPLETED|Initial Screening||0
179457|NCT00576472|416330|P1|NOT COMPLETED|Initial Screening||0
179458|NCT00576472|416316|P15|COMPLETED|Initial Screening||0
179459|NCT00576472|416317|P14|COMPLETED|Initial Screening||0
179460|NCT00576472|416318|P13|COMPLETED|Initial Screening||0
179461|NCT00576472|416319|P12|COMPLETED|Initial Screening||0
179462|NCT00576472|416320|P11|COMPLETED|Initial Screening||0
179463|NCT00576472|416321|P10|COMPLETED|Initial Screening||0
179464|NCT00576472|416322|P9|COMPLETED|Initial Screening||0
179465|NCT00576472|416323|P8|COMPLETED|Initial Screening||0
179466|NCT00576472|416324|P7|COMPLETED|Initial Screening||0
179467|NCT00576472|416325|P6|COMPLETED|Initial Screening||0
179468|NCT00576472|416326|P5|COMPLETED|Initial Screening||0
179469|NCT00576472|416327|P4|COMPLETED|Initial Screening||0
179470|NCT00576472|416328|P3|COMPLETED|Initial Screening||199
179471|NCT00576472|416329|P2|COMPLETED|Initial Screening||40
179472|NCT00576472|416330|P1|COMPLETED|Initial Screening||230
179473|NCT00576472|416316|P15|STARTED|Initial Screening||0
179474|NCT00576472|416317|P14|STARTED|Initial Screening||0
179475|NCT00576472|416318|P13|STARTED|Initial Screening||0
179476|NCT00576472|416319|P12|STARTED|Initial Screening||0
179477|NCT00576472|416320|P11|STARTED|Initial Screening||0
179478|NCT00576472|416321|P10|STARTED|Initial Screening||0
179479|NCT00576472|416322|P9|STARTED|Initial Screening||0
179480|NCT00576472|416323|P8|STARTED|Initial Screening||0
179481|NCT00576472|416324|P7|STARTED|Initial Screening||0
179482|NCT00576472|416325|P6|STARTED|Initial Screening||0
179483|NCT00576472|416326|P5|STARTED|Initial Screening||0
179484|NCT00576472|416327|P4|STARTED|Initial Screening||0
179485|NCT00576472|416328|P3|STARTED|Initial Screening||199
179486|NCT00576472|416329|P2|STARTED|Initial Screening||40
179487|NCT00576472|416330|P1|STARTED|Initial Screening||230
179488|NCT00576420|416423|P3|NOT COMPLETED|Overall Study||1
179489|NCT00576420|416424|P2|NOT COMPLETED|Overall Study||0
179490|NCT00576420|416425|P1|NOT COMPLETED|Overall Study||0
179491|NCT00576420|416423|P3|COMPLETED|Overall Study||22
179492|NCT00576420|416424|P2|COMPLETED|Overall Study||24
179493|NCT00576420|416425|P1|COMPLETED|Overall Study||26
179494|NCT00576420|416423|P3|STARTED|Overall Study||23
179495|NCT00576420|416424|P2|STARTED|Overall Study||24
179496|NCT00576420|416425|P1|STARTED|Overall Study||26
179497|NCT00576381|416590|P1|NOT COMPLETED|Overall Study||7
179498|NCT00576381|416590|P1|COMPLETED|Overall Study||23
179499|NCT00576381|416590|P1|STARTED|Overall Study||30
179500|NCT00576316|416594|P1|NOT COMPLETED|Overall Study||20
179501|NCT00576316|416594|P1|COMPLETED|Overall Study|Number of patients who completed study|181
179502|NCT00576316|416594|P1|STARTED|Overall Study|Number of patients recruited|201
179503|NCT00576303|416599|P1|NOT COMPLETED|Long Term Safety Period||16
179504|NCT00576303|416599|P1|COMPLETED|Long Term Safety Period||162
179505|NCT00576303|416599|P1|STARTED|Long Term Safety Period||178
179506|NCT00576303|416599|P1|NOT COMPLETED|Efficacy Evaluation Period||5
179507|NCT00576303|416599|P1|COMPLETED|Efficacy Evaluation Period||178
179508|NCT00576303|416599|P1|STARTED|Efficacy Evaluation Period||183
179509|NCT00576303|416599|P1|NOT COMPLETED|Dose Titration Period||17
179510|NCT00576303|416599|P1|COMPLETED|Dose Titration Period||183
179511|NCT00576303|416599|P1|STARTED|Dose Titration Period||200
179512|NCT00576251|416610|P2|NOT COMPLETED|Overall Study||1
179513|NCT00576251|416611|P1|NOT COMPLETED|Overall Study||1
179514|NCT00576251|416610|P2|COMPLETED|Overall Study||111
179515|NCT00576251|416611|P1|COMPLETED|Overall Study||108
179516|NCT00576251|416610|P2|STARTED|Overall Study||112
179517|NCT00576251|416611|P1|STARTED|Overall Study||109
179518|NCT00576199|416617|P1|NOT COMPLETED|Overall Study||30
179519|NCT00576199|416617|P1|COMPLETED|Overall Study||0
179520|NCT00576199|416617|P1|STARTED|Overall Study||30
179521|NCT00576147|416626|P1|NOT COMPLETED|Overall Study||0
179522|NCT00576147|416626|P1|COMPLETED|Overall Study||431
179523|NCT00576147|416626|P1|STARTED|Overall Study||431
179524|NCT00576056|416630|P1|NOT COMPLETED|Overall Study||14
179525|NCT00576056|416630|P1|COMPLETED|Overall Study||5
179526|NCT00576056|416630|P1|STARTED|Overall Study||19
179527|NCT00575965|416635|P1|NOT COMPLETED|Overall Study||0
179528|NCT00575965|416635|P1|COMPLETED|Overall Study||18
179529|NCT00575965|416635|P1|STARTED|Overall Study||18
179530|NCT00575887|416640|P1|NOT COMPLETED|Overall Study||0
179531|NCT00575887|416640|P1|COMPLETED|Overall Study||25
179532|NCT00575887|416640|P1|STARTED|Overall Study||25
179533|NCT00575666|416646|P2|NOT COMPLETED|Overall Study||3
179534|NCT00575666|416647|P1|NOT COMPLETED|Overall Study||4
179535|NCT00575666|416646|P2|COMPLETED|Overall Study||21
179536|NCT00575666|416647|P1|COMPLETED|Overall Study||17
179537|NCT00575666|416646|P2|STARTED|Overall Study||24
179538|NCT00575666|416647|P1|STARTED|Overall Study||21
179539|NCT00575588|416687|P2|NOT COMPLETED|Overall Study||283
179540|NCT00575588|416688|P1|NOT COMPLETED|Overall Study||263
179541|NCT00575588|416687|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
179542|NCT00575588|416688|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
179543|NCT00575588|416687|P2|STARTED|Overall Study|Randomized and treated|430
179544|NCT00575588|416688|P1|STARTED|Overall Study|Randomized and treated|428
179545|NCT00575510|416711|P3|NOT COMPLETED|Overall Study||17
179546|NCT00575510|416712|P2|NOT COMPLETED|Overall Study||13
179547|NCT00575510|416713|P1|NOT COMPLETED|Overall Study||12
179548|NCT00575510|416711|P3|COMPLETED|Overall Study||96
179549|NCT00575510|416712|P2|COMPLETED|Overall Study||101
179550|NCT00575510|416713|P1|COMPLETED|Overall Study||102
179551|NCT00575510|416711|P3|STARTED|Overall Study||113
179552|NCT00575510|416712|P2|STARTED|Overall Study||114
179553|NCT00575510|416713|P1|STARTED|Overall Study||114
179554|NCT00575380|416726|P2|NOT COMPLETED|Overall Study||3
179555|NCT00575380|416727|P1|NOT COMPLETED|Overall Study||1
179556|NCT00575380|416726|P2|COMPLETED|Overall Study||55
179557|NCT00575380|416727|P1|COMPLETED|Overall Study||57
179558|NCT00575380|416726|P2|STARTED|Overall Study||58
179559|NCT00575380|416727|P1|STARTED|Overall Study||58
179560|NCT00575367|416737|P2|NOT COMPLETED|Overall Study||0
179561|NCT00575367|416738|P1|NOT COMPLETED|Overall Study||0
179562|NCT00575367|416737|P2|COMPLETED|Overall Study||18
179563|NCT00575367|416738|P1|COMPLETED|Overall Study||19
179564|NCT00575367|416737|P2|STARTED|Overall Study||18
179565|NCT00575367|416738|P1|STARTED|Overall Study||19
179566|NCT00575185|416746|P2|NOT COMPLETED|Overall Study||0
179567|NCT00575185|416747|P1|NOT COMPLETED|Overall Study||0
179568|NCT00575185|416746|P2|COMPLETED|Overall Study||11
179569|NCT00575185|416747|P1|COMPLETED|Overall Study||12
179570|NCT00575185|416746|P2|STARTED|Overall Study||11
179571|NCT00575185|416747|P1|STARTED|Overall Study||12
179572|NCT00575146|416755|P1|NOT COMPLETED|Overall Study||3
179573|NCT00575146|416755|P1|COMPLETED|Overall Study||17
179574|NCT00575146|416755|P1|STARTED|Overall Study||20
179575|NCT00575094|416761|P1|NOT COMPLETED|Overall Study||3
179576|NCT00575094|416761|P1|COMPLETED|Overall Study||6
179577|NCT00575094|416761|P1|STARTED|Overall Study||9
179578|NCT00575042|416765|P1|NOT COMPLETED|Overall Study||3
179579|NCT00575042|416765|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
179580|NCT00575042|416765|P1|STARTED|Overall Study||20
179581|NCT00575029|416770|P1|NOT COMPLETED|Overall Study||0
179582|NCT00575029|416770|P1|COMPLETED|Overall Study||7
179583|NCT00575029|416770|P1|STARTED|Overall Study||7
179584|NCT00575016|416779|P4|NOT COMPLETED|Treatment Cycle 2||0
179585|NCT00575016|416780|P3|NOT COMPLETED|Treatment Cycle 2||0
179586|NCT00575016|416781|P2|NOT COMPLETED|Treatment Cycle 2||0
179587|NCT00575016|416782|P1|NOT COMPLETED|Treatment Cycle 2||1
179588|NCT00575016|416779|P4|COMPLETED|Treatment Cycle 2||0
179589|NCT00575016|416780|P3|COMPLETED|Treatment Cycle 2||0
179590|NCT00575016|416781|P2|COMPLETED|Treatment Cycle 2||0
179591|NCT00575016|416782|P1|COMPLETED|Treatment Cycle 2||30
179592|NCT00575016|416779|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
179593|NCT00575016|416780|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
179594|NCT00575016|416781|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
179595|NCT00575016|416782|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
179596|NCT00575016|416779|P4|NOT COMPLETED|Treatment Cycle 1||5
179597|NCT00575016|416780|P3|NOT COMPLETED|Treatment Cycle 1||4
179598|NCT00575016|416781|P2|NOT COMPLETED|Treatment Cycle 1||5
179599|NCT00575016|416782|P1|NOT COMPLETED|Treatment Cycle 1||9
179600|NCT00575016|416779|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
179601|NCT00575016|416780|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
179602|NCT00575016|416781|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
179603|NCT00575016|416782|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
179604|NCT00575016|416779|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
179605|NCT00575016|416780|P3|STARTED|Treatment Cycle 1||19
179606|NCT00575016|416781|P2|STARTED|Treatment Cycle 1||21
179607|NCT00575016|416782|P1|STARTED|Treatment Cycle 1||17
179608|NCT00574990|416803|P3|NOT COMPLETED|Overall Study||0
179609|NCT00574990|416804|P2|NOT COMPLETED|Overall Study||0
179610|NCT00574990|416805|P1|NOT COMPLETED|Overall Study||0
179611|NCT00574990|416803|P3|COMPLETED|Overall Study||8
179612|NCT00574990|416804|P2|COMPLETED|Overall Study||19
179613|NCT00574990|416805|P1|COMPLETED|Overall Study||12
179614|NCT00574990|416803|P3|STARTED|Overall Study||8
179615|NCT00574990|416804|P2|STARTED|Overall Study||19
179616|NCT00574990|416805|P1|STARTED|Overall Study||12
179617|NCT00574912|416816|P1|NOT COMPLETED|Overall Study||8
179618|NCT00574912|416816|P1|COMPLETED|Overall Study||12
179619|NCT00574912|416816|P1|Completed 2.0|Overall Study||12
179620|NCT00574912|416816|P1|Completed 1.5|Overall Study||12
179621|NCT00574912|416816|P1|Completed 1.0|Overall Study||12
179622|NCT00574912|416816|P1|Completed 0.5|Overall Study||12
179623|NCT00574912|416816|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
179624|NCT00574912|416816|P1|STARTED|Overall Study||20
179625|NCT00574873|416830|P2|NOT COMPLETED|Overall Study||251
179626|NCT00574873|416831|P1|NOT COMPLETED|Overall Study||238
179627|NCT00574873|416830|P2|COMPLETED|Overall Study||1
179628|NCT00574873|416831|P1|COMPLETED|Overall Study||12
179629|NCT00574873|416830|P2|Treated|Overall Study||251
179630|NCT00574873|416831|P1|Treated|Overall Study||248
179631|NCT00574873|416830|P2|STARTED|Overall Study||252
179632|NCT00574873|416831|P1|STARTED|Overall Study||250
179633|NCT00574847|416849|P2|NOT COMPLETED|Overall Study||7
179634|NCT00574847|416850|P1|NOT COMPLETED|Overall Study||8
179635|NCT00574847|416849|P2|COMPLETED|Overall Study||56
179636|NCT00574847|416850|P1|COMPLETED|Overall Study||56
179637|NCT00574847|416849|P2|STARTED|Overall Study||63
179638|NCT00574847|416850|P1|STARTED|Overall Study||64
179639|NCT00574834|416885|P3|NOT COMPLETED|Overall Study||0
179640|NCT00574834|416886|P2|NOT COMPLETED|Overall Study||0
179641|NCT00574834|416887|P1|NOT COMPLETED|Overall Study||0
179642|NCT00574834|416885|P3|COMPLETED|Overall Study||4
179643|NCT00574834|416886|P2|COMPLETED|Overall Study||4
179644|NCT00574834|416887|P1|COMPLETED|Overall Study||9
179645|NCT00574834|416885|P3|STARTED|Overall Study||4
179646|NCT00574834|416886|P2|STARTED|Overall Study||4
179647|NCT00574834|416887|P1|STARTED|Overall Study||9
179648|NCT00574795|416895|P1|NOT COMPLETED|Toddler Dose||1
179649|NCT00574795|416895|P1|COMPLETED|Toddler Dose||184
179650|NCT00574795|416895|P1|STARTED|Toddler Dose||185
179651|NCT00574795|416895|P1|NOT COMPLETED|After Infant Series||3
179652|NCT00574795|416895|P1|COMPLETED|After Infant Series||185
179653|NCT00574795|416895|P1|STARTED|After Infant Series||188
179654|NCT00574795|416895|P1|NOT COMPLETED|Infant Series||5
179655|NCT00574795|416895|P1|COMPLETED|Infant Series||188
179656|NCT00574795|416895|P1|Vaccinated Dose 3|Infant Series||190
179657|NCT00574795|416895|P1|Vaccinated Dose 2|Infant Series||190
179658|NCT00574795|416895|P1|Vaccinated Dose 1|Infant Series||193
179659|NCT00574795|416895|P1|STARTED|Infant Series||193
179660|NCT00574704|416916|P4|NOT COMPLETED|Overall Study||0
179661|NCT00574704|416917|P3|NOT COMPLETED|Overall Study||1
179662|NCT00574704|416918|P2|NOT COMPLETED|Overall Study||0
179663|NCT00574704|416919|P1|NOT COMPLETED|Overall Study||0
179664|NCT00574704|416916|P4|COMPLETED|Overall Study||10
179665|NCT00574704|416917|P3|COMPLETED|Overall Study||9
179666|NCT00574704|416918|P2|COMPLETED|Overall Study||10
179667|NCT00574704|416919|P1|COMPLETED|Overall Study||10
179668|NCT00574704|416916|P4|STARTED|Overall Study||10
179669|NCT00574704|416917|P3|STARTED|Overall Study||10
179670|NCT00574704|416918|P2|STARTED|Overall Study||10
179671|NCT00574704|416919|P1|STARTED|Overall Study||10
179672|NCT00574548|416931|P2|NOT COMPLETED|Overall Study||16
179673|NCT00574548|416932|P1|NOT COMPLETED|Overall Study||61
179674|NCT00574548|416931|P2|COMPLETED|Overall Study||222
179675|NCT00574548|416932|P1|COMPLETED|Overall Study||421
179676|NCT00574548|416931|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
179677|NCT00574548|416932|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
179678|NCT00574548|416931|P2|Received Vax 2|Overall Study||223
179679|NCT00574548|416932|P1|Received Vax 2|Overall Study||427
179680|NCT00574548|416931|P2|Withdrawn Before Vax 2|Overall Study||11
179681|NCT00574548|416932|P1|Withdrawn Before Vax 2|Overall Study||41
179682|NCT00574548|416931|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
179683|NCT00574548|416932|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
179684|NCT00574548|416931|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
179685|NCT00574548|416932|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
179686|NCT00574548|416931|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
179687|NCT00574548|416932|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
179688|NCT00574548|416931|P2|STARTED|Overall Study||238
179689|NCT00574548|416932|P1|STARTED|Overall Study||482
179690|NCT00574405|416978|P2|NOT COMPLETED|Overall Study||2
179691|NCT00574405|416979|P1|NOT COMPLETED|Overall Study||3
179692|NCT00574405|416978|P2|COMPLETED|Overall Study||10
179693|NCT00574405|416979|P1|COMPLETED|Overall Study||9
179694|NCT00574405|416978|P2|STARTED|Overall Study||12
179695|NCT00574405|416979|P1|STARTED|Overall Study||12
179696|NCT00574340|416985|P1|NOT COMPLETED|Overall Study||0
179697|NCT00574340|416985|P1|COMPLETED|Overall Study||28
179698|NCT00574340|416985|P1|STARTED|Overall Study||28
179699|NCT00574275|416991|P2|NOT COMPLETED|Overall Study||271
179700|NCT00574275|416992|P1|NOT COMPLETED|Overall Study||275
179701|NCT00574275|416991|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
179702|NCT00574275|416992|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
179703|NCT00574275|416991|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
179704|NCT00574275|416992|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
179705|NCT00574275|416991|P2|TREATED|Overall Study||268
179706|NCT00574275|416992|P1|TREATED|Overall Study||273
179707|NCT00574275|416991|P2|STARTED|Overall Study||271
179708|NCT00574275|416992|P1|STARTED|Overall Study||275
179709|NCT00574249|417010|P2|NOT COMPLETED|Overall Study||28
179710|NCT00574249|417011|P1|NOT COMPLETED|Overall Study||26
179711|NCT00574249|417010|P2|COMPLETED|Overall Study||338
179712|NCT00574249|417011|P1|COMPLETED|Overall Study||338
179713|NCT00574249|417010|P2|STARTED|Overall Study||366
179714|NCT00574249|417011|P1|STARTED|Overall Study||364
179715|NCT00574171|417051|P1|NOT COMPLETED|Overall Study||0
179716|NCT00574171|417051|P1|COMPLETED|Overall Study||29
179717|NCT00574171|417051|P1|STARTED|Overall Study||29
179718|NCT00574145|417057|P2|NOT COMPLETED|Overall Study||1
179719|NCT00574145|417058|P1|NOT COMPLETED|Overall Study||2
179720|NCT00574145|417057|P2|COMPLETED|Overall Study||21
179721|NCT00574145|417058|P1|COMPLETED|Overall Study||20
179722|NCT00574145|417057|P2|STARTED|Overall Study||22
179723|NCT00574145|417058|P1|STARTED|Overall Study||22
179724|NCT00574080|417070|P2|NOT COMPLETED|Overall Study||10
179725|NCT00574080|417071|P1|NOT COMPLETED|Overall Study||10
179726|NCT00574080|417070|P2|COMPLETED|Overall Study||0
179727|NCT00574080|417071|P1|COMPLETED|Overall Study||0
179728|NCT00574080|417070|P2|STARTED|Overall Study||10
179729|NCT00574080|417071|P1|STARTED|Overall Study||10
179730|NCT00574067|417080|P4|NOT COMPLETED|Overall Study||0
179731|NCT00574067|417081|P3|NOT COMPLETED|Overall Study||0
179732|NCT00574067|417082|P2|NOT COMPLETED|Overall Study||1
179733|NCT00574067|417083|P1|NOT COMPLETED|Overall Study||1
179734|NCT00574067|417080|P4|COMPLETED|Overall Study||53
179735|NCT00574067|417081|P3|COMPLETED|Overall Study||54
179736|NCT00574067|417082|P2|COMPLETED|Overall Study||52
179737|NCT00574067|417083|P1|COMPLETED|Overall Study||52
179738|NCT00574067|417080|P4|STARTED|Overall Study||53
179739|NCT00574067|417081|P3|STARTED|Overall Study||54
179740|NCT00574067|417082|P2|STARTED|Overall Study||53
179741|NCT00574067|417083|P1|STARTED|Overall Study||53
179742|NCT00573937|417119|P2|NOT COMPLETED|Overall Study||1
179743|NCT00573937|417120|P1|NOT COMPLETED|Overall Study||0
179744|NCT00573937|417119|P2|COMPLETED|Overall Study||0
179745|NCT00573937|417120|P1|COMPLETED|Overall Study||0
179746|NCT00573937|417119|P2|STARTED|Overall Study||1
179747|NCT00573937|417120|P1|STARTED|Overall Study||0
179748|NCT00573859|417128|P1|NOT COMPLETED|Smoking Versus Abstinence||12
179749|NCT00573859|417128|P1|COMPLETED|Smoking Versus Abstinence||15
179750|NCT00573859|417128|P1|STARTED|Smoking Versus Abstinence||27
179751|NCT00573859|417128|P1|NOT COMPLETED|Medication Versus Placebo||12
179752|NCT00573859|417128|P1|COMPLETED|Medication Versus Placebo||15
179753|NCT00573859|417128|P1|STARTED|Medication Versus Placebo||27
179754|NCT00573768|417137|P3|NOT COMPLETED|Overall Study||4
179755|NCT00573768|417138|P2|NOT COMPLETED|Overall Study||2
179756|NCT00573768|417139|P1|NOT COMPLETED|Overall Study||2
179757|NCT00573768|417137|P3|COMPLETED|Overall Study||87
179758|NCT00573768|417138|P2|COMPLETED|Overall Study||89
179759|NCT00573768|417139|P1|COMPLETED|Overall Study||87
179760|NCT00573768|417137|P3|STARTED|Overall Study||91
179761|NCT00573768|417138|P2|STARTED|Overall Study||91
179762|NCT00573768|417139|P1|STARTED|Overall Study||89
179763|NCT00573755|417149|P2|NOT COMPLETED|Overall Study||0
179764|NCT00573755|417150|P1|NOT COMPLETED|Overall Study||1
179765|NCT00573755|417149|P2|COMPLETED|Overall Study||2
179766|NCT00573755|417150|P1|COMPLETED|Overall Study||1
179767|NCT00573755|417149|P2|STARTED|Overall Study||2
179768|NCT00573755|417150|P1|STARTED|Overall Study||2
179769|NCT00573534|417166|P1|NOT COMPLETED|Overall Study||3
179770|NCT00573534|417166|P1|COMPLETED|Overall Study||5
179771|NCT00573534|417166|P1|STARTED|Overall Study||8
179772|NCT00573508|417173|P2|NOT COMPLETED|Overall Study||41
179773|NCT00573508|417174|P1|NOT COMPLETED|Overall Study||64
179774|NCT00573508|417173|P2|COMPLETED|Overall Study||345
179775|NCT00573508|417174|P1|COMPLETED|Overall Study||318
179776|NCT00573508|417173|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
179777|NCT00573508|417174|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
179778|NCT00573508|417173|P2|STARTED|Overall Study||386
179779|NCT00573508|417174|P1|STARTED|Overall Study||382
179780|NCT00573469|417207|P3|NOT COMPLETED|Overall Study||4
179781|NCT00573469|417208|P2|NOT COMPLETED|Overall Study||4
179782|NCT00573469|417209|P1|NOT COMPLETED|Overall Study||6
179783|NCT00573469|417207|P3|COMPLETED|Overall Study||22
179784|NCT00573469|417208|P2|COMPLETED|Overall Study||21
179785|NCT00573469|417209|P1|COMPLETED|Overall Study||20
179786|NCT00573469|417207|P3|STARTED|Overall Study||26
179787|NCT00573469|417208|P2|STARTED|Overall Study||25
179788|NCT00573469|417209|P1|STARTED|Overall Study||26
179789|NCT00573443|417232|P3|NOT COMPLETED|Open-Label Extension Phase||0
179790|NCT00573443|417233|P2|NOT COMPLETED|Open-Label Extension Phase||0
179791|NCT00573443|417234|P1|NOT COMPLETED|Open-Label Extension Phase||18
179792|NCT00573443|417232|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179793|NCT00573443|417233|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179794|NCT00573443|417234|P1|COMPLETED|Open-Label Extension Phase||235
179795|NCT00573443|417232|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179796|NCT00573443|417233|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179797|NCT00573443|417234|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
179798|NCT00573443|417232|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179799|NCT00573443|417233|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179800|NCT00573443|417234|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
179801|NCT00573443|417232|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179802|NCT00573443|417233|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
179803|NCT00573443|417234|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
179804|NCT00573443|417232|P3|NOT COMPLETED|Double-Blind Phase||15
179805|NCT00573443|417233|P2|NOT COMPLETED|Double-Blind Phase||19
179806|NCT00573443|417234|P1|NOT COMPLETED|Double-Blind Phase||9
179807|NCT00573443|417232|P3|COMPLETED|Double-Blind Phase||94
179808|NCT00573443|417233|P2|COMPLETED|Double-Blind Phase||88
179809|NCT00573443|417234|P1|COMPLETED|Double-Blind Phase||101
179810|NCT00573443|417232|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
179811|NCT00573443|417233|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
179812|NCT00573443|417234|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
179813|NCT00573443|417232|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
179814|NCT00573443|417233|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
179815|NCT00573443|417234|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
179816|NCT00573443|417232|P3|STARTED|Double-Blind Phase||109
179817|NCT00573443|417233|P2|STARTED|Double-Blind Phase||107
179818|NCT00573443|417234|P1|STARTED|Double-Blind Phase||110
179819|NCT00573430|417264|P3|NOT COMPLETED|Overall Study||10
179820|NCT00573430|417265|P2|NOT COMPLETED|Overall Study||5
179821|NCT00573430|417266|P1|NOT COMPLETED|Overall Study||1
179822|NCT00573430|417264|P3|COMPLETED|Overall Study||33
179823|NCT00573430|417265|P2|COMPLETED|Overall Study||40
179824|NCT00573430|417266|P1|COMPLETED|Overall Study||39
179825|NCT00573430|417264|P3|STARTED|Overall Study|randomized|43
179826|NCT00573430|417265|P2|STARTED|Overall Study|randomized|45
179827|NCT00573430|417266|P1|STARTED|Overall Study|randomized|40
179828|NCT00573391|417288|P2|NOT COMPLETED|Overall Study||2
179829|NCT00573391|417289|P1|NOT COMPLETED|Overall Study||3
179830|NCT00573391|417288|P2|COMPLETED|Overall Study||0
179831|NCT00573391|417289|P1|COMPLETED|Overall Study||0
179832|NCT00573391|417288|P2|STARTED|Overall Study||2
179833|NCT00573391|417289|P1|STARTED|Overall Study||3
179834|NCT00573313|417299|P4|NOT COMPLETED|Overall Study||0
179835|NCT00573313|417300|P3|NOT COMPLETED|Overall Study||6
179836|NCT00573313|417301|P2|NOT COMPLETED|Overall Study||0
179837|NCT00573313|417302|P1|NOT COMPLETED|Overall Study||5
179838|NCT00573313|417299|P4|COMPLETED|Overall Study||26
179839|NCT00573313|417300|P3|COMPLETED|Overall Study||13
179840|NCT00573313|417301|P2|COMPLETED|Overall Study||28
179841|NCT00573313|417302|P1|COMPLETED|Overall Study||13
179842|NCT00573313|417299|P4|STARTED|Overall Study||26
179843|NCT00573313|417300|P3|STARTED|Overall Study|Nineteen recruited to start.|19
179844|NCT00573313|417301|P2|STARTED|Overall Study||28
179845|NCT00573313|417302|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
179846|NCT00573287|417312|P2|NOT COMPLETED|Overall Study||3
179847|NCT00573287|417313|P1|NOT COMPLETED|Overall Study||4
179848|NCT00573287|417312|P2|COMPLETED|Overall Study||4
179849|NCT00573287|417313|P1|COMPLETED|Overall Study||3
179850|NCT00573287|417312|P2|STARTED|Overall Study||7
179851|NCT00573287|417313|P1|STARTED|Overall Study||7
179852|NCT00573261|417321|P2|NOT COMPLETED|Overall Study||5
179853|NCT00573261|417322|P1|NOT COMPLETED|Overall Study||6
179854|NCT00573261|417321|P2|COMPLETED|Overall Study||15
179855|NCT00573261|417322|P1|COMPLETED|Overall Study||14
179856|NCT00573261|417321|P2|STARTED|Overall Study||20
179857|NCT00573261|417322|P1|STARTED|Overall Study||20
179858|NCT00573248|417350|P2|NOT COMPLETED|Overall Study||11
179859|NCT00573248|417351|P1|NOT COMPLETED|Overall Study||15
179860|NCT00573248|417350|P2|COMPLETED|Overall Study||27
179861|NCT00573248|417351|P1|COMPLETED|Overall Study||25
179862|NCT00573248|417350|P2|Nicotine Patches and Placebo Patches|Overall Study||27
179863|NCT00573248|417351|P1|Nicotine Patches and Placebo Patches|Overall Study||25
179864|NCT00573248|417350|P2|STARTED|Overall Study||38
179865|NCT00573248|417351|P1|STARTED|Overall Study||40
179866|NCT00573183|417365|P2|NOT COMPLETED|Overall Study||63
179867|NCT00573183|417366|P1|NOT COMPLETED|Overall Study||72
179868|NCT00573183|417365|P2|COMPLETED|Overall Study||174
179869|NCT00573183|417366|P1|COMPLETED|Overall Study||162
179870|NCT00573183|417365|P2|STARTED|Overall Study||237
179871|NCT00573183|417366|P1|STARTED|Overall Study||234
179872|NCT00573170|417374|P6|NOT COMPLETED|Third Treatment Period||2
179873|NCT00573170|417375|P5|NOT COMPLETED|Third Treatment Period||0
179874|NCT00573170|417376|P4|NOT COMPLETED|Third Treatment Period||0
179875|NCT00573170|417377|P3|NOT COMPLETED|Third Treatment Period||0
179876|NCT00573170|417378|P2|NOT COMPLETED|Third Treatment Period||0
179877|NCT00573170|417379|P1|NOT COMPLETED|Third Treatment Period||1
179878|NCT00573170|417374|P6|COMPLETED|Third Treatment Period||51
179879|NCT00573170|417375|P5|COMPLETED|Third Treatment Period||51
179880|NCT00573170|417376|P4|COMPLETED|Third Treatment Period||56
179881|NCT00573170|417377|P3|COMPLETED|Third Treatment Period||55
179882|NCT00573170|417378|P2|COMPLETED|Third Treatment Period||54
179883|NCT00573170|417379|P1|COMPLETED|Third Treatment Period||50
179884|NCT00573170|417374|P6|STARTED|Third Treatment Period||53
179885|NCT00573170|417375|P5|STARTED|Third Treatment Period||51
179886|NCT00573170|417376|P4|STARTED|Third Treatment Period||56
179887|NCT00573170|417377|P3|STARTED|Third Treatment Period||55
179888|NCT00573170|417378|P2|STARTED|Third Treatment Period||54
179889|NCT00573170|417379|P1|STARTED|Third Treatment Period||51
179890|NCT00573170|417374|P6|NOT COMPLETED|Second Washout Period||2
179891|NCT00573170|417375|P5|NOT COMPLETED|Second Washout Period||8
179892|NCT00573170|417376|P4|NOT COMPLETED|Second Washout Period||5
179893|NCT00573170|417377|P3|NOT COMPLETED|Second Washout Period||4
179894|NCT00573170|417378|P2|NOT COMPLETED|Second Washout Period||4
179895|NCT00573170|417379|P1|NOT COMPLETED|Second Washout Period||5
179896|NCT00573170|417374|P6|COMPLETED|Second Washout Period||53
179897|NCT00573170|417375|P5|COMPLETED|Second Washout Period||51
179898|NCT00573170|417376|P4|COMPLETED|Second Washout Period||56
179899|NCT00573170|417377|P3|COMPLETED|Second Washout Period||55
179900|NCT00573170|417378|P2|COMPLETED|Second Washout Period||54
179901|NCT00573170|417379|P1|COMPLETED|Second Washout Period||51
179902|NCT00573170|417374|P6|STARTED|Second Washout Period||55
179903|NCT00573170|417375|P5|STARTED|Second Washout Period||59
179904|NCT00573170|417376|P4|STARTED|Second Washout Period||61
179905|NCT00573170|417377|P3|STARTED|Second Washout Period||59
179906|NCT00573170|417378|P2|STARTED|Second Washout Period||58
179907|NCT00573170|417379|P1|STARTED|Second Washout Period||56
179908|NCT00573170|417374|P6|NOT COMPLETED|Second Treatment Period||0
179909|NCT00573170|417375|P5|NOT COMPLETED|Second Treatment Period||0
179910|NCT00573170|417376|P4|NOT COMPLETED|Second Treatment Period||0
179911|NCT00573170|417377|P3|NOT COMPLETED|Second Treatment Period||0
179912|NCT00573170|417378|P2|NOT COMPLETED|Second Treatment Period||0
179913|NCT00573170|417379|P1|NOT COMPLETED|Second Treatment Period||0
179914|NCT00573170|417374|P6|COMPLETED|Second Treatment Period||55
179915|NCT00573170|417375|P5|COMPLETED|Second Treatment Period||59
179916|NCT00573170|417376|P4|COMPLETED|Second Treatment Period||61
179917|NCT00573170|417377|P3|COMPLETED|Second Treatment Period||59
179918|NCT00573170|417378|P2|COMPLETED|Second Treatment Period||58
179919|NCT00573170|417379|P1|COMPLETED|Second Treatment Period||56
179920|NCT00573170|417374|P6|STARTED|Second Treatment Period||55
179921|NCT00573170|417375|P5|STARTED|Second Treatment Period||59
179922|NCT00573170|417376|P4|STARTED|Second Treatment Period||61
179923|NCT00573170|417377|P3|STARTED|Second Treatment Period||59
179924|NCT00573170|417378|P2|STARTED|Second Treatment Period||58
179925|NCT00573170|417379|P1|STARTED|Second Treatment Period||56
179926|NCT00573170|417374|P6|NOT COMPLETED|First Washout Period||7
179927|NCT00573170|417375|P5|NOT COMPLETED|First Washout Period||3
179928|NCT00573170|417376|P4|NOT COMPLETED|First Washout Period||5
179929|NCT00573170|417377|P3|NOT COMPLETED|First Washout Period||1
179930|NCT00573170|417378|P2|NOT COMPLETED|First Washout Period||2
179931|NCT00573170|417379|P1|NOT COMPLETED|First Washout Period||8
179932|NCT00573170|417374|P6|COMPLETED|First Washout Period||55
179933|NCT00573170|417375|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
179934|NCT00573170|417376|P4|COMPLETED|First Washout Period||61
179935|NCT00573170|417377|P3|COMPLETED|First Washout Period||59
179936|NCT00573170|417378|P2|COMPLETED|First Washout Period||58
179937|NCT00573170|417379|P1|COMPLETED|First Washout Period||56
179938|NCT00573170|417374|P6|STARTED|First Washout Period||62
179939|NCT00573170|417375|P5|STARTED|First Washout Period||62
179940|NCT00573170|417376|P4|STARTED|First Washout Period||66
179941|NCT00573170|417377|P3|STARTED|First Washout Period||60
179942|NCT00573170|417378|P2|STARTED|First Washout Period||60
179943|NCT00573170|417379|P1|STARTED|First Washout Period||64
179944|NCT00573170|417374|P6|NOT COMPLETED|First Treatment Period||0
179945|NCT00573170|417375|P5|NOT COMPLETED|First Treatment Period||1
179946|NCT00573170|417376|P4|NOT COMPLETED|First Treatment Period||0
179947|NCT00573170|417377|P3|NOT COMPLETED|First Treatment Period||0
179948|NCT00573170|417378|P2|NOT COMPLETED|First Treatment Period||0
179949|NCT00573170|417379|P1|NOT COMPLETED|First Treatment Period||0
179950|NCT00573170|417374|P6|COMPLETED|First Treatment Period||62
179951|NCT00573170|417375|P5|COMPLETED|First Treatment Period||62
179952|NCT00573170|417376|P4|COMPLETED|First Treatment Period||66
179953|NCT00573170|417377|P3|COMPLETED|First Treatment Period||60
179954|NCT00573170|417378|P2|COMPLETED|First Treatment Period||60
179955|NCT00573170|417379|P1|COMPLETED|First Treatment Period||64
179956|NCT00573170|417374|P6|STARTED|First Treatment Period||62
179957|NCT00573170|417375|P5|STARTED|First Treatment Period||63
179958|NCT00573170|417376|P4|STARTED|First Treatment Period||66
179959|NCT00573170|417377|P3|STARTED|First Treatment Period||60
179960|NCT00573170|417378|P2|STARTED|First Treatment Period||60
179961|NCT00573170|417379|P1|STARTED|First Treatment Period||64
179962|NCT00573157|417455|P2|NOT COMPLETED|Overall Study||2
179963|NCT00573157|417456|P1|NOT COMPLETED|Overall Study||4
179964|NCT00573157|417455|P2|COMPLETED|Overall Study||0
179965|NCT00573157|417456|P1|COMPLETED|Overall Study||0
179966|NCT00573157|417455|P2|STARTED|Overall Study||2
179967|NCT00573157|417456|P1|STARTED|Overall Study||4
179968|NCT00573144|417468|P2|NOT COMPLETED|Overall Study||3
179969|NCT00573144|417469|P1|NOT COMPLETED|Overall Study||2
179970|NCT00573144|417468|P2|COMPLETED|Overall Study||25
179971|NCT00573144|417469|P1|COMPLETED|Overall Study||28
179972|NCT00573144|417468|P2|STARTED|Overall Study||28
179973|NCT00573144|417469|P1|STARTED|Overall Study||30
179974|NCT00573131|417481|P2|NOT COMPLETED|Overall Study||8
179975|NCT00573131|417482|P1|NOT COMPLETED|Overall Study||10
179976|NCT00573131|417481|P2|COMPLETED|Overall Study||57
179977|NCT00573131|417482|P1|COMPLETED|Overall Study||62
179978|NCT00573131|417481|P2|STARTED|Overall Study||65
179979|NCT00573131|417482|P1|STARTED|Overall Study||72
179980|NCT00573066|417488|P1|NOT COMPLETED|Overall Study||20
179981|NCT00573066|417488|P1|COMPLETED|Overall Study||36
179982|NCT00573066|417488|P1|STARTED|Overall Study||56
179983|NCT00572910|417498|P11|NOT COMPLETED|Overall Study||3
179984|NCT00572910|417499|P10|NOT COMPLETED|Overall Study||6
179985|NCT00572910|417500|P9|NOT COMPLETED|Overall Study||3
179986|NCT00572910|417501|P8|NOT COMPLETED|Overall Study||4
179987|NCT00572910|417502|P7|NOT COMPLETED|Overall Study||4
179988|NCT00572910|417503|P6|NOT COMPLETED|Overall Study||3
179989|NCT00572910|417504|P5|NOT COMPLETED|Overall Study||2
179990|NCT00572910|417505|P4|NOT COMPLETED|Overall Study||4
179991|NCT00572910|417506|P3|NOT COMPLETED|Overall Study||2
179992|NCT00572910|417507|P2|NOT COMPLETED|Overall Study||3
179993|NCT00572910|417508|P1|NOT COMPLETED|Overall Study||4
179994|NCT00572910|417498|P11|COMPLETED|Overall Study||15
179995|NCT00572910|417499|P10|COMPLETED|Overall Study||13
179996|NCT00572910|417500|P9|COMPLETED|Overall Study||16
179997|NCT00572910|417501|P8|COMPLETED|Overall Study||15
179998|NCT00572910|417502|P7|COMPLETED|Overall Study||15
179999|NCT00572910|417503|P6|COMPLETED|Overall Study||16
180000|NCT00572910|417504|P5|COMPLETED|Overall Study||17
180001|NCT00572910|417505|P4|COMPLETED|Overall Study||14
180002|NCT00572910|417506|P3|COMPLETED|Overall Study||17
180003|NCT00572910|417507|P2|COMPLETED|Overall Study||15
180004|NCT00572910|417508|P1|COMPLETED|Overall Study||15
180005|NCT00572910|417498|P11|STARTED|Overall Study||18
180006|NCT00572910|417499|P10|STARTED|Overall Study||19
180007|NCT00572910|417500|P9|STARTED|Overall Study||19
180008|NCT00572910|417501|P8|STARTED|Overall Study||19
180009|NCT00572910|417502|P7|STARTED|Overall Study||19
180010|NCT00572910|417503|P6|STARTED|Overall Study||19
180011|NCT00572910|417504|P5|STARTED|Overall Study||19
180012|NCT00572910|417505|P4|STARTED|Overall Study||18
180013|NCT00572910|417506|P3|STARTED|Overall Study||19
180014|NCT00572910|417507|P2|STARTED|Overall Study||18
180015|NCT00572910|417508|P1|STARTED|Overall Study||19
180016|NCT00572897|417556|P2|NOT COMPLETED|Overall Study||0
180017|NCT00572897|417557|P1|NOT COMPLETED|Overall Study||0
180018|NCT00572897|417556|P2|COMPLETED|Overall Study||34
180019|NCT00572897|417557|P1|COMPLETED|Overall Study||32
180020|NCT00572897|417556|P2|STARTED|Overall Study||34
180021|NCT00572897|417557|P1|STARTED|Overall Study||32
180022|NCT00572832|417575|P2|NOT COMPLETED|Overall Study||12
180023|NCT00572832|417576|P1|NOT COMPLETED|Overall Study||0
180024|NCT00572832|417575|P2|COMPLETED|Overall Study||88
180025|NCT00572832|417576|P1|COMPLETED|Overall Study||100
180026|NCT00572832|417575|P2|STARTED|Overall Study||100
180027|NCT00572832|417576|P1|STARTED|Overall Study||100
180028|NCT00572728|417582|P1|NOT COMPLETED|Overall Study||39
180029|NCT00572728|417582|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
180030|NCT00572728|417582|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
180031|NCT00572728|417582|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
180032|NCT00572728|417582|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
180033|NCT00572728|417582|P1|Pathology Complete|Overall Study||51
180034|NCT00572728|417582|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
180035|NCT00572728|417582|P1|Second Chemotherapy Initiated|Overall Study||59
180036|NCT00572728|417582|P1|Completed FLT2 Scan|Overall Study||60
180037|NCT00572728|417582|P1|First Therapy Initiated|Overall Study||65
180038|NCT00572728|417582|P1|Completed FLT1 Scan|Overall Study||67
180039|NCT00572728|417582|P1|On Study|Overall Study||71
180040|NCT00572728|417582|P1|Did Not Withdraw|Overall Study||72
180041|NCT00572728|417582|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
180042|NCT00572728|417582|P1|Eligible|Overall Study||87
180043|NCT00572728|417582|P1|STARTED|Overall Study|Registered|90
180044|NCT00572572|417596|P2|NOT COMPLETED|Overall Study||6
180045|NCT00572572|417597|P1|NOT COMPLETED|Overall Study||3
180046|NCT00572572|417596|P2|COMPLETED|Overall Study||28
180047|NCT00572572|417597|P1|COMPLETED|Overall Study||32
180048|NCT00572572|417596|P2|STARTED|Overall Study||34
180049|NCT00572572|417597|P1|STARTED|Overall Study||35
180050|NCT00572533|417615|P2|NOT COMPLETED|Overall Study||3
180051|NCT00572533|417616|P1|NOT COMPLETED|Overall Study||7
180052|NCT00572533|417615|P2|COMPLETED|Overall Study||28
180053|NCT00572533|417616|P1|COMPLETED|Overall Study||24
180054|NCT00572533|417615|P2|STARTED|Overall Study||31
180055|NCT00572533|417616|P1|STARTED|Overall Study||31
180056|NCT00572260|417636|P1|NOT COMPLETED|Overall Study||0
180057|NCT00572260|417636|P1|COMPLETED|Overall Study||11
180058|NCT00572260|417636|P1|STARTED|Overall Study||11
180059|NCT00572156|417644|P4|NOT COMPLETED|Overall Study||25
180060|NCT00572156|417645|P3|NOT COMPLETED|Overall Study||27
180061|NCT00572156|417646|P2|NOT COMPLETED|Overall Study||26
180062|NCT00572156|417647|P1|NOT COMPLETED|Overall Study||26
180063|NCT00572156|417644|P4|COMPLETED|Overall Study||1
180064|NCT00572156|417645|P3|COMPLETED|Overall Study||0
180065|NCT00572156|417646|P2|COMPLETED|Overall Study||1
180066|NCT00572156|417647|P1|COMPLETED|Overall Study||0
180067|NCT00572156|417644|P4|STARTED|Overall Study||26
180068|NCT00572156|417645|P3|STARTED|Overall Study||27
180069|NCT00572156|417646|P2|STARTED|Overall Study||27
180070|NCT00572156|417647|P1|STARTED|Overall Study||26
180071|NCT00572117|417707|P2|NOT COMPLETED|Overall Study||2
180072|NCT00572117|417708|P1|NOT COMPLETED|Overall Study||2
180073|NCT00572117|417707|P2|COMPLETED|Overall Study||5
180074|NCT00572117|417708|P1|COMPLETED|Overall Study||3
180075|NCT00572117|417707|P2|STARTED|Overall Study||7
180076|NCT00572117|417708|P1|STARTED|Overall Study||5
180077|NCT00572039|417718|P2|NOT COMPLETED|Overall Study||10
180078|NCT00572039|417719|P1|NOT COMPLETED|Overall Study||16
180079|NCT00572039|417718|P2|COMPLETED|Overall Study||110
180080|NCT00572039|417719|P1|COMPLETED|Overall Study||105
180081|NCT00572039|417718|P2|STARTED|Overall Study||120
180082|NCT00572039|417719|P1|STARTED|Overall Study||121
180083|NCT00571987|417731|P1|NOT COMPLETED|Overall Study||7
180084|NCT00571987|417731|P1|COMPLETED|Overall Study||100
180085|NCT00571987|417731|P1|STARTED|Overall Study||107
180086|NCT00571974|417738|P2|NOT COMPLETED|Phase II||4
180087|NCT00571974|417739|P1|NOT COMPLETED|Phase II||0
180088|NCT00571974|417738|P2|COMPLETED|Phase II||17
180089|NCT00571974|417739|P1|COMPLETED|Phase II||0
180090|NCT00571974|417738|P2|STARTED|Phase II|3 participants are from phase I|21
180091|NCT00571974|417739|P1|STARTED|Phase II||0
180092|NCT00571974|417738|P2|NOT COMPLETED|Phase I||0
180093|NCT00571974|417739|P1|NOT COMPLETED|Phase I||0
180094|NCT00571974|417738|P2|COMPLETED|Phase I||0
180095|NCT00571974|417739|P1|COMPLETED|Phase I||9
180096|NCT00571974|417738|P2|STARTED|Phase I||0
180097|NCT00571974|417739|P1|STARTED|Phase I||9
180098|NCT00571961|417745|P1|NOT COMPLETED|Overall Study||0
180099|NCT00571961|417745|P1|COMPLETED|Overall Study||12
180100|NCT00571961|417745|P1|STARTED|Overall Study||12
180101|NCT00571948|417751|P2|NOT COMPLETED|Overall Study||14
180102|NCT00571948|417752|P1|NOT COMPLETED|Overall Study||11
180103|NCT00571948|417751|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
180104|NCT00571948|417752|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
180105|NCT00571948|417751|P2|STARTED|Overall Study||66
180106|NCT00571948|417752|P1|STARTED|Overall Study||66
180107|NCT00571922|417760|P2|NOT COMPLETED|Overall Study||36
180108|NCT00571922|417761|P1|NOT COMPLETED|Overall Study||36
180109|NCT00571922|417760|P2|COMPLETED|Overall Study||0
180110|NCT00571922|417761|P1|COMPLETED|Overall Study||0
180111|NCT00571922|417760|P2|STARTED|Overall Study||36
180112|NCT00571922|417761|P1|STARTED|Overall Study||36
180113|NCT00571662|417769|P1|NOT COMPLETED|Overall Study||8
180114|NCT00571662|417769|P1|COMPLETED|Overall Study||68
180115|NCT00571662|417769|P1|STARTED|Overall Study||76
180116|NCT00571649|417777|P2|NOT COMPLETED|Follow-up Period||528
180117|NCT00571649|417778|P1|NOT COMPLETED|Follow-up Period||545
180118|NCT00571649|417777|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
180119|NCT00571649|417778|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
180120|NCT00571649|417777|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
180121|NCT00571649|417778|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
180122|NCT00571649|417777|P2|NOT COMPLETED|Treatment Period||1004
180123|NCT00571649|417778|P1|NOT COMPLETED|Treatment Period||1092
180124|NCT00571649|417777|P2|COMPLETED|Treatment Period||3047
180125|NCT00571649|417778|P1|COMPLETED|Treatment Period||2958
180126|NCT00571649|417777|P2|Day 35|Treatment Period||3115
180127|NCT00571649|417778|P1|Day 35|Treatment Period||3033
180128|NCT00571649|417777|P2|Day 10|Treatment Period||3499
180129|NCT00571649|417778|P1|Day 10|Treatment Period||3454
180130|NCT00571649|417777|P2|Participants Received Treatment|Treatment Period||4001
180131|NCT00571649|417778|P1|Participants Received Treatment|Treatment Period||3997
180132|NCT00571649|417777|P2|STARTED|Treatment Period||4051
180133|NCT00571649|417778|P1|STARTED|Treatment Period||4050
180134|NCT00571428|417812|P2|NOT COMPLETED|Overall Study||0
180135|NCT00571428|417813|P1|NOT COMPLETED|Overall Study||0
180136|NCT00571428|417812|P2|COMPLETED|Overall Study||18
180137|NCT00571428|417813|P1|COMPLETED|Overall Study||15
180138|NCT00571428|417812|P2|STARTED|Overall Study||18
180139|NCT00571428|417813|P1|STARTED|Overall Study||15
180140|NCT00571324|417845|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
180141|NCT00571324|417846|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
180142|NCT00571324|417845|P2|COMPLETED|Intervention 2 (7 Hours)||4
180143|NCT00571324|417846|P1|COMPLETED|Intervention 2 (7 Hours)||5
180144|NCT00571324|417845|P2|STARTED|Intervention 2 (7 Hours)||4
180145|NCT00571324|417846|P1|STARTED|Intervention 2 (7 Hours)||5
180146|NCT00571324|417845|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
180147|NCT00571324|417846|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
180148|NCT00571324|417845|P2|COMPLETED|Intervention 1 (7 Hours)||4
180149|NCT00571324|417846|P1|COMPLETED|Intervention 1 (7 Hours)||5
180150|NCT00571324|417845|P2|STARTED|Intervention 1 (7 Hours)||4
180151|NCT00571324|417846|P1|STARTED|Intervention 1 (7 Hours)||5
180152|NCT00571038|417860|P2|NOT COMPLETED|Overall Study||14
180153|NCT00571038|417861|P1|NOT COMPLETED|Overall Study||11
180154|NCT00571038|417860|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
180155|NCT00571038|417861|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
180156|NCT00571038|417860|P2|18 Month Survey Only|Overall Study||163
180157|NCT00571038|417861|P1|18 Month Survey Only|Overall Study||199
180158|NCT00571038|417860|P2|6 Month Follow up|Overall Study||176
180159|NCT00571038|417861|P1|6 Month Follow up|Overall Study||208
180160|NCT00571038|417860|P2|STARTED|Overall Study||185
180161|NCT00571038|417861|P1|STARTED|Overall Study||219
180162|NCT00570960|417909|P2|NOT COMPLETED|Overall Study||0
180163|NCT00570960|417910|P1|NOT COMPLETED|Overall Study||0
180164|NCT00570960|417909|P2|COMPLETED|Overall Study||4
180165|NCT00570960|417910|P1|COMPLETED|Overall Study||4
180166|NCT00570960|417909|P2|STARTED|Overall Study||4
180167|NCT00570960|417910|P1|STARTED|Overall Study||4
180168|NCT00570921|417916|P1|NOT COMPLETED|Overall Study||2
180169|NCT00570921|417916|P1|COMPLETED|Overall Study||31
180170|NCT00570921|417916|P1|STARTED|Overall Study||33
180171|NCT00570908|417922|P1|NOT COMPLETED|Overall Study||7
180172|NCT00570908|417922|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
180173|NCT00570908|417922|P1|STARTED|Overall Study||12
180174|NCT00570778|417926|P4|NOT COMPLETED|Overall Study||4
180175|NCT00570778|417927|P3|NOT COMPLETED|Overall Study||7
180176|NCT00570778|417928|P2|NOT COMPLETED|Overall Study||4
180177|NCT00570778|417929|P1|NOT COMPLETED|Overall Study||4
180178|NCT00570778|417926|P4|COMPLETED|Overall Study||34
180179|NCT00570778|417927|P3|COMPLETED|Overall Study||30
180180|NCT00570778|417928|P2|COMPLETED|Overall Study||34
180181|NCT00570778|417929|P1|COMPLETED|Overall Study||37
180182|NCT00570778|417926|P4|Modified Intent-to-treat Population|Overall Study||37
180183|NCT00570778|417927|P3|Modified Intent-to-treat Population|Overall Study||35
180184|NCT00570778|417928|P2|Modified Intent-to-treat Population|Overall Study||37
180185|NCT00570778|417929|P1|Modified Intent-to-treat Population|Overall Study||40
180186|NCT00570778|417926|P4|Safety Population: Received Study Drug|Overall Study||38
180187|NCT00570778|417927|P3|Safety Population: Received Study Drug|Overall Study||36
180188|NCT00570778|417928|P2|Safety Population: Received Study Drug|Overall Study||38
180189|NCT00570778|417929|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
180190|NCT00570778|417926|P4|STARTED|Overall Study||38
180191|NCT00570778|417927|P3|STARTED|Overall Study||37
180192|NCT00570778|417928|P2|STARTED|Overall Study||38
180193|NCT00570778|417929|P1|STARTED|Overall Study||41
180194|NCT00570765|417950|P3|NOT COMPLETED|Overall Study||0
180195|NCT00570765|417951|P2|NOT COMPLETED|Overall Study||7
180196|NCT00570765|417952|P1|NOT COMPLETED|Overall Study||4
180197|NCT00570765|417950|P3|COMPLETED|Overall Study||23
180198|NCT00570765|417951|P2|COMPLETED|Overall Study||9
180199|NCT00570765|417952|P1|COMPLETED|Overall Study||16
180200|NCT00570765|417950|P3|STARTED|Overall Study||23
180201|NCT00570765|417951|P2|STARTED|Overall Study||16
180202|NCT00570765|417952|P1|STARTED|Overall Study||20
180203|NCT00570739|417970|P4|NOT COMPLETED|Overall Study||12
180204|NCT00570739|417971|P3|NOT COMPLETED|Overall Study||16
180205|NCT00570739|417972|P2|NOT COMPLETED|Overall Study||21
180206|NCT00570739|417973|P1|NOT COMPLETED|Overall Study||21
180207|NCT00570739|417970|P4|COMPLETED|Overall Study||96
180208|NCT00570739|417971|P3|COMPLETED|Overall Study||92
180209|NCT00570739|417972|P2|COMPLETED|Overall Study||124
180210|NCT00570739|417973|P1|COMPLETED|Overall Study||120
180211|NCT00570739|417970|P4|STARTED|Overall Study||108
180212|NCT00570739|417971|P3|STARTED|Overall Study||108
180213|NCT00570739|417972|P2|STARTED|Overall Study||145
180214|NCT00570739|417973|P1|STARTED|Overall Study||141
180215|NCT00570713|418125|P2|NOT COMPLETED|Overall Study||77
180216|NCT00570713|418126|P1|NOT COMPLETED|Overall Study||78
180217|NCT00570713|418125|P2|COMPLETED|Overall Study||0
180218|NCT00570713|418126|P1|COMPLETED|Overall Study||0
180219|NCT00570713|418125|P2|STARTED|Overall Study||77
180220|NCT00570713|418126|P1|STARTED|Overall Study||78
180221|NCT00570687|418138|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180222|NCT00570687|418139|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180223|NCT00570687|418140|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180224|NCT00570687|418141|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180225|NCT00570687|418142|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180226|NCT00570687|418143|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180227|NCT00570687|418144|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180228|NCT00570687|418145|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180229|NCT00570687|418146|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180230|NCT00570687|418147|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180231|NCT00570687|418138|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180232|NCT00570687|418139|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180233|NCT00570687|418140|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180234|NCT00570687|418141|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180235|NCT00570687|418142|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180236|NCT00570687|418143|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
180237|NCT00570687|418144|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
180238|NCT00570687|418145|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
180239|NCT00570687|418146|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
180240|NCT00570687|418147|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
180241|NCT00570687|418138|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180242|NCT00570687|418139|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180243|NCT00570687|418140|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180244|NCT00570687|418141|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180245|NCT00570687|418142|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180246|NCT00570687|418143|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
180247|NCT00570687|418144|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
180248|NCT00570687|418145|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
180249|NCT00570687|418146|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
180250|NCT00570687|418147|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
180251|NCT00570687|418138|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180252|NCT00570687|418139|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180253|NCT00570687|418140|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180254|NCT00570687|418141|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180255|NCT00570687|418142|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180256|NCT00570687|418143|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180257|NCT00570687|418144|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180258|NCT00570687|418145|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180259|NCT00570687|418146|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180260|NCT00570687|418147|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180261|NCT00570687|418138|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180262|NCT00570687|418139|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180263|NCT00570687|418140|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180264|NCT00570687|418141|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180265|NCT00570687|418142|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180266|NCT00570687|418143|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
180267|NCT00570687|418144|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
180268|NCT00570687|418145|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
180269|NCT00570687|418146|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
180270|NCT00570687|418147|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
180271|NCT00570687|418138|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180272|NCT00570687|418139|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180273|NCT00570687|418140|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180274|NCT00570687|418141|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180275|NCT00570687|418142|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180276|NCT00570687|418143|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
180277|NCT00570687|418144|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
180278|NCT00570687|418145|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
180279|NCT00570687|418146|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
180280|NCT00570687|418147|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
180281|NCT00570687|418138|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180282|NCT00570687|418139|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180283|NCT00570687|418140|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180284|NCT00570687|418141|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180285|NCT00570687|418142|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180286|NCT00570687|418143|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180287|NCT00570687|418144|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180288|NCT00570687|418145|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180289|NCT00570687|418146|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180290|NCT00570687|418147|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180291|NCT00570687|418138|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180292|NCT00570687|418139|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180293|NCT00570687|418140|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180294|NCT00570687|418141|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180295|NCT00570687|418142|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180296|NCT00570687|418143|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
180297|NCT00570687|418144|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
180298|NCT00570687|418145|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
180299|NCT00570687|418146|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
180300|NCT00570687|418147|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
180301|NCT00570687|418138|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180302|NCT00570687|418139|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180303|NCT00570687|418140|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180304|NCT00570687|418141|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180305|NCT00570687|418142|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180306|NCT00570687|418143|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
180307|NCT00570687|418144|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
180308|NCT00570687|418145|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
180309|NCT00570687|418146|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
180310|NCT00570687|418147|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
180311|NCT00570687|418138|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180312|NCT00570687|418139|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180313|NCT00570687|418140|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180314|NCT00570687|418141|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180315|NCT00570687|418142|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180316|NCT00570687|418143|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180317|NCT00570687|418144|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180318|NCT00570687|418145|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180319|NCT00570687|418146|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180320|NCT00570687|418147|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180321|NCT00570687|418138|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180322|NCT00570687|418139|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180323|NCT00570687|418140|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180324|NCT00570687|418141|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180325|NCT00570687|418142|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180326|NCT00570687|418143|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
180327|NCT00570687|418144|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
180328|NCT00570687|418145|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
180329|NCT00570687|418146|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
180330|NCT00570687|418147|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
180331|NCT00570687|418138|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180332|NCT00570687|418139|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180333|NCT00570687|418140|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180334|NCT00570687|418141|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180335|NCT00570687|418142|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180336|NCT00570687|418143|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
180337|NCT00570687|418144|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
180338|NCT00570687|418145|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
180339|NCT00570687|418146|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
180340|NCT00570687|418147|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
180341|NCT00570687|418138|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180342|NCT00570687|418139|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180343|NCT00570687|418140|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180344|NCT00570687|418141|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180345|NCT00570687|418142|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180346|NCT00570687|418143|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180347|NCT00570687|418144|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180348|NCT00570687|418145|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180349|NCT00570687|418146|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180350|NCT00570687|418147|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180351|NCT00570687|418138|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180352|NCT00570687|418139|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180353|NCT00570687|418140|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180354|NCT00570687|418141|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180355|NCT00570687|418142|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180356|NCT00570687|418143|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
180357|NCT00570687|418144|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
180358|NCT00570687|418145|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
180359|NCT00570687|418146|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
180360|NCT00570687|418147|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
180361|NCT00570687|418138|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180362|NCT00570687|418139|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180363|NCT00570687|418140|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180364|NCT00570687|418141|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180365|NCT00570687|418142|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180366|NCT00570687|418143|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
180367|NCT00570687|418144|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
180368|NCT00570687|418145|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
180369|NCT00570687|418146|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
180370|NCT00570687|418147|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
180371|NCT00570687|418138|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180372|NCT00570687|418139|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180373|NCT00570687|418140|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180374|NCT00570687|418141|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180375|NCT00570687|418142|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180376|NCT00570687|418143|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180377|NCT00570687|418144|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180378|NCT00570687|418145|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180379|NCT00570687|418146|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180380|NCT00570687|418147|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180381|NCT00570687|418138|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180382|NCT00570687|418139|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180383|NCT00570687|418140|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180384|NCT00570687|418141|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180385|NCT00570687|418142|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180386|NCT00570687|418143|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
180387|NCT00570687|418144|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
180388|NCT00570687|418145|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
180389|NCT00570687|418146|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
180390|NCT00570687|418147|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
180391|NCT00570687|418138|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180392|NCT00570687|418139|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180393|NCT00570687|418140|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180394|NCT00570687|418141|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180395|NCT00570687|418142|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180396|NCT00570687|418143|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
180397|NCT00570687|418144|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
180398|NCT00570687|418145|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
180399|NCT00570687|418146|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
180400|NCT00570687|418147|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
180401|NCT00570687|418138|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180402|NCT00570687|418139|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180403|NCT00570687|418140|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180404|NCT00570687|418141|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180405|NCT00570687|418142|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180406|NCT00570687|418143|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180407|NCT00570687|418144|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180408|NCT00570687|418145|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180409|NCT00570687|418146|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180410|NCT00570687|418147|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180411|NCT00570687|418138|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180412|NCT00570687|418139|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180413|NCT00570687|418140|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180414|NCT00570687|418141|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180415|NCT00570687|418142|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180416|NCT00570687|418143|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
180417|NCT00570687|418144|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
180418|NCT00570687|418145|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
180419|NCT00570687|418146|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
180420|NCT00570687|418147|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
180421|NCT00570687|418138|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180422|NCT00570687|418139|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180423|NCT00570687|418140|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180424|NCT00570687|418141|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180425|NCT00570687|418142|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180426|NCT00570687|418143|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
180427|NCT00570687|418144|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
180428|NCT00570687|418145|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
180429|NCT00570687|418146|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
180430|NCT00570687|418147|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
180431|NCT00570687|418138|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180432|NCT00570687|418139|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180433|NCT00570687|418140|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180434|NCT00570687|418141|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
180435|NCT00570687|418142|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180436|NCT00570687|418143|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180437|NCT00570687|418144|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180438|NCT00570687|418145|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180439|NCT00570687|418146|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180440|NCT00570687|418147|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180441|NCT00570687|418138|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180442|NCT00570687|418139|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180443|NCT00570687|418140|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180444|NCT00570687|418141|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180445|NCT00570687|418142|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180446|NCT00570687|418143|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180447|NCT00570687|418144|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180448|NCT00570687|418145|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180449|NCT00570687|418146|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180450|NCT00570687|418147|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
180451|NCT00570687|418138|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180452|NCT00570687|418139|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180453|NCT00570687|418140|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180454|NCT00570687|418141|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
180455|NCT00570687|418142|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180456|NCT00570687|418143|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180457|NCT00570687|418144|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180458|NCT00570687|418145|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180459|NCT00570687|418146|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180460|NCT00570687|418147|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
180461|NCT00570687|418138|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180462|NCT00570687|418139|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180463|NCT00570687|418140|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180464|NCT00570687|418141|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180465|NCT00570687|418142|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180466|NCT00570687|418143|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180467|NCT00570687|418144|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180468|NCT00570687|418145|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180469|NCT00570687|418146|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180470|NCT00570687|418147|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180471|NCT00570687|418138|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180472|NCT00570687|418139|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180473|NCT00570687|418140|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180474|NCT00570687|418141|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
180475|NCT00570687|418142|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180476|NCT00570687|418143|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180477|NCT00570687|418144|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180478|NCT00570687|418145|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180479|NCT00570687|418146|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180480|NCT00570687|418147|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
180481|NCT00570687|418138|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180482|NCT00570687|418139|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180483|NCT00570687|418140|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180484|NCT00570687|418141|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
180485|NCT00570687|418142|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180486|NCT00570687|418143|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180487|NCT00570687|418144|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180488|NCT00570687|418145|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180489|NCT00570687|418146|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180490|NCT00570687|418147|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
180491|NCT00570687|418138|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180804|NCT00570310|418285|P1|COMPLETED|Overall Study||51
180492|NCT00570687|418139|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
180493|NCT00570687|418140|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180494|NCT00570687|418141|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180495|NCT00570687|418142|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180496|NCT00570687|418143|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180497|NCT00570687|418144|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180498|NCT00570687|418145|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180499|NCT00570687|418146|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180500|NCT00570687|418147|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180501|NCT00570687|418138|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180502|NCT00570687|418139|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180503|NCT00570687|418140|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180504|NCT00570687|418141|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
180505|NCT00570687|418142|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180506|NCT00570687|418143|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180507|NCT00570687|418144|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180508|NCT00570687|418145|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180509|NCT00570687|418146|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180510|NCT00570687|418147|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
180511|NCT00570687|418138|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180512|NCT00570687|418139|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
180513|NCT00570687|418140|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180514|NCT00570687|418141|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
180515|NCT00570687|418142|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180516|NCT00570687|418143|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180517|NCT00570687|418144|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180518|NCT00570687|418145|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180519|NCT00570687|418146|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180520|NCT00570687|418147|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
180521|NCT00570687|418138|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180522|NCT00570687|418139|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180523|NCT00570687|418140|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180524|NCT00570687|418141|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180525|NCT00570687|418142|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180526|NCT00570687|418143|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180527|NCT00570687|418144|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180528|NCT00570687|418145|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180529|NCT00570687|418146|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180530|NCT00570687|418147|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180531|NCT00570687|418138|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180532|NCT00570687|418139|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
180533|NCT00570687|418140|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180534|NCT00570687|418141|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
180535|NCT00570687|418142|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180536|NCT00570687|418143|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180537|NCT00570687|418144|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180538|NCT00570687|418145|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180539|NCT00570687|418146|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180540|NCT00570687|418147|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
180541|NCT00570687|418138|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180542|NCT00570687|418139|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
180543|NCT00570687|418140|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180544|NCT00570687|418141|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
180545|NCT00570687|418142|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180546|NCT00570687|418143|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180547|NCT00570687|418144|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180548|NCT00570687|418145|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180549|NCT00570687|418146|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180550|NCT00570687|418147|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
180551|NCT00570687|418138|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
180552|NCT00570687|418139|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
180553|NCT00570687|418140|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
180554|NCT00570687|418141|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
180555|NCT00570687|418142|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
180556|NCT00570687|418143|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
180557|NCT00570687|418144|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180558|NCT00570687|418145|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180559|NCT00570687|418146|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180560|NCT00570687|418147|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180561|NCT00570687|418138|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180562|NCT00570687|418139|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
180563|NCT00570687|418140|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180564|NCT00570687|418141|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
180565|NCT00570687|418142|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180566|NCT00570687|418143|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180567|NCT00570687|418144|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180568|NCT00570687|418145|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180569|NCT00570687|418146|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180570|NCT00570687|418147|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
180571|NCT00570687|418138|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180572|NCT00570687|418139|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180573|NCT00570687|418140|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180574|NCT00570687|418141|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180575|NCT00570687|418142|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180576|NCT00570687|418143|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
180577|NCT00570687|418144|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
180578|NCT00570687|418145|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
180579|NCT00570687|418146|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
180580|NCT00570687|418147|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
180581|NCT00570687|418138|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180582|NCT00570687|418139|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180583|NCT00570687|418140|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180584|NCT00570687|418141|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180585|NCT00570687|418142|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180586|NCT00570687|418143|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180587|NCT00570687|418144|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180588|NCT00570687|418145|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180589|NCT00570687|418146|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180590|NCT00570687|418147|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180591|NCT00570687|418138|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180592|NCT00570687|418139|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180593|NCT00570687|418140|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180594|NCT00570687|418141|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180595|NCT00570687|418142|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180596|NCT00570687|418143|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180597|NCT00570687|418144|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180598|NCT00570687|418145|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180599|NCT00570687|418146|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180600|NCT00570687|418147|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180601|NCT00570687|418138|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180602|NCT00570687|418139|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180603|NCT00570687|418140|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180604|NCT00570687|418141|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180605|NCT00570687|418142|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180606|NCT00570687|418143|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
180607|NCT00570687|418144|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180608|NCT00570687|418145|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180609|NCT00570687|418146|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180610|NCT00570687|418147|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
180611|NCT00570687|418138|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180612|NCT00570687|418139|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180613|NCT00570687|418140|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180614|NCT00570687|418141|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180615|NCT00570687|418142|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180616|NCT00570687|418143|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180617|NCT00570687|418144|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180618|NCT00570687|418145|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180619|NCT00570687|418146|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180620|NCT00570687|418147|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180621|NCT00570687|418138|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180622|NCT00570687|418139|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180623|NCT00570687|418140|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180624|NCT00570687|418141|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180625|NCT00570687|418142|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180626|NCT00570687|418143|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
180627|NCT00570687|418144|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180628|NCT00570687|418145|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180629|NCT00570687|418146|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180630|NCT00570687|418147|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
180631|NCT00570687|418138|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180632|NCT00570687|418139|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180633|NCT00570687|418140|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180634|NCT00570687|418141|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180635|NCT00570687|418142|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180636|NCT00570687|418143|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
180637|NCT00570687|418144|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
180638|NCT00570687|418145|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
180639|NCT00570687|418146|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
180640|NCT00570687|418147|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
180641|NCT00570687|418138|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180642|NCT00570687|418139|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180643|NCT00570687|418140|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180644|NCT00570687|418141|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180645|NCT00570687|418142|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180646|NCT00570687|418143|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180647|NCT00570687|418144|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180648|NCT00570687|418145|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180649|NCT00570687|418146|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180650|NCT00570687|418147|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180651|NCT00570687|418138|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180652|NCT00570687|418139|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180653|NCT00570687|418140|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180654|NCT00570687|418141|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180655|NCT00570687|418142|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180656|NCT00570687|418143|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180657|NCT00570687|418144|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180658|NCT00570687|418145|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180659|NCT00570687|418146|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180660|NCT00570687|418147|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180661|NCT00570687|418138|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180662|NCT00570687|418139|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180663|NCT00570687|418140|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180664|NCT00570687|418141|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180665|NCT00570687|418142|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180666|NCT00570687|418143|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
180667|NCT00570687|418144|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180668|NCT00570687|418145|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180669|NCT00570687|418146|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180670|NCT00570687|418147|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
180671|NCT00570687|418138|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180672|NCT00570687|418139|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180673|NCT00570687|418140|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180674|NCT00570687|418141|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180675|NCT00570687|418142|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180676|NCT00570687|418143|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180677|NCT00570687|418144|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180678|NCT00570687|418145|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180679|NCT00570687|418146|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180680|NCT00570687|418147|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180681|NCT00570687|418138|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180682|NCT00570687|418139|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180683|NCT00570687|418140|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180684|NCT00570687|418141|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180685|NCT00570687|418142|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180686|NCT00570687|418143|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
180687|NCT00570687|418144|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180688|NCT00570687|418145|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180689|NCT00570687|418146|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180690|NCT00570687|418147|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
180691|NCT00570687|418138|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180692|NCT00570687|418139|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180693|NCT00570687|418140|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180694|NCT00570687|418141|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180695|NCT00570687|418142|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180696|NCT00570687|418143|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
180697|NCT00570687|418144|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
180698|NCT00570687|418145|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
180699|NCT00570687|418146|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
180700|NCT00570687|418147|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
180701|NCT00570687|418138|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180702|NCT00570687|418139|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180703|NCT00570687|418140|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180704|NCT00570687|418141|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180705|NCT00570687|418142|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180706|NCT00570687|418143|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180707|NCT00570687|418144|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180708|NCT00570687|418145|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180709|NCT00570687|418146|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180710|NCT00570687|418147|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180711|NCT00570687|418138|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180712|NCT00570687|418139|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180713|NCT00570687|418140|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180714|NCT00570687|418141|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180715|NCT00570687|418142|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180716|NCT00570687|418143|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180717|NCT00570687|418144|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180718|NCT00570687|418145|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180719|NCT00570687|418146|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180720|NCT00570687|418147|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180721|NCT00570687|418138|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180722|NCT00570687|418139|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180723|NCT00570687|418140|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180724|NCT00570687|418141|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180725|NCT00570687|418142|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180726|NCT00570687|418143|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
180727|NCT00570687|418144|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180728|NCT00570687|418145|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180729|NCT00570687|418146|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180730|NCT00570687|418147|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
180731|NCT00570674|418173|P7|NOT COMPLETED|Overall Study||0
180732|NCT00570674|418174|P6|NOT COMPLETED|Overall Study||0
180733|NCT00570674|418175|P5|NOT COMPLETED|Overall Study||0
180734|NCT00570674|418176|P4|NOT COMPLETED|Overall Study||0
180735|NCT00570674|418177|P3|NOT COMPLETED|Overall Study||1
180736|NCT00570674|418178|P2|NOT COMPLETED|Overall Study||0
180737|NCT00570674|418179|P1|NOT COMPLETED|Overall Study||0
180738|NCT00570674|418173|P7|COMPLETED|Overall Study||0
180739|NCT00570674|418174|P6|COMPLETED|Overall Study||10
180740|NCT00570674|418175|P5|COMPLETED|Overall Study||3
180741|NCT00570674|418176|P4|COMPLETED|Overall Study||3
180742|NCT00570674|418177|P3|COMPLETED|Overall Study||3
180743|NCT00570674|418178|P2|COMPLETED|Overall Study||3
180744|NCT00570674|418179|P1|COMPLETED|Overall Study||6
180745|NCT00570674|418173|P7|Treated|Overall Study||0
180746|NCT00570674|418174|P6|Treated|Overall Study||10
180747|NCT00570674|418175|P5|Treated|Overall Study||3
180748|NCT00570674|418176|P4|Treated|Overall Study||3
180749|NCT00570674|418177|P3|Treated|Overall Study||3
180750|NCT00570674|418178|P2|Treated|Overall Study||3
180751|NCT00570674|418179|P1|Treated|Overall Study||6
180752|NCT00570674|418173|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
180753|NCT00570674|418174|P6|STARTED|Overall Study||10
180754|NCT00570674|418175|P5|STARTED|Overall Study||3
180755|NCT00570674|418176|P4|STARTED|Overall Study||3
180756|NCT00570674|418177|P3|STARTED|Overall Study||4
180757|NCT00570674|418178|P2|STARTED|Overall Study||3
180758|NCT00570674|418179|P1|STARTED|Overall Study||6
180759|NCT00570531|418191|P1|NOT COMPLETED|Overall Study||0
180760|NCT00570531|418191|P1|COMPLETED|Overall Study||6
180761|NCT00570531|418191|P1|STARTED|Overall Study||6
180762|NCT00570505|418197|P1|NOT COMPLETED|Overall Study||41
180763|NCT00570505|418197|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
180764|NCT00570505|418197|P1|STARTED|Overall Study||149
180765|NCT00570492|418210|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
180766|NCT00570492|418211|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
180767|NCT00570492|418212|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
180768|NCT00570492|418210|P3|COMPLETED|52-week Double-blind Treatment Period||186
180769|NCT00570492|418211|P2|COMPLETED|52-week Double-blind Treatment Period||187
180770|NCT00570492|418212|P1|COMPLETED|52-week Double-blind Treatment Period||0
180771|NCT00570492|418210|P3|STARTED|52-week Double-blind Treatment Period||237
180772|NCT00570492|418211|P2|STARTED|52-week Double-blind Treatment Period||237
180773|NCT00570492|418212|P1|STARTED|52-week Double-blind Treatment Period||0
180774|NCT00570492|418210|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
180775|NCT00570492|418211|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
180776|NCT00570492|418212|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
180777|NCT00570492|418210|P3|COMPLETED|16-week Single-blind Baseline Period||0
180778|NCT00570492|418211|P2|COMPLETED|16-week Single-blind Baseline Period||0
180779|NCT00570492|418212|P1|COMPLETED|16-week Single-blind Baseline Period||474
180780|NCT00570492|418210|P3|STARTED|16-week Single-blind Baseline Period||0
180781|NCT00570492|418211|P2|STARTED|16-week Single-blind Baseline Period||0
180782|NCT00570492|418212|P1|STARTED|16-week Single-blind Baseline Period||910
180783|NCT00570401|418250|P1|NOT COMPLETED|Overall Study||2
180784|NCT00570401|418250|P1|COMPLETED|Overall Study||19
180785|NCT00570401|418250|P1|STARTED|Overall Study||21
180786|NCT00570362|418256|P2|NOT COMPLETED|Overall Study||0
180787|NCT00570362|418257|P1|NOT COMPLETED|Overall Study||0
180788|NCT00570362|418256|P2|COMPLETED|Overall Study||30
180789|NCT00570362|418257|P1|COMPLETED|Overall Study||19
180790|NCT00570362|418256|P2|STARTED|Overall Study||30
180791|NCT00570362|418257|P1|STARTED|Overall Study||19
180792|NCT00570349|418266|P3|NOT COMPLETED|Overall Study||0
180793|NCT00570349|418267|P2|NOT COMPLETED|Overall Study||0
180794|NCT00570349|418268|P1|NOT COMPLETED|Overall Study||0
180795|NCT00570349|418266|P3|COMPLETED|Overall Study||6
180796|NCT00570349|418267|P2|COMPLETED|Overall Study||6
180797|NCT00570349|418268|P1|COMPLETED|Overall Study||6
180798|NCT00570349|418266|P3|STARTED|Overall Study||6
180799|NCT00570349|418267|P2|STARTED|Overall Study||6
180800|NCT00570349|418268|P1|STARTED|Overall Study||6
180801|NCT00570310|418284|P2|NOT COMPLETED|Overall Study||6
180802|NCT00570310|418285|P1|NOT COMPLETED|Overall Study||2
180803|NCT00570310|418284|P2|COMPLETED|Overall Study||45
180805|NCT00570310|418284|P2|STARTED|Overall Study||51
180806|NCT00570310|418285|P1|STARTED|Overall Study||53
180807|NCT00570232|418293|P1|NOT COMPLETED|Overall Study||23
180808|NCT00570232|418293|P1|COMPLETED|Overall Study||8
180809|NCT00570232|418293|P1|STARTED|Overall Study||31
180810|NCT00570141|418299|P1|NOT COMPLETED|Overall Study||3
180811|NCT00570141|418299|P1|COMPLETED|Overall Study||10
180812|NCT00570141|418299|P1|STARTED|Overall Study||13
180813|NCT00570089|418304|P2|NOT COMPLETED|Perod 2||0
180814|NCT00570089|418305|P1|NOT COMPLETED|Perod 2||0
180815|NCT00570089|418304|P2|COMPLETED|Perod 2||10
180816|NCT00570089|418305|P1|COMPLETED|Perod 2||10
180817|NCT00570089|418304|P2|STARTED|Perod 2||10
180818|NCT00570089|418305|P1|STARTED|Perod 2||10
180819|NCT00570089|418304|P2|NOT COMPLETED|Period 1||0
180820|NCT00570089|418305|P1|NOT COMPLETED|Period 1||0
180821|NCT00570089|418304|P2|COMPLETED|Period 1||10
180822|NCT00570089|418305|P1|COMPLETED|Period 1||10
180823|NCT00570089|418304|P2|STARTED|Period 1||10
180824|NCT00570089|418305|P1|STARTED|Period 1||10
180825|NCT00570037|418315|P2|NOT COMPLETED|Overall Study||69
180826|NCT00570037|418316|P1|NOT COMPLETED|Overall Study||44
180827|NCT00570037|418315|P2|COMPLETED|Overall Study||237
180828|NCT00570037|418316|P1|COMPLETED|Overall Study||194
180829|NCT00570037|418315|P2|STARTED|Overall Study||306
180830|NCT00570037|418316|P1|STARTED|Overall Study||238
180831|NCT00569946|418326|P1|NOT COMPLETED|Overall Study||59
180832|NCT00569946|418326|P1|COMPLETED|Overall Study||5
180833|NCT00569946|418326|P1|STARTED|Overall Study||64
180834|NCT00569868|418342|P1|NOT COMPLETED|Overall Study||0
180835|NCT00569868|418342|P1|COMPLETED|Overall Study||11
180836|NCT00569868|418342|P1|STARTED|Overall Study||11
180837|NCT00569855|418346|P1|NOT COMPLETED|Overall Study||0
180838|NCT00569855|418346|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
180839|NCT00569855|418346|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
180840|NCT00569803|418358|P8|NOT COMPLETED|Overall Study||1
180841|NCT00569803|418359|P7|NOT COMPLETED|Overall Study||0
180842|NCT00569803|418360|P6|NOT COMPLETED|Overall Study||0
180843|NCT00569803|418361|P5|NOT COMPLETED|Overall Study||0
180844|NCT00569803|418362|P4|NOT COMPLETED|Overall Study||1
180845|NCT00569803|418363|P3|NOT COMPLETED|Overall Study||0
180846|NCT00569803|418364|P2|NOT COMPLETED|Overall Study||0
180847|NCT00569803|418365|P1|NOT COMPLETED|Overall Study||1
180848|NCT00569803|418358|P8|COMPLETED|Overall Study||5
180849|NCT00569803|418359|P7|COMPLETED|Overall Study||10
180850|NCT00569803|418360|P6|COMPLETED|Overall Study||5
180851|NCT00569803|418361|P5|COMPLETED|Overall Study||5
180852|NCT00569803|418362|P4|COMPLETED|Overall Study||5
180853|NCT00569803|418363|P3|COMPLETED|Overall Study||5
180854|NCT00569803|418364|P2|COMPLETED|Overall Study||5
180855|NCT00569803|418365|P1|COMPLETED|Overall Study||4
180856|NCT00569803|418358|P8|STARTED|Overall Study||6
180857|NCT00569803|418359|P7|STARTED|Overall Study||10
180858|NCT00569803|418360|P6|STARTED|Overall Study||5
180859|NCT00569803|418361|P5|STARTED|Overall Study||5
180860|NCT00569803|418362|P4|STARTED|Overall Study||6
180861|NCT00569803|418363|P3|STARTED|Overall Study||5
180862|NCT00569803|418364|P2|STARTED|Overall Study||5
180863|NCT00569803|418365|P1|STARTED|Overall Study||5
180864|NCT00569777|418492|P2|NOT COMPLETED|Overall Study||3
180865|NCT00569777|418493|P1|NOT COMPLETED|Overall Study||10
180866|NCT00569777|418492|P2|COMPLETED|Overall Study||101
180867|NCT00569777|418493|P1|COMPLETED|Overall Study||196
180868|NCT00569777|418492|P2|STARTED|Overall Study||104
180869|NCT00569777|418493|P1|STARTED|Overall Study||206
180870|NCT00569673|418535|P1|NOT COMPLETED|Overall Study||0
180871|NCT00569673|418535|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
180872|NCT00569673|418535|P1|STARTED|Overall Study|Total number participants enrolled on study|71
180873|NCT00569660|418539|P1|NOT COMPLETED|Overall Study||0
180874|NCT00569660|418539|P1|COMPLETED|Overall Study||34
180875|NCT00569660|418539|P1|STARTED|Overall Study||34
180876|NCT00569582|418543|P1|NOT COMPLETED|Overall Study||16
180877|NCT00569582|418543|P1|COMPLETED|Overall Study||34
180878|NCT00569582|418543|P1|STARTED|Overall Study||50
180879|NCT00569530|418550|P2|NOT COMPLETED|Overall Study||0
180880|NCT00569530|418551|P1|NOT COMPLETED|Overall Study||0
180881|NCT00569530|418550|P2|COMPLETED|Overall Study||42
180882|NCT00569530|418551|P1|COMPLETED|Overall Study||43
180883|NCT00569530|418550|P2|STARTED|Overall Study||42
180884|NCT00569530|418551|P1|STARTED|Overall Study||43
180885|NCT00569374|418559|P1|NOT COMPLETED|Overall Study||4
180886|NCT00569374|418559|P1|COMPLETED|Overall Study||4
180887|NCT00569374|418559|P1|STARTED|Overall Study||8
180888|NCT00569270|418569|P2|NOT COMPLETED|Period: Second Intervention||0
180889|NCT00569270|418570|P1|NOT COMPLETED|Period: Second Intervention||0
180890|NCT00569270|418569|P2|COMPLETED|Period: Second Intervention||14
180891|NCT00569270|418570|P1|COMPLETED|Period: Second Intervention||15
180892|NCT00569270|418569|P2|29 Days|Period: Second Intervention||14
180893|NCT00569270|418570|P1|29 Days|Period: Second Intervention||15
180894|NCT00569270|418569|P2|STARTED|Period: Second Intervention||14
180895|NCT00569270|418570|P1|STARTED|Period: Second Intervention||15
180896|NCT00569270|418569|P2|NOT COMPLETED|Period: First Intervention||1
180897|NCT00569270|418570|P1|NOT COMPLETED|Period: First Intervention||0
180898|NCT00569270|418569|P2|COMPLETED|Period: First Intervention||14
180899|NCT00569270|418570|P1|COMPLETED|Period: First Intervention||15
180900|NCT00569270|418569|P2|STARTED|Period: First Intervention||15
180901|NCT00569270|418570|P1|STARTED|Period: First Intervention|randomized cross over study|15
180902|NCT00569231|418605|P1|NOT COMPLETED|Overall Study||7
180903|NCT00569231|418605|P1|COMPLETED|Overall Study||11
180904|NCT00569231|418605|P1|STARTED|Overall Study||18
180905|NCT00569192|418615|P3|NOT COMPLETED|Overall Study||25
180906|NCT00569192|418616|P2|NOT COMPLETED|Overall Study||20
180907|NCT00569192|418617|P1|NOT COMPLETED|Overall Study||23
180908|NCT00569192|418615|P3|COMPLETED|Overall Study||99
180909|NCT00569192|418616|P2|COMPLETED|Overall Study||105
180910|NCT00569192|418617|P1|COMPLETED|Overall Study||88
180911|NCT00569192|418615|P3|STARTED|Overall Study||124
180912|NCT00569192|418616|P2|STARTED|Overall Study||125
180913|NCT00569192|418617|P1|STARTED|Overall Study||111
180914|NCT00569166|418643|P3|NOT COMPLETED|Overall Study||4
180915|NCT00569166|418644|P2|NOT COMPLETED|Overall Study||6
180916|NCT00569166|418645|P1|NOT COMPLETED|Overall Study||9
180917|NCT00569166|418643|P3|COMPLETED|Overall Study||27
180918|NCT00569166|418644|P2|COMPLETED|Overall Study||25
180919|NCT00569166|418645|P1|COMPLETED|Overall Study||21
180920|NCT00569166|418643|P3|STARTED|Overall Study||31
180921|NCT00569166|418644|P2|STARTED|Overall Study||31
180922|NCT00569166|418645|P1|STARTED|Overall Study||30
180923|NCT00569127|418655|P2|NOT COMPLETED|Overall Study||213
180924|NCT00569127|418656|P1|NOT COMPLETED|Overall Study||214
180925|NCT00569127|418655|P2|COMPLETED|Overall Study||0
180926|NCT00569127|418656|P1|COMPLETED|Overall Study||0
180927|NCT00569127|418655|P2|Eligible|Overall Study||202
180928|NCT00569127|418656|P1|Eligible|Overall Study||200
180929|NCT00569127|418655|P2|STARTED|Overall Study||213
180930|NCT00569127|418656|P1|STARTED|Overall Study||214
180931|NCT00569010|418676|P4|NOT COMPLETED|Overall Study||0
180932|NCT00569010|418677|P3|NOT COMPLETED|Overall Study||0
180933|NCT00569010|418678|P2|NOT COMPLETED|Overall Study||0
180934|NCT00569010|418679|P1|NOT COMPLETED|Overall Study||0
180935|NCT00569010|418676|P4|COMPLETED|Overall Study||11
180936|NCT00569010|418677|P3|COMPLETED|Overall Study||11
180937|NCT00569010|418678|P2|COMPLETED|Overall Study||6
180938|NCT00569010|418679|P1|COMPLETED|Overall Study||6
180939|NCT00569010|418676|P4|STARTED|Overall Study||11
180940|NCT00569010|418677|P3|STARTED|Overall Study||11
180941|NCT00569010|418678|P2|STARTED|Overall Study||6
180942|NCT00569010|418679|P1|STARTED|Overall Study||6
180943|NCT00568958|418691|P2|NOT COMPLETED|Follow-Up||4
180944|NCT00568958|418692|P1|NOT COMPLETED|Follow-Up||8
180945|NCT00568958|418691|P2|COMPLETED|Follow-Up||63
180946|NCT00568958|418692|P1|COMPLETED|Follow-Up||53
180947|NCT00568958|418691|P2|STARTED|Follow-Up||67
180948|NCT00568958|418692|P1|STARTED|Follow-Up||61
180949|NCT00568958|418691|P2|NOT COMPLETED|Allocation||3
180950|NCT00568958|418692|P1|NOT COMPLETED|Allocation||9
180951|NCT00568958|418691|P2|COMPLETED|Allocation||67
180952|NCT00568958|418692|P1|COMPLETED|Allocation||61
180953|NCT00568958|418691|P2|STARTED|Allocation||70
180954|NCT00568958|418692|P1|STARTED|Allocation||70
180955|NCT00568854|418712|P2|NOT COMPLETED|Overall Study||0
180956|NCT00568854|418713|P1|NOT COMPLETED|Overall Study||0
180957|NCT00568854|418712|P2|COMPLETED|Overall Study||4
180958|NCT00568854|418713|P1|COMPLETED|Overall Study||6
180959|NCT00568854|418712|P2|STARTED|Overall Study||4
180960|NCT00568854|418713|P1|STARTED|Overall Study||6
180961|NCT00568776|418725|P4|NOT COMPLETED|Overall Study||72
180962|NCT00568776|418726|P3|NOT COMPLETED|Overall Study||74
180963|NCT00568776|418727|P2|NOT COMPLETED|Overall Study||36
180964|NCT00568776|418728|P1|NOT COMPLETED|Overall Study||30
180965|NCT00568776|418725|P4|COMPLETED|Overall Study||19
180966|NCT00568776|418726|P3|COMPLETED|Overall Study||15
180967|NCT00568776|418727|P2|COMPLETED|Overall Study||52
180968|NCT00568776|418728|P1|COMPLETED|Overall Study||53
180969|NCT00568776|418725|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
180970|NCT00568776|418726|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
180971|NCT00568776|418727|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
180972|NCT00568776|418728|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
180973|NCT00568685|418765|P3|NOT COMPLETED|Overall Study||5
180974|NCT00568685|418766|P2|NOT COMPLETED|Overall Study||5
180975|NCT00568685|418767|P1|NOT COMPLETED|Overall Study||10
180976|NCT00568685|418765|P3|COMPLETED|Overall Study||46
180977|NCT00568685|418766|P2|COMPLETED|Overall Study||46
180978|NCT00568685|418767|P1|COMPLETED|Overall Study||41
180979|NCT00568685|418765|P3|STARTED|Overall Study||51
180980|NCT00568685|418766|P2|STARTED|Overall Study||51
180981|NCT00568685|418767|P1|STARTED|Overall Study||51
180982|NCT00568555|418801|P2|NOT COMPLETED|Overall Study||1
180983|NCT00568555|418802|P1|NOT COMPLETED|Overall Study||1
180984|NCT00568555|418801|P2|COMPLETED|Overall Study||14
180985|NCT00568555|418802|P1|COMPLETED|Overall Study||15
180986|NCT00568555|418801|P2|STARTED|Overall Study||15
180987|NCT00568555|418802|P1|STARTED|Overall Study||16
180988|NCT00568451|418820|P4|NOT COMPLETED|Overall Study||7
180989|NCT00568451|418821|P3|NOT COMPLETED|Overall Study||2
180990|NCT00568451|418822|P2|NOT COMPLETED|Overall Study||0
180991|NCT00568451|418823|P1|NOT COMPLETED|Overall Study||0
180992|NCT00568451|418820|P4|COMPLETED|Overall Study||2
180993|NCT00568451|418821|P3|COMPLETED|Overall Study||0
180994|NCT00568451|418822|P2|COMPLETED|Overall Study||0
180995|NCT00568451|418823|P1|COMPLETED|Overall Study||0
180996|NCT00568451|418820|P4|STARTED|Overall Study||9
180997|NCT00568451|418821|P3|STARTED|Overall Study||2
180998|NCT00568451|418822|P2|STARTED|Overall Study||0
180999|NCT00568451|418823|P1|STARTED|Overall Study||0
181000|NCT00568399|418839|P1|NOT COMPLETED|Overall Study||15
181001|NCT00568399|418839|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
181002|NCT00568399|418839|P1|STARTED|Overall Study||37
181003|NCT00568386|418845|P2|NOT COMPLETED|Overall Study||0
181004|NCT00568386|418846|P1|NOT COMPLETED|Overall Study||0
181005|NCT00568386|418845|P2|COMPLETED|Overall Study||20
181006|NCT00568386|418846|P1|COMPLETED|Overall Study||20
181007|NCT00568386|418845|P2|STARTED|Overall Study||20
181008|NCT00568386|418846|P1|STARTED|Overall Study||20
181009|NCT00568178|418854|P6|NOT COMPLETED|Open Label Extension||80
181010|NCT00568178|418855|P5|NOT COMPLETED|Open Label Extension||79
181011|NCT00568178|418856|P4|NOT COMPLETED|Open Label Extension||0
181012|NCT00568178|418857|P3|NOT COMPLETED|Open Label Extension||0
181013|NCT00568178|418858|P2|NOT COMPLETED|Open Label Extension||0
181014|NCT00568178|418859|P1|NOT COMPLETED|Open Label Extension||0
181015|NCT00568178|418854|P6|COMPLETED|Open Label Extension||54
181016|NCT00568178|418855|P5|COMPLETED|Open Label Extension||55
181017|NCT00568178|418856|P4|COMPLETED|Open Label Extension||0
181018|NCT00568178|418857|P3|COMPLETED|Open Label Extension||0
181019|NCT00568178|418858|P2|COMPLETED|Open Label Extension||0
181020|NCT00568178|418859|P1|COMPLETED|Open Label Extension||0
181021|NCT00568178|418854|P6|STARTED|Open Label Extension||134
181022|NCT00568178|418855|P5|STARTED|Open Label Extension||134
181023|NCT00568178|418856|P4|STARTED|Open Label Extension||0
181024|NCT00568178|418857|P3|STARTED|Open Label Extension||0
181025|NCT00568178|418858|P2|STARTED|Open Label Extension||0
181026|NCT00568178|418859|P1|STARTED|Open Label Extension||0
181027|NCT00568178|418854|P6|NOT COMPLETED|Double Blind Base Study||0
181028|NCT00568178|418855|P5|NOT COMPLETED|Double Blind Base Study||0
181029|NCT00568178|418856|P4|NOT COMPLETED|Double Blind Base Study||5
181030|NCT00568178|418857|P3|NOT COMPLETED|Double Blind Base Study||1
181031|NCT00568178|418858|P2|NOT COMPLETED|Double Blind Base Study||6
181032|NCT00568178|418859|P1|NOT COMPLETED|Double Blind Base Study||6
181033|NCT00568178|418854|P6|COMPLETED|Double Blind Base Study||0
181034|NCT00568178|418855|P5|COMPLETED|Double Blind Base Study||0
181035|NCT00568178|418856|P4|COMPLETED|Double Blind Base Study||25
181036|NCT00568178|418857|P3|COMPLETED|Double Blind Base Study||29
181037|NCT00568178|418858|P2|COMPLETED|Double Blind Base Study||118
181038|NCT00568178|418859|P1|COMPLETED|Double Blind Base Study||116
181039|NCT00568178|418854|P6|STARTED|Double Blind Base Study||0
181040|NCT00568178|418855|P5|STARTED|Double Blind Base Study||0
181041|NCT00568178|418856|P4|STARTED|Double Blind Base Study||30
181042|NCT00568178|418857|P3|STARTED|Double Blind Base Study||30
181043|NCT00568178|418858|P2|STARTED|Double Blind Base Study||124
181044|NCT00568178|418859|P1|STARTED|Double Blind Base Study||122
181045|NCT00568087|418877|P2|NOT COMPLETED|Overall Study||7
181046|NCT00568087|418878|P1|NOT COMPLETED|Overall Study||7
181047|NCT00568087|418877|P2|COMPLETED|Overall Study||17
181048|NCT00568087|418878|P1|COMPLETED|Overall Study||15
181049|NCT00568087|418877|P2|Received Intervention|Overall Study||23
181050|NCT00568087|418878|P1|Received Intervention|Overall Study||21
181051|NCT00568087|418877|P2|STARTED|Overall Study||24
181052|NCT00568087|418878|P1|STARTED|Overall Study||22
181053|NCT00568061|418890|P2|NOT COMPLETED|Overall Study||2
181054|NCT00568061|418891|P1|NOT COMPLETED|Overall Study||5
181055|NCT00568061|418890|P2|COMPLETED|Overall Study||14
181056|NCT00568061|418891|P1|COMPLETED|Overall Study||8
181057|NCT00568061|418890|P2|STARTED|Overall Study||16
181058|NCT00568061|418891|P1|STARTED|Overall Study||13
181059|NCT00568022|418900|P3|NOT COMPLETED|Overall Study||0
181060|NCT00568022|418901|P2|NOT COMPLETED|Overall Study||0
181061|NCT00568022|418902|P1|NOT COMPLETED|Overall Study||0
181062|NCT00568022|418900|P3|COMPLETED|Overall Study||3
181063|NCT00568022|418901|P2|COMPLETED|Overall Study||3
181064|NCT00568022|418902|P1|COMPLETED|Overall Study||3
181065|NCT00568022|418900|P3|STARTED|Overall Study||3
181066|NCT00568022|418901|P2|STARTED|Overall Study||3
181067|NCT00568022|418902|P1|STARTED|Overall Study||3
181068|NCT00567996|418935|P3|NOT COMPLETED|Overall Study||70
181069|NCT00567996|418936|P2|NOT COMPLETED|Overall Study||50
181070|NCT00567996|418937|P1|NOT COMPLETED|Overall Study||44
181071|NCT00567996|418935|P3|COMPLETED|Overall Study||265
181072|NCT00567996|418936|P2|COMPLETED|Overall Study||284
181073|NCT00567996|418937|P1|COMPLETED|Overall Study||289
181074|NCT00567996|418935|P3|Intent-to-treat: Received Study Drug|Overall Study||335
181075|NCT00567996|418936|P2|Intent-to-treat: Received Study Drug|Overall Study||333
181076|NCT00567996|418937|P1|Intent-to-treat: Received Study Drug|Overall Study||330
181077|NCT00567996|418935|P3|STARTED|Overall Study||335
181078|NCT00567996|418936|P2|STARTED|Overall Study||334
181079|NCT00567996|418937|P1|STARTED|Overall Study|Randomized participants|333
181080|NCT00567892|418953|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
181081|NCT00567892|418954|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
181082|NCT00567892|418955|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
181083|NCT00567892|418956|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
181084|NCT00567892|418953|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
181085|NCT00567892|418954|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
181086|NCT00567892|418955|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
181087|NCT00567892|418956|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
181088|NCT00567892|418953|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
181089|NCT00567892|418954|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
181090|NCT00567892|418955|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
181091|NCT00567892|418956|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
181092|NCT00567892|418953|P4|NOT COMPLETED|Washout (2 Weeks)||0
181093|NCT00567892|418954|P3|NOT COMPLETED|Washout (2 Weeks)||0
181094|NCT00567892|418955|P2|NOT COMPLETED|Washout (2 Weeks)||0
181095|NCT00567892|418956|P1|NOT COMPLETED|Washout (2 Weeks)||0
181096|NCT00567892|418953|P4|COMPLETED|Washout (2 Weeks)||6
181097|NCT00567892|418954|P3|COMPLETED|Washout (2 Weeks)||9
181098|NCT00567892|418955|P2|COMPLETED|Washout (2 Weeks)||7
181099|NCT00567892|418956|P1|COMPLETED|Washout (2 Weeks)||7
181100|NCT00567892|418953|P4|STARTED|Washout (2 Weeks)||6
181101|NCT00567892|418954|P3|STARTED|Washout (2 Weeks)||9
181102|NCT00567892|418955|P2|STARTED|Washout (2 Weeks)||7
181103|NCT00567892|418956|P1|STARTED|Washout (2 Weeks)||7
181104|NCT00567892|418953|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
181105|NCT00567892|418954|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
181106|NCT00567892|418955|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
181107|NCT00567892|418956|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
181108|NCT00567892|418953|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
181109|NCT00567892|418954|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
181110|NCT00567892|418955|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
181111|NCT00567892|418956|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
181112|NCT00567892|418953|P4|STARTED|First Treatment (2 or 4 Weeks)||10
181113|NCT00567892|418954|P3|STARTED|First Treatment (2 or 4 Weeks)||10
181114|NCT00567892|418955|P2|STARTED|First Treatment (2 or 4 Weeks)||7
181115|NCT00567892|418956|P1|STARTED|First Treatment (2 or 4 Weeks)||7
181116|NCT00567879|418974|P6|NOT COMPLETED|Overall Study||3
181117|NCT00567879|418975|P5|NOT COMPLETED|Overall Study||12
181118|NCT00567879|418976|P4|NOT COMPLETED|Overall Study||6
181119|NCT00567879|418977|P3|NOT COMPLETED|Overall Study||21
181120|NCT00567879|418978|P2|NOT COMPLETED|Overall Study||7
181121|NCT00567879|418979|P1|NOT COMPLETED|Overall Study||7
181122|NCT00567879|418974|P6|COMPLETED|Overall Study||0
181123|NCT00567879|418975|P5|COMPLETED|Overall Study||0
181124|NCT00567879|418976|P4|COMPLETED|Overall Study||0
181125|NCT00567879|418977|P3|COMPLETED|Overall Study||0
181126|NCT00567879|418978|P2|COMPLETED|Overall Study||0
181127|NCT00567879|418979|P1|COMPLETED|Overall Study||0
181128|NCT00567879|418974|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
181129|NCT00567879|418975|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
181130|NCT00567879|418976|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
181131|NCT00567879|418977|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
181132|NCT00567879|418978|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
181133|NCT00567879|418979|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
181134|NCT00567879|418974|P6|STARTED|Overall Study||3
181135|NCT00567879|418975|P5|STARTED|Overall Study||12
181136|NCT00567879|418976|P4|STARTED|Overall Study||6
181137|NCT00567879|418977|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
181138|NCT00567879|418978|P2|STARTED|Overall Study||7
181139|NCT00567879|418979|P1|STARTED|Overall Study||7
181140|NCT00567593|419000|P1|NOT COMPLETED|Overall Study||2
181141|NCT00567593|419000|P1|COMPLETED|Overall Study||10
181142|NCT00567593|419000|P1|STARTED|Overall Study||12
181143|NCT00567541|419006|P2|NOT COMPLETED|Overall Study||1
181144|NCT00567541|419007|P1|NOT COMPLETED|Overall Study||0
181145|NCT00567541|419006|P2|COMPLETED|Overall Study||8
181146|NCT00567541|419007|P1|COMPLETED|Overall Study||7
181147|NCT00567541|419006|P2|STARTED|Overall Study||9
181148|NCT00567541|419007|P1|STARTED|Overall Study||7
181149|NCT00567502|419017|P4|NOT COMPLETED|Overall Study||87
181150|NCT00567502|419018|P3|NOT COMPLETED|Overall Study||908
181151|NCT00567502|419019|P2|NOT COMPLETED|Overall Study||33
181152|NCT00567502|419020|P1|NOT COMPLETED|Overall Study||241
181153|NCT00567502|419017|P4|COMPLETED|Overall Study||23
181154|NCT00567502|419018|P3|COMPLETED|Overall Study||1758
181155|NCT00567502|419019|P2|COMPLETED|Overall Study||108
181156|NCT00567502|419020|P1|COMPLETED|Overall Study||563
181157|NCT00567502|419017|P4|Initiated Treatment|Overall Study||38
181158|NCT00567502|419018|P3|Initiated Treatment|Overall Study||2666
181159|NCT00567502|419019|P2|Initiated Treatment|Overall Study||141
181160|NCT00567502|419020|P1|Initiated Treatment|Overall Study||804
181161|NCT00567502|419017|P4|STARTED|Overall Study||110
181162|NCT00567502|419018|P3|STARTED|Overall Study||2666
181163|NCT00567502|419019|P2|STARTED|Overall Study||141
181164|NCT00567502|419020|P1|STARTED|Overall Study||804
181165|NCT00567476|419057|P2|NOT COMPLETED|Overall Study||4
181166|NCT00567476|419058|P1|NOT COMPLETED|Overall Study||8
181167|NCT00567476|419057|P2|COMPLETED|Overall Study||34
181168|NCT00567476|419058|P1|COMPLETED|Overall Study||70
181169|NCT00567476|419057|P2|STARTED|Overall Study||38
181170|NCT00567476|419058|P1|STARTED|Overall Study||78
181171|NCT00567320|419084|P2|NOT COMPLETED|Overall Study||0
181172|NCT00567320|419085|P1|NOT COMPLETED|Overall Study||0
181173|NCT00567320|419084|P2|COMPLETED|Overall Study||18
181174|NCT00567320|419085|P1|COMPLETED|Overall Study||13
181175|NCT00567320|419084|P2|STARTED|Overall Study||18
181176|NCT00567320|419085|P1|STARTED|Overall Study||13
181177|NCT00567307|419093|P2|NOT COMPLETED|Overall Study||6
181178|NCT00567307|419094|P1|NOT COMPLETED|Overall Study||7
181179|NCT00567307|419093|P2|COMPLETED|Overall Study||99
181180|NCT00567307|419094|P1|COMPLETED|Overall Study||104
181181|NCT00567307|419093|P2|STARTED|Overall Study||105
181182|NCT00567307|419094|P1|STARTED|Overall Study||111
181183|NCT00567268|419100|P1|NOT COMPLETED|Overall Study||50
181184|NCT00567268|419100|P1|COMPLETED|Overall Study||1144
181185|NCT00567268|419100|P1|STARTED|Overall Study||1194
181186|NCT00567255|419151|P2|NOT COMPLETED|Overall Study||228
181187|NCT00567255|419152|P1|NOT COMPLETED|Overall Study||463
181188|NCT00567255|419151|P2|COMPLETED|Overall Study||267
181189|NCT00567255|419152|P1|COMPLETED|Overall Study||538
181190|NCT00567255|419151|P2|STARTED|Overall Study||495
181191|NCT00567255|419152|P1|STARTED|Overall Study||1001
181192|NCT00567242|419198|P2|NOT COMPLETED|Overall Study||0
181193|NCT00567242|419199|P1|NOT COMPLETED|Overall Study||0
181194|NCT00567242|419198|P2|COMPLETED|Overall Study||7
181195|NCT00567242|419199|P1|COMPLETED|Overall Study||7
181196|NCT00567242|419198|P2|STARTED|Overall Study||7
181197|NCT00567242|419199|P1|STARTED|Overall Study||7
181198|NCT00567229|419209|P1|NOT COMPLETED|Overall Study||0
181199|NCT00567229|419209|P1|COMPLETED|Overall Study||3
181200|NCT00567229|419209|P1|STARTED|Overall Study||3
181201|NCT00567190|419215|P2|NOT COMPLETED|Overall Study||264
181202|NCT00567190|419216|P1|NOT COMPLETED|Overall Study||210
181203|NCT00567190|419215|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
181204|NCT00567190|419216|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
181205|NCT00567190|419215|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
181206|NCT00567190|419216|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
181207|NCT00567164|419236|P3|NOT COMPLETED|Overall Study||72
181208|NCT00567164|419237|P2|NOT COMPLETED|Overall Study||73
181209|NCT00567164|419238|P1|NOT COMPLETED|Overall Study||546
181210|NCT00567164|419236|P3|COMPLETED|Overall Study||160
181211|NCT00567164|419237|P2|COMPLETED|Overall Study||161
181212|NCT00567164|419238|P1|COMPLETED|Overall Study||875
181213|NCT00567164|419236|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
181214|NCT00567164|419237|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
181215|NCT00567164|419238|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
181216|NCT00567164|419236|P3|STARTED|Overall Study||232
181217|NCT00567164|419237|P2|STARTED|Overall Study||234
181218|NCT00567164|419238|P1|STARTED|Overall Study||1421
181219|NCT00567112|419310|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
181220|NCT00567112|419311|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
181221|NCT00567112|419312|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
181222|NCT00567112|419310|P3|COMPLETED|Treatment Period 4 (3 Days)||3
181223|NCT00567112|419311|P2|COMPLETED|Treatment Period 4 (3 Days)||7
181224|NCT00567112|419312|P1|COMPLETED|Treatment Period 4 (3 Days)||4
181225|NCT00567112|419310|P3|STARTED|Treatment Period 4 (3 Days)||3
181226|NCT00567112|419311|P2|STARTED|Treatment Period 4 (3 Days)||7
181227|NCT00567112|419312|P1|STARTED|Treatment Period 4 (3 Days)||4
181228|NCT00567112|419310|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
181229|NCT00567112|419311|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
181230|NCT00567112|419312|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
181231|NCT00567112|419310|P3|COMPLETED|Washout Period 3 (3 Days)||3
181232|NCT00567112|419311|P2|COMPLETED|Washout Period 3 (3 Days)||7
181233|NCT00567112|419312|P1|COMPLETED|Washout Period 3 (3 Days)||4
181234|NCT00567112|419310|P3|STARTED|Washout Period 3 (3 Days)||3
181235|NCT00567112|419311|P2|STARTED|Washout Period 3 (3 Days)||7
181236|NCT00567112|419312|P1|STARTED|Washout Period 3 (3 Days)||7
181237|NCT00567112|419310|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
181238|NCT00567112|419311|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
181239|NCT00567112|419312|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
181240|NCT00567112|419310|P3|COMPLETED|Treatment Period 3 (3 Days)||3
181241|NCT00567112|419311|P2|COMPLETED|Treatment Period 3 (3 Days)||7
181242|NCT00567112|419312|P1|COMPLETED|Treatment Period 3 (3 Days)||7
181243|NCT00567112|419310|P3|STARTED|Treatment Period 3 (3 Days)||3
181244|NCT00567112|419311|P2|STARTED|Treatment Period 3 (3 Days)||7
181245|NCT00567112|419312|P1|STARTED|Treatment Period 3 (3 Days)||7
181246|NCT00567112|419310|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
181247|NCT00567112|419311|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
181248|NCT00567112|419312|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
181249|NCT00567112|419310|P3|COMPLETED|Washout Period 2 (3 Days)||3
181250|NCT00567112|419311|P2|COMPLETED|Washout Period 2 (3 Days)||7
181251|NCT00567112|419312|P1|COMPLETED|Washout Period 2 (3 Days)||7
181252|NCT00567112|419310|P3|STARTED|Washout Period 2 (3 Days)||3
181253|NCT00567112|419311|P2|STARTED|Washout Period 2 (3 Days)||7
181254|NCT00567112|419312|P1|STARTED|Washout Period 2 (3 Days)||7
181255|NCT00567112|419310|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
181256|NCT00567112|419311|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
181257|NCT00567112|419312|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
181258|NCT00567112|419310|P3|COMPLETED|Treatment Period 2 (3 Days)||3
181259|NCT00567112|419311|P2|COMPLETED|Treatment Period 2 (3 Days)||7
181260|NCT00567112|419312|P1|COMPLETED|Treatment Period 2 (3 Days)||7
181261|NCT00567112|419310|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
181262|NCT00567112|419311|P2|STARTED|Treatment Period 2 (3 Days)||8
181263|NCT00567112|419312|P1|STARTED|Treatment Period 2 (3 Days)||7
181264|NCT00567112|419310|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
181265|NCT00567112|419311|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
181266|NCT00567112|419312|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
181267|NCT00567112|419310|P3|COMPLETED|Washout Period 1 (3 Days)||0
181268|NCT00567112|419311|P2|COMPLETED|Washout Period 1 (3 Days)||8
181269|NCT00567112|419312|P1|COMPLETED|Washout Period 1 (3 Days)||7
181270|NCT00567112|419310|P3|STARTED|Washout Period 1 (3 Days)||0
181271|NCT00567112|419311|P2|STARTED|Washout Period 1 (3 Days)||8
181272|NCT00567112|419312|P1|STARTED|Washout Period 1 (3 Days)||7
181273|NCT00567112|419310|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
181274|NCT00567112|419311|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
181275|NCT00567112|419312|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
181276|NCT00567112|419310|P3|COMPLETED|Treatment Period 1 (3 Days)||0
181277|NCT00567112|419311|P2|COMPLETED|Treatment Period 1 (3 Days)||8
181278|NCT00567112|419312|P1|COMPLETED|Treatment Period 1 (3 Days)||7
181279|NCT00567112|419310|P3|STARTED|Treatment Period 1 (3 Days)||0
181280|NCT00567112|419311|P2|STARTED|Treatment Period 1 (3 Days)||8
181281|NCT00567112|419312|P1|STARTED|Treatment Period 1 (3 Days)||7
181282|NCT00567008|419336|P2|NOT COMPLETED|Overall Study||1
181283|NCT00567008|419337|P1|NOT COMPLETED|Overall Study||1
181284|NCT00567008|419336|P2|COMPLETED|Overall Study||18
181285|NCT00567008|419337|P1|COMPLETED|Overall Study||17
181286|NCT00567008|419336|P2|STARTED|Overall Study||19
181287|NCT00567008|419337|P1|STARTED|Overall Study||18
181288|NCT00566995|419343|P1|NOT COMPLETED|Overall Study||8
181289|NCT00566995|419343|P1|COMPLETED|Overall Study||29
181290|NCT00566995|419343|P1|STARTED|Overall Study||37
181291|NCT00566982|419350|P2|NOT COMPLETED|Overall Study||69
181292|NCT00566982|419351|P1|NOT COMPLETED|Overall Study||8
181293|NCT00566982|419350|P2|COMPLETED|Overall Study||294
181294|NCT00566982|419351|P1|COMPLETED|Overall Study||55
181295|NCT00566982|419350|P2|STARTED|Overall Study||363
181296|NCT00566982|419351|P1|STARTED|Overall Study||63
181297|NCT00566969|419376|P3|NOT COMPLETED|Overall Study||12
181298|NCT00566969|419377|P2|NOT COMPLETED|Overall Study||9
181299|NCT00566969|419378|P1|NOT COMPLETED|Overall Study||15
181300|NCT00566969|419376|P3|COMPLETED|Overall Study||23
181301|NCT00566969|419377|P2|COMPLETED|Overall Study||28
181302|NCT00566969|419378|P1|COMPLETED|Overall Study||19
181303|NCT00566969|419376|P3|STARTED|Overall Study||35
181304|NCT00566969|419377|P2|STARTED|Overall Study||37
181305|NCT00566969|419378|P1|STARTED|Overall Study||34
181306|NCT00566943|419388|P2|NOT COMPLETED|Overall Study||0
181307|NCT00566943|419389|P1|NOT COMPLETED|Overall Study||0
181308|NCT00566943|419388|P2|COMPLETED|Overall Study||49
181309|NCT00566943|419389|P1|COMPLETED|Overall Study||52
181310|NCT00566943|419388|P2|STARTED|Overall Study||49
181311|NCT00566943|419389|P1|STARTED|Overall Study||52
181312|NCT00566930|419404|P3|NOT COMPLETED|Overall Study||1
181313|NCT00566930|419405|P2|NOT COMPLETED|Overall Study||4
181314|NCT00566930|419406|P1|NOT COMPLETED|Overall Study||2
181315|NCT00566930|419404|P3|COMPLETED|Overall Study||32
181316|NCT00566930|419405|P2|COMPLETED|Overall Study||32
181317|NCT00566930|419406|P1|COMPLETED|Overall Study||27
181318|NCT00566930|419404|P3|STARTED|Overall Study||33
181319|NCT00566930|419405|P2|STARTED|Overall Study||36
181320|NCT00566930|419406|P1|STARTED|Overall Study||29
181321|NCT00566735|419416|P2|NOT COMPLETED|Overall Study||7
181322|NCT00566735|419417|P1|NOT COMPLETED|Overall Study||2
181323|NCT00566735|419416|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
181324|NCT00566735|419417|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
181325|NCT00566735|419416|P2|Withdrew Before Baseline Measures|Overall Study||7
181326|NCT00566735|419417|P1|Withdrew Before Baseline Measures|Overall Study||2
181327|NCT00566735|419416|P2|STARTED|Overall Study||19
181328|NCT00566735|419417|P1|STARTED|Overall Study||20
181329|NCT00566722|419430|P3|NOT COMPLETED|Overall Study||9
181330|NCT00566722|419431|P2|NOT COMPLETED|Overall Study||5
181331|NCT00566722|419432|P1|NOT COMPLETED|Overall Study||2
181332|NCT00566722|419430|P3|COMPLETED|Overall Study||73
181333|NCT00566722|419431|P2|COMPLETED|Overall Study||24
181334|NCT00566722|419432|P1|COMPLETED|Overall Study||39
181335|NCT00566722|419430|P3|STARTED|Overall Study||82
181336|NCT00566722|419431|P2|STARTED|Overall Study||29
181337|NCT00566722|419432|P1|STARTED|Overall Study||41
181338|NCT00566709|419478|P2|NOT COMPLETED|Overall Study||0
181339|NCT00566709|419479|P1|NOT COMPLETED|Overall Study||5
181340|NCT00566709|419478|P2|COMPLETED|Overall Study||51
181341|NCT00566709|419479|P1|COMPLETED|Overall Study||46
181342|NCT00566709|419478|P2|STARTED|Overall Study||51
181343|NCT00566709|419479|P1|STARTED|Overall Study||51
181344|NCT00566696|419495|P1|NOT COMPLETED|Overall Study||42
181345|NCT00566696|419495|P1|COMPLETED|Overall Study||31
181346|NCT00566696|419495|P1|STARTED|Overall Study||73
181347|NCT00566631|419503|P1|NOT COMPLETED|Part 2: Extension Phase||82
181348|NCT00566631|419503|P1|COMPLETED|Part 2: Extension Phase||57
181349|NCT00566631|419503|P1|STARTED|Part 2: Extension Phase||139
181350|NCT00566631|419503|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
181351|NCT00566631|419503|P1|COMPLETED|Between Treatment and Extension Phase||139
181352|NCT00566631|419503|P1|STARTED|Between Treatment and Extension Phase||234
181353|NCT00566631|419503|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
181354|NCT00566631|419503|P1|COMPLETED|Part 1: Core Treatment Phase||234
181355|NCT00566631|419503|P1|STARTED|Part 1: Core Treatment Phase||294
181356|NCT00566579|419520|P2|NOT COMPLETED|Overall Study||0
181357|NCT00566579|419521|P1|NOT COMPLETED|Overall Study||0
181358|NCT00566579|419520|P2|COMPLETED|Overall Study||31
181359|NCT00566579|419521|P1|COMPLETED|Overall Study||29
181360|NCT00566579|419520|P2|STARTED|Overall Study||31
181361|NCT00566579|419521|P1|STARTED|Overall Study||29
181362|NCT00566501|419529|P2|NOT COMPLETED|Overall Study||126
181363|NCT00566501|419530|P1|NOT COMPLETED|Overall Study||156
181364|NCT00566501|419529|P2|COMPLETED|Overall Study||210
181365|NCT00566501|419530|P1|COMPLETED|Overall Study||423
181366|NCT00566501|419529|P2|Not Determined|Overall Study||0
181367|NCT00566501|419530|P1|Not Determined|Overall Study||1
181368|NCT00566501|419529|P2|Other ( Not Specified)|Overall Study||21
181369|NCT00566501|419530|P1|Other ( Not Specified)|Overall Study||24
181370|NCT00566501|419529|P2|Medication Non-compliance|Overall Study||0
181371|NCT00566501|419530|P1|Medication Non-compliance|Overall Study||5
181372|NCT00566501|419529|P2|Protocol Violation|Overall Study||2
181373|NCT00566501|419530|P1|Protocol Violation|Overall Study||2
181374|NCT00566501|419529|P2|Request of Investigator or Sponsor|Overall Study||7
181375|NCT00566501|419530|P1|Request of Investigator or Sponsor|Overall Study||6
181376|NCT00566501|419529|P2|Withdraw of Consent by Subject|Overall Study||30
181377|NCT00566501|419530|P1|Withdraw of Consent by Subject|Overall Study||33
181378|NCT00566501|419529|P2|Lack of Efficacy|Overall Study||3
181379|NCT00566501|419530|P1|Lack of Efficacy|Overall Study||8
181380|NCT00566501|419529|P2|Adverse Event|Overall Study||59
181381|NCT00566501|419530|P1|Adverse Event|Overall Study||68
181382|NCT00566501|419529|P2|Discontinued|Overall Study||122
181383|NCT00566501|419530|P1|Discontinued|Overall Study||146
181384|NCT00566501|419529|P2|Safety Population|Overall Study||332
181385|NCT00566501|419530|P1|Safety Population|Overall Study||570
181386|NCT00566501|419529|P2|STARTED|Overall Study||336
181387|NCT00566501|419530|P1|STARTED|Overall Study||579
181388|NCT00566462|419536|P1|NOT COMPLETED|Overall Study||0
181389|NCT00566462|419536|P1|COMPLETED|Overall Study||1
181390|NCT00566462|419536|P1|STARTED|Overall Study||1
181391|NCT00566254|419543|P2|NOT COMPLETED|Overall Study||14
181392|NCT00566254|419544|P1|NOT COMPLETED|Overall Study||10
181393|NCT00566254|419543|P2|COMPLETED|Overall Study||93
181394|NCT00566254|419544|P1|COMPLETED|Overall Study||90
181395|NCT00566254|419543|P2|STARTED|Overall Study||107
181396|NCT00566254|419544|P1|STARTED|Overall Study||100
181397|NCT00566150|419558|P2|NOT COMPLETED|Overall Study||5
181398|NCT00566150|419559|P1|NOT COMPLETED|Overall Study||9
181399|NCT00566150|419558|P2|COMPLETED|Overall Study||11
181400|NCT00566150|419559|P1|COMPLETED|Overall Study||10
181401|NCT00566150|419558|P2|STARTED|Overall Study||16
181402|NCT00566150|419559|P1|STARTED|Overall Study||19
181403|NCT00566111|419573|P2|NOT COMPLETED|Overall Study||2
181404|NCT00566111|419574|P1|NOT COMPLETED|Overall Study||0
181405|NCT00566111|419573|P2|COMPLETED|Overall Study||1
181406|NCT00566111|419574|P1|COMPLETED|Overall Study||2
181407|NCT00566111|419573|P2|STARTED|Overall Study||3
181408|NCT00566111|419574|P1|STARTED|Overall Study||2
181409|NCT00566020|419588|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
181410|NCT00566020|419589|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
181411|NCT00566020|419588|P2|COMPLETED|46-week Long-term Administration Phase||68
181412|NCT00566020|419589|P1|COMPLETED|46-week Long-term Administration Phase||0
181413|NCT00566020|419588|P2|STARTED|46-week Long-term Administration Phase||85
181414|NCT00566020|419589|P1|STARTED|46-week Long-term Administration Phase||0
181415|NCT00566020|419588|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
181416|NCT00566020|419589|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
181417|NCT00566020|419588|P2|COMPLETED|6-week Dosage Adjustment Phase||0
181418|NCT00566020|419589|P1|COMPLETED|6-week Dosage Adjustment Phase||85
181419|NCT00566020|419588|P2|STARTED|6-week Dosage Adjustment Phase||0
181420|NCT00566020|419589|P1|STARTED|6-week Dosage Adjustment Phase||92
181421|NCT00565812|419617|P3|NOT COMPLETED|Overall Study||130
181422|NCT00565812|419618|P2|NOT COMPLETED|Overall Study||135
181423|NCT00565812|419619|P1|NOT COMPLETED|Overall Study||144
181424|NCT00565812|419617|P3|COMPLETED|Overall Study||356
181425|NCT00565812|419618|P2|COMPLETED|Overall Study||351
181426|NCT00565812|419619|P1|COMPLETED|Overall Study||341
181427|NCT00565812|419617|P3|STARTED|Overall Study||486
181428|NCT00565812|419618|P2|STARTED|Overall Study||486
181429|NCT00565812|419619|P1|STARTED|Overall Study||485
181430|NCT00565747|419758|P2|NOT COMPLETED|Overall Study||73
181431|NCT00565747|419759|P1|NOT COMPLETED|Overall Study||67
181432|NCT00565747|419758|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
181433|NCT00565747|419759|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
181434|NCT00565747|419758|P2|STARTED|Overall Study||678
181435|NCT00565747|419759|P1|STARTED|Overall Study||654
181436|NCT00565721|419769|P1|NOT COMPLETED|Overall Study||17
181437|NCT00565721|419769|P1|COMPLETED|Overall Study||16
181438|NCT00565721|419769|P1|STARTED|Overall Study||33
181439|NCT00565643|419790|P2|NOT COMPLETED|Overall Study||0
181440|NCT00565643|419791|P1|NOT COMPLETED|Overall Study||0
181441|NCT00565643|419790|P2|COMPLETED|Overall Study||373
181442|NCT00565643|419791|P1|COMPLETED|Overall Study||380
181443|NCT00565643|419790|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
181444|NCT00565643|419791|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
181445|NCT00565643|419790|P2|Safety Data|Overall Study||373
181446|NCT00565643|419791|P1|Safety Data|Overall Study||380
181447|NCT00565643|419790|P2|STARTED|Overall Study||373
181448|NCT00565643|419791|P1|STARTED|Overall Study||380
181449|NCT00565604|419809|P1|NOT COMPLETED|Overall Study||4
181450|NCT00565604|419809|P1|COMPLETED|Overall Study||39
181451|NCT00565604|419809|P1|6 Month|Overall Study||39
181452|NCT00565604|419809|P1|6 Week|Overall Study||39
181453|NCT00565604|419809|P1|2 Week|Overall Study||41
181454|NCT00565604|419809|P1|7 Day|Overall Study||41
181455|NCT00565604|419809|P1|STARTED|Overall Study||43
181456|NCT00565461|419820|P4|NOT COMPLETED|Overall Study||3
181457|NCT00565461|419821|P3|NOT COMPLETED|Overall Study||1
181458|NCT00565461|419822|P2|NOT COMPLETED|Overall Study||1
181459|NCT00565461|419823|P1|NOT COMPLETED|Overall Study||0
181460|NCT00565461|419820|P4|COMPLETED|Overall Study||37
181461|NCT00565461|419821|P3|COMPLETED|Overall Study||39
181462|NCT00565461|419822|P2|COMPLETED|Overall Study||39
181463|NCT00565461|419823|P1|COMPLETED|Overall Study||40
181464|NCT00565461|419820|P4|STARTED|Overall Study||40
181465|NCT00565461|419821|P3|STARTED|Overall Study||40
181466|NCT00565461|419822|P2|STARTED|Overall Study||40
181467|NCT00565461|419823|P1|STARTED|Overall Study||40
181468|NCT00565448|419837|P2|NOT COMPLETED|Overall Study||2
181469|NCT00565448|419838|P1|NOT COMPLETED|Overall Study||3
181470|NCT00565448|419837|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
181471|NCT00565448|419838|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
181472|NCT00565448|419837|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
181473|NCT00565448|419838|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
181474|NCT00565409|419849|P4|NOT COMPLETED|Period 2 Double-Blind||59
181475|NCT00565409|419850|P3|NOT COMPLETED|Period 2 Double-Blind||27
181476|NCT00565409|419851|P2|NOT COMPLETED|Period 2 Double-Blind||21
181477|NCT00565409|419852|P1|NOT COMPLETED|Period 2 Double-Blind||0
181478|NCT00565409|419849|P4|COMPLETED|Period 2 Double-Blind||141
181479|NCT00565409|419850|P3|COMPLETED|Period 2 Double-Blind||175
181480|NCT00565409|419851|P2|COMPLETED|Period 2 Double-Blind||181
181481|NCT00565409|419852|P1|COMPLETED|Period 2 Double-Blind||0
181482|NCT00565409|419849|P4|STARTED|Period 2 Double-Blind||200
181483|NCT00565409|419850|P3|STARTED|Period 2 Double-Blind||202
181484|NCT00565409|419851|P2|STARTED|Period 2 Double-Blind||202
181485|NCT00565409|419852|P1|STARTED|Period 2 Double-Blind||0
181486|NCT00565409|419849|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
181487|NCT00565409|419850|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
181488|NCT00565409|419851|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
181489|NCT00565409|419852|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
181490|NCT00565409|419849|P4|COMPLETED|After Period 1, Prior to Period 2||0
181491|NCT00565409|419850|P3|COMPLETED|After Period 1, Prior to Period 2||0
181492|NCT00565409|419851|P2|COMPLETED|After Period 1, Prior to Period 2||0
181493|NCT00565409|419852|P1|COMPLETED|After Period 1, Prior to Period 2||604
181494|NCT00565409|419849|P4|STARTED|After Period 1, Prior to Period 2||0
181495|NCT00565409|419850|P3|STARTED|After Period 1, Prior to Period 2||0
181496|NCT00565409|419851|P2|STARTED|After Period 1, Prior to Period 2||0
181497|NCT00565409|419852|P1|STARTED|After Period 1, Prior to Period 2||756
181498|NCT00565409|419849|P4|NOT COMPLETED|Period 1 Open Label||0
181499|NCT00565409|419850|P3|NOT COMPLETED|Period 1 Open Label||0
181500|NCT00565409|419851|P2|NOT COMPLETED|Period 1 Open Label||0
181501|NCT00565409|419852|P1|NOT COMPLETED|Period 1 Open Label||78
181502|NCT00565409|419849|P4|COMPLETED|Period 1 Open Label||0
181503|NCT00565409|419850|P3|COMPLETED|Period 1 Open Label||0
181504|NCT00565409|419851|P2|COMPLETED|Period 1 Open Label||0
181505|NCT00565409|419852|P1|COMPLETED|Period 1 Open Label||756
181506|NCT00565409|419849|P4|STARTED|Period 1 Open Label||0
181507|NCT00565409|419850|P3|STARTED|Period 1 Open Label||0
181508|NCT00565409|419851|P2|STARTED|Period 1 Open Label||0
181509|NCT00565409|419852|P1|STARTED|Period 1 Open Label||834
181510|NCT00565370|419954|P1|NOT COMPLETED|Overall Study||0
181511|NCT00565370|419954|P1|COMPLETED|Overall Study||21
181512|NCT00565370|419954|P1|STARTED|Overall Study||21
181513|NCT00565266|419962|P1|NOT COMPLETED|Overall Study||36
181514|NCT00565266|419962|P1|COMPLETED|Overall Study||174
181515|NCT00565266|419962|P1|STARTED|Overall Study||210
181516|NCT00565136|419970|P1|NOT COMPLETED|Overall Study||3
181517|NCT00565136|419970|P1|COMPLETED|Overall Study||26
181518|NCT00565136|419970|P1|STARTED|Overall Study||29
181519|NCT00565084|419988|P3|NOT COMPLETED|Third Treatment Period||0
181520|NCT00565084|419989|P2|NOT COMPLETED|Third Treatment Period||0
181521|NCT00565084|419990|P1|NOT COMPLETED|Third Treatment Period||0
181522|NCT00565084|419988|P3|COMPLETED|Third Treatment Period||11
181523|NCT00565084|419989|P2|COMPLETED|Third Treatment Period||11
181524|NCT00565084|419990|P1|COMPLETED|Third Treatment Period||11
181525|NCT00565084|419988|P3|STARTED|Third Treatment Period||11
181526|NCT00565084|419989|P2|STARTED|Third Treatment Period||11
181527|NCT00565084|419990|P1|STARTED|Third Treatment Period||11
181528|NCT00565084|419988|P3|NOT COMPLETED|Second Treatment Period||0
181529|NCT00565084|419989|P2|NOT COMPLETED|Second Treatment Period||0
181530|NCT00565084|419990|P1|NOT COMPLETED|Second Treatment Period||0
181531|NCT00565084|419988|P3|COMPLETED|Second Treatment Period||11
181532|NCT00565084|419989|P2|COMPLETED|Second Treatment Period||11
181533|NCT00565084|419990|P1|COMPLETED|Second Treatment Period||11
181534|NCT00565084|419988|P3|STARTED|Second Treatment Period||11
181535|NCT00565084|419989|P2|STARTED|Second Treatment Period||11
181536|NCT00565084|419990|P1|STARTED|Second Treatment Period||11
181537|NCT00565084|419988|P3|NOT COMPLETED|First Treatment Period||0
181538|NCT00565084|419989|P2|NOT COMPLETED|First Treatment Period||0
181539|NCT00565084|419990|P1|NOT COMPLETED|First Treatment Period||0
181540|NCT00565084|419988|P3|COMPLETED|First Treatment Period||11
181541|NCT00565084|419989|P2|COMPLETED|First Treatment Period||11
181542|NCT00565084|419990|P1|COMPLETED|First Treatment Period||11
181543|NCT00565084|419988|P3|STARTED|First Treatment Period||11
181544|NCT00565084|419989|P2|STARTED|First Treatment Period||11
181545|NCT00565084|419990|P1|STARTED|First Treatment Period||11
181546|NCT00565058|420000|P2|NOT COMPLETED|Overall Study||0
181547|NCT00565058|420001|P1|NOT COMPLETED|Overall Study||1
181548|NCT00565058|420000|P2|COMPLETED|Overall Study||15
181549|NCT00565058|420001|P1|COMPLETED|Overall Study||9
181550|NCT00565058|420000|P2|STARTED|Overall Study||15
181551|NCT00565058|420001|P1|STARTED|Overall Study||10
181552|NCT00565045|420011|P2|NOT COMPLETED|Overall Study||3
181553|NCT00565045|420012|P1|NOT COMPLETED|Overall Study||1
181554|NCT00565045|420011|P2|COMPLETED|Overall Study||8
181555|NCT00565045|420012|P1|COMPLETED|Overall Study||9
181556|NCT00565045|420011|P2|STARTED|Overall Study||11
181557|NCT00565045|420012|P1|STARTED|Overall Study||10
181558|NCT00564954|420028|P2|NOT COMPLETED|Period 2- 1 Week||0
181559|NCT00564954|420029|P1|NOT COMPLETED|Period 2- 1 Week||0
181560|NCT00564954|420028|P2|COMPLETED|Period 2- 1 Week||42
181561|NCT00564954|420029|P1|COMPLETED|Period 2- 1 Week||44
181562|NCT00564954|420028|P2|STARTED|Period 2- 1 Week||42
181563|NCT00564954|420029|P1|STARTED|Period 2- 1 Week||44
181564|NCT00564954|420028|P2|NOT COMPLETED|Period 1- 1 Week||0
181565|NCT00564954|420029|P1|NOT COMPLETED|Period 1- 1 Week||0
181566|NCT00564954|420028|P2|COMPLETED|Period 1- 1 Week||42
181567|NCT00564954|420029|P1|COMPLETED|Period 1- 1 Week||44
181568|NCT00564954|420028|P2|STARTED|Period 1- 1 Week||42
181569|NCT00564954|420029|P1|STARTED|Period 1- 1 Week||44
181570|NCT00564902|420048|P3|NOT COMPLETED|Overall Study||4
181571|NCT00564902|420049|P2|NOT COMPLETED|Overall Study||4
181572|NCT00564902|420050|P1|NOT COMPLETED|Overall Study||1
181573|NCT00564902|420048|P3|COMPLETED|Overall Study||21
181574|NCT00564902|420049|P2|COMPLETED|Overall Study||21
181575|NCT00564902|420050|P1|COMPLETED|Overall Study||9
181576|NCT00564902|420048|P3|12 Months|Overall Study||21
181577|NCT00564902|420049|P2|12 Months|Overall Study||21
181578|NCT00564902|420050|P1|12 Months|Overall Study||9
181579|NCT00564902|420048|P3|8 Months|Overall Study||21
181580|NCT00564902|420049|P2|8 Months|Overall Study||22
181581|NCT00564902|420050|P1|8 Months|Overall Study||9
181582|NCT00564902|420048|P3|4 Months|Overall Study||23
181583|NCT00564902|420049|P2|4 Months|Overall Study||24
181584|NCT00564902|420050|P1|4 Months|Overall Study||9
181585|NCT00564902|420048|P3|STARTED|Overall Study||25
181586|NCT00564902|420049|P2|STARTED|Overall Study||25
181587|NCT00564902|420050|P1|STARTED|Overall Study||10
181588|NCT00564889|420082|P1|NOT COMPLETED|Overall Study||29
181589|NCT00564889|420082|P1|COMPLETED|Overall Study||6
181590|NCT00564889|420082|P1|STARTED|Overall Study||35
181591|NCT00564876|420090|P1|NOT COMPLETED|Overall Study||0
181592|NCT00564876|420090|P1|COMPLETED|Overall Study||2
181593|NCT00564876|420090|P1|STARTED|Overall Study||2
181594|NCT00564850|420097|P1|NOT COMPLETED|Overall Study||2
181595|NCT00564850|420097|P1|COMPLETED|Overall Study||35
181596|NCT00564850|420097|P1|STARTED|Overall Study||37
181597|NCT00564733|420115|P1|NOT COMPLETED|Overall Study||9
181598|NCT00564733|420115|P1|COMPLETED|Overall Study||46
181599|NCT00564733|420115|P1|STARTED|Overall Study||55
181600|NCT00564681|420123|P4|NOT COMPLETED|Overall Study||2
181601|NCT00564681|420124|P3|NOT COMPLETED|Overall Study||3
181602|NCT00564681|420125|P2|NOT COMPLETED|Overall Study||3
181603|NCT00564681|420126|P1|NOT COMPLETED|Overall Study||11
181604|NCT00564681|420123|P4|COMPLETED|Overall Study||19
181605|NCT00564681|420124|P3|COMPLETED|Overall Study||40
181606|NCT00564681|420125|P2|COMPLETED|Overall Study||58
181607|NCT00564681|420126|P1|COMPLETED|Overall Study||106
181608|NCT00564681|420123|P4|STARTED|Overall Study||21
181609|NCT00564681|420124|P3|STARTED|Overall Study||43
181610|NCT00564681|420125|P2|STARTED|Overall Study||61
181611|NCT00564681|420126|P1|STARTED|Overall Study||117
181612|NCT00564629|420149|P2|NOT COMPLETED|Overall Study||9
181613|NCT00564629|420150|P1|NOT COMPLETED|Overall Study||15
181614|NCT00564629|420149|P2|COMPLETED|Overall Study||45
181615|NCT00564629|420150|P1|COMPLETED|Overall Study||36
181616|NCT00564629|420149|P2|STARTED|Overall Study||54
181617|NCT00564629|420150|P1|STARTED|Overall Study||51
181618|NCT00564486|420175|P4|NOT COMPLETED|Overall Study||7
181619|NCT00564486|420176|P3|NOT COMPLETED|Overall Study||3
181620|NCT00564486|420177|P2|NOT COMPLETED|Overall Study||1
181621|NCT00564486|420178|P1|NOT COMPLETED|Overall Study||7
181622|NCT00564486|420175|P4|COMPLETED|Overall Study||60
181623|NCT00564486|420176|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
181624|NCT00564486|420177|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
181625|NCT00564486|420178|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
181626|NCT00564486|420175|P4|STARTED|Overall Study||67
181627|NCT00564486|420176|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
181628|NCT00564486|420177|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
181629|NCT00564486|420178|P1|STARTED|Overall Study||43
181630|NCT00564447|420202|P8|NOT COMPLETED|Overall Study||0
181631|NCT00564447|420203|P7|NOT COMPLETED|Overall Study||0
181632|NCT00564447|420204|P6|NOT COMPLETED|Overall Study||0
181633|NCT00564447|420205|P5|NOT COMPLETED|Overall Study||0
181634|NCT00564447|420206|P4|NOT COMPLETED|Overall Study||0
181635|NCT00564447|420207|P3|NOT COMPLETED|Overall Study||0
181636|NCT00564447|420208|P2|NOT COMPLETED|Overall Study||0
181637|NCT00564447|420209|P1|NOT COMPLETED|Overall Study||0
181638|NCT00564447|420202|P8|COMPLETED|Overall Study||6
181639|NCT00564447|420203|P7|COMPLETED|Overall Study||6
181640|NCT00564447|420204|P6|COMPLETED|Overall Study||6
181641|NCT00564447|420205|P5|COMPLETED|Overall Study||6
181642|NCT00564447|420206|P4|COMPLETED|Overall Study||6
181643|NCT00564447|420207|P3|COMPLETED|Overall Study||6
181644|NCT00564447|420208|P2|COMPLETED|Overall Study||6
181645|NCT00564447|420209|P1|COMPLETED|Overall Study||6
181646|NCT00564447|420202|P8|STARTED|Overall Study||6
181647|NCT00564447|420203|P7|STARTED|Overall Study||6
181648|NCT00564447|420204|P6|STARTED|Overall Study||6
181649|NCT00564447|420205|P5|STARTED|Overall Study||6
181650|NCT00564447|420206|P4|STARTED|Overall Study||6
181651|NCT00564447|420207|P3|STARTED|Overall Study||6
181652|NCT00564447|420208|P2|STARTED|Overall Study||6
181653|NCT00564447|420209|P1|STARTED|Overall Study||6
181654|NCT00564278|420229|P2|NOT COMPLETED|Overall Study||42
181655|NCT00564278|420230|P1|NOT COMPLETED|Overall Study||47
181656|NCT00564278|420229|P2|COMPLETED|Overall Study||56
181657|NCT00564278|420230|P1|COMPLETED|Overall Study||50
181658|NCT00564278|420229|P2|STARTED|Overall Study||98
181659|NCT00564278|420230|P1|STARTED|Overall Study||97
181660|NCT00564265|420246|P1|NOT COMPLETED|Overall Study||0
181661|NCT00564265|420246|P1|COMPLETED|Overall Study||24
181662|NCT00564265|420246|P1|STARTED|Overall Study||24
181663|NCT00563797|420252|P2|NOT COMPLETED|Overall Study||2
181664|NCT00563797|420253|P1|NOT COMPLETED|Overall Study||7
181665|NCT00563797|420252|P2|COMPLETED|Overall Study||8
181666|NCT00563797|420253|P1|COMPLETED|Overall Study||4
181667|NCT00563797|420252|P2|Follow-Up|Overall Study||10
181668|NCT00563797|420253|P1|Follow-Up|Overall Study||11
181669|NCT00563797|420252|P2|Received Allocated Intervention|Overall Study||10
181670|NCT00563797|420253|P1|Received Allocated Intervention|Overall Study||11
181671|NCT00563797|420252|P2|STARTED|Overall Study||10
181672|NCT00563797|420253|P1|STARTED|Overall Study||11
181673|NCT00563706|420274|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181674|NCT00563706|420275|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181675|NCT00563706|420276|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181676|NCT00563706|420277|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181677|NCT00563706|420278|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181678|NCT00563706|420279|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181679|NCT00563706|420280|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181680|NCT00563706|420281|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181681|NCT00563706|420282|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
181682|NCT00563706|420274|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
181683|NCT00563706|420275|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
181684|NCT00563706|420276|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
181685|NCT00563706|420277|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
181686|NCT00563706|420278|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
181687|NCT00563706|420279|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
181688|NCT00563706|420280|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
181689|NCT00563706|420281|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
181690|NCT00563706|420282|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
181691|NCT00563706|420274|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
181692|NCT00563706|420275|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
181693|NCT00563706|420276|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
181694|NCT00563706|420277|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
181695|NCT00563706|420278|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
181696|NCT00563706|420279|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
181697|NCT00563706|420280|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
181698|NCT00563706|420281|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
181699|NCT00563706|420282|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
181700|NCT00563706|420274|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
181701|NCT00563706|420275|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
181702|NCT00563706|420276|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
181703|NCT00563706|420277|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
181704|NCT00563706|420278|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
181705|NCT00563706|420279|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
181706|NCT00563706|420280|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
181707|NCT00563706|420281|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
181708|NCT00563706|420282|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
181709|NCT00563706|420274|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
181710|NCT00563706|420275|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
181711|NCT00563706|420276|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
181712|NCT00563706|420277|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
181713|NCT00563706|420278|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
181714|NCT00563706|420279|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
181715|NCT00563706|420280|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
181716|NCT00563706|420281|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
181717|NCT00563706|420282|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
181718|NCT00563706|420274|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
181719|NCT00563706|420275|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
181720|NCT00563706|420276|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
181721|NCT00563706|420277|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
181722|NCT00563706|420278|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
181723|NCT00563706|420279|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
181724|NCT00563706|420280|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
181725|NCT00563706|420281|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
181726|NCT00563706|420282|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
181727|NCT00563576|420385|P2|NOT COMPLETED|Overall Study||14
181728|NCT00563576|420386|P1|NOT COMPLETED|Overall Study||14
181729|NCT00563576|420385|P2|COMPLETED|Overall Study||22
181730|NCT00563576|420386|P1|COMPLETED|Overall Study||21
181731|NCT00563576|420385|P2|STARTED|Overall Study||36
181732|NCT00563576|420386|P1|STARTED|Overall Study||35
181733|NCT00563381|420398|P2|NOT COMPLETED|Overall Study||648
181734|NCT00563381|420399|P1|NOT COMPLETED|Overall Study||585
181735|NCT00563381|420398|P2|COMPLETED|Overall Study|Completed treatment|3021
181736|NCT00563381|420399|P1|COMPLETED|Overall Study|Completed treatment|3122
181737|NCT00563381|420398|P2|STARTED|Overall Study|Started treatment|3669
181738|NCT00563381|420399|P1|STARTED|Overall Study|Started treatment|3707
181739|NCT00563368|420472|P7|NOT COMPLETED|Overall Study||33
181740|NCT00563368|420473|P6|NOT COMPLETED|Overall Study||30
181741|NCT00563368|420474|P5|NOT COMPLETED|Overall Study||28
181742|NCT00563368|420475|P4|NOT COMPLETED|Overall Study||29
181743|NCT00563368|420476|P3|NOT COMPLETED|Overall Study||30
181744|NCT00563368|420477|P2|NOT COMPLETED|Overall Study||30
181745|NCT00563368|420478|P1|NOT COMPLETED|Overall Study||35
181746|NCT00563368|420472|P7|COMPLETED|Overall Study||75
181747|NCT00563368|420473|P6|COMPLETED|Overall Study||77
181748|NCT00563368|420474|P5|COMPLETED|Overall Study||80
181749|NCT00563368|420475|P4|COMPLETED|Overall Study||78
181750|NCT00563368|420476|P3|COMPLETED|Overall Study||78
181751|NCT00563368|420477|P2|COMPLETED|Overall Study||79
181752|NCT00563368|420478|P1|COMPLETED|Overall Study||74
181753|NCT00563368|420472|P7|STARTED|Overall Study||108
181754|NCT00563368|420473|P6|STARTED|Overall Study||107
181755|NCT00563368|420474|P5|STARTED|Overall Study||108
181756|NCT00563368|420475|P4|STARTED|Overall Study||107
181757|NCT00563368|420476|P3|STARTED|Overall Study||108
181758|NCT00563368|420477|P2|STARTED|Overall Study||109
181759|NCT00563368|420478|P1|STARTED|Overall Study||109
181760|NCT00563316|420501|P1|NOT COMPLETED|Overall Study||12
181761|NCT00563316|420501|P1|COMPLETED|Overall Study||16
181762|NCT00563316|420501|P1|Received Investigational Product|Overall Study||27
181763|NCT00563316|420501|P1|STARTED|Overall Study||28
181764|NCT00563290|420514|P2|NOT COMPLETED|Overall Study||0
181765|NCT00563290|420515|P1|NOT COMPLETED|Overall Study||0
181766|NCT00563290|420514|P2|COMPLETED|Overall Study||4
181767|NCT00563290|420515|P1|COMPLETED|Overall Study||3
181768|NCT00563290|420514|P2|STARTED|Overall Study||4
181769|NCT00563290|420515|P1|STARTED|Overall Study||3
181770|NCT00562861|420526|P2|NOT COMPLETED|Overall Study||11
181771|NCT00562861|420527|P1|NOT COMPLETED|Overall Study||20
181772|NCT00562861|420526|P2|COMPLETED|Overall Study||48
181773|NCT00562861|420527|P1|COMPLETED|Overall Study||40
181774|NCT00562861|420526|P2|STARTED|Overall Study||59
181775|NCT00562861|420527|P1|STARTED|Overall Study||60
181776|NCT00562627|420536|P3|NOT COMPLETED|Overall Study||1
181777|NCT00562627|420537|P2|NOT COMPLETED|Overall Study||1
181778|NCT00562627|420538|P1|NOT COMPLETED|Overall Study||1
181779|NCT00562627|420536|P3|COMPLETED|Overall Study||33
181780|NCT00562627|420537|P2|COMPLETED|Overall Study||33
181781|NCT00562627|420538|P1|COMPLETED|Overall Study||33
181782|NCT00562627|420536|P3|STARTED|Overall Study||34
181783|NCT00562627|420537|P2|STARTED|Overall Study||34
181784|NCT00562627|420538|P1|STARTED|Overall Study||34
181785|NCT00562588|420554|P2|NOT COMPLETED|Overall Study||99
181786|NCT00562588|420555|P1|NOT COMPLETED|Overall Study||92
181787|NCT00562588|420554|P2|COMPLETED|Overall Study||184
181788|NCT00562588|420555|P1|COMPLETED|Overall Study||168
181789|NCT00562588|420554|P2|STARTED|Overall Study||283
181790|NCT00562588|420555|P1|STARTED|Overall Study||260
181791|NCT00562484|420585|P2|NOT COMPLETED|Overall Study||104
181792|NCT00562484|420586|P1|NOT COMPLETED|Overall Study||206
181793|NCT00562484|420585|P2|COMPLETED|Overall Study||4907
181794|NCT00562484|420586|P1|COMPLETED|Overall Study||9827
181795|NCT00562484|420585|P2|STARTED|Overall Study||5011
181796|NCT00562484|420586|P1|STARTED|Overall Study||10033
181797|NCT00562354|420618|P2|NOT COMPLETED|Overall Study||2
181798|NCT00562354|420619|P1|NOT COMPLETED|Overall Study||0
181799|NCT00562354|420618|P2|COMPLETED|Overall Study||135
181800|NCT00562354|420619|P1|COMPLETED|Overall Study||134
181801|NCT00562354|420618|P2|Evaluable Immunogenicity Population|Overall Study||134
181802|NCT00562354|420619|P1|Evaluable Immunogenicity Population|Overall Study||134
181803|NCT00562354|420618|P2|Received Study Treatment|Overall Study||136
181804|NCT00562354|420619|P1|Received Study Treatment|Overall Study||134
181805|NCT00562354|420618|P2|STARTED|Overall Study||137
181806|NCT00562354|420619|P1|STARTED|Overall Study||134
181807|NCT00562328|420660|P1|NOT COMPLETED|Overall Study||0
181808|NCT00562328|420660|P1|COMPLETED|Overall Study||33
181809|NCT00562328|420660|P1|STARTED|Overall Study||33
181810|NCT00562315|420664|P1|NOT COMPLETED|Overall Study||0
181811|NCT00562315|420664|P1|COMPLETED|Overall Study||93
181812|NCT00562315|420664|P1|STARTED|Overall Study||93
181813|NCT00562302|420681|P2|NOT COMPLETED|Overall Study||32
181814|NCT00562302|420682|P1|NOT COMPLETED|Overall Study||20
181815|NCT00562302|420681|P2|COMPLETED|Overall Study||137
181816|NCT00562302|420682|P1|COMPLETED|Overall Study||150
181817|NCT00562302|420681|P2|STARTED|Overall Study||169
181818|NCT00562302|420682|P1|STARTED|Overall Study||170
181819|NCT00562159|420704|P2|NOT COMPLETED|Overall Study||33
181820|NCT00562159|420705|P1|NOT COMPLETED|Overall Study||38
181821|NCT00562159|420704|P2|COMPLETED|Overall Study||192
181822|NCT00562159|420705|P1|COMPLETED|Overall Study||175
181823|NCT00562159|420704|P2|STARTED|Overall Study||225
181824|NCT00562159|420705|P1|STARTED|Overall Study||213
181825|NCT00562120|420717|P4|NOT COMPLETED|Fourth Intervention Period||0
181826|NCT00562120|420718|P3|NOT COMPLETED|Fourth Intervention Period||0
181827|NCT00562120|420719|P2|NOT COMPLETED|Fourth Intervention Period||0
181828|NCT00562120|420720|P1|NOT COMPLETED|Fourth Intervention Period||0
181829|NCT00562120|420717|P4|COMPLETED|Fourth Intervention Period||5
181830|NCT00562120|420718|P3|COMPLETED|Fourth Intervention Period||5
181831|NCT00562120|420719|P2|COMPLETED|Fourth Intervention Period||5
181832|NCT00562120|420720|P1|COMPLETED|Fourth Intervention Period||4
181833|NCT00562120|420717|P4|STARTED|Fourth Intervention Period||5
181834|NCT00562120|420718|P3|STARTED|Fourth Intervention Period||5
181835|NCT00562120|420719|P2|STARTED|Fourth Intervention Period||5
181836|NCT00562120|420720|P1|STARTED|Fourth Intervention Period||4
181837|NCT00562120|420717|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
181838|NCT00562120|420718|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
181839|NCT00562120|420719|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
181840|NCT00562120|420720|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
181841|NCT00562120|420717|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
181842|NCT00562120|420718|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
181843|NCT00562120|420719|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
181844|NCT00562120|420720|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
181845|NCT00562120|420717|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
181846|NCT00562120|420718|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
181847|NCT00562120|420719|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
181848|NCT00562120|420720|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
181849|NCT00562120|420717|P4|NOT COMPLETED|Third Intervention Period||0
181850|NCT00562120|420718|P3|NOT COMPLETED|Third Intervention Period||0
181851|NCT00562120|420719|P2|NOT COMPLETED|Third Intervention Period||0
181852|NCT00562120|420720|P1|NOT COMPLETED|Third Intervention Period||0
181853|NCT00562120|420717|P4|COMPLETED|Third Intervention Period||5
181854|NCT00562120|420718|P3|COMPLETED|Third Intervention Period||5
181855|NCT00562120|420719|P2|COMPLETED|Third Intervention Period||5
181856|NCT00562120|420720|P1|COMPLETED|Third Intervention Period||4
181857|NCT00562120|420717|P4|STARTED|Third Intervention Period||5
181858|NCT00562120|420718|P3|STARTED|Third Intervention Period||5
181859|NCT00562120|420719|P2|STARTED|Third Intervention Period||5
181860|NCT00562120|420720|P1|STARTED|Third Intervention Period||4
181861|NCT00562120|420717|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
181862|NCT00562120|420718|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
181863|NCT00562120|420719|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
181864|NCT00562120|420720|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
181865|NCT00562120|420717|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
181866|NCT00562120|420718|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
181867|NCT00562120|420719|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
181868|NCT00562120|420720|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
181869|NCT00562120|420717|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
181870|NCT00562120|420718|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
181871|NCT00562120|420719|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
181872|NCT00562120|420720|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
181873|NCT00562120|420717|P4|NOT COMPLETED|Second Intervention Period||0
181874|NCT00562120|420718|P3|NOT COMPLETED|Second Intervention Period||0
181875|NCT00562120|420719|P2|NOT COMPLETED|Second Intervention Period||0
181876|NCT00562120|420720|P1|NOT COMPLETED|Second Intervention Period||0
181877|NCT00562120|420717|P4|COMPLETED|Second Intervention Period||5
181878|NCT00562120|420718|P3|COMPLETED|Second Intervention Period||5
181879|NCT00562120|420719|P2|COMPLETED|Second Intervention Period||5
181880|NCT00562120|420720|P1|COMPLETED|Second Intervention Period||4
181881|NCT00562120|420717|P4|STARTED|Second Intervention Period||5
181882|NCT00562120|420718|P3|STARTED|Second Intervention Period||5
181883|NCT00562120|420719|P2|STARTED|Second Intervention Period||5
181884|NCT00562120|420720|P1|STARTED|Second Intervention Period||4
181885|NCT00562120|420717|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
181886|NCT00562120|420718|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
181887|NCT00562120|420719|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
181888|NCT00562120|420720|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
181889|NCT00562120|420717|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
181890|NCT00562120|420718|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
181891|NCT00562120|420719|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
181892|NCT00562120|420720|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
181893|NCT00562120|420717|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
181894|NCT00562120|420718|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
181895|NCT00562120|420719|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
181896|NCT00562120|420720|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
181897|NCT00562120|420717|P4|NOT COMPLETED|First Intervention Period||0
181898|NCT00562120|420718|P3|NOT COMPLETED|First Intervention Period||0
181899|NCT00562120|420719|P2|NOT COMPLETED|First Intervention Period||0
181900|NCT00562120|420720|P1|NOT COMPLETED|First Intervention Period||2
181901|NCT00562120|420717|P4|COMPLETED|First Intervention Period||5
181902|NCT00562120|420718|P3|COMPLETED|First Intervention Period||5
181903|NCT00562120|420719|P2|COMPLETED|First Intervention Period||5
181904|NCT00562120|420720|P1|COMPLETED|First Intervention Period||4
181905|NCT00562120|420717|P4|Treated|First Intervention Period||5
181906|NCT00562120|420718|P3|Treated|First Intervention Period||5
181907|NCT00562120|420719|P2|Treated|First Intervention Period||5
181908|NCT00562120|420720|P1|Treated|First Intervention Period||5
181909|NCT00562120|420717|P4|STARTED|First Intervention Period||5
181910|NCT00562120|420718|P3|STARTED|First Intervention Period||5
181911|NCT00562120|420719|P2|STARTED|First Intervention Period||5
181912|NCT00562120|420720|P1|STARTED|First Intervention Period||6
181913|NCT00562094|420752|P1|NOT COMPLETED|Overall Study||62
181914|NCT00562094|420752|P1|COMPLETED|Overall Study||8554
181915|NCT00562094|420752|P1|STARTED|Overall Study||8616
181916|NCT00561977|420767|P3|NOT COMPLETED|Overall Study||2
181917|NCT00561977|420768|P2|NOT COMPLETED|Overall Study||3
181918|NCT00561977|420769|P1|NOT COMPLETED|Overall Study||0
181919|NCT00561977|420767|P3|COMPLETED|Overall Study||10
181920|NCT00561977|420768|P2|COMPLETED|Overall Study||9
181921|NCT00561977|420769|P1|COMPLETED|Overall Study||12
181922|NCT00561977|420767|P3|STARTED|Overall Study||12
181923|NCT00561977|420768|P2|STARTED|Overall Study||12
181924|NCT00561977|420769|P1|STARTED|Overall Study||12
181925|NCT00561951|420795|P3|NOT COMPLETED|Overall Study||32
181926|NCT00561951|420796|P2|NOT COMPLETED|Overall Study||34
181927|NCT00561951|420797|P1|NOT COMPLETED|Overall Study||33
181928|NCT00561951|420795|P3|COMPLETED|Overall Study||281
181929|NCT00561951|420796|P2|COMPLETED|Overall Study||286
181930|NCT00561951|420797|P1|COMPLETED|Overall Study||285
181931|NCT00561951|420795|P3|STARTED|Overall Study||313
181932|NCT00561951|420796|P2|STARTED|Overall Study||320
181933|NCT00561951|420797|P1|STARTED|Overall Study||318
181934|NCT00561925|420853|P5|NOT COMPLETED|Open-Label Extension Period||50
181935|NCT00561925|420854|P4|NOT COMPLETED|Open-Label Extension Period||43
181936|NCT00561925|420855|P3|NOT COMPLETED|Open-Label Extension Period||0
181937|NCT00561925|420856|P2|NOT COMPLETED|Open-Label Extension Period||0
181938|NCT00561925|420857|P1|NOT COMPLETED|Open-Label Extension Period||0
181939|NCT00561925|420853|P5|COMPLETED|Open-Label Extension Period||328
181940|NCT00561925|420854|P4|COMPLETED|Open-Label Extension Period||315
181941|NCT00561925|420855|P3|COMPLETED|Open-Label Extension Period||0
181942|NCT00561925|420856|P2|COMPLETED|Open-Label Extension Period||1
181943|NCT00561925|420857|P1|COMPLETED|Open-Label Extension Period||0
181944|NCT00561925|420853|P5|STARTED|Open-Label Extension Period||378
181945|NCT00561925|420854|P4|STARTED|Open-Label Extension Period||358
181946|NCT00561925|420855|P3|STARTED|Open-Label Extension Period||0
181947|NCT00561925|420856|P2|STARTED|Open-Label Extension Period||1
181948|NCT00561925|420857|P1|STARTED|Open-Label Extension Period||0
181949|NCT00561925|420853|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
181950|NCT00561925|420854|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
181951|NCT00561925|420855|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
181952|NCT00561925|420856|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
181953|NCT00561925|420857|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
181954|NCT00561925|420853|P5|COMPLETED|144-week Double-blind, Double-dummy||0
181955|NCT00561925|420854|P4|COMPLETED|144-week Double-blind, Double-dummy||0
181956|NCT00561925|420855|P3|COMPLETED|144-week Double-blind, Double-dummy||378
181957|NCT00561925|420856|P2|COMPLETED|144-week Double-blind, Double-dummy||358
181958|NCT00561925|420857|P1|COMPLETED|144-week Double-blind, Double-dummy||0
181959|NCT00561925|420853|P5|STARTED|144-week Double-blind, Double-dummy||0
181960|NCT00561925|420854|P4|STARTED|144-week Double-blind, Double-dummy||0
181961|NCT00561925|420855|P3|STARTED|144-week Double-blind, Double-dummy||505
181962|NCT00561925|420856|P2|STARTED|144-week Double-blind, Double-dummy||508
181963|NCT00561925|420857|P1|STARTED|144-week Double-blind, Double-dummy||0
181964|NCT00561925|420853|P5|NOT COMPLETED|14 Day Lead-In Period||0
181965|NCT00561925|420854|P4|NOT COMPLETED|14 Day Lead-In Period||0
181966|NCT00561925|420855|P3|NOT COMPLETED|14 Day Lead-In Period||0
181967|NCT00561925|420856|P2|NOT COMPLETED|14 Day Lead-In Period||0
181968|NCT00561925|420857|P1|NOT COMPLETED|14 Day Lead-In Period||55
181969|NCT00561925|420853|P5|COMPLETED|14 Day Lead-In Period||0
181970|NCT00561925|420854|P4|COMPLETED|14 Day Lead-In Period||0
181971|NCT00561925|420855|P3|COMPLETED|14 Day Lead-In Period||0
181972|NCT00561925|420856|P2|COMPLETED|14 Day Lead-In Period||0
181973|NCT00561925|420857|P1|COMPLETED|14 Day Lead-In Period||1013
181974|NCT00561925|420853|P5|STARTED|14 Day Lead-In Period||0
181975|NCT00561925|420854|P4|STARTED|14 Day Lead-In Period||0
181976|NCT00561925|420855|P3|STARTED|14 Day Lead-In Period||0
181977|NCT00561925|420856|P2|STARTED|14 Day Lead-In Period||0
181978|NCT00561925|420857|P1|STARTED|14 Day Lead-In Period||1068
181979|NCT00561912|420906|P1|NOT COMPLETED|Overall Study||1
181980|NCT00561912|420906|P1|COMPLETED|Overall Study||1
181981|NCT00561912|420906|P1|STARTED|Overall Study||2
181982|NCT00561834|420910|P1|NOT COMPLETED|Overall Study||0
181983|NCT00561834|420910|P1|COMPLETED|Overall Study||2
181984|NCT00561834|420910|P1|STARTED|Overall Study||2
181985|NCT00561821|420918|P4|NOT COMPLETED|Overall Study||3
181986|NCT00561821|420919|P3|NOT COMPLETED|Overall Study||2
181987|NCT00561821|420920|P2|NOT COMPLETED|Overall Study||6
181988|NCT00561821|420921|P1|NOT COMPLETED|Overall Study||5
181989|NCT00561821|420918|P4|COMPLETED|Overall Study||133
181990|NCT00561821|420919|P3|COMPLETED|Overall Study||132
181991|NCT00561821|420920|P2|COMPLETED|Overall Study||130
181992|NCT00561821|420921|P1|COMPLETED|Overall Study||127
181993|NCT00561821|420918|P4|Treated|Overall Study||136
181994|NCT00561821|420919|P3|Treated|Overall Study||133
181995|NCT00561821|420920|P2|Treated|Overall Study||136
181996|NCT00561821|420921|P1|Treated|Overall Study||132
181997|NCT00561821|420918|P4|STARTED|Overall Study||136
181998|NCT00561821|420919|P3|STARTED|Overall Study||134
181999|NCT00561821|420920|P2|STARTED|Overall Study||136
182000|NCT00561821|420921|P1|STARTED|Overall Study||132
182001|NCT00561795|420997|P4|NOT COMPLETED|Overall Study||0
182002|NCT00561795|420998|P3|NOT COMPLETED|Overall Study||0
182003|NCT00561795|420999|P2|NOT COMPLETED|Overall Study||6
182004|NCT00561795|421000|P1|NOT COMPLETED|Overall Study||4
182005|NCT00561795|420997|P4|COMPLETED|Overall Study||0
182006|NCT00561795|420998|P3|COMPLETED|Overall Study||0
182007|NCT00561795|420999|P2|COMPLETED|Overall Study||0
182008|NCT00561795|421000|P1|COMPLETED|Overall Study||2
182009|NCT00561795|420997|P4|STARTED|Overall Study||0
182010|NCT00561795|420998|P3|STARTED|Overall Study||0
182011|NCT00561795|420999|P2|STARTED|Overall Study||6
182012|NCT00561795|421000|P1|STARTED|Overall Study||6
182013|NCT00561730|421020|P1|NOT COMPLETED|Overall Study||9
182014|NCT00561730|421020|P1|COMPLETED|Overall Study||1986
182015|NCT00561730|421020|P1|STARTED|Overall Study||1995
182016|NCT00561652|421036|P2|NOT COMPLETED|Overall Study||1
182017|NCT00561652|421037|P1|NOT COMPLETED|Overall Study||0
182018|NCT00561652|421036|P2|COMPLETED|Overall Study||19
182019|NCT00561652|421037|P1|COMPLETED|Overall Study||10
182020|NCT00561652|421036|P2|STARTED|Overall Study||20
182021|NCT00561652|421037|P1|STARTED|Overall Study||10
182022|NCT00561600|421057|P2|NOT COMPLETED|Overall Study||16
182023|NCT00561600|421058|P1|NOT COMPLETED|Overall Study||18
182024|NCT00561600|421057|P2|COMPLETED|Overall Study||119
182025|NCT00561600|421058|P1|COMPLETED|Overall Study||112
182026|NCT00561600|421057|P2|STARTED|Overall Study||135
182027|NCT00561600|421058|P1|STARTED|Overall Study||130
182028|NCT00561574|421120|P2|NOT COMPLETED|Overall Study||58
182029|NCT00561574|421121|P1|NOT COMPLETED|Overall Study||48
182030|NCT00561574|421120|P2|COMPLETED|Overall Study||73
182031|NCT00561574|421121|P1|COMPLETED|Overall Study||80
182032|NCT00561574|421120|P2|STARTED|Overall Study||131
182033|NCT00561574|421121|P1|STARTED|Overall Study||128
182034|NCT00561470|421147|P2|NOT COMPLETED|Overall Study||612
182035|NCT00561470|421148|P1|NOT COMPLETED|Overall Study||614
182036|NCT00561470|421147|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
182037|NCT00561470|421148|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
182038|NCT00561470|421147|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
182039|NCT00561470|421148|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
182040|NCT00561470|421147|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
182041|NCT00561470|421148|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
182042|NCT00561470|421147|P2|TREATED|Overall Study||607
182043|NCT00561470|421148|P1|TREATED|Overall Study||609
182044|NCT00561470|421147|P2|STARTED|Overall Study||612
182045|NCT00561470|421148|P1|STARTED|Overall Study||614
182046|NCT00561457|421162|P1|NOT COMPLETED|Overall Study||24
182047|NCT00561457|421162|P1|COMPLETED|Overall Study||110
182048|NCT00561457|421162|P1|STARTED|Overall Study||134
182049|NCT00561431|421168|P2|NOT COMPLETED|Overall Study||0
182050|NCT00561431|421169|P1|NOT COMPLETED|Overall Study||0
182051|NCT00561431|421168|P2|COMPLETED|Overall Study||100
182052|NCT00561431|421169|P1|COMPLETED|Overall Study||100
182053|NCT00561431|421168|P2|STARTED|Overall Study||100
182054|NCT00561431|421169|P1|STARTED|Overall Study||100
182055|NCT00561418|421177|P1|NOT COMPLETED|Overall Study||0
182056|NCT00561418|421177|P1|COMPLETED|Overall Study||23
182057|NCT00561418|421177|P1|STARTED|Overall Study||23
182058|NCT00561392|421184|P1|NOT COMPLETED|Overall Study||53
182059|NCT00561392|421184|P1|COMPLETED|Overall Study||155
182060|NCT00561392|421184|P1|STARTED|Overall Study||208
182061|NCT00561353|421206|P10|NOT COMPLETED|Overall Study||2
182062|NCT00561353|421207|P9|NOT COMPLETED|Overall Study||7
182063|NCT00561353|421208|P8|NOT COMPLETED|Overall Study||4
182064|NCT00561353|421209|P7|NOT COMPLETED|Overall Study||6
182065|NCT00561353|421210|P6|NOT COMPLETED|Overall Study||6
182066|NCT00561353|421211|P5|NOT COMPLETED|Overall Study||1
182067|NCT00561353|421212|P4|NOT COMPLETED|Overall Study||6
182068|NCT00561353|421213|P3|NOT COMPLETED|Overall Study||3
182069|NCT00561353|421214|P2|NOT COMPLETED|Overall Study||3
182070|NCT00561353|421215|P1|NOT COMPLETED|Overall Study||5
182071|NCT00561353|421206|P10|COMPLETED|Overall Study||3
182072|NCT00561353|421207|P9|COMPLETED|Overall Study||2
182073|NCT00561353|421208|P8|COMPLETED|Overall Study||6
182074|NCT00561353|421209|P7|COMPLETED|Overall Study||3
182075|NCT00561353|421210|P6|COMPLETED|Overall Study||3
182076|NCT00561353|421211|P5|COMPLETED|Overall Study||5
182077|NCT00561353|421212|P4|COMPLETED|Overall Study||12
182078|NCT00561353|421213|P3|COMPLETED|Overall Study||10
182079|NCT00561353|421214|P2|COMPLETED|Overall Study||16
182080|NCT00561353|421215|P1|COMPLETED|Overall Study||13
182081|NCT00561353|421206|P10|STARTED|Overall Study||5
182082|NCT00561353|421207|P9|STARTED|Overall Study||9
182083|NCT00561353|421208|P8|STARTED|Overall Study||10
182084|NCT00561353|421209|P7|STARTED|Overall Study||9
182085|NCT00561353|421210|P6|STARTED|Overall Study||9
182086|NCT00561353|421211|P5|STARTED|Overall Study||6
182087|NCT00561353|421212|P4|STARTED|Overall Study||18
182088|NCT00561353|421213|P3|STARTED|Overall Study||13
182089|NCT00561353|421214|P2|STARTED|Overall Study||19
182090|NCT00561353|421215|P1|STARTED|Overall Study||18
182091|NCT00561340|421370|P2|NOT COMPLETED|Overall Study||0
182092|NCT00561340|421371|P1|NOT COMPLETED|Overall Study||6
182093|NCT00561340|421370|P2|COMPLETED|Overall Study||16
182094|NCT00561340|421371|P1|COMPLETED|Overall Study||7
182095|NCT00561340|421370|P2|STARTED|Overall Study||16
182096|NCT00561340|421371|P1|STARTED|Overall Study||13
182097|NCT00561145|421381|P2|NOT COMPLETED|Overall Study||0
182098|NCT00561145|421382|P1|NOT COMPLETED|Overall Study||0
182099|NCT00561145|421381|P2|COMPLETED|Overall Study||17
182100|NCT00561145|421382|P1|COMPLETED|Overall Study||15
182101|NCT00561145|421381|P2|STARTED|Overall Study||17
182102|NCT00561145|421382|P1|STARTED|Overall Study||15
182103|NCT00561015|421394|P6|NOT COMPLETED|Overall Study||3
182104|NCT00561015|421395|P5|NOT COMPLETED|Overall Study||1
182105|NCT00561015|421396|P4|NOT COMPLETED|Overall Study||1
182106|NCT00561015|421397|P3|NOT COMPLETED|Overall Study||0
182107|NCT00561015|421398|P2|NOT COMPLETED|Overall Study||0
182108|NCT00561015|421399|P1|NOT COMPLETED|Overall Study||4
182109|NCT00561015|421394|P6|COMPLETED|Overall Study||6
182110|NCT00561015|421395|P5|COMPLETED|Overall Study||8
182111|NCT00561015|421396|P4|COMPLETED|Overall Study||7
182112|NCT00561015|421397|P3|COMPLETED|Overall Study||9
182113|NCT00561015|421398|P2|COMPLETED|Overall Study||5
182114|NCT00561015|421399|P1|COMPLETED|Overall Study||5
182115|NCT00561015|421394|P6|STARTED|Overall Study||9
182116|NCT00561015|421395|P5|STARTED|Overall Study||9
182117|NCT00561015|421396|P4|STARTED|Overall Study||8
182118|NCT00561015|421397|P3|STARTED|Overall Study||9
182119|NCT00561015|421398|P2|STARTED|Overall Study||5
182120|NCT00561015|421399|P1|STARTED|Overall Study||9
182121|NCT00561002|421475|P2|NOT COMPLETED|Overall Study||0
182122|NCT00561002|421476|P1|NOT COMPLETED|Overall Study||0
182123|NCT00561002|421475|P2|COMPLETED|Overall Study||9
182124|NCT00561002|421476|P1|COMPLETED|Overall Study||23
182125|NCT00561002|421475|P2|STARTED|Overall Study||9
182126|NCT00561002|421476|P1|STARTED|Overall Study||23
182127|NCT00560950|421490|P2|NOT COMPLETED|Overall Study||0
182128|NCT00560950|421491|P1|NOT COMPLETED|Overall Study||1
182129|NCT00560950|421490|P2|COMPLETED|Overall Study||71
182130|NCT00560950|421491|P1|COMPLETED|Overall Study||71
182131|NCT00560950|421490|P2|STARTED|Overall Study||71
182132|NCT00560950|421491|P1|STARTED|Overall Study||72
182133|NCT00560937|421529|P2|NOT COMPLETED|Overall Study||2
182134|NCT00560937|421530|P1|NOT COMPLETED|Overall Study||1
182135|NCT00560937|421529|P2|COMPLETED|Overall Study||9
182136|NCT00560937|421530|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
182137|NCT00560937|421529|P2|STARTED|Overall Study||11
182138|NCT00560937|421530|P1|STARTED|Overall Study||10
182139|NCT00560885|421546|P1|NOT COMPLETED|Overall Study||8
182140|NCT00560885|421546|P1|COMPLETED|Overall Study||47
182141|NCT00560885|421546|P1|2 Year Follow-up|Overall Study||47
182142|NCT00560885|421546|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
182143|NCT00560885|421546|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
182144|NCT00560885|421546|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
182145|NCT00560885|421546|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
182146|NCT00560885|421546|P1|STARTED|Overall Study||55
182147|NCT00560859|421555|P2|NOT COMPLETED|Overall Study||24
182148|NCT00560859|421556|P1|NOT COMPLETED|Overall Study||32
182149|NCT00560859|421555|P2|COMPLETED|Overall Study||203
182150|NCT00560859|421556|P1|COMPLETED|Overall Study||194
182151|NCT00560859|421555|P2|STARTED|Overall Study||227
182152|NCT00560859|421556|P1|STARTED|Overall Study||226
182153|NCT00560833|421571|P5|NOT COMPLETED|Overall Study||42
182154|NCT00560833|421572|P4|NOT COMPLETED|Overall Study||31
182155|NCT00560833|421573|P3|NOT COMPLETED|Overall Study||39
182156|NCT00560833|421574|P2|NOT COMPLETED|Overall Study||26
182157|NCT00560833|421575|P1|NOT COMPLETED|Overall Study||44
182158|NCT00560833|421571|P5|COMPLETED|Overall Study||114
182159|NCT00560833|421572|P4|COMPLETED|Overall Study||124
182160|NCT00560833|421573|P3|COMPLETED|Overall Study||121
182161|NCT00560833|421574|P2|COMPLETED|Overall Study||129
182162|NCT00560833|421575|P1|COMPLETED|Overall Study||273
182163|NCT00560833|421571|P5|Treated|Overall Study|One participant was randomized but not treated|155
182164|NCT00560833|421572|P4|Treated|Overall Study||155
182165|NCT00560833|421573|P3|Treated|Overall Study||160
182166|NCT00560833|421574|P2|Treated|Overall Study|One participant was randomized but not treated|154
182167|NCT00560833|421575|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
182168|NCT00560833|421571|P5|STARTED|Overall Study||156
182169|NCT00560833|421572|P4|STARTED|Overall Study||155
182170|NCT00560833|421573|P3|STARTED|Overall Study||160
182171|NCT00560833|421574|P2|STARTED|Overall Study||155
182172|NCT00560833|421575|P1|STARTED|Overall Study||317
182173|NCT00560794|421607|P1|NOT COMPLETED|Overall Study||11
182174|NCT00560794|421607|P1|COMPLETED|Overall Study||10
182175|NCT00560794|421607|P1|Completed 1 Treatment Cycle|Overall Study||20
182176|NCT00560794|421607|P1|STARTED|Overall Study||21
182177|NCT00560703|421626|P2|NOT COMPLETED|Overall Study||6
182178|NCT00560703|421627|P1|NOT COMPLETED|Overall Study||0
182179|NCT00560703|421626|P2|COMPLETED|Overall Study||18
182180|NCT00560703|421627|P1|COMPLETED|Overall Study||46
182181|NCT00560703|421626|P2|STARTED|Overall Study||24
182182|NCT00560703|421627|P1|STARTED|Overall Study||46
182183|NCT00560612|421637|P2|NOT COMPLETED|Overall Study||0
182184|NCT00560612|421638|P1|NOT COMPLETED|Overall Study||0
182185|NCT00560612|421637|P2|COMPLETED|Overall Study||7
182186|NCT00560612|421638|P1|COMPLETED|Overall Study||5
182187|NCT00560612|421637|P2|STARTED|Overall Study||7
182188|NCT00560612|421638|P1|STARTED|Overall Study||5
182189|NCT00560573|421644|P6|NOT COMPLETED|Overall Study||13
182190|NCT00560573|421645|P5|NOT COMPLETED|Overall Study||7
182191|NCT00560573|421646|P4|NOT COMPLETED|Overall Study||10
182192|NCT00560573|421647|P3|NOT COMPLETED|Overall Study||6
182193|NCT00560573|421648|P2|NOT COMPLETED|Overall Study||3
182194|NCT00560573|421649|P1|NOT COMPLETED|Overall Study||6
182195|NCT00560573|421644|P6|COMPLETED|Overall Study||0
182196|NCT00560573|421645|P5|COMPLETED|Overall Study||1
182197|NCT00560573|421646|P4|COMPLETED|Overall Study||0
182198|NCT00560573|421647|P3|COMPLETED|Overall Study||0
182199|NCT00560573|421648|P2|COMPLETED|Overall Study||0
182200|NCT00560573|421649|P1|COMPLETED|Overall Study||0
182201|NCT00560573|421644|P6|Treated|Overall Study||13
182202|NCT00560573|421645|P5|Treated|Overall Study||7
182203|NCT00560573|421646|P4|Treated|Overall Study||10
182204|NCT00560573|421647|P3|Treated|Overall Study||6
182205|NCT00560573|421648|P2|Treated|Overall Study||3
182206|NCT00560573|421649|P1|Treated|Overall Study||6
182207|NCT00560573|421644|P6|STARTED|Overall Study||13
182208|NCT00560573|421645|P5|STARTED|Overall Study||8
182209|NCT00560573|421646|P4|STARTED|Overall Study||10
182210|NCT00560573|421647|P3|STARTED|Overall Study||6
182211|NCT00560573|421648|P2|STARTED|Overall Study||3
182212|NCT00560573|421649|P1|STARTED|Overall Study||6
182213|NCT00560560|421703|P2|NOT COMPLETED|Overall Study||83
182214|NCT00560560|421704|P1|NOT COMPLETED|Overall Study||85
182215|NCT00560560|421703|P2|COMPLETED|Overall Study||0
182216|NCT00560560|421704|P1|COMPLETED|Overall Study||0
182217|NCT00560560|421703|P2|STARTED|Overall Study||83
182218|NCT00560560|421704|P1|STARTED|Overall Study||85
182219|NCT00560508|421726|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
182220|NCT00560508|421727|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
182221|NCT00560508|421726|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
182222|NCT00560508|421727|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
182223|NCT00560508|421726|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
182224|NCT00560508|421727|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
182225|NCT00560508|421726|P2|NOT COMPLETED|12 Week Double-blind Period||3
182226|NCT00560508|421727|P1|NOT COMPLETED|12 Week Double-blind Period||5
182227|NCT00560508|421726|P2|COMPLETED|12 Week Double-blind Period||53
182228|NCT00560508|421727|P1|COMPLETED|12 Week Double-blind Period||51
182229|NCT00560508|421726|P2|STARTED|12 Week Double-blind Period||56
182230|NCT00560508|421727|P1|STARTED|12 Week Double-blind Period||56
182231|NCT00560417|421786|P2|NOT COMPLETED|Overall Study||17
182232|NCT00560417|421787|P1|NOT COMPLETED|Overall Study||17
182233|NCT00560417|421786|P2|COMPLETED|Overall Study||151
182234|NCT00560417|421787|P1|COMPLETED|Overall Study||154
182235|NCT00560417|421786|P2|Intention to Treat (ITT) Population|Overall Study||167
182236|NCT00560417|421787|P1|Intention to Treat (ITT) Population|Overall Study||170
182237|NCT00560417|421786|P2|STARTED|Overall Study||168
182238|NCT00560417|421787|P1|STARTED|Overall Study||171
182239|NCT00560404|421815|P2|NOT COMPLETED|Overall Study||21
182240|NCT00560404|421816|P1|NOT COMPLETED|Overall Study||36
182241|NCT00560404|421815|P2|COMPLETED|Overall Study||100
182242|NCT00560404|421816|P1|COMPLETED|Overall Study||76
182243|NCT00560404|421815|P2|STARTED|Overall Study||121
182244|NCT00560404|421816|P1|STARTED|Overall Study||112
182245|NCT00560391|421863|P5|NOT COMPLETED|Overall Study||2
182246|NCT00560391|421864|P4|NOT COMPLETED|Overall Study||1
182247|NCT00560391|421865|P3|NOT COMPLETED|Overall Study||0
182248|NCT00560391|421866|P2|NOT COMPLETED|Overall Study||0
182249|NCT00560391|421867|P1|NOT COMPLETED|Overall Study||0
182250|NCT00560391|421863|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
182251|NCT00560391|421864|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
182252|NCT00560391|421865|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
182253|NCT00560391|421866|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
182254|NCT00560391|421867|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
182255|NCT00560391|421863|P5|STARTED|Overall Study|Participants who received treatment|17
182256|NCT00560391|421864|P4|STARTED|Overall Study|Participants who received treatment|6
182257|NCT00560391|421865|P3|STARTED|Overall Study|Participants who received treatment|3
182258|NCT00560391|421866|P2|STARTED|Overall Study|Participants who received treatment|3
182259|NCT00560391|421867|P1|STARTED|Overall Study|Participants who received treatment|6
182260|NCT00560352|421923|P3|NOT COMPLETED|Overall Study||4
182261|NCT00560352|421924|P2|NOT COMPLETED|Overall Study||3
182262|NCT00560352|421925|P1|NOT COMPLETED|Overall Study||7
182263|NCT00560352|421923|P3|COMPLETED|Overall Study||0
182264|NCT00560352|421924|P2|COMPLETED|Overall Study||0
182265|NCT00560352|421925|P1|COMPLETED|Overall Study||0
182266|NCT00560352|421923|P3|STARTED|Overall Study||4
182267|NCT00560352|421924|P2|STARTED|Overall Study||3
182268|NCT00560352|421925|P1|STARTED|Overall Study||7
182269|NCT00560313|421942|P1|NOT COMPLETED|Overall Study||6
182270|NCT00560313|421942|P1|COMPLETED|Overall Study||48
182271|NCT00560313|421942|P1|STARTED|Overall Study||54
182272|NCT00560235|421969|P3|NOT COMPLETED|Phase 2||97
182273|NCT00560235|421970|P2|NOT COMPLETED|Phase 2||0
182274|NCT00560235|421971|P1|NOT COMPLETED|Phase 2||0
182275|NCT00560235|421969|P3|COMPLETED|Phase 2||10
182276|NCT00560235|421970|P2|COMPLETED|Phase 2||0
182277|NCT00560235|421971|P1|COMPLETED|Phase 2||0
182278|NCT00560235|421969|P3|STARTED|Phase 2||107
182279|NCT00560235|421970|P2|STARTED|Phase 2||0
182280|NCT00560235|421971|P1|STARTED|Phase 2||0
182281|NCT00560235|421969|P3|NOT COMPLETED|Phase 1B||0
182282|NCT00560235|421970|P2|NOT COMPLETED|Phase 1B||19
182283|NCT00560235|421971|P1|NOT COMPLETED|Phase 1B||0
182284|NCT00560235|421969|P3|COMPLETED|Phase 1B||0
182285|NCT00560235|421970|P2|COMPLETED|Phase 1B||2
182286|NCT00560235|421971|P1|COMPLETED|Phase 1B||0
182287|NCT00560235|421969|P3|STARTED|Phase 1B||0
182288|NCT00560235|421970|P2|STARTED|Phase 1B||21
182289|NCT00560235|421971|P1|STARTED|Phase 1B||0
182290|NCT00560235|421969|P3|NOT COMPLETED|Phase 1||0
182291|NCT00560235|421970|P2|NOT COMPLETED|Phase 1||0
182292|NCT00560235|421971|P1|NOT COMPLETED|Phase 1||8
182293|NCT00560235|421969|P3|COMPLETED|Phase 1||0
182294|NCT00560235|421970|P2|COMPLETED|Phase 1||0
182295|NCT00560235|421971|P1|COMPLETED|Phase 1||2
182296|NCT00560235|421969|P3|STARTED|Phase 1||0
182297|NCT00560235|421970|P2|STARTED|Phase 1||0
182298|NCT00560235|421971|P1|STARTED|Phase 1||10
182299|NCT00560105|422002|P2|NOT COMPLETED|Overall Study||2
182300|NCT00560105|422003|P1|NOT COMPLETED|Overall Study||1
182301|NCT00560105|422002|P2|COMPLETED|Overall Study||18
182302|NCT00560105|422003|P1|COMPLETED|Overall Study||19
182303|NCT00560105|422002|P2|STARTED|Overall Study||20
182304|NCT00560105|422003|P1|STARTED|Overall Study||20
182305|NCT00560066|422017|P2|NOT COMPLETED|Overall Study||22
182306|NCT00560066|422018|P1|NOT COMPLETED|Overall Study||6
182307|NCT00560066|422017|P2|COMPLETED|Overall Study||980
182308|NCT00560066|422018|P1|COMPLETED|Overall Study||390
182309|NCT00560066|422017|P2|STARTED|Overall Study||1002
182310|NCT00560066|422018|P1|STARTED|Overall Study||396
182311|NCT00559988|422050|P2|NOT COMPLETED|Overall Study||352
182312|NCT00559988|422051|P1|NOT COMPLETED|Overall Study||351
182313|NCT00559988|422050|P2|COMPLETED|Overall Study||1009
182314|NCT00559988|422051|P1|COMPLETED|Overall Study||1006
182315|NCT00559988|422050|P2|STARTED|Overall Study||1361
182316|NCT00559988|422051|P1|STARTED|Overall Study||1357
182317|NCT00559962|422065|P8|NOT COMPLETED|Overall Study||4
182318|NCT00559962|422066|P7|NOT COMPLETED|Overall Study||5
182319|NCT00559962|422067|P6|NOT COMPLETED|Overall Study||5
182320|NCT00559962|422068|P5|NOT COMPLETED|Overall Study||14
182321|NCT00559962|422069|P4|NOT COMPLETED|Overall Study||5
182322|NCT00559962|422070|P3|NOT COMPLETED|Overall Study||10
182323|NCT00559962|422071|P2|NOT COMPLETED|Overall Study||9
182324|NCT00559962|422072|P1|NOT COMPLETED|Overall Study||2
182325|NCT00559962|422065|P8|COMPLETED|Overall Study||25
182326|NCT00559962|422066|P7|COMPLETED|Overall Study||28
182327|NCT00559962|422067|P6|COMPLETED|Overall Study||23
182328|NCT00559962|422068|P5|COMPLETED|Overall Study||21
182329|NCT00559962|422069|P4|COMPLETED|Overall Study||29
182330|NCT00559962|422070|P3|COMPLETED|Overall Study||24
182331|NCT00559962|422071|P2|COMPLETED|Overall Study||25
182332|NCT00559962|422072|P1|COMPLETED|Overall Study||31
182333|NCT00559962|422065|P8|STARTED|Overall Study||29
182334|NCT00559962|422066|P7|STARTED|Overall Study||33
182335|NCT00559962|422067|P6|STARTED|Overall Study||28
182336|NCT00559962|422068|P5|STARTED|Overall Study||35
182337|NCT00559962|422069|P4|STARTED|Overall Study||34
182338|NCT00559962|422070|P3|STARTED|Overall Study||34
182339|NCT00559962|422071|P2|STARTED|Overall Study||34
182340|NCT00559962|422072|P1|STARTED|Overall Study||33
182341|NCT00559949|422092|P1|NOT COMPLETED|Overall Study||7
182342|NCT00559949|422092|P1|COMPLETED|Overall Study||32
182343|NCT00559949|422092|P1|STARTED|Overall Study||39
182344|NCT00559936|422099|P1|NOT COMPLETED|Overall Study||4
182345|NCT00559936|422099|P1|COMPLETED|Overall Study||20
182346|NCT00559936|422099|P1|STARTED|Overall Study||24
182347|NCT00559897|422104|P1|NOT COMPLETED|Overall Study||0
182348|NCT00559897|422104|P1|COMPLETED|Overall Study||6
182349|NCT00559897|422104|P1|STARTED|Overall Study||6
182350|NCT00559754|422108|P1|NOT COMPLETED|Overall Study||11
182351|NCT00559754|422108|P1|COMPLETED|Overall Study||61
182352|NCT00559754|422108|P1|STARTED|Overall Study||72
182353|NCT00559637|422132|P1|NOT COMPLETED|Overall Study||54
182354|NCT00559637|422132|P1|COMPLETED|Overall Study||130
182355|NCT00559637|422132|P1|STARTED|Overall Study||184
182356|NCT00559585|422145|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
182357|NCT00559585|422146|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
182358|NCT00559585|422145|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
182359|NCT00559585|422146|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
182360|NCT00559585|422145|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
182361|NCT00559585|422146|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
182362|NCT00559585|422145|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
182363|NCT00559585|422146|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
182364|NCT00559585|422145|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
182365|NCT00559585|422146|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
182366|NCT00559585|422145|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
182367|NCT00559585|422146|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
182368|NCT00559585|422145|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
182369|NCT00559585|422146|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
182370|NCT00559585|422145|P2|COMPLETED|Double Blind ST Period Main Study||676
182371|NCT00559585|422146|P1|COMPLETED|Double Blind ST Period Main Study||693
182372|NCT00559585|422145|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
182373|NCT00559585|422146|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
182374|NCT00559507|422206|P1|NOT COMPLETED|Overall Study||3
182375|NCT00559507|422206|P1|COMPLETED|Overall Study||9
182376|NCT00559507|422206|P1|STARTED|Overall Study||12
182377|NCT00559377|422212|P1|NOT COMPLETED|Overall Study||9
182378|NCT00559377|422212|P1|COMPLETED|Overall Study||7
182379|NCT00559377|422212|P1|STARTED|Overall Study||16
182380|NCT00559364|422222|P2|NOT COMPLETED|Overall Study||0
182381|NCT00559364|422223|P1|NOT COMPLETED|Overall Study||1
182382|NCT00559364|422222|P2|COMPLETED|Overall Study||20
182383|NCT00559364|422223|P1|COMPLETED|Overall Study||29
182384|NCT00559364|422222|P2|STARTED|Overall Study||20
182385|NCT00559364|422223|P1|STARTED|Overall Study||30
182386|NCT00559273|422235|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
182387|NCT00559273|422236|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
182388|NCT00559273|422235|P2|COMPLETED|Evaluation Period (8 Weeks)||137
182389|NCT00559273|422236|P1|COMPLETED|Evaluation Period (8 Weeks)||141
182390|NCT00559273|422235|P2|STARTED|Evaluation Period (8 Weeks)||142
182391|NCT00559273|422236|P1|STARTED|Evaluation Period (8 Weeks)||144
182392|NCT00559273|422235|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
182393|NCT00559273|422236|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
182394|NCT00559273|422235|P2|COMPLETED|Correction Period (20 Weeks)||142
182395|NCT00559273|422236|P1|COMPLETED|Correction Period (20 Weeks)||144
182396|NCT00559273|422235|P2|Treated|Correction Period (20 Weeks)||154
182397|NCT00559273|422236|P1|Treated|Correction Period (20 Weeks)||151
182398|NCT00559273|422235|P2|STARTED|Correction Period (20 Weeks)||154
182399|NCT00559273|422236|P1|STARTED|Correction Period (20 Weeks)||153
182400|NCT00559104|422258|P2|NOT COMPLETED|Overall Study||0
182401|NCT00559104|422259|P1|NOT COMPLETED|Overall Study||9
182402|NCT00559104|422258|P2|COMPLETED|Overall Study||5
182403|NCT00559104|422259|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
182404|NCT00559104|422258|P2|STARTED|Overall Study||5
182405|NCT00559104|422259|P1|STARTED|Overall Study||55
182406|NCT00559013|422269|P1|NOT COMPLETED|Overall Study||0
182407|NCT00559013|422269|P1|COMPLETED|Overall Study||38
182408|NCT00559013|422269|P1|STARTED|Overall Study||38
182409|NCT00558896|422280|P7|NOT COMPLETED|Overall Study||24
182410|NCT00558896|422281|P6|NOT COMPLETED|Overall Study||52
182411|NCT00558896|422282|P5|NOT COMPLETED|Overall Study||23
182412|NCT00558896|422283|P4|NOT COMPLETED|Overall Study||12
182413|NCT00558896|422284|P3|NOT COMPLETED|Overall Study||5
182414|NCT00558896|422285|P2|NOT COMPLETED|Overall Study||7
182415|NCT00558896|422286|P1|NOT COMPLETED|Overall Study||21
182416|NCT00558896|422280|P7|COMPLETED|Overall Study||9
182417|NCT00558896|422281|P6|COMPLETED|Overall Study||68
182418|NCT00558896|422282|P5|COMPLETED|Overall Study||37
182419|NCT00558896|422283|P4|COMPLETED|Overall Study||23
182420|NCT00558896|422284|P3|COMPLETED|Overall Study||30
182421|NCT00558896|422285|P2|COMPLETED|Overall Study||27
182422|NCT00558896|422286|P1|COMPLETED|Overall Study||39
182423|NCT00558896|422280|P7|STARTED|Overall Study||33
182424|NCT00558896|422281|P6|STARTED|Overall Study||120
182425|NCT00558896|422282|P5|STARTED|Overall Study||60
182426|NCT00558896|422283|P4|STARTED|Overall Study||35
182427|NCT00558896|422284|P3|STARTED|Overall Study||35
182428|NCT00558896|422285|P2|STARTED|Overall Study||34
182429|NCT00558896|422286|P1|STARTED|Overall Study||60
182430|NCT00558870|422318|P2|NOT COMPLETED|Overall Study||0
182431|NCT00558870|422319|P1|NOT COMPLETED|Overall Study||0
182432|NCT00558870|422318|P2|COMPLETED|Overall Study||2
182433|NCT00558870|422319|P1|COMPLETED|Overall Study||2
182434|NCT00558870|422318|P2|STARTED|Overall Study||2
182435|NCT00558870|422319|P1|STARTED|Overall Study||2
182436|NCT00558831|422327|P1|NOT COMPLETED|Overall Study||1
182437|NCT00558831|422327|P1|COMPLETED|Overall Study||10
182438|NCT00558831|422327|P1|STARTED|Overall Study||11
182439|NCT00558792|422336|P3|NOT COMPLETED|Overall Study||0
182440|NCT00558792|422337|P2|NOT COMPLETED|Overall Study||0
182441|NCT00558792|422338|P1|NOT COMPLETED|Overall Study||0
182442|NCT00558792|422336|P3|COMPLETED|Overall Study||60
182443|NCT00558792|422337|P2|COMPLETED|Overall Study||63
182444|NCT00558792|422338|P1|COMPLETED|Overall Study||68
182445|NCT00558792|422336|P3|STARTED|Overall Study||60
182446|NCT00558792|422337|P2|STARTED|Overall Study||63
182447|NCT00558792|422338|P1|STARTED|Overall Study||68
182448|NCT00558753|422384|P2|NOT COMPLETED|Overall Study||7
182449|NCT00558753|422385|P1|NOT COMPLETED|Overall Study||5
182450|NCT00558753|422384|P2|COMPLETED|Overall Study||113
182451|NCT00558753|422385|P1|COMPLETED|Overall Study||115
182452|NCT00558753|422384|P2|STARTED|Overall Study||120
182453|NCT00558753|422385|P1|STARTED|Overall Study||120
182454|NCT00558701|422397|P2|NOT COMPLETED|Overall Study||4
182455|NCT00558701|422398|P1|NOT COMPLETED|Overall Study||1
182456|NCT00558701|422397|P2|COMPLETED|Overall Study||11
182457|NCT00558701|422398|P1|COMPLETED|Overall Study||14
182458|NCT00558701|422397|P2|STARTED|Overall Study||15
182459|NCT00558701|422398|P1|STARTED|Overall Study||15
182460|NCT00558636|422406|P2|NOT COMPLETED|Follow-up||7
182461|NCT00558636|422407|P1|NOT COMPLETED|Follow-up||12
182462|NCT00558636|422406|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
182463|NCT00558636|422407|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
182464|NCT00558636|422406|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
182465|NCT00558636|422407|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
182466|NCT00558636|422406|P2|NOT COMPLETED|Treatment||44
182467|NCT00558636|422407|P1|NOT COMPLETED|Treatment||47
182468|NCT00558636|422406|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
182469|NCT00558636|422407|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
182470|NCT00558636|422406|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
182471|NCT00558636|422407|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
182472|NCT00558636|422406|P2|STARTED|Treatment||44
182473|NCT00558636|422407|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
182474|NCT00558571|422429|P4|NOT COMPLETED|Overall Study||0
182475|NCT00558571|422430|P3|NOT COMPLETED|Overall Study||0
182476|NCT00558571|422431|P2|NOT COMPLETED|Overall Study||0
182477|NCT00558571|422432|P1|NOT COMPLETED|Overall Study||0
182478|NCT00558571|422429|P4|COMPLETED|Overall Study||30
182479|NCT00558571|422430|P3|COMPLETED|Overall Study||16
182480|NCT00558571|422431|P2|COMPLETED|Overall Study||16
182481|NCT00558571|422432|P1|COMPLETED|Overall Study||16
182482|NCT00558571|422429|P4|STARTED|Overall Study||30
182483|NCT00558571|422430|P3|STARTED|Overall Study||16
182484|NCT00558571|422431|P2|STARTED|Overall Study||16
182485|NCT00558571|422432|P1|STARTED|Overall Study||16
182486|NCT00558558|422507|P1|NOT COMPLETED|Overall Study||6
182487|NCT00558558|422507|P1|COMPLETED|Overall Study||0
182488|NCT00558558|422507|P1|STARTED|Overall Study||6
182489|NCT00558467|422513|P2|NOT COMPLETED|Overall Study||4
182490|NCT00558467|422514|P1|NOT COMPLETED|Overall Study||1
182491|NCT00558467|422513|P2|COMPLETED|Overall Study||39
182492|NCT00558467|422514|P1|COMPLETED|Overall Study||19
182493|NCT00558467|422513|P2|STARTED|Overall Study||43
182494|NCT00558467|422514|P1|STARTED|Overall Study||20
182495|NCT00558428|422574|P4|NOT COMPLETED|Overall Study||11
182496|NCT00558428|422575|P3|NOT COMPLETED|Overall Study||4
182497|NCT00558428|422576|P2|NOT COMPLETED|Overall Study||24
182498|NCT00558428|422577|P1|NOT COMPLETED|Overall Study||12
182499|NCT00558428|422574|P4|COMPLETED|Overall Study||266
182500|NCT00558428|422575|P3|COMPLETED|Overall Study||273
182501|NCT00558428|422576|P2|COMPLETED|Overall Study||252
182502|NCT00558428|422577|P1|COMPLETED|Overall Study||255
182503|NCT00558428|422574|P4|STARTED|Overall Study||277
182504|NCT00558428|422575|P3|STARTED|Overall Study||277
182505|NCT00558428|422576|P2|STARTED|Overall Study||276
182506|NCT00558428|422577|P1|STARTED|Overall Study||267
182507|NCT00558363|422617|P2|NOT COMPLETED|Overall Study||36
182508|NCT00558363|422618|P1|NOT COMPLETED|Overall Study||71
182509|NCT00558363|422617|P2|COMPLETED|Overall Study||111
182510|NCT00558363|422618|P1|COMPLETED|Overall Study||76
182511|NCT00558363|422617|P2|STARTED|Overall Study||147
182512|NCT00558363|422618|P1|STARTED|Overall Study||147
182513|NCT00558285|422673|P5|NOT COMPLETED|Overall Study||4
182514|NCT00558285|422674|P4|NOT COMPLETED|Overall Study||4
182515|NCT00558285|422675|P3|NOT COMPLETED|Overall Study||5
182516|NCT00558285|422676|P2|NOT COMPLETED|Overall Study||3
182517|NCT00558285|422677|P1|NOT COMPLETED|Overall Study||6
182518|NCT00558285|422673|P5|COMPLETED|Overall Study||49
182519|NCT00558285|422674|P4|COMPLETED|Overall Study||48
182520|NCT00558285|422675|P3|COMPLETED|Overall Study||46
182521|NCT00558285|422676|P2|COMPLETED|Overall Study||48
182522|NCT00558285|422677|P1|COMPLETED|Overall Study||44
182523|NCT00558285|422673|P5|Safety: Received Study Drug|Overall Study||53
182524|NCT00558285|422674|P4|Safety: Received Study Drug|Overall Study||51
182525|NCT00558285|422675|P3|Safety: Received Study Drug|Overall Study||51
182526|NCT00558285|422676|P2|Safety: Received Study Drug|Overall Study||51
182527|NCT00558285|422677|P1|Safety: Received Study Drug|Overall Study||49
182528|NCT00558285|422673|P5|STARTED|Overall Study||53
182529|NCT00558285|422674|P4|STARTED|Overall Study||52
182530|NCT00558285|422675|P3|STARTED|Overall Study||51
182531|NCT00558285|422676|P2|STARTED|Overall Study||51
182532|NCT00558285|422677|P1|STARTED|Overall Study||50
182533|NCT00558272|422721|P2|NOT COMPLETED|Overall Study||2
182534|NCT00558272|422722|P1|NOT COMPLETED|Overall Study||13
182535|NCT00558272|422721|P2|COMPLETED|Overall Study|4-week treatment period|68
182536|NCT00558272|422722|P1|COMPLETED|Overall Study|4-week treatment period|56
182537|NCT00558272|422721|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
182538|NCT00558272|422722|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
182539|NCT00558272|422721|P2|STARTED|Overall Study|Randomised|70
182540|NCT00558272|422722|P1|STARTED|Overall Study|Randomised|69
182541|NCT00558259|422762|P2|NOT COMPLETED|Overall Study||99
182542|NCT00558259|422763|P1|NOT COMPLETED|Overall Study||71
182543|NCT00558259|422762|P2|COMPLETED|Overall Study|Completed treatment.|563
182544|NCT00558259|422763|P1|COMPLETED|Overall Study|Completed treatment.|610
182545|NCT00558259|422762|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
182546|NCT00558259|422763|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
182547|NCT00558246|422783|P1|NOT COMPLETED|Overall Study||0
182548|NCT00558246|422783|P1|COMPLETED|Overall Study||79
182549|NCT00558246|422783|P1|STARTED|Overall Study||79
182550|NCT00558103|422803|P6|NOT COMPLETED|Monotherapy Extension Phase||9
182551|NCT00558103|422804|P5|NOT COMPLETED|Monotherapy Extension Phase||0
182552|NCT00558103|422805|P4|NOT COMPLETED|Monotherapy Extension Phase||0
182553|NCT00558103|422806|P3|NOT COMPLETED|Monotherapy Extension Phase||0
182554|NCT00558103|422807|P2|NOT COMPLETED|Monotherapy Extension Phase||0
182555|NCT00558103|422808|P1|NOT COMPLETED|Monotherapy Extension Phase||0
182556|NCT00558103|422803|P6|COMPLETED|Monotherapy Extension Phase||0
182557|NCT00558103|422804|P5|COMPLETED|Monotherapy Extension Phase||0
182558|NCT00558103|422805|P4|COMPLETED|Monotherapy Extension Phase||0
182559|NCT00558103|422806|P3|COMPLETED|Monotherapy Extension Phase||0
182560|NCT00558103|422807|P2|COMPLETED|Monotherapy Extension Phase||0
182561|NCT00558103|422808|P1|COMPLETED|Monotherapy Extension Phase||0
182562|NCT00558103|422803|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
182563|NCT00558103|422804|P5|STARTED|Monotherapy Extension Phase||0
182564|NCT00558103|422805|P4|STARTED|Monotherapy Extension Phase||0
182565|NCT00558103|422806|P3|STARTED|Monotherapy Extension Phase||0
182566|NCT00558103|422807|P2|STARTED|Monotherapy Extension Phase||0
182567|NCT00558103|422808|P1|STARTED|Monotherapy Extension Phase||0
182568|NCT00558103|422803|P6|NOT COMPLETED|Randomized Treatment Phase||0
182569|NCT00558103|422804|P5|NOT COMPLETED|Randomized Treatment Phase||5
182570|NCT00558103|422805|P4|NOT COMPLETED|Randomized Treatment Phase||2
182571|NCT00558103|422806|P3|NOT COMPLETED|Randomized Treatment Phase||3
182572|NCT00558103|422807|P2|NOT COMPLETED|Randomized Treatment Phase||4
182573|NCT00558103|422808|P1|NOT COMPLETED|Randomized Treatment Phase||5
182574|NCT00558103|422803|P6|COMPLETED|Randomized Treatment Phase||0
182575|NCT00558103|422804|P5|COMPLETED|Randomized Treatment Phase||33
182576|NCT00558103|422805|P4|COMPLETED|Randomized Treatment Phase||11
182577|NCT00558103|422806|P3|COMPLETED|Randomized Treatment Phase||33
182578|NCT00558103|422807|P2|COMPLETED|Randomized Treatment Phase||34
182579|NCT00558103|422808|P1|COMPLETED|Randomized Treatment Phase||33
182580|NCT00558103|422803|P6|STARTED|Randomized Treatment Phase||0
182581|NCT00558103|422804|P5|STARTED|Randomized Treatment Phase||38
182582|NCT00558103|422805|P4|STARTED|Randomized Treatment Phase||13
182583|NCT00558103|422806|P3|STARTED|Randomized Treatment Phase||36
182584|NCT00558103|422807|P2|STARTED|Randomized Treatment Phase||38
182585|NCT00558103|422808|P1|STARTED|Randomized Treatment Phase||38
182586|NCT00558064|422838|P2|NOT COMPLETED|Overall Study||5
182587|NCT00558064|422839|P1|NOT COMPLETED|Overall Study||5
182588|NCT00558064|422838|P2|COMPLETED|Overall Study||257
182589|NCT00558064|422839|P1|COMPLETED|Overall Study||264
182590|NCT00558064|422838|P2|STARTED|Overall Study||262
182591|NCT00558064|422839|P1|STARTED|Overall Study||269
182592|NCT00558025|422861|P2|NOT COMPLETED|Overall Study||3
182593|NCT00558025|422862|P1|NOT COMPLETED|Overall Study||4
182594|NCT00558025|422861|P2|COMPLETED|Overall Study||49
182595|NCT00558025|422862|P1|COMPLETED|Overall Study||100
182596|NCT00558025|422861|P2|STARTED|Overall Study||52
182597|NCT00558025|422862|P1|STARTED|Overall Study||104
182598|NCT00558012|422886|P2|NOT COMPLETED|Overall Study||18
182599|NCT00558012|422887|P1|NOT COMPLETED|Overall Study||25
182600|NCT00558012|422886|P2|COMPLETED|Overall Study||74
182601|NCT00558012|422887|P1|COMPLETED|Overall Study||64
182602|NCT00558012|422886|P2|STARTED|Overall Study||92
182603|NCT00558012|422887|P1|STARTED|Overall Study||89
182604|NCT00557947|422893|P1|NOT COMPLETED|Overall Study||0
182605|NCT00557947|422893|P1|COMPLETED|Overall Study||83
182606|NCT00557947|422893|P1|STARTED|Overall Study||83
182607|NCT00557856|422909|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
182608|NCT00557856|422910|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
182609|NCT00557856|422911|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
182610|NCT00557856|422912|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
182611|NCT00557856|422913|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
182612|NCT00557856|422914|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
182613|NCT00557856|422915|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
182614|NCT00557856|422916|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
182615|NCT00557856|422917|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
182616|NCT00557856|422909|P9|COMPLETED|Part 2: Exploratory Phase||0
182617|NCT00557856|422910|P8|COMPLETED|Part 2: Exploratory Phase||0
182618|NCT00557856|422911|P7|COMPLETED|Part 2: Exploratory Phase||0
182619|NCT00557856|422912|P6|COMPLETED|Part 2: Exploratory Phase||0
182620|NCT00557856|422913|P5|COMPLETED|Part 2: Exploratory Phase||0
182621|NCT00557856|422914|P4|COMPLETED|Part 2: Exploratory Phase||0
182622|NCT00557856|422915|P3|COMPLETED|Part 2: Exploratory Phase||0
182623|NCT00557856|422916|P2|COMPLETED|Part 2: Exploratory Phase||0
182624|NCT00557856|422917|P1|COMPLETED|Part 2: Exploratory Phase||0
182625|NCT00557856|422909|P9|STARTED|Part 2: Exploratory Phase||24
182626|NCT00557856|422910|P8|STARTED|Part 2: Exploratory Phase||0
182627|NCT00557856|422911|P7|STARTED|Part 2: Exploratory Phase||0
182628|NCT00557856|422912|P6|STARTED|Part 2: Exploratory Phase||0
182629|NCT00557856|422913|P5|STARTED|Part 2: Exploratory Phase||0
182630|NCT00557856|422914|P4|STARTED|Part 2: Exploratory Phase||0
182631|NCT00557856|422915|P3|STARTED|Part 2: Exploratory Phase||0
182632|NCT00557856|422916|P2|STARTED|Part 2: Exploratory Phase||0
182633|NCT00557856|422917|P1|STARTED|Part 2: Exploratory Phase||0
182634|NCT00557856|422909|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
182635|NCT00557856|422910|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
182636|NCT00557856|422911|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
182637|NCT00557856|422912|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
182638|NCT00557856|422913|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
182639|NCT00557856|422914|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
182640|NCT00557856|422915|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
182641|NCT00557856|422916|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
182642|NCT00557856|422917|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
182643|NCT00557856|422909|P9|COMPLETED|Part 1: Dose Escalation Phase||0
182644|NCT00557856|422910|P8|COMPLETED|Part 1: Dose Escalation Phase||0
182645|NCT00557856|422911|P7|COMPLETED|Part 1: Dose Escalation Phase||0
182646|NCT00557856|422912|P6|COMPLETED|Part 1: Dose Escalation Phase||0
182647|NCT00557856|422913|P5|COMPLETED|Part 1: Dose Escalation Phase||0
182648|NCT00557856|422914|P4|COMPLETED|Part 1: Dose Escalation Phase||0
182649|NCT00557856|422915|P3|COMPLETED|Part 1: Dose Escalation Phase||0
182650|NCT00557856|422916|P2|COMPLETED|Part 1: Dose Escalation Phase||0
182651|NCT00557856|422917|P1|COMPLETED|Part 1: Dose Escalation Phase||0
182652|NCT00557856|422909|P9|Treated|Part 1: Dose Escalation Phase||0
182653|NCT00557856|422910|P8|Treated|Part 1: Dose Escalation Phase||6
182654|NCT00557856|422911|P7|Treated|Part 1: Dose Escalation Phase||7
182655|NCT00557856|422912|P6|Treated|Part 1: Dose Escalation Phase||8
182656|NCT00557856|422913|P5|Treated|Part 1: Dose Escalation Phase||4
182657|NCT00557856|422914|P4|Treated|Part 1: Dose Escalation Phase||3
182658|NCT00557856|422915|P3|Treated|Part 1: Dose Escalation Phase||6
182659|NCT00557856|422916|P2|Treated|Part 1: Dose Escalation Phase||5
182660|NCT00557856|422917|P1|Treated|Part 1: Dose Escalation Phase||5
182661|NCT00557856|422909|P9|STARTED|Part 1: Dose Escalation Phase||0
182662|NCT00557856|422910|P8|STARTED|Part 1: Dose Escalation Phase||6
182663|NCT00557856|422911|P7|STARTED|Part 1: Dose Escalation Phase||7
182664|NCT00557856|422912|P6|STARTED|Part 1: Dose Escalation Phase||8
182665|NCT00557856|422913|P5|STARTED|Part 1: Dose Escalation Phase||4
182666|NCT00557856|422914|P4|STARTED|Part 1: Dose Escalation Phase||3
182667|NCT00557856|422915|P3|STARTED|Part 1: Dose Escalation Phase||6
182668|NCT00557856|422916|P2|STARTED|Part 1: Dose Escalation Phase||5
182669|NCT00557856|422917|P1|STARTED|Part 1: Dose Escalation Phase||7
182670|NCT00557830|423116|P3|NOT COMPLETED|Treatment Phase||0
182671|NCT00557830|423117|P2|NOT COMPLETED|Treatment Phase||0
182672|NCT00557830|423118|P1|NOT COMPLETED|Treatment Phase||0
182673|NCT00557830|423116|P3|COMPLETED|Treatment Phase||2
182674|NCT00557830|423117|P2|COMPLETED|Treatment Phase||4
182675|NCT00557830|423118|P1|COMPLETED|Treatment Phase||0
182676|NCT00557830|423116|P3|STARTED|Treatment Phase||2
182677|NCT00557830|423117|P2|STARTED|Treatment Phase||4
182678|NCT00557830|423118|P1|STARTED|Treatment Phase||0
182679|NCT00557830|423116|P3|NOT COMPLETED|Screening Treatment Phase||0
182680|NCT00557830|423117|P2|NOT COMPLETED|Screening Treatment Phase||0
182681|NCT00557830|423118|P1|NOT COMPLETED|Screening Treatment Phase||6
182682|NCT00557830|423116|P3|COMPLETED|Screening Treatment Phase||0
182683|NCT00557830|423117|P2|COMPLETED|Screening Treatment Phase||0
182684|NCT00557830|423118|P1|COMPLETED|Screening Treatment Phase||6
182685|NCT00557830|423116|P3|STARTED|Screening Treatment Phase||0
182686|NCT00557830|423117|P2|STARTED|Screening Treatment Phase||0
182687|NCT00557830|423118|P1|STARTED|Screening Treatment Phase||12
182688|NCT00557622|423140|P2|NOT COMPLETED|12-Week Treatment Phase||1
182689|NCT00557622|423141|P1|NOT COMPLETED|12-Week Treatment Phase||0
182690|NCT00557622|423140|P2|COMPLETED|12-Week Treatment Phase||1
182691|NCT00557622|423141|P1|COMPLETED|12-Week Treatment Phase||1
182692|NCT00557622|423140|P2|STARTED|12-Week Treatment Phase||2
182693|NCT00557622|423141|P1|STARTED|12-Week Treatment Phase||1
182694|NCT00557622|423140|P2|NOT COMPLETED|4-Week Run-in Phase||0
182695|NCT00557622|423141|P1|NOT COMPLETED|4-Week Run-in Phase||2
182696|NCT00557622|423140|P2|COMPLETED|4-Week Run-in Phase||0
182697|NCT00557622|423141|P1|COMPLETED|4-Week Run-in Phase||3
182698|NCT00557622|423140|P2|STARTED|4-Week Run-in Phase||0
182699|NCT00557622|423141|P1|STARTED|4-Week Run-in Phase||5
182700|NCT00557505|423170|P9|NOT COMPLETED|Overall Study||17
182701|NCT00557505|423171|P8|NOT COMPLETED|Overall Study||5
182702|NCT00557505|423172|P7|NOT COMPLETED|Overall Study||3
182703|NCT00557505|423173|P6|NOT COMPLETED|Overall Study||3
182704|NCT00557505|423174|P5|NOT COMPLETED|Overall Study||2
182705|NCT00557505|423175|P4|NOT COMPLETED|Overall Study||3
182706|NCT00557505|423176|P3|NOT COMPLETED|Overall Study||4
182707|NCT00557505|423177|P2|NOT COMPLETED|Overall Study||3
182708|NCT00557505|423178|P1|NOT COMPLETED|Overall Study||3
182709|NCT00557505|423170|P9|COMPLETED|Overall Study||0
182710|NCT00557505|423171|P8|COMPLETED|Overall Study||0
182711|NCT00557505|423172|P7|COMPLETED|Overall Study||0
182712|NCT00557505|423173|P6|COMPLETED|Overall Study||0
182713|NCT00557505|423174|P5|COMPLETED|Overall Study||0
182714|NCT00557505|423175|P4|COMPLETED|Overall Study||0
182715|NCT00557505|423176|P3|COMPLETED|Overall Study||0
182716|NCT00557505|423177|P2|COMPLETED|Overall Study||0
182717|NCT00557505|423178|P1|COMPLETED|Overall Study||0
182718|NCT00557505|423170|P9|STARTED|Overall Study||17
182719|NCT00557505|423171|P8|STARTED|Overall Study||5
182720|NCT00557505|423172|P7|STARTED|Overall Study||3
182721|NCT00557505|423173|P6|STARTED|Overall Study||3
182722|NCT00557505|423174|P5|STARTED|Overall Study||2
182723|NCT00557505|423175|P4|STARTED|Overall Study||3
182724|NCT00557505|423176|P3|STARTED|Overall Study||4
182725|NCT00557505|423177|P2|STARTED|Overall Study||3
182726|NCT00557505|423178|P1|STARTED|Overall Study||3
182727|NCT00557492|423342|P1|NOT COMPLETED|Overall Study||1
182728|NCT00557492|423342|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
182729|NCT00557492|423342|P1|STARTED|Overall Study||59
182730|NCT00557466|423360|P6|NOT COMPLETED|Overall Study||6
182731|NCT00557466|423361|P5|NOT COMPLETED|Overall Study||3
182732|NCT00557466|423362|P4|NOT COMPLETED|Overall Study||4
182733|NCT00557466|423363|P3|NOT COMPLETED|Overall Study||6
182734|NCT00557466|423364|P2|NOT COMPLETED|Overall Study||5
182735|NCT00557466|423365|P1|NOT COMPLETED|Overall Study||4
182736|NCT00557466|423360|P6|COMPLETED|Overall Study||85
182737|NCT00557466|423361|P5|COMPLETED|Overall Study||87
182738|NCT00557466|423362|P4|COMPLETED|Overall Study||92
182739|NCT00557466|423363|P3|COMPLETED|Overall Study||95
182740|NCT00557466|423364|P2|COMPLETED|Overall Study||87
182741|NCT00557466|423365|P1|COMPLETED|Overall Study||94
182742|NCT00557466|423360|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
182743|NCT00557466|423361|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
182744|NCT00557466|423362|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
182745|NCT00557466|423363|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
182746|NCT00557466|423364|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
182747|NCT00557466|423365|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
182833|NCT00557076|423567|P2|STARTED|Overall Study||8
182748|NCT00557466|423360|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
182749|NCT00557466|423361|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
182750|NCT00557466|423362|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
182751|NCT00557466|423363|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
182752|NCT00557466|423364|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
182753|NCT00557466|423365|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
182754|NCT00557466|423360|P6|STARTED|Overall Study||91
182755|NCT00557466|423361|P5|STARTED|Overall Study||90
182756|NCT00557466|423362|P4|STARTED|Overall Study||96
182757|NCT00557466|423363|P3|STARTED|Overall Study||101
182758|NCT00557466|423364|P2|STARTED|Overall Study||92
182759|NCT00557466|423365|P1|STARTED|Overall Study||98
182760|NCT00557440|423418|P3|NOT COMPLETED|Treatment Period 3||0
182761|NCT00557440|423419|P2|NOT COMPLETED|Treatment Period 3||0
182762|NCT00557440|423420|P1|NOT COMPLETED|Treatment Period 3||0
182763|NCT00557440|423418|P3|COMPLETED|Treatment Period 3||12
182764|NCT00557440|423419|P2|COMPLETED|Treatment Period 3||12
182765|NCT00557440|423420|P1|COMPLETED|Treatment Period 3||12
182766|NCT00557440|423418|P3|STARTED|Treatment Period 3||12
182767|NCT00557440|423419|P2|STARTED|Treatment Period 3||12
182768|NCT00557440|423420|P1|STARTED|Treatment Period 3||12
182769|NCT00557440|423418|P3|NOT COMPLETED|Treatment Period 2||0
182770|NCT00557440|423419|P2|NOT COMPLETED|Treatment Period 2||0
182771|NCT00557440|423420|P1|NOT COMPLETED|Treatment Period 2||0
182772|NCT00557440|423418|P3|COMPLETED|Treatment Period 2||12
182773|NCT00557440|423419|P2|COMPLETED|Treatment Period 2||12
182774|NCT00557440|423420|P1|COMPLETED|Treatment Period 2||12
182775|NCT00557440|423418|P3|STARTED|Treatment Period 2||12
182776|NCT00557440|423419|P2|STARTED|Treatment Period 2||12
182777|NCT00557440|423420|P1|STARTED|Treatment Period 2||12
182778|NCT00557440|423418|P3|NOT COMPLETED|Treatment Period 1||1
182779|NCT00557440|423419|P2|NOT COMPLETED|Treatment Period 1||0
182780|NCT00557440|423420|P1|NOT COMPLETED|Treatment Period 1||0
182781|NCT00557440|423418|P3|COMPLETED|Treatment Period 1||12
182782|NCT00557440|423419|P2|COMPLETED|Treatment Period 1||12
182783|NCT00557440|423420|P1|COMPLETED|Treatment Period 1||12
182784|NCT00557440|423418|P3|STARTED|Treatment Period 1||13
182785|NCT00557440|423419|P2|STARTED|Treatment Period 1||12
182786|NCT00557440|423420|P1|STARTED|Treatment Period 1||12
182787|NCT00557362|423444|P4|NOT COMPLETED|Overall Study||3
182788|NCT00557362|423445|P3|NOT COMPLETED|Overall Study||4
182789|NCT00557362|423446|P2|NOT COMPLETED|Overall Study||2
182790|NCT00557362|423447|P1|NOT COMPLETED|Overall Study||2
182791|NCT00557362|423444|P4|COMPLETED|Overall Study||27
182792|NCT00557362|423445|P3|COMPLETED|Overall Study||26
182793|NCT00557362|423446|P2|COMPLETED|Overall Study||28
182794|NCT00557362|423447|P1|COMPLETED|Overall Study||28
182795|NCT00557362|423444|P4|STARTED|Overall Study||30
182796|NCT00557362|423445|P3|STARTED|Overall Study||30
182797|NCT00557362|423446|P2|STARTED|Overall Study||30
182798|NCT00557362|423447|P1|STARTED|Overall Study||30
182799|NCT00557349|423465|P2|NOT COMPLETED|Overall Study||5
182800|NCT00557349|423466|P1|NOT COMPLETED|Overall Study||5
182801|NCT00557349|423465|P2|COMPLETED|Overall Study||13
182802|NCT00557349|423466|P1|COMPLETED|Overall Study||17
182803|NCT00557349|423465|P2|STARTED|Overall Study||18
182804|NCT00557349|423466|P1|STARTED|Overall Study|omeprazole/bicarb|22
182805|NCT00557323|423474|P1|NOT COMPLETED|Overall Study||7
182806|NCT00557323|423474|P1|COMPLETED|Overall Study||27
182807|NCT00557323|423474|P1|STARTED|Overall Study||34
182808|NCT00557310|423479|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
182809|NCT00557310|423479|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
182810|NCT00557310|423479|P1|STARTED|Extension Phase (18 - 24 Months)||30
182811|NCT00557310|423479|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
182812|NCT00557310|423479|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
182813|NCT00557310|423479|P1|STARTED|Main Study (0 - 18 Months)||35
182814|NCT00557284|423501|P2|NOT COMPLETED|Overall Study||0
182815|NCT00557284|423502|P1|NOT COMPLETED|Overall Study||0
182816|NCT00557284|423501|P2|COMPLETED|Overall Study||11
182817|NCT00557284|423502|P1|COMPLETED|Overall Study||9
182818|NCT00557284|423501|P2|STARTED|Overall Study||11
182819|NCT00557284|423502|P1|STARTED|Overall Study||9
182820|NCT00557245|423525|P3|NOT COMPLETED|Overall Study||12
182821|NCT00557245|423526|P2|NOT COMPLETED|Overall Study||12
182822|NCT00557245|423527|P1|NOT COMPLETED|Overall Study||12
182823|NCT00557245|423525|P3|COMPLETED|Overall Study||1574
182824|NCT00557245|423526|P2|COMPLETED|Overall Study||1571
182825|NCT00557245|423527|P1|COMPLETED|Overall Study||1577
182826|NCT00557245|423525|P3|STARTED|Overall Study||1586
182827|NCT00557245|423526|P2|STARTED|Overall Study||1583
182828|NCT00557245|423527|P1|STARTED|Overall Study||1589
182829|NCT00557076|423567|P2|NOT COMPLETED|Overall Study||1
182830|NCT00557076|423568|P1|NOT COMPLETED|Overall Study||0
182831|NCT00557076|423567|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
182832|NCT00557076|423568|P1|COMPLETED|Overall Study||8
182834|NCT00557076|423568|P1|STARTED|Overall Study||8
182835|NCT00556998|423576|P1|NOT COMPLETED|Voriconazole Oral||2
182836|NCT00556998|423576|P1|COMPLETED|Voriconazole Oral||20
182837|NCT00556998|423576|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
182838|NCT00556998|423576|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
182839|NCT00556998|423576|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
182840|NCT00556998|423576|P1|Treated|Voriconazole Intravenous (IV)||26
182841|NCT00556998|423576|P1|STARTED|Voriconazole Intravenous (IV)||26
182842|NCT00556972|423596|P1|NOT COMPLETED|Overall Study||0
182843|NCT00556972|423596|P1|COMPLETED|Overall Study||4
182844|NCT00556972|423596|P1|STARTED|Overall Study||4
182845|NCT00556946|423603|P1|NOT COMPLETED|Overall Study||1
182846|NCT00556946|423603|P1|COMPLETED|Overall Study||16
182847|NCT00556946|423603|P1|STARTED|Overall Study||17
182848|NCT00556933|423611|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
182849|NCT00556933|423612|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
182850|NCT00556933|423613|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
182851|NCT00556933|423614|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
182852|NCT00556933|423611|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
182853|NCT00556933|423612|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
182854|NCT00556933|423613|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
182855|NCT00556933|423614|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
182856|NCT00556933|423611|P4|STARTED|CNI Withdrawal vs. Minimization||43
182857|NCT00556933|423612|P3|STARTED|CNI Withdrawal vs. Minimization||39
182858|NCT00556933|423613|P2|STARTED|CNI Withdrawal vs. Minimization||37
182859|NCT00556933|423614|P1|STARTED|CNI Withdrawal vs. Minimization||43
182860|NCT00556933|423611|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
182861|NCT00556933|423612|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
182862|NCT00556933|423613|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
182863|NCT00556933|423614|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
182864|NCT00556933|423611|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
182865|NCT00556933|423612|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
182866|NCT00556933|423613|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
182867|NCT00556933|423614|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
182868|NCT00556933|423611|P4|STARTED|Single vs. Divided-dose rATG Induction||45
182869|NCT00556933|423612|P3|STARTED|Single vs. Divided-dose rATG Induction||45
182870|NCT00556933|423613|P2|STARTED|Single vs. Divided-dose rATG Induction||45
182871|NCT00556933|423614|P1|STARTED|Single vs. Divided-dose rATG Induction||45
182872|NCT00556894|423671|P3|NOT COMPLETED|Overall Study||19
182873|NCT00556894|423672|P2|NOT COMPLETED|Overall Study||19
182874|NCT00556894|423673|P1|NOT COMPLETED|Overall Study||16
182875|NCT00556894|423671|P3|COMPLETED|Overall Study||65
182876|NCT00556894|423672|P2|COMPLETED|Overall Study||68
182877|NCT00556894|423673|P1|COMPLETED|Overall Study||66
182878|NCT00556894|423671|P3|STARTED|Overall Study||84
182879|NCT00556894|423672|P2|STARTED|Overall Study||87
182880|NCT00556894|423673|P1|STARTED|Overall Study||82
182881|NCT00556712|423683|P2|NOT COMPLETED|Overall Study||438
182882|NCT00556712|423684|P1|NOT COMPLETED|Overall Study||451
182883|NCT00556712|423683|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
182884|NCT00556712|423684|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
182885|NCT00556712|423683|P2|STARTED|Overall Study||438
182886|NCT00556712|423684|P1|STARTED|Overall Study||451
182887|NCT00556673|423762|P2|NOT COMPLETED|Overall Study||2
182888|NCT00556673|423763|P1|NOT COMPLETED|Overall Study||3
182889|NCT00556673|423762|P2|COMPLETED|Overall Study||13
182890|NCT00556673|423763|P1|COMPLETED|Overall Study||13
182891|NCT00556673|423762|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
182892|NCT00556673|423763|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
182893|NCT00556673|423762|P2|STARTED|Overall Study||15
182894|NCT00556673|423763|P1|STARTED|Overall Study||16
182895|NCT00556543|423799|P1|NOT COMPLETED|Overall Study||0
182896|NCT00556543|423799|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
182897|NCT00556543|423799|P1|STARTED|Overall Study||10
182898|NCT00556504|423817|P2|NOT COMPLETED|Overall Study||9
182899|NCT00556504|423818|P1|NOT COMPLETED|Overall Study||8
182900|NCT00556504|423817|P2|COMPLETED|Overall Study||33
182901|NCT00556504|423818|P1|COMPLETED|Overall Study||34
182902|NCT00556504|423817|P2|Safety Population|Overall Study||42
182903|NCT00556504|423818|P1|Safety Population|Overall Study||41
182904|NCT00556504|423817|P2|Intend-to Treat Population|Overall Study||42
182905|NCT00556504|423818|P1|Intend-to Treat Population|Overall Study||42
182906|NCT00556504|423817|P2|STARTED|Overall Study||42
182907|NCT00556504|423818|P1|STARTED|Overall Study||42
182908|NCT00556491|423838|P2|NOT COMPLETED|Overall Study||1
182909|NCT00556491|423839|P1|NOT COMPLETED|Overall Study||1
182910|NCT00556491|423838|P2|COMPLETED|Overall Study||19
182911|NCT00556491|423839|P1|COMPLETED|Overall Study||19
182912|NCT00556491|423838|P2|STARTED|Overall Study||20
182913|NCT00556491|423839|P1|STARTED|Overall Study|January 2008|20
182914|NCT00556478|423847|P2|NOT COMPLETED|Open-Label Phase||10
182915|NCT00556478|423848|P1|NOT COMPLETED|Open-Label Phase||14
182916|NCT00556478|423847|P2|COMPLETED|Open-Label Phase||67
182917|NCT00556478|423848|P1|COMPLETED|Open-Label Phase||132
182918|NCT00556478|423847|P2|Treated in Open-label|Open-Label Phase||71
182919|NCT00556478|423848|P1|Treated in Open-label|Open-Label Phase||142
182920|NCT00556478|423847|P2|STARTED|Open-Label Phase||77
182921|NCT00556478|423848|P1|STARTED|Open-Label Phase||146
182922|NCT00556478|423847|P2|NOT COMPLETED|Double-blind Phase||8
182923|NCT00556478|423848|P1|NOT COMPLETED|Double-blind Phase||21
182924|NCT00556478|423847|P2|COMPLETED|Double-blind Phase||77
182925|NCT00556478|423848|P1|COMPLETED|Double-blind Phase||150
182926|NCT00556478|423847|P2|ITT|Double-blind Phase||82
182927|NCT00556478|423848|P1|ITT|Double-blind Phase||167
182928|NCT00556478|423847|P2|STARTED|Double-blind Phase||85
182929|NCT00556478|423848|P1|STARTED|Double-blind Phase||171
182930|NCT00556452|423876|P3|NOT COMPLETED|Overall Study||0
182931|NCT00556452|423877|P2|NOT COMPLETED|Overall Study||0
182932|NCT00556452|423878|P1|NOT COMPLETED|Overall Study||0
182933|NCT00556452|423876|P3|COMPLETED|Overall Study||19
182934|NCT00556452|423877|P2|COMPLETED|Overall Study||21
182935|NCT00556452|423878|P1|COMPLETED|Overall Study||6
182936|NCT00556452|423876|P3|STARTED|Overall Study||19
182937|NCT00556452|423877|P2|STARTED|Overall Study||21
182938|NCT00556452|423878|P1|STARTED|Overall Study||6
182939|NCT00556426|423884|P1|NOT COMPLETED|Overall Study||9
182940|NCT00556426|423884|P1|COMPLETED|Overall Study||91
182941|NCT00556426|423884|P1|STARTED|Overall Study||100
182942|NCT00556400|423894|P2|NOT COMPLETED|Overall Study||0
182943|NCT00556400|423895|P1|NOT COMPLETED|Overall Study||0
182944|NCT00556400|423894|P2|COMPLETED|Overall Study||0
182945|NCT00556400|423895|P1|COMPLETED|Overall Study||1
182946|NCT00556400|423894|P2|STARTED|Overall Study||0
182947|NCT00556400|423895|P1|STARTED|Overall Study||1
182948|NCT00556374|423906|P2|NOT COMPLETED|Overall Study||220
182949|NCT00556374|423907|P1|NOT COMPLETED|Overall Study||247
182950|NCT00556374|423906|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
182951|NCT00556374|423907|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
182952|NCT00556374|423906|P2|Received Study Drug|Overall Study||1700
182953|NCT00556374|423907|P1|Received Study Drug|Overall Study||1699
182954|NCT00556374|423906|P2|STARTED|Overall Study||1711
182955|NCT00556374|423907|P1|STARTED|Overall Study||1709
182956|NCT00556322|423925|P2|NOT COMPLETED|Overall Study||203
182957|NCT00556322|423926|P1|NOT COMPLETED|Overall Study||221
182958|NCT00556322|423925|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
182959|NCT00556322|423926|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
182960|NCT00556322|423925|P2|STARTED|Overall Study||203
182961|NCT00556322|423926|P1|STARTED|Overall Study||221
182962|NCT00556166|423974|P1|NOT COMPLETED|Overall Study||1
182963|NCT00556166|423974|P1|COMPLETED|Overall Study||3
182964|NCT00556166|423974|P1|STARTED|Overall Study||4
182965|NCT00556140|423979|P1|NOT COMPLETED|Overall Study||3
182966|NCT00556140|423979|P1|COMPLETED|Overall Study||13
182967|NCT00556140|423979|P1|STARTED|Overall Study||16
182968|NCT00556075|423987|P3|NOT COMPLETED|Overall Study||8
182969|NCT00556075|423988|P2|NOT COMPLETED|Overall Study||9
182970|NCT00556075|423989|P1|NOT COMPLETED|Overall Study||13
182971|NCT00556075|423987|P3|COMPLETED|Overall Study||15
182972|NCT00556075|423988|P2|COMPLETED|Overall Study||13
182973|NCT00556075|423989|P1|COMPLETED|Overall Study||9
182974|NCT00556075|423987|P3|STARTED|Overall Study||23
182975|NCT00556075|423988|P2|STARTED|Overall Study||22
182976|NCT00556075|423989|P1|STARTED|Overall Study||22
182977|NCT00556049|424012|P1|NOT COMPLETED|Overall Study||0
182978|NCT00556049|424012|P1|COMPLETED|Overall Study||72
182979|NCT00556049|424012|P1|STARTED|Overall Study||72
182980|NCT00555997|424019|P4|NOT COMPLETED|Phase 2 SPCD||3
182981|NCT00555997|424020|P3|NOT COMPLETED|Phase 2 SPCD||7
182982|NCT00555997|424021|P2|NOT COMPLETED|Phase 2 SPCD||0
182983|NCT00555997|424022|P1|NOT COMPLETED|Phase 2 SPCD||0
182984|NCT00555997|424019|P4|COMPLETED|Phase 2 SPCD||22
182985|NCT00555997|424020|P3|COMPLETED|Phase 2 SPCD||31
182986|NCT00555997|424021|P2|COMPLETED|Phase 2 SPCD||0
182987|NCT00555997|424022|P1|COMPLETED|Phase 2 SPCD||0
182988|NCT00555997|424019|P4|STARTED|Phase 2 SPCD||25
182989|NCT00555997|424020|P3|STARTED|Phase 2 SPCD||38
182990|NCT00555997|424021|P2|STARTED|Phase 2 SPCD||0
182991|NCT00555997|424022|P1|STARTED|Phase 2 SPCD||0
182992|NCT00555997|424019|P4|NOT COMPLETED|Phase 1 SPCD||0
182993|NCT00555997|424020|P3|NOT COMPLETED|Phase 1 SPCD||0
182994|NCT00555997|424021|P2|NOT COMPLETED|Phase 1 SPCD||15
182995|NCT00555997|424022|P1|NOT COMPLETED|Phase 1 SPCD||12
182996|NCT00555997|424019|P4|COMPLETED|Phase 1 SPCD||0
182997|NCT00555997|424020|P3|COMPLETED|Phase 1 SPCD||0
182998|NCT00555997|424021|P2|COMPLETED|Phase 1 SPCD||76
182999|NCT00555997|424022|P1|COMPLETED|Phase 1 SPCD||17
183000|NCT00555997|424019|P4|STARTED|Phase 1 SPCD||0
183001|NCT00555997|424020|P3|STARTED|Phase 1 SPCD||0
183002|NCT00555997|424021|P2|STARTED|Phase 1 SPCD||91
183003|NCT00555997|424022|P1|STARTED|Phase 1 SPCD||29
183004|NCT00555906|424041|P5|NOT COMPLETED|Phase 2||32
183005|NCT00555906|424042|P4|NOT COMPLETED|Phase 2||0
183006|NCT00555906|424043|P3|NOT COMPLETED|Phase 2||0
183007|NCT00555906|424044|P2|NOT COMPLETED|Phase 2||0
183008|NCT00555906|424045|P1|NOT COMPLETED|Phase 2||0
183009|NCT00555906|424041|P5|COMPLETED|Phase 2||0
183010|NCT00555906|424042|P4|COMPLETED|Phase 2||0
183011|NCT00555906|424043|P3|COMPLETED|Phase 2||0
183012|NCT00555906|424044|P2|COMPLETED|Phase 2||0
183013|NCT00555906|424045|P1|COMPLETED|Phase 2||0
183014|NCT00555906|424041|P5|Treated|Phase 2||30
183015|NCT00555906|424042|P4|Treated|Phase 2||0
183016|NCT00555906|424043|P3|Treated|Phase 2||0
183017|NCT00555906|424044|P2|Treated|Phase 2||0
183018|NCT00555906|424045|P1|Treated|Phase 2||0
183019|NCT00555906|424041|P5|STARTED|Phase 2||32
183020|NCT00555906|424042|P4|STARTED|Phase 2||0
183021|NCT00555906|424043|P3|STARTED|Phase 2||0
183022|NCT00555906|424044|P2|STARTED|Phase 2||0
183023|NCT00555906|424045|P1|STARTED|Phase 2||0
183024|NCT00555906|424041|P5|NOT COMPLETED|Phase 1||0
183025|NCT00555906|424042|P4|NOT COMPLETED|Phase 1||5
183026|NCT00555906|424043|P3|NOT COMPLETED|Phase 1||7
183027|NCT00555906|424044|P2|NOT COMPLETED|Phase 1||6
183028|NCT00555906|424045|P1|NOT COMPLETED|Phase 1||3
183029|NCT00555906|424041|P5|COMPLETED|Phase 1||0
183030|NCT00555906|424042|P4|COMPLETED|Phase 1||0
183031|NCT00555906|424043|P3|COMPLETED|Phase 1||0
183032|NCT00555906|424044|P2|COMPLETED|Phase 1||0
183033|NCT00555906|424045|P1|COMPLETED|Phase 1||0
183034|NCT00555906|424041|P5|STARTED|Phase 1||0
183035|NCT00555906|424042|P4|STARTED|Phase 1||5
183036|NCT00555906|424043|P3|STARTED|Phase 1||7
183037|NCT00555906|424044|P2|STARTED|Phase 1||6
183038|NCT00555906|424045|P1|STARTED|Phase 1||3
183039|NCT00555893|424077|P2|NOT COMPLETED|Overall Study||0
183040|NCT00555893|424078|P1|NOT COMPLETED|Overall Study||0
183041|NCT00555893|424077|P2|COMPLETED|Overall Study||63
183042|NCT00555893|424078|P1|COMPLETED|Overall Study||130
183043|NCT00555893|424077|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
183044|NCT00555893|424078|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
183045|NCT00555893|424077|P2|STARTED|Overall Study||63
183046|NCT00555893|424078|P1|STARTED|Overall Study||130
183047|NCT00555880|424088|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
183048|NCT00555880|424089|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
183049|NCT00555880|424088|P2|COMPLETED|Treatment Period 2 (1 Day)||11
183050|NCT00555880|424089|P1|COMPLETED|Treatment Period 2 (1 Day)||13
183051|NCT00555880|424088|P2|STARTED|Treatment Period 2 (1 Day)||11
183052|NCT00555880|424089|P1|STARTED|Treatment Period 2 (1 Day)||13
183053|NCT00555880|424088|P2|NOT COMPLETED|Washout (1 Day)||0
183054|NCT00555880|424089|P1|NOT COMPLETED|Washout (1 Day)||0
183055|NCT00555880|424088|P2|COMPLETED|Washout (1 Day)||11
183056|NCT00555880|424089|P1|COMPLETED|Washout (1 Day)||13
183057|NCT00555880|424088|P2|STARTED|Washout (1 Day)||11
183058|NCT00555880|424089|P1|STARTED|Washout (1 Day)||13
183059|NCT00555880|424088|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
183060|NCT00555880|424089|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
183061|NCT00555880|424088|P2|COMPLETED|Treatment Period 1 (1 Day)||11
183062|NCT00555880|424089|P1|COMPLETED|Treatment Period 1 (1 Day)||13
183063|NCT00555880|424088|P2|STARTED|Treatment Period 1 (1 Day)||11
183064|NCT00555880|424089|P1|STARTED|Treatment Period 1 (1 Day)||13
183065|NCT00555750|424128|P2|NOT COMPLETED|Overall Study||0
183066|NCT00555750|424129|P1|NOT COMPLETED|Overall Study||0
183067|NCT00555750|424128|P2|COMPLETED|Overall Study||10
183068|NCT00555750|424129|P1|COMPLETED|Overall Study||10
183069|NCT00555750|424128|P2|STARTED|Overall Study||10
183070|NCT00555750|424129|P1|STARTED|Overall Study||10
183071|NCT00555672|424161|P2|NOT COMPLETED|Overall Study||10
183072|NCT00555672|424162|P1|NOT COMPLETED|Overall Study||24
183073|NCT00555672|424161|P2|COMPLETED|Overall Study||0
183074|NCT00555672|424162|P1|COMPLETED|Overall Study||0
183075|NCT00555672|424161|P2|STARTED|Overall Study||10
183076|NCT00555672|424162|P1|STARTED|Overall Study||24
183077|NCT00555620|424187|P6|NOT COMPLETED|Overall Study||22
183078|NCT00555620|424188|P5|NOT COMPLETED|Overall Study||3
183079|NCT00555620|424189|P4|NOT COMPLETED|Overall Study||23
183080|NCT00555620|424190|P3|NOT COMPLETED|Overall Study||15
183081|NCT00555620|424191|P2|NOT COMPLETED|Overall Study||7
183082|NCT00555620|424192|P1|NOT COMPLETED|Overall Study||6
183083|NCT00555620|424187|P6|COMPLETED|Overall Study||0
183084|NCT00555620|424188|P5|COMPLETED|Overall Study||0
183085|NCT00555620|424189|P4|COMPLETED|Overall Study||0
183086|NCT00555620|424190|P3|COMPLETED|Overall Study||0
183087|NCT00555620|424191|P2|COMPLETED|Overall Study||0
183088|NCT00555620|424192|P1|COMPLETED|Overall Study||0
183089|NCT00555620|424187|P6|STARTED|Overall Study||22
183090|NCT00555620|424188|P5|STARTED|Overall Study||3
183091|NCT00555620|424189|P4|STARTED|Overall Study||23
183092|NCT00555620|424190|P3|STARTED|Overall Study||15
183093|NCT00555620|424191|P2|STARTED|Overall Study||7
183094|NCT00555620|424192|P1|STARTED|Overall Study||6
183095|NCT00555568|424307|P3|NOT COMPLETED|Overall Study||16
183096|NCT00555568|424308|P2|NOT COMPLETED|Overall Study||16
183097|NCT00555568|424309|P1|NOT COMPLETED|Overall Study||26
183098|NCT00555568|424307|P3|COMPLETED|Overall Study||84
183099|NCT00555568|424308|P2|COMPLETED|Overall Study||82
183100|NCT00555568|424309|P1|COMPLETED|Overall Study||74
183101|NCT00555568|424307|P3|STARTED|Overall Study||100
183102|NCT00555568|424308|P2|STARTED|Overall Study||98
183103|NCT00555568|424309|P1|STARTED|Overall Study||100
183104|NCT00555477|424331|P2|NOT COMPLETED|Overall Study||13
183105|NCT00555477|424332|P1|NOT COMPLETED|Overall Study||2
183106|NCT00555477|424331|P2|COMPLETED|Overall Study||32
183107|NCT00555477|424332|P1|COMPLETED|Overall Study||12
183108|NCT00555477|424331|P2|STARTED|Overall Study||45
183109|NCT00555477|424332|P1|STARTED|Overall Study||14
183110|NCT00555464|424339|P2|NOT COMPLETED|Overall Study||3
183111|NCT00555464|424340|P1|NOT COMPLETED|Overall Study||0
183112|NCT00555464|424339|P2|COMPLETED|Overall Study||1
183113|NCT00555464|424340|P1|COMPLETED|Overall Study||4
183114|NCT00555464|424339|P2|STARTED|Overall Study||4
183115|NCT00555464|424340|P1|STARTED|Overall Study||4
183116|NCT00555438|424348|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
183117|NCT00555438|424348|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
183118|NCT00555438|424348|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
183119|NCT00555438|424348|P1|NOT COMPLETED|10 Days Post-operative||4
183120|NCT00555438|424348|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
183121|NCT00555438|424348|P1|STARTED|10 Days Post-operative||442
183122|NCT00555425|424358|P2|NOT COMPLETED|Overall Study||19
183123|NCT00555425|424359|P1|NOT COMPLETED|Overall Study||51
183124|NCT00555425|424358|P2|COMPLETED|Overall Study||37
183125|NCT00555425|424359|P1|COMPLETED|Overall Study||6
183126|NCT00555425|424358|P2|STARTED|Overall Study||56
183127|NCT00555425|424359|P1|STARTED|Overall Study||57
183128|NCT00555360|424379|P2|NOT COMPLETED|Overall Study||36
183129|NCT00555360|424380|P1|NOT COMPLETED|Overall Study||27
183130|NCT00555360|424379|P2|COMPLETED|Overall Study||153
183131|NCT00555360|424380|P1|COMPLETED|Overall Study||156
183132|NCT00555360|424379|P2|STARTED|Overall Study||189
183133|NCT00555360|424380|P1|STARTED|Overall Study||183
183134|NCT00555321|424395|P5|NOT COMPLETED|Long-term Extension Phase||26
183135|NCT00555321|424396|P4|NOT COMPLETED|Long-term Extension Phase||38
183136|NCT00555321|424397|P3|NOT COMPLETED|Long-term Extension Phase||24
183137|NCT00555321|424398|P2|NOT COMPLETED|Long-term Extension Phase||27
183138|NCT00555321|424399|P1|NOT COMPLETED|Long-term Extension Phase||30
183139|NCT00555321|424395|P5|COMPLETED|Long-term Extension Phase||0
183140|NCT00555321|424396|P4|COMPLETED|Long-term Extension Phase||0
183141|NCT00555321|424397|P3|COMPLETED|Long-term Extension Phase||0
183142|NCT00555321|424398|P2|COMPLETED|Long-term Extension Phase||0
183143|NCT00555321|424399|P1|COMPLETED|Long-term Extension Phase||0
183144|NCT00555321|424395|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
183145|NCT00555321|424396|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
183146|NCT00555321|424397|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
183147|NCT00555321|424398|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
183148|NCT00555321|424399|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
183149|NCT00555321|424395|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
183150|NCT00555321|424396|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
183151|NCT00555321|424397|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
183152|NCT00555321|424398|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
183153|NCT00555321|424399|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
183154|NCT00555321|424395|P5|COMPLETED|Treatment Phase up to 12-months||32
183155|NCT00555321|424396|P4|COMPLETED|Treatment Phase up to 12-months||46
183156|NCT00555321|424397|P3|COMPLETED|Treatment Phase up to 12-months||26
183157|NCT00555321|424398|P2|COMPLETED|Treatment Phase up to 12-months||29
183158|NCT00555321|424399|P1|COMPLETED|Treatment Phase up to 12-months||31
183159|NCT00555321|424395|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
183160|NCT00555321|424396|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
183161|NCT00555321|424397|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
183162|NCT00555321|424398|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
183163|NCT00555321|424399|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
183164|NCT00555321|424395|P5|STARTED|Treatment Phase up to 12-months||54
183165|NCT00555321|424396|P4|STARTED|Treatment Phase up to 12-months||53
183166|NCT00555321|424397|P3|STARTED|Treatment Phase up to 12-months||50
183167|NCT00555321|424398|P2|STARTED|Treatment Phase up to 12-months||51
183168|NCT00555321|424399|P1|STARTED|Treatment Phase up to 12-months||52
183169|NCT00555217|424703|P2|NOT COMPLETED|Overall Study||68
183170|NCT00555217|424704|P1|NOT COMPLETED|Overall Study||75
183171|NCT00555217|424703|P2|COMPLETED|Overall Study||656
183172|NCT00555217|424704|P1|COMPLETED|Overall Study||649
183173|NCT00555217|424703|P2|STARTED|Overall Study||724
183174|NCT00555217|424704|P1|STARTED|Overall Study||724
183175|NCT00555152|424716|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183176|NCT00555152|424717|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183177|NCT00555152|424718|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183178|NCT00555152|424719|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183179|NCT00555152|424716|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
183180|NCT00555152|424717|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183181|NCT00555152|424718|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
183182|NCT00555152|424719|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183183|NCT00555152|424716|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
183184|NCT00555152|424717|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
183185|NCT00555152|424718|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
183186|NCT00555152|424719|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
183187|NCT00555152|424716|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183188|NCT00555152|424717|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183189|NCT00555152|424718|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183190|NCT00555152|424719|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183191|NCT00555152|424716|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
183192|NCT00555152|424717|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183193|NCT00555152|424718|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
183194|NCT00555152|424719|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
183195|NCT00555152|424716|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
183196|NCT00555152|424717|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
183197|NCT00555152|424718|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
183198|NCT00555152|424719|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
183199|NCT00555061|424741|P1|NOT COMPLETED|Overall Study||9
183200|NCT00555061|424741|P1|COMPLETED|Overall Study||78
183201|NCT00555061|424741|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
183202|NCT00555009|424750|P2|NOT COMPLETED|Overall Study||6
183203|NCT00555009|424751|P1|NOT COMPLETED|Overall Study||2
183204|NCT00555009|424750|P2|COMPLETED|Overall Study||0
183205|NCT00555009|424751|P1|COMPLETED|Overall Study||2
183206|NCT00555009|424750|P2|STARTED|Overall Study||6
183207|NCT00555009|424751|P1|STARTED|Overall Study||4
183208|NCT00554996|424773|P1|NOT COMPLETED|Overall Study||0
183209|NCT00554996|424773|P1|COMPLETED|Overall Study||10
183210|NCT00554996|424773|P1|STARTED|Overall Study||10
183211|NCT00554970|424781|P4|NOT COMPLETED|Period 2||0
183212|NCT00554970|424782|P3|NOT COMPLETED|Period 2||1
183213|NCT00554970|424783|P2|NOT COMPLETED|Period 2||0
183214|NCT00554970|424784|P1|NOT COMPLETED|Period 2||0
183215|NCT00554970|424781|P4|COMPLETED|Period 2||8
183216|NCT00554970|424782|P3|COMPLETED|Period 2||7
183217|NCT00554970|424783|P2|COMPLETED|Period 2||8
183218|NCT00554970|424784|P1|COMPLETED|Period 2||7
183219|NCT00554970|424781|P4|STARTED|Period 2||8
183220|NCT00554970|424782|P3|STARTED|Period 2||8
183221|NCT00554970|424783|P2|STARTED|Period 2||8
183222|NCT00554970|424784|P1|STARTED|Period 2||7
183223|NCT00554970|424781|P4|NOT COMPLETED|Period 1||0
183224|NCT00554970|424782|P3|NOT COMPLETED|Period 1||0
183225|NCT00554970|424783|P2|NOT COMPLETED|Period 1||0
183226|NCT00554970|424784|P1|NOT COMPLETED|Period 1||1
183227|NCT00554970|424781|P4|COMPLETED|Period 1||8
183228|NCT00554970|424782|P3|COMPLETED|Period 1||8
183229|NCT00554970|424783|P2|COMPLETED|Period 1||8
183230|NCT00554970|424784|P1|COMPLETED|Period 1||7
183231|NCT00554970|424781|P4|STARTED|Period 1||8
183232|NCT00554970|424782|P3|STARTED|Period 1||8
183233|NCT00554970|424783|P2|STARTED|Period 1||8
183234|NCT00554970|424784|P1|STARTED|Period 1||8
183235|NCT00554853|424816|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
183236|NCT00554853|424817|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
183237|NCT00554853|424816|P2|COMPLETED|Crossover Arm (3 Months)||55
183238|NCT00554853|424817|P1|COMPLETED|Crossover Arm (3 Months)||53
183239|NCT00554853|424816|P2|STARTED|Crossover Arm (3 Months)||57
183240|NCT00554853|424817|P1|STARTED|Crossover Arm (3 Months)||56
183241|NCT00554853|424816|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
183242|NCT00554853|424817|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
183243|NCT00554853|424816|P2|COMPLETED|Washout Period (2 Weeks)||57
183244|NCT00554853|424817|P1|COMPLETED|Washout Period (2 Weeks)||56
183245|NCT00554853|424816|P2|STARTED|Washout Period (2 Weeks)||64
183246|NCT00554853|424817|P1|STARTED|Washout Period (2 Weeks)||56
183247|NCT00554853|424816|P2|NOT COMPLETED|First Arm of Study||7
183248|NCT00554853|424817|P1|NOT COMPLETED|First Arm of Study||16
183249|NCT00554853|424816|P2|COMPLETED|First Arm of Study||64
183250|NCT00554853|424817|P1|COMPLETED|First Arm of Study||56
183251|NCT00554853|424816|P2|STARTED|First Arm of Study||71
183252|NCT00554853|424817|P1|STARTED|First Arm of Study||72
183253|NCT00554801|424831|P2|NOT COMPLETED|Overall Study||0
183254|NCT00554801|424832|P1|NOT COMPLETED|Overall Study||19
183255|NCT00554801|424831|P2|COMPLETED|Overall Study||29
183256|NCT00554801|424832|P1|COMPLETED|Overall Study||36
183257|NCT00554801|424831|P2|STARTED|Overall Study||29
183258|NCT00554801|424832|P1|STARTED|Overall Study||55
183259|NCT00554749|424838|P1|NOT COMPLETED|Overall Study||0
183260|NCT00554749|424838|P1|COMPLETED|Overall Study||7
183261|NCT00554749|424838|P1|STARTED|Overall Study||7
183262|NCT00554671|424845|P2|NOT COMPLETED|Overall Study||16
183263|NCT00554671|424846|P1|NOT COMPLETED|Overall Study||20
183264|NCT00554671|424845|P2|COMPLETED|Overall Study||117
183265|NCT00554671|424846|P1|COMPLETED|Overall Study||97
183266|NCT00554671|424845|P2|STARTED|Overall Study||133
183267|NCT00554671|424846|P1|STARTED|Overall Study||117
183268|NCT00554619|424854|P1|NOT COMPLETED|Overall Study||3
183269|NCT00554619|424854|P1|COMPLETED|Overall Study||18
183270|NCT00554619|424854|P1|STARTED|Overall Study||21
183271|NCT00554463|424866|P1|NOT COMPLETED|Overall Study||0
183272|NCT00554463|424866|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
183273|NCT00554463|424866|P1|STARTED|Overall Study||5
183274|NCT00554372|424872|P2|NOT COMPLETED|Overall Study||0
183275|NCT00554372|424873|P1|NOT COMPLETED|Overall Study||0
183276|NCT00554372|424872|P2|COMPLETED|Overall Study||16
183277|NCT00554372|424873|P1|COMPLETED|Overall Study||14
183278|NCT00554372|424872|P2|STARTED|Overall Study||16
183279|NCT00554372|424873|P1|STARTED|Overall Study||14
183280|NCT00554294|424887|P2|NOT COMPLETED|Overall Study||80
183281|NCT00554294|424888|P1|NOT COMPLETED|Overall Study||160
183282|NCT00554294|424887|P2|COMPLETED|Overall Study||1641
183283|NCT00554294|424888|P1|COMPLETED|Overall Study||1309
183284|NCT00554294|424887|P2|STARTED|Overall Study||1721
183285|NCT00554294|424888|P1|STARTED|Overall Study||1469
183286|NCT00554229|424894|P2|NOT COMPLETED|Overall Study||225
183287|NCT00554229|424895|P1|NOT COMPLETED|Overall Study||226
183288|NCT00554229|424894|P2|COMPLETED|Overall Study||70
183289|NCT00554229|424895|P1|COMPLETED|Overall Study||73
183290|NCT00554229|424894|P2|Patients Who Received Treatment|Overall Study||295
183291|NCT00554229|424895|P1|Patients Who Received Treatment|Overall Study||298
183292|NCT00554229|424894|P2|STARTED|Overall Study||295
183293|NCT00554229|424895|P1|STARTED|Overall Study||299
183294|NCT00554216|424920|P3|NOT COMPLETED|Overall Study||172
183295|NCT00554216|424921|P2|NOT COMPLETED|Overall Study||94
183296|NCT00554216|424922|P1|NOT COMPLETED|Overall Study||242
183297|NCT00554216|424920|P3|COMPLETED|Overall Study||340
183298|NCT00554216|424921|P2|COMPLETED|Overall Study||147
183299|NCT00554216|424922|P1|COMPLETED|Overall Study||272
183300|NCT00554216|424920|P3|STARTED|Overall Study||512
183301|NCT00554216|424921|P2|STARTED|Overall Study||241
183302|NCT00554216|424922|P1|STARTED|Overall Study||514
183303|NCT00554190|424933|P1|NOT COMPLETED|Overall Study||10
183304|NCT00554190|424933|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
183305|NCT00554190|424933|P1|STARTED|Overall Study|29 subjects treated.|29
183306|NCT00554099|424942|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
183307|NCT00554099|424943|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
183308|NCT00554099|424944|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
183309|NCT00554099|424942|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
183310|NCT00554099|424943|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
183311|NCT00554099|424944|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
183312|NCT00554099|424942|P3|STARTED|Non-Treatment Phase (9 Months)||27
183313|NCT00554099|424943|P2|STARTED|Non-Treatment Phase (9 Months)||32
183314|NCT00554099|424944|P1|STARTED|Non-Treatment Phase (9 Months)||29
183315|NCT00554099|424942|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
183316|NCT00554099|424943|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
183317|NCT00554099|424944|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
183318|NCT00554099|424942|P3|COMPLETED|Treatment Period (12 Weeks)||27
183319|NCT00554099|424943|P2|COMPLETED|Treatment Period (12 Weeks)||32
183320|NCT00554099|424944|P1|COMPLETED|Treatment Period (12 Weeks)||29
183321|NCT00554099|424942|P3|STARTED|Treatment Period (12 Weeks)||36
183322|NCT00554099|424943|P2|STARTED|Treatment Period (12 Weeks)||40
183323|NCT00554099|424944|P1|STARTED|Treatment Period (12 Weeks)||41
183324|NCT00553969|424977|P4|NOT COMPLETED|Overall Study||1
183325|NCT00553969|424978|P3|NOT COMPLETED|Overall Study||1
183326|NCT00553969|424979|P2|NOT COMPLETED|Overall Study||0
183327|NCT00553969|424980|P1|NOT COMPLETED|Overall Study||8
183328|NCT00553969|424977|P4|COMPLETED|Overall Study||23
183329|NCT00553969|424978|P3|COMPLETED|Overall Study||21
183330|NCT00553969|424979|P2|COMPLETED|Overall Study||24
183331|NCT00553969|424980|P1|COMPLETED|Overall Study||23
183332|NCT00553969|424977|P4|STARTED|Overall Study||24
183333|NCT00553969|424978|P3|STARTED|Overall Study||22
183334|NCT00553969|424979|P2|STARTED|Overall Study||24
183335|NCT00553969|424980|P1|STARTED|Overall Study||31
183336|NCT00553839|424990|P1|NOT COMPLETED|Overall Study||0
183337|NCT00553839|424990|P1|COMPLETED|Overall Study||21
183338|NCT00553839|424990|P1|STARTED|Overall Study||21
183339|NCT00553787|424999|P3|NOT COMPLETED|Overall Study||262
183340|NCT00553787|425000|P2|NOT COMPLETED|Overall Study||124
183341|NCT00553787|425001|P1|NOT COMPLETED|Overall Study||378
183342|NCT00553787|424999|P3|COMPLETED|Overall Study||733
183343|NCT00553787|425000|P2|COMPLETED|Overall Study||374
183344|NCT00553787|425001|P1|COMPLETED|Overall Study||616
183345|NCT00553787|424999|P3|STARTED|Overall Study||995
183346|NCT00553787|425000|P2|STARTED|Overall Study||498
183347|NCT00553787|425001|P1|STARTED|Overall Study||994
183348|NCT00553696|425016|P4|NOT COMPLETED|Overall Study||1
183349|NCT00553696|425017|P3|NOT COMPLETED|Overall Study||6
183350|NCT00553696|425018|P2|NOT COMPLETED|Overall Study||16
183351|NCT00553696|425019|P1|NOT COMPLETED|Overall Study||4
183352|NCT00553696|425016|P4|COMPLETED|Overall Study||0
183353|NCT00553696|425017|P3|COMPLETED|Overall Study||0
183354|NCT00553696|425018|P2|COMPLETED|Overall Study||0
183355|NCT00553696|425019|P1|COMPLETED|Overall Study||0
183356|NCT00553696|425016|P4|STARTED|Overall Study||1
183357|NCT00553696|425017|P3|STARTED|Overall Study||6
183358|NCT00553696|425018|P2|STARTED|Overall Study||16
183359|NCT00553696|425019|P1|STARTED|Overall Study||4
183360|NCT00553644|425057|P1|NOT COMPLETED|Overall Study||28
183361|NCT00553644|425057|P1|COMPLETED|Overall Study||25
183362|NCT00553644|425057|P1|STARTED|Overall Study||53
183363|NCT00553631|425063|P2|NOT COMPLETED|Overall Study||1
183364|NCT00553631|425064|P1|NOT COMPLETED|Overall Study||1
183365|NCT00553631|425063|P2|COMPLETED|Overall Study||16
183366|NCT00553631|425064|P1|COMPLETED|Overall Study||16
183367|NCT00553631|425063|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
183368|NCT00553631|425064|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
183369|NCT00553605|425086|P2|NOT COMPLETED|Overall Study||3
183370|NCT00553605|425087|P1|NOT COMPLETED|Overall Study||4
183371|NCT00553605|425086|P2|COMPLETED|Overall Study||161
183372|NCT00553605|425087|P1|COMPLETED|Overall Study||172
183373|NCT00553605|425086|P2|Treated|Overall Study||164
183374|NCT00553605|425087|P1|Treated|Overall Study||174
183375|NCT00553605|425086|P2|STARTED|Overall Study||164
183376|NCT00553605|425087|P1|STARTED|Overall Study||176
183377|NCT00553514|425116|P5|NOT COMPLETED|Overall Study||7
183378|NCT00553514|425117|P4|NOT COMPLETED|Overall Study||7
183379|NCT00553514|425118|P3|NOT COMPLETED|Overall Study||6
183380|NCT00553514|425119|P2|NOT COMPLETED|Overall Study||8
183381|NCT00553514|425120|P1|NOT COMPLETED|Overall Study||8
183382|NCT00553514|425116|P5|COMPLETED|Overall Study||8
183383|NCT00553514|425117|P4|COMPLETED|Overall Study||6
183384|NCT00553514|425118|P3|COMPLETED|Overall Study||9
183385|NCT00553514|425119|P2|COMPLETED|Overall Study||6
183386|NCT00553514|425120|P1|COMPLETED|Overall Study||6
183387|NCT00553514|425116|P5|STARTED|Overall Study||15
183388|NCT00553514|425117|P4|STARTED|Overall Study||13
183389|NCT00553514|425118|P3|STARTED|Overall Study||15
183390|NCT00553514|425119|P2|STARTED|Overall Study||14
183391|NCT00553514|425120|P1|STARTED|Overall Study||14
183392|NCT00553501|425157|P1|NOT COMPLETED|Overall Study||4
183393|NCT00553501|425157|P1|COMPLETED|Overall Study||55
183394|NCT00553501|425157|P1|STARTED|Overall Study||59
183395|NCT00553475|425166|P3|NOT COMPLETED|Overall Study||13
183396|NCT00553475|425167|P2|NOT COMPLETED|Overall Study||20
183397|NCT00553475|425168|P1|NOT COMPLETED|Overall Study||16
183398|NCT00553475|425166|P3|COMPLETED|Overall Study||32
183399|NCT00553475|425167|P2|COMPLETED|Overall Study||114
183400|NCT00553475|425168|P1|COMPLETED|Overall Study||119
183401|NCT00553475|425166|P3|STARTED|Overall Study||45
183402|NCT00553475|425167|P2|STARTED|Overall Study||134
183403|NCT00553475|425168|P1|STARTED|Overall Study||135
183404|NCT00553462|425290|P1|NOT COMPLETED|Overall Study||14
183405|NCT00553462|425290|P1|COMPLETED|Overall Study||61
183406|NCT00553462|425290|P1|STARTED|Overall Study||75
183407|NCT00553436|425296|P1|NOT COMPLETED|Overall Study||1
183408|NCT00553436|425296|P1|COMPLETED|Overall Study|09 April 2009|6
183409|NCT00553436|425296|P1|STARTED|Overall Study|20 August 2007|7
183410|NCT00553358|425305|P3|NOT COMPLETED|Overall Study||60
183411|NCT00553358|425306|P2|NOT COMPLETED|Overall Study||12
183412|NCT00553358|425307|P1|NOT COMPLETED|Overall Study||53
183413|NCT00553358|425305|P3|COMPLETED|Overall Study||92
183414|NCT00553358|425306|P2|COMPLETED|Overall Study||137
183415|NCT00553358|425307|P1|COMPLETED|Overall Study||101
183416|NCT00553358|425305|P3|STARTED|Overall Study||152
183417|NCT00553358|425306|P2|STARTED|Overall Study||149
183418|NCT00553358|425307|P1|STARTED|Overall Study||154
183419|NCT00553332|425333|P1|NOT COMPLETED|Overall Study||1
183420|NCT00553332|425333|P1|COMPLETED|Overall Study|evaluable for response|28
183421|NCT00553332|425333|P1|STARTED|Overall Study||29
183422|NCT00553319|425345|P3|NOT COMPLETED|Overall Study||9
183423|NCT00553319|425346|P2|NOT COMPLETED|Overall Study||10
183424|NCT00553319|425347|P1|NOT COMPLETED|Overall Study||14
183425|NCT00553319|425345|P3|COMPLETED|Overall Study||34
183426|NCT00553319|425346|P2|COMPLETED|Overall Study||30
183427|NCT00553319|425347|P1|COMPLETED|Overall Study||29
183428|NCT00553319|425345|P3|STARTED|Overall Study||43
183429|NCT00553319|425346|P2|STARTED|Overall Study||40
183430|NCT00553319|425347|P1|STARTED|Overall Study||43
183431|NCT00553280|425358|P1|NOT COMPLETED|Overall Study||26
183432|NCT00553280|425358|P1|COMPLETED|Overall Study||97
183433|NCT00553280|425358|P1|STARTED|Overall Study||123
183434|NCT00553267|425370|P3|NOT COMPLETED|Overall Study||10
183435|NCT00553267|425371|P2|NOT COMPLETED|Overall Study||18
183436|NCT00553267|425372|P1|NOT COMPLETED|Overall Study||14
183437|NCT00553267|425370|P3|COMPLETED|Overall Study||307
183438|NCT00553267|425371|P2|COMPLETED|Overall Study||297
183439|NCT00553267|425372|P1|COMPLETED|Overall Study||301
183440|NCT00553267|425370|P3|STARTED|Overall Study||317
183441|NCT00553267|425371|P2|STARTED|Overall Study||315
183442|NCT00553267|425372|P1|STARTED|Overall Study||315
183443|NCT00553150|425409|P2|NOT COMPLETED|Overall Study||4
183444|NCT00553150|425410|P1|NOT COMPLETED|Overall Study||0
183445|NCT00553150|425409|P2|COMPLETED|Overall Study||100
183446|NCT00553150|425410|P1|COMPLETED|Overall Study||18
183447|NCT00553150|425409|P2|STARTED|Overall Study||104
183448|NCT00553150|425410|P1|STARTED|Overall Study||18
183449|NCT00552812|425422|P1|NOT COMPLETED|Overall Study||20
183450|NCT00552812|425422|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
183451|NCT00552812|425422|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
183452|NCT00552786|425430|P2|NOT COMPLETED|Second Intervention||0
183453|NCT00552786|425431|P1|NOT COMPLETED|Second Intervention||0
183454|NCT00552786|425430|P2|COMPLETED|Second Intervention||28
183455|NCT00552786|425431|P1|COMPLETED|Second Intervention||25
183456|NCT00552786|425430|P2|STARTED|Second Intervention||28
183457|NCT00552786|425431|P1|STARTED|Second Intervention||25
183458|NCT00552786|425430|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
183459|NCT00552786|425431|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
183460|NCT00552786|425430|P2|COMPLETED|Washout Period of 2 Weeks||28
183461|NCT00552786|425431|P1|COMPLETED|Washout Period of 2 Weeks||25
183462|NCT00552786|425430|P2|STARTED|Washout Period of 2 Weeks||28
183463|NCT00552786|425431|P1|STARTED|Washout Period of 2 Weeks||25
183464|NCT00552786|425430|P2|NOT COMPLETED|First Intervention||0
183465|NCT00552786|425431|P1|NOT COMPLETED|First Intervention||0
183466|NCT00552786|425430|P2|COMPLETED|First Intervention||28
183467|NCT00552786|425431|P1|COMPLETED|First Intervention||25
183468|NCT00552786|425430|P2|Medication and Hearing Evaluation|First Intervention||28
183469|NCT00552786|425431|P1|Medication and Hearing Evaluation|First Intervention||25
183470|NCT00552786|425430|P2|STARTED|First Intervention||28
183471|NCT00552786|425431|P1|STARTED|First Intervention||25
183472|NCT00552760|425441|P2|NOT COMPLETED|Overall Study||33
183473|NCT00552760|425442|P1|NOT COMPLETED|Overall Study||26
183474|NCT00552760|425441|P2|COMPLETED|Overall Study||8
183475|NCT00552760|425442|P1|COMPLETED|Overall Study||16
183476|NCT00552760|425441|P2|STARTED|Overall Study||41
183477|NCT00552760|425442|P1|STARTED|Overall Study||42
183478|NCT00552695|425458|P2|NOT COMPLETED|Overall Study||0
183479|NCT00552695|425459|P1|NOT COMPLETED|Overall Study||0
183480|NCT00552695|425458|P2|COMPLETED|Overall Study|September 2007|23
183481|NCT00552695|425459|P1|COMPLETED|Overall Study|September 2007|22
183482|NCT00552695|425458|P2|STARTED|Overall Study|August 2007|23
183483|NCT00552695|425459|P1|STARTED|Overall Study|August 2007|22
183484|NCT00552669|425469|P2|NOT COMPLETED|Overall Study||7
183485|NCT00552669|425470|P1|NOT COMPLETED|Overall Study||3
183486|NCT00552669|425469|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
183487|NCT00552669|425470|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
183488|NCT00552669|425469|P2|STARTED|Overall Study|patients|100
183489|NCT00552669|425470|P1|STARTED|Overall Study|patients|100
183490|NCT00552578|425482|P2|NOT COMPLETED|Overall Study||1
183491|NCT00552578|425483|P1|NOT COMPLETED|Overall Study||1
183492|NCT00552578|425482|P2|COMPLETED|Overall Study||5
183493|NCT00552578|425483|P1|COMPLETED|Overall Study||5
183494|NCT00552578|425482|P2|STARTED|Overall Study||6
183495|NCT00552578|425483|P1|STARTED|Overall Study||6
183496|NCT00552513|425495|P2|NOT COMPLETED|Overall Study||1
183497|NCT00552513|425496|P1|NOT COMPLETED|Overall Study||5
183498|NCT00552513|425495|P2|COMPLETED|Overall Study||1437
183499|NCT00552513|425496|P1|COMPLETED|Overall Study||1588
183500|NCT00552513|425495|P2|STARTED|Overall Study||1438
183501|NCT00552513|425496|P1|STARTED|Overall Study||1593
183502|NCT00552448|425508|P2|NOT COMPLETED|Overall Study||0
183503|NCT00552448|425509|P1|NOT COMPLETED|Overall Study||1
183504|NCT00552448|425508|P2|COMPLETED|Overall Study||16
183505|NCT00552448|425509|P1|COMPLETED|Overall Study||19
183506|NCT00552448|425508|P2|STARTED|Overall Study||16
183507|NCT00552448|425509|P1|STARTED|Overall Study||20
183508|NCT00552422|425521|P1|NOT COMPLETED|Overall Study||0
183509|NCT00552422|425521|P1|COMPLETED|Overall Study||6
183510|NCT00552422|425521|P1|STARTED|Overall Study||6
183511|NCT00552409|425527|P2|NOT COMPLETED|Overall Study||2
183512|NCT00552409|425528|P1|NOT COMPLETED|Overall Study||1
183513|NCT00552409|425527|P2|COMPLETED|Overall Study||9
183514|NCT00552409|425528|P1|COMPLETED|Overall Study||10
183515|NCT00552409|425527|P2|STARTED|Overall Study||11
183516|NCT00552409|425528|P1|STARTED|Overall Study||11
183517|NCT00552396|425541|P7|NOT COMPLETED|Overall Study||9
183518|NCT00552396|425542|P6|NOT COMPLETED|Overall Study||3
183519|NCT00552396|425543|P5|NOT COMPLETED|Overall Study||3
183520|NCT00552396|425544|P4|NOT COMPLETED|Overall Study||6
183521|NCT00552396|425545|P3|NOT COMPLETED|Overall Study||3
183522|NCT00552396|425546|P2|NOT COMPLETED|Overall Study||3
183523|NCT00552396|425547|P1|NOT COMPLETED|Overall Study||3
183524|NCT00552396|425541|P7|COMPLETED|Overall Study||1
183525|NCT00552396|425542|P6|COMPLETED|Overall Study||0
183526|NCT00552396|425543|P5|COMPLETED|Overall Study||0
183527|NCT00552396|425544|P4|COMPLETED|Overall Study||0
183528|NCT00552396|425545|P3|COMPLETED|Overall Study||0
183529|NCT00552396|425546|P2|COMPLETED|Overall Study||0
183530|NCT00552396|425547|P1|COMPLETED|Overall Study||1
183531|NCT00552396|425541|P7|STARTED|Overall Study||10
183532|NCT00552396|425542|P6|STARTED|Overall Study||3
183533|NCT00552396|425543|P5|STARTED|Overall Study||3
183534|NCT00552396|425544|P4|STARTED|Overall Study||6
183535|NCT00552396|425545|P3|STARTED|Overall Study||3
183536|NCT00552396|425546|P2|STARTED|Overall Study||3
183537|NCT00552396|425547|P1|STARTED|Overall Study||4
183538|NCT00552344|425584|P1|NOT COMPLETED|Overall Study||315
183539|NCT00552344|425584|P1|COMPLETED|Overall Study||87
183540|NCT00552344|425584|P1|STARTED|Overall Study||402
183541|NCT00552305|425593|P1|NOT COMPLETED|Overall Study||250
183542|NCT00552305|425593|P1|COMPLETED|Overall Study||120
183543|NCT00552305|425593|P1|STARTED|Overall Study||370
183544|NCT00552279|425603|P2|NOT COMPLETED|Overall Study||3
183545|NCT00552279|425604|P1|NOT COMPLETED|Overall Study||14
183546|NCT00552279|425603|P2|COMPLETED|Overall Study||398
183547|NCT00552279|425604|P1|COMPLETED|Overall Study||389
183548|NCT00552279|425603|P2|STARTED|Overall Study||401
183549|NCT00552279|425604|P1|STARTED|Overall Study||403
183550|NCT00552240|425630|P2|NOT COMPLETED|Overall Study||18
183551|NCT00552240|425631|P1|NOT COMPLETED|Overall Study||24
183552|NCT00552240|425630|P2|COMPLETED|Overall Study||59
183553|NCT00552240|425631|P1|COMPLETED|Overall Study||51
183554|NCT00552240|425630|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
183555|NCT00552240|425631|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
183556|NCT00552188|425733|P2|NOT COMPLETED|Overall Study||5
183557|NCT00552188|425734|P1|NOT COMPLETED|Overall Study||2
183558|NCT00552188|425733|P2|COMPLETED|Overall Study||21
183559|NCT00552188|425734|P1|COMPLETED|Overall Study||24
183560|NCT00552188|425733|P2|STARTED|Overall Study||26
183561|NCT00552188|425734|P1|STARTED|Overall Study||26
183562|NCT00552175|425745|P3|NOT COMPLETED|Overall Study||14
183563|NCT00552175|425746|P2|NOT COMPLETED|Overall Study||13
183564|NCT00552175|425747|P1|NOT COMPLETED|Overall Study||17
183565|NCT00552175|425745|P3|COMPLETED|Overall Study||72
183566|NCT00552175|425746|P2|COMPLETED|Overall Study||73
183567|NCT00552175|425747|P1|COMPLETED|Overall Study||150
183568|NCT00552175|425745|P3|Full Analysis Set Population|Overall Study||86
183569|NCT00552175|425746|P2|Full Analysis Set Population|Overall Study||85
183570|NCT00552175|425747|P1|Full Analysis Set Population|Overall Study||167
183571|NCT00552175|425745|P3|STARTED|Overall Study||86
183572|NCT00552175|425746|P2|STARTED|Overall Study||86
183573|NCT00552175|425747|P1|STARTED|Overall Study||167
183574|NCT00552110|425787|P5|NOT COMPLETED|Overall Study||9
183575|NCT00552110|425788|P4|NOT COMPLETED|Overall Study||8
183576|NCT00552110|425789|P3|NOT COMPLETED|Overall Study||2
183577|NCT00552110|425790|P2|NOT COMPLETED|Overall Study||5
183578|NCT00552110|425791|P1|NOT COMPLETED|Overall Study||4
183579|NCT00552110|425787|P5|COMPLETED|Overall Study||133
183580|NCT00552110|425788|P4|COMPLETED|Overall Study||133
183581|NCT00552110|425789|P3|COMPLETED|Overall Study||137
183582|NCT00552110|425790|P2|COMPLETED|Overall Study||134
183583|NCT00552110|425791|P1|COMPLETED|Overall Study||142
183584|NCT00552110|425787|P5|STARTED|Overall Study||142
183585|NCT00552110|425788|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
183586|NCT00552110|425789|P3|STARTED|Overall Study||139
183587|NCT00552110|425790|P2|STARTED|Overall Study||139
183588|NCT00552110|425791|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
183589|NCT00552084|425810|P2|NOT COMPLETED|Overall Study||9
183590|NCT00552084|425811|P1|NOT COMPLETED|Overall Study||8
183591|NCT00552084|425810|P2|COMPLETED|Overall Study||55
183592|NCT00552084|425811|P1|COMPLETED|Overall Study||118
183593|NCT00552084|425810|P2|STARTED|Overall Study||64
183594|NCT00552084|425811|P1|STARTED|Overall Study||126
183595|NCT00552058|425819|P2|NOT COMPLETED|Overall Study||24
183596|NCT00552058|425820|P1|NOT COMPLETED|Overall Study||16
183597|NCT00552058|425819|P2|COMPLETED|Overall Study||192
183598|NCT00552058|425820|P1|COMPLETED|Overall Study||207
183599|NCT00552058|425819|P2|STARTED|Overall Study||216
183600|NCT00552058|425820|P1|STARTED|Overall Study||223
183601|NCT00552032|425860|P2|NOT COMPLETED|Overall Study||19
183602|NCT00552032|425861|P1|NOT COMPLETED|Overall Study||17
183603|NCT00552032|425860|P2|COMPLETED|Overall Study||47
183604|NCT00552032|425861|P1|COMPLETED|Overall Study||49
183605|NCT00552032|425860|P2|STARTED|Overall Study||66
183606|NCT00552032|425861|P1|STARTED|Overall Study||66
183607|NCT00551759|425905|P1|NOT COMPLETED|Overall Study||13
183608|NCT00551759|425905|P1|COMPLETED|Overall Study||9
183609|NCT00551759|425905|P1|Received Adjuvant Therapy|Overall Study||12
183610|NCT00551759|425905|P1|Underwent Surgery|Overall Study||17
183611|NCT00551759|425905|P1|Eligible and Began Treatment|Overall Study||21
183612|NCT00551759|425905|P1|STARTED|Overall Study||22
183613|NCT00551746|425911|P2|NOT COMPLETED|Overall Study||8
183614|NCT00551746|425912|P1|NOT COMPLETED|Overall Study||11
183615|NCT00551746|425911|P2|COMPLETED|Overall Study||26
183616|NCT00551746|425912|P1|COMPLETED|Overall Study||25
183617|NCT00551746|425911|P2|STARTED|Overall Study||34
183618|NCT00551746|425912|P1|STARTED|Overall Study||36
183619|NCT00551707|425923|P5|NOT COMPLETED|Overall Study||1
183620|NCT00551707|425924|P4|NOT COMPLETED|Overall Study||4
183621|NCT00551707|425925|P3|NOT COMPLETED|Overall Study||3
183622|NCT00551707|425926|P2|NOT COMPLETED|Overall Study||6
183623|NCT00551707|425927|P1|NOT COMPLETED|Overall Study||0
183624|NCT00551707|425923|P5|COMPLETED|Overall Study||3
183625|NCT00551707|425924|P4|COMPLETED|Overall Study||4
183626|NCT00551707|425925|P3|COMPLETED|Overall Study||10
183627|NCT00551707|425926|P2|COMPLETED|Overall Study||16
183628|NCT00551707|425927|P1|COMPLETED|Overall Study||4
183629|NCT00551707|425923|P5|STARTED|Overall Study||4
183630|NCT00551707|425924|P4|STARTED|Overall Study||8
183631|NCT00551707|425925|P3|STARTED|Overall Study||13
183632|NCT00551707|425926|P2|STARTED|Overall Study||22
183633|NCT00551707|425927|P1|STARTED|Overall Study||4
183634|NCT00551642|425946|P2|NOT COMPLETED|Overall Study||63
183635|NCT00551642|425947|P1|NOT COMPLETED|Overall Study||61
183636|NCT00551642|425946|P2|COMPLETED|Overall Study||338
183637|NCT00551642|425947|P1|COMPLETED|Overall Study||338
183638|NCT00551642|425946|P2|STARTED|Overall Study||401
183639|NCT00551642|425947|P1|STARTED|Overall Study||399
183640|NCT00551421|425953|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
183641|NCT00551421|425953|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
183642|NCT00551421|425953|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
183643|NCT00551421|425953|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
183737|NCT00550680|426276|P1|STARTED|Overall Study||208
183644|NCT00551421|425953|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
183645|NCT00551421|425953|P1|STARTED|Original Protocol, Dose Level 1||3
183646|NCT00551369|425960|P1|NOT COMPLETED|Overall Study||7
183647|NCT00551369|425960|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
183648|NCT00551369|425960|P1|STARTED|Overall Study||33
183649|NCT00551291|425967|P1|NOT COMPLETED|Overall Study||1
183650|NCT00551291|425967|P1|COMPLETED|Overall Study||9
183651|NCT00551291|425967|P1|STARTED|Overall Study||10
183652|NCT00551213|425975|P2|NOT COMPLETED|Overall Study||17
183653|NCT00551213|425976|P1|NOT COMPLETED|Overall Study||50
183654|NCT00551213|425975|P2|COMPLETED|Overall Study||0
183655|NCT00551213|425976|P1|COMPLETED|Overall Study||0
183656|NCT00551213|425975|P2|Treated|Overall Study||15
183657|NCT00551213|425976|P1|Treated|Overall Study||49
183658|NCT00551213|425975|P2|STARTED|Overall Study||17
183659|NCT00551213|425976|P1|STARTED|Overall Study||50
183660|NCT00551200|425992|P1|NOT COMPLETED|Overall Study||4
183661|NCT00551200|425992|P1|COMPLETED|Overall Study||10
183662|NCT00551200|425992|P1|STARTED|Overall Study||14
183663|NCT00551174|426007|P2|NOT COMPLETED|Overall Study||6
183664|NCT00551174|426008|P1|NOT COMPLETED|Overall Study||19
183665|NCT00551174|426007|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
183666|NCT00551174|426008|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
183667|NCT00551174|426007|P2|STARTED|Overall Study||400
183668|NCT00551174|426008|P1|STARTED|Overall Study||381
183669|NCT00551161|426020|P1|NOT COMPLETED|Overall Study||1
183670|NCT00551161|426020|P1|COMPLETED|Overall Study||11
183671|NCT00551161|426020|P1|STARTED|Overall Study||12
183672|NCT00551135|426028|P4|NOT COMPLETED|Overall Study||5
183673|NCT00551135|426029|P3|NOT COMPLETED|Overall Study||5
183674|NCT00551135|426030|P2|NOT COMPLETED|Overall Study||2
183675|NCT00551135|426031|P1|NOT COMPLETED|Overall Study||5
183676|NCT00551135|426028|P4|COMPLETED|Overall Study||103
183677|NCT00551135|426029|P3|COMPLETED|Overall Study||98
183678|NCT00551135|426030|P2|COMPLETED|Overall Study||104
183679|NCT00551135|426031|P1|COMPLETED|Overall Study||103
183680|NCT00551135|426028|P4|STARTED|Overall Study||108
183681|NCT00551135|426029|P3|STARTED|Overall Study||103
183682|NCT00551135|426030|P2|STARTED|Overall Study||106
183683|NCT00551135|426031|P1|STARTED|Overall Study||108
183684|NCT00551070|426145|P1|NOT COMPLETED|Overall Study||0
183685|NCT00551070|426145|P1|COMPLETED|Overall Study||52
183686|NCT00551070|426145|P1|STARTED|Overall Study||52
183687|NCT00551031|426160|P5|NOT COMPLETED|Overall Study||1
183688|NCT00551031|426161|P4|NOT COMPLETED|Overall Study||3
183689|NCT00551031|426162|P3|NOT COMPLETED|Overall Study||2
183690|NCT00551031|426163|P2|NOT COMPLETED|Overall Study||11
183691|NCT00551031|426164|P1|NOT COMPLETED|Overall Study||2
183692|NCT00551031|426160|P5|COMPLETED|Overall Study||185
183693|NCT00551031|426161|P4|COMPLETED|Overall Study||317
183694|NCT00551031|426162|P3|COMPLETED|Overall Study||317
183695|NCT00551031|426163|P2|COMPLETED|Overall Study||625
183696|NCT00551031|426164|P1|COMPLETED|Overall Study||635
183697|NCT00551031|426160|P5|STARTED|Overall Study||186
183698|NCT00551031|426161|P4|STARTED|Overall Study||320
183699|NCT00551031|426162|P3|STARTED|Overall Study||319
183700|NCT00551031|426163|P2|STARTED|Overall Study||636
183701|NCT00551031|426164|P1|STARTED|Overall Study||637
183702|NCT00550953|426193|P2|NOT COMPLETED|Overall Study||6
183703|NCT00550953|426194|P1|NOT COMPLETED|Overall Study||6
183704|NCT00550953|426193|P2|COMPLETED|Overall Study||152
183705|NCT00550953|426194|P1|COMPLETED|Overall Study||150
183706|NCT00550953|426193|P2|STARTED|Overall Study||158
183707|NCT00550953|426194|P1|STARTED|Overall Study||156
183708|NCT00550862|426218|P4|NOT COMPLETED|Overall Study||1
183709|NCT00550862|426219|P3|NOT COMPLETED|Overall Study||16
183710|NCT00550862|426220|P2|NOT COMPLETED|Overall Study||6
183711|NCT00550862|426221|P1|NOT COMPLETED|Overall Study||6
183712|NCT00550862|426218|P4|COMPLETED|Overall Study||37
183713|NCT00550862|426219|P3|COMPLETED|Overall Study||25
183714|NCT00550862|426220|P2|COMPLETED|Overall Study||42
183715|NCT00550862|426221|P1|COMPLETED|Overall Study||32
183716|NCT00550862|426218|P4|STARTED|Overall Study||38
183717|NCT00550862|426219|P3|STARTED|Overall Study||41
183718|NCT00550862|426220|P2|STARTED|Overall Study||48
183719|NCT00550862|426221|P1|STARTED|Overall Study||38
183720|NCT00550771|426241|P2|NOT COMPLETED|Overall Study||10
183721|NCT00550771|426242|P1|NOT COMPLETED|Overall Study||17
183722|NCT00550771|426241|P2|COMPLETED|Overall Study||50
183723|NCT00550771|426242|P1|COMPLETED|Overall Study||104
183724|NCT00550771|426241|P2|STARTED|Overall Study||60
183725|NCT00550771|426242|P1|STARTED|Overall Study||121
183726|NCT00550745|426256|P2|NOT COMPLETED|Overall Study||60
183727|NCT00550745|426257|P1|NOT COMPLETED|Overall Study||87
183728|NCT00550745|426256|P2|COMPLETED|Overall Study||5939
183729|NCT00550745|426257|P1|COMPLETED|Overall Study||5913
183730|NCT00550745|426256|P2|STARTED|Overall Study||5999
183731|NCT00550745|426257|P1|STARTED|Overall Study||6000
183732|NCT00550732|426265|P1|NOT COMPLETED|Overall Study||11
183733|NCT00550732|426265|P1|COMPLETED|Overall Study||29
183734|NCT00550732|426265|P1|STARTED|Overall Study||40
183735|NCT00550680|426276|P1|NOT COMPLETED|Overall Study||56
183736|NCT00550680|426276|P1|COMPLETED|Overall Study||152
183738|NCT00550654|426285|P1|NOT COMPLETED|Overall Study||0
183739|NCT00550654|426285|P1|COMPLETED|Overall Study||1
183740|NCT00550654|426285|P1|STARTED|Overall Study||1
183741|NCT00550589|426295|P1|NOT COMPLETED|Overall Study||0
183742|NCT00550589|426295|P1|COMPLETED|Overall Study||33
183743|NCT00550589|426295|P1|STARTED|Overall Study||33
183744|NCT00550550|426308|P2|NOT COMPLETED|Overall Study||29
183745|NCT00550550|426309|P1|NOT COMPLETED|Overall Study||34
183746|NCT00550550|426308|P2|COMPLETED|Overall Study||140
183747|NCT00550550|426309|P1|COMPLETED|Overall Study||142
183748|NCT00550550|426308|P2|Number Treated|Overall Study||169
183749|NCT00550550|426309|P1|Number Treated|Overall Study||175
183750|NCT00550550|426308|P2|STARTED|Overall Study||169
183751|NCT00550550|426309|P1|STARTED|Overall Study||176
183752|NCT00550459|426323|P2|NOT COMPLETED|Overall Study||3
183753|NCT00550459|426324|P1|NOT COMPLETED|Overall Study||1
183754|NCT00550459|426323|P2|COMPLETED|Overall Study||26
183755|NCT00550459|426324|P1|COMPLETED|Overall Study||27
183756|NCT00550459|426323|P2|STARTED|Overall Study||29
183757|NCT00550459|426324|P1|STARTED|Overall Study||28
183758|NCT00550446|426393|P11|NOT COMPLETED|Post Week 12||1
183759|NCT00550446|426394|P10|NOT COMPLETED|Post Week 12||7
183760|NCT00550446|426395|P9|NOT COMPLETED|Post Week 12||2
183761|NCT00550446|426396|P8|NOT COMPLETED|Post Week 12||1
183762|NCT00550446|426397|P7|NOT COMPLETED|Post Week 12||2
183763|NCT00550446|426398|P6|NOT COMPLETED|Post Week 12||1
183764|NCT00550446|426399|P5|NOT COMPLETED|Post Week 12||2
183765|NCT00550446|426400|P4|NOT COMPLETED|Post Week 12||3
183766|NCT00550446|426401|P3|NOT COMPLETED|Post Week 12||3
183767|NCT00550446|426402|P2|NOT COMPLETED|Post Week 12||2
183768|NCT00550446|426403|P1|NOT COMPLETED|Post Week 12||3
183769|NCT00550446|426393|P11|COMPLETED|Post Week 12||24
183770|NCT00550446|426394|P10|COMPLETED|Post Week 12||37
183771|NCT00550446|426395|P9|COMPLETED|Post Week 12||15
183772|NCT00550446|426396|P8|COMPLETED|Post Week 12||16
183773|NCT00550446|426397|P7|COMPLETED|Post Week 12||19
183774|NCT00550446|426398|P6|COMPLETED|Post Week 12||0
183775|NCT00550446|426399|P5|COMPLETED|Post Week 12||52
183776|NCT00550446|426400|P4|COMPLETED|Post Week 12||55
183777|NCT00550446|426401|P3|COMPLETED|Post Week 12||43
183778|NCT00550446|426402|P2|COMPLETED|Post Week 12||28
183779|NCT00550446|426403|P1|COMPLETED|Post Week 12||24
183780|NCT00550446|426393|P11|STARTED|Post Week 12||25
183781|NCT00550446|426394|P10|STARTED|Post Week 12||44
183782|NCT00550446|426395|P9|STARTED|Post Week 12||17
183783|NCT00550446|426396|P8|STARTED|Post Week 12||17
183784|NCT00550446|426397|P7|STARTED|Post Week 12||21
183785|NCT00550446|426398|P6|STARTED|Post Week 12||1
183786|NCT00550446|426399|P5|STARTED|Post Week 12||54
183787|NCT00550446|426400|P4|STARTED|Post Week 12||58
183788|NCT00550446|426401|P3|STARTED|Post Week 12||46
183789|NCT00550446|426402|P2|STARTED|Post Week 12||30
183790|NCT00550446|426403|P1|STARTED|Post Week 12||27
183791|NCT00550446|426393|P11|NOT COMPLETED|Up To Week 12||0
183792|NCT00550446|426394|P10|NOT COMPLETED|Up To Week 12||0
183793|NCT00550446|426395|P9|NOT COMPLETED|Up To Week 12||0
183794|NCT00550446|426396|P8|NOT COMPLETED|Up To Week 12||0
183795|NCT00550446|426397|P7|NOT COMPLETED|Up To Week 12||13
183796|NCT00550446|426398|P6|NOT COMPLETED|Up To Week 12||8
183797|NCT00550446|426399|P5|NOT COMPLETED|Up To Week 12||3
183798|NCT00550446|426400|P4|NOT COMPLETED|Up To Week 12||3
183799|NCT00550446|426401|P3|NOT COMPLETED|Up To Week 12||4
183800|NCT00550446|426402|P2|NOT COMPLETED|Up To Week 12||5
183801|NCT00550446|426403|P1|NOT COMPLETED|Up To Week 12||10
183802|NCT00550446|426393|P11|COMPLETED|Up To Week 12||0
183803|NCT00550446|426394|P10|COMPLETED|Up To Week 12||0
183804|NCT00550446|426395|P9|COMPLETED|Up To Week 12||0
183805|NCT00550446|426396|P8|COMPLETED|Up To Week 12||0
183806|NCT00550446|426397|P7|COMPLETED|Up To Week 12||46
183807|NCT00550446|426398|P6|COMPLETED|Up To Week 12||45
183808|NCT00550446|426399|P5|COMPLETED|Up To Week 12||54
183809|NCT00550446|426400|P4|COMPLETED|Up To Week 12||58
183810|NCT00550446|426401|P3|COMPLETED|Up To Week 12||46
183811|NCT00550446|426402|P2|COMPLETED|Up To Week 12||47
183812|NCT00550446|426403|P1|COMPLETED|Up To Week 12||44
183813|NCT00550446|426393|P11|Treated|Up To Week 12||0
183814|NCT00550446|426394|P10|Treated|Up To Week 12||0
183815|NCT00550446|426395|P9|Treated|Up To Week 12||0
183816|NCT00550446|426396|P8|Treated|Up To Week 12||0
183817|NCT00550446|426397|P7|Treated|Up To Week 12||59
183818|NCT00550446|426398|P6|Treated|Up To Week 12||53
183819|NCT00550446|426399|P5|Treated|Up To Week 12||57
183820|NCT00550446|426400|P4|Treated|Up To Week 12||61
183821|NCT00550446|426401|P3|Treated|Up To Week 12||49
183822|NCT00550446|426402|P2|Treated|Up To Week 12||51
183823|NCT00550446|426403|P1|Treated|Up To Week 12||54
183824|NCT00550446|426393|P11|STARTED|Up To Week 12||0
183825|NCT00550446|426394|P10|STARTED|Up To Week 12||0
183826|NCT00550446|426395|P9|STARTED|Up To Week 12||0
183827|NCT00550446|426396|P8|STARTED|Up To Week 12||0
183828|NCT00550446|426397|P7|STARTED|Up To Week 12||59
183829|NCT00550446|426398|P6|STARTED|Up To Week 12||53
183830|NCT00550446|426399|P5|STARTED|Up To Week 12||57
183831|NCT00550446|426400|P4|STARTED|Up To Week 12||61
183832|NCT00550446|426401|P3|STARTED|Up To Week 12||50
183833|NCT00550446|426402|P2|STARTED|Up To Week 12||52
183834|NCT00550446|426403|P1|STARTED|Up To Week 12||54
183835|NCT00550407|426837|P3|NOT COMPLETED|26-Week Randomized Phase||24
183836|NCT00550407|426838|P2|NOT COMPLETED|26-Week Randomized Phase||43
183837|NCT00550407|426839|P1|NOT COMPLETED|26-Week Randomized Phase||0
183838|NCT00550407|426837|P3|COMPLETED|26-Week Randomized Phase||21
183839|NCT00550407|426838|P2|COMPLETED|26-Week Randomized Phase||15
183840|NCT00550407|426839|P1|COMPLETED|26-Week Randomized Phase||0
183841|NCT00550407|426837|P3|STARTED|26-Week Randomized Phase||45
183842|NCT00550407|426838|P2|STARTED|26-Week Randomized Phase||58
183843|NCT00550407|426839|P1|STARTED|26-Week Randomized Phase||0
183844|NCT00550407|426837|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
183845|NCT00550407|426838|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
183846|NCT00550407|426839|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
183847|NCT00550407|426837|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
183848|NCT00550407|426838|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
183849|NCT00550407|426839|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
183850|NCT00550407|426837|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
183851|NCT00550407|426838|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
183852|NCT00550407|426839|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
183853|NCT00550368|426874|P2|NOT COMPLETED|Overall Study||0
183854|NCT00550368|426875|P1|NOT COMPLETED|Overall Study||0
183855|NCT00550368|426874|P2|COMPLETED|Overall Study||19
183856|NCT00550368|426875|P1|COMPLETED|Overall Study||26
183857|NCT00550368|426874|P2|STARTED|Overall Study||19
183858|NCT00550368|426875|P1|STARTED|Overall Study||26
183859|NCT00550277|426883|P1|NOT COMPLETED|Overall Study||9
183860|NCT00550277|426883|P1|COMPLETED|Overall Study||11
183861|NCT00550277|426883|P1|STARTED|Overall Study||20
183862|NCT00547703|426889|P2|NOT COMPLETED|Overall Study||0
183863|NCT00547703|426890|P1|NOT COMPLETED|Overall Study||1
183864|NCT00547703|426889|P2|COMPLETED|Overall Study||1
183865|NCT00547703|426890|P1|COMPLETED|Overall Study||3
183866|NCT00547703|426889|P2|STARTED|Overall Study||1
183867|NCT00547703|426890|P1|STARTED|Overall Study||4
183868|NCT00547638|426898|P2|NOT COMPLETED|Overall Study||14
183869|NCT00547638|426899|P1|NOT COMPLETED|Overall Study||24
183870|NCT00547638|426898|P2|COMPLETED|Overall Study||59
183871|NCT00547638|426899|P1|COMPLETED|Overall Study||119
183872|NCT00547638|426898|P2|STARTED|Overall Study||73
183873|NCT00547638|426899|P1|STARTED|Overall Study||143
183874|NCT00550173|426918|P3|NOT COMPLETED|Overall Study||73
183875|NCT00550173|426919|P2|NOT COMPLETED|Overall Study||63
183876|NCT00550173|426920|P1|NOT COMPLETED|Overall Study||72
183877|NCT00550173|426918|P3|COMPLETED|Overall Study||11
183878|NCT00550173|426919|P2|COMPLETED|Overall Study||19
183879|NCT00550173|426920|P1|COMPLETED|Overall Study||9
183880|NCT00550173|426918|P3|Not Discontinued at 18 Months|Overall Study||11
183881|NCT00550173|426919|P2|Not Discontinued at 18 Months|Overall Study||19
183882|NCT00550173|426920|P1|Not Discontinued at 18 Months|Overall Study||9
183883|NCT00550173|426918|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
183884|NCT00550173|426919|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
183885|NCT00550173|426920|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
183886|NCT00550173|426918|P3|STARTED|Overall Study||84
183887|NCT00550173|426919|P2|STARTED|Overall Study||82
183888|NCT00550173|426920|P1|STARTED|Overall Study||81
183889|NCT00550147|426949|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
183890|NCT00550147|426949|P1|COMPLETED|Quetiapine Addition Treatment Period||18
183891|NCT00550147|426949|P1|STARTED|Quetiapine Addition Treatment Period||24
183892|NCT00550147|426949|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
183893|NCT00550147|426949|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
183894|NCT00550147|426949|P1|STARTED|OROS Methylphenidate Monotherapy||30
183895|NCT00550043|426972|P5|NOT COMPLETED|Overall Study||1
183896|NCT00550043|426973|P4|NOT COMPLETED|Overall Study||2
183897|NCT00550043|426974|P3|NOT COMPLETED|Overall Study||1
183898|NCT00550043|426975|P2|NOT COMPLETED|Overall Study||3
183899|NCT00550043|426976|P1|NOT COMPLETED|Overall Study||0
183900|NCT00550043|426972|P5|COMPLETED|Overall Study||9
183901|NCT00550043|426973|P4|COMPLETED|Overall Study||8
183902|NCT00550043|426974|P3|COMPLETED|Overall Study||8
183903|NCT00550043|426975|P2|COMPLETED|Overall Study||9
183904|NCT00550043|426976|P1|COMPLETED|Overall Study||9
183905|NCT00550043|426972|P5|STARTED|Overall Study||10
183906|NCT00550043|426973|P4|STARTED|Overall Study||10
183907|NCT00550043|426974|P3|STARTED|Overall Study||9
183908|NCT00550043|426975|P2|STARTED|Overall Study||12
183909|NCT00550043|426976|P1|STARTED|Overall Study||9
183910|NCT00549939|427031|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
183911|NCT00549939|427032|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
183912|NCT00549939|427033|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
183913|NCT00549939|427031|P3|COMPLETED|40-week Open Label Treatment Period||78
183914|NCT00549939|427032|P2|COMPLETED|40-week Open Label Treatment Period||75
183915|NCT00549939|427033|P1|COMPLETED|40-week Open Label Treatment Period||0
183916|NCT00549939|427031|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
183917|NCT00549939|427032|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
183918|NCT00549939|427033|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
183919|NCT00549939|427031|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
183920|NCT00549939|427032|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
183921|NCT00549939|427033|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
183922|NCT00549939|427031|P3|COMPLETED|12-week Double Blind Treatment Period||56
183923|NCT00549939|427032|P2|COMPLETED|12-week Double Blind Treatment Period||55
183924|NCT00549939|427033|P1|COMPLETED|12-week Double Blind Treatment Period||56
183925|NCT00549939|427031|P3|STARTED|12-week Double Blind Treatment Period||58
183926|NCT00549939|427032|P2|STARTED|12-week Double Blind Treatment Period||57
183927|NCT00549939|427033|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
183928|NCT00549900|427060|P1|NOT COMPLETED|Overall Study||1
183929|NCT00549900|427060|P1|COMPLETED|Overall Study||29
183930|NCT00549900|427060|P1|STARTED|Overall Study||30
183931|NCT00549783|427071|P2|NOT COMPLETED|Overall Study||13
183932|NCT00549783|427072|P1|NOT COMPLETED|Overall Study||8
183933|NCT00549783|427071|P2|COMPLETED|Overall Study||122
183934|NCT00549783|427072|P1|COMPLETED|Overall Study||131
183935|NCT00549783|427071|P2|STARTED|Overall Study||135
183936|NCT00549783|427072|P1|STARTED|Overall Study||139
183937|NCT00549770|427110|P8|NOT COMPLETED|Overall Study||25
183938|NCT00549770|427111|P7|NOT COMPLETED|Overall Study||14
183939|NCT00549770|427112|P6|NOT COMPLETED|Overall Study||13
183940|NCT00549770|427113|P5|NOT COMPLETED|Overall Study||17
183941|NCT00549770|427114|P4|NOT COMPLETED|Overall Study||16
183942|NCT00549770|427115|P3|NOT COMPLETED|Overall Study||10
183943|NCT00549770|427116|P2|NOT COMPLETED|Overall Study||11
183944|NCT00549770|427117|P1|NOT COMPLETED|Overall Study||7
183945|NCT00549770|427110|P8|COMPLETED|Overall Study||148
183946|NCT00549770|427111|P7|COMPLETED|Overall Study||151
183947|NCT00549770|427112|P6|COMPLETED|Overall Study||151
183948|NCT00549770|427113|P5|COMPLETED|Overall Study||149
183949|NCT00549770|427114|P4|COMPLETED|Overall Study||147
183950|NCT00549770|427115|P3|COMPLETED|Overall Study||162
183951|NCT00549770|427116|P2|COMPLETED|Overall Study||158
183952|NCT00549770|427117|P1|COMPLETED|Overall Study||149
183953|NCT00549770|427110|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
183954|NCT00549770|427111|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
183955|NCT00549770|427112|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
183956|NCT00549770|427113|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
183957|NCT00549770|427114|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
183958|NCT00549770|427115|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
183959|NCT00549770|427116|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
183960|NCT00549770|427117|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
183961|NCT00549770|427110|P8|Intent-to-treat Population|Overall Study||172
183962|NCT00549770|427111|P7|Intent-to-treat Population|Overall Study||164
183963|NCT00549770|427112|P6|Intent-to-treat Population|Overall Study||163
183964|NCT00549770|427113|P5|Intent-to-treat Population|Overall Study||163
183965|NCT00549770|427114|P4|Intent-to-treat Population|Overall Study||163
183966|NCT00549770|427115|P3|Intent-to-treat Population|Overall Study||170
183967|NCT00549770|427116|P2|Intent-to-treat Population|Overall Study||168
183968|NCT00549770|427117|P1|Intent-to-treat Population|Overall Study||154
183969|NCT00549770|427110|P8|STARTED|Overall Study||173
183970|NCT00549770|427111|P7|STARTED|Overall Study||165
183971|NCT00549770|427112|P6|STARTED|Overall Study||164
183972|NCT00549770|427113|P5|STARTED|Overall Study||166
183973|NCT00549770|427114|P4|STARTED|Overall Study||163
183974|NCT00549770|427115|P3|STARTED|Overall Study||172
183975|NCT00549770|427116|P2|STARTED|Overall Study||169
183976|NCT00549770|427117|P1|STARTED|Overall Study||156
183977|NCT00549757|427201|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
183978|NCT00549757|427202|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
183979|NCT00549757|427201|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
183980|NCT00549757|427202|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
183981|NCT00549757|427201|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
183982|NCT00549757|427202|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
183983|NCT00549757|427201|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
183984|NCT00549757|427202|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
183985|NCT00549757|427201|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
183986|NCT00549757|427202|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
183987|NCT00549757|427201|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
183988|NCT00549757|427202|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
183989|NCT00549757|427201|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
183990|NCT00549757|427202|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
183991|NCT00549757|427201|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
183992|NCT00549757|427202|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
183993|NCT00549718|427264|P4|NOT COMPLETED|Overall Study||55
183994|NCT00549718|427265|P3|NOT COMPLETED|Overall Study||39
183995|NCT00549718|427266|P2|NOT COMPLETED|Overall Study||37
183996|NCT00549718|427267|P1|NOT COMPLETED|Overall Study||41
183997|NCT00549718|427264|P4|COMPLETED|Overall Study||73
183998|NCT00549718|427265|P3|COMPLETED|Overall Study||85
183999|NCT00549718|427266|P2|COMPLETED|Overall Study||86
184000|NCT00549718|427267|P1|COMPLETED|Overall Study||84
184001|NCT00549718|427264|P4|STARTED|Overall Study||128
184002|NCT00549718|427265|P3|STARTED|Overall Study||124
184003|NCT00549718|427266|P2|STARTED|Overall Study||123
184004|NCT00549718|427267|P1|STARTED|Overall Study||125
184005|NCT00549640|427283|P2|NOT COMPLETED|Overall Study||16
184006|NCT00549640|427284|P1|NOT COMPLETED|Overall Study||18
184007|NCT00549640|427283|P2|COMPLETED|Overall Study||24
184008|NCT00549640|427284|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
184009|NCT00549640|427283|P2|STARTED|Overall Study||40
184010|NCT00549640|427284|P1|STARTED|Overall Study||40
184011|NCT00549601|427297|P3|NOT COMPLETED|Received Study Drug||4
184012|NCT00549601|427298|P2|NOT COMPLETED|Received Study Drug||11
184013|NCT00549601|427299|P1|NOT COMPLETED|Received Study Drug||7
184014|NCT00549601|427297|P3|COMPLETED|Received Study Drug||45
184015|NCT00549601|427298|P2|COMPLETED|Received Study Drug||36
184016|NCT00549601|427299|P1|COMPLETED|Received Study Drug||36
184017|NCT00549601|427297|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
184018|NCT00549601|427298|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
184019|NCT00549601|427299|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
184020|NCT00549601|427297|P3|NOT COMPLETED|Randomized||2
184021|NCT00549601|427298|P2|NOT COMPLETED|Randomized||1
184022|NCT00549601|427299|P1|NOT COMPLETED|Randomized||0
184023|NCT00549601|427297|P3|COMPLETED|Randomized||49
184024|NCT00549601|427298|P2|COMPLETED|Randomized||47
184025|NCT00549601|427299|P1|COMPLETED|Randomized||43
184026|NCT00549601|427297|P3|STARTED|Randomized||51
184027|NCT00549601|427298|P2|STARTED|Randomized||48
184028|NCT00549601|427299|P1|STARTED|Randomized||43
184029|NCT00549549|427325|P4|NOT COMPLETED|Overall Study||25
184030|NCT00549549|427326|P3|NOT COMPLETED|Overall Study||17
184031|NCT00549549|427327|P2|NOT COMPLETED|Overall Study||22
184032|NCT00549549|427328|P1|NOT COMPLETED|Overall Study||24
184033|NCT00549549|427325|P4|COMPLETED|Overall Study||78
184034|NCT00549549|427326|P3|COMPLETED|Overall Study||82
184035|NCT00549549|427327|P2|COMPLETED|Overall Study||77
184036|NCT00549549|427328|P1|COMPLETED|Overall Study||77
184037|NCT00549549|427325|P4|Treated|Overall Study||102
184038|NCT00549549|427326|P3|Treated|Overall Study||98
184039|NCT00549549|427327|P2|Treated|Overall Study||99
184040|NCT00549549|427328|P1|Treated|Overall Study||101
184041|NCT00549549|427325|P4|STARTED|Overall Study||103
184042|NCT00549549|427326|P3|STARTED|Overall Study||99
184043|NCT00549549|427327|P2|STARTED|Overall Study||99
184044|NCT00549549|427328|P1|STARTED|Overall Study||101
184045|NCT00549393|427396|P2|NOT COMPLETED|Period 2||0
184046|NCT00549393|427397|P1|NOT COMPLETED|Period 2||0
184047|NCT00549393|427396|P2|COMPLETED|Period 2||1326
184048|NCT00549393|427397|P1|COMPLETED|Period 2||1103
184049|NCT00549393|427396|P2|STARTED|Period 2|number not equal to period 1 due to unit cross over design|1326
184050|NCT00549393|427397|P1|STARTED|Period 2|number not equal to period 1 due to unit cross over design|1103
184051|NCT00549393|427396|P2|NOT COMPLETED|Period 1||0
184052|NCT00549393|427397|P1|NOT COMPLETED|Period 1||0
184053|NCT00549393|427396|P2|COMPLETED|Period 1||1199
184054|NCT00549393|427397|P1|COMPLETED|Period 1||1319
184055|NCT00549393|427396|P2|STARTED|Period 1|ITT|1199
184056|NCT00549393|427397|P1|STARTED|Period 1|intention to treat (ITT)|1319
184057|NCT00549328|427407|P1|NOT COMPLETED|Overall Study||14
184058|NCT00549328|427407|P1|COMPLETED|Overall Study||0
184059|NCT00549328|427407|P1|STARTED|Overall Study||14
184060|NCT00549302|427418|P3|NOT COMPLETED|Open-Label||69
184061|NCT00549302|427419|P2|NOT COMPLETED|Open-Label||0
184062|NCT00549302|427420|P1|NOT COMPLETED|Open-Label||0
184063|NCT00549302|427418|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
184064|NCT00549302|427419|P2|COMPLETED|Open-Label||0
184065|NCT00549302|427420|P1|COMPLETED|Open-Label||0
184066|NCT00549302|427418|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
184067|NCT00549302|427419|P2|STARTED|Open-Label||0
184068|NCT00549302|427420|P1|STARTED|Open-Label||0
184069|NCT00549302|427418|P3|NOT COMPLETED|Double-Blind||0
184070|NCT00549302|427419|P2|NOT COMPLETED|Double-Blind||53
184071|NCT00549302|427420|P1|NOT COMPLETED|Double-Blind||11
184072|NCT00549302|427418|P3|COMPLETED|Double-Blind||0
184073|NCT00549302|427419|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
184074|NCT00549302|427420|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
184075|NCT00549302|427418|P3|Received at Least One Dose of Study Drug|Double-Blind||0
184076|NCT00549302|427419|P2|Received at Least One Dose of Study Drug|Double-Blind||294
184077|NCT00549302|427420|P1|Received at Least One Dose of Study Drug|Double-Blind||63
184078|NCT00549302|427418|P3|STARTED|Double-Blind||0
184079|NCT00549302|427419|P2|STARTED|Double-Blind||294
184080|NCT00549302|427420|P1|STARTED|Double-Blind||63
184081|NCT00547534|427430|P1|NOT COMPLETED|Overall Study||11
184082|NCT00547534|427430|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
184083|NCT00547534|427430|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
184084|NCT00547521|427438|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
184085|NCT00547521|427439|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
184086|NCT00547521|427438|P2|COMPLETED|Long Term Extension (LTE) Study||59
184087|NCT00547521|427439|P1|COMPLETED|Long Term Extension (LTE) Study||0
184088|NCT00547521|427438|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
184089|NCT00547521|427439|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
184090|NCT00547521|427438|P2|NOT COMPLETED|Short Term Study (4 Months)||4
184091|NCT00547521|427439|P1|NOT COMPLETED|Short Term Study (4 Months)||1
184092|NCT00547521|427438|P2|COMPLETED|Short Term Study (4 Months)||45
184093|NCT00547521|427439|P1|COMPLETED|Short Term Study (4 Months)||50
184094|NCT00547521|427438|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
184095|NCT00547521|427439|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
184096|NCT00549198|427511|P2|NOT COMPLETED|Overall Study||63
184097|NCT00549198|427512|P1|NOT COMPLETED|Overall Study||80
184098|NCT00549198|427511|P2|COMPLETED|Overall Study||134
184099|NCT00549198|427512|P1|COMPLETED|Overall Study||115
184100|NCT00549198|427511|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
184101|NCT00549198|427512|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
184102|NCT00549172|427634|P2|NOT COMPLETED|Overall Study||0
184103|NCT00549172|427635|P1|NOT COMPLETED|Overall Study||0
184104|NCT00549172|427634|P2|COMPLETED|Overall Study||76
184105|NCT00549172|427635|P1|COMPLETED|Overall Study||70
184106|NCT00549172|427634|P2|STARTED|Overall Study||76
184107|NCT00549172|427635|P1|STARTED|Overall Study||70
184108|NCT00549055|427649|P1|NOT COMPLETED|Overall Study||35
184109|NCT00549055|427649|P1|COMPLETED|Overall Study||3
184110|NCT00549055|427649|P1|STARTED|Overall Study||38
184111|NCT00548886|427659|P1|NOT COMPLETED|Overall Study||0
184112|NCT00548886|427659|P1|COMPLETED|Overall Study||7
184113|NCT00548886|427659|P1|STARTED|Overall Study||7
184114|NCT00548860|427665|P2|NOT COMPLETED|Overall Study||175
184115|NCT00548860|427666|P1|NOT COMPLETED|Overall Study||136
184116|NCT00548860|427665|P2|COMPLETED|Overall Study||847
184117|NCT00548860|427666|P1|COMPLETED|Overall Study||860
184118|NCT00548860|427665|P2|STARTED|Overall Study||1022
184119|NCT00548860|427666|P1|STARTED|Overall Study||996
184120|NCT00548847|427672|P1|NOT COMPLETED|Overall Study||7
184121|NCT00548847|427672|P1|COMPLETED|Overall Study||8
184122|NCT00548847|427672|P1|STARTED|Overall Study||15
184123|NCT00548808|427679|P2|NOT COMPLETED|Overall Study||26
184124|NCT00548808|427680|P1|NOT COMPLETED|Overall Study||42
184125|NCT00548808|427679|P2|COMPLETED|Overall Study||186
184126|NCT00548808|427680|P1|COMPLETED|Overall Study||172
184127|NCT00548808|427679|P2|Per-Protocol Set|Overall Study||184
184128|NCT00548808|427680|P1|Per-Protocol Set|Overall Study||177
184129|NCT00548808|427679|P2|Full Analysis Set|Overall Study||212
184130|NCT00548808|427680|P1|Full Analysis Set|Overall Study||211
184131|NCT00548808|427679|P2|STARTED|Overall Study||212
184132|NCT00548808|427680|P1|STARTED|Overall Study||214
184133|NCT00548717|427704|P2|NOT COMPLETED|Overall Study||2
184134|NCT00548717|427705|P1|NOT COMPLETED|Overall Study||9
184135|NCT00548717|427704|P2|COMPLETED|Overall Study||0
184136|NCT00548717|427705|P1|COMPLETED|Overall Study||4
184137|NCT00548717|427704|P2|STARTED|Overall Study||2
184138|NCT00548717|427705|P1|STARTED|Overall Study||13
184139|NCT00548691|427724|P2|NOT COMPLETED|Overall Study||9
184140|NCT00548691|427725|P1|NOT COMPLETED|Overall Study||7
184141|NCT00548691|427724|P2|COMPLETED|Overall Study||250
184142|NCT00548691|427725|P1|COMPLETED|Overall Study||251
184143|NCT00548691|427724|P2|STARTED|Overall Study||259
184144|NCT00548691|427725|P1|STARTED|Overall Study||258
184145|NCT00548548|427733|P2|NOT COMPLETED|Overall Study||366
184146|NCT00548548|427734|P1|NOT COMPLETED|Overall Study||362
184147|NCT00548548|427733|P2|COMPLETED|Overall Study||21
184148|NCT00548548|427734|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
184149|NCT00548548|427733|P2|Safety Population|Overall Study||381
184150|NCT00548548|427734|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
184151|NCT00548548|427733|P2|Treated|Overall Study||384
184152|NCT00548548|427734|P1|Treated|Overall Study||383
184153|NCT00548548|427733|P2|STARTED|Overall Study||387
184154|NCT00548548|427734|P1|STARTED|Overall Study||387
184155|NCT00547456|427754|P1|NOT COMPLETED|Overall Study||0
184156|NCT00547456|427754|P1|COMPLETED|Overall Study||20
184157|NCT00547456|427754|P1|STARTED|Overall Study||20
184158|NCT00547365|427758|P1|NOT COMPLETED|Overall Study||8
184159|NCT00547365|427758|P1|COMPLETED|Overall Study||2
184160|NCT00547365|427758|P1|STARTED|Overall Study||10
184161|NCT00548431|427763|P1|NOT COMPLETED|Overall Study||0
184162|NCT00548431|427763|P1|COMPLETED|Overall Study||38
184163|NCT00548431|427763|P1|STARTED|Overall Study||38
184164|NCT00548418|427767|P1|NOT COMPLETED|Overall Study||0
184165|NCT00548418|427767|P1|COMPLETED|Overall Study||27
184166|NCT00548418|427767|P1|STARTED|Overall Study||27
184167|NCT00548405|427778|P3|NOT COMPLETED|Overall Study||9
184168|NCT00548405|427779|P2|NOT COMPLETED|Overall Study||20
184169|NCT00548405|427780|P1|NOT COMPLETED|Overall Study||56
184170|NCT00548405|427778|P3|COMPLETED|Overall Study||164
184171|NCT00548405|427779|P2|COMPLETED|Overall Study||416
184172|NCT00548405|427780|P1|COMPLETED|Overall Study||175
184173|NCT00548405|427778|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
184174|NCT00548405|427779|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
184175|NCT00548405|427780|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
184176|NCT00548405|427778|P3|STARTED|Overall Study|Randomized.|173
184177|NCT00548405|427779|P2|STARTED|Overall Study|Randomized.|436
184178|NCT00548405|427780|P1|STARTED|Overall Study|Randomized.|231
184179|NCT00548340|427801|P3|NOT COMPLETED|Overall Study||9
184180|NCT00548340|427802|P2|NOT COMPLETED|Overall Study||11
184181|NCT00548340|427803|P1|NOT COMPLETED|Overall Study||8
184182|NCT00548340|427801|P3|COMPLETED|Overall Study||95
184183|NCT00548340|427802|P2|COMPLETED|Overall Study||98
184184|NCT00548340|427803|P1|COMPLETED|Overall Study||101
184185|NCT00548340|427801|P3|STARTED|Overall Study||104
184186|NCT00548340|427802|P2|STARTED|Overall Study||109
184187|NCT00548340|427803|P1|STARTED|Overall Study||109
184188|NCT00548327|427822|P2|NOT COMPLETED|Overall Study||1
184189|NCT00548327|427823|P1|NOT COMPLETED|Overall Study||0
184190|NCT00548327|427822|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
184191|NCT00548327|427823|P1|COMPLETED|Overall Study||6
184192|NCT00548327|427822|P2|STARTED|Overall Study||5
184193|NCT00548327|427823|P1|STARTED|Overall Study||6
184194|NCT00548262|427841|P1|NOT COMPLETED|Overall Study||32
184195|NCT00548262|427841|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
184196|NCT00548262|427841|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
184197|NCT00548249|427871|P5|NOT COMPLETED|Overall Study||21
184198|NCT00548249|427872|P4|NOT COMPLETED|Overall Study||13
184199|NCT00548249|427873|P3|NOT COMPLETED|Overall Study||20
184200|NCT00548249|427874|P2|NOT COMPLETED|Overall Study||13
184201|NCT00548249|427875|P1|NOT COMPLETED|Overall Study||16
184202|NCT00548249|427871|P5|COMPLETED|Overall Study||7
184203|NCT00548249|427872|P4|COMPLETED|Overall Study||9
184204|NCT00548249|427873|P3|COMPLETED|Overall Study||9
184205|NCT00548249|427874|P2|COMPLETED|Overall Study||13
184206|NCT00548249|427875|P1|COMPLETED|Overall Study||10
184207|NCT00548249|427871|P5|STARTED|Overall Study||28
184208|NCT00548249|427872|P4|STARTED|Overall Study||22
184209|NCT00548249|427873|P3|STARTED|Overall Study||29
184210|NCT00548249|427874|P2|STARTED|Overall Study||26
184211|NCT00548249|427875|P1|STARTED|Overall Study||26
184212|NCT00548184|427912|P1|NOT COMPLETED|Overall Study||5
184213|NCT00548184|427912|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
184214|NCT00548184|427912|P1|STARTED|Overall Study||65
184215|NCT00548145|427918|P2|NOT COMPLETED|Overall Study||4
184216|NCT00548145|427919|P1|NOT COMPLETED|Overall Study||1
184217|NCT00548145|427918|P2|COMPLETED|Overall Study||16
184218|NCT00548145|427919|P1|COMPLETED|Overall Study||17
184219|NCT00548145|427918|P2|STARTED|Overall Study||20
184220|NCT00548145|427919|P1|STARTED|Overall Study||18
184221|NCT00548132|427927|P2|NOT COMPLETED|Overall Study||0
184222|NCT00548132|427928|P1|NOT COMPLETED|Overall Study||0
184223|NCT00548132|427927|P2|COMPLETED|Overall Study||554
184224|NCT00548132|427928|P1|COMPLETED|Overall Study||534
184225|NCT00548132|427927|P2|Consented to Study|Overall Study||554
184226|NCT00548132|427928|P1|Consented to Study|Overall Study||534
184227|NCT00548132|427927|P2|STARTED|Overall Study||554
184228|NCT00548132|427928|P1|STARTED|Overall Study||534
184229|NCT00548041|427936|P1|NOT COMPLETED|Overall Study||0
184230|NCT00548041|427936|P1|COMPLETED|Overall Study||100
184231|NCT00548041|427936|P1|STARTED|Overall Study||100
184232|NCT00547911|427944|P6|NOT COMPLETED|Overall Study||0
184233|NCT00547911|427945|P5|NOT COMPLETED|Overall Study||0
184234|NCT00547911|427946|P4|NOT COMPLETED|Overall Study||1
184235|NCT00547911|427947|P3|NOT COMPLETED|Overall Study||0
184236|NCT00547911|427948|P2|NOT COMPLETED|Overall Study||0
184237|NCT00547911|427949|P1|NOT COMPLETED|Overall Study||0
184238|NCT00547911|427944|P6|COMPLETED|Overall Study||3
184239|NCT00547911|427945|P5|COMPLETED|Overall Study||3
184240|NCT00547911|427946|P4|COMPLETED|Overall Study||1
184241|NCT00547911|427947|P3|COMPLETED|Overall Study||2
184242|NCT00547911|427948|P2|COMPLETED|Overall Study||2
184243|NCT00547911|427949|P1|COMPLETED|Overall Study||2
184244|NCT00547911|427944|P6|STARTED|Overall Study||3
184245|NCT00547911|427945|P5|STARTED|Overall Study||3
184246|NCT00547911|427946|P4|STARTED|Overall Study||2
184247|NCT00547911|427947|P3|STARTED|Overall Study||2
184248|NCT00547911|427948|P2|STARTED|Overall Study||2
184249|NCT00547911|427949|P1|STARTED|Overall Study||2
184250|NCT00547157|427980|P2|NOT COMPLETED|Overall Study||23
184251|NCT00547157|427981|P1|NOT COMPLETED|Overall Study||49
184252|NCT00547157|427980|P2|COMPLETED|Overall Study||39
184253|NCT00547157|427981|P1|COMPLETED|Overall Study||41
184254|NCT00547157|427980|P2|STARTED|Overall Study||62
184255|NCT00547157|427981|P1|STARTED|Overall Study||90
184256|NCT00547118|427999|P2|NOT COMPLETED|Overall Study||2
184257|NCT00547118|428000|P1|NOT COMPLETED|Overall Study||1
184258|NCT00547118|427999|P2|COMPLETED|Overall Study||7
184259|NCT00547118|428000|P1|COMPLETED|Overall Study||7
184260|NCT00547118|427999|P2|STARTED|Overall Study||9
184261|NCT00547118|428000|P1|STARTED|Overall Study||8
184262|NCT00546910|428008|P2|NOT COMPLETED|Overall Study||11
184263|NCT00546910|428009|P1|NOT COMPLETED|Overall Study||9
184264|NCT00546910|428008|P2|COMPLETED|Overall Study||51
184265|NCT00546910|428009|P1|COMPLETED|Overall Study||54
184266|NCT00546910|428008|P2|STARTED|Overall Study||62
184267|NCT00546910|428009|P1|STARTED|Overall Study||63
184268|NCT00546897|428029|P2|NOT COMPLETED|Overall Study||0
184269|NCT00546897|428030|P1|NOT COMPLETED|Overall Study||0
184270|NCT00546897|428029|P2|COMPLETED|Overall Study||33
184271|NCT00546897|428030|P1|COMPLETED|Overall Study||15
184272|NCT00546897|428029|P2|STARTED|Overall Study||33
184273|NCT00546897|428030|P1|STARTED|Overall Study||15
184274|NCT00546871|428066|P2|NOT COMPLETED|Study Extension Period||1
184275|NCT00546871|428067|P1|NOT COMPLETED|Study Extension Period||1
184276|NCT00546871|428066|P2|COMPLETED|Study Extension Period||25
184277|NCT00546871|428067|P1|COMPLETED|Study Extension Period||9
184278|NCT00546871|428066|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
184279|NCT00546871|428067|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
184280|NCT00546871|428066|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
184281|NCT00546871|428067|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
184282|NCT00546871|428066|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
184283|NCT00546871|428067|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
184284|NCT00546871|428066|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
184285|NCT00546871|428067|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
184286|NCT00546871|428066|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
184287|NCT00546871|428067|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
184288|NCT00546871|428066|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
184289|NCT00546871|428067|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
184290|NCT00546871|428066|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
184291|NCT00546871|428067|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
184292|NCT00546871|428066|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
184293|NCT00546871|428067|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
184294|NCT00546871|428066|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
184295|NCT00546871|428067|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
184296|NCT00546871|428066|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
184297|NCT00546871|428067|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
184298|NCT00546871|428066|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
184299|NCT00546871|428067|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
184300|NCT00546871|428066|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
184301|NCT00546871|428067|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
184302|NCT00546871|428066|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
184303|NCT00546871|428067|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
184304|NCT00546819|428172|P2|NOT COMPLETED|Overall Study||6
184305|NCT00546819|428173|P1|NOT COMPLETED|Overall Study||8
184306|NCT00546819|428172|P2|COMPLETED|Overall Study||96
184307|NCT00546819|428173|P1|COMPLETED|Overall Study||199
184308|NCT00546819|428172|P2|VACCINATED|Overall Study||100
184309|NCT00546819|428173|P1|VACCINATED|Overall Study||206
184310|NCT00546819|428172|P2|STARTED|Overall Study||102
184311|NCT00546819|428173|P1|STARTED|Overall Study||207
184312|NCT00546754|428185|P2|NOT COMPLETED|Overall Study||49
184313|NCT00546754|428186|P1|NOT COMPLETED|Overall Study||50
184314|NCT00546754|428185|P2|COMPLETED|Overall Study||334
184315|NCT00546754|428186|P1|COMPLETED|Overall Study||375
184316|NCT00546754|428185|P2|Week 12|Overall Study||334
184317|NCT00546754|428186|P1|Week 12|Overall Study||375
184318|NCT00546754|428185|P2|Week 6|Overall Study||347
184319|NCT00546754|428186|P1|Week 6|Overall Study||396
184320|NCT00546754|428185|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
184321|NCT00546754|428186|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
184322|NCT00546754|428185|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
184323|NCT00546754|428186|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
184324|NCT00546728|428218|P2|NOT COMPLETED|Overall Study||0
184325|NCT00546728|428219|P1|NOT COMPLETED|Overall Study||0
184326|NCT00546728|428218|P2|COMPLETED|Overall Study||25
184327|NCT00546728|428219|P1|COMPLETED|Overall Study||25
184328|NCT00546728|428218|P2|STARTED|Overall Study||25
184329|NCT00546728|428219|P1|STARTED|Overall Study||25
184330|NCT00546715|428229|P4|NOT COMPLETED|Overall Study||0
184331|NCT00546715|428230|P3|NOT COMPLETED|Overall Study||0
184332|NCT00546715|428231|P2|NOT COMPLETED|Overall Study||1
184333|NCT00546715|428232|P1|NOT COMPLETED|Overall Study||0
184334|NCT00546715|428229|P4|COMPLETED|Overall Study||2
184335|NCT00546715|428230|P3|COMPLETED|Overall Study||5
184336|NCT00546715|428231|P2|COMPLETED|Overall Study||4
184337|NCT00546715|428232|P1|COMPLETED|Overall Study||6
184338|NCT00546715|428229|P4|STARTED|Overall Study||2
184339|NCT00546715|428230|P3|STARTED|Overall Study||5
184340|NCT00546715|428231|P2|STARTED|Overall Study||5
184341|NCT00546715|428232|P1|STARTED|Overall Study||6
184342|NCT00546637|428287|P2|NOT COMPLETED|Overall Study||49
184343|NCT00546637|428288|P1|NOT COMPLETED|Overall Study||73
184344|NCT00546637|428287|P2|COMPLETED|Overall Study||424
184345|NCT00546637|428288|P1|COMPLETED|Overall Study||401
184346|NCT00546637|428287|P2|Received Treatment|Overall Study||472
184347|NCT00546637|428288|P1|Received Treatment|Overall Study||471
184348|NCT00546637|428287|P2|STARTED|Overall Study||473
184349|NCT00546637|428288|P1|STARTED|Overall Study||474
184350|NCT00546572|428362|P2|NOT COMPLETED|Vax 2 / Year 1||2
184351|NCT00546572|428363|P1|NOT COMPLETED|Vax 2 / Year 1||4
184352|NCT00546572|428362|P2|COMPLETED|Vax 2 / Year 1||402
184353|NCT00546572|428363|P1|COMPLETED|Vax 2 / Year 1||387
184354|NCT00546572|428362|P2|Received Vax 2|Vax 2 / Year 1||404
184355|NCT00546572|428363|P1|Received Vax 2|Vax 2 / Year 1||391
184356|NCT00546572|428362|P2|STARTED|Vax 2 / Year 1||404
184357|NCT00546572|428363|P1|STARTED|Vax 2 / Year 1||391
184358|NCT00546572|428362|P2|NOT COMPLETED|Vax 1 / Year 0||70
184359|NCT00546572|428363|P1|NOT COMPLETED|Vax 1 / Year 0||73
184360|NCT00546572|428362|P2|COMPLETED|Vax 1 / Year 0||404
184361|NCT00546572|428363|P1|COMPLETED|Vax 1 / Year 0||391
184362|NCT00546572|428362|P2|Received Vax 1|Vax 1 / Year 0||473
184363|NCT00546572|428363|P1|Received Vax 1|Vax 1 / Year 0||463
184364|NCT00546572|428362|P2|STARTED|Vax 1 / Year 0||474
184365|NCT00546572|428363|P1|STARTED|Vax 1 / Year 0||464
184366|NCT00546481|428407|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
184367|NCT00546481|428408|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
184368|NCT00546481|428409|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
184369|NCT00546481|428407|P3|COMPLETED|Maintenance Phase (CERA)||50
184370|NCT00546481|428408|P2|COMPLETED|Maintenance Phase (CERA)||0
184371|NCT00546481|428409|P1|COMPLETED|Maintenance Phase (CERA)||0
184372|NCT00546481|428407|P3|STARTED|Maintenance Phase (CERA)||54
184373|NCT00546481|428408|P2|STARTED|Maintenance Phase (CERA)||0
184374|NCT00546481|428409|P1|STARTED|Maintenance Phase (CERA)||0
184375|NCT00546481|428407|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
184376|NCT00546481|428408|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
184377|NCT00546481|428409|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
184378|NCT00546481|428407|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
184379|NCT00546481|428408|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
184380|NCT00546481|428409|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
184381|NCT00546481|428407|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
184382|NCT00546481|428408|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
184383|NCT00546481|428409|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
184384|NCT00546429|428432|P1|NOT COMPLETED|Overall Study||30
184385|NCT00546429|428432|P1|COMPLETED|Overall Study||32
184386|NCT00546429|428432|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
184387|NCT00546377|428436|P1|NOT COMPLETED|Overall Study||7
184388|NCT00546377|428436|P1|COMPLETED|Overall Study||43
184389|NCT00546377|428436|P1|STARTED|Overall Study||50
184390|NCT00546364|428444|P3|NOT COMPLETED|Overall Study||17
184391|NCT00546364|428445|P2|NOT COMPLETED|Overall Study||18
184392|NCT00546364|428446|P1|NOT COMPLETED|Overall Study||17
184393|NCT00546364|428444|P3|COMPLETED|Overall Study|Still on treatment|3
184394|NCT00546364|428445|P2|COMPLETED|Overall Study|Still on treatment|4
184395|NCT00546364|428446|P1|COMPLETED|Overall Study|Still on treatment|3
184396|NCT00546364|428444|P3|Never Treated|Overall Study||0
184397|NCT00546364|428445|P2|Never Treated|Overall Study||0
184398|NCT00546364|428446|P1|Never Treated|Overall Study||0
184399|NCT00546364|428444|P3|STARTED|Overall Study||20
184400|NCT00546364|428445|P2|STARTED|Overall Study||22
184401|NCT00546364|428446|P1|STARTED|Overall Study||20
184402|NCT00546351|428481|P1|NOT COMPLETED|Overall Study||236
184403|NCT00546351|428481|P1|COMPLETED|Overall Study||385
184404|NCT00546351|428481|P1|STARTED|Overall Study||621
184405|NCT00546273|428514|P5|NOT COMPLETED|IV||0
184406|NCT00546273|428515|P4|NOT COMPLETED|IV||0
184407|NCT00546273|428516|P3|NOT COMPLETED|IV||0
184408|NCT00546273|428517|P2|NOT COMPLETED|IV||0
184409|NCT00546273|428518|P1|NOT COMPLETED|IV||0
184410|NCT00546273|428514|P5|COMPLETED|IV||2
184411|NCT00546273|428515|P4|COMPLETED|IV||4
184412|NCT00546273|428516|P3|COMPLETED|IV||0
184413|NCT00546273|428517|P2|COMPLETED|IV||0
184414|NCT00546273|428518|P1|COMPLETED|IV||0
184415|NCT00546273|428514|P5|STARTED|IV||2
184416|NCT00546273|428515|P4|STARTED|IV||4
184417|NCT00546273|428516|P3|STARTED|IV||0
184418|NCT00546273|428517|P2|STARTED|IV||0
184419|NCT00546273|428518|P1|STARTED|IV||0
184420|NCT00546273|428514|P5|NOT COMPLETED|III||0
184421|NCT00546273|428515|P4|NOT COMPLETED|III||0
184422|NCT00546273|428516|P3|NOT COMPLETED|III||0
184423|NCT00546273|428517|P2|NOT COMPLETED|III||0
184424|NCT00546273|428518|P1|NOT COMPLETED|III||0
184425|NCT00546273|428514|P5|COMPLETED|III||2
184426|NCT00546273|428515|P4|COMPLETED|III||0
184427|NCT00546273|428516|P3|COMPLETED|III||4
184428|NCT00546273|428517|P2|COMPLETED|III||0
184429|NCT00546273|428518|P1|COMPLETED|III||0
184430|NCT00546273|428514|P5|STARTED|III||2
184431|NCT00546273|428515|P4|STARTED|III||0
184432|NCT00546273|428516|P3|STARTED|III||4
184433|NCT00546273|428517|P2|STARTED|III||0
184434|NCT00546273|428518|P1|STARTED|III||0
184435|NCT00546273|428514|P5|NOT COMPLETED|II||0
184436|NCT00546273|428515|P4|NOT COMPLETED|II||0
184437|NCT00546273|428516|P3|NOT COMPLETED|II||0
184438|NCT00546273|428517|P2|NOT COMPLETED|II||0
184439|NCT00546273|428518|P1|NOT COMPLETED|II||0
184440|NCT00546273|428514|P5|COMPLETED|II||2
184441|NCT00546273|428515|P4|COMPLETED|II||0
184442|NCT00546273|428516|P3|COMPLETED|II||0
184443|NCT00546273|428517|P2|COMPLETED|II||4
184444|NCT00546273|428518|P1|COMPLETED|II||0
184445|NCT00546273|428514|P5|STARTED|II||2
184446|NCT00546273|428515|P4|STARTED|II||0
184447|NCT00546273|428516|P3|STARTED|II||0
184448|NCT00546273|428517|P2|STARTED|II||4
184449|NCT00546273|428518|P1|STARTED|II||0
184450|NCT00546273|428514|P5|NOT COMPLETED|I||0
184451|NCT00546273|428515|P4|NOT COMPLETED|I||0
184452|NCT00546273|428516|P3|NOT COMPLETED|I||0
184453|NCT00546273|428517|P2|NOT COMPLETED|I||0
184454|NCT00546273|428518|P1|NOT COMPLETED|I||0
184455|NCT00546273|428514|P5|COMPLETED|I||2
184456|NCT00546273|428515|P4|COMPLETED|I||0
184457|NCT00546273|428516|P3|COMPLETED|I||0
184458|NCT00546273|428517|P2|COMPLETED|I||0
184459|NCT00546273|428518|P1|COMPLETED|I||4
184460|NCT00546273|428514|P5|STARTED|I||2
184461|NCT00546273|428515|P4|STARTED|I||0
184462|NCT00546273|428516|P3|STARTED|I||0
184463|NCT00546273|428517|P2|STARTED|I||0
184464|NCT00546273|428518|P1|STARTED|I||4
184465|NCT00546260|428527|P2|NOT COMPLETED|Overall Study||2
184466|NCT00546260|428528|P1|NOT COMPLETED|Overall Study||8
184467|NCT00546260|428527|P2|COMPLETED|Overall Study||32
184468|NCT00546260|428528|P1|COMPLETED|Overall Study||28
184469|NCT00546260|428527|P2|STARTED|Overall Study||34
184470|NCT00546260|428528|P1|STARTED|Overall Study||36
184471|NCT00546156|428540|P2|NOT COMPLETED|Overall Study||1
184472|NCT00546156|428541|P1|NOT COMPLETED|Overall Study||14
184473|NCT00546156|428540|P2|COMPLETED|Overall Study||19
184474|NCT00546156|428541|P1|COMPLETED|Overall Study||70
184475|NCT00546156|428540|P2|STARTED|Overall Study||20
184476|NCT00546156|428541|P1|STARTED|Overall Study||84
184477|NCT00546117|428550|P2|NOT COMPLETED|Overall Study||0
184478|NCT00546117|428551|P1|NOT COMPLETED|Overall Study||4
184479|NCT00546117|428550|P2|COMPLETED|Overall Study||7
184480|NCT00546117|428551|P1|COMPLETED|Overall Study||5
184481|NCT00546117|428550|P2|STARTED|Overall Study||7
184482|NCT00546117|428551|P1|STARTED|Overall Study||9
184483|NCT00546104|428559|P1|NOT COMPLETED|Overall Study||0
184484|NCT00546104|428559|P1|COMPLETED|Overall Study||31
184485|NCT00546104|428559|P1|STARTED|Overall Study||31
184486|NCT00546078|428570|P2|NOT COMPLETED|Overall Study||7
184487|NCT00546078|428571|P1|NOT COMPLETED|Overall Study||4
184488|NCT00546078|428570|P2|COMPLETED|Overall Study||43
184489|NCT00546078|428571|P1|COMPLETED|Overall Study||61
184490|NCT00546078|428570|P2|Month 18|Overall Study||45
184491|NCT00546078|428571|P1|Month 18|Overall Study||61
184492|NCT00546078|428570|P2|STARTED|Overall Study||50
184493|NCT00546078|428571|P1|STARTED|Overall Study||65
184494|NCT00546052|428609|P1|NOT COMPLETED|Overall Study||227
184495|NCT00546052|428609|P1|COMPLETED|Overall Study||1511
184496|NCT00546052|428609|P1|Week 52|Overall Study||1511
184497|NCT00546052|428609|P1|Week 32|Overall Study||1583
184498|NCT00546052|428609|P1|Week 12|Overall Study||1650
184499|NCT00546052|428609|P1|Week 8|Overall Study||1680
184500|NCT00546052|428609|P1|Week 4|Overall Study||1714
184501|NCT00546052|428609|P1|STARTED|Overall Study||1738
184502|NCT00546000|428627|P1|NOT COMPLETED|Overall Study||4
184503|NCT00546000|428627|P1|COMPLETED|Overall Study||52
184504|NCT00546000|428627|P1|STARTED|Overall Study||56
184505|NCT00545974|428634|P2|NOT COMPLETED|Overall Study||3
184506|NCT00545974|428635|P1|NOT COMPLETED|Overall Study||2
184507|NCT00545974|428634|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
184508|NCT00545974|428635|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
184509|NCT00545974|428634|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
184510|NCT00545974|428635|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
184511|NCT00545948|428646|P3|NOT COMPLETED|Overall Study||7
184512|NCT00545948|428647|P2|NOT COMPLETED|Overall Study||1
184513|NCT00545948|428648|P1|NOT COMPLETED|Overall Study||1
184514|NCT00545948|428646|P3|COMPLETED|Overall Study||0
184515|NCT00545948|428647|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
184516|NCT00545948|428648|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
184517|NCT00545948|428646|P3|Assigned Treatment|Overall Study||0
184518|NCT00545948|428647|P2|Assigned Treatment|Overall Study||15
184519|NCT00545948|428648|P1|Assigned Treatment|Overall Study||9
184520|NCT00545948|428646|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
184521|NCT00545948|428647|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
184522|NCT00545948|428648|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
184523|NCT00545844|428658|P1|NOT COMPLETED|Overall Study||12
184524|NCT00545844|428658|P1|COMPLETED|Overall Study||301
184525|NCT00545844|428658|P1|STARTED|Overall Study||313
184526|NCT00545792|428672|P1|NOT COMPLETED|Overall Study||1
184527|NCT00545792|428672|P1|COMPLETED|Overall Study||20
184528|NCT00545792|428672|P1|STARTED|Overall Study||21
184529|NCT00545779|428677|P1|NOT COMPLETED|Overall Study||44
184530|NCT00545779|428677|P1|COMPLETED|Overall Study||633
184531|NCT00545779|428677|P1|STARTED|Overall Study||677
184532|NCT00545766|428690|P1|NOT COMPLETED|Overall Study||5
184533|NCT00545766|428690|P1|COMPLETED|Overall Study||36
184534|NCT00545766|428690|P1|STARTED|Overall Study||41
184535|NCT00545753|428697|P3|NOT COMPLETED|Overall Study||26
184536|NCT00545753|428698|P2|NOT COMPLETED|Overall Study||5
184537|NCT00545753|428699|P1|NOT COMPLETED|Overall Study||16
184538|NCT00545753|428697|P3|COMPLETED|Overall Study||230
184539|NCT00545753|428698|P2|COMPLETED|Overall Study||54
184540|NCT00545753|428699|P1|COMPLETED|Overall Study||227
184541|NCT00545753|428697|P3|STARTED|Overall Study||256
184542|NCT00545753|428698|P2|STARTED|Overall Study||59
184543|NCT00545753|428699|P1|STARTED|Overall Study||243
184544|NCT00545740|428712|P4|NOT COMPLETED|Overall Study||71
184545|NCT00545740|428713|P3|NOT COMPLETED|Overall Study||96
184546|NCT00545740|428714|P2|NOT COMPLETED|Overall Study||83
184547|NCT00545740|428715|P1|NOT COMPLETED|Overall Study||75
184548|NCT00545740|428712|P4|COMPLETED|Overall Study||78
184549|NCT00545740|428713|P3|COMPLETED|Overall Study||55
184550|NCT00545740|428714|P2|COMPLETED|Overall Study||62
184551|NCT00545740|428715|P1|COMPLETED|Overall Study||70
184552|NCT00545740|428712|P4|STARTED|Overall Study||149
184553|NCT00545740|428713|P3|STARTED|Overall Study||151
184554|NCT00545740|428714|P2|STARTED|Overall Study||145
184555|NCT00545740|428715|P1|STARTED|Overall Study||145
184556|NCT00545688|428753|P4|NOT COMPLETED|Follow-Up Period||27
184557|NCT00545688|428754|P3|NOT COMPLETED|Follow-Up Period||20
184558|NCT00545688|428755|P2|NOT COMPLETED|Follow-Up Period||19
184559|NCT00545688|428756|P1|NOT COMPLETED|Follow-Up Period||21
184560|NCT00545688|428753|P4|COMPLETED|Follow-Up Period||60
184561|NCT00545688|428754|P3|COMPLETED|Follow-Up Period||78
184562|NCT00545688|428755|P2|COMPLETED|Follow-Up Period||83
184563|NCT00545688|428756|P1|COMPLETED|Follow-Up Period||77
184564|NCT00545688|428753|P4|STARTED|Follow-Up Period||87
184565|NCT00545688|428754|P3|STARTED|Follow-Up Period||98
184566|NCT00545688|428755|P2|STARTED|Follow-Up Period||102
184567|NCT00545688|428756|P1|STARTED|Follow-Up Period||98
184568|NCT00545688|428753|P4|NOT COMPLETED|Adjuvant Treatment Period||14
184569|NCT00545688|428754|P3|NOT COMPLETED|Adjuvant Treatment Period||4
184570|NCT00545688|428755|P2|NOT COMPLETED|Adjuvant Treatment Period||8
184571|NCT00545688|428756|P1|NOT COMPLETED|Adjuvant Treatment Period||5
184572|NCT00545688|428753|P4|COMPLETED|Adjuvant Treatment Period||74
184573|NCT00545688|428754|P3|COMPLETED|Adjuvant Treatment Period||90
184574|NCT00545688|428755|P2|COMPLETED|Adjuvant Treatment Period||94
184575|NCT00545688|428756|P1|COMPLETED|Adjuvant Treatment Period||98
184576|NCT00545688|428753|P4|STARTED|Adjuvant Treatment Period||88
184577|NCT00545688|428754|P3|STARTED|Adjuvant Treatment Period||94
184578|NCT00545688|428755|P2|STARTED|Adjuvant Treatment Period||102
184579|NCT00545688|428756|P1|STARTED|Adjuvant Treatment Period||103
184580|NCT00545688|428753|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
184581|NCT00545688|428754|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
184582|NCT00545688|428755|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
184583|NCT00545688|428756|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
184584|NCT00545688|428753|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
184585|NCT00545688|428754|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
184586|NCT00545688|428755|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
184587|NCT00545688|428756|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
184588|NCT00545688|428753|P4|STARTED|Neo-Adjuvant Treatment Period||94
184589|NCT00545688|428754|P3|STARTED|Neo-Adjuvant Treatment Period||108
184590|NCT00545688|428755|P2|STARTED|Neo-Adjuvant Treatment Period||107
184591|NCT00545688|428756|P1|STARTED|Neo-Adjuvant Treatment Period||107
184592|NCT00545662|428828|P2|NOT COMPLETED|Overall Study||79
184593|NCT00545662|428829|P1|NOT COMPLETED|Overall Study||85
184594|NCT00545662|428828|P2|COMPLETED|Overall Study||528
184595|NCT00545662|428829|P1|COMPLETED|Overall Study||521
184596|NCT00545662|428828|P2|STARTED|Overall Study||607
184597|NCT00545662|428829|P1|STARTED|Overall Study||606
184598|NCT00545623|428839|P4|NOT COMPLETED|Overall Study||11
184599|NCT00545623|428840|P3|NOT COMPLETED|Overall Study||13
184600|NCT00545623|428841|P2|NOT COMPLETED|Overall Study||10
184601|NCT00545623|428842|P1|NOT COMPLETED|Overall Study||7
184602|NCT00545623|428839|P4|COMPLETED|Overall Study||23
184603|NCT00545623|428840|P3|COMPLETED|Overall Study||20
184604|NCT00545623|428841|P2|COMPLETED|Overall Study||21
184605|NCT00545623|428842|P1|COMPLETED|Overall Study||25
184606|NCT00545623|428839|P4|STARTED|Overall Study||34
184607|NCT00545623|428840|P3|STARTED|Overall Study||33
184608|NCT00545623|428841|P2|STARTED|Overall Study||31
184609|NCT00545623|428842|P1|STARTED|Overall Study||32
184610|NCT00545584|428855|P3|NOT COMPLETED|Overall Study||56
184611|NCT00545584|428856|P2|NOT COMPLETED|Overall Study||80
184612|NCT00545584|428857|P1|NOT COMPLETED|Overall Study||79
184613|NCT00545584|428855|P3|COMPLETED|Overall Study||250
184614|NCT00545584|428856|P2|COMPLETED|Overall Study||334
184615|NCT00545584|428857|P1|COMPLETED|Overall Study||333
184616|NCT00545584|428855|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
184617|NCT00545584|428856|P2|STARTED|Overall Study||414
184618|NCT00545584|428857|P1|STARTED|Overall Study||412
184619|NCT00545571|428868|P1|NOT COMPLETED|Overall Study||67
184620|NCT00545571|428868|P1|COMPLETED|Overall Study||53
184621|NCT00545571|428868|P1|STARTED|Overall Study||120
184622|NCT00545506|428883|P2|NOT COMPLETED|Overall Study||0
184623|NCT00545506|428884|P1|NOT COMPLETED|Overall Study||0
184624|NCT00545506|428883|P2|COMPLETED|Overall Study||3
184625|NCT00545506|428884|P1|COMPLETED|Overall Study||3
184626|NCT00545506|428883|P2|STARTED|Overall Study||3
184627|NCT00545506|428884|P1|STARTED|Overall Study||3
184628|NCT00545441|428892|P2|NOT COMPLETED|Overall Study||16
184629|NCT00545441|428893|P1|NOT COMPLETED|Overall Study||18
184630|NCT00545441|428892|P2|COMPLETED|Overall Study||26
184631|NCT00545441|428893|P1|COMPLETED|Overall Study||26
184632|NCT00545441|428892|P2|STARTED|Overall Study||42
184633|NCT00545441|428893|P1|STARTED|Overall Study||44
184634|NCT00545402|428901|P2|NOT COMPLETED|Overall Study||29
184635|NCT00545402|428902|P1|NOT COMPLETED|Overall Study||34
184636|NCT00545402|428901|P2|COMPLETED|Overall Study||61
184637|NCT00545402|428902|P1|COMPLETED|Overall Study||56
184638|NCT00545402|428901|P2|STARTED|Overall Study||90
184639|NCT00545402|428902|P1|STARTED|Overall Study||90
184640|NCT00545363|428920|P2|NOT COMPLETED|Overall Study||15
184641|NCT00545363|428921|P1|NOT COMPLETED|Overall Study||19
184642|NCT00545363|428920|P2|COMPLETED|Overall Study||343
184643|NCT00545363|428921|P1|COMPLETED|Overall Study||339
184644|NCT00545363|428920|P2|Treated|Overall Study||357
184645|NCT00545363|428921|P1|Treated|Overall Study||354
184646|NCT00545363|428920|P2|STARTED|Overall Study||358
184647|NCT00545363|428921|P1|STARTED|Overall Study||358
184648|NCT00545298|428936|P3|NOT COMPLETED|Overall Study||1
184649|NCT00545298|428937|P2|NOT COMPLETED|Overall Study||0
184650|NCT00545298|428938|P1|NOT COMPLETED|Overall Study||2
184651|NCT00545298|428936|P3|COMPLETED|Overall Study||0
184652|NCT00545298|428937|P2|COMPLETED|Overall Study||1
184653|NCT00545298|428938|P1|COMPLETED|Overall Study||0
184654|NCT00545298|428936|P3|STARTED|Overall Study||1
184655|NCT00545298|428937|P2|STARTED|Overall Study||1
184656|NCT00545298|428938|P1|STARTED|Overall Study||2
184657|NCT00545272|428955|P6|NOT COMPLETED|Overall Study||3
184658|NCT00545272|428956|P5|NOT COMPLETED|Overall Study||2
184659|NCT00545272|428957|P4|NOT COMPLETED|Overall Study||1
184660|NCT00545272|428958|P3|NOT COMPLETED|Overall Study||1
184661|NCT00545272|428959|P2|NOT COMPLETED|Overall Study||1
184662|NCT00545272|428960|P1|NOT COMPLETED|Overall Study||0
184663|NCT00545272|428955|P6|COMPLETED|Overall Study||59
184664|NCT00545272|428956|P5|COMPLETED|Overall Study||62
184665|NCT00545272|428957|P4|COMPLETED|Overall Study||71
184666|NCT00545272|428958|P3|COMPLETED|Overall Study||64
184667|NCT00545272|428959|P2|COMPLETED|Overall Study||67
184668|NCT00545272|428960|P1|COMPLETED|Overall Study||61
184669|NCT00545272|428955|P6|STARTED|Overall Study||62
184670|NCT00545272|428956|P5|STARTED|Overall Study||64
184671|NCT00545272|428957|P4|STARTED|Overall Study||72
184672|NCT00545272|428958|P3|STARTED|Overall Study||65
184673|NCT00545272|428959|P2|STARTED|Overall Study||68
184674|NCT00545272|428960|P1|STARTED|Overall Study||61
184675|NCT00545233|429012|P2|NOT COMPLETED|Overall Study||35
184676|NCT00545233|429013|P1|NOT COMPLETED|Overall Study||46
184677|NCT00545233|429012|P2|COMPLETED|Overall Study||41
184678|NCT00545233|429013|P1|COMPLETED|Overall Study||33
184679|NCT00545233|429012|P2|Intent-to-Treat (ITT)|Overall Study||73
184680|NCT00545233|429013|P1|Intent-to-Treat (ITT)|Overall Study||77
184681|NCT00545233|429012|P2|Safety Set|Overall Study||75
184682|NCT00545233|429013|P1|Safety Set|Overall Study||77
184683|NCT00545233|429012|P2|STARTED|Overall Study||76
184684|NCT00545233|429013|P1|STARTED|Overall Study||79
184685|NCT00545181|429062|P2|NOT COMPLETED|Overall Study||0
184686|NCT00545181|429063|P1|NOT COMPLETED|Overall Study||0
184687|NCT00545181|429062|P2|COMPLETED|Overall Study||25
184688|NCT00545181|429063|P1|COMPLETED|Overall Study||29
184689|NCT00545181|429062|P2|STARTED|Overall Study||25
184690|NCT00545181|429063|P1|STARTED|Overall Study||29
184691|NCT00545168|429072|P3|NOT COMPLETED|Overall Study||21
184692|NCT00545168|429073|P2|NOT COMPLETED|Overall Study||5
184693|NCT00545168|429074|P1|NOT COMPLETED|Overall Study||16
184694|NCT00545168|429072|P3|COMPLETED|Overall Study||193
184695|NCT00545168|429073|P2|COMPLETED|Overall Study||58
184696|NCT00545168|429074|P1|COMPLETED|Overall Study||187
184697|NCT00545168|429072|P3|STARTED|Overall Study||214
184698|NCT00545168|429073|P2|STARTED|Overall Study||63
184699|NCT00545168|429074|P1|STARTED|Overall Study||203
184700|NCT00545155|429083|P1|NOT COMPLETED|Overall Study||0
184701|NCT00545155|429083|P1|COMPLETED|Overall Study||187
184702|NCT00545155|429083|P1|STARTED|Overall Study||187
184703|NCT00545103|429100|P4|NOT COMPLETED|Overall Study||70
184704|NCT00545103|429101|P3|NOT COMPLETED|Overall Study||76
184705|NCT00545103|429102|P2|NOT COMPLETED|Overall Study||78
184706|NCT00545103|429103|P1|NOT COMPLETED|Overall Study||75
184707|NCT00545103|429100|P4|COMPLETED|Overall Study||76
184708|NCT00545103|429101|P3|COMPLETED|Overall Study||74
184709|NCT00545103|429102|P2|COMPLETED|Overall Study||70
184710|NCT00545103|429103|P1|COMPLETED|Overall Study||73
184711|NCT00545103|429100|P4|STARTED|Overall Study||146
184712|NCT00545103|429101|P3|STARTED|Overall Study||150
184713|NCT00545103|429102|P2|STARTED|Overall Study||148
184714|NCT00545103|429103|P1|STARTED|Overall Study||148
184715|NCT00545064|429137|P1|NOT COMPLETED|Overall Study||8
184716|NCT00545064|429137|P1|COMPLETED|Overall Study||170
184717|NCT00545064|429137|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
184718|NCT00545064|429137|P1|Visit 2 (Week 4)|Overall Study||169
184719|NCT00545064|429137|P1|Visit 1 (Baseline)|Overall Study||178
184720|NCT00545064|429137|P1|STARTED|Overall Study||178
184721|NCT00545051|429148|P2|NOT COMPLETED|Overall Study||7
184722|NCT00545051|429149|P1|NOT COMPLETED|Overall Study||9
184723|NCT00545051|429148|P2|COMPLETED|Overall Study||65
184724|NCT00545051|429149|P1|COMPLETED|Overall Study||59
184725|NCT00545051|429148|P2|STARTED|Overall Study||72
184726|NCT00545051|429149|P1|STARTED|Overall Study||68
184727|NCT00545025|429165|P2|NOT COMPLETED|Overall Study||0
184728|NCT00545025|429166|P1|NOT COMPLETED|Overall Study||0
184729|NCT00545025|429165|P2|COMPLETED|Overall Study||83
184730|NCT00545025|429166|P1|COMPLETED|Overall Study||160
184731|NCT00545025|429165|P2|STARTED|Overall Study||83
184732|NCT00545025|429166|P1|STARTED|Overall Study||160
184733|NCT00544908|429186|P1|NOT COMPLETED|Overall Study||0
184734|NCT00544908|429186|P1|COMPLETED|Overall Study||7
184735|NCT00544908|429186|P1|STARTED|Overall Study||7
184736|NCT00544882|429193|P3|NOT COMPLETED|Cycle 3: Follow-up||0
184737|NCT00544882|429194|P2|NOT COMPLETED|Cycle 3: Follow-up||2
184738|NCT00544882|429195|P1|NOT COMPLETED|Cycle 3: Follow-up||0
184739|NCT00544882|429193|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
184740|NCT00544882|429194|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
184741|NCT00544882|429195|P1|COMPLETED|Cycle 3: Follow-up||0
184742|NCT00544882|429193|P3|STARTED|Cycle 3: Follow-up||28
184743|NCT00544882|429194|P2|STARTED|Cycle 3: Follow-up||28
184744|NCT00544882|429195|P1|STARTED|Cycle 3: Follow-up||0
184745|NCT00544882|429193|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
184746|NCT00544882|429194|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
184747|NCT00544882|429195|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
184748|NCT00544882|429193|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
184749|NCT00544882|429194|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
184750|NCT00544882|429195|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
184751|NCT00544882|429193|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
184752|NCT00544882|429194|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
184753|NCT00544882|429195|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
184754|NCT00544882|429193|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
184755|NCT00544882|429194|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
184756|NCT00544882|429195|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
184757|NCT00544882|429193|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
184758|NCT00544882|429194|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
184759|NCT00544882|429195|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
184760|NCT00544882|429193|P3|COMPLETED|Cycle 1: Run-in Cycle||0
184761|NCT00544882|429194|P2|COMPLETED|Cycle 1: Run-in Cycle||0
184762|NCT00544882|429195|P1|COMPLETED|Cycle 1: Run-in Cycle||58
184763|NCT00544882|429193|P3|STARTED|Cycle 1: Run-in Cycle||0
184764|NCT00544882|429194|P2|STARTED|Cycle 1: Run-in Cycle||0
184765|NCT00544882|429195|P1|STARTED|Cycle 1: Run-in Cycle||61
184766|NCT00544869|429220|P3|NOT COMPLETED|Overall Study||0
184767|NCT00544869|429221|P2|NOT COMPLETED|Overall Study||2
184768|NCT00544869|429222|P1|NOT COMPLETED|Overall Study||12
184769|NCT00544869|429220|P3|COMPLETED|Overall Study||2
184770|NCT00544869|429221|P2|COMPLETED|Overall Study||12
184771|NCT00544869|429222|P1|COMPLETED|Overall Study||24
184772|NCT00544869|429220|P3|STARTED|Overall Study||2
184773|NCT00544869|429221|P2|STARTED|Overall Study||14
184774|NCT00544869|429222|P1|STARTED|Overall Study||36
184775|NCT00544817|429230|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
184776|NCT00544817|429230|P1|COMPLETED|Follow-up Systemic Therapy||9
184777|NCT00544817|429230|P1|STARTED|Follow-up Systemic Therapy||28
184778|NCT00544817|429230|P1|NOT COMPLETED|No Treatment Interval||12
184779|NCT00544817|429230|P1|COMPLETED|No Treatment Interval||28
184780|NCT00544817|429230|P1|STARTED|No Treatment Interval||40
184781|NCT00544817|429230|P1|NOT COMPLETED|Combined Modality||7
184782|NCT00544817|429230|P1|COMPLETED|Combined Modality||40
184783|NCT00544817|429230|P1|STARTED|Combined Modality||47
184784|NCT00544778|429236|P1|NOT COMPLETED|Overall Study||0
184785|NCT00544778|429236|P1|COMPLETED|Overall Study||7
184786|NCT00544778|429236|P1|STARTED|Overall Study||7
184787|NCT00544713|429242|P2|NOT COMPLETED|Overall Study||5
184788|NCT00544713|429243|P1|NOT COMPLETED|Overall Study||3
184789|NCT00544713|429242|P2|COMPLETED|Overall Study||109
184790|NCT00544713|429243|P1|COMPLETED|Overall Study||111
184791|NCT00544713|429242|P2|STARTED|Overall Study||114
184792|NCT00544713|429243|P1|STARTED|Overall Study||114
184793|NCT00544674|429273|P1|NOT COMPLETED|Overall Study||1
184794|NCT00544674|429273|P1|COMPLETED|Overall Study||4
184795|NCT00544674|429273|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
184796|NCT00544648|429279|P2|NOT COMPLETED|Overall Study||1
184797|NCT00544648|429280|P1|NOT COMPLETED|Overall Study||3
184798|NCT00544648|429279|P2|COMPLETED|Overall Study||1
184799|NCT00544648|429280|P1|COMPLETED|Overall Study||8
184800|NCT00544648|429279|P2|STARTED|Overall Study||2
184801|NCT00544648|429280|P1|STARTED|Overall Study||11
184802|NCT00544557|429294|P1|NOT COMPLETED|Overall Study||434
184803|NCT00544557|429294|P1|COMPLETED|Overall Study||1251
184804|NCT00544557|429294|P1|STARTED|Overall Study||1685
184805|NCT00544544|429325|P1|NOT COMPLETED|Overall Study||3
184806|NCT00544544|429325|P1|COMPLETED|Overall Study||11
184807|NCT00544544|429325|P1|STARTED|Overall Study||14
184808|NCT00544440|429329|P1|NOT COMPLETED|Overall Study||57
184809|NCT00544440|429329|P1|COMPLETED|Overall Study||0
184810|NCT00544440|429329|P1|STARTED|Overall Study||57
184811|NCT00544167|429336|P1|NOT COMPLETED|Overall Study||29
184812|NCT00544167|429336|P1|COMPLETED|Overall Study||16
184813|NCT00544167|429336|P1|STARTED|Overall Study||45
184814|NCT00543985|429340|P1|NOT COMPLETED|Overall Study||4
184815|NCT00543985|429340|P1|COMPLETED|Overall Study||32
184816|NCT00543985|429340|P1|STARTED|Overall Study||36
184817|NCT00543855|429349|P4|NOT COMPLETED|Overall Study||4
184818|NCT00543855|429350|P3|NOT COMPLETED|Overall Study||6
184819|NCT00543855|429351|P2|NOT COMPLETED|Overall Study||2
184820|NCT00543855|429352|P1|NOT COMPLETED|Overall Study||4
184821|NCT00543855|429349|P4|COMPLETED|Overall Study||30
184822|NCT00543855|429350|P3|COMPLETED|Overall Study||31
184823|NCT00543855|429351|P2|COMPLETED|Overall Study||31
184824|NCT00543855|429352|P1|COMPLETED|Overall Study||31
184825|NCT00543855|429349|P4|STARTED|Overall Study||34
184826|NCT00543855|429350|P3|STARTED|Overall Study||37
184827|NCT00543855|429351|P2|STARTED|Overall Study||33
184828|NCT00543855|429352|P1|STARTED|Overall Study||35
184829|NCT00543803|429374|P1|NOT COMPLETED|Overall Study||142
184830|NCT00543803|429374|P1|COMPLETED|Overall Study||192
184831|NCT00543803|429374|P1|STARTED|Overall Study||334
184832|NCT00543764|429393|P2|NOT COMPLETED|Overall Study||0
184833|NCT00543764|429394|P1|NOT COMPLETED|Overall Study||0
184834|NCT00543764|429393|P2|COMPLETED|Overall Study||50
184835|NCT00543764|429394|P1|COMPLETED|Overall Study||100
184836|NCT00543764|429393|P2|STARTED|Overall Study||50
184837|NCT00543764|429394|P1|STARTED|Overall Study||100
184838|NCT00543725|429402|P2|NOT COMPLETED|Overall Study||74
184839|NCT00543725|429403|P1|NOT COMPLETED|Overall Study||68
184840|NCT00543725|429402|P2|COMPLETED|Overall Study||264
184841|NCT00543725|429403|P1|COMPLETED|Overall Study||272
184842|NCT00543725|429402|P2|STARTED|Overall Study||338
184843|NCT00543725|429403|P1|STARTED|Overall Study||340
184844|NCT00543569|429429|P4|NOT COMPLETED|Overall Study||9
184845|NCT00543569|429430|P3|NOT COMPLETED|Overall Study||20
184846|NCT00543569|429431|P2|NOT COMPLETED|Overall Study||8
184847|NCT00543569|429432|P1|NOT COMPLETED|Overall Study||12
184848|NCT00543569|429429|P4|COMPLETED|Overall Study||72
184849|NCT00543569|429430|P3|COMPLETED|Overall Study||60
184850|NCT00543569|429431|P2|COMPLETED|Overall Study||72
184851|NCT00543569|429432|P1|COMPLETED|Overall Study||70
184852|NCT00543569|429429|P4|Received Treatment|Overall Study||78
184853|NCT00543569|429430|P3|Received Treatment|Overall Study||75
184854|NCT00543569|429431|P2|Received Treatment|Overall Study||77
184855|NCT00543569|429432|P1|Received Treatment|Overall Study||79
184856|NCT00543569|429429|P4|STARTED|Overall Study||81
184857|NCT00543569|429430|P3|STARTED|Overall Study||80
184858|NCT00543569|429431|P2|STARTED|Overall Study||80
184859|NCT00543569|429432|P1|STARTED|Overall Study||82
184860|NCT00543543|429538|P4|NOT COMPLETED|Overall Study||1222
184861|NCT00543543|429539|P3|NOT COMPLETED|Overall Study||14
184862|NCT00543543|429540|P2|NOT COMPLETED|Overall Study||1252
184863|NCT00543543|429541|P1|NOT COMPLETED|Overall Study||20
184864|NCT00543543|429538|P4|COMPLETED|Overall Study|Follow-up was up to 54 months|5887
184865|NCT00543543|429539|P3|COMPLETED|Overall Study|Follow-up was up to 7 months|296
184866|NCT00543543|429540|P2|COMPLETED|Overall Study|Follow-up was up to 54 months|5854
184867|NCT00543543|429541|P1|COMPLETED|Overall Study|Follow-up was up to 7 months|295
184868|NCT00543543|429538|P4|Completed 3 Vaccinations|Overall Study||6934
184869|NCT00543543|429539|P3|Completed 3 Vaccinations|Overall Study||297
184870|NCT00543543|429540|P2|Completed 3 Vaccinations|Overall Study||6928
184871|NCT00543543|429541|P1|Completed 3 Vaccinations|Overall Study||300
184872|NCT00543543|429538|P4|STARTED|Overall Study||7109
184873|NCT00543543|429539|P3|STARTED|Overall Study||310
184874|NCT00543543|429540|P2|STARTED|Overall Study||7106
184875|NCT00543543|429541|P1|STARTED|Overall Study||315
184876|NCT00543296|429577|P1|NOT COMPLETED|Overall Study||7
184877|NCT00543296|429577|P1|COMPLETED|Overall Study||14
184878|NCT00543296|429577|P1|STARTED|Overall Study||21
184879|NCT00543140|429584|P1|NOT COMPLETED|Overall Study||72
184880|NCT00543140|429584|P1|COMPLETED|Overall Study||231
184881|NCT00543140|429584|P1|STARTED|Overall Study||303
184882|NCT00543101|429594|P2|NOT COMPLETED|Overall Study||0
184883|NCT00543101|429595|P1|NOT COMPLETED|Overall Study||0
184884|NCT00543101|429594|P2|COMPLETED|Overall Study||12
184885|NCT00543101|429595|P1|COMPLETED|Overall Study||12
184886|NCT00543101|429594|P2|STARTED|Overall Study||12
184887|NCT00543101|429595|P1|STARTED|Overall Study||12
184888|NCT00542997|429607|P1|NOT COMPLETED|Efficacy Period||3
184889|NCT00542997|429607|P1|COMPLETED|Efficacy Period||43
184890|NCT00542997|429607|P1|STARTED|Efficacy Period||46
184891|NCT00542997|429607|P1|NOT COMPLETED|Wash in / Wash Out Period||5
184892|NCT00542997|429607|P1|COMPLETED|Wash in / Wash Out Period||46
184893|NCT00542997|429607|P1|STARTED|Wash in / Wash Out Period||51
184894|NCT00542971|429622|P1|NOT COMPLETED|Overall Study||0
184895|NCT00542971|429622|P1|COMPLETED|Overall Study||75
184896|NCT00542971|429622|P1|STARTED|Overall Study||75
184897|NCT00542880|429629|P2|NOT COMPLETED|Period 3||2
184898|NCT00542880|429630|P1|NOT COMPLETED|Period 3||0
184899|NCT00542880|429629|P2|COMPLETED|Period 3||201
184900|NCT00542880|429630|P1|COMPLETED|Period 3||204
184901|NCT00542880|429629|P2|STARTED|Period 3||203
184902|NCT00542880|429630|P1|STARTED|Period 3||204
184903|NCT00542880|429629|P2|NOT COMPLETED|Period 2||10
184904|NCT00542880|429630|P1|NOT COMPLETED|Period 2||7
184905|NCT00542880|429629|P2|COMPLETED|Period 2||203
184906|NCT00542880|429630|P1|COMPLETED|Period 2||204
184907|NCT00542880|429629|P2|STARTED|Period 2||213
184908|NCT00542880|429630|P1|STARTED|Period 2||211
184909|NCT00542880|429629|P2|NOT COMPLETED|Period 1||12
184910|NCT00542880|429630|P1|NOT COMPLETED|Period 1||6
184911|NCT00542880|429629|P2|COMPLETED|Period 1||213
184912|NCT00542880|429630|P1|COMPLETED|Period 1||211
184913|NCT00542880|429629|P2|STARTED|Period 1||225
184914|NCT00542880|429630|P1|STARTED|Period 1|This was a cross-over study|217
184915|NCT00542828|429666|P1|NOT COMPLETED|Overall Study||13
184916|NCT00542828|429666|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
184917|NCT00542828|429666|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
184918|NCT00542815|429684|P3|NOT COMPLETED|Overall Study||32
184919|NCT00542815|429685|P2|NOT COMPLETED|Overall Study||32
184920|NCT00542815|429686|P1|NOT COMPLETED|Overall Study||106
184921|NCT00542815|429684|P3|COMPLETED|Overall Study||92
184922|NCT00542815|429685|P2|COMPLETED|Overall Study||44
184923|NCT00542815|429686|P1|COMPLETED|Overall Study||326
184924|NCT00542815|429684|P3|STARTED|Overall Study||124
184925|NCT00542815|429685|P2|STARTED|Overall Study||76
184926|NCT00542815|429686|P1|STARTED|Overall Study||432
184927|NCT00542789|429699|P2|NOT COMPLETED|Overall Study||78
184928|NCT00542789|429700|P1|NOT COMPLETED|Overall Study||41
184929|NCT00542789|429699|P2|COMPLETED|Overall Study||90
184930|NCT00542789|429700|P1|COMPLETED|Overall Study||134
184931|NCT00542789|429699|P2|STARTED|Overall Study|Randomised|168
184932|NCT00542789|429700|P1|STARTED|Overall Study|Randomised|175
184933|NCT00542620|429712|P2|NOT COMPLETED|Overall Study||0
184934|NCT00542620|429713|P1|NOT COMPLETED|Overall Study||0
184935|NCT00542620|429712|P2|COMPLETED|Overall Study||12
184936|NCT00542620|429713|P1|COMPLETED|Overall Study||13
184937|NCT00542620|429712|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
184938|NCT00542620|429713|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
184939|NCT00542620|429712|P2|STARTED|Overall Study||12
184940|NCT00542620|429713|P1|STARTED|Overall Study||13
184941|NCT00542542|429779|P2|NOT COMPLETED|Overall Study||0
184942|NCT00542542|429780|P1|NOT COMPLETED|Overall Study||0
184943|NCT00542542|429779|P2|COMPLETED|Overall Study||44
184944|NCT00542542|429780|P1|COMPLETED|Overall Study||44
184945|NCT00542542|429779|P2|STARTED|Overall Study||44
184946|NCT00542542|429780|P1|STARTED|Overall Study||44
184947|NCT00542425|429791|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
184948|NCT00542425|429792|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
184949|NCT00542425|429793|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
184950|NCT00542425|429794|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
184951|NCT00542425|429795|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
184952|NCT00542425|429791|P5|COMPLETED|Extended 24 Weeks of Treatment||13
184953|NCT00542425|429792|P4|COMPLETED|Extended 24 Weeks of Treatment||6
184954|NCT00542425|429793|P3|COMPLETED|Extended 24 Weeks of Treatment||8
184955|NCT00542425|429794|P2|COMPLETED|Extended 24 Weeks of Treatment||11
184956|NCT00542425|429795|P1|COMPLETED|Extended 24 Weeks of Treatment||10
184957|NCT00542425|429791|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
184958|NCT00542425|429792|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
184959|NCT00542425|429793|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
184960|NCT00542425|429794|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
184961|NCT00542425|429795|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
184962|NCT00542425|429791|P5|NOT COMPLETED|Initial 24 Weeks||6
184963|NCT00542425|429792|P4|NOT COMPLETED|Initial 24 Weeks||11
184964|NCT00542425|429793|P3|NOT COMPLETED|Initial 24 Weeks||7
184965|NCT00542425|429794|P2|NOT COMPLETED|Initial 24 Weeks||10
184966|NCT00542425|429795|P1|NOT COMPLETED|Initial 24 Weeks||4
184967|NCT00542425|429791|P5|COMPLETED|Initial 24 Weeks||39
184968|NCT00542425|429792|P4|COMPLETED|Initial 24 Weeks||34
184969|NCT00542425|429793|P3|COMPLETED|Initial 24 Weeks||36
184970|NCT00542425|429794|P2|COMPLETED|Initial 24 Weeks||33
184971|NCT00542425|429795|P1|COMPLETED|Initial 24 Weeks||42
184972|NCT00542425|429791|P5|STARTED|Initial 24 Weeks||45
184973|NCT00542425|429792|P4|STARTED|Initial 24 Weeks||45
184974|NCT00542425|429793|P3|STARTED|Initial 24 Weeks||43
184975|NCT00542425|429794|P2|STARTED|Initial 24 Weeks||43
184976|NCT00542425|429795|P1|STARTED|Initial 24 Weeks||46
184977|NCT00542386|429833|P6|NOT COMPLETED|Overall Study||50
184978|NCT00542386|429834|P5|NOT COMPLETED|Overall Study||40
184979|NCT00542386|429835|P4|NOT COMPLETED|Overall Study||38
184980|NCT00542386|429836|P3|NOT COMPLETED|Overall Study||33
184981|NCT00542386|429837|P2|NOT COMPLETED|Overall Study||28
184982|NCT00542386|429838|P1|NOT COMPLETED|Overall Study||43
184983|NCT00542386|429833|P6|COMPLETED|Overall Study||82
184984|NCT00542386|429834|P5|COMPLETED|Overall Study||62
184985|NCT00542386|429835|P4|COMPLETED|Overall Study||65
184986|NCT00542386|429836|P3|COMPLETED|Overall Study||66
184987|NCT00542386|429837|P2|COMPLETED|Overall Study||74
184988|NCT00542386|429838|P1|COMPLETED|Overall Study||61
184989|NCT00542386|429833|P6|STARTED|Overall Study||132
184990|NCT00542386|429834|P5|STARTED|Overall Study||102
184991|NCT00542386|429835|P4|STARTED|Overall Study||103
184992|NCT00542386|429836|P3|STARTED|Overall Study||99
184993|NCT00542386|429837|P2|STARTED|Overall Study||102
184994|NCT00542386|429838|P1|STARTED|Overall Study||104
184995|NCT00542321|429860|P2|NOT COMPLETED|Overall Study||1
184996|NCT00542321|429861|P1|NOT COMPLETED|Overall Study||0
184997|NCT00542321|429860|P2|COMPLETED|Overall Study||7
184998|NCT00542321|429861|P1|COMPLETED|Overall Study||8
184999|NCT00542321|429860|P2|STARTED|Overall Study||8
185000|NCT00542321|429861|P1|STARTED|Overall Study||8
185001|NCT00542308|429875|P1|NOT COMPLETED|Overall Study||0
185002|NCT00542308|429875|P1|COMPLETED|Overall Study||90
185003|NCT00542308|429875|P1|STARTED|Overall Study||90
185004|NCT00542269|429883|P3|NOT COMPLETED|Overall Study||6
185005|NCT00542269|429884|P2|NOT COMPLETED|Overall Study||6
185006|NCT00542269|429885|P1|NOT COMPLETED|Overall Study||13
185007|NCT00542269|429883|P3|COMPLETED|Overall Study||51
185008|NCT00542269|429884|P2|COMPLETED|Overall Study||54
185009|NCT00542269|429885|P1|COMPLETED|Overall Study||48
185010|NCT00542269|429883|P3|STARTED|Overall Study||57
185011|NCT00542269|429884|P2|STARTED|Overall Study||60
185012|NCT00542269|429885|P1|STARTED|Overall Study||61
185013|NCT00542178|429920|P8|NOT COMPLETED|Overall Study||85
185014|NCT00542178|429921|P7|NOT COMPLETED|Overall Study||87
185015|NCT00542178|429922|P6|NOT COMPLETED|Overall Study||89
185016|NCT00542178|429923|P5|NOT COMPLETED|Overall Study||64
185017|NCT00542178|429924|P4|NOT COMPLETED|Overall Study||62
185018|NCT00542178|429925|P3|NOT COMPLETED|Overall Study||74
185019|NCT00542178|429926|P2|NOT COMPLETED|Overall Study||80
185020|NCT00542178|429927|P1|NOT COMPLETED|Overall Study||75
185021|NCT00542178|429920|P8|COMPLETED|Overall Study||381
185022|NCT00542178|429921|P7|COMPLETED|Overall Study||406
185023|NCT00542178|429922|P6|COMPLETED|Overall Study||406
185024|NCT00542178|429923|P5|COMPLETED|Overall Study||400
185025|NCT00542178|429924|P4|COMPLETED|Overall Study||308
185026|NCT00542178|429925|P3|COMPLETED|Overall Study||308
185027|NCT00542178|429926|P2|COMPLETED|Overall Study||332
185028|NCT00542178|429927|P1|COMPLETED|Overall Study||315
185029|NCT00542178|429920|P8|STARTED|Overall Study||466
185030|NCT00542178|429921|P7|STARTED|Overall Study||493
185031|NCT00542178|429922|P6|STARTED|Overall Study||495
185032|NCT00542178|429923|P5|STARTED|Overall Study||464
185033|NCT00542178|429924|P4|STARTED|Overall Study||370
185034|NCT00542178|429925|P3|STARTED|Overall Study||382
185035|NCT00542178|429926|P2|STARTED|Overall Study||412
185036|NCT00542178|429927|P1|STARTED|Overall Study||390
185037|NCT00541970|429945|P4|NOT COMPLETED|Month 60||72
185038|NCT00541970|429946|P3|NOT COMPLETED|Month 60||82
185039|NCT00541970|429947|P2|NOT COMPLETED|Month 60||77
185040|NCT00541970|429948|P1|NOT COMPLETED|Month 60||78
185041|NCT00541970|429945|P4|COMPLETED|Month 60||167
185042|NCT00541970|429946|P3|COMPLETED|Month 60||158
185043|NCT00541970|429947|P2|COMPLETED|Month 60||164
185044|NCT00541970|429948|P1|COMPLETED|Month 60||162
185045|NCT00541970|429945|P4|STARTED|Month 60||239
185046|NCT00541970|429946|P3|STARTED|Month 60||240
185047|NCT00541970|429947|P2|STARTED|Month 60||241
185048|NCT00541970|429948|P1|STARTED|Month 60||240
185049|NCT00541970|429945|P4|NOT COMPLETED|Month 48||75
185050|NCT00541970|429946|P3|NOT COMPLETED|Month 48||73
185051|NCT00541970|429947|P2|NOT COMPLETED|Month 48||73
185052|NCT00541970|429948|P1|NOT COMPLETED|Month 48||71
185053|NCT00541970|429945|P4|COMPLETED|Month 48||164
185054|NCT00541970|429946|P3|COMPLETED|Month 48||167
185055|NCT00541970|429947|P2|COMPLETED|Month 48||168
185056|NCT00541970|429948|P1|COMPLETED|Month 48||169
185057|NCT00541970|429945|P4|STARTED|Month 48||239
185058|NCT00541970|429946|P3|STARTED|Month 48||240
185059|NCT00541970|429947|P2|STARTED|Month 48||241
185060|NCT00541970|429948|P1|STARTED|Month 48||240
185061|NCT00541970|429945|P4|NOT COMPLETED|Month 36||60
185062|NCT00541970|429946|P3|NOT COMPLETED|Month 36||66
185063|NCT00541970|429947|P2|NOT COMPLETED|Month 36||66
185064|NCT00541970|429948|P1|NOT COMPLETED|Month 36||61
185065|NCT00541970|429945|P4|COMPLETED|Month 36||179
185066|NCT00541970|429946|P3|COMPLETED|Month 36||174
185067|NCT00541970|429947|P2|COMPLETED|Month 36||175
185068|NCT00541970|429948|P1|COMPLETED|Month 36||179
185069|NCT00541970|429945|P4|STARTED|Month 36||239
185070|NCT00541970|429946|P3|STARTED|Month 36||240
185071|NCT00541970|429947|P2|STARTED|Month 36||241
185072|NCT00541970|429948|P1|STARTED|Month 36||240
185073|NCT00541970|429945|P4|NOT COMPLETED|Month 24||22
185074|NCT00541970|429946|P3|NOT COMPLETED|Month 24||32
185075|NCT00541970|429947|P2|NOT COMPLETED|Month 24||32
185076|NCT00541970|429948|P1|NOT COMPLETED|Month 24||29
185077|NCT00541970|429945|P4|COMPLETED|Month 24||217
185078|NCT00541970|429946|P3|COMPLETED|Month 24||208
185079|NCT00541970|429947|P2|COMPLETED|Month 24||209
185080|NCT00541970|429948|P1|COMPLETED|Month 24||211
185081|NCT00541970|429945|P4|STARTED|Month 24||239
185082|NCT00541970|429946|P3|STARTED|Month 24||240
185083|NCT00541970|429947|P2|STARTED|Month 24||241
185084|NCT00541970|429948|P1|STARTED|Month 24||240
185085|NCT00541970|429945|P4|NOT COMPLETED|Month 18||17
185086|NCT00541970|429946|P3|NOT COMPLETED|Month 18||25
185087|NCT00541970|429947|P2|NOT COMPLETED|Month 18||24
185088|NCT00541970|429948|P1|NOT COMPLETED|Month 18||14
185089|NCT00541970|429945|P4|COMPLETED|Month 18||222
185090|NCT00541970|429946|P3|COMPLETED|Month 18||215
185091|NCT00541970|429947|P2|COMPLETED|Month 18||217
185092|NCT00541970|429948|P1|COMPLETED|Month 18||226
185093|NCT00541970|429945|P4|STARTED|Month 18||239
185094|NCT00541970|429946|P3|STARTED|Month 18||240
185095|NCT00541970|429947|P2|STARTED|Month 18||241
185096|NCT00541970|429948|P1|STARTED|Month 18||240
185097|NCT00541970|429945|P4|NOT COMPLETED|Month 12||16
185098|NCT00541970|429946|P3|NOT COMPLETED|Month 12||21
185099|NCT00541970|429947|P2|NOT COMPLETED|Month 12||22
185100|NCT00541970|429948|P1|NOT COMPLETED|Month 12||12
185101|NCT00541970|429945|P4|COMPLETED|Month 12||223
185102|NCT00541970|429946|P3|COMPLETED|Month 12||219
185103|NCT00541970|429947|P2|COMPLETED|Month 12||219
185104|NCT00541970|429948|P1|COMPLETED|Month 12||228
185105|NCT00541970|429945|P4|STARTED|Month 12||239
185106|NCT00541970|429946|P3|STARTED|Month 12||240
185107|NCT00541970|429947|P2|STARTED|Month 12||241
185108|NCT00541970|429948|P1|STARTED|Month 12||240
185109|NCT00541970|429945|P4|NOT COMPLETED|Month 7||5
185110|NCT00541970|429946|P3|NOT COMPLETED|Month 7||11
185111|NCT00541970|429947|P2|NOT COMPLETED|Month 7||13
185112|NCT00541970|429948|P1|NOT COMPLETED|Month 7||9
185113|NCT00541970|429945|P4|COMPLETED|Month 7||234
185114|NCT00541970|429946|P3|COMPLETED|Month 7||229
185115|NCT00541970|429947|P2|COMPLETED|Month 7||228
185116|NCT00541970|429948|P1|COMPLETED|Month 7||231
185117|NCT00541970|429945|P4|STARTED|Month 7||239
185118|NCT00541970|429946|P3|STARTED|Month 7||240
185119|NCT00541970|429947|P2|STARTED|Month 7||241
185120|NCT00541970|429948|P1|STARTED|Month 7||240
185121|NCT00541775|430100|P3|NOT COMPLETED|Overall Study||8
185122|NCT00541775|430101|P2|NOT COMPLETED|Overall Study||2
185123|NCT00541775|430102|P1|NOT COMPLETED|Overall Study||9
185124|NCT00541775|430100|P3|COMPLETED|Overall Study||84
185125|NCT00541775|430101|P2|COMPLETED|Overall Study||85
185126|NCT00541775|430102|P1|COMPLETED|Overall Study||85
185127|NCT00541775|430100|P3|STARTED|Overall Study||92
185128|NCT00541775|430101|P2|STARTED|Overall Study||87
185129|NCT00541775|430102|P1|STARTED|Overall Study||94
185130|NCT00541671|430118|P2|NOT COMPLETED|Overall Study||0
185131|NCT00541671|430119|P1|NOT COMPLETED|Overall Study||0
185132|NCT00541671|430118|P2|COMPLETED|Overall Study||12
185133|NCT00541671|430119|P1|COMPLETED|Overall Study||13
185134|NCT00541671|430118|P2|STARTED|Overall Study||12
185135|NCT00541671|430119|P1|STARTED|Overall Study||13
185136|NCT00541658|430128|P3|NOT COMPLETED|Overall Study||68
185137|NCT00541658|430129|P2|NOT COMPLETED|Overall Study||73
185138|NCT00541658|430130|P1|NOT COMPLETED|Overall Study||60
185139|NCT00541658|430128|P3|COMPLETED|Overall Study||240
185140|NCT00541658|430129|P2|COMPLETED|Overall Study||234
185141|NCT00541658|430130|P1|COMPLETED|Overall Study||248
185142|NCT00541658|430128|P3|ITT Population|Overall Study||308
185143|NCT00541658|430129|P2|ITT Population|Overall Study||307
185144|NCT00541658|430130|P1|ITT Population|Overall Study||307
185145|NCT00541658|430128|P3|STARTED|Overall Study||308
185146|NCT00541658|430129|P2|STARTED|Overall Study||307
185147|NCT00541658|430130|P1|STARTED|Overall Study||308
185148|NCT00541593|430287|P1|NOT COMPLETED|Overall Study||0
185149|NCT00541593|430287|P1|COMPLETED|Overall Study||5
185150|NCT00541593|430287|P1|STARTED|Overall Study||5
185151|NCT00541450|430293|P2|NOT COMPLETED|Phase B||31
185152|NCT00541450|430294|P1|NOT COMPLETED|Phase B||37
185153|NCT00541450|430293|P2|COMPLETED|Phase B||200
185154|NCT00541450|430294|P1|COMPLETED|Phase B||187
185155|NCT00541450|430293|P2|STARTED|Phase B||231
185156|NCT00541450|430294|P1|STARTED|Phase B||224
185157|NCT00541450|430293|P2|NOT COMPLETED|Phase A||17
185158|NCT00541450|430294|P1|NOT COMPLETED|Phase A||20
185159|NCT00541450|430293|P2|COMPLETED|Phase A||231
185160|NCT00541450|430294|P1|COMPLETED|Phase A||224
185161|NCT00541450|430293|P2|STARTED|Phase A||248
185162|NCT00541450|430294|P1|STARTED|Phase A||244
185163|NCT00541346|430312|P1|NOT COMPLETED|Follow-up||1
185164|NCT00541346|430312|P1|COMPLETED|Follow-up||15
185165|NCT00541346|430312|P1|STARTED|Follow-up||16
185166|NCT00541346|430312|P1|NOT COMPLETED|Baseline||0
185167|NCT00541346|430312|P1|COMPLETED|Baseline||16
185168|NCT00541346|430312|P1|STARTED|Baseline||16
185169|NCT00541307|430326|P1|NOT COMPLETED|Overall Study||24
185170|NCT00541307|430326|P1|COMPLETED|Overall Study||95
185171|NCT00541307|430326|P1|STARTED|Overall Study||119
185172|NCT00541242|430336|P2|NOT COMPLETED|Treatment Period 2||7
185173|NCT00541242|430337|P1|NOT COMPLETED|Treatment Period 2||9
185174|NCT00541242|430336|P2|COMPLETED|Treatment Period 2||266
185175|NCT00541242|430337|P1|COMPLETED|Treatment Period 2||261
185176|NCT00541242|430336|P2|STARTED|Treatment Period 2||273
185177|NCT00541242|430337|P1|STARTED|Treatment Period 2||270
185178|NCT00541242|430336|P2|NOT COMPLETED|Treatment Period 1||0
185179|NCT00541242|430337|P1|NOT COMPLETED|Treatment Period 1||0
185180|NCT00541242|430336|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
185181|NCT00541242|430337|P1|COMPLETED|Treatment Period 1||0
185182|NCT00541242|430336|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
185183|NCT00541242|430337|P1|STARTED|Treatment Period 1||0
185184|NCT00541229|430351|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
185185|NCT00541229|430352|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
185186|NCT00541229|430353|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
185187|NCT00541229|430354|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
185188|NCT00541229|430355|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
185189|NCT00541229|430356|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
185190|NCT00541229|430351|P6|COMPLETED|Treatment Period III (Week 11)||4
185191|NCT00541229|430352|P5|COMPLETED|Treatment Period III (Week 11)||6
185192|NCT00541229|430353|P4|COMPLETED|Treatment Period III (Week 11)||8
185193|NCT00541229|430354|P3|COMPLETED|Treatment Period III (Week 11)||9
185194|NCT00541229|430355|P2|COMPLETED|Treatment Period III (Week 11)||8
185195|NCT00541229|430356|P1|COMPLETED|Treatment Period III (Week 11)||7
185196|NCT00541229|430351|P6|STARTED|Treatment Period III (Week 11)||5
185197|NCT00541229|430352|P5|STARTED|Treatment Period III (Week 11)||7
185198|NCT00541229|430353|P4|STARTED|Treatment Period III (Week 11)||8
185199|NCT00541229|430354|P3|STARTED|Treatment Period III (Week 11)||10
185200|NCT00541229|430355|P2|STARTED|Treatment Period III (Week 11)||8
185201|NCT00541229|430356|P1|STARTED|Treatment Period III (Week 11)||7
185202|NCT00541229|430351|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
185203|NCT00541229|430352|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
185204|NCT00541229|430353|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
185205|NCT00541229|430354|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
185206|NCT00541229|430355|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
185207|NCT00541229|430356|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
185208|NCT00541229|430351|P6|COMPLETED|Washout Period II (Week 7-10)||5
185209|NCT00541229|430352|P5|COMPLETED|Washout Period II (Week 7-10)||7
185210|NCT00541229|430353|P4|COMPLETED|Washout Period II (Week 7-10)||8
185211|NCT00541229|430354|P3|COMPLETED|Washout Period II (Week 7-10)||10
185212|NCT00541229|430355|P2|COMPLETED|Washout Period II (Week 7-10)||8
185213|NCT00541229|430356|P1|COMPLETED|Washout Period II (Week 7-10)||7
185214|NCT00541229|430351|P6|STARTED|Washout Period II (Week 7-10)||8
185215|NCT00541229|430352|P5|STARTED|Washout Period II (Week 7-10)||11
185216|NCT00541229|430353|P4|STARTED|Washout Period II (Week 7-10)||12
185217|NCT00541229|430354|P3|STARTED|Washout Period II (Week 7-10)||12
185218|NCT00541229|430355|P2|STARTED|Washout Period II (Week 7-10)||12
185219|NCT00541229|430356|P1|STARTED|Washout Period II (Week 7-10)||11
185220|NCT00541229|430351|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
185221|NCT00541229|430352|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
185222|NCT00541229|430353|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
185223|NCT00541229|430354|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
185224|NCT00541229|430355|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
185225|NCT00541229|430356|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
185226|NCT00541229|430351|P6|COMPLETED|Treatment Period II (Week 6)||8
185227|NCT00541229|430352|P5|COMPLETED|Treatment Period II (Week 6)||11
185228|NCT00541229|430353|P4|COMPLETED|Treatment Period II (Week 6)||12
185229|NCT00541229|430354|P3|COMPLETED|Treatment Period II (Week 6)||12
185230|NCT00541229|430355|P2|COMPLETED|Treatment Period II (Week 6)||12
185231|NCT00541229|430356|P1|COMPLETED|Treatment Period II (Week 6)||11
185232|NCT00541229|430351|P6|STARTED|Treatment Period II (Week 6)||11
185233|NCT00541229|430352|P5|STARTED|Treatment Period II (Week 6)||13
185234|NCT00541229|430353|P4|STARTED|Treatment Period II (Week 6)||13
185235|NCT00541229|430354|P3|STARTED|Treatment Period II (Week 6)||13
185236|NCT00541229|430355|P2|STARTED|Treatment Period II (Week 6)||13
185237|NCT00541229|430356|P1|STARTED|Treatment Period II (Week 6)||13
185238|NCT00541229|430351|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
185239|NCT00541229|430352|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
185240|NCT00541229|430353|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
185241|NCT00541229|430354|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
185242|NCT00541229|430355|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
185243|NCT00541229|430356|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
185244|NCT00541229|430351|P6|COMPLETED|Washout Period I (Week 2-5)||11
185245|NCT00541229|430352|P5|COMPLETED|Washout Period I (Week 2-5)||13
185246|NCT00541229|430353|P4|COMPLETED|Washout Period I (Week 2-5)||13
185247|NCT00541229|430354|P3|COMPLETED|Washout Period I (Week 2-5)||13
185248|NCT00541229|430355|P2|COMPLETED|Washout Period I (Week 2-5)||13
185249|NCT00541229|430356|P1|COMPLETED|Washout Period I (Week 2-5)||13
185250|NCT00541229|430351|P6|STARTED|Washout Period I (Week 2-5)||16
185251|NCT00541229|430352|P5|STARTED|Washout Period I (Week 2-5)||14
185252|NCT00541229|430353|P4|STARTED|Washout Period I (Week 2-5)||17
185253|NCT00541229|430354|P3|STARTED|Washout Period I (Week 2-5)||17
185254|NCT00541229|430355|P2|STARTED|Washout Period I (Week 2-5)||15
185255|NCT00541229|430356|P1|STARTED|Washout Period I (Week 2-5)||17
185256|NCT00541229|430351|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
185257|NCT00541229|430352|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
185258|NCT00541229|430353|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
185259|NCT00541229|430354|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
185260|NCT00541229|430355|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
185261|NCT00541229|430356|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
185262|NCT00541229|430351|P6|COMPLETED|Treatment Period I (Week 1)||16
185263|NCT00541229|430352|P5|COMPLETED|Treatment Period I (Week 1)||14
185264|NCT00541229|430353|P4|COMPLETED|Treatment Period I (Week 1)||17
185265|NCT00541229|430354|P3|COMPLETED|Treatment Period I (Week 1)||17
185266|NCT00541229|430355|P2|COMPLETED|Treatment Period I (Week 1)||15
185267|NCT00541229|430356|P1|COMPLETED|Treatment Period I (Week 1)||17
185268|NCT00541229|430351|P6|STARTED|Treatment Period I (Week 1)||18
185269|NCT00541229|430352|P5|STARTED|Treatment Period I (Week 1)||14
185270|NCT00541229|430353|P4|STARTED|Treatment Period I (Week 1)||18
185271|NCT00541229|430354|P3|STARTED|Treatment Period I (Week 1)||20
185272|NCT00541229|430355|P2|STARTED|Treatment Period I (Week 1)||16
185273|NCT00541229|430356|P1|STARTED|Treatment Period I (Week 1)||17
185274|NCT00541190|430366|P2|NOT COMPLETED|Overall Study||0
185275|NCT00541190|430367|P1|NOT COMPLETED|Overall Study||0
185276|NCT00541190|430366|P2|COMPLETED|Overall Study||11
185277|NCT00541190|430367|P1|COMPLETED|Overall Study||10
185278|NCT00541190|430366|P2|STARTED|Overall Study||11
185279|NCT00541190|430367|P1|STARTED|Overall Study||10
185280|NCT00541099|430375|P1|NOT COMPLETED|Overall Study||3
185281|NCT00541099|430375|P1|COMPLETED|Overall Study||8
185282|NCT00541099|430375|P1|STARTED|Overall Study||11
185283|NCT00540969|430381|P2|NOT COMPLETED|Overall Study||0
185284|NCT00540969|430382|P1|NOT COMPLETED|Overall Study||0
185285|NCT00540969|430381|P2|COMPLETED|Overall Study||1
185286|NCT00540969|430382|P1|COMPLETED|Overall Study||2
185287|NCT00540969|430381|P2|STARTED|Overall Study||1
185288|NCT00540969|430382|P1|STARTED|Overall Study||2
185289|NCT00540644|430394|P2|NOT COMPLETED|Overall Study||9
185290|NCT00540644|430395|P1|NOT COMPLETED|Overall Study||9
185291|NCT00540644|430394|P2|COMPLETED|Overall Study||13
185292|NCT00540644|430395|P1|COMPLETED|Overall Study||39
185293|NCT00540644|430394|P2|STARTED|Overall Study||22
185294|NCT00540644|430395|P1|STARTED|Overall Study||48
185295|NCT00540592|430415|P10|NOT COMPLETED|Overall Study||2
185296|NCT00540592|430416|P9|NOT COMPLETED|Overall Study||1
185297|NCT00540592|430417|P8|NOT COMPLETED|Overall Study||1
185298|NCT00540592|430418|P7|NOT COMPLETED|Overall Study||0
185299|NCT00540592|430419|P6|NOT COMPLETED|Overall Study||0
185300|NCT00540592|430420|P5|NOT COMPLETED|Overall Study||1
185301|NCT00540592|430421|P4|NOT COMPLETED|Overall Study||1
185302|NCT00540592|430422|P3|NOT COMPLETED|Overall Study||1
185303|NCT00540592|430423|P2|NOT COMPLETED|Overall Study||1
185304|NCT00540592|430424|P1|NOT COMPLETED|Overall Study||2
185305|NCT00540592|430415|P10|COMPLETED|Overall Study||201
185306|NCT00540592|430416|P9|COMPLETED|Overall Study||199
185307|NCT00540592|430417|P8|COMPLETED|Overall Study||198
185308|NCT00540592|430418|P7|COMPLETED|Overall Study||198
185309|NCT00540592|430419|P6|COMPLETED|Overall Study||198
185310|NCT00540592|430420|P5|COMPLETED|Overall Study||198
185311|NCT00540592|430421|P4|COMPLETED|Overall Study||201
185312|NCT00540592|430422|P3|COMPLETED|Overall Study||201
185313|NCT00540592|430423|P2|COMPLETED|Overall Study||201
185314|NCT00540592|430424|P1|COMPLETED|Overall Study||202
185315|NCT00540592|430415|P10|Completed at Day 180|Overall Study||189
185316|NCT00540592|430416|P9|Completed at Day 180|Overall Study||198
185317|NCT00540592|430417|P8|Completed at Day 180|Overall Study||193
185318|NCT00540592|430418|P7|Completed at Day 180|Overall Study||196
185319|NCT00540592|430419|P6|Completed at Day 180|Overall Study||198
185320|NCT00540592|430420|P5|Completed at Day 180|Overall Study||195
185321|NCT00540592|430421|P4|Completed at Day 180|Overall Study||197
185322|NCT00540592|430422|P3|Completed at Day 180|Overall Study||197
185323|NCT00540592|430423|P2|Completed at Day 180|Overall Study||201
185324|NCT00540592|430424|P1|Completed at Day 180|Overall Study||200
185325|NCT00540592|430415|P10|STARTED|Overall Study||203
185326|NCT00540592|430416|P9|STARTED|Overall Study||200
185327|NCT00540592|430417|P8|STARTED|Overall Study||199
185328|NCT00540592|430418|P7|STARTED|Overall Study||198
185329|NCT00540592|430419|P6|STARTED|Overall Study||198
185330|NCT00540592|430420|P5|STARTED|Overall Study||199
185331|NCT00540592|430421|P4|STARTED|Overall Study||202
185332|NCT00540592|430422|P3|STARTED|Overall Study||202
185333|NCT00540592|430423|P2|STARTED|Overall Study||202
185334|NCT00540592|430424|P1|STARTED|Overall Study||204
185335|NCT00540579|430656|P1|NOT COMPLETED|Overall Study||0
185336|NCT00540579|430656|P1|COMPLETED|Overall Study||23
185337|NCT00540579|430656|P1|STARTED|Overall Study||23
185338|NCT00540514|430663|P2|NOT COMPLETED|Overall Study||266
185339|NCT00540514|430664|P1|NOT COMPLETED|Overall Study||246
185340|NCT00540514|430663|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
185341|NCT00540514|430664|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
185342|NCT00540514|430663|P2|Biomarker Population|Overall Study||36
185343|NCT00540514|430664|P1|Biomarker Population|Overall Study||35
185344|NCT00540514|430663|P2|Treated|Overall Study||524
185345|NCT00540514|430664|P1|Treated|Overall Study||514
185346|NCT00540514|430663|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
185347|NCT00540514|430664|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
185348|NCT00540449|430696|P2|NOT COMPLETED|Overall Study||78
185349|NCT00540449|430697|P1|NOT COMPLETED|Overall Study||84
185350|NCT00540449|430696|P2|COMPLETED|Overall Study||266
185351|NCT00540449|430697|P1|COMPLETED|Overall Study||262
185352|NCT00540449|430696|P2|STARTED|Overall Study||344
185353|NCT00540449|430697|P1|STARTED|Overall Study||346
185445|NCT00539942|431123|P2|STARTED|Overall Study||3
185354|NCT00540436|430719|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
185355|NCT00540436|430719|P1|COMPLETED|Second 12-Week Treatment Period||21
185356|NCT00540436|430719|P1|STARTED|Second 12-Week Treatment Period||22
185357|NCT00540436|430719|P1|NOT COMPLETED|First 12-Week Treatment Period||3
185358|NCT00540436|430719|P1|COMPLETED|First 12-Week Treatment Period||22
185359|NCT00540436|430719|P1|STARTED|First 12-Week Treatment Period||25
185360|NCT00540423|430734|P3|NOT COMPLETED|Open-Label Treatment Period||2
185361|NCT00540423|430735|P2|NOT COMPLETED|Open-Label Treatment Period||0
185362|NCT00540423|430736|P1|NOT COMPLETED|Open-Label Treatment Period||0
185363|NCT00540423|430734|P3|COMPLETED|Open-Label Treatment Period||20
185364|NCT00540423|430735|P2|COMPLETED|Open-Label Treatment Period||0
185365|NCT00540423|430736|P1|COMPLETED|Open-Label Treatment Period||0
185366|NCT00540423|430734|P3|STARTED|Open-Label Treatment Period||22
185367|NCT00540423|430735|P2|STARTED|Open-Label Treatment Period||0
185368|NCT00540423|430736|P1|STARTED|Open-Label Treatment Period||0
185369|NCT00540423|430734|P3|NOT COMPLETED|Double-Blind Treatment Period||0
185370|NCT00540423|430735|P2|NOT COMPLETED|Double-Blind Treatment Period||1
185371|NCT00540423|430736|P1|NOT COMPLETED|Double-Blind Treatment Period||0
185372|NCT00540423|430734|P3|COMPLETED|Double-Blind Treatment Period||0
185373|NCT00540423|430735|P2|COMPLETED|Double-Blind Treatment Period||14
185374|NCT00540423|430736|P1|COMPLETED|Double-Blind Treatment Period||8
185375|NCT00540423|430734|P3|STARTED|Double-Blind Treatment Period||0
185376|NCT00540423|430735|P2|STARTED|Double-Blind Treatment Period||15
185377|NCT00540423|430736|P1|STARTED|Double-Blind Treatment Period||8
185378|NCT00538642|430788|P2|NOT COMPLETED|Overall Study||5
185379|NCT00538642|430789|P1|NOT COMPLETED|Overall Study||1
185380|NCT00538642|430788|P2|COMPLETED|Overall Study||9
185381|NCT00538642|430789|P1|COMPLETED|Overall Study||9
185382|NCT00538642|430788|P2|STARTED|Overall Study||14
185383|NCT00538642|430789|P1|STARTED|Overall Study||10
185384|NCT00538629|430829|P1|NOT COMPLETED|Overall Study||22
185385|NCT00538629|430829|P1|COMPLETED|Overall Study||449
185386|NCT00538629|430829|P1|STARTED|Overall Study||471
185387|NCT00538616|430876|P2|NOT COMPLETED|Overall Study||0
185388|NCT00538616|430877|P1|NOT COMPLETED|Overall Study||0
185389|NCT00538616|430876|P2|COMPLETED|Overall Study||3
185390|NCT00538616|430877|P1|COMPLETED|Overall Study||5
185391|NCT00538616|430876|P2|STARTED|Overall Study||3
185392|NCT00538616|430877|P1|STARTED|Overall Study||5
185393|NCT00538590|430885|P2|NOT COMPLETED|Overall Study||0
185394|NCT00538590|430886|P1|NOT COMPLETED|Overall Study||1
185395|NCT00538590|430885|P2|COMPLETED|Overall Study||10
185396|NCT00538590|430886|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
185397|NCT00538590|430885|P2|STARTED|Overall Study||10
185398|NCT00538590|430886|P1|STARTED|Overall Study||10
185399|NCT00540293|430900|P1|NOT COMPLETED|Overall Study||35
185400|NCT00540293|430900|P1|COMPLETED|Overall Study||390
185401|NCT00540293|430900|P1|STARTED|Overall Study||425
185402|NCT00540228|430948|P5|NOT COMPLETED|Overall Study||0
185403|NCT00540228|430949|P4|NOT COMPLETED|Overall Study||0
185404|NCT00540228|430950|P3|NOT COMPLETED|Overall Study||0
185405|NCT00540228|430951|P2|NOT COMPLETED|Overall Study||1
185406|NCT00540228|430952|P1|NOT COMPLETED|Overall Study||3
185407|NCT00540228|430948|P5|COMPLETED|Overall Study||202
185408|NCT00540228|430949|P4|COMPLETED|Overall Study||202
185409|NCT00540228|430950|P3|COMPLETED|Overall Study||204
185410|NCT00540228|430951|P2|COMPLETED|Overall Study||197
185411|NCT00540228|430952|P1|COMPLETED|Overall Study||197
185412|NCT00540228|430948|P5|STARTED|Overall Study||202
185413|NCT00540228|430949|P4|STARTED|Overall Study||202
185414|NCT00540228|430950|P3|STARTED|Overall Study||204
185415|NCT00540228|430951|P2|STARTED|Overall Study||198
185416|NCT00540228|430952|P1|STARTED|Overall Study||200
185417|NCT00540124|431022|P3|NOT COMPLETED|Overall Study||1
185418|NCT00540124|431023|P2|NOT COMPLETED|Overall Study||3
185419|NCT00540124|431024|P1|NOT COMPLETED|Overall Study||4
185420|NCT00540124|431022|P3|COMPLETED|Overall Study||48
185421|NCT00540124|431023|P2|COMPLETED|Overall Study||48
185422|NCT00540124|431024|P1|COMPLETED|Overall Study||47
185423|NCT00540124|431022|P3|STARTED|Overall Study||49
185424|NCT00540124|431023|P2|STARTED|Overall Study||51
185425|NCT00540124|431024|P1|STARTED|Overall Study||51
185426|NCT00540046|431070|P2|NOT COMPLETED|Overall Study||23
185427|NCT00540046|431071|P1|NOT COMPLETED|Overall Study||33
185428|NCT00540046|431070|P2|COMPLETED|Overall Study||88
185429|NCT00540046|431071|P1|COMPLETED|Overall Study||71
185430|NCT00540046|431070|P2|STARTED|Overall Study||111
185431|NCT00540046|431071|P1|STARTED|Overall Study||104
185432|NCT00539994|431082|P3|NOT COMPLETED|Overall Study||2
185433|NCT00539994|431083|P2|NOT COMPLETED|Overall Study||1
185434|NCT00539994|431084|P1|NOT COMPLETED|Overall Study||3
185435|NCT00539994|431082|P3|COMPLETED|Overall Study||13
185436|NCT00539994|431083|P2|COMPLETED|Overall Study||18
185437|NCT00539994|431084|P1|COMPLETED|Overall Study||20
185438|NCT00539994|431082|P3|STARTED|Overall Study||15
185439|NCT00539994|431083|P2|STARTED|Overall Study||19
185440|NCT00539994|431084|P1|STARTED|Overall Study||23
185441|NCT00539942|431123|P2|NOT COMPLETED|Overall Study||0
185442|NCT00539942|431124|P1|NOT COMPLETED|Overall Study||0
185443|NCT00539942|431123|P2|COMPLETED|Overall Study||3
185444|NCT00539942|431124|P1|COMPLETED|Overall Study||4
185446|NCT00539942|431124|P1|STARTED|Overall Study||4
185447|NCT00539864|431134|P2|NOT COMPLETED|Overall Study||2
185448|NCT00539864|431135|P1|NOT COMPLETED|Overall Study||1
185449|NCT00539864|431134|P2|COMPLETED|Overall Study||300
185450|NCT00539864|431135|P1|COMPLETED|Overall Study||299
185451|NCT00539864|431134|P2|STARTED|Overall Study||302
185452|NCT00539864|431135|P1|STARTED|Overall Study||300
185453|NCT00536913|431149|P2|NOT COMPLETED|Overall Study||0
185454|NCT00536913|431150|P1|NOT COMPLETED|Overall Study||0
185455|NCT00536913|431149|P2|COMPLETED|Overall Study||52
185456|NCT00536913|431150|P1|COMPLETED|Overall Study||55
185457|NCT00536913|431149|P2|STARTED|Overall Study||52
185458|NCT00536913|431150|P1|STARTED|Overall Study||55
185459|NCT00536874|431172|P1|NOT COMPLETED|Overall Study||4
185460|NCT00536874|431172|P1|COMPLETED|Overall Study||35
185461|NCT00536874|431172|P1|STARTED|Overall Study||39
185462|NCT00539734|431182|P1|NOT COMPLETED|Overall Study||1
185463|NCT00539734|431182|P1|COMPLETED|Overall Study||25
185464|NCT00539734|431182|P1|STARTED|Overall Study||26
185465|NCT00539695|431187|P1|NOT COMPLETED|Overall Study||13
185466|NCT00539695|431187|P1|COMPLETED|Overall Study||12
185467|NCT00539695|431187|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
185468|NCT00539695|431187|P1|STARTED|Overall Study||25
185469|NCT00539617|431191|P1|NOT COMPLETED|Treatment Period||0
185470|NCT00539617|431191|P1|COMPLETED|Treatment Period||3
185471|NCT00539617|431191|P1|STARTED|Treatment Period||3
185472|NCT00539617|431191|P1|NOT COMPLETED|Run-In Period||1
185473|NCT00539617|431191|P1|COMPLETED|Run-In Period||3
185474|NCT00539617|431191|P1|STARTED|Run-In Period||4
185475|NCT00539617|431191|P1|NOT COMPLETED|Pre-screening Period||3
185476|NCT00539617|431191|P1|COMPLETED|Pre-screening Period||4
185477|NCT00539617|431191|P1|STARTED|Pre-screening Period||7
185478|NCT00539591|431199|P3|NOT COMPLETED|Overall Study||3
185479|NCT00539591|431200|P2|NOT COMPLETED|Overall Study||2
185480|NCT00539591|431201|P1|NOT COMPLETED|Overall Study||5
185481|NCT00539591|431199|P3|COMPLETED|Overall Study||1
185482|NCT00539591|431200|P2|COMPLETED|Overall Study||0
185483|NCT00539591|431201|P1|COMPLETED|Overall Study||18
185484|NCT00539591|431199|P3|STARTED|Overall Study||4
185485|NCT00539591|431200|P2|STARTED|Overall Study||2
185486|NCT00539591|431201|P1|STARTED|Overall Study||23
185487|NCT00539539|431311|P2|NOT COMPLETED|Overall Study||0
185488|NCT00539539|431312|P1|NOT COMPLETED|Overall Study||0
185489|NCT00539539|431311|P2|COMPLETED|Overall Study||771
185490|NCT00539539|431312|P1|COMPLETED|Overall Study||815
185491|NCT00539539|431311|P2|STARTED|Overall Study||771
185492|NCT00539539|431312|P1|STARTED|Overall Study||815
185493|NCT00539526|431335|P3|NOT COMPLETED|Overall Study||2
185494|NCT00539526|431336|P2|NOT COMPLETED|Overall Study||2
185495|NCT00539526|431337|P1|NOT COMPLETED|Overall Study||3
185496|NCT00539526|431335|P3|COMPLETED|Overall Study||36
185497|NCT00539526|431336|P2|COMPLETED|Overall Study||31
185498|NCT00539526|431337|P1|COMPLETED|Overall Study||32
185499|NCT00539526|431335|P3|STARTED|Overall Study||38
185500|NCT00539526|431336|P2|STARTED|Overall Study||33
185501|NCT00539526|431337|P1|STARTED|Overall Study||35
185502|NCT00539513|431353|P2|NOT COMPLETED|Overall Study||2
185503|NCT00539513|431354|P1|NOT COMPLETED|Overall Study||2
185504|NCT00539513|431353|P2|COMPLETED|Overall Study||3
185505|NCT00539513|431354|P1|COMPLETED|Overall Study||3
185506|NCT00539513|431353|P2|Received Allocated Intervention|Overall Study||4
185507|NCT00539513|431354|P1|Received Allocated Intervention|Overall Study||3
185508|NCT00539513|431353|P2|STARTED|Overall Study||5
185509|NCT00539513|431354|P1|STARTED|Overall Study||5
185510|NCT00539305|431368|P2|NOT COMPLETED|Overall Study||2
185511|NCT00539305|431369|P1|NOT COMPLETED|Overall Study||1
185512|NCT00539305|431368|P2|COMPLETED|Overall Study||10
185513|NCT00539305|431369|P1|COMPLETED|Overall Study||9
185514|NCT00539305|431368|P2|STARTED|Overall Study||12
185515|NCT00539305|431369|P1|STARTED|Overall Study||10
185516|NCT00539279|431383|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
185517|NCT00539279|431384|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
185518|NCT00539279|431383|P2|COMPLETED|6-Month Follow-Up Assessment||22
185519|NCT00539279|431384|P1|COMPLETED|6-Month Follow-Up Assessment||17
185520|NCT00539279|431383|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
185521|NCT00539279|431384|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
185522|NCT00539279|431383|P2|NOT COMPLETED|Post-Treatment Assessment||9
185523|NCT00539279|431384|P1|NOT COMPLETED|Post-Treatment Assessment||12
185524|NCT00539279|431383|P2|COMPLETED|Post-Treatment Assessment||29
185525|NCT00539279|431384|P1|COMPLETED|Post-Treatment Assessment||18
185526|NCT00539279|431383|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
185527|NCT00539279|431384|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
185528|NCT00539279|431383|P2|NOT COMPLETED|Treatment||8
185529|NCT00539279|431384|P1|NOT COMPLETED|Treatment||11
185530|NCT00539279|431383|P2|COMPLETED|Treatment||38
185531|NCT00539279|431384|P1|COMPLETED|Treatment||30
185532|NCT00539279|431383|P2|STARTED|Treatment||46
185533|NCT00539279|431384|P1|STARTED|Treatment||41
185534|NCT00539240|431405|P3|NOT COMPLETED|Overall Study||15
185535|NCT00539240|431406|P2|NOT COMPLETED|Overall Study||7
185536|NCT00539240|431407|P1|NOT COMPLETED|Overall Study||6
185537|NCT00539240|431405|P3|COMPLETED|Overall Study||39
185538|NCT00539240|431406|P2|COMPLETED|Overall Study||48
185539|NCT00539240|431407|P1|COMPLETED|Overall Study||53
185540|NCT00539240|431405|P3|STARTED|Overall Study||54
185541|NCT00539240|431406|P2|STARTED|Overall Study||55
185542|NCT00539240|431407|P1|STARTED|Overall Study||59
185543|NCT00539188|431426|P2|NOT COMPLETED|Overall Study||1
185544|NCT00539188|431427|P1|NOT COMPLETED|Overall Study||3
185545|NCT00539188|431426|P2|COMPLETED|Overall Study||1
185546|NCT00539188|431427|P1|COMPLETED|Overall Study||1
185547|NCT00539188|431426|P2|Received Allocated Intervention|Overall Study||2
185548|NCT00539188|431427|P1|Received Allocated Intervention|Overall Study||3
185549|NCT00539188|431426|P2|STARTED|Overall Study||2
185550|NCT00539188|431427|P1|STARTED|Overall Study||4
185551|NCT00539110|431441|P2|NOT COMPLETED|Overall Study||0
185552|NCT00539110|431442|P1|NOT COMPLETED|Overall Study||0
185553|NCT00539110|431441|P2|COMPLETED|Overall Study||5
185554|NCT00539110|431442|P1|COMPLETED|Overall Study||5
185555|NCT00539110|431441|P2|STARTED|Overall Study||5
185556|NCT00539110|431442|P1|STARTED|Overall Study||5
185557|NCT00539032|431450|P2|NOT COMPLETED|Overall Study||1
185558|NCT00539032|431451|P1|NOT COMPLETED|Overall Study||2
185559|NCT00539032|431450|P2|COMPLETED|Overall Study||84
185560|NCT00539032|431451|P1|COMPLETED|Overall Study||151
185561|NCT00539032|431450|P2|STARTED|Overall Study||85
185562|NCT00539032|431451|P1|STARTED|Overall Study||153
185563|NCT00539006|431465|P4|NOT COMPLETED|Post-Study||0
185564|NCT00539006|431466|P3|NOT COMPLETED|Post-Study||0
185565|NCT00539006|431467|P2|NOT COMPLETED|Post-Study||0
185566|NCT00539006|431468|P1|NOT COMPLETED|Post-Study||0
185567|NCT00539006|431465|P4|COMPLETED|Post-Study||81
185568|NCT00539006|431466|P3|COMPLETED|Post-Study||77
185569|NCT00539006|431467|P2|COMPLETED|Post-Study||83
185570|NCT00539006|431468|P1|COMPLETED|Post-Study||75
185571|NCT00539006|431465|P4|STARTED|Post-Study||81
185572|NCT00539006|431466|P3|STARTED|Post-Study||77
185573|NCT00539006|431467|P2|STARTED|Post-Study||83
185574|NCT00539006|431468|P1|STARTED|Post-Study||75
185575|NCT00539006|431465|P4|NOT COMPLETED|Treatment Period 2||0
185576|NCT00539006|431466|P3|NOT COMPLETED|Treatment Period 2||0
185577|NCT00539006|431467|P2|NOT COMPLETED|Treatment Period 2||1
185578|NCT00539006|431468|P1|NOT COMPLETED|Treatment Period 2||1
185579|NCT00539006|431465|P4|COMPLETED|Treatment Period 2||81
185580|NCT00539006|431466|P3|COMPLETED|Treatment Period 2||77
185581|NCT00539006|431467|P2|COMPLETED|Treatment Period 2||83
185582|NCT00539006|431468|P1|COMPLETED|Treatment Period 2||75
185583|NCT00539006|431465|P4|STARTED|Treatment Period 2||81
185584|NCT00539006|431466|P3|STARTED|Treatment Period 2||77
185585|NCT00539006|431467|P2|STARTED|Treatment Period 2||84
185586|NCT00539006|431468|P1|STARTED|Treatment Period 2||76
185587|NCT00539006|431465|P4|NOT COMPLETED|Washout||9
185588|NCT00539006|431466|P3|NOT COMPLETED|Washout||16
185589|NCT00539006|431467|P2|NOT COMPLETED|Washout||10
185590|NCT00539006|431468|P1|NOT COMPLETED|Washout||20
185591|NCT00539006|431465|P4|COMPLETED|Washout||81
185592|NCT00539006|431466|P3|COMPLETED|Washout||77
185593|NCT00539006|431467|P2|COMPLETED|Washout||84
185594|NCT00539006|431468|P1|COMPLETED|Washout||76
185595|NCT00539006|431465|P4|STARTED|Washout||90
185596|NCT00539006|431466|P3|STARTED|Washout||93
185597|NCT00539006|431467|P2|STARTED|Washout||94
185598|NCT00539006|431468|P1|STARTED|Washout||96
185599|NCT00539006|431465|P4|NOT COMPLETED|Treatment Period 1||1
185600|NCT00539006|431466|P3|NOT COMPLETED|Treatment Period 1||2
185601|NCT00539006|431467|P2|NOT COMPLETED|Treatment Period 1||0
185602|NCT00539006|431468|P1|NOT COMPLETED|Treatment Period 1||0
185603|NCT00539006|431465|P4|COMPLETED|Treatment Period 1||90
185604|NCT00539006|431466|P3|COMPLETED|Treatment Period 1||93
185605|NCT00539006|431467|P2|COMPLETED|Treatment Period 1||94
185606|NCT00539006|431468|P1|COMPLETED|Treatment Period 1||96
185607|NCT00539006|431465|P4|STARTED|Treatment Period 1||91
185608|NCT00539006|431466|P3|STARTED|Treatment Period 1||95
185609|NCT00539006|431467|P2|STARTED|Treatment Period 1||94
185610|NCT00539006|431468|P1|STARTED|Treatment Period 1||96
185611|NCT00539006|431465|P4|NOT COMPLETED|Pre-treatment||0
185612|NCT00539006|431466|P3|NOT COMPLETED|Pre-treatment||0
185613|NCT00539006|431467|P2|NOT COMPLETED|Pre-treatment||1
185614|NCT00539006|431468|P1|NOT COMPLETED|Pre-treatment||0
185615|NCT00539006|431465|P4|COMPLETED|Pre-treatment||91
185616|NCT00539006|431466|P3|COMPLETED|Pre-treatment||95
185617|NCT00539006|431467|P2|COMPLETED|Pre-treatment||94
185618|NCT00539006|431468|P1|COMPLETED|Pre-treatment||96
185619|NCT00539006|431465|P4|STARTED|Pre-treatment||91
185620|NCT00539006|431466|P3|STARTED|Pre-treatment||95
185621|NCT00539006|431467|P2|STARTED|Pre-treatment||95
185622|NCT00539006|431468|P1|STARTED|Pre-treatment||96
185623|NCT00538915|431498|P1|NOT COMPLETED|Overall Study||11
185624|NCT00538915|431498|P1|COMPLETED|Overall Study||52
185625|NCT00538915|431498|P1|STARTED|Overall Study||63
185626|NCT00538902|431505|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
185627|NCT00538902|431506|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
185628|NCT00538902|431507|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
185629|NCT00538902|431505|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
185630|NCT00538902|431506|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
185631|NCT00538902|431507|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
185632|NCT00538902|431505|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
185633|NCT00538902|431506|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
185634|NCT00538902|431507|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
185635|NCT00538902|431505|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
185636|NCT00538902|431506|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
185637|NCT00538902|431507|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
185638|NCT00538902|431505|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
185639|NCT00538902|431506|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
185640|NCT00538902|431507|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
185641|NCT00538902|431505|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
185642|NCT00538902|431506|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
185643|NCT00538902|431507|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
185644|NCT00538863|431542|P1|NOT COMPLETED|Open-label Maintenance||106
185645|NCT00538863|431542|P1|COMPLETED|Open-label Maintenance||163
185646|NCT00538863|431542|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
185647|NCT00538863|431542|P1|NOT COMPLETED|Open-label Titration||45
185648|NCT00538863|431542|P1|COMPLETED|Open-label Titration||184
185649|NCT00538863|431542|P1|STARTED|Open-label Titration||229
185650|NCT00538850|431548|P3|NOT COMPLETED|Placebo - Double-blind||3
185651|NCT00538850|431549|P2|NOT COMPLETED|Placebo - Double-blind||0
185652|NCT00538850|431550|P1|NOT COMPLETED|Placebo - Double-blind||0
185653|NCT00538850|431548|P3|COMPLETED|Placebo - Double-blind||95
185654|NCT00538850|431549|P2|COMPLETED|Placebo - Double-blind||0
185655|NCT00538850|431550|P1|COMPLETED|Placebo - Double-blind||0
185656|NCT00538850|431548|P3|STARTED|Placebo - Double-blind||98
185657|NCT00538850|431549|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
185658|NCT00538850|431550|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
185659|NCT00538850|431548|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
185660|NCT00538850|431549|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
185661|NCT00538850|431550|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
185662|NCT00538850|431548|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
185663|NCT00538850|431549|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
185664|NCT00538850|431550|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
185665|NCT00538850|431548|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
185666|NCT00538850|431549|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
185667|NCT00538850|431550|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
185668|NCT00538850|431548|P3|NOT COMPLETED|Titration Period||0
185669|NCT00538850|431549|P2|NOT COMPLETED|Titration Period||0
185670|NCT00538850|431550|P1|NOT COMPLETED|Titration Period||32
185671|NCT00538850|431548|P3|COMPLETED|Titration Period||0
185672|NCT00538850|431549|P2|COMPLETED|Titration Period||0
185673|NCT00538850|431550|P1|COMPLETED|Titration Period||98
185674|NCT00538850|431548|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
185675|NCT00538850|431549|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
185676|NCT00538850|431550|P1|STARTED|Titration Period||130
185677|NCT00538785|431564|P2|NOT COMPLETED|Overall Study||17
185678|NCT00538785|431565|P1|NOT COMPLETED|Overall Study||19
185679|NCT00538785|431564|P2|COMPLETED|Overall Study||595
185680|NCT00538785|431565|P1|COMPLETED|Overall Study||604
185681|NCT00538785|431564|P2|STARTED|Overall Study||612
185682|NCT00538785|431565|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
185683|NCT00538512|431589|P3|NOT COMPLETED|Overall Study||13
185684|NCT00538512|431590|P2|NOT COMPLETED|Overall Study||30
185685|NCT00538512|431591|P1|NOT COMPLETED|Overall Study||27
185686|NCT00538512|431589|P3|COMPLETED|Overall Study||312
185687|NCT00538512|431590|P2|COMPLETED|Overall Study||783
185688|NCT00538512|431591|P1|COMPLETED|Overall Study||787
185689|NCT00538512|431589|P3|STARTED|Overall Study||325
185690|NCT00538512|431590|P2|STARTED|Overall Study||813
185691|NCT00538512|431591|P1|STARTED|Overall Study||814
185692|NCT00538473|431601|P2|NOT COMPLETED|Overall Study||0
185693|NCT00538473|431602|P1|NOT COMPLETED|Overall Study||1
185694|NCT00538473|431601|P2|COMPLETED|Overall Study||35
185695|NCT00538473|431602|P1|COMPLETED|Overall Study||32
185696|NCT00538473|431601|P2|STARTED|Overall Study||35
185697|NCT00538473|431602|P1|STARTED|Overall Study||33
185698|NCT00538434|431638|P4|NOT COMPLETED|Overall Study||6
185699|NCT00538434|431639|P3|NOT COMPLETED|Overall Study||7
185700|NCT00538434|431640|P2|NOT COMPLETED|Overall Study||11
185701|NCT00538434|431641|P1|NOT COMPLETED|Overall Study||9
185702|NCT00538434|431638|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
185703|NCT00538434|431639|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
185704|NCT00538434|431640|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
185705|NCT00538434|431641|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
185706|NCT00538434|431638|P4|Intent-to-treat (ITT) Population|Overall Study||57
185707|NCT00538434|431639|P3|Intent-to-treat (ITT) Population|Overall Study||57
185708|NCT00538434|431640|P2|Intent-to-treat (ITT) Population|Overall Study||57
185709|NCT00538434|431641|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
185710|NCT00538434|431638|P4|STARTED|Overall Study||57
185711|NCT00538434|431639|P3|STARTED|Overall Study||57
185712|NCT00538434|431640|P2|STARTED|Overall Study||57
185713|NCT00538434|431641|P1|STARTED|Overall Study||56
185714|NCT00536809|431663|P1|NOT COMPLETED|Phase II||2
185715|NCT00536809|431663|P1|COMPLETED|Phase II||0
185716|NCT00536809|431663|P1|STARTED|Phase II||2
185717|NCT00536809|431663|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
185718|NCT00536809|431663|P1|COMPLETED|Phase I (Dose-finding Phase)||10
185719|NCT00536809|431663|P1|STARTED|Phase I (Dose-finding Phase)||10
185720|NCT00536744|431686|P2|NOT COMPLETED|Overall Study||28
185721|NCT00536744|431687|P1|NOT COMPLETED|Overall Study||29
185722|NCT00536744|431686|P2|COMPLETED|Overall Study||71
185723|NCT00536744|431687|P1|COMPLETED|Overall Study||78
185724|NCT00536744|431686|P2|STARTED|Overall Study||99
185725|NCT00536744|431687|P1|STARTED|Overall Study||107
185726|NCT00536731|431696|P3|NOT COMPLETED|Overall Study||5
185727|NCT00536731|431697|P2|NOT COMPLETED|Overall Study||5
185728|NCT00536731|431698|P1|NOT COMPLETED|Overall Study||4
185729|NCT00536731|431696|P3|COMPLETED|Overall Study||238
185730|NCT00536731|431697|P2|COMPLETED|Overall Study||241
185731|NCT00536731|431698|P1|COMPLETED|Overall Study||249
185732|NCT00536731|431696|P3|STARTED|Overall Study||243
185733|NCT00536731|431697|P2|STARTED|Overall Study||246
185734|NCT00536731|431698|P1|STARTED|Overall Study||253
185735|NCT00538304|431744|P2|NOT COMPLETED|Overall Study||5
185736|NCT00538304|431745|P1|NOT COMPLETED|Overall Study||7
185737|NCT00538304|431744|P2|COMPLETED|Overall Study||66
185738|NCT00538304|431745|P1|COMPLETED|Overall Study||144
185739|NCT00538304|431744|P2|STARTED|Overall Study||71
185740|NCT00538304|431745|P1|STARTED|Overall Study||151
185741|NCT00538291|431761|P1|NOT COMPLETED|Overall Study||3
185742|NCT00538291|431761|P1|COMPLETED|Overall Study||10
185743|NCT00538291|431761|P1|STARTED|Overall Study||13
185744|NCT00538213|431768|P3|NOT COMPLETED|Overall Study||0
185745|NCT00538213|431769|P2|NOT COMPLETED|Overall Study||0
185746|NCT00538213|431770|P1|NOT COMPLETED|Overall Study||0
185747|NCT00538213|431768|P3|COMPLETED|Overall Study||38
185748|NCT00538213|431769|P2|COMPLETED|Overall Study||40
185749|NCT00538213|431770|P1|COMPLETED|Overall Study||55
185750|NCT00538213|431768|P3|STARTED|Overall Study||38
185751|NCT00538213|431769|P2|STARTED|Overall Study||40
185752|NCT00538213|431770|P1|STARTED|Overall Study||55
185753|NCT00537979|431819|P2|NOT COMPLETED|Overall Study||20
185754|NCT00537979|431820|P1|NOT COMPLETED|Overall Study||6
185755|NCT00537979|431819|P2|COMPLETED|Overall Study||89
185756|NCT00537979|431820|P1|COMPLETED|Overall Study||32
185757|NCT00537979|431819|P2|STARTED|Overall Study||109
185758|NCT00537979|431820|P1|STARTED|Overall Study||38
185759|NCT00537940|431836|P2|NOT COMPLETED|Overall Study||179
185760|NCT00537940|431837|P1|NOT COMPLETED|Overall Study||183
185761|NCT00537940|431836|P2|COMPLETED|Overall Study||62
185762|NCT00537940|431837|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
185763|NCT00537940|431836|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
185764|NCT00537940|431837|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
185765|NCT00537940|431836|P2|Completed Maintenance Phase|Overall Study||172
185766|NCT00537940|431837|P1|Completed Maintenance Phase|Overall Study||187
185767|NCT00537940|431836|P2|Completed Titration Phase|Overall Study||210
185768|NCT00537940|431837|P1|Completed Titration Phase|Overall Study||213
185769|NCT00537940|431836|P2|STARTED|Overall Study||241
185770|NCT00537940|431837|P1|STARTED|Overall Study||241
185771|NCT00536575|431859|P1|NOT COMPLETED|Overall Study||2
185772|NCT00536575|431859|P1|COMPLETED|Overall Study||11
185773|NCT00536575|431859|P1|STARTED|Overall Study||13
185774|NCT00536510|431865|P2|NOT COMPLETED|Overall Study||29
185775|NCT00536510|431866|P1|NOT COMPLETED|Overall Study||82
185776|NCT00536510|431865|P2|COMPLETED|Overall Study||295
185777|NCT00536510|431866|P1|COMPLETED|Overall Study||240
185778|NCT00536510|431865|P2|STARTED|Overall Study||324
185779|NCT00536510|431866|P1|STARTED|Overall Study||322
185780|NCT00536484|431876|P2|NOT COMPLETED|Overall Study||56
185781|NCT00536484|431877|P1|NOT COMPLETED|Overall Study||60
185782|NCT00536484|431876|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
185783|NCT00536484|431877|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
185784|NCT00536484|431876|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
185785|NCT00536484|431877|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
185786|NCT00536471|431911|P4|NOT COMPLETED|Overall Study||74
185787|NCT00536471|431912|P3|NOT COMPLETED|Overall Study||139
185788|NCT00536471|431913|P2|NOT COMPLETED|Overall Study||84
185789|NCT00536471|431914|P1|NOT COMPLETED|Overall Study||156
185790|NCT00536471|431911|P4|COMPLETED|Overall Study||57
185791|NCT00536471|431912|P3|COMPLETED|Overall Study||122
185792|NCT00536471|431913|P2|COMPLETED|Overall Study||43
185793|NCT00536471|431914|P1|COMPLETED|Overall Study||101
185794|NCT00536471|431911|P4|STARTED|Overall Study||131
185795|NCT00536471|431912|P3|STARTED|Overall Study||261
185796|NCT00536471|431913|P2|STARTED|Overall Study||127
185797|NCT00536471|431914|P1|STARTED|Overall Study||257
185798|NCT00536380|432159|P3|NOT COMPLETED|Overall Study||10
185799|NCT00536380|432160|P2|NOT COMPLETED|Overall Study||9
185800|NCT00536380|432161|P1|NOT COMPLETED|Overall Study||12
185801|NCT00536380|432159|P3|COMPLETED|Overall Study||94
185802|NCT00536380|432160|P2|COMPLETED|Overall Study||95
185803|NCT00536380|432161|P1|COMPLETED|Overall Study||94
185804|NCT00536380|432159|P3|STARTED|Overall Study||104
185805|NCT00536380|432160|P2|STARTED|Overall Study||104
185806|NCT00536380|432161|P1|STARTED|Overall Study||106
185807|NCT00537823|432171|P2|NOT COMPLETED|Overall Study||0
185808|NCT00537823|432172|P1|NOT COMPLETED|Overall Study||2
185809|NCT00537823|432171|P2|COMPLETED|Overall Study||2
185810|NCT00537823|432172|P1|COMPLETED|Overall Study||5
185811|NCT00537823|432171|P2|STARTED|Overall Study||2
185812|NCT00537823|432172|P1|STARTED|Overall Study||7
185813|NCT00537810|432198|P4|NOT COMPLETED|Overall Study||4
185814|NCT00537810|432199|P3|NOT COMPLETED|Overall Study||4
185815|NCT00537810|432200|P2|NOT COMPLETED|Overall Study||13
185816|NCT00537810|432201|P1|NOT COMPLETED|Overall Study||6
185817|NCT00537810|432198|P4|COMPLETED|Overall Study||22
185818|NCT00537810|432199|P3|COMPLETED|Overall Study||21
185819|NCT00537810|432200|P2|COMPLETED|Overall Study||14
185820|NCT00537810|432201|P1|COMPLETED|Overall Study||20
185821|NCT00537810|432198|P4|STARTED|Overall Study||26
185822|NCT00537810|432199|P3|STARTED|Overall Study||25
185823|NCT00537810|432200|P2|STARTED|Overall Study||27
185824|NCT00537810|432201|P1|STARTED|Overall Study||26
185825|NCT00537771|432217|P2|NOT COMPLETED|Overall Study||61
185826|NCT00537771|432218|P1|NOT COMPLETED|Overall Study||29
185827|NCT00537771|432217|P2|COMPLETED|Overall Study||114
185828|NCT00537771|432218|P1|COMPLETED|Overall Study||149
185829|NCT00537771|432217|P2|STARTED|Overall Study||175
185830|NCT00537771|432218|P1|STARTED|Overall Study||178
185831|NCT00537745|432228|P1|NOT COMPLETED|Overall Study||5
185832|NCT00537745|432228|P1|COMPLETED|Overall Study||9
185833|NCT00537745|432228|P1|Began Intervention|Overall Study||11
185834|NCT00537745|432228|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
185835|NCT00537680|432236|P3|NOT COMPLETED|Overall Study||0
185836|NCT00537680|432237|P2|NOT COMPLETED|Overall Study||2
185837|NCT00537680|432238|P1|NOT COMPLETED|Overall Study||0
185838|NCT00537680|432236|P3|COMPLETED|Overall Study||24
185839|NCT00537680|432237|P2|COMPLETED|Overall Study||22
185840|NCT00537680|432238|P1|COMPLETED|Overall Study||22
185841|NCT00537680|432236|P3|STARTED|Overall Study||24
185842|NCT00537680|432237|P2|STARTED|Overall Study||24
185843|NCT00537680|432238|P1|STARTED|Overall Study||22
185844|NCT00537511|432246|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
185845|NCT00537511|432246|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
185846|NCT00537511|432246|P1|STARTED|Maintenance Phase (Monotherapy)||8
185847|NCT00537511|432246|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
185848|NCT00537511|432246|P1|COMPLETED|Recovery Period (Monotherapy)||3
185849|NCT00537511|432246|P1|STARTED|Recovery Period (Monotherapy)||11
185850|NCT00537511|432246|P1|NOT COMPLETED|Extension Period (Combination)||6
185851|NCT00537511|432246|P1|COMPLETED|Extension Period (Combination)||11
185852|NCT00537511|432246|P1|STARTED|Extension Period (Combination)||17
185853|NCT00537511|432246|P1|NOT COMPLETED|Treatment Period (Combination)||5
185854|NCT00537511|432246|P1|COMPLETED|Treatment Period (Combination)||17
185855|NCT00537511|432246|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
185856|NCT00537511|432246|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
185857|NCT00537511|432246|P1|STARTED|Treatment Period (Combination)||22
185858|NCT00537485|432273|P2|NOT COMPLETED|Overall Study||10
185859|NCT00537485|432274|P1|NOT COMPLETED|Overall Study||15
185860|NCT00537485|432273|P2|COMPLETED|Overall Study||80
185861|NCT00537485|432274|P1|COMPLETED|Overall Study||75
185862|NCT00537485|432273|P2|STARTED|Overall Study||90
185863|NCT00537485|432274|P1|STARTED|Overall Study||90
185864|NCT00537407|432303|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
185865|NCT00537407|432304|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
185866|NCT00537407|432305|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
185867|NCT00537407|432306|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
185868|NCT00537407|432307|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
185869|NCT00537407|432303|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
185870|NCT00537407|432304|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
185871|NCT00537407|432305|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
185872|NCT00537407|432306|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
185873|NCT00537407|432307|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
185874|NCT00537407|432303|P5|STARTED|Part 2 Weeks 5-48 or 72||10
185875|NCT00537407|432304|P4|STARTED|Part 2 Weeks 5-48 or 72||10
185876|NCT00537407|432305|P3|STARTED|Part 2 Weeks 5-48 or 72||11
185877|NCT00537407|432306|P2|STARTED|Part 2 Weeks 5-48 or 72||9
185878|NCT00537407|432307|P1|STARTED|Part 2 Weeks 5-48 or 72||10
185879|NCT00537407|432303|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
185880|NCT00537407|432304|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
185881|NCT00537407|432305|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
185882|NCT00537407|432306|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
185883|NCT00537407|432307|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
185884|NCT00537407|432303|P5|COMPLETED|Part 1 Weeks 1-4||10
185885|NCT00537407|432304|P4|COMPLETED|Part 1 Weeks 1-4||10
185886|NCT00537407|432305|P3|COMPLETED|Part 1 Weeks 1-4||11
185887|NCT00537407|432306|P2|COMPLETED|Part 1 Weeks 1-4||9
185888|NCT00537407|432307|P1|COMPLETED|Part 1 Weeks 1-4||10
185889|NCT00537407|432303|P5|STARTED|Part 1 Weeks 1-4||10
185890|NCT00537407|432304|P4|STARTED|Part 1 Weeks 1-4||10
185891|NCT00537407|432305|P3|STARTED|Part 1 Weeks 1-4||11
185892|NCT00537407|432306|P2|STARTED|Part 1 Weeks 1-4||9
185893|NCT00537407|432307|P1|STARTED|Part 1 Weeks 1-4||10
185894|NCT00537394|432347|P3|NOT COMPLETED|2nd Year of Follow-up||6
185895|NCT00537394|432348|P2|NOT COMPLETED|2nd Year of Follow-up||9
185896|NCT00537394|432349|P1|NOT COMPLETED|2nd Year of Follow-up||11
185897|NCT00537394|432347|P3|COMPLETED|2nd Year of Follow-up||44
185898|NCT00537394|432348|P2|COMPLETED|2nd Year of Follow-up||159
185899|NCT00537394|432349|P1|COMPLETED|2nd Year of Follow-up||158
185900|NCT00537394|432347|P3|STARTED|2nd Year of Follow-up||50
185901|NCT00537394|432348|P2|STARTED|2nd Year of Follow-up||168
185902|NCT00537394|432349|P1|STARTED|2nd Year of Follow-up||169
185903|NCT00537394|432347|P3|NOT COMPLETED|First Year of Follow-up||3
185904|NCT00537394|432348|P2|NOT COMPLETED|First Year of Follow-up||11
185905|NCT00537394|432349|P1|NOT COMPLETED|First Year of Follow-up||12
185906|NCT00537394|432347|P3|COMPLETED|First Year of Follow-up||50
185907|NCT00537394|432348|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
185908|NCT00537394|432349|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
185909|NCT00537394|432347|P3|STARTED|First Year of Follow-up||53
185910|NCT00537394|432348|P2|STARTED|First Year of Follow-up||179
185911|NCT00537394|432349|P1|STARTED|First Year of Follow-up||181
185912|NCT00537381|432385|P2|NOT COMPLETED|Overall Study||62
185913|NCT00537381|432386|P1|NOT COMPLETED|Overall Study||56
185914|NCT00537381|432385|P2|COMPLETED|Overall Study||4
185915|NCT00537381|432386|P1|COMPLETED|Overall Study||9
185916|NCT00537381|432385|P2|STARTED|Overall Study||66
185917|NCT00537381|432386|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
185918|NCT00537329|432406|P1|NOT COMPLETED|Overall Study||26
185919|NCT00537329|432406|P1|COMPLETED|Overall Study||17
185920|NCT00537329|432406|P1|STARTED|Overall Study||43
185921|NCT00537316|432426|P7|NOT COMPLETED|Part 2||2
185922|NCT00537316|432427|P6|NOT COMPLETED|Part 2||4
185923|NCT00537316|432428|P5|NOT COMPLETED|Part 2||1
185924|NCT00537316|432429|P4|NOT COMPLETED|Part 2||3
185925|NCT00537316|432430|P3|NOT COMPLETED|Part 2||32
185926|NCT00537316|432431|P2|NOT COMPLETED|Part 2||9
185927|NCT00537316|432432|P1|NOT COMPLETED|Part 2||26
185928|NCT00537316|432426|P7|COMPLETED|Part 2||0
185929|NCT00537316|432427|P6|COMPLETED|Part 2||0
185930|NCT00537316|432428|P5|COMPLETED|Part 2||1
185931|NCT00537316|432429|P4|COMPLETED|Part 2||2
185932|NCT00537316|432430|P3|COMPLETED|Part 2||16
185933|NCT00537316|432431|P2|COMPLETED|Part 2||1
185934|NCT00537316|432432|P1|COMPLETED|Part 2||11
185935|NCT00537316|432426|P7|STARTED|Part 2||2
185936|NCT00537316|432427|P6|STARTED|Part 2||4
185937|NCT00537316|432428|P5|STARTED|Part 2||2
185938|NCT00537316|432429|P4|STARTED|Part 2||5
185939|NCT00537316|432430|P3|STARTED|Part 2||48
185940|NCT00537316|432431|P2|STARTED|Part 2||10
185941|NCT00537316|432432|P1|STARTED|Part 2||37
185942|NCT00537316|432426|P7|NOT COMPLETED|Part 1||0
185943|NCT00537316|432427|P6|NOT COMPLETED|Part 1||0
185944|NCT00537316|432428|P5|NOT COMPLETED|Part 1||0
185945|NCT00537316|432429|P4|NOT COMPLETED|Part 1||0
185946|NCT00537316|432430|P3|NOT COMPLETED|Part 1||17
185947|NCT00537316|432431|P2|NOT COMPLETED|Part 1||27
185948|NCT00537316|432432|P1|NOT COMPLETED|Part 1||14
185949|NCT00537316|432426|P7|COMPLETED|Part 1||0
185950|NCT00537316|432427|P6|COMPLETED|Part 1||0
185951|NCT00537316|432428|P5|COMPLETED|Part 1||0
185952|NCT00537316|432429|P4|COMPLETED|Part 1||0
185953|NCT00537316|432430|P3|COMPLETED|Part 1||63
185954|NCT00537316|432431|P2|COMPLETED|Part 1||53
185955|NCT00537316|432432|P1|COMPLETED|Part 1||65
185956|NCT00537316|432426|P7|STARTED|Part 1||0
185957|NCT00537316|432427|P6|STARTED|Part 1||0
185958|NCT00537316|432428|P5|STARTED|Part 1||0
185959|NCT00537316|432429|P4|STARTED|Part 1||0
185960|NCT00537316|432430|P3|STARTED|Part 1||80
185961|NCT00537316|432431|P2|STARTED|Part 1||80
185962|NCT00537316|432432|P1|STARTED|Part 1||79
185963|NCT00537303|432459|P2|NOT COMPLETED|Overall Study||25
185964|NCT00537303|432460|P1|NOT COMPLETED|Overall Study||26
185965|NCT00537303|432459|P2|COMPLETED|Overall Study||125
185966|NCT00537303|432460|P1|COMPLETED|Overall Study||120
185967|NCT00537303|432459|P2|STARTED|Overall Study||150
185968|NCT00537303|432460|P1|STARTED|Overall Study||146
185969|NCT00537277|432476|P1|NOT COMPLETED|Overall Study||49
185970|NCT00537277|432476|P1|COMPLETED|Overall Study||112
185971|NCT00537277|432476|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
185972|NCT00537277|432476|P1|STARTED|Overall Study||161
185973|NCT00537238|432487|P2|NOT COMPLETED|Overall Study||173
185974|NCT00537238|432488|P1|NOT COMPLETED|Overall Study||174
185975|NCT00537238|432487|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
185976|NCT00537238|432488|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
186066|NCT00535938|432692|P2|NOT COMPLETED|Overall Study||462
186067|NCT00535938|432693|P1|NOT COMPLETED|Overall Study||391
185977|NCT00537238|432487|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
185978|NCT00537238|432488|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
185979|NCT00537238|432487|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
185980|NCT00537238|432488|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
185981|NCT00537238|432487|P2|Completed Titration Phase|Overall Study||236
185982|NCT00537238|432488|P1|Completed Titration Phase|Overall Study||226
185983|NCT00537238|432487|P2|STARTED|Overall Study||255
185984|NCT00537238|432488|P1|STARTED|Overall Study||254
185985|NCT00537199|432508|P1|NOT COMPLETED|Overall Study||1
185986|NCT00537199|432508|P1|COMPLETED|Overall Study||0
185987|NCT00537199|432508|P1|STARTED|Overall Study||1
185988|NCT00537095|432514|P2|NOT COMPLETED|Overall Study||57
185989|NCT00537095|432515|P1|NOT COMPLETED|Overall Study||51
185990|NCT00537095|432514|P2|COMPLETED|Overall Study||16
185991|NCT00537095|432515|P1|COMPLETED|Overall Study||21
185992|NCT00537095|432514|P2|STARTED|Overall Study||73
185993|NCT00537095|432515|P1|STARTED|Overall Study||72
185994|NCT00537082|432530|P3|NOT COMPLETED|Overall Study||6
185995|NCT00537082|432531|P2|NOT COMPLETED|Overall Study||9
185996|NCT00537082|432532|P1|NOT COMPLETED|Overall Study||9
185997|NCT00537082|432530|P3|COMPLETED|Overall Study||51
185998|NCT00537082|432531|P2|COMPLETED|Overall Study||48
185999|NCT00537082|432532|P1|COMPLETED|Overall Study||48
186000|NCT00537082|432530|P3|STARTED|Overall Study||57
186001|NCT00537082|432531|P2|STARTED|Overall Study||57
186002|NCT00537082|432532|P1|STARTED|Overall Study||57
186003|NCT00537030|432549|P1|NOT COMPLETED|Overall Study||16
186004|NCT00537030|432549|P1|COMPLETED|Overall Study||43
186005|NCT00537030|432549|P1|STARTED|Overall Study||59
186006|NCT00537017|432553|P1|NOT COMPLETED|Follow-up Phase||9
186007|NCT00537017|432553|P1|COMPLETED|Follow-up Phase||126
186008|NCT00537017|432553|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
186009|NCT00537017|432553|P1|NOT COMPLETED|Treatment Phase||34
186010|NCT00537017|432553|P1|COMPLETED|Treatment Phase||106
186011|NCT00537017|432553|P1|STARTED|Treatment Phase||140
186012|NCT00536978|432564|P1|NOT COMPLETED|Overall Study||22
186013|NCT00536978|432564|P1|COMPLETED|Overall Study||0
186014|NCT00536978|432564|P1|STARTED|Overall Study||22
186015|NCT00536341|432570|P2|NOT COMPLETED|Overall Study||11
186016|NCT00536341|432571|P1|NOT COMPLETED|Overall Study||5
186017|NCT00536341|432570|P2|COMPLETED|Overall Study||43
186018|NCT00536341|432571|P1|COMPLETED|Overall Study||5
186019|NCT00536341|432570|P2|STARTED|Overall Study||54
186020|NCT00536341|432571|P1|STARTED|Overall Study||10
186021|NCT00536263|432584|P3|NOT COMPLETED|Overall Study||21
186022|NCT00536263|432585|P2|NOT COMPLETED|Overall Study||14
186023|NCT00536263|432586|P1|NOT COMPLETED|Overall Study||11
186024|NCT00536263|432584|P3|COMPLETED|Overall Study||204
186025|NCT00536263|432585|P2|COMPLETED|Overall Study||207
186026|NCT00536263|432586|P1|COMPLETED|Overall Study||214
186027|NCT00536263|432584|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
186028|NCT00536263|432585|P2|STARTED|Overall Study||221
186029|NCT00536263|432586|P1|STARTED|Overall Study||225
186030|NCT00536198|432626|P2|NOT COMPLETED|Overall Study||39
186031|NCT00536198|432627|P1|NOT COMPLETED|Overall Study||37
186032|NCT00536198|432626|P2|COMPLETED|Overall Study||88
186033|NCT00536198|432627|P1|COMPLETED|Overall Study||88
186034|NCT00536198|432626|P2|Cycle 6|Overall Study||88
186035|NCT00536198|432627|P1|Cycle 6|Overall Study||88
186036|NCT00536198|432626|P2|Cycle 5|Overall Study||85
186037|NCT00536198|432627|P1|Cycle 5|Overall Study||88
186038|NCT00536198|432626|P2|Cycle 4|Overall Study||98
186039|NCT00536198|432627|P1|Cycle 4|Overall Study||95
186040|NCT00536198|432626|P2|Cycle 3|Overall Study||101
186041|NCT00536198|432627|P1|Cycle 3|Overall Study||100
186042|NCT00536198|432626|P2|Cycle 2|Overall Study||112
186043|NCT00536198|432627|P1|Cycle 2|Overall Study||104
186044|NCT00536198|432626|P2|Cycle 1|Overall Study||123
186045|NCT00536198|432627|P1|Cycle 1|Overall Study||110
186046|NCT00536198|432626|P2|STARTED|Overall Study||127
186047|NCT00536198|432627|P1|STARTED|Overall Study||125
186048|NCT00536172|432657|P2|NOT COMPLETED|Overall Study||9
186049|NCT00536172|432658|P1|NOT COMPLETED|Overall Study||14
186050|NCT00536172|432657|P2|COMPLETED|Overall Study||65
186051|NCT00536172|432658|P1|COMPLETED|Overall Study||60
186052|NCT00536172|432657|P2|STARTED|Overall Study||74
186053|NCT00536172|432658|P1|STARTED|Overall Study||74
186054|NCT00536120|432666|P2|NOT COMPLETED|Overall Study||3
186055|NCT00536120|432667|P1|NOT COMPLETED|Overall Study||6
186056|NCT00536120|432666|P2|COMPLETED|Overall Study||27
186057|NCT00536120|432667|P1|COMPLETED|Overall Study||24
186058|NCT00536120|432666|P2|STARTED|Overall Study||30
186059|NCT00536120|432667|P1|STARTED|Overall Study||30
186060|NCT00536107|432681|P2|NOT COMPLETED|Overall Study||6
186061|NCT00536107|432682|P1|NOT COMPLETED|Overall Study||8
186062|NCT00536107|432681|P2|COMPLETED|Overall Study||0
186063|NCT00536107|432682|P1|COMPLETED|Overall Study||0
186064|NCT00536107|432681|P2|STARTED|Overall Study||6
186065|NCT00536107|432682|P1|STARTED|Overall Study||8
186068|NCT00535938|432692|P2|COMPLETED|Overall Study||404
186069|NCT00535938|432693|P1|COMPLETED|Overall Study||115
186070|NCT00535938|432692|P2|STARTED|Overall Study||866
186071|NCT00535938|432693|P1|STARTED|Overall Study||506
186072|NCT00535873|432729|P1|NOT COMPLETED|Overall Study||0
186073|NCT00535873|432729|P1|COMPLETED|Overall Study||60
186074|NCT00535873|432729|P1|STARTED|Overall Study||60
186075|NCT00535847|432736|P3|NOT COMPLETED|Overall Study||2
186076|NCT00535847|432737|P2|NOT COMPLETED|Overall Study||14
186077|NCT00535847|432738|P1|NOT COMPLETED|Overall Study||22
186078|NCT00535847|432736|P3|COMPLETED|Overall Study||0
186079|NCT00535847|432737|P2|COMPLETED|Overall Study||20
186080|NCT00535847|432738|P1|COMPLETED|Overall Study||59
186081|NCT00535847|432736|P3|STARTED|Overall Study||2
186082|NCT00535847|432737|P2|STARTED|Overall Study||34
186083|NCT00535847|432738|P1|STARTED|Overall Study||81
186084|NCT00535821|432764|P2|NOT COMPLETED|Overall Study||0
186085|NCT00535821|432765|P1|NOT COMPLETED|Overall Study||0
186086|NCT00535821|432764|P2|COMPLETED|Overall Study||3
186087|NCT00535821|432765|P1|COMPLETED|Overall Study||2
186088|NCT00535821|432764|P2|STARTED|Overall Study||3
186089|NCT00535821|432765|P1|STARTED|Overall Study||2
186090|NCT00535782|432773|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
186091|NCT00535782|432774|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
186092|NCT00535782|432775|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
186093|NCT00535782|432773|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
186094|NCT00535782|432774|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
186095|NCT00535782|432775|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
186096|NCT00535782|432773|P3|STARTED|Part 2: 80-Week Open-label Period||124
186097|NCT00535782|432774|P2|STARTED|Part 2: 80-Week Open-label Period||0
186098|NCT00535782|432775|P1|STARTED|Part 2: 80-Week Open-label Period||0
186099|NCT00535782|432773|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
186100|NCT00535782|432774|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
186101|NCT00535782|432775|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
186102|NCT00535782|432773|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
186103|NCT00535782|432774|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
186104|NCT00535782|432775|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
186105|NCT00535782|432773|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
186106|NCT00535782|432774|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
186107|NCT00535782|432775|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
186108|NCT00535782|432773|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
186109|NCT00535782|432774|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
186110|NCT00535782|432775|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
186111|NCT00535782|432773|P3|STARTED|Part 1: 24-Week Double-blind Period||0
186112|NCT00535782|432774|P2|STARTED|Part 1: 24-Week Double-blind Period||63
186113|NCT00535782|432775|P1|STARTED|Part 1: 24-Week Double-blind Period||69
186114|NCT00535769|432792|P2|NOT COMPLETED|Overall Study||0
186115|NCT00535769|432793|P1|NOT COMPLETED|Overall Study||0
186116|NCT00535769|432792|P2|COMPLETED|Overall Study||35
186117|NCT00535769|432793|P1|COMPLETED|Overall Study||35
186118|NCT00535769|432792|P2|STARTED|Overall Study||35
186119|NCT00535769|432793|P1|STARTED|Overall Study||35
186120|NCT00535730|432804|P2|NOT COMPLETED|Overall Study||7
186121|NCT00535730|432805|P1|NOT COMPLETED|Overall Study||2
186122|NCT00535730|432804|P2|COMPLETED|Overall Study||230
186123|NCT00535730|432805|P1|COMPLETED|Overall Study||234
186124|NCT00535730|432804|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
186125|NCT00535730|432805|P1|STARTED|Overall Study||236
186126|NCT00535652|432822|P1|NOT COMPLETED|Overall Study||3
186127|NCT00535652|432822|P1|COMPLETED|Overall Study||20
186128|NCT00535652|432822|P1|STARTED|Overall Study||23
186129|NCT00535587|432830|P4|NOT COMPLETED|Overall Study||13
186130|NCT00535587|432831|P3|NOT COMPLETED|Overall Study||8
186131|NCT00535587|432832|P2|NOT COMPLETED|Overall Study||11
186132|NCT00535587|432833|P1|NOT COMPLETED|Overall Study||10
186133|NCT00535587|432830|P4|COMPLETED|Overall Study||41
186134|NCT00535587|432831|P3|COMPLETED|Overall Study||39
186135|NCT00535587|432832|P2|COMPLETED|Overall Study||42
186136|NCT00535587|432833|P1|COMPLETED|Overall Study||43
186137|NCT00535587|432830|P4|STARTED|Overall Study||54
186138|NCT00535587|432831|P3|STARTED|Overall Study||47
186139|NCT00535587|432832|P2|STARTED|Overall Study||53
186140|NCT00535587|432833|P1|STARTED|Overall Study||53
186141|NCT00535496|432843|P4|NOT COMPLETED|Overall Study||0
186142|NCT00535496|432844|P3|NOT COMPLETED|Overall Study||0
186143|NCT00535496|432845|P2|NOT COMPLETED|Overall Study||2
186144|NCT00535496|432846|P1|NOT COMPLETED|Overall Study||0
186145|NCT00535496|432843|P4|COMPLETED|Overall Study||31
186146|NCT00535496|432844|P3|COMPLETED|Overall Study||30
186147|NCT00535496|432845|P2|COMPLETED|Overall Study||13
186148|NCT00535496|432846|P1|COMPLETED|Overall Study||15
186149|NCT00535496|432843|P4|All-Subjects-Treated (AST) Group|Overall Study||31
186150|NCT00535496|432844|P3|All-Subjects-Treated (AST) Group|Overall Study||30
186151|NCT00535496|432845|P2|All-Subjects-Treated (AST) Group|Overall Study||14
186152|NCT00535496|432846|P1|All-Subjects-Treated (AST) Group|Overall Study||15
186153|NCT00535496|432843|P4|STARTED|Overall Study||31
186154|NCT00535496|432844|P3|STARTED|Overall Study||30
186155|NCT00535496|432845|P2|STARTED|Overall Study||15
186156|NCT00535496|432846|P1|STARTED|Overall Study||15
186157|NCT00535405|432866|P5|NOT COMPLETED|Overall Study||16
186158|NCT00535405|432867|P4|NOT COMPLETED|Overall Study||22
186159|NCT00535405|432868|P3|NOT COMPLETED|Overall Study||18
186160|NCT00535405|432869|P2|NOT COMPLETED|Overall Study||26
186161|NCT00535405|432870|P1|NOT COMPLETED|Overall Study||17
186162|NCT00535405|432866|P5|COMPLETED|Overall Study||241
186163|NCT00535405|432867|P4|COMPLETED|Overall Study||235
186164|NCT00535405|432868|P3|COMPLETED|Overall Study||241
186165|NCT00535405|432869|P2|COMPLETED|Overall Study||233
186166|NCT00535405|432870|P1|COMPLETED|Overall Study||240
186167|NCT00535405|432866|P5|STARTED|Overall Study||257
186168|NCT00535405|432867|P4|STARTED|Overall Study||257
186169|NCT00535405|432868|P3|STARTED|Overall Study||259
186170|NCT00535405|432869|P2|STARTED|Overall Study||259
186171|NCT00535405|432870|P1|STARTED|Overall Study||257
186172|NCT00535392|432907|P1|NOT COMPLETED|Overall Study||0
186173|NCT00535392|432907|P1|COMPLETED|Overall Study||33
186174|NCT00535392|432907|P1|STARTED|Overall Study||33
186175|NCT00535301|432915|P2|NOT COMPLETED|Overall Study||5
186176|NCT00535301|432916|P1|NOT COMPLETED|Overall Study||5
186177|NCT00535301|432915|P2|COMPLETED|Overall Study||33
186178|NCT00535301|432916|P1|COMPLETED|Overall Study||33
186179|NCT00535301|432915|P2|STARTED|Overall Study||38
186180|NCT00535301|432916|P1|STARTED|Overall Study||38
186181|NCT00535288|432931|P5|NOT COMPLETED|Overall Study||42
186182|NCT00535288|432932|P4|NOT COMPLETED|Overall Study||29
186183|NCT00535288|432933|P3|NOT COMPLETED|Overall Study||33
186184|NCT00535288|432934|P2|NOT COMPLETED|Overall Study||32
186185|NCT00535288|432935|P1|NOT COMPLETED|Overall Study||54
186186|NCT00535288|432931|P5|COMPLETED|Overall Study||116
186187|NCT00535288|432932|P4|COMPLETED|Overall Study||122
186188|NCT00535288|432933|P3|COMPLETED|Overall Study||127
186189|NCT00535288|432934|P2|COMPLETED|Overall Study||130
186190|NCT00535288|432935|P1|COMPLETED|Overall Study||260
186191|NCT00535288|432931|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
186192|NCT00535288|432932|P4|STARTED|Overall Study||151
186193|NCT00535288|432933|P3|STARTED|Overall Study||160
186194|NCT00535288|432934|P2|STARTED|Overall Study||162
186195|NCT00535288|432935|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
186196|NCT00535262|433012|P1|NOT COMPLETED|Overall Study||3
186197|NCT00535262|433012|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
186198|NCT00535262|433012|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
186199|NCT00535223|433018|P2|NOT COMPLETED|Overall Study||1
186200|NCT00535223|433019|P1|NOT COMPLETED|Overall Study||4
186201|NCT00535223|433018|P2|COMPLETED|Overall Study||39
186202|NCT00535223|433019|P1|COMPLETED|Overall Study||37
186203|NCT00535223|433018|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
186204|NCT00535223|433019|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
186205|NCT00535145|433027|P1|NOT COMPLETED|Phase II||15
186206|NCT00535145|433027|P1|COMPLETED|Phase II||69
186207|NCT00535145|433027|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
186208|NCT00535145|433027|P1|NOT COMPLETED|Phase I||29
186209|NCT00535145|433027|P1|COMPLETED|Phase I||85
186210|NCT00535145|433027|P1|STARTED|Phase I||114
186211|NCT00535132|433039|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
186212|NCT00535132|433040|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
186213|NCT00535132|433039|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
186214|NCT00535132|433040|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
186215|NCT00535132|433039|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
186216|NCT00535132|433040|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
186217|NCT00535132|433039|P2|NOT COMPLETED|Safety Analysis Set||2
186218|NCT00535132|433040|P1|NOT COMPLETED|Safety Analysis Set||2
186219|NCT00535132|433039|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
186220|NCT00535132|433040|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
186221|NCT00535132|433039|P2|STARTED|Safety Analysis Set||101
186222|NCT00535132|433040|P1|STARTED|Safety Analysis Set||100
186223|NCT00535132|433039|P2|NOT COMPLETED|Randomized Population||0
186224|NCT00535132|433040|P1|NOT COMPLETED|Randomized Population||0
186225|NCT00535132|433039|P2|COMPLETED|Randomized Population||101
186226|NCT00535132|433040|P1|COMPLETED|Randomized Population||100
186227|NCT00535132|433039|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
186228|NCT00535132|433040|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
186229|NCT00534976|433092|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
186230|NCT00534976|433093|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
186231|NCT00534976|433092|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
186232|NCT00534976|433093|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
186233|NCT00534976|433092|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
186234|NCT00534976|433093|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
186235|NCT00534976|433092|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
186236|NCT00534976|433093|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
186237|NCT00534976|433092|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
186238|NCT00534976|433093|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
186239|NCT00534976|433092|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
186240|NCT00534976|433093|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
186241|NCT00534976|433092|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
186242|NCT00534976|433093|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
186243|NCT00534976|433092|P2|COMPLETED|Period 1: Placebo Run-in||33
186244|NCT00534976|433093|P1|COMPLETED|Period 1: Placebo Run-in||33
186245|NCT00534976|433092|P2|STARTED|Period 1: Placebo Run-in||33
186246|NCT00534976|433093|P1|STARTED|Period 1: Placebo Run-in||33
186247|NCT00534937|433115|P2|NOT COMPLETED|Overall Study||12
186248|NCT00534937|433116|P1|NOT COMPLETED|Overall Study||8
186249|NCT00534937|433115|P2|COMPLETED|Overall Study||35
186250|NCT00534937|433116|P1|COMPLETED|Overall Study||34
186251|NCT00534937|433115|P2|STARTED|Overall Study||47
186252|NCT00534937|433116|P1|STARTED|Overall Study||42
186253|NCT00534833|433130|P2|NOT COMPLETED|Overall Study||0
186254|NCT00534833|433131|P1|NOT COMPLETED|Overall Study||0
186255|NCT00534833|433130|P2|COMPLETED|Overall Study||180
186256|NCT00534833|433131|P1|COMPLETED|Overall Study||182
186257|NCT00534833|433130|P2|STARTED|Overall Study||180
186258|NCT00534833|433131|P1|STARTED|Overall Study||182
186259|NCT00534794|433143|P2|NOT COMPLETED|Overall Study||0
186260|NCT00534794|433144|P1|NOT COMPLETED|Overall Study||0
186261|NCT00534794|433143|P2|COMPLETED|Overall Study||39
186262|NCT00534794|433144|P1|COMPLETED|Overall Study||40
186263|NCT00534794|433143|P2|STARTED|Overall Study||39
186264|NCT00534794|433144|P1|STARTED|Overall Study||40
186265|NCT00533702|433154|P2|NOT COMPLETED|Overall Study||2
186266|NCT00533702|433155|P1|NOT COMPLETED|Overall Study||5
186267|NCT00533702|433154|P2|COMPLETED|Overall Study||50
186268|NCT00533702|433155|P1|COMPLETED|Overall Study||49
186269|NCT00533702|433154|P2|Received Any Quantity of Study Drug|Overall Study||50
186270|NCT00533702|433155|P1|Received Any Quantity of Study Drug|Overall Study||52
186271|NCT00533702|433154|P2|STARTED|Overall Study||52
186272|NCT00533702|433155|P1|STARTED|Overall Study||54
186273|NCT00534638|433181|P2|NOT COMPLETED|Overall Study||11791
186274|NCT00534638|433182|P1|NOT COMPLETED|Overall Study||6491
186275|NCT00534638|433181|P2|COMPLETED|Overall Study||5547
186276|NCT00534638|433182|P1|COMPLETED|Overall Study||8346
186277|NCT00534638|433181|P2|STARTED|Overall Study||17338
186278|NCT00534638|433182|P1|STARTED|Overall Study||14837
186279|NCT00534599|433217|P2|NOT COMPLETED|Overall Study||32
186280|NCT00534599|433218|P1|NOT COMPLETED|Overall Study||57
186281|NCT00534599|433217|P2|COMPLETED|Overall Study||168
186282|NCT00534599|433218|P1|COMPLETED|Overall Study||152
186283|NCT00534599|433217|P2|STARTED|Overall Study|Randomized|200
186284|NCT00534599|433218|P1|STARTED|Overall Study|Randomized|209
186285|NCT00534495|433254|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
186286|NCT00534495|433255|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
186287|NCT00534495|433256|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
186288|NCT00534495|433254|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
186289|NCT00534495|433255|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
186290|NCT00534495|433256|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
186291|NCT00534495|433254|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
186292|NCT00534495|433255|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
186293|NCT00534495|433256|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
186294|NCT00534495|433254|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
186295|NCT00534495|433255|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
186296|NCT00534495|433256|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
186297|NCT00534495|433254|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
186298|NCT00534495|433255|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
186299|NCT00534495|433256|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
186300|NCT00534495|433254|P3|STARTED|All Active Treatment Phase Week 4-24||0
186301|NCT00534495|433255|P2|STARTED|All Active Treatment Phase Week 4-24||34
186302|NCT00534495|433256|P1|STARTED|All Active Treatment Phase Week 4-24||36
186303|NCT00534495|433254|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
186304|NCT00534495|433255|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
186305|NCT00534495|433256|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
186306|NCT00534495|433254|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
186307|NCT00534495|433255|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
186308|NCT00534495|433256|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
186309|NCT00534495|433254|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
186310|NCT00534495|433255|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
186311|NCT00534495|433256|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
186312|NCT00534417|433279|P1|NOT COMPLETED|Overall Study||0
186313|NCT00534417|433279|P1|COMPLETED|Overall Study||41
186314|NCT00534417|433279|P1|STARTED|Overall Study||41
186315|NCT00534404|433294|P3|NOT COMPLETED|Overall Study||242
186316|NCT00534404|433295|P2|NOT COMPLETED|Overall Study||143
186317|NCT00534404|433296|P1|NOT COMPLETED|Overall Study||180
186318|NCT00534404|433294|P3|COMPLETED|Overall Study||586
186319|NCT00534404|433295|P2|COMPLETED|Overall Study||687
186320|NCT00534404|433296|P1|COMPLETED|Overall Study||647
186321|NCT00534404|433294|P3|3-month Follow up Completed|Overall Study||593
186322|NCT00534404|433295|P2|3-month Follow up Completed|Overall Study||731
186323|NCT00534404|433296|P1|3-month Follow up Completed|Overall Study||682
186324|NCT00534404|433294|P3|1-month Follow up Completed|Overall Study||626
186325|NCT00534404|433295|P2|1-month Follow up Completed|Overall Study||781
186326|NCT00534404|433296|P1|1-month Follow up Completed|Overall Study||742
186327|NCT00534404|433294|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
186328|NCT00534404|433295|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
186329|NCT00534404|433296|P1|Completed at Least 1 Counseling Call|Overall Study||813
186330|NCT00534404|433294|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
186331|NCT00534404|433295|P2|Completed Second NRT Order|Overall Study||789
186332|NCT00534404|433296|P1|Completed Second NRT Order|Overall Study||640
186333|NCT00534404|433294|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
186334|NCT00534404|433295|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
186335|NCT00534404|433296|P1|Completed First NRT Order|Overall Study||765
186336|NCT00534404|433294|P3|Completed at Least 1 Online Session|Overall Study||658
186337|NCT00534404|433295|P2|Completed at Least 1 Online Session|Overall Study||813
186338|NCT00534404|433296|P1|Completed at Least 1 Online Session|Overall Study||781
186339|NCT00534404|433294|P3|STARTED|Overall Study||828
186340|NCT00534404|433295|P2|STARTED|Overall Study||830
186341|NCT00534404|433296|P1|STARTED|Overall Study||827
186342|NCT00534352|433310|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
186343|NCT00534352|433310|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
186344|NCT00534352|433310|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
186345|NCT00534352|433310|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
186346|NCT00534352|433310|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
186347|NCT00534352|433310|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
186348|NCT00534352|433310|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
186349|NCT00534352|433310|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
186350|NCT00534352|433310|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
186351|NCT00534352|433310|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
186352|NCT00534352|433310|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
186353|NCT00534352|433310|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
186354|NCT00534313|433354|P4|NOT COMPLETED|Long-term Period||33
186355|NCT00534313|433355|P3|NOT COMPLETED|Long-term Period||43
186356|NCT00534313|433356|P2|NOT COMPLETED|Long-term Period||34
186357|NCT00534313|433357|P1|NOT COMPLETED|Long-term Period||37
186358|NCT00534313|433354|P4|COMPLETED|Long-term Period||0
186359|NCT00534313|433355|P3|COMPLETED|Long-term Period||0
186360|NCT00534313|433356|P2|COMPLETED|Long-term Period||0
186361|NCT00534313|433357|P1|COMPLETED|Long-term Period||0
186362|NCT00534313|433354|P4|STARTED|Long-term Period||33
186363|NCT00534313|433355|P3|STARTED|Long-term Period||43
186364|NCT00534313|433356|P2|STARTED|Long-term Period||34
186365|NCT00534313|433357|P1|STARTED|Long-term Period||37
186366|NCT00534313|433354|P4|NOT COMPLETED|Short-term Period||9
186367|NCT00534313|433355|P3|NOT COMPLETED|Short-term Period||2
186368|NCT00534313|433356|P2|NOT COMPLETED|Short-term Period||6
186369|NCT00534313|433357|P1|NOT COMPLETED|Short-term Period||6
186370|NCT00534313|433354|P4|COMPLETED|Short-term Period|Completed the short-term study|33
186371|NCT00534313|433355|P3|COMPLETED|Short-term Period|Completed the short-term study|43
186372|NCT00534313|433356|P2|COMPLETED|Short-term Period|Completed the short-term study|34
186373|NCT00534313|433357|P1|COMPLETED|Short-term Period|Completed the short-term study|37
186374|NCT00534313|433354|P4|STARTED|Short-term Period||42
186375|NCT00534313|433355|P3|STARTED|Short-term Period||45
186376|NCT00534313|433356|P2|STARTED|Short-term Period||40
186377|NCT00534313|433357|P1|STARTED|Short-term Period||43
186378|NCT00534248|433452|P2|NOT COMPLETED|Overall Study||673
186379|NCT00534248|433453|P1|NOT COMPLETED|Overall Study||661
186380|NCT00534248|433452|P2|COMPLETED|Overall Study||10555
186381|NCT00534248|433453|P1|COMPLETED|Overall Study||10550
186382|NCT00534248|433452|P2|VACCINATED|Overall Study||11210
186383|NCT00534248|433453|P1|VACCINATED|Overall Study||11186
186384|NCT00534248|433452|P2|STARTED|Overall Study||11228
186385|NCT00534248|433453|P1|STARTED|Overall Study||11211
186386|NCT00534209|433463|P1|NOT COMPLETED|Overall Study||0
186387|NCT00534209|433463|P1|COMPLETED|Overall Study||1
186388|NCT00534209|433463|P1|STARTED|Overall Study||1
186389|NCT00534105|433469|P2|NOT COMPLETED|Overall Study||39
186390|NCT00534105|433470|P1|NOT COMPLETED|Overall Study||23
186391|NCT00534105|433469|P2|COMPLETED|Overall Study||20
186392|NCT00534105|433470|P1|COMPLETED|Overall Study||24
186393|NCT00534105|433469|P2|STARTED|Overall Study||59
186394|NCT00534105|433470|P1|STARTED|Overall Study||47
186395|NCT00534092|433484|P2|NOT COMPLETED|Overall Study||0
186396|NCT00534092|433485|P1|NOT COMPLETED|Overall Study||2
186397|NCT00534092|433484|P2|COMPLETED|Overall Study||14
186398|NCT00534092|433485|P1|COMPLETED|Overall Study||53
186399|NCT00534092|433484|P2|STARTED|Overall Study||14
186400|NCT00534092|433485|P1|STARTED|Overall Study||55
186401|NCT00533897|433511|P8|NOT COMPLETED|Long Term Extension (LTE)||25
186402|NCT00533897|433512|P7|NOT COMPLETED|Long Term Extension (LTE)||13
186403|NCT00533897|433513|P6|NOT COMPLETED|Long Term Extension (LTE)||0
186404|NCT00533897|433514|P5|NOT COMPLETED|Long Term Extension (LTE)||0
186405|NCT00533897|433515|P4|NOT COMPLETED|Long Term Extension (LTE)||0
186406|NCT00533897|433516|P3|NOT COMPLETED|Long Term Extension (LTE)||0
186407|NCT00533897|433517|P2|NOT COMPLETED|Long Term Extension (LTE)||0
186408|NCT00533897|433518|P1|NOT COMPLETED|Long Term Extension (LTE)||0
186409|NCT00533897|433511|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
186410|NCT00533897|433512|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
186411|NCT00533897|433513|P6|COMPLETED|Long Term Extension (LTE)||0
186412|NCT00533897|433514|P5|COMPLETED|Long Term Extension (LTE)||0
186413|NCT00533897|433515|P4|COMPLETED|Long Term Extension (LTE)||0
186414|NCT00533897|433516|P3|COMPLETED|Long Term Extension (LTE)||0
186415|NCT00533897|433517|P2|COMPLETED|Long Term Extension (LTE)||0
186416|NCT00533897|433518|P1|COMPLETED|Long Term Extension (LTE)||0
186417|NCT00533897|433511|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
186418|NCT00533897|433512|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
186419|NCT00533897|433513|P6|STARTED|Long Term Extension (LTE)||0
186420|NCT00533897|433514|P5|STARTED|Long Term Extension (LTE)||0
186421|NCT00533897|433515|P4|STARTED|Long Term Extension (LTE)||0
186422|NCT00533897|433516|P3|STARTED|Long Term Extension (LTE)||0
186423|NCT00533897|433517|P2|STARTED|Long Term Extension (LTE)||0
186424|NCT00533897|433518|P1|STARTED|Long Term Extension (LTE)||0
186425|NCT00533897|433511|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
186426|NCT00533897|433512|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
186427|NCT00533897|433513|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
186428|NCT00533897|433514|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
186429|NCT00533897|433515|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
186430|NCT00533897|433516|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
186431|NCT00533897|433517|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
186432|NCT00533897|433518|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
186433|NCT00533897|433511|P8|COMPLETED|Re-introduction (RI) Period 3||0
186434|NCT00533897|433512|P7|COMPLETED|Re-introduction (RI) Period 3||0
186435|NCT00533897|433513|P6|COMPLETED|Re-introduction (RI) Period 3||42
186436|NCT00533897|433514|P5|COMPLETED|Re-introduction (RI) Period 3||35
186437|NCT00533897|433515|P4|COMPLETED|Re-introduction (RI) Period 3||40
186438|NCT00533897|433516|P3|COMPLETED|Re-introduction (RI) Period 3||0
186439|NCT00533897|433517|P2|COMPLETED|Re-introduction (RI) Period 3||0
186440|NCT00533897|433518|P1|COMPLETED|Re-introduction (RI) Period 3||0
186441|NCT00533897|433511|P8|STARTED|Re-introduction (RI) Period 3||0
186442|NCT00533897|433512|P7|STARTED|Re-introduction (RI) Period 3||0
186443|NCT00533897|433513|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
186444|NCT00533897|433514|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
186445|NCT00533897|433515|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
186446|NCT00533897|433516|P3|STARTED|Re-introduction (RI) Period 3||0
186447|NCT00533897|433517|P2|STARTED|Re-introduction (RI) Period 3||0
186448|NCT00533897|433518|P1|STARTED|Re-introduction (RI) Period 3||0
186449|NCT00533897|433511|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186450|NCT00533897|433512|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186451|NCT00533897|433513|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186452|NCT00533897|433514|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186453|NCT00533897|433515|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186454|NCT00533897|433516|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
186455|NCT00533897|433517|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
186456|NCT00533897|433518|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186457|NCT00533897|433511|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186458|NCT00533897|433512|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186459|NCT00533897|433513|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186460|NCT00533897|433514|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186461|NCT00533897|433515|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186462|NCT00533897|433516|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
186463|NCT00533897|433517|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
186464|NCT00533897|433518|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
186465|NCT00533897|433511|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186466|NCT00533897|433512|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186467|NCT00533897|433513|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186468|NCT00533897|433514|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186469|NCT00533897|433515|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186470|NCT00533897|433516|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
186471|NCT00533897|433517|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
186472|NCT00533897|433518|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
186473|NCT00533897|433511|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
186474|NCT00533897|433512|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
186475|NCT00533897|433513|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
186476|NCT00533897|433514|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
186477|NCT00533897|433515|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
186478|NCT00533897|433516|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
186479|NCT00533897|433517|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
186480|NCT00533897|433518|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
186481|NCT00533897|433511|P8|COMPLETED|Lead-in (LI) Period 1||0
186482|NCT00533897|433512|P7|COMPLETED|Lead-in (LI) Period 1||0
186483|NCT00533897|433513|P6|COMPLETED|Lead-in (LI) Period 1||0
186484|NCT00533897|433514|P5|COMPLETED|Lead-in (LI) Period 1||0
186485|NCT00533897|433515|P4|COMPLETED|Lead-in (LI) Period 1||0
186486|NCT00533897|433516|P3|COMPLETED|Lead-in (LI) Period 1||0
186487|NCT00533897|433517|P2|COMPLETED|Lead-in (LI) Period 1||0
186488|NCT00533897|433518|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
186489|NCT00533897|433511|P8|STARTED|Lead-in (LI) Period 1||0
186490|NCT00533897|433512|P7|STARTED|Lead-in (LI) Period 1||0
186491|NCT00533897|433513|P6|STARTED|Lead-in (LI) Period 1||0
186492|NCT00533897|433514|P5|STARTED|Lead-in (LI) Period 1||0
186493|NCT00533897|433515|P4|STARTED|Lead-in (LI) Period 1||0
186494|NCT00533897|433516|P3|STARTED|Lead-in (LI) Period 1||0
186495|NCT00533897|433517|P2|STARTED|Lead-in (LI) Period 1||0
186496|NCT00533897|433518|P1|STARTED|Lead-in (LI) Period 1||167
186497|NCT00533546|433656|P1|NOT COMPLETED|Overall Study||0
186498|NCT00533546|433656|P1|COMPLETED|Overall Study||12
186499|NCT00533546|433656|P1|STARTED|Overall Study||12
186500|NCT00533507|433663|P1|NOT COMPLETED|Overall Study||1
186501|NCT00533507|433663|P1|COMPLETED|Overall Study||229
186502|NCT00533507|433663|P1|STARTED|Overall Study||230
186503|NCT00533351|433684|P2|NOT COMPLETED|Period 3||0
186504|NCT00533351|433685|P1|NOT COMPLETED|Period 3||0
186505|NCT00533351|433684|P2|COMPLETED|Period 3||0
186506|NCT00533351|433685|P1|COMPLETED|Period 3||3
186507|NCT00533351|433684|P2|STARTED|Period 3|No patients continued to Period 3|0
186508|NCT00533351|433685|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
186509|NCT00533351|433684|P2|NOT COMPLETED|Period 2||0
186510|NCT00533351|433685|P1|NOT COMPLETED|Period 2||0
186511|NCT00533351|433684|P2|COMPLETED|Period 2||1
186512|NCT00533351|433685|P1|COMPLETED|Period 2||5
186513|NCT00533351|433684|P2|STARTED|Period 2||1
186514|NCT00533351|433685|P1|STARTED|Period 2||5
186515|NCT00533351|433684|P2|NOT COMPLETED|Period 1||1
186516|NCT00533351|433685|P1|NOT COMPLETED|Period 1||2
186517|NCT00533351|433684|P2|COMPLETED|Period 1||1
186518|NCT00533351|433685|P1|COMPLETED|Period 1||5
186519|NCT00533351|433684|P2|STARTED|Period 1||2
186520|NCT00533351|433685|P1|STARTED|Period 1||7
186521|NCT00533273|433695|P2|NOT COMPLETED|Open-label||0
186522|NCT00533273|433696|P1|NOT COMPLETED|Open-label||6
186523|NCT00533273|433695|P2|COMPLETED|Open-label||0
186524|NCT00533273|433696|P1|COMPLETED|Open-label||58
186525|NCT00533273|433695|P2|STARTED|Open-label|no placebo - this phase was open label|0
186526|NCT00533273|433696|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
186527|NCT00533273|433695|P2|NOT COMPLETED|Double-blind||2
186528|NCT00533273|433696|P1|NOT COMPLETED|Double-blind||0
186529|NCT00533273|433695|P2|COMPLETED|Double-blind||19
186530|NCT00533273|433696|P1|COMPLETED|Double-blind||45
186531|NCT00533273|433695|P2|STARTED|Double-blind||21
186532|NCT00533273|433696|P1|STARTED|Double-blind||45
186533|NCT00532948|433705|P3|NOT COMPLETED|Overall Study||4
186534|NCT00532948|433706|P2|NOT COMPLETED|Overall Study||5
186535|NCT00532948|433707|P1|NOT COMPLETED|Overall Study||4
186536|NCT00532948|433705|P3|COMPLETED|Overall Study||2
186537|NCT00532948|433706|P2|COMPLETED|Overall Study||9
186538|NCT00532948|433707|P1|COMPLETED|Overall Study||0
186539|NCT00532948|433705|P3|STARTED|Overall Study||6
186540|NCT00532948|433706|P2|STARTED|Overall Study||14
186541|NCT00532948|433707|P1|STARTED|Overall Study||4
186542|NCT00532935|433739|P2|NOT COMPLETED|Overall Study||52
186543|NCT00532935|433740|P1|NOT COMPLETED|Overall Study||51
186544|NCT00532935|433739|P2|COMPLETED|Overall Study||204
186545|NCT00532935|433740|P1|COMPLETED|Overall Study||210
186546|NCT00532935|433739|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
186547|NCT00532935|433740|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
186548|NCT00532883|433758|P4|NOT COMPLETED|Overall Study||5
186549|NCT00532883|433759|P3|NOT COMPLETED|Overall Study||4
186550|NCT00532883|433760|P2|NOT COMPLETED|Overall Study||7
186551|NCT00532883|433761|P1|NOT COMPLETED|Overall Study||6
186552|NCT00532883|433758|P4|COMPLETED|Overall Study|Study terminated early.|6
186553|NCT00532883|433759|P3|COMPLETED|Overall Study|Study terminated early.|6
186554|NCT00532883|433760|P2|COMPLETED|Overall Study|Study terminated early.|5
186555|NCT00532883|433761|P1|COMPLETED|Overall Study|Study terminated early.|5
186556|NCT00532883|433758|P4|STARTED|Overall Study||11
186557|NCT00532883|433759|P3|STARTED|Overall Study||10
186558|NCT00532883|433760|P2|STARTED|Overall Study||12
186559|NCT00532883|433761|P1|STARTED|Overall Study||11
186560|NCT00532779|433774|P3|NOT COMPLETED|Overall Study||291
186561|NCT00532779|433775|P2|NOT COMPLETED|Overall Study||287
186562|NCT00532779|433776|P1|NOT COMPLETED|Overall Study||294
186563|NCT00532779|433774|P3|COMPLETED|Overall Study||290
186564|NCT00532779|433775|P2|COMPLETED|Overall Study||296
186565|NCT00532779|433776|P1|COMPLETED|Overall Study||284
186566|NCT00532779|433774|P3|STARTED|Overall Study||581
186567|NCT00532779|433775|P2|STARTED|Overall Study||583
186568|NCT00532779|433776|P1|STARTED|Overall Study||578
186569|NCT00532493|433837|P2|NOT COMPLETED|Overall Study||29
186570|NCT00532493|433838|P1|NOT COMPLETED|Overall Study||30
186571|NCT00532493|433837|P2|COMPLETED|Overall Study||123
186572|NCT00532493|433838|P1|COMPLETED|Overall Study||122
186573|NCT00532493|433837|P2|STARTED|Overall Study||152
186574|NCT00532493|433838|P1|STARTED|Overall Study||152
186575|NCT00532480|433868|P1|NOT COMPLETED|Overall Study||3
186576|NCT00532480|433868|P1|COMPLETED|Overall Study||7
186577|NCT00532480|433868|P1|STARTED|Overall Study||10
186578|NCT00532441|433872|P2|NOT COMPLETED|Overall Study||0
186579|NCT00532441|433873|P1|NOT COMPLETED|Overall Study||1
186580|NCT00532441|433872|P2|COMPLETED|Overall Study||11
186581|NCT00532441|433873|P1|COMPLETED|Overall Study||13
186582|NCT00532441|433872|P2|STARTED|Overall Study||11
186583|NCT00532441|433873|P1|STARTED|Overall Study||14
186584|NCT00532298|433888|P6|NOT COMPLETED|Overall Study||2
186585|NCT00532298|433889|P5|NOT COMPLETED|Overall Study||1
186586|NCT00532298|433890|P4|NOT COMPLETED|Overall Study||0
186587|NCT00532298|433891|P3|NOT COMPLETED|Overall Study||1
186588|NCT00532298|433892|P2|NOT COMPLETED|Overall Study||1
186589|NCT00532298|433893|P1|NOT COMPLETED|Overall Study||2
186590|NCT00532298|433888|P6|COMPLETED|Overall Study||261
186591|NCT00532298|433889|P5|COMPLETED|Overall Study||267
186592|NCT00532298|433890|P4|COMPLETED|Overall Study||264
186593|NCT00532298|433891|P3|COMPLETED|Overall Study||263
186594|NCT00532298|433892|P2|COMPLETED|Overall Study||265
186595|NCT00532298|433893|P1|COMPLETED|Overall Study||267
186596|NCT00532298|433888|P6|STARTED|Overall Study||263
186597|NCT00532298|433889|P5|STARTED|Overall Study||268
186598|NCT00532298|433890|P4|STARTED|Overall Study||264
186599|NCT00532298|433891|P3|STARTED|Overall Study||264
186600|NCT00532298|433892|P2|STARTED|Overall Study||266
186601|NCT00532298|433893|P1|STARTED|Overall Study||269
186602|NCT00532259|433973|P1|NOT COMPLETED|Overall Study||32
186603|NCT00532259|433973|P1|COMPLETED|Overall Study||40
186604|NCT00532259|433973|P1|STARTED|Overall Study||72
186605|NCT00532155|433980|P2|NOT COMPLETED|Overall Study||456
186606|NCT00532155|433981|P1|NOT COMPLETED|Overall Study||457
186607|NCT00532155|433980|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
186608|NCT00532155|433981|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
186609|NCT00532155|433980|P2|SAFETY POPULATION|Overall Study||450
186610|NCT00532155|433981|P1|SAFETY POPULATION|Overall Study||455
186611|NCT00532155|433980|P2|STARTED|Overall Study||456
186612|NCT00532155|433981|P1|STARTED|Overall Study||457
186613|NCT00532129|433995|P1|NOT COMPLETED|Follow-up Period||65
186614|NCT00532129|433995|P1|COMPLETED|Follow-up Period||33
186615|NCT00532129|433995|P1|STARTED|Follow-up Period||98
186616|NCT00532129|433995|P1|NOT COMPLETED|Treatment Period||49
186617|NCT00532129|433995|P1|COMPLETED|Treatment Period||51
186618|NCT00532129|433995|P1|STARTED|Treatment Period||100
186619|NCT00531960|434015|P2|NOT COMPLETED|Overall Study||63
186620|NCT00531960|434016|P1|NOT COMPLETED|Overall Study||61
186621|NCT00531960|434015|P2|COMPLETED|Overall Study||0
186622|NCT00531960|434016|P1|COMPLETED|Overall Study||0
186623|NCT00531960|434015|P2|STARTED|Overall Study||63
186624|NCT00531960|434016|P1|STARTED|Overall Study||61
186625|NCT00531947|434034|P2|NOT COMPLETED|Overall Study||51
186626|NCT00531947|434035|P1|NOT COMPLETED|Overall Study||42
186627|NCT00531947|434034|P2|COMPLETED|Overall Study||101
186628|NCT00531947|434035|P1|COMPLETED|Overall Study||114
186629|NCT00531947|434034|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
186630|NCT00531947|434035|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
186631|NCT00531934|434079|P2|NOT COMPLETED|Overall Study||63
186632|NCT00531934|434080|P1|NOT COMPLETED|Overall Study||66
186633|NCT00531934|434079|P2|COMPLETED|Overall Study||11
186634|NCT00531934|434080|P1|COMPLETED|Overall Study||7
186635|NCT00531934|434079|P2|STARTED|Overall Study||74
186636|NCT00531934|434080|P1|STARTED|Overall Study||73
186637|NCT00531843|434150|P2|NOT COMPLETED|Overall Study||0
186638|NCT00531843|434151|P1|NOT COMPLETED|Overall Study||0
186639|NCT00531843|434150|P2|COMPLETED|Overall Study||6
186640|NCT00531843|434151|P1|COMPLETED|Overall Study||81
186641|NCT00531843|434150|P2|STARTED|Overall Study||6
186642|NCT00531843|434151|P1|STARTED|Overall Study||81
186643|NCT00531817|434163|P2|NOT COMPLETED|Entered Extended Treatment Period||57
186644|NCT00531817|434164|P1|NOT COMPLETED|Entered Extended Treatment Period||137
186645|NCT00531817|434163|P2|COMPLETED|Entered Extended Treatment Period||113
186646|NCT00531817|434164|P1|COMPLETED|Entered Extended Treatment Period||206
186647|NCT00531817|434163|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
186648|NCT00531817|434164|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
186649|NCT00531817|434163|P2|NOT COMPLETED|Randomized||34
186650|NCT00531817|434164|P1|NOT COMPLETED|Randomized||59
186651|NCT00531817|434163|P2|COMPLETED|Randomized||173
186652|NCT00531817|434164|P1|COMPLETED|Randomized||353
186653|NCT00531817|434163|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
186654|NCT00531817|434164|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
186655|NCT00531817|434163|P2|STARTED|Randomized||207
186656|NCT00531817|434164|P1|STARTED|Randomized||412
186657|NCT00531752|434195|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
186658|NCT00531752|434196|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
186659|NCT00531752|434197|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
186660|NCT00531752|434198|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
186661|NCT00531752|434195|P4|COMPLETED|Second Double-blind Intervention Period||11
186662|NCT00531752|434196|P3|COMPLETED|Second Double-blind Intervention Period||9
186663|NCT00531752|434197|P2|COMPLETED|Second Double-blind Intervention Period||11
186664|NCT00531752|434198|P1|COMPLETED|Second Double-blind Intervention Period||9
186665|NCT00531752|434195|P4|STARTED|Second Double-blind Intervention Period||13
186666|NCT00531752|434196|P3|STARTED|Second Double-blind Intervention Period||9
186667|NCT00531752|434197|P2|STARTED|Second Double-blind Intervention Period||13
186668|NCT00531752|434198|P1|STARTED|Second Double-blind Intervention Period||11
186669|NCT00531752|434195|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
186670|NCT00531752|434196|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
186671|NCT00531752|434197|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
186672|NCT00531752|434198|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
186673|NCT00531752|434195|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
186674|NCT00531752|434196|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
186675|NCT00531752|434197|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
186676|NCT00531752|434198|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
186677|NCT00531752|434195|P4|STARTED|Wash-out Period (at Least 7 Days)||13
186678|NCT00531752|434196|P3|STARTED|Wash-out Period (at Least 7 Days)||9
186679|NCT00531752|434197|P2|STARTED|Wash-out Period (at Least 7 Days)||13
186680|NCT00531752|434198|P1|STARTED|Wash-out Period (at Least 7 Days)||11
186681|NCT00531752|434195|P4|NOT COMPLETED|First Double-blind Intervention Period||3
186682|NCT00531752|434196|P3|NOT COMPLETED|First Double-blind Intervention Period||7
186683|NCT00531752|434197|P2|NOT COMPLETED|First Double-blind Intervention Period||4
186684|NCT00531752|434198|P1|NOT COMPLETED|First Double-blind Intervention Period||6
186685|NCT00531752|434195|P4|COMPLETED|First Double-blind Intervention Period||13
186686|NCT00531752|434196|P3|COMPLETED|First Double-blind Intervention Period||9
186687|NCT00531752|434197|P2|COMPLETED|First Double-blind Intervention Period||13
186688|NCT00531752|434198|P1|COMPLETED|First Double-blind Intervention Period||11
186689|NCT00531752|434195|P4|Treated|First Double-blind Intervention Period||16
186690|NCT00531752|434196|P3|Treated|First Double-blind Intervention Period||16
186691|NCT00531752|434197|P2|Treated|First Double-blind Intervention Period||17
186692|NCT00531752|434198|P1|Treated|First Double-blind Intervention Period||16
186693|NCT00531752|434195|P4|STARTED|First Double-blind Intervention Period||16
186694|NCT00531752|434196|P3|STARTED|First Double-blind Intervention Period||16
186695|NCT00531752|434197|P2|STARTED|First Double-blind Intervention Period||17
186696|NCT00531752|434198|P1|STARTED|First Double-blind Intervention Period||17
186697|NCT00531661|434277|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
186698|NCT00531661|434278|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
186699|NCT00531661|434277|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
186700|NCT00531661|434278|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
186701|NCT00531661|434277|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
186702|NCT00531661|434278|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
186703|NCT00531661|434277|P2|NOT COMPLETED|6 Months||26
186704|NCT00531661|434278|P1|NOT COMPLETED|6 Months||26
186705|NCT00531661|434277|P2|COMPLETED|6 Months||254
186706|NCT00531661|434278|P1|COMPLETED|6 Months||244
186707|NCT00531661|434277|P2|STARTED|6 Months||280
186708|NCT00531661|434278|P1|STARTED|6 Months||270
186709|NCT00531518|434300|P2|NOT COMPLETED|Overall Study||71
186710|NCT00531518|434301|P1|NOT COMPLETED|Overall Study||32
186711|NCT00531518|434300|P2|COMPLETED|Overall Study||134
186712|NCT00531518|434301|P1|COMPLETED|Overall Study||55
186713|NCT00531518|434300|P2|STARTED|Overall Study||205
186714|NCT00531518|434301|P1|STARTED|Overall Study||87
186715|NCT00531479|434309|P2|NOT COMPLETED|Overall Study||83
186716|NCT00531479|434310|P1|NOT COMPLETED|Overall Study||76
186717|NCT00531479|434309|P2|COMPLETED|Overall Study||146
186718|NCT00531479|434310|P1|COMPLETED|Overall Study||154
186719|NCT00531479|434309|P2|Treated|Overall Study||226
186720|NCT00531479|434310|P1|Treated|Overall Study||228
186721|NCT00531479|434309|P2|STARTED|Overall Study||229
186722|NCT00531479|434310|P1|STARTED|Overall Study||230
186723|NCT00531453|434330|P2|NOT COMPLETED|Overall Study||0
186724|NCT00531453|434331|P1|NOT COMPLETED|Overall Study||0
186725|NCT00531453|434330|P2|COMPLETED|Overall Study|10 April 2009|49
186726|NCT00531453|434331|P1|COMPLETED|Overall Study|10 April 2009|49
186727|NCT00531453|434330|P2|STARTED|Overall Study|02 October 2007|49
186728|NCT00531453|434331|P1|STARTED|Overall Study|02 October 2007|49
186729|NCT00531427|434341|P2|NOT COMPLETED|Overall Study||94
186730|NCT00531427|434342|P1|NOT COMPLETED|Overall Study||73
186731|NCT00531427|434341|P2|COMPLETED|Overall Study||191
186732|NCT00531427|434342|P1|COMPLETED|Overall Study||209
186733|NCT00531427|434341|P2|STARTED|Overall Study||285
186734|NCT00531427|434342|P1|STARTED|Overall Study||282
186735|NCT00531284|434370|P17|NOT COMPLETED|Overall Study||8
186736|NCT00531284|434371|P16|NOT COMPLETED|Overall Study||12
186737|NCT00531284|434372|P15|NOT COMPLETED|Overall Study||4
186738|NCT00531284|434373|P14|NOT COMPLETED|Overall Study||3
186739|NCT00531284|434374|P13|NOT COMPLETED|Overall Study||2
186740|NCT00531284|434375|P12|NOT COMPLETED|Overall Study||24
186741|NCT00531284|434376|P11|NOT COMPLETED|Overall Study||3
186742|NCT00531284|434377|P10|NOT COMPLETED|Overall Study||4
186743|NCT00531284|434378|P9|NOT COMPLETED|Overall Study||11
186744|NCT00531284|434379|P8|NOT COMPLETED|Overall Study||10
186745|NCT00531284|434380|P7|NOT COMPLETED|Overall Study||6
186746|NCT00531284|434381|P6|NOT COMPLETED|Overall Study||7
186747|NCT00531284|434382|P5|NOT COMPLETED|Overall Study||6
186748|NCT00531284|434383|P4|NOT COMPLETED|Overall Study||63
186749|NCT00531284|434384|P3|NOT COMPLETED|Overall Study||6
186750|NCT00531284|434385|P2|NOT COMPLETED|Overall Study||4
186751|NCT00531284|434386|P1|NOT COMPLETED|Overall Study||3
186752|NCT00531284|434370|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186753|NCT00531284|434371|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
186754|NCT00531284|434372|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
186755|NCT00531284|434373|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186756|NCT00531284|434374|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186757|NCT00531284|434375|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186758|NCT00531284|434376|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186759|NCT00531284|434377|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186760|NCT00531284|434378|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186761|NCT00531284|434379|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186762|NCT00531284|434380|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186763|NCT00531284|434381|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186764|NCT00531284|434382|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
186765|NCT00531284|434383|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
186766|NCT00531284|434384|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
186767|NCT00531284|434385|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
186768|NCT00531284|434386|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
186769|NCT00531284|434370|P17|STARTED|Overall Study||8
186770|NCT00531284|434371|P16|STARTED|Overall Study||14
186771|NCT00531284|434372|P15|STARTED|Overall Study||7
186772|NCT00531284|434373|P14|STARTED|Overall Study||3
186773|NCT00531284|434374|P13|STARTED|Overall Study||2
186774|NCT00531284|434375|P12|STARTED|Overall Study||24
186775|NCT00531284|434376|P11|STARTED|Overall Study||3
186776|NCT00531284|434377|P10|STARTED|Overall Study||4
186777|NCT00531284|434378|P9|STARTED|Overall Study||11
186778|NCT00531284|434379|P8|STARTED|Overall Study||10
186779|NCT00531284|434380|P7|STARTED|Overall Study||6
186780|NCT00531284|434381|P6|STARTED|Overall Study||7
186781|NCT00531284|434382|P5|STARTED|Overall Study||6
186782|NCT00531284|434383|P4|STARTED|Overall Study||65
186783|NCT00531284|434384|P3|STARTED|Overall Study||7
186784|NCT00531284|434385|P2|STARTED|Overall Study||4
186785|NCT00531284|434386|P1|STARTED|Overall Study||3
186786|NCT00531206|434536|P1|NOT COMPLETED|Overall Study||20
186787|NCT00531206|434536|P1|COMPLETED|Overall Study||45
186788|NCT00531206|434536|P1|STARTED|Overall Study||65
186789|NCT00531050|434566|P6|NOT COMPLETED|Part 2: Period 3||1
186790|NCT00531050|434567|P5|NOT COMPLETED|Part 2: Period 3||0
186791|NCT00531050|434568|P4|NOT COMPLETED|Part 2: Period 3||0
186792|NCT00531050|434569|P3|NOT COMPLETED|Part 2: Period 3||0
186793|NCT00531050|434570|P2|NOT COMPLETED|Part 2: Period 3||0
186794|NCT00531050|434571|P1|NOT COMPLETED|Part 2: Period 3||1
186795|NCT00531050|434566|P6|COMPLETED|Part 2: Period 3||3
186796|NCT00531050|434567|P5|COMPLETED|Part 2: Period 3||4
186797|NCT00531050|434568|P4|COMPLETED|Part 2: Period 3||4
186798|NCT00531050|434569|P3|COMPLETED|Part 2: Period 3||4
186799|NCT00531050|434570|P2|COMPLETED|Part 2: Period 3||4
186800|NCT00531050|434571|P1|COMPLETED|Part 2: Period 3||2
186801|NCT00531050|434566|P6|STARTED|Part 2: Period 3||4
186802|NCT00531050|434567|P5|STARTED|Part 2: Period 3||4
186803|NCT00531050|434568|P4|STARTED|Part 2: Period 3||4
186804|NCT00531050|434569|P3|STARTED|Part 2: Period 3||4
186805|NCT00531050|434570|P2|STARTED|Part 2: Period 3||4
186806|NCT00531050|434571|P1|STARTED|Part 2: Period 3||3
186807|NCT00531050|434566|P6|NOT COMPLETED|Part 2: Period 2||0
186808|NCT00531050|434567|P5|NOT COMPLETED|Part 2: Period 2||0
186809|NCT00531050|434568|P4|NOT COMPLETED|Part 2: Period 2||0
186810|NCT00531050|434569|P3|NOT COMPLETED|Part 2: Period 2||0
186811|NCT00531050|434570|P2|NOT COMPLETED|Part 2: Period 2||0
186812|NCT00531050|434571|P1|NOT COMPLETED|Part 2: Period 2||0
186813|NCT00531050|434566|P6|COMPLETED|Part 2: Period 2||4
186814|NCT00531050|434567|P5|COMPLETED|Part 2: Period 2||4
186815|NCT00531050|434568|P4|COMPLETED|Part 2: Period 2||4
186816|NCT00531050|434569|P3|COMPLETED|Part 2: Period 2||4
186817|NCT00531050|434570|P2|COMPLETED|Part 2: Period 2||4
186818|NCT00531050|434571|P1|COMPLETED|Part 2: Period 2||3
186819|NCT00531050|434566|P6|STARTED|Part 2: Period 2||4
186820|NCT00531050|434567|P5|STARTED|Part 2: Period 2||4
186821|NCT00531050|434568|P4|STARTED|Part 2: Period 2||4
186822|NCT00531050|434569|P3|STARTED|Part 2: Period 2||4
186823|NCT00531050|434570|P2|STARTED|Part 2: Period 2||4
186824|NCT00531050|434571|P1|STARTED|Part 2: Period 2||3
186825|NCT00531050|434566|P6|NOT COMPLETED|Part 2: Period 1||1
186826|NCT00531050|434567|P5|NOT COMPLETED|Part 2: Period 1||0
186827|NCT00531050|434568|P4|NOT COMPLETED|Part 2: Period 1||0
186828|NCT00531050|434569|P3|NOT COMPLETED|Part 2: Period 1||0
186829|NCT00531050|434570|P2|NOT COMPLETED|Part 2: Period 1||0
186830|NCT00531050|434571|P1|NOT COMPLETED|Part 2: Period 1||0
186831|NCT00531050|434566|P6|COMPLETED|Part 2: Period 1||4
186832|NCT00531050|434567|P5|COMPLETED|Part 2: Period 1||4
186833|NCT00531050|434568|P4|COMPLETED|Part 2: Period 1||4
186834|NCT00531050|434569|P3|COMPLETED|Part 2: Period 1||4
186835|NCT00531050|434570|P2|COMPLETED|Part 2: Period 1||4
186836|NCT00531050|434571|P1|COMPLETED|Part 2: Period 1||3
186837|NCT00531050|434566|P6|STARTED|Part 2: Period 1||5
186838|NCT00531050|434567|P5|STARTED|Part 2: Period 1||4
186839|NCT00531050|434568|P4|STARTED|Part 2: Period 1||4
186840|NCT00531050|434569|P3|STARTED|Part 2: Period 1||4
186841|NCT00531050|434570|P2|STARTED|Part 2: Period 1||4
186842|NCT00531050|434571|P1|STARTED|Part 2: Period 1||3
186843|NCT00531050|434566|P6|NOT COMPLETED|Part 1: Period 3||0
186844|NCT00531050|434567|P5|NOT COMPLETED|Part 1: Period 3||0
186845|NCT00531050|434568|P4|NOT COMPLETED|Part 1: Period 3||0
186846|NCT00531050|434569|P3|NOT COMPLETED|Part 1: Period 3||0
186847|NCT00531050|434570|P2|NOT COMPLETED|Part 1: Period 3||0
186848|NCT00531050|434571|P1|NOT COMPLETED|Part 1: Period 3||1
186849|NCT00531050|434566|P6|COMPLETED|Part 1: Period 3||5
186850|NCT00531050|434567|P5|COMPLETED|Part 1: Period 3||4
186851|NCT00531050|434568|P4|COMPLETED|Part 1: Period 3||4
186852|NCT00531050|434569|P3|COMPLETED|Part 1: Period 3||4
186853|NCT00531050|434570|P2|COMPLETED|Part 1: Period 3||4
186854|NCT00531050|434571|P1|COMPLETED|Part 1: Period 3||3
186855|NCT00531050|434566|P6|STARTED|Part 1: Period 3||5
186856|NCT00531050|434567|P5|STARTED|Part 1: Period 3||4
186857|NCT00531050|434568|P4|STARTED|Part 1: Period 3||4
186858|NCT00531050|434569|P3|STARTED|Part 1: Period 3||4
186859|NCT00531050|434570|P2|STARTED|Part 1: Period 3||4
186860|NCT00531050|434571|P1|STARTED|Part 1: Period 3||4
186861|NCT00531050|434566|P6|NOT COMPLETED|Part 1: Period 2||0
186862|NCT00531050|434567|P5|NOT COMPLETED|Part 1: Period 2||0
186863|NCT00531050|434568|P4|NOT COMPLETED|Part 1: Period 2||0
186864|NCT00531050|434569|P3|NOT COMPLETED|Part 1: Period 2||0
186865|NCT00531050|434570|P2|NOT COMPLETED|Part 1: Period 2||0
186866|NCT00531050|434571|P1|NOT COMPLETED|Part 1: Period 2||0
186867|NCT00531050|434566|P6|COMPLETED|Part 1: Period 2||5
186868|NCT00531050|434567|P5|COMPLETED|Part 1: Period 2||4
186869|NCT00531050|434568|P4|COMPLETED|Part 1: Period 2||4
186870|NCT00531050|434569|P3|COMPLETED|Part 1: Period 2||4
186871|NCT00531050|434570|P2|COMPLETED|Part 1: Period 2||4
186872|NCT00531050|434571|P1|COMPLETED|Part 1: Period 2||4
186873|NCT00531050|434566|P6|STARTED|Part 1: Period 2||5
186874|NCT00531050|434567|P5|STARTED|Part 1: Period 2||4
186875|NCT00531050|434568|P4|STARTED|Part 1: Period 2||4
186876|NCT00531050|434569|P3|STARTED|Part 1: Period 2||4
186877|NCT00531050|434570|P2|STARTED|Part 1: Period 2||4
186878|NCT00531050|434571|P1|STARTED|Part 1: Period 2||4
186879|NCT00531050|434566|P6|NOT COMPLETED|Part 1: Period 1||0
186880|NCT00531050|434567|P5|NOT COMPLETED|Part 1: Period 1||0
186881|NCT00531050|434568|P4|NOT COMPLETED|Part 1: Period 1||1
186882|NCT00531050|434569|P3|NOT COMPLETED|Part 1: Period 1||0
186883|NCT00531050|434570|P2|NOT COMPLETED|Part 1: Period 1||1
186884|NCT00531050|434571|P1|NOT COMPLETED|Part 1: Period 1||0
186885|NCT00531050|434566|P6|COMPLETED|Part 1: Period 1||5
186886|NCT00531050|434567|P5|COMPLETED|Part 1: Period 1||4
186887|NCT00531050|434568|P4|COMPLETED|Part 1: Period 1||4
186888|NCT00531050|434569|P3|COMPLETED|Part 1: Period 1||4
186889|NCT00531050|434570|P2|COMPLETED|Part 1: Period 1||4
186890|NCT00531050|434571|P1|COMPLETED|Part 1: Period 1||4
186891|NCT00531050|434566|P6|STARTED|Part 1: Period 1||5
186892|NCT00531050|434567|P5|STARTED|Part 1: Period 1||4
186893|NCT00531050|434568|P4|STARTED|Part 1: Period 1||5
186894|NCT00531050|434569|P3|STARTED|Part 1: Period 1||4
186895|NCT00531050|434570|P2|STARTED|Part 1: Period 1||5
186896|NCT00531050|434571|P1|STARTED|Part 1: Period 1||4
186897|NCT00531011|434600|P2|NOT COMPLETED|Overall Study||7
186898|NCT00531011|434601|P1|NOT COMPLETED|Overall Study||4
186899|NCT00531011|434600|P2|COMPLETED|Overall Study||90
186900|NCT00531011|434601|P1|COMPLETED|Overall Study||99
186901|NCT00531011|434600|P2|STARTED|Overall Study||97
186902|NCT00531011|434601|P1|STARTED|Overall Study||103
186903|NCT00530946|434647|P4|NOT COMPLETED|Overall Study||2
186904|NCT00530946|434648|P3|NOT COMPLETED|Overall Study||1
186905|NCT00530946|434649|P2|NOT COMPLETED|Overall Study||2
186906|NCT00530946|434650|P1|NOT COMPLETED|Overall Study||2
186907|NCT00530946|434647|P4|COMPLETED|Overall Study||38
186908|NCT00530946|434648|P3|COMPLETED|Overall Study||40
186909|NCT00530946|434649|P2|COMPLETED|Overall Study||39
186910|NCT00530946|434650|P1|COMPLETED|Overall Study||41
186911|NCT00530946|434647|P4|STARTED|Overall Study||40
186912|NCT00530946|434648|P3|STARTED|Overall Study||41
186913|NCT00530946|434649|P2|STARTED|Overall Study||41
186914|NCT00530946|434650|P1|STARTED|Overall Study||43
186915|NCT00530920|434703|P3|NOT COMPLETED|Overall Study||4
186916|NCT00530920|434704|P2|NOT COMPLETED|Overall Study||2
186917|NCT00530920|434705|P1|NOT COMPLETED|Overall Study||0
186918|NCT00530920|434703|P3|COMPLETED|Overall Study||24
186919|NCT00530920|434704|P2|COMPLETED|Overall Study||25
186920|NCT00530920|434705|P1|COMPLETED|Overall Study||30
186921|NCT00530920|434703|P3|STARTED|Overall Study||28
186922|NCT00530920|434704|P2|STARTED|Overall Study||27
186923|NCT00530920|434705|P1|STARTED|Overall Study||30
186924|NCT00530855|434761|P1|NOT COMPLETED|Overall Study||112
186925|NCT00530855|434761|P1|COMPLETED|Overall Study||210
186926|NCT00530855|434761|P1|STARTED|Overall Study||322
186927|NCT00530842|434770|P2|NOT COMPLETED|Period 2||9
186928|NCT00530842|434771|P1|NOT COMPLETED|Period 2||8
186929|NCT00530842|434770|P2|COMPLETED|Period 2||151
186930|NCT00530842|434771|P1|COMPLETED|Period 2||149
186931|NCT00530842|434770|P2|STARTED|Period 2||160
186932|NCT00530842|434771|P1|STARTED|Period 2||157
186933|NCT00530842|434770|P2|NOT COMPLETED|Period 1||11
186934|NCT00530842|434771|P1|NOT COMPLETED|Period 1||14
186935|NCT00530842|434770|P2|COMPLETED|Period 1||161
186936|NCT00530842|434771|P1|COMPLETED|Period 1||158
186937|NCT00530842|434770|P2|STARTED|Period 1||172
186938|NCT00530842|434771|P1|STARTED|Period 1||172
186939|NCT00530842|434770|P2|NOT COMPLETED|Overall Study||21
186940|NCT00530842|434771|P1|NOT COMPLETED|Overall Study||23
186941|NCT00530842|434770|P2|COMPLETED|Overall Study||151
186942|NCT00530842|434771|P1|COMPLETED|Overall Study||149
186943|NCT00530842|434770|P2|STARTED|Overall Study||172
186944|NCT00530842|434771|P1|STARTED|Overall Study||172
186945|NCT00530816|434898|P3|NOT COMPLETED|Overall Study||41
186946|NCT00530816|434899|P2|NOT COMPLETED|Overall Study||42
186947|NCT00530816|434900|P1|NOT COMPLETED|Overall Study||26
186948|NCT00530816|434898|P3|COMPLETED|Overall Study||29
186949|NCT00530816|434899|P2|COMPLETED|Overall Study||17
186950|NCT00530816|434900|P1|COMPLETED|Overall Study||9
186951|NCT00530816|434898|P3|STARTED|Overall Study||70
186952|NCT00530816|434899|P2|STARTED|Overall Study||59
186953|NCT00530816|434900|P1|STARTED|Overall Study||35
186954|NCT00530790|434926|P1|NOT COMPLETED|Overall Study||5
186955|NCT00530790|434926|P1|COMPLETED|Overall Study||30
186956|NCT00530790|434926|P1|STARTED|Overall Study||35
186957|NCT00530777|434948|P2|NOT COMPLETED|Overall Study||5
186958|NCT00530777|434949|P1|NOT COMPLETED|Overall Study||7
186959|NCT00530777|434948|P2|COMPLETED|Overall Study||69
186960|NCT00530777|434949|P1|COMPLETED|Overall Study||67
186961|NCT00530777|434948|P2|STARTED|Overall Study||74
186962|NCT00530777|434949|P1|STARTED|Overall Study||74
186963|NCT00530764|434961|P4|NOT COMPLETED|Overall Study||25
186964|NCT00530764|434962|P3|NOT COMPLETED|Overall Study||20
186965|NCT00530764|434963|P2|NOT COMPLETED|Overall Study||21
186966|NCT00530764|434964|P1|NOT COMPLETED|Overall Study||31
186967|NCT00530764|434961|P4|COMPLETED|Overall Study||66
186968|NCT00530764|434962|P3|COMPLETED|Overall Study||71
186969|NCT00530764|434963|P2|COMPLETED|Overall Study||67
186970|NCT00530764|434964|P1|COMPLETED|Overall Study||59
186971|NCT00530764|434961|P4|STARTED|Overall Study||91
186972|NCT00530764|434962|P3|STARTED|Overall Study||91
186973|NCT00530764|434963|P2|STARTED|Overall Study||88
186974|NCT00530764|434964|P1|STARTED|Overall Study||90
186975|NCT00530712|435006|P1|NOT COMPLETED|12 Month Follow-up Visit||24
186976|NCT00530712|435006|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
186977|NCT00530712|435006|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
186978|NCT00530712|435006|P1|NOT COMPLETED|6 Month Follow-up Visit||12
186979|NCT00530712|435006|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
186980|NCT00530712|435006|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
186981|NCT00530712|435006|P1|NOT COMPLETED|30 Day Follow-up Visit||7
186982|NCT00530712|435006|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
186983|NCT00530712|435006|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
186984|NCT00530712|435006|P1|NOT COMPLETED|Enrollment||0
186985|NCT00530712|435006|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
186986|NCT00530712|435006|P1|STARTED|Enrollment|Total Enrolled Subjects|287
186987|NCT00530634|435021|P1|NOT COMPLETED|Overall Study||0
186988|NCT00530634|435021|P1|COMPLETED|Overall Study||3
186989|NCT00530634|435021|P1|STARTED|Overall Study||3
186990|NCT00530504|435025|P1|NOT COMPLETED|Overall Study||152
186991|NCT00530504|435025|P1|COMPLETED|Overall Study||1348
186992|NCT00530504|435025|P1|STARTED|Overall Study||1500
186993|NCT00530439|435031|P2|NOT COMPLETED|Overall Study||26
186994|NCT00530439|435032|P1|NOT COMPLETED|Overall Study||30
186995|NCT00530439|435031|P2|COMPLETED|Overall Study||154
186996|NCT00530439|435032|P1|COMPLETED|Overall Study||150
186997|NCT00530439|435031|P2|STARTED|Overall Study||180
186998|NCT00530439|435032|P1|STARTED|Overall Study||180
186999|NCT00530348|435040|P2|NOT COMPLETED|Overall Study||19
187000|NCT00530348|435041|P1|NOT COMPLETED|Overall Study||22
187001|NCT00530348|435040|P2|COMPLETED|Overall Study||367
187002|NCT00530348|435041|P1|COMPLETED|Overall Study||173
187087|NCT00529542|435302|P1|STARTED|Overall Study||9
187003|NCT00530348|435040|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
187004|NCT00530348|435041|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
187005|NCT00530348|435040|P2|STARTED|Overall Study|Randomized.|386
187006|NCT00530348|435041|P1|STARTED|Overall Study|Randomized.|195
187007|NCT00530335|435057|P1|NOT COMPLETED|Overall Study||6
187008|NCT00530335|435057|P1|COMPLETED|Overall Study||39
187009|NCT00530335|435057|P1|STARTED|Overall Study||45
187010|NCT00530270|435074|P2|NOT COMPLETED|Overall Study||0
187011|NCT00530270|435075|P1|NOT COMPLETED|Overall Study||1
187012|NCT00530270|435074|P2|COMPLETED|Overall Study||6
187013|NCT00530270|435075|P1|COMPLETED|Overall Study||5
187014|NCT00530270|435074|P2|STARTED|Overall Study||6
187015|NCT00530270|435075|P1|STARTED|Overall Study||6
187016|NCT00530257|435089|P1|NOT COMPLETED|Overall Study||1
187017|NCT00530257|435089|P1|COMPLETED|Overall Study||30
187018|NCT00530257|435089|P1|STARTED|Overall Study||31
187019|NCT00530088|435117|P1|NOT COMPLETED|Overall Study||10
187020|NCT00530088|435117|P1|COMPLETED|Overall Study||20
187021|NCT00530088|435117|P1|STARTED|Overall Study||30
187022|NCT00530023|435124|P2|NOT COMPLETED|Overall Study||1
187023|NCT00530023|435125|P1|NOT COMPLETED|Overall Study||0
187024|NCT00530023|435124|P2|COMPLETED|Overall Study||14
187025|NCT00530023|435125|P1|COMPLETED|Overall Study||14
187026|NCT00530023|435124|P2|STARTED|Overall Study||15
187027|NCT00530023|435125|P1|STARTED|Overall Study||14
187028|NCT00529789|435139|P1|NOT COMPLETED|Study Period IV||6
187029|NCT00529789|435139|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
187030|NCT00529789|435139|P1|STARTED|Study Period IV||48
187031|NCT00529789|435139|P1|NOT COMPLETED|Study Period II/III||24
187032|NCT00529789|435139|P1|COMPLETED|Study Period II/III||48
187033|NCT00529789|435139|P1|STARTED|Study Period II/III||72
187034|NCT00529763|435164|P3|NOT COMPLETED|Overall Study||7
187035|NCT00529763|435165|P2|NOT COMPLETED|Overall Study||33
187036|NCT00529763|435166|P1|NOT COMPLETED|Overall Study||10
187037|NCT00529763|435164|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
187038|NCT00529763|435165|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
187039|NCT00529763|435166|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
187040|NCT00529763|435164|P3|STARTED|Overall Study||59
187041|NCT00529763|435165|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
187042|NCT00529763|435166|P1|STARTED|Overall Study||25
187043|NCT00529659|435204|P2|NOT COMPLETED|Overall Study||23
187044|NCT00529659|435205|P1|NOT COMPLETED|Overall Study||11
187045|NCT00529659|435204|P2|COMPLETED|Overall Study||66
187046|NCT00529659|435205|P1|COMPLETED|Overall Study||70
187047|NCT00529659|435204|P2|STARTED|Overall Study||89
187048|NCT00529659|435205|P1|STARTED|Overall Study||81
187049|NCT00529633|435223|P2|NOT COMPLETED|Overall Study||1
187050|NCT00529633|435224|P1|NOT COMPLETED|Overall Study||1
187051|NCT00529633|435223|P2|COMPLETED|Overall Study||1
187052|NCT00529633|435224|P1|COMPLETED|Overall Study||1
187053|NCT00529633|435223|P2|STARTED|Overall Study||2
187054|NCT00529633|435224|P1|STARTED|Overall Study||2
187055|NCT00529568|435236|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
187056|NCT00529568|435237|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
187057|NCT00529568|435238|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
187058|NCT00529568|435236|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
187059|NCT00529568|435237|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
187060|NCT00529568|435238|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
187061|NCT00529568|435236|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
187062|NCT00529568|435237|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
187063|NCT00529568|435238|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
187064|NCT00529568|435236|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
187065|NCT00529568|435237|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
187066|NCT00529568|435238|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
187067|NCT00529568|435236|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
187068|NCT00529568|435237|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
187069|NCT00529568|435238|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
187070|NCT00529568|435236|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
187071|NCT00529568|435237|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
187072|NCT00529568|435238|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
187073|NCT00529555|435289|P3|NOT COMPLETED|Overall Study||26
187074|NCT00529555|435290|P2|NOT COMPLETED|Overall Study||30
187075|NCT00529555|435291|P1|NOT COMPLETED|Overall Study||29
187076|NCT00529555|435289|P3|COMPLETED|Overall Study||174
187077|NCT00529555|435290|P2|COMPLETED|Overall Study||172
187078|NCT00529555|435291|P1|COMPLETED|Overall Study||171
187079|NCT00529555|435289|P3|STARTED|Overall Study||200
187080|NCT00529555|435290|P2|STARTED|Overall Study||202
187081|NCT00529555|435291|P1|STARTED|Overall Study||200
187082|NCT00529542|435301|P2|NOT COMPLETED|Overall Study||1
187083|NCT00529542|435302|P1|NOT COMPLETED|Overall Study||1
187084|NCT00529542|435301|P2|COMPLETED|Overall Study||10
187085|NCT00529542|435302|P1|COMPLETED|Overall Study||8
187086|NCT00529542|435301|P2|STARTED|Overall Study||11
187088|NCT00529529|435345|P3|NOT COMPLETED|Overall Study||31
187089|NCT00529529|435346|P2|NOT COMPLETED|Overall Study||43
187090|NCT00529529|435347|P1|NOT COMPLETED|Overall Study||43
187091|NCT00529529|435345|P3|COMPLETED|Overall Study||238
187092|NCT00529529|435346|P2|COMPLETED|Overall Study||225
187093|NCT00529529|435347|P1|COMPLETED|Overall Study||225
187094|NCT00529529|435345|P3|STARTED|Overall Study||269
187095|NCT00529529|435346|P2|STARTED|Overall Study||268
187096|NCT00529529|435347|P1|STARTED|Overall Study||268
187097|NCT00529516|435406|P3|NOT COMPLETED|Overall Study||1
187098|NCT00529516|435407|P2|NOT COMPLETED|Overall Study||2
187099|NCT00529516|435408|P1|NOT COMPLETED|Overall Study||3
187100|NCT00529516|435406|P3|COMPLETED|Overall Study||288
187101|NCT00529516|435407|P2|COMPLETED|Overall Study||486
187102|NCT00529516|435408|P1|COMPLETED|Overall Study||472
187103|NCT00529516|435406|P3|STARTED|Overall Study||289
187104|NCT00529516|435407|P2|STARTED|Overall Study||488
187105|NCT00529516|435408|P1|STARTED|Overall Study||475
187106|NCT00529464|435479|P3|NOT COMPLETED|Overall Study||0
187107|NCT00529464|435480|P2|NOT COMPLETED|Overall Study||0
187108|NCT00529464|435481|P1|NOT COMPLETED|Overall Study||0
187109|NCT00529464|435479|P3|COMPLETED|Overall Study||0
187110|NCT00529464|435480|P2|COMPLETED|Overall Study||0
187111|NCT00529464|435481|P1|COMPLETED|Overall Study||0
187112|NCT00529464|435479|P3|STARTED|Overall Study||0
187113|NCT00529464|435480|P2|STARTED|Overall Study||0
187114|NCT00529464|435481|P1|STARTED|Overall Study||0
187115|NCT00529451|435493|P4|NOT COMPLETED|Overall Study||31
187116|NCT00529451|435494|P3|NOT COMPLETED|Overall Study||40
187117|NCT00529451|435495|P2|NOT COMPLETED|Overall Study||48
187118|NCT00529451|435496|P1|NOT COMPLETED|Overall Study||37
187119|NCT00529451|435493|P4|COMPLETED|Overall Study||299
187120|NCT00529451|435494|P3|COMPLETED|Overall Study||292
187121|NCT00529451|435495|P2|COMPLETED|Overall Study||275
187122|NCT00529451|435496|P1|COMPLETED|Overall Study||294
187123|NCT00529451|435493|P4|STARTED|Overall Study||330
187124|NCT00529451|435494|P3|STARTED|Overall Study||332
187125|NCT00529451|435495|P2|STARTED|Overall Study||323
187126|NCT00529451|435496|P1|STARTED|Overall Study||331
187127|NCT00529399|435523|P3|NOT COMPLETED|Overall Study||2
187128|NCT00529399|435524|P2|NOT COMPLETED|Overall Study||1
187129|NCT00529399|435525|P1|NOT COMPLETED|Overall Study||2
187130|NCT00529399|435523|P3|COMPLETED|Overall Study||46
187131|NCT00529399|435524|P2|COMPLETED|Overall Study||48
187132|NCT00529399|435525|P1|COMPLETED|Overall Study||46
187133|NCT00529399|435523|P3|STARTED|Overall Study||48
187134|NCT00529399|435524|P2|STARTED|Overall Study||49
187135|NCT00529399|435525|P1|STARTED|Overall Study||48
187136|NCT00529308|435535|P2|NOT COMPLETED|Overall Study||1
187137|NCT00529308|435536|P1|NOT COMPLETED|Overall Study||1
187138|NCT00529308|435535|P2|COMPLETED|Overall Study||10
187139|NCT00529308|435536|P1|COMPLETED|Overall Study||8
187140|NCT00529308|435535|P2|STARTED|Overall Study||11
187141|NCT00529308|435536|P1|STARTED|Overall Study||9
187142|NCT00529282|435552|P2|NOT COMPLETED|Overall Study||0
187143|NCT00529282|435553|P1|NOT COMPLETED|Overall Study||0
187144|NCT00529282|435552|P2|COMPLETED|Overall Study||2
187145|NCT00529282|435553|P1|COMPLETED|Overall Study||0
187146|NCT00529282|435552|P2|STARTED|Overall Study||2
187147|NCT00529282|435553|P1|STARTED|Overall Study||0
187148|NCT00529243|435565|P1|NOT COMPLETED|Overall Study||3
187149|NCT00529243|435565|P1|COMPLETED|Overall Study||49
187150|NCT00529243|435565|P1|STARTED|Overall Study||52
187151|NCT00529217|435570|P1|NOT COMPLETED|Overall Study||4
187152|NCT00529217|435570|P1|COMPLETED|Overall Study||8
187153|NCT00529217|435570|P1|STARTED|Overall Study||12
187154|NCT00529204|435575|P1|NOT COMPLETED|Overall Study||0
187155|NCT00529204|435575|P1|COMPLETED|Overall Study||1
187156|NCT00529204|435575|P1|STARTED|Overall Study||1
187157|NCT00529191|435583|P2|NOT COMPLETED|Overall Study||0
187158|NCT00529191|435584|P1|NOT COMPLETED|Overall Study||3
187159|NCT00529191|435583|P2|COMPLETED|Overall Study||13
187160|NCT00529191|435584|P1|COMPLETED|Overall Study||24
187161|NCT00529191|435583|P2|STARTED|Overall Study||13
187162|NCT00529191|435584|P1|STARTED|Overall Study||27
187163|NCT00529152|435590|P1|NOT COMPLETED|Overall Study||5
187164|NCT00529152|435590|P1|COMPLETED|Overall Study||95
187165|NCT00529152|435590|P1|STARTED|Overall Study||100
187166|NCT00529126|435598|P4|NOT COMPLETED|Overall Study||0
187167|NCT00529126|435599|P3|NOT COMPLETED|Overall Study||0
187168|NCT00529126|435600|P2|NOT COMPLETED|Overall Study||0
187169|NCT00529126|435601|P1|NOT COMPLETED|Overall Study||0
187170|NCT00529126|435598|P4|COMPLETED|Overall Study||26
187171|NCT00529126|435599|P3|COMPLETED|Overall Study||24
187172|NCT00529126|435600|P2|COMPLETED|Overall Study||25
187173|NCT00529126|435601|P1|COMPLETED|Overall Study||25
187174|NCT00529126|435598|P4|STARTED|Overall Study||26
187175|NCT00529126|435599|P3|STARTED|Overall Study||24
187176|NCT00529126|435600|P2|STARTED|Overall Study||25
187177|NCT00529126|435601|P1|STARTED|Overall Study||25
187178|NCT00529100|435614|P2|NOT COMPLETED|Overall Study||9
187179|NCT00529100|435615|P1|NOT COMPLETED|Overall Study||0
187180|NCT00529100|435614|P2|COMPLETED|Overall Study||24
187181|NCT00529100|435615|P1|COMPLETED|Overall Study||16
187182|NCT00529100|435614|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
187183|NCT00529100|435615|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
187184|NCT00529100|435614|P2|STARTED|Overall Study||33
187185|NCT00529100|435615|P1|STARTED|Overall Study||16
187186|NCT00529087|435632|P3|NOT COMPLETED|Overall Study||16
187187|NCT00529087|435633|P2|NOT COMPLETED|Overall Study||28
187188|NCT00529087|435634|P1|NOT COMPLETED|Overall Study||28
187189|NCT00529087|435632|P3|COMPLETED|Overall Study||146
187190|NCT00529087|435633|P2|COMPLETED|Overall Study||120
187191|NCT00529087|435634|P1|COMPLETED|Overall Study||122
187192|NCT00529087|435632|P3|STARTED|Overall Study||162
187193|NCT00529087|435633|P2|STARTED|Overall Study||148
187194|NCT00529087|435634|P1|STARTED|Overall Study||150
187195|NCT00529035|435698|P1|NOT COMPLETED|Overall Study||1
187196|NCT00529035|435698|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
187197|NCT00529035|435698|P1|STARTED|Overall Study|29 enrolled|29
187198|NCT00527124|435711|P2|NOT COMPLETED|Overall Study||0
187199|NCT00527124|435712|P1|NOT COMPLETED|Overall Study||0
187200|NCT00527124|435711|P2|COMPLETED|Overall Study||28
187201|NCT00527124|435712|P1|COMPLETED|Overall Study||29
187202|NCT00527124|435711|P2|STARTED|Overall Study||28
187203|NCT00527124|435712|P1|STARTED|Overall Study||29
187204|NCT00528957|435720|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||40
187205|NCT00528957|435721|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||34
187206|NCT00528957|435720|P2|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
187207|NCT00528957|435721|P1|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
187208|NCT00528957|435720|P2|STARTED|Second Extension (Week 144 to Week 240)||40
187209|NCT00528957|435721|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
187210|NCT00528957|435720|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
187211|NCT00528957|435721|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
187212|NCT00528957|435720|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
187213|NCT00528957|435721|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
187214|NCT00528957|435720|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
187215|NCT00528957|435721|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
187216|NCT00528957|435720|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
187217|NCT00528957|435721|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
187218|NCT00528957|435720|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
187219|NCT00528957|435721|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
187220|NCT00528957|435720|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
187221|NCT00528957|435721|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
187222|NCT00528931|435764|P1|NOT COMPLETED|Overall Study||1
187223|NCT00528931|435764|P1|COMPLETED|Overall Study||15
187224|NCT00528931|435764|P1|STARTED|Overall Study||16
187225|NCT00528879|435776|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
187226|NCT00528879|435777|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
187227|NCT00528879|435778|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
187228|NCT00528879|435779|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
187229|NCT00528879|435776|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
187230|NCT00528879|435777|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
187231|NCT00528879|435778|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
187232|NCT00528879|435779|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
187233|NCT00528879|435776|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
187234|NCT00528879|435777|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
187235|NCT00528879|435778|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
187236|NCT00528879|435779|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
187237|NCT00528879|435776|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
187238|NCT00528879|435777|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
187239|NCT00528879|435778|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
187240|NCT00528879|435779|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
187241|NCT00528879|435776|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
187242|NCT00528879|435777|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
187243|NCT00528879|435778|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
187244|NCT00528879|435779|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
187245|NCT00528879|435776|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
187246|NCT00528879|435777|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
187247|NCT00528879|435778|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
187248|NCT00528879|435779|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
187249|NCT00528879|435776|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
187250|NCT00528879|435777|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
187251|NCT00528879|435778|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
187252|NCT00528879|435779|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
187253|NCT00528840|435845|P1|NOT COMPLETED|Overall Study||33
187254|NCT00528840|435845|P1|COMPLETED|Overall Study||168
187255|NCT00528840|435845|P1|STARTED|Overall Study||201
187256|NCT00528801|435851|P2|NOT COMPLETED|Overall Study||11
187257|NCT00528801|435852|P1|NOT COMPLETED|Overall Study||27
187258|NCT00528801|435851|P2|COMPLETED|Overall Study||41
187259|NCT00528801|435852|P1|COMPLETED|Overall Study||133
187260|NCT00528801|435851|P2|STARTED|Overall Study||52
187261|NCT00528801|435852|P1|STARTED|Overall Study||160
187262|NCT00528788|435862|P1|NOT COMPLETED|Overall Study||4
187263|NCT00528788|435862|P1|COMPLETED|Overall Study||20
187264|NCT00528788|435862|P1|STARTED|Overall Study||24
187265|NCT00528775|435866|P1|NOT COMPLETED|Overall Study||1
187266|NCT00528775|435866|P1|COMPLETED|Overall Study||5
187267|NCT00528775|435866|P1|STARTED|Overall Study||6
187268|NCT00528645|435874|P1|NOT COMPLETED|Overall Study||3
187269|NCT00528645|435874|P1|COMPLETED|Overall Study||20
187270|NCT00528645|435874|P1|STARTED|Overall Study||23
187271|NCT00528606|435880|P2|NOT COMPLETED|Overall Study||4
187272|NCT00528606|435881|P1|NOT COMPLETED|Overall Study||13
187273|NCT00528606|435880|P2|COMPLETED|Overall Study||100
187274|NCT00528606|435881|P1|COMPLETED|Overall Study||191
187275|NCT00528606|435880|P2|STARTED|Overall Study||104
187276|NCT00528606|435881|P1|STARTED|Overall Study||204
187277|NCT00528567|435889|P2|NOT COMPLETED|Overall Study||308
187278|NCT00528567|435890|P1|NOT COMPLETED|Overall Study||431
187279|NCT00528567|435889|P2|COMPLETED|Overall Study||982
187280|NCT00528567|435890|P1|COMPLETED|Overall Study||870
187281|NCT00528567|435889|P2|Safety Population|Overall Study||1271
187282|NCT00528567|435890|P1|Safety Population|Overall Study||1288
187283|NCT00528567|435889|P2|Intention to Treat|Overall Study||1290
187284|NCT00528567|435890|P1|Intention to Treat|Overall Study||1301
187285|NCT00528567|435889|P2|STARTED|Overall Study||1290
187286|NCT00528567|435890|P1|STARTED|Overall Study||1301
187287|NCT00528541|435930|P2|NOT COMPLETED|Overall Study||1
187288|NCT00528541|435931|P1|NOT COMPLETED|Overall Study||2
187289|NCT00528541|435930|P2|COMPLETED|Overall Study||69
187290|NCT00528541|435931|P1|COMPLETED|Overall Study||73
187291|NCT00528541|435930|P2|STARTED|Overall Study||70
187292|NCT00528541|435931|P1|STARTED|Overall Study||75
187293|NCT00528528|435957|P4|NOT COMPLETED|Overall Study||3
187294|NCT00528528|435958|P3|NOT COMPLETED|Overall Study||3
187295|NCT00528528|435959|P2|NOT COMPLETED|Overall Study||3
187296|NCT00528528|435960|P1|NOT COMPLETED|Overall Study||3
187297|NCT00528528|435957|P4|COMPLETED|Overall Study||36
187298|NCT00528528|435958|P3|COMPLETED|Overall Study||37
187299|NCT00528528|435959|P2|COMPLETED|Overall Study||39
187300|NCT00528528|435960|P1|COMPLETED|Overall Study||37
187301|NCT00528528|435957|P4|Ongoing at Time of Cut-off|Overall Study||0
187302|NCT00528528|435958|P3|Ongoing at Time of Cut-off|Overall Study||1
187303|NCT00528528|435959|P2|Ongoing at Time of Cut-off|Overall Study||0
187304|NCT00528528|435960|P1|Ongoing at Time of Cut-off|Overall Study||0
187305|NCT00528528|435957|P4|STARTED|Overall Study||39
187306|NCT00528528|435958|P3|STARTED|Overall Study||40
187307|NCT00528528|435959|P2|STARTED|Overall Study||42
187308|NCT00528528|435960|P1|STARTED|Overall Study||40
187309|NCT00528450|435994|P1|NOT COMPLETED|Overall Study||0
187310|NCT00528450|435994|P1|COMPLETED|Overall Study||1
187311|NCT00528450|435994|P1|STARTED|Overall Study||1
187312|NCT00528424|435998|P1|NOT COMPLETED|Overall Study||29
187313|NCT00528424|435998|P1|COMPLETED|Overall Study||257
187314|NCT00528424|435998|P1|STARTED|Overall Study||286
187315|NCT00528411|436005|P3|NOT COMPLETED|Overall Study||1
187316|NCT00528411|436006|P2|NOT COMPLETED|Overall Study||3
187317|NCT00528411|436007|P1|NOT COMPLETED|Overall Study||5
187318|NCT00528411|436005|P3|COMPLETED|Overall Study||11
187319|NCT00528411|436006|P2|COMPLETED|Overall Study||51
187320|NCT00528411|436007|P1|COMPLETED|Overall Study||52
187321|NCT00528411|436005|P3|STARTED|Overall Study||12
187322|NCT00528411|436006|P2|STARTED|Overall Study||54
187323|NCT00528411|436007|P1|STARTED|Overall Study||57
187324|NCT00528398|436130|P1|NOT COMPLETED|Overall Study||0
187325|NCT00528398|436130|P1|COMPLETED|Overall Study||111
187326|NCT00528398|436130|P1|STARTED|Overall Study||111
187327|NCT00528372|436144|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
187328|NCT00528372|436145|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
187329|NCT00528372|436146|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
187330|NCT00528372|436147|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
187331|NCT00528372|436148|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
187332|NCT00528372|436149|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
187333|NCT00528372|436150|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
187334|NCT00528372|436151|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
187335|NCT00528372|436152|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
187336|NCT00528372|436144|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
187337|NCT00528372|436145|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
187338|NCT00528372|436146|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
187339|NCT00528372|436147|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
187340|NCT00528372|436148|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
187341|NCT00528372|436149|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
187342|NCT00528372|436150|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
187343|NCT00528372|436151|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
187344|NCT00528372|436152|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
187345|NCT00528372|436144|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
187346|NCT00528372|436145|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
187347|NCT00528372|436146|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
187348|NCT00528372|436147|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
187349|NCT00528372|436148|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
187350|NCT00528372|436149|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
187351|NCT00528372|436150|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
187352|NCT00528372|436151|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
187353|NCT00528372|436152|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
187354|NCT00528372|436144|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
187355|NCT00528372|436145|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
187356|NCT00528372|436146|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
187357|NCT00528372|436147|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
187358|NCT00528372|436148|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
187359|NCT00528372|436149|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
187360|NCT00528372|436150|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
187361|NCT00528372|436151|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
187362|NCT00528372|436152|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
187363|NCT00528372|436144|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
187364|NCT00528372|436145|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
187365|NCT00528372|436146|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
187366|NCT00528372|436147|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
187367|NCT00528372|436148|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
187368|NCT00528372|436149|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
187369|NCT00528372|436150|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
187370|NCT00528372|436151|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
187371|NCT00528372|436152|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
187372|NCT00528372|436144|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
187373|NCT00528372|436145|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
187374|NCT00528372|436146|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
187375|NCT00528372|436147|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
187376|NCT00528372|436148|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
187377|NCT00528372|436149|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
187378|NCT00528372|436150|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
187379|NCT00528372|436151|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
187380|NCT00528372|436152|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
187381|NCT00528268|436266|P2|NOT COMPLETED|Overall Study||1
187382|NCT00528268|436267|P1|NOT COMPLETED|Overall Study||1
187383|NCT00528268|436266|P2|COMPLETED|Overall Study||7
187384|NCT00528268|436267|P1|COMPLETED|Overall Study||5
187385|NCT00528268|436266|P2|STARTED|Overall Study||8
187386|NCT00528268|436267|P1|STARTED|Overall Study||6
187387|NCT00527111|436275|P2|NOT COMPLETED|Overall Study||22
187388|NCT00527111|436276|P1|NOT COMPLETED|Overall Study||20
187389|NCT00527111|436275|P2|COMPLETED|Overall Study||47
187390|NCT00527111|436276|P1|COMPLETED|Overall Study||50
187391|NCT00527111|436275|P2|STARTED|Overall Study||69
187392|NCT00527111|436276|P1|STARTED|Overall Study||70
187393|NCT00527098|436292|P2|NOT COMPLETED|Overall Study||0
187394|NCT00527098|436293|P1|NOT COMPLETED|Overall Study||0
187395|NCT00527098|436292|P2|COMPLETED|Overall Study||83
187396|NCT00527098|436293|P1|COMPLETED|Overall Study||36
187397|NCT00527098|436292|P2|STARTED|Overall Study||83
187398|NCT00527098|436293|P1|STARTED|Overall Study||36
187399|NCT00527072|436298|P1|NOT COMPLETED|Overall Study||36
187400|NCT00527072|436298|P1|COMPLETED|Overall Study||179
187401|NCT00527072|436298|P1|STARTED|Overall Study||215
187402|NCT00526994|436307|P3|NOT COMPLETED|Overall Study||107
187403|NCT00526994|436308|P2|NOT COMPLETED|Overall Study||121
187404|NCT00526994|436309|P1|NOT COMPLETED|Overall Study||108
187405|NCT00526994|436307|P3|COMPLETED|Overall Study||791
187406|NCT00526994|436308|P2|COMPLETED|Overall Study||772
187407|NCT00526994|436309|P1|COMPLETED|Overall Study||801
187408|NCT00526994|436307|P3|STARTED|Overall Study||898
187409|NCT00526994|436308|P2|STARTED|Overall Study||893
187410|NCT00526994|436309|P1|STARTED|Overall Study||909
187411|NCT00525915|436328|P2|NOT COMPLETED|Overall Study||9
187412|NCT00525915|436329|P1|NOT COMPLETED|Overall Study||8
187413|NCT00525915|436328|P2|COMPLETED|Overall Study||54
187414|NCT00525915|436329|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
187415|NCT00525915|436328|P2|STARTED|Overall Study||63
187416|NCT00525915|436329|P1|STARTED|Overall Study||63
187417|NCT00525902|436335|P1|NOT COMPLETED|Overall Study||1
187418|NCT00525902|436335|P1|COMPLETED|Overall Study||30
187419|NCT00525902|436335|P1|50 Weeks|Overall Study||12
187420|NCT00525902|436335|P1|10 Weeks|Overall Study||30
187421|NCT00525902|436335|P1|STARTED|Overall Study||31
187422|NCT00528112|436342|P2|NOT COMPLETED|Extension Phase||157
187423|NCT00528112|436343|P1|NOT COMPLETED|Extension Phase||0
187424|NCT00528112|436342|P2|COMPLETED|Extension Phase||550
187425|NCT00528112|436343|P1|COMPLETED|Extension Phase||0
187426|NCT00528112|436342|P2|STARTED|Extension Phase||707
187427|NCT00528112|436343|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
187428|NCT00528112|436342|P2|NOT COMPLETED|Treatment up to 3 Years||583
187429|NCT00528112|436343|P1|NOT COMPLETED|Treatment up to 3 Years||613
187430|NCT00528112|436342|P2|COMPLETED|Treatment up to 3 Years||870
187431|NCT00528112|436343|P1|COMPLETED|Treatment up to 3 Years||819
187432|NCT00528112|436342|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
187433|NCT00528112|436343|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
187434|NCT00528112|436342|P2|STARTED|Treatment up to 3 Years||1453
187435|NCT00528112|436343|P1|STARTED|Treatment up to 3 Years||1432
187436|NCT00528021|436401|P4|NOT COMPLETED|Overall Study||9
187437|NCT00528021|436402|P3|NOT COMPLETED|Overall Study||7
187438|NCT00528021|436403|P2|NOT COMPLETED|Overall Study||13
187439|NCT00528021|436404|P1|NOT COMPLETED|Overall Study||17
187440|NCT00528021|436401|P4|COMPLETED|Overall Study||47
187441|NCT00528021|436402|P3|COMPLETED|Overall Study||49
187442|NCT00528021|436403|P2|COMPLETED|Overall Study||46
187443|NCT00528021|436404|P1|COMPLETED|Overall Study||42
187444|NCT00528021|436401|P4|STARTED|Overall Study||56
187445|NCT00528021|436402|P3|STARTED|Overall Study||56
187446|NCT00528021|436403|P2|STARTED|Overall Study||59
187447|NCT00528021|436404|P1|STARTED|Overall Study||59
187448|NCT00527982|436416|P2|NOT COMPLETED|Overall Study||0
187449|NCT00527982|436417|P1|NOT COMPLETED|Overall Study||1
187450|NCT00527982|436416|P2|COMPLETED|Overall Study||0
187451|NCT00527982|436417|P1|COMPLETED|Overall Study||0
187452|NCT00527982|436416|P2|STARTED|Overall Study||0
187453|NCT00527982|436417|P1|STARTED|Overall Study||1
187454|NCT00527943|436425|P2|NOT COMPLETED|Overall Study||146
187455|NCT00527943|436426|P1|NOT COMPLETED|Overall Study||160
187456|NCT00527943|436425|P2|COMPLETED|Overall Study||6327
187457|NCT00527943|436426|P1|COMPLETED|Overall Study||6311
187458|NCT00527943|436425|P2|Received Treatment|Overall Study||6446
187459|NCT00527943|436426|P1|Received Treatment|Overall Study||6441
187460|NCT00527943|436425|P2|STARTED|Overall Study||6473
187461|NCT00527943|436426|P1|STARTED|Overall Study||6471
187462|NCT00527904|436458|P1|NOT COMPLETED|Overall Study||96
187463|NCT00527904|436458|P1|COMPLETED|Overall Study||143
187464|NCT00527904|436458|P1|STARTED|Overall Study||239
187465|NCT00527878|436462|P2|NOT COMPLETED|Intervention 2||0
187466|NCT00527878|436463|P1|NOT COMPLETED|Intervention 2||0
187467|NCT00527878|436462|P2|COMPLETED|Intervention 2||4
187468|NCT00527878|436463|P1|COMPLETED|Intervention 2||5
187469|NCT00527878|436462|P2|STARTED|Intervention 2||4
187470|NCT00527878|436463|P1|STARTED|Intervention 2||5
187471|NCT00527878|436462|P2|NOT COMPLETED|Intervention 1||3
187472|NCT00527878|436463|P1|NOT COMPLETED|Intervention 1||2
187473|NCT00527878|436462|P2|COMPLETED|Intervention 1||4
187474|NCT00527878|436463|P1|COMPLETED|Intervention 1||5
187475|NCT00527878|436462|P2|STARTED|Intervention 1||7
187476|NCT00527878|436463|P1|STARTED|Intervention 1||7
187477|NCT00527826|436477|P2|NOT COMPLETED|Overall Study||26
187478|NCT00527826|436478|P1|NOT COMPLETED|Overall Study||21
187479|NCT00527826|436477|P2|COMPLETED|Overall Study||80
187480|NCT00527826|436478|P1|COMPLETED|Overall Study||87
187481|NCT00527826|436477|P2|STARTED|Overall Study||106
187482|NCT00527826|436478|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
187483|NCT00527787|436527|P2|NOT COMPLETED|Overall Study||63
187484|NCT00527787|436528|P1|NOT COMPLETED|Overall Study||38
187485|NCT00527787|436527|P2|COMPLETED|Overall Study||153
187486|NCT00527787|436528|P1|COMPLETED|Overall Study||180
187487|NCT00527787|436527|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
187488|NCT00527787|436528|P1|STARTED|Overall Study||218
187489|NCT00527735|436553|P3|NOT COMPLETED|Overall Study||107
187490|NCT00527735|436554|P2|NOT COMPLETED|Overall Study||107
187491|NCT00527735|436555|P1|NOT COMPLETED|Overall Study||108
187492|NCT00527735|436553|P3|COMPLETED|Overall Study|Still on treatment|2
187493|NCT00527735|436554|P2|COMPLETED|Overall Study|Still on treatment|2
187494|NCT00527735|436555|P1|COMPLETED|Overall Study|Still on treatment|5
187495|NCT00527735|436553|P3|STARTED|Overall Study|Treated|109
187496|NCT00527735|436554|P2|STARTED|Overall Study|Treated|109
187497|NCT00527735|436555|P1|STARTED|Overall Study|Treated|113
187498|NCT00527722|436629|P2|NOT COMPLETED|Overall Study||0
187499|NCT00527722|436630|P1|NOT COMPLETED|Overall Study||0
187500|NCT00527722|436629|P2|COMPLETED|Overall Study||25
187501|NCT00527722|436630|P1|COMPLETED|Overall Study||22
187502|NCT00527722|436629|P2|STARTED|Overall Study||25
187503|NCT00527722|436630|P1|STARTED|Overall Study||22
187504|NCT00527618|436636|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
187505|NCT00527618|436637|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
187506|NCT00527618|436636|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
187507|NCT00527618|436637|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
187508|NCT00527618|436636|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
187509|NCT00527618|436637|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
187510|NCT00527618|436636|P2|NOT COMPLETED|Week 13-14 (Washout)||0
187511|NCT00527618|436637|P1|NOT COMPLETED|Week 13-14 (Washout)||1
187512|NCT00527618|436636|P2|COMPLETED|Week 13-14 (Washout)||16
187513|NCT00527618|436637|P1|COMPLETED|Week 13-14 (Washout)||12
187514|NCT00527618|436636|P2|STARTED|Week 13-14 (Washout)||16
187515|NCT00527618|436637|P1|STARTED|Week 13-14 (Washout)||13
187516|NCT00527618|436636|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
187517|NCT00527618|436637|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
187518|NCT00527618|436636|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
187519|NCT00527618|436637|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
187520|NCT00527618|436636|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
187521|NCT00527618|436637|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
187522|NCT00527605|436652|P2|NOT COMPLETED|Overall Study||11
187523|NCT00527605|436653|P1|NOT COMPLETED|Overall Study||13
187524|NCT00527605|436652|P2|COMPLETED|Overall Study||116
187525|NCT00527605|436653|P1|COMPLETED|Overall Study||113
187526|NCT00527605|436652|P2|STARTED|Overall Study||127
187527|NCT00527605|436653|P1|STARTED|Overall Study||126
187528|NCT00527592|436689|P1|NOT COMPLETED|Overall Study||0
187529|NCT00527592|436689|P1|COMPLETED|Overall Study||54
187530|NCT00527592|436689|P1|STARTED|Overall Study||54
187531|NCT00527514|436695|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
187532|NCT00527514|436695|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
187533|NCT00527514|436695|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
187534|NCT00527514|436695|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
187535|NCT00527514|436695|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
187536|NCT00527514|436695|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
187537|NCT00527514|436695|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
187538|NCT00527514|436695|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
187539|NCT00527514|436695|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
187540|NCT00527514|436695|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
187541|NCT00527514|436695|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
187542|NCT00527514|436695|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
187543|NCT00527488|436711|P4|NOT COMPLETED|Overall Study||0
187544|NCT00527488|436712|P3|NOT COMPLETED|Overall Study||1
187545|NCT00527488|436713|P2|NOT COMPLETED|Overall Study||1
187546|NCT00527488|436714|P1|NOT COMPLETED|Overall Study||0
187547|NCT00527488|436711|P4|COMPLETED|Overall Study||13
187548|NCT00527488|436712|P3|COMPLETED|Overall Study||12
187549|NCT00527488|436713|P2|COMPLETED|Overall Study||12
187550|NCT00527488|436714|P1|COMPLETED|Overall Study||13
187551|NCT00527488|436711|P4|STARTED|Overall Study||13
187552|NCT00527488|436712|P3|STARTED|Overall Study||13
187553|NCT00527488|436713|P2|STARTED|Overall Study||13
187554|NCT00527488|436714|P1|STARTED|Overall Study||13
187555|NCT00527475|436790|P2|NOT COMPLETED|Overall Study||1
187556|NCT00527475|436791|P1|NOT COMPLETED|Overall Study||3
187557|NCT00527475|436790|P2|COMPLETED|Overall Study||29
187558|NCT00527475|436791|P1|COMPLETED|Overall Study||27
187559|NCT00527475|436790|P2|STARTED|Overall Study||30
187560|NCT00527475|436791|P1|STARTED|Overall Study||30
187561|NCT00527423|436797|P1|NOT COMPLETED|Overall Study||37
187562|NCT00527423|436797|P1|COMPLETED|Overall Study||120
187563|NCT00527423|436797|P1|STARTED|Overall Study||157
187564|NCT00527397|436803|P1|NOT COMPLETED|Overall Study||24
187565|NCT00527397|436803|P1|COMPLETED|Overall Study||0
187566|NCT00527397|436803|P1|STARTED|Overall Study||24
187567|NCT00527332|436829|P2|NOT COMPLETED|Overall Study||9
187568|NCT00527332|436830|P1|NOT COMPLETED|Overall Study||9
187569|NCT00527332|436829|P2|COMPLETED|Overall Study||80
187570|NCT00527332|436830|P1|COMPLETED|Overall Study||82
187571|NCT00527332|436829|P2|STARTED|Overall Study||89
187572|NCT00527332|436830|P1|STARTED|Overall Study||91
187573|NCT00527319|436839|P3|NOT COMPLETED|Overall Study||6
187574|NCT00527319|436840|P2|NOT COMPLETED|Overall Study||4
187575|NCT00527319|436841|P1|NOT COMPLETED|Overall Study||6
187576|NCT00527319|436839|P3|COMPLETED|Overall Study||7
187577|NCT00527319|436840|P2|COMPLETED|Overall Study||8
187578|NCT00527319|436841|P1|COMPLETED|Overall Study||6
187579|NCT00527319|436839|P3|STARTED|Overall Study||13
187580|NCT00527319|436840|P2|STARTED|Overall Study||12
187581|NCT00527319|436841|P1|STARTED|Overall Study||12
187582|NCT00526890|436852|P1|NOT COMPLETED|Overall Study||7
187583|NCT00526890|436852|P1|COMPLETED|Overall Study||14
187584|NCT00526890|436852|P1|STARTED|Overall Study||21
187585|NCT00526799|436863|P2|NOT COMPLETED|Overall Study||1
187586|NCT00526799|436864|P1|NOT COMPLETED|Overall Study||1
187587|NCT00526799|436863|P2|COMPLETED|Overall Study||13
187588|NCT00526799|436864|P1|COMPLETED|Overall Study||15
187589|NCT00526799|436863|P2|STARTED|Overall Study||14
187590|NCT00526799|436864|P1|STARTED|Overall Study||16
187591|NCT00526669|436872|P2|NOT COMPLETED|Combined Treatment Phase||8
187592|NCT00526669|436873|P1|NOT COMPLETED|Combined Treatment Phase||0
187593|NCT00526669|436872|P2|COMPLETED|Combined Treatment Phase||59
187594|NCT00526669|436873|P1|COMPLETED|Combined Treatment Phase||0
187595|NCT00526669|436872|P2|STARTED|Combined Treatment Phase||67
187596|NCT00526669|436873|P1|STARTED|Combined Treatment Phase||0
187597|NCT00526669|436872|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
187598|NCT00526669|436873|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
187599|NCT00526669|436872|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
187600|NCT00526669|436873|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
187601|NCT00526669|436872|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
187602|NCT00526669|436873|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
187603|NCT00526630|436902|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
187604|NCT00526630|436903|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
187605|NCT00526630|436902|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
187606|NCT00526630|436903|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
187607|NCT00526630|436902|P2|STARTED|Second Intervention Period - 12 Weeks||8
187608|NCT00526630|436903|P1|STARTED|Second Intervention Period - 12 Weeks||12
187609|NCT00526630|436902|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
187610|NCT00526630|436903|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
187611|NCT00526630|436902|P2|COMPLETED|First Intervention Period - 12 Weeks||8
187612|NCT00526630|436903|P1|COMPLETED|First Intervention Period - 12 Weeks||12
187613|NCT00526630|436902|P2|STARTED|First Intervention Period - 12 Weeks||11
187614|NCT00526630|436903|P1|STARTED|First Intervention Period - 12 Weeks||12
187615|NCT00526474|436933|P2|NOT COMPLETED|Overall Study||272
187616|NCT00526474|436934|P1|NOT COMPLETED|Overall Study||292
187617|NCT00526474|436933|P2|COMPLETED|Overall Study||12953
187618|NCT00526474|436934|P1|COMPLETED|Overall Study||12932
187619|NCT00526474|436933|P2|Received Study Drug|Overall Study||13186
187620|NCT00526474|436934|P1|Received Study Drug|Overall Study||13166
187621|NCT00526474|436933|P2|STARTED|Overall Study||13225
187622|NCT00526474|436934|P1|STARTED|Overall Study||13224
187623|NCT00526331|437002|P1|NOT COMPLETED|Overall Study||55
187624|NCT00526331|437002|P1|COMPLETED|Overall Study||0
187625|NCT00526331|437002|P1|STARTED|Overall Study||55
187626|NCT00526292|437006|P1|NOT COMPLETED|Overall Study||0
187627|NCT00526292|437006|P1|COMPLETED|Overall Study||6
187628|NCT00526292|437006|P1|STARTED|Overall Study||6
187629|NCT00526227|437010|P1|NOT COMPLETED|Overall Study||2
187630|NCT00526227|437010|P1|COMPLETED|Overall Study||79
187631|NCT00526227|437010|P1|STARTED|Overall Study||81
187632|NCT00526188|437015|P1|NOT COMPLETED|Overall Study||0
187633|NCT00526188|437015|P1|COMPLETED|Overall Study||234
187634|NCT00526188|437015|P1|STARTED|Overall Study||234
187635|NCT00526162|437021|P1|NOT COMPLETED|Overall Study||3
187636|NCT00526162|437021|P1|COMPLETED|Overall Study||80
187637|NCT00526162|437021|P1|STARTED|Overall Study||83
187638|NCT00526123|437028|P2|NOT COMPLETED|Overall Study||246
187639|NCT00526123|437029|P1|NOT COMPLETED|Overall Study||264
187640|NCT00526123|437028|P2|COMPLETED|Overall Study||50
187641|NCT00526123|437029|P1|COMPLETED|Overall Study||39
187642|NCT00526123|437028|P2|STARTED|Overall Study|Intent-to-Treat population|296
187643|NCT00526123|437029|P1|STARTED|Overall Study|Intent-to-Treat population|303
187644|NCT00526110|437051|P2|NOT COMPLETED|Overall Study||41
187645|NCT00526110|437052|P1|NOT COMPLETED|Overall Study||2
187646|NCT00526110|437051|P2|COMPLETED|Overall Study||4
187647|NCT00526110|437052|P1|COMPLETED|Overall Study||51
187648|NCT00526110|437051|P2|STARTED|Overall Study||45
187649|NCT00526110|437052|P1|STARTED|Overall Study||53
187650|NCT00526097|437061|P2|NOT COMPLETED|Overall Study||56
187651|NCT00526097|437062|P1|NOT COMPLETED|Overall Study||15
187652|NCT00526097|437061|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
187653|NCT00526097|437062|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
187654|NCT00526097|437061|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
187655|NCT00526097|437062|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
187656|NCT00526058|437240|P2|NOT COMPLETED|Period: Second Intervention||0
187657|NCT00526058|437241|P1|NOT COMPLETED|Period: Second Intervention||0
187658|NCT00526058|437240|P2|COMPLETED|Period: Second Intervention||9
187659|NCT00526058|437241|P1|COMPLETED|Period: Second Intervention||9
187660|NCT00526058|437240|P2|STARTED|Period: Second Intervention||9
187661|NCT00526058|437241|P1|STARTED|Period: Second Intervention||9
187662|NCT00526058|437240|P2|NOT COMPLETED|Period: First Intervention||0
187663|NCT00526058|437241|P1|NOT COMPLETED|Period: First Intervention||0
187664|NCT00526058|437240|P2|COMPLETED|Period: First Intervention||9
187665|NCT00526058|437241|P1|COMPLETED|Period: First Intervention||9
187666|NCT00526058|437240|P2|STARTED|Period: First Intervention||9
187667|NCT00526058|437241|P1|STARTED|Period: First Intervention||9
187668|NCT00525876|437249|P2|NOT COMPLETED|Overall Study||0
187669|NCT00525876|437250|P1|NOT COMPLETED|Overall Study||0
187670|NCT00525876|437249|P2|COMPLETED|Overall Study||20
187671|NCT00525876|437250|P1|COMPLETED|Overall Study||16
187672|NCT00525876|437249|P2|STARTED|Overall Study||20
187673|NCT00525876|437250|P1|STARTED|Overall Study||16
187674|NCT00525837|437256|P1|NOT COMPLETED|Overall Study||4
187675|NCT00525837|437256|P1|COMPLETED|Overall Study||14
187676|NCT00525837|437256|P1|STARTED|Overall Study||18
187677|NCT00525824|437264|P4|NOT COMPLETED|Overall Study||15
187678|NCT00525824|437265|P3|NOT COMPLETED|Overall Study||19
187679|NCT00525824|437266|P2|NOT COMPLETED|Overall Study||28
187680|NCT00525824|437267|P1|NOT COMPLETED|Overall Study||19
187681|NCT00525824|437264|P4|COMPLETED|Overall Study||188
187682|NCT00525824|437265|P3|COMPLETED|Overall Study||183
187683|NCT00525824|437266|P2|COMPLETED|Overall Study||186
187684|NCT00525824|437267|P1|COMPLETED|Overall Study||195
187685|NCT00525824|437264|P4|STARTED|Overall Study|Randomized population|203
187686|NCT00525824|437265|P3|STARTED|Overall Study|Randomized population|202
187687|NCT00525824|437266|P2|STARTED|Overall Study|Randomized population|214
187688|NCT00525824|437267|P1|STARTED|Overall Study|Randomized population|214
187689|NCT00525798|437331|P2|NOT COMPLETED|Overall Study||599
187690|NCT00525798|437332|P1|NOT COMPLETED|Overall Study||756
187691|NCT00525798|437331|P2|COMPLETED|Overall Study||1732
187692|NCT00525798|437332|P1|COMPLETED|Overall Study||1578
187693|NCT00525798|437331|P2|STARTED|Overall Study||2331
187694|NCT00525798|437332|P1|STARTED|Overall Study||2334
187695|NCT00525733|437342|P2|NOT COMPLETED|Overall Study||3
187696|NCT00525733|437343|P1|NOT COMPLETED|Overall Study||3
187697|NCT00525733|437342|P2|COMPLETED|Overall Study||23
187698|NCT00525733|437343|P1|COMPLETED|Overall Study||11
187699|NCT00525733|437342|P2|STARTED|Overall Study||26
187700|NCT00525733|437343|P1|STARTED|Overall Study||14
187701|NCT00525603|437349|P1|NOT COMPLETED|Overall Study||0
187702|NCT00525603|437349|P1|COMPLETED|Overall Study||60
187703|NCT00525603|437349|P1|STARTED|Overall Study||60
187704|NCT00525525|437355|P2|NOT COMPLETED|Overall Study||0
187705|NCT00525525|437356|P1|NOT COMPLETED|Overall Study||0
187706|NCT00525525|437355|P2|COMPLETED|Overall Study||15
187707|NCT00525525|437356|P1|COMPLETED|Overall Study||59
187708|NCT00525525|437355|P2|STARTED|Overall Study||15
187709|NCT00525525|437356|P1|STARTED|Overall Study||59
187710|NCT00525512|437365|P4|NOT COMPLETED|Open-Label Phase||5
187711|NCT00525512|437366|P3|NOT COMPLETED|Open-Label Phase||6
187712|NCT00525512|437367|P2|NOT COMPLETED|Open-Label Phase||0
187713|NCT00525512|437368|P1|NOT COMPLETED|Open-Label Phase||0
187714|NCT00525512|437365|P4|COMPLETED|Open-Label Phase||189
187715|NCT00525512|437366|P3|COMPLETED|Open-Label Phase||158
187716|NCT00525512|437367|P2|COMPLETED|Open-Label Phase||0
187717|NCT00525512|437368|P1|COMPLETED|Open-Label Phase||0
187718|NCT00525512|437365|P4|STARTED|Open-Label Phase||194
187719|NCT00525512|437366|P3|STARTED|Open-Label Phase||164
187720|NCT00525512|437367|P2|STARTED|Open-Label Phase||0
187721|NCT00525512|437368|P1|STARTED|Open-Label Phase||0
187722|NCT00525512|437365|P4|NOT COMPLETED|Double-Blind Phase||0
187723|NCT00525512|437366|P3|NOT COMPLETED|Double-Blind Phase||0
187724|NCT00525512|437367|P2|NOT COMPLETED|Double-Blind Phase||66
187725|NCT00525512|437368|P1|NOT COMPLETED|Double-Blind Phase||96
187726|NCT00525512|437365|P4|COMPLETED|Double-Blind Phase||0
187727|NCT00525512|437366|P3|COMPLETED|Double-Blind Phase||0
187728|NCT00525512|437367|P2|COMPLETED|Double-Blind Phase||194
187729|NCT00525512|437368|P1|COMPLETED|Double-Blind Phase||163
187730|NCT00525512|437365|P4|STARTED|Double-Blind Phase||0
187731|NCT00525512|437366|P3|STARTED|Double-Blind Phase||0
187732|NCT00525512|437367|P2|STARTED|Double-Blind Phase||260
187733|NCT00525512|437368|P1|STARTED|Double-Blind Phase||259
187734|NCT00525499|437510|P4|NOT COMPLETED|Overall Study||7
187735|NCT00525499|437511|P3|NOT COMPLETED|Overall Study||7
187736|NCT00525499|437512|P2|NOT COMPLETED|Overall Study||7
187737|NCT00525499|437513|P1|NOT COMPLETED|Overall Study||7
187738|NCT00525499|437510|P4|COMPLETED|Overall Study||39
187739|NCT00525499|437511|P3|COMPLETED|Overall Study||40
187740|NCT00525499|437512|P2|COMPLETED|Overall Study||39
187741|NCT00525499|437513|P1|COMPLETED|Overall Study||40
187742|NCT00525499|437510|P4|STARTED|Overall Study||46
187743|NCT00525499|437511|P3|STARTED|Overall Study||47
187744|NCT00525499|437512|P2|STARTED|Overall Study||46
187745|NCT00525499|437513|P1|STARTED|Overall Study||47
187746|NCT00525421|437529|P2|NOT COMPLETED|Overall Study||0
187747|NCT00525421|437530|P1|NOT COMPLETED|Overall Study||0
187748|NCT00525421|437529|P2|COMPLETED|Overall Study||10
187749|NCT00525421|437530|P1|COMPLETED|Overall Study||10
187750|NCT00525421|437529|P2|STARTED|Overall Study||10
187751|NCT00525421|437530|P1|STARTED|Overall Study|Enrollment started october 2007|10
187752|NCT00525265|437540|P2|NOT COMPLETED|Overall Study||0
187753|NCT00525265|437541|P1|NOT COMPLETED|Overall Study||1
187754|NCT00525265|437540|P2|COMPLETED|Overall Study||10
187755|NCT00525265|437541|P1|COMPLETED|Overall Study||9
187756|NCT00525265|437540|P2|STARTED|Overall Study||10
187757|NCT00525265|437541|P1|STARTED|Overall Study||10
187758|NCT00525174|437549|P2|NOT COMPLETED|Overall Study||8
187759|NCT00525174|437550|P1|NOT COMPLETED|Overall Study||9
187760|NCT00525174|437549|P2|COMPLETED|Overall Study||81
187761|NCT00525174|437550|P1|COMPLETED|Overall Study||88
187762|NCT00525174|437549|P2|STARTED|Overall Study||89
187763|NCT00525174|437550|P1|STARTED|Overall Study||97
187764|NCT00525161|437598|P1|NOT COMPLETED|Overall Study||1
187765|NCT00525161|437598|P1|COMPLETED|Overall Study||10
187766|NCT00525161|437598|P1|STARTED|Overall Study||11
187767|NCT00525148|437608|P4|NOT COMPLETED|Overall Study||61
187768|NCT00525148|437609|P3|NOT COMPLETED|Overall Study||7
187769|NCT00525148|437610|P2|NOT COMPLETED|Overall Study||38
187770|NCT00525148|437611|P1|NOT COMPLETED|Overall Study||23
187771|NCT00525148|437608|P4|COMPLETED|Overall Study||0
187772|NCT00525148|437609|P3|COMPLETED|Overall Study||0
187773|NCT00525148|437610|P2|COMPLETED|Overall Study||0
187774|NCT00525148|437611|P1|COMPLETED|Overall Study||0
187775|NCT00525148|437608|P4|STARTED|Overall Study|entered and treated|61
187776|NCT00525148|437609|P3|STARTED|Overall Study|entered and treated|7
187777|NCT00525148|437610|P2|STARTED|Overall Study|entered and treated|38
187778|NCT00525148|437611|P1|STARTED|Overall Study|entered and treated|23
187779|NCT00525135|437629|P1|NOT COMPLETED|Overall Study||0
187780|NCT00525135|437629|P1|COMPLETED|Overall Study||5
187781|NCT00525135|437629|P1|STARTED|Overall Study||5
187782|NCT00524940|437637|P1|NOT COMPLETED|Overall Study||0
187783|NCT00524940|437637|P1|COMPLETED|Overall Study||124
187784|NCT00524940|437637|P1|STARTED|Overall Study||124
187785|NCT00524771|437644|P2|NOT COMPLETED|Overall Study||585
187786|NCT00524771|437645|P1|NOT COMPLETED|Overall Study||220
187787|NCT00524771|437644|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
187788|NCT00524771|437645|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
187789|NCT00524771|437644|P2|STARTED|Overall Study||17016
187790|NCT00524771|437645|P1|STARTED|Overall Study||17084
187791|NCT00524745|437659|P4|NOT COMPLETED|Overall Study||22
187792|NCT00524745|437660|P3|NOT COMPLETED|Overall Study||29
187793|NCT00524745|437661|P2|NOT COMPLETED|Overall Study||13
187794|NCT00524745|437662|P1|NOT COMPLETED|Overall Study||34
187795|NCT00524745|437659|P4|COMPLETED|Overall Study||205
187796|NCT00524745|437660|P3|COMPLETED|Overall Study||212
187797|NCT00524745|437661|P2|COMPLETED|Overall Study||193
187798|NCT00524745|437662|P1|COMPLETED|Overall Study||195
187799|NCT00524745|437659|P4|STARTED|Overall Study||227
187800|NCT00524745|437660|P3|STARTED|Overall Study||241
187801|NCT00524745|437661|P2|STARTED|Overall Study||206
187802|NCT00524745|437662|P1|STARTED|Overall Study||229
187803|NCT00524680|437688|P4|NOT COMPLETED|Overall Study||6
187804|NCT00524680|437689|P3|NOT COMPLETED|Overall Study||3
187805|NCT00524680|437690|P2|NOT COMPLETED|Overall Study||1
187806|NCT00524680|437691|P1|NOT COMPLETED|Overall Study||3
187807|NCT00524680|437688|P4|COMPLETED|Overall Study||34
187808|NCT00524680|437689|P3|COMPLETED|Overall Study||33
187809|NCT00524680|437690|P2|COMPLETED|Overall Study||34
187810|NCT00524680|437691|P1|COMPLETED|Overall Study||34
187811|NCT00524680|437688|P4|STARTED|Overall Study||40
187812|NCT00524680|437689|P3|STARTED|Overall Study||36
187813|NCT00524680|437690|P2|STARTED|Overall Study||35
187814|NCT00524680|437691|P1|STARTED|Overall Study||37
187815|NCT00524589|437713|P1|NOT COMPLETED|Overall Study||18
187816|NCT00524589|437713|P1|COMPLETED|Overall Study||0
187817|NCT00524589|437713|P1|STARTED|Overall Study||18
187818|NCT00524576|437719|P2|NOT COMPLETED|Overall Study||0
187819|NCT00524576|437720|P1|NOT COMPLETED|Overall Study||0
187820|NCT00524576|437719|P2|COMPLETED|Overall Study||47
187821|NCT00524576|437720|P1|COMPLETED|Overall Study||97
187822|NCT00524576|437719|P2|STARTED|Overall Study||47
187823|NCT00524576|437720|P1|STARTED|Overall Study||97
187824|NCT00524537|437738|P1|NOT COMPLETED|Overall Study||2574
187825|NCT00524537|437738|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
187826|NCT00524537|437738|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
187827|NCT00524537|437738|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
187828|NCT00524537|437738|P1|Discontinued|Overall Study|Discontinued from study|2811
187829|NCT00524537|437738|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
187830|NCT00524511|437754|P2|NOT COMPLETED|Overall Study||7
187831|NCT00524511|437755|P1|NOT COMPLETED|Overall Study||4
187832|NCT00524511|437754|P2|COMPLETED|Overall Study||61
187833|NCT00524511|437755|P1|COMPLETED|Overall Study||64
187834|NCT00524511|437754|P2|STARTED|Overall Study||68
187835|NCT00524511|437755|P1|STARTED|Overall Study||68
187836|NCT00524459|437763|P1|NOT COMPLETED|Overall Study||2
187837|NCT00524459|437763|P1|COMPLETED|Overall Study||4
187838|NCT00524459|437763|P1|STARTED|Overall Study||6
187839|NCT00524420|437773|P2|NOT COMPLETED|Overall Study||0
187840|NCT00524420|437774|P1|NOT COMPLETED|Overall Study||1
187841|NCT00524420|437773|P2|COMPLETED|Overall Study||11
187842|NCT00524420|437774|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
187843|NCT00524420|437773|P2|STARTED|Overall Study||11
187844|NCT00524420|437774|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
187845|NCT00524394|437786|P1|NOT COMPLETED|Overall Study||1
187846|NCT00524394|437786|P1|COMPLETED|Overall Study||1
187847|NCT00524394|437786|P1|STARTED|Overall Study||2
187848|NCT00524368|437792|P2|NOT COMPLETED|Overall Study||48
187849|NCT00524368|437793|P1|NOT COMPLETED|Overall Study||41
187850|NCT00524368|437792|P2|COMPLETED|Overall Study||248
187851|NCT00524368|437793|P1|COMPLETED|Overall Study||253
187852|NCT00524368|437792|P2|STARTED|Overall Study||296
187853|NCT00524368|437793|P1|STARTED|Overall Study||294
187854|NCT00524342|437821|P1|NOT COMPLETED|Overall Study||0
187855|NCT00524342|437821|P1|COMPLETED|Overall Study||7
187856|NCT00524342|437821|P1|STARTED|Overall Study||7
187857|NCT00524316|437826|P1|NOT COMPLETED|Overall Study||16
187858|NCT00524316|437826|P1|COMPLETED|Overall Study||0
187859|NCT00524316|437826|P1|STARTED|Overall Study||16
187860|NCT00524303|437838|P3|NOT COMPLETED|Overall Study||18
187861|NCT00524303|437839|P2|NOT COMPLETED|Overall Study||10
187862|NCT00524303|437840|P1|NOT COMPLETED|Overall Study||12
187863|NCT00524303|437838|P3|COMPLETED|Overall Study||15
187864|NCT00524303|437839|P2|COMPLETED|Overall Study||24
187865|NCT00524303|437840|P1|COMPLETED|Overall Study||21
187866|NCT00524303|437838|P3|STARTED|Overall Study||33
187867|NCT00524303|437839|P2|STARTED|Overall Study||34
187868|NCT00524303|437840|P1|STARTED|Overall Study||33
187869|NCT00524264|437870|P2|NOT COMPLETED|Overall Study||27
187870|NCT00524264|437871|P1|NOT COMPLETED|Overall Study||20
187871|NCT00524264|437870|P2|COMPLETED|Overall Study||57
187872|NCT00524264|437871|P1|COMPLETED|Overall Study||144
187873|NCT00524264|437870|P2|STARTED|Overall Study||84
187874|NCT00524264|437871|P1|STARTED|Overall Study||164
187875|NCT00524225|437883|P1|NOT COMPLETED|Overall Study||0
187876|NCT00524225|437883|P1|COMPLETED|Overall Study||3
187877|NCT00524225|437883|P1|STARTED|Overall Study||3
187878|NCT00524134|437888|P1|NOT COMPLETED|Overall Study||2
187879|NCT00524134|437888|P1|COMPLETED|Overall Study||4
187880|NCT00524134|437888|P1|STARTED|Overall Study||6
187881|NCT00524121|437895|P1|NOT COMPLETED|Overall Study||19
187882|NCT00524121|437895|P1|COMPLETED|Overall Study||3
187883|NCT00524121|437895|P1|STARTED|Overall Study||22
187884|NCT00524043|437915|P3|NOT COMPLETED|Overall Study||31
187885|NCT00524043|437916|P2|NOT COMPLETED|Overall Study||28
187886|NCT00524043|437917|P1|NOT COMPLETED|Overall Study||30
187887|NCT00524043|437915|P3|COMPLETED|Overall Study||35
187888|NCT00524043|437916|P2|COMPLETED|Overall Study||42
187889|NCT00524043|437917|P1|COMPLETED|Overall Study||34
187890|NCT00524043|437915|P3|STARTED|Overall Study||66
187891|NCT00524043|437916|P2|STARTED|Overall Study||70
187892|NCT00524043|437917|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
187893|NCT00524030|437939|P2|NOT COMPLETED|Overall Study||59
187894|NCT00524030|437940|P1|NOT COMPLETED|Overall Study||17
187895|NCT00524030|437939|P2|COMPLETED|Overall Study||70
187896|NCT00524030|437940|P1|COMPLETED|Overall Study||15
187897|NCT00524030|437939|P2|Completed Taper/Titration Phase|Overall Study||70
187898|NCT00524030|437940|P1|Completed Taper/Titration Phase|Overall Study||15
187899|NCT00524030|437939|P2|Completed Double-Blind Treatment Phase|Overall Study||70
187900|NCT00524030|437940|P1|Completed Double-Blind Treatment Phase|Overall Study||15
187901|NCT00524030|437939|P2|STARTED|Overall Study||129
187902|NCT00524030|437940|P1|STARTED|Overall Study||32
187903|NCT00523991|437958|P2|NOT COMPLETED|Overall Study||27
187904|NCT00523991|437959|P1|NOT COMPLETED|Overall Study||21
187905|NCT00523991|437958|P2|COMPLETED|Overall Study||211
187906|NCT00523991|437959|P1|COMPLETED|Overall Study||198
187907|NCT00523991|437958|P2|STARTED|Overall Study||238
187908|NCT00523991|437959|P1|STARTED|Overall Study||219
187909|NCT00523978|438239|P2|NOT COMPLETED|Overall Study||8
187910|NCT00523978|438240|P1|NOT COMPLETED|Overall Study||9
187911|NCT00523978|438239|P2|COMPLETED|Overall Study||79
187912|NCT00523978|438240|P1|COMPLETED|Overall Study||162
187913|NCT00523978|438239|P2|STARTED|Overall Study||87
187914|NCT00523978|438240|P1|STARTED|Overall Study||171
187915|NCT00523939|438254|P2|NOT COMPLETED|Overall Study||0
187916|NCT00523939|438255|P1|NOT COMPLETED|Overall Study||0
187917|NCT00523939|438254|P2|COMPLETED|Overall Study||2
187918|NCT00523939|438255|P1|COMPLETED|Overall Study||2
187919|NCT00523939|438254|P2|STARTED|Overall Study||2
187920|NCT00523939|438255|P1|STARTED|Overall Study||2
187921|NCT00523848|438262|P1|NOT COMPLETED|Overall Study||24
187922|NCT00523848|438262|P1|COMPLETED|Overall Study||22
187923|NCT00523848|438262|P1|Treated With Study Therapy|Overall Study||44
187924|NCT00523848|438262|P1|STARTED|Overall Study||46
187925|NCT00523809|438268|P1|NOT COMPLETED|Overall Study||0
187926|NCT00523809|438268|P1|COMPLETED|Overall Study||5
187927|NCT00523809|438268|P1|STARTED|Overall Study||5
187928|NCT00523744|438272|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
187929|NCT00523744|438272|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
187930|NCT00523744|438272|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
187931|NCT00523744|438272|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
187932|NCT00523744|438272|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
187933|NCT00523744|438272|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
187934|NCT00523744|438272|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
187935|NCT00523744|438272|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
187936|NCT00523744|438272|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
187937|NCT00523718|438291|P2|NOT COMPLETED|Overall Study||0
187938|NCT00523718|438292|P1|NOT COMPLETED|Overall Study||3
187939|NCT00523718|438291|P2|COMPLETED|Overall Study||18
187940|NCT00523718|438292|P1|COMPLETED|Overall Study||17
187941|NCT00523718|438291|P2|STARTED|Overall Study||18
187942|NCT00523718|438292|P1|STARTED|Overall Study||20
187943|NCT00523705|438306|P2|NOT COMPLETED|Overall Study||1
187944|NCT00523705|438307|P1|NOT COMPLETED|Overall Study||0
187945|NCT00523705|438306|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
187946|NCT00523705|438307|P1|COMPLETED|Overall Study||7
187947|NCT00523705|438306|P2|STARTED|Overall Study||4
187948|NCT00523705|438307|P1|STARTED|Overall Study||7
187949|NCT00523640|438319|P1|NOT COMPLETED|Overall Study||1
187950|NCT00523640|438319|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
187951|NCT00523640|438319|P1|STARTED|Overall Study||30
187952|NCT00523614|438327|P2|NOT COMPLETED|Overall Study||0
187953|NCT00523614|438328|P1|NOT COMPLETED|Overall Study||0
187954|NCT00523614|438327|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
187955|NCT00523614|438328|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
187956|NCT00523614|438327|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
187957|NCT00523614|438328|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
187958|NCT00523549|438336|P2|NOT COMPLETED|Overall Study||16
187959|NCT00523549|438337|P1|NOT COMPLETED|Overall Study||19
187960|NCT00523549|438336|P2|COMPLETED|Overall Study||99
187961|NCT00523549|438337|P1|COMPLETED|Overall Study||95
187962|NCT00523549|438336|P2|STARTED|Overall Study||115
187963|NCT00523549|438337|P1|STARTED|Overall Study||114
187964|NCT00523419|438355|P1|NOT COMPLETED|Overall Study||32
187965|NCT00523419|438355|P1|COMPLETED|Overall Study||0
187966|NCT00523419|438355|P1|STARTED|Overall Study||32
187967|NCT00523367|438365|P1|NOT COMPLETED|Overall Study||23
187968|NCT00523367|438365|P1|COMPLETED|Overall Study||2
187969|NCT00523367|438365|P1|STARTED|Overall Study||25
187970|NCT00523341|438371|P2|NOT COMPLETED|Overall Study||1000
187971|NCT00523341|438372|P1|NOT COMPLETED|Overall Study||924
187972|NCT00523341|438371|P2|COMPLETED|Overall Study||1343
187973|NCT00523341|438372|P1|COMPLETED|Overall Study||1283
187974|NCT00523341|438371|P2|Received Treatment|Overall Study||2343
187975|NCT00523341|438372|P1|Received Treatment|Overall Study||2206
187976|NCT00523341|438371|P2|STARTED|Overall Study||2343
187977|NCT00523341|438372|P1|STARTED|Overall Study||2207
187978|NCT00523237|438416|P1|NOT COMPLETED|Overall Study||0
187979|NCT00523237|438416|P1|COMPLETED|Overall Study||14
187980|NCT00523237|438416|P1|STARTED|Overall Study||14
187981|NCT00522951|438420|P2|NOT COMPLETED|Period 2||1
187982|NCT00522951|438421|P1|NOT COMPLETED|Period 2||2
187983|NCT00522951|438420|P2|COMPLETED|Period 2||75
187984|NCT00522951|438421|P1|COMPLETED|Period 2||84
187985|NCT00522951|438420|P2|Subjects Received Treatment|Period 2||75
187986|NCT00522951|438421|P1|Subjects Received Treatment|Period 2||84
187987|NCT00522951|438420|P2|STARTED|Period 2||76
187988|NCT00522951|438421|P1|STARTED|Period 2||86
187989|NCT00522951|438420|P2|NOT COMPLETED|Washout Period||2
187990|NCT00522951|438421|P1|NOT COMPLETED|Washout Period||0
187991|NCT00522951|438420|P2|COMPLETED|Washout Period||76
187992|NCT00522951|438421|P1|COMPLETED|Washout Period||86
187993|NCT00522951|438420|P2|STARTED|Washout Period||78
187994|NCT00522951|438421|P1|STARTED|Washout Period||86
187995|NCT00522951|438420|P2|NOT COMPLETED|Period 1||1
187996|NCT00522951|438421|P1|NOT COMPLETED|Period 1||0
187997|NCT00522951|438420|P2|COMPLETED|Period 1||78
187998|NCT00522951|438421|P1|COMPLETED|Period 1||86
187999|NCT00522951|438420|P2|Received Treatment|Period 1||78
188000|NCT00522951|438421|P1|Received Treatment|Period 1||86
188001|NCT00522951|438420|P2|STARTED|Period 1||79
188002|NCT00522951|438421|P1|STARTED|Period 1||86
188003|NCT00522925|438464|P3|NOT COMPLETED|Overall Study||2
188004|NCT00522925|438465|P2|NOT COMPLETED|Overall Study||1
188005|NCT00522925|438466|P1|NOT COMPLETED|Overall Study||8
188006|NCT00522925|438464|P3|COMPLETED|Overall Study||36
188007|NCT00522925|438465|P2|COMPLETED|Overall Study||38
188008|NCT00522925|438466|P1|COMPLETED|Overall Study||28
188009|NCT00522925|438464|P3|STARTED|Overall Study||38
188010|NCT00522925|438465|P2|STARTED|Overall Study||39
188011|NCT00522925|438466|P1|STARTED|Overall Study||36
188012|NCT00522873|438476|P2|NOT COMPLETED|Overall Study||44
188013|NCT00522873|438477|P1|NOT COMPLETED|Overall Study||96
188014|NCT00522873|438476|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
188015|NCT00522873|438477|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
188016|NCT00522873|438476|P2|Received Treatment|Overall Study||172
188017|NCT00522873|438477|P1|Received Treatment|Overall Study||489
188018|NCT00522873|438476|P2|STARTED|Overall Study||172
188019|NCT00522873|438477|P1|STARTED|Overall Study||490
188020|NCT00522795|438486|P1|NOT COMPLETED|Overall Study||0
188021|NCT00522795|438486|P1|COMPLETED|Overall Study||40
188022|NCT00522795|438486|P1|STARTED|Overall Study||40
188023|NCT00522626|438490|P1|NOT COMPLETED|Overall Study||7
188024|NCT00522626|438490|P1|COMPLETED|Overall Study||12
188025|NCT00522626|438490|P1|STARTED|Overall Study||19
188026|NCT00522457|438494|P1|NOT COMPLETED|Overall Study||18
188027|NCT00522457|438494|P1|COMPLETED|Overall Study||1
188028|NCT00522457|438494|P1|STARTED|Overall Study||19
188029|NCT00522431|438500|P1|NOT COMPLETED|Overall Study||11
188030|NCT00522431|438500|P1|COMPLETED|Overall Study||138
188031|NCT00522431|438500|P1|STARTED|Overall Study||149
188032|NCT00522418|438506|P2|NOT COMPLETED|Overall Study||58
188033|NCT00522418|438507|P1|NOT COMPLETED|Overall Study||57
188034|NCT00522418|438506|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
188035|NCT00522418|438507|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
188036|NCT00522418|438506|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
188037|NCT00522418|438507|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
188038|NCT00522418|438506|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
188039|NCT00522418|438507|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
188040|NCT00522418|438506|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
188041|NCT00522418|438507|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
188042|NCT00522418|438506|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
188043|NCT00522418|438507|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
188044|NCT00522418|438506|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
188045|NCT00522418|438507|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
188134|NCT00521586|438766|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
188046|NCT00522418|438506|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
188047|NCT00522418|438507|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
188048|NCT00522418|438506|P2|STARTED|Overall Study||63
188049|NCT00522418|438507|P1|STARTED|Overall Study||59
188050|NCT00522392|438555|P2|NOT COMPLETED|Overall Study||13
188051|NCT00522392|438556|P1|NOT COMPLETED|Overall Study||8
188052|NCT00522392|438555|P2|COMPLETED|Overall Study||12
188053|NCT00522392|438556|P1|COMPLETED|Overall Study||15
188054|NCT00522392|438555|P2|Pts w/ QOL Assessments Complete|Overall Study||8
188055|NCT00522392|438556|P1|Pts w/ QOL Assessments Complete|Overall Study||12
188056|NCT00522392|438555|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
188057|NCT00522392|438556|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
188058|NCT00522392|438555|P2|STARTED|Overall Study||25
188059|NCT00522392|438556|P1|STARTED|Overall Study||23
188060|NCT00522379|438573|P5|NOT COMPLETED|Overall Study||27
188061|NCT00522379|438574|P4|NOT COMPLETED|Overall Study||14
188062|NCT00522379|438575|P3|NOT COMPLETED|Overall Study||22
188063|NCT00522379|438576|P2|NOT COMPLETED|Overall Study||23
188064|NCT00522379|438577|P1|NOT COMPLETED|Overall Study||22
188065|NCT00522379|438573|P5|COMPLETED|Overall Study||81
188066|NCT00522379|438574|P4|COMPLETED|Overall Study||80
188067|NCT00522379|438575|P3|COMPLETED|Overall Study||82
188068|NCT00522379|438576|P2|COMPLETED|Overall Study||84
188069|NCT00522379|438577|P1|COMPLETED|Overall Study||79
188070|NCT00522379|438573|P5|STARTED|Overall Study||108
188071|NCT00522379|438574|P4|STARTED|Overall Study||94
188072|NCT00522379|438575|P3|STARTED|Overall Study||104
188073|NCT00522379|438576|P2|STARTED|Overall Study||107
188074|NCT00522379|438577|P1|STARTED|Overall Study||101
188075|NCT00522301|438679|P1|NOT COMPLETED|Overall Study||6
188076|NCT00522301|438679|P1|COMPLETED|Overall Study||0
188077|NCT00522301|438679|P1|STARTED|Overall Study||6
188078|NCT00522275|438683|P1|NOT COMPLETED|Overall Study||170
188079|NCT00522275|438683|P1|COMPLETED|Overall Study||138
188080|NCT00522275|438683|P1|STARTED|Overall Study||308
188081|NCT00522171|438693|P2|NOT COMPLETED|Overall Study||0
188082|NCT00522171|438694|P1|NOT COMPLETED|Overall Study||0
188083|NCT00522171|438693|P2|COMPLETED|Overall Study||15
188084|NCT00522171|438694|P1|COMPLETED|Overall Study||15
188085|NCT00522171|438693|P2|STARTED|Overall Study||15
188086|NCT00522171|438694|P1|STARTED|Overall Study||15
188087|NCT00522041|438704|P2|NOT COMPLETED|Overall Study||12
188088|NCT00522041|438705|P1|NOT COMPLETED|Overall Study||17
188089|NCT00522041|438704|P2|COMPLETED|Overall Study||113
188090|NCT00522041|438705|P1|COMPLETED|Overall Study||106
188091|NCT00522041|438704|P2|Received Treatment|Overall Study||124
188092|NCT00522041|438705|P1|Received Treatment|Overall Study||123
188093|NCT00522041|438704|P2|STARTED|Overall Study||125
188094|NCT00522041|438705|P1|STARTED|Overall Study||123
188095|NCT00521989|438720|P5|NOT COMPLETED|Overall Study||23
188096|NCT00521989|438721|P4|NOT COMPLETED|Overall Study||12
188097|NCT00521989|438722|P3|NOT COMPLETED|Overall Study||16
188098|NCT00521989|438723|P2|NOT COMPLETED|Overall Study||17
188099|NCT00521989|438724|P1|NOT COMPLETED|Overall Study||20
188100|NCT00521989|438720|P5|COMPLETED|Overall Study||35
188101|NCT00521989|438721|P4|COMPLETED|Overall Study||42
188102|NCT00521989|438722|P3|COMPLETED|Overall Study||41
188103|NCT00521989|438723|P2|COMPLETED|Overall Study||37
188104|NCT00521989|438724|P1|COMPLETED|Overall Study||36
188105|NCT00521989|438720|P5|STARTED|Overall Study||58
188106|NCT00521989|438721|P4|STARTED|Overall Study||54
188107|NCT00521989|438722|P3|STARTED|Overall Study||57
188108|NCT00521989|438723|P2|STARTED|Overall Study||54
188109|NCT00521989|438724|P1|STARTED|Overall Study||56
188110|NCT00521976|438736|P1|NOT COMPLETED|Overall Study||0
188111|NCT00521976|438736|P1|COMPLETED|Overall Study||871
188112|NCT00521976|438736|P1|STARTED|Overall Study||871
188113|NCT00521924|438743|P2|NOT COMPLETED|Overall Study||4
188114|NCT00521924|438744|P1|NOT COMPLETED|Overall Study||4
188115|NCT00521924|438743|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
188116|NCT00521924|438744|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
188117|NCT00521924|438743|P2|STARTED|Overall Study|Subjects randomized|4
188118|NCT00521924|438744|P1|STARTED|Overall Study|Subjects randomized|4
188119|NCT00521599|438753|P3|NOT COMPLETED|Overall Study||36
188120|NCT00521599|438754|P2|NOT COMPLETED|Overall Study||29
188121|NCT00521599|438755|P1|NOT COMPLETED|Overall Study||25
188122|NCT00521599|438753|P3|COMPLETED|Overall Study||100
188123|NCT00521599|438754|P2|COMPLETED|Overall Study||239
188124|NCT00521599|438755|P1|COMPLETED|Overall Study||243
188125|NCT00521599|438753|P3|STARTED|Overall Study||136
188126|NCT00521599|438754|P2|STARTED|Overall Study||268
188127|NCT00521599|438755|P1|STARTED|Overall Study||268
188128|NCT00521586|438766|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
188129|NCT00521586|438767|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
188130|NCT00521586|438766|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
188131|NCT00521586|438767|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
188132|NCT00521586|438766|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
188133|NCT00521586|438767|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
188135|NCT00521586|438767|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
188136|NCT00521586|438766|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
188137|NCT00521586|438767|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
188138|NCT00521586|438766|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
188139|NCT00521586|438767|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
188140|NCT00521586|438766|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
188141|NCT00521586|438767|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
188142|NCT00521586|438766|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
188143|NCT00521586|438767|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
188144|NCT00521586|438766|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
188145|NCT00521586|438767|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
188146|NCT00521586|438766|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
188147|NCT00521586|438767|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
188148|NCT00521586|438766|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
188149|NCT00521586|438767|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
188150|NCT00521586|438766|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
188151|NCT00521586|438767|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
188152|NCT00521586|438766|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
188153|NCT00521586|438767|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
188154|NCT00521586|438766|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
188155|NCT00521586|438767|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
188156|NCT00521586|438766|P2|STARTED|Initial Vaccination (Year 0)||562
188157|NCT00521586|438767|P1|STARTED|Initial Vaccination (Year 0)||554
188158|NCT00521456|438827|P2|NOT COMPLETED|Overall Study||28
188159|NCT00521456|438828|P1|NOT COMPLETED|Overall Study||13
188160|NCT00521456|438827|P2|COMPLETED|Overall Study||59
188161|NCT00521456|438828|P1|COMPLETED|Overall Study||163
188162|NCT00521456|438827|P2|STARTED|Overall Study||87
188163|NCT00521456|438828|P1|STARTED|Overall Study||176
188164|NCT00521365|438840|P1|NOT COMPLETED|Overall Study||20
188165|NCT00521365|438840|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
188166|NCT00521365|438840|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
188167|NCT00521365|438840|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
188168|NCT00521365|438840|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
188169|NCT00521365|438840|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
188170|NCT00521352|438859|P2|NOT COMPLETED|Overall Study||3
188171|NCT00521352|438860|P1|NOT COMPLETED|Overall Study||1
188172|NCT00521352|438859|P2|COMPLETED|Overall Study||10
188173|NCT00521352|438860|P1|COMPLETED|Overall Study||11
188174|NCT00521352|438859|P2|STARTED|Overall Study||13
188175|NCT00521352|438860|P1|STARTED|Overall Study||12
188176|NCT00521339|438870|P3|NOT COMPLETED|Observational Follow Up Phase||0
188177|NCT00521339|438871|P2|NOT COMPLETED|Observational Follow Up Phase||0
188178|NCT00521339|438872|P1|NOT COMPLETED|Observational Follow Up Phase||0
188179|NCT00521339|438870|P3|COMPLETED|Observational Follow Up Phase||4
188180|NCT00521339|438871|P2|COMPLETED|Observational Follow Up Phase||4
188181|NCT00521339|438872|P1|COMPLETED|Observational Follow Up Phase||14
188182|NCT00521339|438870|P3|STARTED|Observational Follow Up Phase||4
188183|NCT00521339|438871|P2|STARTED|Observational Follow Up Phase||4
188184|NCT00521339|438872|P1|STARTED|Observational Follow Up Phase||14
188185|NCT00521339|438870|P3|NOT COMPLETED|Treatment Extension Phase||3
188186|NCT00521339|438871|P2|NOT COMPLETED|Treatment Extension Phase||0
188187|NCT00521339|438872|P1|NOT COMPLETED|Treatment Extension Phase||0
188188|NCT00521339|438870|P3|COMPLETED|Treatment Extension Phase||4
188189|NCT00521339|438871|P2|COMPLETED|Treatment Extension Phase||4
188190|NCT00521339|438872|P1|COMPLETED|Treatment Extension Phase||0
188191|NCT00521339|438870|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
188192|NCT00521339|438871|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
188193|NCT00521339|438872|P1|STARTED|Treatment Extension Phase||0
188194|NCT00521339|438870|P3|NOT COMPLETED|Treatment Phase||0
188195|NCT00521339|438871|P2|NOT COMPLETED|Treatment Phase||0
188196|NCT00521339|438872|P1|NOT COMPLETED|Treatment Phase||12
188197|NCT00521339|438870|P3|COMPLETED|Treatment Phase||0
188198|NCT00521339|438871|P2|COMPLETED|Treatment Phase||0
188199|NCT00521339|438872|P1|COMPLETED|Treatment Phase||19
188200|NCT00521339|438870|P3|Received Apremilast|Treatment Phase||0
188201|NCT00521339|438871|P2|Received Apremilast|Treatment Phase||0
188202|NCT00521339|438872|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
188203|NCT00521339|438870|P3|STARTED|Treatment Phase||0
188204|NCT00521339|438871|P2|STARTED|Treatment Phase||0
188205|NCT00521339|438872|P1|STARTED|Treatment Phase||31
188206|NCT00521144|438940|P5|NOT COMPLETED|Overall Study||7
188207|NCT00521144|438941|P4|NOT COMPLETED|Overall Study||1
188208|NCT00521144|438942|P3|NOT COMPLETED|Overall Study||2
188209|NCT00521144|438943|P2|NOT COMPLETED|Overall Study||3
188210|NCT00521144|438944|P1|NOT COMPLETED|Overall Study||4
188211|NCT00521144|438940|P5|COMPLETED|Overall Study||0
188212|NCT00521144|438941|P4|COMPLETED|Overall Study||0
188213|NCT00521144|438942|P3|COMPLETED|Overall Study||1
188214|NCT00521144|438943|P2|COMPLETED|Overall Study||2
188215|NCT00521144|438944|P1|COMPLETED|Overall Study||2
188216|NCT00521144|438940|P5|STARTED|Overall Study||7
188217|NCT00521144|438941|P4|STARTED|Overall Study||1
188218|NCT00521144|438942|P3|STARTED|Overall Study||3
188219|NCT00521144|438943|P2|STARTED|Overall Study||5
188220|NCT00521144|438944|P1|STARTED|Overall Study||6
188221|NCT00521053|438956|P1|NOT COMPLETED|Observation Phase||68
188222|NCT00521053|438956|P1|COMPLETED|Observation Phase||12
188223|NCT00521053|438956|P1|STARTED|Observation Phase||80
188224|NCT00521053|438956|P1|NOT COMPLETED|Treatment Phase||0
188225|NCT00521053|438956|P1|COMPLETED|Treatment Phase||80
188226|NCT00521053|438956|P1|Received 4 Cycles of PV-10|Treatment Phase||3
188227|NCT00521053|438956|P1|Received 3 Cycles of PV-10|Treatment Phase||16
188228|NCT00521053|438956|P1|Received 2 Cycles of PV-10|Treatment Phase||26
188229|NCT00521053|438956|P1|Received 1 Cycle of PV-10|Treatment Phase||35
188230|NCT00521053|438956|P1|STARTED|Treatment Phase||80
188231|NCT00521014|438966|P1|NOT COMPLETED|Overall Study||1
188232|NCT00521014|438966|P1|COMPLETED|Overall Study||13
188233|NCT00521014|438966|P1|STARTED|Overall Study||14
188234|NCT00520975|438972|P2|NOT COMPLETED|Overall Study||48
188235|NCT00520975|438973|P1|NOT COMPLETED|Overall Study||48
188236|NCT00520975|438972|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
188237|NCT00520975|438973|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
188238|NCT00520975|438972|P2|Treated and Reported Adverse Events Data|Overall Study||45
188239|NCT00520975|438973|P1|Treated and Reported Adverse Events Data|Overall Study||47
188240|NCT00520975|438972|P2|STARTED|Overall Study||48
188241|NCT00520975|438973|P1|STARTED|Overall Study||48
188242|NCT00520936|439005|P8|NOT COMPLETED|Overall Study||1
188243|NCT00520936|439006|P7|NOT COMPLETED|Overall Study||4
188244|NCT00520936|439007|P6|NOT COMPLETED|Overall Study||0
188245|NCT00520936|439008|P5|NOT COMPLETED|Overall Study||1
188246|NCT00520936|439009|P4|NOT COMPLETED|Overall Study||0
188247|NCT00520936|439010|P3|NOT COMPLETED|Overall Study||2
188248|NCT00520936|439011|P2|NOT COMPLETED|Overall Study||4
188249|NCT00520936|439012|P1|NOT COMPLETED|Overall Study||0
188250|NCT00520936|439005|P8|COMPLETED|Overall Study||9
188251|NCT00520936|439006|P7|COMPLETED|Overall Study||7
188252|NCT00520936|439007|P6|COMPLETED|Overall Study||10
188253|NCT00520936|439008|P5|COMPLETED|Overall Study||5
188254|NCT00520936|439009|P4|COMPLETED|Overall Study||5
188255|NCT00520936|439010|P3|COMPLETED|Overall Study||7
188256|NCT00520936|439011|P2|COMPLETED|Overall Study||7
188257|NCT00520936|439012|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
188258|NCT00520936|439005|P8|STARTED|Overall Study||10
188259|NCT00520936|439006|P7|STARTED|Overall Study||11
188260|NCT00520936|439007|P6|STARTED|Overall Study||10
188261|NCT00520936|439008|P5|STARTED|Overall Study||6
188262|NCT00520936|439009|P4|STARTED|Overall Study||5
188263|NCT00520936|439010|P3|STARTED|Overall Study||9
188264|NCT00520936|439011|P2|STARTED|Overall Study||11
188265|NCT00520936|439012|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
188266|NCT00520845|439039|P1|NOT COMPLETED|Overall Study||22
188267|NCT00520845|439039|P1|COMPLETED|Overall Study||1
188268|NCT00520845|439039|P1|STARTED|Overall Study||23
188269|NCT00520767|439047|P1|NOT COMPLETED|Overall Study||2
188270|NCT00520767|439047|P1|COMPLETED|Overall Study||33
188271|NCT00520767|439047|P1|STARTED|Overall Study||35
188272|NCT00520741|439053|P2|NOT COMPLETED|Overall Study||125
188273|NCT00520741|439054|P1|NOT COMPLETED|Overall Study||37
188274|NCT00520741|439053|P2|COMPLETED|Overall Study||194
188275|NCT00520741|439054|P1|COMPLETED|Overall Study||69
188276|NCT00520741|439053|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
188277|NCT00520741|439054|P1|STARTED|Overall Study||106
188278|NCT00520676|439072|P2|NOT COMPLETED|Overall Study||103
188279|NCT00520676|439073|P1|NOT COMPLETED|Overall Study||101
188280|NCT00520676|439072|P2|COMPLETED|Overall Study||29
188281|NCT00520676|439073|P1|COMPLETED|Overall Study||27
188282|NCT00520676|439072|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
188283|NCT00520676|439073|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
188284|NCT00520676|439072|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
188285|NCT00520676|439073|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
188286|NCT00520676|439072|P2|STARTED|Overall Study||132
188287|NCT00520676|439073|P1|STARTED|Overall Study||128
188288|NCT00520572|439099|P6|NOT COMPLETED|Overall Study||2
188289|NCT00520572|439100|P5|NOT COMPLETED|Overall Study||12
188290|NCT00520572|439101|P4|NOT COMPLETED|Overall Study||14
188291|NCT00520572|439102|P3|NOT COMPLETED|Overall Study||15
188292|NCT00520572|439103|P2|NOT COMPLETED|Overall Study||14
188293|NCT00520572|439104|P1|NOT COMPLETED|Overall Study||12
188294|NCT00520572|439099|P6|COMPLETED|Overall Study|Participants completed the study.|62
188295|NCT00520572|439100|P5|COMPLETED|Overall Study|Participants completed the study.|53
188296|NCT00520572|439101|P4|COMPLETED|Overall Study|Participants completed the study.|50
188297|NCT00520572|439102|P3|COMPLETED|Overall Study|Participants completed the study.|49
188298|NCT00520572|439103|P2|COMPLETED|Overall Study|Participants completed the study.|50
188299|NCT00520572|439104|P1|COMPLETED|Overall Study|Participants completed the study.|52
188300|NCT00520572|439099|P6|STARTED|Overall Study|Participants randomised.|64
188301|NCT00520572|439100|P5|STARTED|Overall Study|Participants randomised.|65
188302|NCT00520572|439101|P4|STARTED|Overall Study|Participants randomised.|64
188303|NCT00520572|439102|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
188304|NCT00520572|439103|P2|STARTED|Overall Study|Participants randomised.|64
188305|NCT00520572|439104|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
188306|NCT00520546|439142|P1|NOT COMPLETED|Overall Study||6
188307|NCT00520546|439142|P1|COMPLETED|Overall Study||38
188308|NCT00520546|439142|P1|STARTED|Overall Study||44
188309|NCT00519818|439157|P1|NOT COMPLETED|Overall Study||0
188310|NCT00519818|439157|P1|COMPLETED|Overall Study||14
188311|NCT00519818|439157|P1|STARTED|Overall Study||14
188312|NCT00519779|439167|P2|NOT COMPLETED|Overall Study||1
188313|NCT00519779|439168|P1|NOT COMPLETED|Overall Study||0
188314|NCT00519779|439167|P2|COMPLETED|Overall Study||33
188315|NCT00519779|439168|P1|COMPLETED|Overall Study||34
188316|NCT00519779|439167|P2|STARTED|Overall Study||34
188317|NCT00519779|439168|P1|STARTED|Overall Study||34
188318|NCT00519649|439184|P1|NOT COMPLETED|Overall Study||1
188319|NCT00519649|439184|P1|COMPLETED|Overall Study||299
188320|NCT00519649|439184|P1|STARTED|Overall Study||300
188321|NCT00520494|439193|P1|NOT COMPLETED|Overall Study||1
188322|NCT00520494|439193|P1|COMPLETED|Overall Study||17
188323|NCT00520494|439193|P1|STARTED|Overall Study||18
188324|NCT00520468|439216|P1|NOT COMPLETED|Overall Study||0
188325|NCT00520468|439216|P1|COMPLETED|Overall Study||14
188326|NCT00520468|439216|P1|STARTED|Overall Study||14
188327|NCT00520403|439220|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
188328|NCT00520403|439220|P1|COMPLETED|Bevacizumab Monotherapy||0
188329|NCT00520403|439220|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
188330|NCT00520403|439220|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
188331|NCT00520403|439220|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
188332|NCT00520403|439220|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
188333|NCT00520351|439229|P2|NOT COMPLETED|Second Intervention||0
188334|NCT00520351|439230|P1|NOT COMPLETED|Second Intervention||0
188335|NCT00520351|439229|P2|COMPLETED|Second Intervention||14
188336|NCT00520351|439230|P1|COMPLETED|Second Intervention||14
188337|NCT00520351|439229|P2|STARTED|Second Intervention||14
188338|NCT00520351|439230|P1|STARTED|Second Intervention||14
188339|NCT00520351|439229|P2|NOT COMPLETED|First Intervention||1
188340|NCT00520351|439230|P1|NOT COMPLETED|First Intervention||1
188341|NCT00520351|439229|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
188342|NCT00520351|439230|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
188343|NCT00520351|439229|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
188344|NCT00520351|439230|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
188345|NCT00520234|439244|P2|NOT COMPLETED|Overall Study||2
188346|NCT00520234|439245|P1|NOT COMPLETED|Overall Study||1
188347|NCT00520234|439244|P2|COMPLETED|Overall Study||102
188348|NCT00520234|439245|P1|COMPLETED|Overall Study||117
188349|NCT00520234|439244|P2|STARTED|Overall Study||104
188350|NCT00520234|439245|P1|STARTED|Overall Study||118
188351|NCT00520013|439258|P3|NOT COMPLETED|Overall Study||11
188352|NCT00520013|439259|P2|NOT COMPLETED|Overall Study||15
188353|NCT00520013|439260|P1|NOT COMPLETED|Overall Study||12
188354|NCT00520013|439258|P3|COMPLETED|Overall Study||0
188355|NCT00520013|439259|P2|COMPLETED|Overall Study||10
188356|NCT00520013|439260|P1|COMPLETED|Overall Study||11
188357|NCT00520013|439258|P3|Treated|Overall Study||11
188358|NCT00520013|439259|P2|Treated|Overall Study||25
188359|NCT00520013|439260|P1|Treated|Overall Study||23
188360|NCT00520013|439258|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
188361|NCT00520013|439259|P2|STARTED|Overall Study||25
188362|NCT00520013|439260|P1|STARTED|Overall Study||23
188363|NCT00519636|439274|P4|NOT COMPLETED|Post Study Period||1
188364|NCT00519636|439275|P3|NOT COMPLETED|Post Study Period||0
188365|NCT00519636|439276|P2|NOT COMPLETED|Post Study Period||0
188366|NCT00519636|439277|P1|NOT COMPLETED|Post Study Period||0
188367|NCT00519636|439274|P4|COMPLETED|Post Study Period||85
188368|NCT00519636|439275|P3|COMPLETED|Post Study Period||74
188369|NCT00519636|439276|P2|COMPLETED|Post Study Period||71
188370|NCT00519636|439277|P1|COMPLETED|Post Study Period||69
188371|NCT00519636|439274|P4|STARTED|Post Study Period||86
188372|NCT00519636|439275|P3|STARTED|Post Study Period||74
188373|NCT00519636|439276|P2|STARTED|Post Study Period||71
188374|NCT00519636|439277|P1|STARTED|Post Study Period||69
188375|NCT00519636|439274|P4|NOT COMPLETED|Treatment Period 2||2
188376|NCT00519636|439275|P3|NOT COMPLETED|Treatment Period 2||1
188377|NCT00519636|439276|P2|NOT COMPLETED|Treatment Period 2||1
188378|NCT00519636|439277|P1|NOT COMPLETED|Treatment Period 2||0
188379|NCT00519636|439274|P4|COMPLETED|Treatment Period 2||86
188380|NCT00519636|439275|P3|COMPLETED|Treatment Period 2||74
188381|NCT00519636|439276|P2|COMPLETED|Treatment Period 2||71
188382|NCT00519636|439277|P1|COMPLETED|Treatment Period 2||69
188383|NCT00519636|439274|P4|STARTED|Treatment Period 2||88
188384|NCT00519636|439275|P3|STARTED|Treatment Period 2||75
188385|NCT00519636|439276|P2|STARTED|Treatment Period 2||72
188386|NCT00519636|439277|P1|STARTED|Treatment Period 2||69
188387|NCT00519636|439274|P4|NOT COMPLETED|Washout Period||5
188388|NCT00519636|439275|P3|NOT COMPLETED|Washout Period||14
188389|NCT00519636|439276|P2|NOT COMPLETED|Washout Period||14
188390|NCT00519636|439277|P1|NOT COMPLETED|Washout Period||20
188391|NCT00519636|439274|P4|COMPLETED|Washout Period||88
188392|NCT00519636|439275|P3|COMPLETED|Washout Period||75
188393|NCT00519636|439276|P2|COMPLETED|Washout Period||72
188394|NCT00519636|439277|P1|COMPLETED|Washout Period||69
188395|NCT00519636|439274|P4|STARTED|Washout Period||93
188396|NCT00519636|439275|P3|STARTED|Washout Period||89
188397|NCT00519636|439276|P2|STARTED|Washout Period||86
188398|NCT00519636|439277|P1|STARTED|Washout Period||89
188399|NCT00519636|439274|P4|NOT COMPLETED|Treatment Period 1||0
188400|NCT00519636|439275|P3|NOT COMPLETED|Treatment Period 1||1
188401|NCT00519636|439276|P2|NOT COMPLETED|Treatment Period 1||0
188402|NCT00519636|439277|P1|NOT COMPLETED|Treatment Period 1||2
188403|NCT00519636|439274|P4|COMPLETED|Treatment Period 1||93
188404|NCT00519636|439275|P3|COMPLETED|Treatment Period 1||89
188405|NCT00519636|439276|P2|COMPLETED|Treatment Period 1||86
188406|NCT00519636|439277|P1|COMPLETED|Treatment Period 1||89
188407|NCT00519636|439274|P4|STARTED|Treatment Period 1||93
188408|NCT00519636|439275|P3|STARTED|Treatment Period 1||90
188409|NCT00519636|439276|P2|STARTED|Treatment Period 1||86
188410|NCT00519636|439277|P1|STARTED|Treatment Period 1||91
188411|NCT00519623|439307|P1|NOT COMPLETED|Overall Study||1
188412|NCT00519623|439307|P1|COMPLETED|Overall Study||8
188413|NCT00519623|439307|P1|STARTED|Overall Study||9
188414|NCT00519532|439312|P1|NOT COMPLETED|Overall Study||18
188415|NCT00519532|439312|P1|COMPLETED|Overall Study||66
188416|NCT00519532|439312|P1|STARTED|Overall Study||84
188417|NCT00519376|439319|P16|NOT COMPLETED|Treatment Period 4||0
188418|NCT00519376|439320|P15|NOT COMPLETED|Treatment Period 4||0
188419|NCT00519376|439321|P14|NOT COMPLETED|Treatment Period 4||0
188420|NCT00519376|439322|P13|NOT COMPLETED|Treatment Period 4||0
188421|NCT00519376|439323|P12|NOT COMPLETED|Treatment Period 4||0
188422|NCT00519376|439324|P11|NOT COMPLETED|Treatment Period 4||0
188423|NCT00519376|439325|P10|NOT COMPLETED|Treatment Period 4||0
188424|NCT00519376|439326|P9|NOT COMPLETED|Treatment Period 4||0
188425|NCT00519376|439327|P8|NOT COMPLETED|Treatment Period 4||0
188426|NCT00519376|439328|P7|NOT COMPLETED|Treatment Period 4||0
188427|NCT00519376|439329|P6|NOT COMPLETED|Treatment Period 4||0
188428|NCT00519376|439330|P5|NOT COMPLETED|Treatment Period 4||0
188429|NCT00519376|439331|P4|NOT COMPLETED|Treatment Period 4||0
188430|NCT00519376|439332|P3|NOT COMPLETED|Treatment Period 4||1
188431|NCT00519376|439333|P2|NOT COMPLETED|Treatment Period 4||0
188432|NCT00519376|439334|P1|NOT COMPLETED|Treatment Period 4||0
188433|NCT00519376|439319|P16|COMPLETED|Treatment Period 4||1
188434|NCT00519376|439320|P15|COMPLETED|Treatment Period 4||1
188435|NCT00519376|439321|P14|COMPLETED|Treatment Period 4||1
188436|NCT00519376|439322|P13|COMPLETED|Treatment Period 4||0
188437|NCT00519376|439323|P12|COMPLETED|Treatment Period 4||1
188438|NCT00519376|439324|P11|COMPLETED|Treatment Period 4||1
188439|NCT00519376|439325|P10|COMPLETED|Treatment Period 4||1
188440|NCT00519376|439326|P9|COMPLETED|Treatment Period 4||1
188441|NCT00519376|439327|P8|COMPLETED|Treatment Period 4||1
188442|NCT00519376|439328|P7|COMPLETED|Treatment Period 4||1
188443|NCT00519376|439329|P6|COMPLETED|Treatment Period 4||1
188444|NCT00519376|439330|P5|COMPLETED|Treatment Period 4||1
188445|NCT00519376|439331|P4|COMPLETED|Treatment Period 4||2
188446|NCT00519376|439332|P3|COMPLETED|Treatment Period 4||1
188447|NCT00519376|439333|P2|COMPLETED|Treatment Period 4||2
188448|NCT00519376|439334|P1|COMPLETED|Treatment Period 4||2
188449|NCT00519376|439319|P16|STARTED|Treatment Period 4||1
188450|NCT00519376|439320|P15|STARTED|Treatment Period 4||1
188451|NCT00519376|439321|P14|STARTED|Treatment Period 4||1
188452|NCT00519376|439322|P13|STARTED|Treatment Period 4||0
188453|NCT00519376|439323|P12|STARTED|Treatment Period 4||1
188454|NCT00519376|439324|P11|STARTED|Treatment Period 4||1
188455|NCT00519376|439325|P10|STARTED|Treatment Period 4||1
188456|NCT00519376|439326|P9|STARTED|Treatment Period 4||1
188457|NCT00519376|439327|P8|STARTED|Treatment Period 4||1
188458|NCT00519376|439328|P7|STARTED|Treatment Period 4||1
188459|NCT00519376|439329|P6|STARTED|Treatment Period 4||1
188460|NCT00519376|439330|P5|STARTED|Treatment Period 4||1
188461|NCT00519376|439331|P4|STARTED|Treatment Period 4||2
188462|NCT00519376|439332|P3|STARTED|Treatment Period 4||2
188463|NCT00519376|439333|P2|STARTED|Treatment Period 4||2
188464|NCT00519376|439334|P1|STARTED|Treatment Period 4||2
188465|NCT00519376|439319|P16|NOT COMPLETED|Washout Period 3||0
188466|NCT00519376|439320|P15|NOT COMPLETED|Washout Period 3||0
188467|NCT00519376|439321|P14|NOT COMPLETED|Washout Period 3||0
188468|NCT00519376|439322|P13|NOT COMPLETED|Washout Period 3||0
188469|NCT00519376|439323|P12|NOT COMPLETED|Washout Period 3||0
188470|NCT00519376|439324|P11|NOT COMPLETED|Washout Period 3||0
188471|NCT00519376|439325|P10|NOT COMPLETED|Washout Period 3||0
188472|NCT00519376|439326|P9|NOT COMPLETED|Washout Period 3||0
188473|NCT00519376|439327|P8|NOT COMPLETED|Washout Period 3||0
188474|NCT00519376|439328|P7|NOT COMPLETED|Washout Period 3||0
188475|NCT00519376|439329|P6|NOT COMPLETED|Washout Period 3||0
188476|NCT00519376|439330|P5|NOT COMPLETED|Washout Period 3||0
188477|NCT00519376|439331|P4|NOT COMPLETED|Washout Period 3||0
188478|NCT00519376|439332|P3|NOT COMPLETED|Washout Period 3||0
188479|NCT00519376|439333|P2|NOT COMPLETED|Washout Period 3||0
188480|NCT00519376|439334|P1|NOT COMPLETED|Washout Period 3||0
188481|NCT00519376|439319|P16|COMPLETED|Washout Period 3||1
188482|NCT00519376|439320|P15|COMPLETED|Washout Period 3||1
188483|NCT00519376|439321|P14|COMPLETED|Washout Period 3||1
188484|NCT00519376|439322|P13|COMPLETED|Washout Period 3||0
188485|NCT00519376|439323|P12|COMPLETED|Washout Period 3||1
188486|NCT00519376|439324|P11|COMPLETED|Washout Period 3||1
188487|NCT00519376|439325|P10|COMPLETED|Washout Period 3||1
188488|NCT00519376|439326|P9|COMPLETED|Washout Period 3||1
188489|NCT00519376|439327|P8|COMPLETED|Washout Period 3||1
188490|NCT00519376|439328|P7|COMPLETED|Washout Period 3||1
188491|NCT00519376|439329|P6|COMPLETED|Washout Period 3||1
188492|NCT00519376|439330|P5|COMPLETED|Washout Period 3||1
188493|NCT00519376|439331|P4|COMPLETED|Washout Period 3||2
188494|NCT00519376|439332|P3|COMPLETED|Washout Period 3||2
188495|NCT00519376|439333|P2|COMPLETED|Washout Period 3||2
188496|NCT00519376|439334|P1|COMPLETED|Washout Period 3||2
188497|NCT00519376|439319|P16|STARTED|Washout Period 3||1
188498|NCT00519376|439320|P15|STARTED|Washout Period 3||1
188499|NCT00519376|439321|P14|STARTED|Washout Period 3||1
188500|NCT00519376|439322|P13|STARTED|Washout Period 3||0
188501|NCT00519376|439323|P12|STARTED|Washout Period 3||1
188502|NCT00519376|439324|P11|STARTED|Washout Period 3||1
188503|NCT00519376|439325|P10|STARTED|Washout Period 3||1
188504|NCT00519376|439326|P9|STARTED|Washout Period 3||1
188505|NCT00519376|439327|P8|STARTED|Washout Period 3||1
188506|NCT00519376|439328|P7|STARTED|Washout Period 3||1
188507|NCT00519376|439329|P6|STARTED|Washout Period 3||1
188508|NCT00519376|439330|P5|STARTED|Washout Period 3||1
188509|NCT00519376|439331|P4|STARTED|Washout Period 3||2
188510|NCT00519376|439332|P3|STARTED|Washout Period 3||2
188511|NCT00519376|439333|P2|STARTED|Washout Period 3||2
188512|NCT00519376|439334|P1|STARTED|Washout Period 3||2
188513|NCT00519376|439319|P16|NOT COMPLETED|Treatment Period 3||0
188514|NCT00519376|439320|P15|NOT COMPLETED|Treatment Period 3||0
188515|NCT00519376|439321|P14|NOT COMPLETED|Treatment Period 3||0
188516|NCT00519376|439322|P13|NOT COMPLETED|Treatment Period 3||0
188517|NCT00519376|439323|P12|NOT COMPLETED|Treatment Period 3||0
188518|NCT00519376|439324|P11|NOT COMPLETED|Treatment Period 3||0
188519|NCT00519376|439325|P10|NOT COMPLETED|Treatment Period 3||0
188520|NCT00519376|439326|P9|NOT COMPLETED|Treatment Period 3||0
188521|NCT00519376|439327|P8|NOT COMPLETED|Treatment Period 3||0
188522|NCT00519376|439328|P7|NOT COMPLETED|Treatment Period 3||0
188523|NCT00519376|439329|P6|NOT COMPLETED|Treatment Period 3||0
188524|NCT00519376|439330|P5|NOT COMPLETED|Treatment Period 3||0
188525|NCT00519376|439331|P4|NOT COMPLETED|Treatment Period 3||0
188526|NCT00519376|439332|P3|NOT COMPLETED|Treatment Period 3||0
188527|NCT00519376|439333|P2|NOT COMPLETED|Treatment Period 3||0
188528|NCT00519376|439334|P1|NOT COMPLETED|Treatment Period 3||0
188529|NCT00519376|439319|P16|COMPLETED|Treatment Period 3||1
188530|NCT00519376|439320|P15|COMPLETED|Treatment Period 3||1
188531|NCT00519376|439321|P14|COMPLETED|Treatment Period 3||1
188532|NCT00519376|439322|P13|COMPLETED|Treatment Period 3||0
188533|NCT00519376|439323|P12|COMPLETED|Treatment Period 3||1
188534|NCT00519376|439324|P11|COMPLETED|Treatment Period 3||1
188535|NCT00519376|439325|P10|COMPLETED|Treatment Period 3||1
188536|NCT00519376|439326|P9|COMPLETED|Treatment Period 3||1
188537|NCT00519376|439327|P8|COMPLETED|Treatment Period 3||1
188538|NCT00519376|439328|P7|COMPLETED|Treatment Period 3||1
188539|NCT00519376|439329|P6|COMPLETED|Treatment Period 3||1
188540|NCT00519376|439330|P5|COMPLETED|Treatment Period 3||1
188541|NCT00519376|439331|P4|COMPLETED|Treatment Period 3||2
188542|NCT00519376|439332|P3|COMPLETED|Treatment Period 3||2
188543|NCT00519376|439333|P2|COMPLETED|Treatment Period 3||2
188544|NCT00519376|439334|P1|COMPLETED|Treatment Period 3||2
188545|NCT00519376|439319|P16|STARTED|Treatment Period 3||1
188546|NCT00519376|439320|P15|STARTED|Treatment Period 3||1
188547|NCT00519376|439321|P14|STARTED|Treatment Period 3||1
188548|NCT00519376|439322|P13|STARTED|Treatment Period 3||0
188549|NCT00519376|439323|P12|STARTED|Treatment Period 3||1
188550|NCT00519376|439324|P11|STARTED|Treatment Period 3||1
188551|NCT00519376|439325|P10|STARTED|Treatment Period 3||1
188552|NCT00519376|439326|P9|STARTED|Treatment Period 3||1
188553|NCT00519376|439327|P8|STARTED|Treatment Period 3||1
188554|NCT00519376|439328|P7|STARTED|Treatment Period 3||1
188555|NCT00519376|439329|P6|STARTED|Treatment Period 3||1
188556|NCT00519376|439330|P5|STARTED|Treatment Period 3||1
188557|NCT00519376|439331|P4|STARTED|Treatment Period 3||2
188558|NCT00519376|439332|P3|STARTED|Treatment Period 3||2
188559|NCT00519376|439333|P2|STARTED|Treatment Period 3||2
188560|NCT00519376|439334|P1|STARTED|Treatment Period 3||2
188561|NCT00519376|439319|P16|NOT COMPLETED|Washout Period 2||0
188562|NCT00519376|439320|P15|NOT COMPLETED|Washout Period 2||0
188563|NCT00519376|439321|P14|NOT COMPLETED|Washout Period 2||0
188564|NCT00519376|439322|P13|NOT COMPLETED|Washout Period 2||0
188565|NCT00519376|439323|P12|NOT COMPLETED|Washout Period 2||0
188566|NCT00519376|439324|P11|NOT COMPLETED|Washout Period 2||0
188567|NCT00519376|439325|P10|NOT COMPLETED|Washout Period 2||0
188568|NCT00519376|439326|P9|NOT COMPLETED|Washout Period 2||0
188569|NCT00519376|439327|P8|NOT COMPLETED|Washout Period 2||0
188570|NCT00519376|439328|P7|NOT COMPLETED|Washout Period 2||0
188571|NCT00519376|439329|P6|NOT COMPLETED|Washout Period 2||0
188572|NCT00519376|439330|P5|NOT COMPLETED|Washout Period 2||0
188573|NCT00519376|439331|P4|NOT COMPLETED|Washout Period 2||0
188574|NCT00519376|439332|P3|NOT COMPLETED|Washout Period 2||0
188575|NCT00519376|439333|P2|NOT COMPLETED|Washout Period 2||0
188576|NCT00519376|439334|P1|NOT COMPLETED|Washout Period 2||0
188577|NCT00519376|439319|P16|COMPLETED|Washout Period 2||1
188578|NCT00519376|439320|P15|COMPLETED|Washout Period 2||1
188579|NCT00519376|439321|P14|COMPLETED|Washout Period 2||1
188580|NCT00519376|439322|P13|COMPLETED|Washout Period 2||0
188581|NCT00519376|439323|P12|COMPLETED|Washout Period 2||1
188582|NCT00519376|439324|P11|COMPLETED|Washout Period 2||1
188583|NCT00519376|439325|P10|COMPLETED|Washout Period 2||1
188584|NCT00519376|439326|P9|COMPLETED|Washout Period 2||1
188585|NCT00519376|439327|P8|COMPLETED|Washout Period 2||1
188586|NCT00519376|439328|P7|COMPLETED|Washout Period 2||1
188587|NCT00519376|439329|P6|COMPLETED|Washout Period 2||1
188588|NCT00519376|439330|P5|COMPLETED|Washout Period 2||1
188589|NCT00519376|439331|P4|COMPLETED|Washout Period 2||2
188590|NCT00519376|439332|P3|COMPLETED|Washout Period 2||2
188591|NCT00519376|439333|P2|COMPLETED|Washout Period 2||2
188592|NCT00519376|439334|P1|COMPLETED|Washout Period 2||2
188593|NCT00519376|439319|P16|STARTED|Washout Period 2||1
188594|NCT00519376|439320|P15|STARTED|Washout Period 2||1
188595|NCT00519376|439321|P14|STARTED|Washout Period 2||1
188596|NCT00519376|439322|P13|STARTED|Washout Period 2||0
188597|NCT00519376|439323|P12|STARTED|Washout Period 2||1
188598|NCT00519376|439324|P11|STARTED|Washout Period 2||1
188599|NCT00519376|439325|P10|STARTED|Washout Period 2||1
188600|NCT00519376|439326|P9|STARTED|Washout Period 2||1
188601|NCT00519376|439327|P8|STARTED|Washout Period 2||1
188602|NCT00519376|439328|P7|STARTED|Washout Period 2||1
188603|NCT00519376|439329|P6|STARTED|Washout Period 2||1
188604|NCT00519376|439330|P5|STARTED|Washout Period 2||1
188605|NCT00519376|439331|P4|STARTED|Washout Period 2||2
188606|NCT00519376|439332|P3|STARTED|Washout Period 2||2
188607|NCT00519376|439333|P2|STARTED|Washout Period 2||2
188608|NCT00519376|439334|P1|STARTED|Washout Period 2||2
188609|NCT00519376|439319|P16|NOT COMPLETED|Treatment Period 2||0
188610|NCT00519376|439320|P15|NOT COMPLETED|Treatment Period 2||0
188611|NCT00519376|439321|P14|NOT COMPLETED|Treatment Period 2||0
188612|NCT00519376|439322|P13|NOT COMPLETED|Treatment Period 2||1
188613|NCT00519376|439323|P12|NOT COMPLETED|Treatment Period 2||0
188614|NCT00519376|439324|P11|NOT COMPLETED|Treatment Period 2||0
188615|NCT00519376|439325|P10|NOT COMPLETED|Treatment Period 2||0
188616|NCT00519376|439326|P9|NOT COMPLETED|Treatment Period 2||0
188617|NCT00519376|439327|P8|NOT COMPLETED|Treatment Period 2||0
188618|NCT00519376|439328|P7|NOT COMPLETED|Treatment Period 2||0
188619|NCT00519376|439329|P6|NOT COMPLETED|Treatment Period 2||0
188620|NCT00519376|439330|P5|NOT COMPLETED|Treatment Period 2||0
188621|NCT00519376|439331|P4|NOT COMPLETED|Treatment Period 2||0
188622|NCT00519376|439332|P3|NOT COMPLETED|Treatment Period 2||0
188623|NCT00519376|439333|P2|NOT COMPLETED|Treatment Period 2||0
188624|NCT00519376|439334|P1|NOT COMPLETED|Treatment Period 2||0
188625|NCT00519376|439319|P16|COMPLETED|Treatment Period 2||1
188626|NCT00519376|439320|P15|COMPLETED|Treatment Period 2||1
188627|NCT00519376|439321|P14|COMPLETED|Treatment Period 2||1
188628|NCT00519376|439322|P13|COMPLETED|Treatment Period 2||0
188629|NCT00519376|439323|P12|COMPLETED|Treatment Period 2||1
188630|NCT00519376|439324|P11|COMPLETED|Treatment Period 2||1
188631|NCT00519376|439325|P10|COMPLETED|Treatment Period 2||1
188632|NCT00519376|439326|P9|COMPLETED|Treatment Period 2||1
188633|NCT00519376|439327|P8|COMPLETED|Treatment Period 2||1
188634|NCT00519376|439328|P7|COMPLETED|Treatment Period 2||1
188635|NCT00519376|439329|P6|COMPLETED|Treatment Period 2||1
188636|NCT00519376|439330|P5|COMPLETED|Treatment Period 2||1
188637|NCT00519376|439331|P4|COMPLETED|Treatment Period 2||2
188638|NCT00519376|439332|P3|COMPLETED|Treatment Period 2||2
188639|NCT00519376|439333|P2|COMPLETED|Treatment Period 2||2
188640|NCT00519376|439334|P1|COMPLETED|Treatment Period 2||2
188641|NCT00519376|439319|P16|STARTED|Treatment Period 2||1
188642|NCT00519376|439320|P15|STARTED|Treatment Period 2||1
188643|NCT00519376|439321|P14|STARTED|Treatment Period 2||1
188644|NCT00519376|439322|P13|STARTED|Treatment Period 2||1
188645|NCT00519376|439323|P12|STARTED|Treatment Period 2||1
188646|NCT00519376|439324|P11|STARTED|Treatment Period 2||1
188647|NCT00519376|439325|P10|STARTED|Treatment Period 2||1
188648|NCT00519376|439326|P9|STARTED|Treatment Period 2||1
188649|NCT00519376|439327|P8|STARTED|Treatment Period 2||1
188650|NCT00519376|439328|P7|STARTED|Treatment Period 2||1
188651|NCT00519376|439329|P6|STARTED|Treatment Period 2||1
188652|NCT00519376|439330|P5|STARTED|Treatment Period 2||1
188653|NCT00519376|439331|P4|STARTED|Treatment Period 2||2
188654|NCT00519376|439332|P3|STARTED|Treatment Period 2||2
188655|NCT00519376|439333|P2|STARTED|Treatment Period 2||2
188656|NCT00519376|439334|P1|STARTED|Treatment Period 2||2
188657|NCT00519376|439319|P16|NOT COMPLETED|Washout Period 1||0
188658|NCT00519376|439320|P15|NOT COMPLETED|Washout Period 1||0
188659|NCT00519376|439321|P14|NOT COMPLETED|Washout Period 1||0
188660|NCT00519376|439322|P13|NOT COMPLETED|Washout Period 1||0
188661|NCT00519376|439323|P12|NOT COMPLETED|Washout Period 1||0
188662|NCT00519376|439324|P11|NOT COMPLETED|Washout Period 1||0
188663|NCT00519376|439325|P10|NOT COMPLETED|Washout Period 1||0
188664|NCT00519376|439326|P9|NOT COMPLETED|Washout Period 1||0
188665|NCT00519376|439327|P8|NOT COMPLETED|Washout Period 1||0
188666|NCT00519376|439328|P7|NOT COMPLETED|Washout Period 1||0
188667|NCT00519376|439329|P6|NOT COMPLETED|Washout Period 1||0
188668|NCT00519376|439330|P5|NOT COMPLETED|Washout Period 1||0
188669|NCT00519376|439331|P4|NOT COMPLETED|Washout Period 1||0
188670|NCT00519376|439332|P3|NOT COMPLETED|Washout Period 1||0
188671|NCT00519376|439333|P2|NOT COMPLETED|Washout Period 1||0
188672|NCT00519376|439334|P1|NOT COMPLETED|Washout Period 1||0
188673|NCT00519376|439319|P16|COMPLETED|Washout Period 1||1
188674|NCT00519376|439320|P15|COMPLETED|Washout Period 1||1
188675|NCT00519376|439321|P14|COMPLETED|Washout Period 1||1
188676|NCT00519376|439322|P13|COMPLETED|Washout Period 1||1
188677|NCT00519376|439323|P12|COMPLETED|Washout Period 1||1
188678|NCT00519376|439324|P11|COMPLETED|Washout Period 1||1
188679|NCT00519376|439325|P10|COMPLETED|Washout Period 1||1
188680|NCT00519376|439326|P9|COMPLETED|Washout Period 1||1
188681|NCT00519376|439327|P8|COMPLETED|Washout Period 1||1
188682|NCT00519376|439328|P7|COMPLETED|Washout Period 1||1
188683|NCT00519376|439329|P6|COMPLETED|Washout Period 1||1
188684|NCT00519376|439330|P5|COMPLETED|Washout Period 1||1
188685|NCT00519376|439331|P4|COMPLETED|Washout Period 1||2
188686|NCT00519376|439332|P3|COMPLETED|Washout Period 1||2
188687|NCT00519376|439333|P2|COMPLETED|Washout Period 1||2
188688|NCT00519376|439334|P1|COMPLETED|Washout Period 1||2
188689|NCT00519376|439319|P16|STARTED|Washout Period 1||1
188690|NCT00519376|439320|P15|STARTED|Washout Period 1||1
188691|NCT00519376|439321|P14|STARTED|Washout Period 1||1
188692|NCT00519376|439322|P13|STARTED|Washout Period 1||1
188693|NCT00519376|439323|P12|STARTED|Washout Period 1||1
188694|NCT00519376|439324|P11|STARTED|Washout Period 1||1
188695|NCT00519376|439325|P10|STARTED|Washout Period 1||1
188696|NCT00519376|439326|P9|STARTED|Washout Period 1||1
188697|NCT00519376|439327|P8|STARTED|Washout Period 1||1
188698|NCT00519376|439328|P7|STARTED|Washout Period 1||1
188699|NCT00519376|439329|P6|STARTED|Washout Period 1||1
188700|NCT00519376|439330|P5|STARTED|Washout Period 1||1
188701|NCT00519376|439331|P4|STARTED|Washout Period 1||2
188702|NCT00519376|439332|P3|STARTED|Washout Period 1||2
188703|NCT00519376|439333|P2|STARTED|Washout Period 1||2
188704|NCT00519376|439334|P1|STARTED|Washout Period 1||2
188705|NCT00519376|439319|P16|NOT COMPLETED|Treatment Period 1||0
188706|NCT00519376|439320|P15|NOT COMPLETED|Treatment Period 1||0
188707|NCT00519376|439321|P14|NOT COMPLETED|Treatment Period 1||0
188708|NCT00519376|439322|P13|NOT COMPLETED|Treatment Period 1||0
188709|NCT00519376|439323|P12|NOT COMPLETED|Treatment Period 1||0
188710|NCT00519376|439324|P11|NOT COMPLETED|Treatment Period 1||0
188711|NCT00519376|439325|P10|NOT COMPLETED|Treatment Period 1||0
188712|NCT00519376|439326|P9|NOT COMPLETED|Treatment Period 1||0
188713|NCT00519376|439327|P8|NOT COMPLETED|Treatment Period 1||0
188714|NCT00519376|439328|P7|NOT COMPLETED|Treatment Period 1||0
188715|NCT00519376|439329|P6|NOT COMPLETED|Treatment Period 1||0
188716|NCT00519376|439330|P5|NOT COMPLETED|Treatment Period 1||0
188717|NCT00519376|439331|P4|NOT COMPLETED|Treatment Period 1||0
188718|NCT00519376|439332|P3|NOT COMPLETED|Treatment Period 1||0
188719|NCT00519376|439333|P2|NOT COMPLETED|Treatment Period 1||0
188720|NCT00519376|439334|P1|NOT COMPLETED|Treatment Period 1||0
188721|NCT00519376|439319|P16|COMPLETED|Treatment Period 1||1
188722|NCT00519376|439320|P15|COMPLETED|Treatment Period 1||1
188723|NCT00519376|439321|P14|COMPLETED|Treatment Period 1||1
188724|NCT00519376|439322|P13|COMPLETED|Treatment Period 1||1
188725|NCT00519376|439323|P12|COMPLETED|Treatment Period 1||1
188726|NCT00519376|439324|P11|COMPLETED|Treatment Period 1||1
188727|NCT00519376|439325|P10|COMPLETED|Treatment Period 1||1
188728|NCT00519376|439326|P9|COMPLETED|Treatment Period 1||1
188729|NCT00519376|439327|P8|COMPLETED|Treatment Period 1||1
188730|NCT00519376|439328|P7|COMPLETED|Treatment Period 1||1
188731|NCT00519376|439329|P6|COMPLETED|Treatment Period 1||1
188732|NCT00519376|439330|P5|COMPLETED|Treatment Period 1||1
188733|NCT00519376|439331|P4|COMPLETED|Treatment Period 1||2
188734|NCT00519376|439332|P3|COMPLETED|Treatment Period 1||2
188735|NCT00519376|439333|P2|COMPLETED|Treatment Period 1||2
188736|NCT00519376|439334|P1|COMPLETED|Treatment Period 1||2
188737|NCT00519376|439319|P16|STARTED|Treatment Period 1||1
188738|NCT00519376|439320|P15|STARTED|Treatment Period 1||1
188739|NCT00519376|439321|P14|STARTED|Treatment Period 1||1
188740|NCT00519376|439322|P13|STARTED|Treatment Period 1||1
188741|NCT00519376|439323|P12|STARTED|Treatment Period 1||1
188742|NCT00519376|439324|P11|STARTED|Treatment Period 1||1
188743|NCT00519376|439325|P10|STARTED|Treatment Period 1||1
188744|NCT00519376|439326|P9|STARTED|Treatment Period 1||1
188745|NCT00519376|439327|P8|STARTED|Treatment Period 1||1
188746|NCT00519376|439328|P7|STARTED|Treatment Period 1||1
188747|NCT00519376|439329|P6|STARTED|Treatment Period 1||1
188748|NCT00519376|439330|P5|STARTED|Treatment Period 1||1
188749|NCT00519376|439331|P4|STARTED|Treatment Period 1||2
188750|NCT00519376|439332|P3|STARTED|Treatment Period 1||2
188751|NCT00519376|439333|P2|STARTED|Treatment Period 1||2
188752|NCT00519376|439334|P1|STARTED|Treatment Period 1||2
188753|NCT00519285|439458|P2|NOT COMPLETED|Overall Study||612
188754|NCT00519285|439459|P1|NOT COMPLETED|Overall Study||612
188755|NCT00519285|439458|P2|COMPLETED|Overall Study||0
188756|NCT00519285|439459|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
188757|NCT00519285|439458|P2|Still Treated at Cut-off Date|Overall Study||2
188758|NCT00519285|439459|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
188759|NCT00519285|439458|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
188760|NCT00519285|439459|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
188761|NCT00519285|439458|P2|STARTED|Overall Study|Randomized|612
188762|NCT00519285|439459|P1|STARTED|Overall Study|Randomized|612
188763|NCT00519194|439485|P1|NOT COMPLETED|Overall Study||21
188764|NCT00519194|439485|P1|COMPLETED|Overall Study||91
188765|NCT00519194|439485|P1|STARTED|Overall Study||112
188766|NCT00519090|439491|P2|NOT COMPLETED|Overall Study||0
188767|NCT00519090|439492|P1|NOT COMPLETED|Overall Study||0
188768|NCT00519090|439491|P2|COMPLETED|Overall Study||4
188769|NCT00519090|439492|P1|COMPLETED|Overall Study||2
188770|NCT00519090|439491|P2|STARTED|Overall Study||4
188771|NCT00519090|439492|P1|STARTED|Overall Study||2
188772|NCT00519077|439500|P1|NOT COMPLETED|Overall Study||8
188773|NCT00519077|439500|P1|COMPLETED|Overall Study||36
188774|NCT00519077|439500|P1|STARTED|Overall Study||44
188775|NCT00518986|439507|P2|NOT COMPLETED|Overall Study||26
188776|NCT00518986|439508|P1|NOT COMPLETED|Overall Study||26
188777|NCT00518986|439507|P2|COMPLETED|Overall Study||98
188778|NCT00518986|439508|P1|COMPLETED|Overall Study||99
188779|NCT00518986|439507|P2|STARTED|Overall Study||124
188780|NCT00518986|439508|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
188781|NCT00518882|439634|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
188782|NCT00518882|439635|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
188783|NCT00518882|439634|P2|COMPLETED|Open-Label Extension, Week 26-78||138
188784|NCT00518882|439635|P1|COMPLETED|Open-Label Extension, Week 26-78||161
188785|NCT00518882|439634|P2|STARTED|Open-Label Extension, Week 26-78||187
188786|NCT00518882|439635|P1|STARTED|Open-Label Extension, Week 26-78||202
188787|NCT00518882|439634|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
188788|NCT00518882|439635|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
188789|NCT00518882|439634|P2|COMPLETED|Double-Blind, Week 0-26||187
188790|NCT00518882|439635|P1|COMPLETED|Double-Blind, Week 0-26||202
188791|NCT00518882|439634|P2|Randomised|Double-Blind, Week 0-26||231
188792|NCT00518882|439635|P1|Randomised|Double-Blind, Week 0-26||233
188793|NCT00518882|439634|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
188794|NCT00518882|439635|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
188795|NCT00518713|439753|P4|NOT COMPLETED|Overall Study||18
188796|NCT00518713|439754|P3|NOT COMPLETED|Overall Study||18
188797|NCT00518713|439755|P2|NOT COMPLETED|Overall Study||17
188798|NCT00518713|439756|P1|NOT COMPLETED|Overall Study||8
188799|NCT00518713|439753|P4|COMPLETED|Overall Study||41
188800|NCT00518713|439754|P3|COMPLETED|Overall Study||41
188801|NCT00518713|439755|P2|COMPLETED|Overall Study||45
188802|NCT00518713|439756|P1|COMPLETED|Overall Study||50
188803|NCT00518713|439753|P4|Modified Intent-to-Treat Population|Overall Study||57
188804|NCT00518713|439754|P3|Modified Intent-to-Treat Population|Overall Study||49
188805|NCT00518713|439755|P2|Modified Intent-to-Treat Population|Overall Study||58
188806|NCT00518713|439756|P1|Modified Intent-to-Treat Population|Overall Study||53
188807|NCT00518713|439753|P4|STARTED|Overall Study||59
188808|NCT00518713|439754|P3|STARTED|Overall Study||59
188809|NCT00518713|439755|P2|STARTED|Overall Study||62
188810|NCT00518713|439756|P1|STARTED|Overall Study||58
188811|NCT00518687|439816|P2|NOT COMPLETED|Overall Study||1420
188812|NCT00518687|439817|P1|NOT COMPLETED|Overall Study||1437
188813|NCT00518687|439816|P2|COMPLETED|Overall Study||2585
188814|NCT00518687|439817|P1|COMPLETED|Overall Study||2568
188815|NCT00518687|439816|P2|Vaccinated|Overall Study||3982
188816|NCT00518687|439817|P1|Vaccinated|Overall Study||3981
188817|NCT00518687|439816|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
188818|NCT00518687|439817|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
188819|NCT00518622|439837|P8|NOT COMPLETED|Overall Study||0
188820|NCT00518622|439838|P7|NOT COMPLETED|Overall Study||0
188821|NCT00518622|439839|P6|NOT COMPLETED|Overall Study||0
188822|NCT00518622|439840|P5|NOT COMPLETED|Overall Study||0
188823|NCT00518622|439841|P4|NOT COMPLETED|Overall Study||0
188824|NCT00518622|439842|P3|NOT COMPLETED|Overall Study||1
188825|NCT00518622|439843|P2|NOT COMPLETED|Overall Study||1
188826|NCT00518622|439844|P1|NOT COMPLETED|Overall Study||0
188827|NCT00518622|439837|P8|COMPLETED|Overall Study||5
188828|NCT00518622|439838|P7|COMPLETED|Overall Study||4
188829|NCT00518622|439839|P6|COMPLETED|Overall Study||5
188830|NCT00518622|439840|P5|COMPLETED|Overall Study||6
188831|NCT00518622|439841|P4|COMPLETED|Overall Study||5
188832|NCT00518622|439842|P3|COMPLETED|Overall Study||5
188833|NCT00518622|439843|P2|COMPLETED|Overall Study||5
188834|NCT00518622|439844|P1|COMPLETED|Overall Study||3
188835|NCT00518622|439837|P8|Discontinued Therapy|Overall Study||0
188836|NCT00518622|439838|P7|Discontinued Therapy|Overall Study||0
188837|NCT00518622|439839|P6|Discontinued Therapy|Overall Study||0
188838|NCT00518622|439840|P5|Discontinued Therapy|Overall Study||0
188839|NCT00518622|439841|P4|Discontinued Therapy|Overall Study||0
188840|NCT00518622|439842|P3|Discontinued Therapy|Overall Study||0
188841|NCT00518622|439843|P2|Discontinued Therapy|Overall Study||1
188842|NCT00518622|439844|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
188843|NCT00518622|439837|P8|Completed Therapy|Overall Study||5
188844|NCT00518622|439838|P7|Completed Therapy|Overall Study||4
188845|NCT00518622|439839|P6|Completed Therapy|Overall Study||5
188846|NCT00518622|439840|P5|Completed Therapy|Overall Study||6
188847|NCT00518622|439841|P4|Completed Therapy|Overall Study||5
188848|NCT00518622|439842|P3|Completed Therapy|Overall Study||6
188849|NCT00518622|439843|P2|Completed Therapy|Overall Study||5
188850|NCT00518622|439844|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
188851|NCT00518622|439837|P8|STARTED|Overall Study||5
188852|NCT00518622|439838|P7|STARTED|Overall Study||4
188853|NCT00518622|439839|P6|STARTED|Overall Study||5
188854|NCT00518622|439840|P5|STARTED|Overall Study||6
188855|NCT00518622|439841|P4|STARTED|Overall Study||5
188856|NCT00518622|439842|P3|STARTED|Overall Study||6
188857|NCT00518622|439843|P2|STARTED|Overall Study||6
188858|NCT00518622|439844|P1|STARTED|Overall Study||3
188859|NCT00518531|439872|P2|NOT COMPLETED|Treatment Period 2||20
188860|NCT00518531|439873|P1|NOT COMPLETED|Treatment Period 2||3
188861|NCT00518531|439872|P2|COMPLETED|Treatment Period 2||95
188862|NCT00518531|439873|P1|COMPLETED|Treatment Period 2||103
188863|NCT00518531|439872|P2|Received Treatment|Treatment Period 2||110
188864|NCT00518531|439873|P1|Received Treatment|Treatment Period 2||106
188865|NCT00518531|439872|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
188866|NCT00518531|439873|P1|STARTED|Treatment Period 2||106
188867|NCT00518531|439872|P2|NOT COMPLETED|Treatment Period 1||12
188868|NCT00518531|439873|P1|NOT COMPLETED|Treatment Period 1||18
188869|NCT00518531|439872|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
188870|NCT00518531|439873|P1|COMPLETED|Treatment Period 1||106
188871|NCT00518531|439872|P2|Received Treatment|Treatment Period 1||124
188872|NCT00518531|439873|P1|Received Treatment|Treatment Period 1||119
188873|NCT00518531|439872|P2|STARTED|Treatment Period 1||126
188874|NCT00518531|439873|P1|STARTED|Treatment Period 1||124
188875|NCT00518336|439909|P2|NOT COMPLETED|Year 9||1
188876|NCT00518336|439910|P1|NOT COMPLETED|Year 9||5
188877|NCT00518336|439909|P2|COMPLETED|Year 9||212
188878|NCT00518336|439910|P1|COMPLETED|Year 9||219
188879|NCT00518336|439909|P2|STARTED|Year 9||213
188880|NCT00518336|439910|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
188881|NCT00518336|439909|P2|NOT COMPLETED|Year 8||2
188882|NCT00518336|439910|P1|NOT COMPLETED|Year 8||1
188883|NCT00518336|439909|P2|COMPLETED|Year 8||211
188884|NCT00518336|439910|P1|COMPLETED|Year 8||222
188885|NCT00518336|439909|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
188886|NCT00518336|439910|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
188887|NCT00518336|439909|P2|NOT COMPLETED|Year 7||3
188888|NCT00518336|439910|P1|NOT COMPLETED|Year 7||2
188889|NCT00518336|439909|P2|COMPLETED|Year 7||208
188890|NCT00518336|439910|P1|COMPLETED|Year 7||220
188891|NCT00518336|439909|P2|STARTED|Year 7||211
188892|NCT00518336|439910|P1|STARTED|Year 7||222
188893|NCT00518323|440076|P4|NOT COMPLETED|Overall Study||25
188894|NCT00518323|440077|P3|NOT COMPLETED|Overall Study||11
188895|NCT00518323|440078|P2|NOT COMPLETED|Overall Study||8
188896|NCT00518323|440079|P1|NOT COMPLETED|Overall Study||19
188897|NCT00518323|440076|P4|COMPLETED|Overall Study||26
188898|NCT00518323|440077|P3|COMPLETED|Overall Study||37
188899|NCT00518323|440078|P2|COMPLETED|Overall Study||40
188900|NCT00518323|440079|P1|COMPLETED|Overall Study||35
188901|NCT00518323|440076|P4|STARTED|Overall Study||51
188902|NCT00518323|440077|P3|STARTED|Overall Study||48
188903|NCT00518323|440078|P2|STARTED|Overall Study||48
188904|NCT00518323|440079|P1|STARTED|Overall Study||54
188905|NCT00518284|440109|P4|NOT COMPLETED|Overall Study||2
188906|NCT00518284|440110|P3|NOT COMPLETED|Overall Study||1
188907|NCT00518284|440111|P2|NOT COMPLETED|Overall Study||3
188908|NCT00518284|440112|P1|NOT COMPLETED|Overall Study||0
188909|NCT00518284|440109|P4|COMPLETED|Overall Study||0
188910|NCT00518284|440110|P3|COMPLETED|Overall Study||0
188911|NCT00518284|440111|P2|COMPLETED|Overall Study||0
188912|NCT00518284|440112|P1|COMPLETED|Overall Study||0
188913|NCT00518284|440109|P4|STARTED|Overall Study||2
188914|NCT00518284|440110|P3|STARTED|Overall Study||1
188915|NCT00518284|440111|P2|STARTED|Overall Study||3
188916|NCT00518284|440112|P1|STARTED|Overall Study||0
188917|NCT00518180|440169|P3|NOT COMPLETED|Overall Study||82
188918|NCT00518180|440170|P2|NOT COMPLETED|Overall Study||69
188919|NCT00518180|440171|P1|NOT COMPLETED|Overall Study||65
188920|NCT00518180|440169|P3|COMPLETED|Overall Study||457
188921|NCT00518180|440170|P2|COMPLETED|Overall Study||472
188922|NCT00518180|440171|P1|COMPLETED|Overall Study||475
188923|NCT00518180|440169|P3|STARTED|Overall Study||539
188924|NCT00518180|440170|P2|STARTED|Overall Study||541
188925|NCT00518180|440171|P1|STARTED|Overall Study||540
188926|NCT00518115|440223|P10|NOT COMPLETED|Overall Study||15
188927|NCT00518115|440224|P9|NOT COMPLETED|Overall Study||5
188928|NCT00518115|440225|P8|NOT COMPLETED|Overall Study||15
188929|NCT00518115|440226|P7|NOT COMPLETED|Overall Study||8
188930|NCT00518115|440227|P6|NOT COMPLETED|Overall Study||15
188931|NCT00518115|440228|P5|NOT COMPLETED|Overall Study||10
188932|NCT00518115|440229|P4|NOT COMPLETED|Overall Study||11
188933|NCT00518115|440230|P3|NOT COMPLETED|Overall Study||17
188934|NCT00518115|440231|P2|NOT COMPLETED|Overall Study||6
188935|NCT00518115|440232|P1|NOT COMPLETED|Overall Study||12
188936|NCT00518115|440223|P10|COMPLETED|Overall Study||20
188937|NCT00518115|440224|P9|COMPLETED|Overall Study||30
188938|NCT00518115|440225|P8|COMPLETED|Overall Study||20
188939|NCT00518115|440226|P7|COMPLETED|Overall Study||25
188940|NCT00518115|440227|P6|COMPLETED|Overall Study||19
188941|NCT00518115|440228|P5|COMPLETED|Overall Study||21
188942|NCT00518115|440229|P4|COMPLETED|Overall Study||24
188943|NCT00518115|440230|P3|COMPLETED|Overall Study||19
188944|NCT00518115|440231|P2|COMPLETED|Overall Study||29
188945|NCT00518115|440232|P1|COMPLETED|Overall Study||40
188946|NCT00518115|440223|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
188947|NCT00518115|440224|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
188948|NCT00518115|440225|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
188949|NCT00518115|440226|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
188950|NCT00518115|440227|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
188951|NCT00518115|440228|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
188952|NCT00518115|440229|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
188953|NCT00518115|440230|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
188954|NCT00518115|440231|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
188955|NCT00518115|440232|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
188956|NCT00518115|440223|P10|STARTED|Overall Study||35
188957|NCT00518115|440224|P9|STARTED|Overall Study||35
188958|NCT00518115|440225|P8|STARTED|Overall Study||35
188959|NCT00518115|440226|P7|STARTED|Overall Study||33
188960|NCT00518115|440227|P6|STARTED|Overall Study||34
188961|NCT00518115|440228|P5|STARTED|Overall Study||31
188962|NCT00518115|440229|P4|STARTED|Overall Study||35
188963|NCT00518115|440230|P3|STARTED|Overall Study||36
188964|NCT00518115|440231|P2|STARTED|Overall Study||35
188965|NCT00518115|440232|P1|STARTED|Overall Study||52
188966|NCT00518089|440390|P2|NOT COMPLETED|Overall Study||31
188967|NCT00518089|440391|P1|NOT COMPLETED|Overall Study||28
188968|NCT00518089|440390|P2|COMPLETED|Overall Study||398
188969|NCT00518089|440391|P1|COMPLETED|Overall Study||402
188970|NCT00518089|440390|P2|STARTED|Overall Study||429
188971|NCT00518089|440391|P1|STARTED|Overall Study||430
188972|NCT00518011|440407|P2|NOT COMPLETED|Overall Study||8
188973|NCT00518011|440408|P1|NOT COMPLETED|Overall Study||9
188974|NCT00518011|440407|P2|COMPLETED|Overall Study||0
188975|NCT00518011|440408|P1|COMPLETED|Overall Study||0
188976|NCT00518011|440407|P2|STARTED|Overall Study||8
188977|NCT00518011|440408|P1|STARTED|Overall Study||9
188978|NCT00517933|440430|P2|NOT COMPLETED|Period 2||13
188979|NCT00517933|440431|P1|NOT COMPLETED|Period 2||6
188980|NCT00517933|440430|P2|COMPLETED|Period 2||70
188981|NCT00517933|440431|P1|COMPLETED|Period 2||73
188982|NCT00517933|440430|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
188983|NCT00517933|440431|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
188984|NCT00517933|440430|P2|NOT COMPLETED|Period 1||6
188985|NCT00517933|440431|P1|NOT COMPLETED|Period 1||8
188986|NCT00517933|440430|P2|COMPLETED|Period 1||85
188987|NCT00517933|440431|P1|COMPLETED|Period 1||81
188988|NCT00517933|440430|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
188989|NCT00517933|440431|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
188990|NCT00517881|440495|P1|NOT COMPLETED|Overall Study||5
188991|NCT00517881|440495|P1|COMPLETED|Overall Study||24
188992|NCT00517881|440495|P1|STARTED|Overall Study||29
188993|NCT00517829|440507|P2|NOT COMPLETED|Overall Study||75
188994|NCT00517829|440508|P1|NOT COMPLETED|Overall Study||75
188995|NCT00517829|440507|P2|COMPLETED|Overall Study||0
188996|NCT00517829|440508|P1|COMPLETED|Overall Study||0
188997|NCT00517829|440507|P2|STARTED|Overall Study||75
188998|NCT00517829|440508|P1|STARTED|Overall Study||75
188999|NCT00517751|440522|P1|NOT COMPLETED|Overall Study||129
189000|NCT00517751|440522|P1|COMPLETED|Overall Study||33
189001|NCT00517751|440522|P1|STARTED|Overall Study||162
189002|NCT00517699|440545|P1|NOT COMPLETED|Overall Study||5
189003|NCT00517699|440545|P1|COMPLETED|Overall Study||0
189004|NCT00517699|440545|P1|STARTED|Overall Study||5
189005|NCT00517634|440553|P6|NOT COMPLETED|Third Treatment Period||0
189006|NCT00517634|440554|P5|NOT COMPLETED|Third Treatment Period||0
189007|NCT00517634|440555|P4|NOT COMPLETED|Third Treatment Period||0
189008|NCT00517634|440556|P3|NOT COMPLETED|Third Treatment Period||0
189009|NCT00517634|440557|P2|NOT COMPLETED|Third Treatment Period||0
189010|NCT00517634|440558|P1|NOT COMPLETED|Third Treatment Period||0
189011|NCT00517634|440553|P6|COMPLETED|Third Treatment Period||4
189012|NCT00517634|440554|P5|COMPLETED|Third Treatment Period||3
189013|NCT00517634|440555|P4|COMPLETED|Third Treatment Period||3
189014|NCT00517634|440556|P3|COMPLETED|Third Treatment Period||4
189015|NCT00517634|440557|P2|COMPLETED|Third Treatment Period||4
189016|NCT00517634|440558|P1|COMPLETED|Third Treatment Period||4
189017|NCT00517634|440553|P6|STARTED|Third Treatment Period||4
189018|NCT00517634|440554|P5|STARTED|Third Treatment Period||3
189019|NCT00517634|440555|P4|STARTED|Third Treatment Period||3
189020|NCT00517634|440556|P3|STARTED|Third Treatment Period||4
189021|NCT00517634|440557|P2|STARTED|Third Treatment Period||4
189022|NCT00517634|440558|P1|STARTED|Third Treatment Period||4
189023|NCT00517634|440553|P6|NOT COMPLETED|Second Treatment Period||0
189024|NCT00517634|440554|P5|NOT COMPLETED|Second Treatment Period||1
189025|NCT00517634|440555|P4|NOT COMPLETED|Second Treatment Period||0
189026|NCT00517634|440556|P3|NOT COMPLETED|Second Treatment Period||0
189027|NCT00517634|440557|P2|NOT COMPLETED|Second Treatment Period||0
189028|NCT00517634|440558|P1|NOT COMPLETED|Second Treatment Period||0
189029|NCT00517634|440553|P6|COMPLETED|Second Treatment Period||4
189030|NCT00517634|440554|P5|COMPLETED|Second Treatment Period||3
189031|NCT00517634|440555|P4|COMPLETED|Second Treatment Period||3
189032|NCT00517634|440556|P3|COMPLETED|Second Treatment Period||4
189033|NCT00517634|440557|P2|COMPLETED|Second Treatment Period||4
189034|NCT00517634|440558|P1|COMPLETED|Second Treatment Period||4
189035|NCT00517634|440553|P6|STARTED|Second Treatment Period||4
189036|NCT00517634|440554|P5|STARTED|Second Treatment Period||4
189037|NCT00517634|440555|P4|STARTED|Second Treatment Period||3
189038|NCT00517634|440556|P3|STARTED|Second Treatment Period||4
189039|NCT00517634|440557|P2|STARTED|Second Treatment Period||4
189040|NCT00517634|440558|P1|STARTED|Second Treatment Period||4
189041|NCT00517634|440553|P6|NOT COMPLETED|First Treatment Period||0
189042|NCT00517634|440554|P5|NOT COMPLETED|First Treatment Period||0
189043|NCT00517634|440555|P4|NOT COMPLETED|First Treatment Period||0
189044|NCT00517634|440556|P3|NOT COMPLETED|First Treatment Period||0
189045|NCT00517634|440557|P2|NOT COMPLETED|First Treatment Period||0
189046|NCT00517634|440558|P1|NOT COMPLETED|First Treatment Period||0
189047|NCT00517634|440553|P6|COMPLETED|First Treatment Period||4
189048|NCT00517634|440554|P5|COMPLETED|First Treatment Period||4
189049|NCT00517634|440555|P4|COMPLETED|First Treatment Period||3
189050|NCT00517634|440556|P3|COMPLETED|First Treatment Period||4
189051|NCT00517634|440557|P2|COMPLETED|First Treatment Period||4
189052|NCT00517634|440558|P1|COMPLETED|First Treatment Period||4
189053|NCT00517634|440553|P6|STARTED|First Treatment Period||4
189054|NCT00517634|440554|P5|STARTED|First Treatment Period||4
189055|NCT00517634|440555|P4|STARTED|First Treatment Period||3
189056|NCT00517634|440556|P3|STARTED|First Treatment Period||4
189057|NCT00517634|440557|P2|STARTED|First Treatment Period||4
189058|NCT00517634|440558|P1|STARTED|First Treatment Period||4
189059|NCT00516386|440569|P1|NOT COMPLETED|Overall Study||6
189060|NCT00516386|440569|P1|COMPLETED|Overall Study||10
189061|NCT00516386|440569|P1|STARTED|Overall Study||16
189062|NCT00517595|440574|P1|NOT COMPLETED|Overall Study||0
189063|NCT00517595|440574|P1|COMPLETED|Overall Study||48
189064|NCT00517595|440574|P1|STARTED|Overall Study||48
189065|NCT00517530|440590|P7|NOT COMPLETED|Overall Study||19
189066|NCT00517530|440591|P6|NOT COMPLETED|Overall Study||19
189067|NCT00517530|440592|P5|NOT COMPLETED|Overall Study||20
189068|NCT00517530|440593|P4|NOT COMPLETED|Overall Study||21
189069|NCT00517530|440594|P3|NOT COMPLETED|Overall Study||18
189070|NCT00517530|440595|P2|NOT COMPLETED|Overall Study||13
189071|NCT00517530|440596|P1|NOT COMPLETED|Overall Study||19
189072|NCT00517530|440590|P7|COMPLETED|Overall Study||1
189073|NCT00517530|440591|P6|COMPLETED|Overall Study||0
189074|NCT00517530|440592|P5|COMPLETED|Overall Study||1
189075|NCT00517530|440593|P4|COMPLETED|Overall Study||1
189076|NCT00517530|440594|P3|COMPLETED|Overall Study||0
189077|NCT00517530|440595|P2|COMPLETED|Overall Study||0
189078|NCT00517530|440596|P1|COMPLETED|Overall Study||2
189079|NCT00517530|440590|P7|Retreated Population|Overall Study||0
189080|NCT00517530|440591|P6|Retreated Population|Overall Study||2
189081|NCT00517530|440592|P5|Retreated Population|Overall Study||2
189082|NCT00517530|440593|P4|Retreated Population|Overall Study||4
189083|NCT00517530|440594|P3|Retreated Population|Overall Study||1
189084|NCT00517530|440595|P2|Retreated Population|Overall Study||2
189085|NCT00517530|440596|P1|Retreated Population|Overall Study||2
189086|NCT00517530|440590|P7|Completed Follow-up|Overall Study||1
189087|NCT00517530|440591|P6|Completed Follow-up|Overall Study||0
189088|NCT00517530|440592|P5|Completed Follow-up|Overall Study||0
189089|NCT00517530|440593|P4|Completed Follow-up|Overall Study||1
189090|NCT00517530|440594|P3|Completed Follow-up|Overall Study||0
189091|NCT00517530|440595|P2|Completed Follow-up|Overall Study||0
189092|NCT00517530|440596|P1|Completed Follow-up|Overall Study||2
189093|NCT00517530|440590|P7|Started Follow-up|Overall Study||19
189094|NCT00517530|440591|P6|Started Follow-up|Overall Study||16
189095|NCT00517530|440592|P5|Started Follow-up|Overall Study||17
189096|NCT00517530|440593|P4|Started Follow-up|Overall Study||21
189097|NCT00517530|440594|P3|Started Follow-up|Overall Study||17
189098|NCT00517530|440595|P2|Started Follow-up|Overall Study||13
189099|NCT00517530|440596|P1|Started Follow-up|Overall Study||20
189100|NCT00517530|440590|P7|Completed Treatment|Overall Study||13
189101|NCT00517530|440591|P6|Completed Treatment|Overall Study||9
189102|NCT00517530|440592|P5|Completed Treatment|Overall Study||9
189103|NCT00517530|440593|P4|Completed Treatment|Overall Study||18
189104|NCT00517530|440594|P3|Completed Treatment|Overall Study||13
189105|NCT00517530|440595|P2|Completed Treatment|Overall Study||13
189106|NCT00517530|440596|P1|Completed Treatment|Overall Study||11
189107|NCT00517530|440590|P7|STARTED|Overall Study||20
189108|NCT00517530|440591|P6|STARTED|Overall Study||19
189109|NCT00517530|440592|P5|STARTED|Overall Study||21
189110|NCT00517530|440593|P4|STARTED|Overall Study||22
189111|NCT00517530|440594|P3|STARTED|Overall Study||18
189112|NCT00517530|440595|P2|STARTED|Overall Study||13
189113|NCT00517530|440596|P1|STARTED|Overall Study||21
189114|NCT00517413|440656|P1|NOT COMPLETED|Overall Study||61
189115|NCT00517413|440656|P1|COMPLETED|Overall Study||102
189116|NCT00517413|440656|P1|STARTED|Overall Study||163
189117|NCT00517361|440677|P1|NOT COMPLETED|Overall Study||11
189118|NCT00517361|440677|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
189119|NCT00517361|440677|P1|STARTED|Overall Study||11
189120|NCT00517192|440686|P2|NOT COMPLETED|Overall Study||20
189121|NCT00517192|440687|P1|NOT COMPLETED|Overall Study||19
189122|NCT00517192|440686|P2|COMPLETED|Overall Study||0
189123|NCT00517192|440687|P1|COMPLETED|Overall Study||0
189124|NCT00517192|440686|P2|STARTED|Overall Study||20
189125|NCT00517192|440687|P1|STARTED|Overall Study||19
189126|NCT00517075|440739|P4|NOT COMPLETED|Overall Study||0
189127|NCT00517075|440740|P3|NOT COMPLETED|Overall Study||0
189128|NCT00517075|440741|P2|NOT COMPLETED|Overall Study||0
189129|NCT00517075|440742|P1|NOT COMPLETED|Overall Study||0
189130|NCT00517075|440739|P4|COMPLETED|Overall Study||0
189131|NCT00517075|440740|P3|COMPLETED|Overall Study||0
189132|NCT00517075|440741|P2|COMPLETED|Overall Study||0
189133|NCT00517075|440742|P1|COMPLETED|Overall Study||0
189134|NCT00517075|440739|P4|STARTED|Overall Study||0
189135|NCT00517075|440740|P3|STARTED|Overall Study||0
189136|NCT00517075|440741|P2|STARTED|Overall Study||0
189137|NCT00517075|440742|P1|STARTED|Overall Study||0
189138|NCT00517010|440780|P1|NOT COMPLETED|Overall Study||1
189139|NCT00517010|440780|P1|COMPLETED|Overall Study||5
189140|NCT00517010|440780|P1|STARTED|Overall Study||6
189141|NCT00516919|440785|P2|NOT COMPLETED|Overall Study||7
189142|NCT00516919|440786|P1|NOT COMPLETED|Overall Study||10
189143|NCT00516919|440785|P2|COMPLETED|Overall Study||32
189144|NCT00516919|440786|P1|COMPLETED|Overall Study||30
189145|NCT00516919|440785|P2|STARTED|Overall Study||39
189146|NCT00516919|440786|P1|STARTED|Overall Study||40
189147|NCT00516906|440794|P2|NOT COMPLETED|Overall Study||2
189148|NCT00516906|440795|P1|NOT COMPLETED|Overall Study||6
189149|NCT00516906|440794|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
189150|NCT00516906|440795|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
189151|NCT00516906|440794|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
189152|NCT00516906|440795|P1|STARTED|Overall Study||36
189153|NCT00516893|440805|P1|NOT COMPLETED|Overall Study||21
189154|NCT00516893|440805|P1|COMPLETED|Overall Study||92
189155|NCT00516893|440805|P1|Received Study Treatment|Overall Study||112
189156|NCT00516893|440805|P1|STARTED|Overall Study||113
189157|NCT00516737|440814|P2|NOT COMPLETED|Overall Study||8
189158|NCT00516737|440815|P1|NOT COMPLETED|Overall Study||11
189159|NCT00516737|440814|P2|COMPLETED|Overall Study||96
189160|NCT00516737|440815|P1|COMPLETED|Overall Study||92
189161|NCT00516737|440814|P2|STARTED|Overall Study||104
189162|NCT00516737|440815|P1|STARTED|Overall Study||103
189163|NCT00516321|440835|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
189164|NCT00516321|440836|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
189165|NCT00516321|440837|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
189166|NCT00516321|440835|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
189167|NCT00516321|440836|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
189168|NCT00516321|440837|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
189169|NCT00516321|440835|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
189170|NCT00516321|440836|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
189171|NCT00516321|440837|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
189172|NCT00516321|440835|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
189173|NCT00516321|440836|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
189174|NCT00516321|440837|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
189175|NCT00516321|440835|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
189176|NCT00516321|440836|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
189177|NCT00516321|440837|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
189178|NCT00516321|440835|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
189179|NCT00516321|440836|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
189180|NCT00516321|440837|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
189181|NCT00516295|440888|P3|NOT COMPLETED|Overall Study||0
189182|NCT00516295|440889|P2|NOT COMPLETED|Overall Study||0
189183|NCT00516295|440890|P1|NOT COMPLETED|Overall Study||3
189184|NCT00516295|440888|P3|COMPLETED|Overall Study||0
189185|NCT00516295|440889|P2|COMPLETED|Overall Study||0
189186|NCT00516295|440890|P1|COMPLETED|Overall Study||4
189187|NCT00516295|440888|P3|STARTED|Overall Study||0
189188|NCT00516295|440889|P2|STARTED|Overall Study||0
189189|NCT00516295|440890|P1|STARTED|Overall Study||7
189190|NCT00516269|440903|P2|NOT COMPLETED|Overall Study||3
189191|NCT00516269|440904|P1|NOT COMPLETED|Overall Study||2
189192|NCT00516269|440903|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
189193|NCT00516269|440904|P1|COMPLETED|Overall Study|2 patients had an early termination|17
189194|NCT00516269|440903|P2|STARTED|Overall Study||19
189195|NCT00516269|440904|P1|STARTED|Overall Study||19
189196|NCT00516217|440910|P1|NOT COMPLETED|Overall Study||0
189197|NCT00516217|440910|P1|COMPLETED|Overall Study||29
189198|NCT00516217|440910|P1|STARTED|Overall Study||29
189199|NCT00516165|440916|P1|NOT COMPLETED|Overall Study||0
189200|NCT00516165|440916|P1|COMPLETED|Overall Study||28
189201|NCT00516165|440916|P1|STARTED|Overall Study||28
189202|NCT00516139|440925|P1|NOT COMPLETED|Overall Study||38
189203|NCT00516139|440925|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
189204|NCT00516139|440925|P1|STARTED|Overall Study||122
189205|NCT00516074|440956|P2|NOT COMPLETED|Overall Study||3
189206|NCT00516074|440957|P1|NOT COMPLETED|Overall Study||6
189207|NCT00516074|440956|P2|COMPLETED|Overall Study||23
189208|NCT00516074|440957|P1|COMPLETED|Overall Study||22
189209|NCT00516074|440956|P2|STARTED|Overall Study||26
189210|NCT00516074|440957|P1|STARTED|Overall Study||28
189211|NCT00516048|440975|P3|NOT COMPLETED|Overall Study||1
189212|NCT00516048|440976|P2|NOT COMPLETED|Overall Study||2
189213|NCT00516048|440977|P1|NOT COMPLETED|Overall Study||0
189214|NCT00516048|440975|P3|COMPLETED|Overall Study||0
189215|NCT00516048|440976|P2|COMPLETED|Overall Study||40
189216|NCT00516048|440977|P1|COMPLETED|Overall Study||15
189217|NCT00516048|440975|P3|STARTED|Overall Study||1
189218|NCT00516048|440976|P2|STARTED|Overall Study||42
189219|NCT00516048|440977|P1|STARTED|Overall Study||15
189220|NCT00515879|440993|P2|NOT COMPLETED|Overall Study||20
189221|NCT00515879|440994|P1|NOT COMPLETED|Overall Study||25
189222|NCT00515879|440993|P2|COMPLETED|Overall Study||62
189223|NCT00515879|440994|P1|COMPLETED|Overall Study||62
189224|NCT00515879|440993|P2|STARTED|Overall Study||82
189225|NCT00515879|440994|P1|STARTED|Overall Study||87
189226|NCT00515827|441004|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
189227|NCT00515827|441005|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
189228|NCT00515827|441004|P2|COMPLETED|Second Intervention (12 Weeks)||25
189229|NCT00515827|441005|P1|COMPLETED|Second Intervention (12 Weeks)||25
189230|NCT00515827|441004|P2|STARTED|Second Intervention (12 Weeks)||25
189231|NCT00515827|441005|P1|STARTED|Second Intervention (12 Weeks)||26
189232|NCT00515827|441004|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
189233|NCT00515827|441005|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
189234|NCT00515827|441004|P2|COMPLETED|First Intervention (12 Weeks)||25
189235|NCT00515827|441005|P1|COMPLETED|First Intervention (12 Weeks)||26
189236|NCT00515827|441004|P2|STARTED|First Intervention (12 Weeks)||26
189237|NCT00515827|441005|P1|STARTED|First Intervention (12 Weeks)||27
189238|NCT00515697|441027|P1|NOT COMPLETED|Overall Study||0
189239|NCT00515697|441027|P1|COMPLETED|Overall Study||39
189240|NCT00515697|441027|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
189241|NCT00515697|441027|P1|STARTED|Overall Study||39
189242|NCT00515671|441040|P2|NOT COMPLETED|Overall Study||17
189243|NCT00515671|441041|P1|NOT COMPLETED|Overall Study||17
189244|NCT00515671|441040|P2|COMPLETED|Overall Study||41
189245|NCT00515671|441041|P1|COMPLETED|Overall Study||43
189246|NCT00515671|441040|P2|STARTED|Overall Study||58
189247|NCT00515671|441041|P1|STARTED|Overall Study||60
189248|NCT00515619|441049|P1|NOT COMPLETED|Overall Study||216
189249|NCT00515619|441049|P1|COMPLETED|Overall Study||160
189250|NCT00515619|441049|P1|Safety Set|Overall Study||376
189251|NCT00515619|441049|P1|STARTED|Overall Study||376
189252|NCT00515541|441061|P4|NOT COMPLETED|Overall Study||5
189253|NCT00515541|441062|P3|NOT COMPLETED|Overall Study||0
189254|NCT00515541|441063|P2|NOT COMPLETED|Overall Study||5
189255|NCT00515541|441064|P1|NOT COMPLETED|Overall Study||0
189256|NCT00515541|441061|P4|COMPLETED|Overall Study||6
189257|NCT00515541|441062|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
189258|NCT00515541|441063|P2|COMPLETED|Overall Study||7
189259|NCT00515541|441064|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
189260|NCT00515541|441061|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
189261|NCT00515541|441062|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
189262|NCT00515541|441063|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
189263|NCT00515541|441064|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
189264|NCT00515541|441061|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
189265|NCT00515541|441062|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
189266|NCT00515541|441063|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
189267|NCT00515541|441064|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
189268|NCT00515541|441061|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
189269|NCT00515541|441062|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
189270|NCT00515541|441063|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
189271|NCT00515541|441064|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
189272|NCT00515541|441061|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
189273|NCT00515541|441062|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
189274|NCT00515541|441063|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
189275|NCT00515541|441064|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
189276|NCT00515541|441061|P4|STARTED|Overall Study||11
189277|NCT00515541|441062|P3|STARTED|Overall Study||10
189278|NCT00515541|441063|P2|STARTED|Overall Study||12
189279|NCT00515541|441064|P1|STARTED|Overall Study||10
189280|NCT00515502|441086|P12|NOT COMPLETED|Treatment Period 4||0
189281|NCT00515502|441087|P11|NOT COMPLETED|Treatment Period 4||0
189282|NCT00515502|441088|P10|NOT COMPLETED|Treatment Period 4||0
189283|NCT00515502|441089|P9|NOT COMPLETED|Treatment Period 4||0
189284|NCT00515502|441090|P8|NOT COMPLETED|Treatment Period 4||0
189285|NCT00515502|441091|P7|NOT COMPLETED|Treatment Period 4||0
189286|NCT00515502|441092|P6|NOT COMPLETED|Treatment Period 4||0
189287|NCT00515502|441093|P5|NOT COMPLETED|Treatment Period 4||0
189288|NCT00515502|441094|P4|NOT COMPLETED|Treatment Period 4||0
189289|NCT00515502|441095|P3|NOT COMPLETED|Treatment Period 4||0
189290|NCT00515502|441096|P2|NOT COMPLETED|Treatment Period 4||0
189291|NCT00515502|441097|P1|NOT COMPLETED|Treatment Period 4||0
189292|NCT00515502|441086|P12|COMPLETED|Treatment Period 4||0
189293|NCT00515502|441087|P11|COMPLETED|Treatment Period 4||1
189294|NCT00515502|441088|P10|COMPLETED|Treatment Period 4||2
189295|NCT00515502|441089|P9|COMPLETED|Treatment Period 4||0
189296|NCT00515502|441090|P8|COMPLETED|Treatment Period 4||1
189297|NCT00515502|441091|P7|COMPLETED|Treatment Period 4||1
189298|NCT00515502|441092|P6|COMPLETED|Treatment Period 4||1
189299|NCT00515502|441093|P5|COMPLETED|Treatment Period 4||3
189300|NCT00515502|441094|P4|COMPLETED|Treatment Period 4||3
189301|NCT00515502|441095|P3|COMPLETED|Treatment Period 4||4
189302|NCT00515502|441096|P2|COMPLETED|Treatment Period 4||3
189303|NCT00515502|441097|P1|COMPLETED|Treatment Period 4||1
189304|NCT00515502|441086|P12|STARTED|Treatment Period 4||0
189305|NCT00515502|441087|P11|STARTED|Treatment Period 4||1
189306|NCT00515502|441088|P10|STARTED|Treatment Period 4||2
189307|NCT00515502|441089|P9|STARTED|Treatment Period 4||0
189308|NCT00515502|441090|P8|STARTED|Treatment Period 4||1
189309|NCT00515502|441091|P7|STARTED|Treatment Period 4||1
189310|NCT00515502|441092|P6|STARTED|Treatment Period 4||1
189311|NCT00515502|441093|P5|STARTED|Treatment Period 4||3
189312|NCT00515502|441094|P4|STARTED|Treatment Period 4||3
189313|NCT00515502|441095|P3|STARTED|Treatment Period 4||4
189314|NCT00515502|441096|P2|STARTED|Treatment Period 4||3
189315|NCT00515502|441097|P1|STARTED|Treatment Period 4||1
189316|NCT00515502|441086|P12|NOT COMPLETED|Washout Period 3||0
189317|NCT00515502|441087|P11|NOT COMPLETED|Washout Period 3||0
189318|NCT00515502|441088|P10|NOT COMPLETED|Washout Period 3||0
189319|NCT00515502|441089|P9|NOT COMPLETED|Washout Period 3||0
189320|NCT00515502|441090|P8|NOT COMPLETED|Washout Period 3||0
189321|NCT00515502|441091|P7|NOT COMPLETED|Washout Period 3||0
189322|NCT00515502|441092|P6|NOT COMPLETED|Washout Period 3||0
189323|NCT00515502|441093|P5|NOT COMPLETED|Washout Period 3||0
189324|NCT00515502|441094|P4|NOT COMPLETED|Washout Period 3||0
189325|NCT00515502|441095|P3|NOT COMPLETED|Washout Period 3||0
189326|NCT00515502|441096|P2|NOT COMPLETED|Washout Period 3||0
189327|NCT00515502|441097|P1|NOT COMPLETED|Washout Period 3||0
189328|NCT00515502|441086|P12|COMPLETED|Washout Period 3||0
189329|NCT00515502|441087|P11|COMPLETED|Washout Period 3||1
189330|NCT00515502|441088|P10|COMPLETED|Washout Period 3||2
189331|NCT00515502|441089|P9|COMPLETED|Washout Period 3||0
189332|NCT00515502|441090|P8|COMPLETED|Washout Period 3||1
189333|NCT00515502|441091|P7|COMPLETED|Washout Period 3||1
189334|NCT00515502|441092|P6|COMPLETED|Washout Period 3||1
189335|NCT00515502|441093|P5|COMPLETED|Washout Period 3||3
189336|NCT00515502|441094|P4|COMPLETED|Washout Period 3||3
189337|NCT00515502|441095|P3|COMPLETED|Washout Period 3||4
189338|NCT00515502|441096|P2|COMPLETED|Washout Period 3||3
189339|NCT00515502|441097|P1|COMPLETED|Washout Period 3||1
189340|NCT00515502|441086|P12|STARTED|Washout Period 3||0
189341|NCT00515502|441087|P11|STARTED|Washout Period 3||1
189342|NCT00515502|441088|P10|STARTED|Washout Period 3||2
189343|NCT00515502|441089|P9|STARTED|Washout Period 3||0
189344|NCT00515502|441090|P8|STARTED|Washout Period 3||1
189345|NCT00515502|441091|P7|STARTED|Washout Period 3||1
189346|NCT00515502|441092|P6|STARTED|Washout Period 3||1
189347|NCT00515502|441093|P5|STARTED|Washout Period 3||3
189348|NCT00515502|441094|P4|STARTED|Washout Period 3||3
189349|NCT00515502|441095|P3|STARTED|Washout Period 3||4
189350|NCT00515502|441096|P2|STARTED|Washout Period 3||3
189351|NCT00515502|441097|P1|STARTED|Washout Period 3||1
189352|NCT00515502|441086|P12|NOT COMPLETED|Treatment Period 3||0
189353|NCT00515502|441087|P11|NOT COMPLETED|Treatment Period 3||0
189354|NCT00515502|441088|P10|NOT COMPLETED|Treatment Period 3||0
189355|NCT00515502|441089|P9|NOT COMPLETED|Treatment Period 3||0
189356|NCT00515502|441090|P8|NOT COMPLETED|Treatment Period 3||0
189357|NCT00515502|441091|P7|NOT COMPLETED|Treatment Period 3||0
189358|NCT00515502|441092|P6|NOT COMPLETED|Treatment Period 3||0
189359|NCT00515502|441093|P5|NOT COMPLETED|Treatment Period 3||0
189360|NCT00515502|441094|P4|NOT COMPLETED|Treatment Period 3||0
189361|NCT00515502|441095|P3|NOT COMPLETED|Treatment Period 3||0
189362|NCT00515502|441096|P2|NOT COMPLETED|Treatment Period 3||0
189363|NCT00515502|441097|P1|NOT COMPLETED|Treatment Period 3||0
189364|NCT00515502|441086|P12|COMPLETED|Treatment Period 3||0
189365|NCT00515502|441087|P11|COMPLETED|Treatment Period 3||1
189366|NCT00515502|441088|P10|COMPLETED|Treatment Period 3||2
189367|NCT00515502|441089|P9|COMPLETED|Treatment Period 3||0
189368|NCT00515502|441090|P8|COMPLETED|Treatment Period 3||1
189369|NCT00515502|441091|P7|COMPLETED|Treatment Period 3||1
189370|NCT00515502|441092|P6|COMPLETED|Treatment Period 3||1
189371|NCT00515502|441093|P5|COMPLETED|Treatment Period 3||3
189372|NCT00515502|441094|P4|COMPLETED|Treatment Period 3||3
189373|NCT00515502|441095|P3|COMPLETED|Treatment Period 3||4
189374|NCT00515502|441096|P2|COMPLETED|Treatment Period 3||3
189375|NCT00515502|441097|P1|COMPLETED|Treatment Period 3||1
189376|NCT00515502|441086|P12|STARTED|Treatment Period 3||0
189377|NCT00515502|441087|P11|STARTED|Treatment Period 3||1
189378|NCT00515502|441088|P10|STARTED|Treatment Period 3||2
189379|NCT00515502|441089|P9|STARTED|Treatment Period 3||0
189380|NCT00515502|441090|P8|STARTED|Treatment Period 3||1
189381|NCT00515502|441091|P7|STARTED|Treatment Period 3||1
189382|NCT00515502|441092|P6|STARTED|Treatment Period 3||1
189383|NCT00515502|441093|P5|STARTED|Treatment Period 3||3
189384|NCT00515502|441094|P4|STARTED|Treatment Period 3||3
189385|NCT00515502|441095|P3|STARTED|Treatment Period 3||4
189386|NCT00515502|441096|P2|STARTED|Treatment Period 3||3
189387|NCT00515502|441097|P1|STARTED|Treatment Period 3||1
189388|NCT00515502|441086|P12|NOT COMPLETED|Washout Period 2||0
189389|NCT00515502|441087|P11|NOT COMPLETED|Washout Period 2||0
189390|NCT00515502|441088|P10|NOT COMPLETED|Washout Period 2||0
189391|NCT00515502|441089|P9|NOT COMPLETED|Washout Period 2||0
189392|NCT00515502|441090|P8|NOT COMPLETED|Washout Period 2||0
189393|NCT00515502|441091|P7|NOT COMPLETED|Washout Period 2||0
189394|NCT00515502|441092|P6|NOT COMPLETED|Washout Period 2||0
189395|NCT00515502|441093|P5|NOT COMPLETED|Washout Period 2||0
189396|NCT00515502|441094|P4|NOT COMPLETED|Washout Period 2||0
189397|NCT00515502|441095|P3|NOT COMPLETED|Washout Period 2||0
189398|NCT00515502|441096|P2|NOT COMPLETED|Washout Period 2||0
189399|NCT00515502|441097|P1|NOT COMPLETED|Washout Period 2||0
189400|NCT00515502|441086|P12|COMPLETED|Washout Period 2||0
189401|NCT00515502|441087|P11|COMPLETED|Washout Period 2||1
189402|NCT00515502|441088|P10|COMPLETED|Washout Period 2||2
189403|NCT00515502|441089|P9|COMPLETED|Washout Period 2||0
189404|NCT00515502|441090|P8|COMPLETED|Washout Period 2||1
189405|NCT00515502|441091|P7|COMPLETED|Washout Period 2||1
189406|NCT00515502|441092|P6|COMPLETED|Washout Period 2||1
189407|NCT00515502|441093|P5|COMPLETED|Washout Period 2||3
189408|NCT00515502|441094|P4|COMPLETED|Washout Period 2||3
189409|NCT00515502|441095|P3|COMPLETED|Washout Period 2||4
189410|NCT00515502|441096|P2|COMPLETED|Washout Period 2||3
189411|NCT00515502|441097|P1|COMPLETED|Washout Period 2||1
189412|NCT00515502|441086|P12|STARTED|Washout Period 2||0
189413|NCT00515502|441087|P11|STARTED|Washout Period 2||1
189414|NCT00515502|441088|P10|STARTED|Washout Period 2||2
189415|NCT00515502|441089|P9|STARTED|Washout Period 2||0
189416|NCT00515502|441090|P8|STARTED|Washout Period 2||1
189417|NCT00515502|441091|P7|STARTED|Washout Period 2||1
189418|NCT00515502|441092|P6|STARTED|Washout Period 2||1
189419|NCT00515502|441093|P5|STARTED|Washout Period 2||3
189420|NCT00515502|441094|P4|STARTED|Washout Period 2||3
189421|NCT00515502|441095|P3|STARTED|Washout Period 2||4
189422|NCT00515502|441096|P2|STARTED|Washout Period 2||3
189423|NCT00515502|441097|P1|STARTED|Washout Period 2||1
189424|NCT00515502|441086|P12|NOT COMPLETED|Treatment Period 2||0
189425|NCT00515502|441087|P11|NOT COMPLETED|Treatment Period 2||0
189426|NCT00515502|441088|P10|NOT COMPLETED|Treatment Period 2||0
189427|NCT00515502|441089|P9|NOT COMPLETED|Treatment Period 2||0
189428|NCT00515502|441090|P8|NOT COMPLETED|Treatment Period 2||0
189429|NCT00515502|441091|P7|NOT COMPLETED|Treatment Period 2||0
189430|NCT00515502|441092|P6|NOT COMPLETED|Treatment Period 2||0
189431|NCT00515502|441093|P5|NOT COMPLETED|Treatment Period 2||0
189432|NCT00515502|441094|P4|NOT COMPLETED|Treatment Period 2||0
189433|NCT00515502|441095|P3|NOT COMPLETED|Treatment Period 2||0
189434|NCT00515502|441096|P2|NOT COMPLETED|Treatment Period 2||1
189435|NCT00515502|441097|P1|NOT COMPLETED|Treatment Period 2||0
189436|NCT00515502|441086|P12|COMPLETED|Treatment Period 2||0
189437|NCT00515502|441087|P11|COMPLETED|Treatment Period 2||1
189438|NCT00515502|441088|P10|COMPLETED|Treatment Period 2||2
189439|NCT00515502|441089|P9|COMPLETED|Treatment Period 2||0
189440|NCT00515502|441090|P8|COMPLETED|Treatment Period 2||1
189441|NCT00515502|441091|P7|COMPLETED|Treatment Period 2||1
189442|NCT00515502|441092|P6|COMPLETED|Treatment Period 2||1
189443|NCT00515502|441093|P5|COMPLETED|Treatment Period 2||3
189444|NCT00515502|441094|P4|COMPLETED|Treatment Period 2||3
189445|NCT00515502|441095|P3|COMPLETED|Treatment Period 2||4
189446|NCT00515502|441096|P2|COMPLETED|Treatment Period 2||3
189447|NCT00515502|441097|P1|COMPLETED|Treatment Period 2||1
189448|NCT00515502|441086|P12|STARTED|Treatment Period 2||0
189449|NCT00515502|441087|P11|STARTED|Treatment Period 2||1
189450|NCT00515502|441088|P10|STARTED|Treatment Period 2||2
189451|NCT00515502|441089|P9|STARTED|Treatment Period 2||0
189452|NCT00515502|441090|P8|STARTED|Treatment Period 2||1
189453|NCT00515502|441091|P7|STARTED|Treatment Period 2||1
189454|NCT00515502|441092|P6|STARTED|Treatment Period 2||1
189455|NCT00515502|441093|P5|STARTED|Treatment Period 2||3
189456|NCT00515502|441094|P4|STARTED|Treatment Period 2||3
189457|NCT00515502|441095|P3|STARTED|Treatment Period 2||4
189458|NCT00515502|441096|P2|STARTED|Treatment Period 2||4
189459|NCT00515502|441097|P1|STARTED|Treatment Period 2||1
189460|NCT00515502|441086|P12|NOT COMPLETED|Washout Period 1||0
189461|NCT00515502|441087|P11|NOT COMPLETED|Washout Period 1||0
189462|NCT00515502|441088|P10|NOT COMPLETED|Washout Period 1||0
189463|NCT00515502|441089|P9|NOT COMPLETED|Washout Period 1||0
189464|NCT00515502|441090|P8|NOT COMPLETED|Washout Period 1||0
189465|NCT00515502|441091|P7|NOT COMPLETED|Washout Period 1||0
189466|NCT00515502|441092|P6|NOT COMPLETED|Washout Period 1||0
189467|NCT00515502|441093|P5|NOT COMPLETED|Washout Period 1||0
189468|NCT00515502|441094|P4|NOT COMPLETED|Washout Period 1||0
189469|NCT00515502|441095|P3|NOT COMPLETED|Washout Period 1||0
189470|NCT00515502|441096|P2|NOT COMPLETED|Washout Period 1||0
189471|NCT00515502|441097|P1|NOT COMPLETED|Washout Period 1||0
189472|NCT00515502|441086|P12|COMPLETED|Washout Period 1||0
189473|NCT00515502|441087|P11|COMPLETED|Washout Period 1||1
189474|NCT00515502|441088|P10|COMPLETED|Washout Period 1||2
189475|NCT00515502|441089|P9|COMPLETED|Washout Period 1||0
189476|NCT00515502|441090|P8|COMPLETED|Washout Period 1||1
189477|NCT00515502|441091|P7|COMPLETED|Washout Period 1||1
189478|NCT00515502|441092|P6|COMPLETED|Washout Period 1||1
189479|NCT00515502|441093|P5|COMPLETED|Washout Period 1||3
189480|NCT00515502|441094|P4|COMPLETED|Washout Period 1||3
189481|NCT00515502|441095|P3|COMPLETED|Washout Period 1||4
189482|NCT00515502|441096|P2|COMPLETED|Washout Period 1||4
189483|NCT00515502|441097|P1|COMPLETED|Washout Period 1||1
189484|NCT00515502|441086|P12|STARTED|Washout Period 1||0
189485|NCT00515502|441087|P11|STARTED|Washout Period 1||1
189486|NCT00515502|441088|P10|STARTED|Washout Period 1||2
189487|NCT00515502|441089|P9|STARTED|Washout Period 1||0
189488|NCT00515502|441090|P8|STARTED|Washout Period 1||1
189489|NCT00515502|441091|P7|STARTED|Washout Period 1||1
189490|NCT00515502|441092|P6|STARTED|Washout Period 1||1
189491|NCT00515502|441093|P5|STARTED|Washout Period 1||3
189492|NCT00515502|441094|P4|STARTED|Washout Period 1||3
189493|NCT00515502|441095|P3|STARTED|Washout Period 1||4
189494|NCT00515502|441096|P2|STARTED|Washout Period 1||4
189495|NCT00515502|441097|P1|STARTED|Washout Period 1||1
189496|NCT00515502|441086|P12|NOT COMPLETED|Treatment Period 1||1
189497|NCT00515502|441087|P11|NOT COMPLETED|Treatment Period 1||0
189498|NCT00515502|441088|P10|NOT COMPLETED|Treatment Period 1||0
189499|NCT00515502|441089|P9|NOT COMPLETED|Treatment Period 1||1
189500|NCT00515502|441090|P8|NOT COMPLETED|Treatment Period 1||0
189501|NCT00515502|441091|P7|NOT COMPLETED|Treatment Period 1||1
189502|NCT00515502|441092|P6|NOT COMPLETED|Treatment Period 1||0
189503|NCT00515502|441093|P5|NOT COMPLETED|Treatment Period 1||0
189504|NCT00515502|441094|P4|NOT COMPLETED|Treatment Period 1||0
189505|NCT00515502|441095|P3|NOT COMPLETED|Treatment Period 1||0
189506|NCT00515502|441096|P2|NOT COMPLETED|Treatment Period 1||0
189507|NCT00515502|441097|P1|NOT COMPLETED|Treatment Period 1||0
189508|NCT00515502|441086|P12|COMPLETED|Treatment Period 1||0
189509|NCT00515502|441087|P11|COMPLETED|Treatment Period 1||1
189510|NCT00515502|441088|P10|COMPLETED|Treatment Period 1||2
189511|NCT00515502|441089|P9|COMPLETED|Treatment Period 1||0
189512|NCT00515502|441090|P8|COMPLETED|Treatment Period 1||1
189513|NCT00515502|441091|P7|COMPLETED|Treatment Period 1||1
189514|NCT00515502|441092|P6|COMPLETED|Treatment Period 1||1
189515|NCT00515502|441093|P5|COMPLETED|Treatment Period 1||3
189516|NCT00515502|441094|P4|COMPLETED|Treatment Period 1||3
189517|NCT00515502|441095|P3|COMPLETED|Treatment Period 1||4
189518|NCT00515502|441096|P2|COMPLETED|Treatment Period 1||4
189519|NCT00515502|441097|P1|COMPLETED|Treatment Period 1||1
189520|NCT00515502|441086|P12|STARTED|Treatment Period 1||1
189521|NCT00515502|441087|P11|STARTED|Treatment Period 1||1
189522|NCT00515502|441088|P10|STARTED|Treatment Period 1||2
189523|NCT00515502|441089|P9|STARTED|Treatment Period 1||1
189524|NCT00515502|441090|P8|STARTED|Treatment Period 1||1
189525|NCT00515502|441091|P7|STARTED|Treatment Period 1||2
189526|NCT00515502|441092|P6|STARTED|Treatment Period 1||1
189527|NCT00515502|441093|P5|STARTED|Treatment Period 1||3
189528|NCT00515502|441094|P4|STARTED|Treatment Period 1||3
189529|NCT00515502|441095|P3|STARTED|Treatment Period 1||4
189530|NCT00515502|441096|P2|STARTED|Treatment Period 1||4
189531|NCT00515502|441097|P1|STARTED|Treatment Period 1||1
189532|NCT00515463|441257|P2|NOT COMPLETED|Overall Study||14
189533|NCT00515463|441258|P1|NOT COMPLETED|Overall Study||14
189534|NCT00515463|441257|P2|COMPLETED|Overall Study||142
189535|NCT00515463|441258|P1|COMPLETED|Overall Study||141
189536|NCT00515463|441257|P2|Received Study Medication|Overall Study||156
189537|NCT00515463|441258|P1|Received Study Medication|Overall Study||154
189538|NCT00515463|441257|P2|STARTED|Overall Study||156
189539|NCT00515463|441258|P1|STARTED|Overall Study||155
189540|NCT00515437|441412|P4|NOT COMPLETED|Overall Study||1
189541|NCT00515437|441413|P3|NOT COMPLETED|Overall Study||0
189542|NCT00515437|441414|P2|NOT COMPLETED|Overall Study||0
189543|NCT00515437|441415|P1|NOT COMPLETED|Overall Study||0
189544|NCT00515437|441412|P4|COMPLETED|Overall Study||14
189545|NCT00515437|441413|P3|COMPLETED|Overall Study||13
189546|NCT00515437|441414|P2|COMPLETED|Overall Study||12
189547|NCT00515437|441415|P1|COMPLETED|Overall Study||14
189548|NCT00515437|441412|P4|STARTED|Overall Study||15
189549|NCT00515437|441413|P3|STARTED|Overall Study||13
189550|NCT00515437|441414|P2|STARTED|Overall Study||12
189551|NCT00515437|441415|P1|STARTED|Overall Study||14
189552|NCT00515216|441437|P1|NOT COMPLETED|Overall Study||1
189553|NCT00515216|441437|P1|COMPLETED|Overall Study||25
189554|NCT00515216|441437|P1|STARTED|Overall Study||26
189555|NCT00515203|441461|P2|NOT COMPLETED|Overall Study||0
189556|NCT00515203|441462|P1|NOT COMPLETED|Overall Study||0
189557|NCT00515203|441461|P2|COMPLETED|Overall Study||5
189558|NCT00515203|441462|P1|COMPLETED|Overall Study||17
189559|NCT00515203|441461|P2|STARTED|Overall Study||5
189560|NCT00515203|441462|P1|STARTED|Overall Study||17
189561|NCT00515177|441480|P2|NOT COMPLETED|Overall Study||1
189562|NCT00515177|441481|P1|NOT COMPLETED|Overall Study||2
189563|NCT00515177|441480|P2|COMPLETED|Overall Study||9
189564|NCT00515177|441481|P1|COMPLETED|Overall Study||18
189565|NCT00515177|441480|P2|STARTED|Overall Study||10
189566|NCT00515177|441481|P1|STARTED|Overall Study||20
189567|NCT00515112|441499|P2|NOT COMPLETED|Overall Study||3
189568|NCT00515112|441500|P1|NOT COMPLETED|Overall Study||3
189569|NCT00515112|441499|P2|COMPLETED|Overall Study||0
189570|NCT00515112|441500|P1|COMPLETED|Overall Study||0
189571|NCT00515112|441499|P2|STARTED|Overall Study||3
189572|NCT00515112|441500|P1|STARTED|Overall Study||3
189573|NCT00515099|441510|P2|NOT COMPLETED|Overall Study||4
189574|NCT00515099|441511|P1|NOT COMPLETED|Overall Study||3
189575|NCT00515099|441510|P2|COMPLETED|Overall Study||16
189576|NCT00515099|441511|P1|COMPLETED|Overall Study||35
189577|NCT00515099|441510|P2|STARTED|Overall Study||20
189578|NCT00515099|441511|P1|STARTED|Overall Study||38
189579|NCT00515086|441533|P4|NOT COMPLETED|Overall Study||6
189580|NCT00515086|441534|P3|NOT COMPLETED|Overall Study||5
189581|NCT00515086|441535|P2|NOT COMPLETED|Overall Study||6
189582|NCT00515086|441536|P1|NOT COMPLETED|Overall Study||24
189583|NCT00515086|441533|P4|COMPLETED|Overall Study||0
189584|NCT00515086|441534|P3|COMPLETED|Overall Study||0
189585|NCT00515086|441535|P2|COMPLETED|Overall Study||0
189586|NCT00515086|441536|P1|COMPLETED|Overall Study||0
189587|NCT00515086|441533|P4|STARTED|Overall Study||6
189588|NCT00515086|441534|P3|STARTED|Overall Study||5
189589|NCT00515086|441535|P2|STARTED|Overall Study||6
189590|NCT00515086|441536|P1|STARTED|Overall Study||24
189591|NCT00515073|441563|P1|NOT COMPLETED|Overall Study||2
189592|NCT00515073|441563|P1|COMPLETED|Overall Study||28
189593|NCT00515073|441563|P1|STARTED|Overall Study||30
189594|NCT00515034|441571|P4|NOT COMPLETED|Overall Study||5
189595|NCT00515034|441572|P3|NOT COMPLETED|Overall Study||8
189596|NCT00515034|441573|P2|NOT COMPLETED|Overall Study||2
189597|NCT00515034|441574|P1|NOT COMPLETED|Overall Study||8
189598|NCT00515034|441571|P4|COMPLETED|Overall Study||15
189599|NCT00515034|441572|P3|COMPLETED|Overall Study||54
189600|NCT00515034|441573|P2|COMPLETED|Overall Study||13
189601|NCT00515034|441574|P1|COMPLETED|Overall Study||41
189602|NCT00515034|441571|P4|TREATED|Overall Study||19
189603|NCT00515034|441572|P3|TREATED|Overall Study||61
189604|NCT00515034|441573|P2|TREATED|Overall Study||15
189605|NCT00515034|441574|P1|TREATED|Overall Study||48
189606|NCT00515034|441571|P4|STARTED|Overall Study||20
189607|NCT00515034|441572|P3|STARTED|Overall Study||62
189608|NCT00515034|441573|P2|STARTED|Overall Study||15
189609|NCT00515034|441574|P1|STARTED|Overall Study||49
189610|NCT00515008|441594|P2|NOT COMPLETED|Overall Study||4
189611|NCT00515008|441595|P1|NOT COMPLETED|Overall Study||3
189612|NCT00515008|441594|P2|COMPLETED|Overall Study||29
189613|NCT00515008|441595|P1|COMPLETED|Overall Study||30
189614|NCT00515008|441594|P2|Completed 12 Week Evaluation|Overall Study||29
189615|NCT00515008|441595|P1|Completed 12 Week Evaluation|Overall Study||32
189616|NCT00515008|441594|P2|STARTED|Overall Study||33
189617|NCT00515008|441595|P1|STARTED|Overall Study||33
189618|NCT00514943|441619|P2|NOT COMPLETED|Stage 2||36
189619|NCT00514943|441620|P1|NOT COMPLETED|Stage 2||32
189620|NCT00514943|441619|P2|COMPLETED|Stage 2||0
189621|NCT00514943|441620|P1|COMPLETED|Stage 2||0
189622|NCT00514943|441619|P2|STARTED|Stage 2||36
189623|NCT00514943|441620|P1|STARTED|Stage 2||32
189624|NCT00514943|441619|P2|NOT COMPLETED|Stage 1||26
189625|NCT00514943|441620|P1|NOT COMPLETED|Stage 1||30
189626|NCT00514943|441619|P2|COMPLETED|Stage 1||36
189627|NCT00514943|441620|P1|COMPLETED|Stage 1||32
189628|NCT00514943|441619|P2|STARTED|Stage 1|2 randomized patients were not treated|62
189629|NCT00514943|441620|P1|STARTED|Stage 1|1 randomized patient was not treated|62
189630|NCT00514917|441678|P2|NOT COMPLETED|Overall Study||115
189631|NCT00514917|441679|P1|NOT COMPLETED|Overall Study||126
189632|NCT00514917|441678|P2|COMPLETED|Overall Study||91
189633|NCT00514917|441679|P1|COMPLETED|Overall Study||81
189634|NCT00514917|441678|P2|Testosterone-Specific Evaluable|Overall Study||124
189635|NCT00514917|441679|P1|Testosterone-Specific Evaluable|Overall Study||122
189636|NCT00514917|441678|P2|Completed Study Treatment|Overall Study||182
189637|NCT00514917|441679|P1|Completed Study Treatment|Overall Study||170
189638|NCT00514917|441678|P2|Treated|Overall Study||204
189639|NCT00514917|441679|P1|Treated|Overall Study||196
189640|NCT00514917|441678|P2|STARTED|Overall Study||206
189641|NCT00514917|441679|P1|STARTED|Overall Study||207
189642|NCT00514852|441707|P2|NOT COMPLETED|Overall Study||5
189643|NCT00514852|441708|P1|NOT COMPLETED|Overall Study||5
189644|NCT00514852|441707|P2|COMPLETED|Overall Study||154
189645|NCT00514852|441708|P1|COMPLETED|Overall Study||152
189646|NCT00514852|441707|P2|STARTED|Overall Study||159
189647|NCT00514852|441708|P1|STARTED|Overall Study||157
189648|NCT00514813|441736|P4|NOT COMPLETED|Overall Study||4
189649|NCT00514813|441737|P3|NOT COMPLETED|Overall Study||47
189650|NCT00514813|441738|P2|NOT COMPLETED|Overall Study||86
189651|NCT00514813|441739|P1|NOT COMPLETED|Overall Study||15
189652|NCT00514813|441736|P4|COMPLETED|Overall Study||0
189653|NCT00514813|441737|P3|COMPLETED|Overall Study||0
189654|NCT00514813|441738|P2|COMPLETED|Overall Study||0
189655|NCT00514813|441739|P1|COMPLETED|Overall Study||0
189656|NCT00514813|441736|P4|STARTED|Overall Study||4
189657|NCT00514813|441737|P3|STARTED|Overall Study||47
189658|NCT00514813|441738|P2|STARTED|Overall Study||86
189659|NCT00514813|441739|P1|STARTED|Overall Study||15
189660|NCT00514735|441759|P2|NOT COMPLETED|Overall Study||6
189661|NCT00514735|441760|P1|NOT COMPLETED|Overall Study||14
189662|NCT00514735|441759|P2|COMPLETED|Overall Study||66
189663|NCT00514735|441760|P1|COMPLETED|Overall Study||124
189664|NCT00514735|441759|P2|STARTED|Overall Study||72
189665|NCT00514735|441760|P1|STARTED|Overall Study||138
189666|NCT00514709|441780|P2|NOT COMPLETED|Overall Study||0
189667|NCT00514709|441781|P1|NOT COMPLETED|Overall Study||0
189668|NCT00514709|441780|P2|COMPLETED|Overall Study||613
189669|NCT00514709|441781|P1|COMPLETED|Overall Study||1230
189670|NCT00514709|441780|P2|STARTED|Overall Study||613
189671|NCT00514709|441781|P1|STARTED|Overall Study||1230
189672|NCT00514683|441796|P5|NOT COMPLETED|Overall Study||33
189673|NCT00514683|441797|P4|NOT COMPLETED|Overall Study||14
189674|NCT00514683|441798|P3|NOT COMPLETED|Overall Study||18
189675|NCT00514683|441799|P2|NOT COMPLETED|Overall Study||25
189676|NCT00514683|441800|P1|NOT COMPLETED|Overall Study||26
189677|NCT00514683|441796|P5|COMPLETED|Overall Study||53
189678|NCT00514683|441797|P4|COMPLETED|Overall Study||72
189679|NCT00514683|441798|P3|COMPLETED|Overall Study||68
189680|NCT00514683|441799|P2|COMPLETED|Overall Study||62
189681|NCT00514683|441800|P1|COMPLETED|Overall Study||61
189682|NCT00514683|441796|P5|STARTED|Overall Study|Randomised|86
189683|NCT00514683|441797|P4|STARTED|Overall Study|Randomised|86
189684|NCT00514683|441798|P3|STARTED|Overall Study|Randomised|86
189685|NCT00514683|441799|P2|STARTED|Overall Study|Randomised|87
189686|NCT00514683|441800|P1|STARTED|Overall Study|Randomised|87
189687|NCT00514592|441991|P1|NOT COMPLETED|Overall Study||0
189688|NCT00514592|441991|P1|COMPLETED|Overall Study||230
189689|NCT00514592|441991|P1|STARTED|Overall Study||230
189690|NCT00514514|441999|P3|NOT COMPLETED|Extension - 4 Years||21
189691|NCT00514514|442000|P2|NOT COMPLETED|Extension - 4 Years||22
189692|NCT00514514|442001|P1|NOT COMPLETED|Extension - 4 Years||37
189693|NCT00514514|441999|P3|COMPLETED|Extension - 4 Years||113
189694|NCT00514514|442000|P2|COMPLETED|Extension - 4 Years||117
189695|NCT00514514|442001|P1|COMPLETED|Extension - 4 Years||108
189696|NCT00514514|441999|P3|Non-randomized (Followed)|Extension - 4 Years||0
189697|NCT00514514|442000|P2|Non-randomized (Followed)|Extension - 4 Years||0
189698|NCT00514514|442001|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
189699|NCT00514514|441999|P3|STARTED|Extension - 4 Years||134
189700|NCT00514514|442000|P2|STARTED|Extension - 4 Years||139
189701|NCT00514514|442001|P1|STARTED|Extension - 4 Years||145
189702|NCT00514514|441999|P3|NOT COMPLETED|Randomized - 9 Month||38
189703|NCT00514514|442000|P2|NOT COMPLETED|Randomized - 9 Month||61
189704|NCT00514514|442001|P1|NOT COMPLETED|Randomized - 9 Month||39
189705|NCT00514514|441999|P3|COMPLETED|Randomized - 9 Month||124
189706|NCT00514514|442000|P2|COMPLETED|Randomized - 9 Month||110
189707|NCT00514514|442001|P1|COMPLETED|Randomized - 9 Month||127
189708|NCT00514514|441999|P3|Randomized - Received Treatment|Randomized - 9 Month||161
189709|NCT00514514|442000|P2|Randomized - Received Treatment|Randomized - 9 Month||171
189710|NCT00514514|442001|P1|Randomized - Received Treatment|Randomized - 9 Month||165
189711|NCT00514514|441999|P3|STARTED|Randomized - 9 Month||162
189712|NCT00514514|442000|P2|STARTED|Randomized - 9 Month||171
189713|NCT00514514|442001|P1|STARTED|Randomized - 9 Month||166
189714|NCT00514514|441999|P3|NOT COMPLETED|Pre-phase||0
189715|NCT00514514|442000|P2|NOT COMPLETED|Pre-phase||0
189716|NCT00514514|442001|P1|NOT COMPLETED|Pre-phase||303
189717|NCT00514514|441999|P3|COMPLETED|Pre-phase||0
189718|NCT00514514|442000|P2|COMPLETED|Pre-phase||0
189719|NCT00514514|442001|P1|COMPLETED|Pre-phase||499
189720|NCT00514514|441999|P3|STARTED|Pre-phase||0
189721|NCT00514514|442000|P2|STARTED|Pre-phase||0
189722|NCT00514514|442001|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
189723|NCT00514501|442045|P1|NOT COMPLETED|Overall Study||3
189724|NCT00514501|442045|P1|COMPLETED|Overall Study||507
189725|NCT00514501|442045|P1|STARTED|Overall Study||510
189726|NCT00514215|442051|P1|NOT COMPLETED|Overall Study||0
189727|NCT00514215|442051|P1|COMPLETED|Overall Study||8
189728|NCT00514215|442051|P1|STARTED|Overall Study||8
189729|NCT00514137|442055|P1|NOT COMPLETED|Overall Study||0
189730|NCT00514137|442055|P1|COMPLETED|Overall Study||13
189731|NCT00514137|442055|P1|STARTED|Overall Study||13
189732|NCT00514020|442062|P1|NOT COMPLETED|Overall Study||28
189733|NCT00514020|442062|P1|COMPLETED|Overall Study||5
189734|NCT00514020|442062|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
189735|NCT00513799|442070|P4|NOT COMPLETED|Four-Month Follow-Up||3
189736|NCT00513799|442071|P3|NOT COMPLETED|Four-Month Follow-Up||7
189737|NCT00513799|442072|P2|NOT COMPLETED|Four-Month Follow-Up||5
189738|NCT00513799|442073|P1|NOT COMPLETED|Four-Month Follow-Up||0
189739|NCT00513799|442070|P4|COMPLETED|Four-Month Follow-Up||51
189740|NCT00513799|442071|P3|COMPLETED|Four-Month Follow-Up||57
189741|NCT00513799|442072|P2|COMPLETED|Four-Month Follow-Up||57
189742|NCT00513799|442073|P1|COMPLETED|Four-Month Follow-Up||64
189743|NCT00513799|442070|P4|STARTED|Four-Month Follow-Up||54
189744|NCT00513799|442071|P3|STARTED|Four-Month Follow-Up||64
189745|NCT00513799|442072|P2|STARTED|Four-Month Follow-Up||62
189746|NCT00513799|442073|P1|STARTED|Four-Month Follow-Up||64
189747|NCT00513799|442070|P4|NOT COMPLETED|One-Month Follow-Up||21
189748|NCT00513799|442071|P3|NOT COMPLETED|One-Month Follow-Up||11
189749|NCT00513799|442072|P2|NOT COMPLETED|One-Month Follow-Up||13
189750|NCT00513799|442073|P1|NOT COMPLETED|One-Month Follow-Up||11
189751|NCT00513799|442070|P4|COMPLETED|One-Month Follow-Up||54
189752|NCT00513799|442071|P3|COMPLETED|One-Month Follow-Up||64
189753|NCT00513799|442072|P2|COMPLETED|One-Month Follow-Up||62
189754|NCT00513799|442073|P1|COMPLETED|One-Month Follow-Up||64
189755|NCT00513799|442070|P4|STARTED|One-Month Follow-Up||75
189756|NCT00513799|442071|P3|STARTED|One-Month Follow-Up||75
189757|NCT00513799|442072|P2|STARTED|One-Month Follow-Up||75
189758|NCT00513799|442073|P1|STARTED|One-Month Follow-Up||75
189759|NCT00513708|442094|P3|NOT COMPLETED|Overall Study||4
189760|NCT00513708|442095|P2|NOT COMPLETED|Overall Study||4
189761|NCT00513708|442096|P1|NOT COMPLETED|Overall Study||4
189762|NCT00513708|442094|P3|COMPLETED|Overall Study||46
189763|NCT00513708|442095|P2|COMPLETED|Overall Study||46
189764|NCT00513708|442096|P1|COMPLETED|Overall Study||46
189765|NCT00513708|442094|P3|STARTED|Overall Study||50
189766|NCT00513708|442095|P2|STARTED|Overall Study||50
189767|NCT00513708|442096|P1|STARTED|Overall Study||50
189768|NCT00513682|442110|P1|NOT COMPLETED|Treatment Phase||0
189769|NCT00513682|442110|P1|COMPLETED|Treatment Phase||7
189770|NCT00513682|442110|P1|STARTED|Treatment Phase||7
189771|NCT00513682|442110|P1|NOT COMPLETED|Washout Phase||2
189772|NCT00513682|442110|P1|COMPLETED|Washout Phase||7
189773|NCT00513682|442110|P1|STARTED|Washout Phase||9
189774|NCT00513682|442110|P1|NOT COMPLETED|Screening Phase||0
189775|NCT00513682|442110|P1|COMPLETED|Screening Phase||9
189776|NCT00513682|442110|P1|STARTED|Screening Phase||9
189777|NCT00513617|442122|P3|NOT COMPLETED|Overall Study||8
189778|NCT00513617|442123|P2|NOT COMPLETED|Overall Study||10
189779|NCT00513617|442124|P1|NOT COMPLETED|Overall Study||11
189780|NCT00513617|442122|P3|COMPLETED|Overall Study||30
189781|NCT00513617|442123|P2|COMPLETED|Overall Study||25
189782|NCT00513617|442124|P1|COMPLETED|Overall Study||25
189783|NCT00513617|442122|P3|STARTED|Overall Study||38
189784|NCT00513617|442123|P2|STARTED|Overall Study||35
189785|NCT00513617|442124|P1|STARTED|Overall Study||36
189786|NCT00513604|442140|P5|NOT COMPLETED|Overall Study||0
189787|NCT00513604|442141|P4|NOT COMPLETED|Overall Study||0
189788|NCT00513604|442142|P3|NOT COMPLETED|Overall Study||3
189789|NCT00513604|442143|P2|NOT COMPLETED|Overall Study||3
189790|NCT00513604|442144|P1|NOT COMPLETED|Overall Study||2
189791|NCT00513604|442140|P5|COMPLETED|Overall Study||35
189792|NCT00513604|442141|P4|COMPLETED|Overall Study||34
189793|NCT00513604|442142|P3|COMPLETED|Overall Study||21
189794|NCT00513604|442143|P2|COMPLETED|Overall Study||36
189795|NCT00513604|442144|P1|COMPLETED|Overall Study||24
189796|NCT00513604|442140|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
189797|NCT00513604|442141|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
189798|NCT00513604|442142|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
189799|NCT00513604|442143|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
189800|NCT00513604|442144|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
189801|NCT00513526|442161|P1|NOT COMPLETED|Overall Study||17
189802|NCT00513526|442161|P1|COMPLETED|Overall Study||92
189803|NCT00513526|442161|P1|STARTED|Overall Study||109
189804|NCT00513500|442178|P2|NOT COMPLETED|Overall Study||54
189805|NCT00513500|442179|P1|NOT COMPLETED|Overall Study||41
189806|NCT00513500|442178|P2|COMPLETED|Overall Study||2054
189807|NCT00513500|442179|P1|COMPLETED|Overall Study||976
189808|NCT00513500|442178|P2|STARTED|Overall Study||2108
189809|NCT00513500|442179|P1|STARTED|Overall Study||1017
189810|NCT00513435|442189|P1|NOT COMPLETED|Overall Study||0
189811|NCT00513435|442189|P1|COMPLETED|Overall Study||9
189812|NCT00513435|442189|P1|STARTED|Overall Study||9
189813|NCT00513409|442196|P2|NOT COMPLETED|Overall Study||6
189814|NCT00513409|442197|P1|NOT COMPLETED|Overall Study||2
189815|NCT00513409|442196|P2|COMPLETED|Overall Study||73
189816|NCT00513409|442197|P1|COMPLETED|Overall Study||82
189817|NCT00513409|442196|P2|STARTED|Overall Study||79
189818|NCT00513409|442197|P1|STARTED|Overall Study||84
189819|NCT00513370|442223|P1|NOT COMPLETED|Overall Study||24
189820|NCT00513370|442223|P1|COMPLETED|Overall Study||179
189821|NCT00513370|442223|P1|STARTED|Overall Study||203
189822|NCT00513357|442253|P2|NOT COMPLETED|Overall Study||10
189823|NCT00513357|442254|P1|NOT COMPLETED|Overall Study||15
189824|NCT00513357|442253|P2|COMPLETED|Overall Study||25
189825|NCT00513357|442254|P1|COMPLETED|Overall Study||23
189826|NCT00513357|442253|P2|STARTED|Overall Study||35
189827|NCT00513357|442254|P1|STARTED|Overall Study||38
189828|NCT00513344|442260|P1|NOT COMPLETED|3rd Intervention 1 Day||0
189829|NCT00513344|442260|P1|COMPLETED|3rd Intervention 1 Day||5
189830|NCT00513344|442260|P1|STARTED|3rd Intervention 1 Day||5
189831|NCT00513344|442260|P1|NOT COMPLETED|Washout Period 3 Days||0
189832|NCT00513344|442260|P1|COMPLETED|Washout Period 3 Days||5
189833|NCT00513344|442260|P1|STARTED|Washout Period 3 Days||5
189834|NCT00513344|442260|P1|NOT COMPLETED|2nd Intervention 1 Day||0
189835|NCT00513344|442260|P1|COMPLETED|2nd Intervention 1 Day||5
189836|NCT00513344|442260|P1|STARTED|2nd Intervention 1 Day||5
189837|NCT00513344|442260|P1|NOT COMPLETED|Washout Period 3 Days||0
189838|NCT00513344|442260|P1|COMPLETED|Washout Period 3 Days||5
189839|NCT00513344|442260|P1|STARTED|Washout Period 3 Days||5
189840|NCT00513344|442260|P1|NOT COMPLETED|1st Intervention 1 Day||0
189841|NCT00513344|442260|P1|COMPLETED|1st Intervention 1 Day||5
189842|NCT00513344|442260|P1|STARTED|1st Intervention 1 Day||5
189843|NCT00513344|442260|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
189844|NCT00513344|442260|P1|COMPLETED|Diet Restriction (3 Days)||5
189845|NCT00513344|442260|P1|STARTED|Diet Restriction (3 Days)||5
189846|NCT00513305|442273|P2|NOT COMPLETED|Overall Study||27
189847|NCT00513305|442274|P1|NOT COMPLETED|Overall Study||28
189848|NCT00513305|442273|P2|COMPLETED|Overall Study||7
189849|NCT00513305|442274|P1|COMPLETED|Overall Study||5
189850|NCT00513305|442273|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
189851|NCT00513305|442274|P1|STARTED|Overall Study||33
189852|NCT00513292|442292|P2|NOT COMPLETED|Overall Study||0
189853|NCT00513292|442293|P1|NOT COMPLETED|Overall Study||0
189854|NCT00513292|442292|P2|COMPLETED|Overall Study||142
189855|NCT00513292|442293|P1|COMPLETED|Overall Study||138
189856|NCT00513292|442292|P2|STARTED|Overall Study||142
189857|NCT00513292|442293|P1|STARTED|Overall Study||138
189858|NCT00513240|442311|P2|NOT COMPLETED|Overall Study||7
189859|NCT00513240|442312|P1|NOT COMPLETED|Overall Study||13
189860|NCT00513240|442311|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
189861|NCT00513240|442312|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
189862|NCT00513240|442311|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
189863|NCT00513240|442312|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
189864|NCT00513240|442311|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
189865|NCT00513240|442312|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
189866|NCT00513071|442319|P1|NOT COMPLETED|Overall Study||5
189867|NCT00513071|442319|P1|COMPLETED|Overall Study||23
189868|NCT00513071|442319|P1|STARTED|Overall Study||28
189869|NCT00513019|442326|P2|NOT COMPLETED|Overall Study||5
189870|NCT00513019|442327|P1|NOT COMPLETED|Overall Study||5
189871|NCT00513019|442326|P2|COMPLETED|Overall Study||13
189872|NCT00513019|442327|P1|COMPLETED|Overall Study||12
189873|NCT00513019|442326|P2|STARTED|Overall Study||18
189874|NCT00513019|442327|P1|STARTED|Overall Study||17
189875|NCT00512902|442333|P1|NOT COMPLETED|Overall Study||8
189876|NCT00512902|442333|P1|COMPLETED|Overall Study||12
189877|NCT00512902|442333|P1|STARTED|Overall Study||20
189878|NCT00512876|442341|P1|NOT COMPLETED|Overall Study||4
189879|NCT00512876|442341|P1|COMPLETED|Overall Study||20
189880|NCT00512876|442341|P1|STARTED|Overall Study||24
189881|NCT00512798|442348|P2|NOT COMPLETED|Overall Study||27
189882|NCT00512798|442349|P1|NOT COMPLETED|Overall Study||19
189883|NCT00512798|442348|P2|COMPLETED|Overall Study||1
189884|NCT00512798|442349|P1|COMPLETED|Overall Study||0
189885|NCT00512798|442348|P2|STARTED|Overall Study||28
189886|NCT00512798|442349|P1|STARTED|Overall Study||19
189887|NCT00512252|442361|P3|NOT COMPLETED|Overall Study||3
189888|NCT00512252|442362|P2|NOT COMPLETED|Overall Study||0
189889|NCT00512252|442363|P1|NOT COMPLETED|Overall Study||0
189890|NCT00512252|442361|P3|COMPLETED|Overall Study||43
189891|NCT00512252|442362|P2|COMPLETED|Overall Study||3
189892|NCT00512252|442363|P1|COMPLETED|Overall Study||3
189893|NCT00512252|442361|P3|STARTED|Overall Study||46
189894|NCT00512252|442362|P2|STARTED|Overall Study||3
189895|NCT00512252|442363|P1|STARTED|Overall Study||3
189896|NCT00512148|442391|P1|NOT COMPLETED|Long Term Follow Up Period||6
189897|NCT00512148|442391|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
189898|NCT00512148|442391|P1|STARTED|Long Term Follow Up Period||6
189899|NCT00512148|442391|P1|NOT COMPLETED|Primay Study Period||1
189900|NCT00512148|442391|P1|COMPLETED|Primay Study Period||6
189901|NCT00512148|442391|P1|STARTED|Primay Study Period||7
189902|NCT00512096|442396|P1|NOT COMPLETED|Overall Study||7
189903|NCT00512096|442396|P1|COMPLETED|Overall Study||23
189904|NCT00512096|442396|P1|STARTED|Overall Study||30
189905|NCT00511914|442402|P2|NOT COMPLETED|Overall Study||0
189906|NCT00511914|442403|P1|NOT COMPLETED|Overall Study||0
189907|NCT00511914|442402|P2|COMPLETED|Overall Study||67
189908|NCT00511914|442403|P1|COMPLETED|Overall Study||68
189909|NCT00511914|442402|P2|STARTED|Overall Study||67
189910|NCT00511914|442403|P1|STARTED|Overall Study||68
189911|NCT00511901|442419|P2|NOT COMPLETED|Overall Study||3
189912|NCT00511901|442420|P1|NOT COMPLETED|Overall Study||1
189913|NCT00511901|442419|P2|COMPLETED|Overall Study||8
189914|NCT00511901|442420|P1|COMPLETED|Overall Study||10
189915|NCT00511901|442419|P2|STARTED|Overall Study||11
189916|NCT00511901|442420|P1|STARTED|Overall Study||11
189917|NCT00511862|442443|P3|NOT COMPLETED|Overall Study||0
189918|NCT00511862|442444|P2|NOT COMPLETED|Overall Study||0
189919|NCT00511862|442445|P1|NOT COMPLETED|Overall Study||0
189920|NCT00511862|442443|P3|COMPLETED|Overall Study||47
189921|NCT00511862|442444|P2|COMPLETED|Overall Study||43
189922|NCT00511862|442445|P1|COMPLETED|Overall Study||61
189923|NCT00511862|442443|P3|STARTED|Overall Study||47
189924|NCT00511862|442444|P2|STARTED|Overall Study||43
189925|NCT00511862|442445|P1|STARTED|Overall Study||61
189926|NCT00511836|442458|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
189927|NCT00511836|442459|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
189928|NCT00511836|442458|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
189929|NCT00511836|442459|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
189930|NCT00511836|442458|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
189931|NCT00511836|442459|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
189932|NCT00511836|442458|P2|NOT COMPLETED|Double-blind Period||0
189933|NCT00511836|442459|P1|NOT COMPLETED|Double-blind Period||1
189934|NCT00511836|442458|P2|COMPLETED|Double-blind Period||15
189935|NCT00511836|442459|P1|COMPLETED|Double-blind Period||15
189936|NCT00511836|442458|P2|STARTED|Double-blind Period||15
189937|NCT00511836|442459|P1|STARTED|Double-blind Period||16
189938|NCT00511810|442476|P2|NOT COMPLETED|Overall Study||5
189939|NCT00511810|442477|P1|NOT COMPLETED|Overall Study||1
189940|NCT00511810|442476|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
189941|NCT00511810|442477|P1|COMPLETED|Overall Study||7
189942|NCT00511810|442476|P2|STARTED|Overall Study||12
189943|NCT00511810|442477|P1|STARTED|Overall Study||8
189944|NCT00511797|442487|P4|NOT COMPLETED|Overall Study||15
189945|NCT00511797|442488|P3|NOT COMPLETED|Overall Study||11
189946|NCT00511797|442489|P2|NOT COMPLETED|Overall Study||8
189947|NCT00511797|442490|P1|NOT COMPLETED|Overall Study||7
189948|NCT00511797|442487|P4|COMPLETED|Overall Study||47
189949|NCT00511797|442488|P3|COMPLETED|Overall Study||51
189950|NCT00511797|442489|P2|COMPLETED|Overall Study||55
189951|NCT00511797|442490|P1|COMPLETED|Overall Study||55
189952|NCT00511797|442487|P4|Subjects Received Treatment|Overall Study|FAS|58
189953|NCT00511797|442488|P3|Subjects Received Treatment|Overall Study|FAS|61
189954|NCT00511797|442489|P2|Subjects Received Treatment|Overall Study|FAS|62
189955|NCT00511797|442490|P1|Subjects Received Treatment|Overall Study|FAS|61
189956|NCT00511797|442487|P4|Subjects Dispensed Drugs|Overall Study||59
189957|NCT00511797|442488|P3|Subjects Dispensed Drugs|Overall Study||61
189958|NCT00511797|442489|P2|Subjects Dispensed Drugs|Overall Study||63
189959|NCT00511797|442490|P1|Subjects Dispensed Drugs|Overall Study||61
189960|NCT00511797|442487|P4|STARTED|Overall Study||62
189961|NCT00511797|442488|P3|STARTED|Overall Study||62
189962|NCT00511797|442489|P2|STARTED|Overall Study||63
189963|NCT00511797|442490|P1|STARTED|Overall Study||62
189964|NCT00511706|442594|P2|NOT COMPLETED|Overall Study||5
189965|NCT00511706|442595|P1|NOT COMPLETED|Overall Study||8
189966|NCT00511706|442594|P2|COMPLETED|Overall Study||115
189967|NCT00511706|442595|P1|COMPLETED|Overall Study||115
189968|NCT00511706|442594|P2|STARTED|Overall Study||120
189969|NCT00511706|442595|P1|STARTED|Overall Study||123
189970|NCT00511667|442609|P2|NOT COMPLETED|Overall Study||3
189971|NCT00511667|442610|P1|NOT COMPLETED|Overall Study||12
189972|NCT00511667|442609|P2|COMPLETED|Overall Study||15
189973|NCT00511667|442610|P1|COMPLETED|Overall Study||40
189974|NCT00511667|442609|P2|STARTED|Overall Study||18
189975|NCT00511667|442610|P1|STARTED|Overall Study||52
189976|NCT00511472|442645|P2|NOT COMPLETED|Overall Study||6
189977|NCT00511472|442646|P1|NOT COMPLETED|Overall Study||3
189978|NCT00511472|442645|P2|COMPLETED|Overall Study||17
189979|NCT00511472|442646|P1|COMPLETED|Overall Study||44
189980|NCT00511472|442645|P2|STARTED|Overall Study||23
189981|NCT00511472|442646|P1|STARTED|Overall Study||47
189982|NCT00511433|442665|P2|NOT COMPLETED|Overall Study||1
189983|NCT00511433|442666|P1|NOT COMPLETED|Overall Study||6
189984|NCT00511433|442665|P2|COMPLETED|Overall Study||15
189985|NCT00511433|442666|P1|COMPLETED|Overall Study||26
189986|NCT00511433|442665|P2|STARTED|Overall Study||16
189987|NCT00511433|442666|P1|STARTED|Overall Study||32
189988|NCT00511355|442706|P2|NOT COMPLETED|Overall Study||9
189989|NCT00511355|442707|P1|NOT COMPLETED|Overall Study||7
189990|NCT00511355|442706|P2|COMPLETED|Overall Study||52
189991|NCT00511355|442707|P1|COMPLETED|Overall Study||53
189992|NCT00511355|442706|P2|STARTED|Overall Study||61
189993|NCT00511355|442707|P1|STARTED|Overall Study||60
189994|NCT00511342|442807|P2|NOT COMPLETED|Overall Study||22
189995|NCT00511342|442808|P1|NOT COMPLETED|Overall Study||13
189996|NCT00511342|442807|P2|COMPLETED|Overall Study||32
189997|NCT00511342|442808|P1|COMPLETED|Overall Study||43
189998|NCT00511342|442807|P2|STARTED|Overall Study||54
189999|NCT00511342|442808|P1|STARTED|Overall Study||56
190000|NCT00511238|442834|P2|NOT COMPLETED|Overall Study||226
190001|NCT00511238|442835|P1|NOT COMPLETED|Overall Study||42
190002|NCT00511238|442834|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
190003|NCT00511238|442835|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
190004|NCT00511238|442834|P2|STARTED|Overall Study||266
190005|NCT00511238|442835|P1|STARTED|Overall Study||46
190006|NCT00511199|442854|P2|NOT COMPLETED|Overall Study||125
190007|NCT00511199|442855|P1|NOT COMPLETED|Overall Study||449
190008|NCT00511199|442854|P2|COMPLETED|Overall Study||410
190009|NCT00511199|442855|P1|COMPLETED|Overall Study||1142
190010|NCT00511199|442854|P2|STARTED|Overall Study||535
190011|NCT00511199|442855|P1|STARTED|Overall Study||1591
190012|NCT00511173|442879|P1|NOT COMPLETED|Overall Study||0
190013|NCT00511173|442879|P1|COMPLETED|Overall Study||102
190014|NCT00511173|442879|P1|STARTED|Overall Study||102
190015|NCT00511134|442886|P2|NOT COMPLETED|Overall Study||2
190016|NCT00511134|442887|P1|NOT COMPLETED|Overall Study||0
190017|NCT00511134|442886|P2|COMPLETED|Overall Study||1
190018|NCT00511134|442887|P1|COMPLETED|Overall Study||1
190019|NCT00511134|442886|P2|STARTED|Overall Study||3
190020|NCT00511134|442887|P1|STARTED|Overall Study||1
190021|NCT00511108|442899|P4|NOT COMPLETED|Overall Study||5
190022|NCT00511108|442900|P3|NOT COMPLETED|Overall Study||5
190023|NCT00511108|442901|P2|NOT COMPLETED|Overall Study||2
190024|NCT00511108|442902|P1|NOT COMPLETED|Overall Study||6
190025|NCT00511108|442899|P4|COMPLETED|Overall Study||48
190026|NCT00511108|442900|P3|COMPLETED|Overall Study||47
190027|NCT00511108|442901|P2|COMPLETED|Overall Study||52
190028|NCT00511108|442902|P1|COMPLETED|Overall Study||46
190029|NCT00511108|442899|P4|STARTED|Overall Study||53
190030|NCT00511108|442900|P3|STARTED|Overall Study||52
190031|NCT00511108|442901|P2|STARTED|Overall Study||54
190032|NCT00511108|442902|P1|STARTED|Overall Study||52
190033|NCT00511004|442923|P3|NOT COMPLETED|Overall Study||4
190034|NCT00511004|442924|P2|NOT COMPLETED|Overall Study||0
190035|NCT00511004|442925|P1|NOT COMPLETED|Overall Study||0
190036|NCT00511004|442923|P3|COMPLETED|Overall Study||10
190037|NCT00511004|442924|P2|COMPLETED|Overall Study||13
190038|NCT00511004|442925|P1|COMPLETED|Overall Study||13
190039|NCT00511004|442923|P3|STARTED|Overall Study||14
190040|NCT00511004|442924|P2|STARTED|Overall Study||13
190041|NCT00511004|442925|P1|STARTED|Overall Study||13
190042|NCT00510952|442944|P2|NOT COMPLETED|Overall Study||16
190043|NCT00510952|442945|P1|NOT COMPLETED|Overall Study||26
190044|NCT00510952|442944|P2|COMPLETED|Overall Study||220
190045|NCT00510952|442945|P1|COMPLETED|Overall Study||209
190046|NCT00510952|442944|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
190047|NCT00510952|442945|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
190048|NCT00510952|442944|P2|STARTED|Overall Study||236
190049|NCT00510952|442945|P1|STARTED|Overall Study||235
190050|NCT00510887|442971|P1|NOT COMPLETED|Overall Study||1
190051|NCT00510887|442971|P1|COMPLETED|Overall Study||11
190052|NCT00510887|442971|P1|STARTED|Overall Study||12
190053|NCT00510874|442987|P7|NOT COMPLETED|Overall Study||1
190054|NCT00510874|442988|P6|NOT COMPLETED|Overall Study||0
190055|NCT00510874|442989|P5|NOT COMPLETED|Overall Study||7
190056|NCT00510874|442990|P4|NOT COMPLETED|Overall Study||3
190057|NCT00510874|442991|P3|NOT COMPLETED|Overall Study||1
190058|NCT00510874|442992|P2|NOT COMPLETED|Overall Study||4
190059|NCT00510874|442993|P1|NOT COMPLETED|Overall Study||3
190060|NCT00510874|442987|P7|COMPLETED|Overall Study|Upto Day 182|49
190061|NCT00510874|442988|P6|COMPLETED|Overall Study|Upto Day 182|50
190062|NCT00510874|442989|P5|COMPLETED|Overall Study|Upto Day 182|141
190063|NCT00510874|442990|P4|COMPLETED|Overall Study|Upto Day 182|148
190064|NCT00510874|442991|P3|COMPLETED|Overall Study|Upto Day 182|150
190065|NCT00510874|442992|P2|COMPLETED|Overall Study|Upto Day 182|148
190066|NCT00510874|442993|P1|COMPLETED|Overall Study|Upto Day 182|75
190067|NCT00510874|442987|P7|STARTED|Overall Study||50
190068|NCT00510874|442988|P6|STARTED|Overall Study||50
190069|NCT00510874|442989|P5|STARTED|Overall Study||148
190070|NCT00510874|442990|P4|STARTED|Overall Study||151
190071|NCT00510874|442991|P3|STARTED|Overall Study||151
190072|NCT00510874|442992|P2|STARTED|Overall Study||152
190073|NCT00510874|442993|P1|STARTED|Overall Study||78
190074|NCT00510835|443096|P3|NOT COMPLETED|Overall Study||2
190075|NCT00510835|443097|P2|NOT COMPLETED|Overall Study||2
190076|NCT00510835|443098|P1|NOT COMPLETED|Overall Study||6
190077|NCT00510835|443096|P3|COMPLETED|Overall Study||456
190078|NCT00510835|443097|P2|COMPLETED|Overall Study||446
190079|NCT00510835|443098|P1|COMPLETED|Overall Study||439
190080|NCT00510835|443096|P3|STARTED|Overall Study||458
190081|NCT00510835|443097|P2|STARTED|Overall Study||448
190082|NCT00510835|443098|P1|STARTED|Overall Study||445
190083|NCT00510809|443109|P3|NOT COMPLETED|Overall Study||0
190084|NCT00510809|443110|P2|NOT COMPLETED|Overall Study||0
190085|NCT00510809|443111|P1|NOT COMPLETED|Overall Study||0
190086|NCT00510809|443109|P3|COMPLETED|Overall Study||18
190087|NCT00510809|443110|P2|COMPLETED|Overall Study||18
190088|NCT00510809|443111|P1|COMPLETED|Overall Study||18
190089|NCT00510809|443109|P3|STARTED|Overall Study||18
190090|NCT00510809|443110|P2|STARTED|Overall Study||18
190091|NCT00510809|443111|P1|STARTED|Overall Study||18
190092|NCT00510783|443124|P2|NOT COMPLETED|Overall Study||29
190093|NCT00510783|443125|P1|NOT COMPLETED|Overall Study||31
190094|NCT00510783|443124|P2|COMPLETED|Overall Study||47
190095|NCT00510783|443125|P1|COMPLETED|Overall Study||51
190096|NCT00510783|443124|P2|STARTED|Overall Study||76
190097|NCT00510783|443125|P1|STARTED|Overall Study||82
190098|NCT00510744|443131|P1|NOT COMPLETED|Overall Study||0
190099|NCT00510744|443131|P1|COMPLETED|Overall Study||5
190100|NCT00510744|443131|P1|STARTED|Overall Study||5
190101|NCT00510692|443137|P2|NOT COMPLETED|Overall Study||3
190102|NCT00510692|443138|P1|NOT COMPLETED|Overall Study||2
190103|NCT00510692|443137|P2|COMPLETED|Overall Study||26
190104|NCT00510692|443138|P1|COMPLETED|Overall Study||27
190105|NCT00510692|443137|P2|STARTED|Overall Study||29
190106|NCT00510692|443138|P1|STARTED|Overall Study||29
190107|NCT00510653|443152|P1|NOT COMPLETED|Overall Study||11
190108|NCT00510653|443152|P1|COMPLETED|Overall Study||13
190109|NCT00510653|443152|P1|STARTED|Overall Study||24
190110|NCT00510510|443159|P3|NOT COMPLETED|Overall Study||17
190111|NCT00510510|443160|P2|NOT COMPLETED|Overall Study||9
190112|NCT00510510|443161|P1|NOT COMPLETED|Overall Study||5
190113|NCT00510510|443159|P3|COMPLETED|Overall Study||74
190114|NCT00510510|443160|P2|COMPLETED|Overall Study||89
190115|NCT00510510|443161|P1|COMPLETED|Overall Study||87
190116|NCT00510510|443159|P3|STARTED|Overall Study||91
190117|NCT00510510|443160|P2|STARTED|Overall Study||98
190118|NCT00510510|443161|P1|STARTED|Overall Study||92
190119|NCT00510497|443172|P1|NOT COMPLETED|Overall Study||3
190120|NCT00510497|443172|P1|COMPLETED|Overall Study||8
190121|NCT00510497|443172|P1|STARTED|Overall Study||11
190122|NCT00510484|443179|P2|NOT COMPLETED|Period 2||0
190123|NCT00510484|443180|P1|NOT COMPLETED|Period 2||0
190124|NCT00510484|443179|P2|COMPLETED|Period 2||15
190125|NCT00510484|443180|P1|COMPLETED|Period 2||16
190126|NCT00510484|443179|P2|STARTED|Period 2||15
190127|NCT00510484|443180|P1|STARTED|Period 2||16
190128|NCT00510484|443179|P2|NOT COMPLETED|Wash-out Period||1
190129|NCT00510484|443180|P1|NOT COMPLETED|Wash-out Period||0
190130|NCT00510484|443179|P2|COMPLETED|Wash-out Period||15
190131|NCT00510484|443180|P1|COMPLETED|Wash-out Period||16
190132|NCT00510484|443179|P2|STARTED|Wash-out Period||16
190133|NCT00510484|443180|P1|STARTED|Wash-out Period||16
190134|NCT00510484|443179|P2|NOT COMPLETED|Period 1||0
190135|NCT00510484|443180|P1|NOT COMPLETED|Period 1||0
190136|NCT00510484|443179|P2|COMPLETED|Period 1||16
190137|NCT00510484|443180|P1|COMPLETED|Period 1||16
190138|NCT00510484|443179|P2|STARTED|Period 1||16
190139|NCT00510484|443180|P1|STARTED|Period 1||16
190140|NCT00510289|443200|P1|NOT COMPLETED|Overall Study||12
190141|NCT00510289|443200|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
190142|NCT00510289|443200|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
190143|NCT00510289|443200|P1|STARTED|Overall Study|All patients who consented|19
190144|NCT00510276|443210|P2|NOT COMPLETED|Extension Open-Label Phase||48
190145|NCT00510276|443211|P1|NOT COMPLETED|Extension Open-Label Phase||33
190146|NCT00510276|443210|P2|COMPLETED|Extension Open-Label Phase||81
190147|NCT00510276|443211|P1|COMPLETED|Extension Open-Label Phase||78
190148|NCT00510276|443210|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
190149|NCT00510276|443211|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
190150|NCT00510276|443210|P2|NOT COMPLETED|Acute Double-Blind Phase||95
190151|NCT00510276|443211|P1|NOT COMPLETED|Acute Double-Blind Phase||105
190152|NCT00510276|443210|P2|COMPLETED|Acute Double-Blind Phase||130
190153|NCT00510276|443211|P1|COMPLETED|Acute Double-Blind Phase||115
190154|NCT00510276|443210|P2|STARTED|Acute Double-Blind Phase||225
190155|NCT00510276|443211|P1|STARTED|Acute Double-Blind Phase||220
190156|NCT00510224|443296|P1|NOT COMPLETED|Overall Study||3
190157|NCT00510224|443296|P1|COMPLETED|Overall Study||10
190158|NCT00510224|443296|P1|STARTED|Overall Study||13
190159|NCT00510146|443305|P2|NOT COMPLETED|Open-Label Treatment||26
190160|NCT00510146|443306|P1|NOT COMPLETED|Open-Label Treatment||71
190161|NCT00510146|443305|P2|COMPLETED|Open-Label Treatment||96
190162|NCT00510146|443306|P1|COMPLETED|Open-Label Treatment||196
190163|NCT00510146|443305|P2|STARTED|Open-Label Treatment||122
190164|NCT00510146|443306|P1|STARTED|Open-Label Treatment||267
190165|NCT00510146|443305|P2|NOT COMPLETED|Double-Blind Treatment||49
190166|NCT00510146|443306|P1|NOT COMPLETED|Double-Blind Treatment||76
190167|NCT00510146|443305|P2|COMPLETED|Double-Blind Treatment||122
190168|NCT00510146|443306|P1|COMPLETED|Double-Blind Treatment||267
190169|NCT00510146|443305|P2|STARTED|Double-Blind Treatment||171
190170|NCT00510146|443306|P1|STARTED|Double-Blind Treatment||343
190171|NCT00510068|443395|P2|NOT COMPLETED|Open-label Period||0
190172|NCT00510068|443396|P1|NOT COMPLETED|Open-label Period||225
190173|NCT00510068|443395|P2|COMPLETED|Open-label Period||0
190174|NCT00510068|443396|P1|COMPLETED|Open-label Period||0
190175|NCT00510068|443395|P2|STARTED|Open-label Period||0
190176|NCT00510068|443396|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
190177|NCT00510068|443395|P2|NOT COMPLETED|Double-blind Period||203
190178|NCT00510068|443396|P1|NOT COMPLETED|Double-blind Period||207
190179|NCT00510068|443395|P2|COMPLETED|Double-blind Period||0
190180|NCT00510068|443396|P1|COMPLETED|Double-blind Period||0
190181|NCT00510068|443395|P2|Safety Population|Double-blind Period||203
190182|NCT00510068|443396|P1|Safety Population|Double-blind Period||204
190183|NCT00510068|443395|P2|STARTED|Double-blind Period||203
190184|NCT00510068|443396|P1|STARTED|Double-blind Period||207
190185|NCT00509925|443437|P2|NOT COMPLETED|Overall Study||1
190186|NCT00509925|443438|P1|NOT COMPLETED|Overall Study||0
190187|NCT00509925|443437|P2|COMPLETED|Overall Study||10
190188|NCT00509925|443438|P1|COMPLETED|Overall Study||12
190189|NCT00509925|443437|P2|STARTED|Overall Study||11
190190|NCT00509925|443438|P1|STARTED|Overall Study||12
190191|NCT00509899|443486|P8|NOT COMPLETED|Overall Study||1
190192|NCT00509899|443487|P7|NOT COMPLETED|Overall Study||1
190193|NCT00509899|443488|P6|NOT COMPLETED|Overall Study||10
190194|NCT00509899|443489|P5|NOT COMPLETED|Overall Study||5
190195|NCT00509899|443490|P4|NOT COMPLETED|Overall Study||4
190196|NCT00509899|443491|P3|NOT COMPLETED|Overall Study||20
190197|NCT00509899|443492|P2|NOT COMPLETED|Overall Study||9
190198|NCT00509899|443493|P1|NOT COMPLETED|Overall Study||16
190199|NCT00509899|443486|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
190200|NCT00509899|443487|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
190201|NCT00509899|443488|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
190202|NCT00509899|443489|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
190203|NCT00509899|443490|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
190204|NCT00509899|443491|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
190205|NCT00509899|443492|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
190206|NCT00509899|443493|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
190207|NCT00509899|443486|P8|STARTED|Overall Study||3
190208|NCT00509899|443487|P7|STARTED|Overall Study||6
190209|NCT00509899|443488|P6|STARTED|Overall Study||22
190210|NCT00509899|443489|P5|STARTED|Overall Study||6
190211|NCT00509899|443490|P4|STARTED|Overall Study||5
190212|NCT00509899|443491|P3|STARTED|Overall Study||47
190213|NCT00509899|443492|P2|STARTED|Overall Study||35
190214|NCT00509899|443493|P1|STARTED|Overall Study||30
190215|NCT00509873|443533|P2|NOT COMPLETED|Overall Study||15
190216|NCT00509873|443534|P1|NOT COMPLETED|Overall Study||11
190217|NCT00509873|443533|P2|COMPLETED|Overall Study||276
190218|NCT00509873|443534|P1|COMPLETED|Overall Study||276
190219|NCT00509873|443533|P2|STARTED|Overall Study||291
190220|NCT00509873|443534|P1|STARTED|Overall Study||287
190221|NCT00509795|443552|P4|NOT COMPLETED|Overall Study||27
190222|NCT00509795|443553|P3|NOT COMPLETED|Overall Study||27
190223|NCT00509795|443554|P2|NOT COMPLETED|Overall Study||11
190224|NCT00509795|443555|P1|NOT COMPLETED|Overall Study||22
190225|NCT00509795|443552|P4|COMPLETED|Overall Study||276
190226|NCT00509795|443553|P3|COMPLETED|Overall Study||277
190227|NCT00509795|443554|P2|COMPLETED|Overall Study||293
190228|NCT00509795|443555|P1|COMPLETED|Overall Study||284
190229|NCT00509795|443552|P4|Per Protocol Set (PPS) Population|Overall Study||265
190230|NCT00509795|443553|P3|Per Protocol Set (PPS) Population|Overall Study||270
190231|NCT00509795|443554|P2|Per Protocol Set (PPS) Population|Overall Study||285
190232|NCT00509795|443555|P1|Per Protocol Set (PPS) Population|Overall Study||269
190233|NCT00509795|443552|P4|Full Analysis Set (FAS) Population|Overall Study||301
190234|NCT00509795|443553|P3|Full Analysis Set (FAS) Population|Overall Study||301
190235|NCT00509795|443554|P2|Full Analysis Set (FAS) Population|Overall Study||304
190236|NCT00509795|443555|P1|Full Analysis Set (FAS) Population|Overall Study||304
190237|NCT00509795|443552|P4|Patients Received Treatment (SAF)|Overall Study||303
190238|NCT00509795|443553|P3|Patients Received Treatment (SAF)|Overall Study||304
190239|NCT00509795|443554|P2|Patients Received Treatment (SAF)|Overall Study||304
190240|NCT00509795|443555|P1|Patients Received Treatment (SAF)|Overall Study||304
190241|NCT00509795|443552|P4|STARTED|Overall Study||303
190242|NCT00509795|443553|P3|STARTED|Overall Study||304
190243|NCT00509795|443554|P2|STARTED|Overall Study||304
190244|NCT00509795|443555|P1|STARTED|Overall Study||306
190245|NCT00509769|443586|P1|NOT COMPLETED|Overall Study||91
190246|NCT00509769|443586|P1|COMPLETED|Overall Study||21
190247|NCT00509769|443586|P1|STARTED|Overall Study||112
190248|NCT00509600|443595|P1|NOT COMPLETED|Overall Study||1
190249|NCT00509600|443595|P1|COMPLETED|Overall Study||0
190250|NCT00509600|443595|P1|STARTED|Overall Study||1
190251|NCT00509587|443599|P1|NOT COMPLETED|Overall Study||0
190252|NCT00509587|443599|P1|COMPLETED|Overall Study||21
190253|NCT00509587|443599|P1|STARTED|Overall Study||21
190254|NCT00509496|443609|P2|NOT COMPLETED|Overall Study||0
190255|NCT00509496|443610|P1|NOT COMPLETED|Overall Study||0
190256|NCT00509496|443609|P2|COMPLETED|Overall Study||2
190257|NCT00509496|443610|P1|COMPLETED|Overall Study||19
190258|NCT00509496|443609|P2|STARTED|Overall Study||2
190259|NCT00509496|443610|P1|STARTED|Overall Study||19
190260|NCT00509366|443623|P5|NOT COMPLETED|Overall Study||0
190261|NCT00509366|443624|P4|NOT COMPLETED|Overall Study||0
190262|NCT00509366|443625|P3|NOT COMPLETED|Overall Study||1
190263|NCT00509366|443626|P2|NOT COMPLETED|Overall Study||1
190264|NCT00509366|443627|P1|NOT COMPLETED|Overall Study||1
190265|NCT00509366|443623|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
190266|NCT00509366|443624|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
190267|NCT00509366|443625|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
190268|NCT00509366|443626|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
190269|NCT00509366|443627|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
190270|NCT00509366|443623|P5|Assigned Treatment|Overall Study||0
190271|NCT00509366|443624|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
190272|NCT00509366|443625|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
190273|NCT00509366|443626|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
190274|NCT00509366|443627|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
190275|NCT00509366|443623|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
190276|NCT00509366|443624|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
190277|NCT00509366|443625|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
190278|NCT00509366|443626|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
190279|NCT00509366|443627|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
190280|NCT00509288|443640|P2|NOT COMPLETED|Overall Study||0
190281|NCT00509288|443641|P1|NOT COMPLETED|Overall Study||0
190282|NCT00509288|443640|P2|COMPLETED|Overall Study||3
190283|NCT00509288|443641|P1|COMPLETED|Overall Study||21
190284|NCT00509288|443640|P2|STARTED|Overall Study||3
190285|NCT00509288|443641|P1|STARTED|Overall Study||21
190286|NCT00509262|443651|P2|NOT COMPLETED|Overall Study||42
190287|NCT00509262|443652|P1|NOT COMPLETED|Overall Study||47
190288|NCT00509262|443651|P2|COMPLETED|Overall Study||170
190289|NCT00509262|443652|P1|COMPLETED|Overall Study||164
190290|NCT00509262|443651|P2|STARTED|Overall Study||212
190291|NCT00509262|443652|P1|STARTED|Overall Study||211
190292|NCT00509249|443664|P1|NOT COMPLETED|Overall Study||0
190293|NCT00509249|443664|P1|COMPLETED|Overall Study||18
190294|NCT00509249|443664|P1|STARTED|Overall Study||18
190295|NCT00509236|443670|P2|NOT COMPLETED|Overall Study||20
190296|NCT00509236|443671|P1|NOT COMPLETED|Overall Study||17
190297|NCT00509236|443670|P2|COMPLETED|Overall Study||45
190298|NCT00509236|443671|P1|COMPLETED|Overall Study||47
190299|NCT00509236|443670|P2|STARTED|Overall Study||65
190300|NCT00509236|443671|P1|STARTED|Overall Study||64
190301|NCT00509223|443686|P2|NOT COMPLETED|Overall Study||72
190302|NCT00509223|443687|P1|NOT COMPLETED|Overall Study||88
190303|NCT00509223|443686|P2|COMPLETED|Overall Study||137
190304|NCT00509223|443687|P1|COMPLETED|Overall Study||119
190305|NCT00509223|443686|P2|STARTED|Overall Study||209
190306|NCT00509223|443687|P1|STARTED|Overall Study||207
190307|NCT00509197|443695|P2|NOT COMPLETED|Overall Study||0
190308|NCT00509197|443696|P1|NOT COMPLETED|Overall Study||0
190309|NCT00509197|443695|P2|COMPLETED|Overall Study||6
190310|NCT00509197|443696|P1|COMPLETED|Overall Study||6
190311|NCT00509197|443695|P2|STARTED|Overall Study||6
190312|NCT00509197|443696|P1|STARTED|Overall Study||6
190313|NCT00509106|443710|P2|NOT COMPLETED|Overall Study||29
190314|NCT00509106|443711|P1|NOT COMPLETED|Overall Study||31
190315|NCT00509106|443710|P2|COMPLETED|Overall Study||278
190316|NCT00509106|443711|P1|COMPLETED|Overall Study||284
190317|NCT00509106|443710|P2|STARTED|Overall Study||307
190318|NCT00509106|443711|P1|STARTED|Overall Study||315
190319|NCT00509067|443719|P2|NOT COMPLETED|Overall Study||5
190320|NCT00509067|443720|P1|NOT COMPLETED|Overall Study||4
190321|NCT00509067|443719|P2|COMPLETED|Overall Study||19
190322|NCT00509067|443720|P1|COMPLETED|Overall Study||15
190323|NCT00509067|443719|P2|STARTED|Overall Study||24
190324|NCT00509067|443720|P1|STARTED|Overall Study||19
190325|NCT00509041|443726|P1|NOT COMPLETED|Overall Study||0
190326|NCT00509041|443726|P1|COMPLETED|Overall Study||43
190327|NCT00509041|443726|P1|STARTED|Overall Study||43
190328|NCT00509028|443735|P2|NOT COMPLETED|Overall Study||7
190329|NCT00509028|443736|P1|NOT COMPLETED|Overall Study||12
190330|NCT00509028|443735|P2|COMPLETED|Overall Study||113
190331|NCT00509028|443736|P1|COMPLETED|Overall Study||109
190332|NCT00509028|443735|P2|STARTED|Overall Study||120
190333|NCT00509028|443736|P1|STARTED|Overall Study||121
190334|NCT00508924|443772|P4|NOT COMPLETED|Overall Study||1
190335|NCT00508924|443773|P3|NOT COMPLETED|Overall Study||1
190336|NCT00508924|443774|P2|NOT COMPLETED|Overall Study||0
190337|NCT00508924|443775|P1|NOT COMPLETED|Overall Study||0
190338|NCT00508924|443772|P4|COMPLETED|Overall Study||33
190339|NCT00508924|443773|P3|COMPLETED|Overall Study||31
190340|NCT00508924|443774|P2|COMPLETED|Overall Study||38
190341|NCT00508924|443775|P1|COMPLETED|Overall Study||36
190342|NCT00508924|443772|P4|STARTED|Overall Study||34
190343|NCT00508924|443773|P3|STARTED|Overall Study||32
190344|NCT00508924|443774|P2|STARTED|Overall Study||38
190345|NCT00508924|443775|P1|STARTED|Overall Study||36
190346|NCT00508872|443789|P1|NOT COMPLETED|Overall Study||2
190347|NCT00508872|443789|P1|COMPLETED|Overall Study||0
190348|NCT00508872|443789|P1|STARTED|Overall Study||2
190349|NCT00508820|443795|P2|NOT COMPLETED|Overall Study||64
190350|NCT00508820|443796|P1|NOT COMPLETED|Overall Study||55
190351|NCT00508820|443795|P2|COMPLETED|Overall Study||175
190352|NCT00508820|443796|P1|COMPLETED|Overall Study||113
190353|NCT00508820|443795|P2|STARTED|Overall Study||239
190354|NCT00508820|443796|P1|STARTED|Overall Study||168
190355|NCT00508755|443806|P1|NOT COMPLETED|Overall Study||1
190356|NCT00508755|443806|P1|COMPLETED|Overall Study||5
190357|NCT00508755|443806|P1|STARTED|Overall Study||6
190358|NCT00508742|443814|P2|NOT COMPLETED|Period 3: Toddler Dose||15
190359|NCT00508742|443815|P1|NOT COMPLETED|Period 3: Toddler Dose||25
190360|NCT00508742|443814|P2|COMPLETED|Period 3: Toddler Dose||863
190361|NCT00508742|443815|P1|COMPLETED|Period 3: Toddler Dose||858
190362|NCT00508742|443814|P2|STARTED|Period 3: Toddler Dose||878
190363|NCT00508742|443815|P1|STARTED|Period 3: Toddler Dose||883
190364|NCT00508742|443814|P2|NOT COMPLETED|Period 2: After Infant Series||11
190365|NCT00508742|443815|P1|NOT COMPLETED|Period 2: After Infant Series||7
190366|NCT00508742|443814|P2|COMPLETED|Period 2: After Infant Series||878
190367|NCT00508742|443815|P1|COMPLETED|Period 2: After Infant Series||883
190368|NCT00508742|443814|P2|STARTED|Period 2: After Infant Series||889
190369|NCT00508742|443815|P1|STARTED|Period 2: After Infant Series||890
190370|NCT00508742|443814|P2|NOT COMPLETED|Period 1: Infant Series||45
190371|NCT00508742|443815|P1|NOT COMPLETED|Period 1: Infant Series||42
190372|NCT00508742|443814|P2|COMPLETED|Period 1: Infant Series||889
190373|NCT00508742|443815|P1|COMPLETED|Period 1: Infant Series||890
190374|NCT00508742|443814|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
190375|NCT00508742|443815|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
190376|NCT00508742|443814|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
190377|NCT00508742|443815|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
190378|NCT00508742|443814|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
190379|NCT00508742|443815|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
190380|NCT00508742|443814|P2|STARTED|Period 1: Infant Series||934
190381|NCT00508742|443815|P1|STARTED|Period 1: Infant Series||932
190382|NCT00508716|443831|P2|NOT COMPLETED|Overall Study||0
190383|NCT00508716|443832|P1|NOT COMPLETED|Overall Study||0
190384|NCT00508716|443831|P2|COMPLETED|Overall Study||63
190385|NCT00508716|443832|P1|COMPLETED|Overall Study||61
190386|NCT00508716|443831|P2|STARTED|Overall Study||63
190387|NCT00508716|443832|P1|STARTED|Overall Study||61
190388|NCT00508651|443840|P2|NOT COMPLETED|Overall Study||2
190389|NCT00508651|443841|P1|NOT COMPLETED|Overall Study||4
190390|NCT00508651|443840|P2|COMPLETED|Overall Study||8
190391|NCT00508651|443841|P1|COMPLETED|Overall Study||16
190392|NCT00508651|443840|P2|STARTED|Overall Study||10
190393|NCT00508651|443841|P1|STARTED|Overall Study||20
190394|NCT00508521|443915|P1|NOT COMPLETED|Overall Study||0
190395|NCT00508521|443915|P1|COMPLETED|Overall Study||4
190396|NCT00508521|443915|P1|STARTED|Overall Study||4
190397|NCT00508482|443922|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
190398|NCT00508482|443923|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
190399|NCT00508482|443924|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
190400|NCT00508482|443922|P3|COMPLETED|at the 12th Week of Follow-up||98
190401|NCT00508482|443923|P2|COMPLETED|at the 12th Week of Follow-up||96
190402|NCT00508482|443924|P1|COMPLETED|at the 12th Week of Follow-up||196
190403|NCT00508482|443922|P3|STARTED|at the 12th Week of Follow-up||98
190404|NCT00508482|443923|P2|STARTED|at the 12th Week of Follow-up||96
190405|NCT00508482|443924|P1|STARTED|at the 12th Week of Follow-up||196
190406|NCT00508482|443922|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
190407|NCT00508482|443923|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
190408|NCT00508482|443924|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
190409|NCT00508482|443922|P3|COMPLETED|at the 4th Week of Follow-up||98
190410|NCT00508482|443923|P2|COMPLETED|at the 4th Week of Follow-up||96
190411|NCT00508482|443924|P1|COMPLETED|at the 4th Week of Follow-up||196
190412|NCT00508482|443922|P3|STARTED|at the 4th Week of Follow-up||99
190413|NCT00508482|443923|P2|STARTED|at the 4th Week of Follow-up||102
190414|NCT00508482|443924|P1|STARTED|at the 4th Week of Follow-up||216
190415|NCT00508482|443922|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
190416|NCT00508482|443923|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
190417|NCT00508482|443924|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
190418|NCT00508482|443922|P3|COMPLETED|Over 4 Weeks of Treatment||99
190419|NCT00508482|443923|P2|COMPLETED|Over 4 Weeks of Treatment||102
190420|NCT00508482|443924|P1|COMPLETED|Over 4 Weeks of Treatment||216
190421|NCT00508482|443922|P3|STARTED|Over 4 Weeks of Treatment||119
190422|NCT00508482|443923|P2|STARTED|Over 4 Weeks of Treatment||119
190423|NCT00508482|443924|P1|STARTED|Over 4 Weeks of Treatment||237
190424|NCT00508469|443961|P2|NOT COMPLETED|Overall Study||10
190425|NCT00508469|443962|P1|NOT COMPLETED|Overall Study||17
190426|NCT00508469|443961|P2|COMPLETED|Overall Study||40
190427|NCT00508469|443962|P1|COMPLETED|Overall Study||35
190428|NCT00508469|443961|P2|STARTED|Overall Study||50
190429|NCT00508469|443962|P1|STARTED|Overall Study||52
190430|NCT00508404|443968|P1|NOT COMPLETED|Overall Study||42
190431|NCT00508404|443968|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
190432|NCT00508404|443968|P1|STARTED|Overall Study||154
190433|NCT00508391|443995|P2|NOT COMPLETED|Second Treatment||0
190434|NCT00508391|443996|P1|NOT COMPLETED|Second Treatment||2
190435|NCT00508391|443995|P2|COMPLETED|Second Treatment||59
190436|NCT00508391|443996|P1|COMPLETED|Second Treatment||52
190437|NCT00508391|443995|P2|STARTED|Second Treatment||59
190438|NCT00508391|443996|P1|STARTED|Second Treatment||54
190439|NCT00508391|443995|P2|NOT COMPLETED|First Treatment||3
190440|NCT00508391|443996|P1|NOT COMPLETED|First Treatment||6
190441|NCT00508391|443995|P2|COMPLETED|First Treatment||59
190442|NCT00508391|443996|P1|COMPLETED|First Treatment||54
190443|NCT00508391|443995|P2|STARTED|First Treatment||62
190444|NCT00508391|443996|P1|STARTED|First Treatment||60
190445|NCT00508274|444007|P1|NOT COMPLETED|Overall Study||2
190446|NCT00508274|444007|P1|COMPLETED|Overall Study||50
190447|NCT00508274|444007|P1|STARTED|Overall Study||52
190448|NCT00508157|444018|P2|NOT COMPLETED|Overall Study||3
190449|NCT00508157|444019|P1|NOT COMPLETED|Overall Study||2
190450|NCT00508157|444018|P2|COMPLETED|Overall Study||23
190451|NCT00508157|444019|P1|COMPLETED|Overall Study||24
190452|NCT00508157|444018|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
190453|NCT00508157|444019|P1|Safety Sample|Overall Study||26
190454|NCT00508157|444018|P2|Randomized Sample|Overall Study||26
190455|NCT00508157|444019|P1|Randomized Sample|Overall Study||26
190456|NCT00508157|444018|P2|STARTED|Overall Study||26
190457|NCT00508157|444019|P1|STARTED|Overall Study||26
190458|NCT00508144|444041|P1|NOT COMPLETED|Overall Study||11
190459|NCT00508144|444041|P1|COMPLETED|Overall Study||53
190460|NCT00508144|444041|P1|STARTED|Overall Study||64
190461|NCT00508118|444047|P2|NOT COMPLETED|Overall Study||0
190462|NCT00508118|444048|P1|NOT COMPLETED|Overall Study||0
190463|NCT00508118|444047|P2|COMPLETED|Overall Study||4
190464|NCT00508118|444048|P1|COMPLETED|Overall Study||3
190465|NCT00508118|444047|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
190466|NCT00508118|444048|P1|STARTED|Overall Study||3
190467|NCT00508027|444067|P1|NOT COMPLETED|Dose Level 3||0
190468|NCT00508027|444067|P1|COMPLETED|Dose Level 3||2
190469|NCT00508027|444067|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
190470|NCT00508027|444067|P1|NOT COMPLETED|Dose Level 2||4
190471|NCT00508027|444067|P1|COMPLETED|Dose Level 2||16
190472|NCT00508027|444067|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
190473|NCT00508027|444067|P1|NOT COMPLETED|Dose Level 1||8
190474|NCT00508027|444067|P1|COMPLETED|Dose Level 1||12
190475|NCT00508027|444067|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
190476|NCT00508001|444108|P3|NOT COMPLETED|Overall Study||7
190477|NCT00508001|444109|P2|NOT COMPLETED|Overall Study||12
190478|NCT00508001|444110|P1|NOT COMPLETED|Overall Study||19
190479|NCT00508001|444108|P3|COMPLETED|Overall Study||16
190480|NCT00508001|444109|P2|COMPLETED|Overall Study||13
190481|NCT00508001|444110|P1|COMPLETED|Overall Study||0
190482|NCT00508001|444108|P3|Secondary Treatment Phase|Overall Study||16
190483|NCT00508001|444109|P2|Secondary Treatment Phase|Overall Study||13
190484|NCT00508001|444110|P1|Secondary Treatment Phase|Overall Study||0
190485|NCT00508001|444108|P3|STARTED|Overall Study||23
190486|NCT00508001|444109|P2|STARTED|Overall Study||25
190487|NCT00508001|444110|P1|STARTED|Overall Study||19
190488|NCT00507819|444127|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
190489|NCT00507819|444128|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
190490|NCT00507819|444127|P2|COMPLETED|Second Intervention (6 Weeks)||14
190491|NCT00507819|444128|P1|COMPLETED|Second Intervention (6 Weeks)||13
190492|NCT00507819|444127|P2|STARTED|Second Intervention (6 Weeks)||14
190493|NCT00507819|444128|P1|STARTED|Second Intervention (6 Weeks)||13
190494|NCT00507819|444127|P2|NOT COMPLETED|Washout (6 Weeks)||0
190495|NCT00507819|444128|P1|NOT COMPLETED|Washout (6 Weeks)||1
190496|NCT00507819|444127|P2|COMPLETED|Washout (6 Weeks)||14
190497|NCT00507819|444128|P1|COMPLETED|Washout (6 Weeks)||13
190498|NCT00507819|444127|P2|STARTED|Washout (6 Weeks)||14
190499|NCT00507819|444128|P1|STARTED|Washout (6 Weeks)||14
190500|NCT00507819|444127|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
190501|NCT00507819|444128|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
190502|NCT00507819|444127|P2|COMPLETED|First Intervention (6 Weeks)||14
190503|NCT00507819|444128|P1|COMPLETED|First Intervention (6 Weeks)||14
190504|NCT00507819|444127|P2|STARTED|First Intervention (6 Weeks)||14
190505|NCT00507819|444128|P1|STARTED|First Intervention (6 Weeks)||14
190506|NCT00507767|444140|P1|NOT COMPLETED|Overall Study||0
190507|NCT00507767|444140|P1|COMPLETED|Overall Study||15
190508|NCT00507767|444140|P1|STARTED|Overall Study||15
190509|NCT00507689|444147|P2|NOT COMPLETED|Randomized Period||2
190510|NCT00507689|444148|P1|NOT COMPLETED|Randomized Period||1
190511|NCT00507689|444147|P2|COMPLETED|Randomized Period||16
190512|NCT00507689|444148|P1|COMPLETED|Randomized Period||18
190513|NCT00507689|444147|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
190514|NCT00507689|444148|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
190515|NCT00507689|444147|P2|NOT COMPLETED|Pre-Randomization Period||0
190516|NCT00507689|444148|P1|NOT COMPLETED|Pre-Randomization Period||3
190517|NCT00507689|444147|P2|COMPLETED|Pre-Randomization Period||0
190518|NCT00507689|444148|P1|COMPLETED|Pre-Randomization Period||37
190519|NCT00507689|444147|P2|STARTED|Pre-Randomization Period||0
190520|NCT00507689|444148|P1|STARTED|Pre-Randomization Period||40
190521|NCT00507559|444165|P1|NOT COMPLETED|Overall Study||71
190522|NCT00507559|444165|P1|COMPLETED|Overall Study||84
190523|NCT00507559|444165|P1|STARTED|Overall Study||155
190524|NCT00507546|444180|P2|NOT COMPLETED|Overall Study||1
190525|NCT00507546|444181|P1|NOT COMPLETED|Overall Study||2
190526|NCT00507546|444180|P2|COMPLETED|Overall Study||3
190527|NCT00507546|444181|P1|COMPLETED|Overall Study||2
190528|NCT00507546|444180|P2|STARTED|Overall Study||4
190529|NCT00507546|444181|P1|STARTED|Overall Study||4
190530|NCT00507507|444191|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
190531|NCT00507507|444192|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
190532|NCT00507507|444191|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
190533|NCT00507507|444192|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
190534|NCT00507507|444191|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
190535|NCT00507507|444192|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
190536|NCT00507507|444191|P2|NOT COMPLETED|Treatment Period||53
190537|NCT00507507|444192|P1|NOT COMPLETED|Treatment Period||52
190538|NCT00507507|444191|P2|COMPLETED|Treatment Period||9
190539|NCT00507507|444192|P1|COMPLETED|Treatment Period||12
190540|NCT00507507|444191|P2|Completed 192 Weeks of Treatment|Treatment Period||52
190541|NCT00507507|444192|P1|Completed 192 Weeks of Treatment|Treatment Period||52
190542|NCT00507507|444191|P2|STARTED|Treatment Period||62
190543|NCT00507507|444192|P1|STARTED|Treatment Period||64
190544|NCT00507455|444227|P3|NOT COMPLETED|Overall Study||12
190545|NCT00507455|444228|P2|NOT COMPLETED|Overall Study||6
190546|NCT00507455|444229|P1|NOT COMPLETED|Overall Study||12
190547|NCT00507455|444227|P3|COMPLETED|Overall Study||62
190548|NCT00507455|444228|P2|COMPLETED|Overall Study||68
190549|NCT00507455|444229|P1|COMPLETED|Overall Study||62
190550|NCT00507455|444227|P3|STARTED|Overall Study||74
190551|NCT00507455|444228|P2|STARTED|Overall Study||74
190552|NCT00507455|444229|P1|STARTED|Overall Study||74
190553|NCT00507442|444292|P4|NOT COMPLETED|Overall Study||5
190554|NCT00507442|444293|P3|NOT COMPLETED|Overall Study||15
190555|NCT00507442|444294|P2|NOT COMPLETED|Overall Study||27
190556|NCT00507442|444295|P1|NOT COMPLETED|Overall Study||16
190557|NCT00507442|444292|P4|COMPLETED|Overall Study||12
190558|NCT00507442|444293|P3|COMPLETED|Overall Study||18
190559|NCT00507442|444294|P2|COMPLETED|Overall Study||39
190560|NCT00507442|444295|P1|COMPLETED|Overall Study||26
190561|NCT00507442|444292|P4|STARTED|Overall Study||17
190562|NCT00507442|444293|P3|STARTED|Overall Study||33
190563|NCT00507442|444294|P2|STARTED|Overall Study||66
190564|NCT00507442|444295|P1|STARTED|Overall Study||42
190565|NCT00507429|444347|P2|NOT COMPLETED|Maintenance Phase||0
190566|NCT00507429|444348|P1|NOT COMPLETED|Maintenance Phase||14
190567|NCT00507429|444347|P2|COMPLETED|Maintenance Phase||0
190568|NCT00507429|444348|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
190569|NCT00507429|444347|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
190570|NCT00507429|444348|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
190571|NCT00507429|444347|P2|NOT COMPLETED|Treatment Phase||18
190572|NCT00507429|444348|P1|NOT COMPLETED|Treatment Phase||37
190573|NCT00507429|444347|P2|COMPLETED|Treatment Phase||7
190574|NCT00507429|444348|P1|COMPLETED|Treatment Phase||18
190575|NCT00507429|444347|P2|STARTED|Treatment Phase|Randomized|25
190576|NCT00507429|444348|P1|STARTED|Treatment Phase|Randomized|55
190577|NCT00507416|444359|P3|NOT COMPLETED|Overall Study||114
190578|NCT00507416|444360|P2|NOT COMPLETED|Overall Study||125
190579|NCT00507416|444361|P1|NOT COMPLETED|Overall Study||118
190580|NCT00507416|444359|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
190581|NCT00507416|444360|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
190582|NCT00507416|444361|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
190583|NCT00507416|444359|P3|Completed 8 Treatment Cycles|Overall Study||69
190584|NCT00507416|444360|P2|Completed 8 Treatment Cycles|Overall Study||60
190585|NCT00507416|444361|P1|Completed 8 Treatment Cycles|Overall Study||82
190586|NCT00507416|444359|P3|Treated (Safety Population)|Overall Study||163
190587|NCT00507416|444360|P2|Treated (Safety Population)|Overall Study||158
190588|NCT00507416|444361|P1|Treated (Safety Population)|Overall Study||165
190589|NCT00507416|444359|P3|STARTED|Overall Study||167
190590|NCT00507416|444360|P2|STARTED|Overall Study||167
190591|NCT00507416|444361|P1|STARTED|Overall Study||168
190592|NCT00507208|444392|P2|NOT COMPLETED|Overall Study||0
190593|NCT00507208|444393|P1|NOT COMPLETED|Overall Study||0
190594|NCT00507208|444392|P2|COMPLETED|Overall Study||26
190595|NCT00507208|444393|P1|COMPLETED|Overall Study||27
190596|NCT00507208|444392|P2|Received Dynasplint in Crossover|Overall Study||3
190597|NCT00507208|444393|P1|Received Dynasplint in Crossover|Overall Study||0
190598|NCT00507208|444392|P2|STARTED|Overall Study||26
190599|NCT00507208|444393|P1|STARTED|Overall Study||27
190600|NCT00503997|444399|P1|NOT COMPLETED|Overall Study||8
190601|NCT00503997|444399|P1|COMPLETED|Overall Study||34
190602|NCT00503997|444399|P1|STARTED|Overall Study||42
190603|NCT00503984|444405|P6|NOT COMPLETED|Overall Study||0
190604|NCT00503984|444406|P5|NOT COMPLETED|Overall Study||1
190605|NCT00503984|444407|P4|NOT COMPLETED|Overall Study||0
190606|NCT00503984|444408|P3|NOT COMPLETED|Overall Study||0
190607|NCT00503984|444409|P2|NOT COMPLETED|Overall Study||2
190608|NCT00503984|444410|P1|NOT COMPLETED|Overall Study||0
190609|NCT00503984|444405|P6|COMPLETED|Overall Study||1
190610|NCT00503984|444406|P5|COMPLETED|Overall Study||5
190611|NCT00503984|444407|P4|COMPLETED|Overall Study||6
190612|NCT00503984|444408|P3|COMPLETED|Overall Study||3
190613|NCT00503984|444409|P2|COMPLETED|Overall Study||1
190614|NCT00503984|444410|P1|COMPLETED|Overall Study||3
190615|NCT00503984|444405|P6|STARTED|Overall Study||1
190616|NCT00503984|444406|P5|STARTED|Overall Study||6
190617|NCT00503984|444407|P4|STARTED|Overall Study||6
190618|NCT00503984|444408|P3|STARTED|Overall Study||3
190619|NCT00503984|444409|P2|STARTED|Overall Study||3
190620|NCT00503984|444410|P1|STARTED|Overall Study||3
190621|NCT00503906|444436|P1|NOT COMPLETED|Overall Study||1
190622|NCT00503906|444436|P1|COMPLETED|Overall Study||29
190623|NCT00503906|444436|P1|STARTED|Overall Study||30
190624|NCT00507130|444448|P4|NOT COMPLETED|Overall Study||1
190625|NCT00507130|444449|P3|NOT COMPLETED|Overall Study||1
190626|NCT00507130|444450|P2|NOT COMPLETED|Overall Study||0
190627|NCT00507130|444451|P1|NOT COMPLETED|Overall Study||1
190628|NCT00507130|444448|P4|COMPLETED|Overall Study||8
190629|NCT00507130|444449|P3|COMPLETED|Overall Study||8
190630|NCT00507130|444450|P2|COMPLETED|Overall Study||9
190631|NCT00507130|444451|P1|COMPLETED|Overall Study||8
190632|NCT00507130|444448|P4|STARTED|Overall Study||9
190633|NCT00507130|444449|P3|STARTED|Overall Study||9
190634|NCT00507130|444450|P2|STARTED|Overall Study||9
190635|NCT00507130|444451|P1|STARTED|Overall Study||9
190636|NCT00506948|444493|P1|NOT COMPLETED|Overall Study||10
190637|NCT00506948|444493|P1|COMPLETED|Overall Study||0
190638|NCT00506948|444493|P1|STARTED|Overall Study||10
190639|NCT00506922|444502|P5|NOT COMPLETED|Overall Study||1
190640|NCT00506922|444503|P4|NOT COMPLETED|Overall Study||2
190641|NCT00506922|444504|P3|NOT COMPLETED|Overall Study||0
190642|NCT00506922|444505|P2|NOT COMPLETED|Overall Study||0
190643|NCT00506922|444506|P1|NOT COMPLETED|Overall Study||0
190644|NCT00506922|444502|P5|COMPLETED|Overall Study||10
190645|NCT00506922|444503|P4|COMPLETED|Overall Study||61
190646|NCT00506922|444504|P3|COMPLETED|Overall Study||29
190647|NCT00506922|444505|P2|COMPLETED|Overall Study||10
190648|NCT00506922|444506|P1|COMPLETED|Overall Study||37
190649|NCT00506922|444502|P5|STARTED|Overall Study||11
190650|NCT00506922|444503|P4|STARTED|Overall Study||63
190651|NCT00506922|444504|P3|STARTED|Overall Study||29
190652|NCT00506922|444505|P2|STARTED|Overall Study||10
190653|NCT00506922|444506|P1|STARTED|Overall Study||37
190654|NCT00506883|444517|P3|NOT COMPLETED|Overall Study||4
190655|NCT00506883|444518|P2|NOT COMPLETED|Overall Study||3
190656|NCT00506883|444519|P1|NOT COMPLETED|Overall Study||7
190657|NCT00506883|444517|P3|COMPLETED|Overall Study||55
190658|NCT00506883|444518|P2|COMPLETED|Overall Study||71
190659|NCT00506883|444519|P1|COMPLETED|Overall Study||45
190660|NCT00506883|444517|P3|STARTED|Overall Study||59
190661|NCT00506883|444518|P2|STARTED|Overall Study||74
190662|NCT00506883|444519|P1|STARTED|Overall Study||52
190663|NCT00506857|444527|P1|NOT COMPLETED|Overall Study||0
190664|NCT00506857|444527|P1|COMPLETED|Overall Study||80
190665|NCT00506857|444527|P1|STARTED|Overall Study||80
190666|NCT00506831|444532|P1|NOT COMPLETED|Overall Study||2
190667|NCT00506831|444532|P1|COMPLETED|Overall Study||7
190668|NCT00506831|444532|P1|STARTED|Overall Study||9
190669|NCT00506714|444538|P2|NOT COMPLETED|Overall Study||0
190670|NCT00506714|444539|P1|NOT COMPLETED|Overall Study||0
190671|NCT00506714|444538|P2|COMPLETED|Overall Study||13
190672|NCT00506714|444539|P1|COMPLETED|Overall Study||13
190673|NCT00506714|444538|P2|STARTED|Overall Study||13
190674|NCT00506714|444539|P1|STARTED|Overall Study||13
190675|NCT00506675|444549|P2|NOT COMPLETED|Overall Study||0
190676|NCT00506675|444550|P1|NOT COMPLETED|Overall Study||0
190677|NCT00506675|444549|P2|COMPLETED|Overall Study||28
190678|NCT00506675|444550|P1|COMPLETED|Overall Study||27
190679|NCT00506675|444549|P2|STARTED|Overall Study||28
190680|NCT00506675|444550|P1|STARTED|Overall Study||27
190681|NCT00506662|444564|P2|NOT COMPLETED|Overall Study||28
190682|NCT00506662|444565|P1|NOT COMPLETED|Overall Study||17
190683|NCT00506662|444564|P2|COMPLETED|Overall Study||20
190684|NCT00506662|444565|P1|COMPLETED|Overall Study||21
190685|NCT00506662|444564|P2|STARTED|Overall Study||48
190686|NCT00506662|444565|P1|STARTED|Overall Study||38
190687|NCT00506597|444595|P1|NOT COMPLETED|Overall Study||0
190688|NCT00506597|444595|P1|COMPLETED|Overall Study||33
190689|NCT00506597|444595|P1|STARTED|Overall Study||33
190690|NCT00506493|444599|P1|NOT COMPLETED|Overall Study||11
190691|NCT00506493|444599|P1|COMPLETED|Overall Study||64
190692|NCT00506493|444599|P1|STARTED|Overall Study||75
190693|NCT00506454|444608|P2|NOT COMPLETED|Overall Study||1
190694|NCT00506454|444609|P1|NOT COMPLETED|Overall Study||1
190695|NCT00506454|444608|P2|COMPLETED|Overall Study||10
190696|NCT00506454|444609|P1|COMPLETED|Overall Study||10
190697|NCT00506454|444608|P2|STARTED|Overall Study||11
190698|NCT00506454|444609|P1|STARTED|Overall Study||11
190699|NCT00506441|444615|P2|NOT COMPLETED|Period 2; Double-blind Period||5
190700|NCT00506441|444616|P1|NOT COMPLETED|Period 2; Double-blind Period||3
190701|NCT00506441|444615|P2|COMPLETED|Period 2; Double-blind Period||79
190702|NCT00506441|444616|P1|COMPLETED|Period 2; Double-blind Period||82
190703|NCT00506441|444615|P2|STARTED|Period 2; Double-blind Period||84
190704|NCT00506441|444616|P1|STARTED|Period 2; Double-blind Period||85
190705|NCT00506441|444615|P2|NOT COMPLETED|Period 1; Open-label Period||0
190706|NCT00506441|444616|P1|NOT COMPLETED|Period 1; Open-label Period||76
190707|NCT00506441|444615|P2|COMPLETED|Period 1; Open-label Period||0
190708|NCT00506441|444616|P1|COMPLETED|Period 1; Open-label Period||169
190709|NCT00506441|444615|P2|STARTED|Period 1; Open-label Period||0
190710|NCT00506441|444616|P1|STARTED|Period 1; Open-label Period||245
190711|NCT00506415|444624|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
190712|NCT00506415|444625|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190713|NCT00506415|444626|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190714|NCT00506415|444627|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190715|NCT00506415|444624|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
190716|NCT00506415|444625|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190717|NCT00506415|444626|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190718|NCT00506415|444627|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
190719|NCT00506415|444624|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
190720|NCT00506415|444625|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
190721|NCT00506415|444626|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
190722|NCT00506415|444627|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
190723|NCT00506415|444624|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
190724|NCT00506415|444625|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
190725|NCT00506415|444626|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
190726|NCT00506415|444627|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
190727|NCT00506415|444624|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
190728|NCT00506415|444625|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
190729|NCT00506415|444626|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
190730|NCT00506415|444627|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
190731|NCT00506415|444624|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
190732|NCT00506415|444625|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
190733|NCT00506415|444626|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
190734|NCT00506415|444627|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
190735|NCT00506415|444624|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190736|NCT00506415|444625|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190737|NCT00506415|444626|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190738|NCT00506415|444627|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
190739|NCT00506415|444624|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190740|NCT00506415|444625|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190741|NCT00506415|444626|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
190742|NCT00506415|444627|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
190743|NCT00506415|444624|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
190744|NCT00506415|444625|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
190745|NCT00506415|444626|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
190746|NCT00506415|444627|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
190747|NCT00506415|444624|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
190748|NCT00506415|444625|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
190749|NCT00506415|444626|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
190750|NCT00506415|444627|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
190751|NCT00506389|444652|P3|NOT COMPLETED|Follow-up Period||0
190752|NCT00506389|444653|P2|NOT COMPLETED|Follow-up Period||0
190753|NCT00506389|444654|P1|NOT COMPLETED|Follow-up Period||0
190754|NCT00506389|444652|P3|COMPLETED|Follow-up Period||136
190755|NCT00506389|444653|P2|COMPLETED|Follow-up Period||138
190756|NCT00506389|444654|P1|COMPLETED|Follow-up Period||139
190757|NCT00506389|444652|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
190758|NCT00506389|444653|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
190759|NCT00506389|444654|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
190760|NCT00506389|444652|P3|NOT COMPLETED|In-treatment Period||12
190761|NCT00506389|444653|P2|NOT COMPLETED|In-treatment Period||15
190762|NCT00506389|444654|P1|NOT COMPLETED|In-treatment Period||26
190763|NCT00506389|444652|P3|COMPLETED|In-treatment Period||125
190764|NCT00506389|444653|P2|COMPLETED|In-treatment Period||124
190765|NCT00506389|444654|P1|COMPLETED|In-treatment Period||117
190766|NCT00506389|444652|P3|All Participants Treated|In-treatment Period||136
190767|NCT00506389|444653|P2|All Participants Treated|In-treatment Period||138
190768|NCT00506389|444654|P1|All Participants Treated|In-treatment Period||139
190769|NCT00506389|444652|P3|STARTED|In-treatment Period||137
190770|NCT00506389|444653|P2|STARTED|In-treatment Period||139
190771|NCT00506389|444654|P1|STARTED|In-treatment Period||143
190772|NCT00506285|444673|P2|NOT COMPLETED|6-month Open Label Phase||12
190773|NCT00506285|444674|P1|NOT COMPLETED|6-month Open Label Phase||10
190774|NCT00506285|444673|P2|COMPLETED|6-month Open Label Phase||19
190775|NCT00506285|444674|P1|COMPLETED|6-month Open Label Phase||10
190776|NCT00506285|444673|P2|STARTED|6-month Open Label Phase||31
190777|NCT00506285|444674|P1|STARTED|6-month Open Label Phase||20
190778|NCT00506285|444673|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
190779|NCT00506285|444674|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
190780|NCT00506285|444673|P2|COMPLETED|Double Blind Cross-Over Phase||31
190781|NCT00506285|444674|P1|COMPLETED|Double Blind Cross-Over Phase||20
190782|NCT00506285|444673|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
190783|NCT00506285|444674|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
190784|NCT00506285|444673|P2|STARTED|Double Blind Cross-Over Phase||36
190785|NCT00506285|444674|P1|STARTED|Double Blind Cross-Over Phase||29
190786|NCT00506285|444673|P2|NOT COMPLETED|3 Week Screening Phase||10
190787|NCT00506285|444674|P1|NOT COMPLETED|3 Week Screening Phase||17
190788|NCT00506285|444673|P2|COMPLETED|3 Week Screening Phase||36
190789|NCT00506285|444674|P1|COMPLETED|3 Week Screening Phase||29
190790|NCT00506285|444673|P2|STARTED|3 Week Screening Phase||46
190791|NCT00506285|444674|P1|STARTED|3 Week Screening Phase||46
190792|NCT00506155|444682|P1|NOT COMPLETED|Overall Study||0
190793|NCT00506155|444682|P1|COMPLETED|Overall Study||60
190794|NCT00506155|444682|P1|STARTED|Overall Study||60
190795|NCT00506077|444689|P2|NOT COMPLETED|Treatment Period 2||1
190796|NCT00506077|444690|P1|NOT COMPLETED|Treatment Period 2||1
190797|NCT00506077|444689|P2|COMPLETED|Treatment Period 2||23
190798|NCT00506077|444690|P1|COMPLETED|Treatment Period 2||23
190799|NCT00506077|444689|P2|STARTED|Treatment Period 2||24
190800|NCT00506077|444690|P1|STARTED|Treatment Period 2||24
190801|NCT00506077|444689|P2|NOT COMPLETED|Washout||0
190802|NCT00506077|444690|P1|NOT COMPLETED|Washout||0
190803|NCT00506077|444689|P2|COMPLETED|Washout||24
190804|NCT00506077|444690|P1|COMPLETED|Washout||24
190805|NCT00506077|444689|P2|STARTED|Washout||24
190806|NCT00506077|444690|P1|STARTED|Washout||24
190807|NCT00506077|444689|P2|NOT COMPLETED|Treatment Period 1||3
190808|NCT00506077|444690|P1|NOT COMPLETED|Treatment Period 1||4
190809|NCT00506077|444689|P2|COMPLETED|Treatment Period 1||24
190810|NCT00506077|444690|P1|COMPLETED|Treatment Period 1||24
190811|NCT00506077|444689|P2|STARTED|Treatment Period 1||27
190812|NCT00506077|444690|P1|STARTED|Treatment Period 1||28
190813|NCT00506064|444712|P2|NOT COMPLETED|Overall Study||0
190814|NCT00506064|444713|P1|NOT COMPLETED|Overall Study||0
190815|NCT00506064|444712|P2|COMPLETED|Overall Study||0
190816|NCT00506064|444713|P1|COMPLETED|Overall Study||1
190817|NCT00506064|444712|P2|STARTED|Overall Study||0
190818|NCT00506064|444713|P1|STARTED|Overall Study||1
190819|NCT00506025|444722|P3|NOT COMPLETED|Overall Study||0
190820|NCT00506025|444723|P2|NOT COMPLETED|Overall Study||0
190821|NCT00506025|444724|P1|NOT COMPLETED|Overall Study||0
190822|NCT00506025|444722|P3|COMPLETED|Overall Study||8
190823|NCT00506025|444723|P2|COMPLETED|Overall Study||9
190824|NCT00506025|444724|P1|COMPLETED|Overall Study||10
190825|NCT00506025|444722|P3|STARTED|Overall Study||8
190826|NCT00506025|444723|P2|STARTED|Overall Study||9
190827|NCT00506025|444724|P1|STARTED|Overall Study||10
190828|NCT00505934|444732|P1|NOT COMPLETED|Overall Study||3
190829|NCT00505934|444732|P1|COMPLETED|Overall Study||16
190830|NCT00505934|444732|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
190831|NCT00505921|444738|P1|NOT COMPLETED|Overall Study||9
190832|NCT00505921|444738|P1|COMPLETED|Overall Study||18
190833|NCT00505921|444738|P1|STARTED|Overall Study||27
190834|NCT00505895|444744|P2|NOT COMPLETED|Overall Study||0
190835|NCT00505895|444745|P1|NOT COMPLETED|Overall Study||0
190836|NCT00505895|444744|P2|COMPLETED|Overall Study||23
190837|NCT00505895|444745|P1|COMPLETED|Overall Study||27
190838|NCT00505895|444744|P2|STARTED|Overall Study||23
190839|NCT00505895|444745|P1|STARTED|Overall Study||27
190840|NCT00505778|444755|P2|NOT COMPLETED|Overall Study||135
190841|NCT00505778|444756|P1|NOT COMPLETED|Overall Study||134
190842|NCT00505778|444755|P2|COMPLETED|Overall Study||378
190843|NCT00505778|444756|P1|COMPLETED|Overall Study||380
190844|NCT00505778|444755|P2|Intent to Treat (ITT) Population|Overall Study||511
190845|NCT00505778|444756|P1|Intent to Treat (ITT) Population|Overall Study||512
190846|NCT00505778|444755|P2|STARTED|Overall Study||513
190847|NCT00505778|444756|P1|STARTED|Overall Study||514
190848|NCT00505765|444775|P3|NOT COMPLETED|Overall Study||3
190849|NCT00505765|444776|P2|NOT COMPLETED|Overall Study||3
190850|NCT00505765|444777|P1|NOT COMPLETED|Overall Study||2
190851|NCT00505765|444775|P3|COMPLETED|Overall Study||19
190852|NCT00505765|444776|P2|COMPLETED|Overall Study||17
190853|NCT00505765|444777|P1|COMPLETED|Overall Study||19
190854|NCT00505765|444775|P3|Mid-Point Assessment|Overall Study||21
190855|NCT00505765|444776|P2|Mid-Point Assessment|Overall Study||19
190856|NCT00505765|444777|P1|Mid-Point Assessment|Overall Study||20
190857|NCT00505765|444775|P3|STARTED|Overall Study||22
190858|NCT00505765|444776|P2|STARTED|Overall Study||20
190859|NCT00505765|444777|P1|STARTED|Overall Study||21
190860|NCT00505752|444804|P4|NOT COMPLETED|Overall Study||6
190861|NCT00505752|444805|P3|NOT COMPLETED|Overall Study||8
190862|NCT00505752|444806|P2|NOT COMPLETED|Overall Study||9
190863|NCT00505752|444807|P1|NOT COMPLETED|Overall Study||6
190864|NCT00505752|444804|P4|COMPLETED|Overall Study||126
190865|NCT00505752|444805|P3|COMPLETED|Overall Study||120
190866|NCT00505752|444806|P2|COMPLETED|Overall Study||119
190867|NCT00505752|444807|P1|COMPLETED|Overall Study||126
190868|NCT00505752|444804|P4|STARTED|Overall Study||132
190869|NCT00505752|444805|P3|STARTED|Overall Study||128
190870|NCT00505752|444806|P2|STARTED|Overall Study||128
190871|NCT00505752|444807|P1|STARTED|Overall Study||132
190872|NCT00505687|444821|P1|NOT COMPLETED|Overall Study||95
190873|NCT00505687|444821|P1|COMPLETED|Overall Study||91
190874|NCT00505687|444821|P1|STARTED|Overall Study||186
190875|NCT00505661|444827|P1|NOT COMPLETED|Overall Study||4
190876|NCT00505661|444827|P1|COMPLETED|Overall Study||12
190877|NCT00505661|444827|P1|STARTED|Overall Study||16
190878|NCT00505635|444831|P1|NOT COMPLETED|Overall Study||0
190879|NCT00505635|444831|P1|COMPLETED|Overall Study||5
190880|NCT00505635|444831|P1|STARTED|Overall Study||5
190881|NCT00505622|444838|P3|NOT COMPLETED|Overall Study||96
190882|NCT00505622|444839|P2|NOT COMPLETED|Overall Study||108
190883|NCT00505622|444840|P1|NOT COMPLETED|Overall Study||121
190884|NCT00505622|444838|P3|COMPLETED|Overall Study||0
190885|NCT00505622|444839|P2|COMPLETED|Overall Study||0
190886|NCT00505622|444840|P1|COMPLETED|Overall Study||0
190887|NCT00505622|444838|P3|STARTED|Overall Study||96
190888|NCT00505622|444839|P2|STARTED|Overall Study||108
190889|NCT00505622|444840|P1|STARTED|Overall Study||121
190890|NCT00505518|444857|P1|NOT COMPLETED|Overall Study||0
190891|NCT00505518|444857|P1|COMPLETED|Overall Study||9
190892|NCT00505518|444857|P1|STARTED|Overall Study||9
190893|NCT00505414|444865|P5|NOT COMPLETED|Maintenance Phase||0
190894|NCT00505414|444866|P4|NOT COMPLETED|Maintenance Phase||0
190895|NCT00505414|444867|P3|NOT COMPLETED|Maintenance Phase||8
190896|NCT00505414|444868|P2|NOT COMPLETED|Maintenance Phase||5
190897|NCT00505414|444869|P1|NOT COMPLETED|Maintenance Phase||6
190898|NCT00505414|444865|P5|COMPLETED|Maintenance Phase||0
190899|NCT00505414|444866|P4|COMPLETED|Maintenance Phase||0
190900|NCT00505414|444867|P3|COMPLETED|Maintenance Phase||6
190901|NCT00505414|444868|P2|COMPLETED|Maintenance Phase||10
190902|NCT00505414|444869|P1|COMPLETED|Maintenance Phase||12
190903|NCT00505414|444865|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
190904|NCT00505414|444866|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
190905|NCT00505414|444867|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
190906|NCT00505414|444868|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
190907|NCT00505414|444869|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
190908|NCT00505414|444865|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
190909|NCT00505414|444866|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
190910|NCT00505414|444867|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
190911|NCT00505414|444868|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
190912|NCT00505414|444869|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
190913|NCT00505414|444865|P5|NOT COMPLETED|Titration Phase||12
190914|NCT00505414|444866|P4|NOT COMPLETED|Titration Phase||30
190915|NCT00505414|444867|P3|NOT COMPLETED|Titration Phase||0
190916|NCT00505414|444868|P2|NOT COMPLETED|Titration Phase||0
190917|NCT00505414|444869|P1|NOT COMPLETED|Titration Phase||0
190918|NCT00505414|444865|P5|COMPLETED|Titration Phase||19
190919|NCT00505414|444866|P4|COMPLETED|Titration Phase||32
190920|NCT00505414|444867|P3|COMPLETED|Titration Phase||0
190921|NCT00505414|444868|P2|COMPLETED|Titration Phase||0
190922|NCT00505414|444869|P1|COMPLETED|Titration Phase||0
190923|NCT00505414|444865|P5|STARTED|Titration Phase||31
190924|NCT00505414|444866|P4|STARTED|Titration Phase||62
190925|NCT00505414|444867|P3|STARTED|Titration Phase||0
190926|NCT00505414|444868|P2|STARTED|Titration Phase||0
190927|NCT00505414|444869|P1|STARTED|Titration Phase||0
190928|NCT00505375|444886|P2|NOT COMPLETED|Overall Study||5
190929|NCT00505375|444887|P1|NOT COMPLETED|Overall Study||4
190930|NCT00505375|444886|P2|COMPLETED|Overall Study||30
190931|NCT00505375|444887|P1|COMPLETED|Overall Study||73
190932|NCT00505375|444886|P2|STARTED|Overall Study||35
190933|NCT00505375|444887|P1|STARTED|Overall Study||77
190934|NCT00505284|444898|P5|NOT COMPLETED|Overall Study||33
190935|NCT00505284|444899|P4|NOT COMPLETED|Overall Study||19
190936|NCT00505284|444900|P3|NOT COMPLETED|Overall Study||12
190937|NCT00505284|444901|P2|NOT COMPLETED|Overall Study||16
190938|NCT00505284|444902|P1|NOT COMPLETED|Overall Study||10
190939|NCT00505284|444898|P5|COMPLETED|Overall Study||37
190940|NCT00505284|444899|P4|COMPLETED|Overall Study||49
190941|NCT00505284|444900|P3|COMPLETED|Overall Study||57
190942|NCT00505284|444901|P2|COMPLETED|Overall Study||56
190943|NCT00505284|444902|P1|COMPLETED|Overall Study||63
190944|NCT00505284|444898|P5|STARTED|Overall Study||70
190945|NCT00505284|444899|P4|STARTED|Overall Study||68
190946|NCT00505284|444900|P3|STARTED|Overall Study||69
190947|NCT00505284|444901|P2|STARTED|Overall Study||72
190948|NCT00505284|444902|P1|STARTED|Overall Study||73
190949|NCT00505076|444972|P3|NOT COMPLETED|Overall Study||5
190950|NCT00505076|444973|P2|NOT COMPLETED|Overall Study||2
190951|NCT00505076|444974|P1|NOT COMPLETED|Overall Study||3
190952|NCT00505076|444972|P3|COMPLETED|Overall Study||17
190953|NCT00505076|444973|P2|COMPLETED|Overall Study||17
190954|NCT00505076|444974|P1|COMPLETED|Overall Study||19
190955|NCT00505076|444972|P3|STARTED|Overall Study||22
190956|NCT00505076|444973|P2|STARTED|Overall Study||19
190957|NCT00505076|444974|P1|STARTED|Overall Study||22
190958|NCT00504985|444988|P1|NOT COMPLETED|Overall Study||0
190959|NCT00504985|444988|P1|COMPLETED|Overall Study||14
190960|NCT00504985|444988|P1|STARTED|Overall Study||14
190961|NCT00504777|444992|P1|NOT COMPLETED|Overall Study||1
190962|NCT00504777|444992|P1|COMPLETED|Overall Study||35
190963|NCT00504777|444992|P1|STARTED|Overall Study||36
190964|NCT00504725|445001|P2|NOT COMPLETED|Overall Study||0
190965|NCT00504725|445002|P1|NOT COMPLETED|Overall Study||1
190966|NCT00504725|445001|P2|COMPLETED|Overall Study||20
190967|NCT00504725|445002|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
190968|NCT00504725|445001|P2|STARTED|Overall Study||20
190969|NCT00504725|445002|P1|STARTED|Overall Study||21
190970|NCT00504660|445014|P2|NOT COMPLETED|Overall Study||0
190971|NCT00504660|445015|P1|NOT COMPLETED|Overall Study||0
190972|NCT00504660|445014|P2|COMPLETED|Overall Study||43
190973|NCT00504660|445015|P1|COMPLETED|Overall Study||31
190974|NCT00504660|445014|P2|STARTED|Overall Study||43
190975|NCT00504660|445015|P1|STARTED|Overall Study||31
190976|NCT00504595|445025|P4|NOT COMPLETED|Overall Study||0
190977|NCT00504595|445026|P3|NOT COMPLETED|Overall Study||2
190978|NCT00504595|445027|P2|NOT COMPLETED|Overall Study||0
190979|NCT00504595|445028|P1|NOT COMPLETED|Overall Study||1
190980|NCT00504595|445025|P4|COMPLETED|Overall Study||10
190981|NCT00504595|445026|P3|COMPLETED|Overall Study||8
190982|NCT00504595|445027|P2|COMPLETED|Overall Study||10
190983|NCT00504595|445028|P1|COMPLETED|Overall Study||49
190984|NCT00504595|445025|P4|STARTED|Overall Study||10
190985|NCT00504595|445026|P3|STARTED|Overall Study||10
190986|NCT00504595|445027|P2|STARTED|Overall Study||10
190987|NCT00504595|445028|P1|STARTED|Overall Study||50
190988|NCT00504556|445045|P5|NOT COMPLETED|Overall Study||25
190989|NCT00504556|445046|P4|NOT COMPLETED|Overall Study||128
190990|NCT00504556|445047|P3|NOT COMPLETED|Overall Study||31
190991|NCT00504556|445048|P2|NOT COMPLETED|Overall Study||38
190992|NCT00504556|445049|P1|NOT COMPLETED|Overall Study||35
190993|NCT00504556|445045|P5|COMPLETED|Overall Study||226
190994|NCT00504556|445046|P4|COMPLETED|Overall Study||52
190995|NCT00504556|445047|P3|COMPLETED|Overall Study||204
190996|NCT00504556|445048|P2|COMPLETED|Overall Study||207
190997|NCT00504556|445049|P1|COMPLETED|Overall Study||200
190998|NCT00504556|445045|P5|Pharmacodynamic Analysis Set|Overall Study||244
190999|NCT00504556|445046|P4|Pharmacodynamic Analysis Set|Overall Study||170
191000|NCT00504556|445047|P3|Pharmacodynamic Analysis Set|Overall Study||228
191001|NCT00504556|445048|P2|Pharmacodynamic Analysis Set|Overall Study||236
191002|NCT00504556|445049|P1|Pharmacodynamic Analysis Set|Overall Study||230
191003|NCT00504556|445045|P5|Per Protocol Analysis Set|Overall Study||250
191004|NCT00504556|445046|P4|Per Protocol Analysis Set|Overall Study||180
191005|NCT00504556|445047|P3|Per Protocol Analysis Set|Overall Study||234
191006|NCT00504556|445048|P2|Per Protocol Analysis Set|Overall Study||243
191007|NCT00504556|445049|P1|Per Protocol Analysis Set|Overall Study||235
191008|NCT00504556|445045|P5|Safety Analysis Set|Overall Study||250
191009|NCT00504556|445046|P4|Safety Analysis Set|Overall Study||180
191010|NCT00504556|445047|P3|Safety Analysis Set|Overall Study||234
191011|NCT00504556|445048|P2|Safety Analysis Set|Overall Study||244
191012|NCT00504556|445049|P1|Safety Analysis Set|Overall Study||235
191013|NCT00504556|445045|P5|STARTED|Overall Study||251
191014|NCT00504556|445046|P4|STARTED|Overall Study||180
191015|NCT00504556|445047|P3|STARTED|Overall Study||235
191016|NCT00504556|445048|P2|STARTED|Overall Study||245
191017|NCT00504556|445049|P1|STARTED|Overall Study||235
191018|NCT00504504|445109|P1|NOT COMPLETED|Overall Study||0
191019|NCT00504504|445109|P1|COMPLETED|Overall Study||82
191020|NCT00504504|445109|P1|STARTED|Overall Study||82
191021|NCT00504426|445117|P4|NOT COMPLETED|Overall Study||0
191022|NCT00504426|445118|P3|NOT COMPLETED|Overall Study||4
191023|NCT00504426|445119|P2|NOT COMPLETED|Overall Study||1
191024|NCT00504426|445120|P1|NOT COMPLETED|Overall Study||3
191025|NCT00504426|445117|P4|COMPLETED|Overall Study||24
191026|NCT00504426|445118|P3|COMPLETED|Overall Study||18
191027|NCT00504426|445119|P2|COMPLETED|Overall Study||22
191028|NCT00504426|445120|P1|COMPLETED|Overall Study||29
191029|NCT00504426|445117|P4|STARTED|Overall Study||24
191030|NCT00504426|445118|P3|STARTED|Overall Study||22
191031|NCT00504426|445119|P2|STARTED|Overall Study||23
191032|NCT00504426|445120|P1|STARTED|Overall Study||32
191033|NCT00504257|445134|P1|NOT COMPLETED|Overall Study||4
191034|NCT00504257|445134|P1|COMPLETED|Overall Study||41
191035|NCT00504257|445134|P1|STARTED|Overall Study||45
191036|NCT00504231|445146|P4|NOT COMPLETED|Overall Study||0
191037|NCT00504231|445147|P3|NOT COMPLETED|Overall Study||1
191038|NCT00504231|445148|P2|NOT COMPLETED|Overall Study||0
191039|NCT00504231|445149|P1|NOT COMPLETED|Overall Study||0
191040|NCT00504231|445146|P4|COMPLETED|Overall Study||65
191041|NCT00504231|445147|P3|COMPLETED|Overall Study||63
191042|NCT00504231|445148|P2|COMPLETED|Overall Study||64
191043|NCT00504231|445149|P1|COMPLETED|Overall Study||65
191044|NCT00504231|445146|P4|STARTED|Overall Study||65
191045|NCT00504231|445147|P3|STARTED|Overall Study||64
191046|NCT00504231|445148|P2|STARTED|Overall Study||64
191047|NCT00504231|445149|P1|STARTED|Overall Study||65
191048|NCT00504166|445169|P2|NOT COMPLETED|Overall Study||14
191049|NCT00504166|445170|P1|NOT COMPLETED|Overall Study||6
191050|NCT00504166|445169|P2|COMPLETED|Overall Study||13
191051|NCT00504166|445170|P1|COMPLETED|Overall Study||20
191052|NCT00504166|445169|P2|STARTED|Overall Study||27
191053|NCT00504166|445170|P1|STARTED|Overall Study||26
191054|NCT00504153|445176|P1|NOT COMPLETED|Overall Study||6
191055|NCT00504153|445176|P1|COMPLETED|Overall Study||13
191056|NCT00504153|445176|P1|STARTED|Overall Study||19
191057|NCT00504075|445184|P1|NOT COMPLETED|Overall Study||8
191058|NCT00504075|445184|P1|COMPLETED|Overall Study||27
191059|NCT00504075|445184|P1|STARTED|Overall Study||35
191060|NCT00503841|445190|P1|NOT COMPLETED|Overall Study||44
191061|NCT00503841|445190|P1|COMPLETED|Overall Study||0
191062|NCT00503841|445190|P1|STARTED|Overall Study||44
191063|NCT00503776|445198|P4|NOT COMPLETED|Overall Study||2
191064|NCT00503776|445199|P3|NOT COMPLETED|Overall Study||2
191065|NCT00503776|445200|P2|NOT COMPLETED|Overall Study||0
191066|NCT00503776|445201|P1|NOT COMPLETED|Overall Study||1
191067|NCT00503776|445198|P4|COMPLETED|Overall Study||8
191068|NCT00503776|445199|P3|COMPLETED|Overall Study||10
191069|NCT00503776|445200|P2|COMPLETED|Overall Study||12
191070|NCT00503776|445201|P1|COMPLETED|Overall Study||7
191071|NCT00503776|445198|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
191072|NCT00503776|445199|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
191073|NCT00503776|445200|P2|STARTED|Overall Study||12
191074|NCT00503776|445201|P1|STARTED|Overall Study||8
191075|NCT00503750|445219|P1|NOT COMPLETED|Overall Study||0
191076|NCT00503750|445219|P1|COMPLETED|Overall Study||27
191077|NCT00503750|445219|P1|STARTED|Overall Study||27
191078|NCT00503698|445226|P2|NOT COMPLETED|Overall Study||355
191079|NCT00503698|445227|P1|NOT COMPLETED|Overall Study||357
191080|NCT00503698|445226|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
191081|NCT00503698|445227|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
191082|NCT00503698|445226|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
191083|NCT00503698|445227|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
191084|NCT00503698|445226|P2|STARTED|Overall Study|Randomised|355
191085|NCT00503698|445227|P1|STARTED|Overall Study|Randomised|357
191086|NCT00503425|445241|P1|NOT COMPLETED|Overall Study||54
191087|NCT00503425|445241|P1|COMPLETED|Overall Study||161
191088|NCT00503425|445241|P1|STARTED|Overall Study||215
191089|NCT00503399|445251|P2|NOT COMPLETED|Overall Study||8
191090|NCT00503399|445252|P1|NOT COMPLETED|Overall Study||7
191091|NCT00503399|445251|P2|COMPLETED|Overall Study||39
191092|NCT00503399|445252|P1|COMPLETED|Overall Study||38
191093|NCT00503399|445251|P2|STARTED|Overall Study||47
191094|NCT00503399|445252|P1|STARTED|Overall Study||45
191095|NCT00503308|445276|P2|NOT COMPLETED|Overall Study||1
191096|NCT00503308|445277|P1|NOT COMPLETED|Overall Study||2
191097|NCT00503308|445276|P2|COMPLETED|Overall Study||134
191098|NCT00503308|445277|P1|COMPLETED|Overall Study||144
191099|NCT00503308|445276|P2|STARTED|Overall Study||135
191100|NCT00503308|445277|P1|STARTED|Overall Study||146
191101|NCT00503113|445286|P3|NOT COMPLETED|Overall Study||28
191102|NCT00503113|445287|P2|NOT COMPLETED|Overall Study||28
191103|NCT00503113|445288|P1|NOT COMPLETED|Overall Study||33
191104|NCT00503113|445286|P3|COMPLETED|Overall Study||241
191105|NCT00503113|445287|P2|COMPLETED|Overall Study||236
191106|NCT00503113|445288|P1|COMPLETED|Overall Study||235
191107|NCT00503113|445286|P3|Safety Population|Overall Study||267
191108|NCT00503113|445287|P2|Safety Population|Overall Study||263
191109|NCT00503113|445288|P1|Safety Population|Overall Study||263
191110|NCT00503113|445286|P3|Per Protocol Population (PP)|Overall Study||241
191111|NCT00503113|445287|P2|Per Protocol Population (PP)|Overall Study||243
191112|NCT00503113|445288|P1|Per Protocol Population (PP)|Overall Study||246
191113|NCT00503113|445286|P3|Intent to Treat Population (ITT)|Overall Study||268
191114|NCT00503113|445287|P2|Intent to Treat Population (ITT)|Overall Study||261
191115|NCT00503113|445288|P1|Intent to Treat Population (ITT)|Overall Study||262
191116|NCT00503113|445286|P3|STARTED|Overall Study||269
191117|NCT00503113|445287|P2|STARTED|Overall Study||264
191118|NCT00503113|445288|P1|STARTED|Overall Study||268
191119|NCT00503009|445320|P3|NOT COMPLETED|Overall Study||3
191120|NCT00503009|445321|P2|NOT COMPLETED|Overall Study||2
191121|NCT00503009|445322|P1|NOT COMPLETED|Overall Study||1
191122|NCT00503009|445320|P3|COMPLETED|Overall Study||3
191123|NCT00503009|445321|P2|COMPLETED|Overall Study||3
191124|NCT00503009|445322|P1|COMPLETED|Overall Study||4
191125|NCT00503009|445320|P3|STARTED|Overall Study||6
191126|NCT00503009|445321|P2|STARTED|Overall Study||5
191127|NCT00503009|445322|P1|STARTED|Overall Study||5
191128|NCT00502996|445339|P1|NOT COMPLETED|Overall Study||44
191129|NCT00502996|445339|P1|COMPLETED|Overall Study||188
191130|NCT00502996|445339|P1|STARTED|Overall Study||232
191131|NCT00502944|445365|P2|NOT COMPLETED|Overall Study||1766
191132|NCT00502944|445366|P1|NOT COMPLETED|Overall Study||1064
191133|NCT00502944|445365|P2|COMPLETED|Overall Study||643
191134|NCT00502944|445366|P1|COMPLETED|Overall Study||1382
191135|NCT00502944|445365|P2|STARTED|Overall Study||2409
191136|NCT00502944|445366|P1|STARTED|Overall Study||2446
191137|NCT00502905|445378|P1|NOT COMPLETED|Overall Study||0
191138|NCT00502905|445378|P1|COMPLETED|Overall Study||196
191139|NCT00502905|445378|P1|STARTED|Overall Study||196
191140|NCT00502853|445382|P1|NOT COMPLETED|Overall Study||0
191141|NCT00502853|445382|P1|COMPLETED|Overall Study||10
191142|NCT00502853|445382|P1|STARTED|Overall Study||10
191143|NCT00502840|445407|P1|NOT COMPLETED|Overall Study||100
191144|NCT00502840|445407|P1|COMPLETED|Overall Study||93
191145|NCT00502840|445407|P1|STARTED|Overall Study||193
191146|NCT00502801|445435|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
191147|NCT00502801|445435|P1|COMPLETED|End of Therapy to Test of Cure||121
191148|NCT00502801|445435|P1|STARTED|End of Therapy to Test of Cure||129
191149|NCT00502801|445435|P1|NOT COMPLETED|Treatment Period||54
191150|NCT00502801|445435|P1|COMPLETED|Treatment Period||129
191151|NCT00502801|445435|P1|STARTED|Treatment Period||183
191152|NCT00502775|445443|P3|NOT COMPLETED|Overall Study||13
191153|NCT00502775|445444|P2|NOT COMPLETED|Overall Study||15
191154|NCT00502775|445445|P1|NOT COMPLETED|Overall Study||10
191155|NCT00502775|445443|P3|COMPLETED|Overall Study||214
191156|NCT00502775|445444|P2|COMPLETED|Overall Study||209
191157|NCT00502775|445445|P1|COMPLETED|Overall Study||219
191158|NCT00502775|445443|P3|STARTED|Overall Study||227
191159|NCT00502775|445444|P2|STARTED|Overall Study||224
191160|NCT00502775|445445|P1|STARTED|Overall Study||229
191161|NCT00502697|445488|P2|NOT COMPLETED|Overall Study||12
191162|NCT00502697|445489|P1|NOT COMPLETED|Overall Study||13
191163|NCT00502697|445488|P2|COMPLETED|Overall Study||102
191164|NCT00502697|445489|P1|COMPLETED|Overall Study||109
191165|NCT00502697|445488|P2|STARTED|Overall Study||114
191166|NCT00502697|445489|P1|STARTED|Overall Study||122
191167|NCT00502671|445497|P1|NOT COMPLETED|Overall Study||77
191168|NCT00502671|445497|P1|COMPLETED|Overall Study||151
191169|NCT00502671|445497|P1|STARTED|Overall Study||228
191170|NCT00502593|445514|P12|NOT COMPLETED|Overall Study||0
191171|NCT00502593|445515|P11|NOT COMPLETED|Overall Study||2
191172|NCT00502593|445516|P10|NOT COMPLETED|Overall Study||0
191173|NCT00502593|445517|P9|NOT COMPLETED|Overall Study||6
191174|NCT00502593|445518|P8|NOT COMPLETED|Overall Study||0
191175|NCT00502593|445519|P7|NOT COMPLETED|Overall Study||5
191176|NCT00502593|445520|P6|NOT COMPLETED|Overall Study||0
191177|NCT00502593|445521|P5|NOT COMPLETED|Overall Study||4
191178|NCT00502593|445522|P4|NOT COMPLETED|Overall Study||4
191179|NCT00502593|445523|P3|NOT COMPLETED|Overall Study||10
191180|NCT00502593|445524|P2|NOT COMPLETED|Overall Study||2
191181|NCT00502593|445525|P1|NOT COMPLETED|Overall Study||3
191182|NCT00502593|445514|P12|COMPLETED|Overall Study||18
191183|NCT00502593|445515|P11|COMPLETED|Overall Study||47
191184|NCT00502593|445516|P10|COMPLETED|Overall Study||17
191185|NCT00502593|445517|P9|COMPLETED|Overall Study||43
191186|NCT00502593|445518|P8|COMPLETED|Overall Study||17
191187|NCT00502593|445519|P7|COMPLETED|Overall Study||44
191188|NCT00502593|445520|P6|COMPLETED|Overall Study||17
191189|NCT00502593|445521|P5|COMPLETED|Overall Study||47
191190|NCT00502593|445522|P4|COMPLETED|Overall Study||14
191191|NCT00502593|445523|P3|COMPLETED|Overall Study||41
191192|NCT00502593|445524|P2|COMPLETED|Overall Study||16
191193|NCT00502593|445525|P1|COMPLETED|Overall Study||48
191194|NCT00502593|445514|P12|STARTED|Overall Study||18
191195|NCT00502593|445515|P11|STARTED|Overall Study||49
191196|NCT00502593|445516|P10|STARTED|Overall Study||17
191197|NCT00502593|445517|P9|STARTED|Overall Study||49
191198|NCT00502593|445518|P8|STARTED|Overall Study||17
191199|NCT00502593|445519|P7|STARTED|Overall Study||49
191200|NCT00502593|445520|P6|STARTED|Overall Study||17
191201|NCT00502593|445521|P5|STARTED|Overall Study||51
191202|NCT00502593|445522|P4|STARTED|Overall Study||18
191203|NCT00502593|445523|P3|STARTED|Overall Study||51
191204|NCT00502593|445524|P2|STARTED|Overall Study||18
191205|NCT00502593|445525|P1|STARTED|Overall Study||51
191206|NCT00502320|446041|P2|NOT COMPLETED|Overall Study||7
191207|NCT00502320|446042|P1|NOT COMPLETED|Overall Study||6
191208|NCT00502320|446041|P2|COMPLETED|Overall Study||18
191209|NCT00502320|446042|P1|COMPLETED|Overall Study||19
191210|NCT00502320|446041|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
191211|NCT00502320|446042|P1|Screening Visit|Overall Study||25
191212|NCT00502320|446041|P2|STARTED|Overall Study||25
191213|NCT00502320|446042|P1|STARTED|Overall Study||25
191214|NCT00502242|446054|P2|NOT COMPLETED|Overall Study||56
191215|NCT00502242|446055|P1|NOT COMPLETED|Overall Study||51
191216|NCT00502242|446054|P2|COMPLETED|Overall Study||84
191217|NCT00502242|446055|P1|COMPLETED|Overall Study||104
191218|NCT00502242|446054|P2|STARTED|Overall Study||140
191219|NCT00502242|446055|P1|STARTED|Overall Study||155
191220|NCT00502216|446108|P2|NOT COMPLETED|Overall Study||0
191221|NCT00502216|446109|P1|NOT COMPLETED|Overall Study||0
191222|NCT00502216|446108|P2|COMPLETED|Overall Study||19
191223|NCT00502216|446109|P1|COMPLETED|Overall Study||21
191224|NCT00502216|446108|P2|STARTED|Overall Study||19
191225|NCT00502216|446109|P1|STARTED|Overall Study||21
191226|NCT00502203|446115|P1|NOT COMPLETED|Overall Study||1
191227|NCT00502203|446115|P1|COMPLETED|Overall Study||22
191228|NCT00502203|446115|P1|STARTED|Overall Study||23
191229|NCT00501345|446119|P1|NOT COMPLETED|Overall Study||0
191230|NCT00501345|446119|P1|COMPLETED|Overall Study||5
191231|NCT00501345|446119|P1|STARTED|Overall Study||5
191232|NCT00501293|446125|P2|NOT COMPLETED|Maintenance Period||28
191233|NCT00501293|446126|P1|NOT COMPLETED|Maintenance Period||46
191234|NCT00501293|446125|P2|COMPLETED|Maintenance Period||25
191235|NCT00501293|446126|P1|COMPLETED|Maintenance Period||63
191236|NCT00501293|446125|P2|STARTED|Maintenance Period||53
191237|NCT00501293|446126|P1|STARTED|Maintenance Period||109
191238|NCT00501293|446125|P2|NOT COMPLETED|Optimization Period||0
191239|NCT00501293|446126|P1|NOT COMPLETED|Optimization Period||1
191240|NCT00501293|446125|P2|COMPLETED|Optimization Period||53
191241|NCT00501293|446126|P1|COMPLETED|Optimization Period||109
191242|NCT00501293|446125|P2|STARTED|Optimization Period||53
191243|NCT00501293|446126|P1|STARTED|Optimization Period||110
191244|NCT00501228|446153|P1|NOT COMPLETED|Overall Study||1
191245|NCT00501228|446153|P1|COMPLETED|Overall Study||1
191246|NCT00501228|446153|P1|STARTED|Overall Study||2
191247|NCT00501995|446157|P1|NOT COMPLETED|Overall Study||1
191248|NCT00501995|446157|P1|COMPLETED|Overall Study||5
191249|NCT00501995|446157|P1|STARTED|Overall Study||6
191250|NCT00501969|446161|P1|NOT COMPLETED|Overall Study||206
191251|NCT00501969|446161|P1|COMPLETED|Overall Study||189
191252|NCT00501969|446161|P1|STARTED|Overall Study||395
191253|NCT00501943|446169|P2|NOT COMPLETED|Overall Study||3
191254|NCT00501943|446170|P1|NOT COMPLETED|Overall Study||2
191255|NCT00501943|446169|P2|COMPLETED|Overall Study||18
191256|NCT00501943|446170|P1|COMPLETED|Overall Study||20
191257|NCT00501943|446169|P2|STARTED|Overall Study||21
191258|NCT00501943|446170|P1|STARTED|Overall Study||22
191259|NCT00501891|446186|P1|NOT COMPLETED|Overall Study||0
191260|NCT00501891|446186|P1|COMPLETED|Overall Study||32
191261|NCT00501891|446186|P1|STARTED|Overall Study||32
191262|NCT00501852|446193|P1|NOT COMPLETED|Overall Study||5
191263|NCT00501852|446193|P1|COMPLETED|Overall Study||78
191264|NCT00501852|446193|P1|Tiotropium|Overall Study||55
191265|NCT00501852|446193|P1|Placebo|Overall Study||55
191266|NCT00501852|446193|P1|NVA237 100µg|Overall Study||54
191267|NCT00501852|446193|P1|NVA237 50µg|Overall Study||53
191268|NCT00501852|446193|P1|NVA237 25µg|Overall Study||51
191269|NCT00501852|446193|P1|NVA237 12.5µg|Overall Study||55
191270|NCT00501852|446193|P1|STARTED|Overall Study||83
191271|NCT00501644|446213|P1|NOT COMPLETED|Overall Study||5
191272|NCT00501644|446213|P1|COMPLETED|Overall Study||54
191273|NCT00501644|446213|P1|STARTED|Overall Study||59
191274|NCT00501631|446219|P2|NOT COMPLETED|Part B (Open-label Period)||51
191275|NCT00501631|446220|P1|NOT COMPLETED|Part B (Open-label Period)||53
191276|NCT00501631|446219|P2|COMPLETED|Part B (Open-label Period)||48
191277|NCT00501631|446220|P1|COMPLETED|Part B (Open-label Period)||37
191278|NCT00501631|446219|P2|STARTED|Part B (Open-label Period)||99
191279|NCT00501631|446220|P1|STARTED|Part B (Open-label Period)||90
191280|NCT00501631|446219|P2|NOT COMPLETED|Part A (Double-blind Period)||49
191281|NCT00501631|446220|P1|NOT COMPLETED|Part A (Double-blind Period)||62
191282|NCT00501631|446219|P2|COMPLETED|Part A (Double-blind Period)||99
191283|NCT00501631|446220|P1|COMPLETED|Part A (Double-blind Period)||90
191284|NCT00501631|446219|P2|STARTED|Part A (Double-blind Period)||148
191285|NCT00501631|446220|P1|STARTED|Part A (Double-blind Period)||152
191286|NCT00501592|446229|P3|NOT COMPLETED|Overall Study||3
191287|NCT00501592|446230|P2|NOT COMPLETED|Overall Study||5
191288|NCT00501592|446231|P1|NOT COMPLETED|Overall Study||0
191289|NCT00501592|446229|P3|COMPLETED|Overall Study||20
191290|NCT00501592|446230|P2|COMPLETED|Overall Study||16
191291|NCT00501592|446231|P1|COMPLETED|Overall Study||20
191292|NCT00501592|446229|P3|STARTED|Overall Study||23
191293|NCT00501592|446230|P2|STARTED|Overall Study||21
191294|NCT00501592|446231|P1|STARTED|Overall Study||20
191295|NCT00501085|446242|P1|NOT COMPLETED|Overall Study||432
191296|NCT00501085|446242|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
191297|NCT00501085|446242|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
191298|NCT00501046|446252|P2|NOT COMPLETED|Overall Study||294
191299|NCT00501046|446253|P1|NOT COMPLETED|Overall Study||270
191300|NCT00501046|446252|P2|COMPLETED|Overall Study||213
191301|NCT00501046|446253|P1|COMPLETED|Overall Study||238
191302|NCT00501046|446252|P2|STARTED|Overall Study||507
191303|NCT00501046|446253|P1|STARTED|Overall Study||508
191304|NCT00501007|446259|P2|NOT COMPLETED|Overall Study||25
191305|NCT00501007|446260|P1|NOT COMPLETED|Overall Study||29
191306|NCT00501007|446259|P2|COMPLETED|Overall Study||78
191307|NCT00501007|446260|P1|COMPLETED|Overall Study||71
191308|NCT00501007|446259|P2|STARTED|Overall Study||103
191309|NCT00501007|446260|P1|STARTED|Overall Study||100
191310|NCT00500760|446268|P2|NOT COMPLETED|Overall Study||24
191311|NCT00500760|446269|P1|NOT COMPLETED|Overall Study||43
191312|NCT00500760|446268|P2|COMPLETED|Overall Study||40
191313|NCT00500760|446269|P1|COMPLETED|Overall Study||46
191314|NCT00500760|446268|P2|Received Treatment|Overall Study||63
191315|NCT00500760|446269|P1|Received Treatment|Overall Study||87
191316|NCT00500760|446268|P2|STARTED|Overall Study||64
191317|NCT00500760|446269|P1|STARTED|Overall Study||89
191318|NCT00500682|446289|P2|NOT COMPLETED|Overall Study||287
191319|NCT00500682|446290|P1|NOT COMPLETED|Overall Study||306
191320|NCT00500682|446289|P2|COMPLETED|Overall Study||223
191321|NCT00500682|446290|P1|COMPLETED|Overall Study||204
191322|NCT00500682|446289|P2|STARTED|Overall Study||510
191323|NCT00500682|446290|P1|STARTED|Overall Study||510
191324|NCT00500656|446300|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
191325|NCT00500656|446301|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
191326|NCT00500656|446302|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
191327|NCT00500656|446303|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
191328|NCT00500656|446300|P4|COMPLETED|Open Label Extension (OLE) Phase||6
191329|NCT00500656|446301|P3|COMPLETED|Open Label Extension (OLE) Phase||1
191330|NCT00500656|446302|P2|COMPLETED|Open Label Extension (OLE) Phase||9
191331|NCT00500656|446303|P1|COMPLETED|Open Label Extension (OLE) Phase||16
191332|NCT00500656|446300|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
191333|NCT00500656|446301|P3|STARTED|Open Label Extension (OLE) Phase||2
191334|NCT00500656|446302|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
191335|NCT00500656|446303|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
191336|NCT00500656|446300|P4|NOT COMPLETED|Controlled Phase||8
191337|NCT00500656|446301|P3|NOT COMPLETED|Controlled Phase||1
191338|NCT00500656|446302|P2|NOT COMPLETED|Controlled Phase||10
191339|NCT00500656|446303|P1|NOT COMPLETED|Controlled Phase||10
191340|NCT00500656|446300|P4|COMPLETED|Controlled Phase||0
191341|NCT00500656|446301|P3|COMPLETED|Controlled Phase||2
191342|NCT00500656|446302|P2|COMPLETED|Controlled Phase||28
191343|NCT00500656|446303|P1|COMPLETED|Controlled Phase||26
191344|NCT00500656|446300|P4|STARTED|Controlled Phase||8
191345|NCT00500656|446301|P3|STARTED|Controlled Phase||3
191346|NCT00500656|446302|P2|STARTED|Controlled Phase||38
191347|NCT00500656|446303|P1|STARTED|Controlled Phase||36
191348|NCT00500578|446317|P2|NOT COMPLETED|Overall Study||0
191349|NCT00500578|446318|P1|NOT COMPLETED|Overall Study||0
191350|NCT00500578|446317|P2|COMPLETED|Overall Study|All completed|32
191351|NCT00500578|446318|P1|COMPLETED|Overall Study|All completed|18
191352|NCT00500578|446317|P2|STARTED|Overall Study||32
191353|NCT00500578|446318|P1|STARTED|Overall Study||18
191354|NCT00500539|446324|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
191355|NCT00500539|446324|P1|COMPLETED|Follow-up Period (16 Weeks)||136
191356|NCT00500539|446324|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
191357|NCT00500539|446324|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
191358|NCT00500539|446324|P1|COMPLETED|Treatment Period (24 Weeks)||140
191359|NCT00500539|446324|P1|STARTED|Treatment Period (24 Weeks)||155
191360|NCT00500448|446333|P2|NOT COMPLETED|Overall Study||0
191361|NCT00500448|446334|P1|NOT COMPLETED|Overall Study||0
191362|NCT00500448|446333|P2|COMPLETED|Overall Study||16
191363|NCT00500448|446334|P1|COMPLETED|Overall Study||14
191364|NCT00500448|446333|P2|STARTED|Overall Study||16
191365|NCT00500448|446334|P1|STARTED|Overall Study||14
191366|NCT00500370|446350|P2|NOT COMPLETED|Overall Study||34
191367|NCT00500370|446351|P1|NOT COMPLETED|Overall Study||33
191368|NCT00500370|446350|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
191369|NCT00500370|446351|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
191370|NCT00500370|446350|P2|Treatment Complete (Week 24)|Overall Study||54
191371|NCT00500370|446351|P1|Treatment Complete (Week 24)|Overall Study||48
191372|NCT00500370|446350|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
191373|NCT00500370|446351|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
191374|NCT00500370|446350|P2|STARTED|Overall Study||83
191375|NCT00500370|446351|P1|STARTED|Overall Study||80
191376|NCT00500357|446387|P1|NOT COMPLETED|Overall Study||1
191377|NCT00500357|446387|P1|COMPLETED|Overall Study||104
191378|NCT00500357|446387|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
191379|NCT00500357|446387|P1|Received 13vPnC (Vax 3)|Overall Study||105
191380|NCT00500357|446387|P1|STARTED|Overall Study||105
191381|NCT00500318|446408|P2|NOT COMPLETED|Overall Study||17
191382|NCT00500318|446409|P1|NOT COMPLETED|Overall Study||5
191383|NCT00500318|446408|P2|COMPLETED|Overall Study||78
191384|NCT00500318|446409|P1|COMPLETED|Overall Study||81
191385|NCT00500318|446408|P2|STARTED|Overall Study||95
191386|NCT00500318|446409|P1|STARTED|Overall Study||86
191387|NCT00500292|446426|P3|NOT COMPLETED|Overall Study||27
191388|NCT00500292|446427|P2|NOT COMPLETED|Overall Study||31
191389|NCT00500292|446428|P1|NOT COMPLETED|Overall Study||25
191390|NCT00500292|446426|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|10
191391|NCT00500292|446427|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|4
191392|NCT00500292|446428|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
191393|NCT00500292|446426|P3|STARTED|Overall Study|randomised patients|37
191394|NCT00500292|446427|P2|STARTED|Overall Study|randomised patients|35
191395|NCT00500292|446428|P1|STARTED|Overall Study|randomised patients|32
191396|NCT00500266|446436|P1|NOT COMPLETED|Overall Study||13
191397|NCT00500266|446436|P1|COMPLETED|Overall Study||1040
191398|NCT00500266|446436|P1|Treated|Overall Study||1049
191399|NCT00500266|446436|P1|STARTED|Overall Study||1053
191400|NCT00500240|446445|P2|NOT COMPLETED|Overall Study||0
191401|NCT00500240|446446|P1|NOT COMPLETED|Overall Study||0
191402|NCT00500240|446445|P2|COMPLETED|Overall Study||26
191403|NCT00500240|446446|P1|COMPLETED|Overall Study||25
191404|NCT00500240|446445|P2|STARTED|Overall Study||26
191405|NCT00500240|446446|P1|STARTED|Overall Study||25
191406|NCT00500149|446456|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
191407|NCT00500149|446457|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
191408|NCT00500149|446456|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
191409|NCT00500149|446457|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
191410|NCT00500149|446456|P2|STARTED|Second Intervention (Cross-over Phase)||57
191411|NCT00500149|446457|P1|STARTED|Second Intervention (Cross-over Phase)||56
191412|NCT00500149|446456|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
191413|NCT00500149|446457|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
191414|NCT00500149|446456|P2|COMPLETED|First Intervention (Cross-over Phase)||57
191415|NCT00500149|446457|P1|COMPLETED|First Intervention (Cross-over Phase)||56
191416|NCT00500149|446456|P2|STARTED|First Intervention (Cross-over Phase)||59
191417|NCT00500149|446457|P1|STARTED|First Intervention (Cross-over Phase)||58
191418|NCT00500149|446456|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
191419|NCT00500149|446457|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
191420|NCT00500149|446456|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
191421|NCT00500149|446457|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
191422|NCT00500149|446456|P2|STARTED|Enrolled (Dose-optimization Phase)||0
191423|NCT00500149|446457|P1|STARTED|Enrolled (Dose-optimization Phase)||129
191424|NCT00500110|446465|P1|NOT COMPLETED|Overall Study||3
191425|NCT00500110|446465|P1|COMPLETED|Overall Study||36
191426|NCT00500110|446465|P1|STARTED|Overall Study||39
191427|NCT00500071|446469|P1|NOT COMPLETED|30-day Safety Follow-up||17
191428|NCT00500071|446469|P1|COMPLETED|30-day Safety Follow-up||278
191429|NCT00500071|446469|P1|STARTED|30-day Safety Follow-up||295
191430|NCT00500071|446469|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
191431|NCT00500071|446469|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
191432|NCT00500071|446469|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
191433|NCT00500071|446469|P1|NOT COMPLETED|Screening and Washout Phase||1
191434|NCT00500071|446469|P1|COMPLETED|Screening and Washout Phase||317
191435|NCT00500071|446469|P1|STARTED|Screening and Washout Phase||318
191436|NCT00499915|446480|P2|NOT COMPLETED|Overall Study||6
191437|NCT00499915|446481|P1|NOT COMPLETED|Overall Study||15
191438|NCT00499915|446480|P2|COMPLETED|Overall Study||76
191439|NCT00499915|446481|P1|COMPLETED|Overall Study||68
191440|NCT00499915|446480|P2|STARTED|Overall Study||82
191441|NCT00499915|446481|P1|STARTED|Overall Study||83
191442|NCT00499889|446487|P1|NOT COMPLETED|Overall Study||1
191443|NCT00499889|446487|P1|COMPLETED|Overall Study||41
191444|NCT00499889|446487|P1|STARTED|Overall Study||42
191445|NCT00499863|446495|P2|NOT COMPLETED|Overall Study||43
191446|NCT00499863|446496|P1|NOT COMPLETED|Overall Study||50
191447|NCT00499863|446495|P2|COMPLETED|Overall Study||29
191448|NCT00499863|446496|P1|COMPLETED|Overall Study||95
191449|NCT00499863|446495|P2|STARTED|Overall Study||72
191450|NCT00499863|446496|P1|STARTED|Overall Study||145
191451|NCT00499694|446524|P1|NOT COMPLETED|Overall Study||1
191452|NCT00499694|446524|P1|COMPLETED|Overall Study||30
191453|NCT00499694|446524|P1|STARTED|Overall Study||31
191454|NCT00499681|446530|P2|NOT COMPLETED|Overall Study||2
191455|NCT00499681|446531|P1|NOT COMPLETED|Overall Study||0
191456|NCT00499681|446530|P2|COMPLETED|Overall Study||0
191457|NCT00499681|446531|P1|COMPLETED|Overall Study||4
191458|NCT00499681|446530|P2|STARTED|Overall Study||2
191459|NCT00499681|446531|P1|STARTED|Overall Study||4
191460|NCT00499603|446539|P2|NOT COMPLETED|Overall Study||1
191461|NCT00499603|446540|P1|NOT COMPLETED|Overall Study||0
191462|NCT00499603|446539|P2|COMPLETED|Overall Study||22
191463|NCT00499603|446540|P1|COMPLETED|Overall Study||27
191464|NCT00499603|446539|P2|STARTED|Overall Study||23
191465|NCT00499603|446540|P1|STARTED|Overall Study||27
191466|NCT00499590|446553|P3|NOT COMPLETED|Overall Study||113
191467|NCT00499590|446554|P2|NOT COMPLETED|Overall Study||112
191468|NCT00499590|446555|P1|NOT COMPLETED|Overall Study||113
191469|NCT00499590|446553|P3|COMPLETED|Overall Study||0
191470|NCT00499590|446554|P2|COMPLETED|Overall Study||0
191471|NCT00499590|446555|P1|COMPLETED|Overall Study||0
191472|NCT00499590|446553|P3|STARTED|Overall Study||113
191473|NCT00499590|446554|P2|STARTED|Overall Study||112
191474|NCT00499590|446555|P1|STARTED|Overall Study||113
191475|NCT00499486|446566|P1|NOT COMPLETED|Overall Study||16
191476|NCT00499486|446566|P1|COMPLETED|Overall Study||31
191477|NCT00499486|446566|P1|STARTED|Overall Study||47
191478|NCT00499473|446574|P2|NOT COMPLETED|Overall Study||0
191479|NCT00499473|446575|P1|NOT COMPLETED|Overall Study||6
191480|NCT00499473|446574|P2|COMPLETED|Overall Study||4
191481|NCT00499473|446575|P1|COMPLETED|Overall Study|Patients evaluable|21
191482|NCT00499473|446574|P2|STARTED|Overall Study||4
191483|NCT00499473|446575|P1|STARTED|Overall Study||27
191484|NCT00499447|446591|P1|NOT COMPLETED|Overall Study||0
191485|NCT00499447|446591|P1|COMPLETED|Overall Study||13
191486|NCT00499447|446591|P1|STARTED|Overall Study||13
191487|NCT00499408|446595|P1|NOT COMPLETED|Overall Study||0
191488|NCT00499408|446595|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
191489|NCT00499408|446595|P1|STARTED|Overall Study||26
191490|NCT00499369|446604|P5|NOT COMPLETED|Overall Study||12
191491|NCT00499369|446605|P4|NOT COMPLETED|Overall Study||9
191492|NCT00499369|446606|P3|NOT COMPLETED|Overall Study||17
191493|NCT00499369|446607|P2|NOT COMPLETED|Overall Study||18
191494|NCT00499369|446608|P1|NOT COMPLETED|Overall Study||16
191495|NCT00499369|446604|P5|COMPLETED|Overall Study||0
191496|NCT00499369|446605|P4|COMPLETED|Overall Study||0
191497|NCT00499369|446606|P3|COMPLETED|Overall Study||0
191498|NCT00499369|446607|P2|COMPLETED|Overall Study||0
191499|NCT00499369|446608|P1|COMPLETED|Overall Study||0
191500|NCT00499369|446604|P5|Eligible|Overall Study||12
191501|NCT00499369|446605|P4|Eligible|Overall Study||8
191502|NCT00499369|446606|P3|Eligible|Overall Study||16
191503|NCT00499369|446607|P2|Eligible|Overall Study||16
191504|NCT00499369|446608|P1|Eligible|Overall Study||14
191505|NCT00499369|446604|P5|STARTED|Overall Study||12
191506|NCT00499369|446605|P4|STARTED|Overall Study||9
191507|NCT00499369|446606|P3|STARTED|Overall Study||17
191508|NCT00499369|446607|P2|STARTED|Overall Study||18
191509|NCT00499369|446608|P1|STARTED|Overall Study||16
191510|NCT00499343|446637|P2|NOT COMPLETED|Overall Study||0
191511|NCT00499343|446638|P1|NOT COMPLETED|Overall Study||0
191512|NCT00499343|446637|P2|COMPLETED|Overall Study||43
191513|NCT00499343|446638|P1|COMPLETED|Overall Study||41
191514|NCT00499343|446637|P2|STARTED|Overall Study||43
191515|NCT00499343|446638|P1|STARTED|Overall Study||41
191516|NCT00499252|446644|P1|NOT COMPLETED|Overall Study||12
191517|NCT00499252|446644|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
191518|NCT00499252|446644|P1|STARTED|Overall Study||51
191519|NCT00499122|446650|P1|NOT COMPLETED|Overall Study||0
191520|NCT00499122|446650|P1|COMPLETED|Overall Study||41
191521|NCT00499122|446650|P1|STARTED|Overall Study||41
191522|NCT00499109|446656|P2|NOT COMPLETED|Overall Study||7
191523|NCT00499109|446657|P1|NOT COMPLETED|Overall Study||18
191524|NCT00499109|446656|P2|COMPLETED|Overall Study||85
191525|NCT00499109|446657|P1|COMPLETED|Overall Study||165
191526|NCT00499109|446656|P2|STARTED|Overall Study||92
191527|NCT00499109|446657|P1|STARTED|Overall Study||183
191528|NCT00499096|446672|P2|NOT COMPLETED|Overall Study||20
191529|NCT00499096|446673|P1|NOT COMPLETED|Overall Study||23
191530|NCT00499096|446672|P2|COMPLETED|Overall Study||40
191531|NCT00499096|446673|P1|COMPLETED|Overall Study||35
191532|NCT00499096|446672|P2|STARTED|Overall Study||60
191533|NCT00499096|446673|P1|STARTED|Overall Study||58
191534|NCT00499031|446691|P1|NOT COMPLETED|Overall Study||3
191535|NCT00499031|446691|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
191536|NCT00499031|446691|P1|STARTED|Overall Study|Total number participants enrolled on study|38
191537|NCT00498940|446698|P2|NOT COMPLETED|Overall Study||0
191538|NCT00498940|446699|P1|NOT COMPLETED|Overall Study||0
191539|NCT00498940|446698|P2|COMPLETED|Overall Study||31
191540|NCT00498940|446699|P1|COMPLETED|Overall Study||30
191541|NCT00498940|446698|P2|STARTED|Overall Study||31
191542|NCT00498940|446699|P1|STARTED|Overall Study||30
191543|NCT00498927|446705|P1|NOT COMPLETED|Overall Study||0
191544|NCT00498927|446705|P1|COMPLETED|Overall Study||47
191545|NCT00498927|446705|P1|STARTED|Overall Study||47
191546|NCT00498797|446712|P2|NOT COMPLETED|Overall Study||29
191547|NCT00498797|446713|P1|NOT COMPLETED|Overall Study||38
191548|NCT00498797|446712|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
191549|NCT00498797|446713|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
191550|NCT00498797|446712|P2|STARTED|Overall Study|randomised patients|43
191551|NCT00498797|446713|P1|STARTED|Overall Study|randomised patients|43
191552|NCT00498706|446723|P2|NOT COMPLETED|Overall Study||0
191553|NCT00498706|446724|P1|NOT COMPLETED|Overall Study||0
191554|NCT00498706|446723|P2|COMPLETED|Overall Study||162
191555|NCT00498706|446724|P1|COMPLETED|Overall Study||163
191556|NCT00498706|446723|P2|Post Treatment Week 18|Overall Study||162
191557|NCT00498706|446724|P1|Post Treatment Week 18|Overall Study||163
191558|NCT00498706|446723|P2|STARTED|Overall Study||162
191559|NCT00498706|446724|P1|STARTED|Overall Study||163
191560|NCT00498628|446738|P2|NOT COMPLETED|Overall Study||21
191561|NCT00498628|446739|P1|NOT COMPLETED|Overall Study||15
191562|NCT00498628|446738|P2|COMPLETED|Overall Study||92
191563|NCT00498628|446739|P1|COMPLETED|Overall Study||90
191564|NCT00498628|446738|P2|STARTED|Overall Study||113
191565|NCT00498628|446739|P1|STARTED|Overall Study||105
191566|NCT00498615|446745|P6|NOT COMPLETED|Placebo||0
191567|NCT00498615|446746|P5|NOT COMPLETED|Placebo||0
191568|NCT00498615|446747|P4|NOT COMPLETED|Placebo||0
191569|NCT00498615|446748|P3|NOT COMPLETED|Placebo||0
191570|NCT00498615|446749|P2|NOT COMPLETED|Placebo||0
191571|NCT00498615|446750|P1|NOT COMPLETED|Placebo||0
191572|NCT00498615|446745|P6|COMPLETED|Placebo||3
191573|NCT00498615|446746|P5|COMPLETED|Placebo||3
191574|NCT00498615|446747|P4|COMPLETED|Placebo||2
191575|NCT00498615|446748|P3|COMPLETED|Placebo||3
191576|NCT00498615|446749|P2|COMPLETED|Placebo||4
191577|NCT00498615|446750|P1|COMPLETED|Placebo||2
191578|NCT00498615|446745|P6|STARTED|Placebo||3
191579|NCT00498615|446746|P5|STARTED|Placebo||3
191580|NCT00498615|446747|P4|STARTED|Placebo||2
191581|NCT00498615|446748|P3|STARTED|Placebo||3
191582|NCT00498615|446749|P2|STARTED|Placebo||4
191583|NCT00498615|446750|P1|STARTED|Placebo||2
191584|NCT00498615|446745|P6|NOT COMPLETED|Fasudil 40mg||0
191585|NCT00498615|446746|P5|NOT COMPLETED|Fasudil 40mg||0
191586|NCT00498615|446747|P4|NOT COMPLETED|Fasudil 40mg||0
191587|NCT00498615|446748|P3|NOT COMPLETED|Fasudil 40mg||0
191588|NCT00498615|446749|P2|NOT COMPLETED|Fasudil 40mg||0
191589|NCT00498615|446750|P1|NOT COMPLETED|Fasudil 40mg||0
191590|NCT00498615|446745|P6|COMPLETED|Fasudil 40mg||3
191591|NCT00498615|446746|P5|COMPLETED|Fasudil 40mg||3
191592|NCT00498615|446747|P4|COMPLETED|Fasudil 40mg||2
191593|NCT00498615|446748|P3|COMPLETED|Fasudil 40mg||3
191594|NCT00498615|446749|P2|COMPLETED|Fasudil 40mg||4
191595|NCT00498615|446750|P1|COMPLETED|Fasudil 40mg||2
191596|NCT00498615|446745|P6|STARTED|Fasudil 40mg||3
191597|NCT00498615|446746|P5|STARTED|Fasudil 40mg||3
191598|NCT00498615|446747|P4|STARTED|Fasudil 40mg||2
191599|NCT00498615|446748|P3|STARTED|Fasudil 40mg||3
191600|NCT00498615|446749|P2|STARTED|Fasudil 40mg||4
191601|NCT00498615|446750|P1|STARTED|Fasudil 40mg||2
191602|NCT00498615|446745|P6|NOT COMPLETED|Fasudil 80mg||0
191603|NCT00498615|446746|P5|NOT COMPLETED|Fasudil 80mg||0
191604|NCT00498615|446747|P4|NOT COMPLETED|Fasudil 80mg||0
191605|NCT00498615|446748|P3|NOT COMPLETED|Fasudil 80mg||0
191606|NCT00498615|446749|P2|NOT COMPLETED|Fasudil 80mg||0
191607|NCT00498615|446750|P1|NOT COMPLETED|Fasudil 80mg||0
191608|NCT00498615|446745|P6|COMPLETED|Fasudil 80mg||3
191609|NCT00498615|446746|P5|COMPLETED|Fasudil 80mg||3
191610|NCT00498615|446747|P4|COMPLETED|Fasudil 80mg||2
191611|NCT00498615|446748|P3|COMPLETED|Fasudil 80mg||3
191612|NCT00498615|446749|P2|COMPLETED|Fasudil 80mg||4
191613|NCT00498615|446750|P1|COMPLETED|Fasudil 80mg||2
191614|NCT00498615|446745|P6|STARTED|Fasudil 80mg||3
191615|NCT00498615|446746|P5|STARTED|Fasudil 80mg||3
191616|NCT00498615|446747|P4|STARTED|Fasudil 80mg||2
191617|NCT00498615|446748|P3|STARTED|Fasudil 80mg||3
191618|NCT00498615|446749|P2|STARTED|Fasudil 80mg||4
191619|NCT00498615|446750|P1|STARTED|Fasudil 80mg||2
191620|NCT00498602|446771|P7|NOT COMPLETED|Overall Study||2
191621|NCT00498602|446772|P6|NOT COMPLETED|Overall Study||13
191622|NCT00498602|446773|P5|NOT COMPLETED|Overall Study||4
191623|NCT00498602|446774|P4|NOT COMPLETED|Overall Study||5
191624|NCT00498602|446775|P3|NOT COMPLETED|Overall Study||8
191625|NCT00498602|446776|P2|NOT COMPLETED|Overall Study||10
191626|NCT00498602|446777|P1|NOT COMPLETED|Overall Study||10
191627|NCT00498602|446771|P7|COMPLETED|Overall Study||15
191628|NCT00498602|446772|P6|COMPLETED|Overall Study||31
191629|NCT00498602|446773|P5|COMPLETED|Overall Study||8
191630|NCT00498602|446774|P4|COMPLETED|Overall Study||30
191631|NCT00498602|446775|P3|COMPLETED|Overall Study||32
191632|NCT00498602|446776|P2|COMPLETED|Overall Study||51
191633|NCT00498602|446777|P1|COMPLETED|Overall Study||26
191634|NCT00498602|446771|P7|Treated|Overall Study||17
191635|NCT00498602|446772|P6|Treated|Overall Study||44
191636|NCT00498602|446773|P5|Treated|Overall Study||12
191637|NCT00498602|446774|P4|Treated|Overall Study||35
191638|NCT00498602|446775|P3|Treated|Overall Study||40
191639|NCT00498602|446776|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
191640|NCT00498602|446777|P1|Treated|Overall Study||36
191641|NCT00498602|446771|P7|STARTED|Overall Study||17
191642|NCT00498602|446772|P6|STARTED|Overall Study||44
191643|NCT00498602|446773|P5|STARTED|Overall Study||12
191644|NCT00498602|446774|P4|STARTED|Overall Study||35
191645|NCT00498602|446775|P3|STARTED|Overall Study||40
191646|NCT00498602|446776|P2|STARTED|Overall Study||61
191647|NCT00498602|446777|P1|STARTED|Overall Study||36
191648|NCT00498550|446816|P2|NOT COMPLETED|Overall Study||1
191649|NCT00498550|446817|P1|NOT COMPLETED|Overall Study||0
191650|NCT00498550|446816|P2|COMPLETED|Overall Study||15
191651|NCT00498550|446817|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
191652|NCT00498550|446816|P2|STARTED|Overall Study||16
191653|NCT00498550|446817|P1|STARTED|Overall Study||15
191654|NCT00498485|446825|P2|NOT COMPLETED|Overall Study||5
191655|NCT00498485|446826|P1|NOT COMPLETED|Overall Study||1
191656|NCT00498485|446825|P2|COMPLETED|Overall Study||5
191657|NCT00498485|446826|P1|COMPLETED|Overall Study||6
191658|NCT00498485|446825|P2|STARTED|Overall Study||10
191659|NCT00498485|446826|P1|STARTED|Overall Study||7
191660|NCT00498433|446837|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
191661|NCT00498433|446838|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
191662|NCT00498433|446839|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
191663|NCT00498433|446837|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
191664|NCT00498433|446838|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
191665|NCT00498433|446839|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
191666|NCT00498433|446837|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
191667|NCT00498433|446838|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
191668|NCT00498433|446839|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
191669|NCT00498433|446837|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
191670|NCT00498433|446838|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
191671|NCT00498433|446839|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
191672|NCT00498433|446837|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
191673|NCT00498433|446838|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
191674|NCT00498433|446839|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
191675|NCT00498433|446837|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
191676|NCT00498433|446838|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
191677|NCT00498433|446839|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
191678|NCT00498433|446837|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191679|NCT00498433|446838|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191680|NCT00498433|446839|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191681|NCT00498433|446837|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
191682|NCT00498433|446838|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191683|NCT00498433|446839|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191684|NCT00498433|446837|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
191685|NCT00498433|446838|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191686|NCT00498433|446839|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
191687|NCT00498433|446837|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191688|NCT00498433|446838|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191689|NCT00498433|446839|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191690|NCT00498433|446837|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191691|NCT00498433|446838|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
191692|NCT00498433|446839|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191693|NCT00498433|446837|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191694|NCT00498433|446838|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
191695|NCT00498433|446839|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
191696|NCT00498433|446837|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191697|NCT00498433|446838|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191698|NCT00498433|446839|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191699|NCT00498433|446837|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191700|NCT00498433|446838|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191701|NCT00498433|446839|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
191702|NCT00498433|446837|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191703|NCT00498433|446838|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
191704|NCT00498433|446839|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
191705|NCT00498368|446884|P2|NOT COMPLETED|Overall Study||2
191706|NCT00498368|446885|P1|NOT COMPLETED|Overall Study||3
191707|NCT00498368|446884|P2|COMPLETED|Overall Study||15
191708|NCT00498368|446885|P1|COMPLETED|Overall Study||14
191709|NCT00498368|446884|P2|STARTED|Overall Study||17
191710|NCT00498368|446885|P1|STARTED|Overall Study||17
191711|NCT00498355|446897|P1|NOT COMPLETED|Overall Study||1
191712|NCT00498355|446897|P1|COMPLETED|Overall Study||6
191713|NCT00498355|446897|P1|STARTED|Overall Study||7
191714|NCT00498186|446901|P1|NOT COMPLETED|Overall Study||173
191715|NCT00498186|446901|P1|COMPLETED|Overall Study||122
191716|NCT00498186|446901|P1|STARTED|Overall Study||295
191717|NCT00497874|446908|P2|NOT COMPLETED|Overall Study||116
191718|NCT00497874|446909|P1|NOT COMPLETED|Overall Study||147
191719|NCT00497874|446908|P2|COMPLETED|Overall Study||343
191720|NCT00497874|446909|P1|COMPLETED|Overall Study||296
191721|NCT00497874|446908|P2|STARTED|Overall Study||459
191722|NCT00497874|446909|P1|STARTED|Overall Study||443
191723|NCT00497796|446927|P2|NOT COMPLETED|Overall Study||59
191724|NCT00497796|446928|P1|NOT COMPLETED|Overall Study||85
191725|NCT00497796|446927|P2|COMPLETED|Overall Study||101
191726|NCT00497796|446928|P1|COMPLETED|Overall Study||62
191727|NCT00497796|446927|P2|STARTED|Overall Study||160
191728|NCT00497796|446928|P1|STARTED|Overall Study||147
191729|NCT00497770|446960|P4|NOT COMPLETED|Overall Study||0
191730|NCT00497770|446961|P3|NOT COMPLETED|Overall Study||0
191731|NCT00497770|446962|P2|NOT COMPLETED|Overall Study||0
191732|NCT00497770|446963|P1|NOT COMPLETED|Overall Study||0
191733|NCT00497770|446960|P4|COMPLETED|Overall Study||28
191734|NCT00497770|446961|P3|COMPLETED|Overall Study||37
191735|NCT00497770|446962|P2|COMPLETED|Overall Study||65
191736|NCT00497770|446963|P1|COMPLETED|Overall Study||304
191737|NCT00497770|446960|P4|STARTED|Overall Study||28
191738|NCT00497770|446961|P3|STARTED|Overall Study||37
191739|NCT00497770|446962|P2|STARTED|Overall Study||65
191740|NCT00497770|446963|P1|STARTED|Overall Study||304
191741|NCT00497198|447015|P2|NOT COMPLETED|Overall Study||5
191742|NCT00497198|447016|P1|NOT COMPLETED|Overall Study||5
191743|NCT00497198|447015|P2|COMPLETED|Overall Study||86
191744|NCT00497198|447016|P1|COMPLETED|Overall Study||87
191745|NCT00497198|447015|P2|STARTED|Overall Study||91
191746|NCT00497198|447016|P1|STARTED|Overall Study||92
191747|NCT00497146|447032|P2|NOT COMPLETED|Long-term Follow-up Period||6
191748|NCT00497146|447033|P1|NOT COMPLETED|Long-term Follow-up Period||15
191749|NCT00497146|447032|P2|COMPLETED|Long-term Follow-up Period||66
191750|NCT00497146|447033|P1|COMPLETED|Long-term Follow-up Period||50
191751|NCT00497146|447032|P2|STARTED|Long-term Follow-up Period||72
191752|NCT00497146|447033|P1|STARTED|Long-term Follow-up Period||65
191753|NCT00497146|447032|P2|NOT COMPLETED|Treatment Period||21
191754|NCT00497146|447033|P1|NOT COMPLETED|Treatment Period||27
191755|NCT00497146|447032|P2|COMPLETED|Treatment Period||91
191756|NCT00497146|447033|P1|COMPLETED|Treatment Period||88
191757|NCT00497146|447032|P2|STARTED|Treatment Period||112
191758|NCT00497146|447033|P1|STARTED|Treatment Period||115
191759|NCT00497081|447075|P2|NOT COMPLETED|Overall Study||2
191760|NCT00497081|447076|P1|NOT COMPLETED|Overall Study||2
191761|NCT00497081|447075|P2|COMPLETED|Overall Study||28
191762|NCT00497081|447076|P1|COMPLETED|Overall Study||28
191763|NCT00497081|447075|P2|STARTED|Overall Study||30
191764|NCT00497081|447076|P1|STARTED|Overall Study||30
191765|NCT00497055|447088|P2|NOT COMPLETED|Overall Study||5
191766|NCT00497055|447089|P1|NOT COMPLETED|Overall Study||10
191767|NCT00497055|447088|P2|COMPLETED|Overall Study||40
191768|NCT00497055|447089|P1|COMPLETED|Overall Study||35
191769|NCT00497055|447088|P2|STARTED|Overall Study||45
191770|NCT00497055|447089|P1|STARTED|Overall Study||45
191771|NCT00496964|447101|P2|NOT COMPLETED|Overall Study||1
191772|NCT00496964|447102|P1|NOT COMPLETED|Overall Study||0
191773|NCT00496964|447101|P2|COMPLETED|Overall Study||3
191774|NCT00496964|447102|P1|COMPLETED|Overall Study||1
191775|NCT00496964|447101|P2|STARTED|Overall Study||4
191776|NCT00496964|447102|P1|STARTED|Overall Study||1
191777|NCT00496873|447110|P1|NOT COMPLETED|Overall Study||7
191778|NCT00496873|447110|P1|COMPLETED|Overall Study||78
191779|NCT00496873|447110|P1|STARTED|Overall Study||85
191780|NCT00496860|447119|P3|NOT COMPLETED|Overall Study||0
191781|NCT00496860|447120|P2|NOT COMPLETED|Overall Study||1
191782|NCT00496860|447121|P1|NOT COMPLETED|Overall Study||1
191783|NCT00496860|447119|P3|COMPLETED|Overall Study||6
191784|NCT00496860|447120|P2|COMPLETED|Overall Study||15
191785|NCT00496860|447121|P1|COMPLETED|Overall Study||3
191786|NCT00496860|447119|P3|STARTED|Overall Study||6
191787|NCT00496860|447120|P2|STARTED|Overall Study||16
191788|NCT00496860|447121|P1|STARTED|Overall Study||4
191789|NCT00496834|447143|P2|NOT COMPLETED|Overall Study||13
191790|NCT00496834|447144|P1|NOT COMPLETED|Overall Study||18
191791|NCT00496834|447143|P2|COMPLETED|Overall Study||87
191792|NCT00496834|447144|P1|COMPLETED|Overall Study||83
191793|NCT00496834|447143|P2|STARTED|Overall Study||100
191794|NCT00496834|447144|P1|STARTED|Overall Study||101
191795|NCT00496808|447156|P1|NOT COMPLETED|Overall Study||0
191796|NCT00496808|447156|P1|COMPLETED|Overall Study||69
191797|NCT00496808|447156|P1|STARTED|Overall Study||69
191798|NCT00496782|447163|P2|NOT COMPLETED|Overall Study||2
191799|NCT00496782|447164|P1|NOT COMPLETED|Overall Study||1
191800|NCT00496782|447163|P2|COMPLETED|Overall Study||5
191801|NCT00496782|447164|P1|COMPLETED|Overall Study||8
191802|NCT00496782|447163|P2|STARTED|Overall Study||7
191803|NCT00496782|447164|P1|STARTED|Overall Study||9
191804|NCT00496769|447198|P2|NOT COMPLETED|Overall Study||649
191805|NCT00496769|447199|P1|NOT COMPLETED|Overall Study||558
191806|NCT00496769|447198|P2|COMPLETED|Overall Study||2142
191807|NCT00496769|447199|P1|COMPLETED|Overall Study||2249
191808|NCT00496769|447198|P2|Received Treatment|Overall Study||2708
191809|NCT00496769|447199|P1|Received Treatment|Overall Study||2798
191810|NCT00496769|447198|P2|STARTED|Overall Study|Randomized|2791
191811|NCT00496769|447199|P1|STARTED|Overall Study|Randomized|2807
191812|NCT00496730|447223|P2|NOT COMPLETED|Overall Study||5
191813|NCT00496730|447224|P1|NOT COMPLETED|Overall Study||6
191814|NCT00496730|447223|P2|COMPLETED|Overall Study||121
191815|NCT00496730|447224|P1|COMPLETED|Overall Study||124
191816|NCT00496730|447223|P2|STARTED|Overall Study||126
191817|NCT00496730|447224|P1|STARTED|Overall Study||130
191818|NCT00496626|447236|P2|NOT COMPLETED|Overall Study||6
191819|NCT00496626|447237|P1|NOT COMPLETED|Overall Study||6
191820|NCT00496626|447236|P2|COMPLETED|Overall Study||292
191821|NCT00496626|447237|P1|COMPLETED|Overall Study||296
191822|NCT00496626|447236|P2|STARTED|Overall Study||298
191823|NCT00496626|447237|P1|STARTED|Overall Study||302
191824|NCT00496483|447249|P1|NOT COMPLETED|Overall Study||12
191825|NCT00496483|447249|P1|COMPLETED|Overall Study||48
191826|NCT00496483|447249|P1|Dosed|Overall Study||51
191827|NCT00496483|447249|P1|STARTED|Overall Study||60
191828|NCT00496470|447266|P2|NOT COMPLETED|Overall Study||29
191829|NCT00496470|447267|P1|NOT COMPLETED|Overall Study||26
191830|NCT00496470|447266|P2|COMPLETED|Overall Study||302
191831|NCT00496470|447267|P1|COMPLETED|Overall Study||303
191832|NCT00496470|447266|P2|Received Study Medication|Overall Study||330
191833|NCT00496470|447267|P1|Received Study Medication|Overall Study||329
191834|NCT00496470|447266|P2|STARTED|Overall Study||331
191835|NCT00496470|447267|P1|STARTED|Overall Study||329
191836|NCT00496379|447345|P1|NOT COMPLETED|Overall Study||0
191837|NCT00496379|447345|P1|COMPLETED|Overall Study||15
191838|NCT00496379|447345|P1|STARTED|Overall Study||15
191839|NCT00496340|447353|P1|NOT COMPLETED|Overall Study||0
191840|NCT00496340|447353|P1|COMPLETED|Overall Study||42
191841|NCT00496340|447353|P1|STARTED|Overall Study||42
191842|NCT00496262|447366|P1|NOT COMPLETED|Overall Study||0
191843|NCT00496262|447366|P1|COMPLETED|Overall Study||15
191844|NCT00496262|447366|P1|STARTED|Overall Study||15
191845|NCT00496197|447379|P1|NOT COMPLETED|Overall Study||122
191846|NCT00496197|447379|P1|COMPLETED|Overall Study||160
191847|NCT00496197|447379|P1|STARTED|Overall Study||282
191848|NCT00496080|447406|P1|NOT COMPLETED|Overall Study||27
191849|NCT00496080|447406|P1|COMPLETED|Overall Study||60
191850|NCT00496080|447406|P1|STARTED|Overall Study||87
191851|NCT00496054|447416|P1|NOT COMPLETED|Overall Study||8
191852|NCT00496054|447416|P1|COMPLETED|Overall Study||102
191853|NCT00496054|447416|P1|STARTED|Overall Study||110
191854|NCT00495820|447445|P2|NOT COMPLETED|Overall Study||1
191855|NCT00495820|447446|P1|NOT COMPLETED|Overall Study||1
191856|NCT00495820|447445|P2|COMPLETED|Overall Study||29
191857|NCT00495820|447446|P1|COMPLETED|Overall Study||29
191858|NCT00495820|447445|P2|STARTED|Overall Study||30
191859|NCT00495820|447446|P1|STARTED|Overall Study||30
191860|NCT00495794|447458|P2|NOT COMPLETED|Overall Study||0
191861|NCT00495794|447459|P1|NOT COMPLETED|Overall Study||522
191862|NCT00495794|447458|P2|COMPLETED|Overall Study||2303
191863|NCT00495794|447459|P1|COMPLETED|Overall Study||1797
191864|NCT00495794|447458|P2|STARTED|Overall Study||2303
191865|NCT00495794|447459|P1|STARTED|Overall Study||2319
191866|NCT00495755|447469|P1|NOT COMPLETED|Overall Study||3
191867|NCT00495755|447469|P1|COMPLETED|Overall Study||10
191868|NCT00495755|447469|P1|STARTED|Overall Study||13
191869|NCT00495677|447481|P7|NOT COMPLETED|Stage 2 (25 Days)||0
191870|NCT00495677|447482|P6|NOT COMPLETED|Stage 2 (25 Days)||0
191871|NCT00495677|447483|P5|NOT COMPLETED|Stage 2 (25 Days)||0
191872|NCT00495677|447484|P4|NOT COMPLETED|Stage 2 (25 Days)||0
191873|NCT00495677|447485|P3|NOT COMPLETED|Stage 2 (25 Days)||0
191874|NCT00495677|447486|P2|NOT COMPLETED|Stage 2 (25 Days)||0
191875|NCT00495677|447487|P1|NOT COMPLETED|Stage 2 (25 Days)||0
191876|NCT00495677|447481|P7|COMPLETED|Stage 2 (25 Days)||7
191877|NCT00495677|447482|P6|COMPLETED|Stage 2 (25 Days)||8
191878|NCT00495677|447483|P5|COMPLETED|Stage 2 (25 Days)||8
191879|NCT00495677|447484|P4|COMPLETED|Stage 2 (25 Days)||0
191880|NCT00495677|447485|P3|COMPLETED|Stage 2 (25 Days)||0
191881|NCT00495677|447486|P2|COMPLETED|Stage 2 (25 Days)||0
191882|NCT00495677|447487|P1|COMPLETED|Stage 2 (25 Days)||0
191883|NCT00495677|447481|P7|STARTED|Stage 2 (25 Days)||7
191884|NCT00495677|447482|P6|STARTED|Stage 2 (25 Days)||8
191885|NCT00495677|447483|P5|STARTED|Stage 2 (25 Days)||8
191886|NCT00495677|447484|P4|STARTED|Stage 2 (25 Days)||0
191887|NCT00495677|447485|P3|STARTED|Stage 2 (25 Days)||0
191888|NCT00495677|447486|P2|STARTED|Stage 2 (25 Days)||0
191889|NCT00495677|447487|P1|STARTED|Stage 2 (25 Days)||0
191890|NCT00495677|447481|P7|NOT COMPLETED|Stage 1 (25 Days)||0
191891|NCT00495677|447482|P6|NOT COMPLETED|Stage 1 (25 Days)||0
191892|NCT00495677|447483|P5|NOT COMPLETED|Stage 1 (25 Days)||0
191893|NCT00495677|447484|P4|NOT COMPLETED|Stage 1 (25 Days)||0
191894|NCT00495677|447485|P3|NOT COMPLETED|Stage 1 (25 Days)||1
191895|NCT00495677|447486|P2|NOT COMPLETED|Stage 1 (25 Days)||0
191896|NCT00495677|447487|P1|NOT COMPLETED|Stage 1 (25 Days)||0
191897|NCT00495677|447481|P7|COMPLETED|Stage 1 (25 Days)||0
191898|NCT00495677|447482|P6|COMPLETED|Stage 1 (25 Days)||0
191899|NCT00495677|447483|P5|COMPLETED|Stage 1 (25 Days)||0
191900|NCT00495677|447484|P4|COMPLETED|Stage 1 (25 Days)||6
191901|NCT00495677|447485|P3|COMPLETED|Stage 1 (25 Days)||5
191902|NCT00495677|447486|P2|COMPLETED|Stage 1 (25 Days)||6
191903|NCT00495677|447487|P1|COMPLETED|Stage 1 (25 Days)||2
191904|NCT00495677|447481|P7|STARTED|Stage 1 (25 Days)||0
191905|NCT00495677|447482|P6|STARTED|Stage 1 (25 Days)||0
191906|NCT00495677|447483|P5|STARTED|Stage 1 (25 Days)||0
191907|NCT00495677|447484|P4|STARTED|Stage 1 (25 Days)||6
191908|NCT00495677|447485|P3|STARTED|Stage 1 (25 Days)||6
191909|NCT00495677|447486|P2|STARTED|Stage 1 (25 Days)||6
191910|NCT00495677|447487|P1|STARTED|Stage 1 (25 Days)||2
191911|NCT00495625|447542|P1|NOT COMPLETED|Overall Study||10
191912|NCT00495625|447542|P1|COMPLETED|Overall Study||23
191913|NCT00495625|447542|P1|STARTED|Overall Study||33
191914|NCT00495612|447553|P2|NOT COMPLETED|Overall Study||0
191915|NCT00495612|447554|P1|NOT COMPLETED|Overall Study||4
191916|NCT00495612|447553|P2|COMPLETED|Overall Study||33
191917|NCT00495612|447554|P1|COMPLETED|Overall Study||32
191918|NCT00495612|447553|P2|STARTED|Overall Study||33
191919|NCT00495612|447554|P1|STARTED|Overall Study||36
191920|NCT00495586|447572|P2|NOT COMPLETED|Overall Study||4
191921|NCT00495586|447573|P1|NOT COMPLETED|Overall Study||4
191922|NCT00495586|447572|P2|COMPLETED|Overall Study||158
191923|NCT00495586|447573|P1|COMPLETED|Overall Study||152
191924|NCT00495586|447572|P2|STARTED|Overall Study||162
191925|NCT00495586|447573|P1|STARTED|Overall Study||156
191926|NCT00495495|447581|P1|NOT COMPLETED|Overall Study||99
191927|NCT00495495|447581|P1|COMPLETED|Overall Study||295
191928|NCT00495495|447581|P1|STARTED|Overall Study||394
191929|NCT00495391|447596|P2|NOT COMPLETED|Overall Study||21
191930|NCT00495391|447597|P1|NOT COMPLETED|Overall Study||36
191931|NCT00495391|447596|P2|COMPLETED|Overall Study||1
191932|NCT00495391|447597|P1|COMPLETED|Overall Study||6
191933|NCT00495391|447596|P2|From Baseline to End of Follow up|Overall Study||1
191934|NCT00495391|447597|P1|From Baseline to End of Follow up|Overall Study||6
191935|NCT00495391|447596|P2|From Baseline to End of Treatment|Overall Study||1
191936|NCT00495391|447597|P1|From Baseline to End of Treatment|Overall Study||6
191937|NCT00495391|447596|P2|From Baseline to Week 16|Overall Study||11
191938|NCT00495391|447597|P1|From Baseline to Week 16|Overall Study||24
191939|NCT00495391|447596|P2|From Baseline to Week 8|Overall Study||20
191940|NCT00495391|447597|P1|From Baseline to Week 8|Overall Study||31
191941|NCT00495391|447596|P2|STARTED|Overall Study||22
191942|NCT00495391|447597|P1|STARTED|Overall Study||42
191943|NCT00495222|447617|P1|NOT COMPLETED|Overall Study||0
191944|NCT00495222|447617|P1|COMPLETED|Overall Study||9
191945|NCT00495222|447617|P1|STARTED|Overall Study||9
191946|NCT00495157|447623|P3|NOT COMPLETED|Overall Study||13
191947|NCT00495157|447624|P2|NOT COMPLETED|Overall Study||23
191948|NCT00495157|447625|P1|NOT COMPLETED|Overall Study||16
191949|NCT00495157|447623|P3|COMPLETED|Overall Study||101
191950|NCT00495157|447624|P2|COMPLETED|Overall Study||92
191951|NCT00495157|447625|P1|COMPLETED|Overall Study||97
191952|NCT00495157|447623|P3|STARTED|Overall Study||114
191953|NCT00495157|447624|P2|STARTED|Overall Study||115
191954|NCT00495157|447625|P1|STARTED|Overall Study||113
191955|NCT00495131|447635|P2|NOT COMPLETED|Overall Study||6
191956|NCT00495131|447636|P1|NOT COMPLETED|Overall Study||7
191957|NCT00495131|447635|P2|COMPLETED|Overall Study||148
191958|NCT00495131|447636|P1|COMPLETED|Overall Study||147
191959|NCT00495131|447635|P2|STARTED|Overall Study||154
191960|NCT00495131|447636|P1|STARTED|Overall Study||154
191961|NCT00495079|447646|P1|NOT COMPLETED|Overall Study||0
191962|NCT00495079|447646|P1|COMPLETED|Overall Study||65
191963|NCT00495079|447646|P1|STARTED|Overall Study||65
191964|NCT00494975|447655|P2|NOT COMPLETED|Overall Study||1
191965|NCT00494975|447656|P1|NOT COMPLETED|Overall Study||2
191966|NCT00494975|447655|P2|COMPLETED|Overall Study||10
191967|NCT00494975|447656|P1|COMPLETED|Overall Study||8
191968|NCT00494975|447655|P2|STARTED|Overall Study||11
191969|NCT00494975|447656|P1|STARTED|Overall Study||10
191970|NCT00494871|447664|P2|NOT COMPLETED|Follow-up (FU) Period||23
191971|NCT00494871|447665|P1|NOT COMPLETED|Follow-up (FU) Period||29
191972|NCT00494871|447664|P2|COMPLETED|Follow-up (FU) Period||616
191973|NCT00494871|447665|P1|COMPLETED|Follow-up (FU) Period||610
191974|NCT00494871|447664|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
191975|NCT00494871|447665|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
191976|NCT00494871|447664|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
191977|NCT00494871|447665|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
191978|NCT00494871|447664|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
191979|NCT00494871|447665|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
191980|NCT00494871|447664|P2|COMPLETED|Double-blind (DB) Treatment Period||468
191981|NCT00494871|447665|P1|COMPLETED|Double-blind (DB) Treatment Period||480
191982|NCT00494871|447664|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
191983|NCT00494871|447665|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
191984|NCT00494871|447664|P2|STARTED|Double-blind (DB) Treatment Period||640
191985|NCT00494871|447665|P1|STARTED|Double-blind (DB) Treatment Period||640
191986|NCT00494806|447697|P2|NOT COMPLETED|Overall Study||0
191987|NCT00494806|447698|P1|NOT COMPLETED|Overall Study||0
191988|NCT00494806|447697|P2|COMPLETED|Overall Study||32
191989|NCT00494806|447698|P1|COMPLETED|Overall Study||34
191990|NCT00494806|447697|P2|STARTED|Overall Study||32
191991|NCT00494806|447698|P1|STARTED|Overall Study||34
191992|NCT00494780|447706|P2|NOT COMPLETED|Overall Study||13
191993|NCT00494780|447707|P1|NOT COMPLETED|Overall Study||11
191994|NCT00494780|447706|P2|COMPLETED|Overall Study||17
191995|NCT00494780|447707|P1|COMPLETED|Overall Study||18
191996|NCT00494780|447706|P2|STARTED|Overall Study||30
191997|NCT00494780|447707|P1|STARTED|Overall Study||29
191998|NCT00494676|447745|P2|NOT COMPLETED|Second Intervention||1
191999|NCT00494676|447746|P1|NOT COMPLETED|Second Intervention||1
192000|NCT00494676|447745|P2|COMPLETED|Second Intervention||28
192001|NCT00494676|447746|P1|COMPLETED|Second Intervention||33
192002|NCT00494676|447745|P2|STARTED|Second Intervention||29
192003|NCT00494676|447746|P1|STARTED|Second Intervention||34
192004|NCT00494676|447745|P2|NOT COMPLETED|First Intervention||3
192005|NCT00494676|447746|P1|NOT COMPLETED|First Intervention||1
192006|NCT00494676|447745|P2|COMPLETED|First Intervention||29
192007|NCT00494676|447746|P1|COMPLETED|First Intervention||34
192008|NCT00494676|447745|P2|STARTED|First Intervention||32
192009|NCT00494676|447746|P1|STARTED|First Intervention||35
192010|NCT00494676|447745|P2|NOT COMPLETED|Allocation||4
192011|NCT00494676|447746|P1|NOT COMPLETED|Allocation||2
192012|NCT00494676|447745|P2|COMPLETED|Allocation||32
192013|NCT00494676|447746|P1|COMPLETED|Allocation||35
192014|NCT00494676|447745|P2|STARTED|Allocation||36
192015|NCT00494676|447746|P1|STARTED|Allocation||37
192016|NCT00494585|447753|P1|NOT COMPLETED|Overall Study||0
192017|NCT00494585|447753|P1|COMPLETED|Overall Study||22
192018|NCT00494585|447753|P1|STARTED|Overall Study||22
192019|NCT00494507|447761|P4|NOT COMPLETED|Open-Label Phase||5
192020|NCT00494507|447762|P3|NOT COMPLETED|Open-Label Phase||5
192021|NCT00494507|447763|P2|NOT COMPLETED|Open-Label Phase||1
192022|NCT00494507|447764|P1|NOT COMPLETED|Open-Label Phase||0
192023|NCT00494507|447761|P4|COMPLETED|Open-Label Phase||14
192024|NCT00494507|447762|P3|COMPLETED|Open-Label Phase||17
192025|NCT00494507|447763|P2|COMPLETED|Open-Label Phase||7
192026|NCT00494507|447764|P1|COMPLETED|Open-Label Phase||9
192027|NCT00494507|447761|P4|STARTED|Open-Label Phase||19
192028|NCT00494507|447762|P3|STARTED|Open-Label Phase||22
192029|NCT00494507|447763|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
192030|NCT00494507|447764|P1|STARTED|Open-Label Phase||9
192031|NCT00494507|447761|P4|NOT COMPLETED|Double-Blind Phase||1
192032|NCT00494507|447762|P3|NOT COMPLETED|Double-Blind Phase||2
192033|NCT00494507|447763|P2|NOT COMPLETED|Double-Blind Phase||0
192034|NCT00494507|447764|P1|NOT COMPLETED|Double-Blind Phase||3
192035|NCT00494507|447761|P4|COMPLETED|Double-Blind Phase||19
192036|NCT00494507|447762|P3|COMPLETED|Double-Blind Phase||22
192037|NCT00494507|447763|P2|COMPLETED|Double-Blind Phase||9
192038|NCT00494507|447764|P1|COMPLETED|Double-Blind Phase||9
192039|NCT00494507|447761|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
192040|NCT00494507|447762|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
192041|NCT00494507|447763|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
192042|NCT00494507|447764|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
192043|NCT00494507|447761|P4|STARTED|Double-Blind Phase||20
192044|NCT00494507|447762|P3|STARTED|Double-Blind Phase||24
192045|NCT00494507|447763|P2|STARTED|Double-Blind Phase||9
192046|NCT00494507|447764|P1|STARTED|Double-Blind Phase||12
192047|NCT00494494|447790|P2|NOT COMPLETED|Overall Study||0
192048|NCT00494494|447791|P1|NOT COMPLETED|Overall Study||0
192049|NCT00494494|447790|P2|COMPLETED|Overall Study||39
192050|NCT00494494|447791|P1|COMPLETED|Overall Study||40
192051|NCT00494494|447790|P2|STARTED|Overall Study||39
192052|NCT00494494|447791|P1|STARTED|Overall Study||40
192053|NCT00494481|447807|P2|NOT COMPLETED|Overall Study||24
192054|NCT00494481|447808|P1|NOT COMPLETED|Overall Study||29
192055|NCT00494481|447807|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
192056|NCT00494481|447808|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
192057|NCT00494481|447807|P2|STARTED|Overall Study|randomised patients|29
192058|NCT00494481|447808|P1|STARTED|Overall Study|randomised patients|35
192059|NCT00494442|447816|P2|NOT COMPLETED|Overall Study||16
192060|NCT00494442|447817|P1|NOT COMPLETED|Overall Study||17
192061|NCT00494442|447816|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
192062|NCT00494442|447817|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
192063|NCT00494442|447816|P2|STARTED|Overall Study|Patients received treatment|33
192064|NCT00494442|447817|P1|STARTED|Overall Study|Patients received treatment|24
192065|NCT00494299|447833|P2|NOT COMPLETED|Overall Study||229
192066|NCT00494299|447834|P1|NOT COMPLETED|Overall Study||229
192067|NCT00494299|447833|P2|COMPLETED|Overall Study||0
192068|NCT00494299|447834|P1|COMPLETED|Overall Study||0
192069|NCT00494299|447833|P2|Received Treatment|Overall Study||227
192070|NCT00494299|447834|P1|Received Treatment|Overall Study||229
192071|NCT00494299|447833|P2|STARTED|Overall Study||229
192072|NCT00494299|447834|P1|STARTED|Overall Study||229
192073|NCT00494234|447846|P2|NOT COMPLETED|Overall Study||10
192074|NCT00494234|447847|P1|NOT COMPLETED|Overall Study||15
192075|NCT00494234|447846|P2|COMPLETED|Overall Study||17
192076|NCT00494234|447847|P1|COMPLETED|Overall Study||12
192077|NCT00494234|447846|P2|STARTED|Overall Study||27
192078|NCT00494234|447847|P1|STARTED|Overall Study||27
192079|NCT00494221|447866|P3|NOT COMPLETED|Overall Study||14
192080|NCT00494221|447867|P2|NOT COMPLETED|Overall Study||11
192081|NCT00494221|447868|P1|NOT COMPLETED|Overall Study||16
192082|NCT00494221|447866|P3|COMPLETED|Overall Study||44
192083|NCT00494221|447867|P2|COMPLETED|Overall Study||45
192084|NCT00494221|447868|P1|COMPLETED|Overall Study||42
192085|NCT00494221|447866|P3|STARTED|Overall Study||58
192086|NCT00494221|447867|P2|STARTED|Overall Study||56
192087|NCT00494221|447868|P1|STARTED|Overall Study||58
192088|NCT00494143|447888|P6|NOT COMPLETED|Overall Study||0
192089|NCT00494143|447889|P5|NOT COMPLETED|Overall Study||0
192090|NCT00494143|447890|P4|NOT COMPLETED|Overall Study||0
192091|NCT00494143|447891|P3|NOT COMPLETED|Overall Study||0
192092|NCT00494143|447892|P2|NOT COMPLETED|Overall Study||0
192093|NCT00494143|447893|P1|NOT COMPLETED|Overall Study||0
192094|NCT00494143|447888|P6|COMPLETED|Overall Study||0
192095|NCT00494143|447889|P5|COMPLETED|Overall Study||1
192096|NCT00494143|447890|P4|COMPLETED|Overall Study||0
192097|NCT00494143|447891|P3|COMPLETED|Overall Study||3
192098|NCT00494143|447892|P2|COMPLETED|Overall Study||2
192099|NCT00494143|447893|P1|COMPLETED|Overall Study||1
192100|NCT00494143|447888|P6|STARTED|Overall Study||0
192101|NCT00494143|447889|P5|STARTED|Overall Study||1
192102|NCT00494143|447890|P4|STARTED|Overall Study||0
192103|NCT00494143|447891|P3|STARTED|Overall Study||3
192104|NCT00494143|447892|P2|STARTED|Overall Study||2
192105|NCT00494143|447893|P1|STARTED|Overall Study||1
192106|NCT00494091|447909|P2|NOT COMPLETED|Overall Study||76
192107|NCT00494091|447910|P1|NOT COMPLETED|Overall Study||6
192108|NCT00494091|447909|P2|COMPLETED|Overall Study||0
192109|NCT00494091|447910|P1|COMPLETED|Overall Study||0
192110|NCT00494091|447909|P2|STARTED|Overall Study||76
192111|NCT00494091|447910|P1|STARTED|Overall Study||6
192112|NCT00494026|447932|P1|NOT COMPLETED|Overall Study||4
192113|NCT00494026|447932|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
192114|NCT00494026|447932|P1|STARTED|Overall Study||4
192115|NCT00494013|447942|P2|NOT COMPLETED|Overall Study||36
192116|NCT00494013|447943|P1|NOT COMPLETED|Overall Study||30
192117|NCT00494013|447942|P2|COMPLETED|Overall Study||183
192118|NCT00494013|447943|P1|COMPLETED|Overall Study||193
192119|NCT00494013|447942|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
192120|NCT00494013|447943|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
192121|NCT00494013|447942|P2|STARTED|Overall Study||219
192122|NCT00494013|447943|P1|STARTED|Overall Study||223
192123|NCT00493974|447973|P2|NOT COMPLETED|Overall Study||14
192124|NCT00493974|447974|P1|NOT COMPLETED|Overall Study||13
192125|NCT00493974|447973|P2|COMPLETED|Overall Study||45
192126|NCT00493974|447974|P1|COMPLETED|Overall Study||47
192127|NCT00493974|447973|P2|STARTED|Overall Study||59
192128|NCT00493974|447974|P1|STARTED|Overall Study||60
192129|NCT00493805|447992|P2|NOT COMPLETED|Overall Study||0
192130|NCT00493805|447993|P1|NOT COMPLETED|Overall Study||0
192131|NCT00493805|447992|P2|COMPLETED|Overall Study||42
192132|NCT00493805|447993|P1|COMPLETED|Overall Study||17
192133|NCT00493805|447992|P2|STARTED|Overall Study||42
192134|NCT00493805|447993|P1|STARTED|Overall Study||17
192135|NCT00493779|448001|P1|NOT COMPLETED|Overall Study||1
192136|NCT00493779|448001|P1|COMPLETED|Overall Study|Completed follow-up phase|97
192137|NCT00493779|448001|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
192138|NCT00493649|448008|P1|NOT COMPLETED|Overall Study||82
192139|NCT00493649|448008|P1|COMPLETED|Overall Study||411
192140|NCT00493649|448008|P1|STARTED|Overall Study||493
192141|NCT00493636|448021|P2|NOT COMPLETED|Overall Study||2
192142|NCT00493636|448022|P1|NOT COMPLETED|Overall Study||2
192143|NCT00493636|448021|P2|COMPLETED|Overall Study||77
192144|NCT00493636|448022|P1|COMPLETED|Overall Study||79
192145|NCT00493636|448021|P2|STARTED|Overall Study||79
192146|NCT00493636|448022|P1|STARTED|Overall Study||81
192147|NCT00493454|448036|P1|NOT COMPLETED|Overall Study||1
192148|NCT00493454|448036|P1|COMPLETED|Overall Study||5
192149|NCT00493454|448036|P1|STARTED|Overall Study||6
192150|NCT00493311|448042|P2|NOT COMPLETED|Overall Study||2
192151|NCT00493311|448043|P1|NOT COMPLETED|Overall Study||2
192152|NCT00493311|448042|P2|COMPLETED|Overall Study||29
192153|NCT00493311|448043|P1|COMPLETED|Overall Study||27
192154|NCT00493311|448042|P2|STARTED|Overall Study||31
192155|NCT00493311|448043|P1|STARTED|Overall Study||29
192156|NCT00493285|448063|P6|NOT COMPLETED|Overall Study||0
192157|NCT00493285|448064|P5|NOT COMPLETED|Overall Study||1
192158|NCT00493285|448065|P4|NOT COMPLETED|Overall Study||0
192159|NCT00493285|448066|P3|NOT COMPLETED|Overall Study||0
192160|NCT00493285|448067|P2|NOT COMPLETED|Overall Study||0
192161|NCT00493285|448068|P1|NOT COMPLETED|Overall Study||0
192162|NCT00493285|448063|P6|COMPLETED|Overall Study||5
192163|NCT00493285|448064|P5|COMPLETED|Overall Study||9
192164|NCT00493285|448065|P4|COMPLETED|Overall Study||6
192165|NCT00493285|448066|P3|COMPLETED|Overall Study||9
192166|NCT00493285|448067|P2|COMPLETED|Overall Study||6
192167|NCT00493285|448068|P1|COMPLETED|Overall Study||13
192168|NCT00493285|448063|P6|STARTED|Overall Study||5
192169|NCT00493285|448064|P5|STARTED|Overall Study||10
192170|NCT00493285|448065|P4|STARTED|Overall Study||6
192171|NCT00493285|448066|P3|STARTED|Overall Study||9
192172|NCT00493285|448067|P2|STARTED|Overall Study||6
192173|NCT00493285|448068|P1|STARTED|Overall Study||13
192174|NCT00493246|448300|P8|NOT COMPLETED|Overall Study||0
192175|NCT00493246|448301|P7|NOT COMPLETED|Overall Study||1
192176|NCT00493246|448302|P6|NOT COMPLETED|Overall Study||1
192177|NCT00493246|448303|P5|NOT COMPLETED|Overall Study||1
192178|NCT00493246|448304|P4|NOT COMPLETED|Overall Study||0
192179|NCT00493246|448305|P3|NOT COMPLETED|Overall Study||0
192180|NCT00493246|448306|P2|NOT COMPLETED|Overall Study||0
192181|NCT00493246|448307|P1|NOT COMPLETED|Overall Study||0
192182|NCT00493246|448300|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
192183|NCT00493246|448301|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
192184|NCT00493246|448302|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
192185|NCT00493246|448303|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
192186|NCT00493246|448304|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
192187|NCT00493246|448305|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
192188|NCT00493246|448306|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
192189|NCT00493246|448307|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
192190|NCT00493246|448300|P8|STARTED|Overall Study|All subjects who were randomized.|10
192191|NCT00493246|448301|P7|STARTED|Overall Study|All subjects who were randomized.|12
192192|NCT00493246|448302|P6|STARTED|Overall Study|All subjects who were randomized.|16
192193|NCT00493246|448303|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
192194|NCT00493246|448304|P4|STARTED|Overall Study||13
192195|NCT00493246|448305|P3|STARTED|Overall Study||12
192196|NCT00493246|448306|P2|STARTED|Overall Study||1
192197|NCT00493246|448307|P1|STARTED|Overall Study||2
192198|NCT00493220|448371|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192199|NCT00493220|448372|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192200|NCT00493220|448373|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192201|NCT00493220|448374|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192202|NCT00493220|448375|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192203|NCT00493220|448376|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
192204|NCT00493220|448371|P6|COMPLETED|Final 7-Day Safety Follow-up||5
192205|NCT00493220|448372|P5|COMPLETED|Final 7-Day Safety Follow-up||5
192206|NCT00493220|448373|P4|COMPLETED|Final 7-Day Safety Follow-up||5
192207|NCT00493220|448374|P3|COMPLETED|Final 7-Day Safety Follow-up||5
192208|NCT00493220|448375|P2|COMPLETED|Final 7-Day Safety Follow-up||5
192209|NCT00493220|448376|P1|COMPLETED|Final 7-Day Safety Follow-up||4
192210|NCT00493220|448371|P6|STARTED|Final 7-Day Safety Follow-up||5
192211|NCT00493220|448372|P5|STARTED|Final 7-Day Safety Follow-up||5
192212|NCT00493220|448373|P4|STARTED|Final 7-Day Safety Follow-up||5
192213|NCT00493220|448374|P3|STARTED|Final 7-Day Safety Follow-up||5
192214|NCT00493220|448375|P2|STARTED|Final 7-Day Safety Follow-up||5
192215|NCT00493220|448376|P1|STARTED|Final 7-Day Safety Follow-up||4
192216|NCT00493220|448371|P6|NOT COMPLETED|Third Intervention||0
192217|NCT00493220|448372|P5|NOT COMPLETED|Third Intervention||0
192218|NCT00493220|448373|P4|NOT COMPLETED|Third Intervention||0
192219|NCT00493220|448374|P3|NOT COMPLETED|Third Intervention||0
192220|NCT00493220|448375|P2|NOT COMPLETED|Third Intervention||0
192221|NCT00493220|448376|P1|NOT COMPLETED|Third Intervention||1
192222|NCT00493220|448371|P6|COMPLETED|Third Intervention||5
192223|NCT00493220|448372|P5|COMPLETED|Third Intervention||5
192224|NCT00493220|448373|P4|COMPLETED|Third Intervention||5
192225|NCT00493220|448374|P3|COMPLETED|Third Intervention||5
192226|NCT00493220|448375|P2|COMPLETED|Third Intervention||5
192227|NCT00493220|448376|P1|COMPLETED|Third Intervention||4
192228|NCT00493220|448371|P6|STARTED|Third Intervention||5
192229|NCT00493220|448372|P5|STARTED|Third Intervention||5
192230|NCT00493220|448373|P4|STARTED|Third Intervention||5
192231|NCT00493220|448374|P3|STARTED|Third Intervention||5
192232|NCT00493220|448375|P2|STARTED|Third Intervention||5
192233|NCT00493220|448376|P1|STARTED|Third Intervention||5
192234|NCT00493220|448371|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192235|NCT00493220|448372|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192236|NCT00493220|448373|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192237|NCT00493220|448374|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192238|NCT00493220|448375|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192239|NCT00493220|448376|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
192240|NCT00493220|448371|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192241|NCT00493220|448372|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192242|NCT00493220|448373|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192243|NCT00493220|448374|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192244|NCT00493220|448375|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192245|NCT00493220|448376|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
192246|NCT00493220|448371|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
192247|NCT00493220|448372|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
192248|NCT00493220|448373|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
192249|NCT00493220|448374|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
192250|NCT00493220|448375|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
192251|NCT00493220|448376|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
192252|NCT00493220|448371|P6|NOT COMPLETED|Second Intervention||0
192253|NCT00493220|448372|P5|NOT COMPLETED|Second Intervention||0
192254|NCT00493220|448373|P4|NOT COMPLETED|Second Intervention||0
192255|NCT00493220|448374|P3|NOT COMPLETED|Second Intervention||0
192256|NCT00493220|448375|P2|NOT COMPLETED|Second Intervention||0
192257|NCT00493220|448376|P1|NOT COMPLETED|Second Intervention||0
192258|NCT00493220|448371|P6|COMPLETED|Second Intervention||5
192259|NCT00493220|448372|P5|COMPLETED|Second Intervention||5
192260|NCT00493220|448373|P4|COMPLETED|Second Intervention||5
192261|NCT00493220|448374|P3|COMPLETED|Second Intervention||5
192262|NCT00493220|448375|P2|COMPLETED|Second Intervention||5
192263|NCT00493220|448376|P1|COMPLETED|Second Intervention||5
192264|NCT00493220|448371|P6|STARTED|Second Intervention||5
192265|NCT00493220|448372|P5|STARTED|Second Intervention||5
192266|NCT00493220|448373|P4|STARTED|Second Intervention||5
192267|NCT00493220|448374|P3|STARTED|Second Intervention||5
192268|NCT00493220|448375|P2|STARTED|Second Intervention||5
192269|NCT00493220|448376|P1|STARTED|Second Intervention||5
192270|NCT00493220|448371|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192271|NCT00493220|448372|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192272|NCT00493220|448373|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192273|NCT00493220|448374|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192274|NCT00493220|448375|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192275|NCT00493220|448376|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
192276|NCT00493220|448371|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192277|NCT00493220|448372|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192278|NCT00493220|448373|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192279|NCT00493220|448374|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192280|NCT00493220|448375|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192281|NCT00493220|448376|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
192282|NCT00493220|448371|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
192283|NCT00493220|448372|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
192284|NCT00493220|448373|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
192285|NCT00493220|448374|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
192286|NCT00493220|448375|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
192287|NCT00493220|448376|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
192288|NCT00493220|448371|P6|NOT COMPLETED|First Intervention||0
192289|NCT00493220|448372|P5|NOT COMPLETED|First Intervention||0
192290|NCT00493220|448373|P4|NOT COMPLETED|First Intervention||0
192291|NCT00493220|448374|P3|NOT COMPLETED|First Intervention||0
192292|NCT00493220|448375|P2|NOT COMPLETED|First Intervention||0
192293|NCT00493220|448376|P1|NOT COMPLETED|First Intervention||0
192294|NCT00493220|448371|P6|COMPLETED|First Intervention||5
192295|NCT00493220|448372|P5|COMPLETED|First Intervention||5
192296|NCT00493220|448373|P4|COMPLETED|First Intervention||5
192297|NCT00493220|448374|P3|COMPLETED|First Intervention||5
192298|NCT00493220|448375|P2|COMPLETED|First Intervention||5
192299|NCT00493220|448376|P1|COMPLETED|First Intervention||5
192300|NCT00493220|448371|P6|STARTED|First Intervention||5
192301|NCT00493220|448372|P5|STARTED|First Intervention||5
192302|NCT00493220|448373|P4|STARTED|First Intervention||5
192303|NCT00493220|448374|P3|STARTED|First Intervention||5
192304|NCT00493220|448375|P2|STARTED|First Intervention||5
192305|NCT00493220|448376|P1|STARTED|First Intervention||5
192306|NCT00493181|448393|P1|NOT COMPLETED|Overall Study||0
192307|NCT00493181|448393|P1|COMPLETED|Overall Study||8
192308|NCT00493181|448393|P1|STARTED|Overall Study||8
192309|NCT00493038|448399|P2|NOT COMPLETED|Follow-up||0
192310|NCT00493038|448400|P1|NOT COMPLETED|Follow-up||1
192311|NCT00493038|448399|P2|COMPLETED|Follow-up||126
192312|NCT00493038|448400|P1|COMPLETED|Follow-up||122
192313|NCT00493038|448399|P2|STARTED|Follow-up||126
192314|NCT00493038|448400|P1|STARTED|Follow-up||123
192315|NCT00493038|448399|P2|NOT COMPLETED|Treatment||20
192316|NCT00493038|448400|P1|NOT COMPLETED|Treatment||24
192317|NCT00493038|448399|P2|COMPLETED|Treatment||126
192318|NCT00493038|448400|P1|COMPLETED|Treatment||123
192319|NCT00493038|448399|P2|Test-of-Cure Visit|Treatment||126
192320|NCT00493038|448400|P1|Test-of-Cure Visit|Treatment||123
192321|NCT00493038|448399|P2|Treated With Study Medication|Treatment||142
192322|NCT00493038|448400|P1|Treated With Study Medication|Treatment||145
192323|NCT00493038|448399|P2|Randomization|Treatment||146
192324|NCT00493038|448400|P1|Randomization|Treatment||147
192325|NCT00493038|448399|P2|STARTED|Treatment||146
192326|NCT00493038|448400|P1|STARTED|Treatment||147
192327|NCT00493012|448416|P2|NOT COMPLETED|Overall Study||17
192328|NCT00493012|448417|P1|NOT COMPLETED|Overall Study||18
192329|NCT00493012|448416|P2|COMPLETED|Overall Study||83
192330|NCT00493012|448417|P1|COMPLETED|Overall Study||82
192331|NCT00493012|448416|P2|STARTED|Overall Study||100
192332|NCT00493012|448417|P1|STARTED|Overall Study||100
192333|NCT00492973|448445|P2|NOT COMPLETED|Overall Study||1
192334|NCT00492973|448446|P1|NOT COMPLETED|Overall Study||0
192335|NCT00492973|448445|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
192336|NCT00492973|448446|P1|COMPLETED|Overall Study||37
192337|NCT00492973|448445|P2|STARTED|Overall Study||39
192338|NCT00492973|448446|P1|STARTED|Overall Study||37
192339|NCT00492856|448460|P4|NOT COMPLETED|Post-consolidation||1
192340|NCT00492856|448461|P3|NOT COMPLETED|Post-consolidation||27
192341|NCT00492856|448462|P2|NOT COMPLETED|Post-consolidation||12
192342|NCT00492856|448463|P1|NOT COMPLETED|Post-consolidation||0
192343|NCT00492856|448460|P4|COMPLETED|Post-consolidation||0
192344|NCT00492856|448461|P3|COMPLETED|Post-consolidation||0
192345|NCT00492856|448462|P2|COMPLETED|Post-consolidation||29
192346|NCT00492856|448463|P1|COMPLETED|Post-consolidation||0
192347|NCT00492856|448460|P4|STARTED|Post-consolidation||1
192348|NCT00492856|448461|P3|STARTED|Post-consolidation||27
192349|NCT00492856|448462|P2|STARTED|Post-consolidation||41
192350|NCT00492856|448463|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
192351|NCT00492856|448460|P4|NOT COMPLETED|Consolidation||0
192352|NCT00492856|448461|P3|NOT COMPLETED|Consolidation||0
192353|NCT00492856|448462|P2|NOT COMPLETED|Consolidation||0
192354|NCT00492856|448463|P1|NOT COMPLETED|Consolidation||9
192355|NCT00492856|448460|P4|COMPLETED|Consolidation||0
192356|NCT00492856|448461|P3|COMPLETED|Consolidation||0
192357|NCT00492856|448462|P2|COMPLETED|Consolidation||0
192358|NCT00492856|448463|P1|COMPLETED|Consolidation||83
192359|NCT00492856|448460|P4|STARTED|Consolidation||0
192360|NCT00492856|448461|P3|STARTED|Consolidation||0
192361|NCT00492856|448462|P2|STARTED|Consolidation||0
192362|NCT00492856|448463|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
192363|NCT00492856|448460|P4|NOT COMPLETED|Induction||0
192364|NCT00492856|448461|P3|NOT COMPLETED|Induction||0
192365|NCT00492856|448462|P2|NOT COMPLETED|Induction||0
192366|NCT00492856|448463|P1|NOT COMPLETED|Induction||6
192367|NCT00492856|448460|P4|COMPLETED|Induction||0
192368|NCT00492856|448461|P3|COMPLETED|Induction||0
192369|NCT00492856|448462|P2|COMPLETED|Induction||0
192370|NCT00492856|448463|P1|COMPLETED|Induction||99
192371|NCT00492856|448460|P4|STARTED|Induction||0
192372|NCT00492856|448461|P3|STARTED|Induction||0
192373|NCT00492856|448462|P2|STARTED|Induction||0
192374|NCT00492856|448463|P1|STARTED|Induction||105
192375|NCT00492752|448477|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
192376|NCT00492752|448478|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
192377|NCT00492752|448479|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
192378|NCT00492752|448480|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
192379|NCT00492752|448477|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
192380|NCT00492752|448478|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
192381|NCT00492752|448479|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
192382|NCT00492752|448480|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
192383|NCT00492752|448477|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
192384|NCT00492752|448478|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
192385|NCT00492752|448479|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
192386|NCT00492752|448480|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
192387|NCT00492752|448477|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
192388|NCT00492752|448478|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
192389|NCT00492752|448479|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
192390|NCT00492752|448480|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
192391|NCT00492752|448477|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
192392|NCT00492752|448478|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
192393|NCT00492752|448479|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
192394|NCT00492752|448480|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
192395|NCT00492752|448477|P4|NOT COMPLETED|Double Blind Treatment||0
192396|NCT00492752|448478|P3|NOT COMPLETED|Double Blind Treatment||3
192397|NCT00492752|448479|P2|NOT COMPLETED|Double Blind Treatment||0
192398|NCT00492752|448480|P1|NOT COMPLETED|Double Blind Treatment||14
192399|NCT00492752|448477|P4|COMPLETED|Double Blind Treatment||6
192400|NCT00492752|448478|P3|COMPLETED|Double Blind Treatment||67
192401|NCT00492752|448479|P2|COMPLETED|Double Blind Treatment||16
192402|NCT00492752|448480|P1|COMPLETED|Double Blind Treatment||120
192403|NCT00492752|448477|P4|Received Treatment|Double Blind Treatment|Safety Population|6
192404|NCT00492752|448478|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
192405|NCT00492752|448479|P2|Received Treatment|Double Blind Treatment|Safety Population|16
192406|NCT00492752|448480|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
192407|NCT00492752|448477|P4|STARTED|Double Blind Treatment||6
192408|NCT00492752|448478|P3|STARTED|Double Blind Treatment||70
192409|NCT00492752|448479|P2|STARTED|Double Blind Treatment||16
192410|NCT00492752|448480|P1|STARTED|Double Blind Treatment||134
192411|NCT00492726|448515|P2|NOT COMPLETED|Overall Study||36
192412|NCT00492726|448516|P1|NOT COMPLETED|Overall Study||50
192413|NCT00492726|448515|P2|COMPLETED|Overall Study||358
192414|NCT00492726|448516|P1|COMPLETED|Overall Study||360
192415|NCT00492726|448515|P2|End of Study|Overall Study||358
192416|NCT00492726|448516|P1|End of Study|Overall Study||360
192417|NCT00492726|448515|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
192418|NCT00492726|448516|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
192419|NCT00492726|448515|P2|STARTED|Overall Study||394
192420|NCT00492726|448516|P1|STARTED|Overall Study||410
192421|NCT00492583|448542|P2|NOT COMPLETED|Overall Study||0
192422|NCT00492583|448543|P1|NOT COMPLETED|Overall Study||0
192423|NCT00492583|448542|P2|COMPLETED|Overall Study||87
192424|NCT00492583|448543|P1|COMPLETED|Overall Study||95
192425|NCT00492583|448542|P2|STARTED|Overall Study||87
192426|NCT00492583|448543|P1|STARTED|Overall Study||95
192427|NCT00492557|448551|P2|NOT COMPLETED|Overall Study||23
192428|NCT00492557|448552|P1|NOT COMPLETED|Overall Study||24
192429|NCT00492557|448551|P2|COMPLETED|Overall Study||557
192430|NCT00492557|448552|P1|COMPLETED|Overall Study||556
192431|NCT00492557|448551|P2|Vaccinated Dose 2|Overall Study||558
192432|NCT00492557|448552|P1|Vaccinated Dose 2|Overall Study||560
192433|NCT00492557|448551|P2|Vaccinated Dose 1|Overall Study||575
192434|NCT00492557|448552|P1|Vaccinated Dose 1|Overall Study||577
192435|NCT00492557|448551|P2|STARTED|Overall Study||580
192436|NCT00492557|448552|P1|STARTED|Overall Study||580
192437|NCT00492544|448568|P1|NOT COMPLETED|Overall Study||0
192438|NCT00492544|448568|P1|COMPLETED|Overall Study||100
192439|NCT00492544|448568|P1|STARTED|Overall Study||100
192440|NCT00492531|448582|P2|NOT COMPLETED|Overall Study||23
192441|NCT00492531|448583|P1|NOT COMPLETED|Overall Study||22
192442|NCT00492531|448582|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
192443|NCT00492531|448583|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
192444|NCT00492531|448582|P2|STARTED|Overall Study||37
192445|NCT00492531|448583|P1|STARTED|Overall Study||37
192446|NCT00492401|448595|P1|NOT COMPLETED|Overall Study||0
192447|NCT00492401|448595|P1|COMPLETED|Overall Study||55
192448|NCT00492401|448595|P1|STARTED|Overall Study||55
192449|NCT00492336|448606|P2|NOT COMPLETED|Overall Study||6
192450|NCT00492336|448607|P1|NOT COMPLETED|Overall Study||2
192451|NCT00492336|448606|P2|COMPLETED|Overall Study||23
192452|NCT00492336|448607|P1|COMPLETED|Overall Study||26
192453|NCT00492336|448606|P2|STARTED|Overall Study||29
192454|NCT00492336|448607|P1|STARTED|Overall Study||28
192455|NCT00492297|448613|P1|NOT COMPLETED|Survival Only Follow-up||59
192456|NCT00492297|448613|P1|COMPLETED|Survival Only Follow-up||0
192457|NCT00492297|448613|P1|STARTED|Survival Only Follow-up||59
192458|NCT00492297|448613|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
192459|NCT00492297|448613|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
192460|NCT00492297|448613|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
192461|NCT00492297|448613|P1|NOT COMPLETED|Treatment||5
192462|NCT00492297|448613|P1|COMPLETED|Treatment||78
192463|NCT00492297|448613|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
192464|NCT00492297|448613|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
192465|NCT00492297|448613|P1|STARTED|Treatment||83
192466|NCT00492284|448631|P4|NOT COMPLETED|Overall Study||10
192467|NCT00492284|448632|P3|NOT COMPLETED|Overall Study||6
192468|NCT00492284|448633|P2|NOT COMPLETED|Overall Study||4
192469|NCT00492284|448634|P1|NOT COMPLETED|Overall Study||1
192470|NCT00492284|448631|P4|COMPLETED|Overall Study||31
192471|NCT00492284|448632|P3|COMPLETED|Overall Study||37
192472|NCT00492284|448633|P2|COMPLETED|Overall Study||35
192473|NCT00492284|448634|P1|COMPLETED|Overall Study||38
192474|NCT00492284|448631|P4|STARTED|Overall Study||41
192475|NCT00492284|448632|P3|STARTED|Overall Study||43
192476|NCT00492284|448633|P2|STARTED|Overall Study||39
192477|NCT00492284|448634|P1|STARTED|Overall Study||39
192478|NCT00492232|448678|P2|NOT COMPLETED|Open-Label Treatment||0
192479|NCT00492232|448679|P1|NOT COMPLETED|Open-Label Treatment||1
192480|NCT00492232|448678|P2|COMPLETED|Open-Label Treatment||0
192481|NCT00492232|448679|P1|COMPLETED|Open-Label Treatment||88
192482|NCT00492232|448678|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
192483|NCT00492232|448679|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
192484|NCT00492232|448678|P2|NOT COMPLETED|Double-Blind Treatment||25
192485|NCT00492232|448679|P1|NOT COMPLETED|Double-Blind Treatment||18
192486|NCT00492232|448678|P2|COMPLETED|Double-Blind Treatment||45
192487|NCT00492232|448679|P1|COMPLETED|Double-Blind Treatment||47
192488|NCT00492232|448678|P2|STARTED|Double-Blind Treatment||70
192489|NCT00492232|448679|P1|STARTED|Double-Blind Treatment||65
192490|NCT00492232|448678|P2|NOT COMPLETED|Placebo Run-in||70
192491|NCT00492232|448679|P1|NOT COMPLETED|Placebo Run-in||0
192492|NCT00492232|448678|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
192493|NCT00492232|448679|P1|COMPLETED|Placebo Run-in||0
192494|NCT00492232|448678|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
192495|NCT00492232|448679|P1|STARTED|Placebo Run-in||0
192496|NCT00492206|448711|P1|NOT COMPLETED|Overall Study||0
192497|NCT00492206|448711|P1|COMPLETED|Overall Study||40
192498|NCT00492206|448711|P1|STARTED|Overall Study||40
192499|NCT00492089|448720|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
192500|NCT00492089|448721|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
192501|NCT00492089|448720|P2|COMPLETED|Second Intervention (6 Weeks)||6
192502|NCT00492089|448721|P1|COMPLETED|Second Intervention (6 Weeks)||5
192503|NCT00492089|448720|P2|STARTED|Second Intervention (6 Weeks)||6
192504|NCT00492089|448721|P1|STARTED|Second Intervention (6 Weeks)||5
192505|NCT00492089|448720|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
192506|NCT00492089|448721|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
192507|NCT00492089|448720|P2|COMPLETED|First Intervention (6 Weeks)||6
192508|NCT00492089|448721|P1|COMPLETED|First Intervention (6 Weeks)||5
192509|NCT00492089|448720|P2|STARTED|First Intervention (6 Weeks)||6
192510|NCT00492089|448721|P1|STARTED|First Intervention (6 Weeks)||5
192511|NCT00492063|448731|P4|NOT COMPLETED|Overall Study||10
192512|NCT00492063|448732|P3|NOT COMPLETED|Overall Study||11
192513|NCT00492063|448733|P2|NOT COMPLETED|Overall Study||14
192514|NCT00492063|448734|P1|NOT COMPLETED|Overall Study||10
192515|NCT00492063|448731|P4|COMPLETED|Overall Study||666
192516|NCT00492063|448732|P3|COMPLETED|Overall Study||667
192517|NCT00492063|448733|P2|COMPLETED|Overall Study||634
192518|NCT00492063|448734|P1|COMPLETED|Overall Study||642
192519|NCT00492063|448731|P4|STARTED|Overall Study||676
192520|NCT00492063|448732|P3|STARTED|Overall Study||678
192521|NCT00492063|448733|P2|STARTED|Overall Study||648
192522|NCT00492063|448734|P1|STARTED|Overall Study||652
192523|NCT00492024|448758|P2|NOT COMPLETED|Follow up||2
192524|NCT00492024|448759|P1|NOT COMPLETED|Follow up||1
192525|NCT00492024|448758|P2|COMPLETED|Follow up||99
192526|NCT00492024|448759|P1|COMPLETED|Follow up||221
192527|NCT00492024|448758|P2|STARTED|Follow up||101
192528|NCT00492024|448759|P1|STARTED|Follow up||222
192529|NCT00492024|448758|P2|NOT COMPLETED|Treatment||22
192530|NCT00492024|448759|P1|NOT COMPLETED|Treatment||29
192531|NCT00492024|448758|P2|COMPLETED|Treatment||101
192532|NCT00492024|448759|P1|COMPLETED|Treatment||222
192533|NCT00492024|448758|P2|STARTED|Treatment||123
192534|NCT00492024|448759|P1|STARTED|Treatment||251
192535|NCT00491894|448775|P1|NOT COMPLETED|Overall Study||34
192536|NCT00491894|448775|P1|COMPLETED|Overall Study||103
192537|NCT00491894|448775|P1|STARTED|Overall Study||137
192538|NCT00491829|448786|P3|NOT COMPLETED|Overall Study||75
192539|NCT00491829|448787|P2|NOT COMPLETED|Overall Study||114
192540|NCT00491829|448788|P1|NOT COMPLETED|Overall Study||95
192541|NCT00491829|448786|P3|COMPLETED|Overall Study||243
192542|NCT00491829|448787|P2|COMPLETED|Overall Study||202
192543|NCT00491829|448788|P1|COMPLETED|Overall Study||216
192544|NCT00491829|448786|P3|STARTED|Overall Study||318
192545|NCT00491829|448787|P2|STARTED|Overall Study||316
192546|NCT00491829|448788|P1|STARTED|Overall Study||311
192547|NCT00491764|448802|P6|NOT COMPLETED|Overall Study||9
192548|NCT00491764|448803|P5|NOT COMPLETED|Overall Study||3
192549|NCT00491764|448804|P4|NOT COMPLETED|Overall Study||8
192550|NCT00491764|448805|P3|NOT COMPLETED|Overall Study||8
192551|NCT00491764|448806|P2|NOT COMPLETED|Overall Study||7
192552|NCT00491764|448807|P1|NOT COMPLETED|Overall Study||5
192553|NCT00491764|448802|P6|COMPLETED|Overall Study||27
192554|NCT00491764|448803|P5|COMPLETED|Overall Study||33
192555|NCT00491764|448804|P4|COMPLETED|Overall Study||28
192556|NCT00491764|448805|P3|COMPLETED|Overall Study||28
192557|NCT00491764|448806|P2|COMPLETED|Overall Study||30
192558|NCT00491764|448807|P1|COMPLETED|Overall Study||32
192559|NCT00491764|448802|P6|STARTED|Overall Study||36
192560|NCT00491764|448803|P5|STARTED|Overall Study||36
192561|NCT00491764|448804|P4|STARTED|Overall Study||36
192562|NCT00491764|448805|P3|STARTED|Overall Study||36
192563|NCT00491764|448806|P2|STARTED|Overall Study||37
192564|NCT00491764|448807|P1|STARTED|Overall Study||37
192565|NCT00491738|448835|P2|NOT COMPLETED|Overall Study||0
192566|NCT00491738|448836|P1|NOT COMPLETED|Overall Study||0
192567|NCT00491738|448835|P2|COMPLETED|Overall Study||9
192568|NCT00491738|448836|P1|COMPLETED|Overall Study||7
192569|NCT00491738|448835|P2|STARTED|Overall Study||9
192570|NCT00491738|448836|P1|STARTED|Overall Study||7
192571|NCT00491608|448840|P1|NOT COMPLETED|Overall Study||3
192572|NCT00491608|448840|P1|COMPLETED|Overall Study||206
192573|NCT00491608|448840|P1|STARTED|Overall Study|Participants who received treatment|209
192574|NCT00491556|448851|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
192575|NCT00491556|448852|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
192576|NCT00491556|448851|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
192577|NCT00491556|448852|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
192578|NCT00491556|448851|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
192579|NCT00491556|448852|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
192580|NCT00491556|448851|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
192581|NCT00491556|448852|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
192582|NCT00491556|448851|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
192583|NCT00491556|448852|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
192584|NCT00491556|448851|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
192585|NCT00491556|448852|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
192586|NCT00491556|448851|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
192587|NCT00491556|448852|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
192588|NCT00491530|448911|P3|NOT COMPLETED|Overall Study||5
192589|NCT00491530|448912|P2|NOT COMPLETED|Overall Study||6
192590|NCT00491530|448913|P1|NOT COMPLETED|Overall Study||12
192591|NCT00491530|448911|P3|COMPLETED|Overall Study||81
192592|NCT00491530|448912|P2|COMPLETED|Overall Study||44
192593|NCT00491530|448913|P1|COMPLETED|Overall Study||162
192594|NCT00491530|448911|P3|STARTED|Overall Study||86
192595|NCT00491530|448912|P2|STARTED|Overall Study||50
192596|NCT00491530|448913|P1|STARTED|Overall Study||174
192597|NCT00491504|448943|P4|NOT COMPLETED|Overall Study||4
192598|NCT00491504|448944|P3|NOT COMPLETED|Overall Study||4
192599|NCT00491504|448945|P2|NOT COMPLETED|Overall Study||1
192600|NCT00491504|448946|P1|NOT COMPLETED|Overall Study||0
192601|NCT00491504|448943|P4|COMPLETED|Overall Study||73
192602|NCT00491504|448944|P3|COMPLETED|Overall Study||74
192603|NCT00491504|448945|P2|COMPLETED|Overall Study||77
192604|NCT00491504|448946|P1|COMPLETED|Overall Study||77
192605|NCT00491504|448943|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
192606|NCT00491504|448944|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
192607|NCT00491504|448945|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
192608|NCT00491504|448946|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
192609|NCT00491400|448956|P2|NOT COMPLETED|Overall Study||4
192610|NCT00491400|448957|P1|NOT COMPLETED|Overall Study||5
192611|NCT00491400|448956|P2|COMPLETED|Overall Study||9
192612|NCT00491400|448957|P1|COMPLETED|Overall Study||10
192613|NCT00491400|448956|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
192614|NCT00491400|448957|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
192615|NCT00491400|448956|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
192616|NCT00491400|448957|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
192617|NCT00491400|448956|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
192618|NCT00491400|448957|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
192619|NCT00491400|448956|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
192620|NCT00491400|448957|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
192621|NCT00491400|448956|P2|STARTED|Overall Study||13
192622|NCT00491400|448957|P1|STARTED|Overall Study||15
192623|NCT00491387|448965|P1|NOT COMPLETED|Overall Study||0
192624|NCT00491387|448965|P1|COMPLETED|Overall Study||24
192625|NCT00491387|448965|P1|Study Enrollment|Overall Study||24
192626|NCT00491387|448965|P1|STARTED|Overall Study||24
192627|NCT00491374|448971|P2|NOT COMPLETED|Overall Study||0
192628|NCT00491374|448972|P1|NOT COMPLETED|Overall Study||0
192629|NCT00491374|448971|P2|COMPLETED|Overall Study||0
192630|NCT00491374|448972|P1|COMPLETED|Overall Study||0
192631|NCT00491374|448971|P2|STARTED|Overall Study||0
192632|NCT00491374|448972|P1|STARTED|Overall Study||0
192633|NCT00491244|448980|P2|NOT COMPLETED|Overall Study||20
192634|NCT00491244|448981|P1|NOT COMPLETED|Overall Study||27
192635|NCT00491244|448980|P2|COMPLETED|Overall Study||168
192636|NCT00491244|448981|P1|COMPLETED|Overall Study||162
192637|NCT00491244|448980|P2|STARTED|Overall Study||188
192638|NCT00491244|448981|P1|STARTED|Overall Study||189
192639|NCT00491179|448991|P2|NOT COMPLETED|Overall Study||2
192640|NCT00491179|448992|P1|NOT COMPLETED|Overall Study||7
192641|NCT00491179|448991|P2|COMPLETED|Overall Study||8
192642|NCT00491179|448992|P1|COMPLETED|Overall Study||18
192643|NCT00491179|448991|P2|STARTED|Overall Study||10
192644|NCT00491179|448992|P1|STARTED|Overall Study||25
192645|NCT00491075|449000|P1|NOT COMPLETED|Overall Study||2
192646|NCT00491075|449000|P1|COMPLETED|Overall Study||14
192647|NCT00491075|449000|P1|STARTED|Overall Study||16
192648|NCT00490971|449006|P5|NOT COMPLETED|Maintenance||39
192649|NCT00490971|449007|P4|NOT COMPLETED|Maintenance||53
192650|NCT00490971|449008|P3|NOT COMPLETED|Maintenance||51
192651|NCT00490971|449009|P2|NOT COMPLETED|Maintenance||0
192652|NCT00490971|449010|P1|NOT COMPLETED|Maintenance||0
192653|NCT00490971|449006|P5|COMPLETED|Maintenance||44
192654|NCT00490971|449007|P4|COMPLETED|Maintenance||96
192655|NCT00490971|449008|P3|COMPLETED|Maintenance||96
192656|NCT00490971|449009|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
192657|NCT00490971|449010|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
192658|NCT00490971|449006|P5|STARTED|Maintenance||83
192659|NCT00490971|449007|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
192660|NCT00490971|449008|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
192661|NCT00490971|449009|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
192662|NCT00490971|449010|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
192663|NCT00490971|449006|P5|NOT COMPLETED|Acute/Continuation||0
192664|NCT00490971|449007|P4|NOT COMPLETED|Acute/Continuation||0
192665|NCT00490971|449008|P3|NOT COMPLETED|Acute/Continuation||0
192666|NCT00490971|449009|P2|NOT COMPLETED|Acute/Continuation||62
192667|NCT00490971|449010|P1|NOT COMPLETED|Acute/Continuation||306
192668|NCT00490971|449006|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192669|NCT00490971|449007|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192670|NCT00490971|449008|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192671|NCT00490971|449009|P2|COMPLETED|Acute/Continuation||86
192672|NCT00490971|449010|P1|COMPLETED|Acute/Continuation||308
192673|NCT00490971|449006|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192674|NCT00490971|449007|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192675|NCT00490971|449008|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
192676|NCT00490971|449009|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
192677|NCT00490971|449010|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
192678|NCT00490945|449057|P5|NOT COMPLETED|Overall Study||0
192679|NCT00490945|449058|P4|NOT COMPLETED|Overall Study||0
192680|NCT00490945|449059|P3|NOT COMPLETED|Overall Study||0
192681|NCT00490945|449060|P2|NOT COMPLETED|Overall Study||1
192682|NCT00490945|449061|P1|NOT COMPLETED|Overall Study||0
192683|NCT00490945|449057|P5|COMPLETED|Overall Study||7
192684|NCT00490945|449058|P4|COMPLETED|Overall Study||7
192685|NCT00490945|449059|P3|COMPLETED|Overall Study||8
192686|NCT00490945|449060|P2|COMPLETED|Overall Study||8
192687|NCT00490945|449061|P1|COMPLETED|Overall Study||8
192688|NCT00490945|449057|P5|STARTED|Overall Study||7
192689|NCT00490945|449058|P4|STARTED|Overall Study||7
192690|NCT00490945|449059|P3|STARTED|Overall Study||8
192691|NCT00490945|449060|P2|STARTED|Overall Study||9
192692|NCT00490945|449061|P1|STARTED|Overall Study||8
192693|NCT00490919|449097|P3|NOT COMPLETED|Double-blind Phase||84
192694|NCT00490919|449098|P2|NOT COMPLETED|Double-blind Phase||86
192695|NCT00490919|449099|P1|NOT COMPLETED|Double-blind Phase||0
192696|NCT00490919|449097|P3|COMPLETED|Double-blind Phase||199
192697|NCT00490919|449098|P2|COMPLETED|Double-blind Phase||170
192698|NCT00490919|449099|P1|COMPLETED|Double-blind Phase||0
192699|NCT00490919|449097|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
192700|NCT00490919|449098|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
192701|NCT00490919|449099|P1|STARTED|Double-blind Phase||0
192702|NCT00490919|449097|P3|NOT COMPLETED|Open-label Run-in Period||0
192703|NCT00490919|449098|P2|NOT COMPLETED|Open-label Run-in Period||0
192704|NCT00490919|449099|P1|NOT COMPLETED|Open-label Run-in Period||483
192705|NCT00490919|449097|P3|COMPLETED|Open-label Run-in Period||0
192706|NCT00490919|449098|P2|COMPLETED|Open-label Run-in Period||0
192707|NCT00490919|449099|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
192708|NCT00490919|449097|P3|STARTED|Open-label Run-in Period||0
192709|NCT00490919|449098|P2|STARTED|Open-label Run-in Period||0
192710|NCT00490919|449099|P1|STARTED|Open-label Run-in Period||1024
192711|NCT00490841|449110|P1|NOT COMPLETED|Overall Study||13
192712|NCT00490841|449110|P1|COMPLETED|Overall Study||189
192713|NCT00490841|449110|P1|STARTED|Overall Study||202
192714|NCT00490815|449132|P2|NOT COMPLETED|Overall Study||9
192715|NCT00490815|449133|P1|NOT COMPLETED|Overall Study||8
192716|NCT00490815|449132|P2|COMPLETED|Overall Study||8
192717|NCT00490815|449133|P1|COMPLETED|Overall Study||12
192718|NCT00490815|449132|P2|STARTED|Overall Study||17
192719|NCT00490815|449133|P1|STARTED|Overall Study||20
192720|NCT00490802|449143|P2|NOT COMPLETED|Overall Study||2
192721|NCT00490802|449144|P1|NOT COMPLETED|Overall Study||1
192722|NCT00490802|449143|P2|COMPLETED|Overall Study||7
192723|NCT00490802|449144|P1|COMPLETED|Overall Study||9
192724|NCT00490802|449143|P2|STARTED|Overall Study||9
192725|NCT00490802|449144|P1|STARTED|Overall Study||10
192726|NCT00490724|449161|P3|NOT COMPLETED|Period II||3
192727|NCT00490724|449162|P2|NOT COMPLETED|Period II||1
192728|NCT00490724|449163|P1|NOT COMPLETED|Period II||3
192729|NCT00490724|449161|P3|COMPLETED|Period II||16
192730|NCT00490724|449162|P2|COMPLETED|Period II||19
192731|NCT00490724|449163|P1|COMPLETED|Period II||18
192732|NCT00490724|449161|P3|STARTED|Period II||19
192733|NCT00490724|449162|P2|STARTED|Period II||20
192734|NCT00490724|449163|P1|STARTED|Period II||21
192735|NCT00490724|449161|P3|NOT COMPLETED|Period I||1
192736|NCT00490724|449162|P2|NOT COMPLETED|Period I||0
192737|NCT00490724|449163|P1|NOT COMPLETED|Period I||0
192738|NCT00490724|449161|P3|COMPLETED|Period I||19
192739|NCT00490724|449162|P2|COMPLETED|Period I||20
192740|NCT00490724|449163|P1|COMPLETED|Period I||21
192741|NCT00490724|449161|P3|STARTED|Period I||20
192742|NCT00490724|449162|P2|STARTED|Period I||20
192743|NCT00490724|449163|P1|STARTED|Period I||21
192744|NCT00490698|449228|P1|NOT COMPLETED|Overall Study||10
192745|NCT00490698|449228|P1|COMPLETED|Overall Study||1
192746|NCT00490698|449228|P1|STARTED|Overall Study||11
192747|NCT00490646|449234|P2|NOT COMPLETED|Overall Study||2
192748|NCT00490646|449235|P1|NOT COMPLETED|Overall Study||2
192749|NCT00490646|449234|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
192750|NCT00490646|449235|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
192751|NCT00490646|449234|P2|Treated|Overall Study||24
192752|NCT00490646|449235|P1|Treated|Overall Study||24
192753|NCT00490646|449234|P2|STARTED|Overall Study||25
192754|NCT00490646|449235|P1|STARTED|Overall Study||25
192755|NCT00490555|449259|P4|NOT COMPLETED|Overall Study||0
192756|NCT00490555|449260|P3|NOT COMPLETED|Overall Study||2
192757|NCT00490555|449261|P2|NOT COMPLETED|Overall Study||0
192758|NCT00490555|449262|P1|NOT COMPLETED|Overall Study||0
192759|NCT00490555|449259|P4|COMPLETED|Overall Study||7
192760|NCT00490555|449260|P3|COMPLETED|Overall Study||7
192761|NCT00490555|449261|P2|COMPLETED|Overall Study||8
192762|NCT00490555|449262|P1|COMPLETED|Overall Study||8
192763|NCT00490555|449259|P4|STARTED|Overall Study||7
192764|NCT00490555|449260|P3|STARTED|Overall Study||9
192765|NCT00490555|449261|P2|STARTED|Overall Study||8
192766|NCT00490555|449262|P1|STARTED|Overall Study||8
192767|NCT00490542|449290|P2|NOT COMPLETED|Overall Study||4
192768|NCT00490542|449291|P1|NOT COMPLETED|Overall Study||7
192769|NCT00490542|449290|P2|COMPLETED|Overall Study||31
192770|NCT00490542|449291|P1|COMPLETED|Overall Study||31
192771|NCT00490542|449290|P2|STARTED|Overall Study||35
192772|NCT00490542|449291|P1|STARTED|Overall Study||38
192773|NCT00490477|449299|P2|NOT COMPLETED|Overall Study||0
192774|NCT00490477|449300|P1|NOT COMPLETED|Overall Study||0
192775|NCT00490477|449299|P2|COMPLETED|Overall Study||8
192776|NCT00490477|449300|P1|COMPLETED|Overall Study||8
192777|NCT00490477|449299|P2|STARTED|Overall Study||8
192778|NCT00490477|449300|P1|STARTED|Overall Study||8
192779|NCT00490269|449308|P2|NOT COMPLETED|Placebo Then Dronabinol||0
192780|NCT00490269|449309|P1|NOT COMPLETED|Placebo Then Dronabinol||0
192781|NCT00490269|449308|P2|COMPLETED|Placebo Then Dronabinol||6
192782|NCT00490269|449309|P1|COMPLETED|Placebo Then Dronabinol||6
192783|NCT00490269|449308|P2|STARTED|Placebo Then Dronabinol||6
192784|NCT00490269|449309|P1|STARTED|Placebo Then Dronabinol||6
192785|NCT00490269|449308|P2|NOT COMPLETED|Dronabinol Then Placebo||0
192786|NCT00490269|449309|P1|NOT COMPLETED|Dronabinol Then Placebo||0
192787|NCT00490269|449308|P2|COMPLETED|Dronabinol Then Placebo||6
192788|NCT00490269|449309|P1|COMPLETED|Dronabinol Then Placebo||6
192789|NCT00490269|449308|P2|STARTED|Dronabinol Then Placebo||6
192790|NCT00490269|449309|P1|STARTED|Dronabinol Then Placebo||6
192791|NCT00490256|449317|P2|NOT COMPLETED|Overall Study||0
192792|NCT00490256|449318|P1|NOT COMPLETED|Overall Study||0
192793|NCT00490256|449317|P2|COMPLETED|Overall Study||7
192794|NCT00490256|449318|P1|COMPLETED|Overall Study||7
192795|NCT00490256|449317|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
192796|NCT00490256|449318|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
192797|NCT00490256|449317|P2|STARTED|Overall Study||7
192798|NCT00490256|449318|P1|STARTED|Overall Study||7
192799|NCT00490139|449328|P4|NOT COMPLETED|Overall Study||307
192800|NCT00490139|449329|P3|NOT COMPLETED|Overall Study||434
192801|NCT00490139|449330|P2|NOT COMPLETED|Overall Study||275
192802|NCT00490139|449331|P1|NOT COMPLETED|Overall Study||308
192803|NCT00490139|449328|P4|COMPLETED|Overall Study||1790
192804|NCT00490139|449329|P3|COMPLETED|Overall Study||1666
192805|NCT00490139|449330|P2|COMPLETED|Overall Study||1816
192806|NCT00490139|449331|P1|COMPLETED|Overall Study||1785
192807|NCT00490139|449328|P4|STARTED|Overall Study||2097
192808|NCT00490139|449329|P3|STARTED|Overall Study||2100
192809|NCT00490139|449330|P2|STARTED|Overall Study||2091
192810|NCT00490139|449331|P1|STARTED|Overall Study||2093
192811|NCT00490100|449361|P1|NOT COMPLETED|Overall Study||3
192812|NCT00490100|449361|P1|COMPLETED|Overall Study||3
192813|NCT00490100|449361|P1|STARTED|Overall Study||6
192814|NCT00490035|449370|P4|NOT COMPLETED|Overall Study||6
192815|NCT00490035|449371|P3|NOT COMPLETED|Overall Study||12
192816|NCT00490035|449372|P2|NOT COMPLETED|Overall Study||6
192817|NCT00490035|449373|P1|NOT COMPLETED|Overall Study||8
192818|NCT00490035|449370|P4|COMPLETED|Overall Study||94
192819|NCT00490035|449371|P3|COMPLETED|Overall Study||88
192820|NCT00490035|449372|P2|COMPLETED|Overall Study||93
192821|NCT00490035|449373|P1|COMPLETED|Overall Study||92
192822|NCT00490035|449370|P4|STARTED|Overall Study||100
192823|NCT00490035|449371|P3|STARTED|Overall Study||100
192824|NCT00490035|449372|P2|STARTED|Overall Study||99
192825|NCT00490035|449373|P1|STARTED|Overall Study||100
192826|NCT00490022|449469|P2|NOT COMPLETED|Overall Study||3
192827|NCT00490022|449470|P1|NOT COMPLETED|Overall Study||1
192828|NCT00490022|449469|P2|COMPLETED|Overall Study||12
192829|NCT00490022|449470|P1|COMPLETED|Overall Study||15
192830|NCT00490022|449469|P2|STARTED|Overall Study||15
192831|NCT00490022|449470|P1|STARTED|Overall Study||16
192832|NCT00489970|449480|P2|NOT COMPLETED|Persistence Year 5||0
192833|NCT00489970|449481|P1|NOT COMPLETED|Persistence Year 5||0
192834|NCT00489970|449480|P2|COMPLETED|Persistence Year 5||401
192835|NCT00489970|449481|P1|COMPLETED|Persistence Year 5||856
192836|NCT00489970|449480|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
192837|NCT00489970|449481|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
192838|NCT00489970|449480|P2|NOT COMPLETED|Persistence Year 3||0
192839|NCT00489970|449481|P1|NOT COMPLETED|Persistence Year 3||0
192840|NCT00489970|449480|P2|COMPLETED|Persistence Year 3||486
192841|NCT00489970|449481|P1|COMPLETED|Persistence Year 3||1019
192842|NCT00489970|449480|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
192843|NCT00489970|449481|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
192844|NCT00489970|449480|P2|NOT COMPLETED|Persistence Year 1||0
192845|NCT00489970|449481|P1|NOT COMPLETED|Persistence Year 1||0
192846|NCT00489970|449480|P2|COMPLETED|Persistence Year 1||523
192847|NCT00489970|449481|P1|COMPLETED|Persistence Year 1||1069
192848|NCT00489970|449480|P2|STARTED|Persistence Year 1||523
192849|NCT00489970|449481|P1|STARTED|Persistence Year 1||1069
192850|NCT00489866|449507|P2|NOT COMPLETED|Overall Study||0
192851|NCT00489866|449508|P1|NOT COMPLETED|Overall Study||2
192852|NCT00489866|449507|P2|COMPLETED|Overall Study||7
192853|NCT00489866|449508|P1|COMPLETED|Overall Study||5
192854|NCT00489866|449507|P2|STARTED|Overall Study||7
192855|NCT00489866|449508|P1|STARTED|Overall Study||7
192856|NCT00489853|449522|P3|NOT COMPLETED|Follow-up Period||0
192857|NCT00489853|449523|P2|NOT COMPLETED|Follow-up Period||0
192858|NCT00489853|449524|P1|NOT COMPLETED|Follow-up Period||0
192859|NCT00489853|449522|P3|COMPLETED|Follow-up Period||33
192860|NCT00489853|449523|P2|COMPLETED|Follow-up Period||29
192861|NCT00489853|449524|P1|COMPLETED|Follow-up Period||29
192862|NCT00489853|449522|P3|STARTED|Follow-up Period||33
192863|NCT00489853|449523|P2|STARTED|Follow-up Period||29
192864|NCT00489853|449524|P1|STARTED|Follow-up Period||29
192865|NCT00489853|449522|P3|NOT COMPLETED|Treatment Period 3||0
192866|NCT00489853|449523|P2|NOT COMPLETED|Treatment Period 3||1
192867|NCT00489853|449524|P1|NOT COMPLETED|Treatment Period 3||0
192868|NCT00489853|449522|P3|COMPLETED|Treatment Period 3||33
192869|NCT00489853|449523|P2|COMPLETED|Treatment Period 3||29
192870|NCT00489853|449524|P1|COMPLETED|Treatment Period 3||29
192871|NCT00489853|449522|P3|STARTED|Treatment Period 3||33
192872|NCT00489853|449523|P2|STARTED|Treatment Period 3||30
192873|NCT00489853|449524|P1|STARTED|Treatment Period 3||29
192874|NCT00489853|449522|P3|NOT COMPLETED|Wash-out Period 2||2
192875|NCT00489853|449523|P2|NOT COMPLETED|Wash-out Period 2||3
192876|NCT00489853|449524|P1|NOT COMPLETED|Wash-out Period 2||4
192877|NCT00489853|449522|P3|COMPLETED|Wash-out Period 2||31
192878|NCT00489853|449523|P2|COMPLETED|Wash-out Period 2||32
192879|NCT00489853|449524|P1|COMPLETED|Wash-out Period 2||29
192880|NCT00489853|449522|P3|STARTED|Wash-out Period 2||33
192881|NCT00489853|449523|P2|STARTED|Wash-out Period 2||35
192882|NCT00489853|449524|P1|STARTED|Wash-out Period 2||33
192883|NCT00489853|449522|P3|NOT COMPLETED|Treatment Period 2||0
192884|NCT00489853|449523|P2|NOT COMPLETED|Treatment Period 2||0
192885|NCT00489853|449524|P1|NOT COMPLETED|Treatment Period 2||0
192886|NCT00489853|449522|P3|COMPLETED|Treatment Period 2||33
192887|NCT00489853|449523|P2|COMPLETED|Treatment Period 2||35
192888|NCT00489853|449524|P1|COMPLETED|Treatment Period 2||33
192889|NCT00489853|449522|P3|STARTED|Treatment Period 2||33
192890|NCT00489853|449523|P2|STARTED|Treatment Period 2||35
192891|NCT00489853|449524|P1|STARTED|Treatment Period 2||33
192892|NCT00489853|449522|P3|NOT COMPLETED|Wash-out Period 1||6
192893|NCT00489853|449523|P2|NOT COMPLETED|Wash-out Period 1||3
192894|NCT00489853|449524|P1|NOT COMPLETED|Wash-out Period 1||1
192895|NCT00489853|449522|P3|COMPLETED|Wash-out Period 1||32
192896|NCT00489853|449523|P2|COMPLETED|Wash-out Period 1||34
192897|NCT00489853|449524|P1|COMPLETED|Wash-out Period 1||35
192898|NCT00489853|449522|P3|STARTED|Wash-out Period 1||38
192899|NCT00489853|449523|P2|STARTED|Wash-out Period 1||37
192900|NCT00489853|449524|P1|STARTED|Wash-out Period 1||36
192901|NCT00489853|449522|P3|NOT COMPLETED|Treatment Period 1||0
192902|NCT00489853|449523|P2|NOT COMPLETED|Treatment Period 1||0
192903|NCT00489853|449524|P1|NOT COMPLETED|Treatment Period 1||0
192904|NCT00489853|449522|P3|COMPLETED|Treatment Period 1||38
192905|NCT00489853|449523|P2|COMPLETED|Treatment Period 1||37
192906|NCT00489853|449524|P1|COMPLETED|Treatment Period 1||36
192907|NCT00489853|449522|P3|STARTED|Treatment Period 1||38
192908|NCT00489853|449523|P2|STARTED|Treatment Period 1||37
192909|NCT00489853|449524|P1|STARTED|Treatment Period 1||36
192910|NCT00489736|449621|P2|NOT COMPLETED|Overall Study||69
192911|NCT00489736|449622|P1|NOT COMPLETED|Overall Study||96
192912|NCT00489736|449621|P2|COMPLETED|Overall Study|completed study drug period|186
192913|NCT00489736|449622|P1|COMPLETED|Overall Study|completed study drug period|153
192914|NCT00489736|449621|P2|STARTED|Overall Study|Randomized and treated patients|255
192915|NCT00489736|449622|P1|STARTED|Overall Study|Randomized and treated patients|249
192916|NCT00489554|449632|P1|NOT COMPLETED|Overall Study||4
192917|NCT00489554|449632|P1|COMPLETED|Overall Study||226
192918|NCT00489554|449632|P1|STARTED|Overall Study||230
192919|NCT00489541|449652|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
192920|NCT00489541|449653|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
192921|NCT00489541|449652|P2|COMPLETED|9-Month Angiographic Follow-up||108
192922|NCT00489541|449653|P1|COMPLETED|9-Month Angiographic Follow-up||197
192923|NCT00489541|449652|P2|STARTED|9-Month Angiographic Follow-up||125
192924|NCT00489541|449653|P1|STARTED|9-Month Angiographic Follow-up||224
192925|NCT00489541|449652|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
192926|NCT00489541|449653|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
192927|NCT00489541|449652|P2|COMPLETED|12-Month Clinical Follow-up||120
192928|NCT00489541|449653|P1|COMPLETED|12-Month Clinical Follow-up||215
192929|NCT00489541|449652|P2|STARTED|12-Month Clinical Follow-up||125
192930|NCT00489541|449653|P1|STARTED|12-Month Clinical Follow-up||224
192931|NCT00489489|449664|P3|NOT COMPLETED|Overall Study||3
192932|NCT00489489|449665|P2|NOT COMPLETED|Overall Study||5
192933|NCT00489489|449666|P1|NOT COMPLETED|Overall Study||3
192934|NCT00489489|449664|P3|COMPLETED|Overall Study|completed treatment period|37
192935|NCT00489489|449665|P2|COMPLETED|Overall Study|completed treatment period|32
192936|NCT00489489|449666|P1|COMPLETED|Overall Study|completed treatment period|38
192937|NCT00489489|449664|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
192938|NCT00489489|449665|P2|Treated|Overall Study||36
192939|NCT00489489|449666|P1|Treated|Overall Study||41
192940|NCT00489489|449664|P3|STARTED|Overall Study|randomized|40
192941|NCT00489489|449665|P2|STARTED|Overall Study|randomized|37
192942|NCT00489489|449666|P1|STARTED|Overall Study|randomized|41
192943|NCT00489424|449697|P3|NOT COMPLETED|Overall Study||5
192944|NCT00489424|449698|P2|NOT COMPLETED|Overall Study||5
192945|NCT00489424|449699|P1|NOT COMPLETED|Overall Study||4
192946|NCT00489424|449697|P3|COMPLETED|Overall Study||257
192947|NCT00489424|449698|P2|COMPLETED|Overall Study||259
192948|NCT00489424|449699|P1|COMPLETED|Overall Study||263
192949|NCT00489424|449697|P3|STARTED|Overall Study||262
192950|NCT00489424|449698|P2|STARTED|Overall Study||264
192951|NCT00489424|449699|P1|STARTED|Overall Study||267
192952|NCT00489359|449730|P2|NOT COMPLETED|Overall Study||29
192953|NCT00489359|449731|P1|NOT COMPLETED|Overall Study||7
192954|NCT00489359|449730|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
192955|NCT00489359|449731|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
192956|NCT00489359|449730|P2|STARTED|Overall Study||66
192957|NCT00489359|449731|P1|STARTED|Overall Study||20
192958|NCT00489268|449759|P5|NOT COMPLETED|Overall Study||20
192959|NCT00489268|449760|P4|NOT COMPLETED|Overall Study||0
192960|NCT00489268|449761|P3|NOT COMPLETED|Overall Study||1
192961|NCT00489268|449762|P2|NOT COMPLETED|Overall Study||0
192962|NCT00489268|449763|P1|NOT COMPLETED|Overall Study||0
192963|NCT00489268|449759|P5|COMPLETED|Overall Study||50
192964|NCT00489268|449760|P4|COMPLETED|Overall Study||11
192965|NCT00489268|449761|P3|COMPLETED|Overall Study||9
192966|NCT00489268|449762|P2|COMPLETED|Overall Study||10
192967|NCT00489268|449763|P1|COMPLETED|Overall Study||1
192968|NCT00489268|449759|P5|STARTED|Overall Study||70
192969|NCT00489268|449760|P4|STARTED|Overall Study||11
192970|NCT00489268|449761|P3|STARTED|Overall Study||10
192971|NCT00489268|449762|P2|STARTED|Overall Study||10
192972|NCT00489268|449763|P1|STARTED|Overall Study||1
192973|NCT00489255|449792|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
192974|NCT00489255|449793|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
192975|NCT00489255|449792|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
192976|NCT00489255|449793|P1|COMPLETED|Period 3: Days 57 to 84||24
192977|NCT00489255|449792|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
192978|NCT00489255|449793|P1|STARTED|Period 3: Days 57 to 84||28
192979|NCT00489255|449792|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
192980|NCT00489255|449793|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
192981|NCT00489255|449792|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
192982|NCT00489255|449793|P1|COMPLETED|Period 2: Days 29 to 56||61
192983|NCT00489255|449792|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
192984|NCT00489255|449793|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
192985|NCT00489255|449792|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
192986|NCT00489255|449793|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
192987|NCT00489255|449792|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
192988|NCT00489255|449793|P1|STARTED|Period 2: Days 29 to 56||64
192989|NCT00489255|449792|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
192990|NCT00489255|449793|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
192991|NCT00489255|449792|P2|COMPLETED|Period 1: Days 1 to 28||34
192992|NCT00489255|449793|P1|COMPLETED|Period 1: Days 1 to 28||107
192993|NCT00489255|449792|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
192994|NCT00489255|449793|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
192995|NCT00489255|449792|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
192996|NCT00489255|449793|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
192997|NCT00489255|449792|P2|STARTED|Period 1: Days 1 to 28||46
192998|NCT00489255|449793|P1|STARTED|Period 1: Days 1 to 28||136
192999|NCT00489255|449792|P2|NOT COMPLETED|Screening and Initial Randomization||3
193000|NCT00489255|449793|P1|NOT COMPLETED|Screening and Initial Randomization||9
193001|NCT00489255|449792|P2|COMPLETED|Screening and Initial Randomization||46
193002|NCT00489255|449793|P1|COMPLETED|Screening and Initial Randomization||136
193003|NCT00489255|449792|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
193004|NCT00489255|449793|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
193005|NCT00489086|449841|P1|NOT COMPLETED|Overall Study||23
193006|NCT00489086|449841|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
193007|NCT00489086|449841|P1|STARTED|Overall Study||36
193008|NCT00488865|449845|P1|NOT COMPLETED|Overall Study||0
193009|NCT00488865|449845|P1|COMPLETED|Overall Study||100
193010|NCT00488865|449845|P1|STARTED|Overall Study||100
193011|NCT00488826|449854|P3|NOT COMPLETED|Overall Study||26
193012|NCT00488826|449855|P2|NOT COMPLETED|Overall Study||52
193013|NCT00488826|449856|P1|NOT COMPLETED|Overall Study||56
193014|NCT00488826|449854|P3|COMPLETED|Overall Study||178
193015|NCT00488826|449855|P2|COMPLETED|Overall Study||244
193016|NCT00488826|449856|P1|COMPLETED|Overall Study||244
193017|NCT00488826|449854|P3|STARTED|Overall Study||204
193018|NCT00488826|449855|P2|STARTED|Overall Study||296
193019|NCT00488826|449856|P1|STARTED|Overall Study||300
193020|NCT00488774|449871|P4|NOT COMPLETED|Overall Study||3
193021|NCT00488774|449872|P3|NOT COMPLETED|Overall Study||5
193022|NCT00488774|449873|P2|NOT COMPLETED|Overall Study||5
193023|NCT00488774|449874|P1|NOT COMPLETED|Overall Study||8
193024|NCT00488774|449871|P4|COMPLETED|Overall Study||74
193025|NCT00488774|449872|P3|COMPLETED|Overall Study||70
193026|NCT00488774|449873|P2|COMPLETED|Overall Study||57
193027|NCT00488774|449874|P1|COMPLETED|Overall Study||69
193028|NCT00488774|449871|P4|STARTED|Overall Study||77
193029|NCT00488774|449872|P3|STARTED|Overall Study||75
193030|NCT00488774|449873|P2|STARTED|Overall Study||62
193031|NCT00488774|449874|P1|STARTED|Overall Study||77
193032|NCT00488683|449891|P3|NOT COMPLETED|Overall Study||2
193033|NCT00488683|449892|P2|NOT COMPLETED|Overall Study||6
193034|NCT00488683|449893|P1|NOT COMPLETED|Overall Study||12
193035|NCT00488683|449891|P3|COMPLETED|Overall Study||52
193036|NCT00488683|449892|P2|COMPLETED|Overall Study||48
193037|NCT00488683|449893|P1|COMPLETED|Overall Study||96
193038|NCT00488683|449891|P3|STARTED|Overall Study||54
193039|NCT00488683|449892|P2|STARTED|Overall Study||54
193040|NCT00488683|449893|P1|STARTED|Overall Study||108
193041|NCT00488644|449952|P1|NOT COMPLETED|Overall Study||2
193042|NCT00488644|449952|P1|COMPLETED|Overall Study||10
193043|NCT00488644|449952|P1|STARTED|Overall Study||12
193044|NCT00488631|449962|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
193045|NCT00488631|449963|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
193046|NCT00488631|449964|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
193047|NCT00488631|449965|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
193048|NCT00488631|449966|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193049|NCT00488631|449967|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193050|NCT00488631|449968|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193051|NCT00488631|449969|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193052|NCT00488631|449970|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193053|NCT00488631|449971|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
193054|NCT00488631|449962|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
193055|NCT00488631|449963|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
193056|NCT00488631|449964|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
193057|NCT00488631|449965|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
193058|NCT00488631|449966|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
193059|NCT00488631|449967|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
193060|NCT00488631|449968|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
193061|NCT00488631|449969|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
193062|NCT00488631|449970|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
193063|NCT00488631|449971|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
193064|NCT00488631|449962|P10|STARTED|Open Label Study Extension (Week 54-228)||7
193065|NCT00488631|449963|P9|STARTED|Open Label Study Extension (Week 54-228)||470
193066|NCT00488631|449964|P8|STARTED|Open Label Study Extension (Week 54-228)||93
193067|NCT00488631|449965|P7|STARTED|Open Label Study Extension (Week 54-228)||96
193068|NCT00488631|449966|P6|STARTED|Open Label Study Extension (Week 54-228)||0
193069|NCT00488631|449967|P5|STARTED|Open Label Study Extension (Week 54-228)||0
193070|NCT00488631|449968|P4|STARTED|Open Label Study Extension (Week 54-228)||0
193071|NCT00488631|449969|P3|STARTED|Open Label Study Extension (Week 54-228)||0
193072|NCT00488631|449970|P2|STARTED|Open Label Study Extension (Week 54-228)||0
193073|NCT00488631|449971|P1|STARTED|Open Label Study Extension (Week 54-228)||0
193074|NCT00488631|449962|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
193075|NCT00488631|449963|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
193076|NCT00488631|449964|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
193077|NCT00488631|449965|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
193078|NCT00488631|449966|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
193079|NCT00488631|449967|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
193080|NCT00488631|449968|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
193081|NCT00488631|449969|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
193082|NCT00488631|449970|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
193083|NCT00488631|449971|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
193084|NCT00488631|449962|P10|COMPLETED|Double Blind Period (Week 0-54)||0
193085|NCT00488631|449963|P9|COMPLETED|Double Blind Period (Week 0-54)||0
193086|NCT00488631|449964|P8|COMPLETED|Double Blind Period (Week 0-54)||0
193087|NCT00488631|449965|P7|COMPLETED|Double Blind Period (Week 0-54)||0
193088|NCT00488631|449966|P6|COMPLETED|Double Blind Period (Week 0-54)||189
193089|NCT00488631|449967|P5|COMPLETED|Double Blind Period (Week 0-54)||127
193090|NCT00488631|449968|P4|COMPLETED|Double Blind Period (Week 0-54)||88
193091|NCT00488631|449969|P3|COMPLETED|Double Blind Period (Week 0-54)||109
193092|NCT00488631|449970|P2|COMPLETED|Double Blind Period (Week 0-54)||111
193093|NCT00488631|449971|P1|COMPLETED|Double Blind Period (Week 0-54)||113
193094|NCT00488631|449962|P10|STARTED|Double Blind Period (Week 0-54)||0
193095|NCT00488631|449963|P9|STARTED|Double Blind Period (Week 0-54)||0
193096|NCT00488631|449964|P8|STARTED|Double Blind Period (Week 0-54)||0
193097|NCT00488631|449965|P7|STARTED|Double Blind Period (Week 0-54)||0
193098|NCT00488631|449966|P6|STARTED|Double Blind Period (Week 0-54)||405
193099|NCT00488631|449967|P5|STARTED|Double Blind Period (Week 0-54)||230
193100|NCT00488631|449968|P4|STARTED|Double Blind Period (Week 0-54)||129
193101|NCT00488631|449969|P3|STARTED|Double Blind Period (Week 0-54)||154
193102|NCT00488631|449970|P2|STARTED|Double Blind Period (Week 0-54)||154
193103|NCT00488631|449971|P1|STARTED|Double Blind Period (Week 0-54)||156
193104|NCT00488592|450006|P1|NOT COMPLETED|Overall Study||3
193105|NCT00488592|450006|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
193106|NCT00488592|450006|P1|STARTED|Overall Study|10 subjects were accrued|10
193107|NCT00488514|450010|P1|NOT COMPLETED|Overall Study||293
193108|NCT00488514|450010|P1|COMPLETED|Overall Study||363
193109|NCT00488514|450010|P1|STARTED|Overall Study||656
193110|NCT00488488|450083|P1|NOT COMPLETED|Overall Study||268
193111|NCT00488488|450083|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
193112|NCT00488488|450083|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
193113|NCT00488488|450083|P1|STARTED|Overall Study||1028
193114|NCT00488475|450098|P1|NOT COMPLETED|Overall Study||1754
193115|NCT00488475|450098|P1|COMPLETED|Overall Study||3191
193116|NCT00488475|450098|P1|STARTED|Overall Study||4945
193117|NCT00488345|450127|P3|NOT COMPLETED|Overall Study||3
193118|NCT00488345|450128|P2|NOT COMPLETED|Overall Study||4
193119|NCT00488345|450129|P1|NOT COMPLETED|Overall Study||0
193120|NCT00488345|450127|P3|COMPLETED|Overall Study||17
193121|NCT00488345|450128|P2|COMPLETED|Overall Study||17
193122|NCT00488345|450129|P1|COMPLETED|Overall Study||17
193123|NCT00488345|450127|P3|STARTED|Overall Study||20
193124|NCT00488345|450128|P2|STARTED|Overall Study||21
193125|NCT00488345|450129|P1|STARTED|Overall Study||17
193126|NCT00488319|450155|P3|NOT COMPLETED|Overall Study||122
193127|NCT00488319|450156|P2|NOT COMPLETED|Overall Study||43
193128|NCT00488319|450157|P1|NOT COMPLETED|Overall Study||15
193129|NCT00488319|450155|P3|COMPLETED|Overall Study||121
193130|NCT00488319|450156|P2|COMPLETED|Overall Study||75
193131|NCT00488319|450157|P1|COMPLETED|Overall Study||24
193132|NCT00488319|450155|P3|STARTED|Overall Study||243
193133|NCT00488319|450156|P2|STARTED|Overall Study||118
193134|NCT00488319|450157|P1|STARTED|Overall Study||39
193135|NCT00488293|450244|P2|NOT COMPLETED|Overall Study||30
193136|NCT00488293|450245|P1|NOT COMPLETED|Overall Study||36
193137|NCT00488293|450244|P2|COMPLETED|Overall Study||166
193138|NCT00488293|450245|P1|COMPLETED|Overall Study||160
193139|NCT00488293|450244|P2|STARTED|Overall Study||196
193140|NCT00488293|450245|P1|STARTED|Overall Study||196
193141|NCT00488059|450269|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
193142|NCT00488059|450270|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193143|NCT00488059|450271|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193144|NCT00488059|450269|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
193145|NCT00488059|450270|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193146|NCT00488059|450271|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193147|NCT00488059|450269|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
193148|NCT00488059|450270|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193149|NCT00488059|450271|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
193150|NCT00488059|450269|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193151|NCT00488059|450270|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
193152|NCT00488059|450271|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193153|NCT00488059|450269|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193154|NCT00488059|450270|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
193155|NCT00488059|450271|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193156|NCT00488059|450269|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193157|NCT00488059|450270|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
193158|NCT00488059|450271|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
193159|NCT00488059|450269|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
193160|NCT00488059|450270|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
193161|NCT00488059|450271|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
193162|NCT00488059|450269|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
193163|NCT00488059|450270|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
193164|NCT00488059|450271|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
193165|NCT00488059|450269|P3|STARTED|Phase I: ENF 90mg SC BID||0
193166|NCT00488059|450270|P2|STARTED|Phase I: ENF 90mg SC BID||0
193167|NCT00488059|450271|P1|STARTED|Phase I: ENF 90mg SC BID||29
193168|NCT00487981|450288|P1|NOT COMPLETED|Overall Study||1
193169|NCT00487981|450288|P1|COMPLETED|Overall Study||0
193170|NCT00487981|450288|P1|STARTED|Overall Study||1
193171|NCT00487942|450296|P4|NOT COMPLETED|Overall Study||2
193172|NCT00487942|450297|P3|NOT COMPLETED|Overall Study||3
193173|NCT00487942|450298|P2|NOT COMPLETED|Overall Study||3
193174|NCT00487942|450299|P1|NOT COMPLETED|Overall Study||3
193175|NCT00487942|450296|P4|COMPLETED|Overall Study||13
193176|NCT00487942|450297|P3|COMPLETED|Overall Study||12
193177|NCT00487942|450298|P2|COMPLETED|Overall Study||12
193178|NCT00487942|450299|P1|COMPLETED|Overall Study||12
193179|NCT00487942|450296|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
193180|NCT00487942|450297|P3|STARTED|Overall Study||15
193181|NCT00487942|450298|P2|STARTED|Overall Study||15
193182|NCT00487942|450299|P1|STARTED|Overall Study||15
193183|NCT00487825|450683|P2|NOT COMPLETED|Overall Study||5
193184|NCT00487825|450684|P1|NOT COMPLETED|Overall Study||6
193185|NCT00487825|450683|P2|COMPLETED|Overall Study||21
193186|NCT00487825|450684|P1|COMPLETED|Overall Study||46
193187|NCT00487825|450683|P2|STARTED|Overall Study||26
193188|NCT00487825|450684|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
193189|NCT00487721|450698|P2|NOT COMPLETED|Overall Study||0
193190|NCT00487721|450699|P1|NOT COMPLETED|Overall Study||0
193191|NCT00487721|450698|P2|COMPLETED|Overall Study||6
193192|NCT00487721|450699|P1|COMPLETED|Overall Study||6
193193|NCT00487721|450698|P2|STARTED|Overall Study||6
193194|NCT00487721|450699|P1|STARTED|Overall Study||6
193195|NCT00487695|450704|P2|NOT COMPLETED|Second Procedure||3
193196|NCT00487695|450705|P1|NOT COMPLETED|Second Procedure||1
193197|NCT00487695|450704|P2|COMPLETED|Second Procedure||20
193198|NCT00487695|450705|P1|COMPLETED|Second Procedure||19
193199|NCT00487695|450704|P2|STARTED|Second Procedure||23
193200|NCT00487695|450705|P1|STARTED|Second Procedure||20
193201|NCT00487695|450704|P2|NOT COMPLETED|First Procedure||0
193202|NCT00487695|450705|P1|NOT COMPLETED|First Procedure||3
193203|NCT00487695|450704|P2|COMPLETED|First Procedure||23
193204|NCT00487695|450705|P1|COMPLETED|First Procedure||20
193205|NCT00487695|450704|P2|STARTED|First Procedure||23
193206|NCT00487695|450705|P1|STARTED|First Procedure||23
193207|NCT00487669|450721|P1|NOT COMPLETED|Overall Study||0
193208|NCT00487669|450721|P1|COMPLETED|Overall Study||12
193209|NCT00487669|450721|P1|STARTED|Overall Study||12
193210|NCT00487578|450733|P2|NOT COMPLETED|Overall Study||4
193211|NCT00487578|450734|P1|NOT COMPLETED|Overall Study||1
193212|NCT00487578|450733|P2|COMPLETED|Overall Study||5
193213|NCT00487578|450734|P1|COMPLETED|Overall Study||2
193214|NCT00487578|450733|P2|STARTED|Overall Study||9
193215|NCT00487578|450734|P1|STARTED|Overall Study||3
193216|NCT00487565|450750|P1|NOT COMPLETED|Overall Study||28
193217|NCT00487565|450750|P1|COMPLETED|Overall Study||182
193218|NCT00487565|450750|P1|STARTED|Overall Study||210
193219|NCT00487552|450754|P1|NOT COMPLETED|Overall Study||6
193220|NCT00487552|450754|P1|COMPLETED|Overall Study||12
193221|NCT00487552|450754|P1|STARTED|Overall Study||18
193222|NCT00487539|450763|P4|NOT COMPLETED|Overall Study||4
193223|NCT00487539|450764|P3|NOT COMPLETED|Overall Study||3
193224|NCT00487539|450765|P2|NOT COMPLETED|Overall Study||3
193225|NCT00487539|450766|P1|NOT COMPLETED|Overall Study||7
193226|NCT00487539|450763|P4|COMPLETED|Overall Study||327
193227|NCT00487539|450764|P3|COMPLETED|Overall Study||328
193228|NCT00487539|450765|P2|COMPLETED|Overall Study||69
193229|NCT00487539|450766|P1|COMPLETED|Overall Study||324
193230|NCT00487539|450763|P4|STARTED|Overall Study||331
193231|NCT00487539|450764|P3|STARTED|Overall Study||331
193232|NCT00487539|450765|P2|STARTED|Overall Study||72
193233|NCT00487539|450766|P1|STARTED|Overall Study||331
193234|NCT00487461|450787|P3|NOT COMPLETED|Overall Study||4
193235|NCT00487461|450788|P2|NOT COMPLETED|Overall Study||2
193236|NCT00487461|450789|P1|NOT COMPLETED|Overall Study||0
193237|NCT00487461|450787|P3|COMPLETED|Overall Study||7
193238|NCT00487461|450788|P2|COMPLETED|Overall Study||10
193239|NCT00487461|450789|P1|COMPLETED|Overall Study||2
193240|NCT00487461|450787|P3|STARTED|Overall Study||11
193241|NCT00487461|450788|P2|STARTED|Overall Study||12
193242|NCT00487461|450789|P1|STARTED|Overall Study||2
193243|NCT00487435|450800|P1|NOT COMPLETED|Overall Study||485
193244|NCT00487435|450800|P1|COMPLETED|Overall Study||669
193245|NCT00487435|450800|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
193246|NCT00487396|450805|P1|NOT COMPLETED|Overall Study||3
193247|NCT00487396|450805|P1|COMPLETED|Overall Study||95
193248|NCT00487396|450805|P1|STARTED|Overall Study||98
193249|NCT00487279|450813|P2|NOT COMPLETED|Overall Study||2
193250|NCT00487279|450814|P1|NOT COMPLETED|Overall Study||1
193251|NCT00487279|450813|P2|COMPLETED|Overall Study||35
193252|NCT00487279|450814|P1|COMPLETED|Overall Study||43
193253|NCT00487279|450813|P2|STARTED|Overall Study||37
193254|NCT00487279|450814|P1|STARTED|Overall Study||44
193255|NCT00487240|450824|P2|NOT COMPLETED|Overall Study||26
193256|NCT00487240|450825|P1|NOT COMPLETED|Overall Study||31
193257|NCT00487240|450824|P2|COMPLETED|Overall Study||166
193258|NCT00487240|450825|P1|COMPLETED|Overall Study||164
193259|NCT00487240|450824|P2|Full Analysis Set (ITT Population)|Overall Study||189
193260|NCT00487240|450825|P1|Full Analysis Set (ITT Population)|Overall Study||192
193261|NCT00487240|450824|P2|STARTED|Overall Study||192
193262|NCT00487240|450825|P1|STARTED|Overall Study||195
193263|NCT00487188|450853|P3|NOT COMPLETED|Maintenance Phase||1
193264|NCT00487188|450854|P2|NOT COMPLETED|Maintenance Phase||0
193265|NCT00487188|450855|P1|NOT COMPLETED|Maintenance Phase||3
193266|NCT00487188|450853|P3|COMPLETED|Maintenance Phase||8
193267|NCT00487188|450854|P2|COMPLETED|Maintenance Phase||8
193268|NCT00487188|450855|P1|COMPLETED|Maintenance Phase||7
193269|NCT00487188|450853|P3|STARTED|Maintenance Phase||9
193270|NCT00487188|450854|P2|STARTED|Maintenance Phase||8
193271|NCT00487188|450855|P1|STARTED|Maintenance Phase||10
193272|NCT00487188|450853|P3|NOT COMPLETED|Induction Phase||0
193273|NCT00487188|450854|P2|NOT COMPLETED|Induction Phase||7
193274|NCT00487188|450855|P1|NOT COMPLETED|Induction Phase||9
193275|NCT00487188|450853|P3|COMPLETED|Induction Phase||0
193276|NCT00487188|450854|P2|COMPLETED|Induction Phase||9
193277|NCT00487188|450855|P1|COMPLETED|Induction Phase||22
193278|NCT00487188|450853|P3|Safety Population|Induction Phase||0
193279|NCT00487188|450854|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
193280|NCT00487188|450855|P1|Safety Population|Induction Phase||29
193281|NCT00487188|450853|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
193282|NCT00487188|450854|P2|STARTED|Induction Phase||16
193283|NCT00487188|450855|P1|STARTED|Induction Phase||31
193284|NCT00487162|450894|P2|NOT COMPLETED|Overall Study||5
193285|NCT00487162|450895|P1|NOT COMPLETED|Overall Study||2
193286|NCT00487162|450894|P2|COMPLETED|Overall Study||21
193287|NCT00487162|450895|P1|COMPLETED|Overall Study||28
193288|NCT00487162|450894|P2|STARTED|Overall Study||26
193289|NCT00487162|450895|P1|STARTED|Overall Study||30
193290|NCT00487084|450906|P3|NOT COMPLETED|Overall Study||5
193291|NCT00487084|450907|P2|NOT COMPLETED|Overall Study||3
193292|NCT00487084|450908|P1|NOT COMPLETED|Overall Study||4
193293|NCT00487084|450906|P3|COMPLETED|Overall Study||28
193294|NCT00487084|450907|P2|COMPLETED|Overall Study||30
193295|NCT00487084|450908|P1|COMPLETED|Overall Study||29
193296|NCT00487084|450906|P3|STARTED|Overall Study||33
193297|NCT00487084|450907|P2|STARTED|Overall Study||33
193298|NCT00487084|450908|P1|STARTED|Overall Study||33
193299|NCT00486954|450929|P5|NOT COMPLETED|Randomized Part||14
193300|NCT00486954|450930|P4|NOT COMPLETED|Randomized Part||20
193301|NCT00486954|450931|P3|NOT COMPLETED|Randomized Part||0
193302|NCT00486954|450932|P2|NOT COMPLETED|Randomized Part||0
193303|NCT00486954|450933|P1|NOT COMPLETED|Randomized Part||0
193304|NCT00486954|450929|P5|COMPLETED|Randomized Part||115
193305|NCT00486954|450930|P4|COMPLETED|Randomized Part||112
193306|NCT00486954|450931|P3|COMPLETED|Randomized Part||0
193307|NCT00486954|450932|P2|COMPLETED|Randomized Part||0
193308|NCT00486954|450933|P1|COMPLETED|Randomized Part||0
193309|NCT00486954|450929|P5|STARTED|Randomized Part||129
193310|NCT00486954|450930|P4|STARTED|Randomized Part||132
193311|NCT00486954|450931|P3|STARTED|Randomized Part||0
193312|NCT00486954|450932|P2|STARTED|Randomized Part||0
193313|NCT00486954|450933|P1|STARTED|Randomized Part||0
193314|NCT00486954|450929|P5|NOT COMPLETED|Pilot Part||0
193315|NCT00486954|450930|P4|NOT COMPLETED|Pilot Part||0
193316|NCT00486954|450931|P3|NOT COMPLETED|Pilot Part||6
193317|NCT00486954|450932|P2|NOT COMPLETED|Pilot Part||0
193318|NCT00486954|450933|P1|NOT COMPLETED|Pilot Part||6
193319|NCT00486954|450929|P5|COMPLETED|Pilot Part||0
193320|NCT00486954|450930|P4|COMPLETED|Pilot Part||0
193321|NCT00486954|450931|P3|COMPLETED|Pilot Part||0
193322|NCT00486954|450932|P2|COMPLETED|Pilot Part||0
193323|NCT00486954|450933|P1|COMPLETED|Pilot Part||0
193324|NCT00486954|450929|P5|STARTED|Pilot Part||0
193325|NCT00486954|450930|P4|STARTED|Pilot Part||0
193326|NCT00486954|450931|P3|STARTED|Pilot Part||6
193327|NCT00486954|450932|P2|STARTED|Pilot Part||0
193328|NCT00486954|450933|P1|STARTED|Pilot Part||6
193329|NCT00486902|451031|P2|NOT COMPLETED|Overall Study||5
193330|NCT00486902|451032|P1|NOT COMPLETED|Overall Study||9
193331|NCT00486902|451031|P2|COMPLETED|Overall Study||89
193332|NCT00486902|451032|P1|COMPLETED|Overall Study||85
193333|NCT00486902|451031|P2|STARTED|Overall Study||94
193334|NCT00486902|451032|P1|STARTED|Overall Study||94
193335|NCT00486863|451054|P2|NOT COMPLETED|Overall Study||3
193336|NCT00486863|451055|P1|NOT COMPLETED|Overall Study||1
193337|NCT00486863|451054|P2|COMPLETED|Overall Study||183
193338|NCT00486863|451055|P1|COMPLETED|Overall Study||183
193339|NCT00486863|451054|P2|STARTED|Overall Study||186
193340|NCT00486863|451055|P1|STARTED|Overall Study||184
193341|NCT00486837|451099|P2|NOT COMPLETED|Overall Study||7
193342|NCT00486837|451100|P1|NOT COMPLETED|Overall Study||9
193343|NCT00486837|451099|P2|COMPLETED|Overall Study||28
193344|NCT00486837|451100|P1|COMPLETED|Overall Study||28
193345|NCT00486837|451099|P2|STARTED|Overall Study||35
193346|NCT00486837|451100|P1|STARTED|Overall Study||37
193347|NCT00486811|451119|P3|NOT COMPLETED|Overall Study||214
193348|NCT00486811|451120|P2|NOT COMPLETED|Overall Study||141
193349|NCT00486811|451121|P1|NOT COMPLETED|Overall Study||122
193350|NCT00486811|451119|P3|COMPLETED|Overall Study||119
193351|NCT00486811|451120|P2|COMPLETED|Overall Study||179
193352|NCT00486811|451121|P1|COMPLETED|Overall Study||215
193353|NCT00486811|451119|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
193354|NCT00486811|451120|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
193355|NCT00486811|451121|P1|STARTED|Overall Study||337
193356|NCT00486759|451164|P2|NOT COMPLETED|Safety Follow-up||118
193357|NCT00486759|451165|P1|NOT COMPLETED|Safety Follow-up||139
193358|NCT00486759|451164|P2|COMPLETED|Safety Follow-up||142
193359|NCT00486759|451165|P1|COMPLETED|Safety Follow-up||64
193360|NCT00486759|451164|P2|STARTED|Safety Follow-up||260
193361|NCT00486759|451165|P1|STARTED|Safety Follow-up||203
193362|NCT00486759|451164|P2|NOT COMPLETED|Treatment||137
193363|NCT00486759|451165|P1|NOT COMPLETED|Treatment||187
193364|NCT00486759|451164|P2|COMPLETED|Treatment||260
193365|NCT00486759|451165|P1|COMPLETED|Treatment||203
193366|NCT00486759|451164|P2|STARTED|Treatment||397
193367|NCT00486759|451165|P1|STARTED|Treatment||390
193368|NCT00486720|451177|P2|NOT COMPLETED|Overall Study||12
193369|NCT00486720|451178|P1|NOT COMPLETED|Overall Study||10
193370|NCT00486720|451177|P2|COMPLETED|Overall Study||0
193371|NCT00486720|451178|P1|COMPLETED|Overall Study||0
193372|NCT00486720|451177|P2|STARTED|Overall Study||12
193373|NCT00486720|451178|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
193374|NCT00486525|451188|P2|NOT COMPLETED|Overall Study||13
193375|NCT00486525|451189|P1|NOT COMPLETED|Overall Study||6
193376|NCT00486525|451188|P2|COMPLETED|Overall Study||87
193377|NCT00486525|451189|P1|COMPLETED|Overall Study||94
193378|NCT00486525|451188|P2|STARTED|Overall Study||100
193379|NCT00486525|451189|P1|STARTED|Overall Study||100
193380|NCT00486434|451207|P2|NOT COMPLETED|Overall Study||134
193381|NCT00486434|451208|P1|NOT COMPLETED|Overall Study||194
193382|NCT00486434|451207|P2|COMPLETED|Overall Study||454
193383|NCT00486434|451208|P1|COMPLETED|Overall Study||394
193384|NCT00486434|451207|P2|STARTED|Overall Study||588
193385|NCT00486434|451208|P1|STARTED|Overall Study||588
193386|NCT00486330|451218|P1|NOT COMPLETED|Overall Study||2
193387|NCT00486330|451218|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
193388|NCT00486330|451218|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
193389|NCT00486291|451224|P2|NOT COMPLETED|Overall Study||29
193390|NCT00486291|451225|P1|NOT COMPLETED|Overall Study||16
193391|NCT00486291|451224|P2|COMPLETED|Overall Study||76
193392|NCT00486291|451225|P1|COMPLETED|Overall Study||89
193393|NCT00486291|451224|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
193394|NCT00486291|451225|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
193395|NCT00486278|451233|P1|NOT COMPLETED|Overall Study||9
193396|NCT00486278|451233|P1|COMPLETED|Overall Study||42
193397|NCT00486278|451233|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
193398|NCT00486265|451367|P1|NOT COMPLETED|Overall Study||9
193399|NCT00486265|451367|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
193400|NCT00486265|451367|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
193401|NCT00486252|451371|P1|NOT COMPLETED|Overall Study||58
193402|NCT00486252|451371|P1|COMPLETED|Overall Study||938
193403|NCT00486252|451371|P1|STARTED|Overall Study||996
193404|NCT00486226|451386|P1|NOT COMPLETED|Overall Study||13
193405|NCT00486226|451386|P1|COMPLETED|Overall Study||92
193406|NCT00486226|451386|P1|STARTED|Overall Study||105
193407|NCT00486044|451396|P2|NOT COMPLETED|Overall Study||3
193408|NCT00486044|451397|P1|NOT COMPLETED|Overall Study||2
193409|NCT00486044|451396|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
193410|NCT00486044|451397|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
193411|NCT00486044|451396|P2|STARTED|Overall Study|23 in MRI sub-study|49
193412|NCT00486044|451397|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
193413|NCT00486018|451412|P3|NOT COMPLETED|Overall Study||6
193414|NCT00486018|451413|P2|NOT COMPLETED|Overall Study||6
193415|NCT00486018|451414|P1|NOT COMPLETED|Overall Study||9
193416|NCT00486018|451412|P3|COMPLETED|Overall Study||125
193417|NCT00486018|451413|P2|COMPLETED|Overall Study||128
193418|NCT00486018|451414|P1|COMPLETED|Overall Study||123
193419|NCT00486018|451412|P3|Received Drug (Safety Population)|Overall Study||130
193420|NCT00486018|451413|P2|Received Drug (Safety Population)|Overall Study||134
193421|NCT00486018|451414|P1|Received Drug (Safety Population)|Overall Study||131
193422|NCT00486018|451412|P3|STARTED|Overall Study||131
193423|NCT00486018|451413|P2|STARTED|Overall Study||134
193424|NCT00486018|451414|P1|STARTED|Overall Study||132
193425|NCT00485953|451442|P2|NOT COMPLETED|Overall Study||7
193426|NCT00485953|451443|P1|NOT COMPLETED|Overall Study||7
193427|NCT00485953|451442|P2|COMPLETED|Overall Study||47
193428|NCT00485953|451443|P1|COMPLETED|Overall Study||48
193429|NCT00485953|451442|P2|STARTED|Overall Study||54
193430|NCT00485953|451443|P1|STARTED|Overall Study||55
193431|NCT00485836|451452|P3|NOT COMPLETED|Overall Study||11
193432|NCT00485836|451453|P2|NOT COMPLETED|Overall Study||3
193433|NCT00485836|451454|P1|NOT COMPLETED|Overall Study||15
193434|NCT00485836|451452|P3|COMPLETED|Overall Study||119
193435|NCT00485836|451453|P2|COMPLETED|Overall Study||129
193436|NCT00485836|451454|P1|COMPLETED|Overall Study||115
193437|NCT00485836|451452|P3|Received Study Drug (Safety Population)|Overall Study||129
193438|NCT00485836|451453|P2|Received Study Drug (Safety Population)|Overall Study||132
193439|NCT00485836|451454|P1|Received Study Drug (Safety Population)|Overall Study||129
193440|NCT00485836|451452|P3|STARTED|Overall Study||130
193441|NCT00485836|451453|P2|STARTED|Overall Study||132
193442|NCT00485836|451454|P1|STARTED|Overall Study||130
193443|NCT00485758|451482|P2|NOT COMPLETED|Overall Study||65
193444|NCT00485758|451483|P1|NOT COMPLETED|Overall Study||156
193445|NCT00485758|451482|P2|COMPLETED|Overall Study||277
193446|NCT00485758|451483|P1|COMPLETED|Overall Study||298
193447|NCT00485758|451482|P2|STARTED|Overall Study||342
193448|NCT00485758|451483|P1|STARTED|Overall Study||454
193449|NCT00485732|451495|P2|NOT COMPLETED|Overall Study||9
193450|NCT00485732|451496|P1|NOT COMPLETED|Overall Study||8
193451|NCT00485732|451495|P2|COMPLETED|Overall Study||67
193452|NCT00485732|451496|P1|COMPLETED|Overall Study||141
193453|NCT00485732|451495|P2|STARTED|Overall Study||76
193454|NCT00485732|451496|P1|STARTED|Overall Study||149
193455|NCT00485693|451518|P2|NOT COMPLETED|Overall Study||0
193456|NCT00485693|451519|P1|NOT COMPLETED|Overall Study||0
193457|NCT00485693|451518|P2|COMPLETED|Overall Study||104
193458|NCT00485693|451519|P1|COMPLETED|Overall Study||34
193459|NCT00485693|451518|P2|STARTED|Overall Study||104
193460|NCT00485693|451519|P1|STARTED|Overall Study||34
193461|NCT00485485|451528|P1|NOT COMPLETED|Overall Study||0
193462|NCT00485485|451528|P1|COMPLETED|Overall Study||7
193463|NCT00485485|451528|P1|STARTED|Overall Study||7
193464|NCT00485472|451534|P2|NOT COMPLETED|Overall Study||12
193465|NCT00485472|451535|P1|NOT COMPLETED|Overall Study||16
193466|NCT00485472|451534|P2|COMPLETED|Overall Study||64
193467|NCT00485472|451535|P1|COMPLETED|Overall Study||57
193468|NCT00485472|451534|P2|Entered Maintenance Phase|Overall Study||67
193469|NCT00485472|451535|P1|Entered Maintenance Phase|Overall Study||65
193470|NCT00485472|451534|P2|STARTED|Overall Study||76
193471|NCT00485472|451535|P1|STARTED|Overall Study||73
193472|NCT00485433|451561|P4|NOT COMPLETED|Overall Study||0
193473|NCT00485433|451562|P3|NOT COMPLETED|Overall Study||0
193474|NCT00485433|451563|P2|NOT COMPLETED|Overall Study||0
193475|NCT00485433|451564|P1|NOT COMPLETED|Overall Study||0
193476|NCT00485433|451561|P4|COMPLETED|Overall Study||25
193477|NCT00485433|451562|P3|COMPLETED|Overall Study||24
193478|NCT00485433|451563|P2|COMPLETED|Overall Study||25
193479|NCT00485433|451564|P1|COMPLETED|Overall Study||24
193480|NCT00485433|451561|P4|STARTED|Overall Study||25
193481|NCT00485433|451562|P3|STARTED|Overall Study||24
193482|NCT00485433|451563|P2|STARTED|Overall Study||25
193483|NCT00485433|451564|P1|STARTED|Overall Study||24
193484|NCT00485303|451572|P1|NOT COMPLETED|Overall Study||56
193485|NCT00485303|451572|P1|COMPLETED|Overall Study||2
193486|NCT00485303|451572|P1|STARTED|Overall Study||58
193487|NCT00485264|451590|P6|NOT COMPLETED|Overall Study||0
193488|NCT00485264|451591|P5|NOT COMPLETED|Overall Study||0
193489|NCT00485264|451592|P4|NOT COMPLETED|Overall Study||10
193490|NCT00485264|451593|P3|NOT COMPLETED|Overall Study||0
193491|NCT00485264|451594|P2|NOT COMPLETED|Overall Study||1
193492|NCT00485264|451595|P1|NOT COMPLETED|Overall Study||6
193493|NCT00485264|451590|P6|COMPLETED|Overall Study|Not included in this interim analysis|0
193494|NCT00485264|451591|P5|COMPLETED|Overall Study|Not included in this interim analysis|0
193495|NCT00485264|451592|P4|COMPLETED|Overall Study|Completed week 48|11
193496|NCT00485264|451593|P3|COMPLETED|Overall Study|Completed week 48|18
193497|NCT00485264|451594|P2|COMPLETED|Overall Study|Completed week 48|15
193498|NCT00485264|451595|P1|COMPLETED|Overall Study|Completed week 48|65
193499|NCT00485264|451590|P6|Completed Week 24|Overall Study||0
193500|NCT00485264|451591|P5|Completed Week 24|Overall Study||0
193501|NCT00485264|451592|P4|Completed Week 24|Overall Study||21
193502|NCT00485264|451593|P3|Completed Week 24|Overall Study||18
193503|NCT00485264|451594|P2|Completed Week 24|Overall Study||16
193504|NCT00485264|451595|P1|Completed Week 24|Overall Study||67
193505|NCT00485264|451590|P6|STARTED|Overall Study|Not included in this interim analysis|0
193506|NCT00485264|451591|P5|STARTED|Overall Study|Not included in this interim analysis|0
193507|NCT00485264|451592|P4|STARTED|Overall Study||21
193508|NCT00485264|451593|P3|STARTED|Overall Study||18
193509|NCT00485264|451594|P2|STARTED|Overall Study||16
193510|NCT00485264|451595|P1|STARTED|Overall Study||71
193511|NCT00485173|451681|P2|NOT COMPLETED|Overall Study||64
193512|NCT00485173|451682|P1|NOT COMPLETED|Overall Study||36
193513|NCT00485173|451681|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
193514|NCT00485173|451682|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
193515|NCT00485173|451681|P2|STARTED|Overall Study||486
193516|NCT00485173|451682|P1|STARTED|Overall Study||224
193517|NCT00485069|451724|P2|NOT COMPLETED|Overall Study||12
193518|NCT00485069|451725|P1|NOT COMPLETED|Overall Study||18
193519|NCT00485069|451724|P2|COMPLETED|Overall Study||46
193520|NCT00485069|451725|P1|COMPLETED|Overall Study||47
193521|NCT00485069|451724|P2|STARTED|Overall Study||58
193522|NCT00485069|451725|P1|STARTED|Overall Study||65
193523|NCT00484939|451770|P2|NOT COMPLETED|Overall Study||140
193524|NCT00484939|451771|P1|NOT COMPLETED|Overall Study||140
193525|NCT00484939|451770|P2|COMPLETED|Overall Study||0
193526|NCT00484939|451771|P1|COMPLETED|Overall Study||0
193527|NCT00484939|451770|P2|STARTED|Overall Study||140
193528|NCT00484939|451771|P1|STARTED|Overall Study||140
193529|NCT00484679|451791|P1|NOT COMPLETED|Overall Study||3
193530|NCT00484679|451791|P1|COMPLETED|Overall Study||15
193531|NCT00484679|451791|P1|STARTED|Overall Study||18
193532|NCT00484419|451798|P3|NOT COMPLETED|Overall Study||11
193533|NCT00484419|451799|P2|NOT COMPLETED|Overall Study||5
193534|NCT00484419|451800|P1|NOT COMPLETED|Overall Study||12
193535|NCT00484419|451798|P3|COMPLETED|Overall Study||45
193536|NCT00484419|451799|P2|COMPLETED|Overall Study||51
193537|NCT00484419|451800|P1|COMPLETED|Overall Study||45
193538|NCT00484419|451798|P3|STARTED|Overall Study||56
193539|NCT00484419|451799|P2|STARTED|Overall Study||56
193540|NCT00484419|451800|P1|STARTED|Overall Study||57
193541|NCT00484393|451858|P2|NOT COMPLETED|Overall Study||0
193542|NCT00484393|451859|P1|NOT COMPLETED|Overall Study||0
193543|NCT00484393|451858|P2|COMPLETED|Overall Study||3
193544|NCT00484393|451859|P1|COMPLETED|Overall Study||4
193545|NCT00484393|451858|P2|STARTED|Overall Study||3
193546|NCT00484393|451859|P1|STARTED|Overall Study||4
193547|NCT00484315|451867|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
193548|NCT00484315|451868|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
193549|NCT00484315|451867|P2|COMPLETED|9-Month Angiographic Follow-up||61
193550|NCT00484315|451868|P1|COMPLETED|9-Month Angiographic Follow-up||228
193551|NCT00484315|451867|P2|STARTED|9-Month Angiographic Follow-up||74
193552|NCT00484315|451868|P1|STARTED|9-Month Angiographic Follow-up||256
193553|NCT00484315|451867|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
193554|NCT00484315|451868|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
193555|NCT00484315|451867|P2|COMPLETED|12-Month Clinical Follow-up||311
193556|NCT00484315|451868|P1|COMPLETED|12-Month Clinical Follow-up||914
193557|NCT00484315|451867|P2|STARTED|12-Month Clinical Follow-up||320
193558|NCT00484315|451868|P1|STARTED|12-Month Clinical Follow-up||942
193559|NCT00484289|451879|P3|NOT COMPLETED|Post Marketing Phase||0
193560|NCT00484289|451880|P2|NOT COMPLETED|Post Marketing Phase||1
193561|NCT00484289|451881|P1|NOT COMPLETED|Post Marketing Phase||0
193562|NCT00484289|451879|P3|COMPLETED|Post Marketing Phase||10
193563|NCT00484289|451880|P2|COMPLETED|Post Marketing Phase||141
193564|NCT00484289|451881|P1|COMPLETED|Post Marketing Phase||10
193565|NCT00484289|451879|P3|STARTED|Post Marketing Phase||10
193566|NCT00484289|451880|P2|STARTED|Post Marketing Phase||142
193567|NCT00484289|451881|P1|STARTED|Post Marketing Phase||10
193568|NCT00484289|451879|P3|NOT COMPLETED|Long Term Phase||16
193569|NCT00484289|451880|P2|NOT COMPLETED|Long Term Phase||36
193570|NCT00484289|451881|P1|NOT COMPLETED|Long Term Phase||3
193571|NCT00484289|451879|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
193572|NCT00484289|451880|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
193573|NCT00484289|451881|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
193574|NCT00484289|451879|P3|STARTED|Long Term Phase||26
193575|NCT00484289|451880|P2|STARTED|Long Term Phase||178
193576|NCT00484289|451881|P1|STARTED|Long Term Phase||13
193577|NCT00484185|451953|P1|NOT COMPLETED|Overall Study||71
193578|NCT00484185|451953|P1|COMPLETED|Overall Study||112
193579|NCT00484185|451953|P1|Treated|Overall Study||178
193580|NCT00484185|451953|P1|STARTED|Overall Study||183
193581|NCT00484159|451975|P3|NOT COMPLETED|Overall Study||0
193582|NCT00484159|451976|P2|NOT COMPLETED|Overall Study||1
193583|NCT00484159|451977|P1|NOT COMPLETED|Overall Study||1
193584|NCT00484159|451975|P3|COMPLETED|Overall Study||51
193585|NCT00484159|451976|P2|COMPLETED|Overall Study||49
193586|NCT00484159|451977|P1|COMPLETED|Overall Study||49
193587|NCT00484159|451975|P3|STARTED|Overall Study||51
193588|NCT00484159|451976|P2|STARTED|Overall Study||50
193589|NCT00484159|451977|P1|STARTED|Overall Study||50
193590|NCT00484094|451988|P1|NOT COMPLETED|Overall Study||42
193591|NCT00484094|451988|P1|COMPLETED|Overall Study||167
193592|NCT00484094|451988|P1|STARTED|Overall Study||209
193593|NCT00483938|452004|P7|NOT COMPLETED|Overall Study||40
193594|NCT00483938|452005|P6|NOT COMPLETED|Overall Study||8
193595|NCT00483938|452006|P5|NOT COMPLETED|Overall Study||2
193596|NCT00483938|452007|P4|NOT COMPLETED|Overall Study||6
193597|NCT00483938|452008|P3|NOT COMPLETED|Overall Study||0
193598|NCT00483938|452009|P2|NOT COMPLETED|Overall Study||19
193599|NCT00483938|452010|P1|NOT COMPLETED|Overall Study||5
193600|NCT00483938|452004|P7|COMPLETED|Overall Study||0
193601|NCT00483938|452005|P6|COMPLETED|Overall Study||18
193602|NCT00483938|452006|P5|COMPLETED|Overall Study||23
193603|NCT00483938|452007|P4|COMPLETED|Overall Study||25
193604|NCT00483938|452008|P3|COMPLETED|Overall Study||30
193605|NCT00483938|452009|P2|COMPLETED|Overall Study||24
193606|NCT00483938|452010|P1|COMPLETED|Overall Study||36
193607|NCT00483938|452004|P7|STARTED|Overall Study||40
193608|NCT00483938|452005|P6|STARTED|Overall Study||26
193609|NCT00483938|452006|P5|STARTED|Overall Study||25
193610|NCT00483938|452007|P4|STARTED|Overall Study||31
193611|NCT00483938|452008|P3|STARTED|Overall Study||30
193612|NCT00483938|452009|P2|STARTED|Overall Study||43
193613|NCT00483938|452010|P1|STARTED|Overall Study||41
193614|NCT00482729|452033|P2|NOT COMPLETED|Overall Study||218
193615|NCT00482729|452034|P1|NOT COMPLETED|Overall Study||217
193616|NCT00482729|452033|P2|COMPLETED|Overall Study||406
193617|NCT00482729|452034|P1|COMPLETED|Overall Study||409
193618|NCT00482729|452033|P2|Completed Phase B|Overall Study||406
193619|NCT00482729|452034|P1|Completed Phase B|Overall Study||409
193620|NCT00482729|452033|P2|Completed Phase A|Overall Study||482
193621|NCT00482729|452034|P1|Completed Phase A|Overall Study||484
193622|NCT00482729|452033|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
193623|NCT00482729|452034|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
193624|NCT00482703|452050|P2|NOT COMPLETED|Overall Study||0
193625|NCT00482703|452051|P1|NOT COMPLETED|Overall Study||1
193626|NCT00482703|452050|P2|COMPLETED|Overall Study||12
193627|NCT00482703|452051|P1|COMPLETED|Overall Study||10
193628|NCT00482703|452050|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
193629|NCT00482703|452051|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
193630|NCT00483756|452099|P3|NOT COMPLETED|Overall Study||52
193631|NCT00483756|452100|P2|NOT COMPLETED|Overall Study||50
193632|NCT00483756|452101|P1|NOT COMPLETED|Overall Study||33
193633|NCT00483756|452099|P3|COMPLETED|Overall Study||59
193634|NCT00483756|452100|P2|COMPLETED|Overall Study||60
193635|NCT00483756|452101|P1|COMPLETED|Overall Study||77
193636|NCT00483756|452099|P3|Treated|Overall Study||107
193637|NCT00483756|452100|P2|Treated|Overall Study||106
193638|NCT00483756|452101|P1|Treated|Overall Study||109
193639|NCT00483756|452099|P3|STARTED|Overall Study||111
193640|NCT00483756|452100|P2|STARTED|Overall Study||110
193641|NCT00483756|452101|P1|STARTED|Overall Study||110
193642|NCT00483717|452165|P2|NOT COMPLETED|Overall Study||21
193643|NCT00483717|452166|P1|NOT COMPLETED|Overall Study||24
193644|NCT00483717|452165|P2|COMPLETED|Overall Study||65
193645|NCT00483717|452166|P1|COMPLETED|Overall Study||63
193646|NCT00483717|452165|P2|STARTED|Overall Study||86
193647|NCT00483717|452166|P1|STARTED|Overall Study||87
193648|NCT00483704|452189|P3|NOT COMPLETED|Treatment||156
193649|NCT00483704|452190|P2|NOT COMPLETED|Treatment||129
193650|NCT00483704|452191|P1|NOT COMPLETED|Treatment||129
193651|NCT00483704|452189|P3|COMPLETED|Treatment||399
193652|NCT00483704|452190|P2|COMPLETED|Treatment||420
193653|NCT00483704|452191|P1|COMPLETED|Treatment||444
193654|NCT00483704|452189|P3|STARTED|Treatment||555
193655|NCT00483704|452190|P2|STARTED|Treatment||549
193656|NCT00483704|452191|P1|STARTED|Treatment||573
193657|NCT00483704|452189|P3|NOT COMPLETED|Randomization||91
193658|NCT00483704|452190|P2|NOT COMPLETED|Randomization||96
193659|NCT00483704|452191|P1|NOT COMPLETED|Randomization||71
193660|NCT00483704|452189|P3|COMPLETED|Randomization||555
193661|NCT00483704|452190|P2|COMPLETED|Randomization||549
193662|NCT00483704|452191|P1|COMPLETED|Randomization||573
193663|NCT00483704|452189|P3|STARTED|Randomization||646
193664|NCT00483704|452190|P2|STARTED|Randomization||645
193665|NCT00483704|452191|P1|STARTED|Randomization||644
193666|NCT00483652|452237|P2|NOT COMPLETED|Post-study Follow-up||0
193667|NCT00483652|452238|P1|NOT COMPLETED|Post-study Follow-up||0
193668|NCT00483652|452237|P2|COMPLETED|Post-study Follow-up||114
193669|NCT00483652|452238|P1|COMPLETED|Post-study Follow-up||113
193670|NCT00483652|452237|P2|STARTED|Post-study Follow-up||114
193671|NCT00483652|452238|P1|STARTED|Post-study Follow-up||113
193672|NCT00483652|452237|P2|NOT COMPLETED|Double-blind Treatment Period||5
193673|NCT00483652|452238|P1|NOT COMPLETED|Double-blind Treatment Period||7
193674|NCT00483652|452237|P2|COMPLETED|Double-blind Treatment Period||114
193675|NCT00483652|452238|P1|COMPLETED|Double-blind Treatment Period||113
193676|NCT00483652|452237|P2|STARTED|Double-blind Treatment Period||119
193677|NCT00483652|452238|P1|STARTED|Double-blind Treatment Period||120
193678|NCT00483574|452248|P2|NOT COMPLETED|Overall Study||13
193679|NCT00483574|452249|P1|NOT COMPLETED|Overall Study||102
193680|NCT00483574|452248|P2|COMPLETED|Overall Study||308
193681|NCT00483574|452249|P1|COMPLETED|Overall Study||951
193682|NCT00483574|452248|P2|STARTED|Overall Study||321
193683|NCT00483574|452249|P1|STARTED|Overall Study||1053
193684|NCT00483548|452259|P2|NOT COMPLETED|Overall Study||46
193685|NCT00483548|452260|P1|NOT COMPLETED|Overall Study||60
193686|NCT00483548|452259|P2|COMPLETED|Overall Study||104
193687|NCT00483548|452260|P1|COMPLETED|Overall Study||88
193688|NCT00483548|452259|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
193689|NCT00483548|452260|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
193690|NCT00483548|452259|P2|STARTED|Overall Study||150
193691|NCT00483548|452260|P1|STARTED|Overall Study||148
193692|NCT00483496|452298|P1|NOT COMPLETED|Overall Study||1
193693|NCT00483496|452298|P1|COMPLETED|Overall Study||15
193694|NCT00483496|452298|P1|STARTED|Overall Study||16
193695|NCT00483379|452311|P2|NOT COMPLETED|Extension Period||0
193696|NCT00483379|452312|P1|NOT COMPLETED|Extension Period||0
193697|NCT00483379|452311|P2|COMPLETED|Extension Period||2
193698|NCT00483379|452312|P1|COMPLETED|Extension Period||1
193699|NCT00483379|452311|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
193700|NCT00483379|452312|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
193701|NCT00483379|452311|P2|NOT COMPLETED|Treatment Period||0
193702|NCT00483379|452312|P1|NOT COMPLETED|Treatment Period||2
193703|NCT00483379|452311|P2|COMPLETED|Treatment Period||7
193704|NCT00483379|452312|P1|COMPLETED|Treatment Period||4
193705|NCT00483379|452311|P2|STARTED|Treatment Period||7
193706|NCT00483379|452312|P1|STARTED|Treatment Period||6
193707|NCT00483327|452348|P1|NOT COMPLETED|Overall Study||10
193708|NCT00483327|452348|P1|COMPLETED|Overall Study||20
193709|NCT00483327|452348|P1|STARTED|Overall Study||30
193710|NCT00483262|452357|P2|NOT COMPLETED|Overall Study||0
193711|NCT00483262|452358|P1|NOT COMPLETED|Overall Study||0
193712|NCT00483262|452357|P2|COMPLETED|Overall Study||43
193713|NCT00483262|452358|P1|COMPLETED|Overall Study||20
193714|NCT00483262|452357|P2|STARTED|Overall Study||43
193715|NCT00483262|452358|P1|STARTED|Overall Study||20
193716|NCT00483184|452371|P3|NOT COMPLETED|Overall Study||3
193717|NCT00483184|452372|P2|NOT COMPLETED|Overall Study||4
193718|NCT00483184|452373|P1|NOT COMPLETED|Overall Study||5
193719|NCT00483184|452371|P3|COMPLETED|Overall Study||23
193720|NCT00483184|452372|P2|COMPLETED|Overall Study||27
193721|NCT00483184|452373|P1|COMPLETED|Overall Study||22
193722|NCT00483184|452371|P3|STARTED|Overall Study||26
193723|NCT00483184|452372|P2|STARTED|Overall Study||31
193724|NCT00483184|452373|P1|STARTED|Overall Study||27
193725|NCT00483119|452383|P2|NOT COMPLETED|Overall Study||1
193726|NCT00483119|452384|P1|NOT COMPLETED|Overall Study||1
193727|NCT00483119|452383|P2|COMPLETED|Overall Study||3
193728|NCT00483119|452384|P1|COMPLETED|Overall Study||4
193729|NCT00483119|452383|P2|STARTED|Overall Study||4
193730|NCT00483119|452384|P1|STARTED|Overall Study||5
193731|NCT00483041|452398|P2|NOT COMPLETED|Overall Study||1
193732|NCT00483041|452399|P1|NOT COMPLETED|Overall Study||0
193733|NCT00483041|452398|P2|COMPLETED|Overall Study||5
193734|NCT00483041|452399|P1|COMPLETED|Overall Study||5
193735|NCT00483041|452398|P2|STARTED|Overall Study||6
193736|NCT00483041|452399|P1|STARTED|Overall Study||5
193737|NCT00483002|452429|P1|NOT COMPLETED|Overall Study||2554
193738|NCT00483002|452429|P1|COMPLETED|Overall Study||1165
193739|NCT00483002|452429|P1|STARTED|Overall Study||3719
193740|NCT00482911|452437|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
193741|NCT00482911|452438|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
193742|NCT00482911|452437|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
193743|NCT00482911|452438|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
193744|NCT00482911|452437|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
193745|NCT00482911|452438|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
193746|NCT00482911|452437|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
193747|NCT00482911|452438|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
193748|NCT00482911|452437|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
193749|NCT00482911|452438|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
193750|NCT00482911|452437|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
193751|NCT00482911|452438|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
193752|NCT00482911|452437|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
193753|NCT00482911|452438|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
193754|NCT00482911|452437|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
193755|NCT00482911|452438|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
193756|NCT00482911|452437|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
193757|NCT00482911|452438|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
193758|NCT00482625|452446|P1|NOT COMPLETED|Overall Study||0
193759|NCT00482625|452446|P1|COMPLETED|Overall Study||6
193760|NCT00482625|452446|P1|STARTED|Overall Study||6
193761|NCT00482612|452459|P4|NOT COMPLETED|Follow-up Period||8
193762|NCT00482612|452460|P3|NOT COMPLETED|Follow-up Period||22
193763|NCT00482612|452461|P2|NOT COMPLETED|Follow-up Period||18
193764|NCT00482612|452462|P1|NOT COMPLETED|Follow-up Period||14
193765|NCT00482612|452459|P4|COMPLETED|Follow-up Period||127
193766|NCT00482612|452460|P3|COMPLETED|Follow-up Period||106
193767|NCT00482612|452461|P2|COMPLETED|Follow-up Period||107
193768|NCT00482612|452462|P1|COMPLETED|Follow-up Period||123
193769|NCT00482612|452459|P4|STARTED|Follow-up Period||135
193770|NCT00482612|452460|P3|STARTED|Follow-up Period||128
193771|NCT00482612|452461|P2|STARTED|Follow-up Period||125
193772|NCT00482612|452462|P1|STARTED|Follow-up Period||137
193773|NCT00482612|452459|P4|NOT COMPLETED|In-treatment Period||0
193774|NCT00482612|452460|P3|NOT COMPLETED|In-treatment Period||1
193775|NCT00482612|452461|P2|NOT COMPLETED|In-treatment Period||0
193776|NCT00482612|452462|P1|NOT COMPLETED|In-treatment Period||0
193777|NCT00482612|452459|P4|COMPLETED|In-treatment Period||135
193778|NCT00482612|452460|P3|COMPLETED|In-treatment Period||128
193779|NCT00482612|452461|P2|COMPLETED|In-treatment Period||125
193780|NCT00482612|452462|P1|COMPLETED|In-treatment Period||137
193781|NCT00482612|452459|P4|Treated|In-treatment Period||135
193782|NCT00482612|452460|P3|Treated|In-treatment Period||128
193783|NCT00482612|452461|P2|Treated|In-treatment Period||125
193784|NCT00482612|452462|P1|Treated|In-treatment Period||137
193785|NCT00482612|452459|P4|STARTED|In-treatment Period||135
193786|NCT00482612|452460|P3|STARTED|In-treatment Period||129
193787|NCT00482612|452461|P2|STARTED|In-treatment Period||125
193788|NCT00482612|452462|P1|STARTED|In-treatment Period||137
193789|NCT00482547|452490|P2|NOT COMPLETED|Overall Study||161
193790|NCT00482547|452491|P1|NOT COMPLETED|Overall Study||173
193791|NCT00482547|452490|P2|COMPLETED|Overall Study||428
193792|NCT00482547|452491|P1|COMPLETED|Overall Study||426
193793|NCT00482547|452490|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
193794|NCT00482547|452491|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
193795|NCT00482547|452490|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
193796|NCT00482547|452491|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
193797|NCT00482547|452490|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
193798|NCT00482547|452491|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
193799|NCT00482274|452511|P1|NOT COMPLETED|Overall Study||1
193800|NCT00482274|452511|P1|COMPLETED|Overall Study||2
193801|NCT00482274|452511|P1|STARTED|Overall Study||3
193802|NCT00482170|452521|P2|NOT COMPLETED|Overall Study||20
193803|NCT00482170|452522|P1|NOT COMPLETED|Overall Study||15
193804|NCT00482170|452521|P2|COMPLETED|Overall Study||194
193805|NCT00482170|452522|P1|COMPLETED|Overall Study||192
193806|NCT00482170|452521|P2|Treated|Overall Study||211
193807|NCT00482170|452522|P1|Treated|Overall Study||207
193808|NCT00482170|452521|P2|STARTED|Overall Study||214
193809|NCT00482170|452522|P1|STARTED|Overall Study||207
193810|NCT00482014|452644|P4|NOT COMPLETED|Overall Study||23
193811|NCT00482014|452645|P3|NOT COMPLETED|Overall Study||11
193812|NCT00482014|452646|P2|NOT COMPLETED|Overall Study||6
193813|NCT00482014|452647|P1|NOT COMPLETED|Overall Study||7
193814|NCT00482014|452644|P4|COMPLETED|Overall Study||29
193815|NCT00482014|452645|P3|COMPLETED|Overall Study||35
193816|NCT00482014|452646|P2|COMPLETED|Overall Study||7
193817|NCT00482014|452647|P1|COMPLETED|Overall Study||2
193818|NCT00482014|452644|P4|STARTED|Overall Study||52
193819|NCT00482014|452645|P3|STARTED|Overall Study||46
193820|NCT00482014|452646|P2|STARTED|Overall Study||13
193821|NCT00482014|452647|P1|STARTED|Overall Study||9
193822|NCT00481988|452671|P2|NOT COMPLETED|Overall Study||1
193823|NCT00481988|452672|P1|NOT COMPLETED|Overall Study||1
193824|NCT00481988|452671|P2|COMPLETED|Overall Study||8
193825|NCT00481988|452672|P1|COMPLETED|Overall Study||11
193826|NCT00481988|452671|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
193827|NCT00481988|452672|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
193828|NCT00481988|452671|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
193829|NCT00481988|452672|P1|STARTED|Overall Study||12
193830|NCT00481871|452685|P5|NOT COMPLETED|Overall Study||0
193831|NCT00481871|452686|P4|NOT COMPLETED|Overall Study||0
193832|NCT00481871|452687|P3|NOT COMPLETED|Overall Study||1
193833|NCT00481871|452688|P2|NOT COMPLETED|Overall Study||0
193834|NCT00481871|452689|P1|NOT COMPLETED|Overall Study||0
193835|NCT00481871|452685|P5|COMPLETED|Overall Study||34
193836|NCT00481871|452686|P4|COMPLETED|Overall Study||38
193837|NCT00481871|452687|P3|COMPLETED|Overall Study||17
193838|NCT00481871|452688|P2|COMPLETED|Overall Study||10
193839|NCT00481871|452689|P1|COMPLETED|Overall Study||7
193840|NCT00481871|452685|P5|STARTED|Overall Study||34
193841|NCT00481871|452686|P4|STARTED|Overall Study||38
193842|NCT00481871|452687|P3|STARTED|Overall Study||18
193843|NCT00481871|452688|P2|STARTED|Overall Study||10
193844|NCT00481871|452689|P1|STARTED|Overall Study||7
193845|NCT00481845|452705|P2|NOT COMPLETED|Overall Study||0
193846|NCT00481845|452706|P1|NOT COMPLETED|Overall Study||0
193847|NCT00481845|452705|P2|COMPLETED|Overall Study||0
193848|NCT00481845|452706|P1|COMPLETED|Overall Study||1
193849|NCT00481845|452705|P2|STARTED|Overall Study||0
193850|NCT00481845|452706|P1|STARTED|Overall Study||1
193851|NCT00481767|452716|P2|NOT COMPLETED|Overall Study||21
193852|NCT00481767|452717|P1|NOT COMPLETED|Overall Study||32
193853|NCT00481767|452716|P2|COMPLETED|Overall Study||205
193854|NCT00481767|452717|P1|COMPLETED|Overall Study||418
193855|NCT00481767|452716|P2|STARTED|Overall Study||226
193856|NCT00481767|452717|P1|STARTED|Overall Study||450
193857|NCT00481676|452749|P2|NOT COMPLETED|Overall Study||5
193858|NCT00481676|452750|P1|NOT COMPLETED|Overall Study||2
193859|NCT00481676|452749|P2|COMPLETED|Overall Study||17
193860|NCT00481676|452750|P1|COMPLETED|Overall Study||25
193861|NCT00481676|452749|P2|STARTED|Overall Study||22
193862|NCT00481676|452750|P1|STARTED|Overall Study||27
193863|NCT00480636|452772|P1|NOT COMPLETED|Overall Study||19
193864|NCT00480636|452772|P1|COMPLETED|Overall Study||83
193865|NCT00480636|452772|P1|STARTED|Overall Study||102
193866|NCT00481507|452782|P2|NOT COMPLETED|Overall Study||0
193867|NCT00481507|452783|P1|NOT COMPLETED|Overall Study||0
193868|NCT00481507|452782|P2|COMPLETED|Overall Study||61
193869|NCT00481507|452783|P1|COMPLETED|Overall Study||64
193870|NCT00481507|452782|P2|STARTED|Overall Study||61
193871|NCT00481507|452783|P1|STARTED|Overall Study||64
193872|NCT00481351|452791|P2|NOT COMPLETED|Overall Study||0
193873|NCT00481351|452792|P1|NOT COMPLETED|Overall Study||0
193874|NCT00481351|452791|P2|COMPLETED|Overall Study||12
193875|NCT00481351|452792|P1|COMPLETED|Overall Study||13
193876|NCT00481351|452791|P2|STARTED|Overall Study||12
193877|NCT00481351|452792|P1|STARTED|Overall Study||13
193878|NCT00481247|452808|P2|NOT COMPLETED|Overall Study||260
193879|NCT00481247|452809|P1|NOT COMPLETED|Overall Study||259
193880|NCT00481247|452808|P2|COMPLETED|Overall Study||0
193881|NCT00481247|452809|P1|COMPLETED|Overall Study||0
193882|NCT00481247|452808|P2|Received Treatment|Overall Study||258
193883|NCT00481247|452809|P1|Received Treatment|Overall Study||258
193884|NCT00481247|452808|P2|STARTED|Overall Study|Randomized|260
193885|NCT00481247|452809|P1|STARTED|Overall Study|Randomized|259
193886|NCT00481195|452833|P2|NOT COMPLETED|Overall Study||39
193887|NCT00481195|452834|P1|NOT COMPLETED|Overall Study||39
193888|NCT00481195|452833|P2|COMPLETED|Overall Study||90
193889|NCT00481195|452834|P1|COMPLETED|Overall Study||89
193890|NCT00481195|452833|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
193891|NCT00481195|452834|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
193892|NCT00481078|452920|P2|NOT COMPLETED|Overall Study||20
193893|NCT00481078|452921|P1|NOT COMPLETED|Overall Study||42
193894|NCT00481078|452920|P2|COMPLETED|Overall Study||12
193895|NCT00481078|452921|P1|COMPLETED|Overall Study||20
193896|NCT00481078|452920|P2|STARTED|Overall Study||32
193897|NCT00481078|452921|P1|STARTED|Overall Study||62
193898|NCT00481065|452939|P8|NOT COMPLETED|Overall Study||19
193899|NCT00481065|452940|P7|NOT COMPLETED|Overall Study||16
193900|NCT00481065|452941|P6|NOT COMPLETED|Overall Study||24
193901|NCT00481065|452942|P5|NOT COMPLETED|Overall Study||23
193902|NCT00481065|452943|P4|NOT COMPLETED|Overall Study||15
193903|NCT00481065|452944|P3|NOT COMPLETED|Overall Study||19
193904|NCT00481065|452945|P2|NOT COMPLETED|Overall Study||17
193905|NCT00481065|452946|P1|NOT COMPLETED|Overall Study||22
193906|NCT00481065|452939|P8|COMPLETED|Overall Study||30
193907|NCT00481065|452940|P7|COMPLETED|Overall Study||34
193908|NCT00481065|452941|P6|COMPLETED|Overall Study||27
193909|NCT00481065|452942|P5|COMPLETED|Overall Study||28
193910|NCT00481065|452943|P4|COMPLETED|Overall Study||37
193911|NCT00481065|452944|P3|COMPLETED|Overall Study||32
193912|NCT00481065|452945|P2|COMPLETED|Overall Study||33
193913|NCT00481065|452946|P1|COMPLETED|Overall Study||29
193914|NCT00481065|452939|P8|STARTED|Overall Study||49
193915|NCT00481065|452940|P7|STARTED|Overall Study||50
193916|NCT00481065|452941|P6|STARTED|Overall Study||51
193917|NCT00481065|452942|P5|STARTED|Overall Study||51
193918|NCT00481065|452943|P4|STARTED|Overall Study||52
193919|NCT00481065|452944|P3|STARTED|Overall Study||51
193920|NCT00481065|452945|P2|STARTED|Overall Study||50
193921|NCT00481065|452946|P1|STARTED|Overall Study||51
193922|NCT00480987|453032|P1|NOT COMPLETED|Overall Study||0
193923|NCT00480987|453032|P1|COMPLETED|Overall Study||27
193924|NCT00480987|453032|P1|STARTED|Overall Study||27
193925|NCT00480857|453036|P1|NOT COMPLETED|Overall Study||2
193926|NCT00480857|453036|P1|COMPLETED|Overall Study||17
193927|NCT00480857|453036|P1|STARTED|Overall Study||19
193928|NCT00480779|453043|P2|NOT COMPLETED|Overall Study||3
193929|NCT00480779|453044|P1|NOT COMPLETED|Overall Study||2
193930|NCT00480779|453043|P2|COMPLETED|Overall Study||19
193931|NCT00480779|453044|P1|COMPLETED|Overall Study||24
193932|NCT00480779|453043|P2|STARTED|Overall Study||22
193933|NCT00480779|453044|P1|STARTED|Overall Study||26
193934|NCT00480740|453071|P3|NOT COMPLETED|Overall Study||0
193935|NCT00480740|453072|P2|NOT COMPLETED|Overall Study||0
193936|NCT00480740|453073|P1|NOT COMPLETED|Overall Study||0
193937|NCT00480740|453071|P3|COMPLETED|Overall Study||6
193938|NCT00480740|453072|P2|COMPLETED|Overall Study||9
193939|NCT00480740|453073|P1|COMPLETED|Overall Study||26
193940|NCT00480740|453071|P3|STARTED|Overall Study||6
193941|NCT00480740|453072|P2|STARTED|Overall Study||9
193942|NCT00480740|453073|P1|STARTED|Overall Study||26
193943|NCT00480532|453085|P4|NOT COMPLETED|Overall Study||1
193944|NCT00480532|453086|P3|NOT COMPLETED|Overall Study||4
193945|NCT00480532|453087|P2|NOT COMPLETED|Overall Study||4
193946|NCT00480532|453088|P1|NOT COMPLETED|Overall Study||2
193947|NCT00480532|453085|P4|COMPLETED|Overall Study||31
193948|NCT00480532|453086|P3|COMPLETED|Overall Study||29
193949|NCT00480532|453087|P2|COMPLETED|Overall Study||29
193950|NCT00480532|453088|P1|COMPLETED|Overall Study||31
193951|NCT00480532|453085|P4|STARTED|Overall Study||32
193952|NCT00480532|453086|P3|STARTED|Overall Study||33
193953|NCT00480532|453087|P2|STARTED|Overall Study||33
193954|NCT00480532|453088|P1|STARTED|Overall Study||33
193955|NCT00480493|453108|P2|NOT COMPLETED|Overall Study||7
193956|NCT00480493|453109|P1|NOT COMPLETED|Overall Study||2
193957|NCT00480493|453108|P2|COMPLETED|Overall Study||21
193958|NCT00480493|453109|P1|COMPLETED|Overall Study||30
193959|NCT00480493|453108|P2|Randomized|Overall Study||28
193960|NCT00480493|453109|P1|Randomized|Overall Study||32
193961|NCT00480493|453108|P2|STARTED|Overall Study||28
193962|NCT00480493|453109|P1|STARTED|Overall Study||32
193963|NCT00480324|453121|P2|NOT COMPLETED|Overall Study||16
193964|NCT00480324|453122|P1|NOT COMPLETED|Overall Study||32
193965|NCT00480324|453121|P2|COMPLETED|Overall Study||241
193966|NCT00480324|453122|P1|COMPLETED|Overall Study||476
193967|NCT00480324|453121|P2|STARTED|Overall Study||257
193968|NCT00480324|453122|P1|STARTED|Overall Study||508
193969|NCT00479882|453152|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
193970|NCT00479882|453153|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
193971|NCT00479882|453154|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
193972|NCT00479882|453155|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
193973|NCT00479882|453152|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
193974|NCT00479882|453153|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
193975|NCT00479882|453154|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
193976|NCT00479882|453155|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
193977|NCT00479882|453152|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
193978|NCT00479882|453153|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
193979|NCT00479882|453154|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
193980|NCT00479882|453155|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
193981|NCT00479882|453152|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
193982|NCT00479882|453153|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
193983|NCT00479882|453154|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
193984|NCT00479882|453155|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
193985|NCT00479882|453152|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
193986|NCT00479882|453153|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
193987|NCT00479882|453154|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
193988|NCT00479882|453155|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
193989|NCT00479882|453152|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
193990|NCT00479882|453153|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
193991|NCT00479882|453154|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
193992|NCT00479882|453155|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
193993|NCT00479856|453285|P1|NOT COMPLETED|Overall Study||3
193994|NCT00479856|453285|P1|COMPLETED|Overall Study||6
193995|NCT00479856|453285|P1|STARTED|Overall Study||9
193996|NCT00479765|453294|P1|NOT COMPLETED|Overall Study||4
193997|NCT00479765|453294|P1|COMPLETED|Overall Study||0
193998|NCT00479765|453294|P1|STARTED|Overall Study||4
193999|NCT00479713|453300|P2|NOT COMPLETED|Overall Study||9
194000|NCT00479713|453301|P1|NOT COMPLETED|Overall Study||13
194001|NCT00479713|453300|P2|COMPLETED|Overall Study||295
194002|NCT00479713|453301|P1|COMPLETED|Overall Study||301
194003|NCT00479713|453300|P2|STARTED|Overall Study||304
194004|NCT00479713|453301|P1|STARTED|Overall Study||314
194005|NCT00479674|453325|P1|NOT COMPLETED|Overall Study||41
194006|NCT00479674|453325|P1|COMPLETED|Overall Study||0
194007|NCT00479674|453325|P1|STARTED|Overall Study||41
194008|NCT00479557|453340|P7|NOT COMPLETED|Overall Study||2
194009|NCT00479557|453341|P6|NOT COMPLETED|Overall Study||13
194010|NCT00479557|453342|P5|NOT COMPLETED|Overall Study||4
194011|NCT00479557|453343|P4|NOT COMPLETED|Overall Study||5
194012|NCT00479557|453344|P3|NOT COMPLETED|Overall Study||8
194013|NCT00479557|453345|P2|NOT COMPLETED|Overall Study||10
194014|NCT00479557|453346|P1|NOT COMPLETED|Overall Study||10
194015|NCT00479557|453340|P7|COMPLETED|Overall Study||15
194016|NCT00479557|453341|P6|COMPLETED|Overall Study||31
194017|NCT00479557|453342|P5|COMPLETED|Overall Study||8
194018|NCT00479557|453343|P4|COMPLETED|Overall Study||30
194019|NCT00479557|453344|P3|COMPLETED|Overall Study||32
194020|NCT00479557|453345|P2|COMPLETED|Overall Study||51
194021|NCT00479557|453346|P1|COMPLETED|Overall Study||26
194022|NCT00479557|453340|P7|Treated|Overall Study||17
194023|NCT00479557|453341|P6|Treated|Overall Study||44
194024|NCT00479557|453342|P5|Treated|Overall Study||12
194025|NCT00479557|453343|P4|Treated|Overall Study||35
194026|NCT00479557|453344|P3|Treated|Overall Study||40
194027|NCT00479557|453345|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
194028|NCT00479557|453346|P1|Treated|Overall Study||36
194029|NCT00479557|453340|P7|STARTED|Overall Study||17
194030|NCT00479557|453341|P6|STARTED|Overall Study||44
194031|NCT00479557|453342|P5|STARTED|Overall Study||12
194032|NCT00479557|453343|P4|STARTED|Overall Study||35
194033|NCT00479557|453344|P3|STARTED|Overall Study||40
194034|NCT00479557|453345|P2|STARTED|Overall Study||61
194035|NCT00479557|453346|P1|STARTED|Overall Study||36
194036|NCT00479466|453389|P6|NOT COMPLETED|Overall Study||4
194037|NCT00479466|453390|P5|NOT COMPLETED|Overall Study||8
194038|NCT00479466|453391|P4|NOT COMPLETED|Overall Study||3
194039|NCT00479466|453392|P3|NOT COMPLETED|Overall Study||3
194040|NCT00479466|453393|P2|NOT COMPLETED|Overall Study||8
194041|NCT00479466|453394|P1|NOT COMPLETED|Overall Study||13
194042|NCT00479466|453389|P6|COMPLETED|Overall Study||53
194043|NCT00479466|453390|P5|COMPLETED|Overall Study||48
194044|NCT00479466|453391|P4|COMPLETED|Overall Study||55
194045|NCT00479466|453392|P3|COMPLETED|Overall Study||54
194046|NCT00479466|453393|P2|COMPLETED|Overall Study||49
194047|NCT00479466|453394|P1|COMPLETED|Overall Study||44
194048|NCT00479466|453389|P6|STARTED|Overall Study||57
194049|NCT00479466|453390|P5|STARTED|Overall Study||56
194050|NCT00479466|453391|P4|STARTED|Overall Study||58
194051|NCT00479466|453392|P3|STARTED|Overall Study||57
194052|NCT00479466|453393|P2|STARTED|Overall Study||57
194053|NCT00479466|453394|P1|STARTED|Overall Study||57
194054|NCT00479401|453423|P3|NOT COMPLETED|Overall Study||12
194055|NCT00479401|453424|P2|NOT COMPLETED|Overall Study||37
194056|NCT00479401|453425|P1|NOT COMPLETED|Overall Study||49
194057|NCT00479401|453423|P3|COMPLETED|Overall Study||91
194058|NCT00479401|453424|P2|COMPLETED|Overall Study||176
194059|NCT00479401|453425|P1|COMPLETED|Overall Study||174
194060|NCT00479401|453423|P3|STARTED|Overall Study||103
194061|NCT00479401|453424|P2|STARTED|Overall Study||213
194062|NCT00479401|453425|P1|STARTED|Overall Study||223
194063|NCT00479388|453480|P2|NOT COMPLETED|Overall Study||73
194064|NCT00479388|453481|P1|NOT COMPLETED|Overall Study||132
194065|NCT00479388|453480|P2|COMPLETED|Overall Study||537
194066|NCT00479388|453481|P1|COMPLETED|Overall Study||474
194067|NCT00479388|453480|P2|STARTED|Overall Study||610
194068|NCT00479388|453481|P1|STARTED|Overall Study||606
194069|NCT00479336|453495|P4|NOT COMPLETED|Overall Study||5
194070|NCT00479336|453496|P3|NOT COMPLETED|Overall Study||1
194071|NCT00479336|453497|P2|NOT COMPLETED|Overall Study||6
194072|NCT00479336|453498|P1|NOT COMPLETED|Overall Study||4
194073|NCT00479336|453495|P4|COMPLETED|Overall Study||21
194074|NCT00479336|453496|P3|COMPLETED|Overall Study||24
194075|NCT00479336|453497|P2|COMPLETED|Overall Study||20
194076|NCT00479336|453498|P1|COMPLETED|Overall Study||23
194077|NCT00479336|453495|P4|STARTED|Overall Study||26
194078|NCT00479336|453496|P3|STARTED|Overall Study||25
194079|NCT00479336|453497|P2|STARTED|Overall Study||26
194080|NCT00479336|453498|P1|STARTED|Overall Study||27
194081|NCT00479258|453514|P2|NOT COMPLETED|Overall Study||0
194082|NCT00479258|453515|P1|NOT COMPLETED|Overall Study||0
194083|NCT00479258|453514|P2|COMPLETED|Overall Study||0
194084|NCT00479258|453515|P1|COMPLETED|Overall Study||0
194085|NCT00479258|453514|P2|STARTED|Overall Study||0
194086|NCT00479258|453515|P1|STARTED|Overall Study||0
194087|NCT00479232|453521|P6|NOT COMPLETED|Overall Study||30
194088|NCT00479232|453522|P5|NOT COMPLETED|Overall Study||4
194089|NCT00479232|453523|P4|NOT COMPLETED|Overall Study||3
194090|NCT00479232|453524|P3|NOT COMPLETED|Overall Study||28
194091|NCT00479232|453525|P2|NOT COMPLETED|Overall Study||3
194092|NCT00479232|453526|P1|NOT COMPLETED|Overall Study||3
194093|NCT00479232|453521|P6|COMPLETED|Overall Study||0
194094|NCT00479232|453522|P5|COMPLETED|Overall Study||0
194095|NCT00479232|453523|P4|COMPLETED|Overall Study||0
194096|NCT00479232|453524|P3|COMPLETED|Overall Study||0
194097|NCT00479232|453525|P2|COMPLETED|Overall Study||0
194098|NCT00479232|453526|P1|COMPLETED|Overall Study||0
194099|NCT00479232|453521|P6|STARTED|Overall Study||30
194100|NCT00479232|453522|P5|STARTED|Overall Study||4
194101|NCT00479232|453523|P4|STARTED|Overall Study||3
194102|NCT00479232|453524|P3|STARTED|Overall Study||28
194103|NCT00479232|453525|P2|STARTED|Overall Study||3
194104|NCT00479232|453526|P1|STARTED|Overall Study||3
194105|NCT00479154|453546|P2|NOT COMPLETED|Overall Study||0
194106|NCT00479154|453547|P1|NOT COMPLETED|Overall Study||0
194107|NCT00479154|453546|P2|COMPLETED|Overall Study||3
194108|NCT00479154|453547|P1|COMPLETED|Overall Study||3
194109|NCT00479154|453546|P2|STARTED|Overall Study||3
194110|NCT00479154|453547|P1|STARTED|Overall Study||3
194111|NCT00479089|453555|P2|NOT COMPLETED|Overall Study||0
194112|NCT00479089|453556|P1|NOT COMPLETED|Overall Study||0
194113|NCT00479089|453555|P2|COMPLETED|Overall Study||25
194114|NCT00479089|453556|P1|COMPLETED|Overall Study||25
194115|NCT00479089|453555|P2|STARTED|Overall Study||25
194116|NCT00479089|453556|P1|STARTED|Overall Study||25
194117|NCT00479037|453568|P2|NOT COMPLETED|Overall Study||6
194118|NCT00479037|453569|P1|NOT COMPLETED|Overall Study||3
194119|NCT00479037|453568|P2|COMPLETED|Overall Study||34
194120|NCT00479037|453569|P1|COMPLETED|Overall Study||38
194121|NCT00479037|453568|P2|STARTED|Overall Study||40
194122|NCT00479037|453569|P1|STARTED|Overall Study||41
194123|NCT00478881|453581|P2|NOT COMPLETED|Overall Study||22
194124|NCT00478881|453582|P1|NOT COMPLETED|Overall Study||39
194125|NCT00478881|453581|P2|COMPLETED|Overall Study||176
194126|NCT00478881|453582|P1|COMPLETED|Overall Study||160
194127|NCT00478881|453581|P2|Received Medication|Overall Study||198
194128|NCT00478881|453582|P1|Received Medication|Overall Study||198
194129|NCT00478881|453581|P2|STARTED|Overall Study||198
194130|NCT00478881|453582|P1|STARTED|Overall Study||199
194131|NCT00478777|453606|P1|NOT COMPLETED|Overall Study||77
194132|NCT00478777|453606|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
194133|NCT00478777|453606|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
194134|NCT00478777|453606|P1|STARTED|Overall Study||150
194135|NCT00478673|453613|P1|NOT COMPLETED|12-Months Post-Procedure||64
194136|NCT00478673|453613|P1|COMPLETED|12-Months Post-Procedure||231
194137|NCT00478673|453613|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
194138|NCT00478673|453613|P1|NOT COMPLETED|30-Days Post-Procedure||10
194139|NCT00478673|453613|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
194140|NCT00478673|453613|P1|STARTED|30-Days Post-Procedure||298
194141|NCT00478647|453618|P1|NOT COMPLETED|Overall Study||2
194142|NCT00478647|453618|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
194143|NCT00478647|453618|P1|STARTED|Overall Study||40
194144|NCT00478608|453626|P1|NOT COMPLETED|Overall Study||20
194145|NCT00478608|453626|P1|COMPLETED|Overall Study||59
194146|NCT00478608|453626|P1|STARTED|Overall Study||79
194147|NCT00478569|453634|P1|NOT COMPLETED|Overall Study||409
194148|NCT00478569|453634|P1|COMPLETED|Overall Study||761
194149|NCT00478569|453634|P1|STARTED|Overall Study||1170
194150|NCT00478556|453650|P2|NOT COMPLETED|Overall Study||0
194151|NCT00478556|453651|P1|NOT COMPLETED|Overall Study||0
194152|NCT00478556|453650|P2|COMPLETED|Overall Study||149
194153|NCT00478556|453651|P1|COMPLETED|Overall Study||151
194154|NCT00478556|453650|P2|STARTED|Overall Study||149
194155|NCT00478556|453651|P1|STARTED|Overall Study||151
194156|NCT00478257|453661|P2|NOT COMPLETED|Overall Study||3
194157|NCT00478257|453662|P1|NOT COMPLETED|Overall Study||8
194158|NCT00478257|453661|P2|COMPLETED|Overall Study||13
194159|NCT00478257|453662|P1|COMPLETED|Overall Study||15
194160|NCT00478257|453661|P2|STARTED|Overall Study||16
194161|NCT00478257|453662|P1|STARTED|Overall Study||23
194162|NCT00478244|453668|P1|NOT COMPLETED|Overall Study||1
194163|NCT00478244|453668|P1|COMPLETED|Overall Study||6
194164|NCT00478244|453668|P1|STARTED|Overall Study||7
194165|NCT00478231|453681|P1|NOT COMPLETED|Overall Study||84
194166|NCT00478231|453681|P1|COMPLETED|Overall Study||125
194167|NCT00478231|453681|P1|Treated|Overall Study||206
194168|NCT00478231|453681|P1|STARTED|Overall Study||209
194169|NCT00478218|453702|P2|NOT COMPLETED|Overall Study||0
194170|NCT00478218|453703|P1|NOT COMPLETED|Overall Study||0
194171|NCT00478218|453702|P2|COMPLETED|Overall Study||19
194172|NCT00478218|453703|P1|COMPLETED|Overall Study||34
194173|NCT00478218|453702|P2|STARTED|Overall Study||19
194174|NCT00478218|453703|P1|STARTED|Overall Study||34
194175|NCT00478205|453717|P2|NOT COMPLETED|Overall Study||87
194176|NCT00478205|453718|P1|NOT COMPLETED|Overall Study||296
194177|NCT00478205|453717|P2|COMPLETED|Overall Study||399
194178|NCT00478205|453718|P1|COMPLETED|Overall Study||685
194179|NCT00478205|453717|P2|STARTED|Overall Study||486
194180|NCT00478205|453718|P1|STARTED|Overall Study||981
194181|NCT00478192|453733|P3|NOT COMPLETED|Overall Study||2
194182|NCT00478192|453734|P2|NOT COMPLETED|Overall Study||5
194183|NCT00478192|453735|P1|NOT COMPLETED|Overall Study||4
194184|NCT00478192|453733|P3|COMPLETED|Overall Study||8
194185|NCT00478192|453734|P2|COMPLETED|Overall Study||15
194186|NCT00478192|453735|P1|COMPLETED|Overall Study||16
194187|NCT00478192|453733|P3|End of Treatment|Overall Study||8
194188|NCT00478192|453734|P2|End of Treatment|Overall Study||16
194189|NCT00478192|453735|P1|End of Treatment|Overall Study||18
194190|NCT00478192|453733|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
194191|NCT00478192|453734|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
194192|NCT00478192|453735|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
194193|NCT00478192|453733|P3|STARTED|Overall Study||10
194194|NCT00478192|453734|P2|STARTED|Overall Study||20
194195|NCT00478192|453735|P1|STARTED|Overall Study||20
194196|NCT00478140|453762|P1|NOT COMPLETED|Overall Study||3
194197|NCT00478140|453762|P1|COMPLETED|Overall Study||1
194198|NCT00478140|453762|P1|STARTED|Overall Study||4
194199|NCT00477334|453768|P2|NOT COMPLETED|Overall Study||76
194200|NCT00477334|453769|P1|NOT COMPLETED|Overall Study||170
194201|NCT00477334|453768|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
194202|NCT00477334|453769|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
194203|NCT00477334|453768|P2|Modified Intent to Treat Population|Overall Study||78
194204|NCT00477334|453769|P1|Modified Intent to Treat Population|Overall Study||152
194205|NCT00477334|453768|P2|Participants Completing First Recurrence|Overall Study||92
194206|NCT00477334|453769|P1|Participants Completing First Recurrence|Overall Study||187
194207|NCT00477334|453768|P2|Intent to Treat Population|Overall Study||98
194208|NCT00477334|453769|P1|Intent to Treat Population|Overall Study||201
194209|NCT00477334|453768|P2|Randomized and Took Study Drug|Overall Study||98
194210|NCT00477334|453769|P1|Randomized and Took Study Drug|Overall Study||206
194211|NCT00477334|453768|P2|STARTED|Overall Study||151
194212|NCT00477334|453769|P1|STARTED|Overall Study||312
194213|NCT00477295|453795|P2|NOT COMPLETED|Overall Study||109
194214|NCT00477295|453796|P1|NOT COMPLETED|Overall Study||121
194215|NCT00477295|453795|P2|COMPLETED|Overall Study||192
194216|NCT00477295|453796|P1|COMPLETED|Overall Study||161
194217|NCT00477295|453795|P2|STARTED|Overall Study||301
194218|NCT00477295|453796|P1|STARTED|Overall Study||282
194219|NCT00477269|453824|P3|NOT COMPLETED|Open Label Extension||13
194220|NCT00477269|453825|P2|NOT COMPLETED|Open Label Extension||0
194221|NCT00477269|453826|P1|NOT COMPLETED|Open Label Extension||0
194222|NCT00477269|453824|P3|COMPLETED|Open Label Extension||9
194223|NCT00477269|453825|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
194224|NCT00477269|453826|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
194225|NCT00477269|453824|P3|STARTED|Open Label Extension||22
194226|NCT00477269|453825|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
194227|NCT00477269|453826|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
194228|NCT00477269|453824|P3|NOT COMPLETED|Core Study||0
194229|NCT00477269|453825|P2|NOT COMPLETED|Core Study||8
194230|NCT00477269|453826|P1|NOT COMPLETED|Core Study||9
194231|NCT00477269|453824|P3|COMPLETED|Core Study||0
194232|NCT00477269|453825|P2|COMPLETED|Core Study||23
194233|NCT00477269|453826|P1|COMPLETED|Core Study||19
194234|NCT00477269|453824|P3|STARTED|Core Study||0
194235|NCT00477269|453825|P2|STARTED|Core Study||31
194236|NCT00477269|453826|P1|STARTED|Core Study||28
194237|NCT00477230|453880|P2|NOT COMPLETED|Overall Study||31
194238|NCT00477230|453881|P1|NOT COMPLETED|Overall Study||20
194239|NCT00477230|453880|P2|COMPLETED|Overall Study||1
194240|NCT00477230|453881|P1|COMPLETED|Overall Study||12
194241|NCT00477230|453880|P2|STARTED|Overall Study||32
194242|NCT00477230|453881|P1|STARTED|Overall Study||32
194243|NCT00478036|453890|P3|NOT COMPLETED|Overall Study||0
194244|NCT00478036|453891|P2|NOT COMPLETED|Overall Study||0
194245|NCT00478036|453892|P1|NOT COMPLETED|Overall Study||0
194246|NCT00478036|453890|P3|COMPLETED|Overall Study||14
194247|NCT00478036|453891|P2|COMPLETED|Overall Study||7
194248|NCT00478036|453892|P1|COMPLETED|Overall Study||10
194249|NCT00478036|453890|P3|STARTED|Overall Study||14
194250|NCT00478036|453891|P2|STARTED|Overall Study||7
194251|NCT00478036|453892|P1|STARTED|Overall Study||10
194252|NCT00478023|453905|P5|NOT COMPLETED|Overall Study||55
194253|NCT00478023|453906|P4|NOT COMPLETED|Overall Study||30
194254|NCT00478023|453907|P3|NOT COMPLETED|Overall Study||20
194255|NCT00478023|453908|P2|NOT COMPLETED|Overall Study||24
194256|NCT00478023|453909|P1|NOT COMPLETED|Overall Study||35
194257|NCT00478023|453905|P5|COMPLETED|Overall Study||114
194258|NCT00478023|453906|P4|COMPLETED|Overall Study||146
194259|NCT00478023|453907|P3|COMPLETED|Overall Study||151
194260|NCT00478023|453908|P2|COMPLETED|Overall Study||144
194261|NCT00478023|453909|P1|COMPLETED|Overall Study||135
194262|NCT00478023|453905|P5|STARTED|Overall Study||169
194263|NCT00478023|453906|P4|STARTED|Overall Study||176
194264|NCT00478023|453907|P3|STARTED|Overall Study||171
194265|NCT00478023|453908|P2|STARTED|Overall Study||168
194266|NCT00478023|453909|P1|STARTED|Overall Study||170
194267|NCT00477971|453928|P2|NOT COMPLETED|Overall Study||6
194268|NCT00477971|453929|P1|NOT COMPLETED|Overall Study||17
194269|NCT00477971|453928|P2|COMPLETED|Overall Study||49
194270|NCT00477971|453929|P1|COMPLETED|Overall Study||17
194271|NCT00477971|453928|P2|STARTED|Overall Study||55
194272|NCT00477971|453929|P1|STARTED|Overall Study||34
194273|NCT00477750|453941|P1|NOT COMPLETED|Overall Study||11
194274|NCT00477750|453941|P1|COMPLETED|Overall Study||15
194275|NCT00477750|453941|P1|STARTED|Overall Study||26
194276|NCT00477685|453945|P1|NOT COMPLETED|Overall Study||0
194277|NCT00477685|453945|P1|COMPLETED|Overall Study||10
194278|NCT00477685|453945|P1|STARTED|Overall Study||10
194279|NCT00477672|453953|P3|NOT COMPLETED|Overall Study||16
194280|NCT00477672|453954|P2|NOT COMPLETED|Overall Study||16
194281|NCT00477672|453955|P1|NOT COMPLETED|Overall Study||7
194282|NCT00477672|453953|P3|COMPLETED|Overall Study||83
194283|NCT00477672|453954|P2|COMPLETED|Overall Study||85
194284|NCT00477672|453955|P1|COMPLETED|Overall Study||91
194285|NCT00477672|453953|P3|STARTED|Overall Study||99
194286|NCT00477672|453954|P2|STARTED|Overall Study||101
194287|NCT00477672|453955|P1|STARTED|Overall Study||98
194288|NCT00477633|453966|P1|NOT COMPLETED|Overall Study||709
194289|NCT00477633|453966|P1|COMPLETED|Overall Study||991
194290|NCT00477633|453966|P1|STARTED|Overall Study||1700
194291|NCT00477607|453974|P2|NOT COMPLETED|Overall Study||7
194292|NCT00477607|453975|P1|NOT COMPLETED|Overall Study||7
194293|NCT00477607|453974|P2|COMPLETED|Overall Study||13
194294|NCT00477607|453975|P1|COMPLETED|Overall Study||12
194295|NCT00477607|453974|P2|STARTED|Overall Study||20
194296|NCT00477607|453975|P1|STARTED|Overall Study||19
194297|NCT00477594|453987|P2|NOT COMPLETED|Follow-up Period||1
194298|NCT00477594|453988|P1|NOT COMPLETED|Follow-up Period||3
194299|NCT00477594|453987|P2|COMPLETED|Follow-up Period||4
194300|NCT00477594|453988|P1|COMPLETED|Follow-up Period||13
194301|NCT00477594|453987|P2|STARTED|Follow-up Period||5
194302|NCT00477594|453988|P1|STARTED|Follow-up Period||16
194303|NCT00477594|453987|P2|NOT COMPLETED|Year 3||0
194304|NCT00477594|453988|P1|NOT COMPLETED|Year 3||2
194305|NCT00477594|453987|P2|COMPLETED|Year 3||0
194306|NCT00477594|453988|P1|COMPLETED|Year 3||2
194307|NCT00477594|453987|P2|STARTED|Year 3||0
194308|NCT00477594|453988|P1|STARTED|Year 3||4
194309|NCT00477594|453987|P2|NOT COMPLETED|Year 1 and Year 2||4
194310|NCT00477594|453988|P1|NOT COMPLETED|Year 1 and Year 2||9
194311|NCT00477594|453987|P2|COMPLETED|Year 1 and Year 2||1
194312|NCT00477594|453988|P1|COMPLETED|Year 1 and Year 2||7
194313|NCT00477594|453987|P2|STARTED|Year 1 and Year 2||5
194314|NCT00477594|453988|P1|STARTED|Year 1 and Year 2||16
194315|NCT00477490|454049|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
194316|NCT00477490|454050|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
194317|NCT00477490|454051|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
194318|NCT00477490|454052|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
194319|NCT00477490|454053|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
194320|NCT00477490|454054|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
194321|NCT00477490|454055|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
194322|NCT00477490|454056|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
194323|NCT00477490|454057|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
194324|NCT00477490|454049|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
194325|NCT00477490|454050|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
194326|NCT00477490|454051|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
194327|NCT00477490|454052|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
194328|NCT00477490|454053|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
194329|NCT00477490|454054|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
194330|NCT00477490|454055|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
194331|NCT00477490|454056|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
194332|NCT00477490|454057|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
194333|NCT00477490|454049|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
194334|NCT00477490|454050|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
194335|NCT00477490|454051|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
194336|NCT00477490|454052|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
194337|NCT00477490|454053|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
194338|NCT00477490|454054|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
194339|NCT00477490|454055|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
194340|NCT00477490|454056|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
194341|NCT00477490|454057|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
194342|NCT00477490|454049|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
194343|NCT00477490|454050|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
194344|NCT00477490|454051|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
194345|NCT00477490|454052|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
194346|NCT00477490|454053|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
194347|NCT00477490|454054|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
194348|NCT00477490|454055|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
194349|NCT00477490|454056|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
194350|NCT00477490|454057|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
194351|NCT00477490|454049|P9|COMPLETED|Part I: 4 Week Efficacy||0
194352|NCT00477490|454050|P8|COMPLETED|Part I: 4 Week Efficacy||0
194353|NCT00477490|454051|P7|COMPLETED|Part I: 4 Week Efficacy||0
194354|NCT00477490|454052|P6|COMPLETED|Part I: 4 Week Efficacy||0
194355|NCT00477490|454053|P5|COMPLETED|Part I: 4 Week Efficacy||135
194356|NCT00477490|454054|P4|COMPLETED|Part I: 4 Week Efficacy||138
194357|NCT00477490|454055|P3|COMPLETED|Part I: 4 Week Efficacy||148
194358|NCT00477490|454056|P2|COMPLETED|Part I: 4 Week Efficacy||144
194359|NCT00477490|454057|P1|COMPLETED|Part I: 4 Week Efficacy||145
194360|NCT00477490|454049|P9|ITT Population|Part I: 4 Week Efficacy||0
194361|NCT00477490|454050|P8|ITT Population|Part I: 4 Week Efficacy||0
194362|NCT00477490|454051|P7|ITT Population|Part I: 4 Week Efficacy||0
194363|NCT00477490|454052|P6|ITT Population|Part I: 4 Week Efficacy||0
194364|NCT00477490|454053|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
194365|NCT00477490|454054|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
194366|NCT00477490|454055|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
194367|NCT00477490|454056|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
194368|NCT00477490|454057|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
194369|NCT00477490|454049|P9|STARTED|Part I: 4 Week Efficacy||0
194370|NCT00477490|454050|P8|STARTED|Part I: 4 Week Efficacy||0
194371|NCT00477490|454051|P7|STARTED|Part I: 4 Week Efficacy||0
194372|NCT00477490|454052|P6|STARTED|Part I: 4 Week Efficacy||0
194373|NCT00477490|454053|P5|STARTED|Part I: 4 Week Efficacy||160
194374|NCT00477490|454054|P4|STARTED|Part I: 4 Week Efficacy||158
194375|NCT00477490|454055|P3|STARTED|Part I: 4 Week Efficacy||158
194376|NCT00477490|454056|P2|STARTED|Part I: 4 Week Efficacy||163
194377|NCT00477490|454057|P1|STARTED|Part I: 4 Week Efficacy||160
194378|NCT00477464|454141|P1|NOT COMPLETED|Overall Study||51
194379|NCT00477464|454141|P1|COMPLETED|Overall Study||0
194380|NCT00477464|454141|P1|STARTED|Overall Study||51
194381|NCT00477386|454166|P2|NOT COMPLETED|Overall Study||17
194382|NCT00477386|454167|P1|NOT COMPLETED|Overall Study||11
194383|NCT00477386|454166|P2|COMPLETED|Overall Study||0
194384|NCT00477386|454167|P1|COMPLETED|Overall Study||0
194385|NCT00477386|454166|P2|STARTED|Overall Study||17
194386|NCT00477386|454167|P1|STARTED|Overall Study||11
194387|NCT00477204|454177|P2|NOT COMPLETED|Overall Study||0
194388|NCT00477204|454178|P1|NOT COMPLETED|Overall Study||0
194389|NCT00477204|454177|P2|COMPLETED|Overall Study||5
194390|NCT00477204|454178|P1|COMPLETED|Overall Study||4
194391|NCT00477204|454177|P2|STARTED|Overall Study||5
194392|NCT00477204|454178|P1|STARTED|Overall Study||4
194393|NCT00477191|454184|P1|NOT COMPLETED|Overall Study||5
194394|NCT00477191|454184|P1|COMPLETED|Overall Study||13
194395|NCT00477191|454184|P1|STARTED|Overall Study||18
194396|NCT00477152|454191|P1|NOT COMPLETED|Overall Study||3
194397|NCT00477152|454191|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
194398|NCT00477152|454191|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
194399|NCT00476957|454200|P2|NOT COMPLETED|Overall Study||193
194400|NCT00476957|454201|P1|NOT COMPLETED|Overall Study||176
194401|NCT00476957|454200|P2|COMPLETED|Overall Study||4159
194402|NCT00476957|454201|P1|COMPLETED|Overall Study||4181
194403|NCT00476957|454200|P2|STARTED|Overall Study||4352
194404|NCT00476957|454201|P1|STARTED|Overall Study||4357
194405|NCT00476827|454215|P6|NOT COMPLETED|Overall Study||0
194406|NCT00476827|454216|P5|NOT COMPLETED|Overall Study||0
194407|NCT00476827|454217|P4|NOT COMPLETED|Overall Study||0
194408|NCT00476827|454218|P3|NOT COMPLETED|Overall Study||0
194409|NCT00476827|454219|P2|NOT COMPLETED|Overall Study||0
194410|NCT00476827|454220|P1|NOT COMPLETED|Overall Study||0
194411|NCT00476827|454215|P6|COMPLETED|Overall Study||2
194412|NCT00476827|454216|P5|COMPLETED|Overall Study||2
194413|NCT00476827|454217|P4|COMPLETED|Overall Study||0
194414|NCT00476827|454218|P3|COMPLETED|Overall Study||1
194415|NCT00476827|454219|P2|COMPLETED|Overall Study||0
194416|NCT00476827|454220|P1|COMPLETED|Overall Study||3
194417|NCT00476827|454215|P6|STARTED|Overall Study||2
194418|NCT00476827|454216|P5|STARTED|Overall Study||2
194419|NCT00476827|454217|P4|STARTED|Overall Study||0
194420|NCT00476827|454218|P3|STARTED|Overall Study||1
194421|NCT00476827|454219|P2|STARTED|Overall Study||0
194422|NCT00476827|454220|P1|STARTED|Overall Study||3
194423|NCT00476788|454250|P1|NOT COMPLETED|Overall Study||3
194424|NCT00476788|454250|P1|COMPLETED|Overall Study||11
194425|NCT00476788|454250|P1|STARTED|Overall Study||14
194426|NCT00476645|454255|P1|NOT COMPLETED|Overall Study||0
194427|NCT00476645|454255|P1|COMPLETED|Overall Study||10
194428|NCT00476645|454255|P1|STARTED|Overall Study||10
194429|NCT00476593|454265|P4|NOT COMPLETED|Overall Study||22
194430|NCT00476593|454266|P3|NOT COMPLETED|Overall Study||8
194431|NCT00476593|454267|P2|NOT COMPLETED|Overall Study||2
194432|NCT00476593|454268|P1|NOT COMPLETED|Overall Study||10
194433|NCT00476593|454265|P4|COMPLETED|Overall Study||107
194434|NCT00476593|454266|P3|COMPLETED|Overall Study||30
194435|NCT00476593|454267|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
194436|NCT00476593|454268|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
194437|NCT00476593|454265|P4|STARTED|Overall Study||129
194438|NCT00476593|454266|P3|STARTED|Overall Study||38
194439|NCT00476593|454267|P2|STARTED|Overall Study||19
194440|NCT00476593|454268|P1|STARTED|Overall Study||32
194441|NCT00476476|454280|P2|NOT COMPLETED|Overall Study||24
194442|NCT00476476|454281|P1|NOT COMPLETED|Overall Study||2
194443|NCT00476476|454280|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
194444|NCT00476476|454281|P1|COMPLETED|Overall Study||15
194445|NCT00476476|454280|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
194446|NCT00476476|454281|P1|Response Evaluable|Overall Study||17
194447|NCT00476476|454280|P2|STARTED|Overall Study||24
194448|NCT00476476|454281|P1|STARTED|Overall Study||17
194449|NCT00476242|454288|P2|NOT COMPLETED|Overall Study||16
194450|NCT00476242|454289|P1|NOT COMPLETED|Overall Study||8
194451|NCT00476242|454288|P2|COMPLETED|Overall Study||12
194452|NCT00476242|454289|P1|COMPLETED|Overall Study||19
194453|NCT00476242|454288|P2|STARTED|Overall Study||28
194454|NCT00476242|454289|P1|STARTED|Overall Study||27
194455|NCT00476229|454297|P1|NOT COMPLETED|Overall Study||1
194456|NCT00476229|454297|P1|COMPLETED|Overall Study||19
194457|NCT00476229|454297|P1|STARTED|Overall Study||20
194458|NCT00476151|454303|P2|NOT COMPLETED|Overall Study||7
194459|NCT00476151|454304|P1|NOT COMPLETED|Overall Study||3
194460|NCT00476151|454303|P2|COMPLETED|Overall Study||107
194461|NCT00476151|454304|P1|COMPLETED|Overall Study||109
194462|NCT00476151|454303|P2|STARTED|Overall Study||114
194463|NCT00476151|454304|P1|STARTED|Overall Study||112
194464|NCT00476086|454310|P1|NOT COMPLETED|Overall Study||5
194465|NCT00476086|454310|P1|COMPLETED|Overall Study||15
194466|NCT00476086|454310|P1|Received Radiation|Overall Study||15
194467|NCT00476086|454310|P1|Received Chemotherapy|Overall Study||19
194468|NCT00476086|454310|P1|STARTED|Overall Study||20
194469|NCT00476021|454318|P2|NOT COMPLETED|Overall Study||0
194470|NCT00476021|454319|P1|NOT COMPLETED|Overall Study||0
194471|NCT00476021|454318|P2|COMPLETED|Overall Study||51
194472|NCT00476021|454319|P1|COMPLETED|Overall Study||51
194473|NCT00476021|454318|P2|STARTED|Overall Study||51
194474|NCT00476021|454319|P1|STARTED|Overall Study||51
194475|NCT00476008|454335|P2|NOT COMPLETED|Overall Study||8
194476|NCT00476008|454336|P1|NOT COMPLETED|Overall Study||9
194477|NCT00476008|454335|P2|COMPLETED|Overall Study||13
194478|NCT00476008|454336|P1|COMPLETED|Overall Study||13
194479|NCT00476008|454335|P2|6 Month Testing|Overall Study||14
194480|NCT00476008|454336|P1|6 Month Testing|Overall Study||15
194481|NCT00476008|454335|P2|STARTED|Overall Study||21
194482|NCT00476008|454336|P1|STARTED|Overall Study||22
194483|NCT00475904|454363|P3|NOT COMPLETED|Overall Study||4
194484|NCT00475904|454364|P2|NOT COMPLETED|Overall Study||13
194485|NCT00475904|454365|P1|NOT COMPLETED|Overall Study||15
194486|NCT00475904|454363|P3|COMPLETED|Overall Study||72
194487|NCT00475904|454364|P2|COMPLETED|Overall Study||131
194488|NCT00475904|454365|P1|COMPLETED|Overall Study||125
194489|NCT00475904|454363|P3|STARTED|Overall Study||76
194490|NCT00475904|454364|P2|STARTED|Overall Study||144
194491|NCT00475904|454365|P1|STARTED|Overall Study||140
194492|NCT00475878|454378|P2|NOT COMPLETED|Overall Study||0
194493|NCT00475878|454379|P1|NOT COMPLETED|Overall Study||0
194494|NCT00475878|454378|P2|COMPLETED|Overall Study||72
194495|NCT00475878|454379|P1|COMPLETED|Overall Study||75
194496|NCT00475878|454378|P2|STARTED|Overall Study||72
194497|NCT00475878|454379|P1|STARTED|Overall Study||75
194498|NCT00475865|454390|P3|NOT COMPLETED|Overall Study||6
194499|NCT00475865|454391|P2|NOT COMPLETED|Overall Study||5
194500|NCT00475865|454392|P1|NOT COMPLETED|Overall Study||2
194501|NCT00475865|454390|P3|COMPLETED|Overall Study|completed treatment period|34
194502|NCT00475865|454391|P2|COMPLETED|Overall Study|completed treatment period|37
194503|NCT00475865|454392|P1|COMPLETED|Overall Study||39
194504|NCT00475865|454390|P3|Treated|Overall Study||40
194505|NCT00475865|454391|P2|Treated|Overall Study||42
194506|NCT00475865|454392|P1|Treated|Overall Study|completed treatment period|41
194507|NCT00475865|454390|P3|STARTED|Overall Study|randomized|40
194508|NCT00475865|454391|P2|STARTED|Overall Study|randomized|42
194509|NCT00475865|454392|P1|STARTED|Overall Study|randomized|41
194510|NCT00475852|454422|P2|NOT COMPLETED|Overall Study||548
194511|NCT00475852|454423|P1|NOT COMPLETED|Overall Study||517
194512|NCT00475852|454422|P2|COMPLETED|Overall Study||3029
194513|NCT00475852|454423|P1|COMPLETED|Overall Study||3047
194514|NCT00475852|454422|P2|STARTED|Overall Study||3577
194515|NCT00475852|454423|P1|STARTED|Overall Study||3564
194516|NCT00475787|454453|P2|NOT COMPLETED|Overall Study||7
194517|NCT00475787|454454|P1|NOT COMPLETED|Overall Study||8
194518|NCT00475787|454453|P2|COMPLETED|Overall Study||60
194519|NCT00475787|454454|P1|COMPLETED|Overall Study||61
194520|NCT00475787|454453|P2|STARTED|Overall Study||67
194521|NCT00475787|454454|P1|STARTED|Overall Study||69
194522|NCT00475735|454474|P6|NOT COMPLETED|Treatment Period 2||1
194523|NCT00475735|454475|P5|NOT COMPLETED|Treatment Period 2||1
194524|NCT00475735|454476|P4|NOT COMPLETED|Treatment Period 2||2
194525|NCT00475735|454477|P3|NOT COMPLETED|Treatment Period 2||0
194526|NCT00475735|454478|P2|NOT COMPLETED|Treatment Period 2||1
194527|NCT00475735|454479|P1|NOT COMPLETED|Treatment Period 2||0
194528|NCT00475735|454474|P6|COMPLETED|Treatment Period 2||13
194529|NCT00475735|454475|P5|COMPLETED|Treatment Period 2||15
194530|NCT00475735|454476|P4|COMPLETED|Treatment Period 2||4
194531|NCT00475735|454477|P3|COMPLETED|Treatment Period 2||7
194532|NCT00475735|454478|P2|COMPLETED|Treatment Period 2||9
194533|NCT00475735|454479|P1|COMPLETED|Treatment Period 2||10
194534|NCT00475735|454474|P6|STARTED|Treatment Period 2||14
194535|NCT00475735|454475|P5|STARTED|Treatment Period 2||16
194536|NCT00475735|454476|P4|STARTED|Treatment Period 2||6
194537|NCT00475735|454477|P3|STARTED|Treatment Period 2||7
194538|NCT00475735|454478|P2|STARTED|Treatment Period 2||10
194539|NCT00475735|454479|P1|STARTED|Treatment Period 2||10
194540|NCT00475735|454474|P6|NOT COMPLETED|Treatment Washout||0
194541|NCT00475735|454475|P5|NOT COMPLETED|Treatment Washout||0
194542|NCT00475735|454476|P4|NOT COMPLETED|Treatment Washout||0
194543|NCT00475735|454477|P3|NOT COMPLETED|Treatment Washout||0
194544|NCT00475735|454478|P2|NOT COMPLETED|Treatment Washout||2
194545|NCT00475735|454479|P1|NOT COMPLETED|Treatment Washout||0
194546|NCT00475735|454474|P6|COMPLETED|Treatment Washout||14
194547|NCT00475735|454475|P5|COMPLETED|Treatment Washout||16
194548|NCT00475735|454476|P4|COMPLETED|Treatment Washout||6
194549|NCT00475735|454477|P3|COMPLETED|Treatment Washout||7
194550|NCT00475735|454478|P2|COMPLETED|Treatment Washout||10
194551|NCT00475735|454479|P1|COMPLETED|Treatment Washout||10
194552|NCT00475735|454474|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
194553|NCT00475735|454475|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
194554|NCT00475735|454476|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
194555|NCT00475735|454477|P3|STARTED|Treatment Washout||7
194556|NCT00475735|454478|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
194557|NCT00475735|454479|P1|STARTED|Treatment Washout||10
194558|NCT00475735|454474|P6|NOT COMPLETED|Treatment Period 1||3
194559|NCT00475735|454475|P5|NOT COMPLETED|Treatment Period 1||2
194560|NCT00475735|454476|P4|NOT COMPLETED|Treatment Period 1||2
194561|NCT00475735|454477|P3|NOT COMPLETED|Treatment Period 1||0
194562|NCT00475735|454478|P2|NOT COMPLETED|Treatment Period 1||2
194563|NCT00475735|454479|P1|NOT COMPLETED|Treatment Period 1||4
194564|NCT00475735|454474|P6|COMPLETED|Treatment Period 1||12
194565|NCT00475735|454475|P5|COMPLETED|Treatment Period 1||14
194566|NCT00475735|454476|P4|COMPLETED|Treatment Period 1||5
194567|NCT00475735|454477|P3|COMPLETED|Treatment Period 1||7
194568|NCT00475735|454478|P2|COMPLETED|Treatment Period 1||11
194569|NCT00475735|454479|P1|COMPLETED|Treatment Period 1||10
194570|NCT00475735|454474|P6|STARTED|Treatment Period 1||15
194571|NCT00475735|454475|P5|STARTED|Treatment Period 1||16
194572|NCT00475735|454476|P4|STARTED|Treatment Period 1||7
194573|NCT00475735|454477|P3|STARTED|Treatment Period 1||7
194574|NCT00475735|454478|P2|STARTED|Treatment Period 1||13
194575|NCT00475735|454479|P1|STARTED|Treatment Period 1||14
194576|NCT00475722|454492|P2|NOT COMPLETED|Overall Study||12
194577|NCT00475722|454493|P1|NOT COMPLETED|Overall Study||15
194578|NCT00475722|454492|P2|COMPLETED|Overall Study||47
194579|NCT00475722|454493|P1|COMPLETED|Overall Study||46
194580|NCT00475722|454492|P2|STARTED|Overall Study||59
194581|NCT00475722|454493|P1|STARTED|Overall Study||61
194582|NCT00475709|454499|P1|NOT COMPLETED|Overall Study||76
194583|NCT00475709|454499|P1|COMPLETED|Overall Study||946
194584|NCT00475709|454499|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
194585|NCT00475709|454499|P1|STARTED|Overall Study||1022
194586|NCT00475670|454507|P2|NOT COMPLETED|Overall Study||41
194587|NCT00475670|454508|P1|NOT COMPLETED|Overall Study||3
194588|NCT00475670|454507|P2|COMPLETED|Overall Study||0
194589|NCT00475670|454508|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
194590|NCT00475670|454507|P2|STARTED|Overall Study||41
194591|NCT00475670|454508|P1|STARTED|Overall Study||3
194592|NCT00475657|454532|P1|NOT COMPLETED|Overall Study||4
194593|NCT00475657|454532|P1|COMPLETED|Overall Study||1
194594|NCT00475657|454532|P1|STARTED|Overall Study||5
194595|NCT00475501|454544|P4|NOT COMPLETED|Overall Study||4
194596|NCT00475501|454545|P3|NOT COMPLETED|Overall Study||4
194597|NCT00475501|454546|P2|NOT COMPLETED|Overall Study||5
194598|NCT00475501|454547|P1|NOT COMPLETED|Overall Study||7
194599|NCT00475501|454544|P4|COMPLETED|Overall Study||12
194600|NCT00475501|454545|P3|COMPLETED|Overall Study||13
194601|NCT00475501|454546|P2|COMPLETED|Overall Study||8
194602|NCT00475501|454547|P1|COMPLETED|Overall Study||7
194603|NCT00475501|454544|P4|STARTED|Overall Study||16
194604|NCT00475501|454545|P3|STARTED|Overall Study||17
194605|NCT00475501|454546|P2|STARTED|Overall Study||13
194606|NCT00475501|454547|P1|STARTED|Overall Study||14
194607|NCT00475423|454597|P1|NOT COMPLETED|Overall Study||32
194608|NCT00475423|454597|P1|COMPLETED|Overall Study||90
194609|NCT00475423|454597|P1|STARTED|Overall Study||122
194610|NCT00475332|454618|P1|NOT COMPLETED|Overall Study||0
194611|NCT00475332|454618|P1|COMPLETED|Overall Study||2
194612|NCT00475332|454618|P1|STARTED|Overall Study||2
194613|NCT00475319|454626|P3|NOT COMPLETED|Overall Study||4
194614|NCT00475319|454627|P2|NOT COMPLETED|Overall Study||1
194615|NCT00475319|454628|P1|NOT COMPLETED|Overall Study||2
194616|NCT00475319|454626|P3|COMPLETED|Overall Study||99
194617|NCT00475319|454627|P2|COMPLETED|Overall Study||101
194618|NCT00475319|454628|P1|COMPLETED|Overall Study||101
194619|NCT00475319|454626|P3|STARTED|Overall Study||103
194620|NCT00475319|454627|P2|STARTED|Overall Study||102
194621|NCT00475319|454628|P1|STARTED|Overall Study||103
194622|NCT00475306|454643|P4|NOT COMPLETED|Overall Study||1
194623|NCT00475306|454644|P3|NOT COMPLETED|Overall Study||0
194624|NCT00475306|454645|P2|NOT COMPLETED|Overall Study||1
194625|NCT00475306|454646|P1|NOT COMPLETED|Overall Study||1
194626|NCT00475306|454643|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
194627|NCT00475306|454644|P3|COMPLETED|Overall Study||72
194628|NCT00475306|454645|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
194629|NCT00475306|454646|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
194630|NCT00475306|454643|P4|STARTED|Overall Study||72
194631|NCT00475306|454644|P3|STARTED|Overall Study||72
194632|NCT00475306|454645|P2|STARTED|Overall Study||72
194633|NCT00475306|454646|P1|STARTED|Overall Study||73
194634|NCT00475241|454662|P2|NOT COMPLETED|Overall Study||3
194635|NCT00475241|454663|P1|NOT COMPLETED|Overall Study||7
194636|NCT00475241|454662|P2|COMPLETED|Overall Study||15
194637|NCT00475241|454663|P1|COMPLETED|Overall Study||11
194638|NCT00475241|454662|P2|STARTED|Overall Study||18
194639|NCT00475241|454663|P1|STARTED|Overall Study||18
194640|NCT00475176|454669|P1|NOT COMPLETED|Overall Study||4
194641|NCT00475176|454669|P1|COMPLETED|Overall Study||20
194642|NCT00475176|454669|P1|STARTED|Overall Study||24
194643|NCT00475150|454676|P2|NOT COMPLETED|Overall Study||0
194644|NCT00475150|454677|P1|NOT COMPLETED|Overall Study||0
194645|NCT00475150|454676|P2|COMPLETED|Overall Study||16
194646|NCT00475150|454677|P1|COMPLETED|Overall Study||23
194647|NCT00475150|454676|P2|STARTED|Overall Study||16
194648|NCT00475150|454677|P1|STARTED|Overall Study||23
194649|NCT00475085|454694|P4|NOT COMPLETED|Overall Study||20
194650|NCT00475085|454695|P3|NOT COMPLETED|Overall Study||19
194651|NCT00475085|454696|P2|NOT COMPLETED|Overall Study||20
194652|NCT00475085|454697|P1|NOT COMPLETED|Overall Study||18
194653|NCT00475085|454694|P4|COMPLETED|Overall Study||234
194654|NCT00475085|454695|P3|COMPLETED|Overall Study||241
194655|NCT00475085|454696|P2|COMPLETED|Overall Study||234
194656|NCT00475085|454697|P1|COMPLETED|Overall Study||235
194657|NCT00475085|454694|P4|STARTED|Overall Study||254
194658|NCT00475085|454695|P3|STARTED|Overall Study||260
194659|NCT00475085|454696|P2|STARTED|Overall Study||254
194660|NCT00475085|454697|P1|STARTED|Overall Study||253
194661|NCT00475033|454709|P2|NOT COMPLETED|Toddler Dose||0
194662|NCT00475033|454710|P1|NOT COMPLETED|Toddler Dose||4
194663|NCT00475033|454709|P2|COMPLETED|Toddler Dose||282
194664|NCT00475033|454710|P1|COMPLETED|Toddler Dose||283
194665|NCT00475033|454709|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
194666|NCT00475033|454710|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
194667|NCT00475033|454709|P2|NOT COMPLETED|After the Infant Series||8
194668|NCT00475033|454710|P1|NOT COMPLETED|After the Infant Series||6
194669|NCT00475033|454709|P2|COMPLETED|After the Infant Series||282
194670|NCT00475033|454710|P1|COMPLETED|After the Infant Series||287
194671|NCT00475033|454709|P2|Withdrawn After Infant Series|After the Infant Series||8
194672|NCT00475033|454710|P1|Withdrawn After Infant Series|After the Infant Series||6
194673|NCT00475033|454709|P2|STARTED|After the Infant Series||290
194674|NCT00475033|454710|P1|STARTED|After the Infant Series||293
194675|NCT00475033|454709|P2|NOT COMPLETED|Infant Series||13
194676|NCT00475033|454710|P1|NOT COMPLETED|Infant Series||7
194677|NCT00475033|454709|P2|COMPLETED|Infant Series||290
194678|NCT00475033|454710|P1|COMPLETED|Infant Series||293
194679|NCT00475033|454709|P2|Vaccinated Dose 3|Infant Series||294
194680|NCT00475033|454710|P1|Vaccinated Dose 3|Infant Series||293
194681|NCT00475033|454709|P2|Vaccinated Dose 2|Infant Series||296
194682|NCT00475033|454710|P1|Vaccinated Dose 2|Infant Series||297
194683|NCT00475033|454709|P2|Vaccinated Dose 1|Infant Series||303
194684|NCT00475033|454710|P1|Vaccinated Dose 1|Infant Series||300
194685|NCT00475033|454709|P2|STARTED|Infant Series||303
194686|NCT00475033|454710|P1|STARTED|Infant Series||300
194687|NCT00474994|454758|P1|NOT COMPLETED|Overall Study||5
194688|NCT00474994|454758|P1|COMPLETED|Overall Study||48
194689|NCT00474994|454758|P1|STARTED|Overall Study||53
194690|NCT00474968|454764|P2|NOT COMPLETED|Overall Study||16
194691|NCT00474968|454765|P1|NOT COMPLETED|Overall Study||18
194692|NCT00474968|454764|P2|COMPLETED|Overall Study||355
194693|NCT00474968|454765|P1|COMPLETED|Overall Study||348
194694|NCT00474968|454764|P2|STARTED|Overall Study||371
194695|NCT00474968|454765|P1|STARTED|Overall Study||366
194696|NCT00474955|454775|P1|NOT COMPLETED|Overall Study||8
194697|NCT00474955|454775|P1|COMPLETED|Overall Study||19
194698|NCT00474955|454775|P1|STARTED|Overall Study||27
194699|NCT00474929|454791|P5|NOT COMPLETED|Overall Study||0
194700|NCT00474929|454792|P4|NOT COMPLETED|Overall Study||2
194701|NCT00474929|454793|P3|NOT COMPLETED|Overall Study||2
194702|NCT00474929|454794|P2|NOT COMPLETED|Overall Study||1
194703|NCT00474929|454795|P1|NOT COMPLETED|Overall Study||0
194704|NCT00474929|454791|P5|COMPLETED|Overall Study||77
194705|NCT00474929|454792|P4|COMPLETED|Overall Study||5
194706|NCT00474929|454793|P3|COMPLETED|Overall Study||5
194707|NCT00474929|454794|P2|COMPLETED|Overall Study||5
194708|NCT00474929|454795|P1|COMPLETED|Overall Study||6
194709|NCT00474929|454791|P5|STARTED|Overall Study||77
194710|NCT00474929|454792|P4|STARTED|Overall Study||7
194711|NCT00474929|454793|P3|STARTED|Overall Study||7
194712|NCT00474929|454794|P2|STARTED|Overall Study||6
194713|NCT00474929|454795|P1|STARTED|Overall Study||6
194714|NCT00474903|454812|P3|NOT COMPLETED|Overall Study||2
194715|NCT00474903|454813|P2|NOT COMPLETED|Overall Study||5
194716|NCT00474903|454814|P1|NOT COMPLETED|Overall Study||1
194717|NCT00474903|454812|P3|COMPLETED|Overall Study||43
194718|NCT00474903|454813|P2|COMPLETED|Overall Study||42
194719|NCT00474903|454814|P1|COMPLETED|Overall Study||29
194720|NCT00474903|454812|P3|STARTED|Overall Study||45
194721|NCT00474903|454813|P2|STARTED|Overall Study||47
194722|NCT00474903|454814|P1|STARTED|Overall Study||30
194723|NCT00474851|454827|P2|NOT COMPLETED|Overall Study||11
194724|NCT00474851|454828|P1|NOT COMPLETED|Overall Study||8
194725|NCT00474851|454827|P2|COMPLETED|Overall Study||16
194726|NCT00474851|454828|P1|COMPLETED|Overall Study||18
194727|NCT00474851|454827|P2|Completed Baseline|Overall Study||26
194728|NCT00474851|454828|P1|Completed Baseline|Overall Study||25
194729|NCT00474851|454827|P2|STARTED|Overall Study||27
194730|NCT00474851|454828|P1|STARTED|Overall Study||26
194731|NCT00474812|454836|P1|NOT COMPLETED|Overall Study||7
194732|NCT00474812|454836|P1|COMPLETED|Overall Study||44
194733|NCT00474812|454836|P1|STARTED|Overall Study||51
194734|NCT00474786|454846|P2|NOT COMPLETED|Overall Study||253
194735|NCT00474786|454847|P1|NOT COMPLETED|Overall Study||259
194736|NCT00474786|454846|P2|COMPLETED|Overall Study||0
194737|NCT00474786|454847|P1|COMPLETED|Overall Study||0
194738|NCT00474786|454846|P2|STARTED|Overall Study||253
194739|NCT00474786|454847|P1|STARTED|Overall Study||259
194740|NCT00474760|454872|P7|NOT COMPLETED|Overall Study||10
194741|NCT00474760|454873|P6|NOT COMPLETED|Overall Study||29
194742|NCT00474760|454874|P5|NOT COMPLETED|Overall Study||12
194743|NCT00474760|454875|P4|NOT COMPLETED|Overall Study||3
194744|NCT00474760|454876|P3|NOT COMPLETED|Overall Study||3
194745|NCT00474760|454877|P2|NOT COMPLETED|Overall Study||3
194746|NCT00474760|454878|P1|NOT COMPLETED|Overall Study||3
194747|NCT00474760|454872|P7|COMPLETED|Overall Study||1
194748|NCT00474760|454873|P6|COMPLETED|Overall Study||0
194749|NCT00474760|454874|P5|COMPLETED|Overall Study||1
194750|NCT00474760|454875|P4|COMPLETED|Overall Study||0
194751|NCT00474760|454876|P3|COMPLETED|Overall Study||0
194752|NCT00474760|454877|P2|COMPLETED|Overall Study||0
194753|NCT00474760|454878|P1|COMPLETED|Overall Study||0
194754|NCT00474760|454872|P7|STARTED|Overall Study||11
194755|NCT00474760|454873|P6|STARTED|Overall Study||29
194756|NCT00474760|454874|P5|STARTED|Overall Study||13
194757|NCT00474760|454875|P4|STARTED|Overall Study||3
194758|NCT00474760|454876|P3|STARTED|Overall Study||3
194759|NCT00474760|454877|P2|STARTED|Overall Study||3
194760|NCT00474760|454878|P1|STARTED|Overall Study||3
194761|NCT00474708|454985|P2|NOT COMPLETED|Overall Study||25
194762|NCT00474708|454986|P1|NOT COMPLETED|Overall Study||57
194763|NCT00474708|454985|P2|COMPLETED|Overall Study||342
194764|NCT00474708|454986|P1|COMPLETED|Overall Study||734
194765|NCT00474708|454985|P2|STARTED|Overall Study||367
194766|NCT00474708|454986|P1|STARTED|Overall Study||791
194767|NCT00474630|454996|P2|NOT COMPLETED|Overall Study||70
194768|NCT00474630|454997|P1|NOT COMPLETED|Overall Study||160
194769|NCT00474630|454996|P2|COMPLETED|Overall Study||100
194770|NCT00474630|454997|P1|COMPLETED|Overall Study||175
194771|NCT00474630|454996|P2|STARTED|Overall Study||170
194772|NCT00474630|454997|P1|STARTED|Overall Study||335
194773|NCT00474539|455053|P2|NOT COMPLETED|Toddler Dose||0
194774|NCT00474539|455054|P1|NOT COMPLETED|Toddler Dose||1
194775|NCT00474539|455053|P2|COMPLETED|Toddler Dose||220
194776|NCT00474539|455054|P1|COMPLETED|Toddler Dose||208
194777|NCT00474539|455053|P2|STARTED|Toddler Dose||220
194778|NCT00474539|455054|P1|STARTED|Toddler Dose||209
194779|NCT00474539|455053|P2|NOT COMPLETED|After Infant Series||0
194780|NCT00474539|455054|P1|NOT COMPLETED|After Infant Series||4
194781|NCT00474539|455053|P2|COMPLETED|After Infant Series||220
194782|NCT00474539|455054|P1|COMPLETED|After Infant Series||209
194783|NCT00474539|455053|P2|STARTED|After Infant Series||220
194784|NCT00474539|455054|P1|STARTED|After Infant Series||213
194785|NCT00474539|455053|P2|NOT COMPLETED|Infant Series||6
194786|NCT00474539|455054|P1|NOT COMPLETED|Infant Series||10
194787|NCT00474539|455053|P2|COMPLETED|Infant Series||220
194788|NCT00474539|455054|P1|COMPLETED|Infant Series||213
194789|NCT00474539|455053|P2|Vaccinated Dose 3|Infant Series||221
194790|NCT00474539|455054|P1|Vaccinated Dose 3|Infant Series||214
194791|NCT00474539|455053|P2|Vaccinated Dose 2|Infant Series||222
194792|NCT00474539|455054|P1|Vaccinated Dose 2|Infant Series||217
194793|NCT00474539|455053|P2|Vaccinated Dose 1|Infant Series||226
194794|NCT00474539|455054|P1|Vaccinated Dose 1|Infant Series||218
194795|NCT00474539|455053|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
194796|NCT00474539|455054|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
194797|NCT00474526|455119|P17|NOT COMPLETED|Overall Study||9
194798|NCT00474526|455120|P16|NOT COMPLETED|Overall Study||18
194799|NCT00474526|455121|P15|NOT COMPLETED|Overall Study||77
194800|NCT00474526|455122|P14|NOT COMPLETED|Overall Study||156
194801|NCT00474526|455123|P13|NOT COMPLETED|Overall Study||15
194802|NCT00474526|455124|P12|NOT COMPLETED|Overall Study||11
194803|NCT00474526|455125|P11|NOT COMPLETED|Overall Study||10
194804|NCT00474526|455126|P10|NOT COMPLETED|Overall Study||27
194805|NCT00474526|455127|P9|NOT COMPLETED|Overall Study||6
194806|NCT00474526|455128|P8|NOT COMPLETED|Overall Study||6
194807|NCT00474526|455129|P7|NOT COMPLETED|Overall Study||25
194808|NCT00474526|455130|P6|NOT COMPLETED|Overall Study||16
194809|NCT00474526|455131|P5|NOT COMPLETED|Overall Study||68
194810|NCT00474526|455132|P4|NOT COMPLETED|Overall Study||119
194811|NCT00474526|455133|P3|NOT COMPLETED|Overall Study||49
194812|NCT00474526|455134|P2|NOT COMPLETED|Overall Study||46
194813|NCT00474526|455135|P1|NOT COMPLETED|Overall Study||33
194814|NCT00474526|455119|P17|COMPLETED|Overall Study||174
194815|NCT00474526|455120|P16|COMPLETED|Overall Study||152
194816|NCT00474526|455121|P15|COMPLETED|Overall Study||281
194817|NCT00474526|455122|P14|COMPLETED|Overall Study||1270
194818|NCT00474526|455123|P13|COMPLETED|Overall Study||135
194819|NCT00474526|455124|P12|COMPLETED|Overall Study||139
194820|NCT00474526|455125|P11|COMPLETED|Overall Study||141
194821|NCT00474526|455126|P10|COMPLETED|Overall Study||121
194822|NCT00474526|455127|P9|COMPLETED|Overall Study||144
194823|NCT00474526|455128|P8|COMPLETED|Overall Study||145
194824|NCT00474526|455129|P7|COMPLETED|Overall Study||178
194825|NCT00474526|455130|P6|COMPLETED|Overall Study||54
194826|NCT00474526|455131|P5|COMPLETED|Overall Study||8
194827|NCT00474526|455132|P4|COMPLETED|Overall Study||561
194828|NCT00474526|455133|P3|COMPLETED|Overall Study||110
194829|NCT00474526|455134|P2|COMPLETED|Overall Study||120
194830|NCT00474526|455135|P1|COMPLETED|Overall Study||121
194831|NCT00474526|455119|P17|STARTED|Overall Study||183
194832|NCT00474526|455120|P16|STARTED|Overall Study||170
194833|NCT00474526|455121|P15|STARTED|Overall Study||358
194834|NCT00474526|455122|P14|STARTED|Overall Study||1426
194835|NCT00474526|455123|P13|STARTED|Overall Study||150
194836|NCT00474526|455124|P12|STARTED|Overall Study||150
194837|NCT00474526|455125|P11|STARTED|Overall Study||151
194838|NCT00474526|455126|P10|STARTED|Overall Study||148
194839|NCT00474526|455127|P9|STARTED|Overall Study||150
194840|NCT00474526|455128|P8|STARTED|Overall Study||151
194841|NCT00474526|455129|P7|STARTED|Overall Study||203
194842|NCT00474526|455130|P6|STARTED|Overall Study||70
194843|NCT00474526|455131|P5|STARTED|Overall Study||76
194844|NCT00474526|455132|P4|STARTED|Overall Study||680
194845|NCT00474526|455133|P3|STARTED|Overall Study||159
194846|NCT00474526|455134|P2|STARTED|Overall Study||166
194847|NCT00474526|455135|P1|STARTED|Overall Study||154
194848|NCT00474487|455300|P4|NOT COMPLETED|Overall Study||0
194849|NCT00474487|455301|P3|NOT COMPLETED|Overall Study||14
194850|NCT00474487|455302|P2|NOT COMPLETED|Overall Study||2
194851|NCT00474487|455303|P1|NOT COMPLETED|Overall Study||30
194852|NCT00474487|455300|P4|COMPLETED|Overall Study||109
194853|NCT00474487|455301|P3|COMPLETED|Overall Study||885
194854|NCT00474487|455302|P2|COMPLETED|Overall Study||215
194855|NCT00474487|455303|P1|COMPLETED|Overall Study||1576
194856|NCT00474487|455300|P4|STARTED|Overall Study||109
194857|NCT00474487|455301|P3|STARTED|Overall Study||899
194858|NCT00474487|455302|P2|STARTED|Overall Study||217
194859|NCT00474487|455303|P1|STARTED|Overall Study||1606
194860|NCT00474383|455323|P2|NOT COMPLETED|Extension||5
194861|NCT00474383|455324|P1|NOT COMPLETED|Extension||0
194862|NCT00474383|455323|P2|COMPLETED|Extension||0
194863|NCT00474383|455324|P1|COMPLETED|Extension||0
194864|NCT00474383|455323|P2|STARTED|Extension||5
194865|NCT00474383|455324|P1|STARTED|Extension||0
194866|NCT00474383|455323|P2|NOT COMPLETED|Between Main Study and Extension||0
194867|NCT00474383|455324|P1|NOT COMPLETED|Between Main Study and Extension||6
194868|NCT00474383|455323|P2|COMPLETED|Between Main Study and Extension||0
194869|NCT00474383|455324|P1|COMPLETED|Between Main Study and Extension||5
194870|NCT00474383|455323|P2|STARTED|Between Main Study and Extension||0
194871|NCT00474383|455324|P1|STARTED|Between Main Study and Extension||11
194872|NCT00474383|455323|P2|NOT COMPLETED|Main Study||0
194873|NCT00474383|455324|P1|NOT COMPLETED|Main Study||36
194874|NCT00474383|455323|P2|COMPLETED|Main Study||0
194875|NCT00474383|455324|P1|COMPLETED|Main Study||11
194876|NCT00474383|455323|P2|STARTED|Main Study||0
194877|NCT00474383|455324|P1|STARTED|Main Study||47
194878|NCT00474240|455341|P6|NOT COMPLETED|Overall Study||18
194879|NCT00474240|455342|P5|NOT COMPLETED|Overall Study||8
194880|NCT00474240|455343|P4|NOT COMPLETED|Overall Study||16
194881|NCT00474240|455344|P3|NOT COMPLETED|Overall Study||9
194882|NCT00474240|455345|P2|NOT COMPLETED|Overall Study||1
194883|NCT00474240|455346|P1|NOT COMPLETED|Overall Study||1
194884|NCT00474240|455341|P6|COMPLETED|Overall Study||8
194885|NCT00474240|455342|P5|COMPLETED|Overall Study||18
194886|NCT00474240|455343|P4|COMPLETED|Overall Study||10
194887|NCT00474240|455344|P3|COMPLETED|Overall Study||17
194888|NCT00474240|455345|P2|COMPLETED|Overall Study||25
194889|NCT00474240|455346|P1|COMPLETED|Overall Study||26
194890|NCT00474240|455341|P6|STARTED|Overall Study||26
194891|NCT00474240|455342|P5|STARTED|Overall Study||26
194892|NCT00474240|455343|P4|STARTED|Overall Study||26
194893|NCT00474240|455344|P3|STARTED|Overall Study||26
194894|NCT00474240|455345|P2|STARTED|Overall Study||26
194895|NCT00474240|455346|P1|STARTED|Overall Study||27
194896|NCT00474201|455366|P1|NOT COMPLETED|Overall Study||0
194897|NCT00474201|455366|P1|COMPLETED|Overall Study||15
194898|NCT00474201|455366|P1|STARTED|Overall Study||15
194899|NCT00474188|455371|P1|NOT COMPLETED|Overall Study||6
194900|NCT00474188|455371|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
194901|NCT00474188|455371|P1|STARTED|Overall Study||26
194902|NCT00474175|455381|P3|NOT COMPLETED|Overall Study||4
194903|NCT00474175|455382|P2|NOT COMPLETED|Overall Study||7
194904|NCT00474175|455383|P1|NOT COMPLETED|Overall Study||1
194905|NCT00474175|455381|P3|COMPLETED|Overall Study||225
194906|NCT00474175|455382|P2|COMPLETED|Overall Study||226
194907|NCT00474175|455383|P1|COMPLETED|Overall Study||114
194908|NCT00474175|455381|P3|Treated|Overall Study||228
194909|NCT00474175|455382|P2|Treated|Overall Study||233
194910|NCT00474175|455383|P1|Treated|Overall Study||115
194911|NCT00474175|455381|P3|STARTED|Overall Study||229
194912|NCT00474175|455382|P2|STARTED|Overall Study||233
194913|NCT00474175|455383|P1|STARTED|Overall Study||115
194914|NCT00474123|455420|P2|NOT COMPLETED|Overall Study||0
194915|NCT00474123|455421|P1|NOT COMPLETED|Overall Study||0
194916|NCT00474123|455420|P2|COMPLETED|Overall Study||40
194917|NCT00474123|455421|P1|COMPLETED|Overall Study||38
194918|NCT00474123|455420|P2|STARTED|Overall Study||40
194919|NCT00474123|455421|P1|STARTED|Overall Study||38
194920|NCT00474058|455447|P2|NOT COMPLETED|Overall Study||17
194921|NCT00474058|455448|P1|NOT COMPLETED|Overall Study||24
194922|NCT00474058|455447|P2|COMPLETED|Overall Study||80
194923|NCT00474058|455448|P1|COMPLETED|Overall Study||166
194924|NCT00474058|455447|P2|STARTED|Overall Study||97
194925|NCT00474058|455448|P1|STARTED|Overall Study||190
194926|NCT00474045|455462|P2|NOT COMPLETED|Overall Study||101
194927|NCT00474045|455463|P1|NOT COMPLETED|Overall Study||106
194928|NCT00474045|455462|P2|COMPLETED|Overall Study||136
194929|NCT00474045|455463|P1|COMPLETED|Overall Study||127
194930|NCT00474045|455462|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
194931|NCT00474045|455463|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
194932|NCT00474045|455462|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
194933|NCT00474045|455463|P1|Exposed-Pregnant Subjects|Overall Study||152
194934|NCT00474045|455462|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
194935|NCT00474045|455463|P1|Exposed-All Subjects|Overall Study||233
194936|NCT00474045|455462|P2|STARTED|Overall Study||237
194937|NCT00474045|455463|P1|STARTED|Overall Study||233
194938|NCT00473889|455563|P2|NOT COMPLETED|Overall Study||64
194939|NCT00473889|455564|P1|NOT COMPLETED|Overall Study||83
194940|NCT00473889|455563|P2|COMPLETED|Overall Study||63
194941|NCT00473889|455564|P1|COMPLETED|Overall Study||43
194942|NCT00473889|455563|P2|STARTED|Overall Study||127
194943|NCT00473889|455564|P1|STARTED|Overall Study||126
194944|NCT00473876|455576|P2|NOT COMPLETED|Overall Study||1
194945|NCT00473876|455577|P1|NOT COMPLETED|Overall Study||3
194946|NCT00473876|455576|P2|COMPLETED|Overall Study||22
194947|NCT00473876|455577|P1|COMPLETED|Overall Study||36
194948|NCT00473876|455576|P2|STARTED|Overall Study||23
194949|NCT00473876|455577|P1|STARTED|Overall Study||39
194950|NCT00473837|455587|P2|NOT COMPLETED|Overall Study||3
194951|NCT00473837|455588|P1|NOT COMPLETED|Overall Study||1
194952|NCT00473837|455587|P2|COMPLETED|Overall Study||43
194953|NCT00473837|455588|P1|COMPLETED|Overall Study||49
194954|NCT00473837|455587|P2|STARTED|Overall Study||46
194955|NCT00473837|455588|P1|STARTED|Overall Study||50
194956|NCT00473824|455596|P2|NOT COMPLETED|Overall Study||0
194957|NCT00473824|455597|P1|NOT COMPLETED|Overall Study||5
194958|NCT00473824|455596|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
194959|NCT00473824|455597|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
194960|NCT00473824|455596|P2|STARTED|Overall Study||2
194961|NCT00473824|455597|P1|STARTED|Overall Study||5
194962|NCT00473746|455608|P5|NOT COMPLETED|Period 2 (Phase 2)||27
194963|NCT00473746|455609|P4|NOT COMPLETED|Period 2 (Phase 2)||0
194964|NCT00473746|455610|P3|NOT COMPLETED|Period 2 (Phase 2)||0
194965|NCT00473746|455611|P2|NOT COMPLETED|Period 2 (Phase 2)||0
194966|NCT00473746|455612|P1|NOT COMPLETED|Period 2 (Phase 2)||0
194967|NCT00473746|455608|P5|COMPLETED|Period 2 (Phase 2)||6
194968|NCT00473746|455609|P4|COMPLETED|Period 2 (Phase 2)||0
194969|NCT00473746|455610|P3|COMPLETED|Period 2 (Phase 2)||0
194970|NCT00473746|455611|P2|COMPLETED|Period 2 (Phase 2)||0
194971|NCT00473746|455612|P1|COMPLETED|Period 2 (Phase 2)||0
194972|NCT00473746|455608|P5|STARTED|Period 2 (Phase 2)||33
194973|NCT00473746|455609|P4|STARTED|Period 2 (Phase 2)||0
194974|NCT00473746|455610|P3|STARTED|Period 2 (Phase 2)||0
194975|NCT00473746|455611|P2|STARTED|Period 2 (Phase 2)||0
194976|NCT00473746|455612|P1|STARTED|Period 2 (Phase 2)||0
194977|NCT00473746|455608|P5|NOT COMPLETED|Period 1 (Phase 1)||0
194978|NCT00473746|455609|P4|NOT COMPLETED|Period 1 (Phase 1)||10
194979|NCT00473746|455610|P3|NOT COMPLETED|Period 1 (Phase 1)||6
194980|NCT00473746|455611|P2|NOT COMPLETED|Period 1 (Phase 1)||9
194981|NCT00473746|455612|P1|NOT COMPLETED|Period 1 (Phase 1)||6
194982|NCT00473746|455608|P5|COMPLETED|Period 1 (Phase 1)||0
194983|NCT00473746|455609|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
194984|NCT00473746|455610|P3|COMPLETED|Period 1 (Phase 1)||0
194985|NCT00473746|455611|P2|COMPLETED|Period 1 (Phase 1)||0
194986|NCT00473746|455612|P1|COMPLETED|Period 1 (Phase 1)||0
194987|NCT00473746|455608|P5|STARTED|Period 1 (Phase 1)||0
194988|NCT00473746|455609|P4|STARTED|Period 1 (Phase 1)||12
194989|NCT00473746|455610|P3|STARTED|Period 1 (Phase 1)||6
194990|NCT00473746|455611|P2|STARTED|Period 1 (Phase 1)||9
194991|NCT00473746|455612|P1|STARTED|Period 1 (Phase 1)||6
194992|NCT00473655|455660|P3|NOT COMPLETED|Overall Study||8
194993|NCT00473655|455661|P2|NOT COMPLETED|Overall Study||5
194994|NCT00473655|455662|P1|NOT COMPLETED|Overall Study||9
194995|NCT00473655|455660|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
194996|NCT00473655|455661|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
194997|NCT00473655|455662|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
194998|NCT00473655|455660|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
194999|NCT00473655|455661|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
195000|NCT00473655|455662|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
195001|NCT00473642|455697|P3|NOT COMPLETED|Overall Study||2
195002|NCT00473642|455698|P2|NOT COMPLETED|Overall Study||1
195003|NCT00473642|455699|P1|NOT COMPLETED|Overall Study||2
195004|NCT00473642|455697|P3|COMPLETED|Overall Study||8
195005|NCT00473642|455698|P2|COMPLETED|Overall Study||10
195006|NCT00473642|455699|P1|COMPLETED|Overall Study||8
195007|NCT00473642|455697|P3|STARTED|Overall Study||10
195008|NCT00473642|455698|P2|STARTED|Overall Study||11
195009|NCT00473642|455699|P1|STARTED|Overall Study||10
195010|NCT00473590|455709|P2|NOT COMPLETED|Overall Study||38
195011|NCT00473590|455710|P1|NOT COMPLETED|Overall Study||45
195012|NCT00473590|455709|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
195013|NCT00473590|455710|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
195014|NCT00473590|455709|P2|Safety Population|Overall Study||50
195015|NCT00473590|455710|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
195016|NCT00473590|455709|P2|Treated|Overall Study||48
195017|NCT00473590|455710|P1|Treated|Overall Study||52
195018|NCT00473590|455709|P2|STARTED|Overall Study||49
195019|NCT00473590|455710|P1|STARTED|Overall Study||53
195020|NCT00473564|455726|P1|NOT COMPLETED|Overall Study||23
195021|NCT00473564|455726|P1|COMPLETED|Overall Study||147
195022|NCT00473564|455726|P1|STARTED|Overall Study||170
195023|NCT00473512|455736|P5|NOT COMPLETED|Period 2 (Phase 2)||2
195024|NCT00473512|455737|P4|NOT COMPLETED|Period 2 (Phase 2)||23
195025|NCT00473512|455738|P3|NOT COMPLETED|Period 2 (Phase 2)||2
195026|NCT00473512|455739|P2|NOT COMPLETED|Period 2 (Phase 2)||2
195027|NCT00473512|455740|P1|NOT COMPLETED|Period 2 (Phase 2)||1
195028|NCT00473512|455736|P5|COMPLETED|Period 2 (Phase 2)||0
195029|NCT00473512|455737|P4|COMPLETED|Period 2 (Phase 2)||0
195030|NCT00473512|455738|P3|COMPLETED|Period 2 (Phase 2)||0
195031|NCT00473512|455739|P2|COMPLETED|Period 2 (Phase 2)||0
195032|NCT00473512|455740|P1|COMPLETED|Period 2 (Phase 2)||0
195033|NCT00473512|455736|P5|STARTED|Period 2 (Phase 2)||2
195034|NCT00473512|455737|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
195035|NCT00473512|455738|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
195036|NCT00473512|455739|P2|STARTED|Period 2 (Phase 2)||2
195037|NCT00473512|455740|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
195038|NCT00473512|455736|P5|NOT COMPLETED|Period 1 (Phase 1)||1
195039|NCT00473512|455737|P4|NOT COMPLETED|Period 1 (Phase 1)||17
195040|NCT00473512|455738|P3|NOT COMPLETED|Period 1 (Phase 1)||0
195041|NCT00473512|455739|P2|NOT COMPLETED|Period 1 (Phase 1)||1
195042|NCT00473512|455740|P1|NOT COMPLETED|Period 1 (Phase 1)||1
195043|NCT00473512|455736|P5|COMPLETED|Period 1 (Phase 1)||2
195044|NCT00473512|455737|P4|COMPLETED|Period 1 (Phase 1)||25
195045|NCT00473512|455738|P3|COMPLETED|Period 1 (Phase 1)||3
195046|NCT00473512|455739|P2|COMPLETED|Period 1 (Phase 1)||2
195047|NCT00473512|455740|P1|COMPLETED|Period 1 (Phase 1)||2
195048|NCT00473512|455736|P5|STARTED|Period 1 (Phase 1)||3
195049|NCT00473512|455737|P4|STARTED|Period 1 (Phase 1)||42
195050|NCT00473512|455738|P3|STARTED|Period 1 (Phase 1)||3
195051|NCT00473512|455739|P2|STARTED|Period 1 (Phase 1)||3
195052|NCT00473512|455740|P1|STARTED|Period 1 (Phase 1)||3
195053|NCT00473434|455798|P1|NOT COMPLETED|Overall Study||32
195054|NCT00473434|455798|P1|COMPLETED|Overall Study||32
195055|NCT00473434|455798|P1|STARTED|Overall Study||64
195056|NCT00473382|455863|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
195057|NCT00473382|455864|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
195058|NCT00473382|455865|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
195059|NCT00473382|455863|P3|COMPLETED|Open-label Extension Through Month 60||2
195060|NCT00473382|455864|P2|COMPLETED|Open-label Extension Through Month 60||1
195061|NCT00473382|455865|P1|COMPLETED|Open-label Extension Through Month 60||2
195062|NCT00473382|455863|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
195063|NCT00473382|455864|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
195064|NCT00473382|455865|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
195065|NCT00473382|455863|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
195066|NCT00473382|455864|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
195067|NCT00473382|455865|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
195068|NCT00473382|455863|P3|COMPLETED|Open-label Extension Through Month 48||37
195069|NCT00473382|455864|P2|COMPLETED|Open-label Extension Through Month 48||42
195070|NCT00473382|455865|P1|COMPLETED|Open-label Extension Through Month 48||38
195071|NCT00473382|455863|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
195072|NCT00473382|455864|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
195073|NCT00473382|455865|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
195074|NCT00473382|455863|P3|NOT COMPLETED|Core Study||29
195075|NCT00473382|455864|P2|NOT COMPLETED|Core Study||27
195076|NCT00473382|455865|P1|NOT COMPLETED|Core Study||28
195077|NCT00473382|455863|P3|COMPLETED|Core Study||98
195078|NCT00473382|455864|P2|COMPLETED|Core Study||98
195079|NCT00473382|455865|P1|COMPLETED|Core Study||102
195080|NCT00473382|455863|P3|STARTED|Core Study||127
195081|NCT00473382|455864|P2|STARTED|Core Study||125
195082|NCT00473382|455865|P1|STARTED|Core Study||130
195083|NCT00473330|455923|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
195084|NCT00473330|455924|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
195085|NCT00473330|455925|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
195086|NCT00473330|455923|P3|COMPLETED|Open-label Extension Through Month 60||0
195087|NCT00473330|455924|P2|COMPLETED|Open-label Extension Through Month 60||1
195088|NCT00473330|455925|P1|COMPLETED|Open-label Extension Through Month 60||1
195089|NCT00473330|455923|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
195090|NCT00473330|455924|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
195091|NCT00473330|455925|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
195092|NCT00473330|455923|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
195093|NCT00473330|455924|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
195094|NCT00473330|455925|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
195095|NCT00473330|455923|P3|COMPLETED|Open-label Extension Through Month 48||50
195096|NCT00473330|455924|P2|COMPLETED|Open-label Extension Through Month 48||59
195097|NCT00473330|455925|P1|COMPLETED|Open-label Extension Through Month 48||63
195098|NCT00473330|455923|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
195099|NCT00473330|455924|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
195100|NCT00473330|455925|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
195101|NCT00473330|455923|P3|NOT COMPLETED|Core Study||41
195102|NCT00473330|455924|P2|NOT COMPLETED|Core Study||25
195103|NCT00473330|455925|P1|NOT COMPLETED|Core Study||27
195104|NCT00473330|455923|P3|COMPLETED|Core Study||86
195105|NCT00473330|455924|P2|COMPLETED|Core Study||100
195106|NCT00473330|455925|P1|COMPLETED|Core Study||98
195107|NCT00473330|455923|P3|STARTED|Core Study||127
195108|NCT00473330|455924|P2|STARTED|Core Study||125
195109|NCT00473330|455925|P1|STARTED|Core Study||125
195110|NCT00473265|455980|P1|NOT COMPLETED|Overall Study||20
195111|NCT00473265|455980|P1|COMPLETED|Overall Study||48
195112|NCT00473265|455980|P1|STARTED|Overall Study||68
195113|NCT00472849|455991|P2|NOT COMPLETED|Overall Study||0
195114|NCT00472849|455992|P1|NOT COMPLETED|Overall Study||0
195115|NCT00472849|455991|P2|COMPLETED|Overall Study||78
195116|NCT00472849|455992|P1|COMPLETED|Overall Study||12
195117|NCT00472849|455991|P2|STARTED|Overall Study||78
195118|NCT00472849|455992|P1|STARTED|Overall Study||12
195119|NCT00472797|456000|P2|NOT COMPLETED|Overall Study||1
195120|NCT00472797|456001|P1|NOT COMPLETED|Overall Study||4
195121|NCT00472797|456000|P2|COMPLETED|Overall Study||112
195122|NCT00472797|456001|P1|COMPLETED|Overall Study||115
195123|NCT00472797|456000|P2|STARTED|Overall Study||113
195124|NCT00472797|456001|P1|STARTED|Overall Study||119
195125|NCT00472732|456027|P2|NOT COMPLETED|Overall Study||0
195126|NCT00472732|456028|P1|NOT COMPLETED|Overall Study||0
195127|NCT00472732|456027|P2|COMPLETED|Overall Study||22
195128|NCT00472732|456028|P1|COMPLETED|Overall Study||24
195129|NCT00472732|456027|P2|STARTED|Overall Study||22
195130|NCT00472732|456028|P1|STARTED|Overall Study||24
195131|NCT00472576|456040|P2|NOT COMPLETED|Second Intervention||0
195132|NCT00472576|456041|P1|NOT COMPLETED|Second Intervention||0
195133|NCT00472576|456040|P2|COMPLETED|Second Intervention||3
195134|NCT00472576|456041|P1|COMPLETED|Second Intervention||2
195135|NCT00472576|456040|P2|STARTED|Second Intervention||3
195136|NCT00472576|456041|P1|STARTED|Second Intervention||2
195137|NCT00472576|456040|P2|NOT COMPLETED|First Intervention||0
195138|NCT00472576|456041|P1|NOT COMPLETED|First Intervention||0
195139|NCT00472576|456040|P2|COMPLETED|First Intervention||3
195140|NCT00472576|456041|P1|COMPLETED|First Intervention||2
195141|NCT00472576|456040|P2|STARTED|First Intervention||3
195142|NCT00472576|456041|P1|STARTED|First Intervention||2
195143|NCT00472446|456053|P4|NOT COMPLETED|Overall Study||6
195144|NCT00472446|456054|P3|NOT COMPLETED|Overall Study||7
195145|NCT00472446|456055|P2|NOT COMPLETED|Overall Study||6
195146|NCT00472446|456056|P1|NOT COMPLETED|Overall Study||5
195147|NCT00472446|456053|P4|COMPLETED|Overall Study||39
195148|NCT00472446|456054|P3|COMPLETED|Overall Study||38
195149|NCT00472446|456055|P2|COMPLETED|Overall Study||41
195150|NCT00472446|456056|P1|COMPLETED|Overall Study||41
195151|NCT00472446|456053|P4|STARTED|Overall Study||45
195152|NCT00472446|456054|P3|STARTED|Overall Study||45
195153|NCT00472446|456055|P2|STARTED|Overall Study||47
195154|NCT00472446|456056|P1|STARTED|Overall Study||46
195155|NCT00472420|456086|P1|NOT COMPLETED|Follow-up Period||17
195156|NCT00472420|456086|P1|COMPLETED|Follow-up Period||15
195157|NCT00472420|456086|P1|STARTED|Follow-up Period||32
195158|NCT00472420|456086|P1|NOT COMPLETED|Induction Treatment Period||16
195159|NCT00472420|456086|P1|COMPLETED|Induction Treatment Period||32
195160|NCT00472420|456086|P1|STARTED|Induction Treatment Period||48
195161|NCT00470418|456094|P2|NOT COMPLETED|Overall Study||0
195162|NCT00470418|456095|P1|NOT COMPLETED|Overall Study||1
195163|NCT00470418|456094|P2|COMPLETED|Overall Study||3
195164|NCT00470418|456095|P1|COMPLETED|Overall Study||6
195165|NCT00470418|456094|P2|STARTED|Overall Study||3
195166|NCT00470418|456095|P1|STARTED|Overall Study||7
195167|NCT00470392|456105|P2|NOT COMPLETED|Overall Study||0
195168|NCT00470392|456106|P1|NOT COMPLETED|Overall Study||0
195169|NCT00470392|456105|P2|COMPLETED|Overall Study||2
195170|NCT00470392|456106|P1|COMPLETED|Overall Study||7
195171|NCT00470392|456105|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
195172|NCT00470392|456106|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
195173|NCT00470301|456116|P1|NOT COMPLETED|Overall Study||5
195174|NCT00470301|456116|P1|COMPLETED|Overall Study||55
195175|NCT00470301|456116|P1|STARTED|Overall Study||60
195176|NCT00470275|456120|P1|NOT COMPLETED|Overall Study||10
195177|NCT00470275|456120|P1|COMPLETED|Overall Study||0
195178|NCT00470275|456120|P1|STARTED|Overall Study||10
195179|NCT00470262|456126|P2|NOT COMPLETED|Overall Study||0
195180|NCT00470262|456127|P1|NOT COMPLETED|Overall Study||2
195181|NCT00470262|456126|P2|COMPLETED|Overall Study||12
195182|NCT00470262|456127|P1|COMPLETED|Overall Study||13
195183|NCT00470262|456126|P2|STARTED|Overall Study||12
195184|NCT00470262|456127|P1|STARTED|Overall Study||15
195185|NCT00470184|456135|P1|NOT COMPLETED|Overall Study||22
195186|NCT00470184|456135|P1|COMPLETED|Overall Study||19
195187|NCT00470184|456135|P1|Treated With Study Therapy|Overall Study||36
195188|NCT00470184|456135|P1|STARTED|Overall Study||41
195189|NCT00472303|456144|P3|NOT COMPLETED|Maintenance Phase||17
195190|NCT00472303|456145|P2|NOT COMPLETED|Maintenance Phase||16
195191|NCT00472303|456146|P1|NOT COMPLETED|Maintenance Phase||17
195192|NCT00472303|456144|P3|COMPLETED|Maintenance Phase||95
195193|NCT00472303|456145|P2|COMPLETED|Maintenance Phase||93
195194|NCT00472303|456146|P1|COMPLETED|Maintenance Phase||89
195195|NCT00472303|456144|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
195196|NCT00472303|456145|P2|STARTED|Maintenance Phase||109
195197|NCT00472303|456146|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
195198|NCT00472303|456144|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
195199|NCT00472303|456145|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
195200|NCT00472303|456146|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
195201|NCT00472303|456144|P3|COMPLETED|Discontinuations After Titration Phase||0
195286|NCT00471380|456395|P1|COMPLETED|Third Intervention||17
195287|NCT00471380|456394|P2|STARTED|Third Intervention||16
195202|NCT00472303|456145|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
195203|NCT00472303|456146|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
195204|NCT00472303|456144|P3|STARTED|Discontinuations After Titration Phase||0
195205|NCT00472303|456145|P2|STARTED|Discontinuations After Titration Phase||129
195206|NCT00472303|456146|P1|STARTED|Discontinuations After Titration Phase||279
195207|NCT00472303|456144|P3|NOT COMPLETED|Titration Phase||0
195208|NCT00472303|456145|P2|NOT COMPLETED|Titration Phase||29
195209|NCT00472303|456146|P1|NOT COMPLETED|Titration Phase||59
195210|NCT00472303|456144|P3|COMPLETED|Titration Phase||0
195211|NCT00472303|456145|P2|COMPLETED|Titration Phase||129
195212|NCT00472303|456146|P1|COMPLETED|Titration Phase||279
195213|NCT00472303|456144|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
195214|NCT00472303|456145|P2|STARTED|Titration Phase||158
195215|NCT00472303|456146|P1|STARTED|Titration Phase||338
195216|NCT00472290|456209|P1|NOT COMPLETED|Overall Study||72
195217|NCT00472290|456209|P1|COMPLETED|Overall Study||0
195218|NCT00472290|456209|P1|STARTED|Overall Study||72
195219|NCT00472199|456221|P2|NOT COMPLETED|Overall Study||60
195220|NCT00472199|456222|P1|NOT COMPLETED|Overall Study||35
195221|NCT00472199|456221|P2|COMPLETED|Overall Study||103
195222|NCT00472199|456222|P1|COMPLETED|Overall Study||131
195223|NCT00472199|456221|P2|STARTED|Overall Study||163
195224|NCT00472199|456222|P1|STARTED|Overall Study||166
195225|NCT00472082|456288|P1|NOT COMPLETED|Overall Study||5
195226|NCT00472082|456288|P1|COMPLETED|Overall Study||0
195227|NCT00472082|456288|P1|STARTED|Overall Study||5
195228|NCT00472056|456297|P4|NOT COMPLETED|Overall Study||0
195229|NCT00472056|456298|P3|NOT COMPLETED|Overall Study||0
195230|NCT00472056|456299|P2|NOT COMPLETED|Overall Study||0
195231|NCT00472056|456300|P1|NOT COMPLETED|Overall Study||0
195232|NCT00472056|456297|P4|COMPLETED|Overall Study||17
195233|NCT00472056|456298|P3|COMPLETED|Overall Study||32
195234|NCT00472056|456299|P2|COMPLETED|Overall Study||19
195235|NCT00472056|456300|P1|COMPLETED|Overall Study||25
195236|NCT00472056|456297|P4|STARTED|Overall Study||17
195237|NCT00472056|456298|P3|STARTED|Overall Study||32
195238|NCT00472056|456299|P2|STARTED|Overall Study||19
195239|NCT00472056|456300|P1|STARTED|Overall Study||25
195240|NCT00472030|456310|P2|NOT COMPLETED|Overall Study||0
195241|NCT00472030|456311|P1|NOT COMPLETED|Overall Study||1
195242|NCT00472030|456310|P2|COMPLETED|Overall Study||0
195243|NCT00472030|456311|P1|COMPLETED|Overall Study||1
195244|NCT00472030|456310|P2|STARTED|Overall Study||0
195245|NCT00472030|456311|P1|STARTED|Overall Study||2
195246|NCT00471822|456327|P1|NOT COMPLETED|Overall Study||2
195247|NCT00471822|456327|P1|COMPLETED|Overall Study||9705
195248|NCT00471822|456327|P1|Treated|Overall Study||9705
195249|NCT00471822|456327|P1|STARTED|Overall Study||9707
195250|NCT00471718|456335|P1|NOT COMPLETED|Overall Study||27
195251|NCT00471718|456335|P1|COMPLETED|Overall Study||0
195252|NCT00471718|456335|P1|STARTED|Overall Study||27
195253|NCT00471705|456347|P3|NOT COMPLETED|Overall Study||15
195254|NCT00471705|456348|P2|NOT COMPLETED|Overall Study||22
195255|NCT00471705|456349|P1|NOT COMPLETED|Overall Study||24
195256|NCT00471705|456347|P3|COMPLETED|Overall Study||134
195257|NCT00471705|456348|P2|COMPLETED|Overall Study||121
195258|NCT00471705|456349|P1|COMPLETED|Overall Study||121
195259|NCT00471705|456347|P3|STARTED|Overall Study||149
195260|NCT00471705|456348|P2|STARTED|Overall Study||143
195261|NCT00471705|456349|P1|STARTED|Overall Study||145
195262|NCT00471536|456363|P1|NOT COMPLETED|Overall Study||1
195263|NCT00471536|456363|P1|COMPLETED|Overall Study||18
195264|NCT00471536|456363|P1|STARTED|Overall Study||19
195265|NCT00471497|456375|P3|NOT COMPLETED|Overall Study||40
195266|NCT00471497|456376|P2|NOT COMPLETED|Overall Study||35
195267|NCT00471497|456377|P1|NOT COMPLETED|Overall Study||46
195268|NCT00471497|456375|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
195269|NCT00471497|456376|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
195270|NCT00471497|456377|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
195271|NCT00471497|456375|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
195272|NCT00471497|456376|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
195273|NCT00471497|456377|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
195274|NCT00471497|456375|P3|STARTED|Overall Study||281
195275|NCT00471497|456376|P2|STARTED|Overall Study||282
195276|NCT00471497|456377|P1|STARTED|Overall Study||283
195277|NCT00471445|456387|P2|NOT COMPLETED|Overall Study||2
195278|NCT00471445|456388|P1|NOT COMPLETED|Overall Study||2
195279|NCT00471445|456387|P2|COMPLETED|Overall Study||231
195280|NCT00471445|456388|P1|COMPLETED|Overall Study||227
195281|NCT00471445|456387|P2|STARTED|Overall Study||233
195282|NCT00471445|456388|P1|STARTED|Overall Study||229
195283|NCT00471380|456394|P2|NOT COMPLETED|Third Intervention||2
195284|NCT00471380|456395|P1|NOT COMPLETED|Third Intervention||1
195285|NCT00471380|456394|P2|COMPLETED|Third Intervention||14
195288|NCT00471380|456395|P1|STARTED|Third Intervention||18
195289|NCT00471380|456394|P2|NOT COMPLETED|Second Intervention||4
195290|NCT00471380|456395|P1|NOT COMPLETED|Second Intervention||0
195291|NCT00471380|456394|P2|COMPLETED|Second Intervention||16
195292|NCT00471380|456395|P1|COMPLETED|Second Intervention||18
195293|NCT00471380|456394|P2|STARTED|Second Intervention||20
195294|NCT00471380|456395|P1|STARTED|Second Intervention||18
195295|NCT00471380|456394|P2|NOT COMPLETED|First Intervention||4
195296|NCT00471380|456395|P1|NOT COMPLETED|First Intervention||4
195297|NCT00471380|456394|P2|COMPLETED|First Intervention||20
195298|NCT00471380|456395|P1|COMPLETED|First Intervention||18
195299|NCT00471380|456394|P2|STARTED|First Intervention||24
195300|NCT00471380|456395|P1|STARTED|First Intervention||22
195301|NCT00471354|456401|P1|NOT COMPLETED|Overall Study||52
195302|NCT00471354|456401|P1|COMPLETED|Overall Study||176
195303|NCT00471354|456401|P1|STARTED|Overall Study||228
195304|NCT00471328|456413|P2|NOT COMPLETED|Extension Phase||67
195305|NCT00471328|456414|P1|NOT COMPLETED|Extension Phase||41
195306|NCT00471328|456413|P2|COMPLETED|Extension Phase||0
195307|NCT00471328|456414|P1|COMPLETED|Extension Phase||0
195308|NCT00471328|456413|P2|Started:CrossOver During Extension|Extension Phase||10
195309|NCT00471328|456414|P1|Started:CrossOver During Extension|Extension Phase||0
195310|NCT00471328|456413|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
195311|NCT00471328|456414|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
195312|NCT00471328|456413|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
195313|NCT00471328|456414|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
195314|NCT00471328|456413|P2|STARTED|Extension Phase||67
195315|NCT00471328|456414|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
195316|NCT00471328|456413|P2|NOT COMPLETED|Core Phase||67
195317|NCT00471328|456414|P1|NOT COMPLETED|Core Phase||107
195318|NCT00471328|456413|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
195319|NCT00471328|456414|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
195320|NCT00471328|456413|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
195321|NCT00471328|456414|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
195322|NCT00471328|456413|P2|STARTED|Core Phase||83
195323|NCT00471328|456414|P1|STARTED|Core Phase||165
195324|NCT00471315|456433|P1|NOT COMPLETED|Overall Study||8
195325|NCT00471315|456433|P1|COMPLETED|Overall Study||10
195326|NCT00471315|456433|P1|STARTED|Overall Study||18
195327|NCT00471276|456438|P1|NOT COMPLETED|Overall Study||83
195328|NCT00471276|456438|P1|COMPLETED|Overall Study||0
195329|NCT00471276|456438|P1|STARTED|Overall Study||83
195330|NCT00471146|456463|P2|NOT COMPLETED|Overall Study||174
195331|NCT00471146|456464|P1|NOT COMPLETED|Overall Study||172
195332|NCT00471146|456463|P2|COMPLETED|Overall Study||142
195333|NCT00471146|456464|P1|COMPLETED|Overall Study||142
195334|NCT00471146|456463|P2|Treated|Overall Study||308
195335|NCT00471146|456464|P1|Treated|Overall Study||305
195336|NCT00471146|456463|P2|STARTED|Overall Study||316
195337|NCT00471146|456464|P1|STARTED|Overall Study||314
195338|NCT00471107|456489|P3|NOT COMPLETED|Overall Study||3
195339|NCT00471107|456490|P2|NOT COMPLETED|Overall Study||1
195340|NCT00471107|456491|P1|NOT COMPLETED|Overall Study||3
195341|NCT00471107|456489|P3|COMPLETED|Overall Study||12
195342|NCT00471107|456490|P2|COMPLETED|Overall Study||14
195343|NCT00471107|456491|P1|COMPLETED|Overall Study||12
195344|NCT00471107|456489|P3|STARTED|Overall Study||15
195345|NCT00471107|456490|P2|STARTED|Overall Study||15
195346|NCT00471107|456491|P1|STARTED|Overall Study||15
195347|NCT00471068|456501|P2|NOT COMPLETED|Overall Study||1
195348|NCT00471068|456502|P1|NOT COMPLETED|Overall Study||1
195349|NCT00471068|456501|P2|COMPLETED|Overall Study||24
195350|NCT00471068|456502|P1|COMPLETED|Overall Study||20
195351|NCT00471068|456501|P2|STARTED|Overall Study||25
195352|NCT00471068|456502|P1|STARTED|Overall Study||21
195353|NCT00470847|456508|P1|NOT COMPLETED|Overall Study||1
195354|NCT00470847|456508|P1|COMPLETED|Overall Study||34
195355|NCT00470847|456508|P1|STARTED|Overall Study||35
195356|NCT00470834|456521|P2|NOT COMPLETED|Extension Period (24 Months)||23
195357|NCT00470834|456522|P1|NOT COMPLETED|Extension Period (24 Months)||15
195358|NCT00470834|456521|P2|COMPLETED|Extension Period (24 Months)||7
195359|NCT00470834|456522|P1|COMPLETED|Extension Period (24 Months)||11
195360|NCT00470834|456521|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
195361|NCT00470834|456522|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
195362|NCT00470834|456521|P2|NOT COMPLETED|Treatment Period (18 Months)||31
195363|NCT00470834|456522|P1|NOT COMPLETED|Treatment Period (18 Months)||38
195364|NCT00470834|456521|P2|COMPLETED|Treatment Period (18 Months)||31
195365|NCT00470834|456522|P1|COMPLETED|Treatment Period (18 Months)||27
195366|NCT00470834|456521|P2|STARTED|Treatment Period (18 Months)||62
195367|NCT00470834|456522|P1|STARTED|Treatment Period (18 Months)||65
195368|NCT00470626|456536|P1|NOT COMPLETED|Overall Study||17
195369|NCT00470626|456536|P1|COMPLETED|Overall Study||112
195370|NCT00470626|456536|P1|STARTED|Overall Study||129
195371|NCT00470600|456544|P2|NOT COMPLETED|Overall Study||0
195372|NCT00470600|456545|P1|NOT COMPLETED|Overall Study||0
195373|NCT00470600|456544|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
195457|NCT00468312|456689|P1|NOT COMPLETED|Overall Study||4
195374|NCT00470600|456545|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
195375|NCT00470600|456544|P2|STARTED|Overall Study||99
195376|NCT00470600|456545|P1|STARTED|Overall Study||86
195377|NCT00470535|456555|P1|NOT COMPLETED|Overall Study||18
195378|NCT00470535|456555|P1|COMPLETED|Overall Study||0
195379|NCT00470535|456555|P1|STARTED|Overall Study||18
195380|NCT00470470|456564|P1|NOT COMPLETED|Overall Study||5
195381|NCT00470470|456564|P1|COMPLETED|Overall Study||25
195382|NCT00470470|456564|P1|STARTED|Overall Study||30
195383|NCT00470158|456574|P5|NOT COMPLETED|Overall Study||6
195384|NCT00470158|456575|P4|NOT COMPLETED|Overall Study||5
195385|NCT00470158|456576|P3|NOT COMPLETED|Overall Study||8
195386|NCT00470158|456577|P2|NOT COMPLETED|Overall Study||8
195387|NCT00470158|456578|P1|NOT COMPLETED|Overall Study||8
195388|NCT00470158|456574|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
195389|NCT00470158|456575|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
195390|NCT00470158|456576|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
195391|NCT00470158|456577|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
195392|NCT00470158|456578|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
195393|NCT00470158|456574|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
195394|NCT00470158|456575|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
195395|NCT00470158|456576|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
195396|NCT00470158|456577|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
195397|NCT00470158|456578|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
195398|NCT00470106|456594|P4|NOT COMPLETED|Overall Study||2
195399|NCT00470106|456595|P3|NOT COMPLETED|Overall Study||7
195400|NCT00470106|456596|P2|NOT COMPLETED|Overall Study||5
195401|NCT00470106|456597|P1|NOT COMPLETED|Overall Study||3
195402|NCT00470106|456594|P4|COMPLETED|Overall Study||19
195403|NCT00470106|456595|P3|COMPLETED|Overall Study||14
195404|NCT00470106|456596|P2|COMPLETED|Overall Study||19
195405|NCT00470106|456597|P1|COMPLETED|Overall Study||16
195406|NCT00470106|456594|P4|STARTED|Overall Study||21
195407|NCT00470106|456595|P3|STARTED|Overall Study||21
195408|NCT00470106|456596|P2|STARTED|Overall Study||24
195409|NCT00470106|456597|P1|STARTED|Overall Study||19
195410|NCT00470067|456611|P1|NOT COMPLETED|Overall Study||7
195411|NCT00470067|456611|P1|COMPLETED|Overall Study||2
195412|NCT00470067|456611|P1|STARTED|Overall Study||9
195413|NCT00470054|456615|P1|NOT COMPLETED|Overall Study||1
195414|NCT00470054|456615|P1|COMPLETED|Overall Study||43
195415|NCT00470054|456615|P1|STARTED|Overall Study||44
195416|NCT00469898|456623|P1|NOT COMPLETED|Overall Study||25
195417|NCT00469898|456623|P1|COMPLETED|Overall Study||25
195418|NCT00469898|456623|P1|STARTED|Overall Study||50
195419|NCT00469859|456632|P2|NOT COMPLETED|Overall Study||2
195420|NCT00469859|456633|P1|NOT COMPLETED|Overall Study||0
195421|NCT00469859|456632|P2|COMPLETED|Overall Study||6
195422|NCT00469859|456633|P1|COMPLETED|Overall Study||6
195423|NCT00469859|456632|P2|STARTED|Overall Study||8
195424|NCT00469859|456633|P1|STARTED|Overall Study||6
195425|NCT00469833|456641|P1|NOT COMPLETED|Overall Study||2
195426|NCT00469833|456641|P1|COMPLETED|Overall Study||15
195427|NCT00469833|456641|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
195428|NCT00469508|456653|P2|NOT COMPLETED|Overall Study||24
195429|NCT00469508|456654|P1|NOT COMPLETED|Overall Study||20
195430|NCT00469508|456653|P2|COMPLETED|Overall Study||13
195431|NCT00469508|456654|P1|COMPLETED|Overall Study||14
195432|NCT00469508|456653|P2|STARTED|Overall Study||37
195433|NCT00469508|456654|P1|STARTED|Overall Study||34
195434|NCT00469456|456668|P2|NOT COMPLETED|Overall Study||4
195435|NCT00469456|456669|P1|NOT COMPLETED|Overall Study||9
195436|NCT00469456|456668|P2|COMPLETED|Overall Study||131
195437|NCT00469456|456669|P1|COMPLETED|Overall Study||120
195438|NCT00469456|456668|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
195439|NCT00469456|456669|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
195440|NCT00469391|456679|P2|NOT COMPLETED|Overall Study||5
195441|NCT00469391|456680|P1|NOT COMPLETED|Overall Study||14
195442|NCT00469391|456679|P2|COMPLETED|Overall Study||24
195443|NCT00469391|456680|P1|COMPLETED|Overall Study||13
195444|NCT00469391|456679|P2|Patient Preference|Overall Study||1
195445|NCT00469391|456680|P1|Patient Preference|Overall Study||0
195446|NCT00469391|456679|P2|Lost to Follow up|Overall Study||1
195447|NCT00469391|456680|P1|Lost to Follow up|Overall Study||0
195448|NCT00469391|456679|P2|Adverse Event|Overall Study||0
195449|NCT00469391|456680|P1|Adverse Event|Overall Study||8
195450|NCT00469391|456679|P2|Unsuccessful Implant Procedure|Overall Study||0
195451|NCT00469391|456680|P1|Unsuccessful Implant Procedure|Overall Study||4
195452|NCT00469391|456679|P2|Discontinued Prior to Procedure|Overall Study||3
195453|NCT00469391|456680|P1|Discontinued Prior to Procedure|Overall Study||2
195454|NCT00469391|456679|P2|STARTED|Overall Study||29
195455|NCT00469391|456680|P1|STARTED|Overall Study||27
195456|NCT00468312|456688|P2|NOT COMPLETED|Overall Study||5
195458|NCT00468312|456688|P2|COMPLETED|Overall Study||204
195459|NCT00468312|456689|P1|COMPLETED|Overall Study||216
195460|NCT00468312|456688|P2|STARTED|Overall Study||209
195461|NCT00468312|456689|P1|STARTED|Overall Study||220
195462|NCT00468299|456705|P2|NOT COMPLETED|Overall Study||1
195463|NCT00468299|456706|P1|NOT COMPLETED|Overall Study||0
195464|NCT00468299|456705|P2|COMPLETED|Overall Study||7
195465|NCT00468299|456706|P1|COMPLETED|Overall Study||9
195466|NCT00468299|456705|P2|STARTED|Overall Study||8
195467|NCT00468299|456706|P1|STARTED|Overall Study||9
195468|NCT00468286|456716|P2|NOT COMPLETED|Overall Study||12
195469|NCT00468286|456717|P1|NOT COMPLETED|Overall Study||7
195470|NCT00468286|456716|P2|COMPLETED|Overall Study||54
195471|NCT00468286|456717|P1|COMPLETED|Overall Study||60
195472|NCT00468286|456716|P2|STARTED|Overall Study||66
195473|NCT00468286|456717|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
195474|NCT00468208|456739|P1|NOT COMPLETED|Overall Study||0
195475|NCT00468208|456739|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
195476|NCT00468208|456739|P1|STARTED|Overall Study||20
195477|NCT00469274|456749|P2|NOT COMPLETED|Overall Study||0
195478|NCT00469274|456750|P1|NOT COMPLETED|Overall Study||0
195479|NCT00469274|456749|P2|COMPLETED|Overall Study||42
195480|NCT00469274|456750|P1|COMPLETED|Overall Study||44
195481|NCT00469274|456749|P2|STARTED|Overall Study||42
195482|NCT00469274|456750|P1|STARTED|Overall Study||44
195483|NCT00469209|456759|P3|NOT COMPLETED|Overall Study||1
195484|NCT00469209|456760|P2|NOT COMPLETED|Overall Study||0
195485|NCT00469209|456761|P1|NOT COMPLETED|Overall Study||1
195486|NCT00469209|456759|P3|COMPLETED|Overall Study||19
195487|NCT00469209|456760|P2|COMPLETED|Overall Study||20
195488|NCT00469209|456761|P1|COMPLETED|Overall Study||19
195489|NCT00469209|456759|P3|STARTED|Overall Study||20
195490|NCT00469209|456760|P2|STARTED|Overall Study||20
195491|NCT00469209|456761|P1|STARTED|Overall Study||20
195492|NCT00469092|456771|P2|NOT COMPLETED|Overall Study||21
195493|NCT00469092|456772|P1|NOT COMPLETED|Overall Study||26
195494|NCT00469092|456771|P2|COMPLETED|Overall Study||220
195495|NCT00469092|456772|P1|COMPLETED|Overall Study||213
195496|NCT00469092|456771|P2|Exposed to Study Drug|Overall Study||238
195497|NCT00469092|456772|P1|Exposed to Study Drug|Overall Study||231
195498|NCT00469092|456771|P2|STARTED|Overall Study||241
195499|NCT00469092|456772|P1|STARTED|Overall Study||239
195500|NCT00469079|456791|P3|NOT COMPLETED|Overall Study||19
195501|NCT00469079|456792|P2|NOT COMPLETED|Overall Study||22
195502|NCT00469079|456793|P1|NOT COMPLETED|Overall Study||9
195503|NCT00469079|456791|P3|COMPLETED|Overall Study||32
195504|NCT00469079|456792|P2|COMPLETED|Overall Study||30
195505|NCT00469079|456793|P1|COMPLETED|Overall Study||18
195506|NCT00469079|456791|P3|STARTED|Overall Study||51
195507|NCT00469079|456792|P2|STARTED|Overall Study||52
195508|NCT00469079|456793|P1|STARTED|Overall Study||27
195509|NCT00468845|456813|P3|NOT COMPLETED|Overall Study||30
195510|NCT00468845|456814|P2|NOT COMPLETED|Overall Study||34
195511|NCT00468845|456815|P1|NOT COMPLETED|Overall Study||21
195512|NCT00468845|456813|P3|COMPLETED|Overall Study||139
195513|NCT00468845|456814|P2|COMPLETED|Overall Study||136
195514|NCT00468845|456815|P1|COMPLETED|Overall Study||141
195515|NCT00468845|456813|P3|Received Treatment|Overall Study||167
195516|NCT00468845|456814|P2|Received Treatment|Overall Study||166
195517|NCT00468845|456815|P1|Received Treatment|Overall Study||161
195518|NCT00468845|456813|P3|STARTED|Overall Study||169
195519|NCT00468845|456814|P2|STARTED|Overall Study||170
195520|NCT00468845|456815|P1|STARTED|Overall Study||162
195521|NCT00468819|456952|P3|NOT COMPLETED|Overall Study||2
195522|NCT00468819|456953|P2|NOT COMPLETED|Overall Study||0
195523|NCT00468819|456954|P1|NOT COMPLETED|Overall Study||6
195524|NCT00468819|456952|P3|COMPLETED|Overall Study||46
195525|NCT00468819|456953|P2|COMPLETED|Overall Study||44
195526|NCT00468819|456954|P1|COMPLETED|Overall Study||42
195527|NCT00468819|456952|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
195528|NCT00468819|456953|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
195529|NCT00468819|456954|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
195530|NCT00468819|456952|P3|STARTED|Overall Study|Enrolled participants|48
195531|NCT00468819|456953|P2|STARTED|Overall Study|Enrolled participants|44
195532|NCT00468819|456954|P1|STARTED|Overall Study|Enrolled participants|48
195533|NCT00468728|457034|P2|NOT COMPLETED|Follow-up||31
195534|NCT00468728|457035|P1|NOT COMPLETED|Follow-up||34
195535|NCT00468728|457034|P2|COMPLETED|Follow-up||222
195536|NCT00468728|457035|P1|COMPLETED|Follow-up||222
195537|NCT00468728|457034|P2|STARTED|Follow-up||253
195538|NCT00468728|457035|P1|STARTED|Follow-up||256
195539|NCT00468728|457034|P2|NOT COMPLETED|Treatment||11
195540|NCT00468728|457035|P1|NOT COMPLETED|Treatment||4
195541|NCT00468728|457034|P2|COMPLETED|Treatment||253
195542|NCT00468728|457035|P1|COMPLETED|Treatment||256
195543|NCT00468728|457034|P2|STARTED|Treatment||264
195544|NCT00468728|457035|P1|STARTED|Treatment||260
195545|NCT00468728|457034|P2|NOT COMPLETED|Enrollment||7
195546|NCT00468728|457035|P1|NOT COMPLETED|Enrollment||4
195547|NCT00468728|457034|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
195548|NCT00468728|457035|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
195549|NCT00468728|457034|P2|STARTED|Enrollment||271
195550|NCT00468728|457035|P1|STARTED|Enrollment||264
195551|NCT00468676|457047|P2|NOT COMPLETED|Overall Study||12
195552|NCT00468676|457048|P1|NOT COMPLETED|Overall Study||16
195553|NCT00468676|457047|P2|COMPLETED|Overall Study||94
195554|NCT00468676|457048|P1|COMPLETED|Overall Study||92
195555|NCT00468676|457047|P2|STARTED|Overall Study||106
195556|NCT00468676|457048|P1|STARTED|Overall Study||108
195557|NCT00468650|457065|P1|NOT COMPLETED|Overall Study||7
195558|NCT00468650|457065|P1|COMPLETED|Overall Study||110
195559|NCT00468650|457065|P1|STARTED|Overall Study||117
195560|NCT00468585|457113|P4|NOT COMPLETED|Overall Study||1
195561|NCT00468585|457114|P3|NOT COMPLETED|Overall Study||5
195562|NCT00468585|457115|P2|NOT COMPLETED|Overall Study||0
195563|NCT00468585|457116|P1|NOT COMPLETED|Overall Study||1
195564|NCT00468585|457113|P4|COMPLETED|Overall Study||5
195565|NCT00468585|457114|P3|COMPLETED|Overall Study||45
195566|NCT00468585|457115|P2|COMPLETED|Overall Study||3
195567|NCT00468585|457116|P1|COMPLETED|Overall Study||3
195568|NCT00468585|457113|P4|STARTED|Overall Study||6
195569|NCT00468585|457114|P3|STARTED|Overall Study||50
195570|NCT00468585|457115|P2|STARTED|Overall Study||3
195571|NCT00468585|457116|P1|STARTED|Overall Study||4
195572|NCT00468559|457128|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
195573|NCT00468559|457129|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
195574|NCT00468559|457130|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
195575|NCT00468559|457128|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
195576|NCT00468559|457129|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
195577|NCT00468559|457130|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
195578|NCT00468559|457128|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
195579|NCT00468559|457129|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
195580|NCT00468559|457130|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
195581|NCT00468559|457128|P3|NOT COMPLETED|Open-label Treatment Phase||0
195582|NCT00468559|457129|P2|NOT COMPLETED|Open-label Treatment Phase||0
195583|NCT00468559|457130|P1|NOT COMPLETED|Open-label Treatment Phase||18
195584|NCT00468559|457128|P3|COMPLETED|Open-label Treatment Phase||0
195585|NCT00468559|457129|P2|COMPLETED|Open-label Treatment Phase||0
195586|NCT00468559|457130|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
195587|NCT00468559|457128|P3|STARTED|Open-label Treatment Phase||0
195588|NCT00468559|457129|P2|STARTED|Open-label Treatment Phase||0
195589|NCT00468559|457130|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
195590|NCT00468546|457158|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
195591|NCT00468546|457159|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
195592|NCT00468546|457158|P2|COMPLETED|Week 24 to Week 104 Analysis||83
195593|NCT00468546|457159|P1|COMPLETED|Week 24 to Week 104 Analysis||103
195594|NCT00468546|457158|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
195595|NCT00468546|457159|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
195596|NCT00468546|457158|P2|NOT COMPLETED|Week 24 Analysis||55
195597|NCT00468546|457159|P1|NOT COMPLETED|Week 24 Analysis||97
195598|NCT00468546|457158|P2|COMPLETED|Week 24 Analysis||253
195599|NCT00468546|457159|P1|COMPLETED|Week 24 Analysis||111
195600|NCT00468546|457158|P2|STARTED|Week 24 Analysis||308
195601|NCT00468546|457159|P1|STARTED|Week 24 Analysis||208
195602|NCT00468481|457189|P2|NOT COMPLETED|Overall Study||24
195603|NCT00468481|457190|P1|NOT COMPLETED|Overall Study||88
195604|NCT00468481|457189|P2|COMPLETED|Overall Study||70
195605|NCT00468481|457190|P1|COMPLETED|Overall Study||203
195606|NCT00468481|457189|P2|Subjects Treated|Overall Study||94
195607|NCT00468481|457190|P1|Subjects Treated|Overall Study||285
195608|NCT00468481|457189|P2|STARTED|Overall Study||94
195609|NCT00468481|457190|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
195610|NCT00468143|457288|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
195611|NCT00468143|457289|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
195612|NCT00468143|457288|P2|COMPLETED|Second Intervention (3 Weeks)||24
195613|NCT00468143|457289|P1|COMPLETED|Second Intervention (3 Weeks)||25
195614|NCT00468143|457288|P2|STARTED|Second Intervention (3 Weeks)||27
195615|NCT00468143|457289|P1|STARTED|Second Intervention (3 Weeks)||28
195616|NCT00468143|457288|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
195617|NCT00468143|457289|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
195618|NCT00468143|457288|P2|COMPLETED|First Intervention (3 Weeks)||27
195619|NCT00468143|457289|P1|COMPLETED|First Intervention (3 Weeks)||28
195620|NCT00468143|457288|P2|STARTED|First Intervention (3 Weeks)||31
195621|NCT00468143|457289|P1|STARTED|First Intervention (3 Weeks)||31
195622|NCT00468104|457303|P2|NOT COMPLETED|Second Intervention||4
195623|NCT00468104|457304|P1|NOT COMPLETED|Second Intervention||5
195624|NCT00468104|457303|P2|COMPLETED|Second Intervention||37
195625|NCT00468104|457304|P1|COMPLETED|Second Intervention||3
195626|NCT00468104|457303|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
195627|NCT00468104|457304|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
195628|NCT00468104|457303|P2|NOT COMPLETED|First Intervention||1
195629|NCT00468104|457304|P1|NOT COMPLETED|First Intervention||9
195630|NCT00468104|457303|P2|COMPLETED|First Intervention||45
195631|NCT00468104|457304|P1|COMPLETED|First Intervention||45
195632|NCT00468104|457303|P2|STARTED|First Intervention||46
195633|NCT00468104|457304|P1|STARTED|First Intervention||54
195634|NCT00468052|457321|P2|NOT COMPLETED|Overall Study||8
195635|NCT00468052|457322|P1|NOT COMPLETED|Overall Study||7
195636|NCT00468052|457321|P2|COMPLETED|Overall Study||61
195637|NCT00468052|457322|P1|COMPLETED|Overall Study||61
195638|NCT00468052|457321|P2|Target Enrollment|Overall Study||70
195639|NCT00468052|457322|P1|Target Enrollment|Overall Study||70
195640|NCT00468052|457321|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
195641|NCT00468052|457322|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
195642|NCT00467961|457340|P1|NOT COMPLETED|Overall Study||7
195643|NCT00467961|457340|P1|COMPLETED|Overall Study||24
195644|NCT00467961|457340|P1|STARTED|Overall Study||31
195645|NCT00467896|457344|P1|NOT COMPLETED|Overall Study||51
195646|NCT00467896|457344|P1|COMPLETED|Overall Study||11
195647|NCT00467896|457344|P1|STARTED|Overall Study||62
195648|NCT00467857|457366|P2|NOT COMPLETED|Overall Study||8
195649|NCT00467857|457367|P1|NOT COMPLETED|Overall Study||3
195650|NCT00467857|457366|P2|COMPLETED|Overall Study||139
195651|NCT00467857|457367|P1|COMPLETED|Overall Study||143
195652|NCT00467857|457366|P2|STARTED|Overall Study||147
195653|NCT00467857|457367|P1|STARTED|Overall Study||146
195654|NCT00467844|457402|P3|NOT COMPLETED|Overall Study||14
195655|NCT00467844|457403|P2|NOT COMPLETED|Overall Study||20
195656|NCT00467844|457404|P1|NOT COMPLETED|Overall Study||19
195657|NCT00467844|457402|P3|COMPLETED|Overall Study||38
195658|NCT00467844|457403|P2|COMPLETED|Overall Study||34
195659|NCT00467844|457404|P1|COMPLETED|Overall Study||34
195660|NCT00467844|457402|P3|STARTED|Overall Study||52
195661|NCT00467844|457403|P2|STARTED|Overall Study||54
195662|NCT00467844|457404|P1|STARTED|Overall Study||53
195663|NCT00467831|457415|P1|NOT COMPLETED|Overall Study||3
195664|NCT00467831|457415|P1|COMPLETED|Overall Study||0
195665|NCT00467831|457415|P1|STARTED|Overall Study||3
195666|NCT00467779|457434|P15|NOT COMPLETED|Stage 3||17
195667|NCT00467779|457435|P14|NOT COMPLETED|Stage 3||0
195668|NCT00467779|457436|P13|NOT COMPLETED|Stage 3||0
195669|NCT00467779|457437|P12|NOT COMPLETED|Stage 3||0
195670|NCT00467779|457438|P11|NOT COMPLETED|Stage 3||0
195671|NCT00467779|457439|P10|NOT COMPLETED|Stage 3||0
195672|NCT00467779|457440|P9|NOT COMPLETED|Stage 3||0
195673|NCT00467779|457441|P8|NOT COMPLETED|Stage 3||0
195674|NCT00467779|457442|P7|NOT COMPLETED|Stage 3||0
195675|NCT00467779|457443|P6|NOT COMPLETED|Stage 3||0
195676|NCT00467779|457444|P5|NOT COMPLETED|Stage 3||0
195677|NCT00467779|457445|P4|NOT COMPLETED|Stage 3||0
195678|NCT00467779|457446|P3|NOT COMPLETED|Stage 3||0
195679|NCT00467779|457447|P2|NOT COMPLETED|Stage 3||0
195680|NCT00467779|457448|P1|NOT COMPLETED|Stage 3||0
195681|NCT00467779|457434|P15|COMPLETED|Stage 3||3
195682|NCT00467779|457435|P14|COMPLETED|Stage 3||0
195683|NCT00467779|457436|P13|COMPLETED|Stage 3||0
195684|NCT00467779|457437|P12|COMPLETED|Stage 3||0
195685|NCT00467779|457438|P11|COMPLETED|Stage 3||0
195686|NCT00467779|457439|P10|COMPLETED|Stage 3||0
195687|NCT00467779|457440|P9|COMPLETED|Stage 3||0
195688|NCT00467779|457441|P8|COMPLETED|Stage 3||0
195689|NCT00467779|457442|P7|COMPLETED|Stage 3||0
195690|NCT00467779|457443|P6|COMPLETED|Stage 3||0
195691|NCT00467779|457444|P5|COMPLETED|Stage 3||0
195692|NCT00467779|457445|P4|COMPLETED|Stage 3||0
195693|NCT00467779|457446|P3|COMPLETED|Stage 3||0
195694|NCT00467779|457447|P2|COMPLETED|Stage 3||0
195695|NCT00467779|457448|P1|COMPLETED|Stage 3||0
195696|NCT00467779|457434|P15|STARTED|Stage 3||20
195697|NCT00467779|457435|P14|STARTED|Stage 3||0
195698|NCT00467779|457436|P13|STARTED|Stage 3||0
195699|NCT00467779|457437|P12|STARTED|Stage 3||0
195700|NCT00467779|457438|P11|STARTED|Stage 3||0
195701|NCT00467779|457439|P10|STARTED|Stage 3||0
195702|NCT00467779|457440|P9|STARTED|Stage 3||0
195703|NCT00467779|457441|P8|STARTED|Stage 3||0
195704|NCT00467779|457442|P7|STARTED|Stage 3||0
195705|NCT00467779|457443|P6|STARTED|Stage 3||0
195706|NCT00467779|457444|P5|STARTED|Stage 3||0
195707|NCT00467779|457445|P4|STARTED|Stage 3||0
195708|NCT00467779|457446|P3|STARTED|Stage 3||0
195709|NCT00467779|457447|P2|STARTED|Stage 3||0
195710|NCT00467779|457448|P1|STARTED|Stage 3||0
195711|NCT00467779|457434|P15|NOT COMPLETED|Stage 2A||0
195712|NCT00467779|457435|P14|NOT COMPLETED|Stage 2A||21
195713|NCT00467779|457436|P13|NOT COMPLETED|Stage 2A||0
195714|NCT00467779|457437|P12|NOT COMPLETED|Stage 2A||0
195715|NCT00467779|457438|P11|NOT COMPLETED|Stage 2A||0
195716|NCT00467779|457439|P10|NOT COMPLETED|Stage 2A||0
195717|NCT00467779|457440|P9|NOT COMPLETED|Stage 2A||0
195718|NCT00467779|457441|P8|NOT COMPLETED|Stage 2A||0
195719|NCT00467779|457442|P7|NOT COMPLETED|Stage 2A||0
195720|NCT00467779|457443|P6|NOT COMPLETED|Stage 2A||0
195721|NCT00467779|457444|P5|NOT COMPLETED|Stage 2A||0
195722|NCT00467779|457445|P4|NOT COMPLETED|Stage 2A||0
195723|NCT00467779|457446|P3|NOT COMPLETED|Stage 2A||0
195724|NCT00467779|457447|P2|NOT COMPLETED|Stage 2A||0
195725|NCT00467779|457448|P1|NOT COMPLETED|Stage 2A||0
195726|NCT00467779|457434|P15|COMPLETED|Stage 2A||0
195727|NCT00467779|457435|P14|COMPLETED|Stage 2A||1
195728|NCT00467779|457436|P13|COMPLETED|Stage 2A||0
195729|NCT00467779|457437|P12|COMPLETED|Stage 2A||0
195730|NCT00467779|457438|P11|COMPLETED|Stage 2A||0
195731|NCT00467779|457439|P10|COMPLETED|Stage 2A||0
195732|NCT00467779|457440|P9|COMPLETED|Stage 2A||0
195733|NCT00467779|457441|P8|COMPLETED|Stage 2A||0
195734|NCT00467779|457442|P7|COMPLETED|Stage 2A||0
195735|NCT00467779|457443|P6|COMPLETED|Stage 2A||0
195736|NCT00467779|457444|P5|COMPLETED|Stage 2A||0
195737|NCT00467779|457445|P4|COMPLETED|Stage 2A||0
195738|NCT00467779|457446|P3|COMPLETED|Stage 2A||0
195739|NCT00467779|457447|P2|COMPLETED|Stage 2A||0
195740|NCT00467779|457448|P1|COMPLETED|Stage 2A||0
195741|NCT00467779|457434|P15|STARTED|Stage 2A||0
195742|NCT00467779|457435|P14|STARTED|Stage 2A||22
195743|NCT00467779|457436|P13|STARTED|Stage 2A||0
195744|NCT00467779|457437|P12|STARTED|Stage 2A||0
195745|NCT00467779|457438|P11|STARTED|Stage 2A||0
195746|NCT00467779|457439|P10|STARTED|Stage 2A||0
195747|NCT00467779|457440|P9|STARTED|Stage 2A||0
195748|NCT00467779|457441|P8|STARTED|Stage 2A||0
195749|NCT00467779|457442|P7|STARTED|Stage 2A||0
195750|NCT00467779|457443|P6|STARTED|Stage 2A||0
195751|NCT00467779|457444|P5|STARTED|Stage 2A||0
195752|NCT00467779|457445|P4|STARTED|Stage 2A||0
195753|NCT00467779|457446|P3|STARTED|Stage 2A||0
195754|NCT00467779|457447|P2|STARTED|Stage 2A||0
195755|NCT00467779|457448|P1|STARTED|Stage 2A||0
195756|NCT00467779|457434|P15|NOT COMPLETED|Stage 2||0
195757|NCT00467779|457435|P14|NOT COMPLETED|Stage 2||0
195758|NCT00467779|457436|P13|NOT COMPLETED|Stage 2||0
195759|NCT00467779|457437|P12|NOT COMPLETED|Stage 2||0
195760|NCT00467779|457438|P11|NOT COMPLETED|Stage 2||0
195761|NCT00467779|457439|P10|NOT COMPLETED|Stage 2||0
195762|NCT00467779|457440|P9|NOT COMPLETED|Stage 2||21
195763|NCT00467779|457441|P8|NOT COMPLETED|Stage 2||0
195764|NCT00467779|457442|P7|NOT COMPLETED|Stage 2||0
195765|NCT00467779|457443|P6|NOT COMPLETED|Stage 2||0
195766|NCT00467779|457444|P5|NOT COMPLETED|Stage 2||0
195767|NCT00467779|457445|P4|NOT COMPLETED|Stage 2||0
195768|NCT00467779|457446|P3|NOT COMPLETED|Stage 2||0
195769|NCT00467779|457447|P2|NOT COMPLETED|Stage 2||0
195770|NCT00467779|457448|P1|NOT COMPLETED|Stage 2||0
195771|NCT00467779|457434|P15|COMPLETED|Stage 2||0
195772|NCT00467779|457435|P14|COMPLETED|Stage 2||0
195773|NCT00467779|457436|P13|COMPLETED|Stage 2||0
195774|NCT00467779|457437|P12|COMPLETED|Stage 2||0
195775|NCT00467779|457438|P11|COMPLETED|Stage 2||0
195776|NCT00467779|457439|P10|COMPLETED|Stage 2||0
195777|NCT00467779|457440|P9|COMPLETED|Stage 2||0
195778|NCT00467779|457441|P8|COMPLETED|Stage 2||0
195779|NCT00467779|457442|P7|COMPLETED|Stage 2||0
195780|NCT00467779|457443|P6|COMPLETED|Stage 2||0
195781|NCT00467779|457444|P5|COMPLETED|Stage 2||0
195782|NCT00467779|457445|P4|COMPLETED|Stage 2||0
195783|NCT00467779|457446|P3|COMPLETED|Stage 2||0
195784|NCT00467779|457447|P2|COMPLETED|Stage 2||0
195785|NCT00467779|457448|P1|COMPLETED|Stage 2||0
195786|NCT00467779|457434|P15|STARTED|Stage 2||0
195787|NCT00467779|457435|P14|STARTED|Stage 2||0
195788|NCT00467779|457436|P13|STARTED|Stage 2||0
195789|NCT00467779|457437|P12|STARTED|Stage 2||0
195790|NCT00467779|457438|P11|STARTED|Stage 2||0
195791|NCT00467779|457439|P10|STARTED|Stage 2||0
195792|NCT00467779|457440|P9|STARTED|Stage 2||21
195793|NCT00467779|457441|P8|STARTED|Stage 2||0
195794|NCT00467779|457442|P7|STARTED|Stage 2||0
195795|NCT00467779|457443|P6|STARTED|Stage 2||0
195796|NCT00467779|457444|P5|STARTED|Stage 2||0
195797|NCT00467779|457445|P4|STARTED|Stage 2||0
195798|NCT00467779|457446|P3|STARTED|Stage 2||0
195799|NCT00467779|457447|P2|STARTED|Stage 2||0
195800|NCT00467779|457448|P1|STARTED|Stage 2||0
195801|NCT00467779|457434|P15|NOT COMPLETED|Stage 1A||0
195802|NCT00467779|457435|P14|NOT COMPLETED|Stage 1A||0
195803|NCT00467779|457436|P13|NOT COMPLETED|Stage 1A||6
195804|NCT00467779|457437|P12|NOT COMPLETED|Stage 1A||8
195805|NCT00467779|457438|P11|NOT COMPLETED|Stage 1A||3
195806|NCT00467779|457439|P10|NOT COMPLETED|Stage 1A||3
195807|NCT00467779|457440|P9|NOT COMPLETED|Stage 1A||0
195808|NCT00467779|457441|P8|NOT COMPLETED|Stage 1A||0
195809|NCT00467779|457442|P7|NOT COMPLETED|Stage 1A||0
195810|NCT00467779|457443|P6|NOT COMPLETED|Stage 1A||0
195811|NCT00467779|457444|P5|NOT COMPLETED|Stage 1A||0
195812|NCT00467779|457445|P4|NOT COMPLETED|Stage 1A||0
195813|NCT00467779|457446|P3|NOT COMPLETED|Stage 1A||0
195814|NCT00467779|457447|P2|NOT COMPLETED|Stage 1A||0
195815|NCT00467779|457448|P1|NOT COMPLETED|Stage 1A||0
195816|NCT00467779|457434|P15|COMPLETED|Stage 1A||0
195817|NCT00467779|457435|P14|COMPLETED|Stage 1A||0
195818|NCT00467779|457436|P13|COMPLETED|Stage 1A||0
195819|NCT00467779|457437|P12|COMPLETED|Stage 1A||0
195820|NCT00467779|457438|P11|COMPLETED|Stage 1A||0
195821|NCT00467779|457439|P10|COMPLETED|Stage 1A||0
195822|NCT00467779|457440|P9|COMPLETED|Stage 1A||0
195823|NCT00467779|457441|P8|COMPLETED|Stage 1A||0
195824|NCT00467779|457442|P7|COMPLETED|Stage 1A||0
195825|NCT00467779|457443|P6|COMPLETED|Stage 1A||0
195826|NCT00467779|457444|P5|COMPLETED|Stage 1A||0
195827|NCT00467779|457445|P4|COMPLETED|Stage 1A||0
195828|NCT00467779|457446|P3|COMPLETED|Stage 1A||0
195829|NCT00467779|457447|P2|COMPLETED|Stage 1A||0
195830|NCT00467779|457448|P1|COMPLETED|Stage 1A||0
195831|NCT00467779|457434|P15|STARTED|Stage 1A||0
195832|NCT00467779|457435|P14|STARTED|Stage 1A||0
195833|NCT00467779|457436|P13|STARTED|Stage 1A||6
195834|NCT00467779|457437|P12|STARTED|Stage 1A||8
195835|NCT00467779|457438|P11|STARTED|Stage 1A||3
195836|NCT00467779|457439|P10|STARTED|Stage 1A||3
195837|NCT00467779|457440|P9|STARTED|Stage 1A||0
195838|NCT00467779|457441|P8|STARTED|Stage 1A||0
195839|NCT00467779|457442|P7|STARTED|Stage 1A||0
195840|NCT00467779|457443|P6|STARTED|Stage 1A||0
195841|NCT00467779|457444|P5|STARTED|Stage 1A||0
195842|NCT00467779|457445|P4|STARTED|Stage 1A||0
195843|NCT00467779|457446|P3|STARTED|Stage 1A||0
195844|NCT00467779|457447|P2|STARTED|Stage 1A||0
195845|NCT00467779|457448|P1|STARTED|Stage 1A||0
195846|NCT00467779|457434|P15|NOT COMPLETED|Stage 1||0
195847|NCT00467779|457435|P14|NOT COMPLETED|Stage 1||0
195848|NCT00467779|457436|P13|NOT COMPLETED|Stage 1||0
195849|NCT00467779|457437|P12|NOT COMPLETED|Stage 1||0
195850|NCT00467779|457438|P11|NOT COMPLETED|Stage 1||0
195851|NCT00467779|457439|P10|NOT COMPLETED|Stage 1||0
195852|NCT00467779|457440|P9|NOT COMPLETED|Stage 1||0
195853|NCT00467779|457441|P8|NOT COMPLETED|Stage 1||7
195854|NCT00467779|457442|P7|NOT COMPLETED|Stage 1||7
195855|NCT00467779|457443|P6|NOT COMPLETED|Stage 1||5
195856|NCT00467779|457444|P5|NOT COMPLETED|Stage 1||3
195857|NCT00467779|457445|P4|NOT COMPLETED|Stage 1||3
195858|NCT00467779|457446|P3|NOT COMPLETED|Stage 1||3
195859|NCT00467779|457447|P2|NOT COMPLETED|Stage 1||3
195860|NCT00467779|457448|P1|NOT COMPLETED|Stage 1||4
195861|NCT00467779|457434|P15|COMPLETED|Stage 1||0
195862|NCT00467779|457435|P14|COMPLETED|Stage 1||0
195863|NCT00467779|457436|P13|COMPLETED|Stage 1||0
195864|NCT00467779|457437|P12|COMPLETED|Stage 1||0
195865|NCT00467779|457438|P11|COMPLETED|Stage 1||0
195866|NCT00467779|457439|P10|COMPLETED|Stage 1||0
195867|NCT00467779|457440|P9|COMPLETED|Stage 1||0
195868|NCT00467779|457441|P8|COMPLETED|Stage 1||0
195869|NCT00467779|457442|P7|COMPLETED|Stage 1||0
195870|NCT00467779|457443|P6|COMPLETED|Stage 1||1
195871|NCT00467779|457444|P5|COMPLETED|Stage 1||0
195872|NCT00467779|457445|P4|COMPLETED|Stage 1||0
195873|NCT00467779|457446|P3|COMPLETED|Stage 1||0
195874|NCT00467779|457447|P2|COMPLETED|Stage 1||0
195875|NCT00467779|457448|P1|COMPLETED|Stage 1||0
195876|NCT00467779|457434|P15|STARTED|Stage 1||0
195877|NCT00467779|457435|P14|STARTED|Stage 1||0
195878|NCT00467779|457436|P13|STARTED|Stage 1||0
195879|NCT00467779|457437|P12|STARTED|Stage 1||0
195880|NCT00467779|457438|P11|STARTED|Stage 1||0
195881|NCT00467779|457439|P10|STARTED|Stage 1||0
195882|NCT00467779|457440|P9|STARTED|Stage 1||0
195883|NCT00467779|457441|P8|STARTED|Stage 1||7
195884|NCT00467779|457442|P7|STARTED|Stage 1||7
195885|NCT00467779|457443|P6|STARTED|Stage 1||6
195886|NCT00467779|457444|P5|STARTED|Stage 1||3
195887|NCT00467779|457445|P4|STARTED|Stage 1||3
195888|NCT00467779|457446|P3|STARTED|Stage 1||3
195889|NCT00467779|457447|P2|STARTED|Stage 1||3
195890|NCT00467779|457448|P1|STARTED|Stage 1||4
195891|NCT00467753|457622|P2|NOT COMPLETED|Overall Study||2
195892|NCT00467753|457623|P1|NOT COMPLETED|Overall Study||3
195893|NCT00467753|457622|P2|COMPLETED|Overall Study||0
195894|NCT00467753|457623|P1|COMPLETED|Overall Study||0
195895|NCT00467753|457622|P2|STARTED|Overall Study||2
195896|NCT00467753|457623|P1|STARTED|Overall Study||3
195897|NCT00467740|457634|P5|NOT COMPLETED|Overall Study||0
195898|NCT00467740|457635|P4|NOT COMPLETED|Overall Study||1
195899|NCT00467740|457636|P3|NOT COMPLETED|Overall Study||2
195900|NCT00467740|457637|P2|NOT COMPLETED|Overall Study||3
195901|NCT00467740|457638|P1|NOT COMPLETED|Overall Study||1
195902|NCT00467740|457634|P5|COMPLETED|Overall Study||61
195903|NCT00467740|457635|P4|COMPLETED|Overall Study||59
195904|NCT00467740|457636|P3|COMPLETED|Overall Study||58
195905|NCT00467740|457637|P2|COMPLETED|Overall Study||58
195906|NCT00467740|457638|P1|COMPLETED|Overall Study||53
195907|NCT00467740|457634|P5|STARTED|Overall Study||61
195908|NCT00467740|457635|P4|STARTED|Overall Study||60
195909|NCT00467740|457636|P3|STARTED|Overall Study||60
195910|NCT00467740|457637|P2|STARTED|Overall Study||61
195911|NCT00467740|457638|P1|STARTED|Overall Study||54
195912|NCT00467649|457827|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
195913|NCT00467649|457828|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195914|NCT00467649|457829|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
195915|NCT00467649|457830|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195916|NCT00467649|457831|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195917|NCT00467649|457832|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195918|NCT00467649|457827|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
195919|NCT00467649|457828|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
195920|NCT00467649|457829|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
195921|NCT00467649|457830|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
195922|NCT00467649|457831|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195923|NCT00467649|457832|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
195924|NCT00467649|457827|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
195925|NCT00467649|457828|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
195926|NCT00467649|457829|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
195927|NCT00467649|457830|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
195928|NCT00467649|457831|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
195929|NCT00467649|457832|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
195930|NCT00467649|457827|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
195931|NCT00467649|457828|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
195932|NCT00467649|457829|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
195933|NCT00467649|457830|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
195934|NCT00467649|457831|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
195935|NCT00467649|457832|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
195936|NCT00467649|457827|P6|COMPLETED|Phase 1 (Randomized Population)||0
195937|NCT00467649|457828|P5|COMPLETED|Phase 1 (Randomized Population)||0
195938|NCT00467649|457829|P4|COMPLETED|Phase 1 (Randomized Population)||0
195939|NCT00467649|457830|P3|COMPLETED|Phase 1 (Randomized Population)||0
195940|NCT00467649|457831|P2|COMPLETED|Phase 1 (Randomized Population)||50
195941|NCT00467649|457832|P1|COMPLETED|Phase 1 (Randomized Population)||48
195942|NCT00467649|457827|P6|Intent to Treat|Phase 1 (Randomized Population)||0
195943|NCT00467649|457828|P5|Intent to Treat|Phase 1 (Randomized Population)||0
195944|NCT00467649|457829|P4|Intent to Treat|Phase 1 (Randomized Population)||0
195945|NCT00467649|457830|P3|Intent to Treat|Phase 1 (Randomized Population)||0
195946|NCT00467649|457831|P2|Intent to Treat|Phase 1 (Randomized Population)||56
195947|NCT00467649|457832|P1|Intent to Treat|Phase 1 (Randomized Population)||56
195948|NCT00467649|457827|P6|STARTED|Phase 1 (Randomized Population)||0
195949|NCT00467649|457828|P5|STARTED|Phase 1 (Randomized Population)||0
195950|NCT00467649|457829|P4|STARTED|Phase 1 (Randomized Population)||0
195951|NCT00467649|457830|P3|STARTED|Phase 1 (Randomized Population)||0
195952|NCT00467649|457831|P2|STARTED|Phase 1 (Randomized Population)||56
195953|NCT00467649|457832|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
195954|NCT00467610|457872|P1|NOT COMPLETED|Overall Study||1
195955|NCT00467610|457872|P1|COMPLETED|Overall Study||5
195956|NCT00467610|457872|P1|STARTED|Overall Study||6
195957|NCT00467597|457883|P2|NOT COMPLETED|Overall Study||0
195958|NCT00467597|457884|P1|NOT COMPLETED|Overall Study||2
195959|NCT00467597|457883|P2|COMPLETED|Overall Study||6
195960|NCT00467597|457884|P1|COMPLETED|Overall Study||24
195961|NCT00467597|457883|P2|STARTED|Overall Study||6
195962|NCT00467597|457884|P1|STARTED|Overall Study||26
195963|NCT00467584|457897|P3|NOT COMPLETED|Overall Study||1
195964|NCT00467584|457898|P2|NOT COMPLETED|Overall Study||5
195965|NCT00467584|457899|P1|NOT COMPLETED|Overall Study||4
195966|NCT00467584|457897|P3|COMPLETED|Overall Study||20
195967|NCT00467584|457898|P2|COMPLETED|Overall Study||15
195968|NCT00467584|457899|P1|COMPLETED|Overall Study||17
195969|NCT00467584|457897|P3|STARTED|Overall Study||21
195970|NCT00467584|457898|P2|STARTED|Overall Study||20
195971|NCT00467584|457899|P1|STARTED|Overall Study||21
195972|NCT00467558|457909|P2|NOT COMPLETED|Overall Study||0
195973|NCT00467558|457910|P1|NOT COMPLETED|Overall Study||2
195974|NCT00467558|457909|P2|COMPLETED|Overall Study||3
195975|NCT00467558|457910|P1|COMPLETED|Overall Study||2
195976|NCT00467558|457909|P2|STARTED|Overall Study||3
195977|NCT00467558|457910|P1|STARTED|Overall Study||4
195978|NCT00467519|457920|P2|NOT COMPLETED|Overall Study||23
195979|NCT00467519|457921|P1|NOT COMPLETED|Overall Study||14
195980|NCT00467519|457920|P2|COMPLETED|Overall Study||488
195981|NCT00467519|457921|P1|COMPLETED|Overall Study||517
195982|NCT00467519|457920|P2|STARTED|Overall Study||511
195983|NCT00467519|457921|P1|STARTED|Overall Study||531
195984|NCT00467389|457937|P2|NOT COMPLETED|Overall Study||0
195985|NCT00467389|457938|P1|NOT COMPLETED|Overall Study||0
195986|NCT00467389|457937|P2|COMPLETED|Overall Study||6
195987|NCT00467389|457938|P1|COMPLETED|Overall Study||6
195988|NCT00467389|457937|P2|STARTED|Overall Study||6
195989|NCT00467389|457938|P1|STARTED|Overall Study||6
195990|NCT00467363|457950|P2|NOT COMPLETED|Overall Study||70
195991|NCT00467363|457951|P1|NOT COMPLETED|Overall Study||80
195992|NCT00467363|457950|P2|COMPLETED|Overall Study||543
195993|NCT00467363|457951|P1|COMPLETED|Overall Study||535
195994|NCT00467363|457950|P2|STARTED|Overall Study||613
195995|NCT00467363|457951|P1|STARTED|Overall Study||615
195996|NCT00467285|457987|P2|NOT COMPLETED|Overall Study||4
195997|NCT00467285|457988|P1|NOT COMPLETED|Overall Study||4
195998|NCT00467285|457987|P2|COMPLETED|Overall Study||60
195999|NCT00467285|457988|P1|COMPLETED|Overall Study||28
196000|NCT00467285|457987|P2|STARTED|Overall Study||64
196001|NCT00467285|457988|P1|STARTED|Overall Study||32
196002|NCT00467259|458008|P2|NOT COMPLETED|Overall Study||242
196003|NCT00467259|458009|P1|NOT COMPLETED|Overall Study||75
196004|NCT00467259|458008|P2|COMPLETED|Overall Study||778
196005|NCT00467259|458009|P1|COMPLETED|Overall Study||176
196006|NCT00467259|458008|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
196007|NCT00467259|458009|P1|ITT Population|Overall Study||251
196008|NCT00467259|458008|P2|STARTED|Overall Study||1020
196009|NCT00467259|458009|P1|STARTED|Overall Study||251
196010|NCT00467051|458019|P1|NOT COMPLETED|Overall Study||2
196011|NCT00467051|458019|P1|COMPLETED|Overall Study||18
196012|NCT00467051|458019|P1|STARTED|Overall Study||20
196013|NCT00467038|458025|P2|NOT COMPLETED|Overall Study||0
196014|NCT00467038|458026|P1|NOT COMPLETED|Overall Study||0
196015|NCT00467038|458025|P2|COMPLETED|Overall Study||11
196016|NCT00467038|458026|P1|COMPLETED|Overall Study||11
196017|NCT00467038|458025|P2|STARTED|Overall Study||11
196018|NCT00467038|458026|P1|STARTED|Overall Study||11
196019|NCT00466947|458036|P2|NOT COMPLETED|Study End Analysis Period||2534
196020|NCT00466947|458037|P1|NOT COMPLETED|Study End Analysis Period||2496
196021|NCT00466947|458036|P2|COMPLETED|Study End Analysis Period||9265
196022|NCT00466947|458037|P1|COMPLETED|Study End Analysis Period||9302
196023|NCT00466947|458036|P2|STARTED|Study End Analysis Period||11799
196024|NCT00466947|458037|P1|STARTED|Study End Analysis Period||11798
196025|NCT00466947|458036|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
196026|NCT00466947|458037|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
196027|NCT00466947|458036|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
196028|NCT00466947|458037|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
196029|NCT00466947|458036|P2|Ongoing|Primary Outcome Analysis Period||11863
196030|NCT00466947|458037|P1|Ongoing|Primary Outcome Analysis Period||11875
196031|NCT00466947|458036|P2|STARTED|Primary Outcome Analysis Period||11863
196032|NCT00466947|458037|P1|STARTED|Primary Outcome Analysis Period||11875
196033|NCT00466882|458159|P1|NOT COMPLETED|Overall Study||0
196034|NCT00466882|458159|P1|COMPLETED|Overall Study||3
196035|NCT00466882|458159|P1|STARTED|Overall Study||3
196036|NCT00466817|458165|P2|NOT COMPLETED|Overall Study||4
196037|NCT00466817|458166|P1|NOT COMPLETED|Overall Study||5
196038|NCT00466817|458165|P2|COMPLETED|Overall Study||43
196039|NCT00466817|458166|P1|COMPLETED|Overall Study||44
196040|NCT00466817|458165|P2|STARTED|Overall Study||47
196041|NCT00466817|458166|P1|STARTED|Overall Study||49
196042|NCT00466687|458219|P1|NOT COMPLETED|Overall Study||34
196043|NCT00466687|458219|P1|COMPLETED|Overall Study||0
196044|NCT00466687|458219|P1|STARTED|Overall Study||34
196045|NCT00466505|458226|P1|NOT COMPLETED|Overall Study||17
196046|NCT00466505|458226|P1|COMPLETED|Overall Study||0
196047|NCT00466505|458226|P1|STARTED|Overall Study||17
196048|NCT00466323|458240|P2|NOT COMPLETED|Overall Study||23
196049|NCT00466323|458241|P1|NOT COMPLETED|Overall Study||28
196050|NCT00466323|458240|P2|COMPLETED|Overall Study||92
196051|NCT00466323|458241|P1|COMPLETED|Overall Study||89
196052|NCT00466323|458240|P2|STARTED|Overall Study||115
196053|NCT00466323|458241|P1|STARTED|Overall Study||117
196054|NCT00466310|458256|P3|NOT COMPLETED|Overall Study||0
196055|NCT00466310|458257|P2|NOT COMPLETED|Overall Study||0
196056|NCT00466310|458258|P1|NOT COMPLETED|Overall Study||0
196057|NCT00466310|458256|P3|COMPLETED|Overall Study||31
196058|NCT00466310|458257|P2|COMPLETED|Overall Study||20
196059|NCT00466310|458258|P1|COMPLETED|Overall Study||20
196060|NCT00466310|458256|P3|STARTED|Overall Study||31
196061|NCT00466310|458257|P2|STARTED|Overall Study||20
196062|NCT00466310|458258|P1|STARTED|Overall Study||20
196063|NCT00466206|458266|P1|NOT COMPLETED|Overall Study||0
196064|NCT00466206|458266|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
196065|NCT00466206|458266|P1|STARTED|Overall Study||10
196066|NCT00466193|458276|P2|NOT COMPLETED|Overall Study||8
196067|NCT00466193|458277|P1|NOT COMPLETED|Overall Study||12
196068|NCT00466193|458276|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
196069|NCT00466193|458277|P1|COMPLETED|Overall Study||138
196070|NCT00466193|458276|P2|STARTED|Overall Study||145
196071|NCT00466193|458277|P1|STARTED|Overall Study||150
196072|NCT00466167|458304|P3|NOT COMPLETED|Overall Study||21
196073|NCT00466167|458305|P2|NOT COMPLETED|Overall Study||12
196074|NCT00466167|458306|P1|NOT COMPLETED|Overall Study||20
196075|NCT00466167|458304|P3|COMPLETED|Overall Study||157
196076|NCT00466167|458305|P2|COMPLETED|Overall Study||163
196077|NCT00466167|458306|P1|COMPLETED|Overall Study||145
196078|NCT00466167|458304|P3|STARTED|Overall Study||178
196079|NCT00466167|458305|P2|STARTED|Overall Study||175
196080|NCT00466167|458306|P1|STARTED|Overall Study||165
196081|NCT00465998|458362|P1|NOT COMPLETED|Overall Study||0
196082|NCT00465998|458362|P1|COMPLETED|Overall Study||275
196083|NCT00465998|458362|P1|STARTED|Overall Study||275
196084|NCT00465985|458367|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
196085|NCT00465985|458368|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
196086|NCT00465985|458367|P2|COMPLETED|Part III - Open-label Treatment Period||0
196087|NCT00465985|458368|P1|COMPLETED|Part III - Open-label Treatment Period||29
196088|NCT00465985|458367|P2|STARTED|Part III - Open-label Treatment Period||0
196089|NCT00465985|458368|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
196090|NCT00465985|458367|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
196091|NCT00465985|458368|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
196092|NCT00465985|458367|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
196093|NCT00465985|458368|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
196094|NCT00465985|458367|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
196095|NCT00465985|458368|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
196096|NCT00465985|458367|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
196097|NCT00465985|458368|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
196098|NCT00465985|458367|P2|COMPLETED|Part I - Open-label Treatment Period||0
196191|NCT00464737|458744|P1|NOT COMPLETED|Overall Study||32
196099|NCT00465985|458368|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
196100|NCT00465985|458367|P2|STARTED|Part I - Open-label Treatment Period||0
196101|NCT00465985|458368|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
196102|NCT00465972|458391|P2|NOT COMPLETED|Overall Study||1
196103|NCT00465972|458392|P1|NOT COMPLETED|Overall Study||2
196104|NCT00465972|458391|P2|COMPLETED|Overall Study||23
196105|NCT00465972|458392|P1|COMPLETED|Overall Study||18
196106|NCT00465972|458391|P2|STARTED|Overall Study||24
196107|NCT00465972|458392|P1|STARTED|Overall Study||20
196108|NCT00465894|458402|P2|NOT COMPLETED|Overall Study||3
196109|NCT00465894|458403|P1|NOT COMPLETED|Overall Study||5
196110|NCT00465894|458402|P2|COMPLETED|Overall Study||25
196111|NCT00465894|458403|P1|COMPLETED|Overall Study||25
196112|NCT00465894|458402|P2|STARTED|Overall Study||28
196113|NCT00465894|458403|P1|STARTED|Overall Study||30
196114|NCT00465816|458412|P3|NOT COMPLETED|Overall Study||2
196115|NCT00465816|458413|P2|NOT COMPLETED|Overall Study||0
196116|NCT00465816|458414|P1|NOT COMPLETED|Overall Study||0
196117|NCT00465816|458412|P3|COMPLETED|Overall Study||120
196118|NCT00465816|458413|P2|COMPLETED|Overall Study||122
196119|NCT00465816|458414|P1|COMPLETED|Overall Study||367
196120|NCT00465816|458412|P3|STARTED|Overall Study||122
196121|NCT00465816|458413|P2|STARTED|Overall Study||122
196122|NCT00465816|458414|P1|STARTED|Overall Study||367
196123|NCT00465738|458496|P2|NOT COMPLETED|Overall Study||6
196124|NCT00465738|458497|P1|NOT COMPLETED|Overall Study||6
196125|NCT00465738|458496|P2|COMPLETED|Overall Study||89
196126|NCT00465738|458497|P1|COMPLETED|Overall Study||91
196127|NCT00465738|458496|P2|STARTED|Overall Study||95
196128|NCT00465738|458497|P1|STARTED|Overall Study||97
196129|NCT00465647|458591|P4|NOT COMPLETED|Overall Study||13
196130|NCT00465647|458592|P3|NOT COMPLETED|Overall Study||11
196131|NCT00465647|458593|P2|NOT COMPLETED|Overall Study||8
196132|NCT00465647|458594|P1|NOT COMPLETED|Overall Study||13
196133|NCT00465647|458591|P4|COMPLETED|Overall Study||12
196134|NCT00465647|458592|P3|COMPLETED|Overall Study||18
196135|NCT00465647|458593|P2|COMPLETED|Overall Study||15
196136|NCT00465647|458594|P1|COMPLETED|Overall Study||26
196137|NCT00465647|458591|P4|STARTED|Overall Study||25
196138|NCT00465647|458592|P3|STARTED|Overall Study||29
196139|NCT00465647|458593|P2|STARTED|Overall Study||23
196140|NCT00465647|458594|P1|STARTED|Overall Study||39
196141|NCT00465530|458619|P2|NOT COMPLETED|Overall Study||4
196142|NCT00465530|458620|P1|NOT COMPLETED|Overall Study||2
196143|NCT00465530|458619|P2|COMPLETED|Overall Study||15
196144|NCT00465530|458620|P1|COMPLETED|Overall Study||19
196145|NCT00465530|458619|P2|STARTED|Overall Study||19
196146|NCT00465530|458620|P1|STARTED|Overall Study||21
196147|NCT00465361|458630|P1|NOT COMPLETED|Post-Intervention Assessment||0
196148|NCT00465361|458630|P1|COMPLETED|Post-Intervention Assessment||3
196149|NCT00465361|458630|P1|STARTED|Post-Intervention Assessment||3
196150|NCT00465361|458630|P1|NOT COMPLETED|Baseline Assessment||4
196151|NCT00465361|458630|P1|COMPLETED|Baseline Assessment||3
196152|NCT00465361|458630|P1|STARTED|Baseline Assessment||7
196153|NCT00465179|458634|P1|NOT COMPLETED|Overall Study||53
196154|NCT00465179|458634|P1|COMPLETED|Overall Study||4
196155|NCT00465179|458634|P1|STARTED|Overall Study||57
196156|NCT00465101|458640|P1|NOT COMPLETED|Overall Study||59
196157|NCT00465101|458640|P1|COMPLETED|Overall Study||91
196158|NCT00465101|458640|P1|STARTED|Overall Study||150
196159|NCT00465088|458675|P2|NOT COMPLETED|Overall Study||9
196160|NCT00465088|458676|P1|NOT COMPLETED|Overall Study||32
196161|NCT00465088|458675|P2|COMPLETED|Overall Study||70
196162|NCT00465088|458676|P1|COMPLETED|Overall Study||82
196163|NCT00465088|458675|P2|STARTED|Overall Study||79
196164|NCT00465088|458676|P1|STARTED|Overall Study|For both arms, started means treated.|114
196165|NCT00464945|458710|P2|NOT COMPLETED|Toddler Dose||1
196166|NCT00464945|458711|P1|NOT COMPLETED|Toddler Dose||0
196167|NCT00464945|458710|P2|COMPLETED|Toddler Dose||130
196168|NCT00464945|458711|P1|COMPLETED|Toddler Dose||131
196169|NCT00464945|458710|P2|STARTED|Toddler Dose||131
196170|NCT00464945|458711|P1|STARTED|Toddler Dose||131
196171|NCT00464945|458710|P2|NOT COMPLETED|After Infant Series||2
196172|NCT00464945|458711|P1|NOT COMPLETED|After Infant Series||0
196173|NCT00464945|458710|P2|COMPLETED|After Infant Series||131
196174|NCT00464945|458711|P1|COMPLETED|After Infant Series||131
196175|NCT00464945|458710|P2|STARTED|After Infant Series||133
196176|NCT00464945|458711|P1|STARTED|After Infant Series||131
196177|NCT00464945|458710|P2|NOT COMPLETED|Infant Series||1
196178|NCT00464945|458711|P1|NOT COMPLETED|Infant Series||4
196179|NCT00464945|458710|P2|COMPLETED|Infant Series||133
196180|NCT00464945|458711|P1|COMPLETED|Infant Series||131
196181|NCT00464945|458710|P2|Vaccinated Dose 3|Infant Series||133
196182|NCT00464945|458711|P1|Vaccinated Dose 3|Infant Series||132
196183|NCT00464945|458710|P2|Vaccinated Dose 2|Infant Series||133
196184|NCT00464945|458711|P1|Vaccinated Dose 2|Infant Series||132
196185|NCT00464945|458710|P2|Vaccinated Dose 1|Infant Series||134
196186|NCT00464945|458711|P1|Vaccinated Dose 1|Infant Series||134
196187|NCT00464945|458710|P2|STARTED|Infant Series||134
196188|NCT00464945|458711|P1|STARTED|Infant Series||135
196189|NCT00464737|458742|P3|NOT COMPLETED|Overall Study||55
196190|NCT00464737|458743|P2|NOT COMPLETED|Overall Study||32
196192|NCT00464737|458742|P3|COMPLETED|Overall Study||19
196193|NCT00464737|458743|P2|COMPLETED|Overall Study||42
196194|NCT00464737|458744|P1|COMPLETED|Overall Study||50
196195|NCT00464737|458742|P3|STARTED|Overall Study||74
196196|NCT00464737|458743|P2|STARTED|Overall Study||74
196197|NCT00464737|458744|P1|STARTED|Overall Study||82
196198|NCT00464711|458791|P1|NOT COMPLETED|Overall Study||15
196199|NCT00464711|458791|P1|COMPLETED|Overall Study||25
196200|NCT00464711|458791|P1|STARTED|Overall Study||40
196201|NCT00464685|458797|P2|NOT COMPLETED|Overall Study||33
196202|NCT00464685|458798|P1|NOT COMPLETED|Overall Study||23
196203|NCT00464685|458797|P2|COMPLETED|Overall Study||94
196204|NCT00464685|458798|P1|COMPLETED|Overall Study||103
196205|NCT00464685|458797|P2|STARTED|Overall Study||127
196206|NCT00464685|458798|P1|STARTED|Overall Study||126
196207|NCT00464672|458814|P6|NOT COMPLETED|Overall Study||4
196208|NCT00464672|458815|P5|NOT COMPLETED|Overall Study||10
196209|NCT00464672|458816|P4|NOT COMPLETED|Overall Study||1
196210|NCT00464672|458817|P3|NOT COMPLETED|Overall Study||0
196211|NCT00464672|458818|P2|NOT COMPLETED|Overall Study||10
196212|NCT00464672|458819|P1|NOT COMPLETED|Overall Study||25
196213|NCT00464672|458814|P6|COMPLETED|Overall Study||195
196214|NCT00464672|458815|P5|COMPLETED|Overall Study||392
196215|NCT00464672|458816|P4|COMPLETED|Overall Study||199
196216|NCT00464672|458817|P3|COMPLETED|Overall Study||400
196217|NCT00464672|458818|P2|COMPLETED|Overall Study||222
196218|NCT00464672|458819|P1|COMPLETED|Overall Study||435
196219|NCT00464672|458814|P6|STARTED|Overall Study||199
196220|NCT00464672|458815|P5|STARTED|Overall Study||402
196221|NCT00464672|458816|P4|STARTED|Overall Study||200
196222|NCT00464672|458817|P3|STARTED|Overall Study||400
196223|NCT00464672|458818|P2|STARTED|Overall Study||232
196224|NCT00464672|458819|P1|STARTED|Overall Study||460
196225|NCT00464646|458891|P2|NOT COMPLETED|Overall Study||0
196226|NCT00464646|458892|P1|NOT COMPLETED|Overall Study||0
196227|NCT00464646|458891|P2|COMPLETED|Overall Study||29
196228|NCT00464646|458892|P1|COMPLETED|Overall Study||76
196229|NCT00464646|458891|P2|STARTED|Overall Study||29
196230|NCT00464646|458892|P1|STARTED|Overall Study||76
196231|NCT00464542|458898|P1|NOT COMPLETED|Post-treatment||0
196232|NCT00464542|458898|P1|COMPLETED|Post-treatment||10
196233|NCT00464542|458898|P1|STARTED|Post-treatment||10
196234|NCT00464542|458898|P1|NOT COMPLETED|Pre-treatment||2
196235|NCT00464542|458898|P1|COMPLETED|Pre-treatment||10
196236|NCT00464542|458898|P1|STARTED|Pre-treatment||12
196237|NCT00464490|458905|P2|NOT COMPLETED|Overall Study||11
196238|NCT00464490|458906|P1|NOT COMPLETED|Overall Study||11
196239|NCT00464490|458905|P2|COMPLETED|Overall Study||10
196240|NCT00464490|458906|P1|COMPLETED|Overall Study||10
196241|NCT00464490|458905|P2|STARTED|Overall Study||21
196242|NCT00464490|458906|P1|STARTED|Overall Study||21
196243|NCT00464464|458914|P2|NOT COMPLETED|Overall Study||3
196244|NCT00464464|458915|P1|NOT COMPLETED|Overall Study||5
196245|NCT00464464|458914|P2|COMPLETED|Overall Study||36
196246|NCT00464464|458915|P1|COMPLETED|Overall Study||36
196247|NCT00464464|458914|P2|STARTED|Overall Study||39
196248|NCT00464464|458915|P1|STARTED|Overall Study||41
196249|NCT00464438|458929|P2|NOT COMPLETED|Overall Study||6
196250|NCT00464438|458930|P1|NOT COMPLETED|Overall Study||2
196251|NCT00464438|458929|P2|COMPLETED|Overall Study||80
196252|NCT00464438|458930|P1|COMPLETED|Overall Study||83
196253|NCT00464438|458929|P2|STARTED|Overall Study||86
196254|NCT00464438|458930|P1|STARTED|Overall Study||85
196255|NCT00464334|458953|P11|NOT COMPLETED|Overall Study||4
196256|NCT00464334|458954|P10|NOT COMPLETED|Overall Study||1
196257|NCT00464334|458955|P9|NOT COMPLETED|Overall Study||6
196258|NCT00464334|458956|P8|NOT COMPLETED|Overall Study||1
196259|NCT00464334|458957|P7|NOT COMPLETED|Overall Study||3
196260|NCT00464334|458958|P6|NOT COMPLETED|Overall Study||4
196261|NCT00464334|458959|P5|NOT COMPLETED|Overall Study||4
196262|NCT00464334|458960|P4|NOT COMPLETED|Overall Study||4
196263|NCT00464334|458961|P3|NOT COMPLETED|Overall Study||5
196264|NCT00464334|458962|P2|NOT COMPLETED|Overall Study||8
196265|NCT00464334|458963|P1|NOT COMPLETED|Overall Study||1
196266|NCT00464334|458953|P11|COMPLETED|Overall Study||4
196267|NCT00464334|458954|P10|COMPLETED|Overall Study||4
196268|NCT00464334|458955|P9|COMPLETED|Overall Study||2
196269|NCT00464334|458956|P8|COMPLETED|Overall Study||7
196270|NCT00464334|458957|P7|COMPLETED|Overall Study||6
196271|NCT00464334|458958|P6|COMPLETED|Overall Study||3
196272|NCT00464334|458959|P5|COMPLETED|Overall Study||3
196273|NCT00464334|458960|P4|COMPLETED|Overall Study||4
196274|NCT00464334|458961|P3|COMPLETED|Overall Study||3
196275|NCT00464334|458962|P2|COMPLETED|Overall Study||5
196276|NCT00464334|458963|P1|COMPLETED|Overall Study||4
196277|NCT00464334|458953|P11|STARTED|Overall Study||8
196278|NCT00464334|458954|P10|STARTED|Overall Study||5
196279|NCT00464334|458955|P9|STARTED|Overall Study||8
196280|NCT00464334|458956|P8|STARTED|Overall Study||8
196281|NCT00464334|458957|P7|STARTED|Overall Study||9
196282|NCT00464334|458958|P6|STARTED|Overall Study||7
196283|NCT00464334|458959|P5|STARTED|Overall Study||7
196284|NCT00464334|458960|P4|STARTED|Overall Study||8
196285|NCT00464334|458961|P3|STARTED|Overall Study||8
196286|NCT00464334|458962|P2|STARTED|Overall Study||13
196287|NCT00464334|458963|P1|STARTED|Overall Study||5
196288|NCT00464308|459023|P3|NOT COMPLETED|Overall Study||59
196289|NCT00464308|459024|P2|NOT COMPLETED|Overall Study||63
196290|NCT00464308|459025|P1|NOT COMPLETED|Overall Study||69
196291|NCT00464308|459023|P3|COMPLETED|Overall Study||400
196292|NCT00464308|459024|P2|COMPLETED|Overall Study||406
196293|NCT00464308|459025|P1|COMPLETED|Overall Study||395
196294|NCT00464308|459023|P3|STARTED|Overall Study||459
196295|NCT00464308|459024|P2|STARTED|Overall Study||469
196296|NCT00464308|459025|P1|STARTED|Overall Study||464
196297|NCT00464269|459055|P4|NOT COMPLETED|Overall Study||9
196298|NCT00464269|459056|P3|NOT COMPLETED|Overall Study||7
196299|NCT00464269|459057|P2|NOT COMPLETED|Overall Study||17
196300|NCT00464269|459058|P1|NOT COMPLETED|Overall Study||6
196301|NCT00464269|459055|P4|COMPLETED|Overall Study||93
196302|NCT00464269|459056|P3|COMPLETED|Overall Study||93
196303|NCT00464269|459057|P2|COMPLETED|Overall Study||82
196304|NCT00464269|459058|P1|COMPLETED|Overall Study||93
196305|NCT00464269|459055|P4|STARTED|Overall Study||102
196306|NCT00464269|459056|P3|STARTED|Overall Study||100
196307|NCT00464269|459057|P2|STARTED|Overall Study||99
196308|NCT00464269|459058|P1|STARTED|Overall Study||99
196309|NCT00464204|459154|P2|NOT COMPLETED|Overall Study||32
196310|NCT00464204|459155|P1|NOT COMPLETED|Overall Study||49
196311|NCT00464204|459154|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
196312|NCT00464204|459155|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
196313|NCT00464204|459154|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
196314|NCT00464204|459155|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
196315|NCT00464204|459154|P2|Day 90 Follow-up Performed|Overall Study||74
196316|NCT00464204|459155|P1|Day 90 Follow-up Performed|Overall Study||69
196317|NCT00464204|459154|P2|Day 30 Follow-up Performed|Overall Study||83
196318|NCT00464204|459155|P1|Day 30 Follow-up Performed|Overall Study||89
196319|NCT00464204|459154|P2|Completed Treatment|Overall Study||83
196320|NCT00464204|459155|P1|Completed Treatment|Overall Study||81
196321|NCT00464204|459154|P2|STARTED|Overall Study||96
196322|NCT00464204|459155|P1|STARTED|Overall Study||100
196323|NCT00464087|459192|P3|NOT COMPLETED|Overall Study||29
196324|NCT00464087|459193|P2|NOT COMPLETED|Overall Study||0
196325|NCT00464087|459194|P1|NOT COMPLETED|Overall Study||0
196326|NCT00464087|459192|P3|COMPLETED|Overall Study||0
196327|NCT00464087|459193|P2|COMPLETED|Overall Study||51
196328|NCT00464087|459194|P1|COMPLETED|Overall Study||49
196329|NCT00464087|459192|P3|STARTED|Overall Study||29
196330|NCT00464087|459193|P2|STARTED|Overall Study||51
196331|NCT00464087|459194|P1|STARTED|Overall Study||49
196332|NCT00463866|459212|P2|NOT COMPLETED|Overall Study||340
196333|NCT00463866|459213|P1|NOT COMPLETED|Overall Study||309
196334|NCT00463866|459212|P2|COMPLETED|Overall Study||3705
196335|NCT00463866|459213|P1|COMPLETED|Overall Study||3699
196336|NCT00463866|459212|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
196337|NCT00463866|459213|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
196338|NCT00463840|459233|P1|NOT COMPLETED|Overall Study||12
196339|NCT00463840|459233|P1|COMPLETED|Overall Study||12
196340|NCT00463840|459233|P1|STARTED|Overall Study||24
196341|NCT00463801|459237|P1|NOT COMPLETED|Overall Study||13
196342|NCT00463801|459237|P1|COMPLETED|Overall Study||39
196343|NCT00463801|459237|P1|STARTED|Overall Study||52
196344|NCT00463788|459243|P2|NOT COMPLETED|Overall Study||54
196345|NCT00463788|459244|P1|NOT COMPLETED|Overall Study||109
196346|NCT00463788|459243|P2|COMPLETED|Overall Study||4
196347|NCT00463788|459244|P1|COMPLETED|Overall Study||6
196348|NCT00463788|459243|P2|Treated|Overall Study||57
196349|NCT00463788|459244|P1|Treated|Overall Study||114
196350|NCT00463788|459243|P2|STARTED|Overall Study||58
196351|NCT00463788|459244|P1|STARTED|Overall Study||115
196352|NCT00463606|459262|P3|NOT COMPLETED|Overall Study||20
196353|NCT00463606|459263|P2|NOT COMPLETED|Overall Study||34
196354|NCT00463606|459264|P1|NOT COMPLETED|Overall Study||41
196355|NCT00463606|459262|P3|COMPLETED|Overall Study||231
196356|NCT00463606|459263|P2|COMPLETED|Overall Study||220
196357|NCT00463606|459264|P1|COMPLETED|Overall Study||212
196358|NCT00463606|459262|P3|STARTED|Overall Study||251
196359|NCT00463606|459263|P2|STARTED|Overall Study||254
196360|NCT00463606|459264|P1|STARTED|Overall Study||253
196361|NCT00463580|459289|P2|NOT COMPLETED|Overall Study||2
196362|NCT00463580|459290|P1|NOT COMPLETED|Overall Study||3
196363|NCT00463580|459289|P2|COMPLETED|Overall Study||28
196364|NCT00463580|459290|P1|COMPLETED|Overall Study||27
196365|NCT00463580|459289|P2|STARTED|Overall Study||30
196366|NCT00463580|459290|P1|STARTED|Overall Study||30
196367|NCT00463567|459305|P7|NOT COMPLETED|Overall Study||11
196368|NCT00463567|459306|P6|NOT COMPLETED|Overall Study||21
196369|NCT00463567|459307|P5|NOT COMPLETED|Overall Study||23
196370|NCT00463567|459308|P4|NOT COMPLETED|Overall Study||131
196371|NCT00463567|459309|P3|NOT COMPLETED|Overall Study||89
196372|NCT00463567|459310|P2|NOT COMPLETED|Overall Study||77
196373|NCT00463567|459311|P1|NOT COMPLETED|Overall Study||95
196374|NCT00463567|459305|P7|COMPLETED|Overall Study||112
196375|NCT00463567|459306|P6|COMPLETED|Overall Study||102
196376|NCT00463567|459307|P5|COMPLETED|Overall Study||107
196377|NCT00463567|459308|P4|COMPLETED|Overall Study||294
196378|NCT00463567|459309|P3|COMPLETED|Overall Study||331
196379|NCT00463567|459310|P2|COMPLETED|Overall Study||341
196380|NCT00463567|459311|P1|COMPLETED|Overall Study||325
196466|NCT00462943|459582|P2|COMPLETED|Overall Study||1
196381|NCT00463567|459305|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
196382|NCT00463567|459306|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
196383|NCT00463567|459307|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
196384|NCT00463567|459308|P4|Safety Population: Received Study Drug|Overall Study||418
196385|NCT00463567|459309|P3|Safety Population: Received Study Drug|Overall Study||415
196386|NCT00463567|459310|P2|Safety Population: Received Study Drug|Overall Study||416
196387|NCT00463567|459311|P1|Safety Population: Received Study Drug|Overall Study||416
196388|NCT00463567|459305|P7|STARTED|Overall Study||123
196389|NCT00463567|459306|P6|STARTED|Overall Study||123
196390|NCT00463567|459307|P5|STARTED|Overall Study||130
196391|NCT00463567|459308|P4|STARTED|Overall Study||425
196392|NCT00463567|459309|P3|STARTED|Overall Study||420
196393|NCT00463567|459310|P2|STARTED|Overall Study||418
196394|NCT00463567|459311|P1|STARTED|Overall Study|Randomized Participants|420
196395|NCT00463437|459346|P4|NOT COMPLETED|Overall Study||7
196396|NCT00463437|459347|P3|NOT COMPLETED|Overall Study||6
196397|NCT00463437|459348|P2|NOT COMPLETED|Overall Study||11
196398|NCT00463437|459349|P1|NOT COMPLETED|Overall Study||4
196399|NCT00463437|459346|P4|COMPLETED|Overall Study||350
196400|NCT00463437|459347|P3|COMPLETED|Overall Study||352
196401|NCT00463437|459348|P2|COMPLETED|Overall Study||352
196402|NCT00463437|459349|P1|COMPLETED|Overall Study||355
196403|NCT00463437|459346|P4|STARTED|Overall Study||357
196404|NCT00463437|459347|P3|STARTED|Overall Study||358
196405|NCT00463437|459348|P2|STARTED|Overall Study||363
196406|NCT00463437|459349|P1|STARTED|Overall Study||359
196407|NCT00463385|459415|P4|NOT COMPLETED|Overall Study||22
196408|NCT00463385|459416|P3|NOT COMPLETED|Overall Study||22
196409|NCT00463385|459417|P2|NOT COMPLETED|Overall Study||22
196410|NCT00463385|459418|P1|NOT COMPLETED|Overall Study||22
196411|NCT00463385|459415|P4|COMPLETED|Overall Study||0
196412|NCT00463385|459416|P3|COMPLETED|Overall Study||0
196413|NCT00463385|459417|P2|COMPLETED|Overall Study||0
196414|NCT00463385|459418|P1|COMPLETED|Overall Study||0
196415|NCT00463385|459415|P4|Treated|Overall Study||22
196416|NCT00463385|459416|P3|Treated|Overall Study||19
196417|NCT00463385|459417|P2|Treated|Overall Study||22
196418|NCT00463385|459418|P1|Treated|Overall Study||22
196419|NCT00463385|459415|P4|STARTED|Overall Study||22
196420|NCT00463385|459416|P3|STARTED|Overall Study||22
196421|NCT00463385|459417|P2|STARTED|Overall Study||22
196422|NCT00463385|459418|P1|STARTED|Overall Study||22
196423|NCT00463346|459470|P2|NOT COMPLETED|Overall Study||3
196424|NCT00463346|459471|P1|NOT COMPLETED|Overall Study||3
196425|NCT00463346|459470|P2|COMPLETED|Overall Study||8
196426|NCT00463346|459471|P1|COMPLETED|Overall Study||9
196427|NCT00463346|459470|P2|STARTED|Overall Study||11
196428|NCT00463346|459471|P1|STARTED|Overall Study||12
196429|NCT00463229|459481|P2|NOT COMPLETED|Overall Study||10
196430|NCT00463229|459482|P1|NOT COMPLETED|Overall Study||9
196431|NCT00463229|459481|P2|COMPLETED|Overall Study||39
196432|NCT00463229|459482|P1|COMPLETED|Overall Study||43
196433|NCT00463229|459481|P2|STARTED|Overall Study||49
196434|NCT00463229|459482|P1|STARTED|Overall Study||52
196435|NCT00463047|459488|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
196436|NCT00463047|459489|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
196437|NCT00463047|459488|P2|COMPLETED|Double-Blind Treatment Period 2||88
196438|NCT00463047|459489|P1|COMPLETED|Double-Blind Treatment Period 2||92
196439|NCT00463047|459488|P2|STARTED|Double-Blind Treatment Period 2||90
196440|NCT00463047|459489|P1|STARTED|Double-Blind Treatment Period 2||93
196441|NCT00463047|459488|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
196442|NCT00463047|459489|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
196443|NCT00463047|459488|P2|COMPLETED|Double-Blind Treatment Period 1||90
196444|NCT00463047|459489|P1|COMPLETED|Double-Blind Treatment Period 1||93
196445|NCT00463047|459488|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
196446|NCT00463047|459489|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
196447|NCT00463047|459488|P2|NOT COMPLETED|Titration Period 2||23
196448|NCT00463047|459489|P1|NOT COMPLETED|Titration Period 2||30
196449|NCT00463047|459488|P2|COMPLETED|Titration Period 2||98
196450|NCT00463047|459489|P1|COMPLETED|Titration Period 2||93
196451|NCT00463047|459488|P2|STARTED|Titration Period 2||121
196452|NCT00463047|459489|P1|STARTED|Titration Period 2||123
196453|NCT00463047|459488|P2|NOT COMPLETED|Titration Period 1||39
196454|NCT00463047|459489|P1|NOT COMPLETED|Titration Period 1||37
196455|NCT00463047|459488|P2|COMPLETED|Titration Period 1||121
196456|NCT00463047|459489|P1|COMPLETED|Titration Period 1||123
196457|NCT00463047|459488|P2|STARTED|Titration Period 1||160
196458|NCT00463047|459489|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
196459|NCT00462982|459574|P1|NOT COMPLETED|Overall Study||3
196460|NCT00462982|459574|P1|COMPLETED|Overall Study||5
196461|NCT00462982|459574|P1|STARTED|Overall Study||8
196462|NCT00462943|459581|P3|NOT COMPLETED|Overall Study||23
196463|NCT00462943|459582|P2|NOT COMPLETED|Overall Study||30
196464|NCT00462943|459583|P1|NOT COMPLETED|Overall Study||45
196465|NCT00462943|459581|P3|COMPLETED|Overall Study||0
196467|NCT00462943|459583|P1|COMPLETED|Overall Study||1
196468|NCT00462943|459581|P3|STARTED|Overall Study||23
196469|NCT00462943|459582|P2|STARTED|Overall Study||31
196470|NCT00462943|459583|P1|STARTED|Overall Study||46
196471|NCT00462917|459654|P4|NOT COMPLETED|Overall Study||11
196472|NCT00462917|459655|P3|NOT COMPLETED|Overall Study||12
196473|NCT00462917|459656|P2|NOT COMPLETED|Overall Study||10
196474|NCT00462917|459657|P1|NOT COMPLETED|Overall Study||10
196475|NCT00462917|459654|P4|COMPLETED|Overall Study||66
196476|NCT00462917|459655|P3|COMPLETED|Overall Study||54
196477|NCT00462917|459656|P2|COMPLETED|Overall Study||65
196478|NCT00462917|459657|P1|COMPLETED|Overall Study||62
196479|NCT00462917|459654|P4|Completed 6 Month Follow-up|Overall Study||66
196480|NCT00462917|459655|P3|Completed 6 Month Follow-up|Overall Study||55
196481|NCT00462917|459656|P2|Completed 6 Month Follow-up|Overall Study||68
196482|NCT00462917|459657|P1|Completed 6 Month Follow-up|Overall Study||63
196483|NCT00462917|459654|P4|Completed 6 Week Follow-up|Overall Study||68
196484|NCT00462917|459655|P3|Completed 6 Week Follow-up|Overall Study||55
196485|NCT00462917|459656|P2|Completed 6 Week Follow-up|Overall Study||70
196486|NCT00462917|459657|P1|Completed 6 Week Follow-up|Overall Study||63
196487|NCT00462917|459654|P4|Received Risk Information|Overall Study||68
196488|NCT00462917|459655|P3|Received Risk Information|Overall Study||55
196489|NCT00462917|459656|P2|Received Risk Information|Overall Study||70
196490|NCT00462917|459657|P1|Received Risk Information|Overall Study||64
196491|NCT00462917|459654|P4|Met With Genetic Counselor|Overall Study||71
196492|NCT00462917|459655|P3|Met With Genetic Counselor|Overall Study||56
196493|NCT00462917|459656|P2|Met With Genetic Counselor|Overall Study||71
196494|NCT00462917|459657|P1|Met With Genetic Counselor|Overall Study||66
196495|NCT00462917|459654|P4|STARTED|Overall Study||77
196496|NCT00462917|459655|P3|STARTED|Overall Study||66
196497|NCT00462917|459656|P2|STARTED|Overall Study||75
196498|NCT00462917|459657|P1|STARTED|Overall Study||72
196499|NCT00462865|459675|P1|NOT COMPLETED|Overall Study||1
196500|NCT00462865|459675|P1|COMPLETED|Overall Study||17
196501|NCT00462865|459675|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
196502|NCT00462839|459681|P2|NOT COMPLETED|Viewed Second||0
196503|NCT00462839|459682|P1|NOT COMPLETED|Viewed Second||0
196504|NCT00462839|459681|P2|COMPLETED|Viewed Second||53
196505|NCT00462839|459682|P1|COMPLETED|Viewed Second||53
196506|NCT00462839|459681|P2|STARTED|Viewed Second||53
196507|NCT00462839|459682|P1|STARTED|Viewed Second||53
196508|NCT00462839|459681|P2|NOT COMPLETED|Viewed First||0
196509|NCT00462839|459682|P1|NOT COMPLETED|Viewed First||0
196510|NCT00462839|459681|P2|COMPLETED|Viewed First||53
196511|NCT00462839|459682|P1|COMPLETED|Viewed First||53
196512|NCT00462839|459681|P2|STARTED|Viewed First||53
196513|NCT00462839|459682|P1|STARTED|Viewed First||53
196514|NCT00462826|459694|P1|NOT COMPLETED|Overall Study||5
196515|NCT00462826|459694|P1|COMPLETED|Overall Study||44
196516|NCT00462826|459694|P1|STARTED|Overall Study||49
196517|NCT00462748|459701|P3|NOT COMPLETED|Overall Study||11
196518|NCT00462748|459702|P2|NOT COMPLETED|Overall Study||11
196519|NCT00462748|459703|P1|NOT COMPLETED|Overall Study||12
196520|NCT00462748|459701|P3|COMPLETED|Overall Study||251
196521|NCT00462748|459702|P2|COMPLETED|Overall Study||252
196522|NCT00462748|459703|P1|COMPLETED|Overall Study||249
196523|NCT00462748|459701|P3|STARTED|Overall Study||262
196524|NCT00462748|459702|P2|STARTED|Overall Study||263
196525|NCT00462748|459703|P1|STARTED|Overall Study||261
196526|NCT00462722|459714|P3|NOT COMPLETED|Overall Study||12
196527|NCT00462722|459715|P2|NOT COMPLETED|Overall Study||4
196528|NCT00462722|459716|P1|NOT COMPLETED|Overall Study||13
196529|NCT00462722|459714|P3|COMPLETED|Overall Study||42
196530|NCT00462722|459715|P2|COMPLETED|Overall Study||51
196531|NCT00462722|459716|P1|COMPLETED|Overall Study||37
196532|NCT00462722|459714|P3|STARTED|Overall Study||54
196533|NCT00462722|459715|P2|STARTED|Overall Study||55
196534|NCT00462722|459716|P1|STARTED|Overall Study||50
196535|NCT00462709|459748|P1|NOT COMPLETED|Overall Study||67
196536|NCT00462709|459748|P1|COMPLETED|Overall Study||79
196537|NCT00462709|459748|P1|STARTED|Overall Study||146
196538|NCT00462670|459757|P2|NOT COMPLETED|Overall Study||7
196539|NCT00462670|459758|P1|NOT COMPLETED|Overall Study||5
196540|NCT00462670|459757|P2|COMPLETED|Overall Study||46
196541|NCT00462670|459758|P1|COMPLETED|Overall Study||52
196542|NCT00462670|459757|P2|STARTED|Overall Study||53
196543|NCT00462670|459758|P1|STARTED|Overall Study||57
196544|NCT00462644|459768|P2|NOT COMPLETED|Overall Study||0
196545|NCT00462644|459769|P1|NOT COMPLETED|Overall Study||0
196546|NCT00462644|459768|P2|COMPLETED|Overall Study||12
196547|NCT00462644|459769|P1|COMPLETED|Overall Study||18
196548|NCT00462644|459768|P2|STARTED|Overall Study||12
196549|NCT00462644|459769|P1|STARTED|Overall Study||18
196550|NCT00462501|459787|P1|NOT COMPLETED|Overall Study||5
196551|NCT00462501|459787|P1|COMPLETED|Overall Study||30
196552|NCT00462501|459787|P1|STARTED|Overall Study||35
196553|NCT00462462|459793|P2|NOT COMPLETED|Overall Study||1
196554|NCT00462462|459794|P1|NOT COMPLETED|Overall Study||0
196555|NCT00462462|459793|P2|COMPLETED|Overall Study||13
196556|NCT00462462|459794|P1|COMPLETED|Overall Study||17
196557|NCT00462462|459793|P2|STARTED|Overall Study||14
196558|NCT00462462|459794|P1|STARTED|Overall Study||17
196559|NCT00462449|459804|P2|NOT COMPLETED|Overall Study||0
196560|NCT00462449|459805|P1|NOT COMPLETED|Overall Study||0
196561|NCT00462449|459804|P2|COMPLETED|Overall Study||10
196562|NCT00462449|459805|P1|COMPLETED|Overall Study||13
196563|NCT00462449|459804|P2|STARTED|Overall Study||10
196564|NCT00462449|459805|P1|STARTED|Overall Study||13
196565|NCT00462423|459815|P1|NOT COMPLETED|Overall Study||0
196566|NCT00462423|459815|P1|COMPLETED|Overall Study||50
196567|NCT00462423|459815|P1|STARTED|Overall Study||50
196568|NCT00462384|459822|P1|NOT COMPLETED|Overall Study||9
196569|NCT00462384|459822|P1|COMPLETED|Overall Study||30
196570|NCT00462384|459822|P1|STARTED|Overall Study||39
196571|NCT00462345|459830|P1|NOT COMPLETED|Overall Study||3
196572|NCT00462345|459830|P1|COMPLETED|Overall Study||37
196573|NCT00462345|459830|P1|Completed First Course|Overall Study||38
196574|NCT00462345|459830|P1|STARTED|Overall Study||40
196575|NCT00462332|459854|P2|NOT COMPLETED|Overall Study||0
196576|NCT00462332|459855|P1|NOT COMPLETED|Overall Study||0
196577|NCT00462332|459854|P2|COMPLETED|Overall Study||41
196578|NCT00462332|459855|P1|COMPLETED|Overall Study||45
196579|NCT00462332|459854|P2|STARTED|Overall Study||41
196580|NCT00462332|459855|P1|STARTED|Overall Study||45
196581|NCT00462306|459865|P2|NOT COMPLETED|Overall Study||13
196582|NCT00462306|459866|P1|NOT COMPLETED|Overall Study||0
196583|NCT00462306|459865|P2|COMPLETED|Overall Study||490
196584|NCT00462306|459866|P1|COMPLETED|Overall Study||4074
196585|NCT00462306|459865|P2|STARTED|Overall Study||503
196586|NCT00462306|459866|P1|STARTED|Overall Study||4074
196587|NCT00462280|459878|P4|NOT COMPLETED|Overall Study||3
196588|NCT00462280|459879|P3|NOT COMPLETED|Overall Study||0
196589|NCT00462280|459880|P2|NOT COMPLETED|Overall Study||7
196590|NCT00462280|459881|P1|NOT COMPLETED|Overall Study||10
196591|NCT00462280|459878|P4|COMPLETED|Overall Study||4
196592|NCT00462280|459879|P3|COMPLETED|Overall Study||7
196593|NCT00462280|459880|P2|COMPLETED|Overall Study||25
196594|NCT00462280|459881|P1|COMPLETED|Overall Study||24
196595|NCT00462280|459878|P4|STARTED|Overall Study||7
196596|NCT00462280|459879|P3|STARTED|Overall Study||7
196597|NCT00462280|459880|P2|STARTED|Overall Study||32
196598|NCT00462280|459881|P1|STARTED|Overall Study||34
196599|NCT00462228|459941|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
196600|NCT00462228|459941|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
196601|NCT00462228|459941|P1|STARTED|No Treatment (Washout) 4 Weeks||11
196602|NCT00462228|459941|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
196603|NCT00462228|459941|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
196604|NCT00462228|459941|P1|STARTED|Placebo or Memantine 12 Weeks||11
196605|NCT00462228|459941|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
196606|NCT00462228|459941|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
196607|NCT00462228|459941|P1|STARTED|No Treatment (Washout) 4 Weeks||11
196608|NCT00462228|459941|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
196609|NCT00462228|459941|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
196610|NCT00462228|459941|P1|STARTED|Memantine or Placebo 12 Weeks||11
196611|NCT00462072|459965|P3|NOT COMPLETED|Week 10||0
196612|NCT00462072|459966|P2|NOT COMPLETED|Week 10||0
196613|NCT00462072|459967|P1|NOT COMPLETED|Week 10||0
196614|NCT00462072|459965|P3|COMPLETED|Week 10||9
196615|NCT00462072|459966|P2|COMPLETED|Week 10||12
196616|NCT00462072|459967|P1|COMPLETED|Week 10||10
196617|NCT00462072|459965|P3|STARTED|Week 10||9
196618|NCT00462072|459966|P2|STARTED|Week 10||12
196619|NCT00462072|459967|P1|STARTED|Week 10||10
196620|NCT00462072|459965|P3|NOT COMPLETED|Baseline (Week 0)||0
196621|NCT00462072|459966|P2|NOT COMPLETED|Baseline (Week 0)||0
196622|NCT00462072|459967|P1|NOT COMPLETED|Baseline (Week 0)||0
196623|NCT00462072|459965|P3|COMPLETED|Baseline (Week 0)||9
196624|NCT00462072|459966|P2|COMPLETED|Baseline (Week 0)||12
196625|NCT00462072|459967|P1|COMPLETED|Baseline (Week 0)||10
196626|NCT00462072|459965|P3|STARTED|Baseline (Week 0)||9
196627|NCT00462072|459966|P2|STARTED|Baseline (Week 0)||12
196628|NCT00462072|459967|P1|STARTED|Baseline (Week 0)||10
196629|NCT00462020|459983|P2|NOT COMPLETED|Overall Study||0
196630|NCT00462020|459984|P1|NOT COMPLETED|Overall Study||0
196631|NCT00462020|459983|P2|COMPLETED|Overall Study||50
196632|NCT00462020|459984|P1|COMPLETED|Overall Study||52
196633|NCT00462020|459983|P2|STARTED|Overall Study||50
196634|NCT00462020|459984|P1|STARTED|Overall Study||52
196635|NCT00461981|459992|P2|NOT COMPLETED|Overall Study||9
196636|NCT00461981|459993|P1|NOT COMPLETED|Overall Study||11
196637|NCT00461981|459992|P2|COMPLETED|Overall Study||42
196638|NCT00461981|459993|P1|COMPLETED|Overall Study||39
196639|NCT00461981|459992|P2|STARTED|Overall Study||51
196640|NCT00461981|459993|P1|STARTED|Overall Study||50
196641|NCT00461851|460103|P1|NOT COMPLETED|Overall Study||2
196642|NCT00461851|460103|P1|COMPLETED|Overall Study||17
196643|NCT00461851|460103|P1|STARTED|Overall Study||19
196644|NCT00461786|460107|P1|NOT COMPLETED|Overall Study||3
196645|NCT00461786|460107|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
196646|NCT00461786|460107|P1|STARTED|Overall Study||51
196647|NCT00460993|460117|P2|NOT COMPLETED|Phase 2 (6 Days)||0
196648|NCT00460993|460118|P1|NOT COMPLETED|Phase 2 (6 Days)||0
196649|NCT00460993|460117|P2|COMPLETED|Phase 2 (6 Days)||17
196650|NCT00460993|460118|P1|COMPLETED|Phase 2 (6 Days)||14
196651|NCT00460993|460117|P2|STARTED|Phase 2 (6 Days)||17
196652|NCT00460993|460118|P1|STARTED|Phase 2 (6 Days)||14
196653|NCT00460993|460117|P2|NOT COMPLETED|Phase 1 (6 Days)||0
196654|NCT00460993|460118|P1|NOT COMPLETED|Phase 1 (6 Days)||0
196655|NCT00460993|460117|P2|COMPLETED|Phase 1 (6 Days)||17
196656|NCT00460993|460118|P1|COMPLETED|Phase 1 (6 Days)||14
196657|NCT00460993|460117|P2|STARTED|Phase 1 (6 Days)||17
196658|NCT00460993|460118|P1|STARTED|Phase 1 (6 Days)||14
196659|NCT00461708|460126|P2|NOT COMPLETED|Overall Study||38
196660|NCT00461708|460127|P1|NOT COMPLETED|Overall Study||115
196661|NCT00461708|460126|P2|COMPLETED|Overall Study||0
196662|NCT00461708|460127|P1|COMPLETED|Overall Study||0
196663|NCT00461708|460126|P2|STARTED|Overall Study||38
196664|NCT00461708|460127|P1|STARTED|Overall Study||115
196665|NCT00461630|460155|P2|NOT COMPLETED|Overall Study||827
196666|NCT00461630|460156|P1|NOT COMPLETED|Overall Study||906
196667|NCT00461630|460155|P2|COMPLETED|Overall Study||12008
196668|NCT00461630|460156|P1|COMPLETED|Overall Study||11932
196669|NCT00461630|460155|P2|STARTED|Overall Study||12835
196670|NCT00461630|460156|P1|STARTED|Overall Study||12838
196671|NCT00461513|460172|P2|NOT COMPLETED|Overall Study||27
196672|NCT00461513|460173|P1|NOT COMPLETED|Overall Study||28
196673|NCT00461513|460172|P2|COMPLETED|Overall Study||172
196674|NCT00461513|460173|P1|COMPLETED|Overall Study||165
196675|NCT00461513|460172|P2|STARTED|Overall Study||199
196676|NCT00461513|460173|P1|STARTED|Overall Study||193
196677|NCT00461500|460181|P2|NOT COMPLETED|Overall Study||6
196678|NCT00461500|460182|P1|NOT COMPLETED|Overall Study||7
196679|NCT00461500|460181|P2|COMPLETED|Overall Study||38
196680|NCT00461500|460182|P1|COMPLETED|Overall Study||30
196681|NCT00461500|460181|P2|STARTED|Overall Study||44
196682|NCT00461500|460182|P1|STARTED|Overall Study||37
196683|NCT00461331|460212|P2|NOT COMPLETED|Intervention 2||0
196684|NCT00461331|460213|P1|NOT COMPLETED|Intervention 2||0
196685|NCT00461331|460212|P2|COMPLETED|Intervention 2||10
196686|NCT00461331|460213|P1|COMPLETED|Intervention 2||10
196687|NCT00461331|460212|P2|STARTED|Intervention 2||10
196688|NCT00461331|460213|P1|STARTED|Intervention 2||10
196689|NCT00461331|460212|P2|NOT COMPLETED|Washout||0
196690|NCT00461331|460213|P1|NOT COMPLETED|Washout||0
196691|NCT00461331|460212|P2|COMPLETED|Washout||10
196692|NCT00461331|460213|P1|COMPLETED|Washout||10
196693|NCT00461331|460212|P2|STARTED|Washout||10
196694|NCT00461331|460213|P1|STARTED|Washout||10
196695|NCT00461331|460212|P2|NOT COMPLETED|Intervention 1||0
196696|NCT00461331|460213|P1|NOT COMPLETED|Intervention 1||0
196697|NCT00461331|460212|P2|COMPLETED|Intervention 1||10
196698|NCT00461331|460213|P1|COMPLETED|Intervention 1||10
196699|NCT00461331|460212|P2|STARTED|Intervention 1||10
196700|NCT00461331|460213|P1|STARTED|Intervention 1||10
196701|NCT00461305|460225|P2|NOT COMPLETED|Continued Treatment||0
196702|NCT00461305|460226|P1|NOT COMPLETED|Continued Treatment||95
196703|NCT00461305|460225|P2|COMPLETED|Continued Treatment||0
196704|NCT00461305|460226|P1|COMPLETED|Continued Treatment||254
196705|NCT00461305|460225|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
196706|NCT00461305|460226|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
196707|NCT00461305|460225|P2|NOT COMPLETED|Treatment||9
196708|NCT00461305|460226|P1|NOT COMPLETED|Treatment||101
196709|NCT00461305|460225|P2|COMPLETED|Treatment||56
196710|NCT00461305|460226|P1|COMPLETED|Treatment||254
196711|NCT00461305|460225|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
196712|NCT00461305|460226|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
196713|NCT00461305|460225|P2|Subjects Dispensed Drugs|Treatment||65
196714|NCT00461305|460226|P1|Subjects Dispensed Drugs|Treatment||350
196715|NCT00461305|460225|P2|STARTED|Treatment|Enrolled|65
196716|NCT00461305|460226|P1|STARTED|Treatment|Enrolled|355
196717|NCT00461292|460289|P3|NOT COMPLETED|Treatment Cycle 2||0
196718|NCT00461292|460290|P2|NOT COMPLETED|Treatment Cycle 2||2
196719|NCT00461292|460291|P1|NOT COMPLETED|Treatment Cycle 2||5
196720|NCT00461292|460289|P3|COMPLETED|Treatment Cycle 2||0
196721|NCT00461292|460290|P2|COMPLETED|Treatment Cycle 2||72
196722|NCT00461292|460291|P1|COMPLETED|Treatment Cycle 2||58
196723|NCT00461292|460289|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
196724|NCT00461292|460290|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
196725|NCT00461292|460291|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
196726|NCT00461292|460289|P3|NOT COMPLETED|Treatment Cycle 1||11
196727|NCT00461292|460290|P2|NOT COMPLETED|Treatment Cycle 1||12
196728|NCT00461292|460291|P1|NOT COMPLETED|Treatment Cycle 1||15
196729|NCT00461292|460289|P3|COMPLETED|Treatment Cycle 1||81
196730|NCT00461292|460290|P2|COMPLETED|Treatment Cycle 1||80
196731|NCT00461292|460291|P1|COMPLETED|Treatment Cycle 1||76
196732|NCT00461292|460289|P3|STARTED|Treatment Cycle 1||92
196733|NCT00461292|460290|P2|STARTED|Treatment Cycle 1||92
196734|NCT00461292|460291|P1|STARTED|Treatment Cycle 1||91
196735|NCT00461253|460310|P2|NOT COMPLETED|Overall Study||19798
196736|NCT00461253|460311|P1|NOT COMPLETED|Overall Study||4980
196737|NCT00461253|460310|P2|COMPLETED|Overall Study|Analyzed controls|20452
196738|NCT00461253|460311|P1|COMPLETED|Overall Study|Analyzed cases|5113
196739|NCT00461253|460310|P2|STARTED|Overall Study|Identified controls|40250
196740|NCT00461253|460311|P1|STARTED|Overall Study|Identified cases|10093
196741|NCT00461175|460319|P2|NOT COMPLETED|Overall Study||365
196742|NCT00461175|460320|P1|NOT COMPLETED|Overall Study||522
196743|NCT00461175|460319|P2|COMPLETED|Overall Study||18370
196744|NCT00461175|460320|P1|COMPLETED|Overall Study||43078
196745|NCT00461175|460319|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
196746|NCT00461175|460320|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
196747|NCT00461123|460330|P2|NOT COMPLETED|Overall Study||6
196748|NCT00461123|460331|P1|NOT COMPLETED|Overall Study||6
196749|NCT00461123|460330|P2|COMPLETED|Overall Study||19
196750|NCT00461123|460331|P1|COMPLETED|Overall Study||19
196751|NCT00461123|460330|P2|STARTED|Overall Study||25
196752|NCT00461123|460331|P1|STARTED|Overall Study||25
196753|NCT00461097|460347|P2|NOT COMPLETED|Overall Study||0
196754|NCT00461097|460348|P1|NOT COMPLETED|Overall Study||0
196755|NCT00461097|460347|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
196756|NCT00461097|460348|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
196757|NCT00461097|460347|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
196758|NCT00461097|460348|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
196759|NCT00461097|460347|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
196760|NCT00461097|460348|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
196761|NCT00461097|460347|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
196762|NCT00461097|460348|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
196763|NCT00461097|460347|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
196764|NCT00461097|460348|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
196765|NCT00461097|460347|P2|STARTED|Overall Study||15
196766|NCT00461097|460348|P1|STARTED|Overall Study||40
196767|NCT00461032|460366|P2|NOT COMPLETED|Overall Study||44
196768|NCT00461032|460367|P1|NOT COMPLETED|Overall Study||37
196769|NCT00461032|460366|P2|COMPLETED|Overall Study||536
196770|NCT00461032|460367|P1|COMPLETED|Overall Study||545
196771|NCT00461032|460366|P2|STARTED|Overall Study||580
196772|NCT00461032|460367|P1|STARTED|Overall Study||582
196773|NCT00460811|460384|P5|NOT COMPLETED|Overall Study||20
196774|NCT00460811|460385|P4|NOT COMPLETED|Overall Study||18
196775|NCT00460811|460386|P3|NOT COMPLETED|Overall Study||14
196776|NCT00460811|460387|P2|NOT COMPLETED|Overall Study||15
196777|NCT00460811|460388|P1|NOT COMPLETED|Overall Study||16
196778|NCT00460811|460384|P5|COMPLETED|Overall Study||65
196779|NCT00460811|460385|P4|COMPLETED|Overall Study||71
196780|NCT00460811|460386|P3|COMPLETED|Overall Study||71
196781|NCT00460811|460387|P2|COMPLETED|Overall Study||67
196782|NCT00460811|460388|P1|COMPLETED|Overall Study||63
196783|NCT00460811|460384|P5|STARTED|Overall Study||85
196784|NCT00460811|460385|P4|STARTED|Overall Study||89
196785|NCT00460811|460386|P3|STARTED|Overall Study||85
196786|NCT00460811|460387|P2|STARTED|Overall Study||82
196787|NCT00460811|460388|P1|STARTED|Overall Study||79
196788|NCT00460798|460430|P1|NOT COMPLETED|Overall Study||340
196789|NCT00460798|460430|P1|COMPLETED|Overall Study||108
196790|NCT00460798|460430|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
196791|NCT00460798|460430|P1|STARTED|Overall Study||448
196792|NCT00460746|460438|P1|NOT COMPLETED|Overall Study||2
196793|NCT00460746|460438|P1|COMPLETED|Overall Study||8
196794|NCT00460746|460438|P1|STARTED|Overall Study||10
196795|NCT00460655|460453|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
196796|NCT00460655|460454|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
196797|NCT00460655|460455|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196798|NCT00460655|460456|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196799|NCT00460655|460453|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
196800|NCT00460655|460454|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
196801|NCT00460655|460455|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
196802|NCT00460655|460456|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
196803|NCT00460655|460453|P4|STARTED|Open-Label Phase (36 Weeks)||61
196804|NCT00460655|460454|P3|STARTED|Open-Label Phase (36 Weeks)||52
196805|NCT00460655|460455|P2|STARTED|Open-Label Phase (36 Weeks)||0
196806|NCT00460655|460456|P1|STARTED|Open-Label Phase (36 Weeks)||0
196807|NCT00460655|460453|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196808|NCT00460655|460454|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196809|NCT00460655|460455|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
196810|NCT00460655|460456|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
196811|NCT00460655|460453|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
196812|NCT00460655|460454|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
196813|NCT00460655|460455|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
196814|NCT00460655|460456|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
196815|NCT00460655|460453|P4|STARTED|Double-Blind Phase (12 Weeks)||0
196816|NCT00460655|460454|P3|STARTED|Double-Blind Phase (12 Weeks)||0
196817|NCT00460655|460455|P2|STARTED|Double-Blind Phase (12 Weeks)||62
196818|NCT00460655|460456|P1|STARTED|Double-Blind Phase (12 Weeks)||58
196819|NCT00460603|460500|P12|NOT COMPLETED|Phase 2||41
196820|NCT00460603|460501|P11|NOT COMPLETED|Phase 2||43
196821|NCT00460603|460502|P10|NOT COMPLETED|Phase 2||42
196822|NCT00460603|460503|P9|NOT COMPLETED|Phase 2||0
196823|NCT00460603|460504|P8|NOT COMPLETED|Phase 2||0
196824|NCT00460603|460505|P7|NOT COMPLETED|Phase 2||0
196825|NCT00460603|460506|P6|NOT COMPLETED|Phase 2||0
196826|NCT00460603|460507|P5|NOT COMPLETED|Phase 2||0
196827|NCT00460603|460508|P4|NOT COMPLETED|Phase 2||0
196828|NCT00460603|460509|P3|NOT COMPLETED|Phase 2||0
196829|NCT00460603|460510|P2|NOT COMPLETED|Phase 2||0
196830|NCT00460603|460511|P1|NOT COMPLETED|Phase 2||0
196831|NCT00460603|460500|P12|COMPLETED|Phase 2||0
196832|NCT00460603|460501|P11|COMPLETED|Phase 2||0
196833|NCT00460603|460502|P10|COMPLETED|Phase 2||0
196834|NCT00460603|460503|P9|COMPLETED|Phase 2||0
196835|NCT00460603|460504|P8|COMPLETED|Phase 2||0
196836|NCT00460603|460505|P7|COMPLETED|Phase 2||0
196837|NCT00460603|460506|P6|COMPLETED|Phase 2||0
196838|NCT00460603|460507|P5|COMPLETED|Phase 2||0
196839|NCT00460603|460508|P4|COMPLETED|Phase 2||0
196840|NCT00460603|460509|P3|COMPLETED|Phase 2||0
196841|NCT00460603|460510|P2|COMPLETED|Phase 2||0
196842|NCT00460603|460511|P1|COMPLETED|Phase 2||0
196843|NCT00460603|460500|P12|Treated|Phase 2||41
196844|NCT00460603|460501|P11|Treated|Phase 2||43
196845|NCT00460603|460502|P10|Treated|Phase 2||39
196846|NCT00460603|460503|P9|Treated|Phase 2||0
196847|NCT00460603|460504|P8|Treated|Phase 2||0
196848|NCT00460603|460505|P7|Treated|Phase 2||0
196849|NCT00460603|460506|P6|Treated|Phase 2||0
196850|NCT00460603|460507|P5|Treated|Phase 2||0
196851|NCT00460603|460508|P4|Treated|Phase 2||0
196852|NCT00460603|460509|P3|Treated|Phase 2||0
196853|NCT00460603|460510|P2|Treated|Phase 2||0
196854|NCT00460603|460511|P1|Treated|Phase 2||0
196855|NCT00460603|460500|P12|STARTED|Phase 2||41
196856|NCT00460603|460501|P11|STARTED|Phase 2||43
196857|NCT00460603|460502|P10|STARTED|Phase 2||42
196858|NCT00460603|460503|P9|STARTED|Phase 2||0
196859|NCT00460603|460504|P8|STARTED|Phase 2||0
196860|NCT00460603|460505|P7|STARTED|Phase 2||0
196861|NCT00460603|460506|P6|STARTED|Phase 2||0
196862|NCT00460603|460507|P5|STARTED|Phase 2||0
196863|NCT00460603|460508|P4|STARTED|Phase 2||0
196864|NCT00460603|460509|P3|STARTED|Phase 2||0
196865|NCT00460603|460510|P2|STARTED|Phase 2||0
196866|NCT00460603|460511|P1|STARTED|Phase 2||0
196867|NCT00460603|460500|P12|NOT COMPLETED|Phase 1||0
196868|NCT00460603|460501|P11|NOT COMPLETED|Phase 1||0
196869|NCT00460603|460502|P10|NOT COMPLETED|Phase 1||0
196870|NCT00460603|460503|P9|NOT COMPLETED|Phase 1||18
196871|NCT00460603|460504|P8|NOT COMPLETED|Phase 1||3
196872|NCT00460603|460505|P7|NOT COMPLETED|Phase 1||6
196873|NCT00460603|460506|P6|NOT COMPLETED|Phase 1||4
196874|NCT00460603|460507|P5|NOT COMPLETED|Phase 1||6
196875|NCT00460603|460508|P4|NOT COMPLETED|Phase 1||8
196876|NCT00460603|460509|P3|NOT COMPLETED|Phase 1||4
196877|NCT00460603|460510|P2|NOT COMPLETED|Phase 1||6
196878|NCT00460603|460511|P1|NOT COMPLETED|Phase 1||6
196879|NCT00460603|460500|P12|COMPLETED|Phase 1||0
196880|NCT00460603|460501|P11|COMPLETED|Phase 1||0
196881|NCT00460603|460502|P10|COMPLETED|Phase 1||0
196882|NCT00460603|460503|P9|COMPLETED|Phase 1||0
196883|NCT00460603|460504|P8|COMPLETED|Phase 1||0
196884|NCT00460603|460505|P7|COMPLETED|Phase 1||0
196885|NCT00460603|460506|P6|COMPLETED|Phase 1||0
196886|NCT00460603|460507|P5|COMPLETED|Phase 1||0
196887|NCT00460603|460508|P4|COMPLETED|Phase 1||0
196888|NCT00460603|460509|P3|COMPLETED|Phase 1||0
196889|NCT00460603|460510|P2|COMPLETED|Phase 1||0
196890|NCT00460603|460511|P1|COMPLETED|Phase 1||0
196891|NCT00460603|460500|P12|STARTED|Phase 1||0
196892|NCT00460603|460501|P11|STARTED|Phase 1||0
196893|NCT00460603|460502|P10|STARTED|Phase 1||0
196894|NCT00460603|460503|P9|STARTED|Phase 1||18
196895|NCT00460603|460504|P8|STARTED|Phase 1||3
196896|NCT00460603|460505|P7|STARTED|Phase 1||6
196897|NCT00460603|460506|P6|STARTED|Phase 1||4
196898|NCT00460603|460507|P5|STARTED|Phase 1||6
196899|NCT00460603|460508|P4|STARTED|Phase 1||8
196900|NCT00460603|460509|P3|STARTED|Phase 1||4
196901|NCT00460603|460510|P2|STARTED|Phase 1||6
196902|NCT00460603|460511|P1|STARTED|Phase 1||6
196903|NCT00460577|460605|P2|NOT COMPLETED|Overall Study||6
196904|NCT00460577|460606|P1|NOT COMPLETED|Overall Study||2
196905|NCT00460577|460605|P2|COMPLETED|Overall Study||24
196906|NCT00460577|460606|P1|COMPLETED|Overall Study||28
196907|NCT00460577|460605|P2|STARTED|Overall Study||30
196908|NCT00460577|460606|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
196909|NCT00460564|460624|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196910|NCT00460564|460625|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
196911|NCT00460564|460626|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
196912|NCT00460564|460627|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
196913|NCT00460564|460628|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196914|NCT00460564|460629|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196915|NCT00460564|460630|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196916|NCT00460564|460631|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
196917|NCT00460564|460624|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
196918|NCT00460564|460625|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
196919|NCT00460564|460626|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
196920|NCT00460564|460627|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
196921|NCT00460564|460628|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
196922|NCT00460564|460629|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
196923|NCT00460564|460630|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
196924|NCT00460564|460631|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
196925|NCT00460564|460624|P8|STARTED|Open-Label Phase (36 Weeks)||11
196926|NCT00460564|460625|P7|STARTED|Open-Label Phase (36 Weeks)||21
196927|NCT00460564|460626|P6|STARTED|Open-Label Phase (36 Weeks)||25
196928|NCT00460564|460627|P5|STARTED|Open-Label Phase (36 Weeks)||47
196929|NCT00460564|460628|P4|STARTED|Open-Label Phase (36 Weeks)||0
196930|NCT00460564|460629|P3|STARTED|Open-Label Phase (36 Weeks)||0
196931|NCT00460564|460630|P2|STARTED|Open-Label Phase (36 Weeks)||0
196932|NCT00460564|460631|P1|STARTED|Open-Label Phase (36 Weeks)||0
196933|NCT00460564|460624|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196934|NCT00460564|460625|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196935|NCT00460564|460626|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196936|NCT00460564|460627|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196937|NCT00460564|460628|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196938|NCT00460564|460629|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
196939|NCT00460564|460630|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
196940|NCT00460564|460631|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
196941|NCT00460564|460624|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
196942|NCT00460564|460625|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
196943|NCT00460564|460626|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
196944|NCT00460564|460627|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
196945|NCT00460564|460628|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
196946|NCT00460564|460629|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
196947|NCT00460564|460630|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
196948|NCT00460564|460631|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
196949|NCT00460564|460624|P8|STARTED|Double-Blind Phase (12 Weeks)||0
196950|NCT00460564|460625|P7|STARTED|Double-Blind Phase (12 Weeks)||0
196951|NCT00460564|460626|P6|STARTED|Double-Blind Phase (12 Weeks)||0
196952|NCT00460564|460627|P5|STARTED|Double-Blind Phase (12 Weeks)||0
196953|NCT00460564|460628|P4|STARTED|Double-Blind Phase (12 Weeks)||11
196954|NCT00460564|460629|P3|STARTED|Double-Blind Phase (12 Weeks)||21
196955|NCT00460564|460630|P2|STARTED|Double-Blind Phase (12 Weeks)||26
196956|NCT00460564|460631|P1|STARTED|Double-Blind Phase (12 Weeks)||51
196957|NCT00460551|460725|P1|NOT COMPLETED|Overall Study||0
196958|NCT00460551|460725|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
196959|NCT00460551|460725|P1|STARTED|Overall Study||13
196960|NCT00460525|460732|P2|NOT COMPLETED|Overall Study||5
196961|NCT00460525|460733|P1|NOT COMPLETED|Overall Study||11
196962|NCT00460525|460732|P2|COMPLETED|Overall Study||194
196963|NCT00460525|460733|P1|COMPLETED|Overall Study||190
196964|NCT00460525|460732|P2|STARTED|Overall Study||199
196965|NCT00460525|460733|P1|STARTED|Overall Study||201
196966|NCT00460421|460776|P3|NOT COMPLETED|Overall Study||0
196967|NCT00460421|460777|P2|NOT COMPLETED|Overall Study||0
196968|NCT00460421|460778|P1|NOT COMPLETED|Overall Study||0
196969|NCT00460421|460776|P3|COMPLETED|Overall Study||9
196970|NCT00460421|460777|P2|COMPLETED|Overall Study||9
196971|NCT00460421|460778|P1|COMPLETED|Overall Study||9
196972|NCT00460421|460776|P3|STARTED|Overall Study||9
196973|NCT00460421|460777|P2|STARTED|Overall Study||9
196974|NCT00460421|460778|P1|STARTED|Overall Study||9
196975|NCT00460408|460826|P4|NOT COMPLETED|Overall Study||0
196976|NCT00460408|460827|P3|NOT COMPLETED|Overall Study||6
196977|NCT00460408|460828|P2|NOT COMPLETED|Overall Study||3
196978|NCT00460408|460829|P1|NOT COMPLETED|Overall Study||67
196979|NCT00460408|460826|P4|COMPLETED|Overall Study||7
196980|NCT00460408|460827|P3|COMPLETED|Overall Study||69
196981|NCT00460408|460828|P2|COMPLETED|Overall Study||13
196982|NCT00460408|460829|P1|COMPLETED|Overall Study||336
196983|NCT00460408|460826|P4|STARTED|Overall Study||7
196984|NCT00460408|460827|P3|STARTED|Overall Study||75
196985|NCT00460408|460828|P2|STARTED|Overall Study||16
196986|NCT00460408|460829|P1|STARTED|Overall Study||403
196987|NCT00460265|460866|P2|NOT COMPLETED|Overall Study||89
196988|NCT00460265|460867|P1|NOT COMPLETED|Overall Study||85
196989|NCT00460265|460866|P2|COMPLETED|Overall Study|Completed study=death|241
196990|NCT00460265|460867|P1|COMPLETED|Overall Study|Completed study=death|243
196991|NCT00460265|460866|P2|Received Study Medication|Overall Study||325
196992|NCT00460265|460867|P1|Received Study Medication|Overall Study||325
196993|NCT00460265|460866|P2|Randomized While Alive|Overall Study||330
196994|NCT00460265|460867|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
196995|NCT00460265|460866|P2|STARTED|Overall Study||330
196996|NCT00460265|460867|P1|STARTED|Overall Study||328
196997|NCT00460031|460883|P1|NOT COMPLETED|Overall Study||11
196998|NCT00460031|460883|P1|COMPLETED|Overall Study||23
196999|NCT00460031|460883|P1|STARTED|Overall Study||34
197000|NCT00459979|460891|P1|NOT COMPLETED|Overall Study||2
197001|NCT00459979|460891|P1|COMPLETED|Overall Study||28
197002|NCT00459979|460891|P1|STARTED|Overall Study||30
197003|NCT00459953|460903|P2|NOT COMPLETED|Overall Study||1
197004|NCT00459953|460904|P1|NOT COMPLETED|Overall Study||1
197005|NCT00459953|460903|P2|COMPLETED|Overall Study||70
197006|NCT00459953|460904|P1|COMPLETED|Overall Study||71
197007|NCT00459953|460903|P2|STARTED|Overall Study||71
197008|NCT00459953|460904|P1|STARTED|Overall Study||72
197009|NCT00459875|460910|P1|NOT COMPLETED|Overall Study||3
197010|NCT00459875|460910|P1|COMPLETED|Overall Study||21
197011|NCT00459875|460910|P1|STARTED|Overall Study||24
197012|NCT00459862|460914|P1|NOT COMPLETED|Overall Study||0
197013|NCT00459862|460914|P1|COMPLETED|Overall Study||34
197014|NCT00459862|460914|P1|STARTED|Overall Study||34
197015|NCT00459810|460923|P1|NOT COMPLETED|Overall Study||0
197016|NCT00459810|460923|P1|COMPLETED|Overall Study||21
197017|NCT00459810|460923|P1|STARTED|Overall Study||21
197018|NCT00459732|460933|P2|NOT COMPLETED|Overall Study||3
197019|NCT00459732|460934|P1|NOT COMPLETED|Overall Study||4
197020|NCT00459732|460933|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
197021|NCT00459732|460934|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
197022|NCT00459732|460933|P2|STARTED|Overall Study||17
197023|NCT00459732|460934|P1|STARTED|Overall Study||23
197024|NCT00459706|460946|P2|NOT COMPLETED|Overall Study||21
197025|NCT00459706|460947|P1|NOT COMPLETED|Overall Study||26
197026|NCT00459706|460946|P2|COMPLETED|Overall Study||294
197027|NCT00459706|460947|P1|COMPLETED|Overall Study||299
197028|NCT00459706|460946|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
197029|NCT00459706|460947|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
197030|NCT00459706|460946|P2|STARTED|Overall Study||315
197031|NCT00459706|460947|P1|STARTED|Overall Study||325
197032|NCT00459667|461090|P3|NOT COMPLETED|Overall Study||20
197033|NCT00459667|461091|P2|NOT COMPLETED|Overall Study||47
197034|NCT00459667|461092|P1|NOT COMPLETED|Overall Study||38
197035|NCT00459667|461090|P3|COMPLETED|Overall Study||161
197036|NCT00459667|461091|P2|COMPLETED|Overall Study||600
197037|NCT00459667|461092|P1|COMPLETED|Overall Study||554
197038|NCT00459667|461090|P3|Started Treatment|Overall Study||180
197039|NCT00459667|461091|P2|Started Treatment|Overall Study||644
197040|NCT00459667|461092|P1|Started Treatment|Overall Study||586
197041|NCT00459667|461090|P3|Study Medication Dispensed|Overall Study||180
197042|NCT00459667|461091|P2|Study Medication Dispensed|Overall Study||645
197043|NCT00459667|461092|P1|Study Medication Dispensed|Overall Study||586
197044|NCT00459667|461090|P3|STARTED|Overall Study||181
197045|NCT00459667|461091|P2|STARTED|Overall Study||647
197046|NCT00459667|461092|P1|STARTED|Overall Study||592
197047|NCT00459537|461114|P2|NOT COMPLETED|Overall Study||76
197048|NCT00459537|461115|P1|NOT COMPLETED|Overall Study||66
197049|NCT00459537|461114|P2|COMPLETED|Overall Study||446
197050|NCT00459537|461115|P1|COMPLETED|Overall Study||441
197051|NCT00459537|461114|P2|Safety Population|Overall Study||512
197052|NCT00459537|461115|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
197053|NCT00459537|461114|P2|STARTED|Overall Study||522
197054|NCT00459537|461115|P1|STARTED|Overall Study||507
197055|NCT00459368|461131|P2|NOT COMPLETED|Overall Study||329
197056|NCT00459368|461132|P1|NOT COMPLETED|Overall Study||295
197057|NCT00459368|461131|P2|COMPLETED|Overall Study||1034
197058|NCT00459368|461132|P1|COMPLETED|Overall Study||1040
197059|NCT00459368|461131|P2|STARTED|Overall Study||1363
197060|NCT00459368|461132|P1|STARTED|Overall Study||1335
197061|NCT00459355|461140|P2|NOT COMPLETED|Overall Study||18
197062|NCT00459355|461141|P1|NOT COMPLETED|Overall Study||20
197063|NCT00459355|461140|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
197064|NCT00459355|461141|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
197065|NCT00459355|461140|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
197066|NCT00459355|461141|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
197067|NCT00459342|461153|P1|NOT COMPLETED|Overall Study||1
197068|NCT00459342|461153|P1|COMPLETED|Overall Study||34
197069|NCT00459342|461153|P1|STARTED|Overall Study||35
197070|NCT00459316|461162|P3|NOT COMPLETED|Step 3||1
197071|NCT00459316|461163|P2|NOT COMPLETED|Step 3||0
197072|NCT00459316|461164|P1|NOT COMPLETED|Step 3||3
197073|NCT00459316|461162|P3|COMPLETED|Step 3||39
197074|NCT00459316|461163|P2|COMPLETED|Step 3||0
197075|NCT00459316|461164|P1|COMPLETED|Step 3||149
197076|NCT00459316|461162|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
197077|NCT00459316|461163|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
197078|NCT00459316|461164|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
197079|NCT00459316|461162|P3|NOT COMPLETED|Steps 1 & 2||2
197080|NCT00459316|461163|P2|NOT COMPLETED|Steps 1 & 2||7
197081|NCT00459316|461164|P1|NOT COMPLETED|Steps 1 & 2||21
197082|NCT00459316|461162|P3|COMPLETED|Steps 1 & 2||57
197083|NCT00459316|461163|P2|COMPLETED|Steps 1 & 2||32
197084|NCT00459316|461164|P1|COMPLETED|Steps 1 & 2||259
197085|NCT00459316|461162|P3|STARTED|Steps 1 & 2||59
197086|NCT00459316|461163|P2|STARTED|Steps 1 & 2||39
197087|NCT00459316|461164|P1|STARTED|Steps 1 & 2||280
197088|NCT00459303|461218|P1|NOT COMPLETED|Overall Study||0
197089|NCT00459303|461218|P1|COMPLETED|Overall Study||20
197090|NCT00459303|461218|P1|STARTED|Overall Study||20
197091|NCT00459290|461229|P1|NOT COMPLETED|Overall Study||5
197092|NCT00459290|461229|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
197093|NCT00459290|461229|P1|STARTED|Overall Study||24
197094|NCT00459186|461243|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
197095|NCT00459186|461243|P1|COMPLETED|Combination RAD001 + Docetaxel||15
197096|NCT00459186|461243|P1|STARTED|Combination RAD001 + Docetaxel||15
197097|NCT00459186|461243|P1|NOT COMPLETED|PET Imaging and Assessment||3
197098|NCT00459186|461243|P1|COMPLETED|PET Imaging and Assessment||15
197099|NCT00459186|461243|P1|STARTED|PET Imaging and Assessment||18
197100|NCT00459186|461243|P1|NOT COMPLETED|Single Agent RAD001||1
197101|NCT00459186|461243|P1|COMPLETED|Single Agent RAD001||18
197102|NCT00459186|461243|P1|STARTED|Single Agent RAD001||19
197103|NCT00459134|461250|P2|NOT COMPLETED|Overall Study||25
197104|NCT00459134|461251|P1|NOT COMPLETED|Overall Study||23
197105|NCT00459134|461250|P2|COMPLETED|Overall Study||67
197106|NCT00459134|461251|P1|COMPLETED|Overall Study||71
197107|NCT00459134|461250|P2|STARTED|Overall Study||92
197108|NCT00459134|461251|P1|STARTED|Overall Study||94
197109|NCT00459121|461259|P1|NOT COMPLETED|Overall Study||0
197110|NCT00459121|461259|P1|COMPLETED|Overall Study||2
197111|NCT00459121|461259|P1|STARTED|Overall Study||2
197112|NCT00459108|461263|P1|NOT COMPLETED|Overall Study||11
197113|NCT00459108|461263|P1|COMPLETED|Overall Study||14
197114|NCT00459108|461263|P1|STARTED|Overall Study||25
197115|NCT00459056|461270|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
197116|NCT00459056|461271|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
197117|NCT00459056|461270|P2|COMPLETED|Second Intervention (Final Three Months)||14
197118|NCT00459056|461271|P1|COMPLETED|Second Intervention (Final Three Months)||9
197119|NCT00459056|461270|P2|STARTED|Second Intervention (Final Three Months)||14
197120|NCT00459056|461271|P1|STARTED|Second Intervention (Final Three Months)||9
197121|NCT00459056|461270|P2|NOT COMPLETED|Washout (1 Month)||0
197122|NCT00459056|461271|P1|NOT COMPLETED|Washout (1 Month)||0
197123|NCT00459056|461270|P2|COMPLETED|Washout (1 Month)||14
197124|NCT00459056|461271|P1|COMPLETED|Washout (1 Month)||9
197125|NCT00459056|461270|P2|STARTED|Washout (1 Month)||14
197126|NCT00459056|461271|P1|STARTED|Washout (1 Month)||9
197127|NCT00459056|461270|P2|NOT COMPLETED|First Intervention (First Three Months)||1
197128|NCT00459056|461271|P1|NOT COMPLETED|First Intervention (First Three Months)||1
197129|NCT00459056|461270|P2|COMPLETED|First Intervention (First Three Months)||14
197130|NCT00459056|461271|P1|COMPLETED|First Intervention (First Three Months)||9
197131|NCT00459056|461270|P2|STARTED|First Intervention (First Three Months)||15
197132|NCT00459056|461271|P1|STARTED|First Intervention (First Three Months)||10
197133|NCT00459043|461279|P2|NOT COMPLETED|Overall Study||0
197134|NCT00459043|461280|P1|NOT COMPLETED|Overall Study||1
197135|NCT00459043|461279|P2|COMPLETED|Overall Study||15
197136|NCT00459043|461280|P1|COMPLETED|Overall Study||14
197137|NCT00459043|461279|P2|STARTED|Overall Study||15
197138|NCT00459043|461280|P1|STARTED|Overall Study||15
197139|NCT00458952|461292|P2|NOT COMPLETED|Overall Study||5
197140|NCT00458952|461293|P1|NOT COMPLETED|Overall Study||2
197141|NCT00458952|461292|P2|COMPLETED|Overall Study||9
197142|NCT00458952|461293|P1|COMPLETED|Overall Study||5
197143|NCT00458952|461292|P2|STARTED|Overall Study||14
197144|NCT00458952|461293|P1|STARTED|Overall Study||7
197145|NCT00458822|461297|P1|NOT COMPLETED|Overall Study||0
197146|NCT00458822|461297|P1|COMPLETED|Overall Study||40
197147|NCT00458822|461297|P1|STARTED|Overall Study||40
197148|NCT00458705|461301|P1|NOT COMPLETED|Overall Study||5
197149|NCT00458705|461301|P1|COMPLETED|Overall Study||40
197150|NCT00458705|461301|P1|STARTED|Overall Study||45
197151|NCT00458536|461305|P1|NOT COMPLETED|Overall Study||19
197152|NCT00458536|461305|P1|COMPLETED|Overall Study||19
197153|NCT00458536|461305|P1|STARTED|Overall Study||38
197154|NCT00458406|461311|P2|NOT COMPLETED|Month 3||0
197155|NCT00458406|461312|P1|NOT COMPLETED|Month 3||0
197156|NCT00458406|461311|P2|COMPLETED|Month 3||13
197157|NCT00458406|461312|P1|COMPLETED|Month 3||43
197158|NCT00458406|461311|P2|STARTED|Month 3||13
197159|NCT00458406|461312|P1|STARTED|Month 3||43
197160|NCT00458406|461311|P2|NOT COMPLETED|Month 1||0
197161|NCT00458406|461312|P1|NOT COMPLETED|Month 1||0
197162|NCT00458406|461311|P2|COMPLETED|Month 1||13
197163|NCT00458406|461312|P1|COMPLETED|Month 1||43
197164|NCT00458406|461311|P2|STARTED|Month 1||13
197165|NCT00458406|461312|P1|STARTED|Month 1||43
197166|NCT00458302|461332|P2|NOT COMPLETED|Overall Study||24
197167|NCT00458302|461333|P1|NOT COMPLETED|Overall Study||20
197168|NCT00458302|461332|P2|COMPLETED|Overall Study||103
197169|NCT00458302|461333|P1|COMPLETED|Overall Study||109
197170|NCT00458302|461332|P2|STARTED|Overall Study||127
197171|NCT00458302|461333|P1|STARTED|Overall Study||129
197172|NCT00458237|461367|P3|NOT COMPLETED|Overall Study||0
197173|NCT00458237|461368|P2|NOT COMPLETED|Overall Study||0
197174|NCT00458237|461369|P1|NOT COMPLETED|Overall Study||0
197175|NCT00458237|461367|P3|COMPLETED|Overall Study||5
197176|NCT00458237|461368|P2|COMPLETED|Overall Study||3
197177|NCT00458237|461369|P1|COMPLETED|Overall Study||3
197178|NCT00458237|461367|P3|STARTED|Overall Study||5
197179|NCT00458237|461368|P2|STARTED|Overall Study||3
197180|NCT00458237|461369|P1|STARTED|Overall Study||3
197181|NCT00458211|461378|P1|NOT COMPLETED|Overall Study||16
197182|NCT00458211|461378|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
197183|NCT00458211|461378|P1|STARTED|Overall Study||40
197184|NCT00457977|461391|P2|NOT COMPLETED|Overall Study||25
197185|NCT00457977|461392|P1|NOT COMPLETED|Overall Study||28
197186|NCT00457977|461391|P2|COMPLETED|Overall Study||66
197187|NCT00457977|461392|P1|COMPLETED|Overall Study||62
197188|NCT00457977|461391|P2|2-Year|Overall Study||66
197189|NCT00457977|461392|P1|2-Year|Overall Study||62
197190|NCT00457977|461391|P2|1-Year|Overall Study||76
197191|NCT00457977|461392|P1|1-Year|Overall Study||69
197192|NCT00457977|461391|P2|1-Month|Overall Study||87
197193|NCT00457977|461392|P1|1-Month|Overall Study||88
197194|NCT00457977|461391|P2|STARTED|Overall Study||91
197195|NCT00457977|461392|P1|STARTED|Overall Study||90
197196|NCT00457951|461403|P3|NOT COMPLETED|Overall Study||12
197197|NCT00457951|461404|P2|NOT COMPLETED|Overall Study||16
197198|NCT00457951|461405|P1|NOT COMPLETED|Overall Study||0
197199|NCT00457951|461403|P3|COMPLETED|Overall Study||60
197200|NCT00457951|461404|P2|COMPLETED|Overall Study||50
197201|NCT00457951|461405|P1|COMPLETED|Overall Study||13
197202|NCT00457951|461403|P3|STARTED|Overall Study||72
197203|NCT00457951|461404|P2|STARTED|Overall Study||66
197204|NCT00457951|461405|P1|STARTED|Overall Study||13
197205|NCT00457821|461420|P8|NOT COMPLETED|Part 2||1
197206|NCT00457821|461421|P7|NOT COMPLETED|Part 2||0
197207|NCT00457821|461422|P6|NOT COMPLETED|Part 2||0
197208|NCT00457821|461423|P5|NOT COMPLETED|Part 2||0
197209|NCT00457821|461424|P4|NOT COMPLETED|Part 2||0
197210|NCT00457821|461425|P3|NOT COMPLETED|Part 2||0
197211|NCT00457821|461426|P2|NOT COMPLETED|Part 2||0
197212|NCT00457821|461427|P1|NOT COMPLETED|Part 2||0
197213|NCT00457821|461420|P8|COMPLETED|Part 2||4
197214|NCT00457821|461421|P7|COMPLETED|Part 2||7
197215|NCT00457821|461422|P6|COMPLETED|Part 2||8
197216|NCT00457821|461423|P5|COMPLETED|Part 2||0
197217|NCT00457821|461424|P4|COMPLETED|Part 2||0
197218|NCT00457821|461425|P3|COMPLETED|Part 2||0
197219|NCT00457821|461426|P2|COMPLETED|Part 2||0
197220|NCT00457821|461427|P1|COMPLETED|Part 2||0
197221|NCT00457821|461420|P8|Completed Study Drug Treatment|Part 2||4
197222|NCT00457821|461421|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
197223|NCT00457821|461422|P6|Completed Study Drug Treatment|Part 2||8
197224|NCT00457821|461423|P5|Completed Study Drug Treatment|Part 2||0
197225|NCT00457821|461424|P4|Completed Study Drug Treatment|Part 2||0
197226|NCT00457821|461425|P3|Completed Study Drug Treatment|Part 2||0
197227|NCT00457821|461426|P2|Completed Study Drug Treatment|Part 2||0
197228|NCT00457821|461427|P1|Completed Study Drug Treatment|Part 2||0
197229|NCT00457821|461420|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
197230|NCT00457821|461421|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
197231|NCT00457821|461422|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
197232|NCT00457821|461423|P5|STARTED|Part 2|Arm in Part 1 only|0
197233|NCT00457821|461424|P4|STARTED|Part 2|Arm in Part 1 only|0
197234|NCT00457821|461425|P3|STARTED|Part 2|Arm in Part 1 only|0
197235|NCT00457821|461426|P2|STARTED|Part 2|Arm in Part 1 only|0
197236|NCT00457821|461427|P1|STARTED|Part 2|Arm in Part 1 only|0
197237|NCT00457821|461420|P8|NOT COMPLETED|Part 1||0
197238|NCT00457821|461421|P7|NOT COMPLETED|Part 1||0
197239|NCT00457821|461422|P6|NOT COMPLETED|Part 1||0
197240|NCT00457821|461423|P5|NOT COMPLETED|Part 1||0
197241|NCT00457821|461424|P4|NOT COMPLETED|Part 1||0
197242|NCT00457821|461425|P3|NOT COMPLETED|Part 1||1
197243|NCT00457821|461426|P2|NOT COMPLETED|Part 1||0
197244|NCT00457821|461427|P1|NOT COMPLETED|Part 1||0
197245|NCT00457821|461420|P8|COMPLETED|Part 1||0
197246|NCT00457821|461421|P7|COMPLETED|Part 1||0
197247|NCT00457821|461422|P6|COMPLETED|Part 1||0
197248|NCT00457821|461423|P5|COMPLETED|Part 1||4
197249|NCT00457821|461424|P4|COMPLETED|Part 1||4
197250|NCT00457821|461425|P3|COMPLETED|Part 1||4
197251|NCT00457821|461426|P2|COMPLETED|Part 1||4
197252|NCT00457821|461427|P1|COMPLETED|Part 1||4
197253|NCT00457821|461420|P8|STARTED|Part 1|Arm in Part 2 only|0
197254|NCT00457821|461421|P7|STARTED|Part 1|Arm in Part 2 only|0
197255|NCT00457821|461422|P6|STARTED|Part 1|Arm in Part 2 only|0
197256|NCT00457821|461423|P5|STARTED|Part 1|Number of subjects randomized|4
197257|NCT00457821|461424|P4|STARTED|Part 1|Number of subjects randomized|4
197258|NCT00457821|461425|P3|STARTED|Part 1|Number of subjects randomized|5
197259|NCT00457821|461426|P2|STARTED|Part 1|Number of subjects randomized|4
197260|NCT00457821|461427|P1|STARTED|Part 1|Number of subjects randomized|4
197261|NCT00457795|461456|P1|NOT COMPLETED|Overall Study||0
197262|NCT00457795|461456|P1|COMPLETED|Overall Study||15
197263|NCT00457795|461456|P1|STARTED|Overall Study||15
197264|NCT00457743|461466|P3|NOT COMPLETED|Overall Study||3
197265|NCT00457743|461467|P2|NOT COMPLETED|Overall Study||27
197266|NCT00457743|461468|P1|NOT COMPLETED|Overall Study||3
197267|NCT00457743|461466|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
197268|NCT00457743|461467|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
197269|NCT00457743|461468|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
197270|NCT00457743|461466|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
197271|NCT00457743|461467|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
197272|NCT00457743|461468|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
197273|NCT00457743|461466|P3|Completed Phase 1|Overall Study||3
197274|NCT00457743|461467|P2|Completed Phase 1|Overall Study||6
197275|NCT00457743|461468|P1|Completed Phase 1|Overall Study||3
197276|NCT00457743|461466|P3|Enrolled in Phase 1|Overall Study||3
197277|NCT00457743|461467|P2|Enrolled in Phase 1|Overall Study||6
197278|NCT00457743|461468|P1|Enrolled in Phase 1|Overall Study||3
197279|NCT00457743|461466|P3|STARTED|Overall Study|Overall study|3
197280|NCT00457743|461467|P2|STARTED|Overall Study|Overall study|30
197281|NCT00457743|461468|P1|STARTED|Overall Study|Overall study|3
197282|NCT00457730|461512|P2|NOT COMPLETED|Overall Study||1
197283|NCT00457730|461513|P1|NOT COMPLETED|Overall Study||4
197284|NCT00457730|461512|P2|COMPLETED|Overall Study||19
197285|NCT00457730|461513|P1|COMPLETED|Overall Study||14
197286|NCT00457730|461512|P2|STARTED|Overall Study||20
197287|NCT00457730|461513|P1|STARTED|Overall Study||18
197288|NCT00457691|461525|P2|NOT COMPLETED|Overall Study||382
197289|NCT00457691|461526|P1|NOT COMPLETED|Overall Study||386
197290|NCT00457691|461525|P2|COMPLETED|Overall Study||0
197291|NCT00457691|461526|P1|COMPLETED|Overall Study||0
197292|NCT00457691|461525|P2|STARTED|Overall Study||382
197293|NCT00457691|461526|P1|STARTED|Overall Study||386
197294|NCT00456547|461548|P2|NOT COMPLETED|Overall Study||0
197295|NCT00456547|461549|P1|NOT COMPLETED|Overall Study||0
197296|NCT00456547|461548|P2|COMPLETED|Overall Study||12
197297|NCT00456547|461549|P1|COMPLETED|Overall Study||12
197298|NCT00456547|461548|P2|STARTED|Overall Study||12
197299|NCT00456547|461549|P1|STARTED|Overall Study||12
197300|NCT00456521|461563|P2|NOT COMPLETED|Overall Study||84
197301|NCT00456521|461564|P1|NOT COMPLETED|Overall Study||249
197302|NCT00456521|461563|P2|COMPLETED|Overall Study||118
197303|NCT00456521|461564|P1|COMPLETED|Overall Study||342
197304|NCT00456521|461563|P2|STARTED|Overall Study||202
197305|NCT00456521|461564|P1|STARTED|Overall Study||591
197306|NCT00456508|461604|P1|NOT COMPLETED|Overall Study||0
197307|NCT00456508|461604|P1|COMPLETED|Overall Study||147
197308|NCT00456508|461604|P1|STARTED|Overall Study||147
197309|NCT00456495|461610|P1|NOT COMPLETED|Overall Study||2
197310|NCT00456495|461610|P1|COMPLETED|Overall Study||3
197311|NCT00456495|461610|P1|STARTED|Overall Study||5
197312|NCT00457418|461614|P1|NOT COMPLETED|Post PK Maintenance||28
197313|NCT00457418|461614|P1|COMPLETED|Post PK Maintenance||3
197314|NCT00457418|461614|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
197315|NCT00457418|461614|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
197316|NCT00457418|461614|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
197317|NCT00457418|461614|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
197318|NCT00457392|461626|P2|NOT COMPLETED|Overall Study||480
197319|NCT00457392|461627|P1|NOT COMPLETED|Overall Study||480
197320|NCT00457392|461626|P2|COMPLETED|Overall Study||0
197321|NCT00457392|461627|P1|COMPLETED|Overall Study||0
197322|NCT00457392|461626|P2|Treated|Overall Study||477
197323|NCT00457392|461627|P1|Treated|Overall Study||473
197324|NCT00457392|461626|P2|STARTED|Overall Study||480
197325|NCT00457392|461627|P1|STARTED|Overall Study||480
197326|NCT00457301|461645|P2|NOT COMPLETED|Overall Study||24
197327|NCT00457301|461646|P1|NOT COMPLETED|Overall Study||23
197328|NCT00457301|461645|P2|COMPLETED|Overall Study||84
197329|NCT00457301|461646|P1|COMPLETED|Overall Study||82
197330|NCT00457301|461645|P2|STARTED|Overall Study||108
197331|NCT00457301|461646|P1|STARTED|Overall Study||105
197332|NCT00457249|461660|P2|NOT COMPLETED|Overall Study||2
197333|NCT00457249|461661|P1|NOT COMPLETED|Overall Study||12
197334|NCT00457249|461660|P2|COMPLETED|Overall Study||389
197335|NCT00457249|461661|P1|COMPLETED|Overall Study||1158
197336|NCT00457249|461660|P2|STARTED|Overall Study||391
197337|NCT00457249|461661|P1|STARTED|Overall Study||1170
197338|NCT00457197|461675|P2|NOT COMPLETED|Overall Study||1
197339|NCT00457197|461676|P1|NOT COMPLETED|Overall Study||1
197340|NCT00457197|461675|P2|COMPLETED|Overall Study||44
197341|NCT00457197|461676|P1|COMPLETED|Overall Study||44
197342|NCT00457197|461675|P2|STARTED|Overall Study||45
197343|NCT00457197|461676|P1|STARTED|Overall Study||45
197344|NCT00457015|461700|P2|NOT COMPLETED|Overall Study||1
197345|NCT00457015|461701|P1|NOT COMPLETED|Overall Study||0
197346|NCT00457015|461700|P2|COMPLETED|Overall Study||47
197347|NCT00457015|461701|P1|COMPLETED|Overall Study||48
197348|NCT00457015|461700|P2|STARTED|Overall Study||48
197349|NCT00457015|461701|P1|STARTED|Overall Study||48
197350|NCT00457002|461717|P2|NOT COMPLETED|Overall Study||757
197351|NCT00457002|461718|P1|NOT COMPLETED|Overall Study||813
197352|NCT00457002|461717|P2|COMPLETED|Overall Study||2516
197353|NCT00457002|461718|P1|COMPLETED|Overall Study||2442
197354|NCT00457002|461717|P2|STARTED|Overall Study||3273
197355|NCT00457002|461718|P1|STARTED|Overall Study||3255
197356|NCT00456989|461786|P1|NOT COMPLETED|Overall Study||0
197357|NCT00456989|461786|P1|COMPLETED|Overall Study||39
197358|NCT00456989|461786|P1|STARTED|Overall Study||39
197359|NCT00456846|461792|P2|NOT COMPLETED|Overall Study||28
197360|NCT00456846|461793|P1|NOT COMPLETED|Overall Study||16
197361|NCT00456846|461792|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
197362|NCT00456846|461793|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
197363|NCT00456846|461792|P2|STARTED|Overall Study||76
197364|NCT00456846|461793|P1|STARTED|Overall Study||47
197365|NCT00456807|461815|P2|NOT COMPLETED|Overall Study||0
197366|NCT00456807|461816|P1|NOT COMPLETED|Overall Study||1
197367|NCT00456807|461815|P2|COMPLETED|Overall Study||47
197368|NCT00456807|461816|P1|COMPLETED|Overall Study||52
197369|NCT00456807|461815|P2|STARTED|Overall Study||47
197370|NCT00456807|461816|P1|STARTED|Overall Study||53
197371|NCT00456755|461834|P2|NOT COMPLETED|Overall Study||1
197372|NCT00456755|461835|P1|NOT COMPLETED|Overall Study||2
197373|NCT00456755|461834|P2|COMPLETED|Overall Study||62
197374|NCT00456755|461835|P1|COMPLETED|Overall Study||61
197375|NCT00456755|461834|P2|STARTED|Overall Study||63
197376|NCT00456755|461835|P1|STARTED|Overall Study||63
197377|NCT00456625|461843|P1|NOT COMPLETED|Overall Study||0
197378|NCT00456625|461843|P1|COMPLETED|Overall Study||76
197379|NCT00456625|461843|P1|STARTED|Overall Study||76
197380|NCT00456612|461849|P1|NOT COMPLETED|Overall Study||3
197381|NCT00456612|461849|P1|COMPLETED|Overall Study||1
197382|NCT00456612|461849|P1|STARTED|Overall Study||4
197383|NCT00456599|461854|P1|NOT COMPLETED|Overall Study||3
197384|NCT00456599|461854|P1|COMPLETED|Overall Study||68
197385|NCT00456599|461854|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
197386|NCT00456599|461854|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
197387|NCT00456599|461854|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
197388|NCT00456599|461854|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
197389|NCT00456599|461854|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
197390|NCT00456599|461854|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
197391|NCT00456599|461854|P1|STARTED|Overall Study||71
197392|NCT00456261|461862|P2|NOT COMPLETED|Maintenance Therapy||0
197393|NCT00456261|461863|P1|NOT COMPLETED|Maintenance Therapy||0
197394|NCT00456261|461862|P2|COMPLETED|Maintenance Therapy||29
197395|NCT00456261|461863|P1|COMPLETED|Maintenance Therapy||3
197396|NCT00456261|461862|P2|STARTED|Maintenance Therapy||29
197397|NCT00456261|461863|P1|STARTED|Maintenance Therapy||3
197398|NCT00456261|461862|P2|NOT COMPLETED|Combination Therapy||26
197399|NCT00456261|461863|P1|NOT COMPLETED|Combination Therapy||52
197400|NCT00456261|461862|P2|COMPLETED|Combination Therapy||29
197401|NCT00456261|461863|P1|COMPLETED|Combination Therapy||3
197402|NCT00456261|461862|P2|STARTED|Combination Therapy||55
197403|NCT00456261|461863|P1|STARTED|Combination Therapy||55
197404|NCT00455975|461875|P2|NOT COMPLETED|Overall Study||21
197405|NCT00455975|461876|P1|NOT COMPLETED|Overall Study||18
197406|NCT00455975|461875|P2|COMPLETED|Overall Study||40
197407|NCT00455975|461876|P1|COMPLETED|Overall Study||40
197408|NCT00455975|461875|P2|STARTED|Overall Study||61
197409|NCT00455975|461876|P1|STARTED|Overall Study||58
197410|NCT00455858|461888|P1|NOT COMPLETED|Overall Study||6
197411|NCT00455858|461888|P1|COMPLETED|Overall Study||81
197412|NCT00455858|461888|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
197413|NCT00455702|461898|P2|NOT COMPLETED|Overall Study||3
197414|NCT00455702|461899|P1|NOT COMPLETED|Overall Study||3
197415|NCT00455702|461898|P2|COMPLETED|Overall Study||16
197416|NCT00455702|461899|P1|COMPLETED|Overall Study||16
197417|NCT00455702|461898|P2|STARTED|Overall Study||19
197418|NCT00455702|461899|P1|STARTED|Overall Study||19
197419|NCT00455663|461910|P3|NOT COMPLETED|Overall Study||3
197420|NCT00455663|461911|P2|NOT COMPLETED|Overall Study||4
197421|NCT00455663|461912|P1|NOT COMPLETED|Overall Study||3
197422|NCT00455663|461910|P3|COMPLETED|Overall Study||29
197423|NCT00455663|461911|P2|COMPLETED|Overall Study||32
197424|NCT00455663|461912|P1|COMPLETED|Overall Study||34
197425|NCT00455663|461910|P3|STARTED|Overall Study||32
197426|NCT00455663|461911|P2|STARTED|Overall Study||36
197427|NCT00455663|461912|P1|STARTED|Overall Study||37
197428|NCT00455533|461931|P3|NOT COMPLETED|Period Two: Randomized Period||6
197429|NCT00455533|461932|P2|NOT COMPLETED|Period Two: Randomized Period||6
197430|NCT00455533|461933|P1|NOT COMPLETED|Period Two: Randomized Period||0
197431|NCT00455533|461931|P3|COMPLETED|Period Two: Randomized Period||138
197432|NCT00455533|461932|P2|COMPLETED|Period Two: Randomized Period||139
197433|NCT00455533|461933|P1|COMPLETED|Period Two: Randomized Period||0
197434|NCT00455533|461931|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
197435|NCT00455533|461932|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
197436|NCT00455533|461933|P1|STARTED|Period Two: Randomized Period||0
197437|NCT00455533|461931|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
197438|NCT00455533|461932|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
197439|NCT00455533|461933|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
197440|NCT00455533|461931|P3|COMPLETED|Period One: Initial Chemotherapy||0
197441|NCT00455533|461932|P2|COMPLETED|Period One: Initial Chemotherapy||0
197442|NCT00455533|461933|P1|COMPLETED|Period One: Initial Chemotherapy||295
197443|NCT00455533|461931|P3|STARTED|Period One: Initial Chemotherapy||0
197444|NCT00455533|461932|P2|STARTED|Period One: Initial Chemotherapy||0
197445|NCT00455533|461933|P1|STARTED|Period One: Initial Chemotherapy||313
197446|NCT00455520|461982|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
197447|NCT00455520|461983|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
197448|NCT00455520|461982|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
197449|NCT00455520|461983|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
197450|NCT00455520|461982|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
197533|NCT00454987|462172|P1|COMPLETED|Year 4||206
197451|NCT00455520|461983|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
197452|NCT00455520|461982|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
197453|NCT00455520|461983|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
197454|NCT00455520|461982|P2|COMPLETED|Open Label Tapentadol Extended Release||0
197455|NCT00455520|461983|P1|COMPLETED|Open Label Tapentadol Extended Release||395
197456|NCT00455520|461982|P2|STARTED|Open Label Tapentadol Extended Release||0
197457|NCT00455520|461983|P1|STARTED|Open Label Tapentadol Extended Release||591
197458|NCT00455455|461999|P2|NOT COMPLETED|Second Intervention||0
197459|NCT00455455|462000|P1|NOT COMPLETED|Second Intervention||0
197460|NCT00455455|461999|P2|COMPLETED|Second Intervention||24
197461|NCT00455455|462000|P1|COMPLETED|Second Intervention||24
197462|NCT00455455|461999|P2|STARTED|Second Intervention||24
197463|NCT00455455|462000|P1|STARTED|Second Intervention||24
197464|NCT00455455|461999|P2|NOT COMPLETED|Washout||0
197465|NCT00455455|462000|P1|NOT COMPLETED|Washout||1
197466|NCT00455455|461999|P2|COMPLETED|Washout||24
197467|NCT00455455|462000|P1|COMPLETED|Washout||24
197468|NCT00455455|461999|P2|STARTED|Washout||24
197469|NCT00455455|462000|P1|STARTED|Washout||25
197470|NCT00455455|461999|P2|NOT COMPLETED|First Intervention||0
197471|NCT00455455|462000|P1|NOT COMPLETED|First Intervention||0
197472|NCT00455455|461999|P2|COMPLETED|First Intervention||24
197473|NCT00455455|462000|P1|COMPLETED|First Intervention||25
197474|NCT00455455|461999|P2|STARTED|First Intervention||24
197475|NCT00455455|462000|P1|STARTED|First Intervention||25
197476|NCT00455455|461999|P2|NOT COMPLETED|Washout||1
197477|NCT00455455|462000|P1|NOT COMPLETED|Washout||0
197478|NCT00455455|461999|P2|COMPLETED|Washout||24
197479|NCT00455455|462000|P1|COMPLETED|Washout||25
197480|NCT00455455|461999|P2|STARTED|Washout||25
197481|NCT00455455|462000|P1|STARTED|Washout||25
197482|NCT00455429|462020|P4|NOT COMPLETED|Overall Study||14
197483|NCT00455429|462021|P3|NOT COMPLETED|Overall Study||1
197484|NCT00455429|462022|P2|NOT COMPLETED|Overall Study||5
197485|NCT00455429|462023|P1|NOT COMPLETED|Overall Study||2
197486|NCT00455429|462020|P4|COMPLETED|Overall Study||20
197487|NCT00455429|462021|P3|COMPLETED|Overall Study||16
197488|NCT00455429|462022|P2|COMPLETED|Overall Study||10
197489|NCT00455429|462023|P1|COMPLETED|Overall Study||16
197490|NCT00455429|462020|P4|Treated|Overall Study||32
197491|NCT00455429|462021|P3|Treated|Overall Study||17
197492|NCT00455429|462022|P2|Treated|Overall Study||15
197493|NCT00455429|462023|P1|Treated|Overall Study||18
197494|NCT00455429|462020|P4|STARTED|Overall Study||34
197495|NCT00455429|462021|P3|STARTED|Overall Study||17
197496|NCT00455429|462022|P2|STARTED|Overall Study||15
197497|NCT00455429|462023|P1|STARTED|Overall Study||18
197498|NCT00455195|462082|P2|NOT COMPLETED|Extension Study AGLU03206||0
197499|NCT00455195|462083|P1|NOT COMPLETED|Extension Study AGLU03206||0
197500|NCT00455195|462082|P2|COMPLETED|Extension Study AGLU03206||26
197501|NCT00455195|462083|P1|COMPLETED|Extension Study AGLU03206||55
197502|NCT00455195|462082|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
197503|NCT00455195|462083|P1|STARTED|Extension Study AGLU03206||55
197504|NCT00455195|462082|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
197505|NCT00455195|462083|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
197506|NCT00455195|462082|P2|COMPLETED|Double-blind Study AGLU02704||26
197507|NCT00455195|462083|P1|COMPLETED|Double-blind Study AGLU02704||55
197508|NCT00455195|462082|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
197509|NCT00455195|462083|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
197510|NCT00455013|462100|P3|NOT COMPLETED|Long Term Extension (LTE)||7
197511|NCT00455013|462101|P2|NOT COMPLETED|Long Term Extension (LTE)||3
197512|NCT00455013|462102|P1|NOT COMPLETED|Long Term Extension (LTE)||2
197513|NCT00455013|462100|P3|COMPLETED|Long Term Extension (LTE)||20
197514|NCT00455013|462101|P2|COMPLETED|Long Term Extension (LTE)||16
197515|NCT00455013|462102|P1|COMPLETED|Long Term Extension (LTE)||25
197516|NCT00455013|462100|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
197517|NCT00455013|462101|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
197518|NCT00455013|462102|P1|STARTED|Long Term Extension (LTE)||27
197519|NCT00455013|462100|P3|NOT COMPLETED|Short Term Period||2
197520|NCT00455013|462101|P2|NOT COMPLETED|Short Term Period||5
197521|NCT00455013|462102|P1|NOT COMPLETED|Short Term Period||6
197522|NCT00455013|462100|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
197523|NCT00455013|462101|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
197524|NCT00455013|462102|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
197525|NCT00455013|462100|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
197526|NCT00455013|462101|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
197527|NCT00455013|462102|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
197528|NCT00454987|462170|P3|NOT COMPLETED|Year 4||0
197529|NCT00454987|462171|P2|NOT COMPLETED|Year 4||0
197530|NCT00454987|462172|P1|NOT COMPLETED|Year 4||0
197531|NCT00454987|462170|P3|COMPLETED|Year 4||0
197532|NCT00454987|462171|P2|COMPLETED|Year 4||62
197534|NCT00454987|462170|P3|STARTED|Year 4||0
197535|NCT00454987|462171|P2|STARTED|Year 4||62
197536|NCT00454987|462172|P1|STARTED|Year 4||206
197537|NCT00454987|462170|P3|NOT COMPLETED|Year 2||0
197538|NCT00454987|462171|P2|NOT COMPLETED|Year 2||0
197539|NCT00454987|462172|P1|NOT COMPLETED|Year 2||0
197540|NCT00454987|462170|P3|COMPLETED|Year 2||74
197541|NCT00454987|462171|P2|COMPLETED|Year 2||77
197542|NCT00454987|462172|P1|COMPLETED|Year 2||235
197543|NCT00454987|462170|P3|STARTED|Year 2||74
197544|NCT00454987|462171|P2|STARTED|Year 2||77
197545|NCT00454987|462172|P1|STARTED|Year 2||235
197546|NCT00454987|462170|P3|NOT COMPLETED|Year 1||0
197547|NCT00454987|462171|P2|NOT COMPLETED|Year 1||0
197548|NCT00454987|462172|P1|NOT COMPLETED|Year 1||0
197549|NCT00454987|462170|P3|COMPLETED|Year 1||0
197550|NCT00454987|462171|P2|COMPLETED|Year 1||67
197551|NCT00454987|462172|P1|COMPLETED|Year 1||221
197552|NCT00454987|462170|P3|STARTED|Year 1||0
197553|NCT00454987|462171|P2|STARTED|Year 1||67
197554|NCT00454987|462172|P1|STARTED|Year 1||221
197555|NCT00454987|462170|P3|NOT COMPLETED|Booster Period||0
197556|NCT00454987|462171|P2|NOT COMPLETED|Booster Period||1
197557|NCT00454987|462172|P1|NOT COMPLETED|Booster Period||2
197558|NCT00454987|462170|P3|COMPLETED|Booster Period||0
197559|NCT00454987|462171|P2|COMPLETED|Booster Period||116
197560|NCT00454987|462172|P1|COMPLETED|Booster Period||357
197561|NCT00454987|462170|P3|STARTED|Booster Period||0
197562|NCT00454987|462171|P2|STARTED|Booster Period||117
197563|NCT00454987|462172|P1|STARTED|Booster Period||359
197564|NCT00454857|462243|P1|NOT COMPLETED|Overall Study||54
197565|NCT00454857|462243|P1|COMPLETED|Overall Study||272
197566|NCT00454857|462243|P1|Completed ≥1 Observational Study Visit|Overall Study||319
197567|NCT00454857|462243|P1|Completed Retrospective Chart Review|Overall Study||324
197568|NCT00454857|462243|P1|STARTED|Overall Study||326
197569|NCT00454818|462268|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
197570|NCT00454818|462269|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
197571|NCT00454818|462270|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
197572|NCT00454818|462271|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
197573|NCT00454818|462272|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
197574|NCT00454818|462268|P5|COMPLETED|Phase 2: Randomized Double-blind||10
197575|NCT00454818|462269|P4|COMPLETED|Phase 2: Randomized Double-blind||8
197576|NCT00454818|462270|P3|COMPLETED|Phase 2: Randomized Double-blind||5
197577|NCT00454818|462271|P2|COMPLETED|Phase 2: Randomized Double-blind||6
197578|NCT00454818|462272|P1|COMPLETED|Phase 2: Randomized Double-blind||0
197579|NCT00454818|462268|P5|STARTED|Phase 2: Randomized Double-blind||14
197580|NCT00454818|462269|P4|STARTED|Phase 2: Randomized Double-blind||9
197581|NCT00454818|462270|P3|STARTED|Phase 2: Randomized Double-blind||8
197582|NCT00454818|462271|P2|STARTED|Phase 2: Randomized Double-blind||8
197583|NCT00454818|462272|P1|STARTED|Phase 2: Randomized Double-blind||0
197584|NCT00454818|462268|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
197585|NCT00454818|462269|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
197586|NCT00454818|462270|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
197587|NCT00454818|462271|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
197588|NCT00454818|462272|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
197589|NCT00454818|462268|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
197590|NCT00454818|462269|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
197591|NCT00454818|462270|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
197592|NCT00454818|462271|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
197593|NCT00454818|462272|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
197594|NCT00454818|462268|P5|STARTED|Phase I: Open-label Dose-escalation||0
197595|NCT00454818|462269|P4|STARTED|Phase I: Open-label Dose-escalation||3
197596|NCT00454818|462270|P3|STARTED|Phase I: Open-label Dose-escalation||3
197597|NCT00454818|462271|P2|STARTED|Phase I: Open-label Dose-escalation||3
197598|NCT00454818|462272|P1|STARTED|Phase I: Open-label Dose-escalation||3
197599|NCT00454805|462351|P2|NOT COMPLETED|Overall Study||23
197600|NCT00454805|462352|P1|NOT COMPLETED|Overall Study||26
197601|NCT00454805|462351|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
197602|NCT00454805|462352|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
197603|NCT00454805|462351|P2|STARTED|Overall Study|Randomised|31
197604|NCT00454805|462352|P1|STARTED|Overall Study|Randomised|31
197605|NCT00454779|462368|P2|NOT COMPLETED|Second-line Treatment Phase||3
197606|NCT00454779|462369|P1|NOT COMPLETED|Second-line Treatment Phase||0
197607|NCT00454779|462368|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
197608|NCT00454779|462369|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
197609|NCT00454779|462368|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
197610|NCT00454779|462369|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
197611|NCT00454779|462368|P2|NOT COMPLETED|First-line Treatment Phase||8
197612|NCT00454779|462369|P1|NOT COMPLETED|First-line Treatment Phase||5
197613|NCT00454779|462368|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
197614|NCT00454779|462369|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
197615|NCT00454779|462368|P2|Received Study Medication|First-line Treatment Phase||55
197616|NCT00454779|462369|P1|Received Study Medication|First-line Treatment Phase||56
197617|NCT00454779|462368|P2|STARTED|First-line Treatment Phase||57
197618|NCT00454779|462369|P1|STARTED|First-line Treatment Phase||56
197619|NCT00454649|462407|P10|NOT COMPLETED|Overall Study||5
197620|NCT00454649|462408|P9|NOT COMPLETED|Overall Study||20
197621|NCT00454649|462409|P8|NOT COMPLETED|Overall Study||19
197622|NCT00454649|462410|P7|NOT COMPLETED|Overall Study||9
197623|NCT00454649|462411|P6|NOT COMPLETED|Overall Study||7
197624|NCT00454649|462412|P5|NOT COMPLETED|Overall Study||1
197625|NCT00454649|462413|P4|NOT COMPLETED|Overall Study||6
197626|NCT00454649|462414|P3|NOT COMPLETED|Overall Study||19
197627|NCT00454649|462415|P2|NOT COMPLETED|Overall Study||4
197628|NCT00454649|462416|P1|NOT COMPLETED|Overall Study||3
197629|NCT00454649|462407|P10|COMPLETED|Overall Study||1
197630|NCT00454649|462408|P9|COMPLETED|Overall Study||1
197631|NCT00454649|462409|P8|COMPLETED|Overall Study||0
197632|NCT00454649|462410|P7|COMPLETED|Overall Study||0
197633|NCT00454649|462411|P6|COMPLETED|Overall Study||0
197634|NCT00454649|462412|P5|COMPLETED|Overall Study||0
197635|NCT00454649|462413|P4|COMPLETED|Overall Study||1
197636|NCT00454649|462414|P3|COMPLETED|Overall Study||1
197637|NCT00454649|462415|P2|COMPLETED|Overall Study||1
197638|NCT00454649|462416|P1|COMPLETED|Overall Study||0
197639|NCT00454649|462407|P10|STARTED|Overall Study||6
197640|NCT00454649|462408|P9|STARTED|Overall Study||21
197641|NCT00454649|462409|P8|STARTED|Overall Study||19
197642|NCT00454649|462410|P7|STARTED|Overall Study||9
197643|NCT00454649|462411|P6|STARTED|Overall Study||7
197644|NCT00454649|462412|P5|STARTED|Overall Study||1
197645|NCT00454649|462413|P4|STARTED|Overall Study||7
197646|NCT00454649|462414|P3|STARTED|Overall Study||20
197647|NCT00454649|462415|P2|STARTED|Overall Study||5
197648|NCT00454649|462416|P1|STARTED|Overall Study||3
197649|NCT00454636|462545|P4|NOT COMPLETED|Overall Study||32
197650|NCT00454636|462546|P3|NOT COMPLETED|Overall Study||20
197651|NCT00454636|462547|P2|NOT COMPLETED|Overall Study||23
197652|NCT00454636|462548|P1|NOT COMPLETED|Overall Study||31
197653|NCT00454636|462545|P4|COMPLETED|Overall Study||26
197654|NCT00454636|462546|P3|COMPLETED|Overall Study||7
197655|NCT00454636|462547|P2|COMPLETED|Overall Study||9
197656|NCT00454636|462548|P1|COMPLETED|Overall Study||10
197657|NCT00454636|462545|P4|STARTED|Overall Study||58
197658|NCT00454636|462546|P3|STARTED|Overall Study||27
197659|NCT00454636|462547|P2|STARTED|Overall Study||32
197660|NCT00454636|462548|P1|STARTED|Overall Study||41
197661|NCT00454584|462581|P6|NOT COMPLETED|After Controlled Period||32
197662|NCT00454584|462582|P5|NOT COMPLETED|After Controlled Period||12
197663|NCT00454584|462583|P4|NOT COMPLETED|After Controlled Period||26
197664|NCT00454584|462584|P3|NOT COMPLETED|After Controlled Period||0
197665|NCT00454584|462585|P2|NOT COMPLETED|After Controlled Period||0
197666|NCT00454584|462586|P1|NOT COMPLETED|After Controlled Period||0
197667|NCT00454584|462581|P6|COMPLETED|After Controlled Period||310
197668|NCT00454584|462582|P5|COMPLETED|After Controlled Period||189
197669|NCT00454584|462583|P4|COMPLETED|After Controlled Period||310
197670|NCT00454584|462584|P3|COMPLETED|After Controlled Period||0
197671|NCT00454584|462585|P2|COMPLETED|After Controlled Period||0
197672|NCT00454584|462586|P1|COMPLETED|After Controlled Period||0
197673|NCT00454584|462581|P6|STARTED|After Controlled Period||342
197674|NCT00454584|462582|P5|STARTED|After Controlled Period||201
197675|NCT00454584|462583|P4|STARTED|After Controlled Period||336
197676|NCT00454584|462584|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
197677|NCT00454584|462585|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
197678|NCT00454584|462586|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
197679|NCT00454584|462581|P6|NOT COMPLETED|Controlled Period||0
197680|NCT00454584|462582|P5|NOT COMPLETED|Controlled Period||0
197681|NCT00454584|462583|P4|NOT COMPLETED|Controlled Period||0
197682|NCT00454584|462584|P3|NOT COMPLETED|Controlled Period||5
197683|NCT00454584|462585|P2|NOT COMPLETED|Controlled Period||8
197684|NCT00454584|462586|P1|NOT COMPLETED|Controlled Period||11
197685|NCT00454584|462581|P6|COMPLETED|Controlled Period||0
197686|NCT00454584|462582|P5|COMPLETED|Controlled Period||0
197687|NCT00454584|462583|P4|COMPLETED|Controlled Period||0
197688|NCT00454584|462584|P3|COMPLETED|Controlled Period||342
197689|NCT00454584|462585|P2|COMPLETED|Controlled Period||201
197690|NCT00454584|462586|P1|COMPLETED|Controlled Period||336
197691|NCT00454584|462581|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
197692|NCT00454584|462582|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
197693|NCT00454584|462583|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
197694|NCT00454584|462584|P3|STARTED|Controlled Period||347
197695|NCT00454584|462585|P2|STARTED|Controlled Period||209
197696|NCT00454584|462586|P1|STARTED|Controlled Period||347
197697|NCT00454571|462608|P2|NOT COMPLETED|Overall Study||6
197698|NCT00454571|462609|P1|NOT COMPLETED|Overall Study||13
197699|NCT00454571|462608|P2|COMPLETED|Overall Study||13
197700|NCT00454571|462609|P1|COMPLETED|Overall Study||5
197701|NCT00454571|462608|P2|STARTED|Overall Study||19
197702|NCT00454571|462609|P1|STARTED|Overall Study||18
197703|NCT00454532|462621|P4|NOT COMPLETED|Overall Study||0
197704|NCT00454532|462622|P3|NOT COMPLETED|Overall Study||0
197705|NCT00454532|462623|P2|NOT COMPLETED|Overall Study||0
197706|NCT00454532|462624|P1|NOT COMPLETED|Overall Study||0
197707|NCT00454532|462621|P4|COMPLETED|Overall Study||7
197708|NCT00454532|462622|P3|COMPLETED|Overall Study||3
197709|NCT00454532|462623|P2|COMPLETED|Overall Study||6
197710|NCT00454532|462624|P1|COMPLETED|Overall Study||11
197711|NCT00454532|462621|P4|STARTED|Overall Study||7
197712|NCT00454532|462622|P3|STARTED|Overall Study||3
197713|NCT00454532|462623|P2|STARTED|Overall Study||6
197714|NCT00454532|462624|P1|STARTED|Overall Study||11
197715|NCT00454363|462644|P2|NOT COMPLETED|Overall Study||2
197716|NCT00454363|462645|P1|NOT COMPLETED|Overall Study||5
197717|NCT00454363|462644|P2|COMPLETED|Overall Study||29
197718|NCT00454363|462645|P1|COMPLETED|Overall Study||15
197719|NCT00454363|462644|P2|STARTED|Overall Study||31
197720|NCT00454363|462645|P1|STARTED|Overall Study||20
197721|NCT00454246|462655|P3|NOT COMPLETED|Overall Study||9
197722|NCT00454246|462656|P2|NOT COMPLETED|Overall Study||29
197723|NCT00454246|462657|P1|NOT COMPLETED|Overall Study||73
197724|NCT00454246|462655|P3|COMPLETED|Overall Study||0
197725|NCT00454246|462656|P2|COMPLETED|Overall Study||0
197726|NCT00454246|462657|P1|COMPLETED|Overall Study||0
197727|NCT00454246|462655|P3|STARTED|Overall Study||9
197728|NCT00454246|462656|P2|STARTED|Overall Study||29
197729|NCT00454246|462657|P1|STARTED|Overall Study||73
197730|NCT00454207|462673|P2|NOT COMPLETED|Overall Study||2
197731|NCT00454207|462674|P1|NOT COMPLETED|Overall Study||4
197732|NCT00454207|462673|P2|COMPLETED|Overall Study||21
197733|NCT00454207|462674|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
197734|NCT00454207|462673|P2|STARTED|Overall Study||23
197735|NCT00454207|462674|P1|STARTED|Overall Study||21
197736|NCT00454194|462719|P2|NOT COMPLETED|Overall Study||14
197737|NCT00454194|462720|P1|NOT COMPLETED|Overall Study||22
197738|NCT00454194|462719|P2|COMPLETED|Overall Study||37
197739|NCT00454194|462720|P1|COMPLETED|Overall Study||25
197740|NCT00454194|462719|P2|STARTED|Overall Study||51
197741|NCT00454194|462720|P1|STARTED|Overall Study||47
197742|NCT00454181|462738|P2|NOT COMPLETED|Overall Study||3
197743|NCT00454181|462739|P1|NOT COMPLETED|Overall Study||15
197744|NCT00454181|462738|P2|COMPLETED|Overall Study||11
197745|NCT00454181|462739|P1|COMPLETED|Overall Study||30
197746|NCT00454181|462738|P2|STARTED|Overall Study||14
197747|NCT00454181|462739|P1|STARTED|Overall Study||45
197748|NCT00454142|462755|P1|NOT COMPLETED|Overall Study||1
197749|NCT00454142|462755|P1|COMPLETED|Overall Study||32
197750|NCT00454142|462755|P1|STARTED|Overall Study||33
197751|NCT00453362|462770|P1|NOT COMPLETED|Overall Study||87
197752|NCT00453362|462770|P1|COMPLETED|Overall Study||1
197753|NCT00453362|462770|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
197754|NCT00453362|462770|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
197755|NCT00453362|462770|P1|Treated With Erlotinib|Overall Study||74
197756|NCT00453362|462770|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
197757|NCT00453349|462796|P2|NOT COMPLETED|Completed Study||34
197758|NCT00453349|462797|P1|NOT COMPLETED|Completed Study||27
197759|NCT00453349|462796|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
197760|NCT00453349|462797|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
197761|NCT00453349|462796|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
197762|NCT00453349|462797|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
197763|NCT00453349|462796|P2|STARTED|Completed Study||232
197764|NCT00453349|462797|P1|STARTED|Completed Study||228
197765|NCT00453349|462796|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
197766|NCT00453349|462797|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
197767|NCT00453349|462796|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
197768|NCT00453349|462797|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
197769|NCT00453349|462796|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
197770|NCT00453349|462797|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
197771|NCT00453349|462796|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
197772|NCT00453349|462797|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
197773|NCT00453349|462796|P2|NOT COMPLETED|Randomized||23
197774|NCT00453349|462797|P1|NOT COMPLETED|Randomized||25
197775|NCT00453349|462796|P2|COMPLETED|Randomized||209
197776|NCT00453349|462797|P1|COMPLETED|Randomized||203
197777|NCT00453349|462796|P2|STARTED|Randomized||232
197778|NCT00453349|462797|P1|STARTED|Randomized||228
197779|NCT00453336|462823|P1|NOT COMPLETED|Overall Study||0
197780|NCT00453336|462823|P1|COMPLETED|Overall Study||45
197781|NCT00453336|462823|P1|STARTED|Overall Study||45
197782|NCT00453310|462828|P1|NOT COMPLETED|Overall Study||10
197783|NCT00453310|462828|P1|COMPLETED|Overall Study||0
197784|NCT00453310|462828|P1|STARTED|Overall Study||10
197785|NCT00454116|462835|P3|NOT COMPLETED|Overall Study||28
197786|NCT00454116|462836|P2|NOT COMPLETED|Overall Study||29
197787|NCT00454116|462837|P1|NOT COMPLETED|Overall Study||27
197788|NCT00454116|462835|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
197879|NCT00453063|463055|P2|STARTED|Overall Study||215
197789|NCT00454116|462836|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
197790|NCT00454116|462837|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
197791|NCT00454116|462835|P3|STARTED|Overall Study|randomised patients|35
197792|NCT00454116|462836|P2|STARTED|Overall Study|randomised patients|36
197793|NCT00454116|462837|P1|STARTED|Overall Study|randomised patients|35
197794|NCT00454051|462847|P2|NOT COMPLETED|Overall Study||3
197795|NCT00454051|462848|P1|NOT COMPLETED|Overall Study||3
197796|NCT00454051|462847|P2|COMPLETED|Overall Study||8
197797|NCT00454051|462848|P1|COMPLETED|Overall Study||17
197798|NCT00454051|462847|P2|STARTED|Overall Study||11
197799|NCT00454051|462848|P1|STARTED|Overall Study||20
197800|NCT00453999|462881|P3|NOT COMPLETED|Overall Study||3
197801|NCT00453999|462882|P2|NOT COMPLETED|Overall Study||5
197802|NCT00453999|462883|P1|NOT COMPLETED|Overall Study||5
197803|NCT00453999|462881|P3|COMPLETED|Overall Study||43
197804|NCT00453999|462882|P2|COMPLETED|Overall Study||41
197805|NCT00453999|462883|P1|COMPLETED|Overall Study||40
197806|NCT00453999|462881|P3|STARTED|Overall Study||46
197807|NCT00453999|462882|P2|STARTED|Overall Study||46
197808|NCT00453999|462883|P1|STARTED|Overall Study||45
197809|NCT00453986|462911|P5|NOT COMPLETED|Overall Study||0
197810|NCT00453986|462912|P4|NOT COMPLETED|Overall Study||2
197811|NCT00453986|462913|P3|NOT COMPLETED|Overall Study||6
197812|NCT00453986|462914|P2|NOT COMPLETED|Overall Study||5
197813|NCT00453986|462915|P1|NOT COMPLETED|Overall Study||6
197814|NCT00453986|462911|P5|COMPLETED|Overall Study||105
197815|NCT00453986|462912|P4|COMPLETED|Overall Study||310
197816|NCT00453986|462913|P3|COMPLETED|Overall Study||307
197817|NCT00453986|462914|P2|COMPLETED|Overall Study||306
197818|NCT00453986|462915|P1|COMPLETED|Overall Study||305
197819|NCT00453986|462911|P5|STARTED|Overall Study||105
197820|NCT00453986|462912|P4|STARTED|Overall Study||312
197821|NCT00453986|462913|P3|STARTED|Overall Study||313
197822|NCT00453986|462914|P2|STARTED|Overall Study||311
197823|NCT00453986|462915|P1|STARTED|Overall Study||311
197824|NCT00453973|463010|P2|NOT COMPLETED|Overall Study||48
197825|NCT00453973|463011|P1|NOT COMPLETED|Overall Study||51
197826|NCT00453973|463010|P2|COMPLETED|Overall Study||15
197827|NCT00453973|463011|P1|COMPLETED|Overall Study||0
197828|NCT00453973|463010|P2|STARTED|Overall Study||63
197829|NCT00453973|463011|P1|STARTED|Overall Study||51
197830|NCT00453206|463017|P1|NOT COMPLETED|Overall Study||1
197831|NCT00453206|463017|P1|COMPLETED|Overall Study||65
197832|NCT00453206|463017|P1|STARTED|Overall Study||66
197833|NCT00453193|463021|P1|NOT COMPLETED|Overall Study||0
197834|NCT00453193|463021|P1|COMPLETED|Overall Study||24
197835|NCT00453193|463021|P1|STARTED|Overall Study||24
197836|NCT00453154|463028|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
197837|NCT00453154|463029|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
197838|NCT00453154|463030|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
197839|NCT00453154|463031|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
197840|NCT00453154|463028|P4|COMPLETED|Open Label Sunitinib Crossover||0
197841|NCT00453154|463029|P3|COMPLETED|Open Label Sunitinib Crossover||18
197842|NCT00453154|463030|P2|COMPLETED|Open Label Sunitinib Crossover||0
197843|NCT00453154|463031|P1|COMPLETED|Open Label Sunitinib Crossover||0
197844|NCT00453154|463028|P4|STARTED|Open Label Sunitinib Crossover||0
197845|NCT00453154|463029|P3|STARTED|Open Label Sunitinib Crossover||18
197846|NCT00453154|463030|P2|STARTED|Open Label Sunitinib Crossover||0
197847|NCT00453154|463031|P1|STARTED|Open Label Sunitinib Crossover||0
197848|NCT00453154|463028|P4|NOT COMPLETED|Double BIind Maintenance||49
197849|NCT00453154|463029|P3|NOT COMPLETED|Double BIind Maintenance||46
197850|NCT00453154|463030|P2|NOT COMPLETED|Double BIind Maintenance||0
197851|NCT00453154|463031|P1|NOT COMPLETED|Double BIind Maintenance||0
197852|NCT00453154|463028|P4|COMPLETED|Double BIind Maintenance||0
197853|NCT00453154|463029|P3|COMPLETED|Double BIind Maintenance||0
197854|NCT00453154|463030|P2|COMPLETED|Double BIind Maintenance||0
197855|NCT00453154|463031|P1|COMPLETED|Double BIind Maintenance||0
197856|NCT00453154|463028|P4|STARTED|Double BIind Maintenance||49
197857|NCT00453154|463029|P3|STARTED|Double BIind Maintenance||46
197858|NCT00453154|463030|P2|STARTED|Double BIind Maintenance||0
197859|NCT00453154|463031|P1|STARTED|Double BIind Maintenance||0
197860|NCT00453154|463028|P4|NOT COMPLETED|Combination Chemotherapy||0
197861|NCT00453154|463029|P3|NOT COMPLETED|Combination Chemotherapy||0
197862|NCT00453154|463030|P2|NOT COMPLETED|Combination Chemotherapy||49
197863|NCT00453154|463031|P1|NOT COMPLETED|Combination Chemotherapy||0
197864|NCT00453154|463028|P4|COMPLETED|Combination Chemotherapy||0
197865|NCT00453154|463029|P3|COMPLETED|Combination Chemotherapy||0
197866|NCT00453154|463030|P2|COMPLETED|Combination Chemotherapy||95
197867|NCT00453154|463031|P1|COMPLETED|Combination Chemotherapy||12
197868|NCT00453154|463028|P4|STARTED|Combination Chemotherapy||0
197869|NCT00453154|463029|P3|STARTED|Combination Chemotherapy||0
197870|NCT00453154|463030|P2|STARTED|Combination Chemotherapy||144
197871|NCT00453154|463031|P1|STARTED|Combination Chemotherapy||12
197872|NCT00453102|463044|P1|NOT COMPLETED|Overall Study||2
197873|NCT00453102|463044|P1|COMPLETED|Overall Study||16
197874|NCT00453102|463044|P1|STARTED|Overall Study||18
197875|NCT00453063|463055|P2|NOT COMPLETED|Overall Study||3
197876|NCT00453063|463056|P1|NOT COMPLETED|Overall Study||3
197877|NCT00453063|463055|P2|COMPLETED|Overall Study||212
197878|NCT00453063|463056|P1|COMPLETED|Overall Study||208
197880|NCT00453063|463056|P1|STARTED|Overall Study||211
197881|NCT00452868|463070|P1|NOT COMPLETED|Overall Study||2
197882|NCT00452868|463070|P1|COMPLETED|Overall Study||11
197883|NCT00452868|463070|P1|STARTED|Overall Study||13
197884|NCT00452790|463076|P2|NOT COMPLETED|Toddler Dose||2
197885|NCT00452790|463077|P1|NOT COMPLETED|Toddler Dose||0
197886|NCT00452790|463076|P2|COMPLETED|Toddler Dose||198
197887|NCT00452790|463077|P1|COMPLETED|Toddler Dose||198
197888|NCT00452790|463076|P2|STARTED|Toddler Dose||200
197889|NCT00452790|463077|P1|STARTED|Toddler Dose||198
197890|NCT00452790|463076|P2|NOT COMPLETED|After Infant Series||14
197891|NCT00452790|463077|P1|NOT COMPLETED|After Infant Series||21
197892|NCT00452790|463076|P2|COMPLETED|After Infant Series||200
197893|NCT00452790|463077|P1|COMPLETED|After Infant Series||198
197894|NCT00452790|463076|P2|STARTED|After Infant Series||214
197895|NCT00452790|463077|P1|STARTED|After Infant Series||219
197896|NCT00452790|463076|P2|NOT COMPLETED|Infant Series||141
197897|NCT00452790|463077|P1|NOT COMPLETED|Infant Series||135
197898|NCT00452790|463076|P2|COMPLETED|Infant Series||214
197899|NCT00452790|463077|P1|COMPLETED|Infant Series||219
197900|NCT00452790|463076|P2|Vaccinated Dose 3|Infant Series||218
197901|NCT00452790|463077|P1|Vaccinated Dose 3|Infant Series||221
197902|NCT00452790|463076|P2|Vaccinated Dose 2|Infant Series||300
197903|NCT00452790|463077|P1|Vaccinated Dose 2|Infant Series||300
197904|NCT00452790|463076|P2|Vaccinated Dose 1|Infant Series||353
197905|NCT00452790|463077|P1|Vaccinated Dose 1|Infant Series||353
197906|NCT00452790|463076|P2|STARTED|Infant Series||355
197907|NCT00452790|463077|P1|STARTED|Infant Series||354
197908|NCT00452699|463113|P2|NOT COMPLETED|Overall Study||73
197909|NCT00452699|463114|P1|NOT COMPLETED|Overall Study||81
197910|NCT00452699|463113|P2|COMPLETED|Overall Study||242
197911|NCT00452699|463114|P1|COMPLETED|Overall Study||225
197912|NCT00452699|463113|P2|STARTED|Overall Study||315
197913|NCT00452699|463114|P1|STARTED|Overall Study||306
197914|NCT00452673|463130|P5|NOT COMPLETED|Dose Expansion Period||21
197915|NCT00452673|463131|P4|NOT COMPLETED|Dose Expansion Period||0
197916|NCT00452673|463132|P3|NOT COMPLETED|Dose Expansion Period||0
197917|NCT00452673|463133|P2|NOT COMPLETED|Dose Expansion Period||0
197918|NCT00452673|463134|P1|NOT COMPLETED|Dose Expansion Period||0
197919|NCT00452673|463130|P5|COMPLETED|Dose Expansion Period||0
197920|NCT00452673|463131|P4|COMPLETED|Dose Expansion Period||0
197921|NCT00452673|463132|P3|COMPLETED|Dose Expansion Period||0
197922|NCT00452673|463133|P2|COMPLETED|Dose Expansion Period||0
197923|NCT00452673|463134|P1|COMPLETED|Dose Expansion Period||0
197924|NCT00452673|463130|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
197925|NCT00452673|463131|P4|STARTED|Dose Expansion Period||0
197926|NCT00452673|463132|P3|STARTED|Dose Expansion Period||0
197927|NCT00452673|463133|P2|STARTED|Dose Expansion Period||0
197928|NCT00452673|463134|P1|STARTED|Dose Expansion Period||0
197929|NCT00452673|463130|P5|NOT COMPLETED|Dose Escalation Period||0
197930|NCT00452673|463131|P4|NOT COMPLETED|Dose Escalation Period||9
197931|NCT00452673|463132|P3|NOT COMPLETED|Dose Escalation Period||6
197932|NCT00452673|463133|P2|NOT COMPLETED|Dose Escalation Period||9
197933|NCT00452673|463134|P1|NOT COMPLETED|Dose Escalation Period||7
197934|NCT00452673|463130|P5|COMPLETED|Dose Escalation Period||0
197935|NCT00452673|463131|P4|COMPLETED|Dose Escalation Period||0
197936|NCT00452673|463132|P3|COMPLETED|Dose Escalation Period||0
197937|NCT00452673|463133|P2|COMPLETED|Dose Escalation Period||0
197938|NCT00452673|463134|P1|COMPLETED|Dose Escalation Period||0
197939|NCT00452673|463130|P5|STARTED|Dose Escalation Period||0
197940|NCT00452673|463131|P4|STARTED|Dose Escalation Period||9
197941|NCT00452673|463132|P3|STARTED|Dose Escalation Period||6
197942|NCT00452673|463133|P2|STARTED|Dose Escalation Period||9
197943|NCT00452673|463134|P1|STARTED|Dose Escalation Period||7
197944|NCT00452543|463166|P2|NOT COMPLETED|Overall Study||6
197945|NCT00452543|463167|P1|NOT COMPLETED|Overall Study||5
197946|NCT00452543|463166|P2|COMPLETED|Overall Study||5
197947|NCT00452543|463167|P1|COMPLETED|Overall Study||7
197948|NCT00452543|463166|P2|STARTED|Overall Study||11
197949|NCT00452543|463167|P1|STARTED|Overall Study||12
197950|NCT00452530|463181|P2|NOT COMPLETED|Overall Study||136
197951|NCT00452530|463182|P1|NOT COMPLETED|Overall Study||136
197952|NCT00452530|463181|P2|COMPLETED|Overall Study||1393
197953|NCT00452530|463182|P1|COMPLETED|Overall Study||1392
197954|NCT00452530|463181|P2|Primary Participants|Overall Study||997
197955|NCT00452530|463182|P1|Primary Participants|Overall Study||976
197956|NCT00452530|463181|P2|Evaluable Participants|Overall Study||921
197957|NCT00452530|463182|P1|Evaluable Participants|Overall Study||907
197958|NCT00452530|463181|P2|Received Treatment|Overall Study||1508
197959|NCT00452530|463182|P1|Received Treatment|Overall Study||1501
197960|NCT00452530|463181|P2|STARTED|Overall Study|Randomized|1529
197961|NCT00452530|463182|P1|STARTED|Overall Study|Randomized|1528
197962|NCT00452452|463203|P3|NOT COMPLETED|Overall Study||1
197963|NCT00452452|463204|P2|NOT COMPLETED|Overall Study||0
197964|NCT00452452|463205|P1|NOT COMPLETED|Overall Study||2
197965|NCT00452452|463203|P3|COMPLETED|Overall Study||152
197966|NCT00452452|463204|P2|COMPLETED|Overall Study||112
197967|NCT00452452|463205|P1|COMPLETED|Overall Study||88
197968|NCT00452452|463203|P3|Vaccinated Dose 3|Overall Study||0
197969|NCT00452452|463204|P2|Vaccinated Dose 3|Overall Study||0
197970|NCT00452452|463205|P1|Vaccinated Dose 3|Overall Study||89
197971|NCT00452452|463203|P3|Vaccinated Dose 2|Overall Study||0
197972|NCT00452452|463204|P2|Vaccinated Dose 2|Overall Study||112
197973|NCT00452452|463205|P1|Vaccinated Dose 2|Overall Study||90
197974|NCT00452452|463203|P3|Vaccinated Dose 1|Overall Study||152
197975|NCT00452452|463204|P2|Vaccinated Dose 1|Overall Study||112
197976|NCT00452452|463205|P1|Vaccinated Dose 1|Overall Study||90
197977|NCT00452452|463203|P3|STARTED|Overall Study||153
197978|NCT00452452|463204|P2|STARTED|Overall Study||112
197979|NCT00452452|463205|P1|STARTED|Overall Study||90
197980|NCT00452426|463230|P2|NOT COMPLETED|Overall Study||11
197981|NCT00452426|463231|P1|NOT COMPLETED|Overall Study||7
197982|NCT00452426|463230|P2|COMPLETED|Overall Study||493
197983|NCT00452426|463231|P1|COMPLETED|Overall Study||489
197984|NCT00452426|463230|P2|STARTED|Overall Study||504
197985|NCT00452426|463231|P1|STARTED|Overall Study||496
197986|NCT00452400|463250|P5|NOT COMPLETED|Overall Study||3
197987|NCT00452400|463251|P4|NOT COMPLETED|Overall Study||1
197988|NCT00452400|463252|P3|NOT COMPLETED|Overall Study||7
197989|NCT00452400|463253|P2|NOT COMPLETED|Overall Study||1
197990|NCT00452400|463254|P1|NOT COMPLETED|Overall Study||5
197991|NCT00452400|463250|P5|COMPLETED|Overall Study||76
197992|NCT00452400|463251|P4|COMPLETED|Overall Study||85
197993|NCT00452400|463252|P3|COMPLETED|Overall Study||73
197994|NCT00452400|463253|P2|COMPLETED|Overall Study||80
197995|NCT00452400|463254|P1|COMPLETED|Overall Study||74
197996|NCT00452400|463250|P5|STARTED|Overall Study||79
197997|NCT00452400|463251|P4|STARTED|Overall Study||86
197998|NCT00452400|463252|P3|STARTED|Overall Study||80
197999|NCT00452400|463253|P2|STARTED|Overall Study||81
198000|NCT00452400|463254|P1|STARTED|Overall Study||79
198001|NCT00452387|463426|P1|NOT COMPLETED|Overall Study||0
198002|NCT00452387|463426|P1|COMPLETED|Overall Study||22
198003|NCT00452387|463426|P1|STARTED|Overall Study||22
198004|NCT00452374|463434|P1|NOT COMPLETED|Overall Study||0
198005|NCT00452374|463434|P1|COMPLETED|Overall Study||48
198006|NCT00452374|463434|P1|STARTED|Overall Study||48
198007|NCT00452361|463441|P2|NOT COMPLETED|Overall Study||10
198008|NCT00452361|463442|P1|NOT COMPLETED|Overall Study||21
198009|NCT00452361|463441|P2|COMPLETED|Overall Study||0
198010|NCT00452361|463442|P1|COMPLETED|Overall Study||0
198011|NCT00452361|463441|P2|STARTED|Overall Study||10
198012|NCT00452361|463442|P1|STARTED|Overall Study||21
198013|NCT00452348|463486|P2|NOT COMPLETED|Overall Study||84
198014|NCT00452348|463487|P1|NOT COMPLETED|Overall Study||79
198015|NCT00452348|463486|P2|COMPLETED|Overall Study||234
198016|NCT00452348|463487|P1|COMPLETED|Overall Study||231
198017|NCT00452348|463486|P2|STARTED|Overall Study||318
198018|NCT00452348|463487|P1|STARTED|Overall Study||310
198019|NCT00452335|463502|P3|NOT COMPLETED|Overall Study||9
198020|NCT00452335|463503|P2|NOT COMPLETED|Overall Study||4
198021|NCT00452335|463504|P1|NOT COMPLETED|Overall Study||2
198022|NCT00452335|463502|P3|COMPLETED|Overall Study||23
198023|NCT00452335|463503|P2|COMPLETED|Overall Study||61
198024|NCT00452335|463504|P1|COMPLETED|Overall Study||25
198025|NCT00452335|463502|P3|STARTED|Overall Study||32
198026|NCT00452335|463503|P2|STARTED|Overall Study||65
198027|NCT00452335|463504|P1|STARTED|Overall Study||27
198028|NCT00452114|463541|P2|NOT COMPLETED|Overall Study||3
198029|NCT00452114|463542|P1|NOT COMPLETED|Overall Study||3
198030|NCT00452114|463541|P2|COMPLETED|Overall Study||10
198031|NCT00452114|463542|P1|COMPLETED|Overall Study||12
198032|NCT00452114|463541|P2|STARTED|Overall Study||13
198033|NCT00452114|463542|P1|STARTED|Overall Study||15
198034|NCT00451958|463552|P5|NOT COMPLETED|CS21A (NCT00451958)||0
198035|NCT00451958|463553|P4|NOT COMPLETED|CS21A (NCT00451958)||39
198036|NCT00451958|463554|P3|NOT COMPLETED|CS21A (NCT00451958)||42
198037|NCT00451958|463555|P2|NOT COMPLETED|CS21A (NCT00451958)||77
198038|NCT00451958|463556|P1|NOT COMPLETED|CS21A (NCT00451958)||65
198039|NCT00451958|463552|P5|COMPLETED|CS21A (NCT00451958)||0
198040|NCT00451958|463553|P4|COMPLETED|CS21A (NCT00451958)||27
198041|NCT00451958|463554|P3|COMPLETED|CS21A (NCT00451958)||27
198042|NCT00451958|463555|P2|COMPLETED|CS21A (NCT00451958)||49
198043|NCT00451958|463556|P1|COMPLETED|CS21A (NCT00451958)||60
198044|NCT00451958|463552|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
198045|NCT00451958|463553|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
198046|NCT00451958|463554|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
198047|NCT00451958|463555|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
198048|NCT00451958|463556|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
198049|NCT00451958|463552|P5|NOT COMPLETED|CS21 (NCT00295750)||32
198050|NCT00451958|463553|P4|NOT COMPLETED|CS21 (NCT00295750)||0
198051|NCT00451958|463554|P3|NOT COMPLETED|CS21 (NCT00295750)||0
198052|NCT00451958|463555|P2|NOT COMPLETED|CS21 (NCT00295750)||43
198053|NCT00451958|463556|P1|NOT COMPLETED|CS21 (NCT00295750)||41
198054|NCT00451958|463552|P5|COMPLETED|CS21 (NCT00295750)||172
198055|NCT00451958|463553|P4|COMPLETED|CS21 (NCT00295750)||0
198056|NCT00451958|463554|P3|COMPLETED|CS21 (NCT00295750)||0
198057|NCT00451958|463555|P2|COMPLETED|CS21 (NCT00295750)||163
198058|NCT00451958|463556|P1|COMPLETED|CS21 (NCT00295750)||169
198059|NCT00451958|463552|P5|STARTED|CS21 (NCT00295750)||204
198151|NCT00450437|463794|P2|COMPLETED|Overall Study||524
198060|NCT00451958|463553|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
198061|NCT00451958|463554|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
198062|NCT00451958|463555|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
198063|NCT00451958|463556|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
198064|NCT00451906|463586|P1|NOT COMPLETED|Overall Study||2239
198065|NCT00451906|463586|P1|COMPLETED|Overall Study||13
198066|NCT00451906|463586|P1|STARTED|Overall Study||2252
198067|NCT00451698|463596|P2|NOT COMPLETED|Overall Study||0
198068|NCT00451698|463597|P1|NOT COMPLETED|Overall Study||0
198069|NCT00451698|463596|P2|COMPLETED|Overall Study||6
198070|NCT00451698|463597|P1|COMPLETED|Overall Study||3
198071|NCT00451698|463596|P2|STARTED|Overall Study||6
198072|NCT00451698|463597|P1|STARTED|Overall Study||3
198073|NCT00451451|463609|P4|NOT COMPLETED|Overall Study||58
198074|NCT00451451|463610|P3|NOT COMPLETED|Overall Study||72
198075|NCT00451451|463611|P2|NOT COMPLETED|Overall Study||75
198076|NCT00451451|463612|P1|NOT COMPLETED|Overall Study||85
198077|NCT00451451|463609|P4|COMPLETED|Overall Study||292
198078|NCT00451451|463610|P3|COMPLETED|Overall Study||273
198079|NCT00451451|463611|P2|COMPLETED|Overall Study||284
198080|NCT00451451|463612|P1|COMPLETED|Overall Study||278
198081|NCT00451451|463609|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
198082|NCT00451451|463610|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
198083|NCT00451451|463611|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
198084|NCT00451451|463612|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
198085|NCT00451282|463641|P2|NOT COMPLETED|Overall Study||5
198086|NCT00451282|463642|P1|NOT COMPLETED|Overall Study||6
198087|NCT00451282|463641|P2|COMPLETED|Overall Study||34
198088|NCT00451282|463642|P1|COMPLETED|Overall Study||40
198089|NCT00451282|463641|P2|STARTED|Overall Study||39
198090|NCT00451282|463642|P1|STARTED|Overall Study||46
198091|NCT00451204|463656|P2|NOT COMPLETED|Overall Study||20
198092|NCT00451204|463657|P1|NOT COMPLETED|Overall Study||22
198093|NCT00451204|463656|P2|COMPLETED|Overall Study||56
198094|NCT00451204|463657|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
198095|NCT00451204|463656|P2|STARTED|Overall Study||76
198096|NCT00451204|463657|P1|STARTED|Overall Study||82
198097|NCT00451191|463675|P2|NOT COMPLETED|Overall Study||11
198098|NCT00451191|463676|P1|NOT COMPLETED|Overall Study||15
198099|NCT00451191|463675|P2|COMPLETED|Overall Study||55
198100|NCT00451191|463676|P1|COMPLETED|Overall Study||53
198101|NCT00451191|463675|P2|STARTED|Overall Study||66
198102|NCT00451191|463676|P1|STARTED|Overall Study||68
198103|NCT00451048|463682|P1|NOT COMPLETED|Overall Study||0
198104|NCT00451048|463682|P1|COMPLETED|Overall Study||10
198105|NCT00451048|463682|P1|STARTED|Overall Study||10
198106|NCT00450866|463686|P2|NOT COMPLETED|Overall Study||3
198107|NCT00450866|463687|P1|NOT COMPLETED|Overall Study||7
198108|NCT00450866|463686|P2|COMPLETED|Overall Study||7
198109|NCT00450866|463687|P1|COMPLETED|Overall Study||38
198110|NCT00450866|463686|P2|STARTED|Overall Study||10
198111|NCT00450866|463687|P1|STARTED|Overall Study||45
198112|NCT00450801|463697|P1|NOT COMPLETED|Overall Study||1
198113|NCT00450801|463697|P1|COMPLETED|Overall Study||21
198114|NCT00450801|463697|P1|STARTED|Overall Study||22
198115|NCT00450749|463711|P3|NOT COMPLETED|Overall Study||2
198116|NCT00450749|463712|P2|NOT COMPLETED|Overall Study||1
198117|NCT00450749|463713|P1|NOT COMPLETED|Overall Study||0
198118|NCT00450749|463711|P3|COMPLETED|Overall Study||2
198119|NCT00450749|463712|P2|COMPLETED|Overall Study||2
198120|NCT00450749|463713|P1|COMPLETED|Overall Study||3
198121|NCT00450749|463711|P3|STARTED|Overall Study||4
198122|NCT00450749|463712|P2|STARTED|Overall Study||3
198123|NCT00450749|463713|P1|STARTED|Overall Study||3
198124|NCT00450723|463721|P1|NOT COMPLETED|Overall Study||5
198125|NCT00450723|463721|P1|COMPLETED|Overall Study||34
198126|NCT00450723|463721|P1|STARTED|Overall Study||39
198127|NCT00450658|463729|P2|NOT COMPLETED|Overall Study||90
198128|NCT00450658|463730|P1|NOT COMPLETED|Overall Study||143
198129|NCT00450658|463729|P2|COMPLETED|Overall Study||122
198130|NCT00450658|463730|P1|COMPLETED|Overall Study||272
198131|NCT00450658|463729|P2|STARTED|Overall Study||212
198132|NCT00450658|463730|P1|STARTED|Overall Study||415
198133|NCT00450619|463744|P2|NOT COMPLETED|Overall Study||1
198134|NCT00450619|463745|P1|NOT COMPLETED|Overall Study||4
198135|NCT00450619|463744|P2|COMPLETED|Overall Study||21
198136|NCT00450619|463745|P1|COMPLETED|Overall Study||18
198137|NCT00450619|463744|P2|STARTED|Overall Study||22
198138|NCT00450619|463745|P1|STARTED|Overall Study||22
198139|NCT00450580|463771|P2|NOT COMPLETED|Overall Study||16
198140|NCT00450580|463772|P1|NOT COMPLETED|Overall Study||16
198141|NCT00450580|463771|P2|COMPLETED|Overall Study||90
198142|NCT00450580|463772|P1|COMPLETED|Overall Study||90
198143|NCT00450580|463771|P2|STARTED|Overall Study||106
198144|NCT00450580|463772|P1|STARTED|Overall Study||106
198145|NCT00450437|463792|P4|NOT COMPLETED|Overall Study||11
198146|NCT00450437|463793|P3|NOT COMPLETED|Overall Study||24
198147|NCT00450437|463794|P2|NOT COMPLETED|Overall Study||16
198148|NCT00450437|463795|P1|NOT COMPLETED|Overall Study||46
198149|NCT00450437|463792|P4|COMPLETED|Overall Study||325
198150|NCT00450437|463793|P3|COMPLETED|Overall Study||999
198152|NCT00450437|463795|P1|COMPLETED|Overall Study||1594
198153|NCT00450437|463792|P4|STARTED|Overall Study||336
198154|NCT00450437|463793|P3|STARTED|Overall Study||1023
198155|NCT00450437|463794|P2|STARTED|Overall Study||540
198156|NCT00450437|463795|P1|STARTED|Overall Study||1640
198157|NCT00450424|463819|P2|NOT COMPLETED|Overall Study||11
198158|NCT00450424|463820|P1|NOT COMPLETED|Overall Study||20
198159|NCT00450424|463819|P2|COMPLETED|Overall Study||106
198160|NCT00450424|463820|P1|COMPLETED|Overall Study||102
198161|NCT00450424|463819|P2|STARTED|Overall Study||117
198162|NCT00450424|463820|P1|STARTED|Overall Study||122
198163|NCT00450372|463826|P1|NOT COMPLETED|Overall Study||1
198164|NCT00450372|463826|P1|COMPLETED|Overall Study||37
198165|NCT00450372|463826|P1|STARTED|Overall Study||38
198166|NCT00450333|463839|P4|NOT COMPLETED|Overall Study||28
198167|NCT00450333|463840|P3|NOT COMPLETED|Overall Study||25
198168|NCT00450333|463841|P2|NOT COMPLETED|Overall Study||63
198169|NCT00450333|463842|P1|NOT COMPLETED|Overall Study||54
198170|NCT00450333|463839|P4|COMPLETED|Overall Study||74
198171|NCT00450333|463840|P3|COMPLETED|Overall Study||75
198172|NCT00450333|463841|P2|COMPLETED|Overall Study||44
198173|NCT00450333|463842|P1|COMPLETED|Overall Study||44
198174|NCT00450333|463839|P4|STARTED|Overall Study||102
198175|NCT00450333|463840|P3|STARTED|Overall Study||100
198176|NCT00450333|463841|P2|STARTED|Overall Study||107
198177|NCT00450333|463842|P1|STARTED|Overall Study||98
198178|NCT00450294|463860|P1|NOT COMPLETED|Overall Study||0
198179|NCT00450294|463860|P1|COMPLETED|Overall Study||10
198180|NCT00450294|463860|P1|STARTED|Overall Study||10
198181|NCT00450255|463865|P1|NOT COMPLETED|Overall Study||1
198182|NCT00450255|463865|P1|COMPLETED|Overall Study||40
198183|NCT00450255|463865|P1|STARTED|Overall Study||41
198184|NCT00450242|463873|P2|NOT COMPLETED|Overall Study||1
198185|NCT00450242|463874|P1|NOT COMPLETED|Overall Study||3
198186|NCT00450242|463873|P2|COMPLETED|Overall Study||6
198187|NCT00450242|463874|P1|COMPLETED|Overall Study||4
198188|NCT00450242|463873|P2|STARTED|Overall Study||7
198189|NCT00450242|463874|P1|STARTED|Overall Study||7
198190|NCT00450216|463888|P2|NOT COMPLETED|Overall Study||129
198191|NCT00450216|463889|P1|NOT COMPLETED|Overall Study||174
198192|NCT00450216|463888|P2|COMPLETED|Overall Study||170
198193|NCT00450216|463889|P1|COMPLETED|Overall Study||433
198194|NCT00450216|463888|P2|STARTED|Overall Study||299
198195|NCT00450216|463889|P1|STARTED|Overall Study||607
198196|NCT00450112|463903|P2|NOT COMPLETED|Overall Study||6
198197|NCT00450112|463904|P1|NOT COMPLETED|Overall Study||13
198198|NCT00450112|463903|P2|COMPLETED|Overall Study||71
198199|NCT00450112|463904|P1|COMPLETED|Overall Study||112
198200|NCT00450112|463903|P2|Analyzed Participants|Overall Study||74
198201|NCT00450112|463904|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
198202|NCT00450112|463903|P2|Received Injection|Overall Study||74
198203|NCT00450112|463904|P1|Received Injection|Overall Study||125
198204|NCT00450112|463903|P2|STARTED|Overall Study||77
198205|NCT00450112|463904|P1|STARTED|Overall Study||125
198206|NCT00450073|463929|P3|NOT COMPLETED|Overall Study||1
198207|NCT00450073|463930|P2|NOT COMPLETED|Overall Study||0
198208|NCT00450073|463931|P1|NOT COMPLETED|Overall Study||1
198209|NCT00450073|463929|P3|COMPLETED|Overall Study||9
198210|NCT00450073|463930|P2|COMPLETED|Overall Study||10
198211|NCT00450073|463931|P1|COMPLETED|Overall Study||9
198212|NCT00450073|463929|P3|STARTED|Overall Study||10
198213|NCT00450073|463930|P2|STARTED|Overall Study||10
198214|NCT00450073|463931|P1|STARTED|Overall Study||10
198215|NCT00449956|463942|P3|NOT COMPLETED|Overall Study||9
198216|NCT00449956|463943|P2|NOT COMPLETED|Overall Study||4
198217|NCT00449956|463944|P1|NOT COMPLETED|Overall Study||10
198218|NCT00449956|463942|P3|COMPLETED|Overall Study||184
198219|NCT00449956|463943|P2|COMPLETED|Overall Study||88
198220|NCT00449956|463944|P1|COMPLETED|Overall Study||179
198221|NCT00449956|463942|P3|STARTED|Overall Study||193
198222|NCT00449956|463943|P2|STARTED|Overall Study||92
198223|NCT00449956|463944|P1|STARTED|Overall Study||189
198224|NCT00449930|463960|P2|NOT COMPLETED|Overall Study||75
198225|NCT00449930|463961|P1|NOT COMPLETED|Overall Study||61
198226|NCT00449930|463960|P2|COMPLETED|Overall Study||447
198227|NCT00449930|463961|P1|COMPLETED|Overall Study||467
198228|NCT00449930|463960|P2|STARTED|Overall Study||522
198229|NCT00449930|463961|P1|STARTED|Overall Study||528
198230|NCT00449865|463977|P2|NOT COMPLETED|Overall Study||534
198231|NCT00449865|463978|P1|NOT COMPLETED|Overall Study||522
198232|NCT00449865|463977|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
198233|NCT00449865|463978|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
198234|NCT00449865|463977|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
198235|NCT00449865|463978|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
198236|NCT00449865|463977|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
198237|NCT00449865|463978|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
198238|NCT00449865|463977|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
198239|NCT00449865|463978|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
198240|NCT00449865|463977|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
198241|NCT00449865|463978|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
198242|NCT00449865|463977|P2|STARTED|Overall Study||874
198243|NCT00449865|463978|P1|STARTED|Overall Study||867
198244|NCT00449787|463986|P2|NOT COMPLETED|Overall Study||100
198245|NCT00449787|463987|P1|NOT COMPLETED|Overall Study||105
198246|NCT00449787|463986|P2|COMPLETED|Overall Study||98
198247|NCT00449787|463987|P1|COMPLETED|Overall Study||98
198248|NCT00449787|463986|P2|STARTED|Overall Study||198
198249|NCT00449787|463987|P1|STARTED|Overall Study||203
198250|NCT00449748|463997|P1|NOT COMPLETED|Overall Study||0
198251|NCT00449748|463997|P1|COMPLETED|Overall Study||10
198252|NCT00449748|463997|P1|STARTED|Overall Study||10
198253|NCT00449696|464003|P2|NOT COMPLETED|Overall Study||9
198254|NCT00449696|464004|P1|NOT COMPLETED|Overall Study||20
198255|NCT00449696|464003|P2|COMPLETED|Overall Study||119
198256|NCT00449696|464004|P1|COMPLETED|Overall Study||231
198257|NCT00449696|464003|P2|Analyzed Participants|Overall Study||128
198258|NCT00449696|464004|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
198259|NCT00449696|464003|P2|Received Injection|Overall Study||128
198260|NCT00449696|464004|P1|Received Injection|Overall Study||249
198261|NCT00449696|464003|P2|STARTED|Overall Study||128
198262|NCT00449696|464004|P1|STARTED|Overall Study||251
198263|NCT00449644|464030|P4|NOT COMPLETED|Overall Study||32
198264|NCT00449644|464031|P3|NOT COMPLETED|Overall Study||29
198265|NCT00449644|464032|P2|NOT COMPLETED|Overall Study||13
198266|NCT00449644|464033|P1|NOT COMPLETED|Overall Study||10
198267|NCT00449644|464030|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
198268|NCT00449644|464031|P3|COMPLETED|Overall Study||50
198269|NCT00449644|464032|P2|COMPLETED|Overall Study||11
198270|NCT00449644|464033|P1|COMPLETED|Overall Study||13
198271|NCT00449644|464030|P4|Rollover|Overall Study||1
198272|NCT00449644|464031|P3|Rollover|Overall Study||0
198273|NCT00449644|464032|P2|Rollover|Overall Study||0
198274|NCT00449644|464033|P1|Rollover|Overall Study||0
198275|NCT00449644|464030|P4|STARTED|Overall Study||81
198276|NCT00449644|464031|P3|STARTED|Overall Study||79
198277|NCT00449644|464032|P2|STARTED|Overall Study||24
198278|NCT00449644|464033|P1|STARTED|Overall Study||23
198279|NCT00449540|464053|P3|NOT COMPLETED|Treatment Phase||17
198280|NCT00449540|464054|P2|NOT COMPLETED|Treatment Phase||20
198281|NCT00449540|464055|P1|NOT COMPLETED|Treatment Phase||0
198282|NCT00449540|464053|P3|COMPLETED|Treatment Phase||82
198283|NCT00449540|464054|P2|COMPLETED|Treatment Phase||82
198284|NCT00449540|464055|P1|COMPLETED|Treatment Phase||0
198285|NCT00449540|464053|P3|STARTED|Treatment Phase||99
198286|NCT00449540|464054|P2|STARTED|Treatment Phase||102
198287|NCT00449540|464055|P1|STARTED|Treatment Phase||0
198288|NCT00449540|464053|P3|NOT COMPLETED|Pretreatment Phase||0
198289|NCT00449540|464054|P2|NOT COMPLETED|Pretreatment Phase||0
198290|NCT00449540|464055|P1|NOT COMPLETED|Pretreatment Phase||66
198291|NCT00449540|464053|P3|COMPLETED|Pretreatment Phase||0
198292|NCT00449540|464054|P2|COMPLETED|Pretreatment Phase||0
198293|NCT00449540|464055|P1|COMPLETED|Pretreatment Phase||201
198294|NCT00449540|464053|P3|STARTED|Pretreatment Phase||0
198295|NCT00449540|464054|P2|STARTED|Pretreatment Phase||0
198296|NCT00449540|464055|P1|STARTED|Pretreatment Phase||267
198297|NCT00449176|464072|P3|NOT COMPLETED|Overall Study||167
198298|NCT00449176|464073|P2|NOT COMPLETED|Overall Study||195
198299|NCT00449176|464074|P1|NOT COMPLETED|Overall Study||152
198300|NCT00449176|464072|P3|COMPLETED|Overall Study||152
198301|NCT00449176|464073|P2|COMPLETED|Overall Study||133
198302|NCT00449176|464074|P1|COMPLETED|Overall Study||166
198303|NCT00449176|464072|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
198304|NCT00449176|464073|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
198305|NCT00449176|464074|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
198306|NCT00449163|464100|P1|NOT COMPLETED|Overall Study||3
198307|NCT00449163|464100|P1|COMPLETED|Overall Study||22
198308|NCT00449163|464100|P1|STARTED|Overall Study||25
198309|NCT00449150|464109|P3|NOT COMPLETED|Overall Study||47
198310|NCT00449150|464110|P2|NOT COMPLETED|Overall Study||53
198311|NCT00449150|464111|P1|NOT COMPLETED|Overall Study||46
198312|NCT00449150|464109|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
198313|NCT00449150|464110|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
198314|NCT00449150|464111|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
198315|NCT00449150|464109|P3|STARTED|Overall Study||218
198316|NCT00449150|464110|P2|STARTED|Overall Study||230
198317|NCT00449150|464111|P1|STARTED|Overall Study||219
198318|NCT00449072|464121|P2|NOT COMPLETED|Overall Study||42
198319|NCT00449072|464122|P1|NOT COMPLETED|Overall Study||41
198320|NCT00449072|464121|P2|COMPLETED|Overall Study||109
198321|NCT00449072|464122|P1|COMPLETED|Overall Study||107
198322|NCT00449072|464121|P2|STARTED|Overall Study||151
198323|NCT00449072|464122|P1|STARTED|Overall Study||148
198324|NCT00449046|464146|P1|NOT COMPLETED|Overall Study||0
198325|NCT00449046|464146|P1|COMPLETED|Overall Study||40
198326|NCT00449046|464146|P1|STARTED|Overall Study||40
198327|NCT00449033|464159|P2|NOT COMPLETED|Follow-up Period||434
198328|NCT00449033|464160|P1|NOT COMPLETED|Follow-up Period||425
198329|NCT00449033|464159|P2|COMPLETED|Follow-up Period||0
198330|NCT00449033|464160|P1|COMPLETED|Follow-up Period||0
198331|NCT00449033|464159|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
198332|NCT00449033|464160|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
198333|NCT00449033|464159|P2|NOT COMPLETED|Treatment Period||452
198334|NCT00449033|464160|P1|NOT COMPLETED|Treatment Period||452
198335|NCT00449033|464159|P2|COMPLETED|Treatment Period||0
198336|NCT00449033|464160|P1|COMPLETED|Treatment Period||0
198337|NCT00449033|464159|P2|Received Treatment|Treatment Period||449
198338|NCT00449033|464160|P1|Received Treatment|Treatment Period||452
198339|NCT00449033|464159|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
198340|NCT00449033|464160|P1|STARTED|Treatment Period||452
198341|NCT00448916|464198|P4|NOT COMPLETED|Overall Study||6
198342|NCT00448916|464199|P3|NOT COMPLETED|Overall Study||6
198343|NCT00448916|464200|P2|NOT COMPLETED|Overall Study||6
198344|NCT00448916|464201|P1|NOT COMPLETED|Overall Study||7
198345|NCT00448916|464198|P4|COMPLETED|Overall Study||5
198346|NCT00448916|464199|P3|COMPLETED|Overall Study||6
198347|NCT00448916|464200|P2|COMPLETED|Overall Study||9
198348|NCT00448916|464201|P1|COMPLETED|Overall Study||9
198349|NCT00448916|464198|P4|STARTED|Overall Study||11
198350|NCT00448916|464199|P3|STARTED|Overall Study||12
198351|NCT00448916|464200|P2|STARTED|Overall Study||15
198352|NCT00448916|464201|P1|STARTED|Overall Study||16
198353|NCT00448864|464275|P3|NOT COMPLETED|Overall Study||1
198354|NCT00448864|464276|P2|NOT COMPLETED|Overall Study||5
198355|NCT00448864|464277|P1|NOT COMPLETED|Overall Study||5
198356|NCT00448864|464275|P3|COMPLETED|Overall Study||18
198357|NCT00448864|464276|P2|COMPLETED|Overall Study||24
198358|NCT00448864|464277|P1|COMPLETED|Overall Study||22
198359|NCT00448864|464275|P3|Completed Post-operative Period|Overall Study||18
198360|NCT00448864|464276|P2|Completed Post-operative Period|Overall Study||25
198361|NCT00448864|464277|P1|Completed Post-operative Period|Overall Study||26
198362|NCT00448864|464275|P3|Started Post-operative Period|Overall Study||18
198363|NCT00448864|464276|P2|Started Post-operative Period|Overall Study||25
198364|NCT00448864|464277|P1|Started Post-operative Period|Overall Study||26
198365|NCT00448864|464275|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
198366|NCT00448864|464276|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
198367|NCT00448864|464277|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
198368|NCT00448864|464275|P3|STARTED|Overall Study||19
198369|NCT00448864|464276|P2|STARTED|Overall Study||29
198370|NCT00448864|464277|P1|STARTED|Overall Study||27
198371|NCT00448760|464293|P1|NOT COMPLETED|Overall Study||3
198372|NCT00448760|464293|P1|COMPLETED|Overall Study||26
198373|NCT00448760|464293|P1|STARTED|Overall Study||29
198374|NCT00448708|464302|P2|NOT COMPLETED|Overall Study||31
198375|NCT00448708|464303|P1|NOT COMPLETED|Overall Study||35
198376|NCT00448708|464302|P2|COMPLETED|Overall Study||79
198377|NCT00448708|464303|P1|COMPLETED|Overall Study||77
198378|NCT00448708|464302|P2|STARTED|Overall Study||110
198379|NCT00448708|464303|P1|STARTED|Overall Study||112
198380|NCT00448682|464311|P1|NOT COMPLETED|Overall Study||0
198381|NCT00448682|464311|P1|COMPLETED|Overall Study||25
198382|NCT00448682|464311|P1|STARTED|Overall Study||25
198383|NCT00448630|464317|P1|NOT COMPLETED|Overall Study||27
198384|NCT00448630|464317|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
198385|NCT00448630|464317|P1|STARTED|Overall Study||328
198386|NCT00448591|464362|P1|NOT COMPLETED|Overall Study||2296
198387|NCT00448591|464362|P1|COMPLETED|Overall Study||0
198388|NCT00448591|464362|P1|STARTED|Overall Study||2296
198389|NCT00448539|464373|P2|NOT COMPLETED|Overall Study||152
198390|NCT00448539|464374|P1|NOT COMPLETED|Overall Study||134
198391|NCT00448539|464373|P2|COMPLETED|Overall Study||0
198392|NCT00448539|464374|P1|COMPLETED|Overall Study||0
198393|NCT00448539|464373|P2|STARTED|Overall Study||152
198394|NCT00448539|464374|P1|STARTED|Overall Study||134
198395|NCT00448448|464382|P2|NOT COMPLETED|Overall Study||41
198396|NCT00448448|464383|P1|NOT COMPLETED|Overall Study||100
198397|NCT00448448|464382|P2|COMPLETED|Overall Study||96
198398|NCT00448448|464383|P1|COMPLETED|Overall Study||146
198399|NCT00448448|464382|P2|STARTED|Overall Study||137
198400|NCT00448448|464383|P1|STARTED|Overall Study||246
198401|NCT00448435|464389|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
198402|NCT00448435|464390|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
198403|NCT00448435|464389|P2|COMPLETED|Extension Period - 20 Weeks||0
198404|NCT00448435|464390|P1|COMPLETED|Extension Period - 20 Weeks||50
198405|NCT00448435|464389|P2|STARTED|Extension Period - 20 Weeks||0
198406|NCT00448435|464390|P1|STARTED|Extension Period - 20 Weeks||50
198407|NCT00448435|464389|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
198408|NCT00448435|464390|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
198409|NCT00448435|464389|P2|COMPLETED|Treatment Period II - 4 Weeks||25
198410|NCT00448435|464390|P1|COMPLETED|Treatment Period II - 4 Weeks||25
198411|NCT00448435|464389|P2|STARTED|Treatment Period II - 4 Weeks||25
198412|NCT00448435|464390|P1|STARTED|Treatment Period II - 4 Weeks||25
198413|NCT00448435|464389|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
198414|NCT00448435|464390|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
198415|NCT00448435|464389|P2|COMPLETED|Washout Period - 2 Weeks||25
198416|NCT00448435|464390|P1|COMPLETED|Washout Period - 2 Weeks||25
198417|NCT00448435|464389|P2|STARTED|Washout Period - 2 Weeks||25
198418|NCT00448435|464390|P1|STARTED|Washout Period - 2 Weeks||26
198419|NCT00448435|464389|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
198420|NCT00448435|464390|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
198421|NCT00448435|464389|P2|COMPLETED|Treatment Period I - 4 Weeks||25
198422|NCT00448435|464390|P1|COMPLETED|Treatment Period I - 4 Weeks||26
198423|NCT00448435|464389|P2|STARTED|Treatment Period I - 4 Weeks||25
198424|NCT00448435|464390|P1|STARTED|Treatment Period I - 4 Weeks||26
198425|NCT00448344|464418|P2|NOT COMPLETED|Overall Study||36
198426|NCT00448344|464419|P1|NOT COMPLETED|Overall Study||30
198427|NCT00448344|464418|P2|COMPLETED|Overall Study||200
198428|NCT00448344|464419|P1|COMPLETED|Overall Study||205
198429|NCT00448344|464418|P2|STARTED|Overall Study||236
198430|NCT00448344|464419|P1|STARTED|Overall Study||235
198431|NCT00448279|464429|P2|NOT COMPLETED|Overall Study||29
198432|NCT00448279|464430|P1|NOT COMPLETED|Overall Study||29
198433|NCT00448279|464429|P2|COMPLETED|Overall Study||0
198434|NCT00448279|464430|P1|COMPLETED|Overall Study||0
198435|NCT00448279|464429|P2|STARTED|Overall Study||29
198436|NCT00448279|464430|P1|STARTED|Overall Study||29
198437|NCT00448227|464446|P1|NOT COMPLETED|Overall Study||0
198438|NCT00448227|464446|P1|COMPLETED|Overall Study||18
198439|NCT00448227|464446|P1|STARTED|Overall Study||18
198440|NCT00448175|464475|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
198441|NCT00448175|464476|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
198442|NCT00448175|464475|P2|COMPLETED|Continued PTNS Through 12 Months||0
198443|NCT00448175|464476|P1|COMPLETED|Continued PTNS Through 12 Months||25
198444|NCT00448175|464475|P2|STARTED|Continued PTNS Through 12 Months||0
198445|NCT00448175|464476|P1|STARTED|Continued PTNS Through 12 Months||35
198446|NCT00448175|464475|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
198447|NCT00448175|464476|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
198448|NCT00448175|464475|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
198449|NCT00448175|464476|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
198450|NCT00448175|464475|P2|STARTED|12 Weeks PTNS vs. Drug||50
198451|NCT00448175|464476|P1|STARTED|12 Weeks PTNS vs. Drug||50
198452|NCT00448136|464484|P2|NOT COMPLETED|Overall Study||8
198453|NCT00448136|464485|P1|NOT COMPLETED|Overall Study||4
198454|NCT00448136|464484|P2|COMPLETED|Overall Study||41
198455|NCT00448136|464485|P1|COMPLETED|Overall Study||30
198456|NCT00448136|464484|P2|STARTED|Overall Study||49
198457|NCT00448136|464485|P1|STARTED|Overall Study||34
198458|NCT00448123|464523|P2|NOT COMPLETED|Overall Study||12
198459|NCT00448123|464524|P1|NOT COMPLETED|Overall Study||15
198460|NCT00448123|464523|P2|COMPLETED|Overall Study||53
198461|NCT00448123|464524|P1|COMPLETED|Overall Study||47
198462|NCT00448123|464523|P2|STARTED|Overall Study||65
198463|NCT00448123|464524|P1|STARTED|Overall Study||62
198464|NCT00448019|464534|P1|NOT COMPLETED|Overall Study||7
198465|NCT00448019|464534|P1|COMPLETED|Overall Study||57
198466|NCT00448019|464534|P1|STARTED|Overall Study||64
198467|NCT00447902|464542|P2|NOT COMPLETED|Overall Study||6
198468|NCT00447902|464543|P1|NOT COMPLETED|Overall Study||4
198469|NCT00447902|464542|P2|COMPLETED|Overall Study||0
198470|NCT00447902|464543|P1|COMPLETED|Overall Study||1
198471|NCT00447902|464542|P2|STARTED|Overall Study||6
198472|NCT00447902|464543|P1|STARTED|Overall Study||5
198473|NCT00447603|464583|P3|NOT COMPLETED|Filter Period||15
198474|NCT00447603|464584|P2|NOT COMPLETED|Filter Period||4
198475|NCT00447603|464585|P1|NOT COMPLETED|Filter Period||0
198476|NCT00447603|464583|P3|COMPLETED|Filter Period||0
198477|NCT00447603|464584|P2|COMPLETED|Filter Period||0
198478|NCT00447603|464585|P1|COMPLETED|Filter Period||0
198479|NCT00447603|464583|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
198480|NCT00447603|464584|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
198481|NCT00447603|464585|P1|STARTED|Filter Period||0
198482|NCT00447603|464583|P3|NOT COMPLETED|Screening||0
198483|NCT00447603|464584|P2|NOT COMPLETED|Screening||0
198484|NCT00447603|464585|P1|NOT COMPLETED|Screening||21
198485|NCT00447603|464583|P3|COMPLETED|Screening||0
198486|NCT00447603|464584|P2|COMPLETED|Screening||0
198487|NCT00447603|464585|P1|COMPLETED|Screening||19
198488|NCT00447603|464583|P3|STARTED|Screening||0
198489|NCT00447603|464584|P2|STARTED|Screening||0
198490|NCT00447603|464585|P1|STARTED|Screening||40
198491|NCT00447590|464605|P1|NOT COMPLETED|Overall Study||60
198492|NCT00447590|464605|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
198493|NCT00447590|464605|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
198494|NCT00447499|464614|P1|NOT COMPLETED|Overall Study||7
198495|NCT00447499|464614|P1|COMPLETED|Overall Study||52
198496|NCT00447499|464614|P1|STARTED|Overall Study||59
198497|NCT00447421|464624|P1|NOT COMPLETED|Overall Study||6
198498|NCT00447421|464624|P1|COMPLETED|Overall Study||3
198499|NCT00447421|464624|P1|STARTED|Overall Study||9
198500|NCT00447382|464636|P2|NOT COMPLETED|Overall Study||6
198501|NCT00447382|464637|P1|NOT COMPLETED|Overall Study||6
198502|NCT00447382|464636|P2|COMPLETED|Overall Study||160
198503|NCT00447382|464637|P1|COMPLETED|Overall Study||158
198504|NCT00447382|464636|P2|STARTED|Overall Study||166
198505|NCT00447382|464637|P1|STARTED|Overall Study||164
198506|NCT00447330|464689|P1|NOT COMPLETED|Overall Study||2
198507|NCT00447330|464689|P1|COMPLETED|Overall Study||58
198508|NCT00447330|464689|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
198509|NCT00447278|464698|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
198510|NCT00447278|464699|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
198511|NCT00447278|464698|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
198512|NCT00447278|464699|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
198513|NCT00447278|464698|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
198514|NCT00447278|464699|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
198515|NCT00447278|464698|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
198516|NCT00447278|464699|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
198517|NCT00447278|464698|P2|COMPLETED|Period II (6 Month Open-Label)||171
198518|NCT00447278|464699|P1|COMPLETED|Period II (6 Month Open-Label)||157
198519|NCT00447278|464698|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
198520|NCT00447278|464699|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
198521|NCT00447278|464698|P2|STARTED|Period II (6 Month Open-Label)||200
198522|NCT00447278|464699|P1|STARTED|Period II (6 Month Open-Label)||199
198523|NCT00447265|464720|P2|NOT COMPLETED|Overall Study||0
198524|NCT00447265|464721|P1|NOT COMPLETED|Overall Study||1
198525|NCT00447265|464720|P2|COMPLETED|Overall Study||0
198526|NCT00447265|464721|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
198527|NCT00447265|464720|P2|STARTED|Overall Study||0
198528|NCT00447265|464721|P1|STARTED|Overall Study||1
198529|NCT00447226|464734|P2|NOT COMPLETED|Double-blind Phase||3
198530|NCT00447226|464735|P1|NOT COMPLETED|Double-blind Phase||4
198531|NCT00447226|464734|P2|COMPLETED|Double-blind Phase||0
198532|NCT00447226|464735|P1|COMPLETED|Double-blind Phase||0
198533|NCT00447226|464734|P2|STARTED|Double-blind Phase||3
198534|NCT00447226|464735|P1|STARTED|Double-blind Phase||4
198535|NCT00447226|464734|P2|NOT COMPLETED|12-Week Open-label Phase||25
198536|NCT00447226|464735|P1|NOT COMPLETED|12-Week Open-label Phase||0
198537|NCT00447226|464734|P2|COMPLETED|12-Week Open-label Phase||7
198538|NCT00447226|464735|P1|COMPLETED|12-Week Open-label Phase||0
198539|NCT00447226|464734|P2|STARTED|12-Week Open-label Phase||32
198540|NCT00447226|464735|P1|STARTED|12-Week Open-label Phase||0
198541|NCT00447122|464753|P1|NOT COMPLETED|Overall Study||2
198542|NCT00447122|464753|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
198543|NCT00447122|464753|P1|STARTED|Overall Study||31
198544|NCT00447057|464761|P4|NOT COMPLETED|Overall Study||26
198545|NCT00447057|464762|P3|NOT COMPLETED|Overall Study||19
198546|NCT00447057|464763|P2|NOT COMPLETED|Overall Study||73
198547|NCT00447057|464764|P1|NOT COMPLETED|Overall Study||83
198548|NCT00447057|464761|P4|COMPLETED|Overall Study||0
198549|NCT00447057|464762|P3|COMPLETED|Overall Study||0
198550|NCT00447057|464763|P2|COMPLETED|Overall Study||3
198551|NCT00447057|464764|P1|COMPLETED|Overall Study||0
198552|NCT00447057|464761|P4|STARTED|Overall Study||26
198553|NCT00447057|464762|P3|STARTED|Overall Study||19
198554|NCT00447057|464763|P2|STARTED|Overall Study||76
198555|NCT00447057|464764|P1|STARTED|Overall Study||83
198556|NCT00447005|464782|P1|NOT COMPLETED|Overall Study||12
198557|NCT00447005|464782|P1|COMPLETED|Overall Study||0
198558|NCT00447005|464782|P1|STARTED|Overall Study||12
198559|NCT00446992|464796|P1|NOT COMPLETED|Overall Study||16
198560|NCT00446992|464796|P1|COMPLETED|Overall Study|Intervention Completion|14
198561|NCT00446992|464796|P1|STARTED|Overall Study|Beginning of Intervention|30
198562|NCT00446849|464808|P1|NOT COMPLETED|Maintenance Phase||70
198563|NCT00446849|464808|P1|COMPLETED|Maintenance Phase||138
198564|NCT00446849|464808|P1|STARTED|Maintenance Phase||208
198565|NCT00446849|464808|P1|NOT COMPLETED|Acute Phase||82
198566|NCT00446849|464808|P1|COMPLETED|Acute Phase||56
198567|NCT00446849|464808|P1|STARTED|Acute Phase||138
198568|NCT00446797|464820|P2|NOT COMPLETED|Overall Study||12
198569|NCT00446797|464821|P1|NOT COMPLETED|Overall Study||8
198570|NCT00446797|464820|P2|COMPLETED|Overall Study||125
198571|NCT00446797|464821|P1|COMPLETED|Overall Study||133
198572|NCT00446797|464820|P2|STARTED|Overall Study||137
198573|NCT00446797|464821|P1|STARTED|Overall Study||141
198574|NCT00446654|464867|P2|NOT COMPLETED|Overall Study||0
198575|NCT00446654|464868|P1|NOT COMPLETED|Overall Study||2
198576|NCT00446654|464867|P2|COMPLETED|Overall Study||22
198577|NCT00446654|464868|P1|COMPLETED|Overall Study||19
198578|NCT00446654|464867|P2|STARTED|Overall Study||22
198579|NCT00446654|464868|P1|STARTED|Overall Study||21
198580|NCT00446641|464876|P2|NOT COMPLETED|Overall Study||10
198581|NCT00446641|464877|P1|NOT COMPLETED|Overall Study||17
198582|NCT00446641|464876|P2|COMPLETED|Overall Study||109
198583|NCT00446641|464877|P1|COMPLETED|Overall Study||108
198584|NCT00446641|464876|P2|STARTED|Overall Study||119
198585|NCT00446641|464877|P1|STARTED|Overall Study||125
198586|NCT00446563|464897|P2|NOT COMPLETED|Overall Study||9
198587|NCT00446563|464898|P1|NOT COMPLETED|Overall Study||7
198588|NCT00446563|464897|P2|COMPLETED|Overall Study||38
198589|NCT00446563|464898|P1|COMPLETED|Overall Study||36
198590|NCT00446563|464897|P2|STARTED|Overall Study||47
198591|NCT00446563|464898|P1|STARTED|Overall Study||43
198592|NCT00446511|464936|P4|NOT COMPLETED|Overall Study||6
198593|NCT00446511|464937|P3|NOT COMPLETED|Overall Study||7
198594|NCT00446511|464938|P2|NOT COMPLETED|Overall Study||2
198595|NCT00446511|464939|P1|NOT COMPLETED|Overall Study||10
198596|NCT00446511|464936|P4|COMPLETED|Overall Study||103
198597|NCT00446511|464937|P3|COMPLETED|Overall Study||96
198598|NCT00446511|464938|P2|COMPLETED|Overall Study||15
198599|NCT00446511|464939|P1|COMPLETED|Overall Study||11
198600|NCT00446511|464936|P4|STARTED|Overall Study||109
198601|NCT00446511|464937|P3|STARTED|Overall Study||103
198602|NCT00446511|464938|P2|STARTED|Overall Study||17
198603|NCT00446511|464939|P1|STARTED|Overall Study||21
198604|NCT00446459|464963|P1|NOT COMPLETED|12 Months||18
198605|NCT00446459|464963|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
198606|NCT00446459|464963|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
198607|NCT00446459|464963|P1|NOT COMPLETED|8 Months||12
198608|NCT00446459|464963|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
198609|NCT00446459|464963|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
198610|NCT00446446|464971|P1|NOT COMPLETED|Overall Study||24
198611|NCT00446446|464971|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
198612|NCT00446446|464971|P1|STARTED|Overall Study||52
198613|NCT00446290|464982|P1|NOT COMPLETED|Overall Study||0
198614|NCT00446290|464982|P1|COMPLETED|Overall Study||21
198615|NCT00446290|464982|P1|STARTED|Overall Study||21
198616|NCT00446264|464986|P1|NOT COMPLETED|Overall Study||0
198617|NCT00446264|464986|P1|COMPLETED|Overall Study||14
198618|NCT00446264|464986|P1|STARTED|Overall Study||14
198619|NCT00446251|464995|P1|NOT COMPLETED|Overall Study||5
198620|NCT00446251|464995|P1|COMPLETED|Overall Study||9
198621|NCT00446251|464995|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
198622|NCT00446199|465005|P4|NOT COMPLETED|Overall Study||30
198623|NCT00446199|465006|P3|NOT COMPLETED|Overall Study||27
198624|NCT00446199|465007|P2|NOT COMPLETED|Overall Study||20
198625|NCT00446199|465008|P1|NOT COMPLETED|Overall Study||23
198626|NCT00446199|465005|P4|COMPLETED|Overall Study||153
198627|NCT00446199|465006|P3|COMPLETED|Overall Study||158
198628|NCT00446199|465007|P2|COMPLETED|Overall Study||164
198629|NCT00446199|465008|P1|COMPLETED|Overall Study||160
198630|NCT00446199|465005|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
198631|NCT00446199|465006|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
198632|NCT00446199|465007|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
198633|NCT00446199|465008|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
198634|NCT00446199|465005|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
198635|NCT00446199|465006|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
198636|NCT00446199|465007|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
198637|NCT00446199|465008|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
198638|NCT00446199|465005|P4|STARTED|Overall Study||183
198639|NCT00446199|465006|P3|STARTED|Overall Study||185
198640|NCT00446199|465007|P2|STARTED|Overall Study||184
198641|NCT00446199|465008|P1|STARTED|Overall Study||183
198642|NCT00446147|465088|P2|NOT COMPLETED|Overall Study||14
198643|NCT00446147|465089|P1|NOT COMPLETED|Overall Study||15
198644|NCT00446147|465088|P2|COMPLETED|Overall Study||180
198645|NCT00446147|465089|P1|COMPLETED|Overall Study||180
198646|NCT00446147|465088|P2|STARTED|Overall Study||194
198647|NCT00446147|465089|P1|STARTED|Overall Study||195
198648|NCT00446134|465101|P4|NOT COMPLETED|Overall Study||45
198649|NCT00446134|465102|P3|NOT COMPLETED|Overall Study||43
198650|NCT00446134|465103|P2|NOT COMPLETED|Overall Study||45
198651|NCT00446134|465104|P1|NOT COMPLETED|Overall Study||34
198652|NCT00446134|465101|P4|COMPLETED|Overall Study||25
198653|NCT00446134|465102|P3|COMPLETED|Overall Study||26
198654|NCT00446134|465103|P2|COMPLETED|Overall Study||25
198655|NCT00446134|465104|P1|COMPLETED|Overall Study||35
198656|NCT00446134|465101|P4|STARTED|Overall Study||70
198657|NCT00446134|465102|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
198658|NCT00446134|465103|P2|STARTED|Overall Study||70
198659|NCT00446134|465104|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
198660|NCT00446095|465131|P5|NOT COMPLETED|Phase I (28 Days)||3
198661|NCT00446095|465132|P4|NOT COMPLETED|Phase I (28 Days)||1
198662|NCT00446095|465133|P3|NOT COMPLETED|Phase I (28 Days)||0
198663|NCT00446095|465134|P2|NOT COMPLETED|Phase I (28 Days)||0
198664|NCT00446095|465135|P1|NOT COMPLETED|Phase I (28 Days)||0
198665|NCT00446095|465131|P5|COMPLETED|Phase I (28 Days)||4
198666|NCT00446095|465132|P4|COMPLETED|Phase I (28 Days)||5
198667|NCT00446095|465133|P3|COMPLETED|Phase I (28 Days)||0
198668|NCT00446095|465134|P2|COMPLETED|Phase I (28 Days)||0
198669|NCT00446095|465135|P1|COMPLETED|Phase I (28 Days)||0
198670|NCT00446095|465131|P5|STARTED|Phase I (28 Days)||7
198671|NCT00446095|465132|P4|STARTED|Phase I (28 Days)||6
198672|NCT00446095|465133|P3|STARTED|Phase I (28 Days)||0
198673|NCT00446095|465134|P2|STARTED|Phase I (28 Days)||0
198674|NCT00446095|465135|P1|STARTED|Phase I (28 Days)||0
198675|NCT00446095|465131|P5|NOT COMPLETED|Phase II (8 Weeks)||0
198676|NCT00446095|465132|P4|NOT COMPLETED|Phase II (8 Weeks)||0
198677|NCT00446095|465133|P3|NOT COMPLETED|Phase II (8 Weeks)||3
198678|NCT00446095|465134|P2|NOT COMPLETED|Phase II (8 Weeks)||3
198679|NCT00446095|465135|P1|NOT COMPLETED|Phase II (8 Weeks)||12
198680|NCT00446095|465131|P5|COMPLETED|Phase II (8 Weeks)||0
198681|NCT00446095|465132|P4|COMPLETED|Phase II (8 Weeks)||0
198682|NCT00446095|465133|P3|COMPLETED|Phase II (8 Weeks)||21
198683|NCT00446095|465134|P2|COMPLETED|Phase II (8 Weeks)||18
198684|NCT00446095|465135|P1|COMPLETED|Phase II (8 Weeks)||11
198685|NCT00446095|465131|P5|STARTED|Phase II (8 Weeks)||0
198686|NCT00446095|465132|P4|STARTED|Phase II (8 Weeks)||0
198687|NCT00446095|465133|P3|STARTED|Phase II (8 Weeks)||24
198688|NCT00446095|465134|P2|STARTED|Phase II (8 Weeks)||21
198689|NCT00446095|465135|P1|STARTED|Phase II (8 Weeks)||23
198690|NCT00446030|465158|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
198691|NCT00446030|465159|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
198692|NCT00446030|465158|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
198693|NCT00446030|465159|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
198694|NCT00446030|465158|P2|STARTED|FOLLOW-UP (up to 2-years)||34
198695|NCT00446030|465159|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
198696|NCT00446030|465158|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
198697|NCT00446030|465159|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
198698|NCT00446030|465158|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
198699|NCT00446030|465159|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
198700|NCT00446030|465158|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
198701|NCT00446030|465159|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
198702|NCT00446030|465158|P2|STARTED|TREATMENT (up to 52 Weeks)||34
198703|NCT00446030|465159|P1|STARTED|TREATMENT (up to 52 Weeks)||93
198704|NCT00445939|465170|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
198705|NCT00445939|465171|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
198706|NCT00445939|465172|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
198707|NCT00445939|465173|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
198708|NCT00445939|465170|P4|COMPLETED|Period B - Week 4 - Week 8||20
198709|NCT00445939|465171|P3|COMPLETED|Period B - Week 4 - Week 8||0
198710|NCT00445939|465172|P2|COMPLETED|Period B - Week 4 - Week 8||0
198711|NCT00445939|465173|P1|COMPLETED|Period B - Week 4 - Week 8||14
198712|NCT00445939|465170|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
198713|NCT00445939|465171|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
198714|NCT00445939|465172|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
198715|NCT00445939|465173|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
198716|NCT00445939|465170|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
198717|NCT00445939|465171|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
198718|NCT00445939|465172|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
198719|NCT00445939|465173|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
198720|NCT00445939|465170|P4|COMPLETED|Period A - Week 0 - Week 4||0
198721|NCT00445939|465171|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
198722|NCT00445939|465172|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
198723|NCT00445939|465173|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
198724|NCT00445939|465170|P4|STARTED|Period A - Week 0 - Week 4||0
198725|NCT00445939|465171|P3|STARTED|Period A - Week 0 - Week 4||23
198726|NCT00445939|465172|P2|STARTED|Period A - Week 0 - Week 4||34
198727|NCT00445939|465173|P1|STARTED|Period A - Week 0 - Week 4||33
198728|NCT00443898|465200|P4|NOT COMPLETED|Overall Study||18
198729|NCT00443898|465201|P3|NOT COMPLETED|Overall Study||29
198730|NCT00443898|465202|P2|NOT COMPLETED|Overall Study||25
198731|NCT00443898|465203|P1|NOT COMPLETED|Overall Study||24
198732|NCT00443898|465200|P4|COMPLETED|Overall Study||110
198733|NCT00443898|465201|P3|COMPLETED|Overall Study||107
198734|NCT00443898|465202|P2|COMPLETED|Overall Study||103
198735|NCT00443898|465203|P1|COMPLETED|Overall Study||102
198736|NCT00443898|465200|P4|STARTED|Overall Study||128
198737|NCT00443898|465201|P3|STARTED|Overall Study||136
198738|NCT00443898|465202|P2|STARTED|Overall Study||128
198739|NCT00443898|465203|P1|STARTED|Overall Study||126
198740|NCT00443872|465225|P1|NOT COMPLETED|Overall Study||17
198741|NCT00443872|465225|P1|COMPLETED|Overall Study||60
198742|NCT00443872|465225|P1|STARTED|Overall Study||77
198743|NCT00443820|465242|P4|NOT COMPLETED|Overall Study||17
198744|NCT00443820|465243|P3|NOT COMPLETED|Overall Study||18
198745|NCT00443820|465244|P2|NOT COMPLETED|Overall Study||19
198746|NCT00443820|465245|P1|NOT COMPLETED|Overall Study||21
198747|NCT00443820|465242|P4|COMPLETED|Overall Study||111
198748|NCT00443820|465243|P3|COMPLETED|Overall Study||117
198749|NCT00443820|465244|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
198750|NCT00443820|465245|P1|COMPLETED|Overall Study||112
198751|NCT00443820|465242|P4|Safety Population|Overall Study||126
198752|NCT00443820|465243|P3|Safety Population|Overall Study||134
198753|NCT00443820|465244|P2|Safety Population|Overall Study||129
198754|NCT00443820|465245|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
198755|NCT00443820|465242|P4|STARTED|Overall Study||128
198756|NCT00443820|465243|P3|STARTED|Overall Study||135
198757|NCT00443820|465244|P2|STARTED|Overall Study||130
198758|NCT00443820|465245|P1|STARTED|Overall Study||133
198759|NCT00443781|465267|P1|NOT COMPLETED|Overall Study||25
198760|NCT00443781|465267|P1|COMPLETED|Overall Study||37
198761|NCT00443781|465267|P1|STARTED|Overall Study||62
198762|NCT00443755|465273|P2|NOT COMPLETED|Overall Study||1
198763|NCT00443755|465274|P1|NOT COMPLETED|Overall Study||2
198764|NCT00443755|465273|P2|COMPLETED|Overall Study||13
198765|NCT00443755|465274|P1|COMPLETED|Overall Study||12
198766|NCT00443755|465273|P2|STARTED|Overall Study||14
198767|NCT00443755|465274|P1|STARTED|Overall Study||14
198768|NCT00445848|465306|P1|NOT COMPLETED|Overall Study||85
198769|NCT00445848|465306|P1|COMPLETED|Overall Study||0
198770|NCT00445848|465306|P1|STARTED|Overall Study||85
198771|NCT00445770|465316|P3|NOT COMPLETED|Overall Study||31
198772|NCT00445770|465317|P2|NOT COMPLETED|Overall Study||35
198773|NCT00445770|465318|P1|NOT COMPLETED|Overall Study||53
198774|NCT00445770|465316|P3|COMPLETED|Overall Study||151
198775|NCT00445770|465317|P2|COMPLETED|Overall Study||157
198776|NCT00445770|465318|P1|COMPLETED|Overall Study||123
198777|NCT00445770|465316|P3|STARTED|Overall Study||182
198778|NCT00445770|465317|P2|STARTED|Overall Study||192
198779|NCT00445770|465318|P1|STARTED|Overall Study||176
198780|NCT00445705|465389|P4|NOT COMPLETED|Overall Study||14
198781|NCT00445705|465390|P3|NOT COMPLETED|Overall Study||11
198782|NCT00445705|465391|P2|NOT COMPLETED|Overall Study||11
198783|NCT00445705|465392|P1|NOT COMPLETED|Overall Study||9
198784|NCT00445705|465389|P4|COMPLETED|Overall Study||39
198785|NCT00445705|465390|P3|COMPLETED|Overall Study||41
198786|NCT00445705|465391|P2|COMPLETED|Overall Study||42
198787|NCT00445705|465392|P1|COMPLETED|Overall Study||44
198788|NCT00445705|465389|P4|STARTED|Overall Study||53
198789|NCT00445705|465390|P3|STARTED|Overall Study||52
198790|NCT00445705|465391|P2|STARTED|Overall Study||53
198791|NCT00445705|465392|P1|STARTED|Overall Study||53
198792|NCT00445679|465418|P4|NOT COMPLETED|Overall Study||47
198793|NCT00445679|465419|P3|NOT COMPLETED|Overall Study||66
198794|NCT00445679|465420|P2|NOT COMPLETED|Overall Study||46
198795|NCT00445679|465421|P1|NOT COMPLETED|Overall Study||48
198796|NCT00445679|465418|P4|COMPLETED|Overall Study||149
198797|NCT00445679|465419|P3|COMPLETED|Overall Study||139
198798|NCT00445679|465420|P2|COMPLETED|Overall Study||157
198799|NCT00445679|465421|P1|COMPLETED|Overall Study||155
198800|NCT00445679|465418|P4|STARTED|Overall Study||196
198801|NCT00445679|465419|P3|STARTED|Overall Study||205
198802|NCT00445679|465420|P2|STARTED|Overall Study||203
198803|NCT00445679|465421|P1|STARTED|Overall Study||203
198804|NCT00445588|465455|P1|NOT COMPLETED|Overall Study||0
198805|NCT00445588|465455|P1|COMPLETED|Overall Study||56
198806|NCT00445588|465455|P1|STARTED|Overall Study||56
198807|NCT00445549|465460|P1|NOT COMPLETED|Overall Study||12
198808|NCT00445549|465460|P1|COMPLETED|Overall Study||0
198809|NCT00445549|465460|P1|STARTED|Overall Study||12
198810|NCT00445484|465467|P2|NOT COMPLETED|Overall Study||1
198811|NCT00445484|465468|P1|NOT COMPLETED|Overall Study||4
198812|NCT00445484|465467|P2|COMPLETED|Overall Study||10
198813|NCT00445484|465468|P1|COMPLETED|Overall Study||7
198814|NCT00445484|465467|P2|STARTED|Overall Study||11
198815|NCT00445484|465468|P1|STARTED|Overall Study||11
198816|NCT00445432|465483|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
198817|NCT00445432|465484|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
198818|NCT00445432|465485|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
198819|NCT00445432|465486|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
198820|NCT00445432|465483|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
198821|NCT00445432|465484|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
198822|NCT00445432|465485|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
198823|NCT00445432|465486|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
198824|NCT00445432|465483|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
198825|NCT00445432|465484|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
198826|NCT00445432|465485|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
198827|NCT00445432|465486|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
198828|NCT00445432|465483|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
198829|NCT00445432|465484|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
198830|NCT00445432|465485|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
198831|NCT00445432|465486|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
198832|NCT00445432|465483|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
198833|NCT00445432|465484|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
198834|NCT00445432|465485|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
198835|NCT00445432|465486|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
198926|NCT00444925|465776|P1|COMPLETED|Double-blind Treatment Period||304
198836|NCT00445432|465483|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
198837|NCT00445432|465484|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
198838|NCT00445432|465485|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
198839|NCT00445432|465486|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
198840|NCT00445341|465519|P1|NOT COMPLETED|Overall Study||2
198841|NCT00445341|465519|P1|COMPLETED|Overall Study||26
198842|NCT00445341|465519|P1|STARTED|Overall Study||28
198843|NCT00445328|465526|P2|NOT COMPLETED|Overall Study||6
198844|NCT00445328|465527|P1|NOT COMPLETED|Overall Study||3
198845|NCT00445328|465526|P2|COMPLETED|Overall Study||36
198846|NCT00445328|465527|P1|COMPLETED|Overall Study||39
198847|NCT00445328|465526|P2|Received Treatment|Overall Study||42
198848|NCT00445328|465527|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
198849|NCT00445328|465526|P2|STARTED|Overall Study||42
198850|NCT00445328|465527|P1|STARTED|Overall Study||42
198851|NCT00445315|465550|P5|NOT COMPLETED|Overall Study||0
198852|NCT00445315|465551|P4|NOT COMPLETED|Overall Study||0
198853|NCT00445315|465552|P3|NOT COMPLETED|Overall Study||0
198854|NCT00445315|465553|P2|NOT COMPLETED|Overall Study||0
198855|NCT00445315|465554|P1|NOT COMPLETED|Overall Study||0
198856|NCT00445315|465550|P5|COMPLETED|Overall Study||8
198857|NCT00445315|465551|P4|COMPLETED|Overall Study||6
198858|NCT00445315|465552|P3|COMPLETED|Overall Study||6
198859|NCT00445315|465553|P2|COMPLETED|Overall Study||6
198860|NCT00445315|465554|P1|COMPLETED|Overall Study||6
198861|NCT00445315|465550|P5|STARTED|Overall Study||8
198862|NCT00445315|465551|P4|STARTED|Overall Study||6
198863|NCT00445315|465552|P3|STARTED|Overall Study||6
198864|NCT00445315|465553|P2|STARTED|Overall Study||6
198865|NCT00445315|465554|P1|STARTED|Overall Study||6
198866|NCT00445302|465648|P4|NOT COMPLETED|Overall Study||0
198867|NCT00445302|465649|P3|NOT COMPLETED|Overall Study||0
198868|NCT00445302|465650|P2|NOT COMPLETED|Overall Study||0
198869|NCT00445302|465651|P1|NOT COMPLETED|Overall Study||0
198870|NCT00445302|465648|P4|COMPLETED|Overall Study||6
198871|NCT00445302|465649|P3|COMPLETED|Overall Study||6
198872|NCT00445302|465650|P2|COMPLETED|Overall Study||5
198873|NCT00445302|465651|P1|COMPLETED|Overall Study||6
198874|NCT00445302|465648|P4|STARTED|Overall Study||6
198875|NCT00445302|465649|P3|STARTED|Overall Study||6
198876|NCT00445302|465650|P2|STARTED|Overall Study||5
198877|NCT00445302|465651|P1|STARTED|Overall Study||6
198878|NCT00445263|465679|P2|NOT COMPLETED|Overall Study||1
198879|NCT00445263|465680|P1|NOT COMPLETED|Overall Study||0
198880|NCT00445263|465679|P2|COMPLETED|Overall Study||86
198881|NCT00445263|465680|P1|COMPLETED|Overall Study||83
198882|NCT00445263|465679|P2|STARTED|Overall Study||87
198883|NCT00445263|465680|P1|STARTED|Overall Study||83
198884|NCT00445224|465688|P2|NOT COMPLETED|Combined Exercises||0
198885|NCT00445224|465689|P1|NOT COMPLETED|Combined Exercises||0
198886|NCT00445224|465688|P2|COMPLETED|Combined Exercises||13
198887|NCT00445224|465689|P1|COMPLETED|Combined Exercises||13
198888|NCT00445224|465688|P2|STARTED|Combined Exercises||13
198889|NCT00445224|465689|P1|STARTED|Combined Exercises||13
198890|NCT00445224|465688|P2|NOT COMPLETED|Specific Exercises||3
198891|NCT00445224|465689|P1|NOT COMPLETED|Specific Exercises||4
198892|NCT00445224|465688|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
198893|NCT00445224|465689|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
198894|NCT00445224|465688|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
198895|NCT00445224|465689|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
198896|NCT00445224|465688|P2|Baseline|Specific Exercises||16
198897|NCT00445224|465689|P1|Baseline|Specific Exercises||17
198898|NCT00445224|465688|P2|STARTED|Specific Exercises||16
198899|NCT00445224|465689|P1|STARTED|Specific Exercises||17
198900|NCT00445146|465699|P1|NOT COMPLETED|Overall Study||119
198901|NCT00445146|465699|P1|COMPLETED|Overall Study||73
198902|NCT00445146|465699|P1|STARTED|Overall Study||192
198903|NCT00445003|465721|P3|NOT COMPLETED|Overall Study||4
198904|NCT00445003|465722|P2|NOT COMPLETED|Overall Study||10
198905|NCT00445003|465723|P1|NOT COMPLETED|Overall Study||5
198906|NCT00445003|465721|P3|COMPLETED|Overall Study||105
198907|NCT00445003|465722|P2|COMPLETED|Overall Study||103
198908|NCT00445003|465723|P1|COMPLETED|Overall Study||118
198909|NCT00445003|465721|P3|STARTED|Overall Study||109
198910|NCT00445003|465722|P2|STARTED|Overall Study||113
198911|NCT00445003|465723|P1|STARTED|Overall Study||123
198912|NCT00444951|465755|P3|NOT COMPLETED|Overall Study||3
198913|NCT00444951|465756|P2|NOT COMPLETED|Overall Study||6
198914|NCT00444951|465757|P1|NOT COMPLETED|Overall Study||5
198915|NCT00444951|465755|P3|COMPLETED|Overall Study||160
198916|NCT00444951|465756|P2|COMPLETED|Overall Study||136
198917|NCT00444951|465757|P1|COMPLETED|Overall Study||140
198918|NCT00444951|465755|P3|STARTED|Overall Study||163
198919|NCT00444951|465756|P2|STARTED|Overall Study||142
198920|NCT00444951|465757|P1|STARTED|Overall Study||145
198921|NCT00444925|465774|P3|NOT COMPLETED|Double-blind Treatment Period||81
198922|NCT00444925|465775|P2|NOT COMPLETED|Double-blind Treatment Period||56
198923|NCT00444925|465776|P1|NOT COMPLETED|Double-blind Treatment Period||30
198924|NCT00444925|465774|P3|COMPLETED|Double-blind Treatment Period||598
198925|NCT00444925|465775|P2|COMPLETED|Double-blind Treatment Period||628
198927|NCT00444925|465774|P3|STARTED|Double-blind Treatment Period||679
198928|NCT00444925|465775|P2|STARTED|Double-blind Treatment Period||684
198929|NCT00444925|465776|P1|STARTED|Double-blind Treatment Period||334
198930|NCT00444925|465774|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
198931|NCT00444925|465775|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
198932|NCT00444925|465776|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
198933|NCT00444925|465774|P3|COMPLETED|Randomized to Double-blind Treatment||679
198934|NCT00444925|465775|P2|COMPLETED|Randomized to Double-blind Treatment||684
198935|NCT00444925|465776|P1|COMPLETED|Randomized to Double-blind Treatment||334
198936|NCT00444925|465774|P3|STARTED|Randomized to Double-blind Treatment||685
198937|NCT00444925|465775|P2|STARTED|Randomized to Double-blind Treatment||690
198938|NCT00444925|465776|P1|STARTED|Randomized to Double-blind Treatment||337
198939|NCT00444925|465774|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
198940|NCT00444925|465775|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
198941|NCT00444925|465776|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
198942|NCT00444925|465774|P3|COMPLETED|Single-blind Placebo Run-In Period||0
198943|NCT00444925|465775|P2|COMPLETED|Single-blind Placebo Run-In Period||0
198944|NCT00444925|465776|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
198945|NCT00444925|465774|P3|STARTED|Single-blind Placebo Run-In Period||0
198946|NCT00444925|465775|P2|STARTED|Single-blind Placebo Run-In Period||0
198947|NCT00444925|465776|P1|STARTED|Single-blind Placebo Run-In Period||2446
198948|NCT00444912|465840|P2|NOT COMPLETED|Overall Study||2
198949|NCT00444912|465841|P1|NOT COMPLETED|Overall Study||3
198950|NCT00444912|465840|P2|COMPLETED|Overall Study||13
198951|NCT00444912|465841|P1|COMPLETED|Overall Study||12
198952|NCT00444912|465840|P2|Received Transplant|Overall Study||14
198953|NCT00444912|465841|P1|Received Transplant|Overall Study||14
198954|NCT00444912|465840|P2|Received Plerixafor|Overall Study||15
198955|NCT00444912|465841|P1|Received Plerixafor|Overall Study||15
198956|NCT00444912|465840|P2|STARTED|Overall Study||15
198957|NCT00444912|465841|P1|STARTED|Overall Study||15
198958|NCT00444795|465869|P1|NOT COMPLETED|Overall Study||3
198959|NCT00444795|465869|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
198960|NCT00444795|465869|P1|STARTED|Overall Study||620
198961|NCT00444626|465874|P1|NOT COMPLETED|Repeat Treatment Period||0
198962|NCT00444626|465874|P1|COMPLETED|Repeat Treatment Period||105
198963|NCT00444626|465874|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
198964|NCT00444626|465874|P1|NOT COMPLETED|Initial Treatment Period||12
198965|NCT00444626|465874|P1|COMPLETED|Initial Treatment Period||128
198966|NCT00444626|465874|P1|STARTED|Initial Treatment Period||140
198967|NCT00444600|465904|P4|NOT COMPLETED|Overall Study||10
198968|NCT00444600|465905|P3|NOT COMPLETED|Overall Study||10
198969|NCT00444600|465906|P2|NOT COMPLETED|Overall Study||16
198970|NCT00444600|465907|P1|NOT COMPLETED|Overall Study||19
198971|NCT00444600|465904|P4|COMPLETED|Overall Study|Number of eyes|176
198972|NCT00444600|465905|P3|COMPLETED|Overall Study|Number of eyes|178
198973|NCT00444600|465906|P2|COMPLETED|Overall Study|Number of eyes|171
198974|NCT00444600|465907|P1|COMPLETED|Overall Study|Number of eyes|274
198975|NCT00444600|465904|P4|STARTED|Overall Study|Number of eyes|186
198976|NCT00444600|465905|P3|STARTED|Overall Study|Number of eyes|188
198977|NCT00444600|465906|P2|STARTED|Overall Study|Number of eyes|187
198978|NCT00444600|465907|P1|STARTED|Overall Study|Number of eyes|293
198979|NCT00444587|465999|P2|NOT COMPLETED|Overall Study||15
198980|NCT00444587|466000|P1|NOT COMPLETED|Overall Study||83
198981|NCT00444587|465999|P2|COMPLETED|Overall Study||1
198982|NCT00444587|466000|P1|COMPLETED|Overall Study||10
198983|NCT00444587|465999|P2|STARTED|Overall Study||16
198984|NCT00444587|466000|P1|STARTED|Overall Study||93
198985|NCT00444535|466021|P1|NOT COMPLETED|Overall Study||24
198986|NCT00444535|466021|P1|COMPLETED|Overall Study||28
198987|NCT00444535|466021|P1|STARTED|Overall Study||52
198988|NCT00444457|466032|P4|NOT COMPLETED|Toddler Dose||8
198989|NCT00444457|466033|P3|NOT COMPLETED|Toddler Dose||4
198990|NCT00444457|466034|P2|NOT COMPLETED|Toddler Dose||6
198991|NCT00444457|466035|P1|NOT COMPLETED|Toddler Dose||7
198992|NCT00444457|466032|P4|COMPLETED|Toddler Dose||200
198993|NCT00444457|466033|P3|COMPLETED|Toddler Dose||404
198994|NCT00444457|466034|P2|COMPLETED|Toddler Dose||391
198995|NCT00444457|466035|P1|COMPLETED|Toddler Dose||408
198996|NCT00444457|466032|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
198997|NCT00444457|466033|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
198998|NCT00444457|466034|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
198999|NCT00444457|466035|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
199000|NCT00444457|466032|P4|NOT COMPLETED|After Infant Series||10
199001|NCT00444457|466033|P3|NOT COMPLETED|After Infant Series||19
199002|NCT00444457|466034|P2|NOT COMPLETED|After Infant Series||30
199003|NCT00444457|466035|P1|NOT COMPLETED|After Infant Series||20
199004|NCT00444457|466032|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
199005|NCT00444457|466033|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
199006|NCT00444457|466034|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
199007|NCT00444457|466035|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
199008|NCT00444457|466032|P4|STARTED|After Infant Series||218
199009|NCT00444457|466033|P3|STARTED|After Infant Series||427
199010|NCT00444457|466034|P2|STARTED|After Infant Series||427
199011|NCT00444457|466035|P1|STARTED|After Infant Series||435
199012|NCT00444457|466032|P4|NOT COMPLETED|Infant Series||28
199013|NCT00444457|466033|P3|NOT COMPLETED|Infant Series||61
199014|NCT00444457|466034|P2|NOT COMPLETED|Infant Series||61
199015|NCT00444457|466035|P1|NOT COMPLETED|Infant Series||54
199016|NCT00444457|466032|P4|COMPLETED|Infant Series||218
199017|NCT00444457|466033|P3|COMPLETED|Infant Series||428
199018|NCT00444457|466034|P2|COMPLETED|Infant Series||427
199019|NCT00444457|466035|P1|COMPLETED|Infant Series||435
199020|NCT00444457|466032|P4|Vaccinated Dose 3|Infant Series||225
199021|NCT00444457|466033|P3|Vaccinated Dose 3|Infant Series||438
199022|NCT00444457|466034|P2|Vaccinated Dose 3|Infant Series||435
199023|NCT00444457|466035|P1|Vaccinated Dose 3|Infant Series||442
199024|NCT00444457|466032|P4|Vaccinated Dose 2|Infant Series||228
199025|NCT00444457|466033|P3|Vaccinated Dose 2|Infant Series||455
199026|NCT00444457|466034|P2|Vaccinated Dose 2|Infant Series||447
199027|NCT00444457|466035|P1|Vaccinated Dose 2|Infant Series||455
199028|NCT00444457|466032|P4|Vaccinated Dose 1|Infant Series||244
199029|NCT00444457|466033|P3|Vaccinated Dose 1|Infant Series||485
199030|NCT00444457|466034|P2|Vaccinated Dose 1|Infant Series||484
199031|NCT00444457|466035|P1|Vaccinated Dose 1|Infant Series||486
199032|NCT00444457|466032|P4|STARTED|Infant Series||246
199033|NCT00444457|466033|P3|STARTED|Infant Series||489
199034|NCT00444457|466034|P2|STARTED|Infant Series||488
199035|NCT00444457|466035|P1|STARTED|Infant Series||489
199036|NCT00444275|466100|P5|NOT COMPLETED|Maintenance Treatment Phase||179
199037|NCT00444275|466101|P4|NOT COMPLETED|Maintenance Treatment Phase||133
199038|NCT00444275|466102|P3|NOT COMPLETED|Maintenance Treatment Phase||161
199039|NCT00444275|466103|P2|NOT COMPLETED|Maintenance Treatment Phase||0
199040|NCT00444275|466104|P1|NOT COMPLETED|Maintenance Treatment Phase||0
199041|NCT00444275|466100|P5|COMPLETED|Maintenance Treatment Phase||701
199042|NCT00444275|466101|P4|COMPLETED|Maintenance Treatment Phase||764
199043|NCT00444275|466102|P3|COMPLETED|Maintenance Treatment Phase||747
199044|NCT00444275|466103|P2|COMPLETED|Maintenance Treatment Phase||0
199045|NCT00444275|466104|P1|COMPLETED|Maintenance Treatment Phase||0
199046|NCT00444275|466100|P5|STARTED|Maintenance Treatment Phase||880
199047|NCT00444275|466101|P4|STARTED|Maintenance Treatment Phase||897
199048|NCT00444275|466102|P3|STARTED|Maintenance Treatment Phase||908
199049|NCT00444275|466103|P2|STARTED|Maintenance Treatment Phase||0
199050|NCT00444275|466104|P1|STARTED|Maintenance Treatment Phase||0
199051|NCT00444275|466100|P5|NOT COMPLETED|Initial Treatment Phase||0
199052|NCT00444275|466101|P4|NOT COMPLETED|Initial Treatment Phase||0
199053|NCT00444275|466102|P3|NOT COMPLETED|Initial Treatment Phase||0
199054|NCT00444275|466103|P2|NOT COMPLETED|Initial Treatment Phase||96
199055|NCT00444275|466104|P1|NOT COMPLETED|Initial Treatment Phase||248
199056|NCT00444275|466100|P5|COMPLETED|Initial Treatment Phase||0
199057|NCT00444275|466101|P4|COMPLETED|Initial Treatment Phase||0
199058|NCT00444275|466102|P3|COMPLETED|Initial Treatment Phase||0
199059|NCT00444275|466103|P2|COMPLETED|Initial Treatment Phase||777
199060|NCT00444275|466104|P1|COMPLETED|Initial Treatment Phase||1908
199061|NCT00444275|466100|P5|STARTED|Initial Treatment Phase||0
199062|NCT00444275|466101|P4|STARTED|Initial Treatment Phase||0
199063|NCT00444275|466102|P3|STARTED|Initial Treatment Phase||0
199064|NCT00444275|466103|P2|STARTED|Initial Treatment Phase||873
199065|NCT00444275|466104|P1|STARTED|Initial Treatment Phase||2156
199066|NCT00444106|466157|P3|NOT COMPLETED|Overall Study||1
199067|NCT00444106|466158|P2|NOT COMPLETED|Overall Study||1
199068|NCT00444106|466159|P1|NOT COMPLETED|Overall Study||2
199069|NCT00444106|466157|P3|COMPLETED|Overall Study||52
199070|NCT00444106|466158|P2|COMPLETED|Overall Study||52
199071|NCT00444106|466159|P1|COMPLETED|Overall Study||157
199072|NCT00444106|466157|P3|Completed Treatment Period|Overall Study||53
199073|NCT00444106|466158|P2|Completed Treatment Period|Overall Study||53
199074|NCT00444106|466159|P1|Completed Treatment Period|Overall Study||159
199075|NCT00444106|466157|P3|STARTED|Overall Study||53
199076|NCT00444106|466158|P2|STARTED|Overall Study||53
199077|NCT00444106|466159|P1|STARTED|Overall Study||159
199078|NCT00444067|466176|P2|NOT COMPLETED|Overall Study||1
199079|NCT00444067|466177|P1|NOT COMPLETED|Overall Study||0
199080|NCT00444067|466176|P2|COMPLETED|Overall Study||23
199081|NCT00444067|466177|P1|COMPLETED|Overall Study||74
199082|NCT00444067|466176|P2|STARTED|Overall Study||24
199083|NCT00444067|466177|P1|STARTED|Overall Study||74
199084|NCT00443729|466189|P2|NOT COMPLETED|Overall Study||7
199085|NCT00443729|466190|P1|NOT COMPLETED|Overall Study||10
199086|NCT00443729|466189|P2|COMPLETED|Overall Study||172
199087|NCT00443729|466190|P1|COMPLETED|Overall Study||166
199088|NCT00443729|466189|P2|Treated|Overall Study||178
199089|NCT00443729|466190|P1|Treated|Overall Study||176
199090|NCT00443729|466189|P2|STARTED|Overall Study||179
199091|NCT00443729|466190|P1|STARTED|Overall Study||176
199092|NCT00443703|466238|P2|NOT COMPLETED|Overall Study||18
199093|NCT00443703|466239|P1|NOT COMPLETED|Overall Study||28
199094|NCT00443703|466238|P2|COMPLETED|Overall Study||157
199095|NCT00443703|466239|P1|COMPLETED|Overall Study||149
199096|NCT00443703|466238|P2|Treated|Overall Study||174
199097|NCT00443703|466239|P1|Treated|Overall Study||174
199098|NCT00443703|466238|P2|STARTED|Overall Study||175
199099|NCT00443703|466239|P1|STARTED|Overall Study||177
199100|NCT00443651|466291|P2|NOT COMPLETED|Overall Study||58
199101|NCT00443651|466292|P1|NOT COMPLETED|Overall Study||95
199102|NCT00443651|466291|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
199103|NCT00443651|466292|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
199104|NCT00443651|466291|P2|Week 48|Overall Study||134
199105|NCT00443651|466292|P1|Week 48|Overall Study||338
199106|NCT00443651|466291|P2|Week 24|Overall Study||160
199107|NCT00443651|466292|P1|Week 24|Overall Study||376
199108|NCT00443651|466291|P2|STARTED|Overall Study||176
199109|NCT00443651|466292|P1|STARTED|Overall Study||401
199110|NCT00443599|466312|P2|NOT COMPLETED|Overall Study||3
199111|NCT00443599|466313|P1|NOT COMPLETED|Overall Study||6
199112|NCT00443599|466312|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
199113|NCT00443599|466313|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
199114|NCT00443599|466312|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
199115|NCT00443599|466313|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
199116|NCT00443560|466321|P2|NOT COMPLETED|Overall Study||30
199117|NCT00443560|466322|P1|NOT COMPLETED|Overall Study||60
199118|NCT00443560|466321|P2|COMPLETED|Overall Study||1051
199119|NCT00443560|466322|P1|COMPLETED|Overall Study||1021
199120|NCT00443560|466321|P2|STARTED|Overall Study||1081
199121|NCT00443560|466322|P1|STARTED|Overall Study||1081
199122|NCT00443534|466332|P1|NOT COMPLETED|Overall Study||123
199123|NCT00443534|466332|P1|COMPLETED|Overall Study||0
199124|NCT00443534|466332|P1|Treated|Overall Study||122
199125|NCT00443534|466332|P1|STARTED|Overall Study||123
199126|NCT00443456|466339|P1|NOT COMPLETED|Overall Study||18
199127|NCT00443456|466339|P1|COMPLETED|Overall Study||116
199128|NCT00443456|466339|P1|STARTED|Overall Study||134
199129|NCT00443430|466374|P2|NOT COMPLETED|Overall Study||4
199130|NCT00443430|466375|P1|NOT COMPLETED|Overall Study||4
199131|NCT00443430|466374|P2|COMPLETED|Overall Study||38
199132|NCT00443430|466375|P1|COMPLETED|Overall Study||39
199133|NCT00443430|466374|P2|STARTED|Overall Study||42
199134|NCT00443430|466375|P1|STARTED|Overall Study||43
199135|NCT00443352|466385|P1|NOT COMPLETED|Overall Study||5
199136|NCT00443352|466385|P1|COMPLETED|Overall Study||22
199137|NCT00443352|466385|P1|STARTED|Overall Study||27
199138|NCT00443209|466391|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
199139|NCT00443209|466392|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
199140|NCT00443209|466391|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
199141|NCT00443209|466392|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
199142|NCT00443209|466391|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
199143|NCT00443209|466392|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
199144|NCT00443209|466391|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
199145|NCT00443209|466392|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
199146|NCT00443209|466391|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
199147|NCT00443209|466392|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
199148|NCT00443209|466391|P2|Treated|Months 1 to 12 Treatment Period||313
199149|NCT00443209|466392|P1|Treated|Months 1 to 12 Treatment Period||641
199150|NCT00443209|466391|P2|STARTED|Months 1 to 12 Treatment Period||356
199151|NCT00443209|466392|P1|STARTED|Months 1 to 12 Treatment Period||712
199152|NCT00443118|466409|P3|NOT COMPLETED|Overall Study||0
199153|NCT00443118|466410|P2|NOT COMPLETED|Overall Study||1
199154|NCT00443118|466411|P1|NOT COMPLETED|Overall Study||4
199155|NCT00443118|466409|P3|COMPLETED|Overall Study||226
199156|NCT00443118|466410|P2|COMPLETED|Overall Study||290
199157|NCT00443118|466411|P1|COMPLETED|Overall Study||511
199158|NCT00443118|466409|P3|STARTED|Overall Study||226
199159|NCT00443118|466410|P2|STARTED|Overall Study||291
199160|NCT00443118|466411|P1|STARTED|Overall Study||515
199161|NCT00443053|466457|P2|NOT COMPLETED|Overall Study||33
199162|NCT00443053|466458|P1|NOT COMPLETED|Overall Study||21
199163|NCT00443053|466457|P2|COMPLETED|Overall Study||1467
199164|NCT00443053|466458|P1|COMPLETED|Overall Study||1481
199165|NCT00443053|466457|P2|STARTED|Overall Study||1500
199166|NCT00443053|466458|P1|STARTED|Overall Study||1502
199167|NCT00443040|466479|P3|NOT COMPLETED|Overall Study||1
199168|NCT00443040|466480|P2|NOT COMPLETED|Overall Study||0
199169|NCT00443040|466481|P1|NOT COMPLETED|Overall Study||4
199170|NCT00443040|466479|P3|COMPLETED|Overall Study||9
199171|NCT00443040|466480|P2|COMPLETED|Overall Study||11
199172|NCT00443040|466481|P1|COMPLETED|Overall Study||10
199173|NCT00443040|466479|P3|STARTED|Overall Study||10
199174|NCT00443040|466480|P2|STARTED|Overall Study||11
199175|NCT00443040|466481|P1|STARTED|Overall Study||14
199176|NCT00442962|466489|P1|NOT COMPLETED|Overall Study||8
199177|NCT00442962|466489|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
199178|NCT00442962|466489|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
199179|NCT00442962|466489|P1|STARTED|Overall Study||54
199180|NCT00442936|466507|P4|NOT COMPLETED|Overall Study||1
199181|NCT00442936|466508|P3|NOT COMPLETED|Overall Study||1
199182|NCT00442936|466509|P2|NOT COMPLETED|Overall Study||0
199183|NCT00442936|466510|P1|NOT COMPLETED|Overall Study||1
199184|NCT00442936|466507|P4|COMPLETED|Overall Study||347
199185|NCT00442936|466508|P3|COMPLETED|Overall Study||344
199186|NCT00442936|466509|P2|COMPLETED|Overall Study||354
199187|NCT00442936|466510|P1|COMPLETED|Overall Study||332
199188|NCT00442936|466507|P4|STARTED|Overall Study||348
199189|NCT00442936|466508|P3|STARTED|Overall Study||345
199190|NCT00442936|466509|P2|STARTED|Overall Study||354
199191|NCT00442936|466510|P1|STARTED|Overall Study||333
199192|NCT00442897|466558|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
199193|NCT00442897|466559|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
199194|NCT00442897|466558|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
199195|NCT00442897|466559|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
199196|NCT00442897|466558|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
199197|NCT00442897|466559|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
199198|NCT00442897|466558|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
199199|NCT00442897|466559|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
199200|NCT00442897|466558|P2|COMPLETED|Base Study (12 Week Follow-up)||99
199201|NCT00442897|466559|P1|COMPLETED|Base Study (12 Week Follow-up)||101
199202|NCT00442897|466558|P2|STARTED|Base Study (12 Week Follow-up)||111
199203|NCT00442897|466559|P1|STARTED|Base Study (12 Week Follow-up)||118
199204|NCT00442702|466569|P2|NOT COMPLETED|Evaluation Period||4
199205|NCT00442702|466570|P1|NOT COMPLETED|Evaluation Period||5
199206|NCT00442702|466569|P2|COMPLETED|Evaluation Period||107
199207|NCT00442702|466570|P1|COMPLETED|Evaluation Period||97
199208|NCT00442702|466569|P2|STARTED|Evaluation Period||111
199209|NCT00442702|466570|P1|STARTED|Evaluation Period||102
199210|NCT00442702|466569|P2|NOT COMPLETED|Titration Period||3
199211|NCT00442702|466570|P1|NOT COMPLETED|Titration Period||12
199212|NCT00442702|466569|P2|COMPLETED|Titration Period||111
199213|NCT00442702|466570|P1|COMPLETED|Titration Period||102
199214|NCT00442702|466569|P2|Safety Population|Titration Period||113
199215|NCT00442702|466570|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
199216|NCT00442702|466569|P2|STARTED|Titration Period||114
199217|NCT00442702|466570|P1|STARTED|Titration Period||114
199218|NCT00442689|466585|P3|NOT COMPLETED|Overall Study||9
199219|NCT00442689|466586|P2|NOT COMPLETED|Overall Study||11
199220|NCT00442689|466587|P1|NOT COMPLETED|Overall Study||10
199221|NCT00442689|466585|P3|COMPLETED|Overall Study||13
199222|NCT00442689|466586|P2|COMPLETED|Overall Study||13
199223|NCT00442689|466587|P1|COMPLETED|Overall Study||11
199224|NCT00442689|466585|P3|STARTED|Overall Study||22
199225|NCT00442689|466586|P2|STARTED|Overall Study||24
199226|NCT00442689|466587|P1|STARTED|Overall Study||21
199227|NCT00442611|466615|P2|NOT COMPLETED|Overall Study||0
199228|NCT00442611|466616|P1|NOT COMPLETED|Overall Study||1
199229|NCT00442611|466615|P2|COMPLETED|Overall Study||3
199230|NCT00442611|466616|P1|COMPLETED|Overall Study||6
199231|NCT00442611|466615|P2|STARTED|Overall Study||3
199232|NCT00442611|466616|P1|STARTED|Overall Study||7
199233|NCT00442598|466629|P3|NOT COMPLETED|Overall Study||0
199234|NCT00442598|466630|P2|NOT COMPLETED|Overall Study||8
199235|NCT00442598|466631|P1|NOT COMPLETED|Overall Study||6
199236|NCT00442598|466629|P3|COMPLETED|Overall Study||0
199237|NCT00442598|466630|P2|COMPLETED|Overall Study||2
199238|NCT00442598|466631|P1|COMPLETED|Overall Study||1
199239|NCT00442598|466629|P3|Two Cycles|Overall Study||0
199240|NCT00442598|466630|P2|Two Cycles|Overall Study||6
199241|NCT00442598|466631|P1|Two Cycles|Overall Study||5
199242|NCT00442598|466629|P3|STARTED|Overall Study||0
199243|NCT00442598|466630|P2|STARTED|Overall Study||10
199244|NCT00442598|466631|P1|STARTED|Overall Study||7
199245|NCT00442572|466649|P2|NOT COMPLETED|Overall Study||3
199246|NCT00442572|466650|P1|NOT COMPLETED|Overall Study||8
199247|NCT00442572|466649|P2|COMPLETED|Overall Study||1
199248|NCT00442572|466650|P1|COMPLETED|Overall Study||9
199249|NCT00442572|466649|P2|STARTED|Overall Study||4
199250|NCT00442572|466650|P1|STARTED|Overall Study||17
199251|NCT00442559|466690|P2|NOT COMPLETED|Overall Study||35
199252|NCT00442559|466691|P1|NOT COMPLETED|Overall Study||34
199253|NCT00442559|466690|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
199254|NCT00442559|466691|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
199255|NCT00442559|466690|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
199256|NCT00442559|466691|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
199257|NCT00442559|466690|P2|STARTED|Overall Study||91
199258|NCT00442559|466691|P1|STARTED|Overall Study||100
199259|NCT00442546|466706|P3|NOT COMPLETED|Overall Study||33
199260|NCT00442546|466707|P2|NOT COMPLETED|Overall Study||37
199261|NCT00442546|466708|P1|NOT COMPLETED|Overall Study||26
199262|NCT00442546|466706|P3|COMPLETED|Overall Study||71
199263|NCT00442546|466707|P2|COMPLETED|Overall Study||63
199264|NCT00442546|466708|P1|COMPLETED|Overall Study||77
199265|NCT00442546|466706|P3|Received Treatment|Overall Study||98
199266|NCT00442546|466707|P2|Received Treatment|Overall Study||96
199267|NCT00442546|466708|P1|Received Treatment|Overall Study||98
199268|NCT00442546|466706|P3|STARTED|Overall Study||104
199269|NCT00442546|466707|P2|STARTED|Overall Study||100
199270|NCT00442546|466708|P1|STARTED|Overall Study||103
199271|NCT00442507|466830|P1|NOT COMPLETED|Overall Study||0
199272|NCT00442507|466830|P1|COMPLETED|Overall Study||6
199273|NCT00442507|466830|P1|STARTED|Overall Study||6
199274|NCT00442468|466837|P1|NOT COMPLETED|Overall Study||183
199275|NCT00442468|466837|P1|COMPLETED|Overall Study||1100
199276|NCT00442468|466837|P1|STARTED|Overall Study||1283
199277|NCT00442416|466867|P2|NOT COMPLETED|Overall Study||39
199278|NCT00442416|466868|P1|NOT COMPLETED|Overall Study||37
199279|NCT00442416|466867|P2|COMPLETED|Overall Study||2
199280|NCT00442416|466868|P1|COMPLETED|Overall Study||2
199281|NCT00442416|466867|P2|STARTED|Overall Study||41
199282|NCT00442416|466868|P1|STARTED|Overall Study||39
199283|NCT00442364|466901|P1|NOT COMPLETED|Overall Study||0
199284|NCT00442364|466901|P1|COMPLETED|Overall Study||60
199285|NCT00442364|466901|P1|STARTED|Overall Study||60
199286|NCT00442351|466907|P2|NOT COMPLETED|Overall Study||6
199287|NCT00442351|466908|P1|NOT COMPLETED|Overall Study||7
199288|NCT00442351|466907|P2|COMPLETED|Overall Study||3
199289|NCT00442351|466908|P1|COMPLETED|Overall Study||10
199290|NCT00442351|466907|P2|STARTED|Overall Study||9
199291|NCT00442351|466908|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
199292|NCT00442338|466917|P3|NOT COMPLETED|Overall Study||0
199293|NCT00442338|466918|P2|NOT COMPLETED|Overall Study||0
199294|NCT00442338|466919|P1|NOT COMPLETED|Overall Study||0
199295|NCT00442338|466917|P3|COMPLETED|Overall Study||31
199296|NCT00442338|466918|P2|COMPLETED|Overall Study||30
199297|NCT00442338|466919|P1|COMPLETED|Overall Study||30
199298|NCT00442338|466917|P3|STARTED|Overall Study||31
199299|NCT00442338|466918|P2|STARTED|Overall Study||30
199300|NCT00442338|466919|P1|STARTED|Overall Study||30
199301|NCT00442169|466933|P6|NOT COMPLETED|Part 2||0
199302|NCT00442169|466934|P5|NOT COMPLETED|Part 2||0
199303|NCT00442169|466935|P4|NOT COMPLETED|Part 2||0
199304|NCT00442169|466936|P3|NOT COMPLETED|Part 2||0
199305|NCT00442169|466937|P2|NOT COMPLETED|Part 2||0
199306|NCT00442169|466938|P1|NOT COMPLETED|Part 2||0
199307|NCT00442169|466933|P6|COMPLETED|Part 2||57
199308|NCT00442169|466934|P5|COMPLETED|Part 2||25
199309|NCT00442169|466935|P4|COMPLETED|Part 2||0
199310|NCT00442169|466936|P3|COMPLETED|Part 2||0
199311|NCT00442169|466937|P2|COMPLETED|Part 2||0
199312|NCT00442169|466938|P1|COMPLETED|Part 2||0
199313|NCT00442169|466933|P6|STARTED|Part 2||57
199314|NCT00442169|466934|P5|STARTED|Part 2||25
199315|NCT00442169|466935|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
199316|NCT00442169|466936|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
199317|NCT00442169|466937|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
199318|NCT00442169|466938|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
199319|NCT00442169|466933|P6|NOT COMPLETED|Part 1||0
199320|NCT00442169|466934|P5|NOT COMPLETED|Part 1||0
199321|NCT00442169|466935|P4|NOT COMPLETED|Part 1||0
199322|NCT00442169|466936|P3|NOT COMPLETED|Part 1||0
199323|NCT00442169|466937|P2|NOT COMPLETED|Part 1||0
199324|NCT00442169|466938|P1|NOT COMPLETED|Part 1||0
199325|NCT00442169|466933|P6|COMPLETED|Part 1||0
199326|NCT00442169|466934|P5|COMPLETED|Part 1||0
199327|NCT00442169|466935|P4|COMPLETED|Part 1||31
199328|NCT00442169|466936|P3|COMPLETED|Part 1||40
199329|NCT00442169|466937|P2|COMPLETED|Part 1||24
199330|NCT00442169|466938|P1|COMPLETED|Part 1||17
199331|NCT00442169|466933|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
199332|NCT00442169|466934|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
199333|NCT00442169|466935|P4|STARTED|Part 1||31
199334|NCT00442169|466936|P3|STARTED|Part 1||40
199335|NCT00442169|466937|P2|STARTED|Part 1||24
199336|NCT00442169|466938|P1|STARTED|Part 1||17
199337|NCT00442117|466978|P2|NOT COMPLETED|Overall Study||38
199338|NCT00442117|466979|P1|NOT COMPLETED|Overall Study||38
199339|NCT00442117|466978|P2|COMPLETED|Overall Study||49
199340|NCT00442117|466979|P1|COMPLETED|Overall Study||47
199341|NCT00442117|466978|P2|STARTED|Overall Study||87
199342|NCT00442117|466979|P1|STARTED|Overall Study||85
199343|NCT00442013|466993|P2|NOT COMPLETED|Overall Study||17
199344|NCT00442013|466994|P1|NOT COMPLETED|Overall Study||26
199345|NCT00442013|466993|P2|COMPLETED|Overall Study||132
199346|NCT00442013|466994|P1|COMPLETED|Overall Study||131
199347|NCT00442013|466993|P2|STARTED|Overall Study||149
199348|NCT00442013|466994|P1|STARTED|Overall Study||157
199349|NCT00441974|467010|P1|NOT COMPLETED|Overall Study||128
199350|NCT00441974|467010|P1|COMPLETED|Overall Study||1342
199351|NCT00441974|467010|P1|STARTED|Overall Study||1470
199352|NCT00441792|467026|P2|NOT COMPLETED|Overall Study||2
199353|NCT00441792|467027|P1|NOT COMPLETED|Overall Study||0
199354|NCT00441792|467026|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
199355|NCT00441792|467027|P1|COMPLETED|Overall Study||59
199356|NCT00441792|467026|P2|STARTED|Overall Study||63
199357|NCT00441792|467027|P1|STARTED|Overall Study||59
199358|NCT00441766|467039|P4|NOT COMPLETED|Overall Study||6
199359|NCT00441766|467040|P3|NOT COMPLETED|Overall Study||9
199360|NCT00441766|467041|P2|NOT COMPLETED|Overall Study||7
199361|NCT00441766|467042|P1|NOT COMPLETED|Overall Study||14
199362|NCT00441766|467039|P4|COMPLETED|Overall Study||48
199363|NCT00441766|467040|P3|COMPLETED|Overall Study||44
199364|NCT00441766|467041|P2|COMPLETED|Overall Study||46
199365|NCT00441766|467042|P1|COMPLETED|Overall Study||39
199366|NCT00441766|467039|P4|STARTED|Overall Study||54
199367|NCT00441766|467040|P3|STARTED|Overall Study||53
199368|NCT00441766|467041|P2|STARTED|Overall Study||53
199369|NCT00441766|467042|P1|STARTED|Overall Study||53
199370|NCT00441727|467067|P3|NOT COMPLETED|Overall Study||168
199371|NCT00441727|467068|P2|NOT COMPLETED|Overall Study||118
199372|NCT00441727|467069|P1|NOT COMPLETED|Overall Study||106
199373|NCT00441727|467067|P3|COMPLETED|Overall Study|ITT/randomised|637
199374|NCT00441727|467068|P2|COMPLETED|Overall Study|ITT/randomised|686
199375|NCT00441727|467069|P1|COMPLETED|Overall Study|ITT/randomised|711
199376|NCT00441727|467067|P3|STARTED|Overall Study|ITT/randomised|805
199377|NCT00441727|467068|P2|STARTED|Overall Study|ITT/randomised|804
199378|NCT00441727|467069|P1|STARTED|Overall Study|ITT/randomised|817
199379|NCT00441701|467102|P10|NOT COMPLETED|Overall Study||0
199380|NCT00441701|467103|P9|NOT COMPLETED|Overall Study||0
199381|NCT00441701|467104|P8|NOT COMPLETED|Overall Study||0
199382|NCT00441701|467105|P7|NOT COMPLETED|Overall Study||0
199383|NCT00441701|467106|P6|NOT COMPLETED|Overall Study||3
199384|NCT00441701|467107|P5|NOT COMPLETED|Overall Study||2
199385|NCT00441701|467108|P4|NOT COMPLETED|Overall Study||3
199386|NCT00441701|467109|P3|NOT COMPLETED|Overall Study||4
199387|NCT00441701|467110|P2|NOT COMPLETED|Overall Study||4
199388|NCT00441701|467111|P1|NOT COMPLETED|Overall Study||5
199389|NCT00441701|467102|P10|COMPLETED|Overall Study||0
199390|NCT00441701|467103|P9|COMPLETED|Overall Study||0
199391|NCT00441701|467104|P8|COMPLETED|Overall Study||0
199392|NCT00441701|467105|P7|COMPLETED|Overall Study||0
199393|NCT00441701|467106|P6|COMPLETED|Overall Study||8
199394|NCT00441701|467107|P5|COMPLETED|Overall Study||20
199395|NCT00441701|467108|P4|COMPLETED|Overall Study||8
199396|NCT00441701|467109|P3|COMPLETED|Overall Study||18
199397|NCT00441701|467110|P2|COMPLETED|Overall Study||7
199398|NCT00441701|467111|P1|COMPLETED|Overall Study||17
199399|NCT00441701|467102|P10|STARTED|Overall Study||0
199400|NCT00441701|467103|P9|STARTED|Overall Study||0
199401|NCT00441701|467104|P8|STARTED|Overall Study||0
199402|NCT00441701|467105|P7|STARTED|Overall Study||0
199403|NCT00441701|467106|P6|STARTED|Overall Study||11
199404|NCT00441701|467107|P5|STARTED|Overall Study||22
199405|NCT00441701|467108|P4|STARTED|Overall Study||11
199406|NCT00441701|467109|P3|STARTED|Overall Study||22
199407|NCT00441701|467110|P2|STARTED|Overall Study||11
199408|NCT00441701|467111|P1|STARTED|Overall Study||22
199409|NCT00441584|467193|P1|NOT COMPLETED|Overall Study||105
199410|NCT00441584|467193|P1|COMPLETED|Overall Study||12
199411|NCT00441584|467193|P1|STARTED|Overall Study||117
199412|NCT00441558|467197|P1|NOT COMPLETED|Overall Study||1056
199413|NCT00441558|467197|P1|COMPLETED|Overall Study||667
199414|NCT00441558|467197|P1|STARTED|Overall Study||1723
199415|NCT00441545|467201|P2|NOT COMPLETED|Second Intervention||7
199416|NCT00441545|467202|P1|NOT COMPLETED|Second Intervention||12
199417|NCT00441545|467201|P2|COMPLETED|Second Intervention||68
199418|NCT00441545|467202|P1|COMPLETED|Second Intervention||65
199419|NCT00441545|467201|P2|STARTED|Second Intervention||75
199420|NCT00441545|467202|P1|STARTED|Second Intervention||77
199421|NCT00441545|467201|P2|NOT COMPLETED|Washout||0
199422|NCT00441545|467202|P1|NOT COMPLETED|Washout||0
199423|NCT00441545|467201|P2|COMPLETED|Washout||75
199424|NCT00441545|467202|P1|COMPLETED|Washout||77
199425|NCT00441545|467201|P2|STARTED|Washout||75
199426|NCT00441545|467202|P1|STARTED|Washout||77
199427|NCT00441545|467201|P2|NOT COMPLETED|First Intervention||12
199428|NCT00441545|467202|P1|NOT COMPLETED|First Intervention||18
199429|NCT00441545|467201|P2|COMPLETED|First Intervention||75
199430|NCT00441545|467202|P1|COMPLETED|First Intervention||77
199431|NCT00441545|467201|P2|STARTED|First Intervention||87
199432|NCT00441545|467202|P1|STARTED|First Intervention||95
199433|NCT00441480|467216|P2|NOT COMPLETED|Overall Study||4
199434|NCT00441480|467217|P1|NOT COMPLETED|Overall Study||3
199435|NCT00441480|467216|P2|COMPLETED|Overall Study||41
199436|NCT00441480|467217|P1|COMPLETED|Overall Study||43
199437|NCT00441480|467216|P2|STARTED|Overall Study||45
199438|NCT00441480|467217|P1|STARTED|Overall Study||46
199439|NCT00441467|467249|P1|NOT COMPLETED|Overall Study||18
199440|NCT00441467|467249|P1|COMPLETED|Overall Study||4
199441|NCT00441467|467249|P1|4 Cycles|Overall Study||7
199442|NCT00441467|467249|P1|2 Cycles|Overall Study||17
199443|NCT00441467|467249|P1|STARTED|Overall Study||22
199444|NCT00441441|467257|P2|NOT COMPLETED|Overall Study||14
199445|NCT00441441|467258|P1|NOT COMPLETED|Overall Study||11
199446|NCT00441441|467257|P2|COMPLETED|Overall Study||163
199447|NCT00441441|467258|P1|COMPLETED|Overall Study||162
199448|NCT00441441|467257|P2|STARTED|Overall Study||177
199449|NCT00441441|467258|P1|STARTED|Overall Study||173
199450|NCT00441363|467318|P2|NOT COMPLETED|Overall Study||15
199451|NCT00441363|467319|P1|NOT COMPLETED|Overall Study||17
199452|NCT00441363|467318|P2|COMPLETED|Overall Study||19
199453|NCT00441363|467319|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
199454|NCT00441363|467318|P2|STARTED|Overall Study||34
199455|NCT00441363|467319|P1|STARTED|Overall Study||32
199456|NCT00441337|467331|P4|NOT COMPLETED|Overall Study||21
199457|NCT00441337|467332|P3|NOT COMPLETED|Overall Study||6
199458|NCT00441337|467333|P2|NOT COMPLETED|Overall Study||6
199459|NCT00441337|467334|P1|NOT COMPLETED|Overall Study||6
199460|NCT00441337|467331|P4|COMPLETED|Overall Study||0
199461|NCT00441337|467332|P3|COMPLETED|Overall Study||0
199462|NCT00441337|467333|P2|COMPLETED|Overall Study||0
199463|NCT00441337|467334|P1|COMPLETED|Overall Study||0
199464|NCT00441337|467331|P4|STARTED|Overall Study||21
199465|NCT00441337|467332|P3|STARTED|Overall Study||6
199466|NCT00441337|467333|P2|STARTED|Overall Study||6
199467|NCT00441337|467334|P1|STARTED|Overall Study||6
199468|NCT00441285|467417|P5|NOT COMPLETED|Overall Study||0
199469|NCT00441285|467418|P4|NOT COMPLETED|Overall Study||0
199470|NCT00441285|467419|P3|NOT COMPLETED|Overall Study||0
199471|NCT00441285|467420|P2|NOT COMPLETED|Overall Study||0
199472|NCT00441285|467421|P1|NOT COMPLETED|Overall Study||0
199473|NCT00441285|467417|P5|COMPLETED|Overall Study||43
199474|NCT00441285|467418|P4|COMPLETED|Overall Study||40
199475|NCT00441285|467419|P3|COMPLETED|Overall Study||41
199476|NCT00441285|467420|P2|COMPLETED|Overall Study||16
199477|NCT00441285|467421|P1|COMPLETED|Overall Study||16
199478|NCT00441285|467417|P5|STARTED|Overall Study||43
199479|NCT00441285|467418|P4|STARTED|Overall Study||40
199480|NCT00441285|467419|P3|STARTED|Overall Study||41
199481|NCT00441285|467420|P2|STARTED|Overall Study||16
199482|NCT00441285|467421|P1|STARTED|Overall Study||16
199483|NCT00441272|467447|P2|NOT COMPLETED|Overall Study||25
199484|NCT00441272|467448|P1|NOT COMPLETED|Overall Study||25
199485|NCT00441272|467447|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
199486|NCT00441272|467448|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
199487|NCT00441272|467447|P2|STARTED|Overall Study||25
199488|NCT00441272|467448|P1|STARTED|Overall Study||25
199489|NCT00441259|467456|P2|NOT COMPLETED|Overall Study||0
199490|NCT00441259|467457|P1|NOT COMPLETED|Overall Study||0
199491|NCT00441259|467456|P2|COMPLETED|Overall Study||48
199492|NCT00441259|467457|P1|COMPLETED|Overall Study||48
199493|NCT00441259|467456|P2|STARTED|Overall Study||48
199494|NCT00441259|467457|P1|STARTED|Overall Study||48
199495|NCT00441168|467475|P2|NOT COMPLETED|Follow-up Period||9
199496|NCT00441168|467476|P1|NOT COMPLETED|Follow-up Period||12
199497|NCT00441168|467475|P2|COMPLETED|Follow-up Period||4
199498|NCT00441168|467476|P1|COMPLETED|Follow-up Period||5
199499|NCT00441168|467475|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
199500|NCT00441168|467476|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
199501|NCT00441168|467475|P2|NOT COMPLETED|Treatment Period||6
199502|NCT00441168|467476|P1|NOT COMPLETED|Treatment Period||11
199503|NCT00441168|467475|P2|COMPLETED|Treatment Period||7
199504|NCT00441168|467476|P1|COMPLETED|Treatment Period||6
199505|NCT00441168|467475|P2|TREATED|Treatment Period||13
199506|NCT00441168|467476|P1|TREATED|Treatment Period||16
199507|NCT00441168|467475|P2|STARTED|Treatment Period||13
199508|NCT00441168|467476|P1|STARTED|Treatment Period||17
199509|NCT00441142|467490|P4|NOT COMPLETED|Overall Study||68
199510|NCT00441142|467491|P3|NOT COMPLETED|Overall Study||22
199511|NCT00441142|467492|P2|NOT COMPLETED|Overall Study||7
199512|NCT00441142|467493|P1|NOT COMPLETED|Overall Study||6
199513|NCT00441142|467490|P4|COMPLETED|Overall Study||1
199514|NCT00441142|467491|P3|COMPLETED|Overall Study||7
199515|NCT00441142|467492|P2|COMPLETED|Overall Study||0
199516|NCT00441142|467493|P1|COMPLETED|Overall Study||0
199517|NCT00441142|467490|P4|STARTED|Overall Study||69
199518|NCT00441142|467491|P3|STARTED|Overall Study||29
199519|NCT00441142|467492|P2|STARTED|Overall Study||7
199520|NCT00441142|467493|P1|STARTED|Overall Study||6
199521|NCT00441116|467511|P2|NOT COMPLETED|Overall Study||2
199522|NCT00441116|467512|P1|NOT COMPLETED|Overall Study||3
199523|NCT00441116|467511|P2|COMPLETED|Overall Study||75
199524|NCT00441116|467512|P1|COMPLETED|Overall Study||73
199525|NCT00441116|467511|P2|STARTED|Overall Study||77
199526|NCT00441116|467512|P1|STARTED|Overall Study||76
199527|NCT00441103|467580|P2|NOT COMPLETED|Overall Study||4
199528|NCT00441103|467581|P1|NOT COMPLETED|Overall Study||11
199529|NCT00441103|467580|P2|COMPLETED|Overall Study||56
199530|NCT00441103|467581|P1|COMPLETED|Overall Study||109
199531|NCT00441103|467580|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
199532|NCT00441103|467581|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
199533|NCT00441064|467594|P2|NOT COMPLETED|Overall Study||7
199534|NCT00441064|467595|P1|NOT COMPLETED|Overall Study||10
199535|NCT00441064|467594|P2|COMPLETED|Overall Study||56
199536|NCT00441064|467595|P1|COMPLETED|Overall Study||59
199537|NCT00441064|467594|P2|Intent-to-treat (ITT) Population|Overall Study||57
199538|NCT00441064|467595|P1|Intent-to-treat (ITT) Population|Overall Study||61
199539|NCT00441064|467594|P2|Safety Population (SP)|Overall Study||63
199540|NCT00441064|467595|P1|Safety Population (SP)|Overall Study||69
199541|NCT00441064|467594|P2|STARTED|Overall Study||63
199542|NCT00441064|467595|P1|STARTED|Overall Study||69
199543|NCT00441012|467607|P2|NOT COMPLETED|Overall Study||13
199544|NCT00441012|467608|P1|NOT COMPLETED|Overall Study||18
199545|NCT00441012|467607|P2|COMPLETED|Overall Study||263
199546|NCT00441012|467608|P1|COMPLETED|Overall Study||252
199547|NCT00441012|467607|P2|Vaccination Visit 3|Overall Study||269
199548|NCT00441012|467608|P1|Vaccination Visit 3|Overall Study||265
199549|NCT00441012|467607|P2|Vaccination Visit 2|Overall Study||272
199550|NCT00441012|467608|P1|Vaccination Visit 2|Overall Study||267
199634|NCT00440531|467761|P2|COMPLETED|Overall Study||178
199635|NCT00440531|467762|P1|COMPLETED|Overall Study||175
199551|NCT00441012|467607|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
199552|NCT00441012|467608|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
199553|NCT00441012|467607|P2|STARTED|Overall Study||276
199554|NCT00441012|467608|P1|STARTED|Overall Study||270
199555|NCT00440947|467622|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
199556|NCT00440947|467623|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
199557|NCT00440947|467624|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
199558|NCT00440947|467625|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
199559|NCT00440947|467626|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
199560|NCT00440947|467622|P5|COMPLETED|Optional 60-Week Extension Phase||154
199561|NCT00440947|467623|P4|COMPLETED|Optional 60-Week Extension Phase||160
199562|NCT00440947|467624|P3|COMPLETED|Optional 60-Week Extension Phase||0
199563|NCT00440947|467625|P2|COMPLETED|Optional 60-Week Extension Phase||0
199564|NCT00440947|467626|P1|COMPLETED|Optional 60-Week Extension Phase||0
199565|NCT00440947|467622|P5|STARTED|Optional 60-Week Extension Phase||180
199566|NCT00440947|467623|P4|STARTED|Optional 60-Week Extension Phase||189
199567|NCT00440947|467624|P3|STARTED|Optional 60-Week Extension Phase||0
199568|NCT00440947|467625|P2|STARTED|Optional 60-Week Extension Phase||0
199569|NCT00440947|467626|P1|STARTED|Optional 60-Week Extension Phase||0
199570|NCT00440947|467622|P5|NOT COMPLETED|48-Week Randomization Phase||0
199571|NCT00440947|467623|P4|NOT COMPLETED|48-Week Randomization Phase||0
199572|NCT00440947|467624|P3|NOT COMPLETED|48-Week Randomization Phase||24
199573|NCT00440947|467625|P2|NOT COMPLETED|48-Week Randomization Phase||16
199574|NCT00440947|467626|P1|NOT COMPLETED|48-Week Randomization Phase||0
199575|NCT00440947|467622|P5|COMPLETED|48-Week Randomization Phase||0
199576|NCT00440947|467623|P4|COMPLETED|48-Week Randomization Phase||0
199577|NCT00440947|467624|P3|COMPLETED|48-Week Randomization Phase||185
199578|NCT00440947|467625|P2|COMPLETED|48-Week Randomization Phase||194
199579|NCT00440947|467626|P1|COMPLETED|48-Week Randomization Phase||0
199580|NCT00440947|467622|P5|STARTED|48-Week Randomization Phase||0
199581|NCT00440947|467623|P4|STARTED|48-Week Randomization Phase||0
199582|NCT00440947|467624|P3|STARTED|48-Week Randomization Phase||209
199583|NCT00440947|467625|P2|STARTED|48-Week Randomization Phase||210
199584|NCT00440947|467626|P1|STARTED|48-Week Randomization Phase||0
199585|NCT00440947|467622|P5|NOT COMPLETED|36-Week Induction Phase||0
199586|NCT00440947|467623|P4|NOT COMPLETED|36-Week Induction Phase||0
199587|NCT00440947|467624|P3|NOT COMPLETED|36-Week Induction Phase||0
199588|NCT00440947|467625|P2|NOT COMPLETED|36-Week Induction Phase||0
199589|NCT00440947|467626|P1|NOT COMPLETED|36-Week Induction Phase||73
199590|NCT00440947|467622|P5|COMPLETED|36-Week Induction Phase||0
199591|NCT00440947|467623|P4|COMPLETED|36-Week Induction Phase||0
199592|NCT00440947|467624|P3|COMPLETED|36-Week Induction Phase||0
199593|NCT00440947|467625|P2|COMPLETED|36-Week Induction Phase||0
199594|NCT00440947|467626|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
199595|NCT00440947|467622|P5|STARTED|36-Week Induction Phase||0
199596|NCT00440947|467623|P4|STARTED|36-Week Induction Phase||0
199597|NCT00440947|467624|P3|STARTED|36-Week Induction Phase||0
199598|NCT00440947|467625|P2|STARTED|36-Week Induction Phase||0
199599|NCT00440947|467626|P1|STARTED|36-Week Induction Phase||515
199600|NCT00440830|467681|P4|NOT COMPLETED|Overall Study||0
199601|NCT00440830|467682|P3|NOT COMPLETED|Overall Study||0
199602|NCT00440830|467683|P2|NOT COMPLETED|Overall Study||0
199603|NCT00440830|467684|P1|NOT COMPLETED|Overall Study||0
199604|NCT00440830|467681|P4|COMPLETED|Overall Study||10
199605|NCT00440830|467682|P3|COMPLETED|Overall Study||30
199606|NCT00440830|467683|P2|COMPLETED|Overall Study||8
199607|NCT00440830|467684|P1|COMPLETED|Overall Study||20
199608|NCT00440830|467681|P4|STARTED|Overall Study||10
199609|NCT00440830|467682|P3|STARTED|Overall Study||30
199610|NCT00440830|467683|P2|STARTED|Overall Study||8
199611|NCT00440830|467684|P1|STARTED|Overall Study||20
199612|NCT00440700|467701|P3|NOT COMPLETED|Overall Study||4
199613|NCT00440700|467702|P2|NOT COMPLETED|Overall Study||8
199614|NCT00440700|467703|P1|NOT COMPLETED|Overall Study||8
199615|NCT00440700|467701|P3|COMPLETED|Overall Study||120
199616|NCT00440700|467702|P2|COMPLETED|Overall Study||110
199617|NCT00440700|467703|P1|COMPLETED|Overall Study||114
199618|NCT00440700|467701|P3|STARTED|Overall Study||124
199619|NCT00440700|467702|P2|STARTED|Overall Study||118
199620|NCT00440700|467703|P1|STARTED|Overall Study||122
199621|NCT00440557|467726|P3|NOT COMPLETED|Overall Study||35
199622|NCT00440557|467727|P2|NOT COMPLETED|Overall Study||29
199623|NCT00440557|467728|P1|NOT COMPLETED|Overall Study||25
199624|NCT00440557|467726|P3|COMPLETED|Overall Study||90
199625|NCT00440557|467727|P2|COMPLETED|Overall Study||96
199626|NCT00440557|467728|P1|COMPLETED|Overall Study||98
199627|NCT00440557|467726|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
199628|NCT00440557|467727|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
199629|NCT00440557|467728|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
199630|NCT00440531|467760|P3|NOT COMPLETED|Overall Study||7
199631|NCT00440531|467761|P2|NOT COMPLETED|Overall Study||5
199632|NCT00440531|467762|P1|NOT COMPLETED|Overall Study||10
199633|NCT00440531|467760|P3|COMPLETED|Overall Study||165
199636|NCT00440531|467760|P3|Vaccination 3|Overall Study||166
199637|NCT00440531|467761|P2|Vaccination 3|Overall Study||178
199638|NCT00440531|467762|P1|Vaccination 3|Overall Study||176
199639|NCT00440531|467760|P3|Vaccination 2|Overall Study||171
199640|NCT00440531|467761|P2|Vaccination 2|Overall Study||182
199641|NCT00440531|467762|P1|Vaccination 2|Overall Study||181
199642|NCT00440531|467760|P3|Vaccination 1|Overall Study||172
199643|NCT00440531|467761|P2|Vaccination 1|Overall Study||183
199644|NCT00440531|467762|P1|Vaccination 1|Overall Study||183
199645|NCT00440531|467760|P3|STARTED|Overall Study||172
199646|NCT00440531|467761|P2|STARTED|Overall Study||183
199647|NCT00440531|467762|P1|STARTED|Overall Study||185
199648|NCT00440518|467779|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
199649|NCT00440518|467780|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
199650|NCT00440518|467781|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
199651|NCT00440518|467779|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
199652|NCT00440518|467780|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
199653|NCT00440518|467781|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
199654|NCT00440518|467779|P3|STARTED|Maintenance and Safety Follow-up Periods||70
199655|NCT00440518|467780|P2|STARTED|Maintenance and Safety Follow-up Periods||63
199656|NCT00440518|467781|P1|STARTED|Maintenance and Safety Follow-up Periods||59
199657|NCT00440518|467779|P3|NOT COMPLETED|Randomized /Titration Period||4
199658|NCT00440518|467780|P2|NOT COMPLETED|Randomized /Titration Period||9
199659|NCT00440518|467781|P1|NOT COMPLETED|Randomized /Titration Period||13
199660|NCT00440518|467779|P3|COMPLETED|Randomized /Titration Period||70
199661|NCT00440518|467780|P2|COMPLETED|Randomized /Titration Period||63
199662|NCT00440518|467781|P1|COMPLETED|Randomized /Titration Period||59
199663|NCT00440518|467779|P3|STARTED|Randomized /Titration Period||74
199664|NCT00440518|467780|P2|STARTED|Randomized /Titration Period||72
199665|NCT00440518|467781|P1|STARTED|Randomized /Titration Period||72
199666|NCT00440505|467801|P6|NOT COMPLETED|Third Intervention||0
199667|NCT00440505|467802|P5|NOT COMPLETED|Third Intervention||0
199668|NCT00440505|467803|P4|NOT COMPLETED|Third Intervention||1
199669|NCT00440505|467804|P3|NOT COMPLETED|Third Intervention||0
199670|NCT00440505|467805|P2|NOT COMPLETED|Third Intervention||0
199671|NCT00440505|467806|P1|NOT COMPLETED|Third Intervention||0
199672|NCT00440505|467801|P6|COMPLETED|Third Intervention||5
199673|NCT00440505|467802|P5|COMPLETED|Third Intervention||5
199674|NCT00440505|467803|P4|COMPLETED|Third Intervention||1
199675|NCT00440505|467804|P3|COMPLETED|Third Intervention||1
199676|NCT00440505|467805|P2|COMPLETED|Third Intervention||2
199677|NCT00440505|467806|P1|COMPLETED|Third Intervention||5
199678|NCT00440505|467801|P6|STARTED|Third Intervention||5
199679|NCT00440505|467802|P5|STARTED|Third Intervention||5
199680|NCT00440505|467803|P4|STARTED|Third Intervention||2
199681|NCT00440505|467804|P3|STARTED|Third Intervention||1
199682|NCT00440505|467805|P2|STARTED|Third Intervention||2
199683|NCT00440505|467806|P1|STARTED|Third Intervention||5
199684|NCT00440505|467801|P6|NOT COMPLETED|Second Intervention||0
199685|NCT00440505|467802|P5|NOT COMPLETED|Second Intervention||0
199686|NCT00440505|467803|P4|NOT COMPLETED|Second Intervention||0
199687|NCT00440505|467804|P3|NOT COMPLETED|Second Intervention||0
199688|NCT00440505|467805|P2|NOT COMPLETED|Second Intervention||0
199689|NCT00440505|467806|P1|NOT COMPLETED|Second Intervention||0
199690|NCT00440505|467801|P6|COMPLETED|Second Intervention||5
199691|NCT00440505|467802|P5|COMPLETED|Second Intervention||5
199692|NCT00440505|467803|P4|COMPLETED|Second Intervention||2
199693|NCT00440505|467804|P3|COMPLETED|Second Intervention||1
199694|NCT00440505|467805|P2|COMPLETED|Second Intervention||2
199695|NCT00440505|467806|P1|COMPLETED|Second Intervention||5
199696|NCT00440505|467801|P6|STARTED|Second Intervention||5
199697|NCT00440505|467802|P5|STARTED|Second Intervention||5
199698|NCT00440505|467803|P4|STARTED|Second Intervention||2
199699|NCT00440505|467804|P3|STARTED|Second Intervention||1
199700|NCT00440505|467805|P2|STARTED|Second Intervention||2
199701|NCT00440505|467806|P1|STARTED|Second Intervention||5
199702|NCT00440505|467801|P6|NOT COMPLETED|First Intervention||0
199703|NCT00440505|467802|P5|NOT COMPLETED|First Intervention||0
199704|NCT00440505|467803|P4|NOT COMPLETED|First Intervention||0
199705|NCT00440505|467804|P3|NOT COMPLETED|First Intervention||0
199706|NCT00440505|467805|P2|NOT COMPLETED|First Intervention||0
199707|NCT00440505|467806|P1|NOT COMPLETED|First Intervention||0
199708|NCT00440505|467801|P6|COMPLETED|First Intervention||5
199709|NCT00440505|467802|P5|COMPLETED|First Intervention||5
199710|NCT00440505|467803|P4|COMPLETED|First Intervention||2
199711|NCT00440505|467804|P3|COMPLETED|First Intervention||1
199712|NCT00440505|467805|P2|COMPLETED|First Intervention||2
199713|NCT00440505|467806|P1|COMPLETED|First Intervention||5
199714|NCT00440505|467801|P6|STARTED|First Intervention||5
199715|NCT00440505|467802|P5|STARTED|First Intervention||5
199716|NCT00440505|467803|P4|STARTED|First Intervention||2
199717|NCT00440505|467804|P3|STARTED|First Intervention||1
199718|NCT00440505|467805|P2|STARTED|First Intervention||2
199719|NCT00440505|467806|P1|STARTED|First Intervention||5
199720|NCT00440466|467826|P3|NOT COMPLETED|Overall Study||41
199721|NCT00440466|467827|P2|NOT COMPLETED|Overall Study||15
199722|NCT00440466|467828|P1|NOT COMPLETED|Overall Study||13
199723|NCT00440466|467826|P3|COMPLETED|Overall Study||174
199724|NCT00440466|467827|P2|COMPLETED|Overall Study||92
199725|NCT00440466|467828|P1|COMPLETED|Overall Study||95
199726|NCT00440466|467826|P3|STARTED|Overall Study||215
199727|NCT00440466|467827|P2|STARTED|Overall Study||107
199728|NCT00440466|467828|P1|STARTED|Overall Study||108
199729|NCT00440401|467862|P2|NOT COMPLETED|Overall Study||6
199730|NCT00440401|467863|P1|NOT COMPLETED|Overall Study||4
199731|NCT00440401|467862|P2|COMPLETED|Overall Study||54
199732|NCT00440401|467863|P1|COMPLETED|Overall Study||55
199733|NCT00440401|467862|P2|STARTED|Overall Study||60
199734|NCT00440401|467863|P1|STARTED|Overall Study||59
199735|NCT00440310|467873|P2|NOT COMPLETED|Overall Study||30
199736|NCT00440310|467874|P1|NOT COMPLETED|Overall Study||28
199737|NCT00440310|467873|P2|COMPLETED|Overall Study||209
199738|NCT00440310|467874|P1|COMPLETED|Overall Study||216
199739|NCT00440310|467873|P2|Treated|Overall Study||232
199740|NCT00440310|467874|P1|Treated|Overall Study||222
199741|NCT00440310|467873|P2|STARTED|Overall Study||239
199742|NCT00440310|467874|P1|STARTED|Overall Study||244
199743|NCT00440297|467882|P2|NOT COMPLETED|Overall Study||18
199744|NCT00440297|467883|P1|NOT COMPLETED|Overall Study||23
199745|NCT00440297|467882|P2|COMPLETED|Overall Study||120
199746|NCT00440297|467883|P1|COMPLETED|Overall Study||116
199747|NCT00440297|467882|P2|Vaccination Visit 4|Overall Study||122
199748|NCT00440297|467883|P1|Vaccination Visit 4|Overall Study||116
199749|NCT00440297|467882|P2|Vaccination Visit 3|Overall Study||125
199750|NCT00440297|467883|P1|Vaccination Visit 3|Overall Study||124
199751|NCT00440297|467882|P2|Vaccination Visit 2|Overall Study||134
199752|NCT00440297|467883|P1|Vaccination Visit 2|Overall Study||136
199753|NCT00440297|467882|P2|Vaccination Visit 1|Overall Study||138
199754|NCT00440297|467883|P1|Vaccination Visit 1|Overall Study||138
199755|NCT00440297|467882|P2|STARTED|Overall Study||138
199756|NCT00440297|467883|P1|STARTED|Overall Study||139
199757|NCT00440271|467899|P2|NOT COMPLETED|Overall Study||15
199758|NCT00440271|467900|P1|NOT COMPLETED|Overall Study||12
199759|NCT00440271|467899|P2|COMPLETED|Overall Study||3
199760|NCT00440271|467900|P1|COMPLETED|Overall Study||3
199761|NCT00440271|467899|P2|STARTED|Overall Study||18
199762|NCT00440271|467900|P1|STARTED|Overall Study||15
199763|NCT00440232|467934|P2|NOT COMPLETED|Overall Study||4
199764|NCT00440232|467935|P1|NOT COMPLETED|Overall Study||3
199765|NCT00440232|467934|P2|COMPLETED|Overall Study||34
199766|NCT00440232|467935|P1|COMPLETED|Overall Study||33
199767|NCT00440232|467934|P2|STARTED|Overall Study||38
199768|NCT00440232|467935|P1|STARTED|Overall Study||36
199769|NCT00440193|467945|P2|NOT COMPLETED|Observational Period||38
199770|NCT00440193|467946|P1|NOT COMPLETED|Observational Period||45
199771|NCT00440193|467945|P2|COMPLETED|Observational Period||1369
199772|NCT00440193|467946|P1|COMPLETED|Observational Period||1380
199773|NCT00440193|467945|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
199774|NCT00440193|467946|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
199775|NCT00440193|467945|P2|NOT COMPLETED|Treatment Period||351
199776|NCT00440193|467946|P1|NOT COMPLETED|Treatment Period||305
199777|NCT00440193|467945|P2|COMPLETED|Treatment Period||1367
199778|NCT00440193|467946|P1|COMPLETED|Treatment Period||1426
199779|NCT00440193|467945|P2|Participants Received Treatment|Treatment Period||1711
199780|NCT00440193|467946|P1|Participants Received Treatment|Treatment Period||1718
199781|NCT00440193|467945|P2|STARTED|Treatment Period||1718
199782|NCT00440193|467946|P1|STARTED|Treatment Period||1731
199783|NCT00440180|467982|P2|NOT COMPLETED|Overall Study||0
199784|NCT00440180|467983|P1|NOT COMPLETED|Overall Study||0
199785|NCT00440180|467982|P2|COMPLETED|Overall Study||10
199786|NCT00440180|467983|P1|COMPLETED|Overall Study||10
199787|NCT00440180|467982|P2|STARTED|Overall Study||10
199788|NCT00440180|467983|P1|STARTED|Overall Study||10
199789|NCT00440050|467991|P2|NOT COMPLETED|Overall Study||67
199790|NCT00440050|467992|P1|NOT COMPLETED|Overall Study||40
199791|NCT00440050|467991|P2|COMPLETED|Overall Study||171
199792|NCT00440050|467992|P1|COMPLETED|Overall Study||124
199793|NCT00440050|467991|P2|STARTED|Overall Study||238
199794|NCT00440050|467992|P1|STARTED|Overall Study||164
199795|NCT00440011|468006|P2|NOT COMPLETED|Overall Study||3
199796|NCT00440011|468007|P1|NOT COMPLETED|Overall Study||4
199797|NCT00440011|468006|P2|COMPLETED|Overall Study||132
199798|NCT00440011|468007|P1|COMPLETED|Overall Study||127
199799|NCT00440011|468006|P2|STARTED|Overall Study||135
199800|NCT00440011|468007|P1|STARTED|Overall Study||131
199801|NCT00439946|468015|P1|NOT COMPLETED|Overall Study||0
199802|NCT00439946|468015|P1|COMPLETED|Overall Study||8
199803|NCT00439946|468015|P1|STARTED|Overall Study||8
199804|NCT00439777|468034|P2|NOT COMPLETED|Observational Period||41
199805|NCT00439777|468035|P1|NOT COMPLETED|Observational Period||41
199806|NCT00439777|468034|P2|COMPLETED|Observational Period||2156
199807|NCT00439777|468035|P1|COMPLETED|Observational Period||2165
199808|NCT00439777|468034|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
199896|NCT00439270|468281|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
199809|NCT00439777|468035|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
199810|NCT00439777|468034|P2|NOT COMPLETED|Treatment Period||459
199811|NCT00439777|468035|P1|NOT COMPLETED|Treatment Period||419
199812|NCT00439777|468034|P2|COMPLETED|Treatment Period||1954
199813|NCT00439777|468035|P1|COMPLETED|Treatment Period||2001
199814|NCT00439777|468034|P2|Participants Received Treatment|Treatment Period||2405
199815|NCT00439777|468035|P1|Participants Received Treatment|Treatment Period||2412
199816|NCT00439777|468034|P2|STARTED|Treatment Period||2413
199817|NCT00439777|468035|P1|STARTED|Treatment Period||2420
199818|NCT00439738|468073|P2|NOT COMPLETED|Overall Study||28
199819|NCT00439738|468074|P1|NOT COMPLETED|Overall Study||36
199820|NCT00439738|468073|P2|COMPLETED|Overall Study||178
199821|NCT00439738|468074|P1|COMPLETED|Overall Study||170
199822|NCT00439738|468073|P2|STARTED|Overall Study||206
199823|NCT00439738|468074|P1|STARTED|Overall Study||206
199824|NCT00439725|468094|P2|NOT COMPLETED|Observational Period||7
199825|NCT00439725|468095|P1|NOT COMPLETED|Observational Period||8
199826|NCT00439725|468094|P2|COMPLETED|Observational Period||553
199827|NCT00439725|468095|P1|COMPLETED|Observational Period||569
199828|NCT00439725|468094|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
199829|NCT00439725|468095|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
199830|NCT00439725|468094|P2|NOT COMPLETED|Treatment Period||246
199831|NCT00439725|468095|P1|NOT COMPLETED|Treatment Period||236
199832|NCT00439725|468094|P2|COMPLETED|Treatment Period||349
199833|NCT00439725|468095|P1|COMPLETED|Treatment Period||366
199834|NCT00439725|468094|P2|Participants Received Treatment|Treatment Period|Safety population|590
199835|NCT00439725|468095|P1|Participants Received Treatment|Treatment Period|Safety population|598
199836|NCT00439725|468094|P2|STARTED|Treatment Period||595
199837|NCT00439725|468095|P1|STARTED|Treatment Period||602
199838|NCT00439647|468141|P2|NOT COMPLETED|Overall Study||71
199839|NCT00439647|468142|P1|NOT COMPLETED|Overall Study||58
199840|NCT00439647|468141|P2|COMPLETED|Overall Study||540
199841|NCT00439647|468142|P1|COMPLETED|Overall Study||530
199842|NCT00439647|468141|P2|Modified Intent to Treat (mITT)|Overall Study||574
199843|NCT00439647|468142|P1|Modified Intent to Treat (mITT)|Overall Study||553
199844|NCT00439647|468141|P2|STARTED|Overall Study||611
199845|NCT00439647|468142|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
199846|NCT00439608|468174|P1|NOT COMPLETED|Overall Study||0
199847|NCT00439608|468174|P1|COMPLETED|Overall Study||60
199848|NCT00439608|468174|P1|STARTED|Overall Study||60
199849|NCT00439569|468178|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
199850|NCT00439569|468178|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
199851|NCT00439569|468178|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
199852|NCT00439569|468178|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
199853|NCT00439569|468178|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
199854|NCT00439569|468178|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
199855|NCT00439517|468191|P2|NOT COMPLETED|Overall Study||0
199856|NCT00439517|468192|P1|NOT COMPLETED|Overall Study||2
199857|NCT00439517|468191|P2|COMPLETED|Overall Study||150
199858|NCT00439517|468192|P1|COMPLETED|Overall Study||150
199859|NCT00439517|468191|P2|STARTED|Overall Study||150
199860|NCT00439517|468192|P1|STARTED|Overall Study||152
199861|NCT00439413|468216|P2|NOT COMPLETED|Overall Study||37
199862|NCT00439413|468217|P1|NOT COMPLETED|Overall Study||31
199863|NCT00439413|468216|P2|COMPLETED|Overall Study||88
199864|NCT00439413|468217|P1|COMPLETED|Overall Study||90
199865|NCT00439413|468216|P2|STARTED|Overall Study||125
199866|NCT00439413|468217|P1|STARTED|Overall Study||121
199867|NCT00439335|468227|P2|NOT COMPLETED|Overall Study||0
199868|NCT00439335|468228|P1|NOT COMPLETED|Overall Study||2
199869|NCT00439335|468227|P2|COMPLETED|Overall Study||114
199870|NCT00439335|468228|P1|COMPLETED|Overall Study||111
199871|NCT00439335|468227|P2|STARTED|Overall Study||114
199872|NCT00439335|468228|P1|STARTED|Overall Study||113
199873|NCT00439309|468260|P2|NOT COMPLETED|Follow-Up||2
199874|NCT00439309|468261|P1|NOT COMPLETED|Follow-Up||3
199875|NCT00439309|468260|P2|COMPLETED|Follow-Up||13
199876|NCT00439309|468261|P1|COMPLETED|Follow-Up||51
199877|NCT00439309|468260|P2|STARTED|Follow-Up||15
199878|NCT00439309|468261|P1|STARTED|Follow-Up||54
199879|NCT00439309|468260|P2|NOT COMPLETED|Treatment||0
199880|NCT00439309|468261|P1|NOT COMPLETED|Treatment||0
199881|NCT00439309|468260|P2|COMPLETED|Treatment||15
199882|NCT00439309|468261|P1|COMPLETED|Treatment||54
199883|NCT00439309|468260|P2|STARTED|Treatment||15
199884|NCT00439309|468261|P1|STARTED|Treatment||54
199885|NCT00439270|468280|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
199886|NCT00439270|468281|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
199887|NCT00439270|468282|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
199888|NCT00439270|468283|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
199889|NCT00439270|468284|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
199890|NCT00439270|468280|P5|COMPLETED|Phase 2 (51.6 Months)||0
199891|NCT00439270|468281|P4|COMPLETED|Phase 2 (51.6 Months)||0
199892|NCT00439270|468282|P3|COMPLETED|Phase 2 (51.6 Months)||0
199893|NCT00439270|468283|P2|COMPLETED|Phase 2 (51.6 Months)||0
199894|NCT00439270|468284|P1|COMPLETED|Phase 2 (51.6 Months)||0
199895|NCT00439270|468280|P5|STARTED|Phase 2 (51.6 Months)||0
199897|NCT00439270|468282|P3|STARTED|Phase 2 (51.6 Months)||0
199898|NCT00439270|468283|P2|STARTED|Phase 2 (51.6 Months)||0
199899|NCT00439270|468284|P1|STARTED|Phase 2 (51.6 Months)||0
199900|NCT00439270|468280|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
199901|NCT00439270|468281|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
199902|NCT00439270|468282|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
199903|NCT00439270|468283|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
199904|NCT00439270|468284|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
199905|NCT00439270|468280|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
199906|NCT00439270|468281|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
199907|NCT00439270|468282|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
199908|NCT00439270|468283|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
199909|NCT00439270|468284|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
199910|NCT00439270|468280|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
199911|NCT00439270|468281|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
199912|NCT00439270|468282|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
199913|NCT00439270|468283|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
199914|NCT00439270|468284|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
199915|NCT00439244|468326|P3|NOT COMPLETED|Overall Study||7
199916|NCT00439244|468327|P2|NOT COMPLETED|Overall Study||6
199917|NCT00439244|468328|P1|NOT COMPLETED|Overall Study||11
199918|NCT00439244|468326|P3|COMPLETED|Overall Study||131
199919|NCT00439244|468327|P2|COMPLETED|Overall Study||131
199920|NCT00439244|468328|P1|COMPLETED|Overall Study||126
199921|NCT00439244|468326|P3|Safety Population|Overall Study||137
199922|NCT00439244|468327|P2|Safety Population|Overall Study||137
199923|NCT00439244|468328|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
199924|NCT00439244|468326|P3|STARTED|Overall Study||138
199925|NCT00439244|468327|P2|STARTED|Overall Study||137
199926|NCT00439244|468328|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
199927|NCT00439231|468348|P1|NOT COMPLETED|Overall Study||28
199928|NCT00439231|468348|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
199929|NCT00439231|468348|P1|STARTED|Overall Study||33
199930|NCT00439218|468352|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
199931|NCT00439218|468352|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
199932|NCT00439218|468352|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
199933|NCT00439218|468352|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
199934|NCT00439218|468352|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
199935|NCT00439218|468352|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
199936|NCT00439179|468367|P4|NOT COMPLETED|Overall Study||0
199937|NCT00439179|468368|P3|NOT COMPLETED|Overall Study||0
199938|NCT00439179|468369|P2|NOT COMPLETED|Overall Study||2
199939|NCT00439179|468370|P1|NOT COMPLETED|Overall Study||0
199940|NCT00439179|468367|P4|COMPLETED|Overall Study||5
199941|NCT00439179|468368|P3|COMPLETED|Overall Study||6
199942|NCT00439179|468369|P2|COMPLETED|Overall Study||11
199943|NCT00439179|468370|P1|COMPLETED|Overall Study||3
199944|NCT00439179|468367|P4|STARTED|Overall Study|2 with biliry|5
199945|NCT00439179|468368|P3|STARTED|Overall Study|2 with biliary|6
199946|NCT00439179|468369|P2|STARTED|Overall Study|2 with biliary|13
199947|NCT00439179|468370|P1|STARTED|Overall Study|1 with biliary|3
199948|NCT00439140|468387|P3|NOT COMPLETED|Treatment Cycle 2||0
199949|NCT00439140|468388|P2|NOT COMPLETED|Treatment Cycle 2||1
199950|NCT00439140|468389|P1|NOT COMPLETED|Treatment Cycle 2||2
199951|NCT00439140|468387|P3|COMPLETED|Treatment Cycle 2||0
199952|NCT00439140|468388|P2|COMPLETED|Treatment Cycle 2||6
199953|NCT00439140|468389|P1|COMPLETED|Treatment Cycle 2||11
199954|NCT00439140|468387|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
199955|NCT00439140|468388|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
199956|NCT00439140|468389|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
199957|NCT00439140|468387|P3|NOT COMPLETED|Treatment Cycle 1||1
199958|NCT00439140|468388|P2|NOT COMPLETED|Treatment Cycle 1||4
199959|NCT00439140|468389|P1|NOT COMPLETED|Treatment Cycle 1||1
199960|NCT00439140|468387|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
199961|NCT00439140|468388|P2|COMPLETED|Treatment Cycle 1||10
199962|NCT00439140|468389|P1|COMPLETED|Treatment Cycle 1||14
199963|NCT00439140|468387|P3|STARTED|Treatment Cycle 1||12
199964|NCT00439140|468388|P2|STARTED|Treatment Cycle 1||14
199965|NCT00439140|468389|P1|STARTED|Treatment Cycle 1||15
199966|NCT00438971|468418|P1|NOT COMPLETED|Overall Study||2
199967|NCT00438971|468418|P1|COMPLETED|Overall Study||15
199968|NCT00438971|468418|P1|STARTED|Overall Study||17
199969|NCT00438932|468433|P4|NOT COMPLETED|Overall Study||0
199970|NCT00438932|468434|P3|NOT COMPLETED|Overall Study||0
199971|NCT00438932|468435|P2|NOT COMPLETED|Overall Study||0
199972|NCT00438932|468436|P1|NOT COMPLETED|Overall Study||0
199973|NCT00438932|468433|P4|COMPLETED|Overall Study||4
199974|NCT00438932|468434|P3|COMPLETED|Overall Study||4
199975|NCT00438932|468435|P2|COMPLETED|Overall Study||4
199976|NCT00438932|468436|P1|COMPLETED|Overall Study||4
199977|NCT00438932|468433|P4|STARTED|Overall Study||4
199978|NCT00438932|468434|P3|STARTED|Overall Study||4
199979|NCT00438932|468435|P2|STARTED|Overall Study||4
199980|NCT00438932|468436|P1|STARTED|Overall Study||4
199981|NCT00438880|468452|P2|NOT COMPLETED|Overall Study||0
199982|NCT00438880|468453|P1|NOT COMPLETED|Overall Study||0
199983|NCT00438880|468452|P2|COMPLETED|Overall Study||8
199984|NCT00438880|468453|P1|COMPLETED|Overall Study||30
199985|NCT00438880|468452|P2|STARTED|Overall Study||8
199986|NCT00438880|468453|P1|STARTED|Overall Study||30
199987|NCT00438854|468465|P1|NOT COMPLETED|Overall Study||0
199988|NCT00438854|468465|P1|COMPLETED|Overall Study||15
199989|NCT00438854|468465|P1|STARTED|Overall Study||15
199990|NCT00438815|468469|P1|NOT COMPLETED|Overall Study||70
199991|NCT00438815|468469|P1|COMPLETED|Overall Study||43
199992|NCT00438815|468469|P1|STARTED|Overall Study||113
199993|NCT00438750|468481|P2|NOT COMPLETED|Overall Study||9
199994|NCT00438750|468482|P1|NOT COMPLETED|Overall Study||9
199995|NCT00438750|468481|P2|COMPLETED|Overall Study||37
199996|NCT00438750|468482|P1|COMPLETED|Overall Study||39
199997|NCT00438750|468481|P2|STARTED|Overall Study||46
199998|NCT00438750|468482|P1|STARTED|Overall Study||48
199999|NCT00438672|468502|P2|NOT COMPLETED|Overall Study||9
200000|NCT00438672|468503|P1|NOT COMPLETED|Overall Study||7
200001|NCT00438672|468502|P2|COMPLETED|Overall Study||24
200002|NCT00438672|468503|P1|COMPLETED|Overall Study||24
200003|NCT00438672|468502|P2|STARTED|Overall Study||33
200004|NCT00438672|468503|P1|STARTED|Overall Study||31
200005|NCT00438659|468513|P2|NOT COMPLETED|Overall Study||4
200006|NCT00438659|468514|P1|NOT COMPLETED|Overall Study||6
200007|NCT00438659|468513|P2|COMPLETED|Overall Study||82
200008|NCT00438659|468514|P1|COMPLETED|Overall Study||84
200009|NCT00438659|468513|P2|STARTED|Overall Study||86
200010|NCT00438659|468514|P1|STARTED|Overall Study||90
200011|NCT00436748|468538|P2|NOT COMPLETED|Overall Study||12
200012|NCT00436748|468539|P1|NOT COMPLETED|Overall Study||11
200013|NCT00436748|468538|P2|COMPLETED|Overall Study||45
200014|NCT00436748|468539|P1|COMPLETED|Overall Study||48
200015|NCT00436748|468538|P2|Received Treatment|Overall Study||56
200016|NCT00436748|468539|P1|Received Treatment|Overall Study||58
200017|NCT00436748|468538|P2|STARTED|Overall Study||57
200018|NCT00436748|468539|P1|STARTED|Overall Study||59
200019|NCT00438490|468575|P2|NOT COMPLETED|Overall Study||0
200020|NCT00438490|468576|P1|NOT COMPLETED|Overall Study||0
200021|NCT00438490|468575|P2|COMPLETED|Overall Study||9
200022|NCT00438490|468576|P1|COMPLETED|Overall Study||12
200023|NCT00438490|468575|P2|STARTED|Overall Study||9
200024|NCT00438490|468576|P1|STARTED|Overall Study||12
200025|NCT00438464|468584|P2|NOT COMPLETED|Overall Study||7
200026|NCT00438464|468585|P1|NOT COMPLETED|Overall Study||14
200027|NCT00438464|468584|P2|COMPLETED|Overall Study||94
200028|NCT00438464|468585|P1|COMPLETED|Overall Study||89
200029|NCT00438464|468584|P2|Received Assigned Intervention|Overall Study||94
200030|NCT00438464|468585|P1|Received Assigned Intervention|Overall Study||89
200031|NCT00438464|468584|P2|STARTED|Overall Study||101
200032|NCT00438464|468585|P1|STARTED|Overall Study||103
200033|NCT00438451|468640|P3|NOT COMPLETED|Overall Study||53
200034|NCT00438451|468641|P2|NOT COMPLETED|Overall Study||66
200035|NCT00438451|468642|P1|NOT COMPLETED|Overall Study||47
200036|NCT00438451|468640|P3|COMPLETED|Overall Study||65
200037|NCT00438451|468641|P2|COMPLETED|Overall Study||55
200038|NCT00438451|468642|P1|COMPLETED|Overall Study||75
200039|NCT00438451|468640|P3|Maintenance Phase (Week 7-58)|Overall Study||93
200040|NCT00438451|468641|P2|Maintenance Phase (Week 7-58)|Overall Study||89
200041|NCT00438451|468642|P1|Maintenance Phase (Week 7-58)|Overall Study||93
200042|NCT00438451|468640|P3|ITT Population|Overall Study||117
200043|NCT00438451|468641|P2|ITT Population|Overall Study||120
200044|NCT00438451|468642|P1|ITT Population|Overall Study||122
200045|NCT00438451|468640|P3|Safety Population|Overall Study||117
200046|NCT00438451|468641|P2|Safety Population|Overall Study||121
200047|NCT00438451|468642|P1|Safety Population|Overall Study||122
200048|NCT00438451|468640|P3|STARTED|Overall Study||118
200049|NCT00438451|468641|P2|STARTED|Overall Study||121
200050|NCT00438451|468642|P1|STARTED|Overall Study||122
200051|NCT00438399|468686|P6|NOT COMPLETED|Overall Study||6
200052|NCT00438399|468687|P5|NOT COMPLETED|Overall Study||3
200053|NCT00438399|468688|P4|NOT COMPLETED|Overall Study||4
200054|NCT00438399|468689|P3|NOT COMPLETED|Overall Study||7
200055|NCT00438399|468690|P2|NOT COMPLETED|Overall Study||8
200056|NCT00438399|468691|P1|NOT COMPLETED|Overall Study||8
200057|NCT00438399|468686|P6|COMPLETED|Overall Study||31
200058|NCT00438399|468687|P5|COMPLETED|Overall Study||30
200059|NCT00438399|468688|P4|COMPLETED|Overall Study||32
200060|NCT00438399|468689|P3|COMPLETED|Overall Study||28
200061|NCT00438399|468690|P2|COMPLETED|Overall Study||32
200062|NCT00438399|468691|P1|COMPLETED|Overall Study||30
200063|NCT00438399|468686|P6|TREATED & ANALYZED|Overall Study||31
200064|NCT00438399|468687|P5|TREATED & ANALYZED|Overall Study||30
200065|NCT00438399|468688|P4|TREATED & ANALYZED|Overall Study||32
200066|NCT00438399|468689|P3|TREATED & ANALYZED|Overall Study||28
200067|NCT00438399|468690|P2|TREATED & ANALYZED|Overall Study||32
200068|NCT00438399|468691|P1|TREATED & ANALYZED|Overall Study||30
200069|NCT00438399|468686|P6|STARTED|Overall Study||37
200070|NCT00438399|468687|P5|STARTED|Overall Study||33
200071|NCT00438399|468688|P4|STARTED|Overall Study||36
200072|NCT00438399|468689|P3|STARTED|Overall Study||35
200073|NCT00438399|468690|P2|STARTED|Overall Study||40
200074|NCT00438399|468691|P1|STARTED|Overall Study||38
200075|NCT00438360|468702|P2|NOT COMPLETED|Overall Study||43
200076|NCT00438360|468703|P1|NOT COMPLETED|Overall Study||72
200077|NCT00438360|468702|P2|COMPLETED|Overall Study||38
200078|NCT00438360|468703|P1|COMPLETED|Overall Study||90
200079|NCT00438360|468702|P2|Intention to Treat (ITT) Population|Overall Study||79
200080|NCT00438360|468703|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
200081|NCT00438360|468702|P2|STARTED|Overall Study||81
200082|NCT00438360|468703|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
200083|NCT00438204|468717|P1|NOT COMPLETED|Overall Study||0
200084|NCT00438204|468717|P1|COMPLETED|Overall Study||39
200085|NCT00438204|468717|P1|STARTED|Overall Study||39
200086|NCT00438100|468723|P2|NOT COMPLETED|Overall Study||4
200087|NCT00438100|468724|P1|NOT COMPLETED|Overall Study||2
200088|NCT00438100|468723|P2|COMPLETED|Overall Study||65
200089|NCT00438100|468724|P1|COMPLETED|Overall Study||71
200090|NCT00438100|468723|P2|STARTED|Overall Study||69
200091|NCT00438100|468724|P1|STARTED|Overall Study||73
200092|NCT00437983|468732|P2|NOT COMPLETED|Overall Study||13
200093|NCT00437983|468733|P1|NOT COMPLETED|Overall Study||13
200094|NCT00437983|468732|P2|COMPLETED|Overall Study||65
200095|NCT00437983|468733|P1|COMPLETED|Overall Study||66
200096|NCT00437983|468732|P2|STARTED|Overall Study||78
200097|NCT00437983|468733|P1|STARTED|Overall Study||79
200098|NCT00437645|468745|P2|NOT COMPLETED|Overall Study||115
200099|NCT00437645|468746|P1|NOT COMPLETED|Overall Study||35
200100|NCT00437645|468745|P2|COMPLETED|Overall Study||476
200101|NCT00437645|468746|P1|COMPLETED|Overall Study||557
200102|NCT00437645|468745|P2|STARTED|Overall Study||591
200103|NCT00437645|468746|P1|STARTED|Overall Study||592
200104|NCT00437489|468762|P2|NOT COMPLETED|Overall Study||22
200105|NCT00437489|468763|P1|NOT COMPLETED|Overall Study||23
200106|NCT00437489|468762|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
200107|NCT00437489|468763|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
200108|NCT00437489|468762|P2|STARTED|Overall Study||24
200109|NCT00437489|468763|P1|STARTED|Overall Study||25
200110|NCT00437398|468775|P1|NOT COMPLETED|Overall Study||0
200111|NCT00437398|468775|P1|COMPLETED|Overall Study||2
200112|NCT00437398|468775|P1|STARTED|Overall Study||2
200113|NCT00437281|468800|P20|NOT COMPLETED|Overall Study||1
200114|NCT00437281|468801|P19|NOT COMPLETED|Overall Study||1
200115|NCT00437281|468802|P18|NOT COMPLETED|Overall Study||0
200116|NCT00437281|468803|P17|NOT COMPLETED|Overall Study||0
200117|NCT00437281|468804|P16|NOT COMPLETED|Overall Study||0
200118|NCT00437281|468805|P15|NOT COMPLETED|Overall Study||1
200119|NCT00437281|468806|P14|NOT COMPLETED|Overall Study||1
200120|NCT00437281|468807|P13|NOT COMPLETED|Overall Study||0
200121|NCT00437281|468808|P12|NOT COMPLETED|Overall Study||0
200122|NCT00437281|468809|P11|NOT COMPLETED|Overall Study||0
200123|NCT00437281|468810|P10|NOT COMPLETED|Overall Study||1
200124|NCT00437281|468811|P9|NOT COMPLETED|Overall Study||0
200125|NCT00437281|468812|P8|NOT COMPLETED|Overall Study||0
200126|NCT00437281|468813|P7|NOT COMPLETED|Overall Study||0
200127|NCT00437281|468814|P6|NOT COMPLETED|Overall Study||1
200128|NCT00437281|468815|P5|NOT COMPLETED|Overall Study||0
200129|NCT00437281|468816|P4|NOT COMPLETED|Overall Study||1
200130|NCT00437281|468817|P3|NOT COMPLETED|Overall Study||0
200131|NCT00437281|468818|P2|NOT COMPLETED|Overall Study||0
200132|NCT00437281|468819|P1|NOT COMPLETED|Overall Study||0
200133|NCT00437281|468800|P20|COMPLETED|Overall Study||2
200134|NCT00437281|468801|P19|COMPLETED|Overall Study||1
200135|NCT00437281|468802|P18|COMPLETED|Overall Study||4
200136|NCT00437281|468803|P17|COMPLETED|Overall Study||3
200137|NCT00437281|468804|P16|COMPLETED|Overall Study||3
200138|NCT00437281|468805|P15|COMPLETED|Overall Study||4
200139|NCT00437281|468806|P14|COMPLETED|Overall Study||2
200140|NCT00437281|468807|P13|COMPLETED|Overall Study||2
200141|NCT00437281|468808|P12|COMPLETED|Overall Study||3
200142|NCT00437281|468809|P11|COMPLETED|Overall Study||3
200143|NCT00437281|468810|P10|COMPLETED|Overall Study||4
200144|NCT00437281|468811|P9|COMPLETED|Overall Study||3
200145|NCT00437281|468812|P8|COMPLETED|Overall Study||3
200146|NCT00437281|468813|P7|COMPLETED|Overall Study||3
200147|NCT00437281|468814|P6|COMPLETED|Overall Study||3
200148|NCT00437281|468815|P5|COMPLETED|Overall Study||4
200149|NCT00437281|468816|P4|COMPLETED|Overall Study||2
200150|NCT00437281|468817|P3|COMPLETED|Overall Study||3
200151|NCT00437281|468818|P2|COMPLETED|Overall Study||3
200152|NCT00437281|468819|P1|COMPLETED|Overall Study||3
200153|NCT00437281|468800|P20|STARTED|Overall Study||3
200154|NCT00437281|468801|P19|STARTED|Overall Study||2
200155|NCT00437281|468802|P18|STARTED|Overall Study||4
200156|NCT00437281|468803|P17|STARTED|Overall Study||3
200157|NCT00437281|468804|P16|STARTED|Overall Study||3
200158|NCT00437281|468805|P15|STARTED|Overall Study||5
200159|NCT00437281|468806|P14|STARTED|Overall Study||3
200160|NCT00437281|468807|P13|STARTED|Overall Study||2
200161|NCT00437281|468808|P12|STARTED|Overall Study||3
200162|NCT00437281|468809|P11|STARTED|Overall Study||3
200163|NCT00437281|468810|P10|STARTED|Overall Study||5
200164|NCT00437281|468811|P9|STARTED|Overall Study||3
200165|NCT00437281|468812|P8|STARTED|Overall Study||3
200166|NCT00437281|468813|P7|STARTED|Overall Study||3
200167|NCT00437281|468814|P6|STARTED|Overall Study||4
200168|NCT00437281|468815|P5|STARTED|Overall Study||4
200169|NCT00437281|468816|P4|STARTED|Overall Study||3
200170|NCT00437281|468817|P3|STARTED|Overall Study||3
200171|NCT00437281|468818|P2|STARTED|Overall Study||3
200172|NCT00437281|468819|P1|STARTED|Overall Study||3
200173|NCT00437203|469123|P10|NOT COMPLETED|Overall Study||4
200174|NCT00437203|469124|P9|NOT COMPLETED|Overall Study||3
200175|NCT00437203|469125|P8|NOT COMPLETED|Overall Study||3
200176|NCT00437203|469126|P7|NOT COMPLETED|Overall Study||7
200177|NCT00437203|469127|P6|NOT COMPLETED|Overall Study||3
200178|NCT00437203|469128|P5|NOT COMPLETED|Overall Study||3
200179|NCT00437203|469129|P4|NOT COMPLETED|Overall Study||3
200180|NCT00437203|469130|P3|NOT COMPLETED|Overall Study||3
200181|NCT00437203|469131|P2|NOT COMPLETED|Overall Study||8
200182|NCT00437203|469132|P1|NOT COMPLETED|Overall Study||6
200183|NCT00437203|469123|P10|COMPLETED|Overall Study||0
200184|NCT00437203|469124|P9|COMPLETED|Overall Study||0
200185|NCT00437203|469125|P8|COMPLETED|Overall Study||0
200186|NCT00437203|469126|P7|COMPLETED|Overall Study||0
200187|NCT00437203|469127|P6|COMPLETED|Overall Study||0
200188|NCT00437203|469128|P5|COMPLETED|Overall Study||0
200189|NCT00437203|469129|P4|COMPLETED|Overall Study||0
200190|NCT00437203|469130|P3|COMPLETED|Overall Study||0
200191|NCT00437203|469131|P2|COMPLETED|Overall Study||0
200192|NCT00437203|469132|P1|COMPLETED|Overall Study||0
200193|NCT00437203|469123|P10|STARTED|Overall Study||4
200194|NCT00437203|469124|P9|STARTED|Overall Study||3
200195|NCT00437203|469125|P8|STARTED|Overall Study||3
200196|NCT00437203|469126|P7|STARTED|Overall Study||7
200197|NCT00437203|469127|P6|STARTED|Overall Study||3
200198|NCT00437203|469128|P5|STARTED|Overall Study||3
200199|NCT00437203|469129|P4|STARTED|Overall Study||3
200200|NCT00437203|469130|P3|STARTED|Overall Study||3
200201|NCT00437203|469131|P2|STARTED|Overall Study||8
200202|NCT00437203|469132|P1|STARTED|Overall Study||6
200203|NCT00437125|469236|P1|NOT COMPLETED|Overall Study||32
200204|NCT00437125|469236|P1|COMPLETED|Overall Study||119
200205|NCT00437125|469236|P1|STARTED|Overall Study||151
200206|NCT00437073|469257|P2|NOT COMPLETED|Overall Study||1
200207|NCT00437073|469258|P1|NOT COMPLETED|Overall Study||1
200208|NCT00437073|469257|P2|COMPLETED|Overall Study||8
200209|NCT00437073|469258|P1|COMPLETED|Overall Study||12
200210|NCT00437073|469257|P2|STARTED|Overall Study||9
200211|NCT00437073|469258|P1|STARTED|Overall Study||13
200212|NCT00437034|469286|P1|NOT COMPLETED|Overall Study||6
200213|NCT00437034|469286|P1|COMPLETED|Overall Study||0
200214|NCT00437034|469286|P1|STARTED|Overall Study||6
200215|NCT00436982|469292|P2|NOT COMPLETED|Overall Study||5
200216|NCT00436982|469293|P1|NOT COMPLETED|Overall Study||5
200217|NCT00436982|469292|P2|COMPLETED|Overall Study||25
200218|NCT00436982|469293|P1|COMPLETED|Overall Study||25
200219|NCT00436982|469292|P2|STARTED|Overall Study||30
200220|NCT00436982|469293|P1|STARTED|Overall Study||30
200221|NCT00436969|469301|P2|NOT COMPLETED|Overall Study||52
200222|NCT00436969|469302|P1|NOT COMPLETED|Overall Study||22
200223|NCT00436969|469301|P2|COMPLETED|Overall Study||134
200224|NCT00436969|469302|P1|COMPLETED|Overall Study||66
200225|NCT00436969|469301|P2|Randomized But Not Treated|Overall Study||3
200226|NCT00436969|469302|P1|Randomized But Not Treated|Overall Study||1
200227|NCT00436969|469301|P2|STARTED|Overall Study||186
200228|NCT00436969|469302|P1|STARTED|Overall Study||88
200229|NCT00436956|469350|P2|NOT COMPLETED|Overall Study||0
200230|NCT00436956|469351|P1|NOT COMPLETED|Overall Study||1
200231|NCT00436956|469350|P2|COMPLETED|Overall Study||23
200232|NCT00436956|469351|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
200233|NCT00436956|469350|P2|STARTED|Overall Study||23
200234|NCT00436956|469351|P1|STARTED|Overall Study||36
200235|NCT00436917|469360|P1|NOT COMPLETED|Overall Study||54
200236|NCT00436917|469360|P1|COMPLETED|Overall Study||0
200237|NCT00436917|469360|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
200238|NCT00436904|469364|P1|NOT COMPLETED|Overall Study||0
200239|NCT00436904|469364|P1|COMPLETED|Overall Study||30
200240|NCT00436904|469364|P1|STARTED|Overall Study||30
200241|NCT00436852|469375|P2|NOT COMPLETED|Overall Study||45
200242|NCT00436852|469376|P1|NOT COMPLETED|Overall Study||35
200243|NCT00436852|469375|P2|COMPLETED|Overall Study||2
200244|NCT00436852|469376|P1|COMPLETED|Overall Study||10
200245|NCT00436852|469375|P2|STARTED|Overall Study||47
200246|NCT00436852|469376|P1|STARTED|Overall Study||45
200247|NCT00436826|469386|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
200248|NCT00436826|469387|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
200249|NCT00436826|469388|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
200250|NCT00436826|469389|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
200251|NCT00436826|469390|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
200252|NCT00436826|469391|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
200253|NCT00436826|469386|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
200254|NCT00436826|469387|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
200255|NCT00436826|469388|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
200256|NCT00436826|469389|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
200257|NCT00436826|469390|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
200258|NCT00436826|469391|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
200259|NCT00436826|469386|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
200260|NCT00436826|469387|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
200261|NCT00436826|469388|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
200343|NCT00436501|469476|P1|COMPLETED|Complete Study Participation||9
200262|NCT00436826|469389|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
200263|NCT00436826|469390|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
200264|NCT00436826|469391|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
200265|NCT00436826|469386|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
200266|NCT00436826|469387|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
200267|NCT00436826|469388|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
200268|NCT00436826|469389|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
200269|NCT00436826|469390|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
200270|NCT00436826|469391|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
200271|NCT00436826|469386|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
200272|NCT00436826|469387|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
200273|NCT00436826|469388|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
200274|NCT00436826|469389|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
200275|NCT00436826|469390|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
200276|NCT00436826|469391|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
200277|NCT00436826|469386|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
200278|NCT00436826|469387|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
200279|NCT00436826|469388|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
200280|NCT00436826|469389|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
200281|NCT00436826|469390|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
200282|NCT00436826|469391|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
200283|NCT00436826|469386|P6|NOT COMPLETED|Double Blind Period||0
200284|NCT00436826|469387|P5|NOT COMPLETED|Double Blind Period||0
200285|NCT00436826|469388|P4|NOT COMPLETED|Double Blind Period||0
200286|NCT00436826|469389|P3|NOT COMPLETED|Double Blind Period||0
200287|NCT00436826|469390|P2|NOT COMPLETED|Double Blind Period||11
200288|NCT00436826|469391|P1|NOT COMPLETED|Double Blind Period||13
200289|NCT00436826|469386|P6|COMPLETED|Double Blind Period||0
200290|NCT00436826|469387|P5|COMPLETED|Double Blind Period||0
200291|NCT00436826|469388|P4|COMPLETED|Double Blind Period||0
200292|NCT00436826|469389|P3|COMPLETED|Double Blind Period||0
200293|NCT00436826|469390|P2|COMPLETED|Double Blind Period||37
200294|NCT00436826|469391|P1|COMPLETED|Double Blind Period||111
200295|NCT00436826|469386|P6|STARTED|Double Blind Period||0
200296|NCT00436826|469387|P5|STARTED|Double Blind Period||0
200297|NCT00436826|469388|P4|STARTED|Double Blind Period||0
200298|NCT00436826|469389|P3|STARTED|Double Blind Period||0
200299|NCT00436826|469390|P2|STARTED|Double Blind Period||48
200300|NCT00436826|469391|P1|STARTED|Double Blind Period||124
200301|NCT00436644|469411|P1|NOT COMPLETED|Overall Study||3
200302|NCT00436644|469411|P1|COMPLETED|Overall Study||15
200303|NCT00436644|469411|P1|STARTED|Overall Study||18
200304|NCT00436618|469421|P3|NOT COMPLETED|Overall Study||61
200305|NCT00436618|469422|P2|NOT COMPLETED|Overall Study||27
200306|NCT00436618|469423|P1|NOT COMPLETED|Overall Study||30
200307|NCT00436618|469421|P3|COMPLETED|Overall Study||46
200308|NCT00436618|469422|P2|COMPLETED|Overall Study||28
200309|NCT00436618|469423|P1|COMPLETED|Overall Study||84
200310|NCT00436618|469421|P3|STARTED|Overall Study||107
200311|NCT00436618|469422|P2|STARTED|Overall Study||55
200312|NCT00436618|469423|P1|STARTED|Overall Study||114
200313|NCT00436605|469440|P1|NOT COMPLETED|Overall Study||3
200314|NCT00436605|469440|P1|COMPLETED|Overall Study||36
200315|NCT00436605|469440|P1|STARTED|Overall Study||39
200316|NCT00436566|469445|P1|NOT COMPLETED|Overall Study||3
200317|NCT00436566|469445|P1|COMPLETED|Overall Study||109
200318|NCT00436566|469445|P1|STARTED|Overall Study||112
200319|NCT00436553|469452|P3|NOT COMPLETED|Overall Study||10
200320|NCT00436553|469453|P2|NOT COMPLETED|Overall Study||12
200321|NCT00436553|469454|P1|NOT COMPLETED|Overall Study||13
200322|NCT00436553|469452|P3|COMPLETED|Overall Study||102
200323|NCT00436553|469453|P2|COMPLETED|Overall Study||93
200324|NCT00436553|469454|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
200325|NCT00436553|469452|P3|STARTED|Overall Study||112
200326|NCT00436553|469453|P2|STARTED|Overall Study||105
200327|NCT00436553|469454|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
200328|NCT00436501|469475|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
200329|NCT00436501|469476|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
200330|NCT00436501|469475|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
200331|NCT00436501|469476|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
200332|NCT00436501|469475|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
200333|NCT00436501|469476|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
200334|NCT00436501|469475|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
200335|NCT00436501|469476|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
200336|NCT00436501|469475|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
200337|NCT00436501|469476|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
200338|NCT00436501|469475|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
200339|NCT00436501|469476|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
200340|NCT00436501|469475|P2|NOT COMPLETED|Complete Study Participation||0
200341|NCT00436501|469476|P1|NOT COMPLETED|Complete Study Participation||0
200342|NCT00436501|469475|P2|COMPLETED|Complete Study Participation||49
200344|NCT00436501|469475|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
200345|NCT00436501|469476|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
200346|NCT00436345|469489|P2|NOT COMPLETED|Overall Study||0
200347|NCT00436345|469490|P1|NOT COMPLETED|Overall Study||3
200348|NCT00436345|469489|P2|COMPLETED|Overall Study||18
200349|NCT00436345|469490|P1|COMPLETED|Overall Study||18
200350|NCT00436345|469489|P2|STARTED|Overall Study||18
200351|NCT00436345|469490|P1|STARTED|Overall Study||21
200352|NCT00436332|469543|P1|NOT COMPLETED|Overall Study||83
200353|NCT00436332|469543|P1|COMPLETED|Overall Study||1
200354|NCT00436332|469543|P1|Eligible and Began Protocol Therapy|Overall Study||79
200355|NCT00436332|469543|P1|Eligible|Overall Study||82
200356|NCT00436332|469543|P1|STARTED|Overall Study||84
200357|NCT00436215|469549|P1|NOT COMPLETED|Overall Study||4
200358|NCT00436215|469549|P1|COMPLETED|Overall Study||51
200359|NCT00436215|469549|P1|STARTED|Overall Study||55
200360|NCT00436163|469555|P1|NOT COMPLETED|Overall Study||3
200361|NCT00436163|469555|P1|COMPLETED|Overall Study||36
200362|NCT00436163|469555|P1|STARTED|Overall Study||39
200363|NCT00436046|469569|P3|NOT COMPLETED|Overall Study||0
200364|NCT00436046|469570|P2|NOT COMPLETED|Overall Study||0
200365|NCT00436046|469571|P1|NOT COMPLETED|Overall Study||0
200366|NCT00436046|469569|P3|COMPLETED|Overall Study||31
200367|NCT00436046|469570|P2|COMPLETED|Overall Study||32
200368|NCT00436046|469571|P1|COMPLETED|Overall Study||32
200369|NCT00436046|469569|P3|STARTED|Overall Study||31
200370|NCT00436046|469570|P2|STARTED|Overall Study||32
200371|NCT00436046|469571|P1|STARTED|Overall Study||32
200372|NCT00436007|469603|P3|NOT COMPLETED|Overall Study||23
200373|NCT00436007|469604|P2|NOT COMPLETED|Overall Study||14
200374|NCT00436007|469605|P1|NOT COMPLETED|Overall Study||19
200375|NCT00436007|469603|P3|COMPLETED|Overall Study||148
200376|NCT00436007|469604|P2|COMPLETED|Overall Study||156
200377|NCT00436007|469605|P1|COMPLETED|Overall Study||151
200378|NCT00436007|469603|P3|STARTED|Overall Study||171
200379|NCT00436007|469604|P2|STARTED|Overall Study||170
200380|NCT00436007|469605|P1|STARTED|Overall Study||170
200381|NCT00435994|469653|P3|NOT COMPLETED|Overall Study||0
200382|NCT00435994|469654|P2|NOT COMPLETED|Overall Study||0
200383|NCT00435994|469655|P1|NOT COMPLETED|Overall Study||7
200384|NCT00435994|469653|P3|COMPLETED|Overall Study||12
200385|NCT00435994|469654|P2|COMPLETED|Overall Study||25
200386|NCT00435994|469655|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
200387|NCT00435994|469653|P3|STARTED|Overall Study||12
200388|NCT00435994|469654|P2|STARTED|Overall Study||25
200389|NCT00435994|469655|P1|STARTED|Overall Study||22
200390|NCT00435929|469666|P2|NOT COMPLETED|Overall Study||0
200391|NCT00435929|469667|P1|NOT COMPLETED|Overall Study||0
200392|NCT00435929|469666|P2|COMPLETED|Overall Study||9
200393|NCT00435929|469667|P1|COMPLETED|Overall Study||7
200394|NCT00435929|469666|P2|STARTED|Overall Study||9
200395|NCT00435929|469667|P1|STARTED|Overall Study||7
200396|NCT00435825|469697|P4|NOT COMPLETED|Overall Study||16
200397|NCT00435825|469698|P3|NOT COMPLETED|Overall Study||11
200398|NCT00435825|469699|P2|NOT COMPLETED|Overall Study||12
200399|NCT00435825|469700|P1|NOT COMPLETED|Overall Study||18
200400|NCT00435825|469697|P4|COMPLETED|Overall Study||120
200401|NCT00435825|469698|P3|COMPLETED|Overall Study||127
200402|NCT00435825|469699|P2|COMPLETED|Overall Study||124
200403|NCT00435825|469700|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
200404|NCT00435825|469697|P4|Completed 48 Weeks Treatment|Overall Study||117
200405|NCT00435825|469698|P3|Completed 48 Weeks Treatment|Overall Study||124
200406|NCT00435825|469699|P2|Completed 48 Weeks Treatment|Overall Study||0
200407|NCT00435825|469700|P1|Completed 48 Weeks Treatment|Overall Study||0
200408|NCT00435825|469697|P4|Completed 24 Weeks Treatment|Overall Study||131
200409|NCT00435825|469698|P3|Completed 24 Weeks Treatment|Overall Study||134
200410|NCT00435825|469699|P2|Completed 24 Weeks Treatment|Overall Study||126
200411|NCT00435825|469700|P1|Completed 24 Weeks Treatment|Overall Study||128
200412|NCT00435825|469697|P4|Entered Follow-up|Overall Study||133
200413|NCT00435825|469698|P3|Entered Follow-up|Overall Study||135
200414|NCT00435825|469699|P2|Entered Follow-up|Overall Study||132
200415|NCT00435825|469700|P1|Entered Follow-up|Overall Study||140
200416|NCT00435825|469697|P4|Received Study Drug|Overall Study||136
200417|NCT00435825|469698|P3|Received Study Drug|Overall Study||136
200418|NCT00435825|469699|P2|Received Study Drug|Overall Study||136
200419|NCT00435825|469700|P1|Received Study Drug|Overall Study||140
200420|NCT00435825|469697|P4|STARTED|Overall Study||136
200421|NCT00435825|469698|P3|STARTED|Overall Study||138
200422|NCT00435825|469699|P2|STARTED|Overall Study||136
200423|NCT00435825|469700|P1|STARTED|Overall Study||141
200424|NCT00435591|469758|P4|NOT COMPLETED|Overall Study||11
200425|NCT00435591|469759|P3|NOT COMPLETED|Overall Study||5
200426|NCT00435591|469760|P2|NOT COMPLETED|Overall Study||4
200427|NCT00435591|469761|P1|NOT COMPLETED|Overall Study||7
200428|NCT00435591|469758|P4|COMPLETED|Overall Study||19
200429|NCT00435591|469759|P3|COMPLETED|Overall Study||25
200430|NCT00435591|469760|P2|COMPLETED|Overall Study||27
200431|NCT00435591|469761|P1|COMPLETED|Overall Study||23
200432|NCT00435591|469758|P4|End of Treatment|Overall Study||23
200433|NCT00435591|469759|P3|End of Treatment|Overall Study||27
200434|NCT00435591|469760|P2|End of Treatment|Overall Study||27
200435|NCT00435591|469761|P1|End of Treatment|Overall Study||25
200436|NCT00435591|469758|P4|Full Analysis Set|Overall Study||29
200437|NCT00435591|469759|P3|Full Analysis Set|Overall Study||30
200438|NCT00435591|469760|P2|Full Analysis Set|Overall Study||29
200439|NCT00435591|469761|P1|Full Analysis Set|Overall Study||28
200440|NCT00435591|469758|P4|Safety Analysis Set|Overall Study||29
200441|NCT00435591|469759|P3|Safety Analysis Set|Overall Study||30
200442|NCT00435591|469760|P2|Safety Analysis Set|Overall Study||30
200443|NCT00435591|469761|P1|Safety Analysis Set|Overall Study||28
200444|NCT00435591|469758|P4|STARTED|Overall Study||30
200445|NCT00435591|469759|P3|STARTED|Overall Study||30
200446|NCT00435591|469760|P2|STARTED|Overall Study||31
200447|NCT00435591|469761|P1|STARTED|Overall Study||30
200448|NCT00435539|469791|P5|NOT COMPLETED|Overall Study||0
200449|NCT00435539|469792|P4|NOT COMPLETED|Overall Study||0
200450|NCT00435539|469793|P3|NOT COMPLETED|Overall Study||0
200451|NCT00435539|469794|P2|NOT COMPLETED|Overall Study||0
200452|NCT00435539|469795|P1|NOT COMPLETED|Overall Study||0
200453|NCT00435539|469791|P5|COMPLETED|Overall Study||12
200454|NCT00435539|469792|P4|COMPLETED|Overall Study||12
200455|NCT00435539|469793|P3|COMPLETED|Overall Study||11
200456|NCT00435539|469794|P2|COMPLETED|Overall Study||13
200457|NCT00435539|469795|P1|COMPLETED|Overall Study||12
200458|NCT00435539|469791|P5|STARTED|Overall Study||12
200459|NCT00435539|469792|P4|STARTED|Overall Study||12
200460|NCT00435539|469793|P3|STARTED|Overall Study||11
200461|NCT00435539|469794|P2|STARTED|Overall Study||13
200462|NCT00435539|469795|P1|STARTED|Overall Study||12
200463|NCT00435487|469812|P2|NOT COMPLETED|Overall Study||15
200464|NCT00435487|469813|P1|NOT COMPLETED|Overall Study||12
200465|NCT00435487|469812|P2|COMPLETED|Overall Study||71
200466|NCT00435487|469813|P1|COMPLETED|Overall Study||76
200467|NCT00435487|469812|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
200468|NCT00435487|469813|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
200469|NCT00435487|469812|P2|STARTED|Overall Study||86
200470|NCT00435487|469813|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
200471|NCT00435409|469831|P3|NOT COMPLETED|Overall Study||78
200472|NCT00435409|469832|P2|NOT COMPLETED|Overall Study||143
200473|NCT00435409|469833|P1|NOT COMPLETED|Overall Study||221
200474|NCT00435409|469831|P3|COMPLETED|Overall Study||0
200475|NCT00435409|469832|P2|COMPLETED|Overall Study||0
200476|NCT00435409|469833|P1|COMPLETED|Overall Study||0
200477|NCT00435409|469831|P3|Treated|Overall Study||78
200478|NCT00435409|469832|P2|Treated|Overall Study||139
200479|NCT00435409|469833|P1|Treated|Overall Study||217
200480|NCT00435409|469831|P3|STARTED|Overall Study||78
200481|NCT00435409|469832|P2|STARTED|Overall Study||143
200482|NCT00435409|469833|P1|STARTED|Overall Study||221
200483|NCT00435370|469855|P2|NOT COMPLETED|Overall Study||20
200484|NCT00435370|469856|P1|NOT COMPLETED|Overall Study||22
200485|NCT00435370|469855|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
200486|NCT00435370|469856|P1|COMPLETED|Overall Study||68
200487|NCT00435370|469855|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
200488|NCT00435370|469856|P1|STARTED|Overall Study||90
200489|NCT00435188|469864|P2|NOT COMPLETED|Overall Study||23
200490|NCT00435188|469865|P1|NOT COMPLETED|Overall Study||22
200491|NCT00435188|469864|P2|COMPLETED|Overall Study||176
200492|NCT00435188|469865|P1|COMPLETED|Overall Study||177
200493|NCT00435188|469864|P2|STARTED|Overall Study||199
200494|NCT00435188|469865|P1|STARTED|Overall Study||199
200495|NCT00435162|469908|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
200496|NCT00435162|469909|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
200497|NCT00435162|469910|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
200498|NCT00435162|469911|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
200499|NCT00435162|469912|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
200500|NCT00435162|469913|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
200501|NCT00435162|469908|P6|COMPLETED|Period 2 (2 Weeks)||15
200502|NCT00435162|469909|P5|COMPLETED|Period 2 (2 Weeks)||15
200503|NCT00435162|469910|P4|COMPLETED|Period 2 (2 Weeks)||8
200504|NCT00435162|469911|P3|COMPLETED|Period 2 (2 Weeks)||6
200505|NCT00435162|469912|P2|COMPLETED|Period 2 (2 Weeks)||14
200506|NCT00435162|469913|P1|COMPLETED|Period 2 (2 Weeks)||15
200507|NCT00435162|469908|P6|STARTED|Period 2 (2 Weeks)||15
200508|NCT00435162|469909|P5|STARTED|Period 2 (2 Weeks)||15
200509|NCT00435162|469910|P4|STARTED|Period 2 (2 Weeks)||8
200510|NCT00435162|469911|P3|STARTED|Period 2 (2 Weeks)||6
200511|NCT00435162|469912|P2|STARTED|Period 2 (2 Weeks)||15
200512|NCT00435162|469913|P1|STARTED|Period 2 (2 Weeks)||15
200513|NCT00435162|469908|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
200514|NCT00435162|469909|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
200515|NCT00435162|469910|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
200516|NCT00435162|469911|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
200517|NCT00435162|469912|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
200518|NCT00435162|469913|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
200519|NCT00435162|469908|P6|COMPLETED|Period 1 (6 Weeks)||15
200520|NCT00435162|469909|P5|COMPLETED|Period 1 (6 Weeks)||15
200521|NCT00435162|469910|P4|COMPLETED|Period 1 (6 Weeks)||8
200522|NCT00435162|469911|P3|COMPLETED|Period 1 (6 Weeks)||6
200523|NCT00435162|469912|P2|COMPLETED|Period 1 (6 Weeks)||15
200524|NCT00435162|469913|P1|COMPLETED|Period 1 (6 Weeks)||15
200525|NCT00435162|469908|P6|STARTED|Period 1 (6 Weeks)||15
200526|NCT00435162|469909|P5|STARTED|Period 1 (6 Weeks)||15
200527|NCT00435162|469910|P4|STARTED|Period 1 (6 Weeks)||8
200528|NCT00435162|469911|P3|STARTED|Period 1 (6 Weeks)||6
200529|NCT00435162|469912|P2|STARTED|Period 1 (6 Weeks)||15
200530|NCT00435162|469913|P1|STARTED|Period 1 (6 Weeks)||15
200531|NCT00435045|469933|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
200532|NCT00435045|469934|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
200533|NCT00435045|469933|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
200534|NCT00435045|469934|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
200535|NCT00435045|469933|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
200536|NCT00435045|469934|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
200537|NCT00435045|469933|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
200538|NCT00435045|469934|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
200539|NCT00435045|469933|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
200540|NCT00435045|469934|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
200541|NCT00435045|469933|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
200542|NCT00435045|469934|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
200543|NCT00435045|469933|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
200544|NCT00435045|469934|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
200545|NCT00435045|469933|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
200546|NCT00435045|469934|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
200547|NCT00435045|469933|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
200548|NCT00435045|469934|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
200549|NCT00435019|469990|P2|NOT COMPLETED|Overall Study||10
200550|NCT00435019|469991|P1|NOT COMPLETED|Overall Study||13
200551|NCT00435019|469990|P2|COMPLETED|Overall Study||161
200552|NCT00435019|469991|P1|COMPLETED|Overall Study||164
200553|NCT00435019|469990|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
200554|NCT00435019|469991|P1|Exposed to Study Drug|Overall Study||177
200555|NCT00435019|469990|P2|STARTED|Overall Study|Randomised|171
200556|NCT00435019|469991|P1|STARTED|Overall Study|Randomised|177
200557|NCT00434993|470003|P2|NOT COMPLETED|Overall Study||0
200558|NCT00434993|470004|P1|NOT COMPLETED|Overall Study||0
200559|NCT00434993|470003|P2|COMPLETED|Overall Study||130
200560|NCT00434993|470004|P1|COMPLETED|Overall Study||152
200561|NCT00434993|470003|P2|STARTED|Overall Study||130
200562|NCT00434993|470004|P1|STARTED|Overall Study||152
200563|NCT00434967|470032|P4|NOT COMPLETED|Overall Study||14
200564|NCT00434967|470033|P3|NOT COMPLETED|Overall Study||9
200565|NCT00434967|470034|P2|NOT COMPLETED|Overall Study||8
200566|NCT00434967|470035|P1|NOT COMPLETED|Overall Study||7
200567|NCT00434967|470032|P4|COMPLETED|Overall Study||478
200568|NCT00434967|470033|P3|COMPLETED|Overall Study||461
200569|NCT00434967|470034|P2|COMPLETED|Overall Study||457
200570|NCT00434967|470035|P1|COMPLETED|Overall Study||90
200571|NCT00434967|470032|P4|STARTED|Overall Study||492
200572|NCT00434967|470033|P3|STARTED|Overall Study||470
200573|NCT00434967|470034|P2|STARTED|Overall Study||465
200574|NCT00434967|470035|P1|STARTED|Overall Study||97
200575|NCT00434954|470055|P2|NOT COMPLETED|Overall Study||71
200576|NCT00434954|470056|P1|NOT COMPLETED|Overall Study||82
200577|NCT00434954|470055|P2|COMPLETED|Overall Study||175
200578|NCT00434954|470056|P1|COMPLETED|Overall Study||166
200579|NCT00434954|470055|P2|Completed - Previous Treatment MET + SU|Overall Study||38
200580|NCT00434954|470056|P1|Completed - Previous Treatment MET + SU|Overall Study||31
200581|NCT00434954|470055|P2|Completed - Previous Treatment MET Only|Overall Study||137
200582|NCT00434954|470056|P1|Completed - Previous Treatment MET Only|Overall Study||135
200583|NCT00434954|470055|P2|FAS - Previous Treatment MET + SU|Overall Study||60
200584|NCT00434954|470056|P1|FAS - Previous Treatment MET + SU|Overall Study||66
200585|NCT00434954|470055|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
200586|NCT00434954|470056|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
200587|NCT00434954|470055|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
200588|NCT00434954|470056|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
200589|NCT00434954|470055|P2|Started - Previous Treatment MET + SU|Overall Study||65
200590|NCT00434954|470056|P1|Started - Previous Treatment MET + SU|Overall Study||66
200591|NCT00434954|470055|P2|Started - Previous Treatment MET Only|Overall Study||181
200592|NCT00434954|470056|P1|Started - Previous Treatment MET Only|Overall Study||182
200593|NCT00434954|470055|P2|STARTED|Overall Study||246
200594|NCT00434954|470056|P1|STARTED|Overall Study||248
200595|NCT00434876|470086|P2|NOT COMPLETED|Overall Study||1
200596|NCT00434876|470087|P1|NOT COMPLETED|Overall Study||1
200597|NCT00434876|470086|P2|COMPLETED|Overall Study||10
200598|NCT00434876|470087|P1|COMPLETED|Overall Study||10
200599|NCT00434876|470086|P2|STARTED|Overall Study||11
200600|NCT00434876|470087|P1|STARTED|Overall Study||11
200601|NCT00434759|470101|P2|NOT COMPLETED|Overall Study||5
200602|NCT00434759|470102|P1|NOT COMPLETED|Overall Study||24
200603|NCT00434759|470101|P2|COMPLETED|Overall Study||38
200604|NCT00434759|470102|P1|COMPLETED|Overall Study||22
200605|NCT00434759|470101|P2|STARTED|Overall Study||43
200606|NCT00434759|470102|P1|STARTED|Overall Study||46
200607|NCT00434642|470118|P2|NOT COMPLETED|Open-label Treatment Phase||11
200608|NCT00434642|470119|P1|NOT COMPLETED|Open-label Treatment Phase||0
200609|NCT00434642|470118|P2|COMPLETED|Open-label Treatment Phase||1
200610|NCT00434642|470119|P1|COMPLETED|Open-label Treatment Phase||0
200611|NCT00434642|470118|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
200612|NCT00434642|470119|P1|STARTED|Open-label Treatment Phase||0
200613|NCT00434642|470118|P2|NOT COMPLETED|Blinded Treatment Phase||229
200614|NCT00434642|470119|P1|NOT COMPLETED|Blinded Treatment Phase||242
200615|NCT00434642|470118|P2|COMPLETED|Blinded Treatment Phase||13
200616|NCT00434642|470119|P1|COMPLETED|Blinded Treatment Phase||0
200617|NCT00434642|470118|P2|STARTED|Blinded Treatment Phase||242
200618|NCT00434642|470119|P1|STARTED|Blinded Treatment Phase||242
200619|NCT00434590|470137|P2|NOT COMPLETED|Overall Study||5
200620|NCT00434590|470138|P1|NOT COMPLETED|Overall Study||5
200621|NCT00434590|470137|P2|COMPLETED|Overall Study||0
200622|NCT00434590|470138|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
200623|NCT00434590|470137|P2|STARTED|Overall Study||5
200624|NCT00434590|470138|P1|STARTED|Overall Study||5
200625|NCT00434434|470147|P3|NOT COMPLETED|Overall Study||1
200626|NCT00434434|470148|P2|NOT COMPLETED|Overall Study||0
200627|NCT00434434|470149|P1|NOT COMPLETED|Overall Study||2
200628|NCT00434434|470147|P3|COMPLETED|Overall Study||13
200629|NCT00434434|470148|P2|COMPLETED|Overall Study||24
200630|NCT00434434|470149|P1|COMPLETED|Overall Study||21
200631|NCT00434434|470147|P3|STARTED|Overall Study||14
200632|NCT00434434|470148|P2|STARTED|Overall Study||24
200633|NCT00434434|470149|P1|STARTED|Overall Study||23
200634|NCT00434421|470160|P1|NOT COMPLETED|Overall Study||2
200635|NCT00434421|470160|P1|COMPLETED|Overall Study||26
200636|NCT00434421|470160|P1|STARTED|Overall Study||28
200637|NCT00434356|470166|P2|NOT COMPLETED|Overall Study||23
200638|NCT00434356|470167|P1|NOT COMPLETED|Overall Study||23
200639|NCT00434356|470166|P2|COMPLETED|Overall Study||0
200640|NCT00434356|470167|P1|COMPLETED|Overall Study||0
200641|NCT00434356|470166|P2|STARTED|Overall Study||23
200642|NCT00434356|470167|P1|STARTED|Overall Study||23
200643|NCT00434330|470188|P6|NOT COMPLETED|Overall Study||1
200644|NCT00434330|470189|P5|NOT COMPLETED|Overall Study||1
200645|NCT00434330|470190|P4|NOT COMPLETED|Overall Study||2
200646|NCT00434330|470191|P3|NOT COMPLETED|Overall Study||3
200647|NCT00434330|470192|P2|NOT COMPLETED|Overall Study||0
200648|NCT00434330|470193|P1|NOT COMPLETED|Overall Study||1
200649|NCT00434330|470188|P6|COMPLETED|Overall Study||14
200650|NCT00434330|470189|P5|COMPLETED|Overall Study||14
200651|NCT00434330|470190|P4|COMPLETED|Overall Study||13
200652|NCT00434330|470191|P3|COMPLETED|Overall Study||13
200653|NCT00434330|470192|P2|COMPLETED|Overall Study||15
200654|NCT00434330|470193|P1|COMPLETED|Overall Study||14
200655|NCT00434330|470188|P6|STARTED|Overall Study||15
200656|NCT00434330|470189|P5|STARTED|Overall Study||15
200657|NCT00434330|470190|P4|STARTED|Overall Study||15
200658|NCT00434330|470191|P3|STARTED|Overall Study||16
200659|NCT00434330|470192|P2|STARTED|Overall Study||15
200660|NCT00434330|470193|P1|STARTED|Overall Study||15
200661|NCT00434304|470225|P1|NOT COMPLETED|Overall Study||20
200662|NCT00434304|470225|P1|COMPLETED|Overall Study||42
200663|NCT00434304|470225|P1|STARTED|Overall Study||62
200664|NCT00434278|470263|P2|NOT COMPLETED|Overall Study||0
200665|NCT00434278|470264|P1|NOT COMPLETED|Overall Study||2
200666|NCT00434278|470263|P2|COMPLETED|Overall Study||13
200667|NCT00434278|470264|P1|COMPLETED|Overall Study||12
200668|NCT00434278|470263|P2|STARTED|Overall Study||13
200669|NCT00434278|470264|P1|STARTED|Overall Study||14
200670|NCT00434252|470274|P2|NOT COMPLETED|Overall Study||131
200671|NCT00434252|470275|P1|NOT COMPLETED|Overall Study||64
200672|NCT00434252|470274|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
200673|NCT00434252|470275|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
200674|NCT00434252|470274|P2|Treated|Overall Study||143
200675|NCT00434252|470275|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
200676|NCT00434252|470274|P2|STARTED|Overall Study||143
200677|NCT00434252|470275|P1|STARTED|Overall Study||71
200678|NCT00434226|470297|P2|NOT COMPLETED|Overall Study||26
200679|NCT00434226|470298|P1|NOT COMPLETED|Overall Study||30
200680|NCT00434226|470297|P2|COMPLETED|Overall Study||0
200681|NCT00434226|470298|P1|COMPLETED|Overall Study||0
200682|NCT00434226|470297|P2|STARTED|Overall Study||26
200683|NCT00434226|470298|P1|STARTED|Overall Study||30
200684|NCT00434213|470309|P1|NOT COMPLETED|Overall Study||49
200685|NCT00434213|470309|P1|COMPLETED|Overall Study||260
200686|NCT00434213|470309|P1|STARTED|Overall Study||309
200687|NCT00434161|470317|P3|NOT COMPLETED|Overall Study||11
200688|NCT00434161|470318|P2|NOT COMPLETED|Overall Study||3
200689|NCT00434161|470319|P1|NOT COMPLETED|Overall Study||10
200690|NCT00434161|470317|P3|COMPLETED|Overall Study||104
200691|NCT00434161|470318|P2|COMPLETED|Overall Study||54
200692|NCT00434161|470319|P1|COMPLETED|Overall Study||99
200693|NCT00434161|470317|P3|STARTED|Overall Study||115
200694|NCT00434161|470318|P2|STARTED|Overall Study||57
200695|NCT00434161|470319|P1|STARTED|Overall Study||109
200696|NCT00434148|470363|P2|NOT COMPLETED|Overall Study||73
200697|NCT00434148|470364|P1|NOT COMPLETED|Overall Study||69
200698|NCT00434148|470363|P2|COMPLETED|Overall Study||7
200699|NCT00434148|470364|P1|COMPLETED|Overall Study||13
200700|NCT00434148|470363|P2|Completed Month 12; Entered Extension|Overall Study||32
200701|NCT00434148|470364|P1|Completed Month 12; Entered Extension|Overall Study||26
200702|NCT00434148|470363|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
200703|NCT00434148|470364|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
200704|NCT00434148|470363|P2|Completed Month 12|Overall Study||39
200705|NCT00434148|470364|P1|Completed Month 12|Overall Study||39
200706|NCT00434148|470363|P2|STARTED|Overall Study||80
200707|NCT00434148|470364|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
200708|NCT00434122|470400|P2|NOT COMPLETED|Overall Study||7
200709|NCT00434122|470401|P1|NOT COMPLETED|Overall Study||6
200710|NCT00434122|470400|P2|COMPLETED|Overall Study||36
200711|NCT00434122|470401|P1|COMPLETED|Overall Study||36
200712|NCT00434122|470400|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
200713|NCT00434122|470401|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
200714|NCT00434122|470400|P2|STARTED|Overall Study|Randomised|43
200715|NCT00434122|470401|P1|STARTED|Overall Study|Randomised|42
200716|NCT00434109|470410|P1|NOT COMPLETED|Overall Study||18
200717|NCT00434109|470410|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
200718|NCT00434109|470410|P1|STARTED|Overall Study||39
200719|NCT00434057|470419|P1|NOT COMPLETED|Overall Study||1
200720|NCT00434057|470419|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
200721|NCT00434057|470419|P1|STARTED|Overall Study||1383
200722|NCT00434018|470425|P2|NOT COMPLETED|Overall Study||12
200723|NCT00434018|470426|P1|NOT COMPLETED|Overall Study||17
200724|NCT00434018|470425|P2|COMPLETED|Overall Study||57
200725|NCT00434018|470426|P1|COMPLETED|Overall Study||52
200726|NCT00434018|470425|P2|STARTED|Overall Study||69
200727|NCT00434018|470426|P1|STARTED|Overall Study||69
200728|NCT00433914|470444|P2|NOT COMPLETED|Overall Study||3
200729|NCT00433914|470445|P1|NOT COMPLETED|Overall Study||0
200730|NCT00433914|470444|P2|COMPLETED|Overall Study||27
200731|NCT00433914|470445|P1|COMPLETED|Overall Study||30
200732|NCT00433914|470444|P2|STARTED|Overall Study||30
200733|NCT00433914|470445|P1|STARTED|Overall Study||30
200734|NCT00433836|470465|P2|NOT COMPLETED|Overall Study||6
200735|NCT00433836|470466|P1|NOT COMPLETED|Overall Study||13
200736|NCT00433836|470465|P2|COMPLETED|Overall Study||143
200737|NCT00433836|470466|P1|COMPLETED|Overall Study||138
200738|NCT00433836|470465|P2|STARTED|Overall Study||149
200739|NCT00433836|470466|P1|STARTED|Overall Study||151
200740|NCT00433771|470478|P1|NOT COMPLETED|Overall Study||19
200741|NCT00433771|470478|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
200742|NCT00433771|470478|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
200743|NCT00433745|470494|P1|NOT COMPLETED|Overall Study||0
200744|NCT00433745|470494|P1|COMPLETED|Overall Study||4
200745|NCT00433745|470494|P1|STARTED|Overall Study||4
200746|NCT00433654|470501|P2|NOT COMPLETED|Overall Study||5
200747|NCT00433654|470502|P1|NOT COMPLETED|Overall Study||15
200748|NCT00433654|470501|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
200749|NCT00433654|470502|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
200750|NCT00433654|470501|P2|STARTED|Overall Study||206
200751|NCT00433654|470502|P1|STARTED|Overall Study||258
200752|NCT00433537|470533|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
200753|NCT00433537|470534|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
200754|NCT00433537|470535|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
200755|NCT00433537|470533|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
200756|NCT00433537|470534|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
200757|NCT00433537|470535|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
200758|NCT00433537|470533|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
200759|NCT00433537|470534|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
200760|NCT00433537|470535|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
200761|NCT00433537|470533|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
200762|NCT00433537|470534|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
200763|NCT00433537|470535|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
200764|NCT00433537|470533|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
200765|NCT00433537|470534|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
200766|NCT00433537|470535|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
200767|NCT00433537|470533|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
200768|NCT00433537|470534|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
200769|NCT00433537|470535|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
200770|NCT00433537|470533|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
200771|NCT00433537|470534|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
200772|NCT00433537|470535|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
200773|NCT00433537|470533|P3|STARTED|Step 1 - VcR-CVAD Induction||10
200774|NCT00433537|470534|P2|STARTED|Step 1 - VcR-CVAD Induction||22
200775|NCT00433537|470535|P1|STARTED|Step 1 - VcR-CVAD Induction||45
200776|NCT00433446|470544|P1|NOT COMPLETED|Overall Study||61
200777|NCT00433446|470544|P1|COMPLETED|Overall Study||1
200778|NCT00433446|470544|P1|Eligible and Began Protocol Therapy|Overall Study||53
200779|NCT00433446|470544|P1|Eligible|Overall Study||53
200780|NCT00433446|470544|P1|STARTED|Overall Study||62
200781|NCT00433381|470554|P2|NOT COMPLETED|Overall Study||3
200782|NCT00433381|470555|P1|NOT COMPLETED|Overall Study||5
200783|NCT00433381|470554|P2|COMPLETED|Overall Study||57
200784|NCT00433381|470555|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
200785|NCT00433381|470554|P2|STARTED|Overall Study||60
200786|NCT00433381|470555|P1|STARTED|Overall Study||63
200787|NCT00433329|470561|P1|NOT COMPLETED|Overall Study||21
200788|NCT00433329|470561|P1|COMPLETED|Overall Study||79
200789|NCT00433329|470561|P1|STARTED|Overall Study||100
200790|NCT00433290|470567|P2|NOT COMPLETED|Overall Study||17
200791|NCT00433290|470568|P1|NOT COMPLETED|Overall Study||35
200792|NCT00433290|470567|P2|COMPLETED|Overall Study||111
200793|NCT00433290|470568|P1|COMPLETED|Overall Study||93
200794|NCT00433290|470567|P2|STARTED|Overall Study||128
200795|NCT00433290|470568|P1|STARTED|Overall Study||128
200796|NCT00432237|470639|P4|NOT COMPLETED|Overall Study||124
200797|NCT00432237|470640|P3|NOT COMPLETED|Overall Study||109
200798|NCT00432237|470641|P2|NOT COMPLETED|Overall Study||101
200799|NCT00432237|470642|P1|NOT COMPLETED|Overall Study||67
200800|NCT00432237|470639|P4|COMPLETED|Overall Study||366
200801|NCT00432237|470640|P3|COMPLETED|Overall Study||375
200802|NCT00432237|470641|P2|COMPLETED|Overall Study||384
200803|NCT00432237|470642|P1|COMPLETED|Overall Study||177
200804|NCT00432237|470639|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
200805|NCT00432237|470640|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
200806|NCT00432237|470641|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
200807|NCT00432237|470642|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
200808|NCT00432237|470639|P4|Completed--With Data|Overall Study||365
200809|NCT00432237|470640|P3|Completed--With Data|Overall Study||370
200810|NCT00432237|470641|P2|Completed--With Data|Overall Study||381
200811|NCT00432237|470642|P1|Completed--With Data|Overall Study||176
200812|NCT00432237|470639|P4|STARTED|Overall Study||490
200813|NCT00432237|470640|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
200814|NCT00432237|470641|P2|STARTED|Overall Study||485
200815|NCT00432237|470642|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
200816|NCT00431184|470682|P2|NOT COMPLETED|Second Intervention (Day 2)||0
200817|NCT00431184|470683|P1|NOT COMPLETED|Second Intervention (Day 2)||0
200818|NCT00431184|470682|P2|COMPLETED|Second Intervention (Day 2)||9
200819|NCT00431184|470683|P1|COMPLETED|Second Intervention (Day 2)||10
200820|NCT00431184|470682|P2|STARTED|Second Intervention (Day 2)||9
200821|NCT00431184|470683|P1|STARTED|Second Intervention (Day 2)||10
200822|NCT00431184|470682|P2|NOT COMPLETED|1st Intervention (Day 1)||0
200823|NCT00431184|470683|P1|NOT COMPLETED|1st Intervention (Day 1)||0
200824|NCT00431184|470682|P2|COMPLETED|1st Intervention (Day 1)||9
200825|NCT00431184|470683|P1|COMPLETED|1st Intervention (Day 1)||10
200826|NCT00431184|470682|P2|STARTED|1st Intervention (Day 1)||9
200827|NCT00431184|470683|P1|STARTED|1st Intervention (Day 1)||10
200828|NCT00431132|470691|P1|NOT COMPLETED|Overall Study||44
200829|NCT00431132|470691|P1|COMPLETED|Overall Study||292
200830|NCT00431132|470691|P1|STARTED|Overall Study||336
200831|NCT00431067|470696|P1|NOT COMPLETED|Overall Study||41
200832|NCT00431067|470696|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
200833|NCT00431067|470696|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
200834|NCT00431041|470706|P2|NOT COMPLETED|Overall Study||24
200835|NCT00431041|470707|P1|NOT COMPLETED|Overall Study||16
200836|NCT00431041|470706|P2|COMPLETED|Overall Study||40
200837|NCT00431041|470707|P1|COMPLETED|Overall Study||52
200838|NCT00431041|470706|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
200839|NCT00431041|470707|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
200840|NCT00433199|470721|P2|NOT COMPLETED|Open-Label Period||34
200841|NCT00433199|470722|P1|NOT COMPLETED|Open-Label Period||0
200842|NCT00433199|470721|P2|COMPLETED|Open-Label Period||185
200843|NCT00433199|470722|P1|COMPLETED|Open-Label Period||0
200844|NCT00433199|470721|P2|STARTED|Open-Label Period||219
200845|NCT00433199|470722|P1|STARTED|Open-Label Period||0
200846|NCT00433199|470721|P2|NOT COMPLETED|Double-Blind Period||66
200847|NCT00433199|470722|P1|NOT COMPLETED|Double-Blind Period||12
200848|NCT00433199|470721|P2|COMPLETED|Double-Blind Period||168
200849|NCT00433199|470722|P1|COMPLETED|Double-Blind Period||28
200850|NCT00433199|470721|P2|STARTED|Double-Blind Period||234
200851|NCT00433199|470722|P1|STARTED|Double-Blind Period||40
200852|NCT00433160|470742|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
200853|NCT00433160|470743|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
200854|NCT00433160|470742|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
200855|NCT00433160|470743|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
200856|NCT00433160|470742|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
200857|NCT00433160|470743|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
200939|NCT00432601|471078|P1|COMPLETED|Time 2 to Time 3||122
200858|NCT00433160|470742|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
200859|NCT00433160|470743|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
200860|NCT00433160|470742|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
200861|NCT00433160|470743|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
200862|NCT00433160|470742|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
200863|NCT00433160|470743|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
200864|NCT00433160|470742|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
200865|NCT00433160|470743|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
200866|NCT00433160|470742|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
200867|NCT00433160|470743|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
200868|NCT00433160|470742|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
200869|NCT00433160|470743|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
200870|NCT00433160|470742|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
200871|NCT00433160|470743|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
200872|NCT00433160|470742|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
200873|NCT00433160|470743|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
200874|NCT00433160|470742|P2|STARTED|52-Week Double-Blind (DB) Period||70
200875|NCT00433160|470743|P1|STARTED|52-Week Double-Blind (DB) Period||137
200876|NCT00433017|470793|P2|NOT COMPLETED|Overall Study||101
200877|NCT00433017|470794|P1|NOT COMPLETED|Overall Study||96
200878|NCT00433017|470793|P2|COMPLETED|Overall Study||32
200879|NCT00433017|470794|P1|COMPLETED|Overall Study||26
200880|NCT00433017|470793|P2|Completed 12 Month Phase|Overall Study||126
200881|NCT00433017|470794|P1|Completed 12 Month Phase|Overall Study||114
200882|NCT00433017|470793|P2|STARTED|Overall Study||133
200883|NCT00433017|470794|P1|STARTED|Overall Study||122
200884|NCT00432835|470810|P2|NOT COMPLETED|Overall Study||7
200885|NCT00432835|470811|P1|NOT COMPLETED|Overall Study||6
200886|NCT00432835|470810|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
200887|NCT00432835|470811|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
200888|NCT00432835|470810|P2|Completed 2nd Intervention|Overall Study||23
200889|NCT00432835|470811|P1|Completed 2nd Intervention|Overall Study||22
200890|NCT00432835|470810|P2|Completed 1st Intervention|Overall Study||23
200891|NCT00432835|470811|P1|Completed 1st Intervention|Overall Study||22
200892|NCT00432835|470810|P2|STARTED|Overall Study||30
200893|NCT00432835|470811|P1|STARTED|Overall Study||28
200894|NCT00432809|470824|P3|NOT COMPLETED|2 Year Sub-study||1
200895|NCT00432809|470825|P2|NOT COMPLETED|2 Year Sub-study||2
200896|NCT00432809|470826|P1|NOT COMPLETED|2 Year Sub-study||3
200897|NCT00432809|470824|P3|COMPLETED|2 Year Sub-study||19
200898|NCT00432809|470825|P2|COMPLETED|2 Year Sub-study||18
200899|NCT00432809|470826|P1|COMPLETED|2 Year Sub-study||17
200900|NCT00432809|470824|P3|STARTED|2 Year Sub-study||20
200901|NCT00432809|470825|P2|STARTED|2 Year Sub-study||20
200902|NCT00432809|470826|P1|STARTED|2 Year Sub-study||20
200903|NCT00432809|470824|P3|NOT COMPLETED|1 Year Follow-up||1
200904|NCT00432809|470825|P2|NOT COMPLETED|1 Year Follow-up||0
200905|NCT00432809|470826|P1|NOT COMPLETED|1 Year Follow-up||9
200906|NCT00432809|470824|P3|COMPLETED|1 Year Follow-up||49
200907|NCT00432809|470825|P2|COMPLETED|1 Year Follow-up||50
200908|NCT00432809|470826|P1|COMPLETED|1 Year Follow-up||41
200909|NCT00432809|470824|P3|STARTED|1 Year Follow-up||50
200910|NCT00432809|470825|P2|STARTED|1 Year Follow-up||50
200911|NCT00432809|470826|P1|STARTED|1 Year Follow-up||50
200912|NCT00432744|470899|P2|NOT COMPLETED|Months 7 - 12||1
200913|NCT00432744|470900|P1|NOT COMPLETED|Months 7 - 12||1
200914|NCT00432744|470899|P2|COMPLETED|Months 7 - 12||7
200915|NCT00432744|470900|P1|COMPLETED|Months 7 - 12||6
200916|NCT00432744|470899|P2|STARTED|Months 7 - 12||8
200917|NCT00432744|470900|P1|STARTED|Months 7 - 12||7
200918|NCT00432744|470899|P2|NOT COMPLETED|Months 0-6||4
200919|NCT00432744|470900|P1|NOT COMPLETED|Months 0-6||5
200920|NCT00432744|470899|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
200921|NCT00432744|470900|P1|COMPLETED|Months 0-6||7
200922|NCT00432744|470899|P2|STARTED|Months 0-6||12
200923|NCT00432744|470900|P1|STARTED|Months 0-6||12
200924|NCT00432666|470912|P2|NOT COMPLETED|Open-Label Extension Period||0
200925|NCT00432666|470913|P1|NOT COMPLETED|Open-Label Extension Period||25
200926|NCT00432666|470912|P2|COMPLETED|Open-Label Extension Period||0
200927|NCT00432666|470913|P1|COMPLETED|Open-Label Extension Period||120
200928|NCT00432666|470912|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
200929|NCT00432666|470913|P1|STARTED|Open-Label Extension Period||145
200930|NCT00432666|470912|P2|NOT COMPLETED|Main Period||1
200931|NCT00432666|470913|P1|NOT COMPLETED|Main Period||2
200932|NCT00432666|470912|P2|COMPLETED|Main Period||74
200933|NCT00432666|470913|P1|COMPLETED|Main Period||71
200934|NCT00432666|470912|P2|STARTED|Main Period||75
200935|NCT00432666|470913|P1|STARTED|Main Period||73
200936|NCT00432601|471077|P2|NOT COMPLETED|Time 2 to Time 3||22
200937|NCT00432601|471078|P1|NOT COMPLETED|Time 2 to Time 3||19
200938|NCT00432601|471077|P2|COMPLETED|Time 2 to Time 3||122
200940|NCT00432601|471077|P2|STARTED|Time 2 to Time 3||144
200941|NCT00432601|471078|P1|STARTED|Time 2 to Time 3||141
200942|NCT00432601|471077|P2|NOT COMPLETED|Time 1 to Time 2||368
200943|NCT00432601|471078|P1|NOT COMPLETED|Time 1 to Time 2||369
200944|NCT00432601|471077|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
200945|NCT00432601|471078|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
200946|NCT00432601|471077|P2|STARTED|Time 1 to Time 2||512
200947|NCT00432601|471078|P1|STARTED|Time 1 to Time 2||510
200948|NCT00432562|471086|P2|NOT COMPLETED|Overall Study||0
200949|NCT00432562|471087|P1|NOT COMPLETED|Overall Study||3
200950|NCT00432562|471086|P2|COMPLETED|Overall Study||15
200951|NCT00432562|471087|P1|COMPLETED|Overall Study||13
200952|NCT00432562|471086|P2|STARTED|Overall Study||15
200953|NCT00432562|471087|P1|STARTED|Overall Study||16
200954|NCT00432458|471113|P2|NOT COMPLETED|Overall Study||1
200955|NCT00432458|471114|P1|NOT COMPLETED|Overall Study||5
200956|NCT00432458|471113|P2|COMPLETED|Overall Study||32
200957|NCT00432458|471114|P1|COMPLETED|Overall Study||30
200958|NCT00432458|471113|P2|STARTED|Overall Study||33
200959|NCT00432458|471114|P1|STARTED|Overall Study||35
200960|NCT00432445|471132|P1|NOT COMPLETED|Overall Study||0
200961|NCT00432445|471132|P1|COMPLETED|Overall Study||2
200962|NCT00432445|471132|P1|STARTED|Overall Study||2
200963|NCT00432341|471138|P2|NOT COMPLETED|Overall Study||0
200964|NCT00432341|471139|P1|NOT COMPLETED|Overall Study||0
200965|NCT00432341|471138|P2|COMPLETED|Overall Study||30
200966|NCT00432341|471139|P1|COMPLETED|Overall Study||24
200967|NCT00432341|471138|P2|STARTED|Overall Study||30
200968|NCT00432341|471139|P1|STARTED|Overall Study||24
200969|NCT00432276|471165|P2|NOT COMPLETED|Overall Study||156
200970|NCT00432276|471166|P1|NOT COMPLETED|Overall Study||121
200971|NCT00432276|471165|P2|COMPLETED|Overall Study||243
200972|NCT00432276|471166|P1|COMPLETED|Overall Study||283
200973|NCT00432276|471165|P2|Per Protocol Set|Overall Study||306
200974|NCT00432276|471166|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
200975|NCT00432276|471165|P2|STARTED|Overall Study||399
200976|NCT00432276|471166|P1|STARTED|Overall Study||404
200977|NCT00432159|471257|P5|NOT COMPLETED|Overall Study||10
200978|NCT00432159|471258|P4|NOT COMPLETED|Overall Study||5
200979|NCT00432159|471259|P3|NOT COMPLETED|Overall Study||4
200980|NCT00432159|471260|P2|NOT COMPLETED|Overall Study||30
200981|NCT00432159|471261|P1|NOT COMPLETED|Overall Study||22
200982|NCT00432159|471257|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
200983|NCT00432159|471258|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
200984|NCT00432159|471259|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
200985|NCT00432159|471260|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
200986|NCT00432159|471261|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
200987|NCT00432159|471257|P5|STARTED|Overall Study||89
200988|NCT00432159|471258|P4|STARTED|Overall Study||20
200989|NCT00432159|471259|P3|STARTED|Overall Study||39
200990|NCT00432159|471260|P2|STARTED|Overall Study||167
200991|NCT00432159|471261|P1|STARTED|Overall Study||185
200992|NCT00431964|471367|P2|NOT COMPLETED|Overall Study||8
200993|NCT00431964|471368|P1|NOT COMPLETED|Overall Study||6
200994|NCT00431964|471367|P2|COMPLETED|Overall Study||124
200995|NCT00431964|471368|P1|COMPLETED|Overall Study||125
200996|NCT00431964|471367|P2|Withdrew From Study|Overall Study||5
200997|NCT00431964|471368|P1|Withdrew From Study|Overall Study||6
200998|NCT00431964|471367|P2|Did Not Receive Drug|Overall Study||3
200999|NCT00431964|471368|P1|Did Not Receive Drug|Overall Study||0
201000|NCT00431964|471367|P2|Randomized/Received Drug|Overall Study||129
201001|NCT00431964|471368|P1|Randomized/Received Drug|Overall Study||131
201002|NCT00431964|471367|P2|STARTED|Overall Study||132
201003|NCT00431964|471368|P1|STARTED|Overall Study||131
201004|NCT00431951|471378|P4|NOT COMPLETED|Overall Study||2
201005|NCT00431951|471379|P3|NOT COMPLETED|Overall Study||2
201006|NCT00431951|471380|P2|NOT COMPLETED|Overall Study||2
201007|NCT00431951|471381|P1|NOT COMPLETED|Overall Study||1
201008|NCT00431951|471378|P4|COMPLETED|Overall Study||4
201009|NCT00431951|471379|P3|COMPLETED|Overall Study||6
201010|NCT00431951|471380|P2|COMPLETED|Overall Study||6
201011|NCT00431951|471381|P1|COMPLETED|Overall Study||7
201012|NCT00431951|471378|P4|STARTED|Overall Study||6
201013|NCT00431951|471379|P3|STARTED|Overall Study||8
201014|NCT00431951|471380|P2|STARTED|Overall Study||8
201015|NCT00431951|471381|P1|STARTED|Overall Study||8
201016|NCT00431834|471439|P1|NOT COMPLETED|Overall Study||13
201017|NCT00431834|471439|P1|COMPLETED|Overall Study||62
201018|NCT00431834|471439|P1|STARTED|Overall Study||75
201019|NCT00431626|471448|P2|NOT COMPLETED|Overall Study||0
201020|NCT00431626|471449|P1|NOT COMPLETED|Overall Study||0
201021|NCT00431626|471448|P2|COMPLETED|Overall Study||0
201022|NCT00431626|471449|P1|COMPLETED|Overall Study||4
201023|NCT00431626|471448|P2|STARTED|Overall Study||0
201024|NCT00431626|471449|P1|STARTED|Overall Study||4
201025|NCT00431496|471455|P1|NOT COMPLETED|Overall Study||11
201026|NCT00431496|471455|P1|COMPLETED|Overall Study||60
201027|NCT00431496|471455|P1|STARTED|Overall Study||71
201028|NCT00431444|471466|P2|NOT COMPLETED|Overall Study||7
201029|NCT00431444|471467|P1|NOT COMPLETED|Overall Study||5
201030|NCT00431444|471466|P2|COMPLETED|Overall Study||46
201031|NCT00431444|471467|P1|COMPLETED|Overall Study||51
201032|NCT00431444|471466|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
201033|NCT00431444|471467|P1|STARTED|Overall Study||56
201034|NCT00430950|471493|P2|NOT COMPLETED|Overall Study||13
201035|NCT00430950|471494|P1|NOT COMPLETED|Overall Study||13
201036|NCT00430950|471493|P2|COMPLETED|Overall Study||495
201037|NCT00430950|471494|P1|COMPLETED|Overall Study||489
201038|NCT00430950|471493|P2|STARTED|Overall Study||508
201039|NCT00430950|471494|P1|STARTED|Overall Study||502
201040|NCT00430937|471510|P2|NOT COMPLETED|Overall Study||28
201041|NCT00430937|471511|P1|NOT COMPLETED|Overall Study||27
201042|NCT00430937|471510|P2|COMPLETED|Overall Study||64
201043|NCT00430937|471511|P1|COMPLETED|Overall Study||70
201044|NCT00430937|471510|P2|STARTED|Overall Study||92
201045|NCT00430937|471511|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
201046|NCT00430781|471522|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
201047|NCT00430781|471523|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
201048|NCT00430781|471524|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
201049|NCT00430781|471522|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
201050|NCT00430781|471523|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
201051|NCT00430781|471524|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
201052|NCT00430781|471522|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
201053|NCT00430781|471523|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
201054|NCT00430781|471524|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
201055|NCT00430781|471522|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
201056|NCT00430781|471523|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
201057|NCT00430781|471524|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
201058|NCT00430781|471522|P3|COMPLETED|Final Analysis; 31 July 2008||26
201059|NCT00430781|471523|P2|COMPLETED|Final Analysis; 31 July 2008||39
201060|NCT00430781|471524|P1|COMPLETED|Final Analysis; 31 July 2008||0
201061|NCT00430781|471522|P3|Ongoing|Final Analysis; 31 July 2008||32
201062|NCT00430781|471523|P2|Ongoing|Final Analysis; 31 July 2008||29
201063|NCT00430781|471524|P1|Ongoing|Final Analysis; 31 July 2008||0
201064|NCT00430781|471522|P3|STARTED|Final Analysis; 31 July 2008||74
201065|NCT00430781|471523|P2|STARTED|Final Analysis; 31 July 2008||78
201066|NCT00430781|471524|P1|STARTED|Final Analysis; 31 July 2008||0
201067|NCT00430781|471522|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
201068|NCT00430781|471523|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
201069|NCT00430781|471524|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
201070|NCT00430781|471522|P3|COMPLETED|Interim Analysis; 11 February 2008||0
201071|NCT00430781|471523|P2|COMPLETED|Interim Analysis; 11 February 2008||0
201072|NCT00430781|471524|P1|COMPLETED|Interim Analysis; 11 February 2008||0
201073|NCT00430781|471522|P3|Ongoing|Interim Analysis; 11 February 2008||25
201074|NCT00430781|471523|P2|Ongoing|Interim Analysis; 11 February 2008||20
201075|NCT00430781|471524|P1|Ongoing|Interim Analysis; 11 February 2008||23
201076|NCT00430781|471522|P3|STARTED|Interim Analysis; 11 February 2008||60
201077|NCT00430781|471523|P2|STARTED|Interim Analysis; 11 February 2008||58
201078|NCT00430781|471524|P1|STARTED|Interim Analysis; 11 February 2008||59
201079|NCT00430768|471550|P3|NOT COMPLETED|Overall Study||0
201080|NCT00430768|471551|P2|NOT COMPLETED|Overall Study||0
201081|NCT00430768|471552|P1|NOT COMPLETED|Overall Study||0
201082|NCT00430768|471550|P3|COMPLETED|Overall Study||3
201083|NCT00430768|471551|P2|COMPLETED|Overall Study||3
201084|NCT00430768|471552|P1|COMPLETED|Overall Study||3
201085|NCT00430768|471550|P3|STARTED|Overall Study||3
201086|NCT00430768|471551|P2|STARTED|Overall Study||3
201087|NCT00430768|471552|P1|STARTED|Overall Study||3
201088|NCT00430755|471566|P1|NOT COMPLETED|Overall Study||53
201089|NCT00430755|471566|P1|COMPLETED|Overall Study||45
201090|NCT00430755|471566|P1|STARTED|Overall Study||98
201091|NCT00430716|471573|P3|NOT COMPLETED|Open Label Phase||7
201092|NCT00430716|471574|P2|NOT COMPLETED|Open Label Phase||7
201093|NCT00430716|471575|P1|NOT COMPLETED|Open Label Phase||9
201094|NCT00430716|471573|P3|COMPLETED|Open Label Phase||32
201095|NCT00430716|471574|P2|COMPLETED|Open Label Phase||31
201096|NCT00430716|471575|P1|COMPLETED|Open Label Phase||27
201097|NCT00430716|471573|P3|STARTED|Open Label Phase||39
201098|NCT00430716|471574|P2|STARTED|Open Label Phase||38
201099|NCT00430716|471575|P1|STARTED|Open Label Phase||36
201100|NCT00430716|471573|P3|NOT COMPLETED|Double Blind Phase||6
201101|NCT00430716|471574|P2|NOT COMPLETED|Double Blind Phase||5
201102|NCT00430716|471575|P1|NOT COMPLETED|Double Blind Phase||6
201103|NCT00430716|471573|P3|COMPLETED|Double Blind Phase||39
201104|NCT00430716|471574|P2|COMPLETED|Double Blind Phase||38
201105|NCT00430716|471575|P1|COMPLETED|Double Blind Phase||36
201106|NCT00430716|471573|P3|Treated|Double Blind Phase||45
201107|NCT00430716|471574|P2|Treated|Double Blind Phase||43
201108|NCT00430716|471575|P1|Treated|Double Blind Phase||41
201109|NCT00430716|471573|P3|STARTED|Double Blind Phase||45
201110|NCT00430716|471574|P2|STARTED|Double Blind Phase||43
201111|NCT00430716|471575|P1|STARTED|Double Blind Phase||42
201112|NCT00430677|471607|P3|NOT COMPLETED|Long-term Extension Period||63
201113|NCT00430677|471608|P2|NOT COMPLETED|Long-term Extension Period||58
201114|NCT00430677|471609|P1|NOT COMPLETED|Long-term Extension Period||60
201115|NCT00430677|471607|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
201116|NCT00430677|471608|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
201117|NCT00430677|471609|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
201118|NCT00430677|471607|P3|STARTED|Long-term Extension Period||74
201119|NCT00430677|471608|P2|STARTED|Long-term Extension Period||67
201120|NCT00430677|471609|P1|STARTED|Long-term Extension Period||70
201121|NCT00430677|471607|P3|NOT COMPLETED|Short-term Period||22
201122|NCT00430677|471608|P2|NOT COMPLETED|Short-term Period||25
201123|NCT00430677|471609|P1|NOT COMPLETED|Short-term Period||23
201124|NCT00430677|471607|P3|COMPLETED|Short-term Period|Completed the short-term period|78
201125|NCT00430677|471608|P2|COMPLETED|Short-term Period|Completed the short-term period|74
201126|NCT00430677|471609|P1|COMPLETED|Short-term Period|Completed the short-term period|76
201127|NCT00430677|471607|P3|STARTED|Short-term Period||100
201128|NCT00430677|471608|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
201129|NCT00430677|471609|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
201130|NCT00430638|471732|P2|NOT COMPLETED|Overall Study||48
201131|NCT00430638|471733|P1|NOT COMPLETED|Overall Study||78
201132|NCT00430638|471732|P2|COMPLETED|Overall Study||92
201133|NCT00430638|471733|P1|COMPLETED|Overall Study||60
201134|NCT00430638|471732|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
201135|NCT00430638|471733|P1|STARTED|Overall Study||138
201136|NCT00430625|471751|P2|NOT COMPLETED|Overall Study||0
201137|NCT00430625|471752|P1|NOT COMPLETED|Overall Study||0
201138|NCT00430625|471751|P2|COMPLETED|Overall Study||12
201139|NCT00430625|471752|P1|COMPLETED|Overall Study||13
201140|NCT00430625|471751|P2|STARTED|Overall Study||12
201141|NCT00430625|471752|P1|STARTED|Overall Study||13
201142|NCT00430508|471772|P4|NOT COMPLETED|Overall Study||5
201143|NCT00430508|471773|P3|NOT COMPLETED|Overall Study||13
201144|NCT00430508|471774|P2|NOT COMPLETED|Overall Study||6
201145|NCT00430508|471775|P1|NOT COMPLETED|Overall Study||3
201146|NCT00430508|471772|P4|COMPLETED|Overall Study||269
201147|NCT00430508|471773|P3|COMPLETED|Overall Study||266
201148|NCT00430508|471774|P2|COMPLETED|Overall Study||272
201149|NCT00430508|471775|P1|COMPLETED|Overall Study||137
201150|NCT00430508|471772|P4|STARTED|Overall Study||274
201151|NCT00430508|471773|P3|STARTED|Overall Study||279
201152|NCT00430508|471774|P2|STARTED|Overall Study||278
201153|NCT00430508|471775|P1|STARTED|Overall Study||140
201154|NCT00430495|471813|P4|NOT COMPLETED|Overall Study||4
201155|NCT00430495|471814|P3|NOT COMPLETED|Overall Study||13
201156|NCT00430495|471815|P2|NOT COMPLETED|Overall Study||7
201157|NCT00430495|471816|P1|NOT COMPLETED|Overall Study||14
201158|NCT00430495|471813|P4|COMPLETED|Overall Study||60
201159|NCT00430495|471814|P3|COMPLETED|Overall Study||49
201160|NCT00430495|471815|P2|COMPLETED|Overall Study||59
201161|NCT00430495|471816|P1|COMPLETED|Overall Study||50
201162|NCT00430495|471813|P4|Treated|Overall Study||64
201163|NCT00430495|471814|P3|Treated|Overall Study||62
201164|NCT00430495|471815|P2|Treated|Overall Study||66
201165|NCT00430495|471816|P1|Treated|Overall Study||62
201166|NCT00430495|471813|P4|STARTED|Overall Study||64
201167|NCT00430495|471814|P3|STARTED|Overall Study||62
201168|NCT00430495|471815|P2|STARTED|Overall Study||66
201169|NCT00430495|471816|P1|STARTED|Overall Study||64
201170|NCT00430352|471854|P1|NOT COMPLETED|Overall Study||138
201171|NCT00430352|471854|P1|COMPLETED|Overall Study||407
201172|NCT00430352|471854|P1|STARTED|Overall Study||545
201173|NCT00430300|471872|P4|NOT COMPLETED|Overall Study||2
201174|NCT00430300|471873|P3|NOT COMPLETED|Overall Study||6
201175|NCT00430300|471874|P2|NOT COMPLETED|Overall Study||2
201176|NCT00430300|471875|P1|NOT COMPLETED|Overall Study||2
201177|NCT00430300|471872|P4|COMPLETED|Overall Study||15
201178|NCT00430300|471873|P3|COMPLETED|Overall Study||29
201179|NCT00430300|471874|P2|COMPLETED|Overall Study||16
201180|NCT00430300|471875|P1|COMPLETED|Overall Study||15
201181|NCT00430300|471872|P4|STARTED|Overall Study||17
201182|NCT00430300|471873|P3|STARTED|Overall Study||35
201183|NCT00430300|471874|P2|STARTED|Overall Study||18
201184|NCT00430300|471875|P1|STARTED|Overall Study||17
201185|NCT00430248|471980|P3|NOT COMPLETED|Overall Study||135
201186|NCT00430248|471981|P2|NOT COMPLETED|Overall Study||158
201187|NCT00430248|471982|P1|NOT COMPLETED|Overall Study||125
201188|NCT00430248|471980|P3|COMPLETED|Overall Study||621
201189|NCT00430248|471981|P2|COMPLETED|Overall Study||598
201190|NCT00430248|471982|P1|COMPLETED|Overall Study||632
201191|NCT00430248|471980|P3|STARTED|Overall Study||756
201192|NCT00430248|471981|P2|STARTED|Overall Study||756
201193|NCT00430248|471982|P1|STARTED|Overall Study||757
201194|NCT00430092|472041|P3|NOT COMPLETED|Overall Study||57
201195|NCT00430092|472042|P2|NOT COMPLETED|Overall Study||4
201196|NCT00430092|472043|P1|NOT COMPLETED|Overall Study||6
201197|NCT00430092|472041|P3|COMPLETED|Overall Study||56
201198|NCT00430092|472042|P2|COMPLETED|Overall Study||48
201199|NCT00430092|472043|P1|COMPLETED|Overall Study||48
201200|NCT00430092|472041|P3|STARTED|Overall Study||113
201201|NCT00430092|472042|P2|STARTED|Overall Study||52
201202|NCT00430092|472043|P1|STARTED|Overall Study||54
201203|NCT00430027|472048|P1|NOT COMPLETED|Overall Study||8
201204|NCT00430027|472048|P1|COMPLETED|Overall Study||0
201205|NCT00430027|472048|P1|STARTED|Overall Study||8
201206|NCT00429949|472052|P1|NOT COMPLETED|Overall Study||0
201207|NCT00429949|472052|P1|COMPLETED|Overall Study||21
201208|NCT00429949|472052|P1|STARTED|Overall Study||21
201209|NCT00429923|472065|P3|NOT COMPLETED|Overall Study||39
201210|NCT00429923|472066|P2|NOT COMPLETED|Overall Study||4
201211|NCT00429923|472067|P1|NOT COMPLETED|Overall Study||5
201212|NCT00429923|472065|P3|COMPLETED|Overall Study||68
201213|NCT00429923|472066|P2|COMPLETED|Overall Study||51
201214|NCT00429923|472067|P1|COMPLETED|Overall Study||52
201215|NCT00429923|472065|P3|STARTED|Overall Study||107
201216|NCT00429923|472066|P2|STARTED|Overall Study||55
201217|NCT00429923|472067|P1|STARTED|Overall Study||57
201218|NCT00428844|472075|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
201219|NCT00428844|472076|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
201220|NCT00428844|472077|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
201221|NCT00428844|472075|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
201222|NCT00428844|472076|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
201223|NCT00428844|472077|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
201224|NCT00428844|472075|P3|STARTED|Completed Test of Cure (TOC) Visit||19
201225|NCT00428844|472076|P2|STARTED|Completed Test of Cure (TOC) Visit||18
201226|NCT00428844|472077|P1|STARTED|Completed Test of Cure (TOC) Visit||23
201227|NCT00428844|472075|P3|NOT COMPLETED|Completed Study Drug Treatment||7
201228|NCT00428844|472076|P2|NOT COMPLETED|Completed Study Drug Treatment||6
201229|NCT00428844|472077|P1|NOT COMPLETED|Completed Study Drug Treatment||2
201230|NCT00428844|472075|P3|COMPLETED|Completed Study Drug Treatment||19
201231|NCT00428844|472076|P2|COMPLETED|Completed Study Drug Treatment||18
201232|NCT00428844|472077|P1|COMPLETED|Completed Study Drug Treatment||23
201233|NCT00428844|472075|P3|Received First Dose|Completed Study Drug Treatment||25
201234|NCT00428844|472076|P2|Received First Dose|Completed Study Drug Treatment||24
201235|NCT00428844|472077|P1|Received First Dose|Completed Study Drug Treatment||25
201236|NCT00428844|472075|P3|STARTED|Completed Study Drug Treatment||26
201237|NCT00428844|472076|P2|STARTED|Completed Study Drug Treatment||24
201238|NCT00428844|472077|P1|STARTED|Completed Study Drug Treatment||25
201239|NCT00428792|472100|P2|NOT COMPLETED|Overall Study||4
201240|NCT00428792|472101|P1|NOT COMPLETED|Overall Study||1
201241|NCT00428792|472100|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
201242|NCT00428792|472101|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
201243|NCT00428792|472100|P2|STARTED|Overall Study||70
201244|NCT00428792|472101|P1|STARTED|Overall Study||80
201245|NCT00429793|472125|P1|NOT COMPLETED|Overall Study||6
201246|NCT00429793|472125|P1|COMPLETED|Overall Study||54
201247|NCT00429793|472125|P1|STARTED|Overall Study||60
201248|NCT00429702|472134|P2|NOT COMPLETED|Overall Study||0
201249|NCT00429702|472135|P1|NOT COMPLETED|Overall Study||0
201250|NCT00429702|472134|P2|COMPLETED|Overall Study||4
201251|NCT00429702|472135|P1|COMPLETED|Overall Study||3
201252|NCT00429702|472134|P2|STARTED|Overall Study||4
201253|NCT00429702|472135|P1|STARTED|Overall Study||3
201254|NCT00429663|472145|P2|NOT COMPLETED|Overall Study||39
201255|NCT00429663|472146|P1|NOT COMPLETED|Overall Study||36
201256|NCT00429663|472145|P2|COMPLETED|Overall Study||41
201257|NCT00429663|472146|P1|COMPLETED|Overall Study||40
201258|NCT00429663|472145|P2|STARTED|Overall Study||80
201259|NCT00429663|472146|P1|STARTED|Overall Study||76
201260|NCT00429572|472160|P1|NOT COMPLETED|Overall Study||1
201261|NCT00429572|472160|P1|COMPLETED|Overall Study||18
201262|NCT00429572|472160|P1|STARTED|Overall Study||19
201263|NCT00429507|472168|P1|NOT COMPLETED|Overall Study||0
201264|NCT00429507|472168|P1|COMPLETED|Overall Study||12
201265|NCT00429507|472168|P1|STARTED|Overall Study||12
201266|NCT00429494|472172|P1|NOT COMPLETED|Overall Study||15
201267|NCT00429494|472172|P1|COMPLETED|Overall Study||44
201268|NCT00429494|472172|P1|STARTED|Overall Study||59
201269|NCT00429416|472176|P1|NOT COMPLETED|Overall Study||1
201270|NCT00429416|472176|P1|COMPLETED|Overall Study||13
201271|NCT00429416|472176|P1|STARTED|Overall Study||14
201272|NCT00429403|472186|P2|NOT COMPLETED|Overall Study||0
201273|NCT00429403|472187|P1|NOT COMPLETED|Overall Study||0
201274|NCT00429403|472186|P2|COMPLETED|Overall Study||0
201275|NCT00429403|472187|P1|COMPLETED|Overall Study||1
201276|NCT00429403|472186|P2|STARTED|Overall Study||0
201277|NCT00429403|472187|P1|STARTED|Overall Study||1
201278|NCT00429364|472195|P2|NOT COMPLETED|Overall Study||33
201279|NCT00429364|472196|P1|NOT COMPLETED|Overall Study||32
201280|NCT00429364|472195|P2|COMPLETED|Overall Study||272
201281|NCT00429364|472196|P1|COMPLETED|Overall Study||271
201282|NCT00429364|472195|P2|STARTED|Overall Study||305
201283|NCT00429364|472196|P1|STARTED|Overall Study||303
201284|NCT00429299|472255|P3|NOT COMPLETED|Overall Study||4
201285|NCT00429299|472256|P2|NOT COMPLETED|Overall Study||7
201286|NCT00429299|472257|P1|NOT COMPLETED|Overall Study||4
201287|NCT00429299|472255|P3|COMPLETED|Overall Study||42
201288|NCT00429299|472256|P2|COMPLETED|Overall Study||32
201289|NCT00429299|472257|P1|COMPLETED|Overall Study||32
201290|NCT00429299|472255|P3|STARTED|Overall Study||46
201291|NCT00429299|472256|P2|STARTED|Overall Study||39
201292|NCT00429299|472257|P1|STARTED|Overall Study||36
201293|NCT00429182|472286|P1|NOT COMPLETED|Overall Study||7
201294|NCT00429182|472286|P1|COMPLETED|Overall Study||25
201295|NCT00429182|472286|P1|STARTED|Overall Study||32
201296|NCT00429169|472293|P2|NOT COMPLETED|Overall Study||2
201297|NCT00429169|472294|P1|NOT COMPLETED|Overall Study||2
201298|NCT00429169|472293|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
201299|NCT00429169|472294|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
201300|NCT00429169|472293|P2|STARTED|Overall Study||40
201301|NCT00429169|472294|P1|STARTED|Overall Study||38
201302|NCT00429143|472304|P1|NOT COMPLETED|Overall Study||0
201303|NCT00429143|472304|P1|COMPLETED|Overall Study||27
201304|NCT00429143|472304|P1|STARTED|Overall Study||27
201305|NCT00429104|472312|P1|NOT COMPLETED|Overall Study||1
201306|NCT00429104|472312|P1|COMPLETED|Overall Study||17
201307|NCT00429104|472312|P1|STARTED|Overall Study||18
201308|NCT00429026|472317|P1|NOT COMPLETED|Overall Study||40
201309|NCT00429026|472317|P1|COMPLETED|Overall Study||0
201310|NCT00429026|472317|P1|STARTED|Overall Study||40
201311|NCT00428974|472325|P4|NOT COMPLETED|Overall Study||3
201312|NCT00428974|472326|P3|NOT COMPLETED|Overall Study||1
201313|NCT00428974|472327|P2|NOT COMPLETED|Overall Study||0
201314|NCT00428974|472328|P1|NOT COMPLETED|Overall Study||8
201315|NCT00428974|472325|P4|COMPLETED|Overall Study||16
201316|NCT00428974|472326|P3|COMPLETED|Overall Study||14
201317|NCT00428974|472327|P2|COMPLETED|Overall Study||17
201318|NCT00428974|472328|P1|COMPLETED|Overall Study||17
201319|NCT00428974|472325|P4|STARTED|Overall Study||19
201320|NCT00428974|472326|P3|STARTED|Overall Study||15
201321|NCT00428974|472327|P2|STARTED|Overall Study||17
201322|NCT00428974|472328|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
201323|NCT00428922|472342|P1|NOT COMPLETED|Overall Study||0
201324|NCT00428922|472342|P1|COMPLETED|Overall Study||26
201325|NCT00428922|472342|P1|STARTED|Overall Study||26
201326|NCT00428597|472351|P2|NOT COMPLETED|Overall Study||85
201327|NCT00428597|472352|P1|NOT COMPLETED|Overall Study||86
201328|NCT00428597|472351|P2|COMPLETED|Overall Study||0
201329|NCT00428597|472352|P1|COMPLETED|Overall Study||0
201330|NCT00428597|472351|P2|Received Treatment|Overall Study||82
201331|NCT00428597|472352|P1|Received Treatment|Overall Study||83
201332|NCT00428597|472351|P2|STARTED|Overall Study||85
201333|NCT00428597|472352|P1|STARTED|Overall Study||86
201334|NCT00428584|472394|P2|NOT COMPLETED|Extension Phase||29
201335|NCT00428584|472395|P1|NOT COMPLETED|Extension Phase||21
201336|NCT00428584|472394|P2|COMPLETED|Extension Phase||34
201337|NCT00428584|472395|P1|COMPLETED|Extension Phase||35
201338|NCT00428584|472394|P2|STARTED|Extension Phase||63
201339|NCT00428584|472395|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
201340|NCT00428584|472394|P2|NOT COMPLETED|Comparative Phase||1
201341|NCT00428584|472395|P1|NOT COMPLETED|Comparative Phase||9
201342|NCT00428584|472394|P2|COMPLETED|Comparative Phase||63
201343|NCT00428584|472395|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
201344|NCT00428584|472394|P2|STARTED|Comparative Phase||64
201345|NCT00428584|472395|P1|STARTED|Comparative Phase||65
201346|NCT00428441|472419|P1|NOT COMPLETED|Overall Study||1
201347|NCT00428441|472419|P1|COMPLETED|Overall Study||74
201348|NCT00428441|472419|P1|STARTED|Overall Study||75
201349|NCT00428389|472425|P2|NOT COMPLETED|Extension Phase||26
201350|NCT00428389|472426|P1|NOT COMPLETED|Extension Phase||32
201351|NCT00428389|472425|P2|COMPLETED|Extension Phase||91
201352|NCT00428389|472426|P1|COMPLETED|Extension Phase||85
201353|NCT00428389|472425|P2|STARTED|Extension Phase||117
201354|NCT00428389|472426|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
201355|NCT00428389|472425|P2|NOT COMPLETED|Core Phase||11
201356|NCT00428389|472426|P1|NOT COMPLETED|Core Phase||11
201357|NCT00428389|472425|P2|COMPLETED|Core Phase||120
201358|NCT00428389|472426|P1|COMPLETED|Core Phase||120
201359|NCT00428389|472425|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
201360|NCT00428389|472426|P1|Intent-to-treat Population|Core Phase||131
201361|NCT00428389|472425|P2|STARTED|Core Phase||131
201362|NCT00428389|472426|P1|STARTED|Core Phase||131
201363|NCT00428246|472447|P3|NOT COMPLETED|Overall Study||1
201364|NCT00428246|472448|P2|NOT COMPLETED|Overall Study||0
201365|NCT00428246|472449|P1|NOT COMPLETED|Overall Study||1
201366|NCT00428246|472447|P3|COMPLETED|Overall Study||7
201367|NCT00428246|472448|P2|COMPLETED|Overall Study||8
201368|NCT00428246|472449|P1|COMPLETED|Overall Study||7
201369|NCT00428246|472447|P3|STARTED|Overall Study||8
201370|NCT00428246|472448|P2|STARTED|Overall Study||8
201371|NCT00428246|472449|P1|STARTED|Overall Study||8
201372|NCT00428220|472457|P1|NOT COMPLETED|Overall Study||223
201373|NCT00428220|472457|P1|COMPLETED|Overall Study||0
201374|NCT00428220|472457|P1|STARTED|Overall Study||223
201375|NCT00428116|472475|P2|NOT COMPLETED|Overall Study||0
201376|NCT00428116|472476|P1|NOT COMPLETED|Overall Study||3
201377|NCT00428116|472475|P2|COMPLETED|Overall Study||21
201378|NCT00428116|472476|P1|COMPLETED|Overall Study||18
201379|NCT00428116|472475|P2|STARTED|Overall Study||21
201380|NCT00428116|472476|P1|STARTED|Overall Study||21
201381|NCT00428077|472484|P1|NOT COMPLETED|Overall Study||0
201382|NCT00428077|472484|P1|COMPLETED|Overall Study||4
201383|NCT00428077|472484|P1|STARTED|Overall Study||4
201384|NCT00427999|472488|P1|NOT COMPLETED|Overall Study||32
201385|NCT00427999|472488|P1|COMPLETED|Overall Study||33
201386|NCT00427999|472488|P1|Extension Follow-up|Overall Study||19
201387|NCT00427999|472488|P1|Intent to Treat (ITT)|Overall Study||61
201388|NCT00427999|472488|P1|STARTED|Overall Study||65
201389|NCT00427973|472497|P1|NOT COMPLETED|Overall Study||0
201390|NCT00427973|472497|P1|COMPLETED|Overall Study||17
201391|NCT00427973|472497|P1|STARTED|Overall Study||17
201392|NCT00427960|472506|P2|NOT COMPLETED|Overall Study||4
201393|NCT00427960|472507|P1|NOT COMPLETED|Overall Study||2
201394|NCT00427960|472506|P2|COMPLETED|Overall Study||21
201395|NCT00427960|472507|P1|COMPLETED|Overall Study||28
201396|NCT00427960|472506|P2|STARTED|Overall Study||25
201397|NCT00427960|472507|P1|STARTED|Overall Study||30
201398|NCT00427934|472545|P4|NOT COMPLETED|Overall Study||15
201399|NCT00427934|472546|P3|NOT COMPLETED|Overall Study||23
201400|NCT00427934|472547|P2|NOT COMPLETED|Overall Study||0
201401|NCT00427934|472548|P1|NOT COMPLETED|Overall Study||1
201402|NCT00427934|472545|P4|COMPLETED|Overall Study||19
201403|NCT00427934|472546|P3|COMPLETED|Overall Study||55
201404|NCT00427934|472547|P2|COMPLETED|Overall Study||8
201405|NCT00427934|472548|P1|COMPLETED|Overall Study||7
201406|NCT00427934|472545|P4|Treated|Overall Study||33
201407|NCT00427934|472546|P3|Treated|Overall Study||77
201408|NCT00427934|472547|P2|Treated|Overall Study||8
201409|NCT00427934|472548|P1|Treated|Overall Study||8
201410|NCT00427934|472545|P4|STARTED|Overall Study||34
201411|NCT00427934|472546|P3|STARTED|Overall Study||78
201412|NCT00427934|472547|P2|STARTED|Overall Study||8
201413|NCT00427934|472548|P1|STARTED|Overall Study||8
201414|NCT00427921|472616|P1|NOT COMPLETED|Overall Study||50
201415|NCT00427921|472616|P1|COMPLETED|Overall Study||254
201416|NCT00427921|472616|P1|STARTED|Overall Study||304
201417|NCT00427895|472639|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
201418|NCT00427895|472640|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
201419|NCT00427895|472641|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
201420|NCT00427895|472642|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
201421|NCT00427895|472643|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
201422|NCT00427895|472644|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
201423|NCT00427895|472645|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
201424|NCT00427895|472646|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
201425|NCT00427895|472639|P8|COMPLETED|Vax 2/Year 3 to 4||212
201426|NCT00427895|472640|P7|COMPLETED|Vax 2/Year 3 to 4||189
201427|NCT00427895|472641|P6|COMPLETED|Vax 2/Year 3 to 4||108
201428|NCT00427895|472642|P5|COMPLETED|Vax 2/Year 3 to 4||107
201429|NCT00427895|472643|P4|COMPLETED|Vax 2/Year 3 to 4||0
201430|NCT00427895|472644|P3|COMPLETED|Vax 2/Year 3 to 4||0
201431|NCT00427895|472645|P2|COMPLETED|Vax 2/Year 3 to 4||0
201432|NCT00427895|472646|P1|COMPLETED|Vax 2/Year 3 to 4||0
201433|NCT00427895|472639|P8|STARTED|Vax 2/Year 3 to 4||214
201434|NCT00427895|472640|P7|STARTED|Vax 2/Year 3 to 4||189
201435|NCT00427895|472641|P6|STARTED|Vax 2/Year 3 to 4||108
201436|NCT00427895|472642|P5|STARTED|Vax 2/Year 3 to 4||108
201437|NCT00427895|472643|P4|STARTED|Vax 2/Year 3 to 4||0
201438|NCT00427895|472644|P3|STARTED|Vax 2/Year 3 to 4||0
201439|NCT00427895|472645|P2|STARTED|Vax 2/Year 3 to 4||0
201440|NCT00427895|472646|P1|STARTED|Vax 2/Year 3 to 4||0
201441|NCT00427895|472639|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201442|NCT00427895|472640|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201443|NCT00427895|472641|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201444|NCT00427895|472642|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201445|NCT00427895|472643|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
201446|NCT00427895|472644|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
201447|NCT00427895|472645|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
201448|NCT00427895|472646|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
201449|NCT00427895|472639|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201450|NCT00427895|472640|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201451|NCT00427895|472641|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201452|NCT00427895|472642|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201453|NCT00427895|472643|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
201454|NCT00427895|472644|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
201455|NCT00427895|472645|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
201456|NCT00427895|472646|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
201457|NCT00427895|472639|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
201458|NCT00427895|472640|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
201459|NCT00427895|472641|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
201460|NCT00427895|472642|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
201461|NCT00427895|472643|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
201462|NCT00427895|472644|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
201463|NCT00427895|472645|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
201464|NCT00427895|472646|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
201465|NCT00427895|472639|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
201466|NCT00427895|472640|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
201467|NCT00427895|472641|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
201468|NCT00427895|472642|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
201469|NCT00427895|472643|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
201470|NCT00427895|472644|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
201471|NCT00427895|472645|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
201472|NCT00427895|472646|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
201473|NCT00427895|472639|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
201474|NCT00427895|472640|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
201475|NCT00427895|472641|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
201476|NCT00427895|472642|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
201477|NCT00427895|472643|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
201478|NCT00427895|472644|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
201479|NCT00427895|472645|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
201480|NCT00427895|472646|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
201481|NCT00427895|472639|P8|STARTED|Vax 1/Year 1 Follow-up||0
201482|NCT00427895|472640|P7|STARTED|Vax 1/Year 1 Follow-up||0
201483|NCT00427895|472641|P6|STARTED|Vax 1/Year 1 Follow-up||0
201484|NCT00427895|472642|P5|STARTED|Vax 1/Year 1 Follow-up||0
201485|NCT00427895|472643|P4|STARTED|Vax 1/Year 1 Follow-up||502
201486|NCT00427895|472644|P3|STARTED|Vax 1/Year 1 Follow-up||392
201487|NCT00427895|472645|P2|STARTED|Vax 1/Year 1 Follow-up||411
201488|NCT00427895|472646|P1|STARTED|Vax 1/Year 1 Follow-up||411
201489|NCT00427895|472639|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201490|NCT00427895|472640|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201491|NCT00427895|472641|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201492|NCT00427895|472642|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201493|NCT00427895|472643|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
201494|NCT00427895|472644|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201495|NCT00427895|472645|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201496|NCT00427895|472646|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
201497|NCT00427895|472639|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
201498|NCT00427895|472640|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
201499|NCT00427895|472641|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
201500|NCT00427895|472642|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
201501|NCT00427895|472643|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
201502|NCT00427895|472644|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
201503|NCT00427895|472645|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
201504|NCT00427895|472646|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
201505|NCT00427895|472639|P8|STARTED|Between 6-Month Follow-up - Year 1||0
201506|NCT00427895|472640|P7|STARTED|Between 6-Month Follow-up - Year 1||0
201507|NCT00427895|472641|P6|STARTED|Between 6-Month Follow-up - Year 1||0
201508|NCT00427895|472642|P5|STARTED|Between 6-Month Follow-up - Year 1||0
201509|NCT00427895|472643|P4|STARTED|Between 6-Month Follow-up - Year 1||854
201510|NCT00427895|472644|P3|STARTED|Between 6-Month Follow-up - Year 1||392
201511|NCT00427895|472645|P2|STARTED|Between 6-Month Follow-up - Year 1||411
201512|NCT00427895|472646|P1|STARTED|Between 6-Month Follow-up - Year 1||411
201513|NCT00427895|472639|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201514|NCT00427895|472640|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201515|NCT00427895|472641|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201516|NCT00427895|472642|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201517|NCT00427895|472643|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
201518|NCT00427895|472644|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
201519|NCT00427895|472645|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
201520|NCT00427895|472646|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
201521|NCT00427895|472639|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201522|NCT00427895|472640|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201523|NCT00427895|472641|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201524|NCT00427895|472642|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
201525|NCT00427895|472643|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
201526|NCT00427895|472644|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
201527|NCT00427895|472645|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
201528|NCT00427895|472646|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
201529|NCT00427895|472639|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
201530|NCT00427895|472640|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
201531|NCT00427895|472641|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
201532|NCT00427895|472642|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
201533|NCT00427895|472643|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
201534|NCT00427895|472644|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
201535|NCT00427895|472645|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
201536|NCT00427895|472646|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
201537|NCT00427895|472639|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
201538|NCT00427895|472640|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
201539|NCT00427895|472641|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
201540|NCT00427895|472642|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
201541|NCT00427895|472643|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
201542|NCT00427895|472644|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
201543|NCT00427895|472645|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
201544|NCT00427895|472646|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
201545|NCT00427804|472703|P2|NOT COMPLETED|Overall Study||0
201546|NCT00427804|472704|P1|NOT COMPLETED|Overall Study||0
201547|NCT00427804|472703|P2|COMPLETED|Overall Study||5
201548|NCT00427804|472704|P1|COMPLETED|Overall Study||4
201549|NCT00427804|472703|P2|STARTED|Overall Study||5
201550|NCT00427804|472704|P1|STARTED|Overall Study||4
201551|NCT00427791|472712|P2|NOT COMPLETED|Overall Study||0
201552|NCT00427791|472713|P1|NOT COMPLETED|Overall Study||0
201553|NCT00427791|472712|P2|COMPLETED|Overall Study||13
201554|NCT00427791|472713|P1|COMPLETED|Overall Study||10
201555|NCT00427791|472712|P2|STARTED|Overall Study||13
201556|NCT00427791|472713|P1|STARTED|Overall Study||10
201557|NCT00427765|472721|P1|NOT COMPLETED|Overall Study||0
201558|NCT00427765|472721|P1|COMPLETED|Overall Study||164
201559|NCT00427765|472721|P1|STARTED|Overall Study||164
201560|NCT00427700|472727|P2|NOT COMPLETED|Overall Study||11
201561|NCT00427700|472728|P1|NOT COMPLETED|Overall Study||3
201562|NCT00427700|472727|P2|COMPLETED|Overall Study||31
201563|NCT00427700|472728|P1|COMPLETED|Overall Study||37
201564|NCT00427700|472727|P2|STARTED|Overall Study||42
201565|NCT00427700|472728|P1|STARTED|Overall Study||40
201566|NCT00427661|472736|P1|NOT COMPLETED|Overall Study||0
201567|NCT00427661|472736|P1|COMPLETED|Overall Study||8
201568|NCT00427661|472736|P1|STARTED|Overall Study||8
201569|NCT00427635|472744|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
201570|NCT00427635|472745|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
201571|NCT00427635|472744|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
201572|NCT00427635|472745|P1|COMPLETED|Study Completion to Safety Follow-up||25
201573|NCT00427635|472744|P2|STARTED|Study Completion to Safety Follow-up||26
201574|NCT00427635|472745|P1|STARTED|Study Completion to Safety Follow-up||25
201575|NCT00427635|472744|P2|NOT COMPLETED|Treatment Phase||0
201576|NCT00427635|472745|P1|NOT COMPLETED|Treatment Phase||1
201577|NCT00427635|472744|P2|COMPLETED|Treatment Phase|ITT population|26
201578|NCT00427635|472745|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
201579|NCT00427635|472744|P2|STARTED|Treatment Phase|Randomised|26
201580|NCT00427635|472745|P1|STARTED|Treatment Phase|Randomised|26
201581|NCT00427557|472773|P1|NOT COMPLETED|Overall Study||0
201582|NCT00427557|472773|P1|COMPLETED|Overall Study||30
201583|NCT00427557|472773|P1|STARTED|Overall Study||30
201584|NCT00427349|472777|P1|NOT COMPLETED|Overall Study||46
201585|NCT00427349|472777|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
201586|NCT00427349|472777|P1|Eligible and Treated|Overall Study||44
201587|NCT00427349|472777|P1|Treated|Overall Study||45
201588|NCT00427349|472777|P1|Eligible|Overall Study||45
201589|NCT00427349|472777|P1|STARTED|Overall Study||46
201590|NCT00427336|472783|P1|NOT COMPLETED|Overall Study||0
201591|NCT00427336|472783|P1|COMPLETED|Overall Study||9
201592|NCT00427336|472783|P1|STARTED|Overall Study||9
201593|NCT00427037|472789|P2|NOT COMPLETED|Overall Study||7
201594|NCT00427037|472790|P1|NOT COMPLETED|Overall Study||7
201595|NCT00427037|472789|P2|COMPLETED|Overall Study||10
201596|NCT00427037|472790|P1|COMPLETED|Overall Study||10
201597|NCT00427037|472789|P2|STARTED|Overall Study||17
201598|NCT00427037|472790|P1|STARTED|Overall Study||17
201599|NCT00427011|472798|P1|NOT COMPLETED|Overall Study||25
201600|NCT00427011|472798|P1|COMPLETED|Overall Study||0
201601|NCT00427011|472798|P1|STARTED|Overall Study||25
201602|NCT00426855|472809|P1|NOT COMPLETED|Overall Study||0
201603|NCT00426855|472809|P1|COMPLETED|Overall Study||12
201604|NCT00426855|472809|P1|STARTED|Overall Study||12
201605|NCT00426842|472813|P1|NOT COMPLETED|Overall Study||1
201606|NCT00426842|472813|P1|COMPLETED|Overall Study||10
201607|NCT00426842|472813|P1|STARTED|Overall Study||11
201608|NCT00426764|472819|P1|NOT COMPLETED|Overall Study||98
201609|NCT00426764|472819|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
201610|NCT00426764|472819|P1|Received 6 or More Treatment Cycles|Overall Study||36
201611|NCT00426764|472819|P1|Received 4 or More Treatment Cycles|Overall Study||50
201612|NCT00426764|472819|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
201613|NCT00426764|472819|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
201614|NCT00426751|472835|P2|NOT COMPLETED|Overall Study||20
201615|NCT00426751|472836|P1|NOT COMPLETED|Overall Study||22
201616|NCT00426751|472835|P2|COMPLETED|Overall Study||183
201617|NCT00426751|472836|P1|COMPLETED|Overall Study||204
201618|NCT00426751|472835|P2|STARTED|Overall Study||203
201619|NCT00426751|472836|P1|STARTED|Overall Study||226
201620|NCT00426660|472880|P1|NOT COMPLETED|Overall Study||131
201621|NCT00426660|472880|P1|COMPLETED|Overall Study||916
201622|NCT00426660|472880|P1|Safety Analysis Set|Overall Study||1032
201623|NCT00426660|472880|P1|Treated|Overall Study||1032
201624|NCT00426660|472880|P1|STARTED|Overall Study||1047
201625|NCT00426556|472911|P4|NOT COMPLETED|Phase II - Extension Phase||23
201626|NCT00426556|472912|P3|NOT COMPLETED|Phase II - Extension Phase||0
201627|NCT00426556|472913|P2|NOT COMPLETED|Phase II - Extension Phase||0
201628|NCT00426556|472914|P1|NOT COMPLETED|Phase II - Extension Phase||0
201629|NCT00426556|472911|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
201630|NCT00426556|472912|P3|COMPLETED|Phase II - Extension Phase||0
201631|NCT00426556|472913|P2|COMPLETED|Phase II - Extension Phase||0
201632|NCT00426556|472914|P1|COMPLETED|Phase II - Extension Phase||0
201724|NCT00425373|473052|P9|STARTED|Overall Study||166
201633|NCT00426556|472911|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
201634|NCT00426556|472912|P3|STARTED|Phase II - Extension Phase||0
201635|NCT00426556|472913|P2|STARTED|Phase II - Extension Phase||0
201636|NCT00426556|472914|P1|STARTED|Phase II - Extension Phase||0
201637|NCT00426556|472911|P4|NOT COMPLETED|Phase II - Core Phase||27
201638|NCT00426556|472912|P3|NOT COMPLETED|Phase II - Core Phase||0
201639|NCT00426556|472913|P2|NOT COMPLETED|Phase II - Core Phase||0
201640|NCT00426556|472914|P1|NOT COMPLETED|Phase II - Core Phase||0
201641|NCT00426556|472911|P4|COMPLETED|Phase II - Core Phase||28
201642|NCT00426556|472912|P3|COMPLETED|Phase II - Core Phase||0
201643|NCT00426556|472913|P2|COMPLETED|Phase II - Core Phase||0
201644|NCT00426556|472914|P1|COMPLETED|Phase II - Core Phase||0
201645|NCT00426556|472911|P4|STARTED|Phase II - Core Phase||55
201646|NCT00426556|472912|P3|STARTED|Phase II - Core Phase||0
201647|NCT00426556|472913|P2|STARTED|Phase II - Core Phase||0
201648|NCT00426556|472914|P1|STARTED|Phase II - Core Phase||0
201649|NCT00426556|472911|P4|NOT COMPLETED|Phase I - Extension Phase||0
201650|NCT00426556|472912|P3|NOT COMPLETED|Phase I - Extension Phase||7
201651|NCT00426556|472913|P2|NOT COMPLETED|Phase I - Extension Phase||6
201652|NCT00426556|472914|P1|NOT COMPLETED|Phase I - Extension Phase||5
201653|NCT00426556|472911|P4|COMPLETED|Phase I - Extension Phase||0
201654|NCT00426556|472912|P3|COMPLETED|Phase I - Extension Phase||0
201655|NCT00426556|472913|P2|COMPLETED|Phase I - Extension Phase||1
201656|NCT00426556|472914|P1|COMPLETED|Phase I - Extension Phase||0
201657|NCT00426556|472911|P4|STARTED|Phase I - Extension Phase||0
201658|NCT00426556|472912|P3|STARTED|Phase I - Extension Phase||7
201659|NCT00426556|472913|P2|STARTED|Phase I - Extension Phase||7
201660|NCT00426556|472914|P1|STARTED|Phase I - Extension Phase||5
201661|NCT00426556|472911|P4|NOT COMPLETED|Phase I - Core Phase||0
201662|NCT00426556|472912|P3|NOT COMPLETED|Phase I - Core Phase||3
201663|NCT00426556|472913|P2|NOT COMPLETED|Phase I - Core Phase||10
201664|NCT00426556|472914|P1|NOT COMPLETED|Phase I - Core Phase||1
201665|NCT00426556|472911|P4|COMPLETED|Phase I - Core Phase||0
201666|NCT00426556|472912|P3|COMPLETED|Phase I - Core Phase||7
201667|NCT00426556|472913|P2|COMPLETED|Phase I - Core Phase||7
201668|NCT00426556|472914|P1|COMPLETED|Phase I - Core Phase||5
201669|NCT00426556|472911|P4|STARTED|Phase I - Core Phase||0
201670|NCT00426556|472912|P3|STARTED|Phase I - Core Phase||10
201671|NCT00426556|472913|P2|STARTED|Phase I - Core Phase||17
201672|NCT00426556|472914|P1|STARTED|Phase I - Core Phase||6
201673|NCT00426361|472939|P3|NOT COMPLETED|Overall Study||5
201674|NCT00426361|472940|P2|NOT COMPLETED|Overall Study||5
201675|NCT00426361|472941|P1|NOT COMPLETED|Overall Study||4
201676|NCT00426361|472939|P3|COMPLETED|Overall Study||243
201677|NCT00426361|472940|P2|COMPLETED|Overall Study||250
201678|NCT00426361|472941|P1|COMPLETED|Overall Study||244
201679|NCT00426361|472939|P3|STARTED|Overall Study||248
201680|NCT00426361|472940|P2|STARTED|Overall Study||255
201681|NCT00426361|472941|P1|STARTED|Overall Study||248
201682|NCT00426283|472993|P2|NOT COMPLETED|Overall Study||1
201683|NCT00426283|472994|P1|NOT COMPLETED|Overall Study||5
201684|NCT00426283|472993|P2|COMPLETED|Overall Study||13
201685|NCT00426283|472994|P1|COMPLETED|Overall Study||23
201686|NCT00426283|472993|P2|STARTED|Overall Study||14
201687|NCT00426283|472994|P1|STARTED|Overall Study||28
201688|NCT00426270|473000|P1|NOT COMPLETED|Overall Study||6
201689|NCT00426270|473000|P1|COMPLETED|Overall Study||110
201690|NCT00426270|473000|P1|STARTED|Overall Study||116
201691|NCT00426231|473010|P2|NOT COMPLETED|Overall Study||12
201692|NCT00426231|473011|P1|NOT COMPLETED|Overall Study||9
201693|NCT00426231|473010|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
201694|NCT00426231|473011|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
201695|NCT00426231|473010|P2|STARTED|Overall Study||37
201696|NCT00426231|473011|P1|STARTED|Overall Study||36
201697|NCT00426153|473021|P2|NOT COMPLETED|Overall Study||0
201698|NCT00426153|473022|P1|NOT COMPLETED|Overall Study||0
201699|NCT00426153|473021|P2|COMPLETED|Overall Study||14
201700|NCT00426153|473022|P1|COMPLETED|Overall Study||28
201701|NCT00426153|473021|P2|STARTED|Overall Study||14
201702|NCT00426153|473022|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
201703|NCT00425386|473034|P1|NOT COMPLETED|Overall Study||3
201704|NCT00425386|473034|P1|COMPLETED|Overall Study||43
201705|NCT00425386|473034|P1|STARTED|Overall Study||46
201706|NCT00425373|473052|P9|NOT COMPLETED|Overall Study||18
201707|NCT00425373|473053|P8|NOT COMPLETED|Overall Study||10
201708|NCT00425373|473054|P7|NOT COMPLETED|Overall Study||7
201709|NCT00425373|473055|P6|NOT COMPLETED|Overall Study||9
201710|NCT00425373|473056|P5|NOT COMPLETED|Overall Study||10
201711|NCT00425373|473057|P4|NOT COMPLETED|Overall Study||2
201712|NCT00425373|473058|P3|NOT COMPLETED|Overall Study||3
201713|NCT00425373|473059|P2|NOT COMPLETED|Overall Study||3
201714|NCT00425373|473060|P1|NOT COMPLETED|Overall Study||5
201715|NCT00425373|473052|P9|COMPLETED|Overall Study||148
201716|NCT00425373|473053|P8|COMPLETED|Overall Study||151
201717|NCT00425373|473054|P7|COMPLETED|Overall Study||154
201718|NCT00425373|473055|P6|COMPLETED|Overall Study||154
201719|NCT00425373|473056|P5|COMPLETED|Overall Study||159
201720|NCT00425373|473057|P4|COMPLETED|Overall Study||160
201721|NCT00425373|473058|P3|COMPLETED|Overall Study||157
201722|NCT00425373|473059|P2|COMPLETED|Overall Study||164
201723|NCT00425373|473060|P1|COMPLETED|Overall Study||154
201725|NCT00425373|473053|P8|STARTED|Overall Study||161
201726|NCT00425373|473054|P7|STARTED|Overall Study||161
201727|NCT00425373|473055|P6|STARTED|Overall Study||163
201728|NCT00425373|473056|P5|STARTED|Overall Study||169
201729|NCT00425373|473057|P4|STARTED|Overall Study||162
201730|NCT00425373|473058|P3|STARTED|Overall Study||160
201731|NCT00425373|473059|P2|STARTED|Overall Study||167
201732|NCT00425373|473060|P1|STARTED|Overall Study||159
201733|NCT00425308|473118|P2|NOT COMPLETED|Overall Study||1
201734|NCT00425308|473119|P1|NOT COMPLETED|Overall Study||4
201735|NCT00425308|473118|P2|COMPLETED|Overall Study||14
201736|NCT00425308|473119|P1|COMPLETED|Overall Study||11
201737|NCT00425308|473118|P2|STARTED|Overall Study||15
201738|NCT00425308|473119|P1|STARTED|Overall Study||15
201739|NCT00425945|473149|P2|NOT COMPLETED|Overall Study||5
201740|NCT00425945|473150|P1|NOT COMPLETED|Overall Study||4
201741|NCT00425945|473149|P2|COMPLETED|Overall Study||61
201742|NCT00425945|473150|P1|COMPLETED|Overall Study||60
201743|NCT00425945|473149|P2|STARTED|Overall Study||66
201744|NCT00425945|473150|P1|STARTED|Overall Study||64
201745|NCT00425854|473188|P2|NOT COMPLETED|Overall Study||21
201746|NCT00425854|473189|P1|NOT COMPLETED|Overall Study||29
201747|NCT00425854|473188|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
201748|NCT00425854|473189|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
201749|NCT00425854|473188|P2|STARTED|Overall Study|Treated|21
201750|NCT00425854|473189|P1|STARTED|Overall Study|Treated|29
201751|NCT00425750|473210|P1|NOT COMPLETED|Overall Study||25
201752|NCT00425750|473210|P1|COMPLETED|Overall Study||0
201753|NCT00425750|473210|P1|STARTED|Overall Study||25
201754|NCT00425698|473218|P2|NOT COMPLETED|Overall Study||2
201755|NCT00425698|473219|P1|NOT COMPLETED|Overall Study||3
201756|NCT00425698|473218|P2|COMPLETED|Overall Study||42
201757|NCT00425698|473219|P1|COMPLETED|Overall Study||41
201758|NCT00425698|473218|P2|STARTED|Overall Study||44
201759|NCT00425698|473219|P1|STARTED|Overall Study||44
201760|NCT00425503|473225|P1|NOT COMPLETED|Overall Study||3
201761|NCT00425503|473225|P1|COMPLETED|Overall Study||37
201762|NCT00425503|473225|P1|STARTED|Overall Study||40
201763|NCT00425438|473231|P2|NOT COMPLETED|Overall Study||27
201764|NCT00425438|473232|P1|NOT COMPLETED|Overall Study||25
201765|NCT00425438|473231|P2|COMPLETED|Overall Study||0
201766|NCT00425438|473232|P1|COMPLETED|Overall Study||0
201767|NCT00425438|473231|P2|STARTED|Overall Study||27
201768|NCT00425438|473232|P1|STARTED|Overall Study||25
201769|NCT00425269|473250|P2|NOT COMPLETED|Overall Study||20
201770|NCT00425269|473251|P1|NOT COMPLETED|Overall Study||19
201771|NCT00425269|473250|P2|COMPLETED|Overall Study||77
201772|NCT00425269|473251|P1|COMPLETED|Overall Study||82
201773|NCT00425269|473250|P2|STARTED|Overall Study||97
201774|NCT00425269|473251|P1|STARTED|Overall Study||101
201775|NCT00425113|473329|P2|NOT COMPLETED|Overall Study||2
201776|NCT00425113|473330|P1|NOT COMPLETED|Overall Study||2
201777|NCT00425113|473329|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
201778|NCT00425113|473330|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
201779|NCT00425113|473329|P2|Exposed to Study Drug|Overall Study||17
201780|NCT00425113|473330|P1|Exposed to Study Drug|Overall Study||16
201781|NCT00425113|473329|P2|STARTED|Overall Study||18
201782|NCT00425113|473330|P1|STARTED|Overall Study||17
201783|NCT00425100|473338|P1|NOT COMPLETED|Overall Study||53
201784|NCT00425100|473338|P1|COMPLETED|Overall Study||463
201785|NCT00425100|473338|P1|STARTED|Overall Study||516
201786|NCT00425061|473382|P7|NOT COMPLETED|Overall Study||19
201787|NCT00425061|473383|P6|NOT COMPLETED|Overall Study||4
201788|NCT00425061|473384|P5|NOT COMPLETED|Overall Study||26
201789|NCT00425061|473385|P4|NOT COMPLETED|Overall Study||2
201790|NCT00425061|473386|P3|NOT COMPLETED|Overall Study||0
201791|NCT00425061|473387|P2|NOT COMPLETED|Overall Study||2
201792|NCT00425061|473388|P1|NOT COMPLETED|Overall Study||2
201793|NCT00425061|473382|P7|COMPLETED|Overall Study||26
201794|NCT00425061|473383|P6|COMPLETED|Overall Study||0
201795|NCT00425061|473384|P5|COMPLETED|Overall Study||19
201796|NCT00425061|473385|P4|COMPLETED|Overall Study||14
201797|NCT00425061|473386|P3|COMPLETED|Overall Study||16
201798|NCT00425061|473387|P2|COMPLETED|Overall Study||15
201799|NCT00425061|473388|P1|COMPLETED|Overall Study||14
201800|NCT00425061|473382|P7|STARTED|Overall Study||45
201801|NCT00425061|473383|P6|STARTED|Overall Study||4
201802|NCT00425061|473384|P5|STARTED|Overall Study||45
201803|NCT00425061|473385|P4|STARTED|Overall Study||16
201804|NCT00425061|473386|P3|STARTED|Overall Study||16
201805|NCT00425061|473387|P2|STARTED|Overall Study||17
201806|NCT00425061|473388|P1|STARTED|Overall Study||16
201807|NCT00424775|473504|P2|NOT COMPLETED|Overall Study||0
201808|NCT00424775|473505|P1|NOT COMPLETED|Overall Study||3
201809|NCT00424775|473504|P2|COMPLETED|Overall Study||0
201810|NCT00424775|473505|P1|COMPLETED|Overall Study||0
201811|NCT00424775|473504|P2|STARTED|Overall Study||0
201812|NCT00424775|473505|P1|STARTED|Overall Study||3
201813|NCT00424762|473515|P2|NOT COMPLETED|Overall Study||22
201814|NCT00424762|473516|P1|NOT COMPLETED|Overall Study||20
201815|NCT00424762|473515|P2|COMPLETED|Overall Study||54
201816|NCT00424762|473516|P1|COMPLETED|Overall Study||54
201817|NCT00424762|473515|P2|STARTED|Overall Study||76
201818|NCT00424762|473516|P1|STARTED|Overall Study||74
201819|NCT00424749|473526|P1|NOT COMPLETED|Overall Study||1
201820|NCT00424749|473526|P1|COMPLETED|Overall Study||3
201821|NCT00424749|473526|P1|STARTED|Overall Study||4
201822|NCT00424645|473533|P2|NOT COMPLETED|Overall Study||0
201823|NCT00424645|473534|P1|NOT COMPLETED|Overall Study||1
201824|NCT00424645|473533|P2|COMPLETED|Overall Study||0
201825|NCT00424645|473534|P1|COMPLETED|Overall Study||2
201826|NCT00424645|473533|P2|STARTED|Overall Study||0
201827|NCT00424645|473534|P1|STARTED|Overall Study||3
201828|NCT00424632|473542|P10|NOT COMPLETED|Overall Study||6
201829|NCT00424632|473543|P9|NOT COMPLETED|Overall Study||16
201830|NCT00424632|473544|P8|NOT COMPLETED|Overall Study||3
201831|NCT00424632|473545|P7|NOT COMPLETED|Overall Study||7
201832|NCT00424632|473546|P6|NOT COMPLETED|Overall Study||15
201833|NCT00424632|473547|P5|NOT COMPLETED|Overall Study||3
201834|NCT00424632|473548|P4|NOT COMPLETED|Overall Study||4
201835|NCT00424632|473549|P3|NOT COMPLETED|Overall Study||1
201836|NCT00424632|473550|P2|NOT COMPLETED|Overall Study||1
201837|NCT00424632|473551|P1|NOT COMPLETED|Overall Study||1
201838|NCT00424632|473542|P10|COMPLETED|Overall Study||0
201839|NCT00424632|473543|P9|COMPLETED|Overall Study||0
201840|NCT00424632|473544|P8|COMPLETED|Overall Study||0
201841|NCT00424632|473545|P7|COMPLETED|Overall Study||0
201842|NCT00424632|473546|P6|COMPLETED|Overall Study||0
201843|NCT00424632|473547|P5|COMPLETED|Overall Study||0
201844|NCT00424632|473548|P4|COMPLETED|Overall Study||0
201845|NCT00424632|473549|P3|COMPLETED|Overall Study||0
201846|NCT00424632|473550|P2|COMPLETED|Overall Study||0
201847|NCT00424632|473551|P1|COMPLETED|Overall Study||0
201848|NCT00424632|473542|P10|STARTED|Overall Study||6
201849|NCT00424632|473543|P9|STARTED|Overall Study||16
201850|NCT00424632|473544|P8|STARTED|Overall Study||3
201851|NCT00424632|473545|P7|STARTED|Overall Study||7
201852|NCT00424632|473546|P6|STARTED|Overall Study||15
201853|NCT00424632|473547|P5|STARTED|Overall Study||3
201854|NCT00424632|473548|P4|STARTED|Overall Study||4
201855|NCT00424632|473549|P3|STARTED|Overall Study||1
201856|NCT00424632|473550|P2|STARTED|Overall Study||1
201857|NCT00424632|473551|P1|STARTED|Overall Study||1
201858|NCT00424619|473685|P3|NOT COMPLETED|3 Month||0
201859|NCT00424619|473686|P2|NOT COMPLETED|3 Month||0
201860|NCT00424619|473687|P1|NOT COMPLETED|3 Month||0
201861|NCT00424619|473685|P3|COMPLETED|3 Month||17
201862|NCT00424619|473686|P2|COMPLETED|3 Month||18
201863|NCT00424619|473687|P1|COMPLETED|3 Month||12
201864|NCT00424619|473685|P3|STARTED|3 Month||17
201865|NCT00424619|473686|P2|STARTED|3 Month||18
201866|NCT00424619|473687|P1|STARTED|3 Month||12
201867|NCT00424619|473685|P3|NOT COMPLETED|4 Week||0
201868|NCT00424619|473686|P2|NOT COMPLETED|4 Week||0
201869|NCT00424619|473687|P1|NOT COMPLETED|4 Week||0
201870|NCT00424619|473685|P3|COMPLETED|4 Week||17
201871|NCT00424619|473686|P2|COMPLETED|4 Week||17
201872|NCT00424619|473687|P1|COMPLETED|4 Week||18
201873|NCT00424619|473685|P3|STARTED|4 Week||17
201874|NCT00424619|473686|P2|STARTED|4 Week||17
201875|NCT00424619|473687|P1|STARTED|4 Week||18
201876|NCT00424619|473685|P3|NOT COMPLETED|Baseline||1
201877|NCT00424619|473686|P2|NOT COMPLETED|Baseline||0
201878|NCT00424619|473687|P1|NOT COMPLETED|Baseline||0
201879|NCT00424619|473685|P3|COMPLETED|Baseline||20
201880|NCT00424619|473686|P2|COMPLETED|Baseline||22
201881|NCT00424619|473687|P1|COMPLETED|Baseline||22
201882|NCT00424619|473685|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
201883|NCT00424619|473686|P2|STARTED|Baseline||22
201884|NCT00424619|473687|P1|STARTED|Baseline||22
201885|NCT00424593|473721|P2|NOT COMPLETED|Dose-Blind Extension Period||0
201886|NCT00424593|473722|P1|NOT COMPLETED|Dose-Blind Extension Period||64
201887|NCT00424593|473721|P2|COMPLETED|Dose-Blind Extension Period||0
201888|NCT00424593|473722|P1|COMPLETED|Dose-Blind Extension Period||117
201889|NCT00424593|473721|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
201890|NCT00424593|473722|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
201891|NCT00424593|473721|P2|NOT COMPLETED|Acute Double-Blind Period||23
201892|NCT00424593|473722|P1|NOT COMPLETED|Acute Double-Blind Period||31
201893|NCT00424593|473721|P2|COMPLETED|Acute Double-Blind Period||98
201894|NCT00424593|473722|P1|COMPLETED|Acute Double-Blind Period||84
201895|NCT00424593|473721|P2|STARTED|Acute Double-Blind Period||121
201896|NCT00424593|473722|P1|STARTED|Acute Double-Blind Period||115
201897|NCT00424554|473768|P2|NOT COMPLETED|Overall Study||0
201898|NCT00424554|473769|P1|NOT COMPLETED|Overall Study||0
201899|NCT00424554|473768|P2|COMPLETED|Overall Study||6
201900|NCT00424554|473769|P1|COMPLETED|Overall Study||34
201901|NCT00424554|473768|P2|STARTED|Overall Study||6
201902|NCT00424554|473769|P1|STARTED|Overall Study||34
201903|NCT00424528|473786|P3|NOT COMPLETED|Overall Study||4
201904|NCT00424528|473787|P2|NOT COMPLETED|Overall Study||4
201905|NCT00424528|473788|P1|NOT COMPLETED|Overall Study||5
201906|NCT00424528|473786|P3|COMPLETED|Overall Study||74
201907|NCT00424528|473787|P2|COMPLETED|Overall Study||76
201908|NCT00424528|473788|P1|COMPLETED|Overall Study||71
201909|NCT00424528|473786|P3|STARTED|Overall Study||78
201910|NCT00424528|473787|P2|STARTED|Overall Study||80
201911|NCT00424528|473788|P1|STARTED|Overall Study||76
201912|NCT00424515|473843|P2|NOT COMPLETED|Overall Study||13
201913|NCT00424515|473844|P1|NOT COMPLETED|Overall Study||11
201914|NCT00424515|473843|P2|COMPLETED|Overall Study||0
201915|NCT00424515|473844|P1|COMPLETED|Overall Study||0
201916|NCT00424515|473843|P2|STARTED|Overall Study||13
201917|NCT00424515|473844|P1|STARTED|Overall Study||11
201918|NCT00424502|473854|P1|NOT COMPLETED|Overall Study||0
201919|NCT00424502|473854|P1|COMPLETED|Overall Study||20
201920|NCT00424502|473854|P1|STARTED|Overall Study||20
201921|NCT00424476|473866|P3|NOT COMPLETED|Overall Study||49
201922|NCT00424476|473867|P2|NOT COMPLETED|Overall Study||48
201923|NCT00424476|473868|P1|NOT COMPLETED|Overall Study||61
201924|NCT00424476|473866|P3|COMPLETED|Overall Study||241
201925|NCT00424476|473867|P2|COMPLETED|Overall Study||240
201926|NCT00424476|473868|P1|COMPLETED|Overall Study||226
201927|NCT00424476|473866|P3|STARTED|Overall Study||290
201928|NCT00424476|473867|P2|STARTED|Overall Study||288
201929|NCT00424476|473868|P1|STARTED|Overall Study||287
201930|NCT00424398|473894|P3|NOT COMPLETED|Overall Study||0
201931|NCT00424398|473895|P2|NOT COMPLETED|Overall Study||1
201932|NCT00424398|473896|P1|NOT COMPLETED|Overall Study||3
201933|NCT00424398|473894|P3|COMPLETED|Overall Study||36
201934|NCT00424398|473895|P2|COMPLETED|Overall Study||35
201935|NCT00424398|473896|P1|COMPLETED|Overall Study||32
201936|NCT00424398|473894|P3|STARTED|Overall Study||36
201937|NCT00424398|473895|P2|STARTED|Overall Study||36
201938|NCT00424398|473896|P1|STARTED|Overall Study||35
201939|NCT00424385|473940|P1|NOT COMPLETED|Cohort 1||1
201940|NCT00424385|473940|P1|COMPLETED|Cohort 1||4
201941|NCT00424385|473940|P1|STARTED|Cohort 1||5
201942|NCT00424385|473940|P1|NOT COMPLETED|Cohort 0||6
201943|NCT00424385|473940|P1|COMPLETED|Cohort 0||6
201944|NCT00424385|473940|P1|STARTED|Cohort 0||12
201945|NCT00424372|473947|P1|NOT COMPLETED|Overall Study||31
201946|NCT00424372|473947|P1|COMPLETED|Overall Study||95
201947|NCT00424372|473947|P1|STARTED|Overall Study||126
201948|NCT00424346|473959|P4|NOT COMPLETED|Extension Phase||55
201949|NCT00424346|473960|P3|NOT COMPLETED|Extension Phase||55
201950|NCT00424346|473961|P2|NOT COMPLETED|Extension Phase||102
201951|NCT00424346|473962|P1|NOT COMPLETED|Extension Phase||0
201952|NCT00424346|473959|P4|COMPLETED|Extension Phase||3
201953|NCT00424346|473960|P3|COMPLETED|Extension Phase||4
201954|NCT00424346|473961|P2|COMPLETED|Extension Phase||8
201955|NCT00424346|473962|P1|COMPLETED|Extension Phase||0
201956|NCT00424346|473959|P4|STARTED|Extension Phase||58
201957|NCT00424346|473960|P3|STARTED|Extension Phase||59
201958|NCT00424346|473961|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
201959|NCT00424346|473962|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
201960|NCT00424346|473959|P4|NOT COMPLETED|Core Study||7
201961|NCT00424346|473960|P3|NOT COMPLETED|Core Study||4
201962|NCT00424346|473961|P2|NOT COMPLETED|Core Study||8
201963|NCT00424346|473962|P1|NOT COMPLETED|Core Study||9
201964|NCT00424346|473959|P4|COMPLETED|Core Study||63
201965|NCT00424346|473960|P3|COMPLETED|Core Study||65
201966|NCT00424346|473961|P2|COMPLETED|Core Study||56
201967|NCT00424346|473962|P1|COMPLETED|Core Study||62
201968|NCT00424346|473959|P4|STARTED|Core Study||70
201969|NCT00424346|473960|P3|STARTED|Core Study||69
201970|NCT00424346|473961|P2|STARTED|Core Study||64
201971|NCT00424346|473962|P1|STARTED|Core Study||71
201972|NCT00424294|474077|P2|NOT COMPLETED|Overall Study||15
201973|NCT00424294|474078|P1|NOT COMPLETED|Overall Study||8
201974|NCT00424294|474077|P2|COMPLETED|Overall Study||19
201975|NCT00424294|474078|P1|COMPLETED|Overall Study||28
201976|NCT00424294|474077|P2|Treated|Overall Study||34
201977|NCT00424294|474078|P1|Treated|Overall Study||35
201978|NCT00424294|474077|P2|STARTED|Overall Study||34
201979|NCT00424294|474078|P1|STARTED|Overall Study||36
201980|NCT00424268|474128|P2|NOT COMPLETED|Overall Study||39
201981|NCT00424268|474129|P1|NOT COMPLETED|Overall Study||62
201982|NCT00424268|474128|P2|COMPLETED|Overall Study||333
201983|NCT00424268|474129|P1|COMPLETED|Overall Study||309
201984|NCT00424268|474128|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
201985|NCT00424268|474129|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
201986|NCT00424255|474145|P2|NOT COMPLETED|Overall Study||346
201987|NCT00424255|474146|P1|NOT COMPLETED|Overall Study||342
201988|NCT00424255|474145|P2|COMPLETED|Overall Study||0
201989|NCT00424255|474146|P1|COMPLETED|Overall Study||0
201990|NCT00424255|474145|P2|STARTED|Overall Study||346
201991|NCT00424255|474146|P1|STARTED|Overall Study||342
201992|NCT00424190|474194|P2|NOT COMPLETED|Overall Study||30
201993|NCT00424190|474195|P1|NOT COMPLETED|Overall Study||22
201994|NCT00424190|474194|P2|COMPLETED|Overall Study||317
201995|NCT00424190|474195|P1|COMPLETED|Overall Study||329
201996|NCT00424190|474194|P2|STARTED|Overall Study||347
201997|NCT00424190|474195|P1|STARTED|Overall Study||351
201998|NCT00424177|474201|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
201999|NCT00424177|474201|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
202000|NCT00424177|474201|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
202001|NCT00424177|474201|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
202002|NCT00424177|474201|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
202003|NCT00424177|474201|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
202080|NCT00423891|474326|P3|COMPLETED|Enrolled||5
202004|NCT00424177|474201|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
202005|NCT00424177|474201|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
202006|NCT00424177|474201|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
202007|NCT00424047|474230|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
202008|NCT00424047|474231|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
202009|NCT00424047|474230|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
202010|NCT00424047|474231|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
202011|NCT00424047|474230|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
202012|NCT00424047|474231|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
202013|NCT00424047|474230|P2|NOT COMPLETED|On Study at Time of Unblinding||167
202014|NCT00424047|474231|P1|NOT COMPLETED|On Study at Time of Unblinding||155
202015|NCT00424047|474230|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
202016|NCT00424047|474231|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
202017|NCT00424047|474230|P2|STARTED|On Study at Time of Unblinding||175
202018|NCT00424047|474231|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
202019|NCT00424047|474230|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
202020|NCT00424047|474231|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
202021|NCT00424047|474230|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
202022|NCT00424047|474231|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
202023|NCT00424047|474230|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
202024|NCT00424047|474231|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
202025|NCT00424047|474230|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
202026|NCT00424047|474231|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
202027|NCT00424047|474230|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
202028|NCT00424047|474231|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
202029|NCT00424021|474263|P4|NOT COMPLETED|AMB-220-E Study Period||10
202030|NCT00424021|474264|P3|NOT COMPLETED|AMB-220-E Study Period||5
202031|NCT00424021|474265|P2|NOT COMPLETED|AMB-220-E Study Period||2
202032|NCT00424021|474266|P1|NOT COMPLETED|AMB-220-E Study Period||1
202033|NCT00424021|474263|P4|COMPLETED|AMB-220-E Study Period||16
202034|NCT00424021|474264|P3|COMPLETED|AMB-220-E Study Period||14
202035|NCT00424021|474265|P2|COMPLETED|AMB-220-E Study Period||5
202036|NCT00424021|474266|P1|COMPLETED|AMB-220-E Study Period||1
202037|NCT00424021|474263|P4|STARTED|AMB-220-E Study Period||26
202038|NCT00424021|474264|P3|STARTED|AMB-220-E Study Period||19
202039|NCT00424021|474265|P2|STARTED|AMB-220-E Study Period||7
202040|NCT00424021|474266|P1|STARTED|AMB-220-E Study Period||2
202041|NCT00424021|474263|P4|NOT COMPLETED|NCT00046319 Study Period||1
202042|NCT00424021|474264|P3|NOT COMPLETED|NCT00046319 Study Period||1
202043|NCT00424021|474265|P2|NOT COMPLETED|NCT00046319 Study Period||3
202044|NCT00424021|474266|P1|NOT COMPLETED|NCT00046319 Study Period||1
202045|NCT00424021|474263|P4|COMPLETED|NCT00046319 Study Period||12
202046|NCT00424021|474264|P3|COMPLETED|NCT00046319 Study Period||15
202047|NCT00424021|474265|P2|COMPLETED|NCT00046319 Study Period||16
202048|NCT00424021|474266|P1|COMPLETED|NCT00046319 Study Period||15
202049|NCT00424021|474263|P4|STARTED|NCT00046319 Study Period||13
202050|NCT00424021|474264|P3|STARTED|NCT00046319 Study Period||16
202051|NCT00424021|474265|P2|STARTED|NCT00046319 Study Period||19
202052|NCT00424021|474266|P1|STARTED|NCT00046319 Study Period||16
202053|NCT00424008|474309|P2|NOT COMPLETED|Overall Study||335
202054|NCT00424008|474310|P1|NOT COMPLETED|Overall Study||349
202055|NCT00424008|474309|P2|COMPLETED|Overall Study||16
202056|NCT00424008|474310|P1|COMPLETED|Overall Study||22
202057|NCT00424008|474309|P2|STARTED|Overall Study||351
202058|NCT00424008|474310|P1|STARTED|Overall Study||371
202059|NCT00423891|474326|P3|NOT COMPLETED|Post-Dosing Follow Up||1
202060|NCT00423891|474327|P2|NOT COMPLETED|Post-Dosing Follow Up||17
202061|NCT00423891|474328|P1|NOT COMPLETED|Post-Dosing Follow Up||2
202062|NCT00423891|474326|P3|COMPLETED|Post-Dosing Follow Up||0
202063|NCT00423891|474327|P2|COMPLETED|Post-Dosing Follow Up||1
202064|NCT00423891|474328|P1|COMPLETED|Post-Dosing Follow Up||20
202065|NCT00423891|474326|P3|STARTED|Post-Dosing Follow Up||1
202066|NCT00423891|474327|P2|STARTED|Post-Dosing Follow Up|1 participant completed treatment but did not enter post dosing follow up period: Withdrew Consent.|18
202067|NCT00423891|474328|P1|STARTED|Post-Dosing Follow Up||22
202068|NCT00423891|474326|P3|NOT COMPLETED|Treatment||4
202069|NCT00423891|474327|P2|NOT COMPLETED|Treatment||0
202070|NCT00423891|474328|P1|NOT COMPLETED|Treatment||2
202071|NCT00423891|474326|P3|COMPLETED|Treatment||1
202072|NCT00423891|474327|P2|COMPLETED|Treatment||19
202073|NCT00423891|474328|P1|COMPLETED|Treatment||22
202074|NCT00423891|474326|P3|STARTED|Treatment||5
202075|NCT00423891|474327|P2|STARTED|Treatment||19
202076|NCT00423891|474328|P1|STARTED|Treatment||24
202077|NCT00423891|474326|P3|NOT COMPLETED|Enrolled||3
202078|NCT00423891|474327|P2|NOT COMPLETED|Enrolled||2
202079|NCT00423891|474328|P1|NOT COMPLETED|Enrolled||11
202081|NCT00423891|474327|P2|COMPLETED|Enrolled||19
202082|NCT00423891|474328|P1|COMPLETED|Enrolled||24
202083|NCT00423891|474326|P3|STARTED|Enrolled||8
202084|NCT00423891|474327|P2|STARTED|Enrolled||21
202085|NCT00423891|474328|P1|STARTED|Enrolled||35
202086|NCT00423878|474397|P2|NOT COMPLETED|Overall Study||8
202087|NCT00423878|474398|P1|NOT COMPLETED|Overall Study||20
202088|NCT00423878|474397|P2|COMPLETED|Overall Study||98
202089|NCT00423878|474398|P1|COMPLETED|Overall Study||89
202090|NCT00423878|474397|P2|STARTED|Overall Study||106
202091|NCT00423878|474398|P1|STARTED|Overall Study||109
202092|NCT00423852|474406|P1|NOT COMPLETED|Overall Study||3
202093|NCT00423852|474406|P1|COMPLETED|Overall Study||23
202094|NCT00423852|474406|P1|STARTED|Overall Study||26
202095|NCT00423813|474414|P3|NOT COMPLETED|Overall Study||74
202096|NCT00423813|474415|P2|NOT COMPLETED|Overall Study||66
202097|NCT00423813|474416|P1|NOT COMPLETED|Overall Study||57
202098|NCT00423813|474414|P3|COMPLETED|Overall Study||116
202099|NCT00423813|474415|P2|COMPLETED|Overall Study||129
202100|NCT00423813|474416|P1|COMPLETED|Overall Study||131
202101|NCT00423813|474414|P3|Treated|Overall Study||189
202102|NCT00423813|474415|P2|Treated|Overall Study||194
202103|NCT00423813|474416|P1|Treated|Overall Study||188
202104|NCT00423813|474414|P3|STARTED|Overall Study||190
202105|NCT00423813|474415|P2|STARTED|Overall Study||195
202106|NCT00423813|474416|P1|STARTED|Overall Study||188
202107|NCT00423800|474426|P2|NOT COMPLETED|Overall Study||1
202108|NCT00423800|474427|P1|NOT COMPLETED|Overall Study||0
202109|NCT00423800|474426|P2|COMPLETED|Overall Study||1
202110|NCT00423800|474427|P1|COMPLETED|Overall Study||3
202111|NCT00423800|474426|P2|STARTED|Overall Study||2
202112|NCT00423800|474427|P1|STARTED|Overall Study||3
202113|NCT00423735|474439|P3|NOT COMPLETED|Overall Study||0
202114|NCT00423735|474440|P2|NOT COMPLETED|Overall Study||6
202115|NCT00423735|474441|P1|NOT COMPLETED|Overall Study||8
202116|NCT00423735|474439|P3|COMPLETED|Overall Study||0
202117|NCT00423735|474440|P2|COMPLETED|Overall Study||29
202118|NCT00423735|474441|P1|COMPLETED|Overall Study||21
202119|NCT00423735|474439|P3|STARTED|Overall Study||0
202120|NCT00423735|474440|P2|STARTED|Overall Study||35
202121|NCT00423735|474441|P1|STARTED|Overall Study||29
202122|NCT00423722|474452|P2|NOT COMPLETED|Overall Study||13
202123|NCT00423722|474453|P1|NOT COMPLETED|Overall Study||14
202124|NCT00423722|474452|P2|COMPLETED|Overall Study||53
202125|NCT00423722|474453|P1|COMPLETED|Overall Study||49
202126|NCT00423722|474452|P2|STARTED|Overall Study||66
202127|NCT00423722|474453|P1|STARTED|Overall Study||63
202128|NCT00423683|474475|P2|NOT COMPLETED|Overall Study||0
202129|NCT00423683|474476|P1|NOT COMPLETED|Overall Study||1
202130|NCT00423683|474475|P2|COMPLETED|Overall Study||33
202131|NCT00423683|474476|P1|COMPLETED|Overall Study||30
202132|NCT00423683|474475|P2|STARTED|Overall Study||33
202133|NCT00423683|474476|P1|STARTED|Overall Study||31
202134|NCT00423670|474495|P8|NOT COMPLETED|Follow-up Period||3
202135|NCT00423670|474496|P7|NOT COMPLETED|Follow-up Period||9
202136|NCT00423670|474497|P6|NOT COMPLETED|Follow-up Period||0
202137|NCT00423670|474498|P5|NOT COMPLETED|Follow-up Period||2
202138|NCT00423670|474499|P4|NOT COMPLETED|Follow-up Period||5
202139|NCT00423670|474500|P3|NOT COMPLETED|Follow-up Period||11
202140|NCT00423670|474501|P2|NOT COMPLETED|Follow-up Period||16
202141|NCT00423670|474502|P1|NOT COMPLETED|Follow-up Period||3
202142|NCT00423670|474495|P8|COMPLETED|Follow-up Period||32
202143|NCT00423670|474496|P7|COMPLETED|Follow-up Period||41
202144|NCT00423670|474497|P6|COMPLETED|Follow-up Period||14
202145|NCT00423670|474498|P5|COMPLETED|Follow-up Period||89
202146|NCT00423670|474499|P4|COMPLETED|Follow-up Period||91
202147|NCT00423670|474500|P3|COMPLETED|Follow-up Period||85
202148|NCT00423670|474501|P2|COMPLETED|Follow-up Period||84
202149|NCT00423670|474502|P1|COMPLETED|Follow-up Period||94
202150|NCT00423670|474495|P8|STARTED|Follow-up Period||35
202151|NCT00423670|474496|P7|STARTED|Follow-up Period||50
202152|NCT00423670|474497|P6|STARTED|Follow-up Period||14
202153|NCT00423670|474498|P5|STARTED|Follow-up Period||91
202154|NCT00423670|474499|P4|STARTED|Follow-up Period||96
202155|NCT00423670|474500|P3|STARTED|Follow-up Period||96
202156|NCT00423670|474501|P2|STARTED|Follow-up Period||100
202157|NCT00423670|474502|P1|STARTED|Follow-up Period||97
202158|NCT00423670|474495|P8|NOT COMPLETED|Treatment Period||21
202159|NCT00423670|474496|P7|NOT COMPLETED|Treatment Period||31
202160|NCT00423670|474497|P6|NOT COMPLETED|Treatment Period||8
202161|NCT00423670|474498|P5|NOT COMPLETED|Treatment Period||27
202162|NCT00423670|474499|P4|NOT COMPLETED|Treatment Period||40
202163|NCT00423670|474500|P3|NOT COMPLETED|Treatment Period||27
202164|NCT00423670|474501|P2|NOT COMPLETED|Treatment Period||30
202165|NCT00423670|474502|P1|NOT COMPLETED|Treatment Period||52
202166|NCT00423670|474495|P8|COMPLETED|Treatment Period||15
202167|NCT00423670|474496|P7|COMPLETED|Treatment Period||28
202168|NCT00423670|474497|P6|COMPLETED|Treatment Period||8
202169|NCT00423670|474498|P5|COMPLETED|Treatment Period||76
202170|NCT00423670|474499|P4|COMPLETED|Treatment Period||63
202171|NCT00423670|474500|P3|COMPLETED|Treatment Period||76
202172|NCT00423670|474501|P2|COMPLETED|Treatment Period||77
202173|NCT00423670|474502|P1|COMPLETED|Treatment Period||52
202174|NCT00423670|474495|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
202175|NCT00423670|474496|P7|STARTED|Treatment Period||59
202176|NCT00423670|474497|P6|STARTED|Treatment Period||16
202177|NCT00423670|474498|P5|STARTED|Treatment Period||103
202178|NCT00423670|474499|P4|STARTED|Treatment Period||103
202179|NCT00423670|474500|P3|STARTED|Treatment Period||103
202180|NCT00423670|474501|P2|STARTED|Treatment Period||107
202181|NCT00423670|474502|P1|STARTED|Treatment Period||104
202182|NCT00423657|474560|P2|NOT COMPLETED|Overall Study||25
202183|NCT00423657|474561|P1|NOT COMPLETED|Overall Study||26
202184|NCT00423657|474560|P2|COMPLETED|Overall Study||313
202185|NCT00423657|474561|P1|COMPLETED|Overall Study||316
202186|NCT00423657|474560|P2|STARTED|Overall Study||338
202187|NCT00423657|474561|P1|STARTED|Overall Study||342
202188|NCT00423605|474567|P1|NOT COMPLETED|Overall Study||241
202189|NCT00423605|474567|P1|COMPLETED|Overall Study||319
202190|NCT00423605|474567|P1|STARTED|Overall Study||560
202191|NCT00423592|474571|P1|NOT COMPLETED|Overall Study||7
202192|NCT00423592|474571|P1|COMPLETED|Overall Study|Completed study|29
202193|NCT00423592|474571|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
202194|NCT00423592|474571|P1|STARTED|Overall Study|Enrolled|36
202195|NCT00423579|474592|P2|NOT COMPLETED|Overall Study||4
202196|NCT00423579|474593|P1|NOT COMPLETED|Overall Study||4
202197|NCT00423579|474592|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
202198|NCT00423579|474593|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
202199|NCT00423579|474592|P2|STARTED|Overall Study||60
202200|NCT00423579|474593|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
202201|NCT00423488|474601|P2|NOT COMPLETED|Overall Study||1
202202|NCT00423488|474602|P1|NOT COMPLETED|Overall Study||5
202203|NCT00423488|474601|P2|COMPLETED|Overall Study||50
202204|NCT00423488|474602|P1|COMPLETED|Overall Study||37
202205|NCT00423488|474601|P2|STARTED|Overall Study||51
202206|NCT00423488|474602|P1|STARTED|Overall Study||42
202207|NCT00423449|474608|P5|NOT COMPLETED|Overall Study||7
202208|NCT00423449|474609|P4|NOT COMPLETED|Overall Study||22
202209|NCT00423449|474610|P3|NOT COMPLETED|Overall Study||15
202210|NCT00423449|474611|P2|NOT COMPLETED|Overall Study||4
202211|NCT00423449|474612|P1|NOT COMPLETED|Overall Study||3
202212|NCT00423449|474608|P5|COMPLETED|Overall Study||0
202213|NCT00423449|474609|P4|COMPLETED|Overall Study||5
202214|NCT00423449|474610|P3|COMPLETED|Overall Study||2
202215|NCT00423449|474611|P2|COMPLETED|Overall Study||2
202216|NCT00423449|474612|P1|COMPLETED|Overall Study||1
202217|NCT00423449|474608|P5|STARTED|Overall Study||7
202218|NCT00423449|474609|P4|STARTED|Overall Study||27
202219|NCT00423449|474610|P3|STARTED|Overall Study||17
202220|NCT00423449|474611|P2|STARTED|Overall Study||6
202221|NCT00423449|474612|P1|STARTED|Overall Study||4
202222|NCT00423436|474637|P2|NOT COMPLETED|Overall Study||0
202223|NCT00423436|474638|P1|NOT COMPLETED|Overall Study||0
202224|NCT00423436|474637|P2|COMPLETED|Overall Study||33
202225|NCT00423436|474638|P1|COMPLETED|Overall Study||35
202226|NCT00423436|474637|P2|STARTED|Overall Study||33
202227|NCT00423436|474638|P1|STARTED|Overall Study||35
202228|NCT00423358|474646|P2|NOT COMPLETED|Overall Study||0
202229|NCT00423358|474647|P1|NOT COMPLETED|Overall Study||0
202230|NCT00423358|474646|P2|COMPLETED|Overall Study||11
202231|NCT00423358|474647|P1|COMPLETED|Overall Study||11
202232|NCT00423358|474646|P2|STARTED|Overall Study||11
202233|NCT00423358|474647|P1|STARTED|Overall Study||11
202234|NCT00423332|474659|P2|NOT COMPLETED|Overall Study||7
202235|NCT00423332|474660|P1|NOT COMPLETED|Overall Study||9
202236|NCT00423332|474659|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
202237|NCT00423332|474660|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
202238|NCT00423332|474659|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
202239|NCT00423332|474660|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
202240|NCT00423332|474659|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
202241|NCT00423332|474660|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
202242|NCT00423332|474659|P2|STARTED|Overall Study|Number randomised|18
202243|NCT00423332|474660|P1|STARTED|Overall Study|Randomised|53
202244|NCT00423319|474679|P2|NOT COMPLETED|Overall Study||252
202245|NCT00423319|474680|P1|NOT COMPLETED|Overall Study||224
202246|NCT00423319|474679|P2|COMPLETED|Overall Study||2447
202247|NCT00423319|474680|P1|COMPLETED|Overall Study||2484
202248|NCT00423319|474679|P2|Participants Who Received Treatment|Overall Study||2659
202249|NCT00423319|474680|P1|Participants Who Received Treatment|Overall Study||2673
202250|NCT00423319|474679|P2|STARTED|Overall Study|Randomized|2699
202251|NCT00423319|474680|P1|STARTED|Overall Study|Randomized|2708
202252|NCT00423293|474712|P1|NOT COMPLETED|Overall Study||11
202253|NCT00423293|474712|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
202254|NCT00423293|474712|P1|STARTED|Overall Study||63
202255|NCT00423267|474718|P2|NOT COMPLETED|Period B||0
202256|NCT00423267|474719|P1|NOT COMPLETED|Period B||0
202257|NCT00423267|474718|P2|COMPLETED|Period B||0
202258|NCT00423267|474719|P1|COMPLETED|Period B||12
202259|NCT00423267|474718|P2|STARTED|Period B||0
202260|NCT00423267|474719|P1|STARTED|Period B||12
202261|NCT00423267|474718|P2|NOT COMPLETED|Period A||1
202262|NCT00423267|474719|P1|NOT COMPLETED|Period A||2
202263|NCT00423267|474718|P2|COMPLETED|Period A||6
202264|NCT00423267|474719|P1|COMPLETED|Period A||7
202265|NCT00423267|474718|P2|STARTED|Period A||7
202266|NCT00423267|474719|P1|STARTED|Period A||9
202267|NCT00423189|474739|P3|NOT COMPLETED|Overall Study||0
202268|NCT00423189|474740|P2|NOT COMPLETED|Overall Study||1
202269|NCT00423189|474741|P1|NOT COMPLETED|Overall Study||0
202270|NCT00423189|474739|P3|COMPLETED|Overall Study||2
202271|NCT00423189|474740|P2|COMPLETED|Overall Study||2
202272|NCT00423189|474741|P1|COMPLETED|Overall Study||2
202273|NCT00423189|474739|P3|STARTED|Overall Study||2
202274|NCT00423189|474740|P2|STARTED|Overall Study||3
202275|NCT00423189|474741|P1|STARTED|Overall Study||2
202276|NCT00423176|474763|P2|NOT COMPLETED|Overall Study||29
202277|NCT00423176|474764|P1|NOT COMPLETED|Overall Study||16
202278|NCT00423176|474763|P2|COMPLETED|Overall Study||94
202279|NCT00423176|474764|P1|COMPLETED|Overall Study||98
202280|NCT00423176|474763|P2|STARTED|Overall Study||123
202281|NCT00423176|474764|P1|STARTED|Overall Study||114
202282|NCT00423150|474772|P1|NOT COMPLETED|Overall Study||86
202283|NCT00423150|474772|P1|COMPLETED|Overall Study||0
202284|NCT00423150|474772|P1|STARTED|Overall Study||86
202285|NCT00423098|474778|P2|NOT COMPLETED|Overall Study||4
202286|NCT00423098|474779|P1|NOT COMPLETED|Overall Study||3
202287|NCT00423098|474778|P2|COMPLETED|Overall Study||35
202288|NCT00423098|474779|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
202289|NCT00423098|474778|P2|STARTED|Overall Study||39
202290|NCT00423098|474779|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
202291|NCT00423085|474806|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
202292|NCT00423085|474807|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
202293|NCT00423085|474808|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
202294|NCT00423085|474809|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
202295|NCT00423085|474806|P4|COMPLETED|52-Week Open-Label Extension Phase||474
202296|NCT00423085|474807|P3|COMPLETED|52-Week Open-Label Extension Phase||0
202297|NCT00423085|474808|P2|COMPLETED|52-Week Open-Label Extension Phase||0
202298|NCT00423085|474809|P1|COMPLETED|52-Week Open-Label Extension Phase||0
202299|NCT00423085|474806|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
202300|NCT00423085|474807|P3|STARTED|52-Week Open-Label Extension Phase||0
202301|NCT00423085|474808|P2|STARTED|52-Week Open-Label Extension Phase||0
202302|NCT00423085|474809|P1|STARTED|52-Week Open-Label Extension Phase||0
202303|NCT00423085|474806|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
202304|NCT00423085|474807|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
202305|NCT00423085|474808|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
202306|NCT00423085|474809|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
202307|NCT00423085|474806|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
202308|NCT00423085|474807|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
202309|NCT00423085|474808|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
202310|NCT00423085|474809|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
202311|NCT00423085|474806|P4|STARTED|24-Week Double-Blind Treatment Phase||0
202312|NCT00423085|474807|P3|STARTED|24-Week Double-Blind Treatment Phase||287
202313|NCT00423085|474808|P2|STARTED|24-Week Double-Blind Treatment Phase||284
202314|NCT00423085|474809|P1|STARTED|24-Week Double-Blind Treatment Phase||288
202315|NCT00423046|474838|P2|NOT COMPLETED|Overall Study||345
202316|NCT00423046|474839|P1|NOT COMPLETED|Overall Study||340
202317|NCT00423046|474838|P2|COMPLETED|Overall Study|Completed until Month 60|208
202318|NCT00423046|474839|P1|COMPLETED|Overall Study|Completed until Month 60|213
202319|NCT00423046|474838|P2|STARTED|Overall Study||553
202320|NCT00423046|474839|P1|STARTED|Overall Study||553
202321|NCT00422942|474905|P1|NOT COMPLETED|Overall Study||3
202322|NCT00422942|474905|P1|COMPLETED|Overall Study||0
202323|NCT00422942|474905|P1|STARTED|Overall Study||3
202324|NCT00422903|474924|P2|NOT COMPLETED|Overall Study||5
202325|NCT00422903|474925|P1|NOT COMPLETED|Overall Study||4
202326|NCT00422903|474924|P2|COMPLETED|Overall Study||38
202327|NCT00422903|474925|P1|COMPLETED|Overall Study||45
202328|NCT00422903|474924|P2|STARTED|Overall Study||43
202329|NCT00422903|474925|P1|STARTED|Overall Study||49
202330|NCT00422734|474951|P2|NOT COMPLETED|Overall Study||21
202331|NCT00422734|474952|P1|NOT COMPLETED|Overall Study||14
202332|NCT00422734|474951|P2|COMPLETED|Overall Study||243
202333|NCT00422734|474952|P1|COMPLETED|Overall Study||64
202334|NCT00422734|474951|P2|STARTED|Overall Study||264
202335|NCT00422734|474952|P1|STARTED|Overall Study||78
202336|NCT00422669|474987|P3|NOT COMPLETED|Overall Study||7
202337|NCT00422669|474988|P2|NOT COMPLETED|Overall Study||100
202338|NCT00422669|474989|P1|NOT COMPLETED|Overall Study||98
202339|NCT00422669|474987|P3|COMPLETED|Overall Study||0
202340|NCT00422669|474988|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
202341|NCT00422669|474989|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
202342|NCT00422669|474987|P3|STARTED|Overall Study||7
202343|NCT00422669|474988|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
202344|NCT00422669|474989|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
202345|NCT00422656|475010|P1|NOT COMPLETED|Overall Study||0
202346|NCT00422656|475010|P1|COMPLETED|Overall Study||37
202347|NCT00422656|475010|P1|STARTED|Overall Study||37
202348|NCT00422513|475016|P2|NOT COMPLETED|Overall Study||106
202349|NCT00422513|475017|P1|NOT COMPLETED|Overall Study||107
202350|NCT00422513|475016|P2|COMPLETED|Overall Study||24
202351|NCT00422513|475017|P1|COMPLETED|Overall Study||23
202352|NCT00422513|475016|P2|STARTED|Overall Study||130
202353|NCT00422513|475017|P1|STARTED|Overall Study||130
202354|NCT00422448|475029|P1|NOT COMPLETED|Overall Study||0
202355|NCT00422448|475029|P1|COMPLETED|Overall Study||43
202356|NCT00422448|475029|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
202357|NCT00422422|475034|P1|NOT COMPLETED|Overall Study||10
202358|NCT00422422|475034|P1|COMPLETED|Overall Study||90
202359|NCT00422422|475034|P1|STARTED|Overall Study||100
202360|NCT00422383|475051|P5|NOT COMPLETED|Overall Study||3
202361|NCT00422383|475052|P4|NOT COMPLETED|Overall Study||2
202362|NCT00422383|475053|P3|NOT COMPLETED|Overall Study||4
202363|NCT00422383|475054|P2|NOT COMPLETED|Overall Study||14
202364|NCT00422383|475055|P1|NOT COMPLETED|Overall Study||15
202365|NCT00422383|475051|P5|COMPLETED|Overall Study||22
202366|NCT00422383|475052|P4|COMPLETED|Overall Study||4
202367|NCT00422383|475053|P3|COMPLETED|Overall Study||89
202368|NCT00422383|475054|P2|COMPLETED|Overall Study||106
202369|NCT00422383|475055|P1|COMPLETED|Overall Study||119
202370|NCT00422383|475051|P5|STARTED|Overall Study||25
202371|NCT00422383|475052|P4|STARTED|Overall Study||6
202372|NCT00422383|475053|P3|STARTED|Overall Study||93
202373|NCT00422383|475054|P2|STARTED|Overall Study||120
202374|NCT00422383|475055|P1|STARTED|Overall Study||134
202375|NCT00422292|475198|P4|NOT COMPLETED|Overall Study||24
202376|NCT00422292|475199|P3|NOT COMPLETED|Overall Study||22
202377|NCT00422292|475200|P2|NOT COMPLETED|Overall Study||66
202378|NCT00422292|475201|P1|NOT COMPLETED|Overall Study||18
202379|NCT00422292|475198|P4|COMPLETED|Overall Study||452
202380|NCT00422292|475199|P3|COMPLETED|Overall Study||224
202381|NCT00422292|475200|P2|COMPLETED|Overall Study||598
202382|NCT00422292|475201|P1|COMPLETED|Overall Study||239
202383|NCT00422292|475198|P4|STARTED|Overall Study||476
202384|NCT00422292|475199|P3|STARTED|Overall Study||246
202385|NCT00422292|475200|P2|STARTED|Overall Study||664
202386|NCT00422292|475201|P1|STARTED|Overall Study||257
202387|NCT00422279|475229|P2|NOT COMPLETED|Overall Study||0
202388|NCT00422279|475230|P1|NOT COMPLETED|Overall Study||0
202389|NCT00422279|475229|P2|COMPLETED|Overall Study||2
202390|NCT00422279|475230|P1|COMPLETED|Overall Study||2
202391|NCT00422279|475229|P2|24 Month After Loading Period|Overall Study||2
202392|NCT00422279|475230|P1|24 Month After Loading Period|Overall Study||2
202393|NCT00422279|475229|P2|STARTED|Overall Study||2
202394|NCT00422279|475230|P1|STARTED|Overall Study||2
202395|NCT00422227|475240|P2|NOT COMPLETED|Overall Study||15
202396|NCT00422227|475241|P1|NOT COMPLETED|Overall Study||4
202397|NCT00422227|475240|P2|COMPLETED|Overall Study||88
202398|NCT00422227|475241|P1|COMPLETED|Overall Study||193
202399|NCT00422227|475240|P2|STARTED|Overall Study||103
202400|NCT00422227|475241|P1|STARTED|Overall Study||197
202401|NCT00422201|475265|P1|NOT COMPLETED|Overall Study||11
202402|NCT00422201|475265|P1|COMPLETED|Overall Study||7
202403|NCT00422201|475265|P1|STARTED|Overall Study||18
202404|NCT00422162|475271|P2|NOT COMPLETED|Overall Study||30
202405|NCT00422162|475272|P1|NOT COMPLETED|Overall Study||24
202406|NCT00422162|475271|P2|COMPLETED|Overall Study||142
202407|NCT00422162|475272|P1|COMPLETED|Overall Study||143
202408|NCT00422162|475271|P2|Received Treatment|Overall Study||171
202409|NCT00422162|475272|P1|Received Treatment|Overall Study||167
202410|NCT00422162|475271|P2|STARTED|Overall Study||172
202411|NCT00422162|475272|P1|STARTED|Overall Study||167
202412|NCT00422097|475332|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202413|NCT00422097|475333|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202414|NCT00422097|475334|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202415|NCT00422097|475335|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202416|NCT00422097|475336|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202417|NCT00422097|475337|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202418|NCT00422097|475338|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202419|NCT00422097|475339|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
202420|NCT00422097|475332|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
202421|NCT00422097|475333|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
202422|NCT00422097|475334|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
202423|NCT00422097|475335|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
202424|NCT00422097|475336|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
202425|NCT00422097|475337|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
202426|NCT00422097|475338|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
202427|NCT00422097|475339|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
202428|NCT00422097|475332|P8|STARTED|Ixabepilone With Famotidine or Food||7
202429|NCT00422097|475333|P7|STARTED|Ixabepilone With Famotidine or Food||8
202430|NCT00422097|475334|P6|STARTED|Ixabepilone With Famotidine or Food||0
202431|NCT00422097|475335|P5|STARTED|Ixabepilone With Famotidine or Food||0
202432|NCT00422097|475336|P4|STARTED|Ixabepilone With Famotidine or Food||0
202433|NCT00422097|475337|P3|STARTED|Ixabepilone With Famotidine or Food||0
202434|NCT00422097|475338|P2|STARTED|Ixabepilone With Famotidine or Food||0
202435|NCT00422097|475339|P1|STARTED|Ixabepilone With Famotidine or Food||0
202436|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 6||0
202437|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 6||0
202438|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 6||0
202439|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 6||0
202440|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 6||0
202441|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 6||0
202442|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 6||0
202443|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 6||0
202444|NCT00422097|475332|P8|COMPLETED|Dose Level 6||0
202445|NCT00422097|475333|P7|COMPLETED|Dose Level 6||0
202446|NCT00422097|475334|P6|COMPLETED|Dose Level 6||6
202447|NCT00422097|475335|P5|COMPLETED|Dose Level 6||0
202448|NCT00422097|475336|P4|COMPLETED|Dose Level 6||0
202449|NCT00422097|475337|P3|COMPLETED|Dose Level 6||0
202450|NCT00422097|475338|P2|COMPLETED|Dose Level 6||0
202451|NCT00422097|475339|P1|COMPLETED|Dose Level 6||0
202452|NCT00422097|475332|P8|STARTED|Dose Level 6||0
202453|NCT00422097|475333|P7|STARTED|Dose Level 6||0
202454|NCT00422097|475334|P6|STARTED|Dose Level 6||6
202455|NCT00422097|475335|P5|STARTED|Dose Level 6||0
202456|NCT00422097|475336|P4|STARTED|Dose Level 6||0
202457|NCT00422097|475337|P3|STARTED|Dose Level 6||0
202458|NCT00422097|475338|P2|STARTED|Dose Level 6||0
202459|NCT00422097|475339|P1|STARTED|Dose Level 6||0
202460|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 5||0
202461|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 5||0
202462|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 5||0
202463|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 5||0
202464|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 5||0
202465|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 5||0
202466|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 5||0
202467|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 5||0
202468|NCT00422097|475332|P8|COMPLETED|Dose Level 5||0
202469|NCT00422097|475333|P7|COMPLETED|Dose Level 5||0
202470|NCT00422097|475334|P6|COMPLETED|Dose Level 5||0
202471|NCT00422097|475335|P5|COMPLETED|Dose Level 5||23
202472|NCT00422097|475336|P4|COMPLETED|Dose Level 5||0
202473|NCT00422097|475337|P3|COMPLETED|Dose Level 5||0
202474|NCT00422097|475338|P2|COMPLETED|Dose Level 5||0
202475|NCT00422097|475339|P1|COMPLETED|Dose Level 5||0
202476|NCT00422097|475332|P8|STARTED|Dose Level 5||0
202477|NCT00422097|475333|P7|STARTED|Dose Level 5||0
202478|NCT00422097|475334|P6|STARTED|Dose Level 5||0
202479|NCT00422097|475335|P5|STARTED|Dose Level 5||23
202480|NCT00422097|475336|P4|STARTED|Dose Level 5||0
202481|NCT00422097|475337|P3|STARTED|Dose Level 5||0
202482|NCT00422097|475338|P2|STARTED|Dose Level 5||0
202483|NCT00422097|475339|P1|STARTED|Dose Level 5||0
202484|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 4||0
202485|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 4||0
202486|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 4||0
202487|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 4||0
202488|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 4||0
202489|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 4||0
202490|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 4||0
202491|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 4||0
202492|NCT00422097|475332|P8|COMPLETED|Dose Level 4||0
202493|NCT00422097|475333|P7|COMPLETED|Dose Level 4||0
202494|NCT00422097|475334|P6|COMPLETED|Dose Level 4||0
202495|NCT00422097|475335|P5|COMPLETED|Dose Level 4||0
202496|NCT00422097|475336|P4|COMPLETED|Dose Level 4||3
202497|NCT00422097|475337|P3|COMPLETED|Dose Level 4||0
202498|NCT00422097|475338|P2|COMPLETED|Dose Level 4||0
202499|NCT00422097|475339|P1|COMPLETED|Dose Level 4||0
202500|NCT00422097|475332|P8|STARTED|Dose Level 4||0
202501|NCT00422097|475333|P7|STARTED|Dose Level 4||0
202502|NCT00422097|475334|P6|STARTED|Dose Level 4||0
202503|NCT00422097|475335|P5|STARTED|Dose Level 4||0
202504|NCT00422097|475336|P4|STARTED|Dose Level 4||3
202505|NCT00422097|475337|P3|STARTED|Dose Level 4||0
202506|NCT00422097|475338|P2|STARTED|Dose Level 4||0
202507|NCT00422097|475339|P1|STARTED|Dose Level 4||0
202508|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 3||0
202509|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 3||0
202510|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 3||0
202511|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 3||0
202512|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 3||0
202513|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 3||0
202514|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 3||0
202515|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 3||0
202516|NCT00422097|475332|P8|COMPLETED|Dose Level 3||0
202517|NCT00422097|475333|P7|COMPLETED|Dose Level 3||0
202518|NCT00422097|475334|P6|COMPLETED|Dose Level 3||0
202519|NCT00422097|475335|P5|COMPLETED|Dose Level 3||0
202520|NCT00422097|475336|P4|COMPLETED|Dose Level 3||0
202521|NCT00422097|475337|P3|COMPLETED|Dose Level 3||3
202522|NCT00422097|475338|P2|COMPLETED|Dose Level 3||0
202523|NCT00422097|475339|P1|COMPLETED|Dose Level 3||0
202524|NCT00422097|475332|P8|STARTED|Dose Level 3||0
202525|NCT00422097|475333|P7|STARTED|Dose Level 3||0
202526|NCT00422097|475334|P6|STARTED|Dose Level 3||0
202527|NCT00422097|475335|P5|STARTED|Dose Level 3||0
202528|NCT00422097|475336|P4|STARTED|Dose Level 3||0
202529|NCT00422097|475337|P3|STARTED|Dose Level 3||3
202530|NCT00422097|475338|P2|STARTED|Dose Level 3||0
202531|NCT00422097|475339|P1|STARTED|Dose Level 3||0
202532|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 2||0
202533|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 2||0
202534|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 2||0
202535|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 2||0
202536|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 2||0
202537|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 2||0
202538|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 2||1
202539|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 2||0
202540|NCT00422097|475332|P8|COMPLETED|Dose Level 2||0
202541|NCT00422097|475333|P7|COMPLETED|Dose Level 2||0
202542|NCT00422097|475334|P6|COMPLETED|Dose Level 2||0
202543|NCT00422097|475335|P5|COMPLETED|Dose Level 2||0
202544|NCT00422097|475336|P4|COMPLETED|Dose Level 2||0
202545|NCT00422097|475337|P3|COMPLETED|Dose Level 2||0
202546|NCT00422097|475338|P2|COMPLETED|Dose Level 2||5
202547|NCT00422097|475339|P1|COMPLETED|Dose Level 2||0
202548|NCT00422097|475332|P8|STARTED|Dose Level 2||0
202549|NCT00422097|475333|P7|STARTED|Dose Level 2||0
202550|NCT00422097|475334|P6|STARTED|Dose Level 2||0
202551|NCT00422097|475335|P5|STARTED|Dose Level 2||0
202552|NCT00422097|475336|P4|STARTED|Dose Level 2||0
202553|NCT00422097|475337|P3|STARTED|Dose Level 2||0
202554|NCT00422097|475338|P2|STARTED|Dose Level 2||6
202555|NCT00422097|475339|P1|STARTED|Dose Level 2||0
202556|NCT00422097|475332|P8|NOT COMPLETED|Dose Level 1||0
202557|NCT00422097|475333|P7|NOT COMPLETED|Dose Level 1||0
202558|NCT00422097|475334|P6|NOT COMPLETED|Dose Level 1||0
202559|NCT00422097|475335|P5|NOT COMPLETED|Dose Level 1||0
202560|NCT00422097|475336|P4|NOT COMPLETED|Dose Level 1||0
202561|NCT00422097|475337|P3|NOT COMPLETED|Dose Level 1||0
202562|NCT00422097|475338|P2|NOT COMPLETED|Dose Level 1||0
202563|NCT00422097|475339|P1|NOT COMPLETED|Dose Level 1||0
202564|NCT00422097|475332|P8|COMPLETED|Dose Level 1||0
202565|NCT00422097|475333|P7|COMPLETED|Dose Level 1||0
202566|NCT00422097|475334|P6|COMPLETED|Dose Level 1||0
202567|NCT00422097|475335|P5|COMPLETED|Dose Level 1||0
202568|NCT00422097|475336|P4|COMPLETED|Dose Level 1||0
202569|NCT00422097|475337|P3|COMPLETED|Dose Level 1||0
202570|NCT00422097|475338|P2|COMPLETED|Dose Level 1||0
202571|NCT00422097|475339|P1|COMPLETED|Dose Level 1||3
202572|NCT00422097|475332|P8|STARTED|Dose Level 1||0
202573|NCT00422097|475333|P7|STARTED|Dose Level 1||0
202574|NCT00422097|475334|P6|STARTED|Dose Level 1||0
202575|NCT00422097|475335|P5|STARTED|Dose Level 1||0
202576|NCT00422097|475336|P4|STARTED|Dose Level 1||0
202577|NCT00422097|475337|P3|STARTED|Dose Level 1||0
202578|NCT00422097|475338|P2|STARTED|Dose Level 1||0
202579|NCT00422097|475339|P1|STARTED|Dose Level 1||3
202580|NCT00422058|475404|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
202581|NCT00422058|475405|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
202582|NCT00422058|475406|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
202583|NCT00422058|475407|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
202584|NCT00422058|475408|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
202585|NCT00422058|475409|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
202586|NCT00422058|475404|P6|COMPLETED|Open-Label Extension, Week 20-104||45
202587|NCT00422058|475405|P5|COMPLETED|Open-Label Extension, Week 20-104||47
202588|NCT00422058|475406|P4|COMPLETED|Open-Label Extension, Week 20-104||45
202589|NCT00422058|475407|P3|COMPLETED|Open-Label Extension, Week 20-104||38
202590|NCT00422058|475408|P2|COMPLETED|Open-Label Extension, Week 20-104||46
202591|NCT00422058|475409|P1|COMPLETED|Open-Label Extension, Week 20-104||47
202592|NCT00422058|475404|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
202593|NCT00422058|475405|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
202594|NCT00422058|475406|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
202595|NCT00422058|475407|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
202596|NCT00422058|475408|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
202597|NCT00422058|475409|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
202598|NCT00422058|475404|P6|STARTED|Open-Label Extension, Week 20-104||79
202599|NCT00422058|475405|P5|STARTED|Open-Label Extension, Week 20-104||82
202600|NCT00422058|475406|P4|STARTED|Open-Label Extension, Week 20-104||73
202601|NCT00422058|475407|P3|STARTED|Open-Label Extension, Week 20-104||74
202602|NCT00422058|475408|P2|STARTED|Open-Label Extension, Week 20-104||85
202603|NCT00422058|475409|P1|STARTED|Open-Label Extension, Week 20-104||79
202604|NCT00422058|475404|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
202605|NCT00422058|475405|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
202606|NCT00422058|475406|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
202607|NCT00422058|475407|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
202608|NCT00422058|475408|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
202609|NCT00422058|475409|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
202610|NCT00422058|475404|P6|COMPLETED|Double-Blind, Week 0-20||79
202611|NCT00422058|475405|P5|COMPLETED|Double-Blind, Week 0-20||82
202612|NCT00422058|475406|P4|COMPLETED|Double-Blind, Week 0-20||73
202613|NCT00422058|475407|P3|COMPLETED|Double-Blind, Week 0-20||74
202614|NCT00422058|475408|P2|COMPLETED|Double-Blind, Week 0-20||85
202615|NCT00422058|475409|P1|COMPLETED|Double-Blind, Week 0-20||79
202616|NCT00422058|475404|P6|STARTED|Double-Blind, Week 0-20||95
202617|NCT00422058|475405|P5|STARTED|Double-Blind, Week 0-20||93
202618|NCT00422058|475406|P4|STARTED|Double-Blind, Week 0-20||93
202619|NCT00422058|475407|P3|STARTED|Double-Blind, Week 0-20||90
202620|NCT00422058|475408|P2|STARTED|Double-Blind, Week 0-20||95
202621|NCT00422058|475409|P1|STARTED|Double-Blind, Week 0-20||98
202622|NCT00422032|475539|P2|NOT COMPLETED|Overall Study||0
202623|NCT00422032|475540|P1|NOT COMPLETED|Overall Study||0
202624|NCT00422032|475539|P2|COMPLETED|Overall Study||21
202625|NCT00422032|475540|P1|COMPLETED|Overall Study||37
202626|NCT00422032|475539|P2|STARTED|Overall Study||21
202627|NCT00422032|475540|P1|STARTED|Overall Study||37
202628|NCT00421993|475550|P4|NOT COMPLETED|Overall Study||57
202629|NCT00421993|475551|P3|NOT COMPLETED|Overall Study||52
202630|NCT00421993|475552|P2|NOT COMPLETED|Overall Study||49
202631|NCT00421993|475553|P1|NOT COMPLETED|Overall Study||53
202632|NCT00421993|475550|P4|COMPLETED|Overall Study||361
202633|NCT00421993|475551|P3|COMPLETED|Overall Study||363
202634|NCT00421993|475552|P2|COMPLETED|Overall Study||369
202635|NCT00421993|475553|P1|COMPLETED|Overall Study||366
202636|NCT00421993|475550|P4|STARTED|Overall Study||418
202637|NCT00421993|475551|P3|STARTED|Overall Study||415
202638|NCT00421993|475552|P2|STARTED|Overall Study||418
202639|NCT00421993|475553|P1|STARTED|Overall Study||419
202640|NCT00421954|475583|P1|NOT COMPLETED|Overall Study||0
202641|NCT00421954|475583|P1|COMPLETED|Overall Study||0
202642|NCT00421954|475583|P1|STARTED|Overall Study||0
202643|NCT00421928|475590|P3|NOT COMPLETED|Overall Study||134
202644|NCT00421928|475591|P2|NOT COMPLETED|Overall Study||224
202645|NCT00421928|475592|P1|NOT COMPLETED|Overall Study||163
202646|NCT00421928|475590|P3|COMPLETED|Overall Study||203
202647|NCT00421928|475591|P2|COMPLETED|Overall Study||118
202648|NCT00421928|475592|P1|COMPLETED|Overall Study||181
202649|NCT00421928|475590|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
202650|NCT00421928|475591|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
202651|NCT00421928|475592|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
202652|NCT00421889|475627|P9|NOT COMPLETED|Overall Study||11
202653|NCT00421889|475628|P8|NOT COMPLETED|Overall Study||2
202654|NCT00421889|475629|P7|NOT COMPLETED|Overall Study||4
202655|NCT00421889|475630|P6|NOT COMPLETED|Overall Study||35
202656|NCT00421889|475631|P5|NOT COMPLETED|Overall Study||6
202657|NCT00421889|475632|P4|NOT COMPLETED|Overall Study||4
202658|NCT00421889|475633|P3|NOT COMPLETED|Overall Study||3
202659|NCT00421889|475634|P2|NOT COMPLETED|Overall Study||5
202660|NCT00421889|475635|P1|NOT COMPLETED|Overall Study||5
202661|NCT00421889|475627|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
202662|NCT00421889|475628|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
202663|NCT00421889|475629|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
202664|NCT00421889|475630|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
202665|NCT00421889|475631|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
202666|NCT00421889|475632|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
202667|NCT00421889|475633|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
202668|NCT00421889|475634|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
202669|NCT00421889|475635|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
202670|NCT00421889|475627|P9|STARTED|Overall Study||15
202671|NCT00421889|475628|P8|STARTED|Overall Study||3
202672|NCT00421889|475629|P7|STARTED|Overall Study||4
202673|NCT00421889|475630|P6|STARTED|Overall Study||35
202674|NCT00421889|475631|P5|STARTED|Overall Study||6
202675|NCT00421889|475632|P4|STARTED|Overall Study||4
202676|NCT00421889|475633|P3|STARTED|Overall Study||3
202677|NCT00421889|475634|P2|STARTED|Overall Study||5
202678|NCT00421889|475635|P1|STARTED|Overall Study||5
202679|NCT00421733|475680|P3|NOT COMPLETED|Overall Study||20
202680|NCT00421733|475681|P2|NOT COMPLETED|Overall Study||26
202681|NCT00421733|475682|P1|NOT COMPLETED|Overall Study||15
202682|NCT00421733|475680|P3|COMPLETED|Overall Study||73
202683|NCT00421733|475681|P2|COMPLETED|Overall Study||69
202684|NCT00421733|475682|P1|COMPLETED|Overall Study||78
202685|NCT00421733|475680|P3|STARTED|Overall Study||93
202686|NCT00421733|475681|P2|STARTED|Overall Study||95
202687|NCT00421733|475682|P1|STARTED|Overall Study||93
202688|NCT00421603|475702|P2|NOT COMPLETED|Overall Study||12
202689|NCT00421603|475703|P1|NOT COMPLETED|Overall Study||11
202690|NCT00421603|475702|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
202691|NCT00421603|475703|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
202692|NCT00421603|475702|P2|STARTED|Overall Study||42
202693|NCT00421603|475703|P1|STARTED|Overall Study||39
202694|NCT00421408|475711|P2|NOT COMPLETED|Overall Study||45
202695|NCT00421408|475712|P1|NOT COMPLETED|Overall Study||42
202696|NCT00421408|475711|P2|COMPLETED|Overall Study||61
202697|NCT00421408|475712|P1|COMPLETED|Overall Study||60
202698|NCT00421408|475711|P2|STARTED|Overall Study||106
202699|NCT00421408|475712|P1|STARTED|Overall Study||102
202700|NCT00421343|475730|P1|NOT COMPLETED|Overall Study||6
202701|NCT00421343|475730|P1|COMPLETED|Overall Study||23
202702|NCT00421343|475730|P1|STARTED|Overall Study||29
202703|NCT00421174|475736|P2|NOT COMPLETED|Overall Study||1
202704|NCT00421174|475737|P1|NOT COMPLETED|Overall Study||2
202705|NCT00421174|475736|P2|COMPLETED|Overall Study||18
202706|NCT00421174|475737|P1|COMPLETED|Overall Study||16
202707|NCT00421174|475736|P2|STARTED|Overall Study||19
202708|NCT00421174|475737|P1|STARTED|Overall Study||18
202709|NCT00420992|475767|P2|NOT COMPLETED|Maintenance Phase||75
202710|NCT00420992|475768|P1|NOT COMPLETED|Maintenance Phase||61
202711|NCT00420992|475767|P2|COMPLETED|Maintenance Phase||98
202712|NCT00420992|475768|P1|COMPLETED|Maintenance Phase||110
202713|NCT00420992|475767|P2|STARTED|Maintenance Phase||173
202714|NCT00420992|475768|P1|STARTED|Maintenance Phase||171
202715|NCT00420992|475767|P2|NOT COMPLETED|Titration Phase||0
202716|NCT00420992|475768|P1|NOT COMPLETED|Titration Phase||203
202717|NCT00420992|475767|P2|COMPLETED|Titration Phase||0
202718|NCT00420992|475768|P1|COMPLETED|Titration Phase||344
202719|NCT00420992|475767|P2|STARTED|Titration Phase||0
202720|NCT00420992|475768|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
202721|NCT00420927|475782|P7|NOT COMPLETED|Period 2||53
202722|NCT00420927|475783|P6|NOT COMPLETED|Period 2||15
202723|NCT00420927|475784|P5|NOT COMPLETED|Period 2||43
202724|NCT00420927|475785|P4|NOT COMPLETED|Period 2||10
202725|NCT00420927|475786|P3|NOT COMPLETED|Period 2||13
202726|NCT00420927|475787|P2|NOT COMPLETED|Period 2||0
202727|NCT00420927|475788|P1|NOT COMPLETED|Period 2||0
202728|NCT00420927|475782|P7|COMPLETED|Period 2||295
202729|NCT00420927|475783|P6|COMPLETED|Period 2||97
202730|NCT00420927|475784|P5|COMPLETED|Period 2||216
202731|NCT00420927|475785|P4|COMPLETED|Period 2||95
202732|NCT00420927|475786|P3|COMPLETED|Period 2||89
202733|NCT00420927|475787|P2|COMPLETED|Period 2||0
202734|NCT00420927|475788|P1|COMPLETED|Period 2||0
202735|NCT00420927|475782|P7|STARTED|Period 2||348
202736|NCT00420927|475783|P6|STARTED|Period 2||112
202737|NCT00420927|475784|P5|STARTED|Period 2||259
202738|NCT00420927|475785|P4|STARTED|Period 2||105
202739|NCT00420927|475786|P3|STARTED|Period 2||102
202740|NCT00420927|475787|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
202741|NCT00420927|475788|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
202742|NCT00420927|475782|P7|NOT COMPLETED|Period 1||0
202743|NCT00420927|475783|P6|NOT COMPLETED|Period 1||0
202744|NCT00420927|475784|P5|NOT COMPLETED|Period 1||0
202745|NCT00420927|475785|P4|NOT COMPLETED|Period 1||0
202746|NCT00420927|475786|P3|NOT COMPLETED|Period 1||0
202747|NCT00420927|475787|P2|NOT COMPLETED|Period 1||57
202748|NCT00420927|475788|P1|NOT COMPLETED|Period 1||49
202749|NCT00420927|475782|P7|COMPLETED|Period 1||0
202750|NCT00420927|475783|P6|COMPLETED|Period 1||0
202751|NCT00420927|475784|P5|COMPLETED|Period 1||0
202752|NCT00420927|475785|P4|COMPLETED|Period 1||0
202753|NCT00420927|475786|P3|COMPLETED|Period 1||0
202754|NCT00420927|475787|P2|COMPLETED|Period 1||460
202755|NCT00420927|475788|P1|COMPLETED|Period 1||466
202756|NCT00420927|475782|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
202757|NCT00420927|475783|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
202758|NCT00420927|475784|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
202759|NCT00420927|475785|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
202760|NCT00420927|475786|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
202761|NCT00420927|475787|P2|STARTED|Period 1||517
202762|NCT00420927|475788|P1|STARTED|Period 1||515
202763|NCT00418834|475894|P2|NOT COMPLETED|Overall Study||20
202764|NCT00418834|475895|P1|NOT COMPLETED|Overall Study||23
202765|NCT00418834|475894|P2|COMPLETED|Overall Study||507
202766|NCT00418834|475895|P1|COMPLETED|Overall Study||503
202767|NCT00418834|475894|P2|STARTED|Overall Study||527
202768|NCT00418834|475895|P1|STARTED|Overall Study||526
202769|NCT00418717|475955|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
202770|NCT00418717|475955|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
202771|NCT00418717|475955|P1|STARTED|Treatment Period B - Weeks 5-12||41
202772|NCT00418717|475955|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
202773|NCT00418717|475955|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
202774|NCT00418717|475955|P1|STARTED|Treatment Period A - Weeks 1-4||42
202775|NCT00418691|475963|P3|NOT COMPLETED|Overall Study||5
202776|NCT00418691|475964|P2|NOT COMPLETED|Overall Study||2
202777|NCT00418691|475965|P1|NOT COMPLETED|Overall Study||2
202778|NCT00418691|475963|P3|COMPLETED|Overall Study||5
202779|NCT00418691|475964|P2|COMPLETED|Overall Study||10
202780|NCT00418691|475965|P1|COMPLETED|Overall Study||9
202781|NCT00418691|475963|P3|STARTED|Overall Study||10
202782|NCT00418691|475964|P2|STARTED|Overall Study||12
202783|NCT00418691|475965|P1|STARTED|Overall Study||11
202784|NCT00420849|475973|P1|NOT COMPLETED|Overall Study||331
202785|NCT00420849|475973|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
202786|NCT00420849|475973|P1|STARTED|Overall Study||587
202787|NCT00420784|476042|P4|NOT COMPLETED|Overall Study||78
202788|NCT00420784|476043|P3|NOT COMPLETED|Overall Study||53
202789|NCT00420784|476044|P2|NOT COMPLETED|Overall Study||58
202790|NCT00420784|476045|P1|NOT COMPLETED|Overall Study||29
202791|NCT00420784|476042|P4|COMPLETED|Overall Study||36
202792|NCT00420784|476043|P3|COMPLETED|Overall Study||58
202793|NCT00420784|476044|P2|COMPLETED|Overall Study||55
202794|NCT00420784|476045|P1|COMPLETED|Overall Study||86
202795|NCT00420784|476042|P4|STARTED|Overall Study||114
202796|NCT00420784|476043|P3|STARTED|Overall Study||111
202797|NCT00420784|476044|P2|STARTED|Overall Study||113
202798|NCT00420784|476045|P1|STARTED|Overall Study||115
202799|NCT00420745|476074|P2|NOT COMPLETED|Overall Study||6
202800|NCT00420745|476075|P1|NOT COMPLETED|Overall Study||15
202801|NCT00420745|476074|P2|COMPLETED|Overall Study||333
202802|NCT00420745|476075|P1|COMPLETED|Overall Study||655
202803|NCT00420745|476074|P2|STARTED|Overall Study||339
202804|NCT00420745|476075|P1|STARTED|Overall Study||670
202805|NCT00420628|476093|P2|NOT COMPLETED|Overall Study||4
202806|NCT00420628|476094|P1|NOT COMPLETED|Overall Study||9
202807|NCT00420628|476093|P2|COMPLETED|Overall Study||32
202808|NCT00420628|476094|P1|COMPLETED|Overall Study||63
202809|NCT00420628|476093|P2|STARTED|Overall Study||36
202810|NCT00420628|476094|P1|STARTED|Overall Study||72
202811|NCT00420511|476110|P2|NOT COMPLETED|Overall Study||1
202812|NCT00420511|476111|P1|NOT COMPLETED|Overall Study||2
202813|NCT00420511|476110|P2|COMPLETED|Overall Study||10
202814|NCT00420511|476111|P1|COMPLETED|Overall Study||8
202815|NCT00420511|476110|P2|STARTED|Overall Study||11
202816|NCT00420511|476111|P1|STARTED|Overall Study||10
202817|NCT00418665|476124|P3|NOT COMPLETED|Treatment Extension||2
202818|NCT00418665|476125|P2|NOT COMPLETED|Treatment Extension||4
202819|NCT00418665|476126|P1|NOT COMPLETED|Treatment Extension||6
202820|NCT00418665|476124|P3|COMPLETED|Treatment Extension||7
202821|NCT00418665|476125|P2|COMPLETED|Treatment Extension||4
202822|NCT00418665|476126|P1|COMPLETED|Treatment Extension||1
202823|NCT00418665|476124|P3|STARTED|Treatment Extension||9
202824|NCT00418665|476125|P2|STARTED|Treatment Extension||8
202825|NCT00418665|476126|P1|STARTED|Treatment Extension||7
202826|NCT00418665|476124|P3|NOT COMPLETED|Treatment Period||4
202827|NCT00418665|476125|P2|NOT COMPLETED|Treatment Period||6
202828|NCT00418665|476126|P1|NOT COMPLETED|Treatment Period||5
202829|NCT00418665|476124|P3|COMPLETED|Treatment Period||9
202830|NCT00418665|476125|P2|COMPLETED|Treatment Period||8
202831|NCT00418665|476126|P1|COMPLETED|Treatment Period||7
202832|NCT00418665|476124|P3|Received Study Medication|Treatment Period||13
202833|NCT00418665|476125|P2|Received Study Medication|Treatment Period||13
202834|NCT00418665|476126|P1|Received Study Medication|Treatment Period||11
202835|NCT00418665|476124|P3|STARTED|Treatment Period||13
202836|NCT00418665|476125|P2|STARTED|Treatment Period||14
202837|NCT00418665|476126|P1|STARTED|Treatment Period||12
202838|NCT00418574|476145|P2|NOT COMPLETED|Overall Study||23
202839|NCT00418574|476146|P1|NOT COMPLETED|Overall Study||48
202840|NCT00418574|476145|P2|COMPLETED|Overall Study||272
202841|NCT00418574|476146|P1|COMPLETED|Overall Study||545
202842|NCT00418574|476145|P2|TREATED|Overall Study||294
202843|NCT00418574|476146|P1|TREATED|Overall Study||592
202844|NCT00418574|476145|P2|STARTED|Overall Study||295
202845|NCT00418574|476146|P1|STARTED|Overall Study||593
202846|NCT00418561|476160|P3|NOT COMPLETED|Overall Study||0
202847|NCT00418561|476161|P2|NOT COMPLETED|Overall Study||1
202848|NCT00418561|476162|P1|NOT COMPLETED|Overall Study||0
202849|NCT00418561|476160|P3|COMPLETED|Overall Study||4
202850|NCT00418561|476161|P2|COMPLETED|Overall Study||4
202851|NCT00418561|476162|P1|COMPLETED|Overall Study||4
202852|NCT00418561|476160|P3|STARTED|Overall Study||4
202853|NCT00418561|476161|P2|STARTED|Overall Study||5
202854|NCT00418561|476162|P1|STARTED|Overall Study||4
202855|NCT00418522|476232|P2|NOT COMPLETED|Overall Study||42
202856|NCT00418522|476233|P1|NOT COMPLETED|Overall Study||83
202857|NCT00418522|476232|P2|COMPLETED|Overall Study||152
202858|NCT00418522|476233|P1|COMPLETED|Overall Study||136
202859|NCT00418522|476232|P2|Received Treatment|Overall Study||190
202860|NCT00418522|476233|P1|Received Treatment|Overall Study||212
202861|NCT00418522|476232|P2|STARTED|Overall Study||194
202862|NCT00418522|476233|P1|STARTED|Overall Study||219
202863|NCT00420420|476279|P2|NOT COMPLETED|Overall Study||4
202864|NCT00420420|476280|P1|NOT COMPLETED|Overall Study||8
202865|NCT00420420|476279|P2|COMPLETED|Overall Study||67
202866|NCT00420420|476280|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
202867|NCT00420420|476279|P2|STARTED|Overall Study|Number of patients randomized.|71
202868|NCT00420420|476280|P1|STARTED|Overall Study|Number of patients randomized.|73
202869|NCT00420407|476298|P2|NOT COMPLETED|Overall Study||6
202870|NCT00420407|476299|P1|NOT COMPLETED|Overall Study||4
202871|NCT00420407|476298|P2|COMPLETED|Overall Study||34
202872|NCT00420407|476299|P1|COMPLETED|Overall Study||37
202873|NCT00420407|476298|P2|STARTED|Overall Study||40
202874|NCT00420407|476299|P1|STARTED|Overall Study||41
202875|NCT00420342|476308|P3|NOT COMPLETED|Overall Study||1
202876|NCT00420342|476309|P2|NOT COMPLETED|Overall Study||2
202877|NCT00420342|476310|P1|NOT COMPLETED|Overall Study||1
202878|NCT00420342|476308|P3|COMPLETED|Overall Study||28
202879|NCT00420342|476309|P2|COMPLETED|Overall Study||31
202880|NCT00420342|476310|P1|COMPLETED|Overall Study||29
202881|NCT00420342|476308|P3|Received Treatment|Overall Study||29
202882|NCT00420342|476309|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
202883|NCT00420342|476310|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
202884|NCT00420342|476308|P3|STARTED|Overall Study||29
202885|NCT00420342|476309|P2|STARTED|Overall Study||33
202886|NCT00420342|476310|P1|STARTED|Overall Study||30
202887|NCT00420303|476353|P2|NOT COMPLETED|Overall Study||4
202888|NCT00420303|476354|P1|NOT COMPLETED|Overall Study||1
202889|NCT00420303|476353|P2|COMPLETED|Overall Study||8
202890|NCT00420303|476354|P1|COMPLETED|Overall Study||11
202891|NCT00420303|476353|P2|STARTED|Overall Study||12
202892|NCT00420303|476354|P1|STARTED|Overall Study||12
202893|NCT00420290|476366|P2|NOT COMPLETED|Overall Study||4
202894|NCT00420290|476367|P1|NOT COMPLETED|Overall Study||4
202895|NCT00420290|476366|P2|COMPLETED|Overall Study||7
202896|NCT00420290|476367|P1|COMPLETED|Overall Study||7
202897|NCT00420290|476366|P2|STARTED|Overall Study||11
202898|NCT00420290|476367|P1|STARTED|Overall Study||11
202899|NCT00420238|476383|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
202900|NCT00420238|476384|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
202901|NCT00420238|476383|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
202902|NCT00420238|476384|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
202903|NCT00420238|476383|P2|STARTED|12 Week Open-Label Treatment Period 2||39
202904|NCT00420238|476384|P1|STARTED|12 Week Open-Label Treatment Period 2||38
202905|NCT00420238|476383|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
202906|NCT00420238|476384|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
202907|NCT00420238|476383|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
202908|NCT00420238|476384|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
202909|NCT00420238|476383|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
202910|NCT00420238|476384|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
202911|NCT00420212|476523|P3|NOT COMPLETED|Overall Study||96
202912|NCT00420212|476524|P2|NOT COMPLETED|Overall Study||95
202913|NCT00420212|476525|P1|NOT COMPLETED|Overall Study||91
202914|NCT00420212|476523|P3|COMPLETED|Overall Study||320
202915|NCT00420212|476524|P2|COMPLETED|Overall Study||315
202916|NCT00420212|476525|P1|COMPLETED|Overall Study||317
202917|NCT00420212|476523|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
202918|NCT00420212|476524|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
202919|NCT00420212|476525|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
202920|NCT00420199|476551|P2|NOT COMPLETED|Overall Study||0
202921|NCT00420199|476552|P1|NOT COMPLETED|Overall Study||1
202922|NCT00420199|476551|P2|COMPLETED|Overall Study||23
202923|NCT00420199|476552|P1|COMPLETED|Overall Study||26
202924|NCT00420199|476551|P2|STARTED|Overall Study||23
202925|NCT00420199|476552|P1|STARTED|Overall Study||27
202926|NCT00420095|476607|P2|NOT COMPLETED|Overall Study||1
202927|NCT00420095|476608|P1|NOT COMPLETED|Overall Study||3
202928|NCT00420095|476607|P2|COMPLETED|Overall Study||59
202929|NCT00420095|476608|P1|COMPLETED|Overall Study||54
202930|NCT00420095|476607|P2|STARTED|Overall Study||60
202931|NCT00420095|476608|P1|STARTED|Overall Study||57
202932|NCT00420056|476626|P1|NOT COMPLETED|Overall Study||17
202933|NCT00420056|476626|P1|COMPLETED|Overall Study||0
202934|NCT00420056|476626|P1|STARTED|Overall Study||17
202935|NCT00420017|476650|P2|NOT COMPLETED|Overall Study||0
202936|NCT00420017|476651|P1|NOT COMPLETED|Overall Study||2
202937|NCT00420017|476650|P2|COMPLETED|Overall Study||40
202938|NCT00420017|476651|P1|COMPLETED|Overall Study|40 completed analysis|38
202939|NCT00420017|476650|P2|STARTED|Overall Study||40
202940|NCT00420017|476651|P1|STARTED|Overall Study||40
202941|NCT00419952|476665|P2|NOT COMPLETED|Overall Study||125
202942|NCT00419952|476666|P1|NOT COMPLETED|Overall Study||149
202943|NCT00419952|476665|P2|COMPLETED|Overall Study||240
202944|NCT00419952|476666|P1|COMPLETED|Overall Study||228
202945|NCT00419952|476665|P2|STARTED|Overall Study||365
202946|NCT00419952|476666|P1|STARTED|Overall Study||377
202947|NCT00419926|476700|P2|NOT COMPLETED|Overall Study||10
202948|NCT00419926|476701|P1|NOT COMPLETED|Overall Study||14
202949|NCT00419926|476700|P2|COMPLETED|Overall Study||148
202950|NCT00419926|476701|P1|COMPLETED|Overall Study||141
202951|NCT00419926|476700|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
202952|NCT00419926|476701|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
202953|NCT00419770|476717|P2|NOT COMPLETED|Overall Study||1
202954|NCT00419770|476718|P1|NOT COMPLETED|Overall Study||5
202955|NCT00419770|476717|P2|COMPLETED|Overall Study||8
202956|NCT00419770|476718|P1|COMPLETED|Overall Study||6
202957|NCT00419770|476717|P2|STARTED|Overall Study||9
202958|NCT00419770|476718|P1|STARTED|Overall Study||11
202959|NCT00419757|476726|P2|NOT COMPLETED|Overall Study||21
202960|NCT00419757|476727|P1|NOT COMPLETED|Overall Study||18
202961|NCT00419757|476726|P2|COMPLETED|Overall Study|Randomized patients|102
202962|NCT00419757|476727|P1|COMPLETED|Overall Study|Randomized patients|109
202963|NCT00419757|476726|P2|STARTED|Overall Study|Randomized patients|123
202964|NCT00419757|476727|P1|STARTED|Overall Study|Randomized patients|127
202965|NCT00419744|476766|P3|NOT COMPLETED|Overall Study||133
202966|NCT00419744|476767|P2|NOT COMPLETED|Overall Study||118
202967|NCT00419744|476768|P1|NOT COMPLETED|Overall Study||117
202968|NCT00419744|476766|P3|COMPLETED|Overall Study||271
202969|NCT00419744|476767|P2|COMPLETED|Overall Study||290
202970|NCT00419744|476768|P1|COMPLETED|Overall Study||290
202971|NCT00419744|476766|P3|STARTED|Overall Study||404
202972|NCT00419744|476767|P2|STARTED|Overall Study||408
202973|NCT00419744|476768|P1|STARTED|Overall Study||407
202974|NCT00418379|476800|P3|NOT COMPLETED|Year 5||3
202975|NCT00418379|476801|P2|NOT COMPLETED|Year 5||5
202976|NCT00418379|476802|P1|NOT COMPLETED|Year 5||2
202977|NCT00418379|476800|P3|COMPLETED|Year 5||131
202978|NCT00418379|476801|P2|COMPLETED|Year 5||115
202979|NCT00418379|476802|P1|COMPLETED|Year 5||126
202980|NCT00418379|476800|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
202981|NCT00418379|476801|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
202982|NCT00418379|476802|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
202983|NCT00418379|476800|P3|NOT COMPLETED|Year 4||2
202984|NCT00418379|476801|P2|NOT COMPLETED|Year 4||5
202985|NCT00418379|476802|P1|NOT COMPLETED|Year 4||3
202986|NCT00418379|476800|P3|COMPLETED|Year 4||154
202987|NCT00418379|476801|P2|COMPLETED|Year 4||136
202988|NCT00418379|476802|P1|COMPLETED|Year 4||142
202989|NCT00418379|476800|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
202990|NCT00418379|476801|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
202991|NCT00418379|476802|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
202992|NCT00418379|476800|P3|NOT COMPLETED|Year 3||3
202993|NCT00418379|476801|P2|NOT COMPLETED|Year 3||2
202994|NCT00418379|476802|P1|NOT COMPLETED|Year 3||3
202995|NCT00418379|476800|P3|COMPLETED|Year 3||163
202996|NCT00418379|476801|P2|COMPLETED|Year 3||146
202997|NCT00418379|476802|P1|COMPLETED|Year 3||148
202998|NCT00418379|476800|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
202999|NCT00418379|476801|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
203000|NCT00418379|476802|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
203001|NCT00418379|476800|P3|NOT COMPLETED|Year 2||10
203002|NCT00418379|476801|P2|NOT COMPLETED|Year 2||4
203003|NCT00418379|476802|P1|NOT COMPLETED|Year 2||8
203004|NCT00418379|476800|P3|COMPLETED|Year 2||172
203005|NCT00418379|476801|P2|COMPLETED|Year 2||155
203006|NCT00418379|476802|P1|COMPLETED|Year 2||159
203007|NCT00418379|476800|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
203008|NCT00418379|476801|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
203009|NCT00418379|476802|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
203010|NCT00418379|476800|P3|NOT COMPLETED|Year 1||15
203011|NCT00418379|476801|P2|NOT COMPLETED|Year 1||28
203012|NCT00418379|476802|P1|NOT COMPLETED|Year 1||18
203013|NCT00418379|476800|P3|COMPLETED|Year 1||204
203014|NCT00418379|476801|P2|COMPLETED|Year 1||179
203015|NCT00418379|476802|P1|COMPLETED|Year 1||189
203016|NCT00418379|476800|P3|STARTED|Year 1||219
203017|NCT00418379|476801|P2|STARTED|Year 1||207
203018|NCT00418379|476802|P1|STARTED|Year 1||207
203019|NCT00419445|476813|P3|NOT COMPLETED|Overall Study||1
203020|NCT00419445|476814|P2|NOT COMPLETED|Overall Study||2
203021|NCT00419445|476815|P1|NOT COMPLETED|Overall Study||1
203022|NCT00419445|476813|P3|COMPLETED|Overall Study||7
203023|NCT00419445|476814|P2|COMPLETED|Overall Study||14
203024|NCT00419445|476815|P1|COMPLETED|Overall Study||7
203025|NCT00419445|476813|P3|STARTED|Overall Study||8
203026|NCT00419445|476814|P2|STARTED|Overall Study||16
203027|NCT00419445|476815|P1|STARTED|Overall Study||8
203028|NCT00419393|476823|P1|NOT COMPLETED|Overall Study||24
203029|NCT00419393|476823|P1|COMPLETED|Overall Study||166
203030|NCT00419393|476823|P1|STARTED|Overall Study|One subject did not receive medication|190
203031|NCT00419380|476833|P2|NOT COMPLETED|Overall Study||10
203032|NCT00419380|476834|P1|NOT COMPLETED|Overall Study||1
203033|NCT00419380|476833|P2|COMPLETED|Overall Study||12
203034|NCT00419380|476834|P1|COMPLETED|Overall Study||18
203035|NCT00419380|476833|P2|STARTED|Overall Study||22
203036|NCT00419380|476834|P1|STARTED|Overall Study||19
203037|NCT00419341|476842|P1|NOT COMPLETED|Efficacy Period||10
203038|NCT00419341|476842|P1|COMPLETED|Efficacy Period||28
203039|NCT00419341|476842|P1|STARTED|Efficacy Period||38
203040|NCT00419341|476842|P1|NOT COMPLETED|Wash in/Wash Out Period||11
203041|NCT00419341|476842|P1|COMPLETED|Wash in/Wash Out Period||38
203042|NCT00419341|476842|P1|STARTED|Wash in/Wash Out Period||49
203043|NCT00419315|476865|P2|NOT COMPLETED|Overall Study||0
203044|NCT00419315|476866|P1|NOT COMPLETED|Overall Study||0
203045|NCT00419315|476865|P2|COMPLETED|Overall Study||78
203046|NCT00419315|476866|P1|COMPLETED|Overall Study||85
203047|NCT00419315|476865|P2|STARTED|Overall Study||78
203048|NCT00419315|476866|P1|STARTED|Overall Study||85
203049|NCT00419263|476877|P3|NOT COMPLETED|Overall Study||3
203050|NCT00419263|476878|P2|NOT COMPLETED|Overall Study||2
203051|NCT00419263|476879|P1|NOT COMPLETED|Overall Study||3
203052|NCT00419263|476877|P3|COMPLETED|Overall Study||112
203053|NCT00419263|476878|P2|COMPLETED|Overall Study||112
203054|NCT00419263|476879|P1|COMPLETED|Overall Study||112
203055|NCT00419263|476877|P3|STARTED|Overall Study||115
203056|NCT00419263|476878|P2|STARTED|Overall Study||114
203057|NCT00419263|476879|P1|STARTED|Overall Study||115
203058|NCT00419159|476908|P2|NOT COMPLETED|Overall Study||100
203059|NCT00419159|476909|P1|NOT COMPLETED|Overall Study||99
203060|NCT00419159|476908|P2|COMPLETED|Overall Study||0
203061|NCT00419159|476909|P1|COMPLETED|Overall Study||0
203062|NCT00419159|476908|P2|STARTED|Overall Study||100
203063|NCT00419159|476909|P1|STARTED|Overall Study|Full Analysis Set|99
203064|NCT00419120|476923|P1|NOT COMPLETED|Long Term Follow up Period||10
203065|NCT00419120|476923|P1|COMPLETED|Long Term Follow up Period||0
203066|NCT00419120|476923|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
203067|NCT00419120|476923|P1|NOT COMPLETED|Primary Study Period||0
203068|NCT00419120|476923|P1|COMPLETED|Primary Study Period||10
203069|NCT00419120|476923|P1|STARTED|Primary Study Period||10
203070|NCT00419094|476930|P2|NOT COMPLETED|Overall Study||30
203071|NCT00419094|476931|P1|NOT COMPLETED|Overall Study||7
203072|NCT00419094|476930|P2|COMPLETED|Overall Study||141
203073|NCT00419094|476931|P1|COMPLETED|Overall Study||50
203074|NCT00419094|476930|P2|STARTED|Overall Study||171
203075|NCT00419094|476931|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
203076|NCT00419003|476945|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
203077|NCT00419003|476946|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
203078|NCT00419003|476945|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
203079|NCT00419003|476946|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
203080|NCT00419003|476945|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
203081|NCT00419003|476946|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
203082|NCT00419003|476945|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
203083|NCT00419003|476946|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
203084|NCT00419003|476945|P2|COMPLETED|Phase I, Ketamine Infusion||7
203085|NCT00419003|476946|P1|COMPLETED|Phase I, Ketamine Infusion||7
203086|NCT00419003|476945|P2|STARTED|Phase I, Ketamine Infusion||13
203087|NCT00419003|476946|P1|STARTED|Phase I, Ketamine Infusion||13
203088|NCT00418977|476957|P2|NOT COMPLETED|Overall Study||3
203089|NCT00418977|476958|P1|NOT COMPLETED|Overall Study||3
203090|NCT00418977|476957|P2|COMPLETED|Overall Study||13
203091|NCT00418977|476958|P1|COMPLETED|Overall Study||40
203092|NCT00418977|476957|P2|STARTED|Overall Study||16
203093|NCT00418977|476958|P1|STARTED|Overall Study||43
203094|NCT00418964|476975|P3|NOT COMPLETED|Overall Study||6
203095|NCT00418964|476976|P2|NOT COMPLETED|Overall Study||3
203096|NCT00418964|476977|P1|NOT COMPLETED|Overall Study||1
203097|NCT00418964|476975|P3|COMPLETED|Overall Study||14
203098|NCT00418964|476976|P2|COMPLETED|Overall Study||17
203099|NCT00418964|476977|P1|COMPLETED|Overall Study||21
203100|NCT00418964|476975|P3|STARTED|Overall Study||20
203101|NCT00418964|476976|P2|STARTED|Overall Study||20
203102|NCT00418964|476977|P1|STARTED|Overall Study||22
203103|NCT00418951|476988|P3|NOT COMPLETED|Overall Study||0
203104|NCT00418951|476989|P2|NOT COMPLETED|Overall Study||0
203105|NCT00418951|476990|P1|NOT COMPLETED|Overall Study||0
203106|NCT00418951|476988|P3|COMPLETED|Overall Study||40
203107|NCT00418951|476989|P2|COMPLETED|Overall Study||33
203108|NCT00418951|476990|P1|COMPLETED|Overall Study||39
203109|NCT00418951|476988|P3|STARTED|Overall Study||40
203110|NCT00418951|476989|P2|STARTED|Overall Study||33
203111|NCT00418951|476990|P1|STARTED|Overall Study||39
203112|NCT00418938|477000|P2|NOT COMPLETED|Overall Study||23
203113|NCT00418938|477001|P1|NOT COMPLETED|Overall Study||24
203114|NCT00418938|477000|P2|COMPLETED|Overall Study||108
203115|NCT00418938|477001|P1|COMPLETED|Overall Study||109
203116|NCT00418938|477000|P2|STARTED|Overall Study||131
203117|NCT00418938|477001|P1|STARTED|Overall Study||133
203118|NCT00418886|477021|P2|NOT COMPLETED|Overall Study||255
203119|NCT00418886|477022|P1|NOT COMPLETED|Overall Study||226
203120|NCT00418886|477021|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
203121|NCT00418886|477022|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
203122|NCT00418886|477021|P2|STARTED|Overall Study|randomised patients|278
203123|NCT00418886|477022|P1|STARTED|Overall Study|randomised patients|256
203124|NCT00418314|477048|P2|NOT COMPLETED|Overall Study||2
203125|NCT00418314|477049|P1|NOT COMPLETED|Overall Study||1
203126|NCT00418314|477048|P2|COMPLETED|Overall Study||828
203127|NCT00418314|477049|P1|COMPLETED|Overall Study||816
203128|NCT00418314|477048|P2|STARTED|Overall Study||830
203129|NCT00418314|477049|P1|STARTED|Overall Study||817
203130|NCT00418184|477061|P2|NOT COMPLETED|Open-label Phase||5
203131|NCT00418184|477062|P1|NOT COMPLETED|Open-label Phase||5
203132|NCT00418184|477061|P2|COMPLETED|Open-label Phase|5 dropped out|43
203133|NCT00418184|477062|P1|COMPLETED|Open-label Phase|5 dropped out|97
203134|NCT00418184|477061|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
203135|NCT00418184|477062|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
203136|NCT00418184|477061|P2|NOT COMPLETED|Double-blind Phase||11
203137|NCT00418184|477062|P1|NOT COMPLETED|Double-blind Phase||27
203138|NCT00418184|477061|P2|COMPLETED|Double-blind Phase||52
203139|NCT00418184|477062|P1|COMPLETED|Double-blind Phase||110
203140|NCT00418184|477061|P2|STARTED|Double-blind Phase||63
203141|NCT00418184|477062|P1|STARTED|Double-blind Phase||137
203142|NCT00418093|477070|P1|NOT COMPLETED|Overall Study||0
203143|NCT00418093|477070|P1|COMPLETED|Overall Study||19
203144|NCT00418093|477070|P1|Completed Study|Overall Study||19
203145|NCT00418093|477070|P1|STARTED|Overall Study||19
203146|NCT00418015|477081|P4|NOT COMPLETED|Overall Study||0
203147|NCT00418015|477082|P3|NOT COMPLETED|Overall Study||0
203148|NCT00418015|477083|P2|NOT COMPLETED|Overall Study||0
203149|NCT00418015|477084|P1|NOT COMPLETED|Overall Study||0
203150|NCT00418015|477081|P4|COMPLETED|Overall Study||25
203151|NCT00418015|477082|P3|COMPLETED|Overall Study||78
203152|NCT00418015|477083|P2|COMPLETED|Overall Study||46
203153|NCT00418015|477084|P1|COMPLETED|Overall Study||144
203154|NCT00418015|477081|P4|STARTED|Overall Study||25
203155|NCT00418015|477082|P3|STARTED|Overall Study||78
203156|NCT00418015|477083|P2|STARTED|Overall Study||46
203157|NCT00418015|477084|P1|STARTED|Overall Study||144
203158|NCT00417989|477112|P2|NOT COMPLETED|Overall Study||22
203159|NCT00417989|477113|P1|NOT COMPLETED|Overall Study||20
203160|NCT00417989|477112|P2|COMPLETED|Overall Study||219
203161|NCT00417989|477113|P1|COMPLETED|Overall Study||224
203162|NCT00417989|477112|P2|STARTED|Overall Study||241
203163|NCT00417989|477113|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
203164|NCT00417976|477133|P1|NOT COMPLETED|Overall Study||3
203165|NCT00417976|477133|P1|COMPLETED|Overall Study||39
203166|NCT00417976|477133|P1|STARTED|Overall Study||42
203167|NCT00417963|477138|P1|NOT COMPLETED|Overall Study||41
203168|NCT00417963|477138|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
203169|NCT00417963|477138|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
203170|NCT00417885|477155|P1|NOT COMPLETED|Overall Study||6
203171|NCT00417885|477155|P1|COMPLETED|Overall Study||0
203172|NCT00417885|477155|P1|STARTED|Overall Study||6
203173|NCT00417612|477166|P2|NOT COMPLETED|Overall Study||3
203174|NCT00417612|477167|P1|NOT COMPLETED|Overall Study||3
203175|NCT00417612|477166|P2|COMPLETED|Overall Study||8
203176|NCT00417612|477167|P1|COMPLETED|Overall Study||19
203177|NCT00417612|477166|P2|STARTED|Overall Study||11
203178|NCT00417612|477167|P1|STARTED|Overall Study||22
203179|NCT00417482|477193|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
203180|NCT00417482|477194|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
203181|NCT00417482|477195|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
203182|NCT00417482|477193|P3|COMPLETED|Phase B 2nd 16 Weeks||10
203183|NCT00417482|477194|P2|COMPLETED|Phase B 2nd 16 Weeks||14
203184|NCT00417482|477195|P1|COMPLETED|Phase B 2nd 16 Weeks||10
203185|NCT00417482|477193|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
203186|NCT00417482|477194|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
203187|NCT00417482|477195|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
203188|NCT00417482|477193|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
203189|NCT00417482|477194|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
203190|NCT00417482|477195|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
203191|NCT00417482|477193|P3|COMPLETED|Phase B 1st 16 Weeks||13
203192|NCT00417482|477194|P2|COMPLETED|Phase B 1st 16 Weeks||27
203193|NCT00417482|477195|P1|COMPLETED|Phase B 1st 16 Weeks||13
203194|NCT00417482|477193|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
203195|NCT00417482|477194|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
203196|NCT00417482|477195|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
203197|NCT00417417|477221|P2|NOT COMPLETED|Overall Study||0
203198|NCT00417417|477222|P1|NOT COMPLETED|Overall Study||0
203199|NCT00417417|477221|P2|COMPLETED|Overall Study||6
203200|NCT00417417|477222|P1|COMPLETED|Overall Study||4
203201|NCT00417417|477221|P2|STARTED|Overall Study||6
203202|NCT00417417|477222|P1|STARTED|Overall Study||4
203203|NCT00417274|477230|P1|NOT COMPLETED|Overall Study||0
203204|NCT00417274|477230|P1|COMPLETED|Overall Study||31
203205|NCT00417274|477230|P1|STARTED|Overall Study||31
203206|NCT00417248|477234|P1|NOT COMPLETED|Overall Study||8
203207|NCT00417248|477234|P1|COMPLETED|Overall Study||0
203208|NCT00417248|477234|P1|STARTED|Overall Study||8
203209|NCT00417170|477241|P2|NOT COMPLETED|Overall Study||3
203210|NCT00417170|477242|P1|NOT COMPLETED|Overall Study||2
203211|NCT00417170|477241|P2|COMPLETED|Overall Study||22
203212|NCT00417170|477242|P1|COMPLETED|Overall Study||21
203213|NCT00417170|477241|P2|Pharmacodynamics Population|Overall Study||23
203214|NCT00417170|477242|P1|Pharmacodynamics Population|Overall Study||21
203215|NCT00417170|477241|P2|STARTED|Overall Study||25
203216|NCT00417170|477242|P1|STARTED|Overall Study|"Started indicates Safety population."|23
203217|NCT00417079|477258|P2|NOT COMPLETED|Overall Study||273
203218|NCT00417079|477259|P1|NOT COMPLETED|Overall Study||331
203219|NCT00417079|477258|P2|COMPLETED|Overall Study|Randomized patients|105
203220|NCT00417079|477259|P1|COMPLETED|Overall Study|Randomized patients|46
203221|NCT00417079|477258|P2|STARTED|Overall Study|Randomized patients|378
203222|NCT00417079|477259|P1|STARTED|Overall Study|Randomized patients|377
203223|NCT00417027|477282|P3|NOT COMPLETED|Overall Study||5
203224|NCT00417027|477283|P2|NOT COMPLETED|Overall Study||5
203225|NCT00417027|477284|P1|NOT COMPLETED|Overall Study||0
203226|NCT00417027|477282|P3|COMPLETED|Overall Study||54
203227|NCT00417027|477283|P2|COMPLETED|Overall Study||60
203228|NCT00417027|477284|P1|COMPLETED|Overall Study||66
203229|NCT00417027|477282|P3|STARTED|Overall Study||59
203230|NCT00417027|477283|P2|STARTED|Overall Study||65
203231|NCT00417027|477284|P1|STARTED|Overall Study||66
203232|NCT00416884|477310|P1|NOT COMPLETED|Overall Study||1
203233|NCT00416884|477310|P1|COMPLETED|Overall Study||0
203234|NCT00416884|477310|P1|STARTED|Overall Study||1
203235|NCT00416793|477314|P1|NOT COMPLETED|Overall Study||0
203236|NCT00416793|477314|P1|COMPLETED|Overall Study||9
203237|NCT00416793|477314|P1|STARTED|Overall Study||9
203238|NCT00416624|477322|P4|NOT COMPLETED|Overall Study||17
203239|NCT00416624|477323|P3|NOT COMPLETED|Overall Study||18
203240|NCT00416624|477324|P2|NOT COMPLETED|Overall Study||27
203241|NCT00416624|477325|P1|NOT COMPLETED|Overall Study||22
203242|NCT00416624|477322|P4|COMPLETED|Overall Study||40
203243|NCT00416624|477323|P3|COMPLETED|Overall Study||40
203244|NCT00416624|477324|P2|COMPLETED|Overall Study||33
203245|NCT00416624|477325|P1|COMPLETED|Overall Study||39
203246|NCT00416624|477322|P4|STARTED|Overall Study||57
203247|NCT00416624|477323|P3|STARTED|Overall Study||58
203248|NCT00416624|477324|P2|STARTED|Overall Study||60
203249|NCT00416624|477325|P1|STARTED|Overall Study||61
203250|NCT00416598|477379|P1|NOT COMPLETED|Decitabine Maintenance||72
203251|NCT00416598|477379|P1|COMPLETED|Decitabine Maintenance||62
203252|NCT00416598|477379|P1|STARTED|Decitabine Maintenance||134
203253|NCT00416598|477379|P1|NOT COMPLETED|Induction & Intensification||412
203254|NCT00416598|477379|P1|COMPLETED|Induction & Intensification||134
203255|NCT00416598|477379|P1|STARTED|Induction & Intensification||546
203256|NCT00416572|477387|P3|NOT COMPLETED|Overall Study||8
203257|NCT00416572|477388|P2|NOT COMPLETED|Overall Study||7
203258|NCT00416572|477389|P1|NOT COMPLETED|Overall Study||13
203259|NCT00416572|477387|P3|COMPLETED|Overall Study||76
203260|NCT00416572|477388|P2|COMPLETED|Overall Study||78
203261|NCT00416572|477389|P1|COMPLETED|Overall Study||70
203262|NCT00416572|477387|P3|STARTED|Overall Study||84
203263|NCT00416572|477388|P2|STARTED|Overall Study||85
203264|NCT00416572|477389|P1|STARTED|Overall Study||83
203265|NCT00416520|477405|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
203266|NCT00416520|477406|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
203267|NCT00416520|477407|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
203268|NCT00416520|477408|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
203269|NCT00416520|477405|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
203270|NCT00416520|477406|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
203271|NCT00416520|477407|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
203272|NCT00416520|477408|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
203273|NCT00416520|477405|P4|STARTED|Placebo-controlled Withdrawal Period||54
203274|NCT00416520|477406|P3|STARTED|Placebo-controlled Withdrawal Period||50
203275|NCT00416520|477407|P2|STARTED|Placebo-controlled Withdrawal Period||0
203276|NCT00416520|477408|P1|STARTED|Placebo-controlled Withdrawal Period||0
203277|NCT00416520|477405|P4|NOT COMPLETED|Open-label Period||0
203278|NCT00416520|477406|P3|NOT COMPLETED|Open-label Period||0
203279|NCT00416520|477407|P2|NOT COMPLETED|Open-label Period||32
203280|NCT00416520|477408|P1|NOT COMPLETED|Open-label Period||60
203281|NCT00416520|477405|P4|COMPLETED|Open-label Period||0
203282|NCT00416520|477406|P3|COMPLETED|Open-label Period||0
203283|NCT00416520|477407|P2|COMPLETED|Open-label Period||139
203284|NCT00416520|477408|P1|COMPLETED|Open-label Period||105
203285|NCT00416520|477405|P4|STARTED|Open-label Period||0
203286|NCT00416520|477406|P3|STARTED|Open-label Period||0
203287|NCT00416520|477407|P2|STARTED|Open-label Period||171
203288|NCT00416520|477408|P1|STARTED|Open-label Period||165
203289|NCT00416494|477420|P2|NOT COMPLETED|Overall Study||0
203290|NCT00416494|477421|P1|NOT COMPLETED|Overall Study||0
203291|NCT00416494|477420|P2|COMPLETED|Overall Study||31
203292|NCT00416494|477421|P1|COMPLETED|Overall Study||19
203293|NCT00416494|477420|P2|STARTED|Overall Study||31
203294|NCT00416494|477421|P1|STARTED|Overall Study||19
203295|NCT00416455|477437|P2|NOT COMPLETED|Overall Study||8
203296|NCT00416455|477438|P1|NOT COMPLETED|Overall Study||16
203297|NCT00416455|477437|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
203298|NCT00416455|477438|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
203299|NCT00416455|477437|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
203300|NCT00416455|477438|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
203301|NCT00415532|477452|P2|NOT COMPLETED|Safety Follow Up Period||12
203302|NCT00415532|477453|P1|NOT COMPLETED|Safety Follow Up Period||9
203303|NCT00415532|477452|P2|COMPLETED|Safety Follow Up Period||18
203304|NCT00415532|477453|P1|COMPLETED|Safety Follow Up Period||34
203305|NCT00415532|477452|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
203306|NCT00415532|477453|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
203307|NCT00415532|477452|P2|NOT COMPLETED|Treatment Period||15
203308|NCT00415532|477453|P1|NOT COMPLETED|Treatment Period||17
203309|NCT00415532|477452|P2|COMPLETED|Treatment Period||142
203310|NCT00415532|477453|P1|COMPLETED|Treatment Period||60
203311|NCT00415532|477452|P2|Switched to Romiplostim Group|Treatment Period||0
203312|NCT00415532|477453|P1|Switched to Romiplostim Group|Treatment Period||2
203313|NCT00415532|477452|P2|Received Treatment|Treatment Period||154
203314|NCT00415532|477453|P1|Received Treatment|Treatment Period||75
203315|NCT00415532|477452|P2|STARTED|Treatment Period||157
203316|NCT00415532|477453|P1|STARTED|Treatment Period||77
203317|NCT00415506|477475|P2|NOT COMPLETED|Overall Study||1
203318|NCT00415506|477476|P1|NOT COMPLETED|Overall Study||3
203319|NCT00415506|477475|P2|COMPLETED|Overall Study||9
203320|NCT00415506|477476|P1|COMPLETED|Overall Study||9
203321|NCT00415506|477475|P2|STARTED|Overall Study||10
203322|NCT00415506|477476|P1|STARTED|Overall Study||12
203323|NCT00415493|477486|P2|NOT COMPLETED|Overall Study||0
203324|NCT00415493|477487|P1|NOT COMPLETED|Overall Study||0
203325|NCT00415493|477486|P2|COMPLETED|Overall Study||12
203326|NCT00415493|477487|P1|COMPLETED|Overall Study||12
203327|NCT00415493|477486|P2|STARTED|Overall Study||12
203328|NCT00415493|477487|P1|STARTED|Overall Study||12
203329|NCT00416195|477495|P2|NOT COMPLETED|Overall Study||4
203330|NCT00416195|477496|P1|NOT COMPLETED|Overall Study||2
203331|NCT00416195|477495|P2|COMPLETED|Overall Study||34
203332|NCT00416195|477496|P1|COMPLETED|Overall Study||8
203333|NCT00416195|477495|P2|STARTED|Overall Study||38
203334|NCT00416195|477496|P1|STARTED|Overall Study||10
203335|NCT00416182|477506|P2|NOT COMPLETED|Overall Study||2
203336|NCT00416182|477507|P1|NOT COMPLETED|Overall Study||3
203337|NCT00416182|477506|P2|COMPLETED|Overall Study||6
203338|NCT00416182|477507|P1|COMPLETED|Overall Study||5
203339|NCT00416182|477506|P2|STARTED|Overall Study||8
203340|NCT00416182|477507|P1|STARTED|Overall Study||8
203341|NCT00416078|477521|P2|NOT COMPLETED|Overall Study||8
203342|NCT00416078|477522|P1|NOT COMPLETED|Overall Study||11
203343|NCT00416078|477521|P2|COMPLETED|Overall Study||16
203344|NCT00416078|477522|P1|COMPLETED|Overall Study||18
203345|NCT00416078|477521|P2|STARTED|Overall Study||24
203346|NCT00416078|477522|P1|STARTED|Overall Study||29
203347|NCT00415909|477538|P1|NOT COMPLETED|Overall Study||3
203348|NCT00415909|477538|P1|COMPLETED|Overall Study||0
203349|NCT00415909|477538|P1|STARTED|Overall Study||3
203350|NCT00415870|477544|P2|NOT COMPLETED|Overall Study||7
203351|NCT00415870|477545|P1|NOT COMPLETED|Overall Study||6
203352|NCT00415870|477544|P2|COMPLETED|Overall Study||26
203353|NCT00415870|477545|P1|COMPLETED|Overall Study||26
203354|NCT00415870|477544|P2|STARTED|Overall Study||33
203355|NCT00415870|477545|P1|STARTED|Overall Study||32
203356|NCT00415857|477553|P2|NOT COMPLETED|Overall Study||0
203357|NCT00415857|477554|P1|NOT COMPLETED|Overall Study||0
203358|NCT00415857|477553|P2|COMPLETED|Overall Study||3
203359|NCT00415857|477554|P1|COMPLETED|Overall Study||2
203360|NCT00415857|477553|P2|STARTED|Overall Study||3
203361|NCT00415857|477554|P1|STARTED|Overall Study||2
203362|NCT00415623|477564|P2|NOT COMPLETED|Overall Study||5
203363|NCT00415623|477565|P1|NOT COMPLETED|Overall Study||5
203364|NCT00415623|477564|P2|COMPLETED|Overall Study||146
203365|NCT00415623|477565|P1|COMPLETED|Overall Study||149
203366|NCT00415623|477564|P2|STARTED|Overall Study||151
203367|NCT00415623|477565|P1|STARTED|Overall Study||154
203368|NCT00415610|477592|P3|NOT COMPLETED|Overall Study||5
203369|NCT00415610|477593|P2|NOT COMPLETED|Overall Study||2
203370|NCT00415610|477594|P1|NOT COMPLETED|Overall Study||3
203371|NCT00415610|477592|P3|COMPLETED|Overall Study||17
203372|NCT00415610|477593|P2|COMPLETED|Overall Study||18
203373|NCT00415610|477594|P1|COMPLETED|Overall Study||15
203374|NCT00415610|477592|P3|STARTED|Overall Study||22
203375|NCT00415610|477593|P2|STARTED|Overall Study||20
203376|NCT00415610|477594|P1|STARTED|Overall Study||18
203377|NCT00415597|477608|P1|NOT COMPLETED|Treatment||305
203378|NCT00415597|477608|P1|COMPLETED|Treatment||160
203379|NCT00415597|477608|P1|STARTED|Treatment||465
203380|NCT00415597|477608|P1|NOT COMPLETED|Enrollment||2
203381|NCT00415597|477608|P1|COMPLETED|Enrollment||465
203382|NCT00415597|477608|P1|STARTED|Enrollment||467
203383|NCT00415194|477616|P2|NOT COMPLETED|Overall Study||342
203384|NCT00415194|477617|P1|NOT COMPLETED|Overall Study||328
203385|NCT00415194|477616|P2|COMPLETED|Overall Study||55
203386|NCT00415194|477617|P1|COMPLETED|Overall Study||70
203387|NCT00415194|477616|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
203388|NCT00415194|477617|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
203389|NCT00415194|477616|P2|STARTED|Overall Study||397
203390|NCT00415194|477617|P1|STARTED|Overall Study||398
203391|NCT00415168|477633|P1|NOT COMPLETED|Overall Study||52
203392|NCT00415168|477633|P1|COMPLETED|Overall Study||1
203393|NCT00415168|477633|P1|Completed Treatment|Overall Study||15
203394|NCT00415168|477633|P1|STARTED|Overall Study||53
203395|NCT00415051|477643|P1|NOT COMPLETED|Overall Study||1
203396|NCT00415051|477643|P1|COMPLETED|Overall Study||19
203397|NCT00415051|477643|P1|STARTED|Overall Study||20
203398|NCT00414973|477654|P4|NOT COMPLETED|Overall Study||0
203399|NCT00414973|477655|P3|NOT COMPLETED|Overall Study||3
203400|NCT00414973|477656|P2|NOT COMPLETED|Overall Study||10
203401|NCT00414973|477657|P1|NOT COMPLETED|Overall Study||28
203402|NCT00414973|477654|P4|COMPLETED|Overall Study||11
203403|NCT00414973|477655|P3|COMPLETED|Overall Study||21
203404|NCT00414973|477656|P2|COMPLETED|Overall Study||99
203405|NCT00414973|477657|P1|COMPLETED|Overall Study||190
203406|NCT00414973|477654|P4|STARTED|Overall Study||11
203407|NCT00414973|477655|P3|STARTED|Overall Study||24
203408|NCT00414973|477656|P2|STARTED|Overall Study||109
203409|NCT00414973|477657|P1|STARTED|Overall Study||218
203410|NCT00414908|477677|P2|NOT COMPLETED|Overall Study||1
203411|NCT00414908|477678|P1|NOT COMPLETED|Overall Study||1
203412|NCT00414908|477677|P2|COMPLETED|Overall Study||28
203413|NCT00414908|477678|P1|COMPLETED|Overall Study||24
203414|NCT00414908|477677|P2|STARTED|Overall Study||29
203415|NCT00414908|477678|P1|STARTED|Overall Study||25
203416|NCT00414817|477702|P2|NOT COMPLETED|Overall Study||3016
203417|NCT00414817|477703|P1|NOT COMPLETED|Overall Study||3130
203418|NCT00414817|477702|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
203419|NCT00414817|477703|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
203420|NCT00414817|477702|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
203421|NCT00414817|477703|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
203506|NCT00414466|477857|P3|COMPLETED|Overall Study||40
203422|NCT00414817|477702|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
203423|NCT00414817|477703|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
203424|NCT00414817|477702|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
203425|NCT00414817|477703|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
203426|NCT00414817|477702|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
203427|NCT00414817|477703|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
203428|NCT00414817|477702|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
203429|NCT00414817|477703|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
203430|NCT00414817|477702|P2|STARTED|Overall Study||7031
203431|NCT00414817|477703|P1|STARTED|Overall Study||7033
203432|NCT00414726|477715|P2|NOT COMPLETED|Overall Study||1
203433|NCT00414726|477716|P1|NOT COMPLETED|Overall Study||0
203434|NCT00414726|477715|P2|COMPLETED|Overall Study||41
203435|NCT00414726|477716|P1|COMPLETED|Overall Study||43
203436|NCT00414726|477715|P2|STARTED|Overall Study||42
203437|NCT00414726|477716|P1|STARTED|Overall Study||43
203438|NCT00414700|477726|P2|NOT COMPLETED|Overall Study||3
203439|NCT00414700|477727|P1|NOT COMPLETED|Overall Study||6
203440|NCT00414700|477726|P2|COMPLETED|Overall Study||58
203441|NCT00414700|477727|P1|COMPLETED|Overall Study||51
203442|NCT00414700|477726|P2|STARTED|Overall Study||61
203443|NCT00414700|477727|P1|STARTED|Overall Study||57
203444|NCT00414661|477751|P4|NOT COMPLETED|Overall Study||3
203445|NCT00414661|477752|P3|NOT COMPLETED|Overall Study||2
203446|NCT00414661|477753|P2|NOT COMPLETED|Overall Study||14
203447|NCT00414661|477754|P1|NOT COMPLETED|Overall Study||14
203448|NCT00414661|477751|P4|COMPLETED|Overall Study||0
203449|NCT00414661|477752|P3|COMPLETED|Overall Study||20
203450|NCT00414661|477753|P2|COMPLETED|Overall Study||75
203451|NCT00414661|477754|P1|COMPLETED|Overall Study||34
203452|NCT00414661|477751|P4|STARTED|Overall Study||3
203453|NCT00414661|477752|P3|STARTED|Overall Study||22
203454|NCT00414661|477753|P2|STARTED|Overall Study||89
203455|NCT00414661|477754|P1|STARTED|Overall Study||48
203456|NCT00414635|477778|P2|NOT COMPLETED|Overall Study||2
203457|NCT00414635|477779|P1|NOT COMPLETED|Overall Study||5
203458|NCT00414635|477778|P2|COMPLETED|Overall Study||28
203459|NCT00414635|477779|P1|COMPLETED|Overall Study||25
203460|NCT00414635|477778|P2|STARTED|Overall Study||30
203461|NCT00414635|477779|P1|STARTED|Overall Study||30
203462|NCT00414609|477799|P3|NOT COMPLETED|Extension Study||57
203463|NCT00414609|477800|P2|NOT COMPLETED|Extension Study||0
203464|NCT00414609|477801|P1|NOT COMPLETED|Extension Study||0
203465|NCT00414609|477799|P3|COMPLETED|Extension Study||365
203466|NCT00414609|477800|P2|COMPLETED|Extension Study||0
203467|NCT00414609|477801|P1|COMPLETED|Extension Study||0
203468|NCT00414609|477799|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
203469|NCT00414609|477800|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
203470|NCT00414609|477801|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
203471|NCT00414609|477799|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
203472|NCT00414609|477800|P2|STARTED|Extension Study||0
203473|NCT00414609|477801|P1|STARTED|Extension Study||0
203474|NCT00414609|477799|P3|NOT COMPLETED|Core Study||0
203475|NCT00414609|477800|P2|NOT COMPLETED|Core Study||45
203476|NCT00414609|477801|P1|NOT COMPLETED|Core Study||34
203477|NCT00414609|477799|P3|COMPLETED|Core Study||0
203478|NCT00414609|477800|P2|COMPLETED|Core Study||378
203479|NCT00414609|477801|P1|COMPLETED|Core Study||363
203480|NCT00414609|477799|P3|Echocardiogram Evaluable Set|Core Study||0
203481|NCT00414609|477800|P2|Echocardiogram Evaluable Set|Core Study||343
203482|NCT00414609|477801|P1|Echocardiogram Evaluable Set|Core Study||330
203483|NCT00414609|477799|P3|Received Study Drug|Core Study||0
203484|NCT00414609|477800|P2|Received Study Drug|Core Study||422
203485|NCT00414609|477801|P1|Received Study Drug|Core Study||397
203486|NCT00414609|477799|P3|STARTED|Core Study||0
203487|NCT00414609|477800|P2|STARTED|Core Study||423
203488|NCT00414609|477801|P1|STARTED|Core Study||397
203489|NCT00414596|477824|P1|NOT COMPLETED|Overall Study||2
203490|NCT00414596|477824|P1|COMPLETED|Overall Study|April 2007|18
203491|NCT00414596|477824|P1|STARTED|Overall Study|December 2006|20
203492|NCT00414544|477833|P1|NOT COMPLETED|Overall Study||14
203493|NCT00414544|477833|P1|COMPLETED|Overall Study||131
203494|NCT00414544|477833|P1|STARTED|Overall Study||145
203495|NCT00414518|477841|P2|NOT COMPLETED|Overall Study||0
203496|NCT00414518|477842|P1|NOT COMPLETED|Overall Study||0
203497|NCT00414518|477841|P2|COMPLETED|Overall Study||9
203498|NCT00414518|477842|P1|COMPLETED|Overall Study||7
203499|NCT00414518|477841|P2|STARTED|Overall Study||9
203500|NCT00414518|477842|P1|STARTED|Overall Study||7
203501|NCT00414466|477856|P4|NOT COMPLETED|Overall Study||1
203502|NCT00414466|477857|P3|NOT COMPLETED|Overall Study||1
203503|NCT00414466|477858|P2|NOT COMPLETED|Overall Study||0
203504|NCT00414466|477859|P1|NOT COMPLETED|Overall Study||2
203505|NCT00414466|477856|P4|COMPLETED|Overall Study||42
203507|NCT00414466|477858|P2|COMPLETED|Overall Study||42
203508|NCT00414466|477859|P1|COMPLETED|Overall Study||42
203509|NCT00414466|477856|P4|STARTED|Overall Study||43
203510|NCT00414466|477857|P3|STARTED|Overall Study||41
203511|NCT00414466|477858|P2|STARTED|Overall Study||42
203512|NCT00414466|477859|P1|STARTED|Overall Study||44
203513|NCT00414453|477877|P1|NOT COMPLETED|Overall Study||16
203514|NCT00414453|477877|P1|COMPLETED|Overall Study||3
203515|NCT00414453|477877|P1|STARTED|Overall Study||19
203516|NCT00414440|477925|P2|NOT COMPLETED|Extension Period||140
203517|NCT00414440|477926|P1|NOT COMPLETED|Extension Period||150
203518|NCT00414440|477925|P2|COMPLETED|Extension Period|Extension|77
203519|NCT00414440|477926|P1|COMPLETED|Extension Period|Extension|64
203520|NCT00414440|477925|P2|STARTED|Extension Period|Extension|217
203521|NCT00414440|477926|P1|STARTED|Extension Period|Extension|214
203522|NCT00414440|477925|P2|NOT COMPLETED|Core Period||32
203523|NCT00414440|477926|P1|NOT COMPLETED|Core Period||70
203524|NCT00414440|477925|P2|COMPLETED|Core Period|Core period|185
203525|NCT00414440|477926|P1|COMPLETED|Core Period|Core period|144
203526|NCT00414440|477925|P2|STARTED|Core Period|Core period|217
203527|NCT00414440|477926|P1|STARTED|Core Period|Core period|214
203528|NCT00414388|477940|P1|NOT COMPLETED|Overall Study||1
203529|NCT00414388|477940|P1|COMPLETED|Overall Study||21
203530|NCT00414388|477940|P1|STARTED|Overall Study||22
203531|NCT00414310|477948|P2|NOT COMPLETED|Overall Study||0
203532|NCT00414310|477949|P1|NOT COMPLETED|Overall Study||1
203533|NCT00414310|477948|P2|COMPLETED|Overall Study||79
203534|NCT00414310|477949|P1|COMPLETED|Overall Study||70
203535|NCT00414310|477948|P2|STARTED|Overall Study||79
203536|NCT00414310|477949|P1|STARTED|Overall Study||71
203537|NCT00414206|477958|P3|NOT COMPLETED|Overall Study||55
203538|NCT00414206|477959|P2|NOT COMPLETED|Overall Study||56
203539|NCT00414206|477960|P1|NOT COMPLETED|Overall Study||58
203540|NCT00414206|477958|P3|COMPLETED|Overall Study||59
203541|NCT00414206|477959|P2|COMPLETED|Overall Study||58
203542|NCT00414206|477960|P1|COMPLETED|Overall Study||57
203543|NCT00414206|477958|P3|STARTED|Overall Study||114
203544|NCT00414206|477959|P2|STARTED|Overall Study||114
203545|NCT00414206|477960|P1|STARTED|Overall Study||115
203546|NCT00414167|477970|P2|NOT COMPLETED|Overall Study||3
203547|NCT00414167|477971|P1|NOT COMPLETED|Overall Study||4
203548|NCT00414167|477970|P2|COMPLETED|Overall Study||27
203549|NCT00414167|477971|P1|COMPLETED|Overall Study||27
203550|NCT00414167|477970|P2|STARTED|Overall Study||30
203551|NCT00414167|477971|P1|STARTED|Overall Study||31
203552|NCT00414050|477983|P4|NOT COMPLETED|Overall Study||8
203553|NCT00414050|477984|P3|NOT COMPLETED|Overall Study||6
203554|NCT00414050|477985|P2|NOT COMPLETED|Overall Study||8
203555|NCT00414050|477986|P1|NOT COMPLETED|Overall Study||9
203556|NCT00414050|477983|P4|COMPLETED|Overall Study||423
203557|NCT00414050|477984|P3|COMPLETED|Overall Study||423
203558|NCT00414050|477985|P2|COMPLETED|Overall Study||419
203559|NCT00414050|477986|P1|COMPLETED|Overall Study||422
203560|NCT00414050|477983|P4|Received Vaccination 3|Overall Study||424
203561|NCT00414050|477984|P3|Received Vaccination 3|Overall Study||425
203562|NCT00414050|477985|P2|Received Vaccination 3|Overall Study||419
203563|NCT00414050|477986|P1|Received Vaccination 3|Overall Study||424
203564|NCT00414050|477983|P4|Received Vaccination 2|Overall Study||425
203565|NCT00414050|477984|P3|Received Vaccination 2|Overall Study||425
203566|NCT00414050|477985|P2|Received Vaccination 2|Overall Study||421
203567|NCT00414050|477986|P1|Received Vaccination 2|Overall Study||425
203568|NCT00414050|477983|P4|Received Vaccination 1|Overall Study||431
203569|NCT00414050|477984|P3|Received Vaccination 1|Overall Study||429
203570|NCT00414050|477985|P2|Received Vaccination 1|Overall Study||426
203571|NCT00414050|477986|P1|Received Vaccination 1|Overall Study||431
203572|NCT00414050|477983|P4|STARTED|Overall Study||431
203573|NCT00414050|477984|P3|STARTED|Overall Study||429
203574|NCT00414050|477985|P2|STARTED|Overall Study||427
203575|NCT00414050|477986|P1|STARTED|Overall Study||431
203576|NCT00414011|478000|P1|NOT COMPLETED|Overall Study||5
203577|NCT00414011|478000|P1|COMPLETED|Overall Study||35
203578|NCT00414011|478000|P1|STARTED|Overall Study||40
203579|NCT00413972|478009|P4|NOT COMPLETED|Overall Study||3
203580|NCT00413972|478010|P3|NOT COMPLETED|Overall Study||10
203581|NCT00413972|478011|P2|NOT COMPLETED|Overall Study||8
203582|NCT00413972|478012|P1|NOT COMPLETED|Overall Study||7
203583|NCT00413972|478009|P4|COMPLETED|Overall Study||95
203584|NCT00413972|478010|P3|COMPLETED|Overall Study||88
203585|NCT00413972|478011|P2|COMPLETED|Overall Study||90
203586|NCT00413972|478012|P1|COMPLETED|Overall Study||91
203587|NCT00413972|478009|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
203588|NCT00413972|478010|P3|STARTED|Overall Study||98
203589|NCT00413972|478011|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
203590|NCT00413972|478012|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
203591|NCT00413959|478022|P1|NOT COMPLETED|Overall Study||1
203592|NCT00413959|478022|P1|COMPLETED|Overall Study||11
203593|NCT00413959|478022|P1|STARTED|Overall Study||12
203594|NCT00413920|478029|P2|NOT COMPLETED|Overall Study||28
203595|NCT00413920|478030|P1|NOT COMPLETED|Overall Study||28
203596|NCT00413920|478029|P2|COMPLETED|Overall Study||82
203597|NCT00413920|478030|P1|COMPLETED|Overall Study||84
203598|NCT00413920|478029|P2|STARTED|Overall Study||110
203599|NCT00413920|478030|P1|STARTED|Overall Study||112
203600|NCT00413894|478045|P1|NOT COMPLETED|Overall Study||80
203601|NCT00413894|478045|P1|COMPLETED|Overall Study||344
203602|NCT00413894|478045|P1|STARTED|Overall Study||424
203603|NCT00413660|478067|P11|NOT COMPLETED|Post Week 12||1
203604|NCT00413660|478068|P10|NOT COMPLETED|Post Week 12||1
203605|NCT00413660|478069|P9|NOT COMPLETED|Post Week 12||0
203606|NCT00413660|478070|P8|NOT COMPLETED|Post Week 12||0
203607|NCT00413660|478071|P7|NOT COMPLETED|Post Week 12||3
203608|NCT00413660|478072|P6|NOT COMPLETED|Post Week 12||3
203609|NCT00413660|478073|P5|NOT COMPLETED|Post Week 12||6
203610|NCT00413660|478074|P4|NOT COMPLETED|Post Week 12||1
203611|NCT00413660|478075|P3|NOT COMPLETED|Post Week 12||8
203612|NCT00413660|478076|P2|NOT COMPLETED|Post Week 12||4
203613|NCT00413660|478077|P1|NOT COMPLETED|Post Week 12||3
203614|NCT00413660|478067|P11|COMPLETED|Post Week 12||17
203615|NCT00413660|478068|P10|COMPLETED|Post Week 12||12
203616|NCT00413660|478069|P9|COMPLETED|Post Week 12||13
203617|NCT00413660|478070|P8|COMPLETED|Post Week 12||21
203618|NCT00413660|478071|P7|COMPLETED|Post Week 12||37
203619|NCT00413660|478072|P6|COMPLETED|Post Week 12||54
203620|NCT00413660|478073|P5|COMPLETED|Post Week 12||60
203621|NCT00413660|478074|P4|COMPLETED|Post Week 12||66
203622|NCT00413660|478075|P3|COMPLETED|Post Week 12||56
203623|NCT00413660|478076|P2|COMPLETED|Post Week 12||44
203624|NCT00413660|478077|P1|COMPLETED|Post Week 12||40
203625|NCT00413660|478067|P11|STARTED|Post Week 12||18
203626|NCT00413660|478068|P10|STARTED|Post Week 12||13
203627|NCT00413660|478069|P9|STARTED|Post Week 12||13
203628|NCT00413660|478070|P8|STARTED|Post Week 12||21
203629|NCT00413660|478071|P7|STARTED|Post Week 12||40
203630|NCT00413660|478072|P6|STARTED|Post Week 12||57
203631|NCT00413660|478073|P5|STARTED|Post Week 12||66
203632|NCT00413660|478074|P4|STARTED|Post Week 12||67
203633|NCT00413660|478075|P3|STARTED|Post Week 12||64
203634|NCT00413660|478076|P2|STARTED|Post Week 12||48
203635|NCT00413660|478077|P1|STARTED|Post Week 12||43
203636|NCT00413660|478067|P11|NOT COMPLETED|Up To Week 12||0
203637|NCT00413660|478068|P10|NOT COMPLETED|Up To Week 12||0
203638|NCT00413660|478069|P9|NOT COMPLETED|Up To Week 12||0
203639|NCT00413660|478070|P8|NOT COMPLETED|Up To Week 12||0
203640|NCT00413660|478071|P7|NOT COMPLETED|Up To Week 12||11
203641|NCT00413660|478072|P6|NOT COMPLETED|Up To Week 12||10
203642|NCT00413660|478073|P5|NOT COMPLETED|Up To Week 12||9
203643|NCT00413660|478074|P4|NOT COMPLETED|Up To Week 12||8
203644|NCT00413660|478075|P3|NOT COMPLETED|Up To Week 12||7
203645|NCT00413660|478076|P2|NOT COMPLETED|Up To Week 12||7
203646|NCT00413660|478077|P1|NOT COMPLETED|Up To Week 12||7
203647|NCT00413660|478067|P11|COMPLETED|Up To Week 12||0
203648|NCT00413660|478068|P10|COMPLETED|Up To Week 12||0
203649|NCT00413660|478069|P9|COMPLETED|Up To Week 12||0
203650|NCT00413660|478070|P8|COMPLETED|Up To Week 12||0
203651|NCT00413660|478071|P7|COMPLETED|Up To Week 12||58
203652|NCT00413660|478072|P6|COMPLETED|Up To Week 12||70
203653|NCT00413660|478073|P5|COMPLETED|Up To Week 12||66
203654|NCT00413660|478074|P4|COMPLETED|Up To Week 12||67
203655|NCT00413660|478075|P3|COMPLETED|Up To Week 12||64
203656|NCT00413660|478076|P2|COMPLETED|Up To Week 12||61
203657|NCT00413660|478077|P1|COMPLETED|Up To Week 12||64
203658|NCT00413660|478067|P11|Treated|Up To Week 12||0
203659|NCT00413660|478068|P10|Treated|Up To Week 12||0
203660|NCT00413660|478069|P9|Treated|Up To Week 12||0
203661|NCT00413660|478070|P8|Treated|Up To Week 12||0
203662|NCT00413660|478071|P7|Treated|Up To Week 12||69
203663|NCT00413660|478072|P6|Treated|Up To Week 12||80
203664|NCT00413660|478073|P5|Treated|Up To Week 12||75
203665|NCT00413660|478074|P4|Treated|Up To Week 12||74
203666|NCT00413660|478075|P3|Treated|Up To Week 12||71
203667|NCT00413660|478076|P2|Treated|Up To Week 12||68
203668|NCT00413660|478077|P1|Treated|Up To Week 12||70
203669|NCT00413660|478067|P11|STARTED|Up To Week 12||0
203670|NCT00413660|478068|P10|STARTED|Up To Week 12||0
203671|NCT00413660|478069|P9|STARTED|Up To Week 12||0
203672|NCT00413660|478070|P8|STARTED|Up To Week 12||0
203673|NCT00413660|478071|P7|STARTED|Up To Week 12||69
203674|NCT00413660|478072|P6|STARTED|Up To Week 12||80
203675|NCT00413660|478073|P5|STARTED|Up To Week 12||75
203676|NCT00413660|478074|P4|STARTED|Up To Week 12||75
203677|NCT00413660|478075|P3|STARTED|Up To Week 12||71
203678|NCT00413660|478076|P2|STARTED|Up To Week 12||68
203679|NCT00413660|478077|P1|STARTED|Up To Week 12||71
203680|NCT00413634|478425|P2|NOT COMPLETED|Overall Study||0
203681|NCT00413634|478426|P1|NOT COMPLETED|Overall Study||0
203682|NCT00413634|478425|P2|COMPLETED|Overall Study||12
203683|NCT00413634|478426|P1|COMPLETED|Overall Study||12
203684|NCT00413634|478425|P2|STARTED|Overall Study||12
203685|NCT00413634|478426|P1|STARTED|Overall Study||12
203686|NCT00413582|478464|P2|NOT COMPLETED|Overall Study||0
203687|NCT00413582|478465|P1|NOT COMPLETED|Overall Study||0
203688|NCT00413582|478464|P2|COMPLETED|Overall Study|all enrolled completed|55
203689|NCT00413582|478465|P1|COMPLETED|Overall Study|all enrolled completed|55
203690|NCT00413582|478464|P2|Completion of Study|Overall Study|all enrolled completed|55
203691|NCT00413582|478465|P1|Completion of Study|Overall Study|all enrolled completed|55
203692|NCT00413582|478464|P2|STARTED|Overall Study|all enrolled completed|55
203693|NCT00413582|478465|P1|STARTED|Overall Study|all enrolled completed|55
203694|NCT00413478|478473|P1|NOT COMPLETED|Overall Study||0
203695|NCT00413478|478473|P1|COMPLETED|Overall Study||9
203696|NCT00413478|478473|P1|STARTED|Overall Study||9
203697|NCT00413413|478480|P3|NOT COMPLETED|Double-Blind||18
203698|NCT00413413|478481|P2|NOT COMPLETED|Double-Blind||14
203699|NCT00413413|478482|P1|NOT COMPLETED|Double-Blind||15
203700|NCT00413413|478480|P3|COMPLETED|Double-Blind||285
203701|NCT00413413|478481|P2|COMPLETED|Double-Blind||293
203702|NCT00413413|478482|P1|COMPLETED|Double-Blind||293
203703|NCT00413413|478480|P3|STARTED|Double-Blind||303
203704|NCT00413413|478481|P2|STARTED|Double-Blind||307
203705|NCT00413413|478482|P1|STARTED|Double-Blind||308
203706|NCT00413413|478480|P3|NOT COMPLETED|Single-Blind||0
203707|NCT00413413|478481|P2|NOT COMPLETED|Single-Blind||216
203708|NCT00413413|478482|P1|NOT COMPLETED|Single-Blind||0
203709|NCT00413413|478480|P3|COMPLETED|Single-Blind||0
203710|NCT00413413|478481|P2|COMPLETED|Single-Blind||918
203711|NCT00413413|478482|P1|COMPLETED|Single-Blind||0
203712|NCT00413413|478480|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
203713|NCT00413413|478481|P2|STARTED|Single-Blind||1134
203714|NCT00413413|478482|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
203715|NCT00413400|478504|P2|NOT COMPLETED|Overall Study||4
203716|NCT00413400|478505|P1|NOT COMPLETED|Overall Study||2
203717|NCT00413400|478504|P2|COMPLETED|Overall Study||12
203718|NCT00413400|478505|P1|COMPLETED|Overall Study||22
203719|NCT00413400|478504|P2|3 Month Visit|Overall Study||12
203720|NCT00413400|478505|P1|3 Month Visit|Overall Study||22
203721|NCT00413400|478504|P2|STARTED|Overall Study||16
203722|NCT00413400|478505|P1|STARTED|Overall Study||24
203723|NCT00413374|478533|P1|NOT COMPLETED|Overall Study||6
203724|NCT00413374|478533|P1|COMPLETED|Overall Study||34
203725|NCT00413374|478533|P1|STARTED|Overall Study||40
203726|NCT00413335|478540|P2|NOT COMPLETED|Overall Study||0
203727|NCT00413335|478541|P1|NOT COMPLETED|Overall Study||0
203728|NCT00413335|478540|P2|COMPLETED|Overall Study||9
203729|NCT00413335|478541|P1|COMPLETED|Overall Study||12
203730|NCT00413335|478540|P2|STARTED|Overall Study||9
203731|NCT00413335|478541|P1|STARTED|Overall Study||12
203732|NCT00413283|478559|P4|NOT COMPLETED|Overall Study||4
203733|NCT00413283|478560|P3|NOT COMPLETED|Overall Study||2
203734|NCT00413283|478561|P2|NOT COMPLETED|Overall Study||3
203735|NCT00413283|478562|P1|NOT COMPLETED|Overall Study||1
203736|NCT00413283|478559|P4|COMPLETED|Overall Study||13
203737|NCT00413283|478560|P3|COMPLETED|Overall Study||16
203738|NCT00413283|478561|P2|COMPLETED|Overall Study||13
203739|NCT00413283|478562|P1|COMPLETED|Overall Study||11
203740|NCT00413283|478559|P4|Received Study Drug|Overall Study||16
203741|NCT00413283|478560|P3|Received Study Drug|Overall Study||18
203742|NCT00413283|478561|P2|Received Study Drug|Overall Study||16
203743|NCT00413283|478562|P1|Received Study Drug|Overall Study||12
203744|NCT00413283|478559|P4|STARTED|Overall Study||17
203745|NCT00413283|478560|P3|STARTED|Overall Study||18
203746|NCT00413283|478561|P2|STARTED|Overall Study||16
203747|NCT00413283|478562|P1|STARTED|Overall Study||12
203748|NCT00413244|478594|P2|NOT COMPLETED|Overall Study||1
203749|NCT00413244|478595|P1|NOT COMPLETED|Overall Study||10
203750|NCT00413244|478594|P2|COMPLETED|Overall Study||19
203751|NCT00413244|478595|P1|COMPLETED|Overall Study||21
203752|NCT00413244|478594|P2|STARTED|Overall Study||20
203753|NCT00413244|478595|P1|STARTED|Overall Study||31
203754|NCT00413231|478623|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
203755|NCT00413231|478623|P1|COMPLETED|365-day to 60-month Post Treatment||93
203756|NCT00413231|478623|P1|STARTED|365-day to 60-month Post Treatment||139
203757|NCT00413231|478623|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
203758|NCT00413231|478623|P1|COMPLETED|30-day to 365-day Post Treatment||139
203759|NCT00413231|478623|P1|STARTED|30-day to 365-day Post Treatment||152
203760|NCT00413231|478623|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
203761|NCT00413231|478623|P1|COMPLETED|0 to 30-day Post Treatment||152
203762|NCT00413231|478623|P1|STARTED|0 to 30-day Post Treatment||160
203763|NCT00413153|478655|P2|NOT COMPLETED|Overall Study||1
203764|NCT00413153|478656|P1|NOT COMPLETED|Overall Study||2
203765|NCT00413153|478655|P2|COMPLETED|Overall Study||7
203766|NCT00413153|478656|P1|COMPLETED|Overall Study||5
203767|NCT00413153|478655|P2|STARTED|Overall Study||8
203768|NCT00413153|478656|P1|STARTED|Overall Study||7
203769|NCT00413062|478680|P2|NOT COMPLETED|Overall Study||210
203770|NCT00413062|478681|P1|NOT COMPLETED|Overall Study||678
203771|NCT00413062|478680|P2|COMPLETED|Overall Study||344
203772|NCT00413062|478681|P1|COMPLETED|Overall Study||988
203773|NCT00413062|478680|P2|STARTED|Overall Study||554
203774|NCT00413062|478681|P1|STARTED|Overall Study||1666
203775|NCT00413049|478707|P2|NOT COMPLETED|Overall Study||18
203776|NCT00413049|478708|P1|NOT COMPLETED|Overall Study||24
203777|NCT00413049|478707|P2|COMPLETED|Overall Study||331
203778|NCT00413049|478708|P1|COMPLETED|Overall Study||325
203779|NCT00413049|478707|P2|STARTED|Overall Study||349
203780|NCT00413049|478708|P1|STARTED|Overall Study||349
203781|NCT00413036|478724|P1|NOT COMPLETED|Overall Study||217
203782|NCT00413036|478724|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
203783|NCT00413036|478724|P1|STARTED|Overall Study||217
203784|NCT00413010|478734|P2|NOT COMPLETED|Overall Study||63
203785|NCT00413010|478735|P1|NOT COMPLETED|Overall Study||72
203786|NCT00413010|478734|P2|COMPLETED|Overall Study||113
203787|NCT00413010|478735|P1|COMPLETED|Overall Study||108
203788|NCT00413010|478734|P2|STARTED|Overall Study||176
203789|NCT00413010|478735|P1|STARTED|Overall Study||180
203790|NCT00412984|478757|P2|NOT COMPLETED|Overall Study||2493
203791|NCT00412984|478758|P1|NOT COMPLETED|Overall Study||2310
203792|NCT00412984|478757|P2|COMPLETED|Overall Study||6588
203793|NCT00412984|478758|P1|COMPLETED|Overall Study||6810
203794|NCT00412984|478757|P2|STARTED|Overall Study|Randomized participants|9081
203795|NCT00412984|478758|P1|STARTED|Overall Study|Randomized participants|9120
203796|NCT00412971|478802|P2|NOT COMPLETED|Overall Study||10
203797|NCT00412971|478803|P1|NOT COMPLETED|Overall Study||30
203798|NCT00412971|478802|P2|COMPLETED|Overall Study||108
203799|NCT00412971|478803|P1|COMPLETED|Overall Study||85
203800|NCT00412971|478802|P2|STARTED|Overall Study||118
203801|NCT00412971|478803|P1|STARTED|Overall Study||115
203802|NCT00412958|478816|P4|NOT COMPLETED|Overall Study||1
203803|NCT00412958|478817|P3|NOT COMPLETED|Overall Study||0
203804|NCT00412958|478818|P2|NOT COMPLETED|Overall Study||4
203805|NCT00412958|478819|P1|NOT COMPLETED|Overall Study||3
203806|NCT00412958|478816|P4|COMPLETED|Overall Study||30
203807|NCT00412958|478817|P3|COMPLETED|Overall Study||32
203808|NCT00412958|478818|P2|COMPLETED|Overall Study||29
203809|NCT00412958|478819|P1|COMPLETED|Overall Study||26
203810|NCT00412958|478816|P4|STARTED|Overall Study||31
203811|NCT00412958|478817|P3|STARTED|Overall Study||32
203812|NCT00412958|478818|P2|STARTED|Overall Study||33
203813|NCT00412958|478819|P1|STARTED|Overall Study||29
203814|NCT00412932|478829|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
203815|NCT00412932|478829|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
203816|NCT00412932|478829|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
203817|NCT00412932|478829|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
203818|NCT00412932|478829|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
203819|NCT00412932|478829|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
203820|NCT00412932|478829|P1|NOT COMPLETED|Olmesartan 40 mg||8
203821|NCT00412932|478829|P1|COMPLETED|Olmesartan 40 mg||161
203822|NCT00412932|478829|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
203823|NCT00412932|478829|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
203824|NCT00412932|478829|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
203825|NCT00412932|478829|P1|STARTED|Olmesartan (Olm) 20 mg||178
203826|NCT00412893|478840|P2|NOT COMPLETED|Overall Study||144
203827|NCT00412893|478841|P1|NOT COMPLETED|Overall Study||145
203828|NCT00412893|478840|P2|COMPLETED|Overall Study|Defined as completed treatment|120
203829|NCT00412893|478841|P1|COMPLETED|Overall Study|Defined as completed treatment|118
203830|NCT00412893|478840|P2|Received Treatment|Overall Study||258
203831|NCT00412893|478841|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
203832|NCT00412893|478840|P2|STARTED|Overall Study||264
203833|NCT00412893|478841|P1|STARTED|Overall Study||263
203834|NCT00412867|478867|P1|NOT COMPLETED|Overall Study||0
203835|NCT00412867|478867|P1|COMPLETED|Overall Study||58
203836|NCT00412867|478867|P1|STARTED|Overall Study||58
203837|NCT00412854|478876|P2|NOT COMPLETED|Overall Study||16
203838|NCT00412854|478877|P1|NOT COMPLETED|Overall Study||14
203839|NCT00412854|478876|P2|COMPLETED|Overall Study||314
203840|NCT00412854|478877|P1|COMPLETED|Overall Study||316
203841|NCT00412854|478876|P2|STARTED|Overall Study||330
203842|NCT00412854|478877|P1|STARTED|Overall Study||330
203843|NCT00412841|478905|P2|NOT COMPLETED|Overall Study||5
203844|NCT00412841|478906|P1|NOT COMPLETED|Overall Study||10
203845|NCT00412841|478905|P2|COMPLETED|Overall Study||16
203846|NCT00412841|478906|P1|COMPLETED|Overall Study||12
203847|NCT00412841|478905|P2|STARTED|Overall Study||21
203848|NCT00412841|478906|P1|STARTED|Overall Study||22
203849|NCT00412750|478917|P3|NOT COMPLETED|Overall Study||23
203850|NCT00412750|478918|P2|NOT COMPLETED|Overall Study||21
203851|NCT00412750|478919|P1|NOT COMPLETED|Overall Study||31
203852|NCT00412750|478917|P3|COMPLETED|Overall Study||31
203853|NCT00412750|478918|P2|COMPLETED|Overall Study||34
203854|NCT00412750|478919|P1|COMPLETED|Overall Study||19
203855|NCT00412750|478917|P3|STARTED|Overall Study||54
203856|NCT00412750|478918|P2|STARTED|Overall Study||55
203857|NCT00412750|478919|P1|STARTED|Overall Study||50
203858|NCT00412737|478944|P2|NOT COMPLETED|Overall Study||6
203859|NCT00412737|478945|P1|NOT COMPLETED|Overall Study||16
203860|NCT00412737|478944|P2|COMPLETED|Overall Study||232
203861|NCT00412737|478945|P1|COMPLETED|Overall Study||221
203862|NCT00412737|478944|P2|STARTED|Overall Study||238
203863|NCT00412737|478945|P1|STARTED|Overall Study||237
203864|NCT00412607|478963|P1|NOT COMPLETED|Overall Study||104
203865|NCT00412607|478963|P1|COMPLETED|Overall Study||145
203866|NCT00412607|478963|P1|Started Study Catheter|Overall Study||233
203867|NCT00412607|478963|P1|STARTED|Overall Study||249
203868|NCT00412542|478976|P2|NOT COMPLETED|Overall Study||3
203869|NCT00412542|478977|P1|NOT COMPLETED|Overall Study||0
203870|NCT00412542|478976|P2|COMPLETED|Overall Study||42
203871|NCT00412542|478977|P1|COMPLETED|Overall Study||33
203872|NCT00412542|478976|P2|STARTED|Overall Study||45
203873|NCT00412542|478977|P1|STARTED|Overall Study||33
203874|NCT00412529|478983|P2|NOT COMPLETED|Overall Study||0
203875|NCT00412529|478984|P1|NOT COMPLETED|Overall Study||0
203876|NCT00412529|478983|P2|COMPLETED|Overall Study||21
203877|NCT00412529|478984|P1|COMPLETED|Overall Study||23
203878|NCT00412529|478983|P2|STARTED|Overall Study||21
203879|NCT00412529|478984|P1|STARTED|Overall Study||23
203880|NCT00412516|479007|P3|NOT COMPLETED|Overall Study||0
203881|NCT00412516|479008|P2|NOT COMPLETED|Overall Study||0
203882|NCT00412516|479009|P1|NOT COMPLETED|Overall Study||0
203883|NCT00412516|479007|P3|COMPLETED|Overall Study||214
203884|NCT00412516|479008|P2|COMPLETED|Overall Study||212
203885|NCT00412516|479009|P1|COMPLETED|Overall Study||93
203886|NCT00412516|479007|P3|STARTED|Overall Study||214
203887|NCT00412516|479008|P2|STARTED|Overall Study||212
203888|NCT00412516|479009|P1|STARTED|Overall Study||93
203889|NCT00412464|479026|P1|NOT COMPLETED|Overall Study||0
203890|NCT00412464|479026|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
203891|NCT00412464|479026|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
203892|NCT00412451|479038|P4|NOT COMPLETED|Overall Study||2
203893|NCT00412451|479039|P3|NOT COMPLETED|Overall Study||1
203894|NCT00412451|479040|P2|NOT COMPLETED|Overall Study||0
203895|NCT00412451|479041|P1|NOT COMPLETED|Overall Study||0
203896|NCT00412451|479038|P4|COMPLETED|Overall Study||11
203897|NCT00412451|479039|P3|COMPLETED|Overall Study||14
203898|NCT00412451|479040|P2|COMPLETED|Overall Study||15
203899|NCT00412451|479041|P1|COMPLETED|Overall Study||8
203900|NCT00412451|479038|P4|STARTED|Overall Study||13
203901|NCT00412451|479039|P3|STARTED|Overall Study||15
203902|NCT00412451|479040|P2|STARTED|Overall Study||15
203903|NCT00412451|479041|P1|STARTED|Overall Study||8
203904|NCT00412425|479053|P2|NOT COMPLETED|Overall Study||0
203905|NCT00412425|479054|P1|NOT COMPLETED|Overall Study||0
203906|NCT00412425|479053|P2|COMPLETED|Overall Study||15
203907|NCT00412425|479054|P1|COMPLETED|Overall Study||15
203908|NCT00412425|479053|P2|STARTED|Overall Study||15
203909|NCT00412425|479054|P1|STARTED|Overall Study||15
203910|NCT00412373|479062|P2|NOT COMPLETED|Overall Study||77
203911|NCT00412373|479063|P1|NOT COMPLETED|Overall Study||41
203912|NCT00412373|479062|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
203913|NCT00412373|479063|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
203914|NCT00412373|479062|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
203915|NCT00412373|479063|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
203916|NCT00412360|479105|P2|NOT COMPLETED|Overall Study||3
203917|NCT00412360|479106|P1|NOT COMPLETED|Overall Study||1
203918|NCT00412360|479105|P2|COMPLETED|Overall Study||108
203919|NCT00412360|479106|P1|COMPLETED|Overall Study||112
203920|NCT00412360|479105|P2|STARTED|Overall Study||111
203921|NCT00412360|479106|P1|STARTED|Overall Study||113
203922|NCT00412243|479130|P1|NOT COMPLETED|Overall Study||0
203923|NCT00412243|479130|P1|COMPLETED|Overall Study||50
203924|NCT00412243|479130|P1|STARTED|Overall Study||50
203925|NCT00412217|479136|P2|NOT COMPLETED|Overall Study||48
203926|NCT00412217|479137|P1|NOT COMPLETED|Overall Study||46
203927|NCT00412217|479136|P2|COMPLETED|Overall Study||0
203928|NCT00412217|479137|P1|COMPLETED|Overall Study||0
203929|NCT00412217|479136|P2|STARTED|Overall Study||48
203930|NCT00412217|479137|P1|STARTED|Overall Study||46
203931|NCT00412113|479151|P2|NOT COMPLETED|Overall Study||15
203932|NCT00412113|479152|P1|NOT COMPLETED|Overall Study||12
203933|NCT00412113|479151|P2|COMPLETED|Overall Study|15-April-2008|107
203934|NCT00412113|479152|P1|COMPLETED|Overall Study|15-April-2008|111
203935|NCT00412113|479151|P2|Received Treatment|Overall Study||122
203936|NCT00412113|479152|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
203937|NCT00412113|479151|P2|STARTED|Overall Study|15-January-2007|122
203938|NCT00412113|479152|P1|STARTED|Overall Study|15-January-2007|123
203939|NCT00412087|479206|P2|NOT COMPLETED|Overall Study||65
203940|NCT00412087|479207|P1|NOT COMPLETED|Overall Study||62
203941|NCT00412087|479206|P2|COMPLETED|Overall Study||66
203942|NCT00412087|479207|P1|COMPLETED|Overall Study||72
203943|NCT00412087|479206|P2|STARTED|Overall Study||131
203944|NCT00412087|479207|P1|STARTED|Overall Study||134
203945|NCT00412074|479218|P3|NOT COMPLETED|Overall Study||67
203946|NCT00412074|479219|P2|NOT COMPLETED|Overall Study||22
203947|NCT00412074|479220|P1|NOT COMPLETED|Overall Study||77
203948|NCT00412074|479218|P3|COMPLETED|Overall Study||128
203949|NCT00412074|479219|P2|COMPLETED|Overall Study||44
203950|NCT00412074|479220|P1|COMPLETED|Overall Study||122
203951|NCT00412074|479218|P3|STARTED|Overall Study||195
203952|NCT00412074|479219|P2|STARTED|Overall Study||66
203953|NCT00412074|479220|P1|STARTED|Overall Study||199
203954|NCT00412061|479236|P2|NOT COMPLETED|Open Label Phase||170
203955|NCT00412061|479237|P1|NOT COMPLETED|Open Label Phase||0
203956|NCT00412061|479236|P2|COMPLETED|Open Label Phase||0
203957|NCT00412061|479237|P1|COMPLETED|Open Label Phase||0
203958|NCT00412061|479236|P2|STARTED|Open Label Phase||170
203959|NCT00412061|479237|P1|STARTED|Open Label Phase||0
203960|NCT00412061|479236|P2|NOT COMPLETED|Double Blind Phase||213
203961|NCT00412061|479237|P1|NOT COMPLETED|Double Blind Phase||216
203962|NCT00412061|479236|P2|COMPLETED|Double Blind Phase||0
203963|NCT00412061|479237|P1|COMPLETED|Double Blind Phase||0
203964|NCT00412061|479236|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
203965|NCT00412061|479237|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
203966|NCT00412061|479236|P2|STARTED|Double Blind Phase||213
203967|NCT00412061|479237|P1|STARTED|Double Blind Phase||216
203968|NCT00411788|479255|P1|NOT COMPLETED|Overall Study||2
203969|NCT00411788|479255|P1|COMPLETED|Overall Study||9
203970|NCT00411788|479255|P1|STARTED|Overall Study||11
203971|NCT00411762|479264|P1|NOT COMPLETED|Overall Study||5
203972|NCT00411762|479264|P1|COMPLETED|Overall Study||20
203973|NCT00411762|479264|P1|STARTED|Overall Study||25
203974|NCT00411749|479271|P2|NOT COMPLETED|Overall Study||0
203975|NCT00411749|479272|P1|NOT COMPLETED|Overall Study||0
203976|NCT00411749|479271|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
203977|NCT00411749|479272|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
203978|NCT00411749|479271|P2|Vaccinated|Overall Study||25
203979|NCT00411749|479272|P1|Vaccinated|Overall Study||82
203980|NCT00411749|479271|P2|STARTED|Overall Study||25
203981|NCT00411749|479272|P1|STARTED|Overall Study||82
203982|NCT00411671|479288|P1|NOT COMPLETED|Overall Study||20
203983|NCT00411671|479288|P1|COMPLETED|Overall Study||85
203984|NCT00411671|479288|P1|STARTED|Overall Study||105
203985|NCT00411645|479296|P2|NOT COMPLETED|Overall Study||164
203986|NCT00411645|479297|P1|NOT COMPLETED|Overall Study||81
203987|NCT00411645|479296|P2|COMPLETED|Overall Study||290
203988|NCT00411645|479297|P1|COMPLETED|Overall Study||146
203989|NCT00411645|479296|P2|STARTED|Overall Study||454
203990|NCT00411645|479297|P1|STARTED|Overall Study||227
203991|NCT00411619|479321|P1|NOT COMPLETED|Overall Study||6
203992|NCT00411619|479321|P1|COMPLETED|Overall Study||22
203993|NCT00411619|479321|P1|STARTED|Overall Study||28
203994|NCT00411554|479328|P2|NOT COMPLETED|Overall Study||9
203995|NCT00411554|479329|P1|NOT COMPLETED|Overall Study||8
203996|NCT00411554|479328|P2|COMPLETED|Overall Study||147
203997|NCT00411554|479329|P1|COMPLETED|Overall Study||155
203998|NCT00411554|479328|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
203999|NCT00411554|479329|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
204000|NCT00411450|479339|P1|NOT COMPLETED|Overall Study||3
204001|NCT00411450|479339|P1|COMPLETED|Overall Study|Ended second-line treatment|113
204002|NCT00411450|479339|P1|Received Treatment|Overall Study||115
204003|NCT00411450|479339|P1|STARTED|Overall Study||116
204004|NCT00411411|479367|P2|NOT COMPLETED|Overall Study||0
204005|NCT00411411|479368|P1|NOT COMPLETED|Overall Study||0
204006|NCT00411411|479367|P2|COMPLETED|Overall Study||25
204007|NCT00411411|479368|P1|COMPLETED|Overall Study||24
204008|NCT00411411|479367|P2|STARTED|Overall Study||25
204009|NCT00411411|479368|P1|STARTED|Overall Study||24
204010|NCT00411398|479376|P1|NOT COMPLETED|Overall Study||5
204011|NCT00411398|479376|P1|COMPLETED|Overall Study||10
204012|NCT00411398|479376|P1|STARTED|Overall Study||15
204013|NCT00411216|479382|P2|NOT COMPLETED|Overall Study||2
204014|NCT00411216|479383|P1|NOT COMPLETED|Overall Study||0
204015|NCT00411216|479382|P2|COMPLETED|Overall Study||8
204016|NCT00411216|479383|P1|COMPLETED|Overall Study||13
204017|NCT00411216|479382|P2|STARTED|Overall Study||10
204018|NCT00411216|479383|P1|STARTED|Overall Study||13
204019|NCT00411151|479389|P1|NOT COMPLETED|Overall Study||47
204020|NCT00411151|479389|P1|COMPLETED|Overall Study||5
204021|NCT00411151|479389|P1|STARTED|Overall Study||52
204022|NCT00410904|479401|P2|NOT COMPLETED|Overall Study||0
204023|NCT00410904|479402|P1|NOT COMPLETED|Overall Study||0
204024|NCT00410904|479401|P2|COMPLETED|Overall Study||20
204025|NCT00410904|479402|P1|COMPLETED|Overall Study||40
204026|NCT00410904|479401|P2|STARTED|Overall Study||20
204027|NCT00410904|479402|P1|STARTED|Overall Study||40
204028|NCT00410891|479408|P1|NOT COMPLETED|Overall Study||0
204029|NCT00410891|479408|P1|COMPLETED|Overall Study||129
204030|NCT00410891|479408|P1|STARTED|Overall Study||129
204031|NCT00410826|479414|P2|NOT COMPLETED|Overall Study||4
204032|NCT00410826|479415|P1|NOT COMPLETED|Overall Study||9
204033|NCT00410826|479414|P2|COMPLETED|Overall Study||95
204034|NCT00410826|479415|P1|COMPLETED|Overall Study||96
204035|NCT00410826|479414|P2|STARTED|Overall Study||99
204036|NCT00410826|479415|P1|STARTED|Overall Study||105
204037|NCT00410761|479425|P2|NOT COMPLETED|Overall Study||72
204038|NCT00410761|479426|P1|NOT COMPLETED|Overall Study||120
204039|NCT00410761|479425|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
204040|NCT00410761|479426|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
204041|NCT00410761|479425|P2|STARTED|Overall Study|randomised patients|100
204042|NCT00410761|479426|P1|STARTED|Overall Study|randomised patients|231
204043|NCT00410514|479449|P3|NOT COMPLETED|Overall Study||7
204044|NCT00410514|479450|P2|NOT COMPLETED|Overall Study||3
204045|NCT00410514|479451|P1|NOT COMPLETED|Overall Study||2
204046|NCT00410514|479449|P3|COMPLETED|Overall Study||58
204047|NCT00410514|479450|P2|COMPLETED|Overall Study||67
204048|NCT00410514|479451|P1|COMPLETED|Overall Study||63
204049|NCT00410514|479449|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
204050|NCT00410514|479450|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
204051|NCT00410514|479451|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
204052|NCT00410514|479449|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
204053|NCT00410514|479450|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
204054|NCT00410514|479451|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
204055|NCT00410514|479449|P3|STARTED|Overall Study||65
204056|NCT00410514|479450|P2|STARTED|Overall Study||70
204057|NCT00410514|479451|P1|STARTED|Overall Study||65
204058|NCT00410488|479512|P2|NOT COMPLETED|Overall Study||0
204059|NCT00410488|479513|P1|NOT COMPLETED|Overall Study||0
204060|NCT00410488|479512|P2|COMPLETED|Overall Study||34
204061|NCT00410488|479513|P1|COMPLETED|Overall Study||16
204062|NCT00410488|479512|P2|STARTED|Overall Study||34
204063|NCT00410488|479513|P1|STARTED|Overall Study||16
204064|NCT00410410|479524|P9|NOT COMPLETED|Open-Label Period (OL)||349
204065|NCT00410410|479525|P8|NOT COMPLETED|Open-Label Period (OL)||0
204066|NCT00410410|479526|P7|NOT COMPLETED|Open-Label Period (OL)||0
204067|NCT00410410|479527|P6|NOT COMPLETED|Open-Label Period (OL)||0
204068|NCT00410410|479528|P5|NOT COMPLETED|Open-Label Period (OL)||0
204069|NCT00410410|479529|P4|NOT COMPLETED|Open-Label Period (OL)||0
204070|NCT00410410|479530|P3|NOT COMPLETED|Open-Label Period (OL)||0
204071|NCT00410410|479531|P2|NOT COMPLETED|Open-Label Period (OL)||0
204072|NCT00410410|479532|P1|NOT COMPLETED|Open-Label Period (OL)||0
204073|NCT00410410|479524|P9|COMPLETED|Open-Label Period (OL)||0
204074|NCT00410410|479525|P8|COMPLETED|Open-Label Period (OL)||0
204075|NCT00410410|479526|P7|COMPLETED|Open-Label Period (OL)||0
204076|NCT00410410|479527|P6|COMPLETED|Open-Label Period (OL)||0
204077|NCT00410410|479528|P5|COMPLETED|Open-Label Period (OL)||0
204078|NCT00410410|479529|P4|COMPLETED|Open-Label Period (OL)||0
204079|NCT00410410|479530|P3|COMPLETED|Open-Label Period (OL)||0
204080|NCT00410410|479531|P2|COMPLETED|Open-Label Period (OL)||0
204081|NCT00410410|479532|P1|COMPLETED|Open-Label Period (OL)||0
204082|NCT00410410|479524|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
204083|NCT00410410|479525|P8|STARTED|Open-Label Period (OL)||0
204084|NCT00410410|479526|P7|STARTED|Open-Label Period (OL)||0
204085|NCT00410410|479527|P6|STARTED|Open-Label Period (OL)||0
204086|NCT00410410|479528|P5|STARTED|Open-Label Period (OL)||0
204087|NCT00410410|479529|P4|STARTED|Open-Label Period (OL)||0
204088|NCT00410410|479530|P3|STARTED|Open-Label Period (OL)||0
204089|NCT00410410|479531|P2|STARTED|Open-Label Period (OL)||0
204090|NCT00410410|479532|P1|STARTED|Open-Label Period (OL)||0
204091|NCT00410410|479524|P9|NOT COMPLETED|Maintenance Period (MP)||0
204092|NCT00410410|479525|P8|NOT COMPLETED|Maintenance Period (MP)||55
204093|NCT00410410|479526|P7|NOT COMPLETED|Maintenance Period (MP)||50
204094|NCT00410410|479527|P6|NOT COMPLETED|Maintenance Period (MP)||0
204095|NCT00410410|479528|P5|NOT COMPLETED|Maintenance Period (MP)||0
204096|NCT00410410|479529|P4|NOT COMPLETED|Maintenance Period (MP)||0
204097|NCT00410410|479530|P3|NOT COMPLETED|Maintenance Period (MP)||0
204098|NCT00410410|479531|P2|NOT COMPLETED|Maintenance Period (MP)||0
204099|NCT00410410|479532|P1|NOT COMPLETED|Maintenance Period (MP)||0
204100|NCT00410410|479524|P9|COMPLETED|Maintenance Period (MP)||0
204101|NCT00410410|479525|P8|COMPLETED|Maintenance Period (MP)||11
204102|NCT00410410|479526|P7|COMPLETED|Maintenance Period (MP)||15
204103|NCT00410410|479527|P6|COMPLETED|Maintenance Period (MP)||0
204104|NCT00410410|479528|P5|COMPLETED|Maintenance Period (MP)||0
204105|NCT00410410|479529|P4|COMPLETED|Maintenance Period (MP)||0
204106|NCT00410410|479530|P3|COMPLETED|Maintenance Period (MP)||0
204107|NCT00410410|479531|P2|COMPLETED|Maintenance Period (MP)||0
204108|NCT00410410|479532|P1|COMPLETED|Maintenance Period (MP)||0
204109|NCT00410410|479524|P9|STARTED|Maintenance Period (MP)||0
204110|NCT00410410|479525|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
204111|NCT00410410|479526|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
204112|NCT00410410|479527|P6|STARTED|Maintenance Period (MP)||0
204113|NCT00410410|479528|P5|STARTED|Maintenance Period (MP)||0
204114|NCT00410410|479529|P4|STARTED|Maintenance Period (MP)||0
204115|NCT00410410|479530|P3|STARTED|Maintenance Period (MP)||0
204116|NCT00410410|479531|P2|STARTED|Maintenance Period (MP)||0
204117|NCT00410410|479532|P1|STARTED|Maintenance Period (MP)||0
204118|NCT00410410|479524|P9|NOT COMPLETED|Induction Period (IP)||0
204119|NCT00410410|479525|P8|NOT COMPLETED|Induction Period (IP)||0
204120|NCT00410410|479526|P7|NOT COMPLETED|Induction Period (IP)||0
204121|NCT00410410|479527|P6|NOT COMPLETED|Induction Period (IP)||29
204122|NCT00410410|479528|P5|NOT COMPLETED|Induction Period (IP)||32
204123|NCT00410410|479529|P4|NOT COMPLETED|Induction Period (IP)||20
204124|NCT00410410|479530|P3|NOT COMPLETED|Induction Period (IP)||17
204125|NCT00410410|479531|P2|NOT COMPLETED|Induction Period (IP)||35
204126|NCT00410410|479532|P1|NOT COMPLETED|Induction Period (IP)||35
204127|NCT00410410|479524|P9|COMPLETED|Induction Period (IP)||0
204128|NCT00410410|479525|P8|COMPLETED|Induction Period (IP)||0
204129|NCT00410410|479526|P7|COMPLETED|Induction Period (IP)||0
204130|NCT00410410|479527|P6|COMPLETED|Induction Period (IP)||21
204131|NCT00410410|479528|P5|COMPLETED|Induction Period (IP)||19
204132|NCT00410410|479529|P4|COMPLETED|Induction Period (IP)||120
204133|NCT00410410|479530|P3|COMPLETED|Induction Period (IP)||53
204134|NCT00410410|479531|P2|COMPLETED|Induction Period (IP)||104
204135|NCT00410410|479532|P1|COMPLETED|Induction Period (IP)||106
204136|NCT00410410|479524|P9|STARTED|Induction Period (IP)||0
204137|NCT00410410|479525|P8|STARTED|Induction Period (IP)||0
204138|NCT00410410|479526|P7|STARTED|Induction Period (IP)||0
204139|NCT00410410|479527|P6|STARTED|Induction Period (IP)||50
204140|NCT00410410|479528|P5|STARTED|Induction Period (IP)||51
204141|NCT00410410|479529|P4|STARTED|Induction Period (IP)||140
204142|NCT00410410|479530|P3|STARTED|Induction Period (IP)||70
204143|NCT00410410|479531|P2|STARTED|Induction Period (IP)||139
204144|NCT00410410|479532|P1|STARTED|Induction Period (IP)||141
204145|NCT00410384|479693|P3|NOT COMPLETED|Overall Study||82
204146|NCT00410384|479694|P2|NOT COMPLETED|Overall Study||72
204147|NCT00410384|479695|P1|NOT COMPLETED|Overall Study||89
204148|NCT00410384|479693|P3|COMPLETED|Overall Study||191
204149|NCT00410384|479694|P2|COMPLETED|Overall Study||199
204150|NCT00410384|479695|P1|COMPLETED|Overall Study||186
204151|NCT00410384|479693|P3|STARTED|Overall Study||273
204152|NCT00410384|479694|P2|STARTED|Overall Study||271
204153|NCT00410384|479695|P1|STARTED|Overall Study||275
204154|NCT00410280|479723|P2|NOT COMPLETED|Overall Study||0
204155|NCT00410280|479724|P1|NOT COMPLETED|Overall Study||0
204156|NCT00410280|479723|P2|COMPLETED|Overall Study||13
204157|NCT00410280|479724|P1|COMPLETED|Overall Study||14
204158|NCT00410280|479723|P2|STARTED|Overall Study||13
204159|NCT00410280|479724|P1|STARTED|Overall Study||14
204160|NCT00410202|479768|P3|NOT COMPLETED|Off-treatment Follow up||12
204161|NCT00410202|479769|P2|NOT COMPLETED|Off-treatment Follow up||8
204162|NCT00410202|479770|P1|NOT COMPLETED|Off-treatment Follow up||14
204163|NCT00410202|479768|P3|COMPLETED|Off-treatment Follow up||2
204164|NCT00410202|479769|P2|COMPLETED|Off-treatment Follow up||0
204165|NCT00410202|479770|P1|COMPLETED|Off-treatment Follow up||1
204166|NCT00410202|479768|P3|STARTED|Off-treatment Follow up||14
204167|NCT00410202|479769|P2|STARTED|Off-treatment Follow up||8
204168|NCT00410202|479770|P1|STARTED|Off-treatment Follow up||15
204169|NCT00410202|479768|P3|NOT COMPLETED|On-Treatment||71
204170|NCT00410202|479769|P2|NOT COMPLETED|On-Treatment||79
204171|NCT00410202|479770|P1|NOT COMPLETED|On-Treatment||75
204172|NCT00410202|479768|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
204173|NCT00410202|479769|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
204174|NCT00410202|479770|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
204175|NCT00410202|479768|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
204176|NCT00410202|479769|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
204177|NCT00410202|479770|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
204178|NCT00410202|479768|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
204179|NCT00410202|479769|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
204180|NCT00410202|479770|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
204181|NCT00410202|479768|P3|STARTED|On-Treatment||137
204182|NCT00410202|479769|P2|STARTED|On-Treatment||140
204183|NCT00410202|479770|P1|STARTED|On-Treatment||138
204184|NCT00410189|479850|P1|NOT COMPLETED|Overall Study||0
204185|NCT00410189|479850|P1|COMPLETED|Overall Study||54
204186|NCT00410189|479850|P1|STARTED|Overall Study||54
204187|NCT00410163|479857|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
204188|NCT00410163|479858|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
204189|NCT00410163|479857|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
204190|NCT00410163|479858|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
204191|NCT00410163|479857|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
204192|NCT00410163|479858|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
204193|NCT00410163|479857|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
204194|NCT00410163|479858|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
204195|NCT00410163|479857|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
204196|NCT00410163|479858|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
204197|NCT00410163|479857|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
204198|NCT00410163|479858|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
204199|NCT00410150|479902|P2|NOT COMPLETED|Overall Study||3
204200|NCT00410150|479903|P1|NOT COMPLETED|Overall Study||2
204201|NCT00410150|479902|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
204202|NCT00410150|479903|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
204203|NCT00410150|479902|P2|STARTED|Overall Study||20
204204|NCT00410150|479903|P1|STARTED|Overall Study||22
204205|NCT00410124|479911|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
204206|NCT00410124|479912|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
204207|NCT00410124|479911|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
204208|NCT00410124|479912|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
204384|NCT00408993|480405|P2|STARTED|Overall Study||109
204209|NCT00410124|479911|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
204210|NCT00410124|479912|P1|STARTED|Extension Phase - Open Label (45 Months)||67
204211|NCT00410124|479911|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
204212|NCT00410124|479912|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
204213|NCT00410124|479911|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
204214|NCT00410124|479912|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
204215|NCT00410124|479911|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
204216|NCT00410124|479912|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
204217|NCT00410124|479911|P2|Ongoing|Core Phase Double Blind (15 Months)||4
204218|NCT00410124|479912|P1|Ongoing|Core Phase Double Blind (15 Months)||13
204219|NCT00410124|479911|P2|STARTED|Core Phase Double Blind (15 Months)||139
204220|NCT00410124|479912|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
204221|NCT00410072|479943|P2|NOT COMPLETED|After Week 48 to Week 96||11
204222|NCT00410072|479944|P1|NOT COMPLETED|After Week 48 to Week 96||6
204223|NCT00410072|479943|P2|COMPLETED|After Week 48 to Week 96||174
204224|NCT00410072|479944|P1|COMPLETED|After Week 48 to Week 96||170
204225|NCT00410072|479943|P2|STARTED|After Week 48 to Week 96||185
204226|NCT00410072|479944|P1|STARTED|After Week 48 to Week 96||176
204227|NCT00410072|479943|P2|NOT COMPLETED|Day 1 to Week 48||12
204228|NCT00410072|479944|P1|NOT COMPLETED|Day 1 to Week 48||6
204229|NCT00410072|479943|P2|COMPLETED|Day 1 to Week 48||185
204230|NCT00410072|479944|P1|COMPLETED|Day 1 to Week 48||176
204231|NCT00410072|479943|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
204232|NCT00410072|479944|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
204233|NCT00410046|479980|P1|NOT COMPLETED|Overall Study||5
204234|NCT00410046|479980|P1|COMPLETED|Overall Study||79
204235|NCT00410046|479980|P1|STARTED|Overall Study||84
204236|NCT00409838|480011|P2|NOT COMPLETED|Long-term Extension Period||0
204237|NCT00409838|480012|P1|NOT COMPLETED|Long-term Extension Period||18
204238|NCT00409838|480011|P2|COMPLETED|Long-term Extension Period||0
204239|NCT00409838|480012|P1|COMPLETED|Long-term Extension Period||87
204240|NCT00409838|480011|P2|STARTED|Long-term Extension Period||0
204241|NCT00409838|480012|P1|STARTED|Long-term Extension Period||105
204242|NCT00409838|480011|P2|NOT COMPLETED|Short-term Period||5
204243|NCT00409838|480012|P1|NOT COMPLETED|Short-term Period||3
204244|NCT00409838|480011|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
204245|NCT00409838|480012|P1|COMPLETED|Short-term Period||53
204246|NCT00409838|480011|P2|Treated (Baseline) Population|Short-term Period||57
204247|NCT00409838|480012|P1|Treated (Baseline) Population|Short-term Period||55
204248|NCT00409838|480011|P2|STARTED|Short-term Period|Randomized|57
204249|NCT00409838|480012|P1|STARTED|Short-term Period|Randomized|56
204250|NCT00409825|480073|P1|NOT COMPLETED|Overall Study||0
204251|NCT00409825|480073|P1|COMPLETED|Overall Study||61
204252|NCT00409825|480073|P1|STARTED|Overall Study||61
204253|NCT00409786|480077|P1|NOT COMPLETED|Overall Study||3
204254|NCT00409786|480077|P1|COMPLETED|Overall Study||47
204255|NCT00409786|480077|P1|STARTED|Overall Study||50
204256|NCT00409773|480086|P5|NOT COMPLETED|Overall Study||10
204257|NCT00409773|480087|P4|NOT COMPLETED|Overall Study||12
204258|NCT00409773|480088|P3|NOT COMPLETED|Overall Study||9
204259|NCT00409773|480089|P2|NOT COMPLETED|Overall Study||7
204260|NCT00409773|480090|P1|NOT COMPLETED|Overall Study||9
204261|NCT00409773|480086|P5|COMPLETED|Overall Study||218
204262|NCT00409773|480087|P4|COMPLETED|Overall Study||216
204263|NCT00409773|480088|P3|COMPLETED|Overall Study||220
204264|NCT00409773|480089|P2|COMPLETED|Overall Study||222
204265|NCT00409773|480090|P1|COMPLETED|Overall Study||220
204266|NCT00409773|480086|P5|STARTED|Overall Study||228
204267|NCT00409773|480087|P4|STARTED|Overall Study||228
204268|NCT00409773|480088|P3|STARTED|Overall Study||229
204269|NCT00409773|480089|P2|STARTED|Overall Study||229
204270|NCT00409773|480090|P1|STARTED|Overall Study||229
204271|NCT00409747|480172|P1|NOT COMPLETED|Overall Study||1
204272|NCT00409747|480172|P1|COMPLETED|Overall Study||10
204273|NCT00409747|480172|P1|STARTED|Overall Study||11
204274|NCT00409708|480179|P2|NOT COMPLETED|Washout||10
204275|NCT00409708|480180|P1|NOT COMPLETED|Washout||21
204276|NCT00409708|480179|P2|COMPLETED|Washout||29
204277|NCT00409708|480180|P1|COMPLETED|Washout||17
204278|NCT00409708|480179|P2|STARTED|Washout||39
204279|NCT00409708|480180|P1|STARTED|Washout||38
204280|NCT00409708|480179|P2|NOT COMPLETED|Treatment||17
204281|NCT00409708|480180|P1|NOT COMPLETED|Treatment||15
204282|NCT00409708|480179|P2|COMPLETED|Treatment||39
204283|NCT00409708|480180|P1|COMPLETED|Treatment||38
204284|NCT00409708|480179|P2|STARTED|Treatment||56
204285|NCT00409708|480180|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
204286|NCT00409682|480201|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
204287|NCT00409682|480202|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
204288|NCT00409682|480203|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
204289|NCT00409682|480201|P3|COMPLETED|EOW Double-blind Maintenance Period||66
204290|NCT00409682|480202|P2|COMPLETED|EOW Double-blind Maintenance Period||58
204291|NCT00409682|480203|P1|COMPLETED|EOW Double-blind Maintenance Period||0
204292|NCT00409682|480201|P3|STARTED|EOW Double-blind Maintenance Period||93
204293|NCT00409682|480202|P2|STARTED|EOW Double-blind Maintenance Period||95
204294|NCT00409682|480203|P1|STARTED|EOW Double-blind Maintenance Period||0
204295|NCT00409682|480201|P3|NOT COMPLETED|Open-label Induction Period||0
204296|NCT00409682|480202|P2|NOT COMPLETED|Open-label Induction Period||0
204297|NCT00409682|480203|P1|NOT COMPLETED|Open-label Induction Period||4
204298|NCT00409682|480201|P3|COMPLETED|Open-label Induction Period||0
204299|NCT00409682|480202|P2|COMPLETED|Open-label Induction Period||0
204300|NCT00409682|480203|P1|COMPLETED|Open-label Induction Period||188
204301|NCT00409682|480201|P3|STARTED|Open-label Induction Period||0
204302|NCT00409682|480202|P2|STARTED|Open-label Induction Period||0
204303|NCT00409682|480203|P1|STARTED|Open-label Induction Period||192
204304|NCT00409617|480220|P1|NOT COMPLETED|Overall Study||160
204305|NCT00409617|480220|P1|COMPLETED|Overall Study||785
204306|NCT00409617|480220|P1|STARTED|Overall Study||945
204307|NCT00409578|480236|P4|NOT COMPLETED|Overall Study||67
204308|NCT00409578|480237|P3|NOT COMPLETED|Overall Study||54
204309|NCT00409578|480238|P2|NOT COMPLETED|Overall Study||70
204310|NCT00409578|480239|P1|NOT COMPLETED|Overall Study||52
204311|NCT00409578|480236|P4|COMPLETED|Overall Study||214
204312|NCT00409578|480237|P3|COMPLETED|Overall Study||215
204313|NCT00409578|480238|P2|COMPLETED|Overall Study||201
204314|NCT00409578|480239|P1|COMPLETED|Overall Study||228
204315|NCT00409578|480236|P4|STARTED|Overall Study||281
204316|NCT00409578|480237|P3|STARTED|Overall Study||269
204317|NCT00409578|480238|P2|STARTED|Overall Study||271
204318|NCT00409578|480239|P1|STARTED|Overall Study||280
204319|NCT00409565|480261|P1|NOT COMPLETED|Overall Study||1
204320|NCT00409565|480261|P1|COMPLETED|Overall Study||45
204321|NCT00409565|480261|P1|Overall Response Rate|Overall Study||7
204322|NCT00409565|480261|P1|STARTED|Overall Study||46
204323|NCT00409539|480271|P5|NOT COMPLETED|Overall Study||25
204324|NCT00409539|480272|P4|NOT COMPLETED|Overall Study||12
204325|NCT00409539|480273|P3|NOT COMPLETED|Overall Study||14
204326|NCT00409539|480274|P2|NOT COMPLETED|Overall Study||11
204327|NCT00409539|480275|P1|NOT COMPLETED|Overall Study||11
204328|NCT00409539|480271|P5|COMPLETED|Overall Study||85
204329|NCT00409539|480272|P4|COMPLETED|Overall Study||97
204330|NCT00409539|480273|P3|COMPLETED|Overall Study||95
204331|NCT00409539|480274|P2|COMPLETED|Overall Study||100
204332|NCT00409539|480275|P1|COMPLETED|Overall Study||100
204333|NCT00409539|480271|P5|STARTED|Overall Study||110
204334|NCT00409539|480272|P4|STARTED|Overall Study||109
204335|NCT00409539|480273|P3|STARTED|Overall Study||109
204336|NCT00409539|480274|P2|STARTED|Overall Study||111
204337|NCT00409539|480275|P1|STARTED|Overall Study||111
204338|NCT00409409|480294|P2|NOT COMPLETED|Overall Study||4
204339|NCT00409409|480295|P1|NOT COMPLETED|Overall Study||8
204340|NCT00409409|480294|P2|COMPLETED|Overall Study||135
204341|NCT00409409|480295|P1|COMPLETED|Overall Study||131
204342|NCT00409409|480294|P2|STARTED|Overall Study||139
204343|NCT00409409|480295|P1|STARTED|Overall Study||139
204344|NCT00409344|480303|P2|NOT COMPLETED|Overall Study||0
204345|NCT00409344|480304|P1|NOT COMPLETED|Overall Study||0
204346|NCT00409344|480303|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
204347|NCT00409344|480304|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
204348|NCT00409344|480303|P2|STARTED|Overall Study|No participants enrolled|0
204349|NCT00409344|480304|P1|STARTED|Overall Study|No participants enrolled|0
204350|NCT00409331|480322|P1|NOT COMPLETED|Overall Study||1
204351|NCT00409331|480322|P1|COMPLETED|Overall Study||0
204352|NCT00409331|480322|P1|STARTED|Overall Study||1
204353|NCT00409292|480326|P1|NOT COMPLETED|Overall Study||0
204354|NCT00409292|480326|P1|COMPLETED|Overall Study||33
204355|NCT00409292|480326|P1|STARTED|Overall Study||33
204356|NCT00409240|480335|P2|NOT COMPLETED|Overall Study||1
204357|NCT00409240|480336|P1|NOT COMPLETED|Overall Study||3
204358|NCT00409240|480335|P2|COMPLETED|Overall Study||49
204359|NCT00409240|480336|P1|COMPLETED|Overall Study||50
204360|NCT00409240|480335|P2|STARTED|Overall Study||50
204361|NCT00409240|480336|P1|STARTED|Overall Study||53
204362|NCT00409188|480344|P2|NOT COMPLETED|Overall Study||175
204363|NCT00409188|480345|P1|NOT COMPLETED|Overall Study||383
204364|NCT00409188|480344|P2|COMPLETED|Overall Study||332
204365|NCT00409188|480345|P1|COMPLETED|Overall Study||623
204366|NCT00409188|480344|P2|STARTED|Overall Study||507
204367|NCT00409188|480345|P1|STARTED|Overall Study||1006
204368|NCT00409175|480361|P2|NOT COMPLETED|Overall Study||19
204369|NCT00409175|480362|P1|NOT COMPLETED|Overall Study||18
204370|NCT00409175|480361|P2|COMPLETED|Overall Study||44
204371|NCT00409175|480362|P1|COMPLETED|Overall Study||47
204372|NCT00409175|480361|P2|STARTED|Overall Study||63
204373|NCT00409175|480362|P1|STARTED|Overall Study||65
204374|NCT00409006|480388|P2|NOT COMPLETED|Overall Study||12
204375|NCT00409006|480389|P1|NOT COMPLETED|Overall Study||20
204376|NCT00409006|480388|P2|COMPLETED|Overall Study||19
204377|NCT00409006|480389|P1|COMPLETED|Overall Study||19
204378|NCT00409006|480388|P2|STARTED|Overall Study||31
204379|NCT00409006|480389|P1|STARTED|Overall Study||39
204380|NCT00408993|480405|P2|NOT COMPLETED|Overall Study||17
204381|NCT00408993|480406|P1|NOT COMPLETED|Overall Study||19
204382|NCT00408993|480405|P2|COMPLETED|Overall Study||92
204383|NCT00408993|480406|P1|COMPLETED|Overall Study||87
204385|NCT00408993|480406|P1|STARTED|Overall Study||106
204386|NCT00408928|480438|P1|NOT COMPLETED|Overall Study||3
204387|NCT00408928|480438|P1|COMPLETED|Overall Study||8
204388|NCT00408928|480438|P1|STARTED|Overall Study||11
204389|NCT00408902|480443|P1|NOT COMPLETED|Overall Study||10
204390|NCT00408902|480443|P1|COMPLETED|Overall Study||0
204391|NCT00408902|480443|P1|STARTED|Overall Study||10
204392|NCT00408876|480452|P4|NOT COMPLETED|Overall Study||35
204393|NCT00408876|480453|P3|NOT COMPLETED|Overall Study||50
204394|NCT00408876|480454|P2|NOT COMPLETED|Overall Study||36
204395|NCT00408876|480455|P1|NOT COMPLETED|Overall Study||16
204396|NCT00408876|480452|P4|COMPLETED|Overall Study||82
204397|NCT00408876|480453|P3|COMPLETED|Overall Study||62
204398|NCT00408876|480454|P2|COMPLETED|Overall Study||80
204399|NCT00408876|480455|P1|COMPLETED|Overall Study||43
204400|NCT00408876|480452|P4|STARTED|Overall Study||117
204401|NCT00408876|480453|P3|STARTED|Overall Study||112
204402|NCT00408876|480454|P2|STARTED|Overall Study||116
204403|NCT00408876|480455|P1|STARTED|Overall Study||59
204404|NCT00408694|480705|P1|NOT COMPLETED|Overall Study||2
204405|NCT00408694|480705|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
204406|NCT00408694|480705|P1|STARTED|Overall Study||46
204407|NCT00408681|480709|P1|NOT COMPLETED|Overall Study||9
204408|NCT00408681|480709|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
204409|NCT00408681|480709|P1|STARTED|Overall Study||20
204410|NCT00408629|480728|P2|NOT COMPLETED|Overall Study||125
204411|NCT00408629|480729|P1|NOT COMPLETED|Overall Study||97
204412|NCT00408629|480728|P2|COMPLETED|Overall Study||135
204413|NCT00408629|480729|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
204414|NCT00408629|480728|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
204415|NCT00408629|480729|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
204416|NCT00408421|480770|P3|NOT COMPLETED|Treatment Re-Randomization||5
204417|NCT00408421|480771|P2|NOT COMPLETED|Treatment Re-Randomization||7
204418|NCT00408421|480772|P1|NOT COMPLETED|Treatment Re-Randomization||7
204419|NCT00408421|480770|P3|COMPLETED|Treatment Re-Randomization||38
204420|NCT00408421|480771|P2|COMPLETED|Treatment Re-Randomization||39
204421|NCT00408421|480772|P1|COMPLETED|Treatment Re-Randomization||96
204422|NCT00408421|480770|P3|STARTED|Treatment Re-Randomization||43
204423|NCT00408421|480771|P2|STARTED|Treatment Re-Randomization||46
204424|NCT00408421|480772|P1|STARTED|Treatment Re-Randomization||103
204425|NCT00408421|480770|P3|NOT COMPLETED|Treatment Initial Randomization||0
204426|NCT00408421|480771|P2|NOT COMPLETED|Treatment Initial Randomization||22
204427|NCT00408421|480772|P1|NOT COMPLETED|Treatment Initial Randomization||17
204428|NCT00408421|480770|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
204429|NCT00408421|480771|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
204430|NCT00408421|480772|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
204431|NCT00408421|480770|P3|STARTED|Treatment Initial Randomization||0
204432|NCT00408421|480771|P2|STARTED|Treatment Initial Randomization||111
204433|NCT00408421|480772|P1|STARTED|Treatment Initial Randomization||120
204434|NCT00408317|480846|P2|NOT COMPLETED|Second Intervention Period||2
204435|NCT00408317|480847|P1|NOT COMPLETED|Second Intervention Period||2
204436|NCT00408317|480846|P2|COMPLETED|Second Intervention Period||14
204437|NCT00408317|480847|P1|COMPLETED|Second Intervention Period||12
204438|NCT00408317|480846|P2|STARTED|Second Intervention Period||16
204439|NCT00408317|480847|P1|STARTED|Second Intervention Period||14
204440|NCT00408317|480846|P2|NOT COMPLETED|First Intervention Period||1
204441|NCT00408317|480847|P1|NOT COMPLETED|First Intervention Period||0
204442|NCT00408317|480846|P2|COMPLETED|First Intervention Period||16
204443|NCT00408317|480847|P1|COMPLETED|First Intervention Period||14
204444|NCT00408317|480846|P2|STARTED|First Intervention Period||17
204445|NCT00408317|480847|P1|STARTED|First Intervention Period||14
204446|NCT00408200|480861|P2|NOT COMPLETED|Overall Study||0
204447|NCT00408200|480862|P1|NOT COMPLETED|Overall Study||0
204448|NCT00408200|480861|P2|COMPLETED|Overall Study||53
204449|NCT00408200|480862|P1|COMPLETED|Overall Study||57
204450|NCT00408200|480861|P2|STARTED|Overall Study||53
204451|NCT00408200|480862|P1|STARTED|Overall Study||57
204452|NCT00408070|480870|P1|NOT COMPLETED|Overall Study||0
204453|NCT00408070|480870|P1|COMPLETED|Overall Study||5
204454|NCT00408070|480870|P1|STARTED|Overall Study||5
204455|NCT00407966|480874|P1|NOT COMPLETED|Overall Study||0
204456|NCT00407966|480874|P1|COMPLETED|Overall Study||45
204457|NCT00407966|480874|P1|CR|Overall Study||30
204458|NCT00407966|480874|P1|STARTED|Overall Study||45
204459|NCT00407797|480878|P1|NOT COMPLETED|Overall Study||18
204460|NCT00407797|480878|P1|COMPLETED|Overall Study||118
204461|NCT00407797|480878|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
204462|NCT00407797|480878|P1|STARTED|Overall Study||136
204463|NCT00407745|480895|P2|NOT COMPLETED|Overall Study||17
204464|NCT00407745|480896|P1|NOT COMPLETED|Overall Study||19
204465|NCT00407745|480895|P2|COMPLETED|Overall Study||91
204466|NCT00407745|480896|P1|COMPLETED|Overall Study||93
204467|NCT00407745|480895|P2|Treated|Overall Study||107
204468|NCT00407745|480896|P1|Treated|Overall Study||112
204469|NCT00407745|480895|P2|STARTED|Overall Study||108
204470|NCT00407745|480896|P1|STARTED|Overall Study||112
204471|NCT00407654|480968|P1|NOT COMPLETED|Overall Study||0
204472|NCT00407654|480968|P1|COMPLETED|Overall Study||75
204473|NCT00407654|480968|P1|STARTED|Overall Study||75
204474|NCT00407563|480980|P1|NOT COMPLETED|Overall Study||1
204475|NCT00407563|480980|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
204476|NCT00407563|480980|P1|STARTED|Overall Study||48
204477|NCT00407550|480990|P2|NOT COMPLETED|Overall Study||4
204478|NCT00407550|480991|P1|NOT COMPLETED|Overall Study||3
204479|NCT00407550|480990|P2|COMPLETED|Overall Study||5
204480|NCT00407550|480991|P1|COMPLETED|Overall Study||7
204481|NCT00407550|480990|P2|STARTED|Overall Study||9
204482|NCT00407550|480991|P1|STARTED|Overall Study||10
204483|NCT00407537|480999|P2|NOT COMPLETED|Overall Study||44
204484|NCT00407537|481000|P1|NOT COMPLETED|Overall Study||93
204485|NCT00407537|480999|P2|COMPLETED|Overall Study||638
204486|NCT00407537|481000|P1|COMPLETED|Overall Study||686
204487|NCT00407537|480999|P2|Eligible for Efficacy Analysis|Overall Study||657
204488|NCT00407537|481000|P1|Eligible for Efficacy Analysis|Overall Study||760
204489|NCT00407537|480999|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
204490|NCT00407537|481000|P1|STARTED|Overall Study||779
204491|NCT00407511|481048|P1|NOT COMPLETED|Overall Study||22
204492|NCT00407511|481048|P1|COMPLETED|Overall Study||99
204493|NCT00407511|481048|P1|STARTED|Overall Study||121
204494|NCT00407485|481062|P1|NOT COMPLETED|Overall Study||0
204495|NCT00407485|481062|P1|COMPLETED|Overall Study||22
204496|NCT00407485|481062|P1|STARTED|Overall Study||22
204497|NCT00407355|481069|P2|NOT COMPLETED|Overall Study||11
204498|NCT00407355|481070|P1|NOT COMPLETED|Overall Study||10
204499|NCT00407355|481069|P2|COMPLETED|Overall Study||9
204500|NCT00407355|481070|P1|COMPLETED|Overall Study||10
204501|NCT00407355|481069|P2|STARTED|Overall Study||20
204502|NCT00407355|481070|P1|STARTED|Overall Study||20
204503|NCT00407030|481081|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
204504|NCT00407030|481082|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
204505|NCT00407030|481083|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
204506|NCT00407030|481081|P3|COMPLETED|Extension Period - up to 68 Weeks||0
204507|NCT00407030|481082|P2|COMPLETED|Extension Period - up to 68 Weeks||74
204508|NCT00407030|481083|P1|COMPLETED|Extension Period - up to 68 Weeks||84
204509|NCT00407030|481081|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
204510|NCT00407030|481082|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
204511|NCT00407030|481083|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
204512|NCT00407030|481081|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
204513|NCT00407030|481082|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
204514|NCT00407030|481083|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
204515|NCT00407030|481081|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
204516|NCT00407030|481082|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
204517|NCT00407030|481083|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
204518|NCT00407030|481081|P3|STARTED|Main Period - 8 to 20 Weeks||74
204519|NCT00407030|481082|P2|STARTED|Main Period - 8 to 20 Weeks||78
204520|NCT00407030|481083|P1|STARTED|Main Period - 8 to 20 Weeks||81
204521|NCT00406848|481111|P2|NOT COMPLETED|Overall Study||54
204522|NCT00406848|481112|P1|NOT COMPLETED|Overall Study||93
204523|NCT00406848|481111|P2|COMPLETED|Overall Study||67
204524|NCT00406848|481112|P1|COMPLETED|Overall Study||156
204525|NCT00406848|481111|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
204526|NCT00406848|481112|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
204527|NCT00406783|481176|P2|NOT COMPLETED|Overall Study||15
204528|NCT00406783|481177|P1|NOT COMPLETED|Overall Study||14
204529|NCT00406783|481176|P2|COMPLETED|Overall Study||256
204530|NCT00406783|481177|P1|COMPLETED|Overall Study||262
204531|NCT00406783|481176|P2|STARTED|Overall Study||271
204532|NCT00406783|481177|P1|STARTED|Overall Study||276
204533|NCT00406718|481192|P3|NOT COMPLETED|Overall Study||8
204534|NCT00406718|481193|P2|NOT COMPLETED|Overall Study||14
204535|NCT00406718|481194|P1|NOT COMPLETED|Overall Study||4
204536|NCT00406718|481192|P3|COMPLETED|Overall Study||39
204537|NCT00406718|481193|P2|COMPLETED|Overall Study||34
204538|NCT00406718|481194|P1|COMPLETED|Overall Study||43
204539|NCT00406718|481192|P3|STARTED|Overall Study||47
204540|NCT00406718|481193|P2|STARTED|Overall Study||48
204541|NCT00406718|481194|P1|STARTED|Overall Study||47
204542|NCT00406692|481208|P1|NOT COMPLETED|Overall Study||7
204543|NCT00406692|481208|P1|COMPLETED|Overall Study||9
204544|NCT00406692|481208|P1|STARTED|Overall Study||16
204545|NCT00406653|481218|P7|NOT COMPLETED|Open-Label Period||324
204546|NCT00406653|481219|P6|NOT COMPLETED|Open-Label Period||0
204547|NCT00406653|481220|P5|NOT COMPLETED|Open-Label Period||0
204548|NCT00406653|481221|P4|NOT COMPLETED|Open-Label Period||0
204549|NCT00406653|481222|P3|NOT COMPLETED|Open-Label Period||0
204550|NCT00406653|481223|P2|NOT COMPLETED|Open-Label Period||0
204551|NCT00406653|481224|P1|NOT COMPLETED|Open-Label Period||0
204552|NCT00406653|481218|P7|COMPLETED|Open-Label Period||0
204553|NCT00406653|481219|P6|COMPLETED|Open-Label Period||0
204554|NCT00406653|481220|P5|COMPLETED|Open-Label Period||0
204555|NCT00406653|481221|P4|COMPLETED|Open-Label Period||0
204556|NCT00406653|481222|P3|COMPLETED|Open-Label Period||0
204557|NCT00406653|481223|P2|COMPLETED|Open-Label Period||0
204558|NCT00406653|481224|P1|COMPLETED|Open-Label Period||0
204559|NCT00406653|481218|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
204560|NCT00406653|481219|P6|STARTED|Open-Label Period||0
204561|NCT00406653|481220|P5|STARTED|Open-Label Period||0
204562|NCT00406653|481221|P4|STARTED|Open-Label Period||0
204563|NCT00406653|481222|P3|STARTED|Open-Label Period||0
204564|NCT00406653|481223|P2|STARTED|Open-Label Period||0
204565|NCT00406653|481224|P1|STARTED|Open-Label Period||0
204566|NCT00406653|481218|P7|NOT COMPLETED|Maintenance Period||0
204567|NCT00406653|481219|P6|NOT COMPLETED|Maintenance Period||36
204568|NCT00406653|481220|P5|NOT COMPLETED|Maintenance Period||30
204569|NCT00406653|481221|P4|NOT COMPLETED|Maintenance Period||0
204570|NCT00406653|481222|P3|NOT COMPLETED|Maintenance Period||0
204571|NCT00406653|481223|P2|NOT COMPLETED|Maintenance Period||0
204572|NCT00406653|481224|P1|NOT COMPLETED|Maintenance Period||0
204573|NCT00406653|481218|P7|COMPLETED|Maintenance Period||0
204574|NCT00406653|481219|P6|COMPLETED|Maintenance Period||10
204575|NCT00406653|481220|P5|COMPLETED|Maintenance Period||14
204576|NCT00406653|481221|P4|COMPLETED|Maintenance Period||0
204577|NCT00406653|481222|P3|COMPLETED|Maintenance Period||0
204578|NCT00406653|481223|P2|COMPLETED|Maintenance Period||0
204579|NCT00406653|481224|P1|COMPLETED|Maintenance Period||0
204580|NCT00406653|481218|P7|STARTED|Maintenance Period||0
204581|NCT00406653|481219|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
204582|NCT00406653|481220|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
204583|NCT00406653|481221|P4|STARTED|Maintenance Period||0
204584|NCT00406653|481222|P3|STARTED|Maintenance Period||0
204585|NCT00406653|481223|P2|STARTED|Maintenance Period||0
204586|NCT00406653|481224|P1|STARTED|Maintenance Period||0
204587|NCT00406653|481218|P7|NOT COMPLETED|Induction Period||0
204588|NCT00406653|481219|P6|NOT COMPLETED|Induction Period||0
204589|NCT00406653|481220|P5|NOT COMPLETED|Induction Period||0
204590|NCT00406653|481221|P4|NOT COMPLETED|Induction Period||26
204591|NCT00406653|481222|P3|NOT COMPLETED|Induction Period||18
204592|NCT00406653|481223|P2|NOT COMPLETED|Induction Period||34
204593|NCT00406653|481224|P1|NOT COMPLETED|Induction Period||15
204594|NCT00406653|481218|P7|COMPLETED|Induction Period||0
204595|NCT00406653|481219|P6|COMPLETED|Induction Period||0
204596|NCT00406653|481220|P5|COMPLETED|Induction Period||0
204597|NCT00406653|481221|P4|COMPLETED|Induction Period||102
204598|NCT00406653|481222|P3|COMPLETED|Induction Period||112
204599|NCT00406653|481223|P2|COMPLETED|Induction Period||94
204600|NCT00406653|481224|P1|COMPLETED|Induction Period||50
204601|NCT00406653|481218|P7|STARTED|Induction Period||0
204602|NCT00406653|481219|P6|STARTED|Induction Period||0
204603|NCT00406653|481220|P5|STARTED|Induction Period||0
204604|NCT00406653|481221|P4|STARTED|Induction Period||128
204605|NCT00406653|481222|P3|STARTED|Induction Period||130
204606|NCT00406653|481223|P2|STARTED|Induction Period||128
204607|NCT00406653|481224|P1|STARTED|Induction Period||65
204608|NCT00406640|481305|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
204609|NCT00406640|481306|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
204610|NCT00406640|481305|P2|COMPLETED|OL Extension Phase for Non-Responders||36
204611|NCT00406640|481306|P1|COMPLETED|OL Extension Phase for Non-Responders||47
204612|NCT00406640|481305|P2|STARTED|OL Extension Phase for Non-Responders||60
204613|NCT00406640|481306|P1|STARTED|OL Extension Phase for Non-Responders||69
204614|NCT00406640|481305|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
204615|NCT00406640|481306|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
204616|NCT00406640|481305|P2|COMPLETED|DB Continuation Phase for Responders||151
204617|NCT00406640|481306|P1|COMPLETED|DB Continuation Phase for Responders||139
204618|NCT00406640|481305|P2|STARTED|DB Continuation Phase for Responders||188
204619|NCT00406640|481306|P1|STARTED|DB Continuation Phase for Responders||172
204620|NCT00406640|481305|P2|NOT COMPLETED|Acute Phase||43
204621|NCT00406640|481306|P1|NOT COMPLETED|Acute Phase||51
204622|NCT00406640|481305|P2|COMPLETED|Acute Phase||256
204623|NCT00406640|481306|P1|COMPLETED|Acute Phase||245
204624|NCT00406640|481305|P2|STARTED|Acute Phase||299
204625|NCT00406640|481306|P1|STARTED|Acute Phase||296
204626|NCT00406393|481338|P2|NOT COMPLETED|Overall Study||1
204627|NCT00406393|481339|P1|NOT COMPLETED|Overall Study||2
204628|NCT00406393|481338|P2|COMPLETED|Overall Study||152
204629|NCT00406393|481339|P1|COMPLETED|Overall Study||149
204630|NCT00406393|481338|P2|STARTED|Overall Study||153
204631|NCT00406393|481339|P1|STARTED|Overall Study||151
204632|NCT00406367|481369|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
204633|NCT00406367|481370|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
204634|NCT00406367|481369|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
204635|NCT00406367|481370|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
204636|NCT00406367|481369|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
204637|NCT00406367|481370|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
204638|NCT00406367|481369|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
204639|NCT00406367|481370|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
204640|NCT00406367|481369|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
204641|NCT00406367|481370|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
204642|NCT00406367|481369|P2|STARTED|Main Period - 6 to 20 Weeks||34
204643|NCT00406367|481370|P1|STARTED|Main Period - 6 to 20 Weeks||75
204644|NCT00406354|481385|P3|NOT COMPLETED|All Randomized and Treated Patients||22
204645|NCT00406354|481386|P2|NOT COMPLETED|All Randomized and Treated Patients||13
204646|NCT00406354|481387|P1|NOT COMPLETED|All Randomized and Treated Patients||16
204647|NCT00406354|481385|P3|COMPLETED|All Randomized and Treated Patients||37
204648|NCT00406354|481386|P2|COMPLETED|All Randomized and Treated Patients||48
204649|NCT00406354|481387|P1|COMPLETED|All Randomized and Treated Patients||44
204650|NCT00406354|481385|P3|STARTED|All Randomized and Treated Patients||59
204651|NCT00406354|481386|P2|STARTED|All Randomized and Treated Patients||61
204652|NCT00406354|481387|P1|STARTED|All Randomized and Treated Patients||60
204653|NCT00406354|481385|P3|NOT COMPLETED|All Randomized Patients||1
204654|NCT00406354|481386|P2|NOT COMPLETED|All Randomized Patients||0
204655|NCT00406354|481387|P1|NOT COMPLETED|All Randomized Patients||0
204656|NCT00406354|481385|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
204657|NCT00406354|481386|P2|COMPLETED|All Randomized Patients||61
204658|NCT00406354|481387|P1|COMPLETED|All Randomized Patients||60
204659|NCT00406354|481385|P3|STARTED|All Randomized Patients||60
204660|NCT00406354|481386|P2|STARTED|All Randomized Patients||61
204661|NCT00406354|481387|P1|STARTED|All Randomized Patients||60
204662|NCT00406315|481458|P1|NOT COMPLETED|Overall Study||141
204663|NCT00406315|481458|P1|COMPLETED|Overall Study||100
204664|NCT00406315|481458|P1|STARTED|Overall Study|Started = Treated|241
204665|NCT00406276|481476|P1|NOT COMPLETED|Overall Study||4
204666|NCT00406276|481476|P1|COMPLETED|Overall Study||24
204667|NCT00406276|481476|P1|STARTED|Overall Study||28
204668|NCT00406133|481485|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
204669|NCT00406133|481486|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
204670|NCT00406133|481487|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
204671|NCT00406133|481488|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
204672|NCT00406133|481485|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
204673|NCT00406133|481486|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
204674|NCT00406133|481487|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
204675|NCT00406133|481488|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
204676|NCT00406133|481485|P4|STARTED|Phase 2 (Second 26 Week Period)||60
204677|NCT00406133|481486|P3|STARTED|Phase 2 (Second 26 Week Period)||67
204678|NCT00406133|481487|P2|STARTED|Phase 2 (Second 26 Week Period)||155
204679|NCT00406133|481488|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
204680|NCT00406133|481485|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
204681|NCT00406133|481486|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
204682|NCT00406133|481487|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
204683|NCT00406133|481488|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
204684|NCT00406133|481485|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
204685|NCT00406133|481486|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
204686|NCT00406133|481487|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
204687|NCT00406133|481488|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
204688|NCT00406133|481485|P4|STARTED|Phase 1 (First 26 Week Period)||62
204689|NCT00406133|481486|P3|STARTED|Phase 1 (First 26 Week Period)||67
204690|NCT00406133|481487|P2|STARTED|Phase 1 (First 26 Week Period)||157
204691|NCT00406133|481488|P1|STARTED|Phase 1 (First 26 Week Period)||165
204692|NCT00406107|481544|P2|NOT COMPLETED|Overall Study||1
204693|NCT00406107|481545|P1|NOT COMPLETED|Overall Study||1
204694|NCT00406107|481544|P2|COMPLETED|Overall Study||4
204695|NCT00406107|481545|P1|COMPLETED|Overall Study||14
204696|NCT00406107|481544|P2|STARTED|Overall Study||5
204697|NCT00406107|481545|P1|STARTED|Overall Study||15
204698|NCT00406029|481560|P5|NOT COMPLETED|Overall Study||8
204699|NCT00406029|481561|P4|NOT COMPLETED|Overall Study||17
204700|NCT00406029|481562|P3|NOT COMPLETED|Overall Study||10
204701|NCT00406029|481563|P2|NOT COMPLETED|Overall Study||8
204702|NCT00406029|481564|P1|NOT COMPLETED|Overall Study||16
204703|NCT00406029|481560|P5|COMPLETED|Overall Study||41
204704|NCT00406029|481561|P4|COMPLETED|Overall Study||40
204705|NCT00406029|481562|P3|COMPLETED|Overall Study||39
204706|NCT00406029|481563|P2|COMPLETED|Overall Study||41
204707|NCT00406029|481564|P1|COMPLETED|Overall Study||33
204708|NCT00406029|481560|P5|Treated|Overall Study||47
204709|NCT00406029|481561|P4|Treated|Overall Study||54
204710|NCT00406029|481562|P3|Treated|Overall Study||47
204711|NCT00406029|481563|P2|Treated|Overall Study||49
204712|NCT00406029|481564|P1|Treated|Overall Study||49
204713|NCT00406029|481560|P5|STARTED|Overall Study||49
204714|NCT00406029|481561|P4|STARTED|Overall Study||57
204715|NCT00406029|481562|P3|STARTED|Overall Study||49
204716|NCT00406029|481563|P2|STARTED|Overall Study||49
204717|NCT00406029|481564|P1|STARTED|Overall Study||49
204718|NCT00405964|481668|P2|NOT COMPLETED|Overall Study||95
204719|NCT00405964|481669|P1|NOT COMPLETED|Overall Study||59
204720|NCT00405964|481668|P2|COMPLETED|Overall Study||261
204721|NCT00405964|481669|P1|COMPLETED|Overall Study||301
204722|NCT00405964|481668|P2|STARTED|Overall Study||356
204723|NCT00405964|481669|P1|STARTED|Overall Study||360
204724|NCT00405938|481681|P2|NOT COMPLETED|Overall Study||0
204725|NCT00405938|481682|P1|NOT COMPLETED|Overall Study||0
204726|NCT00405938|481681|P2|COMPLETED|Overall Study||41
204727|NCT00405938|481682|P1|COMPLETED|Overall Study||38
204728|NCT00405938|481681|P2|STARTED|Overall Study||41
204729|NCT00405938|481682|P1|STARTED|Overall Study||38
204730|NCT00405912|481691|P3|NOT COMPLETED|Overall Study||16
204731|NCT00405912|481692|P2|NOT COMPLETED|Overall Study||19
204732|NCT00405912|481693|P1|NOT COMPLETED|Overall Study||16
204733|NCT00405912|481691|P3|COMPLETED|Overall Study||23
204734|NCT00405912|481692|P2|COMPLETED|Overall Study||21
204735|NCT00405912|481693|P1|COMPLETED|Overall Study||23
204736|NCT00405912|481691|P3|STARTED|Overall Study||39
204737|NCT00405912|481692|P2|STARTED|Overall Study||40
204738|NCT00405912|481693|P1|STARTED|Overall Study||39
204739|NCT00405821|481706|P2|NOT COMPLETED|Overall Study||22
204740|NCT00405821|481707|P1|NOT COMPLETED|Overall Study||22
204741|NCT00405821|481706|P2|COMPLETED|Overall Study||198
204742|NCT00405821|481707|P1|COMPLETED|Overall Study||198
204743|NCT00405821|481706|P2|STARTED|Overall Study||220
204744|NCT00405821|481707|P1|STARTED|Overall Study||220
204745|NCT00405756|481720|P3|NOT COMPLETED|Follow-up||88
204746|NCT00405756|481721|P2|NOT COMPLETED|Follow-up||90
204747|NCT00405756|481722|P1|NOT COMPLETED|Follow-up||75
204748|NCT00405756|481720|P3|COMPLETED|Follow-up||0
204749|NCT00405756|481721|P2|COMPLETED|Follow-up||0
204750|NCT00405756|481722|P1|COMPLETED|Follow-up||0
204751|NCT00405756|481720|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
204752|NCT00405756|481721|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
204753|NCT00405756|481722|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
204754|NCT00405756|481720|P3|NOT COMPLETED|Open-label Extension||72
204755|NCT00405756|481721|P2|NOT COMPLETED|Open-label Extension||47
204756|NCT00405756|481722|P1|NOT COMPLETED|Open-label Extension||19
204757|NCT00405756|481720|P3|COMPLETED|Open-label Extension||0
204758|NCT00405756|481721|P2|COMPLETED|Open-label Extension||0
204759|NCT00405756|481722|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
204760|NCT00405756|481720|P3|STARTED|Open-label Extension||72
204761|NCT00405756|481721|P2|STARTED|Open-label Extension||47
204762|NCT00405756|481722|P1|STARTED|Open-label Extension||19
204763|NCT00405756|481720|P3|NOT COMPLETED|Double-blind Treatment||154
204764|NCT00405756|481721|P2|NOT COMPLETED|Double-blind Treatment||153
204765|NCT00405756|481722|P1|NOT COMPLETED|Double-blind Treatment||152
204766|NCT00405756|481720|P3|COMPLETED|Double-blind Treatment||0
204767|NCT00405756|481721|P2|COMPLETED|Double-blind Treatment||0
204768|NCT00405756|481722|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
204769|NCT00405756|481720|P3|Safety Population|Double-blind Treatment||153
204770|NCT00405756|481721|P2|Safety Population|Double-blind Treatment||152
204771|NCT00405756|481722|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
204772|NCT00405756|481720|P3|STARTED|Double-blind Treatment||154
204773|NCT00405756|481721|P2|STARTED|Double-blind Treatment||153
204774|NCT00405756|481722|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
204775|NCT00405704|481812|P2|NOT COMPLETED|Overall Study||46
204776|NCT00405704|481813|P1|NOT COMPLETED|Overall Study||41
204777|NCT00405704|481812|P2|COMPLETED|Overall Study||259
204778|NCT00405704|481813|P1|COMPLETED|Overall Study||261
204779|NCT00405704|481812|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
204780|NCT00405704|481813|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
204781|NCT00405704|481812|P2|Recurrent UTI With E. Coli|Overall Study||57
204782|NCT00405704|481813|P1|Recurrent UTI With E. Coli|Overall Study||30
204783|NCT00405704|481812|P2|Outcome Stool Assessed|Overall Study||210
204784|NCT00405704|481813|P1|Outcome Stool Assessed|Overall Study||203
204785|NCT00405704|481812|P2|Completed Assessments for New Scarring|Overall Study||227
204786|NCT00405704|481813|P1|Completed Assessments for New Scarring|Overall Study||220
204787|NCT00405704|481812|P2|Completed Outcome Renal Scan|Overall Study||235
204788|NCT00405704|481813|P1|Completed Outcome Renal Scan|Overall Study||227
204789|NCT00405704|481812|P2|STARTED|Overall Study||305
204790|NCT00405704|481813|P1|STARTED|Overall Study||302
204791|NCT00405652|481833|P1|NOT COMPLETED|Overall Study||4
204792|NCT00405652|481833|P1|COMPLETED|Overall Study||30
204793|NCT00405652|481833|P1|STARTED|Overall Study||34
204794|NCT00405639|481840|P2|NOT COMPLETED|Overall Study||0
204795|NCT00405639|481841|P1|NOT COMPLETED|Overall Study||3
204796|NCT00405639|481840|P2|COMPLETED|Overall Study||12
204797|NCT00405639|481841|P1|COMPLETED|Overall Study||22
204798|NCT00405639|481840|P2|STARTED|Overall Study||12
204799|NCT00405639|481841|P1|STARTED|Overall Study||25
204800|NCT00405548|481855|P2|NOT COMPLETED|Overall Study||1
204801|NCT00405548|481856|P1|NOT COMPLETED|Overall Study||4
204802|NCT00405548|481855|P2|COMPLETED|Overall Study||12
204803|NCT00405548|481856|P1|COMPLETED|Overall Study||24
204804|NCT00405548|481855|P2|STARTED|Overall Study||13
204805|NCT00405548|481856|P1|STARTED|Overall Study||28
204806|NCT00405509|481870|P2|NOT COMPLETED|Overall Study||0
204807|NCT00405509|481871|P1|NOT COMPLETED|Overall Study||0
204808|NCT00405509|481870|P2|COMPLETED|Overall Study||22
204809|NCT00405509|481871|P1|COMPLETED|Overall Study||11
204810|NCT00405509|481870|P2|STARTED|Overall Study||22
204811|NCT00405509|481871|P1|STARTED|Overall Study||11
204812|NCT00405288|481887|P2|NOT COMPLETED|Overall Study||0
204813|NCT00405288|481888|P1|NOT COMPLETED|Overall Study||0
204814|NCT00405288|481887|P2|COMPLETED|Overall Study||204
204815|NCT00405288|481888|P1|COMPLETED|Overall Study||204
204816|NCT00405288|481887|P2|STARTED|Overall Study||204
204817|NCT00405288|481888|P1|STARTED|Overall Study||204
204818|NCT00405275|481918|P2|NOT COMPLETED|Overall Study||19
204819|NCT00405275|481919|P1|NOT COMPLETED|Overall Study||23
204820|NCT00405275|481918|P2|COMPLETED|Overall Study||156
204821|NCT00405275|481919|P1|COMPLETED|Overall Study||155
204822|NCT00405275|481918|P2|24 Week (Switch)|Overall Study||44
204823|NCT00405275|481919|P1|24 Week (Switch)|Overall Study||44
204824|NCT00405275|481918|P2|24 Week (no Switch)|Overall Study||121
204825|NCT00405275|481919|P1|24 Week (no Switch)|Overall Study||119
204826|NCT00405275|481918|P2|24 Weeks (Total)|Overall Study||165
204827|NCT00405275|481919|P1|24 Weeks (Total)|Overall Study||163
204828|NCT00405275|481918|P2|STARTED|Overall Study||175
204829|NCT00405275|481919|P1|STARTED|Overall Study||178
204830|NCT00405067|481928|P3|NOT COMPLETED|Overall Study||5
204831|NCT00405067|481929|P2|NOT COMPLETED|Overall Study||9
204832|NCT00405067|481930|P1|NOT COMPLETED|Overall Study||4
204833|NCT00405067|481928|P3|COMPLETED|Overall Study||24
204834|NCT00405067|481929|P2|COMPLETED|Overall Study||19
204835|NCT00405067|481930|P1|COMPLETED|Overall Study||24
204836|NCT00405067|481928|P3|STARTED|Overall Study||29
204837|NCT00405067|481929|P2|STARTED|Overall Study||28
204838|NCT00405067|481930|P1|STARTED|Overall Study||28
204839|NCT00404924|481967|P2|NOT COMPLETED|Overall Study||306
204840|NCT00404924|481968|P1|NOT COMPLETED|Overall Study||603
204841|NCT00404924|481967|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
204842|NCT00404924|481968|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
204843|NCT00404924|481967|P2|STARTED|Overall Study|randomised patients|307
204844|NCT00404924|481968|P1|STARTED|Overall Study|randomised patients|617
204845|NCT00404820|481986|P2|NOT COMPLETED|Overall Study||24
204846|NCT00404820|481987|P1|NOT COMPLETED|Overall Study||19
204847|NCT00404820|481986|P2|COMPLETED|Overall Study||172
204848|NCT00404820|481987|P1|COMPLETED|Overall Study||389
204849|NCT00404820|481986|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
204850|NCT00404820|481987|P1|Started Treatment|Overall Study||408
204851|NCT00404820|481986|P2|STARTED|Overall Study||196
204852|NCT00404820|481987|P1|STARTED|Overall Study||408
204853|NCT00404651|482009|P4|NOT COMPLETED|Overall Study||21
204854|NCT00404651|482010|P3|NOT COMPLETED|Overall Study||45
204855|NCT00404651|482011|P2|NOT COMPLETED|Overall Study||28
204856|NCT00404651|482012|P1|NOT COMPLETED|Overall Study||39
204857|NCT00404651|482009|P4|COMPLETED|Overall Study||146
204858|NCT00404651|482010|P3|COMPLETED|Overall Study||294
204859|NCT00404651|482011|P2|COMPLETED|Overall Study||315
204860|NCT00404651|482012|P1|COMPLETED|Overall Study||301
204861|NCT00404651|482009|P4|STARTED|Overall Study||167
204862|NCT00404651|482010|P3|STARTED|Overall Study||339
204863|NCT00404651|482011|P2|STARTED|Overall Study||343
204864|NCT00404651|482012|P1|STARTED|Overall Study||340
204865|NCT00404547|482040|P2|NOT COMPLETED|Overall Study||25
204866|NCT00404547|482041|P1|NOT COMPLETED|Overall Study||90
204867|NCT00404547|482040|P2|COMPLETED|Overall Study||334
204868|NCT00404547|482041|P1|COMPLETED|Overall Study||672
204869|NCT00404547|482040|P2|STARTED|Overall Study||359
204870|NCT00404547|482041|P1|STARTED|Overall Study||762
204871|NCT00404495|482051|P2|NOT COMPLETED|Overall Study||11
204872|NCT00404495|482052|P1|NOT COMPLETED|Overall Study||44
204873|NCT00404495|482051|P2|COMPLETED|Overall Study||6
204874|NCT00404495|482052|P1|COMPLETED|Overall Study||22
204875|NCT00404495|482051|P2|STARTED|Overall Study||17
204876|NCT00404495|482052|P1|STARTED|Overall Study||66
204877|NCT00404352|482071|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
204878|NCT00404352|482072|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
204879|NCT00404352|482073|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
204880|NCT00404352|482074|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204881|NCT00404352|482075|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204882|NCT00404352|482076|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204883|NCT00404352|482077|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204884|NCT00404352|482078|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204885|NCT00404352|482079|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
204886|NCT00404352|482071|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
204887|NCT00404352|482072|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
204888|NCT00404352|482073|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
204889|NCT00404352|482074|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
204890|NCT00404352|482075|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
204891|NCT00404352|482076|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
204892|NCT00404352|482077|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
204893|NCT00404352|482078|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
204894|NCT00404352|482079|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
204895|NCT00404352|482071|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
204896|NCT00404352|482072|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
204897|NCT00404352|482073|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
204898|NCT00404352|482074|P6|STARTED|Open Label Extension (up to 36 Months)||0
204899|NCT00404352|482075|P5|STARTED|Open Label Extension (up to 36 Months)||0
204900|NCT00404352|482076|P4|STARTED|Open Label Extension (up to 36 Months)||0
204901|NCT00404352|482077|P3|STARTED|Open Label Extension (up to 36 Months)||0
204902|NCT00404352|482078|P2|STARTED|Open Label Extension (up to 36 Months)||0
204903|NCT00404352|482079|P1|STARTED|Open Label Extension (up to 36 Months)||0
204904|NCT00404352|482071|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
204905|NCT00404352|482072|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
204906|NCT00404352|482073|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
204907|NCT00404352|482074|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
204908|NCT00404352|482075|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
204909|NCT00404352|482076|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
204910|NCT00404352|482077|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
204911|NCT00404352|482078|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
204912|NCT00404352|482079|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
204913|NCT00404352|482071|P9|COMPLETED|Open Label (up to 24 Month)||0
204914|NCT00404352|482072|P8|COMPLETED|Open Label (up to 24 Month)||0
204915|NCT00404352|482073|P7|COMPLETED|Open Label (up to 24 Month)||0
204916|NCT00404352|482074|P6|COMPLETED|Open Label (up to 24 Month)||52
204917|NCT00404352|482075|P5|COMPLETED|Open Label (up to 24 Month)||28
204918|NCT00404352|482076|P4|COMPLETED|Open Label (up to 24 Month)||28
204919|NCT00404352|482077|P3|COMPLETED|Open Label (up to 24 Month)||0
204920|NCT00404352|482078|P2|COMPLETED|Open Label (up to 24 Month)||0
204921|NCT00404352|482079|P1|COMPLETED|Open Label (up to 24 Month)||0
204922|NCT00404352|482071|P9|STARTED|Open Label (up to 24 Month)||0
204923|NCT00404352|482072|P8|STARTED|Open Label (up to 24 Month)||0
204924|NCT00404352|482073|P7|STARTED|Open Label (up to 24 Month)||0
204925|NCT00404352|482074|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
204926|NCT00404352|482075|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
204927|NCT00404352|482076|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
204928|NCT00404352|482077|P3|STARTED|Open Label (up to 24 Month)||0
204929|NCT00404352|482078|P2|STARTED|Open Label (up to 24 Month)||0
204930|NCT00404352|482079|P1|STARTED|Open Label (up to 24 Month)||0
204931|NCT00404352|482071|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
204932|NCT00404352|482072|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
204933|NCT00404352|482073|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
204934|NCT00404352|482074|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
204935|NCT00404352|482075|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
204936|NCT00404352|482076|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
204937|NCT00404352|482077|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
204938|NCT00404352|482078|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
204939|NCT00404352|482079|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
204940|NCT00404352|482071|P9|COMPLETED|Double Blind (up to 24 Month)||0
204941|NCT00404352|482072|P8|COMPLETED|Double Blind (up to 24 Month)||0
204942|NCT00404352|482073|P7|COMPLETED|Double Blind (up to 24 Month)||0
204943|NCT00404352|482074|P6|COMPLETED|Double Blind (up to 24 Month)||0
204944|NCT00404352|482075|P5|COMPLETED|Double Blind (up to 24 Month)||0
204945|NCT00404352|482076|P4|COMPLETED|Double Blind (up to 24 Month)||0
204946|NCT00404352|482077|P3|COMPLETED|Double Blind (up to 24 Month)||92
204947|NCT00404352|482078|P2|COMPLETED|Double Blind (up to 24 Month)||128
204948|NCT00404352|482079|P1|COMPLETED|Double Blind (up to 24 Month)||119
204949|NCT00404352|482071|P9|Treated|Double Blind (up to 24 Month)||0
204950|NCT00404352|482072|P8|Treated|Double Blind (up to 24 Month)||0
204951|NCT00404352|482073|P7|Treated|Double Blind (up to 24 Month)||0
204952|NCT00404352|482074|P6|Treated|Double Blind (up to 24 Month)||0
204953|NCT00404352|482075|P5|Treated|Double Blind (up to 24 Month)||0
204954|NCT00404352|482076|P4|Treated|Double Blind (up to 24 Month)||0
204955|NCT00404352|482077|P3|Treated|Double Blind (up to 24 Month)||171
204956|NCT00404352|482078|P2|Treated|Double Blind (up to 24 Month)||173
204957|NCT00404352|482079|P1|Treated|Double Blind (up to 24 Month)||171
204958|NCT00404352|482071|P9|STARTED|Double Blind (up to 24 Month)||0
204959|NCT00404352|482072|P8|STARTED|Double Blind (up to 24 Month)||0
204960|NCT00404352|482073|P7|STARTED|Double Blind (up to 24 Month)||0
204961|NCT00404352|482074|P6|STARTED|Double Blind (up to 24 Month)||0
204962|NCT00404352|482075|P5|STARTED|Double Blind (up to 24 Month)||0
204963|NCT00404352|482076|P4|STARTED|Double Blind (up to 24 Month)||0
204964|NCT00404352|482077|P3|STARTED|Double Blind (up to 24 Month)||171
204965|NCT00404352|482078|P2|STARTED|Double Blind (up to 24 Month)||175
204966|NCT00404352|482079|P1|STARTED|Double Blind (up to 24 Month)||171
204967|NCT00404248|482114|P9|NOT COMPLETED|Overall Study||0
204968|NCT00404248|482115|P8|NOT COMPLETED|Overall Study||0
204969|NCT00404248|482116|P7|NOT COMPLETED|Overall Study||0
204970|NCT00404248|482117|P6|NOT COMPLETED|Overall Study||0
204971|NCT00404248|482118|P5|NOT COMPLETED|Overall Study||0
204972|NCT00404248|482119|P4|NOT COMPLETED|Overall Study||0
204973|NCT00404248|482120|P3|NOT COMPLETED|Overall Study||0
204974|NCT00404248|482121|P2|NOT COMPLETED|Overall Study||1
204975|NCT00404248|482122|P1|NOT COMPLETED|Overall Study||0
204976|NCT00404248|482114|P9|COMPLETED|Overall Study||3
204977|NCT00404248|482115|P8|COMPLETED|Overall Study||6
204978|NCT00404248|482116|P7|COMPLETED|Overall Study||6
204979|NCT00404248|482117|P6|COMPLETED|Overall Study||3
204980|NCT00404248|482118|P5|COMPLETED|Overall Study||3
204981|NCT00404248|482119|P4|COMPLETED|Overall Study||2
204982|NCT00404248|482120|P3|COMPLETED|Overall Study||5
204983|NCT00404248|482121|P2|COMPLETED|Overall Study||3
204984|NCT00404248|482122|P1|COMPLETED|Overall Study||3
204985|NCT00404248|482114|P9|STARTED|Overall Study||3
204986|NCT00404248|482115|P8|STARTED|Overall Study||6
204987|NCT00404248|482116|P7|STARTED|Overall Study||6
204988|NCT00404248|482117|P6|STARTED|Overall Study||3
204989|NCT00404248|482118|P5|STARTED|Overall Study||3
204990|NCT00404248|482119|P4|STARTED|Overall Study||2
204991|NCT00404248|482120|P3|STARTED|Overall Study||5
204992|NCT00404248|482121|P2|STARTED|Overall Study||4
204993|NCT00404248|482122|P1|STARTED|Overall Study||3
204994|NCT00404092|482157|P4|NOT COMPLETED|Overall Study||0
204995|NCT00404092|482158|P3|NOT COMPLETED|Overall Study||1
204996|NCT00404092|482159|P2|NOT COMPLETED|Overall Study||0
204997|NCT00404092|482160|P1|NOT COMPLETED|Overall Study||1
204998|NCT00404092|482157|P4|COMPLETED|Overall Study||20
204999|NCT00404092|482158|P3|COMPLETED|Overall Study||8
205000|NCT00404092|482159|P2|COMPLETED|Overall Study||8
205001|NCT00404092|482160|P1|COMPLETED|Overall Study||8
205002|NCT00404092|482157|P4|STARTED|Overall Study||20
205003|NCT00404092|482158|P3|STARTED|Overall Study||9
205004|NCT00404092|482159|P2|STARTED|Overall Study||8
205005|NCT00404092|482160|P1|STARTED|Overall Study||9
205006|NCT00404079|482176|P2|NOT COMPLETED|Overall Study||20
205007|NCT00404079|482177|P1|NOT COMPLETED|Overall Study||22
205008|NCT00404079|482176|P2|COMPLETED|Overall Study||105
205009|NCT00404079|482177|P1|COMPLETED|Overall Study||103
205010|NCT00404079|482176|P2|STARTED|Overall Study||125
205011|NCT00404079|482177|P1|STARTED|Overall Study||125
205012|NCT00403845|482183|P4|NOT COMPLETED|Treatment Period 4||0
205013|NCT00403845|482184|P3|NOT COMPLETED|Treatment Period 4||0
205014|NCT00403845|482185|P2|NOT COMPLETED|Treatment Period 4||0
205015|NCT00403845|482186|P1|NOT COMPLETED|Treatment Period 4||0
205016|NCT00403845|482183|P4|COMPLETED|Treatment Period 4||11
205017|NCT00403845|482184|P3|COMPLETED|Treatment Period 4||11
205018|NCT00403845|482185|P2|COMPLETED|Treatment Period 4||13
205019|NCT00403845|482186|P1|COMPLETED|Treatment Period 4||10
205020|NCT00403845|482183|P4|STARTED|Treatment Period 4||11
205021|NCT00403845|482184|P3|STARTED|Treatment Period 4||11
205022|NCT00403845|482185|P2|STARTED|Treatment Period 4||13
205023|NCT00403845|482186|P1|STARTED|Treatment Period 4||10
205024|NCT00403845|482183|P4|NOT COMPLETED|Treatment Period 3||2
205025|NCT00403845|482184|P3|NOT COMPLETED|Treatment Period 3||0
205026|NCT00403845|482185|P2|NOT COMPLETED|Treatment Period 3||0
205027|NCT00403845|482186|P1|NOT COMPLETED|Treatment Period 3||0
205028|NCT00403845|482183|P4|COMPLETED|Treatment Period 3||11
205029|NCT00403845|482184|P3|COMPLETED|Treatment Period 3||11
205030|NCT00403845|482185|P2|COMPLETED|Treatment Period 3||13
205031|NCT00403845|482186|P1|COMPLETED|Treatment Period 3||10
205032|NCT00403845|482183|P4|STARTED|Treatment Period 3||13
205033|NCT00403845|482184|P3|STARTED|Treatment Period 3||11
205034|NCT00403845|482185|P2|STARTED|Treatment Period 3||13
205035|NCT00403845|482186|P1|STARTED|Treatment Period 3||10
205036|NCT00403845|482183|P4|NOT COMPLETED|Treatment Period 2||0
205037|NCT00403845|482184|P3|NOT COMPLETED|Treatment Period 2||0
205038|NCT00403845|482185|P2|NOT COMPLETED|Treatment Period 2||0
205039|NCT00403845|482186|P1|NOT COMPLETED|Treatment Period 2||1
205040|NCT00403845|482183|P4|COMPLETED|Treatment Period 2||13
205041|NCT00403845|482184|P3|COMPLETED|Treatment Period 2||11
205042|NCT00403845|482185|P2|COMPLETED|Treatment Period 2||13
205043|NCT00403845|482186|P1|COMPLETED|Treatment Period 2||10
205044|NCT00403845|482183|P4|STARTED|Treatment Period 2||13
205045|NCT00403845|482184|P3|STARTED|Treatment Period 2||11
205046|NCT00403845|482185|P2|STARTED|Treatment Period 2||13
205047|NCT00403845|482186|P1|STARTED|Treatment Period 2||11
205048|NCT00403845|482183|P4|NOT COMPLETED|Treatment Period 1||1
205049|NCT00403845|482184|P3|NOT COMPLETED|Treatment Period 1||0
205050|NCT00403845|482185|P2|NOT COMPLETED|Treatment Period 1||0
205051|NCT00403845|482186|P1|NOT COMPLETED|Treatment Period 1||1
205052|NCT00403845|482183|P4|COMPLETED|Treatment Period 1||13
205053|NCT00403845|482184|P3|COMPLETED|Treatment Period 1||11
205054|NCT00403845|482185|P2|COMPLETED|Treatment Period 1||13
205055|NCT00403845|482186|P1|COMPLETED|Treatment Period 1||11
205056|NCT00403845|482183|P4|STARTED|Treatment Period 1||14
205057|NCT00403845|482184|P3|STARTED|Treatment Period 1||11
205058|NCT00403845|482185|P2|STARTED|Treatment Period 1||13
205059|NCT00403845|482186|P1|STARTED|Treatment Period 1||12
205060|NCT00403767|482210|P2|NOT COMPLETED|Overall Study||2468
205061|NCT00403767|482211|P1|NOT COMPLETED|Overall Study||2520
205062|NCT00403767|482210|P2|COMPLETED|Overall Study||4657
205063|NCT00403767|482211|P1|COMPLETED|Overall Study||4591
205064|NCT00403767|482210|P2|STARTED|Overall Study||7125
205065|NCT00403767|482211|P1|STARTED|Overall Study||7111
205066|NCT00403754|482235|P4|NOT COMPLETED|Open Label: Salmeterol||0
205067|NCT00403754|482236|P3|NOT COMPLETED|Open Label: Salmeterol||0
205068|NCT00403754|482237|P2|NOT COMPLETED|Open Label: Salmeterol||0
205069|NCT00403754|482238|P1|NOT COMPLETED|Open Label: Salmeterol||0
205070|NCT00403754|482235|P4|COMPLETED|Open Label: Salmeterol||11
205071|NCT00403754|482236|P3|COMPLETED|Open Label: Salmeterol||8
205072|NCT00403754|482237|P2|COMPLETED|Open Label: Salmeterol||9
205073|NCT00403754|482238|P1|COMPLETED|Open Label: Salmeterol||11
205074|NCT00403754|482235|P4|STARTED|Open Label: Salmeterol||11
205075|NCT00403754|482236|P3|STARTED|Open Label: Salmeterol||8
205076|NCT00403754|482237|P2|STARTED|Open Label: Salmeterol||9
205077|NCT00403754|482238|P1|STARTED|Open Label: Salmeterol||11
205078|NCT00403754|482235|P4|NOT COMPLETED|Core Treatment Period 4||0
205079|NCT00403754|482236|P3|NOT COMPLETED|Core Treatment Period 4||0
205080|NCT00403754|482237|P2|NOT COMPLETED|Core Treatment Period 4||0
205081|NCT00403754|482238|P1|NOT COMPLETED|Core Treatment Period 4||0
205082|NCT00403754|482235|P4|COMPLETED|Core Treatment Period 4||11
205083|NCT00403754|482236|P3|COMPLETED|Core Treatment Period 4||8
205084|NCT00403754|482237|P2|COMPLETED|Core Treatment Period 4||9
205085|NCT00403754|482238|P1|COMPLETED|Core Treatment Period 4||11
205086|NCT00403754|482235|P4|STARTED|Core Treatment Period 4||11
205087|NCT00403754|482236|P3|STARTED|Core Treatment Period 4||8
205088|NCT00403754|482237|P2|STARTED|Core Treatment Period 4||9
205089|NCT00403754|482238|P1|STARTED|Core Treatment Period 4||11
205090|NCT00403754|482235|P4|NOT COMPLETED|Core Treatment Period 3||0
205091|NCT00403754|482236|P3|NOT COMPLETED|Core Treatment Period 3||0
205092|NCT00403754|482237|P2|NOT COMPLETED|Core Treatment Period 3||0
205093|NCT00403754|482238|P1|NOT COMPLETED|Core Treatment Period 3||0
205094|NCT00403754|482235|P4|COMPLETED|Core Treatment Period 3||11
205095|NCT00403754|482236|P3|COMPLETED|Core Treatment Period 3||8
205096|NCT00403754|482237|P2|COMPLETED|Core Treatment Period 3||9
205097|NCT00403754|482238|P1|COMPLETED|Core Treatment Period 3||11
205098|NCT00403754|482235|P4|STARTED|Core Treatment Period 3||11
205099|NCT00403754|482236|P3|STARTED|Core Treatment Period 3||8
205100|NCT00403754|482237|P2|STARTED|Core Treatment Period 3||9
205101|NCT00403754|482238|P1|STARTED|Core Treatment Period 3||11
205102|NCT00403754|482235|P4|NOT COMPLETED|Core Treatment Period 2||0
205103|NCT00403754|482236|P3|NOT COMPLETED|Core Treatment Period 2||1
205104|NCT00403754|482237|P2|NOT COMPLETED|Core Treatment Period 2||0
205105|NCT00403754|482238|P1|NOT COMPLETED|Core Treatment Period 2||0
205106|NCT00403754|482235|P4|COMPLETED|Core Treatment Period 2||11
205107|NCT00403754|482236|P3|COMPLETED|Core Treatment Period 2||8
205108|NCT00403754|482237|P2|COMPLETED|Core Treatment Period 2||9
205109|NCT00403754|482238|P1|COMPLETED|Core Treatment Period 2||11
205110|NCT00403754|482235|P4|STARTED|Core Treatment Period 2||11
205111|NCT00403754|482236|P3|STARTED|Core Treatment Period 2||9
205112|NCT00403754|482237|P2|STARTED|Core Treatment Period 2||9
205113|NCT00403754|482238|P1|STARTED|Core Treatment Period 2||11
205114|NCT00403754|482235|P4|NOT COMPLETED|Core Treatment Period 1||0
205115|NCT00403754|482236|P3|NOT COMPLETED|Core Treatment Period 1||0
205116|NCT00403754|482237|P2|NOT COMPLETED|Core Treatment Period 1||1
205117|NCT00403754|482238|P1|NOT COMPLETED|Core Treatment Period 1||0
205118|NCT00403754|482235|P4|COMPLETED|Core Treatment Period 1||11
205119|NCT00403754|482236|P3|COMPLETED|Core Treatment Period 1||9
205120|NCT00403754|482237|P2|COMPLETED|Core Treatment Period 1||9
205121|NCT00403754|482238|P1|COMPLETED|Core Treatment Period 1||11
205122|NCT00403754|482235|P4|STARTED|Core Treatment Period 1||11
205123|NCT00403754|482236|P3|STARTED|Core Treatment Period 1||9
205124|NCT00403754|482237|P2|STARTED|Core Treatment Period 1||10
205125|NCT00403754|482238|P1|STARTED|Core Treatment Period 1||11
205126|NCT00403585|482265|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
205127|NCT00403585|482265|P1|COMPLETED|Open-Label Phase; Extension Study||74
205128|NCT00403585|482265|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
205129|NCT00403585|482265|P1|NOT COMPLETED|Initial Treatment Phase||2
205130|NCT00403585|482265|P1|COMPLETED|Initial Treatment Phase||102
205131|NCT00403585|482265|P1|STARTED|Initial Treatment Phase||104
205132|NCT00403481|482274|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
205133|NCT00403481|482274|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
205134|NCT00403481|482274|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
205135|NCT00403481|482274|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
205136|NCT00403481|482274|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
205137|NCT00403481|482274|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
205138|NCT00403481|482274|P1|NOT COMPLETED|Olm 40 mg||5
205139|NCT00403481|482274|P1|COMPLETED|Olm 40 mg||177
205140|NCT00403481|482274|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
205141|NCT00403481|482274|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
205142|NCT00403481|482274|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
205143|NCT00403481|482274|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
205144|NCT00403455|482289|P1|NOT COMPLETED|Overall Study||1
205145|NCT00403455|482289|P1|COMPLETED|Overall Study||37
205146|NCT00403455|482289|P1|STARTED|Overall Study||38
205147|NCT00403403|482295|P2|NOT COMPLETED|Overall Study||0
205148|NCT00403403|482296|P1|NOT COMPLETED|Overall Study||0
205149|NCT00403403|482295|P2|COMPLETED|Overall Study||52
205150|NCT00403403|482296|P1|COMPLETED|Overall Study||50
205151|NCT00403403|482295|P2|Safety-Evaluable Patients|Overall Study||51
205152|NCT00403403|482296|P1|Safety-Evaluable Patients|Overall Study||47
205153|NCT00403403|482295|P2|STARTED|Overall Study||52
205154|NCT00403403|482296|P1|STARTED|Overall Study||50
205155|NCT00403273|482312|P2|NOT COMPLETED|Overall Study||4
205156|NCT00403273|482313|P1|NOT COMPLETED|Overall Study||3
205157|NCT00403273|482312|P2|COMPLETED|Overall Study||25
205158|NCT00403273|482313|P1|COMPLETED|Overall Study||22
205159|NCT00403273|482312|P2|STARTED|Overall Study||29
205160|NCT00403273|482313|P1|STARTED|Overall Study||25
205161|NCT00403234|482343|P4|NOT COMPLETED|Overall Study||0
205162|NCT00403234|482344|P3|NOT COMPLETED|Overall Study||1
205163|NCT00403234|482345|P2|NOT COMPLETED|Overall Study||1
205164|NCT00403234|482346|P1|NOT COMPLETED|Overall Study||1
205165|NCT00403234|482343|P4|COMPLETED|Overall Study||2
205166|NCT00403234|482344|P3|COMPLETED|Overall Study||2
205167|NCT00403234|482345|P2|COMPLETED|Overall Study||2
205168|NCT00403234|482346|P1|COMPLETED|Overall Study||1
205169|NCT00403234|482343|P4|STARTED|Overall Study||2
205170|NCT00403234|482344|P3|STARTED|Overall Study||3
205171|NCT00403234|482345|P2|STARTED|Overall Study||3
205172|NCT00403234|482346|P1|STARTED|Overall Study||2
205173|NCT00402987|482360|P4|NOT COMPLETED|Overall Study||0
205174|NCT00402987|482361|P3|NOT COMPLETED|Overall Study||1
205175|NCT00402987|482362|P2|NOT COMPLETED|Overall Study||0
205176|NCT00402987|482363|P1|NOT COMPLETED|Overall Study||0
205177|NCT00402987|482360|P4|COMPLETED|Overall Study||89
205178|NCT00402987|482361|P3|COMPLETED|Overall Study||44
205179|NCT00402987|482362|P2|COMPLETED|Overall Study||45
205180|NCT00402987|482363|P1|COMPLETED|Overall Study||90
205181|NCT00402987|482360|P4|STARTED|Overall Study||89
205182|NCT00402987|482361|P3|STARTED|Overall Study||45
205183|NCT00402987|482362|P2|STARTED|Overall Study||45
205184|NCT00402987|482363|P1|STARTED|Overall Study||90
205185|NCT00402896|482525|P1|NOT COMPLETED|Overall Study||0
205186|NCT00402896|482525|P1|COMPLETED|Overall Study||20
205187|NCT00402896|482525|P1|STARTED|Overall Study||20
205188|NCT00402883|482529|P1|NOT COMPLETED|Maintenance Therapy||0
205189|NCT00402883|482529|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
205190|NCT00402883|482529|P1|STARTED|Maintenance Therapy||5
205191|NCT00402883|482529|P1|NOT COMPLETED|Consolidation Therapy||0
205192|NCT00402883|482529|P1|COMPLETED|Consolidation Therapy||5
205193|NCT00402883|482529|P1|STARTED|Consolidation Therapy||5
205194|NCT00402883|482529|P1|NOT COMPLETED|Induction Therapy||0
205195|NCT00402883|482529|P1|COMPLETED|Induction Therapy||5
205196|NCT00402883|482529|P1|STARTED|Induction Therapy||5
205197|NCT00402740|482533|P1|NOT COMPLETED|Overall Study||80
205198|NCT00402740|482533|P1|COMPLETED|Overall Study||242
205199|NCT00402740|482533|P1|STARTED|Overall Study||322
205200|NCT00402727|482545|P2|NOT COMPLETED|Overall Study||34
205201|NCT00402727|482546|P1|NOT COMPLETED|Overall Study||42
205202|NCT00402727|482545|P2|COMPLETED|Overall Study||347
205203|NCT00402727|482546|P1|COMPLETED|Overall Study||390
205204|NCT00402727|482545|P2|Achieving Test Of Cure (TOC)|Overall Study||347
205205|NCT00402727|482546|P1|Achieving Test Of Cure (TOC)|Overall Study||390
205206|NCT00402727|482545|P2|Achieving End Of Treatment (EOT)|Overall Study||355
205207|NCT00402727|482546|P1|Achieving End Of Treatment (EOT)|Overall Study||408
205208|NCT00402727|482545|P2|STARTED|Overall Study||381
205209|NCT00402727|482546|P1|STARTED|Overall Study||432
205210|NCT00402714|482576|P2|NOT COMPLETED|Overall Study||0
205211|NCT00402714|482577|P1|NOT COMPLETED|Overall Study||0
205212|NCT00402714|482576|P2|COMPLETED|Overall Study||11
205213|NCT00402714|482577|P1|COMPLETED|Overall Study||3
205214|NCT00402714|482576|P2|STARTED|Overall Study||11
205215|NCT00402714|482577|P1|STARTED|Overall Study||3
205216|NCT00402688|482588|P3|NOT COMPLETED|Overall Study||15
205217|NCT00402688|482589|P2|NOT COMPLETED|Overall Study||16
205218|NCT00402688|482590|P1|NOT COMPLETED|Overall Study||21
205219|NCT00402688|482588|P3|COMPLETED|Overall Study||65
205220|NCT00402688|482589|P2|COMPLETED|Overall Study||65
205221|NCT00402688|482590|P1|COMPLETED|Overall Study||60
205222|NCT00402688|482588|P3|STARTED|Overall Study||80
205223|NCT00402688|482589|P2|STARTED|Overall Study||81
205224|NCT00402688|482590|P1|STARTED|Overall Study||81
205225|NCT00402649|482613|P1|NOT COMPLETED|Overall Study||2
205226|NCT00402649|482613|P1|COMPLETED|Overall Study||33
205227|NCT00402649|482613|P1|STARTED|Overall Study||35
205228|NCT00402597|482628|P5|NOT COMPLETED|Overall Study||124
205229|NCT00402597|482629|P4|NOT COMPLETED|Overall Study||74
205230|NCT00402597|482630|P3|NOT COMPLETED|Overall Study||212
205231|NCT00402597|482631|P2|NOT COMPLETED|Overall Study||46
205232|NCT00402597|482632|P1|NOT COMPLETED|Overall Study||191
205233|NCT00402597|482628|P5|COMPLETED|Overall Study||479
205234|NCT00402597|482629|P4|COMPLETED|Overall Study||279
205235|NCT00402597|482630|P3|COMPLETED|Overall Study||834
205236|NCT00402597|482631|P2|COMPLETED|Overall Study||261
205237|NCT00402597|482632|P1|COMPLETED|Overall Study||962
205238|NCT00402597|482628|P5|STARTED|Overall Study||603
205239|NCT00402597|482629|P4|STARTED|Overall Study||353
205240|NCT00402597|482630|P3|STARTED|Overall Study||1046
205241|NCT00402597|482631|P2|STARTED|Overall Study||307
205242|NCT00402597|482632|P1|STARTED|Overall Study||1153
205243|NCT00402363|482673|P4|NOT COMPLETED|Overall Study||10
205244|NCT00402363|482674|P3|NOT COMPLETED|Overall Study||6
205245|NCT00402363|482675|P2|NOT COMPLETED|Overall Study||30
205246|NCT00402363|482676|P1|NOT COMPLETED|Overall Study||33
205247|NCT00402363|482673|P4|COMPLETED|Overall Study||45
205248|NCT00402363|482674|P3|COMPLETED|Overall Study||60
205249|NCT00402363|482675|P2|COMPLETED|Overall Study||246
205250|NCT00402363|482676|P1|COMPLETED|Overall Study||233
205251|NCT00402363|482673|P4|STARTED|Overall Study||55
205252|NCT00402363|482674|P3|STARTED|Overall Study||66
205253|NCT00402363|482675|P2|STARTED|Overall Study||276
205254|NCT00402363|482676|P1|STARTED|Overall Study||266
205255|NCT00402337|482739|P5|NOT COMPLETED|Overall Study||8
205256|NCT00402337|482740|P4|NOT COMPLETED|Overall Study||12
205257|NCT00402337|482741|P3|NOT COMPLETED|Overall Study||4
205258|NCT00402337|482742|P2|NOT COMPLETED|Overall Study||6
205259|NCT00402337|482743|P1|NOT COMPLETED|Overall Study||5
205260|NCT00402337|482739|P5|COMPLETED|Overall Study||61
205261|NCT00402337|482740|P4|COMPLETED|Overall Study||51
205262|NCT00402337|482741|P3|COMPLETED|Overall Study||58
205263|NCT00402337|482742|P2|COMPLETED|Overall Study||51
205264|NCT00402337|482743|P1|COMPLETED|Overall Study||54
205265|NCT00402337|482739|P5|STARTED|Overall Study||69
205266|NCT00402337|482740|P4|STARTED|Overall Study||63
205267|NCT00402337|482741|P3|STARTED|Overall Study||62
205268|NCT00402337|482742|P2|STARTED|Overall Study||57
205269|NCT00402337|482743|P1|STARTED|Overall Study||59
205270|NCT00402324|482782|P2|NOT COMPLETED|Overall Study||41
205271|NCT00402324|482783|P1|NOT COMPLETED|Overall Study||43
205272|NCT00402324|482782|P2|COMPLETED|Overall Study||60
205273|NCT00402324|482783|P1|COMPLETED|Overall Study||58
205274|NCT00402324|482782|P2|STARTED|Overall Study||101
205275|NCT00402324|482783|P1|STARTED|Overall Study||101
205276|NCT00402285|482816|P3|NOT COMPLETED|Overall Study||2
205277|NCT00402285|482817|P2|NOT COMPLETED|Overall Study||6
205278|NCT00402285|482818|P1|NOT COMPLETED|Overall Study||7
205279|NCT00402285|482816|P3|COMPLETED|Overall Study||26
205280|NCT00402285|482817|P2|COMPLETED|Overall Study||21
205281|NCT00402285|482818|P1|COMPLETED|Overall Study||22
205282|NCT00402285|482816|P3|STARTED|Overall Study||28
205283|NCT00402285|482817|P2|STARTED|Overall Study||27
205284|NCT00402285|482818|P1|STARTED|Overall Study||29
205285|NCT00402246|482826|P2|NOT COMPLETED|Overall Study||234
205286|NCT00402246|482827|P1|NOT COMPLETED|Overall Study||220
205287|NCT00402246|482826|P2|COMPLETED|Overall Study||749
205288|NCT00402246|482827|P1|COMPLETED|Overall Study||794
205289|NCT00402246|482826|P2|STARTED|Overall Study||983
205290|NCT00402246|482827|P1|STARTED|Overall Study||1014
205291|NCT00402233|482861|P4|NOT COMPLETED|Overall Study||11
205292|NCT00402233|482862|P3|NOT COMPLETED|Overall Study||11
205293|NCT00402233|482863|P2|NOT COMPLETED|Overall Study||10
205294|NCT00402233|482864|P1|NOT COMPLETED|Overall Study||5
205295|NCT00402233|482861|P4|COMPLETED|Overall Study||62
205296|NCT00402233|482862|P3|COMPLETED|Overall Study||70
205297|NCT00402233|482863|P2|COMPLETED|Overall Study||70
205298|NCT00402233|482864|P1|COMPLETED|Overall Study||72
205299|NCT00402233|482861|P4|STARTED|Overall Study||73
205300|NCT00402233|482862|P3|STARTED|Overall Study||81
205301|NCT00402233|482863|P2|STARTED|Overall Study||80
205302|NCT00402233|482864|P1|STARTED|Overall Study||77
205303|NCT00402194|482888|P2|NOT COMPLETED|Overall Study||0
205304|NCT00402194|482889|P1|NOT COMPLETED|Overall Study||0
205305|NCT00402194|482888|P2|COMPLETED|Overall Study||8
205306|NCT00402194|482889|P1|COMPLETED|Overall Study||9
205307|NCT00402194|482888|P2|STARTED|Overall Study||8
205308|NCT00402194|482889|P1|STARTED|Overall Study||9
205309|NCT00402168|482899|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
205310|NCT00402168|482900|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
205311|NCT00402168|482899|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
205312|NCT00402168|482900|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
205313|NCT00402168|482899|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
205314|NCT00402168|482900|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
205315|NCT00402168|482899|P2|NOT COMPLETED|Long Term (LT)||17
205316|NCT00402168|482900|P1|NOT COMPLETED|Long Term (LT)||11
205317|NCT00402168|482899|P2|COMPLETED|Long Term (LT)||64
205318|NCT00402168|482900|P1|COMPLETED|Long Term (LT)||70
205319|NCT00402168|482899|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
205320|NCT00402168|482900|P1|STARTED|Long Term (LT)||81
205321|NCT00402168|482899|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
205322|NCT00402168|482900|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
205323|NCT00402168|482899|P2|COMPLETED|Treatment (up to 12 Months)||86
205324|NCT00402168|482900|P1|COMPLETED|Treatment (up to 12 Months)||81
205325|NCT00402168|482899|P2|STARTED|Treatment (up to 12 Months)||88
205326|NCT00402168|482900|P1|STARTED|Treatment (up to 12 Months)||83
205327|NCT00402168|482899|P2|NOT COMPLETED|Randomized||1
205328|NCT00402168|482900|P1|NOT COMPLETED|Randomized||1
205329|NCT00402168|482899|P2|COMPLETED|Randomized||88
205330|NCT00402168|482900|P1|COMPLETED|Randomized||83
205331|NCT00402168|482899|P2|STARTED|Randomized||89
205332|NCT00402168|482900|P1|STARTED|Randomized||84
205333|NCT00402103|482957|P2|NOT COMPLETED|Overall Study||13
205334|NCT00402103|482958|P1|NOT COMPLETED|Overall Study||91
205335|NCT00402103|482957|P2|COMPLETED|Overall Study||73
205336|NCT00402103|482958|P1|COMPLETED|Overall Study||379
205337|NCT00402103|482957|P2|STARTED|Overall Study||86
205338|NCT00402103|482958|P1|STARTED|Overall Study||470
205339|NCT00402051|482974|P2|NOT COMPLETED|Overall Study||35
205340|NCT00402051|482975|P1|NOT COMPLETED|Overall Study||38
205341|NCT00402051|482974|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
205342|NCT00402051|482975|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
205343|NCT00402051|482974|P2|Received Treatment|Overall Study||65
205344|NCT00402051|482975|P1|Received Treatment|Overall Study||65
205345|NCT00402051|482974|P2|STARTED|Overall Study||67
205346|NCT00402051|482975|P1|STARTED|Overall Study||66
205347|NCT00402025|482992|P3|NOT COMPLETED|Overall Study||10
205348|NCT00402025|482993|P2|NOT COMPLETED|Overall Study||3
205349|NCT00402025|482994|P1|NOT COMPLETED|Overall Study||2
205350|NCT00402025|482992|P3|COMPLETED|Overall Study||0
205351|NCT00402025|482993|P2|COMPLETED|Overall Study||1
205352|NCT00402025|482994|P1|COMPLETED|Overall Study||1
205353|NCT00402025|482992|P3|STARTED|Overall Study||10
205354|NCT00402025|482993|P2|STARTED|Overall Study||4
205355|NCT00402025|482994|P1|STARTED|Overall Study||3
205356|NCT00401973|483020|P3|NOT COMPLETED|Overall Study||23
205357|NCT00401973|483021|P2|NOT COMPLETED|Overall Study||26
205358|NCT00401973|483022|P1|NOT COMPLETED|Overall Study||11
205359|NCT00401973|483020|P3|COMPLETED|Overall Study||50
205360|NCT00401973|483021|P2|COMPLETED|Overall Study||50
205361|NCT00401973|483022|P1|COMPLETED|Overall Study||39
205362|NCT00401973|483020|P3|STARTED|Overall Study||73
205363|NCT00401973|483021|P2|STARTED|Overall Study||76
205364|NCT00401973|483022|P1|STARTED|Overall Study||50
205365|NCT00401843|483062|P3|NOT COMPLETED|Overall Study||142
205366|NCT00401843|483063|P2|NOT COMPLETED|Overall Study||144
205367|NCT00401843|483064|P1|NOT COMPLETED|Overall Study||21
205368|NCT00401843|483062|P3|COMPLETED|Overall Study||0
205369|NCT00401843|483063|P2|COMPLETED|Overall Study||0
205370|NCT00401843|483064|P1|COMPLETED|Overall Study||0
205371|NCT00401843|483062|P3|Treated|Overall Study||139
205372|NCT00401843|483063|P2|Treated|Overall Study||142
205373|NCT00401843|483064|P1|Treated|Overall Study||21
205374|NCT00401843|483062|P3|STARTED|Overall Study||142
205375|NCT00401843|483063|P2|STARTED|Overall Study||144
205376|NCT00401843|483064|P1|STARTED|Overall Study||21
205377|NCT00401830|483082|P2|NOT COMPLETED|Overall Study||32
205378|NCT00401830|483083|P1|NOT COMPLETED|Overall Study||31
205379|NCT00401830|483082|P2|COMPLETED|Overall Study||46
205380|NCT00401830|483083|P1|COMPLETED|Overall Study||50
205381|NCT00401830|483082|P2|STARTED|Overall Study||78
205382|NCT00401830|483083|P1|STARTED|Overall Study||81
205383|NCT00401778|483118|P3|NOT COMPLETED|Overall Study||1
205384|NCT00401778|483119|P2|NOT COMPLETED|Overall Study||1
205385|NCT00401778|483120|P1|NOT COMPLETED|Overall Study||1
205386|NCT00401778|483118|P3|COMPLETED|Overall Study||10
205387|NCT00401778|483119|P2|COMPLETED|Overall Study||11
205388|NCT00401778|483120|P1|COMPLETED|Overall Study||9
205389|NCT00401778|483118|P3|STARTED|Overall Study||11
205390|NCT00401778|483119|P2|STARTED|Overall Study||12
205391|NCT00401778|483120|P1|STARTED|Overall Study||10
205392|NCT00401752|483134|P2|NOT COMPLETED|Overall Study||18
205393|NCT00401752|483135|P1|NOT COMPLETED|Overall Study||10
205394|NCT00401752|483134|P2|COMPLETED|Overall Study||94
205395|NCT00401752|483135|P1|COMPLETED|Overall Study||97
205396|NCT00401752|483134|P2|Patients Included in Per-Protocol Popula|Overall Study||99
205397|NCT00401752|483135|P1|Patients Included in Per-Protocol Popula|Overall Study||100
205398|NCT00401752|483134|P2|Patients Included in Safety Population|Overall Study||110
205399|NCT00401752|483135|P1|Patients Included in Safety Population|Overall Study||107
205400|NCT00401752|483134|P2|Patients Included in ITT Population|Overall Study||111
205401|NCT00401752|483135|P1|Patients Included in ITT Population|Overall Study||106
205402|NCT00401752|483134|P2|Number of Patients Received Treatment|Overall Study||111
205403|NCT00401752|483135|P1|Number of Patients Received Treatment|Overall Study||107
205404|NCT00401752|483134|P2|STARTED|Overall Study||112
205405|NCT00401752|483135|P1|STARTED|Overall Study||107
205406|NCT00401726|483153|P2|NOT COMPLETED|Overall Study||112
205407|NCT00401726|483154|P1|NOT COMPLETED|Overall Study||97
205408|NCT00401726|483153|P2|COMPLETED|Overall Study||156
205409|NCT00401726|483154|P1|COMPLETED|Overall Study||172
205410|NCT00401726|483153|P2|STARTED|Overall Study||268
205411|NCT00401726|483154|P1|STARTED|Overall Study||269
205412|NCT00401622|483176|P2|NOT COMPLETED|Overall Study||43
205413|NCT00401622|483177|P1|NOT COMPLETED|Overall Study||34
205414|NCT00401622|483176|P2|COMPLETED|Overall Study||117
205415|NCT00401622|483177|P1|COMPLETED|Overall Study||126
205416|NCT00401622|483176|P2|STARTED|Overall Study||160
205417|NCT00401622|483177|P1|STARTED|Overall Study||160
205418|NCT00401544|483189|P4|NOT COMPLETED|Overall Study||16
205419|NCT00401544|483190|P3|NOT COMPLETED|Overall Study||12
205420|NCT00401544|483191|P2|NOT COMPLETED|Overall Study||18
205421|NCT00401544|483192|P1|NOT COMPLETED|Overall Study||18
205422|NCT00401544|483189|P4|COMPLETED|Overall Study||44
205423|NCT00401544|483190|P3|COMPLETED|Overall Study||48
205424|NCT00401544|483191|P2|COMPLETED|Overall Study||44
205425|NCT00401544|483192|P1|COMPLETED|Overall Study||38
205426|NCT00401544|483189|P4|STARTED|Overall Study|Randomized and treated|60
205427|NCT00401544|483190|P3|STARTED|Overall Study|Randomized and treated|60
205428|NCT00401544|483191|P2|STARTED|Overall Study|Randomized and treated|62
205429|NCT00401544|483192|P1|STARTED|Overall Study|Randomized and treated|56
205430|NCT00401531|483232|P2|NOT COMPLETED|Overall Study||10
205431|NCT00401531|483233|P1|NOT COMPLETED|Overall Study||9
205432|NCT00401531|483232|P2|COMPLETED|Overall Study||196
205433|NCT00401531|483233|P1|COMPLETED|Overall Study||197
205434|NCT00401531|483232|P2|STARTED|Overall Study||206
205435|NCT00401531|483233|P1|STARTED|Overall Study||206
205436|NCT00401414|483252|P3|NOT COMPLETED|Overall Study||0
205437|NCT00401414|483253|P2|NOT COMPLETED|Overall Study||0
205438|NCT00401414|483254|P1|NOT COMPLETED|Overall Study||0
205439|NCT00401414|483252|P3|COMPLETED|Overall Study||79
205440|NCT00401414|483253|P2|COMPLETED|Overall Study||147
205441|NCT00401414|483254|P1|COMPLETED|Overall Study||118
205442|NCT00401414|483252|P3|STARTED|Overall Study||79
205443|NCT00401414|483253|P2|STARTED|Overall Study||147
205444|NCT00401414|483254|P1|STARTED|Overall Study||118
205445|NCT00401401|483278|P4|NOT COMPLETED|Overall Study||3
205446|NCT00401401|483279|P3|NOT COMPLETED|Overall Study||1
205447|NCT00401401|483280|P2|NOT COMPLETED|Overall Study||0
205448|NCT00401401|483281|P1|NOT COMPLETED|Overall Study||0
205449|NCT00401401|483278|P4|COMPLETED|Overall Study||9
205450|NCT00401401|483279|P3|COMPLETED|Overall Study||5
205451|NCT00401401|483280|P2|COMPLETED|Overall Study||6
205452|NCT00401401|483281|P1|COMPLETED|Overall Study||6
205453|NCT00401401|483278|P4|STARTED|Overall Study||12
205454|NCT00401401|483279|P3|STARTED|Overall Study||6
205455|NCT00401401|483280|P2|STARTED|Overall Study||6
205456|NCT00401401|483281|P1|STARTED|Overall Study||6
205457|NCT00401258|483303|P1|NOT COMPLETED|Overall Study||7
205458|NCT00401258|483303|P1|COMPLETED|Overall Study||8
205459|NCT00401258|483303|P1|STARTED|Overall Study||15
205460|NCT00401245|483311|P8|NOT COMPLETED|Double Blind Tapering Phase||7
205461|NCT00401245|483312|P7|NOT COMPLETED|Double Blind Tapering Phase||7
205462|NCT00401245|483313|P6|NOT COMPLETED|Double Blind Tapering Phase||4
205463|NCT00401245|483314|P5|NOT COMPLETED|Double Blind Tapering Phase||4
205464|NCT00401245|483315|P4|NOT COMPLETED|Double Blind Tapering Phase||0
205465|NCT00401245|483316|P3|NOT COMPLETED|Double Blind Tapering Phase||0
205466|NCT00401245|483317|P2|NOT COMPLETED|Double Blind Tapering Phase||0
205467|NCT00401245|483318|P1|NOT COMPLETED|Double Blind Tapering Phase||0
205468|NCT00401245|483311|P8|COMPLETED|Double Blind Tapering Phase||95
205469|NCT00401245|483312|P7|COMPLETED|Double Blind Tapering Phase||80
205470|NCT00401245|483313|P6|COMPLETED|Double Blind Tapering Phase||90
205471|NCT00401245|483314|P5|COMPLETED|Double Blind Tapering Phase||97
205472|NCT00401245|483315|P4|COMPLETED|Double Blind Tapering Phase||0
205473|NCT00401245|483316|P3|COMPLETED|Double Blind Tapering Phase||0
205474|NCT00401245|483317|P2|COMPLETED|Double Blind Tapering Phase||0
205475|NCT00401245|483318|P1|COMPLETED|Double Blind Tapering Phase||0
205476|NCT00401245|483311|P8|STARTED|Double Blind Tapering Phase||102
205477|NCT00401245|483312|P7|STARTED|Double Blind Tapering Phase||87
205478|NCT00401245|483313|P6|STARTED|Double Blind Tapering Phase||94
205479|NCT00401245|483314|P5|STARTED|Double Blind Tapering Phase||101
205480|NCT00401245|483315|P4|STARTED|Double Blind Tapering Phase||0
205481|NCT00401245|483316|P3|STARTED|Double Blind Tapering Phase||0
205482|NCT00401245|483317|P2|STARTED|Double Blind Tapering Phase||0
205483|NCT00401245|483318|P1|STARTED|Double Blind Tapering Phase||0
205484|NCT00401245|483311|P8|NOT COMPLETED|Open Label Phase||0
205485|NCT00401245|483312|P7|NOT COMPLETED|Open Label Phase||0
205486|NCT00401245|483313|P6|NOT COMPLETED|Open Label Phase||0
205487|NCT00401245|483314|P5|NOT COMPLETED|Open Label Phase||0
205488|NCT00401245|483315|P4|NOT COMPLETED|Open Label Phase||21
205489|NCT00401245|483316|P3|NOT COMPLETED|Open Label Phase||23
205490|NCT00401245|483317|P2|NOT COMPLETED|Open Label Phase||35
205491|NCT00401245|483318|P1|NOT COMPLETED|Open Label Phase||21
205492|NCT00401245|483311|P8|COMPLETED|Open Label Phase||0
205493|NCT00401245|483312|P7|COMPLETED|Open Label Phase||0
205494|NCT00401245|483313|P6|COMPLETED|Open Label Phase||0
205495|NCT00401245|483314|P5|COMPLETED|Open Label Phase||0
205496|NCT00401245|483315|P4|COMPLETED|Open Label Phase||84
205497|NCT00401245|483316|P3|COMPLETED|Open Label Phase||95
205498|NCT00401245|483317|P2|COMPLETED|Open Label Phase||81
205499|NCT00401245|483318|P1|COMPLETED|Open Label Phase||101
205500|NCT00401245|483311|P8|STARTED|Open Label Phase||0
205501|NCT00401245|483312|P7|STARTED|Open Label Phase||0
205502|NCT00401245|483313|P6|STARTED|Open Label Phase||0
205503|NCT00401245|483314|P5|STARTED|Open Label Phase||0
205504|NCT00401245|483315|P4|STARTED|Open Label Phase||105
205505|NCT00401245|483316|P3|STARTED|Open Label Phase||118
205506|NCT00401245|483317|P2|STARTED|Open Label Phase||116
205507|NCT00401245|483318|P1|STARTED|Open Label Phase||122
205508|NCT00401245|483311|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
205509|NCT00401245|483312|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
205510|NCT00401245|483313|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
205511|NCT00401245|483314|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
205512|NCT00401245|483315|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
205513|NCT00401245|483316|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
205514|NCT00401245|483317|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
205515|NCT00401245|483318|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
205603|NCT00400764|483441|P3|STARTED|Phase II||23
205516|NCT00401245|483311|P8|COMPLETED|Between Titration and Open Label Phase||0
205517|NCT00401245|483312|P7|COMPLETED|Between Titration and Open Label Phase||0
205518|NCT00401245|483313|P6|COMPLETED|Between Titration and Open Label Phase||0
205519|NCT00401245|483314|P5|COMPLETED|Between Titration and Open Label Phase||0
205520|NCT00401245|483315|P4|COMPLETED|Between Titration and Open Label Phase||105
205521|NCT00401245|483316|P3|COMPLETED|Between Titration and Open Label Phase||118
205522|NCT00401245|483317|P2|COMPLETED|Between Titration and Open Label Phase||116
205523|NCT00401245|483318|P1|COMPLETED|Between Titration and Open Label Phase||122
205524|NCT00401245|483311|P8|STARTED|Between Titration and Open Label Phase||0
205525|NCT00401245|483312|P7|STARTED|Between Titration and Open Label Phase||0
205526|NCT00401245|483313|P6|STARTED|Between Titration and Open Label Phase||0
205527|NCT00401245|483314|P5|STARTED|Between Titration and Open Label Phase||0
205528|NCT00401245|483315|P4|STARTED|Between Titration and Open Label Phase||107
205529|NCT00401245|483316|P3|STARTED|Between Titration and Open Label Phase||118
205530|NCT00401245|483317|P2|STARTED|Between Titration and Open Label Phase||118
205531|NCT00401245|483318|P1|STARTED|Between Titration and Open Label Phase||122
205532|NCT00401245|483311|P8|NOT COMPLETED|Double Blind Titration Phase||0
205533|NCT00401245|483312|P7|NOT COMPLETED|Double Blind Titration Phase||0
205534|NCT00401245|483313|P6|NOT COMPLETED|Double Blind Titration Phase||0
205535|NCT00401245|483314|P5|NOT COMPLETED|Double Blind Titration Phase||0
205536|NCT00401245|483315|P4|NOT COMPLETED|Double Blind Titration Phase||15
205537|NCT00401245|483316|P3|NOT COMPLETED|Double Blind Titration Phase||6
205538|NCT00401245|483317|P2|NOT COMPLETED|Double Blind Titration Phase||3
205539|NCT00401245|483318|P1|NOT COMPLETED|Double Blind Titration Phase||4
205540|NCT00401245|483311|P8|COMPLETED|Double Blind Titration Phase||0
205541|NCT00401245|483312|P7|COMPLETED|Double Blind Titration Phase||0
205542|NCT00401245|483313|P6|COMPLETED|Double Blind Titration Phase||0
205543|NCT00401245|483314|P5|COMPLETED|Double Blind Titration Phase||0
205544|NCT00401245|483315|P4|COMPLETED|Double Blind Titration Phase||107
205545|NCT00401245|483316|P3|COMPLETED|Double Blind Titration Phase||118
205546|NCT00401245|483317|P2|COMPLETED|Double Blind Titration Phase||118
205547|NCT00401245|483318|P1|COMPLETED|Double Blind Titration Phase||122
205548|NCT00401245|483311|P8|STARTED|Double Blind Titration Phase||0
205549|NCT00401245|483312|P7|STARTED|Double Blind Titration Phase||0
205550|NCT00401245|483313|P6|STARTED|Double Blind Titration Phase||0
205551|NCT00401245|483314|P5|STARTED|Double Blind Titration Phase||0
205552|NCT00401245|483315|P4|STARTED|Double Blind Titration Phase||122
205553|NCT00401245|483316|P3|STARTED|Double Blind Titration Phase||124
205554|NCT00401245|483317|P2|STARTED|Double Blind Titration Phase||121
205555|NCT00401245|483318|P1|STARTED|Double Blind Titration Phase||126
205556|NCT00401193|483386|P3|NOT COMPLETED|Overall Study||6
205557|NCT00401193|483387|P2|NOT COMPLETED|Overall Study||11
205558|NCT00401193|483388|P1|NOT COMPLETED|Overall Study||15
205559|NCT00401193|483386|P3|COMPLETED|Overall Study||63
205560|NCT00401193|483387|P2|COMPLETED|Overall Study||106
205561|NCT00401193|483388|P1|COMPLETED|Overall Study||103
205562|NCT00401193|483386|P3|Modified Intent to Treat Population|Overall Study||67
205563|NCT00401193|483387|P2|Modified Intent to Treat Population|Overall Study||115
205564|NCT00401193|483388|P1|Modified Intent to Treat Population|Overall Study||112
205565|NCT00401193|483386|P3|Intent to Treat Population|Overall Study||67
205566|NCT00401193|483387|P2|Intent to Treat Population|Overall Study||115
205567|NCT00401193|483388|P1|Intent to Treat Population|Overall Study||115
205568|NCT00401193|483386|P3|STARTED|Overall Study||69
205569|NCT00401193|483387|P2|STARTED|Overall Study||117
205570|NCT00401193|483388|P1|STARTED|Overall Study||118
205571|NCT00401102|483402|P1|NOT COMPLETED|Overall Study||7
205572|NCT00401102|483402|P1|COMPLETED|Overall Study||5
205573|NCT00401102|483402|P1|STARTED|Overall Study||12
205574|NCT00400881|483408|P2|NOT COMPLETED|Overall Study||0
205575|NCT00400881|483409|P1|NOT COMPLETED|Overall Study||0
205576|NCT00400881|483408|P2|COMPLETED|Overall Study||60
205577|NCT00400881|483409|P1|COMPLETED|Overall Study||62
205578|NCT00400881|483408|P2|STARTED|Overall Study||60
205579|NCT00400881|483409|P1|STARTED|Overall Study||62
205580|NCT00400829|483417|P1|NOT COMPLETED|Overall Study||0
205581|NCT00400829|483417|P1|COMPLETED|Overall Study||66
205582|NCT00400829|483417|P1|STARTED|Overall Study||66
205583|NCT00400803|483423|P1|NOT COMPLETED|Overall Study||0
205584|NCT00400803|483423|P1|COMPLETED|Overall Study||35
205585|NCT00400803|483423|P1|STARTED|Overall Study||35
205586|NCT00400764|483439|P5|NOT COMPLETED|Phase II||11
205587|NCT00400764|483440|P4|NOT COMPLETED|Phase II||26
205588|NCT00400764|483441|P3|NOT COMPLETED|Phase II||23
205589|NCT00400764|483442|P2|NOT COMPLETED|Phase II||0
205590|NCT00400764|483443|P1|NOT COMPLETED|Phase II||0
205591|NCT00400764|483439|P5|COMPLETED|Phase II||0
205592|NCT00400764|483440|P4|COMPLETED|Phase II||0
205593|NCT00400764|483441|P3|COMPLETED|Phase II||0
205594|NCT00400764|483442|P2|COMPLETED|Phase II||0
205595|NCT00400764|483443|P1|COMPLETED|Phase II||0
205596|NCT00400764|483439|P5|Treated|Phase II||11
205597|NCT00400764|483440|P4|Treated|Phase II||26
205598|NCT00400764|483441|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
205599|NCT00400764|483442|P2|Treated|Phase II||0
205600|NCT00400764|483443|P1|Treated|Phase II||0
205601|NCT00400764|483439|P5|STARTED|Phase II||11
205602|NCT00400764|483440|P4|STARTED|Phase II||26
205604|NCT00400764|483442|P2|STARTED|Phase II||0
205605|NCT00400764|483443|P1|STARTED|Phase II||0
205606|NCT00400764|483439|P5|NOT COMPLETED|Phase Ib||0
205607|NCT00400764|483440|P4|NOT COMPLETED|Phase Ib||0
205608|NCT00400764|483441|P3|NOT COMPLETED|Phase Ib||0
205609|NCT00400764|483442|P2|NOT COMPLETED|Phase Ib||4
205610|NCT00400764|483443|P1|NOT COMPLETED|Phase Ib||6
205611|NCT00400764|483439|P5|COMPLETED|Phase Ib||0
205612|NCT00400764|483440|P4|COMPLETED|Phase Ib||0
205613|NCT00400764|483441|P3|COMPLETED|Phase Ib||0
205614|NCT00400764|483442|P2|COMPLETED|Phase Ib||2
205615|NCT00400764|483443|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
205616|NCT00400764|483439|P5|Treated|Phase Ib||0
205617|NCT00400764|483440|P4|Treated|Phase Ib||0
205618|NCT00400764|483441|P3|Treated|Phase Ib||0
205619|NCT00400764|483442|P2|Treated|Phase Ib||6
205620|NCT00400764|483443|P1|Treated|Phase Ib||6
205621|NCT00400764|483439|P5|STARTED|Phase Ib||0
205622|NCT00400764|483440|P4|STARTED|Phase Ib||0
205623|NCT00400764|483441|P3|STARTED|Phase Ib||0
205624|NCT00400764|483442|P2|STARTED|Phase Ib||6
205625|NCT00400764|483443|P1|STARTED|Phase Ib||6
205626|NCT00400712|483496|P2|NOT COMPLETED|Overall Study||16
205627|NCT00400712|483497|P1|NOT COMPLETED|Overall Study||17
205628|NCT00400712|483496|P2|COMPLETED|Overall Study||35
205629|NCT00400712|483497|P1|COMPLETED|Overall Study||35
205630|NCT00400712|483496|P2|STARTED|Overall Study||51
205631|NCT00400712|483497|P1|STARTED|Overall Study||52
205632|NCT00400686|483515|P1|NOT COMPLETED|Overall Study||0
205633|NCT00400686|483515|P1|COMPLETED|Overall Study||31
205634|NCT00400686|483515|P1|STARTED|Overall Study||31
205635|NCT00400634|483523|P2|NOT COMPLETED|Overall Study||1
205636|NCT00400634|483524|P1|NOT COMPLETED|Overall Study||4
205637|NCT00400634|483523|P2|COMPLETED|Overall Study||19
205638|NCT00400634|483524|P1|COMPLETED|Overall Study||34
205639|NCT00400634|483523|P2|STARTED|Overall Study||20
205640|NCT00400634|483524|P1|STARTED|Overall Study||38
205641|NCT00400569|483532|P1|NOT COMPLETED|Overall Study||1
205642|NCT00400569|483532|P1|COMPLETED|Overall Study||47
205643|NCT00400569|483532|P1|STARTED|Overall Study||48
205644|NCT00400400|483545|P2|NOT COMPLETED|Overall Study||15
205645|NCT00400400|483546|P1|NOT COMPLETED|Overall Study||14
205646|NCT00400400|483545|P2|COMPLETED|Overall Study||185
205647|NCT00400400|483546|P1|COMPLETED|Overall Study||186
205648|NCT00400400|483545|P2|Intent-to-Treat Population|Overall Study||197
205649|NCT00400400|483546|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
205650|NCT00400400|483545|P2|STARTED|Overall Study||200
205651|NCT00400400|483546|P1|STARTED|Overall Study||200
205652|NCT00400205|483564|P1|NOT COMPLETED|Overall Study||5
205653|NCT00400205|483564|P1|COMPLETED|Overall Study||9
205654|NCT00400205|483564|P1|STARTED|Overall Study||14
205655|NCT00400179|483570|P2|NOT COMPLETED|Overall Study||18
205656|NCT00400179|483571|P1|NOT COMPLETED|Overall Study||6
205657|NCT00400179|483570|P2|COMPLETED|Overall Study||508
205658|NCT00400179|483571|P1|COMPLETED|Overall Study|Received Treatment|521
205659|NCT00400179|483570|P2|STARTED|Overall Study||526
205660|NCT00400179|483571|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
205661|NCT00400153|483588|P3|NOT COMPLETED|Overall Study||61
205662|NCT00400153|483589|P2|NOT COMPLETED|Overall Study||55
205663|NCT00400153|483590|P1|NOT COMPLETED|Overall Study||48
205664|NCT00400153|483588|P3|COMPLETED|Overall Study||422
205665|NCT00400153|483589|P2|COMPLETED|Overall Study||436
205666|NCT00400153|483590|P1|COMPLETED|Overall Study||438
205667|NCT00400153|483588|P3|STARTED|Overall Study||483
205668|NCT00400153|483589|P2|STARTED|Overall Study||491
205669|NCT00400153|483590|P1|STARTED|Overall Study||486
205670|NCT00399893|483837|P2|NOT COMPLETED|Overall Study||0
205671|NCT00399893|483838|P1|NOT COMPLETED|Overall Study||1
205672|NCT00399893|483837|P2|COMPLETED|Overall Study||3
205673|NCT00399893|483838|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
205674|NCT00399893|483837|P2|STARTED|Overall Study||3
205675|NCT00399893|483838|P1|STARTED|Overall Study||2
205676|NCT00399763|483866|P2|NOT COMPLETED|Overall Study||3
205677|NCT00399763|483867|P1|NOT COMPLETED|Overall Study||2
205678|NCT00399763|483866|P2|COMPLETED|Overall Study||32
205679|NCT00399763|483867|P1|COMPLETED|Overall Study||33
205680|NCT00399763|483866|P2|STARTED|Overall Study||35
205681|NCT00399763|483867|P1|STARTED|Overall Study||35
205682|NCT00399568|483879|P2|NOT COMPLETED|Overall Study||9
205683|NCT00399568|483880|P1|NOT COMPLETED|Overall Study||12
205684|NCT00399568|483879|P2|COMPLETED|Overall Study||156
205685|NCT00399568|483880|P1|COMPLETED|Overall Study||154
205686|NCT00399568|483879|P2|STARTED|Overall Study||165
205687|NCT00399568|483880|P1|STARTED|Overall Study||166
205688|NCT00399542|483894|P2|NOT COMPLETED|Overall Study||43
205689|NCT00399542|483895|P1|NOT COMPLETED|Overall Study||84
205690|NCT00399542|483894|P2|COMPLETED|Overall Study||151
205691|NCT00399542|483895|P1|COMPLETED|Overall Study||303
205692|NCT00399542|483894|P2|STARTED|Overall Study||194
205693|NCT00399542|483895|P1|STARTED|Overall Study||387
205694|NCT00399516|483957|P1|NOT COMPLETED|Overall Study||2
205695|NCT00399516|483957|P1|COMPLETED|Overall Study||19
205696|NCT00399516|483957|P1|STARTED|Overall Study||21
205697|NCT00399360|483965|P4|NOT COMPLETED|Overall Study||6
205698|NCT00399360|483966|P3|NOT COMPLETED|Overall Study||3
205699|NCT00399360|483967|P2|NOT COMPLETED|Overall Study||3
205700|NCT00399360|483968|P1|NOT COMPLETED|Overall Study||2
205701|NCT00399360|483965|P4|COMPLETED|Overall Study||9
205702|NCT00399360|483966|P3|COMPLETED|Overall Study||10
205703|NCT00399360|483967|P2|COMPLETED|Overall Study||8
205704|NCT00399360|483968|P1|COMPLETED|Overall Study||9
205705|NCT00399360|483965|P4|STARTED|Overall Study||15
205706|NCT00399360|483966|P3|STARTED|Overall Study||13
205707|NCT00399360|483967|P2|STARTED|Overall Study||11
205708|NCT00399360|483968|P1|STARTED|Overall Study||11
205709|NCT00399308|484017|P3|NOT COMPLETED|Overall Study||1
205710|NCT00399308|484018|P2|NOT COMPLETED|Overall Study||0
205711|NCT00399308|484019|P1|NOT COMPLETED|Overall Study||0
205712|NCT00399308|484017|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
205713|NCT00399308|484018|P2|COMPLETED|Overall Study||15
205714|NCT00399308|484019|P1|COMPLETED|Overall Study||13
205715|NCT00399308|484017|P3|STARTED|Overall Study||12
205716|NCT00399308|484018|P2|STARTED|Overall Study||15
205717|NCT00399308|484019|P1|STARTED|Overall Study||13
205718|NCT00399035|484039|P3|NOT COMPLETED|Overall Study||252
205719|NCT00399035|484040|P2|NOT COMPLETED|Overall Study||158
205720|NCT00399035|484041|P1|NOT COMPLETED|Overall Study||313
205721|NCT00399035|484039|P3|COMPLETED|Overall Study||106
205722|NCT00399035|484040|P2|COMPLETED|Overall Study||58
205723|NCT00399035|484041|P1|COMPLETED|Overall Study||189
205724|NCT00399035|484039|P3|STARTED|Overall Study||358
205725|NCT00399035|484040|P2|STARTED|Overall Study||216
205726|NCT00399035|484041|P1|STARTED|Overall Study||502
205727|NCT00398983|484062|P2|NOT COMPLETED|Overall Study||0
205728|NCT00398983|484063|P1|NOT COMPLETED|Overall Study||0
205729|NCT00398983|484062|P2|COMPLETED|Overall Study||25
205730|NCT00398983|484063|P1|COMPLETED|Overall Study||20
205731|NCT00398983|484062|P2|STARTED|Overall Study||25
205732|NCT00398983|484063|P1|STARTED|Overall Study||20
205733|NCT00398918|484069|P1|NOT COMPLETED|Overall Study||0
205734|NCT00398918|484069|P1|COMPLETED|Overall Study||10
205735|NCT00398918|484069|P1|STARTED|Overall Study||10
205736|NCT00398632|484074|P1|NOT COMPLETED|Overall Study||2
205737|NCT00398632|484074|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
205738|NCT00398632|484074|P1|STARTED|Overall Study||6
205739|NCT00398411|484080|P2|NOT COMPLETED|Overall Study||1
205740|NCT00398411|484081|P1|NOT COMPLETED|Overall Study||0
205741|NCT00398411|484080|P2|COMPLETED|Overall Study||31
205742|NCT00398411|484081|P1|COMPLETED|Overall Study||34
205743|NCT00398411|484080|P2|STARTED|Overall Study||32
205744|NCT00398411|484081|P1|STARTED|Overall Study||34
205745|NCT00398398|484097|P1|NOT COMPLETED|Overall Study||0
205746|NCT00398398|484097|P1|COMPLETED|Overall Study||44
205747|NCT00398398|484097|P1|STARTED|Overall Study||44
205748|NCT00398320|484104|P1|NOT COMPLETED|Overall Study||6
205749|NCT00398320|484104|P1|COMPLETED|Overall Study||34
205750|NCT00398320|484104|P1|STARTED|Overall Study||40
205751|NCT00398216|484117|P5|NOT COMPLETED|Overall Study||15
205752|NCT00398216|484118|P4|NOT COMPLETED|Overall Study||22
205753|NCT00398216|484119|P3|NOT COMPLETED|Overall Study||21
205754|NCT00398216|484120|P2|NOT COMPLETED|Overall Study||19
205755|NCT00398216|484121|P1|NOT COMPLETED|Overall Study||11
205756|NCT00398216|484117|P5|COMPLETED|Overall Study||157
205757|NCT00398216|484118|P4|COMPLETED|Overall Study||155
205758|NCT00398216|484119|P3|COMPLETED|Overall Study||164
205759|NCT00398216|484120|P2|COMPLETED|Overall Study||151
205760|NCT00398216|484121|P1|COMPLETED|Overall Study||181
205761|NCT00398216|484117|P5|STARTED|Overall Study||172
205762|NCT00398216|484118|P4|STARTED|Overall Study||177
205763|NCT00398216|484119|P3|STARTED|Overall Study||185
205764|NCT00398216|484120|P2|STARTED|Overall Study||170
205765|NCT00398216|484121|P1|STARTED|Overall Study||192
205766|NCT00398138|484148|P1|NOT COMPLETED|Overall Study||2
205767|NCT00398138|484148|P1|COMPLETED|Overall Study||10
205768|NCT00398138|484148|P1|STARTED|Overall Study||12
205769|NCT00398112|484153|P1|NOT COMPLETED|Overall Study||18
205770|NCT00398112|484153|P1|COMPLETED|Overall Study||0
205771|NCT00398112|484153|P1|STARTED|Overall Study||18
205772|NCT00398086|484164|P3|NOT COMPLETED|Overall Study||2
205773|NCT00398086|484165|P2|NOT COMPLETED|Overall Study||23
205774|NCT00398086|484166|P1|NOT COMPLETED|Overall Study||9
205775|NCT00398086|484164|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
205776|NCT00398086|484165|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
205777|NCT00398086|484166|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
205778|NCT00398086|484164|P3|Phase 1, Dose Escalation Population|Overall Study||3
205779|NCT00398086|484165|P2|Phase 1, Dose Escalation Population|Overall Study||7
205780|NCT00398086|484166|P1|Phase 1, Dose Escalation Population|Overall Study||20
205781|NCT00398086|484164|P3|STARTED|Overall Study||3
205782|NCT00398086|484165|P2|STARTED|Overall Study||44
205783|NCT00398086|484166|P1|STARTED|Overall Study||20
205784|NCT00398047|484198|P1|NOT COMPLETED|Overall Study||3
205785|NCT00398047|484198|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
205786|NCT00398047|484198|P1|STARTED|Overall Study||3
205787|NCT00397930|484210|P2|NOT COMPLETED|Overall Study||51
205788|NCT00397930|484211|P1|NOT COMPLETED|Overall Study||38
205789|NCT00397930|484210|P2|COMPLETED|Overall Study||153
205790|NCT00397930|484211|P1|COMPLETED|Overall Study||168
205791|NCT00397930|484210|P2|STARTED|Overall Study||204
205792|NCT00397930|484211|P1|STARTED|Overall Study||206
205793|NCT00397904|484217|P1|NOT COMPLETED|Overall Study||0
205794|NCT00397904|484217|P1|COMPLETED|Overall Study||16
205795|NCT00397904|484217|P1|STARTED|Overall Study||16
205796|NCT00397891|484226|P5|NOT COMPLETED|Overall Study||1
205797|NCT00397891|484227|P4|NOT COMPLETED|Overall Study||0
205798|NCT00397891|484228|P3|NOT COMPLETED|Overall Study||0
205799|NCT00397891|484229|P2|NOT COMPLETED|Overall Study||0
205800|NCT00397891|484230|P1|NOT COMPLETED|Overall Study||1
205801|NCT00397891|484226|P5|COMPLETED|Overall Study||7
205802|NCT00397891|484227|P4|COMPLETED|Overall Study||6
205803|NCT00397891|484228|P3|COMPLETED|Overall Study||6
205804|NCT00397891|484229|P2|COMPLETED|Overall Study||6
205805|NCT00397891|484230|P1|COMPLETED|Overall Study||5
205806|NCT00397891|484226|P5|STARTED|Overall Study||8
205807|NCT00397891|484227|P4|STARTED|Overall Study||6
205808|NCT00397891|484228|P3|STARTED|Overall Study||6
205809|NCT00397891|484229|P2|STARTED|Overall Study||6
205810|NCT00397891|484230|P1|STARTED|Overall Study||6
205811|NCT00397878|484328|P1|NOT COMPLETED|Overall Study||0
205812|NCT00397878|484328|P1|COMPLETED|Overall Study||10
205813|NCT00397878|484328|P1|STARTED|Overall Study||10
205814|NCT00397839|484334|P2|NOT COMPLETED|Overall Study||18
205815|NCT00397839|484335|P1|NOT COMPLETED|Overall Study||7
205816|NCT00397839|484334|P2|COMPLETED|Overall Study||69
205817|NCT00397839|484335|P1|COMPLETED|Overall Study||41
205818|NCT00397839|484334|P2|STARTED|Overall Study||87
205819|NCT00397839|484335|P1|STARTED|Overall Study||48
205820|NCT00397631|484351|P2|NOT COMPLETED|Overall Study||44
205821|NCT00397631|484352|P1|NOT COMPLETED|Overall Study||30
205822|NCT00397631|484351|P2|COMPLETED|Overall Study||215
205823|NCT00397631|484352|P1|COMPLETED|Overall Study||231
205824|NCT00397631|484351|P2|STARTED|Overall Study||259
205825|NCT00397631|484352|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
205826|NCT00397540|484364|P2|NOT COMPLETED|Overall Study||0
205827|NCT00397540|484365|P1|NOT COMPLETED|Overall Study||1
205828|NCT00397540|484364|P2|COMPLETED|Overall Study||85
205829|NCT00397540|484365|P1|COMPLETED|Overall Study||59
205830|NCT00397540|484364|P2|STARTED|Overall Study||85
205831|NCT00397540|484365|P1|STARTED|Overall Study||60
205832|NCT00397514|484371|P1|NOT COMPLETED|Overall Study||9
205833|NCT00397514|484371|P1|COMPLETED|Overall Study||25
205834|NCT00397514|484371|P1|STARTED|Overall Study||34
205835|NCT00397488|484381|P1|NOT COMPLETED|Overall Study||7
205836|NCT00397488|484381|P1|COMPLETED|Overall Study||71
205837|NCT00397488|484381|P1|STARTED|Overall Study||78
205838|NCT00397462|484388|P3|NOT COMPLETED|Overall Study||0
205839|NCT00397462|484389|P2|NOT COMPLETED|Overall Study||0
205840|NCT00397462|484390|P1|NOT COMPLETED|Overall Study||0
205841|NCT00397462|484388|P3|COMPLETED|Overall Study||15
205842|NCT00397462|484389|P2|COMPLETED|Overall Study||13
205843|NCT00397462|484390|P1|COMPLETED|Overall Study||16
205844|NCT00397462|484388|P3|STARTED|Overall Study||15
205845|NCT00397462|484389|P2|STARTED|Overall Study||13
205846|NCT00397462|484390|P1|STARTED|Overall Study||16
205847|NCT00397254|484401|P2|NOT COMPLETED|Overall Study||2
205848|NCT00397254|484402|P1|NOT COMPLETED|Overall Study||2
205849|NCT00397254|484401|P2|COMPLETED|Overall Study||74
205850|NCT00397254|484402|P1|COMPLETED|Overall Study||77
205851|NCT00397254|484401|P2|STARTED|Overall Study||76
205852|NCT00397254|484402|P1|STARTED|Overall Study||79
205853|NCT00397215|484424|P4|NOT COMPLETED|Month 24 (Day 720)||0
205854|NCT00397215|484425|P3|NOT COMPLETED|Month 24 (Day 720)||0
205855|NCT00397215|484426|P2|NOT COMPLETED|Month 24 (Day 720)||0
205856|NCT00397215|484427|P1|NOT COMPLETED|Month 24 (Day 720)||0
205857|NCT00397215|484424|P4|COMPLETED|Month 24 (Day 720)||36
205858|NCT00397215|484425|P3|COMPLETED|Month 24 (Day 720)||117
205859|NCT00397215|484426|P2|COMPLETED|Month 24 (Day 720)||45
205860|NCT00397215|484427|P1|COMPLETED|Month 24 (Day 720)||122
205861|NCT00397215|484424|P4|STARTED|Month 24 (Day 720)||36
205862|NCT00397215|484425|P3|STARTED|Month 24 (Day 720)||117
205863|NCT00397215|484426|P2|STARTED|Month 24 (Day 720)||45
205864|NCT00397215|484427|P1|STARTED|Month 24 (Day 720)||122
205865|NCT00397215|484424|P4|NOT COMPLETED|Month 12 (Day 360)||0
205866|NCT00397215|484425|P3|NOT COMPLETED|Month 12 (Day 360)||0
205867|NCT00397215|484426|P2|NOT COMPLETED|Month 12 (Day 360)||0
205868|NCT00397215|484427|P1|NOT COMPLETED|Month 12 (Day 360)||0
205869|NCT00397215|484424|P4|COMPLETED|Month 12 (Day 360)||42
205870|NCT00397215|484425|P3|COMPLETED|Month 12 (Day 360)||125
205871|NCT00397215|484426|P2|COMPLETED|Month 12 (Day 360)||48
205872|NCT00397215|484427|P1|COMPLETED|Month 12 (Day 360)||130
205873|NCT00397215|484424|P4|STARTED|Month 12 (Day 360)||42
205874|NCT00397215|484425|P3|STARTED|Month 12 (Day 360)||125
205875|NCT00397215|484426|P2|STARTED|Month 12 (Day 360)||48
205876|NCT00397215|484427|P1|STARTED|Month 12 (Day 360)||130
205877|NCT00397215|484424|P4|NOT COMPLETED|Month 6 (Day 180)||0
205878|NCT00397215|484425|P3|NOT COMPLETED|Month 6 (Day 180)||5
205879|NCT00397215|484426|P2|NOT COMPLETED|Month 6 (Day 180)||3
205880|NCT00397215|484427|P1|NOT COMPLETED|Month 6 (Day 180)||2
205881|NCT00397215|484424|P4|COMPLETED|Month 6 (Day 180)||51
205882|NCT00397215|484425|P3|COMPLETED|Month 6 (Day 180)||153
205883|NCT00397215|484426|P2|COMPLETED|Month 6 (Day 180)||55
205884|NCT00397215|484427|P1|COMPLETED|Month 6 (Day 180)||162
205885|NCT00397215|484424|P4|STARTED|Month 6 (Day 180)||51
205886|NCT00397215|484425|P3|STARTED|Month 6 (Day 180)||158
205887|NCT00397215|484426|P2|STARTED|Month 6 (Day 180)||58
205888|NCT00397215|484427|P1|STARTED|Month 6 (Day 180)||164
205889|NCT00397215|484424|P4|NOT COMPLETED|Month 0 (Day 0)||4
205890|NCT00397215|484425|P3|NOT COMPLETED|Month 0 (Day 0)||6
205891|NCT00397215|484426|P2|NOT COMPLETED|Month 0 (Day 0)||5
205892|NCT00397215|484427|P1|NOT COMPLETED|Month 0 (Day 0)||7
205893|NCT00397215|484424|P4|COMPLETED|Month 0 (Day 0)||48
205894|NCT00397215|484425|P3|COMPLETED|Month 0 (Day 0)||153
205895|NCT00397215|484426|P2|COMPLETED|Month 0 (Day 0)||56
205896|NCT00397215|484427|P1|COMPLETED|Month 0 (Day 0)||158
205897|NCT00397215|484424|P4|STARTED|Month 0 (Day 0)||52
205898|NCT00397215|484425|P3|STARTED|Month 0 (Day 0)||159
205899|NCT00397215|484426|P2|STARTED|Month 0 (Day 0)||61
205900|NCT00397215|484427|P1|STARTED|Month 0 (Day 0)||165
205901|NCT00397189|484563|P2|NOT COMPLETED|Extension Period||43
205902|NCT00397189|484564|P1|NOT COMPLETED|Extension Period||113
205903|NCT00397189|484563|P2|COMPLETED|Extension Period||134
205904|NCT00397189|484564|P1|COMPLETED|Extension Period||421
205905|NCT00397189|484563|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
205906|NCT00397189|484564|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
205907|NCT00397189|484563|P2|NOT COMPLETED|3 Weeks Period||22
205908|NCT00397189|484564|P1|NOT COMPLETED|3 Weeks Period||21
205909|NCT00397189|484563|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
205910|NCT00397189|484564|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
205911|NCT00397189|484563|P2|STARTED|3 Weeks Period||395
205912|NCT00397189|484564|P1|STARTED|3 Weeks Period||394
205913|NCT00397150|484572|P2|NOT COMPLETED|Overall Study||145
205914|NCT00397150|484573|P1|NOT COMPLETED|Overall Study||135
205915|NCT00397150|484572|P2|COMPLETED|Overall Study||1111
205916|NCT00397150|484573|P1|COMPLETED|Overall Study||1188
205917|NCT00397150|484572|P2|STARTED|Overall Study||1256
205918|NCT00397150|484573|P1|STARTED|Overall Study||1323
205919|NCT00397033|484588|P3|NOT COMPLETED|Overall Study||23
205920|NCT00397033|484589|P2|NOT COMPLETED|Overall Study||37
205921|NCT00397033|484590|P1|NOT COMPLETED|Overall Study||44
205922|NCT00397033|484588|P3|COMPLETED|Overall Study||77
205923|NCT00397033|484589|P2|COMPLETED|Overall Study||72
205924|NCT00397033|484590|P1|COMPLETED|Overall Study||63
205925|NCT00397033|484588|P3|ITT Population|Overall Study||98
205926|NCT00397033|484589|P2|ITT Population|Overall Study||105
205927|NCT00397033|484590|P1|ITT Population|Overall Study||107
205928|NCT00397033|484588|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
205929|NCT00397033|484589|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
205930|NCT00397033|484590|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
205931|NCT00397033|484588|P3|STARTED|Overall Study||100
205932|NCT00397033|484589|P2|STARTED|Overall Study||109
205933|NCT00397033|484590|P1|STARTED|Overall Study||107
205934|NCT00396981|484651|P2|NOT COMPLETED|Overall Study||9
205935|NCT00396981|484652|P1|NOT COMPLETED|Overall Study||15
205936|NCT00396981|484651|P2|COMPLETED|Overall Study||306
205937|NCT00396981|484652|P1|COMPLETED|Overall Study||296
205938|NCT00396981|484651|P2|STARTED|Overall Study||315
205939|NCT00396981|484652|P1|STARTED|Overall Study||311
205940|NCT00396877|484672|P2|NOT COMPLETED|Overall Study||8
205941|NCT00396877|484673|P1|NOT COMPLETED|Overall Study||6
205942|NCT00396877|484672|P2|COMPLETED|Overall Study|Completed follow-up|459
205943|NCT00396877|484673|P1|COMPLETED|Overall Study|Completed follow-up|433
205944|NCT00396877|484672|P2|Completed Treatment|Overall Study||352
205945|NCT00396877|484673|P1|Completed Treatment|Overall Study||356
205946|NCT00396877|484672|P2|Treated|Overall Study||464
205947|NCT00396877|484673|P1|Treated|Overall Study||436
205948|NCT00396877|484672|P2|STARTED|Overall Study|Randomized|467
205949|NCT00396877|484673|P1|STARTED|Overall Study|Randomized|439
205950|NCT00396812|484683|P1|NOT COMPLETED|Overall Study||1
205951|NCT00396812|484683|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
205952|NCT00396812|484683|P1|STARTED|Overall Study||4
205953|NCT00396656|484695|P2|NOT COMPLETED|Second Treatment Period||1
205954|NCT00396656|484696|P1|NOT COMPLETED|Second Treatment Period||0
205955|NCT00396656|484695|P2|COMPLETED|Second Treatment Period||12
205956|NCT00396656|484696|P1|COMPLETED|Second Treatment Period||15
205957|NCT00396656|484695|P2|STARTED|Second Treatment Period||13
205958|NCT00396656|484696|P1|STARTED|Second Treatment Period||15
205959|NCT00396656|484695|P2|NOT COMPLETED|First Treatment Period||2
205960|NCT00396656|484696|P1|NOT COMPLETED|First Treatment Period||0
205961|NCT00396656|484695|P2|COMPLETED|First Treatment Period||13
205962|NCT00396656|484696|P1|COMPLETED|First Treatment Period||15
205963|NCT00396656|484695|P2|STARTED|First Treatment Period||15
205964|NCT00396656|484696|P1|STARTED|First Treatment Period||15
205965|NCT00396630|484714|P2|NOT COMPLETED|Overall Study||5
205966|NCT00396630|484715|P1|NOT COMPLETED|Overall Study||5
205967|NCT00396630|484714|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
205968|NCT00396630|484715|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
205969|NCT00396630|484714|P2|STARTED|Overall Study||100
205970|NCT00396630|484715|P1|STARTED|Overall Study||100
205971|NCT00396591|484732|P1|NOT COMPLETED|Overall Study||16
205972|NCT00396591|484732|P1|COMPLETED|Overall Study||0
205973|NCT00396591|484732|P1|STARTED|Overall Study||16
205974|NCT00396565|484745|P3|NOT COMPLETED|Overall Study||17
205975|NCT00396565|484746|P2|NOT COMPLETED|Overall Study||91
205976|NCT00396565|484747|P1|NOT COMPLETED|Overall Study||48
205977|NCT00396565|484745|P3|COMPLETED|Overall Study||30
205978|NCT00396565|484746|P2|COMPLETED|Overall Study||47
205979|NCT00396565|484747|P1|COMPLETED|Overall Study||88
205980|NCT00396565|484745|P3|STARTED|Overall Study||47
205981|NCT00396565|484746|P2|STARTED|Overall Study||138
205982|NCT00396565|484747|P1|STARTED|Overall Study||136
205983|NCT00395876|484772|P2|NOT COMPLETED|Overall Study||0
205984|NCT00395876|484773|P1|NOT COMPLETED|Overall Study||3
205985|NCT00395876|484772|P2|COMPLETED|Overall Study||50
205986|NCT00395876|484773|P1|COMPLETED|Overall Study||47
205987|NCT00395876|484772|P2|STARTED|Overall Study||50
205988|NCT00395876|484773|P1|STARTED|Overall Study||50
205989|NCT00395863|484801|P2|NOT COMPLETED|Overall Study||3
205990|NCT00395863|484802|P1|NOT COMPLETED|Overall Study||2
205991|NCT00395863|484801|P2|COMPLETED|Overall Study||20
205992|NCT00395863|484802|P1|COMPLETED|Overall Study||21
205993|NCT00395863|484801|P2|STARTED|Overall Study||23
205994|NCT00395863|484802|P1|STARTED|Overall Study||23
205995|NCT00395850|484837|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
205996|NCT00395850|484838|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
205997|NCT00395850|484839|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
205998|NCT00395850|484840|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
205999|NCT00395850|484837|P4|COMPLETED|Disulfiram/Placebo Treatment||8
206000|NCT00395850|484838|P3|COMPLETED|Disulfiram/Placebo Treatment||5
206001|NCT00395850|484839|P2|COMPLETED|Disulfiram/Placebo Treatment||9
206002|NCT00395850|484840|P1|COMPLETED|Disulfiram/Placebo Treatment||11
206003|NCT00395850|484837|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
206004|NCT00395850|484838|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
206005|NCT00395850|484839|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
206006|NCT00395850|484840|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
206007|NCT00395850|484837|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
206008|NCT00395850|484838|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
206009|NCT00395850|484839|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
206010|NCT00395850|484840|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
206011|NCT00395850|484837|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
206012|NCT00395850|484838|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
206013|NCT00395850|484839|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
206014|NCT00395850|484840|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
206015|NCT00395850|484837|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
206016|NCT00395850|484838|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
206017|NCT00395850|484839|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
206018|NCT00395850|484840|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
206019|NCT00395850|484837|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
206020|NCT00395850|484838|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
206021|NCT00395850|484839|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
206022|NCT00395850|484840|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
206023|NCT00395850|484837|P4|COMPLETED|Pre-randomization Baseline/Induction||0
206024|NCT00395850|484838|P3|COMPLETED|Pre-randomization Baseline/Induction||0
206025|NCT00395850|484839|P2|COMPLETED|Pre-randomization Baseline/Induction||0
206026|NCT00395850|484840|P1|COMPLETED|Pre-randomization Baseline/Induction||107
206027|NCT00395850|484837|P4|STARTED|Pre-randomization Baseline/Induction||0
206028|NCT00395850|484838|P3|STARTED|Pre-randomization Baseline/Induction||0
206029|NCT00395850|484839|P2|STARTED|Pre-randomization Baseline/Induction||0
206030|NCT00395850|484840|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
206031|NCT00395746|484857|P3|NOT COMPLETED|Overall Study||22
206032|NCT00395746|484858|P2|NOT COMPLETED|Overall Study||4
206033|NCT00395746|484859|P1|NOT COMPLETED|Overall Study||10
206034|NCT00395746|484857|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
206035|NCT00395746|484858|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
206036|NCT00395746|484859|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
206037|NCT00395746|484857|P3|STARTED|Overall Study|Exposed to study drug|88
206038|NCT00395746|484858|P2|STARTED|Overall Study|Exposed to study drug|88
206039|NCT00395746|484859|P1|STARTED|Overall Study|Exposed to study drug|88
206040|NCT00395733|484905|P2|NOT COMPLETED|Period 2||5
206041|NCT00395733|484906|P1|NOT COMPLETED|Period 2||2
206042|NCT00395733|484905|P2|COMPLETED|Period 2||37
206043|NCT00395733|484906|P1|COMPLETED|Period 2||39
206044|NCT00395733|484905|P2|STARTED|Period 2||42
206045|NCT00395733|484906|P1|STARTED|Period 2||41
206046|NCT00395733|484905|P2|NOT COMPLETED|Period 1||0
206047|NCT00395733|484906|P1|NOT COMPLETED|Period 1||0
206048|NCT00395733|484905|P2|COMPLETED|Period 1||42
206049|NCT00395733|484906|P1|COMPLETED|Period 1||41
206050|NCT00395733|484905|P2|STARTED|Period 1||42
206051|NCT00395733|484906|P1|STARTED|Period 1||41
206052|NCT00395694|484930|P2|NOT COMPLETED|Continuation Phase||13
206053|NCT00395694|484931|P1|NOT COMPLETED|Continuation Phase||15
206054|NCT00395694|484930|P2|COMPLETED|Continuation Phase||35
206055|NCT00395694|484931|P1|COMPLETED|Continuation Phase||34
206056|NCT00395694|484930|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
206057|NCT00395694|484931|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
206058|NCT00395694|484930|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
206059|NCT00395694|484931|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
206060|NCT00395694|484930|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
206061|NCT00395694|484931|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
206062|NCT00395694|484930|P2|STARTED|Escalation Phase + Maintenance Phase||51
206063|NCT00395694|484931|P1|STARTED|Escalation Phase + Maintenance Phase||51
206064|NCT00396409|484964|P2|NOT COMPLETED|Period 2 - 2008||2
206065|NCT00396409|484965|P1|NOT COMPLETED|Period 2 - 2008||7
206066|NCT00396409|484964|P2|COMPLETED|Period 2 - 2008||53
206067|NCT00396409|484965|P1|COMPLETED|Period 2 - 2008||52
206068|NCT00396409|484964|P2|STARTED|Period 2 - 2008||55
206069|NCT00396409|484965|P1|STARTED|Period 2 - 2008||59
206070|NCT00396409|484964|P2|NOT COMPLETED|Between Period 1 and Period 2||2
206071|NCT00396409|484965|P1|NOT COMPLETED|Between Period 1 and Period 2||3
206072|NCT00396409|484964|P2|COMPLETED|Between Period 1 and Period 2||55
206073|NCT00396409|484965|P1|COMPLETED|Between Period 1 and Period 2||59
206074|NCT00396409|484964|P2|STARTED|Between Period 1 and Period 2||57
206075|NCT00396409|484965|P1|STARTED|Between Period 1 and Period 2||62
206076|NCT00396409|484964|P2|NOT COMPLETED|Period 1 - 2007||6
206077|NCT00396409|484965|P1|NOT COMPLETED|Period 1 - 2007||3
206078|NCT00396409|484964|P2|COMPLETED|Period 1 - 2007||57
206079|NCT00396409|484965|P1|COMPLETED|Period 1 - 2007||62
206080|NCT00396409|484964|P2|STARTED|Period 1 - 2007||63
206081|NCT00396409|484965|P1|STARTED|Period 1 - 2007||65
206082|NCT00396383|484995|P1|NOT COMPLETED|Overall Study||3
206083|NCT00396383|484995|P1|COMPLETED|Overall Study||6
206084|NCT00396383|484995|P1|STARTED|Overall Study||9
206085|NCT00396331|485008|P1|NOT COMPLETED|Overall Study||32
206086|NCT00396331|485008|P1|COMPLETED|Overall Study||68
206087|NCT00396331|485008|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
206088|NCT00396331|485008|P1|Number of Participants Treated|Overall Study||100
206089|NCT00396331|485008|P1|STARTED|Overall Study||100
206090|NCT00396318|485061|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
206091|NCT00396318|485061|P1|COMPLETED|7-Day Post-Treatment Contact||240
206092|NCT00396318|485061|P1|STARTED|7-Day Post-Treatment Contact||241
206093|NCT00396318|485061|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
206094|NCT00396318|485061|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
206095|NCT00396318|485061|P1|STARTED|48- to 96-Hour Follow-Up Period||246
206096|NCT00396318|485061|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
206097|NCT00396318|485061|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
206098|NCT00396318|485061|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
206099|NCT00396292|485074|P2|NOT COMPLETED|Overall Study||16
206100|NCT00396292|485075|P1|NOT COMPLETED|Overall Study||9
206101|NCT00396292|485074|P2|COMPLETED|Overall Study||162
206102|NCT00396292|485075|P1|COMPLETED|Overall Study||165
206103|NCT00396292|485074|P2|STARTED|Overall Study||178
206104|NCT00396292|485075|P1|STARTED|Overall Study||174
206105|NCT00396279|485081|P1|NOT COMPLETED|Overall Study||30
206106|NCT00396279|485081|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
206107|NCT00396279|485081|P1|STARTED|Overall Study||37
206108|NCT00396266|485092|P2|NOT COMPLETED|Overall Study||0
206109|NCT00396266|485093|P1|NOT COMPLETED|Overall Study||0
206110|NCT00396266|485092|P2|COMPLETED|Overall Study||14
206111|NCT00396266|485093|P1|COMPLETED|Overall Study||8
206112|NCT00396266|485092|P2|STARTED|Overall Study||14
206113|NCT00396266|485093|P1|STARTED|Overall Study||8
206114|NCT00396253|485114|P1|NOT COMPLETED|Overall Study||13
206115|NCT00396253|485114|P1|COMPLETED|Overall Study||210
206116|NCT00396253|485114|P1|STARTED|Overall Study||223
206117|NCT00396201|485126|P1|NOT COMPLETED|Follow-up Period||0
206118|NCT00396201|485126|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
206119|NCT00396201|485126|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
206120|NCT00396201|485126|P1|NOT COMPLETED|Treatment Period||0
206121|NCT00396201|485126|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
206122|NCT00396201|485126|P1|STARTED|Treatment Period||22
206123|NCT00396162|485145|P2|NOT COMPLETED|Overall Study||3
206124|NCT00396162|485146|P1|NOT COMPLETED|Overall Study||2
206125|NCT00396162|485145|P2|COMPLETED|Overall Study||35
206126|NCT00396162|485146|P1|COMPLETED|Overall Study||37
206127|NCT00396162|485145|P2|STARTED|Overall Study||38
206128|NCT00396162|485146|P1|STARTED|Overall Study||39
206129|NCT00396136|485158|P1|NOT COMPLETED|Overall Study||125
206130|NCT00396136|485158|P1|COMPLETED|Overall Study||96
206131|NCT00396136|485158|P1|STARTED|Overall Study||221
206132|NCT00396097|485165|P2|NOT COMPLETED|Overall Study||46
206133|NCT00396097|485166|P1|NOT COMPLETED|Overall Study||26
206134|NCT00396097|485165|P2|COMPLETED|Overall Study||156
206135|NCT00396097|485166|P1|COMPLETED|Overall Study||88
206136|NCT00396097|485165|P2|STARTED|Overall Study||202
206137|NCT00396097|485166|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
206138|NCT00396084|485194|P6|NOT COMPLETED|Overall Study||2
206139|NCT00396084|485195|P5|NOT COMPLETED|Overall Study||1
206140|NCT00396084|485196|P4|NOT COMPLETED|Overall Study||1
206141|NCT00396084|485197|P3|NOT COMPLETED|Overall Study||0
206142|NCT00396084|485198|P2|NOT COMPLETED|Overall Study||0
206143|NCT00396084|485199|P1|NOT COMPLETED|Overall Study||0
206144|NCT00396084|485194|P6|COMPLETED|Overall Study||18
206145|NCT00396084|485195|P5|COMPLETED|Overall Study||9
206146|NCT00396084|485196|P4|COMPLETED|Overall Study||9
206147|NCT00396084|485197|P3|COMPLETED|Overall Study||10
206148|NCT00396084|485198|P2|COMPLETED|Overall Study||10
206149|NCT00396084|485199|P1|COMPLETED|Overall Study||10
206150|NCT00396084|485194|P6|STARTED|Overall Study||20
206151|NCT00396084|485195|P5|STARTED|Overall Study||10
206152|NCT00396084|485196|P4|STARTED|Overall Study||10
206153|NCT00396084|485197|P3|STARTED|Overall Study||10
206154|NCT00396084|485198|P2|STARTED|Overall Study||10
206155|NCT00396084|485199|P1|STARTED|Overall Study||10
206156|NCT00396032|485274|P2|NOT COMPLETED|Overall Study||5
206157|NCT00396032|485275|P1|NOT COMPLETED|Overall Study||4
206158|NCT00396032|485274|P2|COMPLETED|Overall Study||71
206159|NCT00396032|485275|P1|COMPLETED|Overall Study||70
206160|NCT00396032|485274|P2|STARTED|Overall Study||76
206161|NCT00396032|485275|P1|STARTED|Overall Study||74
206162|NCT00396006|485289|P1|NOT COMPLETED|Overall Study||0
206163|NCT00396006|485289|P1|COMPLETED|Overall Study||13
206164|NCT00396006|485289|P1|STARTED|Overall Study||13
206165|NCT00395993|485306|P2|NOT COMPLETED|Overall Study||19
206166|NCT00395993|485307|P1|NOT COMPLETED|Overall Study||35
206167|NCT00395993|485306|P2|COMPLETED|Overall Study||212
206168|NCT00395993|485307|P1|COMPLETED|Overall Study||211
206169|NCT00395993|485306|P2|STARTED|Overall Study||231
206170|NCT00395993|485307|P1|STARTED|Overall Study||246
206171|NCT00395967|485313|P1|NOT COMPLETED|Follow-up Period||2
206172|NCT00395967|485313|P1|COMPLETED|Follow-up Period||3
206173|NCT00395967|485313|P1|STARTED|Follow-up Period|Participants who had transplants.|5
206174|NCT00395967|485313|P1|NOT COMPLETED|Treatment Period||1
206175|NCT00395967|485313|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
206176|NCT00395967|485313|P1|STARTED|Treatment Period||5
206177|NCT00395642|485322|P1|NOT COMPLETED|Overall Study||13
206178|NCT00395642|485322|P1|COMPLETED|Overall Study||53
206179|NCT00395642|485322|P1|STARTED|Overall Study||66
206180|NCT00395629|485329|P3|NOT COMPLETED|Extension Study||3
206181|NCT00395629|485330|P2|NOT COMPLETED|Extension Study||0
206182|NCT00395629|485331|P1|NOT COMPLETED|Extension Study||0
206183|NCT00395629|485329|P3|COMPLETED|Extension Study||8
206184|NCT00395629|485330|P2|COMPLETED|Extension Study||6
206185|NCT00395629|485331|P1|COMPLETED|Extension Study||9
206186|NCT00395629|485329|P3|STARTED|Extension Study||11
206187|NCT00395629|485330|P2|STARTED|Extension Study||6
206188|NCT00395629|485331|P1|STARTED|Extension Study||9
206189|NCT00395629|485329|P3|NOT COMPLETED|Core Study||7
206190|NCT00395629|485330|P2|NOT COMPLETED|Core Study||4
206191|NCT00395629|485331|P1|NOT COMPLETED|Core Study||1
206192|NCT00395629|485329|P3|COMPLETED|Core Study||16
206193|NCT00395629|485330|P2|COMPLETED|Core Study||11
206194|NCT00395629|485331|P1|COMPLETED|Core Study||10
206195|NCT00395629|485329|P3|STARTED|Core Study||23
206196|NCT00395629|485330|P2|STARTED|Core Study||15
206197|NCT00395629|485331|P1|STARTED|Core Study||11
206198|NCT00395512|485349|P4|NOT COMPLETED|Overall Study||38
206199|NCT00395512|485350|P3|NOT COMPLETED|Overall Study||28
206200|NCT00395512|485351|P2|NOT COMPLETED|Overall Study||37
206201|NCT00395512|485352|P1|NOT COMPLETED|Overall Study||38
206202|NCT00395512|485349|P4|COMPLETED|Overall Study||126
206203|NCT00395512|485350|P3|COMPLETED|Overall Study||136
206204|NCT00395512|485351|P2|COMPLETED|Overall Study||126
206205|NCT00395512|485352|P1|COMPLETED|Overall Study||126
206206|NCT00395512|485349|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
206207|NCT00395512|485350|P3|Safety Set|Overall Study||164
206208|NCT00395512|485351|P2|Safety Set|Overall Study||163
206209|NCT00395512|485352|P1|Safety Set|Overall Study||164
206210|NCT00395512|485349|P4|STARTED|Overall Study||164
206211|NCT00395512|485350|P3|STARTED|Overall Study||164
206212|NCT00395512|485351|P2|STARTED|Overall Study||163
206213|NCT00395512|485352|P1|STARTED|Overall Study||164
206214|NCT00395486|485524|P2|NOT COMPLETED|Overall Study||5
206215|NCT00395486|485525|P1|NOT COMPLETED|Overall Study||6
206216|NCT00395486|485524|P2|COMPLETED|Overall Study|Completed subjects|121
206217|NCT00395486|485525|P1|COMPLETED|Overall Study|Completed subjects|126
206218|NCT00395486|485524|P2|STARTED|Overall Study|Randomized subjects|126
206219|NCT00395486|485525|P1|STARTED|Overall Study|Randomized subjects|132
206220|NCT00395460|485555|P2|NOT COMPLETED|Overall Study||0
206221|NCT00395460|485556|P1|NOT COMPLETED|Overall Study||1
206222|NCT00395460|485555|P2|COMPLETED|Overall Study||75
206223|NCT00395460|485556|P1|COMPLETED|Overall Study||71
206224|NCT00395460|485555|P2|Received Treatment|Overall Study||75
206225|NCT00395460|485556|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
206226|NCT00395460|485555|P2|STARTED|Overall Study||75
206227|NCT00395460|485556|P1|STARTED|Overall Study||72
206228|NCT00395447|485580|P2|NOT COMPLETED|Overall Study||111
206229|NCT00395447|485581|P1|NOT COMPLETED|Overall Study||121
206230|NCT00395447|485580|P2|COMPLETED|Overall Study||602
206231|NCT00395447|485581|P1|COMPLETED|Overall Study||910
206232|NCT00395447|485580|P2|STARTED|Overall Study||713
206233|NCT00395447|485581|P1|STARTED|Overall Study||1031
206234|NCT00395343|485589|P2|NOT COMPLETED|Overall Study||36
206235|NCT00395343|485590|P1|NOT COMPLETED|Overall Study||41
206236|NCT00395343|485589|P2|COMPLETED|Overall Study||283
206237|NCT00395343|485590|P1|COMPLETED|Overall Study||281
206238|NCT00395343|485589|P2|STARTED|Overall Study||319
206239|NCT00395343|485590|P1|STARTED|Overall Study||322
206240|NCT00395304|485608|P6|NOT COMPLETED|Treatment Period 3||1
206241|NCT00395304|485609|P5|NOT COMPLETED|Treatment Period 3||0
206242|NCT00395304|485610|P4|NOT COMPLETED|Treatment Period 3||2
206243|NCT00395304|485611|P3|NOT COMPLETED|Treatment Period 3||0
206244|NCT00395304|485612|P2|NOT COMPLETED|Treatment Period 3||2
206245|NCT00395304|485613|P1|NOT COMPLETED|Treatment Period 3||1
206246|NCT00395304|485608|P6|COMPLETED|Treatment Period 3||27
206247|NCT00395304|485609|P5|COMPLETED|Treatment Period 3||27
206248|NCT00395304|485610|P4|COMPLETED|Treatment Period 3||25
206249|NCT00395304|485611|P3|COMPLETED|Treatment Period 3||29
206250|NCT00395304|485612|P2|COMPLETED|Treatment Period 3||20
206251|NCT00395304|485613|P1|COMPLETED|Treatment Period 3||29
206252|NCT00395304|485608|P6|STARTED|Treatment Period 3||28
206253|NCT00395304|485609|P5|STARTED|Treatment Period 3||27
206254|NCT00395304|485610|P4|STARTED|Treatment Period 3||27
206255|NCT00395304|485611|P3|STARTED|Treatment Period 3||29
206256|NCT00395304|485612|P2|STARTED|Treatment Period 3||22
206257|NCT00395304|485613|P1|STARTED|Treatment Period 3||30
206258|NCT00395304|485608|P6|NOT COMPLETED|Treatment Period 2||2
206259|NCT00395304|485609|P5|NOT COMPLETED|Treatment Period 2||0
206260|NCT00395304|485610|P4|NOT COMPLETED|Treatment Period 2||1
206261|NCT00395304|485611|P3|NOT COMPLETED|Treatment Period 2||1
206262|NCT00395304|485612|P2|NOT COMPLETED|Treatment Period 2||4
206263|NCT00395304|485613|P1|NOT COMPLETED|Treatment Period 2||0
206264|NCT00395304|485608|P6|COMPLETED|Treatment Period 2||28
206265|NCT00395304|485609|P5|COMPLETED|Treatment Period 2||27
206266|NCT00395304|485610|P4|COMPLETED|Treatment Period 2||27
206267|NCT00395304|485611|P3|COMPLETED|Treatment Period 2||29
206268|NCT00395304|485612|P2|COMPLETED|Treatment Period 2||22
206269|NCT00395304|485613|P1|COMPLETED|Treatment Period 2||30
206270|NCT00395304|485608|P6|STARTED|Treatment Period 2||30
206271|NCT00395304|485609|P5|STARTED|Treatment Period 2||27
206272|NCT00395304|485610|P4|STARTED|Treatment Period 2||28
206273|NCT00395304|485611|P3|STARTED|Treatment Period 2||30
206274|NCT00395304|485612|P2|STARTED|Treatment Period 2||26
206275|NCT00395304|485613|P1|STARTED|Treatment Period 2||30
206276|NCT00395304|485608|P6|NOT COMPLETED|Treatment Period 1||2
206277|NCT00395304|485609|P5|NOT COMPLETED|Treatment Period 1||1
206278|NCT00395304|485610|P4|NOT COMPLETED|Treatment Period 1||3
206279|NCT00395304|485611|P3|NOT COMPLETED|Treatment Period 1||0
206280|NCT00395304|485612|P2|NOT COMPLETED|Treatment Period 1||4
206281|NCT00395304|485613|P1|NOT COMPLETED|Treatment Period 1||1
206282|NCT00395304|485608|P6|COMPLETED|Treatment Period 1||30
206283|NCT00395304|485609|P5|COMPLETED|Treatment Period 1||27
206284|NCT00395304|485610|P4|COMPLETED|Treatment Period 1||28
206285|NCT00395304|485611|P3|COMPLETED|Treatment Period 1||30
206286|NCT00395304|485612|P2|COMPLETED|Treatment Period 1||26
206287|NCT00395304|485613|P1|COMPLETED|Treatment Period 1||30
206288|NCT00395304|485608|P6|STARTED|Treatment Period 1||32
206289|NCT00395304|485609|P5|STARTED|Treatment Period 1||28
206290|NCT00395304|485610|P4|STARTED|Treatment Period 1||31
206291|NCT00395304|485611|P3|STARTED|Treatment Period 1||30
206292|NCT00395304|485612|P2|STARTED|Treatment Period 1||30
206293|NCT00395304|485613|P1|STARTED|Treatment Period 1||31
206294|NCT00395291|485617|P2|NOT COMPLETED|Second Intervention||0
206295|NCT00395291|485618|P1|NOT COMPLETED|Second Intervention||0
206296|NCT00395291|485617|P2|COMPLETED|Second Intervention||9
206297|NCT00395291|485618|P1|COMPLETED|Second Intervention||13
206298|NCT00395291|485617|P2|STARTED|Second Intervention||9
206299|NCT00395291|485618|P1|STARTED|Second Intervention||13
206300|NCT00395291|485617|P2|NOT COMPLETED|Washout Period for 30 Days||0
206301|NCT00395291|485618|P1|NOT COMPLETED|Washout Period for 30 Days||2
206302|NCT00395291|485617|P2|COMPLETED|Washout Period for 30 Days||9
206303|NCT00395291|485618|P1|COMPLETED|Washout Period for 30 Days||13
206304|NCT00395291|485617|P2|STARTED|Washout Period for 30 Days||9
206305|NCT00395291|485618|P1|STARTED|Washout Period for 30 Days||15
206306|NCT00395291|485617|P2|NOT COMPLETED|First Intervention||0
206307|NCT00395291|485618|P1|NOT COMPLETED|First Intervention||2
206308|NCT00395291|485617|P2|COMPLETED|First Intervention||9
206309|NCT00395291|485618|P1|COMPLETED|First Intervention||15
206310|NCT00395291|485617|P2|STARTED|First Intervention||9
206311|NCT00395291|485618|P1|STARTED|First Intervention||17
206312|NCT00395226|485650|P2|NOT COMPLETED|Overall Study||5
206313|NCT00395226|485651|P1|NOT COMPLETED|Overall Study||4
206314|NCT00395226|485650|P2|COMPLETED|Overall Study||22
206315|NCT00395226|485651|P1|COMPLETED|Overall Study||22
206316|NCT00395226|485650|P2|STARTED|Overall Study||27
206317|NCT00395226|485651|P1|STARTED|Overall Study||26
206318|NCT00395161|485659|P2|NOT COMPLETED|Overall Study||0
206319|NCT00395161|485660|P1|NOT COMPLETED|Overall Study||0
206320|NCT00395161|485659|P2|COMPLETED|Overall Study||144
206321|NCT00395161|485660|P1|COMPLETED|Overall Study||149
206322|NCT00395161|485659|P2|STARTED|Overall Study||144
206323|NCT00395161|485660|P1|STARTED|Overall Study||149
206324|NCT00395135|485676|P5|NOT COMPLETED|Year 2||190
206325|NCT00395135|485677|P4|NOT COMPLETED|Year 2||88
206326|NCT00395135|485678|P3|NOT COMPLETED|Year 2||147
206327|NCT00395135|485679|P2|NOT COMPLETED|Year 2||0
206328|NCT00395135|485680|P1|NOT COMPLETED|Year 2||0
206329|NCT00395135|485676|P5|COMPLETED|Year 2||507
206330|NCT00395135|485677|P4|COMPLETED|Year 2||195
206331|NCT00395135|485678|P3|COMPLETED|Year 2||426
206332|NCT00395135|485679|P2|COMPLETED|Year 2||0
206333|NCT00395135|485680|P1|COMPLETED|Year 2||0
206334|NCT00395135|485676|P5|STARTED|Year 2||697
206335|NCT00395135|485677|P4|STARTED|Year 2||283
206336|NCT00395135|485678|P3|STARTED|Year 2||573
206337|NCT00395135|485679|P2|STARTED|Year 2||0
206338|NCT00395135|485680|P1|STARTED|Year 2||0
206339|NCT00395135|485676|P5|NOT COMPLETED|Year 1||0
206340|NCT00395135|485677|P4|NOT COMPLETED|Year 1||0
206341|NCT00395135|485678|P3|NOT COMPLETED|Year 1||0
206342|NCT00395135|485679|P2|NOT COMPLETED|Year 1||871
206343|NCT00395135|485680|P1|NOT COMPLETED|Year 1||712
206344|NCT00395135|485676|P5|COMPLETED|Year 1||0
206345|NCT00395135|485677|P4|COMPLETED|Year 1||0
206346|NCT00395135|485678|P3|COMPLETED|Year 1||0
206347|NCT00395135|485679|P2|COMPLETED|Year 1||716
206348|NCT00395135|485680|P1|COMPLETED|Year 1||883
206349|NCT00395135|485676|P5|STARTED|Year 1||0
206350|NCT00395135|485677|P4|STARTED|Year 1||0
206351|NCT00395135|485678|P3|STARTED|Year 1||0
206352|NCT00395135|485679|P2|STARTED|Year 1||1587
206353|NCT00395135|485680|P1|STARTED|Year 1||1595
206354|NCT00395083|485698|P2|NOT COMPLETED|Overall Study||8
206355|NCT00395083|485699|P1|NOT COMPLETED|Overall Study||10
206356|NCT00395083|485698|P2|COMPLETED|Overall Study||201
206357|NCT00395083|485699|P1|COMPLETED|Overall Study||207
206358|NCT00395083|485698|P2|STARTED|Overall Study||209
206359|NCT00395083|485699|P1|STARTED|Overall Study||217
206360|NCT00395057|485715|P4|NOT COMPLETED|Overall Study||33
206361|NCT00395057|485716|P3|NOT COMPLETED|Overall Study||33
206362|NCT00395057|485717|P2|NOT COMPLETED|Overall Study||34
206363|NCT00395057|485718|P1|NOT COMPLETED|Overall Study||32
206364|NCT00395057|485715|P4|COMPLETED|Overall Study||1
206365|NCT00395057|485716|P3|COMPLETED|Overall Study||2
206366|NCT00395057|485717|P2|COMPLETED|Overall Study||1
206367|NCT00395057|485718|P1|COMPLETED|Overall Study||2
206368|NCT00395057|485715|P4|STARTED|Overall Study||34
206369|NCT00395057|485716|P3|STARTED|Overall Study||35
206370|NCT00395057|485717|P2|STARTED|Overall Study||35
206371|NCT00395057|485718|P1|STARTED|Overall Study||34
206372|NCT00395044|485746|P2|NOT COMPLETED|Overall Study||14
206373|NCT00395044|485747|P1|NOT COMPLETED|Overall Study||18
206374|NCT00395044|485746|P2|COMPLETED|Overall Study||11
206375|NCT00395044|485747|P1|COMPLETED|Overall Study||7
206376|NCT00395044|485746|P2|STARTED|Overall Study||25
206377|NCT00395044|485747|P1|STARTED|Overall Study||25
206378|NCT00395018|485765|P1|NOT COMPLETED|Off-Treatment Follow-up||4
206379|NCT00395018|485765|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
206380|NCT00395018|485765|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
206381|NCT00395018|485765|P1|NOT COMPLETED|On-Treatment||10
206382|NCT00395018|485765|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
206383|NCT00395018|485765|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
206384|NCT00395018|485765|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
206385|NCT00395018|485765|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
206386|NCT00394953|485786|P2|NOT COMPLETED|Second Treatment Period||74
206387|NCT00394953|485787|P1|NOT COMPLETED|Second Treatment Period||29
206388|NCT00394953|485786|P2|COMPLETED|Second Treatment Period||148
206389|NCT00394953|485787|P1|COMPLETED|Second Treatment Period||187
206390|NCT00394953|485786|P2|STARTED|Second Treatment Period||222
206391|NCT00394953|485787|P1|STARTED|Second Treatment Period||216
206392|NCT00394953|485786|P2|NOT COMPLETED|First Treatment Period||22
206393|NCT00394953|485787|P1|NOT COMPLETED|First Treatment Period||29
206394|NCT00394953|485786|P2|COMPLETED|First Treatment Period||222
206395|NCT00394953|485787|P1|COMPLETED|First Treatment Period||216
206396|NCT00394953|485786|P2|STARTED|First Treatment Period||244
206397|NCT00394953|485787|P1|STARTED|First Treatment Period||245
206398|NCT00394914|485805|P3|NOT COMPLETED|Treatment Period||6
206399|NCT00394914|485806|P2|NOT COMPLETED|Treatment Period||10
206400|NCT00394914|485807|P1|NOT COMPLETED|Treatment Period||0
206401|NCT00394914|485805|P3|COMPLETED|Treatment Period||151
206402|NCT00394914|485806|P2|COMPLETED|Treatment Period||144
206403|NCT00394914|485807|P1|COMPLETED|Treatment Period||0
206404|NCT00394914|485805|P3|STARTED|Treatment Period||157
206405|NCT00394914|485806|P2|STARTED|Treatment Period||154
206406|NCT00394914|485807|P1|STARTED|Treatment Period||0
206407|NCT00394914|485805|P3|NOT COMPLETED|Pre-exposure Period||0
206408|NCT00394914|485806|P2|NOT COMPLETED|Pre-exposure Period||0
206409|NCT00394914|485807|P1|NOT COMPLETED|Pre-exposure Period||0
206410|NCT00394914|485805|P3|COMPLETED|Pre-exposure Period||0
206411|NCT00394914|485806|P2|COMPLETED|Pre-exposure Period||0
206412|NCT00394914|485807|P1|COMPLETED|Pre-exposure Period||311
206413|NCT00394914|485805|P3|STARTED|Pre-exposure Period||0
206414|NCT00394914|485806|P2|STARTED|Pre-exposure Period||0
206415|NCT00394914|485807|P1|STARTED|Pre-exposure Period||311
206416|NCT00394914|485805|P3|NOT COMPLETED|Screening Period||0
206417|NCT00394914|485806|P2|NOT COMPLETED|Screening Period||0
206418|NCT00394914|485807|P1|NOT COMPLETED|Screening Period||0
206419|NCT00394914|485805|P3|COMPLETED|Screening Period||0
206420|NCT00394914|485806|P2|COMPLETED|Screening Period||0
206421|NCT00394914|485807|P1|COMPLETED|Screening Period||311
206422|NCT00394914|485805|P3|STARTED|Screening Period||0
206423|NCT00394914|485806|P2|STARTED|Screening Period||0
206424|NCT00394914|485807|P1|STARTED|Screening Period||311
206425|NCT00394901|485835|P4|NOT COMPLETED|Double-blind Phase||27
206426|NCT00394901|485836|P3|NOT COMPLETED|Double-blind Phase||18
206427|NCT00394901|485837|P2|NOT COMPLETED|Double-blind Phase||14
206428|NCT00394901|485838|P1|NOT COMPLETED|Double-blind Phase||15
206429|NCT00394901|485835|P4|COMPLETED|Double-blind Phase||70
206430|NCT00394901|485836|P3|COMPLETED|Double-blind Phase||71
206431|NCT00394901|485837|P2|COMPLETED|Double-blind Phase||73
206432|NCT00394901|485838|P1|COMPLETED|Double-blind Phase||83
206433|NCT00394901|485835|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
206434|NCT00394901|485836|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
206435|NCT00394901|485837|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
206436|NCT00394901|485838|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
206437|NCT00394901|485835|P4|NOT COMPLETED|Baseline Phase||0
206438|NCT00394901|485836|P3|NOT COMPLETED|Baseline Phase||1
206439|NCT00394901|485837|P2|NOT COMPLETED|Baseline Phase||0
206440|NCT00394901|485838|P1|NOT COMPLETED|Baseline Phase||0
206441|NCT00394901|485835|P4|COMPLETED|Baseline Phase||97
206442|NCT00394901|485836|P3|COMPLETED|Baseline Phase||89
206443|NCT00394901|485837|P2|COMPLETED|Baseline Phase||87
206444|NCT00394901|485838|P1|COMPLETED|Baseline Phase||98
206445|NCT00394901|485835|P4|STARTED|Baseline Phase|Subjects randomized|97
206446|NCT00394901|485836|P3|STARTED|Baseline Phase|Subjects randomized|90
206447|NCT00394901|485837|P2|STARTED|Baseline Phase|Subjects randomized|87
206448|NCT00394901|485838|P1|STARTED|Baseline Phase|Subjects randomized|98
206449|NCT00394888|486066|P3|NOT COMPLETED|Overall Study||0
206450|NCT00394888|486067|P2|NOT COMPLETED|Overall Study||0
206451|NCT00394888|486068|P1|NOT COMPLETED|Overall Study||0
206452|NCT00394888|486066|P3|COMPLETED|Overall Study||201
206453|NCT00394888|486067|P2|COMPLETED|Overall Study||48
206454|NCT00394888|486068|P1|COMPLETED|Overall Study||108
206455|NCT00394888|486066|P3|STARTED|Overall Study||201
206456|NCT00394888|486067|P2|STARTED|Overall Study||48
206457|NCT00394888|486068|P1|STARTED|Overall Study||108
206458|NCT00394836|486081|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
206459|NCT00394836|486082|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
206460|NCT00394836|486081|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
206461|NCT00394836|486082|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
206462|NCT00394836|486081|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
206463|NCT00394836|486082|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
206464|NCT00394836|486081|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
206465|NCT00394836|486082|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
206466|NCT00394836|486081|P2|COMPLETED|Teatment or Follow-up Phase||8
206467|NCT00394836|486082|P1|COMPLETED|Teatment or Follow-up Phase||2
206468|NCT00394836|486081|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
206469|NCT00394836|486082|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
206470|NCT00394836|486081|P2|STARTED|Teatment or Follow-up Phase||86
206471|NCT00394836|486082|P1|STARTED|Teatment or Follow-up Phase||30
206472|NCT00394771|486128|P4|NOT COMPLETED|Overall Study||39
206473|NCT00394771|486129|P3|NOT COMPLETED|Overall Study||47
206474|NCT00394771|486130|P2|NOT COMPLETED|Overall Study||34
206475|NCT00394771|486131|P1|NOT COMPLETED|Overall Study||41
206476|NCT00394771|486128|P4|COMPLETED|Overall Study||109
206477|NCT00394771|486129|P3|COMPLETED|Overall Study||96
206478|NCT00394771|486130|P2|COMPLETED|Overall Study||102
206479|NCT00394771|486131|P1|COMPLETED|Overall Study||99
206480|NCT00394771|486128|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
206481|NCT00394771|486129|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
206482|NCT00394771|486130|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
206483|NCT00394771|486131|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
206484|NCT00394771|486128|P4|STARTED|Overall Study|Safety population of treated participants|148
206485|NCT00394771|486129|P3|STARTED|Overall Study|Safety population of treated participants|143
206486|NCT00394771|486130|P2|STARTED|Overall Study|Safety population of treated participants|136
206487|NCT00394771|486131|P1|STARTED|Overall Study|Safety population of treated participants|140
206488|NCT00394706|486201|P8|NOT COMPLETED|Overall Study||0
206489|NCT00394706|486202|P7|NOT COMPLETED|Overall Study||3
206490|NCT00394706|486203|P6|NOT COMPLETED|Overall Study||7
206491|NCT00394706|486204|P5|NOT COMPLETED|Overall Study||2
206492|NCT00394706|486205|P4|NOT COMPLETED|Overall Study||1
206493|NCT00394706|486206|P3|NOT COMPLETED|Overall Study||9
206494|NCT00394706|486207|P2|NOT COMPLETED|Overall Study||2
206495|NCT00394706|486208|P1|NOT COMPLETED|Overall Study||4
206496|NCT00394706|486201|P8|COMPLETED|Overall Study||851
206497|NCT00394706|486202|P7|COMPLETED|Overall Study||926
206498|NCT00394706|486203|P6|COMPLETED|Overall Study||1377
206499|NCT00394706|486204|P5|COMPLETED|Overall Study||1634
206500|NCT00394706|486205|P4|COMPLETED|Overall Study||1632
206501|NCT00394706|486206|P3|COMPLETED|Overall Study||1615
206502|NCT00394706|486207|P2|COMPLETED|Overall Study||1860
206503|NCT00394706|486208|P1|COMPLETED|Overall Study||1815
206504|NCT00394706|486201|P8|STARTED|Overall Study||851
206505|NCT00394706|486202|P7|STARTED|Overall Study||929
206506|NCT00394706|486203|P6|STARTED|Overall Study||1384
206507|NCT00394706|486204|P5|STARTED|Overall Study||1636
206508|NCT00394706|486205|P4|STARTED|Overall Study||1633
206509|NCT00394706|486206|P3|STARTED|Overall Study||1624
206510|NCT00394706|486207|P2|STARTED|Overall Study||1862
206511|NCT00394706|486208|P1|STARTED|Overall Study||1819
206512|NCT00394654|486228|P2|NOT COMPLETED|Overall Study||0
206513|NCT00394654|486229|P1|NOT COMPLETED|Overall Study||2
206514|NCT00394654|486228|P2|COMPLETED|Overall Study||15
206515|NCT00394654|486229|P1|COMPLETED|Overall Study||13
206516|NCT00394654|486228|P2|STARTED|Overall Study||15
206517|NCT00394654|486229|P1|STARTED|Overall Study||15
206518|NCT00394589|486294|P3|NOT COMPLETED|Overall Study||7
206519|NCT00394589|486295|P2|NOT COMPLETED|Overall Study||3
206520|NCT00394589|486296|P1|NOT COMPLETED|Overall Study||8
206521|NCT00394589|486294|P3|COMPLETED|Overall Study||11
206522|NCT00394589|486295|P2|COMPLETED|Overall Study||8
206523|NCT00394589|486296|P1|COMPLETED|Overall Study||6
206524|NCT00394589|486294|P3|STARTED|Overall Study||18
206525|NCT00394589|486295|P2|STARTED|Overall Study||11
206526|NCT00394589|486296|P1|STARTED|Overall Study||14
206527|NCT00394524|486306|P2|NOT COMPLETED|Overall Study||10
206528|NCT00394524|486307|P1|NOT COMPLETED|Overall Study||11
206529|NCT00394524|486306|P2|COMPLETED|Overall Study||68
206530|NCT00394524|486307|P1|COMPLETED|Overall Study||68
206531|NCT00394524|486306|P2|STARTED|Overall Study||78
206532|NCT00394524|486307|P1|STARTED|Overall Study||79
206533|NCT00394472|486319|P2|NOT COMPLETED|Overall Study||11
206534|NCT00394472|486320|P1|NOT COMPLETED|Overall Study||9
206535|NCT00394472|486319|P2|COMPLETED|Overall Study||111
206536|NCT00394472|486320|P1|COMPLETED|Overall Study||113
206537|NCT00394472|486319|P2|STARTED|Overall Study||122
206538|NCT00394472|486320|P1|STARTED|Overall Study||122
206539|NCT00394433|486328|P1|NOT COMPLETED|Overall Study||3
206540|NCT00394433|486328|P1|COMPLETED|Overall Study||35
206541|NCT00394433|486328|P1|Evaluable and Treated|Overall Study||35
206542|NCT00394433|486328|P1|STARTED|Overall Study||38
206543|NCT00394355|486339|P4|NOT COMPLETED|Overall Study||31
206544|NCT00394355|486340|P3|NOT COMPLETED|Overall Study||38
206545|NCT00394355|486341|P2|NOT COMPLETED|Overall Study||34
206546|NCT00394355|486342|P1|NOT COMPLETED|Overall Study||35
206547|NCT00394355|486339|P4|COMPLETED|Overall Study||111
206548|NCT00394355|486340|P3|COMPLETED|Overall Study||109
206549|NCT00394355|486341|P2|COMPLETED|Overall Study||103
206550|NCT00394355|486342|P1|COMPLETED|Overall Study||105
206551|NCT00394355|486339|P4|STARTED|Overall Study||142
206552|NCT00394355|486340|P3|STARTED|Overall Study||147
206553|NCT00394355|486341|P2|STARTED|Overall Study||137
206554|NCT00394355|486342|P1|STARTED|Overall Study||140
206555|NCT00394329|486368|P4|NOT COMPLETED|Overall Study||24
206556|NCT00394329|486369|P3|NOT COMPLETED|Overall Study||13
206557|NCT00394329|486370|P2|NOT COMPLETED|Overall Study||9
206558|NCT00394329|486371|P1|NOT COMPLETED|Overall Study||8
206559|NCT00394329|486368|P4|COMPLETED|Overall Study||50
206560|NCT00394329|486369|P3|COMPLETED|Overall Study||58
206561|NCT00394329|486370|P2|COMPLETED|Overall Study||63
206562|NCT00394329|486371|P1|COMPLETED|Overall Study||63
206563|NCT00394329|486368|P4|STARTED|Overall Study||74
206564|NCT00394329|486369|P3|STARTED|Overall Study||71
206565|NCT00394329|486370|P2|STARTED|Overall Study||72
206566|NCT00394329|486371|P1|STARTED|Overall Study||71
206567|NCT00394277|486385|P4|NOT COMPLETED|Overall Study||125
206568|NCT00394277|486386|P3|NOT COMPLETED|Overall Study||120
206569|NCT00394277|486387|P2|NOT COMPLETED|Overall Study||60
206570|NCT00394277|486388|P1|NOT COMPLETED|Overall Study||58
206571|NCT00394277|486385|P4|COMPLETED|Overall Study||266
206572|NCT00394277|486386|P3|COMPLETED|Overall Study||273
206573|NCT00394277|486387|P2|COMPLETED|Overall Study||136
206574|NCT00394277|486388|P1|COMPLETED|Overall Study||137
206575|NCT00394277|486385|P4|STARTED|Overall Study||391
206576|NCT00394277|486386|P3|STARTED|Overall Study||393
206577|NCT00394277|486387|P2|STARTED|Overall Study||196
206578|NCT00394277|486388|P1|STARTED|Overall Study||195
206579|NCT00394251|486412|P2|NOT COMPLETED|Overall Study||38
206580|NCT00394251|486413|P1|NOT COMPLETED|Overall Study||37
206581|NCT00394251|486412|P2|COMPLETED|Overall Study||61
206582|NCT00394251|486413|P1|COMPLETED|Overall Study||61
206583|NCT00394251|486412|P2|At Least One Dose of Taxane|Overall Study||93
206584|NCT00394251|486413|P1|At Least One Dose of Taxane|Overall Study||93
206585|NCT00394251|486412|P2|STARTED|Overall Study||99
206586|NCT00394251|486413|P1|STARTED|Overall Study||98
206587|NCT00394212|486441|P2|NOT COMPLETED|Overall Study||1
206588|NCT00394212|486442|P1|NOT COMPLETED|Overall Study||7
206589|NCT00394212|486441|P2|COMPLETED|Overall Study||26
206590|NCT00394212|486442|P1|COMPLETED|Overall Study||43
206591|NCT00394212|486441|P2|6 Month Follow-up|Overall Study||26
206592|NCT00394212|486442|P1|6 Month Follow-up|Overall Study||43
206593|NCT00394212|486441|P2|3 Month Follow-up|Overall Study||26
206594|NCT00394212|486442|P1|3 Month Follow-up|Overall Study||45
206595|NCT00394212|486441|P2|6 Week Follow-up|Overall Study||26
206596|NCT00394212|486442|P1|6 Week Follow-up|Overall Study||45
206597|NCT00394212|486441|P2|STARTED|Overall Study||27
206598|NCT00394212|486442|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
206599|NCT00394095|486456|P2|NOT COMPLETED|Overall Study||0
206600|NCT00394095|486457|P1|NOT COMPLETED|Overall Study||1
206601|NCT00394095|486456|P2|COMPLETED|Overall Study||14
206602|NCT00394095|486457|P1|COMPLETED|Overall Study||16
206603|NCT00394095|486456|P2|Screened|Overall Study||14
206604|NCT00394095|486457|P1|Screened|Overall Study||17
206605|NCT00394095|486456|P2|STARTED|Overall Study||14
206606|NCT00394095|486457|P1|STARTED|Overall Study||17
206607|NCT00394082|486465|P1|NOT COMPLETED|Overall Study||26
206608|NCT00394082|486465|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
206609|NCT00394082|486465|P1|At Least One Response Assessment|Overall Study||43
206610|NCT00394082|486465|P1|STARTED|Overall Study||50
206611|NCT00393939|486476|P2|NOT COMPLETED|Overall Study||297
206612|NCT00393939|486477|P1|NOT COMPLETED|Overall Study||296
206613|NCT00393939|486476|P2|COMPLETED|Overall Study||0
206614|NCT00393939|486477|P1|COMPLETED|Overall Study||0
206615|NCT00393939|486476|P2|Treated|Overall Study||293
206616|NCT00393939|486477|P1|Treated|Overall Study||295
206617|NCT00393939|486476|P2|STARTED|Overall Study||297
206618|NCT00393939|486477|P1|STARTED|Overall Study||296
206619|NCT00393913|486495|P1|NOT COMPLETED|CPAP Withdrawal||0
206620|NCT00393913|486495|P1|COMPLETED|CPAP Withdrawal||42
206621|NCT00393913|486495|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
206622|NCT00393913|486495|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
206623|NCT00393913|486495|P1|NOT COMPLETED|CPAP||7
206624|NCT00393913|486495|P1|COMPLETED|CPAP||93
206625|NCT00393913|486495|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
206626|NCT00393913|486495|P1|NOT COMPLETED|Initial Assessment||37
206627|NCT00393913|486495|P1|COMPLETED|Initial Assessment||107
206628|NCT00393913|486495|P1|STARTED|Initial Assessment||144
206629|NCT00393887|486503|P2|NOT COMPLETED|Overall Study||9
206630|NCT00393887|486504|P1|NOT COMPLETED|Overall Study||16
206631|NCT00393887|486503|P2|COMPLETED|Overall Study||41
206632|NCT00393887|486504|P1|COMPLETED|Overall Study||34
206633|NCT00393887|486503|P2|1 Year|Overall Study||50
206634|NCT00393887|486504|P1|1 Year|Overall Study||45
206635|NCT00393887|486503|P2|STARTED|Overall Study||50
206636|NCT00393887|486504|P1|STARTED|Overall Study||50
206637|NCT00393874|486513|P3|NOT COMPLETED|Overall Study||2
206638|NCT00393874|486514|P2|NOT COMPLETED|Overall Study||4
206639|NCT00393874|486515|P1|NOT COMPLETED|Overall Study||3
206640|NCT00393874|486513|P3|COMPLETED|Overall Study||13
206641|NCT00393874|486514|P2|COMPLETED|Overall Study||13
206642|NCT00393874|486515|P1|COMPLETED|Overall Study||15
206643|NCT00393874|486513|P3|STARTED|Overall Study||15
206644|NCT00393874|486514|P2|STARTED|Overall Study||17
206645|NCT00393874|486515|P1|STARTED|Overall Study||18
206646|NCT00393861|486532|P1|NOT COMPLETED|Overall Study||26
206647|NCT00393861|486532|P1|COMPLETED|Overall Study||3
206648|NCT00393861|486532|P1|STARTED|Overall Study||29
206649|NCT00393848|486543|P4|NOT COMPLETED|Overall Study||1
206650|NCT00393848|486544|P3|NOT COMPLETED|Overall Study||2
206651|NCT00393848|486545|P2|NOT COMPLETED|Overall Study||0
206652|NCT00393848|486546|P1|NOT COMPLETED|Overall Study||0
206653|NCT00393848|486543|P4|COMPLETED|Overall Study||8
206654|NCT00393848|486544|P3|COMPLETED|Overall Study||4
206655|NCT00393848|486545|P2|COMPLETED|Overall Study||9
206656|NCT00393848|486546|P1|COMPLETED|Overall Study||16
206657|NCT00393848|486543|P4|STARTED|Overall Study||9
206658|NCT00393848|486544|P3|STARTED|Overall Study||6
206659|NCT00393848|486545|P2|STARTED|Overall Study||9
206660|NCT00393848|486546|P1|STARTED|Overall Study||16
206661|NCT00393796|486560|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
206662|NCT00393796|486561|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
206663|NCT00393796|486560|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
206664|NCT00393796|486561|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
206665|NCT00393796|486560|P2|STARTED|Open Label Period - Placebo to SUTENT||16
206666|NCT00393796|486561|P1|STARTED|Open Label Period - Placebo to SUTENT||0
206667|NCT00393796|486560|P2|NOT COMPLETED|Double Blind Period||0
206668|NCT00393796|486561|P1|NOT COMPLETED|Double Blind Period||0
206669|NCT00393796|486560|P2|COMPLETED|Double Blind Period||28
206670|NCT00393796|486561|P1|COMPLETED|Double Blind Period||26
206671|NCT00393796|486560|P2|STARTED|Double Blind Period||28
206672|NCT00393796|486561|P1|STARTED|Double Blind Period||26
206673|NCT00393718|486569|P2|NOT COMPLETED|Overall Study||22
206674|NCT00393718|486570|P1|NOT COMPLETED|Overall Study||43
206675|NCT00393718|486569|P2|COMPLETED|Overall Study||110
206676|NCT00393718|486570|P1|COMPLETED|Overall Study||225
206677|NCT00393718|486569|P2|STARTED|Overall Study||132
206678|NCT00393718|486570|P1|STARTED|Overall Study||268
206679|NCT00393705|486602|P2|NOT COMPLETED|Overall Study||23
206680|NCT00393705|486603|P1|NOT COMPLETED|Overall Study||23
206681|NCT00393705|486602|P2|COMPLETED|Overall Study||128
206682|NCT00393705|486603|P1|COMPLETED|Overall Study||128
206683|NCT00393705|486602|P2|Received at Least One Dose of Study Drug|Overall Study||139
206684|NCT00393705|486603|P1|Received at Least One Dose of Study Drug|Overall Study||139
206685|NCT00393705|486602|P2|STARTED|Overall Study||151
206686|NCT00393705|486603|P1|STARTED|Overall Study||151
206687|NCT00393523|486632|P5|NOT COMPLETED|Overall Study||1
206688|NCT00393523|486633|P4|NOT COMPLETED|Overall Study||6
206689|NCT00393523|486634|P3|NOT COMPLETED|Overall Study||4
206690|NCT00393523|486635|P2|NOT COMPLETED|Overall Study||9
206691|NCT00393523|486636|P1|NOT COMPLETED|Overall Study||12
206692|NCT00393523|486632|P5|COMPLETED|Overall Study||19
206693|NCT00393523|486633|P4|COMPLETED|Overall Study||348
206694|NCT00393523|486634|P3|COMPLETED|Overall Study||349
206695|NCT00393523|486635|P2|COMPLETED|Overall Study||366
206696|NCT00393523|486636|P1|COMPLETED|Overall Study||364
206697|NCT00393523|486632|P5|Vaccination Visit 1|Overall Study||20
206698|NCT00393523|486633|P4|Vaccination Visit 1|Overall Study||352
206699|NCT00393523|486634|P3|Vaccination Visit 1|Overall Study||349
206700|NCT00393523|486635|P2|Vaccination Visit 1|Overall Study||375
206701|NCT00393523|486636|P1|Vaccination Visit 1|Overall Study||374
206702|NCT00393523|486632|P5|STARTED|Overall Study||20
206703|NCT00393523|486633|P4|STARTED|Overall Study||354
206704|NCT00393523|486634|P3|STARTED|Overall Study||353
206705|NCT00393523|486635|P2|STARTED|Overall Study||375
206706|NCT00393523|486636|P1|STARTED|Overall Study||376
206707|NCT00393510|486653|P2|NOT COMPLETED|Overall Study||9
206708|NCT00393510|486654|P1|NOT COMPLETED|Overall Study||3
206709|NCT00393510|486653|P2|COMPLETED|Overall Study||31
206710|NCT00393510|486654|P1|COMPLETED|Overall Study||37
206711|NCT00393510|486653|P2|STARTED|Overall Study||40
206712|NCT00393510|486654|P1|STARTED|Overall Study||40
206713|NCT00393484|486666|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
206714|NCT00393484|486667|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
206715|NCT00393484|486666|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
206716|NCT00393484|486667|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
206717|NCT00393484|486666|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
206718|NCT00393484|486667|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
206719|NCT00393484|486666|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
206720|NCT00393484|486667|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
206721|NCT00393484|486666|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
206722|NCT00393484|486667|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
206723|NCT00393484|486666|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
206724|NCT00393484|486667|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
206725|NCT00393484|486666|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
206726|NCT00393484|486667|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
206727|NCT00393484|486666|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
206728|NCT00393484|486667|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
206729|NCT00393484|486666|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
206730|NCT00393484|486667|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
206731|NCT00393458|486703|P4|NOT COMPLETED|Overall Study||137
206732|NCT00393458|486704|P3|NOT COMPLETED|Overall Study||112
206733|NCT00393458|486705|P2|NOT COMPLETED|Overall Study||102
206734|NCT00393458|486706|P1|NOT COMPLETED|Overall Study||99
206735|NCT00393458|486703|P4|COMPLETED|Overall Study||295
206736|NCT00393458|486704|P3|COMPLETED|Overall Study||323
206737|NCT00393458|486705|P2|COMPLETED|Overall Study||326
206738|NCT00393458|486706|P1|COMPLETED|Overall Study||338
206739|NCT00393458|486703|P4|Exposed to Study Medication or Placebo|Overall Study||432
206740|NCT00393458|486704|P3|Exposed to Study Medication or Placebo|Overall Study||434
206741|NCT00393458|486705|P2|Exposed to Study Medication or Placebo|Overall Study||425
206742|NCT00393458|486706|P1|Exposed to Study Medication or Placebo|Overall Study||437
206743|NCT00393458|486703|P4|STARTED|Overall Study||432
206744|NCT00393458|486704|P3|STARTED|Overall Study||435
206745|NCT00393458|486705|P2|STARTED|Overall Study||428
206746|NCT00393458|486706|P1|STARTED|Overall Study||437
206747|NCT00393380|486720|P1|NOT COMPLETED|Overall Study||0
206748|NCT00393380|486720|P1|COMPLETED|Overall Study||13
206749|NCT00393380|486720|P1|STARTED|Overall Study||13
206750|NCT00393367|486733|P2|NOT COMPLETED|Overall Study||7
206751|NCT00393367|486734|P1|NOT COMPLETED|Overall Study||2
206752|NCT00393367|486733|P2|COMPLETED|Overall Study||81
206753|NCT00393367|486734|P1|COMPLETED|Overall Study||89
206754|NCT00393367|486733|P2|STARTED|Overall Study||88
206755|NCT00393367|486734|P1|STARTED|Overall Study||91
206756|NCT00393094|486762|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
206757|NCT00393094|486762|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
206758|NCT00393094|486762|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
206759|NCT00393094|486762|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
206760|NCT00393094|486762|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
206761|NCT00393094|486762|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
206762|NCT00393068|486769|P1|NOT COMPLETED|Overall Study||18
206763|NCT00393068|486769|P1|COMPLETED|Overall Study||44
206764|NCT00393068|486769|P1|STARTED|Overall Study||62
206765|NCT00393029|486775|P2|NOT COMPLETED|Overall Study||1
206766|NCT00393029|486776|P1|NOT COMPLETED|Overall Study||0
206767|NCT00393029|486775|P2|COMPLETED|Overall Study||9
206768|NCT00393029|486776|P1|COMPLETED|Overall Study||2
206769|NCT00393029|486775|P2|STARTED|Overall Study||10
206770|NCT00393029|486776|P1|STARTED|Overall Study||2
206771|NCT00392925|486789|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
206772|NCT00392925|486790|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
206773|NCT00392925|486791|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
206774|NCT00392925|486792|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
206775|NCT00392925|486789|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
206776|NCT00392925|486790|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
206777|NCT00392925|486791|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
206778|NCT00392925|486792|P1|COMPLETED|Randomization to Treatment Group Period||0
206779|NCT00392925|486789|P4|STARTED|Randomization to Treatment Group Period||56
206780|NCT00392925|486790|P3|STARTED|Randomization to Treatment Group Period||56
206781|NCT00392925|486791|P2|STARTED|Randomization to Treatment Group Period||27
206782|NCT00392925|486792|P1|STARTED|Randomization to Treatment Group Period||0
206783|NCT00392925|486789|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206784|NCT00392925|486790|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206785|NCT00392925|486791|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206786|NCT00392925|486792|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
206787|NCT00392925|486789|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206788|NCT00392925|486790|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206789|NCT00392925|486791|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
206790|NCT00392925|486792|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
206791|NCT00392925|486789|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
206792|NCT00392925|486790|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
206793|NCT00392925|486791|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
206794|NCT00392925|486792|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
206795|NCT00392860|486880|P3|NOT COMPLETED|Overall Study||0
206796|NCT00392860|486881|P2|NOT COMPLETED|Overall Study||0
206797|NCT00392860|486882|P1|NOT COMPLETED|Overall Study||0
206798|NCT00392860|486880|P3|COMPLETED|Overall Study||1
206799|NCT00392860|486881|P2|COMPLETED|Overall Study||0
206800|NCT00392860|486882|P1|COMPLETED|Overall Study||3
206801|NCT00392860|486880|P3|STARTED|Overall Study||1
206802|NCT00392860|486881|P2|STARTED|Overall Study||0
206803|NCT00392860|486882|P1|STARTED|Overall Study||3
206804|NCT00392834|486890|P2|NOT COMPLETED|Overall Study||0
206805|NCT00392834|486891|P1|NOT COMPLETED|Overall Study||0
206806|NCT00392834|486890|P2|COMPLETED|Overall Study||32
206807|NCT00392834|486891|P1|COMPLETED|Overall Study||2
206808|NCT00392834|486890|P2|STARTED|Overall Study||32
206809|NCT00392834|486891|P1|STARTED|Overall Study||2
206810|NCT00392821|486897|P1|NOT COMPLETED|Overall Study||19
206811|NCT00392821|486897|P1|COMPLETED|Overall Study||59
206812|NCT00392821|486897|P1|STARTED|Overall Study||78
206813|NCT00392808|486906|P4|NOT COMPLETED|Overall Study||4
206814|NCT00392808|486907|P3|NOT COMPLETED|Overall Study||2
206815|NCT00392808|486908|P2|NOT COMPLETED|Overall Study||3
206816|NCT00392808|486909|P1|NOT COMPLETED|Overall Study||6
206817|NCT00392808|486906|P4|COMPLETED|Overall Study||100
206818|NCT00392808|486907|P3|COMPLETED|Overall Study||107
206819|NCT00392808|486908|P2|COMPLETED|Overall Study||86
206820|NCT00392808|486909|P1|COMPLETED|Overall Study||81
206821|NCT00392808|486906|P4|STARTED|Overall Study||104
206822|NCT00392808|486907|P3|STARTED|Overall Study||109
206823|NCT00392808|486908|P2|STARTED|Overall Study||89
206824|NCT00392808|486909|P1|STARTED|Overall Study||87
206825|NCT00392782|486923|P1|NOT COMPLETED|Overall Study||0
206826|NCT00392782|486923|P1|COMPLETED|Overall Study||24
206827|NCT00392782|486923|P1|STARTED|Overall Study||24
206828|NCT00392769|486933|P1|NOT COMPLETED|Overall Study||10
206829|NCT00392769|486933|P1|COMPLETED|Overall Study||23
206830|NCT00392769|486933|P1|STARTED|Overall Study||33
206831|NCT00392704|486937|P1|NOT COMPLETED|Combined Modality Therapy||5
206832|NCT00392704|486937|P1|COMPLETED|Combined Modality Therapy||49
206833|NCT00392704|486937|P1|STARTED|Combined Modality Therapy||54
206834|NCT00392704|486937|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
206835|NCT00392704|486937|P1|COMPLETED|Neoadjuvant Chemotherapy||54
206836|NCT00392704|486937|P1|STARTED|Neoadjuvant Chemotherapy||60
206837|NCT00392678|486946|P4|NOT COMPLETED|Overall Study||1
206838|NCT00392678|486947|P3|NOT COMPLETED|Overall Study||2
206839|NCT00392678|486948|P2|NOT COMPLETED|Overall Study||1
206840|NCT00392678|486949|P1|NOT COMPLETED|Overall Study||0
206841|NCT00392678|486946|P4|COMPLETED|Overall Study||26
206842|NCT00392678|486947|P3|COMPLETED|Overall Study||25
206843|NCT00392678|486948|P2|COMPLETED|Overall Study||26
206844|NCT00392678|486949|P1|COMPLETED|Overall Study||27
206845|NCT00392678|486946|P4|STARTED|Overall Study||27
206846|NCT00392678|486947|P3|STARTED|Overall Study||27
206847|NCT00392678|486948|P2|STARTED|Overall Study||27
206848|NCT00392678|486949|P1|STARTED|Overall Study||27
206849|NCT00392496|486983|P1|NOT COMPLETED|Overall Study||0
206850|NCT00392496|486983|P1|COMPLETED|Overall Study||19
206851|NCT00392496|486983|P1|STARTED|Overall Study||19
206852|NCT00392444|486987|P1|NOT COMPLETED|Overall Study||0
206853|NCT00392444|486987|P1|COMPLETED|Overall Study||39
206854|NCT00392444|486987|P1|STARTED|Overall Study||39
206855|NCT00392392|486991|P1|NOT COMPLETED|Overall Study||20
206856|NCT00392392|486991|P1|COMPLETED|Overall Study||9
206857|NCT00392392|486991|P1|STARTED|Overall Study||29
206858|NCT00392379|486997|P2|NOT COMPLETED|Overall Study||38
206859|NCT00392379|486998|P1|NOT COMPLETED|Overall Study||22
206860|NCT00392379|486997|P2|COMPLETED|Overall Study|Medication period|96
206861|NCT00392379|486998|P1|COMPLETED|Overall Study|Medication period|114
206862|NCT00392379|486997|P2|STARTED|Overall Study|Medication period|134
206863|NCT00392379|486998|P1|STARTED|Overall Study|Medication period|136
206864|NCT00392288|487011|P3|NOT COMPLETED|Overall Study||17
206865|NCT00392288|487012|P2|NOT COMPLETED|Overall Study||22
206866|NCT00392288|487013|P1|NOT COMPLETED|Overall Study||32
206867|NCT00392288|487011|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
206868|NCT00392288|487012|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
206869|NCT00392288|487013|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
206870|NCT00392288|487011|P3|Treatment Period|Overall Study||175
206871|NCT00392288|487012|P2|Treatment Period|Overall Study||174
206872|NCT00392288|487013|P1|Treatment Period|Overall Study||172
206873|NCT00392288|487011|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
206874|NCT00392288|487012|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
206875|NCT00392288|487013|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
206876|NCT00392236|487029|P2|NOT COMPLETED|Overall Study||6
206877|NCT00392236|487030|P1|NOT COMPLETED|Overall Study||12
206878|NCT00392236|487029|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
206879|NCT00392236|487030|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
206880|NCT00392236|487029|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
206881|NCT00392236|487030|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
206882|NCT00392223|487038|P2|NOT COMPLETED|Overall Study||13
206883|NCT00392223|487039|P1|NOT COMPLETED|Overall Study||9
206884|NCT00392223|487038|P2|COMPLETED|Overall Study||47
206885|NCT00392223|487039|P1|COMPLETED|Overall Study||49
206886|NCT00392223|487038|P2|STARTED|Overall Study||60
206887|NCT00392223|487039|P1|STARTED|Overall Study||58
206888|NCT00392197|487057|P2|NOT COMPLETED|Overall Study||30
206889|NCT00392197|487058|P1|NOT COMPLETED|Overall Study||21
206890|NCT00392197|487057|P2|COMPLETED|Overall Study||33
206891|NCT00392197|487058|P1|COMPLETED|Overall Study||27
206892|NCT00392197|487057|P2|STARTED|Overall Study||63
206893|NCT00392197|487058|P1|STARTED|Overall Study||48
206894|NCT00392171|487066|P1|NOT COMPLETED|Overall Study||105
206895|NCT00392171|487066|P1|COMPLETED|Overall Study||15
206896|NCT00392171|487066|P1|STARTED|Overall Study||120
206897|NCT00391989|487070|P1|NOT COMPLETED|Overall Study||2
206898|NCT00391989|487070|P1|COMPLETED|Overall Study||53
206899|NCT00391989|487070|P1|STARTED|Overall Study||55
206900|NCT00391976|487077|P3|NOT COMPLETED|Overall Study||35
206901|NCT00391976|487078|P2|NOT COMPLETED|Overall Study||25
206902|NCT00391976|487079|P1|NOT COMPLETED|Overall Study||27
206903|NCT00391976|487077|P3|COMPLETED|Overall Study||0
206904|NCT00391976|487078|P2|COMPLETED|Overall Study||18
206905|NCT00391976|487079|P1|COMPLETED|Overall Study||18
206906|NCT00391976|487077|P3|Safety Population|Overall Study||35
206907|NCT00391976|487078|P2|Safety Population|Overall Study||43
206908|NCT00391976|487079|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
206909|NCT00391976|487077|P3|Randomized|Overall Study||0
206910|NCT00391976|487078|P2|Randomized|Overall Study||43
206911|NCT00391976|487079|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
206912|NCT00391976|487077|P3|STARTED|Overall Study||35
206913|NCT00391976|487078|P2|STARTED|Overall Study||43
206914|NCT00391976|487079|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
206915|NCT00391898|487103|P2|NOT COMPLETED|Overall Study||10
206916|NCT00391898|487104|P1|NOT COMPLETED|Overall Study||11
206917|NCT00391898|487103|P2|COMPLETED|Overall Study||39
206918|NCT00391898|487104|P1|COMPLETED|Overall Study||35
206919|NCT00391898|487103|P2|STARTED|Overall Study||49
206920|NCT00391898|487104|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
206921|NCT00391872|487124|P2|NOT COMPLETED|Overall Study||255
206922|NCT00391872|487125|P1|NOT COMPLETED|Overall Study||307
206923|NCT00391872|487124|P2|COMPLETED|Overall Study||9036
206924|NCT00391872|487125|P1|COMPLETED|Overall Study||9026
206925|NCT00391872|487124|P2|STARTED|Overall Study||9291
206926|NCT00391872|487125|P1|STARTED|Overall Study||9333
206927|NCT00391846|487163|P2|NOT COMPLETED|Overall Study||7
206928|NCT00391846|487164|P1|NOT COMPLETED|Overall Study||8
206929|NCT00391846|487163|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
206930|NCT00391846|487164|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
206931|NCT00391846|487163|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
206932|NCT00391846|487164|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
206933|NCT00391807|487184|P1|NOT COMPLETED|Overall Study||715
206934|NCT00391807|487184|P1|COMPLETED|Overall Study||968
206935|NCT00391807|487184|P1|STARTED|Overall Study||1683
206936|NCT00391768|487211|P7|NOT COMPLETED|Overall Study||4
206937|NCT00391768|487212|P6|NOT COMPLETED|Overall Study||3
206938|NCT00391768|487213|P5|NOT COMPLETED|Overall Study||2
206939|NCT00391768|487214|P4|NOT COMPLETED|Overall Study||1
206940|NCT00391768|487215|P3|NOT COMPLETED|Overall Study||1
206941|NCT00391768|487216|P2|NOT COMPLETED|Overall Study||0
206942|NCT00391768|487217|P1|NOT COMPLETED|Overall Study||0
206943|NCT00391768|487211|P7|COMPLETED|Overall Study||19
206944|NCT00391768|487212|P6|COMPLETED|Overall Study||7
206945|NCT00391768|487213|P5|COMPLETED|Overall Study||22
206946|NCT00391768|487214|P4|COMPLETED|Overall Study||7
206947|NCT00391768|487215|P3|COMPLETED|Overall Study||6
206948|NCT00391768|487216|P2|COMPLETED|Overall Study||3
206949|NCT00391768|487217|P1|COMPLETED|Overall Study||12
206950|NCT00391768|487211|P7|STARTED|Overall Study||23
206951|NCT00391768|487212|P6|STARTED|Overall Study||10
206952|NCT00391768|487213|P5|STARTED|Overall Study||24
206953|NCT00391768|487214|P4|STARTED|Overall Study||8
206954|NCT00391768|487215|P3|STARTED|Overall Study||7
206955|NCT00391768|487216|P2|STARTED|Overall Study||3
206956|NCT00391768|487217|P1|STARTED|Overall Study||12
206957|NCT00391716|487285|P3|NOT COMPLETED|Overall Study||19
206958|NCT00391716|487286|P2|NOT COMPLETED|Overall Study||19
206959|NCT00391716|487287|P1|NOT COMPLETED|Overall Study||27
206960|NCT00391716|487285|P3|COMPLETED|Overall Study||30
206961|NCT00391716|487286|P2|COMPLETED|Overall Study||28
206962|NCT00391716|487287|P1|COMPLETED|Overall Study||27
206963|NCT00391716|487285|P3|STARTED|Overall Study||49
206964|NCT00391716|487286|P2|STARTED|Overall Study||47
206965|NCT00391716|487287|P1|STARTED|Overall Study||54
206966|NCT00391625|487304|P1|NOT COMPLETED|Month 84||0
206967|NCT00391625|487304|P1|COMPLETED|Month 84||8
206968|NCT00391625|487304|P1|STARTED|Month 84||8
206969|NCT00391625|487304|P1|NOT COMPLETED|Month 50||1
206970|NCT00391625|487304|P1|COMPLETED|Month 50||8
206971|NCT00391625|487304|P1|STARTED|Month 50||9
206972|NCT00391625|487304|P1|NOT COMPLETED|Month 14||1
206973|NCT00391625|487304|P1|COMPLETED|Month 14||9
206974|NCT00391625|487304|P1|STARTED|Month 14||10
206975|NCT00391625|487304|P1|NOT COMPLETED|Baseline||0
206976|NCT00391625|487304|P1|COMPLETED|Baseline||10
206977|NCT00391625|487304|P1|STARTED|Baseline||10
206978|NCT00391599|487346|P2|NOT COMPLETED|Overall Study||0
206979|NCT00391599|487347|P1|NOT COMPLETED|Overall Study||0
206980|NCT00391599|487346|P2|COMPLETED|Overall Study||65
206981|NCT00391599|487347|P1|COMPLETED|Overall Study||65
206982|NCT00391599|487346|P2|STARTED|Overall Study||65
206983|NCT00391599|487347|P1|STARTED|Overall Study||65
206984|NCT00391586|487357|P1|NOT COMPLETED|Overall Study||24
206985|NCT00391586|487357|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
206986|NCT00391586|487357|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
206987|NCT00391586|487357|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
206988|NCT00391586|487357|P1|STARTED|Overall Study||45
206989|NCT00391469|487366|P2|NOT COMPLETED|Overall Study||0
206990|NCT00391469|487367|P1|NOT COMPLETED|Overall Study||0
206991|NCT00391469|487366|P2|COMPLETED|Overall Study||671
206992|NCT00391469|487367|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
206993|NCT00391469|487366|P2|STARTED|Overall Study||671
206994|NCT00391469|487367|P1|STARTED|Overall Study||688
206995|NCT00391443|487381|P2|NOT COMPLETED|Overall Study||0
206996|NCT00391443|487382|P1|NOT COMPLETED|Overall Study||0
206997|NCT00391443|487381|P2|COMPLETED|Overall Study||407
206998|NCT00391443|487382|P1|COMPLETED|Overall Study||209
206999|NCT00391443|487381|P2|STARTED|Overall Study||407
207000|NCT00391443|487382|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
207001|NCT00391391|487394|P4|NOT COMPLETED|Overall Study||19
207002|NCT00391391|487395|P3|NOT COMPLETED|Overall Study||23
207003|NCT00391391|487396|P2|NOT COMPLETED|Overall Study||10
207004|NCT00391391|487397|P1|NOT COMPLETED|Overall Study||9
207005|NCT00391391|487394|P4|COMPLETED|Overall Study||145
207006|NCT00391391|487395|P3|COMPLETED|Overall Study||138
207007|NCT00391391|487396|P2|COMPLETED|Overall Study||87
207008|NCT00391391|487397|P1|COMPLETED|Overall Study||89
207009|NCT00391391|487394|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
207010|NCT00391391|487395|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
207011|NCT00391391|487396|P2|STARTED|Overall Study||97
207012|NCT00391391|487397|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
207013|NCT00391365|487429|P2|NOT COMPLETED|Overall Study||19
207014|NCT00391365|487430|P1|NOT COMPLETED|Overall Study||25
207015|NCT00391365|487429|P2|COMPLETED|Overall Study||151
207016|NCT00391365|487430|P1|COMPLETED|Overall Study||78
207017|NCT00391365|487429|P2|STARTED|Overall Study||170
207018|NCT00391365|487430|P1|STARTED|Overall Study||103
207019|NCT00391274|487442|P2|NOT COMPLETED|Overall Study||57
207020|NCT00391274|487443|P1|NOT COMPLETED|Overall Study||61
207021|NCT00391274|487442|P2|COMPLETED|Overall Study||47
207022|NCT00391274|487443|P1|COMPLETED|Overall Study||46
207023|NCT00391274|487442|P2|Received at Least One Dose of Study Drug|Overall Study||102
207024|NCT00391274|487443|P1|Received at Least One Dose of Study Drug|Overall Study||106
207025|NCT00391274|487442|P2|STARTED|Overall Study||104
207026|NCT00391274|487443|P1|STARTED|Overall Study||107
207027|NCT00391222|487462|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
207028|NCT00391222|487463|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
207029|NCT00391222|487464|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
207030|NCT00391222|487465|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
207031|NCT00391222|487462|P4|COMPLETED|Period III (Double-Blind Treatment)||0
207032|NCT00391222|487463|P3|COMPLETED|Period III (Double-Blind Treatment)||108
207033|NCT00391222|487464|P2|COMPLETED|Period III (Double-Blind Treatment)||113
207034|NCT00391222|487465|P1|COMPLETED|Period III (Double-Blind Treatment)||104
207035|NCT00391222|487462|P4|STARTED|Period III (Double-Blind Treatment)||0
207036|NCT00391222|487463|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
207037|NCT00391222|487464|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
207038|NCT00391222|487465|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
207039|NCT00391222|487462|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
207040|NCT00391222|487463|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
207041|NCT00391222|487464|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
207042|NCT00391222|487465|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
207043|NCT00391222|487462|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
207044|NCT00391222|487463|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
207045|NCT00391222|487464|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
207046|NCT00391222|487465|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
207047|NCT00391222|487462|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
207048|NCT00391222|487463|P3|STARTED|Period II (Open-label Risperidone LAI)||0
207049|NCT00391222|487464|P2|STARTED|Period II (Open-label Risperidone LAI)||0
207050|NCT00391222|487465|P1|STARTED|Period II (Open-label Risperidone LAI)||0
207051|NCT00391092|487491|P2|NOT COMPLETED|Overall Study||216
207052|NCT00391092|487492|P1|NOT COMPLETED|Overall Study||208
207053|NCT00391092|487491|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
207054|NCT00391092|487492|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
207055|NCT00391092|487491|P2|Received Treatment|Overall Study||215
207056|NCT00391092|487492|P1|Received Treatment|Overall Study||206
207057|NCT00391092|487491|P2|STARTED|Overall Study||216
207058|NCT00391092|487492|P1|STARTED|Overall Study||208
207059|NCT00391079|487512|P2|NOT COMPLETED|Overall Study||16
207060|NCT00391079|487513|P1|NOT COMPLETED|Overall Study||26
207061|NCT00391079|487512|P2|COMPLETED|Overall Study||156
207062|NCT00391079|487513|P1|COMPLETED|Overall Study||141
207063|NCT00391079|487512|P2|STARTED|Overall Study||172
207064|NCT00391079|487513|P1|STARTED|Overall Study||167
207065|NCT00391053|487535|P4|NOT COMPLETED|Overall Study||10
207066|NCT00391053|487536|P3|NOT COMPLETED|Overall Study||2
207067|NCT00391053|487537|P2|NOT COMPLETED|Overall Study||1
207068|NCT00391053|487538|P1|NOT COMPLETED|Overall Study||9
207069|NCT00391053|487535|P4|COMPLETED|Overall Study||1252
207070|NCT00391053|487536|P3|COMPLETED|Overall Study||868
207071|NCT00391053|487537|P2|COMPLETED|Overall Study||847
207072|NCT00391053|487538|P1|COMPLETED|Overall Study||848
207073|NCT00391053|487535|P4|STARTED|Overall Study||1262
207074|NCT00391053|487536|P3|STARTED|Overall Study||870
207075|NCT00391053|487537|P2|STARTED|Overall Study||848
207076|NCT00391053|487538|P1|STARTED|Overall Study||857
207077|NCT00391027|487562|P2|NOT COMPLETED|Overall Study||12
207078|NCT00391027|487563|P1|NOT COMPLETED|Overall Study||25
207079|NCT00391027|487562|P2|COMPLETED|Overall Study||110
207080|NCT00391027|487563|P1|COMPLETED|Overall Study||110
207081|NCT00391027|487562|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
207082|NCT00391027|487563|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
207083|NCT00390884|487603|P2|NOT COMPLETED|Overall Study||2
207084|NCT00390884|487604|P1|NOT COMPLETED|Overall Study||2
207085|NCT00390884|487603|P2|COMPLETED|Overall Study||55
207086|NCT00390884|487604|P1|COMPLETED|Overall Study||114
207087|NCT00390884|487603|P2|STARTED|Overall Study||57
207088|NCT00390884|487604|P1|STARTED|Overall Study||116
207089|NCT00390858|487616|P2|NOT COMPLETED|Overall Study||7
207090|NCT00390858|487617|P1|NOT COMPLETED|Overall Study||9
207091|NCT00390858|487616|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
207092|NCT00390858|487617|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
207093|NCT00390858|487616|P2|Completed Core & Entered Extension Study|Overall Study||20
207094|NCT00390858|487617|P1|Completed Core & Entered Extension Study|Overall Study||19
207095|NCT00390858|487616|P2|STARTED|Overall Study|20 Participants started the Core Study|20
207096|NCT00390858|487617|P1|STARTED|Overall Study|20 participants started the Core Study|20
207097|NCT00390806|487633|P2|NOT COMPLETED|Overall Study||32
207098|NCT00390806|487634|P1|NOT COMPLETED|Overall Study||30
207099|NCT00390806|487633|P2|COMPLETED|Overall Study||204
207100|NCT00390806|487634|P1|COMPLETED|Overall Study||206
207101|NCT00390806|487633|P2|Ongoing|Overall Study||2
207102|NCT00390806|487634|P1|Ongoing|Overall Study||4
207103|NCT00390806|487633|P2|STARTED|Overall Study||236
207104|NCT00390806|487634|P1|STARTED|Overall Study||236
207105|NCT00390780|487702|P2|NOT COMPLETED|Overall Study||27
207106|NCT00390780|487703|P1|NOT COMPLETED|Overall Study||23
207107|NCT00390780|487702|P2|COMPLETED|Overall Study||260
207108|NCT00390780|487703|P1|COMPLETED|Overall Study||268
207109|NCT00390780|487702|P2|Treatment|Overall Study||287
207110|NCT00390780|487703|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
207111|NCT00390780|487702|P2|STARTED|Overall Study||287
207112|NCT00390780|487703|P1|STARTED|Overall Study||291
207113|NCT00390689|487736|P3|NOT COMPLETED|Overall Study||3
207114|NCT00390689|487737|P2|NOT COMPLETED|Overall Study||5
207115|NCT00390689|487738|P1|NOT COMPLETED|Overall Study||5
207116|NCT00390689|487736|P3|COMPLETED|Overall Study||50
207117|NCT00390689|487737|P2|COMPLETED|Overall Study||48
207118|NCT00390689|487738|P1|COMPLETED|Overall Study||43
207119|NCT00390689|487736|P3|STARTED|Overall Study||53
207120|NCT00390689|487737|P2|STARTED|Overall Study||53
207121|NCT00390689|487738|P1|STARTED|Overall Study||48
207122|NCT00390611|487798|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
207123|NCT00390611|487799|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
207124|NCT00390611|487798|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
207125|NCT00390611|487799|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
207126|NCT00390611|487798|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
207127|NCT00390611|487799|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
207128|NCT00390611|487798|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
207129|NCT00390611|487799|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
207130|NCT00390611|487798|P2|COMPLETED|6 Cycles of Study Treatment||37
207131|NCT00390611|487799|P1|COMPLETED|6 Cycles of Study Treatment||34
207132|NCT00390611|487798|P2|STARTED|6 Cycles of Study Treatment||42
207133|NCT00390611|487799|P1|STARTED|6 Cycles of Study Treatment||43
207134|NCT00390572|487813|P2|NOT COMPLETED|Overall Study||5
207135|NCT00390572|487814|P1|NOT COMPLETED|Overall Study||8
207136|NCT00390572|487813|P2|COMPLETED|Overall Study||64
207137|NCT00390572|487814|P1|COMPLETED|Overall Study||60
207138|NCT00390572|487813|P2|STARTED|Overall Study||69
207139|NCT00390572|487814|P1|STARTED|Overall Study||68
207140|NCT00390559|487828|P1|NOT COMPLETED|Overall Study||44
207141|NCT00390559|487828|P1|COMPLETED|Overall Study||80
207142|NCT00390559|487828|P1|ActiveP/PlaceboC|Overall Study||90
207143|NCT00390559|487828|P1|PlaceboP/PlaceboC|Overall Study||93
207144|NCT00390559|487828|P1|ActiveP/ActiveC|Overall Study||87
207145|NCT00390559|487828|P1|Received PlaceboP/Active C|Overall Study||93
207146|NCT00390559|487828|P1|STARTED|Overall Study||124
207147|NCT00390546|487840|P2|NOT COMPLETED|Overall Study||5
207148|NCT00390546|487841|P1|NOT COMPLETED|Overall Study||6
207149|NCT00390546|487840|P2|COMPLETED|Overall Study||34
207150|NCT00390546|487841|P1|COMPLETED|Overall Study||27
207151|NCT00390546|487840|P2|STARTED|Overall Study||39
207152|NCT00390546|487841|P1|STARTED|Overall Study||33
207153|NCT00390468|487851|P1|NOT COMPLETED|Overall Study||3
207154|NCT00390468|487851|P1|COMPLETED|Overall Study||15
207155|NCT00390468|487851|P1|STARTED|Overall Study||18
207156|NCT00390455|487857|P2|NOT COMPLETED|Overall Study||23
207157|NCT00390455|487858|P1|NOT COMPLETED|Overall Study||32
207158|NCT00390455|487857|P2|COMPLETED|Overall Study||124
207159|NCT00390455|487858|P1|COMPLETED|Overall Study||116
207160|NCT00390455|487857|P2|STARTED|Overall Study||147
207161|NCT00390455|487858|P1|STARTED|Overall Study||148
207162|NCT00390416|487876|P1|NOT COMPLETED|Overall Study||4
207163|NCT00390416|487876|P1|COMPLETED|Overall Study||44
207164|NCT00390416|487876|P1|STARTED|Overall Study||48
207165|NCT00390364|487882|P1|NOT COMPLETED|Overall Study||0
207166|NCT00390364|487882|P1|COMPLETED|Overall Study||1
207167|NCT00390364|487882|P1|STARTED|Overall Study||1
207168|NCT00390234|487886|P1|NOT COMPLETED|Overall Study||0
207169|NCT00390234|487886|P1|COMPLETED|Overall Study||63
207170|NCT00390234|487886|P1|STARTED|Overall Study||63
207171|NCT00390221|487897|P3|NOT COMPLETED|Overall Study||15
207172|NCT00390221|487898|P2|NOT COMPLETED|Overall Study||20
207173|NCT00390221|487899|P1|NOT COMPLETED|Overall Study||18
207174|NCT00390221|487897|P3|COMPLETED|Overall Study||194
207175|NCT00390221|487898|P2|COMPLETED|Overall Study||188
207176|NCT00390221|487899|P1|COMPLETED|Overall Study||186
207177|NCT00390221|487897|P3|STARTED|Overall Study||209
207178|NCT00390221|487898|P2|STARTED|Overall Study||208
207179|NCT00390221|487899|P1|STARTED|Overall Study||204
207180|NCT00390182|487920|P1|NOT COMPLETED|Overall Study||5
207181|NCT00390182|487920|P1|COMPLETED|Overall Study||33
207182|NCT00390182|487920|P1|STARTED|Overall Study||38
207183|NCT00389974|487926|P1|NOT COMPLETED|Overall Study||0
207184|NCT00389974|487926|P1|COMPLETED|Overall Study||19
207185|NCT00389974|487926|P1|STARTED|Overall Study||19
207186|NCT00389857|487932|P2|NOT COMPLETED|Overall Study||0
207187|NCT00389857|487933|P1|NOT COMPLETED|Overall Study||0
207188|NCT00389857|487932|P2|COMPLETED|Overall Study||17
207189|NCT00389857|487933|P1|COMPLETED|Overall Study||14
207190|NCT00389857|487932|P2|STARTED|Overall Study||17
207191|NCT00389857|487933|P1|STARTED|Overall Study||14
207192|NCT00389831|487945|P2|NOT COMPLETED|Overall Study||7
207193|NCT00389831|487946|P1|NOT COMPLETED|Overall Study||0
207194|NCT00389831|487945|P2|COMPLETED|Overall Study||27
207195|NCT00389831|487946|P1|COMPLETED|Overall Study||10
207196|NCT00389831|487945|P2|STARTED|Overall Study||34
207197|NCT00389831|487946|P1|STARTED|Overall Study||10
207198|NCT00389818|487972|P1|NOT COMPLETED|Overall Study||3
207199|NCT00389818|487972|P1|COMPLETED|Overall Study||40
207200|NCT00389818|487972|P1|STARTED|Overall Study||43
207201|NCT00389597|487980|P4|NOT COMPLETED|Overall Study||6
207202|NCT00389597|487981|P3|NOT COMPLETED|Overall Study||4
207203|NCT00389597|487982|P2|NOT COMPLETED|Overall Study||6
207204|NCT00389597|487983|P1|NOT COMPLETED|Overall Study||8
207205|NCT00389597|487980|P4|COMPLETED|Overall Study||99
207206|NCT00389597|487981|P3|COMPLETED|Overall Study||221
207207|NCT00389597|487982|P2|COMPLETED|Overall Study||75
207208|NCT00389597|487983|P1|COMPLETED|Overall Study||156
207209|NCT00389597|487980|P4|24 mo|Overall Study||99
207210|NCT00389597|487981|P3|24 mo|Overall Study||221
207211|NCT00389597|487982|P2|24 mo|Overall Study||75
207212|NCT00389597|487983|P1|24 mo|Overall Study||156
207213|NCT00389597|487980|P4|STARTED|Overall Study||105
207214|NCT00389597|487981|P3|STARTED|Overall Study||225
207215|NCT00389597|487982|P2|STARTED|Overall Study||81
207216|NCT00389597|487983|P1|STARTED|Overall Study||164
207217|NCT00389532|487995|P2|NOT COMPLETED|Overall Study||0
207218|NCT00389532|487996|P1|NOT COMPLETED|Overall Study||0
207219|NCT00389532|487995|P2|COMPLETED|Overall Study||56
207220|NCT00389532|487996|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
207221|NCT00389532|487995|P2|STARTED|Overall Study||56
207222|NCT00389532|487996|P1|STARTED|Overall Study||60
207223|NCT00389519|488008|P4|NOT COMPLETED|Treated||4
207224|NCT00389519|488009|P3|NOT COMPLETED|Treated||0
207225|NCT00389519|488010|P2|NOT COMPLETED|Treated||1
207226|NCT00389519|488011|P1|NOT COMPLETED|Treated||2
207227|NCT00389519|488008|P4|COMPLETED|Treated||76
207228|NCT00389519|488009|P3|COMPLETED|Treated||40
207229|NCT00389519|488010|P2|COMPLETED|Treated||40
207230|NCT00389519|488011|P1|COMPLETED|Treated||79
207231|NCT00389519|488008|P4|STARTED|Treated||80
207232|NCT00389519|488009|P3|STARTED|Treated||40
207233|NCT00389519|488010|P2|STARTED|Treated||41
207234|NCT00389519|488011|P1|STARTED|Treated||81
207235|NCT00389519|488008|P4|NOT COMPLETED|Randomized||0
207236|NCT00389519|488009|P3|NOT COMPLETED|Randomized||0
207237|NCT00389519|488010|P2|NOT COMPLETED|Randomized||0
207238|NCT00389519|488011|P1|NOT COMPLETED|Randomized||2
207239|NCT00389519|488008|P4|COMPLETED|Randomized||80
207240|NCT00389519|488009|P3|COMPLETED|Randomized||40
207241|NCT00389519|488010|P2|COMPLETED|Randomized||41
207242|NCT00389519|488011|P1|COMPLETED|Randomized||81
207243|NCT00389519|488008|P4|STARTED|Randomized||80
207244|NCT00389519|488009|P3|STARTED|Randomized||40
207245|NCT00389519|488010|P2|STARTED|Randomized||41
207246|NCT00389519|488011|P1|STARTED|Randomized||83
207247|NCT00389519|488008|P4|NOT COMPLETED|Placebo Run-In||0
207248|NCT00389519|488009|P3|NOT COMPLETED|Placebo Run-In||0
207249|NCT00389519|488010|P2|NOT COMPLETED|Placebo Run-In||0
207250|NCT00389519|488011|P1|NOT COMPLETED|Placebo Run-In||178
207251|NCT00389519|488008|P4|COMPLETED|Placebo Run-In||0
207252|NCT00389519|488009|P3|COMPLETED|Placebo Run-In||0
207253|NCT00389519|488010|P2|COMPLETED|Placebo Run-In||0
207254|NCT00389519|488011|P1|COMPLETED|Placebo Run-In||244
207255|NCT00389519|488008|P4|STARTED|Placebo Run-In||0
207256|NCT00389519|488009|P3|STARTED|Placebo Run-In||0
207257|NCT00389519|488010|P2|STARTED|Placebo Run-In||0
207258|NCT00389519|488011|P1|STARTED|Placebo Run-In||422
207259|NCT00389493|488040|P3|NOT COMPLETED|Overall Study||3
207260|NCT00389493|488041|P2|NOT COMPLETED|Overall Study||8
207261|NCT00389493|488042|P1|NOT COMPLETED|Overall Study||3
207262|NCT00389493|488040|P3|COMPLETED|Overall Study||17
207263|NCT00389493|488041|P2|COMPLETED|Overall Study||32
207264|NCT00389493|488042|P1|COMPLETED|Overall Study||37
207265|NCT00389493|488040|P3|STARTED|Overall Study||20
207266|NCT00389493|488041|P2|STARTED|Overall Study||40
207267|NCT00389493|488042|P1|STARTED|Overall Study||40
207268|NCT00389467|488066|P4|NOT COMPLETED|Overall Study||0
207269|NCT00389467|488067|P3|NOT COMPLETED|Overall Study||0
207270|NCT00389467|488068|P2|NOT COMPLETED|Overall Study||0
207271|NCT00389467|488069|P1|NOT COMPLETED|Overall Study||0
207272|NCT00389467|488066|P4|COMPLETED|Overall Study||20
207273|NCT00389467|488067|P3|COMPLETED|Overall Study||30
207274|NCT00389467|488068|P2|COMPLETED|Overall Study||34
207275|NCT00389467|488069|P1|COMPLETED|Overall Study||34
207276|NCT00389467|488066|P4|STARTED|Overall Study||20
207277|NCT00389467|488067|P3|STARTED|Overall Study||30
207278|NCT00389467|488068|P2|STARTED|Overall Study||34
207279|NCT00389467|488069|P1|STARTED|Overall Study||34
207280|NCT00389441|488088|P1|NOT COMPLETED|Overall Study||52
207281|NCT00389441|488088|P1|COMPLETED|Overall Study||0
207282|NCT00389441|488088|P1|STARTED|Overall Study||52
207283|NCT00389324|488097|P1|NOT COMPLETED|Subcutaneous Phase||7
207284|NCT00389324|488097|P1|COMPLETED|Subcutaneous Phase||25
207285|NCT00389324|488097|P1|STARTED|Subcutaneous Phase||32
207286|NCT00389324|488097|P1|NOT COMPLETED|Intravenous Phase||0
207287|NCT00389324|488097|P1|COMPLETED|Intravenous Phase||32
207288|NCT00389324|488097|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
207289|NCT00389324|488097|P1|NOT COMPLETED|Run-In Phase||3
207290|NCT00389324|488097|P1|COMPLETED|Run-In Phase||18
207291|NCT00389324|488097|P1|STARTED|Run-In Phase||21
207292|NCT00389207|488107|P3|NOT COMPLETED|Overall Study||41
207293|NCT00389207|488108|P2|NOT COMPLETED|Overall Study||72
207294|NCT00389207|488109|P1|NOT COMPLETED|Overall Study||63
207295|NCT00389207|488107|P3|COMPLETED|Overall Study||152
207296|NCT00389207|488108|P2|COMPLETED|Overall Study||116
207297|NCT00389207|488109|P1|COMPLETED|Overall Study||125
207298|NCT00389207|488107|P3|STARTED|Overall Study||193
207299|NCT00389207|488108|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
207300|NCT00389207|488109|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
207301|NCT00389168|488213|P2|NOT COMPLETED|Overall Study||5
207302|NCT00389168|488214|P1|NOT COMPLETED|Overall Study||9
207303|NCT00389168|488213|P2|COMPLETED|Overall Study||53
207304|NCT00389168|488214|P1|COMPLETED|Overall Study||47
207305|NCT00389168|488213|P2|STARTED|Overall Study||58
207306|NCT00389168|488214|P1|STARTED|Overall Study||56
207307|NCT00389064|488232|P2|NOT COMPLETED|Overall Study||59
207308|NCT00389064|488233|P1|NOT COMPLETED|Overall Study||45
207309|NCT00389064|488232|P2|COMPLETED|Overall Study||168
207310|NCT00389064|488233|P1|COMPLETED|Overall Study||178
207311|NCT00389064|488232|P2|STARTED|Overall Study||227
207312|NCT00389064|488233|P1|STARTED|Overall Study||223
207313|NCT00388973|488261|P2|NOT COMPLETED|Overall Study||58
207314|NCT00388973|488262|P1|NOT COMPLETED|Overall Study||56
207315|NCT00388973|488261|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
207316|NCT00388973|488262|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
207317|NCT00388973|488261|P2|Completed Study|Overall Study||114
207318|NCT00388973|488262|P1|Completed Study|Overall Study||110
207319|NCT00388973|488261|P2|STARTED|Overall Study|Randomized|172
207320|NCT00388973|488262|P1|STARTED|Overall Study|Randomized|166
207321|NCT00388947|488282|P1|NOT COMPLETED|Overall Study||47
207322|NCT00388947|488282|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
207323|NCT00388947|488282|P1|STARTED|Overall Study||1590
207324|NCT00388804|488289|P2|NOT COMPLETED|Overall Study||0
207325|NCT00388804|488290|P1|NOT COMPLETED|Overall Study||0
207326|NCT00388804|488289|P2|COMPLETED|Overall Study||21
207327|NCT00388804|488290|P1|COMPLETED|Overall Study||17
207328|NCT00388804|488289|P2|STARTED|Overall Study||21
207329|NCT00388804|488290|P1|STARTED|Overall Study||17
207330|NCT00388037|488296|P1|NOT COMPLETED|Overall Study||1
207331|NCT00388037|488296|P1|COMPLETED|Overall Study||30
207332|NCT00388037|488296|P1|STARTED|Overall Study||31
207333|NCT00387153|488300|P1|NOT COMPLETED|Overall Study||8
207334|NCT00387153|488300|P1|COMPLETED|Overall Study||0
207335|NCT00387153|488300|P1|STARTED|Overall Study||8
207336|NCT00388726|488306|P2|NOT COMPLETED|Overall Study||244
207337|NCT00388726|488307|P1|NOT COMPLETED|Overall Study||484
207338|NCT00388726|488306|P2|COMPLETED|Overall Study||10
207339|NCT00388726|488307|P1|COMPLETED|Overall Study||24
207340|NCT00388726|488306|P2|STARTED|Overall Study||254
207341|NCT00388726|488307|P1|STARTED|Overall Study||508
207342|NCT00388583|488321|P2|NOT COMPLETED|Overall Study||4
207343|NCT00388583|488322|P1|NOT COMPLETED|Overall Study||6
207344|NCT00388583|488321|P2|COMPLETED|Overall Study||406
207345|NCT00388583|488322|P1|COMPLETED|Overall Study||401
207346|NCT00388583|488321|P2|STARTED|Overall Study||410
207347|NCT00388583|488322|P1|STARTED|Overall Study||407
207348|NCT00388505|488336|P2|NOT COMPLETED|Overall Study||38
207349|NCT00388505|488337|P1|NOT COMPLETED|Overall Study||83
207350|NCT00388505|488336|P2|COMPLETED|Overall Study||171
207351|NCT00388505|488337|P1|COMPLETED|Overall Study||225
207352|NCT00388505|488336|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
207353|NCT00388505|488337|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
207354|NCT00388154|488359|P1|NOT COMPLETED|Overall Study||1
207355|NCT00388154|488359|P1|COMPLETED|Overall Study||20
207356|NCT00388154|488359|P1|STARTED|Overall Study||21
207357|NCT00387959|488364|P1|NOT COMPLETED|Overall Study||1
207358|NCT00387959|488364|P1|COMPLETED|Overall Study||16
207359|NCT00387959|488364|P1|STARTED|Overall Study||17
207360|NCT00387894|488368|P1|NOT COMPLETED|Overall Study||1
207361|NCT00387894|488368|P1|COMPLETED|Overall Study||5
207362|NCT00387894|488368|P1|STARTED|Overall Study||6
207363|NCT00387881|488375|P2|NOT COMPLETED|Overall Study||102
207364|NCT00387881|488376|P1|NOT COMPLETED|Overall Study||89
207365|NCT00387881|488375|P2|COMPLETED|Overall Study||243
207366|NCT00387881|488376|P1|COMPLETED|Overall Study||245
207367|NCT00387881|488375|P2|STARTED|Overall Study||345
207368|NCT00387881|488376|P1|STARTED|Overall Study||334
207369|NCT00387829|488400|P2|NOT COMPLETED|Intent-to-treat Population||30
207370|NCT00387829|488401|P1|NOT COMPLETED|Intent-to-treat Population||38
207371|NCT00387829|488400|P2|COMPLETED|Intent-to-treat Population||136
207372|NCT00387829|488401|P1|COMPLETED|Intent-to-treat Population||139
207373|NCT00387829|488400|P2|STARTED|Intent-to-treat Population||166
207374|NCT00387829|488401|P1|STARTED|Intent-to-treat Population||177
207375|NCT00387829|488400|P2|NOT COMPLETED|Safety Population||33
207376|NCT00387829|488401|P1|NOT COMPLETED|Safety Population||39
207377|NCT00387829|488400|P2|COMPLETED|Safety Population||136
207378|NCT00387829|488401|P1|COMPLETED|Safety Population||139
207379|NCT00387829|488400|P2|STARTED|Safety Population||169
207380|NCT00387829|488401|P1|STARTED|Safety Population||178
207381|NCT00387790|488409|P1|NOT COMPLETED|Overall Study||14
207382|NCT00387790|488409|P1|COMPLETED|Overall Study||50
207383|NCT00387790|488409|P1|STARTED|Overall Study||64
207384|NCT00387764|488413|P1|NOT COMPLETED|Overall Study||31
207385|NCT00387764|488413|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
207386|NCT00387764|488413|P1|STARTED|Overall Study||80
207387|NCT00387751|488431|P1|NOT COMPLETED|Overall Study||0
207388|NCT00387751|488431|P1|COMPLETED|Overall Study||14
207389|NCT00387751|488431|P1|STARTED|Overall Study||14
207390|NCT00387725|488439|P4|NOT COMPLETED|Overall Study||2
207391|NCT00387725|488440|P3|NOT COMPLETED|Overall Study||2
207392|NCT00387725|488441|P2|NOT COMPLETED|Overall Study||1
207393|NCT00387725|488442|P1|NOT COMPLETED|Overall Study||1
207394|NCT00387725|488439|P4|COMPLETED|Overall Study||43
207395|NCT00387725|488440|P3|COMPLETED|Overall Study||43
207396|NCT00387725|488441|P2|COMPLETED|Overall Study||15
207397|NCT00387725|488442|P1|COMPLETED|Overall Study||20
207398|NCT00387725|488439|P4|STARTED|Overall Study||45
207399|NCT00387725|488440|P3|STARTED|Overall Study||45
207400|NCT00387725|488441|P2|STARTED|Overall Study||16
207401|NCT00387725|488442|P1|STARTED|Overall Study||21
207402|NCT00387647|488460|P1|NOT COMPLETED|Overall Study||18
207403|NCT00387647|488460|P1|COMPLETED|Overall Study||6
207404|NCT00387647|488460|P1|STARTED|Overall Study||24
207405|NCT00387621|488469|P2|NOT COMPLETED|Second Intervention||0
207406|NCT00387621|488470|P1|NOT COMPLETED|Second Intervention||0
207407|NCT00387621|488469|P2|COMPLETED|Second Intervention||29
207408|NCT00387621|488470|P1|COMPLETED|Second Intervention||29
207409|NCT00387621|488469|P2|STARTED|Second Intervention||29
207410|NCT00387621|488470|P1|STARTED|Second Intervention||29
207411|NCT00387621|488469|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
207412|NCT00387621|488470|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
207413|NCT00387621|488469|P2|COMPLETED|Washout Period of 2 Weeks||29
207414|NCT00387621|488470|P1|COMPLETED|Washout Period of 2 Weeks||29
207415|NCT00387621|488469|P2|STARTED|Washout Period of 2 Weeks||29
207416|NCT00387621|488470|P1|STARTED|Washout Period of 2 Weeks||29
207417|NCT00387621|488469|P2|NOT COMPLETED|First Intervention||0
207418|NCT00387621|488470|P1|NOT COMPLETED|First Intervention||0
207419|NCT00387621|488469|P2|COMPLETED|First Intervention||29
207420|NCT00387621|488470|P1|COMPLETED|First Intervention||29
207421|NCT00387621|488469|P2|STARTED|First Intervention||29
207422|NCT00387621|488470|P1|STARTED|First Intervention||29
207423|NCT00387426|488500|P1|NOT COMPLETED|Overall Study||14
207424|NCT00387426|488500|P1|COMPLETED|Overall Study||0
207425|NCT00387426|488500|P1|STARTED|Overall Study||14
207426|NCT00387348|488507|P3|NOT COMPLETED|Overall Study||4
207427|NCT00387348|488508|P2|NOT COMPLETED|Overall Study||3
207428|NCT00387348|488509|P1|NOT COMPLETED|Overall Study||3
207429|NCT00387348|488507|P3|COMPLETED|Overall Study||7
207430|NCT00387348|488508|P2|COMPLETED|Overall Study||2
207431|NCT00387348|488509|P1|COMPLETED|Overall Study||5
207432|NCT00387348|488507|P3|STARTED|Overall Study||11
207433|NCT00387348|488508|P2|STARTED|Overall Study||5
207434|NCT00387348|488509|P1|STARTED|Overall Study||8
207435|NCT00387335|488525|P2|NOT COMPLETED|Overall Study||0
207436|NCT00387335|488526|P1|NOT COMPLETED|Overall Study||0
207437|NCT00387335|488525|P2|COMPLETED|Overall Study||7
207438|NCT00387335|488526|P1|COMPLETED|Overall Study||15
207439|NCT00387335|488525|P2|STARTED|Overall Study||7
207440|NCT00387335|488526|P1|STARTED|Overall Study||15
207441|NCT00387127|488540|P2|NOT COMPLETED|Overall Study||34
207442|NCT00387127|488541|P1|NOT COMPLETED|Overall Study||33
207443|NCT00387127|488540|P2|COMPLETED|Overall Study||0
207444|NCT00387127|488541|P1|COMPLETED|Overall Study||0
207445|NCT00387127|488540|P2|STARTED|Overall Study||34
207446|NCT00387127|488541|P1|STARTED|Overall Study||33
207447|NCT00387088|488583|P2|NOT COMPLETED|Overall Study||373
207448|NCT00387088|488584|P1|NOT COMPLETED|Overall Study||318
207449|NCT00387088|488583|P2|COMPLETED|Overall Study||1629
207450|NCT00387088|488584|P1|COMPLETED|Overall Study||1671
207451|NCT00387088|488583|P2|STARTED|Overall Study||2002
207452|NCT00387088|488584|P1|STARTED|Overall Study||1989
207453|NCT00387036|488628|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
207454|NCT00387036|488629|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
207455|NCT00387036|488628|P2|COMPLETED|2-Week Crossover Second Intervention||6
207456|NCT00387036|488629|P1|COMPLETED|2-Week Crossover Second Intervention||6
207457|NCT00387036|488628|P2|STARTED|2-Week Crossover Second Intervention||6
207458|NCT00387036|488629|P1|STARTED|2-Week Crossover Second Intervention||6
207459|NCT00387036|488628|P2|NOT COMPLETED|2-Week Placebo Washout||0
207460|NCT00387036|488629|P1|NOT COMPLETED|2-Week Placebo Washout||0
207461|NCT00387036|488628|P2|COMPLETED|2-Week Placebo Washout||6
207462|NCT00387036|488629|P1|COMPLETED|2-Week Placebo Washout||6
207463|NCT00387036|488628|P2|STARTED|2-Week Placebo Washout||6
207464|NCT00387036|488629|P1|STARTED|2-Week Placebo Washout||6
207465|NCT00387036|488628|P2|NOT COMPLETED|2-Week First Intervention||0
207466|NCT00387036|488629|P1|NOT COMPLETED|2-Week First Intervention||0
207467|NCT00387036|488628|P2|COMPLETED|2-Week First Intervention||6
207468|NCT00387036|488629|P1|COMPLETED|2-Week First Intervention||6
207469|NCT00387036|488628|P2|STARTED|2-Week First Intervention||6
207470|NCT00387036|488629|P1|STARTED|2-Week First Intervention||6
207471|NCT00387023|488637|P1|NOT COMPLETED|Overall Study||0
207472|NCT00387023|488637|P1|COMPLETED|Overall Study||12
207473|NCT00387023|488637|P1|STARTED|Overall Study||12
207474|NCT00387010|488641|P1|NOT COMPLETED|Treatment Period||11
207475|NCT00387010|488641|P1|COMPLETED|Treatment Period||169
207476|NCT00387010|488641|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
207477|NCT00387010|488641|P1|STARTED|Treatment Period||180
207478|NCT00387010|488641|P1|NOT COMPLETED|Dose Titration Period||38
207479|NCT00387010|488641|P1|COMPLETED|Dose Titration Period||180
207480|NCT00387010|488641|P1|STARTED|Dose Titration Period||218
207481|NCT00386880|488662|P2|NOT COMPLETED|Overall Study||0
207482|NCT00386880|488663|P1|NOT COMPLETED|Overall Study||0
207483|NCT00386880|488662|P2|COMPLETED|Overall Study||8
207484|NCT00386880|488663|P1|COMPLETED|Overall Study||30
207485|NCT00386880|488662|P2|STARTED|Overall Study||8
207486|NCT00386880|488663|P1|STARTED|Overall Study||30
207487|NCT00386776|488668|P1|NOT COMPLETED|Overall Study||8
207488|NCT00386776|488668|P1|COMPLETED|Overall Study||32
207489|NCT00386776|488668|P1|STARTED|Overall Study||40
207490|NCT00386607|488678|P2|NOT COMPLETED|Extension||17
207491|NCT00386607|488679|P1|NOT COMPLETED|Extension||0
207492|NCT00386607|488678|P2|COMPLETED|Extension||145
207493|NCT00386607|488679|P1|COMPLETED|Extension||0
207494|NCT00386607|488678|P2|STARTED|Extension||162
207495|NCT00386607|488679|P1|STARTED|Extension||0
207496|NCT00386607|488678|P2|NOT COMPLETED|Core||0
207497|NCT00386607|488679|P1|NOT COMPLETED|Core||115
207498|NCT00386607|488678|P2|COMPLETED|Core||0
207499|NCT00386607|488679|P1|COMPLETED|Core||486
207500|NCT00386607|488678|P2|STARTED|Core||0
207501|NCT00386607|488679|P1|STARTED|Core||601
207502|NCT00386477|488697|P2|NOT COMPLETED|Overall Study||0
207503|NCT00386477|488698|P1|NOT COMPLETED|Overall Study||0
207504|NCT00386477|488697|P2|COMPLETED|Overall Study||145
207505|NCT00386477|488698|P1|COMPLETED|Overall Study||155
207506|NCT00386477|488697|P2|STARTED|Overall Study||145
207507|NCT00386477|488698|P1|STARTED|Overall Study||155
207508|NCT00386425|488707|P3|NOT COMPLETED|Overall Study||0
207509|NCT00386425|488708|P2|NOT COMPLETED|Overall Study||1
207510|NCT00386425|488709|P1|NOT COMPLETED|Overall Study||3
207511|NCT00386425|488707|P3|COMPLETED|Overall Study||53
207512|NCT00386425|488708|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
207513|NCT00386425|488709|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
207514|NCT00386425|488707|P3|Received Study Drug|Overall Study||53
207515|NCT00386425|488708|P2|Received Study Drug|Overall Study||206
207516|NCT00386425|488709|P1|Received Study Drug|Overall Study||227
207517|NCT00386425|488707|P3|STARTED|Overall Study||53
207518|NCT00386425|488708|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
207519|NCT00386425|488709|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
207520|NCT00386360|488735|P2|NOT COMPLETED|Overall Study||17
207521|NCT00386360|488736|P1|NOT COMPLETED|Overall Study||9
207522|NCT00386360|488735|P2|COMPLETED|Overall Study||95
207523|NCT00386360|488736|P1|COMPLETED|Overall Study||40
207524|NCT00386360|488735|P2|Primary Efficacy|Overall Study||77
207525|NCT00386360|488736|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
207526|NCT00386360|488735|P2|Intent to Treat Population (ITT)|Overall Study||110
207527|NCT00386360|488736|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
207528|NCT00386360|488735|P2|STARTED|Overall Study||112
207529|NCT00386360|488736|P1|STARTED|Overall Study||49
207530|NCT00386334|488770|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
207531|NCT00386334|488771|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
207532|NCT00386334|488770|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
207533|NCT00386334|488771|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
207534|NCT00386334|488770|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
207535|NCT00386334|488771|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
207536|NCT00386334|488770|P2|NOT COMPLETED|Double Blind Period||47
207537|NCT00386334|488771|P1|NOT COMPLETED|Double Blind Period||46
207538|NCT00386334|488770|P2|COMPLETED|Double Blind Period||147
207539|NCT00386334|488771|P1|COMPLETED|Double Blind Period||148
207540|NCT00386334|488770|P2|STARTED|Double Blind Period||194
207541|NCT00386334|488771|P1|STARTED|Double Blind Period||194
207542|NCT00386308|488915|P2|NOT COMPLETED|Overall Study||19
207543|NCT00386308|488916|P1|NOT COMPLETED|Overall Study||29
207544|NCT00386308|488915|P2|COMPLETED|Overall Study||54
207545|NCT00386308|488916|P1|COMPLETED|Overall Study||94
207546|NCT00386308|488915|P2|Modified Intent to Treat Population|Overall Study||72
207547|NCT00386308|488916|P1|Modified Intent to Treat Population|Overall Study||115
207548|NCT00386308|488915|P2|Intent to Treat Population|Overall Study||72
207549|NCT00386308|488916|P1|Intent to Treat Population|Overall Study||117
207550|NCT00386308|488915|P2|STARTED|Overall Study||73
207551|NCT00386308|488916|P1|STARTED|Overall Study||123
207552|NCT00386256|488932|P4|NOT COMPLETED|Overall Study||0
207553|NCT00386256|488933|P3|NOT COMPLETED|Overall Study||0
207554|NCT00386256|488934|P2|NOT COMPLETED|Overall Study||0
207555|NCT00386256|488935|P1|NOT COMPLETED|Overall Study||0
207556|NCT00386256|488932|P4|COMPLETED|Overall Study||3
207557|NCT00386256|488933|P3|COMPLETED|Overall Study||4
207558|NCT00386256|488934|P2|COMPLETED|Overall Study||15
207559|NCT00386256|488935|P1|COMPLETED|Overall Study||16
207560|NCT00386256|488932|P4|STARTED|Overall Study||3
207561|NCT00386256|488933|P3|STARTED|Overall Study||4
207562|NCT00386256|488934|P2|STARTED|Overall Study||15
207563|NCT00386256|488935|P1|STARTED|Overall Study||16
207564|NCT00386243|488951|P2|NOT COMPLETED|Overall Study||13
207565|NCT00386243|488952|P1|NOT COMPLETED|Overall Study||7
207566|NCT00386243|488951|P2|COMPLETED|Overall Study||108
207567|NCT00386243|488952|P1|COMPLETED|Overall Study||114
207568|NCT00386243|488951|P2|STARTED|Overall Study||121
207569|NCT00386243|488952|P1|STARTED|Overall Study||121
207570|NCT00386152|488963|P3|NOT COMPLETED|Overall Study||33
207571|NCT00386152|488964|P2|NOT COMPLETED|Overall Study||40
207572|NCT00386152|488965|P1|NOT COMPLETED|Overall Study||44
207573|NCT00386152|488963|P3|COMPLETED|Overall Study||42
207574|NCT00386152|488964|P2|COMPLETED|Overall Study||37
207575|NCT00386152|488965|P1|COMPLETED|Overall Study||31
207576|NCT00386152|488963|P3|STARTED|Overall Study|number of subjects treated|75
207577|NCT00386152|488964|P2|STARTED|Overall Study|number of subjects treated|77
207578|NCT00386152|488965|P1|STARTED|Overall Study|number of subjects treated|75
207579|NCT00386100|488984|P2|NOT COMPLETED|Overall Study||131
207580|NCT00386100|488985|P1|NOT COMPLETED|Overall Study||154
207581|NCT00386100|488984|P2|COMPLETED|Overall Study||217
207582|NCT00386100|488985|P1|COMPLETED|Overall Study||186
207583|NCT00386100|488984|P2|STARTED|Overall Study||348
207584|NCT00386100|488985|P1|STARTED|Overall Study||340
207585|NCT00386009|489049|P2|NOT COMPLETED|Overall Study||10
207586|NCT00386009|489050|P1|NOT COMPLETED|Overall Study||9
207587|NCT00386009|489049|P2|COMPLETED|Overall Study||89
207588|NCT00386009|489050|P1|COMPLETED|Overall Study||92
207589|NCT00386009|489049|P2|STARTED|Overall Study||99
207590|NCT00386009|489050|P1|STARTED|Overall Study||101
207591|NCT00385996|489088|P1|NOT COMPLETED|Overall Study||0
207592|NCT00385996|489088|P1|COMPLETED|Overall Study||22
207593|NCT00385996|489088|P1|STARTED|Overall Study||22
207594|NCT00385944|489095|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
207595|NCT00385944|489096|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
207596|NCT00385944|489097|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
207597|NCT00385944|489095|P3|COMPLETED|2nd Maintenance Dose Period||0
207598|NCT00385944|489096|P2|COMPLETED|2nd Maintenance Dose Period||19
207599|NCT00385944|489097|P1|COMPLETED|2nd Maintenance Dose Period||22
207600|NCT00385944|489095|P3|STARTED|2nd Maintenance Dose Period||0
207601|NCT00385944|489096|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
207602|NCT00385944|489097|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
207603|NCT00385944|489095|P3|NOT COMPLETED|1st Maintenance Dose Period||0
207604|NCT00385944|489096|P2|NOT COMPLETED|1st Maintenance Dose Period||1
207605|NCT00385944|489097|P1|NOT COMPLETED|1st Maintenance Dose Period||4
207606|NCT00385944|489095|P3|COMPLETED|1st Maintenance Dose Period||0
207607|NCT00385944|489096|P2|COMPLETED|1st Maintenance Dose Period||24
207608|NCT00385944|489097|P1|COMPLETED|1st Maintenance Dose Period||25
207609|NCT00385944|489095|P3|STARTED|1st Maintenance Dose Period||0
207610|NCT00385944|489096|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
207611|NCT00385944|489097|P1|STARTED|1st Maintenance Dose Period||29
207612|NCT00385944|489095|P3|NOT COMPLETED|Loading Dose||0
207613|NCT00385944|489096|P2|NOT COMPLETED|Loading Dose||0
207614|NCT00385944|489097|P1|NOT COMPLETED|Loading Dose||0
207615|NCT00385944|489095|P3|COMPLETED|Loading Dose||56
207616|NCT00385944|489096|P2|COMPLETED|Loading Dose||0
207617|NCT00385944|489097|P1|COMPLETED|Loading Dose||0
207618|NCT00385944|489095|P3|STARTED|Loading Dose||56
207619|NCT00385944|489096|P2|STARTED|Loading Dose||0
207620|NCT00385944|489097|P1|STARTED|Loading Dose||0
207621|NCT00385918|489140|P3|NOT COMPLETED|Intervention Phase After Randomization||0
207622|NCT00385918|489141|P2|NOT COMPLETED|Intervention Phase After Randomization||0
207623|NCT00385918|489142|P1|NOT COMPLETED|Intervention Phase After Randomization||3
207624|NCT00385918|489140|P3|COMPLETED|Intervention Phase After Randomization||0
207625|NCT00385918|489141|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
207626|NCT00385918|489142|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
207627|NCT00385918|489140|P3|STARTED|Intervention Phase After Randomization||0
207628|NCT00385918|489141|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
207629|NCT00385918|489142|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
207630|NCT00385918|489140|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
207631|NCT00385918|489141|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
207632|NCT00385918|489142|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
207633|NCT00385918|489140|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
207634|NCT00385918|489141|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
207635|NCT00385918|489142|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
207636|NCT00385918|489140|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
207637|NCT00385918|489141|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
207638|NCT00385918|489142|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
207639|NCT00385918|489140|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
207640|NCT00385918|489141|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
207641|NCT00385918|489142|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
207642|NCT00385918|489140|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
207643|NCT00385918|489141|P2|STARTED|Feasibility & Baseline Measurement Phase||0
207644|NCT00385918|489142|P1|STARTED|Feasibility & Baseline Measurement Phase||0
207645|NCT00385840|489166|P2|NOT COMPLETED|Overall Study||14
207646|NCT00385840|489167|P1|NOT COMPLETED|Overall Study||4
207647|NCT00385840|489166|P2|COMPLETED|Overall Study||531
207648|NCT00385840|489167|P1|COMPLETED|Overall Study||129
207649|NCT00385840|489166|P2|STARTED|Overall Study||545
207650|NCT00385840|489167|P1|STARTED|Overall Study||133
207651|NCT00385827|489190|P3|NOT COMPLETED|Part 2||48
207652|NCT00385827|489191|P2|NOT COMPLETED|Part 2||33
207653|NCT00385827|489192|P1|NOT COMPLETED|Part 2||0
207654|NCT00385827|489190|P3|COMPLETED|Part 2||0
207655|NCT00385827|489191|P2|COMPLETED|Part 2||16
207656|NCT00385827|489192|P1|COMPLETED|Part 2||0
207657|NCT00385827|489190|P3|Treated|Part 2||46
207658|NCT00385827|489191|P2|Treated|Part 2||47
207659|NCT00385827|489192|P1|Treated|Part 2||0
207660|NCT00385827|489190|P3|STARTED|Part 2||48
207661|NCT00385827|489191|P2|STARTED|Part 2||49
207662|NCT00385827|489192|P1|STARTED|Part 2||0
207663|NCT00385827|489190|P3|NOT COMPLETED|Part 1||0
207664|NCT00385827|489191|P2|NOT COMPLETED|Part 1||0
207665|NCT00385827|489192|P1|NOT COMPLETED|Part 1||9
207666|NCT00385827|489190|P3|COMPLETED|Part 1||0
207667|NCT00385827|489191|P2|COMPLETED|Part 1||0
207668|NCT00385827|489192|P1|COMPLETED|Part 1||0
207669|NCT00385827|489190|P3|Treated|Part 1||0
207670|NCT00385827|489191|P2|Treated|Part 1||0
207671|NCT00385827|489192|P1|Treated|Part 1||9
207672|NCT00385827|489190|P3|STARTED|Part 1||0
207673|NCT00385827|489191|P2|STARTED|Part 1||0
207674|NCT00385827|489192|P1|STARTED|Part 1||9
207675|NCT00385736|489215|P3|NOT COMPLETED|Safety Analysis Set||80
207676|NCT00385736|489216|P2|NOT COMPLETED|Safety Analysis Set||44
207677|NCT00385736|489217|P1|NOT COMPLETED|Safety Analysis Set||70
207678|NCT00385736|489215|P3|COMPLETED|Safety Analysis Set||143
207679|NCT00385736|489216|P2|COMPLETED|Safety Analysis Set||86
207680|NCT00385736|489217|P1|COMPLETED|Safety Analysis Set||153
207681|NCT00385736|489215|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
207682|NCT00385736|489216|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
207683|NCT00385736|489217|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
207684|NCT00385736|489215|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
207685|NCT00385736|489216|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
207686|NCT00385736|489217|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
207687|NCT00385736|489215|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
207688|NCT00385736|489216|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
207689|NCT00385736|489217|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
207690|NCT00385736|489215|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
207691|NCT00385736|489216|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
207692|NCT00385736|489217|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
207693|NCT00385736|489215|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
207694|NCT00385736|489216|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
207695|NCT00385736|489217|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
207696|NCT00385736|489215|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
207697|NCT00385736|489216|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
207698|NCT00385736|489217|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
207699|NCT00385736|489215|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
207700|NCT00385736|489216|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
207701|NCT00385736|489217|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
207702|NCT00385723|489262|P3|NOT COMPLETED|Overall Study||2
207703|NCT00385723|489263|P2|NOT COMPLETED|Overall Study||1
207704|NCT00385723|489264|P1|NOT COMPLETED|Overall Study||2
207705|NCT00385723|489262|P3|COMPLETED|Overall Study||44
207706|NCT00385723|489263|P2|COMPLETED|Overall Study||45
207707|NCT00385723|489264|P1|COMPLETED|Overall Study||44
207708|NCT00385723|489262|P3|STARTED|Overall Study||46
207709|NCT00385723|489263|P2|STARTED|Overall Study||46
207710|NCT00385723|489264|P1|STARTED|Overall Study||46
207711|NCT00385684|489278|P2|NOT COMPLETED|PHASE B||0
207712|NCT00385684|489279|P1|NOT COMPLETED|PHASE B||0
207713|NCT00385684|489278|P2|COMPLETED|PHASE B||3
207714|NCT00385684|489279|P1|COMPLETED|PHASE B||5
207715|NCT00385684|489278|P2|STARTED|PHASE B||3
207716|NCT00385684|489279|P1|STARTED|PHASE B||5
207717|NCT00385684|489278|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
207718|NCT00385684|489279|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
207719|NCT00385684|489278|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
207720|NCT00385684|489279|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
207721|NCT00385684|489278|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
207722|NCT00385684|489279|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
207723|NCT00385684|489278|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
207724|NCT00385684|489279|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
207725|NCT00385684|489278|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
207726|NCT00385684|489279|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
207727|NCT00385684|489278|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
207728|NCT00385684|489279|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
207729|NCT00385671|489288|P3|NOT COMPLETED|Overall Study||36
207730|NCT00385671|489289|P2|NOT COMPLETED|Overall Study||51
207731|NCT00385671|489290|P1|NOT COMPLETED|Overall Study||38
207732|NCT00385671|489288|P3|COMPLETED|Overall Study||99
207733|NCT00385671|489289|P2|COMPLETED|Overall Study||87
207734|NCT00385671|489290|P1|COMPLETED|Overall Study||96
207735|NCT00385671|489288|P3|STARTED|Overall Study||135
207736|NCT00385671|489289|P2|STARTED|Overall Study||138
207737|NCT00385671|489290|P1|STARTED|Overall Study||134
207738|NCT00385593|489446|P2|NOT COMPLETED|Overall Study||37
207739|NCT00385593|489447|P1|NOT COMPLETED|Overall Study||58
207740|NCT00385593|489446|P2|COMPLETED|Overall Study||289
207741|NCT00385593|489447|P1|COMPLETED|Overall Study||270
207742|NCT00385593|489446|P2|STARTED|Overall Study||326
207743|NCT00385593|489447|P1|STARTED|Overall Study||328
207744|NCT00385580|489465|P2|NOT COMPLETED|Overall Study||0
207745|NCT00385580|489466|P1|NOT COMPLETED|Overall Study||0
207746|NCT00385580|489465|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
207747|NCT00385580|489466|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
207748|NCT00385580|489465|P2|STARTED|Overall Study|Number of participants treated.|47
207749|NCT00385580|489466|P1|STARTED|Overall Study|Number of participants treated.|48
207750|NCT00385541|489557|P2|NOT COMPLETED|Overall Study||1
207751|NCT00385541|489558|P1|NOT COMPLETED|Overall Study||0
207752|NCT00385541|489557|P2|COMPLETED|Overall Study||24
207753|NCT00385541|489558|P1|COMPLETED|Overall Study||25
207754|NCT00385541|489557|P2|STARTED|Overall Study||25
207755|NCT00385541|489558|P1|STARTED|Overall Study||25
207756|NCT00385515|489574|P2|NOT COMPLETED|Overall Study||3
207757|NCT00385515|489575|P1|NOT COMPLETED|Overall Study||4
207758|NCT00385515|489574|P2|COMPLETED|Overall Study||21
207759|NCT00385515|489575|P1|COMPLETED|Overall Study||53
207760|NCT00385515|489574|P2|STARTED|Overall Study||24
207761|NCT00385515|489575|P1|STARTED|Overall Study||57
207762|NCT00385268|489583|P2|NOT COMPLETED|Overall Study||8
207763|NCT00385268|489584|P1|NOT COMPLETED|Overall Study||16
207764|NCT00385268|489583|P2|COMPLETED|Overall Study||18
207765|NCT00385268|489584|P1|COMPLETED|Overall Study||18
207766|NCT00385268|489583|P2|STARTED|Overall Study||26
207767|NCT00385268|489584|P1|STARTED|Overall Study||34
207768|NCT00385216|489590|P2|NOT COMPLETED|Second Intervention||0
207769|NCT00385216|489591|P1|NOT COMPLETED|Second Intervention||0
207770|NCT00385216|489590|P2|COMPLETED|Second Intervention||9
207771|NCT00385216|489591|P1|COMPLETED|Second Intervention||11
207772|NCT00385216|489590|P2|STARTED|Second Intervention||9
207773|NCT00385216|489591|P1|STARTED|Second Intervention||11
207774|NCT00385216|489590|P2|NOT COMPLETED|First Intervention||0
207775|NCT00385216|489591|P1|NOT COMPLETED|First Intervention||0
207776|NCT00385216|489590|P2|COMPLETED|First Intervention||9
207777|NCT00385216|489591|P1|COMPLETED|First Intervention||11
207778|NCT00385216|489590|P2|STARTED|First Intervention||9
207779|NCT00385216|489591|P1|STARTED|First Intervention||11
207780|NCT00385203|489605|P2|NOT COMPLETED|Overall Study||7
207781|NCT00385203|489606|P1|NOT COMPLETED|Overall Study||26
207782|NCT00385203|489605|P2|COMPLETED|Overall Study||3
207783|NCT00385203|489606|P1|COMPLETED|Overall Study||0
207784|NCT00385203|489605|P2|STARTED|Overall Study||10
207785|NCT00385203|489606|P1|STARTED|Overall Study||26
207786|NCT00385138|489626|P2|NOT COMPLETED|Overall Study||28
207787|NCT00385138|489627|P1|NOT COMPLETED|Overall Study||30
207788|NCT00385138|489626|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
207789|NCT00385138|489627|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
207790|NCT00385138|489626|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
207791|NCT00385138|489627|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
207792|NCT00385138|489626|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
207793|NCT00385138|489627|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
207794|NCT00385138|489626|P2|Intent-to-treat (ITT)|Overall Study||2669
207795|NCT00385138|489627|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
207796|NCT00385138|489626|P2|STARTED|Overall Study||2669
207797|NCT00385138|489627|P1|STARTED|Overall Study||2695
207798|NCT00384956|489671|P1|NOT COMPLETED|Overall Study||3
207799|NCT00384956|489671|P1|COMPLETED|Overall Study||22
207800|NCT00384956|489671|P1|STARTED|Overall Study||25
207801|NCT00384930|489688|P5|NOT COMPLETED|Overall Study||47
207802|NCT00384930|489689|P4|NOT COMPLETED|Overall Study||41
207803|NCT00384930|489690|P3|NOT COMPLETED|Overall Study||30
207804|NCT00384930|489691|P2|NOT COMPLETED|Overall Study||27
207805|NCT00384930|489692|P1|NOT COMPLETED|Overall Study||27
207806|NCT00384930|489688|P5|COMPLETED|Overall Study||162
207807|NCT00384930|489689|P4|COMPLETED|Overall Study||175
207808|NCT00384930|489690|P3|COMPLETED|Overall Study||182
207809|NCT00384930|489691|P2|COMPLETED|Overall Study||182
207810|NCT00384930|489692|P1|COMPLETED|Overall Study||185
207811|NCT00384930|489688|P5|Received Double-Blind Study Drug|Overall Study||209
207812|NCT00384930|489689|P4|Received Double-Blind Study Drug|Overall Study||216
207813|NCT00384930|489690|P3|Received Double-Blind Study Drug|Overall Study||212
207814|NCT00384930|489691|P2|Received Double-Blind Study Drug|Overall Study||208
207815|NCT00384930|489692|P1|Received Double-Blind Study Drug|Overall Study||211
207816|NCT00384930|489688|P5|STARTED|Overall Study||209
207817|NCT00384930|489689|P4|STARTED|Overall Study||216
207818|NCT00384930|489690|P3|STARTED|Overall Study||212
207819|NCT00384930|489691|P2|STARTED|Overall Study||209
207820|NCT00384930|489692|P1|STARTED|Overall Study||212
207821|NCT00384813|489748|P2|NOT COMPLETED|Overall Study||0
207822|NCT00384813|489749|P1|NOT COMPLETED|Overall Study||2
207823|NCT00384813|489748|P2|COMPLETED|Overall Study||20
207824|NCT00384813|489749|P1|COMPLETED|Overall Study||21
207825|NCT00384813|489748|P2|STARTED|Overall Study||20
207826|NCT00384813|489749|P1|STARTED|Overall Study||23
207827|NCT00384748|489757|P2|NOT COMPLETED|Overall Study||0
207828|NCT00384748|489758|P1|NOT COMPLETED|Overall Study||0
207829|NCT00384748|489757|P2|COMPLETED|Overall Study||23
207830|NCT00384748|489758|P1|COMPLETED|Overall Study||25
207831|NCT00384748|489757|P2|STARTED|Overall Study||23
207832|NCT00384748|489758|P1|STARTED|Overall Study||25
207833|NCT00384670|489764|P1|NOT COMPLETED|Overall Study||0
207834|NCT00384670|489764|P1|COMPLETED|Overall Study||7
207835|NCT00384670|489764|P1|STARTED|Overall Study||7
207836|NCT00384397|489777|P3|NOT COMPLETED|Overall Study||33
207837|NCT00384397|489778|P2|NOT COMPLETED|Overall Study||46
207838|NCT00384397|489779|P1|NOT COMPLETED|Overall Study||32
207839|NCT00384397|489777|P3|COMPLETED|Overall Study||385
207840|NCT00384397|489778|P2|COMPLETED|Overall Study||247
207841|NCT00384397|489779|P1|COMPLETED|Overall Study||375
207842|NCT00384397|489777|P3|STARTED|Overall Study||418
207843|NCT00384397|489778|P2|STARTED|Overall Study||293
207844|NCT00384397|489779|P1|STARTED|Overall Study||407
207845|NCT00384293|489798|P3|NOT COMPLETED|Post-randomization Period||219
207846|NCT00384293|489799|P2|NOT COMPLETED|Post-randomization Period||214
207847|NCT00384293|489800|P1|NOT COMPLETED|Post-randomization Period||0
207848|NCT00384293|489798|P3|COMPLETED|Post-randomization Period||0
207849|NCT00384293|489799|P2|COMPLETED|Post-randomization Period||0
207850|NCT00384293|489800|P1|COMPLETED|Post-randomization Period||0
207851|NCT00384293|489798|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
207852|NCT00384293|489799|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
207853|NCT00384293|489800|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
207854|NCT00384293|489798|P3|STARTED|Post-randomization Period||219
207855|NCT00384293|489799|P2|STARTED|Post-randomization Period||214
207856|NCT00384293|489800|P1|STARTED|Post-randomization Period||0
207857|NCT00384293|489798|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
207858|NCT00384293|489799|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
207859|NCT00384293|489800|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
207860|NCT00384293|489798|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
207861|NCT00384293|489799|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
207862|NCT00384293|489800|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
207863|NCT00384293|489798|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
207864|NCT00384293|489799|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
207865|NCT00384293|489800|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
207866|NCT00384293|489798|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
207867|NCT00384293|489799|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
207868|NCT00384293|489800|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
207869|NCT00384293|489798|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
207870|NCT00384293|489799|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
207871|NCT00384293|489800|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
207872|NCT00383565|489811|P1|NOT COMPLETED|Overall Study||0
207873|NCT00383565|489811|P1|COMPLETED|Overall Study||9
207874|NCT00383565|489811|P1|STARTED|Overall Study||9
207875|NCT00383552|489821|P4|NOT COMPLETED|Overall Study||72
207876|NCT00383552|489822|P3|NOT COMPLETED|Overall Study||61
207877|NCT00383552|489823|P2|NOT COMPLETED|Overall Study||41
207878|NCT00383552|489824|P1|NOT COMPLETED|Overall Study||36
207879|NCT00383552|489821|P4|COMPLETED|Overall Study||116
207880|NCT00383552|489822|P3|COMPLETED|Overall Study||127
207881|NCT00383552|489823|P2|COMPLETED|Overall Study||147
207882|NCT00383552|489824|P1|COMPLETED|Overall Study||146
207883|NCT00383552|489821|P4|STARTED|Overall Study||188
207884|NCT00383552|489822|P3|STARTED|Overall Study||188
207885|NCT00383552|489823|P2|STARTED|Overall Study||188
207886|NCT00383552|489824|P1|STARTED|Overall Study||182
207887|NCT00384241|489865|P2|NOT COMPLETED|Overall Study||0
207888|NCT00384241|489866|P1|NOT COMPLETED|Overall Study||0
207889|NCT00384241|489865|P2|COMPLETED|Overall Study||599
207890|NCT00384241|489866|P1|COMPLETED|Overall Study||500
207891|NCT00384241|489865|P2|STARTED|Overall Study||599
207892|NCT00384241|489866|P1|STARTED|Overall Study||500
207893|NCT00384189|489876|P4|NOT COMPLETED|Overall Study||40
207894|NCT00384189|489877|P3|NOT COMPLETED|Overall Study||58
207895|NCT00384189|489878|P2|NOT COMPLETED|Overall Study||57
207896|NCT00384189|489879|P1|NOT COMPLETED|Overall Study||50
207897|NCT00384189|489876|P4|COMPLETED|Overall Study||110
207898|NCT00384189|489877|P3|COMPLETED|Overall Study||255
207899|NCT00384189|489878|P2|COMPLETED|Overall Study||255
207900|NCT00384189|489879|P1|COMPLETED|Overall Study||255
207901|NCT00384189|489876|P4|Actual Treatment Received|Overall Study||146
207902|NCT00384189|489877|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
207903|NCT00384189|489878|P2|Actual Treatment Received|Overall Study||312
207904|NCT00384189|489879|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
207905|NCT00384189|489876|P4|Randomized, Not Treated|Overall Study||4
207906|NCT00384189|489877|P3|Randomized, Not Treated|Overall Study||2
207907|NCT00384189|489878|P2|Randomized, Not Treated|Overall Study||0
207908|NCT00384189|489879|P1|Randomized, Not Treated|Overall Study||1
207909|NCT00384189|489876|P4|STARTED|Overall Study||150
207910|NCT00384189|489877|P3|STARTED|Overall Study||313
207911|NCT00384189|489878|P2|STARTED|Overall Study||312
207912|NCT00384189|489879|P1|STARTED|Overall Study||305
207913|NCT00384176|489940|P3|NOT COMPLETED|Overall Study||132
207914|NCT00384176|489941|P2|NOT COMPLETED|Overall Study||319
207915|NCT00384176|489942|P1|NOT COMPLETED|Overall Study||312
207916|NCT00384176|489940|P3|COMPLETED|Overall Study||60
207917|NCT00384176|489941|P2|COMPLETED|Overall Study||394
207918|NCT00384176|489942|P1|COMPLETED|Overall Study||397
207919|NCT00384176|489940|P3|STARTED|Overall Study||192
207920|NCT00384176|489941|P2|STARTED|Overall Study||713
207921|NCT00384176|489942|P1|STARTED|Overall Study||709
207922|NCT00384085|489968|P3|NOT COMPLETED|Overall Study||56
207923|NCT00384085|489969|P2|NOT COMPLETED|Overall Study||46
207924|NCT00384085|489970|P1|NOT COMPLETED|Overall Study||39
207925|NCT00384085|489968|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
207926|NCT00384085|489969|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
207927|NCT00384085|489970|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
207928|NCT00384085|489968|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
207929|NCT00384085|489969|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
207930|NCT00384085|489970|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
207931|NCT00384085|489968|P3|Treated (Safety Population)|Overall Study||194
207932|NCT00384085|489969|P2|Treated (Safety Population)|Overall Study||194
207933|NCT00384085|489970|P1|Treated (Safety Population)|Overall Study||194
207934|NCT00384085|489968|P3|Intent-To-Treat (ITT)|Overall Study||197
207935|NCT00384085|489969|P2|Intent-To-Treat (ITT)|Overall Study||196
207936|NCT00384085|489970|P1|Intent-To-Treat (ITT)|Overall Study||195
207937|NCT00384085|489968|P3|STARTED|Overall Study|Randomized|197
207938|NCT00384085|489969|P2|STARTED|Overall Study|Randomized|196
207939|NCT00384085|489970|P1|STARTED|Overall Study|Randomized|195
207940|NCT00384059|489996|P2|NOT COMPLETED|Toddler Dose||2
207941|NCT00384059|489997|P1|NOT COMPLETED|Toddler Dose||1
207942|NCT00384059|489996|P2|COMPLETED|Toddler Dose||120
207943|NCT00384059|489997|P1|COMPLETED|Toddler Dose||130
207944|NCT00384059|489996|P2|STARTED|Toddler Dose||122
207945|NCT00384059|489997|P1|STARTED|Toddler Dose||131
207946|NCT00384059|489996|P2|NOT COMPLETED|After Infant Series||10
207947|NCT00384059|489997|P1|NOT COMPLETED|After Infant Series||4
207948|NCT00384059|489996|P2|COMPLETED|After Infant Series||122
207949|NCT00384059|489997|P1|COMPLETED|After Infant Series||131
207950|NCT00384059|489996|P2|STARTED|After Infant Series||132
207951|NCT00384059|489997|P1|STARTED|After Infant Series||135
207952|NCT00384059|489996|P2|NOT COMPLETED|Infant Series||13
207953|NCT00384059|489997|P1|NOT COMPLETED|Infant Series||6
207954|NCT00384059|489996|P2|COMPLETED|Infant Series||132
207955|NCT00384059|489997|P1|COMPLETED|Infant Series||135
207956|NCT00384059|489996|P2|Vaccinated Dose 2|Infant Series||135
207957|NCT00384059|489997|P1|Vaccinated Dose 2|Infant Series||136
207958|NCT00384059|489996|P2|Vaccinated Dose 1|Infant Series||139
207959|NCT00384059|489997|P1|Vaccinated Dose 1|Infant Series||139
207960|NCT00384059|489996|P2|STARTED|Infant Series||145
207961|NCT00384059|489997|P1|STARTED|Infant Series||141
207962|NCT00384033|490047|P4|NOT COMPLETED|Overall Study||40
207963|NCT00384033|490048|P3|NOT COMPLETED|Overall Study||43
207964|NCT00384033|490049|P2|NOT COMPLETED|Overall Study||35
207965|NCT00384033|490050|P1|NOT COMPLETED|Overall Study||41
207966|NCT00384033|490047|P4|COMPLETED|Overall Study||119
207967|NCT00384033|490048|P3|COMPLETED|Overall Study||117
207968|NCT00384033|490049|P2|COMPLETED|Overall Study||120
207969|NCT00384033|490050|P1|COMPLETED|Overall Study||123
207970|NCT00384033|490047|P4|Treated|Overall Study||157
207971|NCT00384033|490048|P3|Treated|Overall Study||150
207972|NCT00384033|490049|P2|Treated|Overall Study||148
207973|NCT00384033|490050|P1|Treated|Overall Study||161
207974|NCT00384033|490047|P4|STARTED|Overall Study||159
207975|NCT00384033|490048|P3|STARTED|Overall Study||160
207976|NCT00384033|490049|P2|STARTED|Overall Study||155
207977|NCT00384033|490050|P1|STARTED|Overall Study||164
207978|NCT00383786|490094|P2|NOT COMPLETED|Overall Study||12
207979|NCT00383786|490095|P1|NOT COMPLETED|Overall Study||4
207980|NCT00383786|490094|P2|COMPLETED|Overall Study||13
207981|NCT00383786|490095|P1|COMPLETED|Overall Study||18
207982|NCT00383786|490094|P2|STARTED|Overall Study||25
207983|NCT00383786|490095|P1|STARTED|Overall Study||22
207984|NCT00383760|490101|P1|NOT COMPLETED|Overall Study||0
207985|NCT00383760|490101|P1|COMPLETED|Overall Study||15
207986|NCT00383760|490101|P1|STARTED|Overall Study||15
207987|NCT00383721|490120|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
207988|NCT00383721|490121|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
207989|NCT00383721|490122|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
207990|NCT00383721|490123|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
207991|NCT00383721|490124|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
207992|NCT00383721|490120|P5|COMPLETED|26-Week Treatment Safety Extension||8
207993|NCT00383721|490121|P4|COMPLETED|26-Week Treatment Safety Extension||131
207994|NCT00383721|490122|P3|COMPLETED|26-Week Treatment Safety Extension||126
207995|NCT00383721|490123|P2|COMPLETED|26-Week Treatment Safety Extension||136
207996|NCT00383721|490124|P1|COMPLETED|26-Week Treatment Safety Extension||126
207997|NCT00383721|490120|P5|STARTED|26-Week Treatment Safety Extension||8
207998|NCT00383721|490121|P4|STARTED|26-Week Treatment Safety Extension||148
207999|NCT00383721|490122|P3|STARTED|26-Week Treatment Safety Extension||149
208000|NCT00383721|490123|P2|STARTED|26-Week Treatment Safety Extension||153
208001|NCT00383721|490124|P1|STARTED|26-Week Treatment Safety Extension||145
208002|NCT00383721|490120|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
208003|NCT00383721|490121|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
208004|NCT00383721|490122|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
208005|NCT00383721|490123|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
208006|NCT00383721|490124|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
208007|NCT00383721|490120|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
208008|NCT00383721|490121|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
208009|NCT00383721|490122|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
208010|NCT00383721|490123|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
208011|NCT00383721|490124|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
208012|NCT00383721|490120|P5|STARTED|26-Week Double-Blind Treatment Period||236
208013|NCT00383721|490121|P4|STARTED|26-Week Double-Blind Treatment Period||243
208014|NCT00383721|490122|P3|STARTED|26-Week Double-Blind Treatment Period||253
208015|NCT00383721|490123|P2|STARTED|26-Week Double-Blind Treatment Period||239
208016|NCT00383721|490124|P1|STARTED|26-Week Double-Blind Treatment Period||225
208017|NCT00383435|490166|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
208018|NCT00383435|490167|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
208019|NCT00383435|490168|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
208020|NCT00383435|490169|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
208021|NCT00383435|490170|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
208022|NCT00383435|490166|P5|COMPLETED|26-Week Treatment Safety Extension||10
208023|NCT00383435|490167|P4|COMPLETED|26-Week Treatment Safety Extension||116
208024|NCT00383435|490168|P3|COMPLETED|26-Week Treatment Safety Extension||108
208025|NCT00383435|490169|P2|COMPLETED|26-Week Treatment Safety Extension||121
208026|NCT00383435|490170|P1|COMPLETED|26-Week Treatment Safety Extension||117
208027|NCT00383435|490166|P5|STARTED|26-Week Treatment Safety Extension||13
208028|NCT00383435|490167|P4|STARTED|26-Week Treatment Safety Extension||131
208029|NCT00383435|490168|P3|STARTED|26-Week Treatment Safety Extension||124
208030|NCT00383435|490169|P2|STARTED|26-Week Treatment Safety Extension||130
208031|NCT00383435|490170|P1|STARTED|26-Week Treatment Safety Extension||131
208032|NCT00383435|490166|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
208033|NCT00383435|490167|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
208034|NCT00383435|490168|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
208035|NCT00383435|490169|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
208036|NCT00383435|490170|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
208037|NCT00383435|490166|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
208038|NCT00383435|490167|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
208039|NCT00383435|490168|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
208040|NCT00383435|490169|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
208041|NCT00383435|490170|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
208042|NCT00383435|490166|P5|STARTED|26-Week Double-Blind Treatment Period||212
208043|NCT00383435|490167|P4|STARTED|26-Week Double-Blind Treatment Period||209
208044|NCT00383435|490168|P3|STARTED|26-Week Double-Blind Treatment Period||210
208045|NCT00383435|490169|P2|STARTED|26-Week Double-Blind Treatment Period||207
208046|NCT00383435|490170|P1|STARTED|26-Week Double-Blind Treatment Period||217
208047|NCT00383331|490209|P2|NOT COMPLETED|Overall Study||1
208048|NCT00383331|490210|P1|NOT COMPLETED|Overall Study||0
208049|NCT00383331|490209|P2|COMPLETED|Overall Study||8
208050|NCT00383331|490210|P1|COMPLETED|Overall Study||10
208051|NCT00383331|490209|P2|STARTED|Overall Study||9
208052|NCT00383331|490210|P1|STARTED|Overall Study||10
208053|NCT00383266|490226|P1|NOT COMPLETED|Overall Study||0
208054|NCT00383266|490226|P1|COMPLETED|Overall Study||9
208055|NCT00383266|490226|P1|STARTED|Overall Study||9
208056|NCT00383240|490239|P4|NOT COMPLETED|Overall Study||77
208057|NCT00383240|490240|P3|NOT COMPLETED|Overall Study||85
208058|NCT00383240|490241|P2|NOT COMPLETED|Overall Study||33
208059|NCT00383240|490242|P1|NOT COMPLETED|Overall Study||35
208060|NCT00383240|490239|P4|COMPLETED|Overall Study||119
208061|NCT00383240|490240|P3|COMPLETED|Overall Study||117
208062|NCT00383240|490241|P2|COMPLETED|Overall Study||159
208063|NCT00383240|490242|P1|COMPLETED|Overall Study||156
208064|NCT00383240|490239|P4|STARTED|Overall Study||196
208065|NCT00383240|490240|P3|STARTED|Overall Study||202
208066|NCT00383240|490241|P2|STARTED|Overall Study||192
208067|NCT00383240|490242|P1|STARTED|Overall Study||191
208068|NCT00383162|490273|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
208069|NCT00383162|490274|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
208070|NCT00383162|490273|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
208071|NCT00383162|490274|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
208072|NCT00383162|490273|P2|STARTED|Migraine Attack 2 (Period 2)||73
208073|NCT00383162|490274|P1|STARTED|Migraine Attack 2 (Period 2)||67
208074|NCT00383162|490273|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
208075|NCT00383162|490274|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
208076|NCT00383162|490273|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
208077|NCT00383162|490274|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
208078|NCT00383162|490273|P2|STARTED|Migraine Attack 1 (Period 1)||86
208079|NCT00383162|490274|P1|STARTED|Migraine Attack 1 (Period 1)||87
208080|NCT00383149|490316|P1|NOT COMPLETED|Overall Study||54
208081|NCT00383149|490316|P1|COMPLETED|Overall Study||0
208082|NCT00383149|490316|P1|STARTED|Overall Study||54
208083|NCT00383123|490335|P2|NOT COMPLETED|Overall Study||86
208084|NCT00383123|490336|P1|NOT COMPLETED|Overall Study||111
208085|NCT00383123|490335|P2|COMPLETED|Overall Study||1124
208086|NCT00383123|490336|P1|COMPLETED|Overall Study||2004
208087|NCT00383123|490335|P2|STARTED|Overall Study||1210
208088|NCT00383123|490336|P1|STARTED|Overall Study||2115
208089|NCT00383110|490358|P2|NOT COMPLETED|Overall Study||0
208090|NCT00383110|490359|P1|NOT COMPLETED|Overall Study||0
208091|NCT00383110|490358|P2|COMPLETED|Overall Study||150
208092|NCT00383110|490359|P1|COMPLETED|Overall Study||150
208093|NCT00383110|490358|P2|STARTED|Overall Study||150
208094|NCT00383110|490359|P1|STARTED|Overall Study||150
208095|NCT00383084|490377|P2|NOT COMPLETED|Overall Study||10
208096|NCT00383084|490378|P1|NOT COMPLETED|Overall Study||12
208097|NCT00383084|490377|P2|COMPLETED|Overall Study||28
208098|NCT00383084|490378|P1|COMPLETED|Overall Study||34
208099|NCT00383084|490377|P2|STARTED|Overall Study||38
208100|NCT00383084|490378|P1|STARTED|Overall Study||46
208101|NCT00383071|490394|P4|NOT COMPLETED|Overall Study||3
208102|NCT00383071|490395|P3|NOT COMPLETED|Overall Study||7
208103|NCT00383071|490396|P2|NOT COMPLETED|Overall Study||4
208104|NCT00383071|490397|P1|NOT COMPLETED|Overall Study||0
208105|NCT00383071|490394|P4|COMPLETED|Overall Study||22
208106|NCT00383071|490395|P3|COMPLETED|Overall Study||44
208107|NCT00383071|490396|P2|COMPLETED|Overall Study||21
208108|NCT00383071|490397|P1|COMPLETED|Overall Study||25
208109|NCT00383071|490394|P4|STARTED|Overall Study||25
208110|NCT00383071|490395|P3|STARTED|Overall Study||51
208111|NCT00383071|490396|P2|STARTED|Overall Study||25
208112|NCT00383071|490397|P1|STARTED|Overall Study||25
208113|NCT00383019|490409|P2|NOT COMPLETED|Overall Study||2
208114|NCT00383019|490410|P1|NOT COMPLETED|Overall Study||5
208115|NCT00383019|490409|P2|COMPLETED|Overall Study||143
208116|NCT00383019|490410|P1|COMPLETED|Overall Study||139
208117|NCT00383019|490409|P2|STARTED|Overall Study||145
208118|NCT00383019|490410|P1|STARTED|Overall Study||144
208119|NCT00382993|490432|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
208120|NCT00382993|490433|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
208121|NCT00382993|490432|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
208122|NCT00382993|490433|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
208123|NCT00382993|490432|P2|STARTED|Migraine Attack 2 (Period 2)||67
208124|NCT00382993|490433|P1|STARTED|Migraine Attack 2 (Period 2)||70
208125|NCT00382993|490432|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
208126|NCT00382993|490433|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
208127|NCT00382993|490432|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
208128|NCT00382993|490433|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
208129|NCT00382993|490432|P2|STARTED|Migraine Attack 1 (Period 1)||85
208130|NCT00382993|490433|P1|STARTED|Migraine Attack 1 (Period 1)||84
208131|NCT00382967|490477|P2|NOT COMPLETED|Overall Study||1
208132|NCT00382967|490478|P1|NOT COMPLETED|Overall Study||1
208133|NCT00382967|490477|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
208134|NCT00382967|490478|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
208135|NCT00382967|490477|P2|STARTED|Overall Study||138
208136|NCT00382967|490478|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
208137|NCT00382928|490488|P2|NOT COMPLETED|Overall Study||0
208138|NCT00382928|490489|P1|NOT COMPLETED|Overall Study||0
208139|NCT00382928|490488|P2|COMPLETED|Overall Study||95
208140|NCT00382928|490489|P1|COMPLETED|Overall Study||97
208141|NCT00382928|490488|P2|STARTED|Overall Study||95
208142|NCT00382928|490489|P1|STARTED|Overall Study||97
208143|NCT00382863|490503|P2|NOT COMPLETED|Overall Study||36
208144|NCT00382863|490504|P1|NOT COMPLETED|Overall Study||15
208145|NCT00382863|490503|P2|COMPLETED|Overall Study||78
208146|NCT00382863|490504|P1|COMPLETED|Overall Study||81
208147|NCT00382863|490503|P2|STARTED|Overall Study||114
208148|NCT00382863|490504|P1|STARTED|Overall Study||96
208149|NCT00382785|490560|P2|NOT COMPLETED|Overall Study||0
208150|NCT00382785|490561|P1|NOT COMPLETED|Overall Study||0
208151|NCT00382785|490560|P2|COMPLETED|Overall Study||26
208152|NCT00382785|490561|P1|COMPLETED|Overall Study||25
208153|NCT00382785|490560|P2|STARTED|Overall Study||26
208154|NCT00382785|490561|P1|STARTED|Overall Study||25
208155|NCT00382733|490571|P5|NOT COMPLETED|Overall Study||0
208156|NCT00382733|490572|P4|NOT COMPLETED|Overall Study||0
208157|NCT00382733|490573|P3|NOT COMPLETED|Overall Study||0
208158|NCT00382733|490574|P2|NOT COMPLETED|Overall Study||1
208159|NCT00382733|490575|P1|NOT COMPLETED|Overall Study||0
208160|NCT00382733|490571|P5|COMPLETED|Overall Study||2
208161|NCT00382733|490572|P4|COMPLETED|Overall Study||14
208162|NCT00382733|490573|P3|COMPLETED|Overall Study||3
208163|NCT00382733|490574|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
208164|NCT00382733|490575|P1|COMPLETED|Overall Study||3
208165|NCT00382733|490571|P5|STARTED|Overall Study||2
208166|NCT00382733|490572|P4|STARTED|Overall Study||14
208167|NCT00382733|490573|P3|STARTED|Overall Study||3
208168|NCT00382733|490574|P2|STARTED|Overall Study||4
208169|NCT00382733|490575|P1|STARTED|Overall Study||3
208170|NCT00382720|490596|P3|NOT COMPLETED|Overall Study||86
208171|NCT00382720|490597|P2|NOT COMPLETED|Overall Study||89
208172|NCT00382720|490598|P1|NOT COMPLETED|Overall Study||79
208173|NCT00382720|490596|P3|COMPLETED|Overall Study||0
208174|NCT00382720|490597|P2|COMPLETED|Overall Study||0
208175|NCT00382720|490598|P1|COMPLETED|Overall Study||0
208176|NCT00382720|490596|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
208177|NCT00382720|490597|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
208178|NCT00382720|490598|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
208179|NCT00382720|490596|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
208180|NCT00382720|490597|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
208181|NCT00382720|490598|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
208182|NCT00382720|490596|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
208183|NCT00382720|490597|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
208184|NCT00382720|490598|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
208185|NCT00382720|490596|P3|STARTED|Overall Study||86
208186|NCT00382720|490597|P2|STARTED|Overall Study||89
208187|NCT00382720|490598|P1|STARTED|Overall Study||79
208188|NCT00382590|490614|P2|NOT COMPLETED|Overall Study||0
208189|NCT00382590|490615|P1|NOT COMPLETED|Overall Study||0
208190|NCT00382590|490614|P2|COMPLETED|Overall Study||6
208191|NCT00382590|490615|P1|COMPLETED|Overall Study||4
208192|NCT00382590|490614|P2|STARTED|Overall Study||6
208193|NCT00382590|490615|P1|STARTED|Overall Study||4
208194|NCT00382408|490623|P2|NOT COMPLETED|Overall Study||54
208195|NCT00382408|490624|P1|NOT COMPLETED|Overall Study||144
208196|NCT00382408|490623|P2|COMPLETED|Overall Study||955
208197|NCT00382408|490624|P1|COMPLETED|Overall Study||2887
208198|NCT00382408|490623|P2|STARTED|Overall Study||1009
208199|NCT00382408|490624|P1|STARTED|Overall Study||3031
208200|NCT00382291|490639|P3|NOT COMPLETED|Overall Study||8
208201|NCT00382291|490640|P2|NOT COMPLETED|Overall Study||7
208202|NCT00382291|490641|P1|NOT COMPLETED|Overall Study||4
208203|NCT00382291|490639|P3|COMPLETED|Overall Study||13
208204|NCT00382291|490640|P2|COMPLETED|Overall Study||10
208205|NCT00382291|490641|P1|COMPLETED|Overall Study||14
208206|NCT00382291|490639|P3|STARTED|Overall Study||21
208207|NCT00382291|490640|P2|STARTED|Overall Study||17
208208|NCT00382291|490641|P1|STARTED|Overall Study||18
208209|NCT00382174|490654|P3|NOT COMPLETED|Overall Study||21
208210|NCT00382174|490655|P2|NOT COMPLETED|Overall Study||17
208211|NCT00382174|490656|P1|NOT COMPLETED|Overall Study||4
208212|NCT00382174|490654|P3|COMPLETED|Overall Study||51
208213|NCT00382174|490655|P2|COMPLETED|Overall Study||37
208214|NCT00382174|490656|P1|COMPLETED|Overall Study||14
208215|NCT00382174|490654|P3|STARTED|Overall Study||72
208216|NCT00382174|490655|P2|STARTED|Overall Study||54
208217|NCT00382174|490656|P1|STARTED|Overall Study||18
208218|NCT00382148|490669|P2|NOT COMPLETED|Overall Study||0
208219|NCT00382148|490670|P1|NOT COMPLETED|Overall Study||1
208220|NCT00382148|490669|P2|COMPLETED|Overall Study||7
208221|NCT00382148|490670|P1|COMPLETED|Overall Study||3
208222|NCT00382148|490669|P2|STARTED|Overall Study||7
208223|NCT00382148|490670|P1|STARTED|Overall Study||4
208224|NCT00382109|490684|P2|NOT COMPLETED|Overall Study||4
208225|NCT00382109|490685|P1|NOT COMPLETED|Overall Study||12
208226|NCT00382109|490684|P2|COMPLETED|Overall Study||66
208227|NCT00382109|490685|P1|COMPLETED|Overall Study||64
208228|NCT00382109|490684|P2|STARTED|Overall Study||70
208229|NCT00382109|490685|P1|STARTED|Overall Study||76
208230|NCT00382031|490707|P2|NOT COMPLETED|Overall Study||0
208231|NCT00382031|490708|P1|NOT COMPLETED|Overall Study||0
208232|NCT00382031|490707|P2|COMPLETED|Overall Study||95
208233|NCT00382031|490708|P1|COMPLETED|Overall Study||191
208326|NCT00381485|490908|P2|COMPLETED|Double-Blind Treatment Period||228
208234|NCT00382031|490707|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
208235|NCT00382031|490708|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
208236|NCT00381940|490720|P1|NOT COMPLETED|Overall Study||5
208237|NCT00381940|490720|P1|COMPLETED|Overall Study||21
208238|NCT00381940|490720|P1|STARTED|Overall Study||26
208239|NCT00381888|490724|P1|NOT COMPLETED|Overall Study||17
208240|NCT00381888|490724|P1|COMPLETED|Overall Study||27
208241|NCT00381888|490724|P1|STARTED|Overall Study||44
208242|NCT00381862|490729|P1|NOT COMPLETED|Overall Study||10
208243|NCT00381862|490729|P1|COMPLETED|Overall Study||44
208244|NCT00381862|490729|P1|STARTED|Overall Study||54
208245|NCT00381849|490735|P2|NOT COMPLETED|Open-label||0
208246|NCT00381849|490736|P1|NOT COMPLETED|Open-label||0
208247|NCT00381849|490735|P2|COMPLETED|Open-label||9
208248|NCT00381849|490736|P1|COMPLETED|Open-label||10
208249|NCT00381849|490735|P2|STARTED|Open-label||9
208250|NCT00381849|490736|P1|STARTED|Open-label||10
208251|NCT00381849|490735|P2|NOT COMPLETED|Second Intervention||0
208252|NCT00381849|490736|P1|NOT COMPLETED|Second Intervention||0
208253|NCT00381849|490735|P2|COMPLETED|Second Intervention||9
208254|NCT00381849|490736|P1|COMPLETED|Second Intervention||10
208255|NCT00381849|490735|P2|STARTED|Second Intervention||9
208256|NCT00381849|490736|P1|STARTED|Second Intervention||10
208257|NCT00381849|490735|P2|NOT COMPLETED|Wash Out||1
208258|NCT00381849|490736|P1|NOT COMPLETED|Wash Out||0
208259|NCT00381849|490735|P2|COMPLETED|Wash Out||9
208260|NCT00381849|490736|P1|COMPLETED|Wash Out||10
208261|NCT00381849|490735|P2|STARTED|Wash Out||10
208262|NCT00381849|490736|P1|STARTED|Wash Out||10
208263|NCT00381849|490735|P2|NOT COMPLETED|First Intervention||0
208264|NCT00381849|490736|P1|NOT COMPLETED|First Intervention||0
208265|NCT00381849|490735|P2|COMPLETED|First Intervention||10
208266|NCT00381849|490736|P1|COMPLETED|First Intervention||10
208267|NCT00381849|490735|P2|STARTED|First Intervention||10
208268|NCT00381849|490736|P1|STARTED|First Intervention||10
208269|NCT00381810|490754|P1|NOT COMPLETED|B Cell Follow-up||7
208270|NCT00381810|490754|P1|COMPLETED|B Cell Follow-up||0
208271|NCT00381810|490754|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
208272|NCT00381810|490754|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
208273|NCT00381810|490754|P1|COMPLETED|Treatment and Safety Follow-up||16
208274|NCT00381810|490754|P1|STARTED|Treatment and Safety Follow-up||31
208275|NCT00381797|490763|P5|NOT COMPLETED|Overall Study||2
208276|NCT00381797|490764|P4|NOT COMPLETED|Overall Study||1
208277|NCT00381797|490765|P3|NOT COMPLETED|Overall Study||0
208278|NCT00381797|490766|P2|NOT COMPLETED|Overall Study||1
208279|NCT00381797|490767|P1|NOT COMPLETED|Overall Study||1
208280|NCT00381797|490763|P5|COMPLETED|Overall Study||35
208281|NCT00381797|490764|P4|COMPLETED|Overall Study||14
208282|NCT00381797|490765|P3|COMPLETED|Overall Study||10
208283|NCT00381797|490766|P2|COMPLETED|Overall Study||16
208284|NCT00381797|490767|P1|COMPLETED|Overall Study||17
208285|NCT00381797|490763|P5|STARTED|Overall Study||37
208286|NCT00381797|490764|P4|STARTED|Overall Study||15
208287|NCT00381797|490765|P3|STARTED|Overall Study||10
208288|NCT00381797|490766|P2|STARTED|Overall Study||17
208289|NCT00381797|490767|P1|STARTED|Overall Study||18
208290|NCT00381693|490817|P1|NOT COMPLETED|Overall Study||8
208291|NCT00381693|490817|P1|COMPLETED|Overall Study||2
208292|NCT00381693|490817|P1|STARTED|Overall Study||10
208293|NCT00381628|490828|P4|NOT COMPLETED|Overall Study||0
208294|NCT00381628|490829|P3|NOT COMPLETED|Overall Study||0
208295|NCT00381628|490830|P2|NOT COMPLETED|Overall Study||0
208296|NCT00381628|490831|P1|NOT COMPLETED|Overall Study||0
208297|NCT00381628|490828|P4|COMPLETED|Overall Study||14
208298|NCT00381628|490829|P3|COMPLETED|Overall Study||0
208299|NCT00381628|490830|P2|COMPLETED|Overall Study||27
208300|NCT00381628|490831|P1|COMPLETED|Overall Study||18
208301|NCT00381628|490828|P4|STARTED|Overall Study||14
208302|NCT00381628|490829|P3|STARTED|Overall Study||0
208303|NCT00381628|490830|P2|STARTED|Overall Study||27
208304|NCT00381628|490831|P1|STARTED|Overall Study||18
208305|NCT00381615|490845|P4|NOT COMPLETED|Overall Study||2
208306|NCT00381615|490846|P3|NOT COMPLETED|Overall Study||1
208307|NCT00381615|490847|P2|NOT COMPLETED|Overall Study||5
208308|NCT00381615|490848|P1|NOT COMPLETED|Overall Study||4
208309|NCT00381615|490845|P4|COMPLETED|Overall Study||22
208310|NCT00381615|490846|P3|COMPLETED|Overall Study||24
208311|NCT00381615|490847|P2|COMPLETED|Overall Study||45
208312|NCT00381615|490848|P1|COMPLETED|Overall Study||44
208313|NCT00381615|490845|P4|STARTED|Overall Study||24
208314|NCT00381615|490846|P3|STARTED|Overall Study||25
208315|NCT00381615|490847|P2|STARTED|Overall Study||50
208316|NCT00381615|490848|P1|STARTED|Overall Study||48
208317|NCT00381550|490898|P1|NOT COMPLETED|Overall Study||0
208318|NCT00381550|490898|P1|COMPLETED|Overall Study||35
208319|NCT00381550|490898|P1|STARTED|Overall Study||35
208320|NCT00381485|490906|P4|NOT COMPLETED|Double-Blind Treatment Period||33
208321|NCT00381485|490907|P3|NOT COMPLETED|Double-Blind Treatment Period||25
208322|NCT00381485|490908|P2|NOT COMPLETED|Double-Blind Treatment Period||27
208323|NCT00381485|490909|P1|NOT COMPLETED|Double-Blind Treatment Period||0
208324|NCT00381485|490906|P4|COMPLETED|Double-Blind Treatment Period||207
208325|NCT00381485|490907|P3|COMPLETED|Double-Blind Treatment Period||208
208327|NCT00381485|490909|P1|COMPLETED|Double-Blind Treatment Period||0
208328|NCT00381485|490906|P4|STARTED|Double-Blind Treatment Period||240
208329|NCT00381485|490907|P3|STARTED|Double-Blind Treatment Period||233
208330|NCT00381485|490908|P2|STARTED|Double-Blind Treatment Period||255
208331|NCT00381485|490909|P1|STARTED|Double-Blind Treatment Period||0
208332|NCT00381485|490906|P4|NOT COMPLETED|Open-Label Run-In Period||0
208333|NCT00381485|490907|P3|NOT COMPLETED|Open-Label Run-In Period||0
208334|NCT00381485|490908|P2|NOT COMPLETED|Open-Label Run-In Period||0
208335|NCT00381485|490909|P1|NOT COMPLETED|Open-Label Run-In Period||106
208336|NCT00381485|490906|P4|COMPLETED|Open-Label Run-In Period||0
208337|NCT00381485|490907|P3|COMPLETED|Open-Label Run-In Period||0
208338|NCT00381485|490908|P2|COMPLETED|Open-Label Run-In Period||0
208339|NCT00381485|490909|P1|COMPLETED|Open-Label Run-In Period||728
208340|NCT00381485|490906|P4|STARTED|Open-Label Run-In Period||0
208341|NCT00381485|490907|P3|STARTED|Open-Label Run-In Period||0
208342|NCT00381485|490908|P2|STARTED|Open-Label Run-In Period||0
208343|NCT00381485|490909|P1|STARTED|Open-Label Run-In Period||834
208344|NCT00381381|490927|P1|NOT COMPLETED|Overall Study||64
208345|NCT00381381|490927|P1|COMPLETED|Overall Study||135
208346|NCT00381381|490927|P1|STARTED|Overall Study||199
208347|NCT00381303|490936|P2|NOT COMPLETED|Overall Study||33
208348|NCT00381303|490937|P1|NOT COMPLETED|Overall Study||94
208349|NCT00381303|490936|P2|COMPLETED|Overall Study||109
208350|NCT00381303|490937|P1|COMPLETED|Overall Study||193
208351|NCT00381303|490936|P2|STARTED|Overall Study||142
208352|NCT00381303|490937|P1|STARTED|Overall Study||287
208353|NCT00381095|490999|P2|NOT COMPLETED|Overall Study||21
208354|NCT00381095|491000|P1|NOT COMPLETED|Overall Study||13
208355|NCT00381095|490999|P2|COMPLETED|Overall Study||59
208356|NCT00381095|491000|P1|COMPLETED|Overall Study||59
208357|NCT00381095|490999|P2|STARTED|Overall Study||80
208358|NCT00381095|491000|P1|STARTED|Overall Study||72
208359|NCT00381043|491032|P2|NOT COMPLETED|Overall Study||8
208360|NCT00381043|491033|P1|NOT COMPLETED|Overall Study||12
208361|NCT00381043|491032|P2|COMPLETED|Overall Study||41
208362|NCT00381043|491033|P1|COMPLETED|Overall Study||39
208363|NCT00381043|491032|P2|STARTED|Overall Study||49
208364|NCT00381043|491033|P1|STARTED|Overall Study||51
208365|NCT00381004|491051|P1|NOT COMPLETED|Overall Study||0
208366|NCT00381004|491051|P1|COMPLETED|Overall Study||60
208367|NCT00381004|491051|P1|STARTED|Overall Study||60
208368|NCT00380978|491059|P2|NOT COMPLETED|Overall Study||10
208369|NCT00380978|491060|P1|NOT COMPLETED|Overall Study||2
208370|NCT00380978|491059|P2|COMPLETED|Overall Study||400
208371|NCT00380978|491060|P1|COMPLETED|Overall Study||406
208372|NCT00380978|491059|P2|STARTED|Overall Study||410
208373|NCT00380978|491060|P1|STARTED|Overall Study||408
208374|NCT00380874|491082|P2|NOT COMPLETED|Overall Study||10
208375|NCT00380874|491083|P1|NOT COMPLETED|Overall Study||13
208376|NCT00380874|491082|P2|COMPLETED|Overall Study||19
208377|NCT00380874|491083|P1|COMPLETED|Overall Study||19
208378|NCT00380874|491082|P2|STARTED|Overall Study||29
208379|NCT00380874|491083|P1|STARTED|Overall Study||32
208380|NCT00380861|491101|P2|NOT COMPLETED|Overall Study||17
208381|NCT00380861|491102|P1|NOT COMPLETED|Overall Study||18
208382|NCT00380861|491101|P2|COMPLETED|Overall Study||74
208383|NCT00380861|491102|P1|COMPLETED|Overall Study||75
208384|NCT00380861|491101|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
208385|NCT00380861|491102|P1|STARTED|Overall Study||93
208386|NCT00380718|491108|P1|NOT COMPLETED|Overall Study||18
208387|NCT00380718|491108|P1|COMPLETED|Overall Study||15
208388|NCT00380718|491108|P1|Received Escalated Dose in Cycle 2|Overall Study||25
208389|NCT00380718|491108|P1|Received at Least One Dose of Study Drug|Overall Study||33
208390|NCT00380718|491108|P1|STARTED|Overall Study||33
208391|NCT00380692|491120|P2|NOT COMPLETED|Study Period III - Open Label||12
208392|NCT00380692|491121|P1|NOT COMPLETED|Study Period III - Open Label||6
208393|NCT00380692|491120|P2|COMPLETED|Study Period III - Open Label||34
208394|NCT00380692|491121|P1|COMPLETED|Study Period III - Open Label||36
208395|NCT00380692|491120|P2|STARTED|Study Period III - Open Label||46
208396|NCT00380692|491121|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
208397|NCT00380692|491120|P2|NOT COMPLETED|Study Period II - Double Blind||3
208398|NCT00380692|491121|P1|NOT COMPLETED|Study Period II - Double Blind||5
208399|NCT00380692|491120|P2|COMPLETED|Study Period II - Double Blind||46
208400|NCT00380692|491121|P1|COMPLETED|Study Period II - Double Blind||43
208401|NCT00380692|491120|P2|STARTED|Study Period II - Double Blind||49
208402|NCT00380692|491121|P1|STARTED|Study Period II - Double Blind||48
208403|NCT00380588|491169|P2|NOT COMPLETED|Overall Study||40
208404|NCT00380588|491170|P1|NOT COMPLETED|Overall Study||39
208405|NCT00380588|491169|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
208406|NCT00380588|491170|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
208407|NCT00380588|491169|P2|Received at Least One Dose of Study Drug|Overall Study||42
208408|NCT00380588|491170|P1|Received at Least One Dose of Study Drug|Overall Study||41
208409|NCT00380588|491169|P2|STARTED|Overall Study||42
208410|NCT00380588|491170|P1|STARTED|Overall Study||42
208411|NCT00380367|491182|P1|NOT COMPLETED|Overall Study||2
208412|NCT00380367|491182|P1|COMPLETED|Overall Study||108
208413|NCT00380367|491182|P1|STARTED|Overall Study||110
208414|NCT00380250|491189|P2|NOT COMPLETED|Overall Study||55
208415|NCT00380250|491190|P1|NOT COMPLETED|Overall Study||99
208416|NCT00380250|491189|P2|COMPLETED|Overall Study||139
208417|NCT00380250|491190|P1|COMPLETED|Overall Study||297
208418|NCT00380250|491189|P2|STARTED|Overall Study||194
208419|NCT00380250|491190|P1|STARTED|Overall Study||396
208420|NCT00380081|491258|P6|NOT COMPLETED|Overall Study||1
208421|NCT00380081|491259|P5|NOT COMPLETED|Overall Study||1
208422|NCT00380081|491260|P4|NOT COMPLETED|Overall Study||0
208423|NCT00380081|491261|P3|NOT COMPLETED|Overall Study||0
208424|NCT00380081|491262|P2|NOT COMPLETED|Overall Study||0
208425|NCT00380081|491263|P1|NOT COMPLETED|Overall Study||0
208426|NCT00380081|491258|P6|COMPLETED|Overall Study||13
208427|NCT00380081|491259|P5|COMPLETED|Overall Study||12
208428|NCT00380081|491260|P4|COMPLETED|Overall Study||15
208429|NCT00380081|491261|P3|COMPLETED|Overall Study||13
208430|NCT00380081|491262|P2|COMPLETED|Overall Study||13
208431|NCT00380081|491263|P1|COMPLETED|Overall Study||14
208432|NCT00380081|491258|P6|STARTED|Overall Study||14
208433|NCT00380081|491259|P5|STARTED|Overall Study||13
208434|NCT00380081|491260|P4|STARTED|Overall Study||15
208435|NCT00380081|491261|P3|STARTED|Overall Study||13
208436|NCT00380081|491262|P2|STARTED|Overall Study||13
208437|NCT00380081|491263|P1|STARTED|Overall Study||14
208438|NCT00380068|491313|P1|NOT COMPLETED|Overall Study||69
208439|NCT00380068|491313|P1|COMPLETED|Overall Study||155
208440|NCT00380068|491313|P1|STARTED|Overall Study||224
208441|NCT00379899|491335|P2|NOT COMPLETED|Overall Study||40
208442|NCT00379899|491336|P1|NOT COMPLETED|Overall Study||40
208443|NCT00379899|491335|P2|COMPLETED|Overall Study||140
208444|NCT00379899|491336|P1|COMPLETED|Overall Study||140
208445|NCT00379899|491335|P2|STARTED|Overall Study||180
208446|NCT00379899|491336|P1|STARTED|Overall Study||180
208447|NCT00379834|491364|P1|NOT COMPLETED|Overall Study||2
208448|NCT00379834|491364|P1|COMPLETED|Overall Study||8
208449|NCT00379834|491364|P1|STARTED|Overall Study||10
208450|NCT00379821|491372|P4|NOT COMPLETED|Overall Study||79
208451|NCT00379821|491373|P3|NOT COMPLETED|Overall Study||67
208452|NCT00379821|491374|P2|NOT COMPLETED|Overall Study||89
208453|NCT00379821|491375|P1|NOT COMPLETED|Overall Study||73
208454|NCT00379821|491372|P4|COMPLETED|Overall Study||81
208455|NCT00379821|491373|P3|COMPLETED|Overall Study||93
208456|NCT00379821|491374|P2|COMPLETED|Overall Study||71
208457|NCT00379821|491375|P1|COMPLETED|Overall Study||87
208458|NCT00379821|491372|P4|STARTED|Overall Study||160
208459|NCT00379821|491373|P3|STARTED|Overall Study||160
208460|NCT00379821|491374|P2|STARTED|Overall Study||160
208461|NCT00379821|491375|P1|STARTED|Overall Study||160
208462|NCT00379808|491516|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
208463|NCT00379808|491517|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
208464|NCT00379808|491516|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
208465|NCT00379808|491517|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
208466|NCT00379808|491516|P2|STARTED|Intervention Period 2 (4 Weeks)||11
208467|NCT00379808|491517|P1|STARTED|Intervention Period 2 (4 Weeks)||11
208468|NCT00379808|491516|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
208469|NCT00379808|491517|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
208470|NCT00379808|491516|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
208471|NCT00379808|491517|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
208472|NCT00379808|491516|P2|STARTED|Intervention Period 1 (4 Weeks)||11
208473|NCT00379808|491517|P1|STARTED|Intervention Period 1 (4 Weeks)||11
208474|NCT00379795|491538|P5|NOT COMPLETED|Overall Study||49
208475|NCT00379795|491539|P4|NOT COMPLETED|Overall Study||68
208476|NCT00379795|491540|P3|NOT COMPLETED|Overall Study||93
208477|NCT00379795|491541|P2|NOT COMPLETED|Overall Study||51
208478|NCT00379795|491542|P1|NOT COMPLETED|Overall Study||476
208479|NCT00379795|491538|P5|COMPLETED|Overall Study||14
208480|NCT00379795|491539|P4|COMPLETED|Overall Study||6
208481|NCT00379795|491540|P3|COMPLETED|Overall Study||23
208482|NCT00379795|491541|P2|COMPLETED|Overall Study||23
208483|NCT00379795|491542|P1|COMPLETED|Overall Study||50
208484|NCT00379795|491538|P5|Received Ranibizumab in Extension Study|Overall Study||0
208485|NCT00379795|491539|P4|Received Ranibizumab in Extension Study|Overall Study||55
208486|NCT00379795|491540|P3|Received Ranibizumab in Extension Study|Overall Study||113
208487|NCT00379795|491541|P2|Received Ranibizumab in Extension Study|Overall Study||41
208488|NCT00379795|491542|P1|Received Ranibizumab in Extension Study|Overall Study||377
208489|NCT00379795|491538|P5|STARTED|Overall Study||63
208490|NCT00379795|491539|P4|STARTED|Overall Study||74
208491|NCT00379795|491540|P3|STARTED|Overall Study||116
208492|NCT00379795|491541|P2|STARTED|Overall Study||74
208493|NCT00379795|491542|P1|STARTED|Overall Study||526
208494|NCT00379769|491572|P6|NOT COMPLETED|Observational Follow-up||148
208495|NCT00379769|491573|P5|NOT COMPLETED|Observational Follow-up||149
208496|NCT00379769|491574|P4|NOT COMPLETED|Observational Follow-up||0
208497|NCT00379769|491575|P3|NOT COMPLETED|Observational Follow-up||0
208498|NCT00379769|491576|P2|NOT COMPLETED|Observational Follow-up||0
208499|NCT00379769|491577|P1|NOT COMPLETED|Observational Follow-up||0
208500|NCT00379769|491572|P6|COMPLETED|Observational Follow-up||1102
208501|NCT00379769|491573|P5|COMPLETED|Observational Follow-up||1131
208502|NCT00379769|491574|P4|COMPLETED|Observational Follow-up||0
208503|NCT00379769|491575|P3|COMPLETED|Observational Follow-up||0
208504|NCT00379769|491576|P2|COMPLETED|Observational Follow-up||0
208505|NCT00379769|491577|P1|COMPLETED|Observational Follow-up||0
208506|NCT00379769|491572|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
208507|NCT00379769|491573|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
208508|NCT00379769|491574|P4|STARTED|Observational Follow-up||0
208509|NCT00379769|491575|P3|STARTED|Observational Follow-up||0
208510|NCT00379769|491576|P2|STARTED|Observational Follow-up||0
208511|NCT00379769|491577|P1|STARTED|Observational Follow-up||0
208512|NCT00379769|491572|P6|NOT COMPLETED|Main Study||0
208513|NCT00379769|491573|P5|NOT COMPLETED|Main Study||0
208514|NCT00379769|491574|P4|NOT COMPLETED|Main Study||230
208515|NCT00379769|491575|P3|NOT COMPLETED|Main Study||207
208516|NCT00379769|491576|P2|NOT COMPLETED|Main Study||199
208517|NCT00379769|491577|P1|NOT COMPLETED|Main Study||178
208518|NCT00379769|491572|P6|COMPLETED|Main Study||0
208519|NCT00379769|491573|P5|COMPLETED|Main Study||0
208520|NCT00379769|491574|P4|COMPLETED|Main Study||892
208521|NCT00379769|491575|P3|COMPLETED|Main Study||896
208522|NCT00379769|491576|P2|COMPLETED|Main Study||906
208523|NCT00379769|491577|P1|COMPLETED|Main Study||939
208524|NCT00379769|491572|P6|STARTED|Main Study||0
208525|NCT00379769|491573|P5|STARTED|Main Study||0
208526|NCT00379769|491574|P4|STARTED|Main Study||1122
208527|NCT00379769|491575|P3|STARTED|Main Study||1103
208528|NCT00379769|491576|P2|STARTED|Main Study||1105
208529|NCT00379769|491577|P1|STARTED|Main Study||1117
208530|NCT00379639|491736|P5|NOT COMPLETED|Overall Study||6
208531|NCT00379639|491737|P4|NOT COMPLETED|Overall Study||6
208532|NCT00379639|491738|P3|NOT COMPLETED|Overall Study||9
208533|NCT00379639|491739|P2|NOT COMPLETED|Overall Study||5
208534|NCT00379639|491740|P1|NOT COMPLETED|Overall Study||3
208535|NCT00379639|491736|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
208536|NCT00379639|491737|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
208537|NCT00379639|491738|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
208538|NCT00379639|491739|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
208539|NCT00379639|491740|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
208540|NCT00379639|491736|P5|Completed 6 Cycles of Therapy|Overall Study||0
208541|NCT00379639|491737|P4|Completed 6 Cycles of Therapy|Overall Study||0
208542|NCT00379639|491738|P3|Completed 6 Cycles of Therapy|Overall Study||1
208543|NCT00379639|491739|P2|Completed 6 Cycles of Therapy|Overall Study||2
208544|NCT00379639|491740|P1|Completed 6 Cycles of Therapy|Overall Study||4
208545|NCT00379639|491736|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
208546|NCT00379639|491737|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
208547|NCT00379639|491738|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
208548|NCT00379639|491739|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
208549|NCT00379639|491740|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
208550|NCT00379639|491736|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
208551|NCT00379639|491737|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
208552|NCT00379639|491738|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
208553|NCT00379639|491739|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
208554|NCT00379639|491740|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
208555|NCT00379587|491762|P1|NOT COMPLETED|Overall Study||2
208556|NCT00379587|491762|P1|COMPLETED|Overall Study||63
208557|NCT00379587|491762|P1|STARTED|Overall Study||65
208558|NCT00379574|491769|P1|NOT COMPLETED|Overall Study||0
208559|NCT00379574|491769|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
208560|NCT00379574|491769|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
208561|NCT00379353|491776|P2|NOT COMPLETED|Overall Study||6
208562|NCT00379353|491777|P1|NOT COMPLETED|Overall Study||11
208563|NCT00379353|491776|P2|COMPLETED|Overall Study||9
208564|NCT00379353|491777|P1|COMPLETED|Overall Study||5
208565|NCT00379353|491776|P2|STARTED|Overall Study||15
208566|NCT00379353|491777|P1|STARTED|Overall Study||16
208567|NCT00379288|491811|P4|NOT COMPLETED|Overall Study||8
208568|NCT00379288|491812|P3|NOT COMPLETED|Overall Study||10
208569|NCT00379288|491813|P2|NOT COMPLETED|Overall Study||22
208570|NCT00379288|491814|P1|NOT COMPLETED|Overall Study||19
208571|NCT00379288|491811|P4|COMPLETED|Overall Study||57
208572|NCT00379288|491812|P3|COMPLETED|Overall Study||58
208573|NCT00379288|491813|P2|COMPLETED|Overall Study||108
208574|NCT00379288|491814|P1|COMPLETED|Overall Study||122
208575|NCT00379288|491811|P4|STARTED|Overall Study||65
208576|NCT00379288|491812|P3|STARTED|Overall Study||68
208577|NCT00379288|491813|P2|STARTED|Overall Study||130
208578|NCT00379288|491814|P1|STARTED|Overall Study||141
208579|NCT00379236|491826|P3|NOT COMPLETED|Open-label Extension||55
208580|NCT00379236|491827|P2|NOT COMPLETED|Open-label Extension||0
208581|NCT00379236|491828|P1|NOT COMPLETED|Open-label Extension||0
208582|NCT00379236|491826|P3|COMPLETED|Open-label Extension||378
208583|NCT00379236|491827|P2|COMPLETED|Open-label Extension||0
208584|NCT00379236|491828|P1|COMPLETED|Open-label Extension||0
208585|NCT00379236|491826|P3|STARTED|Open-label Extension||433
208586|NCT00379236|491827|P2|STARTED|Open-label Extension||0
208587|NCT00379236|491828|P1|STARTED|Open-label Extension||0
208588|NCT00379236|491826|P3|NOT COMPLETED|Double-blind||0
208589|NCT00379236|491827|P2|NOT COMPLETED|Double-blind||36
208590|NCT00379236|491828|P1|NOT COMPLETED|Double-blind||36
208591|NCT00379236|491826|P3|COMPLETED|Double-blind||0
208592|NCT00379236|491827|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
208593|NCT00379236|491828|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
208594|NCT00379236|491826|P3|STARTED|Double-blind||0
208595|NCT00379236|491827|P2|STARTED|Double-blind||295
208596|NCT00379236|491828|P1|STARTED|Double-blind||293
208597|NCT00379210|491873|P2|NOT COMPLETED|Overall Study||7
208598|NCT00379210|491874|P1|NOT COMPLETED|Overall Study||10
208599|NCT00379210|491873|P2|COMPLETED|Overall Study||23
208600|NCT00379210|491874|P1|COMPLETED|Overall Study||20
208601|NCT00379210|491873|P2|STARTED|Overall Study||30
208602|NCT00379210|491874|P1|STARTED|Overall Study||30
208603|NCT00378703|491884|P4|NOT COMPLETED|Overall Study||91
208604|NCT00378703|491885|P3|NOT COMPLETED|Overall Study||90
208605|NCT00378703|491886|P2|NOT COMPLETED|Overall Study||91
208606|NCT00378703|491887|P1|NOT COMPLETED|Overall Study||89
208607|NCT00378703|491884|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
208608|NCT00378703|491885|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
208609|NCT00378703|491886|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
208610|NCT00378703|491887|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
208611|NCT00378703|491884|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
208612|NCT00378703|491885|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
208613|NCT00378703|491886|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
208614|NCT00378703|491887|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
208615|NCT00378703|491884|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
208616|NCT00378703|491885|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
208617|NCT00378703|491886|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
208618|NCT00378703|491887|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
208619|NCT00378703|491884|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
208620|NCT00378703|491885|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
208621|NCT00378703|491886|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
208622|NCT00378703|491887|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
208623|NCT00378599|491909|P1|NOT COMPLETED|Overall Study||52
208624|NCT00378599|491909|P1|COMPLETED|Overall Study||73
208625|NCT00378599|491909|P1|STARTED|Overall Study||125
208626|NCT00378573|491913|P1|NOT COMPLETED|Follow-up||14
208627|NCT00378573|491913|P1|COMPLETED|Follow-up||3
208628|NCT00378573|491913|P1|STARTED|Follow-up||17
208629|NCT00378573|491913|P1|NOT COMPLETED|Treatment Period||17
208630|NCT00378573|491913|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
208631|NCT00378573|491913|P1|STARTED|Treatment Period||17
208632|NCT00378560|491921|P2|NOT COMPLETED|Overall Study||58
208633|NCT00378560|491922|P1|NOT COMPLETED|Overall Study||56
208634|NCT00378560|491921|P2|COMPLETED|Overall Study||454
208635|NCT00378560|491922|P1|COMPLETED|Overall Study||453
208636|NCT00378560|491921|P2|Vaccinated|Overall Study||512
208637|NCT00378560|491922|P1|Vaccinated|Overall Study||509
208638|NCT00378560|491921|P2|STARTED|Overall Study||512
208639|NCT00378560|491922|P1|STARTED|Overall Study||509
208640|NCT00378534|491936|P1|NOT COMPLETED|Overall Study||60
208641|NCT00378534|491936|P1|COMPLETED|Overall Study|Transplantation Recipients|55
208642|NCT00378534|491936|P1|STARTED|Overall Study||115
208643|NCT00378508|491942|P2|NOT COMPLETED|Overall Study||3
208644|NCT00378508|491943|P1|NOT COMPLETED|Overall Study||2
208645|NCT00378508|491942|P2|COMPLETED|Overall Study||31
208646|NCT00378508|491943|P1|COMPLETED|Overall Study||27
208647|NCT00378508|491942|P2|Received Intervention/Placebo|Overall Study||31
208648|NCT00378508|491943|P1|Received Intervention/Placebo|Overall Study||28
208649|NCT00378508|491942|P2|Randomized|Overall Study||34
208650|NCT00378508|491943|P1|Randomized|Overall Study||29
208651|NCT00378508|491942|P2|STARTED|Overall Study||34
208652|NCT00378508|491943|P1|STARTED|Overall Study||29
208653|NCT00378378|491962|P3|NOT COMPLETED|Overall Study||2
208654|NCT00378378|491963|P2|NOT COMPLETED|Overall Study||1
208655|NCT00378378|491964|P1|NOT COMPLETED|Overall Study||0
208656|NCT00378378|491962|P3|COMPLETED|Overall Study||24
208657|NCT00378378|491963|P2|COMPLETED|Overall Study||49
208658|NCT00378378|491964|P1|COMPLETED|Overall Study||51
208659|NCT00378378|491962|P3|STARTED|Overall Study||26
208660|NCT00378378|491963|P2|STARTED|Overall Study||50
208661|NCT00378378|491964|P1|STARTED|Overall Study||51
208662|NCT00378326|491975|P1|NOT COMPLETED|Overall Study||0
208663|NCT00378326|491975|P1|COMPLETED|Overall Study||26
208664|NCT00378326|491975|P1|STARTED|Overall Study||26
208665|NCT00378209|491981|P1|NOT COMPLETED|Overall Study||22
208666|NCT00378209|491981|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
208667|NCT00378209|491981|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
208668|NCT00378105|491991|P2|NOT COMPLETED|Overall Study||30
208669|NCT00378105|491992|P1|NOT COMPLETED|Overall Study||20
208670|NCT00378105|491991|P2|COMPLETED|Overall Study||5
208671|NCT00378105|491992|P1|COMPLETED|Overall Study||11
208672|NCT00378105|491991|P2|STARTED|Overall Study||35
208673|NCT00378105|491992|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
208674|NCT00378079|492004|P3|NOT COMPLETED|Overall Study||0
208675|NCT00378079|492005|P2|NOT COMPLETED|Overall Study||1
208676|NCT00378079|492006|P1|NOT COMPLETED|Overall Study||6
208677|NCT00378079|492004|P3|COMPLETED|Overall Study||71
208678|NCT00378079|492005|P2|COMPLETED|Overall Study||69
208679|NCT00378079|492006|P1|COMPLETED|Overall Study||64
208680|NCT00378079|492004|P3|STARTED|Overall Study||71
208681|NCT00378079|492005|P2|STARTED|Overall Study||70
208682|NCT00378079|492006|P1|STARTED|Overall Study||70
208683|NCT00378014|492028|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
208684|NCT00378014|492029|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
208685|NCT00378014|492028|P2|COMPLETED|Extension (Month 12 to Month 59)||26
208686|NCT00378014|492029|P1|COMPLETED|Extension (Month 12 to Month 59)||27
208687|NCT00378014|492028|P2|STARTED|Extension (Month 12 to Month 59)||40
208688|NCT00378014|492029|P1|STARTED|Extension (Month 12 to Month 59)||41
208689|NCT00378014|492028|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
208690|NCT00378014|492029|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
208691|NCT00378014|492028|P2|COMPLETED|Core (Randomization to Month 11)||90
208692|NCT00378014|492029|P1|COMPLETED|Core (Randomization to Month 11)||87
208693|NCT00378014|492028|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
208694|NCT00378014|492029|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
208695|NCT00378014|492028|P2|STARTED|Core (Randomization to Month 11)||102
208696|NCT00378014|492029|P1|STARTED|Core (Randomization to Month 11)||101
208697|NCT00377962|492055|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
208698|NCT00377962|492056|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
208699|NCT00377962|492055|P2|COMPLETED|Extension Study: 12-24 Months||123
208700|NCT00377962|492056|P1|COMPLETED|Extension Study: 12-24 Months||98
208701|NCT00377962|492055|P2|STARTED|Extension Study: 12-24 Months||127
208702|NCT00377962|492056|P1|STARTED|Extension Study: 12-24 Months||108
208703|NCT00377962|492055|P2|NOT COMPLETED|Core Study: 0-12 Months||9
208704|NCT00377962|492056|P1|NOT COMPLETED|Core Study: 0-12 Months||28
208705|NCT00377962|492055|P2|COMPLETED|Core Study: 0-12 Months||133
208706|NCT00377962|492056|P1|COMPLETED|Core Study: 0-12 Months||112
208707|NCT00377962|492055|P2|STARTED|Core Study: 0-12 Months||142
208708|NCT00377962|492056|P1|STARTED|Core Study: 0-12 Months||140
208709|NCT00377858|492092|P2|NOT COMPLETED|Overall Study||27
208710|NCT00377858|492093|P1|NOT COMPLETED|Overall Study||31
208711|NCT00377858|492092|P2|COMPLETED|Overall Study||215
208712|NCT00377858|492093|P1|COMPLETED|Overall Study||211
208713|NCT00377858|492092|P2|Had at Least One Post-Baseline Value|Overall Study||240
208714|NCT00377858|492093|P1|Had at Least One Post-Baseline Value|Overall Study||239
208715|NCT00377858|492092|P2|STARTED|Overall Study||242
208716|NCT00377858|492093|P1|STARTED|Overall Study||242
208717|NCT00377832|492123|P2|NOT COMPLETED|Overall Study||0
208718|NCT00377832|492124|P1|NOT COMPLETED|Overall Study||0
208719|NCT00377832|492123|P2|COMPLETED|Overall Study||6
208720|NCT00377832|492124|P1|COMPLETED|Overall Study||7
208721|NCT00377832|492123|P2|STARTED|Overall Study||6
208722|NCT00377832|492124|P1|STARTED|Overall Study||7
208723|NCT00377819|492146|P2|NOT COMPLETED|Overall Study||10
208724|NCT00377819|492147|P1|NOT COMPLETED|Overall Study||13
208725|NCT00377819|492146|P2|COMPLETED|Overall Study||243
208726|NCT00377819|492147|P1|COMPLETED|Overall Study||238
208727|NCT00377819|492146|P2|Received Study Medication|Overall Study||253
208728|NCT00377819|492147|P1|Received Study Medication|Overall Study||249
208729|NCT00377819|492146|P2|STARTED|Overall Study||253
208730|NCT00377819|492147|P1|STARTED|Overall Study||251
208731|NCT00377741|492159|P2|NOT COMPLETED|Overall Study||0
208732|NCT00377741|492160|P1|NOT COMPLETED|Overall Study||0
208733|NCT00377741|492159|P2|COMPLETED|Overall Study||15
208734|NCT00377741|492160|P1|COMPLETED|Overall Study||16
208735|NCT00377741|492159|P2|STARTED|Overall Study||15
208736|NCT00377741|492160|P1|STARTED|Overall Study||16
208737|NCT00377676|492176|P2|NOT COMPLETED|Overall Study||322
208738|NCT00377676|492177|P1|NOT COMPLETED|Overall Study||961
208739|NCT00377676|492176|P2|COMPLETED|Overall Study||694
208740|NCT00377676|492177|P1|COMPLETED|Overall Study||1093
208741|NCT00377676|492176|P2|STARTED|Overall Study||1016
208742|NCT00377676|492177|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
208743|NCT00377637|492193|P4|NOT COMPLETED|Maintenance Phase||57
208744|NCT00377637|492194|P3|NOT COMPLETED|Maintenance Phase||43
208745|NCT00377637|492195|P2|NOT COMPLETED|Maintenance Phase||0
208746|NCT00377637|492196|P1|NOT COMPLETED|Maintenance Phase||0
208747|NCT00377637|492193|P4|COMPLETED|Maintenance Phase||54
208748|NCT00377637|492194|P3|COMPLETED|Maintenance Phase||73
208749|NCT00377637|492195|P2|COMPLETED|Maintenance Phase||0
208750|NCT00377637|492196|P1|COMPLETED|Maintenance Phase||0
208751|NCT00377637|492193|P4|STARTED|Maintenance Phase||111
208752|NCT00377637|492194|P3|STARTED|Maintenance Phase||116
208753|NCT00377637|492195|P2|STARTED|Maintenance Phase||0
208754|NCT00377637|492196|P1|STARTED|Maintenance Phase||0
208755|NCT00377637|492193|P4|NOT COMPLETED|Induction Phase||0
208756|NCT00377637|492194|P3|NOT COMPLETED|Induction Phase||0
208757|NCT00377637|492195|P2|NOT COMPLETED|Induction Phase||35
208758|NCT00377637|492196|P1|NOT COMPLETED|Induction Phase||29
208759|NCT00377637|492193|P4|COMPLETED|Induction Phase||0
208760|NCT00377637|492194|P3|COMPLETED|Induction Phase||0
208761|NCT00377637|492195|P2|COMPLETED|Induction Phase||150
208762|NCT00377637|492196|P1|COMPLETED|Induction Phase||156
208763|NCT00377637|492193|P4|Safety Population|Induction Phase||0
208764|NCT00377637|492194|P3|Safety Population|Induction Phase||0
208765|NCT00377637|492195|P2|Safety Population|Induction Phase||184
208766|NCT00377637|492196|P1|Safety Population|Induction Phase||180
208767|NCT00377637|492193|P4|STARTED|Induction Phase||0
208768|NCT00377637|492194|P3|STARTED|Induction Phase||0
208769|NCT00377637|492195|P2|STARTED|Induction Phase|Intent-To-Treat|185
208770|NCT00377637|492196|P1|STARTED|Induction Phase|Intent-To-Treat|185
208771|NCT00377572|492232|P2|NOT COMPLETED|Overall Study||54
208772|NCT00377572|492233|P1|NOT COMPLETED|Overall Study||53
208773|NCT00377572|492232|P2|COMPLETED|Overall Study||157
208774|NCT00377572|492233|P1|COMPLETED|Overall Study||155
208775|NCT00377572|492232|P2|STARTED|Overall Study||211
208776|NCT00377572|492233|P1|STARTED|Overall Study||208
208777|NCT00377520|492271|P1|NOT COMPLETED|Overall Study||1
208778|NCT00377520|492271|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
208779|NCT00377520|492271|P1|STARTED|Overall Study||27
208780|NCT00377455|492276|P1|NOT COMPLETED|Overall Study||1
208781|NCT00377455|492276|P1|COMPLETED|Overall Study||4
208782|NCT00377455|492276|P1|STARTED|Overall Study||5
208783|NCT00377429|492280|P1|NOT COMPLETED|Overall Study||15
208784|NCT00377429|492280|P1|COMPLETED|Overall Study|Completed main study|32
208785|NCT00377429|492280|P1|STARTED|Overall Study|Treated|47
208786|NCT00377403|492291|P2|NOT COMPLETED|Overall Study||7
208787|NCT00377403|492292|P1|NOT COMPLETED|Overall Study||4
208788|NCT00377403|492291|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
208789|NCT00377403|492292|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
208790|NCT00377403|492291|P2|Day 28 Assessment|Overall Study||77
208791|NCT00377403|492292|P1|Day 28 Assessment|Overall Study||82
208792|NCT00377403|492291|P2|Day 10 Assessment|Overall Study||71
208793|NCT00377403|492292|P1|Day 10 Assessment|Overall Study||81
208794|NCT00377403|492291|P2|Day 7 Assessment|Overall Study||75
208795|NCT00377403|492292|P1|Day 7 Assessment|Overall Study||80
208796|NCT00377403|492291|P2|Day -3 Assessment|Overall Study||74
208797|NCT00377403|492292|P1|Day -3 Assessment|Overall Study||81
208798|NCT00377403|492291|P2|STARTED|Overall Study||81
208799|NCT00377403|492292|P1|STARTED|Overall Study||85
208800|NCT00377364|492300|P2|NOT COMPLETED|Overall Study||0
208801|NCT00377364|492301|P1|NOT COMPLETED|Overall Study||2
208802|NCT00377364|492300|P2|COMPLETED|Overall Study||14
208803|NCT00377364|492301|P1|COMPLETED|Overall Study||14
208804|NCT00377364|492300|P2|STARTED|Overall Study||14
208805|NCT00377364|492301|P1|STARTED|Overall Study||16
208806|NCT00377312|492327|P2|NOT COMPLETED|Overall Study||1
208807|NCT00377312|492328|P1|NOT COMPLETED|Overall Study||1
208808|NCT00377312|492327|P2|COMPLETED|Overall Study||4
208809|NCT00377312|492328|P1|COMPLETED|Overall Study||5
208810|NCT00377312|492327|P2|STARTED|Overall Study||5
208811|NCT00377312|492328|P1|STARTED|Overall Study||6
208812|NCT00377299|492360|P2|NOT COMPLETED|Overall Study||24
208813|NCT00377299|492361|P1|NOT COMPLETED|Overall Study||19
208814|NCT00377299|492360|P2|COMPLETED|Overall Study||4
208815|NCT00377299|492361|P1|COMPLETED|Overall Study||13
208816|NCT00377299|492360|P2|STARTED|Overall Study||28
208817|NCT00377299|492361|P1|STARTED|Overall Study||32
208818|NCT00377260|492377|P2|NOT COMPLETED|Overall Study||5
208819|NCT00377260|492378|P1|NOT COMPLETED|Overall Study||2
208820|NCT00377260|492377|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
208821|NCT00377260|492378|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
208822|NCT00377260|492377|P2|STARTED|Overall Study||147
208823|NCT00377260|492378|P1|STARTED|Overall Study||144
208824|NCT00377234|492432|P2|NOT COMPLETED|Overall Study||31
208825|NCT00377234|492433|P1|NOT COMPLETED|Overall Study||34
208826|NCT00377234|492432|P2|COMPLETED|Overall Study||145
208827|NCT00377234|492433|P1|COMPLETED|Overall Study||146
208828|NCT00377234|492432|P2|Safety Analysis Set: Risedronate|Overall Study||174
208829|NCT00377234|492433|P1|Safety Analysis Set: Risedronate|Overall Study||153
208830|NCT00377234|492432|P2|Safety Analysis Set: Ibandronate|Overall Study||150
208831|NCT00377234|492433|P1|Safety Analysis Set: Ibandronate|Overall Study||177
208832|NCT00377234|492432|P2|Safety Analysis Set: Period 2|Overall Study||150
208833|NCT00377234|492433|P1|Safety Analysis Set: Period 2|Overall Study||153
208834|NCT00377234|492432|P2|Safety Analysis Set: Period 1|Overall Study||174
208835|NCT00377234|492433|P1|Safety Analysis Set: Period 1|Overall Study||177
208836|NCT00377234|492432|P2|Received Treatment|Overall Study||174
208837|NCT00377234|492433|P1|Received Treatment|Overall Study||177
208838|NCT00377234|492432|P2|Did Not Receive Study Treatment|Overall Study||2
208839|NCT00377234|492433|P1|Did Not Receive Study Treatment|Overall Study||3
208840|NCT00377234|492432|P2|Randomized|Overall Study||176
208841|NCT00377234|492433|P1|Randomized|Overall Study||180
208842|NCT00377234|492432|P2|STARTED|Overall Study||176
208843|NCT00377234|492433|P1|STARTED|Overall Study||180
208844|NCT00376961|492449|P2|NOT COMPLETED|Maintenance||23
208845|NCT00376961|492450|P1|NOT COMPLETED|Maintenance||0
208846|NCT00376961|492449|P2|COMPLETED|Maintenance||27
208847|NCT00376961|492450|P1|COMPLETED|Maintenance||0
208848|NCT00376961|492449|P2|Eligible|Maintenance||47
208849|NCT00376961|492450|P1|Eligible|Maintenance||0
208850|NCT00376961|492449|P2|STARTED|Maintenance||50
208851|NCT00376961|492450|P1|STARTED|Maintenance||0
208852|NCT00376961|492449|P2|NOT COMPLETED|Initial Registration||0
208853|NCT00376961|492450|P1|NOT COMPLETED|Initial Registration||7
208854|NCT00376961|492449|P2|COMPLETED|Initial Registration||0
208855|NCT00376961|492450|P1|COMPLETED|Initial Registration||61
208856|NCT00376961|492449|P2|Eligible|Initial Registration||0
208857|NCT00376961|492450|P1|Eligible|Initial Registration||65
208858|NCT00376961|492449|P2|STARTED|Initial Registration||0
208859|NCT00376961|492450|P1|STARTED|Initial Registration||68
208860|NCT00376948|492459|P1|NOT COMPLETED|Overall Study||0
208861|NCT00376948|492459|P1|COMPLETED|Overall Study||20
208862|NCT00376948|492459|P1|STARTED|Overall Study||20
208863|NCT00376935|492468|P4|NOT COMPLETED|Overall Study||0
208864|NCT00376935|492469|P3|NOT COMPLETED|Overall Study||0
208865|NCT00376935|492470|P2|NOT COMPLETED|Overall Study||0
208866|NCT00376935|492471|P1|NOT COMPLETED|Overall Study||0
208867|NCT00376935|492468|P4|COMPLETED|Overall Study||24
208868|NCT00376935|492469|P3|COMPLETED|Overall Study||25
208869|NCT00376935|492470|P2|COMPLETED|Overall Study||25
208870|NCT00376935|492471|P1|COMPLETED|Overall Study||25
208871|NCT00376935|492468|P4|STARTED|Overall Study||24
208872|NCT00376935|492469|P3|STARTED|Overall Study||25
208873|NCT00376935|492470|P2|STARTED|Overall Study||25
208874|NCT00376935|492471|P1|STARTED|Overall Study||25
208875|NCT00376805|492509|P1|NOT COMPLETED|Overall Study||0
208876|NCT00376805|492509|P1|COMPLETED|Overall Study||6
208877|NCT00376805|492509|P1|STARTED|Overall Study||6
208878|NCT00376688|492516|P1|NOT COMPLETED|Overall Study||4
208879|NCT00376688|492516|P1|COMPLETED|Overall Study||27
208880|NCT00376688|492516|P1|STARTED|Overall Study||31
208881|NCT00376675|492522|P2|NOT COMPLETED|Overall Study||14
208882|NCT00376675|492523|P1|NOT COMPLETED|Overall Study||20
208883|NCT00376675|492522|P2|COMPLETED|Overall Study||56
208884|NCT00376675|492523|P1|COMPLETED|Overall Study||49
208885|NCT00376675|492522|P2|STARTED|Overall Study||70
208886|NCT00376675|492523|P1|STARTED|Overall Study||69
208887|NCT00376558|492547|P2|NOT COMPLETED|Overall Study||0
208888|NCT00376558|492548|P1|NOT COMPLETED|Overall Study||0
208889|NCT00376558|492547|P2|COMPLETED|Overall Study||25
208890|NCT00376558|492548|P1|COMPLETED|Overall Study||25
208891|NCT00376558|492547|P2|STARTED|Overall Study||25
208892|NCT00376558|492548|P1|STARTED|Overall Study||25
208893|NCT00376532|492557|P2|NOT COMPLETED|Overall Study||6
208894|NCT00376532|492558|P1|NOT COMPLETED|Overall Study||6
208895|NCT00376532|492557|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
208896|NCT00376532|492558|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
208897|NCT00376532|492557|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
208898|NCT00376532|492558|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
208899|NCT00376506|492568|P2|NOT COMPLETED|Overall Study||2
208900|NCT00376506|492569|P1|NOT COMPLETED|Overall Study||0
208901|NCT00376506|492568|P2|COMPLETED|Overall Study||4
208902|NCT00376506|492569|P1|COMPLETED|Overall Study||4
208903|NCT00376506|492568|P2|STARTED|Overall Study||6
208904|NCT00376506|492569|P1|STARTED|Overall Study||4
208905|NCT00376363|492587|P2|NOT COMPLETED|Overall Study||46
208906|NCT00376363|492588|P1|NOT COMPLETED|Overall Study||56
208907|NCT00376363|492587|P2|COMPLETED|Overall Study||87
208908|NCT00376363|492588|P1|COMPLETED|Overall Study||87
208909|NCT00376363|492587|P2|STARTED|Overall Study||133
208910|NCT00376363|492588|P1|STARTED|Overall Study||143
208911|NCT00376259|492600|P2|NOT COMPLETED|Overall Study||21
208912|NCT00376259|492601|P1|NOT COMPLETED|Overall Study||22
208913|NCT00376259|492600|P2|COMPLETED|Overall Study||0
208914|NCT00376259|492601|P1|COMPLETED|Overall Study||0
208915|NCT00376259|492600|P2|Received Study Drug|Overall Study||21
208916|NCT00376259|492601|P1|Received Study Drug|Overall Study||21
208917|NCT00376259|492600|P2|STARTED|Overall Study||21
208918|NCT00376259|492601|P1|STARTED|Overall Study||22
208919|NCT00376168|492615|P2|NOT COMPLETED|Overall Study||1
208920|NCT00376168|492616|P1|NOT COMPLETED|Overall Study||2
208921|NCT00376168|492615|P2|COMPLETED|Overall Study||15
208922|NCT00376168|492616|P1|COMPLETED|Overall Study||14
208923|NCT00376168|492615|P2|STARTED|Overall Study|One patient randomized but not treated|16
208924|NCT00376168|492616|P1|STARTED|Overall Study||16
208925|NCT00375999|492630|P1|NOT COMPLETED|Overall Study||2
208926|NCT00375999|492630|P1|COMPLETED|Overall Study||32
208927|NCT00375999|492630|P1|STARTED|Overall Study||34
208928|NCT00375973|492636|P2|NOT COMPLETED|Overall Study||2
208929|NCT00375973|492637|P1|NOT COMPLETED|Overall Study||10
208930|NCT00375973|492636|P2|COMPLETED|Overall Study||28
208931|NCT00375973|492637|P1|COMPLETED|Overall Study||20
208932|NCT00375973|492636|P2|STARTED|Overall Study||30
208933|NCT00375973|492637|P1|STARTED|Overall Study||30
208934|NCT00375934|492657|P2|NOT COMPLETED|Overall Study||6
208935|NCT00375934|492658|P1|NOT COMPLETED|Overall Study||3
208936|NCT00375934|492657|P2|COMPLETED|Overall Study||95
208937|NCT00375934|492658|P1|COMPLETED|Overall Study||96
208938|NCT00375934|492657|P2|STARTED|Overall Study||101
208939|NCT00375934|492658|P1|STARTED|Overall Study||99
208940|NCT00375752|492686|P2|NOT COMPLETED|Overall Study||15
208941|NCT00375752|492687|P1|NOT COMPLETED|Overall Study||12
208942|NCT00375752|492686|P2|COMPLETED|Overall Study||74
208943|NCT00375752|492687|P1|COMPLETED|Overall Study||67
208944|NCT00375752|492686|P2|STARTED|Overall Study||89
208945|NCT00375752|492687|P1|STARTED|Overall Study||79
208946|NCT00375713|492701|P2|NOT COMPLETED|Overall Study||23
208947|NCT00375713|492702|P1|NOT COMPLETED|Overall Study||20
208948|NCT00375713|492701|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
208949|NCT00375713|492702|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
208950|NCT00375713|492701|P2|STARTED|Overall Study|Randomized population (N=234).|234
208951|NCT00375713|492702|P1|STARTED|Overall Study|Randomized population (N=232).|232
208952|NCT00375518|492716|P2|NOT COMPLETED|Overall Study||17
208953|NCT00375518|492717|P1|NOT COMPLETED|Overall Study||8
208954|NCT00375518|492716|P2|COMPLETED|Overall Study||65
208955|NCT00375518|492717|P1|COMPLETED|Overall Study||72
208956|NCT00375518|492716|P2|STARTED|Overall Study||82
208957|NCT00375518|492717|P1|STARTED|Overall Study||80
208958|NCT00375505|492725|P2|NOT COMPLETED|Overall Study||2
208959|NCT00375505|492726|P1|NOT COMPLETED|Overall Study||1
208960|NCT00375505|492725|P2|COMPLETED|Overall Study||32
208961|NCT00375505|492726|P1|COMPLETED|Overall Study||35
208962|NCT00375505|492725|P2|STARTED|Overall Study||34
208963|NCT00375505|492726|P1|STARTED|Overall Study||36
208964|NCT00375492|492770|P2|NOT COMPLETED|Overall Study||26
208965|NCT00375492|492771|P1|NOT COMPLETED|Overall Study||26
208966|NCT00375492|492770|P2|COMPLETED|Overall Study||72
208967|NCT00375492|492771|P1|COMPLETED|Overall Study||70
208968|NCT00375492|492770|P2|STARTED|Overall Study||98
208969|NCT00375492|492771|P1|STARTED|Overall Study||96
208970|NCT00375427|492801|P2|NOT COMPLETED|Overall Study||74
208971|NCT00375427|492802|P1|NOT COMPLETED|Overall Study||60
208972|NCT00375427|492801|P2|COMPLETED|Overall Study||142
208973|NCT00375427|492802|P1|COMPLETED|Overall Study||149
208974|NCT00375427|492801|P2|STARTED|Overall Study||216
208975|NCT00375427|492802|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
208976|NCT00375219|492827|P3|NOT COMPLETED|Overall Study||21
208977|NCT00375219|492828|P2|NOT COMPLETED|Overall Study||20
208978|NCT00375219|492829|P1|NOT COMPLETED|Overall Study||59
208979|NCT00375219|492827|P3|COMPLETED|Overall Study||0
208980|NCT00375219|492828|P2|COMPLETED|Overall Study||0
208981|NCT00375219|492829|P1|COMPLETED|Overall Study||3
208982|NCT00375219|492827|P3|STARTED|Overall Study||21
208983|NCT00375219|492828|P2|STARTED|Overall Study||20
208984|NCT00375219|492829|P1|STARTED|Overall Study||62
208985|NCT00374907|492897|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
208986|NCT00374907|492898|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
208987|NCT00374907|492897|P2|COMPLETED|116-Week Short-term + Long-term Period||2
208988|NCT00374907|492898|P1|COMPLETED|116-Week Short-term + Long-term Period||7
208989|NCT00374907|492897|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
208990|NCT00374907|492898|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
208991|NCT00374907|492897|P2|STARTED|116-Week Short-term + Long-term Period||16
208992|NCT00374907|492898|P1|STARTED|116-Week Short-term + Long-term Period||20
208993|NCT00374907|492897|P2|NOT COMPLETED|12-Week Short-term Period||1
208994|NCT00374907|492898|P1|NOT COMPLETED|12-Week Short-term Period||3
208995|NCT00374907|492897|P2|COMPLETED|12-Week Short-term Period||15
208996|NCT00374907|492898|P1|COMPLETED|12-Week Short-term Period||17
208997|NCT00374907|492897|P2|STARTED|12-Week Short-term Period||16
208998|NCT00374907|492898|P1|STARTED|12-Week Short-term Period||20
208999|NCT00374868|492910|P1|NOT COMPLETED|Overall Study||36
209000|NCT00374868|492910|P1|COMPLETED|Overall Study||2
209001|NCT00374868|492910|P1|STARTED|Overall Study||38
209002|NCT00374842|492924|P3|NOT COMPLETED|Overall Study||0
209003|NCT00374842|492925|P2|NOT COMPLETED|Overall Study||0
209004|NCT00374842|492926|P1|NOT COMPLETED|Overall Study||0
209005|NCT00374842|492924|P3|COMPLETED|Overall Study||100
209006|NCT00374842|492925|P2|COMPLETED|Overall Study||100
209007|NCT00374842|492926|P1|COMPLETED|Overall Study||100
209008|NCT00374842|492924|P3|STARTED|Overall Study||100
209009|NCT00374842|492925|P2|STARTED|Overall Study||100
209010|NCT00374842|492926|P1|STARTED|Overall Study||100
209011|NCT00374803|492957|P2|NOT COMPLETED|Overall Study||0
209012|NCT00374803|492958|P1|NOT COMPLETED|Overall Study||0
209013|NCT00374803|492957|P2|COMPLETED|Overall Study||23
209014|NCT00374803|492958|P1|COMPLETED|Overall Study||22
209015|NCT00374803|492957|P2|STARTED|Overall Study||23
209016|NCT00374803|492958|P1|STARTED|Overall Study||22
209017|NCT00374543|492974|P2|NOT COMPLETED|Overall Study||0
209018|NCT00374543|492975|P1|NOT COMPLETED|Overall Study||0
209019|NCT00374543|492974|P2|COMPLETED|Overall Study||1
209020|NCT00374543|492975|P1|COMPLETED|Overall Study||2
209021|NCT00374543|492974|P2|STARTED|Overall Study||1
209022|NCT00374543|492975|P1|STARTED|Overall Study||2
209023|NCT00374335|492981|P1|NOT COMPLETED|Overall Study||0
209024|NCT00374335|492981|P1|COMPLETED|Overall Study||261
209025|NCT00374335|492981|P1|STARTED|Overall Study||261
209026|NCT00374322|492988|P2|NOT COMPLETED|Overall Study||1304
209027|NCT00374322|492989|P1|NOT COMPLETED|Overall Study||1257
209028|NCT00374322|492988|P2|COMPLETED|Overall Study||278
209029|NCT00374322|492989|P1|COMPLETED|Overall Study||322
209030|NCT00374322|492988|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
209031|NCT00374322|492989|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
209032|NCT00374322|492988|P2|STARTED|Overall Study||1582
209033|NCT00374322|492989|P1|STARTED|Overall Study||1579
209034|NCT00374244|493027|P2|NOT COMPLETED|Overall Study||0
209035|NCT00374244|493028|P1|NOT COMPLETED|Overall Study||0
209036|NCT00374244|493027|P2|COMPLETED|Overall Study||14
209037|NCT00374244|493028|P1|COMPLETED|Overall Study||14
209038|NCT00374244|493027|P2|STARTED|Overall Study||14
209039|NCT00374244|493028|P1|STARTED|Overall Study||14
209040|NCT00374231|493074|P1|NOT COMPLETED|Overall Study||0
209041|NCT00374231|493074|P1|COMPLETED|Overall Study||40
209042|NCT00374231|493074|P1|STARTED|Overall Study||40
209043|NCT00374140|493080|P1|NOT COMPLETED|Overall Study||2
209044|NCT00374140|493080|P1|COMPLETED|Overall Study||38
209045|NCT00374140|493080|P1|STARTED|Overall Study||40
209046|NCT00374088|493086|P2|NOT COMPLETED|Overall Study||1
209047|NCT00374088|493087|P1|NOT COMPLETED|Overall Study||1
209048|NCT00374088|493086|P2|COMPLETED|Overall Study||10
209049|NCT00374088|493087|P1|COMPLETED|Overall Study||9
209050|NCT00374088|493086|P2|STARTED|Overall Study||11
209051|NCT00374088|493087|P1|STARTED|Overall Study||10
209052|NCT00373958|493099|P2|NOT COMPLETED|Toddler Dose||38
209053|NCT00373958|493100|P1|NOT COMPLETED|Toddler Dose||30
209054|NCT00373958|493099|P2|COMPLETED|Toddler Dose||252
209055|NCT00373958|493100|P1|COMPLETED|Toddler Dose||264
209056|NCT00373958|493099|P2|Vaccinated Toddler Dose|Toddler Dose||265
209057|NCT00373958|493100|P1|Vaccinated Toddler Dose|Toddler Dose||272
209058|NCT00373958|493099|P2|Withdrawn After Infant Series|Toddler Dose||25
209059|NCT00373958|493100|P1|Withdrawn After Infant Series|Toddler Dose||22
209060|NCT00373958|493099|P2|STARTED|Toddler Dose||290
209061|NCT00373958|493100|P1|STARTED|Toddler Dose||294
209062|NCT00373958|493099|P2|NOT COMPLETED|Infant Series||42
209063|NCT00373958|493100|P1|NOT COMPLETED|Infant Series||40
209064|NCT00373958|493099|P2|COMPLETED|Infant Series||290
209065|NCT00373958|493100|P1|COMPLETED|Infant Series||294
209066|NCT00373958|493099|P2|Vaccinated Dose 3|Infant Series||300
209067|NCT00373958|493100|P1|Vaccinated Dose 3|Infant Series||298
209068|NCT00373958|493099|P2|Vaccinated Dose 2|Infant Series||305
209069|NCT00373958|493100|P1|Vaccinated Dose 2|Infant Series||309
209070|NCT00373958|493099|P2|Vaccinated Dose 1|Infant Series||331
209071|NCT00373958|493100|P1|Vaccinated Dose 1|Infant Series||332
209072|NCT00373958|493099|P2|STARTED|Infant Series||332
209073|NCT00373958|493100|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
209074|NCT00373698|493150|P2|NOT COMPLETED|Overall Study||0
209075|NCT00373698|493151|P1|NOT COMPLETED|Overall Study||11
209076|NCT00373698|493150|P2|COMPLETED|Overall Study||99
209077|NCT00373698|493151|P1|COMPLETED|Overall Study||85
209078|NCT00373698|493150|P2|STARTED|Overall Study||99
209079|NCT00373698|493151|P1|STARTED|Overall Study||96
209080|NCT00373685|493165|P2|NOT COMPLETED|Overall Study||1421
209081|NCT00373685|493166|P1|NOT COMPLETED|Overall Study||1439
209082|NCT00373685|493165|P2|COMPLETED|Overall Study||2611
209083|NCT00373685|493166|P1|COMPLETED|Overall Study||2596
209084|NCT00373685|493165|P2|Treated|Overall Study||3955
209085|NCT00373685|493166|P1|Treated|Overall Study||3984
209086|NCT00373685|493165|P2|STARTED|Overall Study||4032
209087|NCT00373685|493166|P1|STARTED|Overall Study||4035
209088|NCT00372567|493203|P3|NOT COMPLETED|Phase 3 Study||12
209089|NCT00372567|493204|P2|NOT COMPLETED|Phase 3 Study||26
209090|NCT00372567|493205|P1|NOT COMPLETED|Phase 3 Study||31
209091|NCT00372567|493203|P3|COMPLETED|Phase 3 Study||0
209092|NCT00372567|493204|P2|COMPLETED|Phase 3 Study||0
209093|NCT00372567|493205|P1|COMPLETED|Phase 3 Study||0
209094|NCT00372567|493203|P3|Received Treatment|Phase 3 Study||12
209095|NCT00372567|493204|P2|Received Treatment|Phase 3 Study||25
209096|NCT00372567|493205|P1|Received Treatment|Phase 3 Study||31
209097|NCT00372567|493203|P3|STARTED|Phase 3 Study||12
209098|NCT00372567|493204|P2|STARTED|Phase 3 Study||26
209099|NCT00372567|493205|P1|STARTED|Phase 3 Study||31
209100|NCT00372567|493203|P3|NOT COMPLETED|Phase 1 Sub-study||0
209101|NCT00372567|493204|P2|NOT COMPLETED|Phase 1 Sub-study||0
209102|NCT00372567|493205|P1|NOT COMPLETED|Phase 1 Sub-study||0
209103|NCT00372567|493203|P3|COMPLETED|Phase 1 Sub-study||12
209104|NCT00372567|493204|P2|COMPLETED|Phase 1 Sub-study||0
209105|NCT00372567|493205|P1|COMPLETED|Phase 1 Sub-study||0
209106|NCT00372567|493203|P3|STARTED|Phase 1 Sub-study||12
209107|NCT00372567|493204|P2|STARTED|Phase 1 Sub-study||0
209108|NCT00372567|493205|P1|STARTED|Phase 1 Sub-study||0
209109|NCT00372528|493233|P1|NOT COMPLETED|Overall Study||21
209110|NCT00372528|493233|P1|COMPLETED|Overall Study||0
209111|NCT00372528|493233|P1|STARTED|Overall Study||21
209112|NCT00373529|493238|P1|NOT COMPLETED|Overall Study||108
209113|NCT00373529|493238|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
209114|NCT00373529|493238|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
209115|NCT00373529|493238|P1|STARTED|Overall Study||116
209116|NCT00373490|493250|P2|NOT COMPLETED|Overall Study||6
209117|NCT00373490|493251|P1|NOT COMPLETED|Overall Study||9
209118|NCT00373490|493250|P2|COMPLETED|Overall Study||0
209119|NCT00373490|493251|P1|COMPLETED|Overall Study||1
209120|NCT00373490|493250|P2|STARTED|Overall Study||6
209121|NCT00373490|493251|P1|STARTED|Overall Study||10
209122|NCT00373425|493274|P5|NOT COMPLETED|Overall Study||72
209123|NCT00373425|493275|P4|NOT COMPLETED|Overall Study||11
209124|NCT00373425|493276|P3|NOT COMPLETED|Overall Study||134
209125|NCT00373425|493277|P2|NOT COMPLETED|Overall Study||153
209126|NCT00373425|493278|P1|NOT COMPLETED|Overall Study||370
209127|NCT00373425|493274|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
209128|NCT00373425|493275|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
209129|NCT00373425|493276|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
209130|NCT00373425|493277|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
209131|NCT00373425|493278|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
209132|NCT00373425|493274|P5|Received Treatment|Overall Study||132
209133|NCT00373425|493275|P4|Received Treatment|Overall Study||7
209134|NCT00373425|493276|P3|Received Treatment|Overall Study||134
209135|NCT00373425|493277|P2|Received Treatment|Overall Study||342
209136|NCT00373425|493278|P1|Received Treatment|Overall Study||612
209137|NCT00373425|493274|P5|STARTED|Overall Study||132
209138|NCT00373425|493275|P4|STARTED|Overall Study||11
209139|NCT00373425|493276|P3|STARTED|Overall Study||134
209140|NCT00373425|493277|P2|STARTED|Overall Study||350
209141|NCT00373425|493278|P1|STARTED|Overall Study||623
209142|NCT00373360|493303|P1|NOT COMPLETED|Overall Study||0
209143|NCT00373360|493303|P1|COMPLETED|Overall Study||10
209144|NCT00373360|493303|P1|STARTED|Overall Study||10
209145|NCT00373334|493334|P3|NOT COMPLETED|Overall Study||13
209146|NCT00373334|493335|P2|NOT COMPLETED|Overall Study||18
209147|NCT00373334|493336|P1|NOT COMPLETED|Overall Study||10
209148|NCT00373334|493334|P3|COMPLETED|Overall Study||32
209149|NCT00373334|493335|P2|COMPLETED|Overall Study||32
209150|NCT00373334|493336|P1|COMPLETED|Overall Study||33
209151|NCT00373334|493334|P3|STARTED|Overall Study||45
209152|NCT00373334|493335|P2|STARTED|Overall Study||50
209153|NCT00373334|493336|P1|STARTED|Overall Study||43
209154|NCT00373269|493352|P2|NOT COMPLETED|Overall Study||0
209155|NCT00373269|493353|P1|NOT COMPLETED|Overall Study||0
209156|NCT00373269|493352|P2|COMPLETED|Overall Study||10
209157|NCT00373269|493353|P1|COMPLETED|Overall Study||11
209158|NCT00373269|493352|P2|STARTED|Overall Study||10
209159|NCT00373269|493353|P1|STARTED|Overall Study||11
209160|NCT00373256|493363|P2|NOT COMPLETED|Overall Study||247
209161|NCT00373256|493364|P1|NOT COMPLETED|Overall Study||241
209162|NCT00373256|493363|P2|COMPLETED|Overall Study||0
209163|NCT00373256|493364|P1|COMPLETED|Overall Study||0
209164|NCT00373256|493363|P2|Treated|Overall Study||236
209165|NCT00373256|493364|P1|Treated|Overall Study||235
209166|NCT00373256|493363|P2|STARTED|Overall Study||247
209167|NCT00373256|493364|P1|STARTED|Overall Study||241
209168|NCT00373113|493390|P2|NOT COMPLETED|Overall Study||244
209169|NCT00373113|493391|P1|NOT COMPLETED|Overall Study||238
209170|NCT00373113|493390|P2|COMPLETED|Overall Study||0
209171|NCT00373113|493391|P1|COMPLETED|Overall Study||0
209172|NCT00373113|493390|P2|Received Treatment|Overall Study||240
209173|NCT00373113|493391|P1|Received Treatment|Overall Study||238
209174|NCT00373113|493390|P2|STARTED|Overall Study||244
209175|NCT00373113|493391|P1|STARTED|Overall Study||238
209176|NCT00372996|493413|P4|NOT COMPLETED|Overall Study||20
209177|NCT00372996|493414|P3|NOT COMPLETED|Overall Study||28
209178|NCT00372996|493415|P2|NOT COMPLETED|Overall Study||14
209179|NCT00372996|493416|P1|NOT COMPLETED|Overall Study||37
209180|NCT00372996|493413|P4|COMPLETED|Overall Study||23
209181|NCT00372996|493414|P3|COMPLETED|Overall Study||33
209182|NCT00372996|493415|P2|COMPLETED|Overall Study||22
209183|NCT00372996|493416|P1|COMPLETED|Overall Study||42
209184|NCT00372996|493413|P4|STARTED|Overall Study||43
209185|NCT00372996|493414|P3|STARTED|Overall Study||61
209186|NCT00372996|493415|P2|STARTED|Overall Study||36
209187|NCT00372996|493416|P1|STARTED|Overall Study||79
209188|NCT00372970|493442|P2|NOT COMPLETED|Overall Study||0
209189|NCT00372970|493443|P1|NOT COMPLETED|Overall Study||0
209190|NCT00372970|493442|P2|COMPLETED|Overall Study||16
209191|NCT00372970|493443|P1|COMPLETED|Overall Study||16
209192|NCT00372970|493442|P2|STARTED|Overall Study||16
209193|NCT00372970|493443|P1|STARTED|Overall Study||16
209194|NCT00372775|493449|P1|NOT COMPLETED|Overall Study||63
209195|NCT00372775|493449|P1|COMPLETED|Overall Study||3
209196|NCT00372775|493449|P1|Received Treatment|Overall Study||64
209197|NCT00372775|493449|P1|STARTED|Overall Study||66
209198|NCT00372697|493471|P2|NOT COMPLETED|Overall Study||1
209199|NCT00372697|493472|P1|NOT COMPLETED|Overall Study||1
209200|NCT00372697|493471|P2|COMPLETED|Overall Study||11
209201|NCT00372697|493472|P1|COMPLETED|Overall Study||15
209202|NCT00372697|493471|P2|STARTED|Overall Study||12
209203|NCT00372697|493472|P1|STARTED|Overall Study||16
209204|NCT00372619|493497|P7|NOT COMPLETED|Overall Study||0
209205|NCT00372619|493498|P6|NOT COMPLETED|Overall Study||3
209206|NCT00372619|493499|P5|NOT COMPLETED|Overall Study||0
209207|NCT00372619|493500|P4|NOT COMPLETED|Overall Study||0
209208|NCT00372619|493501|P3|NOT COMPLETED|Overall Study||0
209209|NCT00372619|493502|P2|NOT COMPLETED|Overall Study||0
209210|NCT00372619|493503|P1|NOT COMPLETED|Overall Study||0
209211|NCT00372619|493497|P7|COMPLETED|Overall Study||2
209212|NCT00372619|493498|P6|COMPLETED|Overall Study||39
209213|NCT00372619|493499|P5|COMPLETED|Overall Study||7
209214|NCT00372619|493500|P4|COMPLETED|Overall Study||10
209215|NCT00372619|493501|P3|COMPLETED|Overall Study||3
209216|NCT00372619|493502|P2|COMPLETED|Overall Study||2
209217|NCT00372619|493503|P1|COMPLETED|Overall Study||8
209218|NCT00372619|493497|P7|STARTED|Overall Study||2
209219|NCT00372619|493498|P6|STARTED|Overall Study||42
209220|NCT00372619|493499|P5|STARTED|Overall Study||7
209221|NCT00372619|493500|P4|STARTED|Overall Study||10
209222|NCT00372619|493501|P3|STARTED|Overall Study||3
209223|NCT00372619|493502|P2|STARTED|Overall Study||2
209224|NCT00372619|493503|P1|STARTED|Overall Study||8
209225|NCT00372593|493522|P3|NOT COMPLETED|Overall Study||4
209226|NCT00372593|493523|P2|NOT COMPLETED|Overall Study||198
209227|NCT00372593|493524|P1|NOT COMPLETED|Overall Study||204
209228|NCT00372593|493522|P3|COMPLETED|Overall Study||3
209229|NCT00372593|493523|P2|COMPLETED|Overall Study||334
209230|NCT00372593|493524|P1|COMPLETED|Overall Study||327
209231|NCT00372593|493522|P3|STARTED|Overall Study||7
209232|NCT00372593|493523|P2|STARTED|Overall Study||532
209233|NCT00372593|493524|P1|STARTED|Overall Study||531
209234|NCT00372489|493535|P1|NOT COMPLETED|Overall Study||79
209235|NCT00372489|493535|P1|COMPLETED|Overall Study||2
209236|NCT00372489|493535|P1|STARTED|Overall Study||81
209237|NCT00372424|493539|P1|NOT COMPLETED|Overall Study||26
209238|NCT00372424|493539|P1|COMPLETED|Overall Study||0
209239|NCT00372424|493539|P1|Treated|Overall Study||25
209240|NCT00372424|493539|P1|STARTED|Overall Study||26
209241|NCT00372411|493553|P3|NOT COMPLETED|Overall Study||3
209242|NCT00372411|493554|P2|NOT COMPLETED|Overall Study||8
209243|NCT00372411|493555|P1|NOT COMPLETED|Overall Study||5
209244|NCT00372411|493553|P3|COMPLETED|Overall Study||25
209245|NCT00372411|493554|P2|COMPLETED|Overall Study||42
209246|NCT00372411|493555|P1|COMPLETED|Overall Study||44
209247|NCT00372411|493553|P3|STARTED|Overall Study||28
209248|NCT00372411|493554|P2|STARTED|Overall Study||50
209249|NCT00372411|493555|P1|STARTED|Overall Study||49
209250|NCT00372385|493579|P4|NOT COMPLETED|Overall Study||8
209251|NCT00372385|493580|P3|NOT COMPLETED|Overall Study||10
209252|NCT00372385|493581|P2|NOT COMPLETED|Overall Study||20
209253|NCT00372385|493582|P1|NOT COMPLETED|Overall Study||33
209254|NCT00372385|493579|P4|COMPLETED|Overall Study||70
209255|NCT00372385|493580|P3|COMPLETED|Overall Study||72
209256|NCT00372385|493581|P2|COMPLETED|Overall Study||61
209257|NCT00372385|493582|P1|COMPLETED|Overall Study||49
209258|NCT00372385|493579|P4|STARTED|Overall Study||78
209259|NCT00372385|493580|P3|STARTED|Overall Study||82
209260|NCT00372385|493581|P2|STARTED|Overall Study||81
209261|NCT00372385|493582|P1|STARTED|Overall Study||82
209262|NCT00372060|493611|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
209263|NCT00372060|493612|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
209264|NCT00372060|493611|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
209265|NCT00372060|493612|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
209266|NCT00372060|493611|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
209267|NCT00372060|493612|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
209268|NCT00372060|493611|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
209269|NCT00372060|493612|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
209270|NCT00372060|493611|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
209271|NCT00372060|493612|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
209272|NCT00372060|493611|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
209273|NCT00372060|493612|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
209274|NCT00371865|493627|P2|NOT COMPLETED|Overall Study||14
209275|NCT00371865|493628|P1|NOT COMPLETED|Overall Study||15
209276|NCT00371865|493627|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
209277|NCT00371865|493628|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
209278|NCT00371865|493627|P2|STARTED|Overall Study||57
209279|NCT00371865|493628|P1|STARTED|Overall Study||57
209280|NCT00371839|493645|P3|NOT COMPLETED|Overall Study||2
209281|NCT00371839|493646|P2|NOT COMPLETED|Overall Study||7
209282|NCT00371839|493647|P1|NOT COMPLETED|Overall Study||17
209283|NCT00371839|493645|P3|COMPLETED|Overall Study||7
209284|NCT00371839|493646|P2|COMPLETED|Overall Study||13
209285|NCT00371839|493647|P1|COMPLETED|Overall Study||32
209286|NCT00371839|493645|P3|STARTED|Overall Study||9
209287|NCT00371839|493646|P2|STARTED|Overall Study||20
209288|NCT00371839|493647|P1|STARTED|Overall Study||49
209289|NCT00371826|493656|P3|NOT COMPLETED|Extension Phase (24 Months)||2
209290|NCT00371826|493657|P2|NOT COMPLETED|Extension Phase (24 Months)||10
209291|NCT00371826|493658|P1|NOT COMPLETED|Extension Phase (24 Months)||5
209292|NCT00371826|493656|P3|COMPLETED|Extension Phase (24 Months)||3
209293|NCT00371826|493657|P2|COMPLETED|Extension Phase (24 Months)||29
209294|NCT00371826|493658|P1|COMPLETED|Extension Phase (24 Months)||18
209295|NCT00371826|493656|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
209296|NCT00371826|493657|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
209297|NCT00371826|493658|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
209298|NCT00371826|493656|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
209299|NCT00371826|493657|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
209300|NCT00371826|493658|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
209301|NCT00371826|493656|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
209302|NCT00371826|493657|P2|STARTED|Extension Phase (24 Months)||39
209303|NCT00371826|493658|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
209304|NCT00371826|493656|P3|NOT COMPLETED|Core Phase (12 Months)||24
209305|NCT00371826|493657|P2|NOT COMPLETED|Core Phase (12 Months)||8
209306|NCT00371826|493658|P1|NOT COMPLETED|Core Phase (12 Months)||24
209307|NCT00371826|493656|P3|COMPLETED|Core Phase (12 Months)||6
209308|NCT00371826|493657|P2|COMPLETED|Core Phase (12 Months)||39
209309|NCT00371826|493658|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
209310|NCT00371826|493656|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
209311|NCT00371826|493657|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
209312|NCT00371826|493658|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
209313|NCT00371826|493656|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
209314|NCT00371826|493657|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
209315|NCT00371826|493658|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
209316|NCT00371826|493656|P3|STARTED|Core Phase (12 Months)||30
209317|NCT00371826|493657|P2|STARTED|Core Phase (12 Months)||47
209318|NCT00371826|493658|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
209319|NCT00371787|493782|P2|NOT COMPLETED|Overall Study||1
209320|NCT00371787|493783|P1|NOT COMPLETED|Overall Study||3
209321|NCT00371787|493782|P2|COMPLETED|Overall Study||11
209322|NCT00371787|493783|P1|COMPLETED|Overall Study||23
209323|NCT00371787|493782|P2|STARTED|Overall Study||12
209324|NCT00371787|493783|P1|STARTED|Overall Study||26
209325|NCT00371761|493797|P2|NOT COMPLETED|Overall Study||10
209326|NCT00371761|493798|P1|NOT COMPLETED|Overall Study||8
209327|NCT00371761|493797|P2|COMPLETED|Overall Study||2
209328|NCT00371761|493798|P1|COMPLETED|Overall Study||5
209329|NCT00371761|493797|P2|STARTED|Overall Study||12
209330|NCT00371761|493798|P1|STARTED|Overall Study||13
209331|NCT00371683|493806|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
209332|NCT00371683|493807|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
209333|NCT00371683|493806|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
209334|NCT00371683|493807|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
209335|NCT00371683|493806|P2|STARTED|Follow-Up Period - Randomized Patients||1533
209336|NCT00371683|493807|P1|STARTED|Follow-Up Period - Randomized Patients||1553
209337|NCT00371683|493806|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
209338|NCT00371683|493807|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
209339|NCT00371683|493806|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
209340|NCT00371683|493807|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
209341|NCT00371683|493806|P2|STARTED|DB Treatment Period-Randomized Patients||1596
209342|NCT00371683|493807|P1|STARTED|DB Treatment Period-Randomized Patients||1599
209343|NCT00371644|493861|P2|NOT COMPLETED|Overall Study||13
209344|NCT00371644|493862|P1|NOT COMPLETED|Overall Study||28
209345|NCT00371644|493861|P2|COMPLETED|Overall Study||44
209346|NCT00371644|493862|P1|COMPLETED|Overall Study||44
209347|NCT00371644|493861|P2|STARTED|Overall Study||57
209348|NCT00371644|493862|P1|STARTED|Overall Study||72
209349|NCT00371631|493868|P1|NOT COMPLETED|Overall Study||0
209350|NCT00371631|493868|P1|COMPLETED|Overall Study||13
209351|NCT00371631|493868|P1|STARTED|Overall Study||13
209352|NCT00371566|493875|P2|NOT COMPLETED|Follow Up Phase||7
209353|NCT00371566|493876|P1|NOT COMPLETED|Follow Up Phase||3
209354|NCT00371566|493875|P2|COMPLETED|Follow Up Phase||58
209355|NCT00371566|493876|P1|COMPLETED|Follow Up Phase||28
209356|NCT00371566|493875|P2|STARTED|Follow Up Phase||65
209357|NCT00371566|493876|P1|STARTED|Follow Up Phase||31
209358|NCT00371566|493875|P2|NOT COMPLETED|Chemoradiation Phase||3
209359|NCT00371566|493876|P1|NOT COMPLETED|Chemoradiation Phase||5
209360|NCT00371566|493875|P2|COMPLETED|Chemoradiation Phase||65
209361|NCT00371566|493876|P1|COMPLETED|Chemoradiation Phase||31
209362|NCT00371566|493875|P2|STARTED|Chemoradiation Phase||68
209363|NCT00371566|493876|P1|STARTED|Chemoradiation Phase||36
209364|NCT00371566|493875|P2|NOT COMPLETED|Treatment Phase||3
209365|NCT00371566|493876|P1|NOT COMPLETED|Treatment Phase||0
209366|NCT00371566|493875|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
209367|NCT00371566|493876|P1|COMPLETED|Treatment Phase||36
209368|NCT00371566|493875|P2|STARTED|Treatment Phase||71
209369|NCT00371566|493876|P1|STARTED|Treatment Phase||36
209370|NCT00371540|493948|P2|NOT COMPLETED|Overall Study||9
209371|NCT00371540|493949|P1|NOT COMPLETED|Overall Study||10
209372|NCT00371540|493948|P2|COMPLETED|Overall Study||87
209373|NCT00371540|493949|P1|COMPLETED|Overall Study||102
209374|NCT00371540|493948|P2|STARTED|Overall Study||96
209375|NCT00371540|493949|P1|STARTED|Overall Study||112
209376|NCT00371462|493961|P2|NOT COMPLETED|Overall Study||8
209377|NCT00371462|493962|P1|NOT COMPLETED|Overall Study||8
209378|NCT00371462|493961|P2|COMPLETED|Overall Study||27
209379|NCT00371462|493962|P1|COMPLETED|Overall Study||27
209380|NCT00371462|493961|P2|STARTED|Overall Study||35
209381|NCT00371462|493962|P1|STARTED|Overall Study||35
209382|NCT00371449|493968|P1|NOT COMPLETED|Overall Study||0
209383|NCT00371449|493968|P1|COMPLETED|Overall Study||120
209384|NCT00371449|493968|P1|STARTED|Overall Study||120
209385|NCT00371436|493979|P2|NOT COMPLETED|Overall Study||21
209386|NCT00371436|493980|P1|NOT COMPLETED|Overall Study||34
209387|NCT00371436|493979|P2|COMPLETED|Overall Study||68
209388|NCT00371436|493980|P1|COMPLETED|Overall Study||58
209389|NCT00371436|493979|P2|STARTED|Overall Study||89
209390|NCT00371436|493980|P1|STARTED|Overall Study||92
209391|NCT00371397|493986|P12|NOT COMPLETED|Session 3||0
209392|NCT00371397|493987|P11|NOT COMPLETED|Session 3||0
209393|NCT00371397|493988|P10|NOT COMPLETED|Session 3||0
209394|NCT00371397|493989|P9|NOT COMPLETED|Session 3||0
209395|NCT00371397|493990|P8|NOT COMPLETED|Session 3||0
209396|NCT00371397|493991|P7|NOT COMPLETED|Session 3||0
209397|NCT00371397|493992|P6|NOT COMPLETED|Session 3||0
209398|NCT00371397|493993|P5|NOT COMPLETED|Session 3||0
209399|NCT00371397|493994|P4|NOT COMPLETED|Session 3||0
209400|NCT00371397|493995|P3|NOT COMPLETED|Session 3||0
209401|NCT00371397|493996|P2|NOT COMPLETED|Session 3||0
209402|NCT00371397|493997|P1|NOT COMPLETED|Session 3||0
209403|NCT00371397|493986|P12|COMPLETED|Session 3||2
209404|NCT00371397|493987|P11|COMPLETED|Session 3||4
209405|NCT00371397|493988|P10|COMPLETED|Session 3||5
209406|NCT00371397|493989|P9|COMPLETED|Session 3||6
209407|NCT00371397|493990|P8|COMPLETED|Session 3||4
209408|NCT00371397|493991|P7|COMPLETED|Session 3||4
209409|NCT00371397|493992|P6|COMPLETED|Session 3||4
209410|NCT00371397|493993|P5|COMPLETED|Session 3||3
209411|NCT00371397|493994|P4|COMPLETED|Session 3||2
209412|NCT00371397|493995|P3|COMPLETED|Session 3||5
209413|NCT00371397|493996|P2|COMPLETED|Session 3||7
209414|NCT00371397|493997|P1|COMPLETED|Session 3||4
209415|NCT00371397|493986|P12|STARTED|Session 3||2
209416|NCT00371397|493987|P11|STARTED|Session 3||4
209417|NCT00371397|493988|P10|STARTED|Session 3||5
209418|NCT00371397|493989|P9|STARTED|Session 3||6
209419|NCT00371397|493990|P8|STARTED|Session 3||4
209420|NCT00371397|493991|P7|STARTED|Session 3||4
209421|NCT00371397|493992|P6|STARTED|Session 3||4
209422|NCT00371397|493993|P5|STARTED|Session 3||3
209423|NCT00371397|493994|P4|STARTED|Session 3||2
209424|NCT00371397|493995|P3|STARTED|Session 3||5
209425|NCT00371397|493996|P2|STARTED|Session 3||7
209426|NCT00371397|493997|P1|STARTED|Session 3||4
209427|NCT00371397|493986|P12|NOT COMPLETED|Session 2||0
209428|NCT00371397|493987|P11|NOT COMPLETED|Session 2||0
209429|NCT00371397|493988|P10|NOT COMPLETED|Session 2||0
209430|NCT00371397|493989|P9|NOT COMPLETED|Session 2||0
209431|NCT00371397|493990|P8|NOT COMPLETED|Session 2||0
209432|NCT00371397|493991|P7|NOT COMPLETED|Session 2||0
209433|NCT00371397|493992|P6|NOT COMPLETED|Session 2||0
209434|NCT00371397|493993|P5|NOT COMPLETED|Session 2||0
209435|NCT00371397|493994|P4|NOT COMPLETED|Session 2||0
209436|NCT00371397|493995|P3|NOT COMPLETED|Session 2||0
209437|NCT00371397|493996|P2|NOT COMPLETED|Session 2||0
209438|NCT00371397|493997|P1|NOT COMPLETED|Session 2||0
209439|NCT00371397|493986|P12|COMPLETED|Session 2||2
209440|NCT00371397|493987|P11|COMPLETED|Session 2||4
209441|NCT00371397|493988|P10|COMPLETED|Session 2||5
209442|NCT00371397|493989|P9|COMPLETED|Session 2||6
209443|NCT00371397|493990|P8|COMPLETED|Session 2||4
209444|NCT00371397|493991|P7|COMPLETED|Session 2||4
209445|NCT00371397|493992|P6|COMPLETED|Session 2||4
209446|NCT00371397|493993|P5|COMPLETED|Session 2||3
209447|NCT00371397|493994|P4|COMPLETED|Session 2||2
209448|NCT00371397|493995|P3|COMPLETED|Session 2||5
209449|NCT00371397|493996|P2|COMPLETED|Session 2||7
209450|NCT00371397|493997|P1|COMPLETED|Session 2||4
209451|NCT00371397|493986|P12|STARTED|Session 2||2
209452|NCT00371397|493987|P11|STARTED|Session 2||4
209453|NCT00371397|493988|P10|STARTED|Session 2||5
209454|NCT00371397|493989|P9|STARTED|Session 2||6
209455|NCT00371397|493990|P8|STARTED|Session 2||4
209456|NCT00371397|493991|P7|STARTED|Session 2||4
209457|NCT00371397|493992|P6|STARTED|Session 2||4
209458|NCT00371397|493993|P5|STARTED|Session 2||3
209459|NCT00371397|493994|P4|STARTED|Session 2||2
209460|NCT00371397|493995|P3|STARTED|Session 2||5
209461|NCT00371397|493996|P2|STARTED|Session 2||7
209462|NCT00371397|493997|P1|STARTED|Session 2||4
209463|NCT00371397|493986|P12|NOT COMPLETED|Session 1||0
209464|NCT00371397|493987|P11|NOT COMPLETED|Session 1||0
209465|NCT00371397|493988|P10|NOT COMPLETED|Session 1||0
209466|NCT00371397|493989|P9|NOT COMPLETED|Session 1||0
209467|NCT00371397|493990|P8|NOT COMPLETED|Session 1||1
209468|NCT00371397|493991|P7|NOT COMPLETED|Session 1||0
209469|NCT00371397|493992|P6|NOT COMPLETED|Session 1||0
209470|NCT00371397|493993|P5|NOT COMPLETED|Session 1||0
209471|NCT00371397|493994|P4|NOT COMPLETED|Session 1||0
209472|NCT00371397|493995|P3|NOT COMPLETED|Session 1||0
209473|NCT00371397|493996|P2|NOT COMPLETED|Session 1||0
209474|NCT00371397|493997|P1|NOT COMPLETED|Session 1||1
209475|NCT00371397|493986|P12|COMPLETED|Session 1||2
209476|NCT00371397|493987|P11|COMPLETED|Session 1||4
209477|NCT00371397|493988|P10|COMPLETED|Session 1||5
209478|NCT00371397|493989|P9|COMPLETED|Session 1||6
209479|NCT00371397|493990|P8|COMPLETED|Session 1||4
209480|NCT00371397|493991|P7|COMPLETED|Session 1||4
209481|NCT00371397|493992|P6|COMPLETED|Session 1||4
209482|NCT00371397|493993|P5|COMPLETED|Session 1||3
209483|NCT00371397|493994|P4|COMPLETED|Session 1||2
209484|NCT00371397|493995|P3|COMPLETED|Session 1||5
209485|NCT00371397|493996|P2|COMPLETED|Session 1||7
209486|NCT00371397|493997|P1|COMPLETED|Session 1||4
209487|NCT00371397|493986|P12|STARTED|Session 1||2
209488|NCT00371397|493987|P11|STARTED|Session 1||4
209489|NCT00371397|493988|P10|STARTED|Session 1||5
209490|NCT00371397|493989|P9|STARTED|Session 1||6
209491|NCT00371397|493990|P8|STARTED|Session 1||5
209492|NCT00371397|493991|P7|STARTED|Session 1||4
209493|NCT00371397|493992|P6|STARTED|Session 1||4
209494|NCT00371397|493993|P5|STARTED|Session 1||3
209495|NCT00371397|493994|P4|STARTED|Session 1||2
209496|NCT00371397|493995|P3|STARTED|Session 1||5
209497|NCT00371397|493996|P2|STARTED|Session 1||7
209498|NCT00371397|493997|P1|STARTED|Session 1||5
209499|NCT00371345|494005|P2|NOT COMPLETED|Overall Study||46
209500|NCT00371345|494006|P1|NOT COMPLETED|Overall Study||24
209501|NCT00371345|494005|P2|COMPLETED|Overall Study||0
209502|NCT00371345|494006|P1|COMPLETED|Overall Study||0
209503|NCT00371345|494005|P2|STARTED|Overall Study||46
209504|NCT00371345|494006|P1|STARTED|Overall Study||24
209505|NCT00371267|494065|P2|NOT COMPLETED|Overall Study||18
209506|NCT00371267|494066|P1|NOT COMPLETED|Overall Study||9
209507|NCT00371267|494065|P2|COMPLETED|Overall Study||32
209508|NCT00371267|494066|P1|COMPLETED|Overall Study||39
209509|NCT00371267|494065|P2|STARTED|Overall Study||50
209510|NCT00371267|494066|P1|STARTED|Overall Study||48
209511|NCT00371254|494082|P2|NOT COMPLETED|Overall Study||21
209512|NCT00371254|494083|P1|NOT COMPLETED|Overall Study||23
209513|NCT00371254|494082|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
209514|NCT00371254|494083|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
209515|NCT00371254|494082|P2|STARTED|Overall Study|Number of participants treated|21
209516|NCT00371254|494083|P1|STARTED|Overall Study|Number of participants treated|23
209517|NCT00371176|494135|P2|NOT COMPLETED|Overall Study||8
209518|NCT00371176|494136|P1|NOT COMPLETED|Overall Study||5
209519|NCT00371176|494135|P2|COMPLETED|Overall Study||5
209520|NCT00371176|494136|P1|COMPLETED|Overall Study||8
209521|NCT00371176|494135|P2|Completed Treatment|Overall Study||9
209522|NCT00371176|494136|P1|Completed Treatment|Overall Study||10
209523|NCT00371176|494135|P2|STARTED|Overall Study||13
209524|NCT00371176|494136|P1|STARTED|Overall Study||13
209525|NCT00371150|494166|P2|NOT COMPLETED|Overall Study||2
209526|NCT00371150|494167|P1|NOT COMPLETED|Overall Study||3
209527|NCT00371150|494166|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
209528|NCT00371150|494167|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
209529|NCT00371150|494166|P2|Discontinued at or After Week 48 Visit|Overall Study||1
209530|NCT00371150|494167|P1|Discontinued at or After Week 48 Visit|Overall Study||2
209531|NCT00371150|494166|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
209532|NCT00371150|494167|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
209533|NCT00371150|494166|P2|STARTED|Overall Study||6
209534|NCT00371150|494167|P1|STARTED|Overall Study||40
209535|NCT00371137|494202|P3|NOT COMPLETED|Overall Study||79
209536|NCT00371137|494203|P2|NOT COMPLETED|Overall Study||63
209537|NCT00371137|494204|P1|NOT COMPLETED|Overall Study||72
209538|NCT00371137|494202|P3|COMPLETED|Overall Study||104
209539|NCT00371137|494203|P2|COMPLETED|Overall Study||119
209540|NCT00371137|494204|P1|COMPLETED|Overall Study||111
209541|NCT00371137|494202|P3|Treated|Overall Study||182
209542|NCT00371137|494203|P2|Treated|Overall Study||182
209543|NCT00371137|494204|P1|Treated|Overall Study||183
209544|NCT00371137|494202|P3|STARTED|Overall Study||183
209545|NCT00371137|494203|P2|STARTED|Overall Study||182
209546|NCT00371137|494204|P1|STARTED|Overall Study||183
209547|NCT00370994|494214|P2|NOT COMPLETED|Overall Study||0
209548|NCT00370994|494215|P1|NOT COMPLETED|Overall Study||0
209549|NCT00370994|494214|P2|COMPLETED|Overall Study||60
209550|NCT00370994|494215|P1|COMPLETED|Overall Study||60
209551|NCT00370994|494214|P2|STARTED|Overall Study||60
209552|NCT00370994|494215|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
209553|NCT00370838|494225|P2|NOT COMPLETED|Taper||0
209554|NCT00370838|494226|P1|NOT COMPLETED|Taper||0
209555|NCT00370838|494225|P2|COMPLETED|Taper||3
209556|NCT00370838|494226|P1|COMPLETED|Taper||7
209557|NCT00370838|494225|P2|STARTED|Taper||3
209558|NCT00370838|494226|P1|STARTED|Taper||7
209559|NCT00370838|494225|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
209560|NCT00370838|494226|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
209561|NCT00370838|494225|P2|COMPLETED|Period 2 (Days 65-107)||3
209562|NCT00370838|494226|P1|COMPLETED|Period 2 (Days 65-107)||7
209563|NCT00370838|494225|P2|STARTED|Period 2 (Days 65-107)||3
209564|NCT00370838|494226|P1|STARTED|Period 2 (Days 65-107)||7
209565|NCT00370838|494225|P2|NOT COMPLETED|Washout (Days 51-64)||0
209566|NCT00370838|494226|P1|NOT COMPLETED|Washout (Days 51-64)||0
209567|NCT00370838|494225|P2|COMPLETED|Washout (Days 51-64)||3
209568|NCT00370838|494226|P1|COMPLETED|Washout (Days 51-64)||7
209569|NCT00370838|494225|P2|STARTED|Washout (Days 51-64)||3
209570|NCT00370838|494226|P1|STARTED|Washout (Days 51-64)||7
209571|NCT00370838|494225|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
209572|NCT00370838|494226|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
209573|NCT00370838|494225|P2|COMPLETED|Period 1 (Days 8-50)||3
209574|NCT00370838|494226|P1|COMPLETED|Period 1 (Days 8-50)||7
209575|NCT00370838|494225|P2|STARTED|Period 1 (Days 8-50)||3
209576|NCT00370838|494226|P1|STARTED|Period 1 (Days 8-50)||7
209577|NCT00370552|494247|P3|NOT COMPLETED|Overall Study||32
209578|NCT00370552|494248|P2|NOT COMPLETED|Overall Study||45
209579|NCT00370552|494249|P1|NOT COMPLETED|Overall Study||46
209580|NCT00370552|494247|P3|COMPLETED|Overall Study||0
209581|NCT00370552|494248|P2|COMPLETED|Overall Study||0
209582|NCT00370552|494249|P1|COMPLETED|Overall Study||0
209583|NCT00370552|494247|P3|STARTED|Overall Study|Randomized|32
209584|NCT00370552|494248|P2|STARTED|Overall Study|Randomized|45
209585|NCT00370552|494249|P1|STARTED|Overall Study|Randomized|46
209586|NCT00370331|494289|P2|NOT COMPLETED|Overall Study||23
209587|NCT00370331|494290|P1|NOT COMPLETED|Overall Study||7
209588|NCT00370331|494289|P2|COMPLETED|Overall Study||112
209589|NCT00370331|494290|P1|COMPLETED|Overall Study||55
209590|NCT00370331|494289|P2|STARTED|Overall Study||135
209591|NCT00370331|494290|P1|STARTED|Overall Study||62
209592|NCT00370292|494316|P1|NOT COMPLETED|Overall Study||13
209593|NCT00370292|494316|P1|COMPLETED|Overall Study||6
209594|NCT00370292|494316|P1|STARTED|Overall Study||19
209595|NCT00370149|494329|P2|NOT COMPLETED|Overall Study||19
209596|NCT00370149|494330|P1|NOT COMPLETED|Overall Study||19
209597|NCT00370149|494329|P2|COMPLETED|Overall Study||142
209598|NCT00370149|494330|P1|COMPLETED|Overall Study||146
209599|NCT00370149|494329|P2|STARTED|Overall Study||161
209600|NCT00370149|494330|P1|STARTED|Overall Study||165
209601|NCT00370071|494340|P1|NOT COMPLETED|Overall Study||2
209602|NCT00370071|494340|P1|COMPLETED|Overall Study||37
209603|NCT00370071|494340|P1|STARTED|Overall Study||39
209604|NCT00370032|494357|P2|NOT COMPLETED|Follow-up Period||0
209605|NCT00370032|494358|P1|NOT COMPLETED|Follow-up Period||1
209606|NCT00370032|494357|P2|COMPLETED|Follow-up Period||22
209607|NCT00370032|494358|P1|COMPLETED|Follow-up Period||22
209608|NCT00370032|494357|P2|STARTED|Follow-up Period||22
209609|NCT00370032|494358|P1|STARTED|Follow-up Period||23
209610|NCT00370032|494357|P2|NOT COMPLETED|Treatment Period 2||0
209611|NCT00370032|494358|P1|NOT COMPLETED|Treatment Period 2||0
209612|NCT00370032|494357|P2|COMPLETED|Treatment Period 2||22
209613|NCT00370032|494358|P1|COMPLETED|Treatment Period 2||23
209614|NCT00370032|494357|P2|STARTED|Treatment Period 2||22
209615|NCT00370032|494358|P1|STARTED|Treatment Period 2||23
209616|NCT00370032|494357|P2|NOT COMPLETED|Washout Period||2
209617|NCT00370032|494358|P1|NOT COMPLETED|Washout Period||1
209618|NCT00370032|494357|P2|COMPLETED|Washout Period||22
209619|NCT00370032|494358|P1|COMPLETED|Washout Period||23
209620|NCT00370032|494357|P2|STARTED|Washout Period||24
209621|NCT00370032|494358|P1|STARTED|Washout Period||24
209622|NCT00370032|494357|P2|NOT COMPLETED|Treatment Period 1||1
209623|NCT00370032|494358|P1|NOT COMPLETED|Treatment Period 1||0
209624|NCT00370032|494357|P2|COMPLETED|Treatment Period 1||24
209625|NCT00370032|494358|P1|COMPLETED|Treatment Period 1||24
209626|NCT00370032|494357|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
209627|NCT00370032|494358|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
209628|NCT00369967|494378|P2|NOT COMPLETED|Overall Study||12
209629|NCT00369967|494379|P1|NOT COMPLETED|Overall Study||23
209630|NCT00369967|494378|P2|COMPLETED|Overall Study||5
209631|NCT00369967|494379|P1|COMPLETED|Overall Study||8
209632|NCT00369967|494378|P2|STARTED|Overall Study||17
209633|NCT00369967|494379|P1|STARTED|Overall Study||31
209634|NCT00369941|494397|P2|NOT COMPLETED|Overall Study||100
209635|NCT00369941|494398|P1|NOT COMPLETED|Overall Study||72
209636|NCT00369941|494397|P2|COMPLETED|Overall Study||184
209637|NCT00369941|494398|P1|COMPLETED|Overall Study||210
209638|NCT00369941|494397|P2|Treated|Overall Study||282
209639|NCT00369941|494398|P1|Treated|Overall Study||281
209640|NCT00369941|494397|P2|STARTED|Overall Study||284
209641|NCT00369941|494398|P1|STARTED|Overall Study||282
209642|NCT00369928|494551|P3|NOT COMPLETED|Overall Study||20
209643|NCT00369928|494552|P2|NOT COMPLETED|Overall Study||16
209644|NCT00369928|494553|P1|NOT COMPLETED|Overall Study||8
209645|NCT00369928|494551|P3|COMPLETED|Overall Study||66
209646|NCT00369928|494552|P2|COMPLETED|Overall Study||69
209647|NCT00369928|494553|P1|COMPLETED|Overall Study||77
209648|NCT00369928|494551|P3|STARTED|Overall Study||86
209649|NCT00369928|494552|P2|STARTED|Overall Study||85
209650|NCT00369928|494553|P1|STARTED|Overall Study||85
209651|NCT00369915|494563|P2|NOT COMPLETED|Overall Study||3
209652|NCT00369915|494564|P1|NOT COMPLETED|Overall Study||6
209653|NCT00369915|494563|P2|COMPLETED|Overall Study||4
209654|NCT00369915|494564|P1|COMPLETED|Overall Study||4
209655|NCT00369915|494563|P2|STARTED|Overall Study||7
209656|NCT00369915|494564|P1|STARTED|Overall Study||10
209657|NCT00369824|494578|P6|NOT COMPLETED|Overall Study||11
209658|NCT00369824|494579|P5|NOT COMPLETED|Overall Study||18
209659|NCT00369824|494580|P4|NOT COMPLETED|Overall Study||15
209660|NCT00369824|494581|P3|NOT COMPLETED|Overall Study||12
209661|NCT00369824|494582|P2|NOT COMPLETED|Overall Study||19
209662|NCT00369824|494583|P1|NOT COMPLETED|Overall Study||15
209663|NCT00369824|494578|P6|COMPLETED|Overall Study||204
209664|NCT00369824|494579|P5|COMPLETED|Overall Study||196
209665|NCT00369824|494580|P4|COMPLETED|Overall Study||199
209666|NCT00369824|494581|P3|COMPLETED|Overall Study||202
209667|NCT00369824|494582|P2|COMPLETED|Overall Study||195
209668|NCT00369824|494583|P1|COMPLETED|Overall Study||197
209669|NCT00369824|494578|P6|STARTED|Overall Study||215
209670|NCT00369824|494579|P5|STARTED|Overall Study||214
209671|NCT00369824|494580|P4|STARTED|Overall Study||214
209672|NCT00369824|494581|P3|STARTED|Overall Study||214
209673|NCT00369824|494582|P2|STARTED|Overall Study||214
209674|NCT00369824|494583|P1|STARTED|Overall Study||212
209675|NCT00369746|494683|P2|NOT COMPLETED|Overall Study||0
209676|NCT00369746|494684|P1|NOT COMPLETED|Overall Study||0
209677|NCT00369746|494683|P2|COMPLETED|Overall Study||536
209678|NCT00369746|494684|P1|COMPLETED|Overall Study||138
209679|NCT00369746|494683|P2|STARTED|Overall Study||536
209680|NCT00369746|494684|P1|STARTED|Overall Study||138
209681|NCT00369681|494694|P1|NOT COMPLETED|Overall Study||1
209682|NCT00369681|494694|P1|COMPLETED|Overall Study||49
209683|NCT00369681|494694|P1|STARTED|Overall Study||50
209684|NCT00369668|494703|P3|NOT COMPLETED|Overall Study||7
209685|NCT00369668|494704|P2|NOT COMPLETED|Overall Study||5
209686|NCT00369668|494705|P1|NOT COMPLETED|Overall Study||4
209687|NCT00369668|494703|P3|COMPLETED|Overall Study||3
209688|NCT00369668|494704|P2|COMPLETED|Overall Study||5
209689|NCT00369668|494705|P1|COMPLETED|Overall Study||6
209690|NCT00369668|494703|P3|STARTED|Overall Study||10
209691|NCT00369668|494704|P2|STARTED|Overall Study||10
209692|NCT00369668|494705|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
209693|NCT00369655|494719|P1|NOT COMPLETED|Overall Study||2
209694|NCT00369655|494719|P1|COMPLETED|Overall Study||19
209695|NCT00369655|494719|P1|STARTED|Overall Study||21
209696|NCT00369590|494730|P2|NOT COMPLETED|Overall Study||0
209697|NCT00369590|494731|P1|NOT COMPLETED|Overall Study||0
209698|NCT00369590|494730|P2|COMPLETED|Overall Study||42
209699|NCT00369590|494731|P1|COMPLETED|Overall Study||16
209700|NCT00369590|494730|P2|STARTED|Overall Study||42
209701|NCT00369590|494731|P1|STARTED|Overall Study||16
209702|NCT00369564|494748|P2|NOT COMPLETED|Overall Study||23
209703|NCT00369564|494749|P1|NOT COMPLETED|Overall Study||43
209704|NCT00369564|494748|P2|COMPLETED|Overall Study||100
209705|NCT00369564|494749|P1|COMPLETED|Overall Study||84
209706|NCT00369564|494748|P2|STARTED|Overall Study||123
209707|NCT00369564|494749|P1|STARTED|Overall Study||127
209708|NCT00369512|494755|P1|NOT COMPLETED|Overall Study||0
209709|NCT00369512|494755|P1|COMPLETED|Overall Study||15
209710|NCT00369512|494755|P1|STARTED|Overall Study||15
209711|NCT00369486|494766|P5|NOT COMPLETED|34-Week Visit||3
209712|NCT00369486|494767|P4|NOT COMPLETED|34-Week Visit||3
209713|NCT00369486|494768|P3|NOT COMPLETED|34-Week Visit||1
209714|NCT00369486|494769|P2|NOT COMPLETED|34-Week Visit||1
209715|NCT00369486|494770|P1|NOT COMPLETED|34-Week Visit||0
209716|NCT00369486|494766|P5|COMPLETED|34-Week Visit|Number of eyes|22
209717|NCT00369486|494767|P4|COMPLETED|34-Week Visit|Number of eyes|19
209718|NCT00369486|494768|P3|COMPLETED|34-Week Visit|Number of eyes|22
209719|NCT00369486|494769|P2|COMPLETED|34-Week Visit|Number of eyes|20
209720|NCT00369486|494770|P1|COMPLETED|34-Week Visit|Number of eyes|38
209721|NCT00369486|494766|P5|STARTED|34-Week Visit|Number of eyes that|25
209722|NCT00369486|494767|P4|STARTED|34-Week Visit|Number of eyes|22
209723|NCT00369486|494768|P3|STARTED|34-Week Visit|Number of eyes|23
209724|NCT00369486|494769|P2|STARTED|34-Week Visit|Number of eyes|21
209725|NCT00369486|494770|P1|STARTED|34-Week Visit|Number of eyes|38
209726|NCT00369486|494766|P5|NOT COMPLETED|17-Week Visit||1
209727|NCT00369486|494767|P4|NOT COMPLETED|17-Week Visit||1
209728|NCT00369486|494768|P3|NOT COMPLETED|17-Week Visit||1
209729|NCT00369486|494769|P2|NOT COMPLETED|17-Week Visit||0
209730|NCT00369486|494770|P1|NOT COMPLETED|17-Week Visit||0
209731|NCT00369486|494766|P5|COMPLETED|17-Week Visit|Number of eyes|24
209732|NCT00369486|494767|P4|COMPLETED|17-Week Visit|Number of eyes|21
209733|NCT00369486|494768|P3|COMPLETED|17-Week Visit|Number of eyes|22
209734|NCT00369486|494769|P2|COMPLETED|17-Week Visit|Number of eyes|21
209735|NCT00369486|494770|P1|COMPLETED|17-Week Visit|Number of eyes|38
209736|NCT00369486|494766|P5|STARTED|17-Week Visit|Number of eyes|25
209737|NCT00369486|494767|P4|STARTED|17-Week Visit|Number of eyes|22
209738|NCT00369486|494768|P3|STARTED|17-Week Visit|Number of eyes|23
209739|NCT00369486|494769|P2|STARTED|17-Week Visit|Number of eyes|21
209740|NCT00369486|494770|P1|STARTED|17-Week Visit|Number of eyes|38
209741|NCT00369486|494766|P5|NOT COMPLETED|8-Week Visit||1
209742|NCT00369486|494767|P4|NOT COMPLETED|8-Week Visit||1
209743|NCT00369486|494768|P3|NOT COMPLETED|8-Week Visit||0
209744|NCT00369486|494769|P2|NOT COMPLETED|8-Week Visit||1
209745|NCT00369486|494770|P1|NOT COMPLETED|8-Week Visit||0
209746|NCT00369486|494766|P5|COMPLETED|8-Week Visit|Number of eyes|24
209747|NCT00369486|494767|P4|COMPLETED|8-Week Visit|Number of eyes|21
209748|NCT00369486|494768|P3|COMPLETED|8-Week Visit|Number of eyes|22
209749|NCT00369486|494769|P2|COMPLETED|8-Week Visit|Number of eyes|20
209750|NCT00369486|494770|P1|COMPLETED|8-Week Visit|Number of eyes|38
209751|NCT00369486|494766|P5|STARTED|8-Week Visit|Number of eyes|25
209752|NCT00369486|494767|P4|STARTED|8-Week Visit|Number of eyes|22
209753|NCT00369486|494768|P3|STARTED|8-Week Visit|Number of eyes|22
209754|NCT00369486|494769|P2|STARTED|8-Week Visit|Number of eyes|21
209755|NCT00369486|494770|P1|STARTED|8-Week Visit|Number of eyes|38
209756|NCT00369486|494766|P5|NOT COMPLETED|4-Week Visit||1
209757|NCT00369486|494767|P4|NOT COMPLETED|4-Week Visit||2
209758|NCT00369486|494768|P3|NOT COMPLETED|4-Week Visit||1
209759|NCT00369486|494769|P2|NOT COMPLETED|4-Week Visit||2
209760|NCT00369486|494770|P1|NOT COMPLETED|4-Week Visit||2
209761|NCT00369486|494766|P5|COMPLETED|4-Week Visit|Number of eyes|24
209762|NCT00369486|494767|P4|COMPLETED|4-Week Visit|Number of eyes|20
209763|NCT00369486|494768|P3|COMPLETED|4-Week Visit|Number of eyes|22
209764|NCT00369486|494769|P2|COMPLETED|4-Week Visit|Number of eyes;|19
209765|NCT00369486|494770|P1|COMPLETED|4-Week Visit|Number of eyes|36
209766|NCT00369486|494766|P5|STARTED|4-Week Visit|Number of eyes|25
209767|NCT00369486|494767|P4|STARTED|4-Week Visit|Number of eyes|22
209768|NCT00369486|494768|P3|STARTED|4-Week Visit|Number of eyes|23
209769|NCT00369486|494769|P2|STARTED|4-Week Visit|Number of eyes|21
209770|NCT00369486|494770|P1|STARTED|4-Week Visit|Number of eyes|38
209771|NCT00369382|494809|P2|NOT COMPLETED|Overall Study||3
209772|NCT00369382|494810|P1|NOT COMPLETED|Overall Study||10
209773|NCT00369382|494809|P2|COMPLETED|Overall Study||54
209774|NCT00369382|494810|P1|COMPLETED|Overall Study||49
209775|NCT00369382|494809|P2|Completed Assigned Treatment Regimen|Overall Study||33
209776|NCT00369382|494810|P1|Completed Assigned Treatment Regimen|Overall Study||48
209777|NCT00369382|494809|P2|Received Treatment|Overall Study||57
209778|NCT00369382|494810|P1|Received Treatment|Overall Study||57
209779|NCT00369382|494809|P2|STARTED|Overall Study||57
209780|NCT00369382|494810|P1|STARTED|Overall Study||59
209781|NCT00369343|494843|P2|NOT COMPLETED|Open-label Phase||30
209782|NCT00369343|494844|P1|NOT COMPLETED|Open-label Phase||57
209783|NCT00369343|494843|P2|COMPLETED|Open-label Phase||79
209784|NCT00369343|494844|P1|COMPLETED|Open-label Phase||155
209785|NCT00369343|494843|P2|STARTED|Open-label Phase||109
209786|NCT00369343|494844|P1|STARTED|Open-label Phase||212
209787|NCT00369343|494843|P2|NOT COMPLETED|Double-blind Phase||16
209788|NCT00369343|494844|P1|NOT COMPLETED|Double-blind Phase||44
209789|NCT00369343|494843|P2|COMPLETED|Double-blind Phase||109
209790|NCT00369343|494844|P1|COMPLETED|Double-blind Phase||212
209791|NCT00369343|494843|P2|STARTED|Double-blind Phase||125
209792|NCT00369343|494844|P1|STARTED|Double-blind Phase||256
209793|NCT00369317|494877|P1|NOT COMPLETED|Overall Study||20
209794|NCT00369317|494877|P1|COMPLETED|Overall Study||185
209795|NCT00369317|494877|P1|STARTED|Overall Study||205
209796|NCT00369278|494884|P2|NOT COMPLETED|Overall Study||21
209797|NCT00369278|494885|P1|NOT COMPLETED|Overall Study||24
209798|NCT00369278|494884|P2|COMPLETED|Overall Study||44
209799|NCT00369278|494885|P1|COMPLETED|Overall Study||39
209800|NCT00369278|494884|P2|STARTED|Overall Study||65
209801|NCT00369278|494885|P1|STARTED|Overall Study||63
209802|NCT00369265|494901|P2|NOT COMPLETED|Overall Study||7
209803|NCT00369265|494902|P1|NOT COMPLETED|Overall Study||4
209804|NCT00369265|494901|P2|COMPLETED|Overall Study||0
209805|NCT00369265|494902|P1|COMPLETED|Overall Study||0
209806|NCT00369265|494901|P2|STARTED|Overall Study||7
209807|NCT00369265|494902|P1|STARTED|Overall Study||4
209808|NCT00369226|494910|P2|NOT COMPLETED|Phase II (45 Days)||0
209809|NCT00369226|494911|P1|NOT COMPLETED|Phase II (45 Days)||0
209810|NCT00369226|494910|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
209811|NCT00369226|494911|P1|COMPLETED|Phase II (45 Days)||0
209812|NCT00369226|494910|P2|STARTED|Phase II (45 Days)||32
209813|NCT00369226|494911|P1|STARTED|Phase II (45 Days)||0
209814|NCT00369226|494910|P2|NOT COMPLETED|Phase I (45 Days)||0
209815|NCT00369226|494911|P1|NOT COMPLETED|Phase I (45 Days)||0
209816|NCT00369226|494910|P2|COMPLETED|Phase I (45 Days)||0
209817|NCT00369226|494911|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
209818|NCT00369226|494910|P2|STARTED|Phase I (45 Days)||0
209819|NCT00369226|494911|P1|STARTED|Phase I (45 Days)||13
209820|NCT00369161|494923|P2|NOT COMPLETED|Overall Study||24
209821|NCT00369161|494924|P1|NOT COMPLETED|Overall Study||27
209822|NCT00369161|494923|P2|COMPLETED|Overall Study||95
209823|NCT00369161|494924|P1|COMPLETED|Overall Study||82
209824|NCT00369161|494923|P2|Intention to Treat (ITT)|Overall Study||117
209825|NCT00369161|494924|P1|Intention to Treat (ITT)|Overall Study||107
209826|NCT00369161|494923|P2|STARTED|Overall Study||119
209827|NCT00369161|494924|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
209828|NCT00369122|494934|P1|NOT COMPLETED|Overall Study||11
209829|NCT00369122|494934|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
209830|NCT00369122|494934|P1|STARTED|Overall Study||60
209831|NCT00368992|494938|P1|NOT COMPLETED|Overall Study||110
209832|NCT00368992|494938|P1|COMPLETED|Overall Study||0
209833|NCT00368992|494938|P1|STARTED|Overall Study||110
209834|NCT00368979|494947|P2|NOT COMPLETED|Overall Study||30
209835|NCT00368979|494948|P1|NOT COMPLETED|Overall Study||25
209836|NCT00368979|494947|P2|COMPLETED|Overall Study||163
209837|NCT00368979|494948|P1|COMPLETED|Overall Study||160
209838|NCT00368979|494947|P2|STARTED|Overall Study||193
209839|NCT00368979|494948|P1|STARTED|Overall Study||185
209840|NCT00368966|494964|P2|NOT COMPLETED|Toddler Dose||3
209841|NCT00368966|494965|P1|NOT COMPLETED|Toddler Dose||1
209842|NCT00368966|494964|P2|COMPLETED|Toddler Dose||286
209843|NCT00368966|494965|P1|COMPLETED|Toddler Dose||292
209844|NCT00368966|494964|P2|STARTED|Toddler Dose||289
209845|NCT00368966|494965|P1|STARTED|Toddler Dose||293
209846|NCT00368966|494964|P2|NOT COMPLETED|After Infant||5
209847|NCT00368966|494965|P1|NOT COMPLETED|After Infant||6
209848|NCT00368966|494964|P2|COMPLETED|After Infant||289
209849|NCT00368966|494965|P1|COMPLETED|After Infant||293
209850|NCT00368966|494964|P2|STARTED|After Infant||294
209851|NCT00368966|494965|P1|STARTED|After Infant||299
209852|NCT00368966|494964|P2|NOT COMPLETED|Infant Series||10
209853|NCT00368966|494965|P1|NOT COMPLETED|Infant Series||16
209854|NCT00368966|494964|P2|COMPLETED|Infant Series||294
209855|NCT00368966|494965|P1|COMPLETED|Infant Series||299
209856|NCT00368966|494964|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
209857|NCT00368966|494965|P1|Vaccinated Dose 3|Infant Series||301
209858|NCT00368966|494964|P2|Vaccinated Dose 2|Infant Series||298
209859|NCT00368966|494965|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
209860|NCT00368966|494964|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
209861|NCT00368966|494965|P1|Vaccinated Dose 1|Infant Series||314
209862|NCT00368966|494964|P2|STARTED|Infant Series||304
209863|NCT00368966|494965|P1|STARTED|Infant Series||315
209864|NCT00368927|495021|P2|NOT COMPLETED|Overall Study||3
209865|NCT00368927|495022|P1|NOT COMPLETED|Overall Study||5
209866|NCT00368927|495021|P2|COMPLETED|Overall Study||27
209867|NCT00368927|495022|P1|COMPLETED|Overall Study||26
209868|NCT00368927|495021|P2|STARTED|Overall Study||30
209869|NCT00368927|495022|P1|STARTED|Overall Study||31
209870|NCT00368875|495030|P2|NOT COMPLETED|Overall Study||48
209871|NCT00368875|495031|P1|NOT COMPLETED|Overall Study||6
209872|NCT00368875|495030|P2|COMPLETED|Overall Study||0
209873|NCT00368875|495031|P1|COMPLETED|Overall Study||0
209874|NCT00368875|495030|P2|STARTED|Overall Study||48
209875|NCT00368875|495031|P1|STARTED|Overall Study||6
209876|NCT00368849|495039|P2|NOT COMPLETED|Overall Study||2
209877|NCT00368849|495040|P1|NOT COMPLETED|Overall Study||0
209878|NCT00368849|495039|P2|COMPLETED|Overall Study||8
209879|NCT00368849|495040|P1|COMPLETED|Overall Study||10
209880|NCT00368849|495039|P2|STARTED|Overall Study||10
209881|NCT00368849|495040|P1|STARTED|Overall Study||10
209882|NCT00368745|495056|P2|NOT COMPLETED|Double-blind Treatment Period||31
209883|NCT00368745|495057|P1|NOT COMPLETED|Double-blind Treatment Period||26
209884|NCT00368745|495056|P2|COMPLETED|Double-blind Treatment Period||19
209885|NCT00368745|495057|P1|COMPLETED|Double-blind Treatment Period||30
209886|NCT00368745|495056|P2|STARTED|Double-blind Treatment Period||50
209887|NCT00368745|495057|P1|STARTED|Double-blind Treatment Period||56
209888|NCT00368745|495056|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
209889|NCT00368745|495057|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
209890|NCT00368745|495056|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
209891|NCT00368745|495057|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
209892|NCT00368745|495056|P2|STARTED|Randomized to Double-blind Treatment||51
209893|NCT00368745|495057|P1|STARTED|Randomized to Double-blind Treatment||57
209894|NCT00368641|495089|P2|NOT COMPLETED|Overall Study||6
209895|NCT00368641|495090|P1|NOT COMPLETED|Overall Study||6
209896|NCT00368641|495089|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
209897|NCT00368641|495090|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
209898|NCT00368641|495089|P2|STARTED|Overall Study||6
209899|NCT00368641|495090|P1|STARTED|Overall Study||6
209900|NCT00368550|495098|P2|NOT COMPLETED|Overall Study||23
209901|NCT00368550|495099|P1|NOT COMPLETED|Overall Study||28
209902|NCT00368550|495098|P2|COMPLETED|Overall Study||48
209903|NCT00368550|495099|P1|COMPLETED|Overall Study||35
209904|NCT00368550|495098|P2|STARTED|Overall Study||71
209905|NCT00368550|495099|P1|STARTED|Overall Study||63
209906|NCT00368537|495111|P2|NOT COMPLETED|Baseline Participants||24
209907|NCT00368537|495112|P1|NOT COMPLETED|Baseline Participants||24
209908|NCT00368537|495111|P2|COMPLETED|Baseline Participants||239
209909|NCT00368537|495112|P1|COMPLETED|Baseline Participants||244
209910|NCT00368537|495111|P2|STARTED|Baseline Participants||263
209911|NCT00368537|495112|P1|STARTED|Baseline Participants||268
209912|NCT00368537|495111|P2|NOT COMPLETED|Randomization||6
209913|NCT00368537|495112|P1|NOT COMPLETED|Randomization||13
209914|NCT00368537|495111|P2|COMPLETED|Randomization||263
209915|NCT00368537|495112|P1|COMPLETED|Randomization||268
209916|NCT00368537|495111|P2|STARTED|Randomization||269
209917|NCT00368537|495112|P1|STARTED|Randomization||281
209918|NCT00368472|495126|P1|NOT COMPLETED|Overall Study||105
209919|NCT00368472|495126|P1|COMPLETED|Overall Study||33
209920|NCT00368472|495126|P1|STARTED|Overall Study||138
209921|NCT00368459|495134|P2|NOT COMPLETED|Overall Study||1
209922|NCT00368459|495135|P1|NOT COMPLETED|Overall Study||2
209923|NCT00368459|495134|P2|COMPLETED|Overall Study||20
209924|NCT00368459|495135|P1|COMPLETED|Overall Study||19
209925|NCT00368459|495134|P2|STARTED|Overall Study||21
209926|NCT00368459|495135|P1|STARTED|Overall Study||21
209927|NCT00368316|495161|P2|NOT COMPLETED|Overall Study||46
209928|NCT00368316|495162|P1|NOT COMPLETED|Overall Study||42
209929|NCT00368316|495161|P2|COMPLETED|Overall Study||1319
209930|NCT00368316|495162|P1|COMPLETED|Overall Study||1392
209931|NCT00368316|495161|P2|STARTED|Overall Study||1365
209932|NCT00368316|495162|P1|STARTED|Overall Study||1434
209933|NCT00368290|495174|P2|NOT COMPLETED|Overall Study||10
209934|NCT00368290|495175|P1|NOT COMPLETED|Overall Study||13
209935|NCT00368290|495174|P2|COMPLETED|Overall Study||37
209936|NCT00368290|495175|P1|COMPLETED|Overall Study||34
209937|NCT00368290|495174|P2|STARTED|Overall Study||47
209938|NCT00368290|495175|P1|STARTED|Overall Study||47
209939|NCT00368277|495185|P2|NOT COMPLETED|Overall Study||108
209940|NCT00368277|495186|P1|NOT COMPLETED|Overall Study||113
209941|NCT00368277|495185|P2|COMPLETED|Overall Study||336
209942|NCT00368277|495186|P1|COMPLETED|Overall Study||344
209943|NCT00368277|495185|P2|STARTED|Overall Study||444
209944|NCT00368277|495186|P1|STARTED|Overall Study||457
209945|NCT00368251|495201|P3|NOT COMPLETED|Overall Study||1
209946|NCT00368251|495202|P2|NOT COMPLETED|Overall Study||0
209947|NCT00368251|495203|P1|NOT COMPLETED|Overall Study||1
209948|NCT00368251|495201|P3|COMPLETED|Overall Study||17
209949|NCT00368251|495202|P2|COMPLETED|Overall Study||20
209950|NCT00368251|495203|P1|COMPLETED|Overall Study||17
209951|NCT00368251|495201|P3|STARTED|Overall Study||18
209952|NCT00368251|495202|P2|STARTED|Overall Study||20
209953|NCT00368251|495203|P1|STARTED|Overall Study||18
209954|NCT00368108|495226|P3|NOT COMPLETED|Overall Study||68
209955|NCT00368108|495227|P2|NOT COMPLETED|Overall Study||53
209956|NCT00368108|495228|P1|NOT COMPLETED|Overall Study||64
209957|NCT00368108|495226|P3|COMPLETED|Overall Study||182
209958|NCT00368108|495227|P2|COMPLETED|Overall Study||198
209959|NCT00368108|495228|P1|COMPLETED|Overall Study||187
209960|NCT00368108|495226|P3|STARTED|Overall Study||250
209961|NCT00368108|495227|P2|STARTED|Overall Study||251
209962|NCT00368108|495228|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
209963|NCT00368069|495247|P2|NOT COMPLETED|Overall Study||7
209964|NCT00368069|495248|P1|NOT COMPLETED|Overall Study||8
209965|NCT00368069|495247|P2|COMPLETED|Overall Study||72
209966|NCT00368069|495248|P1|COMPLETED|Overall Study||71
209967|NCT00368069|495247|P2|STARTED|Overall Study||79
209968|NCT00368069|495248|P1|STARTED|Overall Study||79
209969|NCT00367991|495266|P2|NOT COMPLETED|Overall Study||2
209970|NCT00367991|495267|P1|NOT COMPLETED|Overall Study||2
209971|NCT00367991|495266|P2|COMPLETED|Overall Study||13
209972|NCT00367991|495267|P1|COMPLETED|Overall Study||27
209973|NCT00367991|495266|P2|STARTED|Overall Study||15
209974|NCT00367991|495267|P1|STARTED|Overall Study||29
209975|NCT00366678|495275|P3|NOT COMPLETED|Toddler Dose||0
209976|NCT00366678|495276|P2|NOT COMPLETED|Toddler Dose||1
209977|NCT00366678|495277|P1|NOT COMPLETED|Toddler Dose||5
209978|NCT00366678|495275|P3|COMPLETED|Toddler Dose||137
209979|NCT00366678|495276|P2|COMPLETED|Toddler Dose||151
209980|NCT00366678|495277|P1|COMPLETED|Toddler Dose||268
209981|NCT00366678|495275|P3|STARTED|Toddler Dose||137
209982|NCT00366678|495276|P2|STARTED|Toddler Dose||152
209983|NCT00366678|495277|P1|STARTED|Toddler Dose||273
209984|NCT00366678|495275|P3|NOT COMPLETED|After Infant||0
209985|NCT00366678|495276|P2|NOT COMPLETED|After Infant||10
209986|NCT00366678|495277|P1|NOT COMPLETED|After Infant||17
209987|NCT00366678|495275|P3|COMPLETED|After Infant||0
209988|NCT00366678|495276|P2|COMPLETED|After Infant||289
209989|NCT00366678|495277|P1|COMPLETED|After Infant||273
209990|NCT00366678|495275|P3|STARTED|After Infant||0
209991|NCT00366678|495276|P2|STARTED|After Infant||299
209992|NCT00366678|495277|P1|STARTED|After Infant||290
209993|NCT00366678|495275|P3|NOT COMPLETED|Infant Series||0
209994|NCT00366678|495276|P2|NOT COMPLETED|Infant Series||10
209995|NCT00366678|495277|P1|NOT COMPLETED|Infant Series||14
209996|NCT00366678|495275|P3|COMPLETED|Infant Series||0
209997|NCT00366678|495276|P2|COMPLETED|Infant Series||299
209998|NCT00366678|495277|P1|COMPLETED|Infant Series||290
209999|NCT00366678|495275|P3|Vaccinated Dose 3|Infant Series||0
210000|NCT00366678|495276|P2|Vaccinated Dose 3|Infant Series||302
210001|NCT00366678|495277|P1|Vaccinated Dose 3|Infant Series||291
210002|NCT00366678|495275|P3|Vaccinated Dose 2|Infant Series||0
210003|NCT00366678|495276|P2|Vaccinated Dose 2|Infant Series||304
210004|NCT00366678|495277|P1|Vaccinated Dose 2|Infant Series||295
210005|NCT00366678|495275|P3|Vaccinated Dose 1|Infant Series||0
210006|NCT00366678|495276|P2|Vaccinated Dose 1|Infant Series||309
210007|NCT00366678|495277|P1|Vaccinated Dose 1|Infant Series||302
210008|NCT00366678|495275|P3|STARTED|Infant Series||0
210009|NCT00366678|495276|P2|STARTED|Infant Series||309
210010|NCT00366678|495277|P1|STARTED|Infant Series||304
210011|NCT00366626|495344|P2|NOT COMPLETED|Overall Study||0
210012|NCT00366626|495345|P1|NOT COMPLETED|Overall Study||0
210013|NCT00366626|495344|P2|COMPLETED|Overall Study||45
210014|NCT00366626|495345|P1|COMPLETED|Overall Study||38
210015|NCT00366626|495344|P2|STARTED|Overall Study||45
210016|NCT00366626|495345|P1|STARTED|Overall Study||38
210017|NCT00367835|495359|P2|NOT COMPLETED|Overall Study||31
210018|NCT00367835|495360|P1|NOT COMPLETED|Overall Study||29
210019|NCT00367835|495359|P2|COMPLETED|Overall Study||48
210020|NCT00367835|495360|P1|COMPLETED|Overall Study||109
210021|NCT00367835|495359|P2|STARTED|Overall Study||79
210022|NCT00367835|495360|P1|STARTED|Overall Study||138
210023|NCT00367770|495386|P1|NOT COMPLETED|Overall Study||2
210024|NCT00367770|495386|P1|COMPLETED|Overall Study||35
210025|NCT00367770|495386|P1|STARTED|Overall Study||37
210026|NCT00367744|495394|P2|NOT COMPLETED|Overall Study||5
210027|NCT00367744|495395|P1|NOT COMPLETED|Overall Study||4
210028|NCT00367744|495394|P2|COMPLETED|Overall Study||32
210029|NCT00367744|495395|P1|COMPLETED|Overall Study||30
210030|NCT00367744|495394|P2|STARTED|Overall Study||37
210031|NCT00367744|495395|P1|STARTED|Overall Study||34
210032|NCT00367679|495403|P1|NOT COMPLETED|Overall Study||0
210033|NCT00367679|495403|P1|COMPLETED|Overall Study||35
210034|NCT00367679|495403|P1|STARTED|Overall Study||35
210035|NCT00367640|495424|P4|NOT COMPLETED|Overall Study||10
210036|NCT00367640|495425|P3|NOT COMPLETED|Overall Study||19
210037|NCT00367640|495426|P2|NOT COMPLETED|Overall Study||22
210038|NCT00367640|495427|P1|NOT COMPLETED|Overall Study||18
210039|NCT00367640|495424|P4|COMPLETED|Overall Study||146
210040|NCT00367640|495425|P3|COMPLETED|Overall Study||141
210041|NCT00367640|495426|P2|COMPLETED|Overall Study||133
210042|NCT00367640|495427|P1|COMPLETED|Overall Study||139
210043|NCT00367640|495424|P4|STARTED|Overall Study||156
210044|NCT00367640|495425|P3|STARTED|Overall Study||160
210045|NCT00367640|495426|P2|STARTED|Overall Study||155
210046|NCT00367640|495427|P1|STARTED|Overall Study||157
210047|NCT00367601|495437|P1|NOT COMPLETED|Overall Study||0
210048|NCT00367601|495437|P1|COMPLETED|Overall Study||25
210049|NCT00367601|495437|P1|STARTED|Overall Study||25
210050|NCT00367484|495443|P1|NOT COMPLETED|Overall Study||17
210051|NCT00367484|495443|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
210052|NCT00367484|495443|P1|STARTED|Overall Study||460
210053|NCT00367432|495447|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
210054|NCT00367432|495448|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
210055|NCT00367432|495447|P2|COMPLETED|Second Period (up to 54 Months)||69
210056|NCT00367432|495448|P1|COMPLETED|Second Period (up to 54 Months)||188
210057|NCT00367432|495447|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
210058|NCT00367432|495448|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
210059|NCT00367432|495447|P2|NOT COMPLETED|First Period (16 Weeks)||0
210060|NCT00367432|495448|P1|NOT COMPLETED|First Period (16 Weeks)||38
210061|NCT00367432|495447|P2|COMPLETED|First Period (16 Weeks)||0
210062|NCT00367432|495448|P1|COMPLETED|First Period (16 Weeks)||275
210063|NCT00367432|495447|P2|STARTED|First Period (16 Weeks)||0
210064|NCT00367432|495448|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
210065|NCT00367380|495463|P3|NOT COMPLETED|Overall Study||0
210066|NCT00367380|495464|P2|NOT COMPLETED|Overall Study||0
210067|NCT00367380|495465|P1|NOT COMPLETED|Overall Study||0
210068|NCT00367380|495463|P3|COMPLETED|Overall Study||6
210069|NCT00367380|495464|P2|COMPLETED|Overall Study||6
210070|NCT00367380|495465|P1|COMPLETED|Overall Study||6
210071|NCT00367380|495463|P3|STARTED|Overall Study||6
210072|NCT00367380|495464|P2|STARTED|Overall Study||6
210073|NCT00367380|495465|P1|STARTED|Overall Study||6
210074|NCT00367341|495475|P2|NOT COMPLETED|Overall Study||0
210075|NCT00367341|495476|P1|NOT COMPLETED|Overall Study||2
210076|NCT00367341|495475|P2|COMPLETED|Overall Study||40
210077|NCT00367341|495476|P1|COMPLETED|Overall Study||40
210078|NCT00367341|495475|P2|STARTED|Overall Study||40
210079|NCT00367341|495476|P1|STARTED|Overall Study||42
210080|NCT00367237|495486|P2|NOT COMPLETED|Overall Study||11
210081|NCT00367237|495487|P1|NOT COMPLETED|Overall Study||10
210082|NCT00367237|495486|P2|COMPLETED|Overall Study||47
210083|NCT00367237|495487|P1|COMPLETED|Overall Study||47
210084|NCT00367237|495486|P2|STARTED|Overall Study|Number of subjects randomized|58
210085|NCT00367237|495487|P1|STARTED|Overall Study|Number of subjects randomized|57
210086|NCT00367133|495496|P3|NOT COMPLETED|3 Years||18
210087|NCT00367133|495497|P2|NOT COMPLETED|3 Years||23
210088|NCT00367133|495498|P1|NOT COMPLETED|3 Years||28
210089|NCT00367133|495496|P3|COMPLETED|3 Years||98
210090|NCT00367133|495497|P2|COMPLETED|3 Years||93
210091|NCT00367133|495498|P1|COMPLETED|3 Years||115
210092|NCT00367133|495496|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
210093|NCT00367133|495497|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
210094|NCT00367133|495498|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
210095|NCT00367133|495496|P3|NOT COMPLETED|2 Years||49
210096|NCT00367133|495497|P2|NOT COMPLETED|2 Years||36
210097|NCT00367133|495498|P1|NOT COMPLETED|2 Years||58
210098|NCT00367133|495496|P3|COMPLETED|2 Years||205
210099|NCT00367133|495497|P2|COMPLETED|2 Years||220
210100|NCT00367133|495498|P1|COMPLETED|2 Years||272
210101|NCT00367133|495496|P3|STARTED|2 Years|Number of Eyes|254
210102|NCT00367133|495497|P2|STARTED|2 Years|Number of Eyes|256
210103|NCT00367133|495498|P1|STARTED|2 Years|Number of Eyes|330
210104|NCT00367055|495550|P2|NOT COMPLETED|Overall Study||11
210105|NCT00367055|495551|P1|NOT COMPLETED|Overall Study||11
210106|NCT00367055|495550|P2|COMPLETED|Overall Study||30
210107|NCT00367055|495551|P1|COMPLETED|Overall Study||32
210108|NCT00367055|495550|P2|STARTED|Overall Study||41
210109|NCT00367055|495551|P1|STARTED|Overall Study||43
210110|NCT00366899|495567|P2|NOT COMPLETED|Toddler Dose||1
210111|NCT00366899|495568|P1|NOT COMPLETED|Toddler Dose||2
210112|NCT00366899|495567|P2|COMPLETED|Toddler Dose||281
210113|NCT00366899|495568|P1|COMPLETED|Toddler Dose||285
210114|NCT00366899|495567|P2|STARTED|Toddler Dose||282
210115|NCT00366899|495568|P1|STARTED|Toddler Dose||287
210116|NCT00366899|495567|P2|NOT COMPLETED|After Infant Series||9
210117|NCT00366899|495568|P1|NOT COMPLETED|After Infant Series||7
210118|NCT00366899|495567|P2|COMPLETED|After Infant Series||282
210119|NCT00366899|495568|P1|COMPLETED|After Infant Series||287
210120|NCT00366899|495567|P2|STARTED|After Infant Series||291
210121|NCT00366899|495568|P1|STARTED|After Infant Series||294
210122|NCT00366899|495567|P2|NOT COMPLETED|Infant Series||12
210123|NCT00366899|495568|P1|NOT COMPLETED|Infant Series||9
210124|NCT00366899|495567|P2|COMPLETED|Infant Series||291
210125|NCT00366899|495568|P1|COMPLETED|Infant Series||294
210126|NCT00366899|495567|P2|Vaccinated Dose 2|Infant Series||293
210127|NCT00366899|495568|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
210128|NCT00366899|495567|P2|Vaccinated Dose 1|Infant Series||302
210129|NCT00366899|495568|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
210130|NCT00366899|495567|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
210131|NCT00366899|495568|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
210132|NCT00366548|495628|P2|NOT COMPLETED|Toddler Dose||0
210133|NCT00366548|495629|P1|NOT COMPLETED|Toddler Dose||0
210134|NCT00366548|495628|P2|COMPLETED|Toddler Dose||244
210135|NCT00366548|495629|P1|COMPLETED|Toddler Dose||240
210136|NCT00366548|495628|P2|STARTED|Toddler Dose||244
210137|NCT00366548|495629|P1|STARTED|Toddler Dose||240
210138|NCT00366548|495628|P2|NOT COMPLETED|After Infant Series||1
210139|NCT00366548|495629|P1|NOT COMPLETED|After Infant Series||6
210140|NCT00366548|495628|P2|COMPLETED|After Infant Series||244
210141|NCT00366548|495629|P1|COMPLETED|After Infant Series||240
210142|NCT00366548|495628|P2|STARTED|After Infant Series||245
210143|NCT00366548|495629|P1|STARTED|After Infant Series||246
210144|NCT00366548|495628|P2|NOT COMPLETED|Infant Series||5
210145|NCT00366548|495629|P1|NOT COMPLETED|Infant Series||4
210146|NCT00366548|495628|P2|COMPLETED|Infant Series||245
210147|NCT00366548|495629|P1|COMPLETED|Infant Series||246
210148|NCT00366548|495628|P2|Vaccinated Dose 3|Infant Series||247
210149|NCT00366548|495629|P1|Vaccinated Dose 3|Infant Series||246
210150|NCT00366548|495628|P2|Vaccinated Dose 2|Infant Series||249
210151|NCT00366548|495629|P1|Vaccinated Dose 2|Infant Series||246
210152|NCT00366548|495628|P2|Vaccinated Dose 1|Infant Series||250
210153|NCT00366548|495629|P1|Vaccinated Dose 1|Infant Series||250
210154|NCT00366548|495628|P2|STARTED|Infant Series||250
210155|NCT00366548|495629|P1|STARTED|Infant Series||250
210156|NCT00366444|495665|P2|NOT COMPLETED|Overall Study||2
210157|NCT00366444|495666|P1|NOT COMPLETED|Overall Study||1
210158|NCT00366444|495665|P2|COMPLETED|Overall Study||97
210159|NCT00366444|495666|P1|COMPLETED|Overall Study||101
210160|NCT00366444|495665|P2|STARTED|Overall Study||99
210161|NCT00366444|495666|P1|STARTED|Overall Study||102
210162|NCT00366340|495694|P2|NOT COMPLETED|Toddler Dose||1
210163|NCT00366340|495695|P1|NOT COMPLETED|Toddler Dose||1
210164|NCT00366340|495694|P2|COMPLETED|Toddler Dose||286
210165|NCT00366340|495695|P1|COMPLETED|Toddler Dose||289
210166|NCT00366340|495694|P2|STARTED|Toddler Dose||287
210167|NCT00366340|495695|P1|STARTED|Toddler Dose||290
210168|NCT00366340|495694|P2|NOT COMPLETED|After the Infant Series||6
210169|NCT00366340|495695|P1|NOT COMPLETED|After the Infant Series||3
210170|NCT00366340|495694|P2|COMPLETED|After the Infant Series||287
210171|NCT00366340|495695|P1|COMPLETED|After the Infant Series||290
210172|NCT00366340|495694|P2|STARTED|After the Infant Series||293
210173|NCT00366340|495695|P1|STARTED|After the Infant Series||293
210174|NCT00366340|495694|P2|NOT COMPLETED|Infant Series||10
210175|NCT00366340|495695|P1|NOT COMPLETED|Infant Series||8
210176|NCT00366340|495694|P2|COMPLETED|Infant Series||293
210177|NCT00366340|495695|P1|COMPLETED|Infant Series||293
210178|NCT00366340|495694|P2|Vaccinated Dose 3|Infant Series||293
210179|NCT00366340|495695|P1|Vaccinated Dose 3|Infant Series||294
210180|NCT00366340|495694|P2|Vaccinated Dose 2|Infant Series||297
210181|NCT00366340|495695|P1|Vaccinated Dose 2|Infant Series||296
210182|NCT00366340|495694|P2|Vaccinated Dose 1|Infant Series||303
210183|NCT00366340|495695|P1|Vaccinated Dose 1|Infant Series||300
210184|NCT00366340|495694|P2|STARTED|Infant Series||303
210185|NCT00366340|495695|P1|STARTED|Infant Series||301
210186|NCT00366301|495753|P4|NOT COMPLETED|Overall Study||8
210187|NCT00366301|495754|P3|NOT COMPLETED|Overall Study||4
210188|NCT00366301|495755|P2|NOT COMPLETED|Overall Study||6
210189|NCT00366301|495756|P1|NOT COMPLETED|Overall Study||8
210190|NCT00366301|495753|P4|COMPLETED|Overall Study||116
210191|NCT00366301|495754|P3|COMPLETED|Overall Study||122
210192|NCT00366301|495755|P2|COMPLETED|Overall Study||120
210193|NCT00366301|495756|P1|COMPLETED|Overall Study||116
210194|NCT00366301|495753|P4|Either 6W or 14W CRP Obtained|Overall Study||119
210195|NCT00366301|495754|P3|Either 6W or 14W CRP Obtained|Overall Study||124
210196|NCT00366301|495755|P2|Either 6W or 14W CRP Obtained|Overall Study||124
210197|NCT00366301|495756|P1|Either 6W or 14W CRP Obtained|Overall Study||120
210198|NCT00366301|495753|P4|STARTED|Overall Study||124
210199|NCT00366301|495754|P3|STARTED|Overall Study||126
210200|NCT00366301|495755|P2|STARTED|Overall Study||126
210201|NCT00366301|495756|P1|STARTED|Overall Study||124
210202|NCT00366275|495766|P1|NOT COMPLETED|Overall Study||6
210203|NCT00366275|495766|P1|COMPLETED|Overall Study||58
210204|NCT00366275|495766|P1|STARTED|Overall Study||64
210205|NCT00366249|495772|P2|NOT COMPLETED|Overall Study||78
210206|NCT00366249|495773|P1|NOT COMPLETED|Overall Study||131
210207|NCT00366249|495772|P2|COMPLETED|Overall Study||430
210208|NCT00366249|495773|P1|COMPLETED|Overall Study||422
210209|NCT00366249|495772|P2|STARTED|Overall Study||508
210210|NCT00366249|495773|P1|STARTED|Overall Study||553
210211|NCT00366106|495787|P1|NOT COMPLETED|Overall Study||0
210212|NCT00366106|495787|P1|COMPLETED|Overall Study||32
210213|NCT00366106|495787|P1|STARTED|Overall Study||32
210214|NCT00366028|495796|P2|NOT COMPLETED|Overall Study||0
210215|NCT00366028|495797|P1|NOT COMPLETED|Overall Study||0
210216|NCT00366028|495796|P2|COMPLETED|Overall Study||735
210217|NCT00366028|495797|P1|COMPLETED|Overall Study||889
210218|NCT00366028|495796|P2|STARTED|Overall Study||735
210219|NCT00366028|495797|P1|STARTED|Overall Study||889
210220|NCT00365976|495807|P2|NOT COMPLETED|Overall Study||5
210221|NCT00365976|495808|P1|NOT COMPLETED|Overall Study||1
210222|NCT00365976|495807|P2|COMPLETED|Overall Study||20
210223|NCT00365976|495808|P1|COMPLETED|Overall Study||32
210224|NCT00365976|495807|P2|STARTED|Overall Study||25
210225|NCT00365976|495808|P1|STARTED|Overall Study||33
210226|NCT00365872|495839|P3|NOT COMPLETED|Overall Study||0
210227|NCT00365872|495840|P2|NOT COMPLETED|Overall Study||0
210228|NCT00365872|495841|P1|NOT COMPLETED|Overall Study||0
210229|NCT00365872|495839|P3|COMPLETED|Overall Study||6
210230|NCT00365872|495840|P2|COMPLETED|Overall Study||6
210231|NCT00365872|495841|P1|COMPLETED|Overall Study||5
210232|NCT00365872|495839|P3|STARTED|Overall Study||6
210233|NCT00365872|495840|P2|STARTED|Overall Study||6
210234|NCT00365872|495841|P1|STARTED|Overall Study||5
210235|NCT00365859|495854|P4|NOT COMPLETED|Overall Study||131
210236|NCT00365859|495855|P3|NOT COMPLETED|Overall Study||67
210237|NCT00365859|495856|P2|NOT COMPLETED|Overall Study||33
210238|NCT00365859|495857|P1|NOT COMPLETED|Overall Study||31
210239|NCT00365859|495854|P4|COMPLETED|Overall Study||199
210240|NCT00365859|495855|P3|COMPLETED|Overall Study||107
210241|NCT00365859|495856|P2|COMPLETED|Overall Study||37
210242|NCT00365859|495857|P1|COMPLETED|Overall Study||55
210243|NCT00365859|495854|P4|Efficacy Population|Overall Study||322
210244|NCT00365859|495855|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
210245|NCT00365859|495856|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
210246|NCT00365859|495857|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
210247|NCT00365859|495854|P4|Safety Population|Overall Study||330
210248|NCT00365859|495855|P3|Safety Population|Overall Study||174
210249|NCT00365859|495856|P2|Safety Population|Overall Study||70
210250|NCT00365859|495857|P1|Safety Population|Overall Study||86
210251|NCT00365859|495854|P4|STARTED|Overall Study||330
210252|NCT00365859|495855|P3|STARTED|Overall Study||174
210253|NCT00365859|495856|P2|STARTED|Overall Study||70
210254|NCT00365859|495857|P1|STARTED|Overall Study||86
210255|NCT00365846|495946|P1|NOT COMPLETED|Overall Study||1
210256|NCT00365846|495946|P1|COMPLETED|Overall Study||28
210257|NCT00365846|495946|P1|STARTED|Overall Study||29
210258|NCT00365768|495957|P2|NOT COMPLETED|Overall Study||0
210259|NCT00365768|495958|P1|NOT COMPLETED|Overall Study||0
210260|NCT00365768|495957|P2|COMPLETED|Overall Study||25
210261|NCT00365768|495958|P1|COMPLETED|Overall Study||24
210262|NCT00365768|495957|P2|STARTED|Overall Study||25
210263|NCT00365768|495958|P1|STARTED|Overall Study||24
210264|NCT00365716|495971|P7|NOT COMPLETED|Extension 2||10
210265|NCT00365716|495972|P6|NOT COMPLETED|Extension 2||0
210266|NCT00365716|495973|P5|NOT COMPLETED|Extension 2||0
210267|NCT00365716|495974|P4|NOT COMPLETED|Extension 2||0
210268|NCT00365716|495975|P3|NOT COMPLETED|Extension 2||0
210269|NCT00365716|495976|P2|NOT COMPLETED|Extension 2||0
210270|NCT00365716|495977|P1|NOT COMPLETED|Extension 2||0
210271|NCT00365716|495971|P7|COMPLETED|Extension 2||7
210272|NCT00365716|495972|P6|COMPLETED|Extension 2||0
210273|NCT00365716|495973|P5|COMPLETED|Extension 2||0
210274|NCT00365716|495974|P4|COMPLETED|Extension 2||0
210275|NCT00365716|495975|P3|COMPLETED|Extension 2||0
210276|NCT00365716|495976|P2|COMPLETED|Extension 2||0
210277|NCT00365716|495977|P1|COMPLETED|Extension 2||0
210278|NCT00365716|495971|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
210279|NCT00365716|495972|P6|STARTED|Extension 2||0
210280|NCT00365716|495973|P5|STARTED|Extension 2||0
210281|NCT00365716|495974|P4|STARTED|Extension 2||0
210282|NCT00365716|495975|P3|STARTED|Extension 2||0
210283|NCT00365716|495976|P2|STARTED|Extension 2||0
210284|NCT00365716|495977|P1|STARTED|Extension 2||0
210285|NCT00365716|495971|P7|NOT COMPLETED|Extension 1||0
210286|NCT00365716|495972|P6|NOT COMPLETED|Extension 1||22
210287|NCT00365716|495973|P5|NOT COMPLETED|Extension 1||0
210288|NCT00365716|495974|P4|NOT COMPLETED|Extension 1||0
210289|NCT00365716|495975|P3|NOT COMPLETED|Extension 1||0
210290|NCT00365716|495976|P2|NOT COMPLETED|Extension 1||0
210291|NCT00365716|495977|P1|NOT COMPLETED|Extension 1||0
210292|NCT00365716|495971|P7|COMPLETED|Extension 1||0
210293|NCT00365716|495972|P6|COMPLETED|Extension 1||219
210294|NCT00365716|495973|P5|COMPLETED|Extension 1||0
210295|NCT00365716|495974|P4|COMPLETED|Extension 1||0
210296|NCT00365716|495975|P3|COMPLETED|Extension 1||0
210297|NCT00365716|495976|P2|COMPLETED|Extension 1||0
210298|NCT00365716|495977|P1|COMPLETED|Extension 1||0
210299|NCT00365716|495971|P7|STARTED|Extension 1||0
210300|NCT00365716|495972|P6|STARTED|Extension 1||241
210301|NCT00365716|495973|P5|STARTED|Extension 1||0
210302|NCT00365716|495974|P4|STARTED|Extension 1||0
210303|NCT00365716|495975|P3|STARTED|Extension 1||0
210304|NCT00365716|495976|P2|STARTED|Extension 1||0
210305|NCT00365716|495977|P1|STARTED|Extension 1||0
210306|NCT00365716|495971|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
210307|NCT00365716|495972|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
210308|NCT00365716|495973|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
210309|NCT00365716|495974|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
210310|NCT00365716|495975|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
210311|NCT00365716|495976|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
210312|NCT00365716|495977|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
210313|NCT00365716|495971|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
210314|NCT00365716|495972|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
210315|NCT00365716|495973|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
210316|NCT00365716|495974|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
210317|NCT00365716|495975|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
210318|NCT00365716|495976|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
210319|NCT00365716|495977|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
210320|NCT00365716|495971|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
210321|NCT00365716|495972|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
210322|NCT00365716|495973|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
210323|NCT00365716|495974|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
210324|NCT00365716|495975|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
210325|NCT00365716|495976|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
210326|NCT00365716|495977|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
210327|NCT00365716|495971|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
210328|NCT00365716|495972|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
210329|NCT00365716|495973|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
210330|NCT00365716|495974|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
210331|NCT00365716|495975|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
210332|NCT00365716|495976|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
210333|NCT00365716|495977|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
210334|NCT00365716|495971|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
210335|NCT00365716|495972|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
210336|NCT00365716|495973|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
210337|NCT00365716|495974|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
210338|NCT00365716|495975|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
210339|NCT00365716|495976|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
210340|NCT00365716|495977|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
210341|NCT00365716|495971|P7|STARTED|Base Study (Day 1 to Month 7)||0
210342|NCT00365716|495972|P6|STARTED|Base Study (Day 1 to Month 7)||0
210343|NCT00365716|495973|P5|STARTED|Base Study (Day 1 to Month 7)||146
210344|NCT00365716|495974|P4|STARTED|Base Study (Day 1 to Month 7)||146
210345|NCT00365716|495975|P3|STARTED|Base Study (Day 1 to Month 7)||292
210346|NCT00365716|495976|P2|STARTED|Base Study (Day 1 to Month 7)||284
210347|NCT00365716|495977|P1|STARTED|Base Study (Day 1 to Month 7)||290
210348|NCT00365599|495992|P1|NOT COMPLETED|Overall Study||0
210349|NCT00365599|495992|P1|COMPLETED|Overall Study||43
210350|NCT00365599|495992|P1|STARTED|Overall Study||43
210351|NCT00365547|495998|P1|NOT COMPLETED|Overall Study||3
210352|NCT00365547|495998|P1|COMPLETED|Overall Study||43
210353|NCT00365547|495998|P1|STARTED|Overall Study||46
210354|NCT00365508|496008|P2|NOT COMPLETED|Overall Study||154
210355|NCT00365508|496009|P1|NOT COMPLETED|Overall Study||139
210356|NCT00365508|496008|P2|COMPLETED|Overall Study||167
210357|NCT00365508|496009|P1|COMPLETED|Overall Study||182
210358|NCT00365508|496008|P2|STARTED|Overall Study||321
210359|NCT00365508|496009|P1|STARTED|Overall Study||321
210360|NCT00365456|496017|P2|NOT COMPLETED|Trial Period III (12 Months)||5
210361|NCT00365456|496018|P1|NOT COMPLETED|Trial Period III (12 Months)||18
210362|NCT00365456|496017|P2|COMPLETED|Trial Period III (12 Months)||127
210363|NCT00365456|496018|P1|COMPLETED|Trial Period III (12 Months)||118
210364|NCT00365456|496017|P2|STARTED|Trial Period III (12 Months)||132
210365|NCT00365456|496018|P1|STARTED|Trial Period III (12 Months)||136
210366|NCT00365456|496017|P2|NOT COMPLETED|Trial Period II (12 Months)||14
210367|NCT00365456|496018|P1|NOT COMPLETED|Trial Period II (12 Months)||0
210368|NCT00365456|496017|P2|COMPLETED|Trial Period II (12 Months)||268
210369|NCT00365456|496018|P1|COMPLETED|Trial Period II (12 Months)||0
210370|NCT00365456|496017|P2|STARTED|Trial Period II (12 Months)||282
210371|NCT00365456|496018|P1|STARTED|Trial Period II (12 Months)||0
210372|NCT00365456|496017|P2|NOT COMPLETED|Trial Period I (12 Months)||0
210373|NCT00365456|496018|P1|NOT COMPLETED|Trial Period I (12 Months)||125
210374|NCT00365456|496017|P2|COMPLETED|Trial Period I (12 Months)||0
210375|NCT00365456|496018|P1|COMPLETED|Trial Period I (12 Months)||282
210376|NCT00365456|496017|P2|STARTED|Trial Period I (12 Months)||0
210377|NCT00365456|496018|P1|STARTED|Trial Period I (12 Months)||407
210378|NCT00365417|496024|P1|NOT COMPLETED|Overall Study||0
210379|NCT00365417|496024|P1|COMPLETED|Overall Study||45
210380|NCT00365417|496024|P1|STARTED|Overall Study||45
210381|NCT00365391|496030|P1|NOT COMPLETED|Overall Study||0
210382|NCT00365391|496030|P1|COMPLETED|Overall Study||27
210383|NCT00365391|496030|P1|STARTED|Overall Study||27
210384|NCT00365378|496040|P3|NOT COMPLETED|Extension||197
210385|NCT00365378|496041|P2|NOT COMPLETED|Extension||0
210386|NCT00365378|496042|P1|NOT COMPLETED|Extension||0
210387|NCT00365378|496040|P3|COMPLETED|Extension||203
210388|NCT00365378|496041|P2|COMPLETED|Extension||0
210389|NCT00365378|496042|P1|COMPLETED|Extension||0
210390|NCT00365378|496040|P3|STARTED|Extension||400
210391|NCT00365378|496041|P2|STARTED|Extension||0
210392|NCT00365378|496042|P1|STARTED|Extension||0
210393|NCT00365378|496040|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
210394|NCT00365378|496041|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
210395|NCT00365378|496042|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
210396|NCT00365378|496040|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
210397|NCT00365378|496041|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
210398|NCT00365378|496042|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
210399|NCT00365378|496040|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
210400|NCT00365378|496041|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
210401|NCT00365378|496042|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
210402|NCT00365378|496040|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
210403|NCT00365378|496041|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
210404|NCT00365378|496042|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
210405|NCT00365378|496040|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
210406|NCT00365378|496041|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
210407|NCT00365378|496042|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
210408|NCT00365378|496040|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
210409|NCT00365378|496041|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
210410|NCT00365378|496042|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
210411|NCT00365378|496040|P3|STARTED|Vaccination (Day 1 to Month 7)||0
210412|NCT00365378|496041|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
210413|NCT00365378|496042|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
210414|NCT00365365|496056|P3|NOT COMPLETED|Overall Study||15
210415|NCT00365365|496057|P2|NOT COMPLETED|Overall Study||36
210416|NCT00365365|496058|P1|NOT COMPLETED|Overall Study||34
210417|NCT00365365|496056|P3|COMPLETED|Overall Study||44
210418|NCT00365365|496057|P2|COMPLETED|Overall Study||41
210419|NCT00365365|496058|P1|COMPLETED|Overall Study||44
210420|NCT00365365|496056|P3|COMPLETED TREATMENT|Overall Study||45
210421|NCT00365365|496057|P2|COMPLETED TREATMENT|Overall Study||36
210422|NCT00365365|496058|P1|COMPLETED TREATMENT|Overall Study||38
210423|NCT00365365|496056|P3|TREATED (SAFETY POPULATION)|Overall Study||59
210424|NCT00365365|496057|P2|TREATED (SAFETY POPULATION)|Overall Study||75
210425|NCT00365365|496058|P1|TREATED (SAFETY POPULATION)|Overall Study||78
210426|NCT00365365|496056|P3|STARTED|Overall Study||59
210427|NCT00365365|496057|P2|STARTED|Overall Study||77
210428|NCT00365365|496058|P1|STARTED|Overall Study||78
210429|NCT00365352|496075|P3|NOT COMPLETED|Overall Study||15
210430|NCT00365352|496076|P2|NOT COMPLETED|Overall Study||11
210431|NCT00365352|496077|P1|NOT COMPLETED|Overall Study||20
210432|NCT00365352|496075|P3|COMPLETED|Overall Study||98
210433|NCT00365352|496076|P2|COMPLETED|Overall Study||104
210434|NCT00365352|496077|P1|COMPLETED|Overall Study||77
210435|NCT00365352|496075|P3|Modified Intent-to-Treat Population|Overall Study||111
210436|NCT00365352|496076|P2|Modified Intent-to-Treat Population|Overall Study||114
210437|NCT00365352|496077|P1|Modified Intent-to-Treat Population|Overall Study||96
210438|NCT00365352|496075|P3|Safety Population|Overall Study||111
210439|NCT00365352|496076|P2|Safety Population|Overall Study||115
210440|NCT00365352|496077|P1|Safety Population|Overall Study||96
210441|NCT00365352|496075|P3|STARTED|Overall Study||113
210442|NCT00365352|496076|P2|STARTED|Overall Study||115
210443|NCT00365352|496077|P1|STARTED|Overall Study||97
210444|NCT00365300|496161|P2|NOT COMPLETED|Double-blind Phase||9
210445|NCT00365300|496162|P1|NOT COMPLETED|Double-blind Phase||11
210446|NCT00365300|496161|P2|COMPLETED|Double-blind Phase||45
210447|NCT00365300|496162|P1|COMPLETED|Double-blind Phase||43
210448|NCT00365300|496161|P2|STARTED|Double-blind Phase||54
210449|NCT00365300|496162|P1|STARTED|Double-blind Phase||54
210450|NCT00365300|496161|P2|NOT COMPLETED|Open-label Phase||0
210451|NCT00365300|496162|P1|NOT COMPLETED|Open-label Phase||22
210452|NCT00365300|496161|P2|COMPLETED|Open-label Phase||0
210453|NCT00365300|496162|P1|COMPLETED|Open-label Phase||107
210454|NCT00365300|496161|P2|STARTED|Open-label Phase||0
210455|NCT00365300|496162|P1|STARTED|Open-label Phase||129
210456|NCT00365274|496171|P1|NOT COMPLETED|Overall Study||0
210457|NCT00365274|496171|P1|COMPLETED|Overall Study||6
210458|NCT00365274|496171|P1|STARTED|Overall Study||6
210459|NCT00365261|496177|P2|NOT COMPLETED|Overall Study||3
210460|NCT00365261|496178|P1|NOT COMPLETED|Overall Study||3
210461|NCT00365261|496177|P2|COMPLETED|Overall Study||19
210462|NCT00365261|496178|P1|COMPLETED|Overall Study||20
210463|NCT00365261|496177|P2|STARTED|Overall Study||22
210464|NCT00365261|496178|P1|STARTED|Overall Study||23
210465|NCT00365209|496188|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
210466|NCT00365209|496188|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
210467|NCT00365209|496188|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
210468|NCT00365209|496188|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
210469|NCT00365209|496188|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
210470|NCT00365209|496188|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
210471|NCT00365144|496217|P1|NOT COMPLETED|Overall Study||0
210472|NCT00365144|496217|P1|COMPLETED|Overall Study||36
210473|NCT00365144|496217|P1|STARTED|Overall Study||36
210474|NCT00365105|496225|P2|NOT COMPLETED|Overall Study||4
210475|NCT00365105|496226|P1|NOT COMPLETED|Overall Study||6
210476|NCT00365105|496225|P2|COMPLETED|Overall Study||128
210477|NCT00365105|496226|P1|COMPLETED|Overall Study||123
210478|NCT00365105|496225|P2|STARTED|Overall Study||132
210479|NCT00365105|496226|P1|STARTED|Overall Study||129
210480|NCT00365053|496232|P1|NOT COMPLETED|Overall Study||0
210481|NCT00365053|496232|P1|COMPLETED|Overall Study||13
210482|NCT00365053|496232|P1|STARTED|Overall Study||13
210483|NCT00364286|496238|P1|NOT COMPLETED|Overall Study||0
210484|NCT00364286|496238|P1|COMPLETED|Overall Study||17
210485|NCT00364286|496238|P1|STARTED|Overall Study||17
210486|NCT00364182|496245|P3|NOT COMPLETED|Fourth Intervention||0
210487|NCT00364182|496246|P2|NOT COMPLETED|Fourth Intervention||0
210488|NCT00364182|496247|P1|NOT COMPLETED|Fourth Intervention||0
210489|NCT00364182|496245|P3|COMPLETED|Fourth Intervention||22
210490|NCT00364182|496246|P2|COMPLETED|Fourth Intervention||19
210491|NCT00364182|496247|P1|COMPLETED|Fourth Intervention||0
210492|NCT00364182|496245|P3|STARTED|Fourth Intervention||22
210493|NCT00364182|496246|P2|STARTED|Fourth Intervention||19
210494|NCT00364182|496247|P1|STARTED|Fourth Intervention||0
210495|NCT00364182|496245|P3|NOT COMPLETED|Third Intervention||1
210496|NCT00364182|496246|P2|NOT COMPLETED|Third Intervention||1
210497|NCT00364182|496247|P1|NOT COMPLETED|Third Intervention||0
210498|NCT00364182|496245|P3|COMPLETED|Third Intervention||22
210499|NCT00364182|496246|P2|COMPLETED|Third Intervention||19
210500|NCT00364182|496247|P1|COMPLETED|Third Intervention||0
210501|NCT00364182|496245|P3|STARTED|Third Intervention||23
210502|NCT00364182|496246|P2|STARTED|Third Intervention||20
210503|NCT00364182|496247|P1|STARTED|Third Intervention||0
210504|NCT00364182|496245|P3|NOT COMPLETED|Second Intervention||2
210505|NCT00364182|496246|P2|NOT COMPLETED|Second Intervention||2
210506|NCT00364182|496247|P1|NOT COMPLETED|Second Intervention||0
210507|NCT00364182|496245|P3|COMPLETED|Second Intervention||23
210508|NCT00364182|496246|P2|COMPLETED|Second Intervention||20
210509|NCT00364182|496247|P1|COMPLETED|Second Intervention||0
210510|NCT00364182|496245|P3|Randomized|Second Intervention||25
210511|NCT00364182|496246|P2|Randomized|Second Intervention||22
210512|NCT00364182|496247|P1|Randomized|Second Intervention||0
210513|NCT00364182|496245|P3|STARTED|Second Intervention||25
210514|NCT00364182|496246|P2|STARTED|Second Intervention||22
210515|NCT00364182|496247|P1|STARTED|Second Intervention||0
210516|NCT00364182|496245|P3|NOT COMPLETED|First Intervention||0
210517|NCT00364182|496246|P2|NOT COMPLETED|First Intervention||0
210518|NCT00364182|496247|P1|NOT COMPLETED|First Intervention||3
210519|NCT00364182|496245|P3|COMPLETED|First Intervention||25
210520|NCT00364182|496246|P2|COMPLETED|First Intervention||22
210521|NCT00364182|496247|P1|COMPLETED|First Intervention||0
210522|NCT00364182|496245|P3|STARTED|First Intervention||25
210523|NCT00364182|496246|P2|STARTED|First Intervention||22
210524|NCT00364182|496247|P1|STARTED|First Intervention||3
210525|NCT00364156|496281|P2|NOT COMPLETED|Overall Study||81
210526|NCT00364156|496282|P1|NOT COMPLETED|Overall Study||79
210527|NCT00364156|496281|P2|COMPLETED|Overall Study||205
210528|NCT00364156|496282|P1|COMPLETED|Overall Study||203
210529|NCT00364156|496281|P2|STARTED|Overall Study||286
210530|NCT00364156|496282|P1|STARTED|Overall Study||282
210531|NCT00364949|496290|P2|NOT COMPLETED|Overall Study||0
210532|NCT00364949|496291|P1|NOT COMPLETED|Overall Study||0
210533|NCT00364949|496290|P2|COMPLETED|Overall Study||39
210534|NCT00364949|496291|P1|COMPLETED|Overall Study||31
210535|NCT00364949|496290|P2|STARTED|Overall Study||39
210536|NCT00364949|496291|P1|STARTED|Overall Study||31
210537|NCT00364923|496309|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
210538|NCT00364923|496309|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
210539|NCT00364923|496309|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
210540|NCT00364923|496309|P1|NOT COMPLETED|Treatment With Pralatrexate||4
210541|NCT00364923|496309|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
210542|NCT00364923|496309|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
210543|NCT00364858|496318|P2|NOT COMPLETED|Overall Study||22
210544|NCT00364858|496319|P1|NOT COMPLETED|Overall Study||7
210545|NCT00364858|496318|P2|COMPLETED|Overall Study||40
210546|NCT00364858|496319|P1|COMPLETED|Overall Study||26
210547|NCT00364858|496318|P2|STARTED|Overall Study||62
210548|NCT00364858|496319|P1|STARTED|Overall Study||33
210549|NCT00364845|496334|P2|NOT COMPLETED|Overall Study||11
210550|NCT00364845|496335|P1|NOT COMPLETED|Overall Study||11
210551|NCT00364845|496334|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
210552|NCT00364845|496335|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
210553|NCT00364845|496334|P2|STARTED|Overall Study||23
210554|NCT00364845|496335|P1|STARTED|Overall Study||28
210555|NCT00364832|496356|P12|NOT COMPLETED|Extension Year 2||3
210556|NCT00364832|496357|P11|NOT COMPLETED|Extension Year 2||5
210557|NCT00364832|496358|P10|NOT COMPLETED|Extension Year 2||5
210558|NCT00364832|496359|P9|NOT COMPLETED|Extension Year 2||0
210559|NCT00364832|496360|P8|NOT COMPLETED|Extension Year 2||0
210560|NCT00364832|496361|P7|NOT COMPLETED|Extension Year 2||0
210561|NCT00364832|496362|P6|NOT COMPLETED|Extension Year 2||0
210562|NCT00364832|496363|P5|NOT COMPLETED|Extension Year 2||0
210563|NCT00364832|496364|P4|NOT COMPLETED|Extension Year 2||0
210564|NCT00364832|496365|P3|NOT COMPLETED|Extension Year 2||0
210565|NCT00364832|496366|P2|NOT COMPLETED|Extension Year 2||0
210566|NCT00364832|496367|P1|NOT COMPLETED|Extension Year 2||0
210567|NCT00364832|496356|P12|COMPLETED|Extension Year 2||11
210568|NCT00364832|496357|P11|COMPLETED|Extension Year 2||9
210569|NCT00364832|496358|P10|COMPLETED|Extension Year 2||9
210570|NCT00364832|496359|P9|COMPLETED|Extension Year 2||0
210571|NCT00364832|496360|P8|COMPLETED|Extension Year 2||0
210572|NCT00364832|496361|P7|COMPLETED|Extension Year 2||0
210573|NCT00364832|496362|P6|COMPLETED|Extension Year 2||0
210574|NCT00364832|496363|P5|COMPLETED|Extension Year 2||0
210575|NCT00364832|496364|P4|COMPLETED|Extension Year 2||0
210576|NCT00364832|496365|P3|COMPLETED|Extension Year 2||0
210577|NCT00364832|496366|P2|COMPLETED|Extension Year 2||0
210578|NCT00364832|496367|P1|COMPLETED|Extension Year 2||0
210579|NCT00364832|496356|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
210580|NCT00364832|496357|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
210581|NCT00364832|496358|P10|STARTED|Extension Year 2||14
210582|NCT00364832|496359|P9|STARTED|Extension Year 2||0
210583|NCT00364832|496360|P8|STARTED|Extension Year 2||0
210584|NCT00364832|496361|P7|STARTED|Extension Year 2||0
210585|NCT00364832|496362|P6|STARTED|Extension Year 2||0
210586|NCT00364832|496363|P5|STARTED|Extension Year 2||0
210587|NCT00364832|496364|P4|STARTED|Extension Year 2||0
210588|NCT00364832|496365|P3|STARTED|Extension Year 2||0
210589|NCT00364832|496366|P2|STARTED|Extension Year 2||0
210590|NCT00364832|496367|P1|STARTED|Extension Year 2||0
210591|NCT00364832|496356|P12|NOT COMPLETED|Extension Year 1||10
210592|NCT00364832|496357|P11|NOT COMPLETED|Extension Year 1||2
210593|NCT00364832|496358|P10|NOT COMPLETED|Extension Year 1||4
210594|NCT00364832|496359|P9|NOT COMPLETED|Extension Year 1||0
210595|NCT00364832|496360|P8|NOT COMPLETED|Extension Year 1||0
210596|NCT00364832|496361|P7|NOT COMPLETED|Extension Year 1||0
210597|NCT00364832|496362|P6|NOT COMPLETED|Extension Year 1||0
210598|NCT00364832|496363|P5|NOT COMPLETED|Extension Year 1||0
210599|NCT00364832|496364|P4|NOT COMPLETED|Extension Year 1||0
210600|NCT00364832|496365|P3|NOT COMPLETED|Extension Year 1||0
210601|NCT00364832|496366|P2|NOT COMPLETED|Extension Year 1||0
210602|NCT00364832|496367|P1|NOT COMPLETED|Extension Year 1||0
210603|NCT00364832|496356|P12|COMPLETED|Extension Year 1||17
210604|NCT00364832|496357|P11|COMPLETED|Extension Year 1||15
210605|NCT00364832|496358|P10|COMPLETED|Extension Year 1||14
210606|NCT00364832|496359|P9|COMPLETED|Extension Year 1||0
210607|NCT00364832|496360|P8|COMPLETED|Extension Year 1||0
210608|NCT00364832|496361|P7|COMPLETED|Extension Year 1||0
210609|NCT00364832|496362|P6|COMPLETED|Extension Year 1||0
210610|NCT00364832|496363|P5|COMPLETED|Extension Year 1||0
210611|NCT00364832|496364|P4|COMPLETED|Extension Year 1||0
210612|NCT00364832|496365|P3|COMPLETED|Extension Year 1||0
210613|NCT00364832|496366|P2|COMPLETED|Extension Year 1||0
210614|NCT00364832|496367|P1|COMPLETED|Extension Year 1||0
210615|NCT00364832|496356|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
210616|NCT00364832|496357|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
210617|NCT00364832|496358|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
210618|NCT00364832|496359|P9|STARTED|Extension Year 1||0
210619|NCT00364832|496360|P8|STARTED|Extension Year 1||0
210620|NCT00364832|496361|P7|STARTED|Extension Year 1||0
210621|NCT00364832|496362|P6|STARTED|Extension Year 1||0
210622|NCT00364832|496363|P5|STARTED|Extension Year 1||0
210623|NCT00364832|496364|P4|STARTED|Extension Year 1||0
210624|NCT00364832|496365|P3|STARTED|Extension Year 1||0
210625|NCT00364832|496366|P2|STARTED|Extension Year 1||0
210626|NCT00364832|496367|P1|STARTED|Extension Year 1||0
210627|NCT00364832|496356|P12|NOT COMPLETED|Core Period||0
210628|NCT00364832|496357|P11|NOT COMPLETED|Core Period||0
210629|NCT00364832|496358|P10|NOT COMPLETED|Core Period||0
210630|NCT00364832|496359|P9|NOT COMPLETED|Core Period||0
210631|NCT00364832|496360|P8|NOT COMPLETED|Core Period||1
210632|NCT00364832|496361|P7|NOT COMPLETED|Core Period||4
210633|NCT00364832|496362|P6|NOT COMPLETED|Core Period||0
210634|NCT00364832|496363|P5|NOT COMPLETED|Core Period||0
210635|NCT00364832|496364|P4|NOT COMPLETED|Core Period||1
210636|NCT00364832|496365|P3|NOT COMPLETED|Core Period||1
210637|NCT00364832|496366|P2|NOT COMPLETED|Core Period||2
210638|NCT00364832|496367|P1|NOT COMPLETED|Core Period||2
210639|NCT00364832|496356|P12|COMPLETED|Core Period||0
210640|NCT00364832|496357|P11|COMPLETED|Core Period||0
210641|NCT00364832|496358|P10|COMPLETED|Core Period||0
210642|NCT00364832|496359|P9|COMPLETED|Core Period||16
210643|NCT00364832|496360|P8|COMPLETED|Core Period||14
210644|NCT00364832|496361|P7|COMPLETED|Core Period||12
210645|NCT00364832|496362|P6|COMPLETED|Core Period||12
210646|NCT00364832|496363|P5|COMPLETED|Core Period||16
210647|NCT00364832|496364|P4|COMPLETED|Core Period||15
210648|NCT00364832|496365|P3|COMPLETED|Core Period||14
210649|NCT00364832|496366|P2|COMPLETED|Core Period||13
210650|NCT00364832|496367|P1|COMPLETED|Core Period||14
210651|NCT00364832|496356|P12|STARTED|Core Period||0
210652|NCT00364832|496357|P11|STARTED|Core Period||0
210653|NCT00364832|496358|P10|STARTED|Core Period||0
210654|NCT00364832|496359|P9|STARTED|Core Period||16
210655|NCT00364832|496360|P8|STARTED|Core Period||15
210656|NCT00364832|496361|P7|STARTED|Core Period||16
210657|NCT00364832|496362|P6|STARTED|Core Period||12
210658|NCT00364832|496363|P5|STARTED|Core Period||16
210659|NCT00364832|496364|P4|STARTED|Core Period||16
210660|NCT00364832|496365|P3|STARTED|Core Period||15
210661|NCT00364832|496366|P2|STARTED|Core Period||15
210662|NCT00364832|496367|P1|STARTED|Core Period||16
210663|NCT00364793|496424|P4|NOT COMPLETED|Overall Study||3
210664|NCT00364793|496425|P3|NOT COMPLETED|Overall Study||4
210665|NCT00364793|496426|P2|NOT COMPLETED|Overall Study||5
210666|NCT00364793|496427|P1|NOT COMPLETED|Overall Study||8
210667|NCT00364793|496424|P4|COMPLETED|Overall Study||5
210668|NCT00364793|496425|P3|COMPLETED|Overall Study||0
210669|NCT00364793|496426|P2|COMPLETED|Overall Study||5
210670|NCT00364793|496427|P1|COMPLETED|Overall Study||7
210671|NCT00364793|496424|P4|STARTED|Overall Study||8
210672|NCT00364793|496425|P3|STARTED|Overall Study||4
210673|NCT00364793|496426|P2|STARTED|Overall Study||10
210674|NCT00364793|496427|P1|STARTED|Overall Study||15
210675|NCT00364611|496563|P2|NOT COMPLETED|Overall Study||21
210676|NCT00364611|496564|P1|NOT COMPLETED|Overall Study||51
210677|NCT00364611|496563|P2|COMPLETED|Overall Study||0
210678|NCT00364611|496564|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
210679|NCT00364611|496563|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
210680|NCT00364611|496564|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
210681|NCT00364611|496563|P2|STARTED|Overall Study||21
210682|NCT00364611|496564|P1|STARTED|Overall Study||52
210683|NCT00364533|496587|P5|NOT COMPLETED|Overall Study||51
210684|NCT00364533|496588|P4|NOT COMPLETED|Overall Study||31
210685|NCT00364533|496589|P3|NOT COMPLETED|Overall Study||45
210686|NCT00364533|496590|P2|NOT COMPLETED|Overall Study||40
210687|NCT00364533|496591|P1|NOT COMPLETED|Overall Study||42
210688|NCT00364533|496587|P5|COMPLETED|Overall Study||24
210689|NCT00364533|496588|P4|COMPLETED|Overall Study||36
210690|NCT00364533|496589|P3|COMPLETED|Overall Study||30
210691|NCT00364533|496590|P2|COMPLETED|Overall Study||31
210692|NCT00364533|496591|P1|COMPLETED|Overall Study||35
210693|NCT00364533|496587|P5|STARTED|Overall Study||75
210694|NCT00364533|496588|P4|STARTED|Overall Study||67
210695|NCT00364533|496589|P3|STARTED|Overall Study||75
210696|NCT00364533|496590|P2|STARTED|Overall Study||71
210697|NCT00364533|496591|P1|STARTED|Overall Study||77
210698|NCT00364377|496615|P2|NOT COMPLETED|Overall Study||0
210699|NCT00364377|496616|P1|NOT COMPLETED|Overall Study||0
210700|NCT00364377|496615|P2|COMPLETED|Overall Study||11
210701|NCT00364377|496616|P1|COMPLETED|Overall Study||11
210702|NCT00364377|496615|P2|STARTED|Overall Study||11
210703|NCT00364377|496616|P1|STARTED|Overall Study||11
210704|NCT00364351|496624|P2|NOT COMPLETED|Overall Study||583
210705|NCT00364351|496625|P1|NOT COMPLETED|Overall Study||592
210706|NCT00364351|496624|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|34
210707|NCT00364351|496625|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|31
210708|NCT00364351|496624|P2|STARTED|Overall Study|randomised patients|617
210709|NCT00364351|496625|P1|STARTED|Overall Study|randomised patients|623
210710|NCT00364130|496645|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
210711|NCT00364130|496646|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
210712|NCT00364130|496645|P2|COMPLETED|Post Intervention Follow-up Period||50
210713|NCT00364130|496646|P1|COMPLETED|Post Intervention Follow-up Period||55
210714|NCT00364130|496645|P2|STARTED|Post Intervention Follow-up Period||61
210715|NCT00364130|496646|P1|STARTED|Post Intervention Follow-up Period||60
210716|NCT00364130|496645|P2|NOT COMPLETED|Intervention Period||8
210717|NCT00364130|496646|P1|NOT COMPLETED|Intervention Period||9
210718|NCT00364130|496645|P2|COMPLETED|Intervention Period||61
210719|NCT00364130|496646|P1|COMPLETED|Intervention Period||60
210720|NCT00364130|496645|P2|STARTED|Intervention Period||69
210721|NCT00364130|496646|P1|STARTED|Intervention Period||69
210722|NCT00364013|496668|P2|NOT COMPLETED|Overall Study||95
210723|NCT00364013|496669|P1|NOT COMPLETED|Overall Study||101
210724|NCT00364013|496668|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
210818|NCT00362648|496979|P3|NOT COMPLETED|Overall Study||9
210819|NCT00362648|496980|P2|NOT COMPLETED|Overall Study||134
210725|NCT00364013|496669|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
210726|NCT00364013|496668|P2|Received Study Drug|Overall Study||583
210727|NCT00364013|496669|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
210728|NCT00364013|496668|P2|STARTED|Overall Study||590
210729|NCT00364013|496669|P1|STARTED|Overall Study||593
210730|NCT00363896|496697|P2|NOT COMPLETED|Overall Study||47
210731|NCT00363896|496698|P1|NOT COMPLETED|Overall Study||89
210732|NCT00363896|496697|P2|COMPLETED|Overall Study||169
210733|NCT00363896|496698|P1|COMPLETED|Overall Study||538
210734|NCT00363896|496697|P2|STARTED|Overall Study||216
210735|NCT00363896|496698|P1|STARTED|Overall Study||627
210736|NCT00363883|496710|P1|NOT COMPLETED|Overall Study||0
210737|NCT00363883|496710|P1|COMPLETED|Overall Study||14
210738|NCT00363883|496710|P1|STARTED|Overall Study||14
210739|NCT00363805|496719|P3|NOT COMPLETED|Overall Study||3
210740|NCT00363805|496720|P2|NOT COMPLETED|Overall Study||6
210741|NCT00363805|496721|P1|NOT COMPLETED|Overall Study||4
210742|NCT00363805|496719|P3|COMPLETED|Overall Study||70
210743|NCT00363805|496720|P2|COMPLETED|Overall Study||57
210744|NCT00363805|496721|P1|COMPLETED|Overall Study||38
210745|NCT00363805|496719|P3|STARTED|Overall Study||73
210746|NCT00363805|496720|P2|STARTED|Overall Study||63
210747|NCT00363805|496721|P1|STARTED|Overall Study||42
210748|NCT00363779|496732|P1|NOT COMPLETED|Overall Study||0
210749|NCT00363779|496732|P1|COMPLETED|Overall Study||5
210750|NCT00363779|496732|P1|STARTED|Overall Study||5
210751|NCT00363675|496737|P1|NOT COMPLETED|Overall Study||0
210752|NCT00363675|496737|P1|COMPLETED|Overall Study||3
210753|NCT00363675|496737|P1|Completed Testing|Overall Study||3
210754|NCT00363675|496737|P1|STARTED|Overall Study||3
210755|NCT00363467|496744|P1|NOT COMPLETED|Overall Study||1
210756|NCT00363467|496744|P1|COMPLETED|Overall Study||2
210757|NCT00363467|496744|P1|STARTED|Overall Study||3
210758|NCT00363415|496754|P2|NOT COMPLETED|Overall Study||249
210759|NCT00363415|496755|P1|NOT COMPLETED|Overall Study||361
210760|NCT00363415|496754|P2|COMPLETED|Overall Study||206
210761|NCT00363415|496755|P1|COMPLETED|Overall Study||92
210762|NCT00363415|496754|P2|Received at Least One Dose of Study Drug|Overall Study||447
210763|NCT00363415|496755|P1|Received at Least One Dose of Study Drug|Overall Study||433
210764|NCT00363415|496754|P2|STARTED|Overall Study||455
210765|NCT00363415|496755|P1|STARTED|Overall Study||453
210766|NCT00363311|496773|P2|NOT COMPLETED|Overall Study||45
210767|NCT00363311|496774|P1|NOT COMPLETED|Overall Study||76
210768|NCT00363311|496773|P2|COMPLETED|Overall Study||102
210769|NCT00363311|496774|P1|COMPLETED|Overall Study||79
210770|NCT00363311|496773|P2|STARTED|Overall Study||147
210771|NCT00363311|496774|P1|STARTED|Overall Study||155
210772|NCT00363246|496838|P1|NOT COMPLETED|Overall Study||97
210773|NCT00363246|496838|P1|COMPLETED|Overall Study||669
210774|NCT00363246|496838|P1|STARTED|Overall Study||766
210775|NCT00363168|496845|P2|NOT COMPLETED|Overall Study||0
210776|NCT00363168|496846|P1|NOT COMPLETED|Overall Study||0
210777|NCT00363168|496845|P2|COMPLETED|Overall Study||2
210778|NCT00363168|496846|P1|COMPLETED|Overall Study||5
210779|NCT00363168|496845|P2|STARTED|Overall Study||2
210780|NCT00363168|496846|P1|STARTED|Overall Study||5
210781|NCT00363142|496856|P2|NOT COMPLETED|Overall Study||3
210782|NCT00363142|496857|P1|NOT COMPLETED|Overall Study||7
210783|NCT00363142|496856|P2|COMPLETED|Overall Study||66
210784|NCT00363142|496857|P1|COMPLETED|Overall Study||133
210785|NCT00363142|496856|P2|STARTED|Overall Study||69
210786|NCT00363142|496857|P1|STARTED|Overall Study||140
210787|NCT00363129|496886|P2|NOT COMPLETED|Overall Study||33
210788|NCT00363129|496887|P1|NOT COMPLETED|Overall Study||29
210789|NCT00363129|496886|P2|COMPLETED|Overall Study||60
210790|NCT00363129|496887|P1|COMPLETED|Overall Study||67
210791|NCT00363129|496886|P2|STARTED|Overall Study||93
210792|NCT00363129|496887|P1|STARTED|Overall Study||96
210793|NCT00363077|496903|P2|NOT COMPLETED|Overall Study||0
210794|NCT00363077|496904|P1|NOT COMPLETED|Overall Study||0
210795|NCT00363077|496903|P2|COMPLETED|Overall Study||75
210796|NCT00363077|496904|P1|COMPLETED|Overall Study||75
210797|NCT00363077|496903|P2|STARTED|Overall Study||75
210798|NCT00363077|496904|P1|STARTED|Overall Study||75
210799|NCT00363051|496930|P2|NOT COMPLETED|Overall Study||22
210800|NCT00363051|496931|P1|NOT COMPLETED|Overall Study||38
210801|NCT00363051|496930|P2|COMPLETED|Overall Study||23
210802|NCT00363051|496931|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
210803|NCT00363051|496930|P2|STARTED|Overall Study||45
210804|NCT00363051|496931|P1|STARTED|Overall Study||115
210805|NCT00363038|496948|P1|NOT COMPLETED|Overall Study||0
210806|NCT00363038|496948|P1|COMPLETED|Overall Study||16
210807|NCT00363038|496948|P1|STARTED|Overall Study||16
210808|NCT00362882|496954|P2|NOT COMPLETED|Overall Study||0
210809|NCT00362882|496955|P1|NOT COMPLETED|Overall Study||0
210810|NCT00362882|496954|P2|COMPLETED|Overall Study||41
210811|NCT00362882|496955|P1|COMPLETED|Overall Study||40
210812|NCT00362882|496954|P2|STARTED|Overall Study||41
210813|NCT00362882|496955|P1|STARTED|Overall Study||40
210814|NCT00362817|496965|P1|NOT COMPLETED|Overall Study||0
210815|NCT00362817|496965|P1|COMPLETED|Overall Study||17
210816|NCT00362817|496965|P1|STARTED|Overall Study||17
210817|NCT00362648|496978|P4|NOT COMPLETED|Overall Study||11
210820|NCT00362648|496981|P1|NOT COMPLETED|Overall Study||126
210821|NCT00362648|496978|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
210822|NCT00362648|496979|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
210823|NCT00362648|496980|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
210824|NCT00362648|496981|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
210825|NCT00362648|496978|P4|Vaccinated at Visit 3|Overall Study||1007
210826|NCT00362648|496979|P3|Vaccinated at Visit 3|Overall Study||1009
210827|NCT00362648|496980|P2|Vaccinated at Visit 3|Overall Study||2612
210828|NCT00362648|496981|P1|Vaccinated at Visit 3|Overall Study||2613
210829|NCT00362648|496978|P4|Vaccinated at Visit 2|Overall Study||1009
210830|NCT00362648|496979|P3|Vaccinated at Visit 2|Overall Study||1013
210831|NCT00362648|496980|P2|Vaccinated at Visit 2|Overall Study||2666
210832|NCT00362648|496981|P1|Vaccinated at Visit 2|Overall Study||2657
210833|NCT00362648|496978|P4|Vaccinated at Visit 1|Overall Study||1018
210834|NCT00362648|496979|P3|Vaccinated at Visit 1|Overall Study||1018
210835|NCT00362648|496980|P2|Vaccinated at Visit 1|Overall Study||2735
210836|NCT00362648|496981|P1|Vaccinated at Visit 1|Overall Study||2733
210837|NCT00362648|496978|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
210838|NCT00362648|496979|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
210839|NCT00362648|496980|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
210840|NCT00362648|496981|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
210841|NCT00362609|496999|P2|NOT COMPLETED|Overall Study||2
210842|NCT00362609|497000|P1|NOT COMPLETED|Overall Study||0
210843|NCT00362609|496999|P2|COMPLETED|Overall Study||38
210844|NCT00362609|497000|P1|COMPLETED|Overall Study||19
210845|NCT00362609|496999|P2|STARTED|Overall Study||40
210846|NCT00362609|497000|P1|STARTED|Overall Study||19
210847|NCT00362466|497014|P2|NOT COMPLETED|Overall Study||0
210848|NCT00362466|497015|P1|NOT COMPLETED|Overall Study||0
210849|NCT00362466|497014|P2|COMPLETED|Overall Study||1
210850|NCT00362466|497015|P1|COMPLETED|Overall Study||2
210851|NCT00362466|497014|P2|STARTED|Overall Study||1
210852|NCT00362466|497015|P1|STARTED|Overall Study||2
210853|NCT00362453|497037|P2|NOT COMPLETED|Overall Study||0
210854|NCT00362453|497038|P1|NOT COMPLETED|Overall Study||0
210855|NCT00362453|497037|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
210856|NCT00362453|497038|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
210857|NCT00362453|497037|P2|STARTED|Overall Study||20
210858|NCT00362453|497038|P1|STARTED|Overall Study||20
210859|NCT00362414|497068|P1|NOT COMPLETED|Overall Study||3
210860|NCT00362414|497068|P1|COMPLETED|Overall Study||12
210861|NCT00362414|497068|P1|STARTED|Overall Study||15
210862|NCT00362401|497088|P3|NOT COMPLETED|Overall Study||0
210863|NCT00362401|497089|P2|NOT COMPLETED|Overall Study||0
210864|NCT00362401|497090|P1|NOT COMPLETED|Overall Study||0
210865|NCT00362401|497088|P3|COMPLETED|Overall Study||40
210866|NCT00362401|497089|P2|COMPLETED|Overall Study||29
210867|NCT00362401|497090|P1|COMPLETED|Overall Study||15
210868|NCT00362401|497088|P3|STARTED|Overall Study||40
210869|NCT00362401|497089|P2|STARTED|Overall Study||29
210870|NCT00362401|497090|P1|STARTED|Overall Study||15
210871|NCT00362375|497097|P2|NOT COMPLETED|Overall Study||35
210872|NCT00362375|497098|P1|NOT COMPLETED|Overall Study||40
210873|NCT00362375|497097|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
210874|NCT00362375|497098|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
210875|NCT00362375|497097|P2|STARTED|Overall Study|Number eligible and randomized|152
210876|NCT00362375|497098|P1|STARTED|Overall Study|Number eligible and randomized|161
210877|NCT00362336|497115|P3|NOT COMPLETED|Overall Study||3
210878|NCT00362336|497116|P2|NOT COMPLETED|Overall Study||7
210879|NCT00362336|497117|P1|NOT COMPLETED|Overall Study||10
210880|NCT00362336|497115|P3|COMPLETED|Overall Study||134
210881|NCT00362336|497116|P2|COMPLETED|Overall Study||235
210882|NCT00362336|497117|P1|COMPLETED|Overall Study||233
210883|NCT00362336|497115|P3|STARTED|Overall Study||137
210884|NCT00362336|497116|P2|STARTED|Overall Study||242
210885|NCT00362336|497117|P1|STARTED|Overall Study||243
210886|NCT00362297|497145|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
210887|NCT00362297|497146|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
210888|NCT00362297|497145|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
210889|NCT00362297|497146|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
210890|NCT00362297|497145|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
210891|NCT00362297|497146|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
210892|NCT00362297|497145|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
210893|NCT00362297|497146|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
210894|NCT00362297|497145|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
210895|NCT00362297|497146|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
210896|NCT00362297|497145|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
210897|NCT00362297|497146|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
210898|NCT00362232|497154|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
210899|NCT00362232|497155|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
210900|NCT00362232|497154|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
210901|NCT00362232|497155|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
210902|NCT00362232|497154|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
210903|NCT00362232|497155|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
210904|NCT00362232|497154|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
210905|NCT00362232|497155|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
210906|NCT00362232|497154|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
210907|NCT00362232|497155|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
210908|NCT00362232|497154|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
210909|NCT00362232|497155|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
210910|NCT00362232|497154|P2|STARTED|Treatment (12 +/- 2 Days)||1564
210911|NCT00362232|497155|P1|STARTED|Treatment (12 +/- 2 Days)||1584
210912|NCT00362180|497200|P9|NOT COMPLETED|20 Week Safety Follow-up||0
210913|NCT00362180|497201|P8|NOT COMPLETED|20 Week Safety Follow-up||0
210914|NCT00362180|497202|P7|NOT COMPLETED|20 Week Safety Follow-up||0
210915|NCT00362180|497203|P6|NOT COMPLETED|20 Week Safety Follow-up||0
210916|NCT00362180|497204|P5|NOT COMPLETED|20 Week Safety Follow-up||0
210917|NCT00362180|497205|P4|NOT COMPLETED|20 Week Safety Follow-up||0
210918|NCT00362180|497206|P3|NOT COMPLETED|20 Week Safety Follow-up||0
210919|NCT00362180|497207|P2|NOT COMPLETED|20 Week Safety Follow-up||0
210920|NCT00362180|497208|P1|NOT COMPLETED|20 Week Safety Follow-up||0
210921|NCT00362180|497200|P9|COMPLETED|20 Week Safety Follow-up||1
210922|NCT00362180|497201|P8|COMPLETED|20 Week Safety Follow-up||3
210923|NCT00362180|497202|P7|COMPLETED|20 Week Safety Follow-up||0
210924|NCT00362180|497203|P6|COMPLETED|20 Week Safety Follow-up||9
210925|NCT00362180|497204|P5|COMPLETED|20 Week Safety Follow-up||11
210926|NCT00362180|497205|P4|COMPLETED|20 Week Safety Follow-up||0
210927|NCT00362180|497206|P3|COMPLETED|20 Week Safety Follow-up||1
210928|NCT00362180|497207|P2|COMPLETED|20 Week Safety Follow-up||2
210929|NCT00362180|497208|P1|COMPLETED|20 Week Safety Follow-up||3
210930|NCT00362180|497200|P9|STARTED|20 Week Safety Follow-up||1
210931|NCT00362180|497201|P8|STARTED|20 Week Safety Follow-up||3
210932|NCT00362180|497202|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
210933|NCT00362180|497203|P6|STARTED|20 Week Safety Follow-up||9
210934|NCT00362180|497204|P5|STARTED|20 Week Safety Follow-up||11
210935|NCT00362180|497205|P4|STARTED|20 Week Safety Follow-up||0
210936|NCT00362180|497206|P3|STARTED|20 Week Safety Follow-up||1
210937|NCT00362180|497207|P2|STARTED|20 Week Safety Follow-up||2
210938|NCT00362180|497208|P1|STARTED|20 Week Safety Follow-up||3
210939|NCT00362180|497200|P9|NOT COMPLETED|Treated Period||0
210940|NCT00362180|497201|P8|NOT COMPLETED|Treated Period||1
210941|NCT00362180|497202|P7|NOT COMPLETED|Treated Period||0
210942|NCT00362180|497203|P6|NOT COMPLETED|Treated Period||1
210943|NCT00362180|497204|P5|NOT COMPLETED|Treated Period||0
210944|NCT00362180|497205|P4|NOT COMPLETED|Treated Period||0
210945|NCT00362180|497206|P3|NOT COMPLETED|Treated Period||0
210946|NCT00362180|497207|P2|NOT COMPLETED|Treated Period||0
210947|NCT00362180|497208|P1|NOT COMPLETED|Treated Period||1
210948|NCT00362180|497200|P9|COMPLETED|Treated Period||1
210949|NCT00362180|497201|P8|COMPLETED|Treated Period||2
210950|NCT00362180|497202|P7|COMPLETED|Treated Period||6
210951|NCT00362180|497203|P6|COMPLETED|Treated Period||9
210952|NCT00362180|497204|P5|COMPLETED|Treated Period||11
210953|NCT00362180|497205|P4|COMPLETED|Treated Period||0
210954|NCT00362180|497206|P3|COMPLETED|Treated Period||1
210955|NCT00362180|497207|P2|COMPLETED|Treated Period||2
210956|NCT00362180|497208|P1|COMPLETED|Treated Period||3
210957|NCT00362180|497200|P9|STARTED|Treated Period||1
210958|NCT00362180|497201|P8|STARTED|Treated Period||3
210959|NCT00362180|497202|P7|STARTED|Treated Period||6
210960|NCT00362180|497203|P6|STARTED|Treated Period||10
210961|NCT00362180|497204|P5|STARTED|Treated Period||11
210962|NCT00362180|497205|P4|STARTED|Treated Period||0
210963|NCT00362180|497206|P3|STARTED|Treated Period||1
210964|NCT00362180|497207|P2|STARTED|Treated Period||2
210965|NCT00362180|497208|P1|STARTED|Treated Period||4
210966|NCT00362128|497269|P1|NOT COMPLETED|Overall Study||0
210967|NCT00362128|497269|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
210968|NCT00362128|497269|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
210969|NCT00362115|497280|P7|NOT COMPLETED|Overall Study||12
210970|NCT00362115|497281|P6|NOT COMPLETED|Overall Study||7
210971|NCT00362115|497282|P5|NOT COMPLETED|Overall Study||7
210972|NCT00362115|497283|P4|NOT COMPLETED|Overall Study||4
210973|NCT00362115|497284|P3|NOT COMPLETED|Overall Study||7
210974|NCT00362115|497285|P2|NOT COMPLETED|Overall Study||6
210975|NCT00362115|497286|P1|NOT COMPLETED|Overall Study||2
210976|NCT00362115|497280|P7|COMPLETED|Overall Study||52
210977|NCT00362115|497281|P6|COMPLETED|Overall Study||57
210978|NCT00362115|497282|P5|COMPLETED|Overall Study||57
210979|NCT00362115|497283|P4|COMPLETED|Overall Study||59
210980|NCT00362115|497284|P3|COMPLETED|Overall Study||57
210981|NCT00362115|497285|P2|COMPLETED|Overall Study||59
210982|NCT00362115|497286|P1|COMPLETED|Overall Study||63
210983|NCT00362115|497280|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
210984|NCT00362115|497281|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
210985|NCT00362115|497282|P5|STARTED|Overall Study||64
210986|NCT00362115|497283|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
210987|NCT00362115|497284|P3|STARTED|Overall Study||64
211068|NCT00361335|497548|P3|COMPLETED|IV Period: Baseline to E0||107
210988|NCT00362115|497285|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
210989|NCT00362115|497286|P1|STARTED|Overall Study||65
210990|NCT00361972|497437|P2|NOT COMPLETED|Overall Study||0
210991|NCT00361972|497438|P1|NOT COMPLETED|Overall Study||0
210992|NCT00361972|497437|P2|COMPLETED|Overall Study||9
210993|NCT00361972|497438|P1|COMPLETED|Overall Study||8
210994|NCT00361972|497437|P2|STARTED|Overall Study||9
210995|NCT00361972|497438|P1|STARTED|Overall Study||8
210996|NCT00361634|497446|P1|NOT COMPLETED|Overall Study||2
210997|NCT00361634|497446|P1|COMPLETED|Overall Study||12
210998|NCT00361634|497446|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
210999|NCT00361634|497446|P1|STARTED|Overall Study||14
211000|NCT00361595|497464|P1|NOT COMPLETED|Overall Study||0
211001|NCT00361595|497464|P1|COMPLETED|Overall Study||35
211002|NCT00361595|497464|P1|STARTED|Overall Study||35
211003|NCT00361569|497475|P4|NOT COMPLETED|Overall Study||21
211004|NCT00361569|497476|P3|NOT COMPLETED|Overall Study||18
211005|NCT00361569|497477|P2|NOT COMPLETED|Overall Study||11
211006|NCT00361569|497478|P1|NOT COMPLETED|Overall Study||12
211007|NCT00361569|497475|P4|COMPLETED|Overall Study||135
211008|NCT00361569|497476|P3|COMPLETED|Overall Study||137
211009|NCT00361569|497477|P2|COMPLETED|Overall Study||150
211010|NCT00361569|497478|P1|COMPLETED|Overall Study||138
211011|NCT00361569|497475|P4|STARTED|Overall Study||156
211012|NCT00361569|497476|P3|STARTED|Overall Study||155
211013|NCT00361569|497477|P2|STARTED|Overall Study||161
211014|NCT00361569|497478|P1|STARTED|Overall Study||150
211015|NCT00361504|497502|P2|NOT COMPLETED|Overall Study||145
211016|NCT00361504|497503|P1|NOT COMPLETED|Overall Study||481
211017|NCT00361504|497502|P2|COMPLETED|Overall Study||78
211018|NCT00361504|497503|P1|COMPLETED|Overall Study||413
211019|NCT00361504|497502|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
211020|NCT00361504|497503|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
211021|NCT00361439|497513|P2|NOT COMPLETED|Overall Study||0
211022|NCT00361439|497514|P1|NOT COMPLETED|Overall Study||0
211023|NCT00361439|497513|P2|COMPLETED|Overall Study||9
211024|NCT00361439|497514|P1|COMPLETED|Overall Study||8
211025|NCT00361439|497513|P2|STARTED|Overall Study||9
211026|NCT00361439|497514|P1|STARTED|Overall Study||8
211027|NCT00361374|497529|P3|NOT COMPLETED|Overall Study||12
211028|NCT00361374|497530|P2|NOT COMPLETED|Overall Study||15
211029|NCT00361374|497531|P1|NOT COMPLETED|Overall Study||15
211030|NCT00361374|497529|P3|COMPLETED|Overall Study||53
211031|NCT00361374|497530|P2|COMPLETED|Overall Study||50
211032|NCT00361374|497531|P1|COMPLETED|Overall Study||51
211033|NCT00361374|497529|P3|STARTED|Overall Study||65
211034|NCT00361374|497530|P2|STARTED|Overall Study||65
211035|NCT00361374|497531|P1|STARTED|Overall Study||66
211036|NCT00361335|497544|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
211037|NCT00361335|497545|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
211038|NCT00361335|497546|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
211039|NCT00361335|497547|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
211040|NCT00361335|497548|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
211041|NCT00361335|497549|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
211042|NCT00361335|497550|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
211043|NCT00361335|497544|P7|COMPLETED|SC Period: Week E0 to Week E24||164
211044|NCT00361335|497545|P6|COMPLETED|SC Period: Week E0 to Week E24||23
211045|NCT00361335|497546|P5|COMPLETED|SC Period: Week E0 to Week E24||3
211046|NCT00361335|497547|P4|COMPLETED|SC Period: Week E0 to Week E24||59
211047|NCT00361335|497548|P3|COMPLETED|SC Period: Week E0 to Week E24||99
211048|NCT00361335|497549|P2|COMPLETED|SC Period: Week E0 to Week E24||56
211049|NCT00361335|497550|P1|COMPLETED|SC Period: Week E0 to Week E24||80
211050|NCT00361335|497544|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
211051|NCT00361335|497545|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
211052|NCT00361335|497546|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
211053|NCT00361335|497547|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
211054|NCT00361335|497548|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
211055|NCT00361335|497549|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
211056|NCT00361335|497550|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
211057|NCT00361335|497544|P7|NOT COMPLETED|IV Period: Baseline to E0||0
211058|NCT00361335|497545|P6|NOT COMPLETED|IV Period: Baseline to E0||0
211059|NCT00361335|497546|P5|NOT COMPLETED|IV Period: Baseline to E0||24
211060|NCT00361335|497547|P4|NOT COMPLETED|IV Period: Baseline to E0||27
211061|NCT00361335|497548|P3|NOT COMPLETED|IV Period: Baseline to E0||21
211062|NCT00361335|497549|P2|NOT COMPLETED|IV Period: Baseline to E0||29
211063|NCT00361335|497550|P1|NOT COMPLETED|IV Period: Baseline to E0||20
211064|NCT00361335|497544|P7|COMPLETED|IV Period: Baseline to E0||0
211065|NCT00361335|497545|P6|COMPLETED|IV Period: Baseline to E0||0
211066|NCT00361335|497546|P5|COMPLETED|IV Period: Baseline to E0||105
211067|NCT00361335|497547|P4|COMPLETED|IV Period: Baseline to E0||102
211069|NCT00361335|497549|P2|COMPLETED|IV Period: Baseline to E0||99
211070|NCT00361335|497550|P1|COMPLETED|IV Period: Baseline to E0||109
211071|NCT00361335|497544|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
211072|NCT00361335|497545|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
211073|NCT00361335|497546|P5|STARTED|IV Period: Baseline to E0||129
211074|NCT00361335|497547|P4|STARTED|IV Period: Baseline to E0||129
211075|NCT00361335|497548|P3|STARTED|IV Period: Baseline to E0||128
211076|NCT00361335|497549|P2|STARTED|IV Period: Baseline to E0||128
211077|NCT00361335|497550|P1|STARTED|IV Period: Baseline to E0||129
211078|NCT00361283|497594|P1|NOT COMPLETED|Overall Study||27
211079|NCT00361283|497594|P1|COMPLETED|Overall Study||81
211080|NCT00361283|497594|P1|STARTED|Overall Study||108
211081|NCT00361270|497602|P4|NOT COMPLETED|Overall Study||13
211082|NCT00361270|497603|P3|NOT COMPLETED|Overall Study||10
211083|NCT00361270|497604|P2|NOT COMPLETED|Overall Study||14
211084|NCT00361270|497605|P1|NOT COMPLETED|Overall Study||24
211085|NCT00361270|497602|P4|COMPLETED|Overall Study||25
211086|NCT00361270|497603|P3|COMPLETED|Overall Study||25
211087|NCT00361270|497604|P2|COMPLETED|Overall Study||25
211088|NCT00361270|497605|P1|COMPLETED|Overall Study||25
211089|NCT00361270|497602|P4|STARTED|Overall Study||38
211090|NCT00361270|497603|P3|STARTED|Overall Study||35
211091|NCT00361270|497604|P2|STARTED|Overall Study||39
211092|NCT00361270|497605|P1|STARTED|Overall Study||49
211093|NCT00361257|497625|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
211094|NCT00361257|497626|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
211095|NCT00361257|497625|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
211096|NCT00361257|497626|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
211097|NCT00361257|497625|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
211098|NCT00361257|497626|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
211099|NCT00361257|497625|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
211100|NCT00361257|497626|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
211101|NCT00361257|497625|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
211102|NCT00361257|497626|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
211103|NCT00361257|497625|P2|STARTED|Step 1: Minocycline vs. Placebo||55
211104|NCT00361257|497626|P1|STARTED|Step 1: Minocycline vs. Placebo||52
211105|NCT00361231|497678|P1|NOT COMPLETED|Overall Study||34
211106|NCT00361231|497678|P1|COMPLETED|Overall Study||1
211107|NCT00361231|497678|P1|STARTED|Overall Study||35
211108|NCT00361218|497683|P1|NOT COMPLETED|Overall Study||23
211109|NCT00361218|497683|P1|COMPLETED|Overall Study||30
211110|NCT00361218|497683|P1|Completed Baseline Assessment|Overall Study||47
211111|NCT00361218|497683|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
211112|NCT00361140|497690|P3|NOT COMPLETED|Overall Study||0
211113|NCT00361140|497691|P2|NOT COMPLETED|Overall Study||0
211114|NCT00361140|497692|P1|NOT COMPLETED|Overall Study||0
211115|NCT00361140|497690|P3|COMPLETED|Overall Study||3
211116|NCT00361140|497691|P2|COMPLETED|Overall Study||29
211117|NCT00361140|497692|P1|COMPLETED|Overall Study||40
211118|NCT00361140|497690|P3|STARTED|Overall Study||3
211119|NCT00361140|497691|P2|STARTED|Overall Study||29
211120|NCT00361140|497692|P1|STARTED|Overall Study||40
211121|NCT00360971|497705|P2|NOT COMPLETED|Overall Study||0
211122|NCT00360971|497706|P1|NOT COMPLETED|Overall Study||0
211123|NCT00360971|497705|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
211124|NCT00360971|497706|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
211125|NCT00360971|497705|P2|STARTED|Overall Study||11
211126|NCT00360971|497706|P1|STARTED|Overall Study||10
211127|NCT00360828|497712|P1|NOT COMPLETED|Overall Study||1
211128|NCT00360828|497712|P1|COMPLETED|Overall Study||9
211129|NCT00360828|497712|P1|STARTED|Overall Study||10
211130|NCT00360724|497722|P2|NOT COMPLETED|Overall Study||4
211131|NCT00360724|497723|P1|NOT COMPLETED|Overall Study||4
211132|NCT00360724|497722|P2|COMPLETED|Overall Study||28
211133|NCT00360724|497723|P1|COMPLETED|Overall Study||29
211134|NCT00360724|497722|P2|STARTED|Overall Study||32
211135|NCT00360724|497723|P1|STARTED|Overall Study||33
211136|NCT00360698|497747|P2|NOT COMPLETED|Treatment Period||1
211137|NCT00360698|497748|P1|NOT COMPLETED|Treatment Period||1
211138|NCT00360698|497747|P2|COMPLETED|Treatment Period||56
211139|NCT00360698|497748|P1|COMPLETED|Treatment Period||48
211140|NCT00360698|497747|P2|STARTED|Treatment Period||57
211141|NCT00360698|497748|P1|STARTED|Treatment Period||49
211142|NCT00360698|497747|P2|NOT COMPLETED|Run-In||10
211143|NCT00360698|497748|P1|NOT COMPLETED|Run-In||0
211144|NCT00360698|497747|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
211145|NCT00360698|497748|P1|COMPLETED|Run-In||0
211146|NCT00360698|497747|P2|STARTED|Run-In||135
211147|NCT00360698|497748|P1|STARTED|Run-In||0
211148|NCT00360685|497776|P2|NOT COMPLETED|Overall Study||0
211149|NCT00360685|497777|P1|NOT COMPLETED|Overall Study||0
211150|NCT00360685|497776|P2|COMPLETED|Overall Study||42
211151|NCT00360685|497777|P1|COMPLETED|Overall Study||47
211152|NCT00360685|497776|P2|STARTED|Overall Study||42
211153|NCT00360685|497777|P1|STARTED|Overall Study||47
211154|NCT00360672|497787|P1|NOT COMPLETED|Overall Study||0
211155|NCT00360672|497787|P1|COMPLETED|Overall Study||27
211156|NCT00360672|497787|P1|STARTED|Overall Study||27
211157|NCT00360568|497793|P2|NOT COMPLETED|Overall Study||5
211158|NCT00360568|497794|P1|NOT COMPLETED|Overall Study||2
211159|NCT00360568|497793|P2|COMPLETED|Overall Study||24
211160|NCT00360568|497794|P1|COMPLETED|Overall Study||31
211161|NCT00360568|497793|P2|STARTED|Overall Study||29
211162|NCT00360568|497794|P1|STARTED|Overall Study||33
211163|NCT00360555|497905|P4|NOT COMPLETED|Overall Study||112
211164|NCT00360555|497906|P3|NOT COMPLETED|Overall Study||145
211165|NCT00360555|497907|P2|NOT COMPLETED|Overall Study||134
211166|NCT00360555|497908|P1|NOT COMPLETED|Overall Study||122
211167|NCT00360555|497905|P4|COMPLETED|Overall Study||287
211168|NCT00360555|497906|P3|COMPLETED|Overall Study||251
211169|NCT00360555|497907|P2|COMPLETED|Overall Study||259
211170|NCT00360555|497908|P1|COMPLETED|Overall Study||274
211171|NCT00360555|497905|P4|STARTED|Overall Study||399
211172|NCT00360555|497906|P3|STARTED|Overall Study||396
211173|NCT00360555|497907|P2|STARTED|Overall Study||393
211174|NCT00360555|497908|P1|STARTED|Overall Study||396
211175|NCT00360529|497925|P3|NOT COMPLETED|Overall Study||91
211176|NCT00360529|497926|P2|NOT COMPLETED|Overall Study||65
211177|NCT00360529|497927|P1|NOT COMPLETED|Overall Study||61
211178|NCT00360529|497925|P3|COMPLETED|Overall Study||199
211179|NCT00360529|497926|P2|COMPLETED|Overall Study||230
211180|NCT00360529|497927|P1|COMPLETED|Overall Study||234
211181|NCT00360529|497925|P3|STARTED|Overall Study||290
211182|NCT00360529|497926|P2|STARTED|Overall Study||295
211183|NCT00360529|497927|P1|STARTED|Overall Study||295
211184|NCT00360490|497955|P2|NOT COMPLETED|Overall Study||11
211185|NCT00360490|497956|P1|NOT COMPLETED|Overall Study||9
211186|NCT00360490|497955|P2|COMPLETED|Overall Study||72
211187|NCT00360490|497956|P1|COMPLETED|Overall Study||73
211188|NCT00360490|497955|P2|STARTED|Overall Study||83
211189|NCT00360490|497956|P1|STARTED|Overall Study||82
211190|NCT00360412|497991|P2|NOT COMPLETED|Overall Study||662
211191|NCT00360412|497992|P1|NOT COMPLETED|Overall Study||333
211192|NCT00360412|497991|P2|COMPLETED|Overall Study||2
211193|NCT00360412|497992|P1|COMPLETED|Overall Study||0
211194|NCT00360412|497991|P2|STARTED|Overall Study||664
211195|NCT00360412|497992|P1|STARTED|Overall Study||333
211196|NCT00360399|498007|P3|NOT COMPLETED|Overall Study||46
211197|NCT00360399|498008|P2|NOT COMPLETED|Overall Study||36
211198|NCT00360399|498009|P1|NOT COMPLETED|Overall Study||28
211199|NCT00360399|498007|P3|COMPLETED|Overall Study||69
211200|NCT00360399|498008|P2|COMPLETED|Overall Study||79
211201|NCT00360399|498009|P1|COMPLETED|Overall Study||86
211202|NCT00360399|498007|P3|Had Post-randomization Assessment|Overall Study||105
211203|NCT00360399|498008|P2|Had Post-randomization Assessment|Overall Study||106
211204|NCT00360399|498009|P1|Had Post-randomization Assessment|Overall Study||105
211205|NCT00360399|498007|P3|STARTED|Overall Study||115
211206|NCT00360399|498008|P2|STARTED|Overall Study||115
211207|NCT00360399|498009|P1|STARTED|Overall Study||114
211208|NCT00360360|498032|P1|NOT COMPLETED|Overall Study||6
211209|NCT00360360|498032|P1|COMPLETED|Overall Study||54
211210|NCT00360360|498032|P1|STARTED|Overall Study||60
211211|NCT00360334|498039|P2|NOT COMPLETED|Overall Study||13
211212|NCT00360334|498040|P1|NOT COMPLETED|Overall Study||19
211213|NCT00360334|498039|P2|COMPLETED|Overall Study||104
211214|NCT00360334|498040|P1|COMPLETED|Overall Study||99
211215|NCT00360334|498039|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
211216|NCT00360334|498040|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
211217|NCT00360334|498039|P2|STARTED|Overall Study||117
211218|NCT00360334|498040|P1|STARTED|Overall Study||118
211219|NCT00360308|498103|P3|NOT COMPLETED|Overall Study||88
211220|NCT00360308|498104|P2|NOT COMPLETED|Overall Study||79
211221|NCT00360308|498105|P1|NOT COMPLETED|Overall Study||76
211222|NCT00360308|498103|P3|COMPLETED|Overall Study||154
211223|NCT00360308|498104|P2|COMPLETED|Overall Study||155
211224|NCT00360308|498105|P1|COMPLETED|Overall Study||171
211225|NCT00360308|498103|P3|STARTED|Overall Study||242
211226|NCT00360308|498104|P2|STARTED|Overall Study||234
211227|NCT00360308|498105|P1|STARTED|Overall Study||247
211228|NCT00360282|498122|P4|NOT COMPLETED|Second Intervention||0
211229|NCT00360282|498123|P3|NOT COMPLETED|Second Intervention||0
211230|NCT00360282|498124|P2|NOT COMPLETED|Second Intervention||1
211231|NCT00360282|498125|P1|NOT COMPLETED|Second Intervention||0
211232|NCT00360282|498122|P4|COMPLETED|Second Intervention||6
211233|NCT00360282|498123|P3|COMPLETED|Second Intervention||6
211234|NCT00360282|498124|P2|COMPLETED|Second Intervention||7
211235|NCT00360282|498125|P1|COMPLETED|Second Intervention||6
211236|NCT00360282|498122|P4|STARTED|Second Intervention||6
211237|NCT00360282|498123|P3|STARTED|Second Intervention||6
211238|NCT00360282|498124|P2|STARTED|Second Intervention||8
211239|NCT00360282|498125|P1|STARTED|Second Intervention||6
211240|NCT00360282|498122|P4|NOT COMPLETED|Washout 1-3 Weeks||0
211241|NCT00360282|498123|P3|NOT COMPLETED|Washout 1-3 Weeks||1
211242|NCT00360282|498124|P2|NOT COMPLETED|Washout 1-3 Weeks||0
211243|NCT00360282|498125|P1|NOT COMPLETED|Washout 1-3 Weeks||0
211244|NCT00360282|498122|P4|COMPLETED|Washout 1-3 Weeks||6
211245|NCT00360282|498123|P3|COMPLETED|Washout 1-3 Weeks||6
211246|NCT00360282|498124|P2|COMPLETED|Washout 1-3 Weeks||8
211247|NCT00360282|498125|P1|COMPLETED|Washout 1-3 Weeks||6
211248|NCT00360282|498122|P4|STARTED|Washout 1-3 Weeks||6
211249|NCT00360282|498123|P3|STARTED|Washout 1-3 Weeks||7
211250|NCT00360282|498124|P2|STARTED|Washout 1-3 Weeks||8
211251|NCT00360282|498125|P1|STARTED|Washout 1-3 Weeks||6
211252|NCT00360282|498122|P4|NOT COMPLETED|First Intervention||0
211253|NCT00360282|498123|P3|NOT COMPLETED|First Intervention||0
211254|NCT00360282|498124|P2|NOT COMPLETED|First Intervention||0
211255|NCT00360282|498125|P1|NOT COMPLETED|First Intervention||0
211256|NCT00360282|498122|P4|COMPLETED|First Intervention||6
211257|NCT00360282|498123|P3|COMPLETED|First Intervention||7
211258|NCT00360282|498124|P2|COMPLETED|First Intervention||8
211259|NCT00360282|498125|P1|COMPLETED|First Intervention||6
211260|NCT00360282|498122|P4|STARTED|First Intervention||6
211261|NCT00360282|498123|P3|STARTED|First Intervention||7
211262|NCT00360282|498124|P2|STARTED|First Intervention||8
211263|NCT00360282|498125|P1|STARTED|First Intervention||6
211264|NCT00360269|498137|P2|NOT COMPLETED|Overall Study||12
211265|NCT00360269|498138|P1|NOT COMPLETED|Overall Study||10
211266|NCT00360269|498137|P2|COMPLETED|Overall Study||7
211267|NCT00360269|498138|P1|COMPLETED|Overall Study||9
211268|NCT00360269|498137|P2|STARTED|Overall Study||19
211269|NCT00360269|498138|P1|STARTED|Overall Study||19
211270|NCT00360243|498156|P4|NOT COMPLETED|Overall Study||125
211271|NCT00360243|498157|P3|NOT COMPLETED|Overall Study||156
211272|NCT00360243|498158|P2|NOT COMPLETED|Overall Study||120
211273|NCT00360243|498159|P1|NOT COMPLETED|Overall Study||102
211274|NCT00360243|498156|P4|COMPLETED|Overall Study||224
211275|NCT00360243|498157|P3|COMPLETED|Overall Study||180
211276|NCT00360243|498158|P2|COMPLETED|Overall Study||243
211277|NCT00360243|498159|P1|COMPLETED|Overall Study||235
211278|NCT00360243|498156|P4|STARTED|Overall Study||349
211279|NCT00360243|498157|P3|STARTED|Overall Study||336
211280|NCT00360243|498158|P2|STARTED|Overall Study||363
211281|NCT00360243|498159|P1|STARTED|Overall Study||337
211282|NCT00360009|498176|P3|NOT COMPLETED|Overall Study||3
211283|NCT00360009|498177|P2|NOT COMPLETED|Overall Study||4
211284|NCT00360009|498178|P1|NOT COMPLETED|Overall Study||0
211285|NCT00360009|498176|P3|COMPLETED|Overall Study||23
211286|NCT00360009|498177|P2|COMPLETED|Overall Study||22
211287|NCT00360009|498178|P1|COMPLETED|Overall Study||10
211288|NCT00360009|498176|P3|STARTED|Overall Study||26
211289|NCT00360009|498177|P2|STARTED|Overall Study||26
211290|NCT00360009|498178|P1|STARTED|Overall Study||10
211291|NCT00359983|498219|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
211292|NCT00359983|498220|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
211293|NCT00359983|498221|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
211294|NCT00359983|498219|P3|COMPLETED|Year 5 Persistence Follow-up||42
211295|NCT00359983|498220|P2|COMPLETED|Year 5 Persistence Follow-up||44
211296|NCT00359983|498221|P1|COMPLETED|Year 5 Persistence Follow-up||95
211297|NCT00359983|498219|P3|STARTED|Year 5 Persistence Follow-up||42
211298|NCT00359983|498220|P2|STARTED|Year 5 Persistence Follow-up||44
211299|NCT00359983|498221|P1|STARTED|Year 5 Persistence Follow-up||95
211300|NCT00359983|498219|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
211301|NCT00359983|498220|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
211302|NCT00359983|498221|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
211303|NCT00359983|498219|P3|COMPLETED|Year 3 Persistence Follow-up||51
211304|NCT00359983|498220|P2|COMPLETED|Year 3 Persistence Follow-up||47
211305|NCT00359983|498221|P1|COMPLETED|Year 3 Persistence Follow-up||103
211306|NCT00359983|498219|P3|STARTED|Year 3 Persistence Follow-up||51
211307|NCT00359983|498220|P2|STARTED|Year 3 Persistence Follow-up||47
211308|NCT00359983|498221|P1|STARTED|Year 3 Persistence Follow-up||103
211309|NCT00359983|498219|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
211310|NCT00359983|498220|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
211311|NCT00359983|498221|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
211312|NCT00359983|498219|P3|COMPLETED|Year 1 Persistence Follow-up||62
211313|NCT00359983|498220|P2|COMPLETED|Year 1 Persistence Follow-up||70
211314|NCT00359983|498221|P1|COMPLETED|Year 1 Persistence Follow-up||138
211315|NCT00359983|498219|P3|STARTED|Year 1 Persistence Follow-up||62
211316|NCT00359983|498220|P2|STARTED|Year 1 Persistence Follow-up||70
211317|NCT00359983|498221|P1|STARTED|Year 1 Persistence Follow-up||138
211318|NCT00359944|498256|P3|NOT COMPLETED|Overall Study||19
211319|NCT00359944|498257|P2|NOT COMPLETED|Overall Study||19
211320|NCT00359944|498258|P1|NOT COMPLETED|Overall Study||16
211321|NCT00359944|498256|P3|COMPLETED|Overall Study||38
211322|NCT00359944|498257|P2|COMPLETED|Overall Study||28
211323|NCT00359944|498258|P1|COMPLETED|Overall Study||34
211324|NCT00359944|498256|P3|STARTED|Overall Study||57
211325|NCT00359944|498257|P2|STARTED|Overall Study||47
211326|NCT00359944|498258|P1|STARTED|Overall Study||50
211327|NCT00359801|498274|P2|NOT COMPLETED|Overall Study||220
211328|NCT00359801|498275|P1|NOT COMPLETED|Overall Study||305
211329|NCT00359801|498274|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
211330|NCT00359801|498275|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
211331|NCT00359801|498274|P2|STARTED|Overall Study||989
211332|NCT00359801|498275|P1|STARTED|Overall Study||987
211333|NCT00359788|498309|P2|NOT COMPLETED|Overall Study||17
211334|NCT00359788|498310|P1|NOT COMPLETED|Overall Study||23
211335|NCT00359788|498309|P2|COMPLETED|Overall Study||159
211336|NCT00359788|498310|P1|COMPLETED|Overall Study||150
211337|NCT00359788|498309|P2|STARTED|Overall Study||176
211338|NCT00359788|498310|P1|STARTED|Overall Study||173
211339|NCT00359762|498544|P5|NOT COMPLETED|Period I||0
211340|NCT00359762|498545|P4|NOT COMPLETED|Period I||0
211341|NCT00359762|498546|P3|NOT COMPLETED|Period I||0
211342|NCT00359762|498547|P2|NOT COMPLETED|Period I||0
211343|NCT00359762|498548|P1|NOT COMPLETED|Period I||0
211344|NCT00359762|498544|P5|COMPLETED|Period I||0
211345|NCT00359762|498545|P4|COMPLETED|Period I||0
211346|NCT00359762|498546|P3|COMPLETED|Period I||0
211347|NCT00359762|498547|P2|COMPLETED|Period I||0
211348|NCT00359762|498548|P1|COMPLETED|Period I||0
211349|NCT00359762|498544|P5|STARTED|Period I||0
211350|NCT00359762|498545|P4|STARTED|Period I||0
211351|NCT00359762|498546|P3|STARTED|Period I||0
211352|NCT00359762|498547|P2|STARTED|Period I||0
211353|NCT00359762|498548|P1|STARTED|Period I||0
211354|NCT00359762|498544|P5|NOT COMPLETED|Period III||0
211355|NCT00359762|498545|P4|NOT COMPLETED|Period III||65
211356|NCT00359762|498546|P3|NOT COMPLETED|Period III||30
211357|NCT00359762|498547|P2|NOT COMPLETED|Period III||29
211358|NCT00359762|498548|P1|NOT COMPLETED|Period III||0
211359|NCT00359762|498544|P5|COMPLETED|Period III||0
211360|NCT00359762|498545|P4|COMPLETED|Period III||101
211361|NCT00359762|498546|P3|COMPLETED|Period III||47
211362|NCT00359762|498547|P2|COMPLETED|Period III||48
211363|NCT00359762|498548|P1|COMPLETED|Period III||0
211364|NCT00359762|498544|P5|Extension ITT Efficacy Population|Period III||0
211365|NCT00359762|498545|P4|Extension ITT Efficacy Population|Period III||164
211366|NCT00359762|498546|P3|Extension ITT Efficacy Population|Period III||75
211367|NCT00359762|498547|P2|Extension ITT Efficacy Population|Period III||73
211368|NCT00359762|498548|P1|Extension ITT Efficacy Population|Period III||0
211369|NCT00359762|498544|P5|Extension ITT Safety Population|Period III||0
211370|NCT00359762|498545|P4|Extension ITT Safety Population|Period III||166
211371|NCT00359762|498546|P3|Extension ITT Safety Population|Period III||76
211372|NCT00359762|498547|P2|Extension ITT Safety Population|Period III||74
211373|NCT00359762|498548|P1|Extension ITT Safety Population|Period III||0
211374|NCT00359762|498544|P5|STARTED|Period III||0
211375|NCT00359762|498545|P4|STARTED|Period III||166
211376|NCT00359762|498546|P3|STARTED|Period III||77
211377|NCT00359762|498547|P2|STARTED|Period III||77
211378|NCT00359762|498548|P1|STARTED|Period III||0
211379|NCT00359762|498544|P5|NOT COMPLETED|Period II||174
211380|NCT00359762|498545|P4|NOT COMPLETED|Period II||0
211381|NCT00359762|498546|P3|NOT COMPLETED|Period II||0
211382|NCT00359762|498547|P2|NOT COMPLETED|Period II||0
211383|NCT00359762|498548|P1|NOT COMPLETED|Period II||128
211384|NCT00359762|498544|P5|COMPLETED|Period II||341
211385|NCT00359762|498545|P4|COMPLETED|Period II||0
211386|NCT00359762|498546|P3|COMPLETED|Period II||0
211387|NCT00359762|498547|P2|COMPLETED|Period II||0
211388|NCT00359762|498548|P1|COMPLETED|Period II||386
211389|NCT00359762|498544|P5|Without Treatment Failure|Period II||138
211390|NCT00359762|498545|P4|Without Treatment Failure|Period II||0
211391|NCT00359762|498546|P3|Without Treatment Failure|Period II||0
211392|NCT00359762|498547|P2|Without Treatment Failure|Period II||0
211393|NCT00359762|498548|P1|Without Treatment Failure|Period II||124
211394|NCT00359762|498544|P5|Met Primary Endpoint|Period II||203
211395|NCT00359762|498545|P4|Met Primary Endpoint|Period II||0
211396|NCT00359762|498546|P3|Met Primary Endpoint|Period II||0
211397|NCT00359762|498547|P2|Met Primary Endpoint|Period II||0
211398|NCT00359762|498548|P1|Met Primary Endpoint|Period II||262
211399|NCT00359762|498544|P5|ITT Efficacy Population|Period II||490
211400|NCT00359762|498545|P4|ITT Efficacy Population|Period II||0
211401|NCT00359762|498546|P3|ITT Efficacy Population|Period II||0
211402|NCT00359762|498547|P2|ITT Efficacy Population|Period II||0
211403|NCT00359762|498548|P1|ITT Efficacy Population|Period II||487
211404|NCT00359762|498544|P5|Intent to Treat (ITT) Safety Population|Period II||511
211405|NCT00359762|498545|P4|Intent to Treat (ITT) Safety Population|Period II||0
211406|NCT00359762|498546|P3|Intent to Treat (ITT) Safety Population|Period II||0
211407|NCT00359762|498547|P2|Intent to Treat (ITT) Safety Population|Period II||0
211408|NCT00359762|498548|P1|Intent to Treat (ITT) Safety Population|Period II||508
211409|NCT00359762|498544|P5|STARTED|Period II||515
211410|NCT00359762|498545|P4|STARTED|Period II||0
211411|NCT00359762|498546|P3|STARTED|Period II||0
211412|NCT00359762|498547|P2|STARTED|Period II||0
211413|NCT00359762|498548|P1|STARTED|Period II||514
211414|NCT00359736|498611|P2|NOT COMPLETED|Overall Study||0
211415|NCT00359736|498612|P1|NOT COMPLETED|Overall Study||0
211416|NCT00359736|498611|P2|COMPLETED|Overall Study||15
211417|NCT00359736|498612|P1|COMPLETED|Overall Study||14
211418|NCT00359736|498611|P2|STARTED|Overall Study||15
211419|NCT00359736|498612|P1|STARTED|Overall Study||14
211420|NCT00359632|498622|P2|NOT COMPLETED|Overall Study||0
211421|NCT00359632|498623|P1|NOT COMPLETED|Overall Study||4
211422|NCT00359632|498622|P2|COMPLETED|Overall Study||9
211423|NCT00359632|498623|P1|COMPLETED|Overall Study||20
211424|NCT00359632|498622|P2|STARTED|Overall Study||9
211425|NCT00359632|498623|P1|STARTED|Overall Study||24
211426|NCT00359619|498637|P7|NOT COMPLETED|Overall Study||4
211427|NCT00359619|498638|P6|NOT COMPLETED|Overall Study||5
211428|NCT00359619|498639|P5|NOT COMPLETED|Overall Study||3
211429|NCT00359619|498640|P4|NOT COMPLETED|Overall Study||3
211430|NCT00359619|498641|P3|NOT COMPLETED|Overall Study||7
211431|NCT00359619|498642|P2|NOT COMPLETED|Overall Study||5
211432|NCT00359619|498643|P1|NOT COMPLETED|Overall Study||8
211433|NCT00359619|498637|P7|COMPLETED|Overall Study||46
211434|NCT00359619|498638|P6|COMPLETED|Overall Study||45
211435|NCT00359619|498639|P5|COMPLETED|Overall Study||45
211436|NCT00359619|498640|P4|COMPLETED|Overall Study||45
211437|NCT00359619|498641|P3|COMPLETED|Overall Study||42
211438|NCT00359619|498642|P2|COMPLETED|Overall Study||45
211439|NCT00359619|498643|P1|COMPLETED|Overall Study||80
211440|NCT00359619|498637|P7|STARTED|Overall Study||50
211441|NCT00359619|498638|P6|STARTED|Overall Study||50
211442|NCT00359619|498639|P5|STARTED|Overall Study||48
211443|NCT00359619|498640|P4|STARTED|Overall Study||48
211444|NCT00359619|498641|P3|STARTED|Overall Study||49
211445|NCT00359619|498642|P2|STARTED|Overall Study||50
211446|NCT00359619|498643|P1|STARTED|Overall Study||88
211447|NCT00359424|498773|P2|NOT COMPLETED|Overall Study||67
211448|NCT00359424|498774|P1|NOT COMPLETED|Overall Study||130
211449|NCT00359424|498773|P2|COMPLETED|Overall Study||155
211450|NCT00359424|498774|P1|COMPLETED|Overall Study||304
211451|NCT00359424|498773|P2|270 Day Follow up|Overall Study||159
211452|NCT00359424|498774|P1|270 Day Follow up|Overall Study||313
211453|NCT00359424|498773|P2|180 Day Follow up|Overall Study||167
211454|NCT00359424|498774|P1|180 Day Follow up|Overall Study||325
211455|NCT00359424|498773|P2|90 Day Follow up|Overall Study||172
211456|NCT00359424|498774|P1|90 Day Follow up|Overall Study||343
211457|NCT00359424|498773|P2|STARTED|Overall Study||222
211458|NCT00359424|498774|P1|STARTED|Overall Study||434
211459|NCT00359281|498813|P9|NOT COMPLETED|Overall Study||0
211460|NCT00359281|498814|P8|NOT COMPLETED|Overall Study||0
211461|NCT00359281|498815|P7|NOT COMPLETED|Overall Study||2
211462|NCT00359281|498816|P6|NOT COMPLETED|Overall Study||0
211463|NCT00359281|498817|P5|NOT COMPLETED|Overall Study||0
211464|NCT00359281|498818|P4|NOT COMPLETED|Overall Study||0
211465|NCT00359281|498819|P3|NOT COMPLETED|Overall Study||0
211466|NCT00359281|498820|P2|NOT COMPLETED|Overall Study||0
211467|NCT00359281|498821|P1|NOT COMPLETED|Overall Study||1
211468|NCT00359281|498813|P9|COMPLETED|Overall Study||20
211469|NCT00359281|498814|P8|COMPLETED|Overall Study||15
211470|NCT00359281|498815|P7|COMPLETED|Overall Study||16
211471|NCT00359281|498816|P6|COMPLETED|Overall Study||15
211472|NCT00359281|498817|P5|COMPLETED|Overall Study||10
211473|NCT00359281|498818|P4|COMPLETED|Overall Study||10
211474|NCT00359281|498819|P3|COMPLETED|Overall Study||10
211475|NCT00359281|498820|P2|COMPLETED|Overall Study||15
211476|NCT00359281|498821|P1|COMPLETED|Overall Study||15
211477|NCT00359281|498813|P9|STARTED|Overall Study||20
211478|NCT00359281|498814|P8|STARTED|Overall Study||15
211479|NCT00359281|498815|P7|STARTED|Overall Study||18
211480|NCT00359281|498816|P6|STARTED|Overall Study||15
211481|NCT00359281|498817|P5|STARTED|Overall Study||10
211482|NCT00359281|498818|P4|STARTED|Overall Study||10
211483|NCT00359281|498819|P3|STARTED|Overall Study||10
211484|NCT00359281|498820|P2|STARTED|Overall Study||15
211485|NCT00359281|498821|P1|STARTED|Overall Study||16
211486|NCT00359216|498853|P2|NOT COMPLETED|Overall Study||1
211487|NCT00359216|498854|P1|NOT COMPLETED|Overall Study||0
211488|NCT00359216|498853|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
211489|NCT00359216|498854|P1|COMPLETED|Overall Study||20
211490|NCT00359216|498853|P2|STARTED|Overall Study||10
211491|NCT00359216|498854|P1|STARTED|Overall Study||20
211492|NCT00359203|498862|P2|NOT COMPLETED|Overall Study||0
211493|NCT00359203|498863|P1|NOT COMPLETED|Overall Study||0
211494|NCT00359203|498862|P2|COMPLETED|Overall Study||38
211495|NCT00359203|498863|P1|COMPLETED|Overall Study||39
211496|NCT00359203|498862|P2|STARTED|Overall Study||38
211497|NCT00359203|498863|P1|STARTED|Overall Study||39
211498|NCT00359138|498872|P3|NOT COMPLETED|Overall Study||0
211499|NCT00359138|498873|P2|NOT COMPLETED|Overall Study||0
211500|NCT00359138|498874|P1|NOT COMPLETED|Overall Study||0
211501|NCT00359138|498872|P3|COMPLETED|Overall Study||12
211502|NCT00359138|498873|P2|COMPLETED|Overall Study||12
211503|NCT00359138|498874|P1|COMPLETED|Overall Study||12
211504|NCT00359138|498872|P3|STARTED|Overall Study||12
211505|NCT00359138|498873|P2|STARTED|Overall Study||12
211506|NCT00359138|498874|P1|STARTED|Overall Study||12
211507|NCT00359021|498884|P2|NOT COMPLETED|Overall Study||52
211508|NCT00359021|498885|P1|NOT COMPLETED|Overall Study||81
211509|NCT00359021|498884|P2|COMPLETED|Overall Study||195
211510|NCT00359021|498885|P1|COMPLETED|Overall Study||175
211511|NCT00359021|498884|P2|STARTED|Overall Study||247
211512|NCT00359021|498885|P1|STARTED|Overall Study||256
211513|NCT00358956|498897|P1|NOT COMPLETED|Overall Study||8
211514|NCT00358956|498897|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
211515|NCT00358956|498897|P1|STARTED|Overall Study||19
211516|NCT00358917|498909|P2|NOT COMPLETED|Overall Study||69
211517|NCT00358917|498910|P1|NOT COMPLETED|Overall Study||66
211518|NCT00358917|498909|P2|COMPLETED|Overall Study||230
211519|NCT00358917|498910|P1|COMPLETED|Overall Study||234
211520|NCT00358917|498909|P2|STARTED|Overall Study||299
211521|NCT00358917|498910|P1|STARTED|Overall Study||300
211522|NCT00358826|498928|P8|NOT COMPLETED|MDCT Substudy||0
211523|NCT00358826|498929|P7|NOT COMPLETED|MDCT Substudy||0
211524|NCT00358826|498930|P6|NOT COMPLETED|MDCT Substudy||2
211525|NCT00358826|498931|P5|NOT COMPLETED|MDCT Substudy||1
211526|NCT00358826|498932|P4|NOT COMPLETED|MDCT Substudy||0
211527|NCT00358826|498933|P3|NOT COMPLETED|MDCT Substudy||0
211528|NCT00358826|498934|P2|NOT COMPLETED|MDCT Substudy||0
211529|NCT00358826|498935|P1|NOT COMPLETED|MDCT Substudy||0
211530|NCT00358826|498928|P8|COMPLETED|MDCT Substudy||27
211531|NCT00358826|498929|P7|COMPLETED|MDCT Substudy||19
211532|NCT00358826|498930|P6|COMPLETED|MDCT Substudy||20
211533|NCT00358826|498931|P5|COMPLETED|MDCT Substudy||24
211534|NCT00358826|498932|P4|COMPLETED|MDCT Substudy||0
211535|NCT00358826|498933|P3|COMPLETED|MDCT Substudy||0
211536|NCT00358826|498934|P2|COMPLETED|MDCT Substudy||0
211537|NCT00358826|498935|P1|COMPLETED|MDCT Substudy||0
211538|NCT00358826|498928|P8|STARTED|MDCT Substudy||27
211539|NCT00358826|498929|P7|STARTED|MDCT Substudy||19
211540|NCT00358826|498930|P6|STARTED|MDCT Substudy||22
211541|NCT00358826|498931|P5|STARTED|MDCT Substudy||25
211542|NCT00358826|498932|P4|STARTED|MDCT Substudy||0
211543|NCT00358826|498933|P3|STARTED|MDCT Substudy||0
211544|NCT00358826|498934|P2|STARTED|MDCT Substudy||0
211545|NCT00358826|498935|P1|STARTED|MDCT Substudy||0
211546|NCT00358826|498928|P8|NOT COMPLETED|Core Study||0
211547|NCT00358826|498929|P7|NOT COMPLETED|Core Study||0
211548|NCT00358826|498930|P6|NOT COMPLETED|Core Study||0
211549|NCT00358826|498931|P5|NOT COMPLETED|Core Study||0
211550|NCT00358826|498932|P4|NOT COMPLETED|Core Study||2
211551|NCT00358826|498933|P3|NOT COMPLETED|Core Study||2
211552|NCT00358826|498934|P2|NOT COMPLETED|Core Study||5
211553|NCT00358826|498935|P1|NOT COMPLETED|Core Study||3
211554|NCT00358826|498928|P8|COMPLETED|Core Study||0
211555|NCT00358826|498929|P7|COMPLETED|Core Study||0
211556|NCT00358826|498930|P6|COMPLETED|Core Study||0
211557|NCT00358826|498931|P5|COMPLETED|Core Study||0
211558|NCT00358826|498932|P4|COMPLETED|Core Study||50
211559|NCT00358826|498933|P3|COMPLETED|Core Study||42
211560|NCT00358826|498934|P2|COMPLETED|Core Study||41
211561|NCT00358826|498935|P1|COMPLETED|Core Study||46
211562|NCT00358826|498928|P8|STARTED|Core Study||0
211563|NCT00358826|498929|P7|STARTED|Core Study||0
211564|NCT00358826|498930|P6|STARTED|Core Study||0
211565|NCT00358826|498931|P5|STARTED|Core Study||0
211566|NCT00358826|498932|P4|STARTED|Core Study||52
211567|NCT00358826|498933|P3|STARTED|Core Study||44
211568|NCT00358826|498934|P2|STARTED|Core Study||46
211569|NCT00358826|498935|P1|STARTED|Core Study||49
211570|NCT00358735|498971|P2|NOT COMPLETED|Overall Study||17
211571|NCT00358735|498972|P1|NOT COMPLETED|Overall Study||8
211572|NCT00358735|498971|P2|COMPLETED|Overall Study|Efficacy|190
211573|NCT00358735|498972|P1|COMPLETED|Overall Study|Efficacy|196
211574|NCT00358735|498971|P2|Not Completed Safety|Overall Study||13
211575|NCT00358735|498972|P1|Not Completed Safety|Overall Study||6
211576|NCT00358735|498971|P2|Completed Safety|Overall Study||194
211577|NCT00358735|498972|P1|Completed Safety|Overall Study||198
211578|NCT00358735|498971|P2|STARTED|Overall Study||207
211579|NCT00358735|498972|P1|STARTED|Overall Study||204
211580|NCT00358670|499002|P2|NOT COMPLETED|Overall Study||219
211581|NCT00358670|499003|P1|NOT COMPLETED|Overall Study||222
211582|NCT00358670|499002|P2|COMPLETED|Overall Study||0
211583|NCT00358670|499003|P1|COMPLETED|Overall Study||0
211584|NCT00358670|499002|P2|STARTED|Overall Study||219
211585|NCT00358670|499003|P1|STARTED|Overall Study||222
211586|NCT00358644|499017|P1|NOT COMPLETED|Overall Study||50
211587|NCT00358644|499017|P1|COMPLETED|Overall Study||5
211588|NCT00358644|499017|P1|STARTED|Overall Study||55
211589|NCT00358579|499023|P2|NOT COMPLETED|Overall Study||0
211590|NCT00358579|499024|P1|NOT COMPLETED|Overall Study||0
211591|NCT00358579|499023|P2|COMPLETED|Overall Study||374
211592|NCT00358579|499024|P1|COMPLETED|Overall Study||353
211593|NCT00358579|499023|P2|STARTED|Overall Study||374
211594|NCT00358579|499024|P1|STARTED|Overall Study||353
211595|NCT00358527|499040|P2|NOT COMPLETED|Overall Study||3
211596|NCT00358527|499041|P1|NOT COMPLETED|Overall Study||13
211597|NCT00358527|499040|P2|COMPLETED|Overall Study||131
211598|NCT00358527|499041|P1|COMPLETED|Overall Study||254
211599|NCT00358527|499040|P2|STARTED|Overall Study||134
211600|NCT00358527|499041|P1|STARTED|Overall Study||267
211601|NCT00358501|499051|P2|NOT COMPLETED|Overall Study||0
211602|NCT00358501|499052|P1|NOT COMPLETED|Overall Study||0
211603|NCT00358501|499051|P2|COMPLETED|Overall Study||32
211604|NCT00358501|499052|P1|COMPLETED|Overall Study||102
211605|NCT00358501|499051|P2|STARTED|Overall Study||32
211606|NCT00358501|499052|P1|STARTED|Overall Study||102
211607|NCT00358462|499067|P2|NOT COMPLETED|Overall Study||64
211608|NCT00358462|499068|P1|NOT COMPLETED|Overall Study||59
211609|NCT00358462|499067|P2|COMPLETED|Overall Study||238
211610|NCT00358462|499068|P1|COMPLETED|Overall Study||245
211611|NCT00358462|499067|P2|STARTED|Overall Study||302
211612|NCT00358462|499068|P1|STARTED|Overall Study||304
211613|NCT00358449|499079|P3|NOT COMPLETED|Overall Study||2
211614|NCT00358449|499080|P2|NOT COMPLETED|Overall Study||1
211615|NCT00358449|499081|P1|NOT COMPLETED|Overall Study||4
211616|NCT00358449|499079|P3|COMPLETED|Overall Study||18
211617|NCT00358449|499080|P2|COMPLETED|Overall Study||19
211618|NCT00358449|499081|P1|COMPLETED|Overall Study||15
211619|NCT00358449|499079|P3|STARTED|Overall Study||20
211620|NCT00358449|499080|P2|STARTED|Overall Study||20
211621|NCT00358449|499081|P1|STARTED|Overall Study||19
211622|NCT00358436|499184|P2|NOT COMPLETED|Overall Study||86
211623|NCT00358436|499185|P1|NOT COMPLETED|Overall Study||154
211624|NCT00358436|499184|P2|COMPLETED|Overall Study||118
211625|NCT00358436|499185|P1|COMPLETED|Overall Study||446
211626|NCT00358436|499184|P2|STARTED|Overall Study||204
211627|NCT00358436|499185|P1|STARTED|Overall Study||600
211628|NCT00358332|499201|P4|NOT COMPLETED|Overall Study||0
211629|NCT00358332|499202|P3|NOT COMPLETED|Overall Study||1
211630|NCT00358332|499203|P2|NOT COMPLETED|Overall Study||3
211631|NCT00358332|499204|P1|NOT COMPLETED|Overall Study||0
211632|NCT00358332|499201|P4|COMPLETED|Overall Study||25
211633|NCT00358332|499202|P3|COMPLETED|Overall Study||29
211634|NCT00358332|499203|P2|COMPLETED|Overall Study||27
211635|NCT00358332|499204|P1|COMPLETED|Overall Study||15
211636|NCT00358332|499201|P4|STARTED|Overall Study||25
211637|NCT00358332|499202|P3|STARTED|Overall Study||30
211638|NCT00358332|499203|P2|STARTED|Overall Study||30
211639|NCT00358332|499204|P1|STARTED|Overall Study||15
211640|NCT00358215|499256|P2|NOT COMPLETED|Overall Study||652
211641|NCT00358215|499257|P1|NOT COMPLETED|Overall Study||679
211642|NCT00358215|499256|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
211643|NCT00358215|499257|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
211644|NCT00358215|499256|P2|Received Investigational Product|Overall Study||1133
211645|NCT00358215|499257|P1|Received Investigational Product|Overall Study||1140
211646|NCT00358215|499256|P2|STARTED|Overall Study||1136
211647|NCT00358215|499257|P1|STARTED|Overall Study||1142
211648|NCT00358150|499271|P1|NOT COMPLETED|Overall Study||7
211649|NCT00358150|499271|P1|COMPLETED|Overall Study||19
211650|NCT00358150|499271|P1|STARTED|Overall Study||26
211651|NCT00358007|499293|P1|NOT COMPLETED|Overall Study||2
211652|NCT00358007|499293|P1|COMPLETED|Overall Study||28
211653|NCT00358007|499293|P1|STARTED|Overall Study||30
211654|NCT00357994|499300|P2|NOT COMPLETED|Overall Study||3
211655|NCT00357994|499301|P1|NOT COMPLETED|Overall Study||2
211656|NCT00357994|499300|P2|COMPLETED|Overall Study||31
211657|NCT00357994|499301|P1|COMPLETED|Overall Study||35
211658|NCT00357994|499300|P2|STARTED|Overall Study||34
211659|NCT00357994|499301|P1|STARTED|Overall Study||37
211660|NCT00357968|499355|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
211661|NCT00357968|499356|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
211662|NCT00357968|499355|P2|COMPLETED|Crossover Maintenance Dose Phase||55
211663|NCT00357968|499356|P1|COMPLETED|Crossover Maintenance Dose Phase||54
211664|NCT00357968|499355|P2|STARTED|Crossover Maintenance Dose Phase||55
211665|NCT00357968|499356|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
211666|NCT00357968|499355|P2|NOT COMPLETED|First Maintenance Dose Phase||44
211667|NCT00357968|499356|P1|NOT COMPLETED|First Maintenance Dose Phase||48
211668|NCT00357968|499355|P2|COMPLETED|First Maintenance Dose Phase||55
211669|NCT00357968|499356|P1|COMPLETED|First Maintenance Dose Phase||54
211670|NCT00357968|499355|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
211671|NCT00357968|499356|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
211672|NCT00357968|499355|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
211673|NCT00357968|499356|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
211674|NCT00357968|499355|P2|Received Loading Dose|First Maintenance Dose Phase||99
211675|NCT00357968|499356|P1|Received Loading Dose|First Maintenance Dose Phase||102
211676|NCT00357968|499355|P2|STARTED|First Maintenance Dose Phase||99
211677|NCT00357968|499356|P1|STARTED|First Maintenance Dose Phase||102
211678|NCT00357955|499400|P2|NOT COMPLETED|Overall Study||3
211679|NCT00357955|499401|P1|NOT COMPLETED|Overall Study||6
211680|NCT00357955|499400|P2|COMPLETED|Overall Study||51
211681|NCT00357955|499401|P1|COMPLETED|Overall Study||58
211682|NCT00357955|499400|P2|STARTED|Overall Study||54
211683|NCT00357955|499401|P1|STARTED|Overall Study||64
211684|NCT00357903|499409|P2|NOT COMPLETED|Overall Study||43
211685|NCT00357903|499410|P1|NOT COMPLETED|Overall Study||363
211686|NCT00357903|499409|P2|COMPLETED|Overall Study||15
211687|NCT00357903|499410|P1|COMPLETED|Overall Study||218
211688|NCT00357903|499409|P2|STARTED|Overall Study||58
211689|NCT00357903|499410|P1|STARTED|Overall Study||581
211690|NCT00357734|499448|P1|NOT COMPLETED|Overall Study||4
211691|NCT00357734|499448|P1|COMPLETED|Overall Study||10
211692|NCT00357734|499448|P1|Patient Received 500 mg of ZD1839|Overall Study||1
211693|NCT00357734|499448|P1|Patients Received 250 mg of ZD1839|Overall Study||13
211694|NCT00357734|499448|P1|STARTED|Overall Study||14
211695|NCT00357552|499457|P1|NOT COMPLETED|Weeks 24 to 104||5
211696|NCT00357552|499457|P1|COMPLETED|Weeks 24 to 104||117
211697|NCT00357552|499457|P1|STARTED|Weeks 24 to 104||122
211698|NCT00357552|499457|P1|NOT COMPLETED|Weeks 0 to 24||1
211699|NCT00357552|499457|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
211700|NCT00357552|499457|P1|STARTED|Weeks 0 to 24||123
211701|NCT00357552|499457|P1|NOT COMPLETED|Screening||84
211702|NCT00357552|499457|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
211703|NCT00357552|499457|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
211704|NCT00357500|499470|P1|NOT COMPLETED|Overall Study||77
211705|NCT00357500|499470|P1|COMPLETED|Overall Study||24
211800|NCT00356278|499777|P1|STARTED|Overall Study||53
211979|NCT00355082|500208|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
211706|NCT00357500|499470|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
211707|NCT00357500|499470|P1|STARTED|Overall Study||101
211708|NCT00357396|499479|P2|NOT COMPLETED|Overall Study||0
211709|NCT00357396|499480|P1|NOT COMPLETED|Overall Study||1
211710|NCT00357396|499479|P2|COMPLETED|Overall Study||4
211711|NCT00357396|499480|P1|COMPLETED|Overall Study||5
211712|NCT00357396|499479|P2|STARTED|Overall Study||4
211713|NCT00357396|499480|P1|STARTED|Overall Study||6
211714|NCT00357162|499485|P1|NOT COMPLETED|Overall Study||0
211715|NCT00357162|499485|P1|COMPLETED|Overall Study||21
211716|NCT00357162|499485|P1|STARTED|Overall Study||21
211717|NCT00357110|499495|P2|NOT COMPLETED|Overall Study||5
211718|NCT00357110|499496|P1|NOT COMPLETED|Overall Study||5
211719|NCT00357110|499495|P2|COMPLETED|Overall Study||2
211720|NCT00357110|499496|P1|COMPLETED|Overall Study||1
211721|NCT00357110|499495|P2|STARTED|Overall Study||7
211722|NCT00357110|499496|P1|STARTED|Overall Study||6
211723|NCT00357097|499504|P2|NOT COMPLETED|Overall Study||29
211724|NCT00357097|499505|P1|NOT COMPLETED|Overall Study||54
211725|NCT00357097|499504|P2|COMPLETED|Overall Study||38
211726|NCT00357097|499505|P1|COMPLETED|Overall Study||145
211727|NCT00357097|499504|P2|STARTED|Overall Study||67
211728|NCT00357097|499505|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
211729|NCT00357032|499549|P1|NOT COMPLETED|Overall Study||0
211730|NCT00357032|499549|P1|COMPLETED|Overall Study||12
211731|NCT00357032|499549|P1|STARTED|Overall Study||12
211732|NCT00357006|499557|P3|NOT COMPLETED|Overall Study||3
211733|NCT00357006|499558|P2|NOT COMPLETED|Overall Study||5
211734|NCT00357006|499559|P1|NOT COMPLETED|Overall Study||2
211735|NCT00357006|499557|P3|COMPLETED|Overall Study||59
211736|NCT00357006|499558|P2|COMPLETED|Overall Study||51
211737|NCT00357006|499559|P1|COMPLETED|Overall Study||60
211738|NCT00357006|499557|P3|STARTED|Overall Study||62
211739|NCT00357006|499558|P2|STARTED|Overall Study||56
211740|NCT00357006|499559|P1|STARTED|Overall Study||62
211741|NCT00356915|499570|P3|NOT COMPLETED|Overall Study||42
211742|NCT00356915|499571|P2|NOT COMPLETED|Overall Study||94
211743|NCT00356915|499572|P1|NOT COMPLETED|Overall Study||76
211744|NCT00356915|499570|P3|COMPLETED|Overall Study||156
211745|NCT00356915|499571|P2|COMPLETED|Overall Study||496
211746|NCT00356915|499572|P1|COMPLETED|Overall Study||517
211747|NCT00356915|499570|P3|STARTED|Overall Study||198
211748|NCT00356915|499571|P2|STARTED|Overall Study||590
211749|NCT00356915|499572|P1|STARTED|Overall Study||593
211750|NCT00356889|499589|P1|NOT COMPLETED|Overall Study||3
211751|NCT00356889|499589|P1|COMPLETED|Overall Study||53
211752|NCT00356889|499589|P1|STARTED|Overall Study||56
211753|NCT00356863|499598|P2|NOT COMPLETED|Overall Study||75
211754|NCT00356863|499599|P1|NOT COMPLETED|Overall Study||92
211755|NCT00356863|499598|P2|COMPLETED|Overall Study||445
211756|NCT00356863|499599|P1|COMPLETED|Overall Study||412
211757|NCT00356863|499598|P2|STARTED|Overall Study||520
211758|NCT00356863|499599|P1|STARTED|Overall Study||504
211759|NCT00356811|499625|P1|NOT COMPLETED|Overall Study||49
211760|NCT00356811|499625|P1|COMPLETED|Overall Study||8
211761|NCT00356811|499625|P1|STARTED|Overall Study||57
211762|NCT00356590|499638|P1|NOT COMPLETED|Overall Study||274
211763|NCT00356590|499638|P1|COMPLETED|Overall Study||194
211764|NCT00356590|499638|P1|STARTED|Overall Study||468
211765|NCT00356525|499674|P4|NOT COMPLETED|Overall Study||9
211766|NCT00356525|499675|P3|NOT COMPLETED|Overall Study||7
211767|NCT00356525|499676|P2|NOT COMPLETED|Overall Study||11
211768|NCT00356525|499677|P1|NOT COMPLETED|Overall Study||14
211769|NCT00356525|499674|P4|COMPLETED|Overall Study||0
211770|NCT00356525|499675|P3|COMPLETED|Overall Study||0
211771|NCT00356525|499676|P2|COMPLETED|Overall Study||0
211772|NCT00356525|499677|P1|COMPLETED|Overall Study||0
211773|NCT00356525|499674|P4|STARTED|Overall Study||9
211774|NCT00356525|499675|P3|STARTED|Overall Study||7
211775|NCT00356525|499676|P2|STARTED|Overall Study||11
211776|NCT00356525|499677|P1|STARTED|Overall Study||14
211777|NCT00356421|499705|P2|NOT COMPLETED|Overall Study||17
211778|NCT00356421|499706|P1|NOT COMPLETED|Overall Study||32
211779|NCT00356421|499705|P2|COMPLETED|Overall Study||3
211780|NCT00356421|499706|P1|COMPLETED|Overall Study||6
211781|NCT00356421|499705|P2|STARTED|Overall Study||20
211782|NCT00356421|499706|P1|STARTED|Overall Study||38
211783|NCT00356408|499746|P1|NOT COMPLETED|Overall Study||60
211784|NCT00356408|499746|P1|COMPLETED|Overall Study||43
211785|NCT00356408|499746|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
211786|NCT00356304|499763|P2|NOT COMPLETED|Overall Study||4
211787|NCT00356304|499764|P1|NOT COMPLETED|Overall Study||2
211788|NCT00356304|499763|P2|COMPLETED|Overall Study||20
211789|NCT00356304|499764|P1|COMPLETED|Overall Study||24
211790|NCT00356304|499763|P2|STARTED|Overall Study||24
211791|NCT00356304|499764|P1|STARTED|Overall Study||26
211792|NCT00356278|499775|P3|NOT COMPLETED|Overall Study||19
211793|NCT00356278|499776|P2|NOT COMPLETED|Overall Study||15
211794|NCT00356278|499777|P1|NOT COMPLETED|Overall Study||25
211795|NCT00356278|499775|P3|COMPLETED|Overall Study||34
211796|NCT00356278|499776|P2|COMPLETED|Overall Study||35
211797|NCT00356278|499777|P1|COMPLETED|Overall Study||28
211798|NCT00356278|499775|P3|STARTED|Overall Study||53
211799|NCT00356278|499776|P2|STARTED|Overall Study||50
211801|NCT00356200|499814|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
211802|NCT00356200|499815|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
211803|NCT00356200|499814|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
211804|NCT00356200|499815|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
211805|NCT00356200|499814|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
211806|NCT00356200|499815|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
211807|NCT00356200|499814|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
211808|NCT00356200|499815|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
211809|NCT00356200|499814|P2|COMPLETED|Cohort 1: 10 ug/ml||0
211810|NCT00356200|499815|P1|COMPLETED|Cohort 1: 10 ug/ml||4
211811|NCT00356200|499814|P2|STARTED|Cohort 1: 10 ug/ml||0
211812|NCT00356200|499815|P1|STARTED|Cohort 1: 10 ug/ml||5
211813|NCT00356148|499829|P2|NOT COMPLETED|Overall Study||1
211814|NCT00356148|499830|P1|NOT COMPLETED|Overall Study||2
211815|NCT00356148|499829|P2|COMPLETED|Overall Study||182
211816|NCT00356148|499830|P1|COMPLETED|Overall Study||187
211817|NCT00356148|499829|P2|STARTED|Overall Study||183
211818|NCT00356148|499830|P1|STARTED|Overall Study||189
211819|NCT00356135|499841|P3|NOT COMPLETED|Overall Study||5
211820|NCT00356135|499842|P2|NOT COMPLETED|Overall Study||2
211821|NCT00356135|499843|P1|NOT COMPLETED|Overall Study||4
211822|NCT00356135|499841|P3|COMPLETED|Overall Study||39
211823|NCT00356135|499842|P2|COMPLETED|Overall Study||46
211824|NCT00356135|499843|P1|COMPLETED|Overall Study||43
211825|NCT00356135|499841|P3|STARTED|Overall Study||44
211826|NCT00356135|499842|P2|STARTED|Overall Study||48
211827|NCT00356135|499843|P1|STARTED|Overall Study||47
211828|NCT00356122|499865|P1|NOT COMPLETED|FOLLOW-UP||41
211829|NCT00356122|499865|P1|COMPLETED|FOLLOW-UP||12
211830|NCT00356122|499865|P1|STARTED|FOLLOW-UP||53
211831|NCT00356122|499865|P1|NOT COMPLETED|TREATMENT||45
211832|NCT00356122|499865|P1|COMPLETED|TREATMENT||8
211833|NCT00356122|499865|P1|STARTED|TREATMENT||53
211834|NCT00356057|499876|P3|NOT COMPLETED|Overall Study||12
211835|NCT00356057|499877|P2|NOT COMPLETED|Overall Study||14
211836|NCT00356057|499878|P1|NOT COMPLETED|Overall Study||13
211837|NCT00356057|499876|P3|COMPLETED|Overall Study||22
211838|NCT00356057|499877|P2|COMPLETED|Overall Study||47
211839|NCT00356057|499878|P1|COMPLETED|Overall Study||45
211840|NCT00356057|499876|P3|IMPLANTED|Overall Study||25
211841|NCT00356057|499877|P2|IMPLANTED|Overall Study||52
211842|NCT00356057|499878|P1|IMPLANTED|Overall Study||49
211843|NCT00356057|499876|P3|STARTED|Overall Study||34
211844|NCT00356057|499877|P2|STARTED|Overall Study||61
211845|NCT00356057|499878|P1|STARTED|Overall Study||58
211846|NCT00355914|499886|P2|NOT COMPLETED|Overall Study||0
211847|NCT00355914|499887|P1|NOT COMPLETED|Overall Study||0
211848|NCT00355914|499886|P2|COMPLETED|Overall Study||60
211849|NCT00355914|499887|P1|COMPLETED|Overall Study||60
211850|NCT00355914|499886|P2|STARTED|Overall Study||60
211851|NCT00355914|499887|P1|STARTED|Overall Study||60
211852|NCT00355797|499898|P3|NOT COMPLETED|Overall Study||142
211853|NCT00355797|499899|P2|NOT COMPLETED|Overall Study||148
211854|NCT00355797|499900|P1|NOT COMPLETED|Overall Study||240
211855|NCT00355797|499898|P3|COMPLETED|Overall Study||239
211856|NCT00355797|499899|P2|COMPLETED|Overall Study||221
211857|NCT00355797|499900|P1|COMPLETED|Overall Study||501
211858|NCT00355797|499898|P3|STARTED|Overall Study||381
211859|NCT00355797|499899|P2|STARTED|Overall Study||369
211860|NCT00355797|499900|P1|STARTED|Overall Study||741
211861|NCT00355784|499932|P3|NOT COMPLETED|Overall Study||2
211862|NCT00355784|499933|P2|NOT COMPLETED|Overall Study||0
211863|NCT00355784|499934|P1|NOT COMPLETED|Overall Study||0
211864|NCT00355784|499932|P3|COMPLETED|Overall Study||5
211865|NCT00355784|499933|P2|COMPLETED|Overall Study||8
211866|NCT00355784|499934|P1|COMPLETED|Overall Study||9
211867|NCT00355784|499932|P3|STARTED|Overall Study||7
211868|NCT00355784|499933|P2|STARTED|Overall Study||8
211869|NCT00355784|499934|P1|STARTED|Overall Study||9
211870|NCT00355706|499968|P2|NOT COMPLETED|Overall Study||0
211871|NCT00355706|499969|P1|NOT COMPLETED|Overall Study||0
211872|NCT00355706|499968|P2|COMPLETED|Overall Study||50
211873|NCT00355706|499969|P1|COMPLETED|Overall Study||50
211874|NCT00355706|499968|P2|STARTED|Overall Study||50
211875|NCT00355706|499969|P1|STARTED|Overall Study||50
211876|NCT00355615|499983|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
211877|NCT00355615|499984|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
211878|NCT00355615|499985|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
211879|NCT00355615|499986|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
211880|NCT00355615|499987|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
211881|NCT00355615|499983|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
211882|NCT00355615|499984|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
211883|NCT00355615|499985|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
211884|NCT00355615|499986|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
211885|NCT00355615|499987|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
211886|NCT00355615|499983|P5|STARTED|40-week Rosuvastatin Open Label Period||173
211887|NCT00355615|499984|P4|STARTED|40-week Rosuvastatin Open Label Period||0
211888|NCT00355615|499985|P3|STARTED|40-week Rosuvastatin Open Label Period||0
211889|NCT00355615|499986|P2|STARTED|40-week Rosuvastatin Open Label Period||0
211890|NCT00355615|499987|P1|STARTED|40-week Rosuvastatin Open Label Period||0
211891|NCT00355615|499983|P5|NOT COMPLETED|Randomized Double Blind Period||0
211892|NCT00355615|499984|P4|NOT COMPLETED|Randomized Double Blind Period||1
211893|NCT00355615|499985|P3|NOT COMPLETED|Randomized Double Blind Period||1
211894|NCT00355615|499986|P2|NOT COMPLETED|Randomized Double Blind Period||0
211895|NCT00355615|499987|P1|NOT COMPLETED|Randomized Double Blind Period||1
211896|NCT00355615|499983|P5|COMPLETED|Randomized Double Blind Period||0
211897|NCT00355615|499984|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
211898|NCT00355615|499985|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
211899|NCT00355615|499986|P2|COMPLETED|Randomized Double Blind Period||44
211900|NCT00355615|499987|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
211901|NCT00355615|499983|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
211902|NCT00355615|499984|P4|STARTED|Randomized Double Blind Period||46
211903|NCT00355615|499985|P3|STARTED|Randomized Double Blind Period||45
211904|NCT00355615|499986|P2|STARTED|Randomized Double Blind Period||44
211905|NCT00355615|499987|P1|STARTED|Randomized Double Blind Period||42
211906|NCT00355472|500046|P1|NOT COMPLETED|Overall Study||1
211907|NCT00355472|500046|P1|COMPLETED|Overall Study||15
211908|NCT00355472|500046|P1|STARTED|Overall Study||16
211909|NCT00355394|500073|P2|NOT COMPLETED|Overall Study||0
211910|NCT00355394|500074|P1|NOT COMPLETED|Overall Study||0
211911|NCT00355394|500073|P2|COMPLETED|Overall Study||16
211912|NCT00355394|500074|P1|COMPLETED|Overall Study||15
211913|NCT00355394|500073|P2|STARTED|Overall Study||16
211914|NCT00355394|500074|P1|STARTED|Overall Study||15
211915|NCT00355368|500092|P2|NOT COMPLETED|Overall Study||9
211916|NCT00355368|500093|P1|NOT COMPLETED|Overall Study||10
211917|NCT00355368|500092|P2|COMPLETED|Overall Study||201
211918|NCT00355368|500093|P1|COMPLETED|Overall Study||200
211919|NCT00355368|500092|P2|STARTED|Overall Study||210
211920|NCT00355368|500093|P1|STARTED|Overall Study||210
211921|NCT00355147|500107|P2|NOT COMPLETED|Overall Study||20
211922|NCT00355147|500108|P1|NOT COMPLETED|Overall Study||18
211923|NCT00355147|500107|P2|COMPLETED|Overall Study||67
211924|NCT00355147|500108|P1|COMPLETED|Overall Study||69
211925|NCT00355147|500107|P2|STARTED|Overall Study||87
211926|NCT00355147|500108|P1|STARTED|Overall Study||87
211927|NCT00355134|500127|P5|NOT COMPLETED|Extension Phase||19
211928|NCT00355134|500128|P4|NOT COMPLETED|Extension Phase||16
211929|NCT00355134|500129|P3|NOT COMPLETED|Extension Phase||0
211930|NCT00355134|500130|P2|NOT COMPLETED|Extension Phase||37
211931|NCT00355134|500131|P1|NOT COMPLETED|Extension Phase||31
211932|NCT00355134|500127|P5|COMPLETED|Extension Phase||88
211933|NCT00355134|500128|P4|COMPLETED|Extension Phase||89
211934|NCT00355134|500129|P3|COMPLETED|Extension Phase||0
211935|NCT00355134|500130|P2|COMPLETED|Extension Phase||180
211936|NCT00355134|500131|P1|COMPLETED|Extension Phase||172
211937|NCT00355134|500127|P5|STARTED|Extension Phase||107
211938|NCT00355134|500128|P4|STARTED|Extension Phase||105
211939|NCT00355134|500129|P3|STARTED|Extension Phase||0
211940|NCT00355134|500130|P2|STARTED|Extension Phase||217
211941|NCT00355134|500131|P1|STARTED|Extension Phase||203
211942|NCT00355134|500127|P5|NOT COMPLETED|Core Phase||0
211943|NCT00355134|500128|P4|NOT COMPLETED|Core Phase||0
211944|NCT00355134|500129|P3|NOT COMPLETED|Core Phase||100
211945|NCT00355134|500130|P2|NOT COMPLETED|Core Phase||86
211946|NCT00355134|500131|P1|NOT COMPLETED|Core Phase||119
211947|NCT00355134|500127|P5|COMPLETED|Core Phase||0
211948|NCT00355134|500128|P4|COMPLETED|Core Phase||0
211949|NCT00355134|500129|P3|COMPLETED|Core Phase||255
211950|NCT00355134|500130|P2|COMPLETED|Core Phase||272
211951|NCT00355134|500131|P1|COMPLETED|Core Phase||251
211952|NCT00355134|500127|P5|STARTED|Core Phase||0
211953|NCT00355134|500128|P4|STARTED|Core Phase||0
211954|NCT00355134|500129|P3|STARTED|Core Phase||355
211955|NCT00355134|500130|P2|STARTED|Core Phase||358
211956|NCT00355134|500131|P1|STARTED|Core Phase||370
211957|NCT00355121|500174|P3|NOT COMPLETED|Overall Study||5
211958|NCT00355121|500175|P2|NOT COMPLETED|Overall Study||29
211959|NCT00355121|500176|P1|NOT COMPLETED|Overall Study||21
211960|NCT00355121|500174|P3|COMPLETED|Overall Study||170
211961|NCT00355121|500175|P2|COMPLETED|Overall Study||324
211962|NCT00355121|500176|P1|COMPLETED|Overall Study||332
211963|NCT00355121|500174|P3|STARTED|Overall Study||175
211964|NCT00355121|500175|P2|STARTED|Overall Study||353
211965|NCT00355121|500176|P1|STARTED|Overall Study||353
211966|NCT00355082|500207|P3|NOT COMPLETED|Continuation Phase||3
211967|NCT00355082|500208|P2|NOT COMPLETED|Continuation Phase||0
211968|NCT00355082|500209|P1|NOT COMPLETED|Continuation Phase||24
211969|NCT00355082|500207|P3|COMPLETED|Continuation Phase||8
211970|NCT00355082|500208|P2|COMPLETED|Continuation Phase||0
211971|NCT00355082|500209|P1|COMPLETED|Continuation Phase||160
211972|NCT00355082|500207|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
211973|NCT00355082|500208|P2|STARTED|Continuation Phase||0
211974|NCT00355082|500209|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
211975|NCT00355082|500207|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
211976|NCT00355082|500208|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
211977|NCT00355082|500209|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
211978|NCT00355082|500207|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
211980|NCT00355082|500209|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
211981|NCT00355082|500207|P3|STARTED|Double-Blind (DB) Treatment Phase||0
211982|NCT00355082|500208|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
211983|NCT00355082|500209|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
211984|NCT00355030|500231|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
211985|NCT00355030|500232|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
211986|NCT00355030|500231|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
211987|NCT00355030|500232|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
211988|NCT00355030|500231|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
211989|NCT00355030|500232|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
211990|NCT00355030|500231|P2|NOT COMPLETED|Study Period 1 Treatment||44
211991|NCT00355030|500232|P1|NOT COMPLETED|Study Period 1 Treatment||45
211992|NCT00355030|500231|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
211993|NCT00355030|500232|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
211994|NCT00355030|500231|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
211995|NCT00355030|500232|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
211996|NCT00355030|500231|P2|STARTED|Study Period 1 Treatment||45
211997|NCT00355030|500232|P1|STARTED|Study Period 1 Treatment||46
211998|NCT00354978|500254|P1|NOT COMPLETED|Overall Study||0
211999|NCT00354978|500254|P1|COMPLETED|Overall Study||43
212000|NCT00354978|500254|P1|STARTED|Overall Study||43
212001|NCT00354913|500258|P1|NOT COMPLETED|Overall Study||0
212002|NCT00354913|500258|P1|COMPLETED|Overall Study||21
212003|NCT00354913|500258|P1|STARTED|Overall Study||21
212004|NCT00354887|500265|P1|NOT COMPLETED|Overall Study||1
212005|NCT00354887|500265|P1|COMPLETED|Overall Study||29
212006|NCT00354887|500265|P1|STARTED|Overall Study||30
212007|NCT00354770|500271|P2|NOT COMPLETED|Overall Study||3
212008|NCT00354770|500272|P1|NOT COMPLETED|Overall Study||3
212009|NCT00354770|500271|P2|COMPLETED|Overall Study||22
212010|NCT00354770|500272|P1|COMPLETED|Overall Study||22
212011|NCT00354770|500271|P2|STARTED|Overall Study||25
212012|NCT00354770|500272|P1|STARTED|Overall Study||25
212013|NCT00354744|500278|P1|NOT COMPLETED|Overall Study||42
212014|NCT00354744|500278|P1|COMPLETED|Overall Study||67
212015|NCT00354744|500278|P1|STARTED|Overall Study||109
212016|NCT00354679|500283|P1|NOT COMPLETED|Overall Study||1
212017|NCT00354679|500283|P1|COMPLETED|Overall Study||33
212018|NCT00354679|500283|P1|STARTED|Overall Study||34
212019|NCT00354640|500287|P1|NOT COMPLETED|Overall Study||0
212020|NCT00354640|500287|P1|COMPLETED|Overall Study||11
212021|NCT00354640|500287|P1|STARTED|Overall Study||11
212022|NCT00354601|500292|P1|NOT COMPLETED|Overall Study||2
212023|NCT00354601|500292|P1|COMPLETED|Overall Study||0
212024|NCT00354601|500292|P1|STARTED|Overall Study||2
212025|NCT00354484|500301|P2|NOT COMPLETED|Overall Study||3
212026|NCT00354484|500302|P1|NOT COMPLETED|Overall Study||4
212027|NCT00354484|500301|P2|COMPLETED|Overall Study||144
212028|NCT00354484|500302|P1|COMPLETED|Overall Study||138
212029|NCT00354484|500301|P2|STARTED|Overall Study||147
212030|NCT00354484|500302|P1|STARTED|Overall Study||142
212031|NCT00354341|500310|P2|NOT COMPLETED|Overall Study||7
212032|NCT00354341|500311|P1|NOT COMPLETED|Overall Study||3
212033|NCT00354341|500310|P2|COMPLETED|Overall Study||75
212034|NCT00354341|500311|P1|COMPLETED|Overall Study||85
212035|NCT00354341|500310|P2|STARTED|Overall Study||82
212036|NCT00354341|500311|P1|STARTED|Overall Study||88
212037|NCT00354172|500327|P1|NOT COMPLETED|Overall Study||1
212038|NCT00354172|500327|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
212039|NCT00354172|500327|P1|STARTED|Overall Study||16
212040|NCT00354159|500347|P2|NOT COMPLETED|Long-term Follow-up||176
212041|NCT00354159|500348|P1|NOT COMPLETED|Long-term Follow-up||180
212042|NCT00354159|500347|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
212043|NCT00354159|500348|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
212044|NCT00354159|500347|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
212045|NCT00354159|500348|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
212046|NCT00354159|500347|P2|NOT COMPLETED|Randomized Study Period||22
212047|NCT00354159|500348|P1|NOT COMPLETED|Randomized Study Period||22
212048|NCT00354159|500347|P2|COMPLETED|Randomized Study Period||176
212049|NCT00354159|500348|P1|COMPLETED|Randomized Study Period||180
212050|NCT00354159|500347|P2|STARTED|Randomized Study Period||198
212051|NCT00354159|500348|P1|STARTED|Randomized Study Period||202
212052|NCT00354107|500391|P1|NOT COMPLETED|Overall Study||5
212053|NCT00354107|500391|P1|COMPLETED|Overall Study||0
212054|NCT00354107|500391|P1|STARTED|Overall Study||5
212055|NCT00354029|500397|P2|NOT COMPLETED|Overall Study||2
212056|NCT00354029|500398|P1|NOT COMPLETED|Overall Study||4
212057|NCT00354029|500397|P2|COMPLETED|Overall Study||38
212058|NCT00354029|500398|P1|COMPLETED|Overall Study||39
212059|NCT00354029|500397|P2|STARTED|Overall Study||40
212060|NCT00354029|500398|P1|STARTED|Overall Study||43
212061|NCT00353977|500404|P1|NOT COMPLETED|Overall Study||0
212062|NCT00353977|500404|P1|COMPLETED|Overall Study||38
212063|NCT00353977|500404|P1|STARTED|Overall Study||38
212064|NCT00353795|500408|P1|NOT COMPLETED|Overall Study||0
212065|NCT00353795|500408|P1|COMPLETED|Overall Study||179
212066|NCT00353795|500408|P1|STARTED|Overall Study||179
212067|NCT00353704|500414|P2|NOT COMPLETED|Overall Study||1
212068|NCT00353704|500415|P1|NOT COMPLETED|Overall Study||3
212069|NCT00353704|500414|P2|COMPLETED|Overall Study||24
212070|NCT00353704|500415|P1|COMPLETED|Overall Study||22
212071|NCT00353704|500414|P2|STARTED|Overall Study||25
212072|NCT00353704|500415|P1|STARTED|Overall Study||25
212073|NCT00353652|500429|P6|NOT COMPLETED|Overall Study||5
212074|NCT00353652|500430|P5|NOT COMPLETED|Overall Study||5
212075|NCT00353652|500431|P4|NOT COMPLETED|Overall Study||0
212076|NCT00353652|500432|P3|NOT COMPLETED|Overall Study||0
212077|NCT00353652|500433|P2|NOT COMPLETED|Overall Study||0
212078|NCT00353652|500434|P1|NOT COMPLETED|Overall Study||0
212079|NCT00353652|500429|P6|COMPLETED|Overall Study||18
212080|NCT00353652|500430|P5|COMPLETED|Overall Study||18
212081|NCT00353652|500431|P4|COMPLETED|Overall Study||7
212082|NCT00353652|500432|P3|COMPLETED|Overall Study||17
212083|NCT00353652|500433|P2|COMPLETED|Overall Study||17
212084|NCT00353652|500434|P1|COMPLETED|Overall Study||17
212085|NCT00353652|500429|P6|STARTED|Overall Study||23
212086|NCT00353652|500430|P5|STARTED|Overall Study||23
212087|NCT00353652|500431|P4|STARTED|Overall Study||7
212088|NCT00353652|500432|P3|STARTED|Overall Study||17
212089|NCT00353652|500433|P2|STARTED|Overall Study||17
212090|NCT00353652|500434|P1|STARTED|Overall Study||17
212091|NCT00353496|500450|P2|NOT COMPLETED|Overall Study||17
212092|NCT00353496|500451|P1|NOT COMPLETED|Overall Study||16
212093|NCT00353496|500450|P2|COMPLETED|Overall Study||86
212094|NCT00353496|500451|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
212095|NCT00353496|500450|P2|STARTED|Overall Study||103
212096|NCT00353496|500451|P1|STARTED|Overall Study||101
212097|NCT00353431|500468|P2|NOT COMPLETED|Overall Study||0
212098|NCT00353431|500469|P1|NOT COMPLETED|Overall Study||0
212099|NCT00353431|500468|P2|COMPLETED|Overall Study||67
212100|NCT00353431|500469|P1|COMPLETED|Overall Study||63
212101|NCT00353431|500468|P2|STARTED|Overall Study||67
212102|NCT00353431|500469|P1|STARTED|Overall Study||63
212103|NCT00353418|500485|P2|NOT COMPLETED|Overall Study||158
212104|NCT00353418|500486|P1|NOT COMPLETED|Overall Study||83
212105|NCT00353418|500485|P2|COMPLETED|Overall Study||119
212106|NCT00353418|500486|P1|COMPLETED|Overall Study||55
212107|NCT00353418|500485|P2|STARTED|Overall Study||277
212108|NCT00353418|500486|P1|STARTED|Overall Study||138
212109|NCT00353366|500504|P1|NOT COMPLETED|Overall Study||143
212110|NCT00353366|500504|P1|COMPLETED|Overall Study||1289
212111|NCT00353366|500504|P1|STARTED|Overall Study||1432
212112|NCT00353301|500511|P1|NOT COMPLETED|Overall Study||0
212113|NCT00353301|500511|P1|COMPLETED|Overall Study||25
212114|NCT00353301|500511|P1|STARTED|Overall Study||25
212115|NCT00353275|500518|P2|NOT COMPLETED|Overall Study||0
212116|NCT00353275|500519|P1|NOT COMPLETED|Overall Study||0
212117|NCT00353275|500518|P2|COMPLETED|Overall Study||3
212118|NCT00353275|500519|P1|COMPLETED|Overall Study||2
212119|NCT00353275|500518|P2|STARTED|Overall Study||3
212120|NCT00353275|500519|P1|STARTED|Overall Study||2
212121|NCT00353262|500525|P1|NOT COMPLETED|Overall Study||29
212122|NCT00353262|500525|P1|COMPLETED|Overall Study||7
212123|NCT00353262|500525|P1|STARTED|Overall Study||36
212124|NCT00352118|500542|P1|NOT COMPLETED|Overall Study||4
212125|NCT00352118|500542|P1|COMPLETED|Overall Study||0
212126|NCT00352118|500542|P1|STARTED|Overall Study||4
212127|NCT00352105|500552|P1|NOT COMPLETED|Overall Study||40
212128|NCT00352105|500552|P1|COMPLETED|Overall Study||20
212129|NCT00352105|500552|P1|STARTED|Overall Study||60
212130|NCT00352053|500563|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
212131|NCT00352053|500564|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
212132|NCT00352053|500563|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
212133|NCT00352053|500564|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
212134|NCT00352053|500563|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
212135|NCT00352053|500564|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
212136|NCT00352053|500563|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
212137|NCT00352053|500564|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
212138|NCT00352053|500563|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
212139|NCT00352053|500564|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
212140|NCT00352053|500563|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
212141|NCT00352053|500564|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
212142|NCT00352053|500563|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
212143|NCT00352053|500564|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
212144|NCT00352053|500563|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
212145|NCT00352053|500564|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
212231|NCT00352365|501109|P1|STARTED|Induction Therapy||41
212146|NCT00352053|500563|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
212147|NCT00352053|500564|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
212148|NCT00352053|500563|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
212149|NCT00352053|500564|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
212150|NCT00352053|500563|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
212151|NCT00352053|500564|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
212152|NCT00352053|500563|P2|STARTED|Double-Blind Phase (Through Week 48)||42
212153|NCT00352053|500564|P1|STARTED|Double-Blind Phase (Through Week 48)||45
212154|NCT00352027|500731|P1|NOT COMPLETED|Overall Study||3
212155|NCT00352027|500731|P1|COMPLETED|Overall Study||77
212156|NCT00352027|500731|P1|STARTED|Overall Study||80
212157|NCT00353119|501002|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
212158|NCT00353119|501003|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
212159|NCT00353119|501002|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
212160|NCT00353119|501003|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
212161|NCT00353119|501002|P2|STARTED|Second Intervention Week 12 to Week 28||10
212162|NCT00353119|501003|P1|STARTED|Second Intervention Week 12 to Week 28||5
212163|NCT00353119|501002|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
212164|NCT00353119|501003|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
212165|NCT00353119|501002|P2|COMPLETED|First Intervention Day 0 to Week 12||10
212166|NCT00353119|501003|P1|COMPLETED|First Intervention Day 0 to Week 12||5
212167|NCT00353119|501002|P2|STARTED|First Intervention Day 0 to Week 12||10
212168|NCT00353119|501003|P1|STARTED|First Intervention Day 0 to Week 12||5
212169|NCT00352911|501015|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
212170|NCT00352911|501016|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
212171|NCT00352911|501015|P2|COMPLETED|300mg Twice Daily (14 Days)||3
212172|NCT00352911|501016|P1|COMPLETED|300mg Twice Daily (14 Days)||15
212173|NCT00352911|501015|P2|STARTED|300mg Twice Daily (14 Days)||3
212174|NCT00352911|501016|P1|STARTED|300mg Twice Daily (14 Days)||16
212175|NCT00352911|501015|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
212176|NCT00352911|501016|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
212177|NCT00352911|501015|P2|COMPLETED|150mg Twice Daily (14 Days)||3
212178|NCT00352911|501016|P1|COMPLETED|150mg Twice Daily (14 Days)||16
212179|NCT00352911|501015|P2|STARTED|150mg Twice Daily (14 Days)||3
212180|NCT00352911|501016|P1|STARTED|150mg Twice Daily (14 Days)||16
212181|NCT00352885|501024|P2|NOT COMPLETED|Overall Study||8
212182|NCT00352885|501025|P1|NOT COMPLETED|Overall Study||5
212183|NCT00352885|501024|P2|COMPLETED|Overall Study||3
212184|NCT00352885|501025|P1|COMPLETED|Overall Study||4
212185|NCT00352885|501024|P2|STARTED|Overall Study||11
212186|NCT00352885|501025|P1|STARTED|Overall Study||9
212187|NCT00352846|501033|P2|NOT COMPLETED|Overall Study||13
212188|NCT00352846|501034|P1|NOT COMPLETED|Overall Study||8
212189|NCT00352846|501033|P2|COMPLETED|Overall Study||24
212190|NCT00352846|501034|P1|COMPLETED|Overall Study||29
212191|NCT00352846|501033|P2|STARTED|Overall Study||37
212192|NCT00352846|501034|P1|STARTED|Overall Study||37
212193|NCT00352781|501040|P1|NOT COMPLETED|Overall Study||883
212194|NCT00352781|501040|P1|COMPLETED|Overall Study||884
212195|NCT00352781|501040|P1|STARTED|Overall Study||1767
212196|NCT00352755|501045|P1|NOT COMPLETED|Overall Study||2
212197|NCT00352755|501045|P1|COMPLETED|Overall Study||16
212198|NCT00352755|501045|P1|STARTED|Overall Study||18
212199|NCT00352690|501055|P2|NOT COMPLETED|Overall Study||0
212200|NCT00352690|501056|P1|NOT COMPLETED|Overall Study||2
212201|NCT00352690|501055|P2|COMPLETED|Overall Study||0
212202|NCT00352690|501056|P1|COMPLETED|Overall Study||8
212203|NCT00352690|501055|P2|STARTED|Overall Study||0
212204|NCT00352690|501056|P1|STARTED|Overall Study||10
212205|NCT00352664|501076|P2|NOT COMPLETED|Overall Study||0
212206|NCT00352664|501077|P1|NOT COMPLETED|Overall Study||7
212207|NCT00352664|501076|P2|COMPLETED|Overall Study||0
212208|NCT00352664|501077|P1|COMPLETED|Overall Study||20
212209|NCT00352664|501076|P2|STARTED|Overall Study||0
212210|NCT00352664|501077|P1|STARTED|Overall Study||27
212211|NCT00352612|501085|P2|NOT COMPLETED|Overall Study||0
212212|NCT00352612|501086|P1|NOT COMPLETED|Overall Study||0
212213|NCT00352612|501085|P2|COMPLETED|Overall Study||100
212214|NCT00352612|501086|P1|COMPLETED|Overall Study||100
212215|NCT00352612|501085|P2|STARTED|Overall Study||100
212216|NCT00352612|501086|P1|STARTED|Overall Study||100
212217|NCT00352417|501094|P2|NOT COMPLETED|Overall Study||5
212218|NCT00352417|501095|P1|NOT COMPLETED|Overall Study||5
212219|NCT00352417|501094|P2|COMPLETED|Overall Study||21
212220|NCT00352417|501095|P1|COMPLETED|Overall Study||19
212221|NCT00352417|501094|P2|STARTED|Overall Study||26
212222|NCT00352417|501095|P1|STARTED|Overall Study||24
212223|NCT00352365|501109|P1|NOT COMPLETED|Maintenance Therapy||12
212224|NCT00352365|501109|P1|COMPLETED|Maintenance Therapy||0
212225|NCT00352365|501109|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
212226|NCT00352365|501109|P1|STARTED|Maintenance Therapy||12
212227|NCT00352365|501109|P1|NOT COMPLETED|Induction Therapy||27
212228|NCT00352365|501109|P1|COMPLETED|Induction Therapy||14
212229|NCT00352365|501109|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
212230|NCT00352365|501109|P1|Eligible|Induction Therapy||38
212232|NCT00351936|501119|P1|NOT COMPLETED|Overall Study||0
212233|NCT00351936|501119|P1|COMPLETED|Overall Study||15
212234|NCT00351936|501119|P1|STARTED|Overall Study||15
212235|NCT00351741|501138|P2|NOT COMPLETED|Overall Study||0
212236|NCT00351741|501139|P1|NOT COMPLETED|Overall Study||0
212237|NCT00351741|501138|P2|COMPLETED|Overall Study||31
212238|NCT00351741|501139|P1|COMPLETED|Overall Study||31
212239|NCT00351741|501138|P2|STARTED|Overall Study||31
212240|NCT00351741|501139|P1|STARTED|Overall Study||31
212241|NCT00351533|501159|P2|NOT COMPLETED|Overall Study||5
212242|NCT00351533|501160|P1|NOT COMPLETED|Overall Study||2
212243|NCT00351533|501159|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
212244|NCT00351533|501160|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
212245|NCT00351533|501159|P2|STARTED|Overall Study||49
212246|NCT00351533|501160|P1|STARTED|Overall Study||41
212247|NCT00351377|501220|P1|NOT COMPLETED|Overall Study||7
212248|NCT00351377|501220|P1|COMPLETED|Overall Study||104
212249|NCT00351377|501220|P1|STARTED|Overall Study||111
212250|NCT00351351|501234|P2|NOT COMPLETED|Overall Study||4
212251|NCT00351351|501235|P1|NOT COMPLETED|Overall Study||9
212252|NCT00351351|501234|P2|COMPLETED|Overall Study||32
212253|NCT00351351|501235|P1|COMPLETED|Overall Study||25
212254|NCT00351351|501234|P2|STARTED|Overall Study||36
212255|NCT00351351|501235|P1|STARTED|Overall Study||34
212256|NCT00351273|501244|P3|NOT COMPLETED|Overall Study||5
212257|NCT00351273|501245|P2|NOT COMPLETED|Overall Study||2
212258|NCT00351273|501246|P1|NOT COMPLETED|Overall Study||1
212259|NCT00351273|501244|P3|COMPLETED|Overall Study||10
212260|NCT00351273|501245|P2|COMPLETED|Overall Study||10
212261|NCT00351273|501246|P1|COMPLETED|Overall Study||14
212262|NCT00351273|501244|P3|STARTED|Overall Study||15
212263|NCT00351273|501245|P2|STARTED|Overall Study||12
212264|NCT00351273|501246|P1|STARTED|Overall Study||15
212265|NCT00351039|501254|P1|NOT COMPLETED|Overall Study||0
212266|NCT00351039|501254|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
212267|NCT00351039|501254|P1|STARTED|Overall Study||8
212268|NCT00351000|501263|P1|NOT COMPLETED|Overall Study||3
212269|NCT00351000|501263|P1|COMPLETED|Overall Study||21
212270|NCT00351000|501263|P1|STARTED|Overall Study||24
212271|NCT00350870|501274|P4|NOT COMPLETED|Overall Study||15
212272|NCT00350870|501275|P3|NOT COMPLETED|Overall Study||16
212273|NCT00350870|501276|P2|NOT COMPLETED|Overall Study||17
212274|NCT00350870|501277|P1|NOT COMPLETED|Overall Study||22
212275|NCT00350870|501274|P4|COMPLETED|Overall Study||7
212276|NCT00350870|501275|P3|COMPLETED|Overall Study||6
212277|NCT00350870|501276|P2|COMPLETED|Overall Study||11
212278|NCT00350870|501277|P1|COMPLETED|Overall Study||5
212279|NCT00350870|501274|P4|Had at Least 1 Day of Med|Overall Study||19
212280|NCT00350870|501275|P3|Had at Least 1 Day of Med|Overall Study||18
212281|NCT00350870|501276|P2|Had at Least 1 Day of Med|Overall Study||24
212282|NCT00350870|501277|P1|Had at Least 1 Day of Med|Overall Study||19
212283|NCT00350870|501274|P4|STARTED|Overall Study||22
212284|NCT00350870|501275|P3|STARTED|Overall Study||22
212285|NCT00350870|501276|P2|STARTED|Overall Study||28
212286|NCT00350870|501277|P1|STARTED|Overall Study||27
212287|NCT00350844|501291|P1|NOT COMPLETED|Overall Study||1
212288|NCT00350844|501291|P1|COMPLETED|Overall Study||5
212289|NCT00350844|501291|P1|STARTED|Overall Study||6
212290|NCT00350792|501295|P1|NOT COMPLETED|Overall Study||33
212291|NCT00350792|501295|P1|COMPLETED|Overall Study||29
212292|NCT00350792|501295|P1|STARTED|Overall Study||62
212293|NCT00350779|501305|P2|NOT COMPLETED|Overall Study||21
212294|NCT00350779|501306|P1|NOT COMPLETED|Overall Study||22
212295|NCT00350779|501305|P2|COMPLETED|Overall Study||71
212296|NCT00350779|501306|P1|COMPLETED|Overall Study||148
212297|NCT00350779|501305|P2|STARTED|Overall Study||92
212298|NCT00350779|501306|P1|STARTED|Overall Study||170
212299|NCT00350727|501327|P3|NOT COMPLETED|Phase II||22
212300|NCT00350727|501328|P2|NOT COMPLETED|Phase II||19
212301|NCT00350727|501329|P1|NOT COMPLETED|Phase II||0
212302|NCT00350727|501327|P3|COMPLETED|Phase II||0
212303|NCT00350727|501328|P2|COMPLETED|Phase II||0
212304|NCT00350727|501329|P1|COMPLETED|Phase II||0
212305|NCT00350727|501327|P3|STARTED|Phase II||22
212306|NCT00350727|501328|P2|STARTED|Phase II||19
212307|NCT00350727|501329|P1|STARTED|Phase II||0
212308|NCT00350727|501327|P3|NOT COMPLETED|Phase I: Dose Escalation||0
212309|NCT00350727|501328|P2|NOT COMPLETED|Phase I: Dose Escalation||0
212310|NCT00350727|501329|P1|NOT COMPLETED|Phase I: Dose Escalation||34
212311|NCT00350727|501327|P3|COMPLETED|Phase I: Dose Escalation||0
212312|NCT00350727|501328|P2|COMPLETED|Phase I: Dose Escalation||0
212313|NCT00350727|501329|P1|COMPLETED|Phase I: Dose Escalation||0
212314|NCT00350727|501327|P3|STARTED|Phase I: Dose Escalation||0
212315|NCT00350727|501328|P2|STARTED|Phase I: Dose Escalation||0
212316|NCT00350727|501329|P1|STARTED|Phase I: Dose Escalation||34
212317|NCT00350636|501473|P2|NOT COMPLETED|Overall Study||45
212318|NCT00350636|501474|P1|NOT COMPLETED|Overall Study||43
212319|NCT00350636|501473|P2|COMPLETED|Overall Study||355
212320|NCT00350636|501474|P1|COMPLETED|Overall Study||346
212321|NCT00350636|501473|P2|STARTED|Overall Study||400
212322|NCT00350636|501474|P1|STARTED|Overall Study||389
212323|NCT00350623|501493|P3|NOT COMPLETED|Overall Study||6
212324|NCT00350623|501494|P2|NOT COMPLETED|Overall Study||4
212325|NCT00350623|501495|P1|NOT COMPLETED|Overall Study||8
212326|NCT00350623|501493|P3|COMPLETED|Overall Study||62
212327|NCT00350623|501494|P2|COMPLETED|Overall Study||67
212328|NCT00350623|501495|P1|COMPLETED|Overall Study||63
212329|NCT00350623|501493|P3|STARTED|Overall Study||68
212330|NCT00350623|501494|P2|STARTED|Overall Study||71
212331|NCT00350623|501495|P1|STARTED|Overall Study||71
212332|NCT00350532|501505|P2|NOT COMPLETED|Overall Study||0
212333|NCT00350532|501506|P1|NOT COMPLETED|Overall Study||0
212334|NCT00350532|501505|P2|COMPLETED|Overall Study||19
212335|NCT00350532|501506|P1|COMPLETED|Overall Study||24
212336|NCT00350532|501505|P2|STARTED|Overall Study||19
212337|NCT00350532|501506|P1|STARTED|Overall Study||24
212338|NCT00350519|501514|P2|NOT COMPLETED|Overall Study||6
212339|NCT00350519|501515|P1|NOT COMPLETED|Overall Study||4
212340|NCT00350519|501514|P2|COMPLETED|Overall Study||13
212341|NCT00350519|501515|P1|COMPLETED|Overall Study||14
212342|NCT00350519|501514|P2|STARTED|Overall Study||19
212343|NCT00350519|501515|P1|STARTED|Overall Study||18
212344|NCT00350402|501529|P2|NOT COMPLETED|Overall Study||1
212345|NCT00350402|501530|P1|NOT COMPLETED|Overall Study||1
212346|NCT00350402|501529|P2|COMPLETED|Overall Study||20
212347|NCT00350402|501530|P1|COMPLETED|Overall Study||20
212348|NCT00350402|501529|P2|STARTED|Overall Study||21
212349|NCT00350402|501530|P1|STARTED|Overall Study||21
212350|NCT00350363|501542|P1|NOT COMPLETED|Overall Study||0
212351|NCT00350363|501542|P1|COMPLETED|Overall Study||60
212352|NCT00350363|501542|P1|STARTED|Overall Study||60
212353|NCT00350272|501548|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
212354|NCT00350272|501549|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
212355|NCT00350272|501548|P2|COMPLETED|Open-Label 84 Week Treatment||27
212356|NCT00350272|501549|P1|COMPLETED|Open-Label 84 Week Treatment||21
212357|NCT00350272|501548|P2|STARTED|Open-Label 84 Week Treatment||35
212358|NCT00350272|501549|P1|STARTED|Open-Label 84 Week Treatment||30
212359|NCT00350272|501548|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
212360|NCT00350272|501549|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
212361|NCT00350272|501548|P2|COMPLETED|Blinded 12 Week Treatment||35
212362|NCT00350272|501549|P1|COMPLETED|Blinded 12 Week Treatment||30
212363|NCT00350272|501548|P2|STARTED|Blinded 12 Week Treatment||37
212364|NCT00350272|501549|P1|STARTED|Blinded 12 Week Treatment||39
212365|NCT00348374|501559|P2|NOT COMPLETED|Overall Study||32
212366|NCT00348374|501560|P1|NOT COMPLETED|Overall Study||19
212367|NCT00348374|501559|P2|COMPLETED|Overall Study||71
212368|NCT00348374|501560|P1|COMPLETED|Overall Study||69
212369|NCT00348374|501559|P2|Received Study Treatment|Overall Study||96
212370|NCT00348374|501560|P1|Received Study Treatment|Overall Study||88
212371|NCT00348374|501559|P2|STARTED|Overall Study||103
212372|NCT00348374|501560|P1|STARTED|Overall Study||88
212373|NCT00348348|501607|P2|NOT COMPLETED|Overall Study||27
212374|NCT00348348|501608|P1|NOT COMPLETED|Overall Study||25
212375|NCT00348348|501607|P2|COMPLETED|Overall Study||555
212376|NCT00348348|501608|P1|COMPLETED|Overall Study||554
212377|NCT00348348|501607|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
212378|NCT00348348|501608|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
212379|NCT00348283|501622|P2|NOT COMPLETED|Open Label||34
212380|NCT00348283|501623|P1|NOT COMPLETED|Open Label||0
212381|NCT00348283|501622|P2|COMPLETED|Open Label||66
212382|NCT00348283|501623|P1|COMPLETED|Open Label||0
212383|NCT00348283|501622|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
212384|NCT00348283|501623|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
212385|NCT00348283|501622|P2|NOT COMPLETED|Double Blind||10
212386|NCT00348283|501623|P1|NOT COMPLETED|Double Blind||5
212387|NCT00348283|501622|P2|COMPLETED|Double Blind||54
212388|NCT00348283|501623|P1|COMPLETED|Double Blind||60
212389|NCT00348283|501622|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
212390|NCT00348283|501623|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
212391|NCT00348283|501622|P2|NOT COMPLETED|Induction||6
212392|NCT00348283|501623|P1|NOT COMPLETED|Induction||0
212393|NCT00348283|501622|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
212394|NCT00348283|501623|P1|COMPLETED|Induction||0
212395|NCT00348283|501622|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
212396|NCT00348283|501623|P1|STARTED|Induction||0
212397|NCT00350220|501641|P2|NOT COMPLETED|Overall Study||0
212398|NCT00350220|501642|P1|NOT COMPLETED|Overall Study||0
212399|NCT00350220|501641|P2|COMPLETED|Overall Study||30
212400|NCT00350220|501642|P1|COMPLETED|Overall Study||30
212401|NCT00350220|501641|P2|STARTED|Overall Study||30
212402|NCT00350220|501642|P1|STARTED|Overall Study||30
212403|NCT00350207|501653|P3|NOT COMPLETED|Overall Study||7
212404|NCT00350207|501654|P2|NOT COMPLETED|Overall Study||6
212405|NCT00350207|501655|P1|NOT COMPLETED|Overall Study||8
212406|NCT00350207|501653|P3|COMPLETED|Overall Study||119
212407|NCT00350207|501654|P2|COMPLETED|Overall Study||128
212408|NCT00350207|501655|P1|COMPLETED|Overall Study||120
212409|NCT00350207|501653|P3|STARTED|Overall Study||126
212410|NCT00350207|501654|P2|STARTED|Overall Study||134
212411|NCT00350207|501655|P1|STARTED|Overall Study||128
212412|NCT00350142|501849|P1|NOT COMPLETED|Overall Study||0
212413|NCT00350142|501849|P1|COMPLETED|Overall Study||20
212414|NCT00350142|501849|P1|STARTED|Overall Study||20
212415|NCT00349921|501858|P4|NOT COMPLETED|Second Spinal Injection||0
212416|NCT00349921|501859|P3|NOT COMPLETED|Second Spinal Injection||0
212417|NCT00349921|501860|P2|NOT COMPLETED|Second Spinal Injection||0
212418|NCT00349921|501861|P1|NOT COMPLETED|Second Spinal Injection||0
212419|NCT00349921|501858|P4|COMPLETED|Second Spinal Injection||1
212420|NCT00349921|501859|P3|COMPLETED|Second Spinal Injection||0
212421|NCT00349921|501860|P2|COMPLETED|Second Spinal Injection||10
212422|NCT00349921|501861|P1|COMPLETED|Second Spinal Injection||9
212423|NCT00349921|501858|P4|STARTED|Second Spinal Injection||1
212424|NCT00349921|501859|P3|STARTED|Second Spinal Injection||0
212425|NCT00349921|501860|P2|STARTED|Second Spinal Injection||10
212426|NCT00349921|501861|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
212427|NCT00349921|501858|P4|NOT COMPLETED|First Spinal Injection||0
212428|NCT00349921|501859|P3|NOT COMPLETED|First Spinal Injection||1
212429|NCT00349921|501860|P2|NOT COMPLETED|First Spinal Injection||0
212430|NCT00349921|501861|P1|NOT COMPLETED|First Spinal Injection||1
212431|NCT00349921|501858|P4|COMPLETED|First Spinal Injection||1
212432|NCT00349921|501859|P3|COMPLETED|First Spinal Injection||0
212433|NCT00349921|501860|P2|COMPLETED|First Spinal Injection||10
212434|NCT00349921|501861|P1|COMPLETED|First Spinal Injection||9
212435|NCT00349921|501858|P4|STARTED|First Spinal Injection||1
212436|NCT00349921|501859|P3|STARTED|First Spinal Injection||1
212437|NCT00349921|501860|P2|STARTED|First Spinal Injection||10
212438|NCT00349921|501861|P1|STARTED|First Spinal Injection||10
212439|NCT00349908|501872|P2|NOT COMPLETED|Overall Study||4
212440|NCT00349908|501873|P1|NOT COMPLETED|Overall Study||0
212441|NCT00349908|501872|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
212442|NCT00349908|501873|P1|COMPLETED|Overall Study||10
212443|NCT00349908|501872|P2|STARTED|Overall Study||10
212444|NCT00349908|501873|P1|STARTED|Overall Study||10
212445|NCT00349752|501893|P2|NOT COMPLETED|Overall Study||64
212446|NCT00349752|501894|P1|NOT COMPLETED|Overall Study||59
212447|NCT00349752|501893|P2|COMPLETED|Overall Study||23
212448|NCT00349752|501894|P1|COMPLETED|Overall Study||28
212449|NCT00349752|501893|P2|STARTED|Overall Study||87
212450|NCT00349752|501894|P1|STARTED|Overall Study||87
212451|NCT00349622|501922|P2|NOT COMPLETED|Overall Study||96
212452|NCT00349622|501923|P1|NOT COMPLETED|Overall Study||178
212453|NCT00349622|501922|P2|COMPLETED|Overall Study||77
212454|NCT00349622|501923|P1|COMPLETED|Overall Study||162
212455|NCT00349622|501922|P2|STARTED|Overall Study||173
212456|NCT00349622|501923|P1|STARTED|Overall Study||340
212457|NCT00349466|501941|P2|NOT COMPLETED|Overall Study||3
212458|NCT00349466|501942|P1|NOT COMPLETED|Overall Study||9
212459|NCT00349466|501941|P2|COMPLETED|Overall Study||35
212460|NCT00349466|501942|P1|COMPLETED|Overall Study||33
212461|NCT00349466|501941|P2|STARTED|Overall Study||38
212462|NCT00349466|501942|P1|STARTED|Overall Study||42
212463|NCT00349388|501950|P2|NOT COMPLETED|Overall Study||0
212464|NCT00349388|501951|P1|NOT COMPLETED|Overall Study||0
212465|NCT00349388|501950|P2|COMPLETED|Overall Study||1
212466|NCT00349388|501951|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
212467|NCT00349388|501950|P2|STARTED|Overall Study||1
212468|NCT00349388|501951|P1|STARTED|Overall Study|no patients enrolled|0
212469|NCT00349349|501960|P3|NOT COMPLETED|Overall Study||6
212470|NCT00349349|501961|P2|NOT COMPLETED|Overall Study||62
212471|NCT00349349|501962|P1|NOT COMPLETED|Overall Study||53
212472|NCT00349349|501960|P3|COMPLETED|Overall Study||10
212473|NCT00349349|501961|P2|COMPLETED|Overall Study||50
212474|NCT00349349|501962|P1|COMPLETED|Overall Study||42
212475|NCT00349349|501960|P3|STARTED|Overall Study||16
212476|NCT00349349|501961|P2|STARTED|Overall Study||112
212477|NCT00349349|501962|P1|STARTED|Overall Study||95
212478|NCT00349336|502028|P2|NOT COMPLETED|Overall Study||14
212479|NCT00349336|502029|P1|NOT COMPLETED|Overall Study||13
212480|NCT00349336|502028|P2|COMPLETED|Overall Study||18
212481|NCT00349336|502029|P1|COMPLETED|Overall Study||19
212482|NCT00349336|502028|P2|STARTED|Overall Study||32
212483|NCT00349336|502029|P1|STARTED|Overall Study||32
212484|NCT00348933|502051|P1|NOT COMPLETED|Overall Study||25
212485|NCT00348933|502051|P1|COMPLETED|Overall Study||65
212486|NCT00348933|502051|P1|STARTED|Overall Study||90
212487|NCT00348881|502059|P2|NOT COMPLETED|Overall Study||12
212488|NCT00348881|502060|P1|NOT COMPLETED|Overall Study||17
212489|NCT00348881|502059|P2|COMPLETED|Overall Study||697
212490|NCT00348881|502060|P1|COMPLETED|Overall Study||1407
212491|NCT00348881|502059|P2|STARTED|Overall Study||709
212492|NCT00348881|502060|P1|STARTED|Overall Study||1424
212493|NCT00348790|502072|P1|NOT COMPLETED|Completed Treatment||25
212494|NCT00348790|502072|P1|COMPLETED|Completed Treatment||0
212495|NCT00348790|502072|P1|STARTED|Completed Treatment||25
212496|NCT00348790|502072|P1|NOT COMPLETED|Began Treatment||0
212497|NCT00348790|502072|P1|COMPLETED|Began Treatment||25
212498|NCT00348790|502072|P1|STARTED|Began Treatment||25
212499|NCT00348686|502077|P1|NOT COMPLETED|Overall Study||66
212500|NCT00348686|502077|P1|COMPLETED|Overall Study||249
212501|NCT00348686|502077|P1|STARTED|Overall Study||315
212502|NCT00348673|502094|P9|NOT COMPLETED|Stage 2||0
212503|NCT00348673|502095|P8|NOT COMPLETED|Stage 2||0
212504|NCT00348673|502096|P7|NOT COMPLETED|Stage 2||0
212505|NCT00348673|502097|P6|NOT COMPLETED|Stage 2||0
212506|NCT00348673|502098|P5|NOT COMPLETED|Stage 2||0
212507|NCT00348673|502099|P4|NOT COMPLETED|Stage 2||0
212508|NCT00348673|502100|P3|NOT COMPLETED|Stage 2||0
212509|NCT00348673|502101|P2|NOT COMPLETED|Stage 2||0
212510|NCT00348673|502102|P1|NOT COMPLETED|Stage 2||0
212511|NCT00348673|502094|P9|COMPLETED|Stage 2||2
212512|NCT00348673|502095|P8|COMPLETED|Stage 2||6
212513|NCT00348673|502096|P7|COMPLETED|Stage 2||6
212514|NCT00348673|502097|P6|COMPLETED|Stage 2||6
212515|NCT00348673|502098|P5|COMPLETED|Stage 2||0
212516|NCT00348673|502099|P4|COMPLETED|Stage 2||0
212517|NCT00348673|502100|P3|COMPLETED|Stage 2||0
212518|NCT00348673|502101|P2|COMPLETED|Stage 2||0
212519|NCT00348673|502102|P1|COMPLETED|Stage 2||0
212520|NCT00348673|502094|P9|STARTED|Stage 2||2
212521|NCT00348673|502095|P8|STARTED|Stage 2||6
212522|NCT00348673|502096|P7|STARTED|Stage 2||6
212523|NCT00348673|502097|P6|STARTED|Stage 2||6
212524|NCT00348673|502098|P5|STARTED|Stage 2||0
212525|NCT00348673|502099|P4|STARTED|Stage 2||0
212526|NCT00348673|502100|P3|STARTED|Stage 2||0
212527|NCT00348673|502101|P2|STARTED|Stage 2||0
212528|NCT00348673|502102|P1|STARTED|Stage 2||0
212529|NCT00348673|502094|P9|NOT COMPLETED|Stage 1||0
212530|NCT00348673|502095|P8|NOT COMPLETED|Stage 1||0
212531|NCT00348673|502096|P7|NOT COMPLETED|Stage 1||0
212532|NCT00348673|502097|P6|NOT COMPLETED|Stage 1||0
212533|NCT00348673|502098|P5|NOT COMPLETED|Stage 1||0
212534|NCT00348673|502099|P4|NOT COMPLETED|Stage 1||0
212535|NCT00348673|502100|P3|NOT COMPLETED|Stage 1||1
212536|NCT00348673|502101|P2|NOT COMPLETED|Stage 1||0
212537|NCT00348673|502102|P1|NOT COMPLETED|Stage 1||0
212538|NCT00348673|502094|P9|COMPLETED|Stage 1||0
212539|NCT00348673|502095|P8|COMPLETED|Stage 1||0
212540|NCT00348673|502096|P7|COMPLETED|Stage 1||0
212541|NCT00348673|502097|P6|COMPLETED|Stage 1||0
212542|NCT00348673|502098|P5|COMPLETED|Stage 1||4
212543|NCT00348673|502099|P4|COMPLETED|Stage 1||6
212544|NCT00348673|502100|P3|COMPLETED|Stage 1||6
212545|NCT00348673|502101|P2|COMPLETED|Stage 1||6
212546|NCT00348673|502102|P1|COMPLETED|Stage 1||6
212547|NCT00348673|502094|P9|Treated|Stage 1||0
212548|NCT00348673|502095|P8|Treated|Stage 1||0
212549|NCT00348673|502096|P7|Treated|Stage 1||0
212550|NCT00348673|502097|P6|Treated|Stage 1||0
212551|NCT00348673|502098|P5|Treated|Stage 1||4
212552|NCT00348673|502099|P4|Treated|Stage 1||6
212553|NCT00348673|502100|P3|Treated|Stage 1||6
212554|NCT00348673|502101|P2|Treated|Stage 1||6
212555|NCT00348673|502102|P1|Treated|Stage 1||6
212556|NCT00348673|502094|P9|STARTED|Stage 1||0
212557|NCT00348673|502095|P8|STARTED|Stage 1||0
212558|NCT00348673|502096|P7|STARTED|Stage 1||0
212559|NCT00348673|502097|P6|STARTED|Stage 1||0
212560|NCT00348673|502098|P5|STARTED|Stage 1||4
212561|NCT00348673|502099|P4|STARTED|Stage 1||6
212562|NCT00348673|502100|P3|STARTED|Stage 1||7
212563|NCT00348673|502101|P2|STARTED|Stage 1||6
212564|NCT00348673|502102|P1|STARTED|Stage 1||6
212565|NCT00348556|502149|P1|NOT COMPLETED|Overall Study||1
212566|NCT00348556|502149|P1|COMPLETED|Overall Study||3
212567|NCT00348556|502149|P1|STARTED|Overall Study||4
212568|NCT00347958|502154|P1|NOT COMPLETED|Overall Study||4
212569|NCT00347958|502154|P1|COMPLETED|Overall Study||540
212570|NCT00347958|502154|P1|STARTED|Overall Study||544
212571|NCT00347932|502163|P2|NOT COMPLETED|Overall Study||52
212572|NCT00347932|502164|P1|NOT COMPLETED|Overall Study||31
212573|NCT00347932|502163|P2|COMPLETED|Overall Study||430
212574|NCT00347932|502164|P1|COMPLETED|Overall Study||444
212575|NCT00347932|502163|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
212576|NCT00347932|502164|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
212577|NCT00347919|502179|P3|NOT COMPLETED|Overall Study||38
212578|NCT00347919|502180|P2|NOT COMPLETED|Overall Study||76
212579|NCT00347919|502181|P1|NOT COMPLETED|Overall Study||71
212580|NCT00347919|502179|P3|COMPLETED|Overall Study||2
212581|NCT00347919|502180|P2|COMPLETED|Overall Study||0
212582|NCT00347919|502181|P1|COMPLETED|Overall Study||2
212583|NCT00347919|502179|P3|STARTED|Overall Study|Safety Population|40
212584|NCT00347919|502180|P2|STARTED|Overall Study|Safety Population|76
212585|NCT00347919|502181|P1|STARTED|Overall Study|Safety Population|73
212586|NCT00347438|502201|P1|NOT COMPLETED|Overall Study||2
212587|NCT00347438|502201|P1|COMPLETED|Overall Study||16
212588|NCT00347438|502201|P1|STARTED|Overall Study||18
212589|NCT00347360|502223|P15|NOT COMPLETED|Overall Study||4
212590|NCT00347360|502224|P14|NOT COMPLETED|Overall Study||8
212591|NCT00347360|502225|P13|NOT COMPLETED|Overall Study||10
212592|NCT00347360|502226|P12|NOT COMPLETED|Overall Study||6
212593|NCT00347360|502227|P11|NOT COMPLETED|Overall Study||5
212594|NCT00347360|502228|P10|NOT COMPLETED|Overall Study||9
212595|NCT00347360|502229|P9|NOT COMPLETED|Overall Study||6
212596|NCT00347360|502230|P8|NOT COMPLETED|Overall Study||3
212597|NCT00347360|502231|P7|NOT COMPLETED|Overall Study||7
212598|NCT00347360|502232|P6|NOT COMPLETED|Overall Study||8
212599|NCT00347360|502233|P5|NOT COMPLETED|Overall Study||5
212600|NCT00347360|502234|P4|NOT COMPLETED|Overall Study||13
212601|NCT00347360|502235|P3|NOT COMPLETED|Overall Study||6
212602|NCT00347360|502236|P2|NOT COMPLETED|Overall Study||8
212603|NCT00347360|502237|P1|NOT COMPLETED|Overall Study||5
212604|NCT00347360|502223|P15|COMPLETED|Overall Study||39
212605|NCT00347360|502224|P14|COMPLETED|Overall Study||36
212606|NCT00347360|502225|P13|COMPLETED|Overall Study||34
212607|NCT00347360|502226|P12|COMPLETED|Overall Study||37
212608|NCT00347360|502227|P11|COMPLETED|Overall Study||39
212609|NCT00347360|502228|P10|COMPLETED|Overall Study||35
212610|NCT00347360|502229|P9|COMPLETED|Overall Study||38
212611|NCT00347360|502230|P8|COMPLETED|Overall Study||40
212612|NCT00347360|502231|P7|COMPLETED|Overall Study||37
212613|NCT00347360|502232|P6|COMPLETED|Overall Study||36
212614|NCT00347360|502233|P5|COMPLETED|Overall Study||39
212615|NCT00347360|502234|P4|COMPLETED|Overall Study||30
212616|NCT00347360|502235|P3|COMPLETED|Overall Study||37
212617|NCT00347360|502236|P2|COMPLETED|Overall Study||35
212618|NCT00347360|502237|P1|COMPLETED|Overall Study||39
212619|NCT00347360|502223|P15|STARTED|Overall Study||43
212620|NCT00347360|502224|P14|STARTED|Overall Study||44
212621|NCT00347360|502225|P13|STARTED|Overall Study||44
212622|NCT00347360|502226|P12|STARTED|Overall Study||43
212623|NCT00347360|502227|P11|STARTED|Overall Study||44
212624|NCT00347360|502228|P10|STARTED|Overall Study||44
212625|NCT00347360|502229|P9|STARTED|Overall Study||44
212626|NCT00347360|502230|P8|STARTED|Overall Study||43
212627|NCT00347360|502231|P7|STARTED|Overall Study||44
212628|NCT00347360|502232|P6|STARTED|Overall Study||44
212629|NCT00347360|502233|P5|STARTED|Overall Study||44
212630|NCT00347360|502234|P4|STARTED|Overall Study||43
212631|NCT00347360|502235|P3|STARTED|Overall Study||43
212632|NCT00347360|502236|P2|STARTED|Overall Study||43
212633|NCT00347360|502237|P1|STARTED|Overall Study||44
212634|NCT00347308|502419|P1|NOT COMPLETED|Overall Study||0
212635|NCT00347308|502419|P1|COMPLETED|Overall Study||40
212636|NCT00347308|502419|P1|STARTED|Overall Study||40
212637|NCT00347022|502425|P2|NOT COMPLETED|Overall Study||5
212638|NCT00347022|502426|P1|NOT COMPLETED|Overall Study||12
212639|NCT00347022|502425|P2|COMPLETED|Overall Study||66
212640|NCT00347022|502426|P1|COMPLETED|Overall Study||62
212641|NCT00347022|502425|P2|STARTED|Overall Study||71
212642|NCT00347022|502426|P1|STARTED|Overall Study||74
212643|NCT00347009|502432|P1|NOT COMPLETED|Overall Study||27
212644|NCT00347009|502432|P1|COMPLETED|Overall Study||128
212645|NCT00347009|502432|P1|STARTED|Overall Study||155
212646|NCT00345683|502451|P2|NOT COMPLETED|Overall Study||9
212647|NCT00345683|502452|P1|NOT COMPLETED|Overall Study||25
212648|NCT00345683|502451|P2|COMPLETED|Overall Study||1001
212649|NCT00345683|502452|P1|COMPLETED|Overall Study||2985
212650|NCT00345683|502451|P2|STARTED|Overall Study||1010
212651|NCT00345683|502452|P1|STARTED|Overall Study||3010
212652|NCT00345631|502475|P3|NOT COMPLETED|Overall Study||6
212653|NCT00345631|502476|P2|NOT COMPLETED|Overall Study||8
212654|NCT00345631|502477|P1|NOT COMPLETED|Overall Study||4
212655|NCT00345631|502475|P3|COMPLETED|Overall Study||128
212656|NCT00345631|502476|P2|COMPLETED|Overall Study||259
212657|NCT00345631|502477|P1|COMPLETED|Overall Study||83
212658|NCT00345631|502475|P3|STARTED|Overall Study||134
212659|NCT00345631|502476|P2|STARTED|Overall Study||267
212660|NCT00345631|502477|P1|STARTED|Overall Study||87
212661|NCT00345605|502509|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
212662|NCT00345605|502510|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
212663|NCT00345605|502509|P2|COMPLETED|Arm 2, Opposite Treatment||6
212664|NCT00345605|502510|P1|COMPLETED|Arm 2, Opposite Treatment||5
212665|NCT00345605|502509|P2|STARTED|Arm 2, Opposite Treatment||6
212666|NCT00345605|502510|P1|STARTED|Arm 2, Opposite Treatment||6
212667|NCT00345605|502509|P2|NOT COMPLETED|Crossover Wash-out||0
212668|NCT00345605|502510|P1|NOT COMPLETED|Crossover Wash-out||0
212669|NCT00345605|502509|P2|COMPLETED|Crossover Wash-out||6
212670|NCT00345605|502510|P1|COMPLETED|Crossover Wash-out||6
212671|NCT00345605|502509|P2|STARTED|Crossover Wash-out||6
212672|NCT00345605|502510|P1|STARTED|Crossover Wash-out||6
212673|NCT00345605|502509|P2|NOT COMPLETED|Interval||0
212674|NCT00345605|502510|P1|NOT COMPLETED|Interval||0
212675|NCT00345605|502509|P2|COMPLETED|Interval||6
212676|NCT00345605|502510|P1|COMPLETED|Interval||6
212677|NCT00345605|502509|P2|STARTED|Interval||6
212678|NCT00345605|502510|P1|STARTED|Interval||6
212679|NCT00345605|502509|P2|NOT COMPLETED|Arm 1||1
212680|NCT00345605|502510|P1|NOT COMPLETED|Arm 1||0
212681|NCT00345605|502509|P2|COMPLETED|Arm 1||5
212682|NCT00345605|502510|P1|COMPLETED|Arm 1||6
212683|NCT00345605|502509|P2|STARTED|Arm 1||6
212684|NCT00345605|502510|P1|STARTED|Arm 1||6
212685|NCT00345605|502509|P2|NOT COMPLETED|Initial Washout||0
212686|NCT00345605|502510|P1|NOT COMPLETED|Initial Washout||0
212687|NCT00345605|502509|P2|COMPLETED|Initial Washout||6
212688|NCT00345605|502510|P1|COMPLETED|Initial Washout||6
212689|NCT00345605|502509|P2|STARTED|Initial Washout||6
212690|NCT00345605|502510|P1|STARTED|Initial Washout||6
212691|NCT00345592|502530|P2|NOT COMPLETED|Overall Study||24
212692|NCT00345592|502531|P1|NOT COMPLETED|Overall Study||25
212693|NCT00345592|502530|P2|COMPLETED|Overall Study||173
212694|NCT00345592|502531|P1|COMPLETED|Overall Study||174
212695|NCT00345592|502530|P2|STARTED|Overall Study||197
212696|NCT00345592|502531|P1|STARTED|Overall Study||199
212697|NCT00346697|502539|P2|NOT COMPLETED|Overall Study||1
212698|NCT00346697|502540|P1|NOT COMPLETED|Overall Study||0
212699|NCT00346697|502539|P2|COMPLETED|Overall Study||23
212700|NCT00346697|502540|P1|COMPLETED|Overall Study||24
212701|NCT00346697|502539|P2|STARTED|Overall Study||24
212702|NCT00346697|502540|P1|STARTED|Overall Study||24
212703|NCT00346632|502576|P10|NOT COMPLETED|Overall Study||3
212704|NCT00346632|502577|P9|NOT COMPLETED|Overall Study||4
212705|NCT00346632|502578|P8|NOT COMPLETED|Overall Study||4
212706|NCT00346632|502579|P7|NOT COMPLETED|Overall Study||5
212707|NCT00346632|502580|P6|NOT COMPLETED|Overall Study||2
212708|NCT00346632|502581|P5|NOT COMPLETED|Overall Study||4
212709|NCT00346632|502582|P4|NOT COMPLETED|Overall Study||3
212710|NCT00346632|502583|P3|NOT COMPLETED|Overall Study||6
212711|NCT00346632|502584|P2|NOT COMPLETED|Overall Study||3
212712|NCT00346632|502585|P1|NOT COMPLETED|Overall Study||3
212713|NCT00346632|502576|P10|COMPLETED|Overall Study||0
212714|NCT00346632|502577|P9|COMPLETED|Overall Study||0
212715|NCT00346632|502578|P8|COMPLETED|Overall Study||0
212716|NCT00346632|502579|P7|COMPLETED|Overall Study||0
212717|NCT00346632|502580|P6|COMPLETED|Overall Study||0
212718|NCT00346632|502581|P5|COMPLETED|Overall Study||0
212719|NCT00346632|502582|P4|COMPLETED|Overall Study||0
212720|NCT00346632|502583|P3|COMPLETED|Overall Study||0
212721|NCT00346632|502584|P2|COMPLETED|Overall Study||0
212722|NCT00346632|502585|P1|COMPLETED|Overall Study||0
212723|NCT00346632|502576|P10|STARTED|Overall Study||3
212724|NCT00346632|502577|P9|STARTED|Overall Study||4
212725|NCT00346632|502578|P8|STARTED|Overall Study||4
212726|NCT00346632|502579|P7|STARTED|Overall Study||5
212727|NCT00346632|502580|P6|STARTED|Overall Study||2
212728|NCT00346632|502581|P5|STARTED|Overall Study||4
212729|NCT00346632|502582|P4|STARTED|Overall Study||3
212730|NCT00346632|502583|P3|STARTED|Overall Study||6
212731|NCT00346632|502584|P2|STARTED|Overall Study||3
212732|NCT00346632|502585|P1|STARTED|Overall Study||3
212733|NCT00346476|502728|P1|NOT COMPLETED|Overall Study||0
212734|NCT00346476|502728|P1|COMPLETED|Overall Study||1250
212735|NCT00346476|502728|P1|STARTED|Overall Study||1250
212736|NCT00346398|502735|P2|NOT COMPLETED|Overall Study||2
212737|NCT00346398|502736|P1|NOT COMPLETED|Overall Study||3
212738|NCT00346398|502735|P2|COMPLETED|Overall Study||24
212739|NCT00346398|502736|P1|COMPLETED|Overall Study||22
212740|NCT00346398|502735|P2|STARTED|Overall Study||26
212741|NCT00346398|502736|P1|STARTED|Overall Study||25
212742|NCT00346333|502748|P2|NOT COMPLETED|Overall Study||8
212743|NCT00346333|502749|P1|NOT COMPLETED|Overall Study||5
212744|NCT00346333|502748|P2|COMPLETED|Overall Study||111
212745|NCT00346333|502749|P1|COMPLETED|Overall Study||116
212746|NCT00346333|502748|P2|STARTED|Overall Study||119
212747|NCT00346333|502749|P1|STARTED|Overall Study||121
212748|NCT00346268|502765|P2|NOT COMPLETED|Overall Study||3
212749|NCT00346268|502766|P1|NOT COMPLETED|Overall Study||2
212750|NCT00346268|502765|P2|COMPLETED|Overall Study||50
212751|NCT00346268|502766|P1|COMPLETED|Overall Study||50
212752|NCT00346268|502765|P2|STARTED|Overall Study||53
212753|NCT00346268|502766|P1|STARTED|Overall Study||52
212754|NCT00346151|502798|P1|NOT COMPLETED|Overall Study||3
212755|NCT00346151|502798|P1|COMPLETED|Overall Study||2
212756|NCT00346151|502798|P1|STARTED|Overall Study||5
212757|NCT00346034|502816|P1|NOT COMPLETED|Overall Study||57
212758|NCT00346034|502816|P1|COMPLETED|Overall Study||300
212759|NCT00346034|502816|P1|STARTED|Overall Study||357
212760|NCT00345878|502823|P2|NOT COMPLETED|Overall Study||1
212761|NCT00345878|502824|P1|NOT COMPLETED|Overall Study||4
212762|NCT00345878|502823|P2|COMPLETED|Overall Study||135
212763|NCT00345878|502824|P1|COMPLETED|Overall Study||131
212764|NCT00345878|502823|P2|STARTED|Overall Study||136
212765|NCT00345878|502824|P1|STARTED|Overall Study||135
212766|NCT00345839|502842|P2|NOT COMPLETED|Overall Study||159
212767|NCT00345839|502843|P1|NOT COMPLETED|Overall Study||149
212768|NCT00345839|502842|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
212769|NCT00345839|502843|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
212770|NCT00345839|502842|P2|STARTED|Overall Study|Randomized to placebo|1935
212771|NCT00345839|502843|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
212772|NCT00345579|502869|P2|NOT COMPLETED|Overall Study||65
212773|NCT00345579|502870|P1|NOT COMPLETED|Overall Study||164
212774|NCT00345579|502869|P2|COMPLETED|Overall Study||1048
212775|NCT00345579|502870|P1|COMPLETED|Overall Study||3114
212776|NCT00345579|502869|P2|STARTED|Overall Study||1113
212777|NCT00345579|502870|P1|STARTED|Overall Study||3278
212778|NCT00345540|502890|P1|NOT COMPLETED|Overall Study||1
212779|NCT00345540|502890|P1|COMPLETED|Overall Study||15
212780|NCT00345540|502890|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
212781|NCT00345397|502896|P1|NOT COMPLETED|Overall Study||1
212782|NCT00345397|502896|P1|COMPLETED|Overall Study||6
212783|NCT00345397|502896|P1|STARTED|Overall Study||7
212784|NCT00345384|502903|P2|NOT COMPLETED|Overall Study||0
212785|NCT00345384|502904|P1|NOT COMPLETED|Overall Study||0
212786|NCT00345384|502903|P2|COMPLETED|Overall Study||19
212787|NCT00345384|502904|P1|COMPLETED|Overall Study||19
212788|NCT00345384|502903|P2|STARTED|Overall Study||19
212789|NCT00345384|502904|P1|STARTED|Overall Study||19
212790|NCT00345293|502912|P2|NOT COMPLETED|Overall Study||0
212791|NCT00345293|502913|P1|NOT COMPLETED|Overall Study||2
212792|NCT00345293|502912|P2|COMPLETED|Overall Study||3
212793|NCT00345293|502913|P1|COMPLETED|Overall Study||8
212794|NCT00345293|502912|P2|STARTED|Overall Study||3
212795|NCT00345293|502913|P1|STARTED|Overall Study||10
212796|NCT00345254|502922|P2|NOT COMPLETED|Overall Study||0
212797|NCT00345254|502923|P1|NOT COMPLETED|Overall Study||0
212798|NCT00345254|502922|P2|COMPLETED|Overall Study||30
212799|NCT00345254|502923|P1|COMPLETED|Overall Study||30
212800|NCT00345254|502922|P2|STARTED|Overall Study||30
212801|NCT00345254|502923|P1|STARTED|Overall Study||30
212802|NCT00345176|502933|P4|NOT COMPLETED|Overall Study||10
212803|NCT00345176|502934|P3|NOT COMPLETED|Overall Study||6
212804|NCT00345176|502935|P2|NOT COMPLETED|Overall Study||6
212805|NCT00345176|502936|P1|NOT COMPLETED|Overall Study||5
212806|NCT00345176|502933|P4|COMPLETED|Overall Study||1069
212807|NCT00345176|502934|P3|COMPLETED|Overall Study||1062
212808|NCT00345176|502935|P2|COMPLETED|Overall Study||1038
212809|NCT00345176|502936|P1|COMPLETED|Overall Study||1007
212810|NCT00345176|502933|P4|STARTED|Overall Study||1079
212811|NCT00345176|502934|P3|STARTED|Overall Study||1068
212812|NCT00345176|502935|P2|STARTED|Overall Study||1044
212813|NCT00345176|502936|P1|STARTED|Overall Study||1012
212814|NCT00345046|502959|P3|NOT COMPLETED|Overall Study||2
212815|NCT00345046|502960|P2|NOT COMPLETED|Overall Study||1
212816|NCT00345046|502961|P1|NOT COMPLETED|Overall Study||1
212817|NCT00345046|502959|P3|COMPLETED|Overall Study||14
212818|NCT00345046|502960|P2|COMPLETED|Overall Study||21
212819|NCT00345046|502961|P1|COMPLETED|Overall Study||17
212820|NCT00345046|502959|P3|STARTED|Overall Study||16
212821|NCT00345046|502960|P2|STARTED|Overall Study||22
212822|NCT00345046|502961|P1|STARTED|Overall Study||18
212823|NCT00345033|502971|P2|NOT COMPLETED|Overall Study||4
212824|NCT00345033|502972|P1|NOT COMPLETED|Overall Study||4
212825|NCT00345033|502971|P2|COMPLETED|Overall Study||14
212826|NCT00345033|502972|P1|COMPLETED|Overall Study||16
212827|NCT00345033|502971|P2|STARTED|Overall Study||18
212828|NCT00345033|502972|P1|STARTED|Overall Study||20
212829|NCT00344968|502991|P3|NOT COMPLETED|Overall Study||116
212830|NCT00344968|502992|P2|NOT COMPLETED|Overall Study||102
212831|NCT00344968|502993|P1|NOT COMPLETED|Overall Study||59
212832|NCT00344968|502991|P3|COMPLETED|Overall Study||279
212833|NCT00344968|502992|P2|COMPLETED|Overall Study||274
212834|NCT00344968|502993|P1|COMPLETED|Overall Study||126
212835|NCT00344968|502991|P3|STARTED|Overall Study||395
212836|NCT00344968|502992|P2|STARTED|Overall Study||376
212837|NCT00344968|502993|P1|STARTED|Overall Study||185
212838|NCT00344773|503004|P1|NOT COMPLETED|Overall Study||21
212839|NCT00344773|503004|P1|COMPLETED|Overall Study||25
212840|NCT00344773|503004|P1|STARTED|Overall Study||46
212841|NCT00344682|503012|P2|NOT COMPLETED|Overall Study||1
212842|NCT00344682|503013|P1|NOT COMPLETED|Overall Study||4
212843|NCT00344682|503012|P2|COMPLETED|Overall Study||14
212844|NCT00344682|503013|P1|COMPLETED|Overall Study||12
212845|NCT00344682|503012|P2|STARTED|Overall Study||15
212846|NCT00344682|503013|P1|STARTED|Overall Study||16
212847|NCT00344500|503027|P3|NOT COMPLETED|Overall Study||2
212848|NCT00344500|503028|P2|NOT COMPLETED|Overall Study||35
212849|NCT00344500|503029|P1|NOT COMPLETED|Overall Study||23
212850|NCT00344500|503027|P3|COMPLETED|Overall Study||12
212851|NCT00344500|503028|P2|COMPLETED|Overall Study||25
212852|NCT00344500|503029|P1|COMPLETED|Overall Study||25
212853|NCT00344500|503027|P3|STARTED|Overall Study||14
212854|NCT00344500|503028|P2|STARTED|Overall Study||60
212855|NCT00344500|503029|P1|STARTED|Overall Study||48
212856|NCT00344487|503040|P1|NOT COMPLETED|Overall Study||1
212857|NCT00344487|503040|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
212858|NCT00344487|503040|P1|STARTED|Overall Study||3
212859|NCT00344448|503046|P2|NOT COMPLETED|Open Label||1
212860|NCT00344448|503047|P1|NOT COMPLETED|Open Label||2
212861|NCT00344448|503046|P2|COMPLETED|Open Label||2
212862|NCT00344448|503047|P1|COMPLETED|Open Label||2
212863|NCT00344448|503046|P2|STARTED|Open Label||3
212864|NCT00344448|503047|P1|STARTED|Open Label||4
212865|NCT00344448|503046|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
212866|NCT00344448|503047|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
212867|NCT00344448|503046|P2|COMPLETED|Double Blind, Placebo Controlled||3
212868|NCT00344448|503047|P1|COMPLETED|Double Blind, Placebo Controlled||4
212869|NCT00344448|503046|P2|STARTED|Double Blind, Placebo Controlled||3
212870|NCT00344448|503047|P1|STARTED|Double Blind, Placebo Controlled||6
212871|NCT00344448|503046|P2|NOT COMPLETED|Screening||1
212872|NCT00344448|503047|P1|NOT COMPLETED|Screening||0
212873|NCT00344448|503046|P2|COMPLETED|Screening||3
212874|NCT00344448|503047|P1|COMPLETED|Screening||6
212875|NCT00344448|503046|P2|STARTED|Screening||4
212876|NCT00344448|503047|P1|STARTED|Screening|No randomization during the screening phase|6
212877|NCT00344370|503055|P2|NOT COMPLETED|Overall Study||3
212878|NCT00344370|503056|P1|NOT COMPLETED|Overall Study||15
212879|NCT00344370|503055|P2|COMPLETED|Overall Study||68
212880|NCT00344370|503056|P1|COMPLETED|Overall Study||128
212881|NCT00344370|503055|P2|STARTED|Overall Study||71
212882|NCT00344370|503056|P1|STARTED|Overall Study||143
212883|NCT00344305|503066|P2|NOT COMPLETED|Overall Study||1
212884|NCT00344305|503067|P1|NOT COMPLETED|Overall Study||2
212885|NCT00344305|503066|P2|COMPLETED|Overall Study||99
212886|NCT00344305|503067|P1|COMPLETED|Overall Study||98
212887|NCT00344305|503066|P2|STARTED|Overall Study||100
212888|NCT00344305|503067|P1|STARTED|Overall Study||100
212889|NCT00344175|503098|P2|NOT COMPLETED|Overall Study||10
212890|NCT00344175|503099|P1|NOT COMPLETED|Overall Study||12
212891|NCT00344175|503098|P2|COMPLETED|Overall Study||47
212892|NCT00344175|503099|P1|COMPLETED|Overall Study||109
212893|NCT00344175|503098|P2|STARTED|Overall Study||57
212894|NCT00344175|503099|P1|STARTED|Overall Study||121
212895|NCT00344032|503111|P2|NOT COMPLETED|Overall Study||10
212896|NCT00344032|503112|P1|NOT COMPLETED|Overall Study||14
212897|NCT00344032|503111|P2|COMPLETED|Overall Study||168
212898|NCT00344032|503112|P1|COMPLETED|Overall Study||162
212899|NCT00344032|503111|P2|STARTED|Overall Study||178
212900|NCT00344032|503112|P1|STARTED|Overall Study||176
212901|NCT00343915|503130|P2|NOT COMPLETED|Month 66 Follow-up||0
212902|NCT00343915|503131|P1|NOT COMPLETED|Month 66 Follow-up||0
212903|NCT00343915|503130|P2|COMPLETED|Month 66 Follow-up||76
212904|NCT00343915|503131|P1|COMPLETED|Month 66 Follow-up||158
212905|NCT00343915|503130|P2|STARTED|Month 66 Follow-up||76
212906|NCT00343915|503131|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
212907|NCT00343915|503130|P2|NOT COMPLETED|Month 54 Follow-up||0
212908|NCT00343915|503131|P1|NOT COMPLETED|Month 54 Follow-up||0
212909|NCT00343915|503130|P2|COMPLETED|Month 54 Follow-up||79
212910|NCT00343915|503131|P1|COMPLETED|Month 54 Follow-up||166
212911|NCT00343915|503130|P2|STARTED|Month 54 Follow-up||79
212912|NCT00343915|503131|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
212913|NCT00343915|503130|P2|NOT COMPLETED|Month 42 Follow-up||0
212914|NCT00343915|503131|P1|NOT COMPLETED|Month 42 Follow-up||0
212915|NCT00343915|503130|P2|COMPLETED|Month 42 Follow-up||84
212916|NCT00343915|503131|P1|COMPLETED|Month 42 Follow-up||174
212917|NCT00343915|503130|P2|STARTED|Month 42 Follow-up||84
212918|NCT00343915|503131|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
212919|NCT00343915|503130|P2|NOT COMPLETED|Month 30 Follow-up||0
212920|NCT00343915|503131|P1|NOT COMPLETED|Month 30 Follow-up||0
212921|NCT00343915|503130|P2|COMPLETED|Month 30 Follow-up||88
212922|NCT00343915|503131|P1|COMPLETED|Month 30 Follow-up||179
212923|NCT00343915|503130|P2|STARTED|Month 30 Follow-up||88
212924|NCT00343915|503131|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
212925|NCT00343915|503130|P2|NOT COMPLETED|Primary Study||3
212926|NCT00343915|503131|P1|NOT COMPLETED|Primary Study||4
212927|NCT00343915|503130|P2|COMPLETED|Primary Study||123
212928|NCT00343915|503131|P1|COMPLETED|Primary Study||254
212929|NCT00343915|503130|P2|STARTED|Primary Study||126
212930|NCT00343915|503131|P1|STARTED|Primary Study||258
212931|NCT00343889|503157|P2|NOT COMPLETED|Overall Study||1
212932|NCT00343889|503158|P1|NOT COMPLETED|Overall Study||3
212933|NCT00343889|503157|P2|COMPLETED|Overall Study||188
212934|NCT00343889|503158|P1|COMPLETED|Overall Study||187
212935|NCT00343889|503157|P2|STARTED|Overall Study||189
212936|NCT00343889|503158|P1|STARTED|Overall Study||190
212937|NCT00343564|503185|P11|NOT COMPLETED|Overall Study||0
212938|NCT00343564|503186|P10|NOT COMPLETED|Overall Study||0
212939|NCT00343564|503187|P9|NOT COMPLETED|Overall Study||0
212940|NCT00343564|503188|P8|NOT COMPLETED|Overall Study||0
212941|NCT00343564|503189|P7|NOT COMPLETED|Overall Study||0
212942|NCT00343564|503190|P6|NOT COMPLETED|Overall Study||0
212943|NCT00343564|503191|P5|NOT COMPLETED|Overall Study||0
212944|NCT00343564|503192|P4|NOT COMPLETED|Overall Study||0
212945|NCT00343564|503193|P3|NOT COMPLETED|Overall Study||0
212946|NCT00343564|503194|P2|NOT COMPLETED|Overall Study||0
212947|NCT00343564|503195|P1|NOT COMPLETED|Overall Study||0
212948|NCT00343564|503185|P11|COMPLETED|Overall Study||8
212949|NCT00343564|503186|P10|COMPLETED|Overall Study||8
212950|NCT00343564|503187|P9|COMPLETED|Overall Study||3
212951|NCT00343564|503188|P8|COMPLETED|Overall Study||3
212952|NCT00343564|503189|P7|COMPLETED|Overall Study||4
212953|NCT00343564|503190|P6|COMPLETED|Overall Study||9
212954|NCT00343564|503191|P5|COMPLETED|Overall Study||10
212955|NCT00343564|503192|P4|COMPLETED|Overall Study||7
212956|NCT00343564|503193|P3|COMPLETED|Overall Study||3
212957|NCT00343564|503194|P2|COMPLETED|Overall Study||7
212958|NCT00343564|503195|P1|COMPLETED|Overall Study||6
212959|NCT00343564|503185|P11|STARTED|Overall Study||8
212960|NCT00343564|503186|P10|STARTED|Overall Study||8
212961|NCT00343564|503187|P9|STARTED|Overall Study||3
212962|NCT00343564|503188|P8|STARTED|Overall Study||3
212963|NCT00343564|503189|P7|STARTED|Overall Study||4
212964|NCT00343564|503190|P6|STARTED|Overall Study||9
212965|NCT00343564|503191|P5|STARTED|Overall Study||10
212966|NCT00343564|503192|P4|STARTED|Overall Study||7
212967|NCT00343564|503193|P3|STARTED|Overall Study||3
212968|NCT00343564|503194|P2|STARTED|Overall Study||7
212969|NCT00343564|503195|P1|STARTED|Overall Study||6
212970|NCT00343512|503210|P1|NOT COMPLETED|Overall Study||2
212971|NCT00343512|503210|P1|COMPLETED|Overall Study||32
212972|NCT00343512|503210|P1|STARTED|Overall Study||34
212973|NCT00343460|503222|P3|NOT COMPLETED|Cycle 2 - 4||0
212974|NCT00343460|503223|P2|NOT COMPLETED|Cycle 2 - 4||50
212975|NCT00343460|503224|P1|NOT COMPLETED|Cycle 2 - 4||56
212976|NCT00343460|503222|P3|COMPLETED|Cycle 2 - 4||0
212977|NCT00343460|503223|P2|COMPLETED|Cycle 2 - 4||515
212978|NCT00343460|503224|P1|COMPLETED|Cycle 2 - 4||528
212979|NCT00343460|503222|P3|STARTED|Cycle 2 - 4||0
212980|NCT00343460|503223|P2|STARTED|Cycle 2 - 4||565
212981|NCT00343460|503224|P1|STARTED|Cycle 2 - 4||584
212982|NCT00343460|503222|P3|NOT COMPLETED|Cycle 1||18
212983|NCT00343460|503223|P2|NOT COMPLETED|Cycle 1||22
212984|NCT00343460|503224|P1|NOT COMPLETED|Cycle 1||22
212985|NCT00343460|503222|P3|COMPLETED|Cycle 1||454
212986|NCT00343460|503223|P2|COMPLETED|Cycle 1||459
212987|NCT00343460|503224|P1|COMPLETED|Cycle 1||453
212988|NCT00343460|503222|P3|STARTED|Cycle 1||472
212989|NCT00343460|503223|P2|STARTED|Cycle 1||481
212990|NCT00343460|503224|P1|STARTED|Cycle 1||475
212991|NCT00343382|503298|P3|NOT COMPLETED|Overall Study||17
212992|NCT00343382|503299|P2|NOT COMPLETED|Overall Study||14
212993|NCT00343382|503300|P1|NOT COMPLETED|Overall Study||4
212994|NCT00343382|503298|P3|COMPLETED|Overall Study||49
212995|NCT00343382|503299|P2|COMPLETED|Overall Study||51
212996|NCT00343382|503300|P1|COMPLETED|Overall Study||60
212997|NCT00343382|503298|P3|STARTED|Overall Study||66
212998|NCT00343382|503299|P2|STARTED|Overall Study||65
212999|NCT00343382|503300|P1|STARTED|Overall Study||64
213000|NCT00343291|503319|P2|NOT COMPLETED|Overall Study||56
213001|NCT00343291|503320|P1|NOT COMPLETED|Overall Study||57
213002|NCT00343291|503319|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
213003|NCT00343291|503320|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
213004|NCT00343291|503319|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
213005|NCT00343291|503320|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
213006|NCT00343291|503319|P2|STARTED|Overall Study||61
213007|NCT00343291|503320|P1|STARTED|Overall Study||60
213008|NCT00343252|503336|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
213009|NCT00343252|503337|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
213010|NCT00343252|503336|P2|COMPLETED|18 Months (All Treated Participants)||269
213011|NCT00343252|503337|P1|COMPLETED|18 Months (All Treated Participants)||259
213012|NCT00343252|503336|P2|STARTED|18 Months (All Treated Participants)||350
213013|NCT00343252|503337|P1|STARTED|18 Months (All Treated Participants)||360
213014|NCT00343252|503336|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
213015|NCT00343252|503337|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
213016|NCT00343252|503336|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
213017|NCT00343252|503337|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
213018|NCT00343252|503336|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
213019|NCT00343252|503337|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
213020|NCT00343252|503336|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
213021|NCT00343252|503337|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
213022|NCT00343252|503336|P2|COMPLETED|6 Months (All Treated Participants)||306
213023|NCT00343252|503337|P1|COMPLETED|6 Months (All Treated Participants)||304
213024|NCT00343252|503336|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
213025|NCT00343252|503337|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
213026|NCT00343252|503336|P2|NOT COMPLETED|All Randomized Participants||82
213027|NCT00343252|503337|P1|NOT COMPLETED|All Randomized Participants||102
213028|NCT00343252|503336|P2|COMPLETED|All Randomized Participants||269
213029|NCT00343252|503337|P1|COMPLETED|All Randomized Participants||259
213030|NCT00343252|503336|P2|STARTED|All Randomized Participants||351
213031|NCT00343252|503337|P1|STARTED|All Randomized Participants||361
213032|NCT00343083|503383|P1|NOT COMPLETED|Overall Study||21
213033|NCT00343083|503383|P1|COMPLETED|Overall Study||22
213034|NCT00343083|503383|P1|STARTED|Overall Study||43
213035|NCT00343044|503392|P1|NOT COMPLETED|Overall Study||0
213036|NCT00343044|503392|P1|COMPLETED|Overall Study||40
213037|NCT00343044|503392|P1|STARTED|Overall Study||40
213038|NCT00342628|503402|P3|NOT COMPLETED|Overall Study||19
213039|NCT00342628|503403|P2|NOT COMPLETED|Overall Study||21
213040|NCT00342628|503404|P1|NOT COMPLETED|Overall Study||20
213041|NCT00342628|503402|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
213042|NCT00342628|503403|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
213043|NCT00342628|503404|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
213044|NCT00342628|503402|P3|STARTED|Overall Study||100
213045|NCT00342628|503403|P2|STARTED|Overall Study||101
213046|NCT00342628|503404|P1|STARTED|Overall Study||100
213047|NCT00342355|503425|P4|NOT COMPLETED|Overall Study||0
213048|NCT00342355|503426|P3|NOT COMPLETED|Overall Study||0
213049|NCT00342355|503427|P2|NOT COMPLETED|Overall Study||0
213050|NCT00342355|503428|P1|NOT COMPLETED|Overall Study||0
213051|NCT00342355|503425|P4|COMPLETED|Overall Study||443
213052|NCT00342355|503426|P3|COMPLETED|Overall Study||444
213053|NCT00342355|503427|P2|COMPLETED|Overall Study||440
213054|NCT00342355|503428|P1|COMPLETED|Overall Study||444
213055|NCT00342355|503425|P4|STARTED|Overall Study||443
213056|NCT00342355|503426|P3|STARTED|Overall Study||444
213057|NCT00342355|503427|P2|STARTED|Overall Study||440
213058|NCT00342355|503428|P1|STARTED|Overall Study||444
213059|NCT00340834|503447|P5|NOT COMPLETED|Extension Phase of Study||44
213060|NCT00340834|503448|P4|NOT COMPLETED|Extension Phase of Study||53
213061|NCT00340834|503449|P3|NOT COMPLETED|Extension Phase of Study||0
213062|NCT00340834|503450|P2|NOT COMPLETED|Extension Phase of Study||76
213063|NCT00340834|503451|P1|NOT COMPLETED|Extension Phase of Study||85
213064|NCT00340834|503447|P5|COMPLETED|Extension Phase of Study||123
213065|NCT00340834|503448|P4|COMPLETED|Extension Phase of Study||123
213066|NCT00340834|503449|P3|COMPLETED|Extension Phase of Study||0
213067|NCT00340834|503450|P2|COMPLETED|Extension Phase of Study||281
213068|NCT00340834|503451|P1|COMPLETED|Extension Phase of Study||245
213069|NCT00340834|503447|P5|Received Study Drug|Extension Phase of Study||167
213070|NCT00340834|503448|P4|Received Study Drug|Extension Phase of Study||174
213071|NCT00340834|503449|P3|Received Study Drug|Extension Phase of Study||0
213072|NCT00340834|503450|P2|Received Study Drug|Extension Phase of Study||356
213073|NCT00340834|503451|P1|Received Study Drug|Extension Phase of Study||330
213074|NCT00340834|503447|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
213075|NCT00340834|503448|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
213076|NCT00340834|503449|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
213077|NCT00340834|503450|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
213078|NCT00340834|503451|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
213079|NCT00340834|503447|P5|NOT COMPLETED|Core Phase of Study||0
213080|NCT00340834|503448|P4|NOT COMPLETED|Core Phase of Study||0
213081|NCT00340834|503449|P3|NOT COMPLETED|Core Phase of Study||49
213082|NCT00340834|503450|P2|NOT COMPLETED|Core Phase of Study||33
213083|NCT00340834|503451|P1|NOT COMPLETED|Core Phase of Study||57
213084|NCT00340834|503447|P5|COMPLETED|Core Phase of Study||0
213085|NCT00340834|503448|P4|COMPLETED|Core Phase of Study||0
213086|NCT00340834|503449|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
213087|NCT00340834|503450|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
213088|NCT00340834|503451|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
213089|NCT00340834|503447|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
213090|NCT00340834|503448|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
213091|NCT00340834|503449|P3|STARTED|Core Phase of Study||435
213092|NCT00340834|503450|P2|STARTED|Core Phase of Study||431
213093|NCT00340834|503451|P1|STARTED|Core Phase of Study||426
213094|NCT00340704|503485|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
213095|NCT00340704|503486|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
213096|NCT00340704|503487|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
213097|NCT00340704|503488|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
213098|NCT00340704|503489|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
213099|NCT00340704|503490|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
213100|NCT00340704|503491|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213101|NCT00340704|503492|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213102|NCT00340704|503493|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213103|NCT00340704|503485|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213104|NCT00340704|503486|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
213105|NCT00340704|503487|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
213106|NCT00340704|503488|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
213107|NCT00340704|503489|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
213108|NCT00340704|503490|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
213109|NCT00340704|503491|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213110|NCT00340704|503492|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213111|NCT00340704|503493|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
213112|NCT00340704|503485|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213113|NCT00340704|503486|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213114|NCT00340704|503487|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213115|NCT00340704|503488|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
213116|NCT00340704|503489|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
213117|NCT00340704|503490|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
213118|NCT00340704|503491|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213119|NCT00340704|503492|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213120|NCT00340704|503493|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
213121|NCT00340704|503485|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
213122|NCT00340704|503486|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
213123|NCT00340704|503487|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
213124|NCT00340704|503488|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
213125|NCT00340704|503489|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
213126|NCT00340704|503490|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
213127|NCT00340704|503491|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
213128|NCT00340704|503492|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
213222|NCT00338988|503775|P1|NOT COMPLETED|Overall Study||1
213129|NCT00340704|503493|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
213130|NCT00340704|503485|P9|NOT COMPLETED|PK Study||0
213131|NCT00340704|503486|P8|NOT COMPLETED|PK Study||0
213132|NCT00340704|503487|P7|NOT COMPLETED|PK Study||0
213133|NCT00340704|503488|P6|NOT COMPLETED|PK Study||0
213134|NCT00340704|503489|P5|NOT COMPLETED|PK Study||0
213135|NCT00340704|503490|P4|NOT COMPLETED|PK Study||0
213136|NCT00340704|503491|P3|NOT COMPLETED|PK Study||1
213137|NCT00340704|503492|P2|NOT COMPLETED|PK Study||1
213138|NCT00340704|503493|P1|NOT COMPLETED|PK Study||0
213139|NCT00340704|503485|P9|COMPLETED|PK Study||0
213140|NCT00340704|503486|P8|COMPLETED|PK Study||0
213141|NCT00340704|503487|P7|COMPLETED|PK Study||0
213142|NCT00340704|503488|P6|COMPLETED|PK Study||0
213143|NCT00340704|503489|P5|COMPLETED|PK Study||0
213144|NCT00340704|503490|P4|COMPLETED|PK Study||0
213145|NCT00340704|503491|P3|COMPLETED|PK Study||10
213146|NCT00340704|503492|P2|COMPLETED|PK Study||9
213147|NCT00340704|503493|P1|COMPLETED|PK Study||10
213148|NCT00340704|503485|P9|STARTED|PK Study||0
213149|NCT00340704|503486|P8|STARTED|PK Study||0
213150|NCT00340704|503487|P7|STARTED|PK Study||0
213151|NCT00340704|503488|P6|STARTED|PK Study||0
213152|NCT00340704|503489|P5|STARTED|PK Study||0
213153|NCT00340704|503490|P4|STARTED|PK Study||0
213154|NCT00340704|503491|P3|STARTED|PK Study||11
213155|NCT00340704|503492|P2|STARTED|PK Study||10
213156|NCT00340704|503493|P1|STARTED|PK Study||10
213157|NCT00340678|503599|P4|NOT COMPLETED|Overall Study||0
213158|NCT00340678|503600|P3|NOT COMPLETED|Overall Study||0
213159|NCT00340678|503601|P2|NOT COMPLETED|Overall Study||0
213160|NCT00340678|503602|P1|NOT COMPLETED|Overall Study||1
213161|NCT00340678|503599|P4|COMPLETED|Overall Study||39
213162|NCT00340678|503600|P3|COMPLETED|Overall Study||39
213163|NCT00340678|503601|P2|COMPLETED|Overall Study||46
213164|NCT00340678|503602|P1|COMPLETED|Overall Study||45
213165|NCT00340678|503599|P4|STARTED|Overall Study||39
213166|NCT00340678|503600|P3|STARTED|Overall Study||39
213167|NCT00340678|503601|P2|STARTED|Overall Study||46
213168|NCT00340678|503602|P1|STARTED|Overall Study||46
213169|NCT00340379|503616|P2|NOT COMPLETED|Overall Study||9
213170|NCT00340379|503617|P1|NOT COMPLETED|Overall Study||8
213171|NCT00340379|503616|P2|COMPLETED|Overall Study||28
213172|NCT00340379|503617|P1|COMPLETED|Overall Study||27
213173|NCT00340379|503616|P2|STARTED|Overall Study||37
213174|NCT00340379|503617|P1|STARTED|Overall Study||35
213175|NCT00339833|503629|P2|NOT COMPLETED|Overall Study||8
213176|NCT00339833|503630|P1|NOT COMPLETED|Overall Study||6
213177|NCT00339833|503629|P2|COMPLETED|Overall Study||18
213178|NCT00339833|503630|P1|COMPLETED|Overall Study||22
213179|NCT00339833|503629|P2|STARTED|Overall Study||26
213180|NCT00339833|503630|P1|STARTED|Overall Study||28
213181|NCT00339183|503640|P2|NOT COMPLETED|Overall Study||105
213182|NCT00339183|503641|P1|NOT COMPLETED|Overall Study||121
213183|NCT00339183|503640|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
213184|NCT00339183|503641|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
213185|NCT00339183|503640|P2|Received Study Drug|Overall Study||593
213186|NCT00339183|503641|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
213187|NCT00339183|503640|P2|STARTED|Overall Study||595
213188|NCT00339183|503641|P1|STARTED|Overall Study||591
213189|NCT00339144|503670|P3|NOT COMPLETED|Overall Study||4
213190|NCT00339144|503671|P2|NOT COMPLETED|Overall Study||3
213191|NCT00339144|503672|P1|NOT COMPLETED|Overall Study||9
213192|NCT00339144|503670|P3|COMPLETED|Overall Study||0
213193|NCT00339144|503671|P2|COMPLETED|Overall Study||0
213194|NCT00339144|503672|P1|COMPLETED|Overall Study||0
213195|NCT00339144|503670|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
213196|NCT00339144|503671|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
213197|NCT00339144|503672|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
213198|NCT00339040|503756|P2|NOT COMPLETED|Stage II||2
213199|NCT00339040|503757|P1|NOT COMPLETED|Stage II||10
213200|NCT00339040|503756|P2|COMPLETED|Stage II||27
213201|NCT00339040|503757|P1|COMPLETED|Stage II||84
213202|NCT00339040|503756|P2|Vaccination 6 at Week 120|Stage II||27
213203|NCT00339040|503757|P1|Vaccination 6 at Week 120|Stage II||0
213204|NCT00339040|503756|P2|Vaccination 5 at Week 104|Stage II||28
213205|NCT00339040|503757|P1|Vaccination 5 at Week 104|Stage II||0
213206|NCT00339040|503756|P2|Vaccination 4 at Week 96|Stage II||29
213207|NCT00339040|503757|P1|Vaccination 4 at Week 96|Stage II||84
213208|NCT00339040|503756|P2|STARTED|Stage II||29
213209|NCT00339040|503757|P1|STARTED|Stage II||94
213210|NCT00339040|503756|P2|NOT COMPLETED|Stage I||1
213211|NCT00339040|503757|P1|NOT COMPLETED|Stage I||2
213212|NCT00339040|503756|P2|COMPLETED|Stage I||29
213213|NCT00339040|503757|P1|COMPLETED|Stage I||94
213214|NCT00339040|503756|P2|Vaccination 3 at Week 24|Stage I||30
213215|NCT00339040|503757|P1|Vaccination 3 at Week 24|Stage I||94
213216|NCT00339040|503756|P2|Vaccination 2 at Week 8|Stage I||30
213217|NCT00339040|503757|P1|Vaccination 2 at Week 8|Stage I||95
213218|NCT00339040|503756|P2|Vaccination 1 at Week 0|Stage I||30
213219|NCT00339040|503757|P1|Vaccination 1 at Week 0|Stage I||96
213220|NCT00339040|503756|P2|STARTED|Stage I||30
213221|NCT00339040|503757|P1|STARTED|Stage I||96
213223|NCT00338988|503775|P1|COMPLETED|Overall Study||43
213224|NCT00338988|503775|P1|STARTED|Overall Study||44
213225|NCT00338962|503784|P4|NOT COMPLETED|Overall Study||3
213226|NCT00338962|503785|P3|NOT COMPLETED|Overall Study||6
213227|NCT00338962|503786|P2|NOT COMPLETED|Overall Study||4
213228|NCT00338962|503787|P1|NOT COMPLETED|Overall Study||8
213229|NCT00338962|503784|P4|COMPLETED|Overall Study||21
213230|NCT00338962|503785|P3|COMPLETED|Overall Study||16
213231|NCT00338962|503786|P2|COMPLETED|Overall Study||16
213232|NCT00338962|503787|P1|COMPLETED|Overall Study||14
213233|NCT00338962|503784|P4|STARTED|Overall Study||24
213234|NCT00338962|503785|P3|STARTED|Overall Study||22
213235|NCT00338962|503786|P2|STARTED|Overall Study||20
213236|NCT00338962|503787|P1|STARTED|Overall Study||22
213237|NCT00338884|503809|P1|NOT COMPLETED|Overall Study||78
213238|NCT00338884|503809|P1|COMPLETED|Overall Study||42
213239|NCT00338884|503809|P1|Received Treatment|Overall Study||119
213240|NCT00338884|503809|P1|STARTED|Overall Study||120
213241|NCT00337779|503843|P2|NOT COMPLETED|Overall Study||79
213242|NCT00337779|503844|P1|NOT COMPLETED|Overall Study||52
213243|NCT00337779|503843|P2|COMPLETED|Overall Study||490
213244|NCT00337779|503844|P1|COMPLETED|Overall Study||534
213245|NCT00337779|503843|P2|STARTED|Overall Study||569
213246|NCT00337779|503844|P1|STARTED|Overall Study||586
213247|NCT00338741|503856|P2|NOT COMPLETED|Overall Study||0
213248|NCT00338741|503857|P1|NOT COMPLETED|Overall Study||2
213249|NCT00338741|503856|P2|COMPLETED|Overall Study||2
213250|NCT00338741|503857|P1|COMPLETED|Overall Study||32
213251|NCT00338741|503856|P2|STARTED|Overall Study||2
213252|NCT00338741|503857|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
213253|NCT00338455|503867|P2|NOT COMPLETED|Overall Study||1
213254|NCT00338455|503868|P1|NOT COMPLETED|Overall Study||3
213255|NCT00338455|503867|P2|COMPLETED|Overall Study||6
213256|NCT00338455|503868|P1|COMPLETED|Overall Study||6
213257|NCT00338455|503867|P2|Administered Study Drug|Overall Study||7
213258|NCT00338455|503868|P1|Administered Study Drug|Overall Study||8
213259|NCT00338455|503867|P2|STARTED|Overall Study||7
213260|NCT00338455|503868|P1|STARTED|Overall Study||9
213261|NCT00338286|503882|P2|NOT COMPLETED|Overall Study||370
213262|NCT00338286|503883|P1|NOT COMPLETED|Overall Study||393
213263|NCT00338286|503882|P2|COMPLETED|Overall Study||680
213264|NCT00338286|503883|P1|COMPLETED|Overall Study||655
213265|NCT00338286|503882|P2|STARTED|Overall Study||1050
213266|NCT00338286|503883|P1|STARTED|Overall Study||1048
213267|NCT00338104|503900|P3|NOT COMPLETED|Overall Study||3
213268|NCT00338104|503901|P2|NOT COMPLETED|Overall Study||1
213269|NCT00338104|503902|P1|NOT COMPLETED|Overall Study||2
213270|NCT00338104|503900|P3|COMPLETED|Overall Study||22
213271|NCT00338104|503901|P2|COMPLETED|Overall Study||24
213272|NCT00338104|503902|P1|COMPLETED|Overall Study||23
213273|NCT00338104|503900|P3|STARTED|Overall Study||25
213274|NCT00338104|503901|P2|STARTED|Overall Study||25
213275|NCT00338104|503902|P1|STARTED|Overall Study||25
213276|NCT00338039|503913|P1|NOT COMPLETED|Overall Study||0
213277|NCT00338039|503913|P1|COMPLETED|Overall Study||69
213278|NCT00338039|503913|P1|STARTED|Overall Study||69
213279|NCT00337987|503918|P1|NOT COMPLETED|Overall Study||0
213280|NCT00337987|503918|P1|COMPLETED|Overall Study||49
213281|NCT00337987|503918|P1|STARTED|Overall Study||49
213282|NCT00337935|503925|P2|NOT COMPLETED|Overall Study||27
213283|NCT00337935|503926|P1|NOT COMPLETED|Overall Study||10
213284|NCT00337935|503925|P2|COMPLETED|Overall Study||91
213285|NCT00337935|503926|P1|COMPLETED|Overall Study||29
213286|NCT00337935|503925|P2|STARTED|Overall Study||118
213287|NCT00337935|503926|P1|STARTED|Overall Study||39
213288|NCT00337818|503939|P3|NOT COMPLETED|Overall Study||107
213289|NCT00337818|503940|P2|NOT COMPLETED|Overall Study||91
213290|NCT00337818|503941|P1|NOT COMPLETED|Overall Study||289
213291|NCT00337818|503939|P3|COMPLETED|Overall Study||51
213292|NCT00337818|503940|P2|COMPLETED|Overall Study||63
213293|NCT00337818|503941|P1|COMPLETED|Overall Study||169
213294|NCT00337818|503939|P3|STARTED|Overall Study||158
213295|NCT00337818|503940|P2|STARTED|Overall Study||154
213296|NCT00337818|503941|P1|STARTED|Overall Study||458
213297|NCT00337727|503963|P2|NOT COMPLETED|Overall Study||12
213298|NCT00337727|503964|P1|NOT COMPLETED|Overall Study||18
213299|NCT00337727|503963|P2|COMPLETED|Overall Study||406
213300|NCT00337727|503964|P1|COMPLETED|Overall Study||412
213301|NCT00337727|503963|P2|STARTED|Overall Study||418
213302|NCT00337727|503964|P1|STARTED|Overall Study||430
213303|NCT00337675|503975|P3|NOT COMPLETED|Overall Study||99
213304|NCT00337675|503976|P2|NOT COMPLETED|Overall Study||103
213305|NCT00337675|503977|P1|NOT COMPLETED|Overall Study||97
213306|NCT00337675|503975|P3|COMPLETED|Overall Study||492
213307|NCT00337675|503976|P2|COMPLETED|Overall Study||488
213308|NCT00337675|503977|P1|COMPLETED|Overall Study||492
213309|NCT00337675|503975|P3|STARTED|Overall Study||591
213310|NCT00337675|503976|P2|STARTED|Overall Study||591
213311|NCT00337675|503977|P1|STARTED|Overall Study||589
213312|NCT00337662|503994|P4|NOT COMPLETED|Study Period III||0
213313|NCT00337662|503995|P3|NOT COMPLETED|Study Period III||44
213314|NCT00337662|503996|P2|NOT COMPLETED|Study Period III||58
213315|NCT00337662|503997|P1|NOT COMPLETED|Study Period III||60
213316|NCT00337662|503994|P4|COMPLETED|Study Period III||0
213317|NCT00337662|503995|P3|COMPLETED|Study Period III||100
213318|NCT00337662|503996|P2|COMPLETED|Study Period III||134
213319|NCT00337662|503997|P1|COMPLETED|Study Period III||126
213320|NCT00337662|503994|P4|STARTED|Study Period III||0
213321|NCT00337662|503995|P3|STARTED|Study Period III||144
213322|NCT00337662|503996|P2|STARTED|Study Period III||192
213323|NCT00337662|503997|P1|STARTED|Study Period III||186
213324|NCT00337662|503994|P4|NOT COMPLETED|Study Period II||106
213325|NCT00337662|503995|P3|NOT COMPLETED|Study Period II||0
213326|NCT00337662|503996|P2|NOT COMPLETED|Study Period II||0
213327|NCT00337662|503997|P1|NOT COMPLETED|Study Period II||0
213328|NCT00337662|503994|P4|COMPLETED|Study Period II||522
213329|NCT00337662|503995|P3|COMPLETED|Study Period II||0
213330|NCT00337662|503996|P2|COMPLETED|Study Period II||0
213331|NCT00337662|503997|P1|COMPLETED|Study Period II||0
213332|NCT00337662|503994|P4|STARTED|Study Period II||628
213333|NCT00337662|503995|P3|STARTED|Study Period II||0
213334|NCT00337662|503996|P2|STARTED|Study Period II||0
213335|NCT00337662|503997|P1|STARTED|Study Period II||0
213336|NCT00337610|504051|P2|NOT COMPLETED|Overall Study||14
213337|NCT00337610|504052|P1|NOT COMPLETED|Overall Study||17
213338|NCT00337610|504051|P2|COMPLETED|Overall Study||80
213339|NCT00337610|504052|P1|COMPLETED|Overall Study||79
213340|NCT00337610|504051|P2|Completed Week 18|Overall Study||82
213341|NCT00337610|504052|P1|Completed Week 18|Overall Study||89
213342|NCT00337610|504051|P2|STARTED|Overall Study||94
213343|NCT00337610|504052|P1|STARTED|Overall Study||96
213344|NCT00337571|504068|P4|NOT COMPLETED|Overall Study||7
213345|NCT00337571|504069|P3|NOT COMPLETED|Overall Study||10
213346|NCT00337571|504070|P2|NOT COMPLETED|Overall Study||9
213347|NCT00337571|504071|P1|NOT COMPLETED|Overall Study||14
213348|NCT00337571|504068|P4|COMPLETED|Overall Study||47
213349|NCT00337571|504069|P3|COMPLETED|Overall Study||49
213350|NCT00337571|504070|P2|COMPLETED|Overall Study||44
213351|NCT00337571|504071|P1|COMPLETED|Overall Study||38
213352|NCT00337571|504068|P4|STARTED|Overall Study||54
213353|NCT00337571|504069|P3|STARTED|Overall Study||59
213354|NCT00337571|504070|P2|STARTED|Overall Study||53
213355|NCT00337571|504071|P1|STARTED|Overall Study||52
213356|NCT00337467|504109|P1|NOT COMPLETED|Overall Study||10
213357|NCT00337467|504109|P1|COMPLETED|Overall Study||51
213358|NCT00337467|504109|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
213359|NCT00337467|504109|P1|STARTED|Overall Study||61
213360|NCT00337428|504128|P2|NOT COMPLETED|Overall Study||3
213361|NCT00337428|504129|P1|NOT COMPLETED|Overall Study||4
213362|NCT00337428|504128|P2|COMPLETED|Overall Study||421
213363|NCT00337428|504129|P1|COMPLETED|Overall Study||415
213364|NCT00337428|504128|P2|STARTED|Overall Study||424
213365|NCT00337428|504129|P1|STARTED|Overall Study||419
213366|NCT00337350|504169|P2|NOT COMPLETED|Overall Study||1
213367|NCT00337350|504170|P1|NOT COMPLETED|Overall Study||1
213368|NCT00337350|504169|P2|COMPLETED|Overall Study||10
213369|NCT00337350|504170|P1|COMPLETED|Overall Study||8
213370|NCT00337350|504169|P2|STARTED|Overall Study||11
213371|NCT00337350|504170|P1|STARTED|Overall Study||9
213372|NCT00337285|504180|P1|NOT COMPLETED|Overall Study||158
213373|NCT00337285|504180|P1|COMPLETED|Overall Study||191
213374|NCT00337285|504180|P1|STARTED|Overall Study||349
213375|NCT00337272|504188|P2|NOT COMPLETED|Withdrawal Period||1
213376|NCT00337272|504189|P1|NOT COMPLETED|Withdrawal Period||0
213377|NCT00337272|504188|P2|COMPLETED|Withdrawal Period||6
213378|NCT00337272|504189|P1|COMPLETED|Withdrawal Period||6
213379|NCT00337272|504188|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
213380|NCT00337272|504189|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
213381|NCT00337272|504188|P2|NOT COMPLETED|Treatment Period||2
213382|NCT00337272|504189|P1|NOT COMPLETED|Treatment Period||1
213383|NCT00337272|504188|P2|COMPLETED|Treatment Period||7
213384|NCT00337272|504189|P1|COMPLETED|Treatment Period||6
213385|NCT00337272|504188|P2|Randomization|Treatment Period||9
213386|NCT00337272|504189|P1|Randomization|Treatment Period||7
213387|NCT00337272|504188|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
213388|NCT00337272|504189|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
213389|NCT00337272|504188|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
213390|NCT00337272|504189|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
213391|NCT00337272|504188|P2|COMPLETED|Screening Period (Pre-randomization)||0
213392|NCT00337272|504189|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
213393|NCT00337272|504188|P2|STARTED|Screening Period (Pre-randomization)||0
213394|NCT00337272|504189|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
213395|NCT00337207|504209|P1|NOT COMPLETED|Overall Study||3
213396|NCT00337207|504209|P1|COMPLETED|Overall Study||52
213397|NCT00337207|504209|P1|STARTED|Overall Study||55
213398|NCT00337194|504215|P2|NOT COMPLETED|Overall Study||4
213399|NCT00337194|504216|P1|NOT COMPLETED|Overall Study||12
213400|NCT00337194|504215|P2|COMPLETED|Overall Study||3
213401|NCT00337194|504216|P1|COMPLETED|Overall Study||11
213402|NCT00337194|504215|P2|STARTED|Overall Study||7
213403|NCT00337194|504216|P1|STARTED|Overall Study||23
213404|NCT00337168|504231|P1|NOT COMPLETED|Overall Study||8
213405|NCT00337168|504231|P1|COMPLETED|Overall Study||29
213406|NCT00337168|504231|P1|Eligible and Treated|Overall Study||36
213407|NCT00337168|504231|P1|Eligible|Overall Study||37
213408|NCT00337168|504231|P1|STARTED|Overall Study||37
213409|NCT00337129|504238|P1|NOT COMPLETED|Overall Study||40
213410|NCT00337129|504238|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
213411|NCT00337129|504238|P1|STARTED|Overall Study||40
213412|NCT00337103|504247|P2|NOT COMPLETED|Overall Study||543
213413|NCT00337103|504248|P1|NOT COMPLETED|Overall Study||549
213414|NCT00337103|504247|P2|COMPLETED|Overall Study||5
213415|NCT00337103|504248|P1|COMPLETED|Overall Study||5
213416|NCT00337103|504247|P2|STARTED|Overall Study||548
213417|NCT00337103|504248|P1|STARTED|Overall Study||554
213418|NCT00337077|504259|P3|NOT COMPLETED|Overall Study||25
213419|NCT00337077|504260|P2|NOT COMPLETED|Overall Study||53
213420|NCT00337077|504261|P1|NOT COMPLETED|Overall Study||43
213421|NCT00337077|504259|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
213422|NCT00337077|504260|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
213423|NCT00337077|504261|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
213424|NCT00337077|504259|P3|Patients With Measurable Disease|Overall Study||13
213425|NCT00337077|504260|P2|Patients With Measurable Disease|Overall Study||38
213426|NCT00337077|504261|P1|Patients With Measurable Disease|Overall Study||26
213427|NCT00337077|504259|P3|Eligible and Treated|Overall Study||24
213428|NCT00337077|504260|P2|Eligible and Treated|Overall Study||51
213429|NCT00337077|504261|P1|Eligible and Treated|Overall Study||41
213430|NCT00337077|504259|P3|Toxicity Assessed|Overall Study||25
213431|NCT00337077|504260|P2|Toxicity Assessed|Overall Study||51
213432|NCT00337077|504261|P1|Toxicity Assessed|Overall Study||42
213433|NCT00337077|504259|P3|Treated|Overall Study||25
213434|NCT00337077|504260|P2|Treated|Overall Study||52
213435|NCT00337077|504261|P1|Treated|Overall Study||42
213436|NCT00337077|504259|P3|STARTED|Overall Study||25
213437|NCT00337077|504260|P2|STARTED|Overall Study||53
213438|NCT00337077|504261|P1|STARTED|Overall Study||43
213439|NCT00336973|504270|P1|NOT COMPLETED|Overall Study||33
213440|NCT00336973|504270|P1|COMPLETED|Overall Study||33
213441|NCT00336973|504270|P1|STARTED|Overall Study||66
213442|NCT00336895|504276|P1|NOT COMPLETED|Overall Study||4
213443|NCT00336895|504276|P1|COMPLETED|Overall Study||26
213444|NCT00336895|504276|P1|STARTED|Overall Study||30
213445|NCT00336856|504282|P1|NOT COMPLETED|Overall Study||4
213446|NCT00336856|504282|P1|COMPLETED|Overall Study||31
213447|NCT00336856|504282|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
213448|NCT00336700|504288|P1|NOT COMPLETED|Overall Study||0
213449|NCT00336700|504288|P1|COMPLETED|Overall Study||25
213450|NCT00336700|504288|P1|STARTED|Overall Study||25
213451|NCT00336583|504297|P1|NOT COMPLETED|Overall Study||2
213452|NCT00336583|504297|P1|COMPLETED|Overall Study||25
213453|NCT00336583|504297|P1|STARTED|Overall Study||27
213454|NCT00336544|504304|P2|NOT COMPLETED|Overall Study||22
213455|NCT00336544|504305|P1|NOT COMPLETED|Overall Study||19
213456|NCT00336544|504304|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
213457|NCT00336544|504305|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
213458|NCT00336544|504304|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
213459|NCT00336544|504305|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
213460|NCT00336505|504319|P2|NOT COMPLETED|Overall Study||27
213461|NCT00336505|504320|P1|NOT COMPLETED|Overall Study||37
213462|NCT00336505|504319|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
213463|NCT00336505|504320|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
213464|NCT00336505|504319|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
213465|NCT00336505|504320|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
213466|NCT00336492|504335|P3|NOT COMPLETED|Overall Study||11
213467|NCT00336492|504336|P2|NOT COMPLETED|Overall Study||4
213468|NCT00336492|504337|P1|NOT COMPLETED|Overall Study||15
213469|NCT00336492|504335|P3|COMPLETED|Overall Study||12
213470|NCT00336492|504336|P2|COMPLETED|Overall Study||18
213471|NCT00336492|504337|P1|COMPLETED|Overall Study||0
213472|NCT00336492|504335|P3|STARTED|Overall Study||23
213473|NCT00336492|504336|P2|STARTED|Overall Study||22
213474|NCT00336492|504337|P1|STARTED|Overall Study||15
213475|NCT00336479|504349|P4|NOT COMPLETED|Overall Study||4
213476|NCT00336479|504350|P3|NOT COMPLETED|Overall Study||26
213477|NCT00336479|504351|P2|NOT COMPLETED|Overall Study||25
213478|NCT00336479|504352|P1|NOT COMPLETED|Overall Study||37
213479|NCT00336479|504349|P4|COMPLETED|Overall Study||13
213480|NCT00336479|504350|P3|COMPLETED|Overall Study||53
213481|NCT00336479|504351|P2|COMPLETED|Overall Study||54
213482|NCT00336479|504352|P1|COMPLETED|Overall Study||38
213483|NCT00336479|504349|P4|STARTED|Overall Study||17
213484|NCT00336479|504350|P3|STARTED|Overall Study||79
213485|NCT00336479|504351|P2|STARTED|Overall Study||79
213486|NCT00336479|504352|P1|STARTED|Overall Study||75
213487|NCT00336323|504380|P5|NOT COMPLETED|Overall Study||3
213488|NCT00336323|504381|P4|NOT COMPLETED|Overall Study||0
213489|NCT00336323|504382|P3|NOT COMPLETED|Overall Study||1
213490|NCT00336323|504383|P2|NOT COMPLETED|Overall Study||1
213491|NCT00336323|504384|P1|NOT COMPLETED|Overall Study||0
213492|NCT00336323|504380|P5|COMPLETED|Overall Study||19
213493|NCT00336323|504381|P4|COMPLETED|Overall Study||22
213494|NCT00336323|504382|P3|COMPLETED|Overall Study||23
213495|NCT00336323|504383|P2|COMPLETED|Overall Study||21
213496|NCT00336323|504384|P1|COMPLETED|Overall Study||19
213497|NCT00336323|504380|P5|24 Week Visit|Overall Study||19
213498|NCT00336323|504381|P4|24 Week Visit|Overall Study||22
213499|NCT00336323|504382|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
213500|NCT00336323|504383|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
213501|NCT00336323|504384|P1|24 Week Visit|Overall Study||18
213502|NCT00336323|504380|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
213503|NCT00336323|504381|P4|18 Week Visit|Overall Study||21
213504|NCT00336323|504382|P3|18 Week Visit|Overall Study||23
213505|NCT00336323|504383|P2|18 Week Visit|Overall Study||22
213506|NCT00336323|504384|P1|18 Week Visit|Overall Study||19
213507|NCT00336323|504380|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
213508|NCT00336323|504381|P4|12 Week Visit|Overall Study||22
213509|NCT00336323|504382|P3|12 Week Visit|Overall Study||24
213510|NCT00336323|504383|P2|12 Week Visit|Overall Study||21
213511|NCT00336323|504384|P1|12 Week Visit|Overall Study||19
213512|NCT00336323|504380|P5|9 Week Visit|Overall Study||19
213513|NCT00336323|504381|P4|9 Week Visit|Overall Study||21
213514|NCT00336323|504382|P3|9 Week Visit|Overall Study||23
213515|NCT00336323|504383|P2|9 Week Visit|Overall Study||21
213516|NCT00336323|504384|P1|9 Week Visit|Overall Study||18
213517|NCT00336323|504380|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
213518|NCT00336323|504381|P4|6 Week Visit|Overall Study||22
213519|NCT00336323|504382|P3|6 Week Visit|Overall Study||24
213520|NCT00336323|504383|P2|6 Week Visit|Overall Study||22
213521|NCT00336323|504384|P1|6 Week Visit|Overall Study||18
213522|NCT00336323|504380|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
213523|NCT00336323|504381|P4|3 Week Visit|Overall Study||22
213524|NCT00336323|504382|P3|3 Week Visit|Overall Study||24
213525|NCT00336323|504383|P2|3 Week Visit|Overall Study||21
213526|NCT00336323|504384|P1|3 Week Visit|Overall Study||18
213527|NCT00336323|504380|P5|STARTED|Overall Study||22
213528|NCT00336323|504381|P4|STARTED|Overall Study||22
213529|NCT00336323|504382|P3|STARTED|Overall Study||24
213530|NCT00336323|504383|P2|STARTED|Overall Study||22
213531|NCT00336323|504384|P1|STARTED|Overall Study||19
213532|NCT00336284|504441|P2|NOT COMPLETED|Overall Study||151
213533|NCT00336284|504442|P1|NOT COMPLETED|Overall Study||236
213534|NCT00336284|504441|P2|COMPLETED|Overall Study||322
213535|NCT00336284|504442|P1|COMPLETED|Overall Study||741
213536|NCT00336284|504441|P2|STARTED|Overall Study||473
213537|NCT00336284|504442|P1|STARTED|Overall Study||977
213538|NCT00336232|504454|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
213539|NCT00336232|504454|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
213540|NCT00336232|504454|P1|STARTED|High Vitamin K (500mcg Daily)||42
213541|NCT00336232|504454|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
213542|NCT00336232|504454|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
213543|NCT00336232|504454|P1|STARTED|Low Vitamin K (10mcg Daily)||42
213544|NCT00336232|504454|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
213545|NCT00336232|504454|P1|COMPLETED|Baseline (200mcg Daily)||42
213546|NCT00336232|504454|P1|STARTED|Baseline (200mcg Daily)||59
213547|NCT00335959|504458|P1|NOT COMPLETED|Overall Study||3
213548|NCT00335959|504458|P1|COMPLETED|Overall Study||4
213549|NCT00335959|504458|P1|Eligible and Began Protocol Therapy|Overall Study||6
213550|NCT00335959|504458|P1|Eligible|Overall Study||6
213551|NCT00335959|504458|P1|STARTED|Overall Study||7
213552|NCT00335777|504463|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
213553|NCT00335777|504463|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
213554|NCT00335777|504463|P1|STARTED|Treated 2 Headaches Per Protocol||35
213555|NCT00335777|504463|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
213556|NCT00335777|504463|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
213557|NCT00335777|504463|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
213558|NCT00335725|504470|P2|NOT COMPLETED|Overall Study||5
213559|NCT00335725|504471|P1|NOT COMPLETED|Overall Study||4
213560|NCT00335725|504470|P2|COMPLETED|Overall Study||71
213561|NCT00335725|504471|P1|COMPLETED|Overall Study||71
213562|NCT00335725|504470|P2|STARTED|Overall Study||76
213563|NCT00335725|504471|P1|STARTED|Overall Study||75
213564|NCT00335517|504479|P1|NOT COMPLETED|Overall Study||2
213565|NCT00335517|504479|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
213566|NCT00335517|504479|P1|STARTED|Overall Study||100
213567|NCT00335504|504487|P4|NOT COMPLETED|Overall Study||0
213568|NCT00335504|504488|P3|NOT COMPLETED|Overall Study||0
213569|NCT00335504|504489|P2|NOT COMPLETED|Overall Study||0
213570|NCT00335504|504490|P1|NOT COMPLETED|Overall Study||0
213571|NCT00335504|504487|P4|COMPLETED|Overall Study||22
213572|NCT00335504|504488|P3|COMPLETED|Overall Study||20
213573|NCT00335504|504489|P2|COMPLETED|Overall Study||21
213574|NCT00335504|504490|P1|COMPLETED|Overall Study||22
213575|NCT00335504|504487|P4|STARTED|Overall Study||22
213576|NCT00335504|504488|P3|STARTED|Overall Study||20
213577|NCT00335504|504489|P2|STARTED|Overall Study||21
213578|NCT00335504|504490|P1|STARTED|Overall Study||22
213579|NCT00335478|504512|P1|NOT COMPLETED|Overall Study||24
213580|NCT00335478|504512|P1|COMPLETED|Overall Study||30
213581|NCT00335478|504512|P1|STARTED|Overall Study||54
213582|NCT00335452|504520|P4|NOT COMPLETED|Overall Study||131
213583|NCT00335452|504521|P3|NOT COMPLETED|Overall Study||159
213584|NCT00335452|504522|P2|NOT COMPLETED|Overall Study||147
213585|NCT00335452|504523|P1|NOT COMPLETED|Overall Study||158
213586|NCT00335452|504520|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
213587|NCT00335452|504521|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
213588|NCT00335452|504522|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
213589|NCT00335452|504523|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
213590|NCT00335452|504520|P4|TREATED WITH ASA|Overall Study||6247
213591|NCT00335452|504521|P3|TREATED WITH ASA|Overall Study||6261
213592|NCT00335452|504522|P2|TREATED WITH ASA|Overall Study||6251
213593|NCT00335452|504523|P1|TREATED WITH ASA|Overall Study||6302
213594|NCT00335452|504520|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
213595|NCT00335452|504521|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
213596|NCT00335452|504522|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
213597|NCT00335452|504523|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
213598|NCT00335452|504520|P4|STARTED|Overall Study|Randomized|6253
213599|NCT00335452|504521|P3|STARTED|Overall Study|Randomized|6267
213600|NCT00335452|504522|P2|STARTED|Overall Study|Randomized|6254
213601|NCT00335452|504523|P1|STARTED|Overall Study|Randomized|6312
213602|NCT00335322|504548|P3|NOT COMPLETED|Overall Study||2
213603|NCT00335322|504549|P2|NOT COMPLETED|Overall Study||2
213604|NCT00335322|504550|P1|NOT COMPLETED|Overall Study||1
213605|NCT00335322|504548|P3|COMPLETED|Overall Study||103
213606|NCT00335322|504549|P2|COMPLETED|Overall Study||105
213607|NCT00335322|504550|P1|COMPLETED|Overall Study||114
213608|NCT00335322|504548|P3|STARTED|Overall Study||105
213609|NCT00335322|504549|P2|STARTED|Overall Study||107
213610|NCT00335322|504550|P1|STARTED|Overall Study||115
213611|NCT00335283|504560|P2|NOT COMPLETED|Overall Study||5
213612|NCT00335283|504561|P1|NOT COMPLETED|Overall Study||6
213613|NCT00335283|504560|P2|COMPLETED|Overall Study||34
213614|NCT00335283|504561|P1|COMPLETED|Overall Study||30
213615|NCT00335283|504560|P2|STARTED|Overall Study||39
213616|NCT00335283|504561|P1|STARTED|Overall Study||36
213617|NCT00335257|504576|P3|NOT COMPLETED|Overall Study||0
213618|NCT00335257|504577|P2|NOT COMPLETED|Overall Study||0
213619|NCT00335257|504578|P1|NOT COMPLETED|Overall Study||0
213620|NCT00335257|504576|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
213621|NCT00335257|504577|P2|COMPLETED|Overall Study||9377
213622|NCT00335257|504578|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
213623|NCT00335257|504576|P3|STARTED|Overall Study||60190
213624|NCT00335257|504577|P2|STARTED|Overall Study||9377
213625|NCT00335257|504578|P1|STARTED|Overall Study||15542
213626|NCT00335153|504595|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
213627|NCT00335153|504595|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
213628|NCT00335153|504595|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
213629|NCT00335153|504595|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
213630|NCT00335153|504595|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
213631|NCT00335153|504595|P1|STARTED|Nasojejunal (NJ) Test Period||354
213632|NCT00334958|504634|P2|NOT COMPLETED|Overall Study||24
213633|NCT00334958|504635|P1|NOT COMPLETED|Overall Study||37
213634|NCT00334958|504634|P2|COMPLETED|Overall Study||156
213635|NCT00334958|504635|P1|COMPLETED|Overall Study||139
213636|NCT00334958|504634|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
213637|NCT00334958|504635|P1|STARTED|Overall Study||176
213638|NCT00334893|504649|P2|NOT COMPLETED|Overall Study||0
213639|NCT00334893|504650|P1|NOT COMPLETED|Overall Study||1
213640|NCT00334893|504649|P2|COMPLETED|Overall Study||37
213641|NCT00334893|504650|P1|COMPLETED|Overall Study||36
213642|NCT00334893|504649|P2|STARTED|Overall Study||37
213643|NCT00334893|504650|P1|STARTED|Overall Study||37
213644|NCT00334815|504658|P2|NOT COMPLETED|Overall Study||10
213645|NCT00334815|504659|P1|NOT COMPLETED|Overall Study||7
213646|NCT00334815|504658|P2|COMPLETED|Overall Study||3
213647|NCT00334815|504659|P1|COMPLETED|Overall Study||9
213648|NCT00334815|504658|P2|STARTED|Overall Study||13
213649|NCT00334815|504659|P1|STARTED|Overall Study||16
213650|NCT00334802|504673|P2|NOT COMPLETED|Overall Study||40
213651|NCT00334802|504674|P1|NOT COMPLETED|Overall Study||6
213652|NCT00334802|504673|P2|COMPLETED|Overall Study||16
213653|NCT00334802|504674|P1|COMPLETED|Overall Study||0
213654|NCT00334802|504673|P2|STARTED|Overall Study||56
213655|NCT00334802|504674|P1|STARTED|Overall Study||6
213656|NCT00334633|504694|P3|NOT COMPLETED|Overall Study||82
213657|NCT00334633|504695|P2|NOT COMPLETED|Overall Study||82
213658|NCT00334633|504696|P1|NOT COMPLETED|Overall Study||80
213659|NCT00334633|504694|P3|COMPLETED|Overall Study||114
213660|NCT00334633|504695|P2|COMPLETED|Overall Study||118
213661|NCT00334633|504696|P1|COMPLETED|Overall Study||117
213662|NCT00334633|504694|P3|STARTED|Overall Study||196
213663|NCT00334633|504695|P2|STARTED|Overall Study||200
213664|NCT00334633|504696|P1|STARTED|Overall Study||197
213665|NCT00334542|504704|P1|NOT COMPLETED|Overall Study||5
213666|NCT00334542|504704|P1|COMPLETED|Overall Study||45
213667|NCT00334542|504704|P1|STARTED|Overall Study||50
213668|NCT00334295|504709|P1|NOT COMPLETED|Overall Study||5
213669|NCT00334295|504709|P1|COMPLETED|Overall Study||30
213670|NCT00334295|504709|P1|STARTED|Overall Study||35
213671|NCT00334282|504719|P2|NOT COMPLETED|Overall Study||108
213672|NCT00334282|504720|P1|NOT COMPLETED|Overall Study||222
213673|NCT00334282|504719|P2|COMPLETED|Overall Study||37
213674|NCT00334282|504720|P1|COMPLETED|Overall Study||68
213675|NCT00334282|504719|P2|STARTED|Overall Study||145
213676|NCT00334282|504720|P1|STARTED|Overall Study||290
213677|NCT00334204|504743|P1|NOT COMPLETED|Overall Study||2
213678|NCT00334204|504743|P1|COMPLETED|Overall Study||56
213679|NCT00334204|504743|P1|STARTED|Overall Study||58
213680|NCT00334113|504751|P2|NOT COMPLETED|Overall Study||3
213681|NCT00334113|504752|P1|NOT COMPLETED|Overall Study||2
213682|NCT00334113|504751|P2|COMPLETED|Overall Study||31
213683|NCT00334113|504752|P1|COMPLETED|Overall Study||30
213684|NCT00334113|504751|P2|STARTED|Overall Study||34
213685|NCT00334113|504752|P1|STARTED|Overall Study||32
213686|NCT00334074|504758|P1|NOT COMPLETED|Overall Study||0
213687|NCT00334074|504758|P1|COMPLETED|Overall Study||30
213688|NCT00334074|504758|P1|STARTED|Overall Study||30
213689|NCT00334061|504763|P1|NOT COMPLETED|Overall Study||0
213690|NCT00334061|504763|P1|COMPLETED|Overall Study|November 2007|125
213691|NCT00334061|504763|P1|STARTED|Overall Study|June 2006|125
213692|NCT00333983|504775|P3|NOT COMPLETED|Overall Study||2
213693|NCT00333983|504776|P2|NOT COMPLETED|Overall Study||5
213694|NCT00333983|504777|P1|NOT COMPLETED|Overall Study||3
213695|NCT00333983|504775|P3|COMPLETED|Overall Study||19
213696|NCT00333983|504776|P2|COMPLETED|Overall Study||16
213697|NCT00333983|504777|P1|COMPLETED|Overall Study||17
213698|NCT00333983|504775|P3|STARTED|Overall Study||21
213699|NCT00333983|504776|P2|STARTED|Overall Study||21
213700|NCT00333983|504777|P1|STARTED|Overall Study||20
213701|NCT00333970|504787|P2|NOT COMPLETED|Overall Study||7
213702|NCT00333970|504788|P1|NOT COMPLETED|Overall Study||13
213703|NCT00333970|504787|P2|COMPLETED|Overall Study||18
213704|NCT00333970|504788|P1|COMPLETED|Overall Study||37
213705|NCT00333970|504787|P2|STARTED|Overall Study||25
213706|NCT00333970|504788|P1|STARTED|Overall Study||50
213707|NCT00333879|504794|P1|NOT COMPLETED|Overall Study||0
213708|NCT00333879|504794|P1|COMPLETED|Overall Study||4
213709|NCT00333879|504794|P1|STARTED|Overall Study||4
213710|NCT00333866|504803|P4|NOT COMPLETED|Overall Study||66
213711|NCT00333866|504804|P3|NOT COMPLETED|Overall Study||51
213712|NCT00333866|504805|P2|NOT COMPLETED|Overall Study||64
213713|NCT00333866|504806|P1|NOT COMPLETED|Overall Study||48
213714|NCT00333866|504803|P4|COMPLETED|Overall Study||121
213715|NCT00333866|504804|P3|COMPLETED|Overall Study||133
213716|NCT00333866|504805|P2|COMPLETED|Overall Study||123
213717|NCT00333866|504806|P1|COMPLETED|Overall Study||141
213718|NCT00333866|504803|P4|TREATED|Overall Study||186
213719|NCT00333866|504804|P3|TREATED|Overall Study||182
213720|NCT00333866|504805|P2|TREATED|Overall Study||184
213721|NCT00333866|504806|P1|TREATED|Overall Study||184
213722|NCT00333866|504803|P4|STARTED|Overall Study||187
213723|NCT00333866|504804|P3|STARTED|Overall Study||184
213724|NCT00333866|504805|P2|STARTED|Overall Study||187
213725|NCT00333866|504806|P1|STARTED|Overall Study||189
213726|NCT00333840|504866|P4|NOT COMPLETED|Second-line Treatment Period||188
213727|NCT00333840|504867|P3|NOT COMPLETED|Second-line Treatment Period||14
213728|NCT00333840|504868|P2|NOT COMPLETED|Second-line Treatment Period||0
213729|NCT00333840|504869|P1|NOT COMPLETED|Second-line Treatment Period||0
213730|NCT00333840|504866|P4|COMPLETED|Second-line Treatment Period||175
213731|NCT00333840|504867|P3|COMPLETED|Second-line Treatment Period||0
213732|NCT00333840|504868|P2|COMPLETED|Second-line Treatment Period||0
213733|NCT00333840|504869|P1|COMPLETED|Second-line Treatment Period||0
213734|NCT00333840|504866|P4|STARTED|Second-line Treatment Period||363
213735|NCT00333840|504867|P3|STARTED|Second-line Treatment Period||14
213736|NCT00333840|504868|P2|STARTED|Second-line Treatment Period||0
213737|NCT00333840|504869|P1|STARTED|Second-line Treatment Period||0
213738|NCT00333840|504866|P4|NOT COMPLETED|First-line Treatment Period||0
213739|NCT00333840|504867|P3|NOT COMPLETED|First-line Treatment Period||0
213740|NCT00333840|504868|P2|NOT COMPLETED|First-line Treatment Period||546
213741|NCT00333840|504869|P1|NOT COMPLETED|First-line Treatment Period||286
213742|NCT00333840|504866|P4|COMPLETED|First-line Treatment Period||0
213743|NCT00333840|504867|P3|COMPLETED|First-line Treatment Period||0
213744|NCT00333840|504868|P2|COMPLETED|First-line Treatment Period||7
213745|NCT00333840|504869|P1|COMPLETED|First-line Treatment Period||267
213746|NCT00333840|504866|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
213747|NCT00333840|504867|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
213748|NCT00333840|504868|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
213749|NCT00333840|504869|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
213750|NCT00333840|504866|P4|STARTED|First-line Treatment Period||0
213751|NCT00333840|504867|P3|STARTED|First-line Treatment Period||0
213752|NCT00333840|504868|P2|STARTED|First-line Treatment Period||553
213753|NCT00333840|504869|P1|STARTED|First-line Treatment Period||553
213754|NCT00333814|504897|P3|NOT COMPLETED|Overall Study||5
213755|NCT00333814|504898|P2|NOT COMPLETED|Overall Study||4
213756|NCT00333814|504899|P1|NOT COMPLETED|Overall Study||3
213757|NCT00333814|504897|P3|COMPLETED|Overall Study||71
213758|NCT00333814|504898|P2|COMPLETED|Overall Study||73
213759|NCT00333814|504899|P1|COMPLETED|Overall Study||73
213760|NCT00333814|504897|P3|STARTED|Overall Study||76
213761|NCT00333814|504898|P2|STARTED|Overall Study||77
213762|NCT00333814|504899|P1|STARTED|Overall Study||76
213763|NCT00333801|504915|P2|NOT COMPLETED|Overall Study||6
213764|NCT00333801|504916|P1|NOT COMPLETED|Overall Study||8
213765|NCT00333801|504915|P2|COMPLETED|Overall Study||36
213766|NCT00333801|504916|P1|COMPLETED|Overall Study||35
213767|NCT00333801|504915|P2|STARTED|Overall Study||42
213768|NCT00333801|504916|P1|STARTED|Overall Study||43
213769|NCT00333788|504934|P1|NOT COMPLETED|Overall Study||162
213770|NCT00333788|504934|P1|COMPLETED|Overall Study||71
213771|NCT00333788|504934|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
213772|NCT00333775|504964|P3|NOT COMPLETED|Overall Study||247
213773|NCT00333775|504965|P2|NOT COMPLETED|Overall Study||248
213774|NCT00333775|504966|P1|NOT COMPLETED|Overall Study||241
213775|NCT00333775|504964|P3|COMPLETED|Overall Study||0
213776|NCT00333775|504965|P2|COMPLETED|Overall Study||0
213777|NCT00333775|504966|P1|COMPLETED|Overall Study||0
213778|NCT00333775|504964|P3|Received Treatment|Overall Study||245
213779|NCT00333775|504965|P2|Received Treatment|Overall Study||247
213780|NCT00333775|504966|P1|Received Treatment|Overall Study||238
213781|NCT00333775|504964|P3|STARTED|Overall Study||247
213782|NCT00333775|504965|P2|STARTED|Overall Study||248
213783|NCT00333775|504966|P1|STARTED|Overall Study||241
213784|NCT00333762|504986|P1|NOT COMPLETED|Overall Study||4
213785|NCT00333762|504986|P1|COMPLETED|Overall Study||0
213786|NCT00333762|504986|P1|STARTED|Overall Study||4
213787|NCT00333710|504993|P3|NOT COMPLETED|Overall Study||1
213788|NCT00333710|504994|P2|NOT COMPLETED|Overall Study||4
213789|NCT00333710|504995|P1|NOT COMPLETED|Overall Study||11
213790|NCT00333710|504993|P3|COMPLETED|Overall Study||15
213791|NCT00333710|504994|P2|COMPLETED|Overall Study||14
213792|NCT00333710|504995|P1|COMPLETED|Overall Study||8
213793|NCT00333710|504993|P3|STARTED|Overall Study||16
213794|NCT00333710|504994|P2|STARTED|Overall Study||18
213795|NCT00333710|504995|P1|STARTED|Overall Study||19
213796|NCT00333619|505005|P2|NOT COMPLETED|Overall Study||10
213797|NCT00333619|505006|P1|NOT COMPLETED|Overall Study||21
213798|NCT00333619|505005|P2|COMPLETED|Overall Study||99
213799|NCT00333619|505006|P1|COMPLETED|Overall Study||89
213800|NCT00333619|505005|P2|3-month Follow-up|Overall Study||105
213801|NCT00333619|505006|P1|3-month Follow-up|Overall Study||101
213802|NCT00333619|505005|P2|Post-treatment|Overall Study||109
213803|NCT00333619|505006|P1|Post-treatment|Overall Study||109
213804|NCT00333619|505005|P2|STARTED|Overall Study||109
213805|NCT00333619|505006|P1|STARTED|Overall Study||110
213806|NCT00333437|505014|P1|NOT COMPLETED|Overall Study||0
213807|NCT00333437|505014|P1|COMPLETED|Overall Study||7
213808|NCT00333437|505014|P1|STARTED|Overall Study||7
213809|NCT00333359|505024|P2|NOT COMPLETED|Overall Study||122
213810|NCT00333359|505025|P1|NOT COMPLETED|Overall Study||73
213811|NCT00333359|505024|P2|COMPLETED|Overall Study||260
213812|NCT00333359|505025|P1|COMPLETED|Overall Study||126
213813|NCT00333359|505024|P2|STARTED|Overall Study||382
213814|NCT00333359|505025|P1|STARTED|Overall Study||199
213815|NCT00333229|505068|P2|NOT COMPLETED|Overall Study||1
213816|NCT00333229|505069|P1|NOT COMPLETED|Overall Study||0
213817|NCT00333229|505068|P2|COMPLETED|Overall Study||4
213818|NCT00333229|505069|P1|COMPLETED|Overall Study||6
213819|NCT00333229|505068|P2|STARTED|Overall Study||5
213820|NCT00333229|505069|P1|STARTED|Overall Study||6
213821|NCT00333138|505086|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
213822|NCT00333138|505087|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
213823|NCT00333138|505088|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
213824|NCT00333138|505086|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
213825|NCT00333138|505087|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
213826|NCT00333138|505088|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
213827|NCT00333138|505086|P3|STARTED|Extension Study (Month6 to End of Study)||80
213828|NCT00333138|505087|P2|STARTED|Extension Study (Month6 to End of Study)||87
213829|NCT00333138|505088|P1|STARTED|Extension Study (Month6 to End of Study)||83
213830|NCT00333138|505086|P3|NOT COMPLETED|Core Study (6 Months)||12
213831|NCT00333138|505087|P2|NOT COMPLETED|Core Study (6 Months)||6
213832|NCT00333138|505088|P1|NOT COMPLETED|Core Study (6 Months)||7
213833|NCT00333138|505086|P3|COMPLETED|Core Study (6 Months)||82
213834|NCT00333138|505087|P2|COMPLETED|Core Study (6 Months)||88
213835|NCT00333138|505088|P1|COMPLETED|Core Study (6 Months)||86
213836|NCT00333138|505086|P3|STARTED|Core Study (6 Months)||94
213837|NCT00333138|505087|P2|STARTED|Core Study (6 Months)||94
213838|NCT00333138|505088|P1|STARTED|Core Study (6 Months)||93
213839|NCT00332839|505127|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
213840|NCT00332839|505128|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
213841|NCT00332839|505127|P2|COMPLETED|Follow-up (Months 12 - 60)||31
213842|NCT00332839|505128|P1|COMPLETED|Follow-up (Months 12 - 60)||29
213843|NCT00332839|505127|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
213844|NCT00332839|505128|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
213845|NCT00332839|505127|P2|NOT COMPLETED|Core (Months 0 - 12)||18
213846|NCT00332839|505128|P1|NOT COMPLETED|Core (Months 0 - 12)||10
213847|NCT00332839|505127|P2|COMPLETED|Core (Months 0 - 12)||28
213848|NCT00332839|505128|P1|COMPLETED|Core (Months 0 - 12)||37
213849|NCT00332839|505127|P2|Safety Set|Core (Months 0 - 12)||46
213850|NCT00332839|505128|P1|Safety Set|Core (Months 0 - 12)||47
213851|NCT00332839|505127|P2|STARTED|Core (Months 0 - 12)||46
213852|NCT00332839|505128|P1|STARTED|Core (Months 0 - 12)||47
213853|NCT00332722|505148|P2|NOT COMPLETED|Overall Study||0
213854|NCT00332722|505149|P1|NOT COMPLETED|Overall Study||0
213855|NCT00332722|505148|P2|COMPLETED|Overall Study||60
213856|NCT00332722|505149|P1|COMPLETED|Overall Study||60
213857|NCT00332722|505148|P2|STARTED|Overall Study||60
213858|NCT00332722|505149|P1|STARTED|Overall Study||60
213859|NCT00332709|505159|P2|NOT COMPLETED|Overall Study||20
213860|NCT00332709|505160|P1|NOT COMPLETED|Overall Study||16
213861|NCT00332709|505159|P2|COMPLETED|Overall Study||21
213862|NCT00332709|505160|P1|COMPLETED|Overall Study||24
213863|NCT00332709|505159|P2|STARTED|Overall Study||41
213864|NCT00332709|505160|P1|STARTED|Overall Study||40
213865|NCT00332696|505184|P2|NOT COMPLETED|Overall Study||30
213866|NCT00332696|505185|P1|NOT COMPLETED|Overall Study||30
213867|NCT00332696|505184|P2|COMPLETED|Overall Study||2
213868|NCT00332696|505185|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
213869|NCT00332696|505184|P2|Completed Day 14 Visit|Overall Study||15
213870|NCT00332696|505185|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
213871|NCT00332696|505184|P2|STARTED|Overall Study||32
213872|NCT00332696|505185|P1|STARTED|Overall Study||32
213873|NCT00332644|505217|P6|NOT COMPLETED|Overall Study||15
213874|NCT00332644|505218|P5|NOT COMPLETED|Overall Study||12
213875|NCT00332644|505219|P4|NOT COMPLETED|Overall Study||20
213876|NCT00332644|505220|P3|NOT COMPLETED|Overall Study||9
213877|NCT00332644|505221|P2|NOT COMPLETED|Overall Study||22
213878|NCT00332644|505222|P1|NOT COMPLETED|Overall Study||12
213879|NCT00332644|505217|P6|COMPLETED|Overall Study||174
213880|NCT00332644|505218|P5|COMPLETED|Overall Study||250
213881|NCT00332644|505219|P4|COMPLETED|Overall Study||244
213882|NCT00332644|505220|P3|COMPLETED|Overall Study||258
213883|NCT00332644|505221|P2|COMPLETED|Overall Study||238
213884|NCT00332644|505222|P1|COMPLETED|Overall Study||250
213885|NCT00332644|505217|P6|STARTED|Overall Study||189
213886|NCT00332644|505218|P5|STARTED|Overall Study||262
213887|NCT00332644|505219|P4|STARTED|Overall Study||264
213888|NCT00332644|505220|P3|STARTED|Overall Study||267
213889|NCT00332644|505221|P2|STARTED|Overall Study||260
213890|NCT00332644|505222|P1|STARTED|Overall Study||262
213891|NCT00332605|505239|P3|NOT COMPLETED|Overall Study||8
213892|NCT00332605|505240|P2|NOT COMPLETED|Overall Study||2
213893|NCT00332605|505241|P1|NOT COMPLETED|Overall Study||2
213894|NCT00332605|505239|P3|COMPLETED|Overall Study||9
213895|NCT00332605|505240|P2|COMPLETED|Overall Study||12
213896|NCT00332605|505241|P1|COMPLETED|Overall Study||12
213897|NCT00332605|505239|P3|STARTED|Overall Study||17
213898|NCT00332605|505240|P2|STARTED|Overall Study||14
213899|NCT00332605|505241|P1|STARTED|Overall Study||14
213900|NCT00332579|505251|P2|NOT COMPLETED|Overall Study||1
213901|NCT00332579|505252|P1|NOT COMPLETED|Overall Study||1
213902|NCT00332579|505251|P2|COMPLETED|Overall Study||12
213903|NCT00332579|505252|P1|COMPLETED|Overall Study||11
213904|NCT00332579|505251|P2|STARTED|Overall Study||13
213905|NCT00332579|505252|P1|STARTED|Overall Study||12
213906|NCT00332488|505261|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
213907|NCT00332488|505262|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
213908|NCT00332488|505263|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
213909|NCT00332488|505261|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
213910|NCT00332488|505262|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
213911|NCT00332488|505263|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
213912|NCT00332488|505261|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
213913|NCT00332488|505262|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
213914|NCT00332488|505263|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
213915|NCT00332488|505261|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
213916|NCT00332488|505262|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
213917|NCT00332488|505263|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
213918|NCT00332488|505261|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
213919|NCT00332488|505262|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
213920|NCT00332488|505263|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
213921|NCT00332488|505261|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
213922|NCT00332488|505262|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
213923|NCT00332488|505263|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
213924|NCT00332462|505275|P1|NOT COMPLETED|Overall Study||16
213925|NCT00332462|505275|P1|COMPLETED|Overall Study||18
213926|NCT00332462|505275|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
213927|NCT00332462|505275|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
213928|NCT00332462|505275|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
213929|NCT00330759|505284|P2|NOT COMPLETED|Overall Study||706
213930|NCT00330759|505285|P1|NOT COMPLETED|Overall Study||712
213931|NCT00330759|505284|P2|COMPLETED|Overall Study||180
213932|NCT00330759|505285|P1|COMPLETED|Overall Study||178
213933|NCT00330759|505284|P2|Received Investigational Product|Overall Study||878
213934|NCT00330759|505285|P1|Received Investigational Product|Overall Study||878
213935|NCT00330759|505284|P2|STARTED|Overall Study||886
213936|NCT00330759|505285|P1|STARTED|Overall Study||890
213937|NCT00330733|505297|P2|NOT COMPLETED|Overall Study||5
213938|NCT00330733|505298|P1|NOT COMPLETED|Overall Study||7
213939|NCT00330733|505297|P2|COMPLETED|Overall Study||29
213940|NCT00330733|505298|P1|COMPLETED|Overall Study||30
213941|NCT00330733|505297|P2|Received Study Medication|Overall Study||34
213942|NCT00330733|505298|P1|Received Study Medication|Overall Study||36
213943|NCT00330733|505297|P2|STARTED|Overall Study||34
213944|NCT00330733|505298|P1|STARTED|Overall Study||37
213945|NCT00330668|505304|P1|NOT COMPLETED|Overall Study||114
213946|NCT00330668|505304|P1|COMPLETED|Overall Study||0
213947|NCT00330668|505304|P1|STARTED|Overall Study||114
213948|NCT00330616|505311|P1|NOT COMPLETED|Overall Study||21
213949|NCT00330616|505311|P1|COMPLETED|Overall Study||14
213950|NCT00330616|505311|P1|STARTED|Overall Study||35
213951|NCT00330564|505330|P1|NOT COMPLETED|Overall Study||0
213952|NCT00330564|505330|P1|COMPLETED|Overall Study||15
213953|NCT00330564|505330|P1|STARTED|Overall Study||15
213954|NCT00332332|505335|P1|NOT COMPLETED|Overall Study||68
213955|NCT00332332|505335|P1|COMPLETED|Overall Study||178
213956|NCT00332332|505335|P1|Received Study Medication|Overall Study||230
213957|NCT00332332|505335|P1|STARTED|Overall Study||246
213958|NCT00332241|505344|P2|NOT COMPLETED|Overall Study||8
213959|NCT00332241|505345|P1|NOT COMPLETED|Overall Study||15
213960|NCT00332241|505344|P2|COMPLETED|Overall Study||39
213961|NCT00332241|505345|P1|COMPLETED|Overall Study||36
213962|NCT00332241|505344|P2|STARTED|Overall Study||47
213963|NCT00332241|505345|P1|STARTED|Overall Study||51
213964|NCT00332189|505365|P1|NOT COMPLETED|Overall Study||21
213965|NCT00332189|505365|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
213966|NCT00332189|505365|P1|STARTED|Overall Study||111
213967|NCT00332163|505372|P2|NOT COMPLETED|Overall Study||0
213968|NCT00332163|505373|P1|NOT COMPLETED|Overall Study||0
213969|NCT00332163|505372|P2|COMPLETED|Overall Study||47
213970|NCT00332163|505373|P1|COMPLETED|Overall Study||48
213971|NCT00332163|505372|P2|Received Treatment|Overall Study||47
213972|NCT00332163|505373|P1|Received Treatment|Overall Study||48
213973|NCT00332163|505372|P2|STARTED|Overall Study||47
213974|NCT00332163|505373|P1|STARTED|Overall Study||48
213975|NCT00330460|505407|P2|NOT COMPLETED|Overall Study||33
213976|NCT00330460|505408|P1|NOT COMPLETED|Overall Study||42
213977|NCT00330460|505407|P2|COMPLETED|Overall Study||561
213978|NCT00330460|505408|P1|COMPLETED|Overall Study||553
213979|NCT00330460|505407|P2|STARTED|Overall Study||594
213980|NCT00330460|505408|P1|STARTED|Overall Study||595
213981|NCT00330421|505422|P2|NOT COMPLETED|Overall Study||0
213982|NCT00330421|505423|P1|NOT COMPLETED|Overall Study||0
213983|NCT00330421|505422|P2|COMPLETED|Overall Study||0
213984|NCT00330421|505423|P1|COMPLETED|Overall Study||15
213985|NCT00330421|505422|P2|STARTED|Overall Study||0
213986|NCT00330421|505423|P1|STARTED|Overall Study||15
213987|NCT00330382|505429|P2|NOT COMPLETED|Overall Study||17
213988|NCT00330382|505430|P1|NOT COMPLETED|Overall Study||24
213989|NCT00330382|505429|P2|COMPLETED|Overall Study||48
213990|NCT00330382|505430|P1|COMPLETED|Overall Study||43
213991|NCT00330382|505429|P2|STARTED|Overall Study||65
213992|NCT00330382|505430|P1|STARTED|Overall Study||67
213993|NCT00331864|505453|P2|NOT COMPLETED|Overall Study||4
213994|NCT00331864|505454|P1|NOT COMPLETED|Overall Study||58
213995|NCT00331864|505453|P2|COMPLETED|Overall Study||14
213996|NCT00331864|505454|P1|COMPLETED|Overall Study||455
213997|NCT00331864|505453|P2|STARTED|Overall Study||18
213998|NCT00331864|505454|P1|STARTED|Overall Study||513
213999|NCT00331799|505473|P1|NOT COMPLETED|Overall Study||3
214000|NCT00331799|505473|P1|COMPLETED|Overall Study||15
214001|NCT00331799|505473|P1|STARTED|Overall Study||18
214002|NCT00331760|505479|P2|NOT COMPLETED|Overall Study||8
214003|NCT00331760|505480|P1|NOT COMPLETED|Overall Study||15
214004|NCT00331760|505479|P2|COMPLETED|Overall Study||40
214005|NCT00331760|505480|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
214006|NCT00331760|505479|P2|STARTED|Overall Study||48
214007|NCT00331760|505480|P1|STARTED|Overall Study||58
214008|NCT00331682|505486|P1|NOT COMPLETED|Overall Study||1
214009|NCT00331682|505486|P1|COMPLETED|Overall Study||9
214010|NCT00331682|505486|P1|STARTED|Overall Study||10
214011|NCT00331422|505492|P1|NOT COMPLETED|Overall Study||5
214012|NCT00331422|505492|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
214013|NCT00331422|505492|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
214014|NCT00331409|505501|P1|NOT COMPLETED|Overall Study||4
214015|NCT00331409|505501|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
214016|NCT00331409|505501|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
214017|NCT00331006|505508|P1|NOT COMPLETED|Follow-Up Phase II||3
214018|NCT00331006|505508|P1|COMPLETED|Follow-Up Phase II||11
214019|NCT00331006|505508|P1|STARTED|Follow-Up Phase II||14
214020|NCT00331006|505508|P1|NOT COMPLETED|Follow-Up Phase I||1
214021|NCT00331006|505508|P1|COMPLETED|Follow-Up Phase I||14
214022|NCT00331006|505508|P1|STARTED|Follow-Up Phase I||15
214023|NCT00331006|505508|P1|NOT COMPLETED|Treatment Phase||1
214024|NCT00331006|505508|P1|COMPLETED|Treatment Phase||15
214025|NCT00331006|505508|P1|STARTED|Treatment Phase||16
214026|NCT00331006|505508|P1|NOT COMPLETED|Screening Phase||7
214027|NCT00331006|505508|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
214028|NCT00331006|505508|P1|STARTED|Screening Phase||23
214029|NCT00330967|505521|P2|NOT COMPLETED|Overall Study||14
214030|NCT00330967|505522|P1|NOT COMPLETED|Overall Study||0
214031|NCT00330967|505521|P2|COMPLETED|Overall Study||11
214032|NCT00330967|505522|P1|COMPLETED|Overall Study||0
214033|NCT00330967|505521|P2|STARTED|Overall Study||25
214034|NCT00330967|505522|P1|STARTED|Overall Study||0
214035|NCT00330928|505533|P1|NOT COMPLETED|Overall Study||17
214036|NCT00330928|505533|P1|COMPLETED|Overall Study||89
214037|NCT00330928|505533|P1|1 Year Phone Contact|Overall Study||89
214038|NCT00330928|505533|P1|7 Day Phone Contact|Overall Study||99
214039|NCT00330928|505533|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
214040|NCT00330915|505538|P1|NOT COMPLETED|Overall Study||0
214041|NCT00330915|505538|P1|COMPLETED|Overall Study||37
214042|NCT00330915|505538|P1|STARTED|Overall Study||37
214043|NCT00330876|505545|P2|NOT COMPLETED|Overall Study||13
214044|NCT00330876|505546|P1|NOT COMPLETED|Overall Study||71
214045|NCT00330876|505545|P2|COMPLETED|Overall Study||77
214046|NCT00330876|505546|P1|COMPLETED|Overall Study||378
214047|NCT00330876|505545|P2|STARTED|Overall Study||90
214048|NCT00330876|505546|P1|STARTED|Overall Study||449
214049|NCT00330174|505556|P2|NOT COMPLETED|Overall Study||19
214050|NCT00330174|505557|P1|NOT COMPLETED|Overall Study||22
214051|NCT00330174|505556|P2|COMPLETED|Overall Study||26
214052|NCT00330174|505557|P1|COMPLETED|Overall Study||23
214053|NCT00330174|505556|P2|STARTED|Overall Study||45
214054|NCT00330174|505557|P1|STARTED|Overall Study||45
214055|NCT00330161|505569|P1|NOT COMPLETED|Overall Study||0
214056|NCT00330161|505569|P1|COMPLETED|Overall Study||29
214057|NCT00330161|505569|P1|STARTED|Overall Study||29
214058|NCT00329901|505581|P3|NOT COMPLETED|Overall Study||4
214059|NCT00329901|505582|P2|NOT COMPLETED|Overall Study||5
214060|NCT00329901|505583|P1|NOT COMPLETED|Overall Study||9
214061|NCT00329901|505581|P3|COMPLETED|Overall Study||353
214062|NCT00329901|505582|P2|COMPLETED|Overall Study||349
214063|NCT00329901|505583|P1|COMPLETED|Overall Study||352
214064|NCT00329901|505581|P3|STARTED|Overall Study||357
214065|NCT00329901|505582|P2|STARTED|Overall Study||354
214066|NCT00329901|505583|P1|STARTED|Overall Study||361
214067|NCT00329849|505613|P2|NOT COMPLETED|Overall Study||4
214068|NCT00329849|505614|P1|NOT COMPLETED|Overall Study||6
214069|NCT00329849|505613|P2|COMPLETED|Overall Study||546
214070|NCT00329849|505614|P1|COMPLETED|Overall Study||944
214071|NCT00329849|505613|P2|STARTED|Overall Study||550
214072|NCT00329849|505614|P1|STARTED|Overall Study||950
214073|NCT00329836|505634|P1|NOT COMPLETED|Overall Study||0
214074|NCT00329836|505634|P1|COMPLETED|Overall Study||41
214075|NCT00329836|505634|P1|STARTED|Overall Study||41
214076|NCT00329784|505642|P2|NOT COMPLETED|Overall Study||5
214077|NCT00329784|505643|P1|NOT COMPLETED|Overall Study||5
214078|NCT00329784|505642|P2|COMPLETED|Overall Study||314
214079|NCT00329784|505643|P1|COMPLETED|Overall Study||316
214080|NCT00329784|505642|P2|STARTED|Overall Study||319
214081|NCT00329784|505643|P1|STARTED|Overall Study||321
214082|NCT00329771|505665|P1|NOT COMPLETED|Overall Study||3
214083|NCT00329771|505665|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
214084|NCT00329771|505665|P1|STARTED|Overall Study||28
214085|NCT00329745|505671|P2|NOT COMPLETED|Overall Study||102
214086|NCT00329745|505672|P1|NOT COMPLETED|Overall Study||87
214087|NCT00329745|505671|P2|COMPLETED|Overall Study||4226
214088|NCT00329745|505672|P1|COMPLETED|Overall Study||4272
214089|NCT00329745|505671|P2|STARTED|Overall Study||4328
214090|NCT00329745|505672|P1|STARTED|Overall Study||4359
214091|NCT00329732|505682|P2|NOT COMPLETED|Overall Study||0
214092|NCT00329732|505683|P1|NOT COMPLETED|Overall Study||0
214093|NCT00329732|505682|P2|COMPLETED|Overall Study||0
214094|NCT00329732|505683|P1|COMPLETED|Overall Study||2
214095|NCT00329732|505682|P2|STARTED|Overall Study||0
214096|NCT00329732|505683|P1|STARTED|Overall Study||2
214097|NCT00329719|505692|P4|NOT COMPLETED|Overall Study||1
214098|NCT00329719|505693|P3|NOT COMPLETED|Overall Study||0
214099|NCT00329719|505694|P2|NOT COMPLETED|Overall Study||0
214100|NCT00329719|505695|P1|NOT COMPLETED|Overall Study||0
214101|NCT00329719|505692|P4|COMPLETED|Overall Study||44
214102|NCT00329719|505693|P3|COMPLETED|Overall Study||9
214103|NCT00329719|505694|P2|COMPLETED|Overall Study||49
214104|NCT00329719|505695|P1|COMPLETED|Overall Study||12
214105|NCT00329719|505692|P4|STARTED|Overall Study||45
214106|NCT00329719|505693|P3|STARTED|Overall Study||9
214107|NCT00329719|505694|P2|STARTED|Overall Study||49
214108|NCT00329719|505695|P1|STARTED|Overall Study||12
214109|NCT00329641|505717|P1|NOT COMPLETED|Overall Study||6
214110|NCT00329641|505717|P1|COMPLETED|Overall Study||19
214111|NCT00329641|505717|P1|Eligible and Received Treatment|Overall Study||24
214112|NCT00329641|505717|P1|Eligible|Overall Study||25
214113|NCT00329641|505717|P1|STARTED|Overall Study||25
214114|NCT00329602|505726|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
214115|NCT00329602|505727|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
214116|NCT00329602|505728|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
214117|NCT00329602|505726|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
214118|NCT00329602|505727|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
214119|NCT00329602|505728|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
214120|NCT00329602|505726|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
214121|NCT00329602|505727|P2|STARTED|40-Week Open-Label Treatment Phase||0
214122|NCT00329602|505728|P1|STARTED|40-Week Open-Label Treatment Phase||0
214123|NCT00329602|505726|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
214124|NCT00329602|505727|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
214125|NCT00329602|505728|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
214126|NCT00329602|505726|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
214127|NCT00329602|505727|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
214128|NCT00329602|505728|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
214129|NCT00329602|505726|P3|STARTED|26-Week Double-Blind Treatment Phase||0
214130|NCT00329602|505727|P2|STARTED|26-Week Double-Blind Treatment Phase||197
214131|NCT00329602|505728|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
214132|NCT00329550|505766|P3|NOT COMPLETED|Overall Study||4
214133|NCT00329550|505767|P2|NOT COMPLETED|Overall Study||4
214134|NCT00329550|505768|P1|NOT COMPLETED|Overall Study||4
214135|NCT00329550|505766|P3|COMPLETED|Overall Study||12
214136|NCT00329550|505767|P2|COMPLETED|Overall Study||11
214137|NCT00329550|505768|P1|COMPLETED|Overall Study||5
214138|NCT00329550|505766|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
214139|NCT00329550|505767|P2|STARTED|Overall Study||15
214140|NCT00329550|505768|P1|STARTED|Overall Study||9
214141|NCT00329524|506015|P1|NOT COMPLETED|Overall Study||0
214142|NCT00329524|506015|P1|COMPLETED|Overall Study||5
214143|NCT00329524|506015|P1|STARTED|Overall Study||5
214144|NCT00329433|506023|P2|NOT COMPLETED|Overall Study||0
214145|NCT00329433|506024|P1|NOT COMPLETED|Overall Study||0
214146|NCT00329433|506023|P2|COMPLETED|Overall Study||59
214147|NCT00329433|506024|P1|COMPLETED|Overall Study||61
214148|NCT00329433|506023|P2|STARTED|Overall Study||59
214149|NCT00329433|506024|P1|STARTED|Overall Study||61
214150|NCT00329420|506033|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
214151|NCT00329420|506034|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
214152|NCT00329420|506035|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
214153|NCT00329420|506033|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
214154|NCT00329420|506034|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
214155|NCT00329420|506035|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
214156|NCT00329420|506033|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
214157|NCT00329420|506034|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
214158|NCT00329420|506035|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
214159|NCT00329420|506033|P3|NOT COMPLETED|Re-induction Phase||8
214160|NCT00329420|506034|P2|NOT COMPLETED|Re-induction Phase||6
214161|NCT00329420|506035|P1|NOT COMPLETED|Re-induction Phase||6
214162|NCT00329420|506033|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
214163|NCT00329420|506034|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
214164|NCT00329420|506035|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
214165|NCT00329420|506033|P3|STARTED|Re-induction Phase||15
214166|NCT00329420|506034|P2|STARTED|Re-induction Phase||13
214167|NCT00329420|506035|P1|STARTED|Re-induction Phase||18
214168|NCT00329407|506414|P1|NOT COMPLETED|Overall Study||1
214169|NCT00329407|506414|P1|COMPLETED|Overall Study||9
214170|NCT00329407|506414|P1|STARTED|Overall Study||10
214171|NCT00329238|506421|P2|NOT COMPLETED|Overall Study||281
214172|NCT00329238|506422|P1|NOT COMPLETED|Overall Study||276
214173|NCT00329238|506421|P2|COMPLETED|Overall Study||1145
214174|NCT00329238|506422|P1|COMPLETED|Overall Study||1154
214175|NCT00329238|506421|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
214176|NCT00329238|506422|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
214177|NCT00329160|506458|P1|NOT COMPLETED|Overall Study||88
214178|NCT00329160|506458|P1|COMPLETED|Overall Study||126
214179|NCT00329160|506458|P1|Treatment Period|Overall Study||214
214180|NCT00329160|506458|P1|Observation Period|Overall Study||214
214181|NCT00329160|506458|P1|STARTED|Overall Study||214
214182|NCT00329108|506467|P2|NOT COMPLETED|Overall Study||12
214183|NCT00329108|506468|P1|NOT COMPLETED|Overall Study||10
214184|NCT00329108|506467|P2|COMPLETED|Overall Study||2
214185|NCT00329108|506468|P1|COMPLETED|Overall Study||5
214186|NCT00329108|506467|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
214187|NCT00329108|506468|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
214188|NCT00329030|506476|P2|NOT COMPLETED|Overall Study||6
214189|NCT00329030|506477|P1|NOT COMPLETED|Overall Study||8
214190|NCT00329030|506476|P2|COMPLETED|Overall Study||107
214191|NCT00329030|506477|P1|COMPLETED|Overall Study||103
214192|NCT00329030|506476|P2|STARTED|Overall Study||113
214193|NCT00329030|506477|P1|STARTED|Overall Study||111
214194|NCT00328926|506508|P3|NOT COMPLETED|Overall Study||2
214195|NCT00328926|506509|P2|NOT COMPLETED|Overall Study||3
214196|NCT00328926|506510|P1|NOT COMPLETED|Overall Study||2
214197|NCT00328926|506508|P3|COMPLETED|Overall Study||1
214198|NCT00328926|506509|P2|COMPLETED|Overall Study||0
214199|NCT00328926|506510|P1|COMPLETED|Overall Study||3
214200|NCT00328926|506508|P3|STARTED|Overall Study||3
214201|NCT00328926|506509|P2|STARTED|Overall Study||3
214202|NCT00328926|506510|P1|STARTED|Overall Study||5
214203|NCT00328861|506526|P2|NOT COMPLETED|Overall Study||0
214204|NCT00328861|506527|P1|NOT COMPLETED|Overall Study||0
214205|NCT00328861|506526|P2|COMPLETED|Overall Study||1
214206|NCT00328861|506527|P1|COMPLETED|Overall Study||7
214207|NCT00328861|506526|P2|STARTED|Overall Study||1
214208|NCT00328861|506527|P1|STARTED|Overall Study||7
214209|NCT00328783|506535|P1|NOT COMPLETED|Overall Study||26
214210|NCT00328783|506535|P1|COMPLETED|Overall Study||86
214211|NCT00328783|506535|P1|STARTED|Overall Study||112
214212|NCT00328770|506540|P1|NOT COMPLETED|Overall Study||0
214213|NCT00328770|506540|P1|COMPLETED|Overall Study||70
214214|NCT00328770|506540|P1|STARTED|Overall Study||70
214215|NCT00328627|506558|P12|NOT COMPLETED|Overall Study||16
214216|NCT00328627|506559|P11|NOT COMPLETED|Overall Study||18
214217|NCT00328627|506560|P10|NOT COMPLETED|Overall Study||32
214218|NCT00328627|506561|P9|NOT COMPLETED|Overall Study||17
214219|NCT00328627|506562|P8|NOT COMPLETED|Overall Study||14
214220|NCT00328627|506563|P7|NOT COMPLETED|Overall Study||35
214221|NCT00328627|506564|P6|NOT COMPLETED|Overall Study||20
214222|NCT00328627|506565|P5|NOT COMPLETED|Overall Study||15
214223|NCT00328627|506566|P4|NOT COMPLETED|Overall Study||37
214224|NCT00328627|506567|P3|NOT COMPLETED|Overall Study||28
214225|NCT00328627|506568|P2|NOT COMPLETED|Overall Study||31
214226|NCT00328627|506569|P1|NOT COMPLETED|Overall Study||59
214227|NCT00328627|506558|P12|COMPLETED|Overall Study||114
214228|NCT00328627|506559|P11|COMPLETED|Overall Study||112
214229|NCT00328627|506560|P10|COMPLETED|Overall Study||97
214230|NCT00328627|506561|P9|COMPLETED|Overall Study||113
214231|NCT00328627|506562|P8|COMPLETED|Overall Study||116
214232|NCT00328627|506563|P7|COMPLETED|Overall Study||94
214233|NCT00328627|506564|P6|COMPLETED|Overall Study||110
214234|NCT00328627|506565|P5|COMPLETED|Overall Study||115
214235|NCT00328627|506566|P4|COMPLETED|Overall Study||93
214236|NCT00328627|506567|P3|COMPLETED|Overall Study||101
214237|NCT00328627|506568|P2|COMPLETED|Overall Study||97
214238|NCT00328627|506569|P1|COMPLETED|Overall Study||70
214239|NCT00328627|506558|P12|Safety Set|Overall Study||130
214240|NCT00328627|506559|P11|Safety Set|Overall Study||130
214241|NCT00328627|506560|P10|Safety Set|Overall Study||129
214242|NCT00328627|506561|P9|Safety Set|Overall Study||130
214243|NCT00328627|506562|P8|Safety Set|Overall Study||130
214244|NCT00328627|506563|P7|Safety Set|Overall Study||129
214245|NCT00328627|506564|P6|Safety Set|Overall Study||130
214246|NCT00328627|506565|P5|Safety Set|Overall Study||130
214247|NCT00328627|506566|P4|Safety Set|Overall Study||129
214248|NCT00328627|506567|P3|Safety Set|Overall Study||129
214249|NCT00328627|506568|P2|Safety Set|Overall Study||128
214250|NCT00328627|506569|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
214251|NCT00328627|506558|P12|STARTED|Overall Study||130
214252|NCT00328627|506559|P11|STARTED|Overall Study||130
214253|NCT00328627|506560|P10|STARTED|Overall Study||129
214254|NCT00328627|506561|P9|STARTED|Overall Study||130
214255|NCT00328627|506562|P8|STARTED|Overall Study||130
214256|NCT00328627|506563|P7|STARTED|Overall Study||129
214257|NCT00328627|506564|P6|STARTED|Overall Study||130
214258|NCT00328627|506565|P5|STARTED|Overall Study||130
214259|NCT00328627|506566|P4|STARTED|Overall Study||130
214260|NCT00328627|506567|P3|STARTED|Overall Study||129
214261|NCT00328627|506568|P2|STARTED|Overall Study||128
214262|NCT00328627|506569|P1|STARTED|Overall Study||129
214263|NCT00328614|508092|P6|NOT COMPLETED|Overall Study||1
214264|NCT00328614|508093|P5|NOT COMPLETED|Overall Study||1
214265|NCT00328614|508094|P4|NOT COMPLETED|Overall Study||1
214266|NCT00328614|508095|P3|NOT COMPLETED|Overall Study||0
214267|NCT00328614|508096|P2|NOT COMPLETED|Overall Study||0
214268|NCT00328614|508097|P1|NOT COMPLETED|Overall Study||0
214269|NCT00328614|508092|P6|COMPLETED|Overall Study||5
214270|NCT00328614|508093|P5|COMPLETED|Overall Study||5
214271|NCT00328614|508094|P4|COMPLETED|Overall Study||5
214272|NCT00328614|508095|P3|COMPLETED|Overall Study||6
214273|NCT00328614|508096|P2|COMPLETED|Overall Study||4
214274|NCT00328614|508097|P1|COMPLETED|Overall Study||4
214275|NCT00328614|508092|P6|STARTED|Overall Study||6
214276|NCT00328614|508093|P5|STARTED|Overall Study||6
214277|NCT00328614|508094|P4|STARTED|Overall Study||6
214278|NCT00328614|508095|P3|STARTED|Overall Study||6
214279|NCT00328614|508096|P2|STARTED|Overall Study||4
214280|NCT00328614|508097|P1|STARTED|Overall Study||4
214281|NCT00328562|508106|P1|NOT COMPLETED|Overall Study||1
214282|NCT00328562|508106|P1|COMPLETED|Overall Study||12
214283|NCT00328562|508106|P1|STARTED|Overall Study||13
214284|NCT00328510|508115|P2|NOT COMPLETED|Overall Study||4
214285|NCT00328510|508116|P1|NOT COMPLETED|Overall Study||10
214286|NCT00328510|508115|P2|COMPLETED|Overall Study||37
214287|NCT00328510|508116|P1|COMPLETED|Overall Study||32
214288|NCT00328510|508115|P2|STARTED|Overall Study||41
214289|NCT00328510|508116|P1|STARTED|Overall Study||42
214290|NCT00328263|508124|P2|NOT COMPLETED|Overall Study||4
214291|NCT00328263|508125|P1|NOT COMPLETED|Overall Study||3
214292|NCT00328263|508124|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
214293|NCT00328263|508125|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
214294|NCT00328263|508124|P2|STARTED|Overall Study||221
214295|NCT00328263|508125|P1|STARTED|Overall Study||216
214296|NCT00328198|508131|P1|NOT COMPLETED|Follow-up||35
214297|NCT00328198|508131|P1|COMPLETED|Follow-up||43
214298|NCT00328198|508131|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
214299|NCT00328198|508131|P1|NOT COMPLETED|Treatment||38
214300|NCT00328198|508131|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
214301|NCT00328198|508131|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
214302|NCT00328172|508146|P5|NOT COMPLETED|Overall Study||5
214303|NCT00328172|508147|P4|NOT COMPLETED|Overall Study||13
214304|NCT00328172|508148|P3|NOT COMPLETED|Overall Study||10
214305|NCT00328172|508149|P2|NOT COMPLETED|Overall Study||14
214306|NCT00328172|508150|P1|NOT COMPLETED|Overall Study||22
214307|NCT00328172|508146|P5|COMPLETED|Overall Study||60
214308|NCT00328172|508147|P4|COMPLETED|Overall Study||42
214309|NCT00328172|508148|P3|COMPLETED|Overall Study||47
214310|NCT00328172|508149|P2|COMPLETED|Overall Study||44
214311|NCT00328172|508150|P1|COMPLETED|Overall Study||45
214312|NCT00328172|508146|P5|STARTED|Overall Study||65
214313|NCT00328172|508147|P4|STARTED|Overall Study||55
214314|NCT00328172|508148|P3|STARTED|Overall Study||57
214315|NCT00328172|508149|P2|STARTED|Overall Study||58
214316|NCT00328172|508150|P1|STARTED|Overall Study||67
214317|NCT00328094|508174|P2|NOT COMPLETED|Overall Study||3
214318|NCT00328094|508175|P1|NOT COMPLETED|Overall Study||3
214319|NCT00328094|508174|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
214320|NCT00328094|508175|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
214321|NCT00328094|508174|P2|STARTED|Overall Study||125
214322|NCT00328094|508175|P1|STARTED|Overall Study||117
214323|NCT00328042|508185|P2|NOT COMPLETED|Overall Study||2
214324|NCT00328042|508186|P1|NOT COMPLETED|Overall Study||0
214325|NCT00328042|508185|P2|COMPLETED|Overall Study||63
214326|NCT00328042|508186|P1|COMPLETED|Overall Study||69
214327|NCT00328042|508185|P2|STARTED|Overall Study||65
214328|NCT00328042|508186|P1|STARTED|Overall Study||69
214329|NCT00327717|508196|P2|NOT COMPLETED|Overall Study||14
214330|NCT00327717|508197|P1|NOT COMPLETED|Overall Study||9
214331|NCT00327717|508196|P2|COMPLETED|Overall Study||106
214332|NCT00327717|508197|P1|COMPLETED|Overall Study||111
214333|NCT00327717|508196|P2|STARTED|Overall Study||120
214334|NCT00327717|508197|P1|STARTED|Overall Study||120
214335|NCT00327470|508223|P2|NOT COMPLETED|Overall Study||63
214336|NCT00327470|508224|P1|NOT COMPLETED|Overall Study||29
214337|NCT00327470|508223|P2|COMPLETED|Overall Study||118
214338|NCT00327470|508224|P1|COMPLETED|Overall Study||78
214339|NCT00327470|508223|P2|Treated|Overall Study||179
214340|NCT00327470|508224|P1|Treated|Overall Study||107
214341|NCT00327470|508223|P2|STARTED|Overall Study||181
214342|NCT00327470|508224|P1|STARTED|Overall Study||107
214343|NCT00327444|508244|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
214344|NCT00327444|508245|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
214345|NCT00327444|508244|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
214346|NCT00327444|508245|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
214347|NCT00327444|508244|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
214348|NCT00327444|508245|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
214349|NCT00327444|508244|P2|STARTED|Open Label Treatment (OL) Period||10
214350|NCT00327444|508245|P1|STARTED|Open Label Treatment (OL) Period||11
214351|NCT00327444|508244|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
214352|NCT00327444|508245|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
214353|NCT00327444|508244|P2|COMPLETED|Double Blind Treatment (DB) Period||0
214354|NCT00327444|508245|P1|COMPLETED|Double Blind Treatment (DB) Period||0
214355|NCT00327444|508244|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
214356|NCT00327444|508245|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
214357|NCT00327444|508244|P2|STARTED|Double Blind Treatment (DB) Period||29
214358|NCT00327444|508245|P1|STARTED|Double Blind Treatment (DB) Period||26
214359|NCT00327392|508257|P1|NOT COMPLETED|Overall Study||0
214360|NCT00327392|508257|P1|COMPLETED|Overall Study||123
214361|NCT00327392|508257|P1|STARTED|Overall Study||123
214362|NCT00327340|508263|P2|NOT COMPLETED|Overall Study||30
214363|NCT00327340|508264|P1|NOT COMPLETED|Overall Study||15
214364|NCT00327340|508263|P2|COMPLETED|Overall Study||16
214365|NCT00327340|508264|P1|COMPLETED|Overall Study||8
214366|NCT00327340|508263|P2|STARTED|Overall Study||46
214367|NCT00327340|508264|P1|STARTED|Overall Study||23
214368|NCT00327171|508278|P2|NOT COMPLETED|Overall Study||109
214369|NCT00327171|508279|P1|NOT COMPLETED|Overall Study||108
214370|NCT00327171|508278|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
214371|NCT00327171|508279|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
214372|NCT00327171|508278|P2|STARTED|Overall Study||109
214373|NCT00327171|508279|P1|STARTED|Overall Study||109
214374|NCT00327015|508311|P4|NOT COMPLETED|Overall Study||109
214375|NCT00327015|508312|P3|NOT COMPLETED|Overall Study||126
214376|NCT00327015|508313|P2|NOT COMPLETED|Overall Study||92
214377|NCT00327015|508314|P1|NOT COMPLETED|Overall Study||91
214378|NCT00327015|508311|P4|COMPLETED|Overall Study||219
214379|NCT00327015|508312|P3|COMPLETED|Overall Study||209
214380|NCT00327015|508313|P2|COMPLETED|Overall Study||231
214381|NCT00327015|508314|P1|COMPLETED|Overall Study||229
214382|NCT00327015|508311|P4|Completed Study Without Being Rescued|Overall Study||144
214383|NCT00327015|508312|P3|Completed Study Without Being Rescued|Overall Study||113
214384|NCT00327015|508313|P2|Completed Study Without Being Rescued|Overall Study||177
214385|NCT00327015|508314|P1|Completed Study Without Being Rescued|Overall Study||179
214386|NCT00327015|508311|P4|STARTED|Overall Study||328
214387|NCT00327015|508312|P3|STARTED|Overall Study||335
214388|NCT00327015|508313|P2|STARTED|Overall Study||323
214389|NCT00327015|508314|P1|STARTED|Overall Study||320
214390|NCT00326963|508356|P1|NOT COMPLETED|Overall Study||33
214391|NCT00326963|508356|P1|COMPLETED|Overall Study||107
214392|NCT00326963|508356|P1|STARTED|Overall Study||140
214393|NCT00326950|508376|P1|NOT COMPLETED|Overall Study||1
214394|NCT00326950|508376|P1|COMPLETED|Overall Study||14
214395|NCT00326950|508376|P1|STARTED|Overall Study||15
214396|NCT00326911|508383|P2|NOT COMPLETED|Overall Study||2
214397|NCT00326911|508384|P1|NOT COMPLETED|Overall Study||1
214398|NCT00326911|508383|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
214399|NCT00326911|508384|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
214400|NCT00326911|508383|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
214401|NCT00326911|508384|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
214402|NCT00326898|508437|P3|NOT COMPLETED|Overall Study||203
214403|NCT00326898|508438|P2|NOT COMPLETED|Overall Study||343
214404|NCT00326898|508439|P1|NOT COMPLETED|Overall Study||351
214405|NCT00326898|508437|P3|COMPLETED|Overall Study||444
214406|NCT00326898|508438|P2|COMPLETED|Overall Study||306
214407|NCT00326898|508439|P1|COMPLETED|Overall Study||296
214408|NCT00326898|508437|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
214409|NCT00326898|508438|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
214410|NCT00326898|508439|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
214411|NCT00326898|508437|P3|Patients With Clear Cell Histology|Overall Study||540
214412|NCT00326898|508438|P2|Patients With Clear Cell Histology|Overall Study||540
214413|NCT00326898|508439|P1|Patients With Clear Cell Histology|Overall Study||542
214414|NCT00326898|508437|P3|Patients With Toxicity Data|Overall Study||626
214415|NCT00326898|508438|P2|Patients With Toxicity Data|Overall Study||628
214416|NCT00326898|508439|P1|Patients With Toxicity Data|Overall Study||625
214417|NCT00326898|508437|P3|STARTED|Overall Study||647
214418|NCT00326898|508438|P2|STARTED|Overall Study||649
214419|NCT00326898|508439|P1|STARTED|Overall Study||647
214420|NCT00326885|508456|P1|NOT COMPLETED|Overall Study||7
214421|NCT00326885|508456|P1|COMPLETED|Overall Study||25
214422|NCT00326885|508456|P1|STARTED|Overall Study||32
214423|NCT00326872|508465|P1|NOT COMPLETED|Overall Study||0
214424|NCT00326872|508465|P1|COMPLETED|Overall Study||26
214425|NCT00326872|508465|P1|STARTED|Overall Study||26
214426|NCT00326781|508476|P2|NOT COMPLETED|Overall Study||32
214427|NCT00326781|508477|P1|NOT COMPLETED|Overall Study||42
214428|NCT00326781|508476|P2|COMPLETED|Overall Study||298
214429|NCT00326781|508477|P1|COMPLETED|Overall Study||302
214430|NCT00326781|508476|P2|STARTED|Overall Study||330
214431|NCT00326781|508477|P1|STARTED|Overall Study||344
214432|NCT00326716|508487|P4|NOT COMPLETED|Infants||0
214433|NCT00326716|508488|P3|NOT COMPLETED|Infants||0
214434|NCT00326716|508489|P2|NOT COMPLETED|Infants||0
214435|NCT00326716|508490|P1|NOT COMPLETED|Infants||0
214436|NCT00326716|508487|P4|COMPLETED|Infants||20
214437|NCT00326716|508488|P3|COMPLETED|Infants||20
214438|NCT00326716|508489|P2|COMPLETED|Infants||0
214439|NCT00326716|508490|P1|COMPLETED|Infants||0
214440|NCT00326716|508487|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
214441|NCT00326716|508488|P3|STARTED|Infants|All infants were followed.|20
214442|NCT00326716|508489|P2|STARTED|Infants||0
214443|NCT00326716|508490|P1|STARTED|Infants||0
214444|NCT00326716|508487|P4|NOT COMPLETED|Pre-Natal Mothers||0
214445|NCT00326716|508488|P3|NOT COMPLETED|Pre-Natal Mothers||0
214446|NCT00326716|508489|P2|NOT COMPLETED|Pre-Natal Mothers||2
214447|NCT00326716|508490|P1|NOT COMPLETED|Pre-Natal Mothers||1
214448|NCT00326716|508487|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
214449|NCT00326716|508488|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
214450|NCT00326716|508489|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
214451|NCT00326716|508490|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
214452|NCT00326716|508487|P4|STARTED|Pre-Natal Mothers||0
214453|NCT00326716|508488|P3|STARTED|Pre-Natal Mothers||0
214454|NCT00326716|508489|P2|STARTED|Pre-Natal Mothers||21
214455|NCT00326716|508490|P1|STARTED|Pre-Natal Mothers||20
214456|NCT00326612|508562|P2|NOT COMPLETED|Overall Study||137
214457|NCT00326612|508563|P1|NOT COMPLETED|Overall Study||129
214458|NCT00326612|508562|P2|COMPLETED|Overall Study||42
214459|NCT00326612|508563|P1|COMPLETED|Overall Study||50
214460|NCT00326612|508562|P2|STARTED|Overall Study||179
214461|NCT00326612|508563|P1|STARTED|Overall Study||179
214462|NCT00326599|508585|P4|NOT COMPLETED|Overall Study||19
214463|NCT00326599|508586|P3|NOT COMPLETED|Overall Study||53
214464|NCT00326599|508587|P2|NOT COMPLETED|Overall Study||1
214465|NCT00326599|508588|P1|NOT COMPLETED|Overall Study||6
214466|NCT00326599|508585|P4|COMPLETED|Overall Study||10
214467|NCT00326599|508586|P3|COMPLETED|Overall Study||5
214468|NCT00326599|508587|P2|COMPLETED|Overall Study||2
214469|NCT00326599|508588|P1|COMPLETED|Overall Study||0
214470|NCT00326599|508585|P4|STARTED|Overall Study||29
214471|NCT00326599|508586|P3|STARTED|Overall Study||58
214472|NCT00326599|508587|P2|STARTED|Overall Study||3
214473|NCT00326599|508588|P1|STARTED|Overall Study||6
214474|NCT00326495|508607|P1|NOT COMPLETED|Overall Study||5
214475|NCT00326495|508607|P1|COMPLETED|Overall Study||46
214476|NCT00326495|508607|P1|STARTED|Overall Study||51
214477|NCT00326417|508614|P4|NOT COMPLETED|Overall Study||3
214478|NCT00326417|508615|P3|NOT COMPLETED|Overall Study||1
214479|NCT00326417|508616|P2|NOT COMPLETED|Overall Study||0
214480|NCT00326417|508617|P1|NOT COMPLETED|Overall Study||14
214481|NCT00326417|508614|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
214482|NCT00326417|508615|P3|COMPLETED|Overall Study||38
214483|NCT00326417|508616|P2|COMPLETED|Overall Study||41
214484|NCT00326417|508617|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
214485|NCT00326417|508614|P4|Phase II|Overall Study||0
214486|NCT00326417|508615|P3|Phase II|Overall Study||33
214487|NCT00326417|508616|P2|Phase II|Overall Study||35
214488|NCT00326417|508617|P1|Phase II|Overall Study||8
214489|NCT00326417|508614|P4|Phase I|Overall Study||3
214490|NCT00326417|508615|P3|Phase I|Overall Study||6
214491|NCT00326417|508616|P2|Phase I|Overall Study||6
214492|NCT00326417|508617|P1|Phase I|Overall Study||6
214493|NCT00326417|508614|P4|STARTED|Overall Study||3
214494|NCT00326417|508615|P3|STARTED|Overall Study||39
214495|NCT00326417|508616|P2|STARTED|Overall Study||41
214496|NCT00326417|508617|P1|STARTED|Overall Study||14
214497|NCT00326196|508635|P2|NOT COMPLETED|Overall Study||0
214498|NCT00326196|508636|P1|NOT COMPLETED|Overall Study||0
214499|NCT00326196|508635|P2|COMPLETED|Overall Study||97
214500|NCT00326196|508636|P1|COMPLETED|Overall Study||101
214501|NCT00326196|508635|P2|STARTED|Overall Study||97
214502|NCT00326196|508636|P1|STARTED|Overall Study||101
214503|NCT00326183|508644|P2|NOT COMPLETED|Overall Study||83
214504|NCT00326183|508645|P1|NOT COMPLETED|Overall Study||200
214505|NCT00326183|508644|P2|COMPLETED|Overall Study||264
214506|NCT00326183|508645|P1|COMPLETED|Overall Study||1253
214507|NCT00326183|508644|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
214508|NCT00326183|508645|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
214509|NCT00326183|508644|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
214510|NCT00326183|508645|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
214511|NCT00326183|508644|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
214512|NCT00326183|508645|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
214513|NCT00326183|508644|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
214514|NCT00326183|508645|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
214515|NCT00326183|508644|P2|STARTED|Overall Study||347
214516|NCT00326183|508645|P1|STARTED|Overall Study||1453
214517|NCT00326170|508671|P1|NOT COMPLETED|Overall Study||0
214518|NCT00326170|508671|P1|COMPLETED|Overall Study||34
214519|NCT00326170|508671|P1|STARTED|Overall Study||34
214520|NCT00326118|508677|P2|NOT COMPLETED|Year 5 Follow up||0
214521|NCT00326118|508678|P1|NOT COMPLETED|Year 5 Follow up||0
214522|NCT00326118|508677|P2|COMPLETED|Year 5 Follow up||78
214523|NCT00326118|508678|P1|COMPLETED|Year 5 Follow up||217
214524|NCT00326118|508677|P2|STARTED|Year 5 Follow up||78
214525|NCT00326118|508678|P1|STARTED|Year 5 Follow up||217
214526|NCT00326118|508677|P2|NOT COMPLETED|Year 4 Follow-up||0
214527|NCT00326118|508678|P1|NOT COMPLETED|Year 4 Follow-up||0
214528|NCT00326118|508677|P2|COMPLETED|Year 4 Follow-up||80
214529|NCT00326118|508678|P1|COMPLETED|Year 4 Follow-up||228
214530|NCT00326118|508677|P2|STARTED|Year 4 Follow-up||80
214531|NCT00326118|508678|P1|STARTED|Year 4 Follow-up||228
214532|NCT00326118|508677|P2|NOT COMPLETED|Year 3 Follow-up||0
214533|NCT00326118|508678|P1|NOT COMPLETED|Year 3 Follow-up||0
214534|NCT00326118|508677|P2|COMPLETED|Year 3 Follow-up||89
214535|NCT00326118|508678|P1|COMPLETED|Year 3 Follow-up||256
214536|NCT00326118|508677|P2|STARTED|Year 3 Follow-up||89
214537|NCT00326118|508678|P1|STARTED|Year 3 Follow-up||256
214538|NCT00326118|508677|P2|NOT COMPLETED|Year 2 Follow-up||0
214539|NCT00326118|508678|P1|NOT COMPLETED|Year 2 Follow-up||0
214540|NCT00326118|508677|P2|COMPLETED|Year 2 Follow-up||92
214541|NCT00326118|508678|P1|COMPLETED|Year 2 Follow-up||270
214542|NCT00326118|508677|P2|STARTED|Year 2 Follow-up||92
214543|NCT00326118|508678|P1|STARTED|Year 2 Follow-up||270
214544|NCT00326118|508677|P2|NOT COMPLETED|Year 1 Follow-up||0
214545|NCT00326118|508678|P1|NOT COMPLETED|Year 1 Follow-up||0
214546|NCT00326118|508677|P2|COMPLETED|Year 1 Follow-up||100
214547|NCT00326118|508678|P1|COMPLETED|Year 1 Follow-up||295
214548|NCT00326118|508677|P2|STARTED|Year 1 Follow-up||100
214549|NCT00326118|508678|P1|STARTED|Year 1 Follow-up||295
214550|NCT00326118|508677|P2|NOT COMPLETED|Active Phase||1
214551|NCT00326118|508678|P1|NOT COMPLETED|Active Phase||4
214552|NCT00326118|508677|P2|COMPLETED|Active Phase||108
214553|NCT00326118|508678|P1|COMPLETED|Active Phase||320
214554|NCT00326118|508677|P2|STARTED|Active Phase||109
214555|NCT00326118|508678|P1|STARTED|Active Phase||324
214556|NCT00326001|508714|P2|NOT COMPLETED|Overall Study||8
214557|NCT00326001|508715|P1|NOT COMPLETED|Overall Study||7
214558|NCT00326001|508714|P2|COMPLETED|Overall Study||219
214559|NCT00326001|508715|P1|COMPLETED|Overall Study||229
214560|NCT00326001|508714|P2|STARTED|Overall Study||227
214561|NCT00326001|508715|P1|STARTED|Overall Study||236
214562|NCT00325897|508729|P2|NOT COMPLETED|Overall Study||13
214563|NCT00325897|508730|P1|NOT COMPLETED|Overall Study||12
214564|NCT00325897|508729|P2|COMPLETED|Overall Study||559
214565|NCT00325897|508730|P1|COMPLETED|Overall Study||558
214566|NCT00325897|508729|P2|STARTED|Overall Study||572
214567|NCT00325897|508730|P1|STARTED|Overall Study||570
214568|NCT00325819|508750|P2|NOT COMPLETED|Overall Study||13
214569|NCT00325819|508751|P1|NOT COMPLETED|Overall Study||9
214570|NCT00325819|508750|P2|COMPLETED|Overall Study||176
214571|NCT00325819|508751|P1|COMPLETED|Overall Study||176
214572|NCT00325819|508750|P2|STARTED|Overall Study||189
214573|NCT00325819|508751|P1|STARTED|Overall Study||185
214574|NCT00325780|508771|P1|NOT COMPLETED|Overall Study||155
214575|NCT00325780|508771|P1|COMPLETED|Overall Study||1200
214576|NCT00325780|508771|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
214577|NCT00325780|508771|P1|STARTED|Overall Study||1355
214578|NCT00325754|508778|P2|NOT COMPLETED|Overall Study||1
214579|NCT00325754|508779|P1|NOT COMPLETED|Overall Study||4
214580|NCT00325754|508778|P2|COMPLETED|Overall Study||10
214581|NCT00325754|508779|P1|COMPLETED|Overall Study||7
214582|NCT00325754|508778|P2|STARTED|Overall Study||11
214583|NCT00325754|508779|P1|STARTED|Overall Study||11
214584|NCT00325598|508795|P2|NOT COMPLETED|Overall Study||0
214585|NCT00325598|508796|P1|NOT COMPLETED|Overall Study||0
214586|NCT00325598|508795|P2|COMPLETED|Overall Study||50
214587|NCT00325598|508796|P1|COMPLETED|Overall Study||50
214588|NCT00325598|508795|P2|STARTED|Overall Study||50
214589|NCT00325598|508796|P1|STARTED|Overall Study||50
214590|NCT00325468|508811|P5|NOT COMPLETED|Overall Study||8
214591|NCT00325468|508812|P4|NOT COMPLETED|Overall Study||34
214592|NCT00325468|508813|P3|NOT COMPLETED|Overall Study||4
214593|NCT00325468|508814|P2|NOT COMPLETED|Overall Study||5
214594|NCT00325468|508815|P1|NOT COMPLETED|Overall Study||11
214595|NCT00325468|508811|P5|COMPLETED|Overall Study||14
214596|NCT00325468|508812|P4|COMPLETED|Overall Study||90
214597|NCT00325468|508813|P3|COMPLETED|Overall Study||10
214598|NCT00325468|508814|P2|COMPLETED|Overall Study||12
214599|NCT00325468|508815|P1|COMPLETED|Overall Study||12
214600|NCT00325468|508811|P5|STARTED|Overall Study||22
214601|NCT00325468|508812|P4|STARTED|Overall Study||124
214602|NCT00325468|508813|P3|STARTED|Overall Study||14
214603|NCT00325468|508814|P2|STARTED|Overall Study||17
214604|NCT00325468|508815|P1|STARTED|Overall Study||23
214605|NCT00325442|508850|P2|NOT COMPLETED|Overall Study||21
214606|NCT00325442|508851|P1|NOT COMPLETED|Overall Study||9
214607|NCT00325442|508850|P2|COMPLETED|Overall Study||153
214608|NCT00325442|508851|P1|COMPLETED|Overall Study||167
214609|NCT00325442|508850|P2|STARTED|Overall Study||174
214610|NCT00325442|508851|P1|STARTED|Overall Study||176
214611|NCT00325416|508898|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
214612|NCT00325416|508899|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
214613|NCT00325416|508898|P2|COMPLETED|Phase II: Treatment at MTD||40
214614|NCT00325416|508899|P1|COMPLETED|Phase II: Treatment at MTD||78
214615|NCT00325416|508898|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
214616|NCT00325416|508899|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
214617|NCT00325416|508898|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
214618|NCT00325416|508899|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
214619|NCT00325416|508898|P2|STARTED|Phase II: Treatment at MTD||42
214620|NCT00325416|508899|P1|STARTED|Phase II: Treatment at MTD||78
214621|NCT00325416|508898|P2|NOT COMPLETED|Phase I: Dose Escalation||16
214622|NCT00325416|508899|P1|NOT COMPLETED|Phase I: Dose Escalation||22
214623|NCT00325416|508898|P2|COMPLETED|Phase I: Dose Escalation||44
214624|NCT00325416|508899|P1|COMPLETED|Phase I: Dose Escalation||48
214625|NCT00325416|508898|P2|STARTED|Phase I: Dose Escalation||60
214626|NCT00325416|508899|P1|STARTED|Phase I: Dose Escalation||70
214627|NCT00325403|508913|P2|NOT COMPLETED|Overall Study||51
214628|NCT00325403|508914|P1|NOT COMPLETED|Overall Study||18
214629|NCT00325403|508913|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
214630|NCT00325403|508914|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
214631|NCT00325403|508913|P2|STARTED|Overall Study||233
214632|NCT00325403|508914|P1|STARTED|Overall Study||116
214633|NCT00325234|508952|P2|NOT COMPLETED|Overall Study||66
214634|NCT00325234|508953|P1|NOT COMPLETED|Overall Study||69
214635|NCT00325234|508952|P2|COMPLETED|Overall Study||0
214636|NCT00325234|508953|P1|COMPLETED|Overall Study||0
214637|NCT00325234|508952|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
214638|NCT00325234|508953|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
214639|NCT00325234|508952|P2|STARTED|Overall Study||66
214640|NCT00325234|508953|P1|STARTED|Overall Study||69
214641|NCT00325195|508972|P3|NOT COMPLETED|Received Intervention: ITT Population||4
214642|NCT00325195|508973|P2|NOT COMPLETED|Received Intervention: ITT Population||25
214643|NCT00325195|508974|P1|NOT COMPLETED|Received Intervention: ITT Population||26
214644|NCT00325195|508972|P3|COMPLETED|Received Intervention: ITT Population||39
214645|NCT00325195|508973|P2|COMPLETED|Received Intervention: ITT Population||59
214646|NCT00325195|508974|P1|COMPLETED|Received Intervention: ITT Population||59
214647|NCT00325195|508972|P3|STARTED|Received Intervention: ITT Population||43
214648|NCT00325195|508973|P2|STARTED|Received Intervention: ITT Population||84
214649|NCT00325195|508974|P1|STARTED|Received Intervention: ITT Population||85
214650|NCT00325195|508972|P3|NOT COMPLETED|Randomized||3
214651|NCT00325195|508973|P2|NOT COMPLETED|Randomized||5
214652|NCT00325195|508974|P1|NOT COMPLETED|Randomized||5
214653|NCT00325195|508972|P3|COMPLETED|Randomized||43
214654|NCT00325195|508973|P2|COMPLETED|Randomized||84
214655|NCT00325195|508974|P1|COMPLETED|Randomized||85
214656|NCT00325195|508972|P3|STARTED|Randomized||46
214657|NCT00325195|508973|P2|STARTED|Randomized||89
214658|NCT00325195|508974|P1|STARTED|Randomized||90
214659|NCT00325156|508997|P1|NOT COMPLETED|Overall Study||112
214660|NCT00325156|508997|P1|COMPLETED|Overall Study||2478
214661|NCT00325156|508997|P1|STARTED|Overall Study||2590
214662|NCT00325143|509004|P1|NOT COMPLETED|Overall Study||26
214663|NCT00325143|509004|P1|COMPLETED|Overall Study||676
214664|NCT00325143|509004|P1|STARTED|Overall Study||702
214665|NCT00325130|509013|P2|NOT COMPLETED|Overall Study||30
214666|NCT00325130|509014|P1|NOT COMPLETED|Overall Study||19
214667|NCT00325130|509013|P2|COMPLETED|Overall Study||494
214668|NCT00325130|509014|P1|COMPLETED|Overall Study||499
214669|NCT00325130|509013|P2|STARTED|Overall Study||524
214670|NCT00325130|509014|P1|STARTED|Overall Study||518
214671|NCT00325078|509057|P3|NOT COMPLETED|Overall Study||2
214672|NCT00325078|509058|P2|NOT COMPLETED|Overall Study||5
214673|NCT00325078|509059|P1|NOT COMPLETED|Overall Study||5
214674|NCT00325078|509057|P3|COMPLETED|Overall Study||23
214675|NCT00325078|509058|P2|COMPLETED|Overall Study||2
214676|NCT00325078|509059|P1|COMPLETED|Overall Study||3
214677|NCT00325078|509057|P3|STARTED|Overall Study||25
214678|NCT00325078|509058|P2|STARTED|Overall Study||7
214679|NCT00325078|509059|P1|STARTED|Overall Study||8
214680|NCT00325039|509071|P2|NOT COMPLETED|Overall Study||14
214681|NCT00325039|509072|P1|NOT COMPLETED|Overall Study||18
214682|NCT00325039|509071|P2|COMPLETED|Overall Study||285
214683|NCT00325039|509072|P1|COMPLETED|Overall Study||280
214684|NCT00325039|509071|P2|STARTED|Overall Study||299
214685|NCT00325039|509072|P1|STARTED|Overall Study||298
214686|NCT00324961|509086|P1|NOT COMPLETED|Overall Study||43
214687|NCT00324961|509086|P1|COMPLETED|Overall Study||490
214688|NCT00324961|509086|P1|STARTED|Overall Study||533
214689|NCT00324896|509101|P2|NOT COMPLETED|Overall Study||8
214690|NCT00324896|509102|P1|NOT COMPLETED|Overall Study||3
214691|NCT00324896|509101|P2|COMPLETED|Overall Study||7
214692|NCT00324896|509102|P1|COMPLETED|Overall Study||12
214693|NCT00324896|509101|P2|STARTED|Overall Study||15
214694|NCT00324896|509102|P1|STARTED|Overall Study||15
214695|NCT00324870|509110|P1|NOT COMPLETED|Overall Study||0
214696|NCT00324870|509110|P1|COMPLETED|Overall Study||37
214697|NCT00324870|509110|P1|STARTED|Overall Study||37
214698|NCT00324857|509118|P4|NOT COMPLETED|Overall Study||5
214699|NCT00324857|509119|P3|NOT COMPLETED|Overall Study||7
214700|NCT00324857|509120|P2|NOT COMPLETED|Overall Study||6
214701|NCT00324857|509121|P1|NOT COMPLETED|Overall Study||6
214702|NCT00324857|509118|P4|COMPLETED|Overall Study||158
214703|NCT00324857|509119|P3|COMPLETED|Overall Study||158
214704|NCT00324857|509120|P2|COMPLETED|Overall Study||162
214705|NCT00324857|509121|P1|COMPLETED|Overall Study||161
214706|NCT00324857|509118|P4|STARTED|Overall Study||163
214707|NCT00324857|509119|P3|STARTED|Overall Study||165
214708|NCT00324857|509120|P2|STARTED|Overall Study||168
214709|NCT00324857|509121|P1|STARTED|Overall Study||167
214710|NCT00324740|509131|P3|NOT COMPLETED|Overall Study||1
214711|NCT00324740|509132|P2|NOT COMPLETED|Overall Study||0
214712|NCT00324740|509133|P1|NOT COMPLETED|Overall Study||1
214713|NCT00324740|509131|P3|COMPLETED|Overall Study||3
214714|NCT00324740|509132|P2|COMPLETED|Overall Study||3
214715|NCT00324740|509133|P1|COMPLETED|Overall Study||6
214716|NCT00324740|509131|P3|STARTED|Overall Study||4
214717|NCT00324740|509132|P2|STARTED|Overall Study||3
214718|NCT00324740|509133|P1|STARTED|Overall Study||7
214719|NCT00324701|509142|P2|NOT COMPLETED|Overall Study||17
214720|NCT00324701|509143|P1|NOT COMPLETED|Overall Study||20
214721|NCT00324701|509142|P2|COMPLETED|Overall Study||104
214722|NCT00324701|509143|P1|COMPLETED|Overall Study||100
214723|NCT00324701|509142|P2|Week 8 Assessment|Overall Study||107
214724|NCT00324701|509143|P1|Week 8 Assessment|Overall Study||108
214725|NCT00324701|509142|P2|STARTED|Overall Study||121
214726|NCT00324701|509143|P1|STARTED|Overall Study||120
214727|NCT00324675|509153|P2|NOT COMPLETED|Overall Study||0
214728|NCT00324675|509154|P1|NOT COMPLETED|Overall Study||1
214729|NCT00324675|509153|P2|COMPLETED|Overall Study||14
214730|NCT00324675|509154|P1|COMPLETED|Overall Study||13
214731|NCT00324675|509153|P2|STARTED|Overall Study||14
214732|NCT00324675|509154|P1|STARTED|Overall Study||14
214733|NCT00324649|509162|P2|NOT COMPLETED|Overall Study||5
214734|NCT00324649|509163|P1|NOT COMPLETED|Overall Study||2
214735|NCT00324649|509162|P2|COMPLETED|Overall Study||36
214736|NCT00324649|509163|P1|COMPLETED|Overall Study||37
214737|NCT00324649|509162|P2|STARTED|Overall Study||41
214738|NCT00324649|509163|P1|STARTED|Overall Study||39
214739|NCT00324415|509203|P1|NOT COMPLETED|Overall Study||0
214740|NCT00324415|509203|P1|COMPLETED|Overall Study||45
214741|NCT00324415|509203|P1|STARTED|Overall Study||45
214742|NCT00324350|509218|P2|NOT COMPLETED|Overall Study||0
214743|NCT00324350|509219|P1|NOT COMPLETED|Overall Study||0
214744|NCT00324350|509218|P2|COMPLETED|Overall Study||3632
214745|NCT00324350|509219|P1|COMPLETED|Overall Study||3655
214746|NCT00324350|509218|P2|Falls Follow-Up|Overall Study||3418
214747|NCT00324350|509219|P1|Falls Follow-Up|Overall Study||3364
214748|NCT00324350|509218|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
214749|NCT00324350|509219|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
214750|NCT00324350|509218|P2|STARTED|Overall Study||3632
214751|NCT00324350|509219|P1|STARTED|Overall Study||3655
214752|NCT00324272|509233|P4|NOT COMPLETED|Overall Study||0
214753|NCT00324272|509234|P3|NOT COMPLETED|Overall Study||0
214754|NCT00324272|509235|P2|NOT COMPLETED|Overall Study||0
214755|NCT00324272|509236|P1|NOT COMPLETED|Overall Study||0
214756|NCT00324272|509233|P4|COMPLETED|Overall Study||18
214757|NCT00324272|509234|P3|COMPLETED|Overall Study||18
214758|NCT00324272|509235|P2|COMPLETED|Overall Study||20
214759|NCT00324272|509236|P1|COMPLETED|Overall Study||18
214760|NCT00324272|509233|P4|STARTED|Overall Study||18
214761|NCT00324272|509234|P3|STARTED|Overall Study||18
214762|NCT00324272|509235|P2|STARTED|Overall Study||20
214763|NCT00324272|509236|P1|STARTED|Overall Study||18
214764|NCT00324259|509272|P2|NOT COMPLETED|Overall Study||0
214765|NCT00324259|509273|P1|NOT COMPLETED|Overall Study||0
214766|NCT00324259|509272|P2|COMPLETED|Overall Study||32
214767|NCT00324259|509273|P1|COMPLETED|Overall Study||34
214768|NCT00324259|509272|P2|STARTED|Overall Study||32
214769|NCT00324259|509273|P1|STARTED|Overall Study||34
214770|NCT00324233|509294|P2|NOT COMPLETED|Second Period||7
214771|NCT00324233|509295|P1|NOT COMPLETED|Second Period||5
214772|NCT00324233|509294|P2|COMPLETED|Second Period||11
214773|NCT00324233|509295|P1|COMPLETED|Second Period||12
214774|NCT00324233|509294|P2|STARTED|Second Period||18
214775|NCT00324233|509295|P1|STARTED|Second Period||17
214776|NCT00324233|509294|P2|NOT COMPLETED|First Period||0
214777|NCT00324233|509295|P1|NOT COMPLETED|First Period||1
214778|NCT00324233|509294|P2|COMPLETED|First Period||18
214779|NCT00324233|509295|P1|COMPLETED|First Period||17
214780|NCT00324233|509294|P2|STARTED|First Period||18
214781|NCT00324233|509295|P1|STARTED|First Period||18
214782|NCT00324168|509303|P2|NOT COMPLETED|Overall Study||30
214783|NCT00324168|509304|P1|NOT COMPLETED|Overall Study||28
214784|NCT00324168|509303|P2|COMPLETED|Overall Study||220
214785|NCT00324168|509304|P1|COMPLETED|Overall Study||222
214786|NCT00324168|509303|P2|STARTED|Overall Study||250
214787|NCT00324168|509304|P1|STARTED|Overall Study||250
214788|NCT00324155|509332|P2|NOT COMPLETED|Follow-up Phase||6
214789|NCT00324155|509333|P1|NOT COMPLETED|Follow-up Phase||11
214790|NCT00324155|509332|P2|COMPLETED|Follow-up Phase||245
214791|NCT00324155|509333|P1|COMPLETED|Follow-up Phase||236
214792|NCT00324155|509332|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
214793|NCT00324155|509333|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
214794|NCT00324155|509332|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
214795|NCT00324155|509333|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
214796|NCT00324155|509332|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
214797|NCT00324155|509333|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
214798|NCT00324155|509332|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
214799|NCT00324155|509333|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
214800|NCT00324155|509332|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
214801|NCT00324155|509333|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
214802|NCT00324155|509332|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
214803|NCT00324155|509333|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
214804|NCT00324155|509332|P2|STARTED|Received Treatment in Induction Phase||251
214805|NCT00324155|509333|P1|STARTED|Received Treatment in Induction Phase||247
214806|NCT00324155|509332|P2|NOT COMPLETED|Enrolled and Randomized||1
214807|NCT00324155|509333|P1|NOT COMPLETED|Enrolled and Randomized||3
214808|NCT00324155|509332|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
214809|NCT00324155|509333|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
214810|NCT00324155|509332|P2|STARTED|Enrolled and Randomized||252
214811|NCT00324155|509333|P1|STARTED|Enrolled and Randomized||250
214812|NCT00324116|509363|P1|NOT COMPLETED|Overall Study||32
214813|NCT00324116|509363|P1|COMPLETED|Overall Study||49
214814|NCT00324116|509363|P1|STARTED|Overall Study|subjects received treatment|81
214815|NCT00324038|509375|P2|NOT COMPLETED|Overall Study||51
214816|NCT00324038|509376|P1|NOT COMPLETED|Overall Study||49
214817|NCT00324038|509375|P2|COMPLETED|Overall Study||58
214818|NCT00324038|509376|P1|COMPLETED|Overall Study||61
214819|NCT00324038|509375|P2|STARTED|Overall Study||109
214820|NCT00324038|509376|P1|STARTED|Overall Study||110
214821|NCT00323882|509387|P5|NOT COMPLETED|Overall Study||32
214822|NCT00323882|509388|P4|NOT COMPLETED|Overall Study||7
214823|NCT00323882|509389|P3|NOT COMPLETED|Overall Study||13
214824|NCT00323882|509390|P2|NOT COMPLETED|Overall Study||6
214825|NCT00323882|509391|P1|NOT COMPLETED|Overall Study||8
214826|NCT00323882|509387|P5|COMPLETED|Overall Study||2
214827|NCT00323882|509388|P4|COMPLETED|Overall Study||0
214828|NCT00323882|509389|P3|COMPLETED|Overall Study||3
214829|NCT00323882|509390|P2|COMPLETED|Overall Study||0
214830|NCT00323882|509391|P1|COMPLETED|Overall Study||0
214831|NCT00323882|509387|P5|STARTED|Overall Study||34
214832|NCT00323882|509388|P4|STARTED|Overall Study||7
214833|NCT00323882|509389|P3|STARTED|Overall Study||16
214834|NCT00323882|509390|P2|STARTED|Overall Study||6
214835|NCT00323882|509391|P1|STARTED|Overall Study||8
214836|NCT00323869|509462|P1|NOT COMPLETED|Overall Study||1
214837|NCT00323869|509462|P1|COMPLETED|Overall Study||47
214838|NCT00323869|509462|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
214839|NCT00323869|509462|P1|STARTED|Overall Study|Enrollment|48
214840|NCT00321789|509476|P2|NOT COMPLETED|Overall Study||16
214841|NCT00321789|509477|P1|NOT COMPLETED|Overall Study||15
214842|NCT00321789|509476|P2|COMPLETED|Overall Study||112
214843|NCT00321789|509477|P1|COMPLETED|Overall Study||112
214844|NCT00321789|509476|P2|STARTED|Overall Study||128
214845|NCT00321789|509477|P1|STARTED|Overall Study||127
214846|NCT00321763|509509|P4|NOT COMPLETED|Overall Study||5
214847|NCT00321763|509510|P3|NOT COMPLETED|Overall Study||6
214848|NCT00321763|509511|P2|NOT COMPLETED|Overall Study||2
214849|NCT00321763|509512|P1|NOT COMPLETED|Overall Study||6
214850|NCT00321763|509509|P4|COMPLETED|Overall Study||565
214851|NCT00321763|509510|P3|COMPLETED|Overall Study||848
214852|NCT00321763|509511|P2|COMPLETED|Overall Study||848
214853|NCT00321763|509512|P1|COMPLETED|Overall Study||844
214854|NCT00321763|509509|P4|STARTED|Overall Study||570
214855|NCT00321763|509510|P3|STARTED|Overall Study||854
214856|NCT00321763|509511|P2|STARTED|Overall Study||850
214857|NCT00321763|509512|P1|STARTED|Overall Study||850
214858|NCT00321737|509572|P3|NOT COMPLETED|Overall Study||54
214859|NCT00321737|509573|P2|NOT COMPLETED|Overall Study||48
214860|NCT00321737|509574|P1|NOT COMPLETED|Overall Study||122
214861|NCT00321737|509572|P3|COMPLETED|Overall Study||104
214862|NCT00321737|509573|P2|COMPLETED|Overall Study||92
214863|NCT00321737|509574|P1|COMPLETED|Overall Study||25
214864|NCT00321737|509572|P3|STARTED|Overall Study||158
214865|NCT00321737|509573|P2|STARTED|Overall Study||140
214866|NCT00321737|509574|P1|STARTED|Overall Study||147
214867|NCT00321711|509602|P5|NOT COMPLETED|Part B||5
214868|NCT00321711|509603|P4|NOT COMPLETED|Part B||6
214869|NCT00321711|509604|P3|NOT COMPLETED|Part B||0
214870|NCT00321711|509605|P2|NOT COMPLETED|Part B||0
214871|NCT00321711|509606|P1|NOT COMPLETED|Part B||0
214872|NCT00321711|509602|P5|COMPLETED|Part B||10
214873|NCT00321711|509603|P4|COMPLETED|Part B||8
214874|NCT00321711|509604|P3|COMPLETED|Part B||0
214875|NCT00321711|509605|P2|COMPLETED|Part B||0
214876|NCT00321711|509606|P1|COMPLETED|Part B||0
214877|NCT00321711|509602|P5|STARTED|Part B||15
214878|NCT00321711|509603|P4|STARTED|Part B||14
214879|NCT00321711|509604|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
214880|NCT00321711|509605|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
214881|NCT00321711|509606|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
214882|NCT00321711|509602|P5|NOT COMPLETED|Part A||0
214883|NCT00321711|509603|P4|NOT COMPLETED|Part A||0
214884|NCT00321711|509604|P3|NOT COMPLETED|Part A||11
214885|NCT00321711|509605|P2|NOT COMPLETED|Part A||10
214886|NCT00321711|509606|P1|NOT COMPLETED|Part A||5
214887|NCT00321711|509602|P5|COMPLETED|Part A||0
214888|NCT00321711|509603|P4|COMPLETED|Part A||0
214889|NCT00321711|509604|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
214890|NCT00321711|509605|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
214891|NCT00321711|509606|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
214892|NCT00321711|509602|P5|STARTED|Part A||0
214893|NCT00321711|509603|P4|STARTED|Part A||0
214894|NCT00321711|509604|P3|STARTED|Part A||14
214895|NCT00321711|509605|P2|STARTED|Part A||13
214896|NCT00321711|509606|P1|STARTED|Part A||13
214897|NCT00321698|509638|P5|NOT COMPLETED|Phase II, MTD Dose||0
214898|NCT00321698|509639|P4|NOT COMPLETED|Phase II, MTD Dose||0
214899|NCT00321698|509640|P3|NOT COMPLETED|Phase II, MTD Dose||0
214900|NCT00321698|509641|P2|NOT COMPLETED|Phase II, MTD Dose||0
214901|NCT00321698|509642|P1|NOT COMPLETED|Phase II, MTD Dose||0
214902|NCT00321698|509638|P5|COMPLETED|Phase II, MTD Dose||13
214903|NCT00321698|509639|P4|COMPLETED|Phase II, MTD Dose||0
214904|NCT00321698|509640|P3|COMPLETED|Phase II, MTD Dose||0
214905|NCT00321698|509641|P2|COMPLETED|Phase II, MTD Dose||0
214906|NCT00321698|509642|P1|COMPLETED|Phase II, MTD Dose||0
214907|NCT00321698|509638|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
214908|NCT00321698|509639|P4|STARTED|Phase II, MTD Dose||0
214909|NCT00321698|509640|P3|STARTED|Phase II, MTD Dose||0
214910|NCT00321698|509641|P2|STARTED|Phase II, MTD Dose||0
214911|NCT00321698|509642|P1|STARTED|Phase II, MTD Dose||0
214912|NCT00321698|509638|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
214913|NCT00321698|509639|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
214914|NCT00321698|509640|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
214915|NCT00321698|509641|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
214916|NCT00321698|509642|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
214917|NCT00321698|509638|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
214918|NCT00321698|509639|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
214919|NCT00321698|509640|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
214920|NCT00321698|509641|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
214921|NCT00321698|509642|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
214922|NCT00321698|509638|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
214923|NCT00321698|509639|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
214924|NCT00321698|509640|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
214925|NCT00321698|509641|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
214926|NCT00321698|509642|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
214927|NCT00321685|509656|P1|NOT COMPLETED|Overall Study||39
214928|NCT00321685|509656|P1|COMPLETED|Overall Study||18
214929|NCT00321685|509656|P1|Eligible and Treated|Overall Study||53
214930|NCT00321685|509656|P1|Started Protocol Therapy|Overall Study||55
214931|NCT00321685|509656|P1|Eligible|Overall Study||55
214932|NCT00321685|509656|P1|STARTED|Overall Study||57
214933|NCT00321672|509668|P4|NOT COMPLETED|Overall Study||2
214934|NCT00321672|509669|P3|NOT COMPLETED|Overall Study||11
214935|NCT00321672|509670|P2|NOT COMPLETED|Overall Study||8
214936|NCT00321672|509671|P1|NOT COMPLETED|Overall Study||12
214937|NCT00321672|509668|P4|COMPLETED|Overall Study||71
214938|NCT00321672|509669|P3|COMPLETED|Overall Study||156
214939|NCT00321672|509670|P2|COMPLETED|Overall Study||81
214940|NCT00321672|509671|P1|COMPLETED|Overall Study||153
214941|NCT00321672|509668|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
214942|NCT00321672|509669|P3|STARTED|Overall Study||167
214943|NCT00321672|509670|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
214944|NCT00321672|509671|P1|STARTED|Overall Study||165
214945|NCT00323739|509697|P1|NOT COMPLETED|Overall Study||0
214946|NCT00323739|509697|P1|COMPLETED|Overall Study||80
214947|NCT00323739|509697|P1|STARTED|Overall Study||80
214948|NCT00323635|509704|P2|NOT COMPLETED|Overall Study||0
214949|NCT00323635|509705|P1|NOT COMPLETED|Overall Study||0
214950|NCT00323635|509704|P2|COMPLETED|Overall Study||9
214951|NCT00323635|509705|P1|COMPLETED|Overall Study||10
214952|NCT00323635|509704|P2|STARTED|Overall Study||9
214953|NCT00323635|509705|P1|STARTED|Overall Study||10
214954|NCT00323622|509729|P8|NOT COMPLETED|Overall Study||15
214955|NCT00323622|509730|P7|NOT COMPLETED|Overall Study||5
214956|NCT00323622|509731|P6|NOT COMPLETED|Overall Study||74
214957|NCT00323622|509732|P5|NOT COMPLETED|Overall Study||39
214958|NCT00323622|509733|P4|NOT COMPLETED|Overall Study||12
214959|NCT00323622|509734|P3|NOT COMPLETED|Overall Study||4
214960|NCT00323622|509735|P2|NOT COMPLETED|Overall Study||92
214961|NCT00323622|509736|P1|NOT COMPLETED|Overall Study||31
214962|NCT00323622|509729|P8|COMPLETED|Overall Study||125
214963|NCT00323622|509730|P7|COMPLETED|Overall Study||38
214964|NCT00323622|509731|P6|COMPLETED|Overall Study||454
214965|NCT00323622|509732|P5|COMPLETED|Overall Study||120
214966|NCT00323622|509733|P4|COMPLETED|Overall Study||122
214967|NCT00323622|509734|P3|COMPLETED|Overall Study||38
214968|NCT00323622|509735|P2|COMPLETED|Overall Study||423
214969|NCT00323622|509736|P1|COMPLETED|Overall Study||145
214970|NCT00323622|509729|P8|STARTED|Overall Study||140
214971|NCT00323622|509730|P7|STARTED|Overall Study||43
214972|NCT00323622|509731|P6|STARTED|Overall Study||528
214973|NCT00323622|509732|P5|STARTED|Overall Study||159
214974|NCT00323622|509733|P4|STARTED|Overall Study||134
214975|NCT00323622|509734|P3|STARTED|Overall Study||42
214976|NCT00323622|509735|P2|STARTED|Overall Study||515
214977|NCT00323622|509736|P1|STARTED|Overall Study||176
214978|NCT00323609|509778|P4|NOT COMPLETED|Overall Study||15
214979|NCT00323609|509779|P3|NOT COMPLETED|Overall Study||8
214980|NCT00323609|509780|P2|NOT COMPLETED|Overall Study||99
214981|NCT00323609|509781|P1|NOT COMPLETED|Overall Study||91
214982|NCT00323609|509778|P4|COMPLETED|Overall Study||0
214983|NCT00323609|509779|P3|COMPLETED|Overall Study||0
214984|NCT00323609|509780|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
214985|NCT00323609|509781|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
214986|NCT00323609|509778|P4|STARTED|Overall Study||15
214987|NCT00323609|509779|P3|STARTED|Overall Study||8
214988|NCT00323609|509780|P2|STARTED|Overall Study||190
214989|NCT00323609|509781|P1|STARTED|Overall Study||191
214990|NCT00323557|509817|P2|NOT COMPLETED|Overall Study||0
214991|NCT00323557|509818|P1|NOT COMPLETED|Overall Study||1
214992|NCT00323557|509817|P2|COMPLETED|Overall Study||7
214993|NCT00323557|509818|P1|COMPLETED|Overall Study||24
214994|NCT00323557|509817|P2|STARTED|Overall Study||7
214995|NCT00323557|509818|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
214996|NCT00323492|509827|P3|NOT COMPLETED|Study Phase 2||1
214997|NCT00323492|509828|P2|NOT COMPLETED|Study Phase 2||1
214998|NCT00323492|509829|P1|NOT COMPLETED|Study Phase 2||4
214999|NCT00323492|509827|P3|COMPLETED|Study Phase 2||24
215000|NCT00323492|509828|P2|COMPLETED|Study Phase 2||17
215001|NCT00323492|509829|P1|COMPLETED|Study Phase 2||40
215002|NCT00323492|509827|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
215003|NCT00323492|509828|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
215004|NCT00323492|509829|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
215005|NCT00323492|509827|P3|NOT COMPLETED|Study Phase 1||0
215006|NCT00323492|509828|P2|NOT COMPLETED|Study Phase 1||0
215007|NCT00323492|509829|P1|NOT COMPLETED|Study Phase 1||2
215008|NCT00323492|509827|P3|COMPLETED|Study Phase 1||0
215009|NCT00323492|509828|P2|COMPLETED|Study Phase 1||45
215010|NCT00323492|509829|P1|COMPLETED|Study Phase 1||45
215011|NCT00323492|509827|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
215012|NCT00323492|509828|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
215013|NCT00323492|509829|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
215014|NCT00323492|509827|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
215015|NCT00323492|509828|P2|STARTED|Study Phase 1||45
215016|NCT00323492|509829|P1|STARTED|Study Phase 1||47
215017|NCT00323479|509860|P1|NOT COMPLETED|Overall Study||8
215018|NCT00323479|509860|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
215019|NCT00323479|509860|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
215020|NCT00323479|509860|P1|STARTED|Overall Study||114
215021|NCT00323427|509871|P2|NOT COMPLETED|Overall Study||23
215022|NCT00323427|509872|P1|NOT COMPLETED|Overall Study||31
215023|NCT00323427|509871|P2|COMPLETED|Overall Study||43
215024|NCT00323427|509872|P1|COMPLETED|Overall Study||38
215025|NCT00323427|509871|P2|STARTED|Overall Study||66
215026|NCT00323427|509872|P1|STARTED|Overall Study||69
215027|NCT00321646|509882|P1|NOT COMPLETED|Prostatectomy||0
215028|NCT00321646|509882|P1|COMPLETED|Prostatectomy||37
215029|NCT00321646|509882|P1|STARTED|Prostatectomy||37
215030|NCT00321646|509882|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
215031|NCT00321646|509882|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
215032|NCT00321646|509882|P1|STARTED|Neoadjuvant Chemotherapy||42
215033|NCT00321620|509889|P2|NOT COMPLETED|Overall Study||722
215034|NCT00321620|509890|P1|NOT COMPLETED|Overall Study||743
215035|NCT00321620|509889|P2|COMPLETED|Overall Study||228
215036|NCT00321620|509890|P1|COMPLETED|Overall Study||208
215037|NCT00321620|509889|P2|Received Investigational Product|Overall Study||942
215038|NCT00321620|509890|P1|Received Investigational Product|Overall Study||946
215039|NCT00321620|509889|P2|STARTED|Overall Study||950
215040|NCT00321620|509890|P1|STARTED|Overall Study||951
215041|NCT00321464|509902|P2|NOT COMPLETED|Overall Study||558
215042|NCT00321464|509903|P1|NOT COMPLETED|Overall Study||559
215043|NCT00321464|509902|P2|COMPLETED|Overall Study||468
215044|NCT00321464|509903|P1|COMPLETED|Overall Study||461
215045|NCT00321464|509902|P2|Received Investigational Product|Overall Study||1019
215046|NCT00321464|509903|P1|Received Investigational Product|Overall Study||1014
215047|NCT00321464|509902|P2|STARTED|Overall Study||1026
215048|NCT00321464|509903|P1|STARTED|Overall Study||1020
215049|NCT00323362|509913|P1|NOT COMPLETED|Overall Study||0
215050|NCT00323362|509913|P1|COMPLETED|Overall Study||17
215051|NCT00323362|509913|P1|STARTED|Overall Study||17
215052|NCT00323310|509919|P1|NOT COMPLETED|Overall Study||3
215053|NCT00323310|509919|P1|COMPLETED|Overall Study||89
215054|NCT00323310|509919|P1|STARTED|Overall Study||92
215055|NCT00323297|509934|P2|NOT COMPLETED|Part B (Open-label)||12
215056|NCT00323297|509935|P1|NOT COMPLETED|Part B (Open-label)||9
215057|NCT00323297|509934|P2|COMPLETED|Part B (Open-label)||31
215058|NCT00323297|509935|P1|COMPLETED|Part B (Open-label)||39
215059|NCT00323297|509934|P2|STARTED|Part B (Open-label)||43
215060|NCT00323297|509935|P1|STARTED|Part B (Open-label)||48
215061|NCT00323297|509934|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
215062|NCT00323297|509935|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
215063|NCT00323297|509934|P2|COMPLETED|Part A (Double Blind Randomized)||43
215064|NCT00323297|509935|P1|COMPLETED|Part A (Double Blind Randomized)||48
215065|NCT00323297|509934|P2|STARTED|Part A (Double Blind Randomized)||50
215066|NCT00323297|509935|P1|STARTED|Part A (Double Blind Randomized)||53
215067|NCT00323284|509953|P2|NOT COMPLETED|24 Months Follow-up||22
215068|NCT00323284|509954|P1|NOT COMPLETED|24 Months Follow-up||18
215069|NCT00323284|509953|P2|COMPLETED|24 Months Follow-up||101
215070|NCT00323284|509954|P1|COMPLETED|24 Months Follow-up||98
215071|NCT00323284|509953|P2|STARTED|24 Months Follow-up||123
215072|NCT00323284|509954|P1|STARTED|24 Months Follow-up||116
215073|NCT00323284|509953|P2|NOT COMPLETED|12 Months Follow-up||9
215074|NCT00323284|509954|P1|NOT COMPLETED|12 Months Follow-up||5
215075|NCT00323284|509953|P2|COMPLETED|12 Months Follow-up||114
215076|NCT00323284|509954|P1|COMPLETED|12 Months Follow-up||111
215077|NCT00323284|509953|P2|STARTED|12 Months Follow-up||123
215078|NCT00323284|509954|P1|STARTED|12 Months Follow-up||116
215079|NCT00323271|509964|P2|NOT COMPLETED|Overall Study||3
215080|NCT00323271|509965|P1|NOT COMPLETED|Overall Study||2
215081|NCT00323271|509964|P2|COMPLETED|Overall Study||9
215082|NCT00323271|509965|P1|COMPLETED|Overall Study||11
215083|NCT00323271|509964|P2|STARTED|Overall Study||12
215084|NCT00323271|509965|P1|STARTED|Overall Study||13
215085|NCT00323258|509975|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
215086|NCT00323258|509976|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
215087|NCT00323258|509975|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
215088|NCT00323258|509976|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
215089|NCT00323258|509975|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
215090|NCT00323258|509976|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
215091|NCT00323258|509975|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
215092|NCT00323258|509976|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
215093|NCT00323258|509975|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
215094|NCT00323258|509976|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
215095|NCT00323258|509975|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
215096|NCT00323258|509976|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
215097|NCT00323193|509992|P2|NOT COMPLETED|Overall Study||15
215098|NCT00323193|509993|P1|NOT COMPLETED|Overall Study||23
215099|NCT00323193|509992|P2|COMPLETED|Overall Study||41
215100|NCT00323193|509993|P1|COMPLETED|Overall Study||30
215101|NCT00323193|509992|P2|STARTED|Overall Study||56
215102|NCT00323193|509993|P1|STARTED|Overall Study||53
215103|NCT00323115|510001|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
215104|NCT00323115|510001|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
215105|NCT00323115|510001|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
215106|NCT00323115|510001|P1|NOT COMPLETED|Vaccine Administration||1
215107|NCT00323115|510001|P1|COMPLETED|Vaccine Administration||10
215108|NCT00323115|510001|P1|STARTED|Vaccine Administration||11
215109|NCT00323037|510008|P2|NOT COMPLETED|Overall Study||27
215110|NCT00323037|510009|P1|NOT COMPLETED|Overall Study||33
215111|NCT00323037|510008|P2|COMPLETED|Overall Study||126
215112|NCT00323037|510009|P1|COMPLETED|Overall Study||132
215113|NCT00323037|510008|P2|STARTED|Overall Study|Number randomized|153
215114|NCT00323037|510009|P1|STARTED|Overall Study|Number randomized|165
215115|NCT00322881|510013|P1|NOT COMPLETED|Overall Study||5
215116|NCT00322881|510013|P1|COMPLETED|Overall Study||7
215117|NCT00322881|510013|P1|STARTED|Overall Study||12
215118|NCT00322855|510017|P1|NOT COMPLETED|Overall Study||0
215119|NCT00322855|510017|P1|COMPLETED|Overall Study||1
215120|NCT00322855|510017|P1|STARTED|Overall Study||1
215121|NCT00322842|510023|P2|NOT COMPLETED|Overall Study||2
215122|NCT00322842|510024|P1|NOT COMPLETED|Overall Study||2
215123|NCT00322842|510023|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
215124|NCT00322842|510024|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
215125|NCT00322842|510023|P2|STARTED|Overall Study||31
215126|NCT00322842|510024|P1|STARTED|Overall Study||4
215127|NCT00321373|510052|P3|NOT COMPLETED|Overall Study||3
215128|NCT00321373|510053|P2|NOT COMPLETED|Overall Study||0
215129|NCT00321373|510054|P1|NOT COMPLETED|Overall Study||2
215130|NCT00321373|510052|P3|COMPLETED|Overall Study||404
215131|NCT00321373|510053|P2|COMPLETED|Overall Study||406
215132|NCT00321373|510054|P1|COMPLETED|Overall Study||405
215133|NCT00321373|510052|P3|STARTED|Overall Study||407
215134|NCT00321373|510053|P2|STARTED|Overall Study||406
215135|NCT00321373|510054|P1|STARTED|Overall Study||407
215136|NCT00321321|510077|P1|NOT COMPLETED|Overall Study||0
215137|NCT00321321|510077|P1|COMPLETED|Overall Study||12
215138|NCT00321321|510077|P1|STARTED|Overall Study||12
215139|NCT00322777|510083|P2|NOT COMPLETED|Overall Study||0
215140|NCT00322777|510084|P1|NOT COMPLETED|Overall Study||0
215141|NCT00322777|510083|P2|COMPLETED|Overall Study||45
215142|NCT00322777|510084|P1|COMPLETED|Overall Study||39
215143|NCT00322777|510083|P2|Data Collection at Week 24|Overall Study||45
215144|NCT00322777|510084|P1|Data Collection at Week 24|Overall Study||39
215145|NCT00322777|510083|P2|Data Collection at Week 16|Overall Study||45
215146|NCT00322777|510084|P1|Data Collection at Week 16|Overall Study||39
215147|NCT00322777|510083|P2|Data Collection at Week 8|Overall Study||45
215148|NCT00322777|510084|P1|Data Collection at Week 8|Overall Study||39
215149|NCT00322777|510083|P2|"Data Collection at BASELINE|"|Overall Study||45
215150|NCT00322777|510084|P1|"Data Collection at BASELINE|"|Overall Study||39
215151|NCT00322777|510083|P2|STARTED|Overall Study||45
215152|NCT00322777|510084|P1|STARTED|Overall Study||39
215153|NCT00322712|510094|P1|NOT COMPLETED|Overall Study||1
215154|NCT00322712|510094|P1|COMPLETED|Overall Study||11
215155|NCT00322712|510094|P1|STARTED|Overall Study||12
215156|NCT00322621|510098|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
215157|NCT00322621|510099|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
215158|NCT00322621|510100|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
215159|NCT00322621|510098|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
215160|NCT00322621|510099|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
215161|NCT00322621|510100|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
215162|NCT00322621|510098|P3|STARTED|Period III - Maintenance / Rescue Phase||69
215163|NCT00322621|510099|P2|STARTED|Period III - Maintenance / Rescue Phase||115
215164|NCT00322621|510100|P1|STARTED|Period III - Maintenance / Rescue Phase||0
215165|NCT00322621|510098|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
215166|NCT00322621|510099|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
215167|NCT00322621|510100|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
215168|NCT00322621|510098|P3|COMPLETED|Period II - Acute Therapy Phase||0
215169|NCT00322621|510099|P2|COMPLETED|Period II - Acute Therapy Phase||0
215170|NCT00322621|510100|P1|COMPLETED|Period II - Acute Therapy Phase||184
215171|NCT00322621|510098|P3|STARTED|Period II - Acute Therapy Phase||0
215172|NCT00322621|510099|P2|STARTED|Period II - Acute Therapy Phase||0
215173|NCT00322621|510100|P1|STARTED|Period II - Acute Therapy Phase||216
215174|NCT00322556|510152|P1|NOT COMPLETED|Overall Study||12
215175|NCT00322556|510152|P1|COMPLETED|Overall Study||43
215176|NCT00322556|510152|P1|STARTED|Overall Study||55
215177|NCT00322491|510168|P2|NOT COMPLETED|Overall Study||2
215178|NCT00322491|510169|P1|NOT COMPLETED|Overall Study||2
215179|NCT00322491|510168|P2|COMPLETED|Overall Study||24
215180|NCT00322491|510169|P1|COMPLETED|Overall Study||21
215181|NCT00322491|510168|P2|STARTED|Overall Study||26
215182|NCT00322491|510169|P1|STARTED|Overall Study||23
215183|NCT00322465|510195|P4|NOT COMPLETED|Overall Study||26
215184|NCT00322465|510196|P3|NOT COMPLETED|Overall Study||26
215185|NCT00322465|510197|P2|NOT COMPLETED|Overall Study||24
215186|NCT00322465|510198|P1|NOT COMPLETED|Overall Study||20
215187|NCT00322465|510195|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
215188|NCT00322465|510196|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
215189|NCT00322465|510197|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
215190|NCT00322465|510198|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
215191|NCT00322465|510195|P4|STARTED|Overall Study|Randomized|79
215192|NCT00322465|510196|P3|STARTED|Overall Study|Randomized|77
215193|NCT00322465|510197|P2|STARTED|Overall Study|Randomized|73
215194|NCT00322465|510198|P1|STARTED|Overall Study|Randomized|76
215195|NCT00322452|510259|P2|NOT COMPLETED|Overall Study||276
215196|NCT00322452|510260|P1|NOT COMPLETED|Overall Study||247
215197|NCT00322452|510259|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
215198|NCT00322452|510260|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
215199|NCT00322452|510259|P2|STARTED|Overall Study|Number of patients randomized|608
215200|NCT00322452|510260|P1|STARTED|Overall Study|Number of patients randomized|609
215201|NCT00322439|510296|P1|NOT COMPLETED|Overall Study||1056
215202|NCT00322439|510296|P1|COMPLETED|Overall Study||1455
215203|NCT00322439|510296|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
215204|NCT00322439|510296|P1|STARTED|Overall Study||2511
215205|NCT00322387|510311|P2|NOT COMPLETED|Follow-up Period||3
215206|NCT00322387|510312|P1|NOT COMPLETED|Follow-up Period||2
215207|NCT00322387|510311|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
215208|NCT00322387|510312|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
215209|NCT00322387|510311|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
215210|NCT00322387|510312|P1|STARTED|Follow-up Period|Participants who had transplants|14
215211|NCT00322387|510311|P2|NOT COMPLETED|Treatment Period||1
215212|NCT00322387|510312|P1|NOT COMPLETED|Treatment Period||0
215213|NCT00322387|510311|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
215214|NCT00322387|510312|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
215215|NCT00322387|510311|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
215216|NCT00322387|510312|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
215217|NCT00322374|510346|P4|NOT COMPLETED|Second Escalation||0
215218|NCT00322374|510347|P3|NOT COMPLETED|Second Escalation||6
215219|NCT00322374|510348|P2|NOT COMPLETED|Second Escalation||0
215220|NCT00322374|510349|P1|NOT COMPLETED|Second Escalation||0
215221|NCT00322374|510346|P4|COMPLETED|Second Escalation||0
215222|NCT00322374|510347|P3|COMPLETED|Second Escalation||0
215223|NCT00322374|510348|P2|COMPLETED|Second Escalation||0
215224|NCT00322374|510349|P1|COMPLETED|Second Escalation||0
215225|NCT00322374|510346|P4|STARTED|Second Escalation||0
215226|NCT00322374|510347|P3|STARTED|Second Escalation||6
215227|NCT00322374|510348|P2|STARTED|Second Escalation||0
215228|NCT00322374|510349|P1|STARTED|Second Escalation||0
215229|NCT00322374|510346|P4|NOT COMPLETED|First Escalation||0
215230|NCT00322374|510347|P3|NOT COMPLETED|First Escalation||0
215231|NCT00322374|510348|P2|NOT COMPLETED|First Escalation||30
215232|NCT00322374|510349|P1|NOT COMPLETED|First Escalation||0
215233|NCT00322374|510346|P4|COMPLETED|First Escalation||0
215234|NCT00322374|510347|P3|COMPLETED|First Escalation||0
215235|NCT00322374|510348|P2|COMPLETED|First Escalation||0
215236|NCT00322374|510349|P1|COMPLETED|First Escalation||0
215237|NCT00322374|510346|P4|STARTED|First Escalation||0
215238|NCT00322374|510347|P3|STARTED|First Escalation||0
215239|NCT00322374|510348|P2|STARTED|First Escalation||30
215240|NCT00322374|510349|P1|STARTED|First Escalation||0
215241|NCT00322374|510346|P4|NOT COMPLETED|Starting Dose||0
215242|NCT00322374|510347|P3|NOT COMPLETED|Starting Dose||0
215243|NCT00322374|510348|P2|NOT COMPLETED|Starting Dose||0
215244|NCT00322374|510349|P1|NOT COMPLETED|Starting Dose||6
215245|NCT00322374|510346|P4|COMPLETED|Starting Dose||0
215246|NCT00322374|510347|P3|COMPLETED|Starting Dose||0
215247|NCT00322374|510348|P2|COMPLETED|Starting Dose||0
215248|NCT00322374|510349|P1|COMPLETED|Starting Dose||0
215249|NCT00322374|510346|P4|STARTED|Starting Dose||0
215250|NCT00322374|510347|P3|STARTED|Starting Dose||0
215251|NCT00322374|510348|P2|STARTED|Starting Dose||0
215252|NCT00322374|510349|P1|STARTED|Starting Dose||6
215253|NCT00322374|510346|P4|NOT COMPLETED|Enrollment||0
215254|NCT00322374|510347|P3|NOT COMPLETED|Enrollment||0
215255|NCT00322374|510348|P2|NOT COMPLETED|Enrollment||0
215256|NCT00322374|510349|P1|NOT COMPLETED|Enrollment||0
215257|NCT00322374|510346|P4|COMPLETED|Enrollment||42
215258|NCT00322374|510347|P3|COMPLETED|Enrollment||0
215259|NCT00322374|510348|P2|COMPLETED|Enrollment||0
215260|NCT00322374|510349|P1|COMPLETED|Enrollment||0
215261|NCT00322374|510346|P4|STARTED|Enrollment||42
215262|NCT00322374|510347|P3|STARTED|Enrollment||0
215263|NCT00322374|510348|P2|STARTED|Enrollment||0
215264|NCT00322374|510349|P1|STARTED|Enrollment||0
215265|NCT00322348|510399|P2|NOT COMPLETED|Overall Study||33
215266|NCT00322348|510400|P1|NOT COMPLETED|Overall Study||37
215267|NCT00322348|510399|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
215268|NCT00322348|510400|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
215269|NCT00322348|510399|P2|Received Study Treatment|Overall Study||48
215270|NCT00322348|510400|P1|Received Study Treatment|Overall Study||50
215271|NCT00322348|510399|P2|STARTED|Overall Study||49
215272|NCT00322348|510400|P1|STARTED|Overall Study||49
215273|NCT00322335|510419|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
215274|NCT00322335|510420|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
215275|NCT00322335|510421|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
215276|NCT00322335|510419|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
215277|NCT00322335|510420|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
215278|NCT00322335|510421|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
215279|NCT00322335|510419|P3|STARTED|Subjects 66 Months After Booster Dose||53
215280|NCT00322335|510420|P2|STARTED|Subjects 66 Months After Booster Dose||104
215281|NCT00322335|510421|P1|STARTED|Subjects 66 Months After Booster Dose||48
215282|NCT00322335|510419|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
215283|NCT00322335|510420|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
215284|NCT00322335|510421|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
215285|NCT00322335|510419|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
215286|NCT00322335|510420|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
215287|NCT00322335|510421|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
215288|NCT00322335|510419|P3|STARTED|Subjects 54 Months After Booster Dose||56
215289|NCT00322335|510420|P2|STARTED|Subjects 54 Months After Booster Dose||108
215290|NCT00322335|510421|P1|STARTED|Subjects 54 Months After Booster Dose||50
215291|NCT00322335|510419|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
215292|NCT00322335|510420|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
215293|NCT00322335|510421|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
215294|NCT00322335|510419|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
215295|NCT00322335|510420|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
215296|NCT00322335|510421|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
215297|NCT00322335|510419|P3|STARTED|Subjects 42 Months After Booster Dose||56
215298|NCT00322335|510420|P2|STARTED|Subjects 42 Months After Booster Dose||113
215299|NCT00322335|510421|P1|STARTED|Subjects 42 Months After Booster Dose||51
215300|NCT00322335|510419|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
215301|NCT00322335|510420|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
215302|NCT00322335|510421|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
215303|NCT00322335|510419|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
215304|NCT00322335|510420|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
215305|NCT00322335|510421|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
215306|NCT00322335|510419|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
215307|NCT00322335|510420|P2|STARTED|Subjects 30 Months After Booster Dose||119
215308|NCT00322335|510421|P1|STARTED|Subjects 30 Months After Booster Dose||54
215309|NCT00322335|510419|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
215310|NCT00322335|510420|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
215311|NCT00322335|510421|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
215312|NCT00322335|510419|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
215313|NCT00322335|510420|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
215314|NCT00322335|510421|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
215315|NCT00322335|510419|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
215316|NCT00322335|510420|P2|STARTED|Subjects 18 Months After Booster Dose||123
215317|NCT00322335|510421|P1|STARTED|Subjects 18 Months After Booster Dose||58
215318|NCT00322231|510461|P2|NOT COMPLETED|Period 2||0
215319|NCT00322231|510462|P1|NOT COMPLETED|Period 2||0
215320|NCT00322231|510461|P2|COMPLETED|Period 2||49
215321|NCT00322231|510462|P1|COMPLETED|Period 2||51
215322|NCT00322231|510461|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
215323|NCT00322231|510462|P1|STARTED|Period 2||51
215324|NCT00322231|510461|P2|NOT COMPLETED|Period 1||0
215325|NCT00322231|510462|P1|NOT COMPLETED|Period 1||0
215326|NCT00322231|510461|P2|COMPLETED|Period 1||50
215327|NCT00322231|510462|P1|COMPLETED|Period 1||51
215328|NCT00322231|510461|P2|STARTED|Period 1||50
215329|NCT00322231|510462|P1|STARTED|Period 1||51
215330|NCT00322153|510474|P2|NOT COMPLETED|Overall Study||69
215331|NCT00322153|510475|P1|NOT COMPLETED|Overall Study||63
215332|NCT00322153|510474|P2|COMPLETED|Overall Study||273
215333|NCT00322153|510475|P1|COMPLETED|Overall Study||272
215334|NCT00322153|510474|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
215335|NCT00322153|510475|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
215336|NCT00322153|510474|P2|STARTED|Overall Study|Randomized to Memantine ER|342
215337|NCT00322153|510475|P1|STARTED|Overall Study|Randomized to placebo|335
215338|NCT00322101|510487|P2|NOT COMPLETED|Overall Study||0
215339|NCT00322101|510488|P1|NOT COMPLETED|Overall Study||0
215340|NCT00322101|510487|P2|COMPLETED|Overall Study||11
215341|NCT00322101|510488|P1|COMPLETED|Overall Study||14
215342|NCT00322101|510487|P2|STARTED|Overall Study||11
215343|NCT00322101|510488|P1|STARTED|Overall Study||14
215344|NCT00321984|510507|P3|NOT COMPLETED|Overall Study||26
215345|NCT00321984|510508|P2|NOT COMPLETED|Overall Study||21
215346|NCT00321984|510509|P1|NOT COMPLETED|Overall Study||27
215347|NCT00321984|510507|P3|COMPLETED|Overall Study||289
215348|NCT00321984|510508|P2|COMPLETED|Overall Study||294
215349|NCT00321984|510509|P1|COMPLETED|Overall Study||290
215350|NCT00321984|510507|P3|STARTED|Overall Study||315
215351|NCT00321984|510508|P2|STARTED|Overall Study||315
215352|NCT00321984|510509|P1|STARTED|Overall Study||317
215353|NCT00321932|510528|P2|NOT COMPLETED|Overall Study||21
215354|NCT00321932|510529|P1|NOT COMPLETED|Overall Study||10
215355|NCT00321932|510528|P2|COMPLETED|Overall Study||11
215356|NCT00321932|510529|P1|COMPLETED|Overall Study||19
215357|NCT00321932|510528|P2|STARTED|Overall Study||32
215358|NCT00321932|510529|P1|STARTED|Overall Study||29
215359|NCT00321919|510553|P2|NOT COMPLETED|Overall Study||52
215360|NCT00321919|510554|P1|NOT COMPLETED|Overall Study||75
215361|NCT00321919|510553|P2|COMPLETED|Overall Study||250
215362|NCT00321919|510554|P1|COMPLETED|Overall Study||226
215363|NCT00321919|510553|P2|STARTED|Overall Study||302
215364|NCT00321919|510554|P1|STARTED|Overall Study||301
215365|NCT00321906|510596|P2|NOT COMPLETED|Overall Study||56
215366|NCT00321906|510597|P1|NOT COMPLETED|Overall Study||46
215367|NCT00321906|510596|P2|COMPLETED|Overall Study||31
215368|NCT00321906|510597|P1|COMPLETED|Overall Study||48
215369|NCT00321906|510596|P2|STARTED|Overall Study||87
215370|NCT00321906|510597|P1|STARTED|Overall Study||94
215371|NCT00321893|510619|P2|NOT COMPLETED|Overall Study||14
215372|NCT00321893|510620|P1|NOT COMPLETED|Overall Study||24
215373|NCT00321893|510619|P2|COMPLETED|Overall Study||87
215374|NCT00321893|510620|P1|COMPLETED|Overall Study||77
215375|NCT00321893|510619|P2|STARTED|Overall Study||101
215376|NCT00321893|510620|P1|STARTED|Overall Study||101
215377|NCT00321854|510634|P2|NOT COMPLETED|Overall Study||82
215378|NCT00321854|510635|P1|NOT COMPLETED|Overall Study||63
215379|NCT00321854|510634|P2|COMPLETED|Overall Study||192
215380|NCT00321854|510635|P1|COMPLETED|Overall Study||198
215381|NCT00321854|510634|P2|STARTED|Overall Study||274
215382|NCT00321854|510635|P1|STARTED|Overall Study||261
215383|NCT00321828|510753|P1|NOT COMPLETED|Overall Study||4
215384|NCT00321828|510753|P1|COMPLETED|Overall Study||86
215385|NCT00321828|510753|P1|STARTED|Overall Study||90
215386|NCT00321269|510759|P2|NOT COMPLETED|Overall Study||6
215387|NCT00321269|510760|P1|NOT COMPLETED|Overall Study||8
215388|NCT00321269|510759|P2|COMPLETED|Overall Study||68
215389|NCT00321269|510760|P1|COMPLETED|Overall Study||66
215390|NCT00321269|510759|P2|STARTED|Overall Study||74
215391|NCT00321269|510760|P1|STARTED|Overall Study||74
215392|NCT00320801|510770|P4|NOT COMPLETED|Extension Phase||48
215393|NCT00320801|510771|P3|NOT COMPLETED|Extension Phase||0
215394|NCT00320801|510772|P2|NOT COMPLETED|Extension Phase||0
215395|NCT00320801|510773|P1|NOT COMPLETED|Extension Phase||0
215396|NCT00320801|510770|P4|COMPLETED|Extension Phase||7
215397|NCT00320801|510771|P3|COMPLETED|Extension Phase||0
215398|NCT00320801|510772|P2|COMPLETED|Extension Phase||0
215399|NCT00320801|510773|P1|COMPLETED|Extension Phase||0
215400|NCT00320801|510770|P4|STARTED|Extension Phase||55
215401|NCT00320801|510771|P3|STARTED|Extension Phase||0
215402|NCT00320801|510772|P2|STARTED|Extension Phase||0
215403|NCT00320801|510773|P1|STARTED|Extension Phase||0
215404|NCT00320801|510770|P4|NOT COMPLETED|Double-blind Phase||0
215405|NCT00320801|510771|P3|NOT COMPLETED|Double-blind Phase||14
215406|NCT00320801|510772|P2|NOT COMPLETED|Double-blind Phase||11
215407|NCT00320801|510773|P1|NOT COMPLETED|Double-blind Phase||0
215408|NCT00320801|510770|P4|COMPLETED|Double-blind Phase||0
215409|NCT00320801|510771|P3|COMPLETED|Double-blind Phase||35
215410|NCT00320801|510772|P2|COMPLETED|Double-blind Phase||36
215411|NCT00320801|510773|P1|COMPLETED|Double-blind Phase||0
215412|NCT00320801|510770|P4|STARTED|Double-blind Phase||0
215413|NCT00320801|510771|P3|STARTED|Double-blind Phase||49
215414|NCT00320801|510772|P2|STARTED|Double-blind Phase||47
215415|NCT00320801|510773|P1|STARTED|Double-blind Phase||0
215416|NCT00320801|510770|P4|NOT COMPLETED|Open-label Run-in Period||0
215417|NCT00320801|510771|P3|NOT COMPLETED|Open-label Run-in Period||0
215418|NCT00320801|510772|P2|NOT COMPLETED|Open-label Run-in Period||0
215419|NCT00320801|510773|P1|NOT COMPLETED|Open-label Run-in Period||92
215420|NCT00320801|510770|P4|COMPLETED|Open-label Run-in Period||0
215421|NCT00320801|510771|P3|COMPLETED|Open-label Run-in Period||0
215422|NCT00320801|510772|P2|COMPLETED|Open-label Run-in Period||0
215423|NCT00320801|510773|P1|COMPLETED|Open-label Run-in Period||96
215424|NCT00320801|510770|P4|STARTED|Open-label Run-in Period||0
215425|NCT00320801|510771|P3|STARTED|Open-label Run-in Period||0
215426|NCT00320801|510772|P2|STARTED|Open-label Run-in Period||0
215427|NCT00320801|510773|P1|STARTED|Open-label Run-in Period||188
215428|NCT00320788|510788|P5|NOT COMPLETED|Overall Study||5
215429|NCT00320788|510789|P4|NOT COMPLETED|Overall Study||5
215430|NCT00320788|510790|P3|NOT COMPLETED|Overall Study||3
215431|NCT00320788|510791|P2|NOT COMPLETED|Overall Study||6
215432|NCT00320788|510792|P1|NOT COMPLETED|Overall Study||6
215433|NCT00320788|510788|P5|COMPLETED|Overall Study||26
215434|NCT00320788|510789|P4|COMPLETED|Overall Study||27
215435|NCT00320788|510790|P3|COMPLETED|Overall Study||29
215436|NCT00320788|510791|P2|COMPLETED|Overall Study||26
215437|NCT00320788|510792|P1|COMPLETED|Overall Study||26
215438|NCT00320788|510788|P5|Participants Received Treatment (SAF)|Overall Study||31
215439|NCT00320788|510789|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
215440|NCT00320788|510790|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
215441|NCT00320788|510791|P2|Participants Received Treatment (SAF)|Overall Study||32
215442|NCT00320788|510792|P1|Participants Received Treatment (SAF)|Overall Study||32
215443|NCT00320788|510788|P5|STARTED|Overall Study||31
215444|NCT00320788|510789|P4|STARTED|Overall Study|Participants Randomized|32
215445|NCT00320788|510790|P3|STARTED|Overall Study||32
215446|NCT00320788|510791|P2|STARTED|Overall Study||32
215447|NCT00320788|510792|P1|STARTED|Overall Study||32
215448|NCT00320749|510835|P3|NOT COMPLETED|Overall Study||9
215449|NCT00320749|510836|P2|NOT COMPLETED|Overall Study||2
215450|NCT00320749|510837|P1|NOT COMPLETED|Overall Study||0
215451|NCT00320749|510835|P3|COMPLETED|Overall Study||1
215452|NCT00320749|510836|P2|COMPLETED|Overall Study||6
215453|NCT00320749|510837|P1|COMPLETED|Overall Study||3
215454|NCT00320749|510835|P3|STARTED|Overall Study||10
215455|NCT00320749|510836|P2|STARTED|Overall Study||8
215456|NCT00320749|510837|P1|STARTED|Overall Study||3
215457|NCT00320710|510846|P3|NOT COMPLETED|Overall Study||5
215458|NCT00320710|510847|P2|NOT COMPLETED|Overall Study||76
215459|NCT00320710|510848|P1|NOT COMPLETED|Overall Study||94
215460|NCT00320710|510846|P3|COMPLETED|Overall Study||8
215461|NCT00320710|510847|P2|COMPLETED|Overall Study||127
215462|NCT00320710|510848|P1|COMPLETED|Overall Study||106
215463|NCT00320710|510846|P3|Treated (Safety Set)|Overall Study||13
215464|NCT00320710|510847|P2|Treated (Safety Set)|Overall Study||202
215465|NCT00320710|510848|P1|Treated (Safety Set)|Overall Study||198
215466|NCT00320710|510846|P3|STARTED|Overall Study||13
215467|NCT00320710|510847|P2|STARTED|Overall Study||203
215468|NCT00320710|510848|P1|STARTED|Overall Study||200
215469|NCT00320671|510871|P2|NOT COMPLETED|Overall Study||38
215470|NCT00320671|510872|P1|NOT COMPLETED|Overall Study||33
215471|NCT00320671|510871|P2|COMPLETED|Overall Study||58
215472|NCT00320671|510872|P1|COMPLETED|Overall Study||69
215473|NCT00320671|510871|P2|STARTED|Overall Study||96
215474|NCT00320671|510872|P1|STARTED|Overall Study||102
215475|NCT00320606|510878|P1|NOT COMPLETED|Overall Study||14
215476|NCT00320606|510878|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
215477|NCT00320606|510878|P1|STARTED|Overall Study||20
215478|NCT00320593|510884|P2|NOT COMPLETED|Overall Study||1
215479|NCT00320593|510885|P1|NOT COMPLETED|Overall Study||7
215480|NCT00320593|510884|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
215481|NCT00320593|510885|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
215482|NCT00320593|510884|P2|STARTED|Overall Study||59
215483|NCT00320593|510885|P1|STARTED|Overall Study||59
215484|NCT00320541|510909|P2|NOT COMPLETED|Overall Study||57
215485|NCT00320541|510910|P1|NOT COMPLETED|Overall Study||50
215486|NCT00320541|510909|P2|COMPLETED|Overall Study||36
215487|NCT00320541|510910|P1|COMPLETED|Overall Study||44
215488|NCT00320541|510909|P2|STARTED|Overall Study||93
215489|NCT00320541|510910|P1|STARTED|Overall Study||94
215490|NCT00320528|510937|P3|NOT COMPLETED|Study Period III||106
215491|NCT00320528|510938|P2|NOT COMPLETED|Study Period III||31
215492|NCT00320528|510939|P1|NOT COMPLETED|Study Period III||87
215493|NCT00320528|510937|P3|COMPLETED|Study Period III||2
215494|NCT00320528|510938|P2|COMPLETED|Study Period III||0
215495|NCT00320528|510939|P1|COMPLETED|Study Period III||0
215496|NCT00320528|510937|P3|STARTED|Study Period III||108
215497|NCT00320528|510938|P2|STARTED|Study Period III||31
215498|NCT00320528|510939|P1|STARTED|Study Period III||87
215499|NCT00320528|510937|P3|NOT COMPLETED|Study Period II||22
215500|NCT00320528|510938|P2|NOT COMPLETED|Study Period II||10
215501|NCT00320528|510939|P1|NOT COMPLETED|Study Period II||11
215502|NCT00320528|510937|P3|COMPLETED|Study Period II||108
215503|NCT00320528|510938|P2|COMPLETED|Study Period II||31
215504|NCT00320528|510939|P1|COMPLETED|Study Period II||87
215505|NCT00320528|510937|P3|Received at Least One Dose of Study Drug|Study Period II||128
215506|NCT00320528|510938|P2|Received at Least One Dose of Study Drug|Study Period II||38
215507|NCT00320528|510939|P1|Received at Least One Dose of Study Drug|Study Period II||97
215508|NCT00320528|510937|P3|STARTED|Study Period II||130
215509|NCT00320528|510938|P2|STARTED|Study Period II||41
215510|NCT00320528|510939|P1|STARTED|Study Period II||98
215511|NCT00320515|510974|P1|NOT COMPLETED|Overall Study||49
215512|NCT00320515|510974|P1|COMPLETED|Overall Study||20
215513|NCT00320515|510974|P1|STARTED|Overall Study||69
215514|NCT00320489|510983|P2|NOT COMPLETED|Overall Study||136
215515|NCT00320489|510984|P1|NOT COMPLETED|Overall Study||145
215516|NCT00320489|510983|P2|COMPLETED|Overall Study||124
215517|NCT00320489|510984|P1|COMPLETED|Overall Study||119
215518|NCT00320489|510983|P2|STARTED|Overall Study||260
215519|NCT00320489|510984|P1|STARTED|Overall Study||264
215520|NCT00320411|511040|P1|NOT COMPLETED|Overall Study||4
215521|NCT00320411|511040|P1|COMPLETED|Overall Study||58
215522|NCT00320411|511040|P1|STARTED|Overall Study||62
215523|NCT00320385|511063|P2|NOT COMPLETED|Overall Study||22
215524|NCT00320385|511064|P1|NOT COMPLETED|Overall Study||18
215525|NCT00320385|511063|P2|COMPLETED|Overall Study||126
215526|NCT00320385|511064|P1|COMPLETED|Overall Study||130
215527|NCT00320385|511063|P2|STARTED|Overall Study||148
215528|NCT00320385|511064|P1|STARTED|Overall Study||148
215529|NCT00320372|511087|P2|NOT COMPLETED|Overall Study||163
215530|NCT00320372|511088|P1|NOT COMPLETED|Overall Study||195
215531|NCT00320372|511087|P2|COMPLETED|Overall Study||138
215532|NCT00320372|511088|P1|COMPLETED|Overall Study||299
215533|NCT00320372|511087|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
215534|NCT00320372|511088|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
215535|NCT00320372|511087|P2|VNS Therapy D-23 Original|Overall Study||0
215536|NCT00320372|511088|P1|VNS Therapy D-23 Original|Overall Study||335
215537|NCT00320372|511087|P2|STARTED|Overall Study||301
215538|NCT00320372|511088|P1|STARTED|Overall Study||494
215539|NCT00319644|511115|P2|NOT COMPLETED|Overall Study||0
215540|NCT00319644|511116|P1|NOT COMPLETED|Overall Study||0
215541|NCT00319644|511115|P2|COMPLETED|Overall Study||16
215542|NCT00319644|511116|P1|COMPLETED|Overall Study||21
215543|NCT00319644|511115|P2|STARTED|Overall Study||16
215544|NCT00319644|511116|P1|STARTED|Overall Study||21
215545|NCT00320281|511126|P2|NOT COMPLETED|Overall Study||0
215546|NCT00320281|511127|P1|NOT COMPLETED|Overall Study||0
215547|NCT00320281|511126|P2|COMPLETED|Overall Study||9
215548|NCT00320281|511127|P1|COMPLETED|Overall Study||10
215549|NCT00320281|511126|P2|STARTED|Overall Study||9
215550|NCT00320281|511127|P1|STARTED|Overall Study||10
215551|NCT00320255|511139|P6|NOT COMPLETED|Overall Study||0
215552|NCT00320255|511140|P5|NOT COMPLETED|Overall Study||0
215553|NCT00320255|511141|P4|NOT COMPLETED|Overall Study||8
215554|NCT00320255|511142|P3|NOT COMPLETED|Overall Study||6
215555|NCT00320255|511143|P2|NOT COMPLETED|Overall Study||7
215556|NCT00320255|511144|P1|NOT COMPLETED|Overall Study||11
215557|NCT00320255|511139|P6|COMPLETED|Overall Study||3
215558|NCT00320255|511140|P5|COMPLETED|Overall Study||2
215559|NCT00320255|511141|P4|COMPLETED|Overall Study||25
215560|NCT00320255|511142|P3|COMPLETED|Overall Study||24
215561|NCT00320255|511143|P2|COMPLETED|Overall Study||25
215562|NCT00320255|511144|P1|COMPLETED|Overall Study||19
215563|NCT00320255|511139|P6|Received Treatment|Overall Study||3
215564|NCT00320255|511140|P5|Received Treatment|Overall Study||2
215565|NCT00320255|511141|P4|Received Treatment|Overall Study||32
215566|NCT00320255|511142|P3|Received Treatment|Overall Study||29
215567|NCT00320255|511143|P2|Received Treatment|Overall Study||32
215568|NCT00320255|511144|P1|Received Treatment|Overall Study||29
215569|NCT00320255|511139|P6|STARTED|Overall Study||3
215570|NCT00320255|511140|P5|STARTED|Overall Study||2
215571|NCT00320255|511141|P4|STARTED|Overall Study||33
215572|NCT00320255|511142|P3|STARTED|Overall Study||30
215573|NCT00320255|511143|P2|STARTED|Overall Study||32
215574|NCT00320255|511144|P1|STARTED|Overall Study||30
215575|NCT00320216|511229|P5|NOT COMPLETED|Overall Study||6
215576|NCT00320216|511230|P4|NOT COMPLETED|Overall Study||3
215577|NCT00320216|511231|P3|NOT COMPLETED|Overall Study||6
215578|NCT00320216|511232|P2|NOT COMPLETED|Overall Study||10
215579|NCT00320216|511233|P1|NOT COMPLETED|Overall Study||16
215580|NCT00320216|511229|P5|COMPLETED|Overall Study||58
215581|NCT00320216|511230|P4|COMPLETED|Overall Study||61
215582|NCT00320216|511231|P3|COMPLETED|Overall Study||58
215583|NCT00320216|511232|P2|COMPLETED|Overall Study||54
215584|NCT00320216|511233|P1|COMPLETED|Overall Study||48
215585|NCT00320216|511229|P5|STARTED|Overall Study||64
215586|NCT00320216|511230|P4|STARTED|Overall Study||64
215587|NCT00320216|511231|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
215588|NCT00320216|511232|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
215589|NCT00320216|511233|P1|STARTED|Overall Study||64
215590|NCT00320190|511267|P2|NOT COMPLETED|Long-term (12-month) Extension||2
215591|NCT00320190|511268|P1|NOT COMPLETED|Long-term (12-month) Extension||9
215592|NCT00320190|511267|P2|COMPLETED|Long-term (12-month) Extension||1
215593|NCT00320190|511268|P1|COMPLETED|Long-term (12-month) Extension||2
215594|NCT00320190|511267|P2|STARTED|Long-term (12-month) Extension||3
215595|NCT00320190|511268|P1|STARTED|Long-term (12-month) Extension||11
215596|NCT00320190|511267|P2|NOT COMPLETED|First 12 Months||10
215597|NCT00320190|511268|P1|NOT COMPLETED|First 12 Months||8
215598|NCT00320190|511267|P2|COMPLETED|First 12 Months||3
215599|NCT00320190|511268|P1|COMPLETED|First 12 Months||11
215600|NCT00320190|511267|P2|STARTED|First 12 Months||13
215601|NCT00320190|511268|P1|STARTED|First 12 Months||19
215602|NCT00320112|511288|P2|NOT COMPLETED|Overall Study||5
215603|NCT00320112|511289|P1|NOT COMPLETED|Overall Study||8
215604|NCT00320112|511288|P2|COMPLETED|Overall Study||114
215605|NCT00320112|511289|P1|COMPLETED|Overall Study||117
215606|NCT00320112|511288|P2|STARTED|Overall Study||119
215607|NCT00320112|511289|P1|STARTED|Overall Study||125
215608|NCT00319982|511303|P2|NOT COMPLETED|Overall Study||0
215609|NCT00319982|511304|P1|NOT COMPLETED|Overall Study||1
215610|NCT00319982|511303|P2|COMPLETED|Overall Study||20
215611|NCT00319982|511304|P1|COMPLETED|Overall Study||18
215612|NCT00319982|511303|P2|STARTED|Overall Study||20
215613|NCT00319982|511304|P1|STARTED|Overall Study||19
215614|NCT00319748|511322|P1|NOT COMPLETED|Overall Study||0
215615|NCT00319748|511322|P1|COMPLETED|Overall Study||13
215616|NCT00319748|511322|P1|STARTED|Overall Study||13
215617|NCT00319735|511332|P1|NOT COMPLETED|Overall Study||2
215618|NCT00319735|511332|P1|COMPLETED|Overall Study||39
215619|NCT00319735|511332|P1|STARTED|Overall Study||41
215620|NCT00319696|511345|P1|NOT COMPLETED|Overall Study||60
215621|NCT00319696|511345|P1|COMPLETED|Overall Study||56
215622|NCT00319696|511345|P1|STARTED|Overall Study||116
215623|NCT00319592|511371|P2|NOT COMPLETED|Overall Study||1
215624|NCT00319592|511372|P1|NOT COMPLETED|Overall Study||1
215625|NCT00319592|511371|P2|COMPLETED|Overall Study||29
215626|NCT00319592|511372|P1|COMPLETED|Overall Study||29
215627|NCT00319592|511371|P2|STARTED|Overall Study||30
215628|NCT00319592|511372|P1|STARTED|Overall Study||30
215629|NCT00319553|511388|P2|NOT COMPLETED|Overall Study||4
215630|NCT00319553|511389|P1|NOT COMPLETED|Overall Study||4
215631|NCT00319553|511388|P2|COMPLETED|Overall Study||317
215632|NCT00319553|511389|P1|COMPLETED|Overall Study||319
215633|NCT00319553|511388|P2|STARTED|Overall Study||321
215634|NCT00319553|511389|P1|STARTED|Overall Study||323
215635|NCT00319501|511403|P2|NOT COMPLETED|Open-label Extension Period||0
215636|NCT00319501|511404|P1|NOT COMPLETED|Open-label Extension Period||51
215637|NCT00319501|511403|P2|COMPLETED|Open-label Extension Period||0
215638|NCT00319501|511404|P1|COMPLETED|Open-label Extension Period||0
215639|NCT00319501|511403|P2|Received Treatment|Open-label Extension Period||0
215640|NCT00319501|511404|P1|Received Treatment|Open-label Extension Period||33
215641|NCT00319501|511403|P2|STARTED|Open-label Extension Period||0
215642|NCT00319501|511404|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
215643|NCT00319501|511403|P2|NOT COMPLETED|Open-label Period||0
215644|NCT00319501|511404|P1|NOT COMPLETED|Open-label Period||116
215645|NCT00319501|511403|P2|COMPLETED|Open-label Period||0
215646|NCT00319501|511404|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
215647|NCT00319501|511403|P2|Received Treatment|Open-label Period||0
215648|NCT00319501|511404|P1|Received Treatment|Open-label Period||128
215649|NCT00319501|511403|P2|STARTED|Open-label Period||0
215650|NCT00319501|511404|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
215651|NCT00319501|511403|P2|NOT COMPLETED|Double-blind Period||32
215652|NCT00319501|511404|P1|NOT COMPLETED|Double-blind Period||43
215653|NCT00319501|511403|P2|COMPLETED|Double-blind Period||78
215654|NCT00319501|511404|P1|COMPLETED|Double-blind Period||81
215655|NCT00319501|511403|P2|Received Treatment|Double-blind Period||81
215656|NCT00319501|511404|P1|Received Treatment|Double-blind Period||82
215657|NCT00319501|511403|P2|STARTED|Double-blind Period|Randomized participants|110
215658|NCT00319501|511404|P1|STARTED|Double-blind Period|Randomized participants|124
215659|NCT00319449|511430|P2|NOT COMPLETED|Overall Study||0
215660|NCT00319449|511431|P1|NOT COMPLETED|Overall Study||2
215661|NCT00319449|511430|P2|COMPLETED|Overall Study||12
215662|NCT00319449|511431|P1|COMPLETED|Overall Study||8
215663|NCT00319449|511430|P2|STARTED|Overall Study||12
215664|NCT00319449|511431|P1|STARTED|Overall Study||10
215665|NCT00319436|511443|P2|NOT COMPLETED|Overall Study||7
215666|NCT00319436|511444|P1|NOT COMPLETED|Overall Study||6
215667|NCT00319436|511443|P2|COMPLETED|Overall Study||17
215668|NCT00319436|511444|P1|COMPLETED|Overall Study||17
215669|NCT00319436|511443|P2|STARTED|Overall Study||24
215670|NCT00319436|511444|P1|STARTED|Overall Study||23
215671|NCT00319254|511462|P1|NOT COMPLETED|Overall Study||54
215672|NCT00319254|511462|P1|COMPLETED|Overall Study||21
215673|NCT00319254|511462|P1|Treated|Overall Study||73
215674|NCT00319254|511462|P1|STARTED|Overall Study||75
215675|NCT00319111|511475|P1|NOT COMPLETED|Overall Study||47
215676|NCT00319111|511475|P1|COMPLETED|Overall Study||104
215677|NCT00319111|511475|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
215678|NCT00319046|511485|P1|NOT COMPLETED|Overall Study||8
215679|NCT00319046|511485|P1|COMPLETED|Overall Study||34
215680|NCT00319046|511485|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
215681|NCT00318929|511492|P1|NOT COMPLETED|Overall Study||0
215682|NCT00318929|511492|P1|COMPLETED|Overall Study||14
215683|NCT00318929|511492|P1|STARTED|Overall Study||14
215684|NCT00318812|511498|P2|NOT COMPLETED|Overall Study||0
215685|NCT00318812|511499|P1|NOT COMPLETED|Overall Study||0
215686|NCT00318812|511498|P2|COMPLETED|Overall Study||22
215687|NCT00318812|511499|P1|COMPLETED|Overall Study||18
215688|NCT00318812|511498|P2|STARTED|Overall Study||22
215689|NCT00318812|511499|P1|STARTED|Overall Study||18
215690|NCT00318708|511511|P2|NOT COMPLETED|Overall Study||5
215691|NCT00318708|511512|P1|NOT COMPLETED|Overall Study||8
215692|NCT00318708|511511|P2|COMPLETED|Overall Study||40
215693|NCT00318708|511512|P1|COMPLETED|Overall Study||39
215694|NCT00318708|511511|P2|8-week Milestone|Overall Study||42
215695|NCT00318708|511512|P1|8-week Milestone|Overall Study||42
215696|NCT00318708|511511|P2|STARTED|Overall Study||45
215697|NCT00318708|511512|P1|STARTED|Overall Study||47
215698|NCT00318656|511520|P2|NOT COMPLETED|Overall Study||2
215699|NCT00318656|511521|P1|NOT COMPLETED|Overall Study||0
215700|NCT00318656|511520|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
215701|NCT00318656|511521|P1|COMPLETED|Overall Study||12
215702|NCT00318656|511520|P2|STARTED|Overall Study||11
215703|NCT00318656|511521|P1|STARTED|Overall Study||12
215704|NCT00318591|511559|P2|NOT COMPLETED|Overall Study||45
215705|NCT00318591|511560|P1|NOT COMPLETED|Overall Study||60
215706|NCT00318591|511559|P2|COMPLETED|Overall Study||69
215707|NCT00318591|511560|P1|COMPLETED|Overall Study||45
215708|NCT00318591|511559|P2|STARTED|Overall Study||114
215709|NCT00318591|511560|P1|STARTED|Overall Study||105
215710|NCT00318565|511578|P1|NOT COMPLETED|Overall Study||24
215711|NCT00318565|511578|P1|COMPLETED|Overall Study||267
215712|NCT00318565|511578|P1|STARTED|Overall Study||291
215713|NCT00318474|511585|P2|NOT COMPLETED|Overall Study||17
215714|NCT00318474|511586|P1|NOT COMPLETED|Overall Study||18
215715|NCT00318474|511585|P2|COMPLETED|Overall Study||10
215716|NCT00318474|511586|P1|COMPLETED|Overall Study||7
215717|NCT00318474|511585|P2|STARTED|Overall Study||27
215718|NCT00318474|511586|P1|STARTED|Overall Study||25
215719|NCT00318461|511597|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
215720|NCT00318461|511598|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
215721|NCT00318461|511599|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
215722|NCT00318461|511600|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
215723|NCT00318461|511601|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
215724|NCT00318461|511597|P5|COMPLETED|Open-Label Extension, 18 Months||113
215725|NCT00318461|511598|P4|COMPLETED|Open-Label Extension, 18 Months||31
215726|NCT00318461|511599|P3|COMPLETED|Open-Label Extension, 18 Months||118
215727|NCT00318461|511600|P2|COMPLETED|Open-Label Extension, 18 Months||137
215728|NCT00318461|511601|P1|COMPLETED|Open-Label Extension, 18 Months||130
215729|NCT00318461|511597|P5|STARTED|Open-Label Extension, 18 Months||210
215730|NCT00318461|511598|P4|STARTED|Open-Label Extension, 18 Months||74
215731|NCT00318461|511599|P3|STARTED|Open-Label Extension, 18 Months||191
215732|NCT00318461|511600|P2|STARTED|Open-Label Extension, 18 Months||197
215733|NCT00318461|511601|P1|STARTED|Open-Label Extension, 18 Months||208
215734|NCT00318461|511597|P5|NOT COMPLETED|Double-Blind, 6 Months||34
215735|NCT00318461|511598|P4|NOT COMPLETED|Double-Blind, 6 Months||48
215736|NCT00318461|511599|P3|NOT COMPLETED|Double-Blind, 6 Months||51
215737|NCT00318461|511600|P2|NOT COMPLETED|Double-Blind, 6 Months||44
215738|NCT00318461|511601|P1|NOT COMPLETED|Double-Blind, 6 Months||34
215739|NCT00318461|511597|P5|COMPLETED|Double-Blind, 6 Months||210
215740|NCT00318461|511598|P4|COMPLETED|Double-Blind, 6 Months||74
215741|NCT00318461|511599|P3|COMPLETED|Double-Blind, 6 Months||191
215742|NCT00318461|511600|P2|COMPLETED|Double-Blind, 6 Months||197
215743|NCT00318461|511601|P1|COMPLETED|Double-Blind, 6 Months||208
215744|NCT00318461|511597|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
215745|NCT00318461|511598|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
215746|NCT00318461|511599|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
215747|NCT00318461|511600|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
215748|NCT00318461|511601|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
215749|NCT00318461|511597|P5|STARTED|Double-Blind, 6 Months|Randomised|244
215750|NCT00318461|511598|P4|STARTED|Double-Blind, 6 Months|Randomised|122
215751|NCT00318461|511599|P3|STARTED|Double-Blind, 6 Months|Randomised|242
215752|NCT00318461|511600|P2|STARTED|Double-Blind, 6 Months|Randomised|241
215753|NCT00318461|511601|P1|STARTED|Double-Blind, 6 Months|Randomised|242
215754|NCT00318409|511680|P2|NOT COMPLETED|Overall Study||1
215755|NCT00318409|511681|P1|NOT COMPLETED|Overall Study||2
215756|NCT00318409|511680|P2|COMPLETED|Overall Study||9
215757|NCT00318409|511681|P1|COMPLETED|Overall Study||18
215758|NCT00318409|511680|P2|STARTED|Overall Study||10
215759|NCT00318409|511681|P1|STARTED|Overall Study||20
215760|NCT00318370|511700|P3|NOT COMPLETED|Period 3||33
215761|NCT00318370|511701|P2|NOT COMPLETED|Period 3||0
215762|NCT00318370|511702|P1|NOT COMPLETED|Period 3||0
215763|NCT00318370|511700|P3|COMPLETED|Period 3||3
215764|NCT00318370|511701|P2|COMPLETED|Period 3||0
215765|NCT00318370|511702|P1|COMPLETED|Period 3||0
215766|NCT00318370|511700|P3|STARTED|Period 3||36
215767|NCT00318370|511701|P2|STARTED|Period 3||0
215768|NCT00318370|511702|P1|STARTED|Period 3||0
215769|NCT00318370|511700|P3|NOT COMPLETED|Period 2||0
215770|NCT00318370|511701|P2|NOT COMPLETED|Period 2||11
215771|NCT00318370|511702|P1|NOT COMPLETED|Period 2||0
215772|NCT00318370|511700|P3|COMPLETED|Period 2||0
215773|NCT00318370|511701|P2|COMPLETED|Period 2||36
215774|NCT00318370|511702|P1|COMPLETED|Period 2||0
215775|NCT00318370|511700|P3|STARTED|Period 2||0
215776|NCT00318370|511701|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
215777|NCT00318370|511702|P1|STARTED|Period 2||0
215778|NCT00318370|511700|P3|NOT COMPLETED|Period 1||0
215779|NCT00318370|511701|P2|NOT COMPLETED|Period 1||0
215780|NCT00318370|511702|P1|NOT COMPLETED|Period 1||7
215781|NCT00318370|511700|P3|COMPLETED|Period 1||0
215782|NCT00318370|511701|P2|COMPLETED|Period 1||0
215783|NCT00318370|511702|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
215784|NCT00318370|511700|P3|STARTED|Period 1||0
215785|NCT00318370|511701|P2|STARTED|Period 1||0
215786|NCT00318370|511702|P1|STARTED|Period 1||28
215787|NCT00318292|511714|P2|NOT COMPLETED|Overall Study||0
215788|NCT00318292|511715|P1|NOT COMPLETED|Overall Study||0
215789|NCT00318292|511714|P2|COMPLETED|Overall Study||45
215790|NCT00318292|511715|P1|COMPLETED|Overall Study||45
215791|NCT00318292|511714|P2|STARTED|Overall Study||45
215792|NCT00318292|511715|P1|STARTED|Overall Study||45
215793|NCT00318136|511721|P1|NOT COMPLETED|Overall Study||45
215794|NCT00318136|511721|P1|COMPLETED|Overall Study||2
215795|NCT00318136|511721|P1|STARTED|Overall Study||47
215796|NCT00317941|511730|P3|NOT COMPLETED|Overall Study||8
215797|NCT00317941|511731|P2|NOT COMPLETED|Overall Study||5
215798|NCT00317941|511732|P1|NOT COMPLETED|Overall Study||7
215799|NCT00317941|511730|P3|COMPLETED|Overall Study||60
215800|NCT00317941|511731|P2|COMPLETED|Overall Study||74
215801|NCT00317941|511732|P1|COMPLETED|Overall Study||66
215802|NCT00317941|511730|P3|Fulfilled Requirements PP Population|Overall Study||63
215803|NCT00317941|511731|P2|Fulfilled Requirements PP Population|Overall Study||76
215804|NCT00317941|511732|P1|Fulfilled Requirements PP Population|Overall Study||66
215805|NCT00317941|511730|P3|Fulfilled Requirement Safety Population|Overall Study||65
215806|NCT00317941|511731|P2|Fulfilled Requirement Safety Population|Overall Study||77
215807|NCT00317941|511732|P1|Fulfilled Requirement Safety Population|Overall Study||73
215808|NCT00317941|511730|P3|Participants Received Treatment|Overall Study||68
215809|NCT00317941|511731|P2|Participants Received Treatment|Overall Study||79
215810|NCT00317941|511732|P1|Participants Received Treatment|Overall Study||73
215811|NCT00317941|511730|P3|STARTED|Overall Study||68
215812|NCT00317941|511731|P2|STARTED|Overall Study||79
215813|NCT00317941|511732|P1|STARTED|Overall Study||73
215814|NCT00317720|511773|P2|NOT COMPLETED|Overall Study||0
215815|NCT00317720|511774|P1|NOT COMPLETED|Overall Study||0
215816|NCT00317720|511773|P2|COMPLETED|Overall Study||7
215817|NCT00317720|511774|P1|COMPLETED|Overall Study||40
215818|NCT00317720|511773|P2|STARTED|Overall Study||7
215819|NCT00317720|511774|P1|STARTED|Overall Study||40
215820|NCT00317642|511781|P2|NOT COMPLETED|Overall Study||135
215821|NCT00317642|511782|P1|NOT COMPLETED|Overall Study||122
215822|NCT00317642|511781|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
215823|NCT00317642|511782|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
215824|NCT00317642|511781|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
215825|NCT00317642|511782|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
215826|NCT00317642|511781|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
215827|NCT00317642|511782|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
215828|NCT00317642|511781|P2|STARTED|Overall Study||163
215829|NCT00317642|511782|P1|STARTED|Overall Study||163
215830|NCT00317239|511857|P2|NOT COMPLETED|Overall Study||19
215831|NCT00317239|511858|P1|NOT COMPLETED|Overall Study||13
215832|NCT00317239|511857|P2|COMPLETED|Overall Study||84
215833|NCT00317239|511858|P1|COMPLETED|Overall Study||134
215834|NCT00317239|511857|P2|STARTED|Overall Study||103
215835|NCT00317239|511858|P1|STARTED|Overall Study||147
215836|NCT00317226|511864|P1|NOT COMPLETED|Overall Study||23
215837|NCT00317226|511864|P1|COMPLETED|Overall Study||104
215838|NCT00317226|511864|P1|STARTED|Overall Study||127
215839|NCT00317044|511871|P3|NOT COMPLETED|Overall Study||45
215840|NCT00317044|511872|P2|NOT COMPLETED|Overall Study||40
215841|NCT00317044|511873|P1|NOT COMPLETED|Overall Study||48
215842|NCT00317044|511871|P3|COMPLETED|Overall Study||283
215843|NCT00317044|511872|P2|COMPLETED|Overall Study||273
215844|NCT00317044|511873|P1|COMPLETED|Overall Study||272
215845|NCT00317044|511871|P3|STARTED|Overall Study||328
215846|NCT00317044|511872|P2|STARTED|Overall Study||313
215847|NCT00317044|511873|P1|STARTED|Overall Study||320
215848|NCT00316914|511919|P2|NOT COMPLETED|Overall Study||36
215849|NCT00316914|511920|P1|NOT COMPLETED|Overall Study||33
215850|NCT00316914|511919|P2|COMPLETED|Overall Study||16
215851|NCT00316914|511920|P1|COMPLETED|Overall Study||17
215852|NCT00316914|511919|P2|STARTED|Overall Study||52
215853|NCT00316914|511920|P1|STARTED|Overall Study||50
215854|NCT00316888|511950|P2|NOT COMPLETED|Overall Study||8
215855|NCT00316888|511951|P1|NOT COMPLETED|Overall Study||6
215856|NCT00316888|511950|P2|COMPLETED|Overall Study||27
215857|NCT00316888|511951|P1|COMPLETED|Overall Study||22
215858|NCT00316888|511950|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
215859|NCT00316888|511951|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
215860|NCT00316888|511950|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
215861|NCT00316888|511951|P1|Started Induction Chemotherapy|Overall Study||28
215862|NCT00316888|511950|P2|Treated|Overall Study||34
215863|NCT00316888|511951|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
215864|NCT00316888|511950|P2|Eligible|Overall Study||35
215865|NCT00316888|511951|P1|Eligible|Overall Study||28
215866|NCT00316888|511950|P2|STARTED|Overall Study||35
215867|NCT00316888|511951|P1|STARTED|Overall Study||28
215868|NCT00316719|511967|P2|NOT COMPLETED|Overall Study||6
215869|NCT00316719|511968|P1|NOT COMPLETED|Overall Study||2
215870|NCT00316719|511967|P2|COMPLETED|Overall Study||47
215871|NCT00316719|511968|P1|COMPLETED|Overall Study||50
215872|NCT00316719|511967|P2|STARTED|Overall Study||53
215873|NCT00316719|511968|P1|STARTED|Overall Study||52
215874|NCT00316706|511994|P2|NOT COMPLETED|Overall Study||48
215875|NCT00316706|511995|P1|NOT COMPLETED|Overall Study||38
215876|NCT00316706|511994|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
215877|NCT00316706|511995|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
215878|NCT00316706|511994|P2|STARTED|Overall Study||619
215879|NCT00316706|511995|P1|STARTED|Overall Study||626
215880|NCT00316693|512011|P2|NOT COMPLETED|Overall Study||85
215881|NCT00316693|512012|P1|NOT COMPLETED|Overall Study||77
215882|NCT00316693|512011|P2|COMPLETED|Overall Study||436
215883|NCT00316693|512012|P1|COMPLETED|Overall Study||442
215884|NCT00316693|512011|P2|STARTED|Overall Study||521
215885|NCT00316693|512012|P1|STARTED|Overall Study||519
215886|NCT00316355|512054|P2|NOT COMPLETED|Overall Study||7
215887|NCT00316355|512055|P1|NOT COMPLETED|Overall Study||5
215888|NCT00316355|512054|P2|COMPLETED|Overall Study||12
215889|NCT00316355|512055|P1|COMPLETED|Overall Study||10
215890|NCT00316355|512054|P2|Started Treatment|Overall Study||18
215891|NCT00316355|512055|P1|Started Treatment|Overall Study||12
215892|NCT00316355|512054|P2|STARTED|Overall Study||19
215893|NCT00316355|512055|P1|STARTED|Overall Study||15
215894|NCT00316303|512065|P2|NOT COMPLETED|Overall Study||16
215895|NCT00316303|512066|P1|NOT COMPLETED|Overall Study||11
215896|NCT00316303|512065|P2|COMPLETED|Overall Study||102
215897|NCT00316303|512066|P1|COMPLETED|Overall Study||107
215898|NCT00316303|512065|P2|STARTED|Overall Study||118
215899|NCT00316303|512066|P1|STARTED|Overall Study||118
215900|NCT00316277|512082|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
215901|NCT00316277|512083|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
215902|NCT00316277|512082|P2|COMPLETED|Phase 2 (24 Weeks)||161
215903|NCT00316277|512083|P1|COMPLETED|Phase 2 (24 Weeks)||161
215904|NCT00316277|512082|P2|STARTED|Phase 2 (24 Weeks)||180
215905|NCT00316277|512083|P1|STARTED|Phase 2 (24 Weeks)||180
215906|NCT00316277|512082|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
215907|NCT00316277|512083|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
215908|NCT00316277|512082|P2|COMPLETED|Phase 1 (12 Weeks)||24
215909|NCT00316277|512083|P1|COMPLETED|Phase 1 (12 Weeks)||19
215910|NCT00316277|512082|P2|STARTED|Phase 1 (12 Weeks)||324
215911|NCT00316277|512083|P1|STARTED|Phase 1 (12 Weeks)||329
215912|NCT00316264|512104|P3|NOT COMPLETED|Overall Study||6
215913|NCT00316264|512105|P2|NOT COMPLETED|Overall Study||7
215914|NCT00316264|512106|P1|NOT COMPLETED|Overall Study||6
215915|NCT00316264|512104|P3|COMPLETED|Overall Study||87
215916|NCT00316264|512105|P2|COMPLETED|Overall Study||77
215917|NCT00316264|512106|P1|COMPLETED|Overall Study||77
215918|NCT00316264|512104|P3|STARTED|Overall Study||93
215919|NCT00316264|512105|P2|STARTED|Overall Study||84
215920|NCT00316264|512106|P1|STARTED|Overall Study||83
215921|NCT00316225|512174|P1|NOT COMPLETED|Overall Study||25
215922|NCT00316225|512174|P1|COMPLETED|Overall Study||6
215923|NCT00316225|512174|P1|STARTED|Overall Study||31
215924|NCT00316199|512183|P1|NOT COMPLETED|Overall Study||12
215925|NCT00316199|512183|P1|COMPLETED|Overall Study||48
215926|NCT00316199|512183|P1|STARTED|Overall Study||60
215927|NCT00316186|512191|P1|NOT COMPLETED|Overall Study||12
215928|NCT00316186|512191|P1|COMPLETED|Overall Study||21
215929|NCT00316186|512191|P1|STARTED|Overall Study||33
215930|NCT00316173|512205|P2|NOT COMPLETED|Treatment Phase||42
215931|NCT00316173|512206|P1|NOT COMPLETED|Treatment Phase||0
215932|NCT00316173|512205|P2|COMPLETED|Treatment Phase||13
215933|NCT00316173|512206|P1|COMPLETED|Treatment Phase||0
215934|NCT00316173|512205|P2|STARTED|Treatment Phase||55
215935|NCT00316173|512206|P1|STARTED|Treatment Phase||0
215936|NCT00316173|512205|P2|NOT COMPLETED|Run-in Phase||0
215937|NCT00316173|512206|P1|NOT COMPLETED|Run-in Phase||7
215938|NCT00316173|512205|P2|COMPLETED|Run-in Phase||0
215939|NCT00316173|512206|P1|COMPLETED|Run-in Phase||15
215940|NCT00316173|512205|P2|STARTED|Run-in Phase||0
215941|NCT00316173|512206|P1|STARTED|Run-in Phase||22
215942|NCT00316121|512219|P2|NOT COMPLETED|Overall Study||9
215943|NCT00316121|512220|P1|NOT COMPLETED|Overall Study||22
215944|NCT00316121|512219|P2|COMPLETED|Overall Study||37
215945|NCT00316121|512220|P1|COMPLETED|Overall Study||70
215946|NCT00316121|512219|P2|STARTED|Overall Study||46
215947|NCT00316121|512220|P1|STARTED|Overall Study||92
215948|NCT00316082|512231|P5|NOT COMPLETED|Overall Study||26
215949|NCT00316082|512232|P4|NOT COMPLETED|Overall Study||26
215950|NCT00316082|512233|P3|NOT COMPLETED|Overall Study||27
215951|NCT00316082|512234|P2|NOT COMPLETED|Overall Study||22
215952|NCT00316082|512235|P1|NOT COMPLETED|Overall Study||33
215953|NCT00316082|512231|P5|COMPLETED|Overall Study||48
215954|NCT00316082|512232|P4|COMPLETED|Overall Study||46
215955|NCT00316082|512233|P3|COMPLETED|Overall Study||44
215956|NCT00316082|512234|P2|COMPLETED|Overall Study||52
215957|NCT00316082|512235|P1|COMPLETED|Overall Study||41
215958|NCT00316082|512231|P5|Completed Study Without Being Rescued|Overall Study||31
215959|NCT00316082|512232|P4|Completed Study Without Being Rescued|Overall Study||27
215960|NCT00316082|512233|P3|Completed Study Without Being Rescued|Overall Study||29
215961|NCT00316082|512234|P2|Completed Study Without Being Rescued|Overall Study||35
215962|NCT00316082|512235|P1|Completed Study Without Being Rescued|Overall Study||25
215963|NCT00316082|512231|P5|STARTED|Overall Study||74
215964|NCT00316082|512232|P4|STARTED|Overall Study||72
215965|NCT00316082|512233|P3|STARTED|Overall Study||71
215966|NCT00316082|512234|P2|STARTED|Overall Study||74
215967|NCT00316082|512235|P1|STARTED|Overall Study||74
215968|NCT00316017|512266|P3|NOT COMPLETED|Overall Study||19
215969|NCT00316017|512267|P2|NOT COMPLETED|Overall Study||13
215970|NCT00316017|512268|P1|NOT COMPLETED|Overall Study||11
215971|NCT00316017|512266|P3|COMPLETED|Overall Study||376
215972|NCT00316017|512267|P2|COMPLETED|Overall Study||256
215973|NCT00316017|512268|P1|COMPLETED|Overall Study||220
215974|NCT00316017|512266|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
215975|NCT00316017|512267|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
215976|NCT00316017|512268|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
215977|NCT00316004|512342|P3|NOT COMPLETED|Overall Study||21
215978|NCT00316004|512343|P2|NOT COMPLETED|Overall Study||14
215979|NCT00316004|512344|P1|NOT COMPLETED|Overall Study||14
215980|NCT00316004|512342|P3|COMPLETED|Overall Study||582
215981|NCT00316004|512343|P2|COMPLETED|Overall Study||341
215982|NCT00316004|512344|P1|COMPLETED|Overall Study||359
215983|NCT00316004|512342|P3|STARTED|Overall Study||603
215984|NCT00316004|512343|P2|STARTED|Overall Study||355
215985|NCT00316004|512344|P1|STARTED|Overall Study||373
215986|NCT00315939|512399|P2|NOT COMPLETED|Admission 3 (3 Months)||2
215987|NCT00315939|512400|P1|NOT COMPLETED|Admission 3 (3 Months)||4
215988|NCT00315939|512399|P2|COMPLETED|Admission 3 (3 Months)||49
215989|NCT00315939|512400|P1|COMPLETED|Admission 3 (3 Months)||48
215990|NCT00315939|512399|P2|STARTED|Admission 3 (3 Months)||51
215991|NCT00315939|512400|P1|STARTED|Admission 3 (3 Months)||52
215992|NCT00315939|512399|P2|NOT COMPLETED|Admission 2 (3 Months)||4
215993|NCT00315939|512400|P1|NOT COMPLETED|Admission 2 (3 Months)||4
215994|NCT00315939|512399|P2|COMPLETED|Admission 2 (3 Months)||51
215995|NCT00315939|512400|P1|COMPLETED|Admission 2 (3 Months)||52
215996|NCT00315939|512399|P2|STARTED|Admission 2 (3 Months)||55
215997|NCT00315939|512400|P1|STARTED|Admission 2 (3 Months)||56
215998|NCT00315939|512399|P2|NOT COMPLETED|Admission 1 (3 Months)||6
215999|NCT00315939|512400|P1|NOT COMPLETED|Admission 1 (3 Months)||3
216000|NCT00315939|512399|P2|COMPLETED|Admission 1 (3 Months)||55
216001|NCT00315939|512400|P1|COMPLETED|Admission 1 (3 Months)||56
216002|NCT00315939|512399|P2|STARTED|Admission 1 (3 Months)||61
216003|NCT00315939|512400|P1|STARTED|Admission 1 (3 Months)||59
216004|NCT00315731|512406|P1|NOT COMPLETED|Overall Study||6
216005|NCT00315731|512406|P1|COMPLETED|Overall Study||9
216006|NCT00315731|512406|P1|STARTED|Overall Study||15
216007|NCT00315705|512434|P1|NOT COMPLETED|Phase 2||25
216008|NCT00315705|512434|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
216009|NCT00315705|512434|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
216010|NCT00315705|512434|P1|NOT COMPLETED|Phase 1||25
216011|NCT00315705|512434|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
216012|NCT00315705|512434|P1|STARTED|Phase 1||25
216013|NCT00315614|512471|P1|NOT COMPLETED|Overall Study||0
216014|NCT00315614|512471|P1|COMPLETED|Overall Study||3
216015|NCT00315614|512471|P1|STARTED|Overall Study||3
216016|NCT00315458|512477|P4|NOT COMPLETED|Overall Study||29
216017|NCT00315458|512478|P3|NOT COMPLETED|Overall Study||52
216018|NCT00315458|512479|P2|NOT COMPLETED|Overall Study||12
216019|NCT00315458|512480|P1|NOT COMPLETED|Overall Study||3
216020|NCT00315458|512477|P4|COMPLETED|Overall Study||10
216021|NCT00315458|512478|P3|COMPLETED|Overall Study||107
216022|NCT00315458|512479|P2|COMPLETED|Overall Study||44
216023|NCT00315458|512480|P1|COMPLETED|Overall Study||48
216024|NCT00315458|512477|P4|STARTED|Overall Study||39
216025|NCT00315458|512478|P3|STARTED|Overall Study||159
216026|NCT00315458|512479|P2|STARTED|Overall Study||56
216027|NCT00315458|512480|P1|STARTED|Overall Study||51
216028|NCT00315445|512493|P3|NOT COMPLETED|Overall Study||24
216029|NCT00315445|512494|P2|NOT COMPLETED|Overall Study||16
216030|NCT00315445|512495|P1|NOT COMPLETED|Overall Study||27
216031|NCT00315445|512493|P3|COMPLETED|Overall Study||22
216032|NCT00315445|512494|P2|COMPLETED|Overall Study||27
216033|NCT00315445|512495|P1|COMPLETED|Overall Study||18
216034|NCT00315445|512493|P3|STARTED|Overall Study||46
216035|NCT00315445|512494|P2|STARTED|Overall Study||43
216036|NCT00315445|512495|P1|STARTED|Overall Study||45
216037|NCT00315341|512568|P2|NOT COMPLETED|Overall Study||138
216038|NCT00315341|512569|P1|NOT COMPLETED|Overall Study||400
216039|NCT00315341|512568|P2|COMPLETED|Overall Study||391
216040|NCT00315341|512569|P1|COMPLETED|Overall Study||340
216041|NCT00315341|512568|P2|STARTED|Overall Study||529
216042|NCT00315341|512569|P1|STARTED|Overall Study||740
216043|NCT00315328|512579|P4|NOT COMPLETED|Overall Study||2
216044|NCT00315328|512580|P3|NOT COMPLETED|Overall Study||5
216045|NCT00315328|512581|P2|NOT COMPLETED|Overall Study||7
216046|NCT00315328|512582|P1|NOT COMPLETED|Overall Study||14
216047|NCT00315328|512579|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
216048|NCT00315328|512580|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
216049|NCT00315328|512581|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
216050|NCT00315328|512582|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
216051|NCT00315328|512579|P4|5 Week Visit|Overall Study||19
216052|NCT00315328|512580|P3|5 Week Visit|Overall Study||17
216053|NCT00315328|512581|P2|5 Week Visit|Overall Study||89
216054|NCT00315328|512582|P1|5 Week Visit|Overall Study||91
216055|NCT00315328|512579|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
216056|NCT00315328|512580|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
216057|NCT00315328|512581|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
216058|NCT00315328|512582|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
216059|NCT00315302|512652|P4|NOT COMPLETED|Overall Study||3
216060|NCT00315302|512653|P3|NOT COMPLETED|Overall Study||2
216061|NCT00315302|512654|P2|NOT COMPLETED|Overall Study||2
216062|NCT00315302|512655|P1|NOT COMPLETED|Overall Study||6
216063|NCT00315302|512652|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
216064|NCT00315302|512653|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
216065|NCT00315302|512654|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
216066|NCT00315302|512655|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
216067|NCT00315302|512652|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
216068|NCT00315302|512653|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
216069|NCT00315302|512654|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
216070|NCT00315302|512655|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
216071|NCT00315302|512652|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
216072|NCT00315302|512653|P3|18 Week Primary Outcome Visit|Overall Study||24
216073|NCT00315302|512654|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
216074|NCT00315302|512655|P1|18 Week Primary Outcome Visit|Overall Study||84
216075|NCT00315302|512652|P4|10 Week Visit|Overall Study||29
216076|NCT00315302|512653|P3|10 Week Visit|Overall Study||24
216077|NCT00315302|512654|P2|10 Week Visit|Overall Study||85
216078|NCT00315302|512655|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
216079|NCT00315302|512652|P4|5 Week Visit|Overall Study||30
216080|NCT00315302|512653|P3|5 Week Visit|Overall Study||26
216081|NCT00315302|512654|P2|5 Week Visit|Overall Study||86
216082|NCT00315302|512655|P1|5 Week Visit|Overall Study||85
216083|NCT00315302|512652|P4|STARTED|Overall Study||34
216084|NCT00315302|512653|P3|STARTED|Overall Study||26
216085|NCT00315302|512654|P2|STARTED|Overall Study||90
216086|NCT00315302|512655|P1|STARTED|Overall Study||90
216087|NCT00315146|512701|P4|NOT COMPLETED|Overall Study||0
216088|NCT00315146|512702|P3|NOT COMPLETED|Overall Study||2
216089|NCT00315146|512703|P2|NOT COMPLETED|Overall Study||3
216090|NCT00315146|512704|P1|NOT COMPLETED|Overall Study||2
216091|NCT00315146|512701|P4|COMPLETED|Overall Study||22
216092|NCT00315146|512702|P3|COMPLETED|Overall Study||20
216093|NCT00315146|512703|P2|COMPLETED|Overall Study||19
216094|NCT00315146|512704|P1|COMPLETED|Overall Study||20
216095|NCT00315146|512701|P4|STARTED|Overall Study||22
216096|NCT00315146|512702|P3|STARTED|Overall Study||22
216097|NCT00315146|512703|P2|STARTED|Overall Study||22
216098|NCT00315146|512704|P1|STARTED|Overall Study||22
216099|NCT00315120|512722|P4|NOT COMPLETED|Overall Study||0
216100|NCT00315120|512723|P3|NOT COMPLETED|Overall Study||0
216101|NCT00315120|512724|P2|NOT COMPLETED|Overall Study||0
216102|NCT00315120|512725|P1|NOT COMPLETED|Overall Study||0
216103|NCT00315120|512722|P4|COMPLETED|Overall Study||107
216104|NCT00315120|512723|P3|COMPLETED|Overall Study||115
216105|NCT00315120|512724|P2|COMPLETED|Overall Study||118
216106|NCT00315120|512725|P1|COMPLETED|Overall Study||115
216107|NCT00315120|512722|P4|STARTED|Overall Study||107
216108|NCT00315120|512723|P3|STARTED|Overall Study||115
216109|NCT00315120|512724|P2|STARTED|Overall Study||118
216110|NCT00315120|512725|P1|STARTED|Overall Study||115
216111|NCT00315055|512785|P2|NOT COMPLETED|Overall Study||5
216112|NCT00315055|512786|P1|NOT COMPLETED|Overall Study||3
216113|NCT00315055|512785|P2|COMPLETED|Overall Study||150
216114|NCT00315055|512786|P1|COMPLETED|Overall Study||152
216115|NCT00315055|512785|P2|STARTED|Overall Study||155
216116|NCT00315055|512786|P1|STARTED|Overall Study||155
216117|NCT00314951|512804|P2|NOT COMPLETED|Follow-up||34
216118|NCT00314951|512805|P1|NOT COMPLETED|Follow-up||44
216119|NCT00314951|512804|P2|COMPLETED|Follow-up||255
216120|NCT00314951|512805|P1|COMPLETED|Follow-up||263
216121|NCT00314951|512804|P2|STARTED|Follow-up||289
216122|NCT00314951|512805|P1|STARTED|Follow-up||307
216123|NCT00314951|512804|P2|NOT COMPLETED|Treatment||11
216124|NCT00314951|512805|P1|NOT COMPLETED|Treatment||16
216125|NCT00314951|512804|P2|COMPLETED|Treatment||289
216126|NCT00314951|512805|P1|COMPLETED|Treatment||307
216127|NCT00314951|512804|P2|STARTED|Treatment||300
216128|NCT00314951|512805|P1|STARTED|Treatment||323
216129|NCT00314951|512804|P2|NOT COMPLETED|Enrollment||6
216130|NCT00314951|512805|P1|NOT COMPLETED|Enrollment||0
216131|NCT00314951|512804|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
216132|NCT00314951|512805|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
216133|NCT00314951|512804|P2|STARTED|Enrollment||306
216134|NCT00314951|512805|P1|STARTED|Enrollment||323
216135|NCT00314808|512815|P1|NOT COMPLETED|Overall Study||8
216136|NCT00314808|512815|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
216137|NCT00314808|512815|P1|STARTED|Overall Study||33
216138|NCT00314574|512825|P2|NOT COMPLETED|Overall Study||83
216139|NCT00314574|512826|P1|NOT COMPLETED|Overall Study||94
216140|NCT00314574|512825|P2|COMPLETED|Overall Study||344
216141|NCT00314574|512826|P1|COMPLETED|Overall Study||329
216142|NCT00314574|512825|P2|Safety Population|Overall Study||428
216143|NCT00314574|512826|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
216144|NCT00314574|512825|P2|Received at Least One Dose of Study Drug|Overall Study||427
216145|NCT00314574|512826|P1|Received at Least One Dose of Study Drug|Overall Study||421
216146|NCT00314574|512825|P2|STARTED|Overall Study||427
216147|NCT00314574|512826|P1|STARTED|Overall Study||423
216148|NCT00314106|512842|P2|NOT COMPLETED|Overall Study||0
216149|NCT00314106|512843|P1|NOT COMPLETED|Overall Study||0
216150|NCT00314106|512842|P2|COMPLETED|Overall Study||8
216151|NCT00314106|512843|P1|COMPLETED|Overall Study||18
216152|NCT00314106|512842|P2|STARTED|Overall Study||8
216153|NCT00314106|512843|P1|STARTED|Overall Study||18
216154|NCT00314366|512853|P2|NOT COMPLETED|Overall Study||0
216155|NCT00314366|512854|P1|NOT COMPLETED|Overall Study||1
216156|NCT00314366|512853|P2|COMPLETED|Overall Study||10
216157|NCT00314366|512854|P1|COMPLETED|Overall Study||10
216158|NCT00314366|512853|P2|STARTED|Overall Study||10
216159|NCT00314366|512854|P1|STARTED|Overall Study||11
216160|NCT00314353|512884|P2|NOT COMPLETED|Follow-up||0
216161|NCT00314353|512885|P1|NOT COMPLETED|Follow-up||0
216162|NCT00314353|512884|P2|COMPLETED|Follow-up||0
216163|NCT00314353|512885|P1|COMPLETED|Follow-up||3
216164|NCT00314353|512884|P2|STARTED|Follow-up||0
216165|NCT00314353|512885|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
216166|NCT00314353|512884|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
216167|NCT00314353|512885|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
216168|NCT00314353|512884|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
216169|NCT00314353|512885|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
216170|NCT00314353|512884|P2|STARTED|Protocol Therapy (8 Cycles)||3
216171|NCT00314353|512885|P1|STARTED|Protocol Therapy (8 Cycles)||4
216172|NCT00314340|512891|P1|NOT COMPLETED|Overall Study||1
216173|NCT00314340|512891|P1|COMPLETED|Overall Study||11
216174|NCT00314340|512891|P1|Placebo|Overall Study||12
216175|NCT00314340|512891|P1|Hydrocodone Plus APAP|Overall Study||12
216176|NCT00314340|512891|P1|ER Morphine|Overall Study||11
216177|NCT00314340|512891|P1|STARTED|Overall Study||12
216178|NCT00314327|512897|P1|NOT COMPLETED|Overall Study||1
216179|NCT00314327|512897|P1|COMPLETED|Overall Study||0
216180|NCT00314327|512897|P1|STARTED|Overall Study||1
216181|NCT00314262|512901|P1|NOT COMPLETED|Overall Study||5
216182|NCT00314262|512901|P1|COMPLETED|Overall Study||7
216183|NCT00314262|512901|P1|STARTED|Overall Study||12
216184|NCT00314249|512909|P2|NOT COMPLETED|Overall Study||163
216185|NCT00314249|512910|P1|NOT COMPLETED|Overall Study||152
216186|NCT00314249|512909|P2|COMPLETED|Overall Study||353
216187|NCT00314249|512910|P1|COMPLETED|Overall Study||357
216188|NCT00314249|512909|P2|STARTED|Overall Study||516
216189|NCT00314249|512910|P1|STARTED|Overall Study||509
216190|NCT00314236|512928|P2|NOT COMPLETED|Overall Study||2
216191|NCT00314236|512929|P1|NOT COMPLETED|Overall Study||0
216192|NCT00314236|512928|P2|COMPLETED|Overall Study||37
216193|NCT00314236|512929|P1|COMPLETED|Overall Study||41
216194|NCT00314236|512928|P2|STARTED|Overall Study||39
216195|NCT00314236|512929|P1|STARTED|Overall Study||41
216196|NCT00314145|512943|P2|NOT COMPLETED|Overall Study||29
216197|NCT00314145|512944|P1|NOT COMPLETED|Overall Study||21
216198|NCT00314145|512943|P2|COMPLETED|Overall Study||381
216199|NCT00314145|512944|P1|COMPLETED|Overall Study||389
216200|NCT00314145|512943|P2|STARTED|Overall Study||410
216201|NCT00314145|512944|P1|STARTED|Overall Study||410
216202|NCT00314132|512958|P2|NOT COMPLETED|Overall Study||18
216203|NCT00314132|512959|P1|NOT COMPLETED|Overall Study||8
216204|NCT00314132|512958|P2|COMPLETED|Overall Study||1583
216205|NCT00314132|512959|P1|COMPLETED|Overall Study||395
216206|NCT00314132|512958|P2|STARTED|Overall Study||1601
216207|NCT00314132|512959|P1|STARTED|Overall Study||403
216208|NCT00313911|512969|P2|NOT COMPLETED|Overall Study||41
216209|NCT00313911|512970|P1|NOT COMPLETED|Overall Study||94
216210|NCT00313911|512969|P2|COMPLETED|Overall Study||670
216211|NCT00313911|512970|P1|COMPLETED|Overall Study||1328
216301|NCT00313586|513141|P4|STARTED|Overall Study||23
216212|NCT00313911|512969|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
216213|NCT00313911|512970|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
216214|NCT00313846|512984|P2|NOT COMPLETED|Overall Study||11
216215|NCT00313846|512985|P1|NOT COMPLETED|Overall Study||5
216216|NCT00313846|512984|P2|COMPLETED|Overall Study||153
216217|NCT00313846|512985|P1|COMPLETED|Overall Study||157
216218|NCT00313846|512984|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
216219|NCT00313846|512985|P1|STARTED|Overall Study||162
216220|NCT00313820|512996|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
216221|NCT00313820|512997|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
216222|NCT00313820|512996|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
216223|NCT00313820|512997|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
216224|NCT00313820|512996|P2|STARTED|Pregabalin or Placebo Treatment Period||109
216225|NCT00313820|512997|P1|STARTED|Pregabalin or Placebo Treatment Period||110
216226|NCT00313820|512996|P2|NOT COMPLETED|Assigned to Treatment||0
216227|NCT00313820|512997|P1|NOT COMPLETED|Assigned to Treatment||1
216228|NCT00313820|512996|P2|COMPLETED|Assigned to Treatment||109
216229|NCT00313820|512997|P1|COMPLETED|Assigned to Treatment||110
216230|NCT00313820|512996|P2|STARTED|Assigned to Treatment||109
216231|NCT00313820|512997|P1|STARTED|Assigned to Treatment||111
216232|NCT00313781|513035|P3|NOT COMPLETED|After Crossover||27
216233|NCT00313781|513036|P2|NOT COMPLETED|After Crossover||0
216234|NCT00313781|513037|P1|NOT COMPLETED|After Crossover||0
216235|NCT00313781|513035|P3|COMPLETED|After Crossover||10
216236|NCT00313781|513036|P2|COMPLETED|After Crossover||0
216237|NCT00313781|513037|P1|COMPLETED|After Crossover||0
216238|NCT00313781|513035|P3|STARTED|After Crossover||37
216239|NCT00313781|513036|P2|STARTED|After Crossover||0
216240|NCT00313781|513037|P1|STARTED|After Crossover||0
216241|NCT00313781|513035|P3|NOT COMPLETED|Before Crossover||0
216242|NCT00313781|513036|P2|NOT COMPLETED|Before Crossover||79
216243|NCT00313781|513037|P1|NOT COMPLETED|Before Crossover||75
216244|NCT00313781|513035|P3|COMPLETED|Before Crossover||0
216245|NCT00313781|513036|P2|COMPLETED|Before Crossover||23
216246|NCT00313781|513037|P1|COMPLETED|Before Crossover||27
216247|NCT00313781|513035|P3|Treated|Before Crossover||0
216248|NCT00313781|513036|P2|Treated|Before Crossover||102
216249|NCT00313781|513037|P1|Treated|Before Crossover||97
216250|NCT00313781|513035|P3|STARTED|Before Crossover||0
216251|NCT00313781|513036|P2|STARTED|Before Crossover||102
216252|NCT00313781|513037|P1|STARTED|Before Crossover||102
216253|NCT00313716|513077|P6|NOT COMPLETED|Overall Study||13
216254|NCT00313716|513078|P5|NOT COMPLETED|Overall Study||6
216255|NCT00313716|513079|P4|NOT COMPLETED|Overall Study||4
216256|NCT00313716|513080|P3|NOT COMPLETED|Overall Study||12
216257|NCT00313716|513081|P2|NOT COMPLETED|Overall Study||8
216258|NCT00313716|513082|P1|NOT COMPLETED|Overall Study||5
216259|NCT00313716|513077|P6|COMPLETED|Overall Study||35
216260|NCT00313716|513078|P5|COMPLETED|Overall Study||27
216261|NCT00313716|513079|P4|COMPLETED|Overall Study||16
216262|NCT00313716|513080|P3|COMPLETED|Overall Study||38
216263|NCT00313716|513081|P2|COMPLETED|Overall Study||23
216264|NCT00313716|513082|P1|COMPLETED|Overall Study||13
216265|NCT00313716|513077|P6|STARTED|Overall Study||48
216266|NCT00313716|513078|P5|STARTED|Overall Study||33
216267|NCT00313716|513079|P4|STARTED|Overall Study||20
216268|NCT00313716|513080|P3|STARTED|Overall Study||50
216269|NCT00313716|513081|P2|STARTED|Overall Study||31
216270|NCT00313716|513082|P1|STARTED|Overall Study||18
216271|NCT00313703|513109|P4|NOT COMPLETED|Overall Study||12
216272|NCT00313703|513110|P3|NOT COMPLETED|Overall Study||5
216273|NCT00313703|513111|P2|NOT COMPLETED|Overall Study||2
216274|NCT00313703|513112|P1|NOT COMPLETED|Overall Study||11
216275|NCT00313703|513109|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
216276|NCT00313703|513110|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
216277|NCT00313703|513111|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
216278|NCT00313703|513112|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
216279|NCT00313703|513109|P4|STARTED|Overall Study||12
216280|NCT00313703|513110|P3|STARTED|Overall Study||77
216281|NCT00313703|513111|P2|STARTED|Overall Study||34
216282|NCT00313703|513112|P1|STARTED|Overall Study||186
216283|NCT00313612|513128|P2|NOT COMPLETED|Overall Study||1
216284|NCT00313612|513129|P1|NOT COMPLETED|Overall Study||0
216285|NCT00313612|513128|P2|COMPLETED|Overall Study||19
216286|NCT00313612|513129|P1|COMPLETED|Overall Study||19
216287|NCT00313612|513128|P2|STARTED|Overall Study||20
216288|NCT00313612|513129|P1|STARTED|Overall Study||19
216289|NCT00313586|513141|P4|NOT COMPLETED|Overall Study||23
216290|NCT00313586|513142|P3|NOT COMPLETED|Overall Study||24
216291|NCT00313586|513143|P2|NOT COMPLETED|Overall Study||70
216292|NCT00313586|513144|P1|NOT COMPLETED|Overall Study||70
216293|NCT00313586|513141|P4|COMPLETED|Overall Study||0
216294|NCT00313586|513142|P3|COMPLETED|Overall Study||0
216295|NCT00313586|513143|P2|COMPLETED|Overall Study||5
216296|NCT00313586|513144|P1|COMPLETED|Overall Study||5
216297|NCT00313586|513141|P4|Treated|Overall Study||23
216298|NCT00313586|513142|P3|Treated|Overall Study||24
216299|NCT00313586|513143|P2|Treated|Overall Study||75
216300|NCT00313586|513144|P1|Treated|Overall Study||74
216302|NCT00313586|513142|P3|STARTED|Overall Study||24
216303|NCT00313586|513143|P2|STARTED|Overall Study||75
216304|NCT00313586|513144|P1|STARTED|Overall Study||75
216305|NCT00313443|513152|P1|NOT COMPLETED|Overall Study||0
216306|NCT00313443|513152|P1|COMPLETED|Overall Study||30
216307|NCT00313443|513152|P1|STARTED|Overall Study||30
216308|NCT00313313|513163|P3|NOT COMPLETED|Overall Study||82
216309|NCT00313313|513164|P2|NOT COMPLETED|Overall Study||66
216310|NCT00313313|513165|P1|NOT COMPLETED|Overall Study||63
216311|NCT00313313|513163|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
216312|NCT00313313|513164|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
216313|NCT00313313|513165|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
216314|NCT00313313|513163|P3|STARTED|Overall Study||267
216315|NCT00313313|513164|P2|STARTED|Overall Study||253
216316|NCT00313313|513165|P1|STARTED|Overall Study||248
216317|NCT00313300|513187|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
216318|NCT00313300|513188|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
216319|NCT00313300|513189|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
216320|NCT00313300|513190|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
216321|NCT00313300|513191|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
216322|NCT00313300|513187|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
216323|NCT00313300|513188|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
216324|NCT00313300|513189|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
216325|NCT00313300|513190|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
216326|NCT00313300|513191|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
216327|NCT00313300|513187|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
216328|NCT00313300|513188|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
216329|NCT00313300|513189|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
216330|NCT00313300|513190|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
216331|NCT00313300|513191|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
216332|NCT00313300|513187|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
216333|NCT00313300|513188|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
216334|NCT00313300|513189|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
216335|NCT00313300|513190|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
216336|NCT00313300|513191|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
216337|NCT00313300|513187|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
216338|NCT00313300|513188|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
216339|NCT00313300|513189|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
216340|NCT00313300|513190|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
216341|NCT00313300|513191|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
216342|NCT00313300|513187|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
216343|NCT00313300|513188|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
216344|NCT00313300|513189|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
216345|NCT00313300|513190|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
216346|NCT00313300|513191|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
216347|NCT00313300|513187|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
216348|NCT00313300|513188|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
216349|NCT00313300|513189|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
216350|NCT00313300|513190|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
216351|NCT00313300|513191|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
216352|NCT00313300|513187|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
216353|NCT00313300|513188|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
216354|NCT00313300|513189|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
216355|NCT00313300|513190|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
216356|NCT00313300|513191|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
216357|NCT00313300|513187|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
216358|NCT00313300|513188|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
216359|NCT00313300|513189|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
216360|NCT00313300|513190|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
216361|NCT00313300|513191|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
216362|NCT00313300|513187|P5|STARTED|Randomized in Phase B (26 Weeks)||221
216363|NCT00313300|513188|P4|STARTED|Randomized in Phase B (26 Weeks)||248
216364|NCT00313300|513189|P3|STARTED|Randomized in Phase B (26 Weeks)||134
216365|NCT00313300|513190|P2|STARTED|Randomized in Phase B (26 Weeks)||138
216366|NCT00313300|513191|P1|STARTED|Randomized in Phase B (26 Weeks)||427
216367|NCT00313300|513187|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
216368|NCT00313300|513188|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
216369|NCT00313300|513189|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
216370|NCT00313300|513190|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
216371|NCT00313300|513191|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
216372|NCT00313300|513187|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
216373|NCT00313300|513188|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
216374|NCT00313300|513189|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
216375|NCT00313300|513190|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
216376|NCT00313300|513191|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
216377|NCT00313300|513187|P5|STARTED|Randomized in Phase A (26 Weeks)||0
216378|NCT00313300|513188|P4|STARTED|Randomized in Phase A (26 Weeks)||0
216379|NCT00313300|513189|P3|STARTED|Randomized in Phase A (26 Weeks)||184
216380|NCT00313300|513190|P2|STARTED|Randomized in Phase A (26 Weeks)||179
216381|NCT00313300|513191|P1|STARTED|Randomized in Phase A (26 Weeks)||184
216382|NCT00313209|513243|P2|NOT COMPLETED|Overall Study||82
216383|NCT00313209|513244|P1|NOT COMPLETED|Overall Study||107
216384|NCT00313209|513243|P2|COMPLETED|Overall Study||385
216385|NCT00313209|513244|P1|COMPLETED|Overall Study||359
216386|NCT00313209|513243|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
216387|NCT00313209|513244|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
216388|NCT00313170|513261|P3|NOT COMPLETED|Overall Study||32
216389|NCT00313170|513262|P2|NOT COMPLETED|Overall Study||35
216390|NCT00313170|513263|P1|NOT COMPLETED|Overall Study||36
216391|NCT00313170|513261|P3|COMPLETED|Overall Study||14
216392|NCT00313170|513262|P2|COMPLETED|Overall Study||16
216393|NCT00313170|513263|P1|COMPLETED|Overall Study||11
216394|NCT00313170|513261|P3|STARTED|Overall Study||46
216395|NCT00313170|513262|P2|STARTED|Overall Study||51
216396|NCT00313170|513263|P1|STARTED|Overall Study||47
216397|NCT00313144|513279|P1|NOT COMPLETED|Overall Study||110
216398|NCT00313144|513279|P1|COMPLETED|Overall Study||17
216399|NCT00313144|513279|P1|STARTED|Overall Study||127
216400|NCT00313014|513366|P3|NOT COMPLETED|Overall Study||61
216401|NCT00313014|513367|P2|NOT COMPLETED|Overall Study||73
216402|NCT00313014|513368|P1|NOT COMPLETED|Overall Study||93
216403|NCT00313014|513366|P3|COMPLETED|Overall Study||159
216404|NCT00313014|513367|P2|COMPLETED|Overall Study||146
216405|NCT00313014|513368|P1|COMPLETED|Overall Study||128
216406|NCT00313014|513366|P3|STARTED|Overall Study||220
216407|NCT00313014|513367|P2|STARTED|Overall Study||219
216408|NCT00313014|513368|P1|STARTED|Overall Study||221
216409|NCT00312923|513388|P2|NOT COMPLETED|Overall Study||6
216410|NCT00312923|513389|P1|NOT COMPLETED|Overall Study||9
216411|NCT00312923|513388|P2|COMPLETED|Overall Study||20
216412|NCT00312923|513389|P1|COMPLETED|Overall Study||19
216413|NCT00312923|513388|P2|STARTED|Overall Study||26
216414|NCT00312923|513389|P1|STARTED|Overall Study||28
216415|NCT00312884|513399|P2|NOT COMPLETED|Overall Study||12
216416|NCT00312884|513400|P1|NOT COMPLETED|Overall Study||17
216417|NCT00312884|513399|P2|COMPLETED|Overall Study||79
216418|NCT00312884|513400|P1|COMPLETED|Overall Study||74
216419|NCT00312884|513399|P2|STARTED|Overall Study||91
216420|NCT00312884|513400|P1|STARTED|Overall Study||91
216421|NCT00312858|513414|P2|NOT COMPLETED|Overall Study||93
216422|NCT00312858|513415|P1|NOT COMPLETED|Overall Study||68
216423|NCT00312858|513414|P2|COMPLETED|Overall Study||230
216424|NCT00312858|513415|P1|COMPLETED|Overall Study||262
216425|NCT00312858|513414|P2|Visit 4|Overall Study||240
216426|NCT00312858|513415|P1|Visit 4|Overall Study||262
216427|NCT00312858|513414|P2|Visit 3|Overall Study||261
216428|NCT00312858|513415|P1|Visit 3|Overall Study||273
216429|NCT00312858|513414|P2|Visit 2|Overall Study||294
216430|NCT00312858|513415|P1|Visit 2|Overall Study||305
216431|NCT00312858|513414|P2|Visit 1|Overall Study||323
216432|NCT00312858|513415|P1|Visit 1|Overall Study||330
216433|NCT00312858|513414|P2|STARTED|Overall Study||323
216434|NCT00312858|513415|P1|STARTED|Overall Study||330
216435|NCT00312845|513469|P2|NOT COMPLETED|Overall Study||95
216436|NCT00312845|513470|P1|NOT COMPLETED|Overall Study||99
216437|NCT00312845|513469|P2|COMPLETED|Overall Study||245
216438|NCT00312845|513470|P1|COMPLETED|Overall Study||237
216439|NCT00312845|513469|P2|STARTED|Overall Study||340
216440|NCT00312845|513470|P1|STARTED|Overall Study||336
216441|NCT00312728|513478|P1|NOT COMPLETED|Overall Study||110
216442|NCT00312728|513478|P1|COMPLETED|Overall Study||5
216443|NCT00312728|513478|P1|STARTED|Overall Study||115
216444|NCT00312572|513489|P2|NOT COMPLETED|Overall Study||21
216445|NCT00312572|513490|P1|NOT COMPLETED|Overall Study||16
216446|NCT00312572|513489|P2|COMPLETED|Overall Study||82
216447|NCT00312572|513490|P1|COMPLETED|Overall Study||85
216448|NCT00312572|513489|P2|STARTED|Overall Study||103
216449|NCT00312572|513490|P1|STARTED|Overall Study||101
216450|NCT00312494|513501|P3|NOT COMPLETED|Overall Study||43
216451|NCT00312494|513502|P2|NOT COMPLETED|Overall Study||58
216452|NCT00312494|513503|P1|NOT COMPLETED|Overall Study||71
216453|NCT00312494|513501|P3|COMPLETED|Overall Study||179
216454|NCT00312494|513502|P2|COMPLETED|Overall Study||168
216455|NCT00312494|513503|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
216456|NCT00312494|513501|P3|Received Study Treatment|Overall Study||217
216457|NCT00312494|513502|P2|Received Study Treatment|Overall Study||216
216458|NCT00312494|513503|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
216459|NCT00312494|513501|P3|STARTED|Overall Study||222
216460|NCT00312494|513502|P2|STARTED|Overall Study||226
216461|NCT00312494|513503|P1|STARTED|Overall Study||232
216462|NCT00312377|513537|P2|NOT COMPLETED|Overall Study||668
216463|NCT00312377|513538|P1|NOT COMPLETED|Overall Study||644
216464|NCT00312377|513537|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
216465|NCT00312377|513538|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
216466|NCT00312377|513537|P2|STARTED|Overall Study|randomised patients|697
216467|NCT00312377|513538|P1|STARTED|Overall Study|randomised patients|694
216468|NCT00312338|513562|P2|NOT COMPLETED|Overall Study||3
216469|NCT00312338|513563|P1|NOT COMPLETED|Overall Study||22
216470|NCT00312338|513562|P2|COMPLETED|Overall Study||54
216471|NCT00312338|513563|P1|COMPLETED|Overall Study||83
216472|NCT00312338|513562|P2|STARTED|Overall Study||57
216473|NCT00312338|513563|P1|STARTED|Overall Study||105
216474|NCT00312221|513576|P4|NOT COMPLETED|Double-blind Phase||70
216475|NCT00312221|513577|P3|NOT COMPLETED|Double-blind Phase||72
216476|NCT00312221|513578|P2|NOT COMPLETED|Double-blind Phase||59
216477|NCT00312221|513579|P1|NOT COMPLETED|Double-blind Phase||0
216478|NCT00312221|513576|P4|COMPLETED|Double-blind Phase||63
216479|NCT00312221|513577|P3|COMPLETED|Double-blind Phase||77
216480|NCT00312221|513578|P2|COMPLETED|Double-blind Phase||77
216481|NCT00312221|513579|P1|COMPLETED|Double-blind Phase||0
216482|NCT00312221|513576|P4|STARTED|Double-blind Phase||133
216483|NCT00312221|513577|P3|STARTED|Double-blind Phase||149
216484|NCT00312221|513578|P2|STARTED|Double-blind Phase||136
216485|NCT00312221|513579|P1|STARTED|Double-blind Phase||0
216486|NCT00312221|513576|P4|NOT COMPLETED|Open-label Run-in Period||0
216487|NCT00312221|513577|P3|NOT COMPLETED|Open-label Run-in Period||0
216488|NCT00312221|513578|P2|NOT COMPLETED|Open-label Run-in Period||0
216489|NCT00312221|513579|P1|NOT COMPLETED|Open-label Run-in Period||234
216490|NCT00312221|513576|P4|COMPLETED|Open-label Run-in Period||0
216491|NCT00312221|513577|P3|COMPLETED|Open-label Run-in Period||0
216492|NCT00312221|513578|P2|COMPLETED|Open-label Run-in Period||0
216493|NCT00312221|513579|P1|COMPLETED|Open-label Run-in Period||418
216494|NCT00312221|513576|P4|STARTED|Open-label Run-in Period||0
216495|NCT00312221|513577|P3|STARTED|Open-label Run-in Period||0
216496|NCT00312221|513578|P2|STARTED|Open-label Run-in Period||0
216497|NCT00312221|513579|P1|STARTED|Open-label Run-in Period||652
216498|NCT00312208|513599|P2|NOT COMPLETED|Overall Study||123
216499|NCT00312208|513600|P1|NOT COMPLETED|Overall Study||172
216500|NCT00312208|513599|P2|COMPLETED|Overall Study||1526
216501|NCT00312208|513600|P1|COMPLETED|Overall Study||1477
216502|NCT00312208|513599|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
216503|NCT00312208|513600|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
216504|NCT00312195|513610|P2|NOT COMPLETED|Overall Study||6
216505|NCT00312195|513611|P1|NOT COMPLETED|Overall Study||6
216506|NCT00312195|513610|P2|COMPLETED|Overall Study||123
216507|NCT00312195|513611|P1|COMPLETED|Overall Study||132
216508|NCT00312195|513610|P2|STARTED|Overall Study||129
216509|NCT00312195|513611|P1|STARTED|Overall Study||138
216510|NCT00311766|513627|P2|NOT COMPLETED|Overall Study||5
216511|NCT00311766|513628|P1|NOT COMPLETED|Overall Study||0
216512|NCT00311766|513627|P2|COMPLETED|Overall Study||17
216513|NCT00311766|513628|P1|COMPLETED|Overall Study||8
216514|NCT00311766|513627|P2|STARTED|Overall Study||22
216515|NCT00311766|513628|P1|STARTED|Overall Study||8
216516|NCT00311584|513638|P2|NOT COMPLETED|Overall Study||23
216517|NCT00311584|513639|P1|NOT COMPLETED|Overall Study||20
216518|NCT00311584|513638|P2|COMPLETED|Overall Study||7
216519|NCT00311584|513639|P1|COMPLETED|Overall Study||9
216520|NCT00311584|513638|P2|STARTED|Overall Study||30
216521|NCT00311584|513639|P1|STARTED|Overall Study||29
216522|NCT00311402|513647|P2|NOT COMPLETED|Overall Study||177
216523|NCT00311402|513648|P1|NOT COMPLETED|Overall Study||210
216524|NCT00311402|513647|P2|COMPLETED|Overall Study||462
216525|NCT00311402|513648|P1|COMPLETED|Overall Study||445
216526|NCT00311402|513647|P2|STARTED|Overall Study||639
216527|NCT00311402|513648|P1|STARTED|Overall Study||655
216528|NCT00311376|513675|P3|NOT COMPLETED|Treatment Cycle 2||0
216529|NCT00311376|513676|P2|NOT COMPLETED|Treatment Cycle 2||13
216530|NCT00311376|513677|P1|NOT COMPLETED|Treatment Cycle 2||9
216531|NCT00311376|513675|P3|COMPLETED|Treatment Cycle 2||0
216532|NCT00311376|513676|P2|COMPLETED|Treatment Cycle 2||112
216533|NCT00311376|513677|P1|COMPLETED|Treatment Cycle 2||106
216534|NCT00311376|513675|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
216535|NCT00311376|513676|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
216536|NCT00311376|513677|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
216537|NCT00311376|513675|P3|NOT COMPLETED|Treatment Cycle 1||17
216538|NCT00311376|513676|P2|NOT COMPLETED|Treatment Cycle 1||17
216539|NCT00311376|513677|P1|NOT COMPLETED|Treatment Cycle 1||27
216540|NCT00311376|513675|P3|COMPLETED|Treatment Cycle 1||132
216541|NCT00311376|513676|P2|COMPLETED|Treatment Cycle 1||118
216542|NCT00311376|513677|P1|COMPLETED|Treatment Cycle 1||105
216543|NCT00311376|513675|P3|STARTED|Treatment Cycle 1||149
216544|NCT00311376|513676|P2|STARTED|Treatment Cycle 1||135
216545|NCT00311376|513677|P1|STARTED|Treatment Cycle 1||132
216546|NCT00311363|513697|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
216547|NCT00311363|513698|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
216548|NCT00311363|513699|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
216549|NCT00311363|513697|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
216550|NCT00311363|513698|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
216551|NCT00311363|513699|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
216552|NCT00311363|513697|P3|STARTED|12-Week Double-Blind Treatment Period||96
216553|NCT00311363|513698|P2|STARTED|12-Week Double-Blind Treatment Period||98
216554|NCT00311363|513699|P1|STARTED|12-Week Double-Blind Treatment Period||0
216555|NCT00311363|513697|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
216556|NCT00311363|513698|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
216557|NCT00311363|513699|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
216558|NCT00311363|513697|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
216559|NCT00311363|513698|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
216560|NCT00311363|513699|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
216561|NCT00311363|513697|P3|STARTED|24-Week Single-Blind Treatment Period||0
216562|NCT00311363|513698|P2|STARTED|24-Week Single-Blind Treatment Period||0
216563|NCT00311363|513699|P1|STARTED|24-Week Single-Blind Treatment Period||327
216564|NCT00311311|513759|P2|NOT COMPLETED|Overall Study||9
216565|NCT00311311|513760|P1|NOT COMPLETED|Overall Study||8
216566|NCT00311311|513759|P2|COMPLETED|Overall Study||26
216567|NCT00311311|513760|P1|COMPLETED|Overall Study||29
216568|NCT00311311|513759|P2|STARTED|Overall Study||35
216569|NCT00311311|513760|P1|STARTED|Overall Study||37
216570|NCT00311181|513810|P1|NOT COMPLETED|Overall Study||96
216571|NCT00311181|513810|P1|COMPLETED|Overall Study||121
216572|NCT00311181|513810|P1|STARTED|Overall Study||217
216573|NCT00311155|513816|P1|NOT COMPLETED|Overall Study||93
216574|NCT00311155|513816|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
216575|NCT00311155|513816|P1|STARTED|Overall Study||694
216576|NCT00310856|513828|P3|NOT COMPLETED|Overall Study||8
216577|NCT00310856|513829|P2|NOT COMPLETED|Overall Study||5
216578|NCT00310856|513830|P1|NOT COMPLETED|Overall Study||5
216579|NCT00310856|513828|P3|COMPLETED|Overall Study||42
216580|NCT00310856|513829|P2|COMPLETED|Overall Study||56
216581|NCT00310856|513830|P1|COMPLETED|Overall Study||59
216582|NCT00310856|513828|P3|STARTED|Overall Study||50
216583|NCT00310856|513829|P2|STARTED|Overall Study||61
216584|NCT00310856|513830|P1|STARTED|Overall Study||64
216585|NCT00310817|513854|P4|NOT COMPLETED|Overall Study||8
216586|NCT00310817|513855|P3|NOT COMPLETED|Overall Study||8
216587|NCT00310817|513856|P2|NOT COMPLETED|Overall Study||8
216588|NCT00310817|513857|P1|NOT COMPLETED|Overall Study||11
216589|NCT00310817|513854|P4|COMPLETED|Overall Study||74
216590|NCT00310817|513855|P3|COMPLETED|Overall Study||120
216591|NCT00310817|513856|P2|COMPLETED|Overall Study||198
216592|NCT00310817|513857|P1|COMPLETED|Overall Study||196
216593|NCT00310817|513854|P4|STARTED|Overall Study||82
216594|NCT00310817|513855|P3|STARTED|Overall Study||128
216595|NCT00310817|513856|P2|STARTED|Overall Study||206
216596|NCT00310817|513857|P1|STARTED|Overall Study||207
216597|NCT00310804|513945|P2|NOT COMPLETED|Overall Study||0
216598|NCT00310804|513946|P1|NOT COMPLETED|Overall Study||5
216599|NCT00310804|513945|P2|COMPLETED|Overall Study||171
216600|NCT00310804|513946|P1|COMPLETED|Overall Study||1024
216601|NCT00310804|513945|P2|STARTED|Overall Study||171
216602|NCT00310804|513946|P1|STARTED|Overall Study||1029
216603|NCT00310791|513981|P2|NOT COMPLETED|Overall Study||10
216604|NCT00310791|513982|P1|NOT COMPLETED|Overall Study||10
216605|NCT00310791|513981|P2|COMPLETED|Overall Study||30
216606|NCT00310791|513982|P1|COMPLETED|Overall Study||30
216607|NCT00310791|513981|P2|STARTED|Overall Study||40
216608|NCT00310791|513982|P1|STARTED|Overall Study||40
216609|NCT00309985|513990|P2|NOT COMPLETED|Overall Study||1
216610|NCT00309985|513991|P1|NOT COMPLETED|Overall Study||62
216611|NCT00309985|513990|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
216612|NCT00309985|513991|P1|COMPLETED|Overall Study||335
216613|NCT00309985|513990|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
216614|NCT00309985|513991|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
216615|NCT00309985|513990|P2|Toxicity Analysis|Overall Study||392
216616|NCT00309985|513991|P1|Toxicity Analysis|Overall Study||390
216617|NCT00309985|513990|P2|STARTED|Overall Study||393
216618|NCT00309985|513991|P1|STARTED|Overall Study||397
216619|NCT00309946|514007|P1|NOT COMPLETED|Overall Study||1
216620|NCT00309946|514007|P1|COMPLETED|Overall Study||50
216621|NCT00309946|514007|P1|STARTED|Overall Study||51
216622|NCT00309907|514013|P1|NOT COMPLETED|Overall Study||20
216623|NCT00309907|514013|P1|COMPLETED|Overall Study||19
216624|NCT00309907|514013|P1|STARTED|Overall Study||39
216625|NCT00309777|514021|P4|NOT COMPLETED|Overall Study||4
216626|NCT00309777|514022|P3|NOT COMPLETED|Overall Study||19
216627|NCT00309777|514023|P2|NOT COMPLETED|Overall Study||9
216628|NCT00309777|514024|P1|NOT COMPLETED|Overall Study||23
216629|NCT00309777|514021|P4|COMPLETED|Overall Study||107
216630|NCT00309777|514022|P3|COMPLETED|Overall Study||304
216631|NCT00309777|514023|P2|COMPLETED|Overall Study||99
216632|NCT00309777|514024|P1|COMPLETED|Overall Study||292
216633|NCT00309777|514021|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
216634|NCT00309777|514022|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
216635|NCT00309777|514023|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
216636|NCT00309777|514024|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
216637|NCT00309777|514021|P4|STARTED|Overall Study||111
216638|NCT00309777|514022|P3|STARTED|Overall Study||323
216639|NCT00309777|514023|P2|STARTED|Overall Study||108
216640|NCT00309777|514024|P1|STARTED|Overall Study||315
216641|NCT00310466|514040|P2|NOT COMPLETED|Overall Study||12
216642|NCT00310466|514041|P1|NOT COMPLETED|Overall Study||18
216643|NCT00310466|514040|P2|COMPLETED|Overall Study||101
216644|NCT00310466|514041|P1|COMPLETED|Overall Study||95
216645|NCT00310466|514040|P2|STARTED|Overall Study||113
216646|NCT00310466|514041|P1|STARTED|Overall Study||113
216647|NCT00310440|514055|P2|NOT COMPLETED|Overall Study||13
216648|NCT00310440|514056|P1|NOT COMPLETED|Overall Study||26
216649|NCT00310440|514055|P2|COMPLETED|Overall Study||141
216650|NCT00310440|514056|P1|COMPLETED|Overall Study||139
216651|NCT00310440|514055|P2|STARTED|Overall Study||154
216652|NCT00310440|514056|P1|STARTED|Overall Study||165
216653|NCT00310427|514082|P2|NOT COMPLETED|Overall Study||1
216654|NCT00310427|514083|P1|NOT COMPLETED|Overall Study||2
216655|NCT00310427|514082|P2|COMPLETED|Overall Study||25
216656|NCT00310427|514083|P1|COMPLETED|Overall Study||25
216657|NCT00310427|514082|P2|STARTED|Overall Study||26
216658|NCT00310427|514083|P1|STARTED|Overall Study||27
216659|NCT00310401|514105|P2|NOT COMPLETED|Overall Study||0
216660|NCT00310401|514106|P1|NOT COMPLETED|Overall Study||0
216661|NCT00310401|514105|P2|COMPLETED|Overall Study||246
216662|NCT00310401|514106|P1|COMPLETED|Overall Study||260
216663|NCT00310401|514105|P2|STARTED|Overall Study||246
216664|NCT00310401|514106|P1|STARTED|Overall Study||260
216665|NCT00310375|514114|P2|NOT COMPLETED|Overall Study||68
216666|NCT00310375|514115|P1|NOT COMPLETED|Overall Study||91
216667|NCT00310375|514114|P2|COMPLETED|Overall Study||11
216668|NCT00310375|514115|P1|COMPLETED|Overall Study||11
216669|NCT00310375|514114|P2|STARTED|Overall Study||79
216670|NCT00310375|514115|P1|STARTED|Overall Study||102
216671|NCT00310362|514156|P3|NOT COMPLETED|Overall Study||0
216672|NCT00310362|514157|P2|NOT COMPLETED|Overall Study||0
216673|NCT00310362|514158|P1|NOT COMPLETED|Overall Study||0
216674|NCT00310362|514156|P3|COMPLETED|Overall Study||1206
216675|NCT00310362|514157|P2|COMPLETED|Overall Study||1205
216676|NCT00310362|514158|P1|COMPLETED|Overall Study||1199
216677|NCT00310362|514156|P3|STARTED|Overall Study||1206
216678|NCT00310362|514157|P2|STARTED|Overall Study||1205
216679|NCT00310362|514158|P1|STARTED|Overall Study||1199
216680|NCT00310076|514166|P1|NOT COMPLETED|Overall Study||3
216681|NCT00310076|514166|P1|COMPLETED|Overall Study||26
216682|NCT00310076|514166|P1|STARTED|Overall Study||29
216683|NCT00309751|514172|P2|NOT COMPLETED|Overall Study||15
216684|NCT00309751|514173|P1|NOT COMPLETED|Overall Study||31
216685|NCT00309751|514172|P2|COMPLETED|Overall Study||124
216686|NCT00309751|514173|P1|COMPLETED|Overall Study||248
216687|NCT00309751|514172|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
216688|NCT00309751|514173|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
216689|NCT00309751|514172|P2|STARTED|Overall Study||139
216690|NCT00309751|514173|P1|STARTED|Overall Study||279
216691|NCT00309738|514183|P2|NOT COMPLETED|Overall Study||12
216692|NCT00309738|514184|P1|NOT COMPLETED|Overall Study||13
216693|NCT00309738|514183|P2|COMPLETED|Overall Study||107
216694|NCT00309738|514184|P1|COMPLETED|Overall Study||223
216695|NCT00309738|514183|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
216696|NCT00309738|514184|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
216697|NCT00309738|514183|P2|STARTED|Overall Study||119
216698|NCT00309738|514184|P1|STARTED|Overall Study||236
216699|NCT00309608|514197|P5|NOT COMPLETED|Overall Study||4
216700|NCT00309608|514198|P4|NOT COMPLETED|Overall Study||6
216701|NCT00309608|514199|P3|NOT COMPLETED|Overall Study||10
216702|NCT00309608|514200|P2|NOT COMPLETED|Overall Study||13
216703|NCT00309608|514201|P1|NOT COMPLETED|Overall Study||14
216704|NCT00309608|514197|P5|COMPLETED|Overall Study||61
216705|NCT00309608|514198|P4|COMPLETED|Overall Study||60
216706|NCT00309608|514199|P3|COMPLETED|Overall Study||56
216707|NCT00309608|514200|P2|COMPLETED|Overall Study||52
216708|NCT00309608|514201|P1|COMPLETED|Overall Study||57
216709|NCT00309608|514197|P5|STARTED|Overall Study||65
216710|NCT00309608|514198|P4|STARTED|Overall Study||66
216711|NCT00309608|514199|P3|STARTED|Overall Study||66
216712|NCT00309608|514200|P2|STARTED|Overall Study||65
216713|NCT00309608|514201|P1|STARTED|Overall Study||71
216714|NCT00309465|514228|P6|NOT COMPLETED|Overall Study||0
216715|NCT00309465|514229|P5|NOT COMPLETED|Overall Study||0
216716|NCT00309465|514230|P4|NOT COMPLETED|Overall Study||1
216717|NCT00309465|514231|P3|NOT COMPLETED|Overall Study||0
216718|NCT00309465|514232|P2|NOT COMPLETED|Overall Study||0
216719|NCT00309465|514233|P1|NOT COMPLETED|Overall Study||0
216720|NCT00309465|514228|P6|COMPLETED|Overall Study||76
216721|NCT00309465|514229|P5|COMPLETED|Overall Study||76
216722|NCT00309465|514230|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
216723|NCT00309465|514231|P3|COMPLETED|Overall Study||58
216724|NCT00309465|514232|P2|COMPLETED|Overall Study||58
216725|NCT00309465|514233|P1|COMPLETED|Overall Study||58
216726|NCT00309465|514228|P6|STARTED|Overall Study||76
216727|NCT00309465|514229|P5|STARTED|Overall Study||76
216728|NCT00309465|514230|P4|STARTED|Overall Study||76
216729|NCT00309465|514231|P3|STARTED|Overall Study||58
216730|NCT00309465|514232|P2|STARTED|Overall Study||58
216731|NCT00309465|514233|P1|STARTED|Overall Study||58
216732|NCT00309452|514249|P2|NOT COMPLETED|Overall Study||0
216733|NCT00309452|514250|P1|NOT COMPLETED|Overall Study||3
216734|NCT00309452|514249|P2|COMPLETED|Overall Study||60
216735|NCT00309452|514250|P1|COMPLETED|Overall Study||57
216736|NCT00309452|514249|P2|STARTED|Overall Study||60
216737|NCT00309452|514250|P1|STARTED|Overall Study||60
216738|NCT00309387|514278|P2|NOT COMPLETED|Overall Study||159
216739|NCT00309387|514279|P1|NOT COMPLETED|Overall Study||142
216740|NCT00309387|514278|P2|COMPLETED|Overall Study||351
216741|NCT00309387|514279|P1|COMPLETED|Overall Study||368
216742|NCT00309387|514278|P2|STARTED|Overall Study||510
216743|NCT00309387|514279|P1|STARTED|Overall Study||510
216744|NCT00309244|514297|P2|NOT COMPLETED|Overall Study||97
216745|NCT00309244|514298|P1|NOT COMPLETED|Overall Study||118
216746|NCT00309244|514297|P2|COMPLETED|Overall Study||246
216747|NCT00309244|514298|P1|COMPLETED|Overall Study||216
216748|NCT00309244|514297|P2|STARTED|Overall Study||343
216749|NCT00309244|514298|P1|STARTED|Overall Study||334
216750|NCT00308997|514320|P2|NOT COMPLETED|Overall Study||1
216751|NCT00308997|514321|P1|NOT COMPLETED|Overall Study||1
216752|NCT00308997|514320|P2|COMPLETED|Overall Study||28
216753|NCT00308997|514321|P1|COMPLETED|Overall Study||55
216754|NCT00308997|514320|P2|STARTED|Overall Study||29
216755|NCT00308997|514321|P1|STARTED|Overall Study||56
216756|NCT00308737|514340|P3|NOT COMPLETED|Overall Study||37
216757|NCT00308737|514341|P2|NOT COMPLETED|Overall Study||289
216758|NCT00308737|514342|P1|NOT COMPLETED|Overall Study||463
216759|NCT00308737|514340|P3|COMPLETED|Overall Study||127
216760|NCT00308737|514341|P2|COMPLETED|Overall Study||662
216761|NCT00308737|514342|P1|COMPLETED|Overall Study||475
216762|NCT00308737|514340|P3|STARTED|Overall Study||164
216763|NCT00308737|514341|P2|STARTED|Overall Study||951
216764|NCT00308737|514342|P1|STARTED|Overall Study||938
216765|NCT00308711|514382|P3|NOT COMPLETED|Overall Study||5
216766|NCT00308711|514383|P2|NOT COMPLETED|Overall Study||4
216767|NCT00308711|514384|P1|NOT COMPLETED|Overall Study||2
216768|NCT00308711|514382|P3|COMPLETED|Overall Study||431
216769|NCT00308711|514383|P2|COMPLETED|Overall Study||440
216770|NCT00308711|514384|P1|COMPLETED|Overall Study||426
216771|NCT00308711|514382|P3|STARTED|Overall Study||436
216772|NCT00308711|514383|P2|STARTED|Overall Study||444
216773|NCT00308711|514384|P1|STARTED|Overall Study||428
216774|NCT00308620|514419|P3|NOT COMPLETED|Overall Study||1
216775|NCT00308620|514420|P2|NOT COMPLETED|Overall Study||1
216776|NCT00308620|514421|P1|NOT COMPLETED|Overall Study||1
216777|NCT00308620|514419|P3|COMPLETED|Overall Study||5
216778|NCT00308620|514420|P2|COMPLETED|Overall Study||3
216779|NCT00308620|514421|P1|COMPLETED|Overall Study||2
216780|NCT00308620|514419|P3|STARTED|Overall Study||6
216781|NCT00308620|514420|P2|STARTED|Overall Study||4
216782|NCT00308620|514421|P1|STARTED|Overall Study||3
216783|NCT00308581|514430|P3|NOT COMPLETED|Randomized Maintenance Phase||0
216784|NCT00308581|514431|P2|NOT COMPLETED|Randomized Maintenance Phase||103
216785|NCT00308581|514432|P1|NOT COMPLETED|Randomized Maintenance Phase||105
216786|NCT00308581|514430|P3|COMPLETED|Randomized Maintenance Phase||0
216787|NCT00308581|514431|P2|COMPLETED|Randomized Maintenance Phase||83
216788|NCT00308581|514432|P1|COMPLETED|Randomized Maintenance Phase||82
216789|NCT00308581|514430|P3|STARTED|Randomized Maintenance Phase||0
216790|NCT00308581|514431|P2|STARTED|Randomized Maintenance Phase||186
216791|NCT00308581|514432|P1|STARTED|Randomized Maintenance Phase||187
216792|NCT00308581|514430|P3|NOT COMPLETED|Induction Phase||166
216793|NCT00308581|514431|P2|NOT COMPLETED|Induction Phase||0
216794|NCT00308581|514432|P1|NOT COMPLETED|Induction Phase||0
216795|NCT00308581|514430|P3|COMPLETED|Induction Phase||373
216796|NCT00308581|514431|P2|COMPLETED|Induction Phase|Not applicable in this period|0
216797|NCT00308581|514432|P1|COMPLETED|Induction Phase|Not applicable in this period|0
216798|NCT00308581|514430|P3|STARTED|Induction Phase||539
216799|NCT00308581|514431|P2|STARTED|Induction Phase|Not applicable in this period|0
216800|NCT00308581|514432|P1|STARTED|Induction Phase|Not applicable in this period|0
216801|NCT00308555|514558|P2|NOT COMPLETED|Overall Study||0
216802|NCT00308555|514559|P1|NOT COMPLETED|Overall Study||3
216803|NCT00308555|514558|P2|COMPLETED|Overall Study||11
216804|NCT00308555|514559|P1|COMPLETED|Overall Study||10
216805|NCT00308555|514558|P2|STARTED|Overall Study||11
216806|NCT00308555|514559|P1|STARTED|Overall Study||13
216807|NCT00308516|514567|P2|NOT COMPLETED|Overall Study||21
216808|NCT00308516|514568|P1|NOT COMPLETED|Overall Study||29
216809|NCT00308516|514567|P2|COMPLETED|Overall Study||10
216810|NCT00308516|514568|P1|COMPLETED|Overall Study||6
216811|NCT00308516|514567|P2|STARTED|Overall Study||31
216812|NCT00308516|514568|P1|STARTED|Overall Study||35
216813|NCT00308308|514576|P2|NOT COMPLETED|Overall Study||68
216814|NCT00308308|514577|P1|NOT COMPLETED|Overall Study||103
216815|NCT00308308|514576|P2|COMPLETED|Overall Study||220
216816|NCT00308308|514577|P1|COMPLETED|Overall Study||198
216817|NCT00308308|514576|P2|STARTED|Overall Study||288
216818|NCT00308308|514577|P1|STARTED|Overall Study||301
216819|NCT00308230|514600|P3|NOT COMPLETED|Overall Study||0
216820|NCT00308230|514601|P2|NOT COMPLETED|Overall Study||0
216821|NCT00308230|514602|P1|NOT COMPLETED|Overall Study||0
216822|NCT00308230|514600|P3|COMPLETED|Overall Study||20
216823|NCT00308230|514601|P2|COMPLETED|Overall Study||8
216824|NCT00308230|514602|P1|COMPLETED|Overall Study||6
216825|NCT00308230|514600|P3|STARTED|Overall Study||20
216826|NCT00308230|514601|P2|STARTED|Overall Study||8
216827|NCT00308230|514602|P1|STARTED|Overall Study||6
216828|NCT00308139|514612|P2|NOT COMPLETED|Overall Study||87
216829|NCT00308139|514613|P1|NOT COMPLETED|Overall Study||94
216830|NCT00308139|514612|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
216831|NCT00308139|514613|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
216832|NCT00308139|514612|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
216833|NCT00308139|514613|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
216834|NCT00308139|514612|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
216835|NCT00308139|514613|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
216836|NCT00308139|514612|P2|Pharmacokinetics Population|Overall Study||0
216837|NCT00308139|514613|P1|Pharmacokinetics Population|Overall Study||129
216838|NCT00308139|514612|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
216839|NCT00308139|514613|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
216840|NCT00308139|514612|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
216841|NCT00308139|514613|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
216842|NCT00308139|514612|P2|STARTED|Overall Study||151
216843|NCT00308139|514613|P1|STARTED|Overall Study||152
216844|NCT00308113|514687|P4|NOT COMPLETED|Overall Study||1
216845|NCT00308113|514688|P3|NOT COMPLETED|Overall Study||0
216846|NCT00308113|514689|P2|NOT COMPLETED|Overall Study||0
216847|NCT00308113|514690|P1|NOT COMPLETED|Overall Study||0
216848|NCT00308113|514687|P4|COMPLETED|Overall Study||1
216849|NCT00308113|514688|P3|COMPLETED|Overall Study||1
216850|NCT00308113|514689|P2|COMPLETED|Overall Study||0
216851|NCT00308113|514690|P1|COMPLETED|Overall Study||0
216852|NCT00308113|514687|P4|STARTED|Overall Study||2
216853|NCT00308113|514688|P3|STARTED|Overall Study||1
216854|NCT00308113|514689|P2|STARTED|Overall Study||0
216855|NCT00308113|514690|P1|STARTED|Overall Study||0
216856|NCT00308087|514710|P2|NOT COMPLETED|Overall Study||37
216857|NCT00308087|514711|P1|NOT COMPLETED|Overall Study||36
216858|NCT00308087|514710|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
216859|NCT00308087|514711|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
216860|NCT00308087|514710|P2|STARTED|Overall Study||38
216861|NCT00308087|514711|P1|STARTED|Overall Study||37
216862|NCT00308074|514727|P1|NOT COMPLETED|Overall Study||1
216863|NCT00308074|514727|P1|COMPLETED|Overall Study||13
216864|NCT00308074|514727|P1|STARTED|Overall Study||14
216865|NCT00307931|514734|P1|NOT COMPLETED|Overall Study||1
216866|NCT00307931|514734|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
216867|NCT00307931|514734|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
216868|NCT00307801|514751|P2|NOT COMPLETED|Overall Study||17
216869|NCT00307801|514752|P1|NOT COMPLETED|Overall Study||32
216870|NCT00307801|514751|P2|COMPLETED|Overall Study||65
216871|NCT00307801|514752|P1|COMPLETED|Overall Study||117
216872|NCT00307801|514751|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
216873|NCT00307801|514752|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
216874|NCT00307801|514751|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
216875|NCT00307801|514752|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
216876|NCT00307801|514751|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
216877|NCT00307801|514752|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
216878|NCT00307801|514751|P2|Subjects Received Treatment|Overall Study||81
216879|NCT00307801|514752|P1|Subjects Received Treatment|Overall Study||145
216880|NCT00307801|514751|P2|STARTED|Overall Study||82
216881|NCT00307801|514752|P1|STARTED|Overall Study||149
216882|NCT00307684|514864|P3|NOT COMPLETED|Double Blind Phase||0
216883|NCT00307684|514865|P2|NOT COMPLETED|Double Blind Phase||5
216884|NCT00307684|514866|P1|NOT COMPLETED|Double Blind Phase||2
216885|NCT00307684|514864|P3|COMPLETED|Double Blind Phase||0
216886|NCT00307684|514865|P2|COMPLETED|Double Blind Phase||17
216887|NCT00307684|514866|P1|COMPLETED|Double Blind Phase||21
216888|NCT00307684|514864|P3|STARTED|Double Blind Phase||0
216889|NCT00307684|514865|P2|STARTED|Double Blind Phase||22
216890|NCT00307684|514866|P1|STARTED|Double Blind Phase||23
216891|NCT00307684|514864|P3|NOT COMPLETED|Open Label Phase||56
216892|NCT00307684|514865|P2|NOT COMPLETED|Open Label Phase||0
216893|NCT00307684|514866|P1|NOT COMPLETED|Open Label Phase||0
216894|NCT00307684|514864|P3|COMPLETED|Open Label Phase||99
216895|NCT00307684|514865|P2|COMPLETED|Open Label Phase||0
216896|NCT00307684|514866|P1|COMPLETED|Open Label Phase||0
216897|NCT00307684|514864|P3|STARTED|Open Label Phase|1 screening failure|155
216898|NCT00307684|514865|P2|STARTED|Open Label Phase||0
216899|NCT00307684|514866|P1|STARTED|Open Label Phase||0
216900|NCT00307489|514894|P2|NOT COMPLETED|Week 48 Through Week 168||6
216901|NCT00307489|514895|P1|NOT COMPLETED|Week 48 Through Week 168||6
216902|NCT00307489|514894|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
216903|NCT00307489|514895|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
216904|NCT00307489|514894|P2|STARTED|Week 48 Through Week 168||50
216905|NCT00307489|514895|P1|STARTED|Week 48 Through Week 168||52
216906|NCT00307489|514894|P2|NOT COMPLETED|Baseline Through Week 48||2
216907|NCT00307489|514895|P1|NOT COMPLETED|Baseline Through Week 48||1
216986|NCT00307125|515081|P1|COMPLETED|Pilot Phase||0
216908|NCT00307489|514894|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
216909|NCT00307489|514895|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
216910|NCT00307489|514894|P2|STARTED|Baseline Through Week 48||52
216911|NCT00307489|514895|P1|STARTED|Baseline Through Week 48||53
216912|NCT00307437|514940|P7|NOT COMPLETED|After Controlled Period||113
216913|NCT00307437|514941|P6|NOT COMPLETED|After Controlled Period||122
216914|NCT00307437|514942|P5|NOT COMPLETED|After Controlled Period||55
216915|NCT00307437|514943|P4|NOT COMPLETED|After Controlled Period||58
216916|NCT00307437|514944|P3|NOT COMPLETED|After Controlled Period||0
216917|NCT00307437|514945|P2|NOT COMPLETED|After Controlled Period||0
216918|NCT00307437|514946|P1|NOT COMPLETED|After Controlled Period||0
216919|NCT00307437|514940|P7|COMPLETED|After Controlled Period||289
216920|NCT00307437|514941|P6|COMPLETED|After Controlled Period||281
216921|NCT00307437|514942|P5|COMPLETED|After Controlled Period||140
216922|NCT00307437|514943|P4|COMPLETED|After Controlled Period||139
216923|NCT00307437|514944|P3|COMPLETED|After Controlled Period||0
216924|NCT00307437|514945|P2|COMPLETED|After Controlled Period||0
216925|NCT00307437|514946|P1|COMPLETED|After Controlled Period||0
216926|NCT00307437|514940|P7|STARTED|After Controlled Period||402
216927|NCT00307437|514941|P6|STARTED|After Controlled Period||403
216928|NCT00307437|514942|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
216929|NCT00307437|514943|P4|STARTED|After Controlled Period||197
216930|NCT00307437|514944|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
216931|NCT00307437|514945|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
216932|NCT00307437|514946|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
216933|NCT00307437|514940|P7|NOT COMPLETED|Controlled Period||0
216934|NCT00307437|514941|P6|NOT COMPLETED|Controlled Period||0
216935|NCT00307437|514942|P5|NOT COMPLETED|Controlled Period||0
216936|NCT00307437|514943|P4|NOT COMPLETED|Controlled Period||0
216937|NCT00307437|514944|P3|NOT COMPLETED|Controlled Period||9
216938|NCT00307437|514945|P2|NOT COMPLETED|Controlled Period||6
216939|NCT00307437|514946|P1|NOT COMPLETED|Controlled Period||16
216940|NCT00307437|514940|P7|COMPLETED|Controlled Period||0
216941|NCT00307437|514941|P6|COMPLETED|Controlled Period||0
216942|NCT00307437|514942|P5|COMPLETED|Controlled Period||0
216943|NCT00307437|514943|P4|COMPLETED|Controlled Period||0
216944|NCT00307437|514944|P3|COMPLETED|Controlled Period||402
216945|NCT00307437|514945|P2|COMPLETED|Controlled Period||403
216946|NCT00307437|514946|P1|COMPLETED|Controlled Period||394
216947|NCT00307437|514940|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
216948|NCT00307437|514941|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
216949|NCT00307437|514942|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
216950|NCT00307437|514943|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
216951|NCT00307437|514944|P3|STARTED|Controlled Period||411
216952|NCT00307437|514945|P2|STARTED|Controlled Period||409
216953|NCT00307437|514946|P1|STARTED|Controlled Period||410
216954|NCT00307333|514972|P2|NOT COMPLETED|Overall Study||3
216955|NCT00307333|514973|P1|NOT COMPLETED|Overall Study||11
216956|NCT00307333|514972|P2|COMPLETED|Overall Study||1489
216957|NCT00307333|514973|P1|COMPLETED|Overall Study||1500
216958|NCT00307333|514972|P2|STARTED|Overall Study||1492
216959|NCT00307333|514973|P1|STARTED|Overall Study||1511
216960|NCT00307294|514985|P1|NOT COMPLETED|Overall Study||30
216961|NCT00307294|514985|P1|COMPLETED|Overall Study||9
216962|NCT00307294|514985|P1|STARTED|Overall Study||39
216963|NCT00307164|514991|P2|NOT COMPLETED|Overall Study||14
216964|NCT00307164|514992|P1|NOT COMPLETED|Overall Study||15
216965|NCT00307164|514991|P2|COMPLETED|Overall Study||68
216966|NCT00307164|514992|P1|COMPLETED|Overall Study||68
216967|NCT00307164|514991|P2|STARTED|Overall Study||82
216968|NCT00307164|514992|P1|STARTED|Overall Study||83
216969|NCT00307151|515032|P4|NOT COMPLETED|Overall Study||11
216970|NCT00307151|515033|P3|NOT COMPLETED|Overall Study||20
216971|NCT00307151|515034|P2|NOT COMPLETED|Overall Study||7
216972|NCT00307151|515035|P1|NOT COMPLETED|Overall Study||11
216973|NCT00307151|515032|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
216974|NCT00307151|515033|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
216975|NCT00307151|515034|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
216976|NCT00307151|515035|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
216977|NCT00307151|515032|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
216978|NCT00307151|515033|P3|STARTED|Overall Study||147
216979|NCT00307151|515034|P2|STARTED|Overall Study||82
216980|NCT00307151|515035|P1|STARTED|Overall Study||82
216981|NCT00307125|515079|P3|NOT COMPLETED|Pilot Phase||1
216982|NCT00307125|515080|P2|NOT COMPLETED|Pilot Phase||2
216983|NCT00307125|515081|P1|NOT COMPLETED|Pilot Phase||0
216984|NCT00307125|515079|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
216985|NCT00307125|515080|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
216987|NCT00307125|515079|P3|STARTED|Pilot Phase||7
216988|NCT00307125|515080|P2|STARTED|Pilot Phase||15
216989|NCT00307125|515081|P1|STARTED|Pilot Phase||0
216990|NCT00307125|515079|P3|NOT COMPLETED|Screening Phase||0
216991|NCT00307125|515080|P2|NOT COMPLETED|Screening Phase||0
216992|NCT00307125|515081|P1|NOT COMPLETED|Screening Phase||454
216993|NCT00307125|515079|P3|COMPLETED|Screening Phase||0
216994|NCT00307125|515080|P2|COMPLETED|Screening Phase||0
216995|NCT00307125|515081|P1|COMPLETED|Screening Phase||303
216996|NCT00307125|515079|P3|STARTED|Screening Phase||0
216997|NCT00307125|515080|P2|STARTED|Screening Phase||0
216998|NCT00307125|515081|P1|STARTED|Screening Phase||757
216999|NCT00307086|515103|P1|NOT COMPLETED|Overall Study||5
217000|NCT00307086|515103|P1|COMPLETED|Overall Study||25
217001|NCT00307086|515103|P1|STARTED|Overall Study||30
217002|NCT00307047|515109|P2|NOT COMPLETED|Overall Study||49
217003|NCT00307047|515110|P1|NOT COMPLETED|Overall Study||69
217004|NCT00307047|515109|P2|COMPLETED|Overall Study||1180
217005|NCT00307047|515110|P1|COMPLETED|Overall Study||2389
217006|NCT00307047|515109|P2|STARTED|Overall Study||1229
217007|NCT00307047|515110|P1|STARTED|Overall Study||2458
217008|NCT00306917|515248|P2|NOT COMPLETED|Overall Study||109
217009|NCT00306917|515249|P1|NOT COMPLETED|Overall Study||108
217010|NCT00306917|515248|P2|COMPLETED|Overall Study||15
217011|NCT00306917|515249|P1|COMPLETED|Overall Study||13
217012|NCT00306917|515248|P2|60 Month Follow up|Overall Study||15
217013|NCT00306917|515249|P1|60 Month Follow up|Overall Study||13
217014|NCT00306917|515248|P2|48 Month Follow up|Overall Study||22
217015|NCT00306917|515249|P1|48 Month Follow up|Overall Study||29
217016|NCT00306917|515248|P2|36 Month Follow up|Overall Study||42
217017|NCT00306917|515249|P1|36 Month Follow up|Overall Study||56
217018|NCT00306917|515248|P2|24 Month Follow up|Overall Study||71
217019|NCT00306917|515249|P1|24 Month Follow up|Overall Study||60
217020|NCT00306917|515248|P2|12 Month Follow|Overall Study||94
217021|NCT00306917|515249|P1|12 Month Follow|Overall Study||86
217022|NCT00306917|515248|P2|Postoperative to 6 Month Follow up|Overall Study||100
217023|NCT00306917|515249|P1|Postoperative to 6 Month Follow up|Overall Study||93
217024|NCT00306917|515248|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
217025|NCT00306917|515249|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
217026|NCT00306891|515259|P4|NOT COMPLETED|Part B||17
217027|NCT00306891|515260|P3|NOT COMPLETED|Part B||11
217028|NCT00306891|515261|P2|NOT COMPLETED|Part B||0
217029|NCT00306891|515262|P1|NOT COMPLETED|Part B||0
217030|NCT00306891|515259|P4|COMPLETED|Part B||14
217031|NCT00306891|515260|P3|COMPLETED|Part B||5
217032|NCT00306891|515261|P2|COMPLETED|Part B||0
217033|NCT00306891|515262|P1|COMPLETED|Part B||0
217034|NCT00306891|515259|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
217035|NCT00306891|515260|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
217036|NCT00306891|515261|P2|STARTED|Part B||0
217037|NCT00306891|515262|P1|STARTED|Part B||0
217038|NCT00306891|515259|P4|NOT COMPLETED|Part A||0
217039|NCT00306891|515260|P3|NOT COMPLETED|Part A||0
217040|NCT00306891|515261|P2|NOT COMPLETED|Part A||6
217041|NCT00306891|515262|P1|NOT COMPLETED|Part A||5
217042|NCT00306891|515259|P4|COMPLETED|Part A||0
217043|NCT00306891|515260|P3|COMPLETED|Part A||0
217044|NCT00306891|515261|P2|COMPLETED|Part A||16
217045|NCT00306891|515262|P1|COMPLETED|Part A||18
217046|NCT00306891|515259|P4|STARTED|Part A||0
217047|NCT00306891|515260|P3|STARTED|Part A||0
217048|NCT00306891|515261|P2|STARTED|Part A||22
217049|NCT00306891|515262|P1|STARTED|Part A||23
217050|NCT00306852|515285|P2|NOT COMPLETED|Overall Study||38
217051|NCT00306852|515286|P1|NOT COMPLETED|Overall Study||29
217052|NCT00306852|515285|P2|COMPLETED|Overall Study||69
217053|NCT00306852|515286|P1|COMPLETED|Overall Study||76
217054|NCT00306852|515285|P2|STARTED|Overall Study||107
217055|NCT00306852|515286|P1|STARTED|Overall Study||105
217056|NCT00306787|515304|P2|NOT COMPLETED|Overall Study||241
217057|NCT00306787|515305|P1|NOT COMPLETED|Overall Study||234
217058|NCT00306787|515304|P2|COMPLETED|Overall Study||359
217059|NCT00306787|515305|P1|COMPLETED|Overall Study||345
217060|NCT00306787|515304|P2|Intent to Treat (ITT) Population|Overall Study||381
217061|NCT00306787|515305|P1|Intent to Treat (ITT) Population|Overall Study||370
217062|NCT00306787|515304|P2|Received Study Drug (Safety Population)|Overall Study||385
217063|NCT00306787|515305|P1|Received Study Drug (Safety Population)|Overall Study||371
217064|NCT00306787|515304|P2|STARTED|Overall Study||600
217065|NCT00306787|515305|P1|STARTED|Overall Study||579
217066|NCT00306670|515323|P2|NOT COMPLETED|Overall Study||2
217067|NCT00306670|515324|P1|NOT COMPLETED|Overall Study||0
217068|NCT00306670|515323|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
217069|NCT00306670|515324|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
217070|NCT00306670|515323|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
217071|NCT00306670|515324|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
217072|NCT00306592|515330|P2|NOT COMPLETED|Overall Study||58
217073|NCT00306592|515331|P1|NOT COMPLETED|Overall Study||31
217074|NCT00306592|515330|P2|COMPLETED|Overall Study||632
217075|NCT00306592|515331|P1|COMPLETED|Overall Study||373
217076|NCT00306592|515330|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
217077|NCT00306592|515331|P1|Entered 101-MS-321 Extension Study|Overall Study||22
217078|NCT00306592|515330|P2|Completed at 48 Weeks|Overall Study||632
217079|NCT00306592|515331|P1|Completed at 48 Weeks|Overall Study||81
217080|NCT00306592|515330|P2|Completed Between 24 and 48 Weeks|Overall Study||0
217081|NCT00306592|515331|P1|Completed Between 24 and 48 Weeks|Overall Study||85
217082|NCT00306592|515330|P2|Completed at 24 Weeks|Overall Study||0
217083|NCT00306592|515331|P1|Completed at 24 Weeks|Overall Study||207
217084|NCT00306592|515330|P2|STARTED|Overall Study||690
217085|NCT00306592|515331|P1|STARTED|Overall Study||404
217086|NCT00306527|515341|P4|NOT COMPLETED|Overall Study||6
217087|NCT00306527|515342|P3|NOT COMPLETED|Overall Study||5
217088|NCT00306527|515343|P2|NOT COMPLETED|Overall Study||7
217089|NCT00306527|515344|P1|NOT COMPLETED|Overall Study||6
217090|NCT00306527|515341|P4|COMPLETED|Overall Study||590
217091|NCT00306527|515342|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
217092|NCT00306527|515343|P2|COMPLETED|Overall Study||527
217093|NCT00306527|515344|P1|COMPLETED|Overall Study||527
217094|NCT00306527|515341|P4|STARTED|Overall Study||596
217095|NCT00306527|515342|P3|STARTED|Overall Study||572
217096|NCT00306527|515343|P2|STARTED|Overall Study||534
217097|NCT00306527|515344|P1|STARTED|Overall Study||533
217098|NCT00306488|515398|P2|NOT COMPLETED|Overall Study||1
217099|NCT00306488|515399|P1|NOT COMPLETED|Overall Study||1
217100|NCT00306488|515398|P2|COMPLETED|Overall Study||10
217101|NCT00306488|515399|P1|COMPLETED|Overall Study||10
217102|NCT00306488|515398|P2|STARTED|Overall Study||11
217103|NCT00306488|515399|P1|STARTED|Overall Study||11
217104|NCT00306384|515413|P3|NOT COMPLETED|Overall Study||277
217105|NCT00306384|515414|P2|NOT COMPLETED|Overall Study||508
217106|NCT00306384|515415|P1|NOT COMPLETED|Overall Study||542
217107|NCT00306384|515413|P3|COMPLETED|Overall Study||251
217108|NCT00306384|515414|P2|COMPLETED|Overall Study||891
217109|NCT00306384|515415|P1|COMPLETED|Overall Study||854
217110|NCT00306384|515413|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
217111|NCT00306384|515414|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
217112|NCT00306384|515415|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
217113|NCT00306384|515413|P3|STARTED|Overall Study||528
217114|NCT00306384|515414|P2|STARTED|Overall Study||1399
217115|NCT00306384|515415|P1|STARTED|Overall Study||1396
217116|NCT00306202|515450|P3|NOT COMPLETED|Overall Study||0
217117|NCT00306202|515451|P2|NOT COMPLETED|Overall Study||1
217118|NCT00306202|515452|P1|NOT COMPLETED|Overall Study||6
217119|NCT00306202|515450|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
217120|NCT00306202|515451|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
217121|NCT00306202|515452|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
217122|NCT00306202|515450|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
217123|NCT00306202|515451|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
217124|NCT00306202|515452|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
217125|NCT00306189|515612|P4|NOT COMPLETED|Overall Study||5
217126|NCT00306189|515613|P3|NOT COMPLETED|Overall Study||11
217127|NCT00306189|515614|P2|NOT COMPLETED|Overall Study||6
217128|NCT00306189|515615|P1|NOT COMPLETED|Overall Study||9
217129|NCT00306189|515612|P4|COMPLETED|Overall Study||52
217130|NCT00306189|515613|P3|COMPLETED|Overall Study||45
217131|NCT00306189|515614|P2|COMPLETED|Overall Study||50
217132|NCT00306189|515615|P1|COMPLETED|Overall Study||48
217133|NCT00306189|515612|P4|STARTED|Overall Study||57
217134|NCT00306189|515613|P3|STARTED|Overall Study||56
217135|NCT00306189|515614|P2|STARTED|Overall Study||56
217136|NCT00306189|515615|P1|STARTED|Overall Study||57
217137|NCT00306163|515627|P2|NOT COMPLETED|Overall Study||0
217138|NCT00306163|515628|P1|NOT COMPLETED|Overall Study||0
217139|NCT00306163|515627|P2|COMPLETED|Overall Study||18
217140|NCT00306163|515628|P1|COMPLETED|Overall Study||19
217141|NCT00306163|515627|P2|STARTED|Overall Study||18
217142|NCT00306163|515628|P1|STARTED|Overall Study||19
217143|NCT00305942|515634|P1|NOT COMPLETED|Overall Study||38
217144|NCT00305942|515634|P1|COMPLETED|Overall Study||23
217145|NCT00305942|515634|P1|STARTED|Overall Study||61
217146|NCT00305877|515642|P2|NOT COMPLETED|Overall Study||34
217147|NCT00305877|515643|P1|NOT COMPLETED|Overall Study||24
217148|NCT00305877|515642|P2|COMPLETED|Overall Study||34
217149|NCT00305877|515643|P1|COMPLETED|Overall Study||45
217150|NCT00305877|515642|P2|Included in Efficacy Analysis|Overall Study||62
217151|NCT00305877|515643|P1|Included in Efficacy Analysis|Overall Study||65
217152|NCT00305877|515642|P2|Eligible|Overall Study||66
217153|NCT00305877|515643|P1|Eligible|Overall Study||66
217154|NCT00305877|515642|P2|Treated|Overall Study||63
217155|NCT00305877|515643|P1|Treated|Overall Study||67
217156|NCT00305877|515642|P2|STARTED|Overall Study||68
217157|NCT00305877|515643|P1|STARTED|Overall Study||69
217158|NCT00305864|515657|P4|NOT COMPLETED|Overall Study||13
217159|NCT00305864|515658|P3|NOT COMPLETED|Overall Study||1
217160|NCT00305864|515659|P2|NOT COMPLETED|Overall Study||1
217161|NCT00305864|515660|P1|NOT COMPLETED|Overall Study||0
217162|NCT00305864|515657|P4|COMPLETED|Overall Study||81
217163|NCT00305864|515658|P3|COMPLETED|Overall Study||6
217164|NCT00305864|515659|P2|COMPLETED|Overall Study||9
217165|NCT00305864|515660|P1|COMPLETED|Overall Study||7
217166|NCT00305864|515657|P4|STARTED|Overall Study||94
217167|NCT00305864|515658|P3|STARTED|Overall Study||7
217168|NCT00305864|515659|P2|STARTED|Overall Study||10
217169|NCT00305864|515660|P1|STARTED|Overall Study||7
217170|NCT00305773|515672|P2|NOT COMPLETED|Overall Study||18
217171|NCT00305773|515673|P1|NOT COMPLETED|Overall Study||14
217172|NCT00305773|515672|P2|COMPLETED|Overall Study||4
217173|NCT00305773|515673|P1|COMPLETED|Overall Study||1
217174|NCT00305773|515672|P2|STARTED|Overall Study||22
217175|NCT00305773|515673|P1|STARTED|Overall Study||15
217176|NCT00305760|515687|P1|NOT COMPLETED|Overall Study||47
217177|NCT00305760|515687|P1|COMPLETED|Overall Study||13
217178|NCT00305760|515687|P1|STARTED|Overall Study||60
217179|NCT00305643|515693|P2|NOT COMPLETED|Overall Study||0
217180|NCT00305643|515694|P1|NOT COMPLETED|Overall Study||0
217181|NCT00305643|515693|P2|COMPLETED|Overall Study||5
217182|NCT00305643|515694|P1|COMPLETED|Overall Study||6
217183|NCT00305643|515693|P2|STARTED|Overall Study||5
217184|NCT00305643|515694|P1|STARTED|Overall Study||6
217185|NCT00305604|515704|P2|NOT COMPLETED|Overall Study||47
217186|NCT00305604|515705|P1|NOT COMPLETED|Overall Study||32
217187|NCT00305604|515704|P2|COMPLETED|Overall Study||57
217188|NCT00305604|515705|P1|COMPLETED|Overall Study||70
217189|NCT00305604|515704|P2|STARTED|Overall Study||104
217190|NCT00305604|515705|P1|STARTED|Overall Study||102
217191|NCT00305578|515719|P2|NOT COMPLETED|Overall Study||2
217192|NCT00305578|515720|P1|NOT COMPLETED|Overall Study||3
217193|NCT00305578|515719|P2|COMPLETED|Overall Study||12
217194|NCT00305578|515720|P1|COMPLETED|Overall Study||12
217195|NCT00305578|515719|P2|STARTED|Overall Study||14
217196|NCT00305578|515720|P1|STARTED|Overall Study||15
217197|NCT00305565|515729|P3|NOT COMPLETED|Overall Study (ITT Population)||5
217198|NCT00305565|515730|P2|NOT COMPLETED|Overall Study (ITT Population)||11
217199|NCT00305565|515731|P1|NOT COMPLETED|Overall Study (ITT Population)||13
217200|NCT00305565|515729|P3|COMPLETED|Overall Study (ITT Population)||102
217201|NCT00305565|515730|P2|COMPLETED|Overall Study (ITT Population)||90
217202|NCT00305565|515731|P1|COMPLETED|Overall Study (ITT Population)||89
217203|NCT00305565|515729|P3|STARTED|Overall Study (ITT Population)||107
217204|NCT00305565|515730|P2|STARTED|Overall Study (ITT Population)||101
217205|NCT00305565|515731|P1|STARTED|Overall Study (ITT Population)||102
217206|NCT00305565|515729|P3|NOT COMPLETED|Overall Study (Safety Population)||7
217207|NCT00305565|515730|P2|NOT COMPLETED|Overall Study (Safety Population)||12
217208|NCT00305565|515731|P1|NOT COMPLETED|Overall Study (Safety Population)||14
217209|NCT00305565|515729|P3|COMPLETED|Overall Study (Safety Population)||106
217210|NCT00305565|515730|P2|COMPLETED|Overall Study (Safety Population)||95
217211|NCT00305565|515731|P1|COMPLETED|Overall Study (Safety Population)||97
217212|NCT00305565|515729|P3|STARTED|Overall Study (Safety Population)||113
217213|NCT00305565|515730|P2|STARTED|Overall Study (Safety Population)||107
217214|NCT00305565|515731|P1|STARTED|Overall Study (Safety Population)||111
217215|NCT00305448|515849|P3|NOT COMPLETED|Overall Study||33
217216|NCT00305448|515850|P2|NOT COMPLETED|Overall Study||34
217217|NCT00305448|515851|P1|NOT COMPLETED|Overall Study||31
217218|NCT00305448|515849|P3|COMPLETED|Overall Study||14
217219|NCT00305448|515850|P2|COMPLETED|Overall Study||17
217220|NCT00305448|515851|P1|COMPLETED|Overall Study||14
217221|NCT00305448|515849|P3|STARTED|Overall Study||47
217222|NCT00305448|515850|P2|STARTED|Overall Study||51
217223|NCT00305448|515851|P1|STARTED|Overall Study||45
217224|NCT00305344|515867|P1|NOT COMPLETED|Overall Study||0
217225|NCT00305344|515867|P1|COMPLETED|Overall Study||23
217226|NCT00305344|515867|P1|STARTED|Overall Study||23
217227|NCT00305253|515873|P2|NOT COMPLETED|Overall Study||1
217228|NCT00305253|515874|P1|NOT COMPLETED|Overall Study||0
217229|NCT00305253|515873|P2|COMPLETED|Overall Study||558
217230|NCT00305253|515874|P1|COMPLETED|Overall Study||432
217231|NCT00305253|515873|P2|STARTED|Overall Study||559
217232|NCT00305253|515874|P1|STARTED|Overall Study||432
217233|NCT00305227|515886|P2|NOT COMPLETED|Overall Study||6
217234|NCT00305227|515887|P1|NOT COMPLETED|Overall Study||7
217235|NCT00305227|515886|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
217236|NCT00305227|515887|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
217237|NCT00305227|515886|P2|STARTED|Overall Study||50
217238|NCT00305227|515887|P1|STARTED|Overall Study||50
217239|NCT00305162|515895|P2|NOT COMPLETED|1 Year Follow-up Period||65
217240|NCT00305162|515896|P1|NOT COMPLETED|1 Year Follow-up Period||55
217241|NCT00305162|515895|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
217242|NCT00305162|515896|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
217243|NCT00305162|515895|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
217244|NCT00305162|515896|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
217245|NCT00305162|515895|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
217313|NCT00304187|515990|P2|NOT COMPLETED|Overall Study||1
217246|NCT00305162|515896|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
217247|NCT00305162|515895|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
217248|NCT00305162|515896|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
217249|NCT00305162|515895|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
217250|NCT00305162|515896|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
217251|NCT00305162|515895|P2|STARTED|1 Year Follow-up Period||4447
217252|NCT00305162|515896|P1|STARTED|1 Year Follow-up Period||4435
217253|NCT00305162|515895|P2|NOT COMPLETED|30-day Follow-up Period||63
217254|NCT00305162|515896|P1|NOT COMPLETED|30-day Follow-up Period||62
217255|NCT00305162|515895|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
217256|NCT00305162|515896|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
217257|NCT00305162|515895|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
217258|NCT00305162|515896|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
217259|NCT00305162|515895|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
217260|NCT00305162|515896|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
217261|NCT00305162|515895|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
217262|NCT00305162|515896|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
217263|NCT00305162|515895|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
217264|NCT00305162|515896|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
217265|NCT00305162|515895|P2|STARTED|30-day Follow-up Period||4447
217266|NCT00305162|515896|P1|STARTED|30-day Follow-up Period||4435
217267|NCT00305162|515895|P2|NOT COMPLETED|48 Hour Follow-up Period||16
217268|NCT00305162|515896|P1|NOT COMPLETED|48 Hour Follow-up Period||20
217269|NCT00305162|515895|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
217270|NCT00305162|515896|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
217271|NCT00305162|515895|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
217272|NCT00305162|515896|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
217273|NCT00305162|515895|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
217274|NCT00305162|515896|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
217275|NCT00305162|515895|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
217276|NCT00305162|515896|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
217277|NCT00305162|515895|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
217278|NCT00305162|515896|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
217279|NCT00305162|515895|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
217280|NCT00305162|515896|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
217281|NCT00305162|515895|P2|STARTED|48 Hour Follow-up Period||4447
217282|NCT00305162|515896|P1|STARTED|48 Hour Follow-up Period||4435
217283|NCT00304954|515938|P4|NOT COMPLETED|Overall Study||0
217284|NCT00304954|515939|P3|NOT COMPLETED|Overall Study||1
217285|NCT00304954|515940|P2|NOT COMPLETED|Overall Study||0
217286|NCT00304954|515941|P1|NOT COMPLETED|Overall Study||1
217287|NCT00304954|515938|P4|COMPLETED|Overall Study||3
217288|NCT00304954|515939|P3|COMPLETED|Overall Study||2
217289|NCT00304954|515940|P2|COMPLETED|Overall Study||3
217290|NCT00304954|515941|P1|COMPLETED|Overall Study||3
217291|NCT00304954|515938|P4|STARTED|Overall Study||3
217292|NCT00304954|515939|P3|STARTED|Overall Study||3
217293|NCT00304954|515940|P2|STARTED|Overall Study||3
217294|NCT00304954|515941|P1|STARTED|Overall Study||4
217295|NCT00304915|515961|P2|NOT COMPLETED|Overall Study||16
217296|NCT00304915|515962|P1|NOT COMPLETED|Overall Study||18
217297|NCT00304915|515961|P2|COMPLETED|Overall Study||110
217298|NCT00304915|515962|P1|COMPLETED|Overall Study||105
217299|NCT00304915|515961|P2|STARTED|Overall Study||126
217300|NCT00304915|515962|P1|STARTED|Overall Study||123
217301|NCT00304746|515970|P2|NOT COMPLETED|Overall Study||0
217302|NCT00304746|515971|P1|NOT COMPLETED|Overall Study||0
217303|NCT00304746|515970|P2|COMPLETED|Overall Study||50
217304|NCT00304746|515971|P1|COMPLETED|Overall Study||50
217305|NCT00304746|515970|P2|STARTED|Overall Study||50
217306|NCT00304746|515971|P1|STARTED|Overall Study||50
217307|NCT00304265|515981|P2|NOT COMPLETED|Overall Study||0
217308|NCT00304265|515982|P1|NOT COMPLETED|Overall Study||0
217309|NCT00304265|515981|P2|COMPLETED|Overall Study||98
217310|NCT00304265|515982|P1|COMPLETED|Overall Study||117
217311|NCT00304265|515981|P2|STARTED|Overall Study||98
217312|NCT00304265|515982|P1|STARTED|Overall Study||117
217314|NCT00304187|515991|P1|NOT COMPLETED|Overall Study||2
217315|NCT00304187|515990|P2|COMPLETED|Overall Study||13
217316|NCT00304187|515991|P1|COMPLETED|Overall Study||13
217317|NCT00304187|515990|P2|STARTED|Overall Study||14
217318|NCT00304187|515991|P1|STARTED|Overall Study||15
217319|NCT00304161|515999|P2|NOT COMPLETED|Overall Study||6
217320|NCT00304161|516000|P1|NOT COMPLETED|Overall Study||6
217321|NCT00304161|515999|P2|COMPLETED|Overall Study||21
217322|NCT00304161|516000|P1|COMPLETED|Overall Study||22
217323|NCT00304161|515999|P2|STARTED|Overall Study||27
217324|NCT00304161|516000|P1|STARTED|Overall Study||28
217325|NCT00304096|516010|P2|NOT COMPLETED|Overall Study||0
217326|NCT00304096|516011|P1|NOT COMPLETED|Overall Study||0
217327|NCT00304096|516010|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
217328|NCT00304096|516011|P1|COMPLETED|Overall Study||6
217329|NCT00304096|516010|P2|STARTED|Overall Study||5
217330|NCT00304096|516011|P1|STARTED|Overall Study||6
217331|NCT00304031|516022|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
217332|NCT00304031|516023|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
217333|NCT00304031|516024|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
217334|NCT00304031|516022|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
217335|NCT00304031|516023|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
217336|NCT00304031|516024|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
217337|NCT00304031|516022|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
217338|NCT00304031|516023|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
217339|NCT00304031|516024|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
217340|NCT00304031|516022|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
217341|NCT00304031|516023|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
217342|NCT00304031|516024|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
217343|NCT00304031|516022|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
217344|NCT00304031|516023|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
217345|NCT00304031|516024|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
217346|NCT00304031|516022|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
217347|NCT00304031|516023|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
217348|NCT00304031|516024|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
217349|NCT00304031|516022|P3|NOT COMPLETED|Registration||0
217350|NCT00304031|516023|P2|NOT COMPLETED|Registration||0
217351|NCT00304031|516024|P1|NOT COMPLETED|Registration||48
217352|NCT00304031|516022|P3|COMPLETED|Registration||0
217353|NCT00304031|516023|P2|COMPLETED|Registration||0
217354|NCT00304031|516024|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
217355|NCT00304031|516022|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
217356|NCT00304031|516023|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
217357|NCT00304031|516024|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
217358|NCT00303979|516034|P3|NOT COMPLETED|Single Time Point (18 Month)||0
217359|NCT00303979|516035|P2|NOT COMPLETED|Single Time Point (18 Month)||0
217360|NCT00303979|516036|P1|NOT COMPLETED|Single Time Point (18 Month)||0
217361|NCT00303979|516034|P3|COMPLETED|Single Time Point (18 Month)||9641
217362|NCT00303979|516035|P2|COMPLETED|Single Time Point (18 Month)||0
217363|NCT00303979|516036|P1|COMPLETED|Single Time Point (18 Month)||0
217364|NCT00303979|516034|P3|STARTED|Single Time Point (18 Month)||9641
217365|NCT00303979|516035|P2|STARTED|Single Time Point (18 Month)||0
217366|NCT00303979|516036|P1|STARTED|Single Time Point (18 Month)||0
217367|NCT00303979|516034|P3|NOT COMPLETED|Single Time Point (6 Month)||0
217368|NCT00303979|516035|P2|NOT COMPLETED|Single Time Point (6 Month)||0
217369|NCT00303979|516036|P1|NOT COMPLETED|Single Time Point (6 Month)||0
217370|NCT00303979|516034|P3|COMPLETED|Single Time Point (6 Month)||0
217371|NCT00303979|516035|P2|COMPLETED|Single Time Point (6 Month)||9992
217372|NCT00303979|516036|P1|COMPLETED|Single Time Point (6 Month)||0
217373|NCT00303979|516034|P3|STARTED|Single Time Point (6 Month)||0
217374|NCT00303979|516035|P2|STARTED|Single Time Point (6 Month)||9992
217375|NCT00303979|516036|P1|STARTED|Single Time Point (6 Month)||0
217376|NCT00303979|516034|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
217377|NCT00303979|516035|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
217378|NCT00303979|516036|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
217379|NCT00303979|516034|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
217380|NCT00303979|516035|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
217381|NCT00303979|516036|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
217382|NCT00303979|516034|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
217383|NCT00303979|516035|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
217384|NCT00303979|516036|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
217385|NCT00303966|516046|P1|NOT COMPLETED|Overall Study||0
217386|NCT00303966|516046|P1|COMPLETED|Overall Study||5
217387|NCT00303966|516046|P1|STARTED|Overall Study||5
217388|NCT00303953|516055|P1|NOT COMPLETED|Overall Study||19
217389|NCT00303953|516055|P1|COMPLETED|Overall Study||3
217390|NCT00303953|516055|P1|Eligible and Treated|Overall Study||20
217391|NCT00303953|516055|P1|Eligible|Overall Study||21
217392|NCT00303953|516055|P1|STARTED|Overall Study||22
217393|NCT00303901|516061|P1|NOT COMPLETED|Overall Study||0
217394|NCT00303901|516061|P1|COMPLETED|Overall Study||40
217395|NCT00303901|516061|P1|STARTED|Overall Study||40
217396|NCT00303862|516066|P1|NOT COMPLETED|Overall Study||0
217397|NCT00303862|516066|P1|COMPLETED|Overall Study||10
217398|NCT00303862|516066|P1|STARTED|Overall Study||10
217399|NCT00303823|516075|P2|NOT COMPLETED|Overall Study||10
217400|NCT00303823|516076|P1|NOT COMPLETED|Overall Study||15
217401|NCT00303823|516075|P2|COMPLETED|Overall Study||38
217402|NCT00303823|516076|P1|COMPLETED|Overall Study||35
217403|NCT00303823|516075|P2|STARTED|Overall Study||48
217404|NCT00303823|516076|P1|STARTED|Overall Study||50
217405|NCT00303667|516090|P2|NOT COMPLETED|Overall Study||4
217406|NCT00303667|516091|P1|NOT COMPLETED|Overall Study||0
217407|NCT00303667|516090|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
217408|NCT00303667|516091|P1|COMPLETED|Overall Study||8
217409|NCT00303667|516090|P2|STARTED|Overall Study||39
217410|NCT00303667|516091|P1|STARTED|Overall Study||8
217411|NCT00303628|516115|P2|NOT COMPLETED|Overall Study||73
217412|NCT00303628|516116|P1|NOT COMPLETED|Overall Study||50
217413|NCT00303628|516115|P2|COMPLETED|Overall Study||106
217414|NCT00303628|516116|P1|COMPLETED|Overall Study||126
217415|NCT00303628|516115|P2|Treated|Overall Study||174
217416|NCT00303628|516116|P1|Treated|Overall Study||173
217417|NCT00303628|516115|P2|Eligible|Overall Study||177
217418|NCT00303628|516116|P1|Eligible|Overall Study||171
217419|NCT00303628|516115|P2|STARTED|Overall Study||179
217420|NCT00303628|516116|P1|STARTED|Overall Study||176
217421|NCT00303602|516134|P2|NOT COMPLETED|Overall Study||15
217422|NCT00303602|516135|P1|NOT COMPLETED|Overall Study||19
217423|NCT00303602|516134|P2|COMPLETED|Overall Study||50
217424|NCT00303602|516135|P1|COMPLETED|Overall Study||65
217425|NCT00303602|516134|P2|STARTED|Overall Study||65
217426|NCT00303602|516135|P1|STARTED|Overall Study||84
217427|NCT00303511|516175|P1|NOT COMPLETED|Overall Study||0
217428|NCT00303511|516175|P1|COMPLETED|Overall Study||10
217429|NCT00303511|516175|P1|STARTED|Overall Study||10
217430|NCT00303485|516181|P2|NOT COMPLETED|Overall Study||2
217431|NCT00303485|516182|P1|NOT COMPLETED|Overall Study||1
217432|NCT00303485|516181|P2|COMPLETED|Overall Study||15
217433|NCT00303485|516182|P1|COMPLETED|Overall Study||48
217434|NCT00303485|516181|P2|STARTED|Overall Study||17
217435|NCT00303485|516182|P1|STARTED|Overall Study||49
217436|NCT00303472|516213|P7|NOT COMPLETED|Treatment Extension (Optional)||0
217437|NCT00303472|516214|P6|NOT COMPLETED|Treatment Extension (Optional)||1
217438|NCT00303472|516215|P5|NOT COMPLETED|Treatment Extension (Optional)||4
217439|NCT00303472|516216|P4|NOT COMPLETED|Treatment Extension (Optional)||8
217440|NCT00303472|516217|P3|NOT COMPLETED|Treatment Extension (Optional)||9
217441|NCT00303472|516218|P2|NOT COMPLETED|Treatment Extension (Optional)||6
217442|NCT00303472|516219|P1|NOT COMPLETED|Treatment Extension (Optional)||5
217443|NCT00303472|516213|P7|COMPLETED|Treatment Extension (Optional)||1
217444|NCT00303472|516214|P6|COMPLETED|Treatment Extension (Optional)||4
217445|NCT00303472|516215|P5|COMPLETED|Treatment Extension (Optional)||1
217446|NCT00303472|516216|P4|COMPLETED|Treatment Extension (Optional)||5
217447|NCT00303472|516217|P3|COMPLETED|Treatment Extension (Optional)||2
217448|NCT00303472|516218|P2|COMPLETED|Treatment Extension (Optional)||5
217449|NCT00303472|516219|P1|COMPLETED|Treatment Extension (Optional)||1
217450|NCT00303472|516213|P7|STARTED|Treatment Extension (Optional)||1
217451|NCT00303472|516214|P6|STARTED|Treatment Extension (Optional)||5
217452|NCT00303472|516215|P5|STARTED|Treatment Extension (Optional)||5
217453|NCT00303472|516216|P4|STARTED|Treatment Extension (Optional)||13
217454|NCT00303472|516217|P3|STARTED|Treatment Extension (Optional)||11
217455|NCT00303472|516218|P2|STARTED|Treatment Extension (Optional)||11
217456|NCT00303472|516219|P1|STARTED|Treatment Extension (Optional)||6
217457|NCT00303472|516213|P7|NOT COMPLETED|Treatment Period||2
217458|NCT00303472|516214|P6|NOT COMPLETED|Treatment Period||1
217459|NCT00303472|516215|P5|NOT COMPLETED|Treatment Period||3
217460|NCT00303472|516216|P4|NOT COMPLETED|Treatment Period||2
217461|NCT00303472|516217|P3|NOT COMPLETED|Treatment Period||0
217462|NCT00303472|516218|P2|NOT COMPLETED|Treatment Period||0
217463|NCT00303472|516219|P1|NOT COMPLETED|Treatment Period||0
217464|NCT00303472|516213|P7|COMPLETED|Treatment Period||3
217465|NCT00303472|516214|P6|COMPLETED|Treatment Period||11
217466|NCT00303472|516215|P5|COMPLETED|Treatment Period||8
217467|NCT00303472|516216|P4|COMPLETED|Treatment Period||14
217468|NCT00303472|516217|P3|COMPLETED|Treatment Period||11
217469|NCT00303472|516218|P2|COMPLETED|Treatment Period||11
217470|NCT00303472|516219|P1|COMPLETED|Treatment Period||6
217471|NCT00303472|516213|P7|STARTED|Treatment Period||5
217472|NCT00303472|516214|P6|STARTED|Treatment Period||12
217473|NCT00303472|516215|P5|STARTED|Treatment Period||11
217474|NCT00303472|516216|P4|STARTED|Treatment Period||16
217475|NCT00303472|516217|P3|STARTED|Treatment Period||11
217476|NCT00303472|516218|P2|STARTED|Treatment Period||11
217477|NCT00303472|516219|P1|STARTED|Treatment Period||6
217478|NCT00303459|516279|P2|NOT COMPLETED|Overall Study||89
217479|NCT00303459|516280|P1|NOT COMPLETED|Overall Study||83
217480|NCT00303459|516279|P2|COMPLETED|Overall Study||86
217481|NCT00303459|516280|P1|COMPLETED|Overall Study||76
217482|NCT00303459|516279|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
217483|NCT00303459|516280|P1|STARTED|Overall Study||159
217484|NCT00303446|516306|P2|NOT COMPLETED|Overall Study||4
217485|NCT00303446|516307|P1|NOT COMPLETED|Overall Study||2
217486|NCT00303446|516306|P2|COMPLETED|Overall Study||21
217487|NCT00303446|516307|P1|COMPLETED|Overall Study||23
217488|NCT00303446|516306|P2|STARTED|Overall Study||25
217489|NCT00303446|516307|P1|STARTED|Overall Study||25
217490|NCT00303329|516343|P2|NOT COMPLETED|Overall Study||62
217491|NCT00303329|516344|P1|NOT COMPLETED|Overall Study||35
217492|NCT00303329|516343|P2|COMPLETED|Overall Study||37
217493|NCT00303329|516344|P1|COMPLETED|Overall Study||50
217494|NCT00303329|516343|P2|STARTED|Overall Study||99
217495|NCT00303329|516344|P1|STARTED|Overall Study||85
217496|NCT00303316|516358|P2|NOT COMPLETED|Overall Study||3
217497|NCT00303316|516359|P1|NOT COMPLETED|Overall Study||2
217498|NCT00303316|516358|P2|COMPLETED|Overall Study||223
217499|NCT00303316|516359|P1|COMPLETED|Overall Study||230
217500|NCT00303316|516358|P2|STARTED|Overall Study||226
217501|NCT00303316|516359|P1|STARTED|Overall Study||232
217502|NCT00303186|516371|P1|NOT COMPLETED|Overall Study||52
217503|NCT00303186|516371|P1|COMPLETED|Overall Study||55
217504|NCT00303186|516371|P1|STARTED|Overall Study||107
217505|NCT00303108|516405|P3|NOT COMPLETED|Overall Study||16
217506|NCT00303108|516406|P2|NOT COMPLETED|Overall Study||9
217507|NCT00303108|516407|P1|NOT COMPLETED|Overall Study||12
217508|NCT00303108|516405|P3|COMPLETED|Overall Study||31
217509|NCT00303108|516406|P2|COMPLETED|Overall Study||37
217510|NCT00303108|516407|P1|COMPLETED|Overall Study||31
217511|NCT00303108|516405|P3|STARTED|Overall Study||47
217512|NCT00303108|516406|P2|STARTED|Overall Study||46
217513|NCT00303108|516407|P1|STARTED|Overall Study||43
217514|NCT00303069|516427|P4|NOT COMPLETED|Overall Study||2
217515|NCT00303069|516428|P3|NOT COMPLETED|Overall Study||1
217516|NCT00303069|516429|P2|NOT COMPLETED|Overall Study||0
217517|NCT00303069|516430|P1|NOT COMPLETED|Overall Study||2
217518|NCT00303069|516427|P4|COMPLETED|Overall Study||29
217519|NCT00303069|516428|P3|COMPLETED|Overall Study||33
217520|NCT00303069|516429|P2|COMPLETED|Overall Study||28
217521|NCT00303069|516430|P1|COMPLETED|Overall Study||29
217522|NCT00303069|516427|P4|STARTED|Overall Study||31
217523|NCT00303069|516428|P3|STARTED|Overall Study||34
217524|NCT00303069|516429|P2|STARTED|Overall Study||28
217525|NCT00303069|516430|P1|STARTED|Overall Study||31
217526|NCT00302952|516450|P2|NOT COMPLETED|Overall Study||5
217527|NCT00302952|516451|P1|NOT COMPLETED|Overall Study||3
217528|NCT00302952|516450|P2|COMPLETED|Overall Study||25
217529|NCT00302952|516451|P1|COMPLETED|Overall Study||31
217530|NCT00302952|516450|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
217531|NCT00302952|516451|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
217532|NCT00302952|516450|P2|Started Intent-to-Treat (ITT)|Overall Study||30
217533|NCT00302952|516451|P1|Started Intent-to-Treat (ITT)|Overall Study||34
217534|NCT00302952|516450|P2|STARTED|Overall Study||30
217535|NCT00302952|516451|P1|STARTED|Overall Study||34
217536|NCT00302848|516488|P3|NOT COMPLETED|Overall Study||579
217537|NCT00302848|516489|P2|NOT COMPLETED|Overall Study||419
217538|NCT00302848|516490|P1|NOT COMPLETED|Overall Study||401
217539|NCT00302848|516488|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
217540|NCT00302848|516489|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
217541|NCT00302848|516490|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
217542|NCT00302848|516488|P3|STARTED|Overall Study||26341
217543|NCT00302848|516489|P2|STARTED|Overall Study||15428
217544|NCT00302848|516490|P1|STARTED|Overall Study||16534
217545|NCT00302718|516501|P4|NOT COMPLETED|Overall Study||2
217546|NCT00302718|516502|P3|NOT COMPLETED|Overall Study||2
217547|NCT00302718|516503|P2|NOT COMPLETED|Overall Study||1
217548|NCT00302718|516504|P1|NOT COMPLETED|Overall Study||1
217549|NCT00302718|516501|P4|COMPLETED|Overall Study||19
217550|NCT00302718|516502|P3|COMPLETED|Overall Study||19
217551|NCT00302718|516503|P2|COMPLETED|Overall Study||20
217552|NCT00302718|516504|P1|COMPLETED|Overall Study||19
217553|NCT00302718|516501|P4|STARTED|Overall Study||21
217554|NCT00302718|516502|P3|STARTED|Overall Study||21
217555|NCT00302718|516503|P2|STARTED|Overall Study||21
217556|NCT00302718|516504|P1|STARTED|Overall Study||20
217557|NCT00302458|516536|P1|NOT COMPLETED|Overall Study||3
217558|NCT00302458|516536|P1|COMPLETED|Overall Study||26
217559|NCT00302458|516536|P1|STARTED|Overall Study||29
217560|NCT00302328|516547|P3|NOT COMPLETED|Overall Study||0
217561|NCT00302328|516548|P2|NOT COMPLETED|Overall Study||1
217562|NCT00302328|516549|P1|NOT COMPLETED|Overall Study||0
217563|NCT00302328|516547|P3|COMPLETED|Overall Study||18
217564|NCT00302328|516548|P2|COMPLETED|Overall Study|developed cancer during the study|34
217565|NCT00302328|516549|P1|COMPLETED|Overall Study||25
217566|NCT00302328|516547|P3|STARTED|Overall Study||18
217567|NCT00302328|516548|P2|STARTED|Overall Study||35
217568|NCT00302328|516549|P1|STARTED|Overall Study||25
217569|NCT00302211|516566|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
217570|NCT00302211|516567|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
217571|NCT00302211|516568|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
217572|NCT00302211|516569|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
217573|NCT00302211|516570|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
217574|NCT00302211|516566|P5|COMPLETED|Open Label-Patients From Double-Blind||24
217575|NCT00302211|516567|P4|COMPLETED|Open Label-Patients From Double-Blind||18
217576|NCT00302211|516568|P3|COMPLETED|Open Label-Patients From Double-Blind||0
217577|NCT00302211|516569|P2|COMPLETED|Open Label-Patients From Double-Blind||0
217578|NCT00302211|516570|P1|COMPLETED|Open Label-Patients From Double-Blind||0
217579|NCT00302211|516566|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
217580|NCT00302211|516567|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
217581|NCT00302211|516568|P3|STARTED|Open Label-Patients From Double-Blind||0
217582|NCT00302211|516569|P2|STARTED|Open Label-Patients From Double-Blind||0
217583|NCT00302211|516570|P1|STARTED|Open Label-Patients From Double-Blind||0
217584|NCT00302211|516566|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
217585|NCT00302211|516567|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
217586|NCT00302211|516568|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
217587|NCT00302211|516569|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
217588|NCT00302211|516570|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
217589|NCT00302211|516566|P5|COMPLETED|Double Blind Period (New Patients)||0
217590|NCT00302211|516567|P4|COMPLETED|Double Blind Period (New Patients)||0
217591|NCT00302211|516568|P3|COMPLETED|Double Blind Period (New Patients)||10
217592|NCT00302211|516569|P2|COMPLETED|Double Blind Period (New Patients)||25
217593|NCT00302211|516570|P1|COMPLETED|Double Blind Period (New Patients)||23
217594|NCT00302211|516566|P5|STARTED|Double Blind Period (New Patients)||0
217595|NCT00302211|516567|P4|STARTED|Double Blind Period (New Patients)||0
217596|NCT00302211|516568|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
217597|NCT00302211|516569|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
217598|NCT00302211|516570|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
217599|NCT00302159|516582|P1|NOT COMPLETED|Overall Study||2
217600|NCT00302159|516582|P1|COMPLETED|Overall Study||41
217601|NCT00302159|516582|P1|STARTED|Overall Study||43
217602|NCT00302133|516593|P2|NOT COMPLETED|Overall Study||4
217603|NCT00302133|516594|P1|NOT COMPLETED|Overall Study||4
217604|NCT00302133|516593|P2|COMPLETED|Overall Study||5
217605|NCT00302133|516594|P1|COMPLETED|Overall Study||5
217606|NCT00302133|516593|P2|STARTED|Overall Study||9
217607|NCT00302133|516594|P1|STARTED|Overall Study||9
217608|NCT00302107|516604|P2|NOT COMPLETED|Overall Study||9
217609|NCT00302107|516605|P1|NOT COMPLETED|Overall Study||8
217610|NCT00302107|516604|P2|COMPLETED|Overall Study||30
217611|NCT00302107|516605|P1|COMPLETED|Overall Study||31
217612|NCT00302107|516604|P2|STARTED|Overall Study||39
217613|NCT00302107|516605|P1|STARTED|Overall Study||39
217614|NCT00302081|516614|P3|NOT COMPLETED|Overall Study||52
217615|NCT00302081|516615|P2|NOT COMPLETED|Overall Study||43
217616|NCT00302081|516616|P1|NOT COMPLETED|Overall Study||56
217617|NCT00302081|516614|P3|COMPLETED|Overall Study||178
217618|NCT00302081|516615|P2|COMPLETED|Overall Study||186
217619|NCT00302081|516616|P1|COMPLETED|Overall Study||181
217620|NCT00302081|516614|P3|STARTED|Overall Study||230
217621|NCT00302081|516615|P2|STARTED|Overall Study||229
217622|NCT00302081|516616|P1|STARTED|Overall Study||237
217623|NCT00302068|516627|P3|NOT COMPLETED|Overall Study||1
217624|NCT00302068|516628|P2|NOT COMPLETED|Overall Study||4
217625|NCT00302068|516629|P1|NOT COMPLETED|Overall Study||1
217626|NCT00302068|516627|P3|COMPLETED|Overall Study||23
217627|NCT00302068|516628|P2|COMPLETED|Overall Study||36
217628|NCT00302068|516629|P1|COMPLETED|Overall Study||36
217629|NCT00302068|516627|P3|STARTED|Overall Study||24
217630|NCT00302068|516628|P2|STARTED|Overall Study||40
217631|NCT00302068|516629|P1|STARTED|Overall Study||37
217632|NCT00302055|516657|P2|NOT COMPLETED|Overall Study||13
217633|NCT00302055|516658|P1|NOT COMPLETED|Overall Study||9
217634|NCT00302055|516657|P2|COMPLETED|Overall Study||36
217635|NCT00302055|516658|P1|COMPLETED|Overall Study||14
217636|NCT00302055|516657|P2|STARTED|Overall Study||49
217637|NCT00302055|516658|P1|STARTED|Overall Study||23
217638|NCT00302042|516666|P2|NOT COMPLETED|Overall Study||8
217639|NCT00302042|516667|P1|NOT COMPLETED|Overall Study||7
217640|NCT00302042|516666|P2|COMPLETED|Overall Study||38
217641|NCT00302042|516667|P1|COMPLETED|Overall Study||39
217642|NCT00302042|516666|P2|STARTED|Overall Study||46
217643|NCT00302042|516667|P1|STARTED|Overall Study||46
217644|NCT00302003|516673|P1|NOT COMPLETED|Overall Study||80
217645|NCT00302003|516673|P1|COMPLETED|Overall Study||207
217646|NCT00302003|516673|P1|STARTED|Overall Study||287
217647|NCT00301964|516680|P1|NOT COMPLETED|Overall Study||4
217648|NCT00301964|516680|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
217649|NCT00301964|516680|P1|STARTED|Overall Study||56
217650|NCT00301873|516685|P1|NOT COMPLETED|Overall Study||0
217651|NCT00301873|516685|P1|COMPLETED|Overall Study||59
217652|NCT00301873|516685|P1|STARTED|Overall Study||59
217653|NCT00301834|516691|P1|NOT COMPLETED|Overall Study||1
217654|NCT00301834|516691|P1|COMPLETED|Overall Study||34
217655|NCT00301834|516691|P1|STARTED|Overall Study||35
217656|NCT00301821|516700|P1|NOT COMPLETED|Overall Study||26
217657|NCT00301821|516700|P1|COMPLETED|Overall Study||81
217658|NCT00301821|516700|P1|STARTED|Overall Study||107
217659|NCT00301808|516707|P1|NOT COMPLETED|Overall Study||12
217660|NCT00301808|516707|P1|COMPLETED|Overall Study||17
217661|NCT00301808|516707|P1|STARTED|Overall Study||29
217662|NCT00301756|516711|P1|NOT COMPLETED|Overall Study||0
217663|NCT00301756|516711|P1|COMPLETED|Overall Study||32
217664|NCT00301756|516711|P1|STARTED|Overall Study||32
217665|NCT00301418|516720|P1|NOT COMPLETED|Overall Study||0
217666|NCT00301418|516720|P1|COMPLETED|Overall Study||11
217667|NCT00301418|516720|P1|STARTED|Overall Study||11
217668|NCT00301366|516726|P1|NOT COMPLETED|Overall Study||1
217669|NCT00301366|516726|P1|COMPLETED|Overall Study||37
217670|NCT00301366|516726|P1|STARTED|Overall Study||38
217671|NCT00301262|516732|P2|NOT COMPLETED|Open Label Phase (OL)||2
217672|NCT00301262|516733|P1|NOT COMPLETED|Open Label Phase (OL)||4
217673|NCT00301262|516732|P2|COMPLETED|Open Label Phase (OL)||67
217674|NCT00301262|516733|P1|COMPLETED|Open Label Phase (OL)||79
217675|NCT00301262|516732|P2|STARTED|Open Label Phase (OL)||69
217676|NCT00301262|516733|P1|STARTED|Open Label Phase (OL)||83
217677|NCT00301262|516732|P2|NOT COMPLETED|Double Blind Phase (DB)||13
217678|NCT00301262|516733|P1|NOT COMPLETED|Double Blind Phase (DB)||10
217679|NCT00301262|516732|P2|COMPLETED|Double Blind Phase (DB)||69
217680|NCT00301262|516733|P1|COMPLETED|Double Blind Phase (DB)||84
217681|NCT00301262|516732|P2|STARTED|Double Blind Phase (DB)||82
217682|NCT00301262|516733|P1|STARTED|Double Blind Phase (DB)||94
217683|NCT00301080|516891|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217684|NCT00301080|516892|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217685|NCT00301080|516893|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217686|NCT00301080|516894|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217687|NCT00301080|516895|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217688|NCT00301080|516891|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217689|NCT00301080|516892|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217690|NCT00301080|516893|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217691|NCT00301080|516894|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217692|NCT00301080|516895|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
217693|NCT00301080|516891|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
217694|NCT00301080|516892|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
217695|NCT00301080|516893|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
217696|NCT00301080|516894|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
217697|NCT00301080|516895|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
217698|NCT00301080|516891|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217699|NCT00301080|516892|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217700|NCT00301080|516893|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217701|NCT00301080|516894|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217702|NCT00301080|516895|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
217703|NCT00301080|516891|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217704|NCT00301080|516892|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217705|NCT00301080|516893|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
217706|NCT00301080|516894|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
217707|NCT00301080|516895|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
217708|NCT00301080|516891|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
217709|NCT00301080|516892|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
217710|NCT00301080|516893|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
217711|NCT00301080|516894|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
217712|NCT00301080|516895|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
217713|NCT00301080|516891|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
217714|NCT00301080|516892|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
217715|NCT00301080|516893|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
217716|NCT00301080|516894|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
217717|NCT00301080|516895|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
217718|NCT00301080|516891|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
217719|NCT00301080|516892|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
217720|NCT00301080|516893|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
217721|NCT00301080|516894|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
217722|NCT00301080|516895|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
217723|NCT00301028|516924|P1|NOT COMPLETED|Overall Study||0
217724|NCT00301028|516924|P1|COMPLETED|Overall Study||47
217725|NCT00301028|516924|P1|STARTED|Overall Study||47
217726|NCT00300885|516930|P2|NOT COMPLETED|Follow-up||195
217727|NCT00300885|516931|P1|NOT COMPLETED|Follow-up||178
217815|NCT00300274|517217|P3|NOT COMPLETED|Overall Study||45
217728|NCT00300885|516930|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
217729|NCT00300885|516931|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
217730|NCT00300885|516930|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
217731|NCT00300885|516931|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
217732|NCT00300885|516930|P2|NOT COMPLETED|Treatment||374
217733|NCT00300885|516931|P1|NOT COMPLETED|Treatment||373
217734|NCT00300885|516930|P2|COMPLETED|Treatment||88
217735|NCT00300885|516931|P1|COMPLETED|Treatment||91
217736|NCT00300885|516930|P2|Received Treatment|Treatment||459
217737|NCT00300885|516931|P1|Received Treatment|Treatment||463
217738|NCT00300885|516930|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
217739|NCT00300885|516931|P1|STARTED|Treatment||464
217740|NCT00300755|516950|P3|NOT COMPLETED|Overall Study||2
217741|NCT00300755|516951|P2|NOT COMPLETED|Overall Study||4
217742|NCT00300755|516952|P1|NOT COMPLETED|Overall Study||1
217743|NCT00300755|516950|P3|COMPLETED|Overall Study||19
217744|NCT00300755|516951|P2|COMPLETED|Overall Study||17
217745|NCT00300755|516952|P1|COMPLETED|Overall Study||17
217746|NCT00300755|516950|P3|STARTED|Overall Study||21
217747|NCT00300755|516951|P2|STARTED|Overall Study||21
217748|NCT00300755|516952|P1|STARTED|Overall Study||18
217749|NCT00300677|516969|P1|NOT COMPLETED|Overall Study||0
217750|NCT00300677|516969|P1|COMPLETED|Overall Study||12
217751|NCT00300677|516969|P1|STARTED|Overall Study||12
217752|NCT00300482|516982|P6|NOT COMPLETED|Overall Study||16
217753|NCT00300482|516983|P5|NOT COMPLETED|Overall Study||23
217754|NCT00300482|516984|P4|NOT COMPLETED|Overall Study||24
217755|NCT00300482|516985|P3|NOT COMPLETED|Overall Study||51
217756|NCT00300482|516986|P2|NOT COMPLETED|Overall Study||41
217757|NCT00300482|516987|P1|NOT COMPLETED|Overall Study||41
217758|NCT00300482|516982|P6|COMPLETED|Overall Study||115
217759|NCT00300482|516983|P5|COMPLETED|Overall Study||243
217760|NCT00300482|516984|P4|COMPLETED|Overall Study||237
217761|NCT00300482|516985|P3|COMPLETED|Overall Study||208
217762|NCT00300482|516986|P2|COMPLETED|Overall Study||220
217763|NCT00300482|516987|P1|COMPLETED|Overall Study||220
217764|NCT00300482|516982|P6|STARTED|Overall Study||131
217765|NCT00300482|516983|P5|STARTED|Overall Study||266
217766|NCT00300482|516984|P4|STARTED|Overall Study||261
217767|NCT00300482|516985|P3|STARTED|Overall Study||259
217768|NCT00300482|516986|P2|STARTED|Overall Study||261
217769|NCT00300482|516987|P1|STARTED|Overall Study|"For all arms, started means treated."|261
217770|NCT00300469|517049|P6|NOT COMPLETED|Overall Study||9
217771|NCT00300469|517050|P5|NOT COMPLETED|Overall Study||14
217772|NCT00300469|517051|P4|NOT COMPLETED|Overall Study||9
217773|NCT00300469|517052|P3|NOT COMPLETED|Overall Study||17
217774|NCT00300469|517053|P2|NOT COMPLETED|Overall Study||21
217775|NCT00300469|517054|P1|NOT COMPLETED|Overall Study||21
217776|NCT00300469|517049|P6|COMPLETED|Overall Study||46
217777|NCT00300469|517050|P5|COMPLETED|Overall Study||95
217778|NCT00300469|517051|P4|COMPLETED|Overall Study||104
217779|NCT00300469|517052|P3|COMPLETED|Overall Study||95
217780|NCT00300469|517053|P2|COMPLETED|Overall Study||89
217781|NCT00300469|517054|P1|COMPLETED|Overall Study||89
217782|NCT00300469|517049|P6|STARTED|Overall Study||55
217783|NCT00300469|517050|P5|STARTED|Overall Study||109
217784|NCT00300469|517051|P4|STARTED|Overall Study||113
217785|NCT00300469|517052|P3|STARTED|Overall Study||112
217786|NCT00300469|517053|P2|STARTED|Overall Study||110
217787|NCT00300469|517054|P1|STARTED|Overall Study|"For all arms, started means treated."|110
217788|NCT00300456|517116|P6|NOT COMPLETED|Overall Study||11
217789|NCT00300456|517117|P5|NOT COMPLETED|Overall Study||17
217790|NCT00300456|517118|P4|NOT COMPLETED|Overall Study||14
217791|NCT00300456|517119|P3|NOT COMPLETED|Overall Study||21
217792|NCT00300456|517120|P2|NOT COMPLETED|Overall Study||16
217793|NCT00300456|517121|P1|NOT COMPLETED|Overall Study||16
217794|NCT00300456|517116|P6|COMPLETED|Overall Study||48
217795|NCT00300456|517117|P5|COMPLETED|Overall Study||99
217796|NCT00300456|517118|P4|COMPLETED|Overall Study||105
217797|NCT00300456|517119|P3|COMPLETED|Overall Study||98
217798|NCT00300456|517120|P2|COMPLETED|Overall Study||102
217799|NCT00300456|517121|P1|COMPLETED|Overall Study||103
217800|NCT00300456|517116|P6|STARTED|Overall Study||59
217801|NCT00300456|517117|P5|STARTED|Overall Study||116
217802|NCT00300456|517118|P4|STARTED|Overall Study||119
217803|NCT00300456|517119|P3|STARTED|Overall Study||119
217804|NCT00300456|517120|P2|STARTED|Overall Study||118
217805|NCT00300456|517121|P1|STARTED|Overall Study|"For all arms, started means treated."|119
217806|NCT00300430|517180|P3|NOT COMPLETED|Overall Study||151
217807|NCT00300430|517181|P2|NOT COMPLETED|Overall Study||169
217808|NCT00300430|517182|P1|NOT COMPLETED|Overall Study||367
217809|NCT00300430|517180|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
217810|NCT00300430|517181|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
217811|NCT00300430|517182|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
217812|NCT00300430|517180|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
217813|NCT00300430|517181|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
217814|NCT00300430|517182|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
217816|NCT00300274|517218|P2|NOT COMPLETED|Overall Study||27
217817|NCT00300274|517219|P1|NOT COMPLETED|Overall Study||46
217818|NCT00300274|517217|P3|COMPLETED|Overall Study||226
217819|NCT00300274|517218|P2|COMPLETED|Overall Study||141
217820|NCT00300274|517219|P1|COMPLETED|Overall Study||236
217821|NCT00300274|517217|P3|Completed 12 Month|Overall Study||248
217822|NCT00300274|517218|P2|Completed 12 Month|Overall Study||149
217823|NCT00300274|517219|P1|Completed 12 Month|Overall Study||250
217824|NCT00300274|517217|P3|STARTED|Overall Study||271
217825|NCT00300274|517218|P2|STARTED|Overall Study||168
217826|NCT00300274|517219|P1|STARTED|Overall Study||282
217827|NCT00300235|517259|P5|NOT COMPLETED|Overall Study||0
217828|NCT00300235|517260|P4|NOT COMPLETED|Overall Study||0
217829|NCT00300235|517261|P3|NOT COMPLETED|Overall Study||0
217830|NCT00300235|517262|P2|NOT COMPLETED|Overall Study||0
217831|NCT00300235|517263|P1|NOT COMPLETED|Overall Study||0
217832|NCT00300235|517259|P5|COMPLETED|Overall Study||251
217833|NCT00300235|517260|P4|COMPLETED|Overall Study||362
217834|NCT00300235|517261|P3|COMPLETED|Overall Study||398
217835|NCT00300235|517262|P2|COMPLETED|Overall Study||240
217836|NCT00300235|517263|P1|COMPLETED|Overall Study||208
217837|NCT00300235|517259|P5|STARTED|Overall Study||251
217838|NCT00300235|517260|P4|STARTED|Overall Study||362
217839|NCT00300235|517261|P3|STARTED|Overall Study||398
217840|NCT00300235|517262|P2|STARTED|Overall Study||240
217841|NCT00300235|517263|P1|STARTED|Overall Study||208
217842|NCT00299975|517278|P3|NOT COMPLETED|Overall Study||8
217843|NCT00299975|517279|P2|NOT COMPLETED|Overall Study||1
217844|NCT00299975|517280|P1|NOT COMPLETED|Overall Study||3
217845|NCT00299975|517278|P3|COMPLETED|Overall Study||25
217846|NCT00299975|517279|P2|COMPLETED|Overall Study||31
217847|NCT00299975|517280|P1|COMPLETED|Overall Study||29
217848|NCT00299975|517278|P3|Received Allocated Intervention|Overall Study||32
217849|NCT00299975|517279|P2|Received Allocated Intervention|Overall Study||32
217850|NCT00299975|517280|P1|Received Allocated Intervention|Overall Study||32
217851|NCT00299975|517278|P3|STARTED|Overall Study||33
217852|NCT00299975|517279|P2|STARTED|Overall Study||32
217853|NCT00299975|517280|P1|STARTED|Overall Study||32
217854|NCT00299741|517330|P1|NOT COMPLETED|Overall Study||0
217855|NCT00299741|517330|P1|COMPLETED|Overall Study||36
217856|NCT00299741|517330|P1|STARTED|Overall Study||36
217857|NCT00299702|517337|P2|NOT COMPLETED|Overall Study||50
217858|NCT00299702|517338|P1|NOT COMPLETED|Overall Study||53
217859|NCT00299702|517337|P2|COMPLETED|Overall Study||126
217860|NCT00299702|517338|P1|COMPLETED|Overall Study||126
217861|NCT00299702|517337|P2|STARTED|Overall Study||176
217862|NCT00299702|517338|P1|STARTED|Overall Study||179
217863|NCT00299689|517346|P1|NOT COMPLETED|Overall Study||0
217864|NCT00299689|517346|P1|COMPLETED|Overall Study||69
217865|NCT00299689|517346|P1|STARTED|Overall Study||69
217866|NCT00299546|517353|P3|NOT COMPLETED|Overall Study||86
217867|NCT00299546|517354|P2|NOT COMPLETED|Overall Study||92
217868|NCT00299546|517355|P1|NOT COMPLETED|Overall Study||100
217869|NCT00299546|517353|P3|COMPLETED|Overall Study||67
217870|NCT00299546|517354|P2|COMPLETED|Overall Study||61
217871|NCT00299546|517355|P1|COMPLETED|Overall Study||55
217872|NCT00299546|517353|P3|STARTED|Overall Study||153
217873|NCT00299546|517354|P2|STARTED|Overall Study||153
217874|NCT00299546|517355|P1|STARTED|Overall Study||155
217875|NCT00299416|517380|P1|NOT COMPLETED|Overall Study||0
217876|NCT00299416|517380|P1|COMPLETED|Overall Study||30
217877|NCT00299416|517380|P1|STARTED|Overall Study||30
217878|NCT00299221|517388|P2|NOT COMPLETED|Overall Study||0
217879|NCT00299221|517389|P1|NOT COMPLETED|Overall Study||0
217880|NCT00299221|517388|P2|COMPLETED|Overall Study||71
217881|NCT00299221|517389|P1|COMPLETED|Overall Study||79
217882|NCT00299221|517388|P2|STARTED|Overall Study||71
217883|NCT00299221|517389|P1|STARTED|Overall Study||79
217884|NCT00299156|517406|P3|NOT COMPLETED|Period 2 (Randomized)||0
217885|NCT00299156|517407|P2|NOT COMPLETED|Period 2 (Randomized)||1
217886|NCT00299156|517408|P1|NOT COMPLETED|Period 2 (Randomized)||0
217887|NCT00299156|517406|P3|COMPLETED|Period 2 (Randomized)||16
217888|NCT00299156|517407|P2|COMPLETED|Period 2 (Randomized)||16
217889|NCT00299156|517408|P1|COMPLETED|Period 2 (Randomized)||0
217890|NCT00299156|517406|P3|STARTED|Period 2 (Randomized)||16
217891|NCT00299156|517407|P2|STARTED|Period 2 (Randomized)||17
217892|NCT00299156|517408|P1|STARTED|Period 2 (Randomized)||0
217893|NCT00299156|517406|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
217894|NCT00299156|517407|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
217895|NCT00299156|517408|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
217896|NCT00299156|517406|P3|COMPLETED|Period 1 (Non-Randomized)||0
217897|NCT00299156|517407|P2|COMPLETED|Period 1 (Non-Randomized)||0
217898|NCT00299156|517408|P1|COMPLETED|Period 1 (Non-Randomized)||32
217899|NCT00299156|517406|P3|STARTED|Period 1 (Non-Randomized)||0
217900|NCT00299156|517407|P2|STARTED|Period 1 (Non-Randomized)||0
217901|NCT00299156|517408|P1|STARTED|Period 1 (Non-Randomized)||32
217902|NCT00299130|517419|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
217903|NCT00299130|517420|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
217904|NCT00299130|517421|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
217905|NCT00299130|517419|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
217906|NCT00299130|517420|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
217907|NCT00299130|517421|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
217908|NCT00299130|517419|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
217909|NCT00299130|517420|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
217910|NCT00299130|517421|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
217911|NCT00299130|517419|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
217912|NCT00299130|517420|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
217913|NCT00299130|517421|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
217914|NCT00299130|517419|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
217915|NCT00299130|517420|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
217916|NCT00299130|517421|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
217917|NCT00299130|517419|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
217918|NCT00299130|517420|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
217919|NCT00299130|517421|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
217920|NCT00299130|517419|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
217921|NCT00299130|517420|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
217922|NCT00299130|517421|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
217923|NCT00299130|517419|P3|COMPLETED|Treatment Period (up to 5 Years)||121
217924|NCT00299130|517420|P2|COMPLETED|Treatment Period (up to 5 Years)||125
217925|NCT00299130|517421|P1|COMPLETED|Treatment Period (up to 5 Years)||119
217926|NCT00299130|517419|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
217927|NCT00299130|517420|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
217928|NCT00299130|517421|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
217929|NCT00299130|517419|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
217930|NCT00299130|517420|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
217931|NCT00299130|517421|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
217932|NCT00299130|517419|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
217933|NCT00299130|517420|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
217934|NCT00299130|517421|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
217935|NCT00299130|517419|P3|Treated|Treatment Period (up to 5 Years)||170
217936|NCT00299130|517420|P2|Treated|Treatment Period (up to 5 Years)||167
217937|NCT00299130|517421|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
217938|NCT00299130|517419|P3|STARTED|Treatment Period (up to 5 Years)||171
217939|NCT00299130|517420|P2|STARTED|Treatment Period (up to 5 Years)||168
217940|NCT00299130|517421|P1|STARTED|Treatment Period (up to 5 Years)||172
217941|NCT00299104|517526|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
217942|NCT00299104|517527|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
217943|NCT00299104|517528|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
217944|NCT00299104|517526|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
217945|NCT00299104|517527|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
217946|NCT00299104|517528|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
217947|NCT00299104|517526|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
217948|NCT00299104|517527|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
217949|NCT00299104|517528|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
217950|NCT00299104|517526|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
217951|NCT00299104|517527|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
217952|NCT00299104|517528|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
217953|NCT00299104|517526|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
217954|NCT00299104|517527|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
217955|NCT00299104|517528|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
217956|NCT00299104|517526|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
217957|NCT00299104|517527|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
217958|NCT00299104|517528|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
217959|NCT00299104|517526|P3|NOT COMPLETED|Treatment Period||172
217960|NCT00299104|517527|P2|NOT COMPLETED|Treatment Period||175
217961|NCT00299104|517528|P1|NOT COMPLETED|Treatment Period||189
217962|NCT00299104|517526|P3|COMPLETED|Treatment Period||80
217963|NCT00299104|517527|P2|COMPLETED|Treatment Period||77
217964|NCT00299104|517528|P1|COMPLETED|Treatment Period|Completed Week 152|62
217965|NCT00299104|517526|P3|Completed Week 104|Treatment Period||216
217966|NCT00299104|517527|P2|Completed Week 104|Treatment Period||213
217967|NCT00299104|517528|P1|Completed Week 104|Treatment Period||178
217968|NCT00299104|517526|P3|Completed Week 52|Treatment Period||232
217969|NCT00299104|517527|P2|Completed Week 52|Treatment Period||227
217970|NCT00299104|517528|P1|Completed Week 52|Treatment Period||213
217971|NCT00299104|517526|P3|Completed Week 24|Treatment Period||241
217972|NCT00299104|517527|P2|Completed Week 24|Treatment Period||240
217973|NCT00299104|517528|P1|Completed Week 24|Treatment Period||227
217974|NCT00299104|517526|P3|Safety/ITT: Received Study Drug|Treatment Period||250
217975|NCT00299104|517527|P2|Safety/ITT: Received Study Drug|Treatment Period||249
217976|NCT00299104|517528|P1|Safety/ITT: Received Study Drug|Treatment Period||249
217977|NCT00299104|517526|P3|STARTED|Treatment Period||252
217978|NCT00299104|517527|P2|STARTED|Treatment Period||252
217979|NCT00299104|517528|P1|STARTED|Treatment Period||251
217980|NCT00299000|517625|P2|NOT COMPLETED|Overall Study||0
217981|NCT00299000|517626|P1|NOT COMPLETED|Overall Study||0
217982|NCT00299000|517625|P2|COMPLETED|Overall Study||2
217983|NCT00299000|517626|P1|COMPLETED|Overall Study||2
217984|NCT00299000|517625|P2|STARTED|Overall Study||2
217985|NCT00299000|517626|P1|STARTED|Overall Study||2
217986|NCT00298766|517638|P1|NOT COMPLETED|Overall Study||46
217987|NCT00298766|517638|P1|COMPLETED|Overall Study||24
217988|NCT00298766|517638|P1|STARTED|Overall Study||70
217989|NCT00298558|517651|P4|NOT COMPLETED|10th Annual (A10)||163
217990|NCT00298558|517652|P3|NOT COMPLETED|10th Annual (A10)||171
217991|NCT00298558|517653|P2|NOT COMPLETED|10th Annual (A10)||153
217992|NCT00298558|517654|P1|NOT COMPLETED|10th Annual (A10)||172
217993|NCT00298558|517651|P4|COMPLETED|10th Annual (A10)||285
217994|NCT00298558|517652|P3|COMPLETED|10th Annual (A10)||319
217995|NCT00298558|517653|P2|COMPLETED|10th Annual (A10)||316
217996|NCT00298558|517654|P1|COMPLETED|10th Annual (A10)||300
217997|NCT00298558|517651|P4|STARTED|10th Annual (A10)||448
217998|NCT00298558|517652|P3|STARTED|10th Annual (A10)||490
217999|NCT00298558|517653|P2|STARTED|10th Annual (A10)||469
218000|NCT00298558|517654|P1|STARTED|10th Annual (A10)||472
218001|NCT00298558|517651|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
218002|NCT00298558|517652|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
218003|NCT00298558|517653|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
218004|NCT00298558|517654|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
218005|NCT00298558|517651|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
218006|NCT00298558|517652|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
218007|NCT00298558|517653|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
218008|NCT00298558|517654|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
218009|NCT00298558|517651|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
218010|NCT00298558|517652|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
218011|NCT00298558|517653|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
218012|NCT00298558|517654|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
218013|NCT00298558|517651|P4|NOT COMPLETED|3rd Annual Booster||0
218014|NCT00298558|517652|P3|NOT COMPLETED|3rd Annual Booster||140
218015|NCT00298558|517653|P2|NOT COMPLETED|3rd Annual Booster||128
218016|NCT00298558|517654|P1|NOT COMPLETED|3rd Annual Booster||122
218017|NCT00298558|517651|P4|COMPLETED|3rd Annual Booster||0
218018|NCT00298558|517652|P3|COMPLETED|3rd Annual Booster||230
218019|NCT00298558|517653|P2|COMPLETED|3rd Annual Booster||243
218020|NCT00298558|517654|P1|COMPLETED|3rd Annual Booster||250
218021|NCT00298558|517651|P4|STARTED|3rd Annual Booster||0
218022|NCT00298558|517652|P3|STARTED|3rd Annual Booster||370
218023|NCT00298558|517653|P2|STARTED|3rd Annual Booster||371
218024|NCT00298558|517654|P1|STARTED|3rd Annual Booster||372
218025|NCT00298558|517651|P4|NOT COMPLETED|2nd Annual (A2)||32
218026|NCT00298558|517652|P3|NOT COMPLETED|2nd Annual (A2)||27
218027|NCT00298558|517653|P2|NOT COMPLETED|2nd Annual (A2)||11
218028|NCT00298558|517654|P1|NOT COMPLETED|2nd Annual (A2)||22
218029|NCT00298558|517651|P4|COMPLETED|2nd Annual (A2)||552
218030|NCT00298558|517652|P3|COMPLETED|2nd Annual (A2)||574
218031|NCT00298558|517653|P2|COMPLETED|2nd Annual (A2)||555
218032|NCT00298558|517654|P1|COMPLETED|2nd Annual (A2)||563
218033|NCT00298558|517651|P4|STARTED|2nd Annual (A2)||584
218034|NCT00298558|517652|P3|STARTED|2nd Annual (A2)||601
218035|NCT00298558|517653|P2|STARTED|2nd Annual (A2)||566
218036|NCT00298558|517654|P1|STARTED|2nd Annual (A2)||585
218037|NCT00298558|517651|P4|NOT COMPLETED|1st Annual (A1)||55
218038|NCT00298558|517652|P3|NOT COMPLETED|1st Annual (A1)||52
218039|NCT00298558|517653|P2|NOT COMPLETED|1st Annual (A1)||63
218040|NCT00298558|517654|P1|NOT COMPLETED|1st Annual (A1)||55
218041|NCT00298558|517651|P4|COMPLETED|1st Annual (A1)||584
218042|NCT00298558|517652|P3|COMPLETED|1st Annual (A1)||601
218043|NCT00298558|517653|P2|COMPLETED|1st Annual (A1)||566
218044|NCT00298558|517654|P1|COMPLETED|1st Annual (A1)||585
218045|NCT00298558|517651|P4|STARTED|1st Annual (A1)||639
218046|NCT00298558|517652|P3|STARTED|1st Annual (A1)||653
218047|NCT00298558|517653|P2|STARTED|1st Annual (A1)||629
218048|NCT00298558|517654|P1|STARTED|1st Annual (A1)||640
218049|NCT00298558|517651|P4|NOT COMPLETED|Booster||0
218050|NCT00298558|517652|P3|NOT COMPLETED|Booster||75
218051|NCT00298558|517653|P2|NOT COMPLETED|Booster||70
218052|NCT00298558|517654|P1|NOT COMPLETED|Booster||89
218053|NCT00298558|517651|P4|COMPLETED|Booster||0
218054|NCT00298558|517652|P3|COMPLETED|Booster||295
218055|NCT00298558|517653|P2|COMPLETED|Booster||301
218056|NCT00298558|517654|P1|COMPLETED|Booster||283
218057|NCT00298558|517651|P4|STARTED|Booster||0
218058|NCT00298558|517652|P3|STARTED|Booster||370
218059|NCT00298558|517653|P2|STARTED|Booster||371
218060|NCT00298558|517654|P1|STARTED|Booster||372
218061|NCT00298558|517651|P4|NOT COMPLETED|Immediate Post Test||65
218062|NCT00298558|517652|P3|NOT COMPLETED|Immediate Post Test||59
218063|NCT00298558|517653|P2|NOT COMPLETED|Immediate Post Test||76
218064|NCT00298558|517654|P1|NOT COMPLETED|Immediate Post Test||71
218065|NCT00298558|517651|P4|COMPLETED|Immediate Post Test||639
218066|NCT00298558|517652|P3|COMPLETED|Immediate Post Test||653
218067|NCT00298558|517653|P2|COMPLETED|Immediate Post Test||629
218068|NCT00298558|517654|P1|COMPLETED|Immediate Post Test||640
218069|NCT00298558|517651|P4|STARTED|Immediate Post Test||704
218070|NCT00298558|517652|P3|STARTED|Immediate Post Test||712
218071|NCT00298558|517653|P2|STARTED|Immediate Post Test||705
218072|NCT00298558|517654|P1|STARTED|Immediate Post Test||711
218073|NCT00298558|517651|P4|NOT COMPLETED|Intervention||419
218074|NCT00298558|517652|P3|NOT COMPLETED|Intervention||75
218075|NCT00298558|517653|P2|NOT COMPLETED|Intervention||78
218076|NCT00298558|517654|P1|NOT COMPLETED|Intervention||91
218077|NCT00298558|517651|P4|COMPLETED|Intervention||285
218078|NCT00298558|517652|P3|COMPLETED|Intervention||637
218079|NCT00298558|517653|P2|COMPLETED|Intervention||627
218080|NCT00298558|517654|P1|COMPLETED|Intervention||620
218081|NCT00298558|517651|P4|STARTED|Intervention||704
218082|NCT00298558|517652|P3|STARTED|Intervention||712
218083|NCT00298558|517653|P2|STARTED|Intervention||705
218084|NCT00298558|517654|P1|STARTED|Intervention||711
218085|NCT00298558|517651|P4|NOT COMPLETED|Baseline||0
218086|NCT00298558|517652|P3|NOT COMPLETED|Baseline||0
218087|NCT00298558|517653|P2|NOT COMPLETED|Baseline||0
218088|NCT00298558|517654|P1|NOT COMPLETED|Baseline||0
218089|NCT00298558|517651|P4|COMPLETED|Baseline||704
218090|NCT00298558|517652|P3|COMPLETED|Baseline||712
218091|NCT00298558|517653|P2|COMPLETED|Baseline||705
218092|NCT00298558|517654|P1|COMPLETED|Baseline||711
218093|NCT00298558|517651|P4|STARTED|Baseline||704
218094|NCT00298558|517652|P3|STARTED|Baseline||712
218095|NCT00298558|517653|P2|STARTED|Baseline||705
218096|NCT00298558|517654|P1|STARTED|Baseline||711
218097|NCT00298363|517687|P3|NOT COMPLETED|Overall Study||6
218098|NCT00298363|517688|P2|NOT COMPLETED|Overall Study||8
218099|NCT00298363|517689|P1|NOT COMPLETED|Overall Study||17
218100|NCT00298363|517687|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
218101|NCT00298363|517688|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
218102|NCT00298363|517689|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
218103|NCT00298363|517687|P3|STARTED|Overall Study||22
218104|NCT00298363|517688|P2|STARTED|Overall Study||45
218105|NCT00298363|517689|P1|STARTED|Overall Study||45
218106|NCT00298272|517847|P2|NOT COMPLETED|Safety Follow-up Phase||4
218107|NCT00298272|517848|P1|NOT COMPLETED|Safety Follow-up Phase||4
218108|NCT00298272|517847|P2|COMPLETED|Safety Follow-up Phase||13
218109|NCT00298272|517848|P1|COMPLETED|Safety Follow-up Phase||18
218110|NCT00298272|517847|P2|STARTED|Safety Follow-up Phase||17
218111|NCT00298272|517848|P1|STARTED|Safety Follow-up Phase||22
218112|NCT00298272|517847|P2|NOT COMPLETED|Open Label Retreatment Phase||4
218113|NCT00298272|517848|P1|NOT COMPLETED|Open Label Retreatment Phase||9
218114|NCT00298272|517847|P2|COMPLETED|Open Label Retreatment Phase||12
218115|NCT00298272|517848|P1|COMPLETED|Open Label Retreatment Phase||13
218116|NCT00298272|517847|P2|Completed to Week 56|Open Label Retreatment Phase||12
218117|NCT00298272|517848|P1|Completed to Week 56|Open Label Retreatment Phase||13
218118|NCT00298272|517847|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
218119|NCT00298272|517848|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
218120|NCT00298272|517847|P2|STARTED|Open Label Retreatment Phase||16
218121|NCT00298272|517848|P1|STARTED|Open Label Retreatment Phase||22
218122|NCT00298272|517847|P2|NOT COMPLETED|Double-blind Phase||0
218123|NCT00298272|517848|P1|NOT COMPLETED|Double-blind Phase||8
218124|NCT00298272|517847|P2|COMPLETED|Double-blind Phase||18
218125|NCT00298272|517848|P1|COMPLETED|Double-blind Phase||28
218126|NCT00298272|517847|P2|Completed to Week 56|Double-blind Phase||3
218127|NCT00298272|517848|P1|Completed to Week 56|Double-blind Phase||8
218128|NCT00298272|517847|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
218129|NCT00298272|517848|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
218130|NCT00298272|517847|P2|Safety Population|Double-blind Phase||18
218131|NCT00298272|517848|P1|Safety Population|Double-blind Phase|received treatment|33
218132|NCT00298272|517847|P2|STARTED|Double-blind Phase||18
218133|NCT00298272|517848|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
218134|NCT00298233|517871|P4|NOT COMPLETED|Overall Study||0
218135|NCT00298233|517872|P3|NOT COMPLETED|Overall Study||0
218136|NCT00298233|517873|P2|NOT COMPLETED|Overall Study||0
218137|NCT00298233|517874|P1|NOT COMPLETED|Overall Study||0
218138|NCT00298233|517871|P4|COMPLETED|Overall Study||124
218139|NCT00298233|517872|P3|COMPLETED|Overall Study||122
218140|NCT00298233|517873|P2|COMPLETED|Overall Study||41
218141|NCT00298233|517874|P1|COMPLETED|Overall Study||39
218142|NCT00298233|517871|P4|STARTED|Overall Study||124
218143|NCT00298233|517872|P3|STARTED|Overall Study||122
218144|NCT00298233|517873|P2|STARTED|Overall Study||41
218145|NCT00298233|517874|P1|STARTED|Overall Study||39
218146|NCT00298090|517890|P1|NOT COMPLETED|Overall Study||18
218147|NCT00298090|517890|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
218148|NCT00298090|517890|P1|STARTED|Overall Study||47
218149|NCT00297830|517897|P3|NOT COMPLETED|12 Month Visit||0
218150|NCT00297830|517898|P2|NOT COMPLETED|12 Month Visit||6
218151|NCT00297830|517899|P1|NOT COMPLETED|12 Month Visit||1
218152|NCT00297830|517897|P3|COMPLETED|12 Month Visit||24
218153|NCT00297830|517898|P2|COMPLETED|12 Month Visit||35
218154|NCT00297830|517899|P1|COMPLETED|12 Month Visit||37
218155|NCT00297830|517897|P3|STARTED|12 Month Visit||24
218156|NCT00297830|517898|P2|STARTED|12 Month Visit||41
218157|NCT00297830|517899|P1|STARTED|12 Month Visit||38
218158|NCT00297830|517897|P3|NOT COMPLETED|6 Month Visit||3
218159|NCT00297830|517898|P2|NOT COMPLETED|6 Month Visit||2
218160|NCT00297830|517899|P1|NOT COMPLETED|6 Month Visit||3
218161|NCT00297830|517897|P3|COMPLETED|6 Month Visit||24
218162|NCT00297830|517898|P2|COMPLETED|6 Month Visit||41
218163|NCT00297830|517899|P1|COMPLETED|6 Month Visit||38
218164|NCT00297830|517897|P3|STARTED|6 Month Visit||27
218165|NCT00297830|517898|P2|STARTED|6 Month Visit||43
218166|NCT00297830|517899|P1|STARTED|6 Month Visit||41
218167|NCT00297830|517897|P3|NOT COMPLETED|Baseline||0
218168|NCT00297830|517898|P2|NOT COMPLETED|Baseline||0
218169|NCT00297830|517899|P1|NOT COMPLETED|Baseline||0
218170|NCT00297830|517897|P3|COMPLETED|Baseline||27
218171|NCT00297830|517898|P2|COMPLETED|Baseline||43
218172|NCT00297830|517899|P1|COMPLETED|Baseline||41
218173|NCT00297830|517897|P3|STARTED|Baseline||27
218174|NCT00297830|517898|P2|STARTED|Baseline||43
218175|NCT00297830|517899|P1|STARTED|Baseline||41
218176|NCT00297778|517918|P2|NOT COMPLETED|Overall Study||20
218177|NCT00297778|517919|P1|NOT COMPLETED|Overall Study||19
218178|NCT00297778|517918|P2|COMPLETED|Overall Study||124
218179|NCT00297778|517919|P1|COMPLETED|Overall Study||133
218180|NCT00297778|517918|P2|STARTED|Overall Study||144
218181|NCT00297778|517919|P1|STARTED|Overall Study||152
218182|NCT00297648|517953|P1|NOT COMPLETED|Overall Study||36
218183|NCT00297648|517953|P1|COMPLETED|Overall Study||53
218184|NCT00297648|517953|P1|STARTED|Overall Study||89
218185|NCT00297596|517992|P1|NOT COMPLETED|Overall Study||0
218186|NCT00297596|517992|P1|COMPLETED|Overall Study||25
218187|NCT00297596|517992|P1|STARTED|Overall Study||25
218188|NCT00297492|517999|P3|NOT COMPLETED|6 Month Follow-up||27
218189|NCT00297492|518000|P2|NOT COMPLETED|6 Month Follow-up||49
218190|NCT00297492|518001|P1|NOT COMPLETED|6 Month Follow-up||63
218191|NCT00297492|517999|P3|COMPLETED|6 Month Follow-up||118
218192|NCT00297492|518000|P2|COMPLETED|6 Month Follow-up||237
218193|NCT00297492|518001|P1|COMPLETED|6 Month Follow-up||227
218194|NCT00297492|517999|P3|STARTED|6 Month Follow-up||145
218195|NCT00297492|518000|P2|STARTED|6 Month Follow-up||286
218196|NCT00297492|518001|P1|STARTED|6 Month Follow-up||290
218197|NCT00297492|517999|P3|NOT COMPLETED|Set Quit Date||5
218198|NCT00297492|518000|P2|NOT COMPLETED|Set Quit Date||13
218199|NCT00297492|518001|P1|NOT COMPLETED|Set Quit Date||7
218200|NCT00297492|517999|P3|COMPLETED|Set Quit Date||145
218201|NCT00297492|518000|P2|COMPLETED|Set Quit Date||286
218202|NCT00297492|518001|P1|COMPLETED|Set Quit Date||290
218203|NCT00297492|517999|P3|STARTED|Set Quit Date||150
218204|NCT00297492|518000|P2|STARTED|Set Quit Date||299
218205|NCT00297492|518001|P1|STARTED|Set Quit Date||297
218206|NCT00297427|518011|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
218207|NCT00297427|518012|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
218208|NCT00297427|518011|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
218209|NCT00297427|518012|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
218210|NCT00297427|518011|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
218211|NCT00297427|518012|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
218212|NCT00297427|518011|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
218213|NCT00297427|518012|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
218214|NCT00297427|518011|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
218215|NCT00297427|518012|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
218216|NCT00297427|518011|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
218217|NCT00297427|518012|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
218218|NCT00297427|518011|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
218219|NCT00297427|518012|P1|STARTED|Phase 2: Optional Crossover for Sham||54
218220|NCT00297427|518011|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
218221|NCT00297427|518012|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
218222|NCT00297427|518011|P2|COMPLETED|Phase 1: Initial Intervention||54
218223|NCT00297427|518012|P1|COMPLETED|Phase 1: Initial Intervention||56
218224|NCT00297427|518011|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
218225|NCT00297427|518012|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
218226|NCT00297258|518053|P1|NOT COMPLETED|Overall Study||142
218227|NCT00297258|518053|P1|COMPLETED|Overall Study||0
218228|NCT00297258|518053|P1|STARTED|Overall Study||142
218229|NCT00297232|518072|P1|NOT COMPLETED|Overall Study||605
218230|NCT00297232|518072|P1|COMPLETED|Overall Study||489
218231|NCT00297232|518072|P1|STARTED|Overall Study||1094
218232|NCT00297167|518078|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
218233|NCT00297167|518079|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
218234|NCT00297167|518080|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
218235|NCT00297167|518078|P3|COMPLETED|Open-label Dose Normalization Period 2||31
218236|NCT00297167|518079|P2|COMPLETED|Open-label Dose Normalization Period 2||0
218237|NCT00297167|518080|P1|COMPLETED|Open-label Dose Normalization Period 2||0
218238|NCT00297167|518078|P3|STARTED|Open-label Dose Normalization Period 2||31
218239|NCT00297167|518079|P2|STARTED|Open-label Dose Normalization Period 2||0
218240|NCT00297167|518080|P1|STARTED|Open-label Dose Normalization Period 2||0
218241|NCT00297167|518078|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
218242|NCT00297167|518079|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
218243|NCT00297167|518080|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
218244|NCT00297167|518078|P3|COMPLETED|Second Double-blind Intervention Period||0
218245|NCT00297167|518079|P2|COMPLETED|Second Double-blind Intervention Period||15
218246|NCT00297167|518080|P1|COMPLETED|Second Double-blind Intervention Period||16
218247|NCT00297167|518078|P3|STARTED|Second Double-blind Intervention Period||0
218248|NCT00297167|518079|P2|STARTED|Second Double-blind Intervention Period||15
218249|NCT00297167|518080|P1|STARTED|Second Double-blind Intervention Period||17
218250|NCT00297167|518078|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
218251|NCT00297167|518079|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
218252|NCT00297167|518080|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
218253|NCT00297167|518078|P3|COMPLETED|Open-label Dose Normalization Period 1||32
218254|NCT00297167|518079|P2|COMPLETED|Open-label Dose Normalization Period 1||0
218255|NCT00297167|518080|P1|COMPLETED|Open-label Dose Normalization Period 1||0
218256|NCT00297167|518078|P3|STARTED|Open-label Dose Normalization Period 1||33
218257|NCT00297167|518079|P2|STARTED|Open-label Dose Normalization Period 1||0
218258|NCT00297167|518080|P1|STARTED|Open-label Dose Normalization Period 1||0
218259|NCT00297167|518078|P3|NOT COMPLETED|First Double-blind Intervention Period||0
218260|NCT00297167|518079|P2|NOT COMPLETED|First Double-blind Intervention Period||0
218261|NCT00297167|518080|P1|NOT COMPLETED|First Double-blind Intervention Period||0
218262|NCT00297167|518078|P3|COMPLETED|First Double-blind Intervention Period||0
218263|NCT00297167|518079|P2|COMPLETED|First Double-blind Intervention Period||16
218264|NCT00297167|518080|P1|COMPLETED|First Double-blind Intervention Period||17
218265|NCT00297167|518078|P3|STARTED|First Double-blind Intervention Period||0
218266|NCT00297167|518079|P2|STARTED|First Double-blind Intervention Period||16
218267|NCT00297167|518080|P1|STARTED|First Double-blind Intervention Period||17
218268|NCT00297115|518106|P2|NOT COMPLETED|Overall Study||246
218269|NCT00297115|518107|P1|NOT COMPLETED|Overall Study||245
218270|NCT00297115|518106|P2|COMPLETED|Overall Study||550
218271|NCT00297115|518107|P1|COMPLETED|Overall Study||527
218272|NCT00297115|518106|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
218273|NCT00297115|518107|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
218274|NCT00297102|518125|P2|NOT COMPLETED|Overall Study||233
218275|NCT00297102|518126|P1|NOT COMPLETED|Overall Study||263
218276|NCT00297102|518125|P2|COMPLETED|Overall Study||525
218277|NCT00297102|518126|P1|COMPLETED|Overall Study||502
218278|NCT00297102|518125|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
218279|NCT00297102|518126|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
218280|NCT00297037|518144|P2|NOT COMPLETED|Overall Study||0
218281|NCT00297037|518145|P1|NOT COMPLETED|Overall Study||2
218282|NCT00297037|518144|P2|COMPLETED|Overall Study||11
218283|NCT00297037|518145|P1|COMPLETED|Overall Study||8
218284|NCT00297037|518144|P2|STARTED|Overall Study||11
218285|NCT00297037|518145|P1|STARTED|Overall Study||10
218286|NCT00296816|518157|P1|NOT COMPLETED|Overall Study||74
218287|NCT00296816|518157|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
218288|NCT00296816|518157|P1|STARTED|Overall Study||132
218289|NCT00296647|518174|P5|NOT COMPLETED|Overall Study||20
218290|NCT00296647|518175|P4|NOT COMPLETED|Overall Study||17
218291|NCT00296647|518176|P3|NOT COMPLETED|Overall Study||34
218292|NCT00296647|518177|P2|NOT COMPLETED|Overall Study||28
218293|NCT00296647|518178|P1|NOT COMPLETED|Overall Study||32
218294|NCT00296647|518174|P5|COMPLETED|Overall Study||248
218295|NCT00296647|518175|P4|COMPLETED|Overall Study||262
218296|NCT00296647|518176|P3|COMPLETED|Overall Study||222
218297|NCT00296647|518177|P2|COMPLETED|Overall Study||233
218298|NCT00296647|518178|P1|COMPLETED|Overall Study||250
218299|NCT00296647|518174|P5|STARTED|Overall Study||268
218300|NCT00296647|518175|P4|STARTED|Overall Study||279
218301|NCT00296647|518176|P3|STARTED|Overall Study||256
218302|NCT00296647|518177|P2|STARTED|Overall Study||261
218303|NCT00296647|518178|P1|STARTED|Overall Study||282
218304|NCT00296517|518192|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
218305|NCT00296517|518193|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
218306|NCT00296517|518192|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
218307|NCT00296517|518193|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
218308|NCT00296517|518192|P2|STARTED|Dose Level 3 - Weeks 3-12||161
218309|NCT00296517|518193|P1|STARTED|Dose Level 3 - Weeks 3-12||157
218310|NCT00296517|518192|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
218311|NCT00296517|518193|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
218312|NCT00296517|518192|P2|COMPLETED|Dose Level 2 - Week 2||161
218313|NCT00296517|518193|P1|COMPLETED|Dose Level 2 - Week 2||157
218314|NCT00296517|518192|P2|STARTED|Dose Level 2 - Week 2||166
218315|NCT00296517|518193|P1|STARTED|Dose Level 2 - Week 2||159
218316|NCT00296517|518192|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
218317|NCT00296517|518193|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
218318|NCT00296517|518192|P2|COMPLETED|Dose Level 1 - Week 1||166
218319|NCT00296517|518193|P1|COMPLETED|Dose Level 1 - Week 1||159
218320|NCT00296517|518192|P2|STARTED|Dose Level 1 - Week 1||166
218321|NCT00296517|518193|P1|STARTED|Dose Level 1 - Week 1||159
218322|NCT00296504|518229|P9|NOT COMPLETED|Final Analysis||21
218323|NCT00296504|518230|P8|NOT COMPLETED|Final Analysis||0
218324|NCT00296504|518231|P7|NOT COMPLETED|Final Analysis||0
218325|NCT00296504|518232|P6|NOT COMPLETED|Final Analysis||0
218326|NCT00296504|518233|P5|NOT COMPLETED|Final Analysis||0
218327|NCT00296504|518234|P4|NOT COMPLETED|Final Analysis||0
218328|NCT00296504|518235|P3|NOT COMPLETED|Final Analysis||0
218329|NCT00296504|518236|P2|NOT COMPLETED|Final Analysis||0
218330|NCT00296504|518237|P1|NOT COMPLETED|Final Analysis||0
218331|NCT00296504|518229|P9|COMPLETED|Final Analysis||90
218332|NCT00296504|518230|P8|COMPLETED|Final Analysis||0
218333|NCT00296504|518231|P7|COMPLETED|Final Analysis||0
218334|NCT00296504|518232|P6|COMPLETED|Final Analysis||0
218335|NCT00296504|518233|P5|COMPLETED|Final Analysis||0
218336|NCT00296504|518234|P4|COMPLETED|Final Analysis||0
218337|NCT00296504|518235|P3|COMPLETED|Final Analysis||0
218338|NCT00296504|518236|P2|COMPLETED|Final Analysis||0
218339|NCT00296504|518237|P1|COMPLETED|Final Analysis||0
218340|NCT00296504|518229|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
218341|NCT00296504|518230|P8|STARTED|Final Analysis||0
218342|NCT00296504|518231|P7|STARTED|Final Analysis||0
218343|NCT00296504|518232|P6|STARTED|Final Analysis||0
218344|NCT00296504|518233|P5|STARTED|Final Analysis||0
218345|NCT00296504|518234|P4|STARTED|Final Analysis||0
218346|NCT00296504|518235|P3|STARTED|Final Analysis||0
218347|NCT00296504|518236|P2|STARTED|Final Analysis||0
218348|NCT00296504|518237|P1|STARTED|Final Analysis||0
218349|NCT00296504|518229|P9|NOT COMPLETED|Interim Analysis||0
218350|NCT00296504|518230|P8|NOT COMPLETED|Interim Analysis||49
218351|NCT00296504|518231|P7|NOT COMPLETED|Interim Analysis||74
218352|NCT00296504|518232|P6|NOT COMPLETED|Interim Analysis||37
218353|NCT00296504|518233|P5|NOT COMPLETED|Interim Analysis||37
218354|NCT00296504|518234|P4|NOT COMPLETED|Interim Analysis||43
218355|NCT00296504|518235|P3|NOT COMPLETED|Interim Analysis||105
218356|NCT00296504|518236|P2|NOT COMPLETED|Interim Analysis||18
218357|NCT00296504|518237|P1|NOT COMPLETED|Interim Analysis||76
218358|NCT00296504|518229|P9|COMPLETED|Interim Analysis||0
218359|NCT00296504|518230|P8|COMPLETED|Interim Analysis||37
218360|NCT00296504|518231|P7|COMPLETED|Interim Analysis||30
218361|NCT00296504|518232|P6|COMPLETED|Interim Analysis||41
218362|NCT00296504|518233|P5|COMPLETED|Interim Analysis||36
218363|NCT00296504|518234|P4|COMPLETED|Interim Analysis||11
218364|NCT00296504|518235|P3|COMPLETED|Interim Analysis||116
218365|NCT00296504|518236|P2|COMPLETED|Interim Analysis||0
218366|NCT00296504|518237|P1|COMPLETED|Interim Analysis||43
218367|NCT00296504|518229|P9|Ongoing|Interim Analysis||0
218368|NCT00296504|518230|P8|Ongoing|Interim Analysis||1
218369|NCT00296504|518231|P7|Ongoing|Interim Analysis||30
218370|NCT00296504|518232|P6|Ongoing|Interim Analysis||0
218371|NCT00296504|518233|P5|Ongoing|Interim Analysis||0
218372|NCT00296504|518234|P4|Ongoing|Interim Analysis||22
218373|NCT00296504|518235|P3|Ongoing|Interim Analysis||16
218374|NCT00296504|518236|P2|Ongoing|Interim Analysis||12
218375|NCT00296504|518237|P1|Ongoing|Interim Analysis||32
218376|NCT00296504|518229|P9|STARTED|Interim Analysis||0
218377|NCT00296504|518230|P8|STARTED|Interim Analysis||86
218378|NCT00296504|518231|P7|STARTED|Interim Analysis||104
218379|NCT00296504|518232|P6|STARTED|Interim Analysis||78
218380|NCT00296504|518233|P5|STARTED|Interim Analysis||73
218381|NCT00296504|518234|P4|STARTED|Interim Analysis||54
218382|NCT00296504|518235|P3|STARTED|Interim Analysis||221
218383|NCT00296504|518236|P2|STARTED|Interim Analysis||18
218384|NCT00296504|518237|P1|STARTED|Interim Analysis||119
218385|NCT00296491|518330|P4|NOT COMPLETED|Overall Study||43
218386|NCT00296491|518331|P3|NOT COMPLETED|Overall Study||43
218387|NCT00296491|518332|P2|NOT COMPLETED|Overall Study||53
218388|NCT00296491|518333|P1|NOT COMPLETED|Overall Study||42
218389|NCT00296491|518330|P4|COMPLETED|Overall Study||138
218390|NCT00296491|518331|P3|COMPLETED|Overall Study||137
218391|NCT00296491|518332|P2|COMPLETED|Overall Study||129
218392|NCT00296491|518333|P1|COMPLETED|Overall Study||140
218393|NCT00296491|518330|P4|STARTED|Overall Study||181
218394|NCT00296491|518331|P3|STARTED|Overall Study||180
218395|NCT00296491|518332|P2|STARTED|Overall Study||182
218396|NCT00296491|518333|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
218397|NCT00296400|518362|P3|NOT COMPLETED|Overall Study||13
218398|NCT00296400|518363|P2|NOT COMPLETED|Overall Study||18
218399|NCT00296400|518364|P1|NOT COMPLETED|Overall Study||17
218400|NCT00296400|518362|P3|COMPLETED|Overall Study||67
218401|NCT00296400|518363|P2|COMPLETED|Overall Study||69
218402|NCT00296400|518364|P1|COMPLETED|Overall Study||53
218403|NCT00296400|518362|P3|STARTED|Overall Study||80
218404|NCT00296400|518363|P2|STARTED|Overall Study||87
218405|NCT00296400|518364|P1|STARTED|Overall Study||70
218406|NCT00296374|518588|P3|NOT COMPLETED|Overall Study||29
218407|NCT00296374|518589|P2|NOT COMPLETED|Overall Study||23
218408|NCT00296374|518590|P1|NOT COMPLETED|Overall Study||25
218409|NCT00296374|518588|P3|COMPLETED|Overall Study||82
218410|NCT00296374|518589|P2|COMPLETED|Overall Study||101
218411|NCT00296374|518590|P1|COMPLETED|Overall Study||93
218412|NCT00296374|518588|P3|STARTED|Overall Study||111
218413|NCT00296374|518589|P2|STARTED|Overall Study||124
218414|NCT00296374|518590|P1|STARTED|Overall Study||118
218415|NCT00296335|518813|P2|NOT COMPLETED|Overall Study||122
218416|NCT00296335|518814|P1|NOT COMPLETED|Overall Study||30
218417|NCT00296335|518813|P2|COMPLETED|Overall Study||309
218418|NCT00296335|518814|P1|COMPLETED|Overall Study||394
218419|NCT00296335|518813|P2|STARTED|Overall Study||431
218420|NCT00296335|518814|P1|STARTED|Overall Study||424
218421|NCT00296322|518826|P2|NOT COMPLETED|Overall Study||79
218422|NCT00296322|518827|P1|NOT COMPLETED|Overall Study||21
218423|NCT00296322|518826|P2|COMPLETED|Overall Study||184
218424|NCT00296322|518827|P1|COMPLETED|Overall Study||237
218425|NCT00296322|518826|P2|STARTED|Overall Study||263
218426|NCT00296322|518827|P1|STARTED|Overall Study||258
218427|NCT00296244|518839|P2|NOT COMPLETED|Overall Study||1
218428|NCT00296244|518840|P1|NOT COMPLETED|Overall Study||0
218429|NCT00296244|518839|P2|COMPLETED|Overall Study||19
218430|NCT00296244|518840|P1|COMPLETED|Overall Study||20
218431|NCT00296244|518839|P2|STARTED|Overall Study||20
218432|NCT00296244|518840|P1|STARTED|Overall Study||20
218433|NCT00296231|518856|P1|NOT COMPLETED|Overall Study||0
218434|NCT00296231|518856|P1|COMPLETED|Overall Study||14
218435|NCT00296231|518856|P1|STARTED|Overall Study||14
218436|NCT00296192|518866|P5|NOT COMPLETED|Overall Study||0
218437|NCT00296192|518867|P4|NOT COMPLETED|Overall Study||0
218438|NCT00296192|518868|P3|NOT COMPLETED|Overall Study||0
218439|NCT00296192|518869|P2|NOT COMPLETED|Overall Study||0
218440|NCT00296192|518870|P1|NOT COMPLETED|Overall Study||0
218441|NCT00296192|518866|P5|COMPLETED|Overall Study||16
218442|NCT00296192|518867|P4|COMPLETED|Overall Study||17
218443|NCT00296192|518868|P3|COMPLETED|Overall Study||16
218444|NCT00296192|518869|P2|COMPLETED|Overall Study||16
218445|NCT00296192|518870|P1|COMPLETED|Overall Study||17
218446|NCT00296192|518866|P5|STARTED|Overall Study||16
218447|NCT00296192|518867|P4|STARTED|Overall Study||17
218448|NCT00296192|518868|P3|STARTED|Overall Study||16
218449|NCT00296192|518869|P2|STARTED|Overall Study||16
218450|NCT00296192|518870|P1|STARTED|Overall Study||17
218451|NCT00295880|518902|P1|NOT COMPLETED|Overall Study||2
218452|NCT00295880|518902|P1|COMPLETED|Overall Study||10
218453|NCT00295880|518902|P1|STARTED|Overall Study||12
218454|NCT00295854|518916|P3|NOT COMPLETED|Overall Study||15
218455|NCT00295854|518917|P2|NOT COMPLETED|Overall Study||21
218456|NCT00295854|518918|P1|NOT COMPLETED|Overall Study||18
218457|NCT00295854|518916|P3|COMPLETED|Overall Study||87
218458|NCT00295854|518917|P2|COMPLETED|Overall Study||87
218459|NCT00295854|518918|P1|COMPLETED|Overall Study||77
218460|NCT00295854|518916|P3|ITT Population (N=296)|Overall Study||99
218461|NCT00295854|518917|P2|ITT Population (N=296)|Overall Study||105
218462|NCT00295854|518918|P1|ITT Population (N=296)|Overall Study||92
218463|NCT00295854|518916|P3|Safety Population (N=304)|Overall Study||101
218464|NCT00295854|518917|P2|Safety Population (N=304)|Overall Study||108
218465|NCT00295854|518918|P1|Safety Population (N=304)|Overall Study||95
218466|NCT00295854|518916|P3|STARTED|Overall Study||102
218467|NCT00295854|518917|P2|STARTED|Overall Study||108
218468|NCT00295854|518918|P1|STARTED|Overall Study||95
218469|NCT00295750|518932|P3|NOT COMPLETED|Overall Study||32
218470|NCT00295750|518933|P2|NOT COMPLETED|Overall Study||41
218471|NCT00295750|518934|P1|NOT COMPLETED|Overall Study||43
218472|NCT00295750|518932|P3|COMPLETED|Overall Study||172
218473|NCT00295750|518933|P2|COMPLETED|Overall Study||169
218474|NCT00295750|518934|P1|COMPLETED|Overall Study||163
218475|NCT00295750|518932|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
218476|NCT00295750|518933|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
218477|NCT00295750|518934|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
218478|NCT00295750|518932|P3|STARTED|Overall Study|randomized|204
218479|NCT00295750|518933|P2|STARTED|Overall Study|randomized|210
218480|NCT00295750|518934|P1|STARTED|Overall Study|randomized|206
218481|NCT00295633|518969|P3|NOT COMPLETED|Overall Study||76
218482|NCT00295633|518970|P2|NOT COMPLETED|Overall Study||67
218483|NCT00295633|518971|P1|NOT COMPLETED|Overall Study||62
218484|NCT00295633|518969|P3|COMPLETED|Overall Study||108
218485|NCT00295633|518970|P2|COMPLETED|Overall Study||119
218486|NCT00295633|518971|P1|COMPLETED|Overall Study||133
218487|NCT00295633|518969|P3|Completed Study Without Being Rescued|Overall Study||51
218488|NCT00295633|518970|P2|Completed Study Without Being Rescued|Overall Study||82
218489|NCT00295633|518971|P1|Completed Study Without Being Rescued|Overall Study||88
218490|NCT00295633|518969|P3|STARTED|Overall Study||184
218491|NCT00295633|518970|P2|STARTED|Overall Study||186
218492|NCT00295633|518971|P1|STARTED|Overall Study||195
218493|NCT00295503|518988|P1|NOT COMPLETED|Overall Study||0
218494|NCT00295503|518988|P1|COMPLETED|Overall Study||53
218495|NCT00295503|518988|P1|STARTED|Overall Study||53
218496|NCT00295490|518998|P4|NOT COMPLETED|Overall Study||5
218497|NCT00295490|518999|P3|NOT COMPLETED|Overall Study||4
218498|NCT00295490|519000|P2|NOT COMPLETED|Overall Study||4
218499|NCT00295490|519001|P1|NOT COMPLETED|Overall Study||1
218500|NCT00295490|518998|P4|COMPLETED|Overall Study||12
218501|NCT00295490|518999|P3|COMPLETED|Overall Study||12
218502|NCT00295490|519000|P2|COMPLETED|Overall Study||15
218503|NCT00295490|519001|P1|COMPLETED|Overall Study||14
218504|NCT00295490|518998|P4|STARTED|Overall Study||17
218505|NCT00295490|518999|P3|STARTED|Overall Study||16
218506|NCT00295490|519000|P2|STARTED|Overall Study||19
218507|NCT00295490|519001|P1|STARTED|Overall Study||15
218508|NCT00295061|519041|P2|NOT COMPLETED|Overall Study||0
218509|NCT00295061|519042|P1|NOT COMPLETED|Overall Study||0
218510|NCT00295061|519041|P2|COMPLETED|Overall Study||12
218511|NCT00295061|519042|P1|COMPLETED|Overall Study||12
218512|NCT00295061|519041|P2|STARTED|Overall Study||12
218513|NCT00295061|519042|P1|STARTED|Overall Study||12
218514|NCT00295009|519054|P6|NOT COMPLETED|Overall Study||269
218515|NCT00295009|519055|P5|NOT COMPLETED|Overall Study||58
218516|NCT00295009|519056|P4|NOT COMPLETED|Overall Study||25
218517|NCT00295009|519057|P3|NOT COMPLETED|Overall Study||12
218518|NCT00295009|519058|P2|NOT COMPLETED|Overall Study||49
218519|NCT00295009|519059|P1|NOT COMPLETED|Overall Study||41
218520|NCT00295009|519054|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
218521|NCT00295009|519055|P5|COMPLETED|Overall Study|Completed 60 month visit|116
218522|NCT00295009|519056|P4|COMPLETED|Overall Study|Completed 60 month visit|57
218523|NCT00295009|519057|P3|COMPLETED|Overall Study|Completed 60 month visit|39
218524|NCT00295009|519058|P2|COMPLETED|Overall Study|Completed 60 month visit|134
218525|NCT00295009|519059|P1|COMPLETED|Overall Study|Completed 60 month visit|52
218526|NCT00295009|519054|P6|Completed 24 Month Analysis|Overall Study||198
218527|NCT00295009|519055|P5|Completed 24 Month Analysis|Overall Study||133
218528|NCT00295009|519056|P4|Completed 24 Month Analysis|Overall Study||60
218529|NCT00295009|519057|P3|Completed 24 Month Analysis|Overall Study||45
218530|NCT00295009|519058|P2|Completed 24 Month Analysis|Overall Study||148
218531|NCT00295009|519059|P1|Completed 24 Month Analysis|Overall Study||71
218532|NCT00295009|519054|P6|Treated|Overall Study||259
218533|NCT00295009|519055|P5|Treated|Overall Study||165
218534|NCT00295009|519056|P4|Treated|Overall Study||72
218535|NCT00295009|519057|P3|Treated|Overall Study||50
218536|NCT00295009|519058|P2|Treated|Overall Study||162
218537|NCT00295009|519059|P1|Treated|Overall Study||80
218538|NCT00295009|519054|P6|STARTED|Overall Study||269
218539|NCT00295009|519055|P5|STARTED|Overall Study||174
218540|NCT00295009|519056|P4|STARTED|Overall Study||82
218541|NCT00295009|519057|P3|STARTED|Overall Study||51
218542|NCT00295009|519058|P2|STARTED|Overall Study||183
218543|NCT00295009|519059|P1|STARTED|Overall Study||93
218544|NCT00294762|519081|P2|NOT COMPLETED|Overall Study||3
218545|NCT00294762|519082|P1|NOT COMPLETED|Overall Study||3
218546|NCT00294762|519081|P2|COMPLETED|Overall Study||68
218547|NCT00294762|519082|P1|COMPLETED|Overall Study||69
218548|NCT00294762|519081|P2|STARTED|Overall Study||71
218549|NCT00294762|519082|P1|STARTED|Overall Study||72
218550|NCT00294723|519101|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
218551|NCT00294723|519102|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
218552|NCT00294723|519103|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
218553|NCT00294723|519101|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
218554|NCT00294723|519102|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
218555|NCT00294723|519103|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
218556|NCT00294723|519101|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
218557|NCT00294723|519102|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
218558|NCT00294723|519103|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
218559|NCT00294723|519101|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
218560|NCT00294723|519102|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
218561|NCT00294723|519103|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
218562|NCT00294723|519101|P3|COMPLETED|Open-Label Extension 52 Weeks||97
218563|NCT00294723|519102|P2|COMPLETED|Open-Label Extension 52 Weeks||110
218564|NCT00294723|519103|P1|COMPLETED|Open-Label Extension 52 Weeks||114
218565|NCT00294723|519101|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
218566|NCT00294723|519102|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
218567|NCT00294723|519103|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
218568|NCT00294723|519101|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
218569|NCT00294723|519102|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
218570|NCT00294723|519103|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
218571|NCT00294723|519101|P3|COMPLETED|Double-Blind Period 52 Weeks||152
218572|NCT00294723|519102|P2|COMPLETED|Double-Blind Period 52 Weeks||162
218573|NCT00294723|519103|P1|COMPLETED|Double-Blind Period 52 Weeks||173
218574|NCT00294723|519101|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
218575|NCT00294723|519102|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
218576|NCT00294723|519103|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
218577|NCT00294723|519101|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
218578|NCT00294723|519102|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
218579|NCT00294723|519103|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
218580|NCT00294658|519164|P2|NOT COMPLETED|Overall Study||9
218581|NCT00294658|519165|P1|NOT COMPLETED|Overall Study||6
218582|NCT00294658|519164|P2|COMPLETED|Overall Study||51
218583|NCT00294658|519165|P1|COMPLETED|Overall Study||60
218584|NCT00294658|519164|P2|STARTED|Overall Study||60
218585|NCT00294658|519165|P1|STARTED|Overall Study||66
218586|NCT00294645|519229|P2|NOT COMPLETED|Overall Study||92
218587|NCT00294645|519230|P1|NOT COMPLETED|Overall Study||48
218588|NCT00294645|519229|P2|COMPLETED|Overall Study||510
218589|NCT00294645|519230|P1|COMPLETED|Overall Study||247
218590|NCT00294645|519229|P2|STARTED|Overall Study||602
218591|NCT00294645|519230|P1|STARTED|Overall Study||295
218592|NCT00294515|519264|P2|NOT COMPLETED|Overall Study||28
218593|NCT00294515|519265|P1|NOT COMPLETED|Overall Study||34
218594|NCT00294515|519264|P2|COMPLETED|Overall Study||132
218595|NCT00294515|519265|P1|COMPLETED|Overall Study||132
218596|NCT00294515|519264|P2|STARTED|Overall Study|Randomized|160
218597|NCT00294515|519265|P1|STARTED|Overall Study|Randomized|166
218598|NCT00294398|519281|P2|NOT COMPLETED|Overall Study||26
218599|NCT00294398|519282|P1|NOT COMPLETED|Overall Study||21
218600|NCT00294398|519281|P2|COMPLETED|Overall Study||48
218601|NCT00294398|519282|P1|COMPLETED|Overall Study||57
218602|NCT00294398|519281|P2|STARTED|Overall Study||74
218603|NCT00294398|519282|P1|STARTED|Overall Study||78
218604|NCT00294060|519290|P1|NOT COMPLETED|Overall Study||1173
218605|NCT00294060|519290|P1|COMPLETED|Overall Study||840
218606|NCT00294060|519290|P1|STARTED|Overall Study||2013
218607|NCT00294047|519298|P2|NOT COMPLETED|Month 84||989
218608|NCT00294047|519299|P1|NOT COMPLETED|Month 84||973
218609|NCT00294047|519298|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
218610|NCT00294047|519299|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
218611|NCT00294047|519298|P2|STARTED|Month 84||2870
218612|NCT00294047|519299|P1|STARTED|Month 84||2877
218613|NCT00294047|519298|P2|NOT COMPLETED|Month 48||433
218614|NCT00294047|519299|P1|NOT COMPLETED|Month 48||425
218615|NCT00294047|519298|P2|COMPLETED|Month 48||2438
218616|NCT00294047|519299|P1|COMPLETED|Month 48||2456
218617|NCT00294047|519298|P2|Participated up to Month 48|Month 48||2281
218618|NCT00294047|519299|P1|Participated up to Month 48|Month 48||2305
218619|NCT00294047|519298|P2|STARTED|Month 48||2871
218620|NCT00294047|519299|P1|STARTED|Month 48||2881
218621|NCT00293813|519404|P3|NOT COMPLETED|Overall Study||8
218622|NCT00293813|519405|P2|NOT COMPLETED|Overall Study||9
218623|NCT00293813|519406|P1|NOT COMPLETED|Overall Study||13
218624|NCT00293813|519404|P3|COMPLETED|Overall Study||74
218625|NCT00293813|519405|P2|COMPLETED|Overall Study||74
218626|NCT00293813|519406|P1|COMPLETED|Overall Study||69
218627|NCT00293813|519404|P3|STARTED|Overall Study||82
218628|NCT00293813|519405|P2|STARTED|Overall Study||83
218629|NCT00293813|519406|P1|STARTED|Overall Study||82
218630|NCT00293722|519417|P1|NOT COMPLETED|Overall Study||427
218631|NCT00293722|519417|P1|COMPLETED|Overall Study||864
218632|NCT00293722|519417|P1|STARTED|Overall Study||1291
218633|NCT00293709|519431|P1|NOT COMPLETED|Overall Study||47
218634|NCT00293709|519431|P1|COMPLETED|Overall Study||102
218635|NCT00293709|519431|P1|STARTED|Overall Study||149
218636|NCT00293579|519445|P1|NOT COMPLETED|Overall Study||1
218637|NCT00293579|519445|P1|COMPLETED|Overall Study||4
218638|NCT00293579|519445|P1|STARTED|Overall Study||5
218639|NCT00293540|519454|P2|NOT COMPLETED|Overall Study||8
218640|NCT00293540|519455|P1|NOT COMPLETED|Overall Study||7
218641|NCT00293540|519454|P2|COMPLETED|Overall Study||119
218642|NCT00293540|519455|P1|COMPLETED|Overall Study||115
218643|NCT00293540|519454|P2|STARTED|Overall Study||127
218644|NCT00293540|519455|P1|STARTED|Overall Study||122
218645|NCT00293462|519464|P3|NOT COMPLETED|Overall Study||10
218646|NCT00293462|519465|P2|NOT COMPLETED|Overall Study||8
218647|NCT00293462|519466|P1|NOT COMPLETED|Overall Study||7
218648|NCT00293462|519464|P3|COMPLETED|Overall Study||21
218649|NCT00293462|519465|P2|COMPLETED|Overall Study||21
218650|NCT00293462|519466|P1|COMPLETED|Overall Study||24
218651|NCT00293462|519464|P3|STARTED|Overall Study||31
218652|NCT00293462|519465|P2|STARTED|Overall Study||29
218653|NCT00293462|519466|P1|STARTED|Overall Study||31
218654|NCT00293384|519485|P1|NOT COMPLETED|Overall Study||5
218655|NCT00293384|519485|P1|COMPLETED|Overall Study||35
218656|NCT00293384|519485|P1|STARTED|Overall Study||40
218657|NCT00293293|519494|P2|NOT COMPLETED|Overall Study||2
218658|NCT00293293|519495|P1|NOT COMPLETED|Overall Study||2
218659|NCT00293293|519494|P2|COMPLETED|Overall Study||21
218660|NCT00293293|519495|P1|COMPLETED|Overall Study||18
218661|NCT00293293|519494|P2|STARTED|Overall Study||23
218662|NCT00293293|519495|P1|STARTED|Overall Study||20
218663|NCT00293267|519523|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
218664|NCT00293267|519524|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
218665|NCT00293267|519523|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
218666|NCT00293267|519524|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
218667|NCT00293267|519523|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
218668|NCT00293267|519524|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
218669|NCT00293267|519523|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
218670|NCT00293267|519524|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
218671|NCT00293267|519523|P2|COMPLETED|Extension - Open-Label Week 157-240||26
218672|NCT00293267|519524|P1|COMPLETED|Extension - Open-Label Week 157-240||111
218673|NCT00293267|519523|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
218745|NCT00292981|519779|P1|NOT COMPLETED|Overall Study||39
218746|NCT00292981|519779|P1|COMPLETED|Overall Study||18
218674|NCT00293267|519524|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
218675|NCT00293267|519523|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
218676|NCT00293267|519524|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
218677|NCT00293267|519523|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
218678|NCT00293267|519524|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
218679|NCT00293267|519523|P2|STARTED|Extension - Double-Blind Week 49-156||50
218680|NCT00293267|519524|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
218681|NCT00293267|519523|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
218682|NCT00293267|519524|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
218683|NCT00293267|519523|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
218684|NCT00293267|519524|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
218685|NCT00293267|519523|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
218686|NCT00293267|519524|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
218687|NCT00293267|519523|P2|Treated|Primary Study - Double-Blind Week 0-48||118
218688|NCT00293267|519524|P1|Treated|Primary Study - Double-Blind Week 0-48||232
218689|NCT00293267|519523|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
218690|NCT00293267|519524|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
218691|NCT00293254|519564|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
218692|NCT00293254|519565|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
218693|NCT00293254|519564|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
218694|NCT00293254|519565|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
218695|NCT00293254|519564|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
218696|NCT00293254|519565|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
218697|NCT00293254|519564|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
218698|NCT00293254|519565|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
218699|NCT00293254|519564|P2|COMPLETED|Extension - Open-Label Week 157-240||18
218700|NCT00293254|519565|P1|COMPLETED|Extension - Open-Label Week 157-240||110
218701|NCT00293254|519564|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
218702|NCT00293254|519565|P1|STARTED|Extension - Open-Label Week 157-240||120
218703|NCT00293254|519564|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
218704|NCT00293254|519565|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
218705|NCT00293254|519564|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
218706|NCT00293254|519565|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
218707|NCT00293254|519564|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
218708|NCT00293254|519565|P1|STARTED|Extension - Double-Blind Week 49-156||177
218709|NCT00293254|519564|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
218710|NCT00293254|519565|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
218711|NCT00293254|519564|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
218712|NCT00293254|519565|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
218713|NCT00293254|519564|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
218714|NCT00293254|519565|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
218715|NCT00293254|519564|P2|Treated|Primary Study - Double-Blind Week 0-48||119
218716|NCT00293254|519565|P1|Treated|Primary Study - Double-Blind Week 0-48||230
218717|NCT00293254|519564|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
218718|NCT00293254|519565|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
218719|NCT00293241|519605|P2|NOT COMPLETED|Overall Study||41
218720|NCT00293241|519606|P1|NOT COMPLETED|Overall Study||36
218721|NCT00293241|519605|P2|COMPLETED|Overall Study||265
218722|NCT00293241|519606|P1|COMPLETED|Overall Study||263
218723|NCT00293241|519605|P2|STARTED|Overall Study||306
218724|NCT00293241|519606|P1|STARTED|Overall Study||299
218725|NCT00293059|519650|P2|NOT COMPLETED|Overall Study||19
218726|NCT00293059|519651|P1|NOT COMPLETED|Overall Study||35
218727|NCT00293059|519650|P2|COMPLETED|Overall Study||51
218728|NCT00293059|519651|P1|COMPLETED|Overall Study||85
218729|NCT00293059|519650|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
218730|NCT00293059|519651|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
218731|NCT00293059|519650|P2|Cycle 3/Treatment Day 84|Overall Study||55
218732|NCT00293059|519651|P1|Cycle 3/Treatment Day 84|Overall Study||100
218733|NCT00293059|519650|P2|Cycle 1/Treatment Day 28|Overall Study||64
218734|NCT00293059|519651|P1|Cycle 1/Treatment Day 28|Overall Study||115
218735|NCT00293059|519650|P2|Subjects Received Treatment|Overall Study||66
218736|NCT00293059|519651|P1|Subjects Received Treatment|Overall Study||119
218737|NCT00293059|519650|P2|STARTED|Overall Study||70
218738|NCT00293059|519651|P1|STARTED|Overall Study||120
218739|NCT00291876|519763|P1|NOT COMPLETED|Overall Study||0
218740|NCT00291876|519763|P1|COMPLETED|Overall Study||135
218741|NCT00291876|519763|P1|STARTED|Overall Study||135
218742|NCT00293020|519775|P1|NOT COMPLETED|Overall Study||162
218743|NCT00293020|519775|P1|COMPLETED|Overall Study||82
218744|NCT00293020|519775|P1|STARTED|Overall Study||244
218747|NCT00292981|519779|P1|STARTED|Overall Study||57
218748|NCT00292591|519789|P3|NOT COMPLETED|Overall Study||58
218749|NCT00292591|519790|P2|NOT COMPLETED|Overall Study||56
218750|NCT00292591|519791|P1|NOT COMPLETED|Overall Study||64
218751|NCT00292591|519789|P3|COMPLETED|Overall Study||110
218752|NCT00292591|519790|P2|COMPLETED|Overall Study||111
218753|NCT00292591|519791|P1|COMPLETED|Overall Study||102
218754|NCT00292591|519789|P3|STARTED|Overall Study||168
218755|NCT00292591|519790|P2|STARTED|Overall Study||167
218756|NCT00292591|519791|P1|STARTED|Overall Study||166
218757|NCT00292461|519801|P2|NOT COMPLETED|Overall Study||6
218758|NCT00292461|519802|P1|NOT COMPLETED|Overall Study||10
218759|NCT00292461|519801|P2|COMPLETED|Overall Study||24
218760|NCT00292461|519802|P1|COMPLETED|Overall Study||24
218761|NCT00292461|519801|P2|STARTED|Overall Study||30
218762|NCT00292461|519802|P1|STARTED|Overall Study||34
218763|NCT00292370|519817|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
218764|NCT00292370|519818|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
218765|NCT00292370|519819|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
218766|NCT00292370|519817|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
218767|NCT00292370|519818|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
218768|NCT00292370|519819|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
218769|NCT00292370|519817|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
218770|NCT00292370|519818|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
218771|NCT00292370|519819|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
218772|NCT00292370|519817|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
218773|NCT00292370|519818|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
218774|NCT00292370|519819|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
218775|NCT00292370|519817|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
218776|NCT00292370|519818|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
218777|NCT00292370|519819|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
218778|NCT00292370|519817|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
218779|NCT00292370|519818|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
218780|NCT00292370|519819|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
218781|NCT00292318|519828|P2|NOT COMPLETED|Overall Study||1
218782|NCT00292318|519829|P1|NOT COMPLETED|Overall Study||2
218783|NCT00292318|519828|P2|COMPLETED|Overall Study||2
218784|NCT00292318|519829|P1|COMPLETED|Overall Study||2
218785|NCT00292318|519828|P2|STARTED|Overall Study||3
218786|NCT00292318|519829|P1|STARTED|Overall Study||4
218787|NCT00292227|519839|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
218788|NCT00292227|519840|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
218789|NCT00292227|519841|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
218790|NCT00292227|519839|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
218791|NCT00292227|519840|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
218792|NCT00292227|519841|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
218793|NCT00292227|519839|P3|STARTED|Cross-over Period 2 (Day 39)||30
218794|NCT00292227|519840|P2|STARTED|Cross-over Period 2 (Day 39)||31
218795|NCT00292227|519841|P1|STARTED|Cross-over Period 2 (Day 39)||65
218796|NCT00292227|519839|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
218797|NCT00292227|519840|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
218798|NCT00292227|519841|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
218799|NCT00292227|519839|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
218800|NCT00292227|519840|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
218801|NCT00292227|519841|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
218802|NCT00292227|519839|P3|STARTED|Cross-over Period 1 (Day 32)||30
218803|NCT00292227|519840|P2|STARTED|Cross-over Period 1 (Day 32)||31
218804|NCT00292227|519841|P1|STARTED|Cross-over Period 1 (Day 32)||65
218805|NCT00292227|519839|P3|NOT COMPLETED|Patch Period||3
218806|NCT00292227|519840|P2|NOT COMPLETED|Patch Period||0
218807|NCT00292227|519841|P1|NOT COMPLETED|Patch Period||1
218808|NCT00292227|519839|P3|COMPLETED|Patch Period||30
218809|NCT00292227|519840|P2|COMPLETED|Patch Period||31
218810|NCT00292227|519841|P1|COMPLETED|Patch Period||65
218811|NCT00292227|519839|P3|STARTED|Patch Period||33
218812|NCT00292227|519840|P2|STARTED|Patch Period||31
218813|NCT00292227|519841|P1|STARTED|Patch Period||66
218814|NCT00292188|519923|P3|NOT COMPLETED|Double-Blind||29
218815|NCT00292188|519924|P2|NOT COMPLETED|Double-Blind||31
218816|NCT00292188|519925|P1|NOT COMPLETED|Double-Blind||0
218817|NCT00292188|519923|P3|COMPLETED|Double-Blind||98
218818|NCT00292188|519924|P2|COMPLETED|Double-Blind||96
218819|NCT00292188|519925|P1|COMPLETED|Double-Blind||0
218820|NCT00292188|519923|P3|STARTED|Double-Blind||127
218821|NCT00292188|519924|P2|STARTED|Double-Blind||127
218822|NCT00292188|519925|P1|STARTED|Double-Blind||0
218823|NCT00292188|519923|P3|NOT COMPLETED|Single-Blind||0
218824|NCT00292188|519924|P2|NOT COMPLETED|Single-Blind||0
218825|NCT00292188|519925|P1|NOT COMPLETED|Single-Blind||114
218826|NCT00292188|519923|P3|COMPLETED|Single-Blind||0
218827|NCT00292188|519924|P2|COMPLETED|Single-Blind||0
218828|NCT00292188|519925|P1|COMPLETED|Single-Blind||254
218829|NCT00292188|519923|P3|Received Treatment|Single-Blind||0
218830|NCT00292188|519924|P2|Received Treatment|Single-Blind||0
218831|NCT00292188|519925|P1|Received Treatment|Single-Blind||367
218832|NCT00292188|519923|P3|STARTED|Single-Blind||0
218833|NCT00292188|519924|P2|STARTED|Single-Blind||0
218834|NCT00292188|519925|P1|STARTED|Single-Blind||368
218835|NCT00292162|519986|P2|NOT COMPLETED|Overall Study||2
218836|NCT00292162|519987|P1|NOT COMPLETED|Overall Study||1
218837|NCT00292162|519986|P2|COMPLETED|Overall Study||20
218838|NCT00292162|519987|P1|COMPLETED|Overall Study||18
218839|NCT00292162|519986|P2|STARTED|Overall Study||22
218840|NCT00292162|519987|P1|STARTED|Overall Study||19
218841|NCT00291694|520005|P2|NOT COMPLETED|Overall Study||5
218842|NCT00291694|520006|P1|NOT COMPLETED|Overall Study||3
218843|NCT00291694|520005|P2|COMPLETED|Overall Study||43
218844|NCT00291694|520006|P1|COMPLETED|Overall Study||21
218845|NCT00291694|520005|P2|STARTED|Overall Study||48
218846|NCT00291694|520006|P1|STARTED|Overall Study||24
218847|NCT00291655|520020|P1|NOT COMPLETED|Overall Study||15
218848|NCT00291655|520020|P1|COMPLETED|Overall Study||115
218849|NCT00291655|520020|P1|STARTED|Overall Study||130
218850|NCT00291577|520025|P1|NOT COMPLETED|Overall Study||21
218851|NCT00291577|520025|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
218852|NCT00291577|520025|P1|STARTED|Overall Study||22
218853|NCT00291551|520044|P1|NOT COMPLETED|Overall Study||13
218854|NCT00291551|520044|P1|COMPLETED|Overall Study||26
218855|NCT00291551|520044|P1|STARTED|Overall Study||39
218856|NCT00291330|520061|P2|NOT COMPLETED|Overall Study||97
218857|NCT00291330|520062|P1|NOT COMPLETED|Overall Study||101
218858|NCT00291330|520061|P2|COMPLETED|Overall Study|Completed planned observation time|1169
218859|NCT00291330|520062|P1|COMPLETED|Overall Study|Completed planned observation time|1172
218860|NCT00291330|520061|P2|STARTED|Overall Study|Started Treatment|1266
218861|NCT00291330|520062|P1|STARTED|Overall Study|Started Treatment|1273
218862|NCT00291317|520084|P1|NOT COMPLETED|Overall Study||0
218863|NCT00291317|520084|P1|COMPLETED|Overall Study||6
218864|NCT00291317|520084|P1|STARTED|Overall Study||6
218865|NCT00291226|520091|P2|NOT COMPLETED|Overall Study||1
218866|NCT00291226|520092|P1|NOT COMPLETED|Overall Study||1
218867|NCT00291226|520091|P2|COMPLETED|Overall Study||3
218868|NCT00291226|520092|P1|COMPLETED|Overall Study||3
218869|NCT00291226|520091|P2|STARTED|Overall Study||4
218870|NCT00291226|520092|P1|STARTED|Overall Study||4
218871|NCT00291187|520104|P4|NOT COMPLETED|Overall Study||0
218872|NCT00291187|520105|P3|NOT COMPLETED|Overall Study||1
218873|NCT00291187|520106|P2|NOT COMPLETED|Overall Study||0
218874|NCT00291187|520107|P1|NOT COMPLETED|Overall Study||0
218875|NCT00291187|520104|P4|COMPLETED|Overall Study||106
218876|NCT00291187|520105|P3|COMPLETED|Overall Study||102
218877|NCT00291187|520106|P2|COMPLETED|Overall Study||100
218878|NCT00291187|520107|P1|COMPLETED|Overall Study||103
218879|NCT00291187|520104|P4|STARTED|Overall Study||106
218880|NCT00291187|520105|P3|STARTED|Overall Study||103
218881|NCT00291187|520106|P2|STARTED|Overall Study||100
218882|NCT00291187|520107|P1|STARTED|Overall Study||103
218883|NCT00291161|520133|P4|NOT COMPLETED|Overall Study||65
218884|NCT00291161|520134|P3|NOT COMPLETED|Overall Study||93
218885|NCT00291161|520135|P2|NOT COMPLETED|Overall Study||58
218886|NCT00291161|520136|P1|NOT COMPLETED|Overall Study||81
218887|NCT00291161|520133|P4|COMPLETED|Overall Study||122
218888|NCT00291161|520134|P3|COMPLETED|Overall Study||206
218889|NCT00291161|520135|P2|COMPLETED|Overall Study||134
218890|NCT00291161|520136|P1|COMPLETED|Overall Study||235
218891|NCT00291161|520133|P4|STARTED|Overall Study||187
218892|NCT00291161|520134|P3|STARTED|Overall Study||299
218893|NCT00291161|520135|P2|STARTED|Overall Study||192
218894|NCT00291161|520136|P1|STARTED|Overall Study||316
218895|NCT00291135|520144|P1|NOT COMPLETED|Overall Study||0
218896|NCT00291135|520144|P1|COMPLETED|Overall Study||42
218897|NCT00291135|520144|P1|STARTED|Overall Study||42
218898|NCT00289848|520150|P2|NOT COMPLETED|Overall Study||45
218899|NCT00289848|520151|P1|NOT COMPLETED|Overall Study||46
218900|NCT00289848|520150|P2|COMPLETED|Overall Study||133
218901|NCT00289848|520151|P1|COMPLETED|Overall Study||306
218902|NCT00289848|520150|P2|STARTED|Overall Study||178
218903|NCT00289848|520151|P1|STARTED|Overall Study||352
218904|NCT00289783|520163|P2|NOT COMPLETED|Fourth Dose Phase||24
218905|NCT00289783|520164|P1|NOT COMPLETED|Fourth Dose Phase||87
218906|NCT00289783|520163|P2|COMPLETED|Fourth Dose Phase||899
218907|NCT00289783|520164|P1|COMPLETED|Fourth Dose Phase||2682
218908|NCT00289783|520163|P2|STARTED|Fourth Dose Phase||923
218909|NCT00289783|520164|P1|STARTED|Fourth Dose Phase||2769
218910|NCT00289783|520163|P2|NOT COMPLETED|Primary Phase||83
218911|NCT00289783|520164|P1|NOT COMPLETED|Primary Phase||248
218912|NCT00289783|520163|P2|COMPLETED|Primary Phase||961
218913|NCT00289783|520164|P1|COMPLETED|Primary Phase||2888
218914|NCT00289783|520163|P2|STARTED|Primary Phase||1044
218915|NCT00289783|520164|P1|STARTED|Primary Phase||3136
218916|NCT00289770|520342|P1|NOT COMPLETED|Year 15||1
218917|NCT00289770|520342|P1|COMPLETED|Year 15||49
218918|NCT00289770|520342|P1|STARTED|Year 15||50
218919|NCT00289770|520342|P1|NOT COMPLETED|Year 14||0
218920|NCT00289770|520342|P1|COMPLETED|Year 14||43
218921|NCT00289770|520342|P1|STARTED|Year 14||43
218922|NCT00289770|520342|P1|NOT COMPLETED|Year 13||0
218923|NCT00289770|520342|P1|COMPLETED|Year 13||37
218924|NCT00289770|520342|P1|STARTED|Year 13||37
218925|NCT00289770|520342|P1|NOT COMPLETED|Year 12||0
218926|NCT00289770|520342|P1|COMPLETED|Year 12||40
218927|NCT00289770|520342|P1|STARTED|Year 12||40
218928|NCT00289770|520342|P1|NOT COMPLETED|Year 11||0
218929|NCT00289770|520342|P1|COMPLETED|Year 11||37
218930|NCT00289770|520342|P1|STARTED|Year 11||37
218931|NCT00289757|520354|P1|NOT COMPLETED|Overall Study||0
218932|NCT00289757|520354|P1|COMPLETED|Overall Study||78
218933|NCT00289757|520354|P1|STARTED|Overall Study||78
218934|NCT00289744|520365|P3|NOT COMPLETED|Additional Dose Phase||0
218935|NCT00289744|520366|P2|NOT COMPLETED|Additional Dose Phase||0
218936|NCT00289744|520367|P1|NOT COMPLETED|Additional Dose Phase||0
218937|NCT00289744|520365|P3|COMPLETED|Additional Dose Phase||6
218938|NCT00289744|520366|P2|COMPLETED|Additional Dose Phase||19
218939|NCT00289744|520367|P1|COMPLETED|Additional Dose Phase||0
218940|NCT00289744|520365|P3|STARTED|Additional Dose Phase||6
218941|NCT00289744|520366|P2|STARTED|Additional Dose Phase||19
218942|NCT00289744|520367|P1|STARTED|Additional Dose Phase||0
218943|NCT00289744|520365|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
218944|NCT00289744|520366|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
218945|NCT00289744|520367|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
218946|NCT00289744|520365|P3|COMPLETED|Year 10 Long-term Follow-up||0
218947|NCT00289744|520366|P2|COMPLETED|Year 10 Long-term Follow-up||0
218948|NCT00289744|520367|P1|COMPLETED|Year 10 Long-term Follow-up||171
218949|NCT00289744|520365|P3|STARTED|Year 10 Long-term Follow-up||0
218950|NCT00289744|520366|P2|STARTED|Year 10 Long-term Follow-up||0
218951|NCT00289744|520367|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
218952|NCT00289744|520365|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
218953|NCT00289744|520366|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
218954|NCT00289744|520367|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
218955|NCT00289744|520365|P3|COMPLETED|Year 9 Long-term Follow-up||0
218956|NCT00289744|520366|P2|COMPLETED|Year 9 Long-term Follow-up||0
218957|NCT00289744|520367|P1|COMPLETED|Year 9 Long-term Follow-up||173
218958|NCT00289744|520365|P3|STARTED|Year 9 Long-term Follow-up||0
218959|NCT00289744|520366|P2|STARTED|Year 9 Long-term Follow-up||0
218960|NCT00289744|520367|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
218961|NCT00289744|520365|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
218962|NCT00289744|520366|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
218963|NCT00289744|520367|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
218964|NCT00289744|520365|P3|COMPLETED|Year 8 Long-term Follow-up||0
218965|NCT00289744|520366|P2|COMPLETED|Year 8 Long-term Follow-up||0
218966|NCT00289744|520367|P1|COMPLETED|Year 8 Long-term Follow-up||174
218967|NCT00289744|520365|P3|STARTED|Year 8 Long-term Follow-up||0
218968|NCT00289744|520366|P2|STARTED|Year 8 Long-term Follow-up||0
218969|NCT00289744|520367|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
218970|NCT00289744|520365|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
218971|NCT00289744|520366|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
218972|NCT00289744|520367|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
218973|NCT00289744|520365|P3|COMPLETED|Year 7 Long-term Follow-up||0
218974|NCT00289744|520366|P2|COMPLETED|Year 7 Long-term Follow-up||0
218975|NCT00289744|520367|P1|COMPLETED|Year 7 Long-term Follow-up||175
218976|NCT00289744|520365|P3|STARTED|Year 7 Long-term Follow-up||0
218977|NCT00289744|520366|P2|STARTED|Year 7 Long-term Follow-up||0
218978|NCT00289744|520367|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
218979|NCT00289744|520365|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
218980|NCT00289744|520366|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
218981|NCT00289744|520367|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
218982|NCT00289744|520365|P3|COMPLETED|Year 6 Long-term Follow-up||0
218983|NCT00289744|520366|P2|COMPLETED|Year 6 Long-term Follow-up||0
218984|NCT00289744|520367|P1|COMPLETED|Year 6 Long-term Follow-up||178
218985|NCT00289744|520365|P3|STARTED|Year 6 Long-term Follow-up||0
218986|NCT00289744|520366|P2|STARTED|Year 6 Long-term Follow-up||0
218987|NCT00289744|520367|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
218988|NCT00289718|520385|P1|NOT COMPLETED|Overall Study||0
218989|NCT00289718|520385|P1|COMPLETED|Overall Study||51
218990|NCT00289718|520385|P1|STARTED|Overall Study||51
218991|NCT00290888|520399|P2|NOT COMPLETED|Overall Study||1
218992|NCT00290888|520400|P1|NOT COMPLETED|Overall Study||3
218993|NCT00290888|520399|P2|COMPLETED|Overall Study||44
218994|NCT00290888|520400|P1|COMPLETED|Overall Study||38
218995|NCT00290888|520399|P2|STARTED|Overall Study||45
218996|NCT00290888|520400|P1|STARTED|Overall Study||41
218997|NCT00290810|520408|P1|NOT COMPLETED|Overall Study||0
218998|NCT00290810|520408|P1|COMPLETED|Overall Study||12
218999|NCT00290810|520408|P1|STARTED|Overall Study||12
219000|NCT00290771|520417|P2|NOT COMPLETED|Overall Study||97
219001|NCT00290771|520418|P1|NOT COMPLETED|Overall Study||127
219002|NCT00290771|520417|P2|COMPLETED|Overall Study||3
219003|NCT00290771|520418|P1|COMPLETED|Overall Study||4
219004|NCT00290771|520417|P2|STARTED|Overall Study||100
219005|NCT00290771|520418|P1|STARTED|Overall Study||131
219006|NCT00290758|520442|P2|NOT COMPLETED|Post Intervention rFNA||5
219007|NCT00290758|520443|P1|NOT COMPLETED|Post Intervention rFNA||6
219008|NCT00290758|520442|P2|COMPLETED|Post Intervention rFNA||49
219009|NCT00290758|520443|P1|COMPLETED|Post Intervention rFNA||49
219010|NCT00290758|520442|P2|STARTED|Post Intervention rFNA||54
219011|NCT00290758|520443|P1|STARTED|Post Intervention rFNA||55
219012|NCT00290758|520442|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
219013|NCT00290758|520443|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
219014|NCT00290758|520442|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
219015|NCT00290758|520443|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
219016|NCT00290758|520442|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
219017|NCT00290758|520443|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
219018|NCT00290758|520442|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
219019|NCT00290758|520443|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
219020|NCT00290758|520442|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
219021|NCT00290758|520443|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
219022|NCT00290758|520442|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
219023|NCT00290758|520443|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
219024|NCT00290758|520442|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
219025|NCT00290758|520443|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
219026|NCT00290732|520465|P5|NOT COMPLETED|Overall Study||0
219027|NCT00290732|520466|P4|NOT COMPLETED|Overall Study||0
219028|NCT00290732|520467|P3|NOT COMPLETED|Overall Study||1
219029|NCT00290732|520468|P2|NOT COMPLETED|Overall Study||1
219030|NCT00290732|520469|P1|NOT COMPLETED|Overall Study||0
219031|NCT00290732|520465|P5|COMPLETED|Overall Study||3
219032|NCT00290732|520466|P4|COMPLETED|Overall Study||6
219033|NCT00290732|520467|P3|COMPLETED|Overall Study||3
219034|NCT00290732|520468|P2|COMPLETED|Overall Study||3
219035|NCT00290732|520469|P1|COMPLETED|Overall Study||3
219036|NCT00290732|520465|P5|STARTED|Overall Study||3
219037|NCT00290732|520466|P4|STARTED|Overall Study||6
219038|NCT00290732|520467|P3|STARTED|Overall Study||4
219039|NCT00290732|520468|P2|STARTED|Overall Study||4
219040|NCT00290732|520469|P1|STARTED|Overall Study||3
219041|NCT00290693|520487|P1|NOT COMPLETED|Overall Study||0
219042|NCT00290693|520487|P1|COMPLETED|Overall Study||24
219043|NCT00290693|520487|P1|STARTED|Overall Study||24
219044|NCT00290654|520492|P1|NOT COMPLETED|Overall Study||0
219045|NCT00290654|520492|P1|COMPLETED|Overall Study||41
219046|NCT00290654|520492|P1|STARTED|Overall Study||41
219047|NCT00290615|520503|P1|NOT COMPLETED|Overall Study||0
219048|NCT00290615|520503|P1|COMPLETED|Overall Study||30
219049|NCT00290615|520503|P1|STARTED|Overall Study||30
219050|NCT00290537|520510|P2|NOT COMPLETED|Overall Study||0
219051|NCT00290537|520511|P1|NOT COMPLETED|Overall Study||0
219052|NCT00290537|520510|P2|COMPLETED|Overall Study||0
219053|NCT00290537|520511|P1|COMPLETED|Overall Study||4
219054|NCT00290537|520510|P2|STARTED|Overall Study||0
219055|NCT00290537|520511|P1|STARTED|Overall Study||4
219056|NCT00290472|520519|P3|NOT COMPLETED|Overall Study||0
219057|NCT00290472|520520|P2|NOT COMPLETED|Overall Study||0
219058|NCT00290472|520521|P1|NOT COMPLETED|Overall Study||0
219059|NCT00290472|520519|P3|COMPLETED|Overall Study||18
219060|NCT00290472|520520|P2|COMPLETED|Overall Study||39
219061|NCT00290472|520521|P1|COMPLETED|Overall Study||32
219062|NCT00290472|520519|P3|STARTED|Overall Study||18
219063|NCT00290472|520520|P2|STARTED|Overall Study||39
219064|NCT00290472|520521|P1|STARTED|Overall Study||32
219065|NCT00290407|520533|P1|NOT COMPLETED|Overall Study||0
219066|NCT00290407|520533|P1|COMPLETED|Overall Study||2
219067|NCT00290407|520533|P1|STARTED|Overall Study||2
219068|NCT00290290|520539|P2|NOT COMPLETED|Overall Study||18
219069|NCT00290290|520540|P1|NOT COMPLETED|Overall Study||18
219070|NCT00290290|520539|P2|COMPLETED|Overall Study||391
219071|NCT00290290|520540|P1|COMPLETED|Overall Study||422
219072|NCT00290290|520539|P2|STARTED|Overall Study||409
219073|NCT00290290|520540|P1|STARTED|Overall Study||440
219074|NCT00290251|520546|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
219075|NCT00290251|520547|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
219076|NCT00290251|520548|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
219077|NCT00290251|520546|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
219078|NCT00290251|520547|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
219079|NCT00290251|520548|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
219080|NCT00290251|520546|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
219081|NCT00290251|520547|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
219082|NCT00290251|520548|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
219083|NCT00290251|520546|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
219084|NCT00290251|520547|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
219085|NCT00290251|520548|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
219086|NCT00290251|520546|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
219087|NCT00290251|520547|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
219088|NCT00290251|520548|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
219089|NCT00290251|520546|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
219090|NCT00290251|520547|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
219172|NCT00289913|520677|P2|STARTED|Visit 3 (Stage I and Stage II)||114
219091|NCT00290251|520548|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
219092|NCT00290251|520546|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
219093|NCT00290251|520547|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
219094|NCT00290251|520548|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
219095|NCT00290251|520546|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
219096|NCT00290251|520547|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
219097|NCT00290251|520548|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
219098|NCT00290251|520546|P3|STARTED|Treatment 1 (Months 1 - 3)||14
219099|NCT00290251|520547|P2|STARTED|Treatment 1 (Months 1 - 3)||14
219100|NCT00290251|520548|P1|STARTED|Treatment 1 (Months 1 - 3)||14
219101|NCT00290238|520560|P2|NOT COMPLETED|Overall Study||41
219102|NCT00290238|520561|P1|NOT COMPLETED|Overall Study||42
219103|NCT00290238|520560|P2|COMPLETED|Overall Study||24
219104|NCT00290238|520561|P1|COMPLETED|Overall Study||15
219105|NCT00290238|520560|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
219106|NCT00290238|520561|P1|STARTED|Overall Study||57
219107|NCT00290199|520571|P2|NOT COMPLETED|Overall Study||0
219108|NCT00290199|520572|P1|NOT COMPLETED|Overall Study||0
219109|NCT00290199|520571|P2|COMPLETED|Overall Study||82
219110|NCT00290199|520572|P1|COMPLETED|Overall Study||87
219111|NCT00290199|520571|P2|STARTED|Overall Study||82
219112|NCT00290199|520572|P1|STARTED|Overall Study||87
219113|NCT00290186|520586|P2|NOT COMPLETED|Overall Study||5
219114|NCT00290186|520587|P1|NOT COMPLETED|Overall Study||5
219115|NCT00290186|520586|P2|COMPLETED|Overall Study||19
219116|NCT00290186|520587|P1|COMPLETED|Overall Study||20
219117|NCT00290186|520586|P2|Completed 6-month Followup Assessments|Overall Study||19
219118|NCT00290186|520587|P1|Completed 6-month Followup Assessments|Overall Study||20
219119|NCT00290186|520586|P2|Completed 3-month Followup Assessments|Overall Study||21
219120|NCT00290186|520587|P1|Completed 3-month Followup Assessments|Overall Study||20
219121|NCT00290186|520586|P2|Completed Post-treatment Assessments|Overall Study||22
219122|NCT00290186|520587|P1|Completed Post-treatment Assessments|Overall Study||24
219123|NCT00290186|520586|P2|Completed 8 Weeks of Treatment|Overall Study||22
219124|NCT00290186|520587|P1|Completed 8 Weeks of Treatment|Overall Study||24
219125|NCT00290186|520586|P2|Completed Baseline Assessments|Overall Study||24
219126|NCT00290186|520587|P1|Completed Baseline Assessments|Overall Study||25
219127|NCT00290186|520586|P2|STARTED|Overall Study||24
219128|NCT00290186|520587|P1|STARTED|Overall Study||25
219129|NCT00289991|520627|P2|NOT COMPLETED|Overall Study||80
219130|NCT00289991|520628|P1|NOT COMPLETED|Overall Study||58
219131|NCT00289991|520627|P2|COMPLETED|Overall Study||175
219132|NCT00289991|520628|P1|COMPLETED|Overall Study||176
219133|NCT00289991|520627|P2|STARTED|Overall Study||255
219134|NCT00289991|520628|P1|STARTED|Overall Study||234
219135|NCT00289978|520653|P3|NOT COMPLETED|Overall Study||86
219136|NCT00289978|520654|P2|NOT COMPLETED|Overall Study||56
219137|NCT00289978|520655|P1|NOT COMPLETED|Overall Study||97
219138|NCT00289978|520653|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
219139|NCT00289978|520654|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
219140|NCT00289978|520655|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
219141|NCT00289978|520653|P3|STARTED|Overall Study||418
219142|NCT00289978|520654|P2|STARTED|Overall Study||425
219143|NCT00289978|520655|P1|STARTED|Overall Study||429
219144|NCT00289913|520674|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
219145|NCT00289913|520675|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
219146|NCT00289913|520676|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
219147|NCT00289913|520677|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
219148|NCT00289913|520678|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
219149|NCT00289913|520674|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
219150|NCT00289913|520675|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
219151|NCT00289913|520676|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
219152|NCT00289913|520677|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
219153|NCT00289913|520678|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
219154|NCT00289913|520674|P5|STARTED|Visit 4 (Stage I and Stage II)||597
219155|NCT00289913|520675|P4|STARTED|Visit 4 (Stage I and Stage II)||131
219156|NCT00289913|520676|P3|STARTED|Visit 4 (Stage I and Stage II)||138
219157|NCT00289913|520677|P2|STARTED|Visit 4 (Stage I and Stage II)||106
219158|NCT00289913|520678|P1|STARTED|Visit 4 (Stage I and Stage II)||122
219159|NCT00289913|520674|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
219160|NCT00289913|520675|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
219161|NCT00289913|520676|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
219162|NCT00289913|520677|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
219163|NCT00289913|520678|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
219164|NCT00289913|520674|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
219165|NCT00289913|520675|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
219166|NCT00289913|520676|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
219167|NCT00289913|520677|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
219168|NCT00289913|520678|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
219169|NCT00289913|520674|P5|STARTED|Visit 3 (Stage I and Stage II)||605
219170|NCT00289913|520675|P4|STARTED|Visit 3 (Stage I and Stage II)||135
219171|NCT00289913|520676|P3|STARTED|Visit 3 (Stage I and Stage II)||140
219173|NCT00289913|520678|P1|STARTED|Visit 3 (Stage I and Stage II)||131
219174|NCT00289913|520674|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
219175|NCT00289913|520675|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
219176|NCT00289913|520676|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
219177|NCT00289913|520677|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
219178|NCT00289913|520678|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
219179|NCT00289913|520674|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
219180|NCT00289913|520675|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
219181|NCT00289913|520676|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
219182|NCT00289913|520677|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
219183|NCT00289913|520678|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
219184|NCT00289913|520674|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
219185|NCT00289913|520675|P4|STARTED|Visit 2 (Stage I and Stage II)||141
219186|NCT00289913|520676|P3|STARTED|Visit 2 (Stage I and Stage II)||150
219187|NCT00289913|520677|P2|STARTED|Visit 2 (Stage I and Stage II)||135
219188|NCT00289913|520678|P1|STARTED|Visit 2 (Stage I and Stage II)||146
219189|NCT00289913|520674|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
219190|NCT00289913|520675|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
219191|NCT00289913|520676|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
219192|NCT00289913|520677|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
219193|NCT00289913|520678|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
219194|NCT00289913|520674|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
219195|NCT00289913|520675|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
219196|NCT00289913|520676|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
219197|NCT00289913|520677|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
219198|NCT00289913|520678|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
219199|NCT00289913|520674|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
219200|NCT00289913|520675|P4|STARTED|Visit 1 (Stage I and Stage II)||152
219201|NCT00289913|520676|P3|STARTED|Visit 1 (Stage I and Stage II)||159
219202|NCT00289913|520677|P2|STARTED|Visit 1 (Stage I and Stage II)||151
219203|NCT00289913|520678|P1|STARTED|Visit 1 (Stage I and Stage II)||155
219204|NCT00289900|520709|P6|NOT COMPLETED|Overall Study||61
219205|NCT00289900|520710|P5|NOT COMPLETED|Overall Study||45
219206|NCT00289900|520711|P4|NOT COMPLETED|Overall Study||59
219207|NCT00289900|520712|P3|NOT COMPLETED|Overall Study||33
219208|NCT00289900|520713|P2|NOT COMPLETED|Overall Study||120
219209|NCT00289900|520714|P1|NOT COMPLETED|Overall Study||68
219210|NCT00289900|520709|P6|COMPLETED|Overall Study||372
219211|NCT00289900|520710|P5|COMPLETED|Overall Study||392
219212|NCT00289900|520711|P4|COMPLETED|Overall Study||380
219213|NCT00289900|520712|P3|COMPLETED|Overall Study||265
219214|NCT00289900|520713|P2|COMPLETED|Overall Study||316
219215|NCT00289900|520714|P1|COMPLETED|Overall Study||229
219216|NCT00289900|520709|P6|Treated|Overall Study||433
219217|NCT00289900|520710|P5|Treated|Overall Study||437
219218|NCT00289900|520711|P4|Treated|Overall Study||439
219219|NCT00289900|520712|P3|Treated|Overall Study||298
219220|NCT00289900|520713|P2|Treated|Overall Study||435
219221|NCT00289900|520714|P1|Treated|Overall Study||297
219222|NCT00289900|520709|P6|STARTED|Overall Study||433
219223|NCT00289900|520710|P5|STARTED|Overall Study||437
219224|NCT00289900|520711|P4|STARTED|Overall Study||439
219225|NCT00289900|520712|P3|STARTED|Overall Study||298
219226|NCT00289900|520713|P2|STARTED|Overall Study||436
219227|NCT00289900|520714|P1|STARTED|Overall Study||297
219228|NCT00289887|520818|P2|NOT COMPLETED|Overall Study||29
219229|NCT00289887|520819|P1|NOT COMPLETED|Overall Study||22
219230|NCT00289887|520818|P2|COMPLETED|Overall Study||105
219231|NCT00289887|520819|P1|COMPLETED|Overall Study||105
219232|NCT00289887|520818|P2|STARTED|Overall Study||134
219233|NCT00289887|520819|P1|STARTED|Overall Study||127
219234|NCT00289874|520837|P2|NOT COMPLETED|Overall Study||8
219235|NCT00289874|520838|P1|NOT COMPLETED|Overall Study||6
219236|NCT00289874|520837|P2|COMPLETED|Overall Study||210
219237|NCT00289874|520838|P1|COMPLETED|Overall Study||197
219238|NCT00289874|520837|P2|STARTED|Overall Study||218
219239|NCT00289874|520838|P1|STARTED|Overall Study||203
219240|NCT00289536|520846|P3|NOT COMPLETED|Period 3||1
219241|NCT00289536|520847|P2|NOT COMPLETED|Period 3||0
219242|NCT00289536|520848|P1|NOT COMPLETED|Period 3||0
219243|NCT00289536|520846|P3|COMPLETED|Period 3||9
219244|NCT00289536|520847|P2|COMPLETED|Period 3||9
219245|NCT00289536|520848|P1|COMPLETED|Period 3||7
219246|NCT00289536|520846|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
219247|NCT00289536|520847|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
219248|NCT00289536|520848|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
219249|NCT00289536|520846|P3|NOT COMPLETED|Period 2||0
219250|NCT00289536|520847|P2|NOT COMPLETED|Period 2||0
219251|NCT00289536|520848|P1|NOT COMPLETED|Period 2||0
219252|NCT00289536|520846|P3|COMPLETED|Period 2||7
219253|NCT00289536|520847|P2|COMPLETED|Period 2||9
219254|NCT00289536|520848|P1|COMPLETED|Period 2||10
219255|NCT00289536|520846|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
219256|NCT00289536|520847|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
219257|NCT00289536|520848|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
219258|NCT00289536|520846|P3|NOT COMPLETED|Period 1||0
219259|NCT00289536|520847|P2|NOT COMPLETED|Period 1||0
219260|NCT00289536|520848|P1|NOT COMPLETED|Period 1||0
219261|NCT00289536|520846|P3|COMPLETED|Period 1||9
219262|NCT00289536|520847|P2|COMPLETED|Period 1||8
219263|NCT00289536|520848|P1|COMPLETED|Period 1||9
219264|NCT00289536|520846|P3|STARTED|Period 1||9
219265|NCT00289536|520847|P2|STARTED|Period 1||8
219266|NCT00289536|520848|P1|STARTED|Period 1||9
219267|NCT00289471|520887|P1|NOT COMPLETED|Overall Study||0
219268|NCT00289471|520887|P1|COMPLETED|Overall Study||630
219269|NCT00289471|520887|P1|STARTED|Overall Study||630
219270|NCT00289458|520894|P3|NOT COMPLETED|Overall Study||6
219271|NCT00289458|520895|P2|NOT COMPLETED|Overall Study||6
219272|NCT00289458|520896|P1|NOT COMPLETED|Overall Study||6
219273|NCT00289458|520894|P3|COMPLETED|Overall Study||22
219274|NCT00289458|520895|P2|COMPLETED|Overall Study||20
219275|NCT00289458|520896|P1|COMPLETED|Overall Study||19
219276|NCT00289458|520894|P3|STARTED|Overall Study||28
219277|NCT00289458|520895|P2|STARTED|Overall Study||26
219278|NCT00289458|520896|P1|STARTED|Overall Study||25
219279|NCT00289341|520921|P2|NOT COMPLETED|Overall Study||0
219280|NCT00289341|520922|P1|NOT COMPLETED|Overall Study||0
219281|NCT00289341|520921|P2|COMPLETED|Overall Study||12
219282|NCT00289341|520922|P1|COMPLETED|Overall Study||12
219283|NCT00289341|520921|P2|STARTED|Overall Study||12
219284|NCT00289341|520922|P1|STARTED|Overall Study||12
219285|NCT00289289|520935|P3|NOT COMPLETED|Overall Study||49
219286|NCT00289289|520936|P2|NOT COMPLETED|Overall Study||10
219287|NCT00289289|520937|P1|NOT COMPLETED|Overall Study||19
219288|NCT00289289|520935|P3|COMPLETED|Overall Study||95
219289|NCT00289289|520936|P2|COMPLETED|Overall Study||114
219290|NCT00289289|520937|P1|COMPLETED|Overall Study||113
219291|NCT00289289|520935|P3|STARTED|Overall Study||144
219292|NCT00289289|520936|P2|STARTED|Overall Study||124
219293|NCT00289289|520937|P1|STARTED|Overall Study||132
219294|NCT00289276|520952|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
219295|NCT00289276|520953|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
219296|NCT00289276|520952|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
219297|NCT00289276|520953|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
219298|NCT00289276|520952|P2|STARTED|Second Part of FAST Study (Expansion)||109
219299|NCT00289276|520953|P1|STARTED|Second Part of FAST Study (Expansion)||0
219300|NCT00289276|520952|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
219301|NCT00289276|520953|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
219302|NCT00289276|520952|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
219303|NCT00289276|520953|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
219304|NCT00289276|520952|P2|STARTED|First Part of FAST Study (Pivotal)||0
219305|NCT00289276|520953|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
219306|NCT00289211|520968|P3|NOT COMPLETED|Overall Study||10
219307|NCT00289211|520969|P2|NOT COMPLETED|Overall Study||1
219308|NCT00289211|520970|P1|NOT COMPLETED|Overall Study||0
219309|NCT00289211|520968|P3|COMPLETED|Overall Study||2
219310|NCT00289211|520969|P2|COMPLETED|Overall Study||34
219311|NCT00289211|520970|P1|COMPLETED|Overall Study||36
219312|NCT00289211|520968|P3|STARTED|Overall Study||12
219313|NCT00289211|520969|P2|STARTED|Overall Study||35
219314|NCT00289211|520970|P1|STARTED|Overall Study||36
219315|NCT00289185|520988|P2|NOT COMPLETED|Overall Study||26
219316|NCT00289185|520989|P1|NOT COMPLETED|Overall Study||28
219317|NCT00289185|520988|P2|COMPLETED|Overall Study||144
219318|NCT00289185|520989|P1|COMPLETED|Overall Study||142
219319|NCT00289185|520988|P2|STARTED|Overall Study||170
219320|NCT00289185|520989|P1|STARTED|Overall Study||170
219321|NCT00289133|521036|P2|NOT COMPLETED|Overall Study||298
219322|NCT00289133|521037|P1|NOT COMPLETED|Overall Study||272
219323|NCT00289133|521036|P2|COMPLETED|Overall Study||179
219324|NCT00289133|521037|P1|COMPLETED|Overall Study||189
219325|NCT00289133|521036|P2|STARTED|Overall Study||477
219326|NCT00289133|521037|P1|STARTED|Overall Study||461
219327|NCT00289120|521059|P1|NOT COMPLETED|Overall Study||0
219328|NCT00289120|521059|P1|COMPLETED|Overall Study||13
219329|NCT00289120|521059|P1|STARTED|Overall Study||13
219330|NCT00289107|521077|P2|NOT COMPLETED|Overall Study||44
219331|NCT00289107|521078|P1|NOT COMPLETED|Overall Study||53
219332|NCT00289107|521077|P2|COMPLETED|Overall Study||28
219333|NCT00289107|521078|P1|COMPLETED|Overall Study||24
219334|NCT00289107|521077|P2|STARTED|Overall Study||72
219335|NCT00289107|521078|P1|STARTED|Overall Study||77
219336|NCT00289094|521086|P2|NOT COMPLETED|Overall Study||47
219337|NCT00289094|521087|P1|NOT COMPLETED|Overall Study||47
219338|NCT00289094|521086|P2|COMPLETED|Overall Study||2
219339|NCT00289094|521087|P1|COMPLETED|Overall Study||3
219340|NCT00289094|521086|P2|STARTED|Overall Study||49
219341|NCT00289094|521087|P1|STARTED|Overall Study||50
219342|NCT00289016|521093|P1|NOT COMPLETED|Overall Study||37
219343|NCT00289016|521093|P1|COMPLETED|Overall Study||13
219344|NCT00289016|521093|P1|STARTED|Overall Study||50
219345|NCT00288912|521105|P3|NOT COMPLETED|Overall Study||28
219346|NCT00288912|521106|P2|NOT COMPLETED|Overall Study||17
219347|NCT00288912|521107|P1|NOT COMPLETED|Overall Study||17
219348|NCT00288912|521105|P3|COMPLETED|Overall Study||146
219349|NCT00288912|521106|P2|COMPLETED|Overall Study||157
219350|NCT00288912|521107|P1|COMPLETED|Overall Study||158
219351|NCT00288912|521105|P3|STARTED|Overall Study||174
219352|NCT00288912|521106|P2|STARTED|Overall Study||174
219353|NCT00288912|521107|P1|STARTED|Overall Study||175
219354|NCT00288886|521126|P2|NOT COMPLETED|Overall Study||11
219355|NCT00288886|521127|P1|NOT COMPLETED|Overall Study||11
219356|NCT00288886|521126|P2|COMPLETED|Overall Study||81
219357|NCT00288886|521127|P1|COMPLETED|Overall Study||80
219358|NCT00288886|521126|P2|12-month Follow Up|Overall Study||81
219359|NCT00288886|521127|P1|12-month Follow Up|Overall Study||80
219360|NCT00288886|521126|P2|6-month Follow Up|Overall Study||84
219361|NCT00288886|521127|P1|6-month Follow Up|Overall Study||85
219362|NCT00288886|521126|P2|3-month Follow Up|Overall Study||85
219363|NCT00288886|521127|P1|3-month Follow Up|Overall Study||82
219364|NCT00288886|521126|P2|STARTED|Overall Study||92
219365|NCT00288886|521127|P1|STARTED|Overall Study||91
219366|NCT00288860|521147|P2|NOT COMPLETED|Overall Study||97
219367|NCT00288860|521148|P1|NOT COMPLETED|Overall Study||102
219368|NCT00288860|521147|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
219369|NCT00288860|521148|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
219370|NCT00288860|521147|P2|Completed 12 Month fu Survey|Overall Study||281
219371|NCT00288860|521148|P1|Completed 12 Month fu Survey|Overall Study||257
219372|NCT00288860|521147|P2|Completed 4 Month fu Survey|Overall Study||299
219373|NCT00288860|521148|P1|Completed 4 Month fu Survey|Overall Study||275
219374|NCT00288860|521147|P2|Completed Intake Survey|Overall Study||417
219375|NCT00288860|521148|P1|Completed Intake Survey|Overall Study||408
219376|NCT00288860|521147|P2|STARTED|Overall Study||425
219377|NCT00288860|521148|P1|STARTED|Overall Study||412
219378|NCT00288704|521161|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
219379|NCT00288704|521162|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
219380|NCT00288704|521163|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
219381|NCT00288704|521161|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
219382|NCT00288704|521162|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
219383|NCT00288704|521163|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
219384|NCT00288704|521161|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
219385|NCT00288704|521162|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
219386|NCT00288704|521163|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
219387|NCT00288704|521161|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
219388|NCT00288704|521162|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
219389|NCT00288704|521163|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
219390|NCT00288704|521161|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
219391|NCT00288704|521162|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
219392|NCT00288704|521163|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
219393|NCT00288704|521161|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
219394|NCT00288704|521162|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
219395|NCT00288704|521163|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
219396|NCT00288704|521161|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
219397|NCT00288704|521162|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
219398|NCT00288704|521163|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
219399|NCT00288704|521161|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
219400|NCT00288704|521162|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
219401|NCT00288704|521163|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
219402|NCT00288704|521161|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
219403|NCT00288704|521162|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
219404|NCT00288704|521163|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
219405|NCT00288639|521190|P1|NOT COMPLETED|Overall Study||12
219406|NCT00288639|521190|P1|COMPLETED|Overall Study||86
219407|NCT00288639|521190|P1|STARTED|Overall Study||98
219408|NCT00288600|521209|P2|NOT COMPLETED|Overall Study||0
219409|NCT00288600|521210|P1|NOT COMPLETED|Overall Study||0
219410|NCT00288600|521209|P2|COMPLETED|Overall Study||46
219411|NCT00288600|521210|P1|COMPLETED|Overall Study||46
219412|NCT00288600|521209|P2|STARTED|Overall Study||46
219413|NCT00288600|521210|P1|STARTED|Overall Study||46
219414|NCT00288587|521218|P2|NOT COMPLETED|Overall Study||10
219415|NCT00288587|521219|P1|NOT COMPLETED|Overall Study||5
219416|NCT00288587|521218|P2|COMPLETED|Overall Study||7
219417|NCT00288587|521219|P1|COMPLETED|Overall Study||14
219418|NCT00288587|521218|P2|STARTED|Overall Study||17
219419|NCT00288587|521219|P1|STARTED|Overall Study||19
219420|NCT00288574|521235|P2|NOT COMPLETED|Overall Study||0
219421|NCT00288574|521236|P1|NOT COMPLETED|Overall Study||0
219422|NCT00288574|521235|P2|COMPLETED|Overall Study||44
219423|NCT00288574|521236|P1|COMPLETED|Overall Study||49
219424|NCT00288574|521235|P2|STARTED|Overall Study||44
219425|NCT00288574|521236|P1|STARTED|Overall Study||49
219426|NCT00288509|521242|P1|NOT COMPLETED|Treatment Cycle 4||8
219427|NCT00288509|521242|P1|COMPLETED|Treatment Cycle 4||80
219428|NCT00288509|521242|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
219429|NCT00288509|521242|P1|NOT COMPLETED|Treatment Cycle 3||5
219430|NCT00288509|521242|P1|COMPLETED|Treatment Cycle 3||91
219431|NCT00288509|521242|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
219432|NCT00288509|521242|P1|NOT COMPLETED|Treatment Cycle 2||3
219433|NCT00288509|521242|P1|COMPLETED|Treatment Cycle 2||97
219434|NCT00288509|521242|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
219435|NCT00288509|521242|P1|NOT COMPLETED|Treatment Cycle 1||6
219436|NCT00288509|521242|P1|COMPLETED|Treatment Cycle 1||102
219437|NCT00288509|521242|P1|STARTED|Treatment Cycle 1||108
219438|NCT00288080|521251|P2|NOT COMPLETED|Overall Study||23
219439|NCT00288080|521252|P1|NOT COMPLETED|Overall Study||26
219440|NCT00288080|521251|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
219441|NCT00288080|521252|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
219442|NCT00288080|521251|P2|STARTED|Overall Study||305
219443|NCT00288080|521252|P1|STARTED|Overall Study||307
219444|NCT00288067|521268|P1|NOT COMPLETED|Overall Study||0
219445|NCT00288067|521268|P1|COMPLETED|Overall Study||32
219446|NCT00288067|521268|P1|STARTED|Overall Study||32
219447|NCT00288054|521274|P1|NOT COMPLETED|Overall Study||24
219448|NCT00288054|521274|P1|COMPLETED|Overall Study||0
219449|NCT00288054|521274|P1|STARTED|Overall Study||24
219450|NCT00287872|521282|P1|NOT COMPLETED|Overall Study||0
219451|NCT00287872|521282|P1|COMPLETED|Overall Study||30
219452|NCT00287872|521282|P1|STARTED|Overall Study||30
219453|NCT00287729|521289|P2|NOT COMPLETED|Overall Study||31
219454|NCT00287729|521290|P1|NOT COMPLETED|Overall Study||34
219455|NCT00287729|521289|P2|COMPLETED|Overall Study||142
219456|NCT00287729|521290|P1|COMPLETED|Overall Study||137
219457|NCT00287729|521289|P2|STARTED|Overall Study||173
219458|NCT00287729|521290|P1|STARTED|Overall Study||171
219459|NCT00287716|521313|P3|NOT COMPLETED|Overall Study||31
219460|NCT00287716|521314|P2|NOT COMPLETED|Overall Study||17
219461|NCT00287716|521315|P1|NOT COMPLETED|Overall Study||38
219462|NCT00287716|521313|P3|COMPLETED|Overall Study||143
219463|NCT00287716|521314|P2|COMPLETED|Overall Study||70
219464|NCT00287716|521315|P1|COMPLETED|Overall Study||136
219465|NCT00287716|521313|P3|STARTED|Overall Study||174
219466|NCT00287716|521314|P2|STARTED|Overall Study||87
219467|NCT00287716|521315|P1|STARTED|Overall Study||174
219468|NCT00287339|521346|P2|NOT COMPLETED|Overall Study||0
219469|NCT00287339|521347|P1|NOT COMPLETED|Overall Study||0
219470|NCT00287339|521346|P2|COMPLETED|Overall Study||18
219471|NCT00287339|521347|P1|COMPLETED|Overall Study||22
219472|NCT00287339|521346|P2|STARTED|Overall Study||18
219473|NCT00287339|521347|P1|STARTED|Overall Study||22
219474|NCT00287222|521353|P1|NOT COMPLETED|Overall Study||0
219475|NCT00287222|521353|P1|COMPLETED|Overall Study||21
219476|NCT00287222|521353|P1|STARTED|Overall Study||21
219477|NCT00287079|521359|P2|NOT COMPLETED|Overall Study||1
219478|NCT00287079|521360|P1|NOT COMPLETED|Overall Study||22
219479|NCT00287079|521359|P2|COMPLETED|Overall Study||2
219480|NCT00287079|521360|P1|COMPLETED|Overall Study||10
219481|NCT00287079|521359|P2|STARTED|Overall Study||3
219482|NCT00287079|521360|P1|STARTED|Overall Study||32
219483|NCT00287053|521372|P2|NOT COMPLETED|Overall Study||1
219484|NCT00287053|521373|P1|NOT COMPLETED|Overall Study||4
219485|NCT00287053|521372|P2|COMPLETED|Overall Study||26
219486|NCT00287053|521373|P1|COMPLETED|Overall Study||26
219487|NCT00287053|521372|P2|STARTED|Overall Study||27
219488|NCT00287053|521373|P1|STARTED|Overall Study||30
219489|NCT00286754|521382|P3|NOT COMPLETED|Overall Study||10
219490|NCT00286754|521383|P2|NOT COMPLETED|Overall Study||18
219491|NCT00286754|521384|P1|NOT COMPLETED|Overall Study||20
219492|NCT00286754|521382|P3|COMPLETED|Overall Study||170
219493|NCT00286754|521383|P2|COMPLETED|Overall Study||159
219494|NCT00286754|521384|P1|COMPLETED|Overall Study||156
219495|NCT00286754|521382|P3|STARTED|Overall Study||180
219496|NCT00286754|521383|P2|STARTED|Overall Study||177
219497|NCT00286754|521384|P1|STARTED|Overall Study||176
219498|NCT00286741|521418|P2|NOT COMPLETED|Overall Study||17
219499|NCT00286741|521419|P1|NOT COMPLETED|Overall Study||11
219500|NCT00286741|521418|P2|COMPLETED|Overall Study||89
219501|NCT00286741|521419|P1|COMPLETED|Overall Study||122
219502|NCT00286741|521418|P2|STARTED|Overall Study||106
219503|NCT00286741|521419|P1|STARTED|Overall Study||133
219504|NCT00286728|521429|P2|NOT COMPLETED|Overall Study||29
219505|NCT00286728|521430|P1|NOT COMPLETED|Overall Study||36
219506|NCT00286728|521429|P2|COMPLETED|Overall Study||116
219507|NCT00286728|521430|P1|COMPLETED|Overall Study||106
219508|NCT00286728|521429|P2|STARTED|Overall Study||145
219509|NCT00286728|521430|P1|STARTED|Overall Study||142
219510|NCT00286494|521439|P3|NOT COMPLETED|Overall Study||39
219511|NCT00286494|521440|P2|NOT COMPLETED|Overall Study||44
219512|NCT00286494|521441|P1|NOT COMPLETED|Overall Study||26
219513|NCT00286494|521439|P3|COMPLETED|Overall Study||160
219514|NCT00286494|521440|P2|COMPLETED|Overall Study||153
219515|NCT00286494|521441|P1|COMPLETED|Overall Study||71
219516|NCT00286494|521439|P3|STARTED|Overall Study||199
219517|NCT00286494|521440|P2|STARTED|Overall Study||197
219518|NCT00286494|521441|P1|STARTED|Overall Study||97
219519|NCT00286468|521602|P3|NOT COMPLETED|Overall Study||50
219520|NCT00286468|521603|P2|NOT COMPLETED|Overall Study||50
219521|NCT00286468|521604|P1|NOT COMPLETED|Overall Study||37
219522|NCT00286468|521602|P3|COMPLETED|Overall Study||148
219523|NCT00286468|521603|P2|COMPLETED|Overall Study||153
219524|NCT00286468|521604|P1|COMPLETED|Overall Study||62
219525|NCT00286468|521602|P3|STARTED|Overall Study||198
219526|NCT00286468|521603|P2|STARTED|Overall Study||203
219527|NCT00286468|521604|P1|STARTED|Overall Study||99
219528|NCT00286455|521765|P3|NOT COMPLETED|Overall Study||24
219529|NCT00286455|521766|P2|NOT COMPLETED|Overall Study||28
219530|NCT00286455|521767|P1|NOT COMPLETED|Overall Study||25
219531|NCT00286455|521765|P3|COMPLETED|Overall Study||107
219532|NCT00286455|521766|P2|COMPLETED|Overall Study||105
219533|NCT00286455|521767|P1|COMPLETED|Overall Study||40
219534|NCT00286455|521765|P3|STARTED|Overall Study||131
219535|NCT00286455|521766|P2|STARTED|Overall Study||133
219536|NCT00286455|521767|P1|STARTED|Overall Study||65
219537|NCT00286442|521946|P3|NOT COMPLETED|Overall Study||32
219538|NCT00286442|521947|P2|NOT COMPLETED|Overall Study||45
219539|NCT00286442|521948|P1|NOT COMPLETED|Overall Study||37
219540|NCT00286442|521946|P3|COMPLETED|Overall Study||72
219541|NCT00286442|521947|P2|COMPLETED|Overall Study||165
219542|NCT00286442|521948|P1|COMPLETED|Overall Study||176
219543|NCT00286442|521946|P3|STARTED|Overall Study||104
219544|NCT00286442|521947|P2|STARTED|Overall Study||210
219545|NCT00286442|521948|P1|STARTED|Overall Study||213
219546|NCT00286429|522109|P3|NOT COMPLETED|Overall Study||52
219547|NCT00286429|522110|P2|NOT COMPLETED|Overall Study||48
219548|NCT00286429|522111|P1|NOT COMPLETED|Overall Study||75
219549|NCT00286429|522109|P3|COMPLETED|Overall Study||77
219550|NCT00286429|522110|P2|COMPLETED|Overall Study||83
219551|NCT00286429|522111|P1|COMPLETED|Overall Study||55
219552|NCT00286429|522109|P3|STARTED|Overall Study||129
219553|NCT00286429|522110|P2|STARTED|Overall Study||131
219554|NCT00286429|522111|P1|STARTED|Overall Study||130
219555|NCT00286325|522215|P1|NOT COMPLETED|Overall Study||0
219556|NCT00286325|522215|P1|COMPLETED|Overall Study||8
219557|NCT00286325|522215|P1|STARTED|Overall Study||8
219558|NCT00286182|522225|P2|NOT COMPLETED|Overall Study||3
219559|NCT00286182|522226|P1|NOT COMPLETED|Overall Study||5
219560|NCT00286182|522225|P2|COMPLETED|Overall Study||25
219561|NCT00286182|522226|P1|COMPLETED|Overall Study||23
219562|NCT00286182|522225|P2|STARTED|Overall Study||28
219563|NCT00286182|522226|P1|STARTED|Overall Study||28
219564|NCT00286156|522235|P3|NOT COMPLETED|Overall Study||1
219565|NCT00286156|522236|P2|NOT COMPLETED|Overall Study||1
219566|NCT00286156|522237|P1|NOT COMPLETED|Overall Study||2
219567|NCT00286156|522235|P3|COMPLETED|Overall Study||9
219568|NCT00286156|522236|P2|COMPLETED|Overall Study||9
219569|NCT00286156|522237|P1|COMPLETED|Overall Study||8
219570|NCT00286156|522235|P3|STARTED|Overall Study||10
219571|NCT00286156|522236|P2|STARTED|Overall Study||10
219572|NCT00286156|522237|P1|STARTED|Overall Study||10
219573|NCT00286091|522250|P2|NOT COMPLETED|Open-label Treatment Phase||71
219574|NCT00286091|522251|P1|NOT COMPLETED|Open-label Treatment Phase||77
219575|NCT00286091|522250|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
219576|NCT00286091|522251|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
219577|NCT00286091|522250|P2|Received Treatment|Open-label Treatment Phase||101
219578|NCT00286091|522251|P1|Received Treatment|Open-label Treatment Phase||109
219579|NCT00286091|522250|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
219580|NCT00286091|522251|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
219581|NCT00286091|522250|P2|NOT COMPLETED|Double-blind Treatment Phase||593
219582|NCT00286091|522251|P1|NOT COMPLETED|Double-blind Treatment Phase||584
219583|NCT00286091|522250|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
219584|NCT00286091|522251|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
219585|NCT00286091|522250|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
219586|NCT00286091|522251|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
219587|NCT00286091|522250|P2|Received Treatment|Double-blind Treatment Phase||716
219588|NCT00286091|522251|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
219589|NCT00286091|522250|P2|STARTED|Double-blind Treatment Phase||716
219590|NCT00286091|522251|P1|STARTED|Double-blind Treatment Phase||716
219591|NCT00286078|522265|P2|NOT COMPLETED|Overall Study||34
219592|NCT00286078|522266|P1|NOT COMPLETED|Overall Study||32
219593|NCT00286078|522265|P2|COMPLETED|Overall Study||34
219594|NCT00286078|522266|P1|COMPLETED|Overall Study||40
219595|NCT00286078|522265|P2|12 Weeks|Overall Study||62
219596|NCT00286078|522266|P1|12 Weeks|Overall Study||63
219597|NCT00286078|522265|P2|STARTED|Overall Study||68
219598|NCT00286078|522266|P1|STARTED|Overall Study||72
219599|NCT00284739|522276|P2|NOT COMPLETED|Overall Study||0
219600|NCT00284739|522277|P1|NOT COMPLETED|Overall Study||0
219601|NCT00284739|522276|P2|COMPLETED|Overall Study||9
219602|NCT00284739|522277|P1|COMPLETED|Overall Study||11
219603|NCT00284739|522276|P2|STARTED|Overall Study||9
219604|NCT00284739|522277|P1|STARTED|Overall Study||11
219605|NCT00285818|522289|P2|NOT COMPLETED|Overall Study||2
219606|NCT00285818|522290|P1|NOT COMPLETED|Overall Study||4
219607|NCT00285818|522289|P2|COMPLETED|Overall Study||3
219608|NCT00285818|522290|P1|COMPLETED|Overall Study||2
219609|NCT00285818|522289|P2|STARTED|Overall Study||5
219610|NCT00285818|522290|P1|STARTED|Overall Study||6
219611|NCT00285779|522298|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
219612|NCT00285779|522299|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
219613|NCT00285779|522298|P2|COMPLETED|Follow-up Period (wk 24-32)||10
219614|NCT00285779|522299|P1|COMPLETED|Follow-up Period (wk 24-32)||8
219615|NCT00285779|522298|P2|STARTED|Follow-up Period (wk 24-32)||10
219616|NCT00285779|522299|P1|STARTED|Follow-up Period (wk 24-32)||9
219617|NCT00285779|522298|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
219618|NCT00285779|522299|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
219619|NCT00285779|522298|P2|COMPLETED|Open Label Period (wk 12-24)||10
219620|NCT00285779|522299|P1|COMPLETED|Open Label Period (wk 12-24)||9
219621|NCT00285779|522298|P2|STARTED|Open Label Period (wk 12-24)||12
219622|NCT00285779|522299|P1|STARTED|Open Label Period (wk 12-24)||11
219623|NCT00285779|522298|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
219624|NCT00285779|522299|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
219625|NCT00285779|522298|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
219626|NCT00285779|522299|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
219627|NCT00285779|522298|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
219628|NCT00285779|522299|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
219629|NCT00285584|522307|P2|NOT COMPLETED|Month 9||3
219630|NCT00285584|522308|P1|NOT COMPLETED|Month 9||1
219631|NCT00285584|522307|P2|COMPLETED|Month 9||14
219632|NCT00285584|522308|P1|COMPLETED|Month 9||15
219633|NCT00285584|522307|P2|STARTED|Month 9||17
219634|NCT00285584|522308|P1|STARTED|Month 9||16
219635|NCT00285584|522307|P2|NOT COMPLETED|Month 6||1
219636|NCT00285584|522308|P1|NOT COMPLETED|Month 6||0
219637|NCT00285584|522307|P2|COMPLETED|Month 6||17
219638|NCT00285584|522308|P1|COMPLETED|Month 6||16
219639|NCT00285584|522307|P2|STARTED|Month 6||18
219640|NCT00285584|522308|P1|STARTED|Month 6||16
219641|NCT00285584|522307|P2|NOT COMPLETED|Month 3||3
219642|NCT00285584|522308|P1|NOT COMPLETED|Month 3||4
219643|NCT00285584|522307|P2|COMPLETED|Month 3||18
219644|NCT00285584|522308|P1|COMPLETED|Month 3||16
219645|NCT00285584|522307|P2|STARTED|Month 3||21
219646|NCT00285584|522308|P1|STARTED|Month 3||20
219647|NCT00285584|522307|P2|NOT COMPLETED|Enrollment (Month 0)||0
219648|NCT00285584|522308|P1|NOT COMPLETED|Enrollment (Month 0)||0
219649|NCT00285584|522307|P2|COMPLETED|Enrollment (Month 0)||21
219650|NCT00285584|522308|P1|COMPLETED|Enrollment (Month 0)||20
219651|NCT00285584|522307|P2|STARTED|Enrollment (Month 0)||21
219652|NCT00285584|522308|P1|STARTED|Enrollment (Month 0)||20
219653|NCT00285467|522322|P2|NOT COMPLETED|Overall Study||0
219654|NCT00285467|522323|P1|NOT COMPLETED|Overall Study||0
219655|NCT00285467|522322|P2|COMPLETED|Overall Study||22
219656|NCT00285467|522323|P1|COMPLETED|Overall Study||25
219657|NCT00285467|522322|P2|STARTED|Overall Study||22
219658|NCT00285467|522323|P1|STARTED|Overall Study||25
219659|NCT00285246|522331|P1|NOT COMPLETED|Overall Study||48
219660|NCT00285246|522331|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
219661|NCT00285246|522331|P1|STARTED|Overall Study||838
219662|NCT00285207|522340|P2|NOT COMPLETED|Overall Study||6
219663|NCT00285207|522341|P1|NOT COMPLETED|Overall Study||9
219664|NCT00285207|522340|P2|COMPLETED|Overall Study||71
219665|NCT00285207|522341|P1|COMPLETED|Overall Study||61
219666|NCT00285207|522340|P2|Treated|Overall Study||75
219667|NCT00285207|522341|P1|Treated|Overall Study||63
219668|NCT00285207|522340|P2|STARTED|Overall Study||77
219669|NCT00285207|522341|P1|STARTED|Overall Study||70
219670|NCT00284180|522349|P2|NOT COMPLETED|Overall Study||4
219671|NCT00284180|522350|P1|NOT COMPLETED|Overall Study||0
219672|NCT00284180|522349|P2|COMPLETED|Overall Study||17
219673|NCT00284180|522350|P1|COMPLETED|Overall Study||11
219674|NCT00284180|522349|P2|STARTED|Overall Study||21
219675|NCT00284180|522350|P1|STARTED|Overall Study||11
219676|NCT00284154|522356|P1|NOT COMPLETED|Overall Study||42
219677|NCT00284154|522356|P1|COMPLETED|Overall Study||9
219678|NCT00284154|522356|P1|STARTED|Overall Study||51
219679|NCT00284141|522363|P1|NOT COMPLETED|Overall Study||98
219680|NCT00284141|522363|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
219681|NCT00284141|522363|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
219682|NCT00284141|522363|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
219683|NCT00284141|522363|P1|STARTED|Overall Study||98
219684|NCT00284089|522386|P4|NOT COMPLETED|Extension Phase||12
219685|NCT00284089|522387|P3|NOT COMPLETED|Extension Phase||6
219686|NCT00284089|522388|P2|NOT COMPLETED|Extension Phase||0
219687|NCT00284089|522389|P1|NOT COMPLETED|Extension Phase||2
219688|NCT00284089|522386|P4|COMPLETED|Extension Phase||21
219689|NCT00284089|522387|P3|COMPLETED|Extension Phase||22
219690|NCT00284089|522388|P2|COMPLETED|Extension Phase||6
219691|NCT00284089|522389|P1|COMPLETED|Extension Phase||1
219692|NCT00284089|522386|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
219693|NCT00284089|522387|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
219774|NCT00284050|522535|P3|COMPLETED|Overall Study||40
219694|NCT00284089|522388|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
219695|NCT00284089|522389|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
219696|NCT00284089|522386|P4|NOT COMPLETED|Multiple Dose Phase||4
219697|NCT00284089|522387|P3|NOT COMPLETED|Multiple Dose Phase||4
219698|NCT00284089|522388|P2|NOT COMPLETED|Multiple Dose Phase||0
219699|NCT00284089|522389|P1|NOT COMPLETED|Multiple Dose Phase||1
219700|NCT00284089|522386|P4|COMPLETED|Multiple Dose Phase||37
219701|NCT00284089|522387|P3|COMPLETED|Multiple Dose Phase||31
219702|NCT00284089|522388|P2|COMPLETED|Multiple Dose Phase||6
219703|NCT00284089|522389|P1|COMPLETED|Multiple Dose Phase||4
219704|NCT00284089|522386|P4|STARTED|Multiple Dose Phase||41
219705|NCT00284089|522387|P3|STARTED|Multiple Dose Phase||35
219706|NCT00284089|522388|P2|STARTED|Multiple Dose Phase||6
219707|NCT00284089|522389|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
219708|NCT00284089|522386|P4|NOT COMPLETED|Single Dose Phase||0
219709|NCT00284089|522387|P3|NOT COMPLETED|Single Dose Phase||0
219710|NCT00284089|522388|P2|NOT COMPLETED|Single Dose Phase||0
219711|NCT00284089|522389|P1|NOT COMPLETED|Single Dose Phase||0
219712|NCT00284089|522386|P4|COMPLETED|Single Dose Phase||0
219713|NCT00284089|522387|P3|COMPLETED|Single Dose Phase||0
219714|NCT00284089|522388|P2|COMPLETED|Single Dose Phase||6
219715|NCT00284089|522389|P1|COMPLETED|Single Dose Phase||6
219716|NCT00284089|522386|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
219717|NCT00284089|522387|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
219718|NCT00284089|522388|P2|STARTED|Single Dose Phase||6
219719|NCT00284089|522389|P1|STARTED|Single Dose Phase||6
219720|NCT00285012|522417|P2|NOT COMPLETED|Received Study Tx||94
219721|NCT00285012|522418|P1|NOT COMPLETED|Received Study Tx||72
219722|NCT00285012|522417|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
219723|NCT00285012|522418|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
219724|NCT00285012|522417|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
219725|NCT00285012|522418|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
219726|NCT00285012|522417|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
219727|NCT00285012|522418|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
219728|NCT00285012|522417|P2|STARTED|Received Study Tx||251
219729|NCT00285012|522418|P1|STARTED|Received Study Tx||248
219730|NCT00285012|522417|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
219731|NCT00285012|522418|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
219732|NCT00285012|522417|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
219733|NCT00285012|522418|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
219734|NCT00285012|522417|P2|STARTED|Assigned to Study Treatment (Tx)||254
219735|NCT00285012|522418|P1|STARTED|Assigned to Study Treatment (Tx)||250
219736|NCT00284934|522444|P2|NOT COMPLETED|Overall Study||3
219737|NCT00284934|522445|P1|NOT COMPLETED|Overall Study||4
219738|NCT00284934|522444|P2|COMPLETED|Overall Study||43
219739|NCT00284934|522445|P1|COMPLETED|Overall Study||44
219740|NCT00284934|522444|P2|Intent-to-treat Population (ITT)|Overall Study||45
219741|NCT00284934|522445|P1|Intent-to-treat Population (ITT)|Overall Study||47
219742|NCT00284934|522444|P2|STARTED|Overall Study||46
219743|NCT00284934|522445|P1|STARTED|Overall Study||48
219744|NCT00284856|522460|P3|NOT COMPLETED|Overall Study||60
219745|NCT00284856|522461|P2|NOT COMPLETED|Overall Study||50
219746|NCT00284856|522462|P1|NOT COMPLETED|Overall Study||51
219747|NCT00284856|522460|P3|COMPLETED|Overall Study||276
219748|NCT00284856|522461|P2|COMPLETED|Overall Study||286
219749|NCT00284856|522462|P1|COMPLETED|Overall Study||296
219750|NCT00284856|522460|P3|STARTED|Overall Study||336
219751|NCT00284856|522461|P2|STARTED|Overall Study||336
219752|NCT00284856|522462|P1|STARTED|Overall Study||347
219753|NCT00284557|522478|P2|NOT COMPLETED|Overall Study||13
219754|NCT00284557|522479|P1|NOT COMPLETED|Overall Study||9
219755|NCT00284557|522478|P2|COMPLETED|Overall Study||50
219756|NCT00284557|522479|P1|COMPLETED|Overall Study||58
219757|NCT00284557|522478|P2|STARTED|Overall Study||63
219758|NCT00284557|522479|P1|STARTED|Overall Study||67
219759|NCT00284518|522491|P4|NOT COMPLETED|Overall Study||33
219760|NCT00284518|522492|P3|NOT COMPLETED|Overall Study||28
219761|NCT00284518|522493|P2|NOT COMPLETED|Overall Study||28
219762|NCT00284518|522494|P1|NOT COMPLETED|Overall Study||26
219763|NCT00284518|522491|P4|COMPLETED|Overall Study||61
219764|NCT00284518|522492|P3|COMPLETED|Overall Study||67
219765|NCT00284518|522493|P2|COMPLETED|Overall Study||66
219766|NCT00284518|522494|P1|COMPLETED|Overall Study||71
219767|NCT00284518|522491|P4|STARTED|Overall Study||94
219768|NCT00284518|522492|P3|STARTED|Overall Study||95
219769|NCT00284518|522493|P2|STARTED|Overall Study||94
219770|NCT00284518|522494|P1|STARTED|Overall Study||97
219771|NCT00284050|522535|P3|NOT COMPLETED|Overall Study||9
219772|NCT00284050|522536|P2|NOT COMPLETED|Overall Study||5
219773|NCT00284050|522537|P1|NOT COMPLETED|Overall Study||5
219775|NCT00284050|522536|P2|COMPLETED|Overall Study||46
219776|NCT00284050|522537|P1|COMPLETED|Overall Study||46
219777|NCT00284050|522535|P3|STARTED|Overall Study||49
219778|NCT00284050|522536|P2|STARTED|Overall Study||51
219779|NCT00284050|522537|P1|STARTED|Overall Study||51
219780|NCT00283868|522553|P2|NOT COMPLETED|Overall Study||8
219781|NCT00283868|522554|P1|NOT COMPLETED|Overall Study||7
219782|NCT00283868|522553|P2|COMPLETED|Overall Study||103
219783|NCT00283868|522554|P1|COMPLETED|Overall Study||104
219784|NCT00283868|522553|P2|STARTED|Overall Study||111
219785|NCT00283868|522554|P1|STARTED|Overall Study||111
219786|NCT00283842|522571|P5|NOT COMPLETED|Overall Study||15
219787|NCT00283842|522572|P4|NOT COMPLETED|Overall Study||27
219788|NCT00283842|522573|P3|NOT COMPLETED|Overall Study||31
219789|NCT00283842|522574|P2|NOT COMPLETED|Overall Study||18
219790|NCT00283842|522575|P1|NOT COMPLETED|Overall Study||12
219791|NCT00283842|522571|P5|COMPLETED|Overall Study||75
219792|NCT00283842|522572|P4|COMPLETED|Overall Study||42
219793|NCT00283842|522573|P3|COMPLETED|Overall Study||68
219794|NCT00283842|522574|P2|COMPLETED|Overall Study||69
219795|NCT00283842|522575|P1|COMPLETED|Overall Study||51
219796|NCT00283842|522571|P5|STARTED|Overall Study||90
219797|NCT00283842|522572|P4|STARTED|Overall Study||69
219798|NCT00283842|522573|P3|STARTED|Overall Study||99
219799|NCT00283842|522574|P2|STARTED|Overall Study||87
219800|NCT00283842|522575|P1|STARTED|Overall Study||63
219801|NCT00283816|522594|P2|NOT COMPLETED|Overall Study||2
219802|NCT00283816|522595|P1|NOT COMPLETED|Overall Study||2
219803|NCT00283816|522594|P2|COMPLETED|Overall Study||16
219804|NCT00283816|522595|P1|COMPLETED|Overall Study||16
219805|NCT00283816|522594|P2|STARTED|Overall Study||18
219806|NCT00283816|522595|P1|STARTED|Overall Study||18
219807|NCT00283712|522609|P2|NOT COMPLETED|Overall Study||1
219808|NCT00283712|522610|P1|NOT COMPLETED|Overall Study||0
219809|NCT00283712|522609|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
219810|NCT00283712|522610|P1|COMPLETED|Overall Study||10
219811|NCT00283712|522609|P2|Per-Protocol Sample|Overall Study||7
219812|NCT00283712|522610|P1|Per-Protocol Sample|Overall Study||6
219813|NCT00283712|522609|P2|Safety Sample|Overall Study||10
219814|NCT00283712|522610|P1|Safety Sample|Overall Study||10
219815|NCT00283712|522609|P2|Intent-to-treat Sample|Overall Study||10
219816|NCT00283712|522610|P1|Intent-to-treat Sample|Overall Study||10
219817|NCT00283712|522609|P2|STARTED|Overall Study||10
219818|NCT00283712|522610|P1|STARTED|Overall Study||10
219819|NCT00283686|522648|P4|NOT COMPLETED|Overall Study||32
219820|NCT00283686|522649|P3|NOT COMPLETED|Overall Study||33
219821|NCT00283686|522650|P2|NOT COMPLETED|Overall Study||41
219822|NCT00283686|522651|P1|NOT COMPLETED|Overall Study||29
219823|NCT00283686|522648|P4|COMPLETED|Overall Study||109
219824|NCT00283686|522649|P3|COMPLETED|Overall Study||111
219825|NCT00283686|522650|P2|COMPLETED|Overall Study||92
219826|NCT00283686|522651|P1|COMPLETED|Overall Study||111
219827|NCT00283686|522648|P4|STARTED|Overall Study||141
219828|NCT00283686|522649|P3|STARTED|Overall Study||144
219829|NCT00283686|522650|P2|STARTED|Overall Study||133
219830|NCT00283686|522651|P1|STARTED|Overall Study||140
219831|NCT00283595|522695|P2|NOT COMPLETED|Overall Study||2
219832|NCT00283595|522696|P1|NOT COMPLETED|Overall Study||1
219833|NCT00283595|522695|P2|COMPLETED|Overall Study||9
219834|NCT00283595|522696|P1|COMPLETED|Overall Study||9
219835|NCT00283595|522695|P2|STARTED|Overall Study||11
219836|NCT00283595|522696|P1|STARTED|Overall Study||10
219837|NCT00283439|522708|P4|NOT COMPLETED|Overall Study||9
219838|NCT00283439|522709|P3|NOT COMPLETED|Overall Study||11
219839|NCT00283439|522710|P2|NOT COMPLETED|Overall Study||11
219840|NCT00283439|522711|P1|NOT COMPLETED|Overall Study||8
219841|NCT00283439|522708|P4|COMPLETED|Overall Study||0
219842|NCT00283439|522709|P3|COMPLETED|Overall Study||0
219843|NCT00283439|522710|P2|COMPLETED|Overall Study||0
219844|NCT00283439|522711|P1|COMPLETED|Overall Study||0
219845|NCT00283439|522708|P4|STARTED|Overall Study||9
219846|NCT00283439|522709|P3|STARTED|Overall Study||11
219847|NCT00283439|522710|P2|STARTED|Overall Study||11
219848|NCT00283439|522711|P1|STARTED|Overall Study||8
219849|NCT00283400|522737|P4|NOT COMPLETED|Overall Study||0
219850|NCT00283400|522738|P3|NOT COMPLETED|Overall Study||1
219851|NCT00283400|522739|P2|NOT COMPLETED|Overall Study||1
219852|NCT00283400|522740|P1|NOT COMPLETED|Overall Study||2
219853|NCT00283400|522737|P4|COMPLETED|Overall Study||0
219854|NCT00283400|522738|P3|COMPLETED|Overall Study||6
219855|NCT00283400|522739|P2|COMPLETED|Overall Study||19
219856|NCT00283400|522740|P1|COMPLETED|Overall Study||18
219857|NCT00283400|522737|P4|STARTED|Overall Study||0
219858|NCT00283400|522738|P3|STARTED|Overall Study||7
219859|NCT00283400|522739|P2|STARTED|Overall Study||20
219860|NCT00283400|522740|P1|STARTED|Overall Study||20
219861|NCT00283387|522758|P2|NOT COMPLETED|Second Intervention||0
219862|NCT00283387|522759|P1|NOT COMPLETED|Second Intervention||0
219863|NCT00283387|522758|P2|COMPLETED|Second Intervention||5
219864|NCT00283387|522759|P1|COMPLETED|Second Intervention||5
219865|NCT00283387|522758|P2|STARTED|Second Intervention||5
219866|NCT00283387|522759|P1|STARTED|Second Intervention||5
219867|NCT00283387|522758|P2|NOT COMPLETED|Washout Period of 2 Months||0
219868|NCT00283387|522759|P1|NOT COMPLETED|Washout Period of 2 Months||0
219869|NCT00283387|522758|P2|COMPLETED|Washout Period of 2 Months||5
219870|NCT00283387|522759|P1|COMPLETED|Washout Period of 2 Months||5
219871|NCT00283387|522758|P2|STARTED|Washout Period of 2 Months||5
219872|NCT00283387|522759|P1|STARTED|Washout Period of 2 Months||5
219873|NCT00283387|522758|P2|NOT COMPLETED|First Intervention||2
219874|NCT00283387|522759|P1|NOT COMPLETED|First Intervention||1
219875|NCT00283387|522758|P2|COMPLETED|First Intervention||5
219876|NCT00283387|522759|P1|COMPLETED|First Intervention||5
219877|NCT00283387|522758|P2|STARTED|First Intervention||7
219878|NCT00283387|522759|P1|STARTED|First Intervention||6
219879|NCT00283296|522765|P1|NOT COMPLETED|Overall Study||5
219880|NCT00283296|522765|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
219881|NCT00283296|522765|P1|STARTED|Overall Study||14
219882|NCT00283075|522771|P2|NOT COMPLETED|Overall Study||0
219883|NCT00283075|522772|P1|NOT COMPLETED|Overall Study||0
219884|NCT00283075|522771|P2|COMPLETED|Overall Study||6
219885|NCT00283075|522772|P1|COMPLETED|Overall Study||25
219886|NCT00283075|522771|P2|STARTED|Overall Study||6
219887|NCT00283075|522772|P1|STARTED|Overall Study||25
219888|NCT00283062|522787|P4|NOT COMPLETED|Overall Study||49
219889|NCT00283062|522788|P3|NOT COMPLETED|Overall Study||41
219890|NCT00283062|522789|P2|NOT COMPLETED|Overall Study||7
219891|NCT00283062|522790|P1|NOT COMPLETED|Overall Study||12
219892|NCT00283062|522787|P4|COMPLETED|Overall Study||13
219893|NCT00283062|522788|P3|COMPLETED|Overall Study||15
219894|NCT00283062|522789|P2|COMPLETED|Overall Study||48
219895|NCT00283062|522790|P1|COMPLETED|Overall Study||43
219896|NCT00283062|522787|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
219897|NCT00283062|522788|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
219898|NCT00283062|522789|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
219899|NCT00283062|522790|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
219900|NCT00283062|522787|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
219901|NCT00283062|522788|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
219902|NCT00283062|522789|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
219903|NCT00283062|522790|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
219904|NCT00283062|522787|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
219905|NCT00283062|522788|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
219906|NCT00283062|522789|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
219907|NCT00283062|522790|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
219908|NCT00283062|522787|P4|STARTED|Overall Study||62
219909|NCT00283062|522788|P3|STARTED|Overall Study||56
219910|NCT00283062|522789|P2|STARTED|Overall Study||55
219911|NCT00283062|522790|P1|STARTED|Overall Study||55
219912|NCT00283049|522823|P3|NOT COMPLETED|Overall Study||54
219913|NCT00283049|522824|P2|NOT COMPLETED|Overall Study||45
219914|NCT00283049|522825|P1|NOT COMPLETED|Overall Study||58
219915|NCT00283049|522823|P3|COMPLETED|Overall Study||76
219916|NCT00283049|522824|P2|COMPLETED|Overall Study||83
219917|NCT00283049|522825|P1|COMPLETED|Overall Study||70
219918|NCT00283049|522823|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
219919|NCT00283049|522824|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
219920|NCT00283049|522825|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
219921|NCT00282984|522853|P2|NOT COMPLETED|Overall Study||61
219922|NCT00282984|522854|P1|NOT COMPLETED|Overall Study||51
219923|NCT00282984|522853|P2|COMPLETED|Overall Study||289
219924|NCT00282984|522854|P1|COMPLETED|Overall Study||302
219925|NCT00282984|522853|P2|STARTED|Overall Study||350
219926|NCT00282984|522854|P1|STARTED|Overall Study||353
219927|NCT00282971|522880|P2|NOT COMPLETED|Overall Study||22
219928|NCT00282971|522881|P1|NOT COMPLETED|Overall Study||34
219929|NCT00282971|522880|P2|COMPLETED|Overall Study||149
219930|NCT00282971|522881|P1|COMPLETED|Overall Study||146
219931|NCT00282971|522880|P2|STARTED|Overall Study||171
219932|NCT00282971|522881|P1|STARTED|Overall Study||180
219933|NCT00282919|522891|P1|NOT COMPLETED|Overall Study||7
219934|NCT00282919|522891|P1|COMPLETED|Overall Study||103
219935|NCT00282919|522891|P1|STARTED|Overall Study||110
219936|NCT00282867|522906|P3|NOT COMPLETED|Overall Study||0
219937|NCT00282867|522907|P2|NOT COMPLETED|Overall Study||1
219938|NCT00282867|522908|P1|NOT COMPLETED|Overall Study||1
219939|NCT00282867|522906|P3|COMPLETED|Overall Study||25
219940|NCT00282867|522907|P2|COMPLETED|Overall Study||24
219941|NCT00282867|522908|P1|COMPLETED|Overall Study||23
219942|NCT00282867|522906|P3|STARTED|Overall Study||25
219943|NCT00282867|522907|P2|STARTED|Overall Study||25
219944|NCT00282867|522908|P1|STARTED|Overall Study||24
219945|NCT00282828|522925|P3|NOT COMPLETED|Overall Study||9
219946|NCT00282828|522926|P2|NOT COMPLETED|Overall Study||12
219947|NCT00282828|522927|P1|NOT COMPLETED|Overall Study||6
219948|NCT00282828|522925|P3|COMPLETED|Overall Study||50
219949|NCT00282828|522926|P2|COMPLETED|Overall Study||47
219950|NCT00282828|522927|P1|COMPLETED|Overall Study||57
219951|NCT00282828|522925|P3|STARTED|Overall Study||59
219952|NCT00282828|522926|P2|STARTED|Overall Study||59
219953|NCT00282828|522927|P1|STARTED|Overall Study||63
219954|NCT00282815|522940|P2|NOT COMPLETED|Overall Study||6
219955|NCT00282815|522941|P1|NOT COMPLETED|Overall Study||7
219956|NCT00282815|522940|P2|COMPLETED|Overall Study||11
219957|NCT00282815|522941|P1|COMPLETED|Overall Study||8
219958|NCT00282815|522940|P2|STARTED|Overall Study||17
219959|NCT00282815|522941|P1|STARTED|Overall Study||15
219960|NCT00281697|522952|P2|NOT COMPLETED|Overall Study||197
219961|NCT00281697|522953|P1|NOT COMPLETED|Overall Study||401
219962|NCT00281697|522952|P2|COMPLETED|Overall Study||28
219963|NCT00281697|522953|P1|COMPLETED|Overall Study||58
219964|NCT00281697|522952|P2|STARTED|Overall Study||225
219965|NCT00281697|522953|P1|STARTED|Overall Study||459
219966|NCT00281658|522971|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
219967|NCT00281658|522972|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
219968|NCT00281658|522973|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
219969|NCT00281658|522971|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
219970|NCT00281658|522972|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
219971|NCT00281658|522973|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
219972|NCT00281658|522971|P3|STARTED|Open-label Monotherapy Extension Phase||149
219973|NCT00281658|522972|P2|STARTED|Open-label Monotherapy Extension Phase||0
219974|NCT00281658|522973|P1|STARTED|Open-label Monotherapy Extension Phase||0
219975|NCT00281658|522971|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
219976|NCT00281658|522972|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
219977|NCT00281658|522973|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
219978|NCT00281658|522971|P3|COMPLETED|Double-blind, Randomized Phase||0
219979|NCT00281658|522972|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
219980|NCT00281658|522973|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
219981|NCT00281658|522971|P3|STARTED|Double-blind, Randomized Phase||0
219982|NCT00281658|522972|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
219983|NCT00281658|522973|P1|STARTED|Double-blind, Randomized Phase||222
219984|NCT00281632|522990|P1|NOT COMPLETED|Overall Study||36
219985|NCT00281632|522990|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
219986|NCT00281632|522990|P1|STARTED|Overall Study||36
219987|NCT00282672|523020|P4|NOT COMPLETED|5 Year: Follow up||5
219988|NCT00282672|523021|P3|NOT COMPLETED|5 Year: Follow up||0
219989|NCT00282672|523022|P2|NOT COMPLETED|5 Year: Follow up||5
219990|NCT00282672|523023|P1|NOT COMPLETED|5 Year: Follow up||1
219991|NCT00282672|523020|P4|COMPLETED|5 Year: Follow up||20
219992|NCT00282672|523021|P3|COMPLETED|5 Year: Follow up||12
219993|NCT00282672|523022|P2|COMPLETED|5 Year: Follow up||27
219994|NCT00282672|523023|P1|COMPLETED|5 Year: Follow up||14
219995|NCT00282672|523020|P4|STARTED|5 Year: Follow up|11 withdrew|25
219996|NCT00282672|523021|P3|STARTED|5 Year: Follow up|3 withdrew|12
219997|NCT00282672|523022|P2|STARTED|5 Year: Follow up|7 withdrew|32
219998|NCT00282672|523023|P1|STARTED|5 Year: Follow up|1 withdrew|15
219999|NCT00282672|523020|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
220000|NCT00282672|523021|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
220001|NCT00282672|523022|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
220002|NCT00282672|523023|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
220003|NCT00282672|523020|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
220004|NCT00282672|523021|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
220005|NCT00282672|523022|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
220006|NCT00282672|523023|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
220007|NCT00282672|523020|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
220008|NCT00282672|523021|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
220009|NCT00282672|523022|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
220010|NCT00282672|523023|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
220011|NCT00282672|523020|P4|NOT COMPLETED|1 Year||4
220012|NCT00282672|523021|P3|NOT COMPLETED|1 Year||1
220013|NCT00282672|523022|P2|NOT COMPLETED|1 Year||2
220014|NCT00282672|523023|P1|NOT COMPLETED|1 Year||3
220015|NCT00282672|523020|P4|COMPLETED|1 Year||38
220016|NCT00282672|523021|P3|COMPLETED|1 Year||20
220017|NCT00282672|523022|P2|COMPLETED|1 Year||40
220018|NCT00282672|523023|P1|COMPLETED|1 Year||19
220019|NCT00282672|523020|P4|STARTED|1 Year||42
220020|NCT00282672|523021|P3|STARTED|1 Year||21
220021|NCT00282672|523022|P2|STARTED|1 Year||42
220022|NCT00282672|523023|P1|STARTED|1 Year||22
220023|NCT00282568|523069|P1|NOT COMPLETED|Extended Treatment Period||24
220024|NCT00282568|523069|P1|COMPLETED|Extended Treatment Period||42
220025|NCT00282568|523069|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
220026|NCT00282568|523069|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
220027|NCT00282568|523069|P1|COMPLETED|Pharmacokinetic Treatment Period||67
220028|NCT00282568|523069|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
220029|NCT00282568|523069|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
220030|NCT00282568|523069|P1|STARTED|Pharmacokinetic Treatment Period||70
220031|NCT00282464|523095|P2|NOT COMPLETED|Overall Study||62
220032|NCT00282464|523096|P1|NOT COMPLETED|Overall Study||73
220033|NCT00282464|523095|P2|COMPLETED|Overall Study||134
220034|NCT00282464|523096|P1|COMPLETED|Overall Study||112
220035|NCT00282464|523095|P2|STARTED|Overall Study||196
220036|NCT00282464|523096|P1|STARTED|Overall Study||185
220037|NCT00282347|523146|P2|NOT COMPLETED|B Cell Follow-up Period||0
220038|NCT00282347|523147|P1|NOT COMPLETED|B Cell Follow-up Period||5
220039|NCT00282347|523146|P2|COMPLETED|B Cell Follow-up Period||4
220040|NCT00282347|523147|P1|COMPLETED|B Cell Follow-up Period||15
220041|NCT00282347|523146|P2|STARTED|B Cell Follow-up Period||4
220042|NCT00282347|523147|P1|STARTED|B Cell Follow-up Period||20
220043|NCT00282347|523146|P2|NOT COMPLETED|Safety Follow-up Period||6
220044|NCT00282347|523147|P1|NOT COMPLETED|Safety Follow-up Period||3
220045|NCT00282347|523146|P2|COMPLETED|Safety Follow-up Period||57
220046|NCT00282347|523147|P1|COMPLETED|Safety Follow-up Period||64
220047|NCT00282347|523146|P2|STARTED|Safety Follow-up Period||63
220048|NCT00282347|523147|P1|STARTED|Safety Follow-up Period||67
220049|NCT00282347|523146|P2|NOT COMPLETED|Treatment Period||9
220050|NCT00282347|523147|P1|NOT COMPLETED|Treatment Period||5
220051|NCT00282347|523146|P2|COMPLETED|Treatment Period||63
220052|NCT00282347|523147|P1|COMPLETED|Treatment Period||67
220053|NCT00282347|523146|P2|STARTED|Treatment Period||72
220054|NCT00282347|523147|P1|STARTED|Treatment Period||72
220055|NCT00282334|523173|P2|NOT COMPLETED|Overall Study||5
220056|NCT00282334|523174|P1|NOT COMPLETED|Overall Study||8
220057|NCT00282334|523173|P2|COMPLETED|Overall Study||118
220058|NCT00282334|523174|P1|COMPLETED|Overall Study||105
220059|NCT00282334|523173|P2|STARTED|Overall Study||123
220060|NCT00282334|523174|P1|STARTED|Overall Study||113
220061|NCT00282308|523182|P3|NOT COMPLETED|Safety Follow-up Period||19
220062|NCT00282308|523183|P2|NOT COMPLETED|Safety Follow-up Period||0
220063|NCT00282308|523184|P1|NOT COMPLETED|Safety Follow-up Period||0
220064|NCT00282308|523182|P3|COMPLETED|Safety Follow-up Period||81
220065|NCT00282308|523183|P2|COMPLETED|Safety Follow-up Period||0
220066|NCT00282308|523184|P1|COMPLETED|Safety Follow-up Period||0
220067|NCT00282308|523182|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
220068|NCT00282308|523183|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
220069|NCT00282308|523184|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
220070|NCT00282308|523182|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
220071|NCT00282308|523183|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
220072|NCT00282308|523184|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
220073|NCT00282308|523182|P3|COMPLETED|Optional Extension Re-treatment Period||72
220074|NCT00282308|523183|P2|COMPLETED|Optional Extension Re-treatment Period||0
220075|NCT00282308|523184|P1|COMPLETED|Optional Extension Re-treatment Period||0
220076|NCT00282308|523182|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
220077|NCT00282308|523183|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
220078|NCT00282308|523184|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
220079|NCT00282308|523182|P3|NOT COMPLETED|Treatment Period||0
220080|NCT00282308|523183|P2|NOT COMPLETED|Treatment Period||6
220081|NCT00282308|523184|P1|NOT COMPLETED|Treatment Period||4
220082|NCT00282308|523182|P3|COMPLETED|Treatment Period||0
220083|NCT00282308|523183|P2|COMPLETED|Treatment Period||28
220084|NCT00282308|523184|P1|COMPLETED|Treatment Period||65
220085|NCT00282308|523182|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
220086|NCT00282308|523183|P2|STARTED|Treatment Period||34
220087|NCT00282308|523184|P1|STARTED|Treatment Period||69
220088|NCT00282282|523211|P1|NOT COMPLETED|Overall Study||0
220089|NCT00282282|523211|P1|COMPLETED|Overall Study||29
220090|NCT00282282|523211|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
220091|NCT00282256|523217|P1|NOT COMPLETED|Extension Treatment Period||2
220092|NCT00282256|523217|P1|COMPLETED|Extension Treatment Period||16
220093|NCT00282256|523217|P1|STARTED|Extension Treatment Period||18
220094|NCT00282256|523217|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
220095|NCT00282256|523217|P1|COMPLETED|Pharmacokinetic Treatment Period||18
220096|NCT00282256|523217|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
220097|NCT00282256|523217|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
220098|NCT00282256|523217|P1|STARTED|Pharmacokinetic Treatment Period||19
220099|NCT00282243|523238|P1|NOT COMPLETED|Extension Treatment Period||22
220100|NCT00282243|523238|P1|COMPLETED|Extension Treatment Period||43
220101|NCT00282243|523238|P1|STARTED|Extension Treatment Period||65
220102|NCT00282243|523238|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
220103|NCT00282243|523238|P1|COMPLETED|Pharmacokinetic Treatment Period||65
220104|NCT00282243|523238|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
220105|NCT00282243|523238|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
220106|NCT00282243|523238|P1|STARTED|Pharmacokinetic Treatment Period||70
220107|NCT00282113|523265|P3|NOT COMPLETED|Overall Study||0
220108|NCT00282113|523266|P2|NOT COMPLETED|Overall Study||0
220109|NCT00282113|523267|P1|NOT COMPLETED|Overall Study||1
220110|NCT00282113|523265|P3|COMPLETED|Overall Study||29
220111|NCT00282113|523266|P2|COMPLETED|Overall Study||30
220112|NCT00282113|523267|P1|COMPLETED|Overall Study||30
220113|NCT00282113|523265|P3|STARTED|Overall Study||29
220114|NCT00282113|523266|P2|STARTED|Overall Study||30
220115|NCT00282113|523267|P1|STARTED|Overall Study||31
220116|NCT00282087|523281|P1|NOT COMPLETED|Overall Study||1
220117|NCT00282087|523281|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
220118|NCT00282087|523281|P1|STARTED|Overall Study||47
220119|NCT00282048|523294|P1|NOT COMPLETED|Overall Study||62
220120|NCT00282048|523294|P1|COMPLETED|Overall Study||0
220121|NCT00282048|523294|P1|STARTED|Overall Study||62
220122|NCT00281957|523308|P2|NOT COMPLETED|Overall Study||42
220123|NCT00281957|523309|P1|NOT COMPLETED|Overall Study||67
220124|NCT00281957|523308|P2|COMPLETED|Overall Study||0
220125|NCT00281957|523309|P1|COMPLETED|Overall Study||0
220126|NCT00281957|523308|P2|Eligible and Received Treatment|Overall Study||39
220127|NCT00281957|523309|P1|Eligible and Received Treatment|Overall Study||63
220128|NCT00281957|523308|P2|Eligible|Overall Study||40
220129|NCT00281957|523309|P1|Eligible|Overall Study||66
220130|NCT00281957|523308|P2|STARTED|Overall Study||42
220131|NCT00281957|523309|P1|STARTED|Overall Study||67
220132|NCT00281918|523323|P2|NOT COMPLETED|Overall Study||108
220133|NCT00281918|523324|P1|NOT COMPLETED|Overall Study||142
220134|NCT00281918|523323|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
220135|NCT00281918|523324|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
220136|NCT00281918|523323|P2|Safety Population; Received Study Drug|Overall Study||402
220137|NCT00281918|523324|P1|Safety Population; Received Study Drug|Overall Study||398
220138|NCT00281918|523323|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
220139|NCT00281918|523324|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
220140|NCT00281879|523358|P8|NOT COMPLETED|Overall Study||1
220141|NCT00281879|523359|P7|NOT COMPLETED|Overall Study||0
220142|NCT00281879|523360|P6|NOT COMPLETED|Overall Study||9
220143|NCT00281879|523361|P5|NOT COMPLETED|Overall Study||6
220144|NCT00281879|523362|P4|NOT COMPLETED|Overall Study||0
220145|NCT00281879|523363|P3|NOT COMPLETED|Overall Study||20
220146|NCT00281879|523364|P2|NOT COMPLETED|Overall Study||36
220147|NCT00281879|523365|P1|NOT COMPLETED|Overall Study||128
220148|NCT00281879|523358|P8|COMPLETED|Overall Study||0
220149|NCT00281879|523359|P7|COMPLETED|Overall Study||0
220150|NCT00281879|523360|P6|COMPLETED|Overall Study||0
220151|NCT00281879|523361|P5|COMPLETED|Overall Study||0
220152|NCT00281879|523362|P4|COMPLETED|Overall Study||0
220153|NCT00281879|523363|P3|COMPLETED|Overall Study||0
220154|NCT00281879|523364|P2|COMPLETED|Overall Study||0
220155|NCT00281879|523365|P1|COMPLETED|Overall Study||0
220156|NCT00281879|523358|P8|STARTED|Overall Study||1
220157|NCT00281879|523359|P7|STARTED|Overall Study||0
220158|NCT00281879|523360|P6|STARTED|Overall Study||9
220159|NCT00281879|523361|P5|STARTED|Overall Study||6
220160|NCT00281879|523362|P4|STARTED|Overall Study||0
220161|NCT00281879|523363|P3|STARTED|Overall Study||20
220162|NCT00281879|523364|P2|STARTED|Overall Study||36
220163|NCT00281879|523365|P1|STARTED|Overall Study||128
220164|NCT00281840|523383|P1|NOT COMPLETED|Overall Study||25
220165|NCT00281840|523383|P1|COMPLETED|Overall Study||5
220166|NCT00281840|523383|P1|STARTED|Overall Study||30
220167|NCT00281827|523388|P1|NOT COMPLETED|Overall Study||0
220168|NCT00281827|523388|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
220169|NCT00281827|523388|P1|STARTED|Overall Study||22
220170|NCT00281580|523413|P16|NOT COMPLETED|Overall Study||13
220171|NCT00281580|523414|P15|NOT COMPLETED|Overall Study||7
220172|NCT00281580|523415|P14|NOT COMPLETED|Overall Study||7
220173|NCT00281580|523416|P13|NOT COMPLETED|Overall Study||13
220174|NCT00281580|523417|P12|NOT COMPLETED|Overall Study||10
220175|NCT00281580|523418|P11|NOT COMPLETED|Overall Study||4
220176|NCT00281580|523419|P10|NOT COMPLETED|Overall Study||12
220177|NCT00281580|523420|P9|NOT COMPLETED|Overall Study||8
220178|NCT00281580|523421|P8|NOT COMPLETED|Overall Study||1
220179|NCT00281580|523422|P7|NOT COMPLETED|Overall Study||5
220180|NCT00281580|523423|P6|NOT COMPLETED|Overall Study||3
220181|NCT00281580|523424|P5|NOT COMPLETED|Overall Study||4
220182|NCT00281580|523425|P4|NOT COMPLETED|Overall Study||17
220183|NCT00281580|523426|P3|NOT COMPLETED|Overall Study||5
220184|NCT00281580|523427|P2|NOT COMPLETED|Overall Study||1
220185|NCT00281580|523428|P1|NOT COMPLETED|Overall Study||7
220186|NCT00281580|523413|P16|COMPLETED|Overall Study||116
220187|NCT00281580|523414|P15|COMPLETED|Overall Study||133
220188|NCT00281580|523415|P14|COMPLETED|Overall Study||43
220189|NCT00281580|523416|P13|COMPLETED|Overall Study||129
220190|NCT00281580|523417|P12|COMPLETED|Overall Study||136
220191|NCT00281580|523418|P11|COMPLETED|Overall Study||44
220192|NCT00281580|523419|P10|COMPLETED|Overall Study||117
220193|NCT00281580|523420|P9|COMPLETED|Overall Study||135
220194|NCT00281580|523421|P8|COMPLETED|Overall Study||46
220195|NCT00281580|523422|P7|COMPLETED|Overall Study||39
220196|NCT00281580|523423|P6|COMPLETED|Overall Study||43
220197|NCT00281580|523424|P5|COMPLETED|Overall Study||40
220198|NCT00281580|523425|P4|COMPLETED|Overall Study||118
220199|NCT00281580|523426|P3|COMPLETED|Overall Study||125
220200|NCT00281580|523427|P2|COMPLETED|Overall Study||41
220201|NCT00281580|523428|P1|COMPLETED|Overall Study||39
220202|NCT00281580|523413|P16|STARTED|Overall Study||129
220203|NCT00281580|523414|P15|STARTED|Overall Study||140
220204|NCT00281580|523415|P14|STARTED|Overall Study||50
220205|NCT00281580|523416|P13|STARTED|Overall Study||142
220206|NCT00281580|523417|P12|STARTED|Overall Study||146
220207|NCT00281580|523418|P11|STARTED|Overall Study||48
220208|NCT00281580|523419|P10|STARTED|Overall Study||129
220209|NCT00281580|523420|P9|STARTED|Overall Study||143
220210|NCT00281580|523421|P8|STARTED|Overall Study||47
220211|NCT00281580|523422|P7|STARTED|Overall Study||44
220212|NCT00281580|523423|P6|STARTED|Overall Study||46
220213|NCT00281580|523424|P5|STARTED|Overall Study||44
220214|NCT00281580|523425|P4|STARTED|Overall Study||135
220215|NCT00281580|523426|P3|STARTED|Overall Study||130
220216|NCT00281580|523427|P2|STARTED|Overall Study||42
220217|NCT00281580|523428|P1|STARTED|Overall Study||46
220218|NCT00281528|523775|P3|NOT COMPLETED|Overall Study||79
220219|NCT00281528|523776|P2|NOT COMPLETED|Overall Study||54
220220|NCT00281528|523777|P1|NOT COMPLETED|Overall Study||75
220221|NCT00281528|523775|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
220222|NCT00281528|523776|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
220223|NCT00281528|523777|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
220224|NCT00281528|523775|P3|STARTED|Overall Study||79
220225|NCT00281528|523776|P2|STARTED|Overall Study||54
220226|NCT00281528|523777|P1|STARTED|Overall Study||75
220227|NCT00281463|523821|P1|NOT COMPLETED|Overall Study||0
220228|NCT00281463|523821|P1|COMPLETED|Overall Study||45
220229|NCT00281463|523821|P1|STARTED|Overall Study||45
220230|NCT00281320|523828|P2|NOT COMPLETED|Overall Study||21
220231|NCT00281320|523829|P1|NOT COMPLETED|Overall Study||25
220232|NCT00281320|523828|P2|COMPLETED|Overall Study||40
220233|NCT00281320|523829|P1|COMPLETED|Overall Study||36
220234|NCT00281320|523828|P2|STARTED|Overall Study||61
220235|NCT00281320|523829|P1|STARTED|Overall Study||61
220236|NCT00281099|523851|P2|NOT COMPLETED|Overall Study||222
220237|NCT00281099|523852|P1|NOT COMPLETED|Overall Study||205
220238|NCT00281099|523851|P2|COMPLETED|Overall Study||296
220239|NCT00281099|523852|P1|COMPLETED|Overall Study||308
220240|NCT00281099|523851|P2|STARTED|Overall Study||518
220241|NCT00281099|523852|P1|STARTED|Overall Study||513
220242|NCT00281021|523893|P1|NOT COMPLETED|Overall Study||2
220243|NCT00281021|523893|P1|COMPLETED|Overall Study||24
220244|NCT00281021|523893|P1|STARTED|Overall Study||26
220245|NCT00280917|523901|P4|NOT COMPLETED|Overall Study||2
220246|NCT00280917|523902|P3|NOT COMPLETED|Overall Study||6
220247|NCT00280917|523903|P2|NOT COMPLETED|Overall Study||6
220248|NCT00280917|523904|P1|NOT COMPLETED|Overall Study||2
220249|NCT00280917|523901|P4|COMPLETED|Overall Study||61
220250|NCT00280917|523902|P3|COMPLETED|Overall Study||57
220251|NCT00280917|523903|P2|COMPLETED|Overall Study||57
220252|NCT00280917|523904|P1|COMPLETED|Overall Study||63
220253|NCT00280917|523901|P4|STARTED|Overall Study||63
220254|NCT00280917|523902|P3|STARTED|Overall Study||63
220255|NCT00280917|523903|P2|STARTED|Overall Study||63
220256|NCT00280917|523904|P1|STARTED|Overall Study||65
220257|NCT00280904|523914|P1|NOT COMPLETED|Overall Study||0
220258|NCT00280904|523914|P1|COMPLETED|Overall Study||433
220259|NCT00280904|523914|P1|STARTED|Overall Study||433
220260|NCT00280059|523921|P2|NOT COMPLETED|Extension Phase||38
220261|NCT00280059|523922|P1|NOT COMPLETED|Extension Phase||49
220262|NCT00280059|523921|P2|COMPLETED|Extension Phase||177
220263|NCT00280059|523922|P1|COMPLETED|Extension Phase||145
220264|NCT00280059|523921|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
220265|NCT00280059|523922|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
220266|NCT00280059|523921|P2|NOT COMPLETED|Efficacy Assessment Phase||80
220267|NCT00280059|523922|P1|NOT COMPLETED|Efficacy Assessment Phase||94
220268|NCT00280059|523921|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
220269|NCT00280059|523922|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
220270|NCT00280059|523921|P2|STARTED|Efficacy Assessment Phase||330
220271|NCT00280059|523922|P1|STARTED|Efficacy Assessment Phase||330
220272|NCT00279955|523971|P3|NOT COMPLETED|Overall Study||0
220273|NCT00279955|523972|P2|NOT COMPLETED|Overall Study||0
220274|NCT00279955|523973|P1|NOT COMPLETED|Overall Study||0
220275|NCT00279955|523971|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
220276|NCT00279955|523972|P2|COMPLETED|Overall Study||486
220277|NCT00279955|523973|P1|COMPLETED|Overall Study||157
220278|NCT00279955|523971|P3|STARTED|Overall Study||358
220279|NCT00279955|523972|P2|STARTED|Overall Study||486
220280|NCT00279955|523973|P1|STARTED|Overall Study||157
220281|NCT00280826|523984|P1|NOT COMPLETED|Overall Study||0
220282|NCT00280826|523984|P1|COMPLETED|Overall Study||6
220283|NCT00280826|523984|P1|STARTED|Overall Study||6
220284|NCT00280683|523994|P2|NOT COMPLETED|Overall Study||3
220285|NCT00280683|523995|P1|NOT COMPLETED|Overall Study||2
220286|NCT00280683|523994|P2|COMPLETED|Overall Study||7
220287|NCT00280683|523995|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
220288|NCT00280683|523994|P2|STARTED|Overall Study||10
220289|NCT00280683|523995|P1|STARTED|Overall Study||10
220290|NCT00280566|524005|P3|NOT COMPLETED|Period 2 Double Blind||57
220291|NCT00280566|524006|P2|NOT COMPLETED|Period 2 Double Blind||43
220292|NCT00280566|524007|P1|NOT COMPLETED|Period 2 Double Blind||0
220293|NCT00280566|524005|P3|COMPLETED|Period 2 Double Blind||54
220294|NCT00280566|524006|P2|COMPLETED|Period 2 Double Blind||84
220295|NCT00280566|524007|P1|COMPLETED|Period 2 Double Blind||0
220296|NCT00280566|524005|P3|STARTED|Period 2 Double Blind||111
220297|NCT00280566|524006|P2|STARTED|Period 2 Double Blind||127
220298|NCT00280566|524007|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
220299|NCT00280566|524005|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
220300|NCT00280566|524006|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
220301|NCT00280566|524007|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
220302|NCT00280566|524005|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
220303|NCT00280566|524006|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
220304|NCT00280566|524007|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
220305|NCT00280566|524005|P3|STARTED|Period 1 Open Label Ziprasidone||0
220306|NCT00280566|524006|P2|STARTED|Period 1 Open Label Ziprasidone||0
220307|NCT00280566|524007|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
220308|NCT00280397|524032|P1|NOT COMPLETED|Overall Study||1
220309|NCT00280397|524032|P1|COMPLETED|Overall Study||26
220310|NCT00280397|524032|P1|STARTED|Overall Study||27
220311|NCT00280384|524047|P8|NOT COMPLETED|Overall Study||0
220312|NCT00280384|524048|P7|NOT COMPLETED|Overall Study||0
220313|NCT00280384|524049|P6|NOT COMPLETED|Overall Study||0
220314|NCT00280384|524050|P5|NOT COMPLETED|Overall Study||0
220315|NCT00280384|524051|P4|NOT COMPLETED|Overall Study||0
220316|NCT00280384|524052|P3|NOT COMPLETED|Overall Study||0
220317|NCT00280384|524053|P2|NOT COMPLETED|Overall Study||0
220318|NCT00280384|524054|P1|NOT COMPLETED|Overall Study||0
220319|NCT00280384|524047|P8|COMPLETED|Overall Study||6
220320|NCT00280384|524048|P7|COMPLETED|Overall Study||6
220321|NCT00280384|524049|P6|COMPLETED|Overall Study||6
220322|NCT00280384|524050|P5|COMPLETED|Overall Study||6
220323|NCT00280384|524051|P4|COMPLETED|Overall Study||6
220324|NCT00280384|524052|P3|COMPLETED|Overall Study||6
220325|NCT00280384|524053|P2|COMPLETED|Overall Study||6
220326|NCT00280384|524054|P1|COMPLETED|Overall Study||6
220327|NCT00280384|524047|P8|STARTED|Overall Study||6
220328|NCT00280384|524048|P7|STARTED|Overall Study||6
220329|NCT00280384|524049|P6|STARTED|Overall Study||6
220330|NCT00280384|524050|P5|STARTED|Overall Study||6
220331|NCT00280384|524051|P4|STARTED|Overall Study||6
220332|NCT00280384|524052|P3|STARTED|Overall Study||6
220333|NCT00280384|524053|P2|STARTED|Overall Study||6
220334|NCT00280384|524054|P1|STARTED|Overall Study||6
220335|NCT00280293|524098|P2|NOT COMPLETED|Overall Study||23
220336|NCT00280293|524099|P1|NOT COMPLETED|Overall Study||26
220337|NCT00280293|524098|P2|COMPLETED|Overall Study||34
220338|NCT00280293|524099|P1|COMPLETED|Overall Study||29
220339|NCT00280293|524098|P2|STARTED|Overall Study||57
220340|NCT00280293|524099|P1|STARTED|Overall Study||55
220341|NCT00280241|524111|P1|NOT COMPLETED|Overall Study||10
220342|NCT00280241|524111|P1|COMPLETED|Overall Study||55
220343|NCT00280241|524111|P1|STARTED|Overall Study||65
220344|NCT00279916|524120|P2|NOT COMPLETED|Overall Study||5
220345|NCT00279916|524121|P1|NOT COMPLETED|Overall Study||7
220346|NCT00279916|524120|P2|COMPLETED|Overall Study||41
220347|NCT00279916|524121|P1|COMPLETED|Overall Study||38
220348|NCT00279916|524120|P2|STARTED|Overall Study||46
220349|NCT00279916|524121|P1|STARTED|Overall Study||45
220350|NCT00279708|524131|P2|NOT COMPLETED|Overall Study||5
220351|NCT00279708|524132|P1|NOT COMPLETED|Overall Study||3
220352|NCT00279708|524131|P2|COMPLETED|Overall Study||23
220353|NCT00279708|524132|P1|COMPLETED|Overall Study||24
220354|NCT00279708|524131|P2|STARTED|Overall Study|28 were randomized, one additional subject was enrolled, but not randomized.|28
220355|NCT00279708|524132|P1|STARTED|Overall Study|"Started meaning randomized"|27
220356|NCT00279591|524140|P2|NOT COMPLETED|Overall Study||0
220357|NCT00279591|524141|P1|NOT COMPLETED|Overall Study||0
220358|NCT00279591|524140|P2|COMPLETED|Overall Study||46
220359|NCT00279591|524141|P1|COMPLETED|Overall Study||48
220360|NCT00279591|524140|P2|STARTED|Overall Study||46
220361|NCT00279591|524141|P1|STARTED|Overall Study||48
220362|NCT00279305|524157|P2|NOT COMPLETED|Overall Study||1
220363|NCT00279305|524158|P1|NOT COMPLETED|Overall Study||8
220364|NCT00279305|524157|P2|COMPLETED|Overall Study||29
220365|NCT00279305|524158|P1|COMPLETED|Overall Study||49
220366|NCT00279305|524157|P2|STARTED|Overall Study||30
220367|NCT00279305|524158|P1|STARTED|Overall Study||57
220368|NCT00279214|524166|P2|NOT COMPLETED|Overall Study||2
220369|NCT00279214|524167|P1|NOT COMPLETED|Overall Study||3
220370|NCT00279214|524166|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
220371|NCT00279214|524167|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
220372|NCT00279214|524166|P2|STARTED|Overall Study||21
220373|NCT00279214|524167|P1|STARTED|Overall Study||22
220374|NCT00279201|524197|P6|NOT COMPLETED|Intensification Addendum||37
220375|NCT00279201|524198|P5|NOT COMPLETED|Intensification Addendum||29
220376|NCT00279201|524199|P4|NOT COMPLETED|Intensification Addendum||28
220377|NCT00279201|524200|P3|NOT COMPLETED|Intensification Addendum||23
220378|NCT00279201|524201|P2|NOT COMPLETED|Intensification Addendum||0
220379|NCT00279201|524202|P1|NOT COMPLETED|Intensification Addendum||0
220380|NCT00279201|524197|P6|COMPLETED|Intensification Addendum||162
220381|NCT00279201|524198|P5|COMPLETED|Intensification Addendum||142
220382|NCT00279201|524199|P4|COMPLETED|Intensification Addendum||172
220383|NCT00279201|524200|P3|COMPLETED|Intensification Addendum||151
220384|NCT00279201|524201|P2|COMPLETED|Intensification Addendum||0
220385|NCT00279201|524202|P1|COMPLETED|Intensification Addendum||0
220386|NCT00279201|524197|P6|STARTED|Intensification Addendum||199
220387|NCT00279201|524198|P5|STARTED|Intensification Addendum||171
220388|NCT00279201|524199|P4|STARTED|Intensification Addendum||200
220389|NCT00279201|524200|P3|STARTED|Intensification Addendum||174
220390|NCT00279201|524201|P2|STARTED|Intensification Addendum||0
220391|NCT00279201|524202|P1|STARTED|Intensification Addendum||0
220392|NCT00279201|524197|P6|NOT COMPLETED|Maintenance||0
220393|NCT00279201|524198|P5|NOT COMPLETED|Maintenance||0
220394|NCT00279201|524199|P4|NOT COMPLETED|Maintenance||0
220395|NCT00279201|524200|P3|NOT COMPLETED|Maintenance||0
220396|NCT00279201|524201|P2|NOT COMPLETED|Maintenance||234
220397|NCT00279201|524202|P1|NOT COMPLETED|Maintenance||231
220398|NCT00279201|524197|P6|COMPLETED|Maintenance||0
220399|NCT00279201|524198|P5|COMPLETED|Maintenance||0
220400|NCT00279201|524199|P4|COMPLETED|Maintenance||0
220401|NCT00279201|524200|P3|COMPLETED|Maintenance||0
220402|NCT00279201|524201|P2|COMPLETED|Maintenance||239
220403|NCT00279201|524202|P1|COMPLETED|Maintenance||188
220404|NCT00279201|524197|P6|STARTED|Maintenance||0
220405|NCT00279201|524198|P5|STARTED|Maintenance||0
220406|NCT00279201|524199|P4|STARTED|Maintenance||0
220407|NCT00279201|524200|P3|STARTED|Maintenance||0
220408|NCT00279201|524201|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
220409|NCT00279201|524202|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
220410|NCT00279201|524197|P6|NOT COMPLETED|Initiation||0
220411|NCT00279201|524198|P5|NOT COMPLETED|Initiation||0
220412|NCT00279201|524199|P4|NOT COMPLETED|Initiation||0
220413|NCT00279201|524200|P3|NOT COMPLETED|Initiation||0
220414|NCT00279201|524201|P2|NOT COMPLETED|Initiation||145
220415|NCT00279201|524202|P1|NOT COMPLETED|Initiation||128
220416|NCT00279201|524197|P6|COMPLETED|Initiation||0
220417|NCT00279201|524198|P5|COMPLETED|Initiation||0
220418|NCT00279201|524199|P4|COMPLETED|Initiation||0
220419|NCT00279201|524200|P3|COMPLETED|Initiation||0
220420|NCT00279201|524201|P2|COMPLETED|Initiation||900
220421|NCT00279201|524202|P1|COMPLETED|Initiation||918
220422|NCT00279201|524197|P6|STARTED|Initiation||0
220423|NCT00279201|524198|P5|STARTED|Initiation||0
220424|NCT00279201|524199|P4|STARTED|Initiation||0
220425|NCT00279201|524200|P3|STARTED|Initiation||0
220426|NCT00279201|524201|P2|STARTED|Initiation||1045
220427|NCT00279201|524202|P1|STARTED|Initiation||1046
220428|NCT00278993|524346|P1|NOT COMPLETED|Overall Study||107
220429|NCT00278993|524346|P1|COMPLETED|Overall Study||1
220430|NCT00278993|524346|P1|STARTED|Overall Study||108
220431|NCT00278954|524354|P1|NOT COMPLETED|Overall Study||5
220432|NCT00278954|524354|P1|COMPLETED|Overall Study||45
220433|NCT00278954|524354|P1|STARTED|Overall Study||50
220434|NCT00278915|524362|P1|NOT COMPLETED|Overall Study||1
220435|NCT00278915|524362|P1|COMPLETED|Overall Study||29
220436|NCT00278915|524362|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
220437|NCT00278889|524398|P3|NOT COMPLETED|Overall Study||20
220438|NCT00278889|524399|P2|NOT COMPLETED|Overall Study||27
220439|NCT00278889|524400|P1|NOT COMPLETED|Overall Study||25
220440|NCT00278889|524398|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
220441|NCT00278889|524399|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
220442|NCT00278889|524400|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
220443|NCT00278889|524398|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
220444|NCT00278889|524399|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
220445|NCT00278889|524400|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
220446|NCT00278889|524398|P3|STARTED|Overall Study|Randomised|68
220447|NCT00278889|524399|P2|STARTED|Overall Study|Randomised|74
220448|NCT00278889|524400|P1|STARTED|Overall Study|Randomised|73
220449|NCT00278876|524426|P1|NOT COMPLETED|Overall Study||9
220450|NCT00278876|524426|P1|COMPLETED|Overall Study||38
220451|NCT00278876|524426|P1|STARTED|Overall Study||47
220452|NCT00278863|524434|P2|NOT COMPLETED|Overall Study||2
220453|NCT00278863|524435|P1|NOT COMPLETED|Overall Study||5
220454|NCT00278863|524434|P2|COMPLETED|Overall Study||45
220455|NCT00278863|524435|P1|COMPLETED|Overall Study||44
220456|NCT00278863|524434|P2|STARTED|Overall Study||47
220457|NCT00278863|524435|P1|STARTED|Overall Study||49
220458|NCT00278655|524443|P1|NOT COMPLETED|Overall Study||0
220459|NCT00278655|524443|P1|COMPLETED|Overall Study||21
220460|NCT00278655|524443|P1|STARTED|Overall Study||21
220461|NCT00278525|524450|P2|NOT COMPLETED|Overall Study||0
220462|NCT00278525|524451|P1|NOT COMPLETED|Overall Study||0
220463|NCT00278525|524450|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
220464|NCT00278525|524451|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
220465|NCT00278525|524450|P2|STARTED|Overall Study||10
220466|NCT00278525|524451|P1|STARTED|Overall Study||9
220467|NCT00278395|524459|P1|NOT COMPLETED|Overall Study||3
220468|NCT00278395|524459|P1|COMPLETED|Overall Study||11
220469|NCT00278395|524459|P1|STARTED|Overall Study||14
220470|NCT00277524|524463|P4|NOT COMPLETED|Overall Study||0
220471|NCT00277524|524464|P3|NOT COMPLETED|Overall Study||0
220472|NCT00277524|524465|P2|NOT COMPLETED|Overall Study||0
220473|NCT00277524|524466|P1|NOT COMPLETED|Overall Study||0
220474|NCT00277524|524463|P4|COMPLETED|Overall Study||850
220475|NCT00277524|524464|P3|COMPLETED|Overall Study||1088
220476|NCT00277524|524465|P2|COMPLETED|Overall Study||324
220477|NCT00277524|524466|P1|COMPLETED|Overall Study||621
220478|NCT00277524|524463|P4|STARTED|Overall Study||850
220479|NCT00277524|524464|P3|STARTED|Overall Study||1088
220480|NCT00277524|524465|P2|STARTED|Overall Study||324
220481|NCT00277524|524466|P1|STARTED|Overall Study||621
220482|NCT00277446|524484|P1|NOT COMPLETED|Overall Study||0
220483|NCT00277446|524484|P1|COMPLETED|Overall Study||13
220484|NCT00277446|524484|P1|STARTED|Overall Study||13
220485|NCT00277394|524492|P2|NOT COMPLETED|Overall Study||24
220486|NCT00277394|524493|P1|NOT COMPLETED|Overall Study||37
220487|NCT00277394|524492|P2|COMPLETED|Overall Study||246
220488|NCT00277394|524493|P1|COMPLETED|Overall Study||232
220489|NCT00277394|524492|P2|STARTED|Overall Study||270
220490|NCT00277394|524493|P1|STARTED|Overall Study||269
220491|NCT00277355|524505|P2|NOT COMPLETED|Overall Study||5
220492|NCT00277355|524506|P1|NOT COMPLETED|Overall Study||14
220493|NCT00277355|524505|P2|COMPLETED|Overall Study||22
220494|NCT00277355|524506|P1|COMPLETED|Overall Study||73
220495|NCT00277355|524505|P2|STARTED|Overall Study||27
220496|NCT00277355|524506|P1|STARTED|Overall Study||87
220497|NCT00277212|524514|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
220498|NCT00277212|524515|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
220499|NCT00277212|524516|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
220500|NCT00277212|524514|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
220501|NCT00277212|524515|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
220502|NCT00277212|524516|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
220503|NCT00277212|524514|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
220504|NCT00277212|524515|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
220505|NCT00277212|524516|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
220506|NCT00277212|524514|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
220507|NCT00277212|524515|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
220508|NCT00277212|524516|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
220509|NCT00277212|524514|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
220510|NCT00277212|524515|P2|STARTED|Phase 2 - Double-Blind Treatment||173
220511|NCT00277212|524516|P1|STARTED|Phase 2 - Double-Blind Treatment||0
220512|NCT00277212|524514|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
220513|NCT00277212|524515|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
220514|NCT00277212|524516|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
220515|NCT00277212|524514|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
220516|NCT00277212|524515|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
220517|NCT00277212|524516|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
220518|NCT00277212|524514|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
220519|NCT00277212|524515|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
220520|NCT00277212|524516|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
220521|NCT00277212|524514|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
220522|NCT00277212|524515|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
220523|NCT00277212|524516|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
220524|NCT00277212|524514|P3|STARTED|Phase 1 - Single-Blind Treatment||0
220525|NCT00277212|524515|P2|STARTED|Phase 1 - Single-Blind Treatment||0
220526|NCT00277212|524516|P1|STARTED|Phase 1 - Single-Blind Treatment||787
220527|NCT00277095|524554|P1|NOT COMPLETED|Overall Study||21
220528|NCT00277095|524554|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
220529|NCT00277095|524554|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
220530|NCT00276861|524558|P1|NOT COMPLETED|Overall Study||0
220531|NCT00276861|524558|P1|COMPLETED|Overall Study||10
220532|NCT00276861|524558|P1|STARTED|Overall Study||10
220533|NCT00276614|524563|P1|NOT COMPLETED|Overall Study||3
220534|NCT00276614|524563|P1|COMPLETED|Overall Study||1
220535|NCT00276614|524563|P1|STARTED|Overall Study||4
220536|NCT00276549|524567|P1|NOT COMPLETED|Overall Study||0
220537|NCT00276549|524567|P1|COMPLETED|Overall Study||35
220538|NCT00276549|524567|P1|STARTED|Overall Study||35
220539|NCT00276484|524574|P2|NOT COMPLETED|Overall Study||13
220540|NCT00276484|524575|P1|NOT COMPLETED|Overall Study||9
220541|NCT00276484|524574|P2|COMPLETED|Overall Study||278
220542|NCT00276484|524575|P1|COMPLETED|Overall Study||279
220543|NCT00276484|524574|P2|STARTED|Overall Study||291
220544|NCT00276484|524575|P1|STARTED|Overall Study||288
220545|NCT00276458|524607|P2|NOT COMPLETED|Overall Study||7
220546|NCT00276458|524608|P1|NOT COMPLETED|Overall Study||6
220547|NCT00276458|524607|P2|COMPLETED|Overall Study||91
220548|NCT00276458|524608|P1|COMPLETED|Overall Study||92
220549|NCT00276458|524607|P2|STARTED|Overall Study||98
220550|NCT00276458|524608|P1|STARTED|Overall Study||98
220551|NCT00276419|524642|P2|NOT COMPLETED|Second Intervention||0
220552|NCT00276419|524643|P1|NOT COMPLETED|Second Intervention||0
220553|NCT00276419|524642|P2|COMPLETED|Second Intervention||8
220554|NCT00276419|524643|P1|COMPLETED|Second Intervention||7
220555|NCT00276419|524642|P2|STARTED|Second Intervention||8
220556|NCT00276419|524643|P1|STARTED|Second Intervention||7
220557|NCT00276419|524642|P2|NOT COMPLETED|Wash-out Phase||0
220558|NCT00276419|524643|P1|NOT COMPLETED|Wash-out Phase||0
220559|NCT00276419|524642|P2|COMPLETED|Wash-out Phase||8
220560|NCT00276419|524643|P1|COMPLETED|Wash-out Phase||7
220561|NCT00276419|524642|P2|STARTED|Wash-out Phase||8
220562|NCT00276419|524643|P1|STARTED|Wash-out Phase||7
220563|NCT00276419|524642|P2|NOT COMPLETED|First Intervention||2
220564|NCT00276419|524643|P1|NOT COMPLETED|First Intervention||1
220565|NCT00276419|524642|P2|COMPLETED|First Intervention||8
220566|NCT00276419|524643|P1|COMPLETED|First Intervention||7
220567|NCT00276419|524642|P2|STARTED|First Intervention||10
220568|NCT00276419|524643|P1|STARTED|First Intervention||8
220569|NCT00276406|524655|P2|NOT COMPLETED|Overall Study||0
220570|NCT00276406|524656|P1|NOT COMPLETED|Overall Study||0
220571|NCT00276406|524655|P2|COMPLETED|Overall Study||14
220572|NCT00276406|524656|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
220573|NCT00276406|524655|P2|STARTED|Overall Study||14
220574|NCT00276406|524656|P1|STARTED|Overall Study||16
220575|NCT00276250|524687|P3|NOT COMPLETED|Overall Study||0
220576|NCT00276250|524688|P2|NOT COMPLETED|Overall Study||0
220577|NCT00276250|524689|P1|NOT COMPLETED|Overall Study||0
220578|NCT00276250|524687|P3|COMPLETED|Overall Study||0
220579|NCT00276250|524688|P2|COMPLETED|Overall Study||1
220580|NCT00276250|524689|P1|COMPLETED|Overall Study||4
220581|NCT00276250|524687|P3|STARTED|Overall Study||0
220582|NCT00276250|524688|P2|STARTED|Overall Study||1
220583|NCT00276250|524689|P1|STARTED|Overall Study||4
220584|NCT00276159|524721|P1|NOT COMPLETED|Overall Study||6
220585|NCT00276159|524721|P1|COMPLETED|Overall Study||0
220586|NCT00276159|524721|P1|STARTED|Overall Study||6
220587|NCT00276094|524731|P3|NOT COMPLETED|Overall Study||38
220588|NCT00276094|524732|P2|NOT COMPLETED|Overall Study||42
220589|NCT00276094|524733|P1|NOT COMPLETED|Overall Study||57
220590|NCT00276094|524731|P3|COMPLETED|Overall Study||230
220591|NCT00276094|524732|P2|COMPLETED|Overall Study||234
220592|NCT00276094|524733|P1|COMPLETED|Overall Study||225
220593|NCT00276094|524731|P3|STARTED|Overall Study||268
220594|NCT00276094|524732|P2|STARTED|Overall Study||276
220595|NCT00276094|524733|P1|STARTED|Overall Study||282
220596|NCT00276016|524786|P6|NOT COMPLETED|Intervention 3||0
220597|NCT00276016|524787|P5|NOT COMPLETED|Intervention 3||0
220598|NCT00276016|524788|P4|NOT COMPLETED|Intervention 3||0
220599|NCT00276016|524789|P3|NOT COMPLETED|Intervention 3||0
220600|NCT00276016|524790|P2|NOT COMPLETED|Intervention 3||0
220601|NCT00276016|524791|P1|NOT COMPLETED|Intervention 3||0
220602|NCT00276016|524786|P6|COMPLETED|Intervention 3||6
220603|NCT00276016|524787|P5|COMPLETED|Intervention 3||6
220604|NCT00276016|524788|P4|COMPLETED|Intervention 3||6
220605|NCT00276016|524789|P3|COMPLETED|Intervention 3||7
220606|NCT00276016|524790|P2|COMPLETED|Intervention 3||6
220607|NCT00276016|524791|P1|COMPLETED|Intervention 3||7
220608|NCT00276016|524786|P6|STARTED|Intervention 3||6
220609|NCT00276016|524787|P5|STARTED|Intervention 3||6
220610|NCT00276016|524788|P4|STARTED|Intervention 3||6
220611|NCT00276016|524789|P3|STARTED|Intervention 3||7
220612|NCT00276016|524790|P2|STARTED|Intervention 3||6
220613|NCT00276016|524791|P1|STARTED|Intervention 3||7
220614|NCT00276016|524786|P6|NOT COMPLETED|Wash Out 2||0
220615|NCT00276016|524787|P5|NOT COMPLETED|Wash Out 2||0
220616|NCT00276016|524788|P4|NOT COMPLETED|Wash Out 2||0
220617|NCT00276016|524789|P3|NOT COMPLETED|Wash Out 2||0
220618|NCT00276016|524790|P2|NOT COMPLETED|Wash Out 2||0
220619|NCT00276016|524791|P1|NOT COMPLETED|Wash Out 2||0
220620|NCT00276016|524786|P6|COMPLETED|Wash Out 2||6
220621|NCT00276016|524787|P5|COMPLETED|Wash Out 2||6
220622|NCT00276016|524788|P4|COMPLETED|Wash Out 2||6
220623|NCT00276016|524789|P3|COMPLETED|Wash Out 2||7
220624|NCT00276016|524790|P2|COMPLETED|Wash Out 2||6
220625|NCT00276016|524791|P1|COMPLETED|Wash Out 2||7
220626|NCT00276016|524786|P6|STARTED|Wash Out 2||6
220627|NCT00276016|524787|P5|STARTED|Wash Out 2||6
220628|NCT00276016|524788|P4|STARTED|Wash Out 2||6
220629|NCT00276016|524789|P3|STARTED|Wash Out 2||7
220630|NCT00276016|524790|P2|STARTED|Wash Out 2||6
220631|NCT00276016|524791|P1|STARTED|Wash Out 2||7
220632|NCT00276016|524786|P6|NOT COMPLETED|Intervention 2||0
220633|NCT00276016|524787|P5|NOT COMPLETED|Intervention 2||0
220634|NCT00276016|524788|P4|NOT COMPLETED|Intervention 2||0
220635|NCT00276016|524789|P3|NOT COMPLETED|Intervention 2||0
220636|NCT00276016|524790|P2|NOT COMPLETED|Intervention 2||0
220637|NCT00276016|524791|P1|NOT COMPLETED|Intervention 2||0
220638|NCT00276016|524786|P6|COMPLETED|Intervention 2||6
220639|NCT00276016|524787|P5|COMPLETED|Intervention 2||6
220640|NCT00276016|524788|P4|COMPLETED|Intervention 2||6
220641|NCT00276016|524789|P3|COMPLETED|Intervention 2||7
220642|NCT00276016|524790|P2|COMPLETED|Intervention 2||6
220643|NCT00276016|524791|P1|COMPLETED|Intervention 2||7
220644|NCT00276016|524786|P6|STARTED|Intervention 2||6
220645|NCT00276016|524787|P5|STARTED|Intervention 2||6
220646|NCT00276016|524788|P4|STARTED|Intervention 2||6
220647|NCT00276016|524789|P3|STARTED|Intervention 2||7
220648|NCT00276016|524790|P2|STARTED|Intervention 2||6
220649|NCT00276016|524791|P1|STARTED|Intervention 2||7
220650|NCT00276016|524786|P6|NOT COMPLETED|Wash Out 1||0
220651|NCT00276016|524787|P5|NOT COMPLETED|Wash Out 1||0
220652|NCT00276016|524788|P4|NOT COMPLETED|Wash Out 1||0
220653|NCT00276016|524789|P3|NOT COMPLETED|Wash Out 1||0
220654|NCT00276016|524790|P2|NOT COMPLETED|Wash Out 1||0
220655|NCT00276016|524791|P1|NOT COMPLETED|Wash Out 1||0
220656|NCT00276016|524786|P6|COMPLETED|Wash Out 1||6
220657|NCT00276016|524787|P5|COMPLETED|Wash Out 1||6
220658|NCT00276016|524788|P4|COMPLETED|Wash Out 1||6
220659|NCT00276016|524789|P3|COMPLETED|Wash Out 1||7
220660|NCT00276016|524790|P2|COMPLETED|Wash Out 1||6
220661|NCT00276016|524791|P1|COMPLETED|Wash Out 1||7
220662|NCT00276016|524786|P6|STARTED|Wash Out 1||6
220663|NCT00276016|524787|P5|STARTED|Wash Out 1||6
220664|NCT00276016|524788|P4|STARTED|Wash Out 1||6
220665|NCT00276016|524789|P3|STARTED|Wash Out 1||7
220666|NCT00276016|524790|P2|STARTED|Wash Out 1||6
220667|NCT00276016|524791|P1|STARTED|Wash Out 1||7
220668|NCT00276016|524786|P6|NOT COMPLETED|Intervention 1||0
220669|NCT00276016|524787|P5|NOT COMPLETED|Intervention 1||0
220670|NCT00276016|524788|P4|NOT COMPLETED|Intervention 1||0
220671|NCT00276016|524789|P3|NOT COMPLETED|Intervention 1||0
220672|NCT00276016|524790|P2|NOT COMPLETED|Intervention 1||1
220673|NCT00276016|524791|P1|NOT COMPLETED|Intervention 1||0
220674|NCT00276016|524786|P6|COMPLETED|Intervention 1||6
220675|NCT00276016|524787|P5|COMPLETED|Intervention 1||6
220676|NCT00276016|524788|P4|COMPLETED|Intervention 1||6
220677|NCT00276016|524789|P3|COMPLETED|Intervention 1||7
220678|NCT00276016|524790|P2|COMPLETED|Intervention 1||6
220679|NCT00276016|524791|P1|COMPLETED|Intervention 1||7
220680|NCT00276016|524786|P6|STARTED|Intervention 1||6
220681|NCT00276016|524787|P5|STARTED|Intervention 1||6
220682|NCT00276016|524788|P4|STARTED|Intervention 1||6
220683|NCT00276016|524789|P3|STARTED|Intervention 1||7
220684|NCT00276016|524790|P2|STARTED|Intervention 1||7
220685|NCT00276016|524791|P1|STARTED|Intervention 1||7
220686|NCT00275834|524803|P3|NOT COMPLETED|Overall Study||1
220687|NCT00275834|524804|P2|NOT COMPLETED|Overall Study||3
220688|NCT00275834|524805|P1|NOT COMPLETED|Overall Study||3
220689|NCT00275834|524803|P3|COMPLETED|Overall Study||74
220690|NCT00275834|524804|P2|COMPLETED|Overall Study||73
220691|NCT00275834|524805|P1|COMPLETED|Overall Study||71
220692|NCT00275834|524803|P3|Completed Study While on Study Drug|Overall Study||62
220693|NCT00275834|524804|P2|Completed Study While on Study Drug|Overall Study||51
220694|NCT00275834|524805|P1|Completed Study While on Study Drug|Overall Study||54
220695|NCT00275834|524803|P3|STARTED|Overall Study||75
220696|NCT00275834|524804|P2|STARTED|Overall Study||76
220697|NCT00275834|524805|P1|STARTED|Overall Study||74
220698|NCT00275821|524837|P3|NOT COMPLETED|Overall Study||12
220699|NCT00275821|524838|P2|NOT COMPLETED|Overall Study||23
220700|NCT00275821|524839|P1|NOT COMPLETED|Overall Study||14
220701|NCT00275821|524837|P3|COMPLETED|Overall Study||103
220702|NCT00275821|524838|P2|COMPLETED|Overall Study||95
220703|NCT00275821|524839|P1|COMPLETED|Overall Study||106
220704|NCT00275821|524837|P3|STARTED|Overall Study||115
220705|NCT00275821|524838|P2|STARTED|Overall Study||118
220706|NCT00275821|524839|P1|STARTED|Overall Study||120
220707|NCT00275561|524858|P2|NOT COMPLETED|Overall Study||6
220708|NCT00275561|524859|P1|NOT COMPLETED|Overall Study||2
220709|NCT00275561|524858|P2|COMPLETED|Overall Study||15
220710|NCT00275561|524859|P1|COMPLETED|Overall Study||19
220711|NCT00275561|524858|P2|STARTED|Overall Study||21
220712|NCT00275561|524859|P1|STARTED|Overall Study||21
220713|NCT00275392|524871|P2|NOT COMPLETED|Overall Study||2
220714|NCT00275392|524872|P1|NOT COMPLETED|Overall Study||0
220715|NCT00275392|524871|P2|COMPLETED|Overall Study||17
220716|NCT00275392|524872|P1|COMPLETED|Overall Study||20
220717|NCT00275392|524871|P2|STARTED|Overall Study||19
220718|NCT00275392|524872|P1|STARTED|Overall Study||20
220719|NCT00275340|524882|P2|NOT COMPLETED|Overall Study||4
220720|NCT00275340|524883|P1|NOT COMPLETED|Overall Study||2
220721|NCT00275340|524882|P2|COMPLETED|Overall Study||45
220722|NCT00275340|524883|P1|COMPLETED|Overall Study||50
220723|NCT00275340|524882|P2|STARTED|Overall Study||49
220724|NCT00275340|524883|P1|STARTED|Overall Study||52
220725|NCT00275275|524890|P3|NOT COMPLETED|Overall Study||6
220726|NCT00275275|524891|P2|NOT COMPLETED|Overall Study||2
220727|NCT00275275|524892|P1|NOT COMPLETED|Overall Study||6
220728|NCT00275275|524890|P3|COMPLETED|Overall Study||15
220729|NCT00275275|524891|P2|COMPLETED|Overall Study||18
220730|NCT00275275|524892|P1|COMPLETED|Overall Study||14
220731|NCT00275275|524890|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
220732|NCT00275275|524891|P2|STARTED|Overall Study||20
220733|NCT00275275|524892|P1|STARTED|Overall Study||20
220734|NCT00275262|524902|P2|NOT COMPLETED|Overall Study||9
220735|NCT00275262|524903|P1|NOT COMPLETED|Overall Study||6
220736|NCT00275262|524902|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
220737|NCT00275262|524903|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
220738|NCT00275262|524902|P2|STARTED|Overall Study||13
220739|NCT00275262|524903|P1|STARTED|Overall Study||12
220740|NCT00275028|524917|P1|NOT COMPLETED|Overall Study||47
220741|NCT00275028|524917|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
220742|NCT00275028|524917|P1|STARTED|Overall Study||47
220743|NCT00275002|524924|P2|NOT COMPLETED|Overall Study||16
220744|NCT00275002|524925|P1|NOT COMPLETED|Overall Study||22
220745|NCT00275002|524924|P2|COMPLETED|Overall Study||0
220746|NCT00275002|524925|P1|COMPLETED|Overall Study||3
220747|NCT00275002|524924|P2|STARTED|Overall Study||16
220748|NCT00275002|524925|P1|STARTED|Overall Study||25
220749|NCT00274937|524933|P1|NOT COMPLETED|Overall Study||20
220750|NCT00274937|524933|P1|COMPLETED|Overall Study||91
220751|NCT00274937|524933|P1|STARTED|Overall Study||111
220752|NCT00274924|524945|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
220753|NCT00274924|524946|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
220754|NCT00274924|524947|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
220755|NCT00274924|524945|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
220756|NCT00274924|524946|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
220757|NCT00274924|524947|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
220758|NCT00274924|524945|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
220759|NCT00274924|524946|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
220760|NCT00274924|524947|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
220761|NCT00274924|524945|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
220762|NCT00274924|524946|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
220763|NCT00274924|524947|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
220764|NCT00274924|524945|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
220765|NCT00274924|524946|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
220766|NCT00274924|524947|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
220767|NCT00274924|524945|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
220768|NCT00274924|524946|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
220769|NCT00274924|524947|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
220770|NCT00274924|524945|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
220771|NCT00274924|524946|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
220772|NCT00274924|524947|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
220773|NCT00274924|524945|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
220774|NCT00274924|524946|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
220775|NCT00274924|524947|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
220776|NCT00274924|524945|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
220777|NCT00274924|524946|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
220778|NCT00274924|524947|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
220779|NCT00274846|524956|P1|NOT COMPLETED|Overall Study||1
220780|NCT00274846|524956|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
220781|NCT00274846|524956|P1|STARTED|Overall Study||21
220782|NCT00274781|524964|P1|NOT COMPLETED|Overall Study||0
220783|NCT00274781|524964|P1|COMPLETED|Overall Study||30
220784|NCT00274781|524964|P1|STARTED|Overall Study||30
220785|NCT00274768|524970|P1|NOT COMPLETED|Overall Study||0
220786|NCT00274768|524970|P1|COMPLETED|Overall Study||26
220787|NCT00274768|524970|P1|STARTED|Overall Study||26
220788|NCT00274742|524980|P6|NOT COMPLETED|Overall Study||3
220789|NCT00274742|524981|P5|NOT COMPLETED|Overall Study||16
220790|NCT00274742|524982|P4|NOT COMPLETED|Overall Study||5
220791|NCT00274742|524983|P3|NOT COMPLETED|Overall Study||2
220792|NCT00274742|524984|P2|NOT COMPLETED|Overall Study||8
220793|NCT00274742|524985|P1|NOT COMPLETED|Overall Study||0
220794|NCT00274742|524980|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
220795|NCT00274742|524981|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
220796|NCT00274742|524982|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
220797|NCT00274742|524983|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
220798|NCT00274742|524984|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
220799|NCT00274742|524985|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
220800|NCT00274742|524980|P6|STARTED|Overall Study||4
220801|NCT00274742|524981|P5|STARTED|Overall Study||32
220802|NCT00274742|524982|P4|STARTED|Overall Study||9
220803|NCT00274742|524983|P3|STARTED|Overall Study||6
220804|NCT00274742|524984|P2|STARTED|Overall Study||13
220805|NCT00274742|524985|P1|STARTED|Overall Study||12
220806|NCT00274716|525023|P6|NOT COMPLETED|Phase B||1
220807|NCT00274716|525024|P5|NOT COMPLETED|Phase B||0
220808|NCT00274716|525025|P4|NOT COMPLETED|Phase B||1
220809|NCT00274716|525026|P3|NOT COMPLETED|Phase B||3
220810|NCT00274716|525027|P2|NOT COMPLETED|Phase B||4
220811|NCT00274716|525028|P1|NOT COMPLETED|Phase B||1
220812|NCT00274716|525023|P6|COMPLETED|Phase B||14
220813|NCT00274716|525024|P5|COMPLETED|Phase B||16
220814|NCT00274716|525025|P4|COMPLETED|Phase B||41
220815|NCT00274716|525026|P3|COMPLETED|Phase B||41
220816|NCT00274716|525027|P2|COMPLETED|Phase B||40
220817|NCT00274716|525028|P1|COMPLETED|Phase B||42
220818|NCT00274716|525023|P6|STARTED|Phase B||15
220819|NCT00274716|525024|P5|STARTED|Phase B||16
220820|NCT00274716|525025|P4|STARTED|Phase B||42
220821|NCT00274716|525026|P3|STARTED|Phase B||44
220822|NCT00274716|525027|P2|STARTED|Phase B||44
220823|NCT00274716|525028|P1|STARTED|Phase B||43
220824|NCT00274716|525023|P6|NOT COMPLETED|Phase A||4
220825|NCT00274716|525024|P5|NOT COMPLETED|Phase A||3
220826|NCT00274716|525025|P4|NOT COMPLETED|Phase A||9
220827|NCT00274716|525026|P3|NOT COMPLETED|Phase A||8
220828|NCT00274716|525027|P2|NOT COMPLETED|Phase A||10
220829|NCT00274716|525028|P1|NOT COMPLETED|Phase A||11
220830|NCT00274716|525023|P6|COMPLETED|Phase A||15
220831|NCT00274716|525024|P5|COMPLETED|Phase A||16
220832|NCT00274716|525025|P4|COMPLETED|Phase A||42
220833|NCT00274716|525026|P3|COMPLETED|Phase A||44
220834|NCT00274716|525027|P2|COMPLETED|Phase A||44
220835|NCT00274716|525028|P1|COMPLETED|Phase A||43
220836|NCT00274716|525023|P6|STARTED|Phase A||19
220837|NCT00274716|525024|P5|STARTED|Phase A||19
220838|NCT00274716|525025|P4|STARTED|Phase A||51
220839|NCT00274716|525026|P3|STARTED|Phase A||52
220840|NCT00274716|525027|P2|STARTED|Phase A||54
220841|NCT00274716|525028|P1|STARTED|Phase A||54
220842|NCT00274651|525090|P2|NOT COMPLETED|Overall Study||20
220843|NCT00274651|525091|P1|NOT COMPLETED|Overall Study||28
220844|NCT00274651|525090|P2|COMPLETED|Overall Study||4
220845|NCT00274651|525091|P1|COMPLETED|Overall Study||1
220846|NCT00274651|525090|P2|STARTED|Overall Study||24
220847|NCT00274651|525091|P1|STARTED|Overall Study||29
220848|NCT00274625|525106|P2|NOT COMPLETED|Overall Study||62
220849|NCT00274625|525107|P1|NOT COMPLETED|Overall Study||60
220850|NCT00274625|525106|P2|COMPLETED|Overall Study||141
220851|NCT00274625|525107|P1|COMPLETED|Overall Study||139
220852|NCT00274625|525106|P2|STARTED|Overall Study||203
220853|NCT00274625|525107|P1|STARTED|Overall Study||199
220854|NCT00274469|525115|P2|NOT COMPLETED|Overall Study||50
220855|NCT00274469|525116|P1|NOT COMPLETED|Overall Study||38
220856|NCT00274469|525115|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
220857|NCT00274469|525116|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
220858|NCT00274469|525115|P2|STARTED|Overall Study|Number of patients randomized|103
220859|NCT00274469|525116|P1|STARTED|Overall Study|Number of patients randomized|102
220860|NCT00274456|525134|P4|NOT COMPLETED|Overall Study||45
220861|NCT00274456|525135|P3|NOT COMPLETED|Overall Study||35
220862|NCT00274456|525136|P2|NOT COMPLETED|Overall Study||27
220863|NCT00274456|525137|P1|NOT COMPLETED|Overall Study||37
220864|NCT00274456|525134|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
220865|NCT00274456|525135|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
220866|NCT00274456|525136|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
220867|NCT00274456|525137|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
220868|NCT00274456|525134|P4|At Least One Response Assessment|Overall Study||70
220869|NCT00274456|525135|P3|At Least One Response Assessment|Overall Study||73
220870|NCT00274456|525136|P2|At Least One Response Assessment|Overall Study||76
220871|NCT00274456|525137|P1|At Least One Response Assessment|Overall Study||73
220872|NCT00274456|525134|P4|STARTED|Overall Study||74
220873|NCT00274456|525135|P3|STARTED|Overall Study||74
220874|NCT00274456|525136|P2|STARTED|Overall Study||76
220875|NCT00274456|525137|P1|STARTED|Overall Study||76
220876|NCT00274287|525179|P1|NOT COMPLETED|Overall Study||2
220877|NCT00274287|525179|P1|COMPLETED|Overall Study||13
220878|NCT00274287|525179|P1|STARTED|Overall Study||15
220879|NCT00274261|525185|P2|NOT COMPLETED|Overall Study||337
220880|NCT00274261|525186|P1|NOT COMPLETED|Overall Study||489
220881|NCT00274261|525185|P2|COMPLETED|Overall Study||296
220882|NCT00274261|525186|P1|COMPLETED|Overall Study||443
220883|NCT00274261|525185|P2|STARTED|Overall Study||633
220884|NCT00274261|525186|P1|STARTED|Overall Study||932
220885|NCT00273910|525198|P6|NOT COMPLETED|Overall Study||0
220886|NCT00273910|525199|P5|NOT COMPLETED|Overall Study||0
220887|NCT00273910|525200|P4|NOT COMPLETED|Overall Study||0
220888|NCT00273910|525201|P3|NOT COMPLETED|Overall Study||0
220889|NCT00273910|525202|P2|NOT COMPLETED|Overall Study||0
220890|NCT00273910|525203|P1|NOT COMPLETED|Overall Study||0
220891|NCT00273910|525198|P6|COMPLETED|Overall Study||14
220892|NCT00273910|525199|P5|COMPLETED|Overall Study||15
220893|NCT00273910|525200|P4|COMPLETED|Overall Study||19
220894|NCT00273910|525201|P3|COMPLETED|Overall Study||18
220895|NCT00273910|525202|P2|COMPLETED|Overall Study||19
220896|NCT00273910|525203|P1|COMPLETED|Overall Study||19
220897|NCT00273910|525198|P6|STARTED|Overall Study||14
220898|NCT00273910|525199|P5|STARTED|Overall Study||15
220899|NCT00273910|525200|P4|STARTED|Overall Study||19
220900|NCT00273910|525201|P3|STARTED|Overall Study||18
220901|NCT00273910|525202|P2|STARTED|Overall Study||19
220902|NCT00273910|525203|P1|STARTED|Overall Study||19
220903|NCT00273858|525223|P1|NOT COMPLETED|Overall Study||537
220904|NCT00273858|525223|P1|COMPLETED|Overall Study||343
220905|NCT00273858|525223|P1|STARTED|Overall Study||880
220906|NCT00273793|525238|P6|NOT COMPLETED|Overall Study||0
220907|NCT00273793|525239|P5|NOT COMPLETED|Overall Study||0
220908|NCT00273793|525240|P4|NOT COMPLETED|Overall Study||0
220909|NCT00273793|525241|P3|NOT COMPLETED|Overall Study||0
220910|NCT00273793|525242|P2|NOT COMPLETED|Overall Study||0
220911|NCT00273793|525243|P1|NOT COMPLETED|Overall Study||0
220912|NCT00273793|525238|P6|COMPLETED|Overall Study||29
220913|NCT00273793|525239|P5|COMPLETED|Overall Study||58
220914|NCT00273793|525240|P4|COMPLETED|Overall Study||60
220915|NCT00273793|525241|P3|COMPLETED|Overall Study||18
220916|NCT00273793|525242|P2|COMPLETED|Overall Study||38
220917|NCT00273793|525243|P1|COMPLETED|Overall Study||36
220918|NCT00273793|525238|P6|STARTED|Overall Study||29
220919|NCT00273793|525239|P5|STARTED|Overall Study||58
220920|NCT00273793|525240|P4|STARTED|Overall Study||60
220921|NCT00273793|525241|P3|STARTED|Overall Study||18
220922|NCT00273793|525242|P2|STARTED|Overall Study||38
220923|NCT00273793|525243|P1|STARTED|Overall Study||36
220924|NCT00273754|525265|P2|NOT COMPLETED|Overall Study||0
220925|NCT00273754|525266|P1|NOT COMPLETED|Overall Study||0
220926|NCT00273754|525265|P2|COMPLETED|Overall Study||36
220927|NCT00273754|525266|P1|COMPLETED|Overall Study||36
220928|NCT00273754|525265|P2|STARTED|Overall Study||36
220929|NCT00273754|525266|P1|STARTED|Overall Study||36
220930|NCT00273182|525282|P1|NOT COMPLETED|Overall Study||985
220931|NCT00273182|525282|P1|COMPLETED|Overall Study||1014
220932|NCT00273182|525282|P1|STARTED|Overall Study||1999
220933|NCT00273052|525292|P2|NOT COMPLETED|Overall Study||88
220934|NCT00273052|525293|P1|NOT COMPLETED|Overall Study||69
220935|NCT00273052|525292|P2|COMPLETED|Overall Study||190
220936|NCT00273052|525293|P1|COMPLETED|Overall Study||221
220937|NCT00273052|525292|P2|STARTED|Overall Study||278
220938|NCT00273052|525293|P1|STARTED|Overall Study||290
220939|NCT00272987|525328|P3|NOT COMPLETED|Overall Study||19
220940|NCT00272987|525329|P2|NOT COMPLETED|Overall Study||14
220941|NCT00272987|525330|P1|NOT COMPLETED|Overall Study||21
220942|NCT00272987|525328|P3|COMPLETED|Overall Study||1
220943|NCT00272987|525329|P2|COMPLETED|Overall Study||0
220944|NCT00272987|525330|P1|COMPLETED|Overall Study||8
220945|NCT00272987|525328|P3|Ongoing|Overall Study||15
220946|NCT00272987|525329|P2|Ongoing|Overall Study||14
220947|NCT00272987|525330|P1|Ongoing|Overall Study||20
220948|NCT00272987|525328|P3|STARTED|Overall Study||20
220949|NCT00272987|525329|P2|STARTED|Overall Study||14
220950|NCT00272987|525330|P1|STARTED|Overall Study||29
220951|NCT00272961|525394|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
220952|NCT00272961|525395|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
220953|NCT00272961|525396|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
220954|NCT00272961|525397|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
220955|NCT00272961|525398|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
220956|NCT00272961|525394|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
220957|NCT00272961|525395|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
220958|NCT00272961|525396|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
220959|NCT00272961|525397|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
220960|NCT00272961|525398|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
220961|NCT00272961|525394|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
220962|NCT00272961|525395|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
220963|NCT00272961|525396|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
220964|NCT00272961|525397|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
220965|NCT00272961|525398|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
220966|NCT00272961|525394|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220967|NCT00272961|525395|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220968|NCT00272961|525396|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220969|NCT00272961|525397|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220970|NCT00272961|525398|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
220971|NCT00272961|525394|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220972|NCT00272961|525395|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220973|NCT00272961|525396|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220974|NCT00272961|525397|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
220975|NCT00272961|525398|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
220976|NCT00272961|525394|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
220977|NCT00272961|525395|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
220978|NCT00272961|525396|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
220979|NCT00272961|525397|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
220980|NCT00272961|525398|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
220981|NCT00272792|525457|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
220982|NCT00272792|525458|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
220983|NCT00272792|525457|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
220984|NCT00272792|525458|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
220985|NCT00272792|525457|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
220986|NCT00272792|525458|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
220987|NCT00272792|525457|P2|NOT COMPLETED|Part 1: Responsiveness||0
220988|NCT00272792|525458|P1|NOT COMPLETED|Part 1: Responsiveness||1
220989|NCT00272792|525457|P2|COMPLETED|Part 1: Responsiveness||0
220990|NCT00272792|525458|P1|COMPLETED|Part 1: Responsiveness||89
220991|NCT00272792|525457|P2|STARTED|Part 1: Responsiveness||0
220992|NCT00272792|525458|P1|STARTED|Part 1: Responsiveness||90
220993|NCT00272779|525468|P2|NOT COMPLETED|Baseline Through Week 96||136
220994|NCT00272779|525469|P1|NOT COMPLETED|Baseline Through Week 96||139
220995|NCT00272779|525468|P2|COMPLETED|Baseline Through Week 96||307
220996|NCT00272779|525469|P1|COMPLETED|Baseline Through Week 96||301
220997|NCT00272779|525468|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
220998|NCT00272779|525469|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
220999|NCT00272779|525468|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
221000|NCT00272779|525469|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
221001|NCT00272779|525468|P2|NOT COMPLETED|Baseline Through Week 48||443
221002|NCT00272779|525469|P1|NOT COMPLETED|Baseline Through Week 48||440
221003|NCT00272779|525468|P2|COMPLETED|Baseline Through Week 48||0
221004|NCT00272779|525469|P1|COMPLETED|Baseline Through Week 48||0
221005|NCT00272779|525468|P2|STILL ON TREATMENT|Baseline Through Week 48||368
221006|NCT00272779|525469|P1|STILL ON TREATMENT|Baseline Through Week 48||385
221007|NCT00272779|525468|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
221008|NCT00272779|525469|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
221009|NCT00272779|525468|P2|Discontinued Before Week 48|Baseline Through Week 48||58
221010|NCT00272779|525469|P1|Discontinued Before Week 48|Baseline Through Week 48||39
221011|NCT00272779|525468|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
221012|NCT00272779|525469|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
221013|NCT00272779|525468|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
221014|NCT00272779|525469|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
221015|NCT00272779|525468|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
221016|NCT00272779|525469|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
221017|NCT00272337|525653|P5|NOT COMPLETED|Overall Study||0
221018|NCT00272337|525654|P4|NOT COMPLETED|Overall Study||0
221019|NCT00272337|525655|P3|NOT COMPLETED|Overall Study||0
221020|NCT00272337|525656|P2|NOT COMPLETED|Overall Study||0
221021|NCT00272337|525657|P1|NOT COMPLETED|Overall Study||0
221022|NCT00272337|525653|P5|COMPLETED|Overall Study||8
221023|NCT00272337|525654|P4|COMPLETED|Overall Study||7
221024|NCT00272337|525655|P3|COMPLETED|Overall Study||7
221025|NCT00272337|525656|P2|COMPLETED|Overall Study||7
221026|NCT00272337|525657|P1|COMPLETED|Overall Study||8
221027|NCT00272337|525653|P5|STARTED|Overall Study||8
221028|NCT00272337|525654|P4|STARTED|Overall Study||7
221029|NCT00272337|525655|P3|STARTED|Overall Study||7
221030|NCT00272337|525656|P2|STARTED|Overall Study||7
221031|NCT00272337|525657|P1|STARTED|Overall Study||8
221032|NCT00272311|525674|P5|NOT COMPLETED|Overall Study||0
221033|NCT00272311|525675|P4|NOT COMPLETED|Overall Study||0
221034|NCT00272311|525676|P3|NOT COMPLETED|Overall Study||0
221035|NCT00272311|525677|P2|NOT COMPLETED|Overall Study||0
221036|NCT00272311|525678|P1|NOT COMPLETED|Overall Study||0
221037|NCT00272311|525674|P5|COMPLETED|Overall Study||14
221038|NCT00272311|525675|P4|COMPLETED|Overall Study||14
221039|NCT00272311|525676|P3|COMPLETED|Overall Study||14
221040|NCT00272311|525677|P2|COMPLETED|Overall Study||14
221041|NCT00272311|525678|P1|COMPLETED|Overall Study||14
221042|NCT00272311|525674|P5|STARTED|Overall Study||14
221043|NCT00272311|525675|P4|STARTED|Overall Study||14
221044|NCT00272311|525676|P3|STARTED|Overall Study||14
221045|NCT00272311|525677|P2|STARTED|Overall Study||14
221046|NCT00272311|525678|P1|STARTED|Overall Study||14
221047|NCT00272168|525692|P2|NOT COMPLETED|Overall Study||10
221048|NCT00272168|525693|P1|NOT COMPLETED|Overall Study||10
221049|NCT00272168|525692|P2|COMPLETED|Overall Study||31
221050|NCT00272168|525693|P1|COMPLETED|Overall Study||37
221051|NCT00272168|525692|P2|STARTED|Overall Study||41
221052|NCT00272168|525693|P1|STARTED|Overall Study||47
221053|NCT00272038|525709|P1|NOT COMPLETED|Overall Study||7
221054|NCT00272038|525709|P1|COMPLETED|Overall Study||22
221055|NCT00272038|525709|P1|STARTED|Overall Study||29
221056|NCT00271947|525715|P1|NOT COMPLETED|Overall Study||1
221057|NCT00271947|525715|P1|COMPLETED|Overall Study||0
221058|NCT00271947|525715|P1|STARTED|Overall Study||1
221059|NCT00271856|525721|P2|NOT COMPLETED|Overall Study||18
221060|NCT00271856|525722|P1|NOT COMPLETED|Overall Study||11
221061|NCT00271856|525721|P2|COMPLETED|Overall Study||70
221062|NCT00271856|525722|P1|COMPLETED|Overall Study||78
221063|NCT00271856|525721|P2|STARTED|Overall Study||88
221064|NCT00271856|525722|P1|STARTED|Overall Study||89
221065|NCT00271817|525741|P3|NOT COMPLETED|Part 2||84
221066|NCT00271817|525742|P2|NOT COMPLETED|Part 2||32
221067|NCT00271817|525743|P1|NOT COMPLETED|Part 2||0
221068|NCT00271817|525741|P3|COMPLETED|Part 2||401
221069|NCT00271817|525742|P2|COMPLETED|Part 2||234
221070|NCT00271817|525743|P1|COMPLETED|Part 2||0
221071|NCT00271817|525741|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
221072|NCT00271817|525742|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
221073|NCT00271817|525743|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
221074|NCT00271817|525741|P3|NOT COMPLETED|Part 1||285
221075|NCT00271817|525742|P2|NOT COMPLETED|Part 1||59
221076|NCT00271817|525743|P1|NOT COMPLETED|Part 1||106
221077|NCT00271817|525741|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
221078|NCT00271817|525742|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
221079|NCT00271817|525743|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
221080|NCT00271817|525741|P3|STARTED|Part 1||676
221081|NCT00271817|525742|P2|STARTED|Part 1||272
221082|NCT00271817|525743|P1|STARTED|Part 1||272
221083|NCT00271739|525772|P2|NOT COMPLETED|Overall Study||105
221084|NCT00271739|525773|P1|NOT COMPLETED|Overall Study||115
221085|NCT00271739|525772|P2|COMPLETED|Overall Study||716
221086|NCT00271739|525773|P1|COMPLETED|Overall Study||729
221087|NCT00271739|525772|P2|STARTED|Overall Study||821
221088|NCT00271739|525773|P1|STARTED|Overall Study||844
221089|NCT00271609|525785|P2|NOT COMPLETED|Overall Study||3
221090|NCT00271609|525786|P1|NOT COMPLETED|Overall Study||13
221091|NCT00271609|525785|P2|COMPLETED|Overall Study||29
221092|NCT00271609|525786|P1|COMPLETED|Overall Study||43
221093|NCT00271609|525785|P2|STARTED|Overall Study||32
221094|NCT00271609|525786|P1|STARTED|Overall Study||56
221095|NCT00271596|525796|P2|NOT COMPLETED|Overall Study||1
221096|NCT00271596|525797|P1|NOT COMPLETED|Overall Study||1
221097|NCT00271596|525796|P2|COMPLETED|Overall Study||15
221098|NCT00271596|525797|P1|COMPLETED|Overall Study||16
221099|NCT00271596|525796|P2|STARTED|Overall Study||16
221100|NCT00271596|525797|P1|STARTED|Overall Study||17
221101|NCT00271570|525823|P2|NOT COMPLETED|Overall Study||0
221102|NCT00271570|525824|P1|NOT COMPLETED|Overall Study||0
221103|NCT00271570|525823|P2|COMPLETED|Overall Study||12
221104|NCT00271570|525824|P1|COMPLETED|Overall Study||12
221105|NCT00271570|525823|P2|STARTED|Overall Study||12
221106|NCT00271570|525824|P1|STARTED|Overall Study||12
221107|NCT00271544|525832|P1|NOT COMPLETED|Overall Study||20
221108|NCT00271544|525832|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
221109|NCT00271544|525832|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
221110|NCT00271544|525832|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
221111|NCT00271544|525832|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
221112|NCT00271375|525856|P3|NOT COMPLETED|Overall Study||0
221113|NCT00271375|525857|P2|NOT COMPLETED|Overall Study||0
221114|NCT00271375|525858|P1|NOT COMPLETED|Overall Study||0
221115|NCT00271375|525856|P3|COMPLETED|Overall Study||57
221116|NCT00271375|525857|P2|COMPLETED|Overall Study||83
221117|NCT00271375|525858|P1|COMPLETED|Overall Study||114
221118|NCT00271375|525856|P3|STARTED|Overall Study||57
221119|NCT00271375|525857|P2|STARTED|Overall Study||83
221120|NCT00271375|525858|P1|STARTED|Overall Study||114
221121|NCT00271219|525896|P2|NOT COMPLETED|Overall Study||28
221122|NCT00271219|525897|P1|NOT COMPLETED|Overall Study||16
221123|NCT00271219|525896|P2|COMPLETED|Overall Study||58
221124|NCT00271219|525897|P1|COMPLETED|Overall Study||73
221125|NCT00271219|525896|P2|STARTED|Overall Study||86
221126|NCT00271219|525897|P1|STARTED|Overall Study||89
221127|NCT00271154|525923|P2|NOT COMPLETED|Overall Study||0
221128|NCT00271154|525924|P1|NOT COMPLETED|Overall Study||0
221129|NCT00271154|525923|P2|COMPLETED|Overall Study||419
221130|NCT00271154|525924|P1|COMPLETED|Overall Study||191
221131|NCT00271154|525923|P2|STARTED|Overall Study||419
221132|NCT00271154|525924|P1|STARTED|Overall Study||191
221133|NCT00271024|525937|P4|NOT COMPLETED|Overall Study||24
221134|NCT00271024|525938|P3|NOT COMPLETED|Overall Study||23
221135|NCT00271024|525939|P2|NOT COMPLETED|Overall Study||26
221136|NCT00271024|525940|P1|NOT COMPLETED|Overall Study||22
221137|NCT00271024|525937|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
221138|NCT00271024|525938|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
221139|NCT00271024|525939|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
221140|NCT00271024|525940|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
221141|NCT00271024|525937|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
221142|NCT00271024|525938|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
221143|NCT00271024|525939|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
221144|NCT00271024|525940|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
221145|NCT00271024|525937|P4|STARTED|Overall Study||88
221146|NCT00271024|525938|P3|STARTED|Overall Study||88
221147|NCT00271024|525939|P2|STARTED|Overall Study||77
221148|NCT00271024|525940|P1|STARTED|Overall Study||80
221149|NCT00271011|525982|P1|NOT COMPLETED|Overall Study||0
221150|NCT00271011|525982|P1|COMPLETED|Overall Study||13
221151|NCT00271011|525982|P1|STARTED|Overall Study||13
221152|NCT00270894|525987|P1|NOT COMPLETED|Overall Study||2
221153|NCT00270894|525987|P1|COMPLETED|Overall Study||28
221154|NCT00270894|525987|P1|STARTED|Overall Study||30
221155|NCT00270842|526000|P3|NOT COMPLETED|Overall Study||16
221156|NCT00270842|526001|P2|NOT COMPLETED|Overall Study||16
221157|NCT00270842|526002|P1|NOT COMPLETED|Overall Study||15
221158|NCT00270842|526000|P3|COMPLETED|Overall Study||18
221159|NCT00270842|526001|P2|COMPLETED|Overall Study||18
221160|NCT00270842|526002|P1|COMPLETED|Overall Study||18
221161|NCT00270842|526000|P3|STARTED|Overall Study||34
221162|NCT00270842|526001|P2|STARTED|Overall Study||34
221163|NCT00270842|526002|P1|STARTED|Overall Study||33
221164|NCT00270790|526013|P1|NOT COMPLETED|Overall Study||5
221165|NCT00270790|526013|P1|COMPLETED|Overall Study||16
221166|NCT00270790|526013|P1|STARTED|Overall Study||21
221167|NCT00270634|526022|P4|NOT COMPLETED|Overall Study||5
221168|NCT00270634|526023|P3|NOT COMPLETED|Overall Study||22
221169|NCT00270634|526024|P2|NOT COMPLETED|Overall Study||13
221170|NCT00270634|526025|P1|NOT COMPLETED|Overall Study||17
221171|NCT00270634|526022|P4|COMPLETED|Overall Study||81
221172|NCT00270634|526023|P3|COMPLETED|Overall Study||62
221173|NCT00270634|526024|P2|COMPLETED|Overall Study||64
221174|NCT00270634|526025|P1|COMPLETED|Overall Study||70
221175|NCT00270634|526022|P4|STARTED|Overall Study||86
221176|NCT00270634|526023|P3|STARTED|Overall Study||84
221177|NCT00270634|526024|P2|STARTED|Overall Study||77
221178|NCT00270634|526025|P1|STARTED|Overall Study||87
221179|NCT00270257|526061|P2|NOT COMPLETED|Overall Study||424
221180|NCT00270257|526062|P1|NOT COMPLETED|Overall Study||412
221181|NCT00270257|526061|P2|COMPLETED|Overall Study||204
221182|NCT00270257|526062|P1|COMPLETED|Overall Study||211
221183|NCT00270257|526061|P2|Visit 104|Overall Study||204
221184|NCT00270257|526062|P1|Visit 104|Overall Study||211
221185|NCT00270257|526061|P2|Week 78|Overall Study||285
221186|NCT00270257|526062|P1|Week 78|Overall Study||283
221187|NCT00270257|526061|P2|Week 52|Overall Study||340
221188|NCT00270257|526062|P1|Week 52|Overall Study||362
221189|NCT00270257|526061|P2|Week 26|Overall Study||440
221190|NCT00270257|526062|P1|Week 26|Overall Study||460
221191|NCT00270257|526061|P2|Week 8|Overall Study||443
221192|NCT00270257|526062|P1|Week 8|Overall Study||510
221193|NCT00270257|526061|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
221194|NCT00270257|526062|P1|STARTED|Overall Study||623
221195|NCT00270231|526080|P2|NOT COMPLETED|Second Intervention||1
221196|NCT00270231|526081|P1|NOT COMPLETED|Second Intervention||0
221197|NCT00270231|526080|P2|COMPLETED|Second Intervention||30
221198|NCT00270231|526081|P1|COMPLETED|Second Intervention||30
221199|NCT00270231|526080|P2|STARTED|Second Intervention||31
221200|NCT00270231|526081|P1|STARTED|Second Intervention||30
221201|NCT00270231|526080|P2|NOT COMPLETED|Washout Period||0
221202|NCT00270231|526081|P1|NOT COMPLETED|Washout Period||1
221203|NCT00270231|526080|P2|COMPLETED|Washout Period||31
221204|NCT00270231|526081|P1|COMPLETED|Washout Period||30
221205|NCT00270231|526080|P2|STARTED|Washout Period||31
221206|NCT00270231|526081|P1|STARTED|Washout Period||31
221207|NCT00270231|526080|P2|NOT COMPLETED|First Intervention||1
221208|NCT00270231|526081|P1|NOT COMPLETED|First Intervention||1
221209|NCT00270231|526080|P2|COMPLETED|First Intervention||31
221210|NCT00270231|526081|P1|COMPLETED|First Intervention||31
221211|NCT00270231|526080|P2|STARTED|First Intervention||32
221212|NCT00270231|526081|P1|STARTED|First Intervention||32
221213|NCT00270205|526091|P4|NOT COMPLETED|Overall Study||1
221214|NCT00270205|526092|P3|NOT COMPLETED|Overall Study||0
221215|NCT00270205|526093|P2|NOT COMPLETED|Overall Study||0
221216|NCT00270205|526094|P1|NOT COMPLETED|Overall Study||1
221217|NCT00270205|526091|P4|COMPLETED|Overall Study||6
221218|NCT00270205|526092|P3|COMPLETED|Overall Study||6
221219|NCT00270205|526093|P2|COMPLETED|Overall Study||6
221220|NCT00270205|526094|P1|COMPLETED|Overall Study||5
221221|NCT00270205|526091|P4|STARTED|Overall Study||7
221222|NCT00270205|526092|P3|STARTED|Overall Study||6
221223|NCT00270205|526093|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
221224|NCT00270205|526094|P1|STARTED|Overall Study||6
221225|NCT00269919|526204|P1|NOT COMPLETED|Overall Study||27
221226|NCT00269919|526204|P1|COMPLETED|Overall Study||13
221227|NCT00269919|526204|P1|Treated|Overall Study||39
221228|NCT00269919|526204|P1|STARTED|Overall Study||40
221229|NCT00269633|526223|P2|NOT COMPLETED|Overall Study||0
221230|NCT00269633|526224|P1|NOT COMPLETED|Overall Study||1
221231|NCT00269633|526223|P2|COMPLETED|Overall Study||5
221232|NCT00269633|526224|P1|COMPLETED|Overall Study||3
221233|NCT00269633|526223|P2|STARTED|Overall Study||5
221234|NCT00269633|526224|P1|STARTED|Overall Study||4
221235|NCT00269477|526234|P4|NOT COMPLETED|Overall Study||0
221236|NCT00269477|526235|P3|NOT COMPLETED|Overall Study||1
221237|NCT00269477|526236|P2|NOT COMPLETED|Overall Study||6
221238|NCT00269477|526237|P1|NOT COMPLETED|Overall Study||5
221239|NCT00269477|526234|P4|COMPLETED|Overall Study||60
221240|NCT00269477|526235|P3|COMPLETED|Overall Study||57
221241|NCT00269477|526236|P2|COMPLETED|Overall Study||12
221242|NCT00269477|526237|P1|COMPLETED|Overall Study||4
221243|NCT00269477|526234|P4|STARTED|Overall Study||60
221244|NCT00269477|526235|P3|STARTED|Overall Study||58
221245|NCT00269477|526236|P2|STARTED|Overall Study||18
221246|NCT00269477|526237|P1|STARTED|Overall Study||9
221247|NCT00269152|526253|P2|NOT COMPLETED|Overall Study||10
221248|NCT00269152|526254|P1|NOT COMPLETED|Overall Study||18
221249|NCT00269152|526253|P2|COMPLETED|Overall Study||49
221250|NCT00269152|526254|P1|COMPLETED|Overall Study||45
221251|NCT00269152|526253|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
221252|NCT00269152|526254|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
221253|NCT00269113|526270|P2|NOT COMPLETED|Overall Study||37
221254|NCT00269113|526271|P1|NOT COMPLETED|Overall Study||74
221255|NCT00269113|526270|P2|COMPLETED|Overall Study||146
221256|NCT00269113|526271|P1|COMPLETED|Overall Study||103
221257|NCT00269113|526270|P2|STARTED|Overall Study||183
221258|NCT00269113|526271|P1|STARTED|Overall Study||177
221259|NCT00268983|526291|P2|NOT COMPLETED|Overall Study||0
221260|NCT00268983|526292|P1|NOT COMPLETED|Overall Study||3
221261|NCT00268983|526291|P2|COMPLETED|Overall Study||8
221262|NCT00268983|526292|P1|COMPLETED|Overall Study||3
221263|NCT00268983|526291|P2|STARTED|Overall Study||8
221264|NCT00268983|526292|P1|STARTED|Overall Study||6
221265|NCT00268905|526335|P3|NOT COMPLETED|Overall Study||12
221266|NCT00268905|526336|P2|NOT COMPLETED|Overall Study||9
221267|NCT00268905|526337|P1|NOT COMPLETED|Overall Study||43
221268|NCT00268905|526335|P3|COMPLETED|Overall Study||0
221269|NCT00268905|526336|P2|COMPLETED|Overall Study||0
221270|NCT00268905|526337|P1|COMPLETED|Overall Study||0
221271|NCT00268905|526335|P3|STARTED|Overall Study||12
221272|NCT00268905|526336|P2|STARTED|Overall Study||9
221273|NCT00268905|526337|P1|STARTED|Overall Study||43
221274|NCT00268892|526354|P3|NOT COMPLETED|Overall Study||39
221275|NCT00268892|526355|P2|NOT COMPLETED|Overall Study||42
221276|NCT00268892|526356|P1|NOT COMPLETED|Overall Study||39
221277|NCT00268892|526354|P3|COMPLETED|Overall Study||54
221278|NCT00268892|526355|P2|COMPLETED|Overall Study||53
221279|NCT00268892|526356|P1|COMPLETED|Overall Study||51
221280|NCT00268892|526354|P3|Switched to Higher Dose|Overall Study||76
221281|NCT00268892|526355|P2|Switched to Higher Dose|Overall Study||68
221282|NCT00268892|526356|P1|Switched to Higher Dose|Overall Study||59
221283|NCT00268892|526354|P3|STARTED|Overall Study||93
221284|NCT00268892|526355|P2|STARTED|Overall Study||95
221285|NCT00268892|526356|P1|STARTED|Overall Study||90
221286|NCT00268762|526367|P1|NOT COMPLETED|Overall Study||0
221287|NCT00268762|526367|P1|COMPLETED|Overall Study||65
221288|NCT00268762|526367|P1|STARTED|Overall Study||65
221289|NCT00268463|526375|P2|NOT COMPLETED|Overall Study||12
221290|NCT00268463|526376|P1|NOT COMPLETED|Overall Study||10
221291|NCT00268463|526375|P2|COMPLETED|Overall Study||0
221292|NCT00268463|526376|P1|COMPLETED|Overall Study||0
221293|NCT00268463|526375|P2|STARTED|Overall Study||12
221294|NCT00268463|526376|P1|STARTED|Overall Study||10
221295|NCT00268437|526382|P1|NOT COMPLETED|Overall Study||1
221296|NCT00268437|526382|P1|COMPLETED|Overall Study||26
221297|NCT00268437|526382|P1|STARTED|Overall Study||27
221298|NCT00268346|526389|P2|NOT COMPLETED|Overall Study||3
221299|NCT00268346|526390|P1|NOT COMPLETED|Overall Study||0
221300|NCT00268346|526389|P2|COMPLETED|Overall Study||37
221301|NCT00268346|526390|P1|COMPLETED|Overall Study||18
221302|NCT00268346|526389|P2|Started Treatment|Overall Study||40
221303|NCT00268346|526390|P1|Started Treatment|Overall Study||18
221304|NCT00268346|526389|P2|STARTED|Overall Study||40
221305|NCT00268346|526390|P1|STARTED|Overall Study||18
221306|NCT00268242|526396|P1|NOT COMPLETED|Overall Study||1
221307|NCT00268242|526396|P1|COMPLETED|Overall Study||23
221308|NCT00268242|526396|P1|STARTED|Overall Study||24
221309|NCT00268203|526405|P1|NOT COMPLETED|Overall Study||647
221310|NCT00268203|526405|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
221311|NCT00268203|526405|P1|Completed 2 Years of Follow-up|Overall Study||62
221312|NCT00268203|526405|P1|STARTED|Overall Study||765
221313|NCT00267969|526419|P7|NOT COMPLETED|After Controlled Period||72
221314|NCT00267969|526420|P6|NOT COMPLETED|After Controlled Period||82
221315|NCT00267969|526421|P5|NOT COMPLETED|After Controlled Period||35
221316|NCT00267969|526422|P4|NOT COMPLETED|After Controlled Period||36
221317|NCT00267969|526423|P3|NOT COMPLETED|After Controlled Period||0
221318|NCT00267969|526424|P2|NOT COMPLETED|After Controlled Period||0
221319|NCT00267969|526425|P1|NOT COMPLETED|After Controlled Period||0
221320|NCT00267969|526419|P7|COMPLETED|After Controlled Period||173
221321|NCT00267969|526420|P6|COMPLETED|After Controlled Period||172
221322|NCT00267969|526421|P5|COMPLETED|After Controlled Period||85
221323|NCT00267969|526422|P4|COMPLETED|After Controlled Period||87
221324|NCT00267969|526423|P3|COMPLETED|After Controlled Period||0
221325|NCT00267969|526424|P2|COMPLETED|After Controlled Period||0
221326|NCT00267969|526425|P1|COMPLETED|After Controlled Period||0
221327|NCT00267969|526419|P7|STARTED|After Controlled Period||245
221328|NCT00267969|526420|P6|STARTED|After Controlled Period||254
221329|NCT00267969|526421|P5|STARTED|After Controlled Period||120
221330|NCT00267969|526422|P4|STARTED|After Controlled Period||123
221331|NCT00267969|526423|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
221332|NCT00267969|526424|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
221333|NCT00267969|526425|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
221334|NCT00267969|526419|P7|NOT COMPLETED|Controlled Period||0
221335|NCT00267969|526420|P6|NOT COMPLETED|Controlled Period||0
221336|NCT00267969|526421|P5|NOT COMPLETED|Controlled Period||0
221337|NCT00267969|526422|P4|NOT COMPLETED|Controlled Period||0
221338|NCT00267969|526423|P3|NOT COMPLETED|Controlled Period||11
221339|NCT00267969|526424|P2|NOT COMPLETED|Controlled Period||1
221340|NCT00267969|526425|P1|NOT COMPLETED|Controlled Period||12
221341|NCT00267969|526419|P7|COMPLETED|Controlled Period||0
221342|NCT00267969|526420|P6|COMPLETED|Controlled Period||0
221343|NCT00267969|526421|P5|COMPLETED|Controlled Period||0
221344|NCT00267969|526422|P4|COMPLETED|Controlled Period||0
221345|NCT00267969|526423|P3|COMPLETED|Controlled Period||245
221346|NCT00267969|526424|P2|COMPLETED|Controlled Period||254
221347|NCT00267969|526425|P1|COMPLETED|Controlled Period||243
221348|NCT00267969|526419|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221349|NCT00267969|526420|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221350|NCT00267969|526421|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221351|NCT00267969|526422|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221352|NCT00267969|526423|P3|STARTED|Controlled Period|Number of patients randomized|256
221353|NCT00267969|526424|P2|STARTED|Controlled Period|Number of patients randomized|255
221354|NCT00267969|526425|P1|STARTED|Controlled Period|Number of patients randomized|255
221355|NCT00267956|526451|P4|NOT COMPLETED|After Controlled Period||2
221356|NCT00267956|526452|P3|NOT COMPLETED|After Controlled Period||5
221357|NCT00267956|526453|P2|NOT COMPLETED|After Controlled Period||0
221358|NCT00267956|526454|P1|NOT COMPLETED|After Controlled Period||0
221359|NCT00267956|526451|P4|COMPLETED|After Controlled Period||70
221360|NCT00267956|526452|P3|COMPLETED|After Controlled Period||52
221361|NCT00267956|526453|P2|COMPLETED|After Controlled Period||0
221362|NCT00267956|526454|P1|COMPLETED|After Controlled Period||0
221363|NCT00267956|526451|P4|STARTED|After Controlled Period||72
221364|NCT00267956|526452|P3|STARTED|After Controlled Period||57
221365|NCT00267956|526453|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
221366|NCT00267956|526454|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
221367|NCT00267956|526451|P4|NOT COMPLETED|Controlled Period||0
221368|NCT00267956|526452|P3|NOT COMPLETED|Controlled Period||0
221369|NCT00267956|526453|P2|NOT COMPLETED|Controlled Period||4
221370|NCT00267956|526454|P1|NOT COMPLETED|Controlled Period||13
221371|NCT00267956|526451|P4|COMPLETED|Controlled Period||0
221372|NCT00267956|526452|P3|COMPLETED|Controlled Period||0
221373|NCT00267956|526453|P2|COMPLETED|Controlled Period||72
221374|NCT00267956|526454|P1|COMPLETED|Controlled Period||57
221375|NCT00267956|526451|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221376|NCT00267956|526452|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
221377|NCT00267956|526453|P2|STARTED|Controlled Period||76
221378|NCT00267956|526454|P1|STARTED|Controlled Period||70
221379|NCT00267774|526474|P2|NOT COMPLETED|Overall Study||0
221380|NCT00267774|526475|P1|NOT COMPLETED|Overall Study||0
221381|NCT00267774|526474|P2|COMPLETED|Overall Study||496
221382|NCT00267774|526475|P1|COMPLETED|Overall Study||509
221383|NCT00267774|526474|P2|STARTED|Overall Study||496
221384|NCT00267774|526475|P1|STARTED|Overall Study||509
221385|NCT00267748|526484|P3|NOT COMPLETED|Randomized Period||132
221386|NCT00267748|526485|P2|NOT COMPLETED|Randomized Period||127
221387|NCT00267748|526486|P1|NOT COMPLETED|Randomized Period||0
221388|NCT00267748|526484|P3|COMPLETED|Randomized Period||14
221389|NCT00267748|526485|P2|COMPLETED|Randomized Period||19
221390|NCT00267748|526486|P1|COMPLETED|Randomized Period||0
221391|NCT00267748|526484|P3|Treated|Randomized Period||143
221392|NCT00267748|526485|P2|Treated|Randomized Period||146
221393|NCT00267748|526486|P1|Treated|Randomized Period||0
221394|NCT00267748|526484|P3|STARTED|Randomized Period||146
221395|NCT00267748|526485|P2|STARTED|Randomized Period||146
221396|NCT00267748|526486|P1|STARTED|Randomized Period||0
221397|NCT00267748|526484|P3|NOT COMPLETED|Non-randomized Period||0
221398|NCT00267748|526485|P2|NOT COMPLETED|Non-randomized Period||0
221399|NCT00267748|526486|P1|NOT COMPLETED|Non-randomized Period||23
221400|NCT00267748|526484|P3|COMPLETED|Non-randomized Period||0
221401|NCT00267748|526485|P2|COMPLETED|Non-randomized Period||0
221402|NCT00267748|526486|P1|COMPLETED|Non-randomized Period||2
221403|NCT00267748|526484|P3|STARTED|Non-randomized Period||0
221404|NCT00267748|526485|P2|STARTED|Non-randomized Period||0
221405|NCT00267748|526486|P1|STARTED|Non-randomized Period||25
221406|NCT00267696|526503|P1|NOT COMPLETED|Overall Study||0
221407|NCT00267696|526503|P1|COMPLETED|Overall Study||45
221408|NCT00267696|526503|P1|STARTED|Overall Study||45
221409|NCT00267670|526510|P2|NOT COMPLETED|Overall Study||0
221410|NCT00267670|526511|P1|NOT COMPLETED|Overall Study||4
221411|NCT00267670|526510|P2|COMPLETED|Overall Study||7
221412|NCT00267670|526511|P1|COMPLETED|Overall Study||15
221413|NCT00267670|526510|P2|STARTED|Overall Study||7
221414|NCT00267670|526511|P1|STARTED|Overall Study||19
221415|NCT00267644|526525|P2|NOT COMPLETED|Overall Study||0
221416|NCT00267644|526526|P1|NOT COMPLETED|Overall Study||0
221417|NCT00267644|526525|P2|COMPLETED|Overall Study||63
221418|NCT00267644|526526|P1|COMPLETED|Overall Study||13
221419|NCT00267644|526525|P2|STARTED|Overall Study||63
221420|NCT00267644|526526|P1|STARTED|Overall Study||13
221421|NCT00267631|526536|P2|NOT COMPLETED|Overall Study||0
221422|NCT00267631|526537|P1|NOT COMPLETED|Overall Study||0
221423|NCT00267631|526536|P2|COMPLETED|Overall Study||3031
221424|NCT00267631|526537|P1|COMPLETED|Overall Study||2361
221425|NCT00267631|526536|P2|STARTED|Overall Study||3031
221426|NCT00267631|526537|P1|STARTED|Overall Study||2361
221427|NCT00267488|526543|P1|NOT COMPLETED|Overall Study||11
221428|NCT00267488|526543|P1|COMPLETED|Overall Study||26
221429|NCT00267488|526543|P1|STARTED|Overall Study||37
221430|NCT00264875|526552|P1|NOT COMPLETED|Overall Study||30
221431|NCT00264875|526552|P1|COMPLETED|Overall Study||190
221432|NCT00264875|526552|P1|STARTED|Overall Study||220
221433|NCT00267293|526559|P3|NOT COMPLETED|Overall Study||0
221434|NCT00267293|526560|P2|NOT COMPLETED|Overall Study||0
221435|NCT00267293|526561|P1|NOT COMPLETED|Overall Study||0
221436|NCT00267293|526559|P3|COMPLETED|Overall Study||20
221437|NCT00267293|526560|P2|COMPLETED|Overall Study||20
221438|NCT00267293|526561|P1|COMPLETED|Overall Study||20
221439|NCT00267293|526559|P3|STARTED|Overall Study||20
221440|NCT00267293|526560|P2|STARTED|Overall Study||20
221441|NCT00267293|526561|P1|STARTED|Overall Study||20
221442|NCT00267202|526571|P2|NOT COMPLETED|Overall Study||34
221443|NCT00267202|526572|P1|NOT COMPLETED|Overall Study||53
221444|NCT00267202|526571|P2|COMPLETED|Overall Study||105
221445|NCT00267202|526572|P1|COMPLETED|Overall Study||83
221446|NCT00267202|526571|P2|STARTED|Overall Study||139
221447|NCT00267202|526572|P1|STARTED|Overall Study||136
221448|NCT00267189|526593|P2|NOT COMPLETED|Overall Study||1
221449|NCT00267189|526594|P1|NOT COMPLETED|Overall Study||5
221450|NCT00267189|526593|P2|COMPLETED|Overall Study||72
221451|NCT00267189|526594|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
221452|NCT00267189|526593|P2|Completed Study Medication|Overall Study||72
221453|NCT00267189|526594|P1|Completed Study Medication|Overall Study||54
221454|NCT00267189|526593|P2|STARTED|Overall Study||73
221455|NCT00267189|526594|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
221456|NCT00267150|526604|P1|NOT COMPLETED|Overall Study||1
221457|NCT00267150|526604|P1|COMPLETED|Overall Study||30
221458|NCT00267150|526604|P1|STARTED|Overall Study||31
221459|NCT00267111|526611|P2|NOT COMPLETED|Overall Study||0
221460|NCT00267111|526612|P1|NOT COMPLETED|Overall Study||0
221461|NCT00267111|526611|P2|COMPLETED|Overall Study||55
221462|NCT00267111|526612|P1|COMPLETED|Overall Study||55
221463|NCT00267111|526611|P2|STARTED|Overall Study||55
221464|NCT00267111|526612|P1|STARTED|Overall Study||55
221465|NCT00267098|526628|P8|NOT COMPLETED|Overall Study||15
221466|NCT00267098|526629|P7|NOT COMPLETED|Overall Study||46
221467|NCT00267098|526630|P6|NOT COMPLETED|Overall Study||40
221468|NCT00267098|526631|P5|NOT COMPLETED|Overall Study||37
221469|NCT00267098|526632|P4|NOT COMPLETED|Overall Study||106
221470|NCT00267098|526633|P3|NOT COMPLETED|Overall Study||94
221471|NCT00267098|526634|P2|NOT COMPLETED|Overall Study||51
221472|NCT00267098|526635|P1|NOT COMPLETED|Overall Study||109
221473|NCT00267098|526628|P8|COMPLETED|Overall Study||5
221474|NCT00267098|526629|P7|COMPLETED|Overall Study||55
221475|NCT00267098|526630|P6|COMPLETED|Overall Study||66
221476|NCT00267098|526631|P5|COMPLETED|Overall Study||10
221477|NCT00267098|526632|P4|COMPLETED|Overall Study||135
221478|NCT00267098|526633|P3|COMPLETED|Overall Study||149
221479|NCT00267098|526634|P2|COMPLETED|Overall Study||0
221480|NCT00267098|526635|P1|COMPLETED|Overall Study||0
221481|NCT00267098|526628|P8|STARTED|Overall Study||20
221482|NCT00267098|526629|P7|STARTED|Overall Study||101
221483|NCT00267098|526630|P6|STARTED|Overall Study||106
221484|NCT00267098|526631|P5|STARTED|Overall Study||47
221485|NCT00267098|526632|P4|STARTED|Overall Study||241
221486|NCT00267098|526633|P3|STARTED|Overall Study||243
221487|NCT00267098|526634|P2|STARTED|Overall Study||51
221488|NCT00267098|526635|P1|STARTED|Overall Study||109
221489|NCT00267085|526768|P1|NOT COMPLETED|Overall Study||0
221490|NCT00267085|526768|P1|COMPLETED|Overall Study||10
221491|NCT00267085|526768|P1|STARTED|Overall Study||10
221492|NCT00267059|526772|P1|NOT COMPLETED|Overall Study||0
221493|NCT00267059|526772|P1|COMPLETED|Overall Study||44
221494|NCT00267059|526772|P1|STARTED|Overall Study||44
221495|NCT00267046|526778|P2|NOT COMPLETED|Overall Study||11
221496|NCT00267046|526779|P1|NOT COMPLETED|Overall Study||12
221497|NCT00267046|526778|P2|COMPLETED|Overall Study||5
221498|NCT00267046|526779|P1|COMPLETED|Overall Study||20
221499|NCT00267046|526778|P2|STARTED|Overall Study||16
221500|NCT00267046|526779|P1|STARTED|Overall Study||32
221501|NCT00267007|526789|P2|NOT COMPLETED|Overall Study||1
221502|NCT00267007|526790|P1|NOT COMPLETED|Overall Study||8
221503|NCT00267007|526789|P2|COMPLETED|Overall Study||10
221504|NCT00267007|526790|P1|COMPLETED|Overall Study||11
221505|NCT00267007|526789|P2|STARTED|Overall Study||11
221506|NCT00267007|526790|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
221507|NCT00266864|526800|P2|NOT COMPLETED|Overall Study||2
221508|NCT00266864|526801|P1|NOT COMPLETED|Overall Study||5
221509|NCT00266864|526800|P2|COMPLETED|Overall Study||11
221510|NCT00266864|526801|P1|COMPLETED|Overall Study||13
221511|NCT00266864|526800|P2|STARTED|Overall Study||13
221512|NCT00266864|526801|P1|STARTED|Overall Study||18
221513|NCT00266825|526810|P2|NOT COMPLETED|Completed Follow-Up||24
221514|NCT00266825|526811|P1|NOT COMPLETED|Completed Follow-Up||25
221515|NCT00266825|526810|P2|COMPLETED|Completed Follow-Up||154
221516|NCT00266825|526811|P1|COMPLETED|Completed Follow-Up||147
221517|NCT00266825|526810|P2|STARTED|Completed Follow-Up||178
221518|NCT00266825|526811|P1|STARTED|Completed Follow-Up||172
221519|NCT00266825|526810|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
221520|NCT00266825|526811|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
221521|NCT00266825|526810|P2|COMPLETED|Enrolled and Allocated Intervention||178
221522|NCT00266825|526811|P1|COMPLETED|Enrolled and Allocated Intervention||172
221523|NCT00266825|526810|P2|STARTED|Enrolled and Allocated Intervention||178
221524|NCT00266825|526811|P1|STARTED|Enrolled and Allocated Intervention||172
221525|NCT00266812|526837|P2|NOT COMPLETED|Overall Study||11
221526|NCT00266812|526838|P1|NOT COMPLETED|Overall Study||21
221527|NCT00266812|526837|P2|COMPLETED|Overall Study||2
221528|NCT00266812|526838|P1|COMPLETED|Overall Study||1
221529|NCT00266812|526837|P2|STARTED|Overall Study||13
221530|NCT00266812|526838|P1|STARTED|Overall Study||22
221531|NCT00266799|526846|P2|NOT COMPLETED|Overall Study||34
221532|NCT00266799|526847|P1|NOT COMPLETED|Overall Study||36
221533|NCT00266799|526846|P2|COMPLETED|Overall Study||68
221534|NCT00266799|526847|P1|COMPLETED|Overall Study||62
221535|NCT00266799|526846|P2|STARTED|Overall Study||102
221536|NCT00266799|526847|P1|STARTED|Overall Study||98
221537|NCT00266695|526861|P1|NOT COMPLETED|Overall Study||29
221538|NCT00266695|526861|P1|COMPLETED|Overall Study||174
221539|NCT00266695|526861|P1|STARTED|Overall Study||203
221540|NCT00266656|526873|P2|NOT COMPLETED|Overall Study||13
221541|NCT00266656|526874|P1|NOT COMPLETED|Overall Study||14
221542|NCT00266656|526873|P2|COMPLETED|Overall Study||20
221543|NCT00266656|526874|P1|COMPLETED|Overall Study||22
221544|NCT00266656|526873|P2|STARTED|Overall Study||33
221545|NCT00266656|526874|P1|STARTED|Overall Study||36
221546|NCT00266630|526898|P2|NOT COMPLETED|Overall Study||28
221547|NCT00266630|526899|P1|NOT COMPLETED|Overall Study||42
221548|NCT00266630|526898|P2|COMPLETED|Overall Study||11
221549|NCT00266630|526899|P1|COMPLETED|Overall Study||58
221550|NCT00266630|526898|P2|STARTED|Overall Study||39
221551|NCT00266630|526899|P1|STARTED|Overall Study||100
221552|NCT00264849|526939|P2|NOT COMPLETED|Overall Study||25
221553|NCT00264849|526940|P1|NOT COMPLETED|Overall Study||22
221554|NCT00264849|526939|P2|COMPLETED|Overall Study||106
221555|NCT00264849|526940|P1|COMPLETED|Overall Study||253
221556|NCT00264849|526939|P2|STARTED|Overall Study||131
221557|NCT00264849|526940|P1|STARTED|Overall Study||275
221558|NCT00264810|526976|P2|NOT COMPLETED|Open Label Evaluation Period||6
221559|NCT00264810|526977|P1|NOT COMPLETED|Open Label Evaluation Period||6
221560|NCT00264810|526976|P2|COMPLETED|Open Label Evaluation Period||86
221561|NCT00264810|526977|P1|COMPLETED|Open Label Evaluation Period||89
221562|NCT00264810|526976|P2|1-year Post-implant|Open Label Evaluation Period||90
221563|NCT00264810|526977|P1|1-year Post-implant|Open Label Evaluation Period||92
221564|NCT00264810|526976|P2|STARTED|Open Label Evaluation Period||92
221565|NCT00264810|526977|P1|STARTED|Open Label Evaluation Period||95
221566|NCT00264810|526976|P2|NOT COMPLETED|Blinded Evaluation Period||1
221567|NCT00264810|526977|P1|NOT COMPLETED|Blinded Evaluation Period||1
221568|NCT00264810|526976|P2|COMPLETED|Blinded Evaluation Period||92
221569|NCT00264810|526977|P1|COMPLETED|Blinded Evaluation Period||95
221570|NCT00264810|526976|P2|STARTED|Blinded Evaluation Period||93
221571|NCT00264810|526977|P1|STARTED|Blinded Evaluation Period||96
221572|NCT00264810|526976|P2|NOT COMPLETED|Stimulation Optimization Period||1
221573|NCT00264810|526977|P1|NOT COMPLETED|Stimulation Optimization Period||1
221574|NCT00264810|526976|P2|COMPLETED|Stimulation Optimization Period||93
221575|NCT00264810|526977|P1|COMPLETED|Stimulation Optimization Period||96
221576|NCT00264810|526976|P2|STARTED|Stimulation Optimization Period||94
221577|NCT00264810|526977|P1|STARTED|Stimulation Optimization Period||97
221578|NCT00264810|526976|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
221579|NCT00264810|526977|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
221580|NCT00264810|526976|P2|COMPLETED|Post-Operative Stabilization Period||94
221581|NCT00264810|526977|P1|COMPLETED|Post-Operative Stabilization Period||97
221582|NCT00264810|526976|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
221583|NCT00264810|526977|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
221584|NCT00264810|526976|P2|NOT COMPLETED|Baseline||26
221585|NCT00264810|526977|P1|NOT COMPLETED|Baseline||23
221586|NCT00264810|526976|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
221587|NCT00264810|526977|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
221588|NCT00264810|526976|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
221589|NCT00264810|526977|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
221590|NCT00266409|526989|P4|NOT COMPLETED|Overall Study||22
221591|NCT00266409|526990|P3|NOT COMPLETED|Overall Study||17
221592|NCT00266409|526991|P2|NOT COMPLETED|Overall Study||46
221593|NCT00266409|526992|P1|NOT COMPLETED|Overall Study||45
221594|NCT00266409|526989|P4|COMPLETED|Overall Study||49
221595|NCT00266409|526990|P3|COMPLETED|Overall Study||55
221596|NCT00266409|526991|P2|COMPLETED|Overall Study||92
221597|NCT00266409|526992|P1|COMPLETED|Overall Study||92
221598|NCT00266409|526989|P4|STARTED|Overall Study||71
221599|NCT00266409|526990|P3|STARTED|Overall Study||72
221600|NCT00266409|526991|P2|STARTED|Overall Study||138
221601|NCT00266409|526992|P1|STARTED|Overall Study||137
221602|NCT00266279|527274|P1|NOT COMPLETED|Overall Study||2
221603|NCT00266279|527274|P1|COMPLETED|Overall Study||15
221604|NCT00266279|527274|P1|STARTED|Overall Study||17
221605|NCT00266227|527280|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
221606|NCT00266227|527281|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
221607|NCT00266227|527282|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
221608|NCT00266227|527280|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
221609|NCT00266227|527281|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
221610|NCT00266227|527282|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
221611|NCT00266227|527280|P3|STARTED|Retreatment: Week 48 to Week 72||0
221612|NCT00266227|527281|P2|STARTED|Retreatment: Week 48 to Week 72||134
221613|NCT00266227|527282|P1|STARTED|Retreatment: Week 48 to Week 72||291
221614|NCT00266227|527280|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
221615|NCT00266227|527281|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
221616|NCT00266227|527282|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
221617|NCT00266227|527280|P3|COMPLETED|Retreatment: Up to Week 48||0
221618|NCT00266227|527281|P2|COMPLETED|Retreatment: Up to Week 48||134
221619|NCT00266227|527282|P1|COMPLETED|Retreatment: Up to Week 48||291
221620|NCT00266227|527280|P3|STARTED|Retreatment: Up to Week 48||0
221621|NCT00266227|527281|P2|STARTED|Retreatment: Up to Week 48||157
221622|NCT00266227|527282|P1|STARTED|Retreatment: Up to Week 48||318
221623|NCT00266227|527280|P3|NOT COMPLETED|Initial Treatment||77
221624|NCT00266227|527281|P2|NOT COMPLETED|Initial Treatment||0
221625|NCT00266227|527282|P1|NOT COMPLETED|Initial Treatment||0
221626|NCT00266227|527280|P3|COMPLETED|Initial Treatment||482
221627|NCT00266227|527281|P2|COMPLETED|Initial Treatment||0
221628|NCT00266227|527282|P1|COMPLETED|Initial Treatment||0
221629|NCT00266227|527280|P3|STARTED|Initial Treatment||559
221630|NCT00266227|527281|P2|STARTED|Initial Treatment||0
221631|NCT00266227|527282|P1|STARTED|Initial Treatment||0
221632|NCT00264797|527329|P2|NOT COMPLETED|Overall Study||43
221633|NCT00264797|527330|P1|NOT COMPLETED|Overall Study||33
221634|NCT00264797|527329|P2|COMPLETED|Overall Study||109
221635|NCT00264797|527330|P1|COMPLETED|Overall Study||118
221636|NCT00264797|527329|P2|STARTED|Overall Study||152
221637|NCT00264797|527330|P1|STARTED|Overall Study||151
221638|NCT00266032|527345|P3|NOT COMPLETED|Open-label Safety Extension||25
221639|NCT00266032|527346|P2|NOT COMPLETED|Open-label Safety Extension||14
221640|NCT00266032|527347|P1|NOT COMPLETED|Open-label Safety Extension||41
221641|NCT00266032|527345|P3|COMPLETED|Open-label Safety Extension||140
221642|NCT00266032|527346|P2|COMPLETED|Open-label Safety Extension||115
221643|NCT00266032|527347|P1|COMPLETED|Open-label Safety Extension||448
221644|NCT00266032|527345|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
221645|NCT00266032|527346|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
221646|NCT00266032|527347|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
221647|NCT00266032|527345|P3|NOT COMPLETED|Treatment||47
221648|NCT00266032|527346|P2|NOT COMPLETED|Treatment||64
221649|NCT00266032|527347|P1|NOT COMPLETED|Treatment||111
221650|NCT00266032|527345|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
221651|NCT00266032|527346|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
221652|NCT00266032|527347|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
221653|NCT00266032|527345|P3|Patients Treated and in FAS|Treatment|FAS|216
221654|NCT00266032|527346|P2|Patients Treated and in FAS|Treatment|FAS|209
221655|NCT00266032|527347|P1|Patients Treated and in FAS|Treatment|FAS|642
221656|NCT00266032|527345|P3|Patients Treated|Treatment||229
221657|NCT00266032|527346|P2|Patients Treated|Treatment||221
221658|NCT00266032|527347|P1|Patients Treated|Treatment||684
221659|NCT00266032|527345|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
221660|NCT00266032|527346|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
221661|NCT00266032|527347|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
221662|NCT00265889|527375|P1|NOT COMPLETED|Overall Study||5
221663|NCT00265889|527375|P1|COMPLETED|Overall Study||37
221664|NCT00265889|527375|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
221665|NCT00265889|527375|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
221666|NCT00265889|527375|P1|STARTED|Overall Study||42
221667|NCT00265798|527381|P1|NOT COMPLETED|Overall Study||0
221668|NCT00265798|527381|P1|COMPLETED|Overall Study||38
221669|NCT00265798|527381|P1|STARTED|Overall Study||38
221670|NCT00265785|527387|P1|NOT COMPLETED|Overall Study||27
221671|NCT00265785|527387|P1|COMPLETED|Overall Study||0
221672|NCT00265785|527387|P1|Eligible and Began Protocol Treatment|Overall Study||24
221673|NCT00265785|527387|P1|Eligible|Overall Study||26
221674|NCT00265785|527387|P1|STARTED|Overall Study||27
221675|NCT00265616|527396|P2|NOT COMPLETED|Overall Study||0
221676|NCT00265616|527397|P1|NOT COMPLETED|Overall Study||0
221677|NCT00265616|527396|P2|COMPLETED|Overall Study||9
221678|NCT00265616|527397|P1|COMPLETED|Overall Study||14
221679|NCT00265616|527396|P2|STARTED|Overall Study||9
221680|NCT00265616|527397|P1|STARTED|Overall Study||14
221681|NCT00265512|527415|P2|NOT COMPLETED|Overall Study||95
221682|NCT00265512|527416|P1|NOT COMPLETED|Overall Study||45
221683|NCT00265512|527415|P2|COMPLETED|Overall Study||359
221684|NCT00265512|527416|P1|COMPLETED|Overall Study||168
221685|NCT00265512|527415|P2|STARTED|Overall Study||454
221686|NCT00265512|527416|P1|STARTED|Overall Study||213
221687|NCT00265473|527422|P1|NOT COMPLETED|Overall Study||0
221688|NCT00265473|527422|P1|COMPLETED|Overall Study||5
221689|NCT00265473|527422|P1|STARTED|Overall Study||5
221690|NCT00265395|527432|P2|NOT COMPLETED|Overall Study||17
221691|NCT00265395|527433|P1|NOT COMPLETED|Overall Study||8
221692|NCT00265395|527432|P2|COMPLETED|Overall Study||56
221693|NCT00265395|527433|P1|COMPLETED|Overall Study||78
221694|NCT00265395|527432|P2|STARTED|Overall Study||73
221695|NCT00265395|527433|P1|STARTED|Overall Study||86
221696|NCT00265382|527438|P1|NOT COMPLETED|Overall Study||145
221697|NCT00265382|527438|P1|COMPLETED|Overall Study||76
221698|NCT00265382|527438|P1|STARTED|Overall Study||221
221699|NCT00265343|527458|P2|NOT COMPLETED|Overall Study||19
221700|NCT00265343|527459|P1|NOT COMPLETED|Overall Study||21
221701|NCT00265343|527458|P2|COMPLETED|Overall Study||153
221702|NCT00265343|527459|P1|COMPLETED|Overall Study||113
221703|NCT00265343|527458|P2|STARTED|Overall Study||172
221704|NCT00265343|527459|P1|STARTED|Overall Study||134
221705|NCT00265330|527467|P1|NOT COMPLETED|Overall Study||95
221706|NCT00265330|527467|P1|COMPLETED|Overall Study||67
221707|NCT00265330|527467|P1|STARTED|Overall Study||162
221708|NCT00265317|527493|P4|NOT COMPLETED|Phase 2||65
221709|NCT00265317|527494|P3|NOT COMPLETED|Phase 2||64
221710|NCT00265317|527495|P2|NOT COMPLETED|Phase 2||0
221711|NCT00265317|527496|P1|NOT COMPLETED|Phase 2||0
221712|NCT00265317|527493|P4|COMPLETED|Phase 2||2
221713|NCT00265317|527494|P3|COMPLETED|Phase 2||1
221714|NCT00265317|527495|P2|COMPLETED|Phase 2||0
221715|NCT00265317|527496|P1|COMPLETED|Phase 2||0
221716|NCT00265317|527493|P4|STARTED|Phase 2||67
221717|NCT00265317|527494|P3|STARTED|Phase 2||65
221718|NCT00265317|527495|P2|STARTED|Phase 2||0
221719|NCT00265317|527496|P1|STARTED|Phase 2||0
221720|NCT00265317|527493|P4|NOT COMPLETED|Lead-In||0
221721|NCT00265317|527494|P3|NOT COMPLETED|Lead-In||0
221722|NCT00265317|527495|P2|NOT COMPLETED|Lead-In||17
221723|NCT00265317|527496|P1|NOT COMPLETED|Lead-In||12
221724|NCT00265317|527493|P4|COMPLETED|Lead-In||0
221725|NCT00265317|527494|P3|COMPLETED|Lead-In||0
221726|NCT00265317|527495|P2|COMPLETED|Lead-In||0
221727|NCT00265317|527496|P1|COMPLETED|Lead-In||1
221728|NCT00265317|527493|P4|STARTED|Lead-In||0
221729|NCT00265317|527494|P3|STARTED|Lead-In||0
221730|NCT00265317|527495|P2|STARTED|Lead-In||17
221731|NCT00265317|527496|P1|STARTED|Lead-In||13
221732|NCT00265239|527611|P2|NOT COMPLETED|Overall Study||1
221733|NCT00265239|527612|P1|NOT COMPLETED|Overall Study||2
221734|NCT00265239|527611|P2|COMPLETED|Overall Study||51
221735|NCT00265239|527612|P1|COMPLETED|Overall Study||50
221736|NCT00265239|527611|P2|STARTED|Overall Study||52
221737|NCT00265239|527612|P1|STARTED|Overall Study||52
221738|NCT00265122|527630|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
221739|NCT00265122|527631|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
221740|NCT00265122|527632|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
221741|NCT00265122|527633|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
221742|NCT00265122|527634|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
221743|NCT00265122|527635|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
221744|NCT00265122|527630|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
221745|NCT00265122|527631|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
221746|NCT00265122|527632|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
221747|NCT00265122|527633|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
221748|NCT00265122|527634|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
221749|NCT00265122|527635|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
221750|NCT00265122|527630|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
221751|NCT00265122|527631|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
221752|NCT00265122|527632|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
221753|NCT00265122|527633|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
221754|NCT00265122|527634|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
221755|NCT00265122|527635|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
221756|NCT00265122|527630|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
221757|NCT00265122|527631|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
221758|NCT00265122|527632|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
221759|NCT00265122|527633|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
221760|NCT00265122|527634|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
221761|NCT00265122|527635|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
221762|NCT00265122|527630|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
221763|NCT00265122|527631|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
221764|NCT00265122|527632|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
221765|NCT00265122|527633|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
221766|NCT00265122|527634|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
221767|NCT00265122|527635|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
221768|NCT00265122|527630|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
221769|NCT00265122|527631|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
221770|NCT00265122|527632|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
221771|NCT00265122|527633|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
221772|NCT00265122|527634|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
221773|NCT00265122|527635|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
221774|NCT00265109|527657|P1|NOT COMPLETED|Overall Study||6
221775|NCT00265109|527657|P1|COMPLETED|Overall Study||11
221776|NCT00265109|527657|P1|STARTED|Overall Study||17
221777|NCT00265096|527664|P3|NOT COMPLETED|Overall Study||39
221778|NCT00265096|527665|P2|NOT COMPLETED|Overall Study||51
221779|NCT00265096|527666|P1|NOT COMPLETED|Overall Study||36
221780|NCT00265096|527664|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
221781|NCT00265096|527665|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
221782|NCT00265096|527666|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
221783|NCT00265096|527664|P3|STARTED|Overall Study||146
221784|NCT00265096|527665|P2|STARTED|Overall Study||146
221785|NCT00265096|527666|P1|STARTED|Overall Study||113
221786|NCT00265083|527698|P3|NOT COMPLETED|Overall Study||42
221787|NCT00265083|527699|P2|NOT COMPLETED|Overall Study||42
221788|NCT00265083|527700|P1|NOT COMPLETED|Overall Study||17
221789|NCT00265083|527698|P3|COMPLETED|Overall Study||98
221790|NCT00265083|527699|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
221791|NCT00265083|527700|P1|COMPLETED|Overall Study||61
221792|NCT00265083|527698|P3|STARTED|Overall Study||140
221793|NCT00265083|527699|P2|STARTED|Overall Study|One patient did not receive study agent.|138
221794|NCT00265083|527700|P1|STARTED|Overall Study||78
221795|NCT00264576|527723|P2|NOT COMPLETED|Overall Study||1
221796|NCT00264576|527724|P1|NOT COMPLETED|Overall Study||1
221797|NCT00264576|527723|P2|COMPLETED|Overall Study||304
221798|NCT00264576|527724|P1|COMPLETED|Overall Study||307
221799|NCT00264576|527723|P2|STARTED|Overall Study||305
221800|NCT00264576|527724|P1|STARTED|Overall Study||308
221801|NCT00264550|527748|P4|NOT COMPLETED|Overall Study||30
221802|NCT00264550|527749|P3|NOT COMPLETED|Overall Study||17
221803|NCT00264550|527750|P2|NOT COMPLETED|Overall Study||41
221804|NCT00264550|527751|P1|NOT COMPLETED|Overall Study||43
221805|NCT00264550|527748|P4|COMPLETED|Overall Study||59
221806|NCT00264550|527749|P3|COMPLETED|Overall Study||72
221807|NCT00264550|527750|P2|COMPLETED|Overall Study||92
221808|NCT00264550|527751|P1|COMPLETED|Overall Study||90
221809|NCT00264550|527748|P4|STARTED|Overall Study||89
221810|NCT00264550|527749|P3|STARTED|Overall Study||89
221811|NCT00264550|527750|P2|STARTED|Overall Study||133
221812|NCT00264550|527751|P1|STARTED|Overall Study||133
221813|NCT00264537|527790|P4|NOT COMPLETED|Overall Study||60
221814|NCT00264537|527791|P3|NOT COMPLETED|Overall Study||50
221815|NCT00264537|527792|P2|NOT COMPLETED|Overall Study||58
221816|NCT00264537|527793|P1|NOT COMPLETED|Overall Study||50
221817|NCT00264537|527790|P4|COMPLETED|Overall Study||99
221818|NCT00264537|527791|P3|COMPLETED|Overall Study||109
221819|NCT00264537|527792|P2|COMPLETED|Overall Study||101
221820|NCT00264537|527793|P1|COMPLETED|Overall Study||110
221821|NCT00264537|527790|P4|STARTED|Overall Study||159
221822|NCT00264537|527791|P3|STARTED|Overall Study||159
221823|NCT00264537|527792|P2|STARTED|Overall Study||159
221824|NCT00264537|527793|P1|STARTED|Overall Study||160
221825|NCT00264498|527825|P2|NOT COMPLETED|Crossover Treatment||9
221826|NCT00264498|527826|P1|NOT COMPLETED|Crossover Treatment||6
221827|NCT00264498|527825|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
221828|NCT00264498|527826|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
221829|NCT00264498|527825|P2|STARTED|Crossover Treatment||9
221830|NCT00264498|527826|P1|STARTED|Crossover Treatment||6
221831|NCT00264498|527825|P2|NOT COMPLETED|Randomized Treatment||18
221832|NCT00264498|527826|P1|NOT COMPLETED|Randomized Treatment||17
221833|NCT00264498|527825|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
221834|NCT00264498|527826|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
221835|NCT00264498|527825|P2|STARTED|Randomized Treatment||18
221836|NCT00264498|527826|P1|STARTED|Randomized Treatment||17
221837|NCT00264381|527834|P2|NOT COMPLETED|Overall Study||0
221838|NCT00264381|527835|P1|NOT COMPLETED|Overall Study||0
221839|NCT00264381|527834|P2|COMPLETED|Overall Study||37
221840|NCT00264381|527835|P1|COMPLETED|Overall Study||35
221841|NCT00264381|527834|P2|STARTED|Overall Study||37
221842|NCT00264381|527835|P1|STARTED|Overall Study||35
221843|NCT00264303|527849|P2|NOT COMPLETED|Overall Study||29
221844|NCT00264303|527850|P1|NOT COMPLETED|Overall Study||25
221845|NCT00264303|527849|P2|COMPLETED|Overall Study||419
221846|NCT00264303|527850|P1|COMPLETED|Overall Study||413
221847|NCT00264303|527849|P2|STARTED|Overall Study||448
221848|NCT00264303|527850|P1|STARTED|Overall Study||438
221849|NCT00264290|527868|P2|NOT COMPLETED|Observation (4 Weeks)||0
221850|NCT00264290|527869|P1|NOT COMPLETED|Observation (4 Weeks)||0
221851|NCT00264290|527868|P2|COMPLETED|Observation (4 Weeks)||14
221852|NCT00264290|527869|P1|COMPLETED|Observation (4 Weeks)||15
221853|NCT00264290|527868|P2|STARTED|Observation (4 Weeks)||14
221854|NCT00264290|527869|P1|STARTED|Observation (4 Weeks)||15
221855|NCT00264290|527868|P2|NOT COMPLETED|Intervention (8 Weeks)||0
221856|NCT00264290|527869|P1|NOT COMPLETED|Intervention (8 Weeks)||1
221857|NCT00264290|527868|P2|COMPLETED|Intervention (8 Weeks)||14
221858|NCT00264290|527869|P1|COMPLETED|Intervention (8 Weeks)||15
221859|NCT00264290|527868|P2|STARTED|Intervention (8 Weeks)||14
221860|NCT00264290|527869|P1|STARTED|Intervention (8 Weeks)||16
221861|NCT00264147|527880|P6|NOT COMPLETED|Treatment II Period||33
221862|NCT00264147|527881|P5|NOT COMPLETED|Treatment II Period||33
221863|NCT00264147|527882|P4|NOT COMPLETED|Treatment II Period||0
221864|NCT00264147|527883|P3|NOT COMPLETED|Treatment II Period||0
221865|NCT00264147|527884|P2|NOT COMPLETED|Treatment II Period||0
221866|NCT00264147|527885|P1|NOT COMPLETED|Treatment II Period||0
221867|NCT00264147|527880|P6|COMPLETED|Treatment II Period||116
221868|NCT00264147|527881|P5|COMPLETED|Treatment II Period||147
221869|NCT00264147|527882|P4|COMPLETED|Treatment II Period||0
221870|NCT00264147|527883|P3|COMPLETED|Treatment II Period||0
221871|NCT00264147|527884|P2|COMPLETED|Treatment II Period||0
221872|NCT00264147|527885|P1|COMPLETED|Treatment II Period||0
221873|NCT00264147|527880|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
221874|NCT00264147|527881|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
221875|NCT00264147|527882|P4|STARTED|Treatment II Period||0
221876|NCT00264147|527883|P3|STARTED|Treatment II Period||0
221877|NCT00264147|527884|P2|STARTED|Treatment II Period||0
221878|NCT00264147|527885|P1|STARTED|Treatment II Period||0
221879|NCT00264147|527880|P6|NOT COMPLETED|Treatment I Period||0
221880|NCT00264147|527881|P5|NOT COMPLETED|Treatment I Period||56
221881|NCT00264147|527882|P4|NOT COMPLETED|Treatment I Period||72
221882|NCT00264147|527883|P3|NOT COMPLETED|Treatment I Period||77
221883|NCT00264147|527884|P2|NOT COMPLETED|Treatment I Period||83
221884|NCT00264147|527885|P1|NOT COMPLETED|Treatment I Period||98
221885|NCT00264147|527880|P6|COMPLETED|Treatment I Period||0
221886|NCT00264147|527881|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
221887|NCT00264147|527882|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
221888|NCT00264147|527883|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
221889|NCT00264147|527884|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
221890|NCT00264147|527885|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
221891|NCT00264147|527880|P6|STARTED|Treatment I Period||0
221892|NCT00264147|527881|P5|STARTED|Treatment I Period||155
221893|NCT00264147|527882|P4|STARTED|Treatment I Period||140
221894|NCT00264147|527883|P3|STARTED|Treatment I Period||151
221895|NCT00264147|527884|P2|STARTED|Treatment I Period||154
221896|NCT00264147|527885|P1|STARTED|Treatment I Period||161
221897|NCT00264004|527928|P4|NOT COMPLETED|Overall Study||15
221898|NCT00264004|527929|P3|NOT COMPLETED|Overall Study||14
221899|NCT00264004|527930|P2|NOT COMPLETED|Overall Study||11
221900|NCT00264004|527931|P1|NOT COMPLETED|Overall Study||17
221901|NCT00264004|527928|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
221902|NCT00264004|527929|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
221903|NCT00264004|527930|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
221904|NCT00264004|527931|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
221905|NCT00264004|527928|P4|STARTED|Overall Study|Randomised|34
221906|NCT00264004|527929|P3|STARTED|Overall Study|Randomised|30
221907|NCT00264004|527930|P2|STARTED|Overall Study|Randomised|32
221908|NCT00264004|527931|P1|STARTED|Overall Study|Randomised|30
221909|NCT00263887|527959|P2|NOT COMPLETED|Overall Study||7
221910|NCT00263887|527960|P1|NOT COMPLETED|Overall Study||3
221911|NCT00263887|527959|P2|COMPLETED|Overall Study||32
221912|NCT00263887|527960|P1|COMPLETED|Overall Study||35
221913|NCT00263887|527959|P2|STARTED|Overall Study||39
221914|NCT00263887|527960|P1|STARTED|Overall Study||38
221915|NCT00263757|527968|P2|NOT COMPLETED|Overall Study||8
221916|NCT00263757|527969|P1|NOT COMPLETED|Overall Study||8
221917|NCT00263757|527968|P2|COMPLETED|Overall Study||5
221918|NCT00263757|527969|P1|COMPLETED|Overall Study||4
221919|NCT00263757|527968|P2|STARTED|Overall Study||13
221920|NCT00263757|527969|P1|STARTED|Overall Study||12
221921|NCT00263666|527981|P2|NOT COMPLETED|Overall Study||11
221922|NCT00263666|527982|P1|NOT COMPLETED|Overall Study||7
221923|NCT00263666|527981|P2|COMPLETED|Overall Study||39
221924|NCT00263666|527982|P1|COMPLETED|Overall Study||43
221925|NCT00263666|527981|P2|STARTED|Overall Study||50
221926|NCT00263666|527982|P1|STARTED|Overall Study||50
221927|NCT00263328|528036|P3|NOT COMPLETED|Overall Study||7
221928|NCT00263328|528037|P2|NOT COMPLETED|Overall Study||2
221929|NCT00263328|528038|P1|NOT COMPLETED|Overall Study||8
221930|NCT00263328|528036|P3|COMPLETED|Overall Study||6
221931|NCT00263328|528037|P2|COMPLETED|Overall Study||12
221932|NCT00263328|528038|P1|COMPLETED|Overall Study||10
221933|NCT00263328|528036|P3|STARTED|Overall Study||13
221934|NCT00263328|528037|P2|STARTED|Overall Study||14
221935|NCT00263328|528038|P1|STARTED|Overall Study||18
221936|NCT00262964|528196|P4|NOT COMPLETED|Overall Study||0
221937|NCT00262964|528197|P3|NOT COMPLETED|Overall Study||0
221938|NCT00262964|528198|P2|NOT COMPLETED|Overall Study||0
221939|NCT00262964|528199|P1|NOT COMPLETED|Overall Study||0
221940|NCT00262964|528196|P4|COMPLETED|Overall Study||12
221941|NCT00262964|528197|P3|COMPLETED|Overall Study||17
221942|NCT00262964|528198|P2|COMPLETED|Overall Study||11
221943|NCT00262964|528199|P1|COMPLETED|Overall Study||11
221944|NCT00262964|528196|P4|STARTED|Overall Study||12
221945|NCT00262964|528197|P3|STARTED|Overall Study||17
221946|NCT00262964|528198|P2|STARTED|Overall Study||11
221947|NCT00262964|528199|P1|STARTED|Overall Study||11
221948|NCT00262951|528229|P1|NOT COMPLETED|Overall Study||16
221949|NCT00262951|528229|P1|COMPLETED|Overall Study||7
221950|NCT00262951|528229|P1|STARTED|Overall Study||23
221951|NCT00262925|528234|P1|NOT COMPLETED|Overall Study||11
221952|NCT00262925|528234|P1|COMPLETED|Overall Study||1
221953|NCT00262925|528234|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
221954|NCT00262873|528240|P1|NOT COMPLETED|Overall Study||8
221955|NCT00262873|528240|P1|COMPLETED|Overall Study||0
221956|NCT00262873|528240|P1|STARTED|Overall Study||8
221957|NCT00262860|528251|P1|NOT COMPLETED|Overall Study||2
221958|NCT00262860|528251|P1|COMPLETED|Overall Study||16
221959|NCT00262860|528251|P1|STARTED|Overall Study||18
221960|NCT00262847|528260|P3|NOT COMPLETED|Overall Study||396
221961|NCT00262847|528261|P2|NOT COMPLETED|Overall Study||513
221962|NCT00262847|528262|P1|NOT COMPLETED|Overall Study||518
221963|NCT00262847|528260|P3|COMPLETED|Overall Study||227
221964|NCT00262847|528261|P2|COMPLETED|Overall Study||112
221965|NCT00262847|528262|P1|COMPLETED|Overall Study||107
221966|NCT00262847|528260|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
221967|NCT00262847|528261|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
221968|NCT00262847|528262|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
221969|NCT00262834|528278|P2|NOT COMPLETED|Overall Study||4
221970|NCT00262834|528279|P1|NOT COMPLETED|Overall Study||1
221971|NCT00262834|528278|P2|COMPLETED|Overall Study||25
221972|NCT00262834|528279|P1|COMPLETED|Overall Study||24
221973|NCT00262834|528278|P2|STARTED|Overall Study||29
221974|NCT00262834|528279|P1|STARTED|Overall Study||25
221975|NCT00262743|528289|P2|NOT COMPLETED|Overall Study||12
221976|NCT00262743|528290|P1|NOT COMPLETED|Overall Study||0
221977|NCT00262743|528289|P2|COMPLETED|Overall Study||30
221978|NCT00262743|528290|P1|COMPLETED|Overall Study||27
221979|NCT00262743|528289|P2|STARTED|Overall Study||42
221980|NCT00262743|528290|P1|STARTED|Overall Study||27
221981|NCT00262730|528297|P1|NOT COMPLETED|Overall Study||0
221982|NCT00262730|528297|P1|COMPLETED|Overall Study||97
221983|NCT00262730|528297|P1|STARTED|Overall Study||97
221984|NCT00262639|528305|P4|NOT COMPLETED|Overall Study||0
221985|NCT00262639|528306|P3|NOT COMPLETED|Overall Study||0
221986|NCT00262639|528307|P2|NOT COMPLETED|Overall Study||0
221987|NCT00262639|528308|P1|NOT COMPLETED|Overall Study||0
221988|NCT00262639|528305|P4|COMPLETED|Overall Study||7
221989|NCT00262639|528306|P3|COMPLETED|Overall Study||9
221990|NCT00262639|528307|P2|COMPLETED|Overall Study||26
221991|NCT00262639|528308|P1|COMPLETED|Overall Study||18
221992|NCT00262639|528305|P4|STARTED|Overall Study||7
221993|NCT00262639|528306|P3|STARTED|Overall Study||9
221994|NCT00262639|528307|P2|STARTED|Overall Study||26
221995|NCT00262639|528308|P1|STARTED|Overall Study||18
221996|NCT00262600|528325|P3|NOT COMPLETED|Overall Study||266
221997|NCT00262600|528326|P2|NOT COMPLETED|Overall Study||252
221998|NCT00262600|528327|P1|NOT COMPLETED|Overall Study||235
221999|NCT00262600|528325|P3|COMPLETED|Overall Study||5756
222000|NCT00262600|528326|P2|COMPLETED|Overall Study||5824
222001|NCT00262600|528327|P1|COMPLETED|Overall Study||5780
222002|NCT00262600|528325|P3|STARTED|Overall Study||6022
222003|NCT00262600|528326|P2|STARTED|Overall Study||6076
222004|NCT00262600|528327|P1|STARTED|Overall Study||6015
222005|NCT00262522|528354|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
222006|NCT00262522|528355|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
222007|NCT00262522|528356|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
222008|NCT00262522|528357|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
222009|NCT00262522|528354|P4|COMPLETED|Study Start Through 96 Weeks||0
222010|NCT00262522|528355|P3|COMPLETED|Study Start Through 96 Weeks||254
222011|NCT00262522|528356|P2|COMPLETED|Study Start Through 96 Weeks||0
222012|NCT00262522|528357|P1|COMPLETED|Study Start Through 96 Weeks||256
222013|NCT00262522|528354|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
222014|NCT00262522|528355|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
222015|NCT00262522|528356|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
222016|NCT00262522|528357|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
222017|NCT00262522|528354|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
222018|NCT00262522|528355|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
222019|NCT00262522|528356|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
222020|NCT00262522|528357|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
222021|NCT00262522|528354|P4|COMPLETED|Study Start Through 48 Weeks||0
222022|NCT00262522|528355|P3|COMPLETED|Study Start Through 48 Weeks||276
222023|NCT00262522|528356|P2|COMPLETED|Study Start Through 48 Weeks||0
222024|NCT00262522|528357|P1|COMPLETED|Study Start Through 48 Weeks||284
222025|NCT00262522|528354|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
222026|NCT00262522|528355|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
222027|NCT00262522|528356|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
222028|NCT00262522|528357|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
222029|NCT00262522|528354|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
222030|NCT00262522|528355|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
222031|NCT00262522|528356|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
222032|NCT00262522|528357|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
222033|NCT00262522|528354|P4|COMPLETED|Study Start Through 8 Weeks||160
222034|NCT00262522|528355|P3|COMPLETED|Study Start Through 8 Weeks||155
222035|NCT00262522|528356|P2|COMPLETED|Study Start Through 8 Weeks||161
222036|NCT00262522|528357|P1|COMPLETED|Study Start Through 8 Weeks||163
222037|NCT00262522|528354|P4|STARTED|Study Start Through 8 Weeks||165
222038|NCT00262522|528355|P3|STARTED|Study Start Through 8 Weeks||166
222039|NCT00262522|528356|P2|STARTED|Study Start Through 8 Weeks||166
222040|NCT00262522|528357|P1|STARTED|Study Start Through 8 Weeks||167
222041|NCT00262509|528379|P2|NOT COMPLETED|Overall Study||0
222042|NCT00262509|528380|P1|NOT COMPLETED|Overall Study||0
222043|NCT00262509|528379|P2|COMPLETED|Overall Study||9
222044|NCT00262509|528380|P1|COMPLETED|Overall Study||8
222045|NCT00262509|528379|P2|STARTED|Overall Study||9
222046|NCT00262509|528380|P1|STARTED|Overall Study||8
222047|NCT00262314|528386|P1|NOT COMPLETED|Overall Study||337
222048|NCT00262314|528386|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
222049|NCT00262314|528386|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
222050|NCT00262301|528404|P3|NOT COMPLETED|Open-label Phase||0
222051|NCT00262301|528405|P2|NOT COMPLETED|Open-label Phase||0
222052|NCT00262301|528406|P1|NOT COMPLETED|Open-label Phase||0
222053|NCT00262301|528404|P3|COMPLETED|Open-label Phase||57
222054|NCT00262301|528405|P2|COMPLETED|Open-label Phase||0
222055|NCT00262301|528406|P1|COMPLETED|Open-label Phase||0
222056|NCT00262301|528404|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
222057|NCT00262301|528405|P2|STARTED|Open-label Phase||0
222058|NCT00262301|528406|P1|STARTED|Open-label Phase||0
222059|NCT00262301|528404|P3|NOT COMPLETED|Double-blind Phase||0
222060|NCT00262301|528405|P2|NOT COMPLETED|Double-blind Phase||1
222061|NCT00262301|528406|P1|NOT COMPLETED|Double-blind Phase||1
222062|NCT00262301|528404|P3|COMPLETED|Double-blind Phase||0
222063|NCT00262301|528405|P2|COMPLETED|Double-blind Phase||15
222064|NCT00262301|528406|P1|COMPLETED|Double-blind Phase||15
222065|NCT00262301|528404|P3|STARTED|Double-blind Phase||0
222066|NCT00262301|528405|P2|STARTED|Double-blind Phase||16
222067|NCT00262301|528406|P1|STARTED|Double-blind Phase||16
222068|NCT00262223|528419|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
222069|NCT00262223|528420|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
222070|NCT00262223|528419|P2|COMPLETED|12-month Post-treatment Follow-up||22
222071|NCT00262223|528420|P1|COMPLETED|12-month Post-treatment Follow-up||21
222072|NCT00262223|528419|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
222073|NCT00262223|528420|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
222074|NCT00262223|528419|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
222075|NCT00262223|528420|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
222076|NCT00262223|528419|P2|COMPLETED|6-month Post-treatment Follow-up||28
222077|NCT00262223|528420|P1|COMPLETED|6-month Post-treatment Follow-up||22
222078|NCT00262223|528419|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
222079|NCT00262223|528420|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
222080|NCT00262223|528419|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
222081|NCT00262223|528420|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
222082|NCT00262223|528419|P2|COMPLETED|1-week Post-treatment Follow-up||25
222083|NCT00262223|528420|P1|COMPLETED|1-week Post-treatment Follow-up||24
222084|NCT00262223|528419|P2|STARTED|1-week Post-treatment Follow-up||29
222085|NCT00262223|528420|P1|STARTED|1-week Post-treatment Follow-up||28
222086|NCT00262223|528419|P2|NOT COMPLETED|Treatment Phase||8
222087|NCT00262223|528420|P1|NOT COMPLETED|Treatment Phase||4
222088|NCT00262223|528419|P2|COMPLETED|Treatment Phase||29
222089|NCT00262223|528420|P1|COMPLETED|Treatment Phase||28
222090|NCT00262223|528419|P2|STARTED|Treatment Phase||37
222091|NCT00262223|528420|P1|STARTED|Treatment Phase||32
222092|NCT00262119|528431|P3|NOT COMPLETED|Overall Study||58
222093|NCT00262119|528432|P2|NOT COMPLETED|Overall Study||70
222094|NCT00262119|528433|P1|NOT COMPLETED|Overall Study||58
222095|NCT00262119|528431|P3|COMPLETED|Overall Study||325
222096|NCT00262119|528432|P2|COMPLETED|Overall Study||328
222097|NCT00262119|528433|P1|COMPLETED|Overall Study||327
222098|NCT00262119|528431|P3|STARTED|Overall Study||383
222099|NCT00262119|528432|P2|STARTED|Overall Study||398
222100|NCT00262119|528433|P1|STARTED|Overall Study||385
222101|NCT00262080|528453|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
222102|NCT00262080|528454|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
222103|NCT00262080|528455|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
222104|NCT00262080|528453|P3|COMPLETED|Repeat Dose Treatment Period||14
222105|NCT00262080|528454|P2|COMPLETED|Repeat Dose Treatment Period||25
222106|NCT00262080|528455|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
222107|NCT00262080|528453|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
222108|NCT00262080|528454|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
222200|NCT00261846|528748|P5|NOT COMPLETED|Part 2: Efficacy||60
222109|NCT00262080|528455|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
222110|NCT00262080|528453|P3|NOT COMPLETED|Double Blind Treatment Period||0
222111|NCT00262080|528454|P2|NOT COMPLETED|Double Blind Treatment Period||0
222112|NCT00262080|528455|P1|NOT COMPLETED|Double Blind Treatment Period||1
222113|NCT00262080|528453|P3|COMPLETED|Double Blind Treatment Period||0
222114|NCT00262080|528454|P2|COMPLETED|Double Blind Treatment Period||36
222115|NCT00262080|528455|P1|COMPLETED|Double Blind Treatment Period||35
222116|NCT00262080|528453|P3|STARTED|Double Blind Treatment Period||0
222117|NCT00262080|528454|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
222118|NCT00262080|528455|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
222119|NCT00262067|528475|P4|NOT COMPLETED|Overall Study||113
222120|NCT00262067|528476|P3|NOT COMPLETED|Overall Study||216
222121|NCT00262067|528477|P2|NOT COMPLETED|Overall Study||100
222122|NCT00262067|528478|P1|NOT COMPLETED|Overall Study||219
222123|NCT00262067|528475|P4|COMPLETED|Overall Study||93
222124|NCT00262067|528476|P3|COMPLETED|Overall Study||193
222125|NCT00262067|528477|P2|COMPLETED|Overall Study||107
222126|NCT00262067|528478|P1|COMPLETED|Overall Study||196
222127|NCT00262067|528475|P4|STARTED|Overall Study||206
222128|NCT00262067|528476|P3|STARTED|Overall Study||409
222129|NCT00262067|528477|P2|STARTED|Overall Study||207
222130|NCT00262067|528478|P1|STARTED|Overall Study||415
222131|NCT00262041|528512|P3|NOT COMPLETED|Overall Study||6
222132|NCT00262041|528513|P2|NOT COMPLETED|Overall Study||4
222133|NCT00262041|528514|P1|NOT COMPLETED|Overall Study||2
222134|NCT00262041|528512|P3|COMPLETED|Overall Study||203
222135|NCT00262041|528513|P2|COMPLETED|Overall Study||147
222136|NCT00262041|528514|P1|COMPLETED|Overall Study||162
222137|NCT00262041|528512|P3|STARTED|Overall Study||209
222138|NCT00262041|528513|P2|STARTED|Overall Study||151
222139|NCT00262041|528514|P1|STARTED|Overall Study||164
222140|NCT00262028|528543|P9|NOT COMPLETED|Overall Study||19
222141|NCT00262028|528544|P8|NOT COMPLETED|Overall Study||18
222142|NCT00262028|528545|P7|NOT COMPLETED|Overall Study||12
222143|NCT00262028|528546|P6|NOT COMPLETED|Overall Study||13
222144|NCT00262028|528547|P5|NOT COMPLETED|Overall Study||12
222145|NCT00262028|528548|P4|NOT COMPLETED|Overall Study||23
222146|NCT00262028|528549|P3|NOT COMPLETED|Overall Study||20
222147|NCT00262028|528550|P2|NOT COMPLETED|Overall Study||27
222148|NCT00262028|528551|P1|NOT COMPLETED|Overall Study||24
222149|NCT00262028|528543|P9|COMPLETED|Overall Study||81
222150|NCT00262028|528544|P8|COMPLETED|Overall Study||55
222151|NCT00262028|528545|P7|COMPLETED|Overall Study||59
222152|NCT00262028|528546|P6|COMPLETED|Overall Study||60
222153|NCT00262028|528547|P5|COMPLETED|Overall Study||62
222154|NCT00262028|528548|P4|COMPLETED|Overall Study||134
222155|NCT00262028|528549|P3|COMPLETED|Overall Study||137
222156|NCT00262028|528550|P2|COMPLETED|Overall Study||126
222157|NCT00262028|528551|P1|COMPLETED|Overall Study||128
222158|NCT00262028|528543|P9|STARTED|Overall Study||100
222159|NCT00262028|528544|P8|STARTED|Overall Study||73
222160|NCT00262028|528545|P7|STARTED|Overall Study||71
222161|NCT00262028|528546|P6|STARTED|Overall Study||73
222162|NCT00262028|528547|P5|STARTED|Overall Study||74
222163|NCT00262028|528548|P4|STARTED|Overall Study||157
222164|NCT00262028|528549|P3|STARTED|Overall Study||157
222165|NCT00262028|528550|P2|STARTED|Overall Study||153
222166|NCT00262028|528551|P1|STARTED|Overall Study||152
222167|NCT00262002|528613|P7|NOT COMPLETED|Overall Study||6
222168|NCT00262002|528614|P6|NOT COMPLETED|Overall Study||7
222169|NCT00262002|528615|P5|NOT COMPLETED|Overall Study||7
222170|NCT00262002|528616|P4|NOT COMPLETED|Overall Study||5
222171|NCT00262002|528617|P3|NOT COMPLETED|Overall Study||0
222172|NCT00262002|528618|P2|NOT COMPLETED|Overall Study||6
222173|NCT00262002|528619|P1|NOT COMPLETED|Overall Study||11
222174|NCT00262002|528613|P7|COMPLETED|Overall Study||84
222175|NCT00262002|528614|P6|COMPLETED|Overall Study||83
222176|NCT00262002|528615|P5|COMPLETED|Overall Study||91
222177|NCT00262002|528616|P4|COMPLETED|Overall Study||93
222178|NCT00262002|528617|P3|COMPLETED|Overall Study||45
222179|NCT00262002|528618|P2|COMPLETED|Overall Study||84
222180|NCT00262002|528619|P1|COMPLETED|Overall Study||79
222181|NCT00262002|528613|P7|STARTED|Overall Study||90
222182|NCT00262002|528614|P6|STARTED|Overall Study||90
222183|NCT00262002|528615|P5|STARTED|Overall Study||98
222184|NCT00262002|528616|P4|STARTED|Overall Study||98
222185|NCT00262002|528617|P3|STARTED|Overall Study||45
222186|NCT00262002|528618|P2|STARTED|Overall Study||90
222187|NCT00262002|528619|P1|STARTED|Overall Study||90
222188|NCT00261950|528712|P1|NOT COMPLETED|Overall Study||26
222189|NCT00261950|528712|P1|COMPLETED|Overall Study||84
222190|NCT00261950|528712|P1|STARTED|Overall Study||110
222191|NCT00261846|528739|P14|NOT COMPLETED|Part 2: Efficacy||23
222192|NCT00261846|528740|P13|NOT COMPLETED|Part 2: Efficacy||26
222193|NCT00261846|528741|P12|NOT COMPLETED|Part 2: Efficacy||26
222194|NCT00261846|528742|P11|NOT COMPLETED|Part 2: Efficacy||25
222195|NCT00261846|528743|P10|NOT COMPLETED|Part 2: Efficacy||42
222196|NCT00261846|528744|P9|NOT COMPLETED|Part 2: Efficacy||2
222197|NCT00261846|528745|P8|NOT COMPLETED|Part 2: Efficacy||26
222198|NCT00261846|528746|P7|NOT COMPLETED|Part 2: Efficacy||33
222199|NCT00261846|528747|P6|NOT COMPLETED|Part 2: Efficacy||33
222201|NCT00261846|528749|P4|NOT COMPLETED|Part 2: Efficacy||162
222202|NCT00261846|528750|P3|NOT COMPLETED|Part 2: Efficacy||0
222203|NCT00261846|528751|P2|NOT COMPLETED|Part 2: Efficacy||0
222204|NCT00261846|528752|P1|NOT COMPLETED|Part 2: Efficacy||0
222205|NCT00261846|528739|P14|COMPLETED|Part 2: Efficacy||1
222206|NCT00261846|528740|P13|COMPLETED|Part 2: Efficacy||3
222207|NCT00261846|528741|P12|COMPLETED|Part 2: Efficacy||9
222208|NCT00261846|528742|P11|COMPLETED|Part 2: Efficacy||6
222209|NCT00261846|528743|P10|COMPLETED|Part 2: Efficacy||4
222210|NCT00261846|528744|P9|COMPLETED|Part 2: Efficacy||2
222211|NCT00261846|528745|P8|COMPLETED|Part 2: Efficacy||1
222212|NCT00261846|528746|P7|COMPLETED|Part 2: Efficacy||17
222213|NCT00261846|528747|P6|COMPLETED|Part 2: Efficacy||4
222214|NCT00261846|528748|P5|COMPLETED|Part 2: Efficacy||28
222215|NCT00261846|528749|P4|COMPLETED|Part 2: Efficacy||38
222216|NCT00261846|528750|P3|COMPLETED|Part 2: Efficacy||0
222217|NCT00261846|528751|P2|COMPLETED|Part 2: Efficacy||0
222218|NCT00261846|528752|P1|COMPLETED|Part 2: Efficacy||0
222219|NCT00261846|528739|P14|STARTED|Part 2: Efficacy||24
222220|NCT00261846|528740|P13|STARTED|Part 2: Efficacy||29
222221|NCT00261846|528741|P12|STARTED|Part 2: Efficacy||35
222222|NCT00261846|528742|P11|STARTED|Part 2: Efficacy||31
222223|NCT00261846|528743|P10|STARTED|Part 2: Efficacy|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|46
222224|NCT00261846|528744|P9|STARTED|Part 2: Efficacy||4
222225|NCT00261846|528745|P8|STARTED|Part 2: Efficacy||27
222226|NCT00261846|528746|P7|STARTED|Part 2: Efficacy||50
222227|NCT00261846|528747|P6|STARTED|Part 2: Efficacy||37
222228|NCT00261846|528748|P5|STARTED|Part 2: Efficacy||88
222229|NCT00261846|528749|P4|STARTED|Part 2: Efficacy|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|200
222230|NCT00261846|528750|P3|STARTED|Part 2: Efficacy||0
222231|NCT00261846|528751|P2|STARTED|Part 2: Efficacy||0
222232|NCT00261846|528752|P1|STARTED|Part 2: Efficacy||0
222233|NCT00261846|528739|P14|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222234|NCT00261846|528740|P13|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222235|NCT00261846|528741|P12|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222236|NCT00261846|528742|P11|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222237|NCT00261846|528743|P10|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222238|NCT00261846|528744|P9|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222239|NCT00261846|528745|P8|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222240|NCT00261846|528746|P7|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222241|NCT00261846|528747|P6|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222242|NCT00261846|528748|P5|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222243|NCT00261846|528749|P4|NOT COMPLETED|Part 1: Dose-escalation Phase||0
222244|NCT00261846|528750|P3|NOT COMPLETED|Part 1: Dose-escalation Phase||12
222245|NCT00261846|528751|P2|NOT COMPLETED|Part 1: Dose-escalation Phase||3
222246|NCT00261846|528752|P1|NOT COMPLETED|Part 1: Dose-escalation Phase||3
222247|NCT00261846|528739|P14|COMPLETED|Part 1: Dose-escalation Phase||0
222248|NCT00261846|528740|P13|COMPLETED|Part 1: Dose-escalation Phase||0
222249|NCT00261846|528741|P12|COMPLETED|Part 1: Dose-escalation Phase||0
222250|NCT00261846|528742|P11|COMPLETED|Part 1: Dose-escalation Phase||0
222251|NCT00261846|528743|P10|COMPLETED|Part 1: Dose-escalation Phase||0
222252|NCT00261846|528744|P9|COMPLETED|Part 1: Dose-escalation Phase||0
222253|NCT00261846|528745|P8|COMPLETED|Part 1: Dose-escalation Phase||0
222254|NCT00261846|528746|P7|COMPLETED|Part 1: Dose-escalation Phase||0
222255|NCT00261846|528747|P6|COMPLETED|Part 1: Dose-escalation Phase||0
222256|NCT00261846|528748|P5|COMPLETED|Part 1: Dose-escalation Phase||0
222257|NCT00261846|528749|P4|COMPLETED|Part 1: Dose-escalation Phase||0
222258|NCT00261846|528750|P3|COMPLETED|Part 1: Dose-escalation Phase||0
222259|NCT00261846|528751|P2|COMPLETED|Part 1: Dose-escalation Phase||0
222260|NCT00261846|528752|P1|COMPLETED|Part 1: Dose-escalation Phase||0
222261|NCT00261846|528739|P14|STARTED|Part 1: Dose-escalation Phase||0
222262|NCT00261846|528740|P13|STARTED|Part 1: Dose-escalation Phase||0
222263|NCT00261846|528741|P12|STARTED|Part 1: Dose-escalation Phase||0
222264|NCT00261846|528742|P11|STARTED|Part 1: Dose-escalation Phase||0
222265|NCT00261846|528743|P10|STARTED|Part 1: Dose-escalation Phase||0
222266|NCT00261846|528744|P9|STARTED|Part 1: Dose-escalation Phase||0
222267|NCT00261846|528745|P8|STARTED|Part 1: Dose-escalation Phase||0
222268|NCT00261846|528746|P7|STARTED|Part 1: Dose-escalation Phase||0
222269|NCT00261846|528747|P6|STARTED|Part 1: Dose-escalation Phase||0
222270|NCT00261846|528748|P5|STARTED|Part 1: Dose-escalation Phase||0
222271|NCT00261846|528749|P4|STARTED|Part 1: Dose-escalation Phase||0
222272|NCT00261846|528750|P3|STARTED|Part 1: Dose-escalation Phase||12
222273|NCT00261846|528751|P2|STARTED|Part 1: Dose-escalation Phase||3
222274|NCT00261846|528752|P1|STARTED|Part 1: Dose-escalation Phase||3
222275|NCT00261833|528968|P2|NOT COMPLETED|Overall Study||18
222276|NCT00261833|528969|P1|NOT COMPLETED|Overall Study||9
222277|NCT00261833|528968|P2|COMPLETED|Overall Study||69
222278|NCT00261833|528969|P1|COMPLETED|Overall Study||84
222279|NCT00261833|528968|P2|STARTED|Overall Study||87
222280|NCT00261833|528969|P1|STARTED|Overall Study||93
222281|NCT00261716|529003|P2|NOT COMPLETED|Overall Study||10
222282|NCT00261716|529004|P1|NOT COMPLETED|Overall Study||6
222283|NCT00261716|529003|P2|COMPLETED|Overall Study||11
222284|NCT00261716|529004|P1|COMPLETED|Overall Study||11
222285|NCT00261716|529003|P2|STARTED|Overall Study||21
222286|NCT00261716|529004|P1|STARTED|Overall Study||17
222287|NCT00261495|529024|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
222288|NCT00261495|529025|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
222289|NCT00261495|529024|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
222290|NCT00261495|529025|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
222291|NCT00261495|529024|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
222292|NCT00261495|529025|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
222293|NCT00261495|529024|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
222294|NCT00261495|529025|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
222295|NCT00261495|529024|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
222296|NCT00261495|529025|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
222297|NCT00261495|529024|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
222298|NCT00261495|529025|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
222299|NCT00261495|529024|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
222300|NCT00261495|529025|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
222301|NCT00261495|529024|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
222302|NCT00261495|529025|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
222303|NCT00261495|529024|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
222304|NCT00261495|529025|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
222305|NCT00261443|529189|P3|NOT COMPLETED|4: Extension Phase||2
222306|NCT00261443|529190|P2|NOT COMPLETED|4: Extension Phase||3
222307|NCT00261443|529191|P1|NOT COMPLETED|4: Extension Phase||0
222308|NCT00261443|529189|P3|COMPLETED|4: Extension Phase||21
222309|NCT00261443|529190|P2|COMPLETED|4: Extension Phase||16
222310|NCT00261443|529191|P1|COMPLETED|4: Extension Phase||0
222311|NCT00261443|529189|P3|STARTED|4: Extension Phase||23
222312|NCT00261443|529190|P2|STARTED|4: Extension Phase||19
222313|NCT00261443|529191|P1|STARTED|4: Extension Phase||0
222314|NCT00261443|529189|P3|NOT COMPLETED|3: Assessment of Relapse||65
222315|NCT00261443|529190|P2|NOT COMPLETED|3: Assessment of Relapse||80
222316|NCT00261443|529191|P1|NOT COMPLETED|3: Assessment of Relapse||0
222317|NCT00261443|529189|P3|COMPLETED|3: Assessment of Relapse||103
222318|NCT00261443|529190|P2|COMPLETED|3: Assessment of Relapse||89
222319|NCT00261443|529191|P1|COMPLETED|3: Assessment of Relapse||0
222320|NCT00261443|529189|P3|STARTED|3: Assessment of Relapse||168
222321|NCT00261443|529190|P2|STARTED|3: Assessment of Relapse||169
222322|NCT00261443|529191|P1|STARTED|3: Assessment of Relapse||0
222323|NCT00261443|529189|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
222324|NCT00261443|529190|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
222325|NCT00261443|529191|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
222326|NCT00261443|529189|P3|COMPLETED|2: Stability & Maintenance of Stability||0
222327|NCT00261443|529190|P2|COMPLETED|2: Stability & Maintenance of Stability||0
222328|NCT00261443|529191|P1|COMPLETED|2: Stability & Maintenance of Stability||346
222329|NCT00261443|529189|P3|STARTED|2: Stability & Maintenance of Stability||0
222330|NCT00261443|529190|P2|STARTED|2: Stability & Maintenance of Stability||0
222331|NCT00261443|529191|P1|STARTED|2: Stability & Maintenance of Stability||686
222332|NCT00261443|529189|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
222333|NCT00261443|529190|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
222334|NCT00261443|529191|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
222335|NCT00261443|529189|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
222336|NCT00261443|529190|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
222337|NCT00261443|529191|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
222338|NCT00261443|529189|P3|STARTED|1: Confirmation of Partial Nonresponse||0
222339|NCT00261443|529190|P2|STARTED|1: Confirmation of Partial Nonresponse||0
222340|NCT00261443|529191|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
222341|NCT00260832|529448|P2|NOT COMPLETED|Overall Study||211
222342|NCT00260832|529449|P1|NOT COMPLETED|Overall Study||228
222343|NCT00260832|529448|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
222344|NCT00260832|529449|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
222345|NCT00260832|529448|P2|STARTED|Overall Study||242
222346|NCT00260832|529449|P1|STARTED|Overall Study||243
222347|NCT00260533|529457|P2|NOT COMPLETED|Overall Study||3
222348|NCT00260533|529458|P1|NOT COMPLETED|Overall Study||3
222349|NCT00260533|529457|P2|COMPLETED|Overall Study||10
222350|NCT00260533|529458|P1|COMPLETED|Overall Study||11
222351|NCT00260533|529457|P2|STARTED|Overall Study||13
222352|NCT00260533|529458|P1|STARTED|Overall Study||14
222353|NCT00260429|529466|P2|NOT COMPLETED|Overall Study||0
222354|NCT00260429|529467|P1|NOT COMPLETED|Overall Study||2
222355|NCT00260429|529466|P2|COMPLETED|Overall Study||12
222356|NCT00260429|529467|P1|COMPLETED|Overall Study||21
222357|NCT00260429|529466|P2|STARTED|Overall Study||12
222358|NCT00260429|529467|P1|STARTED|Overall Study||23
222359|NCT00260208|529475|P2|NOT COMPLETED|Overall Study||34
222360|NCT00260208|529476|P1|NOT COMPLETED|Overall Study||47
222361|NCT00260208|529475|P2|COMPLETED|Overall Study||138
222362|NCT00260208|529476|P1|COMPLETED|Overall Study||137
222363|NCT00260208|529475|P2|Modified ITT|Overall Study||96
222364|NCT00260208|529476|P1|Modified ITT|Overall Study||101
222365|NCT00260208|529475|P2|Intent to Treat (ITT) Population|Overall Study||169
222366|NCT00260208|529476|P1|Intent to Treat (ITT) Population|Overall Study||182
222367|NCT00260208|529475|P2|STARTED|Overall Study||172
222368|NCT00260208|529476|P1|STARTED|Overall Study|"Started indicates safety population."|184
222369|NCT00260195|529506|P2|NOT COMPLETED|Overall Study||0
222370|NCT00260195|529507|P1|NOT COMPLETED|Overall Study||0
222371|NCT00260195|529506|P2|COMPLETED|Overall Study||37
222372|NCT00260195|529507|P1|COMPLETED|Overall Study||39
222373|NCT00260195|529506|P2|STARTED|Overall Study||37
222374|NCT00260195|529507|P1|STARTED|Overall Study||39
222375|NCT00260065|529519|P1|NOT COMPLETED|Overall Study||93
222376|NCT00260065|529519|P1|COMPLETED|Overall Study||6
222377|NCT00260065|529519|P1|STARTED|Overall Study||99
222378|NCT00259857|529526|P2|NOT COMPLETED|24 Months Treatment||3
222379|NCT00259857|529527|P1|NOT COMPLETED|24 Months Treatment||0
222380|NCT00259857|529526|P2|COMPLETED|24 Months Treatment||6
222381|NCT00259857|529527|P1|COMPLETED|24 Months Treatment||10
222382|NCT00259857|529526|P2|STARTED|24 Months Treatment||9
222383|NCT00259857|529527|P1|STARTED|24 Months Treatment||10
222384|NCT00259857|529526|P2|NOT COMPLETED|12 Months Treatment||2
222385|NCT00259857|529527|P1|NOT COMPLETED|12 Months Treatment||1
222386|NCT00259857|529526|P2|COMPLETED|12 Months Treatment||9
222387|NCT00259857|529527|P1|COMPLETED|12 Months Treatment||10
222388|NCT00259857|529526|P2|STARTED|12 Months Treatment||11
222389|NCT00259857|529527|P1|STARTED|12 Months Treatment||11
222390|NCT00259740|529545|P2|NOT COMPLETED|Overall Study||53
222391|NCT00259740|529546|P1|NOT COMPLETED|Overall Study||43
222392|NCT00259740|529545|P2|COMPLETED|Overall Study||0
222393|NCT00259740|529546|P1|COMPLETED|Overall Study||0
222394|NCT00259740|529545|P2|Received Study Medication|Overall Study||53
222395|NCT00259740|529546|P1|Received Study Medication|Overall Study||42
222396|NCT00259740|529545|P2|STARTED|Overall Study||53
222397|NCT00259740|529546|P1|STARTED|Overall Study||43
222398|NCT00259649|529556|P1|NOT COMPLETED|Overall Study||10
222399|NCT00259649|529556|P1|COMPLETED|Overall Study||61
222400|NCT00259649|529556|P1|STARTED|Overall Study||71
222401|NCT00259610|529564|P4|NOT COMPLETED|Overall Study||43
222402|NCT00259610|529565|P3|NOT COMPLETED|Overall Study||73
222403|NCT00259610|529566|P2|NOT COMPLETED|Overall Study||46
222404|NCT00259610|529567|P1|NOT COMPLETED|Overall Study||76
222405|NCT00259610|529564|P4|COMPLETED|Overall Study||81
222406|NCT00259610|529565|P3|COMPLETED|Overall Study||182
222407|NCT00259610|529566|P2|COMPLETED|Overall Study||86
222408|NCT00259610|529567|P1|COMPLETED|Overall Study||168
222409|NCT00259610|529564|P4|STARTED|Overall Study||124
222410|NCT00259610|529565|P3|STARTED|Overall Study||255
222411|NCT00259610|529566|P2|STARTED|Overall Study||132
222412|NCT00259610|529567|P1|STARTED|Overall Study||244
222413|NCT00259298|529581|P1|NOT COMPLETED|Overall Study||3
222414|NCT00259298|529581|P1|COMPLETED|Overall Study||9
222415|NCT00259298|529581|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
222416|NCT00259298|529581|P1|STARTED|Overall Study||12
222417|NCT00259285|529589|P1|NOT COMPLETED|Overall Study||0
222418|NCT00259285|529589|P1|COMPLETED|Overall Study||10
222419|NCT00259285|529589|P1|STARTED|Overall Study||10
222420|NCT00259272|529599|P4|NOT COMPLETED|Overall Study||21
222421|NCT00259272|529600|P3|NOT COMPLETED|Overall Study||5
222422|NCT00259272|529601|P2|NOT COMPLETED|Overall Study||7
222423|NCT00259272|529602|P1|NOT COMPLETED|Overall Study||15
222424|NCT00259272|529599|P4|COMPLETED|Overall Study||27
222425|NCT00259272|529600|P3|COMPLETED|Overall Study||21
222426|NCT00259272|529601|P2|COMPLETED|Overall Study||24
222427|NCT00259272|529602|P1|COMPLETED|Overall Study||21
222428|NCT00259272|529599|P4|STARTED|Overall Study||48
222429|NCT00259272|529600|P3|STARTED|Overall Study||26
222430|NCT00259272|529601|P2|STARTED|Overall Study||31
222431|NCT00259272|529602|P1|STARTED|Overall Study||36
222432|NCT00259090|529680|P3|NOT COMPLETED|Overall Study||0
222433|NCT00259090|529681|P2|NOT COMPLETED|Overall Study||0
222434|NCT00259090|529682|P1|NOT COMPLETED|Overall Study||0
222435|NCT00259090|529680|P3|COMPLETED|Overall Study||37
222436|NCT00259090|529681|P2|COMPLETED|Overall Study||31
222437|NCT00259090|529682|P1|COMPLETED|Overall Study||35
222438|NCT00259090|529680|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
222439|NCT00259090|529681|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
222440|NCT00259090|529682|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
222441|NCT00259012|529698|P2|NOT COMPLETED|Overall Study||4
222442|NCT00259012|529699|P1|NOT COMPLETED|Overall Study||2
222443|NCT00259012|529698|P2|COMPLETED|Overall Study||30
222444|NCT00259012|529699|P1|COMPLETED|Overall Study||31
222445|NCT00259012|529698|P2|STARTED|Overall Study||34
222446|NCT00259012|529699|P1|STARTED|Overall Study||33
222447|NCT00258908|529731|P1|NOT COMPLETED|Overall Study||0
222448|NCT00258908|529731|P1|COMPLETED|Overall Study||112
222449|NCT00258908|529731|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
222450|NCT00258895|529739|P2|NOT COMPLETED|Overall Study||3
222451|NCT00258895|529740|P1|NOT COMPLETED|Overall Study||10
222452|NCT00258895|529739|P2|COMPLETED|Overall Study||159
222453|NCT00258895|529740|P1|COMPLETED|Overall Study||477
222454|NCT00258895|529739|P2|STARTED|Overall Study||162
222455|NCT00258895|529740|P1|STARTED|Overall Study||487
222456|NCT00258882|529756|P2|NOT COMPLETED|Pregnancy Surveillance||0
222457|NCT00258882|529757|P1|NOT COMPLETED|Pregnancy Surveillance||0
222458|NCT00258882|529756|P2|COMPLETED|Pregnancy Surveillance||675
222459|NCT00258882|529757|P1|COMPLETED|Pregnancy Surveillance||225
222460|NCT00258882|529756|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
222461|NCT00258882|529757|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
222462|NCT00258882|529756|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
222463|NCT00258882|529757|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
222464|NCT00258882|529756|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
222465|NCT00258882|529757|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
222466|NCT00258882|529756|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
222467|NCT00258882|529757|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
222468|NCT00258882|529756|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
222469|NCT00258882|529757|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
222470|NCT00258882|529756|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
222471|NCT00258882|529757|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
222472|NCT00258882|529756|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
222473|NCT00258882|529757|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
222474|NCT00258856|529776|P4|NOT COMPLETED|Overall Study||1
222475|NCT00258856|529777|P3|NOT COMPLETED|Overall Study||2
222476|NCT00258856|529778|P2|NOT COMPLETED|Overall Study||0
222477|NCT00258856|529779|P1|NOT COMPLETED|Overall Study||3
222478|NCT00258856|529776|P4|COMPLETED|Overall Study||58
222479|NCT00258856|529777|P3|COMPLETED|Overall Study||56
222480|NCT00258856|529778|P2|COMPLETED|Overall Study||58
222481|NCT00258856|529779|P1|COMPLETED|Overall Study||56
222482|NCT00258856|529776|P4|STARTED|Overall Study||59
222483|NCT00258856|529777|P3|STARTED|Overall Study||58
222484|NCT00258856|529778|P2|STARTED|Overall Study||58
222485|NCT00258856|529779|P1|STARTED|Overall Study||59
222486|NCT00258830|529791|P2|NOT COMPLETED|Overall Study||0
222487|NCT00258830|529792|P1|NOT COMPLETED|Overall Study||0
222488|NCT00258830|529791|P2|COMPLETED|Overall Study||60
222489|NCT00258830|529792|P1|COMPLETED|Overall Study||60
222490|NCT00258830|529791|P2|STARTED|Overall Study||60
222491|NCT00258830|529792|P1|STARTED|Overall Study||60
222492|NCT00258817|529806|P2|NOT COMPLETED|Overall Study||0
222493|NCT00258817|529807|P1|NOT COMPLETED|Overall Study||0
222494|NCT00258817|529806|P2|COMPLETED|Overall Study||15
222495|NCT00258817|529807|P1|COMPLETED|Overall Study||15
222496|NCT00258817|529806|P2|STARTED|Overall Study||15
222497|NCT00258817|529807|P1|STARTED|Overall Study||15
222498|NCT00258674|529820|P3|NOT COMPLETED|Overall Study||34
222499|NCT00258674|529821|P2|NOT COMPLETED|Overall Study||53
222500|NCT00258674|529822|P1|NOT COMPLETED|Overall Study||32
222501|NCT00258674|529820|P3|COMPLETED|Overall Study||568
222502|NCT00258674|529821|P2|COMPLETED|Overall Study||758
222503|NCT00258674|529822|P1|COMPLETED|Overall Study||565
222504|NCT00258674|529820|P3|STARTED|Overall Study||602
222505|NCT00258674|529821|P2|STARTED|Overall Study||811
222506|NCT00258674|529822|P1|STARTED|Overall Study||597
222507|NCT00258440|529881|P3|NOT COMPLETED|Overall Study||1
222508|NCT00258440|529882|P2|NOT COMPLETED|Overall Study||0
222509|NCT00258440|529883|P1|NOT COMPLETED|Overall Study||0
222510|NCT00258440|529881|P3|COMPLETED|Overall Study||5
222511|NCT00258440|529882|P2|COMPLETED|Overall Study||0
222512|NCT00258440|529883|P1|COMPLETED|Overall Study||1
222513|NCT00258440|529881|P3|STARTED|Overall Study||6
222514|NCT00258440|529882|P2|STARTED|Overall Study||0
222515|NCT00258440|529883|P1|STARTED|Overall Study||1
222516|NCT00258362|529894|P1|NOT COMPLETED|Overall Study||0
222517|NCT00258362|529894|P1|COMPLETED|Overall Study||41
222518|NCT00258362|529894|P1|STARTED|Overall Study||41
222519|NCT00258349|529899|P1|NOT COMPLETED|Overall Study||0
222520|NCT00258349|529899|P1|COMPLETED|Overall Study||16
222521|NCT00258349|529899|P1|HER2-positive by Central Review|Overall Study||10
222522|NCT00258349|529899|P1|STARTED|Overall Study||16
222523|NCT00258310|529906|P1|NOT COMPLETED|Overall Study||0
222524|NCT00258310|529906|P1|COMPLETED|Overall Study||35
222525|NCT00258310|529906|P1|STARTED|Overall Study||35
222526|NCT00258206|529910|P1|NOT COMPLETED|Overall Study||0
222527|NCT00258206|529910|P1|COMPLETED|Overall Study||21
222528|NCT00258206|529910|P1|STARTED|Overall Study||21
222529|NCT00258154|529916|P2|NOT COMPLETED|Overall Study||7
222530|NCT00258154|529917|P1|NOT COMPLETED|Overall Study||9
222531|NCT00258154|529916|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
222532|NCT00258154|529917|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
222533|NCT00258154|529916|P2|Vaccinated at Visit 3|Overall Study||197
222534|NCT00258154|529917|P1|Vaccinated at Visit 3|Overall Study||195
222535|NCT00258154|529916|P2|Vaccinated at Visit 2|Overall Study||198
222536|NCT00258154|529917|P1|Vaccinated at Visit 2|Overall Study||198
222537|NCT00258154|529916|P2|Vaccinated at Visit 1|Overall Study||202
222538|NCT00258154|529917|P1|Vaccinated at Visit 1|Overall Study||201
222539|NCT00258154|529916|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
222540|NCT00258154|529917|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
222541|NCT00258011|529985|P1|NOT COMPLETED|Overall Study||0
222542|NCT00258011|529985|P1|COMPLETED|Overall Study||3
222543|NCT00258011|529985|P1|STARTED|Overall Study||3
222544|NCT00257933|529992|P2|NOT COMPLETED|Overall Study||0
222545|NCT00257933|529993|P1|NOT COMPLETED|Overall Study||0
222546|NCT00257933|529992|P2|COMPLETED|Overall Study||78
222547|NCT00257933|529993|P1|COMPLETED|Overall Study||74
222548|NCT00257933|529992|P2|STARTED|Overall Study||78
222549|NCT00257933|529993|P1|STARTED|Overall Study||74
222550|NCT00257920|530001|P2|NOT COMPLETED|Period: Second Intervention||1
222551|NCT00257920|530002|P1|NOT COMPLETED|Period: Second Intervention||2
222552|NCT00257920|530001|P2|COMPLETED|Period: Second Intervention||18
222553|NCT00257920|530002|P1|COMPLETED|Period: Second Intervention||19
222554|NCT00257920|530001|P2|STARTED|Period: Second Intervention||19
222555|NCT00257920|530002|P1|STARTED|Period: Second Intervention||21
222556|NCT00257920|530001|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
222557|NCT00257920|530002|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
222558|NCT00257920|530001|P2|COMPLETED|Period: Washout Period of Two Weeks||19
222559|NCT00257920|530002|P1|COMPLETED|Period: Washout Period of Two Weeks||21
222560|NCT00257920|530001|P2|STARTED|Period: Washout Period of Two Weeks||20
222561|NCT00257920|530002|P1|STARTED|Period: Washout Period of Two Weeks||21
222562|NCT00257920|530001|P2|NOT COMPLETED|Period: First Intervention||0
222563|NCT00257920|530002|P1|NOT COMPLETED|Period: First Intervention||0
222564|NCT00257920|530001|P2|COMPLETED|Period: First Intervention||20
222565|NCT00257920|530002|P1|COMPLETED|Period: First Intervention||21
222566|NCT00257920|530001|P2|STARTED|Period: First Intervention||20
222567|NCT00257920|530002|P1|STARTED|Period: First Intervention||21
222568|NCT00257894|530012|P2|NOT COMPLETED|Overall Study||5
222569|NCT00257894|530013|P1|NOT COMPLETED|Overall Study||4
222570|NCT00257894|530012|P2|COMPLETED|Overall Study||15
222571|NCT00257894|530013|P1|COMPLETED|Overall Study||17
222572|NCT00257894|530012|P2|STARTED|Overall Study||20
222573|NCT00257894|530013|P1|STARTED|Overall Study||21
222574|NCT00257686|530031|P6|NOT COMPLETED|Overall Study||9
222575|NCT00257686|530032|P5|NOT COMPLETED|Overall Study||22
222576|NCT00257686|530033|P4|NOT COMPLETED|Overall Study||11
222577|NCT00257686|530034|P3|NOT COMPLETED|Overall Study||18
222578|NCT00257686|530035|P2|NOT COMPLETED|Overall Study||19
222579|NCT00257686|530036|P1|NOT COMPLETED|Overall Study||21
222580|NCT00257686|530031|P6|COMPLETED|Overall Study||95
222581|NCT00257686|530032|P5|COMPLETED|Overall Study||194
222582|NCT00257686|530033|P4|COMPLETED|Overall Study||88
222583|NCT00257686|530034|P3|COMPLETED|Overall Study||208
222584|NCT00257686|530035|P2|COMPLETED|Overall Study||89
222585|NCT00257686|530036|P1|COMPLETED|Overall Study||188
222586|NCT00257686|530031|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
222587|NCT00257686|530032|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
222588|NCT00257686|530033|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
222589|NCT00257686|530034|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
222590|NCT00257686|530035|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
222591|NCT00257686|530036|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
222592|NCT00257686|530031|P6|STARTED|Overall Study||104
222593|NCT00257686|530032|P5|STARTED|Overall Study||216
222594|NCT00257686|530033|P4|STARTED|Overall Study||99
222595|NCT00257686|530034|P3|STARTED|Overall Study||226
222596|NCT00257686|530035|P2|STARTED|Overall Study||108
222597|NCT00257686|530036|P1|STARTED|Overall Study||209
222598|NCT00257660|530058|P2|NOT COMPLETED|Overall Study||23
222599|NCT00257660|530059|P1|NOT COMPLETED|Overall Study||10
222600|NCT00257660|530058|P2|COMPLETED|Overall Study||38
222601|NCT00257660|530059|P1|COMPLETED|Overall Study||45
222602|NCT00257660|530058|P2|STARTED|Overall Study||61
222603|NCT00257660|530059|P1|STARTED|Overall Study||55
222604|NCT00257608|530089|P3|NOT COMPLETED|Post Chemotherapy Phase||244
222605|NCT00257608|530090|P2|NOT COMPLETED|Post Chemotherapy Phase||264
222606|NCT00257608|530091|P1|NOT COMPLETED|Post Chemotherapy Phase||0
222607|NCT00257608|530089|P3|COMPLETED|Post Chemotherapy Phase||126
222608|NCT00257608|530090|P2|COMPLETED|Post Chemotherapy Phase||109
222609|NCT00257608|530091|P1|COMPLETED|Post Chemotherapy Phase||0
222610|NCT00257608|530089|P3|STARTED|Post Chemotherapy Phase||370
222611|NCT00257608|530090|P2|STARTED|Post Chemotherapy Phase||373
222612|NCT00257608|530091|P1|STARTED|Post Chemotherapy Phase||0
222613|NCT00257608|530089|P3|NOT COMPLETED|Chemotherapy Phase||0
222614|NCT00257608|530090|P2|NOT COMPLETED|Chemotherapy Phase||0
222615|NCT00257608|530091|P1|NOT COMPLETED|Chemotherapy Phase||376
222616|NCT00257608|530089|P3|COMPLETED|Chemotherapy Phase||0
222617|NCT00257608|530090|P2|COMPLETED|Chemotherapy Phase||0
222618|NCT00257608|530091|P1|COMPLETED|Chemotherapy Phase||769
222619|NCT00257608|530089|P3|STARTED|Chemotherapy Phase||0
222620|NCT00257608|530090|P2|STARTED|Chemotherapy Phase||0
222621|NCT00257608|530091|P1|STARTED|Chemotherapy Phase||1145
222622|NCT00257556|530117|P2|NOT COMPLETED|Overall Study||10
222623|NCT00257556|530118|P1|NOT COMPLETED|Overall Study||14
222624|NCT00257556|530117|P2|COMPLETED|Overall Study||32
222625|NCT00257556|530118|P1|COMPLETED|Overall Study||24
222626|NCT00257556|530117|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
222627|NCT00257556|530118|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
222628|NCT00257556|530117|P2|STARTED|Overall Study||42
222629|NCT00257556|530118|P1|STARTED|Overall Study||38
222630|NCT00257322|530144|P1|NOT COMPLETED|Overall Study||4
222631|NCT00257322|530144|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
222632|NCT00257322|530144|P1|STARTED|Overall Study|20 subjects accrued.|20
222633|NCT00257309|530151|P2|NOT COMPLETED|Overall Study||2
222634|NCT00257309|530152|P1|NOT COMPLETED|Overall Study||2
222635|NCT00257309|530151|P2|COMPLETED|Overall Study||130
222636|NCT00257309|530152|P1|COMPLETED|Overall Study||132
222637|NCT00257309|530151|P2|STARTED|Overall Study||132
222638|NCT00257309|530152|P1|STARTED|Overall Study||134
222639|NCT00257192|530162|P2|NOT COMPLETED|Overall Study||39
222640|NCT00257192|530163|P1|NOT COMPLETED|Overall Study||58
222641|NCT00257192|530162|P2|COMPLETED|Overall Study||52
222642|NCT00257192|530163|P1|COMPLETED|Overall Study||135
222643|NCT00257192|530162|P2|Received Study Treatment|Overall Study||90
222644|NCT00257192|530163|P1|Received Study Treatment|Overall Study||193
222645|NCT00257192|530162|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
222646|NCT00257192|530163|P1|STARTED|Overall Study||193
222647|NCT00257166|530207|P2|NOT COMPLETED|Overall Study||37
222648|NCT00257166|530208|P1|NOT COMPLETED|Overall Study||53
222649|NCT00257166|530207|P2|COMPLETED|Overall Study||51
222650|NCT00257166|530208|P1|COMPLETED|Overall Study||97
222651|NCT00257166|530207|P2|Treated|Overall Study||88
222652|NCT00257166|530208|P1|Treated|Overall Study||149
222653|NCT00257166|530207|P2|STARTED|Overall Study||88
222654|NCT00257166|530208|P1|STARTED|Overall Study||150
222655|NCT00257010|530220|P1|NOT COMPLETED|Overall Study||128
222656|NCT00257010|530220|P1|COMPLETED|Overall Study||319
222657|NCT00257010|530220|P1|STARTED|Overall Study||447
222658|NCT00256997|530231|P2|NOT COMPLETED|Overall Study||55
222659|NCT00256997|530232|P1|NOT COMPLETED|Overall Study||48
222660|NCT00256997|530231|P2|COMPLETED|Overall Study||31
222661|NCT00256997|530232|P1|COMPLETED|Overall Study||33
222662|NCT00256997|530231|P2|Treated|Overall Study||86
222663|NCT00256997|530232|P1|Treated|Overall Study||79
222664|NCT00256997|530231|P2|STARTED|Overall Study||86
222665|NCT00256997|530232|P1|STARTED|Overall Study||81
222666|NCT00256984|530256|P1|NOT COMPLETED|Overall Study||16
222667|NCT00256984|530256|P1|COMPLETED|Overall Study||59
222668|NCT00256984|530256|P1|STARTED|Overall Study||75
222669|NCT00256750|530269|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
222670|NCT00256750|530270|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
222671|NCT00256750|530271|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
222672|NCT00256750|530269|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
222673|NCT00256750|530270|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
222674|NCT00256750|530271|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
222675|NCT00256750|530269|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
222676|NCT00256750|530270|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
222677|NCT00256750|530271|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
222678|NCT00256750|530269|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
222679|NCT00256750|530270|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
222680|NCT00256750|530271|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
222681|NCT00256750|530269|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
222682|NCT00256750|530270|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
222683|NCT00256750|530271|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
222684|NCT00256750|530269|P3|STARTED|Post-Transplant Treated (36 Months)||164
222685|NCT00256750|530270|P2|STARTED|Post-Transplant Treated (36 Months)||176
222686|NCT00256750|530271|P1|STARTED|Post-Transplant Treated (36 Months)||153
222687|NCT00256750|530269|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
222688|NCT00256750|530270|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
222689|NCT00256750|530271|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
222690|NCT00256750|530269|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
222691|NCT00256750|530270|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
222692|NCT00256750|530271|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
222693|NCT00256750|530269|P3|STARTED|Post-Transplant Treated (24 Months)||173
222694|NCT00256750|530270|P2|STARTED|Post-Transplant Treated (24 Months)||183
222695|NCT00256750|530271|P1|STARTED|Post-Transplant Treated (24 Months)||174
222696|NCT00256750|530269|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
222697|NCT00256750|530270|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
222698|NCT00256750|530271|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
222699|NCT00256750|530269|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
222700|NCT00256750|530270|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
222701|NCT00256750|530271|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
222702|NCT00256750|530269|P3|STARTED|Post-Transplant Treated (12 Months)||219
222703|NCT00256750|530270|P2|STARTED|Post-Transplant Treated (12 Months)||226
222704|NCT00256750|530271|P1|STARTED|Post-Transplant Treated (12 Months)||215
222705|NCT00256750|530269|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
222706|NCT00256750|530270|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
222707|NCT00256750|530271|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
222708|NCT00256750|530269|P3|COMPLETED|Transplanted Pre-Treatment||219
222709|NCT00256750|530270|P2|COMPLETED|Transplanted Pre-Treatment||226
222710|NCT00256750|530271|P1|COMPLETED|Transplanted Pre-Treatment||215
222711|NCT00256750|530269|P3|STARTED|Transplanted Pre-Treatment||219
222712|NCT00256750|530270|P2|STARTED|Transplanted Pre-Treatment||226
222713|NCT00256750|530271|P1|STARTED|Transplanted Pre-Treatment||221
222714|NCT00256724|530407|P2|NOT COMPLETED|Overall Study||8
222715|NCT00256724|530408|P1|NOT COMPLETED|Overall Study||5
222716|NCT00256724|530407|P2|COMPLETED|Overall Study||16
222717|NCT00256724|530408|P1|COMPLETED|Overall Study||18
222718|NCT00256724|530407|P2|STARTED|Overall Study||24
222719|NCT00256724|530408|P1|STARTED|Overall Study||23
222720|NCT00256698|530418|P2|NOT COMPLETED|Overall Study||172
222721|NCT00256698|530419|P1|NOT COMPLETED|Overall Study||167
222722|NCT00256698|530418|P2|COMPLETED|Overall Study||84
222723|NCT00256698|530419|P1|COMPLETED|Overall Study||91
222724|NCT00256698|530418|P2|STARTED|Overall Study||256
222725|NCT00256698|530419|P1|STARTED|Overall Study||258
222726|NCT00256295|530437|P1|NOT COMPLETED|Overall Study||4
222727|NCT00256295|530437|P1|COMPLETED|Overall Study||3
222728|NCT00256295|530437|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
222729|NCT00256243|530443|P1|NOT COMPLETED|Overall Study||10
222730|NCT00256243|530443|P1|COMPLETED|Overall Study||38
222731|NCT00256243|530443|P1|STARTED|Overall Study||48
222732|NCT00256204|530452|P4|NOT COMPLETED|Overall Study||49
222733|NCT00256204|530453|P3|NOT COMPLETED|Overall Study||54
222734|NCT00256204|530454|P2|NOT COMPLETED|Overall Study||50
222735|NCT00256204|530455|P1|NOT COMPLETED|Overall Study||67
222736|NCT00256204|530452|P4|COMPLETED|Overall Study||244
222737|NCT00256204|530453|P3|COMPLETED|Overall Study||241
222738|NCT00256204|530454|P2|COMPLETED|Overall Study||238
222739|NCT00256204|530455|P1|COMPLETED|Overall Study||231
222740|NCT00256204|530452|P4|STARTED|Overall Study||293
222741|NCT00256204|530453|P3|STARTED|Overall Study||295
222742|NCT00256204|530454|P2|STARTED|Overall Study||288
222743|NCT00256204|530455|P1|STARTED|Overall Study||298
222744|NCT00255970|530470|P2|NOT COMPLETED|Overall Study||0
222745|NCT00255970|530471|P1|NOT COMPLETED|Overall Study||0
222746|NCT00255970|530470|P2|COMPLETED|Overall Study||19
222747|NCT00255970|530471|P1|COMPLETED|Overall Study||21
222748|NCT00255970|530470|P2|Final Visit Week 24|Overall Study||19
222749|NCT00255970|530471|P1|Final Visit Week 24|Overall Study||21
222750|NCT00255970|530470|P2|Screening Visit|Overall Study||19
222751|NCT00255970|530471|P1|Screening Visit|Overall Study||21
222752|NCT00255970|530470|P2|STARTED|Overall Study||19
222753|NCT00255970|530471|P1|STARTED|Overall Study||21
222754|NCT00255840|530491|P2|NOT COMPLETED|Overall Study||70
222755|NCT00255840|530492|P1|NOT COMPLETED|Overall Study||63
222756|NCT00255840|530491|P2|COMPLETED|Overall Study||334
222757|NCT00255840|530492|P1|COMPLETED|Overall Study||345
222758|NCT00255840|530491|P2|STARTED|Overall Study||404
222759|NCT00255840|530492|P1|STARTED|Overall Study||408
222760|NCT00255723|530500|P2|NOT COMPLETED|Overall Study||2
222761|NCT00255723|530501|P1|NOT COMPLETED|Overall Study||2
222762|NCT00255723|530500|P2|COMPLETED|Overall Study||39
222763|NCT00255723|530501|P1|COMPLETED|Overall Study||54
222764|NCT00255723|530500|P2|STARTED|Overall Study||41
222765|NCT00255723|530501|P1|STARTED|Overall Study||56
222766|NCT00255684|530507|P1|NOT COMPLETED|Overall Study||0
222767|NCT00255684|530507|P1|COMPLETED|Overall Study||16
222768|NCT00255684|530507|P1|STARTED|Overall Study||16
222769|NCT00255190|530514|P2|NOT COMPLETED|Overall Study||157
222770|NCT00255190|530515|P1|NOT COMPLETED|Overall Study||50
222771|NCT00255190|530514|P2|COMPLETED|Overall Study||281
222772|NCT00255190|530515|P1|COMPLETED|Overall Study||103
222773|NCT00255190|530514|P2|STARTED|Overall Study||438
222774|NCT00255190|530515|P1|STARTED|Overall Study||153
222775|NCT00255177|530583|P4|NOT COMPLETED|Overall Study||2
222776|NCT00255177|530584|P3|NOT COMPLETED|Overall Study||1
222777|NCT00255177|530585|P2|NOT COMPLETED|Overall Study||1
222778|NCT00255177|530586|P1|NOT COMPLETED|Overall Study||2
222779|NCT00255177|530583|P4|COMPLETED|Overall Study||4
222780|NCT00255177|530584|P3|COMPLETED|Overall Study||12
222781|NCT00255177|530585|P2|COMPLETED|Overall Study||13
222782|NCT00255177|530586|P1|COMPLETED|Overall Study||9
222783|NCT00255177|530583|P4|STARTED|Overall Study||6
222784|NCT00255177|530584|P3|STARTED|Overall Study||13
222785|NCT00255177|530585|P2|STARTED|Overall Study||14
222786|NCT00255177|530586|P1|STARTED|Overall Study||11
222787|NCT00255164|530599|P3|NOT COMPLETED|Overall Study||49
222788|NCT00255164|530600|P2|NOT COMPLETED|Overall Study||49
222789|NCT00255164|530601|P1|NOT COMPLETED|Overall Study||123
222790|NCT00255164|530599|P3|COMPLETED|Overall Study||103
222791|NCT00255164|530600|P2|COMPLETED|Overall Study||110
222792|NCT00255164|530601|P1|COMPLETED|Overall Study||17
222793|NCT00255164|530599|P3|STARTED|Overall Study||152
222794|NCT00255164|530600|P2|STARTED|Overall Study||159
222795|NCT00255164|530601|P1|STARTED|Overall Study||140
222796|NCT00255151|530627|P3|NOT COMPLETED|Overall Study||49
222797|NCT00255151|530628|P2|NOT COMPLETED|Overall Study||49
222798|NCT00255151|530629|P1|NOT COMPLETED|Overall Study||123
222799|NCT00255151|530627|P3|COMPLETED|Overall Study||103
222800|NCT00255151|530628|P2|COMPLETED|Overall Study||110
222801|NCT00255151|530629|P1|COMPLETED|Overall Study||17
222802|NCT00255151|530627|P3|STARTED|Overall Study||152
222803|NCT00255151|530628|P2|STARTED|Overall Study||159
222804|NCT00255151|530629|P1|STARTED|Overall Study||140
222805|NCT00255125|530654|P2|NOT COMPLETED|Overall Study||0
222806|NCT00255125|530655|P1|NOT COMPLETED|Overall Study||0
222807|NCT00255125|530654|P2|COMPLETED|Overall Study||42
222808|NCT00255125|530655|P1|COMPLETED|Overall Study||44
222809|NCT00255125|530654|P2|STARTED|Overall Study||42
222810|NCT00255125|530655|P1|STARTED|Overall Study||44
222811|NCT00255047|530665|P4|NOT COMPLETED|Overall Study||46
222812|NCT00255047|530666|P3|NOT COMPLETED|Overall Study||50
222813|NCT00255047|530667|P2|NOT COMPLETED|Overall Study||48
222814|NCT00255047|530668|P1|NOT COMPLETED|Overall Study||48
222815|NCT00255047|530665|P4|COMPLETED|Overall Study||502
222816|NCT00255047|530666|P3|COMPLETED|Overall Study||496
222817|NCT00255047|530667|P2|COMPLETED|Overall Study||487
222818|NCT00255047|530668|P1|COMPLETED|Overall Study||490
222819|NCT00255047|530665|P4|STARTED|Overall Study||548
222820|NCT00255047|530666|P3|STARTED|Overall Study||546
222821|NCT00255047|530667|P2|STARTED|Overall Study||535
222822|NCT00255047|530668|P1|STARTED|Overall Study||538
222823|NCT00255034|530692|P2|NOT COMPLETED|Overall Study||38
222824|NCT00255034|530693|P1|NOT COMPLETED|Overall Study||15
222825|NCT00255034|530692|P2|COMPLETED|Overall Study||26
222826|NCT00255034|530693|P1|COMPLETED|Overall Study||64
222827|NCT00255034|530692|P2|STARTED|Overall Study||64
222828|NCT00255034|530693|P1|STARTED|Overall Study||79
222829|NCT00255008|530703|P4|NOT COMPLETED|Overall Study||22
222830|NCT00255008|530704|P3|NOT COMPLETED|Overall Study||16
222831|NCT00255008|530705|P2|NOT COMPLETED|Overall Study||9
222832|NCT00255008|530706|P1|NOT COMPLETED|Overall Study||32
222833|NCT00255008|530703|P4|COMPLETED|Overall Study||12
222834|NCT00255008|530704|P3|COMPLETED|Overall Study||17
222835|NCT00255008|530705|P2|COMPLETED|Overall Study||0
222836|NCT00255008|530706|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
222837|NCT00255008|530703|P4|STARTED|Overall Study||34
222838|NCT00255008|530704|P3|STARTED|Overall Study||33
222839|NCT00255008|530705|P2|STARTED|Overall Study||9
222840|NCT00255008|530706|P1|STARTED|Overall Study||45
222841|NCT00254995|530718|P2|NOT COMPLETED|Overall Study||0
222842|NCT00254995|530719|P1|NOT COMPLETED|Overall Study||0
222843|NCT00254995|530718|P2|COMPLETED|Overall Study||31065
222844|NCT00254995|530719|P1|COMPLETED|Overall Study||31561
222845|NCT00254995|530718|P2|STARTED|Overall Study||31065
222846|NCT00254995|530719|P1|STARTED|Overall Study||31561
222847|NCT00254982|530742|P2|NOT COMPLETED|Overall Study||31
222848|NCT00254982|530743|P1|NOT COMPLETED|Overall Study||36
222849|NCT00254982|530742|P2|COMPLETED|Overall Study||265
222850|NCT00254982|530743|P1|COMPLETED|Overall Study||261
222851|NCT00254982|530742|P2|STARTED|Overall Study||296
222852|NCT00254982|530743|P1|STARTED|Overall Study||297
222853|NCT00253747|530751|P2|NOT COMPLETED|Overall Study||27
222854|NCT00253747|530752|P1|NOT COMPLETED|Overall Study||24
222855|NCT00253747|530751|P2|COMPLETED|Overall Study||101
222856|NCT00253747|530752|P1|COMPLETED|Overall Study||103
222857|NCT00253747|530751|P2|STARTED|Overall Study||128
222858|NCT00253747|530752|P1|STARTED|Overall Study||127
222859|NCT00253643|530774|P4|NOT COMPLETED|Overall Study||3
222860|NCT00253643|530775|P3|NOT COMPLETED|Overall Study||1
222861|NCT00253643|530776|P2|NOT COMPLETED|Overall Study||0
222862|NCT00253643|530777|P1|NOT COMPLETED|Overall Study||0
222863|NCT00253643|530774|P4|COMPLETED|Overall Study||28
222864|NCT00253643|530775|P3|COMPLETED|Overall Study||28
222865|NCT00253643|530776|P2|COMPLETED|Overall Study||15
222866|NCT00253643|530777|P1|COMPLETED|Overall Study||14
222867|NCT00253643|530774|P4|STARTED|Overall Study||31
222868|NCT00253643|530775|P3|STARTED|Overall Study||29
222869|NCT00253643|530776|P2|STARTED|Overall Study||15
222870|NCT00253643|530777|P1|STARTED|Overall Study||14
222871|NCT00254592|530791|P1|NOT COMPLETED|Overall Study||2
222872|NCT00254592|530791|P1|COMPLETED|Overall Study||41
222873|NCT00254592|530791|P1|STARTED|Overall Study||43
222874|NCT00254566|530797|P2|NOT COMPLETED|Overall Study||26
222875|NCT00254566|530798|P1|NOT COMPLETED|Overall Study||31
222876|NCT00254566|530797|P2|COMPLETED|Overall Study||172
222877|NCT00254566|530798|P1|COMPLETED|Overall Study||167
222878|NCT00254566|530797|P2|STARTED|Overall Study||198
222879|NCT00254566|530798|P1|STARTED|Overall Study||198
222880|NCT00254540|530822|P2|NOT COMPLETED|Overall Study||22
222881|NCT00254540|530823|P1|NOT COMPLETED|Overall Study||19
222882|NCT00254540|530822|P2|COMPLETED|Overall Study||4
222883|NCT00254540|530823|P1|COMPLETED|Overall Study||6
222884|NCT00254540|530822|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
222885|NCT00254540|530823|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
222886|NCT00254501|530852|P2|NOT COMPLETED|Overall Study||1
222887|NCT00254501|530853|P1|NOT COMPLETED|Overall Study||1
222888|NCT00254501|530852|P2|COMPLETED|Overall Study||36
222889|NCT00254501|530853|P1|COMPLETED|Overall Study||31
222890|NCT00254501|530852|P2|STARTED|Overall Study||37
222891|NCT00254501|530853|P1|STARTED|Overall Study||32
222892|NCT00254462|530867|P2|NOT COMPLETED|Overall Study||10
222893|NCT00254462|530868|P1|NOT COMPLETED|Overall Study||8
222894|NCT00254462|530867|P2|COMPLETED|Overall Study||39
222895|NCT00254462|530868|P1|COMPLETED|Overall Study||36
222896|NCT00254462|530867|P2|STARTED|Overall Study||49
222897|NCT00254462|530868|P1|STARTED|Overall Study||44
222898|NCT00254293|530882|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
222899|NCT00254293|530883|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222900|NCT00254293|530884|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222901|NCT00254293|530885|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222902|NCT00254293|530886|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222903|NCT00254293|530887|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222904|NCT00254293|530888|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
222905|NCT00254293|530882|P7|COMPLETED|LTE Open Label Fixed Dosing||35
222906|NCT00254293|530883|P6|COMPLETED|LTE Open Label Fixed Dosing||0
222907|NCT00254293|530884|P5|COMPLETED|LTE Open Label Fixed Dosing||0
222908|NCT00254293|530885|P4|COMPLETED|LTE Open Label Fixed Dosing||0
222909|NCT00254293|530886|P3|COMPLETED|LTE Open Label Fixed Dosing||0
222910|NCT00254293|530887|P2|COMPLETED|LTE Open Label Fixed Dosing||0
222911|NCT00254293|530888|P1|COMPLETED|LTE Open Label Fixed Dosing||0
222912|NCT00254293|530882|P7|STARTED|LTE Open Label Fixed Dosing||48
222913|NCT00254293|530883|P6|STARTED|LTE Open Label Fixed Dosing||0
222914|NCT00254293|530884|P5|STARTED|LTE Open Label Fixed Dosing||0
222915|NCT00254293|530885|P4|STARTED|LTE Open Label Fixed Dosing||0
222916|NCT00254293|530886|P3|STARTED|LTE Open Label Fixed Dosing||0
222917|NCT00254293|530887|P2|STARTED|LTE Open Label Fixed Dosing||0
222918|NCT00254293|530888|P1|STARTED|LTE Open Label Fixed Dosing||0
222919|NCT00254293|530882|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
222920|NCT00254293|530883|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
222921|NCT00254293|530884|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
222922|NCT00254293|530885|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
222923|NCT00254293|530886|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
222924|NCT00254293|530887|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
222925|NCT00254293|530888|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
222926|NCT00254293|530882|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
222927|NCT00254293|530883|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
222928|NCT00254293|530884|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
222929|NCT00254293|530885|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
222930|NCT00254293|530886|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
222931|NCT00254293|530887|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
222932|NCT00254293|530888|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
222933|NCT00254293|530882|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
222934|NCT00254293|530883|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
222935|NCT00254293|530884|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
222936|NCT00254293|530885|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
222937|NCT00254293|530886|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
222938|NCT00254293|530887|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
222939|NCT00254293|530888|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
222940|NCT00254293|530882|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
222941|NCT00254293|530883|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
222942|NCT00254293|530884|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
222943|NCT00254293|530885|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
222944|NCT00254293|530886|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
222945|NCT00254293|530887|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
222946|NCT00254293|530888|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
222947|NCT00254293|530882|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
222948|NCT00254293|530883|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
222949|NCT00254293|530884|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
222950|NCT00254293|530885|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
222951|NCT00254293|530886|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
222952|NCT00254293|530887|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
222953|NCT00254293|530888|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
222954|NCT00254293|530882|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
222955|NCT00254293|530883|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
222956|NCT00254293|530884|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
222957|NCT00254293|530885|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
222958|NCT00254293|530886|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
222959|NCT00254293|530887|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
222960|NCT00254293|530888|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
222961|NCT00254163|530971|P2|NOT COMPLETED|Overall Study||46
222962|NCT00254163|530972|P1|NOT COMPLETED|Overall Study||45
222963|NCT00254163|530971|P2|COMPLETED|Overall Study||46
222964|NCT00254163|530972|P1|COMPLETED|Overall Study||47
222965|NCT00254163|530971|P2|STARTED|Overall Study||92
222966|NCT00254163|530972|P1|STARTED|Overall Study||92
222967|NCT00254072|530996|P2|NOT COMPLETED|Overall Study||0
222968|NCT00254072|530997|P1|NOT COMPLETED|Overall Study||0
222969|NCT00254072|530996|P2|COMPLETED|Overall Study||175
222970|NCT00254072|530997|P1|COMPLETED|Overall Study||180
222971|NCT00254072|530996|P2|STARTED|Overall Study||175
222972|NCT00254072|530997|P1|STARTED|Overall Study||180
222973|NCT00253981|531005|P2|NOT COMPLETED|Overall Study||0
222974|NCT00253981|531006|P1|NOT COMPLETED|Overall Study||0
222975|NCT00253981|531005|P2|COMPLETED|Overall Study||14
222976|NCT00253981|531006|P1|COMPLETED|Overall Study||16
222977|NCT00253981|531005|P2|STARTED|Overall Study||14
222978|NCT00253981|531006|P1|STARTED|Overall Study||16
222979|NCT00253890|531014|P2|NOT COMPLETED|Overall Study||7
222980|NCT00253890|531015|P1|NOT COMPLETED|Overall Study||7
222981|NCT00253890|531014|P2|COMPLETED|Overall Study||61
222982|NCT00253890|531015|P1|COMPLETED|Overall Study||62
222983|NCT00253890|531014|P2|STARTED|Overall Study||68
222984|NCT00253890|531015|P1|STARTED|Overall Study||69
222985|NCT00253513|531021|P1|NOT COMPLETED|Overall Study||0
222986|NCT00253513|531021|P1|COMPLETED|Overall Study||60
222987|NCT00253513|531021|P1|STARTED|Overall Study||60
222988|NCT00253448|531028|P1|NOT COMPLETED|Overall Study||1
222989|NCT00253448|531028|P1|COMPLETED|Overall Study||34
222990|NCT00253448|531028|P1|STARTED|Overall Study||35
222991|NCT00253435|531034|P2|NOT COMPLETED|Overall Study||0
222992|NCT00253435|531035|P1|NOT COMPLETED|Overall Study||0
222993|NCT00253435|531034|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
222994|NCT00253435|531035|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
222995|NCT00253435|531034|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
222996|NCT00253435|531035|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
222997|NCT00253435|531034|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
222998|NCT00253435|531035|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
222999|NCT00253435|531034|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
223000|NCT00253435|531035|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
223001|NCT00253435|531034|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
223002|NCT00253435|531035|P1|STARTED|Overall Study|Total number is 42|42
223003|NCT00253370|531047|P1|NOT COMPLETED|Overall Study||43
223004|NCT00253370|531047|P1|COMPLETED|Overall Study||1
223005|NCT00253370|531047|P1|STARTED|Overall Study||44
223006|NCT00253019|531056|P3|NOT COMPLETED|Overall Study||18
223007|NCT00253019|531057|P2|NOT COMPLETED|Overall Study||31
223008|NCT00253019|531058|P1|NOT COMPLETED|Overall Study||29
223009|NCT00253019|531056|P3|COMPLETED|Overall Study||83
223010|NCT00253019|531057|P2|COMPLETED|Overall Study||78
223011|NCT00253019|531058|P1|COMPLETED|Overall Study||82
223012|NCT00253019|531056|P3|STARTED|Overall Study||101
223013|NCT00253019|531057|P2|STARTED|Overall Study||109
223014|NCT00253019|531058|P1|STARTED|Overall Study||111
223015|NCT00252967|531068|P2|NOT COMPLETED|Overall Study||0
223016|NCT00252967|531069|P1|NOT COMPLETED|Overall Study||0
223017|NCT00252967|531068|P2|COMPLETED|Overall Study||33
223018|NCT00252967|531069|P1|COMPLETED|Overall Study||31
223019|NCT00252967|531068|P2|STARTED|Overall Study||33
223020|NCT00252967|531069|P1|STARTED|Overall Study||31
223021|NCT00252733|531093|P2|NOT COMPLETED|Overall Study||92
223022|NCT00252733|531094|P1|NOT COMPLETED|Overall Study||106
223023|NCT00252733|531093|P2|COMPLETED|Overall Study||618
223024|NCT00252733|531094|P1|COMPLETED|Overall Study||605
223025|NCT00252733|531093|P2|STARTED|Overall Study||710
223026|NCT00252733|531094|P1|STARTED|Overall Study||711
223027|NCT00252720|531104|P2|NOT COMPLETED|Overall Study||165
223028|NCT00252720|531105|P1|NOT COMPLETED|Overall Study||132
223029|NCT00252720|531104|P2|COMPLETED|Overall Study||789
223030|NCT00252720|531105|P1|COMPLETED|Overall Study||819
223031|NCT00252720|531104|P2|STARTED|Overall Study||954
223032|NCT00252720|531105|P1|STARTED|Overall Study||951
223033|NCT00252694|531119|P2|NOT COMPLETED|Overall Study||154
223034|NCT00252694|531120|P1|NOT COMPLETED|Overall Study||144
223035|NCT00252694|531119|P2|COMPLETED|Overall Study||800
223036|NCT00252694|531120|P1|COMPLETED|Overall Study||807
223037|NCT00252694|531119|P2|STARTED|Overall Study||954
223038|NCT00252694|531120|P1|STARTED|Overall Study||951
223039|NCT00252629|531135|P3|NOT COMPLETED|Overall Study||0
223040|NCT00252629|531136|P2|NOT COMPLETED|Overall Study||0
223041|NCT00252629|531137|P1|NOT COMPLETED|Overall Study||1
223042|NCT00252629|531135|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
223043|NCT00252629|531136|P2|COMPLETED|Overall Study||9
223044|NCT00252629|531137|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
223045|NCT00252629|531135|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
223046|NCT00252629|531136|P2|STARTED|Overall Study||9
223047|NCT00252629|531137|P1|STARTED|Overall Study||9
223048|NCT00252590|531153|P3|NOT COMPLETED|Overall Study||3
223049|NCT00252590|531154|P2|NOT COMPLETED|Overall Study||2
223050|NCT00252590|531155|P1|NOT COMPLETED|Overall Study||2
223051|NCT00252590|531153|P3|COMPLETED|Overall Study||31
223052|NCT00252590|531154|P2|COMPLETED|Overall Study||28
223053|NCT00252590|531155|P1|COMPLETED|Overall Study||33
223054|NCT00252590|531153|P3|STARTED|Overall Study||34
223055|NCT00252590|531154|P2|STARTED|Overall Study||30
223056|NCT00252590|531155|P1|STARTED|Overall Study||35
223057|NCT00252564|531168|P2|NOT COMPLETED|Overall Study||44
223058|NCT00252564|531169|P1|NOT COMPLETED|Overall Study||39
223059|NCT00252564|531168|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
223060|NCT00252564|531169|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
223061|NCT00252564|531168|P2|STARTED|Overall Study|From randomization|123
223062|NCT00252564|531169|P1|STARTED|Overall Study|From randomization|124
223063|NCT00252538|531181|P2|NOT COMPLETED|Overall Study||0
223064|NCT00252538|531182|P1|NOT COMPLETED|Overall Study||0
223065|NCT00252538|531181|P2|COMPLETED|Overall Study||114
223066|NCT00252538|531182|P1|COMPLETED|Overall Study||19
223067|NCT00252538|531181|P2|STARTED|Overall Study||114
223068|NCT00252538|531182|P1|STARTED|Overall Study||19
223069|NCT00252512|531189|P2|NOT COMPLETED|12 Month Follow up||1
223070|NCT00252512|531190|P1|NOT COMPLETED|12 Month Follow up||9
223071|NCT00252512|531189|P2|COMPLETED|12 Month Follow up||121
223072|NCT00252512|531190|P1|COMPLETED|12 Month Follow up||123
223073|NCT00252512|531189|P2|STARTED|12 Month Follow up||122
223074|NCT00252512|531190|P1|STARTED|12 Month Follow up||132
223075|NCT00252512|531189|P2|NOT COMPLETED|Six Month Follow up||12
223076|NCT00252512|531190|P1|NOT COMPLETED|Six Month Follow up||4
223077|NCT00252512|531189|P2|COMPLETED|Six Month Follow up||122
223078|NCT00252512|531190|P1|COMPLETED|Six Month Follow up||132
223079|NCT00252512|531189|P2|STARTED|Six Month Follow up||134
223080|NCT00252512|531190|P1|STARTED|Six Month Follow up||136
223081|NCT00252512|531189|P2|NOT COMPLETED|Intervention||31
223082|NCT00252512|531190|P1|NOT COMPLETED|Intervention||29
223083|NCT00252512|531189|P2|COMPLETED|Intervention||134
223084|NCT00252512|531190|P1|COMPLETED|Intervention||136
223085|NCT00252512|531189|P2|STARTED|Intervention||165
223086|NCT00252512|531190|P1|STARTED|Intervention||165
223087|NCT00252499|531199|P3|NOT COMPLETED|Overall Study||0
223088|NCT00252499|531200|P2|NOT COMPLETED|Overall Study||0
223089|NCT00252499|531201|P1|NOT COMPLETED|Overall Study||1
223090|NCT00252499|531199|P3|COMPLETED|Overall Study||6
223091|NCT00252499|531200|P2|COMPLETED|Overall Study||2
223092|NCT00252499|531201|P1|COMPLETED|Overall Study||4
223093|NCT00252499|531199|P3|STARTED|Overall Study||6
223094|NCT00252499|531200|P2|STARTED|Overall Study||2
223095|NCT00252499|531201|P1|STARTED|Overall Study||5
223096|NCT00252239|531228|P4|NOT COMPLETED|Overall Study||1
223097|NCT00252239|531229|P3|NOT COMPLETED|Overall Study||2
223098|NCT00252239|531230|P2|NOT COMPLETED|Overall Study||0
223099|NCT00252239|531231|P1|NOT COMPLETED|Overall Study||1
223100|NCT00252239|531228|P4|COMPLETED|Overall Study||30
223101|NCT00252239|531229|P3|COMPLETED|Overall Study||17
223102|NCT00252239|531230|P2|COMPLETED|Overall Study||31
223103|NCT00252239|531231|P1|COMPLETED|Overall Study||30
223104|NCT00252239|531228|P4|STARTED|Overall Study||31
223105|NCT00252239|531229|P3|STARTED|Overall Study||19
223106|NCT00252239|531230|P2|STARTED|Overall Study||31
223107|NCT00252239|531231|P1|STARTED|Overall Study||31
223108|NCT00252187|531243|P2|NOT COMPLETED|Overall Study||1
223109|NCT00252187|531244|P1|NOT COMPLETED|Overall Study||4
223110|NCT00252187|531243|P2|COMPLETED|Overall Study||20
223111|NCT00252187|531244|P1|COMPLETED|Overall Study||20
223112|NCT00252187|531243|P2|STARTED|Overall Study||21
223113|NCT00252187|531244|P1|STARTED|Overall Study||24
223114|NCT00252057|531266|P2|NOT COMPLETED|Overall Study||8
223115|NCT00252057|531267|P1|NOT COMPLETED|Overall Study||3
223116|NCT00252057|531266|P2|COMPLETED|Overall Study||368
223117|NCT00252057|531267|P1|COMPLETED|Overall Study||370
223118|NCT00252057|531266|P2|STARTED|Overall Study||376
223119|NCT00252057|531267|P1|STARTED|Overall Study||373
223120|NCT00251979|531273|P2|NOT COMPLETED|Overall Study||40
223121|NCT00251979|531274|P1|NOT COMPLETED|Overall Study||38
223122|NCT00251979|531273|P2|COMPLETED|Overall Study||349
223123|NCT00251979|531274|P1|COMPLETED|Overall Study||337
223124|NCT00251979|531273|P2|STARTED|Overall Study|ITT population|389
223125|NCT00251979|531274|P1|STARTED|Overall Study|ITT population|375
223126|NCT00251927|531306|P2|NOT COMPLETED|Overall Study||74
223127|NCT00251927|531307|P1|NOT COMPLETED|Overall Study||108
223128|NCT00251927|531306|P2|COMPLETED|Overall Study|Completed 5 year visit|192
223129|NCT00251927|531307|P1|COMPLETED|Overall Study|Completed 5 year visit|180
223130|NCT00251927|531306|P2|STARTED|Overall Study|Randomised|266
223131|NCT00251927|531307|P1|STARTED|Overall Study|Randomised|288
223132|NCT00251862|531337|P3|NOT COMPLETED|Overall Study||0
223133|NCT00251862|531338|P2|NOT COMPLETED|Overall Study||0
223134|NCT00251862|531339|P1|NOT COMPLETED|Overall Study||0
223135|NCT00251862|531337|P3|COMPLETED|Overall Study||276
223136|NCT00251862|531338|P2|COMPLETED|Overall Study||269
223137|NCT00251862|531339|P1|COMPLETED|Overall Study||280
223138|NCT00251862|531337|P3|STARTED|Overall Study||276
223139|NCT00251862|531338|P2|STARTED|Overall Study||269
223140|NCT00251862|531339|P1|STARTED|Overall Study||280
223141|NCT00251004|531359|P3|NOT COMPLETED|Overall Study||31
223142|NCT00251004|531360|P2|NOT COMPLETED|Overall Study||41
223143|NCT00251004|531361|P1|NOT COMPLETED|Overall Study||45
223144|NCT00251004|531359|P3|COMPLETED|Overall Study||246
223145|NCT00251004|531360|P2|COMPLETED|Overall Study||238
223146|NCT00251004|531361|P1|COMPLETED|Overall Study||232
223147|NCT00251004|531359|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
223148|NCT00251004|531360|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
223149|NCT00251004|531361|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
223150|NCT00251004|531359|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
223151|NCT00251004|531360|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
223152|NCT00251004|531361|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
223153|NCT00251004|531359|P3|STARTED|Overall Study||277
223154|NCT00251004|531360|P2|STARTED|Overall Study||279
223155|NCT00251004|531361|P1|STARTED|Overall Study||277
223156|NCT00250926|531378|P1|NOT COMPLETED|Overall Study||0
223157|NCT00250926|531378|P1|COMPLETED|Overall Study||23
223158|NCT00250926|531378|P1|STARTED|Overall Study||23
223159|NCT00250835|531385|P1|NOT COMPLETED|Overall Study||1
223160|NCT00250835|531385|P1|COMPLETED|Overall Study||37
223161|NCT00250835|531385|P1|STARTED|Overall Study||38
223162|NCT00251758|531397|P3|NOT COMPLETED|Overall Study||27
223163|NCT00251758|531398|P2|NOT COMPLETED|Overall Study||27
223164|NCT00251758|531399|P1|NOT COMPLETED|Overall Study||28
223165|NCT00251758|531397|P3|COMPLETED|Overall Study||277
223166|NCT00251758|531398|P2|COMPLETED|Overall Study||285
223167|NCT00251758|531399|P1|COMPLETED|Overall Study||264
223168|NCT00251758|531397|P3|STARTED|Overall Study||304
223169|NCT00251758|531398|P2|STARTED|Overall Study||312
223170|NCT00251758|531399|P1|STARTED|Overall Study||292
223171|NCT00251745|531419|P3|NOT COMPLETED|Overall Study||27
223172|NCT00251745|531420|P2|NOT COMPLETED|Overall Study||27
223173|NCT00251745|531421|P1|NOT COMPLETED|Overall Study||28
223174|NCT00251745|531419|P3|COMPLETED|Overall Study||277
223175|NCT00251745|531420|P2|COMPLETED|Overall Study||285
223176|NCT00251745|531421|P1|COMPLETED|Overall Study||264
223177|NCT00251745|531419|P3|STARTED|Overall Study||304
223178|NCT00251745|531420|P2|STARTED|Overall Study||312
223179|NCT00251745|531421|P1|STARTED|Overall Study||292
223180|NCT00251719|531441|P3|NOT COMPLETED|Overall Study||30
223181|NCT00251719|531442|P2|NOT COMPLETED|Overall Study||45
223182|NCT00251719|531443|P1|NOT COMPLETED|Overall Study||53
223183|NCT00251719|531441|P3|COMPLETED|Overall Study||643
223184|NCT00251719|531442|P2|COMPLETED|Overall Study||642
223185|NCT00251719|531443|P1|COMPLETED|Overall Study||641
223186|NCT00251719|531441|P3|STARTED|Overall Study||673
223187|NCT00251719|531442|P2|STARTED|Overall Study||687
223188|NCT00251719|531443|P1|STARTED|Overall Study||694
223189|NCT00251693|531469|P3|NOT COMPLETED|Overall Study||46
223190|NCT00251693|531470|P2|NOT COMPLETED|Overall Study||44
223191|NCT00251693|531471|P1|NOT COMPLETED|Overall Study||51
223192|NCT00251693|531469|P3|COMPLETED|Overall Study||644
223193|NCT00251693|531470|P2|COMPLETED|Overall Study||624
223194|NCT00251693|531471|P1|COMPLETED|Overall Study||629
223195|NCT00251693|531469|P3|STARTED|Overall Study||690
223196|NCT00251693|531470|P2|STARTED|Overall Study||668
223197|NCT00251693|531471|P1|STARTED|Overall Study||680
223198|NCT00251641|531496|P2|NOT COMPLETED|Overall Study||88
223199|NCT00251641|531497|P1|NOT COMPLETED|Overall Study||112
223200|NCT00251641|531496|P2|COMPLETED|Overall Study||127
223201|NCT00251641|531497|P1|COMPLETED|Overall Study||541
223202|NCT00251641|531496|P2|STARTED|Overall Study||215
223203|NCT00251641|531497|P1|STARTED|Overall Study||653
223204|NCT00251589|531515|P4|NOT COMPLETED|Overall Study||2
223205|NCT00251589|531516|P3|NOT COMPLETED|Overall Study||2
223206|NCT00251589|531517|P2|NOT COMPLETED|Overall Study||3
223207|NCT00251589|531518|P1|NOT COMPLETED|Overall Study||15
223208|NCT00251589|531515|P4|COMPLETED|Overall Study||0
223209|NCT00251589|531516|P3|COMPLETED|Overall Study||0
223210|NCT00251589|531517|P2|COMPLETED|Overall Study||0
223211|NCT00251589|531518|P1|COMPLETED|Overall Study||1
223212|NCT00251589|531515|P4|STARTED|Overall Study||2
223213|NCT00251589|531516|P3|STARTED|Overall Study||2
223214|NCT00251589|531517|P2|STARTED|Overall Study||3
223215|NCT00251589|531518|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
223216|NCT00251316|531555|P2|NOT COMPLETED|Overall Study||3
223217|NCT00251316|531556|P1|NOT COMPLETED|Overall Study||2
223218|NCT00251316|531555|P2|COMPLETED|Overall Study||14
223219|NCT00251316|531556|P1|COMPLETED|Overall Study||15
223220|NCT00251316|531555|P2|STARTED|Overall Study||17
223221|NCT00251316|531556|P1|STARTED|Overall Study||17
223222|NCT00251303|531564|P2|NOT COMPLETED|Overall Study||1
223223|NCT00251303|531565|P1|NOT COMPLETED|Overall Study||8
223224|NCT00251303|531564|P2|COMPLETED|Overall Study||29
223225|NCT00251303|531565|P1|COMPLETED|Overall Study||22
223226|NCT00251303|531564|P2|STARTED|Overall Study||30
223227|NCT00251303|531565|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
223228|NCT00250718|531573|P1|NOT COMPLETED|Overall Study||3
223229|NCT00250718|531573|P1|COMPLETED|Overall Study||14
223230|NCT00250718|531573|P1|Received Treatment|Overall Study||16
223231|NCT00250718|531573|P1|STARTED|Overall Study||17
223232|NCT00250679|531581|P3|NOT COMPLETED|Overall Study||44
223233|NCT00250679|531582|P2|NOT COMPLETED|Overall Study||49
223234|NCT00250679|531583|P1|NOT COMPLETED|Overall Study||39
223235|NCT00250679|531581|P3|COMPLETED|Overall Study||103
223236|NCT00250679|531582|P2|COMPLETED|Overall Study||100
223237|NCT00250679|531583|P1|COMPLETED|Overall Study||108
223238|NCT00250679|531581|P3|STARTED|Overall Study||147
223239|NCT00250679|531582|P2|STARTED|Overall Study||149
223240|NCT00250679|531583|P1|STARTED|Overall Study||147
223241|NCT00250588|531684|P3|NOT COMPLETED|Overall Study||13
223242|NCT00250588|531685|P2|NOT COMPLETED|Overall Study||19
223243|NCT00250588|531686|P1|NOT COMPLETED|Overall Study||9
223244|NCT00250588|531684|P3|COMPLETED|Overall Study||74
223245|NCT00250588|531685|P2|COMPLETED|Overall Study||65
223246|NCT00250588|531686|P1|COMPLETED|Overall Study||72
223247|NCT00250588|531684|P3|STARTED|Overall Study||87
223248|NCT00250588|531685|P2|STARTED|Overall Study||84
223249|NCT00250588|531686|P1|STARTED|Overall Study||81
223250|NCT00250497|531702|P2|NOT COMPLETED|Overall Study||15
223251|NCT00250497|531703|P1|NOT COMPLETED|Overall Study||5
223252|NCT00250497|531702|P2|COMPLETED|Overall Study||159
223253|NCT00250497|531703|P1|COMPLETED|Overall Study||177
223254|NCT00250497|531702|P2|STARTED|Overall Study||174
223255|NCT00250497|531703|P1|STARTED|Overall Study||182
223256|NCT00250484|531721|P2|NOT COMPLETED|Overall Study||0
223257|NCT00250484|531722|P1|NOT COMPLETED|Overall Study||0
223258|NCT00250484|531721|P2|COMPLETED|Overall Study||8
223259|NCT00250484|531722|P1|COMPLETED|Overall Study||9
223260|NCT00250484|531721|P2|STARTED|Overall Study||8
223261|NCT00250484|531722|P1|STARTED|Overall Study||9
223262|NCT00250458|531732|P2|NOT COMPLETED|Overall Study||17
223263|NCT00250458|531733|P1|NOT COMPLETED|Overall Study||32
223264|NCT00250458|531732|P2|COMPLETED|Overall Study||97
223265|NCT00250458|531733|P1|COMPLETED|Overall Study||200
223266|NCT00250458|531732|P2|STARTED|Overall Study||114
223267|NCT00250458|531733|P1|STARTED|Overall Study||232
223268|NCT00250432|531743|P2|NOT COMPLETED|Overall Study||47
223269|NCT00250432|531744|P1|NOT COMPLETED|Overall Study||45
223270|NCT00250432|531743|P2|COMPLETED|Overall Study||53
223271|NCT00250432|531744|P1|COMPLETED|Overall Study||59
223272|NCT00250432|531743|P2|STARTED|Overall Study||100
223273|NCT00250432|531744|P1|STARTED|Overall Study||104
223274|NCT00249873|531754|P2|NOT COMPLETED|Overall Study||1254
223275|NCT00249873|531755|P1|NOT COMPLETED|Overall Study||1330
223276|NCT00249873|531754|P2|COMPLETED|Overall Study|started and completed study drug|2528
223277|NCT00249873|531755|P1|COMPLETED|Overall Study|started and completed study drug|2442
223278|NCT00249873|531754|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
223279|NCT00249873|531755|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
223280|NCT00249821|531769|P2|NOT COMPLETED|Overall Study||1
223281|NCT00249821|531770|P1|NOT COMPLETED|Overall Study||0
223282|NCT00249821|531769|P2|COMPLETED|Overall Study||11
223283|NCT00249821|531770|P1|COMPLETED|Overall Study||10
223284|NCT00249821|531769|P2|STARTED|Overall Study||12
223285|NCT00249821|531770|P1|STARTED|Overall Study||10
223286|NCT00249795|531792|P2|NOT COMPLETED|Overall Study||1390
223287|NCT00249795|531793|P1|NOT COMPLETED|Overall Study||1394
223288|NCT00249795|531792|P2|COMPLETED|Overall Study|started and completed study drug|3108
223289|NCT00249795|531793|P1|COMPLETED|Overall Study|started and completed study drug|3124
223290|NCT00249795|531792|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
223291|NCT00249795|531793|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
223292|NCT00249613|531813|P2|NOT COMPLETED|12 Month Follow-up||15
223293|NCT00249613|531814|P1|NOT COMPLETED|12 Month Follow-up||17
223294|NCT00249613|531813|P2|COMPLETED|12 Month Follow-up||124
223295|NCT00249613|531814|P1|COMPLETED|12 Month Follow-up||135
223296|NCT00249613|531813|P2|STARTED|12 Month Follow-up||139
223297|NCT00249613|531814|P1|STARTED|12 Month Follow-up||152
223298|NCT00249613|531813|P2|NOT COMPLETED|Baseline||0
223299|NCT00249613|531814|P1|NOT COMPLETED|Baseline||0
223300|NCT00249613|531813|P2|COMPLETED|Baseline||139
223301|NCT00249613|531814|P1|COMPLETED|Baseline||152
223302|NCT00249613|531813|P2|STARTED|Baseline||139
223303|NCT00249613|531814|P1|STARTED|Baseline||152
223304|NCT00249496|531825|P2|NOT COMPLETED|Overall Study||1
223305|NCT00249496|531826|P1|NOT COMPLETED|Overall Study||0
223306|NCT00249496|531825|P2|COMPLETED|Overall Study||26
223307|NCT00249496|531826|P1|COMPLETED|Overall Study||24
223308|NCT00249496|531825|P2|STARTED|Overall Study||27
223309|NCT00249496|531826|P1|STARTED|Overall Study||24
223310|NCT00249470|531834|P2|NOT COMPLETED|Overall Study||0
223311|NCT00249470|531835|P1|NOT COMPLETED|Overall Study||0
223312|NCT00249470|531834|P2|COMPLETED|Overall Study||28
223313|NCT00249470|531835|P1|COMPLETED|Overall Study||28
223314|NCT00249470|531834|P2|STARTED|Overall Study||28
223315|NCT00249470|531835|P1|STARTED|Overall Study||28
223316|NCT00249379|531843|P2|NOT COMPLETED|Overall Study||8
223317|NCT00249379|531844|P1|NOT COMPLETED|Overall Study||8
223318|NCT00249379|531843|P2|COMPLETED|Overall Study||4
223319|NCT00249379|531844|P1|COMPLETED|Overall Study||6
223320|NCT00249379|531843|P2|STARTED|Overall Study||12
223321|NCT00249379|531844|P1|STARTED|Overall Study||14
223322|NCT00249288|531858|P2|NOT COMPLETED|Overall Study||5
223323|NCT00249288|531859|P1|NOT COMPLETED|Overall Study||5
223324|NCT00249288|531858|P2|COMPLETED|Overall Study||14
223325|NCT00249288|531859|P1|COMPLETED|Overall Study||14
223326|NCT00249288|531858|P2|Initiated Treatment|Overall Study||15
223327|NCT00249288|531859|P1|Initiated Treatment|Overall Study||17
223328|NCT00249288|531858|P2|STARTED|Overall Study||19
223329|NCT00249288|531859|P1|STARTED|Overall Study||19
223330|NCT00249249|531869|P4|NOT COMPLETED|Overall Study||3
223331|NCT00249249|531870|P3|NOT COMPLETED|Overall Study||15
223332|NCT00249249|531871|P2|NOT COMPLETED|Overall Study||5
223333|NCT00249249|531872|P1|NOT COMPLETED|Overall Study||20
223334|NCT00249249|531869|P4|COMPLETED|Overall Study||100
223335|NCT00249249|531870|P3|COMPLETED|Overall Study||288
223336|NCT00249249|531871|P2|COMPLETED|Overall Study||98
223337|NCT00249249|531872|P1|COMPLETED|Overall Study||301
223338|NCT00249249|531869|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
223339|NCT00249249|531870|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
223340|NCT00249249|531871|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
223341|NCT00249249|531872|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
223342|NCT00249249|531869|P4|STARTED|Overall Study||103
223343|NCT00249249|531870|P3|STARTED|Overall Study||303
223344|NCT00249249|531871|P2|STARTED|Overall Study||103
223345|NCT00249249|531872|P1|STARTED|Overall Study||321
223346|NCT00247962|531928|P2|NOT COMPLETED|Overall Study||19
223347|NCT00247962|531929|P1|NOT COMPLETED|Overall Study||26
223348|NCT00247962|531928|P2|COMPLETED|Overall Study||168
223349|NCT00247962|531929|P1|COMPLETED|Overall Study||353
223350|NCT00247962|531928|P2|STARTED|Overall Study||187
223351|NCT00247962|531929|P1|STARTED|Overall Study||379
223352|NCT00249002|531937|P1|NOT COMPLETED|Overall Study||7
223353|NCT00249002|531937|P1|COMPLETED|Overall Study||2
223354|NCT00249002|531937|P1|STARTED|Overall Study||9
223355|NCT00248807|531955|P2|NOT COMPLETED|Overall Study||0
223356|NCT00248807|531956|P1|NOT COMPLETED|Overall Study||0
223357|NCT00248807|531955|P2|COMPLETED|Overall Study||11
223358|NCT00248807|531956|P1|COMPLETED|Overall Study||19
223359|NCT00248807|531955|P2|STARTED|Overall Study||11
223360|NCT00248807|531956|P1|STARTED|Overall Study||19
223361|NCT00248794|531973|P3|NOT COMPLETED|Overall Study||3
223362|NCT00248794|531974|P2|NOT COMPLETED|Overall Study||8
223363|NCT00248794|531975|P1|NOT COMPLETED|Overall Study||6
223364|NCT00248794|531973|P3|COMPLETED|Overall Study||7
223365|NCT00248794|531974|P2|COMPLETED|Overall Study||16
223366|NCT00248794|531975|P1|COMPLETED|Overall Study||19
223367|NCT00248794|531973|P3|STARTED|Overall Study||10
223368|NCT00248794|531974|P2|STARTED|Overall Study||24
223369|NCT00248794|531975|P1|STARTED|Overall Study||25
223370|NCT00248781|531997|P2|NOT COMPLETED|Overall Study||4
223371|NCT00248781|531998|P1|NOT COMPLETED|Overall Study||10
223372|NCT00248781|531997|P2|COMPLETED|Overall Study||47
223373|NCT00248781|531998|P1|COMPLETED|Overall Study||42
223374|NCT00248781|531997|P2|STARTED|Overall Study||51
223375|NCT00248781|531998|P1|STARTED|Overall Study||52
223376|NCT00248651|532025|P3|NOT COMPLETED|Overall Study||32
223377|NCT00248651|532026|P2|NOT COMPLETED|Overall Study||40
223378|NCT00248651|532027|P1|NOT COMPLETED|Overall Study||28
223379|NCT00248651|532025|P3|COMPLETED|Overall Study||65
223380|NCT00248651|532026|P2|COMPLETED|Overall Study||58
223381|NCT00248651|532027|P1|COMPLETED|Overall Study||69
223382|NCT00248651|532025|P3|Completed 12 Weeks of Treatment|Overall Study||75
223383|NCT00248651|532026|P2|Completed 12 Weeks of Treatment|Overall Study||66
223384|NCT00248651|532027|P1|Completed 12 Weeks of Treatment|Overall Study||78
223385|NCT00248651|532025|P3|STARTED|Overall Study||97
223386|NCT00248651|532026|P2|STARTED|Overall Study||98
223387|NCT00248651|532027|P1|STARTED|Overall Study||97
223388|NCT00248638|532046|P2|NOT COMPLETED|Overall Study||0
223389|NCT00248638|532047|P1|NOT COMPLETED|Overall Study||0
223390|NCT00248638|532046|P2|COMPLETED|Overall Study||75
223391|NCT00248638|532047|P1|COMPLETED|Overall Study||75
223392|NCT00248638|532046|P2|STARTED|Overall Study||75
223393|NCT00248638|532047|P1|STARTED|Overall Study||75
223394|NCT00248625|532057|P2|NOT COMPLETED|Overall Study||2
223395|NCT00248625|532058|P1|NOT COMPLETED|Overall Study||0
223396|NCT00248625|532057|P2|COMPLETED|Overall Study||90
223397|NCT00248625|532058|P1|COMPLETED|Overall Study||92
223398|NCT00248625|532057|P2|STARTED|Overall Study||92
223399|NCT00248625|532058|P1|STARTED|Overall Study||92
223400|NCT00248560|532078|P1|NOT COMPLETED|Overall Study||0
223401|NCT00248560|532078|P1|COMPLETED|Overall Study||36
223402|NCT00248560|532078|P1|STARTED|Overall Study||36
223403|NCT00248547|532084|P2|NOT COMPLETED|Overall Study||0
223404|NCT00248547|532085|P1|NOT COMPLETED|Overall Study||0
223405|NCT00248547|532084|P2|COMPLETED|Overall Study||20
223406|NCT00248547|532085|P1|COMPLETED|Overall Study||20
223407|NCT00248547|532084|P2|STARTED|Overall Study||20
223408|NCT00248547|532085|P1|STARTED|Overall Study||20
223409|NCT00248287|532093|P2|NOT COMPLETED|Overall Study||19
223410|NCT00248287|532094|P1|NOT COMPLETED|Overall Study||24
223411|NCT00248287|532093|P2|COMPLETED|Overall Study||60
223412|NCT00248287|532094|P1|COMPLETED|Overall Study||51
223413|NCT00248287|532093|P2|STARTED|Overall Study||79
223414|NCT00248287|532094|P1|STARTED|Overall Study||75
223415|NCT00248170|532108|P2|NOT COMPLETED|Overall Study||808
223416|NCT00248170|532109|P1|NOT COMPLETED|Overall Study||761
223417|NCT00248170|532108|P2|COMPLETED|Overall Study||1286
223418|NCT00248170|532109|P1|COMPLETED|Overall Study||1317
223419|NCT00248170|532108|P2|Safety Set|Overall Study||2062
223420|NCT00248170|532109|P1|Safety Set|Overall Study||2049
223421|NCT00248170|532108|P2|Intent-to-treat (ITT)|Overall Study||2075
223422|NCT00248170|532109|P1|Intent-to-treat (ITT)|Overall Study||2061
223423|NCT00248170|532108|P2|STARTED|Overall Study||2094
223424|NCT00248170|532109|P1|STARTED|Overall Study||2078
223425|NCT00247676|532129|P1|NOT COMPLETED|Overall Study||36
223426|NCT00247676|532129|P1|COMPLETED|Overall Study||1
223427|NCT00247676|532129|P1|STARTED|Overall Study||37
223428|NCT00247611|532159|P2|NOT COMPLETED|On Protocol Sample||125
223429|NCT00247611|532160|P1|NOT COMPLETED|On Protocol Sample||111
223430|NCT00247611|532159|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
223431|NCT00247611|532160|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
223432|NCT00247611|532159|P2|STARTED|On Protocol Sample|ITT sample participants|277
223433|NCT00247611|532160|P1|STARTED|On Protocol Sample|ITT sample participants|287
223434|NCT00247611|532159|P2|NOT COMPLETED|Intention to Treat Sample||13
223435|NCT00247611|532160|P1|NOT COMPLETED|Intention to Treat Sample||17
223436|NCT00247611|532159|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
223437|NCT00247611|532160|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
223438|NCT00247611|532159|P2|STARTED|Intention to Treat Sample|Participants randomized|290
223439|NCT00247611|532160|P1|STARTED|Intention to Treat Sample|Participants randomized|304
223440|NCT00247611|532159|P2|NOT COMPLETED|Baselined||13
223441|NCT00247611|532160|P1|NOT COMPLETED|Baselined||17
223442|NCT00247611|532159|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
223443|NCT00247611|532160|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
223444|NCT00247611|532159|P2|STARTED|Baselined|Participants randomized|290
223445|NCT00247611|532160|P1|STARTED|Baselined|Participants randomized|304
223446|NCT00247416|532178|P2|NOT COMPLETED|Overall Study||2
223447|NCT00247416|532179|P1|NOT COMPLETED|Overall Study||1
223448|NCT00247416|532178|P2|COMPLETED|Overall Study||31
223449|NCT00247416|532179|P1|COMPLETED|Overall Study||25
223450|NCT00247416|532178|P2|STARTED|Overall Study||33
223451|NCT00247416|532179|P1|STARTED|Overall Study||26
223452|NCT00247377|532193|P2|NOT COMPLETED|Overall Study||0
223453|NCT00247377|532194|P1|NOT COMPLETED|Overall Study||0
223454|NCT00247377|532193|P2|COMPLETED|Overall Study||86
223455|NCT00247377|532194|P1|COMPLETED|Overall Study||111
223456|NCT00247377|532193|P2|STARTED|Overall Study||86
223457|NCT00247377|532194|P1|STARTED|Overall Study||111
223458|NCT00247273|532220|P2|NOT COMPLETED|Overall Study||137
223459|NCT00247273|532221|P1|NOT COMPLETED|Overall Study||146
223460|NCT00247273|532220|P2|COMPLETED|Overall Study||513
223461|NCT00247273|532221|P1|COMPLETED|Overall Study||498
223462|NCT00247273|532220|P2|Intent to Treat Population|Overall Study||650
223463|NCT00247273|532221|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
223464|NCT00247273|532220|P2|STARTED|Overall Study||650
223465|NCT00247273|532221|P1|STARTED|Overall Study||644
223466|NCT00246805|532267|P2|NOT COMPLETED|Phase 2||0
223467|NCT00246805|532268|P1|NOT COMPLETED|Phase 2||0
223468|NCT00246805|532267|P2|COMPLETED|Phase 2||33
223469|NCT00246805|532268|P1|COMPLETED|Phase 2||33
223470|NCT00246805|532267|P2|STARTED|Phase 2||33
223471|NCT00246805|532268|P1|STARTED|Phase 2||33
223472|NCT00246805|532267|P2|NOT COMPLETED|Phase 1||0
223473|NCT00246805|532268|P1|NOT COMPLETED|Phase 1||1
223474|NCT00246805|532267|P2|COMPLETED|Phase 1||33
223475|NCT00246805|532268|P1|COMPLETED|Phase 1||33
223476|NCT00246805|532267|P2|STARTED|Phase 1||33
223477|NCT00246805|532268|P1|STARTED|Phase 1||34
223478|NCT00246571|532276|P2|NOT COMPLETED|Overall Study||104
223479|NCT00246571|532277|P1|NOT COMPLETED|Overall Study||113
223480|NCT00246571|532276|P2|COMPLETED|Overall Study||0
223481|NCT00246571|532277|P1|COMPLETED|Overall Study||0
223482|NCT00246571|532276|P2|Randomized But Not Treated|Overall Study||1
223483|NCT00246571|532277|P1|Randomized But Not Treated|Overall Study||3
223484|NCT00246571|532276|P2|STARTED|Overall Study||104
223485|NCT00246571|532277|P1|STARTED|Overall Study||113
223486|NCT00246519|532317|P2|NOT COMPLETED|Overall Study||64
223487|NCT00246519|532318|P1|NOT COMPLETED|Overall Study||56
223488|NCT00246519|532317|P2|COMPLETED|Overall Study||382
223489|NCT00246519|532318|P1|COMPLETED|Overall Study||386
223490|NCT00246519|532317|P2|STARTED|Overall Study||446
223491|NCT00246519|532318|P1|STARTED|Overall Study||442
223492|NCT00246376|532329|P5|NOT COMPLETED|Overall Study||17
223493|NCT00246376|532330|P4|NOT COMPLETED|Overall Study||26
223494|NCT00246376|532331|P3|NOT COMPLETED|Overall Study||16
223495|NCT00246376|532332|P2|NOT COMPLETED|Overall Study||19
223496|NCT00246376|532333|P1|NOT COMPLETED|Overall Study||15
223497|NCT00246376|532329|P5|COMPLETED|Overall Study||28
223498|NCT00246376|532330|P4|COMPLETED|Overall Study||21
223499|NCT00246376|532331|P3|COMPLETED|Overall Study||29
223500|NCT00246376|532332|P2|COMPLETED|Overall Study||24
223501|NCT00246376|532333|P1|COMPLETED|Overall Study||26
223502|NCT00246376|532329|P5|After Dietary run-in at Two Weeks|Overall Study||42
223503|NCT00246376|532330|P4|After Dietary run-in at Two Weeks|Overall Study||40
223504|NCT00246376|532331|P3|After Dietary run-in at Two Weeks|Overall Study||41
223505|NCT00246376|532332|P2|After Dietary run-in at Two Weeks|Overall Study||38
223506|NCT00246376|532333|P1|After Dietary run-in at Two Weeks|Overall Study||30
223507|NCT00246376|532329|P5|STARTED|Overall Study||45
223508|NCT00246376|532330|P4|STARTED|Overall Study||47
223509|NCT00246376|532331|P3|STARTED|Overall Study||45
223510|NCT00246376|532332|P2|STARTED|Overall Study||43
223511|NCT00246376|532333|P1|STARTED|Overall Study||41
223512|NCT00246337|532384|P9|NOT COMPLETED|Overall Study||11
223513|NCT00246337|532385|P8|NOT COMPLETED|Overall Study||13
223514|NCT00246337|532386|P7|NOT COMPLETED|Overall Study||9
223515|NCT00246337|532387|P6|NOT COMPLETED|Overall Study||15
223516|NCT00246337|532388|P5|NOT COMPLETED|Overall Study||4
223517|NCT00246337|532389|P4|NOT COMPLETED|Overall Study||1
223518|NCT00246337|532390|P3|NOT COMPLETED|Overall Study||3
223519|NCT00246337|532391|P2|NOT COMPLETED|Overall Study||2
223520|NCT00246337|532392|P1|NOT COMPLETED|Overall Study||32
223521|NCT00246337|532384|P9|COMPLETED|Overall Study||34
223522|NCT00246337|532385|P8|COMPLETED|Overall Study||40
223523|NCT00246337|532386|P7|COMPLETED|Overall Study||45
223524|NCT00246337|532387|P6|COMPLETED|Overall Study||39
223525|NCT00246337|532388|P5|COMPLETED|Overall Study||12
223526|NCT00246337|532389|P4|COMPLETED|Overall Study||16
223527|NCT00246337|532390|P3|COMPLETED|Overall Study||15
223528|NCT00246337|532391|P2|COMPLETED|Overall Study||14
223529|NCT00246337|532392|P1|COMPLETED|Overall Study||115
223530|NCT00246337|532384|P9|Completed Period (Both Doses)|Overall Study||15
223531|NCT00246337|532385|P8|Completed Period (Both Doses)|Overall Study||13
223532|NCT00246337|532386|P7|Completed Period (Both Doses)|Overall Study||16
223533|NCT00246337|532387|P6|Completed Period (Both Doses)|Overall Study||10
223534|NCT00246337|532388|P5|Completed Period (Both Doses)|Overall Study||4
223535|NCT00246337|532389|P4|Completed Period (Both Doses)|Overall Study||11
223536|NCT00246337|532390|P3|Completed Period (Both Doses)|Overall Study||6
223537|NCT00246337|532391|P2|Completed Period (Both Doses)|Overall Study||10
223538|NCT00246337|532392|P1|Completed Period (Both Doses)|Overall Study||69
223539|NCT00246337|532384|P9|Completed Period (Initial Dose)|Overall Study||19
223540|NCT00246337|532385|P8|Completed Period (Initial Dose)|Overall Study||27
223541|NCT00246337|532386|P7|Completed Period (Initial Dose)|Overall Study||29
223542|NCT00246337|532387|P6|Completed Period (Initial Dose)|Overall Study||29
223543|NCT00246337|532388|P5|Completed Period (Initial Dose)|Overall Study||8
223544|NCT00246337|532389|P4|Completed Period (Initial Dose)|Overall Study||5
223545|NCT00246337|532390|P3|Completed Period (Initial Dose)|Overall Study||9
223546|NCT00246337|532391|P2|Completed Period (Initial Dose)|Overall Study||4
223547|NCT00246337|532392|P1|Completed Period (Initial Dose)|Overall Study||46
223548|NCT00246337|532384|P9|STARTED|Overall Study||45
223549|NCT00246337|532385|P8|STARTED|Overall Study||53
223550|NCT00246337|532386|P7|STARTED|Overall Study||54
223551|NCT00246337|532387|P6|STARTED|Overall Study||54
223552|NCT00246337|532388|P5|STARTED|Overall Study||16
223553|NCT00246337|532389|P4|STARTED|Overall Study||17
223554|NCT00246337|532390|P3|STARTED|Overall Study||18
223555|NCT00246337|532391|P2|STARTED|Overall Study||16
223556|NCT00246337|532392|P1|STARTED|Overall Study||147
223557|NCT00246324|532439|P1|NOT COMPLETED|Overall Study||1
223558|NCT00246324|532439|P1|COMPLETED|Overall Study||15
223559|NCT00246324|532439|P1|STARTED|Overall Study||16
223560|NCT00246259|532446|P2|NOT COMPLETED|Overall Study||26
223561|NCT00246259|532447|P1|NOT COMPLETED|Overall Study||28
223562|NCT00246259|532446|P2|COMPLETED|Overall Study||15
223563|NCT00246259|532447|P1|COMPLETED|Overall Study||16
223564|NCT00246259|532446|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
223565|NCT00246259|532447|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
223566|NCT00246259|532446|P2|STARTED|Overall Study||41
223567|NCT00246259|532447|P1|STARTED|Overall Study||44
223568|NCT00246090|532481|P1|NOT COMPLETED|Overall Study||295
223569|NCT00246090|532481|P1|COMPLETED|Overall Study||3
223570|NCT00246090|532481|P1|STARTED|Overall Study||298
223571|NCT00246025|532490|P4|NOT COMPLETED|Overall Study||13
223572|NCT00246025|532491|P3|NOT COMPLETED|Overall Study||10
223573|NCT00246025|532492|P2|NOT COMPLETED|Overall Study||9
223574|NCT00246025|532493|P1|NOT COMPLETED|Overall Study||10
223575|NCT00246025|532490|P4|COMPLETED|Overall Study||116
223576|NCT00246025|532491|P3|COMPLETED|Overall Study||116
223577|NCT00246025|532492|P2|COMPLETED|Overall Study||124
223578|NCT00246025|532493|P1|COMPLETED|Overall Study||114
223579|NCT00246025|532490|P4|STARTED|Overall Study||129
223580|NCT00246025|532491|P3|STARTED|Overall Study||126
223581|NCT00246025|532492|P2|STARTED|Overall Study||133
223582|NCT00246025|532493|P1|STARTED|Overall Study||124
223583|NCT00246012|532552|P9|NOT COMPLETED|Overall Study||28
223584|NCT00246012|532553|P8|NOT COMPLETED|Overall Study||28
223585|NCT00246012|532554|P7|NOT COMPLETED|Overall Study||31
223586|NCT00246012|532555|P6|NOT COMPLETED|Overall Study||28
223587|NCT00246012|532556|P5|NOT COMPLETED|Overall Study||3
223588|NCT00246012|532557|P4|NOT COMPLETED|Overall Study||3
223589|NCT00246012|532558|P3|NOT COMPLETED|Overall Study||2
223590|NCT00246012|532559|P2|NOT COMPLETED|Overall Study||1
223591|NCT00246012|532560|P1|NOT COMPLETED|Overall Study||3
223592|NCT00246012|532552|P9|COMPLETED|Overall Study||4
223593|NCT00246012|532553|P8|COMPLETED|Overall Study||5
223594|NCT00246012|532554|P7|COMPLETED|Overall Study||1
223595|NCT00246012|532555|P6|COMPLETED|Overall Study||4
223596|NCT00246012|532556|P5|COMPLETED|Overall Study||0
223597|NCT00246012|532557|P4|COMPLETED|Overall Study||0
223598|NCT00246012|532558|P3|COMPLETED|Overall Study||1
223599|NCT00246012|532559|P2|COMPLETED|Overall Study||2
223600|NCT00246012|532560|P1|COMPLETED|Overall Study||0
223601|NCT00246012|532552|P9|Treated|Overall Study||32
223602|NCT00246012|532553|P8|Treated|Overall Study||33
223603|NCT00246012|532554|P7|Treated|Overall Study||31
223604|NCT00246012|532555|P6|Treated|Overall Study||31
223605|NCT00246012|532556|P5|Treated|Overall Study||3
223606|NCT00246012|532557|P4|Treated|Overall Study||3
223607|NCT00246012|532558|P3|Treated|Overall Study||3
223608|NCT00246012|532559|P2|Treated|Overall Study||3
223609|NCT00246012|532560|P1|Treated|Overall Study||3
223610|NCT00246012|532552|P9|STARTED|Overall Study||32
223611|NCT00246012|532553|P8|STARTED|Overall Study||33
223612|NCT00246012|532554|P7|STARTED|Overall Study||32
223613|NCT00246012|532555|P6|STARTED|Overall Study||32
223614|NCT00246012|532556|P5|STARTED|Overall Study||3
223615|NCT00246012|532557|P4|STARTED|Overall Study||3
223616|NCT00246012|532558|P3|STARTED|Overall Study||3
223617|NCT00246012|532559|P2|STARTED|Overall Study||3
223618|NCT00246012|532560|P1|STARTED|Overall Study||3
223619|NCT00245960|532655|P2|NOT COMPLETED|Overall Study||28
223620|NCT00245960|532656|P1|NOT COMPLETED|Overall Study||29
223621|NCT00245960|532655|P2|COMPLETED|Overall Study||345
223622|NCT00245960|532656|P1|COMPLETED|Overall Study||350
223623|NCT00245960|532655|P2|STARTED|Overall Study||373
223624|NCT00245960|532656|P1|STARTED|Overall Study||379
223625|NCT00245856|532664|P2|NOT COMPLETED|Period Two||1
223626|NCT00245856|532665|P1|NOT COMPLETED|Period Two||0
223627|NCT00245856|532664|P2|COMPLETED|Period Two||38
223628|NCT00245856|532665|P1|COMPLETED|Period Two||0
223629|NCT00245856|532664|P2|STARTED|Period Two||39
223630|NCT00245856|532665|P1|STARTED|Period Two||0
223631|NCT00245856|532664|P2|NOT COMPLETED|Period One||0
223632|NCT00245856|532665|P1|NOT COMPLETED|Period One||0
223633|NCT00245856|532664|P2|COMPLETED|Period One||0
223634|NCT00245856|532665|P1|COMPLETED|Period One||28
223635|NCT00245856|532664|P2|STARTED|Period One||0
223636|NCT00245856|532665|P1|STARTED|Period One||28
223637|NCT00245635|532674|P2|NOT COMPLETED|Overall Study||0
223638|NCT00245635|532675|P1|NOT COMPLETED|Overall Study||0
223639|NCT00245635|532674|P2|COMPLETED|Overall Study||18
223640|NCT00245635|532675|P1|COMPLETED|Overall Study||25
223641|NCT00245635|532674|P2|STARTED|Overall Study||18
223642|NCT00245635|532675|P1|STARTED|Overall Study||25
223643|NCT00245570|532681|P6|NOT COMPLETED|Treatment Period IV||0
223644|NCT00245570|532682|P5|NOT COMPLETED|Treatment Period IV||0
223645|NCT00245570|532683|P4|NOT COMPLETED|Treatment Period IV||0
223646|NCT00245570|532684|P3|NOT COMPLETED|Treatment Period IV||0
223647|NCT00245570|532685|P2|NOT COMPLETED|Treatment Period IV||0
223648|NCT00245570|532686|P1|NOT COMPLETED|Treatment Period IV||0
223649|NCT00245570|532681|P6|COMPLETED|Treatment Period IV||8
223650|NCT00245570|532682|P5|COMPLETED|Treatment Period IV||8
223651|NCT00245570|532683|P4|COMPLETED|Treatment Period IV||8
223652|NCT00245570|532684|P3|COMPLETED|Treatment Period IV||8
223653|NCT00245570|532685|P2|COMPLETED|Treatment Period IV||7
223654|NCT00245570|532686|P1|COMPLETED|Treatment Period IV||7
223655|NCT00245570|532681|P6|STARTED|Treatment Period IV||8
223656|NCT00245570|532682|P5|STARTED|Treatment Period IV||8
223657|NCT00245570|532683|P4|STARTED|Treatment Period IV||8
223658|NCT00245570|532684|P3|STARTED|Treatment Period IV||8
223659|NCT00245570|532685|P2|STARTED|Treatment Period IV||7
223660|NCT00245570|532686|P1|STARTED|Treatment Period IV||7
223661|NCT00245570|532681|P6|NOT COMPLETED|Washout Between Periods III and IV||0
223662|NCT00245570|532682|P5|NOT COMPLETED|Washout Between Periods III and IV||0
223663|NCT00245570|532683|P4|NOT COMPLETED|Washout Between Periods III and IV||0
223664|NCT00245570|532684|P3|NOT COMPLETED|Washout Between Periods III and IV||0
223665|NCT00245570|532685|P2|NOT COMPLETED|Washout Between Periods III and IV||1
223666|NCT00245570|532686|P1|NOT COMPLETED|Washout Between Periods III and IV||0
223667|NCT00245570|532681|P6|COMPLETED|Washout Between Periods III and IV||8
223668|NCT00245570|532682|P5|COMPLETED|Washout Between Periods III and IV||8
223669|NCT00245570|532683|P4|COMPLETED|Washout Between Periods III and IV||8
223670|NCT00245570|532684|P3|COMPLETED|Washout Between Periods III and IV||8
223671|NCT00245570|532685|P2|COMPLETED|Washout Between Periods III and IV||7
223672|NCT00245570|532686|P1|COMPLETED|Washout Between Periods III and IV||7
223673|NCT00245570|532681|P6|STARTED|Washout Between Periods III and IV||8
223674|NCT00245570|532682|P5|STARTED|Washout Between Periods III and IV||8
223675|NCT00245570|532683|P4|STARTED|Washout Between Periods III and IV||8
223676|NCT00245570|532684|P3|STARTED|Washout Between Periods III and IV||8
223677|NCT00245570|532685|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
223678|NCT00245570|532686|P1|STARTED|Washout Between Periods III and IV||7
223679|NCT00245570|532681|P6|NOT COMPLETED|Treatment Period III||0
223680|NCT00245570|532682|P5|NOT COMPLETED|Treatment Period III||0
223681|NCT00245570|532683|P4|NOT COMPLETED|Treatment Period III||0
223682|NCT00245570|532684|P3|NOT COMPLETED|Treatment Period III||0
223683|NCT00245570|532685|P2|NOT COMPLETED|Treatment Period III||0
223684|NCT00245570|532686|P1|NOT COMPLETED|Treatment Period III||0
223685|NCT00245570|532681|P6|COMPLETED|Treatment Period III||8
223686|NCT00245570|532682|P5|COMPLETED|Treatment Period III||8
223687|NCT00245570|532683|P4|COMPLETED|Treatment Period III||8
223688|NCT00245570|532684|P3|COMPLETED|Treatment Period III||8
223689|NCT00245570|532685|P2|COMPLETED|Treatment Period III||8
223690|NCT00245570|532686|P1|COMPLETED|Treatment Period III||7
223691|NCT00245570|532681|P6|STARTED|Treatment Period III||8
223692|NCT00245570|532682|P5|STARTED|Treatment Period III||8
223693|NCT00245570|532683|P4|STARTED|Treatment Period III||8
223694|NCT00245570|532684|P3|STARTED|Treatment Period III||8
223695|NCT00245570|532685|P2|STARTED|Treatment Period III||8
223696|NCT00245570|532686|P1|STARTED|Treatment Period III||7
223697|NCT00245570|532681|P6|NOT COMPLETED|Washout Between Periods II and III||0
223698|NCT00245570|532682|P5|NOT COMPLETED|Washout Between Periods II and III||0
223699|NCT00245570|532683|P4|NOT COMPLETED|Washout Between Periods II and III||0
223700|NCT00245570|532684|P3|NOT COMPLETED|Washout Between Periods II and III||0
223701|NCT00245570|532685|P2|NOT COMPLETED|Washout Between Periods II and III||0
223702|NCT00245570|532686|P1|NOT COMPLETED|Washout Between Periods II and III||0
223703|NCT00245570|532681|P6|COMPLETED|Washout Between Periods II and III||8
223704|NCT00245570|532682|P5|COMPLETED|Washout Between Periods II and III||8
223705|NCT00245570|532683|P4|COMPLETED|Washout Between Periods II and III||8
223706|NCT00245570|532684|P3|COMPLETED|Washout Between Periods II and III||8
223707|NCT00245570|532685|P2|COMPLETED|Washout Between Periods II and III||8
223708|NCT00245570|532686|P1|COMPLETED|Washout Between Periods II and III||7
223709|NCT00245570|532681|P6|STARTED|Washout Between Periods II and III||8
223710|NCT00245570|532682|P5|STARTED|Washout Between Periods II and III||8
223711|NCT00245570|532683|P4|STARTED|Washout Between Periods II and III||8
223712|NCT00245570|532684|P3|STARTED|Washout Between Periods II and III||8
223713|NCT00245570|532685|P2|STARTED|Washout Between Periods II and III||8
223714|NCT00245570|532686|P1|STARTED|Washout Between Periods II and III||7
223715|NCT00245570|532681|P6|NOT COMPLETED|Treatment Period II||0
223716|NCT00245570|532682|P5|NOT COMPLETED|Treatment Period II||0
223717|NCT00245570|532683|P4|NOT COMPLETED|Treatment Period II||0
223718|NCT00245570|532684|P3|NOT COMPLETED|Treatment Period II||0
223719|NCT00245570|532685|P2|NOT COMPLETED|Treatment Period II||0
223720|NCT00245570|532686|P1|NOT COMPLETED|Treatment Period II||0
223721|NCT00245570|532681|P6|COMPLETED|Treatment Period II||8
223722|NCT00245570|532682|P5|COMPLETED|Treatment Period II||8
223723|NCT00245570|532683|P4|COMPLETED|Treatment Period II||8
223724|NCT00245570|532684|P3|COMPLETED|Treatment Period II||8
223725|NCT00245570|532685|P2|COMPLETED|Treatment Period II||8
223726|NCT00245570|532686|P1|COMPLETED|Treatment Period II||7
223727|NCT00245570|532681|P6|STARTED|Treatment Period II||8
223728|NCT00245570|532682|P5|STARTED|Treatment Period II||8
223729|NCT00245570|532683|P4|STARTED|Treatment Period II||8
223730|NCT00245570|532684|P3|STARTED|Treatment Period II||8
223731|NCT00245570|532685|P2|STARTED|Treatment Period II||8
223732|NCT00245570|532686|P1|STARTED|Treatment Period II||7
223733|NCT00245557|532732|P2|NOT COMPLETED|Overall Study||16
223734|NCT00245557|532733|P1|NOT COMPLETED|Overall Study||6
223735|NCT00245557|532732|P2|COMPLETED|Overall Study||10
223736|NCT00245557|532733|P1|COMPLETED|Overall Study||11
223737|NCT00245557|532732|P2|STARTED|Overall Study||26
223738|NCT00245557|532733|P1|STARTED|Overall Study||17
223739|NCT00245466|532742|P3|NOT COMPLETED|Overall Study||37
223740|NCT00245466|532743|P2|NOT COMPLETED|Overall Study||44
223741|NCT00245466|532744|P1|NOT COMPLETED|Overall Study||36
223742|NCT00245466|532742|P3|COMPLETED|Overall Study||3
223743|NCT00245466|532743|P2|COMPLETED|Overall Study||2
223744|NCT00245466|532744|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
223745|NCT00245466|532742|P3|Started FE200486 CS02A|Overall Study||26
223746|NCT00245466|532743|P2|Started FE200486 CS02A|Overall Study||30
223747|NCT00245466|532744|P1|Started FE200486 CS02A|Overall Study||32
223748|NCT00245466|532742|P3|STARTED|Overall Study||40
223749|NCT00245466|532743|P2|STARTED|Overall Study||46
223750|NCT00245466|532744|P1|STARTED|Overall Study||43
223751|NCT00245219|532761|P3|NOT COMPLETED|Overall Study||2
223752|NCT00245219|532762|P2|NOT COMPLETED|Overall Study||6
223753|NCT00245219|532763|P1|NOT COMPLETED|Overall Study||6
223754|NCT00245219|532761|P3|COMPLETED|Overall Study||58
223755|NCT00245219|532762|P2|COMPLETED|Overall Study||88
223756|NCT00245219|532763|P1|COMPLETED|Overall Study||85
223757|NCT00245219|532761|P3|STARTED|Overall Study||60
223758|NCT00245219|532762|P2|STARTED|Overall Study||94
223759|NCT00245219|532763|P1|STARTED|Overall Study||91
223760|NCT00245128|532777|P1|NOT COMPLETED|Overall Study||10
223761|NCT00245128|532777|P1|COMPLETED|Overall Study||0
223762|NCT00245128|532777|P1|STARTED|Overall Study||10
223763|NCT00245102|532787|P6|NOT COMPLETED|Overall Study||4
223764|NCT00245102|532788|P5|NOT COMPLETED|Overall Study||0
223765|NCT00245102|532789|P4|NOT COMPLETED|Overall Study||3
223766|NCT00245102|532790|P3|NOT COMPLETED|Overall Study||7
223767|NCT00245102|532791|P2|NOT COMPLETED|Overall Study||4
223768|NCT00245102|532792|P1|NOT COMPLETED|Overall Study||7
223769|NCT00245102|532787|P6|COMPLETED|Overall Study||19
223770|NCT00245102|532788|P5|COMPLETED|Overall Study||5
223771|NCT00245102|532789|P4|COMPLETED|Overall Study||10
223772|NCT00245102|532790|P3|COMPLETED|Overall Study||39
223773|NCT00245102|532791|P2|COMPLETED|Overall Study||12
223774|NCT00245102|532792|P1|COMPLETED|Overall Study||37
223775|NCT00245102|532787|P6|STARTED|Overall Study||23
223776|NCT00245102|532788|P5|STARTED|Overall Study||5
223777|NCT00245102|532789|P4|STARTED|Overall Study||13
223778|NCT00245102|532790|P3|STARTED|Overall Study||46
223779|NCT00245102|532791|P2|STARTED|Overall Study||16
223780|NCT00245102|532792|P1|STARTED|Overall Study||44
223781|NCT00245063|532808|P2|NOT COMPLETED|Overall Study||5
223782|NCT00245063|532809|P1|NOT COMPLETED|Overall Study||7
223783|NCT00245063|532808|P2|COMPLETED|Overall Study||8
223784|NCT00245063|532809|P1|COMPLETED|Overall Study||5
223785|NCT00245063|532808|P2|STARTED|Overall Study||13
223786|NCT00245063|532809|P1|STARTED|Overall Study||12
223787|NCT00245050|532817|P2|NOT COMPLETED|Overall Study||2
223788|NCT00245050|532818|P1|NOT COMPLETED|Overall Study||3
223789|NCT00245050|532817|P2|COMPLETED|Overall Study||14
223790|NCT00245050|532818|P1|COMPLETED|Overall Study||15
223791|NCT00245050|532817|P2|STARTED|Overall Study||16
223792|NCT00245050|532818|P1|STARTED|Overall Study||18
223793|NCT00245011|532826|P1|NOT COMPLETED|Overall Study||1
223794|NCT00245011|532826|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
223795|NCT00245011|532826|P1|STARTED|Overall Study||11
223796|NCT00244933|532830|P1|NOT COMPLETED|Overall Study||2
223797|NCT00244933|532830|P1|COMPLETED|Overall Study||17
223798|NCT00244933|532830|P1|STARTED|Overall Study||19
223799|NCT00244881|532834|P1|NOT COMPLETED|Overall Study||3
223800|NCT00244881|532834|P1|COMPLETED|Overall Study||23
223801|NCT00244881|532834|P1|STARTED|Overall Study||26
223802|NCT00244764|532840|P1|NOT COMPLETED|Overall Study||96
223803|NCT00244764|532840|P1|COMPLETED|Overall Study||129
223804|NCT00244764|532840|P1|STARTED|Overall Study||225
223805|NCT00244712|532849|P2|NOT COMPLETED|Overall Study||124
223806|NCT00244712|532850|P1|NOT COMPLETED|Overall Study||109
223807|NCT00244712|532849|P2|COMPLETED|Overall Study||221
223808|NCT00244712|532850|P1|COMPLETED|Overall Study||234
223809|NCT00244712|532849|P2|STARTED|Overall Study||345
223810|NCT00244712|532850|P1|STARTED|Overall Study||343
223811|NCT00244621|532885|P3|NOT COMPLETED|Open-label Treatment Period||2
223812|NCT00244621|532886|P2|NOT COMPLETED|Open-label Treatment Period||1
223813|NCT00244621|532887|P1|NOT COMPLETED|Open-label Treatment Period||1
223814|NCT00244621|532885|P3|COMPLETED|Open-label Treatment Period||28
223815|NCT00244621|532886|P2|COMPLETED|Open-label Treatment Period||28
223816|NCT00244621|532887|P1|COMPLETED|Open-label Treatment Period||25
223817|NCT00244621|532885|P3|STARTED|Open-label Treatment Period||30
223818|NCT00244621|532886|P2|STARTED|Open-label Treatment Period||29
223819|NCT00244621|532887|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
223820|NCT00244621|532885|P3|NOT COMPLETED|Double-blind Treatment Period||2
223821|NCT00244621|532886|P2|NOT COMPLETED|Double-blind Treatment Period||3
223822|NCT00244621|532887|P1|NOT COMPLETED|Double-blind Treatment Period||2
223823|NCT00244621|532885|P3|COMPLETED|Double-blind Treatment Period||30
223824|NCT00244621|532886|P2|COMPLETED|Double-blind Treatment Period||29
223825|NCT00244621|532887|P1|COMPLETED|Double-blind Treatment Period||27
223826|NCT00244621|532885|P3|STARTED|Double-blind Treatment Period||32
223827|NCT00244621|532886|P2|STARTED|Double-blind Treatment Period||32
223828|NCT00244621|532887|P1|STARTED|Double-blind Treatment Period||29
223829|NCT00244374|532904|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
223830|NCT00244374|532905|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
223831|NCT00244374|532906|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
223832|NCT00244374|532907|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
223833|NCT00244374|532908|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
223834|NCT00244374|532904|P5|COMPLETED|Vaccine Adherence Cohort||41
223835|NCT00244374|532905|P4|COMPLETED|Vaccine Adherence Cohort||36
223836|NCT00244374|532906|P3|COMPLETED|Vaccine Adherence Cohort||43
223837|NCT00244374|532907|P2|COMPLETED|Vaccine Adherence Cohort||47
223838|NCT00244374|532908|P1|COMPLETED|Vaccine Adherence Cohort||0
223839|NCT00244374|532904|P5|STARTED|Vaccine Adherence Cohort||41
223840|NCT00244374|532905|P4|STARTED|Vaccine Adherence Cohort||36
223841|NCT00244374|532906|P3|STARTED|Vaccine Adherence Cohort||43
223842|NCT00244374|532907|P2|STARTED|Vaccine Adherence Cohort||47
223843|NCT00244374|532908|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
223844|NCT00244374|532904|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223845|NCT00244374|532905|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223846|NCT00244374|532906|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223847|NCT00244374|532907|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223848|NCT00244374|532908|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
223849|NCT00244374|532904|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223850|NCT00244374|532905|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223851|NCT00244374|532906|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223852|NCT00244374|532907|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
223853|NCT00244374|532908|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
223854|NCT00244374|532904|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
223855|NCT00244374|532905|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
223856|NCT00244374|532906|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
223857|NCT00244374|532907|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
223858|NCT00244374|532908|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
223859|NCT00244374|532904|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
223860|NCT00244374|532905|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
223861|NCT00244374|532906|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
223862|NCT00244374|532907|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
223863|NCT00244374|532908|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
223864|NCT00244374|532904|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
223865|NCT00244374|532905|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
223866|NCT00244374|532906|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
223867|NCT00244374|532907|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
223868|NCT00244374|532908|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
223869|NCT00244374|532904|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
223870|NCT00244374|532905|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
223871|NCT00244374|532906|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
223872|NCT00244374|532907|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
223873|NCT00244374|532908|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
223874|NCT00244374|532904|P5|STARTED|Pre-Randomization Cross-sectional Study||0
223875|NCT00244374|532905|P4|STARTED|Pre-Randomization Cross-sectional Study||0
223876|NCT00244374|532906|P3|STARTED|Pre-Randomization Cross-sectional Study||0
223877|NCT00244374|532907|P2|STARTED|Pre-Randomization Cross-sectional Study||0
223878|NCT00244374|532908|P1|STARTED|Pre-Randomization Cross-sectional Study||546
223879|NCT00244140|532926|P2|NOT COMPLETED|Overall Study||0
223880|NCT00244140|532927|P1|NOT COMPLETED|Overall Study||0
223881|NCT00244140|532926|P2|COMPLETED|Overall Study||22
223882|NCT00244140|532927|P1|COMPLETED|Overall Study||412
223883|NCT00244140|532926|P2|STARTED|Overall Study||22
223884|NCT00244140|532927|P1|STARTED|Overall Study||412
223885|NCT00244101|532942|P3|NOT COMPLETED|Overall Study||0
223886|NCT00244101|532943|P2|NOT COMPLETED|Overall Study||0
223887|NCT00244101|532944|P1|NOT COMPLETED|Overall Study||0
223888|NCT00244101|532942|P3|COMPLETED|Overall Study||216
223889|NCT00244101|532943|P2|COMPLETED|Overall Study||223
223890|NCT00244101|532944|P1|COMPLETED|Overall Study||209
223891|NCT00244101|532942|P3|STARTED|Overall Study||216
223892|NCT00244101|532943|P2|STARTED|Overall Study||223
223893|NCT00244101|532944|P1|STARTED|Overall Study||209
223894|NCT00244010|532954|P2|NOT COMPLETED|Overall Study||0
223895|NCT00244010|532955|P1|NOT COMPLETED|Overall Study||0
223896|NCT00244010|532954|P2|COMPLETED|Overall Study||2
223897|NCT00244010|532955|P1|COMPLETED|Overall Study||2
223898|NCT00244010|532954|P2|STARTED|Overall Study||2
223899|NCT00244010|532955|P1|STARTED|Overall Study||2
223900|NCT00243932|532964|P3|NOT COMPLETED|Stage 2: Efficacy||0
223901|NCT00243932|532965|P2|NOT COMPLETED|Stage 2: Efficacy||0
223902|NCT00243932|532966|P1|NOT COMPLETED|Stage 2: Efficacy||0
223903|NCT00243932|532964|P3|COMPLETED|Stage 2: Efficacy||0
223904|NCT00243932|532965|P2|COMPLETED|Stage 2: Efficacy||40
223905|NCT00243932|532966|P1|COMPLETED|Stage 2: Efficacy||40
223906|NCT00243932|532964|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
223907|NCT00243932|532965|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
223908|NCT00243932|532966|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
223909|NCT00243932|532964|P3|NOT COMPLETED|Stage 1: Dose Selection||0
223910|NCT00243932|532965|P2|NOT COMPLETED|Stage 1: Dose Selection||0
223911|NCT00243932|532966|P1|NOT COMPLETED|Stage 1: Dose Selection||2
223912|NCT00243932|532964|P3|COMPLETED|Stage 1: Dose Selection||35
223913|NCT00243932|532965|P2|COMPLETED|Stage 1: Dose Selection||35
223914|NCT00243932|532966|P1|COMPLETED|Stage 1: Dose Selection||33
223915|NCT00243932|532964|P3|STARTED|Stage 1: Dose Selection||35
223916|NCT00243932|532965|P2|STARTED|Stage 1: Dose Selection||35
223917|NCT00243932|532966|P1|STARTED|Stage 1: Dose Selection||35
223918|NCT00243919|532977|P3|NOT COMPLETED|Overall Study||11
223919|NCT00243919|532978|P2|NOT COMPLETED|Overall Study||18
223920|NCT00243919|532979|P1|NOT COMPLETED|Overall Study||17
223921|NCT00243919|532977|P3|COMPLETED|Overall Study||115
223922|NCT00243919|532978|P2|COMPLETED|Overall Study||125
223923|NCT00243919|532979|P1|COMPLETED|Overall Study||122
223924|NCT00243919|532977|P3|STARTED|Overall Study||126
223925|NCT00243919|532978|P2|STARTED|Overall Study||143
223926|NCT00243919|532979|P1|STARTED|Overall Study||139
223927|NCT00243659|533022|P2|NOT COMPLETED|Overall Study||3
223928|NCT00243659|533023|P1|NOT COMPLETED|Overall Study||2
223929|NCT00243659|533022|P2|COMPLETED|Overall Study||5
223930|NCT00243659|533023|P1|COMPLETED|Overall Study||20
223931|NCT00243659|533022|P2|STARTED|Overall Study||8
223932|NCT00243659|533023|P1|STARTED|Overall Study||22
223933|NCT00243503|533031|P1|NOT COMPLETED|Overall Study||58
223934|NCT00243503|533031|P1|COMPLETED|Overall Study||2
223935|NCT00243503|533031|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
223936|NCT00243412|533048|P2|NOT COMPLETED|Overall Study||11
223937|NCT00243412|533049|P1|NOT COMPLETED|Overall Study||10
223938|NCT00243412|533048|P2|COMPLETED|Overall Study|Completed Week 104|10
223939|NCT00243412|533049|P1|COMPLETED|Overall Study|Completed Week 104|11
223940|NCT00243412|533048|P2|Safety Evaluable|Overall Study||20
223941|NCT00243412|533049|P1|Safety Evaluable|Overall Study||21
223942|NCT00243412|533048|P2|STARTED|Overall Study|Intent to treat|21
223943|NCT00243412|533049|P1|STARTED|Overall Study|Intent to treat|21
223944|NCT00243386|533075|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
223945|NCT00243386|533076|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
223946|NCT00243386|533077|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
223947|NCT00243386|533075|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
223948|NCT00243386|533076|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
223949|NCT00243386|533077|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
223950|NCT00243386|533075|P3|STARTED|PK-Driven or Standard Prophylaxis||32
223951|NCT00243386|533076|P2|STARTED|PK-Driven or Standard Prophylaxis||34
223952|NCT00243386|533077|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
223953|NCT00243386|533075|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
223954|NCT00243386|533076|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
223955|NCT00243386|533077|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
223956|NCT00243386|533075|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
223957|NCT00243386|533076|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
223958|NCT00243386|533077|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
223959|NCT00243386|533075|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
223960|NCT00243386|533076|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
223961|NCT00243386|533077|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
223962|NCT00243386|533075|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
223963|NCT00243386|533076|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
223964|NCT00243386|533077|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
223965|NCT00243386|533075|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
223966|NCT00243386|533076|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
223967|NCT00243386|533077|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
223968|NCT00243386|533075|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
223969|NCT00243386|533076|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
223970|NCT00243386|533077|P1|STARTED|On-Demand Regimen (Study Part 1)||73
223971|NCT00243347|533142|P1|NOT COMPLETED|Overall Study||19
223972|NCT00243347|533142|P1|COMPLETED|Overall Study|Completed study|0
223973|NCT00243347|533142|P1|STARTED|Overall Study|Treated|19
223974|NCT00243269|533151|P4|NOT COMPLETED|Overall Study||4
223975|NCT00243269|533152|P3|NOT COMPLETED|Overall Study||1
223976|NCT00243269|533153|P2|NOT COMPLETED|Overall Study||1
223977|NCT00243269|533154|P1|NOT COMPLETED|Overall Study||3
223978|NCT00243269|533151|P4|COMPLETED|Overall Study||25
223979|NCT00243269|533152|P3|COMPLETED|Overall Study||11
223980|NCT00243269|533153|P2|COMPLETED|Overall Study||10
223981|NCT00243269|533154|P1|COMPLETED|Overall Study||28
223982|NCT00243269|533151|P4|STARTED|Overall Study||29
223983|NCT00243269|533152|P3|STARTED|Overall Study||12
223984|NCT00243269|533153|P2|STARTED|Overall Study||11
223985|NCT00243269|533154|P1|STARTED|Overall Study||31
223986|NCT00243243|533170|P2|NOT COMPLETED|Overall Study||0
223987|NCT00243243|533171|P1|NOT COMPLETED|Overall Study||0
223988|NCT00243243|533170|P2|COMPLETED|Overall Study||10
223989|NCT00243243|533171|P1|COMPLETED|Overall Study||10
223990|NCT00243243|533170|P2|STARTED|Overall Study||10
223991|NCT00243243|533171|P1|STARTED|Overall Study||10
223992|NCT00243191|533177|P1|NOT COMPLETED|Overall Study||0
223993|NCT00243191|533177|P1|COMPLETED|Overall Study||18
223994|NCT00243191|533177|P1|STARTED|Overall Study||18
223995|NCT00243074|533181|P1|NOT COMPLETED|Overall Study||54
223996|NCT00243074|533181|P1|COMPLETED|Overall Study||0
223997|NCT00243074|533181|P1|STARTED|Overall Study||54
223998|NCT00243061|533190|P1|NOT COMPLETED|Overall Study||0
223999|NCT00243061|533190|P1|COMPLETED|Overall Study||24
224000|NCT00243061|533190|P1|STARTED|Overall Study||24
224001|NCT00243022|533201|P2|NOT COMPLETED|Overall Study||1
224002|NCT00243022|533202|P1|NOT COMPLETED|Overall Study||2
224003|NCT00243022|533201|P2|COMPLETED|Overall Study||4
224004|NCT00243022|533202|P1|COMPLETED|Overall Study||5
224005|NCT00243022|533201|P2|STARTED|Overall Study||5
224006|NCT00243022|533202|P1|STARTED|Overall Study||7
224007|NCT00242710|533224|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
224008|NCT00242710|533225|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
224009|NCT00242710|533226|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
224010|NCT00242710|533227|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
224011|NCT00242710|533224|P4|COMPLETED|Study Extension (up to Year 2)||84
224012|NCT00242710|533225|P3|COMPLETED|Study Extension (up to Year 2)||69
224013|NCT00242710|533226|P2|COMPLETED|Study Extension (up to Year 2)||148
224014|NCT00242710|533227|P1|COMPLETED|Study Extension (up to Year 2)||141
224015|NCT00242710|533224|P4|STARTED|Study Extension (up to Year 2)||94
224016|NCT00242710|533225|P3|STARTED|Study Extension (up to Year 2)||84
224017|NCT00242710|533226|P2|STARTED|Study Extension (up to Year 2)||177
224018|NCT00242710|533227|P1|STARTED|Study Extension (up to Year 2)||168
224019|NCT00242710|533224|P4|NOT COMPLETED|Period Between Core Study and Extension||49
224020|NCT00242710|533225|P3|NOT COMPLETED|Period Between Core Study and Extension||48
224021|NCT00242710|533226|P2|NOT COMPLETED|Period Between Core Study and Extension||112
224022|NCT00242710|533227|P1|NOT COMPLETED|Period Between Core Study and Extension||119
224112|NCT00241644|533410|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
224023|NCT00242710|533224|P4|COMPLETED|Period Between Core Study and Extension||94
224024|NCT00242710|533225|P3|COMPLETED|Period Between Core Study and Extension||84
224025|NCT00242710|533226|P2|COMPLETED|Period Between Core Study and Extension||177
224026|NCT00242710|533227|P1|COMPLETED|Period Between Core Study and Extension||168
224027|NCT00242710|533224|P4|STARTED|Period Between Core Study and Extension||143
224028|NCT00242710|533225|P3|STARTED|Period Between Core Study and Extension||132
224029|NCT00242710|533226|P2|STARTED|Period Between Core Study and Extension||289
224030|NCT00242710|533227|P1|STARTED|Period Between Core Study and Extension||287
224031|NCT00242710|533224|P4|NOT COMPLETED|Core Study (up to Year 1)||31
224032|NCT00242710|533225|P3|NOT COMPLETED|Core Study (up to Year 1)||51
224033|NCT00242710|533226|P2|NOT COMPLETED|Core Study (up to Year 1)||64
224034|NCT00242710|533227|P1|NOT COMPLETED|Core Study (up to Year 1)||86
224035|NCT00242710|533224|P4|COMPLETED|Core Study (up to Year 1)||143
224036|NCT00242710|533225|P3|COMPLETED|Core Study (up to Year 1)||132
224037|NCT00242710|533226|P2|COMPLETED|Core Study (up to Year 1)||289
224038|NCT00242710|533227|P1|COMPLETED|Core Study (up to Year 1)||287
224039|NCT00242710|533224|P4|Treated|Core Study (up to Year 1)||172
224040|NCT00242710|533225|P3|Treated|Core Study (up to Year 1)||179
224041|NCT00242710|533226|P2|Treated|Core Study (up to Year 1)||349
224042|NCT00242710|533227|P1|Treated|Core Study (up to Year 1)||361
224043|NCT00242710|533224|P4|STARTED|Core Study (up to Year 1)||174
224044|NCT00242710|533225|P3|STARTED|Core Study (up to Year 1)||183
224045|NCT00242710|533226|P2|STARTED|Core Study (up to Year 1)||353
224046|NCT00242710|533227|P1|STARTED|Core Study (up to Year 1)||373
224047|NCT00242684|533277|P1|NOT COMPLETED|Overall Study||0
224048|NCT00242684|533277|P1|COMPLETED|Overall Study||446
224049|NCT00242684|533277|P1|STARTED|Overall Study||446
224050|NCT00242658|533284|P2|NOT COMPLETED|Overall Study||19
224051|NCT00242658|533285|P1|NOT COMPLETED|Overall Study||22
224052|NCT00242658|533284|P2|COMPLETED|Overall Study||188
224053|NCT00242658|533285|P1|COMPLETED|Overall Study||165
224054|NCT00242658|533284|P2|STARTED|Overall Study||207
224055|NCT00242658|533285|P1|STARTED|Overall Study||187
224056|NCT00242619|533295|P2|NOT COMPLETED|Overall Study||0
224057|NCT00242619|533296|P1|NOT COMPLETED|Overall Study||0
224058|NCT00242619|533295|P2|COMPLETED|Overall Study||4
224059|NCT00242619|533296|P1|COMPLETED|Overall Study||8
224060|NCT00242619|533295|P2|STARTED|Overall Study||4
224061|NCT00242619|533296|P1|STARTED|Overall Study||8
224062|NCT00242580|533307|P3|NOT COMPLETED|Overall Study||14
224063|NCT00242580|533308|P2|NOT COMPLETED|Overall Study||12
224064|NCT00242580|533309|P1|NOT COMPLETED|Overall Study||10
224065|NCT00242580|533307|P3|COMPLETED|Overall Study||24
224066|NCT00242580|533308|P2|COMPLETED|Overall Study||29
224067|NCT00242580|533309|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
224068|NCT00242580|533307|P3|STARTED|Overall Study||38
224069|NCT00242580|533308|P2|STARTED|Overall Study||41
224070|NCT00242580|533309|P1|STARTED|Overall Study||32
224071|NCT00242567|533334|P2|NOT COMPLETED|Overall Study||140
224072|NCT00242567|533335|P1|NOT COMPLETED|Overall Study||166
224073|NCT00242567|533334|P2|COMPLETED|Overall Study||123
224074|NCT00242567|533335|P1|COMPLETED|Overall Study||93
224075|NCT00242567|533334|P2|Never Received Study Drug|Overall Study||191
224076|NCT00242567|533335|P1|Never Received Study Drug|Overall Study||0
224077|NCT00242567|533334|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
224078|NCT00242567|533335|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
224079|NCT00242567|533334|P2|STARTED|Overall Study||263
224080|NCT00242567|533335|P1|STARTED|Overall Study||259
224081|NCT00242502|533351|P1|NOT COMPLETED|Overall Study||0
224082|NCT00242502|533351|P1|COMPLETED|Overall Study||59
224083|NCT00242502|533351|P1|STARTED|Overall Study||59
224084|NCT00242385|533355|P2|NOT COMPLETED|Period 2||0
224085|NCT00242385|533356|P1|NOT COMPLETED|Period 2||0
224086|NCT00242385|533355|P2|COMPLETED|Period 2||11
224087|NCT00242385|533356|P1|COMPLETED|Period 2||14
224088|NCT00242385|533355|P2|STARTED|Period 2||11
224089|NCT00242385|533356|P1|STARTED|Period 2||14
224090|NCT00242385|533355|P2|NOT COMPLETED|Period 1||0
224091|NCT00242385|533356|P1|NOT COMPLETED|Period 1||0
224092|NCT00242385|533355|P2|COMPLETED|Period 1||11
224093|NCT00242385|533356|P1|COMPLETED|Period 1||14
224094|NCT00242385|533355|P2|STARTED|Period 1||11
224095|NCT00242385|533356|P1|STARTED|Period 1||14
224096|NCT00242216|533382|P2|NOT COMPLETED|Overall Study||22
224097|NCT00242216|533383|P1|NOT COMPLETED|Overall Study||18
224098|NCT00242216|533382|P2|COMPLETED|Overall Study||15
224099|NCT00242216|533383|P1|COMPLETED|Overall Study||21
224100|NCT00242216|533382|P2|STARTED|Overall Study||37
224101|NCT00242216|533383|P1|STARTED|Overall Study||39
224102|NCT00241839|533393|P2|NOT COMPLETED|Overall Study||18
224103|NCT00241839|533394|P1|NOT COMPLETED|Overall Study||19
224104|NCT00241839|533393|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
224105|NCT00241839|533394|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
224106|NCT00241839|533393|P2|STARTED|Overall Study||71
224107|NCT00241839|533394|P1|STARTED|Overall Study||71
224108|NCT00241644|533410|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
224109|NCT00241644|533411|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
224110|NCT00241644|533412|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
224111|NCT00241644|533413|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
224113|NCT00241644|533411|P3|COMPLETED|Second Efficacy Period (Year 2)||682
224114|NCT00241644|533412|P2|COMPLETED|Second Efficacy Period (Year 2)||697
224115|NCT00241644|533413|P1|COMPLETED|Second Efficacy Period (Year 2)||710
224116|NCT00241644|533410|P4|STARTED|Second Efficacy Period (Year 2)||1525
224117|NCT00241644|533411|P3|STARTED|Second Efficacy Period (Year 2)||746
224118|NCT00241644|533412|P2|STARTED|Second Efficacy Period (Year 2)||754
224119|NCT00241644|533413|P1|STARTED|Second Efficacy Period (Year 2)||771
224120|NCT00241644|533410|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
224121|NCT00241644|533411|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
224122|NCT00241644|533412|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
224123|NCT00241644|533413|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
224124|NCT00241644|533410|P4|COMPLETED|First Efficacy Period (Year 1)||2803
224125|NCT00241644|533411|P3|COMPLETED|First Efficacy Period (Year 1)||1392
224126|NCT00241644|533412|P2|COMPLETED|First Efficacy Period (Year 1)||1383
224127|NCT00241644|533413|P1|COMPLETED|First Efficacy Period (Year 1)||1420
224128|NCT00241644|533410|P4|STARTED|First Efficacy Period (Year 1)||3298
224129|NCT00241644|533411|P3|STARTED|First Efficacy Period (Year 1)||1641
224130|NCT00241644|533412|P2|STARTED|First Efficacy Period (Year 1)||1651
224131|NCT00241644|533413|P1|STARTED|First Efficacy Period (Year 1)||1647
224132|NCT00241280|533497|P2|NOT COMPLETED|Overall Study||68
224133|NCT00241280|533498|P1|NOT COMPLETED|Overall Study||48
224134|NCT00241280|533497|P2|COMPLETED|Overall Study||186
224135|NCT00241280|533498|P1|COMPLETED|Overall Study||199
224136|NCT00241280|533497|P2|STARTED|Overall Study||254
224137|NCT00241280|533498|P1|STARTED|Overall Study||247
224138|NCT00241176|533506|P1|NOT COMPLETED|Overall Study||0
224139|NCT00241176|533506|P1|COMPLETED|Overall Study||11
224140|NCT00241176|533506|P1|STARTED|Overall Study||11
224141|NCT00240994|533513|P1|NOT COMPLETED|Overall Study||3
224142|NCT00240994|533513|P1|COMPLETED|Overall Study||32
224143|NCT00240994|533513|P1|STARTED|Overall Study||35
224144|NCT00240539|533521|P4|NOT COMPLETED|Overall Study||0
224145|NCT00240539|533522|P3|NOT COMPLETED|Overall Study||0
224146|NCT00240539|533523|P2|NOT COMPLETED|Overall Study||0
224147|NCT00240539|533524|P1|NOT COMPLETED|Overall Study||0
224148|NCT00240539|533521|P4|COMPLETED|Overall Study||1
224149|NCT00240539|533522|P3|COMPLETED|Overall Study||31
224150|NCT00240539|533523|P2|COMPLETED|Overall Study||2
224151|NCT00240539|533524|P1|COMPLETED|Overall Study||2
224152|NCT00240539|533521|P4|STARTED|Overall Study||1
224153|NCT00240539|533522|P3|STARTED|Overall Study||31
224154|NCT00240539|533523|P2|STARTED|Overall Study||2
224155|NCT00240539|533524|P1|STARTED|Overall Study||2
224156|NCT00240526|533546|P4|NOT COMPLETED|Year 20||0
224157|NCT00240526|533547|P3|NOT COMPLETED|Year 20||0
224158|NCT00240526|533548|P2|NOT COMPLETED|Year 20||0
224159|NCT00240526|533549|P1|NOT COMPLETED|Year 20||0
224160|NCT00240526|533546|P4|COMPLETED|Year 20||20
224161|NCT00240526|533547|P3|COMPLETED|Year 20||13
224162|NCT00240526|533548|P2|COMPLETED|Year 20||17
224163|NCT00240526|533549|P1|COMPLETED|Year 20||19
224164|NCT00240526|533546|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
224165|NCT00240526|533547|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
224166|NCT00240526|533548|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
224167|NCT00240526|533549|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
224168|NCT00240526|533546|P4|NOT COMPLETED|Year 19||0
224169|NCT00240526|533547|P3|NOT COMPLETED|Year 19||0
224170|NCT00240526|533548|P2|NOT COMPLETED|Year 19||0
224171|NCT00240526|533549|P1|NOT COMPLETED|Year 19||0
224172|NCT00240526|533546|P4|COMPLETED|Year 19||18
224173|NCT00240526|533547|P3|COMPLETED|Year 19||12
224174|NCT00240526|533548|P2|COMPLETED|Year 19||16
224175|NCT00240526|533549|P1|COMPLETED|Year 19||17
224176|NCT00240526|533546|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
224177|NCT00240526|533547|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
224178|NCT00240526|533548|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
224179|NCT00240526|533549|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
224180|NCT00240526|533546|P4|NOT COMPLETED|Year 18||0
224181|NCT00240526|533547|P3|NOT COMPLETED|Year 18||0
224182|NCT00240526|533548|P2|NOT COMPLETED|Year 18||0
224183|NCT00240526|533549|P1|NOT COMPLETED|Year 18||0
224184|NCT00240526|533546|P4|COMPLETED|Year 18||20
224185|NCT00240526|533547|P3|COMPLETED|Year 18||14
224186|NCT00240526|533548|P2|COMPLETED|Year 18||17
224187|NCT00240526|533549|P1|COMPLETED|Year 18||16
224188|NCT00240526|533546|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
224189|NCT00240526|533547|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
224190|NCT00240526|533548|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
224191|NCT00240526|533549|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
224192|NCT00240526|533546|P4|NOT COMPLETED|Year 17||0
224193|NCT00240526|533547|P3|NOT COMPLETED|Year 17||0
224194|NCT00240526|533548|P2|NOT COMPLETED|Year 17||0
224195|NCT00240526|533549|P1|NOT COMPLETED|Year 17||0
224196|NCT00240526|533546|P4|COMPLETED|Year 17||20
224197|NCT00240526|533547|P3|COMPLETED|Year 17||13
224198|NCT00240526|533548|P2|COMPLETED|Year 17||17
224199|NCT00240526|533549|P1|COMPLETED|Year 17||19
224200|NCT00240526|533546|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
224201|NCT00240526|533547|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
224202|NCT00240526|533548|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
224203|NCT00240526|533549|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
224204|NCT00240526|533546|P4|NOT COMPLETED|Year 16||0
224205|NCT00240526|533547|P3|NOT COMPLETED|Year 16||0
224206|NCT00240526|533548|P2|NOT COMPLETED|Year 16||0
224207|NCT00240526|533549|P1|NOT COMPLETED|Year 16||0
224208|NCT00240526|533546|P4|COMPLETED|Year 16||22
224209|NCT00240526|533547|P3|COMPLETED|Year 16||16
224210|NCT00240526|533548|P2|COMPLETED|Year 16||19
224211|NCT00240526|533549|P1|COMPLETED|Year 16||17
224212|NCT00240526|533546|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
224213|NCT00240526|533547|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
224214|NCT00240526|533548|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
224215|NCT00240526|533549|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
224216|NCT00240526|533546|P4|NOT COMPLETED|Year 15||0
224217|NCT00240526|533547|P3|NOT COMPLETED|Year 15||0
224218|NCT00240526|533548|P2|NOT COMPLETED|Year 15||0
224219|NCT00240526|533549|P1|NOT COMPLETED|Year 15||0
224220|NCT00240526|533546|P4|COMPLETED|Year 15||21
224221|NCT00240526|533547|P3|COMPLETED|Year 15||14
224222|NCT00240526|533548|P2|COMPLETED|Year 15||19
224223|NCT00240526|533549|P1|COMPLETED|Year 15||19
224224|NCT00240526|533546|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
224225|NCT00240526|533547|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
224226|NCT00240526|533548|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
224227|NCT00240526|533549|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
224228|NCT00240500|533585|P6|NOT COMPLETED|Overall Study||1
224229|NCT00240500|533586|P5|NOT COMPLETED|Overall Study||3
224230|NCT00240500|533587|P4|NOT COMPLETED|Overall Study||4
224231|NCT00240500|533588|P3|NOT COMPLETED|Overall Study||3
224232|NCT00240500|533589|P2|NOT COMPLETED|Overall Study||3
224233|NCT00240500|533590|P1|NOT COMPLETED|Overall Study||1
224234|NCT00240500|533585|P6|COMPLETED|Overall Study||2
224235|NCT00240500|533586|P5|COMPLETED|Overall Study||26
224236|NCT00240500|533587|P4|COMPLETED|Overall Study||19
224237|NCT00240500|533588|P3|COMPLETED|Overall Study||14
224238|NCT00240500|533589|P2|COMPLETED|Overall Study||17
224239|NCT00240500|533590|P1|COMPLETED|Overall Study||16
224240|NCT00240500|533585|P6|STARTED|Overall Study||3
224241|NCT00240500|533586|P5|STARTED|Overall Study||29
224242|NCT00240500|533587|P4|STARTED|Overall Study||23
224243|NCT00240500|533588|P3|STARTED|Overall Study||17
224244|NCT00240500|533589|P2|STARTED|Overall Study||20
224245|NCT00240500|533590|P1|STARTED|Overall Study||17
224246|NCT00240487|533612|P2|NOT COMPLETED|Overall Study||0
224247|NCT00240487|533613|P1|NOT COMPLETED|Overall Study||0
224248|NCT00240487|533612|P2|COMPLETED|Overall Study||28
224249|NCT00240487|533613|P1|COMPLETED|Overall Study||24
224250|NCT00240487|533612|P2|STARTED|Overall Study||28
224251|NCT00240487|533613|P1|STARTED|Overall Study||24
224252|NCT00240331|533621|P2|NOT COMPLETED|Overall Study||134
224253|NCT00240331|533622|P1|NOT COMPLETED|Overall Study||126
224254|NCT00240331|533621|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
224255|NCT00240331|533622|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
224256|NCT00240331|533621|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
224257|NCT00240331|533622|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
224258|NCT00240227|533640|P1|NOT COMPLETED|Overall Study||0
224259|NCT00240227|533640|P1|COMPLETED|Overall Study||8
224260|NCT00240227|533640|P1|STARTED|Overall Study||8
224261|NCT00240162|533646|P1|NOT COMPLETED|Overall Study||0
224262|NCT00240162|533646|P1|COMPLETED|Overall Study||21
224263|NCT00240162|533646|P1|STARTED|Overall Study||21
224264|NCT00240110|533655|P2|NOT COMPLETED|Overall Study||7
224265|NCT00240110|533656|P1|NOT COMPLETED|Overall Study||6
224266|NCT00240110|533655|P2|COMPLETED|Overall Study||6
224267|NCT00240110|533656|P1|COMPLETED|Overall Study||7
224268|NCT00240110|533655|P2|STARTED|Overall Study||13
224269|NCT00240110|533656|P1|STARTED|Overall Study||13
224270|NCT00240097|533664|P1|NOT COMPLETED|Part II||23
224271|NCT00240097|533664|P1|COMPLETED|Part II||3
224272|NCT00240097|533664|P1|STARTED|Part II||26
224273|NCT00240097|533664|P1|NOT COMPLETED|Part I||4
224274|NCT00240097|533664|P1|COMPLETED|Part I||26
224275|NCT00240097|533664|P1|STARTED|Part I||30
224276|NCT00240071|533674|P1|NOT COMPLETED|Overall Study||3
224277|NCT00240071|533674|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
224278|NCT00240071|533674|P1|STARTED|Overall Study||30
224279|NCT00239928|533678|P1|NOT COMPLETED|Overall Study||10
224280|NCT00239928|533678|P1|COMPLETED|Overall Study||51
224281|NCT00239928|533678|P1|STARTED|Overall Study||61
224282|NCT00239837|533690|P2|NOT COMPLETED|Overall Study||7
224283|NCT00239837|533691|P1|NOT COMPLETED|Overall Study||3
224284|NCT00239837|533690|P2|COMPLETED|Overall Study|3-year follow-up|45
224285|NCT00239837|533691|P1|COMPLETED|Overall Study|3-year follow-up|45
224286|NCT00239837|533690|P2|6 Months|Overall Study||50
224287|NCT00239837|533691|P1|6 Months|Overall Study||48
224288|NCT00239837|533690|P2|STARTED|Overall Study||52
224289|NCT00239837|533691|P1|STARTED|Overall Study||48
224290|NCT00239720|533713|P2|NOT COMPLETED|Overall Study||1
224291|NCT00239720|533714|P1|NOT COMPLETED|Overall Study||1
224292|NCT00239720|533713|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
224293|NCT00239720|533714|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
224294|NCT00239720|533713|P2|STARTED|Overall Study||1
224295|NCT00239720|533714|P1|STARTED|Overall Study||3
224296|NCT00239681|533722|P2|NOT COMPLETED|Overall Study||715
224297|NCT00239681|533723|P1|NOT COMPLETED|Overall Study||693
224298|NCT00239681|533722|P2|COMPLETED|Overall Study||8186
224299|NCT00239681|533723|P1|COMPLETED|Overall Study||8208
224300|NCT00239681|533722|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
224301|NCT00239681|533723|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
224302|NCT00239681|533722|P2|STARTED|Overall Study||8901
224303|NCT00239681|533723|P1|STARTED|Overall Study||8901
224304|NCT00239642|533742|P3|NOT COMPLETED|Overall Study||2
224305|NCT00239642|533743|P2|NOT COMPLETED|Overall Study||0
224306|NCT00239642|533744|P1|NOT COMPLETED|Overall Study||2
224307|NCT00239642|533742|P3|COMPLETED|Overall Study||47
224308|NCT00239642|533743|P2|COMPLETED|Overall Study||47
224309|NCT00239642|533744|P1|COMPLETED|Overall Study||47
224310|NCT00239642|533742|P3|STARTED|Overall Study||49
224311|NCT00239642|533743|P2|STARTED|Overall Study||47
224312|NCT00239642|533744|P1|STARTED|Overall Study||49
224313|NCT00239356|533778|P2|NOT COMPLETED|Overall Study||9
224314|NCT00239356|533779|P1|NOT COMPLETED|Overall Study||39
224315|NCT00239356|533778|P2|COMPLETED|Overall Study||11
224316|NCT00239356|533779|P1|COMPLETED|Overall Study||58
224317|NCT00239356|533778|P2|STARTED|Overall Study||20
224318|NCT00239356|533779|P1|STARTED|Overall Study||97
224319|NCT00239226|533801|P4|NOT COMPLETED|Overall Study||3
224320|NCT00239226|533802|P3|NOT COMPLETED|Overall Study||1
224321|NCT00239226|533803|P2|NOT COMPLETED|Overall Study||0
224322|NCT00239226|533804|P1|NOT COMPLETED|Overall Study||1
224323|NCT00239226|533801|P4|COMPLETED|Overall Study||14
224324|NCT00239226|533802|P3|COMPLETED|Overall Study||36
224325|NCT00239226|533803|P2|COMPLETED|Overall Study||18
224326|NCT00239226|533804|P1|COMPLETED|Overall Study||29
224327|NCT00239226|533801|P4|STARTED|Overall Study||17
224328|NCT00239226|533802|P3|STARTED|Overall Study||37
224329|NCT00239226|533803|P2|STARTED|Overall Study||18
224330|NCT00239226|533804|P1|STARTED|Overall Study||30
224331|NCT00239005|533816|P2|NOT COMPLETED|Overall Study||12
224332|NCT00239005|533817|P1|NOT COMPLETED|Overall Study||12
224333|NCT00239005|533816|P2|COMPLETED|Overall Study||53
224334|NCT00239005|533817|P1|COMPLETED|Overall Study||57
224335|NCT00239005|533816|P2|Intention-to-treat Population (ITT)|Overall Study||61
224336|NCT00239005|533817|P1|Intention-to-treat Population (ITT)|Overall Study||68
224337|NCT00239005|533816|P2|STARTED|Overall Study||65
224338|NCT00239005|533817|P1|STARTED|Overall Study||69
224339|NCT00238615|533827|P1|NOT COMPLETED|Overall Study||0
224340|NCT00238615|533827|P1|COMPLETED|Overall Study||13
224341|NCT00238615|533827|P1|STARTED|Overall Study||13
224342|NCT00238420|533835|P2|NOT COMPLETED|Overall Study||1
224343|NCT00238420|533836|P1|NOT COMPLETED|Overall Study||1
224344|NCT00238420|533835|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
224345|NCT00238420|533836|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
224346|NCT00238420|533835|P2|STARTED|Overall Study||48
224347|NCT00238420|533836|P1|STARTED|Overall Study||22
224348|NCT00238355|533846|P1|NOT COMPLETED|Overall Study||3
224349|NCT00238355|533846|P1|COMPLETED|Overall Study||10
224350|NCT00238355|533846|P1|STARTED|Overall Study||13
224351|NCT00238303|533853|P3|NOT COMPLETED|Overall Study||9
224352|NCT00238303|533854|P2|NOT COMPLETED|Overall Study||2
224353|NCT00238303|533855|P1|NOT COMPLETED|Overall Study||15
224354|NCT00238303|533853|P3|COMPLETED|Overall Study||11
224355|NCT00238303|533854|P2|COMPLETED|Overall Study||13
224356|NCT00238303|533855|P1|COMPLETED|Overall Study||53
224357|NCT00238303|533853|P3|STARTED|Overall Study||20
224358|NCT00238303|533854|P2|STARTED|Overall Study||15
224359|NCT00238303|533855|P1|STARTED|Overall Study||68
224360|NCT00238238|533875|P3|NOT COMPLETED|Overall Study||0
224361|NCT00238238|533876|P2|NOT COMPLETED|Overall Study||3
224362|NCT00238238|533877|P1|NOT COMPLETED|Overall Study||0
224363|NCT00238238|533875|P3|COMPLETED|Overall Study||46
224364|NCT00238238|533876|P2|COMPLETED|Overall Study||45
224365|NCT00238238|533877|P1|COMPLETED|Overall Study||3
224366|NCT00238238|533875|P3|STARTED|Overall Study||46
224367|NCT00238238|533876|P2|STARTED|Overall Study||48
224368|NCT00238238|533877|P1|STARTED|Overall Study||3
224369|NCT00238121|533890|P2|NOT COMPLETED|Overall Study||2
224370|NCT00238121|533891|P1|NOT COMPLETED|Overall Study||3
224371|NCT00238121|533890|P2|COMPLETED|Overall Study||14
224372|NCT00238121|533891|P1|COMPLETED|Overall Study||37
224373|NCT00238121|533890|P2|STARTED|Overall Study||16
224374|NCT00238121|533891|P1|STARTED|Overall Study||40
224375|NCT00238108|533904|P2|NOT COMPLETED|Overall Study||0
224376|NCT00238108|533905|P1|NOT COMPLETED|Overall Study||0
224377|NCT00238108|533904|P2|COMPLETED|Overall Study||8
224378|NCT00238108|533905|P1|COMPLETED|Overall Study||8
224379|NCT00238108|533904|P2|STARTED|Overall Study||8
224380|NCT00238108|533905|P1|STARTED|Overall Study||8
224381|NCT00237796|533913|P2|NOT COMPLETED|Overall Study||5
224382|NCT00237796|533914|P1|NOT COMPLETED|Overall Study||10
224383|NCT00237796|533913|P2|COMPLETED|Overall Study||33
224384|NCT00237796|533914|P1|COMPLETED|Overall Study||31
224385|NCT00237796|533913|P2|STARTED|Overall Study||38
224386|NCT00237796|533914|P1|STARTED|Overall Study||41
224387|NCT00237770|533934|P2|NOT COMPLETED|Overall Study||0
224388|NCT00237770|533935|P1|NOT COMPLETED|Overall Study||0
224389|NCT00237770|533934|P2|COMPLETED|Overall Study||7
224390|NCT00237770|533935|P1|COMPLETED|Overall Study||9
224391|NCT00237770|533934|P2|STARTED|Overall Study||7
224392|NCT00237770|533935|P1|STARTED|Overall Study||9
224393|NCT00237744|533948|P3|NOT COMPLETED|Overall Study||0
224394|NCT00237744|533949|P2|NOT COMPLETED|Overall Study||1
224395|NCT00237744|533950|P1|NOT COMPLETED|Overall Study||3
224396|NCT00237744|533948|P3|COMPLETED|Overall Study||18
224397|NCT00237744|533949|P2|COMPLETED|Overall Study||10
224398|NCT00237744|533950|P1|COMPLETED|Overall Study||8
224399|NCT00237744|533948|P3|STARTED|Overall Study||18
224400|NCT00237744|533949|P2|STARTED|Overall Study||11
224401|NCT00237744|533950|P1|STARTED|Overall Study||11
224402|NCT00237718|533963|P2|NOT COMPLETED|Overall Study||41
224403|NCT00237718|533964|P1|NOT COMPLETED|Overall Study||46
224404|NCT00237718|533963|P2|COMPLETED|Overall Study||124
224405|NCT00237718|533964|P1|COMPLETED|Overall Study||114
224406|NCT00237718|533963|P2|STARTED|Overall Study||165
224407|NCT00237718|533964|P1|STARTED|Overall Study||160
224408|NCT00237692|533976|P4|NOT COMPLETED|Overall Study||19
224409|NCT00237692|533977|P3|NOT COMPLETED|Overall Study||22
224410|NCT00237692|533978|P2|NOT COMPLETED|Overall Study||14
224411|NCT00237692|533979|P1|NOT COMPLETED|Overall Study||18
224412|NCT00237692|533976|P4|COMPLETED|Overall Study||128
224413|NCT00237692|533977|P3|COMPLETED|Overall Study||127
224414|NCT00237692|533978|P2|COMPLETED|Overall Study||134
224415|NCT00237692|533979|P1|COMPLETED|Overall Study||129
224416|NCT00237692|533976|P4|18 Month f/u|Overall Study||122
224417|NCT00237692|533977|P3|18 Month f/u|Overall Study||126
224418|NCT00237692|533978|P2|18 Month f/u|Overall Study||131
224419|NCT00237692|533979|P1|18 Month f/u|Overall Study||124
224420|NCT00237692|533976|P4|12 Month f/u|Overall Study||127
224421|NCT00237692|533977|P3|12 Month f/u|Overall Study||132
224422|NCT00237692|533978|P2|12 Month f/u|Overall Study||127
224423|NCT00237692|533979|P1|12 Month f/u|Overall Study||137
224424|NCT00237692|533976|P4|6 Month f/u|Overall Study||134
224425|NCT00237692|533977|P3|6 Month f/u|Overall Study||135
224426|NCT00237692|533978|P2|6 Month f/u|Overall Study||134
224427|NCT00237692|533979|P1|6 Month f/u|Overall Study||132
224428|NCT00237692|533976|P4|STARTED|Overall Study||147
224429|NCT00237692|533977|P3|STARTED|Overall Study||149
224430|NCT00237692|533978|P2|STARTED|Overall Study||148
224431|NCT00237692|533979|P1|STARTED|Overall Study||147
224432|NCT00237666|534009|P1|NOT COMPLETED|Overall Study||6
224433|NCT00237666|534009|P1|COMPLETED|Overall Study||24
224434|NCT00237666|534009|P1|STARTED|Overall Study||30
224435|NCT00237458|534019|P1|NOT COMPLETED|Overall Study||3
224436|NCT00237458|534019|P1|COMPLETED|Overall Study||4
224437|NCT00237458|534019|P1|STARTED|Overall Study||7
224438|NCT00237185|534037|P2|NOT COMPLETED|Extension||19
224439|NCT00237185|534038|P1|NOT COMPLETED|Extension||16
224440|NCT00237185|534037|P2|COMPLETED|Extension||13
224441|NCT00237185|534038|P1|COMPLETED|Extension||8
224442|NCT00237185|534037|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
224443|NCT00237185|534038|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
224444|NCT00237185|534037|P2|NOT COMPLETED|Core||37
224445|NCT00237185|534038|P1|NOT COMPLETED|Core||44
224446|NCT00237185|534037|P2|COMPLETED|Core||37
224447|NCT00237185|534038|P1|COMPLETED|Core||30
224448|NCT00237185|534037|P2|Treated Participants|Core||74
224449|NCT00237185|534038|P1|Treated Participants|Core||73
224450|NCT00237185|534037|P2|STARTED|Core||74
224451|NCT00237185|534038|P1|STARTED|Core||74
224452|NCT00237042|534069|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
224453|NCT00237042|534070|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
224454|NCT00237042|534071|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
224455|NCT00237042|534069|P3|COMPLETED|Long Term (12 Month) Follow up||48
224456|NCT00237042|534070|P2|COMPLETED|Long Term (12 Month) Follow up||46
224457|NCT00237042|534071|P1|COMPLETED|Long Term (12 Month) Follow up||48
224458|NCT00237042|534069|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
224459|NCT00237042|534070|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
224460|NCT00237042|534071|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
224461|NCT00237042|534069|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
224462|NCT00237042|534070|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
224463|NCT00237042|534071|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
224464|NCT00237042|534069|P3|COMPLETED|Short Term (6 Month) Follow up||46
224465|NCT00237042|534070|P2|COMPLETED|Short Term (6 Month) Follow up||47
224466|NCT00237042|534071|P1|COMPLETED|Short Term (6 Month) Follow up||50
224467|NCT00237042|534069|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
224468|NCT00237042|534070|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
224469|NCT00237042|534071|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
224470|NCT00237042|534069|P3|NOT COMPLETED|Treatment||38
224471|NCT00237042|534070|P2|NOT COMPLETED|Treatment||7
224472|NCT00237042|534071|P1|NOT COMPLETED|Treatment||6
224473|NCT00237042|534069|P3|COMPLETED|Treatment||36
224474|NCT00237042|534070|P2|COMPLETED|Treatment||50
224475|NCT00237042|534071|P1|COMPLETED|Treatment||54
224476|NCT00237042|534069|P3|STARTED|Treatment||74
224477|NCT00237042|534070|P2|STARTED|Treatment||57
224478|NCT00237042|534071|P1|STARTED|Treatment||60
224479|NCT00236977|534090|P2|NOT COMPLETED|Overall Study||19
224480|NCT00236977|534091|P1|NOT COMPLETED|Overall Study||21
224481|NCT00236977|534090|P2|COMPLETED|Overall Study||72
224482|NCT00236977|534091|P1|COMPLETED|Overall Study||70
224483|NCT00236977|534090|P2|STARTED|Overall Study||91
224484|NCT00236977|534091|P1|STARTED|Overall Study||91
224485|NCT00236951|534113|P4|NOT COMPLETED|Overall Study||31
224486|NCT00236951|534114|P3|NOT COMPLETED|Overall Study||19
224487|NCT00236951|534115|P2|NOT COMPLETED|Overall Study||31
224488|NCT00236951|534116|P1|NOT COMPLETED|Overall Study||26
224489|NCT00236951|534113|P4|COMPLETED|Overall Study||17
224490|NCT00236951|534114|P3|COMPLETED|Overall Study||21
224491|NCT00236951|534115|P2|COMPLETED|Overall Study||46
224492|NCT00236951|534116|P1|COMPLETED|Overall Study||33
224493|NCT00236951|534113|P4|STARTED|Overall Study||48
224494|NCT00236951|534114|P3|STARTED|Overall Study||40
224495|NCT00236951|534115|P2|STARTED|Overall Study||77
224496|NCT00236951|534116|P1|STARTED|Overall Study||59
224497|NCT00236938|534128|P2|NOT COMPLETED|Overall Study||20
224498|NCT00236938|534129|P1|NOT COMPLETED|Overall Study||13
224499|NCT00236938|534128|P2|COMPLETED|Overall Study||26
224500|NCT00236938|534129|P1|COMPLETED|Overall Study||62
224501|NCT00236938|534128|P2|STARTED|Overall Study||46
224502|NCT00236938|534129|P1|STARTED|Overall Study||75
224503|NCT00236899|534145|P4|NOT COMPLETED|Overall Study||40
224504|NCT00236899|534146|P3|NOT COMPLETED|Overall Study||44
224505|NCT00236899|534147|P2|NOT COMPLETED|Overall Study||40
224506|NCT00236899|534148|P1|NOT COMPLETED|Overall Study||42
224507|NCT00236899|534145|P4|COMPLETED|Overall Study||19
224508|NCT00236899|534146|P3|COMPLETED|Overall Study||14
224509|NCT00236899|534147|P2|COMPLETED|Overall Study||24
224510|NCT00236899|534148|P1|COMPLETED|Overall Study||18
224511|NCT00236899|534145|P4|STARTED|Overall Study||59
224512|NCT00236899|534146|P3|STARTED|Overall Study||58
224513|NCT00236899|534147|P2|STARTED|Overall Study||64
224514|NCT00236899|534148|P1|STARTED|Overall Study||60
224515|NCT00236197|534180|P2|NOT COMPLETED|Overall Study||14
224516|NCT00236197|534181|P1|NOT COMPLETED|Overall Study||5
224517|NCT00236197|534180|P2|COMPLETED|Overall Study||293
224518|NCT00236197|534181|P1|COMPLETED|Overall Study||307
224519|NCT00236197|534180|P2|STARTED|Overall Study||307
224520|NCT00236197|534181|P1|STARTED|Overall Study||312
224521|NCT00236184|534189|P2|NOT COMPLETED|Overall Study||11
224522|NCT00236184|534190|P1|NOT COMPLETED|Overall Study||18
224523|NCT00236184|534189|P2|COMPLETED|Overall Study||308
224524|NCT00236184|534190|P1|COMPLETED|Overall Study||292
224525|NCT00236184|534189|P2|STARTED|Overall Study||319
224526|NCT00236184|534190|P1|STARTED|Overall Study||310
224527|NCT00236080|534201|P5|NOT COMPLETED|Overall Study||1
224528|NCT00236080|534202|P4|NOT COMPLETED|Overall Study||2
224529|NCT00236080|534203|P3|NOT COMPLETED|Overall Study||5
224530|NCT00236080|534204|P2|NOT COMPLETED|Overall Study||1
224531|NCT00236080|534205|P1|NOT COMPLETED|Overall Study||2
224532|NCT00236080|534201|P5|COMPLETED|Overall Study||26
224533|NCT00236080|534202|P4|COMPLETED|Overall Study||23
224534|NCT00236080|534203|P3|COMPLETED|Overall Study||22
224535|NCT00236080|534204|P2|COMPLETED|Overall Study||27
224536|NCT00236080|534205|P1|COMPLETED|Overall Study||27
224537|NCT00236080|534201|P5|STARTED|Overall Study||27
224538|NCT00236080|534202|P4|STARTED|Overall Study||25
224539|NCT00236080|534203|P3|STARTED|Overall Study||27
224540|NCT00236080|534204|P2|STARTED|Overall Study||28
224541|NCT00236080|534205|P1|STARTED|Overall Study||29
224542|NCT00235989|534226|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
224543|NCT00235989|534227|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
224544|NCT00235989|534228|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
224545|NCT00235989|534229|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
224546|NCT00235989|534230|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
224547|NCT00235989|534231|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
224548|NCT00235989|534226|P6|COMPLETED|Extension Treatment Period (ET)||0
224549|NCT00235989|534227|P5|COMPLETED|Extension Treatment Period (ET)||0
224550|NCT00235989|534228|P4|COMPLETED|Extension Treatment Period (ET)||14
224551|NCT00235989|534229|P3|COMPLETED|Extension Treatment Period (ET)||14
224552|NCT00235989|534230|P2|COMPLETED|Extension Treatment Period (ET)||2
224553|NCT00235989|534231|P1|COMPLETED|Extension Treatment Period (ET)||8
224554|NCT00235989|534226|P6|STARTED|Extension Treatment Period (ET)||0
224555|NCT00235989|534227|P5|STARTED|Extension Treatment Period (ET)||0
224556|NCT00235989|534228|P4|STARTED|Extension Treatment Period (ET)||20
224557|NCT00235989|534229|P3|STARTED|Extension Treatment Period (ET)||19
224558|NCT00235989|534230|P2|STARTED|Extension Treatment Period (ET)||6
224559|NCT00235989|534231|P1|STARTED|Extension Treatment Period (ET)||16
224560|NCT00235989|534226|P6|NOT COMPLETED|Core Treatment Period (CT)||2
224561|NCT00235989|534227|P5|NOT COMPLETED|Core Treatment Period (CT)||0
224562|NCT00235989|534228|P4|NOT COMPLETED|Core Treatment Period (CT)||0
224563|NCT00235989|534229|P3|NOT COMPLETED|Core Treatment Period (CT)||0
224564|NCT00235989|534230|P2|NOT COMPLETED|Core Treatment Period (CT)||0
224565|NCT00235989|534231|P1|NOT COMPLETED|Core Treatment Period (CT)||0
224566|NCT00235989|534226|P6|COMPLETED|Core Treatment Period (CT)||25
224567|NCT00235989|534227|P5|COMPLETED|Core Treatment Period (CT)||36
224568|NCT00235989|534228|P4|COMPLETED|Core Treatment Period (CT)||0
224569|NCT00235989|534229|P3|COMPLETED|Core Treatment Period (CT)||0
224570|NCT00235989|534230|P2|COMPLETED|Core Treatment Period (CT)||0
224571|NCT00235989|534231|P1|COMPLETED|Core Treatment Period (CT)||0
224572|NCT00235989|534226|P6|STARTED|Core Treatment Period (CT)||27
224573|NCT00235989|534227|P5|STARTED|Core Treatment Period (CT)||36
224574|NCT00235989|534228|P4|STARTED|Core Treatment Period (CT)||0
224575|NCT00235989|534229|P3|STARTED|Core Treatment Period (CT)||0
224576|NCT00235989|534230|P2|STARTED|Core Treatment Period (CT)||0
224577|NCT00235989|534231|P1|STARTED|Core Treatment Period (CT)||0
224578|NCT00235872|534245|P1|NOT COMPLETED|Overall Study||147
224579|NCT00235872|534245|P1|COMPLETED|Overall Study||162
224580|NCT00235872|534245|P1|STARTED|Overall Study||309
224581|NCT00235833|534260|P1|NOT COMPLETED|Overall Study||16
224582|NCT00235833|534260|P1|COMPLETED|Overall Study||9
224583|NCT00235833|534260|P1|STARTED|Overall Study||25
224584|NCT00235755|534276|P3|NOT COMPLETED|12-Week Maintenance Phase||31
224585|NCT00235755|534277|P2|NOT COMPLETED|12-Week Maintenance Phase||27
224586|NCT00235755|534278|P1|NOT COMPLETED|12-Week Maintenance Phase||16
224587|NCT00235755|534276|P3|COMPLETED|12-Week Maintenance Phase||122
224588|NCT00235755|534277|P2|COMPLETED|12-Week Maintenance Phase||135
224589|NCT00235755|534278|P1|COMPLETED|12-Week Maintenance Phase||152
224590|NCT00235755|534276|P3|STARTED|12-Week Maintenance Phase||153
224591|NCT00235755|534277|P2|STARTED|12-Week Maintenance Phase||162
224592|NCT00235755|534278|P1|STARTED|12-Week Maintenance Phase||168
224593|NCT00235755|534276|P3|NOT COMPLETED|4-Week Titration Phase||26
224594|NCT00235755|534277|P2|NOT COMPLETED|4-Week Titration Phase||19
224595|NCT00235755|534278|P1|NOT COMPLETED|4-Week Titration Phase||11
224596|NCT00235755|534276|P3|COMPLETED|4-Week Titration Phase||153
224597|NCT00235755|534277|P2|COMPLETED|4-Week Titration Phase||162
224598|NCT00235755|534278|P1|COMPLETED|4-Week Titration Phase||168
224599|NCT00235755|534276|P3|STARTED|4-Week Titration Phase||179
224600|NCT00235755|534277|P2|STARTED|4-Week Titration Phase||181
224601|NCT00235755|534278|P1|STARTED|4-Week Titration Phase||179
224602|NCT00235716|534356|P4|NOT COMPLETED|Overall Study||62
224603|NCT00235716|534357|P3|NOT COMPLETED|Overall Study||65
224604|NCT00235716|534358|P2|NOT COMPLETED|Overall Study||67
224605|NCT00235716|534359|P1|NOT COMPLETED|Overall Study||62
224606|NCT00235716|534356|P4|COMPLETED|Overall Study||90
224607|NCT00235716|534357|P3|COMPLETED|Overall Study||89
224608|NCT00235716|534358|P2|COMPLETED|Overall Study||88
224609|NCT00235716|534359|P1|COMPLETED|Overall Study||90
224610|NCT00235716|534356|P4|STARTED|Overall Study||152
224611|NCT00235716|534357|P3|STARTED|Overall Study||154
224612|NCT00235716|534358|P2|STARTED|Overall Study||155
224613|NCT00235716|534359|P1|STARTED|Overall Study||152
224614|NCT00235573|534393|P1|NOT COMPLETED|Overall Study||0
224615|NCT00235573|534393|P1|COMPLETED|Overall Study||21
224616|NCT00235573|534393|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
224617|NCT00235456|534399|P2|NOT COMPLETED|Overall Study||7
224618|NCT00235456|534400|P1|NOT COMPLETED|Overall Study||2
224619|NCT00235456|534399|P2|COMPLETED|Overall Study||143
224620|NCT00235456|534400|P1|COMPLETED|Overall Study||148
224621|NCT00235456|534399|P2|STARTED|Overall Study||150
224622|NCT00235456|534400|P1|STARTED|Overall Study||150
224623|NCT00235443|534422|P6|NOT COMPLETED|Overall Study||45
224624|NCT00235443|534423|P5|NOT COMPLETED|Overall Study||30
224625|NCT00235443|534424|P4|NOT COMPLETED|Overall Study||97
224626|NCT00235443|534425|P3|NOT COMPLETED|Overall Study||62
224627|NCT00235443|534426|P2|NOT COMPLETED|Overall Study||38
224628|NCT00235443|534427|P1|NOT COMPLETED|Overall Study||8
224629|NCT00235443|534422|P6|COMPLETED|Overall Study||9
224630|NCT00235443|534423|P5|COMPLETED|Overall Study||9
224631|NCT00235443|534424|P4|COMPLETED|Overall Study||108
224632|NCT00235443|534425|P3|COMPLETED|Overall Study||23
224633|NCT00235443|534426|P2|COMPLETED|Overall Study||19
224634|NCT00235443|534427|P1|COMPLETED|Overall Study||3
224635|NCT00235443|534422|P6|STARTED|Overall Study||54
224636|NCT00235443|534423|P5|STARTED|Overall Study||39
224637|NCT00235443|534424|P4|STARTED|Overall Study||205
224638|NCT00235443|534425|P3|STARTED|Overall Study||85
224639|NCT00235443|534426|P2|STARTED|Overall Study||57
224640|NCT00235443|534427|P1|STARTED|Overall Study||11
224641|NCT00235391|534568|P6|NOT COMPLETED|Overall Study||4
224642|NCT00235391|534569|P5|NOT COMPLETED|Overall Study||12
224643|NCT00235391|534570|P4|NOT COMPLETED|Overall Study||220
224644|NCT00235391|534571|P3|NOT COMPLETED|Overall Study||24
224645|NCT00235391|534572|P2|NOT COMPLETED|Overall Study||18
224646|NCT00235391|534573|P1|NOT COMPLETED|Overall Study||12
224647|NCT00235391|534568|P6|COMPLETED|Overall Study||3
224648|NCT00235391|534569|P5|COMPLETED|Overall Study||31
224649|NCT00235391|534570|P4|COMPLETED|Overall Study||944
224650|NCT00235391|534571|P3|COMPLETED|Overall Study||148
224651|NCT00235391|534572|P2|COMPLETED|Overall Study||182
224652|NCT00235391|534573|P1|COMPLETED|Overall Study||85
224653|NCT00235391|534568|P6|Deferasirox Treatment|Overall Study||7
224654|NCT00235391|534569|P5|Deferasirox Treatment|Overall Study||43
224655|NCT00235391|534570|P4|Deferasirox Treatment|Overall Study||1164
224656|NCT00235391|534571|P3|Deferasirox Treatment|Overall Study||172
224657|NCT00235391|534572|P2|Deferasirox Treatment|Overall Study||200
224658|NCT00235391|534573|P1|Deferasirox Treatment|Overall Study||97
224659|NCT00235391|534568|P6|STARTED|Overall Study||7
224660|NCT00235391|534569|P5|STARTED|Overall Study||43
224661|NCT00235391|534570|P4|STARTED|Overall Study||1164
224662|NCT00235391|534571|P3|STARTED|Overall Study||172
224663|NCT00235391|534572|P2|STARTED|Overall Study||200
224664|NCT00235391|534573|P1|STARTED|Overall Study||97
224665|NCT00235326|534590|P2|NOT COMPLETED|Overall Study||1400
224666|NCT00235326|534591|P1|NOT COMPLETED|Overall Study||746
224667|NCT00235326|534590|P2|COMPLETED|Overall Study||1586
224668|NCT00235326|534591|P1|COMPLETED|Overall Study||829
224669|NCT00235326|534590|P2|STARTED|Overall Study||2986
224670|NCT00235326|534591|P1|STARTED|Overall Study||1575
224671|NCT00234884|534595|P1|NOT COMPLETED|Overall Study||1630
224672|NCT00234884|534595|P1|COMPLETED|Overall Study||1805
224673|NCT00234884|534595|P1|STARTED|Overall Study||3435
224674|NCT00234832|534605|P2|NOT COMPLETED|Overall Study||996
224675|NCT00234832|534606|P1|NOT COMPLETED|Overall Study||1016
224676|NCT00234832|534605|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
224677|NCT00234832|534606|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
224678|NCT00234832|534605|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
224679|NCT00234832|534606|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
224680|NCT00234494|534631|P1|NOT COMPLETED|Overall Study||2
224681|NCT00234494|534631|P1|COMPLETED|Overall Study||43
224682|NCT00234494|534631|P1|STARTED|Overall Study||45
224683|NCT00233519|534640|P2|NOT COMPLETED|Overall Study||1
224684|NCT00233519|534641|P1|NOT COMPLETED|Overall Study||1
224685|NCT00233519|534640|P2|COMPLETED|Overall Study||9
224686|NCT00233519|534641|P1|COMPLETED|Overall Study||6
224687|NCT00233519|534640|P2|STARTED|Overall Study||10
224688|NCT00233519|534641|P1|STARTED|Overall Study||7
224689|NCT00233454|534647|P1|NOT COMPLETED|Overall Study||6
224690|NCT00233454|534647|P1|COMPLETED|Overall Study||20
224691|NCT00233454|534647|P1|2 Months (for Response Rate)|Overall Study||26
224692|NCT00233454|534647|P1|STARTED|Overall Study||26
224693|NCT00233402|534654|P2|NOT COMPLETED|Overall Study||124
224694|NCT00233402|534655|P1|NOT COMPLETED|Overall Study||104
224695|NCT00233402|534654|P2|COMPLETED|Overall Study||271
224696|NCT00233402|534655|P1|COMPLETED|Overall Study||280
224697|NCT00233402|534654|P2|STARTED|Overall Study||395
224698|NCT00233402|534655|P1|STARTED|Overall Study||384
224699|NCT00234286|534666|P1|NOT COMPLETED|Overall Study||0
224700|NCT00234286|534666|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
224701|NCT00234286|534666|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
224702|NCT00234104|534705|P4|NOT COMPLETED|Overall Study||8
224703|NCT00234104|534706|P3|NOT COMPLETED|Overall Study||5
224704|NCT00234104|534707|P2|NOT COMPLETED|Overall Study||1
224705|NCT00234104|534708|P1|NOT COMPLETED|Overall Study||4
224706|NCT00234104|534705|P4|COMPLETED|Overall Study||21
224707|NCT00234104|534706|P3|COMPLETED|Overall Study||29
224708|NCT00234104|534707|P2|COMPLETED|Overall Study||28
224709|NCT00234104|534708|P1|COMPLETED|Overall Study||26
224710|NCT00234104|534705|P4|STARTED|Overall Study||29
224711|NCT00234104|534706|P3|STARTED|Overall Study||34
224712|NCT00234104|534707|P2|STARTED|Overall Study||29
224713|NCT00234104|534708|P1|STARTED|Overall Study||30
224714|NCT00234078|534722|P4|NOT COMPLETED|Overall Study||4
224715|NCT00234078|534723|P3|NOT COMPLETED|Overall Study||10
224716|NCT00234078|534724|P2|NOT COMPLETED|Overall Study||9
224717|NCT00234078|534725|P1|NOT COMPLETED|Overall Study||6
224718|NCT00234078|534722|P4|COMPLETED|Overall Study||68
224719|NCT00234078|534723|P3|COMPLETED|Overall Study||64
224720|NCT00234078|534724|P2|COMPLETED|Overall Study||63
224721|NCT00234078|534725|P1|COMPLETED|Overall Study||66
224722|NCT00234078|534722|P4|STARTED|Overall Study||72
224723|NCT00234078|534723|P3|STARTED|Overall Study||74
224724|NCT00234078|534724|P2|STARTED|Overall Study||72
224725|NCT00234078|534725|P1|STARTED|Overall Study||72
224726|NCT00234065|534749|P2|NOT COMPLETED|Overall Study||356
224727|NCT00234065|534750|P1|NOT COMPLETED|Overall Study||475
224728|NCT00234065|534749|P2|COMPLETED|Overall Study||1004
224729|NCT00234065|534750|P1|COMPLETED|Overall Study||881
224730|NCT00234065|534749|P2|STARTED|Overall Study||1360
224731|NCT00234065|534750|P1|STARTED|Overall Study||1356
224732|NCT00234039|534766|P1|NOT COMPLETED|Overall Study||50
224733|NCT00234039|534766|P1|COMPLETED|Overall Study||8
224734|NCT00234039|534766|P1|Eligible and Began Protocol Therapy|Overall Study||47
224735|NCT00234039|534766|P1|Eligible|Overall Study||49
224736|NCT00234039|534766|P1|STARTED|Overall Study||58
224737|NCT00233987|534773|P1|NOT COMPLETED|Overall Study||15
224738|NCT00233987|534773|P1|COMPLETED|Overall Study||83
224739|NCT00233987|534773|P1|Eligible and Treated|Overall Study||92
224740|NCT00233987|534773|P1|Eligible|Overall Study||94
224741|NCT00233987|534773|P1|STARTED|Overall Study||98
224742|NCT00233948|534782|P6|NOT COMPLETED|Overall Study||0
224743|NCT00233948|534783|P5|NOT COMPLETED|Overall Study||0
224744|NCT00233948|534784|P4|NOT COMPLETED|Overall Study||0
224745|NCT00233948|534785|P3|NOT COMPLETED|Overall Study||0
224746|NCT00233948|534786|P2|NOT COMPLETED|Overall Study||0
224747|NCT00233948|534787|P1|NOT COMPLETED|Overall Study||1
224748|NCT00233948|534782|P6|COMPLETED|Overall Study||12
224749|NCT00233948|534783|P5|COMPLETED|Overall Study||4
224750|NCT00233948|534784|P4|COMPLETED|Overall Study||3
224751|NCT00233948|534785|P3|COMPLETED|Overall Study||3
224752|NCT00233948|534786|P2|COMPLETED|Overall Study||3
224753|NCT00233948|534787|P1|COMPLETED|Overall Study||3
224754|NCT00233948|534782|P6|STARTED|Overall Study||12
224755|NCT00233948|534783|P5|STARTED|Overall Study||4
224756|NCT00233948|534784|P4|STARTED|Overall Study||3
224757|NCT00233948|534785|P3|STARTED|Overall Study||3
224758|NCT00233948|534786|P2|STARTED|Overall Study||3
224759|NCT00233948|534787|P1|STARTED|Overall Study||4
224760|NCT00233324|534806|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
224761|NCT00233324|534807|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
224762|NCT00233324|534808|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
224763|NCT00233324|534809|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
224764|NCT00233324|534806|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
224765|NCT00233324|534807|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
224766|NCT00233324|534808|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
224767|NCT00233324|534809|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
224768|NCT00233324|534806|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
224769|NCT00233324|534807|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
224770|NCT00233324|534808|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
224771|NCT00233324|534809|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
224772|NCT00233324|534806|P4|NOT COMPLETED|Main Study||47
224773|NCT00233324|534807|P3|NOT COMPLETED|Main Study||62
224774|NCT00233324|534808|P2|NOT COMPLETED|Main Study||60
224775|NCT00233324|534809|P1|NOT COMPLETED|Main Study||68
224776|NCT00233324|534806|P4|COMPLETED|Main Study||280
224777|NCT00233324|534807|P3|COMPLETED|Main Study||274
224778|NCT00233324|534808|P2|COMPLETED|Main Study||275
224779|NCT00233324|534809|P1|COMPLETED|Main Study||250
224780|NCT00233324|534806|P4|STARTED|Main Study||327
224781|NCT00233324|534807|P3|STARTED|Main Study||336
224782|NCT00233324|534808|P2|STARTED|Main Study||335
224783|NCT00233324|534809|P1|STARTED|Main Study||318
224784|NCT00233103|534825|P2|NOT COMPLETED|Overall Study||6
224785|NCT00233103|534826|P1|NOT COMPLETED|Overall Study||5
224786|NCT00233103|534825|P2|COMPLETED|Overall Study||19
224787|NCT00233103|534826|P1|COMPLETED|Overall Study||22
224788|NCT00233103|534825|P2|STARTED|Overall Study||25
224789|NCT00233103|534826|P1|STARTED|Overall Study||27
224790|NCT00233090|534840|P2|NOT COMPLETED|Overall Study||0
224791|NCT00233090|534841|P1|NOT COMPLETED|Overall Study||0
224792|NCT00233090|534840|P2|COMPLETED|Overall Study||9
224793|NCT00233090|534841|P1|COMPLETED|Overall Study||12
224794|NCT00233090|534840|P2|STARTED|Overall Study||9
224795|NCT00233090|534841|P1|STARTED|Overall Study||12
224796|NCT00233064|534863|P2|NOT COMPLETED|Overall Study||12
224797|NCT00233064|534864|P1|NOT COMPLETED|Overall Study||14
224798|NCT00233064|534863|P2|COMPLETED|Overall Study||190
224799|NCT00233064|534864|P1|COMPLETED|Overall Study||197
224800|NCT00233064|534863|P2|STARTED|Overall Study||202
224801|NCT00233064|534864|P1|STARTED|Overall Study||211
224802|NCT00232739|534871|P1|NOT COMPLETED|Overall Study||9
224803|NCT00232739|534871|P1|COMPLETED|Overall Study||91
224804|NCT00232739|534871|P1|STARTED|Overall Study||100
224805|NCT00232596|534890|P2|NOT COMPLETED|12-Week Maintenance Phase||28
224806|NCT00232596|534891|P1|NOT COMPLETED|12-Week Maintenance Phase||12
224807|NCT00232596|534890|P2|COMPLETED|12-Week Maintenance Phase||97
224808|NCT00232596|534891|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
224809|NCT00232596|534890|P2|STARTED|12-Week Maintenance Phase||125
224810|NCT00232596|534891|P1|STARTED|12-Week Maintenance Phase||138
224811|NCT00232596|534890|P2|NOT COMPLETED|6-Week Titration Phase||29
224812|NCT00232596|534891|P1|NOT COMPLETED|6-Week Titration Phase||14
224813|NCT00232596|534890|P2|COMPLETED|6-Week Titration Phase||125
224814|NCT00232596|534891|P1|COMPLETED|6-Week Titration Phase||138
224815|NCT00232596|534890|P2|STARTED|6-Week Titration Phase||154
224816|NCT00232596|534891|P1|STARTED|6-Week Titration Phase||152
224817|NCT00232583|534943|P2|NOT COMPLETED|Overall Study||13
224818|NCT00232583|534944|P1|NOT COMPLETED|Overall Study||10
224819|NCT00232583|534943|P2|COMPLETED|Overall Study||16
224820|NCT00232583|534944|P1|COMPLETED|Overall Study||19
224821|NCT00232583|534943|P2|STARTED|Overall Study||29
224822|NCT00232583|534944|P1|STARTED|Overall Study||29
224823|NCT00232557|534952|P2|NOT COMPLETED|Overall Study||5
224824|NCT00232557|534953|P1|NOT COMPLETED|Overall Study||3
224825|NCT00232557|534952|P2|COMPLETED|Overall Study||60
224826|NCT00232557|534953|P1|COMPLETED|Overall Study||68
224827|NCT00232557|534952|P2|STARTED|Overall Study||65
224828|NCT00232557|534953|P1|STARTED|Overall Study||71
224829|NCT00232544|534963|P2|NOT COMPLETED|Overall Study||15
224830|NCT00232544|534964|P1|NOT COMPLETED|Overall Study||20
224831|NCT00232544|534963|P2|COMPLETED|Overall Study||111
224832|NCT00232544|534964|P1|COMPLETED|Overall Study||104
224833|NCT00232544|534963|P2|STARTED|Overall Study||126
224834|NCT00232544|534964|P1|STARTED|Overall Study||124
224835|NCT00232479|534972|P1|NOT COMPLETED|Overall Study||0
224836|NCT00232479|534972|P1|COMPLETED|Overall Study||44
224837|NCT00232479|534972|P1|STARTED|Overall Study||44
224838|NCT00232180|534979|P3|NOT COMPLETED|Open Label Phase||148
224839|NCT00232180|534980|P2|NOT COMPLETED|Open Label Phase||0
224840|NCT00232180|534981|P1|NOT COMPLETED|Open Label Phase||0
224841|NCT00232180|534979|P3|COMPLETED|Open Label Phase||1098
224842|NCT00232180|534980|P2|COMPLETED|Open Label Phase||0
224843|NCT00232180|534981|P1|COMPLETED|Open Label Phase||0
224844|NCT00232180|534979|P3|Treated|Open Label Phase||1245
224845|NCT00232180|534980|P2|Treated|Open Label Phase||0
224846|NCT00232180|534981|P1|Treated|Open Label Phase||0
224847|NCT00232180|534979|P3|STARTED|Open Label Phase||1246
224848|NCT00232180|534980|P2|STARTED|Open Label Phase||0
224849|NCT00232180|534981|P1|STARTED|Open Label Phase||0
224850|NCT00232180|534979|P3|NOT COMPLETED|Double-blind (DB) Phase||0
224851|NCT00232180|534980|P2|NOT COMPLETED|Double-blind (DB) Phase||605
224852|NCT00232180|534981|P1|NOT COMPLETED|Double-blind (DB) Phase||541
224853|NCT00232180|534979|P3|COMPLETED|Double-blind (DB) Phase||0
224854|NCT00232180|534980|P2|COMPLETED|Double-blind (DB) Phase||771
224855|NCT00232180|534981|P1|COMPLETED|Double-blind (DB) Phase||826
224856|NCT00232180|534979|P3|Treated|Double-blind (DB) Phase||0
224857|NCT00232180|534980|P2|Treated|Double-blind (DB) Phase||1372
224858|NCT00232180|534981|P1|Treated|Double-blind (DB) Phase||1364
224859|NCT00232180|534979|P3|STARTED|Double-blind (DB) Phase||0
224860|NCT00232180|534980|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
224861|NCT00232180|534981|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
224862|NCT00232141|535026|P2|NOT COMPLETED|Overall Study||26
224863|NCT00232141|535027|P1|NOT COMPLETED|Overall Study||31
224864|NCT00232141|535026|P2|COMPLETED|Overall Study||125
224865|NCT00232141|535027|P1|COMPLETED|Overall Study||120
224866|NCT00232141|535026|P2|STARTED|Overall Study||151
224867|NCT00232141|535027|P1|STARTED|Overall Study||151
224868|NCT00231816|535097|P2|NOT COMPLETED|Overall Study||12
224869|NCT00231816|535098|P1|NOT COMPLETED|Overall Study||16
224870|NCT00231816|535097|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
224871|NCT00231816|535098|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
224872|NCT00231816|535097|P2|Vaccinated at Visit 2|Overall Study||371
224873|NCT00231816|535098|P1|Vaccinated at Visit 2|Overall Study||369
224874|NCT00231816|535097|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
224875|NCT00231816|535098|P1|Vaccinated at Visit 1|Overall Study||382
224876|NCT00231816|535097|P2|STARTED|Overall Study||381
224877|NCT00231816|535098|P1|STARTED|Overall Study||382
224878|NCT00231777|535113|P2|NOT COMPLETED|Overall Study||2
224879|NCT00231777|535114|P1|NOT COMPLETED|Overall Study||6
224880|NCT00231777|535113|P2|COMPLETED|Overall Study||44
224881|NCT00231777|535114|P1|COMPLETED|Overall Study||164
224882|NCT00231777|535113|P2|STARTED|Overall Study||46
224883|NCT00231777|535114|P1|STARTED|Overall Study||170
224884|NCT00231478|535128|P2|NOT COMPLETED|Overall Study||6
224885|NCT00231478|535129|P1|NOT COMPLETED|Overall Study||8
224886|NCT00231478|535128|P2|COMPLETED|Overall Study||78
224887|NCT00231478|535129|P1|COMPLETED|Overall Study||79
224888|NCT00231478|535128|P2|STARTED|Overall Study||84
224889|NCT00231478|535129|P1|STARTED|Overall Study||87
224890|NCT00231465|535141|P1|NOT COMPLETED|Overall Study||2
224891|NCT00231465|535141|P1|COMPLETED|Overall Study||42
224892|NCT00231465|535141|P1|STARTED|Overall Study||44
224893|NCT00231309|535147|P1|NOT COMPLETED|Overall Study||0
224894|NCT00231309|535147|P1|COMPLETED|Overall Study||10
224895|NCT00231309|535147|P1|STARTED|Overall Study||10
224896|NCT00231283|535152|P1|NOT COMPLETED|Overall Study||5
224897|NCT00231283|535152|P1|COMPLETED|Overall Study||95
224898|NCT00231283|535152|P1|STARTED|Overall Study||100
224899|NCT00231179|535161|P2|NOT COMPLETED|Overall Study||24
224900|NCT00231179|535162|P1|NOT COMPLETED|Overall Study||24
224901|NCT00231179|535161|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
224902|NCT00231179|535162|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
224903|NCT00231179|535161|P2|STARTED|Overall Study||150
224904|NCT00231179|535162|P1|STARTED|Overall Study||152
224905|NCT00231153|535178|P2|NOT COMPLETED|Overall Study||188
224906|NCT00231153|535179|P1|NOT COMPLETED|Overall Study||217
224907|NCT00231153|535178|P2|COMPLETED|Overall Study||720
224908|NCT00231153|535179|P1|COMPLETED|Overall Study||690
224909|NCT00231153|535178|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
224910|NCT00231153|535179|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
224911|NCT00231114|535189|P2|NOT COMPLETED|Post-Treatment Period||1
224912|NCT00231114|535190|P1|NOT COMPLETED|Post-Treatment Period||8
224913|NCT00231114|535189|P2|COMPLETED|Post-Treatment Period||97
224914|NCT00231114|535190|P1|COMPLETED|Post-Treatment Period||181
224915|NCT00231114|535189|P2|STARTED|Post-Treatment Period||98
224916|NCT00231114|535190|P1|STARTED|Post-Treatment Period||189
224917|NCT00231114|535189|P2|NOT COMPLETED|Treatment Period||0
224918|NCT00231114|535190|P1|NOT COMPLETED|Treatment Period||1
224919|NCT00231114|535189|P2|COMPLETED|Treatment Period||98
224920|NCT00231114|535190|P1|COMPLETED|Treatment Period||189
224921|NCT00231114|535189|P2|STARTED|Treatment Period||98
224922|NCT00231114|535190|P1|STARTED|Treatment Period||190
224923|NCT00231114|535189|P2|NOT COMPLETED|Randomized||3
224924|NCT00231114|535190|P1|NOT COMPLETED|Randomized||6
224925|NCT00231114|535189|P2|COMPLETED|Randomized||98
224926|NCT00231114|535190|P1|COMPLETED|Randomized||190
224927|NCT00231114|535189|P2|STARTED|Randomized||101
224928|NCT00231114|535190|P1|STARTED|Randomized||196
224929|NCT00231062|535226|P1|NOT COMPLETED|Overall Study||6
224930|NCT00231062|535226|P1|COMPLETED|Overall Study||109
224931|NCT00231062|535226|P1|STARTED|Overall Study||115
224932|NCT00230971|535234|P2|NOT COMPLETED|Baseline Participants||19
224933|NCT00230971|535235|P1|NOT COMPLETED|Baseline Participants||22
224934|NCT00230971|535234|P2|COMPLETED|Baseline Participants||216
224935|NCT00230971|535235|P1|COMPLETED|Baseline Participants||210
224936|NCT00230971|535234|P2|STARTED|Baseline Participants||235
224937|NCT00230971|535235|P1|STARTED|Baseline Participants||232
224938|NCT00230971|535234|P2|NOT COMPLETED|Randomization||3
224939|NCT00230971|535235|P1|NOT COMPLETED|Randomization||3
224940|NCT00230971|535234|P2|COMPLETED|Randomization||235
224941|NCT00230971|535235|P1|COMPLETED|Randomization||232
224942|NCT00230971|535234|P2|STARTED|Randomization||238
224943|NCT00230971|535235|P1|STARTED|Randomization||235
224944|NCT00230802|535249|P2|NOT COMPLETED|Overall Study||0
224945|NCT00230802|535250|P1|NOT COMPLETED|Overall Study||0
224946|NCT00230802|535249|P2|COMPLETED|Overall Study||23
224947|NCT00230802|535250|P1|COMPLETED|Overall Study||25
224948|NCT00230802|535249|P2|STARTED|Overall Study||23
224949|NCT00230802|535250|P1|STARTED|Overall Study||25
224950|NCT00230282|535260|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
224951|NCT00230282|535260|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
224952|NCT00230282|535260|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
224953|NCT00230282|535260|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
224954|NCT00230282|535260|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
224955|NCT00230282|535260|P1|STARTED|Fludarabine + Cyclophosphamide||25
224956|NCT00230178|535268|P3|NOT COMPLETED|Overall Study||7
224957|NCT00230178|535269|P2|NOT COMPLETED|Overall Study||7
224958|NCT00230178|535270|P1|NOT COMPLETED|Overall Study||4
224959|NCT00230178|535268|P3|COMPLETED|Overall Study||86
224960|NCT00230178|535269|P2|COMPLETED|Overall Study||86
224961|NCT00230178|535270|P1|COMPLETED|Overall Study||90
224962|NCT00230178|535268|P3|Treated|Overall Study||91
224963|NCT00230178|535269|P2|Treated|Overall Study||92
224964|NCT00230178|535270|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
224965|NCT00230178|535268|P3|STARTED|Overall Study||93
224966|NCT00230178|535269|P2|STARTED|Overall Study||93
224967|NCT00230178|535270|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
224968|NCT00230126|535286|P2|NOT COMPLETED|Overall Study||1
224969|NCT00230126|535287|P1|NOT COMPLETED|Overall Study||2
224970|NCT00230126|535286|P2|COMPLETED|Overall Study||27
224971|NCT00230126|535287|P1|COMPLETED|Overall Study||28
224972|NCT00230126|535286|P2|STARTED|Overall Study||28
224973|NCT00230126|535287|P1|STARTED|Overall Study||30
224974|NCT00230100|535299|P2|NOT COMPLETED|Overall Study||0
224975|NCT00230100|535300|P1|NOT COMPLETED|Overall Study||0
224976|NCT00230100|535299|P2|COMPLETED|Overall Study||17
224977|NCT00230100|535300|P1|COMPLETED|Overall Study||29
224978|NCT00230100|535299|P2|STARTED|Overall Study||17
224979|NCT00230100|535300|P1|STARTED|Overall Study||29
224980|NCT00230048|535322|P2|NOT COMPLETED|Overall Study||18
224981|NCT00230048|535323|P1|NOT COMPLETED|Overall Study||13
224982|NCT00230048|535322|P2|COMPLETED|Overall Study||37
224983|NCT00230048|535323|P1|COMPLETED|Overall Study||39
224984|NCT00230048|535322|P2|Completed Intervention/Control Session|Overall Study||55
224985|NCT00230048|535323|P1|Completed Intervention/Control Session|Overall Study||52
224986|NCT00230048|535322|P2|STARTED|Overall Study||55
224987|NCT00230048|535323|P1|STARTED|Overall Study||52
224988|NCT00230022|535333|P2|NOT COMPLETED|Overall Study||0
224989|NCT00230022|535334|P1|NOT COMPLETED|Overall Study||0
224990|NCT00230022|535333|P2|COMPLETED|Overall Study||15
224991|NCT00230022|535334|P1|COMPLETED|Overall Study||15
224992|NCT00230022|535333|P2|STARTED|Overall Study||15
224993|NCT00230022|535334|P1|STARTED|Overall Study||15
224994|NCT00230009|535342|P2|NOT COMPLETED|Follow-up||26
224995|NCT00230009|535343|P1|NOT COMPLETED|Follow-up||31
224996|NCT00230009|535342|P2|COMPLETED|Follow-up||24
224997|NCT00230009|535343|P1|COMPLETED|Follow-up||19
224998|NCT00230009|535342|P2|STARTED|Follow-up||50
224999|NCT00230009|535343|P1|STARTED|Follow-up||50
225000|NCT00230009|535342|P2|NOT COMPLETED|Single Session Intervention/Control||0
225001|NCT00230009|535343|P1|NOT COMPLETED|Single Session Intervention/Control||0
225002|NCT00230009|535342|P2|COMPLETED|Single Session Intervention/Control||50
225003|NCT00230009|535343|P1|COMPLETED|Single Session Intervention/Control||50
225004|NCT00230009|535342|P2|STARTED|Single Session Intervention/Control||50
225005|NCT00230009|535343|P1|STARTED|Single Session Intervention/Control||50
225006|NCT00229970|535360|P3|NOT COMPLETED|Overall Study||0
225007|NCT00229970|535361|P2|NOT COMPLETED|Overall Study||0
225008|NCT00229970|535362|P1|NOT COMPLETED|Overall Study||0
225009|NCT00229970|535360|P3|COMPLETED|Overall Study||75
225010|NCT00229970|535361|P2|COMPLETED|Overall Study||72
225011|NCT00229970|535362|P1|COMPLETED|Overall Study||78
225012|NCT00229970|535360|P3|STARTED|Overall Study||75
225013|NCT00229970|535361|P2|STARTED|Overall Study||72
225014|NCT00229970|535362|P1|STARTED|Overall Study||78
225015|NCT00229957|535372|P2|NOT COMPLETED|Overall Study||12
225016|NCT00229957|535373|P1|NOT COMPLETED|Overall Study||20
225017|NCT00229957|535372|P2|COMPLETED|Overall Study||139
225018|NCT00229957|535373|P1|COMPLETED|Overall Study||132
225019|NCT00229957|535372|P2|STARTED|Overall Study||151
225020|NCT00229957|535373|P1|STARTED|Overall Study||152
225021|NCT00229723|535386|P7|NOT COMPLETED|Maintenance Phase||10
225022|NCT00229723|535387|P6|NOT COMPLETED|Maintenance Phase||19
225023|NCT00229723|535388|P5|NOT COMPLETED|Maintenance Phase||15
225024|NCT00229723|535389|P4|NOT COMPLETED|Maintenance Phase||17
225025|NCT00229723|535390|P3|NOT COMPLETED|Maintenance Phase||9
225026|NCT00229723|535391|P2|NOT COMPLETED|Maintenance Phase||14
225027|NCT00229723|535392|P1|NOT COMPLETED|Maintenance Phase||25
225028|NCT00229723|535386|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
225029|NCT00229723|535387|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
225030|NCT00229723|535388|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
225031|NCT00229723|535389|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
225032|NCT00229723|535390|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
225033|NCT00229723|535391|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
225034|NCT00229723|535392|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
225035|NCT00229723|535386|P7|STARTED|Maintenance Phase||19
225036|NCT00229723|535387|P6|STARTED|Maintenance Phase||31
225037|NCT00229723|535388|P5|STARTED|Maintenance Phase||22
225038|NCT00229723|535389|P4|STARTED|Maintenance Phase||26
225039|NCT00229723|535390|P3|STARTED|Maintenance Phase||25
225040|NCT00229723|535391|P2|STARTED|Maintenance Phase||19
225041|NCT00229723|535392|P1|STARTED|Maintenance Phase||50
225042|NCT00229723|535386|P7|NOT COMPLETED|Concomitant Phase||3
225043|NCT00229723|535387|P6|NOT COMPLETED|Concomitant Phase||3
225044|NCT00229723|535388|P5|NOT COMPLETED|Concomitant Phase||2
225045|NCT00229723|535389|P4|NOT COMPLETED|Concomitant Phase||5
225046|NCT00229723|535390|P3|NOT COMPLETED|Concomitant Phase||6
225047|NCT00229723|535391|P2|NOT COMPLETED|Concomitant Phase||5
225048|NCT00229723|535392|P1|NOT COMPLETED|Concomitant Phase||10
225049|NCT00229723|535386|P7|COMPLETED|Concomitant Phase||19
225050|NCT00229723|535387|P6|COMPLETED|Concomitant Phase||31
225051|NCT00229723|535388|P5|COMPLETED|Concomitant Phase||22
225052|NCT00229723|535389|P4|COMPLETED|Concomitant Phase||26
225053|NCT00229723|535390|P3|COMPLETED|Concomitant Phase||25
225054|NCT00229723|535391|P2|COMPLETED|Concomitant Phase||19
225055|NCT00229723|535392|P1|COMPLETED|Concomitant Phase||50
225056|NCT00229723|535386|P7|STARTED|Concomitant Phase|Received randomized treatment|22
225057|NCT00229723|535387|P6|STARTED|Concomitant Phase|Received randomized treatment|34
225058|NCT00229723|535388|P5|STARTED|Concomitant Phase|Received randomized treatment|24
225059|NCT00229723|535389|P4|STARTED|Concomitant Phase|Received randomized treatment|31
225060|NCT00229723|535390|P3|STARTED|Concomitant Phase|Received randomized treatment|31
225061|NCT00229723|535391|P2|STARTED|Concomitant Phase|Received randomized treatment|24
225062|NCT00229723|535392|P1|STARTED|Concomitant Phase|Received randomized treatment|60
225063|NCT00229658|535445|P2|NOT COMPLETED|Overall Study||167
225064|NCT00229658|535446|P1|NOT COMPLETED|Overall Study||225
225065|NCT00229658|535445|P2|COMPLETED|Overall Study||364
225066|NCT00229658|535446|P1|COMPLETED|Overall Study||541
225067|NCT00229658|535445|P2|STARTED|Overall Study||531
225068|NCT00229658|535446|P1|STARTED|Overall Study||766
225069|NCT00229619|535474|P1|NOT COMPLETED|Overall Study||0
225070|NCT00229619|535474|P1|COMPLETED|Overall Study||11
225071|NCT00229619|535474|P1|STARTED|Overall Study||11
225072|NCT00228813|535478|P1|NOT COMPLETED|Overall Study||4
225073|NCT00228813|535478|P1|COMPLETED|Overall Study||4
225074|NCT00228813|535478|P1|STARTED|Overall Study||8
225075|NCT00228566|535484|P1|NOT COMPLETED|Overall Study||71
225076|NCT00228566|535484|P1|COMPLETED|Overall Study||176
225077|NCT00228566|535484|P1|STARTED|Overall Study||247
225078|NCT00228553|535488|P1|NOT COMPLETED|Overall Study||430
225079|NCT00228553|535488|P1|COMPLETED|Overall Study||313
225080|NCT00228553|535488|P1|STARTED|Overall Study||743
225081|NCT00229203|535494|P2|NOT COMPLETED|Overall Study||19
225082|NCT00229203|535495|P1|NOT COMPLETED|Overall Study||32
225083|NCT00229203|535494|P2|COMPLETED|Overall Study||0
225084|NCT00229203|535495|P1|COMPLETED|Overall Study||0
225085|NCT00229203|535494|P2|STARTED|Overall Study||19
225086|NCT00229203|535495|P1|STARTED|Overall Study||32
225087|NCT00228943|535507|P1|NOT COMPLETED|Week 2||1
225088|NCT00228943|535507|P1|COMPLETED|Week 2||27
225089|NCT00228943|535507|P1|STARTED|Week 2||28
225090|NCT00228943|535507|P1|NOT COMPLETED|Week 1||0
225091|NCT00228943|535507|P1|COMPLETED|Week 1||28
225092|NCT00228943|535507|P1|STARTED|Week 1||28
225093|NCT00228384|535517|P2|NOT COMPLETED|Overall Study||29
225094|NCT00228384|535518|P1|NOT COMPLETED|Overall Study||29
225095|NCT00228384|535517|P2|COMPLETED|Overall Study||47
225096|NCT00228384|535518|P1|COMPLETED|Overall Study||43
225097|NCT00228384|535517|P2|Three Year Follow-up (Final)|Overall Study||47
225098|NCT00228384|535518|P1|Three Year Follow-up (Final)|Overall Study||43
225099|NCT00228384|535517|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
225100|NCT00228384|535518|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
225101|NCT00228384|535517|P2|Baseline|Overall Study||76
225102|NCT00228384|535518|P1|Baseline|Overall Study||72
225103|NCT00228384|535517|P2|STARTED|Overall Study||76
225104|NCT00228384|535518|P1|STARTED|Overall Study||72
225105|NCT00227994|535558|P2|NOT COMPLETED|Overall Study||7
225106|NCT00227994|535559|P1|NOT COMPLETED|Overall Study||7
225107|NCT00227994|535558|P2|COMPLETED|Overall Study||13
225108|NCT00227994|535559|P1|COMPLETED|Overall Study||13
225109|NCT00227994|535558|P2|STARTED|Overall Study||20
225110|NCT00227994|535559|P1|STARTED|Overall Study||20
225111|NCT00227903|535569|P2|NOT COMPLETED|Overall Study||10
225112|NCT00227903|535570|P1|NOT COMPLETED|Overall Study||5
225113|NCT00227903|535569|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
225114|NCT00227903|535570|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
225115|NCT00227903|535569|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
225116|NCT00227903|535570|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
225117|NCT00227903|535569|P2|STARTED|Overall Study||92
225118|NCT00227903|535570|P1|STARTED|Overall Study||91
225119|NCT00227760|535630|P1|NOT COMPLETED|Overall Study||0
225120|NCT00227760|535630|P1|COMPLETED|Overall Study||44
225121|NCT00227760|535630|P1|STARTED|Overall Study||44
225122|NCT00227721|535636|P1|NOT COMPLETED|Overall Study||1
225123|NCT00227721|535636|P1|COMPLETED|Overall Study||29
225124|NCT00227721|535636|P1|STARTED|Overall Study||30
225125|NCT00227591|535640|P1|NOT COMPLETED|Overall Study||1
225126|NCT00227591|535640|P1|COMPLETED|Overall Study||47
225127|NCT00227591|535640|P1|Began Treatment|Overall Study||47
225128|NCT00227591|535640|P1|STARTED|Overall Study|48 pts registered to the study|48
225129|NCT00227370|535646|P2|NOT COMPLETED|Overall Study||24
225130|NCT00227370|535647|P1|NOT COMPLETED|Overall Study||21
225131|NCT00227370|535646|P2|COMPLETED|Overall Study||46
225132|NCT00227370|535647|P1|COMPLETED|Overall Study||45
225133|NCT00227370|535646|P2|STARTED|Overall Study|Treatment Group|70
225134|NCT00227370|535647|P1|STARTED|Overall Study|Placebo Group|66
225135|NCT00227344|535667|P2|NOT COMPLETED|Overall Study||5
225136|NCT00227344|535668|P1|NOT COMPLETED|Overall Study||12
225137|NCT00227344|535667|P2|COMPLETED|Overall Study||37
225138|NCT00227344|535668|P1|COMPLETED|Overall Study||75
225139|NCT00227344|535667|P2|STARTED|Overall Study||42
225140|NCT00227344|535668|P1|STARTED|Overall Study||87
225141|NCT00227305|535688|P1|NOT COMPLETED|Overall Study||144
225142|NCT00227305|535688|P1|COMPLETED|Overall Study|Completed 26 weeks|237
225143|NCT00227305|535688|P1|Drug Received|Overall Study|safety population|380
225144|NCT00227305|535688|P1|STARTED|Overall Study|enrolled|381
225145|NCT00227266|535705|P3|NOT COMPLETED|Overall Study||4
225146|NCT00227266|535706|P2|NOT COMPLETED|Overall Study||0
225147|NCT00227266|535707|P1|NOT COMPLETED|Overall Study||1
225148|NCT00227266|535705|P3|COMPLETED|Overall Study||29
225149|NCT00227266|535706|P2|COMPLETED|Overall Study||30
225150|NCT00227266|535707|P1|COMPLETED|Overall Study||30
225151|NCT00227266|535705|P3|STARTED|Overall Study||33
225152|NCT00227266|535706|P2|STARTED|Overall Study||30
225153|NCT00227266|535707|P1|STARTED|Overall Study||31
225154|NCT00226811|535727|P1|NOT COMPLETED|Overall Study||76
225155|NCT00226811|535727|P1|COMPLETED|Overall Study||2
225156|NCT00226811|535727|P1|STARTED|Overall Study||78
225157|NCT00226655|535737|P1|NOT COMPLETED|Overall Study||79
225158|NCT00226655|535737|P1|COMPLETED|Overall Study||33
225159|NCT00226655|535737|P1|STARTED|Overall Study||112
225160|NCT00226590|535741|P1|NOT COMPLETED|Overall Study||0
225161|NCT00226590|535741|P1|COMPLETED|Overall Study||39
225162|NCT00226590|535741|P1|STARTED|Overall Study||39
225163|NCT00226577|535748|P1|NOT COMPLETED|Overall Study||0
225164|NCT00226577|535748|P1|COMPLETED|Overall Study||52
225165|NCT00226577|535748|P1|STARTED|Overall Study||52
225166|NCT00225784|535756|P1|NOT COMPLETED|Overall Study||4
225167|NCT00225784|535756|P1|COMPLETED|Overall Study||33
225168|NCT00225784|535756|P1|STARTED|Overall Study||37
225169|NCT00225732|535769|P2|NOT COMPLETED|Overall Study||0
225170|NCT00225732|535770|P1|NOT COMPLETED|Overall Study||0
225171|NCT00225732|535769|P2|COMPLETED|Overall Study||166
225172|NCT00225732|535770|P1|COMPLETED|Overall Study||153
225173|NCT00225732|535769|P2|STARTED|Overall Study||166
225174|NCT00225732|535770|P1|STARTED|Overall Study||153
225175|NCT00225498|535776|P1|NOT COMPLETED|Overall Study||0
225176|NCT00225498|535776|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
225177|NCT00225498|535776|P1|STARTED|Overall Study||10
225178|NCT00225277|535782|P2|NOT COMPLETED|Overall Study||95
225179|NCT00225277|535783|P1|NOT COMPLETED|Overall Study||97
225180|NCT00225277|535782|P2|COMPLETED|Overall Study||178
225181|NCT00225277|535783|P1|COMPLETED|Overall Study||177
225182|NCT00225277|535782|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
225277|NCT00224016|536004|P2|NOT COMPLETED|Follow-Up Period||0
225183|NCT00225277|535783|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
225184|NCT00225251|535801|P2|NOT COMPLETED|Overall Study||1
225185|NCT00225251|535802|P1|NOT COMPLETED|Overall Study||1
225186|NCT00225251|535801|P2|COMPLETED|Overall Study||6
225187|NCT00225251|535802|P1|COMPLETED|Overall Study||10
225188|NCT00225251|535801|P2|STARTED|Overall Study||7
225189|NCT00225251|535802|P1|STARTED|Overall Study||11
225190|NCT00225212|535816|P1|NOT COMPLETED|Overall Study||6
225191|NCT00225212|535816|P1|COMPLETED|Overall Study||29
225192|NCT00225212|535816|P1|STARTED|Overall Study||35
225193|NCT00225147|535825|P4|NOT COMPLETED|Open-label Phase||10
225194|NCT00225147|535826|P3|NOT COMPLETED|Open-label Phase||0
225195|NCT00225147|535827|P2|NOT COMPLETED|Open-label Phase||0
225196|NCT00225147|535828|P1|NOT COMPLETED|Open-label Phase||0
225197|NCT00225147|535825|P4|COMPLETED|Open-label Phase||52
225198|NCT00225147|535826|P3|COMPLETED|Open-label Phase||0
225199|NCT00225147|535827|P2|COMPLETED|Open-label Phase||0
225200|NCT00225147|535828|P1|COMPLETED|Open-label Phase||0
225201|NCT00225147|535825|P4|STARTED|Open-label Phase||62
225202|NCT00225147|535826|P3|STARTED|Open-label Phase||0
225203|NCT00225147|535827|P2|STARTED|Open-label Phase||0
225204|NCT00225147|535828|P1|STARTED|Open-label Phase||0
225205|NCT00225147|535825|P4|NOT COMPLETED|Double-blind Phase||0
225206|NCT00225147|535826|P3|NOT COMPLETED|Double-blind Phase||0
225207|NCT00225147|535827|P2|NOT COMPLETED|Double-blind Phase||0
225208|NCT00225147|535828|P1|NOT COMPLETED|Double-blind Phase||0
225209|NCT00225147|535825|P4|COMPLETED|Double-blind Phase||0
225210|NCT00225147|535826|P3|COMPLETED|Double-blind Phase||13
225211|NCT00225147|535827|P2|COMPLETED|Double-blind Phase||12
225212|NCT00225147|535828|P1|COMPLETED|Double-blind Phase||13
225213|NCT00225147|535825|P4|STARTED|Double-blind Phase||0
225214|NCT00225147|535826|P3|STARTED|Double-blind Phase||13
225215|NCT00225147|535827|P2|STARTED|Double-blind Phase||12
225216|NCT00225147|535828|P1|STARTED|Double-blind Phase||13
225217|NCT00225017|535844|P2|NOT COMPLETED|Overall Study||1
225218|NCT00225017|535845|P1|NOT COMPLETED|Overall Study||0
225219|NCT00225017|535844|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
225220|NCT00225017|535845|P1|COMPLETED|Overall Study||26
225221|NCT00225017|535844|P2|STARTED|Overall Study||24
225222|NCT00225017|535845|P1|STARTED|Overall Study||26
225223|NCT00224874|535859|P4|NOT COMPLETED|Overall Study||0
225224|NCT00224874|535860|P3|NOT COMPLETED|Overall Study||1
225225|NCT00224874|535861|P2|NOT COMPLETED|Overall Study||0
225226|NCT00224874|535862|P1|NOT COMPLETED|Overall Study||0
225227|NCT00224874|535859|P4|COMPLETED|Overall Study||42
225228|NCT00224874|535860|P3|COMPLETED|Overall Study||46
225229|NCT00224874|535861|P2|COMPLETED|Overall Study||45
225230|NCT00224874|535862|P1|COMPLETED|Overall Study||46
225231|NCT00224874|535859|P4|STARTED|Overall Study||42
225232|NCT00224874|535860|P3|STARTED|Overall Study||47
225233|NCT00224874|535861|P2|STARTED|Overall Study||45
225234|NCT00224874|535862|P1|STARTED|Overall Study||46
225235|NCT00224770|535907|P3|NOT COMPLETED|Overall Study||0
225236|NCT00224770|535908|P2|NOT COMPLETED|Overall Study||2
225237|NCT00224770|535909|P1|NOT COMPLETED|Overall Study||4
225238|NCT00224770|535907|P3|COMPLETED|Overall Study||14
225239|NCT00224770|535908|P2|COMPLETED|Overall Study||52
225240|NCT00224770|535909|P1|COMPLETED|Overall Study||38
225241|NCT00224770|535907|P3|STARTED|Overall Study||14
225242|NCT00224770|535908|P2|STARTED|Overall Study||54
225243|NCT00224770|535909|P1|STARTED|Overall Study||42
225244|NCT00224289|535941|P1|NOT COMPLETED|Overall Study||0
225245|NCT00224289|535941|P1|COMPLETED|Overall Study||17
225246|NCT00224289|535941|P1|STARTED|Overall Study||17
225247|NCT00224133|535946|P1|NOT COMPLETED|Overall Study||226
225248|NCT00224133|535946|P1|COMPLETED|Overall Study||435
225249|NCT00224133|535946|P1|STARTED|Overall Study||661
225250|NCT00224120|535952|P2|NOT COMPLETED|Overall Study||24
225251|NCT00224120|535953|P1|NOT COMPLETED|Overall Study||22
225252|NCT00224120|535952|P2|COMPLETED|Overall Study||205
225253|NCT00224120|535953|P1|COMPLETED|Overall Study||211
225254|NCT00224120|535952|P2|STARTED|Overall Study||229
225255|NCT00224120|535953|P1|STARTED|Overall Study||233
225256|NCT00224107|535963|P2|NOT COMPLETED|Overall Study||14
225257|NCT00224107|535964|P1|NOT COMPLETED|Overall Study||31
225258|NCT00224107|535963|P2|COMPLETED|Overall Study||214
225259|NCT00224107|535964|P1|COMPLETED|Overall Study||202
225260|NCT00224107|535963|P2|STARTED|Overall Study||228
225261|NCT00224107|535964|P1|STARTED|Overall Study||233
225262|NCT00224055|535974|P2|NOT COMPLETED|Overall Study||14
225263|NCT00224055|535975|P1|NOT COMPLETED|Overall Study||15
225264|NCT00224055|535974|P2|COMPLETED|Overall Study||31
225265|NCT00224055|535975|P1|COMPLETED|Overall Study||29
225266|NCT00224055|535974|P2|STARTED|Overall Study||45
225267|NCT00224055|535975|P1|STARTED|Overall Study||44
225268|NCT00224042|535985|P2|NOT COMPLETED|Overall Study||6
225269|NCT00224042|535986|P1|NOT COMPLETED|Overall Study||6
225270|NCT00224042|535985|P2|COMPLETED|Overall Study||20
225271|NCT00224042|535986|P1|COMPLETED|Overall Study||20
225272|NCT00224042|535985|P2|STARTED|Overall Study||26
225273|NCT00224042|535986|P1|STARTED|Overall Study||26
225274|NCT00224029|535998|P1|NOT COMPLETED|Overall Study||6
225275|NCT00224029|535998|P1|COMPLETED|Overall Study||18
225276|NCT00224029|535998|P1|STARTED|Overall Study||24
225278|NCT00224016|536005|P1|NOT COMPLETED|Follow-Up Period||0
225279|NCT00224016|536004|P2|COMPLETED|Follow-Up Period||0
225280|NCT00224016|536005|P1|COMPLETED|Follow-Up Period||35
225281|NCT00224016|536004|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
225282|NCT00224016|536005|P1|STARTED|Follow-Up Period||35
225283|NCT00224016|536004|P2|NOT COMPLETED|Maintenance Period||1
225284|NCT00224016|536005|P1|NOT COMPLETED|Maintenance Period||2
225285|NCT00224016|536004|P2|COMPLETED|Maintenance Period||14
225286|NCT00224016|536005|P1|COMPLETED|Maintenance Period||36
225287|NCT00224016|536004|P2|STARTED|Maintenance Period||15
225288|NCT00224016|536005|P1|STARTED|Maintenance Period||38
225289|NCT00224016|536004|P2|NOT COMPLETED|Titration Period||1
225290|NCT00224016|536005|P1|NOT COMPLETED|Titration Period||1
225291|NCT00224016|536004|P2|COMPLETED|Titration Period||15
225292|NCT00224016|536005|P1|COMPLETED|Titration Period||38
225293|NCT00224016|536004|P2|STARTED|Titration Period||16
225294|NCT00224016|536005|P1|STARTED|Titration Period||39
225295|NCT00224003|536013|P1|NOT COMPLETED|Overall Study||7
225296|NCT00224003|536013|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
225297|NCT00224003|536013|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
225298|NCT00223977|536020|P3|NOT COMPLETED|Overall Study||3
225299|NCT00223977|536021|P2|NOT COMPLETED|Overall Study||11
225300|NCT00223977|536022|P1|NOT COMPLETED|Overall Study||9
225301|NCT00223977|536020|P3|COMPLETED|Overall Study||39
225302|NCT00223977|536021|P2|COMPLETED|Overall Study||47
225303|NCT00223977|536022|P1|COMPLETED|Overall Study||37
225304|NCT00223977|536020|P3|STARTED|Overall Study||42
225305|NCT00223977|536021|P2|STARTED|Overall Study||58
225306|NCT00223977|536022|P1|STARTED|Overall Study||46
225307|NCT00223821|536044|P2|NOT COMPLETED|Overall Study||10
225308|NCT00223821|536045|P1|NOT COMPLETED|Overall Study||4
225309|NCT00223821|536044|P2|COMPLETED|Overall Study||22
225310|NCT00223821|536045|P1|COMPLETED|Overall Study||28
225311|NCT00223821|536044|P2|Completed 6-month Follow-up|Overall Study||25
225312|NCT00223821|536045|P1|Completed 6-month Follow-up|Overall Study||28
225313|NCT00223821|536044|P2|Completed Post-treatment Assessment|Overall Study||27
225314|NCT00223821|536045|P1|Completed Post-treatment Assessment|Overall Study||31
225315|NCT00223821|536044|P2|Completed Therapy|Overall Study||28
225316|NCT00223821|536045|P1|Completed Therapy|Overall Study||31
225317|NCT00223821|536044|P2|STARTED|Overall Study||32
225318|NCT00223821|536045|P1|STARTED|Overall Study||32
225319|NCT00223808|536056|P3|NOT COMPLETED|Overall Study||5
225320|NCT00223808|536057|P2|NOT COMPLETED|Overall Study||5
225321|NCT00223808|536058|P1|NOT COMPLETED|Overall Study||3
225322|NCT00223808|536056|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
225323|NCT00223808|536057|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
225324|NCT00223808|536058|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
225325|NCT00223808|536056|P3|STARTED|Overall Study||23
225326|NCT00223808|536057|P2|STARTED|Overall Study||22
225327|NCT00223808|536058|P1|STARTED|Overall Study||22
225328|NCT00223795|536075|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
225329|NCT00223795|536076|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
225330|NCT00223795|536075|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
225331|NCT00223795|536076|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
225332|NCT00223795|536075|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
225333|NCT00223795|536076|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
225334|NCT00223795|536075|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
225335|NCT00223795|536076|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
225336|NCT00223795|536075|P2|COMPLETED|First Intervention - Eight Weeks||18
225337|NCT00223795|536076|P1|COMPLETED|First Intervention - Eight Weeks||19
225338|NCT00223795|536075|P2|STARTED|First Intervention - Eight Weeks||27
225339|NCT00223795|536076|P1|STARTED|First Intervention - Eight Weeks||26
225340|NCT00223704|536086|P3|NOT COMPLETED|Overall Study||0
225341|NCT00223704|536087|P2|NOT COMPLETED|Overall Study||0
225342|NCT00223704|536088|P1|NOT COMPLETED|Overall Study||0
225343|NCT00223704|536086|P3|COMPLETED|Overall Study||40
225344|NCT00223704|536087|P2|COMPLETED|Overall Study||37
225345|NCT00223704|536088|P1|COMPLETED|Overall Study||38
225346|NCT00223704|536086|P3|STARTED|Overall Study||40
225347|NCT00223704|536087|P2|STARTED|Overall Study||37
225348|NCT00223704|536088|P1|STARTED|Overall Study||38
225349|NCT00223652|536110|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
225350|NCT00223652|536111|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
225351|NCT00223652|536110|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
225352|NCT00223652|536111|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
225353|NCT00223652|536110|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
225354|NCT00223652|536111|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
225355|NCT00223652|536110|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
225356|NCT00223652|536111|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
225357|NCT00223652|536110|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
225358|NCT00223652|536111|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
225359|NCT00223652|536110|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
225360|NCT00223652|536111|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
225361|NCT00223652|536110|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
225362|NCT00223652|536111|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
225363|NCT00223652|536110|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
225364|NCT00223652|536111|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
225365|NCT00223652|536110|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
225366|NCT00223652|536111|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
225367|NCT00223496|536127|P1|NOT COMPLETED|Overall Study||22
225368|NCT00223496|536127|P1|COMPLETED|Overall Study||10
225369|NCT00223496|536127|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
225370|NCT00223236|536133|P2|NOT COMPLETED|Overall Study||14
225371|NCT00223236|536134|P1|NOT COMPLETED|Overall Study||7
225372|NCT00223236|536133|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
225373|NCT00223236|536134|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
225374|NCT00223236|536133|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
225375|NCT00223236|536134|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
225376|NCT00222729|536146|P1|NOT COMPLETED|Overall Study||3
225377|NCT00222729|536146|P1|COMPLETED|Overall Study||37
225378|NCT00222729|536146|P1|STARTED|Overall Study||40
225379|NCT00221299|536156|P4|NOT COMPLETED|Overall Study||1
225380|NCT00221299|536157|P3|NOT COMPLETED|Overall Study||0
225381|NCT00221299|536158|P2|NOT COMPLETED|Overall Study||2
225382|NCT00221299|536159|P1|NOT COMPLETED|Overall Study||1
225383|NCT00221299|536156|P4|COMPLETED|Overall Study||10
225384|NCT00221299|536157|P3|COMPLETED|Overall Study||14
225385|NCT00221299|536158|P2|COMPLETED|Overall Study||11
225386|NCT00221299|536159|P1|COMPLETED|Overall Study||10
225387|NCT00221299|536156|P4|STARTED|Overall Study||11
225388|NCT00221299|536157|P3|STARTED|Overall Study||14
225389|NCT00221299|536158|P2|STARTED|Overall Study||13
225390|NCT00221299|536159|P1|STARTED|Overall Study||11
225391|NCT00221195|536169|P2|NOT COMPLETED|Overall Study||3
225392|NCT00221195|536170|P1|NOT COMPLETED|Overall Study||5
225393|NCT00221195|536169|P2|COMPLETED|Overall Study||14
225394|NCT00221195|536170|P1|COMPLETED|Overall Study||12
225395|NCT00221195|536169|P2|STARTED|Overall Study||17
225396|NCT00221195|536170|P1|STARTED|Overall Study||17
225397|NCT00220961|536179|P2|NOT COMPLETED|Overall Study||90
225398|NCT00220961|536180|P1|NOT COMPLETED|Overall Study||71
225399|NCT00220961|536179|P2|COMPLETED|Overall Study||213
225400|NCT00220961|536180|P1|COMPLETED|Overall Study||228
225401|NCT00220961|536179|P2|STARTED|Overall Study||303
225402|NCT00220961|536180|P1|STARTED|Overall Study||299
225403|NCT00220805|536196|P2|NOT COMPLETED|Overall Study||11
225404|NCT00220805|536197|P1|NOT COMPLETED|Overall Study||8
225405|NCT00220805|536196|P2|COMPLETED|Overall Study||16
225406|NCT00220805|536197|P1|COMPLETED|Overall Study||22
225407|NCT00220805|536196|P2|STARTED|Overall Study||27
225408|NCT00220805|536197|P1|STARTED|Overall Study||30
225409|NCT00220779|536218|P3|NOT COMPLETED|Overall Study||4
225410|NCT00220779|536219|P2|NOT COMPLETED|Overall Study||4
225411|NCT00220779|536220|P1|NOT COMPLETED|Overall Study||7
225412|NCT00220779|536218|P3|COMPLETED|Overall Study||37
225413|NCT00220779|536219|P2|COMPLETED|Overall Study||38
225414|NCT00220779|536220|P1|COMPLETED|Overall Study||38
225415|NCT00220779|536218|P3|STARTED|Overall Study||41
225416|NCT00220779|536219|P2|STARTED|Overall Study||42
225417|NCT00220779|536220|P1|STARTED|Overall Study||45
225418|NCT00220740|536230|P2|NOT COMPLETED|Withdrawal Period||15
225419|NCT00220740|536231|P1|NOT COMPLETED|Withdrawal Period||6
225420|NCT00220740|536230|P2|COMPLETED|Withdrawal Period||16
225421|NCT00220740|536231|P1|COMPLETED|Withdrawal Period||37
225422|NCT00220740|536230|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
225423|NCT00220740|536231|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
225424|NCT00220740|536230|P2|NOT COMPLETED|Rescue Treatment||18
225425|NCT00220740|536231|P1|NOT COMPLETED|Rescue Treatment||19
225426|NCT00220740|536230|P2|COMPLETED|Rescue Treatment||5
225427|NCT00220740|536231|P1|COMPLETED|Rescue Treatment||26
225428|NCT00220740|536230|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
225429|NCT00220740|536231|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
225430|NCT00220740|536230|P2|NOT COMPLETED|Efficacy Period||46
225431|NCT00220740|536231|P1|NOT COMPLETED|Efficacy Period||26
225432|NCT00220740|536230|P2|COMPLETED|Efficacy Period||12
225433|NCT00220740|536231|P1|COMPLETED|Efficacy Period||33
225434|NCT00220740|536230|P2|STARTED|Efficacy Period||58
225435|NCT00220740|536231|P1|STARTED|Efficacy Period||59
225436|NCT00220727|536245|P2|NOT COMPLETED|Second Infusion (Week <6)||0
225437|NCT00220727|536246|P1|NOT COMPLETED|Second Infusion (Week <6)||1
225438|NCT00220727|536245|P2|COMPLETED|Second Infusion (Week <6)||4
225439|NCT00220727|536246|P1|COMPLETED|Second Infusion (Week <6)||3
225440|NCT00220727|536245|P2|STARTED|Second Infusion (Week <6)||4
225441|NCT00220727|536246|P1|STARTED|Second Infusion (Week <6)||4
225442|NCT00220727|536245|P2|NOT COMPLETED|First Infusion (Week 0)||0
225443|NCT00220727|536246|P1|NOT COMPLETED|First Infusion (Week 0)||0
225444|NCT00220727|536245|P2|COMPLETED|First Infusion (Week 0)||4
225445|NCT00220727|536246|P1|COMPLETED|First Infusion (Week 0)||4
225446|NCT00220727|536245|P2|STARTED|First Infusion (Week 0)||4
225447|NCT00220727|536246|P1|STARTED|First Infusion (Week 0)||4
225448|NCT00220701|536262|P2|NOT COMPLETED|Overall Study||4
225449|NCT00220701|536263|P1|NOT COMPLETED|Overall Study||5
225450|NCT00220701|536262|P2|COMPLETED|Overall Study||13
225451|NCT00220701|536263|P1|COMPLETED|Overall Study||12
225452|NCT00220701|536262|P2|STARTED|Overall Study||17
225453|NCT00220701|536263|P1|STARTED|Overall Study||17
225454|NCT00220636|536279|P1|NOT COMPLETED|Overall Study||4
225455|NCT00220636|536279|P1|COMPLETED|Overall Study||11
225456|NCT00220636|536279|P1|STARTED|Overall Study||15
225457|NCT00219557|536289|P3|NOT COMPLETED|Phase 2||33
225458|NCT00219557|536290|P2|NOT COMPLETED|Phase 2||69
225459|NCT00219557|536291|P1|NOT COMPLETED|Phase 2||0
225460|NCT00219557|536289|P3|COMPLETED|Phase 2||1
225461|NCT00219557|536290|P2|COMPLETED|Phase 2||0
225462|NCT00219557|536291|P1|COMPLETED|Phase 2||0
225463|NCT00219557|536289|P3|Treated|Phase 2||31
225464|NCT00219557|536290|P2|Treated|Phase 2||68
225465|NCT00219557|536291|P1|Treated|Phase 2||0
225466|NCT00219557|536289|P3|STARTED|Phase 2||34
225467|NCT00219557|536290|P2|STARTED|Phase 2||69
225468|NCT00219557|536291|P1|STARTED|Phase 2||0
225469|NCT00219557|536289|P3|NOT COMPLETED|Phase 1||0
225470|NCT00219557|536290|P2|NOT COMPLETED|Phase 1||0
225471|NCT00219557|536291|P1|NOT COMPLETED|Phase 1||7
225472|NCT00219557|536289|P3|COMPLETED|Phase 1||0
225473|NCT00219557|536290|P2|COMPLETED|Phase 1||0
225474|NCT00219557|536291|P1|COMPLETED|Phase 1||1
225475|NCT00219557|536289|P3|STARTED|Phase 1||0
225476|NCT00219557|536290|P2|STARTED|Phase 1||0
225477|NCT00219557|536291|P1|STARTED|Phase 1||8
225478|NCT00219544|536319|P2|NOT COMPLETED|Double Blind Treatment Period||0
225479|NCT00219544|536320|P1|NOT COMPLETED|Double Blind Treatment Period||0
225480|NCT00219544|536319|P2|COMPLETED|Double Blind Treatment Period||77
225481|NCT00219544|536320|P1|COMPLETED|Double Blind Treatment Period||80
225482|NCT00219544|536319|P2|STARTED|Double Blind Treatment Period||77
225483|NCT00219544|536320|P1|STARTED|Double Blind Treatment Period||80
225484|NCT00219544|536319|P2|NOT COMPLETED|Single Blind Treatment Period||0
225485|NCT00219544|536320|P1|NOT COMPLETED|Single Blind Treatment Period||22
225486|NCT00219544|536319|P2|COMPLETED|Single Blind Treatment Period||0
225487|NCT00219544|536320|P1|COMPLETED|Single Blind Treatment Period||234
225488|NCT00219544|536319|P2|STARTED|Single Blind Treatment Period||0
225489|NCT00219544|536320|P1|STARTED|Single Blind Treatment Period||256
225490|NCT00219349|536358|P1|NOT COMPLETED|Escitalopram Phase||11
225491|NCT00219349|536358|P1|COMPLETED|Escitalopram Phase||4
225492|NCT00219349|536358|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|15
225493|NCT00219349|536358|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
225494|NCT00219349|536358|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
225495|NCT00219349|536358|P1|STARTED|Cognitive Behavioral Therapy Phase||25
225496|NCT00219284|536364|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
225497|NCT00219284|536365|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
225498|NCT00219284|536364|P2|COMPLETED|Extension Phase - 8 Weeks||99
225499|NCT00219284|536365|P1|COMPLETED|Extension Phase - 8 Weeks||112
225500|NCT00219284|536364|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
225501|NCT00219284|536365|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
225502|NCT00219284|536364|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
225503|NCT00219284|536365|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
225504|NCT00219284|536364|P2|COMPLETED|Treatment Phase - 16 Weeks||128
225505|NCT00219284|536365|P1|COMPLETED|Treatment Phase - 16 Weeks||136
225506|NCT00219284|536364|P2|STARTED|Treatment Phase - 16 Weeks||179
225507|NCT00219284|536365|P1|STARTED|Treatment Phase - 16 Weeks||180
225508|NCT00219141|536390|P3|NOT COMPLETED|Overall Study||12
225509|NCT00219141|536391|P2|NOT COMPLETED|Overall Study||21
225510|NCT00219141|536392|P1|NOT COMPLETED|Overall Study||14
225511|NCT00219141|536390|P3|COMPLETED|Overall Study||142
225512|NCT00219141|536391|P2|COMPLETED|Overall Study||131
225513|NCT00219141|536392|P1|COMPLETED|Overall Study||140
225514|NCT00219141|536390|P3|STARTED|Overall Study||154
225515|NCT00219141|536391|P2|STARTED|Overall Study||152
225516|NCT00219141|536392|P1|STARTED|Overall Study||154
225517|NCT00218634|536438|P2|NOT COMPLETED|Overall Study||15
225518|NCT00218634|536439|P1|NOT COMPLETED|Overall Study||8
225519|NCT00218634|536438|P2|COMPLETED|Overall Study||30
225520|NCT00218634|536439|P1|COMPLETED|Overall Study||36
225521|NCT00218634|536438|P2|STARTED|Overall Study||45
225522|NCT00218634|536439|P1|STARTED|Overall Study||44
225523|NCT00218543|536459|P1|NOT COMPLETED|Overall Study||15
225524|NCT00218543|536459|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
225525|NCT00218543|536459|P1|STARTED|Overall Study||20
225526|NCT00218465|536466|P2|NOT COMPLETED|Overall Study||18
225527|NCT00218465|536467|P1|NOT COMPLETED|Overall Study||17
225528|NCT00218465|536466|P2|COMPLETED|Overall Study||30
225529|NCT00218465|536467|P1|COMPLETED|Overall Study||33
225530|NCT00218465|536466|P2|STARTED|Overall Study||48
225531|NCT00218465|536467|P1|STARTED|Overall Study||50
225532|NCT00218439|536479|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
225533|NCT00218439|536480|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
225534|NCT00218439|536479|P2|COMPLETED|Second Intervention (4 Weeks)||30
225535|NCT00218439|536480|P1|COMPLETED|Second Intervention (4 Weeks)||33
225536|NCT00218439|536479|P2|STARTED|Second Intervention (4 Weeks)||35
225537|NCT00218439|536480|P1|STARTED|Second Intervention (4 Weeks)||40
225538|NCT00218439|536479|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
225539|NCT00218439|536480|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
225540|NCT00218439|536479|P2|COMPLETED|First Intervention (4 Weeks)||35
225541|NCT00218439|536480|P1|COMPLETED|First Intervention (4 Weeks)||40
225542|NCT00218439|536479|P2|STARTED|First Intervention (4 Weeks)||47
225543|NCT00218439|536480|P1|STARTED|First Intervention (4 Weeks)||58
225544|NCT00218335|536498|P4|NOT COMPLETED|Overall Study||36
225545|NCT00218335|536499|P3|NOT COMPLETED|Overall Study||54
225546|NCT00218335|536500|P2|NOT COMPLETED|Overall Study||3
225547|NCT00218335|536501|P1|NOT COMPLETED|Overall Study||6
225548|NCT00218335|536498|P4|COMPLETED|Overall Study||388
225549|NCT00218335|536499|P3|COMPLETED|Overall Study||319
225550|NCT00218335|536500|P2|COMPLETED|Overall Study||110
225551|NCT00218335|536501|P1|COMPLETED|Overall Study||108
225552|NCT00218335|536498|P4|18 Month Follow-up|Overall Study||368
225553|NCT00218335|536499|P3|18 Month Follow-up|Overall Study||296
225554|NCT00218335|536500|P2|18 Month Follow-up|Overall Study||108
225555|NCT00218335|536501|P1|18 Month Follow-up|Overall Study||101
225556|NCT00218335|536498|P4|12 Month Follow-up|Overall Study||303
225557|NCT00218335|536499|P3|12 Month Follow-up|Overall Study||244
225558|NCT00218335|536500|P2|12 Month Follow-up|Overall Study||102
225559|NCT00218335|536501|P1|12 Month Follow-up|Overall Study||95
225560|NCT00218335|536498|P4|6 Month Follow-up|Overall Study||301
225561|NCT00218335|536499|P3|6 Month Follow-up|Overall Study||219
225562|NCT00218335|536500|P2|6 Month Follow-up|Overall Study||99
225563|NCT00218335|536501|P1|6 Month Follow-up|Overall Study||103
225564|NCT00218335|536498|P4|STARTED|Overall Study||424
225565|NCT00218335|536499|P3|STARTED|Overall Study||373
225566|NCT00218335|536500|P2|STARTED|Overall Study||113
225567|NCT00218335|536501|P1|STARTED|Overall Study||114
225568|NCT00218296|536565|P2|NOT COMPLETED|Overall Study||121
225569|NCT00218296|536566|P1|NOT COMPLETED|Overall Study||111
225570|NCT00218296|536565|P2|COMPLETED|Overall Study||48
225571|NCT00218296|536566|P1|COMPLETED|Overall Study||52
225572|NCT00218296|536565|P2|STARTED|Overall Study||169
225573|NCT00218296|536566|P1|STARTED|Overall Study||163
225574|NCT00217971|536584|P2|NOT COMPLETED|Overall Study||33
225575|NCT00217971|536585|P1|NOT COMPLETED|Overall Study||24
225576|NCT00217971|536584|P2|COMPLETED|Overall Study||44
225577|NCT00217971|536585|P1|COMPLETED|Overall Study||55
225578|NCT00217971|536584|P2|STARTED|Overall Study||77
225579|NCT00217971|536585|P1|STARTED|Overall Study||79
225580|NCT00217724|536591|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
225581|NCT00217724|536592|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
225582|NCT00217724|536591|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
225583|NCT00217724|536592|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
225584|NCT00217724|536591|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
225585|NCT00217724|536592|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
225586|NCT00217724|536591|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
225587|NCT00217724|536592|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
225588|NCT00217724|536591|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
225589|NCT00217724|536592|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
225590|NCT00217724|536591|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
225591|NCT00217724|536592|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
225592|NCT00217672|536600|P2|NOT COMPLETED|Follow-up||0
225593|NCT00217672|536601|P1|NOT COMPLETED|Follow-up||5
225594|NCT00217672|536600|P2|COMPLETED|Follow-up||0
225595|NCT00217672|536601|P1|COMPLETED|Follow-up||69
225596|NCT00217672|536600|P2|STARTED|Follow-up||0
225597|NCT00217672|536601|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
225598|NCT00217672|536600|P2|NOT COMPLETED|Treatment||7
225599|NCT00217672|536601|P1|NOT COMPLETED|Treatment||67
225600|NCT00217672|536600|P2|COMPLETED|Treatment||0
225601|NCT00217672|536601|P1|COMPLETED|Treatment||0
225602|NCT00217672|536600|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
225603|NCT00217672|536601|P1|STARTED|Treatment||67
225604|NCT00217672|536600|P2|NOT COMPLETED|Allocation||0
225605|NCT00217672|536601|P1|NOT COMPLETED|Allocation||2
225606|NCT00217672|536600|P2|COMPLETED|Allocation||7
225607|NCT00217672|536601|P1|COMPLETED|Allocation||67
225608|NCT00217672|536600|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
225609|NCT00217672|536601|P1|STARTED|Allocation||69
225610|NCT00217620|536607|P1|NOT COMPLETED|Overall Study||51
225611|NCT00217620|536607|P1|COMPLETED|Overall Study||0
225612|NCT00217620|536607|P1|Eligible and Began Protocol Therapy|Overall Study||37
225613|NCT00217620|536607|P1|Eligible|Overall Study||38
225614|NCT00217620|536607|P1|STARTED|Overall Study||51
225615|NCT00217581|536618|P1|NOT COMPLETED|Overall Study||1
225616|NCT00217581|536618|P1|COMPLETED|Overall Study||38
225617|NCT00217581|536618|P1|STARTED|Overall Study||39
225618|NCT00217464|536622|P1|NOT COMPLETED|Overall Study||17
225619|NCT00217464|536622|P1|COMPLETED|Overall Study||0
225620|NCT00217464|536622|P1|STARTED|Overall Study||17
225621|NCT00217438|536629|P2|NOT COMPLETED|Overall Study||1
225622|NCT00217438|536630|P1|NOT COMPLETED|Overall Study||0
225713|NCT00216099|536770|P1|NOT COMPLETED|Overall Study||1
225623|NCT00217438|536629|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
225624|NCT00217438|536630|P1|COMPLETED|Overall Study||66
225625|NCT00217438|536629|P2|STARTED|Overall Study||64
225626|NCT00217438|536630|P1|STARTED|Overall Study||66
225627|NCT00217425|536638|P1|NOT COMPLETED|Overall Study||37
225628|NCT00217425|536638|P1|COMPLETED|Overall Study||9
225629|NCT00217425|536638|P1|Eligible and Treated|Overall Study||39
225630|NCT00217425|536638|P1|Treated|Overall Study||44
225631|NCT00217425|536638|P1|STARTED|Overall Study||46
225632|NCT00217399|536644|P1|NOT COMPLETED|Overall Study||0
225633|NCT00217399|536644|P1|COMPLETED|Overall Study||35
225634|NCT00217399|536644|P1|STARTED|Overall Study||35
225635|NCT00217087|536652|P2|NOT COMPLETED|Overall Study||20
225636|NCT00217087|536653|P1|NOT COMPLETED|Overall Study||11
225637|NCT00217087|536652|P2|COMPLETED|Overall Study||17
225638|NCT00217087|536653|P1|COMPLETED|Overall Study||25
225639|NCT00217087|536652|P2|STARTED|Overall Study||37
225640|NCT00217087|536653|P1|STARTED|Overall Study||36
225641|NCT00217022|536667|P2|NOT COMPLETED|Overall Study||1
225642|NCT00217022|536668|P1|NOT COMPLETED|Overall Study||1
225643|NCT00217022|536667|P2|COMPLETED|Overall Study||3
225644|NCT00217022|536668|P1|COMPLETED|Overall Study||11
225645|NCT00217022|536667|P2|STARTED|Overall Study||4
225646|NCT00217022|536668|P1|STARTED|Overall Study||12
225647|NCT00216736|536678|P2|NOT COMPLETED|Overall Study||1
225648|NCT00216736|536679|P1|NOT COMPLETED|Overall Study||1
225649|NCT00216736|536678|P2|COMPLETED|Overall Study||30
225650|NCT00216736|536679|P1|COMPLETED|Overall Study||31
225651|NCT00216736|536678|P2|STARTED|Overall Study||31
225652|NCT00216736|536679|P1|STARTED|Overall Study||32
225653|NCT00216671|536693|P2|NOT COMPLETED|Overall Study||50
225654|NCT00216671|536694|P1|NOT COMPLETED|Overall Study||35
225655|NCT00216671|536693|P2|COMPLETED|Overall Study||60
225656|NCT00216671|536694|P1|COMPLETED|Overall Study||75
225657|NCT00216671|536693|P2|STARTED|Overall Study||110
225658|NCT00216671|536694|P1|STARTED|Overall Study||110
225659|NCT00216476|536712|P3|NOT COMPLETED|Overall Study||17
225660|NCT00216476|536713|P2|NOT COMPLETED|Overall Study||107
225661|NCT00216476|536714|P1|NOT COMPLETED|Overall Study||105
225662|NCT00216476|536712|P3|COMPLETED|Overall Study||28
225663|NCT00216476|536713|P2|COMPLETED|Overall Study||230
225664|NCT00216476|536714|P1|COMPLETED|Overall Study||224
225665|NCT00216476|536712|P3|STARTED|Overall Study||45
225666|NCT00216476|536713|P2|STARTED|Overall Study||337
225667|NCT00216476|536714|P1|STARTED|Overall Study||329
225668|NCT00216320|536734|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
225669|NCT00216320|536735|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
225670|NCT00216320|536736|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
225671|NCT00216320|536734|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
225672|NCT00216320|536735|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
225673|NCT00216320|536736|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
225674|NCT00216320|536734|P3|STARTED|Phase 2 (Weeks 6 -12)||25
225675|NCT00216320|536735|P2|STARTED|Phase 2 (Weeks 6 -12)||35
225676|NCT00216320|536736|P1|STARTED|Phase 2 (Weeks 6 -12)||43
225677|NCT00216320|536734|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
225678|NCT00216320|536735|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
225679|NCT00216320|536736|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
225680|NCT00216320|536734|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
225681|NCT00216320|536735|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
225682|NCT00216320|536736|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
225683|NCT00216320|536734|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
225684|NCT00216320|536735|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
225685|NCT00216320|536736|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
225686|NCT00216203|536751|P1|NOT COMPLETED|Overall Study||2
225687|NCT00216203|536751|P1|COMPLETED|Overall Study||34
225688|NCT00216203|536751|P1|STARTED|Overall Study||36
225689|NCT00216125|536759|P3|NOT COMPLETED|Randomization Phase||8
225690|NCT00216125|536760|P2|NOT COMPLETED|Randomization Phase||11
225691|NCT00216125|536761|P1|NOT COMPLETED|Randomization Phase||0
225692|NCT00216125|536759|P3|COMPLETED|Randomization Phase||74
225693|NCT00216125|536760|P2|COMPLETED|Randomization Phase||73
225694|NCT00216125|536761|P1|COMPLETED|Randomization Phase||0
225695|NCT00216125|536759|P3|DSMB Cohort for Futility|Randomization Phase||74
225696|NCT00216125|536760|P2|DSMB Cohort for Futility|Randomization Phase||73
225697|NCT00216125|536761|P1|DSMB Cohort for Futility|Randomization Phase||0
225698|NCT00216125|536759|P3|STARTED|Randomization Phase||82
225699|NCT00216125|536760|P2|STARTED|Randomization Phase||84
225700|NCT00216125|536761|P1|STARTED|Randomization Phase||0
225701|NCT00216125|536759|P3|NOT COMPLETED|Pre-Randomization Phase||0
225702|NCT00216125|536760|P2|NOT COMPLETED|Pre-Randomization Phase||0
225703|NCT00216125|536761|P1|NOT COMPLETED|Pre-Randomization Phase||77
225704|NCT00216125|536759|P3|COMPLETED|Pre-Randomization Phase||0
225705|NCT00216125|536760|P2|COMPLETED|Pre-Randomization Phase||0
225706|NCT00216125|536761|P1|COMPLETED|Pre-Randomization Phase||166
225707|NCT00216125|536759|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
225708|NCT00216125|536760|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
225709|NCT00216125|536761|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
225710|NCT00216125|536759|P3|STARTED|Pre-Randomization Phase||0
225711|NCT00216125|536760|P2|STARTED|Pre-Randomization Phase||0
225712|NCT00216125|536761|P1|STARTED|Pre-Randomization Phase||243
225714|NCT00216099|536770|P1|COMPLETED|Overall Study||48
225715|NCT00216099|536770|P1|Response Analysis|Overall Study||48
225716|NCT00216099|536770|P1|Toxicity Analysis|Overall Study||49
225717|NCT00216099|536770|P1|STARTED|Overall Study||49
225718|NCT00216086|536781|P1|NOT COMPLETED|Overall Study||4
225719|NCT00216086|536781|P1|COMPLETED|Overall Study||18
225720|NCT00216086|536781|P1|STARTED|Overall Study||22
225721|NCT00216060|536790|P2|NOT COMPLETED|Overall Study||0
225722|NCT00216060|536791|P1|NOT COMPLETED|Overall Study||0
225723|NCT00216060|536790|P2|COMPLETED|Overall Study||31
225724|NCT00216060|536791|P1|COMPLETED|Overall Study||32
225725|NCT00216060|536790|P2|STARTED|Overall Study||31
225726|NCT00216060|536791|P1|STARTED|Overall Study||32
225727|NCT00215943|536813|P2|NOT COMPLETED|Overall Study||14
225728|NCT00215943|536814|P1|NOT COMPLETED|Overall Study||9
225729|NCT00215943|536813|P2|COMPLETED|Overall Study||23
225730|NCT00215943|536814|P1|COMPLETED|Overall Study||27
225731|NCT00215943|536813|P2|STARTED|Overall Study||37
225732|NCT00215943|536814|P1|STARTED|Overall Study||36
225733|NCT00215930|536826|P1|NOT COMPLETED|Overall Study||0
225734|NCT00215930|536826|P1|COMPLETED|Overall Study||53
225735|NCT00215930|536826|P1|STARTED|Overall Study||53
225736|NCT00215787|536832|P1|NOT COMPLETED|Overall Study||0
225737|NCT00215787|536832|P1|COMPLETED|Overall Study||20
225738|NCT00215787|536832|P1|STARTED|Overall Study||20
225739|NCT00215683|536839|P3|NOT COMPLETED|Overall Study||32
225740|NCT00215683|536840|P2|NOT COMPLETED|Overall Study||26
225741|NCT00215683|536841|P1|NOT COMPLETED|Overall Study||29
225742|NCT00215683|536839|P3|COMPLETED|Overall Study||12
225743|NCT00215683|536840|P2|COMPLETED|Overall Study||22
225744|NCT00215683|536841|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
225745|NCT00215683|536839|P3|Switched to 160 mg|Overall Study||36
225746|NCT00215683|536840|P2|Switched to 160 mg|Overall Study||41
225747|NCT00215683|536841|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
225748|NCT00215683|536839|P3|STARTED|Overall Study||44
225749|NCT00215683|536840|P2|STARTED|Overall Study||48
225750|NCT00215683|536841|P1|STARTED|Overall Study|Safety analysis set|45
225751|NCT00215657|536860|P8|NOT COMPLETED|Overall Study||16
225752|NCT00215657|536861|P7|NOT COMPLETED|Overall Study||23
225753|NCT00215657|536862|P6|NOT COMPLETED|Overall Study||20
225754|NCT00215657|536863|P5|NOT COMPLETED|Overall Study||23
225755|NCT00215657|536864|P4|NOT COMPLETED|Overall Study||18
225756|NCT00215657|536865|P3|NOT COMPLETED|Overall Study||11
225757|NCT00215657|536866|P2|NOT COMPLETED|Overall Study||11
225758|NCT00215657|536867|P1|NOT COMPLETED|Overall Study||22
225759|NCT00215657|536860|P8|COMPLETED|Overall Study||11
225760|NCT00215657|536861|P7|COMPLETED|Overall Study||4
225761|NCT00215657|536862|P6|COMPLETED|Overall Study||4
225762|NCT00215657|536863|P5|COMPLETED|Overall Study||4
225763|NCT00215657|536864|P4|COMPLETED|Overall Study||6
225764|NCT00215657|536865|P3|COMPLETED|Overall Study||2
225765|NCT00215657|536866|P2|COMPLETED|Overall Study||1
225766|NCT00215657|536867|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
225767|NCT00215657|536860|P8|Started FE200486 CS07A|Overall Study||23
225768|NCT00215657|536861|P7|Started FE200486 CS07A|Overall Study||14
225769|NCT00215657|536862|P6|Started FE200486 CS07A|Overall Study||20
225770|NCT00215657|536863|P5|Started FE200486 CS07A|Overall Study||17
225771|NCT00215657|536864|P4|Started FE200486 CS07A|Overall Study||24
225772|NCT00215657|536865|P3|Started FE200486 CS07A|Overall Study||7
225773|NCT00215657|536866|P2|Started FE200486 CS07A|Overall Study||6
225774|NCT00215657|536867|P1|Started FE200486 CS07A|Overall Study||20
225775|NCT00215657|536860|P8|Intention-to-treat Population|Overall Study||27
225776|NCT00215657|536861|P7|Intention-to-treat Population|Overall Study||24
225777|NCT00215657|536862|P6|Intention-to-treat Population|Overall Study||24
225778|NCT00215657|536863|P5|Intention-to-treat Population|Overall Study||24
225779|NCT00215657|536864|P4|Intention-to-treat Population|Overall Study||24
225780|NCT00215657|536865|P3|Intention-to-treat Population|Overall Study||12
225781|NCT00215657|536866|P2|Intention-to-treat Population|Overall Study||12
225782|NCT00215657|536867|P1|Intention-to-treat Population|Overall Study||25
225783|NCT00215657|536860|P8|STARTED|Overall Study||27
225784|NCT00215657|536861|P7|STARTED|Overall Study||27
225785|NCT00215657|536862|P6|STARTED|Overall Study||24
225786|NCT00215657|536863|P5|STARTED|Overall Study||27
225787|NCT00215657|536864|P4|STARTED|Overall Study||24
225788|NCT00215657|536865|P3|STARTED|Overall Study||13
225789|NCT00215657|536866|P2|STARTED|Overall Study||12
225790|NCT00215657|536867|P1|STARTED|Overall Study||26
225791|NCT00215553|536900|P7|NOT COMPLETED|Overall Study||0
225792|NCT00215553|536901|P6|NOT COMPLETED|Overall Study||6
225793|NCT00215553|536902|P5|NOT COMPLETED|Overall Study||2
225794|NCT00215553|536903|P4|NOT COMPLETED|Overall Study||1
225795|NCT00215553|536904|P3|NOT COMPLETED|Overall Study||2
225796|NCT00215553|536905|P2|NOT COMPLETED|Overall Study||1
225797|NCT00215553|536906|P1|NOT COMPLETED|Overall Study||0
225798|NCT00215553|536900|P7|COMPLETED|Overall Study||36
225799|NCT00215553|536901|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
225800|NCT00215553|536902|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
225801|NCT00215553|536903|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
225802|NCT00215553|536904|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
225803|NCT00215553|536905|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
225804|NCT00215553|536906|P1|COMPLETED|Overall Study||5
225805|NCT00215553|536900|P7|STARTED|Overall Study||36
225806|NCT00215553|536901|P6|STARTED|Overall Study||38
225807|NCT00215553|536902|P5|STARTED|Overall Study||28
225808|NCT00215553|536903|P4|STARTED|Overall Study||5
225809|NCT00215553|536904|P3|STARTED|Overall Study||6
225810|NCT00215553|536905|P2|STARTED|Overall Study||6
225811|NCT00215553|536906|P1|STARTED|Overall Study||5
225812|NCT00215540|536939|P3|NOT COMPLETED|Overall Study||0
225813|NCT00215540|536940|P2|NOT COMPLETED|Overall Study||0
225814|NCT00215540|536941|P1|NOT COMPLETED|Overall Study||1
225815|NCT00215540|536939|P3|COMPLETED|Overall Study||44
225816|NCT00215540|536940|P2|COMPLETED|Overall Study||47
225817|NCT00215540|536941|P1|COMPLETED|Overall Study||44
225818|NCT00215540|536939|P3|STARTED|Overall Study||44
225819|NCT00215540|536940|P2|STARTED|Overall Study||47
225820|NCT00215540|536941|P1|STARTED|Overall Study||45
225821|NCT00215150|536976|P1|NOT COMPLETED|Randomization Phase Placebo||1
225822|NCT00215150|536976|P1|COMPLETED|Randomization Phase Placebo||10
225823|NCT00215150|536976|P1|STARTED|Randomization Phase Placebo||11
225824|NCT00215150|536976|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
225825|NCT00215150|536976|P1|COMPLETED|Randomization Phase Ziprasidone||7
225826|NCT00215150|536976|P1|STARTED|Randomization Phase Ziprasidone||10
225827|NCT00215150|536976|P1|NOT COMPLETED|Open Label Phase||30
225828|NCT00215150|536976|P1|COMPLETED|Open Label Phase||21
225829|NCT00215150|536976|P1|STARTED|Open Label Phase|Number of subjects consented|51
225830|NCT00215137|536984|P3|NOT COMPLETED|Randomization Period||0
225831|NCT00215137|536985|P2|NOT COMPLETED|Randomization Period||2
225832|NCT00215137|536986|P1|NOT COMPLETED|Randomization Period||0
225833|NCT00215137|536984|P3|COMPLETED|Randomization Period||5
225834|NCT00215137|536985|P2|COMPLETED|Randomization Period||5
225835|NCT00215137|536986|P1|COMPLETED|Randomization Period||0
225836|NCT00215137|536984|P3|STARTED|Randomization Period||5
225837|NCT00215137|536985|P2|STARTED|Randomization Period||7
225838|NCT00215137|536986|P1|STARTED|Randomization Period||0
225839|NCT00215137|536984|P3|NOT COMPLETED|Open Label Escitalopram||0
225840|NCT00215137|536985|P2|NOT COMPLETED|Open Label Escitalopram||0
225841|NCT00215137|536986|P1|NOT COMPLETED|Open Label Escitalopram||1
225842|NCT00215137|536984|P3|COMPLETED|Open Label Escitalopram||0
225843|NCT00215137|536985|P2|COMPLETED|Open Label Escitalopram||0
225844|NCT00215137|536986|P1|COMPLETED|Open Label Escitalopram||13
225845|NCT00215137|536984|P3|STARTED|Open Label Escitalopram||0
225846|NCT00215137|536985|P2|STARTED|Open Label Escitalopram||0
225847|NCT00215137|536986|P1|STARTED|Open Label Escitalopram||14
225848|NCT00214201|536996|P2|NOT COMPLETED|Overall Study||2
225849|NCT00214201|536997|P1|NOT COMPLETED|Overall Study||2
225850|NCT00214201|536996|P2|COMPLETED|Overall Study||18
225851|NCT00214201|536997|P1|COMPLETED|Overall Study||18
225852|NCT00214201|536996|P2|STARTED|Overall Study||20
225853|NCT00214201|536997|P1|STARTED|Overall Study||20
225854|NCT00214903|537011|P4|NOT COMPLETED|Overall Study||0
225855|NCT00214903|537012|P3|NOT COMPLETED|Overall Study||0
225856|NCT00214903|537013|P2|NOT COMPLETED|Overall Study||0
225857|NCT00214903|537014|P1|NOT COMPLETED|Overall Study||0
225858|NCT00214903|537011|P4|COMPLETED|Overall Study||3057
225859|NCT00214903|537012|P3|COMPLETED|Overall Study||4113
225860|NCT00214903|537013|P2|COMPLETED|Overall Study||13384
225861|NCT00214903|537014|P1|COMPLETED|Overall Study||10043
225862|NCT00214903|537011|P4|STARTED|Overall Study||3057
225863|NCT00214903|537012|P3|STARTED|Overall Study||4113
225864|NCT00214903|537013|P2|STARTED|Overall Study||13384
225865|NCT00214903|537014|P1|STARTED|Overall Study||10043
225866|NCT00214786|537028|P1|NOT COMPLETED|Overall Study||3
225867|NCT00214786|537028|P1|COMPLETED|Overall Study||1
225868|NCT00214786|537028|P1|STARTED|Overall Study||4
225869|NCT00214539|537043|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
225870|NCT00214539|537044|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
225871|NCT00214539|537043|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
225872|NCT00214539|537044|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
225873|NCT00214539|537043|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
225874|NCT00214539|537044|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
225875|NCT00214539|537043|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
225876|NCT00214539|537044|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
225877|NCT00214539|537043|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
225878|NCT00214539|537044|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
225879|NCT00214539|537043|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
225880|NCT00214539|537044|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
225881|NCT00214539|537043|P2|NOT COMPLETED|Treatment Period||0
225882|NCT00214539|537044|P1|NOT COMPLETED|Treatment Period||0
225883|NCT00214539|537043|P2|COMPLETED|Treatment Period||17
225884|NCT00214539|537044|P1|COMPLETED|Treatment Period||15
225885|NCT00214539|537043|P2|STARTED|Treatment Period||17
225886|NCT00214539|537044|P1|STARTED|Treatment Period||15
225887|NCT00214539|537043|P2|NOT COMPLETED|Randomized||0
225888|NCT00214539|537044|P1|NOT COMPLETED|Randomized||2
225889|NCT00214539|537043|P2|COMPLETED|Randomized||17
225890|NCT00214539|537044|P1|COMPLETED|Randomized||15
225891|NCT00214539|537043|P2|STARTED|Randomized||17
225892|NCT00214539|537044|P1|STARTED|Randomized||17
225893|NCT00214526|537070|P2|NOT COMPLETED|Post-Treatment Period||0
225894|NCT00214526|537071|P1|NOT COMPLETED|Post-Treatment Period||1
225895|NCT00214526|537070|P2|COMPLETED|Post-Treatment Period||49
225896|NCT00214526|537071|P1|COMPLETED|Post-Treatment Period||52
225897|NCT00214526|537070|P2|STARTED|Post-Treatment Period||49
225898|NCT00214526|537071|P1|STARTED|Post-Treatment Period||53
225899|NCT00214526|537070|P2|NOT COMPLETED|Treatment Period||5
225900|NCT00214526|537071|P1|NOT COMPLETED|Treatment Period||2
225901|NCT00214526|537070|P2|COMPLETED|Treatment Period||49
225902|NCT00214526|537071|P1|COMPLETED|Treatment Period||53
225903|NCT00214526|537070|P2|STARTED|Treatment Period||54
225904|NCT00214526|537071|P1|STARTED|Treatment Period||55
225905|NCT00214526|537070|P2|NOT COMPLETED|Randomized||2
225906|NCT00214526|537071|P1|NOT COMPLETED|Randomized||1
225907|NCT00214526|537070|P2|COMPLETED|Randomized||54
225908|NCT00214526|537071|P1|COMPLETED|Randomized||55
225909|NCT00214526|537070|P2|STARTED|Randomized||56
225910|NCT00214526|537071|P1|STARTED|Randomized||56
225911|NCT00214487|537099|P2|NOT COMPLETED|Overall Study||3
225912|NCT00214487|537100|P1|NOT COMPLETED|Overall Study||5
225913|NCT00214487|537099|P2|COMPLETED|Overall Study||40
225914|NCT00214487|537100|P1|COMPLETED|Overall Study||38
225915|NCT00214487|537099|P2|STARTED|Overall Study||43
225916|NCT00214487|537100|P1|STARTED|Overall Study||43
225917|NCT00214461|537110|P4|NOT COMPLETED|Overall Study||1
225918|NCT00214461|537111|P3|NOT COMPLETED|Overall Study||2
225919|NCT00214461|537112|P2|NOT COMPLETED|Overall Study||0
225920|NCT00214461|537113|P1|NOT COMPLETED|Overall Study||0
225921|NCT00214461|537110|P4|COMPLETED|Overall Study||11
225922|NCT00214461|537111|P3|COMPLETED|Overall Study||10
225923|NCT00214461|537112|P2|COMPLETED|Overall Study||12
225924|NCT00214461|537113|P1|COMPLETED|Overall Study||12
225925|NCT00214461|537110|P4|STARTED|Overall Study||12
225926|NCT00214461|537111|P3|STARTED|Overall Study||12
225927|NCT00214461|537112|P2|STARTED|Overall Study||12
225928|NCT00214461|537113|P1|STARTED|Overall Study||12
225929|NCT00214383|537129|P2|NOT COMPLETED|Overall Study||26
225930|NCT00214383|537130|P1|NOT COMPLETED|Overall Study||16
225931|NCT00214383|537129|P2|COMPLETED|Overall Study||127
225932|NCT00214383|537130|P1|COMPLETED|Overall Study||132
225933|NCT00214383|537129|P2|STARTED|Overall Study||153
225934|NCT00214383|537130|P1|STARTED|Overall Study||148
225935|NCT00214019|537140|P1|NOT COMPLETED|Overall Study||30
225936|NCT00214019|537140|P1|COMPLETED|Overall Study||6
225937|NCT00214019|537140|P1|Fluticasone/Salmeterol Arm|Overall Study||6
225938|NCT00214019|537140|P1|Fluticasone/Placebo Arm|Overall Study||6
225939|NCT00214019|537140|P1|Placebo/Salmeterol Arm|Overall Study||6
225940|NCT00214019|537140|P1|Placebo/Placebo Arm|Overall Study||6
225941|NCT00214019|537140|P1|STARTED|Overall Study||36
225942|NCT00213135|537150|P3|NOT COMPLETED|Overall Study||57
225943|NCT00213135|537151|P2|NOT COMPLETED|Overall Study||35
225944|NCT00213135|537152|P1|NOT COMPLETED|Overall Study||50
225945|NCT00213135|537150|P3|COMPLETED|Overall Study||380
225946|NCT00213135|537151|P2|COMPLETED|Overall Study||398
225947|NCT00213135|537152|P1|COMPLETED|Overall Study||406
225948|NCT00213135|537150|P3|STARTED|Overall Study||437
225949|NCT00213135|537151|P2|STARTED|Overall Study||433
225950|NCT00213135|537152|P1|STARTED|Overall Study||456
225951|NCT00211536|537171|P2|NOT COMPLETED|Overall Study||7
225952|NCT00211536|537172|P1|NOT COMPLETED|Overall Study||4
225953|NCT00211536|537171|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
225954|NCT00211536|537172|P1|COMPLETED|Overall Study||49
225955|NCT00211536|537171|P2|As Treated Data Analysis Set|Overall Study||48
225956|NCT00211536|537172|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
225957|NCT00211536|537171|P2|STARTED|Overall Study||54
225958|NCT00211536|537172|P1|STARTED|Overall Study||53
225959|NCT00211510|537188|P2|NOT COMPLETED|Overall Study||2
225960|NCT00211510|537189|P1|NOT COMPLETED|Overall Study||6
225961|NCT00211510|537188|P2|COMPLETED|Overall Study||72
225962|NCT00211510|537189|P1|COMPLETED|Overall Study||66
225963|NCT00211510|537188|P2|STARTED|Overall Study||74
225964|NCT00211510|537189|P1|STARTED|Overall Study||72
225965|NCT00212758|537205|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
225966|NCT00212758|537206|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
225967|NCT00212758|537205|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
225968|NCT00212758|537206|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
225969|NCT00212758|537205|P2|STARTED|Standard Therapy of GH (12 Months)||9
225970|NCT00212758|537206|P1|STARTED|Standard Therapy of GH (12 Months)||8
225971|NCT00212758|537205|P2|NOT COMPLETED|Second Intervention (7 Days)||0
225972|NCT00212758|537206|P1|NOT COMPLETED|Second Intervention (7 Days)||0
225973|NCT00212758|537205|P2|COMPLETED|Second Intervention (7 Days)||9
225974|NCT00212758|537206|P1|COMPLETED|Second Intervention (7 Days)||8
225975|NCT00212758|537205|P2|STARTED|Second Intervention (7 Days)||9
225976|NCT00212758|537206|P1|STARTED|Second Intervention (7 Days)||8
225977|NCT00212758|537205|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
225978|NCT00212758|537206|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
225979|NCT00212758|537205|P2|COMPLETED|Wash Out Period (2 Weeks)||9
225980|NCT00212758|537206|P1|COMPLETED|Wash Out Period (2 Weeks)||8
225981|NCT00212758|537205|P2|STARTED|Wash Out Period (2 Weeks)||9
225982|NCT00212758|537206|P1|STARTED|Wash Out Period (2 Weeks)||8
225983|NCT00212758|537205|P2|NOT COMPLETED|First Intervention (7 Days)||0
225984|NCT00212758|537206|P1|NOT COMPLETED|First Intervention (7 Days)||0
225985|NCT00212758|537205|P2|COMPLETED|First Intervention (7 Days)||9
225986|NCT00212758|537206|P1|COMPLETED|First Intervention (7 Days)||8
225987|NCT00212758|537205|P2|STARTED|First Intervention (7 Days)||9
225988|NCT00212758|537206|P1|STARTED|First Intervention (7 Days)||8
225989|NCT00212355|537212|P1|NOT COMPLETED|Overall Study||3
225990|NCT00212355|537212|P1|COMPLETED|Overall Study||34
225991|NCT00212355|537212|P1|STARTED|Overall Study||37
225992|NCT00212264|537219|P3|NOT COMPLETED|Overall Study||4
225993|NCT00212264|537220|P2|NOT COMPLETED|Overall Study||16
225994|NCT00212264|537221|P1|NOT COMPLETED|Overall Study||12
225995|NCT00212264|537219|P3|COMPLETED|Overall Study||64
225996|NCT00212264|537220|P2|COMPLETED|Overall Study||54
225997|NCT00212264|537221|P1|COMPLETED|Overall Study||58
225998|NCT00212264|537219|P3|STARTED|Overall Study||68
225999|NCT00212264|537220|P2|STARTED|Overall Study||70
226000|NCT00212264|537221|P1|STARTED|Overall Study||70
226001|NCT00212134|537233|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
226002|NCT00212134|537234|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
226003|NCT00212134|537233|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
226004|NCT00212134|537234|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
226005|NCT00212134|537233|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
226006|NCT00212134|537234|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
226007|NCT00212134|537233|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
226008|NCT00212134|537234|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
226009|NCT00212134|537233|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
226010|NCT00212134|537234|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
226011|NCT00212134|537233|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
226012|NCT00212134|537234|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
226013|NCT00212134|537233|P2|STARTED|Phase 1 (to Age 1 Year)||57
226014|NCT00212134|537234|P1|STARTED|Phase 1 (to Age 1 Year)||57
226015|NCT00211887|537255|P3|NOT COMPLETED|Overall Study||36
226016|NCT00211887|537256|P2|NOT COMPLETED|Overall Study||56
226017|NCT00211887|537257|P1|NOT COMPLETED|Overall Study||102
226018|NCT00211887|537255|P3|COMPLETED|Overall Study||223
226019|NCT00211887|537256|P2|COMPLETED|Overall Study||194
226020|NCT00211887|537257|P1|COMPLETED|Overall Study||397
226021|NCT00211887|537255|P3|STARTED|Overall Study||259
226022|NCT00211887|537256|P2|STARTED|Overall Study||250
226023|NCT00211887|537257|P1|STARTED|Overall Study||499
226024|NCT00211692|537276|P2|NOT COMPLETED|Overall Study||0
226025|NCT00211692|537277|P1|NOT COMPLETED|Overall Study||0
226026|NCT00211692|537276|P2|COMPLETED|Overall Study||31
226027|NCT00211692|537277|P1|COMPLETED|Overall Study||33
226028|NCT00211692|537276|P2|STARTED|Overall Study||31
226029|NCT00211692|537277|P1|STARTED|Overall Study||33
226030|NCT00211237|537287|P2|NOT COMPLETED|Overall Study||30
226031|NCT00211237|537288|P1|NOT COMPLETED|Overall Study||30
226032|NCT00211237|537287|P2|COMPLETED|Overall Study||34
226033|NCT00211237|537288|P1|COMPLETED|Overall Study||40
226034|NCT00211237|537287|P2|STARTED|Overall Study||64
226035|NCT00211237|537288|P1|STARTED|Overall Study||70
226036|NCT00211172|537296|P2|NOT COMPLETED|Overall Study||32
226037|NCT00211172|537297|P1|NOT COMPLETED|Overall Study||39
226038|NCT00211172|537296|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
226039|NCT00211172|537297|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
226040|NCT00211172|537296|P2|STARTED|Overall Study||458
226041|NCT00211172|537297|P1|STARTED|Overall Study||449
226042|NCT00211081|537303|P1|NOT COMPLETED|Overall Study||2
226043|NCT00211081|537303|P1|COMPLETED|Overall Study|Study completed in 2008|10
226044|NCT00211081|537303|P1|STARTED|Overall Study|Study started in 2006|12
226045|NCT00210639|537309|P2|NOT COMPLETED|Overall Study||42
226046|NCT00210639|537310|P1|NOT COMPLETED|Overall Study||63
226047|NCT00210639|537309|P2|COMPLETED|Overall Study||41
226048|NCT00210639|537310|P1|COMPLETED|Overall Study||61
226049|NCT00210639|537309|P2|STARTED|Overall Study||83
226050|NCT00210639|537310|P1|STARTED|Overall Study||124
226051|NCT00210626|537318|P2|NOT COMPLETED|Overall Study||45
226052|NCT00210626|537319|P1|NOT COMPLETED|Overall Study||48
226053|NCT00210626|537318|P2|COMPLETED|Overall Study||50
226054|NCT00210626|537319|P1|COMPLETED|Overall Study||49
226055|NCT00210626|537318|P2|STARTED|Overall Study||95
226056|NCT00210626|537319|P1|STARTED|Overall Study||97
226057|NCT00210470|537327|P1|NOT COMPLETED|Overall Study||1
226058|NCT00210470|537327|P1|COMPLETED|Overall Study||26
226059|NCT00210470|537327|P1|STARTED|Overall Study||27
226060|NCT00209560|537333|P2|NOT COMPLETED|Overall Study||0
226061|NCT00209560|537334|P1|NOT COMPLETED|Overall Study||1
226062|NCT00209560|537333|P2|COMPLETED|Overall Study||42
226063|NCT00209560|537334|P1|COMPLETED|Overall Study||120
226064|NCT00209560|537333|P2|STARTED|Overall Study||42
226065|NCT00209560|537334|P1|STARTED|Overall Study||121
226066|NCT00209417|537344|P2|NOT COMPLETED|Overall Study||0
226067|NCT00209417|537345|P1|NOT COMPLETED|Overall Study||0
226068|NCT00209417|537344|P2|COMPLETED|Overall Study||327
226069|NCT00209417|537345|P1|COMPLETED|Overall Study||321
226070|NCT00209417|537344|P2|STARTED|Overall Study||327
226071|NCT00209417|537345|P1|STARTED|Overall Study||321
226072|NCT00209339|537353|P1|NOT COMPLETED|At 5 Years Follow-up||8
226073|NCT00209339|537353|P1|COMPLETED|At 5 Years Follow-up||15
226074|NCT00209339|537353|P1|STARTED|At 5 Years Follow-up||23
226075|NCT00209339|537353|P1|NOT COMPLETED|At 4 Years Follow-up||5
226076|NCT00209339|537353|P1|COMPLETED|At 4 Years Follow-up||23
226077|NCT00209339|537353|P1|STARTED|At 4 Years Follow-up||28
226078|NCT00209339|537353|P1|NOT COMPLETED|At 3 Years Follow-up||1
226079|NCT00209339|537353|P1|COMPLETED|At 3 Years Follow-up||28
226080|NCT00209339|537353|P1|STARTED|At 3 Years Follow-up||29
226081|NCT00209339|537353|P1|NOT COMPLETED|At 24 Months Follow-up||11
226082|NCT00209339|537353|P1|COMPLETED|At 24 Months Follow-up||29
226083|NCT00209339|537353|P1|STARTED|At 24 Months Follow-up||40
226084|NCT00209339|537353|P1|NOT COMPLETED|At 12 Months Follow-up||15
226085|NCT00209339|537353|P1|COMPLETED|At 12 Months Follow-up||40
226086|NCT00209339|537353|P1|STARTED|At 12 Months Follow-up||55
226087|NCT00209170|537437|P2|NOT COMPLETED|Overall Study||3
226088|NCT00209170|537438|P1|NOT COMPLETED|Overall Study||2
226089|NCT00209170|537437|P2|COMPLETED|Overall Study||4
226090|NCT00209170|537438|P1|COMPLETED|Overall Study||5
226091|NCT00209170|537437|P2|STARTED|Overall Study||7
226092|NCT00209170|537438|P1|STARTED|Overall Study||7
226093|NCT00209131|537446|P2|NOT COMPLETED|Overall Study||11
226094|NCT00209131|537447|P1|NOT COMPLETED|Overall Study||15
226095|NCT00209131|537446|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
226096|NCT00209131|537447|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
226097|NCT00209131|537446|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
226098|NCT00209131|537447|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
226099|NCT00209092|537457|P2|NOT COMPLETED|Overall Study||2
226100|NCT00209092|537458|P1|NOT COMPLETED|Overall Study||8
226101|NCT00209092|537457|P2|COMPLETED|Overall Study||24
226102|NCT00209092|537458|P1|COMPLETED|Overall Study||17
226103|NCT00209092|537457|P2|STARTED|Overall Study||26
226104|NCT00209092|537458|P1|STARTED|Overall Study||25
226105|NCT00209027|537468|P2|NOT COMPLETED|Overall Study||0
226106|NCT00209027|537469|P1|NOT COMPLETED|Overall Study||10
226107|NCT00209027|537468|P2|COMPLETED|Overall Study||10
226108|NCT00209027|537469|P1|COMPLETED|Overall Study||0
226109|NCT00209027|537468|P2|STARTED|Overall Study||10
226110|NCT00209027|537469|P1|STARTED|Overall Study||10
226111|NCT00208975|537475|P1|NOT COMPLETED|Overall Study||0
226112|NCT00208975|537475|P1|COMPLETED|Overall Study||15
226113|NCT00208975|537475|P1|STARTED|Overall Study||15
226114|NCT00208949|537482|P2|NOT COMPLETED|Overall Study||0
226115|NCT00208949|537483|P1|NOT COMPLETED|Overall Study||0
226116|NCT00208949|537482|P2|COMPLETED|Overall Study||25
226117|NCT00208949|537483|P1|COMPLETED|Overall Study||25
226118|NCT00208949|537482|P2|STARTED|Overall Study||25
226119|NCT00208949|537483|P1|STARTED|Overall Study||25
226120|NCT00208767|537493|P2|NOT COMPLETED|Overall Study||7
226121|NCT00208767|537494|P1|NOT COMPLETED|Overall Study||27
226122|NCT00208767|537493|P2|COMPLETED|Overall Study||33
226123|NCT00208767|537494|P1|COMPLETED|Overall Study||53
226124|NCT00208767|537493|P2|STARTED|Overall Study||40
226125|NCT00208767|537494|P1|STARTED|Overall Study||80
226126|NCT00208507|537502|P2|NOT COMPLETED|Overall Study||8
226127|NCT00208507|537503|P1|NOT COMPLETED|Overall Study||14
226128|NCT00208507|537502|P2|COMPLETED|Overall Study||79
226129|NCT00208507|537503|P1|COMPLETED|Overall Study||163
226130|NCT00208507|537502|P2|STARTED|Overall Study||87
226131|NCT00208507|537503|P1|STARTED|Overall Study||177
226132|NCT00208494|537511|P2|NOT COMPLETED|Overall Study||34
226133|NCT00208494|537512|P1|NOT COMPLETED|Overall Study||30
226134|NCT00208494|537511|P2|COMPLETED|Overall Study||162
226135|NCT00208494|537512|P1|COMPLETED|Overall Study||164
226136|NCT00208494|537511|P2|STARTED|Overall Study||196
226137|NCT00208494|537512|P1|STARTED|Overall Study||194
226138|NCT00208325|537522|P4|NOT COMPLETED|Overall Study||14
226139|NCT00208325|537523|P3|NOT COMPLETED|Overall Study||14
226140|NCT00208325|537524|P2|NOT COMPLETED|Overall Study||54
226141|NCT00208325|537525|P1|NOT COMPLETED|Overall Study||51
226142|NCT00208325|537522|P4|COMPLETED|Overall Study||147
226143|NCT00208325|537523|P3|COMPLETED|Overall Study||156
226144|NCT00208325|537524|P2|COMPLETED|Overall Study||142
226145|NCT00208325|537525|P1|COMPLETED|Overall Study||142
226146|NCT00208325|537522|P4|STARTED|Overall Study||161
226147|NCT00208325|537523|P3|STARTED|Overall Study||170
226148|NCT00208325|537524|P2|STARTED|Overall Study||196
226149|NCT00208325|537525|P1|STARTED|Overall Study||193
226150|NCT00208091|537633|P1|NOT COMPLETED|Overall Study||0
226151|NCT00208091|537633|P1|COMPLETED|Overall Study||16
226152|NCT00208091|537633|P1|STARTED|Overall Study||16
226153|NCT00208026|537641|P1|NOT COMPLETED|Overall Study||0
226154|NCT00208026|537641|P1|COMPLETED|Overall Study||3
226155|NCT00208026|537641|P1|STARTED|Overall Study||3
226156|NCT00207740|537649|P4|NOT COMPLETED|Overall Study||43
226157|NCT00207740|537650|P3|NOT COMPLETED|Overall Study||40
226158|NCT00207740|537651|P2|NOT COMPLETED|Overall Study||41
226159|NCT00207740|537652|P1|NOT COMPLETED|Overall Study||29
226241|NCT00206102|537848|P2|COMPLETED|Overall Study||187
226160|NCT00207740|537649|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
226161|NCT00207740|537650|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
226162|NCT00207740|537651|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
226163|NCT00207740|537652|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
226164|NCT00207740|537649|P4|STARTED|Overall Study||78
226165|NCT00207740|537650|P3|STARTED|Overall Study||76
226166|NCT00207740|537651|P2|STARTED|Overall Study||77
226167|NCT00207740|537652|P1|STARTED|Overall Study||78
226168|NCT00207727|537698|P5|NOT COMPLETED|Overall Study||34
226169|NCT00207727|537699|P4|NOT COMPLETED|Overall Study||37
226170|NCT00207727|537700|P3|NOT COMPLETED|Overall Study||41
226171|NCT00207727|537701|P2|NOT COMPLETED|Overall Study||42
226172|NCT00207727|537702|P1|NOT COMPLETED|Overall Study||38
226173|NCT00207727|537698|P5|COMPLETED|Overall Study||16
226174|NCT00207727|537699|P4|COMPLETED|Overall Study||13
226175|NCT00207727|537700|P3|COMPLETED|Overall Study||9
226176|NCT00207727|537701|P2|COMPLETED|Overall Study||8
226177|NCT00207727|537702|P1|COMPLETED|Overall Study||11
226178|NCT00207727|537698|P5|STARTED|Overall Study||50
226179|NCT00207727|537699|P4|STARTED|Overall Study||50
226180|NCT00207727|537700|P3|STARTED|Overall Study||50
226181|NCT00207727|537701|P2|STARTED|Overall Study||50
226182|NCT00207727|537702|P1|STARTED|Overall Study||49
226183|NCT00207714|537729|P5|NOT COMPLETED|Overall Study||5
226184|NCT00207714|537730|P4|NOT COMPLETED|Overall Study||8
226185|NCT00207714|537731|P3|NOT COMPLETED|Overall Study||10
226186|NCT00207714|537732|P2|NOT COMPLETED|Overall Study||7
226187|NCT00207714|537733|P1|NOT COMPLETED|Overall Study||14
226188|NCT00207714|537729|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
226189|NCT00207714|537730|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
226190|NCT00207714|537731|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
226191|NCT00207714|537732|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
226192|NCT00207714|537733|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
226193|NCT00207714|537729|P5|STARTED|Overall Study||34
226194|NCT00207714|537730|P4|STARTED|Overall Study||34
226195|NCT00207714|537731|P3|STARTED|Overall Study||34
226196|NCT00207714|537732|P2|STARTED|Overall Study||35
226197|NCT00207714|537733|P1|STARTED|Overall Study||35
226198|NCT00206440|537754|P2|NOT COMPLETED|Overall Study||4
226199|NCT00206440|537755|P1|NOT COMPLETED|Overall Study||5
226200|NCT00206440|537754|P2|COMPLETED|Overall Study||18
226201|NCT00206440|537755|P1|COMPLETED|Overall Study||16
226202|NCT00206440|537754|P2|STARTED|Overall Study||22
226203|NCT00206440|537755|P1|STARTED|Overall Study||21
226204|NCT00206427|537761|P1|NOT COMPLETED|Overall Study||2
226205|NCT00206427|537761|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
226206|NCT00206427|537761|P1|STARTED|Overall Study|Received First Dose|49
226207|NCT00207142|537768|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
226208|NCT00207142|537769|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
226209|NCT00207142|537770|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
226210|NCT00207142|537771|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
226211|NCT00207142|537768|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
226212|NCT00207142|537769|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
226213|NCT00207142|537770|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
226214|NCT00207142|537771|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
226215|NCT00207142|537768|P4|STARTED|Maintenance Phase/Rescue Phase||50
226216|NCT00207142|537769|P3|STARTED|Maintenance Phase/Rescue Phase||85
226217|NCT00207142|537770|P2|STARTED|Maintenance Phase/Rescue Phase||87
226218|NCT00207142|537771|P1|STARTED|Maintenance Phase/Rescue Phase||0
226219|NCT00207142|537768|P4|NOT COMPLETED|Induction Phase||0
226220|NCT00207142|537769|P3|NOT COMPLETED|Induction Phase||0
226221|NCT00207142|537770|P2|NOT COMPLETED|Induction Phase||0
226222|NCT00207142|537771|P1|NOT COMPLETED|Induction Phase||30
226223|NCT00207142|537768|P4|COMPLETED|Induction Phase||0
226224|NCT00207142|537769|P3|COMPLETED|Induction Phase||0
226225|NCT00207142|537770|P2|COMPLETED|Induction Phase||0
226226|NCT00207142|537771|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
226227|NCT00207142|537768|P4|STARTED|Induction Phase||0
226228|NCT00207142|537769|P3|STARTED|Induction Phase||0
226229|NCT00207142|537770|P2|STARTED|Induction Phase||0
226230|NCT00207142|537771|P1|STARTED|Induction Phase||252
226231|NCT00207090|537808|P1|NOT COMPLETED|Overall Study||7
226232|NCT00207090|537808|P1|COMPLETED|Overall Study||8
226233|NCT00207090|537808|P1|STARTED|Overall Study|Number of participants treated|15
226234|NCT00206726|537837|P1|NOT COMPLETED|Overall Study||51
226235|NCT00206726|537837|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
226236|NCT00206726|537837|P1|4 Cycles Completed|Overall Study|per protocol population|41
226237|NCT00206726|537837|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
226238|NCT00206726|537837|P1|STARTED|Overall Study||60
226239|NCT00206102|537848|P2|NOT COMPLETED|Overall Study||315
226240|NCT00206102|537849|P1|NOT COMPLETED|Overall Study||408
226242|NCT00206102|537849|P1|COMPLETED|Overall Study||188
226243|NCT00206102|537848|P2|STARTED|Overall Study||502
226244|NCT00206102|537849|P1|STARTED|Overall Study||596
226245|NCT00206076|537885|P2|NOT COMPLETED|Overall Study||1
226246|NCT00206076|537886|P1|NOT COMPLETED|Overall Study||3
226247|NCT00206076|537885|P2|COMPLETED|Overall Study||9
226248|NCT00206076|537886|P1|COMPLETED|Overall Study||6
226249|NCT00206076|537885|P2|STARTED|Overall Study||10
226250|NCT00206076|537886|P1|STARTED|Overall Study||9
226251|NCT00205881|537896|P1|NOT COMPLETED|Overall Study||16
226252|NCT00205881|537896|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
226253|NCT00205881|537896|P1|STARTED|Overall Study||32
226254|NCT00205855|537901|P1|NOT COMPLETED|Overall Study||21
226255|NCT00205855|537901|P1|COMPLETED|Overall Study||44
226256|NCT00205855|537901|P1|STARTED|Overall Study||65
226257|NCT00205803|537907|P2|NOT COMPLETED|Toddler Dose||3
226258|NCT00205803|537908|P1|NOT COMPLETED|Toddler Dose||2
226259|NCT00205803|537907|P2|COMPLETED|Toddler Dose||100
226260|NCT00205803|537908|P1|COMPLETED|Toddler Dose||84
226261|NCT00205803|537907|P2|STARTED|Toddler Dose||103
226262|NCT00205803|537908|P1|STARTED|Toddler Dose||86
226263|NCT00205803|537907|P2|NOT COMPLETED|After Infant Series||13
226264|NCT00205803|537908|P1|NOT COMPLETED|After Infant Series||18
226265|NCT00205803|537907|P2|COMPLETED|After Infant Series||103
226266|NCT00205803|537908|P1|COMPLETED|After Infant Series||86
226267|NCT00205803|537907|P2|STARTED|After Infant Series||116
226268|NCT00205803|537908|P1|STARTED|After Infant Series||104
226269|NCT00205803|537907|P2|NOT COMPLETED|Infant Series||11
226270|NCT00205803|537908|P1|NOT COMPLETED|Infant Series||18
226271|NCT00205803|537907|P2|COMPLETED|Infant Series||116
226272|NCT00205803|537908|P1|COMPLETED|Infant Series||104
226273|NCT00205803|537907|P2|Vaccinated Dose 3|Infant Series||118
226274|NCT00205803|537908|P1|Vaccinated Dose 3|Infant Series||110
226275|NCT00205803|537907|P2|Vaccinated Dose 2|Infant Series||122
226276|NCT00205803|537908|P1|Vaccinated Dose 2|Infant Series||115
226277|NCT00205803|537907|P2|Vaccinated Dose 1|Infant Series||126
226278|NCT00205803|537908|P1|Vaccinated Dose 1|Infant Series||121
226279|NCT00205803|537907|P2|STARTED|Infant Series||127
226280|NCT00205803|537908|P1|STARTED|Infant Series||122
226281|NCT00205777|537964|P6|NOT COMPLETED|Study Extension II||282
226282|NCT00205777|537965|P5|NOT COMPLETED|Study Extension II||0
226283|NCT00205777|537966|P4|NOT COMPLETED|Study Extension II||149
226284|NCT00205777|537967|P3|NOT COMPLETED|Study Extension II||0
226285|NCT00205777|537968|P2|NOT COMPLETED|Study Extension II||0
226286|NCT00205777|537969|P1|NOT COMPLETED|Study Extension II||0
226287|NCT00205777|537964|P6|COMPLETED|Study Extension II||860
226288|NCT00205777|537965|P5|COMPLETED|Study Extension II||0
226289|NCT00205777|537966|P4|COMPLETED|Study Extension II||441
226290|NCT00205777|537967|P3|COMPLETED|Study Extension II||0
226291|NCT00205777|537968|P2|COMPLETED|Study Extension II||0
226292|NCT00205777|537969|P1|COMPLETED|Study Extension II||0
226293|NCT00205777|537964|P6|TREATED|Study Extension II||1011
226294|NCT00205777|537965|P5|TREATED|Study Extension II||0
226295|NCT00205777|537966|P4|TREATED|Study Extension II||519
226296|NCT00205777|537967|P3|TREATED|Study Extension II||0
226297|NCT00205777|537968|P2|TREATED|Study Extension II||0
226298|NCT00205777|537969|P1|TREATED|Study Extension II||0
226299|NCT00205777|537964|P6|STARTED|Study Extension II||1142
226300|NCT00205777|537965|P5|STARTED|Study Extension II||0
226301|NCT00205777|537966|P4|STARTED|Study Extension II||590
226302|NCT00205777|537967|P3|STARTED|Study Extension II||0
226303|NCT00205777|537968|P2|STARTED|Study Extension II||0
226304|NCT00205777|537969|P1|STARTED|Study Extension II||0
226305|NCT00205777|537964|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
226306|NCT00205777|537965|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
226307|NCT00205777|537966|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
226308|NCT00205777|537967|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
226309|NCT00205777|537968|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
226310|NCT00205777|537969|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
226311|NCT00205777|537964|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
226312|NCT00205777|537965|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
226313|NCT00205777|537966|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
226314|NCT00205777|537967|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
226315|NCT00205777|537968|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
226316|NCT00205777|537969|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
226317|NCT00205777|537964|P6|STARTED|Completed SE I, Entered Extension SE II||0
226318|NCT00205777|537965|P5|STARTED|Completed SE I, Entered Extension SE II||840
226319|NCT00205777|537966|P4|STARTED|Completed SE I, Entered Extension SE II||830
226320|NCT00205777|537967|P3|STARTED|Completed SE I, Entered Extension SE II||0
226321|NCT00205777|537968|P2|STARTED|Completed SE I, Entered Extension SE II||0
226322|NCT00205777|537969|P1|STARTED|Completed SE I, Entered Extension SE II||833
226323|NCT00205777|537964|P6|NOT COMPLETED|Study Extension I||0
226324|NCT00205777|537965|P5|NOT COMPLETED|Study Extension I||201
226325|NCT00205777|537966|P4|NOT COMPLETED|Study Extension I||228
226326|NCT00205777|537967|P3|NOT COMPLETED|Study Extension I||1070
226327|NCT00205777|537968|P2|NOT COMPLETED|Study Extension I||0
226328|NCT00205777|537969|P1|NOT COMPLETED|Study Extension I||214
226329|NCT00205777|537964|P6|COMPLETED|Study Extension I||0
226330|NCT00205777|537965|P5|COMPLETED|Study Extension I||840
226331|NCT00205777|537966|P4|COMPLETED|Study Extension I||830
226332|NCT00205777|537967|P3|COMPLETED|Study Extension I||0
226333|NCT00205777|537968|P2|COMPLETED|Study Extension I||0
226334|NCT00205777|537969|P1|COMPLETED|Study Extension I||833
226335|NCT00205777|537964|P6|STARTED|Study Extension I||0
226336|NCT00205777|537965|P5|STARTED|Study Extension I||1041
226337|NCT00205777|537966|P4|STARTED|Study Extension I||1058
226338|NCT00205777|537967|P3|STARTED|Study Extension I||1070
226339|NCT00205777|537968|P2|STARTED|Study Extension I||0
226340|NCT00205777|537969|P1|STARTED|Study Extension I||1047
226341|NCT00205777|537964|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
226342|NCT00205777|537965|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
226343|NCT00205777|537966|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
226344|NCT00205777|537967|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
226345|NCT00205777|537968|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
226346|NCT00205777|537969|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
226347|NCT00205777|537964|P6|COMPLETED|Completed Core Study, Entered SE I||0
226348|NCT00205777|537965|P5|COMPLETED|Completed Core Study, Entered SE I||0
226349|NCT00205777|537966|P4|COMPLETED|Completed Core Study, Entered SE I||1058
226350|NCT00205777|537967|P3|COMPLETED|Completed Core Study, Entered SE I||1070
226351|NCT00205777|537968|P2|COMPLETED|Completed Core Study, Entered SE I||1041
226352|NCT00205777|537969|P1|COMPLETED|Completed Core Study, Entered SE I||1047
226353|NCT00205777|537964|P6|STARTED|Completed Core Study, Entered SE I||0
226354|NCT00205777|537965|P5|STARTED|Completed Core Study, Entered SE I||0
226355|NCT00205777|537966|P4|STARTED|Completed Core Study, Entered SE I||1282
226356|NCT00205777|537967|P3|STARTED|Completed Core Study, Entered SE I||1277
226357|NCT00205777|537968|P2|STARTED|Completed Core Study, Entered SE I||1245
226358|NCT00205777|537969|P1|STARTED|Completed Core Study, Entered SE I||1279
226359|NCT00205777|537964|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
226360|NCT00205777|537965|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
226361|NCT00205777|537966|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
226362|NCT00205777|537967|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
226363|NCT00205777|537968|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
226364|NCT00205777|537969|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
226365|NCT00205777|537964|P6|COMPLETED|Core Study (Up to 3 Years)||0
226366|NCT00205777|537965|P5|COMPLETED|Core Study (Up to 3 Years)||0
226367|NCT00205777|537966|P4|COMPLETED|Core Study (Up to 3 Years)||1282
226368|NCT00205777|537967|P3|COMPLETED|Core Study (Up to 3 Years)||1277
226369|NCT00205777|537968|P2|COMPLETED|Core Study (Up to 3 Years)||1245
226370|NCT00205777|537969|P1|COMPLETED|Core Study (Up to 3 Years)||1279
226371|NCT00205777|537964|P6|TREATED|Core Study (Up to 3 Years)||0
226372|NCT00205777|537965|P5|TREATED|Core Study (Up to 3 Years)||0
226373|NCT00205777|537966|P4|TREATED|Core Study (Up to 3 Years)||1885
226374|NCT00205777|537967|P3|TREATED|Core Study (Up to 3 Years)||1849
226375|NCT00205777|537968|P2|TREATED|Core Study (Up to 3 Years)||1872
226376|NCT00205777|537969|P1|TREATED|Core Study (Up to 3 Years)||1886
226377|NCT00205777|537964|P6|STARTED|Core Study (Up to 3 Years)||0
226378|NCT00205777|537965|P5|STARTED|Core Study (Up to 3 Years)||0
226379|NCT00205777|537966|P4|STARTED|Core Study (Up to 3 Years)||1914
226380|NCT00205777|537967|P3|STARTED|Core Study (Up to 3 Years)||1884
226381|NCT00205777|537968|P2|STARTED|Core Study (Up to 3 Years)||1904
226382|NCT00205777|537969|P1|STARTED|Core Study (Up to 3 Years)||1907
226383|NCT00205712|538178|P2|NOT COMPLETED|Overall Study||1
226384|NCT00205712|538179|P1|NOT COMPLETED|Overall Study||0
226385|NCT00205712|538178|P2|COMPLETED|Overall Study||19
226386|NCT00205712|538179|P1|COMPLETED|Overall Study||20
226387|NCT00205712|538178|P2|STARTED|Overall Study||20
226388|NCT00205712|538179|P1|STARTED|Overall Study||20
226389|NCT00205504|538191|P2|NOT COMPLETED|Overall Study||0
226390|NCT00205504|538192|P1|NOT COMPLETED|Overall Study||7
226391|NCT00205504|538191|P2|COMPLETED|Overall Study||15
226392|NCT00205504|538192|P1|COMPLETED|Overall Study||14
226393|NCT00205504|538191|P2|STARTED|Overall Study||15
226394|NCT00205504|538192|P1|STARTED|Overall Study||21
226395|NCT00205049|538218|P2|NOT COMPLETED|Overall Study||0
226396|NCT00205049|538219|P1|NOT COMPLETED|Overall Study||0
226397|NCT00205049|538218|P2|COMPLETED|Overall Study||0
226398|NCT00205049|538219|P1|COMPLETED|Overall Study||0
226399|NCT00205049|538218|P2|STARTED|Overall Study||0
226400|NCT00205049|538219|P1|STARTED|Overall Study||0
226401|NCT00204932|538227|P2|NOT COMPLETED|Overall Study||6
226402|NCT00204932|538228|P1|NOT COMPLETED|Overall Study||2
226403|NCT00204932|538227|P2|COMPLETED|Overall Study||18
226404|NCT00204932|538228|P1|COMPLETED|Overall Study||22
226405|NCT00204932|538227|P2|STARTED|Overall Study||24
226406|NCT00204932|538228|P1|STARTED|Overall Study||24
226407|NCT00204373|538234|P1|NOT COMPLETED|Overall Study||0
226408|NCT00204373|538234|P1|COMPLETED|Overall Study||72
226409|NCT00204373|538234|P1|STARTED|Overall Study||72
226410|NCT00203996|538245|P10|NOT COMPLETED|Overall Study||1
226411|NCT00203996|538246|P9|NOT COMPLETED|Overall Study||0
226412|NCT00203996|538247|P8|NOT COMPLETED|Overall Study||2
226413|NCT00203996|538248|P7|NOT COMPLETED|Overall Study||0
226414|NCT00203996|538249|P6|NOT COMPLETED|Overall Study||0
226415|NCT00203996|538250|P5|NOT COMPLETED|Overall Study||1
226416|NCT00203996|538251|P4|NOT COMPLETED|Overall Study||10
226417|NCT00203996|538252|P3|NOT COMPLETED|Overall Study||0
226418|NCT00203996|538253|P2|NOT COMPLETED|Overall Study||0
226419|NCT00203996|538254|P1|NOT COMPLETED|Overall Study||0
226420|NCT00203996|538245|P10|COMPLETED|Overall Study||2
226421|NCT00203996|538246|P9|COMPLETED|Overall Study||2
226422|NCT00203996|538247|P8|COMPLETED|Overall Study||2
226423|NCT00203996|538248|P7|COMPLETED|Overall Study||2
226424|NCT00203996|538249|P6|COMPLETED|Overall Study||3
226425|NCT00203996|538250|P5|COMPLETED|Overall Study||3
226426|NCT00203996|538251|P4|COMPLETED|Overall Study||9
226427|NCT00203996|538252|P3|COMPLETED|Overall Study||0
226428|NCT00203996|538253|P2|COMPLETED|Overall Study||0
226429|NCT00203996|538254|P1|COMPLETED|Overall Study||0
226430|NCT00203996|538245|P10|Aim 3 Only: Third Intervention|Overall Study||2
226431|NCT00203996|538246|P9|Aim 3 Only: Third Intervention|Overall Study||2
226432|NCT00203996|538247|P8|Aim 3 Only: Third Intervention|Overall Study||2
226433|NCT00203996|538248|P7|Aim 3 Only: Third Intervention|Overall Study||2
226434|NCT00203996|538249|P6|Aim 3 Only: Third Intervention|Overall Study||3
226435|NCT00203996|538250|P5|Aim 3 Only: Third Intervention|Overall Study||0
226436|NCT00203996|538251|P4|Aim 3 Only: Third Intervention|Overall Study||0
226437|NCT00203996|538252|P3|Aim 3 Only: Third Intervention|Overall Study||0
226438|NCT00203996|538253|P2|Aim 3 Only: Third Intervention|Overall Study||0
226439|NCT00203996|538254|P1|Aim 3 Only: Third Intervention|Overall Study||0
226440|NCT00203996|538245|P10|Aim 3 Only: Second Washout|Overall Study||2
226441|NCT00203996|538246|P9|Aim 3 Only: Second Washout|Overall Study||2
226442|NCT00203996|538247|P8|Aim 3 Only: Second Washout|Overall Study||2
226443|NCT00203996|538248|P7|Aim 3 Only: Second Washout|Overall Study||2
226444|NCT00203996|538249|P6|Aim 3 Only: Second Washout|Overall Study||3
226445|NCT00203996|538250|P5|Aim 3 Only: Second Washout|Overall Study||0
226446|NCT00203996|538251|P4|Aim 3 Only: Second Washout|Overall Study||0
226447|NCT00203996|538252|P3|Aim 3 Only: Second Washout|Overall Study||0
226448|NCT00203996|538253|P2|Aim 3 Only: Second Washout|Overall Study||0
226449|NCT00203996|538254|P1|Aim 3 Only: Second Washout|Overall Study||0
226450|NCT00203996|538245|P10|Aim 3 Only: Second Intervention|Overall Study||2
226451|NCT00203996|538246|P9|Aim 3 Only: Second Intervention|Overall Study||2
226452|NCT00203996|538247|P8|Aim 3 Only: Second Intervention|Overall Study||2
226453|NCT00203996|538248|P7|Aim 3 Only: Second Intervention|Overall Study||2
226454|NCT00203996|538249|P6|Aim 3 Only: Second Intervention|Overall Study||3
226455|NCT00203996|538250|P5|Aim 3 Only: Second Intervention|Overall Study||0
226456|NCT00203996|538251|P4|Aim 3 Only: Second Intervention|Overall Study||0
226457|NCT00203996|538252|P3|Aim 3 Only: Second Intervention|Overall Study||0
226458|NCT00203996|538253|P2|Aim 3 Only: Second Intervention|Overall Study||0
226459|NCT00203996|538254|P1|Aim 3 Only: Second Intervention|Overall Study||0
226460|NCT00203996|538245|P10|Aim 3 Only: Washout|Overall Study||2
226461|NCT00203996|538246|P9|Aim 3 Only: Washout|Overall Study||2
226462|NCT00203996|538247|P8|Aim 3 Only: Washout|Overall Study||2
226463|NCT00203996|538248|P7|Aim 3 Only: Washout|Overall Study||2
226464|NCT00203996|538249|P6|Aim 3 Only: Washout|Overall Study||3
226465|NCT00203996|538250|P5|Aim 3 Only: Washout|Overall Study||0
226466|NCT00203996|538251|P4|Aim 3 Only: Washout|Overall Study||0
226467|NCT00203996|538252|P3|Aim 3 Only: Washout|Overall Study||0
226468|NCT00203996|538253|P2|Aim 3 Only: Washout|Overall Study||0
226469|NCT00203996|538254|P1|Aim 3 Only: Washout|Overall Study||0
226470|NCT00203996|538245|P10|Aim 3 Only: First Intervention|Overall Study||3
226471|NCT00203996|538246|P9|Aim 3 Only: First Intervention|Overall Study||2
226472|NCT00203996|538247|P8|Aim 3 Only: First Intervention|Overall Study||4
226473|NCT00203996|538248|P7|Aim 3 Only: First Intervention|Overall Study||2
226474|NCT00203996|538249|P6|Aim 3 Only: First Intervention|Overall Study||3
226475|NCT00203996|538250|P5|Aim 3 Only: First Intervention|Overall Study||0
226476|NCT00203996|538251|P4|Aim 3 Only: First Intervention|Overall Study||0
226477|NCT00203996|538252|P3|Aim 3 Only: First Intervention|Overall Study||0
226478|NCT00203996|538253|P2|Aim 3 Only: First Intervention|Overall Study||0
226479|NCT00203996|538254|P1|Aim 3 Only: First Intervention|Overall Study||0
226480|NCT00203996|538245|P10|STARTED|Overall Study||3
226481|NCT00203996|538246|P9|STARTED|Overall Study||2
226482|NCT00203996|538247|P8|STARTED|Overall Study||4
226483|NCT00203996|538248|P7|STARTED|Overall Study||2
226484|NCT00203996|538249|P6|STARTED|Overall Study||3
226485|NCT00203996|538250|P5|STARTED|Overall Study||4
226486|NCT00203996|538251|P4|STARTED|Overall Study||19
226487|NCT00203996|538252|P3|STARTED|Overall Study||0
226488|NCT00203996|538253|P2|STARTED|Overall Study||0
226489|NCT00203996|538254|P1|STARTED|Overall Study||0
226490|NCT00203931|538303|P2|NOT COMPLETED|Overall Study||5
226491|NCT00203931|538304|P1|NOT COMPLETED|Overall Study||7
226492|NCT00203931|538303|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
226493|NCT00203931|538304|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
226494|NCT00203931|538303|P2|STARTED|Overall Study||28
226495|NCT00203931|538304|P1|STARTED|Overall Study||27
226496|NCT00203892|538321|P3|NOT COMPLETED|Overall Study||0
226497|NCT00203892|538322|P2|NOT COMPLETED|Overall Study||2
226498|NCT00203892|538323|P1|NOT COMPLETED|Overall Study||2
226499|NCT00203892|538321|P3|COMPLETED|Overall Study||6
226500|NCT00203892|538322|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
226501|NCT00203892|538323|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
226502|NCT00203892|538321|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
226503|NCT00203892|538322|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
226504|NCT00203892|538323|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
226505|NCT00203892|538321|P3|STARTED|Overall Study||6
226506|NCT00203892|538322|P2|STARTED|Overall Study||10
226507|NCT00203892|538323|P1|STARTED|Overall Study||7
226508|NCT00203502|538334|P1|NOT COMPLETED|Overall Study||1
226509|NCT00203502|538334|P1|COMPLETED|Overall Study||39
226510|NCT00203502|538334|P1|STARTED|Overall Study||40
226511|NCT00203476|538345|P3|NOT COMPLETED|Overall Study||0
226512|NCT00203476|538346|P2|NOT COMPLETED|Overall Study||1
226513|NCT00203476|538347|P1|NOT COMPLETED|Overall Study||1
226514|NCT00203476|538345|P3|COMPLETED|Overall Study||10
226515|NCT00203476|538346|P2|COMPLETED|Overall Study||9
226516|NCT00203476|538347|P1|COMPLETED|Overall Study||9
226517|NCT00203476|538345|P3|STARTED|Overall Study||10
226518|NCT00203476|538346|P2|STARTED|Overall Study||10
226519|NCT00203476|538347|P1|STARTED|Overall Study||10
226520|NCT00203424|538364|P1|NOT COMPLETED|Follow-up Period||6
226521|NCT00203424|538364|P1|COMPLETED|Follow-up Period||10
226522|NCT00203424|538364|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
226523|NCT00203424|538364|P1|NOT COMPLETED|Treatment Period||11
226524|NCT00203424|538364|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
226525|NCT00203424|538364|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
226526|NCT00203411|538371|P1|NOT COMPLETED|Follow-up||4
226527|NCT00203411|538371|P1|COMPLETED|Follow-up||41
226528|NCT00203411|538371|P1|STARTED|Follow-up||45
226529|NCT00203411|538371|P1|NOT COMPLETED|Treatment Period||0
226530|NCT00203411|538371|P1|COMPLETED|Treatment Period||45
226531|NCT00203411|538371|P1|STARTED|Treatment Period||45
226532|NCT00203307|538380|P2|NOT COMPLETED|Second Intervention||0
226533|NCT00203307|538381|P1|NOT COMPLETED|Second Intervention||0
226534|NCT00203307|538380|P2|COMPLETED|Second Intervention||0
226535|NCT00203307|538381|P1|COMPLETED|Second Intervention||1
226536|NCT00203307|538380|P2|STARTED|Second Intervention||0
226537|NCT00203307|538381|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
226538|NCT00203307|538380|P2|NOT COMPLETED|First Intervention||0
226539|NCT00203307|538381|P1|NOT COMPLETED|First Intervention||2
226540|NCT00203307|538380|P2|COMPLETED|First Intervention||0
226541|NCT00203307|538381|P1|COMPLETED|First Intervention||1
226542|NCT00203307|538380|P2|STARTED|First Intervention||0
226543|NCT00203307|538381|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
226544|NCT00203294|538389|P2|NOT COMPLETED|Overall Study||13
226545|NCT00203294|538390|P1|NOT COMPLETED|Overall Study||8
226546|NCT00203294|538389|P2|COMPLETED|Overall Study||10
226547|NCT00203294|538390|P1|COMPLETED|Overall Study||14
226548|NCT00203294|538389|P2|STARTED|Overall Study||23
226549|NCT00203294|538390|P1|STARTED|Overall Study||22
226550|NCT00203268|538396|P1|NOT COMPLETED|Late Treatment||0
226551|NCT00203268|538396|P1|COMPLETED|Late Treatment||9
226552|NCT00203268|538396|P1|STARTED|Late Treatment||9
226553|NCT00203268|538396|P1|NOT COMPLETED|Early Treatment||4
226554|NCT00203268|538396|P1|COMPLETED|Early Treatment||9
226555|NCT00203268|538396|P1|STARTED|Early Treatment||13
226556|NCT00203242|538402|P1|NOT COMPLETED|Overall Study||1
226557|NCT00203242|538402|P1|COMPLETED|Overall Study||14
226558|NCT00203242|538402|P1|STARTED|Overall Study||15
226559|NCT00203229|538408|P2|NOT COMPLETED|Overall Study||3
226560|NCT00203229|538409|P1|NOT COMPLETED|Overall Study||3
226561|NCT00203229|538408|P2|COMPLETED|Overall Study||7
226562|NCT00203229|538409|P1|COMPLETED|Overall Study||7
226563|NCT00203229|538408|P2|STARTED|Overall Study||10
226564|NCT00203229|538409|P1|STARTED|Overall Study||10
226565|NCT00203216|538415|P1|NOT COMPLETED|Overall Study||4
226566|NCT00203216|538415|P1|COMPLETED|Overall Study||27
226567|NCT00203216|538415|P1|STARTED|Overall Study||31
226568|NCT00203203|538421|P2|NOT COMPLETED|Overall Study||0
226569|NCT00203203|538422|P1|NOT COMPLETED|Overall Study||1
226570|NCT00203203|538421|P2|COMPLETED|Overall Study||20
226571|NCT00203203|538422|P1|COMPLETED|Overall Study||9
226572|NCT00203203|538421|P2|STARTED|Overall Study||20
226573|NCT00203203|538422|P1|STARTED|Overall Study||10
226574|NCT00203047|538454|P2|NOT COMPLETED|Overall Study||203
226575|NCT00203047|538455|P1|NOT COMPLETED|Overall Study||191
226576|NCT00203047|538454|P2|COMPLETED|Overall Study||7
226577|NCT00203047|538455|P1|COMPLETED|Overall Study||13
226578|NCT00203047|538454|P2|In Database as of January 29, 2009|Overall Study||209
226579|NCT00203047|538455|P1|In Database as of January 29, 2009|Overall Study||199
226580|NCT00203047|538454|P2|STARTED|Overall Study||210
226581|NCT00203047|538455|P1|STARTED|Overall Study||204
226582|NCT00202878|538469|P2|NOT COMPLETED|Overall Study||2217
226583|NCT00202878|538470|P1|NOT COMPLETED|Overall Study||2199
226584|NCT00202878|538469|P2|COMPLETED|Overall Study||6860
226585|NCT00202878|538470|P1|COMPLETED|Overall Study||6868
226586|NCT00202878|538469|P2|STARTED|Overall Study||9077
226587|NCT00202878|538470|P1|STARTED|Overall Study||9067
226588|NCT00202839|538484|P2|NOT COMPLETED|Overall Study||10
226589|NCT00202839|538485|P1|NOT COMPLETED|Overall Study||24
226590|NCT00202839|538484|P2|COMPLETED|Overall Study||72
226591|NCT00202839|538485|P1|COMPLETED|Overall Study||54
226592|NCT00202839|538484|P2|STARTED|Overall Study||82
226593|NCT00202839|538485|P1|STARTED|Overall Study||78
226594|NCT00202722|538493|P1|NOT COMPLETED|Overall Study||0
226595|NCT00202722|538493|P1|COMPLETED|Overall Study||41
226596|NCT00202722|538493|P1|STARTED|Overall Study||41
226597|NCT00202449|538501|P3|NOT COMPLETED|Overall Study||12
226598|NCT00202449|538502|P2|NOT COMPLETED|Overall Study||11
226599|NCT00202449|538503|P1|NOT COMPLETED|Overall Study||11
226600|NCT00202449|538501|P3|COMPLETED|Overall Study||9
226601|NCT00202449|538502|P2|COMPLETED|Overall Study||9
226602|NCT00202449|538503|P1|COMPLETED|Overall Study||7
226603|NCT00202449|538501|P3|STARTED|Overall Study||21
226604|NCT00202449|538502|P2|STARTED|Overall Study||20
226605|NCT00202449|538503|P1|STARTED|Overall Study||18
226606|NCT00201877|538517|P1|NOT COMPLETED|Overall Study||0
226607|NCT00201877|538517|P1|COMPLETED|Overall Study||25
226608|NCT00201877|538517|P1|STARTED|Overall Study||25
226609|NCT00201864|538523|P1|NOT COMPLETED|Overall Study||0
226610|NCT00201864|538523|P1|COMPLETED|Overall Study||40
226611|NCT00201864|538523|P1|STARTED|Overall Study||40
226612|NCT00201851|538534|P3|NOT COMPLETED|Overall Study||1
226613|NCT00201851|538535|P2|NOT COMPLETED|Overall Study||2
226614|NCT00201851|538536|P1|NOT COMPLETED|Overall Study||8
226615|NCT00201851|538534|P3|COMPLETED|Overall Study||230
226616|NCT00201851|538535|P2|COMPLETED|Overall Study||255
226617|NCT00201851|538536|P1|COMPLETED|Overall Study||244
226618|NCT00201851|538534|P3|STARTED|Overall Study||231
226619|NCT00201851|538535|P2|STARTED|Overall Study||257
226620|NCT00201851|538536|P1|STARTED|Overall Study||252
226621|NCT00201838|538546|P2|NOT COMPLETED|Overall Study||0
226622|NCT00201838|538547|P1|NOT COMPLETED|Overall Study||0
226623|NCT00201838|538546|P2|COMPLETED|Overall Study||8
226624|NCT00201838|538547|P1|COMPLETED|Overall Study||30
226625|NCT00201838|538546|P2|Treatment Cohort|Overall Study||8
226626|NCT00201838|538547|P1|Treatment Cohort|Overall Study||30
226627|NCT00201838|538546|P2|STARTED|Overall Study||8
226628|NCT00201838|538547|P1|STARTED|Overall Study||30
226629|NCT00201825|538561|P1|NOT COMPLETED|Overall Study||0
226630|NCT00201825|538561|P1|COMPLETED|Overall Study||29
226631|NCT00201825|538561|P1|STARTED|Overall Study||29
226632|NCT00201773|538568|P1|NOT COMPLETED|Overall Study||6
226633|NCT00201773|538568|P1|COMPLETED|Overall Study||16
226634|NCT00201773|538568|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
226635|NCT00201773|538568|P1|Received All Exemestane Therapy|Overall Study||5
226636|NCT00201773|538568|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
226637|NCT00201773|538568|P1|STARTED|Overall Study||22
226638|NCT00201734|538577|P2|NOT COMPLETED|Overall Study||0
226639|NCT00201734|538578|P1|NOT COMPLETED|Overall Study||3
226640|NCT00201734|538577|P2|COMPLETED|Overall Study||25
226641|NCT00201734|538578|P1|COMPLETED|Overall Study||29
226642|NCT00201734|538577|P2|Patients Not Evaluable|Overall Study||0
226643|NCT00201734|538578|P1|Patients Not Evaluable|Overall Study||3
226644|NCT00201734|538577|P2|STARTED|Overall Study||25
226645|NCT00201734|538578|P1|STARTED|Overall Study||32
226646|NCT00201643|538595|P2|NOT COMPLETED|Overall Study||4
226647|NCT00201643|538596|P1|NOT COMPLETED|Overall Study||5
226648|NCT00201643|538595|P2|COMPLETED|Overall Study||210
226649|NCT00201643|538596|P1|COMPLETED|Overall Study||218
226650|NCT00201643|538595|P2|STARTED|Overall Study||214
226651|NCT00201643|538596|P1|STARTED|Overall Study||223
226652|NCT00201448|538620|P2|NOT COMPLETED|Overall Study||0
226653|NCT00201448|538621|P1|NOT COMPLETED|Overall Study||0
226654|NCT00201448|538620|P2|COMPLETED|Overall Study||40
226655|NCT00201448|538621|P1|COMPLETED|Overall Study||42
226656|NCT00201448|538620|P2|STARTED|Overall Study||40
226657|NCT00201448|538621|P1|STARTED|Overall Study||42
226658|NCT00201409|538631|P2|NOT COMPLETED|Overall Study||1
226659|NCT00201409|538632|P1|NOT COMPLETED|Overall Study||1
226660|NCT00201409|538631|P2|COMPLETED|Overall Study||66
226661|NCT00201409|538632|P1|COMPLETED|Overall Study||64
226662|NCT00201409|538631|P2|STARTED|Overall Study||67
226663|NCT00201409|538632|P1|STARTED|Overall Study||65
226664|NCT00201240|538642|P1|NOT COMPLETED|Overall Study||3
226665|NCT00201240|538642|P1|COMPLETED|Overall Study||44
226666|NCT00201240|538642|P1|STARTED|Overall Study||47
226667|NCT00201201|538660|P2|NOT COMPLETED|Overall Study||7
226668|NCT00201201|538661|P1|NOT COMPLETED|Overall Study||5
226669|NCT00201201|538660|P2|COMPLETED|Overall Study||66
226670|NCT00201201|538661|P1|COMPLETED|Overall Study||82
226671|NCT00201201|538660|P2|STARTED|Overall Study||73
226672|NCT00201201|538661|P1|STARTED|Overall Study||87
226673|NCT00201123|538680|P3|NOT COMPLETED|Overall Study||9
226674|NCT00201123|538681|P2|NOT COMPLETED|Overall Study||4
226675|NCT00201123|538682|P1|NOT COMPLETED|Overall Study||6
226676|NCT00201123|538680|P3|COMPLETED|Overall Study||23
226677|NCT00201123|538681|P2|COMPLETED|Overall Study||28
226678|NCT00201123|538682|P1|COMPLETED|Overall Study||26
226679|NCT00201123|538680|P3|Did Not Meet Continuation Criteria|Overall Study||5
226680|NCT00201123|538681|P2|Did Not Meet Continuation Criteria|Overall Study||0
226772|NCT00198822|538833|P2|NOT COMPLETED|Overall Study||20
226681|NCT00201123|538682|P1|Did Not Meet Continuation Criteria|Overall Study||2
226682|NCT00201123|538680|P3|STARTED|Overall Study||32
226683|NCT00201123|538681|P2|STARTED|Overall Study||32
226684|NCT00201123|538682|P1|STARTED|Overall Study||32
226685|NCT00201006|538699|P3|NOT COMPLETED|Overall Study||4
226686|NCT00201006|538700|P2|NOT COMPLETED|Overall Study||2
226687|NCT00201006|538701|P1|NOT COMPLETED|Overall Study||8
226688|NCT00201006|538699|P3|COMPLETED|Overall Study||75
226689|NCT00201006|538700|P2|COMPLETED|Overall Study||70
226690|NCT00201006|538701|P1|COMPLETED|Overall Study||75
226691|NCT00201006|538699|P3|STARTED|Overall Study||79
226692|NCT00201006|538700|P2|STARTED|Overall Study||72
226693|NCT00201006|538701|P1|STARTED|Overall Study||83
226694|NCT00200967|538711|P2|NOT COMPLETED|Run-out Period||0
226695|NCT00200967|538712|P1|NOT COMPLETED|Run-out Period||1
226696|NCT00200967|538711|P2|COMPLETED|Run-out Period||41
226697|NCT00200967|538712|P1|COMPLETED|Run-out Period||34
226698|NCT00200967|538711|P2|STARTED|Run-out Period||41
226699|NCT00200967|538712|P1|STARTED|Run-out Period||35
226700|NCT00200967|538711|P2|NOT COMPLETED|Second Treatment Period||2
226701|NCT00200967|538712|P1|NOT COMPLETED|Second Treatment Period||1
226702|NCT00200967|538711|P2|COMPLETED|Second Treatment Period||41
226703|NCT00200967|538712|P1|COMPLETED|Second Treatment Period||35
226704|NCT00200967|538711|P2|STARTED|Second Treatment Period||43
226705|NCT00200967|538712|P1|STARTED|Second Treatment Period||36
226706|NCT00200967|538711|P2|NOT COMPLETED|Wash-out Period||1
226707|NCT00200967|538712|P1|NOT COMPLETED|Wash-out Period||0
226708|NCT00200967|538711|P2|COMPLETED|Wash-out Period||43
226709|NCT00200967|538712|P1|COMPLETED|Wash-out Period||36
226710|NCT00200967|538711|P2|STARTED|Wash-out Period||44
226711|NCT00200967|538712|P1|STARTED|Wash-out Period||36
226712|NCT00200967|538711|P2|NOT COMPLETED|First Treatment Period||1
226713|NCT00200967|538712|P1|NOT COMPLETED|First Treatment Period||6
226714|NCT00200967|538711|P2|COMPLETED|First Treatment Period||44
226715|NCT00200967|538712|P1|COMPLETED|First Treatment Period||36
226716|NCT00200967|538711|P2|First Treatment Period|First Treatment Period||45
226717|NCT00200967|538712|P1|First Treatment Period|First Treatment Period||42
226718|NCT00200967|538711|P2|STARTED|First Treatment Period||45
226719|NCT00200967|538712|P1|STARTED|First Treatment Period||42
226720|NCT00200785|538742|P2|NOT COMPLETED|Second Intervention||0
226721|NCT00200785|538743|P1|NOT COMPLETED|Second Intervention||0
226722|NCT00200785|538742|P2|COMPLETED|Second Intervention||6
226723|NCT00200785|538743|P1|COMPLETED|Second Intervention||9
226724|NCT00200785|538742|P2|STARTED|Second Intervention||6
226725|NCT00200785|538743|P1|STARTED|Second Intervention||9
226726|NCT00200785|538742|P2|NOT COMPLETED|Washout Period of 1 Week||0
226727|NCT00200785|538743|P1|NOT COMPLETED|Washout Period of 1 Week||0
226728|NCT00200785|538742|P2|COMPLETED|Washout Period of 1 Week||6
226729|NCT00200785|538743|P1|COMPLETED|Washout Period of 1 Week||9
226730|NCT00200785|538742|P2|STARTED|Washout Period of 1 Week||6
226731|NCT00200785|538743|P1|STARTED|Washout Period of 1 Week||9
226732|NCT00200785|538742|P2|NOT COMPLETED|First Intervention||0
226733|NCT00200785|538743|P1|NOT COMPLETED|First Intervention||0
226734|NCT00200785|538742|P2|COMPLETED|First Intervention||6
226735|NCT00200785|538743|P1|COMPLETED|First Intervention||9
226736|NCT00200785|538742|P2|STARTED|First Intervention||6
226737|NCT00200785|538743|P1|STARTED|First Intervention||9
226738|NCT00200356|538753|P2|NOT COMPLETED|Overall Study||7
226739|NCT00200356|538754|P1|NOT COMPLETED|Overall Study||8
226740|NCT00200356|538753|P2|COMPLETED|Overall Study||195
226741|NCT00200356|538754|P1|COMPLETED|Overall Study||191
226742|NCT00200356|538753|P2|Safety Analysis Set|Overall Study||198
226743|NCT00200356|538754|P1|Safety Analysis Set|Overall Study||194
226744|NCT00200356|538753|P2|STARTED|Overall Study||202
226745|NCT00200356|538754|P1|STARTED|Overall Study||199
226746|NCT00200343|538781|P3|NOT COMPLETED|Overall Study||13
226747|NCT00200343|538782|P2|NOT COMPLETED|Overall Study||8
226748|NCT00200343|538783|P1|NOT COMPLETED|Overall Study||16
226749|NCT00200343|538781|P3|COMPLETED|Overall Study||184
226750|NCT00200343|538782|P2|COMPLETED|Overall Study||192
226751|NCT00200343|538783|P1|COMPLETED|Overall Study||183
226752|NCT00200343|538781|P3|STARTED|Overall Study||197
226753|NCT00200343|538782|P2|STARTED|Overall Study||200
226754|NCT00200343|538783|P1|STARTED|Overall Study||199
226755|NCT00200057|538806|P1|NOT COMPLETED|Overall Study||9
226756|NCT00200057|538806|P1|COMPLETED|Overall Study||111
226757|NCT00200057|538806|P1|12 Month Follow-up|Overall Study||111
226758|NCT00200057|538806|P1|6 Month Follow-up|Overall Study||114
226759|NCT00200057|538806|P1|3 Month Follow-up|Overall Study||116
226760|NCT00200057|538806|P1|1 Month Follow-up|Overall Study||117
226761|NCT00200057|538806|P1|STARTED|Overall Study||120
226762|NCT00199914|538818|P2|NOT COMPLETED|Overall Study||6
226763|NCT00199914|538819|P1|NOT COMPLETED|Overall Study||3
226764|NCT00199914|538818|P2|COMPLETED|Overall Study||54
226765|NCT00199914|538819|P1|COMPLETED|Overall Study||50
226766|NCT00199914|538818|P2|STARTED|Overall Study||60
226767|NCT00199914|538819|P1|STARTED|Overall Study||53
226768|NCT00199381|538825|P1|NOT COMPLETED|Overall Study||504
226769|NCT00199381|538825|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
226770|NCT00199381|538825|P1|STARTED|Overall Study||504
226771|NCT00198822|538832|P3|NOT COMPLETED|Overall Study||21
226773|NCT00198822|538834|P1|NOT COMPLETED|Overall Study||14
226774|NCT00198822|538832|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
226775|NCT00198822|538833|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
226776|NCT00198822|538834|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
226777|NCT00198822|538832|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
226778|NCT00198822|538833|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
226779|NCT00198822|538834|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
226780|NCT00197119|538853|P2|NOT COMPLETED|Year 10||0
226781|NCT00197119|538854|P1|NOT COMPLETED|Year 10||0
226782|NCT00197119|538853|P2|COMPLETED|Year 10||108
226783|NCT00197119|538854|P1|COMPLETED|Year 10||120
226784|NCT00197119|538853|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
226785|NCT00197119|538854|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
226786|NCT00197119|538853|P2|NOT COMPLETED|Year 9||0
226787|NCT00197119|538854|P1|NOT COMPLETED|Year 9||0
226788|NCT00197119|538853|P2|COMPLETED|Year 9||114
226789|NCT00197119|538854|P1|COMPLETED|Year 9||121
226790|NCT00197119|538853|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
226791|NCT00197119|538854|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
226792|NCT00197119|538853|P2|NOT COMPLETED|Year 8||0
226793|NCT00197119|538854|P1|NOT COMPLETED|Year 8||0
226794|NCT00197119|538853|P2|COMPLETED|Year 8||115
226795|NCT00197119|538854|P1|COMPLETED|Year 8||122
226796|NCT00197119|538853|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
226797|NCT00197119|538854|P1|STARTED|Year 8||122
226798|NCT00197119|538853|P2|NOT COMPLETED|Year 7||0
226799|NCT00197119|538854|P1|NOT COMPLETED|Year 7||0
226800|NCT00197119|538853|P2|COMPLETED|Year 7||114
226801|NCT00197119|538854|P1|COMPLETED|Year 7||122
226802|NCT00197119|538853|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
226803|NCT00197119|538854|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
226804|NCT00197119|538853|P2|NOT COMPLETED|Year 6||0
226805|NCT00197119|538854|P1|NOT COMPLETED|Year 6||0
226806|NCT00197119|538853|P2|COMPLETED|Year 6||118
226807|NCT00197119|538854|P1|COMPLETED|Year 6||126
226808|NCT00197119|538853|P2|STARTED|Year 6||118
226809|NCT00197119|538854|P1|STARTED|Year 6||126
226810|NCT00197106|538866|P3|NOT COMPLETED|Overall Treatment Period||6
226811|NCT00197106|538867|P2|NOT COMPLETED|Overall Treatment Period||1
226812|NCT00197106|538868|P1|NOT COMPLETED|Overall Treatment Period||0
226813|NCT00197106|538866|P3|COMPLETED|Overall Treatment Period||74
226814|NCT00197106|538867|P2|COMPLETED|Overall Treatment Period||77
226815|NCT00197106|538868|P1|COMPLETED|Overall Treatment Period||0
226816|NCT00197106|538866|P3|STARTED|Overall Treatment Period||80
226817|NCT00197106|538867|P2|STARTED|Overall Treatment Period||78
226818|NCT00197106|538868|P1|STARTED|Overall Treatment Period||0
226819|NCT00197106|538866|P3|NOT COMPLETED|4-Week Run-In Period||0
226820|NCT00197106|538867|P2|NOT COMPLETED|4-Week Run-In Period||0
226821|NCT00197106|538868|P1|NOT COMPLETED|4-Week Run-In Period||99
226822|NCT00197106|538866|P3|COMPLETED|4-Week Run-In Period||0
226823|NCT00197106|538867|P2|COMPLETED|4-Week Run-In Period||0
226824|NCT00197106|538868|P1|COMPLETED|4-Week Run-In Period||158
226825|NCT00197106|538866|P3|STARTED|4-Week Run-In Period||0
226826|NCT00197106|538867|P2|STARTED|4-Week Run-In Period||0
226827|NCT00197106|538868|P1|STARTED|4-Week Run-In Period||257
226828|NCT00198133|538904|P2|NOT COMPLETED|Overall Study||8
226829|NCT00198133|538905|P1|NOT COMPLETED|Overall Study||5
226830|NCT00198133|538904|P2|COMPLETED|Overall Study||3
226831|NCT00198133|538905|P1|COMPLETED|Overall Study||11
226832|NCT00198133|538904|P2|STARTED|Overall Study||11
226833|NCT00198133|538905|P1|STARTED|Overall Study||16
226834|NCT00198081|538917|P2|NOT COMPLETED|Overall Study||0
226835|NCT00198081|538918|P1|NOT COMPLETED|Overall Study||1
226836|NCT00198081|538917|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
226837|NCT00198081|538918|P1|COMPLETED|Overall Study||4
226838|NCT00198081|538917|P2|STARTED|Overall Study|No enrollment on this arm.|0
226839|NCT00198081|538918|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
226840|NCT00198029|538944|P1|NOT COMPLETED|Overall Study||4
226841|NCT00198029|538944|P1|COMPLETED|Overall Study||28
226842|NCT00198029|538944|P1|STARTED|Overall Study||32
226843|NCT00197028|538951|P2|NOT COMPLETED|Overall Study||21
226844|NCT00197028|538952|P1|NOT COMPLETED|Overall Study||16
226845|NCT00197028|538951|P2|COMPLETED|Overall Study||86
226846|NCT00197028|538952|P1|COMPLETED|Overall Study||91
226847|NCT00197028|538951|P2|STARTED|Overall Study||107
226848|NCT00197028|538952|P1|STARTED|Overall Study||107
226849|NCT00197015|538995|P3|NOT COMPLETED|Overall Study||77
226850|NCT00197015|538996|P2|NOT COMPLETED|Overall Study||89
226851|NCT00197015|538997|P1|NOT COMPLETED|Overall Study||50
226852|NCT00197015|538995|P3|COMPLETED|Overall Study||385
226853|NCT00197015|538996|P2|COMPLETED|Overall Study||366
226854|NCT00197015|538997|P1|COMPLETED|Overall Study||274
226855|NCT00197015|538995|P3|STARTED|Overall Study||462
226856|NCT00197015|538996|P2|STARTED|Overall Study||455
226857|NCT00197015|538997|P1|STARTED|Overall Study||324
226858|NCT00196937|539056|P3|NOT COMPLETED|Overall Study||7
226859|NCT00196937|539057|P2|NOT COMPLETED|Overall Study||5
226860|NCT00196937|539058|P1|NOT COMPLETED|Overall Study||9
226861|NCT00196937|539056|P3|COMPLETED|Overall Study||204
226862|NCT00196937|539057|P2|COMPLETED|Overall Study||221
226863|NCT00196937|539058|P1|COMPLETED|Overall Study||220
226864|NCT00196937|539056|P3|STARTED|Overall Study||211
226865|NCT00196937|539057|P2|STARTED|Overall Study||226
226866|NCT00196937|539058|P1|STARTED|Overall Study||229
226867|NCT00197392|539098|P2|NOT COMPLETED|Overall Study||86
226868|NCT00197392|539099|P1|NOT COMPLETED|Overall Study||88
226869|NCT00197392|539098|P2|COMPLETED|Overall Study||134
226870|NCT00197392|539099|P1|COMPLETED|Overall Study||126
226871|NCT00197392|539098|P2|Per Protocol|Overall Study||134
226872|NCT00197392|539099|P1|Per Protocol|Overall Study||126
226873|NCT00197392|539098|P2|Evaluable|Overall Study||181
226874|NCT00197392|539099|P1|Evaluable|Overall Study||176
226875|NCT00197392|539098|P2|Modified Intent to Treat|Overall Study||210
226876|NCT00197392|539099|P1|Modified Intent to Treat|Overall Study||209
226877|NCT00197392|539098|P2|Safety Population|Overall Study||220
226878|NCT00197392|539099|P1|Safety Population|Overall Study||214
226879|NCT00197392|539098|P2|STARTED|Overall Study||220
226880|NCT00197392|539099|P1|STARTED|Overall Study||214
226881|NCT00197236|539131|P3|NOT COMPLETED|Overall Study||23
226882|NCT00197236|539132|P2|NOT COMPLETED|Overall Study||17
226883|NCT00197236|539133|P1|NOT COMPLETED|Overall Study||14
226884|NCT00197236|539131|P3|COMPLETED|Overall Study||109
226885|NCT00197236|539132|P2|COMPLETED|Overall Study||110
226886|NCT00197236|539133|P1|COMPLETED|Overall Study||121
226887|NCT00197236|539131|P3|STARTED|Overall Study||132
226888|NCT00197236|539132|P2|STARTED|Overall Study||127
226889|NCT00197236|539133|P1|STARTED|Overall Study||135
226890|NCT00197184|539182|P2|NOT COMPLETED|Overall Study||0
226891|NCT00197184|539183|P1|NOT COMPLETED|Overall Study||0
226892|NCT00197184|539182|P2|COMPLETED|Overall Study||137
226893|NCT00197184|539183|P1|COMPLETED|Overall Study||139
226894|NCT00197184|539182|P2|STARTED|Overall Study||137
226895|NCT00197184|539183|P1|STARTED|Overall Study||139
226896|NCT00196716|539205|P1|NOT COMPLETED|0.3 mg/kg Period||0
226897|NCT00196716|539205|P1|COMPLETED|0.3 mg/kg Period||21
226898|NCT00196716|539205|P1|STARTED|0.3 mg/kg Period||21
226899|NCT00196716|539205|P1|NOT COMPLETED|1.0 mg/kg Period||0
226900|NCT00196716|539205|P1|COMPLETED|1.0 mg/kg Period||21
226901|NCT00196716|539205|P1|STARTED|1.0 mg/kg Period||21
226902|NCT00196326|539215|P1|NOT COMPLETED|Overall Study||986
226903|NCT00196326|539215|P1|COMPLETED|Overall Study||1249
226904|NCT00196326|539215|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
226905|NCT00196326|539215|P1|Safety Population|Overall Study|Treated participants|2185
226906|NCT00196326|539215|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
226907|NCT00196313|539223|P2|NOT COMPLETED|Overall Study||8
226908|NCT00196313|539224|P1|NOT COMPLETED|Overall Study||11
226909|NCT00196313|539223|P2|COMPLETED|Overall Study||40
226910|NCT00196313|539224|P1|COMPLETED|Overall Study||36
226911|NCT00196313|539223|P2|STARTED|Overall Study||48
226912|NCT00196313|539224|P1|STARTED|Overall Study||47
226913|NCT00196196|539238|P1|NOT COMPLETED|Overall Study||7
226914|NCT00196196|539238|P1|COMPLETED|Overall Study||267
226915|NCT00196196|539238|P1|STARTED|Overall Study||274
226916|NCT00196105|539246|P3|NOT COMPLETED|Overall Study||7
226917|NCT00196105|539247|P2|NOT COMPLETED|Overall Study||5
226918|NCT00196105|539248|P1|NOT COMPLETED|Overall Study||4
226919|NCT00196105|539246|P3|COMPLETED|Overall Study||82
226920|NCT00196105|539247|P2|COMPLETED|Overall Study||83
226921|NCT00196105|539248|P1|COMPLETED|Overall Study||60
226922|NCT00196105|539246|P3|STARTED|Overall Study||89
226923|NCT00196105|539247|P2|STARTED|Overall Study||88
226924|NCT00196105|539248|P1|STARTED|Overall Study||64
226925|NCT00195819|539268|P2|NOT COMPLETED|Open-label||20
226926|NCT00195819|539269|P1|NOT COMPLETED|Open-label||0
226927|NCT00195819|539268|P2|COMPLETED|Open-label||62
226928|NCT00195819|539269|P1|COMPLETED|Open-label||0
226929|NCT00195819|539268|P2|STARTED|Open-label||82
226930|NCT00195819|539269|P1|STARTED|Open-label||0
226931|NCT00195819|539268|P2|NOT COMPLETED|Double-Blind||0
226932|NCT00195819|539269|P1|NOT COMPLETED|Double-Blind||2
226933|NCT00195819|539268|P2|COMPLETED|Double-Blind||38
226934|NCT00195819|539269|P1|COMPLETED|Double-Blind||42
226935|NCT00195819|539268|P2|STARTED|Double-Blind||38
226936|NCT00195819|539269|P1|STARTED|Double-Blind||44
226937|NCT00195715|539319|P1|NOT COMPLETED|Overall Study||377
226938|NCT00195715|539319|P1|COMPLETED|Overall Study||400
226939|NCT00195715|539319|P1|STARTED|Overall Study||777
226940|NCT00195702|539350|P6|NOT COMPLETED|Open-label Extension Phase||78
226941|NCT00195702|539351|P5|NOT COMPLETED|Open-label Extension Phase||78
226942|NCT00195702|539352|P4|NOT COMPLETED|Open-label Extension Phase||99
226943|NCT00195702|539353|P3|NOT COMPLETED|Open-label Extension Phase||0
226944|NCT00195702|539354|P2|NOT COMPLETED|Open-label Extension Phase||0
226945|NCT00195702|539355|P1|NOT COMPLETED|Open-label Extension Phase||0
226946|NCT00195702|539350|P6|COMPLETED|Open-label Extension Phase||56
226947|NCT00195702|539351|P5|COMPLETED|Open-label Extension Phase||80
226948|NCT00195702|539352|P4|COMPLETED|Open-label Extension Phase||66
226949|NCT00195702|539353|P3|COMPLETED|Open-label Extension Phase||0
226950|NCT00195702|539354|P2|COMPLETED|Open-label Extension Phase||0
226951|NCT00195702|539355|P1|COMPLETED|Open-label Extension Phase||0
226952|NCT00195702|539350|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
226953|NCT00195702|539351|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
226954|NCT00195702|539352|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
226955|NCT00195702|539353|P3|STARTED|Open-label Extension Phase||0
226956|NCT00195702|539354|P2|STARTED|Open-label Extension Phase||0
226957|NCT00195702|539355|P1|STARTED|Open-label Extension Phase||0
226958|NCT00195702|539350|P6|NOT COMPLETED|Double-blind Phase||0
226959|NCT00195702|539351|P5|NOT COMPLETED|Double-blind Phase||0
226960|NCT00195702|539352|P4|NOT COMPLETED|Double-blind Phase||0
226961|NCT00195702|539353|P3|NOT COMPLETED|Double-blind Phase||60
226962|NCT00195702|539354|P2|NOT COMPLETED|Double-blind Phase||48
226963|NCT00195702|539355|P1|NOT COMPLETED|Double-blind Phase||44
226964|NCT00195702|539350|P6|COMPLETED|Double-blind Phase||0
226965|NCT00195702|539351|P5|COMPLETED|Double-blind Phase||0
226966|NCT00195702|539352|P4|COMPLETED|Double-blind Phase||0
226967|NCT00195702|539353|P3|COMPLETED|Double-blind Phase||140
226968|NCT00195702|539354|P2|COMPLETED|Double-blind Phase||159
226969|NCT00195702|539355|P1|COMPLETED|Double-blind Phase||168
226970|NCT00195702|539350|P6|STARTED|Double-blind Phase||0
226971|NCT00195702|539351|P5|STARTED|Double-blind Phase||0
226972|NCT00195702|539352|P4|STARTED|Double-blind Phase||0
226973|NCT00195702|539353|P3|STARTED|Double-blind Phase||200
226974|NCT00195702|539354|P2|STARTED|Double-blind Phase||207
226975|NCT00195702|539355|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
226976|NCT00195676|539419|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
226977|NCT00195676|539419|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
226978|NCT00195676|539419|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
226979|NCT00195676|539419|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
226980|NCT00195676|539419|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
226981|NCT00195676|539419|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
226982|NCT00195676|539419|P1|NOT COMPLETED|Period O - Open-label Treatment||606
226983|NCT00195676|539419|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
226984|NCT00195676|539419|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
226985|NCT00195663|539433|P3|NOT COMPLETED|Open-Label Extension Period||97
226986|NCT00195663|539434|P2|NOT COMPLETED|Open-Label Extension Period||74
226987|NCT00195663|539435|P1|NOT COMPLETED|Open-Label Extension Period||76
226988|NCT00195663|539433|P3|COMPLETED|Open-Label Extension Period||86
226989|NCT00195663|539434|P2|COMPLETED|Open-Label Extension Period||85
226990|NCT00195663|539435|P1|COMPLETED|Open-Label Extension Period||79
226991|NCT00195663|539433|P3|STARTED|Open-Label Extension Period||183
226992|NCT00195663|539434|P2|STARTED|Open-Label Extension Period||159
226993|NCT00195663|539435|P1|STARTED|Open-Label Extension Period||155
226994|NCT00195663|539433|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
226995|NCT00195663|539434|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
226996|NCT00195663|539435|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
226997|NCT00195663|539433|P3|COMPLETED|2-year Double-blind Treatment Period||196
226998|NCT00195663|539434|P2|COMPLETED|2-year Double-blind Treatment Period||166
226999|NCT00195663|539435|P1|COMPLETED|2-year Double-blind Treatment Period||164
227000|NCT00195663|539433|P3|STARTED|2-year Double-blind Treatment Period||268
227001|NCT00195663|539434|P2|STARTED|2-year Double-blind Treatment Period||274
227002|NCT00195663|539435|P1|STARTED|2-year Double-blind Treatment Period||257
227003|NCT00195650|539529|P1|NOT COMPLETED|Overall Study||525
227004|NCT00195650|539529|P1|COMPLETED|Overall Study||321
227005|NCT00195650|539529|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
227006|NCT00195507|539545|P2|NOT COMPLETED|Overall Study||118
227007|NCT00195507|539546|P1|NOT COMPLETED|Overall Study||99
227008|NCT00195507|539545|P2|COMPLETED|Overall Study||245
227009|NCT00195507|539546|P1|COMPLETED|Overall Study||258
227010|NCT00195507|539545|P2|STARTED|Overall Study||363
227011|NCT00195507|539546|P1|STARTED|Overall Study||357
227012|NCT00195494|539560|P6|NOT COMPLETED|Year 2||0
227013|NCT00195494|539561|P5|NOT COMPLETED|Year 2||0
227014|NCT00195494|539562|P4|NOT COMPLETED|Year 2||23
227015|NCT00195494|539563|P3|NOT COMPLETED|Year 2||18
227016|NCT00195494|539564|P2|NOT COMPLETED|Year 2||16
227017|NCT00195494|539565|P1|NOT COMPLETED|Year 2||7
227018|NCT00195494|539560|P6|COMPLETED|Year 2||0
227019|NCT00195494|539561|P5|COMPLETED|Year 2||0
227020|NCT00195494|539562|P4|COMPLETED|Year 2||76
227021|NCT00195494|539563|P3|COMPLETED|Year 2||93
227022|NCT00195494|539564|P2|COMPLETED|Year 2||74
227023|NCT00195494|539565|P1|COMPLETED|Year 2||104
227024|NCT00195494|539560|P6|STARTED|Year 2||0
227025|NCT00195494|539561|P5|STARTED|Year 2||0
227026|NCT00195494|539562|P4|STARTED|Year 2||99
227027|NCT00195494|539563|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
227028|NCT00195494|539564|P2|STARTED|Year 2||90
227029|NCT00195494|539565|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
227030|NCT00195494|539560|P6|NOT COMPLETED|Year 1||53
227031|NCT00195494|539561|P5|NOT COMPLETED|Year 1||79
227032|NCT00195494|539562|P4|NOT COMPLETED|Year 1||0
227033|NCT00195494|539563|P3|NOT COMPLETED|Year 1||0
227034|NCT00195494|539564|P2|NOT COMPLETED|Year 1||0
227035|NCT00195494|539565|P1|NOT COMPLETED|Year 1||0
227036|NCT00195494|539560|P6|COMPLETED|Year 1||221
227037|NCT00195494|539561|P5|COMPLETED|Year 1||189
227038|NCT00195494|539562|P4|COMPLETED|Year 1||0
227039|NCT00195494|539563|P3|COMPLETED|Year 1||0
227040|NCT00195494|539564|P2|COMPLETED|Year 1||0
227041|NCT00195494|539565|P1|COMPLETED|Year 1||0
227042|NCT00195494|539560|P6|STARTED|Year 1||274
227043|NCT00195494|539561|P5|STARTED|Year 1||268
227044|NCT00195494|539562|P4|STARTED|Year 1||0
227045|NCT00195494|539563|P3|STARTED|Year 1||0
227046|NCT00195494|539564|P2|STARTED|Year 1||0
227047|NCT00195494|539565|P1|STARTED|Year 1||0
227048|NCT00195442|539583|P1|NOT COMPLETED|Overall Study||136
227049|NCT00195442|539583|P1|COMPLETED|Overall Study||152
227050|NCT00195442|539583|P1|STARTED|Overall Study||288
227051|NCT00195429|539602|P2|NOT COMPLETED|Overall Study||5
227052|NCT00195429|539603|P1|NOT COMPLETED|Overall Study||5
227053|NCT00195429|539602|P2|COMPLETED|Overall Study||18
227054|NCT00195429|539603|P1|COMPLETED|Overall Study||19
227055|NCT00195429|539602|P2|STARTED|Overall Study||23
227056|NCT00195429|539603|P1|STARTED|Overall Study||24
227057|NCT00195403|539611|P1|NOT COMPLETED|Overall Study||0
227058|NCT00195403|539611|P1|COMPLETED|Overall Study||1014
227059|NCT00195403|539611|P1|STARTED|Overall Study||1014
227060|NCT00195351|539619|P2|NOT COMPLETED|Overall Study||16
227061|NCT00195351|539620|P1|NOT COMPLETED|Overall Study||21
227062|NCT00195351|539619|P2|COMPLETED|Overall Study||215
227063|NCT00195351|539620|P1|COMPLETED|Overall Study||215
227064|NCT00195351|539619|P2|STARTED|Overall Study||231
227065|NCT00195351|539620|P1|STARTED|Overall Study||236
227066|NCT00195338|539630|P1|NOT COMPLETED|Overall Study||12
227067|NCT00195338|539630|P1|COMPLETED|Overall Study||13
227068|NCT00195338|539630|P1|STARTED|Overall Study||25
227069|NCT00195273|539640|P2|NOT COMPLETED|Overall Study||14
227070|NCT00195273|539641|P1|NOT COMPLETED|Overall Study||21
227071|NCT00195273|539640|P2|COMPLETED|Overall Study||16
227072|NCT00195273|539641|P1|COMPLETED|Overall Study||10
227073|NCT00195273|539640|P2|STARTED|Overall Study||30
227074|NCT00195273|539641|P1|STARTED|Overall Study||31
227075|NCT00195260|539655|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
227076|NCT00195260|539656|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
227077|NCT00195260|539657|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
227078|NCT00195260|539658|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227079|NCT00195260|539659|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227080|NCT00195260|539660|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227081|NCT00195260|539661|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227082|NCT00195260|539662|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227083|NCT00195260|539663|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227084|NCT00195260|539664|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227085|NCT00195260|539665|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227086|NCT00195260|539655|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
227087|NCT00195260|539656|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227088|NCT00195260|539657|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
227089|NCT00195260|539658|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227090|NCT00195260|539659|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227091|NCT00195260|539660|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227092|NCT00195260|539661|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227093|NCT00195260|539662|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227094|NCT00195260|539663|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227095|NCT00195260|539664|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227096|NCT00195260|539665|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227097|NCT00195260|539655|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
227098|NCT00195260|539656|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
227099|NCT00195260|539657|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
227100|NCT00195260|539658|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227101|NCT00195260|539659|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227102|NCT00195260|539660|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227103|NCT00195260|539661|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227104|NCT00195260|539662|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227105|NCT00195260|539663|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227106|NCT00195260|539664|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227107|NCT00195260|539665|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
227108|NCT00195260|539655|P11|NOT COMPLETED|Part 1: Dose Escalation||0
227109|NCT00195260|539656|P10|NOT COMPLETED|Part 1: Dose Escalation||0
227110|NCT00195260|539657|P9|NOT COMPLETED|Part 1: Dose Escalation||0
227111|NCT00195260|539658|P8|NOT COMPLETED|Part 1: Dose Escalation||6
227112|NCT00195260|539659|P7|NOT COMPLETED|Part 1: Dose Escalation||10
227113|NCT00195260|539660|P6|NOT COMPLETED|Part 1: Dose Escalation||7
227114|NCT00195260|539661|P5|NOT COMPLETED|Part 1: Dose Escalation||7
227115|NCT00195260|539662|P4|NOT COMPLETED|Part 1: Dose Escalation||7
227116|NCT00195260|539663|P3|NOT COMPLETED|Part 1: Dose Escalation||6
227117|NCT00195260|539664|P2|NOT COMPLETED|Part 1: Dose Escalation||4
227118|NCT00195260|539665|P1|NOT COMPLETED|Part 1: Dose Escalation||4
227119|NCT00195260|539655|P11|COMPLETED|Part 1: Dose Escalation||0
227120|NCT00195260|539656|P10|COMPLETED|Part 1: Dose Escalation||0
227121|NCT00195260|539657|P9|COMPLETED|Part 1: Dose Escalation||0
227122|NCT00195260|539658|P8|COMPLETED|Part 1: Dose Escalation||0
227123|NCT00195260|539659|P7|COMPLETED|Part 1: Dose Escalation||0
227124|NCT00195260|539660|P6|COMPLETED|Part 1: Dose Escalation||0
227125|NCT00195260|539661|P5|COMPLETED|Part 1: Dose Escalation||0
227126|NCT00195260|539662|P4|COMPLETED|Part 1: Dose Escalation||0
227127|NCT00195260|539663|P3|COMPLETED|Part 1: Dose Escalation||0
227128|NCT00195260|539664|P2|COMPLETED|Part 1: Dose Escalation||0
227129|NCT00195260|539665|P1|COMPLETED|Part 1: Dose Escalation||0
227130|NCT00195260|539655|P11|STARTED|Part 1: Dose Escalation||0
227131|NCT00195260|539656|P10|STARTED|Part 1: Dose Escalation||0
227132|NCT00195260|539657|P9|STARTED|Part 1: Dose Escalation||0
227133|NCT00195260|539658|P8|STARTED|Part 1: Dose Escalation||6
227134|NCT00195260|539659|P7|STARTED|Part 1: Dose Escalation||10
227135|NCT00195260|539660|P6|STARTED|Part 1: Dose Escalation||7
227136|NCT00195260|539661|P5|STARTED|Part 1: Dose Escalation||7
227137|NCT00195260|539662|P4|STARTED|Part 1: Dose Escalation||7
227138|NCT00195260|539663|P3|STARTED|Part 1: Dose Escalation||6
227139|NCT00195260|539664|P2|STARTED|Part 1: Dose Escalation||4
227140|NCT00195260|539665|P1|STARTED|Part 1: Dose Escalation||4
227141|NCT00194896|539815|P4|NOT COMPLETED|Overall Study||12
227142|NCT00194896|539816|P3|NOT COMPLETED|Overall Study||6
227143|NCT00194896|539817|P2|NOT COMPLETED|Overall Study||5
227144|NCT00194896|539818|P1|NOT COMPLETED|Overall Study||11
227145|NCT00194896|539815|P4|COMPLETED|Overall Study||9
227146|NCT00194896|539816|P3|COMPLETED|Overall Study||7
227147|NCT00194896|539817|P2|COMPLETED|Overall Study||10
227148|NCT00194896|539818|P1|COMPLETED|Overall Study||4
227149|NCT00194896|539815|P4|STARTED|Overall Study||21
227150|NCT00194896|539816|P3|STARTED|Overall Study||13
227151|NCT00194896|539817|P2|STARTED|Overall Study||15
227152|NCT00194896|539818|P1|STARTED|Overall Study||15
227153|NCT00194675|539834|P2|NOT COMPLETED|Overall Study||2
227154|NCT00194675|539835|P1|NOT COMPLETED|Overall Study||5
227155|NCT00194675|539834|P2|COMPLETED|Overall Study||24
227156|NCT00194675|539835|P1|COMPLETED|Overall Study||22
227157|NCT00194675|539834|P2|STARTED|Overall Study||26
227158|NCT00194675|539835|P1|STARTED|Overall Study||27
227159|NCT00194610|539853|P2|NOT COMPLETED|Overall Study||0
227160|NCT00194610|539854|P1|NOT COMPLETED|Overall Study||0
227161|NCT00194610|539853|P2|COMPLETED|Overall Study||9
227162|NCT00194610|539854|P1|COMPLETED|Overall Study||11
227163|NCT00194610|539853|P2|STARTED|Overall Study||9
227164|NCT00194610|539854|P1|STARTED|Overall Study||11
227165|NCT00194532|539862|P2|NOT COMPLETED|Overall Study||0
227166|NCT00194532|539863|P1|NOT COMPLETED|Overall Study||0
227167|NCT00194532|539862|P2|COMPLETED|Overall Study||150
227168|NCT00194532|539863|P1|COMPLETED|Overall Study||150
227169|NCT00194532|539862|P2|STARTED|Overall Study||150
227170|NCT00194532|539863|P1|STARTED|Overall Study||150
227171|NCT00194129|539873|P2|NOT COMPLETED|Overall Study||13
227172|NCT00194129|539874|P1|NOT COMPLETED|Overall Study||10
227173|NCT00194129|539873|P2|COMPLETED|Overall Study||3
227174|NCT00194129|539874|P1|COMPLETED|Overall Study||5
227175|NCT00194129|539873|P2|STARTED|Overall Study||16
227176|NCT00194129|539874|P1|STARTED|Overall Study||15
227177|NCT00194077|539882|P2|NOT COMPLETED|Overall Study||30
227178|NCT00194077|539883|P1|NOT COMPLETED|Overall Study||24
227179|NCT00194077|539882|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
227180|NCT00194077|539883|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
227181|NCT00194077|539882|P2|STARTED|Overall Study||30
227182|NCT00194077|539883|P1|STARTED|Overall Study||30
227183|NCT00194025|539889|P1|NOT COMPLETED|Overall Study||5
227184|NCT00194025|539889|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
227185|NCT00194025|539889|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
227186|NCT00194012|539904|P2|NOT COMPLETED|Open Label Extension||7
227187|NCT00194012|539905|P1|NOT COMPLETED|Open Label Extension||6
227188|NCT00194012|539904|P2|COMPLETED|Open Label Extension||14
227189|NCT00194012|539905|P1|COMPLETED|Open Label Extension||17
227190|NCT00194012|539904|P2|STARTED|Open Label Extension|Participants not completing randomized phase could enroll in open-label ext. Thus the differences.|21
227191|NCT00194012|539905|P1|STARTED|Open Label Extension|Participants not completing randomized phase could enroll in open-label ext. Thus the differences.|23
227192|NCT00194012|539904|P2|NOT COMPLETED|Randomized Phase||23
227193|NCT00194012|539905|P1|NOT COMPLETED|Randomized Phase||15
227194|NCT00194012|539904|P2|COMPLETED|Randomized Phase||6
227195|NCT00194012|539905|P1|COMPLETED|Randomized Phase||15
227196|NCT00194012|539904|P2|STARTED|Randomized Phase||29
227197|NCT00194012|539905|P1|STARTED|Randomized Phase||30
227198|NCT00193609|539913|P1|NOT COMPLETED|Overall Study||4
227199|NCT00193609|539913|P1|COMPLETED|Overall Study||44
227200|NCT00193609|539913|P1|STARTED|Overall Study||48
227201|NCT00193596|539920|P2|NOT COMPLETED|Overall Study||66
227202|NCT00193596|539921|P1|NOT COMPLETED|Overall Study||56
227203|NCT00193596|539920|P2|COMPLETED|Overall Study||39
227204|NCT00193596|539921|P1|COMPLETED|Overall Study||37
227205|NCT00193596|539920|P2|STARTED|Overall Study||105
227206|NCT00193596|539921|P1|STARTED|Overall Study||93
227207|NCT00193492|539931|P2|NOT COMPLETED|Overall Study||15
227208|NCT00193492|539932|P1|NOT COMPLETED|Overall Study||17
227209|NCT00193492|539931|P2|COMPLETED|Overall Study||14
227210|NCT00193492|539932|P1|COMPLETED|Overall Study||14
227211|NCT00193492|539931|P2|STARTED|Overall Study||29
227212|NCT00193492|539932|P1|STARTED|Overall Study||31
227213|NCT00193479|539940|P1|NOT COMPLETED|Maintenance Rituximab||0
227214|NCT00193479|539940|P1|COMPLETED|Maintenance Rituximab||44
227215|NCT00193479|539940|P1|STARTED|Maintenance Rituximab||44
227216|NCT00193479|539940|P1|NOT COMPLETED|Induction Chemotherapy||3
227217|NCT00193479|539940|P1|COMPLETED|Induction Chemotherapy||48
227218|NCT00193479|539940|P1|STARTED|Induction Chemotherapy||51
227219|NCT00193453|539944|P1|NOT COMPLETED|Overall Study||48
227220|NCT00193453|539944|P1|COMPLETED|Overall Study||21
227221|NCT00193453|539944|P1|STARTED|Overall Study||69
227222|NCT00193427|539950|P1|NOT COMPLETED|Overall Study||49
227223|NCT00193427|539950|P1|COMPLETED|Overall Study||26
227224|NCT00193427|539950|P1|STARTED|Overall Study||75
227225|NCT00193414|539957|P1|NOT COMPLETED|Overall Study||58
227226|NCT00193414|539957|P1|COMPLETED|Overall Study||14
227227|NCT00193414|539957|P1|STARTED|Overall Study||72
227228|NCT00193375|539963|P1|NOT COMPLETED|Overall Study||19
227229|NCT00193375|539963|P1|COMPLETED|Overall Study||41
227230|NCT00193375|539963|P1|STARTED|Overall Study||60
227231|NCT00193258|539969|P1|NOT COMPLETED|Overall Study||0
227232|NCT00193258|539969|P1|COMPLETED|Overall Study||94
227233|NCT00193258|539969|P1|STARTED|Overall Study||94
227234|NCT00193219|539975|P1|NOT COMPLETED|Overall Study||30
227235|NCT00193219|539975|P1|COMPLETED|Overall Study||6
227236|NCT00193219|539975|P1|STARTED|Overall Study||36
227237|NCT00193206|539981|P1|NOT COMPLETED|Postoperative Therapy||14
227238|NCT00193206|539981|P1|COMPLETED|Postoperative Therapy||102
227239|NCT00193206|539981|P1|STARTED|Postoperative Therapy||116
227240|NCT00193206|539981|P1|NOT COMPLETED|Surgery||0
227241|NCT00193206|539981|P1|COMPLETED|Surgery||116
227242|NCT00193206|539981|P1|STARTED|Surgery||116
227243|NCT00193206|539981|P1|NOT COMPLETED|Preoperative Therapy||7
227244|NCT00193206|539981|P1|COMPLETED|Preoperative Therapy||116
227245|NCT00193206|539981|P1|STARTED|Preoperative Therapy||123
227246|NCT00193180|539985|P1|NOT COMPLETED|Overall Study||10
227247|NCT00193180|539985|P1|COMPLETED|Overall Study||27
227248|NCT00193180|539985|P1|STARTED|Overall Study||37
227249|NCT00193128|539993|P2|NOT COMPLETED|Overall Study||10
227250|NCT00193128|539994|P1|NOT COMPLETED|Overall Study||0
227251|NCT00193128|539993|P2|COMPLETED|Overall Study||39
227252|NCT00193128|539994|P1|COMPLETED|Overall Study||10
227253|NCT00193128|539993|P2|STARTED|Overall Study||49
227254|NCT00193128|539994|P1|STARTED|Overall Study||10
227255|NCT00193063|540000|P1|NOT COMPLETED|Overall Study||4
227256|NCT00193063|540000|P1|COMPLETED|Overall Study||37
227257|NCT00193063|540000|P1|STARTED|Overall Study||41
227258|NCT00193050|540006|P1|NOT COMPLETED|Adjuvant||10
227259|NCT00193050|540006|P1|COMPLETED|Adjuvant||77
227260|NCT00193050|540006|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
227261|NCT00193050|540006|P1|NOT COMPLETED|Surgery||0
227262|NCT00193050|540006|P1|COMPLETED|Surgery||103
227263|NCT00193050|540006|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
227264|NCT00193050|540006|P1|NOT COMPLETED|Neoadjuvant Treatment||9
227265|NCT00193050|540006|P1|COMPLETED|Neoadjuvant Treatment||101
227266|NCT00193050|540006|P1|STARTED|Neoadjuvant Treatment||110
227267|NCT00193037|540012|P2|NOT COMPLETED|Crossover Treatment||0
227268|NCT00193037|540013|P1|NOT COMPLETED|Crossover Treatment||0
227269|NCT00193037|540012|P2|COMPLETED|Crossover Treatment||24
227270|NCT00193037|540013|P1|COMPLETED|Crossover Treatment||32
227271|NCT00193037|540012|P2|STARTED|Crossover Treatment||24
227272|NCT00193037|540013|P1|STARTED|Crossover Treatment||32
227273|NCT00193037|540012|P2|NOT COMPLETED|Randomized Treatment||28
227274|NCT00193037|540013|P1|NOT COMPLETED|Randomized Treatment||18
227275|NCT00193037|540012|P2|COMPLETED|Randomized Treatment||24
227276|NCT00193037|540013|P1|COMPLETED|Randomized Treatment||32
227277|NCT00193037|540012|P2|STARTED|Randomized Treatment||52
227278|NCT00193037|540013|P1|STARTED|Randomized Treatment||50
227279|NCT00192296|540025|P4|NOT COMPLETED|Overall Study||0
227280|NCT00192296|540026|P3|NOT COMPLETED|Overall Study||0
227281|NCT00192296|540027|P2|NOT COMPLETED|Overall Study||1
227282|NCT00192296|540028|P1|NOT COMPLETED|Overall Study||0
227283|NCT00192296|540025|P4|COMPLETED|Overall Study||6
227284|NCT00192296|540026|P3|COMPLETED|Overall Study||6
227285|NCT00192296|540027|P2|COMPLETED|Overall Study||5
227286|NCT00192296|540028|P1|COMPLETED|Overall Study||6
227287|NCT00192296|540025|P4|STARTED|Overall Study||6
227288|NCT00192296|540026|P3|STARTED|Overall Study||6
227289|NCT00192296|540027|P2|STARTED|Overall Study||6
227290|NCT00192296|540028|P1|STARTED|Overall Study||6
227291|NCT00192647|540084|P2|NOT COMPLETED|Overall Study||146
227292|NCT00192647|540085|P1|NOT COMPLETED|Overall Study||128
227293|NCT00192647|540084|P2|COMPLETED|Overall Study||302
227294|NCT00192647|540085|P1|COMPLETED|Overall Study||320
227295|NCT00192647|540084|P2|Treated|Overall Study||438
227296|NCT00192647|540085|P1|Treated|Overall Study||433
227297|NCT00192647|540084|P2|STARTED|Overall Study||448
227298|NCT00192647|540085|P1|STARTED|Overall Study||448
227299|NCT00192075|540103|P2|NOT COMPLETED|Overall Study||19
227300|NCT00192075|540104|P1|NOT COMPLETED|Overall Study||39
227301|NCT00192075|540103|P2|COMPLETED|Overall Study||23
227302|NCT00192075|540104|P1|COMPLETED|Overall Study||3
227303|NCT00192075|540103|P2|STARTED|Overall Study||42
227304|NCT00192075|540104|P1|STARTED|Overall Study||42
227305|NCT00192036|540129|P1|NOT COMPLETED|Overall Study||21
227306|NCT00192036|540129|P1|COMPLETED|Overall Study||28
227307|NCT00192036|540129|P1|STARTED|Overall Study||49
227308|NCT00192023|540139|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
227309|NCT00192023|540140|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
227310|NCT00192023|540139|P2|COMPLETED|Period IV - Optional Open-Label||0
227311|NCT00192023|540140|P1|COMPLETED|Period IV - Optional Open-Label||49
227312|NCT00192023|540139|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
227313|NCT00192023|540140|P1|STARTED|Period IV - Optional Open-Label||124
227314|NCT00192023|540139|P2|NOT COMPLETED|Period III - Double-Blind||0
227315|NCT00192023|540140|P1|NOT COMPLETED|Period III - Double-Blind||7
227316|NCT00192023|540139|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
227317|NCT00192023|540140|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
227318|NCT00192023|540139|P2|STARTED|Period III - Double-Blind||32
227319|NCT00192023|540140|P1|STARTED|Period III - Double-Blind||107
227320|NCT00191984|540162|P1|NOT COMPLETED|Overall Study||39
227321|NCT00191984|540162|P1|COMPLETED|Overall Study||7
227322|NCT00191984|540162|P1|STARTED|Overall Study||46
227323|NCT00191945|540172|P2|NOT COMPLETED|Open-Label Treatment Extension||0
227324|NCT00191945|540173|P1|NOT COMPLETED|Open-Label Treatment Extension||0
227325|NCT00191945|540172|P2|COMPLETED|Open-Label Treatment Extension||48
227326|NCT00191945|540173|P1|COMPLETED|Open-Label Treatment Extension||94
227327|NCT00191945|540172|P2|STARTED|Open-Label Treatment Extension||48
227328|NCT00191945|540173|P1|STARTED|Open-Label Treatment Extension||94
227329|NCT00191945|540172|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
227330|NCT00191945|540173|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
227331|NCT00191945|540172|P2|COMPLETED|Double-Blind Acute Treatment||48
227332|NCT00191945|540173|P1|COMPLETED|Double-Blind Acute Treatment||94
227333|NCT00191945|540172|P2|STARTED|Double-Blind Acute Treatment||51
227334|NCT00191945|540173|P1|STARTED|Double-Blind Acute Treatment||100
227335|NCT00191906|540209|P4|NOT COMPLETED|Study Period III||0
227336|NCT00191906|540210|P3|NOT COMPLETED|Study Period III||0
227337|NCT00191906|540211|P2|NOT COMPLETED|Study Period III||4
227338|NCT00191906|540212|P1|NOT COMPLETED|Study Period III||5
227339|NCT00191906|540209|P4|COMPLETED|Study Period III||0
227340|NCT00191906|540210|P3|COMPLETED|Study Period III||0
227341|NCT00191906|540211|P2|COMPLETED|Study Period III||7
227342|NCT00191906|540212|P1|COMPLETED|Study Period III||9
227343|NCT00191906|540209|P4|STARTED|Study Period III||0
227344|NCT00191906|540210|P3|STARTED|Study Period III||0
227345|NCT00191906|540211|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
227346|NCT00191906|540212|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
227347|NCT00191906|540209|P4|NOT COMPLETED|Study Period II||0
227348|NCT00191906|540210|P3|NOT COMPLETED|Study Period II||1
227349|NCT00191906|540211|P2|NOT COMPLETED|Study Period II||5
227350|NCT00191906|540212|P1|NOT COMPLETED|Study Period II||0
227351|NCT00191906|540209|P4|COMPLETED|Study Period II||18
227352|NCT00191906|540210|P3|COMPLETED|Study Period II||26
227353|NCT00191906|540211|P2|COMPLETED|Study Period II||32
227354|NCT00191906|540212|P1|COMPLETED|Study Period II||39
227355|NCT00191906|540209|P4|STARTED|Study Period II||18
227356|NCT00191906|540210|P3|STARTED|Study Period II||27
227357|NCT00191906|540211|P2|STARTED|Study Period II||37
227358|NCT00191906|540212|P1|STARTED|Study Period II||39
227359|NCT00191854|540255|P3|NOT COMPLETED|Overall Study||39
227360|NCT00191854|540256|P2|NOT COMPLETED|Overall Study||30
227361|NCT00191854|540257|P1|NOT COMPLETED|Overall Study||37
227362|NCT00191854|540255|P3|COMPLETED|Overall Study||12
227363|NCT00191854|540256|P2|COMPLETED|Overall Study||17
227364|NCT00191854|540257|P1|COMPLETED|Overall Study||12
227365|NCT00191854|540255|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
227366|NCT00191854|540256|P2|Received at Least One Dose of Study Drug|Overall Study||47
227367|NCT00191854|540257|P1|Received at Least One Dose of Study Drug|Overall Study||49
227368|NCT00191854|540255|P3|STARTED|Overall Study||51
227369|NCT00191854|540256|P2|STARTED|Overall Study||47
227370|NCT00191854|540257|P1|STARTED|Overall Study||49
227371|NCT00191815|540277|P1|NOT COMPLETED|Overall Study||40
227372|NCT00191815|540277|P1|COMPLETED|Overall Study||30
227373|NCT00191815|540277|P1|Treated|Overall Study||67
227374|NCT00191815|540277|P1|STARTED|Overall Study||70
227375|NCT00191789|540289|P1|NOT COMPLETED|Overall Study||25
227376|NCT00191789|540289|P1|COMPLETED|Overall Study||40
227377|NCT00191789|540289|P1|STARTED|Overall Study||65
227378|NCT00191724|540306|P5|NOT COMPLETED|Overall Study||3
227379|NCT00191724|540307|P4|NOT COMPLETED|Overall Study||3
227380|NCT00191724|540308|P3|NOT COMPLETED|Overall Study||1
227381|NCT00191724|540309|P2|NOT COMPLETED|Overall Study||1
227382|NCT00191724|540310|P1|NOT COMPLETED|Overall Study||1
227383|NCT00191724|540306|P5|COMPLETED|Overall Study||12
227384|NCT00191724|540307|P4|COMPLETED|Overall Study||5
227385|NCT00191724|540308|P3|COMPLETED|Overall Study||8
227386|NCT00191724|540309|P2|COMPLETED|Overall Study||8
227387|NCT00191724|540310|P1|COMPLETED|Overall Study||5
227388|NCT00191724|540306|P5|STARTED|Overall Study||15
227389|NCT00191724|540307|P4|STARTED|Overall Study||8
227390|NCT00191724|540308|P3|STARTED|Overall Study||9
227391|NCT00191724|540309|P2|STARTED|Overall Study||9
227392|NCT00191724|540310|P1|STARTED|Overall Study||6
227393|NCT00191646|540339|P2|NOT COMPLETED|Overall Study||153
227394|NCT00191646|540340|P1|NOT COMPLETED|Overall Study||171
227395|NCT00191646|540339|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
227396|NCT00191646|540340|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
227397|NCT00191646|540339|P2|Received Crossover Therapy|Overall Study||78
227398|NCT00191646|540340|P1|Received Crossover Therapy|Overall Study||77
227399|NCT00191646|540339|P2|Received Consolidation Therapy|Overall Study||183
227400|NCT00191646|540340|P1|Received Consolidation Therapy|Overall Study||169
227401|NCT00191646|540339|P2|Received Induction Therapy|Overall Study||409
227402|NCT00191646|540340|P1|Received Induction Therapy|Overall Study||411
227403|NCT00191646|540339|P2|STARTED|Overall Study||414
227404|NCT00191646|540340|P1|STARTED|Overall Study||417
227405|NCT00191477|540360|P2|NOT COMPLETED|Overall Study||129
227406|NCT00191477|540361|P1|NOT COMPLETED|Overall Study||138
227407|NCT00191477|540360|P2|COMPLETED|Overall Study||47
227408|NCT00191477|540361|P1|COMPLETED|Overall Study||41
227409|NCT00191477|540360|P2|Received Study Drug|Overall Study||162
227410|NCT00191477|540361|P1|Received Study Drug|Overall Study||166
227411|NCT00191477|540360|P2|STARTED|Overall Study||176
227412|NCT00191477|540361|P1|STARTED|Overall Study||179
227413|NCT00191451|540380|P3|NOT COMPLETED|Overall Study||14
227414|NCT00191451|540381|P2|NOT COMPLETED|Overall Study||14
227415|NCT00191451|540382|P1|NOT COMPLETED|Overall Study||7
227416|NCT00191451|540380|P3|COMPLETED|Overall Study||35
227417|NCT00191451|540381|P2|COMPLETED|Overall Study||37
227418|NCT00191451|540382|P1|COMPLETED|Overall Study||43
227419|NCT00191451|540380|P3|Received at Least One Dose of Study Drug|Overall Study||47
227420|NCT00191451|540381|P2|Received at Least One Dose of Study Drug|Overall Study||48
227421|NCT00191451|540382|P1|Received at Least One Dose of Study Drug|Overall Study||50
227422|NCT00191451|540380|P3|STARTED|Overall Study||49
227423|NCT00191451|540381|P2|STARTED|Overall Study||51
227424|NCT00191451|540382|P1|STARTED|Overall Study||50
227425|NCT00191386|540402|P1|NOT COMPLETED|Overall Study||160
227426|NCT00191386|540402|P1|COMPLETED|Overall Study||68
227427|NCT00191386|540402|P1|3 Years|Overall Study||65
227428|NCT00191386|540402|P1|2 Years|Overall Study||105
227429|NCT00191386|540402|P1|12 Months|Overall Study||149
227430|NCT00191386|540402|P1|6 Months|Overall Study||183
227431|NCT00191386|540402|P1|STARTED|Overall Study||228
227432|NCT00191334|540409|P1|NOT COMPLETED|Overall Study||17
227433|NCT00191334|540409|P1|COMPLETED|Overall Study||33
227434|NCT00191334|540409|P1|STARTED|Overall Study||50
227435|NCT00191308|540417|P1|NOT COMPLETED|Overall Study||1
227436|NCT00191308|540417|P1|COMPLETED|Overall Study||29
227437|NCT00191308|540417|P1|STARTED|Overall Study||30
227438|NCT00191282|540427|P2|NOT COMPLETED|Overall Study||212
227439|NCT00191282|540428|P1|NOT COMPLETED|Overall Study||220
227440|NCT00191282|540427|P2|COMPLETED|Overall Study||346
227441|NCT00191282|540428|P1|COMPLETED|Overall Study||338
227442|NCT00191282|540427|P2|STARTED|Overall Study||558
227443|NCT00191282|540428|P1|STARTED|Overall Study||558
227444|NCT00191269|540488|P2|NOT COMPLETED|Overall Study||58
227445|NCT00191269|540489|P1|NOT COMPLETED|Overall Study||6
227446|NCT00191269|540488|P2|COMPLETED|Overall Study||4
227447|NCT00191269|540489|P1|COMPLETED|Overall Study||0
227448|NCT00191269|540488|P2|STARTED|Overall Study||62
227449|NCT00191269|540489|P1|STARTED|Overall Study||6
227450|NCT00191191|540505|P2|NOT COMPLETED|Overall Study||112
227451|NCT00191191|540506|P1|NOT COMPLETED|Overall Study||114
227452|NCT00191191|540505|P2|COMPLETED|Overall Study||0
227453|NCT00191191|540506|P1|COMPLETED|Overall Study||0
227454|NCT00191191|540505|P2|Full Analysis Set Population|Overall Study||108
227455|NCT00191191|540506|P1|Full Analysis Set Population|Overall Study||108
227456|NCT00191191|540505|P2|Safety Analysis Population|Overall Study||111
227457|NCT00191191|540506|P1|Safety Analysis Population|Overall Study||114
227458|NCT00191191|540505|P2|STARTED|Overall Study||112
227459|NCT00191191|540506|P1|STARTED|Overall Study||114
227460|NCT00191165|540522|P2|NOT COMPLETED|Overall Study||2
227461|NCT00191165|540523|P1|NOT COMPLETED|Overall Study||2
227462|NCT00191165|540522|P2|COMPLETED|Overall Study||11
227463|NCT00191165|540523|P1|COMPLETED|Overall Study||12
227464|NCT00191165|540522|P2|STARTED|Overall Study||13
227465|NCT00191165|540523|P1|STARTED|Overall Study||14
227466|NCT00191152|540535|P2|NOT COMPLETED|Crossover Treatment||28
227467|NCT00191152|540536|P1|NOT COMPLETED|Crossover Treatment||27
227468|NCT00191152|540535|P2|COMPLETED|Crossover Treatment||53
227469|NCT00191152|540536|P1|COMPLETED|Crossover Treatment||50
227470|NCT00191152|540535|P2|Received Treatment|Crossover Treatment||80
227471|NCT00191152|540536|P1|Received Treatment|Crossover Treatment||76
227472|NCT00191152|540535|P2|STARTED|Crossover Treatment||81
227473|NCT00191152|540536|P1|STARTED|Crossover Treatment||77
227474|NCT00191152|540535|P2|NOT COMPLETED|Initial Treatment||153
227475|NCT00191152|540536|P1|NOT COMPLETED|Initial Treatment||141
227476|NCT00191152|540535|P2|COMPLETED|Initial Treatment||83
227477|NCT00191152|540536|P1|COMPLETED|Initial Treatment||98
227478|NCT00191152|540535|P2|Received Initial Treatment|Initial Treatment||227
227479|NCT00191152|540536|P1|Received Initial Treatment|Initial Treatment||236
227480|NCT00191152|540535|P2|STARTED|Initial Treatment||236
227481|NCT00191152|540536|P1|STARTED|Initial Treatment||239
227482|NCT00191139|540568|P2|NOT COMPLETED|Overall Study||12
227483|NCT00191139|540569|P1|NOT COMPLETED|Overall Study||5
227484|NCT00191139|540568|P2|COMPLETED|Overall Study||20
227485|NCT00191139|540569|P1|COMPLETED|Overall Study||27
227486|NCT00191139|540568|P2|STARTED|Overall Study||32
227487|NCT00191139|540569|P1|STARTED|Overall Study||32
227488|NCT00191113|540585|P2|NOT COMPLETED|Addendum 3||0
227489|NCT00191113|540586|P1|NOT COMPLETED|Addendum 3||0
227490|NCT00191113|540585|P2|COMPLETED|Addendum 3||37
227491|NCT00191113|540586|P1|COMPLETED|Addendum 3||20
227492|NCT00191113|540585|P2|STARTED|Addendum 3||37
227493|NCT00191113|540586|P1|STARTED|Addendum 3||20
227494|NCT00191113|540585|P2|NOT COMPLETED|Addendum 2||17
227495|NCT00191113|540586|P1|NOT COMPLETED|Addendum 2||10
227496|NCT00191113|540585|P2|COMPLETED|Addendum 2||31
227497|NCT00191113|540586|P1|COMPLETED|Addendum 2||18
227498|NCT00191113|540585|P2|STARTED|Addendum 2||48
227499|NCT00191113|540586|P1|STARTED|Addendum 2||28
227500|NCT00191113|540585|P2|NOT COMPLETED|Addendum 1||0
227501|NCT00191113|540586|P1|NOT COMPLETED|Addendum 1||0
227502|NCT00191113|540585|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
227503|NCT00191113|540586|P1|COMPLETED|Addendum 1||2
227504|NCT00191113|540585|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
227505|NCT00191113|540586|P1|STARTED|Addendum 1||2
227506|NCT00191113|540585|P2|NOT COMPLETED|Core Study||15
227507|NCT00191113|540586|P1|NOT COMPLETED|Core Study||35
227508|NCT00191113|540585|P2|COMPLETED|Core Study||61
227509|NCT00191113|540586|P1|COMPLETED|Core Study||43
227510|NCT00191113|540585|P2|STARTED|Core Study||76
227511|NCT00191113|540586|P1|STARTED|Core Study||78
227512|NCT00191100|540628|P2|NOT COMPLETED|Overall Study||12
227513|NCT00191100|540629|P1|NOT COMPLETED|Overall Study||42
227514|NCT00191100|540628|P2|COMPLETED|Overall Study||244
227515|NCT00191100|540629|P1|COMPLETED|Overall Study||217
227516|NCT00191100|540628|P2|STARTED|Overall Study||256
227517|NCT00191100|540629|P1|STARTED|Overall Study||259
227518|NCT00190983|540645|P1|NOT COMPLETED|Overall Study||2
227519|NCT00190983|540645|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
227520|NCT00190983|540645|P1|STARTED|Overall Study||29
227521|NCT00190775|540654|P2|NOT COMPLETED|Overall Study||100
227522|NCT00190775|540655|P1|NOT COMPLETED|Overall Study||149
227523|NCT00190775|540654|P2|COMPLETED|Overall Study||134
227524|NCT00190775|540655|P1|COMPLETED|Overall Study||119
227525|NCT00190775|540654|P2|Received Study Drug|Overall Study||234
227526|NCT00190775|540655|P1|Received Study Drug|Overall Study||266
227527|NCT00190775|540654|P2|STARTED|Overall Study||234
227528|NCT00190775|540655|P1|STARTED|Overall Study||268
227529|NCT00190749|540726|P2|NOT COMPLETED|Overall Study||31
227530|NCT00190749|540727|P1|NOT COMPLETED|Overall Study||26
227531|NCT00190749|540726|P2|COMPLETED|Overall Study||31
227532|NCT00190749|540727|P1|COMPLETED|Overall Study||42
227533|NCT00190749|540726|P2|STARTED|Overall Study||62
227534|NCT00190749|540727|P1|STARTED|Overall Study||68
227535|NCT00190684|540791|P1|NOT COMPLETED|Overall Study||1489
227536|NCT00190684|540791|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
227537|NCT00190684|540791|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
227538|NCT00190684|540791|P1|STARTED|Overall Study||1553
227539|NCT00190671|540812|P2|NOT COMPLETED|Overall Study||42
227540|NCT00190671|540813|P1|NOT COMPLETED|Overall Study||27
227541|NCT00190671|540812|P2|COMPLETED|Overall Study||19
227542|NCT00190671|540813|P1|COMPLETED|Overall Study||15
227543|NCT00190671|540812|P2|STARTED|Overall Study||61
227544|NCT00190671|540813|P1|STARTED|Overall Study||42
227545|NCT00187720|540833|P2|NOT COMPLETED|Overall Study||0
227546|NCT00187720|540834|P1|NOT COMPLETED|Overall Study||0
227547|NCT00187720|540833|P2|COMPLETED|Overall Study||14
227548|NCT00187720|540834|P1|COMPLETED|Overall Study||9
227549|NCT00187720|540833|P2|STARTED|Overall Study||14
227550|NCT00187720|540834|P1|STARTED|Overall Study||9
227551|NCT00187681|540842|P2|NOT COMPLETED|Overall Study||0
227552|NCT00187681|540843|P1|NOT COMPLETED|Overall Study||0
227553|NCT00187681|540842|P2|COMPLETED|Overall Study||8
227554|NCT00187681|540843|P1|COMPLETED|Overall Study||12
227555|NCT00187681|540842|P2|STARTED|Overall Study||8
227556|NCT00187681|540843|P1|STARTED|Overall Study||12
227557|NCT00187655|540851|P1|NOT COMPLETED|Overall Study||0
227558|NCT00187655|540851|P1|COMPLETED|Overall Study||24
227559|NCT00187655|540851|P1|STARTED|Overall Study||24
227560|NCT00189540|540858|P2|NOT COMPLETED|Overall Study||1
227561|NCT00189540|540859|P1|NOT COMPLETED|Overall Study||7
227562|NCT00189540|540858|P2|COMPLETED|Overall Study||5
227563|NCT00189540|540859|P1|COMPLETED|Overall Study||14
227564|NCT00189540|540858|P2|STARTED|Overall Study||6
227565|NCT00189540|540859|P1|STARTED|Overall Study||21
227566|NCT00189488|540877|P2|NOT COMPLETED|Overall Study||22
227567|NCT00189488|540878|P1|NOT COMPLETED|Overall Study||15
227568|NCT00189488|540877|P2|COMPLETED|Overall Study||55
227569|NCT00189488|540878|P1|COMPLETED|Overall Study||63
227570|NCT00189488|540877|P2|Received Palifermin/Placebo|Overall Study||76
227571|NCT00189488|540878|P1|Received Palifermin/Placebo|Overall Study||75
227572|NCT00189488|540877|P2|STARTED|Overall Study||77
227573|NCT00189488|540878|P1|STARTED|Overall Study||78
227574|NCT00189475|540900|P2|NOT COMPLETED|Overall Study||0
227575|NCT00189475|540901|P1|NOT COMPLETED|Overall Study||0
227576|NCT00189475|540900|P2|COMPLETED|Overall Study||42
227577|NCT00189475|540901|P1|COMPLETED|Overall Study||42
227578|NCT00189475|540900|P2|STARTED|Overall Study||42
227579|NCT00189475|540901|P1|STARTED|Overall Study||42
227580|NCT00189462|540909|P2|NOT COMPLETED|Overall Study||21
227581|NCT00189462|540910|P1|NOT COMPLETED|Overall Study||23
227582|NCT00189462|540909|P2|COMPLETED|Overall Study||28
227583|NCT00189462|540910|P1|COMPLETED|Overall Study||27
227584|NCT00189462|540909|P2|STARTED|Overall Study||49
227585|NCT00189462|540910|P1|STARTED|Overall Study||50
227586|NCT00189436|540918|P2|NOT COMPLETED|Overall Study||5
227587|NCT00189436|540919|P1|NOT COMPLETED|Overall Study||8
227588|NCT00189436|540918|P2|COMPLETED|Overall Study||25
227589|NCT00189436|540919|P1|COMPLETED|Overall Study||23
227590|NCT00189436|540918|P2|STARTED|Overall Study||30
227591|NCT00189436|540919|P1|STARTED|Overall Study||31
227592|NCT00189423|540927|P2|NOT COMPLETED|Overall Study||766
227593|NCT00189423|540928|P1|NOT COMPLETED|Overall Study||765
227594|NCT00189423|540927|P2|COMPLETED|Overall Study||74
227595|NCT00189423|540928|P1|COMPLETED|Overall Study||48
227596|NCT00189423|540927|P2|STARTED|Overall Study||840
227597|NCT00189423|540928|P1|STARTED|Overall Study||813
227598|NCT00189306|540948|P1|NOT COMPLETED|Long-Term Follow-up||38
227599|NCT00189306|540948|P1|COMPLETED|Long-Term Follow-up||119
227600|NCT00189306|540948|P1|STARTED|Long-Term Follow-up||157
227601|NCT00189306|540948|P1|NOT COMPLETED|Posttreatment Period||12
227602|NCT00189306|540948|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
227603|NCT00189306|540948|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
227604|NCT00189306|540948|P1|NOT COMPLETED|Treatment Period||5
227605|NCT00189306|540948|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
227606|NCT00189306|540948|P1|STARTED|Treatment Period||169
227607|NCT00189137|540955|P2|NOT COMPLETED|Overall Study||0
227608|NCT00189137|540956|P1|NOT COMPLETED|Overall Study||0
227609|NCT00189137|540955|P2|COMPLETED|Overall Study||43
227610|NCT00189137|540956|P1|COMPLETED|Overall Study||37
227611|NCT00189137|540955|P2|STARTED|Overall Study||43
227612|NCT00189137|540956|P1|STARTED|Overall Study||37
227613|NCT00189098|540966|P2|NOT COMPLETED|Overall Study||6
227614|NCT00189098|540967|P1|NOT COMPLETED|Overall Study||5
227615|NCT00189098|540966|P2|COMPLETED|Overall Study||44
227616|NCT00189098|540967|P1|COMPLETED|Overall Study||46
227617|NCT00189098|540966|P2|STARTED|Overall Study||50
227618|NCT00189098|540967|P1|STARTED|Overall Study||51
227619|NCT00187889|540985|P2|NOT COMPLETED|Overall Study||4
227620|NCT00187889|540986|P1|NOT COMPLETED|Overall Study||6
227621|NCT00187889|540985|P2|COMPLETED|Overall Study||22
227622|NCT00187889|540986|P1|COMPLETED|Overall Study||19
227623|NCT00187889|540985|P2|STARTED|Overall Study||26
227624|NCT00187889|540986|P1|STARTED|Overall Study||25
227625|NCT00187876|540996|P2|NOT COMPLETED|Overall Study||0
227626|NCT00187876|540997|P1|NOT COMPLETED|Overall Study||0
227627|NCT00187876|540996|P2|COMPLETED|Overall Study||43
227628|NCT00187876|540997|P1|COMPLETED|Overall Study||24
227629|NCT00187876|540996|P2|STARTED|Overall Study||43
227630|NCT00187876|540997|P1|STARTED|Overall Study||24
227631|NCT00187486|541003|P1|NOT COMPLETED|Overall Study||1
227632|NCT00187486|541003|P1|COMPLETED|Overall Study||65
227633|NCT00187486|541003|P1|STARTED|Overall Study||66
227634|NCT00187226|541014|P6|NOT COMPLETED|Overall Study||0
227635|NCT00187226|541015|P5|NOT COMPLETED|Overall Study||0
227636|NCT00187226|541016|P4|NOT COMPLETED|Overall Study||0
227637|NCT00187226|541017|P3|NOT COMPLETED|Overall Study||0
227638|NCT00187226|541018|P2|NOT COMPLETED|Overall Study||0
227639|NCT00187226|541019|P1|NOT COMPLETED|Overall Study||0
227640|NCT00187226|541014|P6|COMPLETED|Overall Study||1
227641|NCT00187226|541015|P5|COMPLETED|Overall Study||34
227642|NCT00187226|541016|P4|COMPLETED|Overall Study||2
227643|NCT00187226|541017|P3|COMPLETED|Overall Study||28
227644|NCT00187226|541018|P2|COMPLETED|Overall Study||49
227645|NCT00187226|541019|P1|COMPLETED|Overall Study||88
227646|NCT00187226|541014|P6|STARTED|Overall Study||1
227647|NCT00187226|541015|P5|STARTED|Overall Study||34
227648|NCT00187226|541016|P4|STARTED|Overall Study||2
227649|NCT00187226|541017|P3|STARTED|Overall Study||28
227650|NCT00187226|541018|P2|STARTED|Overall Study||49
227651|NCT00187226|541019|P1|STARTED|Overall Study||88
227652|NCT00187200|541035|P2|NOT COMPLETED|Overall Study||18
227653|NCT00187200|541036|P1|NOT COMPLETED|Overall Study||18
227654|NCT00187200|541035|P2|COMPLETED|Overall Study||26
227655|NCT00187200|541036|P1|COMPLETED|Overall Study||31
227656|NCT00187200|541035|P2|STARTED|Overall Study||44
227657|NCT00187200|541036|P1|STARTED|Overall Study||49
227658|NCT00187135|541054|P6|NOT COMPLETED|Visit Three||6
227659|NCT00187135|541055|P5|NOT COMPLETED|Visit Three||8
227660|NCT00187135|541056|P4|NOT COMPLETED|Visit Three||9
227661|NCT00187135|541057|P3|NOT COMPLETED|Visit Three||9
227662|NCT00187135|541058|P2|NOT COMPLETED|Visit Three||7
227663|NCT00187135|541059|P1|NOT COMPLETED|Visit Three||7
227664|NCT00187135|541054|P6|COMPLETED|Visit Three||12
227665|NCT00187135|541055|P5|COMPLETED|Visit Three||11
227666|NCT00187135|541056|P4|COMPLETED|Visit Three||9
227667|NCT00187135|541057|P3|COMPLETED|Visit Three||14
227668|NCT00187135|541058|P2|COMPLETED|Visit Three||17
227669|NCT00187135|541059|P1|COMPLETED|Visit Three||14
227670|NCT00187135|541054|P6|STARTED|Visit Three||18
227671|NCT00187135|541055|P5|STARTED|Visit Three||19
227672|NCT00187135|541056|P4|STARTED|Visit Three||18
227673|NCT00187135|541057|P3|STARTED|Visit Three||23
227674|NCT00187135|541058|P2|STARTED|Visit Three||24
227675|NCT00187135|541059|P1|STARTED|Visit Three||21
227676|NCT00187135|541054|P6|NOT COMPLETED|Visit Two||8
227677|NCT00187135|541055|P5|NOT COMPLETED|Visit Two||6
227678|NCT00187135|541056|P4|NOT COMPLETED|Visit Two||8
227679|NCT00187135|541057|P3|NOT COMPLETED|Visit Two||2
227680|NCT00187135|541058|P2|NOT COMPLETED|Visit Two||3
227681|NCT00187135|541059|P1|NOT COMPLETED|Visit Two||5
227682|NCT00187135|541054|P6|COMPLETED|Visit Two||18
227683|NCT00187135|541055|P5|COMPLETED|Visit Two||19
227684|NCT00187135|541056|P4|COMPLETED|Visit Two||18
227685|NCT00187135|541057|P3|COMPLETED|Visit Two||23
227686|NCT00187135|541058|P2|COMPLETED|Visit Two||24
227687|NCT00187135|541059|P1|COMPLETED|Visit Two||21
227688|NCT00187135|541054|P6|STARTED|Visit Two||26
227689|NCT00187135|541055|P5|STARTED|Visit Two||25
227690|NCT00187135|541056|P4|STARTED|Visit Two||26
227691|NCT00187135|541057|P3|STARTED|Visit Two||25
227692|NCT00187135|541058|P2|STARTED|Visit Two||27
227693|NCT00187135|541059|P1|STARTED|Visit Two||26
227694|NCT00187135|541054|P6|NOT COMPLETED|Visit One||2
227695|NCT00187135|541055|P5|NOT COMPLETED|Visit One||0
227696|NCT00187135|541056|P4|NOT COMPLETED|Visit One||0
227697|NCT00187135|541057|P3|NOT COMPLETED|Visit One||0
227698|NCT00187135|541058|P2|NOT COMPLETED|Visit One||1
227699|NCT00187135|541059|P1|NOT COMPLETED|Visit One||4
227700|NCT00187135|541054|P6|COMPLETED|Visit One||26
227701|NCT00187135|541055|P5|COMPLETED|Visit One||25
227702|NCT00187135|541056|P4|COMPLETED|Visit One||26
227703|NCT00187135|541057|P3|COMPLETED|Visit One||25
227704|NCT00187135|541058|P2|COMPLETED|Visit One||27
227705|NCT00187135|541059|P1|COMPLETED|Visit One||26
227706|NCT00187135|541054|P6|STARTED|Visit One||28
227707|NCT00187135|541055|P5|STARTED|Visit One||25
227708|NCT00187135|541056|P4|STARTED|Visit One||26
227709|NCT00187135|541057|P3|STARTED|Visit One||25
227710|NCT00187135|541058|P2|STARTED|Visit One||28
227711|NCT00187135|541059|P1|STARTED|Visit One||30
227712|NCT00187096|541082|P3|NOT COMPLETED|Overall Study||1
227713|NCT00187096|541083|P2|NOT COMPLETED|Overall Study||0
227714|NCT00187096|541084|P1|NOT COMPLETED|Overall Study||0
227715|NCT00187096|541082|P3|COMPLETED|Overall Study||11
227716|NCT00187096|541083|P2|COMPLETED|Overall Study||3
227717|NCT00187096|541084|P1|COMPLETED|Overall Study||10
227718|NCT00187096|541082|P3|STARTED|Overall Study||12
227719|NCT00187096|541083|P2|STARTED|Overall Study||3
227720|NCT00187096|541084|P1|STARTED|Overall Study||10
227721|NCT00186901|541122|P3|NOT COMPLETED|Overall Study||149
227722|NCT00186901|541123|P2|NOT COMPLETED|Overall Study||45
227723|NCT00186901|541124|P1|NOT COMPLETED|Overall Study||49
227724|NCT00186901|541122|P3|COMPLETED|Overall Study||0
227725|NCT00186901|541123|P2|COMPLETED|Overall Study||96
227726|NCT00186901|541124|P1|COMPLETED|Overall Study||85
227727|NCT00186901|541122|P3|24 Month Follow-up|Overall Study||0
227728|NCT00186901|541123|P2|24 Month Follow-up|Overall Study||107
227729|NCT00186901|541124|P1|24 Month Follow-up|Overall Study||106
227730|NCT00186901|541122|P3|12 Month Follow-up|Overall Study||0
227731|NCT00186901|541123|P2|12 Month Follow-up|Overall Study||122
227732|NCT00186901|541124|P1|12 Month Follow-up|Overall Study||117
227733|NCT00186901|541122|P3|Baseline|Overall Study||0
227734|NCT00186901|541123|P2|Baseline|Overall Study||141
227735|NCT00186901|541124|P1|Baseline|Overall Study||134
227736|NCT00186901|541122|P3|STARTED|Overall Study||149
227737|NCT00186901|541123|P2|STARTED|Overall Study||141
227738|NCT00186901|541124|P1|STARTED|Overall Study||134
227739|NCT00186888|541164|P3|NOT COMPLETED|Overall Study||0
227740|NCT00186888|541165|P2|NOT COMPLETED|Overall Study||3
227741|NCT00186888|541166|P1|NOT COMPLETED|Overall Study||4
227742|NCT00186888|541164|P3|COMPLETED|Overall Study||55
227743|NCT00186888|541165|P2|COMPLETED|Overall Study||24
227744|NCT00186888|541166|P1|COMPLETED|Overall Study||19
227745|NCT00186888|541164|P3|Window Therapy|Overall Study||0
227746|NCT00186888|541165|P2|Window Therapy|Overall Study||27
227747|NCT00186888|541166|P1|Window Therapy|Overall Study||0
227748|NCT00186888|541164|P3|STARTED|Overall Study||55
227749|NCT00186888|541165|P2|STARTED|Overall Study||27
227750|NCT00186888|541166|P1|STARTED|Overall Study||23
227751|NCT00186875|541232|P2|NOT COMPLETED|Overall Study||0
227752|NCT00186875|541233|P1|NOT COMPLETED|Overall Study||0
227753|NCT00186875|541232|P2|COMPLETED|Overall Study||14
227754|NCT00186875|541233|P1|COMPLETED|Overall Study||26
227755|NCT00186875|541232|P2|STARTED|Overall Study||14
227756|NCT00186875|541233|P1|STARTED|Overall Study||26
227757|NCT00186537|541242|P3|NOT COMPLETED|Overall Study||3
227758|NCT00186537|541243|P2|NOT COMPLETED|Overall Study||0
227759|NCT00186537|541244|P1|NOT COMPLETED|Overall Study||7
227760|NCT00186537|541242|P3|COMPLETED|Overall Study||13
227761|NCT00186537|541243|P2|COMPLETED|Overall Study||12
227762|NCT00186537|541244|P1|COMPLETED|Overall Study||12
227763|NCT00186537|541242|P3|STARTED|Overall Study||16
227764|NCT00186537|541243|P2|STARTED|Overall Study||12
227765|NCT00186537|541244|P1|STARTED|Overall Study||19
227766|NCT00185965|541260|P2|NOT COMPLETED|Overall Study||1
227767|NCT00185965|541261|P1|NOT COMPLETED|Overall Study||0
227768|NCT00185965|541260|P2|COMPLETED|Overall Study||14
227769|NCT00185965|541261|P1|COMPLETED|Overall Study||15
227770|NCT00185965|541260|P2|STARTED|Overall Study||15
227771|NCT00185965|541261|P1|STARTED|Overall Study||15
227772|NCT00185692|541267|P1|NOT COMPLETED|Overall Study||16
227773|NCT00185692|541267|P1|COMPLETED|Overall Study||0
227774|NCT00185692|541267|P1|STARTED|Overall Study||16
227775|NCT00185679|541272|P1|NOT COMPLETED|Overall Study||0
227776|NCT00185679|541272|P1|COMPLETED|Overall Study||13
227777|NCT00185679|541272|P1|STARTED|Overall Study||13
227778|NCT00185588|541282|P4|NOT COMPLETED|Overall Study||4
227779|NCT00185588|541283|P3|NOT COMPLETED|Overall Study||6
227780|NCT00185588|541284|P2|NOT COMPLETED|Overall Study||2
227781|NCT00185588|541285|P1|NOT COMPLETED|Overall Study||3
227782|NCT00185588|541282|P4|COMPLETED|Overall Study||13
227783|NCT00185588|541283|P3|COMPLETED|Overall Study||0
227784|NCT00185588|541284|P2|COMPLETED|Overall Study||2
227785|NCT00185588|541285|P1|COMPLETED|Overall Study||3
227786|NCT00185588|541282|P4|STARTED|Overall Study||17
227787|NCT00185588|541283|P3|STARTED|Overall Study||6
227788|NCT00185588|541284|P2|STARTED|Overall Study||4
227789|NCT00185588|541285|P1|STARTED|Overall Study||6
227790|NCT00185458|541299|P1|NOT COMPLETED|HRT Phase||27
227791|NCT00185458|541299|P1|COMPLETED|HRT Phase||141
227792|NCT00185458|541299|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
227793|NCT00185458|541299|P1|NOT COMPLETED|Contraception Phase||58
227794|NCT00185458|541299|P1|COMPLETED|Contraception Phase||336
227795|NCT00185458|541299|P1|STARTED|Contraception Phase||394
227796|NCT00185380|541362|P3|NOT COMPLETED|Overall Study||74
227797|NCT00185380|541363|P2|NOT COMPLETED|Overall Study||72
227798|NCT00185380|541364|P1|NOT COMPLETED|Overall Study||66
227799|NCT00185380|541362|P3|COMPLETED|Overall Study||182
227800|NCT00185380|541363|P2|COMPLETED|Overall Study||174
227801|NCT00185380|541364|P1|COMPLETED|Overall Study||174
227802|NCT00185380|541362|P3|Subjects Received Treatment|Overall Study||254
227803|NCT00185380|541363|P2|Subjects Received Treatment|Overall Study||245
227804|NCT00185380|541364|P1|Subjects Received Treatment|Overall Study||239
227805|NCT00185380|541362|P3|STARTED|Overall Study||256
227806|NCT00185380|541363|P2|STARTED|Overall Study||246
227807|NCT00185380|541364|P1|STARTED|Overall Study||240
227808|NCT00185211|541392|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
227809|NCT00185211|541393|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
227810|NCT00185211|541392|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
227811|NCT00185211|541393|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
227812|NCT00185211|541392|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
227813|NCT00185211|541393|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
227814|NCT00185211|541392|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
227815|NCT00185211|541393|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
227816|NCT00185211|541392|P2|COMPLETED|Placebo-controlled Study (92012)||166
227817|NCT00185211|541393|P1|COMPLETED|Placebo-controlled Study (92012)||271
227818|NCT00185211|541392|P2|STARTED|Placebo-controlled Study (92012)||176
227819|NCT00185211|541393|P1|STARTED|Placebo-controlled Study (92012)||292
227820|NCT00184717|541421|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
227821|NCT00184717|541422|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
227822|NCT00184717|541423|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
227823|NCT00184717|541424|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
227824|NCT00184717|541425|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
227825|NCT00184717|541421|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
227826|NCT00184717|541422|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
227827|NCT00184717|541423|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
227828|NCT00184717|541424|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
227829|NCT00184717|541425|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
227830|NCT00184717|541421|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
227831|NCT00184717|541422|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
227832|NCT00184717|541423|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
227833|NCT00184717|541424|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
227834|NCT00184717|541425|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
227835|NCT00184717|541421|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
227836|NCT00184717|541422|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
227837|NCT00184717|541423|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
227838|NCT00184717|541424|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
227839|NCT00184717|541425|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
227840|NCT00184717|541421|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
227841|NCT00184717|541422|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
227842|NCT00184717|541423|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
227843|NCT00184717|541424|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
227844|NCT00184717|541425|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
227845|NCT00184717|541421|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
227846|NCT00184717|541422|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
227847|NCT00184717|541423|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
227848|NCT00184717|541424|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
227849|NCT00184717|541425|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
227850|NCT00184717|541421|P5|STARTED|Main Period (GHLIQUID-1516)||0
227851|NCT00184717|541422|P4|STARTED|Main Period (GHLIQUID-1516)||0
227852|NCT00184717|541423|P3|STARTED|Main Period (GHLIQUID-1516)||21
227853|NCT00184717|541424|P2|STARTED|Main Period (GHLIQUID-1516)||38
227854|NCT00184717|541425|P1|STARTED|Main Period (GHLIQUID-1516)||39
227855|NCT00184600|541466|P3|NOT COMPLETED|Overall Study||34
227856|NCT00184600|541467|P2|NOT COMPLETED|Overall Study||51
227857|NCT00184600|541468|P1|NOT COMPLETED|Overall Study||45
227858|NCT00184600|541466|P3|COMPLETED|Overall Study||201
227859|NCT00184600|541467|P2|COMPLETED|Overall Study||188
227860|NCT00184600|541468|P1|COMPLETED|Overall Study||189
227861|NCT00184600|541466|P3|STARTED|Overall Study||235
227862|NCT00184600|541467|P2|STARTED|Overall Study||239
227863|NCT00184600|541468|P1|STARTED|Overall Study||234
227864|NCT00184548|541522|P4|NOT COMPLETED|Overall Study||7
227865|NCT00184548|541523|P3|NOT COMPLETED|Overall Study||3
227866|NCT00184548|541524|P2|NOT COMPLETED|Overall Study||13
227867|NCT00184548|541525|P1|NOT COMPLETED|Overall Study||8
227868|NCT00184548|541522|P4|COMPLETED|Overall Study||38
227869|NCT00184548|541523|P3|COMPLETED|Overall Study||44
227870|NCT00184548|541524|P2|COMPLETED|Overall Study||242
227871|NCT00184548|541525|P1|COMPLETED|Overall Study||218
227872|NCT00184548|541522|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
227873|NCT00184548|541523|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
227874|NCT00184548|541524|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
227875|NCT00184548|541525|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
227876|NCT00184548|541522|P4|STARTED|Overall Study||45
227877|NCT00184548|541523|P3|STARTED|Overall Study||47
227878|NCT00184548|541524|P2|STARTED|Overall Study||255
227879|NCT00184548|541525|P1|STARTED|Overall Study||226
227880|NCT00184054|541559|P1|NOT COMPLETED|Overall Study||1
227881|NCT00184054|541559|P1|COMPLETED|Overall Study||10
227882|NCT00184054|541559|P1|STARTED|Overall Study||11
227883|NCT00184028|541564|P1|NOT COMPLETED|Overall Study||10
227884|NCT00184028|541564|P1|COMPLETED|Overall Study||2
227885|NCT00184028|541564|P1|STARTED|Overall Study||12
227886|NCT00183963|541573|P4|NOT COMPLETED|Overall Study||1
227887|NCT00183963|541574|P3|NOT COMPLETED|Overall Study||1
227888|NCT00183963|541575|P2|NOT COMPLETED|Overall Study||1
227889|NCT00183963|541576|P1|NOT COMPLETED|Overall Study||1
227890|NCT00183963|541573|P4|COMPLETED|Overall Study||0
227891|NCT00183963|541574|P3|COMPLETED|Overall Study||0
227892|NCT00183963|541575|P2|COMPLETED|Overall Study||0
227893|NCT00183963|541576|P1|COMPLETED|Overall Study||0
227894|NCT00183963|541573|P4|STARTED|Overall Study||1
227895|NCT00183963|541574|P3|STARTED|Overall Study||1
227896|NCT00183963|541575|P2|STARTED|Overall Study||1
227897|NCT00183963|541576|P1|STARTED|Overall Study||1
227898|NCT00183794|541590|P1|NOT COMPLETED|Overall Study||0
227899|NCT00183794|541590|P1|COMPLETED|Overall Study||20
227900|NCT00183794|541590|P1|STARTED|Overall Study||20
227901|NCT00183729|541597|P2|NOT COMPLETED|Overall Study||5
227902|NCT00183729|541598|P1|NOT COMPLETED|Overall Study||3
227903|NCT00183729|541597|P2|COMPLETED|Overall Study||13
227904|NCT00183729|541598|P1|COMPLETED|Overall Study||14
227905|NCT00183729|541597|P2|STARTED|Overall Study||18
227906|NCT00183729|541598|P1|STARTED|Overall Study||17
227907|NCT00183677|541604|P1|NOT COMPLETED|Overall Study||44
227908|NCT00183677|541604|P1|COMPLETED|Overall Study||53
227909|NCT00183677|541604|P1|STARTED|Overall Study||97
227910|NCT00183625|541610|P4|NOT COMPLETED|Overall Study||14
227911|NCT00183625|541611|P3|NOT COMPLETED|Overall Study||19
227912|NCT00183625|541612|P2|NOT COMPLETED|Overall Study||18
227913|NCT00183625|541613|P1|NOT COMPLETED|Overall Study||18
227914|NCT00183625|541610|P4|COMPLETED|Overall Study||10
227915|NCT00183625|541611|P3|COMPLETED|Overall Study||9
227916|NCT00183625|541612|P2|COMPLETED|Overall Study||10
227917|NCT00183625|541613|P1|COMPLETED|Overall Study||9
227918|NCT00183625|541610|P4|Obtained Employment|Overall Study||14
227919|NCT00183625|541611|P3|Obtained Employment|Overall Study||14
227920|NCT00183625|541612|P2|Obtained Employment|Overall Study||18
227921|NCT00183625|541613|P1|Obtained Employment|Overall Study||21
227922|NCT00183625|541610|P4|STARTED|Overall Study||24
227923|NCT00183625|541611|P3|STARTED|Overall Study||28
227924|NCT00183625|541612|P2|STARTED|Overall Study||28
227925|NCT00183625|541613|P1|STARTED|Overall Study||27
227926|NCT00183469|541623|P2|NOT COMPLETED|Overall Study||29
227927|NCT00183469|541624|P1|NOT COMPLETED|Overall Study||28
227928|NCT00183469|541623|P2|COMPLETED|Overall Study||16
227929|NCT00183469|541624|P1|COMPLETED|Overall Study||13
227930|NCT00183469|541623|P2|STARTED|Overall Study||45
227931|NCT00183469|541624|P1|STARTED|Overall Study||41
227932|NCT00183456|541634|P4|NOT COMPLETED|Overall Study||28
227933|NCT00183456|541635|P3|NOT COMPLETED|Overall Study||16
227934|NCT00183456|541636|P2|NOT COMPLETED|Overall Study||1
227935|NCT00183456|541637|P1|NOT COMPLETED|Overall Study||3
227936|NCT00183456|541634|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
227937|NCT00183456|541635|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
227938|NCT00183456|541636|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
227939|NCT00183456|541637|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
227940|NCT00183456|541634|P4|18 Month Follow-up|Overall Study||207
227941|NCT00183456|541635|P3|18 Month Follow-up|Overall Study||303
227942|NCT00183456|541636|P2|18 Month Follow-up|Overall Study||81
227943|NCT00183456|541637|P1|18 Month Follow-up|Overall Study||80
227944|NCT00183456|541634|P4|12 Month Follow-up|Overall Study||186
227945|NCT00183456|541635|P3|12 Month Follow-up|Overall Study||267
227946|NCT00183456|541636|P2|12 Month Follow-up|Overall Study||74
227947|NCT00183456|541637|P1|12 Month Follow-up|Overall Study||76
227948|NCT00183456|541634|P4|6 Month Follow-up|Overall Study||175
227949|NCT00183456|541635|P3|6 Month Follow-up|Overall Study||278
227950|NCT00183456|541636|P2|6 Month Follow-up|Overall Study||77
227951|NCT00183456|541637|P1|6 Month Follow-up|Overall Study||74
227952|NCT00183456|541634|P4|STARTED|Overall Study||248
227953|NCT00183456|541635|P3|STARTED|Overall Study||329
227954|NCT00183456|541636|P2|STARTED|Overall Study||84
227955|NCT00183456|541637|P1|STARTED|Overall Study||85
227956|NCT00183430|541685|P2|NOT COMPLETED|Overall Study||0
227957|NCT00183430|541686|P1|NOT COMPLETED|Overall Study||6
227958|NCT00183430|541685|P2|COMPLETED|Overall Study||11
227959|NCT00183430|541686|P1|COMPLETED|Overall Study||3
227960|NCT00183430|541685|P2|STARTED|Overall Study||11
227961|NCT00183430|541686|P1|STARTED|Overall Study||9
227962|NCT00183339|541698|P2|NOT COMPLETED|Overall Study||4
227963|NCT00183339|541699|P1|NOT COMPLETED|Overall Study||6
227964|NCT00183339|541698|P2|COMPLETED|Overall Study||4
227965|NCT00183339|541699|P1|COMPLETED|Overall Study||4
227966|NCT00183339|541698|P2|STARTED|Overall Study||8
227967|NCT00183339|541699|P1|STARTED|Overall Study||10
227968|NCT00183274|541711|P6|NOT COMPLETED|Phase 3: Double-Blind||4
227969|NCT00183274|541712|P5|NOT COMPLETED|Phase 3: Double-Blind||20
227970|NCT00183274|541713|P4|NOT COMPLETED|Phase 3: Double-Blind||2
227971|NCT00183274|541714|P3|NOT COMPLETED|Phase 3: Double-Blind||0
227972|NCT00183274|541715|P2|NOT COMPLETED|Phase 3: Double-Blind||0
227973|NCT00183274|541716|P1|NOT COMPLETED|Phase 3: Double-Blind||0
227974|NCT00183274|541711|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
227975|NCT00183274|541712|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
227976|NCT00183274|541713|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
227977|NCT00183274|541714|P3|COMPLETED|Phase 3: Double-Blind||0
227978|NCT00183274|541715|P2|COMPLETED|Phase 3: Double-Blind||0
227979|NCT00183274|541716|P1|COMPLETED|Phase 3: Double-Blind||0
227980|NCT00183274|541711|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
227981|NCT00183274|541712|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
227982|NCT00183274|541713|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
227983|NCT00183274|541714|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
227984|NCT00183274|541715|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
227985|NCT00183274|541716|P1|STARTED|Phase 3: Double-Blind||0
227986|NCT00183274|541711|P6|NOT COMPLETED|Phase 2: Double-Blind||0
227987|NCT00183274|541712|P5|NOT COMPLETED|Phase 2: Double-Blind||0
227988|NCT00183274|541713|P4|NOT COMPLETED|Phase 2: Double-Blind||0
227989|NCT00183274|541714|P3|NOT COMPLETED|Phase 2: Double-Blind||43
227990|NCT00183274|541715|P2|NOT COMPLETED|Phase 2: Double-Blind||26
227991|NCT00183274|541716|P1|NOT COMPLETED|Phase 2: Double-Blind||0
227992|NCT00183274|541711|P6|COMPLETED|Phase 2: Double-Blind||0
227993|NCT00183274|541712|P5|COMPLETED|Phase 2: Double-Blind||0
227994|NCT00183274|541713|P4|COMPLETED|Phase 2: Double-Blind||0
227995|NCT00183274|541714|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
227996|NCT00183274|541715|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
227997|NCT00183274|541716|P1|COMPLETED|Phase 2: Double-Blind||0
227998|NCT00183274|541711|P6|STARTED|Phase 2: Double-Blind||0
227999|NCT00183274|541712|P5|STARTED|Phase 2: Double-Blind||0
228000|NCT00183274|541713|P4|STARTED|Phase 2: Double-Blind||0
228001|NCT00183274|541714|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
228002|NCT00183274|541715|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
228003|NCT00183274|541716|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
228004|NCT00183274|541711|P6|NOT COMPLETED|Phase 1: Open-Label||0
228005|NCT00183274|541712|P5|NOT COMPLETED|Phase 1: Open-Label||0
228006|NCT00183274|541713|P4|NOT COMPLETED|Phase 1: Open-Label||0
228007|NCT00183274|541714|P3|NOT COMPLETED|Phase 1: Open-Label||0
228008|NCT00183274|541715|P2|NOT COMPLETED|Phase 1: Open-Label||0
228009|NCT00183274|541716|P1|NOT COMPLETED|Phase 1: Open-Label||110
228010|NCT00183274|541711|P6|COMPLETED|Phase 1: Open-Label||0
228011|NCT00183274|541712|P5|COMPLETED|Phase 1: Open-Label||0
228012|NCT00183274|541713|P4|COMPLETED|Phase 1: Open-Label||0
228013|NCT00183274|541714|P3|COMPLETED|Phase 1: Open-Label||0
228014|NCT00183274|541715|P2|COMPLETED|Phase 1: Open-Label||0
228015|NCT00183274|541716|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
228016|NCT00183274|541711|P6|STARTED|Phase 1: Open-Label||0
228017|NCT00183274|541712|P5|STARTED|Phase 1: Open-Label||0
228018|NCT00183274|541713|P4|STARTED|Phase 1: Open-Label||0
228019|NCT00183274|541714|P3|STARTED|Phase 1: Open-Label||0
228020|NCT00183274|541715|P2|STARTED|Phase 1: Open-Label||0
228021|NCT00183274|541716|P1|STARTED|Phase 1: Open-Label||268
228022|NCT00183248|541733|P2|NOT COMPLETED|Overall Study||1
228023|NCT00183248|541734|P1|NOT COMPLETED|Overall Study||1
228024|NCT00183248|541733|P2|COMPLETED|Overall Study||4
228025|NCT00183248|541734|P1|COMPLETED|Overall Study||3
228026|NCT00183248|541733|P2|STARTED|Overall Study||5
228027|NCT00183248|541734|P1|STARTED|Overall Study||4
228028|NCT00183196|541755|P3|NOT COMPLETED|Overall Study||18
228029|NCT00183196|541756|P2|NOT COMPLETED|Overall Study||15
228030|NCT00183196|541757|P1|NOT COMPLETED|Overall Study||20
228031|NCT00183196|541755|P3|COMPLETED|Overall Study||32
228032|NCT00183196|541756|P2|COMPLETED|Overall Study||35
228033|NCT00183196|541757|P1|COMPLETED|Overall Study||30
228034|NCT00183196|541755|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
228035|NCT00183196|541756|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
228036|NCT00183196|541757|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
228037|NCT00183092|541767|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
228038|NCT00183092|541768|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
228039|NCT00183092|541769|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
228040|NCT00183092|541770|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
228041|NCT00183092|541767|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
228042|NCT00183092|541768|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
228043|NCT00183092|541769|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
228044|NCT00183092|541770|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
228045|NCT00183092|541767|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
228046|NCT00183092|541768|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
228047|NCT00183092|541769|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
228048|NCT00183092|541770|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
228049|NCT00183092|541767|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
228050|NCT00183092|541768|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
228051|NCT00183092|541769|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
228052|NCT00183092|541770|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
228053|NCT00183092|541767|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
228054|NCT00183092|541768|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
228055|NCT00183092|541769|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
228056|NCT00183092|541770|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
228057|NCT00183092|541767|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
228058|NCT00183092|541768|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
228059|NCT00183092|541769|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
228060|NCT00183092|541770|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
228061|NCT00183092|541767|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
228062|NCT00183092|541768|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
228063|NCT00183092|541769|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
228064|NCT00183092|541770|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
228065|NCT00183092|541767|P4|STARTED|Double-blind (Baseline - Month 2)||0
228066|NCT00183092|541768|P3|STARTED|Double-blind (Baseline - Month 2)||0
228067|NCT00183092|541769|P2|STARTED|Double-blind (Baseline - Month 2)||28
228068|NCT00183092|541770|P1|STARTED|Double-blind (Baseline - Month 2)||23
228069|NCT00182767|541791|P5|NOT COMPLETED|Overall Study||0
228070|NCT00182767|541792|P4|NOT COMPLETED|Overall Study||0
228071|NCT00182767|541793|P3|NOT COMPLETED|Overall Study||0
228072|NCT00182767|541794|P2|NOT COMPLETED|Overall Study||0
228073|NCT00182767|541795|P1|NOT COMPLETED|Overall Study||0
228074|NCT00182767|541791|P5|COMPLETED|Overall Study||24
228075|NCT00182767|541792|P4|COMPLETED|Overall Study||3
228076|NCT00182767|541793|P3|COMPLETED|Overall Study||6
228077|NCT00182767|541794|P2|COMPLETED|Overall Study||6
228078|NCT00182767|541795|P1|COMPLETED|Overall Study||6
228079|NCT00182767|541791|P5|STARTED|Overall Study||24
228080|NCT00182767|541792|P4|STARTED|Overall Study||3
228081|NCT00182767|541793|P3|STARTED|Overall Study||6
228082|NCT00182767|541794|P2|STARTED|Overall Study||6
228083|NCT00182767|541795|P1|STARTED|Overall Study||6
228084|NCT00182689|541812|P2|NOT COMPLETED|Overall Study||49
228085|NCT00182689|541813|P1|NOT COMPLETED|Overall Study||40
228086|NCT00182689|541812|P2|COMPLETED|Overall Study||0
228087|NCT00182689|541813|P1|COMPLETED|Overall Study||0
228088|NCT00182689|541812|P2|Eligible and Began Protocol Therapy|Overall Study||45
228089|NCT00182689|541813|P1|Eligible and Began Protocol Therapy|Overall Study||38
228090|NCT00182689|541812|P2|Eligible|Overall Study||45
228091|NCT00182689|541813|P1|Eligible|Overall Study||39
228092|NCT00182689|541812|P2|STARTED|Overall Study||49
228093|NCT00182689|541813|P1|STARTED|Overall Study||40
228094|NCT00182637|541823|P1|NOT COMPLETED|Overall Study||3
228095|NCT00182637|541823|P1|COMPLETED|Overall Study|off study date|2
228096|NCT00182637|541823|P1|STARTED|Overall Study|active/on treatment date|5
228097|NCT00182091|541833|P4|NOT COMPLETED|Overall Study||0
228098|NCT00182091|541834|P3|NOT COMPLETED|Overall Study||0
228099|NCT00182091|541835|P2|NOT COMPLETED|Overall Study||0
228100|NCT00182091|541836|P1|NOT COMPLETED|Overall Study||1
228101|NCT00182091|541833|P4|COMPLETED|Overall Study||20
228102|NCT00182091|541834|P3|COMPLETED|Overall Study||25
228103|NCT00182091|541835|P2|COMPLETED|Overall Study||15
228104|NCT00182091|541836|P1|COMPLETED|Overall Study||14
228105|NCT00182091|541833|P4|STARTED|Overall Study||20
228106|NCT00182091|541834|P3|STARTED|Overall Study||25
228107|NCT00182091|541835|P2|STARTED|Overall Study||15
228108|NCT00182091|541836|P1|STARTED|Overall Study||15
228109|NCT00182078|541852|P2|NOT COMPLETED|Overall Study||0
228110|NCT00182078|541853|P1|NOT COMPLETED|Overall Study||1
228111|NCT00182078|541852|P2|COMPLETED|Overall Study||17
228112|NCT00182078|541853|P1|COMPLETED|Overall Study||8
228113|NCT00182078|541852|P2|STARTED|Overall Study||17
228114|NCT00182078|541853|P1|STARTED|Overall Study||9
228115|NCT00182000|541865|P2|NOT COMPLETED|Overall Study||2
228116|NCT00182000|541866|P1|NOT COMPLETED|Overall Study||5
228117|NCT00182000|541865|P2|COMPLETED|Overall Study||13
228118|NCT00182000|541866|P1|COMPLETED|Overall Study||9
228119|NCT00182000|541865|P2|STARTED|Overall Study||15
228120|NCT00182000|541866|P1|STARTED|Overall Study||14
228121|NCT00181883|541872|P1|NOT COMPLETED|Overall Study||10
228122|NCT00181883|541872|P1|COMPLETED|Overall Study||20
228123|NCT00181883|541872|P1|STARTED|Overall Study||30
228124|NCT00181844|541876|P1|NOT COMPLETED|Exposed to Study Medication||17
228125|NCT00181844|541876|P1|COMPLETED|Exposed to Study Medication||22
228126|NCT00181844|541876|P1|STARTED|Exposed to Study Medication||39
228127|NCT00181844|541876|P1|NOT COMPLETED|Signed Consent||12
228128|NCT00181844|541876|P1|COMPLETED|Signed Consent||39
228129|NCT00181844|541876|P1|STARTED|Signed Consent||51
228130|NCT00181766|541880|P1|NOT COMPLETED|Overall Study||12
228131|NCT00181766|541880|P1|COMPLETED|Overall Study|Completed the trial.|33
228132|NCT00181766|541880|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
228133|NCT00181714|541885|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
228134|NCT00181714|541885|P1|COMPLETED|Began Treatment With OROS-MPH||30
228135|NCT00181714|541885|P1|STARTED|Began Treatment With OROS-MPH||154
228136|NCT00181714|541885|P1|NOT COMPLETED|Signed Consent/Enrolled||49
228137|NCT00181714|541885|P1|COMPLETED|Signed Consent/Enrolled||154
228138|NCT00181714|541885|P1|STARTED|Signed Consent/Enrolled||203
228139|NCT00181623|541889|P1|NOT COMPLETED|Overall Study||1
228140|NCT00181623|541889|P1|COMPLETED|Overall Study||5
228141|NCT00181623|541889|P1|STARTED|Overall Study||6
228142|NCT00181610|541896|P3|NOT COMPLETED|Overall Study||0
228143|NCT00181610|541897|P2|NOT COMPLETED|Overall Study||1
228144|NCT00181610|541898|P1|NOT COMPLETED|Overall Study||0
228145|NCT00181610|541896|P3|COMPLETED|Overall Study||3
228146|NCT00181610|541897|P2|COMPLETED|Overall Study||3
228147|NCT00181610|541898|P1|COMPLETED|Overall Study||4
228148|NCT00181610|541896|P3|STARTED|Overall Study||3
228149|NCT00181610|541897|P2|STARTED|Overall Study||4
228150|NCT00181610|541898|P1|STARTED|Overall Study||4
228151|NCT00181155|541906|P2|NOT COMPLETED|Overall Study||0
228152|NCT00181155|541907|P1|NOT COMPLETED|Overall Study||2
228153|NCT00181155|541906|P2|COMPLETED|Overall Study||3
228154|NCT00181155|541907|P1|COMPLETED|Overall Study||13
228155|NCT00181155|541906|P2|STARTED|Overall Study||3
228156|NCT00181155|541907|P1|STARTED|Overall Study||15
228157|NCT00180687|541919|P4|NOT COMPLETED|Overall Study||0
228158|NCT00180687|541920|P3|NOT COMPLETED|Overall Study||0
228159|NCT00180687|541921|P2|NOT COMPLETED|Overall Study||0
228160|NCT00180687|541922|P1|NOT COMPLETED|Overall Study||0
228161|NCT00180687|541919|P4|COMPLETED|Overall Study||20
228162|NCT00180687|541920|P3|COMPLETED|Overall Study||20
228163|NCT00180687|541921|P2|COMPLETED|Overall Study||20
228164|NCT00180687|541922|P1|COMPLETED|Overall Study||20
228165|NCT00180687|541919|P4|STARTED|Overall Study||20
228166|NCT00180687|541920|P3|STARTED|Overall Study||20
228167|NCT00180687|541921|P2|STARTED|Overall Study||20
228168|NCT00180687|541922|P1|STARTED|Overall Study||20
228169|NCT00180479|541946|P2|NOT COMPLETED|Overall Study||13
228170|NCT00180479|541947|P1|NOT COMPLETED|Overall Study||16
228171|NCT00180479|541946|P2|COMPLETED|Overall Study||320
228172|NCT00180479|541947|P1|COMPLETED|Overall Study||653
228173|NCT00180479|541946|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
228174|NCT00180479|541947|P1|STARTED|Overall Study||669
228175|NCT00180323|542039|P1|NOT COMPLETED|Overall Study||0
228176|NCT00180323|542039|P1|COMPLETED|Overall Study||43
228177|NCT00180323|542039|P1|STARTED|Overall Study||43
228178|NCT00180271|542048|P2|NOT COMPLETED|Overall Study||0
228179|NCT00180271|542049|P1|NOT COMPLETED|Overall Study||0
228180|NCT00180271|542048|P2|COMPLETED|Overall Study||731
228181|NCT00180271|542049|P1|COMPLETED|Overall Study||1089
228182|NCT00180271|542048|P2|STARTED|Overall Study||731
228183|NCT00180271|542049|P1|STARTED|Overall Study||1089
228184|NCT00179959|542057|P2|NOT COMPLETED|Overall Study||3
228185|NCT00179959|542058|P1|NOT COMPLETED|Overall Study||6
228186|NCT00179959|542057|P2|COMPLETED|Overall Study||13
228187|NCT00179959|542058|P1|COMPLETED|Overall Study||9
228188|NCT00179959|542057|P2|STARTED|Overall Study||16
228189|NCT00179959|542058|P1|STARTED|Overall Study||15
228190|NCT00179673|542064|P1|NOT COMPLETED|Overall Study||43
228191|NCT00179673|542064|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
228192|NCT00179673|542064|P1|Received Study Drug|Overall Study||43
228193|NCT00179673|542064|P1|STARTED|Overall Study||43
228194|NCT00179660|542072|P1|NOT COMPLETED|Overall Study||50
228195|NCT00179660|542072|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
228196|NCT00179660|542072|P1|Completed 12 Cycles of Treatment|Overall Study||12
228197|NCT00179660|542072|P1|Received Study Drug|Overall Study||49
228198|NCT00179660|542072|P1|STARTED|Overall Study||50
228199|NCT00179647|542081|P1|NOT COMPLETED|Overall Study||1913
228200|NCT00179647|542081|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
228201|NCT00179647|542081|P1|STARTED|Overall Study||1913
228202|NCT00179621|542088|P4|NOT COMPLETED|Open-Label Period||43
228203|NCT00179621|542089|P3|NOT COMPLETED|Open-Label Period||28
228204|NCT00179621|542090|P2|NOT COMPLETED|Open-Label Period||28
228205|NCT00179621|542091|P1|NOT COMPLETED|Open-Label Period||0
228206|NCT00179621|542088|P4|COMPLETED|Open-Label Period||13
228207|NCT00179621|542089|P3|COMPLETED|Open-Label Period||19
228208|NCT00179621|542090|P2|COMPLETED|Open-Label Period||14
228209|NCT00179621|542091|P1|COMPLETED|Open-Label Period||0
228210|NCT00179621|542088|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
228211|NCT00179621|542089|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
228212|NCT00179621|542090|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
228213|NCT00179621|542091|P1|STARTED|Open-Label Period||0
228214|NCT00179621|542088|P4|NOT COMPLETED|Double-Blind Period||0
228215|NCT00179621|542089|P3|NOT COMPLETED|Double-Blind Period||30
228216|NCT00179621|542090|P2|NOT COMPLETED|Double-Blind Period||46
228217|NCT00179621|542091|P1|NOT COMPLETED|Double-Blind Period||64
228218|NCT00179621|542088|P4|COMPLETED|Double-Blind Period||0
228219|NCT00179621|542089|P3|COMPLETED|Double-Blind Period||39
228220|NCT00179621|542090|P2|COMPLETED|Double-Blind Period||23
228221|NCT00179621|542091|P1|COMPLETED|Double-Blind Period||3
228222|NCT00179621|542088|P4|STARTED|Double-Blind Period||0
228223|NCT00179621|542089|P3|STARTED|Double-Blind Period||69
228224|NCT00179621|542090|P2|STARTED|Double-Blind Period||69
228225|NCT00179621|542091|P1|STARTED|Double-Blind Period||67
228226|NCT00179309|542144|P2|NOT COMPLETED|Crossover||0
228227|NCT00179309|542145|P1|NOT COMPLETED|Crossover||0
228228|NCT00179309|542144|P2|COMPLETED|Crossover||3
228229|NCT00179309|542145|P1|COMPLETED|Crossover||0
228230|NCT00179309|542144|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
228231|NCT00179309|542145|P1|STARTED|Crossover||0
228232|NCT00179309|542144|P2|NOT COMPLETED|Treatment||5
228233|NCT00179309|542145|P1|NOT COMPLETED|Treatment||4
228234|NCT00179309|542144|P2|COMPLETED|Treatment||18
228235|NCT00179309|542145|P1|COMPLETED|Treatment||21
228236|NCT00179309|542144|P2|STARTED|Treatment||23
228237|NCT00179309|542145|P1|STARTED|Treatment||25
228238|NCT00178919|542155|P2|NOT COMPLETED|Overall Study||25
228239|NCT00178919|542156|P1|NOT COMPLETED|Overall Study||0
228240|NCT00178919|542155|P2|COMPLETED|Overall Study||68
228241|NCT00178919|542156|P1|COMPLETED|Overall Study||19
228242|NCT00178919|542155|P2|STARTED|Overall Study||93
228243|NCT00178919|542156|P1|STARTED|Overall Study||19
228244|NCT00178841|542164|P1|NOT COMPLETED|Overall Study||0
228245|NCT00178841|542164|P1|COMPLETED|Overall Study||4
228246|NCT00178841|542164|P1|STARTED|Overall Study||4
228247|NCT00178711|542172|P2|NOT COMPLETED|Overall Study||0
228248|NCT00178711|542173|P1|NOT COMPLETED|Overall Study||0
228249|NCT00178711|542172|P2|COMPLETED|Overall Study||45
228250|NCT00178711|542173|P1|COMPLETED|Overall Study||52
228251|NCT00178711|542172|P2|STARTED|Overall Study||45
228252|NCT00178711|542173|P1|STARTED|Overall Study||52
228253|NCT00178685|542184|P3|NOT COMPLETED|Overall Study||196
228254|NCT00178685|542185|P2|NOT COMPLETED|Overall Study||204
228255|NCT00178685|542186|P1|NOT COMPLETED|Overall Study||111
228256|NCT00178685|542184|P3|COMPLETED|Overall Study||128
228257|NCT00178685|542185|P2|COMPLETED|Overall Study||120
228258|NCT00178685|542186|P1|COMPLETED|Overall Study||61
228259|NCT00178685|542184|P3|STARTED|Overall Study||324
228260|NCT00178685|542185|P2|STARTED|Overall Study||324
228261|NCT00178685|542186|P1|STARTED|Overall Study||172
228262|NCT00178633|542197|P1|NOT COMPLETED|Overall Study||6
228263|NCT00178633|542197|P1|COMPLETED|Overall Study||37
228264|NCT00178633|542197|P1|STARTED|Overall Study||43
228265|NCT00178503|542205|P1|NOT COMPLETED|MPH Trial: High Dose||0
228266|NCT00178503|542205|P1|COMPLETED|MPH Trial: High Dose||24
228267|NCT00178503|542205|P1|STARTED|MPH Trial: High Dose||24
228268|NCT00178503|542205|P1|NOT COMPLETED|MPH Trial: Med Dose||0
228269|NCT00178503|542205|P1|COMPLETED|MPH Trial: Med Dose||24
228270|NCT00178503|542205|P1|STARTED|MPH Trial: Med Dose||24
228271|NCT00178503|542205|P1|NOT COMPLETED|MPH Trial: Low Dose||0
228272|NCT00178503|542205|P1|COMPLETED|MPH Trial: Low Dose||24
228273|NCT00178503|542205|P1|STARTED|MPH Trial: Low Dose||24
228274|NCT00178503|542205|P1|NOT COMPLETED|MPH Trial: Placebo||0
228275|NCT00178503|542205|P1|COMPLETED|MPH Trial: Placebo||24
228276|NCT00178503|542205|P1|STARTED|MPH Trial: Placebo||24
228277|NCT00178477|542223|P1|NOT COMPLETED|Overall Study||5
228278|NCT00178477|542223|P1|COMPLETED|Overall Study||5
228279|NCT00178477|542223|P1|STARTED|Overall Study||10
228280|NCT00178464|542227|P1|NOT COMPLETED|Overall Study||2
228281|NCT00178464|542227|P1|COMPLETED|Overall Study||9
228282|NCT00178464|542227|P1|STARTED|Overall Study||11
228283|NCT00178256|542232|P4|NOT COMPLETED|Overall Study||2
228284|NCT00178256|542233|P3|NOT COMPLETED|Overall Study||0
228285|NCT00178256|542234|P2|NOT COMPLETED|Overall Study||1
228286|NCT00178256|542235|P1|NOT COMPLETED|Overall Study||4
228287|NCT00178256|542232|P4|COMPLETED|Overall Study||16
228288|NCT00178256|542233|P3|COMPLETED|Overall Study||6
228289|NCT00178256|542234|P2|COMPLETED|Overall Study||6
228290|NCT00178256|542235|P1|COMPLETED|Overall Study||6
228291|NCT00178256|542232|P4|STARTED|Overall Study||18
228292|NCT00178256|542233|P3|STARTED|Overall Study||6
228293|NCT00178256|542234|P2|STARTED|Overall Study||7
228294|NCT00178256|542235|P1|STARTED|Overall Study||10
228295|NCT00178191|542245|P3|NOT COMPLETED|Overall Study||0
228296|NCT00178191|542246|P2|NOT COMPLETED|Overall Study||0
228297|NCT00178191|542247|P1|NOT COMPLETED|Overall Study||0
228298|NCT00178191|542245|P3|COMPLETED|Overall Study||7
228299|NCT00178191|542246|P2|COMPLETED|Overall Study||10
228300|NCT00178191|542247|P1|COMPLETED|Overall Study||11
228301|NCT00178191|542245|P3|STARTED|Overall Study||7
228302|NCT00178191|542246|P2|STARTED|Overall Study||10
228303|NCT00178191|542247|P1|STARTED|Overall Study||11
228304|NCT00178178|542259|P4|NOT COMPLETED|Overall Study||0
228305|NCT00178178|542260|P3|NOT COMPLETED|Overall Study||0
228306|NCT00178178|542261|P2|NOT COMPLETED|Overall Study||0
228307|NCT00178178|542262|P1|NOT COMPLETED|Overall Study||0
228308|NCT00178178|542259|P4|COMPLETED|Overall Study||24
228309|NCT00178178|542260|P3|COMPLETED|Overall Study||24
228310|NCT00178178|542261|P2|COMPLETED|Overall Study||24
228311|NCT00178178|542262|P1|COMPLETED|Overall Study||24
228312|NCT00178178|542259|P4|STARTED|Overall Study||24
228313|NCT00178178|542260|P3|STARTED|Overall Study||24
228314|NCT00178178|542261|P2|STARTED|Overall Study||24
228315|NCT00178178|542262|P1|STARTED|Overall Study||24
228316|NCT00177970|542274|P2|NOT COMPLETED|Overall Study||0
228317|NCT00177970|542275|P1|NOT COMPLETED|Overall Study||0
228318|NCT00177970|542274|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
228319|NCT00177970|542275|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
228320|NCT00177970|542274|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
228321|NCT00177970|542275|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
228322|NCT00177866|542297|P2|NOT COMPLETED|Overall Study||0
228323|NCT00177866|542298|P1|NOT COMPLETED|Overall Study||0
228324|NCT00177866|542297|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
228325|NCT00177866|542298|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
228326|NCT00177866|542297|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
228327|NCT00177866|542298|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
228328|NCT00177671|542308|P2|NOT COMPLETED|Overall Study||14
228329|NCT00177671|542309|P1|NOT COMPLETED|Overall Study||25
228330|NCT00177671|542308|P2|COMPLETED|Overall Study||49
228331|NCT00177671|542309|P1|COMPLETED|Overall Study||42
228332|NCT00177671|542308|P2|Month 24|Overall Study||49
228333|NCT00177671|542309|P1|Month 24|Overall Study||42
228334|NCT00177671|542308|P2|Month 12|Overall Study||57
228335|NCT00177671|542309|P1|Month 12|Overall Study||45
228336|NCT00177671|542308|P2|STARTED|Overall Study||63
228337|NCT00177671|542309|P1|STARTED|Overall Study||67
228338|NCT00177307|542321|P1|NOT COMPLETED|Overall Study||1
228339|NCT00177307|542321|P1|COMPLETED|Overall Study||39
228340|NCT00177307|542321|P1|STARTED|Overall Study||40
228341|NCT00177294|542330|P2|NOT COMPLETED|Overall Study||5
228342|NCT00177294|542331|P1|NOT COMPLETED|Overall Study||7
228343|NCT00177294|542330|P2|COMPLETED|Overall Study||59
228344|NCT00177294|542331|P1|COMPLETED|Overall Study||53
228345|NCT00177294|542330|P2|STARTED|Overall Study||64
228346|NCT00177294|542331|P1|STARTED|Overall Study||60
228347|NCT00177255|542337|P1|NOT COMPLETED|Overall Study||0
228348|NCT00177255|542337|P1|COMPLETED|Overall Study||39
228349|NCT00177255|542337|P1|STARTED|Overall Study||39
228350|NCT00177216|542345|P3|NOT COMPLETED|Overall Study||1
228351|NCT00177216|542346|P2|NOT COMPLETED|Overall Study||3
228352|NCT00177216|542347|P1|NOT COMPLETED|Overall Study||6
228353|NCT00177216|542345|P3|COMPLETED|Overall Study||19
228354|NCT00177216|542346|P2|COMPLETED|Overall Study||20
228355|NCT00177216|542347|P1|COMPLETED|Overall Study||20
228356|NCT00177216|542345|P3|STARTED|Overall Study||20
228357|NCT00177216|542346|P2|STARTED|Overall Study||23
228358|NCT00177216|542347|P1|STARTED|Overall Study||26
228359|NCT00177164|542363|P2|NOT COMPLETED|Overall Study||16
228360|NCT00177164|542364|P1|NOT COMPLETED|Overall Study||9
228361|NCT00177164|542363|P2|COMPLETED|Overall Study||9
228362|NCT00177164|542364|P1|COMPLETED|Overall Study||14
228363|NCT00177164|542363|P2|STARTED|Overall Study||25
228364|NCT00177164|542364|P1|STARTED|Overall Study||23
228365|NCT00176917|542376|P1|NOT COMPLETED|Overall Study||0
228366|NCT00176917|542376|P1|COMPLETED|Overall Study||41
228367|NCT00176917|542376|P1|STARTED|Overall Study||41
228368|NCT00176904|542383|P1|NOT COMPLETED|Overall Study||0
228369|NCT00176904|542383|P1|COMPLETED|Overall Study||135
228370|NCT00176904|542383|P1|STARTED|Overall Study||135
228371|NCT00176878|542391|P1|NOT COMPLETED|Overall Study||0
228372|NCT00176878|542391|P1|COMPLETED|Overall Study||10
228373|NCT00176878|542391|P1|STARTED|Overall Study||10
228374|NCT00176839|542400|P1|NOT COMPLETED|Overall Study||0
228375|NCT00176839|542400|P1|COMPLETED|Overall Study||11
228376|NCT00176839|542400|P1|STARTED|Overall Study||11
228377|NCT00176826|542409|P1|NOT COMPLETED|Overall Study||0
228378|NCT00176826|542409|P1|COMPLETED|Overall Study||22
228379|NCT00176826|542409|P1|STARTED|Overall Study||22
228380|NCT00176800|542419|P1|NOT COMPLETED|Overall Study||0
228381|NCT00176800|542419|P1|COMPLETED|Overall Study||69
228382|NCT00176800|542419|P1|STARTED|Overall Study||69
228383|NCT00176644|542425|P1|NOT COMPLETED|Overall Study||1
228384|NCT00176644|542425|P1|COMPLETED|Overall Study||22
228385|NCT00176644|542425|P1|STARTED|Overall Study||23
228386|NCT00176631|542433|P1|NOT COMPLETED|Overall Study||0
228387|NCT00176631|542433|P1|COMPLETED|Overall Study||10
228388|NCT00176631|542433|P1|STARTED|Overall Study||10
228389|NCT00176605|542438|P1|NOT COMPLETED|Overall Study||2
228390|NCT00176605|542438|P1|COMPLETED|Overall Study||13
228391|NCT00176605|542438|P1|STARTED|Overall Study||15
228392|NCT00176501|542443|P1|NOT COMPLETED|Overall Study||0
228393|NCT00176501|542443|P1|COMPLETED|Overall Study||3
228394|NCT00176501|542443|P1|STARTED|Overall Study||3
228395|NCT00176488|542449|P1|NOT COMPLETED|Overall Study||1
228396|NCT00176488|542449|P1|COMPLETED|Overall Study||30
228397|NCT00176488|542449|P1|STARTED|Overall Study||31
228398|NCT00176462|542457|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
228399|NCT00176462|542458|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
228400|NCT00176462|542457|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
228401|NCT00176462|542458|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
228402|NCT00176462|542457|P2|STARTED|Continuation -up to 30mos Post Remission||26
228403|NCT00176462|542458|P1|STARTED|Continuation -up to 30mos Post Remission||19
228404|NCT00176462|542457|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
228405|NCT00176462|542458|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
228406|NCT00176462|542457|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
228407|NCT00176462|542458|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
228408|NCT00176462|542457|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
228409|NCT00176462|542458|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
228410|NCT00176462|542457|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
228411|NCT00176462|542458|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
228412|NCT00176462|542457|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
228413|NCT00176462|542458|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
228414|NCT00176462|542457|P2|STARTED|Delayed Intensification (8 Weeks)||29
228415|NCT00176462|542458|P1|STARTED|Delayed Intensification (8 Weeks)||20
228416|NCT00176462|542457|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
228417|NCT00176462|542458|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
228418|NCT00176462|542457|P2|COMPLETED|Consolidation (12 Weeks)||29
228419|NCT00176462|542458|P1|COMPLETED|Consolidation (12 Weeks)||20
228420|NCT00176462|542457|P2|STARTED|Consolidation (12 Weeks)||34
228421|NCT00176462|542458|P1|STARTED|Consolidation (12 Weeks)||20
228422|NCT00176462|542457|P2|NOT COMPLETED|Induction (4 Weeks)||5
228423|NCT00176462|542458|P1|NOT COMPLETED|Induction (4 Weeks)||1
228424|NCT00176462|542457|P2|COMPLETED|Induction (4 Weeks)||34
228425|NCT00176462|542458|P1|COMPLETED|Induction (4 Weeks)||20
228426|NCT00176462|542457|P2|STARTED|Induction (4 Weeks)||39
228427|NCT00176462|542458|P1|STARTED|Induction (4 Weeks)||21
228428|NCT00176436|542467|P2|NOT COMPLETED|Overall Study||5
228429|NCT00176436|542468|P1|NOT COMPLETED|Overall Study||6
228430|NCT00176436|542467|P2|COMPLETED|Overall Study||12
228431|NCT00176436|542468|P1|COMPLETED|Overall Study||14
228432|NCT00176436|542467|P2|STARTED|Overall Study||17
228433|NCT00176436|542468|P1|STARTED|Overall Study||20
228434|NCT00176306|542474|P1|NOT COMPLETED|Overall Study||0
228435|NCT00176306|542474|P1|COMPLETED|Overall Study||15
228436|NCT00176306|542474|P1|STARTED|Overall Study||15
228437|NCT00176254|542478|P1|NOT COMPLETED|Overall Study||1
228438|NCT00176254|542478|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
228439|NCT00176254|542478|P1|STARTED|Overall Study||40
228440|NCT00176228|542486|P1|NOT COMPLETED|Overall Study||2
228441|NCT00176228|542486|P1|COMPLETED|Overall Study|Study ended|46
228442|NCT00176228|542486|P1|STARTED|Overall Study|When study began|48
228443|NCT00176202|542493|P2|NOT COMPLETED|Overall Study||16
228444|NCT00176202|542494|P1|NOT COMPLETED|Overall Study||5
228445|NCT00176202|542493|P2|COMPLETED|Overall Study||17
228446|NCT00176202|542494|P1|COMPLETED|Overall Study||27
228447|NCT00176202|542493|P2|STARTED|Overall Study||33
228448|NCT00176202|542494|P1|STARTED|Overall Study||32
228449|NCT00175877|542506|P1|NOT COMPLETED|Overall Study||349
228450|NCT00175877|542506|P1|COMPLETED|Overall Study||497
228451|NCT00175877|542506|P1|STARTED|Overall Study||846
228452|NCT00175019|542540|P3|NOT COMPLETED|Overall Study||57
228453|NCT00175019|542541|P2|NOT COMPLETED|Overall Study||171
228454|NCT00175019|542542|P1|NOT COMPLETED|Overall Study||194
228455|NCT00175019|542540|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
228456|NCT00175019|542541|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
228457|NCT00175019|542542|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
228458|NCT00175019|542540|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
228459|NCT00175019|542541|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
228460|NCT00175019|542542|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
228461|NCT00175006|542586|P1|NOT COMPLETED|Overall Study||0
228462|NCT00175006|542586|P1|COMPLETED|Overall Study||13
228463|NCT00175006|542586|P1|STARTED|Overall Study||13
228464|NCT00174967|542595|P4|NOT COMPLETED|Overall Study||2
228465|NCT00174967|542596|P3|NOT COMPLETED|Overall Study||2
228466|NCT00174967|542597|P2|NOT COMPLETED|Overall Study||3
228467|NCT00174967|542598|P1|NOT COMPLETED|Overall Study||1
228468|NCT00174967|542595|P4|COMPLETED|Overall Study||36
228469|NCT00174967|542596|P3|COMPLETED|Overall Study||36
228470|NCT00174967|542597|P2|COMPLETED|Overall Study||37
228471|NCT00174967|542598|P1|COMPLETED|Overall Study||36
228472|NCT00174967|542595|P4|STARTED|Overall Study||38
228473|NCT00174967|542596|P3|STARTED|Overall Study||38
228474|NCT00174967|542597|P2|STARTED|Overall Study||40
228475|NCT00174967|542598|P1|STARTED|Overall Study||37
228476|NCT00174954|542644|P1|NOT COMPLETED|Overall Study||4
228477|NCT00174954|542644|P1|COMPLETED|Overall Study||28
228478|NCT00174954|542644|P1|STARTED|Overall Study||32
228479|NCT00174941|542652|P4|NOT COMPLETED|Overall Study||58
228480|NCT00174941|542653|P3|NOT COMPLETED|Overall Study||18
228481|NCT00174941|542654|P2|NOT COMPLETED|Overall Study||38
228482|NCT00174941|542655|P1|NOT COMPLETED|Overall Study||2
228483|NCT00174941|542652|P4|COMPLETED|Overall Study||58
228484|NCT00174941|542653|P3|COMPLETED|Overall Study||11
228485|NCT00174941|542654|P2|COMPLETED|Overall Study||41
228486|NCT00174941|542655|P1|COMPLETED|Overall Study||6
228487|NCT00174941|542652|P4|STARTED|Overall Study||116
228488|NCT00174941|542653|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
228489|NCT00174941|542654|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
228490|NCT00174941|542655|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
228491|NCT00174915|542730|P5|NOT COMPLETED|Overall Study||33
228492|NCT00174915|542731|P4|NOT COMPLETED|Overall Study||57
228493|NCT00174915|542732|P3|NOT COMPLETED|Overall Study||48
228494|NCT00174915|542733|P2|NOT COMPLETED|Overall Study||69
228495|NCT00174915|542734|P1|NOT COMPLETED|Overall Study||93
228496|NCT00174915|542730|P5|COMPLETED|Overall Study||101
228497|NCT00174915|542731|P4|COMPLETED|Overall Study||211
228498|NCT00174915|542732|P3|COMPLETED|Overall Study||86
228499|NCT00174915|542733|P2|COMPLETED|Overall Study||200
228500|NCT00174915|542734|P1|COMPLETED|Overall Study||174
228501|NCT00174915|542730|P5|STARTED|Overall Study||134
228502|NCT00174915|542731|P4|STARTED|Overall Study||268
228503|NCT00174915|542732|P3|STARTED|Overall Study||134
228504|NCT00174915|542733|P2|STARTED|Overall Study||269
228505|NCT00174915|542734|P1|STARTED|Overall Study||267
228506|NCT00174785|542793|P2|NOT COMPLETED|Overall Study||716
228507|NCT00174785|542794|P1|NOT COMPLETED|Overall Study||696
228508|NCT00174785|542793|P2|COMPLETED|Overall Study|completed study drug|1611
228509|NCT00174785|542794|P1|COMPLETED|Overall Study|completed study drug|1605
228510|NCT00174785|542793|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
228511|NCT00174785|542794|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
228512|NCT00174460|542810|P2|NOT COMPLETED|Overall Study||1
228513|NCT00174460|542811|P1|NOT COMPLETED|Overall Study||0
228514|NCT00174460|542810|P2|COMPLETED|Overall Study||14
228515|NCT00174460|542811|P1|COMPLETED|Overall Study||18
228516|NCT00174460|542810|P2|Received Study Treatment|Overall Study||14
228517|NCT00174460|542811|P1|Received Study Treatment|Overall Study||18
228518|NCT00174460|542810|P2|STARTED|Overall Study||15
228519|NCT00174460|542811|P1|STARTED|Overall Study||18
228520|NCT00174447|542857|P1|NOT COMPLETED|Overall Study||38
228521|NCT00174447|542857|P1|COMPLETED|Overall Study||5
228522|NCT00174447|542857|P1|STARTED|Overall Study||43
228523|NCT00174382|542866|P1|NOT COMPLETED|Overall Study||33
228524|NCT00174382|542866|P1|COMPLETED|Overall Study||116
228525|NCT00174382|542866|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
228526|NCT00174291|542885|P2|NOT COMPLETED|Overall Study||6
228527|NCT00174291|542886|P1|NOT COMPLETED|Overall Study||5
228528|NCT00174291|542885|P2|COMPLETED|Overall Study||4
228529|NCT00174291|542886|P1|COMPLETED|Overall Study||6
228530|NCT00174291|542885|P2|STARTED|Overall Study||10
228531|NCT00174291|542886|P1|STARTED|Overall Study||11
228532|NCT00174265|542916|P2|NOT COMPLETED|Overall Study||21
228533|NCT00174265|542917|P1|NOT COMPLETED|Overall Study||29
228534|NCT00174265|542916|P2|COMPLETED|Overall Study||89
228535|NCT00174265|542917|P1|COMPLETED|Overall Study||57
228536|NCT00174265|542916|P2|STARTED|Overall Study||110
228537|NCT00174265|542917|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
228538|NCT00174252|542925|P1|NOT COMPLETED|Overall Study||2
228539|NCT00174252|542925|P1|COMPLETED|Overall Study||55
228540|NCT00174252|542925|P1|STARTED|Overall Study||57
228541|NCT00174187|542960|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
228542|NCT00174187|542961|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
228543|NCT00174187|542962|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
228544|NCT00174187|542960|P3|COMPLETED|Period 2 (After 3 Years)||13
228545|NCT00174187|542961|P2|COMPLETED|Period 2 (After 3 Years)||0
228546|NCT00174187|542962|P1|COMPLETED|Period 2 (After 3 Years)||0
228547|NCT00174187|542960|P3|STARTED|Period 2 (After 3 Years)||21
228548|NCT00174187|542961|P2|STARTED|Period 2 (After 3 Years)||0
228549|NCT00174187|542962|P1|STARTED|Period 2 (After 3 Years)||0
228550|NCT00174187|542960|P3|NOT COMPLETED|Between Period 1 and Period 2||5
228551|NCT00174187|542961|P2|NOT COMPLETED|Between Period 1 and Period 2||0
228552|NCT00174187|542962|P1|NOT COMPLETED|Between Period 1 and Period 2||0
228553|NCT00174187|542960|P3|COMPLETED|Between Period 1 and Period 2||21
228554|NCT00174187|542961|P2|COMPLETED|Between Period 1 and Period 2||0
228555|NCT00174187|542962|P1|COMPLETED|Between Period 1 and Period 2||0
228556|NCT00174187|542960|P3|Consented|Between Period 1 and Period 2||24
228557|NCT00174187|542961|P2|Consented|Between Period 1 and Period 2||0
228558|NCT00174187|542962|P1|Consented|Between Period 1 and Period 2||0
228559|NCT00174187|542960|P3|STARTED|Between Period 1 and Period 2||26
228560|NCT00174187|542961|P2|STARTED|Between Period 1 and Period 2||0
228561|NCT00174187|542962|P1|STARTED|Between Period 1 and Period 2||0
228562|NCT00174187|542960|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
228563|NCT00174187|542961|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
228564|NCT00174187|542962|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
228565|NCT00174187|542960|P3|COMPLETED|Period 1 (up to 3 Years)||0
228566|NCT00174187|542961|P2|COMPLETED|Period 1 (up to 3 Years)||11
228567|NCT00174187|542962|P1|COMPLETED|Period 1 (up to 3 Years)||15
228568|NCT00174187|542960|P3|STARTED|Period 1 (up to 3 Years)||0
228569|NCT00174187|542961|P2|STARTED|Period 1 (up to 3 Years)||15
228570|NCT00174187|542962|P1|STARTED|Period 1 (up to 3 Years)||15
228571|NCT00172042|543025|P2|NOT COMPLETED|Overall Study||125
228572|NCT00172042|543026|P1|NOT COMPLETED|Overall Study||158
228573|NCT00172042|543025|P2|COMPLETED|Overall Study||86
228574|NCT00172042|543026|P1|COMPLETED|Overall Study||68
228575|NCT00172042|543025|P2|STARTED|Overall Study||211
228576|NCT00172042|543026|P1|STARTED|Overall Study||226
228577|NCT00171925|543048|P2|NOT COMPLETED|Overall Study||31
228578|NCT00171925|543049|P1|NOT COMPLETED|Overall Study||30
228579|NCT00171925|543048|P2|COMPLETED|Overall Study||40
228580|NCT00171925|543049|P1|COMPLETED|Overall Study||42
228581|NCT00171925|543048|P2|STARTED|Overall Study||71
228582|NCT00171925|543049|P1|STARTED|Overall Study||72
228583|NCT00171873|543061|P2|NOT COMPLETED|Overall Study||3
228584|NCT00171873|543062|P1|NOT COMPLETED|Overall Study||9
228585|NCT00171873|543061|P2|COMPLETED|Overall Study||40
228586|NCT00171873|543062|P1|COMPLETED|Overall Study||33
228587|NCT00171873|543061|P2|STARTED|Overall Study||43
228588|NCT00171873|543062|P1|STARTED|Overall Study||42
228589|NCT00171834|543075|P7|NOT COMPLETED|Overall Study||4
228590|NCT00171834|543076|P6|NOT COMPLETED|Overall Study||35
228591|NCT00171834|543077|P5|NOT COMPLETED|Overall Study||8
228592|NCT00171834|543078|P4|NOT COMPLETED|Overall Study||12
228593|NCT00171834|543079|P3|NOT COMPLETED|Overall Study||12
228594|NCT00171834|543080|P2|NOT COMPLETED|Overall Study||12
228595|NCT00171834|543081|P1|NOT COMPLETED|Overall Study||6
228596|NCT00171834|543075|P7|COMPLETED|Overall Study||0
228597|NCT00171834|543076|P6|COMPLETED|Overall Study||0
228598|NCT00171834|543077|P5|COMPLETED|Overall Study||0
228599|NCT00171834|543078|P4|COMPLETED|Overall Study||0
228600|NCT00171834|543079|P3|COMPLETED|Overall Study||0
228601|NCT00171834|543080|P2|COMPLETED|Overall Study||0
228602|NCT00171834|543081|P1|COMPLETED|Overall Study||0
228603|NCT00171834|543075|P7|Completed 6 Cycles of Treatment|Overall Study||0
228604|NCT00171834|543076|P6|Completed 6 Cycles of Treatment|Overall Study||1
228605|NCT00171834|543077|P5|Completed 6 Cycles of Treatment|Overall Study||2
228606|NCT00171834|543078|P4|Completed 6 Cycles of Treatment|Overall Study||0
228607|NCT00171834|543079|P3|Completed 6 Cycles of Treatment|Overall Study||1
228608|NCT00171834|543080|P2|Completed 6 Cycles of Treatment|Overall Study||0
228609|NCT00171834|543081|P1|Completed 6 Cycles of Treatment|Overall Study||0
228610|NCT00171834|543075|P7|STARTED|Overall Study||4
228611|NCT00171834|543076|P6|STARTED|Overall Study||35
228612|NCT00171834|543077|P5|STARTED|Overall Study||8
228613|NCT00171834|543078|P4|STARTED|Overall Study||12
228614|NCT00171834|543079|P3|STARTED|Overall Study||12
228615|NCT00171834|543080|P2|STARTED|Overall Study||12
228616|NCT00171834|543081|P1|STARTED|Overall Study||6
228617|NCT00171704|543121|P2|NOT COMPLETED|Overall Study||49
228618|NCT00171704|543122|P1|NOT COMPLETED|Overall Study||44
228619|NCT00171704|543121|P2|COMPLETED|Overall Study||81
228620|NCT00171704|543122|P1|COMPLETED|Overall Study||89
228621|NCT00171704|543121|P2|STARTED|Overall Study||130
228622|NCT00171704|543122|P1|STARTED|Overall Study||133
228623|NCT00172185|543146|P4|NOT COMPLETED|Overall Study||4
228624|NCT00172185|543147|P3|NOT COMPLETED|Overall Study||5
228625|NCT00172185|543148|P2|NOT COMPLETED|Overall Study||2
228626|NCT00172185|543149|P1|NOT COMPLETED|Overall Study||0
228627|NCT00172185|543146|P4|COMPLETED|Overall Study||23
228628|NCT00172185|543147|P3|COMPLETED|Overall Study||20
228629|NCT00172185|543148|P2|COMPLETED|Overall Study||5
228630|NCT00172185|543149|P1|COMPLETED|Overall Study||6
228631|NCT00172185|543146|P4|STARTED|Overall Study||27
228632|NCT00172185|543147|P3|STARTED|Overall Study||25
228633|NCT00172185|543148|P2|STARTED|Overall Study||7
228634|NCT00172185|543149|P1|STARTED|Overall Study||6
228635|NCT00171340|543165|P2|NOT COMPLETED|Overall Study||135
228636|NCT00171340|543166|P1|NOT COMPLETED|Overall Study||124
228637|NCT00171340|543165|P2|COMPLETED|Overall Study||398
228638|NCT00171340|543166|P1|COMPLETED|Overall Study||408
228639|NCT00171340|543165|P2|STARTED|Overall Study||533
228640|NCT00171340|543166|P1|STARTED|Overall Study||532
228641|NCT00171314|543182|P2|NOT COMPLETED|Overall Study||78
228642|NCT00171314|543183|P1|NOT COMPLETED|Overall Study||91
228643|NCT00171314|543182|P2|COMPLETED|Overall Study||186
228644|NCT00171314|543183|P1|COMPLETED|Overall Study||172
228645|NCT00171314|543182|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
228646|NCT00171314|543183|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
228647|NCT00171314|543182|P2|STARTED|Overall Study||264
228648|NCT00171314|543183|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
228649|NCT00171301|543199|P2|NOT COMPLETED|Overall Study||9
228650|NCT00171301|543200|P1|NOT COMPLETED|Overall Study||8
228651|NCT00171301|543199|P2|COMPLETED|Overall Study||62
228652|NCT00171301|543200|P1|COMPLETED|Overall Study||154
228653|NCT00171301|543199|P2|Received Deferasirox|Overall Study||69
228654|NCT00171301|543200|P1|Received Deferasirox|Overall Study||162
228655|NCT00171301|543199|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
228656|NCT00171301|543200|P1|STARTED|Overall Study||162
228657|NCT00171210|543213|P2|NOT COMPLETED|Overall Study||115
228658|NCT00171210|543214|P1|NOT COMPLETED|Overall Study||69
228659|NCT00171210|543213|P2|COMPLETED|Overall Study||181
228660|NCT00171210|543214|P1|COMPLETED|Overall Study||190
228661|NCT00171210|543213|P2|STARTED EXTENSION STUDY|Overall Study||247
228662|NCT00171210|543214|P1|STARTED EXTENSION STUDY|Overall Study||259
228663|NCT00171210|543213|P2|STARTED|Overall Study||296
228664|NCT00171210|543214|P1|STARTED|Overall Study||259
228665|NCT00171054|543244|P2|NOT COMPLETED|Overall Study||12
228666|NCT00171054|543245|P1|NOT COMPLETED|Overall Study||10
228667|NCT00171054|543244|P2|COMPLETED|Overall Study||50
228668|NCT00171054|543245|P1|COMPLETED|Overall Study||53
228669|NCT00171054|543244|P2|STARTED|Overall Study||62
228670|NCT00171054|543245|P1|STARTED|Overall Study||63
228671|NCT00170950|543277|P2|NOT COMPLETED|Overall Study||910
228672|NCT00170950|543278|P1|NOT COMPLETED|Overall Study||885
228673|NCT00170950|543277|P2|COMPLETED|Overall Study||4852
228674|NCT00170950|543278|P1|COMPLETED|Overall Study||4859
228675|NCT00170950|543277|P2|STARTED|Overall Study||5762
228676|NCT00170950|543278|P1|STARTED|Overall Study||5744
228677|NCT00170846|543291|P3|NOT COMPLETED|Overall Study||13
228678|NCT00170846|543292|P2|NOT COMPLETED|Overall Study||19
228679|NCT00170846|543293|P1|NOT COMPLETED|Overall Study||11
228680|NCT00170846|543291|P3|COMPLETED|Overall Study||131
228681|NCT00170846|543292|P2|COMPLETED|Overall Study||108
228682|NCT00170846|543293|P1|COMPLETED|Overall Study||112
228683|NCT00170846|543291|P3|STARTED|Overall Study||144
228684|NCT00170846|543292|P2|STARTED|Overall Study||127
228685|NCT00170846|543293|P1|STARTED|Overall Study||123
228686|NCT00170625|543307|P1|NOT COMPLETED|Overall Study||0
228687|NCT00170625|543307|P1|COMPLETED|Overall Study||26
228688|NCT00170625|543307|P1|STARTED|Overall Study||26
228689|NCT00170157|543312|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
228690|NCT00170157|543313|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
228691|NCT00170157|543312|P2|COMPLETED|Treatment Period 2 Crossover||41
228692|NCT00170157|543313|P1|COMPLETED|Treatment Period 2 Crossover||0
228693|NCT00170157|543312|P2|STARTED|Treatment Period 2 Crossover||41
228694|NCT00170157|543313|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
228695|NCT00170157|543312|P2|NOT COMPLETED|Washout Period of 14 Days||17
228696|NCT00170157|543313|P1|NOT COMPLETED|Washout Period of 14 Days||0
228697|NCT00170157|543312|P2|COMPLETED|Washout Period of 14 Days||41
228698|NCT00170157|543313|P1|COMPLETED|Washout Period of 14 Days||0
228699|NCT00170157|543312|P2|STARTED|Washout Period of 14 Days||58
228792|NCT00168389|543856|P2|NOT COMPLETED|Overall Study||48
228700|NCT00170157|543313|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
228701|NCT00170157|543312|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
228702|NCT00170157|543313|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
228703|NCT00170157|543312|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
228704|NCT00170157|543313|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
228705|NCT00170157|543312|P2|STARTED|Treatment Period 1 Initial Randomization||58
228706|NCT00170157|543313|P1|STARTED|Treatment Period 1 Initial Randomization||54
228707|NCT00168844|543321|P3|NOT COMPLETED|Overall Study||91
228708|NCT00168844|543322|P2|NOT COMPLETED|Overall Study||55
228709|NCT00168844|543323|P1|NOT COMPLETED|Overall Study||55
228710|NCT00168844|543321|P3|COMPLETED|Overall Study||228
228711|NCT00168844|543322|P2|COMPLETED|Overall Study||277
228712|NCT00168844|543323|P1|COMPLETED|Overall Study||277
228713|NCT00168844|543321|P3|STARTED|Overall Study||319
228714|NCT00168844|543322|P2|STARTED|Overall Study||332
228715|NCT00168844|543323|P1|STARTED|Overall Study||332
228716|NCT00168831|543505|P3|NOT COMPLETED|Overall Study||114
228717|NCT00168831|543506|P2|NOT COMPLETED|Overall Study||81
228718|NCT00168831|543507|P1|NOT COMPLETED|Overall Study||60
228719|NCT00168831|543505|P3|COMPLETED|Overall Study||220
228720|NCT00168831|543506|P2|COMPLETED|Overall Study||254
228721|NCT00168831|543507|P1|COMPLETED|Overall Study||278
228722|NCT00168831|543505|P3|STARTED|Overall Study||334
228723|NCT00168831|543506|P2|STARTED|Overall Study||335
228724|NCT00168831|543507|P1|STARTED|Overall Study||338
228725|NCT00168818|543689|P3|NOT COMPLETED|Treatment||133
228726|NCT00168818|543690|P2|NOT COMPLETED|Treatment||151
228727|NCT00168818|543691|P1|NOT COMPLETED|Treatment||133
228728|NCT00168818|543689|P3|COMPLETED|Treatment||1021
228729|NCT00168818|543690|P2|COMPLETED|Treatment||1012
228730|NCT00168818|543691|P1|COMPLETED|Treatment||1013
228731|NCT00168818|543689|P3|STARTED|Treatment||1154
228732|NCT00168818|543690|P2|STARTED|Treatment||1163
228733|NCT00168818|543691|P1|STARTED|Treatment||1146
228734|NCT00168818|543689|P3|NOT COMPLETED|Overall Study||124
228735|NCT00168818|543690|P2|NOT COMPLETED|Overall Study||109
228736|NCT00168818|543691|P1|NOT COMPLETED|Overall Study||117
228737|NCT00168818|543689|P3|COMPLETED|Overall Study||1030
228738|NCT00168818|543690|P2|COMPLETED|Overall Study||1054
228739|NCT00168818|543691|P1|COMPLETED|Overall Study||1029
228740|NCT00168818|543689|P3|STARTED|Overall Study||1154
228741|NCT00168818|543690|P2|STARTED|Overall Study||1163
228742|NCT00168818|543691|P1|STARTED|Overall Study||1146
228743|NCT00168805|543735|P3|NOT COMPLETED|Treatment||62
228744|NCT00168805|543736|P2|NOT COMPLETED|Treatment||56
228745|NCT00168805|543737|P1|NOT COMPLETED|Treatment||49
228746|NCT00168805|543735|P3|COMPLETED|Treatment||632
228747|NCT00168805|543736|P2|COMPLETED|Treatment||647
228748|NCT00168805|543737|P1|COMPLETED|Treatment||630
228749|NCT00168805|543735|P3|STARTED|Treatment||694
228750|NCT00168805|543736|P2|STARTED|Treatment||703
228751|NCT00168805|543737|P1|STARTED|Treatment||679
228752|NCT00168805|543735|P3|NOT COMPLETED|Overall Study||78
228753|NCT00168805|543736|P2|NOT COMPLETED|Overall Study||78
228754|NCT00168805|543737|P1|NOT COMPLETED|Overall Study||71
228755|NCT00168805|543735|P3|COMPLETED|Overall Study||616
228756|NCT00168805|543736|P2|COMPLETED|Overall Study||625
228757|NCT00168805|543737|P1|COMPLETED|Overall Study||608
228758|NCT00168805|543735|P3|STARTED|Overall Study||694
228759|NCT00168805|543736|P2|STARTED|Overall Study||703
228760|NCT00168805|543737|P1|STARTED|Overall Study||679
228761|NCT00168454|543784|P6|NOT COMPLETED|Overall Study||6
228762|NCT00168454|543785|P5|NOT COMPLETED|Overall Study||6
228763|NCT00168454|543786|P4|NOT COMPLETED|Overall Study||9
228764|NCT00168454|543787|P3|NOT COMPLETED|Overall Study||6
228765|NCT00168454|543788|P2|NOT COMPLETED|Overall Study||7
228766|NCT00168454|543789|P1|NOT COMPLETED|Overall Study||7
228767|NCT00168454|543784|P6|COMPLETED|Overall Study||50
228768|NCT00168454|543785|P5|COMPLETED|Overall Study||47
228769|NCT00168454|543786|P4|COMPLETED|Overall Study||40
228770|NCT00168454|543787|P3|COMPLETED|Overall Study||48
228771|NCT00168454|543788|P2|COMPLETED|Overall Study||50
228772|NCT00168454|543789|P1|COMPLETED|Overall Study||37
228773|NCT00168454|543784|P6|STARTED|Overall Study||56
228774|NCT00168454|543785|P5|STARTED|Overall Study||53
228775|NCT00168454|543786|P4|STARTED|Overall Study||49
228776|NCT00168454|543787|P3|STARTED|Overall Study||54
228777|NCT00168454|543788|P2|STARTED|Overall Study||57
228778|NCT00168454|543789|P1|STARTED|Overall Study||44
228779|NCT00168428|543835|P2|NOT COMPLETED|Open-Label Phase (OL)||68
228780|NCT00168428|543836|P1|NOT COMPLETED|Open-Label Phase (OL)||44
228781|NCT00168428|543835|P2|COMPLETED|Open-Label Phase (OL)||261
228782|NCT00168428|543836|P1|COMPLETED|Open-Label Phase (OL)||261
228783|NCT00168428|543835|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
228784|NCT00168428|543836|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
228785|NCT00168428|543835|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
228786|NCT00168428|543836|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
228787|NCT00168428|543835|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
228788|NCT00168428|543836|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
228789|NCT00168428|543835|P2|STARTED|Double-Blind Phase (DB)||358
228790|NCT00168428|543836|P1|STARTED|Double-Blind Phase (DB)||347
228791|NCT00168389|543855|P3|NOT COMPLETED|Overall Study||95
228793|NCT00168389|543857|P1|NOT COMPLETED|Overall Study||56
228794|NCT00168389|543855|P3|COMPLETED|Overall Study||70
228795|NCT00168389|543856|P2|COMPLETED|Overall Study||118
228796|NCT00168389|543857|P1|COMPLETED|Overall Study||107
228797|NCT00168389|543855|P3|STARTED|Overall Study||165
228798|NCT00168389|543856|P2|STARTED|Overall Study||166
228799|NCT00168389|543857|P1|STARTED|Overall Study||163
228800|NCT00166296|543885|P2|NOT COMPLETED|Overall Study||9
228801|NCT00166296|543886|P1|NOT COMPLETED|Overall Study||7
228802|NCT00166296|543885|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
228803|NCT00166296|543886|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
228804|NCT00166296|543885|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
228805|NCT00166296|543886|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
228806|NCT00166296|543885|P2|STARTED|Overall Study|Randomized patients|66
228807|NCT00166296|543886|P1|STARTED|Overall Study|Randomized patients|67
228808|NCT00166205|543898|P1|NOT COMPLETED|Overall Study||48
228809|NCT00166205|543898|P1|COMPLETED|Overall Study||228
228810|NCT00166205|543898|P1|Intervention - SAGB Surgery|Overall Study||276
228811|NCT00166205|543898|P1|STARTED|Overall Study||276
228812|NCT00168337|543915|P3|NOT COMPLETED|Overall Study||103
228813|NCT00168337|543916|P2|NOT COMPLETED|Overall Study||69
228814|NCT00168337|543917|P1|NOT COMPLETED|Overall Study||70
228815|NCT00168337|543915|P3|COMPLETED|Overall Study||82
228816|NCT00168337|543916|P2|COMPLETED|Overall Study||112
228817|NCT00168337|543917|P1|COMPLETED|Overall Study||118
228818|NCT00168337|543915|P3|STARTED|Overall Study||185
228819|NCT00168337|543916|P2|STARTED|Overall Study||181
228820|NCT00168337|543917|P1|STARTED|Overall Study||188
228821|NCT00168324|543946|P3|NOT COMPLETED|Open-Label Period||6
228822|NCT00168324|543947|P2|NOT COMPLETED|Open-Label Period||8
228823|NCT00168324|543948|P1|NOT COMPLETED|Open-Label Period||4
228824|NCT00168324|543946|P3|COMPLETED|Open-Label Period||152
228825|NCT00168324|543947|P2|COMPLETED|Open-Label Period||147
228826|NCT00168324|543948|P1|COMPLETED|Open-Label Period||160
228827|NCT00168324|543946|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
228828|NCT00168324|543947|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
228829|NCT00168324|543948|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
228830|NCT00168324|543946|P3|NOT COMPLETED|Double-Blind Period||13
228831|NCT00168324|543947|P2|NOT COMPLETED|Double-Blind Period||7
228832|NCT00168324|543948|P1|NOT COMPLETED|Double-Blind Period||12
228833|NCT00168324|543946|P3|COMPLETED|Double-Blind Period||189
228834|NCT00168324|543947|P2|COMPLETED|Double-Blind Period||189
228835|NCT00168324|543948|P1|COMPLETED|Double-Blind Period||189
228836|NCT00168324|543946|P3|STARTED|Double-Blind Period||202
228837|NCT00168324|543947|P2|STARTED|Double-Blind Period||196
228838|NCT00168324|543948|P1|STARTED|Double-Blind Period||201
228839|NCT00168311|543970|P2|NOT COMPLETED|Overall Study||2
228840|NCT00168311|543971|P1|NOT COMPLETED|Overall Study||0
228841|NCT00168311|543970|P2|COMPLETED|Overall Study||8
228842|NCT00168311|543971|P1|COMPLETED|Overall Study||12
228843|NCT00168311|543970|P2|STARTED|Overall Study||10
228844|NCT00168311|543971|P1|STARTED|Overall Study||12
228845|NCT00168298|543980|P3|NOT COMPLETED|Open-Label Period||8
228846|NCT00168298|543981|P2|NOT COMPLETED|Open-Label Period||5
228847|NCT00168298|543982|P1|NOT COMPLETED|Open-Label Period||7
228848|NCT00168298|543980|P3|COMPLETED|Open-Label Period||160
228849|NCT00168298|543981|P2|COMPLETED|Open-Label Period||168
228850|NCT00168298|543982|P1|COMPLETED|Open-Label Period||172
228851|NCT00168298|543980|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
228852|NCT00168298|543981|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
228853|NCT00168298|543982|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
228854|NCT00168298|543980|P3|NOT COMPLETED|Double-Blind Period||15
228855|NCT00168298|543981|P2|NOT COMPLETED|Double-Blind Period||12
228856|NCT00168298|543982|P1|NOT COMPLETED|Double-Blind Period||12
228857|NCT00168298|543980|P3|COMPLETED|Double-Blind Period||209
228858|NCT00168298|543981|P2|COMPLETED|Double-Blind Period||206
228859|NCT00168298|543982|P1|COMPLETED|Double-Blind Period||214
228860|NCT00168298|543980|P3|STARTED|Double-Blind Period||224
228861|NCT00168298|543981|P2|STARTED|Double-Blind Period||218
228862|NCT00168298|543982|P1|STARTED|Double-Blind Period||226
228863|NCT00168103|544002|P4|NOT COMPLETED|Overall Study||0
228864|NCT00168103|544003|P3|NOT COMPLETED|Overall Study||1
228865|NCT00168103|544004|P2|NOT COMPLETED|Overall Study||5
228866|NCT00168103|544005|P1|NOT COMPLETED|Overall Study||2
228867|NCT00168103|544002|P4|COMPLETED|Overall Study||1
228868|NCT00168103|544003|P3|COMPLETED|Overall Study||41
228869|NCT00168103|544004|P2|COMPLETED|Overall Study||38
228870|NCT00168103|544005|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
228871|NCT00168103|544002|P4|STARTED|Overall Study||1
228872|NCT00168103|544003|P3|STARTED|Overall Study||42
228873|NCT00168103|544004|P2|STARTED|Overall Study||43
228874|NCT00168103|544005|P1|STARTED|Overall Study||40
228875|NCT00168064|544027|P2|NOT COMPLETED|Overall Study||44
228876|NCT00168064|544028|P1|NOT COMPLETED|Overall Study||49
228877|NCT00168064|544027|P2|COMPLETED|Overall Study||86
228878|NCT00168064|544028|P1|COMPLETED|Overall Study||81
228879|NCT00168064|544027|P2|STARTED|Overall Study|127 participants received AP formulation|130
228880|NCT00168064|544028|P1|STARTED|Overall Study|128 participants received PG formulation|130
228881|NCT00168038|544036|P1|NOT COMPLETED|Overall Study||2
228882|NCT00168038|544036|P1|COMPLETED|Overall Study||55
228883|NCT00168038|544036|P1|STARTED|Overall Study||57
228884|NCT00167778|544048|P1|NOT COMPLETED|Overall Study||1
228885|NCT00167778|544048|P1|COMPLETED|Overall Study||10
228886|NCT00167778|544048|P1|STARTED|Overall Study||11
228887|NCT00166166|544099|P2|NOT COMPLETED|Overall Study||0
228888|NCT00166166|544100|P1|NOT COMPLETED|Overall Study||0
228889|NCT00166166|544099|P2|COMPLETED|Overall Study||71
228890|NCT00166166|544100|P1|COMPLETED|Overall Study||103
228891|NCT00166166|544099|P2|STARTED|Overall Study||71
228892|NCT00166166|544100|P1|STARTED|Overall Study||103
228893|NCT00166114|544123|P2|NOT COMPLETED|Overall Study||6
228894|NCT00166114|544124|P1|NOT COMPLETED|Overall Study||14
228895|NCT00166114|544123|P2|COMPLETED|Overall Study||13
228896|NCT00166114|544124|P1|COMPLETED|Overall Study||7
228897|NCT00166114|544123|P2|STARTED|Overall Study||19
228898|NCT00166114|544124|P1|STARTED|Overall Study||21
228899|NCT00167544|544132|P2|NOT COMPLETED|Overall Study||0
228900|NCT00167544|544133|P1|NOT COMPLETED|Overall Study||1
228901|NCT00167544|544132|P2|COMPLETED|Overall Study||33
228902|NCT00167544|544133|P1|COMPLETED|Overall Study||30
228903|NCT00167544|544132|P2|STARTED|Overall Study||33
228904|NCT00167544|544133|P1|STARTED|Overall Study||31
228905|NCT00167245|544149|P2|NOT COMPLETED|Overall Study||41
228906|NCT00167245|544150|P1|NOT COMPLETED|Overall Study||29
228907|NCT00167245|544149|P2|COMPLETED|Overall Study||46
228908|NCT00167245|544150|P1|COMPLETED|Overall Study||54
228909|NCT00167245|544149|P2|STARTED|Overall Study||87
228910|NCT00167245|544150|P1|STARTED|Overall Study||83
228911|NCT00167206|544158|P1|NOT COMPLETED|Overall Study||0
228912|NCT00167206|544158|P1|COMPLETED|Overall Study||16
228913|NCT00167206|544158|P1|STARTED|Overall Study||16
228914|NCT00167102|544172|P2|NOT COMPLETED|Overall Study||0
228915|NCT00167102|544173|P1|NOT COMPLETED|Overall Study||0
228916|NCT00167102|544172|P2|COMPLETED|Overall Study||22
228917|NCT00167102|544173|P1|COMPLETED|Overall Study||23
228918|NCT00167102|544172|P2|STARTED|Overall Study||22
228919|NCT00167102|544173|P1|STARTED|Overall Study||23
228920|NCT00166036|544183|P2|NOT COMPLETED|Overall Study||0
228921|NCT00166036|544184|P1|NOT COMPLETED|Overall Study||0
228922|NCT00166036|544183|P2|COMPLETED|Overall Study||19
228923|NCT00166036|544184|P1|COMPLETED|Overall Study||17
228924|NCT00166036|544183|P2|STARTED|Overall Study||19
228925|NCT00166036|544184|P1|STARTED|Overall Study||17
228926|NCT00165984|544192|P1|NOT COMPLETED|Overall Study||15
228927|NCT00165984|544192|P1|COMPLETED|Overall Study||150
228928|NCT00165984|544192|P1|STARTED|Overall Study||165
228929|NCT00165958|544201|P2|NOT COMPLETED|Overall Study||2
228930|NCT00165958|544202|P1|NOT COMPLETED|Overall Study||1
228931|NCT00165958|544201|P2|COMPLETED|Overall Study||19
228932|NCT00165958|544202|P1|COMPLETED|Overall Study||18
228933|NCT00165958|544201|P2|STARTED|Overall Study||21
228934|NCT00165958|544202|P1|STARTED|Overall Study||19
228935|NCT00165841|544210|P2|NOT COMPLETED|Overall Study||62
228936|NCT00165841|544211|P1|NOT COMPLETED|Overall Study||30
228937|NCT00165841|544210|P2|COMPLETED|Overall Study||35
228938|NCT00165841|544211|P1|COMPLETED|Overall Study||73
228939|NCT00165841|544210|P2|STARTED|Overall Study||97
228940|NCT00165841|544211|P1|STARTED|Overall Study||103
228941|NCT00166712|544219|P2|NOT COMPLETED|Overall Study||5
228942|NCT00166712|544220|P1|NOT COMPLETED|Overall Study||2
228943|NCT00166712|544219|P2|COMPLETED|Overall Study|Completed study participation.|11
228944|NCT00166712|544220|P1|COMPLETED|Overall Study|Completed study participation.|22
228945|NCT00166712|544219|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
228946|NCT00166712|544220|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
228947|NCT00166712|544219|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
228948|NCT00166712|544220|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
228949|NCT00166712|544219|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
228950|NCT00166712|544220|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
228951|NCT00166712|544219|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
228952|NCT00166712|544220|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
228953|NCT00166712|544219|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
228954|NCT00166712|544220|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
228955|NCT00166517|544237|P2|NOT COMPLETED|Overall Study||2
228956|NCT00166517|544238|P1|NOT COMPLETED|Overall Study||5
228957|NCT00166517|544237|P2|COMPLETED|Overall Study||61
228958|NCT00166517|544238|P1|COMPLETED|Overall Study||110
228959|NCT00166517|544237|P2|Vaccinated at Visit 3|Overall Study||61
228960|NCT00166517|544238|P1|Vaccinated at Visit 3|Overall Study||110
228961|NCT00166517|544237|P2|Vaccinated at Visit 2|Overall Study||61
228962|NCT00166517|544238|P1|Vaccinated at Visit 2|Overall Study||112
228963|NCT00166517|544237|P2|Vaccinated at Visit 1|Overall Study||63
228964|NCT00166517|544238|P1|Vaccinated at Visit 1|Overall Study||115
228965|NCT00166517|544237|P2|STARTED|Overall Study||63
228966|NCT00166517|544238|P1|STARTED|Overall Study||115
228967|NCT00166504|544248|P2|NOT COMPLETED|Overall Study||4
228968|NCT00166504|544249|P1|NOT COMPLETED|Overall Study||5
228969|NCT00166504|544248|P2|COMPLETED|Overall Study||91
228970|NCT00166504|544249|P1|COMPLETED|Overall Study||103
228971|NCT00166504|544248|P2|STARTED|Overall Study||95
228972|NCT00166504|544249|P1|STARTED|Overall Study||108
228973|NCT00166361|544257|P2|NOT COMPLETED|Overall Study||0
228974|NCT00166361|544258|P1|NOT COMPLETED|Overall Study||0
228975|NCT00166361|544257|P2|COMPLETED|Overall Study||10
228976|NCT00166361|544258|P1|COMPLETED|Overall Study||14
228977|NCT00166361|544257|P2|STARTED|Overall Study||10
228978|NCT00166361|544258|P1|STARTED|Overall Study||14
228979|NCT00165789|544268|P4|NOT COMPLETED|Overall Study||14
228980|NCT00165789|544269|P3|NOT COMPLETED|Overall Study||1
228981|NCT00165789|544270|P2|NOT COMPLETED|Overall Study||4
228982|NCT00165789|544271|P1|NOT COMPLETED|Overall Study||0
228983|NCT00165789|544268|P4|COMPLETED|Overall Study||21
228984|NCT00165789|544269|P3|COMPLETED|Overall Study||11
228985|NCT00165789|544270|P2|COMPLETED|Overall Study||16
228986|NCT00165789|544271|P1|COMPLETED|Overall Study||8
228987|NCT00165789|544268|P4|STARTED|Overall Study||35
228988|NCT00165789|544269|P3|STARTED|Overall Study||12
228989|NCT00165789|544270|P2|STARTED|Overall Study||20
228990|NCT00165789|544271|P1|STARTED|Overall Study||8
228991|NCT00165776|544325|P4|NOT COMPLETED|Overall Study||2
228992|NCT00165776|544326|P3|NOT COMPLETED|Overall Study||2
228993|NCT00165776|544327|P2|NOT COMPLETED|Overall Study||1
228994|NCT00165776|544328|P1|NOT COMPLETED|Overall Study||4
228995|NCT00165776|544325|P4|COMPLETED|Overall Study||29
228996|NCT00165776|544326|P3|COMPLETED|Overall Study||31
228997|NCT00165776|544327|P2|COMPLETED|Overall Study||33
228998|NCT00165776|544328|P1|COMPLETED|Overall Study||31
228999|NCT00165776|544325|P4|STARTED|Overall Study||31
229000|NCT00165776|544326|P3|STARTED|Overall Study||33
229001|NCT00165776|544327|P2|STARTED|Overall Study||34
229002|NCT00165776|544328|P1|STARTED|Overall Study||35
229003|NCT00165698|544364|P2|NOT COMPLETED|Overall Study||15
229004|NCT00165698|544365|P1|NOT COMPLETED|Overall Study||8
229005|NCT00165698|544364|P2|COMPLETED|Overall Study||105
229006|NCT00165698|544365|P1|COMPLETED|Overall Study||112
229007|NCT00165698|544364|P2|STARTED|Overall Study||120
229008|NCT00165698|544365|P1|STARTED|Overall Study||120
229009|NCT00165672|544391|P2|NOT COMPLETED|Overall Study||1
229010|NCT00165672|544392|P1|NOT COMPLETED|Overall Study||0
229011|NCT00165672|544391|P2|COMPLETED|Overall Study||12
229012|NCT00165672|544392|P1|COMPLETED|Overall Study||13
229013|NCT00165672|544391|P2|STARTED|Overall Study||13
229014|NCT00165672|544392|P1|STARTED|Overall Study||13
229015|NCT00165646|544401|P3|NOT COMPLETED|Overall Study||4
229016|NCT00165646|544402|P2|NOT COMPLETED|Overall Study||5
229017|NCT00165646|544403|P1|NOT COMPLETED|Overall Study||5
229018|NCT00165646|544401|P3|COMPLETED|Overall Study||98
229019|NCT00165646|544402|P2|COMPLETED|Overall Study||88
229020|NCT00165646|544403|P1|COMPLETED|Overall Study||88
229021|NCT00165646|544401|P3|STARTED|Overall Study||102
229022|NCT00165646|544402|P2|STARTED|Overall Study||93
229023|NCT00165646|544403|P1|STARTED|Overall Study||93
229024|NCT00165503|544411|P1|NOT COMPLETED|Overall Study||16
229025|NCT00165503|544411|P1|COMPLETED|Overall Study||0
229026|NCT00165503|544411|P1|STARTED|Overall Study||16
229027|NCT00163293|544418|P3|NOT COMPLETED|Overall Study||19
229028|NCT00163293|544419|P2|NOT COMPLETED|Overall Study||7
229029|NCT00163293|544420|P1|NOT COMPLETED|Overall Study||13
229030|NCT00163293|544418|P3|COMPLETED|Overall Study||66
229031|NCT00163293|544419|P2|COMPLETED|Overall Study||69
229032|NCT00163293|544420|P1|COMPLETED|Overall Study||66
229033|NCT00163293|544418|P3|STARTED|Overall Study||85
229034|NCT00163293|544419|P2|STARTED|Overall Study||76
229035|NCT00163293|544420|P1|STARTED|Overall Study||79
229036|NCT00163657|544437|P3|NOT COMPLETED|Overall Study||37
229037|NCT00163657|544438|P2|NOT COMPLETED|Overall Study||23
229038|NCT00163657|544439|P1|NOT COMPLETED|Overall Study||20
229039|NCT00163657|544437|P3|COMPLETED|Overall Study||116
229040|NCT00163657|544438|P2|COMPLETED|Overall Study||56
229041|NCT00163657|544439|P1|COMPLETED|Overall Study||60
229042|NCT00163657|544437|P3|STARTED|Overall Study||153
229043|NCT00163657|544438|P2|STARTED|Overall Study||79
229044|NCT00163657|544439|P1|STARTED|Overall Study||80
229045|NCT00163215|544450|P1|NOT COMPLETED|Overall Study||15
229046|NCT00163215|544450|P1|COMPLETED|Overall Study||31
229047|NCT00163215|544450|P1|STARTED|Overall Study||46
229048|NCT00163189|544470|P1|NOT COMPLETED|Overall Study||63
229049|NCT00163189|544470|P1|COMPLETED|Overall Study||35
229050|NCT00163189|544470|P1|STARTED|Overall Study||98
229051|NCT00163020|544494|P2|NOT COMPLETED|Overall Study||2
229052|NCT00163020|544495|P1|NOT COMPLETED|Overall Study||0
229053|NCT00163020|544494|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
229054|NCT00163020|544495|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
229055|NCT00163020|544494|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
229056|NCT00163020|544495|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
229057|NCT00162981|544535|P2|NOT COMPLETED|Overall Study||6
229058|NCT00162981|544536|P1|NOT COMPLETED|Overall Study||4
229059|NCT00162981|544535|P2|COMPLETED|Overall Study||30
229060|NCT00162981|544536|P1|COMPLETED|Overall Study||28
229061|NCT00162981|544535|P2|STARTED|Overall Study||36
229062|NCT00162981|544536|P1|STARTED|Overall Study||32
229063|NCT00162942|544552|P2|NOT COMPLETED|Overall Study||52
229064|NCT00162942|544553|P1|NOT COMPLETED|Overall Study||106
229065|NCT00162942|544552|P2|COMPLETED|Overall Study||26
229066|NCT00162942|544553|P1|COMPLETED|Overall Study||51
229067|NCT00162942|544552|P2|Week 12|Overall Study||61
229068|NCT00162942|544553|P1|Week 12|Overall Study||127
229069|NCT00162942|544552|P2|STARTED|Overall Study||78
229070|NCT00162942|544553|P1|STARTED|Overall Study||157
229071|NCT00162370|544601|P1|NOT COMPLETED|Efficacy Population||51
229072|NCT00162370|544601|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
229073|NCT00162370|544601|P1|STARTED|Efficacy Population||366
229074|NCT00162370|544601|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
229075|NCT00162370|544601|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
229076|NCT00162370|544601|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
229077|NCT00162266|544609|P4|NOT COMPLETED|Open-Label Period||137
229078|NCT00162266|544610|P3|NOT COMPLETED|Open-Label Period||0
229079|NCT00162266|544611|P2|NOT COMPLETED|Open-Label Period||0
229080|NCT00162266|544612|P1|NOT COMPLETED|Open-Label Period||0
229081|NCT00162266|544609|P4|COMPLETED|Open-Label Period||82
229082|NCT00162266|544610|P3|COMPLETED|Open-Label Period||0
229083|NCT00162266|544611|P2|COMPLETED|Open-Label Period||0
229084|NCT00162266|544612|P1|COMPLETED|Open-Label Period||0
229085|NCT00162266|544609|P4|STARTED|Open-Label Period||219
229086|NCT00162266|544610|P3|STARTED|Open-Label Period||0
229087|NCT00162266|544611|P2|STARTED|Open-Label Period||0
229088|NCT00162266|544612|P1|STARTED|Open-Label Period||0
229089|NCT00162266|544609|P4|NOT COMPLETED|Double-Blind Period||0
229090|NCT00162266|544610|P3|NOT COMPLETED|Double-Blind Period||48
229091|NCT00162266|544611|P2|NOT COMPLETED|Double-Blind Period||31
229092|NCT00162266|544612|P1|NOT COMPLETED|Double-Blind Period||25
229093|NCT00162266|544609|P4|COMPLETED|Double-Blind Period||0
229094|NCT00162266|544610|P3|COMPLETED|Double-Blind Period||71
229095|NCT00162266|544611|P2|COMPLETED|Double-Blind Period||74
229096|NCT00162266|544612|P1|COMPLETED|Double-Blind Period||90
229097|NCT00162266|544609|P4|Completed Day 1 to Day 181|Double-Blind Period||0
229098|NCT00162266|544610|P3|Completed Day 1 to Day 181|Double-Blind Period||78
229099|NCT00162266|544611|P2|Completed Day 1 to Day 181|Double-Blind Period||80
229100|NCT00162266|544612|P1|Completed Day 1 to Day 181|Double-Blind Period||98
229101|NCT00162266|544609|P4|STARTED|Double-Blind Period||0
229102|NCT00162266|544610|P3|STARTED|Double-Blind Period||119
229103|NCT00162266|544611|P2|STARTED|Double-Blind Period||105
229104|NCT00162266|544612|P1|STARTED|Double-Blind Period||115
229105|NCT00162136|544813|P1|NOT COMPLETED|Overall Study||35
229106|NCT00162136|544813|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
229107|NCT00162136|544813|P1|STARTED|Overall Study||35
229108|NCT00162123|544845|P8|NOT COMPLETED|Overall Study||58
229109|NCT00162123|544846|P7|NOT COMPLETED|Overall Study||4
229110|NCT00162123|544847|P6|NOT COMPLETED|Overall Study||9
229111|NCT00162123|544848|P5|NOT COMPLETED|Overall Study||31
229112|NCT00162123|544849|P4|NOT COMPLETED|Overall Study||8
229113|NCT00162123|544850|P3|NOT COMPLETED|Overall Study||21
229114|NCT00162123|544851|P2|NOT COMPLETED|Overall Study||29
229115|NCT00162123|544852|P1|NOT COMPLETED|Overall Study||44
229116|NCT00162123|544845|P8|COMPLETED|Overall Study|Still on treatment|0
229117|NCT00162123|544846|P7|COMPLETED|Overall Study|Still on treatment|0
229118|NCT00162123|544847|P6|COMPLETED|Overall Study|Still on treatment|4
229119|NCT00162123|544848|P5|COMPLETED|Overall Study|Still on treatment|14
229120|NCT00162123|544849|P4|COMPLETED|Overall Study|Still on treatment|3
229121|NCT00162123|544850|P3|COMPLETED|Overall Study|Still on treatment|3
229122|NCT00162123|544851|P2|COMPLETED|Overall Study|Still on treatment|5
229123|NCT00162123|544852|P1|COMPLETED|Overall Study|Still on treatment|9
229124|NCT00162123|544845|P8|Received Treatment|Overall Study||0
229125|NCT00162123|544846|P7|Received Treatment|Overall Study||4
229126|NCT00162123|544847|P6|Received Treatment|Overall Study||12
229127|NCT00162123|544848|P5|Received Treatment|Overall Study||33
229128|NCT00162123|544849|P4|Received Treatment|Overall Study||11
229129|NCT00162123|544850|P3|Received Treatment|Overall Study||24
229130|NCT00162123|544851|P2|Received Treatment|Overall Study||34
229131|NCT00162123|544852|P1|Received Treatment|Overall Study||53
229132|NCT00162123|544845|P8|STARTED|Overall Study|Enrolled|58
229133|NCT00162123|544846|P7|STARTED|Overall Study|Enrolled|4
229134|NCT00162123|544847|P6|STARTED|Overall Study|Enrolled|13
229135|NCT00162123|544848|P5|STARTED|Overall Study|Enrolled|45
229136|NCT00162123|544849|P4|STARTED|Overall Study|Enrolled|11
229137|NCT00162123|544850|P3|STARTED|Overall Study|Enrolled|24
229138|NCT00162123|544851|P2|STARTED|Overall Study|Enrolled|34
229139|NCT00162123|544852|P1|STARTED|Overall Study|Enrolled|53
229140|NCT00162097|544885|P4|NOT COMPLETED|Overall Study||1
229141|NCT00162097|544886|P3|NOT COMPLETED|Overall Study||0
229142|NCT00162097|544887|P2|NOT COMPLETED|Overall Study||0
229143|NCT00162097|544888|P1|NOT COMPLETED|Overall Study||0
229144|NCT00162097|544885|P4|COMPLETED|Overall Study||6
229145|NCT00162097|544886|P3|COMPLETED|Overall Study||1
229146|NCT00162097|544887|P2|COMPLETED|Overall Study||2
229147|NCT00162097|544888|P1|COMPLETED|Overall Study||6
229148|NCT00162097|544885|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
229149|NCT00162097|544886|P3|STARTED|Overall Study|Treated on Day 1|1
229150|NCT00162097|544887|P2|STARTED|Overall Study|Treated on Day 1|2
229151|NCT00162097|544888|P1|STARTED|Overall Study|Treated on Day 1|6
229152|NCT00162032|544950|P2|NOT COMPLETED|Overall Study||2
229153|NCT00162032|544951|P1|NOT COMPLETED|Overall Study||5
229154|NCT00162032|544950|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
229155|NCT00162032|544951|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
229156|NCT00162032|544950|P2|STARTED|Overall Study||116
229157|NCT00162032|544951|P1|STARTED|Overall Study||329
229158|NCT00161616|544961|P2|NOT COMPLETED|Overall Study||19
229159|NCT00161616|544962|P1|NOT COMPLETED|Overall Study||26
229160|NCT00161616|544961|P2|COMPLETED|Overall Study||119
229161|NCT00161616|544962|P1|COMPLETED|Overall Study||113
229162|NCT00161616|544961|P2|STARTED|Overall Study||138
229163|NCT00161616|544962|P1|STARTED|Overall Study||139
229164|NCT00161473|544972|P2|NOT COMPLETED|Overall Study||6
229165|NCT00161473|544973|P1|NOT COMPLETED|Overall Study||5
229166|NCT00161473|544972|P2|COMPLETED|Overall Study||6
229167|NCT00161473|544973|P1|COMPLETED|Overall Study||7
229168|NCT00161473|544972|P2|STARTED|Overall Study||12
229169|NCT00161473|544973|P1|STARTED|Overall Study||12
229170|NCT00161382|544987|P2|NOT COMPLETED|Overall Study||289
229171|NCT00161382|544988|P1|NOT COMPLETED|Overall Study||249
229172|NCT00161382|544987|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
229173|NCT00161382|544988|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
229174|NCT00161382|544987|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
229175|NCT00161382|544988|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
229176|NCT00161213|544994|P1|NOT COMPLETED|Overall Study||2
229177|NCT00161213|544994|P1|COMPLETED|Overall Study||42
229178|NCT00161213|544994|P1|STARTED|Overall Study||44
229179|NCT00160706|545001|P1|NOT COMPLETED|Overall Study||286
229180|NCT00160706|545001|P1|COMPLETED|Overall Study||24
229181|NCT00160706|545001|P1|STARTED|Overall Study||310
229182|NCT00160693|545013|P1|NOT COMPLETED|Overall Study||235
229183|NCT00160693|545013|P1|COMPLETED|Overall Study||167
229184|NCT00160693|545013|P1|STARTED|Overall Study||402
229185|NCT00160641|545030|P1|NOT COMPLETED|Overall Study||221
229186|NCT00160641|545030|P1|COMPLETED|Overall Study||346
229187|NCT00160641|545030|P1|STARTED|Overall Study||567
229188|NCT00160563|545064|P3|NOT COMPLETED|Overall Study||90
229189|NCT00160563|545065|P2|NOT COMPLETED|Overall Study||45
229190|NCT00160563|545066|P1|NOT COMPLETED|Overall Study||51
229191|NCT00160563|545064|P3|COMPLETED|Overall Study||11
229192|NCT00160563|545065|P2|COMPLETED|Overall Study||2
229193|NCT00160563|545066|P1|COMPLETED|Overall Study||8
229194|NCT00160563|545064|P3|STARTED|Overall Study||101
229195|NCT00160563|545065|P2|STARTED|Overall Study||47
229196|NCT00160563|545066|P1|STARTED|Overall Study||59
229197|NCT00160524|545078|P1|NOT COMPLETED|Overall Study||478
229198|NCT00160524|545078|P1|COMPLETED|Overall Study||117
229199|NCT00160524|545078|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
229200|NCT00160251|545095|P8|NOT COMPLETED|Post-amendment 2||55
229201|NCT00160251|545096|P7|NOT COMPLETED|Post-amendment 2||0
229202|NCT00160251|545097|P6|NOT COMPLETED|Post-amendment 2||0
229203|NCT00160251|545098|P5|NOT COMPLETED|Post-amendment 2||0
229204|NCT00160251|545099|P4|NOT COMPLETED|Post-amendment 2||0
229205|NCT00160251|545100|P3|NOT COMPLETED|Post-amendment 2||0
229206|NCT00160251|545101|P2|NOT COMPLETED|Post-amendment 2||0
229207|NCT00160251|545102|P1|NOT COMPLETED|Post-amendment 2||0
229208|NCT00160251|545095|P8|COMPLETED|Post-amendment 2||88
229209|NCT00160251|545096|P7|COMPLETED|Post-amendment 2||0
229210|NCT00160251|545097|P6|COMPLETED|Post-amendment 2||0
229211|NCT00160251|545098|P5|COMPLETED|Post-amendment 2||0
229212|NCT00160251|545099|P4|COMPLETED|Post-amendment 2||0
229213|NCT00160251|545100|P3|COMPLETED|Post-amendment 2||0
229214|NCT00160251|545101|P2|COMPLETED|Post-amendment 2||0
229215|NCT00160251|545102|P1|COMPLETED|Post-amendment 2||0
229216|NCT00160251|545095|P8|STARTED|Post-amendment 2||143
229217|NCT00160251|545096|P7|STARTED|Post-amendment 2||0
229218|NCT00160251|545097|P6|STARTED|Post-amendment 2||0
229219|NCT00160251|545098|P5|STARTED|Post-amendment 2||0
229220|NCT00160251|545099|P4|STARTED|Post-amendment 2||0
229221|NCT00160251|545100|P3|STARTED|Post-amendment 2||0
229222|NCT00160251|545101|P2|STARTED|Post-amendment 2||0
229223|NCT00160251|545102|P1|STARTED|Post-amendment 2||0
229224|NCT00160251|545095|P8|NOT COMPLETED|Prior to Amendment 2||0
229225|NCT00160251|545096|P7|NOT COMPLETED|Prior to Amendment 2||4
229226|NCT00160251|545097|P6|NOT COMPLETED|Prior to Amendment 2||83
229227|NCT00160251|545098|P5|NOT COMPLETED|Prior to Amendment 2||28
229228|NCT00160251|545099|P4|NOT COMPLETED|Prior to Amendment 2||40
229229|NCT00160251|545100|P3|NOT COMPLETED|Prior to Amendment 2||44
229230|NCT00160251|545101|P2|NOT COMPLETED|Prior to Amendment 2||6
229231|NCT00160251|545102|P1|NOT COMPLETED|Prior to Amendment 2||9
229232|NCT00160251|545095|P8|COMPLETED|Prior to Amendment 2||0
229233|NCT00160251|545096|P7|COMPLETED|Prior to Amendment 2||61
229234|NCT00160251|545097|P6|COMPLETED|Prior to Amendment 2||14
229235|NCT00160251|545098|P5|COMPLETED|Prior to Amendment 2||21
229236|NCT00160251|545099|P4|COMPLETED|Prior to Amendment 2||9
229237|NCT00160251|545100|P3|COMPLETED|Prior to Amendment 2||4
229238|NCT00160251|545101|P2|COMPLETED|Prior to Amendment 2||28
229239|NCT00160251|545102|P1|COMPLETED|Prior to Amendment 2||6
229240|NCT00160251|545095|P8|STARTED|Prior to Amendment 2||0
229241|NCT00160251|545096|P7|STARTED|Prior to Amendment 2||65
229242|NCT00160251|545097|P6|STARTED|Prior to Amendment 2||97
229243|NCT00160251|545098|P5|STARTED|Prior to Amendment 2||49
229244|NCT00160251|545099|P4|STARTED|Prior to Amendment 2||49
229245|NCT00160251|545100|P3|STARTED|Prior to Amendment 2||48
229246|NCT00160251|545101|P2|STARTED|Prior to Amendment 2||34
229247|NCT00160251|545102|P1|STARTED|Prior to Amendment 2||15
229248|NCT00160199|545178|P2|NOT COMPLETED|Overall Study||37
229249|NCT00160199|545179|P1|NOT COMPLETED|Overall Study||24
229250|NCT00160199|545178|P2|COMPLETED|Overall Study||81
229251|NCT00160199|545179|P1|COMPLETED|Overall Study||98
229252|NCT00160199|545178|P2|STARTED|Overall Study||118
229253|NCT00160199|545179|P1|STARTED|Overall Study||122
229254|NCT00159965|545199|P2|NOT COMPLETED|Overall Study||5
229255|NCT00159965|545200|P1|NOT COMPLETED|Overall Study||7
229256|NCT00159965|545199|P2|COMPLETED|Overall Study||14
229257|NCT00159965|545200|P1|COMPLETED|Overall Study||12
229258|NCT00159965|545199|P2|STARTED|Overall Study||19
229259|NCT00159965|545200|P1|STARTED|Overall Study||19
229260|NCT00159913|545236|P4|NOT COMPLETED|Overall Study||2
229261|NCT00159913|545237|P3|NOT COMPLETED|Overall Study||2
229262|NCT00159913|545238|P2|NOT COMPLETED|Overall Study||0
229263|NCT00159913|545239|P1|NOT COMPLETED|Overall Study||2
229264|NCT00159913|545236|P4|COMPLETED|Overall Study||58
229265|NCT00159913|545237|P3|COMPLETED|Overall Study||75
229266|NCT00159913|545238|P2|COMPLETED|Overall Study||55
229267|NCT00159913|545239|P1|COMPLETED|Overall Study||40
229268|NCT00159913|545236|P4|STARTED|Overall Study||60
229269|NCT00159913|545237|P3|STARTED|Overall Study||77
229270|NCT00159913|545238|P2|STARTED|Overall Study||55
229271|NCT00159913|545239|P1|STARTED|Overall Study||42
229272|NCT00159874|545313|P7|NOT COMPLETED|Overall Study||5
229273|NCT00159874|545314|P6|NOT COMPLETED|Overall Study||12
229274|NCT00159874|545315|P5|NOT COMPLETED|Overall Study||8
229275|NCT00159874|545316|P4|NOT COMPLETED|Overall Study||6
229276|NCT00159874|545317|P3|NOT COMPLETED|Overall Study||43
229277|NCT00159874|545318|P2|NOT COMPLETED|Overall Study||30
229278|NCT00159874|545319|P1|NOT COMPLETED|Overall Study||20
229279|NCT00159874|545313|P7|COMPLETED|Overall Study||0
229280|NCT00159874|545314|P6|COMPLETED|Overall Study||11
229281|NCT00159874|545315|P5|COMPLETED|Overall Study||11
229282|NCT00159874|545316|P4|COMPLETED|Overall Study||7
229283|NCT00159874|545317|P3|COMPLETED|Overall Study||34
229284|NCT00159874|545318|P2|COMPLETED|Overall Study||25
229285|NCT00159874|545319|P1|COMPLETED|Overall Study||22
229286|NCT00159874|545313|P7|Treated|Overall Study||5
229287|NCT00159874|545314|P6|Treated|Overall Study||23
229288|NCT00159874|545315|P5|Treated|Overall Study||19
229289|NCT00159874|545316|P4|Treated|Overall Study||13
229290|NCT00159874|545317|P3|Treated|Overall Study||77
229291|NCT00159874|545318|P2|Treated|Overall Study||55
229292|NCT00159874|545319|P1|Treated|Overall Study||42
229293|NCT00159874|545313|P7|STARTED|Overall Study||5
229294|NCT00159874|545314|P6|STARTED|Overall Study||23
229295|NCT00159874|545315|P5|STARTED|Overall Study||19
229296|NCT00159874|545316|P4|STARTED|Overall Study||13
229297|NCT00159874|545317|P3|STARTED|Overall Study||77
229298|NCT00159874|545318|P2|STARTED|Overall Study||55
229299|NCT00159874|545319|P1|STARTED|Overall Study||42
229300|NCT00159861|545489|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
229301|NCT00159861|545490|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
229302|NCT00159861|545489|P2|COMPLETED|Extension Study - up to 3 Years||56
229303|NCT00159861|545490|P1|COMPLETED|Extension Study - up to 3 Years||53
229304|NCT00159861|545489|P2|Treated|Extension Study - up to 3 Years||127
229305|NCT00159861|545490|P1|Treated|Extension Study - up to 3 Years||115
229306|NCT00159861|545489|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
229307|NCT00159861|545490|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
229308|NCT00159861|545489|P2|NOT COMPLETED|Core Study - 16 Weeks||12
229309|NCT00159861|545490|P1|NOT COMPLETED|Core Study - 16 Weeks||25
229310|NCT00159861|545489|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
229311|NCT00159861|545490|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
229312|NCT00159861|545489|P2|Treated|Core Study - 16 Weeks||134
229313|NCT00159861|545490|P1|Treated|Core Study - 16 Weeks||131
229314|NCT00159861|545489|P2|STARTED|Core Study - 16 Weeks||134
229315|NCT00159861|545490|P1|STARTED|Core Study - 16 Weeks||133
229316|NCT00159822|545511|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
229317|NCT00159822|545511|P1|COMPLETED|Post-treatment Follow-up Period||23
229318|NCT00159822|545511|P1|STARTED|Post-treatment Follow-up Period||26
229319|NCT00159822|545511|P1|NOT COMPLETED|Voriconazole Treatment Period||22
229320|NCT00159822|545511|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
229321|NCT00159822|545511|P1|STARTED|Voriconazole Treatment Period||48
229322|NCT00159783|545529|P3|NOT COMPLETED|Overall Study||39
229323|NCT00159783|545530|P2|NOT COMPLETED|Overall Study||27
229324|NCT00159783|545531|P1|NOT COMPLETED|Overall Study||19
229325|NCT00159783|545529|P3|COMPLETED|Overall Study||68
229326|NCT00159783|545530|P2|COMPLETED|Overall Study||52
229327|NCT00159783|545531|P1|COMPLETED|Overall Study||13
229328|NCT00159783|545529|P3|STARTED|Overall Study||107
229329|NCT00159783|545530|P2|STARTED|Overall Study||79
229330|NCT00159783|545531|P1|STARTED|Overall Study||32
229331|NCT00159432|545561|P1|NOT COMPLETED|Overall Study||10
229332|NCT00159432|545561|P1|COMPLETED|Overall Study||53
229333|NCT00159432|545561|P1|STARTED|Overall Study||63
229334|NCT00159419|545568|P2|NOT COMPLETED|Overall Study||0
229335|NCT00159419|545569|P1|NOT COMPLETED|Overall Study||0
229336|NCT00159419|545568|P2|COMPLETED|Overall Study||9
229337|NCT00159419|545569|P1|COMPLETED|Overall Study||9
229338|NCT00159419|545568|P2|STARTED|Overall Study||9
229339|NCT00159419|545569|P1|STARTED|Overall Study||9
229340|NCT00158743|545577|P2|NOT COMPLETED|Overall Study||7
229341|NCT00158743|545578|P1|NOT COMPLETED|Overall Study||9
229342|NCT00158743|545577|P2|COMPLETED|Overall Study||20
229343|NCT00158743|545578|P1|COMPLETED|Overall Study||15
229344|NCT00158743|545577|P2|STARTED|Overall Study||27
229345|NCT00158743|545578|P1|STARTED|Overall Study||24
229346|NCT00158600|545586|P2|NOT COMPLETED|Overall Study||4
229347|NCT00158600|545587|P1|NOT COMPLETED|Overall Study||5
229348|NCT00158600|545586|P2|COMPLETED|Overall Study||26
229349|NCT00158600|545587|P1|COMPLETED|Overall Study||55
229350|NCT00158600|545586|P2|STARTED|Overall Study||30
229351|NCT00158600|545587|P1|STARTED|Overall Study||60
229352|NCT00158379|545605|P1|NOT COMPLETED|Overall Study||0
229353|NCT00158379|545605|P1|COMPLETED|Overall Study||105
229354|NCT00158379|545605|P1|STARTED|Overall Study||105
229355|NCT00158249|545612|P2|NOT COMPLETED|Overall Study||0
229356|NCT00158249|545613|P1|NOT COMPLETED|Overall Study||2
229357|NCT00158249|545612|P2|COMPLETED|Overall Study||10
229358|NCT00158249|545613|P1|COMPLETED|Overall Study||9
229359|NCT00158249|545612|P2|STARTED|Overall Study||10
229360|NCT00158249|545613|P1|STARTED|Overall Study||11
229361|NCT00158223|545623|P2|NOT COMPLETED|Overall Study||3
229362|NCT00158223|545624|P1|NOT COMPLETED|Overall Study||5
229363|NCT00158223|545623|P2|COMPLETED|Overall Study||22
229364|NCT00158223|545624|P1|COMPLETED|Overall Study||23
229365|NCT00158223|545623|P2|STARTED|Overall Study||25
229366|NCT00158223|545624|P1|STARTED|Overall Study||28
229367|NCT00158197|545638|P4|NOT COMPLETED|Overall Study||0
229368|NCT00158197|545639|P3|NOT COMPLETED|Overall Study||0
229369|NCT00158197|545640|P2|NOT COMPLETED|Overall Study||0
229370|NCT00158197|545641|P1|NOT COMPLETED|Overall Study||0
229371|NCT00158197|545638|P4|COMPLETED|Overall Study||29
229372|NCT00158197|545639|P3|COMPLETED|Overall Study||28
229373|NCT00158197|545640|P2|COMPLETED|Overall Study||30
229374|NCT00158197|545641|P1|COMPLETED|Overall Study||32
229375|NCT00158197|545638|P4|STARTED|Overall Study||29
229376|NCT00158197|545639|P3|STARTED|Overall Study||28
229377|NCT00158197|545640|P2|STARTED|Overall Study||30
229378|NCT00158197|545641|P1|STARTED|Overall Study||32
229379|NCT00158054|545661|P2|NOT COMPLETED|Overall Study||3
229380|NCT00158054|545662|P1|NOT COMPLETED|Overall Study||10
229381|NCT00158054|545661|P2|COMPLETED|Overall Study||74
229382|NCT00158054|545662|P1|COMPLETED|Overall Study||70
229383|NCT00158054|545661|P2|STARTED|Overall Study||77
229384|NCT00158054|545662|P1|STARTED|Overall Study||80
229385|NCT00157950|545676|P2|NOT COMPLETED|Overall Study||0
229386|NCT00157950|545677|P1|NOT COMPLETED|Overall Study||1
229387|NCT00157950|545676|P2|COMPLETED|Overall Study||59
229388|NCT00157950|545677|P1|COMPLETED|Overall Study||116
229389|NCT00157950|545676|P2|Vaccinated at Dose 3|Overall Study||59
229390|NCT00157950|545677|P1|Vaccinated at Dose 3|Overall Study||116
229391|NCT00157950|545676|P2|Vaccinated at Dose 2|Overall Study||59
229392|NCT00157950|545677|P1|Vaccinated at Dose 2|Overall Study||117
229393|NCT00157950|545676|P2|Vaccinated at Dose 1|Overall Study||59
229394|NCT00157950|545677|P1|Vaccinated at Dose 1|Overall Study||117
229395|NCT00157950|545676|P2|STARTED|Overall Study||59
229396|NCT00157950|545677|P1|STARTED|Overall Study||117
229397|NCT00157820|545694|P3|NOT COMPLETED|2nd 8 Months||14
229398|NCT00157820|545695|P2|NOT COMPLETED|2nd 8 Months||13
229399|NCT00157820|545696|P1|NOT COMPLETED|2nd 8 Months||5
229400|NCT00157820|545694|P3|COMPLETED|2nd 8 Months||94
229401|NCT00157820|545695|P2|COMPLETED|2nd 8 Months||88
229402|NCT00157820|545696|P1|COMPLETED|2nd 8 Months||98
229403|NCT00157820|545694|P3|STARTED|2nd 8 Months||108
229404|NCT00157820|545695|P2|STARTED|2nd 8 Months||101
229405|NCT00157820|545696|P1|STARTED|2nd 8 Months||103
229406|NCT00157820|545694|P3|NOT COMPLETED|1 Month Wash Out Period||0
229407|NCT00157820|545695|P2|NOT COMPLETED|1 Month Wash Out Period||0
229408|NCT00157820|545696|P1|NOT COMPLETED|1 Month Wash Out Period||0
229409|NCT00157820|545694|P3|COMPLETED|1 Month Wash Out Period||108
229410|NCT00157820|545695|P2|COMPLETED|1 Month Wash Out Period||101
229411|NCT00157820|545696|P1|COMPLETED|1 Month Wash Out Period||103
229412|NCT00157820|545694|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
229413|NCT00157820|545695|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
229414|NCT00157820|545696|P1|STARTED|1 Month Wash Out Period||103
229415|NCT00157820|545694|P3|NOT COMPLETED|1st 8 Month||6
229416|NCT00157820|545695|P2|NOT COMPLETED|1st 8 Month||12
229417|NCT00157820|545696|P1|NOT COMPLETED|1st 8 Month||8
229418|NCT00157820|545694|P3|COMPLETED|1st 8 Month||106
229419|NCT00157820|545695|P2|COMPLETED|1st 8 Month||99
229420|NCT00157820|545696|P1|COMPLETED|1st 8 Month||103
229421|NCT00157820|545694|P3|STARTED|1st 8 Month||112
229422|NCT00157820|545695|P2|STARTED|1st 8 Month||111
229423|NCT00157820|545696|P1|STARTED|1st 8 Month||111
229424|NCT00157820|545694|P3|NOT COMPLETED|Randomized||8
229425|NCT00157820|545695|P2|NOT COMPLETED|Randomized||5
229426|NCT00157820|545696|P1|NOT COMPLETED|Randomized||7
229427|NCT00157820|545694|P3|COMPLETED|Randomized||112
229428|NCT00157820|545695|P2|COMPLETED|Randomized||111
229429|NCT00157820|545696|P1|COMPLETED|Randomized||111
229430|NCT00157820|545694|P3|STARTED|Randomized||120
229431|NCT00157820|545695|P2|STARTED|Randomized||116
229432|NCT00157820|545696|P1|STARTED|Randomized||118
229433|NCT00157755|545709|P6|NOT COMPLETED|Overall Study||5
229434|NCT00157755|545710|P5|NOT COMPLETED|Overall Study||2
229435|NCT00157755|545711|P4|NOT COMPLETED|Overall Study||4
229436|NCT00157755|545712|P3|NOT COMPLETED|Overall Study||7
229437|NCT00157755|545713|P2|NOT COMPLETED|Overall Study||4
229438|NCT00157755|545714|P1|NOT COMPLETED|Overall Study||2
229439|NCT00157755|545709|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
229440|NCT00157755|545710|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
229441|NCT00157755|545711|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
229442|NCT00157755|545712|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
229443|NCT00157755|545713|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
229444|NCT00157755|545714|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
229445|NCT00157755|545709|P6|STARTED|Overall Study||5
229446|NCT00157755|545710|P5|STARTED|Overall Study||12
229447|NCT00157755|545711|P4|STARTED|Overall Study||15
229448|NCT00157755|545712|P3|STARTED|Overall Study||10
229449|NCT00157755|545713|P2|STARTED|Overall Study||19
229450|NCT00157755|545714|P1|STARTED|Overall Study||26
229451|NCT00157248|545740|P4|NOT COMPLETED|Overall Study||47
229452|NCT00157248|545741|P3|NOT COMPLETED|Overall Study||21
229453|NCT00157248|545742|P2|NOT COMPLETED|Overall Study||37
229454|NCT00157248|545743|P1|NOT COMPLETED|Overall Study||48
229455|NCT00157248|545740|P4|COMPLETED|Overall Study||77
229456|NCT00157248|545741|P3|COMPLETED|Overall Study||29
229457|NCT00157248|545742|P2|COMPLETED|Overall Study||52
229458|NCT00157248|545743|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
229459|NCT00157248|545740|P4|STARTED|Overall Study||124
229460|NCT00157248|545741|P3|STARTED|Overall Study||50
229461|NCT00157248|545742|P2|STARTED|Overall Study||89
229462|NCT00157248|545743|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
229463|NCT00157209|545849|P2|NOT COMPLETED|Overall Study||0
229464|NCT00157209|545850|P1|NOT COMPLETED|Overall Study||10
229465|NCT00157209|545849|P2|COMPLETED|Overall Study||83
229466|NCT00157209|545850|P1|COMPLETED|Overall Study||78
229467|NCT00157209|545849|P2|STARTED|Overall Study||83
229468|NCT00157209|545850|P1|STARTED|Overall Study||88
229469|NCT00157196|545864|P1|NOT COMPLETED|Overall Study||9
229470|NCT00157196|545864|P1|COMPLETED|Overall Study||13
229471|NCT00157196|545864|P1|STARTED|Overall Study||22
229472|NCT00157157|545870|P1|NOT COMPLETED|Overall Study||11
229473|NCT00157157|545870|P1|COMPLETED|Overall Study||44
229474|NCT00157157|545870|P1|STARTED|Overall Study||55
229475|NCT00157014|545897|P4|NOT COMPLETED|Overall Study||1
229476|NCT00157014|545898|P3|NOT COMPLETED|Overall Study||1
229477|NCT00157014|545899|P2|NOT COMPLETED|Overall Study||8
229478|NCT00157014|545900|P1|NOT COMPLETED|Overall Study||6
229479|NCT00157014|545897|P4|COMPLETED|Overall Study||5
229480|NCT00157014|545898|P3|COMPLETED|Overall Study||4
229481|NCT00157014|545899|P2|COMPLETED|Overall Study||41
229482|NCT00157014|545900|P1|COMPLETED|Overall Study||45
229483|NCT00157014|545897|P4|Treatment Exposure Population|Overall Study||6
229484|NCT00157014|545898|P3|Treatment Exposure Population|Overall Study||5
229485|NCT00157014|545899|P2|Treatment Exposure Population|Overall Study||46
229486|NCT00157014|545900|P1|Treatment Exposure Population|Overall Study||52
229487|NCT00157014|545897|P4|STARTED|Overall Study||6
229488|NCT00157014|545898|P3|STARTED|Overall Study||5
229489|NCT00157014|545899|P2|STARTED|Overall Study||49
229490|NCT00157014|545900|P1|STARTED|Overall Study||51
229491|NCT00156936|545980|P2|NOT COMPLETED|Overall Study||11
229492|NCT00156936|545981|P1|NOT COMPLETED|Overall Study||72
229493|NCT00156936|545980|P2|COMPLETED|Overall Study||5
229494|NCT00156936|545981|P1|COMPLETED|Overall Study||20
229495|NCT00156936|545980|P2|STARTED|Overall Study||16
229496|NCT00156936|545981|P1|STARTED|Overall Study||92
229497|NCT00156923|545989|P2|NOT COMPLETED|Overall Study||32
229498|NCT00156923|545990|P1|NOT COMPLETED|Overall Study||34
229499|NCT00156923|545989|P2|COMPLETED|Overall Study||20
229500|NCT00156923|545990|P1|COMPLETED|Overall Study||22
229501|NCT00156923|545989|P2|STARTED|Overall Study||52
229502|NCT00156923|545990|P1|STARTED|Overall Study||56
229503|NCT00156910|545998|P2|NOT COMPLETED|Open-Label Phase (OL)||55
229504|NCT00156910|545999|P1|NOT COMPLETED|Open-Label Phase (OL)||33
229505|NCT00156910|545998|P2|COMPLETED|Open-Label Phase (OL)||231
229506|NCT00156910|545999|P1|COMPLETED|Open-Label Phase (OL)||252
229507|NCT00156910|545998|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
229508|NCT00156910|545999|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
229509|NCT00156910|545998|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
229510|NCT00156910|545999|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
229511|NCT00156910|545998|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
229512|NCT00156910|545999|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
229513|NCT00156910|545998|P2|STARTED|Double-Blind Phase (DB)||338
229514|NCT00156910|545999|P1|STARTED|Double-Blind Phase (DB)||341
229515|NCT00156819|546016|P3|NOT COMPLETED|Overall Study||3
229516|NCT00156819|546017|P2|NOT COMPLETED|Overall Study||1
229517|NCT00156819|546018|P1|NOT COMPLETED|Overall Study||1
229518|NCT00156819|546016|P3|COMPLETED|Overall Study||162
229519|NCT00156819|546017|P2|COMPLETED|Overall Study||165
229520|NCT00156819|546018|P1|COMPLETED|Overall Study||168
229521|NCT00156819|546016|P3|STARTED|Overall Study||165
229522|NCT00156819|546017|P2|STARTED|Overall Study||166
229523|NCT00156819|546018|P1|STARTED|Overall Study||169
229524|NCT00156715|546026|P1|NOT COMPLETED|Overall Study||7
229525|NCT00156715|546026|P1|COMPLETED|Overall Study||16
229526|NCT00156715|546026|P1|STARTED|Overall Study||23
229527|NCT00156533|546035|P4|NOT COMPLETED|Overall Study||2
229528|NCT00156533|546036|P3|NOT COMPLETED|Overall Study||2
229529|NCT00156533|546037|P2|NOT COMPLETED|Overall Study||2
229530|NCT00156533|546038|P1|NOT COMPLETED|Overall Study||2
229531|NCT00156533|546035|P4|COMPLETED|Overall Study||3
229532|NCT00156533|546036|P3|COMPLETED|Overall Study||3
229533|NCT00156533|546037|P2|COMPLETED|Overall Study||3
229534|NCT00156533|546038|P1|COMPLETED|Overall Study||3
229535|NCT00156533|546035|P4|STARTED|Overall Study||5
229536|NCT00156533|546036|P3|STARTED|Overall Study||5
229537|NCT00156533|546037|P2|STARTED|Overall Study||5
229538|NCT00156533|546038|P1|STARTED|Overall Study||5
229539|NCT00156390|546054|P2|NOT COMPLETED|Overall Study||8
229540|NCT00156390|546055|P1|NOT COMPLETED|Overall Study||14
229541|NCT00156390|546054|P2|COMPLETED|Overall Study||69
229542|NCT00156390|546055|P1|COMPLETED|Overall Study||96
229543|NCT00156390|546054|P2|STARTED|Overall Study||77
229544|NCT00156390|546055|P1|STARTED|Overall Study||110
229545|NCT00156247|546061|P1|NOT COMPLETED|Overall Study||4
229546|NCT00156247|546061|P1|COMPLETED|Overall Study||5
229547|NCT00156247|546061|P1|STARTED|Overall Study||9
229548|NCT00156065|546070|P3|NOT COMPLETED|Overall Study||27
229549|NCT00156065|546071|P2|NOT COMPLETED|Overall Study||63
229550|NCT00156065|546072|P1|NOT COMPLETED|Overall Study||31
229551|NCT00156065|546070|P3|COMPLETED|Overall Study||16
229552|NCT00156065|546071|P2|COMPLETED|Overall Study||30
229553|NCT00156065|546072|P1|COMPLETED|Overall Study||20
229554|NCT00156065|546070|P3|STARTED|Overall Study||43
229555|NCT00156065|546071|P2|STARTED|Overall Study||93
229556|NCT00156065|546072|P1|STARTED|Overall Study||51
229557|NCT00156013|546083|P1|NOT COMPLETED|Overall Study||2
229558|NCT00156013|546083|P1|COMPLETED|Overall Study||31
229559|NCT00156013|546083|P1|STARTED|Overall Study||33
229560|NCT00153920|546087|P1|NOT COMPLETED|Overall Study||30
229561|NCT00153920|546087|P1|COMPLETED|Overall Study||36
229562|NCT00153920|546087|P1|Eligible and Treated|Overall Study||64
229563|NCT00153920|546087|P1|STARTED|Overall Study||66
229564|NCT00153816|546102|P6|NOT COMPLETED|Overall Study||27
229565|NCT00153816|546103|P5|NOT COMPLETED|Overall Study||17
229566|NCT00153816|546104|P4|NOT COMPLETED|Overall Study||31
229567|NCT00153816|546105|P3|NOT COMPLETED|Overall Study||32
229568|NCT00153816|546106|P2|NOT COMPLETED|Overall Study||32
229569|NCT00153816|546107|P1|NOT COMPLETED|Overall Study||32
229570|NCT00153816|546102|P6|COMPLETED|Overall Study||262
229571|NCT00153816|546103|P5|COMPLETED|Overall Study||278
229572|NCT00153816|546104|P4|COMPLETED|Overall Study||390
229573|NCT00153816|546105|P3|COMPLETED|Overall Study||388
229574|NCT00153816|546106|P2|COMPLETED|Overall Study||387
229575|NCT00153816|546107|P1|COMPLETED|Overall Study||383
229576|NCT00153816|546102|P6|STARTED|Overall Study||289
229577|NCT00153816|546103|P5|STARTED|Overall Study||295
229578|NCT00153816|546104|P4|STARTED|Overall Study||421
229579|NCT00153816|546105|P3|STARTED|Overall Study||420
229580|NCT00153816|546106|P2|STARTED|Overall Study||419
229581|NCT00153816|546107|P1|STARTED|Overall Study||415
229582|NCT00154466|546130|P3|NOT COMPLETED|Overall Study||0
229583|NCT00154466|546131|P2|NOT COMPLETED|Overall Study||0
229584|NCT00154466|546132|P1|NOT COMPLETED|Overall Study||0
229585|NCT00154466|546130|P3|COMPLETED|Overall Study||19
229586|NCT00154466|546131|P2|COMPLETED|Overall Study||19
229587|NCT00154466|546132|P1|COMPLETED|Overall Study||20
229588|NCT00154466|546130|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
229589|NCT00154466|546131|P2|STARTED|Overall Study||19
229590|NCT00154466|546132|P1|STARTED|Overall Study||20
229591|NCT00154375|546144|P2|NOT COMPLETED|Overall Study||106
229592|NCT00154375|546145|P1|NOT COMPLETED|Overall Study||113
229593|NCT00154375|546144|P2|COMPLETED|Overall Study||14
229594|NCT00154375|546145|P1|COMPLETED|Overall Study||7
229767|NCT00151814|546733|P1|NOT COMPLETED|Overall Study||0
229595|NCT00154375|546144|P2|Not Exposed to Study Treatment|Overall Study||2
229596|NCT00154375|546145|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
229597|NCT00154375|546144|P2|Discontinued Study Treatment|Overall Study||104
229598|NCT00154375|546145|P1|Discontinued Study Treatment|Overall Study||111
229599|NCT00154375|546144|P2|STARTED|Overall Study||120
229600|NCT00154375|546145|P1|STARTED|Overall Study||120
229601|NCT00154310|546156|P2|NOT COMPLETED|Overall Study||28
229602|NCT00154310|546157|P1|NOT COMPLETED|Overall Study||37
229603|NCT00154310|546156|P2|COMPLETED|Overall Study||117
229604|NCT00154310|546157|P1|COMPLETED|Overall Study||118
229605|NCT00154310|546156|P2|STARTED|Overall Study||145
229606|NCT00154310|546157|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
229607|NCT00154297|546173|P2|NOT COMPLETED|Overall Study||7
229608|NCT00154297|546174|P1|NOT COMPLETED|Overall Study||8
229609|NCT00154297|546173|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
229610|NCT00154297|546174|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
229611|NCT00154297|546173|P2|STARTED|Overall Study|Randomized population.|74
229612|NCT00154297|546174|P1|STARTED|Overall Study|Randomized population.|65
229613|NCT00154284|546192|P2|NOT COMPLETED|Overall Study||13
229614|NCT00154284|546193|P1|NOT COMPLETED|Overall Study||7
229615|NCT00154284|546192|P2|COMPLETED|Overall Study||42
229616|NCT00154284|546193|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
229617|NCT00154284|546192|P2|Intent to Treat (ITT) Population|Overall Study||53
229618|NCT00154284|546193|P1|Intent to Treat (ITT) Population|Overall Study||57
229619|NCT00154284|546192|P2|STARTED|Overall Study||55
229620|NCT00154284|546193|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
229621|NCT00154102|546207|P2|NOT COMPLETED|Overall Study||2
229622|NCT00154102|546208|P1|NOT COMPLETED|Overall Study||7
229623|NCT00154102|546207|P2|COMPLETED|Overall Study||597
229624|NCT00154102|546208|P1|COMPLETED|Overall Study||592
229625|NCT00154102|546207|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
229626|NCT00154102|546208|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
229627|NCT00154063|546244|P2|NOT COMPLETED|Overall Study||22
229628|NCT00154063|546245|P1|NOT COMPLETED|Overall Study||12
229629|NCT00154063|546244|P2|COMPLETED|Overall Study||80
229630|NCT00154063|546245|P1|COMPLETED|Overall Study||92
229631|NCT00154063|546244|P2|STARTED|Overall Study||102
229632|NCT00154063|546245|P1|STARTED|Overall Study||104
229633|NCT00153985|546301|P1|NOT COMPLETED|Overall Study||0
229634|NCT00153985|546301|P1|COMPLETED|Overall Study||2
229635|NCT00153985|546301|P1|STARTED|Overall Study||2
229636|NCT00152516|546307|P1|NOT COMPLETED|Overall Study||75
229637|NCT00152516|546307|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
229638|NCT00152516|546307|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
229639|NCT00153179|546333|P4|NOT COMPLETED|Study Visit Day 2||0
229640|NCT00153179|546334|P3|NOT COMPLETED|Study Visit Day 2||0
229641|NCT00153179|546335|P2|NOT COMPLETED|Study Visit Day 2||0
229642|NCT00153179|546336|P1|NOT COMPLETED|Study Visit Day 2||0
229643|NCT00153179|546333|P4|COMPLETED|Study Visit Day 2||7
229644|NCT00153179|546334|P3|COMPLETED|Study Visit Day 2||11
229645|NCT00153179|546335|P2|COMPLETED|Study Visit Day 2||8
229646|NCT00153179|546336|P1|COMPLETED|Study Visit Day 2||9
229647|NCT00153179|546333|P4|STARTED|Study Visit Day 2||7
229648|NCT00153179|546334|P3|STARTED|Study Visit Day 2||11
229649|NCT00153179|546335|P2|STARTED|Study Visit Day 2||8
229650|NCT00153179|546336|P1|STARTED|Study Visit Day 2||9
229651|NCT00153179|546333|P4|NOT COMPLETED|Study Visit Day 1||0
229652|NCT00153179|546334|P3|NOT COMPLETED|Study Visit Day 1||0
229653|NCT00153179|546335|P2|NOT COMPLETED|Study Visit Day 1||0
229654|NCT00153179|546336|P1|NOT COMPLETED|Study Visit Day 1||0
229655|NCT00153179|546333|P4|COMPLETED|Study Visit Day 1||9
229656|NCT00153179|546334|P3|COMPLETED|Study Visit Day 1||13
229657|NCT00153179|546335|P2|COMPLETED|Study Visit Day 1||8
229658|NCT00153179|546336|P1|COMPLETED|Study Visit Day 1||10
229659|NCT00153179|546333|P4|STARTED|Study Visit Day 1||9
229660|NCT00153179|546334|P3|STARTED|Study Visit Day 1||13
229661|NCT00153179|546335|P2|STARTED|Study Visit Day 1||8
229662|NCT00153179|546336|P1|STARTED|Study Visit Day 1||10
229663|NCT00153166|546347|P3|NOT COMPLETED|Overall Study||0
229664|NCT00153166|546348|P2|NOT COMPLETED|Overall Study||0
229665|NCT00153166|546349|P1|NOT COMPLETED|Overall Study||0
229666|NCT00153166|546347|P3|COMPLETED|Overall Study||28
229667|NCT00153166|546348|P2|COMPLETED|Overall Study||37
229668|NCT00153166|546349|P1|COMPLETED|Overall Study||11
229669|NCT00153166|546347|P3|Received Placebo and Placebo|Overall Study||7
229670|NCT00153166|546348|P2|Received Placebo and Placebo|Overall Study||9
229671|NCT00153166|546349|P1|Received Placebo and Placebo|Overall Study||3
229672|NCT00153166|546347|P3|Received Placebo and Pioglitazone|Overall Study||7
229673|NCT00153166|546348|P2|Received Placebo and Pioglitazone|Overall Study||10
229674|NCT00153166|546349|P1|Received Placebo and Pioglitazone|Overall Study||3
229675|NCT00153166|546347|P3|Received Atorvastatin and Placebo|Overall Study||7
229676|NCT00153166|546348|P2|Received Atorvastatin and Placebo|Overall Study||9
229677|NCT00153166|546349|P1|Received Atorvastatin and Placebo|Overall Study||2
229768|NCT00151814|546731|P3|COMPLETED|Overall Study||10
229678|NCT00153166|546347|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
229679|NCT00153166|546348|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
229680|NCT00153166|546349|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
229681|NCT00153166|546347|P3|STARTED|Overall Study||28
229682|NCT00153166|546348|P2|STARTED|Overall Study||37
229683|NCT00153166|546349|P1|STARTED|Overall Study||11
229684|NCT00153101|546366|P5|NOT COMPLETED|Overall Study||10
229685|NCT00153101|546367|P4|NOT COMPLETED|Overall Study||8
229686|NCT00153101|546368|P3|NOT COMPLETED|Overall Study||15
229687|NCT00153101|546369|P2|NOT COMPLETED|Overall Study||18
229688|NCT00153101|546370|P1|NOT COMPLETED|Overall Study||17
229689|NCT00153101|546366|P5|COMPLETED|Overall Study||2962
229690|NCT00153101|546367|P4|COMPLETED|Overall Study||2946
229691|NCT00153101|546368|P3|COMPLETED|Overall Study||8561
229692|NCT00153101|546369|P2|COMPLETED|Overall Study||8524
229693|NCT00153101|546370|P1|COMPLETED|Overall Study||8485
229694|NCT00153101|546366|P5|STARTED|Overall Study||2972
229695|NCT00153101|546367|P4|STARTED|Overall Study||2954
229696|NCT00153101|546368|P3|STARTED|Overall Study||8576
229697|NCT00153101|546369|P2|STARTED|Overall Study||8542
229698|NCT00153101|546370|P1|STARTED|Overall Study||8502
229699|NCT00153062|546478|P4|NOT COMPLETED|Overall Study||411
229700|NCT00153062|546479|P3|NOT COMPLETED|Overall Study||415
229701|NCT00153062|546480|P2|NOT COMPLETED|Overall Study||406
229702|NCT00153062|546481|P1|NOT COMPLETED|Overall Study||387
229703|NCT00153062|546478|P4|COMPLETED|Overall Study||4680
229704|NCT00153062|546479|P3|COMPLETED|Overall Study||4645
229705|NCT00153062|546480|P2|COMPLETED|Overall Study||4689
229706|NCT00153062|546481|P1|COMPLETED|Overall Study||4699
229707|NCT00153062|546478|P4|STARTED|Overall Study||5091
229708|NCT00153062|546479|P3|STARTED|Overall Study||5060
229709|NCT00153062|546480|P2|STARTED|Overall Study||5095
229710|NCT00153062|546481|P1|STARTED|Overall Study||5086
229711|NCT00152971|546500|P3|NOT COMPLETED|Treatment||80
229712|NCT00152971|546501|P2|NOT COMPLETED|Treatment||63
229713|NCT00152971|546502|P1|NOT COMPLETED|Treatment||71
229714|NCT00152971|546500|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
229715|NCT00152971|546501|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
229716|NCT00152971|546502|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
229717|NCT00152971|546500|P3|STARTED|Treatment||868
229718|NCT00152971|546501|P2|STARTED|Treatment||871
229719|NCT00152971|546502|P1|STARTED|Treatment||857
229720|NCT00152971|546500|P3|NOT COMPLETED|Overall Study||49
229721|NCT00152971|546501|P2|NOT COMPLETED|Overall Study||48
229722|NCT00152971|546502|P1|NOT COMPLETED|Overall Study||51
229723|NCT00152971|546500|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
229724|NCT00152971|546501|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
229725|NCT00152971|546502|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
229726|NCT00152971|546500|P3|STARTED|Overall Study||868
229727|NCT00152971|546501|P2|STARTED|Overall Study||871
229728|NCT00152971|546502|P1|STARTED|Overall Study||857
229729|NCT00152763|546538|P4|NOT COMPLETED|Overall Study||14
229730|NCT00152763|546539|P3|NOT COMPLETED|Overall Study||4
229731|NCT00152763|546540|P2|NOT COMPLETED|Overall Study||5
229732|NCT00152763|546541|P1|NOT COMPLETED|Overall Study||10
229733|NCT00152763|546538|P4|COMPLETED|Overall Study||63
229734|NCT00152763|546539|P3|COMPLETED|Overall Study||16
229735|NCT00152763|546540|P2|COMPLETED|Overall Study||14
229736|NCT00152763|546541|P1|COMPLETED|Overall Study||67
229737|NCT00152763|546538|P4|STARTED|Overall Study||77
229738|NCT00152763|546539|P3|STARTED|Overall Study||20
229739|NCT00152763|546540|P2|STARTED|Overall Study||19
229740|NCT00152763|546541|P1|STARTED|Overall Study||77
229741|NCT00152009|546661|P4|NOT COMPLETED|Overall Study||33
229742|NCT00152009|546662|P3|NOT COMPLETED|Overall Study||37
229743|NCT00152009|546663|P2|NOT COMPLETED|Overall Study||31
229744|NCT00152009|546664|P1|NOT COMPLETED|Overall Study||29
229745|NCT00152009|546661|P4|COMPLETED|Overall Study||53
229746|NCT00152009|546662|P3|COMPLETED|Overall Study||49
229747|NCT00152009|546663|P2|COMPLETED|Overall Study||55
229748|NCT00152009|546664|P1|COMPLETED|Overall Study||58
229749|NCT00152009|546661|P4|STARTED|Overall Study||86
229750|NCT00152009|546662|P3|STARTED|Overall Study||86
229751|NCT00152009|546663|P2|STARTED|Overall Study||86
229752|NCT00152009|546664|P1|STARTED|Overall Study||87
229753|NCT00151996|546696|P2|NOT COMPLETED|Overall Study||7
229754|NCT00151996|546697|P1|NOT COMPLETED|Overall Study||5
229755|NCT00151996|546696|P2|COMPLETED|Overall Study||26
229756|NCT00151996|546697|P1|COMPLETED|Overall Study||37
229757|NCT00151996|546696|P2|STARTED|Overall Study||33
229758|NCT00151996|546697|P1|STARTED|Overall Study||42
229759|NCT00151892|546713|P2|NOT COMPLETED|Overall Study||83
229760|NCT00151892|546714|P1|NOT COMPLETED|Overall Study||76
229761|NCT00151892|546713|P2|COMPLETED|Overall Study||330
229762|NCT00151892|546714|P1|COMPLETED|Overall Study||340
229763|NCT00151892|546713|P2|STARTED|Overall Study||413
229764|NCT00151892|546714|P1|STARTED|Overall Study||416
229765|NCT00151814|546731|P3|NOT COMPLETED|Overall Study||0
229766|NCT00151814|546732|P2|NOT COMPLETED|Overall Study||0
229769|NCT00151814|546732|P2|COMPLETED|Overall Study||10
229770|NCT00151814|546733|P1|COMPLETED|Overall Study||4
229771|NCT00151814|546731|P3|STARTED|Overall Study||10
229772|NCT00151814|546732|P2|STARTED|Overall Study||10
229773|NCT00151814|546733|P1|STARTED|Overall Study||4
229774|NCT00151775|546759|P12|NOT COMPLETED|Period 4: Open Label||0
229775|NCT00151775|546760|P11|NOT COMPLETED|Period 4: Open Label||0
229776|NCT00151775|546761|P10|NOT COMPLETED|Period 4: Open Label||21
229777|NCT00151775|546762|P9|NOT COMPLETED|Period 4: Open Label||0
229778|NCT00151775|546763|P8|NOT COMPLETED|Period 4: Open Label||0
229779|NCT00151775|546764|P7|NOT COMPLETED|Period 4: Open Label||0
229780|NCT00151775|546765|P6|NOT COMPLETED|Period 4: Open Label||0
229781|NCT00151775|546766|P5|NOT COMPLETED|Period 4: Open Label||30
229782|NCT00151775|546767|P4|NOT COMPLETED|Period 4: Open Label||0
229783|NCT00151775|546768|P3|NOT COMPLETED|Period 4: Open Label||0
229784|NCT00151775|546769|P2|NOT COMPLETED|Period 4: Open Label||0
229785|NCT00151775|546770|P1|NOT COMPLETED|Period 4: Open Label||0
229786|NCT00151775|546759|P12|COMPLETED|Period 4: Open Label||0
229787|NCT00151775|546760|P11|COMPLETED|Period 4: Open Label||57
229788|NCT00151775|546761|P10|COMPLETED|Period 4: Open Label||83
229789|NCT00151775|546762|P9|COMPLETED|Period 4: Open Label||0
229790|NCT00151775|546763|P8|COMPLETED|Period 4: Open Label||0
229791|NCT00151775|546764|P7|COMPLETED|Period 4: Open Label||0
229792|NCT00151775|546765|P6|COMPLETED|Period 4: Open Label||0
229793|NCT00151775|546766|P5|COMPLETED|Period 4: Open Label||149
229794|NCT00151775|546767|P4|COMPLETED|Period 4: Open Label||0
229795|NCT00151775|546768|P3|COMPLETED|Period 4: Open Label||0
229796|NCT00151775|546769|P2|COMPLETED|Period 4: Open Label||0
229797|NCT00151775|546770|P1|COMPLETED|Period 4: Open Label||0
229798|NCT00151775|546759|P12|STARTED|Period 4: Open Label||0
229799|NCT00151775|546760|P11|STARTED|Period 4: Open Label||57
229800|NCT00151775|546761|P10|STARTED|Period 4: Open Label||104
229801|NCT00151775|546762|P9|STARTED|Period 4: Open Label||0
229802|NCT00151775|546763|P8|STARTED|Period 4: Open Label||0
229803|NCT00151775|546764|P7|STARTED|Period 4: Open Label||0
229804|NCT00151775|546765|P6|STARTED|Period 4: Open Label||0
229805|NCT00151775|546766|P5|STARTED|Period 4: Open Label||179
229806|NCT00151775|546767|P4|STARTED|Period 4: Open Label||0
229807|NCT00151775|546768|P3|STARTED|Period 4: Open Label||0
229808|NCT00151775|546769|P2|STARTED|Period 4: Open Label||0
229809|NCT00151775|546770|P1|STARTED|Period 4: Open Label||0
229810|NCT00151775|546759|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
229811|NCT00151775|546760|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229812|NCT00151775|546761|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229813|NCT00151775|546762|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229814|NCT00151775|546763|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
229815|NCT00151775|546764|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
229816|NCT00151775|546765|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
229817|NCT00151775|546766|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229818|NCT00151775|546767|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229819|NCT00151775|546768|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
229820|NCT00151775|546769|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229821|NCT00151775|546770|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
229822|NCT00151775|546759|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
229823|NCT00151775|546760|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
229824|NCT00151775|546761|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
229825|NCT00151775|546762|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
229826|NCT00151775|546763|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
229827|NCT00151775|546764|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
229828|NCT00151775|546765|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
229829|NCT00151775|546766|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
229830|NCT00151775|546767|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
229831|NCT00151775|546768|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
229832|NCT00151775|546769|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
229833|NCT00151775|546770|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
229834|NCT00151775|546759|P12|STARTED|Period 3: Double-blind, Withdrawal||29
229835|NCT00151775|546760|P11|STARTED|Period 3: Double-blind, Withdrawal||29
229836|NCT00151775|546761|P10|STARTED|Period 3: Double-blind, Withdrawal||0
229837|NCT00151775|546762|P9|STARTED|Period 3: Double-blind, Withdrawal||26
229838|NCT00151775|546763|P8|STARTED|Period 3: Double-blind, Withdrawal||28
229839|NCT00151775|546764|P7|STARTED|Period 3: Double-blind, Withdrawal||27
229840|NCT00151775|546765|P6|STARTED|Period 3: Double-blind, Withdrawal||26
229841|NCT00151775|546766|P5|STARTED|Period 3: Double-blind, Withdrawal||0
229842|NCT00151775|546767|P4|STARTED|Period 3: Double-blind, Withdrawal||44
229843|NCT00151775|546768|P3|STARTED|Period 3: Double-blind, Withdrawal||45
229844|NCT00151775|546769|P2|STARTED|Period 3: Double-blind, Withdrawal||45
229845|NCT00151775|546770|P1|STARTED|Period 3: Double-blind, Withdrawal||48
229846|NCT00151775|546759|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229847|NCT00151775|546760|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
229848|NCT00151775|546761|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229849|NCT00151775|546762|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229850|NCT00151775|546763|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229851|NCT00151775|546764|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
229852|NCT00151775|546765|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
229853|NCT00151775|546766|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229854|NCT00151775|546767|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229855|NCT00151775|546768|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
229856|NCT00151775|546769|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
229857|NCT00151775|546770|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
229858|NCT00151775|546759|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
229859|NCT00151775|546760|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
229860|NCT00151775|546761|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
229861|NCT00151775|546762|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
229862|NCT00151775|546763|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
229863|NCT00151775|546764|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
229864|NCT00151775|546765|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
229865|NCT00151775|546766|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
229866|NCT00151775|546767|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
229867|NCT00151775|546768|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
229868|NCT00151775|546769|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
229869|NCT00151775|546770|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
229870|NCT00151775|546759|P12|STARTED|Period 2 - Double-Blind Dose Response||0
229871|NCT00151775|546760|P11|STARTED|Period 2 - Double-Blind Dose Response||60
229872|NCT00151775|546761|P10|STARTED|Period 2 - Double-Blind Dose Response||0
229873|NCT00151775|546762|P9|STARTED|Period 2 - Double-Blind Dose Response||0
229874|NCT00151775|546763|P8|STARTED|Period 2 - Double-Blind Dose Response||0
229875|NCT00151775|546764|P7|STARTED|Period 2 - Double-Blind Dose Response||56
229876|NCT00151775|546765|P6|STARTED|Period 2 - Double-Blind Dose Response||56
229877|NCT00151775|546766|P5|STARTED|Period 2 - Double-Blind Dose Response||0
229878|NCT00151775|546767|P4|STARTED|Period 2 - Double-Blind Dose Response||0
229879|NCT00151775|546768|P3|STARTED|Period 2 - Double-Blind Dose Response||0
229880|NCT00151775|546769|P2|STARTED|Period 2 - Double-Blind Dose Response||95
229881|NCT00151775|546770|P1|STARTED|Period 2 - Double-Blind Dose Response||95
229882|NCT00151476|546814|P2|NOT COMPLETED|FAP Analyzed Subjects||3
229883|NCT00151476|546815|P1|NOT COMPLETED|FAP Analyzed Subjects||0
229884|NCT00151476|546814|P2|COMPLETED|FAP Analyzed Subjects||51
229885|NCT00151476|546815|P1|COMPLETED|FAP Analyzed Subjects||13
229886|NCT00151476|546814|P2|STARTED|FAP Analyzed Subjects||54
229887|NCT00151476|546815|P1|STARTED|FAP Analyzed Subjects||13
229888|NCT00151476|546814|P2|NOT COMPLETED|FAP Identified Subjects||1
229889|NCT00151476|546815|P1|NOT COMPLETED|FAP Identified Subjects||0
229890|NCT00151476|546814|P2|COMPLETED|FAP Identified Subjects||54
229891|NCT00151476|546815|P1|COMPLETED|FAP Identified Subjects||13
229892|NCT00151476|546814|P2|STARTED|FAP Identified Subjects||55
229893|NCT00151476|546815|P1|STARTED|FAP Identified Subjects||13
229894|NCT00151411|546872|P2|NOT COMPLETED|Overall Study||43
229895|NCT00151411|546873|P1|NOT COMPLETED|Overall Study||33
229896|NCT00151411|546872|P2|COMPLETED|Overall Study||16
229897|NCT00151411|546873|P1|COMPLETED|Overall Study||22
229898|NCT00151411|546872|P2|STARTED|Overall Study||59
229899|NCT00151411|546873|P1|STARTED|Overall Study||55
229900|NCT00151372|546881|P2|NOT COMPLETED|Overall Study||29
229901|NCT00151372|546882|P1|NOT COMPLETED|Overall Study||29
229902|NCT00151372|546881|P2|COMPLETED|Overall Study||45
229903|NCT00151372|546882|P1|COMPLETED|Overall Study||38
229904|NCT00151372|546881|P2|STARTED|Overall Study||74
229905|NCT00151372|546882|P1|STARTED|Overall Study||67
229906|NCT00150969|546892|P2|NOT COMPLETED|24-48 Month Extension||100
229907|NCT00150969|546893|P1|NOT COMPLETED|24-48 Month Extension||88
229908|NCT00150969|546892|P2|COMPLETED|24-48 Month Extension||40
229909|NCT00150969|546893|P1|COMPLETED|24-48 Month Extension||33
229910|NCT00150969|546892|P2|STARTED|24-48 Month Extension||140
229911|NCT00150969|546893|P1|STARTED|24-48 Month Extension||121
229912|NCT00150969|546892|P2|NOT COMPLETED|24 Month Main Study||21
229913|NCT00150969|546893|P1|NOT COMPLETED|24 Month Main Study||19
229914|NCT00150969|546892|P2|COMPLETED|24 Month Main Study||202
229915|NCT00150969|546893|P1|COMPLETED|24 Month Main Study||198
229916|NCT00150969|546892|P2|STARTED|24 Month Main Study||223
229917|NCT00150969|546893|P1|STARTED|24 Month Main Study||217
229918|NCT00150618|546930|P5|NOT COMPLETED|Overall Study||25
229919|NCT00150618|546931|P4|NOT COMPLETED|Overall Study||26
229920|NCT00150618|546932|P3|NOT COMPLETED|Overall Study||27
229921|NCT00150618|546933|P2|NOT COMPLETED|Overall Study||18
229922|NCT00150618|546934|P1|NOT COMPLETED|Overall Study||17
229923|NCT00150618|546930|P5|COMPLETED|Overall Study||41
229924|NCT00150618|546931|P4|COMPLETED|Overall Study||40
229925|NCT00150618|546932|P3|COMPLETED|Overall Study||38
229926|NCT00150618|546933|P2|COMPLETED|Overall Study||47
229927|NCT00150618|546934|P1|COMPLETED|Overall Study||45
229928|NCT00150618|546930|P5|STARTED|Overall Study||66
229929|NCT00150618|546931|P4|STARTED|Overall Study||66
229930|NCT00150618|546932|P3|STARTED|Overall Study||65
229931|NCT00150618|546933|P2|STARTED|Overall Study||65
229932|NCT00150618|546934|P1|STARTED|Overall Study||62
229933|NCT00150592|546968|P2|NOT COMPLETED|Overall Study||3
229934|NCT00150592|546969|P1|NOT COMPLETED|Overall Study||7
229935|NCT00150592|546968|P2|COMPLETED|Overall Study||54
229936|NCT00150592|546969|P1|COMPLETED|Overall Study||114
229937|NCT00150592|546968|P2|STARTED|Overall Study||57
229938|NCT00150592|546969|P1|STARTED|Overall Study||121
229939|NCT00150462|547000|P11|NOT COMPLETED|Overall Study||3
229940|NCT00150462|547001|P10|NOT COMPLETED|Overall Study||6
229941|NCT00150462|547002|P9|NOT COMPLETED|Overall Study||6
229942|NCT00150462|547003|P8|NOT COMPLETED|Overall Study||8
229943|NCT00150462|547004|P7|NOT COMPLETED|Overall Study||3
229944|NCT00150462|547005|P6|NOT COMPLETED|Overall Study||4
229945|NCT00150462|547006|P5|NOT COMPLETED|Overall Study||3
229946|NCT00150462|547007|P4|NOT COMPLETED|Overall Study||3
229947|NCT00150462|547008|P3|NOT COMPLETED|Overall Study||4
229948|NCT00150462|547009|P2|NOT COMPLETED|Overall Study||3
229949|NCT00150462|547010|P1|NOT COMPLETED|Overall Study||3
229950|NCT00150462|547000|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
229951|NCT00150462|547001|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
229952|NCT00150462|547002|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229953|NCT00150462|547003|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229954|NCT00150462|547004|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229955|NCT00150462|547005|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229956|NCT00150462|547006|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229957|NCT00150462|547007|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229958|NCT00150462|547008|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229959|NCT00150462|547009|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229960|NCT00150462|547010|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
229961|NCT00150462|547000|P11|STARTED|Overall Study||4
229962|NCT00150462|547001|P10|STARTED|Overall Study||7
229963|NCT00150462|547002|P9|STARTED|Overall Study||6
229964|NCT00150462|547003|P8|STARTED|Overall Study||8
229965|NCT00150462|547004|P7|STARTED|Overall Study||3
229966|NCT00150462|547005|P6|STARTED|Overall Study||4
229967|NCT00150462|547006|P5|STARTED|Overall Study||3
229968|NCT00150462|547007|P4|STARTED|Overall Study||3
229969|NCT00150462|547008|P3|STARTED|Overall Study||4
229970|NCT00150462|547009|P2|STARTED|Overall Study||3
229971|NCT00150462|547010|P1|STARTED|Overall Study||3
229972|NCT00150345|547120|P2|NOT COMPLETED|Overall Study||32
229973|NCT00150345|547121|P1|NOT COMPLETED|Overall Study||34
229974|NCT00150345|547120|P2|COMPLETED|Overall Study||34
229975|NCT00150345|547121|P1|COMPLETED|Overall Study||47
229976|NCT00150345|547120|P2|STARTED|Overall Study||66
229977|NCT00150345|547121|P1|STARTED|Overall Study||81
229978|NCT00150176|547185|P2|NOT COMPLETED|Overall Study||120
229979|NCT00150176|547186|P1|NOT COMPLETED|Overall Study||59
229980|NCT00150176|547185|P2|COMPLETED|Overall Study||72
229981|NCT00150176|547186|P1|COMPLETED|Overall Study||135
229982|NCT00150176|547185|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
229983|NCT00150176|547186|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
229984|NCT00149994|547197|P2|NOT COMPLETED|Overall Study||1
229985|NCT00149994|547198|P1|NOT COMPLETED|Overall Study||1
229986|NCT00149994|547197|P2|COMPLETED|Overall Study||85
229987|NCT00149994|547198|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
229988|NCT00149994|547197|P2|STARTED|Overall Study||86
229989|NCT00149994|547198|P1|STARTED|Overall Study|"Started indicates Safety population."|85
229990|NCT00149890|547206|P2|NOT COMPLETED|Overall Study||18
229991|NCT00149890|547207|P1|NOT COMPLETED|Overall Study||13
229992|NCT00149890|547206|P2|COMPLETED|Overall Study||20
229993|NCT00149890|547207|P1|COMPLETED|Overall Study||26
229994|NCT00149890|547206|P2|STARTED|Overall Study||38
229995|NCT00149890|547207|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
229996|NCT00149825|547227|P2|NOT COMPLETED|Overall Study||3
229997|NCT00149825|547228|P1|NOT COMPLETED|Overall Study||5
229998|NCT00149825|547227|P2|COMPLETED|Overall Study||12
229999|NCT00149825|547228|P1|COMPLETED|Overall Study||10
230000|NCT00149825|547227|P2|STARTED|Overall Study||15
230001|NCT00149825|547228|P1|STARTED|Overall Study||15
230002|NCT00149799|547238|P3|NOT COMPLETED|Discontinuation (Phase II)||9
230003|NCT00149799|547239|P2|NOT COMPLETED|Discontinuation (Phase II)||3
230004|NCT00149799|547240|P1|NOT COMPLETED|Discontinuation (Phase II)||0
230005|NCT00149799|547238|P3|COMPLETED|Discontinuation (Phase II)||21
230006|NCT00149799|547239|P2|COMPLETED|Discontinuation (Phase II)||25
230007|NCT00149799|547240|P1|COMPLETED|Discontinuation (Phase II)||0
230008|NCT00149799|547238|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|30
230009|NCT00149799|547239|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|28
230010|NCT00149799|547240|P1|STARTED|Discontinuation (Phase II)||0
230011|NCT00149799|547238|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
230012|NCT00149799|547239|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
230013|NCT00149799|547240|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
230014|NCT00149799|547238|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
230015|NCT00149799|547239|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
230016|NCT00149799|547240|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
230017|NCT00149799|547238|P3|STARTED|Open Label Escitalopram (Phase I)||0
230018|NCT00149799|547239|P2|STARTED|Open Label Escitalopram (Phase I)||0
230019|NCT00149799|547240|P1|STARTED|Open Label Escitalopram (Phase I)||100
230020|NCT00149747|547250|P2|NOT COMPLETED|Overall Study||3
230021|NCT00149747|547251|P1|NOT COMPLETED|Overall Study||4
230022|NCT00149747|547250|P2|COMPLETED|Overall Study||27
230023|NCT00149747|547251|P1|COMPLETED|Overall Study||32
230024|NCT00149747|547250|P2|STARTED|Overall Study||30
230025|NCT00149747|547251|P1|STARTED|Overall Study||36
230026|NCT00149643|547263|P2|NOT COMPLETED|Overall Study||36
230027|NCT00149643|547264|P1|NOT COMPLETED|Overall Study||34
230028|NCT00149643|547263|P2|COMPLETED|Overall Study||0
230029|NCT00149643|547264|P1|COMPLETED|Overall Study||0
230030|NCT00149643|547263|P2|STARTED|Overall Study||36
230031|NCT00149643|547264|P1|STARTED|Overall Study||34
230032|NCT00149630|547276|P2|NOT COMPLETED|Overall Study||5
230033|NCT00149630|547277|P1|NOT COMPLETED|Overall Study||8
230034|NCT00149630|547276|P2|COMPLETED|Overall Study||35
230035|NCT00149630|547277|P1|COMPLETED|Overall Study||26
230036|NCT00149630|547276|P2|STARTED|Overall Study||40
230037|NCT00149630|547277|P1|STARTED|Overall Study||34
230038|NCT00149227|547289|P2|NOT COMPLETED|Overall Study||0
230039|NCT00149227|547290|P1|NOT COMPLETED|Overall Study||0
230040|NCT00149227|547289|P2|COMPLETED|Overall Study||1514
230041|NCT00149227|547290|P1|COMPLETED|Overall Study||1517
230042|NCT00149227|547289|P2|STARTED|Overall Study||1514
230043|NCT00149227|547290|P1|STARTED|Overall Study||1517
230044|NCT00149214|547316|P2|NOT COMPLETED|Overall Study||17
230045|NCT00149214|547317|P1|NOT COMPLETED|Overall Study||26
230046|NCT00149214|547316|P2|COMPLETED|Overall Study||105
230047|NCT00149214|547317|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
230048|NCT00149214|547316|P2|STARTED|Overall Study||122
230049|NCT00149214|547317|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
230050|NCT00148954|547333|P2|NOT COMPLETED|Overall Study||300
230051|NCT00148954|547334|P1|NOT COMPLETED|Overall Study||307
230052|NCT00148954|547333|P2|COMPLETED|Overall Study||677
230053|NCT00148954|547334|P1|COMPLETED|Overall Study||678
230054|NCT00148954|547333|P2|STARTED|Overall Study||977
230055|NCT00148954|547334|P1|STARTED|Overall Study||985
230056|NCT00148798|547342|P2|NOT COMPLETED|Overall Study||0
230057|NCT00148798|547343|P1|NOT COMPLETED|Overall Study||0
230058|NCT00148798|547342|P2|COMPLETED|Overall Study||568
230059|NCT00148798|547343|P1|COMPLETED|Overall Study||557
230060|NCT00148798|547342|P2|STARTED|Overall Study|ITT Population|568
230061|NCT00148798|547343|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
230062|NCT00148759|547365|P2|NOT COMPLETED|Overall Study||1
230063|NCT00148759|547366|P1|NOT COMPLETED|Overall Study||2
230064|NCT00148759|547365|P2|COMPLETED|Overall Study||11
230065|NCT00148759|547366|P1|COMPLETED|Overall Study||9
230066|NCT00148759|547365|P2|24-hr PK Sampling|Overall Study||11
230067|NCT00148759|547366|P1|24-hr PK Sampling|Overall Study||9
230068|NCT00148759|547365|P2|STARTED|Overall Study||12
230069|NCT00148759|547366|P1|STARTED|Overall Study||11
230070|NCT00148733|547376|P2|NOT COMPLETED|Overall Study||15
230071|NCT00148733|547377|P1|NOT COMPLETED|Overall Study||14
230072|NCT00148733|547376|P2|COMPLETED|Overall Study||1299
230073|NCT00148733|547377|P1|COMPLETED|Overall Study||1300
230074|NCT00148733|547376|P2|STARTED|Overall Study||1314
230075|NCT00148733|547377|P1|STARTED|Overall Study||1314
230076|NCT00148668|547385|P2|NOT COMPLETED|Overall Study||0
230077|NCT00148668|547386|P1|NOT COMPLETED|Overall Study||0
230078|NCT00148668|547385|P2|COMPLETED|Overall Study||40
230079|NCT00148668|547386|P1|COMPLETED|Overall Study||41
230080|NCT00148668|547385|P2|STARTED|Overall Study||40
230081|NCT00148668|547386|P1|STARTED|Overall Study||41
230082|NCT00148122|547392|P1|NOT COMPLETED|Overall Study||2
230083|NCT00148122|547392|P1|COMPLETED|Overall Study||38
230084|NCT00148122|547392|P1|STARTED|Overall Study||40
230085|NCT00148109|547400|P2|NOT COMPLETED|Overall Study||20
230086|NCT00148109|547401|P1|NOT COMPLETED|Overall Study||12
230087|NCT00148109|547400|P2|COMPLETED|Overall Study||1
230088|NCT00148109|547401|P1|COMPLETED|Overall Study||3
230089|NCT00148109|547400|P2|STARTED|Overall Study||21
230090|NCT00148109|547401|P1|STARTED|Overall Study||15
230091|NCT00147966|547411|P1|NOT COMPLETED|Overall Study||0
230092|NCT00147966|547411|P1|COMPLETED|Overall Study||24
230093|NCT00147966|547411|P1|STARTED|Overall Study||24
230094|NCT00147823|547417|P2|NOT COMPLETED|Overall Study||15
230095|NCT00147823|547418|P1|NOT COMPLETED|Overall Study||13
230096|NCT00147823|547417|P2|COMPLETED|Overall Study||16
230097|NCT00147823|547418|P1|COMPLETED|Overall Study||19
230098|NCT00147823|547417|P2|Month 24 Visit|Overall Study||18
230099|NCT00147823|547418|P1|Month 24 Visit|Overall Study||21
230100|NCT00147823|547417|P2|Month 18 Visit|Overall Study||20
230101|NCT00147823|547418|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
230102|NCT00147823|547417|P2|Month 12 CT Scan|Overall Study||25
230103|NCT00147823|547418|P1|Month 12 CT Scan|Overall Study||20
230104|NCT00147823|547417|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
230105|NCT00147823|547418|P1|Month 12 Visit|Overall Study||21
230106|NCT00147823|547417|P2|Month 6 Visit|Overall Study||21
230107|NCT00147823|547418|P1|Month 6 Visit|Overall Study||25
230108|NCT00147823|547417|P2|Month 3 Visit|Overall Study||24
230109|NCT00147823|547418|P1|Month 3 Visit|Overall Study||25
230110|NCT00147823|547417|P2|Week 6 Visit|Overall Study||28
230111|NCT00147823|547418|P1|Week 6 Visit|Overall Study||26
230112|NCT00147823|547417|P2|STARTED|Overall Study||31
230113|NCT00147823|547418|P1|STARTED|Overall Study||32
230114|NCT00147745|547449|P3|NOT COMPLETED|Overall Study||0
230115|NCT00147745|547450|P2|NOT COMPLETED|Overall Study||0
230116|NCT00147745|547451|P1|NOT COMPLETED|Overall Study||1
230117|NCT00147745|547449|P3|COMPLETED|Overall Study||6
230118|NCT00147745|547450|P2|COMPLETED|Overall Study||14
230119|NCT00147745|547451|P1|COMPLETED|Overall Study||15
230120|NCT00147745|547449|P3|STARTED|Overall Study||6
230121|NCT00147745|547450|P2|STARTED|Overall Study||14
230122|NCT00147745|547451|P1|STARTED|Overall Study||16
230123|NCT00147537|547473|P11|NOT COMPLETED|Phase 2||52
230124|NCT00147537|547474|P10|NOT COMPLETED|Phase 2||161
230125|NCT00147537|547475|P9|NOT COMPLETED|Phase 2||0
230126|NCT00147537|547476|P8|NOT COMPLETED|Phase 2||0
230127|NCT00147537|547477|P7|NOT COMPLETED|Phase 2||0
230128|NCT00147537|547478|P6|NOT COMPLETED|Phase 2||0
230129|NCT00147537|547479|P5|NOT COMPLETED|Phase 2||0
230130|NCT00147537|547480|P4|NOT COMPLETED|Phase 2||0
230131|NCT00147537|547481|P3|NOT COMPLETED|Phase 2||0
230132|NCT00147537|547482|P2|NOT COMPLETED|Phase 2||0
230133|NCT00147537|547483|P1|NOT COMPLETED|Phase 2||0
230134|NCT00147537|547473|P11|COMPLETED|Phase 2||3
230135|NCT00147537|547474|P10|COMPLETED|Phase 2||5
230136|NCT00147537|547475|P9|COMPLETED|Phase 2||0
230137|NCT00147537|547476|P8|COMPLETED|Phase 2||0
230138|NCT00147537|547477|P7|COMPLETED|Phase 2||0
230139|NCT00147537|547478|P6|COMPLETED|Phase 2||0
230140|NCT00147537|547479|P5|COMPLETED|Phase 2||0
230141|NCT00147537|547480|P4|COMPLETED|Phase 2||0
230142|NCT00147537|547481|P3|COMPLETED|Phase 2||0
230143|NCT00147537|547482|P2|COMPLETED|Phase 2||0
230144|NCT00147537|547483|P1|COMPLETED|Phase 2||0
230145|NCT00147537|547473|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
230146|NCT00147537|547474|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
230147|NCT00147537|547475|P9|STARTED|Phase 2||0
230148|NCT00147537|547476|P8|STARTED|Phase 2||0
230149|NCT00147537|547477|P7|STARTED|Phase 2||0
230150|NCT00147537|547478|P6|STARTED|Phase 2||0
230151|NCT00147537|547479|P5|STARTED|Phase 2||0
230152|NCT00147537|547480|P4|STARTED|Phase 2||0
230153|NCT00147537|547481|P3|STARTED|Phase 2||0
230154|NCT00147537|547482|P2|STARTED|Phase 2||0
230155|NCT00147537|547483|P1|STARTED|Phase 2||0
230156|NCT00147537|547473|P11|NOT COMPLETED|Phase 1b||0
230157|NCT00147537|547474|P10|NOT COMPLETED|Phase 1b||0
230158|NCT00147537|547475|P9|NOT COMPLETED|Phase 1b||17
230159|NCT00147537|547476|P8|NOT COMPLETED|Phase 1b||7
230160|NCT00147537|547477|P7|NOT COMPLETED|Phase 1b||18
230161|NCT00147537|547478|P6|NOT COMPLETED|Phase 1b||3
230162|NCT00147537|547479|P5|NOT COMPLETED|Phase 1b||3
230163|NCT00147537|547480|P4|NOT COMPLETED|Phase 1b||2
230164|NCT00147537|547481|P3|NOT COMPLETED|Phase 1b||4
230165|NCT00147537|547482|P2|NOT COMPLETED|Phase 1b||2
230166|NCT00147537|547483|P1|NOT COMPLETED|Phase 1b||2
230167|NCT00147537|547473|P11|COMPLETED|Phase 1b||0
230168|NCT00147537|547474|P10|COMPLETED|Phase 1b||0
230169|NCT00147537|547475|P9|COMPLETED|Phase 1b||1
230170|NCT00147537|547476|P8|COMPLETED|Phase 1b||0
230171|NCT00147537|547477|P7|COMPLETED|Phase 1b||0
230172|NCT00147537|547478|P6|COMPLETED|Phase 1b||0
230173|NCT00147537|547479|P5|COMPLETED|Phase 1b||0
230174|NCT00147537|547480|P4|COMPLETED|Phase 1b||1
230175|NCT00147537|547481|P3|COMPLETED|Phase 1b||0
230176|NCT00147537|547482|P2|COMPLETED|Phase 1b||0
230177|NCT00147537|547483|P1|COMPLETED|Phase 1b||1
230178|NCT00147537|547473|P11|STARTED|Phase 1b||0
230179|NCT00147537|547474|P10|STARTED|Phase 1b||0
230180|NCT00147537|547475|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
230181|NCT00147537|547476|P8|STARTED|Phase 1b||7
230182|NCT00147537|547477|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
230183|NCT00147537|547478|P6|STARTED|Phase 1b||3
230184|NCT00147537|547479|P5|STARTED|Phase 1b||3
230185|NCT00147537|547480|P4|STARTED|Phase 1b||3
230186|NCT00147537|547481|P3|STARTED|Phase 1b||4
230187|NCT00147537|547482|P2|STARTED|Phase 1b||2
230188|NCT00147537|547483|P1|STARTED|Phase 1b||3
230189|NCT00146328|547665|P3|NOT COMPLETED|Overall Study||291
230190|NCT00146328|547666|P2|NOT COMPLETED|Overall Study||154
230191|NCT00146328|547667|P1|NOT COMPLETED|Overall Study||141
230192|NCT00146328|547665|P3|COMPLETED|Overall Study||158
230193|NCT00146328|547666|P2|COMPLETED|Overall Study||101
230194|NCT00146328|547667|P1|COMPLETED|Overall Study||150
230195|NCT00146328|547665|P3|STARTED|Overall Study||449
230196|NCT00146328|547666|P2|STARTED|Overall Study||255
230197|NCT00146328|547667|P1|STARTED|Overall Study||291
230198|NCT00147498|547754|P4|NOT COMPLETED|Overall Study||17
230199|NCT00147498|547755|P3|NOT COMPLETED|Overall Study||17
230200|NCT00147498|547756|P2|NOT COMPLETED|Overall Study||9
230201|NCT00147498|547757|P1|NOT COMPLETED|Overall Study||3
230202|NCT00147498|547754|P4|COMPLETED|Overall Study||48
230203|NCT00147498|547755|P3|COMPLETED|Overall Study||52
230204|NCT00147498|547756|P2|COMPLETED|Overall Study||60
230205|NCT00147498|547757|P1|COMPLETED|Overall Study||58
230206|NCT00147498|547754|P4|STARTED|Overall Study||65
230207|NCT00147498|547755|P3|STARTED|Overall Study||69
230208|NCT00147498|547756|P2|STARTED|Overall Study||69
230209|NCT00147498|547757|P1|STARTED|Overall Study||61
230210|NCT00147446|547853|P2|NOT COMPLETED|Overall Study||0
230211|NCT00147446|547854|P1|NOT COMPLETED|Overall Study||0
230212|NCT00147446|547853|P2|COMPLETED|Overall Study||61
230213|NCT00147446|547854|P1|COMPLETED|Overall Study||60
230214|NCT00147446|547853|P2|STARTED|Overall Study||61
230215|NCT00147446|547854|P1|STARTED|Overall Study||60
230216|NCT00147316|547862|P1|NOT COMPLETED|Overall Study||0
230217|NCT00147316|547862|P1|COMPLETED|Overall Study||103
230218|NCT00147316|547862|P1|STARTED|Overall Study||103
230219|NCT00147290|547869|P2|NOT COMPLETED|Overall Study||0
230220|NCT00147290|547870|P1|NOT COMPLETED|Overall Study||0
230221|NCT00147290|547869|P2|COMPLETED|Overall Study||260
230222|NCT00147290|547870|P1|COMPLETED|Overall Study||266
230223|NCT00147290|547869|P2|STARTED|Overall Study||260
230224|NCT00147290|547870|P1|STARTED|Overall Study||266
230225|NCT00147277|547876|P2|NOT COMPLETED|Overall Study||0
230226|NCT00147277|547877|P1|NOT COMPLETED|Overall Study||0
230227|NCT00147277|547876|P2|COMPLETED|Overall Study||450
230228|NCT00147277|547877|P1|COMPLETED|Overall Study||475
230229|NCT00147277|547876|P2|STARTED|Overall Study||450
230230|NCT00147277|547877|P1|STARTED|Overall Study||475
230231|NCT00147238|547881|P1|NOT COMPLETED|Overall Study||8
230232|NCT00147238|547881|P1|COMPLETED|Overall Study||2
230233|NCT00147238|547881|P1|STARTED|Overall Study||10
230234|NCT00147225|547891|P6|NOT COMPLETED|Overall Study||2
230235|NCT00147225|547892|P5|NOT COMPLETED|Overall Study||1
230236|NCT00147225|547893|P4|NOT COMPLETED|Overall Study||1
230237|NCT00147225|547894|P3|NOT COMPLETED|Overall Study||2
230238|NCT00147225|547895|P2|NOT COMPLETED|Overall Study||0
230239|NCT00147225|547896|P1|NOT COMPLETED|Overall Study||1
230240|NCT00147225|547891|P6|COMPLETED|Overall Study||10
230241|NCT00147225|547892|P5|COMPLETED|Overall Study||10
230242|NCT00147225|547893|P4|COMPLETED|Overall Study||10
230243|NCT00147225|547894|P3|COMPLETED|Overall Study||6
230244|NCT00147225|547895|P2|COMPLETED|Overall Study||6
230245|NCT00147225|547896|P1|COMPLETED|Overall Study||6
230246|NCT00147225|547891|P6|STARTED|Overall Study||12
230247|NCT00147225|547892|P5|STARTED|Overall Study||11
230248|NCT00147225|547893|P4|STARTED|Overall Study||11
230249|NCT00147225|547894|P3|STARTED|Overall Study||8
230250|NCT00147225|547895|P2|STARTED|Overall Study||6
230251|NCT00147225|547896|P1|STARTED|Overall Study||7
230252|NCT00147212|547916|P1|NOT COMPLETED|Overall Study||0
230253|NCT00147212|547916|P1|COMPLETED|Overall Study||50
230254|NCT00147212|547916|P1|STARTED|Overall Study||50
230255|NCT00147199|547922|P2|NOT COMPLETED|Overall Study||10
230256|NCT00147199|547923|P1|NOT COMPLETED|Overall Study||13
230257|NCT00147199|547922|P2|COMPLETED|Overall Study||110
230258|NCT00147199|547923|P1|COMPLETED|Overall Study||102
230259|NCT00147199|547922|P2|STARTED|Overall Study||120
230260|NCT00147199|547923|P1|STARTED|Overall Study||115
230261|NCT00147030|547947|P2|NOT COMPLETED|Overall Study||0
230262|NCT00147030|547948|P1|NOT COMPLETED|Overall Study||0
230263|NCT00147030|547947|P2|COMPLETED|Overall Study||162
230264|NCT00147030|547948|P1|COMPLETED|Overall Study||163
230265|NCT00147030|547947|P2|STARTED|Overall Study||162
230266|NCT00147030|547948|P1|STARTED|Overall Study||163
230267|NCT00146848|547999|P3|NOT COMPLETED|Post-randomization||39
230268|NCT00146848|548000|P2|NOT COMPLETED|Post-randomization||47
230269|NCT00146848|548001|P1|NOT COMPLETED|Post-randomization||38
230270|NCT00146848|547999|P3|COMPLETED|Post-randomization||431
230271|NCT00146848|548000|P2|COMPLETED|Post-randomization||441
230272|NCT00146848|548001|P1|COMPLETED|Post-randomization||437
230273|NCT00146848|547999|P3|STARTED|Post-randomization||470
230274|NCT00146848|548000|P2|STARTED|Post-randomization||488
230275|NCT00146848|548001|P1|STARTED|Post-randomization||475
230276|NCT00146848|547999|P3|NOT COMPLETED|Pre-randomization||0
230277|NCT00146848|548000|P2|NOT COMPLETED|Pre-randomization||0
230278|NCT00146848|548001|P1|NOT COMPLETED|Pre-randomization||309
230279|NCT00146848|547999|P3|COMPLETED|Pre-randomization||0
230280|NCT00146848|548000|P2|COMPLETED|Pre-randomization||0
230281|NCT00146848|548001|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
230282|NCT00146848|547999|P3|STARTED|Pre-randomization||0
230283|NCT00146848|548000|P2|STARTED|Pre-randomization||0
230284|NCT00146848|548001|P1|STARTED|Pre-randomization|Registered|1742
230285|NCT00146770|548017|P2|NOT COMPLETED|Overall Study||0
230286|NCT00146770|548018|P1|NOT COMPLETED|Overall Study||5
230287|NCT00146770|548017|P2|COMPLETED|Overall Study||22
230288|NCT00146770|548018|P1|COMPLETED|Overall Study||18
230289|NCT00146770|548017|P2|STARTED|Overall Study||22
230290|NCT00146770|548018|P1|STARTED|Overall Study||23
230291|NCT00146757|548036|P2|NOT COMPLETED|Overall Study||0
230292|NCT00146757|548037|P1|NOT COMPLETED|Overall Study||2
230293|NCT00146757|548036|P2|COMPLETED|Overall Study||4
230294|NCT00146757|548037|P1|COMPLETED|Overall Study||14
230295|NCT00146757|548036|P2|STARTED|Overall Study||4
230296|NCT00146757|548037|P1|STARTED|Overall Study||16
230297|NCT00145795|548056|P2|NOT COMPLETED|Overall Study||0
230298|NCT00145795|548057|P1|NOT COMPLETED|Overall Study||1
230299|NCT00145795|548056|P2|COMPLETED|Overall Study||10
230387|NCT00144963|548457|P1|NOT COMPLETED|Overall Study||0
230300|NCT00145795|548057|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
230301|NCT00145795|548056|P2|STARTED|Overall Study||10
230302|NCT00145795|548057|P1|STARTED|Overall Study||10
230303|NCT00145704|548083|P2|NOT COMPLETED|Overall Study||3
230304|NCT00145704|548084|P1|NOT COMPLETED|Overall Study||3
230305|NCT00145704|548083|P2|COMPLETED|Overall Study||0
230306|NCT00145704|548084|P1|COMPLETED|Overall Study||0
230307|NCT00145704|548083|P2|STARTED|Overall Study||3
230308|NCT00145704|548084|P1|STARTED|Overall Study||3
230309|NCT00145626|548092|P1|NOT COMPLETED|Overall Study||5
230310|NCT00145626|548092|P1|COMPLETED|Overall Study||14
230311|NCT00145626|548092|P1|STARTED|Overall Study||19
230312|NCT00145600|548124|P4|NOT COMPLETED|Overall Study||16
230313|NCT00145600|548125|P3|NOT COMPLETED|Overall Study||5
230314|NCT00145600|548126|P2|NOT COMPLETED|Overall Study||10
230315|NCT00145600|548127|P1|NOT COMPLETED|Overall Study||8
230316|NCT00145600|548124|P4|COMPLETED|Overall Study||130
230317|NCT00145600|548125|P3|COMPLETED|Overall Study||8
230318|NCT00145600|548126|P2|COMPLETED|Overall Study||36
230319|NCT00145600|548127|P1|COMPLETED|Overall Study||83
230320|NCT00145600|548124|P4|STARTED|Overall Study||146
230321|NCT00145600|548125|P3|STARTED|Overall Study||13
230322|NCT00145600|548126|P2|STARTED|Overall Study||46
230323|NCT00145600|548127|P1|STARTED|Overall Study||91
230324|NCT00145587|548241|P2|NOT COMPLETED|Overall Study||0
230325|NCT00145587|548242|P1|NOT COMPLETED|Overall Study||0
230326|NCT00145587|548241|P2|COMPLETED|Overall Study||1
230327|NCT00145587|548242|P1|COMPLETED|Overall Study||5
230328|NCT00145587|548241|P2|STARTED|Overall Study||1
230329|NCT00145587|548242|P1|STARTED|Overall Study||5
230330|NCT00145574|548251|P3|NOT COMPLETED|Open Label Long-term Extension||11
230331|NCT00145574|548252|P2|NOT COMPLETED|Open Label Long-term Extension||0
230332|NCT00145574|548253|P1|NOT COMPLETED|Open Label Long-term Extension||0
230333|NCT00145574|548251|P3|COMPLETED|Open Label Long-term Extension||173
230334|NCT00145574|548252|P2|COMPLETED|Open Label Long-term Extension||0
230335|NCT00145574|548253|P1|COMPLETED|Open Label Long-term Extension||0
230336|NCT00145574|548251|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
230337|NCT00145574|548252|P2|STARTED|Open Label Long-term Extension||0
230338|NCT00145574|548253|P1|STARTED|Open Label Long-term Extension||0
230339|NCT00145574|548251|P3|NOT COMPLETED|Double Blind||2
230340|NCT00145574|548252|P2|NOT COMPLETED|Double Blind||5
230341|NCT00145574|548253|P1|NOT COMPLETED|Double Blind||1
230342|NCT00145574|548251|P3|COMPLETED|Double Blind||62
230343|NCT00145574|548252|P2|COMPLETED|Double Blind||60
230344|NCT00145574|548253|P1|COMPLETED|Double Blind||64
230345|NCT00145574|548251|P3|STARTED|Double Blind||64
230346|NCT00145574|548252|P2|STARTED|Double Blind||65
230347|NCT00145574|548253|P1|STARTED|Double Blind||65
230348|NCT00145509|548310|P2|NOT COMPLETED|Overall Study||21
230349|NCT00145509|548311|P1|NOT COMPLETED|Overall Study||22
230350|NCT00145509|548310|P2|COMPLETED|Overall Study||15
230351|NCT00145509|548311|P1|COMPLETED|Overall Study||19
230352|NCT00145509|548310|P2|STARTED|Overall Study||36
230353|NCT00145509|548311|P1|STARTED|Overall Study||41
230354|NCT00145496|548325|P2|NOT COMPLETED|Overall Study||81
230355|NCT00145496|548326|P1|NOT COMPLETED|Overall Study||123
230356|NCT00145496|548325|P2|COMPLETED|Overall Study||143
230357|NCT00145496|548326|P1|COMPLETED|Overall Study||121
230358|NCT00145496|548325|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
230359|NCT00145496|548326|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
230360|NCT00145418|548336|P1|NOT COMPLETED|Overall Study||0
230361|NCT00145418|548336|P1|COMPLETED|Overall Study||15
230362|NCT00145418|548336|P1|STARTED|Overall Study||15
230363|NCT00145327|548346|P3|NOT COMPLETED|Overall Study||248
230364|NCT00145327|548347|P2|NOT COMPLETED|Overall Study||124
230365|NCT00145327|548348|P1|NOT COMPLETED|Overall Study||142
230366|NCT00145327|548346|P3|COMPLETED|Overall Study||975
230367|NCT00145327|548347|P2|COMPLETED|Overall Study||493
230368|NCT00145327|548348|P1|COMPLETED|Overall Study||474
230369|NCT00145327|548346|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
230370|NCT00145327|548347|P2|STARTED|Overall Study||617
230371|NCT00145327|548348|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
230372|NCT00145249|548404|P3|NOT COMPLETED|Overall Study||17
230373|NCT00145249|548405|P2|NOT COMPLETED|Overall Study||15
230374|NCT00145249|548406|P1|NOT COMPLETED|Overall Study||11
230375|NCT00145249|548404|P3|COMPLETED|Overall Study||31
230376|NCT00145249|548405|P2|COMPLETED|Overall Study||33
230377|NCT00145249|548406|P1|COMPLETED|Overall Study||36
230378|NCT00145249|548404|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
230379|NCT00145249|548405|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
230380|NCT00145249|548406|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
230381|NCT00145119|548447|P1|NOT COMPLETED|Overall Study||45
230382|NCT00145119|548447|P1|COMPLETED|Overall Study||267
230383|NCT00145119|548447|P1|STARTED|Overall Study||312
230384|NCT00145041|548451|P1|NOT COMPLETED|Overall Study||0
230385|NCT00145041|548451|P1|COMPLETED|Overall Study||7
230386|NCT00145041|548451|P1|STARTED|Overall Study||7
230388|NCT00144963|548457|P1|COMPLETED|Overall Study||36
230389|NCT00144963|548457|P1|STARTED|Overall Study||36
230390|NCT00144781|548465|P4|NOT COMPLETED|Overall Study||0
230391|NCT00144781|548466|P3|NOT COMPLETED|Overall Study||0
230392|NCT00144781|548467|P2|NOT COMPLETED|Overall Study||2
230393|NCT00144781|548468|P1|NOT COMPLETED|Overall Study||0
230394|NCT00144781|548465|P4|COMPLETED|Overall Study||9
230395|NCT00144781|548466|P3|COMPLETED|Overall Study||8
230396|NCT00144781|548467|P2|COMPLETED|Overall Study||7
230397|NCT00144781|548468|P1|COMPLETED|Overall Study||8
230398|NCT00144781|548465|P4|STARTED|Overall Study||9
230399|NCT00144781|548466|P3|STARTED|Overall Study||8
230400|NCT00144781|548467|P2|STARTED|Overall Study||9
230401|NCT00144781|548468|P1|STARTED|Overall Study||8
230402|NCT00144339|548488|P2|NOT COMPLETED|Overall Study||1099
230403|NCT00144339|548489|P1|NOT COMPLETED|Overall Study||1358
230404|NCT00144339|548488|P2|COMPLETED|Overall Study||1887
230405|NCT00144339|548489|P1|COMPLETED|Overall Study||1648
230406|NCT00144339|548488|P2|STARTED|Overall Study||2986
230407|NCT00144339|548489|P1|STARTED|Overall Study||3006
230408|NCT00144300|548697|P2|NOT COMPLETED|Overall Study||28
230409|NCT00144300|548698|P1|NOT COMPLETED|Overall Study||29
230410|NCT00144300|548697|P2|COMPLETED|Overall Study||97
230411|NCT00144300|548698|P1|COMPLETED|Overall Study||92
230412|NCT00144300|548697|P2|STARTED|Overall Study||125
230413|NCT00144300|548698|P1|STARTED|Overall Study||121
230414|NCT00144170|548746|P2|NOT COMPLETED|Overall Study||396
230415|NCT00144170|548747|P1|NOT COMPLETED|Overall Study||352
230416|NCT00144170|548746|P2|COMPLETED|Overall Study||32
230417|NCT00144170|548747|P1|COMPLETED|Overall Study||86
230418|NCT00144170|548746|P2|STARTED|Overall Study||428
230419|NCT00144170|548747|P1|STARTED|Overall Study||438
230420|NCT00144027|548937|P2|NOT COMPLETED|Overall Study||11
230421|NCT00144027|548938|P1|NOT COMPLETED|Overall Study||3
230422|NCT00144027|548937|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
230423|NCT00144027|548938|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
230424|NCT00144027|548937|P2|Completed 6 Month Assessment|Overall Study||24
230425|NCT00144027|548938|P1|Completed 6 Month Assessment|Overall Study||37
230426|NCT00144027|548937|P2|Completed Baseline Assessment|Overall Study||29
230427|NCT00144027|548938|P1|Completed Baseline Assessment|Overall Study||39
230428|NCT00144027|548937|P2|STARTED|Overall Study|participants who consented|36
230429|NCT00144027|548938|P1|STARTED|Overall Study|participants who consented|39
230430|NCT00143845|548944|P1|NOT COMPLETED|Overall Study||0
230431|NCT00143845|548944|P1|COMPLETED|Overall Study||54
230432|NCT00143845|548944|P1|STARTED|Overall Study||54
230433|NCT00142935|548952|P3|NOT COMPLETED|Overall Study||7
230434|NCT00142935|548953|P2|NOT COMPLETED|Overall Study||8
230435|NCT00142935|548954|P1|NOT COMPLETED|Overall Study||3
230436|NCT00142935|548952|P3|COMPLETED|Overall Study||23
230437|NCT00142935|548953|P2|COMPLETED|Overall Study||20
230438|NCT00142935|548954|P1|COMPLETED|Overall Study||26
230439|NCT00142935|548952|P3|STARTED|Overall Study||30
230440|NCT00142935|548953|P2|STARTED|Overall Study||28
230441|NCT00142935|548954|P1|STARTED|Overall Study||29
230442|NCT00142909|548979|P2|NOT COMPLETED|Medications Begin||3
230443|NCT00142909|548980|P1|NOT COMPLETED|Medications Begin||9
230444|NCT00142909|548979|P2|COMPLETED|Medications Begin||31
230445|NCT00142909|548980|P1|COMPLETED|Medications Begin||26
230446|NCT00142909|548979|P2|STARTED|Medications Begin||34
230447|NCT00142909|548980|P1|STARTED|Medications Begin||35
230448|NCT00142909|548979|P2|NOT COMPLETED|Randomization||10
230449|NCT00142909|548980|P1|NOT COMPLETED|Randomization||7
230450|NCT00142909|548979|P2|COMPLETED|Randomization||34
230451|NCT00142909|548980|P1|COMPLETED|Randomization||35
230452|NCT00142909|548979|P2|STARTED|Randomization||44
230453|NCT00142909|548980|P1|STARTED|Randomization||42
230454|NCT00143598|548998|P2|NOT COMPLETED|Overall Study||94
230455|NCT00143598|548999|P1|NOT COMPLETED|Overall Study||92
230456|NCT00143598|548998|P2|COMPLETED|Overall Study||302
230457|NCT00143598|548999|P1|COMPLETED|Overall Study||318
230458|NCT00143598|548998|P2|STARTED|Overall Study||396
230459|NCT00143598|548999|P1|STARTED|Overall Study||410
230460|NCT00143507|549013|P2|NOT COMPLETED|Overall Study||652
230461|NCT00143507|549014|P1|NOT COMPLETED|Overall Study||687
230462|NCT00143507|549013|P2|COMPLETED|Overall Study||4786
230463|NCT00143507|549014|P1|COMPLETED|Overall Study||4792
230464|NCT00143507|549013|P2|STARTED|Overall Study||5438
230465|NCT00143507|549014|P1|STARTED|Overall Study||5479
230466|NCT00143455|549048|P4|NOT COMPLETED|Cohort 2||93
230467|NCT00143455|549049|P3|NOT COMPLETED|Cohort 2||106
230468|NCT00143455|549050|P2|NOT COMPLETED|Cohort 2||0
230469|NCT00143455|549051|P1|NOT COMPLETED|Cohort 2||0
230470|NCT00143455|549048|P4|COMPLETED|Cohort 2||111
230471|NCT00143455|549049|P3|COMPLETED|Cohort 2||97
230472|NCT00143455|549050|P2|COMPLETED|Cohort 2||0
230473|NCT00143455|549051|P1|COMPLETED|Cohort 2||0
230474|NCT00143455|549048|P4|Received Treatment|Cohort 2||203
230475|NCT00143455|549049|P3|Received Treatment|Cohort 2||202
230476|NCT00143455|549050|P2|Received Treatment|Cohort 2||0
230477|NCT00143455|549051|P1|Received Treatment|Cohort 2||0
230478|NCT00143455|549048|P4|STARTED|Cohort 2||204
230479|NCT00143455|549049|P3|STARTED|Cohort 2||203
230480|NCT00143455|549050|P2|STARTED|Cohort 2||0
230481|NCT00143455|549051|P1|STARTED|Cohort 2||0
230482|NCT00143455|549048|P4|NOT COMPLETED|Cohort 1||0
230483|NCT00143455|549049|P3|NOT COMPLETED|Cohort 1||0
230484|NCT00143455|549050|P2|NOT COMPLETED|Cohort 1||17
230485|NCT00143455|549051|P1|NOT COMPLETED|Cohort 1||14
230486|NCT00143455|549048|P4|COMPLETED|Cohort 1||0
230487|NCT00143455|549049|P3|COMPLETED|Cohort 1||0
230488|NCT00143455|549050|P2|COMPLETED|Cohort 1||22
230489|NCT00143455|549051|P1|COMPLETED|Cohort 1||25
230490|NCT00143455|549048|P4|Received Treatment|Cohort 1||0
230491|NCT00143455|549049|P3|Received Treatment|Cohort 1||0
230492|NCT00143455|549050|P2|Received Treatment|Cohort 1||38
230493|NCT00143455|549051|P1|Received Treatment|Cohort 1||39
230494|NCT00143455|549048|P4|STARTED|Cohort 1||0
230495|NCT00143455|549049|P3|STARTED|Cohort 1||0
230496|NCT00143455|549050|P2|STARTED|Cohort 1||39
230497|NCT00143455|549051|P1|STARTED|Cohort 1||39
230498|NCT00143403|549085|P2|NOT COMPLETED|Overall Study||46
230499|NCT00143403|549086|P1|NOT COMPLETED|Overall Study||35
230500|NCT00143403|549085|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
230501|NCT00143403|549086|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
230502|NCT00143403|549085|P2|Treated|Overall Study||153
230503|NCT00143403|549086|P1|Treated|Overall Study||153
230504|NCT00143403|549085|P2|STARTED|Overall Study||161
230505|NCT00143403|549086|P1|STARTED|Overall Study||160
230506|NCT00143390|549096|P2|NOT COMPLETED|Overall Study||149
230507|NCT00143390|549097|P1|NOT COMPLETED|Overall Study||149
230508|NCT00143390|549096|P2|COMPLETED|Overall Study||0
230509|NCT00143390|549097|P1|COMPLETED|Overall Study||0
230510|NCT00143390|549096|P2|STARTED|Overall Study||149
230511|NCT00143390|549097|P1|STARTED|Overall Study||149
230512|NCT00143312|549113|P1|NOT COMPLETED|Overall Study||16
230513|NCT00143312|549113|P1|COMPLETED|Overall Study||29
230514|NCT00143312|549113|P1|STARTED|Overall Study||45
230515|NCT00143247|549123|P1|NOT COMPLETED|Overall Study||156
230516|NCT00143247|549123|P1|COMPLETED|Overall Study||17
230517|NCT00143247|549123|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
230518|NCT00142818|549141|P4|NOT COMPLETED|Overall Study||22
230519|NCT00142818|549142|P3|NOT COMPLETED|Overall Study||13
230520|NCT00142818|549143|P2|NOT COMPLETED|Overall Study||21
230521|NCT00142818|549144|P1|NOT COMPLETED|Overall Study||17
230522|NCT00142818|549141|P4|COMPLETED|Overall Study||20
230523|NCT00142818|549142|P3|COMPLETED|Overall Study||24
230524|NCT00142818|549143|P2|COMPLETED|Overall Study||19
230525|NCT00142818|549144|P1|COMPLETED|Overall Study||28
230526|NCT00142818|549141|P4|STARTED|Overall Study||42
230527|NCT00142818|549142|P3|STARTED|Overall Study||37
230528|NCT00142818|549143|P2|STARTED|Overall Study||40
230529|NCT00142818|549144|P1|STARTED|Overall Study||45
230530|NCT00142597|549156|P2|NOT COMPLETED|Overall Study||1
230531|NCT00142597|549157|P1|NOT COMPLETED|Overall Study||3
230532|NCT00142597|549156|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
230533|NCT00142597|549157|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
230534|NCT00142597|549156|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
230535|NCT00142597|549157|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
230536|NCT00142298|549173|P10|NOT COMPLETED|Overall Study||0
230537|NCT00142298|549174|P9|NOT COMPLETED|Overall Study||5
230538|NCT00142298|549175|P8|NOT COMPLETED|Overall Study||8
230539|NCT00142298|549176|P7|NOT COMPLETED|Overall Study||8
230540|NCT00142298|549177|P6|NOT COMPLETED|Overall Study||16
230541|NCT00142298|549178|P5|NOT COMPLETED|Overall Study||10
230542|NCT00142298|549179|P4|NOT COMPLETED|Overall Study||85
230543|NCT00142298|549180|P3|NOT COMPLETED|Overall Study||33
230544|NCT00142298|549181|P2|NOT COMPLETED|Overall Study||176
230545|NCT00142298|549182|P1|NOT COMPLETED|Overall Study||160
230546|NCT00142298|549173|P10|COMPLETED|Overall Study||13
230547|NCT00142298|549174|P9|COMPLETED|Overall Study||52
230548|NCT00142298|549175|P8|COMPLETED|Overall Study||58
230549|NCT00142298|549176|P7|COMPLETED|Overall Study||15
230550|NCT00142298|549177|P6|COMPLETED|Overall Study||10
230551|NCT00142298|549178|P5|COMPLETED|Overall Study||46
230552|NCT00142298|549179|P4|COMPLETED|Overall Study||121
230553|NCT00142298|549180|P3|COMPLETED|Overall Study||90
230554|NCT00142298|549181|P2|COMPLETED|Overall Study||456
230555|NCT00142298|549182|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
230556|NCT00142298|549173|P10|Per Protocol Population|Overall Study||13
230557|NCT00142298|549174|P9|Per Protocol Population|Overall Study||56
230558|NCT00142298|549175|P8|Per Protocol Population|Overall Study||64
230559|NCT00142298|549176|P7|Per Protocol Population|Overall Study||19
230560|NCT00142298|549177|P6|Per Protocol Population|Overall Study||25
230561|NCT00142298|549178|P5|Per Protocol Population|Overall Study||50
230562|NCT00142298|549179|P4|Per Protocol Population|Overall Study||202
230563|NCT00142298|549180|P3|Per Protocol Population|Overall Study||120
230564|NCT00142298|549181|P2|Per Protocol Population|Overall Study||606
230565|NCT00142298|549182|P1|Per Protocol Population|Overall Study||635
230566|NCT00142298|549173|P10|Safety Population|Overall Study||13
230567|NCT00142298|549174|P9|Safety Population|Overall Study||57
230568|NCT00142298|549175|P8|Safety Population|Overall Study||66
230569|NCT00142298|549176|P7|Safety Population|Overall Study||23
230570|NCT00142298|549177|P6|Safety Population|Overall Study||26
230571|NCT00142298|549178|P5|Safety Population|Overall Study||50
230572|NCT00142298|549179|P4|Safety Population|Overall Study||206
230573|NCT00142298|549180|P3|Safety Population|Overall Study||122
230574|NCT00142298|549181|P2|Safety Population|Overall Study||626
230575|NCT00142298|549182|P1|Safety Population|Overall Study||655
230576|NCT00142298|549173|P10|STARTED|Overall Study||13
230577|NCT00142298|549174|P9|STARTED|Overall Study||57
230578|NCT00142298|549175|P8|STARTED|Overall Study||66
230579|NCT00142298|549176|P7|STARTED|Overall Study||23
230580|NCT00142298|549177|P6|STARTED|Overall Study||26
230581|NCT00142298|549178|P5|STARTED|Overall Study||56
230582|NCT00142298|549179|P4|STARTED|Overall Study||206
230583|NCT00142298|549180|P3|STARTED|Overall Study||123
230584|NCT00142298|549181|P2|STARTED|Overall Study||632
230585|NCT00142298|549182|P1|STARTED|Overall Study||667
230586|NCT00142168|549204|P1|NOT COMPLETED|Overall Study||0
230587|NCT00142168|549204|P1|COMPLETED|Overall Study||16
230588|NCT00142168|549204|P1|STARTED|Overall Study||16
230589|NCT00142116|549211|P1|NOT COMPLETED|Overall Study||0
230590|NCT00142116|549211|P1|COMPLETED|Overall Study||25
230591|NCT00142116|549211|P1|STARTED|Overall Study||25
230592|NCT00141921|549216|P1|NOT COMPLETED|Overall Study||141
230593|NCT00141921|549216|P1|COMPLETED|Overall Study||41
230594|NCT00141921|549216|P1|Received Treatment|Overall Study||181
230595|NCT00141921|549216|P1|STARTED|Overall Study||182
230596|NCT00141817|549242|P4|NOT COMPLETED|Overall Study||0
230597|NCT00141817|549243|P3|NOT COMPLETED|Overall Study||1
230598|NCT00141817|549244|P2|NOT COMPLETED|Overall Study||0
230599|NCT00141817|549245|P1|NOT COMPLETED|Overall Study||1
230600|NCT00141817|549242|P4|COMPLETED|Overall Study||13
230601|NCT00141817|549243|P3|COMPLETED|Overall Study||10
230602|NCT00141817|549244|P2|COMPLETED|Overall Study||10
230603|NCT00141817|549245|P1|COMPLETED|Overall Study||6
230604|NCT00141817|549242|P4|STARTED|Overall Study||13
230605|NCT00141817|549243|P3|STARTED|Overall Study||11
230606|NCT00141817|549244|P2|STARTED|Overall Study||10
230607|NCT00141817|549245|P1|STARTED|Overall Study||7
230608|NCT00141778|549286|P3|NOT COMPLETED|Started Study Medication||4
230609|NCT00141778|549287|P2|NOT COMPLETED|Started Study Medication||7
230610|NCT00141778|549288|P1|NOT COMPLETED|Started Study Medication||2
230611|NCT00141778|549286|P3|COMPLETED|Started Study Medication||143
230612|NCT00141778|549287|P2|COMPLETED|Started Study Medication||144
230613|NCT00141778|549288|P1|COMPLETED|Started Study Medication||145
230614|NCT00141778|549286|P3|STARTED|Started Study Medication||147
230615|NCT00141778|549287|P2|STARTED|Started Study Medication||151
230616|NCT00141778|549288|P1|STARTED|Started Study Medication||147
230617|NCT00141778|549286|P3|NOT COMPLETED|Randomization Prior to Study Med||6
230618|NCT00141778|549287|P2|NOT COMPLETED|Randomization Prior to Study Med||2
230619|NCT00141778|549288|P1|NOT COMPLETED|Randomization Prior to Study Med||5
230620|NCT00141778|549286|P3|COMPLETED|Randomization Prior to Study Med||147
230621|NCT00141778|549287|P2|COMPLETED|Randomization Prior to Study Med||151
230622|NCT00141778|549288|P1|COMPLETED|Randomization Prior to Study Med||147
230623|NCT00141778|549286|P3|STARTED|Randomization Prior to Study Med||153
230624|NCT00141778|549287|P2|STARTED|Randomization Prior to Study Med||153
230625|NCT00141778|549288|P1|STARTED|Randomization Prior to Study Med||152
230626|NCT00141765|549326|P1|NOT COMPLETED|Overall Study||0
230627|NCT00141765|549326|P1|COMPLETED|Overall Study||25
230628|NCT00141765|549326|P1|STARTED|Overall Study||25
230629|NCT00141739|549330|P1|NOT COMPLETED|Overall Study||0
230630|NCT00141739|549330|P1|COMPLETED|Overall Study||100
230631|NCT00141739|549330|P1|STARTED|Overall Study|Number of evaluable patients|100
230632|NCT00141726|549341|P1|NOT COMPLETED|Overall Study||3
230633|NCT00141726|549341|P1|COMPLETED|Overall Study||31
230634|NCT00141726|549341|P1|STARTED|Overall Study||34
230635|NCT00141518|549349|P3|NOT COMPLETED|Overall Study||6
230636|NCT00141518|549350|P2|NOT COMPLETED|Overall Study||6
230637|NCT00141518|549351|P1|NOT COMPLETED|Overall Study||16
230638|NCT00141518|549349|P3|COMPLETED|Overall Study||12
230639|NCT00141518|549350|P2|COMPLETED|Overall Study||16
230640|NCT00141518|549351|P1|COMPLETED|Overall Study||21
230641|NCT00141518|549349|P3|Full Analysis Sample|Overall Study||18
230642|NCT00141518|549350|P2|Full Analysis Sample|Overall Study||22
230643|NCT00141518|549351|P1|Full Analysis Sample|Overall Study||27
230644|NCT00141518|549349|P3|Safety Sample|Overall Study||18
230645|NCT00141518|549350|P2|Safety Sample|Overall Study||22
230646|NCT00141518|549351|P1|Safety Sample|Overall Study||36
230647|NCT00141518|549349|P3|STARTED|Overall Study||18
230648|NCT00141518|549350|P2|STARTED|Overall Study||22
230649|NCT00141518|549351|P1|STARTED|Overall Study||37
230650|NCT00141453|549540|P2|NOT COMPLETED|Overall Study||5
230651|NCT00141453|549541|P1|NOT COMPLETED|Overall Study||6
230652|NCT00141453|549540|P2|COMPLETED|Overall Study||284
230653|NCT00141453|549541|P1|COMPLETED|Overall Study||282
230654|NCT00141453|549540|P2|STARTED|Overall Study||289
230655|NCT00141453|549541|P1|STARTED|Overall Study||288
230656|NCT00141297|549555|P10|NOT COMPLETED|Overall Study||6
230657|NCT00141297|549556|P9|NOT COMPLETED|Overall Study||20
230658|NCT00141297|549557|P8|NOT COMPLETED|Overall Study||4
230659|NCT00141297|549558|P7|NOT COMPLETED|Overall Study||3
230660|NCT00141297|549559|P6|NOT COMPLETED|Overall Study||3
230661|NCT00141297|549560|P5|NOT COMPLETED|Overall Study||22
230662|NCT00141297|549561|P4|NOT COMPLETED|Overall Study||3
230663|NCT00141297|549562|P3|NOT COMPLETED|Overall Study||7
230664|NCT00141297|549563|P2|NOT COMPLETED|Overall Study||3
230665|NCT00141297|549564|P1|NOT COMPLETED|Overall Study||3
230666|NCT00141297|549555|P10|COMPLETED|Overall Study||0
230667|NCT00141297|549556|P9|COMPLETED|Overall Study||0
230668|NCT00141297|549557|P8|COMPLETED|Overall Study||0
230669|NCT00141297|549558|P7|COMPLETED|Overall Study||0
230670|NCT00141297|549559|P6|COMPLETED|Overall Study||0
230671|NCT00141297|549560|P5|COMPLETED|Overall Study||0
230672|NCT00141297|549561|P4|COMPLETED|Overall Study||0
230673|NCT00141297|549562|P3|COMPLETED|Overall Study||0
230674|NCT00141297|549563|P2|COMPLETED|Overall Study||0
230675|NCT00141297|549564|P1|COMPLETED|Overall Study||0
230676|NCT00141297|549555|P10|STARTED|Overall Study||6
230677|NCT00141297|549556|P9|STARTED|Overall Study||20
230678|NCT00141297|549557|P8|STARTED|Overall Study||4
230679|NCT00141297|549558|P7|STARTED|Overall Study||3
230680|NCT00141297|549559|P6|STARTED|Overall Study||3
230681|NCT00141297|549560|P5|STARTED|Overall Study||22
230682|NCT00141297|549561|P4|STARTED|Overall Study||3
230683|NCT00141297|549562|P3|STARTED|Overall Study||7
230684|NCT00141297|549563|P2|STARTED|Overall Study||3
230685|NCT00141297|549564|P1|STARTED|Overall Study||3
230686|NCT00141271|549842|P3|NOT COMPLETED|Overall Study||57
230687|NCT00141271|549843|P2|NOT COMPLETED|Overall Study||63
230688|NCT00141271|549844|P1|NOT COMPLETED|Overall Study||80
230689|NCT00141271|549842|P3|COMPLETED|Overall Study||111
230690|NCT00141271|549843|P2|COMPLETED|Overall Study||102
230691|NCT00141271|549844|P1|COMPLETED|Overall Study||91
230692|NCT00141271|549842|P3|STARTED|Overall Study||168
230693|NCT00141271|549843|P2|STARTED|Overall Study||165
230694|NCT00141271|549844|P1|STARTED|Overall Study||171
230695|NCT00141219|549965|P2|NOT COMPLETED|Overall Study||16
230696|NCT00141219|549966|P1|NOT COMPLETED|Overall Study||24
230697|NCT00141219|549965|P2|COMPLETED|Overall Study||62
230698|NCT00141219|549966|P1|COMPLETED|Overall Study||138
230699|NCT00141219|549965|P2|STARTED|Overall Study||78
230700|NCT00141219|549966|P1|STARTED|Overall Study||162
230701|NCT00141102|550018|P2|NOT COMPLETED|Overall Study||625
230702|NCT00141102|550019|P1|NOT COMPLETED|Overall Study||508
230703|NCT00141102|550018|P2|COMPLETED|Overall Study||1621
230704|NCT00141102|550019|P1|COMPLETED|Overall Study||1730
230705|NCT00141102|550018|P2|Received Treatment|Overall Study||2237
230706|NCT00141102|550019|P1|Received Treatment|Overall Study||2223
230707|NCT00141102|550018|P2|STARTED|Overall Study||2246
230708|NCT00141102|550019|P1|STARTED|Overall Study||2238
230709|NCT00141037|550059|P2|NOT COMPLETED|Overall Study||18
230710|NCT00141037|550060|P1|NOT COMPLETED|Overall Study||10
230711|NCT00141037|550059|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
230712|NCT00141037|550060|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
230713|NCT00141037|550059|P2|STARTED|Overall Study||70
230714|NCT00141037|550060|P1|STARTED|Overall Study||60
230715|NCT00140842|550070|P2|NOT COMPLETED|Overall Study||0
230716|NCT00140842|550071|P1|NOT COMPLETED|Overall Study||0
230717|NCT00140842|550070|P2|COMPLETED|Overall Study||15
230718|NCT00140842|550071|P1|COMPLETED|Overall Study||15
230719|NCT00140842|550070|P2|STARTED|Overall Study||15
230720|NCT00140842|550071|P1|STARTED|Overall Study||15
230721|NCT00140621|550079|P1|NOT COMPLETED|Overall Study||0
230722|NCT00140621|550079|P1|COMPLETED|Overall Study||6
230723|NCT00140621|550079|P1|STARTED|Overall Study||6
230724|NCT00140556|550089|P1|NOT COMPLETED|Chemoradiotherapy Period||0
230725|NCT00140556|550089|P1|COMPLETED|Chemoradiotherapy Period||28
230726|NCT00140556|550089|P1|STARTED|Chemoradiotherapy Period||28
230727|NCT00140556|550089|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
230728|NCT00140556|550089|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
230729|NCT00140556|550089|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
230730|NCT00140426|550095|P2|NOT COMPLETED|Overall Study||3
230731|NCT00140426|550096|P1|NOT COMPLETED|Overall Study||0
230732|NCT00140426|550095|P2|COMPLETED|Overall Study||16
230733|NCT00140426|550096|P1|COMPLETED|Overall Study||22
230734|NCT00140426|550095|P2|STARTED|Overall Study||19
230735|NCT00140426|550096|P1|STARTED|Overall Study||22
230736|NCT00140413|550129|P2|NOT COMPLETED|Overall Study||0
230737|NCT00140413|550130|P1|NOT COMPLETED|Overall Study||3
230738|NCT00140413|550129|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
230739|NCT00140413|550130|P1|COMPLETED|Overall Study||10
230740|NCT00140413|550129|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
230741|NCT00140413|550130|P1|Received at Least One Dose of GH|Overall Study||13
230742|NCT00140413|550129|P2|STARTED|Overall Study||7
230743|NCT00140413|550130|P1|STARTED|Overall Study||13
230744|NCT00140140|550140|P3|NOT COMPLETED|Overall Study||2
230745|NCT00140140|550141|P2|NOT COMPLETED|Overall Study||2
230746|NCT00140140|550142|P1|NOT COMPLETED|Overall Study||2
230747|NCT00140140|550140|P3|COMPLETED|Overall Study|Progressive disease|4
230748|NCT00140140|550141|P2|COMPLETED|Overall Study|Progressive disease|4
230749|NCT00140140|550142|P1|COMPLETED|Overall Study|Progressive disease|2
230750|NCT00140140|550140|P3|STARTED|Overall Study||6
230751|NCT00140140|550141|P2|STARTED|Overall Study||6
230752|NCT00140140|550142|P1|STARTED|Overall Study||4
230753|NCT00139997|550181|P2|NOT COMPLETED|Overall Study||2
230754|NCT00139997|550182|P1|NOT COMPLETED|Overall Study||1
230755|NCT00139997|550181|P2|COMPLETED|Overall Study||9
230756|NCT00139997|550182|P1|COMPLETED|Overall Study||14
230757|NCT00139997|550181|P2|STARTED|Overall Study||11
230758|NCT00139997|550182|P1|STARTED|Overall Study||15
230759|NCT00139776|550192|P4|NOT COMPLETED|Period III||106
230760|NCT00139776|550193|P3|NOT COMPLETED|Period III||76
230761|NCT00139776|550194|P2|NOT COMPLETED|Period III||0
230762|NCT00139776|550195|P1|NOT COMPLETED|Period III||0
230763|NCT00139776|550192|P4|COMPLETED|Period III||321
230764|NCT00139776|550193|P3|COMPLETED|Period III||355
230765|NCT00139776|550194|P2|COMPLETED|Period III||0
230766|NCT00139776|550195|P1|COMPLETED|Period III||0
230767|NCT00139776|550192|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
230768|NCT00139776|550193|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
230769|NCT00139776|550194|P2|STARTED|Period III||0
230770|NCT00139776|550195|P1|STARTED|Period III||0
230771|NCT00139776|550192|P4|NOT COMPLETED|Period II||0
230772|NCT00139776|550193|P3|NOT COMPLETED|Period II||0
230773|NCT00139776|550194|P2|NOT COMPLETED|Period II||322
230774|NCT00139776|550195|P1|NOT COMPLETED|Period II||0
230775|NCT00139776|550192|P4|COMPLETED|Period II||0
230776|NCT00139776|550193|P3|COMPLETED|Period II||0
230777|NCT00139776|550194|P2|COMPLETED|Period II||875
230778|NCT00139776|550195|P1|COMPLETED|Period II||0
230779|NCT00139776|550192|P4|STARTED|Period II||0
230780|NCT00139776|550193|P3|STARTED|Period II||0
230781|NCT00139776|550194|P2|STARTED|Period II||1197
230782|NCT00139776|550195|P1|STARTED|Period II||0
230783|NCT00139776|550192|P4|NOT COMPLETED|Period I||0
230784|NCT00139776|550193|P3|NOT COMPLETED|Period I||0
230785|NCT00139776|550194|P2|NOT COMPLETED|Period I||0
230786|NCT00139776|550195|P1|NOT COMPLETED|Period I||575
230787|NCT00139776|550192|P4|COMPLETED|Period I||0
230788|NCT00139776|550193|P3|COMPLETED|Period I||0
230789|NCT00139776|550194|P2|COMPLETED|Period I||0
230790|NCT00139776|550195|P1|COMPLETED|Period I||1197
230791|NCT00139776|550192|P4|STARTED|Period I||0
230792|NCT00139776|550193|P3|STARTED|Period I||0
230793|NCT00139776|550194|P2|STARTED|Period I||0
230794|NCT00139776|550195|P1|STARTED|Period I||1772
230795|NCT00139737|550230|P1|NOT COMPLETED|Overall Study||341
230796|NCT00139737|550230|P1|COMPLETED|Overall Study||3
230797|NCT00139737|550230|P1|Received Treatment|Overall Study||331
230798|NCT00139737|550230|P1|STARTED|Overall Study||344
230799|NCT00139659|550236|P2|NOT COMPLETED|Overall Study||18
230800|NCT00139659|550237|P1|NOT COMPLETED|Overall Study||40
230801|NCT00139659|550236|P2|COMPLETED|Overall Study||123
230802|NCT00139659|550237|P1|COMPLETED|Overall Study||106
230803|NCT00139659|550236|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
230804|NCT00139659|550237|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
230805|NCT00139477|550315|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
230806|NCT00139477|550316|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
230807|NCT00139477|550315|P2|COMPLETED|Second Intervention -6Months to 12Months||18
230808|NCT00139477|550316|P1|COMPLETED|Second Intervention -6Months to 12Months||14
230809|NCT00139477|550315|P2|STARTED|Second Intervention -6Months to 12Months||23
230810|NCT00139477|550316|P1|STARTED|Second Intervention -6Months to 12Months||19
230811|NCT00139477|550315|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
230812|NCT00139477|550316|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
230813|NCT00139477|550315|P2|COMPLETED|First Intervention -Baseline to 6Months||23
230814|NCT00139477|550316|P1|COMPLETED|First Intervention -Baseline to 6Months||19
230815|NCT00139477|550315|P2|STARTED|First Intervention -Baseline to 6Months||35
230816|NCT00139477|550316|P1|STARTED|First Intervention -Baseline to 6Months||31
230817|NCT00138671|550338|P2|NOT COMPLETED|Overall Study||16
230818|NCT00138671|550339|P1|NOT COMPLETED|Overall Study||13
230819|NCT00138671|550338|P2|COMPLETED|Overall Study||30
230820|NCT00138671|550339|P1|COMPLETED|Overall Study||46
230821|NCT00138671|550338|P2|STARTED|Overall Study||46
230822|NCT00138671|550339|P1|STARTED|Overall Study||59
230823|NCT00138658|550389|P1|NOT COMPLETED|Overall Study||61
230824|NCT00138658|550389|P1|COMPLETED|Overall Study||20
230825|NCT00138658|550389|P1|STARTED|Overall Study||81
230826|NCT00138645|550401|P2|NOT COMPLETED|Overall Study||7
230827|NCT00138645|550402|P1|NOT COMPLETED|Overall Study||6
230828|NCT00138645|550401|P2|COMPLETED|Overall Study||23
230829|NCT00138645|550402|P1|COMPLETED|Overall Study||24
230830|NCT00138645|550401|P2|STARTED|Overall Study||30
230831|NCT00138645|550402|P1|STARTED|Overall Study||30
230832|NCT00138424|550412|P4|NOT COMPLETED|Overall Study||0
230833|NCT00138424|550413|P3|NOT COMPLETED|Overall Study||0
230834|NCT00138424|550414|P2|NOT COMPLETED|Overall Study||1
230835|NCT00138424|550415|P1|NOT COMPLETED|Overall Study||0
230836|NCT00138424|550412|P4|COMPLETED|Overall Study||3
230837|NCT00138424|550413|P3|COMPLETED|Overall Study||5
230838|NCT00138424|550414|P2|COMPLETED|Overall Study||4
230839|NCT00138424|550415|P1|COMPLETED|Overall Study||9
230840|NCT00138424|550412|P4|STARTED|Overall Study||3
230841|NCT00138424|550413|P3|STARTED|Overall Study||5
230842|NCT00138424|550414|P2|STARTED|Overall Study||5
230843|NCT00138424|550415|P1|STARTED|Overall Study||9
230844|NCT00138203|550481|P1|NOT COMPLETED|Overall Study||0
230845|NCT00138203|550481|P1|COMPLETED|Overall Study||16
230846|NCT00138203|550481|P1|STARTED|Overall Study||16
230847|NCT00138151|550487|P1|NOT COMPLETED|Overall Study||4
230848|NCT00138151|550487|P1|COMPLETED|Overall Study||29
230849|NCT00138151|550487|P1|STARTED|Overall Study||33
230850|NCT00138125|550493|P1|NOT COMPLETED|Overall Study||0
230851|NCT00138125|550493|P1|COMPLETED|Overall Study||2
230852|NCT00138125|550493|P1|STARTED|Overall Study||2
230853|NCT00138073|550497|P1|NOT COMPLETED|Overall Study||55
230854|NCT00138073|550497|P1|COMPLETED|Overall Study||0
230855|NCT00138073|550497|P1|Pre-intervention Testing|Overall Study||55
230856|NCT00138073|550497|P1|STARTED|Overall Study||55
230857|NCT00138034|550504|P2|NOT COMPLETED|Overall Study||3
230858|NCT00138034|550505|P1|NOT COMPLETED|Overall Study||3
230859|NCT00138034|550504|P2|COMPLETED|Overall Study||20
230860|NCT00138034|550505|P1|COMPLETED|Overall Study||23
230861|NCT00138034|550504|P2|STARTED|Overall Study||23
230862|NCT00138034|550505|P1|STARTED|Overall Study||26
230863|NCT00137969|550515|P2|NOT COMPLETED|Overall Study||21
230864|NCT00137969|550516|P1|NOT COMPLETED|Overall Study||67
230865|NCT00137969|550515|P2|COMPLETED|Overall Study||67
230866|NCT00137969|550516|P1|COMPLETED|Overall Study||107
230867|NCT00137969|550515|P2|Received Study Drug|Overall Study||88
230868|NCT00137969|550516|P1|Received Study Drug|Overall Study||169
230869|NCT00137969|550515|P2|STARTED|Overall Study||88
230870|NCT00137969|550516|P1|STARTED|Overall Study||174
230871|NCT00137631|550538|P2|NOT COMPLETED|Overall Study||41
230872|NCT00137631|550539|P1|NOT COMPLETED|Overall Study||37
230873|NCT00137631|550538|P2|COMPLETED|Overall Study||133
230874|NCT00137631|550539|P1|COMPLETED|Overall Study||127
230875|NCT00137631|550538|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
230876|NCT00137631|550539|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
230877|NCT00137631|550538|P2|Complete 3-month Follow-up|Overall Study||125
230878|NCT00137631|550539|P1|Complete 3-month Follow-up|Overall Study||120
230879|NCT00137631|550538|P2|STARTED|Overall Study||174
230880|NCT00137631|550539|P1|STARTED|Overall Study||164
230881|NCT00137449|550555|P2|NOT COMPLETED|Overall Study||18
230882|NCT00137449|550556|P1|NOT COMPLETED|Overall Study||16
230883|NCT00137449|550555|P2|COMPLETED|Overall Study||12
230884|NCT00137449|550556|P1|COMPLETED|Overall Study||14
230885|NCT00137449|550555|P2|STARTED|Overall Study||30
230886|NCT00137449|550556|P1|STARTED|Overall Study||30
230887|NCT00137436|550593|P1|NOT COMPLETED|Overall Study||43
230888|NCT00137436|550593|P1|COMPLETED|Overall Study||12
230889|NCT00137436|550593|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
230890|NCT00137423|550612|P2|NOT COMPLETED|Overall Study||44
230891|NCT00137423|550613|P1|NOT COMPLETED|Overall Study||39
230892|NCT00137423|550612|P2|COMPLETED|Overall Study||9
230893|NCT00137423|550613|P1|COMPLETED|Overall Study||15
230894|NCT00137423|550612|P2|STARTED|Overall Study||53
230895|NCT00137423|550613|P1|STARTED|Overall Study||54
230896|NCT00137280|550635|P2|NOT COMPLETED|Overall Study||55
230897|NCT00137280|550636|P1|NOT COMPLETED|Overall Study||84
230898|NCT00137280|550635|P2|COMPLETED|Overall Study||357
230899|NCT00137280|550636|P1|COMPLETED|Overall Study||305
230900|NCT00137280|550635|P2|STARTED|Overall Study||412
230901|NCT00137280|550636|P1|STARTED|Overall Study||389
230902|NCT00137267|550650|P2|NOT COMPLETED|Overall Study||21
230903|NCT00137267|550651|P1|NOT COMPLETED|Overall Study||15
230904|NCT00137267|550650|P2|COMPLETED|Overall Study||26
230905|NCT00137267|550651|P1|COMPLETED|Overall Study||40
230906|NCT00137267|550650|P2|STARTED|Overall Study||47
230907|NCT00137267|550651|P1|STARTED|Overall Study||55
230908|NCT00137111|550663|P4|NOT COMPLETED|Total Therapy||0
230909|NCT00137111|550664|P3|NOT COMPLETED|Total Therapy||0
230910|NCT00137111|550665|P2|NOT COMPLETED|Total Therapy||0
230911|NCT00137111|550666|P1|NOT COMPLETED|Total Therapy||40
230912|NCT00137111|550663|P4|COMPLETED|Total Therapy||0
230913|NCT00137111|550664|P3|COMPLETED|Total Therapy||0
230914|NCT00137111|550665|P2|COMPLETED|Total Therapy||0
230915|NCT00137111|550666|P1|COMPLETED|Total Therapy||458
230916|NCT00137111|550663|P4|STARTED|Total Therapy||0
230917|NCT00137111|550664|P3|STARTED|Total Therapy||0
230918|NCT00137111|550665|P2|STARTED|Total Therapy||0
230919|NCT00137111|550666|P1|STARTED|Total Therapy||498
230920|NCT00137111|550663|P4|NOT COMPLETED|Window Therapy||0
230921|NCT00137111|550664|P3|NOT COMPLETED|Window Therapy||0
230922|NCT00137111|550665|P2|NOT COMPLETED|Window Therapy||0
230923|NCT00137111|550666|P1|NOT COMPLETED|Window Therapy||0
230924|NCT00137111|550663|P4|COMPLETED|Window Therapy||142
230925|NCT00137111|550664|P3|COMPLETED|Window Therapy||180
230926|NCT00137111|550665|P2|COMPLETED|Window Therapy||176
230927|NCT00137111|550666|P1|COMPLETED|Window Therapy||0
230928|NCT00137111|550663|P4|STARTED|Window Therapy||142
230929|NCT00137111|550664|P3|STARTED|Window Therapy||180
230930|NCT00137111|550665|P2|STARTED|Window Therapy||176
230931|NCT00137111|550666|P1|STARTED|Window Therapy||0
230932|NCT00137046|550680|P2|NOT COMPLETED|Overall Study||93
230933|NCT00137046|550681|P1|NOT COMPLETED|Overall Study||99
230934|NCT00137046|550680|P2|COMPLETED|Overall Study||198
230935|NCT00137046|550681|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
230936|NCT00137046|550680|P2|Received Study Treatment|Overall Study||290
230937|NCT00137046|550681|P1|Received Study Treatment|Overall Study||290
230938|NCT00137046|550680|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
230939|NCT00137046|550681|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
230940|NCT00136955|550729|P1|NOT COMPLETED|Overall Study||23
230941|NCT00136955|550729|P1|COMPLETED|Overall Study||18
230942|NCT00136955|550729|P1|STARTED|Overall Study||41
230943|NCT00136916|550738|P2|NOT COMPLETED|Overall Study||104
230944|NCT00136916|550739|P1|NOT COMPLETED|Overall Study||125
230945|NCT00136916|550738|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
230946|NCT00136916|550739|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
230947|NCT00136916|550738|P2|Received Treatment|Overall Study||311
230948|NCT00136916|550739|P1|Received Treatment|Overall Study||316
230949|NCT00136916|550738|P2|STARTED|Overall Study||316
230950|NCT00136916|550739|P1|STARTED|Overall Study||319
230951|NCT00136838|550793|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
230952|NCT00136838|550794|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
230953|NCT00136838|550793|P2|COMPLETED|Second Intervention ( 5 Days)||6
230954|NCT00136838|550794|P1|COMPLETED|Second Intervention ( 5 Days)||6
230955|NCT00136838|550793|P2|STARTED|Second Intervention ( 5 Days)||6
230956|NCT00136838|550794|P1|STARTED|Second Intervention ( 5 Days)||6
230957|NCT00136838|550793|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
230958|NCT00136838|550794|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
230959|NCT00136838|550793|P2|COMPLETED|First Intervention ( 5 Days)||6
230960|NCT00136838|550794|P1|COMPLETED|First Intervention ( 5 Days)||6
230961|NCT00136838|550793|P2|STARTED|First Intervention ( 5 Days)||6
230962|NCT00136838|550794|P1|STARTED|First Intervention ( 5 Days)||6
230963|NCT00136812|550804|P2|NOT COMPLETED|Overall Study||0
230964|NCT00136812|550805|P1|NOT COMPLETED|Overall Study||0
230965|NCT00136812|550804|P2|COMPLETED|Overall Study||113
230966|NCT00136812|550805|P1|COMPLETED|Overall Study||111
230967|NCT00136812|550804|P2|STARTED|Overall Study||113
230968|NCT00136812|550805|P1|STARTED|Overall Study||111
230969|NCT00136760|550815|P4|NOT COMPLETED|Overall Study||0
230970|NCT00136760|550816|P3|NOT COMPLETED|Overall Study||0
230971|NCT00136760|550817|P2|NOT COMPLETED|Overall Study||0
230972|NCT00136760|550818|P1|NOT COMPLETED|Overall Study||0
230973|NCT00136760|550815|P4|COMPLETED|Overall Study||13
230974|NCT00136760|550816|P3|COMPLETED|Overall Study||11
230975|NCT00136760|550817|P2|COMPLETED|Overall Study||16
230976|NCT00136760|550818|P1|COMPLETED|Overall Study||12
230977|NCT00136760|550815|P4|STARTED|Overall Study||13
230978|NCT00136760|550816|P3|STARTED|Overall Study||11
230979|NCT00136760|550817|P2|STARTED|Overall Study||16
230980|NCT00136760|550818|P1|STARTED|Overall Study||12
230981|NCT00136695|550834|P2|NOT COMPLETED|Overall Study||8
230982|NCT00136695|550835|P1|NOT COMPLETED|Overall Study||11
230983|NCT00136695|550834|P2|COMPLETED|Overall Study||35
230984|NCT00136695|550835|P1|COMPLETED|Overall Study||34
230985|NCT00136695|550834|P2|STARTED|Overall Study||43
230986|NCT00136695|550835|P1|STARTED|Overall Study||45
230987|NCT00136357|550843|P2|NOT COMPLETED|Overall Study||2
230988|NCT00136357|550844|P1|NOT COMPLETED|Overall Study||3
230989|NCT00136357|550843|P2|COMPLETED|Overall Study||39
230990|NCT00136357|550844|P1|COMPLETED|Overall Study||38
230991|NCT00136357|550843|P2|STARTED|Overall Study||41
230992|NCT00136357|550844|P1|STARTED|Overall Study||41
230993|NCT00136318|550852|P2|NOT COMPLETED|Overall Study||7
230994|NCT00136318|550853|P1|NOT COMPLETED|Overall Study||7
230995|NCT00136318|550852|P2|COMPLETED|Overall Study||84
230996|NCT00136318|550853|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
230997|NCT00136318|550852|P2|STARTED|Overall Study|Took first dose of study medication|91
230998|NCT00136318|550853|P1|STARTED|Overall Study|Took first dose of study medication|90
230999|NCT00136084|550869|P2|NOT COMPLETED|Overall Study||42
231000|NCT00136084|550870|P1|NOT COMPLETED|Overall Study||48
231001|NCT00136084|550869|P2|COMPLETED|Overall Study||72
231002|NCT00136084|550870|P1|COMPLETED|Overall Study||61
231003|NCT00136084|550869|P2|STARTED|Overall Study||114
231004|NCT00136084|550870|P1|STARTED|Overall Study||109
231005|NCT00135798|550886|P3|NOT COMPLETED|Overall Study||0
231006|NCT00135798|550887|P2|NOT COMPLETED|Overall Study||0
231007|NCT00135798|550888|P1|NOT COMPLETED|Overall Study||0
231008|NCT00135798|550886|P3|COMPLETED|Overall Study||32
231009|NCT00135798|550887|P2|COMPLETED|Overall Study||31
231010|NCT00135798|550888|P1|COMPLETED|Overall Study||16
231011|NCT00135798|550886|P3|STARTED|Overall Study||32
231012|NCT00135798|550887|P2|STARTED|Overall Study||31
231013|NCT00135798|550888|P1|STARTED|Overall Study||16
231014|NCT00135694|550907|P3|NOT COMPLETED|Overall Study||7
231015|NCT00135694|550908|P2|NOT COMPLETED|Overall Study||21
231016|NCT00135694|550909|P1|NOT COMPLETED|Overall Study||180
231017|NCT00135694|550907|P3|COMPLETED|Overall Study||11
231018|NCT00135694|550908|P2|COMPLETED|Overall Study||56
231019|NCT00135694|550909|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
231020|NCT00135694|550907|P3|STARTED|Overall Study||18
231021|NCT00135694|550908|P2|STARTED|Overall Study||77
231022|NCT00135694|550909|P1|STARTED|Overall Study||180
231023|NCT00135356|550929|P2|NOT COMPLETED|Overall Study||9
231024|NCT00135356|550930|P1|NOT COMPLETED|Overall Study||17
231025|NCT00135356|550929|P2|COMPLETED|Overall Study||60
231026|NCT00135356|550930|P1|COMPLETED|Overall Study||114
231027|NCT00135356|550929|P2|Discontinued on or After Week 96 Visit|Overall Study||0
231028|NCT00135356|550930|P1|Discontinued on or After Week 96 Visit|Overall Study||1
231029|NCT00135356|550929|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
231030|NCT00135356|550930|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
231031|NCT00135356|550929|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
231032|NCT00135356|550930|P1|STARTED|Overall Study|Number randomized and treated|131
231033|NCT00135330|550973|P3|NOT COMPLETED|Overall Study||11
231034|NCT00135330|550974|P2|NOT COMPLETED|Overall Study||13
231035|NCT00135330|550975|P1|NOT COMPLETED|Overall Study||12
231036|NCT00135330|550973|P3|COMPLETED|Overall Study||34
231037|NCT00135330|550974|P2|COMPLETED|Overall Study||34
231038|NCT00135330|550975|P1|COMPLETED|Overall Study||33
231039|NCT00135330|550973|P3|STARTED|Overall Study||45
231040|NCT00135330|550974|P2|STARTED|Overall Study||47
231041|NCT00135330|550975|P1|STARTED|Overall Study||45
231042|NCT00135200|551067|P1|NOT COMPLETED|Overall Study||0
231043|NCT00135200|551067|P1|COMPLETED|Overall Study||16
231044|NCT00135200|551067|P1|STARTED|Overall Study||16
231045|NCT00134901|551074|P2|NOT COMPLETED|Overall Study||15
231046|NCT00134901|551075|P1|NOT COMPLETED|Overall Study||17
231047|NCT00134901|551074|P2|COMPLETED|Overall Study||27
231048|NCT00134901|551075|P1|COMPLETED|Overall Study||22
231049|NCT00134901|551074|P2|STARTED|Overall Study||42
231050|NCT00134901|551075|P1|STARTED|Overall Study||39
231051|NCT00134784|551087|P4|NOT COMPLETED|Overall Study||1
231052|NCT00134784|551088|P3|NOT COMPLETED|Overall Study||2
231053|NCT00134784|551089|P2|NOT COMPLETED|Overall Study||2
231054|NCT00134784|551090|P1|NOT COMPLETED|Overall Study||2
231055|NCT00134784|551087|P4|COMPLETED|Overall Study||37
231056|NCT00134784|551088|P3|COMPLETED|Overall Study||35
231057|NCT00134784|551089|P2|COMPLETED|Overall Study||36
231058|NCT00134784|551090|P1|COMPLETED|Overall Study||27
231059|NCT00134784|551087|P4|STARTED|Overall Study||38
231060|NCT00134784|551088|P3|STARTED|Overall Study||37
231061|NCT00134784|551089|P2|STARTED|Overall Study||38
231062|NCT00134784|551090|P1|STARTED|Overall Study||29
231063|NCT00134719|551100|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
231064|NCT00134719|551101|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
231065|NCT00134719|551102|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
231066|NCT00134719|551100|P3|COMPLETED|Fourth Dose Vaccination Phase||203
231067|NCT00134719|551101|P2|COMPLETED|Fourth Dose Vaccination Phase||203
231068|NCT00134719|551102|P1|COMPLETED|Fourth Dose Vaccination Phase||623
231069|NCT00134719|551100|P3|STARTED|Fourth Dose Vaccination Phase||204
231070|NCT00134719|551101|P2|STARTED|Fourth Dose Vaccination Phase||206
231071|NCT00134719|551102|P1|STARTED|Fourth Dose Vaccination Phase||625
231072|NCT00134719|551100|P3|NOT COMPLETED|Primary Vaccination Phase||5
231073|NCT00134719|551101|P2|NOT COMPLETED|Primary Vaccination Phase||6
231074|NCT00134719|551102|P1|NOT COMPLETED|Primary Vaccination Phase||14
231075|NCT00134719|551100|P3|COMPLETED|Primary Vaccination Phase||216
231076|NCT00134719|551101|P2|COMPLETED|Primary Vaccination Phase||215
231077|NCT00134719|551102|P1|COMPLETED|Primary Vaccination Phase||647
231078|NCT00134719|551100|P3|STARTED|Primary Vaccination Phase||221
231079|NCT00134719|551101|P2|STARTED|Primary Vaccination Phase||221
231080|NCT00134719|551102|P1|STARTED|Primary Vaccination Phase||661
231081|NCT00134563|551233|P3|NOT COMPLETED|Overall Study||96
231082|NCT00134563|551234|P2|NOT COMPLETED|Overall Study||92
231083|NCT00134563|551235|P1|NOT COMPLETED|Overall Study||104
231084|NCT00134563|551233|P3|COMPLETED|Overall Study|completed treatment period|263
231085|NCT00134563|551234|P2|COMPLETED|Overall Study|completed treatment period|274
231086|NCT00134563|551235|P1|COMPLETED|Overall Study|completed treatment period|259
231087|NCT00134563|551233|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
231088|NCT00134563|551234|P2|Treated|Overall Study||365
231089|NCT00134563|551235|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
231090|NCT00134563|551233|P3|STARTED|Overall Study|Randomized|359
231091|NCT00134563|551234|P2|STARTED|Overall Study|Randomized|366
231092|NCT00134563|551235|P1|STARTED|Overall Study|Randomized|363
231093|NCT00134043|551260|P2|NOT COMPLETED|Overall Study||0
231094|NCT00134043|551261|P1|NOT COMPLETED|Overall Study||0
231095|NCT00134043|551260|P2|COMPLETED|Overall Study||3
231096|NCT00134043|551261|P1|COMPLETED|Overall Study||16
231097|NCT00134043|551260|P2|STARTED|Overall Study||3
231098|NCT00134043|551261|P1|STARTED|Overall Study||16
231099|NCT00134004|551266|P1|NOT COMPLETED|Overall Study||0
231100|NCT00134004|551266|P1|COMPLETED|Overall Study||210
231101|NCT00134004|551266|P1|STARTED|Overall Study||210
231102|NCT00133978|551278|P4|NOT COMPLETED|Overall Study||2
231103|NCT00133978|551279|P3|NOT COMPLETED|Overall Study||0
231104|NCT00133978|551280|P2|NOT COMPLETED|Overall Study||1
231105|NCT00133978|551281|P1|NOT COMPLETED|Overall Study||2
231106|NCT00133978|551278|P4|COMPLETED|Overall Study||300
231107|NCT00133978|551279|P3|COMPLETED|Overall Study||310
231108|NCT00133978|551280|P2|COMPLETED|Overall Study||307
231109|NCT00133978|551281|P1|COMPLETED|Overall Study||301
231110|NCT00133978|551278|P4|STARTED|Overall Study||302
231111|NCT00133978|551279|P3|STARTED|Overall Study||310
231112|NCT00133978|551280|P2|STARTED|Overall Study||308
231113|NCT00133978|551281|P1|STARTED|Overall Study||303
231114|NCT00133952|551305|P2|NOT COMPLETED|Overall Study||28
231115|NCT00133952|551306|P1|NOT COMPLETED|Overall Study||42
231116|NCT00133952|551305|P2|COMPLETED|Overall Study||124
231117|NCT00133952|551306|P1|COMPLETED|Overall Study||115
231118|NCT00133952|551305|P2|Received at Least One Dose of Study Drug|Overall Study||149
231119|NCT00133952|551306|P1|Received at Least One Dose of Study Drug|Overall Study||153
231120|NCT00133952|551305|P2|STARTED|Overall Study||152
231121|NCT00133952|551306|P1|STARTED|Overall Study||157
231122|NCT00133809|551328|P1|NOT COMPLETED|Overall Study||0
231123|NCT00133809|551328|P1|COMPLETED|Overall Study||8
231124|NCT00133809|551328|P1|STARTED|Overall Study||8
231125|NCT00133705|551337|P2|NOT COMPLETED|Overall Study||3
231126|NCT00133705|551338|P1|NOT COMPLETED|Overall Study||2
231127|NCT00133705|551337|P2|COMPLETED|Overall Study||17
231128|NCT00133705|551338|P1|COMPLETED|Overall Study||20
231129|NCT00133705|551337|P2|STARTED|Overall Study||20
231130|NCT00133705|551338|P1|STARTED|Overall Study||22
231131|NCT00133575|551351|P7|NOT COMPLETED|Overall Study||3
231132|NCT00133575|551352|P6|NOT COMPLETED|Overall Study||1
231133|NCT00133575|551353|P5|NOT COMPLETED|Overall Study||4
231134|NCT00133575|551354|P4|NOT COMPLETED|Overall Study||1
231135|NCT00133575|551355|P3|NOT COMPLETED|Overall Study||2
231136|NCT00133575|551356|P2|NOT COMPLETED|Overall Study||0
231137|NCT00133575|551357|P1|NOT COMPLETED|Overall Study||0
231138|NCT00133575|551351|P7|COMPLETED|Overall Study||9
231139|NCT00133575|551352|P6|COMPLETED|Overall Study||9
231140|NCT00133575|551353|P5|COMPLETED|Overall Study||6
231141|NCT00133575|551354|P4|COMPLETED|Overall Study||9
231142|NCT00133575|551355|P3|COMPLETED|Overall Study||8
231143|NCT00133575|551356|P2|COMPLETED|Overall Study||10
231144|NCT00133575|551357|P1|COMPLETED|Overall Study||10
231145|NCT00133575|551351|P7|STARTED|Overall Study||12
231146|NCT00133575|551352|P6|STARTED|Overall Study||10
231147|NCT00133575|551353|P5|STARTED|Overall Study||10
231148|NCT00133575|551354|P4|STARTED|Overall Study||10
231149|NCT00133575|551355|P3|STARTED|Overall Study||10
231150|NCT00133575|551356|P2|STARTED|Overall Study||10
231151|NCT00133575|551357|P1|STARTED|Overall Study||10
231152|NCT00132873|551464|P1|NOT COMPLETED|Overall Study||9
231153|NCT00132873|551464|P1|COMPLETED|Overall Study||50
231154|NCT00132873|551464|P1|STARTED|Overall Study||59
231155|NCT00132808|551472|P3|NOT COMPLETED|Stratum II||9
231156|NCT00132808|551473|P2|NOT COMPLETED|Stratum II||15
231157|NCT00132808|551474|P1|NOT COMPLETED|Stratum II||8
231158|NCT00132808|551472|P3|COMPLETED|Stratum II||116
231159|NCT00132808|551473|P2|COMPLETED|Stratum II||96
231160|NCT00132808|551474|P1|COMPLETED|Stratum II||113
231161|NCT00132808|551472|P3|STARTED|Stratum II||125
231162|NCT00132808|551473|P2|STARTED|Stratum II||111
231163|NCT00132808|551474|P1|STARTED|Stratum II||121
231164|NCT00132808|551472|P3|NOT COMPLETED|Stratum I||5
231165|NCT00132808|551473|P2|NOT COMPLETED|Stratum I||12
231166|NCT00132808|551474|P1|NOT COMPLETED|Stratum I||9
231167|NCT00132808|551472|P3|COMPLETED|Stratum I||72
231168|NCT00132808|551473|P2|COMPLETED|Stratum I||58
231169|NCT00132808|551474|P1|COMPLETED|Stratum I||68
231170|NCT00132808|551472|P3|STARTED|Stratum I||77
231171|NCT00132808|551473|P2|STARTED|Stratum I||70
231172|NCT00132808|551474|P1|STARTED|Stratum I||77
231173|NCT00132769|551499|P2|NOT COMPLETED|Overall Study||11
231174|NCT00132769|551500|P1|NOT COMPLETED|Overall Study||11
231175|NCT00132769|551499|P2|COMPLETED|Overall Study||42
231176|NCT00132769|551500|P1|COMPLETED|Overall Study||42
231177|NCT00132769|551499|P2|STARTED|Overall Study||53
231178|NCT00132769|551500|P1|STARTED|Overall Study||53
231179|NCT00132730|551526|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
231180|NCT00132730|551527|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
231181|NCT00132730|551528|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
231182|NCT00132730|551529|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
231183|NCT00132730|551530|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
231184|NCT00132730|551531|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
231185|NCT00132730|551526|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
231186|NCT00132730|551527|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
231187|NCT00132730|551528|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
231188|NCT00132730|551529|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
231189|NCT00132730|551530|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
231190|NCT00132730|551531|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
231191|NCT00132730|551526|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
231192|NCT00132730|551527|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
231193|NCT00132730|551528|P4|STARTED|Period V - Open-label Extension (EXT2)||0
231194|NCT00132730|551529|P3|STARTED|Period V - Open-label Extension (EXT2)||0
231195|NCT00132730|551530|P2|STARTED|Period V - Open-label Extension (EXT2)||0
231196|NCT00132730|551531|P1|STARTED|Period V - Open-label Extension (EXT2)||0
231197|NCT00132730|551526|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
231198|NCT00132730|551527|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
231199|NCT00132730|551528|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
231200|NCT00132730|551529|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
231201|NCT00132730|551530|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
231202|NCT00132730|551531|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
231203|NCT00132730|551526|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
231204|NCT00132730|551527|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
231205|NCT00132730|551528|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
231206|NCT00132730|551529|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
231207|NCT00132730|551530|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
231208|NCT00132730|551531|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
231209|NCT00132730|551526|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
231210|NCT00132730|551527|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
231211|NCT00132730|551528|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
231212|NCT00132730|551529|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
231213|NCT00132730|551530|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
231214|NCT00132730|551531|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
231215|NCT00132730|551526|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
231216|NCT00132730|551527|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
231217|NCT00132730|551528|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
231218|NCT00132730|551529|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
231219|NCT00132730|551530|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
231220|NCT00132730|551531|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
231221|NCT00132730|551526|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
231222|NCT00132730|551527|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
231223|NCT00132730|551528|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
231224|NCT00132730|551529|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
231225|NCT00132730|551530|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
231226|NCT00132730|551531|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
231227|NCT00132730|551526|P6|STARTED|Period III - Blinded Extension (EXT1)||0
231228|NCT00132730|551527|P5|STARTED|Period III - Blinded Extension (EXT1)||0
231229|NCT00132730|551528|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
231230|NCT00132730|551529|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
231231|NCT00132730|551530|P2|STARTED|Period III - Blinded Extension (EXT1)||0
231232|NCT00132730|551531|P1|STARTED|Period III - Blinded Extension (EXT1)||0
231233|NCT00132730|551526|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
231234|NCT00132730|551527|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
231235|NCT00132730|551528|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
231236|NCT00132730|551529|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
231237|NCT00132730|551530|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
231238|NCT00132730|551531|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
231239|NCT00132730|551526|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
231240|NCT00132730|551527|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
231241|NCT00132730|551528|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
231242|NCT00132730|551529|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
231243|NCT00132730|551530|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
231244|NCT00132730|551531|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
231245|NCT00132730|551526|P6|STARTED|Period II - 12-week Treatment (Base)||0
231246|NCT00132730|551527|P5|STARTED|Period II - 12-week Treatment (Base)||0
231247|NCT00132730|551528|P4|STARTED|Period II - 12-week Treatment (Base)||153
231248|NCT00132730|551529|P3|STARTED|Period II - 12-week Treatment (Base)||153
231249|NCT00132730|551530|P2|STARTED|Period II - 12-week Treatment (Base)||148
231250|NCT00132730|551531|P1|STARTED|Period II - 12-week Treatment (Base)||150
231251|NCT00132730|551526|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231252|NCT00132730|551527|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231253|NCT00132730|551528|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231254|NCT00132730|551529|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231255|NCT00132730|551530|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231256|NCT00132730|551531|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
231257|NCT00132730|551526|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
231258|NCT00132730|551527|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
231259|NCT00132730|551528|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
231260|NCT00132730|551529|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
231261|NCT00132730|551530|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
231262|NCT00132730|551531|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
231263|NCT00132730|551526|P6|STARTED|Period I - Placebo Run-in (Base)||0
231264|NCT00132730|551527|P5|STARTED|Period I - Placebo Run-in (Base)||0
231265|NCT00132730|551528|P4|STARTED|Period I - Placebo Run-in (Base)||153
231266|NCT00132730|551529|P3|STARTED|Period I - Placebo Run-in (Base)||153
231267|NCT00132730|551530|P2|STARTED|Period I - Placebo Run-in (Base)||148
231268|NCT00132730|551531|P1|STARTED|Period I - Placebo Run-in (Base)||150
231269|NCT00132691|551575|P2|NOT COMPLETED|Overall Study||12
231270|NCT00132691|551576|P1|NOT COMPLETED|Overall Study||11
231271|NCT00132691|551575|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
231272|NCT00132691|551576|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
231273|NCT00132691|551575|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
231274|NCT00132691|551576|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
231275|NCT00132678|551616|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
231276|NCT00132678|551617|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
231277|NCT00132678|551618|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
231278|NCT00132678|551616|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
231279|NCT00132678|551617|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
231280|NCT00132678|551618|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
231281|NCT00132678|551616|P3|STARTED|Period IV (Double-Blind Treatment)||0
231282|NCT00132678|551617|P2|STARTED|Period IV (Double-Blind Treatment)||149
231283|NCT00132678|551618|P1|STARTED|Period IV (Double-Blind Treatment)||154
231284|NCT00132678|551616|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
231285|NCT00132678|551617|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
231286|NCT00132678|551618|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
231287|NCT00132678|551616|P3|COMPLETED|Period III (Open-Label Stabilization)||0
231288|NCT00132678|551617|P2|COMPLETED|Period III (Open-Label Stabilization)||0
231289|NCT00132678|551618|P1|COMPLETED|Period III (Open-Label Stabilization)||303
231290|NCT00132678|551616|P3|STARTED|Period III (Open-Label Stabilization)||0
231291|NCT00132678|551617|P2|STARTED|Period III (Open-Label Stabilization)||0
231292|NCT00132678|551618|P1|STARTED|Period III (Open-Label Stabilization)||501
231293|NCT00132678|551616|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
231294|NCT00132678|551617|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
231295|NCT00132678|551618|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
231296|NCT00132678|551616|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
231297|NCT00132678|551617|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
231298|NCT00132678|551618|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
231299|NCT00132678|551616|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
231300|NCT00132678|551617|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
231301|NCT00132678|551618|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
231302|NCT00132496|551632|P2|NOT COMPLETED|Overall Study||2
231303|NCT00132496|551633|P1|NOT COMPLETED|Overall Study||2
231304|NCT00132496|551632|P2|COMPLETED|Overall Study||55
231305|NCT00132496|551633|P1|COMPLETED|Overall Study||52
231306|NCT00132496|551632|P2|STARTED|Overall Study||57
231307|NCT00132496|551633|P1|STARTED|Overall Study||54
231308|NCT00132314|551641|P2|NOT COMPLETED|Overall Study||72
231309|NCT00132314|551642|P1|NOT COMPLETED|Overall Study||73
231310|NCT00132314|551641|P2|COMPLETED|Overall Study||120
231311|NCT00132314|551642|P1|COMPLETED|Overall Study||117
231312|NCT00132314|551641|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
231313|NCT00132314|551642|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
231314|NCT00132314|551641|P2|Received Treatment|Overall Study||185
231315|NCT00132314|551642|P1|Received Treatment|Overall Study||188
231316|NCT00132314|551641|P2|STARTED|Overall Study||192
231317|NCT00132314|551642|P1|STARTED|Overall Study||190
231318|NCT00132132|551652|P2|NOT COMPLETED|Overall Study||2
231319|NCT00132132|551653|P1|NOT COMPLETED|Overall Study||7
231320|NCT00132132|551652|P2|COMPLETED|Overall Study||13
231321|NCT00132132|551653|P1|COMPLETED|Overall Study||8
231322|NCT00132132|551652|P2|STARTED|Overall Study||15
231323|NCT00132132|551653|P1|STARTED|Overall Study||15
231324|NCT00132028|551661|P1|NOT COMPLETED|Overall Study||27
231325|NCT00132028|551661|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
231326|NCT00132028|551661|P1|Eligible and Began Protocol Therapy|Overall Study||25
231327|NCT00132028|551661|P1|Eligible|Overall Study||25
231328|NCT00132028|551661|P1|STARTED|Overall Study||27
231329|NCT00132002|551667|P1|NOT COMPLETED|Overall Study||0
231330|NCT00132002|551667|P1|COMPLETED|Overall Study||14
231331|NCT00132002|551667|P1|STARTED|Overall Study||14
231332|NCT00131937|551673|P1|NOT COMPLETED|Overall Study||14
231333|NCT00131937|551673|P1|COMPLETED|Overall Study||0
231334|NCT00131937|551673|P1|STARTED|Overall Study||14
231335|NCT00131911|551681|P2|NOT COMPLETED|Overall Study||0
231336|NCT00131911|551682|P1|NOT COMPLETED|Overall Study||1
231337|NCT00131911|551681|P2|COMPLETED|Overall Study||42
231338|NCT00131911|551682|P1|COMPLETED|Overall Study||50
231339|NCT00131911|551681|P2|STARTED|Overall Study||42
231340|NCT00131911|551682|P1|STARTED|Overall Study||51
231341|NCT00131885|551699|P4|NOT COMPLETED|Time 2: Second Intervention||0
231342|NCT00131885|551700|P3|NOT COMPLETED|Time 2: Second Intervention||0
231343|NCT00131885|551701|P2|NOT COMPLETED|Time 2: Second Intervention||0
231344|NCT00131885|551702|P1|NOT COMPLETED|Time 2: Second Intervention||0
231345|NCT00131885|551699|P4|COMPLETED|Time 2: Second Intervention||9
231346|NCT00131885|551700|P3|COMPLETED|Time 2: Second Intervention||9
231347|NCT00131885|551701|P2|COMPLETED|Time 2: Second Intervention||9
231348|NCT00131885|551702|P1|COMPLETED|Time 2: Second Intervention||9
231349|NCT00131885|551699|P4|STARTED|Time 2: Second Intervention||9
231350|NCT00131885|551700|P3|STARTED|Time 2: Second Intervention||9
231351|NCT00131885|551701|P2|STARTED|Time 2: Second Intervention||9
231352|NCT00131885|551702|P1|STARTED|Time 2: Second Intervention||9
231353|NCT00131885|551699|P4|NOT COMPLETED|Time 1: First Intervention||0
231354|NCT00131885|551700|P3|NOT COMPLETED|Time 1: First Intervention||0
231355|NCT00131885|551701|P2|NOT COMPLETED|Time 1: First Intervention||0
231356|NCT00131885|551702|P1|NOT COMPLETED|Time 1: First Intervention||0
231357|NCT00131885|551699|P4|COMPLETED|Time 1: First Intervention||9
231358|NCT00131885|551700|P3|COMPLETED|Time 1: First Intervention||9
231359|NCT00131885|551701|P2|COMPLETED|Time 1: First Intervention||9
231360|NCT00131885|551702|P1|COMPLETED|Time 1: First Intervention||9
231361|NCT00131885|551699|P4|STARTED|Time 1: First Intervention||9
231362|NCT00131885|551700|P3|STARTED|Time 1: First Intervention||9
231363|NCT00131885|551701|P2|STARTED|Time 1: First Intervention||9
231364|NCT00131885|551702|P1|STARTED|Time 1: First Intervention||9
231365|NCT00131677|551734|P2|NOT COMPLETED|Overall Study||39
231366|NCT00131677|551735|P1|NOT COMPLETED|Overall Study||30
231367|NCT00131677|551734|P2|COMPLETED|Overall Study||160
231368|NCT00131677|551735|P1|COMPLETED|Overall Study||171
231369|NCT00131677|551734|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
231370|NCT00131677|551735|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
231371|NCT00131664|551752|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
231372|NCT00131664|551753|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
231373|NCT00131664|551754|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
231374|NCT00131664|551755|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
231375|NCT00131664|551756|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
231376|NCT00131664|551757|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
231377|NCT00131664|551752|P6|COMPLETED|Second Period (Additional Drug Added)||22
231378|NCT00131664|551753|P5|COMPLETED|Second Period (Additional Drug Added)||15
231379|NCT00131664|551754|P4|COMPLETED|Second Period (Additional Drug Added)||19
231380|NCT00131664|551755|P3|COMPLETED|Second Period (Additional Drug Added)||76
231381|NCT00131664|551756|P2|COMPLETED|Second Period (Additional Drug Added)||97
231382|NCT00131664|551757|P1|COMPLETED|Second Period (Additional Drug Added)||81
231383|NCT00131664|551752|P6|STARTED|Second Period (Additional Drug Added)||25
231384|NCT00131664|551753|P5|STARTED|Second Period (Additional Drug Added)||16
231385|NCT00131664|551754|P4|STARTED|Second Period (Additional Drug Added)||21
231386|NCT00131664|551755|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
231387|NCT00131664|551756|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
231388|NCT00131664|551757|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
231389|NCT00131664|551752|P6|NOT COMPLETED|First Period (First 6 Months)||0
231390|NCT00131664|551753|P5|NOT COMPLETED|First Period (First 6 Months)||0
231391|NCT00131664|551754|P4|NOT COMPLETED|First Period (First 6 Months)||0
231392|NCT00131664|551755|P3|NOT COMPLETED|First Period (First 6 Months)||16
231393|NCT00131664|551756|P2|NOT COMPLETED|First Period (First 6 Months)||18
231394|NCT00131664|551757|P1|NOT COMPLETED|First Period (First 6 Months)||25
231395|NCT00131664|551752|P6|COMPLETED|First Period (First 6 Months)||0
231396|NCT00131664|551753|P5|COMPLETED|First Period (First 6 Months)||0
231397|NCT00131664|551754|P4|COMPLETED|First Period (First 6 Months)||0
231398|NCT00131664|551755|P3|COMPLETED|First Period (First 6 Months)||104
231399|NCT00131664|551756|P2|COMPLETED|First Period (First 6 Months)||117
231400|NCT00131664|551757|P1|COMPLETED|First Period (First 6 Months)||111
231401|NCT00131664|551752|P6|STARTED|First Period (First 6 Months)||0
231402|NCT00131664|551753|P5|STARTED|First Period (First 6 Months)||0
231403|NCT00131664|551754|P4|STARTED|First Period (First 6 Months)||0
231404|NCT00131664|551755|P3|STARTED|First Period (First 6 Months)||120
231405|NCT00131664|551756|P2|STARTED|First Period (First 6 Months)||135
231406|NCT00131664|551757|P1|STARTED|First Period (First 6 Months)||136
231407|NCT00131573|551818|P2|NOT COMPLETED|Overall Study||26
231408|NCT00131573|551819|P1|NOT COMPLETED|Overall Study||33
231409|NCT00131573|551818|P2|COMPLETED|Overall Study||13
231410|NCT00131573|551819|P1|COMPLETED|Overall Study||13
231411|NCT00131573|551818|P2|STARTED|Overall Study||39
231412|NCT00131573|551819|P1|STARTED|Overall Study||46
231413|NCT00131508|551829|P2|NOT COMPLETED|Overall Study||8
231414|NCT00131508|551830|P1|NOT COMPLETED|Overall Study||3
231415|NCT00131508|551829|P2|COMPLETED|Overall Study||5
231416|NCT00131508|551830|P1|COMPLETED|Overall Study||9
231417|NCT00131508|551829|P2|STARTED|Overall Study||13
231418|NCT00131508|551830|P1|STARTED|Overall Study||12
231419|NCT00131456|551854|P2|NOT COMPLETED|Overall Study||20
231420|NCT00131456|551855|P1|NOT COMPLETED|Overall Study||19
231421|NCT00131456|551854|P2|COMPLETED|Overall Study||31
231422|NCT00131456|551855|P1|COMPLETED|Overall Study||33
231423|NCT00131456|551854|P2|STARTED|Overall Study||51
231424|NCT00131456|551855|P1|STARTED|Overall Study||52
231425|NCT00131378|551865|P4|NOT COMPLETED|Overall Study||9
231426|NCT00131378|551866|P3|NOT COMPLETED|Overall Study||10
231427|NCT00131378|551867|P2|NOT COMPLETED|Overall Study||18
231428|NCT00131378|551868|P1|NOT COMPLETED|Overall Study||11
231429|NCT00131378|551865|P4|COMPLETED|Overall Study||21
231430|NCT00131378|551866|P3|COMPLETED|Overall Study||22
231431|NCT00131378|551867|P2|COMPLETED|Overall Study||22
231432|NCT00131378|551868|P1|COMPLETED|Overall Study||29
231433|NCT00131378|551865|P4|STARTED|Overall Study||30
231434|NCT00131378|551866|P3|STARTED|Overall Study||32
231435|NCT00131378|551867|P2|STARTED|Overall Study||40
231436|NCT00131378|551868|P1|STARTED|Overall Study||40
231437|NCT00131352|551892|P2|NOT COMPLETED|Repeat Treatment Period||0
231438|NCT00131352|551893|P1|NOT COMPLETED|Repeat Treatment Period||2
231439|NCT00131352|551892|P2|COMPLETED|Repeat Treatment Period||0
231440|NCT00131352|551893|P1|COMPLETED|Repeat Treatment Period||158
231441|NCT00131352|551892|P2|STARTED|Repeat Treatment Period||0
231442|NCT00131352|551893|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
231443|NCT00131352|551892|P2|NOT COMPLETED|Initial Treatment Period||12
231444|NCT00131352|551893|P1|NOT COMPLETED|Initial Treatment Period||9
231445|NCT00131352|551892|P2|COMPLETED|Initial Treatment Period||118
231446|NCT00131352|551893|P1|COMPLETED|Initial Treatment Period||114
231447|NCT00131352|551892|P2|Intent to Treat Population|Initial Treatment Period||129
231448|NCT00131352|551893|P1|Intent to Treat Population|Initial Treatment Period||124
231449|NCT00131352|551892|P2|STARTED|Initial Treatment Period|Safety population|130
231450|NCT00131352|551893|P1|STARTED|Initial Treatment Period|Safety population|123
231451|NCT00131248|551915|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
231452|NCT00131248|551916|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
231453|NCT00131248|551915|P2|COMPLETED|Intervention 3 (4-day Course)||9
231454|NCT00131248|551916|P1|COMPLETED|Intervention 3 (4-day Course)||8
231455|NCT00131248|551915|P2|STARTED|Intervention 3 (4-day Course)||9
231456|NCT00131248|551916|P1|STARTED|Intervention 3 (4-day Course)||8
231457|NCT00131248|551915|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
231458|NCT00131248|551916|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
231459|NCT00131248|551915|P2|COMPLETED|Washout 2 (24 Hours)||9
231460|NCT00131248|551916|P1|COMPLETED|Washout 2 (24 Hours)||8
231461|NCT00131248|551915|P2|STARTED|Washout 2 (24 Hours)||9
231462|NCT00131248|551916|P1|STARTED|Washout 2 (24 Hours)||8
231463|NCT00131248|551915|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
231464|NCT00131248|551916|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
231465|NCT00131248|551915|P2|COMPLETED|Intervention 2 (7-day Course)||9
231466|NCT00131248|551916|P1|COMPLETED|Intervention 2 (7-day Course)||8
231467|NCT00131248|551915|P2|STARTED|Intervention 2 (7-day Course)||9
231468|NCT00131248|551916|P1|STARTED|Intervention 2 (7-day Course)||8
231469|NCT00131248|551915|P2|NOT COMPLETED|Washout (24 Hour)||0
231470|NCT00131248|551916|P1|NOT COMPLETED|Washout (24 Hour)||0
231471|NCT00131248|551915|P2|COMPLETED|Washout (24 Hour)||9
231472|NCT00131248|551916|P1|COMPLETED|Washout (24 Hour)||8
231473|NCT00131248|551915|P2|STARTED|Washout (24 Hour)||9
231474|NCT00131248|551916|P1|STARTED|Washout (24 Hour)||8
231475|NCT00131248|551915|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
231476|NCT00131248|551916|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
231477|NCT00131248|551915|P2|COMPLETED|Intervention 1 (3-day Course)||9
231478|NCT00131248|551916|P1|COMPLETED|Intervention 1 (3-day Course)||8
231479|NCT00131248|551915|P2|STARTED|Intervention 1 (3-day Course)||9
231480|NCT00131248|551916|P1|STARTED|Intervention 1 (3-day Course)||9
231481|NCT00130923|551924|P2|NOT COMPLETED|Overall Study||14
231482|NCT00130923|551925|P1|NOT COMPLETED|Overall Study||13
231483|NCT00130923|551924|P2|COMPLETED|Overall Study||32
231484|NCT00130923|551925|P1|COMPLETED|Overall Study||36
231485|NCT00130923|551924|P2|STARTED|Overall Study||46
231486|NCT00130923|551925|P1|STARTED|Overall Study||49
231487|NCT00130832|551933|P2|NOT COMPLETED|Overall Study||17
231488|NCT00130832|551934|P1|NOT COMPLETED|Overall Study||16
231489|NCT00130832|551933|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
231490|NCT00130832|551934|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
231491|NCT00130832|551933|P2|STARTED|Overall Study||363
231492|NCT00130832|551934|P1|STARTED|Overall Study||372
231493|NCT00130793|551946|P2|NOT COMPLETED|Overall Study||4
231494|NCT00130793|551947|P1|NOT COMPLETED|Overall Study||3
231495|NCT00130793|551946|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
231496|NCT00130793|551947|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
231497|NCT00130793|551946|P2|Vaccinated|Overall Study||185
231498|NCT00130793|551947|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
231499|NCT00130793|551946|P2|STARTED|Overall Study||185
231500|NCT00130793|551947|P1|STARTED|Overall Study||183
231501|NCT00130780|551959|P2|NOT COMPLETED|Overall Study||0
231502|NCT00130780|551960|P1|NOT COMPLETED|Overall Study||0
231503|NCT00130780|551959|P2|COMPLETED|Overall Study||20
231504|NCT00130780|551960|P1|COMPLETED|Overall Study||51
231505|NCT00130780|551959|P2|STARTED|Overall Study||20
231506|NCT00130780|551960|P1|STARTED|Overall Study||51
231507|NCT00130728|551968|P2|NOT COMPLETED|Overall Study||213
231508|NCT00130728|551969|P1|NOT COMPLETED|Overall Study||211
231509|NCT00130728|551968|P2|COMPLETED|Overall Study||104
231510|NCT00130728|551969|P1|COMPLETED|Overall Study||108
231511|NCT00130728|551968|P2|Received Study Drug (Safety Population)|Overall Study||313
231512|NCT00130728|551969|P1|Received Study Drug (Safety Population)|Overall Study||313
231513|NCT00130728|551968|P2|STARTED|Overall Study||317
231514|NCT00130728|551969|P1|STARTED|Overall Study||319
231515|NCT00130689|551981|P1|NOT COMPLETED|Overall Study||43
231516|NCT00130689|551981|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
231517|NCT00130689|551981|P1|Treated|Overall Study||35
231518|NCT00130689|551981|P1|Eligible|Overall Study||37
231519|NCT00130689|551981|P1|STARTED|Overall Study||43
231520|NCT00130637|551985|P1|NOT COMPLETED|Overall Study||3
231521|NCT00130637|551985|P1|COMPLETED|Overall Study||3
231522|NCT00130637|551985|P1|STARTED|Overall Study||6
231523|NCT00130520|551990|P1|NOT COMPLETED|Overall Study||39
231524|NCT00130520|551990|P1|COMPLETED|Overall Study||1
231525|NCT00130520|551990|P1|Completion of at Least One Cycle|Overall Study||39
231526|NCT00130520|551990|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
231527|NCT00130286|552000|P4|NOT COMPLETED|Overall Study||2
231528|NCT00130286|552001|P3|NOT COMPLETED|Overall Study||4
231529|NCT00130286|552002|P2|NOT COMPLETED|Overall Study||3
231530|NCT00130286|552003|P1|NOT COMPLETED|Overall Study||0
231531|NCT00130286|552000|P4|COMPLETED|Overall Study||17
231532|NCT00130286|552001|P3|COMPLETED|Overall Study||13
231533|NCT00130286|552002|P2|COMPLETED|Overall Study||16
231534|NCT00130286|552003|P1|COMPLETED|Overall Study||22
231535|NCT00130286|552000|P4|STARTED|Overall Study||19
231536|NCT00130286|552001|P3|STARTED|Overall Study||17
231537|NCT00130286|552002|P2|STARTED|Overall Study||19
231538|NCT00130286|552003|P1|STARTED|Overall Study||22
231539|NCT00130247|552023|P2|NOT COMPLETED|Overall Study||4
231540|NCT00130247|552024|P1|NOT COMPLETED|Overall Study||2
231541|NCT00130247|552023|P2|COMPLETED|Overall Study||194
231542|NCT00130247|552024|P1|COMPLETED|Overall Study||194
231543|NCT00130247|552023|P2|STARTED|Overall Study||198
231544|NCT00130247|552024|P1|STARTED|Overall Study||196
231545|NCT00130039|552042|P2|NOT COMPLETED|Overall Study||18
231546|NCT00130039|552043|P1|NOT COMPLETED|Overall Study||30
231547|NCT00130039|552042|P2|COMPLETED|Overall Study|full analysis set|207
231548|NCT00130039|552043|P1|COMPLETED|Overall Study|full analysis set|202
231549|NCT00130039|552042|P2|STARTED|Overall Study||225
231550|NCT00130039|552043|P1|STARTED|Overall Study||232
231551|NCT00129961|552061|P2|NOT COMPLETED|Overall Study||23
231552|NCT00129961|552062|P1|NOT COMPLETED|Overall Study||19
231553|NCT00129961|552061|P2|COMPLETED|Overall Study||24
231554|NCT00129961|552062|P1|COMPLETED|Overall Study||20
231555|NCT00129961|552061|P2|STARTED|Overall Study||47
231556|NCT00129961|552062|P1|STARTED|Overall Study||39
231557|NCT00129766|552098|P2|NOT COMPLETED|Overall Study||59
231558|NCT00129766|552099|P1|NOT COMPLETED|Overall Study||60
231559|NCT00129766|552098|P2|COMPLETED|Overall Study||3270
231560|NCT00129766|552099|P1|COMPLETED|Overall Study||3246
231561|NCT00129766|552098|P2|STARTED|Overall Study||3329
231562|NCT00129766|552099|P1|STARTED|Overall Study||3306
231563|NCT00129727|552137|P1|NOT COMPLETED|Overall Study||5
231564|NCT00129727|552137|P1|COMPLETED|Overall Study||57
231565|NCT00129727|552137|P1|STARTED|Overall Study||62
231566|NCT00129623|552145|P2|NOT COMPLETED|Overall Study||12
231567|NCT00129623|552146|P1|NOT COMPLETED|Overall Study||10
231568|NCT00129623|552145|P2|COMPLETED|Overall Study||65
231569|NCT00129623|552146|P1|COMPLETED|Overall Study||73
231570|NCT00129623|552145|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
231571|NCT00129623|552146|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
231572|NCT00129623|552145|P2|STARTED|Overall Study||77
231573|NCT00129623|552146|P1|STARTED|Overall Study||83
231574|NCT00129545|552171|P3|NOT COMPLETED|Overall Study||111
231575|NCT00129545|552172|P2|NOT COMPLETED|Overall Study||164
231576|NCT00129545|552173|P1|NOT COMPLETED|Overall Study||26
231577|NCT00129545|552171|P3|COMPLETED|Overall Study||133
231578|NCT00129545|552172|P2|COMPLETED|Overall Study||299
231579|NCT00129545|552173|P1|COMPLETED|Overall Study||67
231580|NCT00129545|552171|P3|STARTED|Overall Study||244
231581|NCT00129545|552172|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
231582|NCT00129545|552173|P1|STARTED|Overall Study||93
231583|NCT00129480|552185|P2|NOT COMPLETED|Overall Study||0
231584|NCT00129480|552186|P1|NOT COMPLETED|Overall Study||0
231585|NCT00129480|552185|P2|COMPLETED|Overall Study||214
231586|NCT00129480|552186|P1|COMPLETED|Overall Study||187
231587|NCT00129480|552185|P2|STARTED|Overall Study||214
231588|NCT00129480|552186|P1|STARTED|Overall Study||187
231589|NCT00129467|552194|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
231590|NCT00129467|552195|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
231591|NCT00129467|552194|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
231592|NCT00129467|552195|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
231593|NCT00129467|552194|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
231594|NCT00129467|552195|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
231595|NCT00129467|552194|P2|NOT COMPLETED|Received Intervention||4
231596|NCT00129467|552195|P1|NOT COMPLETED|Received Intervention||6
231597|NCT00129467|552194|P2|COMPLETED|Received Intervention||13
231598|NCT00129467|552195|P1|COMPLETED|Received Intervention||9
231599|NCT00129467|552194|P2|STARTED|Received Intervention||17
231600|NCT00129467|552195|P1|STARTED|Received Intervention||15
231601|NCT00129441|552203|P2|NOT COMPLETED|Overall Study||0
231602|NCT00129441|552204|P1|NOT COMPLETED|Overall Study||0
231603|NCT00129441|552203|P2|COMPLETED|Overall Study||6
231604|NCT00129441|552204|P1|COMPLETED|Overall Study||9
231605|NCT00129441|552203|P2|Year 1, Visit 8|Overall Study||6
231606|NCT00129441|552204|P1|Year 1, Visit 8|Overall Study||9
231607|NCT00129441|552203|P2|Week 26, Visit 7|Overall Study||6
231608|NCT00129441|552204|P1|Week 26, Visit 7|Overall Study||9
231609|NCT00129441|552203|P2|Week 5, Visit 6|Overall Study||6
231610|NCT00129441|552204|P1|Week 5, Visit 6|Overall Study||9
231611|NCT00129441|552203|P2|Week 4, Visit 5|Overall Study||6
231612|NCT00129441|552204|P1|Week 4, Visit 5|Overall Study||9
231613|NCT00129441|552203|P2|Week 3, Visit 4|Overall Study||6
231614|NCT00129441|552204|P1|Week 3, Visit 4|Overall Study||9
231615|NCT00129441|552203|P2|Week 2, Visit 3|Overall Study||6
231616|NCT00129441|552204|P1|Week 2, Visit 3|Overall Study||9
231617|NCT00129441|552203|P2|Week 1, Visit 2|Overall Study||6
231618|NCT00129441|552204|P1|Week 1, Visit 2|Overall Study||9
231619|NCT00129441|552203|P2|Baseline, Visit 1|Overall Study||6
231620|NCT00129441|552204|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
231621|NCT00129441|552203|P2|STARTED|Overall Study||6
231622|NCT00129441|552204|P1|STARTED|Overall Study||9
231623|NCT00129402|552226|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
231624|NCT00129402|552227|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231625|NCT00129402|552228|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231626|NCT00129402|552229|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231627|NCT00129402|552230|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231628|NCT00129402|552231|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231629|NCT00129402|552232|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231630|NCT00129402|552226|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
231631|NCT00129402|552227|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231632|NCT00129402|552228|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231633|NCT00129402|552229|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231634|NCT00129402|552230|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231635|NCT00129402|552231|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231636|NCT00129402|552232|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
231637|NCT00129402|552226|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
231638|NCT00129402|552227|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
231639|NCT00129402|552228|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
231640|NCT00129402|552229|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
231641|NCT00129402|552230|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
231642|NCT00129402|552231|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
231643|NCT00129402|552232|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
231644|NCT00129402|552226|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231645|NCT00129402|552227|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
231646|NCT00129402|552228|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231647|NCT00129402|552229|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231648|NCT00129402|552230|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
231649|NCT00129402|552231|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231650|NCT00129402|552232|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231651|NCT00129402|552226|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231652|NCT00129402|552227|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
231653|NCT00129402|552228|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231654|NCT00129402|552229|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231655|NCT00129402|552230|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
231656|NCT00129402|552231|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231657|NCT00129402|552232|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
231658|NCT00129402|552226|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
231659|NCT00129402|552227|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
231660|NCT00129402|552228|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
231661|NCT00129402|552229|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
231662|NCT00129402|552230|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
231663|NCT00129402|552231|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
231664|NCT00129402|552232|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
231665|NCT00129402|552226|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
231666|NCT00129402|552227|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
231667|NCT00129402|552228|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
231668|NCT00129402|552229|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
231669|NCT00129402|552230|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
231670|NCT00129402|552231|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
231671|NCT00129402|552232|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
231672|NCT00129402|552226|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
231673|NCT00129402|552227|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
231674|NCT00129402|552228|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
231675|NCT00129402|552229|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
231676|NCT00129402|552230|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
231677|NCT00129402|552231|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
231678|NCT00129402|552232|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
231679|NCT00129402|552226|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
231680|NCT00129402|552227|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
231681|NCT00129402|552228|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
231682|NCT00129402|552229|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
231683|NCT00129402|552230|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
231684|NCT00129402|552231|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
231685|NCT00129402|552232|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
231686|NCT00129311|552251|P2|NOT COMPLETED|Overall Study||19
231687|NCT00129311|552252|P1|NOT COMPLETED|Overall Study||12
231688|NCT00129311|552251|P2|COMPLETED|Overall Study||31
231689|NCT00129311|552252|P1|COMPLETED|Overall Study||39
231690|NCT00129311|552251|P2|STARTED|Overall Study||50
231691|NCT00129311|552252|P1|STARTED|Overall Study||51
231692|NCT00129259|552262|P2|NOT COMPLETED|Overall Study||3
231693|NCT00129259|552263|P1|NOT COMPLETED|Overall Study||3
231694|NCT00129259|552262|P2|COMPLETED|Overall Study||22
231695|NCT00129259|552263|P1|COMPLETED|Overall Study||49
231696|NCT00129259|552262|P2|Received All or Part of Cycle 2|Overall Study||0
231697|NCT00129259|552263|P1|Received All or Part of Cycle 2|Overall Study||40
231698|NCT00129259|552262|P2|Received All or Part of Cycle 1|Overall Study||0
231699|NCT00129259|552263|P1|Received All or Part of Cycle 1|Overall Study||52
231700|NCT00129259|552262|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
231701|NCT00129259|552263|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
231702|NCT00129246|552275|P2|NOT COMPLETED|Overall Study||0
231703|NCT00129246|552276|P1|NOT COMPLETED|Overall Study||0
231704|NCT00129246|552275|P2|COMPLETED|Overall Study||20
231705|NCT00129246|552276|P1|COMPLETED|Overall Study||20
231706|NCT00129246|552275|P2|STARTED|Overall Study||20
231707|NCT00129246|552276|P1|STARTED|Overall Study||20
231708|NCT00129220|552291|P3|NOT COMPLETED|Study Period III||10
231709|NCT00129220|552292|P2|NOT COMPLETED|Study Period III||1
231710|NCT00129220|552293|P1|NOT COMPLETED|Study Period III||13
231711|NCT00129220|552291|P3|COMPLETED|Study Period III||42
231712|NCT00129220|552292|P2|COMPLETED|Study Period III||7
231713|NCT00129220|552293|P1|COMPLETED|Study Period III||59
231714|NCT00129220|552291|P3|STARTED|Study Period III||52
231715|NCT00129220|552292|P2|STARTED|Study Period III||8
231716|NCT00129220|552293|P1|STARTED|Study Period III||72
231717|NCT00129220|552291|P3|NOT COMPLETED|Study Period II||47
231718|NCT00129220|552292|P2|NOT COMPLETED|Study Period II||12
231719|NCT00129220|552293|P1|NOT COMPLETED|Study Period II||33
231720|NCT00129220|552291|P3|COMPLETED|Study Period II||52
231721|NCT00129220|552292|P2|COMPLETED|Study Period II||8
231722|NCT00129220|552293|P1|COMPLETED|Study Period II||72
231723|NCT00129220|552291|P3|Received at Least One Dose of Study Drug|Study Period II||97
231724|NCT00129220|552292|P2|Received at Least One Dose of Study Drug|Study Period II||20
231725|NCT00129220|552293|P1|Received at Least One Dose of Study Drug|Study Period II||104
231726|NCT00129220|552291|P3|STARTED|Study Period II||99
231727|NCT00129220|552292|P2|STARTED|Study Period II||20
231728|NCT00129220|552293|P1|STARTED|Study Period II||105
231729|NCT00129129|552333|P5|NOT COMPLETED|Fourth Dose Phase||6
231730|NCT00129129|552334|P4|NOT COMPLETED|Fourth Dose Phase||4
231731|NCT00129129|552335|P3|NOT COMPLETED|Fourth Dose Phase||0
231732|NCT00129129|552336|P2|NOT COMPLETED|Fourth Dose Phase||0
231733|NCT00129129|552337|P1|NOT COMPLETED|Fourth Dose Phase||4
231734|NCT00129129|552333|P5|COMPLETED|Fourth Dose Phase||124
231735|NCT00129129|552334|P4|COMPLETED|Fourth Dose Phase||128
231736|NCT00129129|552335|P3|COMPLETED|Fourth Dose Phase||0
231737|NCT00129129|552336|P2|COMPLETED|Fourth Dose Phase||0
231738|NCT00129129|552337|P1|COMPLETED|Fourth Dose Phase||232
231739|NCT00129129|552333|P5|STARTED|Fourth Dose Phase||130
231740|NCT00129129|552334|P4|STARTED|Fourth Dose Phase||132
231741|NCT00129129|552335|P3|STARTED|Fourth Dose Phase||0
231742|NCT00129129|552336|P2|STARTED|Fourth Dose Phase||0
231743|NCT00129129|552337|P1|STARTED|Fourth Dose Phase||236
231744|NCT00129129|552333|P5|NOT COMPLETED|Primary Phase||0
231745|NCT00129129|552334|P4|NOT COMPLETED|Primary Phase||0
231746|NCT00129129|552335|P3|NOT COMPLETED|Primary Phase||0
231747|NCT00129129|552336|P2|NOT COMPLETED|Primary Phase||25
231748|NCT00129129|552337|P1|NOT COMPLETED|Primary Phase||25
231749|NCT00129129|552333|P5|COMPLETED|Primary Phase||0
231750|NCT00129129|552334|P4|COMPLETED|Primary Phase||0
231751|NCT00129129|552335|P3|COMPLETED|Primary Phase||150
231752|NCT00129129|552336|P2|COMPLETED|Primary Phase||294
231753|NCT00129129|552337|P1|COMPLETED|Primary Phase||262
231754|NCT00129129|552333|P5|STARTED|Primary Phase||0
231755|NCT00129129|552334|P4|STARTED|Primary Phase||0
231756|NCT00129129|552335|P3|STARTED|Primary Phase||150
231757|NCT00129129|552336|P2|STARTED|Primary Phase||319
231758|NCT00129129|552337|P1|STARTED|Primary Phase||287
231759|NCT00129116|552544|P5|NOT COMPLETED|Booster Phase||1
231760|NCT00129116|552545|P4|NOT COMPLETED|Booster Phase||0
231761|NCT00129116|552546|P3|NOT COMPLETED|Booster Phase||0
231762|NCT00129116|552547|P2|NOT COMPLETED|Booster Phase||0
231763|NCT00129116|552548|P1|NOT COMPLETED|Booster Phase||2
231764|NCT00129116|552544|P5|COMPLETED|Booster Phase||43
231765|NCT00129116|552545|P4|COMPLETED|Booster Phase||44
231766|NCT00129116|552546|P3|COMPLETED|Booster Phase||44
231767|NCT00129116|552547|P2|COMPLETED|Booster Phase||42
231768|NCT00129116|552548|P1|COMPLETED|Booster Phase||45
231769|NCT00129116|552544|P5|STARTED|Booster Phase||44
231770|NCT00129116|552545|P4|STARTED|Booster Phase||44
231771|NCT00129116|552546|P3|STARTED|Booster Phase||44
231772|NCT00129116|552547|P2|STARTED|Booster Phase||42
231773|NCT00129116|552548|P1|STARTED|Booster Phase||47
231774|NCT00129116|552544|P5|NOT COMPLETED|Primary Phase||1
231775|NCT00129116|552545|P4|NOT COMPLETED|Primary Phase||1
231776|NCT00129116|552546|P3|NOT COMPLETED|Primary Phase||1
231777|NCT00129116|552547|P2|NOT COMPLETED|Primary Phase||4
231778|NCT00129116|552548|P1|NOT COMPLETED|Primary Phase||2
231779|NCT00129116|552544|P5|COMPLETED|Primary Phase||76
231780|NCT00129116|552545|P4|COMPLETED|Primary Phase||77
231781|NCT00129116|552546|P3|COMPLETED|Primary Phase||77
231782|NCT00129116|552547|P2|COMPLETED|Primary Phase||73
231783|NCT00129116|552548|P1|COMPLETED|Primary Phase||76
231784|NCT00129116|552544|P5|STARTED|Primary Phase||77
231785|NCT00129116|552545|P4|STARTED|Primary Phase||78
231786|NCT00129116|552546|P3|STARTED|Primary Phase||78
231787|NCT00129116|552547|P2|STARTED|Primary Phase||77
231788|NCT00129116|552548|P1|STARTED|Primary Phase||78
231789|NCT00128921|552813|P3|NOT COMPLETED|Overall Study||0
231790|NCT00128921|552814|P2|NOT COMPLETED|Overall Study||5
231791|NCT00128921|552815|P1|NOT COMPLETED|Overall Study||5
231792|NCT00128921|552813|P3|COMPLETED|Overall Study||0
231793|NCT00128921|552814|P2|COMPLETED|Overall Study||3
231794|NCT00128921|552815|P1|COMPLETED|Overall Study||5
231795|NCT00128921|552813|P3|Received Bortezomib|Overall Study||0
231796|NCT00128921|552814|P2|Received Bortezomib|Overall Study||6
231797|NCT00128921|552815|P1|Received Bortezomib|Overall Study||10
231798|NCT00128921|552813|P3|STARTED|Overall Study||0
231799|NCT00128921|552814|P2|STARTED|Overall Study||8
231800|NCT00128921|552815|P1|STARTED|Overall Study||10
231801|NCT00128830|552832|P1|NOT COMPLETED|Overall Study||72
231802|NCT00128830|552832|P1|COMPLETED|Overall Study||139
231803|NCT00128830|552832|P1|STARTED|Overall Study||211
231804|NCT00128713|552850|P3|NOT COMPLETED|Overall Study||0
231805|NCT00128713|552851|P2|NOT COMPLETED|Overall Study||0
231806|NCT00128713|552852|P1|NOT COMPLETED|Overall Study||0
231807|NCT00128713|552850|P3|COMPLETED|Overall Study||449
231808|NCT00128713|552851|P2|COMPLETED|Overall Study||449
231809|NCT00128713|552852|P1|COMPLETED|Overall Study||453
231810|NCT00128713|552850|P3|STARTED|Overall Study||449
231811|NCT00128713|552851|P2|STARTED|Overall Study||449
231812|NCT00128713|552852|P1|STARTED|Overall Study||453
231813|NCT00128661|552874|P2|NOT COMPLETED|Overall Study||258
231814|NCT00128661|552875|P1|NOT COMPLETED|Overall Study||274
231815|NCT00128661|552874|P2|COMPLETED|Overall Study||3481
231816|NCT00128661|552875|P1|COMPLETED|Overall Study||3453
231817|NCT00128661|552874|P2|STARTED|Overall Study||3739
231818|NCT00128661|552875|P1|STARTED|Overall Study||3727
231819|NCT00128492|552921|P2|NOT COMPLETED|Overall Study||59
231820|NCT00128492|552922|P1|NOT COMPLETED|Overall Study||20
231821|NCT00128492|552921|P2|COMPLETED|Overall Study||130
231822|NCT00128492|552922|P1|COMPLETED|Overall Study||65
231823|NCT00128492|552921|P2|STARTED|Overall Study||189
231824|NCT00128492|552922|P1|STARTED|Overall Study||85
231825|NCT00128401|552982|P2|NOT COMPLETED|Overall Study||4
231826|NCT00128401|552983|P1|NOT COMPLETED|Overall Study||6
231827|NCT00128401|552982|P2|COMPLETED|Overall Study||15
231828|NCT00128401|552983|P1|COMPLETED|Overall Study||14
231829|NCT00128401|552982|P2|STARTED|Overall Study||19
231830|NCT00128401|552983|P1|STARTED|Overall Study||20
231831|NCT00128219|552994|P2|NOT COMPLETED|Overall Study||71
231832|NCT00128219|552995|P1|NOT COMPLETED|Overall Study||69
231833|NCT00128219|552994|P2|COMPLETED|Overall Study||263
231834|NCT00128219|552995|P1|COMPLETED|Overall Study||264
231835|NCT00128219|552994|P2|STARTED|Overall Study||334
231836|NCT00128219|552995|P1|STARTED|Overall Study||333
231837|NCT00128206|553079|P2|NOT COMPLETED|Overall Study||120
231838|NCT00128206|553080|P1|NOT COMPLETED|Overall Study||137
231839|NCT00128206|553079|P2|COMPLETED|Overall Study||60
231840|NCT00128206|553080|P1|COMPLETED|Overall Study||47
231841|NCT00128206|553079|P2|STARTED|Overall Study||180
231842|NCT00128206|553080|P1|STARTED|Overall Study||184
231843|NCT00128193|553098|P12|NOT COMPLETED|Overall Study||2
231844|NCT00128193|553099|P11|NOT COMPLETED|Overall Study||3
231845|NCT00128193|553100|P10|NOT COMPLETED|Overall Study||2
231846|NCT00128193|553101|P9|NOT COMPLETED|Overall Study||2
231847|NCT00128193|553102|P8|NOT COMPLETED|Overall Study||0
231848|NCT00128193|553103|P7|NOT COMPLETED|Overall Study||4
231849|NCT00128193|553104|P6|NOT COMPLETED|Overall Study||3
231850|NCT00128193|553105|P5|NOT COMPLETED|Overall Study||2
231851|NCT00128193|553106|P4|NOT COMPLETED|Overall Study||1
231852|NCT00128193|553107|P3|NOT COMPLETED|Overall Study||3
231853|NCT00128193|553108|P2|NOT COMPLETED|Overall Study||0
231854|NCT00128193|553109|P1|NOT COMPLETED|Overall Study||0
231855|NCT00128193|553098|P12|COMPLETED|Overall Study||18
231856|NCT00128193|553099|P11|COMPLETED|Overall Study||17
231857|NCT00128193|553100|P10|COMPLETED|Overall Study||18
231858|NCT00128193|553101|P9|COMPLETED|Overall Study||18
231859|NCT00128193|553102|P8|COMPLETED|Overall Study||20
231860|NCT00128193|553103|P7|COMPLETED|Overall Study||16
231861|NCT00128193|553104|P6|COMPLETED|Overall Study||17
231862|NCT00128193|553105|P5|COMPLETED|Overall Study||18
231863|NCT00128193|553106|P4|COMPLETED|Overall Study||44
231864|NCT00128193|553107|P3|COMPLETED|Overall Study||42
231865|NCT00128193|553108|P2|COMPLETED|Overall Study||5
231866|NCT00128193|553109|P1|COMPLETED|Overall Study||5
231867|NCT00128193|553098|P12|STARTED|Overall Study||20
231868|NCT00128193|553099|P11|STARTED|Overall Study||20
231869|NCT00128193|553100|P10|STARTED|Overall Study||20
231870|NCT00128193|553101|P9|STARTED|Overall Study||20
231871|NCT00128193|553102|P8|STARTED|Overall Study||20
231872|NCT00128193|553103|P7|STARTED|Overall Study||20
231873|NCT00128193|553104|P6|STARTED|Overall Study||20
231874|NCT00128193|553105|P5|STARTED|Overall Study||20
231875|NCT00128193|553106|P4|STARTED|Overall Study||45
231876|NCT00128193|553107|P3|STARTED|Overall Study||45
231877|NCT00128193|553108|P2|STARTED|Overall Study||5
231878|NCT00128193|553109|P1|STARTED|Overall Study||5
231879|NCT00128180|553345|P2|NOT COMPLETED|Overall Study||0
231880|NCT00128180|553346|P1|NOT COMPLETED|Overall Study||0
231881|NCT00128180|553345|P2|COMPLETED|Overall Study||34
231882|NCT00128180|553346|P1|COMPLETED|Overall Study||32
231883|NCT00128180|553345|P2|STARTED|Overall Study||34
231884|NCT00128180|553346|P1|STARTED|Overall Study||32
231885|NCT00127933|553372|P2|NOT COMPLETED|Overall Study||0
231886|NCT00127933|553373|P1|NOT COMPLETED|Overall Study||1
231887|NCT00127933|553372|P2|COMPLETED|Overall Study||34
231888|NCT00127933|553373|P1|COMPLETED|Overall Study||122
231889|NCT00127933|553372|P2|Postoperative|Overall Study||27
231890|NCT00127933|553373|P1|Postoperative|Overall Study||98
231891|NCT00127933|553372|P2|Quality of Life Population|Overall Study||33
231892|NCT00127933|553373|P1|Quality of Life Population|Overall Study||118
231893|NCT00127933|553372|P2|Safety Population|Overall Study||34
231894|NCT00127933|553373|P1|Safety Population|Overall Study||122
231895|NCT00127933|553372|P2|Clinical Response|Overall Study||34
231896|NCT00127933|553373|P1|Clinical Response|Overall Study||122
231897|NCT00127933|553372|P2|Pathological Response|Overall Study||28
231898|NCT00127933|553373|P1|Pathological Response|Overall Study||101
231899|NCT00127933|553372|P2|STARTED|Overall Study||34
231900|NCT00127933|553373|P1|STARTED|Overall Study||123
231901|NCT00127855|553394|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
231902|NCT00127855|553395|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
231903|NCT00127855|553396|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
231904|NCT00127855|553397|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
231905|NCT00127855|553398|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
231906|NCT00127855|553394|P5|COMPLETED|Polysaccharide Challenge Dose||77
231907|NCT00127855|553395|P4|COMPLETED|Polysaccharide Challenge Dose||81
231908|NCT00127855|553396|P3|COMPLETED|Polysaccharide Challenge Dose||77
231909|NCT00127855|553397|P2|COMPLETED|Polysaccharide Challenge Dose||79
231910|NCT00127855|553398|P1|COMPLETED|Polysaccharide Challenge Dose||80
231911|NCT00127855|553394|P5|STARTED|Polysaccharide Challenge Dose||77
231912|NCT00127855|553395|P4|STARTED|Polysaccharide Challenge Dose||81
231913|NCT00127855|553396|P3|STARTED|Polysaccharide Challenge Dose||77
231914|NCT00127855|553397|P2|STARTED|Polysaccharide Challenge Dose||79
231915|NCT00127855|553398|P1|STARTED|Polysaccharide Challenge Dose||80
231916|NCT00127855|553394|P5|NOT COMPLETED|Primary Vaccination Course||4
231917|NCT00127855|553395|P4|NOT COMPLETED|Primary Vaccination Course||0
231918|NCT00127855|553396|P3|NOT COMPLETED|Primary Vaccination Course||2
231919|NCT00127855|553397|P2|NOT COMPLETED|Primary Vaccination Course||1
231920|NCT00127855|553398|P1|NOT COMPLETED|Primary Vaccination Course||2
231921|NCT00127855|553394|P5|COMPLETED|Primary Vaccination Course||78
231922|NCT00127855|553395|P4|COMPLETED|Primary Vaccination Course||81
231923|NCT00127855|553396|P3|COMPLETED|Primary Vaccination Course||78
231924|NCT00127855|553397|P2|COMPLETED|Primary Vaccination Course||81
231925|NCT00127855|553398|P1|COMPLETED|Primary Vaccination Course||80
231926|NCT00127855|553394|P5|STARTED|Primary Vaccination Course||82
231927|NCT00127855|553395|P4|STARTED|Primary Vaccination Course||81
231928|NCT00127855|553396|P3|STARTED|Primary Vaccination Course||80
231929|NCT00127855|553397|P2|STARTED|Primary Vaccination Course||82
231930|NCT00127855|553398|P1|STARTED|Primary Vaccination Course||82
231931|NCT00127842|553580|P1|NOT COMPLETED|Overall Study||39
231932|NCT00127842|553580|P1|COMPLETED|Overall Study||71
231933|NCT00127842|553580|P1|STARTED|Overall Study||110
231934|NCT00127803|553598|P4|NOT COMPLETED|Overall Study||1
231935|NCT00127803|553599|P3|NOT COMPLETED|Overall Study||0
231936|NCT00127803|553600|P2|NOT COMPLETED|Overall Study||0
231937|NCT00127803|553601|P1|NOT COMPLETED|Overall Study||3
231938|NCT00127803|553598|P4|COMPLETED|Overall Study||11
231939|NCT00127803|553599|P3|COMPLETED|Overall Study||12
231940|NCT00127803|553600|P2|COMPLETED|Overall Study||13
231941|NCT00127803|553601|P1|COMPLETED|Overall Study||10
231942|NCT00127803|553598|P4|STARTED|Overall Study||12
231943|NCT00127803|553599|P3|STARTED|Overall Study||12
231944|NCT00127803|553600|P2|STARTED|Overall Study||13
231945|NCT00127803|553601|P1|STARTED|Overall Study||13
231946|NCT00127790|553623|P4|NOT COMPLETED|Post-Treatment||0
231947|NCT00127790|553624|P3|NOT COMPLETED|Post-Treatment||0
231948|NCT00127790|553625|P2|NOT COMPLETED|Post-Treatment||0
231949|NCT00127790|553626|P1|NOT COMPLETED|Post-Treatment||0
231950|NCT00127790|553623|P4|COMPLETED|Post-Treatment||4
231951|NCT00127790|553624|P3|COMPLETED|Post-Treatment||6
231952|NCT00127790|553625|P2|COMPLETED|Post-Treatment||5
231953|NCT00127790|553626|P1|COMPLETED|Post-Treatment||6
231954|NCT00127790|553623|P4|STARTED|Post-Treatment||4
231955|NCT00127790|553624|P3|STARTED|Post-Treatment||6
231956|NCT00127790|553625|P2|STARTED|Post-Treatment||5
231957|NCT00127790|553626|P1|STARTED|Post-Treatment||6
231958|NCT00127790|553623|P4|NOT COMPLETED|Pre-Treatment||0
231959|NCT00127790|553624|P3|NOT COMPLETED|Pre-Treatment||0
231960|NCT00127790|553625|P2|NOT COMPLETED|Pre-Treatment||0
231961|NCT00127790|553626|P1|NOT COMPLETED|Pre-Treatment||0
231962|NCT00127790|553623|P4|COMPLETED|Pre-Treatment||4
231963|NCT00127790|553624|P3|COMPLETED|Pre-Treatment||6
231964|NCT00127790|553625|P2|COMPLETED|Pre-Treatment||5
231965|NCT00127790|553626|P1|COMPLETED|Pre-Treatment||6
231966|NCT00127790|553623|P4|STARTED|Pre-Treatment||4
231967|NCT00127790|553624|P3|STARTED|Pre-Treatment||6
231968|NCT00127790|553625|P2|STARTED|Pre-Treatment||5
231969|NCT00127790|553626|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
231970|NCT00127712|553650|P2|NOT COMPLETED|Overall Study||0
231971|NCT00127712|553651|P1|NOT COMPLETED|Overall Study||5
231972|NCT00127712|553650|P2|COMPLETED|Overall Study||65
231973|NCT00127712|553651|P1|COMPLETED|Overall Study||60
231974|NCT00127712|553650|P2|STARTED|Overall Study||65
231975|NCT00127712|553651|P1|STARTED|Overall Study||65
231976|NCT00127530|553665|P2|NOT COMPLETED|Overall Study||21
231977|NCT00127530|553666|P1|NOT COMPLETED|Overall Study||1
231978|NCT00127530|553665|P2|COMPLETED|Overall Study||207
231979|NCT00127530|553666|P1|COMPLETED|Overall Study||71
231980|NCT00127530|553665|P2|STARTED|Overall Study||228
231981|NCT00127530|553666|P1|STARTED|Overall Study||72
231982|NCT00127413|553676|P4|NOT COMPLETED|Overall Study||2
231983|NCT00127413|553677|P3|NOT COMPLETED|Overall Study||8
231984|NCT00127413|553678|P2|NOT COMPLETED|Overall Study||4
231985|NCT00127413|553679|P1|NOT COMPLETED|Overall Study||6
231986|NCT00127413|553676|P4|COMPLETED|Overall Study||5
231987|NCT00127413|553677|P3|COMPLETED|Overall Study||5
231988|NCT00127413|553678|P2|COMPLETED|Overall Study||6
231989|NCT00127413|553679|P1|COMPLETED|Overall Study||6
231990|NCT00127413|553676|P4|STARTED|Overall Study||7
231991|NCT00127413|553677|P3|STARTED|Overall Study||13
231992|NCT00127413|553678|P2|STARTED|Overall Study||10
231993|NCT00127413|553679|P1|STARTED|Overall Study||12
231994|NCT00127218|553691|P2|NOT COMPLETED|Overall Study||15
231995|NCT00127218|553692|P1|NOT COMPLETED|Overall Study||13
231996|NCT00127218|553691|P2|COMPLETED|Overall Study||58
231997|NCT00127218|553692|P1|COMPLETED|Overall Study||59
231998|NCT00127218|553691|P2|STARTED|Overall Study||73
231999|NCT00127218|553692|P1|STARTED|Overall Study||72
232000|NCT00127192|553703|P5|NOT COMPLETED|Overall Study||5
232001|NCT00127192|553704|P4|NOT COMPLETED|Overall Study||1
232002|NCT00127192|553705|P3|NOT COMPLETED|Overall Study||2
232003|NCT00127192|553706|P2|NOT COMPLETED|Overall Study||1
232004|NCT00127192|553707|P1|NOT COMPLETED|Overall Study||3
232005|NCT00127192|553703|P5|COMPLETED|Overall Study||68
232006|NCT00127192|553704|P4|COMPLETED|Overall Study||67
232007|NCT00127192|553705|P3|COMPLETED|Overall Study||68
232008|NCT00127192|553706|P2|COMPLETED|Overall Study||71
232009|NCT00127192|553707|P1|COMPLETED|Overall Study||77
232010|NCT00127192|553703|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
232011|NCT00127192|553704|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
232012|NCT00127192|553705|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
232013|NCT00127192|553706|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
232014|NCT00127192|553707|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
232015|NCT00127166|553731|P2|NOT COMPLETED|Period II||0
232016|NCT00127166|553732|P1|NOT COMPLETED|Period II||3
232017|NCT00127166|553731|P2|COMPLETED|Period II||73
232018|NCT00127166|553732|P1|COMPLETED|Period II||72
232019|NCT00127166|553731|P2|STARTED|Period II||73
232020|NCT00127166|553732|P1|STARTED|Period II||75
232021|NCT00127166|553731|P2|NOT COMPLETED|Washout Period||1
232022|NCT00127166|553732|P1|NOT COMPLETED|Washout Period||0
232023|NCT00127166|553731|P2|COMPLETED|Washout Period||73
232024|NCT00127166|553732|P1|COMPLETED|Washout Period||75
232025|NCT00127166|553731|P2|STARTED|Washout Period||74
232026|NCT00127166|553732|P1|STARTED|Washout Period||75
232027|NCT00127166|553731|P2|NOT COMPLETED|Period I||2
232028|NCT00127166|553732|P1|NOT COMPLETED|Period I||3
232029|NCT00127166|553731|P2|COMPLETED|Period I||74
232030|NCT00127166|553732|P1|COMPLETED|Period I||75
232031|NCT00127166|553731|P2|STARTED|Period I||76
232032|NCT00127166|553732|P1|STARTED|Period I||78
232033|NCT00127101|553752|P6|NOT COMPLETED|Continuation Phase||3
232034|NCT00127101|553753|P5|NOT COMPLETED|Continuation Phase||3
232035|NCT00127101|553754|P4|NOT COMPLETED|Continuation Phase||0
232036|NCT00127101|553755|P3|NOT COMPLETED|Continuation Phase||1
232037|NCT00127101|553756|P2|NOT COMPLETED|Continuation Phase||0
232038|NCT00127101|553757|P1|NOT COMPLETED|Continuation Phase||0
232039|NCT00127101|553752|P6|COMPLETED|Continuation Phase||0
232040|NCT00127101|553753|P5|COMPLETED|Continuation Phase||0
232041|NCT00127101|553754|P4|COMPLETED|Continuation Phase||0
232042|NCT00127101|553755|P3|COMPLETED|Continuation Phase||0
232043|NCT00127101|553756|P2|COMPLETED|Continuation Phase||0
232044|NCT00127101|553757|P1|COMPLETED|Continuation Phase||0
232045|NCT00127101|553752|P6|STARTED|Continuation Phase||3
232046|NCT00127101|553753|P5|STARTED|Continuation Phase||3
232047|NCT00127101|553754|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
232048|NCT00127101|553755|P3|STARTED|Continuation Phase||1
232049|NCT00127101|553756|P2|STARTED|Continuation Phase||0
232050|NCT00127101|553757|P1|STARTED|Continuation Phase||0
232051|NCT00127101|553752|P6|NOT COMPLETED|Base Protocol||1
232052|NCT00127101|553753|P5|NOT COMPLETED|Base Protocol||2
232053|NCT00127101|553754|P4|NOT COMPLETED|Base Protocol||0
232054|NCT00127101|553755|P3|NOT COMPLETED|Base Protocol||2
232055|NCT00127101|553756|P2|NOT COMPLETED|Base Protocol||4
232056|NCT00127101|553757|P1|NOT COMPLETED|Base Protocol||2
232057|NCT00127101|553752|P6|COMPLETED|Base Protocol||3
232058|NCT00127101|553753|P5|COMPLETED|Base Protocol||3
232059|NCT00127101|553754|P4|COMPLETED|Base Protocol||3
232060|NCT00127101|553755|P3|COMPLETED|Base Protocol||1
232061|NCT00127101|553756|P2|COMPLETED|Base Protocol||1
232062|NCT00127101|553757|P1|COMPLETED|Base Protocol||1
232063|NCT00127101|553752|P6|STARTED|Base Protocol||4
232064|NCT00127101|553753|P5|STARTED|Base Protocol||5
232065|NCT00127101|553754|P4|STARTED|Base Protocol||3
232066|NCT00127101|553755|P3|STARTED|Base Protocol||3
232067|NCT00127101|553756|P2|STARTED|Base Protocol||5
232068|NCT00127101|553757|P1|STARTED|Base Protocol||3
232069|NCT00127036|553779|P2|NOT COMPLETED|Overall Study||11
232070|NCT00127036|553780|P1|NOT COMPLETED|Overall Study||8
232071|NCT00127036|553779|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
232072|NCT00127036|553780|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
232073|NCT00127036|553779|P2|STARTED|Overall Study||31
232074|NCT00127036|553780|P1|STARTED|Overall Study||34
232075|NCT00126776|553792|P2|NOT COMPLETED|Overall Study||0
232076|NCT00126776|553793|P1|NOT COMPLETED|Overall Study||0
232077|NCT00126776|553792|P2|COMPLETED|Overall Study||371
232078|NCT00126776|553793|P1|COMPLETED|Overall Study||372
232079|NCT00126776|553792|P2|STARTED|Overall Study||371
232080|NCT00126776|553793|P1|STARTED|Overall Study||372
232081|NCT00126750|553799|P2|NOT COMPLETED|Overall Study||266
232082|NCT00126750|553800|P1|NOT COMPLETED|Overall Study||180
232083|NCT00126750|553799|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
232084|NCT00126750|553800|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
232085|NCT00126750|553799|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
232086|NCT00126750|553800|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
232087|NCT00126737|553810|P4|NOT COMPLETED|Overall Study||7
232088|NCT00126737|553811|P3|NOT COMPLETED|Overall Study||6
232089|NCT00126737|553812|P2|NOT COMPLETED|Overall Study||3
232090|NCT00126737|553813|P1|NOT COMPLETED|Overall Study||6
232091|NCT00126737|553810|P4|COMPLETED|Overall Study||18
232092|NCT00126737|553811|P3|COMPLETED|Overall Study||24
232093|NCT00126737|553812|P2|COMPLETED|Overall Study||24
232094|NCT00126737|553813|P1|COMPLETED|Overall Study||22
232095|NCT00126737|553810|P4|STARTED|Overall Study||25
232096|NCT00126737|553811|P3|STARTED|Overall Study||30
232097|NCT00126737|553812|P2|STARTED|Overall Study||27
232098|NCT00126737|553813|P1|STARTED|Overall Study||28
232099|NCT00126659|553842|P3|NOT COMPLETED|Overall Study||2
232100|NCT00126659|553843|P2|NOT COMPLETED|Overall Study||0
232101|NCT00126659|553844|P1|NOT COMPLETED|Overall Study||0
232102|NCT00126659|553842|P3|COMPLETED|Overall Study||2
232103|NCT00126659|553843|P2|COMPLETED|Overall Study||3
232104|NCT00126659|553844|P1|COMPLETED|Overall Study||3
232105|NCT00126659|553842|P3|STARTED|Overall Study||4
232106|NCT00126659|553843|P2|STARTED|Overall Study||3
232107|NCT00126659|553844|P1|STARTED|Overall Study||3
232108|NCT00126594|553852|P2|NOT COMPLETED|Overall Study||37
232109|NCT00126594|553853|P1|NOT COMPLETED|Overall Study||39
232110|NCT00126594|553852|P2|COMPLETED|Overall Study||3
232111|NCT00126594|553853|P1|COMPLETED|Overall Study||1
232112|NCT00126594|553852|P2|STARTED|Overall Study||40
232113|NCT00126594|553853|P1|STARTED|Overall Study||40
232114|NCT00126581|553870|P2|NOT COMPLETED|Overall Study||20
232115|NCT00126581|553871|P1|NOT COMPLETED|Overall Study||13
232116|NCT00126581|553870|P2|COMPLETED|Overall Study||80
232117|NCT00126581|553871|P1|COMPLETED|Overall Study||68
232118|NCT00126581|553870|P2|STARTED|Overall Study||100
232119|NCT00126581|553871|P1|STARTED|Overall Study||81
232120|NCT00126568|553891|P1|NOT COMPLETED|Overall Study||2
232121|NCT00126568|553891|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
232122|NCT00126568|553891|P1|STARTED|Overall Study||20
232123|NCT00126555|553897|P1|NOT COMPLETED|Overall Study||6
232124|NCT00126555|553897|P1|COMPLETED|Overall Study||17
232125|NCT00126555|553897|P1|STARTED|Overall Study||23
232126|NCT00126503|553913|P2|NOT COMPLETED|Overall Study||21
232127|NCT00126503|553914|P1|NOT COMPLETED|Overall Study||47
232128|NCT00126503|553913|P2|COMPLETED|Overall Study||0
232129|NCT00126503|553914|P1|COMPLETED|Overall Study||1
232130|NCT00126503|553913|P2|STARTED|Overall Study||21
232131|NCT00126503|553914|P1|STARTED|Overall Study||48
232132|NCT00126490|553926|P1|NOT COMPLETED|Overall Study||1
232133|NCT00126490|553926|P1|COMPLETED|Overall Study||18
232134|NCT00126490|553926|P1|STARTED|Overall Study||19
232135|NCT00126425|553936|P2|NOT COMPLETED|Overall Study||11
232136|NCT00126425|553937|P1|NOT COMPLETED|Overall Study||41
232137|NCT00126425|553936|P2|COMPLETED|Overall Study||37
232138|NCT00126425|553937|P1|COMPLETED|Overall Study||498
232139|NCT00126425|553936|P2|STARTED|Overall Study||48
232140|NCT00126425|553937|P1|STARTED|Overall Study||539
232141|NCT00126191|553945|P2|NOT COMPLETED|Overall Study||2
232142|NCT00126191|553946|P1|NOT COMPLETED|Overall Study||0
232143|NCT00126191|553945|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
232144|NCT00126191|553946|P1|COMPLETED|Overall Study||2
232145|NCT00126191|553945|P2|STARTED|Overall Study||8
232146|NCT00126191|553946|P1|STARTED|Overall Study||2
232147|NCT00126126|553956|P2|NOT COMPLETED|Overall Study||2
232148|NCT00126126|553957|P1|NOT COMPLETED|Overall Study||0
232149|NCT00126126|553956|P2|COMPLETED|Overall Study||7
232150|NCT00126126|553957|P1|COMPLETED|Overall Study||9
232151|NCT00126126|553956|P2|STARTED|Overall Study||9
232152|NCT00126126|553957|P1|STARTED|Overall Study||9
232153|NCT00126113|553967|P2|NOT COMPLETED|Overall Study||2
232154|NCT00126113|553968|P1|NOT COMPLETED|Overall Study||3
232155|NCT00126113|553967|P2|COMPLETED|Overall Study||35
232156|NCT00126113|553968|P1|COMPLETED|Overall Study||34
232157|NCT00126113|553967|P2|STARTED|Overall Study||37
232158|NCT00126113|553968|P1|STARTED|Overall Study||37
232159|NCT00125957|553982|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
232160|NCT00125957|553983|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
232161|NCT00125957|553982|P2|COMPLETED|Second Intervention (3 Weeks)||17
232162|NCT00125957|553983|P1|COMPLETED|Second Intervention (3 Weeks)||15
232163|NCT00125957|553982|P2|STARTED|Second Intervention (3 Weeks)||17
232164|NCT00125957|553983|P1|STARTED|Second Intervention (3 Weeks)||15
232165|NCT00125957|553982|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
232166|NCT00125957|553983|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
232167|NCT00125957|553982|P2|COMPLETED|First Intervention (3 Weeks)||17
232168|NCT00125957|553983|P1|COMPLETED|First Intervention (3 Weeks)||15
232169|NCT00125957|553982|P2|STARTED|First Intervention (3 Weeks)||17
232170|NCT00125957|553983|P1|STARTED|First Intervention (3 Weeks)||15
232171|NCT00125931|553991|P1|NOT COMPLETED|Overall Study||0
232172|NCT00125931|553991|P1|COMPLETED|Overall Study||10
232173|NCT00125931|553991|P1|STARTED|Overall Study||10
232174|NCT00125619|553998|P2|NOT COMPLETED|Overall Study||0
232175|NCT00125619|553999|P1|NOT COMPLETED|Overall Study||0
232176|NCT00125619|553998|P2|COMPLETED|Overall Study||8
232177|NCT00125619|553999|P1|COMPLETED|Overall Study||8
232178|NCT00125619|553998|P2|STARTED|Overall Study||8
232179|NCT00125619|553999|P1|STARTED|Overall Study||8
232180|NCT00125593|554019|P2|NOT COMPLETED|Overall Study||103
232181|NCT00125593|554020|P1|NOT COMPLETED|Overall Study||101
232182|NCT00125593|554019|P2|COMPLETED|Overall Study||4517
232183|NCT00125593|554020|P1|COMPLETED|Overall Study||4549
232184|NCT00125593|554019|P2|STARTED|Overall Study||4620
232185|NCT00125593|554020|P1|STARTED|Overall Study||4650
232186|NCT00125528|554040|P2|NOT COMPLETED|Overall Study||1
232187|NCT00125528|554041|P1|NOT COMPLETED|Overall Study||2
232188|NCT00125528|554040|P2|COMPLETED|Overall Study||20
232189|NCT00125528|554041|P1|COMPLETED|Overall Study||18
232190|NCT00125528|554040|P2|STARTED|Overall Study||21
232191|NCT00125528|554041|P1|STARTED|Overall Study||20
232192|NCT00125515|554052|P3|NOT COMPLETED|Overall Study||21
232193|NCT00125515|554053|P2|NOT COMPLETED|Overall Study||20
232194|NCT00125515|554054|P1|NOT COMPLETED|Overall Study||20
232195|NCT00125515|554052|P3|COMPLETED|Overall Study||6
232196|NCT00125515|554053|P2|COMPLETED|Overall Study||7
232197|NCT00125515|554054|P1|COMPLETED|Overall Study||7
232198|NCT00125515|554052|P3|STARTED|Overall Study||27
232199|NCT00125515|554053|P2|STARTED|Overall Study||27
232200|NCT00125515|554054|P1|STARTED|Overall Study||27
232201|NCT00125268|554064|P2|NOT COMPLETED|Overall Study||1
232202|NCT00125268|554065|P1|NOT COMPLETED|Overall Study||1
232203|NCT00125268|554064|P2|COMPLETED|Overall Study||13
232204|NCT00125268|554065|P1|COMPLETED|Overall Study||15
232205|NCT00125268|554064|P2|STARTED|Overall Study||14
232206|NCT00125268|554065|P1|STARTED|Overall Study||16
232207|NCT00125242|554077|P2|NOT COMPLETED|Overall Study||2
232208|NCT00125242|554078|P1|NOT COMPLETED|Overall Study||7
232209|NCT00125242|554077|P2|COMPLETED|Overall Study||14
232210|NCT00125242|554078|P1|COMPLETED|Overall Study||87
232211|NCT00125242|554077|P2|STARTED|Overall Study||16
232212|NCT00125242|554078|P1|STARTED|Overall Study||94
232213|NCT00125190|554083|P1|NOT COMPLETED|Overall Study||15
232214|NCT00125190|554083|P1|COMPLETED|Overall Study||30
232215|NCT00125190|554083|P1|STARTED|Overall Study||45
232216|NCT00125164|554101|P4|NOT COMPLETED|Overall Study||6
232217|NCT00125164|554102|P3|NOT COMPLETED|Overall Study||4
232218|NCT00125164|554103|P2|NOT COMPLETED|Overall Study||0
232219|NCT00125164|554104|P1|NOT COMPLETED|Overall Study||2
232220|NCT00125164|554101|P4|COMPLETED|Overall Study||45
232221|NCT00125164|554102|P3|COMPLETED|Overall Study||40
232222|NCT00125164|554103|P2|COMPLETED|Overall Study||16
232223|NCT00125164|554104|P1|COMPLETED|Overall Study||23
232224|NCT00125164|554101|P4|STARTED|Overall Study||51
232225|NCT00125164|554102|P3|STARTED|Overall Study||44
232226|NCT00125164|554103|P2|STARTED|Overall Study||16
232227|NCT00125164|554104|P1|STARTED|Overall Study||25
232228|NCT00125138|554158|P4|NOT COMPLETED|Overall Study||5
232229|NCT00125138|554159|P3|NOT COMPLETED|Overall Study||4
232230|NCT00125138|554160|P2|NOT COMPLETED|Overall Study||3
232231|NCT00125138|554161|P1|NOT COMPLETED|Overall Study||3
232232|NCT00125138|554158|P4|COMPLETED|Overall Study||25
232233|NCT00125138|554159|P3|COMPLETED|Overall Study||21
232234|NCT00125138|554160|P2|COMPLETED|Overall Study||17
232235|NCT00125138|554161|P1|COMPLETED|Overall Study||12
232236|NCT00125138|554158|P4|STARTED|Overall Study||30
232237|NCT00125138|554159|P3|STARTED|Overall Study||25
232238|NCT00125138|554160|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
232239|NCT00125138|554161|P1|STARTED|Overall Study||15
232240|NCT00125034|554177|P2|NOT COMPLETED|Overall Study||0
232241|NCT00125034|554178|P1|NOT COMPLETED|Overall Study||0
232242|NCT00125034|554177|P2|COMPLETED|Overall Study||168
232243|NCT00125034|554178|P1|COMPLETED|Overall Study||170
232244|NCT00125034|554177|P2|STARTED|Overall Study|Randomized & treated|168
232245|NCT00125034|554178|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
232246|NCT00124982|554210|P3|NOT COMPLETED|Long-term Period||89
232247|NCT00124982|554211|P2|NOT COMPLETED|Long-term Period||0
232248|NCT00124982|554212|P1|NOT COMPLETED|Long-term Period||0
232249|NCT00124982|554210|P3|COMPLETED|Long-term Period||441
232250|NCT00124982|554211|P2|COMPLETED|Long-term Period||0
232251|NCT00124982|554212|P1|COMPLETED|Long-term Period||0
232252|NCT00124982|554210|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
232253|NCT00124982|554211|P2|STARTED|Long-term Period||0
232254|NCT00124982|554212|P1|STARTED|Long-term Period||0
232255|NCT00124982|554210|P3|NOT COMPLETED|Short-term Period||0
232256|NCT00124982|554211|P2|NOT COMPLETED|Short-term Period||114
232257|NCT00124982|554212|P1|NOT COMPLETED|Short-term Period||72
232258|NCT00124982|554210|P3|COMPLETED|Short-term Period||0
232259|NCT00124982|554211|P2|COMPLETED|Short-term Period||483
232260|NCT00124982|554212|P1|COMPLETED|Short-term Period||377
232261|NCT00124982|554210|P3|STARTED|Short-term Period||0
232262|NCT00124982|554211|P2|STARTED|Short-term Period||597
232263|NCT00124982|554212|P1|STARTED|Short-term Period||449
232264|NCT00124943|554294|P4|NOT COMPLETED|Phase II||5
232265|NCT00124943|554295|P3|NOT COMPLETED|Phase II||0
232266|NCT00124943|554296|P2|NOT COMPLETED|Phase II||2
232267|NCT00124943|554297|P1|NOT COMPLETED|Phase II||0
232268|NCT00124943|554294|P4|COMPLETED|Phase II||50
232269|NCT00124943|554295|P3|COMPLETED|Phase II||3
232270|NCT00124943|554296|P2|COMPLETED|Phase II||49
232271|NCT00124943|554297|P1|COMPLETED|Phase II||3
232272|NCT00124943|554294|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
232273|NCT00124943|554295|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
232274|NCT00124943|554296|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
232275|NCT00124943|554297|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
232276|NCT00124943|554294|P4|NOT COMPLETED|Phase I||0
232277|NCT00124943|554295|P3|NOT COMPLETED|Phase I||0
232278|NCT00124943|554296|P2|NOT COMPLETED|Phase I||0
232279|NCT00124943|554297|P1|NOT COMPLETED|Phase I||0
232280|NCT00124943|554294|P4|COMPLETED|Phase I||3
232281|NCT00124943|554295|P3|COMPLETED|Phase I||3
232282|NCT00124943|554296|P2|COMPLETED|Phase I||3
232283|NCT00124943|554297|P1|COMPLETED|Phase I||3
232284|NCT00124943|554294|P4|STARTED|Phase I||3
232285|NCT00124943|554295|P3|STARTED|Phase I||3
232286|NCT00124943|554296|P2|STARTED|Phase I||3
232287|NCT00124943|554297|P1|STARTED|Phase I||3
232288|NCT00124748|554337|P2|NOT COMPLETED|Overall Study||284
232289|NCT00124748|554338|P1|NOT COMPLETED|Overall Study||143
232290|NCT00124748|554337|P2|COMPLETED|Overall Study||35
232291|NCT00124748|554338|P1|COMPLETED|Overall Study||14
232292|NCT00124748|554337|P2|Safety Population|Overall Study||316
232293|NCT00124748|554338|P1|Safety Population|Overall Study||157
232294|NCT00124748|554337|P2|STARTED|Overall Study||319
232295|NCT00124748|554338|P1|STARTED|Overall Study||157
232296|NCT00124735|554390|P10|NOT COMPLETED|Overall Study||2
232297|NCT00124735|554391|P9|NOT COMPLETED|Overall Study||3
232298|NCT00124735|554392|P8|NOT COMPLETED|Overall Study||1
232299|NCT00124735|554393|P7|NOT COMPLETED|Overall Study||0
232300|NCT00124735|554394|P6|NOT COMPLETED|Overall Study||2
232301|NCT00124735|554395|P5|NOT COMPLETED|Overall Study||2
232302|NCT00124735|554396|P4|NOT COMPLETED|Overall Study||3
232303|NCT00124735|554397|P3|NOT COMPLETED|Overall Study||0
232304|NCT00124735|554398|P2|NOT COMPLETED|Overall Study||2
232305|NCT00124735|554399|P1|NOT COMPLETED|Overall Study||1
232306|NCT00124735|554390|P10|COMPLETED|Overall Study||18
232307|NCT00124735|554391|P9|COMPLETED|Overall Study||22
232308|NCT00124735|554392|P8|COMPLETED|Overall Study||19
232309|NCT00124735|554393|P7|COMPLETED|Overall Study||6
232310|NCT00124735|554394|P6|COMPLETED|Overall Study||5
232311|NCT00124735|554395|P5|COMPLETED|Overall Study||17
232312|NCT00124735|554396|P4|COMPLETED|Overall Study||18
232313|NCT00124735|554397|P3|COMPLETED|Overall Study||18
232314|NCT00124735|554398|P2|COMPLETED|Overall Study||6
232315|NCT00124735|554399|P1|COMPLETED|Overall Study||4
232316|NCT00124735|554390|P10|STARTED|Overall Study||20
232317|NCT00124735|554391|P9|STARTED|Overall Study||25
232318|NCT00124735|554392|P8|STARTED|Overall Study||20
232319|NCT00124735|554393|P7|STARTED|Overall Study||6
232320|NCT00124735|554394|P6|STARTED|Overall Study||7
232321|NCT00124735|554395|P5|STARTED|Overall Study||19
232322|NCT00124735|554396|P4|STARTED|Overall Study||21
232323|NCT00124735|554397|P3|STARTED|Overall Study||18
232324|NCT00124735|554398|P2|STARTED|Overall Study||8
232325|NCT00124735|554399|P1|STARTED|Overall Study||5
232326|NCT00124709|554445|P2|NOT COMPLETED|Overall Study||272
232327|NCT00124709|554446|P1|NOT COMPLETED|Overall Study||255
232328|NCT00124709|554445|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
232329|NCT00124709|554446|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
232330|NCT00124709|554445|P2|Patients Who Received Study Medication|Overall Study||544
232331|NCT00124709|554446|P1|Patients Who Received Study Medication|Overall Study||543
232332|NCT00124709|554445|P2|STARTED|Overall Study||545
232333|NCT00124709|554446|P1|STARTED|Overall Study||546
232334|NCT00124657|554463|P3|NOT COMPLETED|Overall Study||32
232335|NCT00124657|554464|P2|NOT COMPLETED|Overall Study||5
232336|NCT00124657|554465|P1|NOT COMPLETED|Overall Study||16
232337|NCT00124657|554463|P3|COMPLETED|Overall Study||7
232338|NCT00124657|554464|P2|COMPLETED|Overall Study||0
232339|NCT00124657|554465|P1|COMPLETED|Overall Study||2
232340|NCT00124657|554463|P3|STARTED|Overall Study||39
232341|NCT00124657|554464|P2|STARTED|Overall Study||5
232342|NCT00124657|554465|P1|STARTED|Overall Study||18
232343|NCT00124618|554500|P1|NOT COMPLETED|Overall Study||1
232344|NCT00124618|554500|P1|COMPLETED|Overall Study||57
232345|NCT00124618|554500|P1|STARTED|Overall Study||58
232346|NCT00124579|554507|P1|NOT COMPLETED|Maintenance||2
232347|NCT00124579|554507|P1|COMPLETED|Maintenance||0
232348|NCT00124579|554507|P1|STARTED|Maintenance||2
232349|NCT00124579|554507|P1|NOT COMPLETED|Induction||5
232350|NCT00124579|554507|P1|COMPLETED|Induction||2
232351|NCT00124579|554507|P1|STARTED|Induction||7
232352|NCT00124449|554515|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
232353|NCT00124449|554516|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
232354|NCT00124449|554515|P2|COMPLETED|18-Month Untreated Observation Period||4
232355|NCT00124449|554516|P1|COMPLETED|18-Month Untreated Observation Period||7
232356|NCT00124449|554515|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
232357|NCT00124449|554516|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
232358|NCT00124449|554515|P2|STARTED|18-Month Untreated Observation Period||17
232359|NCT00124449|554516|P1|STARTED|18-Month Untreated Observation Period||22
232360|NCT00124449|554515|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
232361|NCT00124449|554516|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
232362|NCT00124449|554515|P2|COMPLETED|6-month Double-Blind Treatment Period||17
232363|NCT00124449|554516|P1|COMPLETED|6-month Double-Blind Treatment Period||22
232364|NCT00124449|554515|P2|STARTED|6-month Double-Blind Treatment Period||28
232365|NCT00124449|554516|P1|STARTED|6-month Double-Blind Treatment Period||28
232366|NCT00124176|554551|P2|NOT COMPLETED|Overall Study||0
232367|NCT00124176|554552|P1|NOT COMPLETED|Overall Study||0
232368|NCT00124176|554551|P2|COMPLETED|Overall Study||41
232369|NCT00124176|554552|P1|COMPLETED|Overall Study||40
232370|NCT00124176|554551|P2|Received Study Drug|Overall Study||41
232371|NCT00124176|554552|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
232372|NCT00124176|554551|P2|STARTED|Overall Study||41
232373|NCT00124176|554552|P1|STARTED|Overall Study||40
232374|NCT00124072|554570|P4|NOT COMPLETED|Overall Study||500
232375|NCT00124072|554571|P3|NOT COMPLETED|Overall Study||492
232376|NCT00124072|554572|P2|NOT COMPLETED|Overall Study||512
232377|NCT00124072|554573|P1|NOT COMPLETED|Overall Study||514
232378|NCT00124072|554570|P4|COMPLETED|Overall Study||2515
232379|NCT00124072|554571|P3|COMPLETED|Overall Study||2524
232380|NCT00124072|554572|P2|COMPLETED|Overall Study||2504
232381|NCT00124072|554573|P1|COMPLETED|Overall Study||2503
232382|NCT00124072|554570|P4|STARTED|Overall Study||3015
232383|NCT00124072|554571|P3|STARTED|Overall Study||3016
232384|NCT00124072|554572|P2|STARTED|Overall Study||3016
232385|NCT00124072|554573|P1|STARTED|Overall Study||3017
232386|NCT00124020|554585|P2|NOT COMPLETED|Overall Study||91
232387|NCT00124020|554586|P1|NOT COMPLETED|Overall Study||88
232388|NCT00124020|554585|P2|COMPLETED|Overall Study||289
232389|NCT00124020|554586|P1|COMPLETED|Overall Study||289
232390|NCT00124020|554585|P2|STARTED|Overall Study||380
232391|NCT00124020|554586|P1|STARTED|Overall Study||377
232392|NCT00123955|554594|P2|NOT COMPLETED|Overall Study||4
232393|NCT00123955|554595|P1|NOT COMPLETED|Overall Study||5
232394|NCT00123955|554594|P2|COMPLETED|Overall Study||34
232395|NCT00123955|554595|P1|COMPLETED|Overall Study||37
232396|NCT00123955|554594|P2|STARTED|Overall Study||38
232397|NCT00123955|554595|P1|STARTED|Overall Study||42
232398|NCT00123734|554601|P1|NOT COMPLETED|Overall Study||8
232399|NCT00123734|554601|P1|COMPLETED|Overall Study||74
232400|NCT00123734|554601|P1|STARTED|Overall Study||82
232401|NCT00123682|554636|P4|NOT COMPLETED|Overall Study||95
232402|NCT00123682|554637|P3|NOT COMPLETED|Overall Study||154
232403|NCT00123682|554638|P2|NOT COMPLETED|Overall Study||203
232404|NCT00123682|554639|P1|NOT COMPLETED|Overall Study||320
232405|NCT00123682|554636|P4|COMPLETED|Overall Study||430
232406|NCT00123682|554637|P3|COMPLETED|Overall Study||438
232407|NCT00123682|554638|P2|COMPLETED|Overall Study||731
232408|NCT00123682|554639|P1|COMPLETED|Overall Study||749
232409|NCT00123682|554636|P4|STARTED|Overall Study||525
232410|NCT00123682|554637|P3|STARTED|Overall Study||592
232411|NCT00123682|554638|P2|STARTED|Overall Study||934
232412|NCT00123682|554639|P1|STARTED|Overall Study||1069
232413|NCT00123643|554659|P2|NOT COMPLETED|Overall Study||0
232414|NCT00123643|554660|P1|NOT COMPLETED|Overall Study||0
232415|NCT00123643|554659|P2|COMPLETED|Overall Study||16
232416|NCT00123643|554660|P1|COMPLETED|Overall Study||20
232417|NCT00123643|554659|P2|STARTED|Overall Study||16
232418|NCT00123643|554660|P1|STARTED|Overall Study||20
232419|NCT00123630|554668|P2|NOT COMPLETED|Overall Study||0
232420|NCT00123630|554669|P1|NOT COMPLETED|Overall Study||0
232421|NCT00123630|554668|P2|COMPLETED|Overall Study||15
232422|NCT00123630|554669|P1|COMPLETED|Overall Study||15
232423|NCT00123630|554668|P2|STARTED|Overall Study||15
232424|NCT00123630|554669|P1|STARTED|Overall Study||15
232425|NCT00123604|554677|P2|NOT COMPLETED|Overall Study||1
232426|NCT00123604|554678|P1|NOT COMPLETED|Overall Study||1
232427|NCT00123604|554677|P2|COMPLETED|Overall Study||16
232428|NCT00123604|554678|P1|COMPLETED|Overall Study||18
232429|NCT00123604|554677|P2|STARTED|Overall Study||17
232430|NCT00123604|554678|P1|STARTED|Overall Study||19
232431|NCT00123487|554686|P2|NOT COMPLETED|Treated With Study Drug||305
232432|NCT00123487|554687|P1|NOT COMPLETED|Treated With Study Drug||304
232433|NCT00123487|554686|P2|COMPLETED|Treated With Study Drug||0
232434|NCT00123487|554687|P1|COMPLETED|Treated With Study Drug||0
232435|NCT00123487|554686|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
232436|NCT00123487|554687|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
232437|NCT00123487|554686|P2|NOT COMPLETED|Randomized||1
232438|NCT00123487|554687|P1|NOT COMPLETED|Randomized||1
232439|NCT00123487|554686|P2|COMPLETED|Randomized||304
232440|NCT00123487|554687|P1|COMPLETED|Randomized||305
232441|NCT00123487|554686|P2|STARTED|Randomized||305
232442|NCT00123487|554687|P1|STARTED|Randomized||306
232443|NCT00123474|554731|P4|NOT COMPLETED|As Treated at Study Closure||167
232444|NCT00123474|554732|P3|NOT COMPLETED|As Treated at Study Closure||167
232445|NCT00123474|554733|P2|NOT COMPLETED|As Treated at Study Closure||163
232446|NCT00123474|554734|P1|NOT COMPLETED|As Treated at Study Closure||165
232447|NCT00123474|554731|P4|COMPLETED|As Treated at Study Closure||0
232448|NCT00123474|554732|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
232449|NCT00123474|554733|P2|COMPLETED|As Treated at Study Closure||0
232450|NCT00123474|554734|P1|COMPLETED|As Treated at Study Closure||0
232451|NCT00123474|554731|P4|STARTED|As Treated at Study Closure||167
232452|NCT00123474|554732|P3|STARTED|As Treated at Study Closure||167
232453|NCT00123474|554733|P2|STARTED|As Treated at Study Closure||163
232454|NCT00123474|554734|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
232455|NCT00123474|554731|P4|NOT COMPLETED|Randomized to Treatment||1
232456|NCT00123474|554732|P3|NOT COMPLETED|Randomized to Treatment||2
232457|NCT00123474|554733|P2|NOT COMPLETED|Randomized to Treatment||4
232458|NCT00123474|554734|P1|NOT COMPLETED|Randomized to Treatment||1
232459|NCT00123474|554731|P4|COMPLETED|Randomized to Treatment||167
232460|NCT00123474|554732|P3|COMPLETED|Randomized to Treatment||166
232461|NCT00123474|554733|P2|COMPLETED|Randomized to Treatment||163
232462|NCT00123474|554734|P1|COMPLETED|Randomized to Treatment||166
232463|NCT00123474|554731|P4|STARTED|Randomized to Treatment||168
232464|NCT00123474|554732|P3|STARTED|Randomized to Treatment||168
232465|NCT00123474|554733|P2|STARTED|Randomized to Treatment||167
232466|NCT00123474|554734|P1|STARTED|Randomized to Treatment||167
232467|NCT00123422|554828|P3|NOT COMPLETED|Overall Study||10
232468|NCT00123422|554829|P2|NOT COMPLETED|Overall Study||6
232469|NCT00123422|554830|P1|NOT COMPLETED|Overall Study||4
232470|NCT00123422|554828|P3|COMPLETED|Overall Study||25
232471|NCT00123422|554829|P2|COMPLETED|Overall Study||27
232472|NCT00123422|554830|P1|COMPLETED|Overall Study||31
232473|NCT00123422|554828|P3|8-week Testing|Overall Study||27
232474|NCT00123422|554829|P2|8-week Testing|Overall Study||30
232475|NCT00123422|554830|P1|8-week Testing|Overall Study||32
232476|NCT00123422|554828|P3|STARTED|Overall Study||35
232477|NCT00123422|554829|P2|STARTED|Overall Study||33
232478|NCT00123422|554830|P1|STARTED|Overall Study||35
232479|NCT00123409|554843|P2|NOT COMPLETED|Overall Study||3
232480|NCT00123409|554844|P1|NOT COMPLETED|Overall Study||4
232481|NCT00123409|554843|P2|COMPLETED|Overall Study||71
232482|NCT00123409|554844|P1|COMPLETED|Overall Study||68
232483|NCT00123409|554843|P2|STARTED|Overall Study||74
232484|NCT00123409|554844|P1|STARTED|Overall Study||72
232485|NCT00123162|554854|P2|NOT COMPLETED|Overall Study||0
232486|NCT00123162|554855|P1|NOT COMPLETED|Overall Study||0
232487|NCT00123162|554854|P2|COMPLETED|Overall Study||12
232488|NCT00123162|554855|P1|COMPLETED|Overall Study||13
232489|NCT00123162|554854|P2|STARTED|Overall Study||12
232490|NCT00123162|554855|P1|STARTED|Overall Study||13
232491|NCT00123123|554866|P3|NOT COMPLETED|Overall Study||0
232492|NCT00123123|554867|P2|NOT COMPLETED|Overall Study||0
232493|NCT00123123|554868|P1|NOT COMPLETED|Overall Study||0
232494|NCT00123123|554866|P3|COMPLETED|Overall Study||58
232495|NCT00123123|554867|P2|COMPLETED|Overall Study||58
232496|NCT00123123|554868|P1|COMPLETED|Overall Study||59
232497|NCT00123123|554866|P3|STARTED|Overall Study||58
232498|NCT00123123|554867|P2|STARTED|Overall Study||58
232499|NCT00123123|554868|P1|STARTED|Overall Study||59
232500|NCT00122980|554881|P2|NOT COMPLETED|Overall Study||40
232501|NCT00122980|554882|P1|NOT COMPLETED|Overall Study||43
232502|NCT00122980|554881|P2|COMPLETED|Overall Study|Study terminated early|26
232503|NCT00122980|554882|P1|COMPLETED|Overall Study|Study terminated early|24
232504|NCT00122980|554881|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
232505|NCT00122980|554882|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
232506|NCT00122954|554904|P2|NOT COMPLETED|Overall Study||3
232507|NCT00122954|554905|P1|NOT COMPLETED|Overall Study||2
232508|NCT00122954|554904|P2|COMPLETED|Overall Study||18
232509|NCT00122954|554905|P1|COMPLETED|Overall Study||16
232510|NCT00122954|554904|P2|STARTED|Overall Study||21
232511|NCT00122954|554905|P1|STARTED|Overall Study||18
232512|NCT00122681|554913|P2|NOT COMPLETED|Overall Study||1521
232513|NCT00122681|554914|P1|NOT COMPLETED|Overall Study||1514
232514|NCT00122681|554913|P2|COMPLETED|Overall Study||7798
232515|NCT00122681|554914|P1|COMPLETED|Overall Study||7811
232516|NCT00122681|554913|P2|STARTED|Overall Study||9319
232517|NCT00122681|554914|P1|STARTED|Overall Study||9325
232518|NCT00122460|554980|P2|NOT COMPLETED|Overall Study||1
232519|NCT00122460|554981|P1|NOT COMPLETED|Overall Study||7
232520|NCT00122460|554980|P2|COMPLETED|Overall Study||219
232521|NCT00122460|554981|P1|COMPLETED|Overall Study||215
232522|NCT00122460|554980|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
232523|NCT00122460|554981|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
232524|NCT00122447|555007|P4|NOT COMPLETED|Overall Study||3
232525|NCT00122447|555008|P3|NOT COMPLETED|Overall Study||1
232526|NCT00122447|555009|P2|NOT COMPLETED|Overall Study||5
232527|NCT00122447|555010|P1|NOT COMPLETED|Overall Study||1
232528|NCT00122447|555007|P4|COMPLETED|Overall Study||14
232529|NCT00122447|555008|P3|COMPLETED|Overall Study||16
232530|NCT00122447|555009|P2|COMPLETED|Overall Study||13
232531|NCT00122447|555010|P1|COMPLETED|Overall Study||17
232532|NCT00122447|555007|P4|STARTED|Overall Study||17
232533|NCT00122447|555008|P3|STARTED|Overall Study||17
232534|NCT00122447|555009|P2|STARTED|Overall Study||18
232535|NCT00122447|555010|P1|STARTED|Overall Study||18
232536|NCT00122382|555030|P3|NOT COMPLETED|Open-Label Study||26
232537|NCT00122382|555031|P2|NOT COMPLETED|Open-Label Study||0
232538|NCT00122382|555032|P1|NOT COMPLETED|Open-Label Study||0
232539|NCT00122382|555030|P3|COMPLETED|Open-Label Study||433
232540|NCT00122382|555031|P2|COMPLETED|Open-Label Study||0
232541|NCT00122382|555032|P1|COMPLETED|Open-Label Study||0
232542|NCT00122382|555030|P3|STARTED|Open-Label Study||459
232543|NCT00122382|555031|P2|STARTED|Open-Label Study||0
232544|NCT00122382|555032|P1|STARTED|Open-Label Study||0
232545|NCT00122382|555030|P3|NOT COMPLETED|Double-Blind Study||0
232546|NCT00122382|555031|P2|NOT COMPLETED|Double-Blind Study||28
232547|NCT00122382|555032|P1|NOT COMPLETED|Double-Blind Study||24
232548|NCT00122382|555030|P3|COMPLETED|Double-Blind Study||0
232549|NCT00122382|555031|P2|COMPLETED|Double-Blind Study||227
232550|NCT00122382|555032|P1|COMPLETED|Double-Blind Study||232
232551|NCT00122382|555030|P3|Treated|Double-Blind Study||0
232552|NCT00122382|555031|P2|Treated|Double-Blind Study||253
232553|NCT00122382|555032|P1|Treated|Double-Blind Study||256
232554|NCT00122382|555030|P3|STARTED|Double-Blind Study||0
232555|NCT00122382|555031|P2|STARTED|Double-Blind Study|participants randomized|255
232556|NCT00122382|555032|P1|STARTED|Double-Blind Study|participants randomized|256
232557|NCT00122369|555085|P3|NOT COMPLETED|Overall Study||0
232558|NCT00122369|555086|P2|NOT COMPLETED|Overall Study||0
232559|NCT00122369|555087|P1|NOT COMPLETED|Overall Study||0
232560|NCT00122369|555085|P3|COMPLETED|Overall Study||78
232561|NCT00122369|555086|P2|COMPLETED|Overall Study||82
232562|NCT00122369|555087|P1|COMPLETED|Overall Study||76
232563|NCT00122369|555085|P3|STARTED|Overall Study||78
232564|NCT00122369|555086|P2|STARTED|Overall Study||82
232565|NCT00122369|555087|P1|STARTED|Overall Study||76
232566|NCT00122187|555178|P2|NOT COMPLETED|Overall Study||2
232567|NCT00122187|555179|P1|NOT COMPLETED|Overall Study||2
232568|NCT00122187|555178|P2|COMPLETED|Overall Study||2
232569|NCT00122187|555179|P1|COMPLETED|Overall Study||2
232570|NCT00122187|555178|P2|Post-intervention Data Collection|Overall Study||2
232571|NCT00122187|555179|P1|Post-intervention Data Collection|Overall Study||2
232572|NCT00122187|555178|P2|Intervention Implemented|Overall Study||4
232573|NCT00122187|555179|P1|Intervention Implemented|Overall Study||3
232574|NCT00122187|555178|P2|Randomized to Intervention or Usual Care|Overall Study||4
232575|NCT00122187|555179|P1|Randomized to Intervention or Usual Care|Overall Study||4
232576|NCT00122187|555178|P2|Matched by Colonoscopy Volume|Overall Study||4
232577|NCT00122187|555179|P1|Matched by Colonoscopy Volume|Overall Study||4
232578|NCT00122187|555178|P2|STARTED|Overall Study||4
232579|NCT00122187|555179|P1|STARTED|Overall Study||4
232580|NCT00122135|555193|P2|NOT COMPLETED|Overall Study||0
232581|NCT00122135|555194|P1|NOT COMPLETED|Overall Study||3
232582|NCT00122135|555193|P2|COMPLETED|Overall Study||60
232583|NCT00122135|555194|P1|COMPLETED|Overall Study||57
232584|NCT00122135|555193|P2|STARTED|Overall Study||60
232585|NCT00122135|555194|P1|STARTED|Overall Study||60
232586|NCT00122109|555202|P2|NOT COMPLETED|Overall Study||7
232587|NCT00122109|555203|P1|NOT COMPLETED|Overall Study||6
232588|NCT00122109|555202|P2|COMPLETED|Overall Study||57
232589|NCT00122109|555203|P1|COMPLETED|Overall Study||55
232590|NCT00122109|555202|P2|STARTED|Overall Study|ITT|64
232591|NCT00122109|555203|P1|STARTED|Overall Study|ITT|61
232592|NCT00121836|555227|P1|NOT COMPLETED|Overall Study||55
232593|NCT00121836|555227|P1|COMPLETED|Overall Study||54
232594|NCT00121836|555227|P1|STARTED|Overall Study||109
232595|NCT00121810|555238|P2|NOT COMPLETED|Overall Study||39
232596|NCT00121810|555239|P1|NOT COMPLETED|Overall Study||30
232597|NCT00121810|555238|P2|COMPLETED|Overall Study||115
232598|NCT00121810|555239|P1|COMPLETED|Overall Study||121
232599|NCT00121810|555238|P2|Intent-to-Treat (ITT) Population|Overall Study||151
232600|NCT00121810|555239|P1|Intent-to-Treat (ITT) Population|Overall Study||148
232601|NCT00121810|555238|P2|Safety Population|Overall Study||153
232602|NCT00121810|555239|P1|Safety Population|Overall Study||148
232603|NCT00121810|555238|P2|STARTED|Overall Study||154
232604|NCT00121810|555239|P1|STARTED|Overall Study||151
232605|NCT00121719|555267|P14|NOT COMPLETED|Overall Study||7
232606|NCT00121719|555268|P13|NOT COMPLETED|Overall Study||24
232607|NCT00121719|555269|P12|NOT COMPLETED|Overall Study||5
232608|NCT00121719|555270|P11|NOT COMPLETED|Overall Study||6
232609|NCT00121719|555271|P10|NOT COMPLETED|Overall Study||3
232610|NCT00121719|555272|P9|NOT COMPLETED|Overall Study||6
232611|NCT00121719|555273|P8|NOT COMPLETED|Overall Study||9
232612|NCT00121719|555274|P7|NOT COMPLETED|Overall Study||12
232613|NCT00121719|555275|P6|NOT COMPLETED|Overall Study||3
232614|NCT00121719|555276|P5|NOT COMPLETED|Overall Study||3
232615|NCT00121719|555277|P4|NOT COMPLETED|Overall Study||3
232616|NCT00121719|555278|P3|NOT COMPLETED|Overall Study||4
232617|NCT00121719|555279|P2|NOT COMPLETED|Overall Study||4
232618|NCT00121719|555280|P1|NOT COMPLETED|Overall Study||4
232619|NCT00121719|555267|P14|COMPLETED|Overall Study||0
232620|NCT00121719|555268|P13|COMPLETED|Overall Study||0
232621|NCT00121719|555269|P12|COMPLETED|Overall Study||0
232622|NCT00121719|555270|P11|COMPLETED|Overall Study||0
232623|NCT00121719|555271|P10|COMPLETED|Overall Study||0
232624|NCT00121719|555272|P9|COMPLETED|Overall Study||0
232625|NCT00121719|555273|P8|COMPLETED|Overall Study||0
232626|NCT00121719|555274|P7|COMPLETED|Overall Study||0
232627|NCT00121719|555275|P6|COMPLETED|Overall Study||0
232628|NCT00121719|555276|P5|COMPLETED|Overall Study||0
232629|NCT00121719|555277|P4|COMPLETED|Overall Study||0
232630|NCT00121719|555278|P3|COMPLETED|Overall Study||0
232631|NCT00121719|555279|P2|COMPLETED|Overall Study||0
232632|NCT00121719|555280|P1|COMPLETED|Overall Study||0
232633|NCT00121719|555267|P14|STARTED|Overall Study||7
232634|NCT00121719|555268|P13|STARTED|Overall Study||24
232635|NCT00121719|555269|P12|STARTED|Overall Study||5
232636|NCT00121719|555270|P11|STARTED|Overall Study||6
232637|NCT00121719|555271|P10|STARTED|Overall Study||3
232638|NCT00121719|555272|P9|STARTED|Overall Study||6
232639|NCT00121719|555273|P8|STARTED|Overall Study||9
232640|NCT00121719|555274|P7|STARTED|Overall Study||12
232641|NCT00121719|555275|P6|STARTED|Overall Study||3
232642|NCT00121719|555276|P5|STARTED|Overall Study||3
232643|NCT00121719|555277|P4|STARTED|Overall Study||3
232644|NCT00121719|555278|P3|STARTED|Overall Study||4
232645|NCT00121719|555279|P2|STARTED|Overall Study||4
232646|NCT00121719|555280|P1|STARTED|Overall Study||4
232647|NCT00121667|555457|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
232648|NCT00121667|555458|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
232649|NCT00121667|555459|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
232650|NCT00121667|555460|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
232651|NCT00121667|555457|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
232652|NCT00121667|555458|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
232653|NCT00121667|555459|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
232654|NCT00121667|555460|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
232655|NCT00121667|555457|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
232656|NCT00121667|555458|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
232657|NCT00121667|555459|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
232658|NCT00121667|555460|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
232659|NCT00121667|555457|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
232660|NCT00121667|555458|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
232661|NCT00121667|555459|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
232662|NCT00121667|555460|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
232663|NCT00121667|555457|P4|NOT COMPLETED|Short Term (ST) Period||67
232664|NCT00121667|555458|P3|NOT COMPLETED|Short Term (ST) Period||41
232665|NCT00121667|555459|P2|NOT COMPLETED|Short Term (ST) Period||48
232666|NCT00121667|555460|P1|NOT COMPLETED|Short Term (ST) Period||44
232667|NCT00121667|555457|P4|COMPLETED|Short Term (ST) Period||112
232668|NCT00121667|555458|P3|COMPLETED|Short Term (ST) Period||140
232669|NCT00121667|555459|P2|COMPLETED|Short Term (ST) Period||143
232670|NCT00121667|555460|P1|COMPLETED|Short Term (ST) Period||148
232671|NCT00121667|555457|P4|STARTED|Short Term (ST) Period||179
232672|NCT00121667|555458|P3|STARTED|Short Term (ST) Period||181
232673|NCT00121667|555459|P2|STARTED|Short Term (ST) Period||191
232674|NCT00121667|555460|P1|STARTED|Short Term (ST) Period||192
232675|NCT00121641|555558|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
232676|NCT00121641|555559|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
232677|NCT00121641|555560|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
232678|NCT00121641|555561|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
232679|NCT00121641|555562|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
232680|NCT00121641|555558|P5|COMPLETED|48-month Short Term + Long Term Period||8
232681|NCT00121641|555559|P4|COMPLETED|48-month Short Term + Long Term Period||24
232682|NCT00121641|555560|P3|COMPLETED|48-month Short Term + Long Term Period||28
232683|NCT00121641|555561|P2|COMPLETED|48-month Short Term + Long Term Period||24
232684|NCT00121641|555562|P1|COMPLETED|48-month Short Term + Long Term Period||23
232685|NCT00121641|555558|P5|STARTED|48-month Short Term + Long Term Period||66
232686|NCT00121641|555559|P4|STARTED|48-month Short Term + Long Term Period||95
232687|NCT00121641|555560|P3|STARTED|48-month Short Term + Long Term Period||98
232688|NCT00121641|555561|P2|STARTED|48-month Short Term + Long Term Period||106
232689|NCT00121641|555562|P1|STARTED|48-month Short Term + Long Term Period||102
232690|NCT00121641|555558|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
232691|NCT00121641|555559|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
232692|NCT00121641|555560|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
232693|NCT00121641|555561|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
232694|NCT00121641|555562|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
232695|NCT00121641|555558|P5|COMPLETED|24-week Short-term Treatment Period||25
232696|NCT00121641|555559|P4|COMPLETED|24-week Short-term Treatment Period||55
232697|NCT00121641|555560|P3|COMPLETED|24-week Short-term Treatment Period||69
232698|NCT00121641|555561|P2|COMPLETED|24-week Short-term Treatment Period||68
232699|NCT00121641|555562|P1|COMPLETED|24-week Short-term Treatment Period||73
232700|NCT00121641|555558|P5|STARTED|24-week Short-term Treatment Period||66
232701|NCT00121641|555559|P4|STARTED|24-week Short-term Treatment Period||95
232702|NCT00121641|555560|P3|STARTED|24-week Short-term Treatment Period||98
232703|NCT00121641|555561|P2|STARTED|24-week Short-term Treatment Period||106
232704|NCT00121641|555562|P1|STARTED|24-week Short-term Treatment Period||102
232705|NCT00121485|555675|P2|NOT COMPLETED|Overall Study||7
232706|NCT00121485|555676|P1|NOT COMPLETED|Overall Study||1
232707|NCT00121485|555675|P2|COMPLETED|Overall Study||59
232708|NCT00121485|555676|P1|COMPLETED|Overall Study||133
232709|NCT00121485|555675|P2|STARTED|Overall Study||66
232710|NCT00121485|555676|P1|STARTED|Overall Study||134
232711|NCT00121472|555710|P1|NOT COMPLETED|Overall Study||0
232712|NCT00121472|555710|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
232713|NCT00121472|555710|P1|STARTED|Overall Study||194
232714|NCT00121238|555721|P1|NOT COMPLETED|Overall Study||3
232715|NCT00121238|555721|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
232716|NCT00121238|555721|P1|STARTED|Overall Study||16
232717|NCT00121225|555729|P1|NOT COMPLETED|Overall Study||0
232718|NCT00121225|555729|P1|COMPLETED|Overall Study||32
232719|NCT00121225|555729|P1|STARTED|Overall Study||32
232720|NCT00121199|555733|P1|NOT COMPLETED|Overall Study||28
232721|NCT00121199|555733|P1|COMPLETED|Overall Study||45
232722|NCT00121199|555733|P1|Eligible and Began Protocol Therapy|Overall Study||64
232723|NCT00121199|555733|P1|Eligible|Overall Study||64
232724|NCT00121199|555733|P1|STARTED|Overall Study||73
232725|NCT00121186|555740|P1|NOT COMPLETED|Overall Study||0
232726|NCT00121186|555740|P1|COMPLETED|Overall Study||1
232727|NCT00121186|555740|P1|STARTED|Overall Study||1
232728|NCT00121134|555749|P4|NOT COMPLETED|Overall Study||9
232729|NCT00121134|555750|P3|NOT COMPLETED|Overall Study||21
232730|NCT00121134|555751|P2|NOT COMPLETED|Overall Study||15
232731|NCT00121134|555752|P1|NOT COMPLETED|Overall Study||16
232732|NCT00121134|555749|P4|COMPLETED|Overall Study||31
232733|NCT00121134|555750|P3|COMPLETED|Overall Study||20
232734|NCT00121134|555751|P2|COMPLETED|Overall Study||26
232735|NCT00121134|555752|P1|COMPLETED|Overall Study||24
232736|NCT00121134|555749|P4|STARTED|Overall Study||40
232737|NCT00121134|555750|P3|STARTED|Overall Study||41
232738|NCT00121134|555751|P2|STARTED|Overall Study||41
232739|NCT00121134|555752|P1|STARTED|Overall Study||40
232740|NCT00120874|555764|P2|NOT COMPLETED|Overall Study||1
232741|NCT00120874|555765|P1|NOT COMPLETED|Overall Study||0
232742|NCT00120874|555764|P2|COMPLETED|Overall Study||9
232743|NCT00120874|555765|P1|COMPLETED|Overall Study||10
232744|NCT00120874|555764|P2|Completed Study; Started Extension Study|Overall Study||10
232745|NCT00120874|555765|P1|Completed Study; Started Extension Study|Overall Study||10
232746|NCT00120874|555764|P2|STARTED|Overall Study||10
232747|NCT00120874|555765|P1|STARTED|Overall Study||10
232748|NCT00120627|555803|P2|NOT COMPLETED|Overall Study||5
232749|NCT00120627|555804|P1|NOT COMPLETED|Overall Study||5
232750|NCT00120627|555803|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
232751|NCT00120627|555804|P1|COMPLETED|Overall Study||66
232752|NCT00120627|555803|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
232753|NCT00120627|555804|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
232754|NCT00120627|555803|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
232755|NCT00120627|555804|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
232756|NCT00120627|555803|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
232757|NCT00120627|555804|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
232758|NCT00120523|555830|P2|NOT COMPLETED|Follow-Up Period||24
232759|NCT00120523|555831|P1|NOT COMPLETED|Follow-Up Period||30
232760|NCT00120523|555830|P2|COMPLETED|Follow-Up Period||46
232761|NCT00120523|555831|P1|COMPLETED|Follow-Up Period||90
232762|NCT00120523|555830|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
232763|NCT00120523|555831|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
232764|NCT00120523|555830|P2|NOT COMPLETED|Treatment Period||339
232765|NCT00120523|555831|P1|NOT COMPLETED|Treatment Period||369
232766|NCT00120523|555830|P2|COMPLETED|Treatment Period||874
232767|NCT00120523|555831|P1|COMPLETED|Treatment Period||836
232768|NCT00120523|555830|P2|STARTED|Treatment Period||1213
232769|NCT00120523|555831|P1|STARTED|Treatment Period||1205
232770|NCT00120406|555855|P2|NOT COMPLETED|Overall Study||16
232771|NCT00120406|555856|P1|NOT COMPLETED|Overall Study||19
232772|NCT00120406|555855|P2|COMPLETED|Overall Study||222
232773|NCT00120406|555856|P1|COMPLETED|Overall Study||217
232774|NCT00120406|555855|P2|STARTED|Overall Study||238
232775|NCT00120406|555856|P1|STARTED|Overall Study||236
232776|NCT00120289|555866|P2|NOT COMPLETED|Overall Study||109
232777|NCT00120289|555867|P1|NOT COMPLETED|Overall Study||121
232778|NCT00120289|555866|P2|COMPLETED|Overall Study||1587
232779|NCT00120289|555867|P1|COMPLETED|Overall Study||1597
232780|NCT00120289|555866|P2|STARTED|Overall Study||1696
232781|NCT00120289|555867|P1|STARTED|Overall Study||1718
232782|NCT00120250|555879|P2|NOT COMPLETED|Overall Study||2
232783|NCT00120250|555880|P1|NOT COMPLETED|Overall Study||1
232784|NCT00120250|555879|P2|COMPLETED|Overall Study||12
232785|NCT00120250|555880|P1|COMPLETED|Overall Study||12
232786|NCT00120250|555879|P2|STARTED|Overall Study||14
232787|NCT00120250|555880|P1|STARTED|Overall Study||13
232788|NCT00120042|555896|P3|NOT COMPLETED|Overall Study||0
232789|NCT00120042|555897|P2|NOT COMPLETED|Overall Study||0
232790|NCT00120042|555898|P1|NOT COMPLETED|Overall Study||0
232791|NCT00120042|555896|P3|COMPLETED|Overall Study||83
232792|NCT00120042|555897|P2|COMPLETED|Overall Study||83
232793|NCT00120042|555898|P1|COMPLETED|Overall Study||85
232794|NCT00120042|555896|P3|STARTED|Overall Study||83
232795|NCT00120042|555897|P2|STARTED|Overall Study||83
232796|NCT00120042|555898|P1|STARTED|Overall Study||85
232797|NCT00119678|555908|P2|NOT COMPLETED|Open-label Treatment Period||0
232798|NCT00119678|555909|P1|NOT COMPLETED|Open-label Treatment Period||110
232799|NCT00119678|555908|P2|COMPLETED|Open-label Treatment Period||0
232800|NCT00119678|555909|P1|COMPLETED|Open-label Treatment Period||0
232801|NCT00119678|555908|P2|STARTED|Open-label Treatment Period||0
232802|NCT00119678|555909|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
232803|NCT00119678|555908|P2|NOT COMPLETED|Double-blind Treatment Period||26
232804|NCT00119678|555909|P1|NOT COMPLETED|Double-blind Treatment Period||41
232805|NCT00119678|555908|P2|COMPLETED|Double-blind Treatment Period||35
232806|NCT00119678|555909|P1|COMPLETED|Double-blind Treatment Period||81
232807|NCT00119678|555908|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
232808|NCT00119678|555909|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
232809|NCT00119678|555908|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
232810|NCT00119678|555909|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
232811|NCT00119678|555908|P2|STARTED|Double-blind Treatment Period||61
232812|NCT00119678|555909|P1|STARTED|Double-blind Treatment Period||122
232813|NCT00119262|555957|P2|NOT COMPLETED|Overall Study||58
232814|NCT00119262|555958|P1|NOT COMPLETED|Overall Study||46
232815|NCT00119262|555957|P2|COMPLETED|Overall Study||64
232816|NCT00119262|555958|P1|COMPLETED|Overall Study||58
232817|NCT00119262|555957|P2|Eligible and Treated|Overall Study||119
232818|NCT00119262|555958|P1|Eligible and Treated|Overall Study||102
232819|NCT00119262|555957|P2|Treated|Overall Study||120
232820|NCT00119262|555958|P1|Treated|Overall Study||103
232821|NCT00119262|555957|P2|Eligible|Overall Study||120
232822|NCT00119262|555958|P1|Eligible|Overall Study||103
232823|NCT00119262|555957|P2|STARTED|Overall Study||122
232824|NCT00119262|555958|P1|STARTED|Overall Study||104
232825|NCT00119158|555970|P2|NOT COMPLETED|Placebo Treatment||0
232826|NCT00119158|555971|P1|NOT COMPLETED|Placebo Treatment||0
232827|NCT00119158|555970|P2|COMPLETED|Placebo Treatment||45
232828|NCT00119158|555971|P1|COMPLETED|Placebo Treatment||45
232829|NCT00119158|555970|P2|STARTED|Placebo Treatment||45
232830|NCT00119158|555971|P1|STARTED|Placebo Treatment||45
232831|NCT00119158|555970|P2|NOT COMPLETED|Active Treatment||0
232832|NCT00119158|555971|P1|NOT COMPLETED|Active Treatment||0
232833|NCT00119158|555970|P2|COMPLETED|Active Treatment||45
232834|NCT00119158|555971|P1|COMPLETED|Active Treatment||45
232835|NCT00119158|555970|P2|STARTED|Active Treatment||45
232836|NCT00119158|555971|P1|STARTED|Active Treatment|patients are self controls|45
232837|NCT00119041|555982|P3|NOT COMPLETED|Overall Study||0
232838|NCT00119041|555983|P2|NOT COMPLETED|Overall Study||0
232839|NCT00119041|555984|P1|NOT COMPLETED|Overall Study||0
232840|NCT00119041|555982|P3|COMPLETED|Overall Study||22
232841|NCT00119041|555983|P2|COMPLETED|Overall Study||83
232842|NCT00119041|555984|P1|COMPLETED|Overall Study||199
232843|NCT00119041|555982|P3|STARTED|Overall Study||22
232844|NCT00119041|555983|P2|STARTED|Overall Study||83
232845|NCT00119041|555984|P1|STARTED|Overall Study||199
232846|NCT00119015|555995|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
232847|NCT00119015|555996|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
232848|NCT00119015|555997|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
232849|NCT00119015|555995|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
232850|NCT00119015|555996|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
232851|NCT00119015|555997|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
232852|NCT00119015|555995|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
232853|NCT00119015|555996|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
232854|NCT00119015|555997|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
232855|NCT00119015|555995|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
232856|NCT00119015|555996|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
232857|NCT00119015|555997|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
232858|NCT00119015|555995|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
232859|NCT00119015|555996|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
232860|NCT00119015|555997|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
232861|NCT00119015|555995|P3|STARTED|Open-Label Phase (2 Weeks)||0
232862|NCT00119015|555996|P2|STARTED|Open-Label Phase (2 Weeks)||0
232863|NCT00119015|555997|P1|STARTED|Open-Label Phase (2 Weeks)||102
232864|NCT00118911|556013|P2|NOT COMPLETED|Overall Study||5
232865|NCT00118911|556014|P1|NOT COMPLETED|Overall Study||2
232866|NCT00118911|556013|P2|COMPLETED|Overall Study||38
232867|NCT00118911|556014|P1|COMPLETED|Overall Study||41
232868|NCT00118911|556013|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
232869|NCT00118911|556014|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
232870|NCT00118911|556013|P2|6 Month Follow-up|Overall Study||30
232871|NCT00118911|556014|P1|6 Month Follow-up|Overall Study||37
232872|NCT00118911|556013|P2|Completed Post-Treatment Assessment|Overall Study||37
232873|NCT00118911|556014|P1|Completed Post-Treatment Assessment|Overall Study||41
232874|NCT00118911|556013|P2|Received Intervention as Assigned|Overall Study||38
232875|NCT00118911|556014|P1|Received Intervention as Assigned|Overall Study||41
232876|NCT00118911|556013|P2|STARTED|Overall Study||43
232877|NCT00118911|556014|P1|STARTED|Overall Study||43
232878|NCT00118898|556026|P4|NOT COMPLETED|Overall Study||141
232879|NCT00118898|556027|P3|NOT COMPLETED|Overall Study||123
232880|NCT00118898|556028|P2|NOT COMPLETED|Overall Study||141
232881|NCT00118898|556029|P1|NOT COMPLETED|Overall Study||121
232882|NCT00118898|556026|P4|COMPLETED|Overall Study||322
232883|NCT00118898|556027|P3|COMPLETED|Overall Study||342
232884|NCT00118898|556028|P2|COMPLETED|Overall Study||324
232885|NCT00118898|556029|P1|COMPLETED|Overall Study||343
232886|NCT00118898|556026|P4|Initiated Treatment|Overall Study||462
232887|NCT00118898|556027|P3|Initiated Treatment|Overall Study||464
232888|NCT00118898|556028|P2|Initiated Treatment|Overall Study||461
232889|NCT00118898|556029|P1|Initiated Treatment|Overall Study||461
232890|NCT00118898|556026|P4|STARTED|Overall Study||463
232891|NCT00118898|556027|P3|STARTED|Overall Study||465
232892|NCT00118898|556028|P2|STARTED|Overall Study||465
232893|NCT00118898|556029|P1|STARTED|Overall Study||464
232894|NCT00118755|556125|P2|NOT COMPLETED|Overall Study||215
232895|NCT00118755|556126|P1|NOT COMPLETED|Overall Study||210
232896|NCT00118755|556125|P2|COMPLETED|Overall Study||3
232897|NCT00118755|556126|P1|COMPLETED|Overall Study||7
232898|NCT00118755|556125|P2|Safety Population|Overall Study||211
232899|NCT00118755|556126|P1|Safety Population|Overall Study||208
232900|NCT00118755|556125|P2|STARTED|Overall Study||218
232901|NCT00118755|556126|P1|STARTED|Overall Study||217
232902|NCT00118742|556140|P2|NOT COMPLETED|Overall Study||66
232903|NCT00118742|556141|P1|NOT COMPLETED|Overall Study||49
232904|NCT00118742|556140|P2|COMPLETED|Overall Study||82
232905|NCT00118742|556141|P1|COMPLETED|Overall Study||96
232906|NCT00118742|556140|P2|STARTED|Overall Study||148
232907|NCT00118742|556141|P1|STARTED|Overall Study||145
232908|NCT00118534|556155|P2|NOT COMPLETED|Overall Study||0
232909|NCT00118534|556156|P1|NOT COMPLETED|Overall Study||0
232910|NCT00118534|556155|P2|COMPLETED|Overall Study||471
232911|NCT00118534|556156|P1|COMPLETED|Overall Study||472
232912|NCT00118534|556155|P2|STARTED|Overall Study||471
232913|NCT00118534|556156|P1|STARTED|Overall Study||472
232914|NCT00118417|556238|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
232915|NCT00118417|556239|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
232916|NCT00118417|556238|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
232917|NCT00118417|556239|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
232918|NCT00118417|556238|P2|STARTED|Phase III (Weeks 12 to 24)||10
232919|NCT00118417|556239|P1|STARTED|Phase III (Weeks 12 to 24)||9
232920|NCT00118417|556238|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
232921|NCT00118417|556239|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
232922|NCT00118417|556238|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
232923|NCT00118417|556239|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
232924|NCT00118417|556238|P2|STARTED|Phase II (Weeks 6 to 12)||13
232925|NCT00118417|556239|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
232926|NCT00118417|556238|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
232927|NCT00118417|556239|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
232928|NCT00118417|556238|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
232929|NCT00118417|556239|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
232930|NCT00118417|556238|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
232931|NCT00118417|556239|P1|STARTED|Phase I (Weeks 0 to 6)||39
232932|NCT00118404|556252|P3|NOT COMPLETED|Overall Study||20
232933|NCT00118404|556253|P2|NOT COMPLETED|Overall Study||16
232934|NCT00118404|556254|P1|NOT COMPLETED|Overall Study||24
232935|NCT00118404|556252|P3|COMPLETED|Overall Study||49
232936|NCT00118404|556253|P2|COMPLETED|Overall Study||70
232937|NCT00118404|556254|P1|COMPLETED|Overall Study||62
232938|NCT00118404|556252|P3|STARTED|Overall Study||69
232939|NCT00118404|556253|P2|STARTED|Overall Study||86
232940|NCT00118404|556254|P1|STARTED|Overall Study||86
232941|NCT00118378|556270|P2|NOT COMPLETED|Overall Study||8
232942|NCT00118378|556271|P1|NOT COMPLETED|Overall Study||2
232943|NCT00118378|556270|P2|COMPLETED|Overall Study||45
232944|NCT00118378|556271|P1|COMPLETED|Overall Study||60
232945|NCT00118378|556270|P2|STARTED|Overall Study||53
232946|NCT00118378|556271|P1|STARTED|Overall Study||62
232947|NCT00118365|556285|P2|NOT COMPLETED|Overall Study||60
232948|NCT00118365|556286|P1|NOT COMPLETED|Overall Study||59
232949|NCT00118365|556285|P2|COMPLETED|Overall Study||124
232950|NCT00118365|556286|P1|COMPLETED|Overall Study||132
232951|NCT00118365|556285|P2|STARTED|Overall Study||184
232952|NCT00118365|556286|P1|STARTED|Overall Study||191
232953|NCT00118248|556354|P2|NOT COMPLETED|Overall Study||0
232954|NCT00118248|556355|P1|NOT COMPLETED|Overall Study||0
232955|NCT00118248|556354|P2|COMPLETED|Overall Study||24
232956|NCT00118248|556355|P1|COMPLETED|Overall Study||17
232957|NCT00118248|556354|P2|STARTED|Overall Study||24
232958|NCT00118248|556355|P1|STARTED|Overall Study||17
232959|NCT00118157|556368|P1|NOT COMPLETED|Overall Study||12
232960|NCT00118157|556368|P1|COMPLETED|Overall Study||7
232961|NCT00118157|556368|P1|STARTED|Overall Study||19
232962|NCT00118144|556372|P1|NOT COMPLETED|Overall Study||1
232963|NCT00118144|556372|P1|COMPLETED|Overall Study||41
232964|NCT00118144|556372|P1|STARTED|Overall Study||42
232965|NCT00118131|556378|P1|NOT COMPLETED|Overall Study||0
232966|NCT00118131|556378|P1|COMPLETED|Overall Study||49
232967|NCT00118131|556378|P1|STARTED|Overall Study||49
232968|NCT00118053|556385|P1|NOT COMPLETED|Overall Study||0
232969|NCT00118053|556385|P1|COMPLETED|Overall Study||5
232970|NCT00118053|556385|P1|STARTED|Overall Study||5
232971|NCT00118040|556395|P3|NOT COMPLETED|Overall Study||6
232972|NCT00118040|556396|P2|NOT COMPLETED|Overall Study||2
232973|NCT00118040|556397|P1|NOT COMPLETED|Overall Study||1
232974|NCT00118040|556395|P3|COMPLETED|Overall Study||14
232975|NCT00118040|556396|P2|COMPLETED|Overall Study||18
232976|NCT00118040|556397|P1|COMPLETED|Overall Study||19
232977|NCT00118040|556395|P3|STARTED|Overall Study||20
232978|NCT00118040|556396|P2|STARTED|Overall Study||20
232979|NCT00118040|556397|P1|STARTED|Overall Study||20
232980|NCT00117988|556458|P1|NOT COMPLETED|Overall Study||4
232981|NCT00117988|556458|P1|COMPLETED|Overall Study||18
232982|NCT00117988|556458|P1|STARTED|Overall Study||22
232983|NCT00117962|556464|P2|NOT COMPLETED|Overall Study||25
232984|NCT00117962|556465|P1|NOT COMPLETED|Overall Study||22
232985|NCT00117962|556464|P2|COMPLETED|Overall Study||28
232986|NCT00117962|556465|P1|COMPLETED|Overall Study||26
232987|NCT00117962|556464|P2|STARTED|Overall Study||53
232988|NCT00117962|556465|P1|STARTED|Overall Study||48
232989|NCT00117949|556481|P4|NOT COMPLETED|Overall Study||24
232990|NCT00117949|556482|P3|NOT COMPLETED|Overall Study||24
232991|NCT00117949|556483|P2|NOT COMPLETED|Overall Study||24
232992|NCT00117949|556484|P1|NOT COMPLETED|Overall Study||10
232993|NCT00117949|556481|P4|COMPLETED|Overall Study||0
232994|NCT00117949|556482|P3|COMPLETED|Overall Study||0
232995|NCT00117949|556483|P2|COMPLETED|Overall Study||0
232996|NCT00117949|556484|P1|COMPLETED|Overall Study||0
232997|NCT00117949|556481|P4|STARTED|Overall Study||24
232998|NCT00117949|556482|P3|STARTED|Overall Study||24
232999|NCT00117949|556483|P2|STARTED|Overall Study||24
233000|NCT00117949|556484|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
233001|NCT00117845|556518|P1|NOT COMPLETED|Overall Study||1
233002|NCT00117845|556518|P1|COMPLETED|Overall Study||16
233003|NCT00117845|556518|P1|STARTED|Overall Study||17
233004|NCT00117806|556525|P2|NOT COMPLETED|Overall Study||16
233005|NCT00117806|556526|P1|NOT COMPLETED|Overall Study||38
233006|NCT00117806|556525|P2|COMPLETED|Overall Study||60
233007|NCT00117806|556526|P1|COMPLETED|Overall Study||43
233008|NCT00117806|556525|P2|STARTED|Overall Study||76
233009|NCT00117806|556526|P1|STARTED|Overall Study||81
233010|NCT00117793|556536|P1|NOT COMPLETED|Overall Study||12
233011|NCT00117793|556536|P1|COMPLETED|Overall Study||5
233012|NCT00117793|556536|P1|STARTED|Overall Study||17
233013|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
233014|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
233015|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
233016|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
233017|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 337 - 384||93
233018|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 337 - 384||183
233019|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
233020|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
233021|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
233022|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
233023|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 289 - 336||100
233024|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 289 - 336||192
233025|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
233026|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
233027|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
233028|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
233029|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 241 - 288||103
233030|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 241 - 288||202
233031|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
233032|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
233033|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
233034|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
233035|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 193 - 240||106
233036|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 193 - 240||209
233037|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
233038|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
233039|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
233040|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
233041|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 145 - 192||109
233042|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 145 - 192||219
233043|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
233044|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
233045|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
233046|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
233047|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 97 - 144||110
233048|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 97 - 144||225
233049|NCT00117676|556553|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
233050|NCT00117676|556554|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
233051|NCT00117676|556553|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
233052|NCT00117676|556554|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
233053|NCT00117676|556553|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
233054|NCT00117676|556554|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
233055|NCT00117676|556553|P2|NOT COMPLETED|Double-blind Period Through Week 48||4
233056|NCT00117676|556554|P1|NOT COMPLETED|Double-blind Period Through Week 48||6
233057|NCT00117676|556553|P2|COMPLETED|Double-blind Period Through Week 48||121
233058|NCT00117676|556554|P1|COMPLETED|Double-blind Period Through Week 48||244
233059|NCT00117676|556553|P2|STARTED|Double-blind Period Through Week 48||125
233060|NCT00117676|556554|P1|STARTED|Double-blind Period Through Week 48||250
233061|NCT00117637|556631|P2|NOT COMPLETED|Second Intervention (Period 2)||22
233062|NCT00117637|556632|P1|NOT COMPLETED|Second Intervention (Period 2)||10
233063|NCT00117637|556631|P2|COMPLETED|Second Intervention (Period 2)||39
233064|NCT00117637|556632|P1|COMPLETED|Second Intervention (Period 2)||39
233065|NCT00117637|556631|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
233066|NCT00117637|556632|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
233067|NCT00117637|556631|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
233068|NCT00117637|556632|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
233069|NCT00117637|556631|P2|NOT COMPLETED|First Intervention (Period 1)||25
233070|NCT00117637|556632|P1|NOT COMPLETED|First Intervention (Period 1)||18
233071|NCT00117637|556631|P2|COMPLETED|First Intervention (Period 1)||67
233072|NCT00117637|556632|P1|COMPLETED|First Intervention (Period 1)||79
233073|NCT00117637|556631|P2|Subjects Received Treatment|First Intervention (Period 1)||90
233074|NCT00117637|556632|P1|Subjects Received Treatment|First Intervention (Period 1)||97
233075|NCT00117637|556631|P2|STARTED|First Intervention (Period 1)||92
233076|NCT00117637|556632|P1|STARTED|First Intervention (Period 1)||97
233077|NCT00117598|556707|P5|NOT COMPLETED|After Treament Cross Over||4
233078|NCT00117598|556708|P4|NOT COMPLETED|After Treament Cross Over||3
233079|NCT00117598|556709|P3|NOT COMPLETED|After Treament Cross Over||0
233080|NCT00117598|556710|P2|NOT COMPLETED|After Treament Cross Over||0
233081|NCT00117598|556711|P1|NOT COMPLETED|After Treament Cross Over||0
233082|NCT00117598|556707|P5|COMPLETED|After Treament Cross Over||0
233083|NCT00117598|556708|P4|COMPLETED|After Treament Cross Over||0
233084|NCT00117598|556709|P3|COMPLETED|After Treament Cross Over||0
233085|NCT00117598|556710|P2|COMPLETED|After Treament Cross Over||0
233086|NCT00117598|556711|P1|COMPLETED|After Treament Cross Over||0
233087|NCT00117598|556707|P5|STARTED|After Treament Cross Over||4
233088|NCT00117598|556708|P4|STARTED|After Treament Cross Over||3
233089|NCT00117598|556709|P3|STARTED|After Treament Cross Over||0
233090|NCT00117598|556710|P2|STARTED|After Treament Cross Over||0
233091|NCT00117598|556711|P1|STARTED|After Treament Cross Over||0
233092|NCT00117598|556707|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
233093|NCT00117598|556708|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
233094|NCT00117598|556709|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
233095|NCT00117598|556710|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
233096|NCT00117598|556711|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
233097|NCT00117598|556707|P5|COMPLETED|Prior to Treatment Cross Over||0
233098|NCT00117598|556708|P4|COMPLETED|Prior to Treatment Cross Over||0
233099|NCT00117598|556709|P3|COMPLETED|Prior to Treatment Cross Over||4
233100|NCT00117598|556710|P2|COMPLETED|Prior to Treatment Cross Over||3
233101|NCT00117598|556711|P1|COMPLETED|Prior to Treatment Cross Over||0
233102|NCT00117598|556707|P5|STARTED|Prior to Treatment Cross Over||0
233103|NCT00117598|556708|P4|STARTED|Prior to Treatment Cross Over||0
233104|NCT00117598|556709|P3|STARTED|Prior to Treatment Cross Over||56
233105|NCT00117598|556710|P2|STARTED|Prior to Treatment Cross Over||56
233106|NCT00117598|556711|P1|STARTED|Prior to Treatment Cross Over||57
233107|NCT00117585|556739|P1|NOT COMPLETED|Overall Study||0
233108|NCT00117585|556739|P1|COMPLETED|Overall Study||341
233109|NCT00117585|556739|P1|STARTED|Overall Study||341
233110|NCT00117559|556745|P2|NOT COMPLETED|Overall Study||1
233111|NCT00117559|556746|P1|NOT COMPLETED|Overall Study||1
233112|NCT00117559|556745|P2|COMPLETED|Overall Study||9
233113|NCT00117559|556746|P1|COMPLETED|Overall Study||8
233114|NCT00117559|556745|P2|STARTED|Overall Study||10
233115|NCT00117559|556746|P1|STARTED|Overall Study||9
233116|NCT00117338|556754|P2|NOT COMPLETED|Overall Study||4
233117|NCT00117338|556755|P1|NOT COMPLETED|Overall Study||5
233118|NCT00117338|556754|P2|COMPLETED|Overall Study||127
233119|NCT00117338|556755|P1|COMPLETED|Overall Study||140
233120|NCT00117338|556754|P2|STARTED|Overall Study||131
233121|NCT00117338|556755|P1|STARTED|Overall Study||145
233122|NCT00117312|556777|P4|NOT COMPLETED|Overall Study||21
233123|NCT00117312|556778|P3|NOT COMPLETED|Overall Study||24
233124|NCT00117312|556779|P2|NOT COMPLETED|Overall Study||20
233125|NCT00117312|556780|P1|NOT COMPLETED|Overall Study||10
233126|NCT00117312|556777|P4|COMPLETED|Overall Study||3
233127|NCT00117312|556778|P3|COMPLETED|Overall Study||0
233128|NCT00117312|556779|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
233129|NCT00117312|556780|P1|COMPLETED|Overall Study||0
233130|NCT00117312|556777|P4|Started FE200486 CS06A|Overall Study||9
233131|NCT00117312|556778|P3|Started FE200486 CS06A|Overall Study||16
233132|NCT00117312|556779|P2|Started FE200486 CS06A|Overall Study||11
233133|NCT00117312|556780|P1|Started FE200486 CS06A|Overall Study||1
233134|NCT00117312|556777|P4|STARTED|Overall Study||24
233135|NCT00117312|556778|P3|STARTED|Overall Study||24
233136|NCT00117312|556779|P2|STARTED|Overall Study||24
233137|NCT00117312|556780|P1|STARTED|Overall Study||10
233138|NCT00117286|556796|P2|NOT COMPLETED|Overall Study||21
233139|NCT00117286|556797|P1|NOT COMPLETED|Overall Study||28
233140|NCT00117286|556796|P2|COMPLETED|Overall Study||6
233141|NCT00117286|556797|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
233142|NCT00117286|556796|P2|Switched to Higher Dose|Overall Study||17
233143|NCT00117286|556797|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
233144|NCT00117286|556796|P2|STARTED|Overall Study||27
233145|NCT00117286|556797|P1|STARTED|Overall Study|Safety analysis set|30
233146|NCT00117156|556805|P1|NOT COMPLETED|Overall Study||11
233147|NCT00117156|556805|P1|COMPLETED|Overall Study||15
233148|NCT00117156|556805|P1|STARTED|Overall Study||26
233149|NCT00116857|556815|P2|NOT COMPLETED|Overall Study||4
233150|NCT00116857|556816|P1|NOT COMPLETED|Overall Study||3
233151|NCT00116857|556815|P2|COMPLETED|Overall Study||56
233152|NCT00116857|556816|P1|COMPLETED|Overall Study||59
233153|NCT00116857|556815|P2|STARTED|Overall Study||60
233154|NCT00116857|556816|P1|STARTED|Overall Study||62
233155|NCT00116831|556824|P2|NOT COMPLETED|Overall Study||72
233156|NCT00116831|556825|P1|NOT COMPLETED|Overall Study||73
233157|NCT00116831|556824|P2|COMPLETED|Overall Study||259
233158|NCT00116831|556825|P1|COMPLETED|Overall Study||264
233159|NCT00116831|556824|P2|STARTED|Overall Study||331
233160|NCT00116831|556825|P1|STARTED|Overall Study||337
233161|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
233162|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
233163|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
233164|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
233165|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 337 - 384||57
233166|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 337 - 384||98
233167|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
233168|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
233169|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
233170|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
233171|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 289 - 336||64
233172|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 289 - 336||104
233173|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
233174|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
233175|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
233176|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
233177|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 241 - 288||64
233178|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 241 - 288||110
233179|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
233180|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
233181|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
233182|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
233183|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 193 - 240||68
233184|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 193 - 240||123
233185|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
233186|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
233187|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
233188|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
233189|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 145 - 192||74
233190|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 145 - 192||133
233191|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
233192|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
233193|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
233194|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
233195|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 97 - 144||83
233196|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 97 - 144||144
233197|NCT00116805|556903|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
233198|NCT00116805|556904|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
233199|NCT00116805|556903|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
233200|NCT00116805|556904|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
233201|NCT00116805|556903|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
233202|NCT00116805|556904|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
233203|NCT00116805|556903|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
233204|NCT00116805|556904|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
233205|NCT00116805|556903|P2|COMPLETED|Double-blind Period Through Week 48||85
233206|NCT00116805|556904|P1|COMPLETED|Double-blind Period Through Week 48||165
233207|NCT00116805|556903|P2|STARTED|Double-blind Period Through Week 48||90
233208|NCT00116805|556904|P1|STARTED|Double-blind Period Through Week 48||176
233209|NCT00116779|556985|P2|NOT COMPLETED|Overall Study||19
233210|NCT00116779|556986|P1|NOT COMPLETED|Overall Study||21
233211|NCT00116779|556985|P2|COMPLETED|Overall Study||45
233212|NCT00116779|556986|P1|COMPLETED|Overall Study||42
233213|NCT00116779|556985|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
233214|NCT00116779|556986|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
233215|NCT00116753|557019|P3|NOT COMPLETED|Overall Study||24
233216|NCT00116753|557020|P2|NOT COMPLETED|Overall Study||30
233217|NCT00116753|557021|P1|NOT COMPLETED|Overall Study||32
233218|NCT00116753|557019|P3|COMPLETED|Overall Study||128
233219|NCT00116753|557020|P2|COMPLETED|Overall Study||125
233220|NCT00116753|557021|P1|COMPLETED|Overall Study||121
233221|NCT00116753|557019|P3|ITT Population|Overall Study||147
233222|NCT00116753|557020|P2|ITT Population|Overall Study||150
233223|NCT00116753|557021|P1|ITT Population|Overall Study||150
233224|NCT00116753|557019|P3|STARTED|Overall Study||152
233225|NCT00116753|557020|P2|STARTED|Overall Study||155
233226|NCT00116753|557021|P1|STARTED|Overall Study|Randomised.|153
233227|NCT00116688|557043|P2|NOT COMPLETED|Overall Study||4
233228|NCT00116688|557044|P1|NOT COMPLETED|Overall Study||92
233229|NCT00116688|557043|P2|COMPLETED|Overall Study||17
233230|NCT00116688|557044|P1|COMPLETED|Overall Study||200
233231|NCT00116688|557043|P2|Received Study Medication|Overall Study||20
233232|NCT00116688|557044|P1|Received Study Medication|Overall Study||291
233233|NCT00116688|557043|P2|STARTED|Overall Study||21
233234|NCT00116688|557044|P1|STARTED|Overall Study||292
233235|NCT00116649|557059|P1|NOT COMPLETED|Overall Study||155
233236|NCT00116649|557059|P1|COMPLETED|Overall Study||396
233237|NCT00116649|557059|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
233238|NCT00116428|557066|P2|NOT COMPLETED|Overall Study||5
233239|NCT00116428|557067|P1|NOT COMPLETED|Overall Study||3
233240|NCT00116428|557066|P2|COMPLETED|Overall Study||56
233241|NCT00116428|557067|P1|COMPLETED|Overall Study||103
233242|NCT00116428|557066|P2|STARTED|Overall Study||61
233243|NCT00116428|557067|P1|STARTED|Overall Study||106
233244|NCT00116272|557085|P2|NOT COMPLETED|Overall Study||6
233245|NCT00116272|557086|P1|NOT COMPLETED|Overall Study||11
233246|NCT00116272|557085|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
233247|NCT00116272|557086|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
233248|NCT00116272|557085|P2|STARTED|Overall Study||164
233249|NCT00116272|557086|P1|STARTED|Overall Study||370
233250|NCT00116207|557138|P2|NOT COMPLETED|Overall Study||4
233251|NCT00116207|557139|P1|NOT COMPLETED|Overall Study||9
233252|NCT00116207|557138|P2|COMPLETED|Overall Study||18
233253|NCT00116207|557139|P1|COMPLETED|Overall Study||13
233254|NCT00116207|557138|P2|STARTED|Overall Study||22
233255|NCT00116207|557139|P1|STARTED|Overall Study||22
233256|NCT00116168|557155|P4|NOT COMPLETED|Overall Study||0
233257|NCT00116168|557156|P3|NOT COMPLETED|Overall Study||0
233258|NCT00116168|557157|P2|NOT COMPLETED|Overall Study||5
233259|NCT00116168|557158|P1|NOT COMPLETED|Overall Study||6
233260|NCT00116168|557155|P4|COMPLETED|Overall Study||6
233261|NCT00116168|557156|P3|COMPLETED|Overall Study||6
233262|NCT00116168|557157|P2|COMPLETED|Overall Study||6
233263|NCT00116168|557158|P1|COMPLETED|Overall Study||0
233264|NCT00116168|557155|P4|STARTED|Overall Study||6
233265|NCT00116168|557156|P3|STARTED|Overall Study||6
233266|NCT00116168|557157|P2|STARTED|Overall Study||11
233267|NCT00116168|557158|P1|STARTED|Overall Study||6
233268|NCT00115349|557222|P2|NOT COMPLETED|Overall Study||9
233269|NCT00115349|557223|P1|NOT COMPLETED|Overall Study||11
233270|NCT00115349|557222|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
233271|NCT00115349|557223|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
233272|NCT00115349|557222|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
233273|NCT00115349|557223|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
233274|NCT00115297|557231|P2|NOT COMPLETED|Overall Study||0
233275|NCT00115297|557232|P1|NOT COMPLETED|Overall Study||0
233276|NCT00115297|557231|P2|COMPLETED|Overall Study||32
233277|NCT00115297|557232|P1|COMPLETED|Overall Study||30
233278|NCT00115297|557231|P2|STARTED|Overall Study||32
233279|NCT00115297|557232|P1|STARTED|Overall Study||30
233280|NCT00115934|557244|P2|NOT COMPLETED|Overall Study||2
233281|NCT00115934|557245|P1|NOT COMPLETED|Overall Study||4
233282|NCT00115934|557244|P2|COMPLETED|Overall Study||274
233283|NCT00115934|557245|P1|COMPLETED|Overall Study||275
233284|NCT00115934|557244|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
233285|NCT00115934|557245|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
233286|NCT00115869|557285|P2|NOT COMPLETED|Overall Study||296
233287|NCT00115869|557286|P1|NOT COMPLETED|Overall Study||317
233288|NCT00115869|557285|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
233289|NCT00115869|557286|P1|COMPLETED|Overall Study||3894
233290|NCT00115869|557285|P2|Completed Data Collection at 12th Grade|Overall Study||3847
233291|NCT00115869|557286|P1|Completed Data Collection at 12th Grade|Overall Study||3876
233292|NCT00115869|557285|P2|STARTED|Overall Study||4177
233293|NCT00115869|557286|P1|STARTED|Overall Study||4211
233294|NCT00115804|557294|P1|NOT COMPLETED|Overall Study||2
233295|NCT00115804|557294|P1|COMPLETED|Overall Study||4
233296|NCT00115804|557294|P1|STARTED|Overall Study||6
233297|NCT00115765|557309|P4|NOT COMPLETED|Overall Study||31
233298|NCT00115765|557310|P3|NOT COMPLETED|Overall Study||121
233299|NCT00115765|557311|P2|NOT COMPLETED|Overall Study||100
233300|NCT00115765|557312|P1|NOT COMPLETED|Overall Study||35
233301|NCT00115765|557309|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
233302|NCT00115765|557310|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
233303|NCT00115765|557311|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
233304|NCT00115765|557312|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
233305|NCT00115765|557309|P4|STARTED|Overall Study||115
233306|NCT00115765|557310|P3|STARTED|Overall Study||410
233307|NCT00115765|557311|P2|STARTED|Overall Study||413
233308|NCT00115765|557312|P1|STARTED|Overall Study||115
233309|NCT00115739|557350|P1|NOT COMPLETED|Overall Study||3
233310|NCT00115739|557350|P1|COMPLETED|Overall Study||8
233311|NCT00115739|557350|P1|STARTED|Overall Study||11
233312|NCT00115063|557359|P2|NOT COMPLETED|Overall Study||104
233313|NCT00115063|557360|P1|NOT COMPLETED|Overall Study||99
233314|NCT00115063|557359|P2|COMPLETED|Overall Study||86
233315|NCT00115063|557360|P1|COMPLETED|Overall Study||101
233316|NCT00115063|557359|P2|STARTED|Overall Study||190
233317|NCT00115063|557360|P1|STARTED|Overall Study||200
233318|NCT00114972|557378|P2|NOT COMPLETED|Overall Study||12
233319|NCT00114972|557379|P1|NOT COMPLETED|Overall Study||48
233320|NCT00114972|557378|P2|COMPLETED|Overall Study||891
233321|NCT00114972|557379|P1|COMPLETED|Overall Study||849
233322|NCT00114972|557378|P2|STARTED|Overall Study||903
233323|NCT00114972|557379|P1|STARTED|Overall Study||897
233324|NCT00114959|557399|P1|NOT COMPLETED|Overall Study||8
233325|NCT00114959|557399|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
233326|NCT00114959|557399|P1|STARTED|Overall Study||15
233327|NCT00114634|557406|P1|NOT COMPLETED|Overall Study||3
233328|NCT00114634|557406|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
233329|NCT00114634|557406|P1|STARTED|Overall Study||13
233330|NCT00114504|557422|P2|NOT COMPLETED|Overall Study||0
233331|NCT00114504|557423|P1|NOT COMPLETED|Overall Study||0
233332|NCT00114504|557422|P2|COMPLETED|Overall Study||22
233333|NCT00114504|557423|P1|COMPLETED|Overall Study||21
233334|NCT00114504|557422|P2|STARTED|Overall Study||22
233335|NCT00114504|557423|P1|STARTED|Overall Study||21
233336|NCT00114244|557435|P2|NOT COMPLETED|Overall Study||7
233337|NCT00114244|557436|P1|NOT COMPLETED|Overall Study||2
233338|NCT00114244|557435|P2|COMPLETED|Overall Study||30
233339|NCT00114244|557436|P1|COMPLETED|Overall Study||13
233340|NCT00114244|557435|P2|STARTED|Overall Study||37
233341|NCT00114244|557436|P1|STARTED|Overall Study||15
233342|NCT00114166|557446|P1|NOT COMPLETED|Overall Study||1
233343|NCT00114166|557446|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
233344|NCT00114166|557446|P1|Registered to Regimen II|Overall Study||65
233345|NCT00114166|557446|P1|Registered to Regimen I|Overall Study||15
233346|NCT00114166|557446|P1|STARTED|Overall Study|total number of participants enrolled|81
233347|NCT00114127|557454|P2|NOT COMPLETED|Overall Study||4
233348|NCT00114127|557455|P1|NOT COMPLETED|Overall Study||4
233349|NCT00114127|557454|P2|COMPLETED|Overall Study||11
233350|NCT00114127|557455|P1|COMPLETED|Overall Study||9
233351|NCT00114127|557454|P2|STARTED|Overall Study||15
233352|NCT00114127|557455|P1|STARTED|Overall Study||13
233353|NCT00114101|557465|P2|NOT COMPLETED|Overall Study||0
233354|NCT00114101|557466|P1|NOT COMPLETED|Overall Study||0
233355|NCT00114101|557465|P2|COMPLETED|Overall Study||229
233356|NCT00114101|557466|P1|COMPLETED|Overall Study||231
233357|NCT00114101|557465|P2|STARTED|Overall Study||229
233358|NCT00114101|557466|P1|STARTED|Overall Study||231
233359|NCT00113022|557480|P2|NOT COMPLETED|Overall Study||2
233360|NCT00113022|557481|P1|NOT COMPLETED|Overall Study||3
233361|NCT00113022|557480|P2|COMPLETED|Overall Study||2
233362|NCT00113022|557481|P1|COMPLETED|Overall Study||2
233363|NCT00113022|557480|P2|STARTED|Overall Study||4
233364|NCT00113022|557481|P1|STARTED|Overall Study||5
233365|NCT00113919|557487|P1|NOT COMPLETED|Overall Study||14
233366|NCT00113919|557487|P1|COMPLETED|Overall Study||0
233367|NCT00113919|557487|P1|STARTED|Overall Study||14
233368|NCT00113880|557494|P3|NOT COMPLETED|Overall Study||0
233369|NCT00113880|557495|P2|NOT COMPLETED|Overall Study||0
233370|NCT00113880|557496|P1|NOT COMPLETED|Overall Study||0
233371|NCT00113880|557494|P3|COMPLETED|Overall Study||62492
233372|NCT00113880|557495|P2|COMPLETED|Overall Study||71949
233373|NCT00113880|557496|P1|COMPLETED|Overall Study||63061
233374|NCT00113880|557494|P3|STARTED|Overall Study||62492
233375|NCT00113880|557495|P2|STARTED|Overall Study||71949
233376|NCT00113880|557496|P1|STARTED|Overall Study||63061
233377|NCT00113841|557555|P2|NOT COMPLETED|Overall Study||2
233378|NCT00113841|557556|P1|NOT COMPLETED|Overall Study||1
233379|NCT00113841|557555|P2|COMPLETED|Overall Study||15
233380|NCT00113841|557556|P1|COMPLETED|Overall Study||15
233381|NCT00113841|557555|P2|STARTED|Overall Study||17
233382|NCT00113841|557556|P1|STARTED|Overall Study||16
233383|NCT00113763|557564|P2|NOT COMPLETED|Overall Study||26
233384|NCT00113763|557565|P1|NOT COMPLETED|Overall Study||73
233385|NCT00113763|557564|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
233386|NCT00113763|557565|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
233387|NCT00113763|557564|P2|Received Study Drug|Overall Study||0
233388|NCT00113763|557565|P1|Received Study Drug|Overall Study||229
233389|NCT00113763|557564|P2|STARTED|Overall Study||232
233390|NCT00113763|557565|P1|STARTED|Overall Study||231
233391|NCT00113607|557591|P2|NOT COMPLETED|Overall Study||337
233392|NCT00113607|557592|P1|NOT COMPLETED|Overall Study||335
233393|NCT00113607|557591|P2|COMPLETED|Overall Study||0
233394|NCT00113607|557592|P1|COMPLETED|Overall Study||0
233395|NCT00113607|557591|P2|STARTED|Overall Study|Number of randomized participants|337
233396|NCT00113607|557592|P1|STARTED|Overall Study|Number of randomized participants|335
233397|NCT00113568|557606|P1|NOT COMPLETED|Overall Study||545
233398|NCT00113568|557606|P1|COMPLETED|Overall Study||239
233399|NCT00113568|557606|P1|Intent to Treat Population|Overall Study||723
233400|NCT00113568|557606|P1|STARTED|Overall Study||784
233401|NCT00113529|557618|P1|NOT COMPLETED|Overall Study||34
233402|NCT00113529|557618|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
233403|NCT00113529|557618|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
233404|NCT00113516|557651|P2|NOT COMPLETED|Part 2||66
233405|NCT00113516|557652|P1|NOT COMPLETED|Part 2||0
233406|NCT00113516|557651|P2|COMPLETED|Part 2||0
233407|NCT00113516|557652|P1|COMPLETED|Part 2||0
233408|NCT00113516|557651|P2|STARTED|Part 2||66
233409|NCT00113516|557652|P1|STARTED|Part 2||0
233410|NCT00113516|557651|P2|NOT COMPLETED|Part 1||0
233411|NCT00113516|557652|P1|NOT COMPLETED|Part 1||84
233412|NCT00113516|557651|P2|COMPLETED|Part 1||0
233413|NCT00113516|557652|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
233414|NCT00113516|557651|P2|STARTED|Part 1||0
233415|NCT00113516|557652|P1|STARTED|Part 1||84
233416|NCT00113490|557695|P2|NOT COMPLETED|Overall Study||3
233417|NCT00113490|557696|P1|NOT COMPLETED|Overall Study||2
233418|NCT00113490|557695|P2|COMPLETED|Overall Study||67
233419|NCT00113490|557696|P1|COMPLETED|Overall Study||64
233420|NCT00113490|557695|P2|STARTED|Overall Study||70
233421|NCT00113490|557696|P1|STARTED|Overall Study||66
233422|NCT00113425|557709|P1|NOT COMPLETED|Overall Study||15
233423|NCT00113425|557709|P1|COMPLETED|Overall Study||29
233424|NCT00113425|557709|P1|STARTED|Overall Study||44
233425|NCT00113399|557729|P2|NOT COMPLETED|Overall Study||5
233426|NCT00113399|557730|P1|NOT COMPLETED|Overall Study||2
233427|NCT00113399|557729|P2|COMPLETED|Overall Study||3
233428|NCT00113399|557730|P1|COMPLETED|Overall Study||5
233429|NCT00113399|557729|P2|STARTED|Overall Study||8
233430|NCT00113399|557730|P1|STARTED|Overall Study||7
233431|NCT00113386|557738|P2|NOT COMPLETED|Overall Study||4
233432|NCT00113386|557739|P1|NOT COMPLETED|Overall Study||7
233433|NCT00113386|557738|P2|COMPLETED|Overall Study||5
233434|NCT00113386|557739|P1|COMPLETED|Overall Study||3
233435|NCT00113386|557738|P2|STARTED|Overall Study||9
233436|NCT00113386|557739|P1|STARTED|Overall Study||10
233437|NCT00113373|557745|P1|NOT COMPLETED|Overall Study||3
233438|NCT00113373|557745|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
233439|NCT00113373|557745|P1|STARTED|Overall Study||28
233440|NCT00113360|557751|P1|NOT COMPLETED|Overall Study||7
233441|NCT00113360|557751|P1|COMPLETED|Overall Study||60
233442|NCT00113360|557751|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
233443|NCT00113334|557755|P1|NOT COMPLETED|Overall Study||0
233444|NCT00113334|557755|P1|COMPLETED|Overall Study||6
233445|NCT00113334|557755|P1|STARTED|Overall Study||6
233446|NCT00113321|557759|P1|NOT COMPLETED|Overall Study||0
233447|NCT00113321|557759|P1|COMPLETED|Overall Study||16
233448|NCT00113321|557759|P1|STARTED|Overall Study||16
233449|NCT00113295|557765|P2|NOT COMPLETED|Overall Study||1
233450|NCT00113295|557766|P1|NOT COMPLETED|Overall Study||5
233451|NCT00113295|557765|P2|COMPLETED|Overall Study||10
233452|NCT00113295|557766|P1|COMPLETED|Overall Study||6
233453|NCT00113295|557765|P2|STARTED|Overall Study||11
233454|NCT00113295|557766|P1|STARTED|Overall Study||11
233455|NCT00113269|557785|P4|NOT COMPLETED|Overall Study||40
233456|NCT00113269|557786|P3|NOT COMPLETED|Overall Study||41
233457|NCT00113269|557787|P2|NOT COMPLETED|Overall Study||22
233458|NCT00113269|557788|P1|NOT COMPLETED|Overall Study||25
233459|NCT00113269|557785|P4|COMPLETED|Overall Study||140
233460|NCT00113269|557786|P3|COMPLETED|Overall Study||134
233461|NCT00113269|557787|P2|COMPLETED|Overall Study||48
233462|NCT00113269|557788|P1|COMPLETED|Overall Study||51
233463|NCT00113269|557785|P4|Received Treatment|Overall Study||171
233464|NCT00113269|557786|P3|Received Treatment|Overall Study||164
233465|NCT00113269|557787|P2|Received Treatment|Overall Study||69
233466|NCT00113269|557788|P1|Received Treatment|Overall Study||70
233467|NCT00113269|557785|P4|STARTED|Overall Study||180
233468|NCT00113269|557786|P3|STARTED|Overall Study||175
233469|NCT00113269|557787|P2|STARTED|Overall Study||70
233470|NCT00113269|557788|P1|STARTED|Overall Study||76
233471|NCT00113230|557838|P1|NOT COMPLETED|Overall Study||0
233472|NCT00113230|557838|P1|COMPLETED|Overall Study||25
233473|NCT00113230|557838|P1|STARTED|Overall Study||25
233474|NCT00113217|557842|P1|NOT COMPLETED|Overall Study||0
233475|NCT00113217|557842|P1|COMPLETED|Overall Study||50
233476|NCT00113217|557842|P1|STARTED|Overall Study||50
233477|NCT00113087|557848|P2|NOT COMPLETED|Overall Study||21
233478|NCT00113087|557849|P1|NOT COMPLETED|Overall Study||24
233479|NCT00113087|557848|P2|COMPLETED|Overall Study||94
233480|NCT00113087|557849|P1|COMPLETED|Overall Study||91
233481|NCT00113087|557848|P2|STARTED|Overall Study||115
233482|NCT00113087|557849|P1|STARTED|Overall Study||115
233483|NCT00112918|557914|P3|NOT COMPLETED|Overall Study||299
233484|NCT00112918|557915|P2|NOT COMPLETED|Overall Study||345
233485|NCT00112918|557916|P1|NOT COMPLETED|Overall Study||297
233486|NCT00112918|557914|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
233487|NCT00112918|557915|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
233488|NCT00112918|557916|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
233489|NCT00112918|557914|P3|Stage III Disease Population|Overall Study||952
233490|NCT00112918|557915|P2|Stage III Disease Population|Overall Study||960
233491|NCT00112918|557916|P1|Stage III Disease Population|Overall Study||955
233492|NCT00112918|557914|P3|Received Treatment|Overall Study||1135
233493|NCT00112918|557915|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
233494|NCT00112918|557916|P1|Received Treatment|Overall Study||1126
233495|NCT00112918|557914|P3|STARTED|Overall Study||1145
233496|NCT00112918|557915|P2|STARTED|Overall Study||1155
233497|NCT00112918|557916|P1|STARTED|Overall Study||1151
233498|NCT00112905|557939|P1|NOT COMPLETED|Overall Study||12
233499|NCT00112905|557939|P1|COMPLETED|Overall Study||15
233500|NCT00112905|557939|P1|Eligible and Treated|Overall Study||22
233501|NCT00112905|557939|P1|STARTED|Overall Study||27
233502|NCT00112840|557949|P3|NOT COMPLETED|Overall Study||6
233503|NCT00112840|557950|P2|NOT COMPLETED|Overall Study||0
233504|NCT00112840|557951|P1|NOT COMPLETED|Overall Study||2
233505|NCT00112840|557949|P3|COMPLETED|Overall Study||40
233506|NCT00112840|557950|P2|COMPLETED|Overall Study||6
233507|NCT00112840|557951|P1|COMPLETED|Overall Study||6
233508|NCT00112840|557949|P3|STARTED|Overall Study||46
233509|NCT00112840|557950|P2|STARTED|Overall Study||6
233510|NCT00112840|557951|P1|STARTED|Overall Study||8
233511|NCT00112736|557970|P2|NOT COMPLETED|Overall Study||0
233512|NCT00112736|557971|P1|NOT COMPLETED|Overall Study||1
233513|NCT00112736|557970|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
233514|NCT00112736|557971|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
233515|NCT00112736|557970|P2|STARTED|Overall Study||47
233516|NCT00112736|557971|P1|STARTED|Overall Study||22
233517|NCT00112723|557984|P3|NOT COMPLETED|Overall Study||2
233518|NCT00112723|557985|P2|NOT COMPLETED|Overall Study||7
233519|NCT00112723|557986|P1|NOT COMPLETED|Overall Study||2
233520|NCT00112723|557984|P3|COMPLETED|Overall Study||12
233521|NCT00112723|557985|P2|COMPLETED|Overall Study||12
233522|NCT00112723|557986|P1|COMPLETED|Overall Study||11
233523|NCT00112723|557984|P3|Patients Evaluable for Toxicity|Overall Study||12
233524|NCT00112723|557985|P2|Patients Evaluable for Toxicity|Overall Study||12
233525|NCT00112723|557986|P1|Patients Evaluable for Toxicity|Overall Study||11
233526|NCT00112723|557984|P3|STARTED|Overall Study||14
233527|NCT00112723|557985|P2|STARTED|Overall Study||19
233528|NCT00112723|557986|P1|STARTED|Overall Study||13
233529|NCT00112671|558011|P1|NOT COMPLETED|Overall Study||0
233530|NCT00112671|558011|P1|COMPLETED|Overall Study||17
233531|NCT00112671|558011|P1|STARTED|Overall Study||17
233532|NCT00112489|558017|P1|NOT COMPLETED|Overall Study||40
233533|NCT00112489|558017|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
233534|NCT00112489|558017|P1|STARTED|Overall Study|All patients enrolled on study|55
233535|NCT00112437|558026|P15|NOT COMPLETED|12 Month Extension (Year 3)||1
233536|NCT00112437|558027|P14|NOT COMPLETED|12 Month Extension (Year 3)||2
233537|NCT00112437|558028|P13|NOT COMPLETED|12 Month Extension (Year 3)||1
233538|NCT00112437|558029|P12|NOT COMPLETED|12 Month Extension (Year 3)||3
233539|NCT00112437|558030|P11|NOT COMPLETED|12 Month Extension (Year 3)||4
233540|NCT00112437|558031|P10|NOT COMPLETED|12 Month Extension (Year 3)||1
233541|NCT00112437|558032|P9|NOT COMPLETED|12 Month Extension (Year 3)||1
233542|NCT00112437|558033|P8|NOT COMPLETED|12 Month Extension (Year 3)||0
233543|NCT00112437|558034|P7|NOT COMPLETED|12 Month Extension (Year 3)||5
233544|NCT00112437|558035|P6|NOT COMPLETED|12 Month Extension (Year 3)||2
233545|NCT00112437|558036|P5|NOT COMPLETED|12 Month Extension (Year 3)||0
233546|NCT00112437|558037|P4|NOT COMPLETED|12 Month Extension (Year 3)||0
233547|NCT00112437|558038|P3|NOT COMPLETED|12 Month Extension (Year 3)||0
233548|NCT00112437|558039|P2|NOT COMPLETED|12 Month Extension (Year 3)||0
233549|NCT00112437|558040|P1|NOT COMPLETED|12 Month Extension (Year 3)||0
233550|NCT00112437|558026|P15|COMPLETED|12 Month Extension (Year 3)||19
233551|NCT00112437|558027|P14|COMPLETED|12 Month Extension (Year 3)||16
233552|NCT00112437|558028|P13|COMPLETED|12 Month Extension (Year 3)||20
233553|NCT00112437|558029|P12|COMPLETED|12 Month Extension (Year 3)||16
233554|NCT00112437|558030|P11|COMPLETED|12 Month Extension (Year 3)||13
233555|NCT00112437|558031|P10|COMPLETED|12 Month Extension (Year 3)||17
233556|NCT00112437|558032|P9|COMPLETED|12 Month Extension (Year 3)||16
233557|NCT00112437|558033|P8|COMPLETED|12 Month Extension (Year 3)||18
233558|NCT00112437|558034|P7|COMPLETED|12 Month Extension (Year 3)||17
233559|NCT00112437|558035|P6|COMPLETED|12 Month Extension (Year 3)||17
233560|NCT00112437|558036|P5|COMPLETED|12 Month Extension (Year 3)||0
233561|NCT00112437|558037|P4|COMPLETED|12 Month Extension (Year 3)||0
233562|NCT00112437|558038|P3|COMPLETED|12 Month Extension (Year 3)||0
233563|NCT00112437|558039|P2|COMPLETED|12 Month Extension (Year 3)||0
233564|NCT00112437|558040|P1|COMPLETED|12 Month Extension (Year 3)||0
233565|NCT00112437|558026|P15|STARTED|12 Month Extension (Year 3)||20
233566|NCT00112437|558027|P14|STARTED|12 Month Extension (Year 3)||18
233567|NCT00112437|558028|P13|STARTED|12 Month Extension (Year 3)||21
233568|NCT00112437|558029|P12|STARTED|12 Month Extension (Year 3)||19
233569|NCT00112437|558030|P11|STARTED|12 Month Extension (Year 3)||17
233570|NCT00112437|558031|P10|STARTED|12 Month Extension (Year 3)||18
233571|NCT00112437|558032|P9|STARTED|12 Month Extension (Year 3)||17
233572|NCT00112437|558033|P8|STARTED|12 Month Extension (Year 3)||18
233573|NCT00112437|558034|P7|STARTED|12 Month Extension (Year 3)||22
233574|NCT00112437|558035|P6|STARTED|12 Month Extension (Year 3)||19
233575|NCT00112437|558036|P5|STARTED|12 Month Extension (Year 3)||0
233576|NCT00112437|558037|P4|STARTED|12 Month Extension (Year 3)||0
233577|NCT00112437|558038|P3|STARTED|12 Month Extension (Year 3)||0
233578|NCT00112437|558039|P2|STARTED|12 Month Extension (Year 3)||0
233579|NCT00112437|558040|P1|STARTED|12 Month Extension (Year 3)||0
233580|NCT00112437|558026|P15|NOT COMPLETED|12 Month Extension||0
233581|NCT00112437|558027|P14|NOT COMPLETED|12 Month Extension||0
233582|NCT00112437|558028|P13|NOT COMPLETED|12 Month Extension||0
233583|NCT00112437|558029|P12|NOT COMPLETED|12 Month Extension||0
233584|NCT00112437|558030|P11|NOT COMPLETED|12 Month Extension||0
233585|NCT00112437|558031|P10|NOT COMPLETED|12 Month Extension||0
233586|NCT00112437|558032|P9|NOT COMPLETED|12 Month Extension||0
233587|NCT00112437|558033|P8|NOT COMPLETED|12 Month Extension||0
233588|NCT00112437|558034|P7|NOT COMPLETED|12 Month Extension||0
233589|NCT00112437|558035|P6|NOT COMPLETED|12 Month Extension||0
233590|NCT00112437|558036|P5|NOT COMPLETED|12 Month Extension||13
233591|NCT00112437|558037|P4|NOT COMPLETED|12 Month Extension||7
233592|NCT00112437|558038|P3|NOT COMPLETED|12 Month Extension||8
233593|NCT00112437|558039|P2|NOT COMPLETED|12 Month Extension||9
233594|NCT00112437|558040|P1|NOT COMPLETED|12 Month Extension||3
233595|NCT00112437|558026|P15|COMPLETED|12 Month Extension||0
233596|NCT00112437|558027|P14|COMPLETED|12 Month Extension||0
233597|NCT00112437|558028|P13|COMPLETED|12 Month Extension||0
233598|NCT00112437|558029|P12|COMPLETED|12 Month Extension||0
233599|NCT00112437|558030|P11|COMPLETED|12 Month Extension||0
233600|NCT00112437|558031|P10|COMPLETED|12 Month Extension||0
233601|NCT00112437|558032|P9|COMPLETED|12 Month Extension||0
233602|NCT00112437|558033|P8|COMPLETED|12 Month Extension||0
233603|NCT00112437|558034|P7|COMPLETED|12 Month Extension||0
233604|NCT00112437|558035|P6|COMPLETED|12 Month Extension||0
233605|NCT00112437|558036|P5|COMPLETED|12 Month Extension||50
233606|NCT00112437|558037|P4|COMPLETED|12 Month Extension||62
233607|NCT00112437|558038|P3|COMPLETED|12 Month Extension||55
233608|NCT00112437|558039|P2|COMPLETED|12 Month Extension||53
233609|NCT00112437|558040|P1|COMPLETED|12 Month Extension||60
233610|NCT00112437|558026|P15|STARTED|12 Month Extension||0
233611|NCT00112437|558027|P14|STARTED|12 Month Extension||0
233612|NCT00112437|558028|P13|STARTED|12 Month Extension||0
233613|NCT00112437|558029|P12|STARTED|12 Month Extension||0
233614|NCT00112437|558030|P11|STARTED|12 Month Extension||0
233615|NCT00112437|558031|P10|STARTED|12 Month Extension||0
233616|NCT00112437|558032|P9|STARTED|12 Month Extension||0
233617|NCT00112437|558033|P8|STARTED|12 Month Extension||0
233618|NCT00112437|558034|P7|STARTED|12 Month Extension||0
233619|NCT00112437|558035|P6|STARTED|12 Month Extension||0
233620|NCT00112437|558036|P5|STARTED|12 Month Extension||63
233621|NCT00112437|558037|P4|STARTED|12 Month Extension||69
233622|NCT00112437|558038|P3|STARTED|12 Month Extension||63
233623|NCT00112437|558039|P2|STARTED|12 Month Extension||62
233624|NCT00112437|558040|P1|STARTED|12 Month Extension||63
233625|NCT00112437|558026|P15|NOT COMPLETED|12 Month Base Study||0
233626|NCT00112437|558027|P14|NOT COMPLETED|12 Month Base Study||0
233627|NCT00112437|558028|P13|NOT COMPLETED|12 Month Base Study||0
233628|NCT00112437|558029|P12|NOT COMPLETED|12 Month Base Study||0
233629|NCT00112437|558030|P11|NOT COMPLETED|12 Month Base Study||0
233630|NCT00112437|558031|P10|NOT COMPLETED|12 Month Base Study||0
233631|NCT00112437|558032|P9|NOT COMPLETED|12 Month Base Study||0
233632|NCT00112437|558033|P8|NOT COMPLETED|12 Month Base Study||0
233633|NCT00112437|558034|P7|NOT COMPLETED|12 Month Base Study||0
233634|NCT00112437|558035|P6|NOT COMPLETED|12 Month Base Study||0
233635|NCT00112437|558036|P5|NOT COMPLETED|12 Month Base Study||12
233636|NCT00112437|558037|P4|NOT COMPLETED|12 Month Base Study||8
233637|NCT00112437|558038|P3|NOT COMPLETED|12 Month Base Study||12
233638|NCT00112437|558039|P2|NOT COMPLETED|12 Month Base Study||18
233639|NCT00112437|558040|P1|NOT COMPLETED|12 Month Base Study||15
233640|NCT00112437|558026|P15|COMPLETED|12 Month Base Study||0
233641|NCT00112437|558027|P14|COMPLETED|12 Month Base Study||0
233642|NCT00112437|558028|P13|COMPLETED|12 Month Base Study||0
233643|NCT00112437|558029|P12|COMPLETED|12 Month Base Study||0
233644|NCT00112437|558030|P11|COMPLETED|12 Month Base Study||0
233645|NCT00112437|558031|P10|COMPLETED|12 Month Base Study||0
233646|NCT00112437|558032|P9|COMPLETED|12 Month Base Study||0
233647|NCT00112437|558033|P8|COMPLETED|12 Month Base Study||0
233648|NCT00112437|558034|P7|COMPLETED|12 Month Base Study||0
233649|NCT00112437|558035|P6|COMPLETED|12 Month Base Study||0
233650|NCT00112437|558036|P5|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|66
233651|NCT00112437|558037|P4|COMPLETED|12 Month Base Study||71
233652|NCT00112437|558038|P3|COMPLETED|12 Month Base Study||65
233653|NCT00112437|558039|P2|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|64
233654|NCT00112437|558040|P1|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|68
233655|NCT00112437|558026|P15|STARTED|12 Month Base Study||0
233656|NCT00112437|558027|P14|STARTED|12 Month Base Study||0
233657|NCT00112437|558028|P13|STARTED|12 Month Base Study||0
233658|NCT00112437|558029|P12|STARTED|12 Month Base Study||0
233659|NCT00112437|558030|P11|STARTED|12 Month Base Study||0
233660|NCT00112437|558031|P10|STARTED|12 Month Base Study||0
233661|NCT00112437|558032|P9|STARTED|12 Month Base Study||0
233662|NCT00112437|558033|P8|STARTED|12 Month Base Study||0
233663|NCT00112437|558034|P7|STARTED|12 Month Base Study||0
233664|NCT00112437|558035|P6|STARTED|12 Month Base Study||0
233665|NCT00112437|558036|P5|STARTED|12 Month Base Study||78
233666|NCT00112437|558037|P4|STARTED|12 Month Base Study||79
233667|NCT00112437|558038|P3|STARTED|12 Month Base Study||77
233668|NCT00112437|558039|P2|STARTED|12 Month Base Study||82
233669|NCT00112437|558040|P1|STARTED|12 Month Base Study||83
233670|NCT00112385|558299|P2|NOT COMPLETED|Overall Study||1
233671|NCT00112385|558300|P1|NOT COMPLETED|Overall Study||1
233672|NCT00112385|558299|P2|COMPLETED|Overall Study||4
233673|NCT00112385|558300|P1|COMPLETED|Overall Study||10
233674|NCT00112385|558299|P2|STARTED|Overall Study||5
233675|NCT00112385|558300|P1|STARTED|Overall Study||11
233676|NCT00112359|558390|P2|NOT COMPLETED|Overall Study||13
233677|NCT00112359|558391|P1|NOT COMPLETED|Overall Study||27
233678|NCT00112359|558390|P2|COMPLETED|Overall Study||67
233679|NCT00112359|558391|P1|COMPLETED|Overall Study||57
233680|NCT00112359|558390|P2|STARTED|Overall Study||80
233681|NCT00112359|558391|P1|STARTED|Overall Study||84
233682|NCT00112294|558417|P2|NOT COMPLETED|Overall Study||0
233683|NCT00112294|558418|P1|NOT COMPLETED|Overall Study||5
233684|NCT00112294|558417|P2|COMPLETED|Overall Study|Off all study therapies.|320
233685|NCT00112294|558418|P1|COMPLETED|Overall Study|Off all study therapies.|320
233686|NCT00112294|558417|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
233687|NCT00112294|558418|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
233688|NCT00112294|558417|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
233689|NCT00112294|558418|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
233690|NCT00112151|558462|P6|NOT COMPLETED|Overall Study||3
233691|NCT00112151|558463|P5|NOT COMPLETED|Overall Study||6
233692|NCT00112151|558464|P4|NOT COMPLETED|Overall Study||3
233693|NCT00112151|558465|P3|NOT COMPLETED|Overall Study||3
233694|NCT00112151|558466|P2|NOT COMPLETED|Overall Study||5
233695|NCT00112151|558467|P1|NOT COMPLETED|Overall Study||4
233696|NCT00112151|558462|P6|COMPLETED|Overall Study||25
233697|NCT00112151|558463|P5|COMPLETED|Overall Study||22
233698|NCT00112151|558464|P4|COMPLETED|Overall Study||24
233699|NCT00112151|558465|P3|COMPLETED|Overall Study||25
233700|NCT00112151|558466|P2|COMPLETED|Overall Study||23
233701|NCT00112151|558467|P1|COMPLETED|Overall Study||24
233702|NCT00112151|558462|P6|STARTED|Overall Study||28
233703|NCT00112151|558463|P5|STARTED|Overall Study||28
233704|NCT00112151|558464|P4|STARTED|Overall Study||27
233705|NCT00112151|558465|P3|STARTED|Overall Study||28
233706|NCT00112151|558466|P2|STARTED|Overall Study||28
233707|NCT00112151|558467|P1|STARTED|Overall Study||28
233708|NCT00112112|558498|P2|NOT COMPLETED|Overall Study||0
233709|NCT00112112|558499|P1|NOT COMPLETED|Overall Study||0
233710|NCT00112112|558498|P2|COMPLETED|Overall Study||10
233711|NCT00112112|558499|P1|COMPLETED|Overall Study||10
233712|NCT00112112|558498|P2|STARTED|Overall Study||10
233713|NCT00112112|558499|P1|STARTED|Overall Study||10
233714|NCT00112047|558599|P2|NOT COMPLETED|Atripla Phase||20
233715|NCT00112047|558600|P1|NOT COMPLETED|Atripla Phase||18
233716|NCT00112047|558599|P2|COMPLETED|Atripla Phase||106
233717|NCT00112047|558600|P1|COMPLETED|Atripla Phase||142
233718|NCT00112047|558599|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
233719|NCT00112047|558600|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
233720|NCT00112047|558599|P2|NOT COMPLETED|Randomized Phase||88
233721|NCT00112047|558600|P1|NOT COMPLETED|Randomized Phase||70
233722|NCT00112047|558599|P2|COMPLETED|Randomized Phase||166
233723|NCT00112047|558600|P1|COMPLETED|Randomized Phase||187
233724|NCT00112047|558599|P2|STARTED|Randomized Phase|ITT analysis population|254
233725|NCT00112047|558600|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
233726|NCT00111917|558700|P2|NOT COMPLETED|Overall Study||1
233727|NCT00111917|558701|P1|NOT COMPLETED|Overall Study||1
233728|NCT00111917|558700|P2|COMPLETED|Overall Study||3
233729|NCT00111917|558701|P1|COMPLETED|Overall Study||8
233730|NCT00111917|558700|P2|STARTED|Overall Study||4
233731|NCT00111917|558701|P1|STARTED|Overall Study||9
233732|NCT00111813|558713|P6|NOT COMPLETED|Overall Study||6
233733|NCT00111813|558714|P5|NOT COMPLETED|Overall Study||6
233734|NCT00111813|558715|P4|NOT COMPLETED|Overall Study||5
233735|NCT00111813|558716|P3|NOT COMPLETED|Overall Study||10
233736|NCT00111813|558717|P2|NOT COMPLETED|Overall Study||3
233737|NCT00111813|558718|P1|NOT COMPLETED|Overall Study||3
233738|NCT00111813|558713|P6|COMPLETED|Overall Study||0
233739|NCT00111813|558714|P5|COMPLETED|Overall Study||0
233740|NCT00111813|558715|P4|COMPLETED|Overall Study||1
233741|NCT00111813|558716|P3|COMPLETED|Overall Study||0
233742|NCT00111813|558717|P2|COMPLETED|Overall Study||0
233743|NCT00111813|558718|P1|COMPLETED|Overall Study||0
233744|NCT00111813|558713|P6|STARTED|Overall Study||6
233745|NCT00111813|558714|P5|STARTED|Overall Study||6
233746|NCT00111813|558715|P4|STARTED|Overall Study||6
233747|NCT00111813|558716|P3|STARTED|Overall Study||10
233748|NCT00111813|558717|P2|STARTED|Overall Study||3
233749|NCT00111813|558718|P1|STARTED|Overall Study||3
233750|NCT00111761|558753|P2|NOT COMPLETED|Part 2||0
233751|NCT00111761|558754|P1|NOT COMPLETED|Part 2||8
233752|NCT00111761|558753|P2|COMPLETED|Part 2||0
233753|NCT00111761|558754|P1|COMPLETED|Part 2||16
233754|NCT00111761|558753|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
233755|NCT00111761|558754|P1|STARTED|Part 2||24
233756|NCT00111761|558753|P2|NOT COMPLETED|Part 1||5
233757|NCT00111761|558754|P1|NOT COMPLETED|Part 1||0
233758|NCT00111761|558753|P2|COMPLETED|Part 1|Completed through safety followup|14
233759|NCT00111761|558754|P1|COMPLETED|Part 1||0
233760|NCT00111761|558753|P2|STARTED|Part 1||19
233761|NCT00111761|558754|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
233762|NCT00111657|558771|P1|NOT COMPLETED|Overall Study||16
233763|NCT00111657|558771|P1|COMPLETED|Overall Study|Completed all intended doses.|21
233764|NCT00111657|558771|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
233765|NCT00111007|558783|P2|NOT COMPLETED|Long Term Follow-up||45
233766|NCT00111007|558784|P1|NOT COMPLETED|Long Term Follow-up||47
233767|NCT00111007|558783|P2|COMPLETED|Long Term Follow-up||62
233768|NCT00111007|558784|P1|COMPLETED|Long Term Follow-up||54
233769|NCT00111007|558783|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
233770|NCT00111007|558784|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
233771|NCT00111007|558783|P2|NOT COMPLETED|Active Follow-up||2
233772|NCT00111007|558784|P1|NOT COMPLETED|Active Follow-up||6
233773|NCT00111007|558783|P2|COMPLETED|Active Follow-up||2
233774|NCT00111007|558784|P1|COMPLETED|Active Follow-up||0
233775|NCT00111007|558783|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
233776|NCT00111007|558784|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
233777|NCT00111007|558783|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
233778|NCT00111007|558784|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
233779|NCT00111007|558783|P2|COMPLETED|Double-blind (DB) Treatment||24
233780|NCT00111007|558784|P1|COMPLETED|Double-blind (DB) Treatment||27
233781|NCT00111007|558783|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
233782|NCT00111007|558784|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
233783|NCT00111007|558783|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
233784|NCT00111007|558784|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
233785|NCT00110994|558800|P2|NOT COMPLETED|Long Term Follow-up||17
233786|NCT00110994|558801|P1|NOT COMPLETED|Long Term Follow-up||19
233787|NCT00110994|558800|P2|COMPLETED|Long Term Follow-up||30
233788|NCT00110994|558801|P1|COMPLETED|Long Term Follow-up||22
233789|NCT00110994|558800|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
233790|NCT00110994|558801|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
233791|NCT00110994|558800|P2|NOT COMPLETED|Active Follow-up||2
233792|NCT00110994|558801|P1|NOT COMPLETED|Active Follow-up||1
233793|NCT00110994|558800|P2|COMPLETED|Active Follow-up||0
233794|NCT00110994|558801|P1|COMPLETED|Active Follow-up||0
233795|NCT00110994|558800|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
233881|NCT00110214|559161|P2|NOT COMPLETED|Overall Study||503
233796|NCT00110994|558801|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
233797|NCT00110994|558800|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
233798|NCT00110994|558801|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
233799|NCT00110994|558800|P2|COMPLETED|Double-blind (DB) Treatment||3
233800|NCT00110994|558801|P1|COMPLETED|Double-blind (DB) Treatment||9
233801|NCT00110994|558800|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
233802|NCT00110994|558801|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
233803|NCT00110994|558800|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
233804|NCT00110994|558801|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
233805|NCT00110890|558827|P2|NOT COMPLETED|Overall Study||179
233806|NCT00110890|558828|P1|NOT COMPLETED|Overall Study||361
233807|NCT00110890|558827|P2|COMPLETED|Overall Study|Follow-up Phase|5
233808|NCT00110890|558828|P1|COMPLETED|Overall Study|Follow-up Phase|7
233809|NCT00110890|558827|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
233810|NCT00110890|558828|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
233811|NCT00110890|558827|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
233812|NCT00110890|558828|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
233813|NCT00110890|558827|P2|STARTED|Overall Study||184
233814|NCT00110890|558828|P1|STARTED|Overall Study||368
233815|NCT00110812|558845|P3|NOT COMPLETED|Extended Follow-up||4
233816|NCT00110812|558846|P2|NOT COMPLETED|Extended Follow-up||4
233817|NCT00110812|558847|P1|NOT COMPLETED|Extended Follow-up||2
233818|NCT00110812|558845|P3|COMPLETED|Extended Follow-up||69
233819|NCT00110812|558846|P2|COMPLETED|Extended Follow-up||65
233820|NCT00110812|558847|P1|COMPLETED|Extended Follow-up||78
233821|NCT00110812|558845|P3|STARTED|Extended Follow-up||73
233822|NCT00110812|558846|P2|STARTED|Extended Follow-up||69
233823|NCT00110812|558847|P1|STARTED|Extended Follow-up||80
233824|NCT00110812|558845|P3|NOT COMPLETED|Main Study||13
233825|NCT00110812|558846|P2|NOT COMPLETED|Main Study||11
233826|NCT00110812|558847|P1|NOT COMPLETED|Main Study||8
233827|NCT00110812|558845|P3|COMPLETED|Main Study||74
233828|NCT00110812|558846|P2|COMPLETED|Main Study||78
233829|NCT00110812|558847|P1|COMPLETED|Main Study||83
233830|NCT00110812|558845|P3|STARTED|Main Study||87
233831|NCT00110812|558846|P2|STARTED|Main Study||89
233832|NCT00110812|558847|P1|STARTED|Main Study||91
233833|NCT00110617|558892|P2|NOT COMPLETED|Overall Study||29
233834|NCT00110617|558893|P1|NOT COMPLETED|Overall Study||39
233835|NCT00110617|558892|P2|COMPLETED|Overall Study||39
233836|NCT00110617|558893|P1|COMPLETED|Overall Study||96
233837|NCT00110617|558892|P2|On Going at Week 24|Overall Study||53
233838|NCT00110617|558893|P1|On Going at Week 24|Overall Study||126
233839|NCT00110617|558892|P2|Full Analysis 2; Received ICL670|Overall Study||53
233840|NCT00110617|558893|P1|Full Analysis 2; Received ICL670|Overall Study||135
233841|NCT00110617|558892|P2|Safety Set 1; Received Study Drug|Overall Study||56
233842|NCT00110617|558893|P1|Safety Set 1; Received Study Drug|Overall Study||135
233843|NCT00110617|558892|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
233844|NCT00110617|558893|P1|STARTED|Overall Study||135
233845|NCT00110513|558906|P1|NOT COMPLETED|Overall Study||0
233846|NCT00110513|558906|P1|COMPLETED|Overall Study||18
233847|NCT00110513|558906|P1|STARTED|Overall Study||18
233848|NCT00110461|558913|P3|NOT COMPLETED|Acute Phase||23
233849|NCT00110461|558914|P2|NOT COMPLETED|Acute Phase||22
233850|NCT00110461|558915|P1|NOT COMPLETED|Acute Phase||14
233851|NCT00110461|558913|P3|COMPLETED|Acute Phase||76
233852|NCT00110461|558914|P2|COMPLETED|Acute Phase||77
233853|NCT00110461|558915|P1|COMPLETED|Acute Phase||84
233854|NCT00110461|558913|P3|STARTED|Acute Phase||99
233855|NCT00110461|558914|P2|STARTED|Acute Phase||99
233856|NCT00110461|558915|P1|STARTED|Acute Phase||98
233857|NCT00110461|558913|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
233858|NCT00110461|558914|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
233859|NCT00110461|558915|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
233860|NCT00110461|558913|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
233861|NCT00110461|558914|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
233862|NCT00110461|558915|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
233863|NCT00110461|558913|P3|STARTED|30-Week, Double-blind Treatment Phase||99
233864|NCT00110461|558914|P2|STARTED|30-Week, Double-blind Treatment Phase||99
233865|NCT00110461|558915|P1|STARTED|30-Week, Double-blind Treatment Phase||98
233866|NCT00110396|559010|P1|NOT COMPLETED|Overall Study||36
233867|NCT00110396|559010|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
233868|NCT00110396|559010|P1|STARTED|Overall Study||260
233869|NCT00110357|559018|P2|NOT COMPLETED|Overall Study||19
233870|NCT00110357|559019|P1|NOT COMPLETED|Overall Study||27
233871|NCT00110357|559018|P2|COMPLETED|Overall Study|Number Still on Study|0
233872|NCT00110357|559019|P1|COMPLETED|Overall Study|Number Still on Study|0
233873|NCT00110357|559018|P2|STARTED|Overall Study||19
233874|NCT00110357|559019|P1|STARTED|Overall Study||27
233875|NCT00110305|559107|P2|NOT COMPLETED|Overall Study||32
233876|NCT00110305|559108|P1|NOT COMPLETED|Overall Study||114
233877|NCT00110305|559107|P2|COMPLETED|Overall Study||57
233878|NCT00110305|559108|P1|COMPLETED|Overall Study||165
233879|NCT00110305|559107|P2|STARTED|Overall Study||89
233880|NCT00110305|559108|P1|STARTED|Overall Study||279
233882|NCT00110214|559162|P1|NOT COMPLETED|Overall Study||509
233883|NCT00110214|559161|P2|COMPLETED|Overall Study||21
233884|NCT00110214|559162|P1|COMPLETED|Overall Study||17
233885|NCT00110214|559161|P2|STARTED|Overall Study||524
233886|NCT00110214|559162|P1|STARTED|Overall Study||526
233887|NCT00110136|559174|P1|NOT COMPLETED|Overall Study||0
233888|NCT00110136|559174|P1|COMPLETED|Overall Study||9
233889|NCT00110136|559174|P1|STARTED|Overall Study||9
233890|NCT00110084|559183|P1|NOT COMPLETED|Overall Study||28
233891|NCT00110084|559183|P1|COMPLETED|Overall Study||22
233892|NCT00110084|559183|P1|STARTED|Overall Study||50
233893|NCT00110019|559192|P2|NOT COMPLETED|Overall Study||413
233894|NCT00110019|559193|P1|NOT COMPLETED|Overall Study||406
233895|NCT00110019|559192|P2|COMPLETED|Overall Study||0
233896|NCT00110019|559193|P1|COMPLETED|Overall Study||4
233897|NCT00110019|559192|P2|Treated|Overall Study||397
233898|NCT00110019|559193|P1|Treated|Overall Study||393
233899|NCT00110019|559192|P2|Eligible|Overall Study||398
233900|NCT00110019|559193|P1|Eligible|Overall Study||395
233901|NCT00110019|559192|P2|STARTED|Overall Study||413
233902|NCT00110019|559193|P1|STARTED|Overall Study||410
233903|NCT00109967|559205|P2|NOT COMPLETED|Overall Study||6
233904|NCT00109967|559206|P1|NOT COMPLETED|Overall Study||20
233905|NCT00109967|559205|P2|COMPLETED|Overall Study||15
233906|NCT00109967|559206|P1|COMPLETED|Overall Study||30
233907|NCT00109967|559205|P2|STARTED|Overall Study||21
233908|NCT00109967|559206|P1|STARTED|Overall Study||50
233909|NCT00109928|559220|P1|NOT COMPLETED|Overall Study||13
233910|NCT00109928|559220|P1|COMPLETED|Overall Study||21
233911|NCT00109928|559220|P1|Eligible and Began Protocol Therapy|Overall Study||33
233912|NCT00109928|559220|P1|Eligible|Overall Study||33
233913|NCT00109928|559220|P1|STARTED|Overall Study||34
233914|NCT00109876|559227|P1|NOT COMPLETED|Overall Study||0
233915|NCT00109876|559227|P1|COMPLETED|Overall Study||51
233916|NCT00109876|559227|P1|STARTED|Overall Study||51
233917|NCT00109850|559237|P1|NOT COMPLETED|Overall Study||4
233918|NCT00109850|559237|P1|COMPLETED|Overall Study||18
233919|NCT00109850|559237|P1|Eligible and Began Protocol Therapy|Overall Study||21
233920|NCT00109850|559237|P1|Eligible|Overall Study||21
233921|NCT00109850|559237|P1|STARTED|Overall Study||22
233922|NCT00109837|559244|P1|NOT COMPLETED|Overall Study||23
233923|NCT00109837|559244|P1|COMPLETED|Overall Study||56
233924|NCT00109837|559244|P1|Eligible and Ph- and Treated|Overall Study||60
233925|NCT00109837|559244|P1|Eligible and Ph-|Overall Study||61
233926|NCT00109837|559244|P1|Eligible|Overall Study||78
233927|NCT00109837|559244|P1|STARTED|Overall Study||79
233928|NCT00109772|559254|P2|NOT COMPLETED|Open-label Extension||49
233929|NCT00109772|559255|P1|NOT COMPLETED|Open-label Extension||45
233930|NCT00109772|559254|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
233931|NCT00109772|559255|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
233932|NCT00109772|559254|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
233933|NCT00109772|559255|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
233934|NCT00109772|559254|P2|NOT COMPLETED|Double-blind Treatment||15
233935|NCT00109772|559255|P1|NOT COMPLETED|Double-blind Treatment||22
233936|NCT00109772|559254|P2|COMPLETED|Double-blind Treatment||79
233937|NCT00109772|559255|P1|COMPLETED|Double-blind Treatment||68
233938|NCT00109772|559254|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
233939|NCT00109772|559255|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
233940|NCT00109772|559254|P2|STARTED|Double-blind Treatment||94
233941|NCT00109772|559255|P1|STARTED|Double-blind Treatment||90
233942|NCT00109733|559295|P2|NOT COMPLETED|Overall Study||4
233943|NCT00109733|559296|P1|NOT COMPLETED|Overall Study||2
233944|NCT00109733|559295|P2|COMPLETED|Overall Study||12
233945|NCT00109733|559296|P1|COMPLETED|Overall Study||13
233946|NCT00109733|559295|P2|STARTED|Overall Study||16
233947|NCT00109733|559296|P1|STARTED|Overall Study||15
233948|NCT00109590|559313|P3|NOT COMPLETED|Overall Study||4
233949|NCT00109590|559314|P2|NOT COMPLETED|Overall Study||2
233950|NCT00109590|559315|P1|NOT COMPLETED|Overall Study||2
233951|NCT00109590|559313|P3|COMPLETED|Overall Study||56
233952|NCT00109590|559314|P2|COMPLETED|Overall Study||56
233953|NCT00109590|559315|P1|COMPLETED|Overall Study||55
233954|NCT00109590|559313|P3|RECEIVED TREATMENT|Overall Study||57
233955|NCT00109590|559314|P2|RECEIVED TREATMENT|Overall Study||56
233956|NCT00109590|559315|P1|RECEIVED TREATMENT|Overall Study||56
233957|NCT00109590|559313|P3|STARTED|Overall Study||60
233958|NCT00109590|559314|P2|STARTED|Overall Study||58
233959|NCT00109590|559315|P1|STARTED|Overall Study||57
233960|NCT00109577|559357|P2|NOT COMPLETED|Overall Study||3
233961|NCT00109577|559358|P1|NOT COMPLETED|Overall Study||3
233962|NCT00109577|559357|P2|COMPLETED|Overall Study||17
233963|NCT00109577|559358|P1|COMPLETED|Overall Study||17
233964|NCT00109577|559357|P2|STARTED|Overall Study||20
233965|NCT00109577|559358|P1|STARTED|Overall Study||20
233966|NCT00109473|559366|P2|NOT COMPLETED|52 Week Extension Phase||5
233967|NCT00109473|559367|P1|NOT COMPLETED|52 Week Extension Phase||4
234053|NCT00108953|559534|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
233968|NCT00109473|559366|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
233969|NCT00109473|559367|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
233970|NCT00109473|559366|P2|Analyzed|52 Week Extension Phase||8
233971|NCT00109473|559367|P1|Analyzed|52 Week Extension Phase||9
233972|NCT00109473|559366|P2|STARTED|52 Week Extension Phase||8
233973|NCT00109473|559367|P1|STARTED|52 Week Extension Phase||9
233974|NCT00109473|559366|P2|NOT COMPLETED|Week 12 to Week 24||0
233975|NCT00109473|559367|P1|NOT COMPLETED|Week 12 to Week 24||1
233976|NCT00109473|559366|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
233977|NCT00109473|559367|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
233978|NCT00109473|559366|P2|Analyzed|Week 12 to Week 24||9
233979|NCT00109473|559367|P1|Analyzed|Week 12 to Week 24||9
233980|NCT00109473|559366|P2|STARTED|Week 12 to Week 24||9
233981|NCT00109473|559367|P1|STARTED|Week 12 to Week 24||10
233982|NCT00109473|559366|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
233983|NCT00109473|559367|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
233984|NCT00109473|559366|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
233985|NCT00109473|559367|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
233986|NCT00109473|559366|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
233987|NCT00109473|559367|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
233988|NCT00109473|559366|P2|STARTED|Baseline (0 Through 12 Weeks)||10
233989|NCT00109473|559367|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
233990|NCT00109343|559389|P3|NOT COMPLETED|Overall Study||30
233991|NCT00109343|559390|P2|NOT COMPLETED|Overall Study||37
233992|NCT00109343|559391|P1|NOT COMPLETED|Overall Study||64
233993|NCT00109343|559389|P3|COMPLETED|Overall Study||229
233994|NCT00109343|559390|P2|COMPLETED|Overall Study||221
233995|NCT00109343|559391|P1|COMPLETED|Overall Study||446
233996|NCT00109343|559389|P3|Vaccinated at Visit 4|Overall Study||240
233997|NCT00109343|559390|P2|Vaccinated at Visit 4|Overall Study||235
233998|NCT00109343|559391|P1|Vaccinated at Visit 4|Overall Study||466
233999|NCT00109343|559389|P3|Vaccinated at Visit 2|Overall Study||246
234000|NCT00109343|559390|P2|Vaccinated at Visit 2|Overall Study||246
234001|NCT00109343|559391|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
234002|NCT00109343|559389|P3|Vaccinated at Visit 1|Overall Study||259
234003|NCT00109343|559390|P2|Vaccinated at Visit 1|Overall Study||258
234004|NCT00109343|559391|P1|Vaccinated at Visit 1|Overall Study||510
234005|NCT00109343|559389|P3|STARTED|Overall Study||259
234006|NCT00109343|559390|P2|STARTED|Overall Study||258
234007|NCT00109343|559391|P1|STARTED|Overall Study||510
234008|NCT00107900|559438|P6|NOT COMPLETED|Overall Study||9
234009|NCT00107900|559439|P5|NOT COMPLETED|Overall Study||21
234010|NCT00107900|559440|P4|NOT COMPLETED|Overall Study||12
234011|NCT00107900|559441|P3|NOT COMPLETED|Overall Study||25
234012|NCT00107900|559442|P2|NOT COMPLETED|Overall Study||3
234013|NCT00107900|559443|P1|NOT COMPLETED|Overall Study||10
234014|NCT00107900|559438|P6|COMPLETED|Overall Study||94
234015|NCT00107900|559439|P5|COMPLETED|Overall Study||94
234016|NCT00107900|559440|P4|COMPLETED|Overall Study||87
234017|NCT00107900|559441|P3|COMPLETED|Overall Study||104
234018|NCT00107900|559442|P2|COMPLETED|Overall Study||72
234019|NCT00107900|559443|P1|COMPLETED|Overall Study||75
234020|NCT00107900|559438|P6|STARTED|Overall Study||103
234021|NCT00107900|559439|P5|STARTED|Overall Study||115
234022|NCT00107900|559440|P4|STARTED|Overall Study||99
234023|NCT00107900|559441|P3|STARTED|Overall Study||129
234024|NCT00107900|559442|P2|STARTED|Overall Study||75
234025|NCT00107900|559443|P1|STARTED|Overall Study||85
234026|NCT00109031|559479|P4|NOT COMPLETED|Overall Study||0
234027|NCT00109031|559480|P3|NOT COMPLETED|Overall Study||2
234028|NCT00109031|559481|P2|NOT COMPLETED|Overall Study||2
234029|NCT00109031|559482|P1|NOT COMPLETED|Overall Study||0
234030|NCT00109031|559479|P4|COMPLETED|Overall Study||12
234031|NCT00109031|559480|P3|COMPLETED|Overall Study||12
234032|NCT00109031|559481|P2|COMPLETED|Overall Study||8
234033|NCT00109031|559482|P1|COMPLETED|Overall Study||11
234034|NCT00109031|559479|P4|STARTED|Overall Study||12
234035|NCT00109031|559480|P3|STARTED|Overall Study||14
234036|NCT00109031|559481|P2|STARTED|Overall Study||10
234037|NCT00109031|559482|P1|STARTED|Overall Study||11
234038|NCT00109005|559518|P2|NOT COMPLETED|Overall Study||0
234039|NCT00109005|559519|P1|NOT COMPLETED|Overall Study||0
234040|NCT00109005|559518|P2|COMPLETED|Overall Study||9
234041|NCT00109005|559519|P1|COMPLETED|Overall Study||8
234042|NCT00109005|559518|P2|STARTED|Overall Study||9
234043|NCT00109005|559519|P1|STARTED|Overall Study||8
234044|NCT00108953|559533|P2|NOT COMPLETED|Follow-up||33
234045|NCT00108953|559534|P1|NOT COMPLETED|Follow-up||29
234046|NCT00108953|559533|P2|COMPLETED|Follow-up||12
234047|NCT00108953|559534|P1|COMPLETED|Follow-up||11
234048|NCT00108953|559533|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
234049|NCT00108953|559534|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
234050|NCT00108953|559533|P2|NOT COMPLETED|Treatment Period||0
234051|NCT00108953|559534|P1|NOT COMPLETED|Treatment Period||0
234052|NCT00108953|559533|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
234054|NCT00108953|559533|P2|STARTED|Treatment Period|ITT population|49
234055|NCT00108953|559534|P1|STARTED|Treatment Period|ITT population|47
234056|NCT00108862|559556|P2|NOT COMPLETED|Overall Study||62
234057|NCT00108862|559557|P1|NOT COMPLETED|Overall Study||68
234058|NCT00108862|559556|P2|COMPLETED|Overall Study||339
234059|NCT00108862|559557|P1|COMPLETED|Overall Study||337
234060|NCT00108862|559556|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
234061|NCT00108862|559557|P1|STARTED|Overall Study||405
234062|NCT00108732|559585|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
234063|NCT00108732|559585|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
234064|NCT00108732|559585|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
234065|NCT00108732|559585|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
234066|NCT00108732|559585|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
234067|NCT00108732|559585|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
234068|NCT00108732|559585|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
234069|NCT00108628|559594|P2|NOT COMPLETED|Overall Study||10
234070|NCT00108628|559595|P1|NOT COMPLETED|Overall Study||20
234071|NCT00108628|559594|P2|COMPLETED|Overall Study||53
234072|NCT00108628|559595|P1|COMPLETED|Overall Study||41
234073|NCT00108628|559594|P2|Completed Treatment|Overall Study||57
234074|NCT00108628|559595|P1|Completed Treatment|Overall Study||42
234075|NCT00108628|559594|P2|Received One or More Sessions|Overall Study||58
234076|NCT00108628|559595|P1|Received One or More Sessions|Overall Study||53
234077|NCT00108628|559594|P2|STARTED|Overall Study||63
234078|NCT00108628|559595|P1|STARTED|Overall Study||61
234079|NCT00108550|559621|P2|NOT COMPLETED|Overall Study||16
234080|NCT00108550|559622|P1|NOT COMPLETED|Overall Study||16
234081|NCT00108550|559621|P2|COMPLETED|Overall Study||37
234082|NCT00108550|559622|P1|COMPLETED|Overall Study||39
234083|NCT00108550|559621|P2|STARTED|Overall Study||53
234084|NCT00108550|559622|P1|STARTED|Overall Study||55
234085|NCT00108524|559632|P2|NOT COMPLETED|Overall Study||18
234086|NCT00108524|559633|P1|NOT COMPLETED|Overall Study||29
234087|NCT00108524|559632|P2|COMPLETED|Overall Study||61
234088|NCT00108524|559633|P1|COMPLETED|Overall Study||52
234089|NCT00108524|559632|P2|STARTED|Overall Study||79
234090|NCT00108524|559633|P1|STARTED|Overall Study||81
234091|NCT00108485|559645|P2|NOT COMPLETED|Overall Study||2
234092|NCT00108485|559646|P1|NOT COMPLETED|Overall Study||3
234093|NCT00108485|559645|P2|COMPLETED|Overall Study||2
234094|NCT00108485|559646|P1|COMPLETED|Overall Study||2
234095|NCT00108485|559645|P2|STARTED|Overall Study||4
234096|NCT00108485|559646|P1|STARTED|Overall Study||5
234097|NCT00108433|559654|P2|NOT COMPLETED|Overall Study||17
234098|NCT00108433|559655|P1|NOT COMPLETED|Overall Study||21
234099|NCT00108433|559654|P2|COMPLETED|Overall Study||14
234100|NCT00108433|559655|P1|COMPLETED|Overall Study||9
234101|NCT00108433|559654|P2|STARTED|Overall Study||31
234102|NCT00108433|559655|P1|STARTED|Overall Study||30
234103|NCT00108355|559671|P2|NOT COMPLETED|Overall Study||2
234104|NCT00108355|559672|P1|NOT COMPLETED|Overall Study||2
234105|NCT00108355|559671|P2|COMPLETED|Overall Study||12
234106|NCT00108355|559672|P1|COMPLETED|Overall Study||13
234107|NCT00108355|559671|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
234108|NCT00108355|559672|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
234109|NCT00108342|559682|P2|NOT COMPLETED|Overall Study||0
234110|NCT00108342|559683|P1|NOT COMPLETED|Overall Study||1
234111|NCT00108342|559682|P2|COMPLETED|Overall Study||9
234112|NCT00108342|559683|P1|COMPLETED|Overall Study||7
234113|NCT00108342|559682|P2|STARTED|Overall Study||9
234114|NCT00108342|559683|P1|STARTED|Overall Study||8
234115|NCT00107783|559691|P2|NOT COMPLETED|Overall Study||4
234116|NCT00107783|559692|P1|NOT COMPLETED|Overall Study||3
234117|NCT00107783|559691|P2|COMPLETED|Overall Study||16
234118|NCT00107783|559692|P1|COMPLETED|Overall Study||17
234119|NCT00107783|559691|P2|STARTED|Overall Study||20
234120|NCT00107783|559692|P1|STARTED|Overall Study||20
234121|NCT00107653|559708|P2|NOT COMPLETED|Overall Study||76
234122|NCT00107653|559709|P1|NOT COMPLETED|Overall Study||79
234123|NCT00107653|559708|P2|COMPLETED|Overall Study||224
234124|NCT00107653|559709|P1|COMPLETED|Overall Study||190
234125|NCT00107653|559708|P2|STARTED|Overall Study||300
234126|NCT00107653|559709|P1|STARTED|Overall Study||269
234127|NCT00107614|559755|P1|NOT COMPLETED|Overall Study||12
234128|NCT00107614|559755|P1|COMPLETED|Overall Study||0
234129|NCT00107614|559755|P1|STARTED|Overall Study||12
234130|NCT00107575|559761|P2|NOT COMPLETED|Overall Study||10
234131|NCT00107575|559762|P1|NOT COMPLETED|Overall Study||11
234132|NCT00107575|559761|P2|COMPLETED|Overall Study||107
234133|NCT00107575|559762|P1|COMPLETED|Overall Study||108
234134|NCT00107575|559761|P2|STARTED|Overall Study||117
234135|NCT00107575|559762|P1|STARTED|Overall Study||119
234136|NCT00108303|559779|P3|NOT COMPLETED|Overall Study||0
234137|NCT00108303|559780|P2|NOT COMPLETED|Overall Study||0
234138|NCT00108303|559781|P1|NOT COMPLETED|Overall Study||0
234139|NCT00108303|559779|P3|COMPLETED|Overall Study||180
234140|NCT00108303|559780|P2|COMPLETED|Overall Study||179
234141|NCT00108303|559781|P1|COMPLETED|Overall Study||179
234142|NCT00108303|559779|P3|STARTED|Overall Study||180
234143|NCT00108303|559780|P2|STARTED|Overall Study||179
234144|NCT00108303|559781|P1|STARTED|Overall Study||179
234145|NCT00108277|559796|P3|NOT COMPLETED|Overall Study||16
234146|NCT00108277|559797|P2|NOT COMPLETED|Overall Study||12
234147|NCT00108277|559798|P1|NOT COMPLETED|Overall Study||10
234148|NCT00108277|559796|P3|COMPLETED|Overall Study||19
234149|NCT00108277|559797|P2|COMPLETED|Overall Study||16
234150|NCT00108277|559798|P1|COMPLETED|Overall Study||19
234151|NCT00108277|559796|P3|STARTED|Overall Study||35
234152|NCT00108277|559797|P2|STARTED|Overall Study||28
234153|NCT00108277|559798|P1|STARTED|Overall Study||29
234154|NCT00108160|559808|P2|NOT COMPLETED|Overall Study||21
234155|NCT00108160|559809|P1|NOT COMPLETED|Overall Study||39
234156|NCT00108160|559808|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
234157|NCT00108160|559809|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
234158|NCT00108160|559808|P2|Completed Visit 7 (18 mo)|Overall Study||31
234159|NCT00108160|559809|P1|Completed Visit 7 (18 mo)|Overall Study||34
234160|NCT00108160|559808|P2|Completed Visit 6 (15 mo)|Overall Study||33
234161|NCT00108160|559809|P1|Completed Visit 6 (15 mo)|Overall Study||36
234162|NCT00108160|559808|P2|Completed Visit 5 (12 mo)|Overall Study||37
234163|NCT00108160|559809|P1|Completed Visit 5 (12 mo)|Overall Study||37
234164|NCT00108160|559808|P2|Completed Visit 4 (9 mo)|Overall Study||37
234165|NCT00108160|559809|P1|Completed Visit 4 (9 mo)|Overall Study||38
234166|NCT00108160|559808|P2|Completed Visit 3 (6 mo)|Overall Study||38
234167|NCT00108160|559809|P1|Completed Visit 3 (6 mo)|Overall Study||44
234168|NCT00108160|559808|P2|Completed Visit 2 (3 mo)|Overall Study||46
234169|NCT00108160|559809|P1|Completed Visit 2 (3 mo)|Overall Study||54
234170|NCT00108160|559808|P2|Completed Visit 1 (2 Wks)|Overall Study||54
234171|NCT00108160|559809|P1|Completed Visit 1 (2 Wks)|Overall Study||72
234172|NCT00108160|559808|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
234173|NCT00108160|559809|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
234174|NCT00108160|559808|P2|STARTED|Overall Study||63
234175|NCT00108160|559809|P1|STARTED|Overall Study||83
234176|NCT00108082|559822|P3|NOT COMPLETED|Overall Study||43
234177|NCT00108082|559823|P2|NOT COMPLETED|Overall Study||32
234178|NCT00108082|559824|P1|NOT COMPLETED|Overall Study||38
234179|NCT00108082|559822|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
234180|NCT00108082|559823|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
234181|NCT00108082|559824|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
234182|NCT00108082|559822|P3|STARTED|Overall Study||96
234183|NCT00108082|559823|P2|STARTED|Overall Study||100
234184|NCT00108082|559824|P1|STARTED|Overall Study||91
234185|NCT00108069|559873|P2|NOT COMPLETED|Overall Study||13
234186|NCT00108069|559874|P1|NOT COMPLETED|Overall Study||30
234187|NCT00108069|559873|P2|COMPLETED|Overall Study||0
234188|NCT00108069|559874|P1|COMPLETED|Overall Study||0
234189|NCT00108069|559873|P2|STARTED|Overall Study||13
234190|NCT00108069|559874|P1|STARTED|Overall Study||30
234191|NCT00107991|559888|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
234192|NCT00107991|559888|P1|COMPLETED|18-Week Post Treatment Assessment||8
234193|NCT00107991|559888|P1|STARTED|18-Week Post Treatment Assessment||10
234194|NCT00107991|559888|P1|NOT COMPLETED|12 Week Treatment Period||5
234195|NCT00107991|559888|P1|COMPLETED|12 Week Treatment Period||10
234196|NCT00107991|559888|P1|STARTED|12 Week Treatment Period||15
234197|NCT00107991|559888|P1|NOT COMPLETED|Eligibility Assessment||23
234198|NCT00107991|559888|P1|COMPLETED|Eligibility Assessment||15
234199|NCT00107991|559888|P1|STARTED|Eligibility Assessment||38
234200|NCT00107978|559898|P2|NOT COMPLETED|Overall Study||50
234201|NCT00107978|559899|P1|NOT COMPLETED|Overall Study||33
234202|NCT00107978|559898|P2|COMPLETED|Overall Study||431
234203|NCT00107978|559899|P1|COMPLETED|Overall Study||425
234204|NCT00107978|559898|P2|STARTED|Overall Study||481
234205|NCT00107978|559899|P1|STARTED|Overall Study||458
234206|NCT00107952|559907|P2|NOT COMPLETED|Overall Study||81
234207|NCT00107952|559908|P1|NOT COMPLETED|Overall Study||95
234208|NCT00107952|559907|P2|COMPLETED|Overall Study||299
234209|NCT00107952|559908|P1|COMPLETED|Overall Study||286
234210|NCT00107952|559907|P2|STARTED|Overall Study||380
234211|NCT00107952|559908|P1|STARTED|Overall Study||381
234212|NCT00107536|559914|P1|NOT COMPLETED|Overall Study||0
234213|NCT00107536|559914|P1|COMPLETED|Overall Study||26
234214|NCT00107536|559914|P1|STARTED|Overall Study||26
234215|NCT00107380|559924|P1|NOT COMPLETED|Overall Study||30
234216|NCT00107380|559924|P1|COMPLETED|Overall Study||56
234217|NCT00107380|559924|P1|Eligible|Overall Study||84
234218|NCT00107380|559924|P1|STARTED|Overall Study||86
234219|NCT00107315|559930|P1|NOT COMPLETED|Overall Study||15
234220|NCT00107315|559930|P1|COMPLETED|Overall Study||1
234221|NCT00107315|559930|P1|STARTED|Overall Study||16
234222|NCT00107276|559937|P1|NOT COMPLETED|Overall Study||72
234223|NCT00107276|559937|P1|COMPLETED|Overall Study||40
234224|NCT00107276|559937|P1|Eligible|Overall Study||96
234225|NCT00107276|559937|P1|STARTED|Overall Study||112
234226|NCT00107198|559943|P1|NOT COMPLETED|Overall Study||52
234227|NCT00107198|559943|P1|COMPLETED|Overall Study||136
234228|NCT00107198|559943|P1|STARTED|Overall Study||188
234229|NCT00107172|559953|P2|NOT COMPLETED|Overall Study||5
234230|NCT00107172|559954|P1|NOT COMPLETED|Overall Study||5
234231|NCT00107172|559953|P2|COMPLETED|Overall Study||103
234232|NCT00107172|559954|P1|COMPLETED|Overall Study||109
234233|NCT00107172|559953|P2|STARTED|Overall Study||108
234234|NCT00107172|559954|P1|STARTED|Overall Study||114
234235|NCT00107120|559984|P2|NOT COMPLETED|Overall Study||24
234236|NCT00107120|559985|P1|NOT COMPLETED|Overall Study||29
234237|NCT00107120|559984|P2|COMPLETED|Overall Study||133
234238|NCT00107120|559985|P1|COMPLETED|Overall Study||126
234239|NCT00107120|559984|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
234240|NCT00107120|559985|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
234241|NCT00107042|559997|P2|NOT COMPLETED|Overall Study||16
234242|NCT00107042|559998|P1|NOT COMPLETED|Overall Study||22
234243|NCT00107042|559997|P2|COMPLETED|Overall Study||47
234244|NCT00107042|559998|P1|COMPLETED|Overall Study||38
234245|NCT00107042|559997|P2|STARTED|Overall Study||63
234246|NCT00107042|559998|P1|STARTED|Overall Study||60
234247|NCT00106964|560064|P3|NOT COMPLETED|Overall Study||7
234248|NCT00106964|560065|P2|NOT COMPLETED|Overall Study||15
234249|NCT00106964|560066|P1|NOT COMPLETED|Overall Study||13
234250|NCT00106964|560064|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
234251|NCT00106964|560065|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
234252|NCT00106964|560066|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
234253|NCT00106964|560064|P3|STARTED|Overall Study||127
234254|NCT00106964|560065|P2|STARTED|Overall Study||126
234255|NCT00106964|560066|P1|STARTED|Overall Study||118
234256|NCT00106938|560091|P2|NOT COMPLETED|Overall Study||71
234257|NCT00106938|560092|P1|NOT COMPLETED|Overall Study||176
234258|NCT00106938|560091|P2|COMPLETED|Overall Study||293
234259|NCT00106938|560092|P1|COMPLETED|Overall Study||913
234260|NCT00106938|560091|P2|STARTED|Overall Study||364
234261|NCT00106938|560092|P1|STARTED|Overall Study||1089
234262|NCT00106704|560139|P2|NOT COMPLETED|Overall Study||151
234263|NCT00106704|560140|P1|NOT COMPLETED|Overall Study||131
234264|NCT00106704|560139|P2|COMPLETED|Overall Study||68
234265|NCT00106704|560140|P1|COMPLETED|Overall Study||91
234266|NCT00106704|560139|P2|STARTED|Overall Study||219
234267|NCT00106704|560140|P1|STARTED|Overall Study||222
234268|NCT00106639|560151|P3|NOT COMPLETED|Overall Study||2
234269|NCT00106639|560152|P2|NOT COMPLETED|Overall Study||7
234270|NCT00106639|560153|P1|NOT COMPLETED|Overall Study||3
234271|NCT00106639|560151|P3|COMPLETED|Overall Study||19
234272|NCT00106639|560152|P2|COMPLETED|Overall Study||13
234273|NCT00106639|560153|P1|COMPLETED|Overall Study||17
234274|NCT00106639|560151|P3|STARTED|Overall Study||21
234275|NCT00106639|560152|P2|STARTED|Overall Study||20
234276|NCT00106639|560153|P1|STARTED|Overall Study||20
234277|NCT00106626|560280|P4|NOT COMPLETED|Overall Study||13
234278|NCT00106626|560281|P3|NOT COMPLETED|Overall Study||12
234279|NCT00106626|560282|P2|NOT COMPLETED|Overall Study||6
234280|NCT00106626|560283|P1|NOT COMPLETED|Overall Study||10
234281|NCT00106626|560280|P4|COMPLETED|Overall Study||3
234282|NCT00106626|560281|P3|COMPLETED|Overall Study||2
234283|NCT00106626|560282|P2|COMPLETED|Overall Study||3
234284|NCT00106626|560283|P1|COMPLETED|Overall Study||3
234285|NCT00106626|560280|P4|STARTED|Overall Study||16
234286|NCT00106626|560281|P3|STARTED|Overall Study||14
234287|NCT00106626|560282|P2|STARTED|Overall Study||9
234288|NCT00106626|560283|P1|STARTED|Overall Study||13
234289|NCT00106535|560301|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
234290|NCT00106535|560302|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234291|NCT00106535|560303|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234292|NCT00106535|560304|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234293|NCT00106535|560301|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
234294|NCT00106535|560302|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234295|NCT00106535|560303|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234296|NCT00106535|560304|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
234297|NCT00106535|560301|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
234298|NCT00106535|560302|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
234299|NCT00106535|560303|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
234300|NCT00106535|560304|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
234301|NCT00106535|560301|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
234302|NCT00106535|560302|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
234303|NCT00106535|560303|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
234304|NCT00106535|560304|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
234305|NCT00106535|560301|P4|COMPLETED|2-year Placebo Controlled Period||0
234306|NCT00106535|560302|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
234307|NCT00106535|560303|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
234308|NCT00106535|560304|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
234309|NCT00106535|560301|P4|Completed Week 52|2-year Placebo Controlled Period||0
234310|NCT00106535|560302|P3|Completed Week 52|2-year Placebo Controlled Period||338
234311|NCT00106535|560303|P2|Completed Week 52|2-year Placebo Controlled Period||342
234312|NCT00106535|560304|P1|Completed Week 52|2-year Placebo Controlled Period||326
234313|NCT00106535|560301|P4|Completed Week 24|2-year Placebo Controlled Period||0
234314|NCT00106535|560302|P3|Completed Week 24|2-year Placebo Controlled Period||366
234315|NCT00106535|560303|P2|Completed Week 24|2-year Placebo Controlled Period||373
234316|NCT00106535|560304|P1|Completed Week 24|2-year Placebo Controlled Period||356
234317|NCT00106535|560301|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
234318|NCT00106535|560302|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
234319|NCT00106535|560303|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
234320|NCT00106535|560304|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
234321|NCT00106535|560301|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
234322|NCT00106535|560302|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
234323|NCT00106535|560303|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
234324|NCT00106535|560304|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
234325|NCT00106535|560301|P4|STARTED|2-year Placebo Controlled Period||0
234326|NCT00106535|560302|P3|STARTED|2-year Placebo Controlled Period||401
234327|NCT00106535|560303|P2|STARTED|2-year Placebo Controlled Period||401
234328|NCT00106535|560304|P1|STARTED|2-year Placebo Controlled Period||394
234329|NCT00106431|560597|P1|NOT COMPLETED|Overall Study||65
234330|NCT00106431|560597|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
234331|NCT00106431|560597|P1|STARTED|Overall Study||102
234332|NCT00106392|560609|P2|NOT COMPLETED|Overall Study||27
234333|NCT00106392|560610|P1|NOT COMPLETED|Overall Study||26
234334|NCT00106392|560609|P2|COMPLETED|Overall Study||42
234335|NCT00106392|560610|P1|COMPLETED|Overall Study||36
234336|NCT00106392|560609|P2|Full Analysis Set (FAS)|Overall Study||61
234337|NCT00106392|560610|P1|Full Analysis Set (FAS)|Overall Study||53
234338|NCT00106392|560609|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
234339|NCT00106392|560610|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
234340|NCT00106392|560609|P2|STARTED|Overall Study||69
234341|NCT00106392|560610|P1|STARTED|Overall Study||62
234342|NCT00106353|560628|P7|NOT COMPLETED|Part 2||16
234343|NCT00106353|560629|P6|NOT COMPLETED|Part 2||18
234344|NCT00106353|560630|P5|NOT COMPLETED|Part 2||16
234345|NCT00106353|560631|P4|NOT COMPLETED|Part 2||0
234346|NCT00106353|560632|P3|NOT COMPLETED|Part 2||0
234347|NCT00106353|560633|P2|NOT COMPLETED|Part 2||0
234348|NCT00106353|560634|P1|NOT COMPLETED|Part 2||0
234349|NCT00106353|560628|P7|COMPLETED|Part 2||0
234350|NCT00106353|560629|P6|COMPLETED|Part 2||1
234351|NCT00106353|560630|P5|COMPLETED|Part 2||1
234352|NCT00106353|560631|P4|COMPLETED|Part 2||0
234353|NCT00106353|560632|P3|COMPLETED|Part 2||0
234354|NCT00106353|560633|P2|COMPLETED|Part 2||0
234355|NCT00106353|560634|P1|COMPLETED|Part 2||0
234356|NCT00106353|560628|P7|STARTED|Part 2||16
234357|NCT00106353|560629|P6|STARTED|Part 2||19
234358|NCT00106353|560630|P5|STARTED|Part 2||17
234359|NCT00106353|560631|P4|STARTED|Part 2||0
234360|NCT00106353|560632|P3|STARTED|Part 2||0
234361|NCT00106353|560633|P2|STARTED|Part 2||0
234362|NCT00106353|560634|P1|STARTED|Part 2||0
234363|NCT00106353|560628|P7|NOT COMPLETED|Part 1||0
234364|NCT00106353|560629|P6|NOT COMPLETED|Part 1||0
234365|NCT00106353|560630|P5|NOT COMPLETED|Part 1||0
234366|NCT00106353|560631|P4|NOT COMPLETED|Part 1||7
234367|NCT00106353|560632|P3|NOT COMPLETED|Part 1||3
234368|NCT00106353|560633|P2|NOT COMPLETED|Part 1||5
234369|NCT00106353|560634|P1|NOT COMPLETED|Part 1||4
234370|NCT00106353|560628|P7|COMPLETED|Part 1||0
234371|NCT00106353|560629|P6|COMPLETED|Part 1||0
234372|NCT00106353|560630|P5|COMPLETED|Part 1||0
234373|NCT00106353|560631|P4|COMPLETED|Part 1||0
234374|NCT00106353|560632|P3|COMPLETED|Part 1||0
234375|NCT00106353|560633|P2|COMPLETED|Part 1||0
234376|NCT00106353|560634|P1|COMPLETED|Part 1||0
234377|NCT00106353|560628|P7|STARTED|Part 1||0
234378|NCT00106353|560629|P6|STARTED|Part 1||0
234379|NCT00106353|560630|P5|STARTED|Part 1||0
234380|NCT00106353|560631|P4|STARTED|Part 1||7
234381|NCT00106353|560632|P3|STARTED|Part 1||3
234382|NCT00106353|560633|P2|STARTED|Part 1||5
234383|NCT00106353|560634|P1|STARTED|Part 1||4
234384|NCT00106249|560761|P2|NOT COMPLETED|Overall Study||2
234385|NCT00106249|560762|P1|NOT COMPLETED|Overall Study||3
234386|NCT00106249|560761|P2|COMPLETED|Overall Study||11
234387|NCT00106249|560762|P1|COMPLETED|Overall Study||11
234388|NCT00106249|560761|P2|STARTED|Overall Study||13
234389|NCT00106249|560762|P1|STARTED|Overall Study||14
234390|NCT00106184|560774|P2|NOT COMPLETED|Overall Study||2
234391|NCT00106184|560775|P1|NOT COMPLETED|Overall Study||3
234392|NCT00106184|560774|P2|COMPLETED|Overall Study||102
234393|NCT00106184|560775|P1|COMPLETED|Overall Study||93
234394|NCT00106184|560774|P2|Treated|Overall Study|104 subjects were randomized.|102
234395|NCT00106184|560775|P1|Treated|Overall Study|96 subjects were randomized.|93
234396|NCT00106184|560774|P2|STARTED|Overall Study||104
234397|NCT00106184|560775|P1|STARTED|Overall Study||96
234398|NCT00106119|560785|P2|NOT COMPLETED|Second Intervention||0
234399|NCT00106119|560786|P1|NOT COMPLETED|Second Intervention||0
234400|NCT00106119|560785|P2|COMPLETED|Second Intervention||7
234401|NCT00106119|560786|P1|COMPLETED|Second Intervention||7
234402|NCT00106119|560785|P2|STARTED|Second Intervention||7
234403|NCT00106119|560786|P1|STARTED|Second Intervention||7
234404|NCT00106119|560785|P2|NOT COMPLETED|Washout Period of 30 Days||0
234405|NCT00106119|560786|P1|NOT COMPLETED|Washout Period of 30 Days||0
234406|NCT00106119|560785|P2|COMPLETED|Washout Period of 30 Days||7
234407|NCT00106119|560786|P1|COMPLETED|Washout Period of 30 Days||7
234408|NCT00106119|560785|P2|STARTED|Washout Period of 30 Days||7
234409|NCT00106119|560786|P1|STARTED|Washout Period of 30 Days||7
234410|NCT00106119|560785|P2|NOT COMPLETED|First Intervention||0
234411|NCT00106119|560786|P1|NOT COMPLETED|First Intervention||0
234412|NCT00106119|560785|P2|COMPLETED|First Intervention||7
234413|NCT00106119|560786|P1|COMPLETED|First Intervention||7
234414|NCT00106119|560785|P2|STARTED|First Intervention||7
234415|NCT00106119|560786|P1|STARTED|First Intervention||7
234416|NCT00106106|560806|P2|NOT COMPLETED|Overall Study||4
234417|NCT00106106|560807|P1|NOT COMPLETED|Overall Study||4
234418|NCT00106106|560806|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
234419|NCT00106106|560807|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
234420|NCT00106106|560806|P2|Completed Both MRS Scans|Overall Study||15
234421|NCT00106106|560807|P1|Completed Both MRS Scans|Overall Study||18
234422|NCT00106106|560806|P2|STARTED|Overall Study||23
234423|NCT00106106|560807|P1|STARTED|Overall Study||26
234424|NCT00106080|560817|P2|NOT COMPLETED|Overall Study||27
234425|NCT00106080|560818|P1|NOT COMPLETED|Overall Study||43
234426|NCT00106080|560817|P2|COMPLETED|Overall Study||155
234427|NCT00106080|560818|P1|COMPLETED|Overall Study||151
234428|NCT00106080|560817|P2|STARTED|Overall Study||182
234429|NCT00106080|560818|P1|STARTED|Overall Study||194
234430|NCT00106028|560828|P2|NOT COMPLETED|Overall Study||12
234431|NCT00106028|560829|P1|NOT COMPLETED|Overall Study||6
234432|NCT00106028|560828|P2|COMPLETED|Overall Study|Completed Month 36|82
234433|NCT00106028|560829|P1|COMPLETED|Overall Study|Completed Month 36|43
234434|NCT00106028|560828|P2|Month 12 Completed/Started Open Label|Overall Study||87
234435|NCT00106028|560829|P1|Month 12 Completed/Started Open Label|Overall Study||49
234436|NCT00106028|560828|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
234437|NCT00106028|560829|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
234438|NCT00106002|560923|P1|NOT COMPLETED|Overall Study||2
234439|NCT00106002|560923|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
234440|NCT00106002|560923|P1|STARTED|Overall Study||37
234441|NCT00105989|560931|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
234442|NCT00105989|560932|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
234443|NCT00105989|560931|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
234444|NCT00105989|560932|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
234445|NCT00105989|560931|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
234446|NCT00105989|560932|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
234447|NCT00105989|560931|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
234448|NCT00105989|560932|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
234449|NCT00105989|560931|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
234450|NCT00105989|560932|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
234451|NCT00105989|560931|P2|STARTED|Continuation - Open Label:Week 10-34||0
234452|NCT00105989|560932|P1|STARTED|Continuation - Open Label:Week 10-34||413
234453|NCT00105989|560931|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
234454|NCT00105989|560932|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
234455|NCT00105989|560931|P2|COMPLETED|Acute - Open Label: Week 0-10||0
234456|NCT00105989|560932|P1|COMPLETED|Acute - Open Label: Week 0-10||413
234457|NCT00105989|560931|P2|STARTED|Acute - Open Label: Week 0-10||0
234458|NCT00105989|560932|P1|STARTED|Acute - Open Label: Week 0-10||514
234459|NCT00105534|561048|P2|NOT COMPLETED|Overall Study||33
234460|NCT00105534|561049|P1|NOT COMPLETED|Overall Study||22
234461|NCT00105534|561048|P2|COMPLETED|Overall Study||317
234462|NCT00105534|561049|P1|COMPLETED|Overall Study||313
234463|NCT00105534|561048|P2|STARTED|Overall Study||350
234464|NCT00105534|561049|P1|STARTED|Overall Study||335
234465|NCT00105482|561059|P2|NOT COMPLETED|Overall Study||55
234466|NCT00105482|561060|P1|NOT COMPLETED|Overall Study||59
234467|NCT00105482|561059|P2|COMPLETED|Overall Study||30
234468|NCT00105482|561060|P1|COMPLETED|Overall Study||28
234469|NCT00105482|561059|P2|STARTED|Overall Study||85
234470|NCT00105482|561060|P1|STARTED|Overall Study||87
234471|NCT00105469|561076|P2|NOT COMPLETED|Overall Study||11
234472|NCT00105469|561077|P1|NOT COMPLETED|Overall Study||22
234473|NCT00105469|561076|P2|COMPLETED|Overall Study||367
234474|NCT00105469|561077|P1|COMPLETED|Overall Study||343
234475|NCT00105469|561076|P2|STARTED|Overall Study||378
234476|NCT00105469|561077|P1|STARTED|Overall Study||365
234477|NCT00105443|561087|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
234478|NCT00105443|561088|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
234479|NCT00105443|561089|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
234480|NCT00105443|561090|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
234481|NCT00105443|561087|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
234482|NCT00105443|561088|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
234483|NCT00105443|561089|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
234484|NCT00105443|561090|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
234485|NCT00105443|561087|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
234486|NCT00105443|561088|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
234487|NCT00105443|561089|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
234488|NCT00105443|561090|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
234489|NCT00105443|561087|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
234490|NCT00105443|561088|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
234491|NCT00105443|561089|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
234492|NCT00105443|561090|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
234493|NCT00105443|561087|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
234494|NCT00105443|561088|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
234495|NCT00105443|561089|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
234496|NCT00105443|561090|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
234497|NCT00105443|561087|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
234498|NCT00105443|561088|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
234499|NCT00105443|561089|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
234500|NCT00105443|561090|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
234501|NCT00105443|561087|P4|NOT COMPLETED|Double-Blind Treatment||0
234502|NCT00105443|561088|P3|NOT COMPLETED|Double-Blind Treatment||11
234503|NCT00105443|561089|P2|NOT COMPLETED|Double-Blind Treatment||0
234504|NCT00105443|561090|P1|NOT COMPLETED|Double-Blind Treatment||14
234505|NCT00105443|561087|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
234506|NCT00105443|561088|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
234507|NCT00105443|561089|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
234508|NCT00105443|561090|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
234509|NCT00105443|561087|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
234510|NCT00105443|561088|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
234511|NCT00105443|561089|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
234512|NCT00105443|561090|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
234513|NCT00105443|561087|P4|STARTED|Double-Blind Treatment||47
234514|NCT00105443|561088|P3|STARTED|Double-Blind Treatment||256
234515|NCT00105443|561089|P2|STARTED|Double-Blind Treatment||57
234516|NCT00105443|561090|P1|STARTED|Double-Blind Treatment||242
234517|NCT00105235|561117|P1|NOT COMPLETED|Overall Study||7
234518|NCT00105235|561117|P1|COMPLETED|Overall Study||20
234519|NCT00105235|561117|P1|STARTED|Overall Study||27
234520|NCT00105196|561130|P2|NOT COMPLETED|Overall Study||23
234521|NCT00105196|561131|P1|NOT COMPLETED|Overall Study||30
234522|NCT00105196|561130|P2|COMPLETED|Overall Study||149
234523|NCT00105196|561131|P1|COMPLETED|Overall Study||147
234524|NCT00105196|561130|P2|STARTED|Overall Study||172
234525|NCT00105196|561131|P1|STARTED|Overall Study||177
234526|NCT00105183|561154|P3|NOT COMPLETED|Overall Study||23
234527|NCT00105183|561155|P2|NOT COMPLETED|Overall Study||19
234528|NCT00105183|561156|P1|NOT COMPLETED|Overall Study||22
234529|NCT00105183|561154|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
234530|NCT00105183|561155|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
234531|NCT00105183|561156|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
234532|NCT00105183|561154|P3|STARTED|Overall Study|Randomized|62
234533|NCT00105183|561155|P2|STARTED|Overall Study|Randomized|79
234534|NCT00105183|561156|P1|STARTED|Overall Study|Randomized|82
234535|NCT00105157|561192|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
234536|NCT00105157|561193|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
234537|NCT00105157|561194|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
234538|NCT00105157|561195|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
234539|NCT00105157|561192|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
234540|NCT00105157|561193|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
234541|NCT00105157|561194|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
234542|NCT00105157|561195|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
234543|NCT00105157|561192|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
234544|NCT00105157|561193|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
234545|NCT00105157|561194|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
234546|NCT00105157|561195|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
234547|NCT00105157|561192|P4|NOT COMPLETED|Open-Label Continuation of DB||1
234548|NCT00105157|561193|P3|NOT COMPLETED|Open-Label Continuation of DB||9
234549|NCT00105157|561194|P2|NOT COMPLETED|Open-Label Continuation of DB||10
234550|NCT00105157|561195|P1|NOT COMPLETED|Open-Label Continuation of DB||7
234551|NCT00105157|561192|P4|COMPLETED|Open-Label Continuation of DB||5
234552|NCT00105157|561193|P3|COMPLETED|Open-Label Continuation of DB||24
234553|NCT00105157|561194|P2|COMPLETED|Open-Label Continuation of DB||21
234554|NCT00105157|561195|P1|COMPLETED|Open-Label Continuation of DB||23
234555|NCT00105157|561192|P4|STARTED|Open-Label Continuation of DB||6
234556|NCT00105157|561193|P3|STARTED|Open-Label Continuation of DB||33
234557|NCT00105157|561194|P2|STARTED|Open-Label Continuation of DB||31
234558|NCT00105157|561195|P1|STARTED|Open-Label Continuation of DB||30
234559|NCT00105157|561192|P4|NOT COMPLETED|Double-Blind (DB)||39
234560|NCT00105157|561193|P3|NOT COMPLETED|Double-Blind (DB)||12
234561|NCT00105157|561194|P2|NOT COMPLETED|Double-Blind (DB)||14
234562|NCT00105157|561195|P1|NOT COMPLETED|Double-Blind (DB)||14
234563|NCT00105157|561192|P4|COMPLETED|Double-Blind (DB)||6
234564|NCT00105157|561193|P3|COMPLETED|Double-Blind (DB)||33
234565|NCT00105157|561194|P2|COMPLETED|Double-Blind (DB)||31
234566|NCT00105157|561195|P1|COMPLETED|Double-Blind (DB)||30
234567|NCT00105157|561192|P4|Treated|Double-Blind (DB)||45
234568|NCT00105157|561193|P3|Treated|Double-Blind (DB)||45
234569|NCT00105157|561194|P2|Treated|Double-Blind (DB)||45
234570|NCT00105157|561195|P1|Treated|Double-Blind (DB)||43
234571|NCT00105157|561192|P4|STARTED|Double-Blind (DB)||45
234572|NCT00105157|561193|P3|STARTED|Double-Blind (DB)||45
234573|NCT00105157|561194|P2|STARTED|Double-Blind (DB)||45
234574|NCT00105157|561195|P1|STARTED|Double-Blind (DB)||44
234575|NCT00105079|561389|P2|NOT COMPLETED|Overall Study||35
234576|NCT00105079|561390|P1|NOT COMPLETED|Overall Study||39
234577|NCT00105079|561389|P2|COMPLETED|Overall Study||135
234578|NCT00105079|561390|P1|COMPLETED|Overall Study||128
234579|NCT00105079|561389|P2|Safety Population|Overall Study||168
234580|NCT00105079|561390|P1|Safety Population|Overall Study||163
234581|NCT00105079|561389|P2|STARTED|Overall Study||170
234582|NCT00105079|561390|P1|STARTED|Overall Study||167
234583|NCT00105066|561408|P2|NOT COMPLETED|Overall Study||5
234584|NCT00105066|561409|P1|NOT COMPLETED|Overall Study||2
234585|NCT00105066|561408|P2|COMPLETED|Overall Study||45
234586|NCT00105066|561409|P1|COMPLETED|Overall Study||25
234587|NCT00105066|561408|P2|STARTED|Overall Study||50
234588|NCT00105066|561409|P1|STARTED|Overall Study||27
234589|NCT00105027|561425|P6|NOT COMPLETED|Overall Study||13
234590|NCT00105027|561426|P5|NOT COMPLETED|Overall Study||15
234591|NCT00105027|561427|P4|NOT COMPLETED|Overall Study||16
234592|NCT00105027|561428|P3|NOT COMPLETED|Overall Study||9
234593|NCT00105027|561429|P2|NOT COMPLETED|Overall Study||9
234594|NCT00105027|561430|P1|NOT COMPLETED|Overall Study||15
234595|NCT00105027|561425|P6|COMPLETED|Overall Study||125
234596|NCT00105027|561426|P5|COMPLETED|Overall Study||121
234597|NCT00105027|561427|P4|COMPLETED|Overall Study||121
234598|NCT00105027|561428|P3|COMPLETED|Overall Study||82
234599|NCT00105027|561429|P2|COMPLETED|Overall Study||83
234600|NCT00105027|561430|P1|COMPLETED|Overall Study||73
234601|NCT00105027|561425|P6|STARTED|Overall Study||138
234602|NCT00105027|561426|P5|STARTED|Overall Study||136
234603|NCT00105027|561427|P4|STARTED|Overall Study||137
234604|NCT00105027|561428|P3|STARTED|Overall Study||91
234605|NCT00105027|561429|P2|STARTED|Overall Study||92
234606|NCT00105027|561430|P1|STARTED|Overall Study||88
234607|NCT00105001|561447|P3|NOT COMPLETED|Overall Study||0
234608|NCT00105001|561448|P2|NOT COMPLETED|Overall Study||0
234609|NCT00105001|561449|P1|NOT COMPLETED|Overall Study||0
234610|NCT00105001|561447|P3|COMPLETED|Overall Study||69
234611|NCT00105001|561448|P2|COMPLETED|Overall Study||71
234612|NCT00105001|561449|P1|COMPLETED|Overall Study||70
234613|NCT00105001|561447|P3|STARTED|Overall Study||69
234614|NCT00105001|561448|P2|STARTED|Overall Study||71
234615|NCT00105001|561449|P1|STARTED|Overall Study||70
234616|NCT00104884|561469|P1|NOT COMPLETED|Overall Study||4
234617|NCT00104884|561469|P1|COMPLETED|Overall Study||0
234618|NCT00104884|561469|P1|STARTED|Overall Study||4
234619|NCT00104871|561473|P1|NOT COMPLETED|Overall Study||1
234620|NCT00104871|561473|P1|COMPLETED|Overall Study||21
234621|NCT00104871|561473|P1|STARTED|Overall Study||22
234622|NCT00104728|561478|P1|NOT COMPLETED|Overall Study||19
234623|NCT00104728|561478|P1|COMPLETED|Overall Study||23
234624|NCT00104728|561478|P1|STARTED|Overall Study|42 consented on study|42
234625|NCT00104650|561486|P3|NOT COMPLETED|Follow-up Period||10
234626|NCT00104650|561487|P2|NOT COMPLETED|Follow-up Period||13
234627|NCT00104650|561488|P1|NOT COMPLETED|Follow-up Period||11
234628|NCT00104650|561486|P3|COMPLETED|Follow-up Period||18
234629|NCT00104650|561487|P2|COMPLETED|Follow-up Period||12
234630|NCT00104650|561488|P1|COMPLETED|Follow-up Period||14
234631|NCT00104650|561486|P3|STARTED|Follow-up Period||28
234632|NCT00104650|561487|P2|STARTED|Follow-up Period||25
234633|NCT00104650|561488|P1|STARTED|Follow-up Period||25
234634|NCT00104650|561486|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
234635|NCT00104650|561487|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
234636|NCT00104650|561488|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
234637|NCT00104650|561486|P3|COMPLETED|Treatment Period (25 Weeks)||28
234638|NCT00104650|561487|P2|COMPLETED|Treatment Period (25 Weeks)||25
234639|NCT00104650|561488|P1|COMPLETED|Treatment Period (25 Weeks)||25
234640|NCT00104650|561486|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
234641|NCT00104650|561487|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
234642|NCT00104650|561488|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
234643|NCT00104650|561486|P3|STARTED|Treatment Period (25 Weeks)||38
234644|NCT00104650|561487|P2|STARTED|Treatment Period (25 Weeks)||36
234645|NCT00104650|561488|P1|STARTED|Treatment Period (25 Weeks)||37
234646|NCT00104637|561520|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
234647|NCT00104637|561521|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
234648|NCT00104637|561520|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
234649|NCT00104637|561521|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
234650|NCT00104637|561520|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
234651|NCT00104637|561521|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
234652|NCT00104637|561520|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
234653|NCT00104637|561521|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
234654|NCT00104637|561520|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
234655|NCT00104637|561521|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
234656|NCT00104637|561520|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
234657|NCT00104637|561521|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
234658|NCT00104637|561520|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
234659|NCT00104637|561521|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
234660|NCT00104637|561520|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
234661|NCT00104637|561521|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
234662|NCT00104637|561520|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
234663|NCT00104637|561521|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
234664|NCT00104572|561550|P3|NOT COMPLETED|Overall Study||0
234665|NCT00104572|561551|P2|NOT COMPLETED|Overall Study||3
234666|NCT00104572|561552|P1|NOT COMPLETED|Overall Study||3
234667|NCT00104572|561550|P3|COMPLETED|Overall Study||9
234668|NCT00104572|561551|P2|COMPLETED|Overall Study||10
234669|NCT00104572|561552|P1|COMPLETED|Overall Study||10
234670|NCT00104572|561550|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
234671|NCT00104572|561551|P2|STARTED|Overall Study|These are the analysed subjects|13
234672|NCT00104572|561552|P1|STARTED|Overall Study|These are the analysed subjects|13
234673|NCT00104520|561562|P2|NOT COMPLETED|Overall Study||71
234674|NCT00104520|561563|P1|NOT COMPLETED|Overall Study||50
234675|NCT00104520|561562|P2|COMPLETED|Overall Study||64
234676|NCT00104520|561563|P1|COMPLETED|Overall Study||26
234677|NCT00104520|561562|P2|STARTED|Overall Study||135
234678|NCT00104520|561563|P1|STARTED|Overall Study||76
234679|NCT00104416|561583|P5|NOT COMPLETED|Continuation Phase||5
234680|NCT00104416|561584|P4|NOT COMPLETED|Continuation Phase||2
234681|NCT00104416|561585|P3|NOT COMPLETED|Continuation Phase||6
234682|NCT00104416|561586|P2|NOT COMPLETED|Continuation Phase||0
234683|NCT00104416|561587|P1|NOT COMPLETED|Continuation Phase||0
234684|NCT00104416|561583|P5|COMPLETED|Continuation Phase||27
234685|NCT00104416|561584|P4|COMPLETED|Continuation Phase||65
234686|NCT00104416|561585|P3|COMPLETED|Continuation Phase||63
234687|NCT00104416|561586|P2|COMPLETED|Continuation Phase||0
234688|NCT00104416|561587|P1|COMPLETED|Continuation Phase||0
234689|NCT00104416|561583|P5|STARTED|Continuation Phase||32
234690|NCT00104416|561584|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
234691|NCT00104416|561585|P3|STARTED|Continuation Phase||69
234692|NCT00104416|561586|P2|STARTED|Continuation Phase||0
234693|NCT00104416|561587|P1|STARTED|Continuation Phase||0
234694|NCT00104416|561583|P5|NOT COMPLETED|Double-Blind Phase||0
234695|NCT00104416|561584|P4|NOT COMPLETED|Double-Blind Phase||0
234696|NCT00104416|561585|P3|NOT COMPLETED|Double-Blind Phase||0
234697|NCT00104416|561586|P2|NOT COMPLETED|Double-Blind Phase||10
234698|NCT00104416|561587|P1|NOT COMPLETED|Double-Blind Phase||8
234699|NCT00104416|561583|P5|COMPLETED|Double-Blind Phase||0
234700|NCT00104416|561584|P4|COMPLETED|Double-Blind Phase||0
234701|NCT00104416|561585|P3|COMPLETED|Double-Blind Phase||0
234702|NCT00104416|561586|P2|COMPLETED|Double-Blind Phase||66
234703|NCT00104416|561587|P1|COMPLETED|Double-Blind Phase||69
234704|NCT00104416|561583|P5|STARTED|Double-Blind Phase||0
234705|NCT00104416|561584|P4|STARTED|Double-Blind Phase||0
234706|NCT00104416|561585|P3|STARTED|Double-Blind Phase||0
234707|NCT00104416|561586|P2|STARTED|Double-Blind Phase||76
234708|NCT00104416|561587|P1|STARTED|Double-Blind Phase||77
234709|NCT00104299|561632|P2|NOT COMPLETED|Overall Study||10
234710|NCT00104299|561633|P1|NOT COMPLETED|Overall Study||9
234711|NCT00104299|561632|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
234712|NCT00104299|561633|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
234713|NCT00104299|561632|P2|STARTED|Overall Study||98
234714|NCT00104299|561633|P1|STARTED|Overall Study||99
234715|NCT00104247|561655|P2|NOT COMPLETED|Overall Study||1
234716|NCT00104247|561656|P1|NOT COMPLETED|Overall Study||1
234876|NCT00102687|561991|P5|NOT COMPLETED|Maintenance Period||13
234717|NCT00104247|561655|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
234718|NCT00104247|561656|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
234719|NCT00104247|561655|P2|STARTED|Overall Study||47
234720|NCT00104247|561656|P1|STARTED|Overall Study||42
234721|NCT00104234|561664|P2|NOT COMPLETED|Overall Study||1
234722|NCT00104234|561665|P1|NOT COMPLETED|Overall Study||0
234723|NCT00104234|561664|P2|COMPLETED|Overall Study||19
234724|NCT00104234|561665|P1|COMPLETED|Overall Study||19
234725|NCT00104234|561664|P2|STARTED|Overall Study||20
234726|NCT00104234|561665|P1|STARTED|Overall Study||19
234727|NCT00104104|561675|P2|NOT COMPLETED|Overall Study||72
234728|NCT00104104|561676|P1|NOT COMPLETED|Overall Study||75
234729|NCT00104104|561675|P2|COMPLETED|Overall Study||17
234730|NCT00104104|561676|P1|COMPLETED|Overall Study||15
234731|NCT00104104|561675|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
234732|NCT00104104|561676|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
234733|NCT00104104|561675|P2|Safety Population (Including Site 74)|Overall Study||88
234734|NCT00104104|561676|P1|Safety Population (Including Site 74)|Overall Study||88
234735|NCT00104104|561675|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
234736|NCT00104104|561676|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
234737|NCT00104052|561690|P1|NOT COMPLETED|Overall Study||29
234738|NCT00104052|561690|P1|COMPLETED|Overall Study||78
234739|NCT00104052|561690|P1|STARTED|Overall Study||107
234740|NCT00103857|561701|P7|NOT COMPLETED|50-Week Extension Study||0
234741|NCT00103857|561702|P6|NOT COMPLETED|50-Week Extension Study||20
234742|NCT00103857|561703|P5|NOT COMPLETED|50-Week Extension Study||21
234743|NCT00103857|561704|P4|NOT COMPLETED|50-Week Extension Study||36
234744|NCT00103857|561705|P3|NOT COMPLETED|50-Week Extension Study||26
234745|NCT00103857|561706|P2|NOT COMPLETED|50-Week Extension Study||27
234746|NCT00103857|561707|P1|NOT COMPLETED|50-Week Extension Study||38
234747|NCT00103857|561701|P7|COMPLETED|50-Week Extension Study||0
234748|NCT00103857|561702|P6|COMPLETED|50-Week Extension Study||78
234749|NCT00103857|561703|P5|COMPLETED|50-Week Extension Study||101
234750|NCT00103857|561704|P4|COMPLETED|50-Week Extension Study||98
234751|NCT00103857|561705|P3|COMPLETED|50-Week Extension Study||95
234752|NCT00103857|561706|P2|COMPLETED|50-Week Extension Study||80
234753|NCT00103857|561707|P1|COMPLETED|50-Week Extension Study||65
234754|NCT00103857|561701|P7|STARTED|50-Week Extension Study||0
234755|NCT00103857|561702|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
234756|NCT00103857|561703|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
234757|NCT00103857|561704|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
234758|NCT00103857|561705|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
234759|NCT00103857|561706|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
234760|NCT00103857|561707|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
234761|NCT00103857|561701|P7|NOT COMPLETED|54-Week Base Study||38
234762|NCT00103857|561702|P6|NOT COMPLETED|54-Week Base Study||61
234763|NCT00103857|561703|P5|NOT COMPLETED|54-Week Base Study||41
234764|NCT00103857|561704|P4|NOT COMPLETED|54-Week Base Study||42
234765|NCT00103857|561705|P3|NOT COMPLETED|54-Week Base Study||47
234766|NCT00103857|561706|P2|NOT COMPLETED|54-Week Base Study||56
234767|NCT00103857|561707|P1|NOT COMPLETED|54-Week Base Study||57
234768|NCT00103857|561701|P7|COMPLETED|54-Week Base Study||79
234769|NCT00103857|561702|P6|COMPLETED|54-Week Base Study||115
234770|NCT00103857|561703|P5|COMPLETED|54-Week Base Study||141
234771|NCT00103857|561704|P4|COMPLETED|54-Week Base Study||148
234772|NCT00103857|561705|P3|COMPLETED|54-Week Base Study||135
234773|NCT00103857|561706|P2|COMPLETED|54-Week Base Study||126
234774|NCT00103857|561707|P1|COMPLETED|54-Week Base Study||122
234775|NCT00103857|561701|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
234776|NCT00103857|561702|P6|STARTED|54-Week Base Study||176
234777|NCT00103857|561703|P5|STARTED|54-Week Base Study||182
234778|NCT00103857|561704|P4|STARTED|54-Week Base Study||190
234779|NCT00103857|561705|P3|STARTED|54-Week Base Study||182
234780|NCT00103857|561706|P2|STARTED|54-Week Base Study||182
234781|NCT00103857|561707|P1|STARTED|54-Week Base Study||179
234782|NCT00103844|561772|P2|NOT COMPLETED|Overall Study||0
234783|NCT00103844|561773|P1|NOT COMPLETED|Overall Study||0
234784|NCT00103844|561772|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
234785|NCT00103844|561773|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
234786|NCT00103844|561772|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
234787|NCT00103844|561773|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
234788|NCT00103844|561772|P2|STARTED|Overall Study||49
234789|NCT00103844|561773|P1|STARTED|Overall Study||101
234790|NCT00103740|561806|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
234791|NCT00103740|561807|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
234792|NCT00103740|561806|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
234793|NCT00103740|561807|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
234794|NCT00103740|561806|P2|STARTED|Period 2 - Extended Observation Period||63
234795|NCT00103740|561807|P1|STARTED|Period 2 - Extended Observation Period||78
234796|NCT00103740|561806|P2|NOT COMPLETED|Period 1 - Core||4
234797|NCT00103740|561807|P1|NOT COMPLETED|Period 1 - Core||7
234798|NCT00103740|561806|P2|COMPLETED|Period 1 - Core||89
234799|NCT00103740|561807|P1|COMPLETED|Period 1 - Core||85
234800|NCT00103740|561806|P2|STARTED|Period 1 - Core||93
234801|NCT00103740|561807|P1|STARTED|Period 1 - Core||92
234802|NCT00103662|561835|P2|NOT COMPLETED|Overall Study||33
234803|NCT00103662|561836|P1|NOT COMPLETED|Overall Study||19
234804|NCT00103662|561835|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
234805|NCT00103662|561836|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
234806|NCT00103662|561835|P2|STARTED|Overall Study||154
234807|NCT00103662|561836|P1|STARTED|Overall Study||148
234808|NCT00103610|561862|P2|NOT COMPLETED|Overall Study||80
234809|NCT00103610|561863|P1|NOT COMPLETED|Overall Study||38
234810|NCT00103610|561862|P2|COMPLETED|Overall Study||68
234811|NCT00103610|561863|P1|COMPLETED|Overall Study||112
234812|NCT00103610|561862|P2|STARTED|Overall Study||148
234813|NCT00103610|561863|P1|STARTED|Overall Study||150
234814|NCT00103506|561887|P2|NOT COMPLETED|Overall Study||324
234815|NCT00103506|561888|P1|NOT COMPLETED|Overall Study||322
234816|NCT00103506|561887|P2|COMPLETED|Overall Study||0
234817|NCT00103506|561888|P1|COMPLETED|Overall Study||0
234818|NCT00103506|561887|P2|STARTED|Overall Study||324
234819|NCT00103506|561888|P1|STARTED|Overall Study||322
234820|NCT00103311|561900|P2|NOT COMPLETED|Overall Study||1
234821|NCT00103311|561901|P1|NOT COMPLETED|Overall Study||4
234822|NCT00103311|561900|P2|COMPLETED|Overall Study||30
234823|NCT00103311|561901|P1|COMPLETED|Overall Study||29
234824|NCT00103311|561900|P2|STARTED|Overall Study||31
234825|NCT00103311|561901|P1|STARTED|Overall Study||33
234826|NCT00103259|561913|P2|NOT COMPLETED|Overall Study||12
234827|NCT00103259|561914|P1|NOT COMPLETED|Overall Study||12
234828|NCT00103259|561913|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
234829|NCT00103259|561914|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
234830|NCT00103259|561913|P2|Eligible Patients Who Cross Over|Overall Study||10
234831|NCT00103259|561914|P1|Eligible Patients Who Cross Over|Overall Study||0
234832|NCT00103259|561913|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
234833|NCT00103259|561914|P1|Cross Over to the Other Arm|Overall Study||0
234834|NCT00103259|561913|P2|Eligible and Treated|Overall Study||38
234835|NCT00103259|561914|P1|Eligible and Treated|Overall Study||23
234836|NCT00103259|561913|P2|Treated|Overall Study||41
234837|NCT00103259|561914|P1|Treated|Overall Study||23
234838|NCT00103259|561913|P2|Eligible|Overall Study||41
234839|NCT00103259|561914|P1|Eligible|Overall Study||27
234840|NCT00103259|561913|P2|STARTED|Overall Study||44
234841|NCT00103259|561914|P1|STARTED|Overall Study||27
234842|NCT00103207|561926|P1|NOT COMPLETED|Overall Study||38
234843|NCT00103207|561926|P1|COMPLETED|Overall Study||34
234844|NCT00103207|561926|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
234845|NCT00103207|561926|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
234846|NCT00103207|561926|P1|STARTED|Overall Study||72
234847|NCT00103194|561936|P1|NOT COMPLETED|Overall Study||31
234848|NCT00103194|561936|P1|COMPLETED|Overall Study||18
234849|NCT00103194|561936|P1|Eligible and Treated|Overall Study||35
234850|NCT00103194|561936|P1|Eligible|Overall Study||35
234851|NCT00103194|561936|P1|Treated|Overall Study||49
234852|NCT00103194|561936|P1|STARTED|Overall Study||49
234853|NCT00103142|561945|P2|NOT COMPLETED|Overall Study||1
234854|NCT00103142|561946|P1|NOT COMPLETED|Overall Study||3
234855|NCT00103142|561945|P2|COMPLETED|Overall Study||36
234856|NCT00103142|561946|P1|COMPLETED|Overall Study||33
234857|NCT00103142|561945|P2|STARTED|Overall Study||37
234858|NCT00103142|561946|P1|STARTED|Overall Study||36
234859|NCT00103012|561957|P3|NOT COMPLETED|Overall Study||4
234860|NCT00103012|561958|P2|NOT COMPLETED|Overall Study||1
234861|NCT00103012|561959|P1|NOT COMPLETED|Overall Study||3
234862|NCT00103012|561957|P3|COMPLETED|Overall Study||12
234863|NCT00103012|561958|P2|COMPLETED|Overall Study||13
234864|NCT00103012|561959|P1|COMPLETED|Overall Study||14
234865|NCT00103012|561957|P3|STARTED|Overall Study||16
234866|NCT00103012|561958|P2|STARTED|Overall Study||14
234867|NCT00103012|561959|P1|STARTED|Overall Study||17
234868|NCT00102804|561969|P2|NOT COMPLETED|Overall Study||222
234869|NCT00102804|561970|P1|NOT COMPLETED|Overall Study||441
234870|NCT00102804|561969|P2|COMPLETED|Overall Study||0
234871|NCT00102804|561970|P1|COMPLETED|Overall Study||0
234872|NCT00102804|561969|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
234873|NCT00102804|561970|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
234874|NCT00102804|561969|P2|STARTED|Overall Study||222
234875|NCT00102804|561970|P1|STARTED|Overall Study||441
234877|NCT00102687|561992|P4|NOT COMPLETED|Maintenance Period||10
234878|NCT00102687|561993|P3|NOT COMPLETED|Maintenance Period||6
234879|NCT00102687|561994|P2|NOT COMPLETED|Maintenance Period||4
234880|NCT00102687|561995|P1|NOT COMPLETED|Maintenance Period||7
234881|NCT00102687|561991|P5|COMPLETED|Maintenance Period||8
234882|NCT00102687|561992|P4|COMPLETED|Maintenance Period||12
234883|NCT00102687|561993|P3|COMPLETED|Maintenance Period||2
234884|NCT00102687|561994|P2|COMPLETED|Maintenance Period||2
234885|NCT00102687|561995|P1|COMPLETED|Maintenance Period||6
234886|NCT00102687|561991|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
234887|NCT00102687|561992|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
234888|NCT00102687|561993|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
234889|NCT00102687|561994|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
234890|NCT00102687|561995|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
234891|NCT00102687|561991|P5|NOT COMPLETED|Initial Period||0
234892|NCT00102687|561992|P4|NOT COMPLETED|Initial Period||0
234893|NCT00102687|561993|P3|NOT COMPLETED|Initial Period||26
234894|NCT00102687|561994|P2|NOT COMPLETED|Initial Period||28
234895|NCT00102687|561995|P1|NOT COMPLETED|Initial Period||18
234896|NCT00102687|561991|P5|COMPLETED|Initial Period||0
234897|NCT00102687|561992|P4|COMPLETED|Initial Period||0
234898|NCT00102687|561993|P3|COMPLETED|Initial Period||25
234899|NCT00102687|561994|P2|COMPLETED|Initial Period||22
234900|NCT00102687|561995|P1|COMPLETED|Initial Period||32
234901|NCT00102687|561991|P5|STARTED|Initial Period||0
234902|NCT00102687|561992|P4|STARTED|Initial Period||0
234903|NCT00102687|561993|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
234904|NCT00102687|561994|P2|STARTED|Initial Period||50
234905|NCT00102687|561995|P1|STARTED|Initial Period||50
234906|NCT00102596|562059|P2|NOT COMPLETED|Part C||0
234907|NCT00102596|562060|P1|NOT COMPLETED|Part C||0
234908|NCT00102596|562059|P2|COMPLETED|Part C||2
234909|NCT00102596|562060|P1|COMPLETED|Part C||0
234910|NCT00102596|562059|P2|STARTED|Part C|Only 2 patients participated in Part C|2
234911|NCT00102596|562060|P1|STARTED|Part C||0
234912|NCT00102596|562059|P2|NOT COMPLETED|Part B||0
234913|NCT00102596|562060|P1|NOT COMPLETED|Part B||0
234914|NCT00102596|562059|P2|COMPLETED|Part B||10
234915|NCT00102596|562060|P1|COMPLETED|Part B||0
234916|NCT00102596|562059|P2|STARTED|Part B||10
234917|NCT00102596|562060|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
234918|NCT00102596|562059|P2|NOT COMPLETED|Part A||0
234919|NCT00102596|562060|P1|NOT COMPLETED|Part A||7
234920|NCT00102596|562059|P2|COMPLETED|Part A||0
234921|NCT00102596|562060|P1|COMPLETED|Part A||4
234922|NCT00102596|562059|P2|Participants Assigned Treatment|Part A||0
234923|NCT00102596|562060|P1|Participants Assigned Treatment|Part A||5
234924|NCT00102596|562059|P2|STARTED|Part A||0
234925|NCT00102596|562060|P1|STARTED|Part A||11
234926|NCT00102518|562069|P1|NOT COMPLETED|Overall Study||87
234927|NCT00102518|562069|P1|COMPLETED|Overall Study||238
234928|NCT00102518|562069|P1|STARTED|Overall Study||325
234929|NCT00101816|562077|P2|NOT COMPLETED|Overall Study||0
234930|NCT00101816|562078|P1|NOT COMPLETED|Overall Study||0
234931|NCT00101816|562077|P2|COMPLETED|Overall Study||99
234932|NCT00101816|562078|P1|COMPLETED|Overall Study||10
234933|NCT00101816|562077|P2|STARTED|Overall Study||99
234934|NCT00101816|562078|P1|STARTED|Overall Study||10
234935|NCT00101686|562135|P10|NOT COMPLETED|Overall Study||30
234936|NCT00101686|562136|P9|NOT COMPLETED|Overall Study||30
234937|NCT00101686|562137|P8|NOT COMPLETED|Overall Study||30
234938|NCT00101686|562138|P7|NOT COMPLETED|Overall Study||27
234939|NCT00101686|562139|P6|NOT COMPLETED|Overall Study||72
234940|NCT00101686|562140|P5|NOT COMPLETED|Overall Study||73
234941|NCT00101686|562141|P4|NOT COMPLETED|Overall Study||72
234942|NCT00101686|562142|P3|NOT COMPLETED|Overall Study||69
234943|NCT00101686|562143|P2|NOT COMPLETED|Overall Study||73
234944|NCT00101686|562144|P1|NOT COMPLETED|Overall Study||71
234945|NCT00101686|562135|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
234946|NCT00101686|562136|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
234947|NCT00101686|562137|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
234948|NCT00101686|562138|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
234949|NCT00101686|562139|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
234950|NCT00101686|562140|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
234951|NCT00101686|562141|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
234952|NCT00101686|562142|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
234953|NCT00101686|562143|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
234954|NCT00101686|562144|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
234955|NCT00101686|562135|P10|Received Treatment|Overall Study||29
234956|NCT00101686|562136|P9|Received Treatment|Overall Study||30
234957|NCT00101686|562137|P8|Received Treatment|Overall Study||29
234958|NCT00101686|562138|P7|Received Treatment|Overall Study||27
234959|NCT00101686|562139|P6|Received Treatment|Overall Study||70
234960|NCT00101686|562140|P5|Received Treatment|Overall Study||71
234961|NCT00101686|562141|P4|Received Treatment|Overall Study||70
234962|NCT00101686|562142|P3|Received Treatment|Overall Study||67
234963|NCT00101686|562143|P2|Received Treatment|Overall Study||67
234964|NCT00101686|562144|P1|Received Treatment|Overall Study||70
234965|NCT00101686|562135|P10|STARTED|Overall Study||30
234966|NCT00101686|562136|P9|STARTED|Overall Study||30
234967|NCT00101686|562137|P8|STARTED|Overall Study||30
234968|NCT00101686|562138|P7|STARTED|Overall Study||27
234969|NCT00101686|562139|P6|STARTED|Overall Study||72
234970|NCT00101686|562140|P5|STARTED|Overall Study||73
234971|NCT00101686|562141|P4|STARTED|Overall Study||72
234972|NCT00101686|562142|P3|STARTED|Overall Study||69
234973|NCT00101686|562143|P2|STARTED|Overall Study||73
234974|NCT00101686|562144|P1|STARTED|Overall Study||71
234975|NCT00101660|562191|P2|NOT COMPLETED|Overall Study||0
234976|NCT00101660|562192|P1|NOT COMPLETED|Overall Study||0
234977|NCT00101660|562191|P2|COMPLETED|Overall Study||288
234978|NCT00101660|562192|P1|COMPLETED|Overall Study||99
234979|NCT00101660|562191|P2|STARTED|Overall Study||288
234980|NCT00101660|562192|P1|STARTED|Overall Study||99
234981|NCT00101647|562210|P2|NOT COMPLETED|Overall Study||0
234982|NCT00101647|562211|P1|NOT COMPLETED|Overall Study||0
234983|NCT00101647|562210|P2|COMPLETED|Overall Study||161
234984|NCT00101647|562211|P1|COMPLETED|Overall Study||13
234985|NCT00101647|562210|P2|STARTED|Overall Study|Randomized|161
234986|NCT00101647|562211|P1|STARTED|Overall Study|Randomized|13
234987|NCT00101582|562261|P2|NOT COMPLETED|Overall Study||15
234988|NCT00101582|562262|P1|NOT COMPLETED|Overall Study||11
234989|NCT00101582|562261|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
234990|NCT00101582|562262|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
234991|NCT00101582|562261|P2|Received Study Drug|Overall Study||94
234992|NCT00101582|562262|P1|Received Study Drug|Overall Study||91
234993|NCT00101582|562261|P2|STARTED|Overall Study||94
234994|NCT00101582|562262|P1|STARTED|Overall Study||94
234995|NCT00102440|562285|P3|NOT COMPLETED|Overall Study||66
234996|NCT00102440|562286|P2|NOT COMPLETED|Overall Study||98
234997|NCT00102440|562287|P1|NOT COMPLETED|Overall Study||88
234998|NCT00102440|562285|P3|COMPLETED|Overall Study||187
234999|NCT00102440|562286|P2|COMPLETED|Overall Study||153
235000|NCT00102440|562287|P1|COMPLETED|Overall Study||168
235001|NCT00102440|562285|P3|STARTED|Overall Study||253
235002|NCT00102440|562286|P2|STARTED|Overall Study||251
235003|NCT00102440|562287|P1|STARTED|Overall Study||256
235004|NCT00102063|562337|P3|NOT COMPLETED|Overall Study||10
235005|NCT00102063|562338|P2|NOT COMPLETED|Overall Study||18
235006|NCT00102063|562339|P1|NOT COMPLETED|Overall Study||16
235007|NCT00102063|562337|P3|COMPLETED|Overall Study||90
235008|NCT00102063|562338|P2|COMPLETED|Overall Study||84
235009|NCT00102063|562339|P1|COMPLETED|Overall Study||84
235010|NCT00102063|562337|P3|STARTED|Overall Study||100
235011|NCT00102063|562338|P2|STARTED|Overall Study||102
235012|NCT00102063|562339|P1|STARTED|Overall Study||100
235013|NCT00101933|562370|P2|NOT COMPLETED|Overall Study||0
235014|NCT00101933|562371|P1|NOT COMPLETED|Overall Study||0
235015|NCT00101933|562370|P2|COMPLETED|Overall Study||55
235016|NCT00101933|562371|P1|COMPLETED|Overall Study||54
235017|NCT00101933|562370|P2|STARTED|Overall Study||55
235018|NCT00101933|562371|P1|STARTED|Overall Study||54
235019|NCT00101907|562397|P6|NOT COMPLETED|Overall Study||0
235020|NCT00101907|562398|P5|NOT COMPLETED|Overall Study||5
235021|NCT00101907|562399|P4|NOT COMPLETED|Overall Study||1
235022|NCT00101907|562400|P3|NOT COMPLETED|Overall Study||1
235023|NCT00101907|562401|P2|NOT COMPLETED|Overall Study||1
235024|NCT00101907|562402|P1|NOT COMPLETED|Overall Study||2
235025|NCT00101907|562397|P6|COMPLETED|Overall Study||2
235026|NCT00101907|562398|P5|COMPLETED|Overall Study||6
235027|NCT00101907|562399|P4|COMPLETED|Overall Study||5
235028|NCT00101907|562400|P3|COMPLETED|Overall Study||5
235029|NCT00101907|562401|P2|COMPLETED|Overall Study||7
235030|NCT00101907|562402|P1|COMPLETED|Overall Study||6
235031|NCT00101907|562397|P6|STARTED|Overall Study||2
235032|NCT00101907|562398|P5|STARTED|Overall Study||11
235033|NCT00101907|562399|P4|STARTED|Overall Study||6
235034|NCT00101907|562400|P3|STARTED|Overall Study||6
235035|NCT00101907|562401|P2|STARTED|Overall Study||8
235036|NCT00101907|562402|P1|STARTED|Overall Study||8
235037|NCT00101868|562444|P2|NOT COMPLETED|Overall Study||32
235038|NCT00101868|562445|P1|NOT COMPLETED|Overall Study||29
235039|NCT00101868|562444|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
235040|NCT00101868|562445|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
235041|NCT00101868|562444|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
235042|NCT00101868|562445|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
235043|NCT00101452|562458|P3|NOT COMPLETED|Overall Study||43
235044|NCT00101452|562459|P2|NOT COMPLETED|Overall Study||43
235045|NCT00101452|562460|P1|NOT COMPLETED|Overall Study||44
235046|NCT00101452|562458|P3|COMPLETED|Overall Study||22
235047|NCT00101452|562459|P2|COMPLETED|Overall Study||26
235048|NCT00101452|562460|P1|COMPLETED|Overall Study||21
235049|NCT00101452|562458|P3|STARTED|Overall Study||65
235050|NCT00101452|562459|P2|STARTED|Overall Study||69
235051|NCT00101452|562460|P1|STARTED|Overall Study||65
235052|NCT00101439|562470|P2|NOT COMPLETED|Period 2||2
235053|NCT00101439|562471|P1|NOT COMPLETED|Period 2||0
235054|NCT00101439|562470|P2|COMPLETED|Period 2||28
235055|NCT00101439|562471|P1|COMPLETED|Period 2||28
235056|NCT00101439|562470|P2|STARTED|Period 2||30
235057|NCT00101439|562471|P1|STARTED|Period 2||28
235058|NCT00101439|562470|P2|NOT COMPLETED|Period 1||0
235059|NCT00101439|562471|P1|NOT COMPLETED|Period 1||0
235060|NCT00101439|562470|P2|COMPLETED|Period 1||30
235061|NCT00101439|562471|P1|COMPLETED|Period 1||28
235062|NCT00101439|562470|P2|STARTED|Period 1||30
235063|NCT00101439|562471|P1|STARTED|Period 1||28
235064|NCT00101413|562479|P1|NOT COMPLETED|Overall Study||0
235065|NCT00101413|562479|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
235066|NCT00101413|562479|P1|STARTED|Overall Study||52
235067|NCT00101400|562487|P1|NOT COMPLETED|Survival Follow-Up||7
235068|NCT00101400|562487|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
235069|NCT00101400|562487|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
235070|NCT00101400|562487|P1|NOT COMPLETED|Treatment||0
235071|NCT00101400|562487|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
235072|NCT00101400|562487|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
235073|NCT00101361|562498|P2|NOT COMPLETED|Overall Study||0
235074|NCT00101361|562499|P1|NOT COMPLETED|Overall Study||0
235075|NCT00101361|562498|P2|COMPLETED|Overall Study||104
235076|NCT00101361|562499|P1|COMPLETED|Overall Study||108
235077|NCT00101361|562498|P2|STARTED|Overall Study||104
235078|NCT00101361|562499|P1|STARTED|Overall Study||108
235079|NCT00101283|562507|P2|NOT COMPLETED|Overall Study||3
235080|NCT00101283|562508|P1|NOT COMPLETED|Overall Study||0
235081|NCT00101283|562507|P2|COMPLETED|Overall Study||13
235082|NCT00101283|562508|P1|COMPLETED|Overall Study||16
235083|NCT00101283|562507|P2|Began Treatment|Overall Study||13
235084|NCT00101283|562508|P1|Began Treatment|Overall Study||16
235085|NCT00101283|562507|P2|STARTED|Overall Study||16
235086|NCT00101283|562508|P1|STARTED|Overall Study||16
235087|NCT00101192|562518|P1|NOT COMPLETED|Overall Study||7
235088|NCT00101192|562518|P1|COMPLETED|Overall Study||69
235089|NCT00101192|562518|P1|STARTED|Overall Study||76
235090|NCT00101166|562522|P1|NOT COMPLETED|Overall Study||10
235091|NCT00101166|562522|P1|COMPLETED|Overall Study||18
235092|NCT00101166|562522|P1|STARTED|Overall Study||28
235093|NCT00101101|562530|P1|NOT COMPLETED|Overall Study||20
235094|NCT00101101|562530|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
235095|NCT00101101|562530|P1|STARTED|Overall Study||43
235096|NCT00101036|562538|P2|NOT COMPLETED|Overall Study||0
235097|NCT00101036|562539|P1|NOT COMPLETED|Overall Study||0
235098|NCT00101036|562538|P2|COMPLETED|Overall Study||40
235099|NCT00101036|562539|P1|COMPLETED|Overall Study||17
235100|NCT00101036|562538|P2|STARTED|Overall Study||40
235101|NCT00101036|562539|P1|STARTED|Overall Study||17
235102|NCT00100932|562551|P2|NOT COMPLETED|Overall Study||27
235103|NCT00100932|562552|P1|NOT COMPLETED|Overall Study||73
235104|NCT00100932|562551|P2|COMPLETED|Overall Study||1
235105|NCT00100932|562552|P1|COMPLETED|Overall Study||5
235106|NCT00100932|562551|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
235107|NCT00100932|562552|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
235108|NCT00100841|562562|P1|NOT COMPLETED|Overall Study||0
235109|NCT00100841|562562|P1|COMPLETED|Overall Study||66
235110|NCT00100841|562562|P1|STARTED|Overall Study||66
235111|NCT00100815|562567|P1|NOT COMPLETED|Overall Study||49
235112|NCT00100815|562567|P1|COMPLETED|Overall Study||1
235113|NCT00100815|562567|P1|STARTED|Overall Study||50
235114|NCT00100802|562575|P1|NOT COMPLETED|Overall Study||80
235115|NCT00100802|562575|P1|COMPLETED|Overall Study||38
235116|NCT00100802|562575|P1|STARTED|Overall Study||118
235117|NCT00100789|562580|P1|NOT COMPLETED|Overall Study||64
235118|NCT00100789|562580|P1|COMPLETED|Overall Study||3
235119|NCT00100789|562580|P1|Eligible and Began Protocol Therapy|Overall Study||63
235120|NCT00100789|562580|P1|Eligible|Overall Study||64
235121|NCT00100789|562580|P1|STARTED|Overall Study||67
235122|NCT00100698|562589|P2|NOT COMPLETED|Overall Study||2
235123|NCT00100698|562590|P1|NOT COMPLETED|Overall Study||6
235124|NCT00100698|562589|P2|COMPLETED|Overall Study||27
235125|NCT00100698|562590|P1|COMPLETED|Overall Study||21
235126|NCT00100698|562589|P2|STARTED|Overall Study||29
235127|NCT00100698|562590|P1|STARTED|Overall Study||27
235128|NCT00100659|562632|P2|NOT COMPLETED|Overall Study||2
235129|NCT00100659|562633|P1|NOT COMPLETED|Overall Study||3
235130|NCT00100659|562632|P2|COMPLETED|Overall Study||57
235131|NCT00100659|562633|P1|COMPLETED|Overall Study||52
235132|NCT00100659|562632|P2|STARTED|Overall Study||59
235133|NCT00100659|562633|P1|STARTED|Overall Study||55
235134|NCT00099632|562645|P6|NOT COMPLETED|Overall Study||2
235135|NCT00099632|562646|P5|NOT COMPLETED|Overall Study||1
235136|NCT00099632|562647|P4|NOT COMPLETED|Overall Study||1
235137|NCT00099632|562648|P3|NOT COMPLETED|Overall Study||3
235138|NCT00099632|562649|P2|NOT COMPLETED|Overall Study||1
235139|NCT00099632|562650|P1|NOT COMPLETED|Overall Study||1
235140|NCT00099632|562645|P6|COMPLETED|Overall Study||66
235141|NCT00099632|562646|P5|COMPLETED|Overall Study||70
235142|NCT00099632|562647|P4|COMPLETED|Overall Study||66
235143|NCT00099632|562648|P3|COMPLETED|Overall Study||72
235144|NCT00099632|562649|P2|COMPLETED|Overall Study||67
235145|NCT00099632|562650|P1|COMPLETED|Overall Study||72
235146|NCT00099632|562645|P6|STARTED|Overall Study||68
235147|NCT00099632|562646|P5|STARTED|Overall Study||71
235148|NCT00099632|562647|P4|STARTED|Overall Study||67
235149|NCT00099632|562648|P3|STARTED|Overall Study||75
235150|NCT00099632|562649|P2|STARTED|Overall Study||68
235151|NCT00099632|562650|P1|STARTED|Overall Study||73
235152|NCT00100230|562690|P2|NOT COMPLETED|Overall Study||15
235153|NCT00100230|562691|P1|NOT COMPLETED|Overall Study||12
235154|NCT00100230|562690|P2|COMPLETED|Overall Study||22
235155|NCT00100230|562691|P1|COMPLETED|Overall Study||29
235156|NCT00100230|562690|P2|STARTED|Overall Study||37
235157|NCT00100230|562691|P1|STARTED|Overall Study||41
235158|NCT00100178|562704|P3|NOT COMPLETED|Overall Study||10
235159|NCT00100178|562705|P2|NOT COMPLETED|Overall Study||10
235160|NCT00100178|562706|P1|NOT COMPLETED|Overall Study||9
235161|NCT00100178|562704|P3|COMPLETED|Overall Study||32
235162|NCT00100178|562705|P2|COMPLETED|Overall Study||21
235163|NCT00100178|562706|P1|COMPLETED|Overall Study||32
235164|NCT00100178|562704|P3|STARTED|Overall Study||42
235165|NCT00100178|562705|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
235166|NCT00100178|562706|P1|STARTED|Overall Study||41
235167|NCT00100048|562719|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
235168|NCT00100048|562720|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
235169|NCT00100048|562721|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
235170|NCT00100048|562722|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
235171|NCT00100048|562723|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
235172|NCT00100048|562724|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
235173|NCT00100048|562719|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
235174|NCT00100048|562720|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
235175|NCT00100048|562721|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
235176|NCT00100048|562722|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
235177|NCT00100048|562723|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
235178|NCT00100048|562724|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
235179|NCT00100048|562719|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
235180|NCT00100048|562720|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
235181|NCT00100048|562721|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
235182|NCT00100048|562722|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
235183|NCT00100048|562723|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
235184|NCT00100048|562724|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
235185|NCT00100048|562719|P6|Treated|Cohort I & II-Combination Therapy Phase||38
235186|NCT00100048|562720|P5|Treated|Cohort I & II-Combination Therapy Phase||0
235187|NCT00100048|562721|P4|Treated|Cohort I & II-Combination Therapy Phase||40
235188|NCT00100048|562722|P3|Treated|Cohort I & II-Combination Therapy Phase||41
235189|NCT00100048|562723|P2|Treated|Cohort I & II-Combination Therapy Phase||40
235190|NCT00100048|562724|P1|Treated|Cohort I & II-Combination Therapy Phase||39
235191|NCT00100048|562719|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
235192|NCT00100048|562720|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
235193|NCT00100048|562721|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
235194|NCT00100048|562722|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
235195|NCT00100048|562723|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
235196|NCT00100048|562724|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
235197|NCT00100048|562719|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235198|NCT00100048|562720|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235199|NCT00100048|562721|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235200|NCT00100048|562722|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235201|NCT00100048|562723|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235202|NCT00100048|562724|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235203|NCT00100048|562719|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
235204|NCT00100048|562720|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
235205|NCT00100048|562721|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
235206|NCT00100048|562722|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
235207|NCT00100048|562723|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
235208|NCT00100048|562724|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
235209|NCT00100048|562719|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
235210|NCT00100048|562720|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
235211|NCT00100048|562721|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
235212|NCT00100048|562722|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
235213|NCT00100048|562723|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
235214|NCT00100048|562724|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
235301|NCT00098748|562980|P3|NOT COMPLETED|Received Study Treatment||44
235215|NCT00100048|562719|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
235216|NCT00100048|562720|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
235217|NCT00100048|562721|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
235218|NCT00100048|562722|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
235219|NCT00100048|562723|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
235220|NCT00100048|562724|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
235221|NCT00099983|562833|P2|NOT COMPLETED|Overall Study||25
235222|NCT00099983|562834|P1|NOT COMPLETED|Overall Study||24
235223|NCT00099983|562833|P2|COMPLETED|Overall Study||124
235224|NCT00099983|562834|P1|COMPLETED|Overall Study||123
235225|NCT00099983|562833|P2|STARTED|Overall Study||149
235226|NCT00099983|562834|P1|STARTED|Overall Study||147
235227|NCT00099437|562842|P2|NOT COMPLETED|Overall Study||349
235228|NCT00099437|562843|P1|NOT COMPLETED|Overall Study||366
235229|NCT00099437|562842|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
235230|NCT00099437|562843|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
235231|NCT00099437|562842|P2|STARTED|Overall Study|randomised patients|362
235232|NCT00099437|562843|P1|STARTED|Overall Study|randomised patients|374
235233|NCT00099359|562866|P3|NOT COMPLETED|Overall Study||68
235234|NCT00099359|562867|P2|NOT COMPLETED|Overall Study||65
235235|NCT00099359|562868|P1|NOT COMPLETED|Overall Study||54
235236|NCT00099359|562866|P3|COMPLETED|Overall Study||506
235237|NCT00099359|562867|P2|COMPLETED|Overall Study||515
235238|NCT00099359|562868|P1|COMPLETED|Overall Study||527
235239|NCT00099359|562866|P3|STARTED|Overall Study||574
235240|NCT00099359|562867|P2|STARTED|Overall Study||580
235241|NCT00099359|562868|P1|STARTED|Overall Study||581
235242|NCT00099268|562891|P2|NOT COMPLETED|Overall Study||82
235243|NCT00099268|562892|P1|NOT COMPLETED|Overall Study||92
235244|NCT00099268|562891|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
235245|NCT00099268|562892|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
235246|NCT00099268|562891|P2|Intent-to-Treat|Overall Study||372
235247|NCT00099268|562892|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
235248|NCT00099268|562891|P2|STARTED|Overall Study||373
235249|NCT00099268|562892|P1|STARTED|Overall Study||374
235250|NCT00099047|562910|P2|NOT COMPLETED|Overall Study||0
235251|NCT00099047|562911|P1|NOT COMPLETED|Overall Study||0
235252|NCT00099047|562910|P2|COMPLETED|Overall Study||12
235253|NCT00099047|562911|P1|COMPLETED|Overall Study||11
235254|NCT00099047|562910|P2|STARTED|Overall Study||12
235255|NCT00099047|562911|P1|STARTED|Overall Study||11
235256|NCT00099021|562917|P1|NOT COMPLETED|Overall Study||0
235257|NCT00099021|562917|P1|COMPLETED|Overall Study||21
235258|NCT00099021|562917|P1|STARTED|Overall Study||21
235259|NCT00098956|562923|P1|NOT COMPLETED|Overall Study||0
235260|NCT00098956|562923|P1|COMPLETED|Overall Study||19
235261|NCT00098956|562923|P1|STARTED|Overall Study||19
235262|NCT00098865|562928|P1|NOT COMPLETED|Overall Study||9
235263|NCT00098865|562928|P1|COMPLETED|Overall Study||6
235264|NCT00098865|562928|P1|STARTED|Overall Study||15
235265|NCT00098839|562936|P2|NOT COMPLETED|Overall Study||33
235266|NCT00098839|562937|P1|NOT COMPLETED|Overall Study||32
235267|NCT00098839|562936|P2|COMPLETED|Overall Study||27
235268|NCT00098839|562937|P1|COMPLETED|Overall Study||24
235269|NCT00098839|562936|P2|STARTED|Overall Study||60
235270|NCT00098839|562937|P1|STARTED|Overall Study||56
235271|NCT00098813|562947|P1|NOT COMPLETED|Overall Study||19
235272|NCT00098813|562947|P1|COMPLETED|Overall Study||1
235273|NCT00098813|562947|P1|STARTED|Overall Study||20
235274|NCT00098787|562954|P3|NOT COMPLETED|Overall Study||63
235275|NCT00098787|562955|P2|NOT COMPLETED|Overall Study||75
235276|NCT00098787|562956|P1|NOT COMPLETED|Overall Study||73
235277|NCT00098787|562954|P3|COMPLETED|Overall Study||0
235278|NCT00098787|562955|P2|COMPLETED|Overall Study||0
235279|NCT00098787|562956|P1|COMPLETED|Overall Study||0
235280|NCT00098787|562954|P3|Eligible and Treated|Overall Study||59
235281|NCT00098787|562955|P2|Eligible and Treated|Overall Study||66
235282|NCT00098787|562956|P1|Eligible and Treated|Overall Study||61
235283|NCT00098787|562954|P3|Treated|Overall Study||62
235284|NCT00098787|562955|P2|Treated|Overall Study||73
235285|NCT00098787|562956|P1|Treated|Overall Study||70
235286|NCT00098787|562954|P3|STARTED|Overall Study||63
235287|NCT00098787|562955|P2|STARTED|Overall Study||75
235288|NCT00098787|562956|P1|STARTED|Overall Study||73
235289|NCT00098774|562970|P1|NOT COMPLETED|Overall Study||18
235290|NCT00098774|562970|P1|COMPLETED|Overall Study||26
235291|NCT00098774|562970|P1|STARTED|Overall Study||44
235292|NCT00098748|562980|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
235293|NCT00098748|562981|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
235294|NCT00098748|562982|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
235295|NCT00098748|562980|P3|COMPLETED|Continued on Open-Label Treatment||0
235296|NCT00098748|562981|P2|COMPLETED|Continued on Open-Label Treatment||10
235297|NCT00098748|562982|P1|COMPLETED|Continued on Open-Label Treatment||7
235298|NCT00098748|562980|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
235299|NCT00098748|562981|P2|STARTED|Continued on Open-Label Treatment||25
235300|NCT00098748|562982|P1|STARTED|Continued on Open-Label Treatment||15
235302|NCT00098748|562981|P2|NOT COMPLETED|Received Study Treatment||36
235303|NCT00098748|562982|P1|NOT COMPLETED|Received Study Treatment||48
235304|NCT00098748|562980|P3|COMPLETED|Received Study Treatment||18
235305|NCT00098748|562981|P2|COMPLETED|Received Study Treatment||25
235306|NCT00098748|562982|P1|COMPLETED|Received Study Treatment||15
235307|NCT00098748|562980|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
235308|NCT00098748|562981|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
235309|NCT00098748|562982|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
235310|NCT00098748|562980|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
235311|NCT00098748|562981|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
235312|NCT00098748|562982|P1|STARTED|Received Study Treatment||63
235313|NCT00098748|562980|P3|NOT COMPLETED|Assigned to Study Treatment||2
235314|NCT00098748|562981|P2|NOT COMPLETED|Assigned to Study Treatment||2
235315|NCT00098748|562982|P1|NOT COMPLETED|Assigned to Study Treatment||0
235316|NCT00098748|562980|P3|COMPLETED|Assigned to Study Treatment||62
235317|NCT00098748|562981|P2|COMPLETED|Assigned to Study Treatment||61
235318|NCT00098748|562982|P1|COMPLETED|Assigned to Study Treatment||63
235319|NCT00098748|562980|P3|STARTED|Assigned to Study Treatment||64
235320|NCT00098748|562981|P2|STARTED|Assigned to Study Treatment||63
235321|NCT00098748|562982|P1|STARTED|Assigned to Study Treatment||63
235322|NCT00098722|563038|P7|NOT COMPLETED|Observation Phase||17
235323|NCT00098722|563039|P6|NOT COMPLETED|Observation Phase||45
235324|NCT00098722|563040|P5|NOT COMPLETED|Observation Phase||0
235325|NCT00098722|563041|P4|NOT COMPLETED|Observation Phase||0
235326|NCT00098722|563042|P3|NOT COMPLETED|Observation Phase||0
235327|NCT00098722|563043|P2|NOT COMPLETED|Observation Phase||0
235328|NCT00098722|563044|P1|NOT COMPLETED|Observation Phase||0
235329|NCT00098722|563038|P7|COMPLETED|Observation Phase||48
235330|NCT00098722|563039|P6|COMPLETED|Observation Phase||160
235331|NCT00098722|563040|P5|COMPLETED|Observation Phase||0
235332|NCT00098722|563041|P4|COMPLETED|Observation Phase||0
235333|NCT00098722|563042|P3|COMPLETED|Observation Phase||0
235334|NCT00098722|563043|P2|COMPLETED|Observation Phase||0
235335|NCT00098722|563044|P1|COMPLETED|Observation Phase||0
235336|NCT00098722|563038|P7|STARTED|Observation Phase||65
235337|NCT00098722|563039|P6|STARTED|Observation Phase||205
235338|NCT00098722|563040|P5|STARTED|Observation Phase||0
235339|NCT00098722|563041|P4|STARTED|Observation Phase||0
235340|NCT00098722|563042|P3|STARTED|Observation Phase||0
235341|NCT00098722|563043|P2|STARTED|Observation Phase||0
235342|NCT00098722|563044|P1|STARTED|Observation Phase||0
235343|NCT00098722|563038|P7|NOT COMPLETED|Open Label Phase||0
235344|NCT00098722|563039|P6|NOT COMPLETED|Open Label Phase||0
235345|NCT00098722|563040|P5|NOT COMPLETED|Open Label Phase||50
235346|NCT00098722|563041|P4|NOT COMPLETED|Open Label Phase||272
235347|NCT00098722|563042|P3|NOT COMPLETED|Open Label Phase||0
235348|NCT00098722|563043|P2|NOT COMPLETED|Open Label Phase||0
235349|NCT00098722|563044|P1|NOT COMPLETED|Open Label Phase||0
235350|NCT00098722|563038|P7|COMPLETED|Open Label Phase||0
235351|NCT00098722|563039|P6|COMPLETED|Open Label Phase||0
235352|NCT00098722|563040|P5|COMPLETED|Open Label Phase||0
235353|NCT00098722|563041|P4|COMPLETED|Open Label Phase||0
235354|NCT00098722|563042|P3|COMPLETED|Open Label Phase||0
235355|NCT00098722|563043|P2|COMPLETED|Open Label Phase||0
235356|NCT00098722|563044|P1|COMPLETED|Open Label Phase||0
235357|NCT00098722|563038|P7|STARTED|Open Label Phase||0
235358|NCT00098722|563039|P6|STARTED|Open Label Phase||0
235359|NCT00098722|563040|P5|STARTED|Open Label Phase||50
235360|NCT00098722|563041|P4|STARTED|Open Label Phase||272
235361|NCT00098722|563042|P3|STARTED|Open Label Phase||0
235362|NCT00098722|563043|P2|STARTED|Open Label Phase||0
235363|NCT00098722|563044|P1|STARTED|Open Label Phase||0
235364|NCT00098722|563038|P7|NOT COMPLETED|Double Blind Phase||0
235365|NCT00098722|563039|P6|NOT COMPLETED|Double Blind Phase||0
235366|NCT00098722|563040|P5|NOT COMPLETED|Double Blind Phase||0
235367|NCT00098722|563041|P4|NOT COMPLETED|Double Blind Phase||0
235368|NCT00098722|563042|P3|NOT COMPLETED|Double Blind Phase||94
235369|NCT00098722|563043|P2|NOT COMPLETED|Double Blind Phase||194
235370|NCT00098722|563044|P1|NOT COMPLETED|Double Blind Phase||186
235371|NCT00098722|563038|P7|COMPLETED|Double Blind Phase||0
235372|NCT00098722|563039|P6|COMPLETED|Double Blind Phase||0
235373|NCT00098722|563040|P5|COMPLETED|Double Blind Phase||0
235374|NCT00098722|563041|P4|COMPLETED|Double Blind Phase||0
235375|NCT00098722|563042|P3|COMPLETED|Double Blind Phase||0
235376|NCT00098722|563043|P2|COMPLETED|Double Blind Phase||0
235377|NCT00098722|563044|P1|COMPLETED|Double Blind Phase||0
235378|NCT00098722|563038|P7|Treated|Double Blind Phase||0
235379|NCT00098722|563039|P6|Treated|Double Blind Phase||0
235380|NCT00098722|563040|P5|Treated|Double Blind Phase||0
235381|NCT00098722|563041|P4|Treated|Double Blind Phase||0
235382|NCT00098722|563042|P3|Treated|Double Blind Phase||91
235383|NCT00098722|563043|P2|Treated|Double Blind Phase||191
235384|NCT00098722|563044|P1|Treated|Double Blind Phase||182
235385|NCT00098722|563038|P7|STARTED|Double Blind Phase||0
235386|NCT00098722|563039|P6|STARTED|Double Blind Phase||0
235387|NCT00098722|563040|P5|STARTED|Double Blind Phase||0
235388|NCT00098722|563041|P4|STARTED|Double Blind Phase||0
235389|NCT00098722|563042|P3|STARTED|Double Blind Phase||94
235390|NCT00098722|563043|P2|STARTED|Double Blind Phase||194
235391|NCT00098722|563044|P1|STARTED|Double Blind Phase||186
235392|NCT00098670|563107|P1|NOT COMPLETED|Overall Study||0
235393|NCT00098670|563107|P1|COMPLETED|Overall Study||102
235394|NCT00098670|563107|P1|STARTED|Overall Study||102
235395|NCT00098475|563118|P4|NOT COMPLETED|Step 2||0
235396|NCT00098475|563119|P3|NOT COMPLETED|Step 2||0
235397|NCT00098475|563120|P2|NOT COMPLETED|Step 2||10
235398|NCT00098475|563121|P1|NOT COMPLETED|Step 2||5
235399|NCT00098475|563118|P4|COMPLETED|Step 2||0
235400|NCT00098475|563119|P3|COMPLETED|Step 2||0
235401|NCT00098475|563120|P2|COMPLETED|Step 2||5
235402|NCT00098475|563121|P1|COMPLETED|Step 2||0
235403|NCT00098475|563118|P4|Eligible|Step 2||0
235404|NCT00098475|563119|P3|Eligible|Step 2||0
235405|NCT00098475|563120|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
235406|NCT00098475|563121|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
235407|NCT00098475|563118|P4|Treated|Step 2||0
235408|NCT00098475|563119|P3|Treated|Step 2||0
235409|NCT00098475|563120|P2|Treated|Step 2||14
235410|NCT00098475|563121|P1|Treated|Step 2||4
235411|NCT00098475|563118|P4|STARTED|Step 2||0
235412|NCT00098475|563119|P3|STARTED|Step 2||0
235413|NCT00098475|563120|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
235414|NCT00098475|563121|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
235415|NCT00098475|563118|P4|NOT COMPLETED|Step 1||3
235416|NCT00098475|563119|P3|NOT COMPLETED|Step 1||4
235417|NCT00098475|563120|P2|NOT COMPLETED|Step 1||173
235418|NCT00098475|563121|P1|NOT COMPLETED|Step 1||171
235419|NCT00098475|563118|P4|COMPLETED|Step 1||0
235420|NCT00098475|563119|P3|COMPLETED|Step 1||0
235421|NCT00098475|563120|P2|COMPLETED|Step 1||49
235422|NCT00098475|563121|P1|COMPLETED|Step 1||52
235423|NCT00098475|563118|P4|Eligible|Step 1||3
235424|NCT00098475|563119|P3|Eligible|Step 1||4
235425|NCT00098475|563120|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
235426|NCT00098475|563121|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
235427|NCT00098475|563118|P4|Treated|Step 1||3
235428|NCT00098475|563119|P3|Treated|Step 1||4
235429|NCT00098475|563120|P2|Treated|Step 1||220
235430|NCT00098475|563121|P1|Treated|Step 1||223
235431|NCT00098475|563118|P4|STARTED|Step 1||3
235432|NCT00098475|563119|P3|STARTED|Step 1||4
235433|NCT00098475|563120|P2|STARTED|Step 1||222
235434|NCT00098475|563121|P1|STARTED|Step 1||223
235435|NCT00098371|563133|P1|NOT COMPLETED|Overall Study||0
235436|NCT00098371|563133|P1|COMPLETED|Overall Study||64
235437|NCT00098371|563133|P1|STARTED|Overall Study||64
235438|NCT00098345|563158|P1|NOT COMPLETED|Overall Study||13
235439|NCT00098345|563158|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
235440|NCT00098345|563158|P1|STARTED|Overall Study||30
235441|NCT00098306|563171|P7|NOT COMPLETED|Observational Phase||26
235442|NCT00098306|563172|P6|NOT COMPLETED|Observational Phase||46
235443|NCT00098306|563173|P5|NOT COMPLETED|Observational Phase||0
235444|NCT00098306|563174|P4|NOT COMPLETED|Observational Phase||0
235445|NCT00098306|563175|P3|NOT COMPLETED|Observational Phase||0
235446|NCT00098306|563176|P2|NOT COMPLETED|Observational Phase||0
235447|NCT00098306|563177|P1|NOT COMPLETED|Observational Phase||0
235448|NCT00098306|563171|P7|COMPLETED|Observational Phase||55
235449|NCT00098306|563172|P6|COMPLETED|Observational Phase||204
235450|NCT00098306|563173|P5|COMPLETED|Observational Phase||0
235451|NCT00098306|563174|P4|COMPLETED|Observational Phase||0
235452|NCT00098306|563175|P3|COMPLETED|Observational Phase||0
235453|NCT00098306|563176|P2|COMPLETED|Observational Phase||0
235454|NCT00098306|563177|P1|COMPLETED|Observational Phase||0
235455|NCT00098306|563171|P7|STARTED|Observational Phase||81
235456|NCT00098306|563172|P6|STARTED|Observational Phase||250
235457|NCT00098306|563173|P5|STARTED|Observational Phase||0
235458|NCT00098306|563174|P4|STARTED|Observational Phase||0
235459|NCT00098306|563175|P3|STARTED|Observational Phase||0
235460|NCT00098306|563176|P2|STARTED|Observational Phase||0
235461|NCT00098306|563177|P1|STARTED|Observational Phase||0
235462|NCT00098306|563171|P7|NOT COMPLETED|Open Label||0
235463|NCT00098306|563172|P6|NOT COMPLETED|Open Label||0
235464|NCT00098306|563173|P5|NOT COMPLETED|Open Label||62
235465|NCT00098306|563174|P4|NOT COMPLETED|Open Label||327
235466|NCT00098306|563175|P3|NOT COMPLETED|Open Label||0
235467|NCT00098306|563176|P2|NOT COMPLETED|Open Label||0
235468|NCT00098306|563177|P1|NOT COMPLETED|Open Label||0
235469|NCT00098306|563171|P7|COMPLETED|Open Label||0
235470|NCT00098306|563172|P6|COMPLETED|Open Label||0
235471|NCT00098306|563173|P5|COMPLETED|Open Label||0
235472|NCT00098306|563174|P4|COMPLETED|Open Label||0
235473|NCT00098306|563175|P3|COMPLETED|Open Label||0
235474|NCT00098306|563176|P2|COMPLETED|Open Label||0
235475|NCT00098306|563177|P1|COMPLETED|Open Label||0
235476|NCT00098306|563171|P7|STARTED|Open Label||0
235477|NCT00098306|563172|P6|STARTED|Open Label||0
235478|NCT00098306|563173|P5|STARTED|Open Label||62
235479|NCT00098306|563174|P4|STARTED|Open Label||327
235480|NCT00098306|563175|P3|STARTED|Open Label||0
235481|NCT00098306|563176|P2|STARTED|Open Label||0
235482|NCT00098306|563177|P1|STARTED|Open Label||0
235483|NCT00098306|563171|P7|NOT COMPLETED|Double Blind||0
235484|NCT00098306|563172|P6|NOT COMPLETED|Double Blind||0
235485|NCT00098306|563173|P5|NOT COMPLETED|Double Blind||0
235486|NCT00098306|563174|P4|NOT COMPLETED|Double Blind||0
235487|NCT00098306|563175|P3|NOT COMPLETED|Double Blind||120
235488|NCT00098306|563176|P2|NOT COMPLETED|Double Blind||240
235489|NCT00098306|563177|P1|NOT COMPLETED|Double Blind||241
235490|NCT00098306|563171|P7|COMPLETED|Double Blind||0
235491|NCT00098306|563172|P6|COMPLETED|Double Blind||0
235492|NCT00098306|563173|P5|COMPLETED|Double Blind||0
235493|NCT00098306|563174|P4|COMPLETED|Double Blind||0
235494|NCT00098306|563175|P3|COMPLETED|Double Blind||0
235495|NCT00098306|563176|P2|COMPLETED|Double Blind||0
235496|NCT00098306|563177|P1|COMPLETED|Double Blind||0
235497|NCT00098306|563171|P7|Treated|Double Blind||0
235498|NCT00098306|563172|P6|Treated|Double Blind||0
235499|NCT00098306|563173|P5|Treated|Double Blind||0
235500|NCT00098306|563174|P4|Treated|Double Blind||0
235501|NCT00098306|563175|P3|Treated|Double Blind||118
235502|NCT00098306|563176|P2|Treated|Double Blind||235
235503|NCT00098306|563177|P1|Treated|Double Blind||232
235504|NCT00098306|563171|P7|STARTED|Double Blind||0
235505|NCT00098306|563172|P6|STARTED|Double Blind||0
235506|NCT00098306|563173|P5|STARTED|Double Blind||0
235507|NCT00098306|563174|P4|STARTED|Double Blind||0
235508|NCT00098306|563175|P3|STARTED|Double Blind||120
235509|NCT00098306|563176|P2|STARTED|Double Blind||240
235510|NCT00098306|563177|P1|STARTED|Double Blind||241
235511|NCT00098293|563243|P5|NOT COMPLETED|Supplemental Phase (SP)||33
235512|NCT00098293|563244|P4|NOT COMPLETED|Supplemental Phase (SP)||0
235513|NCT00098293|563245|P3|NOT COMPLETED|Supplemental Phase (SP)||0
235514|NCT00098293|563246|P2|NOT COMPLETED|Supplemental Phase (SP)||0
235515|NCT00098293|563247|P1|NOT COMPLETED|Supplemental Phase (SP)||0
235516|NCT00098293|563243|P5|COMPLETED|Supplemental Phase (SP)||94
235517|NCT00098293|563244|P4|COMPLETED|Supplemental Phase (SP)||0
235518|NCT00098293|563245|P3|COMPLETED|Supplemental Phase (SP)||0
235519|NCT00098293|563246|P2|COMPLETED|Supplemental Phase (SP)||0
235520|NCT00098293|563247|P1|COMPLETED|Supplemental Phase (SP)||0
235521|NCT00098293|563243|P5|STARTED|Supplemental Phase (SP)||127
235522|NCT00098293|563244|P4|STARTED|Supplemental Phase (SP)||0
235523|NCT00098293|563245|P3|STARTED|Supplemental Phase (SP)||0
235524|NCT00098293|563246|P2|STARTED|Supplemental Phase (SP)||0
235525|NCT00098293|563247|P1|STARTED|Supplemental Phase (SP)||0
235526|NCT00098293|563243|P5|NOT COMPLETED|Open-label (OL) Phase||0
235527|NCT00098293|563244|P4|NOT COMPLETED|Open-label (OL) Phase||65
235528|NCT00098293|563245|P3|NOT COMPLETED|Open-label (OL) Phase||41
235529|NCT00098293|563246|P2|NOT COMPLETED|Open-label (OL) Phase||25
235530|NCT00098293|563247|P1|NOT COMPLETED|Open-label (OL) Phase||0
235531|NCT00098293|563243|P5|COMPLETED|Open-label (OL) Phase||0
235532|NCT00098293|563244|P4|COMPLETED|Open-label (OL) Phase||65
235533|NCT00098293|563245|P3|COMPLETED|Open-label (OL) Phase||158
235534|NCT00098293|563246|P2|COMPLETED|Open-label (OL) Phase||177
235535|NCT00098293|563247|P1|COMPLETED|Open-label (OL) Phase||0
235536|NCT00098293|563243|P5|STARTED|Open-label (OL) Phase||0
235537|NCT00098293|563244|P4|STARTED|Open-label (OL) Phase||130
235538|NCT00098293|563245|P3|STARTED|Open-label (OL) Phase||199
235539|NCT00098293|563246|P2|STARTED|Open-label (OL) Phase||202
235540|NCT00098293|563247|P1|STARTED|Open-label (OL) Phase||0
235541|NCT00098293|563243|P5|NOT COMPLETED|Between DB and OL Phase||0
235542|NCT00098293|563244|P4|NOT COMPLETED|Between DB and OL Phase||0
235543|NCT00098293|563245|P3|NOT COMPLETED|Between DB and OL Phase||3
235544|NCT00098293|563246|P2|NOT COMPLETED|Between DB and OL Phase||0
235545|NCT00098293|563247|P1|NOT COMPLETED|Between DB and OL Phase||0
235546|NCT00098293|563243|P5|COMPLETED|Between DB and OL Phase||0
235547|NCT00098293|563244|P4|COMPLETED|Between DB and OL Phase||0
235548|NCT00098293|563245|P3|COMPLETED|Between DB and OL Phase||199
235549|NCT00098293|563246|P2|COMPLETED|Between DB and OL Phase||202
235550|NCT00098293|563247|P1|COMPLETED|Between DB and OL Phase||0
235551|NCT00098293|563243|P5|STARTED|Between DB and OL Phase||0
235552|NCT00098293|563244|P4|STARTED|Between DB and OL Phase||0
235553|NCT00098293|563245|P3|STARTED|Between DB and OL Phase||202
235554|NCT00098293|563246|P2|STARTED|Between DB and OL Phase||202
235555|NCT00098293|563247|P1|STARTED|Between DB and OL Phase||0
235556|NCT00098293|563243|P5|NOT COMPLETED|Double-blind (DB) Phase||0
235557|NCT00098293|563244|P4|NOT COMPLETED|Double-blind (DB) Phase||0
235558|NCT00098293|563245|P3|NOT COMPLETED|Double-blind (DB) Phase||170
235559|NCT00098293|563246|P2|NOT COMPLETED|Double-blind (DB) Phase||166
235560|NCT00098293|563247|P1|NOT COMPLETED|Double-blind (DB) Phase||177
235561|NCT00098293|563243|P5|COMPLETED|Double-blind (DB) Phase||0
235562|NCT00098293|563244|P4|COMPLETED|Double-blind (DB) Phase||0
235563|NCT00098293|563245|P3|COMPLETED|Double-blind (DB) Phase||202
235564|NCT00098293|563246|P2|COMPLETED|Double-blind (DB) Phase||202
235565|NCT00098293|563247|P1|COMPLETED|Double-blind (DB) Phase||0
235566|NCT00098293|563243|P5|Treated|Double-blind (DB) Phase||0
235567|NCT00098293|563244|P4|Treated|Double-blind (DB) Phase||0
235568|NCT00098293|563245|P3|Treated|Double-blind (DB) Phase||361
235569|NCT00098293|563246|P2|Treated|Double-blind (DB) Phase||360
235570|NCT00098293|563247|P1|Treated|Double-blind (DB) Phase||174
235571|NCT00098293|563243|P5|STARTED|Double-blind (DB) Phase||0
235572|NCT00098293|563244|P4|STARTED|Double-blind (DB) Phase||0
235573|NCT00098293|563245|P3|STARTED|Double-blind (DB) Phase||372
235574|NCT00098293|563246|P2|STARTED|Double-blind (DB) Phase||368
235575|NCT00098293|563247|P1|STARTED|Double-blind (DB) Phase||177
235576|NCT00098254|563300|P1|NOT COMPLETED|Overall Study||3
235577|NCT00098254|563300|P1|COMPLETED|Overall Study||34
235578|NCT00098254|563300|P1|STARTED|Overall Study||37
235579|NCT00097370|563319|P1|NOT COMPLETED|Stage 3||59
235580|NCT00097370|563319|P1|COMPLETED|Stage 3||0
235581|NCT00097370|563319|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
235582|NCT00097370|563319|P1|NOT COMPLETED|Stage 2||13
235583|NCT00097370|563319|P1|COMPLETED|Stage 2||59
235584|NCT00097370|563319|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
235585|NCT00097370|563319|P1|NOT COMPLETED|Stage 1||6
235586|NCT00097370|563319|P1|COMPLETED|Stage 1||31
235587|NCT00097370|563319|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
235588|NCT00097253|563336|P1|NOT COMPLETED|Water (Control)||0
235589|NCT00097253|563336|P1|COMPLETED|Water (Control)||56
235590|NCT00097253|563336|P1|STARTED|Water (Control)||56
235591|NCT00097253|563336|P1|NOT COMPLETED|Lemon||0
235592|NCT00097253|563336|P1|COMPLETED|Lemon||56
235593|NCT00097253|563336|P1|STARTED|Lemon||56
235594|NCT00097253|563336|P1|NOT COMPLETED|Lavender||0
235595|NCT00097253|563336|P1|COMPLETED|Lavender||56
235596|NCT00097253|563336|P1|STARTED|Lavender||56
235597|NCT00098059|563353|P2|NOT COMPLETED|Overall Study||1
235598|NCT00098059|563354|P1|NOT COMPLETED|Overall Study||0
235599|NCT00098059|563353|P2|COMPLETED|Overall Study||46
235600|NCT00098059|563354|P1|COMPLETED|Overall Study||27
235601|NCT00098059|563353|P2|STARTED|Overall Study||47
235602|NCT00098059|563354|P1|STARTED|Overall Study||27
235603|NCT00097981|563400|P2|NOT COMPLETED|Overall Study||100
235604|NCT00097981|563401|P1|NOT COMPLETED|Overall Study||106
235605|NCT00097981|563400|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
235606|NCT00097981|563401|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
235607|NCT00097981|563400|P2|Received Study Medication|Overall Study||106
235608|NCT00097981|563401|P1|Received Study Medication|Overall Study||110
235609|NCT00097981|563400|P2|STARTED|Overall Study|Enrollment at randomization|112
235610|NCT00097981|563401|P1|STARTED|Overall Study|Enrollment at randomization|113
235611|NCT00097786|563417|P4|NOT COMPLETED|Overall Study||310
235612|NCT00097786|563418|P3|NOT COMPLETED|Overall Study||313
235613|NCT00097786|563419|P2|NOT COMPLETED|Overall Study||292
235614|NCT00097786|563420|P1|NOT COMPLETED|Overall Study||296
235615|NCT00097786|563417|P4|COMPLETED|Overall Study||2036
235616|NCT00097786|563418|P3|COMPLETED|Overall Study||2016
235617|NCT00097786|563419|P2|COMPLETED|Overall Study||2023
235618|NCT00097786|563420|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
235619|NCT00097786|563417|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
235620|NCT00097786|563418|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
235621|NCT00097786|563419|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
235622|NCT00097786|563420|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
235623|NCT00097786|563417|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
235624|NCT00097786|563418|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
235625|NCT00097786|563419|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
235626|NCT00097786|563420|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
235627|NCT00097786|563417|P4|Complete FU for Progression to Diabetes|Overall Study||1762
235628|NCT00097786|563418|P3|Complete FU for Progression to Diabetes|Overall Study||1734
235629|NCT00097786|563419|P2|Complete FU for Progression to Diabetes|Overall Study||1712
235630|NCT00097786|563420|P1|Complete FU for Progression to Diabetes|Overall Study||1709
235631|NCT00097786|563417|P4|STARTED|Overall Study||2346
235632|NCT00097786|563418|P3|STARTED|Overall Study||2329
235633|NCT00097786|563419|P2|STARTED|Overall Study||2315
235634|NCT00097786|563420|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
235635|NCT00097773|563442|P4|NOT COMPLETED|Overall Study||3
235636|NCT00097773|563443|P3|NOT COMPLETED|Overall Study||8
235637|NCT00097773|563444|P2|NOT COMPLETED|Overall Study||8
235638|NCT00097773|563445|P1|NOT COMPLETED|Overall Study||8
235639|NCT00097773|563442|P4|COMPLETED|Overall Study||73
235640|NCT00097773|563443|P3|COMPLETED|Overall Study||68
235641|NCT00097773|563444|P2|COMPLETED|Overall Study||68
235642|NCT00097773|563445|P1|COMPLETED|Overall Study||68
235643|NCT00097773|563442|P4|STARTED|Overall Study||76
235644|NCT00097773|563443|P3|STARTED|Overall Study||76
235645|NCT00097773|563444|P2|STARTED|Overall Study||76
235646|NCT00097773|563445|P1|STARTED|Overall Study||76
235647|NCT00097721|563465|P2|NOT COMPLETED|Overall Study||33
235648|NCT00097721|563466|P1|NOT COMPLETED|Overall Study||71
235649|NCT00097721|563465|P2|COMPLETED|Overall Study||0
235650|NCT00097721|563466|P1|COMPLETED|Overall Study||0
235651|NCT00097721|563465|P2|STARTED|Overall Study||33
235652|NCT00097721|563466|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
235653|NCT00097708|563483|P3|NOT COMPLETED|Overall Study||65
235654|NCT00097708|563484|P2|NOT COMPLETED|Overall Study||56
235655|NCT00097708|563485|P1|NOT COMPLETED|Overall Study||64
235656|NCT00097708|563483|P3|COMPLETED|Overall Study||97
235657|NCT00097708|563484|P2|COMPLETED|Overall Study||120
235658|NCT00097708|563485|P1|COMPLETED|Overall Study||109
235659|NCT00097708|563483|P3|Treated|Overall Study||160
235660|NCT00097708|563484|P2|Treated|Overall Study||176
235661|NCT00097708|563485|P1|Treated|Overall Study||171
235662|NCT00097708|563483|P3|Intent-to-Treat (ITT)|Overall Study||149
235663|NCT00097708|563484|P2|Intent-to-Treat (ITT)|Overall Study||169
235664|NCT00097708|563485|P1|Intent-to-Treat (ITT)|Overall Study||165
235665|NCT00097708|563483|P3|STARTED|Overall Study||162
235666|NCT00097708|563484|P2|STARTED|Overall Study||176
235667|NCT00097708|563485|P1|STARTED|Overall Study||173
235668|NCT00097695|563497|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
235669|NCT00097695|563498|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
235670|NCT00097695|563499|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
235671|NCT00097695|563500|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
235672|NCT00097695|563497|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
235673|NCT00097695|563498|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
235674|NCT00097695|563499|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
235675|NCT00097695|563500|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
235676|NCT00097695|563497|P4|STARTED|The Open Label Extension (OLE) Phase||20
235677|NCT00097695|563498|P3|STARTED|The Open Label Extension (OLE) Phase||3
235678|NCT00097695|563499|P2|STARTED|The Open Label Extension (OLE) Phase||26
235679|NCT00097695|563500|P1|STARTED|The Open Label Extension (OLE) Phase||23
235680|NCT00097695|563497|P4|NOT COMPLETED|The Controlled Phase||20
235681|NCT00097695|563498|P3|NOT COMPLETED|The Controlled Phase||5
235682|NCT00097695|563499|P2|NOT COMPLETED|The Controlled Phase||3
235683|NCT00097695|563500|P1|NOT COMPLETED|The Controlled Phase||4
235684|NCT00097695|563497|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
235685|NCT00097695|563498|P3|COMPLETED|The Controlled Phase||3
235686|NCT00097695|563499|P2|COMPLETED|The Controlled Phase||26
235687|NCT00097695|563500|P1|COMPLETED|The Controlled Phase||23
235688|NCT00097695|563497|P4|STARTED|The Controlled Phase||20
235689|NCT00097695|563498|P3|STARTED|The Controlled Phase||8
235690|NCT00097695|563499|P2|STARTED|The Controlled Phase||29
235691|NCT00097695|563500|P1|STARTED|The Controlled Phase||27
235692|NCT00097591|563516|P2|NOT COMPLETED|Overall Study||394
235693|NCT00097591|563517|P1|NOT COMPLETED|Overall Study||410
235694|NCT00097591|563516|P2|COMPLETED|Overall Study||6401
235695|NCT00097591|563517|P1|COMPLETED|Overall Study||6403
235696|NCT00097591|563516|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
235697|NCT00097591|563517|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
235698|NCT00097539|563540|P7|NOT COMPLETED|Overall Study||171
235699|NCT00097539|563541|P6|NOT COMPLETED|Overall Study||5892
235700|NCT00097539|563542|P5|NOT COMPLETED|Overall Study||1758
235701|NCT00097539|563543|P4|NOT COMPLETED|Overall Study||3585
235702|NCT00097539|563544|P3|NOT COMPLETED|Overall Study||9108
235703|NCT00097539|563545|P2|NOT COMPLETED|Overall Study||6531
235704|NCT00097539|563546|P1|NOT COMPLETED|Overall Study||19066
235705|NCT00097539|563540|P7|COMPLETED|Overall Study||68
235706|NCT00097539|563541|P6|COMPLETED|Overall Study||2118
235707|NCT00097539|563542|P5|COMPLETED|Overall Study||386
235708|NCT00097539|563543|P4|COMPLETED|Overall Study||2066
235709|NCT00097539|563544|P3|COMPLETED|Overall Study||3411
235710|NCT00097539|563545|P2|COMPLETED|Overall Study||2825
235711|NCT00097539|563546|P1|COMPLETED|Overall Study||8220
235712|NCT00097539|563540|P7|STARTED|Overall Study||239
235713|NCT00097539|563541|P6|STARTED|Overall Study||8010
235714|NCT00097539|563542|P5|STARTED|Overall Study||2144
235715|NCT00097539|563543|P4|STARTED|Overall Study||5651
235716|NCT00097539|563544|P3|STARTED|Overall Study||12519
235717|NCT00097539|563545|P2|STARTED|Overall Study||9356
235718|NCT00097539|563546|P1|STARTED|Overall Study||27286
235719|NCT00097500|563592|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
235720|NCT00097500|563593|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
235721|NCT00097500|563592|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
235722|NCT00097500|563593|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
235723|NCT00097500|563592|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
235724|NCT00097500|563593|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
235725|NCT00097500|563592|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
235726|NCT00097500|563593|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
235727|NCT00097500|563592|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
235728|NCT00097500|563593|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
235729|NCT00097500|563592|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
235730|NCT00097500|563593|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
235731|NCT00097448|563617|P2|NOT COMPLETED|Overall Study||1
235732|NCT00097448|563618|P1|NOT COMPLETED|Overall Study||4
235733|NCT00097448|563617|P2|COMPLETED|Overall Study||129
235734|NCT00097448|563618|P1|COMPLETED|Overall Study||121
235735|NCT00097448|563617|P2|STARTED|Overall Study||130
235736|NCT00097448|563618|P1|STARTED|Overall Study||125
235737|NCT00096993|563626|P2|NOT COMPLETED|Overall Study||65
235738|NCT00096993|563627|P1|NOT COMPLETED|Overall Study||65
235739|NCT00096993|563626|P2|COMPLETED|Overall Study||0
235740|NCT00096993|563627|P1|COMPLETED|Overall Study||1
235741|NCT00096993|563626|P2|STARTED|Overall Study||65
235742|NCT00096993|563627|P1|STARTED|Overall Study||66
235743|NCT00096954|563643|P2|NOT COMPLETED|Overall Study||20
235744|NCT00096954|563644|P1|NOT COMPLETED|Overall Study||24
235745|NCT00096954|563643|P2|COMPLETED|Overall Study||154
235746|NCT00096954|563644|P1|COMPLETED|Overall Study||135
235747|NCT00096954|563643|P2|Received Study Drug|Overall Study||171
235748|NCT00096954|563644|P1|Received Study Drug|Overall Study||157
235749|NCT00096954|563643|P2|STARTED|Overall Study||174
235750|NCT00096954|563644|P1|STARTED|Overall Study||159
235751|NCT00096941|563656|P1|NOT COMPLETED|Overall Study||3
235752|NCT00096941|563656|P1|COMPLETED|Overall Study||0
235753|NCT00096941|563656|P1|STARTED|Overall Study||3
235754|NCT00096785|563663|P2|NOT COMPLETED|Overall Study||1
235755|NCT00096785|563664|P1|NOT COMPLETED|Overall Study||2
235756|NCT00096785|563663|P2|COMPLETED|Overall Study|As randomized cohort|33
235757|NCT00096785|563664|P1|COMPLETED|Overall Study|As randomized cohort|33
235758|NCT00096785|563663|P2|As-Treated Population|Overall Study||33
235759|NCT00096785|563664|P1|As-Treated Population|Overall Study||36
235760|NCT00096785|563663|P2|As-Randomized Population|Overall Study||34
235761|NCT00096785|563664|P1|As-Randomized Population|Overall Study||35
235762|NCT00096785|563663|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
235763|NCT00096785|563664|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
235764|NCT00096681|563688|P1|NOT COMPLETED|Overall Study||0
235765|NCT00096681|563688|P1|COMPLETED|Overall Study||762
235766|NCT00096681|563688|P1|STARTED|Overall Study||762
235767|NCT00096538|563693|P1|NOT COMPLETED|Overall Study||1
235768|NCT00096538|563693|P1|COMPLETED|Overall Study||5
235769|NCT00096538|563693|P1|STARTED|Overall Study||6
235770|NCT00096486|563701|P4|NOT COMPLETED|Overall Study||2
235771|NCT00096486|563702|P3|NOT COMPLETED|Overall Study||2
235772|NCT00096486|563703|P2|NOT COMPLETED|Overall Study||0
235773|NCT00096486|563704|P1|NOT COMPLETED|Overall Study||0
235774|NCT00096486|563701|P4|COMPLETED|Overall Study||36
235775|NCT00096486|563702|P3|COMPLETED|Overall Study||24
235776|NCT00096486|563703|P2|COMPLETED|Overall Study||6
235777|NCT00096486|563704|P1|COMPLETED|Overall Study||4
235778|NCT00096486|563701|P4|STARTED|Overall Study||38
235779|NCT00096486|563702|P3|STARTED|Overall Study||26
235780|NCT00096486|563703|P2|STARTED|Overall Study||6
235781|NCT00096486|563704|P1|STARTED|Overall Study||4
235782|NCT00096460|563716|P2|NOT COMPLETED|Overall Study||1
235783|NCT00096460|563717|P1|NOT COMPLETED|Overall Study||7
235784|NCT00096460|563716|P2|COMPLETED|Overall Study||7
235785|NCT00096460|563717|P1|COMPLETED|Overall Study||15
235786|NCT00096460|563716|P2|STARTED|Overall Study||8
235787|NCT00096460|563717|P1|STARTED|Overall Study||22
235788|NCT00096447|563723|P1|NOT COMPLETED|Overall Study||1
235789|NCT00096447|563723|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
235790|NCT00096447|563723|P1|STARTED|Overall Study||31
235791|NCT00096382|563731|P2|NOT COMPLETED|Overall Study||0
235792|NCT00096382|563732|P1|NOT COMPLETED|Overall Study||2
235793|NCT00096382|563731|P2|COMPLETED|Overall Study||3
235794|NCT00096382|563732|P1|COMPLETED|Overall Study||21
235795|NCT00096382|563731|P2|STARTED|Overall Study||3
235796|NCT00096382|563732|P1|STARTED|Overall Study||23
235797|NCT00096356|563742|P2|NOT COMPLETED|Overall Study||53
235798|NCT00096356|563743|P1|NOT COMPLETED|Overall Study||44
235799|NCT00096356|563742|P2|COMPLETED|Overall Study||61
235800|NCT00096356|563743|P1|COMPLETED|Overall Study||78
235801|NCT00096356|563742|P2|STARTED|Overall Study||114
235802|NCT00096356|563743|P1|STARTED|Overall Study||122
235803|NCT00096278|563755|P2|NOT COMPLETED|Overall Study||20
235804|NCT00096278|563756|P1|NOT COMPLETED|Overall Study||18
235805|NCT00096278|563755|P2|COMPLETED|Overall Study||1334
235806|NCT00096278|563756|P1|COMPLETED|Overall Study||1338
235807|NCT00096278|563755|P2|STARTED|Overall Study||1354
235808|NCT00096278|563756|P1|STARTED|Overall Study||1356
235809|NCT00096265|563765|P3|NOT COMPLETED|Overall Study||0
235810|NCT00096265|563766|P2|NOT COMPLETED|Overall Study||0
235811|NCT00096265|563767|P1|NOT COMPLETED|Overall Study||1
235812|NCT00096265|563765|P3|COMPLETED|Overall Study||41
235813|NCT00096265|563766|P2|COMPLETED|Overall Study||40
235814|NCT00096265|563767|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
235815|NCT00096265|563765|P3|STARTED|Overall Study||41
235816|NCT00096265|563766|P2|STARTED|Overall Study||40
235817|NCT00096265|563767|P1|STARTED|Overall Study||45
235818|NCT00096226|563775|P1|NOT COMPLETED|Overall Study||17
235819|NCT00096226|563775|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
235820|NCT00096226|563775|P1|STARTED|Overall Study||60
235821|NCT00096200|563782|P3|NOT COMPLETED|Overall Study||0
235822|NCT00096200|563783|P2|NOT COMPLETED|Overall Study||7
235823|NCT00096200|563784|P1|NOT COMPLETED|Overall Study||1
235824|NCT00096200|563782|P3|COMPLETED|Overall Study||5
235825|NCT00096200|563783|P2|COMPLETED|Overall Study||23
235826|NCT00096200|563784|P1|COMPLETED|Overall Study||8
235827|NCT00096200|563782|P3|STARTED|Overall Study||5
235828|NCT00096200|563783|P2|STARTED|Overall Study||30
235829|NCT00096200|563784|P1|STARTED|Overall Study||9
235830|NCT00096174|563792|P1|NOT COMPLETED|Overall Study||62
235831|NCT00096174|563792|P1|COMPLETED|Overall Study||7
235832|NCT00096174|563792|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
235833|NCT00096174|563792|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
235834|NCT00096174|563792|P1|STARTED|Overall Study||69
235835|NCT00096135|563800|P2|NOT COMPLETED|Overall Study||15
235836|NCT00096135|563801|P1|NOT COMPLETED|Overall Study||63
235837|NCT00096135|563800|P2|COMPLETED|Overall Study||27
235838|NCT00096135|563801|P1|COMPLETED|Overall Study||63
235839|NCT00096135|563800|P2|STARTED|Overall Study||42
235840|NCT00096135|563801|P1|STARTED|Overall Study||126
235841|NCT00096122|563807|P1|NOT COMPLETED|Overall Study||0
235842|NCT00096122|563807|P1|COMPLETED|Overall Study||95
235843|NCT00096122|563807|P1|STARTED|Overall Study||95
235844|NCT00096109|563811|P1|NOT COMPLETED|Overall Study||0
235845|NCT00096109|563811|P1|COMPLETED|Overall Study||11
235846|NCT00096109|563811|P1|STARTED|Overall Study||11
235847|NCT00096031|563817|P1|NOT COMPLETED|Overall Study||63
235848|NCT00096031|563817|P1|COMPLETED|Overall Study||0
235849|NCT00096031|563817|P1|Eligible and Began Protocol Therapy|Overall Study||55
235850|NCT00096031|563817|P1|Eligible|Overall Study||57
235851|NCT00096031|563817|P1|STARTED|Overall Study||63
235852|NCT00096018|563825|P2|NOT COMPLETED|Overall Study||14
235853|NCT00096018|563826|P1|NOT COMPLETED|Overall Study||2
235854|NCT00096018|563825|P2|COMPLETED|Overall Study||16
235855|NCT00096018|563826|P1|COMPLETED|Overall Study||11
235856|NCT00096018|563825|P2|Treated With Study Therapy|Overall Study||25
235857|NCT00096018|563826|P1|Treated With Study Therapy|Overall Study||13
235858|NCT00096018|563825|P2|STARTED|Overall Study||30
235859|NCT00096018|563826|P1|STARTED|Overall Study||13
235860|NCT00095979|563834|P1|NOT COMPLETED|Overall Study||2
235861|NCT00095979|563834|P1|COMPLETED|Overall Study||50
235862|NCT00095979|563834|P1|STARTED|Overall Study||52
235863|NCT00095940|563847|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
235864|NCT00095940|563848|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
235865|NCT00095940|563849|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
235866|NCT00095940|563850|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
235867|NCT00095940|563851|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
235868|NCT00095940|563852|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
235869|NCT00095940|563853|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
235870|NCT00095940|563854|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
235871|NCT00095940|563855|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
235872|NCT00095940|563847|P9|COMPLETED|Lapatinib Continuation/Phase II||1
235873|NCT00095940|563848|P8|COMPLETED|Lapatinib Continuation/Phase II||0
235874|NCT00095940|563849|P7|COMPLETED|Lapatinib Continuation/Phase II||0
235875|NCT00095940|563850|P6|COMPLETED|Lapatinib Continuation/Phase II||0
235876|NCT00095940|563851|P5|COMPLETED|Lapatinib Continuation/Phase II||0
235877|NCT00095940|563852|P4|COMPLETED|Lapatinib Continuation/Phase II||0
235878|NCT00095940|563853|P3|COMPLETED|Lapatinib Continuation/Phase II||1
235879|NCT00095940|563854|P2|COMPLETED|Lapatinib Continuation/Phase II||0
235880|NCT00095940|563855|P1|COMPLETED|Lapatinib Continuation/Phase II||0
235881|NCT00095940|563847|P9|STARTED|Lapatinib Continuation/Phase II||14
235882|NCT00095940|563848|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
235883|NCT00095940|563849|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
235884|NCT00095940|563850|P6|STARTED|Lapatinib Continuation/Phase II||13
235885|NCT00095940|563851|P5|STARTED|Lapatinib Continuation/Phase II||0
235886|NCT00095940|563852|P4|STARTED|Lapatinib Continuation/Phase II||0
235887|NCT00095940|563853|P3|STARTED|Lapatinib Continuation/Phase II||17
235888|NCT00095940|563854|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
235889|NCT00095940|563855|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
235890|NCT00095940|563847|P9|NOT COMPLETED|Molecular Biology Phase||0
235891|NCT00095940|563848|P8|NOT COMPLETED|Molecular Biology Phase||0
235892|NCT00095940|563849|P7|NOT COMPLETED|Molecular Biology Phase||0
235893|NCT00095940|563850|P6|NOT COMPLETED|Molecular Biology Phase||0
235894|NCT00095940|563851|P5|NOT COMPLETED|Molecular Biology Phase||0
235895|NCT00095940|563852|P4|NOT COMPLETED|Molecular Biology Phase||0
235896|NCT00095940|563853|P3|NOT COMPLETED|Molecular Biology Phase||0
235897|NCT00095940|563854|P2|NOT COMPLETED|Molecular Biology Phase||0
235898|NCT00095940|563855|P1|NOT COMPLETED|Molecular Biology Phase||0
235899|NCT00095940|563847|P9|COMPLETED|Molecular Biology Phase||0
235900|NCT00095940|563848|P8|COMPLETED|Molecular Biology Phase||2
235901|NCT00095940|563849|P7|COMPLETED|Molecular Biology Phase||2
235902|NCT00095940|563850|P6|COMPLETED|Molecular Biology Phase||0
235903|NCT00095940|563851|P5|COMPLETED|Molecular Biology Phase||0
235904|NCT00095940|563852|P4|COMPLETED|Molecular Biology Phase||0
235905|NCT00095940|563853|P3|COMPLETED|Molecular Biology Phase||0
235906|NCT00095940|563854|P2|COMPLETED|Molecular Biology Phase||2
235907|NCT00095940|563855|P1|COMPLETED|Molecular Biology Phase||2
235908|NCT00095940|563847|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
235909|NCT00095940|563848|P8|STARTED|Molecular Biology Phase||2
235910|NCT00095940|563849|P7|STARTED|Molecular Biology Phase||2
235911|NCT00095940|563850|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
235912|NCT00095940|563851|P5|STARTED|Molecular Biology Phase||0
235913|NCT00095940|563852|P4|STARTED|Molecular Biology Phase||0
235914|NCT00095940|563853|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
235915|NCT00095940|563854|P2|STARTED|Molecular Biology Phase||2
235916|NCT00095940|563855|P1|STARTED|Molecular Biology Phase||2
235917|NCT00095875|563879|P2|NOT COMPLETED|Overall Study||9
235918|NCT00095875|563880|P1|NOT COMPLETED|Overall Study||14
235919|NCT00095875|563879|P2|COMPLETED|Overall Study||66
235920|NCT00095875|563880|P1|COMPLETED|Overall Study||56
235921|NCT00095875|563879|P2|STARTED|Overall Study||75
235922|NCT00095875|563880|P1|STARTED|Overall Study||70
235923|NCT00095784|563888|P1|NOT COMPLETED|Overall Study||0
235924|NCT00095784|563888|P1|COMPLETED|Overall Study||21
235925|NCT00095784|563888|P1|STARTED|Overall Study||21
235926|NCT00095576|563913|P2|NOT COMPLETED|Overall Study||1481
235927|NCT00095576|563914|P1|NOT COMPLETED|Overall Study||1475
235928|NCT00095576|563913|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
235929|NCT00095576|563914|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
235930|NCT00095576|563913|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
235931|NCT00095576|563914|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
235932|NCT00095576|563913|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
235933|NCT00095576|563914|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
235934|NCT00095576|563913|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
235935|NCT00095576|563914|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
235936|NCT00095576|563913|P2|STARTED|Overall Study||1495
235937|NCT00095576|563914|P1|STARTED|Overall Study||1484
235938|NCT00095498|563929|P3|NOT COMPLETED|Overall Study||39
235939|NCT00095498|563930|P2|NOT COMPLETED|Overall Study||35
235940|NCT00095498|563931|P1|NOT COMPLETED|Overall Study||37
235941|NCT00095498|563929|P3|COMPLETED|Overall Study||39
235942|NCT00095498|563930|P2|COMPLETED|Overall Study||38
235943|NCT00095498|563931|P1|COMPLETED|Overall Study||39
235944|NCT00095498|563929|P3|Received Investigational Product|Overall Study||75
235945|NCT00095498|563930|P2|Received Investigational Product|Overall Study||71
235946|NCT00095498|563931|P1|Received Investigational Product|Overall Study||72
235947|NCT00095498|563929|P3|STARTED|Overall Study||78
235948|NCT00095498|563930|P2|STARTED|Overall Study||73
235949|NCT00095498|563931|P1|STARTED|Overall Study||76
235950|NCT00095303|564358|P2|NOT COMPLETED|Follow Up Study||58
235951|NCT00095303|564359|P1|NOT COMPLETED|Follow Up Study||59
235952|NCT00095303|564358|P2|COMPLETED|Follow Up Study||121
235953|NCT00095303|564359|P1|COMPLETED|Follow Up Study||140
235954|NCT00095303|564358|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
235955|NCT00095303|564359|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
235956|NCT00095303|564358|P2|NOT COMPLETED|Main Study||87
235957|NCT00095303|564359|P1|NOT COMPLETED|Main Study||91
235958|NCT00095303|564358|P2|COMPLETED|Main Study||148
235959|NCT00095303|564359|P1|COMPLETED|Main Study||154
235960|NCT00095303|564358|P2|STARTED|Main Study||235
235961|NCT00095303|564359|P1|STARTED|Main Study||245
235962|NCT00095238|564427|P2|NOT COMPLETED|Overall Study||852
235963|NCT00095238|564428|P1|NOT COMPLETED|Overall Study||857
235964|NCT00095238|564427|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
235965|NCT00095238|564428|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
235966|NCT00095238|564427|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
235967|NCT00095238|564428|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
235968|NCT00095238|564427|P2|STARTED|Overall Study|number randomized|2061
235969|NCT00095238|564428|P1|STARTED|Overall Study|number randomized|2067
235970|NCT00095212|564490|P2|NOT COMPLETED|Overall Study||3
235971|NCT00095212|564491|P1|NOT COMPLETED|Overall Study||1
235972|NCT00095212|564490|P2|COMPLETED|Overall Study||9
235973|NCT00095212|564491|P1|COMPLETED|Overall Study||12
235974|NCT00095212|564490|P2|STARTED|Overall Study||12
235975|NCT00095212|564491|P1|STARTED|Overall Study||13
235976|NCT00095199|564521|P4|NOT COMPLETED|Overall Study||143
235977|NCT00095199|564522|P3|NOT COMPLETED|Overall Study||160
235978|NCT00095199|564523|P2|NOT COMPLETED|Overall Study||242
235979|NCT00095199|564524|P1|NOT COMPLETED|Overall Study||296
235980|NCT00095199|564521|P4|COMPLETED|Overall Study||23
235981|NCT00095199|564522|P3|COMPLETED|Overall Study||7
235982|NCT00095199|564523|P2|COMPLETED|Overall Study||62
235983|NCT00095199|564524|P1|COMPLETED|Overall Study||6
235984|NCT00095199|564521|P4|STARTED|Overall Study||166
235985|NCT00095199|564522|P3|STARTED|Overall Study||167
235986|NCT00095199|564523|P2|STARTED|Overall Study||304
235987|NCT00095199|564524|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
235988|NCT00095173|564562|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
235989|NCT00095173|564563|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
235990|NCT00095173|564564|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
235991|NCT00095173|564565|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
235992|NCT00095173|564566|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
235993|NCT00095173|564567|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
235994|NCT00095173|564562|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
235995|NCT00095173|564563|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
235996|NCT00095173|564564|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
235997|NCT00095173|564565|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
235998|NCT00095173|564566|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
235999|NCT00095173|564567|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
236000|NCT00095173|564562|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
236001|NCT00095173|564563|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
236002|NCT00095173|564564|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
236003|NCT00095173|564565|P3|STARTED|Open-Label Extension Phase (Period C)||0
236004|NCT00095173|564566|P2|STARTED|Open-Label Extension Phase (Period C)||0
236005|NCT00095173|564567|P1|STARTED|Open-Label Extension Phase (Period C)||0
236006|NCT00095173|564562|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
236007|NCT00095173|564563|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
236008|NCT00095173|564564|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
236009|NCT00095173|564565|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
236010|NCT00095173|564566|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
236011|NCT00095173|564567|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
236012|NCT00095173|564562|P6|COMPLETED|Double-Blind Phase (Period B)||0
236013|NCT00095173|564563|P5|COMPLETED|Double-Blind Phase (Period B)||0
236014|NCT00095173|564564|P4|COMPLETED|Double-Blind Phase (Period B)||0
236015|NCT00095173|564565|P3|COMPLETED|Double-Blind Phase (Period B)||31
236016|NCT00095173|564566|P2|COMPLETED|Double-Blind Phase (Period B)||49
236017|NCT00095173|564567|P1|COMPLETED|Double-Blind Phase (Period B)||0
236018|NCT00095173|564562|P6|STARTED|Double-Blind Phase (Period B)||0
236019|NCT00095173|564563|P5|STARTED|Double-Blind Phase (Period B)||0
236020|NCT00095173|564564|P4|STARTED|Double-Blind Phase (Period B)||0
236021|NCT00095173|564565|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
236022|NCT00095173|564566|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
236023|NCT00095173|564567|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
236024|NCT00095173|564562|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
236025|NCT00095173|564563|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
236026|NCT00095173|564564|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
236027|NCT00095173|564565|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
236028|NCT00095173|564566|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
236029|NCT00095173|564567|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
236030|NCT00095173|564562|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
236031|NCT00095173|564563|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
236032|NCT00095173|564564|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
236033|NCT00095173|564565|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
236034|NCT00095173|564566|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
236035|NCT00095173|564567|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
236036|NCT00095173|564562|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
236037|NCT00095173|564563|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
236038|NCT00095173|564564|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
236039|NCT00095173|564565|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
236040|NCT00095173|564566|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
236041|NCT00095173|564567|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
236042|NCT00095147|564605|P5|NOT COMPLETED|Long-term Extension Period||45
236043|NCT00095147|564606|P4|NOT COMPLETED|Long-term Extension Period||0
236044|NCT00095147|564607|P3|NOT COMPLETED|Long-term Extension Period||0
236045|NCT00095147|564608|P2|NOT COMPLETED|Long-term Extension Period||0
236046|NCT00095147|564609|P1|NOT COMPLETED|Long-term Extension Period||0
236047|NCT00095147|564605|P5|COMPLETED|Long-term Extension Period||327
236048|NCT00095147|564606|P4|COMPLETED|Long-term Extension Period||0
236049|NCT00095147|564607|P3|COMPLETED|Long-term Extension Period||0
236050|NCT00095147|564608|P2|COMPLETED|Long-term Extension Period||0
236051|NCT00095147|564609|P1|COMPLETED|Long-term Extension Period||0
236052|NCT00095147|564605|P5|STARTED|Long-term Extension Period||372
236053|NCT00095147|564606|P4|STARTED|Long-term Extension Period||0
236054|NCT00095147|564607|P3|STARTED|Long-term Extension Period||0
236055|NCT00095147|564608|P2|STARTED|Long-term Extension Period||0
236056|NCT00095147|564609|P1|STARTED|Long-term Extension Period||0
236057|NCT00095147|564605|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
236058|NCT00095147|564606|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
236059|NCT00095147|564607|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
236060|NCT00095147|564608|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
236061|NCT00095147|564609|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
236062|NCT00095147|564605|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
236063|NCT00095147|564606|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
236064|NCT00095147|564607|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
236065|NCT00095147|564608|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
236066|NCT00095147|564609|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
236067|NCT00095147|564605|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
236068|NCT00095147|564606|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
236069|NCT00095147|564607|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
236070|NCT00095147|564608|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
236071|NCT00095147|564609|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
236072|NCT00095147|564605|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
236073|NCT00095147|564606|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
236074|NCT00095147|564607|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
236075|NCT00095147|564608|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
236076|NCT00095147|564609|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
236077|NCT00095147|564605|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
236078|NCT00095147|564606|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
236079|NCT00095147|564607|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
236080|NCT00095147|564608|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
236081|NCT00095147|564609|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
236082|NCT00095147|564605|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
236083|NCT00095147|564606|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
236084|NCT00095147|564607|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
236085|NCT00095147|564608|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
236086|NCT00095147|564609|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
236087|NCT00095121|564804|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
236088|NCT00095121|564805|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
236089|NCT00095121|564804|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
236090|NCT00095121|564805|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
236091|NCT00095121|564804|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
236092|NCT00095121|564805|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
236093|NCT00095121|564804|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
236094|NCT00095121|564805|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
236095|NCT00095121|564804|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
236096|NCT00095121|564805|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
236097|NCT00095121|564804|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
236098|NCT00095121|564805|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
236099|NCT00095121|564804|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
236100|NCT00095121|564805|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
236101|NCT00095056|564851|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
236102|NCT00095056|564852|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
236103|NCT00095056|564851|P2|COMPLETED|Phase B (Weeks 12-54)||20
236104|NCT00095056|564852|P1|COMPLETED|Phase B (Weeks 12-54)||46
236105|NCT00095056|564851|P2|STARTED|Phase B (Weeks 12-54)||25
236106|NCT00095056|564852|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
236107|NCT00095056|564851|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
236108|NCT00095056|564852|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
236109|NCT00095056|564851|P2|COMPLETED|Phase A (Weeks 0-12)||25
236110|NCT00095056|564852|P1|COMPLETED|Phase A (Weeks 0-12)||58
236111|NCT00095056|564851|P2|STARTED|Phase A (Weeks 0-12)||26
236112|NCT00095056|564852|P1|STARTED|Phase A (Weeks 0-12)||65
236113|NCT00094900|564860|P1|NOT COMPLETED|Overall Study||1
236114|NCT00094900|564860|P1|COMPLETED|Overall Study||10
236115|NCT00094900|564860|P1|STARTED|Overall Study||11
236116|NCT00094887|564962|P2|NOT COMPLETED|Overall Study||6
236117|NCT00094887|564963|P1|NOT COMPLETED|Overall Study||5
236118|NCT00094887|564962|P2|COMPLETED|Overall Study||69
236119|NCT00094887|564963|P1|COMPLETED|Overall Study||70
236120|NCT00094887|564962|P2|STARTED|Overall Study|75|75
236121|NCT00094887|564963|P1|STARTED|Overall Study|75|75
236122|NCT00094861|564971|P2|NOT COMPLETED|Overall Study||9
236123|NCT00094861|564972|P1|NOT COMPLETED|Overall Study||18
236124|NCT00094861|564971|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
236125|NCT00094861|564972|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
236126|NCT00094861|564971|P2|Participants Treated|Overall Study||48
236127|NCT00094861|564972|P1|Participants Treated|Overall Study||46
236128|NCT00094861|564971|P2|STARTED|Overall Study||49
236129|NCT00094861|564972|P1|STARTED|Overall Study||46
236130|NCT00094835|564999|P7|NOT COMPLETED|Overall Study||2
236131|NCT00094835|565000|P6|NOT COMPLETED|Overall Study||3
236132|NCT00094835|565001|P5|NOT COMPLETED|Overall Study||4
236133|NCT00094835|565002|P4|NOT COMPLETED|Overall Study||1
236134|NCT00094835|565003|P3|NOT COMPLETED|Overall Study||3
236135|NCT00094835|565004|P2|NOT COMPLETED|Overall Study||3
236136|NCT00094835|565005|P1|NOT COMPLETED|Overall Study||4
236137|NCT00094835|564999|P7|COMPLETED|Overall Study||4
236138|NCT00094835|565000|P6|COMPLETED|Overall Study||3
236139|NCT00094835|565001|P5|COMPLETED|Overall Study||3
236140|NCT00094835|565002|P4|COMPLETED|Overall Study||4
236141|NCT00094835|565003|P3|COMPLETED|Overall Study||4
236142|NCT00094835|565004|P2|COMPLETED|Overall Study||8
236143|NCT00094835|565005|P1|COMPLETED|Overall Study||5
236144|NCT00094835|564999|P7|Treated With Motesanib|Overall Study||6
236145|NCT00094835|565000|P6|Treated With Motesanib|Overall Study||5
236146|NCT00094835|565001|P5|Treated With Motesanib|Overall Study||7
236147|NCT00094835|565002|P4|Treated With Motesanib|Overall Study||4
236148|NCT00094835|565003|P3|Treated With Motesanib|Overall Study||6
236149|NCT00094835|565004|P2|Treated With Motesanib|Overall Study||11
236150|NCT00094835|565005|P1|Treated With Motesanib|Overall Study||6
236151|NCT00094835|564999|P7|STARTED|Overall Study||6
236152|NCT00094835|565000|P6|STARTED|Overall Study||6
236153|NCT00094835|565001|P5|STARTED|Overall Study||7
236154|NCT00094835|565002|P4|STARTED|Overall Study||5
236155|NCT00094835|565003|P3|STARTED|Overall Study||7
236156|NCT00094835|565004|P2|STARTED|Overall Study||11
236157|NCT00094835|565005|P1|STARTED|Overall Study||9
236158|NCT00094809|565083|P2|NOT COMPLETED|Overall Study||65
236159|NCT00094809|565084|P1|NOT COMPLETED|Overall Study||52
236160|NCT00094809|565083|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
236161|NCT00094809|565084|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
236162|NCT00094809|565083|P2|Completed All 4 Cycles of Treatment|Overall Study||90
236163|NCT00094809|565084|P1|Completed All 4 Cycles of Treatment|Overall Study||98
236164|NCT00094809|565083|P2|Properly Consented; Received Study Drug|Overall Study||118
236165|NCT00094809|565084|P1|Properly Consented; Received Study Drug|Overall Study||123
236166|NCT00094809|565083|P2|Received Study Drug|Overall Study||118
236167|NCT00094809|565084|P1|Received Study Drug|Overall Study||124
236168|NCT00094809|565083|P2|STARTED|Overall Study||126
236169|NCT00094809|565084|P1|STARTED|Overall Study||126
236170|NCT00094770|565110|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
236171|NCT00094770|565111|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
236172|NCT00094770|565110|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
236173|NCT00094770|565111|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
236174|NCT00094770|565110|P2|STARTED|Year 2 (Week 0 to Week 104)||584
236175|NCT00094770|565111|P1|STARTED|Year 2 (Week 0 to Week 104)||588
236176|NCT00094770|565110|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
236177|NCT00094770|565111|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
236178|NCT00094770|565110|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
236179|NCT00094770|565111|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
236180|NCT00094770|565110|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
236181|NCT00094770|565111|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
236182|NCT00094757|565142|P3|NOT COMPLETED|Overall Study||30
236183|NCT00094757|565143|P2|NOT COMPLETED|Overall Study||62
236184|NCT00094757|565144|P1|NOT COMPLETED|Overall Study||53
236185|NCT00094757|565142|P3|COMPLETED|Overall Study||80
236186|NCT00094757|565143|P2|COMPLETED|Overall Study||144
236187|NCT00094757|565144|P1|COMPLETED|Overall Study||152
236188|NCT00094757|565142|P3|STARTED|Overall Study||110
236189|NCT00094757|565143|P2|STARTED|Overall Study||206
236190|NCT00094757|565144|P1|STARTED|Overall Study||205
236191|NCT00094653|565164|P3|NOT COMPLETED|Overall Study||126
236192|NCT00094653|565165|P2|NOT COMPLETED|Overall Study||106
236193|NCT00094653|565166|P1|NOT COMPLETED|Overall Study||321
236194|NCT00094653|565164|P3|COMPLETED|Overall Study||10
236195|NCT00094653|565165|P2|COMPLETED|Overall Study||31
236196|NCT00094653|565166|P1|COMPLETED|Overall Study||82
236197|NCT00094653|565164|P3|Treated|Overall Study||131
236198|NCT00094653|565165|P2|Treated|Overall Study||131
236199|NCT00094653|565166|P1|Treated|Overall Study||381
236200|NCT00094653|565164|P3|STARTED|Overall Study||136
236201|NCT00094653|565165|P2|STARTED|Overall Study||137
236202|NCT00094653|565166|P1|STARTED|Overall Study||403
236203|NCT00094575|565229|P2|NOT COMPLETED|Overall Study||146
236204|NCT00094575|565230|P1|NOT COMPLETED|Overall Study||146
236205|NCT00094575|565229|P2|COMPLETED|Overall Study||291
236206|NCT00094575|565230|P1|COMPLETED|Overall Study||298
236207|NCT00094575|565229|P2|STARTED|Overall Study||437
236208|NCT00094575|565230|P1|STARTED|Overall Study||444
236209|NCT00094497|565252|P2|NOT COMPLETED|Overall Study||0
236210|NCT00094497|565253|P1|NOT COMPLETED|Overall Study||0
236211|NCT00094497|565252|P2|COMPLETED|Overall Study||153
236212|NCT00094497|565253|P1|COMPLETED|Overall Study||151
236213|NCT00094497|565252|P2|Received Second Line Therapy|Overall Study||101
236214|NCT00094497|565253|P1|Received Second Line Therapy|Overall Study||84
236215|NCT00094497|565252|P2|Treated|Overall Study||149
236216|NCT00094497|565253|P1|Treated|Overall Study||148
236217|NCT00094497|565252|P2|STARTED|Overall Study||153
236218|NCT00094497|565253|P1|STARTED|Overall Study||151
236219|NCT00094458|565270|P6|NOT COMPLETED|OLE: Open-Label Extension||4
236220|NCT00094458|565271|P5|NOT COMPLETED|OLE: Open-Label Extension||5
236221|NCT00094458|565272|P4|NOT COMPLETED|OLE: Open-Label Extension||1
236222|NCT00094458|565273|P3|NOT COMPLETED|OLE: Open-Label Extension||0
236223|NCT00094458|565274|P2|NOT COMPLETED|OLE: Open-Label Extension||0
236224|NCT00094458|565275|P1|NOT COMPLETED|OLE: Open-Label Extension||0
236225|NCT00094458|565270|P6|COMPLETED|OLE: Open-Label Extension||13
236226|NCT00094458|565271|P5|COMPLETED|OLE: Open-Label Extension||13
236227|NCT00094458|565272|P4|COMPLETED|OLE: Open-Label Extension||7
236228|NCT00094458|565273|P3|COMPLETED|OLE: Open-Label Extension||0
236229|NCT00094458|565274|P2|COMPLETED|OLE: Open-Label Extension||0
236230|NCT00094458|565275|P1|COMPLETED|OLE: Open-Label Extension||0
236231|NCT00094458|565270|P6|STARTED|OLE: Open-Label Extension||17
236232|NCT00094458|565271|P5|STARTED|OLE: Open-Label Extension||18
236233|NCT00094458|565272|P4|STARTED|OLE: Open-Label Extension||8
236234|NCT00094458|565273|P3|STARTED|OLE: Open-Label Extension||0
236235|NCT00094458|565274|P2|STARTED|OLE: Open-Label Extension||0
236236|NCT00094458|565275|P1|STARTED|OLE: Open-Label Extension||0
236237|NCT00094458|565270|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
236238|NCT00094458|565271|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
236239|NCT00094458|565272|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
236240|NCT00094458|565273|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
236241|NCT00094458|565274|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
236242|NCT00094458|565275|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
236243|NCT00094458|565270|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
236244|NCT00094458|565271|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
236245|NCT00094458|565272|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
236246|NCT00094458|565273|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
236247|NCT00094458|565274|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
236248|NCT00094458|565275|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
236249|NCT00094458|565270|P6|STARTED|Study Extension: Week 30 Through Week 50||0
236250|NCT00094458|565271|P5|STARTED|Study Extension: Week 30 Through Week 50||0
236251|NCT00094458|565272|P4|STARTED|Study Extension: Week 30 Through Week 50||0
236252|NCT00094458|565273|P3|STARTED|Study Extension: Week 30 Through Week 50||108
236253|NCT00094458|565274|P2|STARTED|Study Extension: Week 30 Through Week 50||97
236254|NCT00094458|565275|P1|STARTED|Study Extension: Week 30 Through Week 50||75
236255|NCT00094458|565270|P6|NOT COMPLETED|Main Study: Through Week 30||0
236256|NCT00094458|565271|P5|NOT COMPLETED|Main Study: Through Week 30||0
236257|NCT00094458|565272|P4|NOT COMPLETED|Main Study: Through Week 30||0
236258|NCT00094458|565273|P3|NOT COMPLETED|Main Study: Through Week 30||48
236259|NCT00094458|565274|P2|NOT COMPLETED|Main Study: Through Week 30||58
236260|NCT00094458|565275|P1|NOT COMPLETED|Main Study: Through Week 30||84
236261|NCT00094458|565270|P6|COMPLETED|Main Study: Through Week 30||0
236262|NCT00094458|565271|P5|COMPLETED|Main Study: Through Week 30||0
236263|NCT00094458|565272|P4|COMPLETED|Main Study: Through Week 30||0
236264|NCT00094458|565273|P3|COMPLETED|Main Study: Through Week 30||121
236265|NCT00094458|565274|P2|COMPLETED|Main Study: Through Week 30||111
236266|NCT00094458|565275|P1|COMPLETED|Main Study: Through Week 30||86
236267|NCT00094458|565270|P6|STARTED|Main Study: Through Week 30||0
236268|NCT00094458|565271|P5|STARTED|Main Study: Through Week 30||0
236269|NCT00094458|565272|P4|STARTED|Main Study: Through Week 30||0
236270|NCT00094458|565273|P3|STARTED|Main Study: Through Week 30||169
236271|NCT00094458|565274|P2|STARTED|Main Study: Through Week 30||169
236272|NCT00094458|565275|P1|STARTED|Main Study: Through Week 30||170
236273|NCT00094328|565313|P1|NOT COMPLETED|Overall Study||1
236274|NCT00094328|565313|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
236275|NCT00094328|565313|P1|STARTED|Overall Study|Received treatment|14
236276|NCT00094302|565323|P2|NOT COMPLETED|Overall Study||406
236277|NCT00094302|565324|P1|NOT COMPLETED|Overall Study||417
236278|NCT00094302|565323|P2|COMPLETED|Overall Study||1316
236279|NCT00094302|565324|P1|COMPLETED|Overall Study||1306
236280|NCT00094302|565323|P2|STARTED|Overall Study||1722
236281|NCT00094302|565324|P1|STARTED|Overall Study||1723
236282|NCT00094172|565380|P2|NOT COMPLETED|Overall Study||7
236283|NCT00094172|565381|P1|NOT COMPLETED|Overall Study||14
236284|NCT00094172|565380|P2|COMPLETED|Overall Study||25
236285|NCT00094172|565381|P1|COMPLETED|Overall Study||36
236286|NCT00094172|565380|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
236287|NCT00094172|565381|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
236288|NCT00094107|565391|P1|NOT COMPLETED|Overall Study||32
236289|NCT00094107|565391|P1|COMPLETED|Overall Study||0
236290|NCT00094107|565391|P1|STARTED|Overall Study||32
236291|NCT00094094|565400|P1|NOT COMPLETED|Overall Study||32
236292|NCT00094094|565400|P1|COMPLETED|Overall Study||0
236293|NCT00094094|565400|P1|STARTED|Overall Study||32
236294|NCT00094055|565409|P1|NOT COMPLETED|Overall Study||60
236295|NCT00094055|565409|P1|COMPLETED|Overall Study||0
236296|NCT00094055|565409|P1|STARTED|Overall Study||60
236297|NCT00093847|565420|P2|NOT COMPLETED|Overall Study||10
236298|NCT00093847|565421|P1|NOT COMPLETED|Overall Study||8
236299|NCT00093847|565420|P2|COMPLETED|Overall Study||24
236300|NCT00093847|565421|P1|COMPLETED|Overall Study||31
236301|NCT00093847|565420|P2|STARTED|Overall Study||34
236302|NCT00093847|565421|P1|STARTED|Overall Study||39
236303|NCT00093808|565429|P1|NOT COMPLETED|Overall Study||2
236304|NCT00093808|565429|P1|COMPLETED|Overall Study||45
236305|NCT00093808|565429|P1|STARTED|Overall Study||47
236306|NCT00093782|565436|P1|NOT COMPLETED|Overall Study||0
236307|NCT00093782|565436|P1|COMPLETED|Overall Study||36
236308|NCT00093782|565436|P1|STARTED|Overall Study||36
236309|NCT00093756|565448|P2|NOT COMPLETED|Overall Study||0
236310|NCT00093756|565449|P1|NOT COMPLETED|Overall Study||0
236311|NCT00093756|565448|P2|COMPLETED|Overall Study||27
236312|NCT00093756|565449|P1|COMPLETED|Overall Study||21
236313|NCT00093756|565448|P2|STARTED|Overall Study||27
236314|NCT00093756|565449|P1|STARTED|Overall Study||21
236315|NCT00093496|565456|P2|NOT COMPLETED|Overall Study||3
236316|NCT00093496|565457|P1|NOT COMPLETED|Overall Study||1
236317|NCT00093496|565456|P2|COMPLETED|Overall Study||11
236318|NCT00093496|565457|P1|COMPLETED|Overall Study||14
236319|NCT00093496|565456|P2|STARTED|Overall Study||14
236320|NCT00093496|565457|P1|STARTED|Overall Study||15
236321|NCT00093470|565470|P2|NOT COMPLETED|Overall Study||0
236322|NCT00093470|565471|P1|NOT COMPLETED|Overall Study||73
236323|NCT00093470|565470|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
236324|NCT00093470|565471|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
236325|NCT00093470|565470|P2|Patients With Toxicity Assessment|Overall Study||69
236326|NCT00093470|565471|P1|Patients With Toxicity Assessment|Overall Study||72
236327|NCT00093470|565470|P2|Treated|Overall Study||71
236328|NCT00093470|565471|P1|Treated|Overall Study||72
236329|NCT00093470|565470|P2|STARTED|Overall Study||71
236330|NCT00093470|565471|P1|STARTED|Overall Study||73
236331|NCT00093379|565479|P1|NOT COMPLETED|Overall Study||0
236332|NCT00093379|565479|P1|COMPLETED|Overall Study||20
236333|NCT00093379|565479|P1|STARTED|Overall Study||20
236334|NCT00093145|565485|P1|NOT COMPLETED|Overall Study||17
236335|NCT00093145|565485|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
236336|NCT00093145|565485|P1|At Least One Response Assessment|Overall Study||31
236337|NCT00093145|565485|P1|STARTED|Overall Study||32
236338|NCT00093041|565500|P6|NOT COMPLETED|Overall Study||3
236339|NCT00093041|565501|P5|NOT COMPLETED|Overall Study||1
236340|NCT00093041|565502|P4|NOT COMPLETED|Overall Study||1
236341|NCT00093041|565503|P3|NOT COMPLETED|Overall Study||2
236342|NCT00093041|565504|P2|NOT COMPLETED|Overall Study||3
236343|NCT00093041|565505|P1|NOT COMPLETED|Overall Study||2
236344|NCT00093041|565500|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
236345|NCT00093041|565501|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
236346|NCT00093041|565502|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
236347|NCT00093041|565503|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
236348|NCT00093041|565504|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
236349|NCT00093041|565505|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
236350|NCT00093041|565500|P6|STARTED|Overall Study||7
236351|NCT00093041|565501|P5|STARTED|Overall Study||4
236352|NCT00093041|565502|P4|STARTED|Overall Study||4
236353|NCT00093041|565503|P3|STARTED|Overall Study||5
236354|NCT00093041|565504|P2|STARTED|Overall Study||4
236355|NCT00093041|565505|P1|STARTED|Overall Study||4
236356|NCT00093015|565527|P2|NOT COMPLETED|Overall Study||664
236357|NCT00093015|565528|P1|NOT COMPLETED|Overall Study||665
236358|NCT00093015|565527|P2|COMPLETED|Overall Study||1348
236359|NCT00093015|565528|P1|COMPLETED|Overall Study||1361
236360|NCT00093015|565527|P2|Received Study Medication|Overall Study||2004
236361|NCT00093015|565528|P1|Received Study Medication|Overall Study||2019
236362|NCT00093015|565527|P2|STARTED|Overall Study||2012
236363|NCT00093015|565528|P1|STARTED|Overall Study||2026
236364|NCT00092677|565556|P2|NOT COMPLETED|Overall Study||11
236365|NCT00092677|565557|P1|NOT COMPLETED|Overall Study||5
236366|NCT00092677|565556|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
236367|NCT00092677|565557|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
236368|NCT00092677|565556|P2|STARTED|Overall Study||929
236369|NCT00092677|565557|P1|STARTED|Overall Study||944
236370|NCT00092547|565601|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
236371|NCT00092547|565602|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
236372|NCT00092547|565603|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
236373|NCT00092547|565601|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
236374|NCT00092547|565602|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
236375|NCT00092547|565603|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
236376|NCT00092547|565601|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
236377|NCT00092547|565602|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
236378|NCT00092547|565603|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
236379|NCT00092547|565601|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
236380|NCT00092547|565602|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
236381|NCT00092547|565603|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
236382|NCT00092547|565601|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
236383|NCT00092547|565602|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
236384|NCT00092547|565603|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
236385|NCT00092547|565601|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
236386|NCT00092547|565602|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
236387|NCT00092547|565603|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
236388|NCT00092547|565601|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
236389|NCT00092547|565602|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
236390|NCT00092547|565603|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
236391|NCT00092547|565601|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
236392|NCT00092547|565602|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
236393|NCT00092547|565603|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
236394|NCT00092547|565601|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
236395|NCT00092547|565602|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
236396|NCT00092547|565603|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
236397|NCT00092547|565601|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
236398|NCT00092547|565602|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
236399|NCT00092547|565603|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
236400|NCT00092547|565601|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
236401|NCT00092547|565602|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
236402|NCT00092547|565603|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
236403|NCT00092547|565601|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
236404|NCT00092547|565602|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
236405|NCT00092547|565603|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
236406|NCT00092547|565601|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
236407|NCT00092547|565602|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
236408|NCT00092547|565603|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
236409|NCT00092547|565601|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
236410|NCT00092547|565602|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
236411|NCT00092547|565603|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
236412|NCT00092547|565601|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
236413|NCT00092547|565602|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
236414|NCT00092547|565603|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
236415|NCT00092547|565601|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
236416|NCT00092547|565602|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
236417|NCT00092547|565603|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
236418|NCT00092547|565601|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
236419|NCT00092547|565602|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
236420|NCT00092547|565603|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
236421|NCT00092547|565601|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
236422|NCT00092547|565602|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
236423|NCT00092547|565603|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
236424|NCT00092547|565601|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
236425|NCT00092547|565602|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
236426|NCT00092547|565603|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
236427|NCT00092547|565601|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
236428|NCT00092547|565602|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
236429|NCT00092547|565603|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
236430|NCT00092547|565601|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
236431|NCT00092547|565602|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
236432|NCT00092547|565603|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
236433|NCT00092547|565601|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
236434|NCT00092547|565602|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
236435|NCT00092547|565603|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
236436|NCT00092547|565601|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
236437|NCT00092547|565602|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
236438|NCT00092547|565603|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
236439|NCT00092547|565601|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
236440|NCT00092547|565602|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
236441|NCT00092547|565603|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
236442|NCT00092547|565601|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
236443|NCT00092547|565602|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
236444|NCT00092547|565603|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
236445|NCT00092547|565601|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
236446|NCT00092547|565602|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
236447|NCT00092547|565603|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
236448|NCT00092534|565647|P3|NOT COMPLETED|Extension Study||145
236449|NCT00092534|565648|P2|NOT COMPLETED|Extension Study||0
236450|NCT00092534|565649|P1|NOT COMPLETED|Extension Study||0
236451|NCT00092534|565647|P3|COMPLETED|Extension Study||449
236452|NCT00092534|565648|P2|COMPLETED|Extension Study||0
236453|NCT00092534|565649|P1|COMPLETED|Extension Study||0
236454|NCT00092534|565647|P3|STARTED|Extension Study||594
236455|NCT00092534|565648|P2|STARTED|Extension Study||0
236456|NCT00092534|565649|P1|STARTED|Extension Study||0
236457|NCT00092534|565647|P3|NOT COMPLETED|Base Study Follow Up Period||0
236458|NCT00092534|565648|P2|NOT COMPLETED|Base Study Follow Up Period||694
236459|NCT00092534|565649|P1|NOT COMPLETED|Base Study Follow Up Period||316
236460|NCT00092534|565647|P3|COMPLETED|Base Study Follow Up Period||0
236461|NCT00092534|565648|P2|COMPLETED|Base Study Follow Up Period||5277
236462|NCT00092534|565649|P1|COMPLETED|Base Study Follow Up Period||5626
236463|NCT00092534|565647|P3|STARTED|Base Study Follow Up Period||0
236542|NCT00092495|565687|P2|COMPLETED|Base Study Follow-up Period||122
236464|NCT00092534|565648|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
236465|NCT00092534|565649|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
236466|NCT00092534|565647|P3|NOT COMPLETED|Base Study Vaccination Period||0
236467|NCT00092534|565648|P2|NOT COMPLETED|Base Study Vaccination Period||126
236468|NCT00092534|565649|P1|NOT COMPLETED|Base Study Vaccination Period||171
236469|NCT00092534|565647|P3|COMPLETED|Base Study Vaccination Period||0
236470|NCT00092534|565648|P2|COMPLETED|Base Study Vaccination Period||5954
236471|NCT00092534|565649|P1|COMPLETED|Base Study Vaccination Period||5916
236472|NCT00092534|565647|P3|STARTED|Base Study Vaccination Period||0
236473|NCT00092534|565648|P2|STARTED|Base Study Vaccination Period||6080
236474|NCT00092534|565649|P1|STARTED|Base Study Vaccination Period||6087
236475|NCT00092521|565667|P4|NOT COMPLETED|Extension Study (Group 4)||209
236476|NCT00092521|565668|P3|NOT COMPLETED|Extension Study (Group 4)||0
236477|NCT00092521|565669|P2|NOT COMPLETED|Extension Study (Group 4)||0
236478|NCT00092521|565670|P1|NOT COMPLETED|Extension Study (Group 4)||0
236479|NCT00092521|565667|P4|COMPLETED|Extension Study (Group 4)||635
236480|NCT00092521|565668|P3|COMPLETED|Extension Study (Group 4)||0
236481|NCT00092521|565669|P2|COMPLETED|Extension Study (Group 4)||0
236482|NCT00092521|565670|P1|COMPLETED|Extension Study (Group 4)||0
236483|NCT00092521|565667|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
236484|NCT00092521|565668|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
236485|NCT00092521|565669|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
236486|NCT00092521|565670|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
236487|NCT00092521|565667|P4|Initiated Extension Study|Extension Study (Group 4)||829
236488|NCT00092521|565668|P3|Initiated Extension Study|Extension Study (Group 4)||0
236489|NCT00092521|565669|P2|Initiated Extension Study|Extension Study (Group 4)||0
236490|NCT00092521|565670|P1|Initiated Extension Study|Extension Study (Group 4)||0
236491|NCT00092521|565667|P4|STARTED|Extension Study (Group 4)||844
236492|NCT00092521|565668|P3|STARTED|Extension Study (Group 4)||0
236493|NCT00092521|565669|P2|STARTED|Extension Study (Group 4)||0
236494|NCT00092521|565670|P1|STARTED|Extension Study (Group 4)||0
236495|NCT00092521|565667|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
236496|NCT00092521|565668|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
236497|NCT00092521|565669|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
236498|NCT00092521|565670|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
236499|NCT00092521|565667|P4|COMPLETED|Follow-Up (After Month 7)||0
236500|NCT00092521|565668|P3|COMPLETED|Follow-Up (After Month 7)||1959
236501|NCT00092521|565669|P2|COMPLETED|Follow-Up (After Month 7)||155
236502|NCT00092521|565670|P1|COMPLETED|Follow-Up (After Month 7)||2353
236503|NCT00092521|565667|P4|STARTED|Follow-Up (After Month 7)||0
236504|NCT00092521|565668|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
236505|NCT00092521|565669|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
236506|NCT00092521|565670|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
236507|NCT00092521|565667|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
236508|NCT00092521|565668|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
236509|NCT00092521|565669|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
236510|NCT00092521|565670|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
236511|NCT00092521|565667|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
236512|NCT00092521|565668|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
236513|NCT00092521|565669|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
236514|NCT00092521|565670|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
236515|NCT00092521|565667|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
236516|NCT00092521|565668|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
236517|NCT00092521|565669|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
236518|NCT00092521|565670|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
236519|NCT00092495|565684|P5|NOT COMPLETED|Extension Study||0
236520|NCT00092495|565685|P4|NOT COMPLETED|Extension Study||0
236521|NCT00092495|565686|P3|NOT COMPLETED|Extension Study||0
236522|NCT00092495|565687|P2|NOT COMPLETED|Extension Study||0
236523|NCT00092495|565688|P1|NOT COMPLETED|Extension Study||0
236524|NCT00092495|565684|P5|COMPLETED|Extension Study||12
236525|NCT00092495|565685|P4|COMPLETED|Extension Study||0
236526|NCT00092495|565686|P3|COMPLETED|Extension Study||0
236527|NCT00092495|565687|P2|COMPLETED|Extension Study||0
236528|NCT00092495|565688|P1|COMPLETED|Extension Study||0
236529|NCT00092495|565684|P5|STARTED|Extension Study||12
236530|NCT00092495|565685|P4|STARTED|Extension Study||0
236531|NCT00092495|565686|P3|STARTED|Extension Study||0
236532|NCT00092495|565687|P2|STARTED|Extension Study||0
236533|NCT00092495|565688|P1|STARTED|Extension Study||0
236534|NCT00092495|565684|P5|NOT COMPLETED|Base Study Follow-up Period||0
236535|NCT00092495|565685|P4|NOT COMPLETED|Base Study Follow-up Period||14
236536|NCT00092495|565686|P3|NOT COMPLETED|Base Study Follow-up Period||4
236537|NCT00092495|565687|P2|NOT COMPLETED|Base Study Follow-up Period||3
236538|NCT00092495|565688|P1|NOT COMPLETED|Base Study Follow-up Period||3
236539|NCT00092495|565684|P5|COMPLETED|Base Study Follow-up Period||0
236540|NCT00092495|565685|P4|COMPLETED|Base Study Follow-up Period||446
236541|NCT00092495|565686|P3|COMPLETED|Base Study Follow-up Period||126
236543|NCT00092495|565688|P1|COMPLETED|Base Study Follow-up Period||112
236544|NCT00092495|565684|P5|STARTED|Base Study Follow-up Period||0
236545|NCT00092495|565685|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
236546|NCT00092495|565686|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
236547|NCT00092495|565687|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
236548|NCT00092495|565688|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
236549|NCT00092495|565684|P5|NOT COMPLETED|Base Study Vaccination Period||0
236550|NCT00092495|565685|P4|NOT COMPLETED|Base Study Vaccination Period||88
236551|NCT00092495|565686|P3|NOT COMPLETED|Base Study Vaccination Period||34
236552|NCT00092495|565687|P2|NOT COMPLETED|Base Study Vaccination Period||22
236553|NCT00092495|565688|P1|NOT COMPLETED|Base Study Vaccination Period||37
236554|NCT00092495|565684|P5|COMPLETED|Base Study Vaccination Period||0
236555|NCT00092495|565685|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
236556|NCT00092495|565686|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
236557|NCT00092495|565687|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
236558|NCT00092495|565688|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
236559|NCT00092495|565684|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
236560|NCT00092495|565685|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
236561|NCT00092495|565686|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
236562|NCT00092495|565687|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
236563|NCT00092495|565688|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
236564|NCT00092495|565684|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
236565|NCT00092495|565685|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
236566|NCT00092495|565686|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
236567|NCT00092495|565687|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
236568|NCT00092495|565688|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
236569|NCT00092495|565684|P5|STARTED|Base Study Vaccination Period||0
236570|NCT00092495|565685|P4|STARTED|Base Study Vaccination Period||1529
236571|NCT00092495|565686|P3|STARTED|Base Study Vaccination Period||508
236572|NCT00092495|565687|P2|STARTED|Base Study Vaccination Period||514
236573|NCT00092495|565688|P1|STARTED|Base Study Vaccination Period||504
236574|NCT00092456|565754|P4|NOT COMPLETED|Overall Study||16
236575|NCT00092456|565755|P3|NOT COMPLETED|Overall Study||29
236576|NCT00092456|565756|P2|NOT COMPLETED|Overall Study||17
236577|NCT00092456|565757|P1|NOT COMPLETED|Overall Study||25
236578|NCT00092456|565754|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
236579|NCT00092456|565755|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
236580|NCT00092456|565756|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
236581|NCT00092456|565757|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
236582|NCT00092456|565754|P4|Vaccinated at Visit 3|Overall Study||98
236583|NCT00092456|565755|P3|Vaccinated at Visit 3|Overall Study||200
236584|NCT00092456|565756|P2|Vaccinated at Visit 3|Overall Study||210
236585|NCT00092456|565757|P1|Vaccinated at Visit 3|Overall Study||202
236586|NCT00092456|565754|P4|Vaccinated at Visit 2|Overall Study||104
236587|NCT00092456|565755|P3|Vaccinated at Visit 2|Overall Study||210
236588|NCT00092456|565756|P2|Vaccinated at Visit 2|Overall Study||217
236589|NCT00092456|565757|P1|Vaccinated at Visit 2|Overall Study||208
236590|NCT00092456|565754|P4|Vaccinated at Visit 1|Overall Study||113
236591|NCT00092456|565755|P3|Vaccinated at Visit 1|Overall Study||229
236592|NCT00092456|565756|P2|Vaccinated at Visit 1|Overall Study||225
236593|NCT00092456|565757|P1|Vaccinated at Visit 1|Overall Study||226
236594|NCT00092456|565754|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
236595|NCT00092456|565755|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
236596|NCT00092456|565756|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
236597|NCT00092456|565757|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
236598|NCT00092443|565805|P2|NOT COMPLETED|Overall Study||54
236599|NCT00092443|565806|P1|NOT COMPLETED|Overall Study||58
236600|NCT00092443|565805|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
236601|NCT00092443|565806|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
236602|NCT00092443|565805|P2|Vaccinated at Visit 3|Overall Study||608
236603|NCT00092443|565806|P1|Vaccinated at Visit 3|Overall Study||593
236604|NCT00092443|565805|P2|Vaccinated at Visit 2|Overall Study||627
236605|NCT00092443|565806|P1|Vaccinated at Visit 2|Overall Study||618
236606|NCT00092443|565805|P2|Vaccinated at Visit 1|Overall Study||660
236607|NCT00092443|565806|P1|Vaccinated at Visit 1|Overall Study||650
236608|NCT00092443|565805|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
236609|NCT00092443|565806|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
236610|NCT00092417|565824|P2|NOT COMPLETED|Overall Study||1
236611|NCT00092417|565825|P1|NOT COMPLETED|Overall Study||5
236612|NCT00092417|565824|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
236613|NCT00092417|565825|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
236614|NCT00092417|565824|P2|Vaccinated|Overall Study||234
236615|NCT00092417|565825|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
236616|NCT00092417|565824|P2|STARTED|Overall Study|Started Period Group 2|234
236617|NCT00092417|565825|P1|STARTED|Overall Study|Started Period Group 1|464
236618|NCT00092131|565839|P2|NOT COMPLETED|Treatment Period II||1
236619|NCT00092131|565840|P1|NOT COMPLETED|Treatment Period II||0
236620|NCT00092131|565839|P2|COMPLETED|Treatment Period II||25
236621|NCT00092131|565840|P1|COMPLETED|Treatment Period II||24
236622|NCT00092131|565839|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
236623|NCT00092131|565840|P1|STARTED|Treatment Period II||24
236624|NCT00092131|565839|P2|NOT COMPLETED|Treatment Period I||0
236625|NCT00092131|565840|P1|NOT COMPLETED|Treatment Period I||1
236626|NCT00092131|565839|P2|COMPLETED|Treatment Period I||26
236627|NCT00092131|565840|P1|COMPLETED|Treatment Period I||24
236628|NCT00092131|565839|P2|STARTED|Treatment Period I||26
236629|NCT00092131|565840|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
236630|NCT00092118|565870|P2|NOT COMPLETED|Overall Study||89
236631|NCT00092118|565871|P1|NOT COMPLETED|Overall Study||84
236632|NCT00092118|565870|P2|COMPLETED|Overall Study||913
236633|NCT00092118|565871|P1|COMPLETED|Overall Study||906
236634|NCT00092118|565870|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
236635|NCT00092118|565871|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
236636|NCT00091962|565884|P3|NOT COMPLETED|Overall Study||0
236637|NCT00091962|565885|P2|NOT COMPLETED|Overall Study||0
236638|NCT00091962|565886|P1|NOT COMPLETED|Overall Study||0
236639|NCT00091962|565884|P3|COMPLETED|Overall Study||151
236640|NCT00091962|565885|P2|COMPLETED|Overall Study||152
236641|NCT00091962|565886|P1|COMPLETED|Overall Study||150
236642|NCT00091962|565884|P3|STARTED|Overall Study||151
236643|NCT00091962|565885|P2|STARTED|Overall Study||152
236644|NCT00091962|565886|P1|STARTED|Overall Study||150
236645|NCT00091949|565905|P2|NOT COMPLETED|Overall Study||151
236646|NCT00091949|565906|P1|NOT COMPLETED|Overall Study||175
236647|NCT00091949|565905|P2|COMPLETED|Overall Study||1786
236648|NCT00091949|565906|P1|COMPLETED|Overall Study||1764
236649|NCT00091949|565905|P2|STARTED|Overall Study||1937
236650|NCT00091949|565906|P1|STARTED|Overall Study||1939
236651|NCT00091832|565930|P6|NOT COMPLETED|Overall Study||11
236652|NCT00091832|565931|P5|NOT COMPLETED|Overall Study||15
236653|NCT00091832|565932|P4|NOT COMPLETED|Overall Study||14
236654|NCT00091832|565933|P3|NOT COMPLETED|Overall Study||12
236655|NCT00091832|565934|P2|NOT COMPLETED|Overall Study||11
236656|NCT00091832|565935|P1|NOT COMPLETED|Overall Study||14
236657|NCT00091832|565930|P6|COMPLETED|Overall Study||32
236658|NCT00091832|565931|P5|COMPLETED|Overall Study||27
236659|NCT00091832|565932|P4|COMPLETED|Overall Study||29
236660|NCT00091832|565933|P3|COMPLETED|Overall Study||30
236661|NCT00091832|565934|P2|COMPLETED|Overall Study||31
236662|NCT00091832|565935|P1|COMPLETED|Overall Study||29
236663|NCT00091832|565930|P6|Received Study Medication|Overall Study||43
236664|NCT00091832|565931|P5|Received Study Medication|Overall Study||42
236665|NCT00091832|565932|P4|Received Study Medication|Overall Study||43
236666|NCT00091832|565933|P3|Received Study Medication|Overall Study||41
236667|NCT00091832|565934|P2|Received Study Medication|Overall Study||42
236668|NCT00091832|565935|P1|Received Study Medication|Overall Study||43
236669|NCT00091832|565930|P6|STARTED|Overall Study||43
236670|NCT00091832|565931|P5|STARTED|Overall Study||42
236671|NCT00091832|565932|P4|STARTED|Overall Study||43
236672|NCT00091832|565933|P3|STARTED|Overall Study||42
236673|NCT00091832|565934|P2|STARTED|Overall Study||42
236674|NCT00091832|565935|P1|STARTED|Overall Study||43
236675|NCT00091819|566053|P2|NOT COMPLETED|Overall Study||46
236676|NCT00091819|566054|P1|NOT COMPLETED|Overall Study||42
236677|NCT00091819|566053|P2|COMPLETED|Overall Study||387
236678|NCT00091819|566054|P1|COMPLETED|Overall Study||387
236679|NCT00091819|566053|P2|STARTED|Overall Study||433
236680|NCT00091819|566054|P1|STARTED|Overall Study||429
236681|NCT00091793|566062|P2|NOT COMPLETED|Overall Study||22
236682|NCT00091793|566063|P1|NOT COMPLETED|Overall Study||24
236683|NCT00091793|566062|P2|COMPLETED|Overall Study||144
236684|NCT00091793|566063|P1|COMPLETED|Overall Study||142
236685|NCT00091793|566062|P2|STARTED|Overall Study||166
236686|NCT00091793|566063|P1|STARTED|Overall Study||166
236687|NCT00091572|566087|P2|NOT COMPLETED|Overall Study||82
236688|NCT00091572|566088|P1|NOT COMPLETED|Overall Study||95
236689|NCT00091572|566087|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
236690|NCT00091572|566088|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
236691|NCT00091572|566087|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
236692|NCT00091572|566088|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
236693|NCT00091507|566102|P2|NOT COMPLETED|Overall Study||19
236694|NCT00091507|566103|P1|NOT COMPLETED|Overall Study||21
236695|NCT00091507|566102|P2|COMPLETED|Overall Study||460
236696|NCT00091507|566103|P1|COMPLETED|Overall Study||411
236697|NCT00091507|566102|P2|STARTED|Overall Study||479
236698|NCT00091507|566103|P1|STARTED|Overall Study||432
236699|NCT00091442|566119|P2|NOT COMPLETED|Overall Study||373
236700|NCT00091442|566120|P1|NOT COMPLETED|Overall Study||369
236701|NCT00091442|566119|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
236702|NCT00091442|566120|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
236703|NCT00091442|566119|P2|STARTED|Overall Study||378
236704|NCT00091442|566120|P1|STARTED|Overall Study||373
236705|NCT00091390|566130|P1|NOT COMPLETED|Overall Study||4
236706|NCT00091390|566130|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
236707|NCT00091390|566130|P1|STARTED|Overall Study||129
236708|NCT00091273|566134|P1|NOT COMPLETED|Overall Study||0
236709|NCT00091273|566134|P1|COMPLETED|Overall Study||9
236710|NCT00091273|566134|P1|STARTED|Overall Study||9
236711|NCT00091169|566142|P2|NOT COMPLETED|Overall Study||53
236712|NCT00091169|566143|P1|NOT COMPLETED|Overall Study||57
236713|NCT00091169|566142|P2|COMPLETED|Overall Study||134
236714|NCT00091169|566143|P1|COMPLETED|Overall Study||132
236715|NCT00091169|566142|P2|Treated|Overall Study||170
236716|NCT00091169|566143|P1|Treated|Overall Study||163
236717|NCT00091169|566142|P2|STARTED|Overall Study||187
236718|NCT00091169|566143|P1|STARTED|Overall Study||189
236719|NCT00091026|566161|P2|NOT COMPLETED|Overall Study||3
236720|NCT00091026|566162|P1|NOT COMPLETED|Overall Study||1
236721|NCT00091026|566161|P2|COMPLETED|Overall Study||68
236722|NCT00091026|566162|P1|COMPLETED|Overall Study||71
236723|NCT00091026|566161|P2|STARTED|Overall Study||71
236724|NCT00091026|566162|P1|STARTED|Overall Study||72
236725|NCT00090987|566172|P1|NOT COMPLETED|Overall Study||21
236726|NCT00090987|566172|P1|COMPLETED|Overall Study||9
236727|NCT00090987|566172|P1|STARTED|Overall Study||30
236728|NCT00090844|566178|P2|NOT COMPLETED|Overall Study||1
236729|NCT00090844|566179|P1|NOT COMPLETED|Overall Study||1
236730|NCT00090844|566178|P2|COMPLETED|Overall Study||21
236731|NCT00090844|566179|P1|COMPLETED|Overall Study||26
236732|NCT00090844|566178|P2|STARTED|Overall Study||22
236733|NCT00090844|566179|P1|STARTED|Overall Study||27
236734|NCT00090779|566187|P2|NOT COMPLETED|Step 3||5
236735|NCT00090779|566188|P1|NOT COMPLETED|Step 3||7
236736|NCT00090779|566187|P2|COMPLETED|Step 3||0
236737|NCT00090779|566188|P1|COMPLETED|Step 3||0
236738|NCT00090779|566187|P2|STARTED|Step 3||5
236739|NCT00090779|566188|P1|STARTED|Step 3||7
236740|NCT00090779|566187|P2|NOT COMPLETED|Step 2||18
236741|NCT00090779|566188|P1|NOT COMPLETED|Step 2||6
236742|NCT00090779|566187|P2|COMPLETED|Step 2||1
236743|NCT00090779|566188|P1|COMPLETED|Step 2||0
236744|NCT00090779|566187|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
236745|NCT00090779|566188|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
236746|NCT00090779|566187|P2|NOT COMPLETED|Step 1||15
236747|NCT00090779|566188|P1|NOT COMPLETED|Step 1||11
236748|NCT00090779|566187|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
236749|NCT00090779|566188|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
236750|NCT00090779|566187|P2|STARTED|Step 1||64
236751|NCT00090779|566188|P1|STARTED|Step 1||66
236752|NCT00090766|566212|P3|NOT COMPLETED|Overall Study||3
236753|NCT00090766|566213|P2|NOT COMPLETED|Overall Study||2
236754|NCT00090766|566214|P1|NOT COMPLETED|Overall Study||3
236755|NCT00090766|566212|P3|COMPLETED|Overall Study||22
236756|NCT00090766|566213|P2|COMPLETED|Overall Study||19
236757|NCT00090766|566214|P1|COMPLETED|Overall Study||14
236758|NCT00090766|566212|P3|STARTED|Overall Study||25
236759|NCT00090766|566213|P2|STARTED|Overall Study||21
236760|NCT00090766|566214|P1|STARTED|Overall Study||17
236761|NCT00090753|566256|P2|NOT COMPLETED|Extended Treatment Period||191
236762|NCT00090753|566257|P1|NOT COMPLETED|Extended Treatment Period||359
236763|NCT00090753|566256|P2|COMPLETED|Extended Treatment Period||59
236764|NCT00090753|566257|P1|COMPLETED|Extended Treatment Period||94
236765|NCT00090753|566256|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
236766|NCT00090753|566257|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
236767|NCT00090753|566256|P2|NOT COMPLETED|First Treatment Period||178
236768|NCT00090753|566257|P1|NOT COMPLETED|First Treatment Period||256
236769|NCT00090753|566256|P2|COMPLETED|First Treatment Period||302
236770|NCT00090753|566257|P1|COMPLETED|First Treatment Period||492
236771|NCT00090753|566256|P2|STARTED|First Treatment Period||480
236772|NCT00090753|566257|P1|STARTED|First Treatment Period||748
236773|NCT00090610|566267|P2|NOT COMPLETED|Overall Study||1
236774|NCT00090610|566268|P1|NOT COMPLETED|Overall Study||1
236775|NCT00090610|566267|P2|COMPLETED|Overall Study||74
236776|NCT00090610|566268|P1|COMPLETED|Overall Study||74
236777|NCT00090610|566267|P2|STARTED|Overall Study||75
236778|NCT00090610|566268|P1|STARTED|Overall Study||75
236779|NCT00090584|566284|P2|NOT COMPLETED|Baseline to 8 Months||41
236780|NCT00090584|566285|P1|NOT COMPLETED|Baseline to 8 Months||44
236781|NCT00090584|566284|P2|COMPLETED|Baseline to 8 Months||112
236782|NCT00090584|566285|P1|COMPLETED|Baseline to 8 Months||110
236783|NCT00090584|566284|P2|STARTED|Baseline to 8 Months||153
236784|NCT00090584|566285|P1|STARTED|Baseline to 8 Months||154
236785|NCT00090584|566284|P2|NOT COMPLETED|Baseline to 10 Weeks||12
236786|NCT00090584|566285|P1|NOT COMPLETED|Baseline to 10 Weeks||15
236787|NCT00090584|566284|P2|COMPLETED|Baseline to 10 Weeks||141
236788|NCT00090584|566285|P1|COMPLETED|Baseline to 10 Weeks||139
236789|NCT00090584|566284|P2|STARTED|Baseline to 10 Weeks||153
236790|NCT00090584|566285|P1|STARTED|Baseline to 10 Weeks||154
236791|NCT00090545|566317|P2|NOT COMPLETED|Overall Study||24
236792|NCT00090545|566318|P1|NOT COMPLETED|Overall Study||22
236793|NCT00090545|566317|P2|COMPLETED|Overall Study||0
236794|NCT00090545|566318|P1|COMPLETED|Overall Study||0
236795|NCT00090545|566317|P2|STARTED|Overall Study||24
236796|NCT00090545|566318|P1|STARTED|Overall Study||22
236797|NCT00090519|566328|P2|NOT COMPLETED|Overall Study||75
236798|NCT00090519|566329|P1|NOT COMPLETED|Overall Study||73
236799|NCT00090519|566328|P2|COMPLETED|Overall Study||285
236800|NCT00090519|566329|P1|COMPLETED|Overall Study||298
236801|NCT00090519|566328|P2|STARTED|Overall Study||360
236802|NCT00090519|566329|P1|STARTED|Overall Study||371
236803|NCT00090493|566353|P1|NOT COMPLETED|Overall Study||2
236804|NCT00090493|566353|P1|COMPLETED|Overall Study||2
236805|NCT00090493|566353|P1|STARTED|Overall Study||4
236806|NCT00090402|566360|P3|NOT COMPLETED|Overall Study||1
236807|NCT00090402|566361|P2|NOT COMPLETED|Overall Study||2
236808|NCT00090402|566362|P1|NOT COMPLETED|Overall Study||2
236809|NCT00090402|566360|P3|COMPLETED|Overall Study||12
236810|NCT00090402|566361|P2|COMPLETED|Overall Study||11
236811|NCT00090402|566362|P1|COMPLETED|Overall Study||11
236812|NCT00090402|566360|P3|STARTED|Overall Study||13
236813|NCT00090402|566361|P2|STARTED|Overall Study||13
236814|NCT00090402|566362|P1|STARTED|Overall Study||13
236815|NCT00090363|566373|P3|NOT COMPLETED|Overall Study||96
236816|NCT00090363|566374|P2|NOT COMPLETED|Overall Study||107
236817|NCT00090363|566375|P1|NOT COMPLETED|Overall Study||106
236818|NCT00090363|566373|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
236819|NCT00090363|566374|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
236820|NCT00090363|566375|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
236821|NCT00090363|566373|P3|Received Study Treatment.|Overall Study||98
236822|NCT00090363|566374|P2|Received Study Treatment.|Overall Study||107
236823|NCT00090363|566375|P1|Received Study Treatment.|Overall Study||107
236824|NCT00090363|566373|P3|STARTED|Overall Study||98
236825|NCT00090363|566374|P2|STARTED|Overall Study||107
236826|NCT00090363|566375|P1|STARTED|Overall Study||107
236827|NCT00090285|566397|P4|NOT COMPLETED|Extension 1||1
236828|NCT00090285|566398|P3|NOT COMPLETED|Extension 1||57
236829|NCT00090285|566399|P2|NOT COMPLETED|Extension 1||0
236830|NCT00090285|566400|P1|NOT COMPLETED|Extension 1||0
236831|NCT00090285|566397|P4|COMPLETED|Extension 1||15
236832|NCT00090285|566398|P3|COMPLETED|Extension 1||1041
236833|NCT00090285|566399|P2|COMPLETED|Extension 1||0
236834|NCT00090285|566400|P1|COMPLETED|Extension 1||0
236835|NCT00090285|566397|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
236836|NCT00090285|566398|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
236837|NCT00090285|566399|P2|STARTED|Extension 1||0
236838|NCT00090285|566400|P1|STARTED|Extension 1||0
236839|NCT00090285|566397|P4|NOT COMPLETED|Base Study Follow-up Period||0
236840|NCT00090285|566398|P3|NOT COMPLETED|Base Study Follow-up Period||0
236841|NCT00090285|566399|P2|NOT COMPLETED|Base Study Follow-up Period||342
236842|NCT00090285|566400|P1|NOT COMPLETED|Base Study Follow-up Period||335
236843|NCT00090285|566397|P4|COMPLETED|Base Study Follow-up Period||0
236844|NCT00090285|566398|P3|COMPLETED|Base Study Follow-up Period||0
236845|NCT00090285|566399|P2|COMPLETED|Base Study Follow-up Period||1479
236846|NCT00090285|566400|P1|COMPLETED|Base Study Follow-up Period||1487
236847|NCT00090285|566397|P4|STARTED|Base Study Follow-up Period||0
236848|NCT00090285|566398|P3|STARTED|Base Study Follow-up Period||0
236849|NCT00090285|566399|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
236850|NCT00090285|566400|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
236851|NCT00090285|566397|P4|NOT COMPLETED|Base Study Vaccination Period||0
236852|NCT00090285|566398|P3|NOT COMPLETED|Base Study Vaccination Period||0
236853|NCT00090285|566399|P2|NOT COMPLETED|Base Study Vaccination Period||219
236854|NCT00090285|566400|P1|NOT COMPLETED|Base Study Vaccination Period||214
236855|NCT00090285|566397|P4|COMPLETED|Base Study Vaccination Period||0
236856|NCT00090285|566398|P3|COMPLETED|Base Study Vaccination Period||0
236857|NCT00090285|566399|P2|COMPLETED|Base Study Vaccination Period||1814
236858|NCT00090285|566400|P1|COMPLETED|Base Study Vaccination Period||1818
236859|NCT00090285|566397|P4|Vaccinated|Base Study Vaccination Period||0
236860|NCT00090285|566398|P3|Vaccinated|Base Study Vaccination Period||0
236861|NCT00090285|566399|P2|Vaccinated|Base Study Vaccination Period||2030
236862|NCT00090285|566400|P1|Vaccinated|Base Study Vaccination Period||2025
236863|NCT00090285|566397|P4|STARTED|Base Study Vaccination Period||0
236864|NCT00090285|566398|P3|STARTED|Base Study Vaccination Period||0
236865|NCT00090285|566399|P2|STARTED|Base Study Vaccination Period||2033
236866|NCT00090285|566400|P1|STARTED|Base Study Vaccination Period||2032
236867|NCT00090259|566419|P2|NOT COMPLETED|Overall Study||48
236868|NCT00090259|566420|P1|NOT COMPLETED|Overall Study||62
236869|NCT00090259|566419|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
236870|NCT00090259|566420|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
236871|NCT00090259|566419|P2|STARTED|Overall Study||1921
236872|NCT00090259|566420|P1|STARTED|Overall Study||1913
236873|NCT00090233|566436|P2|NOT COMPLETED|Overall Study||5065
236874|NCT00090233|566437|P1|NOT COMPLETED|Overall Study||4999
236875|NCT00090233|566436|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
236876|NCT00090233|566437|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
236877|NCT00090233|566436|P2|Vaccinated at Visit 3|Overall Study||29598
236878|NCT00090233|566437|P1|Vaccinated at Visit 3|Overall Study||29667
236879|NCT00090233|566436|P2|Vaccinated at Visit 2|Overall Study||31066
236880|NCT00090233|566437|P1|Vaccinated at Visit 2|Overall Study||31052
236881|NCT00090233|566436|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
236882|NCT00090233|566437|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
236883|NCT00090233|566436|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
236884|NCT00090233|566437|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
236885|NCT00090220|566461|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
236886|NCT00090220|566462|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
236887|NCT00090220|566463|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
236888|NCT00090220|566464|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
236889|NCT00090220|566465|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
236890|NCT00090220|566466|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
236891|NCT00090220|566461|P6|COMPLETED|Long-term Follow-up (EXT2)||623
236892|NCT00090220|566462|P5|COMPLETED|Long-term Follow-up (EXT2)||641
236893|NCT00090220|566463|P4|COMPLETED|Long-term Follow-up (EXT2)||0
236894|NCT00090220|566464|P3|COMPLETED|Long-term Follow-up (EXT2)||0
236895|NCT00090220|566465|P2|COMPLETED|Long-term Follow-up (EXT2)||0
236896|NCT00090220|566466|P1|COMPLETED|Long-term Follow-up (EXT2)||0
236897|NCT00090220|566461|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
236898|NCT00090220|566462|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
236899|NCT00090220|566463|P4|STARTED|Long-term Follow-up (EXT2)||0
236900|NCT00090220|566464|P3|STARTED|Long-term Follow-up (EXT2)||0
236901|NCT00090220|566465|P2|STARTED|Long-term Follow-up (EXT2)||0
236902|NCT00090220|566466|P1|STARTED|Long-term Follow-up (EXT2)||0
236903|NCT00090220|566461|P6|NOT COMPLETED|Extension 1 (EXT1)||0
236904|NCT00090220|566462|P5|NOT COMPLETED|Extension 1 (EXT1)||0
236905|NCT00090220|566463|P4|NOT COMPLETED|Extension 1 (EXT1)||2
236906|NCT00090220|566464|P3|NOT COMPLETED|Extension 1 (EXT1)||55
236907|NCT00090220|566465|P2|NOT COMPLETED|Extension 1 (EXT1)||0
236908|NCT00090220|566466|P1|NOT COMPLETED|Extension 1 (EXT1)||0
236909|NCT00090220|566461|P6|COMPLETED|Extension 1 (EXT1)||0
236910|NCT00090220|566462|P5|COMPLETED|Extension 1 (EXT1)||0
236911|NCT00090220|566463|P4|COMPLETED|Extension 1 (EXT1)||5
236912|NCT00090220|566464|P3|COMPLETED|Extension 1 (EXT1)||1267
236913|NCT00090220|566465|P2|COMPLETED|Extension 1 (EXT1)||0
236914|NCT00090220|566466|P1|COMPLETED|Extension 1 (EXT1)||0
236915|NCT00090220|566461|P6|Vaccinated|Extension 1 (EXT1)||0
236916|NCT00090220|566462|P5|Vaccinated|Extension 1 (EXT1)||0
236917|NCT00090220|566463|P4|Vaccinated|Extension 1 (EXT1)||7
236918|NCT00090220|566464|P3|Vaccinated|Extension 1 (EXT1)||1321
236919|NCT00090220|566465|P2|Vaccinated|Extension 1 (EXT1)||0
236920|NCT00090220|566466|P1|Vaccinated|Extension 1 (EXT1)||0
236921|NCT00090220|566461|P6|STARTED|Extension 1 (EXT1)||0
236922|NCT00090220|566462|P5|STARTED|Extension 1 (EXT1)||0
236923|NCT00090220|566463|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
236924|NCT00090220|566464|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
236925|NCT00090220|566465|P2|STARTED|Extension 1 (EXT1)||0
236926|NCT00090220|566466|P1|STARTED|Extension 1 (EXT1)||0
236927|NCT00090220|566461|P6|NOT COMPLETED|Base Study Follow-up Period||0
236928|NCT00090220|566462|P5|NOT COMPLETED|Base Study Follow-up Period||0
236929|NCT00090220|566463|P4|NOT COMPLETED|Base Study Follow-up Period||0
236930|NCT00090220|566464|P3|NOT COMPLETED|Base Study Follow-up Period||0
236931|NCT00090220|566465|P2|NOT COMPLETED|Base Study Follow-up Period||164
236932|NCT00090220|566466|P1|NOT COMPLETED|Base Study Follow-up Period||160
236933|NCT00090220|566461|P6|COMPLETED|Base Study Follow-up Period||0
236934|NCT00090220|566462|P5|COMPLETED|Base Study Follow-up Period||0
236935|NCT00090220|566463|P4|COMPLETED|Base Study Follow-up Period||0
236936|NCT00090220|566464|P3|COMPLETED|Base Study Follow-up Period||0
236937|NCT00090220|566465|P2|COMPLETED|Base Study Follow-up Period||1687
236938|NCT00090220|566466|P1|COMPLETED|Base Study Follow-up Period||1695
236939|NCT00090220|566461|P6|STARTED|Base Study Follow-up Period||0
236940|NCT00090220|566462|P5|STARTED|Base Study Follow-up Period||0
236941|NCT00090220|566463|P4|STARTED|Base Study Follow-up Period||0
236942|NCT00090220|566464|P3|STARTED|Base Study Follow-up Period||0
236943|NCT00090220|566465|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
236944|NCT00090220|566466|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
236945|NCT00090220|566461|P6|NOT COMPLETED|Base Study Vaccination Period||0
236946|NCT00090220|566462|P5|NOT COMPLETED|Base Study Vaccination Period||0
236947|NCT00090220|566463|P4|NOT COMPLETED|Base Study Vaccination Period||0
236948|NCT00090220|566464|P3|NOT COMPLETED|Base Study Vaccination Period||0
236949|NCT00090220|566465|P2|NOT COMPLETED|Base Study Vaccination Period||63
236950|NCT00090220|566466|P1|NOT COMPLETED|Base Study Vaccination Period||64
236951|NCT00090220|566461|P6|COMPLETED|Base Study Vaccination Period||0
236952|NCT00090220|566462|P5|COMPLETED|Base Study Vaccination Period||0
236953|NCT00090220|566463|P4|COMPLETED|Base Study Vaccination Period||0
236954|NCT00090220|566464|P3|COMPLETED|Base Study Vaccination Period||0
236955|NCT00090220|566465|P2|COMPLETED|Base Study Vaccination Period||1845
236956|NCT00090220|566466|P1|COMPLETED|Base Study Vaccination Period||1847
236957|NCT00090220|566461|P6|Vaccinated|Base Study Vaccination Period||0
236958|NCT00090220|566462|P5|Vaccinated|Base Study Vaccination Period||0
236959|NCT00090220|566463|P4|Vaccinated|Base Study Vaccination Period||0
236960|NCT00090220|566464|P3|Vaccinated|Base Study Vaccination Period||0
236961|NCT00090220|566465|P2|Vaccinated|Base Study Vaccination Period||1907
236962|NCT00090220|566466|P1|Vaccinated|Base Study Vaccination Period||1910
236963|NCT00090220|566461|P6|STARTED|Base Study Vaccination Period||0
236964|NCT00090220|566462|P5|STARTED|Base Study Vaccination Period||0
236965|NCT00090220|566463|P4|STARTED|Base Study Vaccination Period||0
236966|NCT00090220|566464|P3|STARTED|Base Study Vaccination Period||0
236967|NCT00090220|566465|P2|STARTED|Base Study Vaccination Period||1908
236968|NCT00090220|566466|P1|STARTED|Base Study Vaccination Period||1911
236969|NCT00090142|566558|P2|NOT COMPLETED|Treatment Period II||0
236970|NCT00090142|566559|P1|NOT COMPLETED|Treatment Period II||1
236971|NCT00090142|566558|P2|COMPLETED|Treatment Period II||28
236972|NCT00090142|566559|P1|COMPLETED|Treatment Period II||25
236973|NCT00090142|566558|P2|STARTED|Treatment Period II||28
236974|NCT00090142|566559|P1|STARTED|Treatment Period II||26
236975|NCT00090142|566558|P2|NOT COMPLETED|Treatment Period I||3
236976|NCT00090142|566559|P1|NOT COMPLETED|Treatment Period I||5
236977|NCT00090142|566558|P2|COMPLETED|Treatment Period I||28
236978|NCT00090142|566559|P1|COMPLETED|Treatment Period I||26
236979|NCT00090142|566558|P2|STARTED|Treatment Period I||31
236980|NCT00090142|566559|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
236981|NCT00090103|566590|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
236982|NCT00090103|566591|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
236983|NCT00090103|566592|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
236984|NCT00090103|566590|P3|COMPLETED|16-Week Safety Follow-up Period||1143
236985|NCT00090103|566591|P2|COMPLETED|16-Week Safety Follow-up Period||1205
236986|NCT00090103|566592|P1|COMPLETED|16-Week Safety Follow-up Period||1224
236987|NCT00090103|566590|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
236988|NCT00090103|566591|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
236989|NCT00090103|566592|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
236990|NCT00090103|566590|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
236991|NCT00090103|566591|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
236992|NCT00090103|566592|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
236993|NCT00090103|566590|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
236994|NCT00090103|566591|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
236995|NCT00090103|566592|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
236996|NCT00090103|566590|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
236997|NCT00090103|566591|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
236998|NCT00090103|566592|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
236999|NCT00090051|566692|P2|NOT COMPLETED|Overall Study||95
237000|NCT00090051|566693|P1|NOT COMPLETED|Overall Study||109
237001|NCT00090051|566692|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
237002|NCT00090051|566693|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
237003|NCT00090051|566692|P2|Safety Population; Received Study Drug|Overall Study||274
237004|NCT00090051|566693|P1|Safety Population; Received Study Drug|Overall Study||272
237005|NCT00090051|566692|P2|STARTED|Overall Study||276
237006|NCT00090051|566693|P1|STARTED|Overall Study||276
237007|NCT00089999|566729|P2|NOT COMPLETED|Overall Study||69
237008|NCT00089999|566730|P1|NOT COMPLETED|Overall Study||69
237009|NCT00089999|566729|P2|COMPLETED|Overall Study||0
237010|NCT00089999|566730|P1|COMPLETED|Overall Study||0
237011|NCT00089999|566729|P2|STARTED|Overall Study||69
237012|NCT00089999|566730|P1|STARTED|Overall Study||69
237013|NCT00089895|566752|P2|NOT COMPLETED|Overall Study||42
237014|NCT00089895|566753|P1|NOT COMPLETED|Overall Study||35
237015|NCT00089895|566752|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
237016|NCT00089895|566753|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
237017|NCT00089895|566752|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
237018|NCT00089895|566753|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
237019|NCT00089843|566765|P4|NOT COMPLETED|Overall Study||7
237020|NCT00089843|566766|P3|NOT COMPLETED|Overall Study||5
237021|NCT00089843|566767|P2|NOT COMPLETED|Overall Study||4
237022|NCT00089843|566768|P1|NOT COMPLETED|Overall Study||2
237023|NCT00089843|566765|P4|COMPLETED|Overall Study||11
237024|NCT00089843|566766|P3|COMPLETED|Overall Study||15
237025|NCT00089843|566767|P2|COMPLETED|Overall Study||16
237026|NCT00089843|566768|P1|COMPLETED|Overall Study||17
237027|NCT00089843|566765|P4|STARTED|Overall Study||18
237028|NCT00089843|566766|P3|STARTED|Overall Study||20
237029|NCT00089843|566767|P2|STARTED|Overall Study||20
237030|NCT00089843|566768|P1|STARTED|Overall Study||19
237031|NCT00089791|566780|P2|NOT COMPLETED|Overall Study||630
237032|NCT00089791|566781|P1|NOT COMPLETED|Overall Study||700
237033|NCT00089791|566780|P2|COMPLETED|Overall Study||3272
237034|NCT00089791|566781|P1|COMPLETED|Overall Study||3206
237035|NCT00089791|566780|P2|Safety Analysis Set|Overall Study||3886
237036|NCT00089791|566781|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
237037|NCT00089791|566780|P2|Received Study Medication|Overall Study||3879
237038|NCT00089791|566781|P1|Received Study Medication|Overall Study||3883
237039|NCT00089791|566780|P2|STARTED|Overall Study||3902
237040|NCT00089791|566781|P1|STARTED|Overall Study||3906
237041|NCT00089778|566794|P3|NOT COMPLETED|Overall Study||1
237042|NCT00089778|566795|P2|NOT COMPLETED|Overall Study||0
237043|NCT00089778|566796|P1|NOT COMPLETED|Overall Study||0
237044|NCT00089778|566794|P3|COMPLETED|Overall Study||7
237045|NCT00089778|566795|P2|COMPLETED|Overall Study||1
237046|NCT00089778|566796|P1|COMPLETED|Overall Study||2
237047|NCT00089778|566794|P3|STARTED|Overall Study||8
237048|NCT00089778|566795|P2|STARTED|Overall Study||1
237049|NCT00089778|566796|P1|STARTED|Overall Study||2
237050|NCT00089674|566809|P2|NOT COMPLETED|Overall Study||267
237051|NCT00089674|566810|P1|NOT COMPLETED|Overall Study||289
237052|NCT00089674|566809|P2|COMPLETED|Overall Study||467
237053|NCT00089674|566810|P1|COMPLETED|Overall Study||445
237054|NCT00089674|566809|P2|Received Study Drug|Overall Study||726
237055|NCT00089674|566810|P1|Received Study Drug|Overall Study||730
237056|NCT00089674|566809|P2|STARTED|Overall Study||734
237057|NCT00089674|566810|P1|STARTED|Overall Study||734
237058|NCT00089661|566836|P2|NOT COMPLETED|Overall Study||26
237059|NCT00089661|566837|P1|NOT COMPLETED|Overall Study||21
237060|NCT00089661|566836|P2|COMPLETED|Overall Study||99
237061|NCT00089661|566837|P1|COMPLETED|Overall Study||106
237062|NCT00089661|566836|P2|STARTED|Overall Study||125
237063|NCT00089661|566837|P1|STARTED|Overall Study||127
237064|NCT00089648|566853|P1|NOT COMPLETED|Overall Study||41
237065|NCT00089648|566853|P1|COMPLETED|Overall Study||20
237066|NCT00089648|566853|P1|STARTED|Overall Study||61
237067|NCT00089635|566869|P1|NOT COMPLETED|Overall Study||43
237068|NCT00089635|566869|P1|COMPLETED|Overall Study||160
237069|NCT00089635|566869|P1|STARTED|Overall Study||203
237070|NCT00089609|566883|P2|NOT COMPLETED|Overall Study||1
237071|NCT00089609|566884|P1|NOT COMPLETED|Overall Study||3
237072|NCT00089609|566883|P2|COMPLETED|Overall Study||12
237073|NCT00089609|566884|P1|COMPLETED|Overall Study||57
237074|NCT00089609|566883|P2|STARTED|Overall Study||13
237075|NCT00089609|566884|P1|STARTED|Overall Study||60
237076|NCT00089583|566903|P2|NOT COMPLETED|Overall Study||38
237077|NCT00089583|566904|P1|NOT COMPLETED|Overall Study||7
237078|NCT00089583|566903|P2|COMPLETED|Overall Study||51
237079|NCT00089583|566904|P1|COMPLETED|Overall Study||13
237080|NCT00089583|566903|P2|STARTED|Overall Study||89
237081|NCT00089583|566904|P1|STARTED|Overall Study||20
237082|NCT00089544|566998|P2|NOT COMPLETED|Overall Study||0
237083|NCT00089544|566999|P1|NOT COMPLETED|Overall Study||1
237084|NCT00089544|566998|P2|COMPLETED|Overall Study||7
237085|NCT00089544|566999|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
237086|NCT00089544|566998|P2|STARTED|Overall Study||7
237087|NCT00089544|566999|P1|STARTED|Overall Study||16
237088|NCT00089505|567013|P4|NOT COMPLETED|Overall Study||21
237089|NCT00089505|567014|P3|NOT COMPLETED|Overall Study||21
237090|NCT00089505|567015|P2|NOT COMPLETED|Overall Study||2
237091|NCT00089505|567016|P1|NOT COMPLETED|Overall Study||9
237092|NCT00089505|567013|P4|COMPLETED|Overall Study||230
237093|NCT00089505|567014|P3|COMPLETED|Overall Study||228
237094|NCT00089505|567015|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
237095|NCT00089505|567016|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
237096|NCT00089505|567013|P4|STARTED|Overall Study||251
237097|NCT00089505|567014|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
237098|NCT00089505|567015|P2|STARTED|Overall Study||120
237099|NCT00089505|567016|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
237100|NCT00089479|567060|P2|NOT COMPLETED|Overall Study||289
237101|NCT00089479|567061|P1|NOT COMPLETED|Overall Study||331
237102|NCT00089479|567060|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
237103|NCT00089479|567061|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
237104|NCT00089479|567060|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
237105|NCT00089479|567061|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
237106|NCT00089479|567060|P2|STARTED|Overall Study||1307
237107|NCT00089479|567061|P1|STARTED|Overall Study||1304
237108|NCT00089414|567088|P3|NOT COMPLETED|Overall Study||0
237109|NCT00089414|567089|P2|NOT COMPLETED|Overall Study||0
237110|NCT00089414|567090|P1|NOT COMPLETED|Overall Study||0
237111|NCT00089414|567088|P3|COMPLETED|Overall Study||2
237112|NCT00089414|567089|P2|COMPLETED|Overall Study||1
237113|NCT00089414|567090|P1|COMPLETED|Overall Study||2
237114|NCT00089414|567088|P3|STARTED|Overall Study||2
237115|NCT00089414|567089|P2|STARTED|Overall Study||1
237116|NCT00089414|567090|P1|STARTED|Overall Study||2
237117|NCT00089297|567104|P1|NOT COMPLETED|Overall Study||38
237118|NCT00089297|567104|P1|COMPLETED|Overall Study||36
237119|NCT00089297|567104|P1|Eligible|Overall Study||63
237120|NCT00089297|567104|P1|Treated|Overall Study||70
237121|NCT00089297|567104|P1|STARTED|Overall Study||74
237122|NCT00089141|567113|P2|NOT COMPLETED|Overall Study||24
237123|NCT00089141|567114|P1|NOT COMPLETED|Overall Study||18
237124|NCT00089141|567113|P2|COMPLETED|Overall Study||53
237125|NCT00089141|567114|P1|COMPLETED|Overall Study||56
237126|NCT00089141|567113|P2|STARTED|Overall Study||77
237127|NCT00089141|567114|P1|STARTED|Overall Study||74
237128|NCT00089076|567136|P1|NOT COMPLETED|Overall Study||10
237129|NCT00089076|567136|P1|COMPLETED|Overall Study||8
237130|NCT00089076|567136|P1|STARTED|Overall Study||18
237131|NCT00088972|567149|P2|NOT COMPLETED|Overall Study||4
237132|NCT00088972|567150|P1|NOT COMPLETED|Overall Study||2
237133|NCT00088972|567149|P2|COMPLETED|Overall Study||1
237134|NCT00088972|567150|P1|COMPLETED|Overall Study||1
237135|NCT00088972|567149|P2|STARTED|Overall Study||5
237136|NCT00088972|567150|P1|STARTED|Overall Study||3
237137|NCT00088907|567158|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
237138|NCT00088907|567159|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
237139|NCT00088907|567158|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
237140|NCT00088907|567159|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
237141|NCT00088907|567158|P2|Treated|Single Gefitinib Treatment (Step 2)||0
237142|NCT00088907|567159|P1|Treated|Single Gefitinib Treatment (Step 2)||19
237143|NCT00088907|567158|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
237144|NCT00088907|567159|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
237145|NCT00088907|567158|P2|NOT COMPLETED|Randomized Study (Step 1)||134
237146|NCT00088907|567159|P1|NOT COMPLETED|Randomized Study (Step 1)||136
237147|NCT00088907|567158|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
237148|NCT00088907|567159|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
237149|NCT00088907|567158|P2|Eligible and Treated|Randomized Study (Step 1)||122
237150|NCT00088907|567159|P1|Eligible and Treated|Randomized Study (Step 1)||117
237151|NCT00088907|567158|P2|Eligible|Randomized Study (Step 1)||122
237152|NCT00088907|567159|P1|Eligible|Randomized Study (Step 1)||117
237153|NCT00088907|567158|P2|Treated|Randomized Study (Step 1)||124
237154|NCT00088907|567159|P1|Treated|Randomized Study (Step 1)||129
237155|NCT00088907|567158|P2|STARTED|Randomized Study (Step 1)||134
237156|NCT00088907|567159|P1|STARTED|Randomized Study (Step 1)||136
237157|NCT00088881|567170|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
237158|NCT00088881|567170|P1|COMPLETED|Step 3 - Radiation Therapy||1
237159|NCT00088881|567170|P1|STARTED|Step 3 - Radiation Therapy||1
237160|NCT00088881|567170|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
237161|NCT00088881|567170|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
237162|NCT00088881|567170|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
237163|NCT00088881|567170|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
237164|NCT00088881|567170|P1|NOT COMPLETED|Step 1 - R-CHOP||14
237165|NCT00088881|567170|P1|COMPLETED|Step 1 - R-CHOP||48
237166|NCT00088881|567170|P1|Eligible and Treated|Step 1 - R-CHOP||53
237167|NCT00088881|567170|P1|STARTED|Step 1 - R-CHOP||62
237168|NCT00088634|567181|P2|NOT COMPLETED|Overall Study||43
237169|NCT00088634|567182|P1|NOT COMPLETED|Overall Study||38
237170|NCT00088634|567181|P2|COMPLETED|Overall Study||47
237171|NCT00088634|567182|P1|COMPLETED|Overall Study||52
237172|NCT00088634|567181|P2|STARTED|Overall Study||90
237173|NCT00088634|567182|P1|STARTED|Overall Study||90
237174|NCT00088621|567194|P1|NOT COMPLETED|Overall Study||54
237175|NCT00088621|567194|P1|COMPLETED|Overall Study||7
237176|NCT00088621|567194|P1|STARTED|Overall Study||61
237177|NCT00088595|567198|P1|NOT COMPLETED|Overall Study||28
237178|NCT00088595|567198|P1|COMPLETED|Overall Study||17
237179|NCT00088595|567198|P1|STARTED|Overall Study||45
237180|NCT00088465|567214|P1|NOT COMPLETED|Overall Study||561
237181|NCT00088465|567214|P1|COMPLETED|Overall Study||370
237182|NCT00088465|567214|P1|STARTED|Overall Study||931
237183|NCT00088374|567237|P1|NOT COMPLETED|Overall Study||2
237184|NCT00088374|567237|P1|COMPLETED|Overall Study||7
237185|NCT00088374|567237|P1|STARTED|Overall Study||9
237186|NCT00088218|567248|P2|NOT COMPLETED|Overall Study||0
237187|NCT00088218|567249|P1|NOT COMPLETED|Overall Study||0
237188|NCT00088218|567248|P2|COMPLETED|Overall Study||79
237189|NCT00088218|567249|P1|COMPLETED|Overall Study||16
237190|NCT00088218|567248|P2|STARTED|Overall Study||79
237191|NCT00088218|567249|P1|STARTED|Overall Study||16
237192|NCT00088166|567257|P2|NOT COMPLETED|Overall Study||61
237193|NCT00088166|567258|P1|NOT COMPLETED|Overall Study||53
237194|NCT00088166|567257|P2|COMPLETED|Overall Study||39
237195|NCT00088166|567258|P1|COMPLETED|Overall Study||47
237196|NCT00088166|567257|P2|STARTED|Overall Study||100
237197|NCT00088166|567258|P1|STARTED|Overall Study||100
237198|NCT00088153|567282|P2|NOT COMPLETED|Overall Study||25
237199|NCT00088153|567283|P1|NOT COMPLETED|Overall Study||24
237200|NCT00088153|567282|P2|COMPLETED|Overall Study||30
237201|NCT00088153|567283|P1|COMPLETED|Overall Study||31
237202|NCT00088153|567282|P2|STARTED|Overall Study||55
237203|NCT00088153|567283|P1|STARTED|Overall Study||55
237204|NCT00087698|567293|P1|NOT COMPLETED|Overall Study||36
237205|NCT00087698|567293|P1|COMPLETED|Overall Study||41
237206|NCT00087698|567293|P1|STARTED|Overall Study||77
237207|NCT00087685|567302|P1|NOT COMPLETED|Overall Study||14
237208|NCT00087685|567302|P1|COMPLETED|Overall Study||21
237209|NCT00087685|567302|P1|STARTED|Overall Study||35
237210|NCT00087672|567307|P1|NOT COMPLETED|Overall Study||0
237211|NCT00087672|567307|P1|COMPLETED|Overall Study||41
237212|NCT00087672|567307|P1|STARTED|Overall Study||41
237213|NCT00087646|567315|P4|NOT COMPLETED|Overall Study||84
237214|NCT00087646|567316|P3|NOT COMPLETED|Overall Study||65
237215|NCT00087646|567317|P2|NOT COMPLETED|Overall Study||42
237216|NCT00087646|567318|P1|NOT COMPLETED|Overall Study||135
237217|NCT00087646|567315|P4|COMPLETED|Overall Study||229
237218|NCT00087646|567316|P3|COMPLETED|Overall Study||91
237219|NCT00087646|567317|P2|COMPLETED|Overall Study||114
237220|NCT00087646|567318|P1|COMPLETED|Overall Study||182
237221|NCT00087646|567315|P4|STARTED|Overall Study||313
237222|NCT00087646|567316|P3|STARTED|Overall Study||156
237223|NCT00087646|567317|P2|STARTED|Overall Study||156
237224|NCT00087646|567318|P1|STARTED|Overall Study||317
237225|NCT00087633|567346|P2|NOT COMPLETED|Overall Study||17
237226|NCT00087633|567347|P1|NOT COMPLETED|Overall Study||24
237227|NCT00087633|567346|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
237228|NCT00087633|567347|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
237229|NCT00087633|567346|P2|STARTED|Overall Study|Randomized|60
237230|NCT00087633|567347|P1|STARTED|Overall Study|Randomized|55
237231|NCT00087607|567357|P2|NOT COMPLETED|Overall Study||122
237232|NCT00087607|567358|P1|NOT COMPLETED|Overall Study||122
237233|NCT00087607|567357|P2|COMPLETED|Overall Study||71
237234|NCT00087607|567358|P1|COMPLETED|Overall Study||70
237235|NCT00087607|567357|P2|STARTED|Overall Study||193
237236|NCT00087607|567358|P1|STARTED|Overall Study||192
237237|NCT00087594|567398|P2|NOT COMPLETED|Overall Study||12
237238|NCT00087594|567399|P1|NOT COMPLETED|Overall Study||8
237239|NCT00087594|567398|P2|COMPLETED|Overall Study||12
237240|NCT00087594|567399|P1|COMPLETED|Overall Study||16
237241|NCT00087594|567398|P2|STARTED|Overall Study||24
237242|NCT00087594|567399|P1|STARTED|Overall Study||24
237243|NCT00087568|567433|P2|NOT COMPLETED|Overall Study||2
237244|NCT00087568|567434|P1|NOT COMPLETED|Overall Study||30
237245|NCT00087568|567433|P2|COMPLETED|Overall Study||23
237246|NCT00087568|567434|P1|COMPLETED|Overall Study||2
237247|NCT00087568|567433|P2|STARTED|Overall Study||25
237248|NCT00087568|567434|P1|STARTED|Overall Study||32
237249|NCT00087555|567461|P3|NOT COMPLETED|Overall Study||21
237250|NCT00087555|567462|P2|NOT COMPLETED|Overall Study||11
237251|NCT00087555|567463|P1|NOT COMPLETED|Overall Study||12
237252|NCT00087555|567461|P3|COMPLETED|Overall Study||46
237253|NCT00087555|567462|P2|COMPLETED|Overall Study||51
237254|NCT00087555|567463|P1|COMPLETED|Overall Study||54
237255|NCT00087555|567461|P3|Treated|Overall Study||67
237256|NCT00087555|567462|P2|Treated|Overall Study||60
237257|NCT00087555|567463|P1|Treated|Overall Study||65
237258|NCT00087555|567461|P3|STARTED|Overall Study||67
237259|NCT00087555|567462|P2|STARTED|Overall Study||62
237260|NCT00087555|567463|P1|STARTED|Overall Study||66
237261|NCT00087529|567473|P2|NOT COMPLETED|Overall Study||68
237262|NCT00087529|567474|P1|NOT COMPLETED|Overall Study||31
237263|NCT00087529|567473|P2|COMPLETED|Overall Study||224
237264|NCT00087529|567474|P1|COMPLETED|Overall Study||116
237265|NCT00087529|567473|P2|STARTED|Overall Study||292
237266|NCT00087529|567474|P1|STARTED|Overall Study||147
237267|NCT00087516|567489|P4|NOT COMPLETED|Overall Study||85
237268|NCT00087516|567490|P3|NOT COMPLETED|Overall Study||97
237269|NCT00087516|567491|P2|NOT COMPLETED|Overall Study||169
237270|NCT00087516|567492|P1|NOT COMPLETED|Overall Study||161
237271|NCT00087516|567489|P4|COMPLETED|Overall Study||38
237272|NCT00087516|567490|P3|COMPLETED|Overall Study||33
237273|NCT00087516|567491|P2|COMPLETED|Overall Study||81
237274|NCT00087516|567492|P1|COMPLETED|Overall Study||77
237275|NCT00087516|567489|P4|STARTED|Overall Study||123
237276|NCT00087516|567490|P3|STARTED|Overall Study||130
237277|NCT00087516|567491|P2|STARTED|Overall Study||250
237278|NCT00087516|567492|P1|STARTED|Overall Study||238
237279|NCT00087490|567521|P2|NOT COMPLETED|Overall Study||269
237280|NCT00087490|567522|P1|NOT COMPLETED|Overall Study||258
237281|NCT00087490|567521|P2|COMPLETED|Overall Study||264
237282|NCT00087490|567522|P1|COMPLETED|Overall Study||286
237283|NCT00087490|567521|P2|Treated|Overall Study||515
237284|NCT00087490|567522|P1|Treated|Overall Study||537
237285|NCT00087490|567521|P2|STARTED|Overall Study||533
237286|NCT00087490|567522|P1|STARTED|Overall Study||544
237287|NCT00087438|567556|P1|NOT COMPLETED|Overall Study||4
237288|NCT00087438|567556|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
237289|NCT00087438|567556|P1|STARTED|Overall Study||59
237290|NCT00087152|567560|P1|NOT COMPLETED|Overall Study||6
237291|NCT00087152|567560|P1|COMPLETED|Overall Study||21
237292|NCT00087152|567560|P1|STARTED|Overall Study||27
237293|NCT00087139|567569|P3|NOT COMPLETED|Overall Study||36
237294|NCT00087139|567570|P2|NOT COMPLETED|Overall Study||49
237295|NCT00087139|567571|P1|NOT COMPLETED|Overall Study||39
237296|NCT00087139|567569|P3|COMPLETED|Overall Study||0
237297|NCT00087139|567570|P2|COMPLETED|Overall Study||0
237298|NCT00087139|567571|P1|COMPLETED|Overall Study||0
237299|NCT00087139|567569|P3|Patients w/ Measurable Disease Response|Overall Study||0
237300|NCT00087139|567570|P2|Patients w/ Measurable Disease Response|Overall Study||2
237301|NCT00087139|567571|P1|Patients w/ Measurable Disease Response|Overall Study||5
237302|NCT00087139|567569|P3|Patients With PSA Response|Overall Study||4
237303|NCT00087139|567570|P2|Patients With PSA Response|Overall Study||8
237304|NCT00087139|567571|P1|Patients With PSA Response|Overall Study||10
237305|NCT00087139|567569|P3|Patients With Measurable Disease|Overall Study||24
237306|NCT00087139|567570|P2|Patients With Measurable Disease|Overall Study||25
237307|NCT00087139|567571|P1|Patients With Measurable Disease|Overall Study||22
237308|NCT00087139|567569|P3|Patients for the Analysis of PSA Respons|Overall Study||22
237309|NCT00087139|567570|P2|Patients for the Analysis of PSA Respons|Overall Study||34
237310|NCT00087139|567571|P1|Patients for the Analysis of PSA Respons|Overall Study||30
237311|NCT00087139|567569|P3|Eligible and Treated|Overall Study||32
237312|NCT00087139|567570|P2|Eligible and Treated|Overall Study||42
237313|NCT00087139|567571|P1|Eligible and Treated|Overall Study||35
237314|NCT00087139|567569|P3|Treated|Overall Study||36
237315|NCT00087139|567570|P2|Treated|Overall Study||48
237316|NCT00087139|567571|P1|Treated|Overall Study||39
237317|NCT00087139|567569|P3|STARTED|Overall Study||36
237318|NCT00087139|567570|P2|STARTED|Overall Study||49
237319|NCT00087139|567571|P1|STARTED|Overall Study||39
237320|NCT00086996|567586|P1|NOT COMPLETED|Overall Study||64
237321|NCT00086996|567586|P1|COMPLETED|Overall Study||34
237322|NCT00086996|567586|P1|Eligible and Began Protocol Therapy|Overall Study||93
237323|NCT00086996|567586|P1|Eligible|Overall Study||93
237324|NCT00086996|567586|P1|STARTED|Overall Study||98
237325|NCT00086684|567596|P3|NOT COMPLETED|Overall Study||53
237326|NCT00086684|567597|P2|NOT COMPLETED|Overall Study||55
237327|NCT00086684|567598|P1|NOT COMPLETED|Overall Study||55
237328|NCT00086684|567596|P3|COMPLETED|Overall Study||69
237329|NCT00086684|567597|P2|COMPLETED|Overall Study||74
237330|NCT00086684|567598|P1|COMPLETED|Overall Study||63
237331|NCT00086684|567596|P3|STARTED|Overall Study||122
237332|NCT00086684|567597|P2|STARTED|Overall Study||129
237333|NCT00086684|567598|P1|STARTED|Overall Study||118
237334|NCT00086619|567611|P2|NOT COMPLETED|Overall Study||17
237335|NCT00086619|567612|P1|NOT COMPLETED|Overall Study||15
237336|NCT00086619|567611|P2|COMPLETED|Overall Study||23
237337|NCT00086619|567612|P1|COMPLETED|Overall Study||25
237338|NCT00086619|567611|P2|Completed 12 Month Visit|Overall Study||26
237339|NCT00086619|567612|P1|Completed 12 Month Visit|Overall Study||26
237340|NCT00086619|567611|P2|Completed Baseline Visit|Overall Study||36
237341|NCT00086619|567612|P1|Completed Baseline Visit|Overall Study||34
237342|NCT00086619|567611|P2|STARTED|Overall Study||40
237343|NCT00086619|567612|P1|STARTED|Overall Study||40
237344|NCT00086580|567622|P2|NOT COMPLETED|Observation Period||65
237345|NCT00086580|567623|P1|NOT COMPLETED|Observation Period||46
237346|NCT00086580|567622|P2|COMPLETED|Observation Period||56
237347|NCT00086580|567623|P1|COMPLETED|Observation Period||49
237348|NCT00086580|567622|P2|STARTED|Observation Period||121
237349|NCT00086580|567623|P1|STARTED|Observation Period||95
237350|NCT00086580|567622|P2|NOT COMPLETED|Follow-up Period||119
237351|NCT00086580|567623|P1|NOT COMPLETED|Follow-up Period||104
237352|NCT00086580|567622|P2|COMPLETED|Follow-up Period||18
237353|NCT00086580|567623|P1|COMPLETED|Follow-up Period||37
237354|NCT00086580|567622|P2|STARTED|Follow-up Period||137
237355|NCT00086580|567623|P1|STARTED|Follow-up Period||141
237356|NCT00086580|567622|P2|NOT COMPLETED|Treatment Period||60
237357|NCT00086580|567623|P1|NOT COMPLETED|Treatment Period||65
237358|NCT00086580|567622|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
237359|NCT00086580|567623|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
237360|NCT00086580|567622|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
237361|NCT00086580|567623|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
237362|NCT00086580|567622|P2|STARTED|Treatment Period||167
237363|NCT00086580|567623|P1|STARTED|Treatment Period||168
237364|NCT00086515|567669|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
237365|NCT00086515|567670|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
237366|NCT00086515|567669|P2|COMPLETED|Phase B (Weeks 24-104)||109
237367|NCT00086515|567670|P1|COMPLETED|Phase B (Weeks 24-104)||201
237368|NCT00086515|567669|P2|STARTED|Phase B (Weeks 24-104)||164
237369|NCT00086515|567670|P1|STARTED|Phase B (Weeks 24-104)||391
237370|NCT00086515|567669|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
237371|NCT00086515|567670|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
237372|NCT00086515|567669|P2|COMPLETED|Phase A to Phase B Transition Period||164
237373|NCT00086515|567670|P1|COMPLETED|Phase A to Phase B Transition Period||391
237374|NCT00086515|567669|P2|STARTED|Phase A to Phase B Transition Period||192
237375|NCT00086515|567670|P1|STARTED|Phase A to Phase B Transition Period||415
237376|NCT00086515|567669|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
237377|NCT00086515|567670|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
237378|NCT00086515|567669|P2|COMPLETED|Phase A (Weeks 0-24)||192
237379|NCT00086515|567670|P1|COMPLETED|Phase A (Weeks 0-24)||415
237380|NCT00086515|567669|P2|STARTED|Phase A (Weeks 0-24)||237
237381|NCT00086515|567670|P1|STARTED|Phase A (Weeks 0-24)||464
237382|NCT00086502|567682|P2|NOT COMPLETED|Overall Study||20
237383|NCT00086502|567683|P1|NOT COMPLETED|Overall Study||26
237384|NCT00086502|567682|P2|COMPLETED|Overall Study||158
237385|NCT00086502|567683|P1|COMPLETED|Overall Study||149
237386|NCT00086502|567682|P2|STARTED|Overall Study||178
237387|NCT00086502|567683|P1|STARTED|Overall Study||175
237388|NCT00086450|567693|P2|NOT COMPLETED|Overall Study||0
237389|NCT00086450|567694|P1|NOT COMPLETED|Overall Study||0
237390|NCT00086450|567693|P2|COMPLETED|Overall Study||947
237391|NCT00086450|567694|P1|COMPLETED|Overall Study||953
237392|NCT00086450|567693|P2|STARTED|Overall Study||947
237393|NCT00086450|567694|P1|STARTED|Overall Study||953
237394|NCT00086411|567710|P4|NOT COMPLETED|Overall Study||12
237395|NCT00086411|567711|P3|NOT COMPLETED|Overall Study||13
237396|NCT00086411|567712|P2|NOT COMPLETED|Overall Study||11
237397|NCT00086411|567713|P1|NOT COMPLETED|Overall Study||11
237398|NCT00086411|567710|P4|COMPLETED|Overall Study||53
237399|NCT00086411|567711|P3|COMPLETED|Overall Study||49
237400|NCT00086411|567712|P2|COMPLETED|Overall Study||52
237401|NCT00086411|567713|P1|COMPLETED|Overall Study||59
237402|NCT00086411|567710|P4|STARTED|Overall Study||65
237403|NCT00086411|567711|P3|STARTED|Overall Study||62
237404|NCT00086411|567712|P2|STARTED|Overall Study||63
237405|NCT00086411|567713|P1|STARTED|Overall Study||70
237406|NCT00086385|567727|P4|NOT COMPLETED|Overall Study||1
237407|NCT00086385|567728|P3|NOT COMPLETED|Overall Study||1
237408|NCT00086385|567729|P2|NOT COMPLETED|Overall Study||2
237409|NCT00086385|567730|P1|NOT COMPLETED|Overall Study||2
237410|NCT00086385|567727|P4|COMPLETED|Overall Study||98
237411|NCT00086385|567728|P3|COMPLETED|Overall Study||103
237412|NCT00086385|567729|P2|COMPLETED|Overall Study||97
237413|NCT00086385|567730|P1|COMPLETED|Overall Study||98
237414|NCT00086385|567727|P4|STARTED|Overall Study||99
237415|NCT00086385|567728|P3|STARTED|Overall Study||104
237416|NCT00086385|567729|P2|STARTED|Overall Study||99
237417|NCT00086385|567730|P1|STARTED|Overall Study||100
237418|NCT00086346|567742|P2|NOT COMPLETED|Patients Dosed With Test Article||23
237419|NCT00086346|567743|P1|NOT COMPLETED|Patients Dosed With Test Article||140
237420|NCT00086346|567742|P2|COMPLETED|Patients Dosed With Test Article||187
237421|NCT00086346|567743|P1|COMPLETED|Patients Dosed With Test Article||249
237422|NCT00086346|567742|P2|STARTED|Patients Dosed With Test Article||210
237423|NCT00086346|567743|P1|STARTED|Patients Dosed With Test Article||389
237424|NCT00086346|567742|P2|NOT COMPLETED|Randomization||4
237425|NCT00086346|567743|P1|NOT COMPLETED|Randomization||4
237426|NCT00086346|567742|P2|COMPLETED|Randomization||210
237427|NCT00086346|567743|P1|COMPLETED|Randomization||389
237428|NCT00086346|567742|P2|STARTED|Randomization||214
237429|NCT00086346|567743|P1|STARTED|Randomization||393
237430|NCT00086307|567758|P3|NOT COMPLETED|Overall Study||8
237431|NCT00086307|567759|P2|NOT COMPLETED|Overall Study||1
237432|NCT00086307|567760|P1|NOT COMPLETED|Overall Study||2
237433|NCT00086307|567758|P3|COMPLETED|Overall Study||5
237434|NCT00086307|567759|P2|COMPLETED|Overall Study||12
237435|NCT00086307|567760|P1|COMPLETED|Overall Study||11
237436|NCT00086307|567758|P3|STARTED|Overall Study||13
237437|NCT00086307|567759|P2|STARTED|Overall Study||13
237438|NCT00086307|567760|P1|STARTED|Overall Study||13
237439|NCT00086281|567783|P15|NOT COMPLETED|Phase 2||0
237440|NCT00086281|567784|P14|NOT COMPLETED|Phase 2||1
237441|NCT00086281|567785|P13|NOT COMPLETED|Phase 2||1
237442|NCT00086281|567786|P12|NOT COMPLETED|Phase 2||0
237443|NCT00086281|567787|P11|NOT COMPLETED|Phase 2||0
237444|NCT00086281|567788|P10|NOT COMPLETED|Phase 2||0
237445|NCT00086281|567789|P9|NOT COMPLETED|Phase 2||0
237446|NCT00086281|567790|P8|NOT COMPLETED|Phase 2||0
237447|NCT00086281|567791|P7|NOT COMPLETED|Phase 2||0
237448|NCT00086281|567792|P6|NOT COMPLETED|Phase 2||0
237449|NCT00086281|567793|P5|NOT COMPLETED|Phase 2||0
237450|NCT00086281|567794|P4|NOT COMPLETED|Phase 2||0
237451|NCT00086281|567795|P3|NOT COMPLETED|Phase 2||0
237452|NCT00086281|567796|P2|NOT COMPLETED|Phase 2||0
237453|NCT00086281|567797|P1|NOT COMPLETED|Phase 2||0
237454|NCT00086281|567783|P15|COMPLETED|Phase 2||0
237455|NCT00086281|567784|P14|COMPLETED|Phase 2||26
237456|NCT00086281|567785|P13|COMPLETED|Phase 2||22
237457|NCT00086281|567786|P12|COMPLETED|Phase 2||0
237458|NCT00086281|567787|P11|COMPLETED|Phase 2||0
237459|NCT00086281|567788|P10|COMPLETED|Phase 2||0
237460|NCT00086281|567789|P9|COMPLETED|Phase 2||0
237461|NCT00086281|567790|P8|COMPLETED|Phase 2||0
237462|NCT00086281|567791|P7|COMPLETED|Phase 2||0
237463|NCT00086281|567792|P6|COMPLETED|Phase 2||0
237464|NCT00086281|567793|P5|COMPLETED|Phase 2||0
237465|NCT00086281|567794|P4|COMPLETED|Phase 2||0
237466|NCT00086281|567795|P3|COMPLETED|Phase 2||0
237467|NCT00086281|567796|P2|COMPLETED|Phase 2||0
237468|NCT00086281|567797|P1|COMPLETED|Phase 2||0
237469|NCT00086281|567783|P15|STARTED|Phase 2||0
237470|NCT00086281|567784|P14|STARTED|Phase 2||27
237471|NCT00086281|567785|P13|STARTED|Phase 2||23
237472|NCT00086281|567786|P12|STARTED|Phase 2||0
237473|NCT00086281|567787|P11|STARTED|Phase 2||0
237474|NCT00086281|567788|P10|STARTED|Phase 2||0
237475|NCT00086281|567789|P9|STARTED|Phase 2||0
237476|NCT00086281|567790|P8|STARTED|Phase 2||0
237477|NCT00086281|567791|P7|STARTED|Phase 2||0
237478|NCT00086281|567792|P6|STARTED|Phase 2||0
237479|NCT00086281|567793|P5|STARTED|Phase 2||0
237480|NCT00086281|567794|P4|STARTED|Phase 2||0
237481|NCT00086281|567795|P3|STARTED|Phase 2||0
237482|NCT00086281|567796|P2|STARTED|Phase 2||0
237483|NCT00086281|567797|P1|STARTED|Phase 2||0
237484|NCT00086281|567783|P15|NOT COMPLETED|Phase 1||3
237485|NCT00086281|567784|P14|NOT COMPLETED|Phase 1||1
237486|NCT00086281|567785|P13|NOT COMPLETED|Phase 1||1
237487|NCT00086281|567786|P12|NOT COMPLETED|Phase 1||1
237488|NCT00086281|567787|P11|NOT COMPLETED|Phase 1||3
237489|NCT00086281|567788|P10|NOT COMPLETED|Phase 1||1
237490|NCT00086281|567789|P9|NOT COMPLETED|Phase 1||0
237491|NCT00086281|567790|P8|NOT COMPLETED|Phase 1||0
237492|NCT00086281|567791|P7|NOT COMPLETED|Phase 1||0
237493|NCT00086281|567792|P6|NOT COMPLETED|Phase 1||0
237494|NCT00086281|567793|P5|NOT COMPLETED|Phase 1||0
237495|NCT00086281|567794|P4|NOT COMPLETED|Phase 1||0
237496|NCT00086281|567795|P3|NOT COMPLETED|Phase 1||0
237497|NCT00086281|567796|P2|NOT COMPLETED|Phase 1||0
237498|NCT00086281|567797|P1|NOT COMPLETED|Phase 1||0
237499|NCT00086281|567783|P15|COMPLETED|Phase 1||0
237500|NCT00086281|567784|P14|COMPLETED|Phase 1||0
237501|NCT00086281|567785|P13|COMPLETED|Phase 1||0
237502|NCT00086281|567786|P12|COMPLETED|Phase 1||0
237503|NCT00086281|567787|P11|COMPLETED|Phase 1||0
237504|NCT00086281|567788|P10|COMPLETED|Phase 1||0
237505|NCT00086281|567789|P9|COMPLETED|Phase 1||2
237506|NCT00086281|567790|P8|COMPLETED|Phase 1||1
237507|NCT00086281|567791|P7|COMPLETED|Phase 1||1
237508|NCT00086281|567792|P6|COMPLETED|Phase 1||3
237509|NCT00086281|567793|P5|COMPLETED|Phase 1||1
237510|NCT00086281|567794|P4|COMPLETED|Phase 1||11
237511|NCT00086281|567795|P3|COMPLETED|Phase 1||8
237512|NCT00086281|567796|P2|COMPLETED|Phase 1||12
237513|NCT00086281|567797|P1|COMPLETED|Phase 1||11
237514|NCT00086281|567783|P15|STARTED|Phase 1||3
237515|NCT00086281|567784|P14|STARTED|Phase 1||1
237516|NCT00086281|567785|P13|STARTED|Phase 1||1
237517|NCT00086281|567786|P12|STARTED|Phase 1||1
237518|NCT00086281|567787|P11|STARTED|Phase 1||3
237519|NCT00086281|567788|P10|STARTED|Phase 1||1
237520|NCT00086281|567789|P9|STARTED|Phase 1||2
237521|NCT00086281|567790|P8|STARTED|Phase 1||1
237522|NCT00086281|567791|P7|STARTED|Phase 1||1
237523|NCT00086281|567792|P6|STARTED|Phase 1||3
237524|NCT00086281|567793|P5|STARTED|Phase 1||1
237525|NCT00086281|567794|P4|STARTED|Phase 1||11
237526|NCT00086281|567795|P3|STARTED|Phase 1||8
237527|NCT00086281|567796|P2|STARTED|Phase 1||12
237528|NCT00086281|567797|P1|STARTED|Phase 1||11
237529|NCT00086190|567810|P3|NOT COMPLETED|Overall Study||6
237530|NCT00086190|567811|P2|NOT COMPLETED|Overall Study||4
237531|NCT00086190|567812|P1|NOT COMPLETED|Overall Study||8
237532|NCT00086190|567810|P3|COMPLETED|Overall Study||33
237533|NCT00086190|567811|P2|COMPLETED|Overall Study||30
237534|NCT00086190|567812|P1|COMPLETED|Overall Study||34
237535|NCT00086190|567810|P3|STARTED|Overall Study||39
237536|NCT00086190|567811|P2|STARTED|Overall Study||34
237537|NCT00086190|567812|P1|STARTED|Overall Study||42
237538|NCT00086047|567870|P2|NOT COMPLETED|Overall Study||7
237539|NCT00086047|567871|P1|NOT COMPLETED|Overall Study||7
237540|NCT00086047|567870|P2|COMPLETED|Overall Study||50
237541|NCT00086047|567871|P1|COMPLETED|Overall Study||50
237542|NCT00086047|567870|P2|STARTED|Overall Study||57
237543|NCT00086047|567871|P1|STARTED|Overall Study||57
237544|NCT00085917|567879|P2|NOT COMPLETED|Overall Study||3
237545|NCT00085917|567880|P1|NOT COMPLETED|Overall Study||4
237546|NCT00085917|567879|P2|COMPLETED|Overall Study||11
237547|NCT00085917|567880|P1|COMPLETED|Overall Study||11
237548|NCT00085917|567879|P2|STARTED|Overall Study||14
237549|NCT00085917|567880|P1|STARTED|Overall Study||15
237550|NCT00085839|567892|P2|NOT COMPLETED|Overall Study||0
237551|NCT00085839|567893|P1|NOT COMPLETED|Overall Study||0
237552|NCT00085839|567892|P2|COMPLETED|Overall Study||51
237553|NCT00085839|567893|P1|COMPLETED|Overall Study||52
237554|NCT00085839|567892|P2|STARTED|Overall Study||51
237555|NCT00085839|567893|P1|STARTED|Overall Study||52
237556|NCT00085709|567905|P2|NOT COMPLETED|Overall Study||50
237557|NCT00085709|567906|P1|NOT COMPLETED|Overall Study||53
237558|NCT00085709|567905|P2|COMPLETED|Overall Study||270
237559|NCT00085709|567906|P1|COMPLETED|Overall Study||264
237560|NCT00085709|567905|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
237561|NCT00085709|567906|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
237562|NCT00085709|567905|P2|Eligible|Overall Study||301
237563|NCT00085709|567906|P1|Eligible|Overall Study||298
237564|NCT00085709|567905|P2|STARTED|Overall Study||320
237565|NCT00085709|567906|P1|STARTED|Overall Study||317
237566|NCT00085644|567922|P3|NOT COMPLETED|Open-Label Period||109
237567|NCT00085644|567923|P2|NOT COMPLETED|Open-Label Period||0
237568|NCT00085644|567924|P1|NOT COMPLETED|Open-Label Period||0
237569|NCT00085644|567922|P3|COMPLETED|Open-Label Period||202
237570|NCT00085644|567923|P2|COMPLETED|Open-Label Period||0
237571|NCT00085644|567924|P1|COMPLETED|Open-Label Period||0
237572|NCT00085644|567922|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
237573|NCT00085644|567923|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
237574|NCT00085644|567924|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
237575|NCT00085644|567922|P3|NOT COMPLETED|Double-Blind Period||0
237576|NCT00085644|567923|P2|NOT COMPLETED|Double-Blind Period||6
237577|NCT00085644|567924|P1|NOT COMPLETED|Double-Blind Period||13
237578|NCT00085644|567922|P3|COMPLETED|Double-Blind Period||0
237579|NCT00085644|567923|P2|COMPLETED|Double-Blind Period||101
237580|NCT00085644|567924|P1|COMPLETED|Double-Blind Period||195
237581|NCT00085644|567922|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
237582|NCT00085644|567923|P2|STARTED|Double-Blind Period||107
237583|NCT00085644|567924|P1|STARTED|Double-Blind Period||208
237584|NCT00085631|567965|P3|NOT COMPLETED|Overall Study||7
237585|NCT00085631|567966|P2|NOT COMPLETED|Overall Study||11
237586|NCT00085631|567967|P1|NOT COMPLETED|Overall Study||4
237587|NCT00085631|567965|P3|COMPLETED|Overall Study||32
237588|NCT00085631|567966|P2|COMPLETED|Overall Study||38
237589|NCT00085631|567967|P1|COMPLETED|Overall Study||9
237590|NCT00085631|567965|P3|STARTED|Overall Study||39
237591|NCT00085631|567966|P2|STARTED|Overall Study||49
237592|NCT00085631|567967|P1|STARTED|Overall Study||13
237593|NCT00085566|567977|P3|NOT COMPLETED|Overall Study||14
237594|NCT00085566|567978|P2|NOT COMPLETED|Overall Study||0
237595|NCT00085566|567979|P1|NOT COMPLETED|Overall Study||0
237596|NCT00085566|567977|P3|COMPLETED|Overall Study||43
237597|NCT00085566|567978|P2|COMPLETED|Overall Study||3
237598|NCT00085566|567979|P1|COMPLETED|Overall Study||3
237599|NCT00085566|567977|P3|STARTED|Overall Study||57
237600|NCT00085566|567978|P2|STARTED|Overall Study||3
237601|NCT00085566|567979|P1|STARTED|Overall Study||3
237602|NCT00085540|567989|P2|NOT COMPLETED|Overall Study||2
237603|NCT00085540|567990|P1|NOT COMPLETED|Overall Study||0
237604|NCT00085540|567989|P2|COMPLETED|Overall Study||40
237605|NCT00085540|567990|P1|COMPLETED|Overall Study||8
237606|NCT00085540|567989|P2|STARTED|Overall Study||42
237607|NCT00085540|567990|P1|STARTED|Overall Study||8
237608|NCT00085436|567997|P1|NOT COMPLETED|Overall Study||0
237609|NCT00085436|567997|P1|COMPLETED|Overall Study||18
237610|NCT00085436|567997|P1|STARTED|Overall Study||18
237611|NCT00085423|568001|P1|NOT COMPLETED|Overall Study||2
237612|NCT00085423|568001|P1|COMPLETED|Overall Study||18
237613|NCT00085423|568001|P1|STARTED|Overall Study||20
237614|NCT00085293|568007|P1|NOT COMPLETED|Overall Study||0
237615|NCT00085293|568007|P1|COMPLETED|Overall Study||12
237616|NCT00085293|568007|P1|STARTED|Overall Study||12
237617|NCT00085254|568015|P3|NOT COMPLETED|Overall Study||0
237618|NCT00085254|568016|P2|NOT COMPLETED|Overall Study||0
237619|NCT00085254|568017|P1|NOT COMPLETED|Overall Study||0
237620|NCT00085254|568015|P3|COMPLETED|Overall Study||48
237621|NCT00085254|568016|P2|COMPLETED|Overall Study||46
237622|NCT00085254|568017|P1|COMPLETED|Overall Study||18
237623|NCT00085254|568015|P3|STARTED|Overall Study||48
237624|NCT00085254|568016|P2|STARTED|Overall Study||46
237625|NCT00085254|568017|P1|STARTED|Overall Study||18
237626|NCT00085202|568033|P2|NOT COMPLETED|Overall Study||24
237627|NCT00085202|568034|P1|NOT COMPLETED|Overall Study||18
237628|NCT00085202|568033|P2|COMPLETED|Overall Study||120
237629|NCT00085202|568034|P1|COMPLETED|Overall Study||251
237630|NCT00085202|568033|P2|STARTED|Overall Study||144
237631|NCT00085202|568034|P1|STARTED|Overall Study||269
237632|NCT00085098|568047|P2|NOT COMPLETED|Overall Study||2
237633|NCT00085098|568048|P1|NOT COMPLETED|Overall Study||1
237634|NCT00085098|568047|P2|COMPLETED|Overall Study||11
237635|NCT00085098|568048|P1|COMPLETED|Overall Study||10
237636|NCT00085098|568047|P2|STARTED|Overall Study||13
237637|NCT00085098|568048|P1|STARTED|Overall Study||11
237638|NCT00084838|568054|P1|NOT COMPLETED|Overall Study||13
237639|NCT00084838|568054|P1|COMPLETED|Overall Study||12
237640|NCT00084838|568054|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
237641|NCT00084838|568054|P1|STARTED|Overall Study||25
237642|NCT00084747|568076|P1|NOT COMPLETED|Overall Study||13
237643|NCT00084747|568076|P1|COMPLETED|Overall Study||17
237644|NCT00084747|568076|P1|STARTED|Overall Study||30
237645|NCT00084682|568081|P1|NOT COMPLETED|Overall Study||1
237646|NCT00084682|568081|P1|COMPLETED|Overall Study||13
237647|NCT00084682|568081|P1|STARTED|Overall Study||14
237648|NCT00084617|568085|P1|NOT COMPLETED|Overall Study||9
237649|NCT00084617|568085|P1|COMPLETED|Overall Study||30
237650|NCT00084617|568085|P1|STARTED|Overall Study||39
237651|NCT00084487|568091|P1|NOT COMPLETED|Overall Study||1
237652|NCT00084487|568091|P1|COMPLETED|Overall Study||20
237653|NCT00084487|568091|P1|STARTED|Overall Study||21
237654|NCT00084409|568101|P2|NOT COMPLETED|Overall Study||12
237655|NCT00084409|568102|P1|NOT COMPLETED|Overall Study||15
237656|NCT00084409|568101|P2|COMPLETED|Overall Study|4 Current, 8 former|65
237657|NCT00084409|568102|P1|COMPLETED|Overall Study|9 current, 6 former|60
237658|NCT00084409|568101|P2|STARTED|Overall Study|41 current, 36 former|77
237659|NCT00084409|568102|P1|STARTED|Overall Study|40 Current, 35 former|75
237660|NCT00084383|568130|P1|NOT COMPLETED|Overall Study||47
237661|NCT00084383|568130|P1|COMPLETED|Overall Study||13
237662|NCT00084383|568130|P1|STARTED|Overall Study||60
237663|NCT00084318|568137|P2|NOT COMPLETED|Overall Study||13
237664|NCT00084318|568138|P1|NOT COMPLETED|Overall Study||22
237665|NCT00084318|568137|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
237666|NCT00084318|568138|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
237667|NCT00084318|568137|P2|STARTED|Overall Study||119
237668|NCT00084318|568138|P1|STARTED|Overall Study||119
237669|NCT00084266|568156|P2|NOT COMPLETED|Overall Study||423
237670|NCT00084266|568157|P1|NOT COMPLETED|Overall Study||441
237671|NCT00084266|568156|P2|COMPLETED|Overall Study||184
237672|NCT00084266|568157|P1|COMPLETED|Overall Study||177
237673|NCT00084266|568156|P2|Treated|Overall Study||587
237674|NCT00084266|568157|P1|Treated|Overall Study||597
237675|NCT00084266|568156|P2|STARTED|Overall Study||607
237676|NCT00084266|568157|P1|STARTED|Overall Study||618
237677|NCT00084136|568194|P3|NOT COMPLETED|NRTI Comparison||82
237678|NCT00084136|568195|P2|NOT COMPLETED|NRTI Comparison||0
237679|NCT00084136|568196|P1|NOT COMPLETED|NRTI Comparison||101
237680|NCT00084136|568194|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
237681|NCT00084136|568195|P2|COMPLETED|NRTI Comparison||0
237682|NCT00084136|568196|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
237683|NCT00084136|568194|P3|STARTED|NRTI Comparison||526
237684|NCT00084136|568195|P2|STARTED|NRTI Comparison||0
237685|NCT00084136|568196|P1|STARTED|NRTI Comparison||519
237686|NCT00084136|568194|P3|NOT COMPLETED|PI Comparison||0
237687|NCT00084136|568195|P2|NOT COMPLETED|PI Comparison||47
237688|NCT00084136|568196|P1|NOT COMPLETED|PI Comparison||55
237689|NCT00084136|568194|P3|COMPLETED|PI Comparison||0
237690|NCT00084136|568195|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
237691|NCT00084136|568196|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
237692|NCT00084136|568194|P3|STARTED|PI Comparison||0
237693|NCT00084136|568195|P2|STARTED|PI Comparison||526
237694|NCT00084136|568196|P1|STARTED|PI Comparison||519
237695|NCT00084084|568255|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
237696|NCT00084084|568255|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
237697|NCT00084084|568255|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
237698|NCT00084084|568255|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
237699|NCT00084084|568255|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
237700|NCT00084084|568255|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
237701|NCT00083915|568265|P2|NOT COMPLETED|Overall Study||37
237702|NCT00083915|568266|P1|NOT COMPLETED|Overall Study||50
237703|NCT00083915|568265|P2|COMPLETED|Overall Study||8
237704|NCT00083915|568266|P1|COMPLETED|Overall Study||2
237705|NCT00083915|568265|P2|STARTED|Overall Study||45
237706|NCT00083915|568266|P1|STARTED|Overall Study||52
237707|NCT00083889|568274|P2|NOT COMPLETED|Overall Study||375
237708|NCT00083889|568275|P1|NOT COMPLETED|Overall Study||375
237709|NCT00083889|568274|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
237710|NCT00083889|568275|P1|COMPLETED|Overall Study||0
237711|NCT00083889|568274|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
237712|NCT00083889|568275|P1|Received Treatment|Overall Study||375
237713|NCT00083889|568274|P2|STARTED|Overall Study||375
237714|NCT00083889|568275|P1|STARTED|Overall Study||375
237715|NCT00083759|568326|P2|NOT COMPLETED|Overall Study||83
237716|NCT00083759|568327|P1|NOT COMPLETED|Overall Study||84
237717|NCT00083759|568326|P2|COMPLETED|Overall Study||66
237718|NCT00083759|568327|P1|COMPLETED|Overall Study||66
237719|NCT00083759|568326|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
237720|NCT00083759|568327|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
237721|NCT00083720|568335|P1|NOT COMPLETED|Overall Study||0
237722|NCT00083720|568335|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
237723|NCT00083720|568335|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
237724|NCT00083616|568345|P1|NOT COMPLETED|Overall Study||31
237725|NCT00083616|568345|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
237726|NCT00083616|568345|P1|Received Study Medication|Overall Study||182
237727|NCT00083616|568345|P1|STARTED|Overall Study||185
237728|NCT00083551|568359|P2|NOT COMPLETED|Overall Study||0
237729|NCT00083551|568360|P1|NOT COMPLETED|Overall Study||0
237730|NCT00083551|568359|P2|COMPLETED|Overall Study||345
237731|NCT00083551|568360|P1|COMPLETED|Overall Study||323
237732|NCT00083551|568359|P2|STARTED|Overall Study||345
237733|NCT00083551|568360|P1|STARTED|Overall Study||323
237734|NCT00083382|568366|P1|NOT COMPLETED|Overall Study||0
237735|NCT00083382|568366|P1|COMPLETED|Overall Study||83
237736|NCT00083382|568366|P1|STARTED|Overall Study||83
237737|NCT00083226|568370|P1|NOT COMPLETED|Overall Study||42
237738|NCT00083226|568370|P1|COMPLETED|Overall Study||0
237739|NCT00083226|568370|P1|STARTED|Overall Study||42
237740|NCT00083174|568378|P2|NOT COMPLETED|Overall Study||0
237741|NCT00083174|568379|P1|NOT COMPLETED|Overall Study||0
237742|NCT00083174|568378|P2|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2275
237743|NCT00083174|568379|P1|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2285
237744|NCT00083174|568378|P2|STARTED|Overall Study||2275
237745|NCT00083174|568379|P1|STARTED|Overall Study||2285
237746|NCT00083122|568399|P2|NOT COMPLETED|Overall Study||0
237747|NCT00083122|568400|P1|NOT COMPLETED|Overall Study||0
237748|NCT00083122|568399|P2|COMPLETED|Overall Study||5
237749|NCT00083122|568400|P1|COMPLETED|Overall Study||40
237750|NCT00083122|568399|P2|STARTED|Overall Study||5
237751|NCT00083122|568400|P1|STARTED|Overall Study||40
237752|NCT00082888|568409|P1|NOT COMPLETED|Overall Study||22
237753|NCT00082888|568409|P1|COMPLETED|Overall Study||71
237754|NCT00082888|568409|P1|STARTED|Overall Study||93
237755|NCT00082810|568413|P1|NOT COMPLETED|Overall Study||31
237756|NCT00082810|568413|P1|COMPLETED|Overall Study||2
237757|NCT00082810|568413|P1|STARTED|Overall Study||33
237758|NCT00082758|568423|P3|NOT COMPLETED|Overall Study||0
237759|NCT00082758|568424|P2|NOT COMPLETED|Overall Study||17
237760|NCT00082758|568425|P1|NOT COMPLETED|Overall Study||15
237761|NCT00082758|568423|P3|COMPLETED|Overall Study||0
237762|NCT00082758|568424|P2|COMPLETED|Overall Study||7
237763|NCT00082758|568425|P1|COMPLETED|Overall Study||0
237764|NCT00082758|568423|P3|STARTED|Overall Study||0
237765|NCT00082758|568424|P2|STARTED|Overall Study||24
237766|NCT00082758|568425|P1|STARTED|Overall Study||15
237767|NCT00082433|568435|P2|NOT COMPLETED|Overall Study||597
237768|NCT00082433|568436|P1|NOT COMPLETED|Overall Study||594
237769|NCT00082433|568435|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
237770|NCT00082433|568436|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
237771|NCT00082433|568435|P2|STARTED|Overall Study||612
237772|NCT00082433|568436|P1|STARTED|Overall Study||609
237773|NCT00082407|568456|P2|NOT COMPLETED|Overall Study||27
237774|NCT00082407|568457|P1|NOT COMPLETED|Overall Study||56
237775|NCT00082407|568456|P2|COMPLETED|Overall Study||223
237776|NCT00082407|568457|P1|COMPLETED|Overall Study||199
237777|NCT00082407|568456|P2|Received Treatment (Intent to Treat)|Overall Study||248
237778|NCT00082407|568457|P1|Received Treatment (Intent to Treat)|Overall Study||253
237779|NCT00082407|568456|P2|STARTED|Overall Study||250
237780|NCT00082407|568457|P1|STARTED|Overall Study||255
237781|NCT00082381|568477|P2|NOT COMPLETED|Overall Study||26
237782|NCT00082381|568478|P1|NOT COMPLETED|Overall Study||55
237783|NCT00082381|568477|P2|COMPLETED|Overall Study||242
237784|NCT00082381|568478|P1|COMPLETED|Overall Study||228
237785|NCT00082381|568477|P2|Received Treatment (Intent to Treat)|Overall Study||267
237786|NCT00082381|568478|P1|Received Treatment (Intent to Treat)|Overall Study||282
237787|NCT00082381|568477|P2|STARTED|Overall Study||268
237788|NCT00082381|568478|P1|STARTED|Overall Study||283
237789|NCT00082368|568496|P1|NOT COMPLETED|Overall Study||1
237790|NCT00082368|568496|P1|COMPLETED|Overall Study||11
237791|NCT00082368|568496|P1|STARTED|Overall Study||12
237792|NCT00082355|568501|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
237793|NCT00082355|568501|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
237794|NCT00082355|568501|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
237795|NCT00082355|568501|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
237796|NCT00082355|568501|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
237797|NCT00082355|568501|P1|STARTED|Initial Results of Thrombolytic Therapy||30
237798|NCT00082342|568508|P2|NOT COMPLETED|Overall Study||0
237799|NCT00082342|568509|P1|NOT COMPLETED|Overall Study||0
237800|NCT00082342|568508|P2|COMPLETED|Overall Study||12
237801|NCT00082342|568509|P1|COMPLETED|Overall Study||13
237802|NCT00082342|568508|P2|STARTED|Overall Study||12
237803|NCT00082342|568509|P1|STARTED|Overall Study||13
237804|NCT00082329|568529|P1|NOT COMPLETED|Overall Study||0
237805|NCT00082329|568529|P1|COMPLETED|Overall Study||9
237806|NCT00082329|568529|P1|STARTED|Overall Study||9
237807|NCT00082173|568535|P2|NOT COMPLETED|Overall Study||11
237808|NCT00082173|568536|P1|NOT COMPLETED|Overall Study||10
237809|NCT00082173|568535|P2|COMPLETED|Overall Study||61
237810|NCT00082173|568536|P1|COMPLETED|Overall Study||64
237811|NCT00082173|568535|P2|STARTED|Overall Study||72
237812|NCT00082173|568536|P1|STARTED|Overall Study||74
237813|NCT00082017|568544|P2|NOT COMPLETED|Overall Study||0
237814|NCT00082017|568545|P1|NOT COMPLETED|Overall Study||0
237815|NCT00082017|568544|P2|COMPLETED|Overall Study||9
237816|NCT00082017|568545|P1|COMPLETED|Overall Study||11
237817|NCT00082017|568544|P2|STARTED|Overall Study||9
237818|NCT00082017|568545|P1|STARTED|Overall Study||11
237819|NCT00081939|568551|P1|NOT COMPLETED|Overall Study||0
237820|NCT00081939|568551|P1|COMPLETED|Overall Study||303
237821|NCT00081939|568551|P1|STARTED|Overall Study||303
237822|NCT00081861|568555|P1|NOT COMPLETED|Overall Study||0
237823|NCT00081861|568555|P1|COMPLETED|Overall Study||13
237824|NCT00081861|568555|P1|STARTED|Overall Study||13
237825|NCT00081770|568562|P3|NOT COMPLETED|Overall Study||456
237826|NCT00081770|568563|P2|NOT COMPLETED|Overall Study||546
237827|NCT00081770|568564|P1|NOT COMPLETED|Overall Study||502
237828|NCT00081770|568562|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
237829|NCT00081770|568563|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
237830|NCT00081770|568564|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
237831|NCT00081770|568562|P3|STARTED|Overall Study||1035
237832|NCT00081770|568563|P2|STARTED|Overall Study||1016
237833|NCT00081770|568564|P1|STARTED|Overall Study||1019
237834|NCT00081731|568583|P2|NOT COMPLETED|Overall Study||8
237835|NCT00081731|568584|P1|NOT COMPLETED|Overall Study||8
237836|NCT00081731|568583|P2|COMPLETED|Overall Study||459
237837|NCT00081731|568584|P1|COMPLETED|Overall Study||472
237838|NCT00081731|568583|P2|STARTED|Overall Study||467
237839|NCT00081731|568584|P1|STARTED|Overall Study||480
237840|NCT00081653|568604|P2|NOT COMPLETED|Overall Study||37
237841|NCT00081653|568605|P1|NOT COMPLETED|Overall Study||47
237842|NCT00081653|568604|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
237843|NCT00081653|568605|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
237844|NCT00081653|568604|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
237845|NCT00081653|568605|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
237846|NCT00081497|568623|P2|NOT COMPLETED|Overall Study||2
237847|NCT00081497|568624|P1|NOT COMPLETED|Overall Study||3
237848|NCT00081497|568623|P2|COMPLETED|Overall Study||37
237849|NCT00081497|568624|P1|COMPLETED|Overall Study||25
237850|NCT00081497|568623|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
237851|NCT00081497|568624|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
237852|NCT00081458|568642|P3|NOT COMPLETED|Overall Study||4
237853|NCT00081458|568643|P2|NOT COMPLETED|Overall Study||8
237854|NCT00081458|568644|P1|NOT COMPLETED|Overall Study||1
237855|NCT00081458|568642|P3|COMPLETED|Overall Study||29
237856|NCT00081458|568643|P2|COMPLETED|Overall Study||27
237857|NCT00081458|568644|P1|COMPLETED|Overall Study||15
237858|NCT00081458|568642|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
237859|NCT00081458|568643|P2|Received Treatment|Overall Study||35
237860|NCT00081458|568644|P1|Received Treatment|Overall Study||16
237861|NCT00081458|568642|P3|STARTED|Overall Study||33
237862|NCT00081458|568643|P2|STARTED|Overall Study||35
237863|NCT00081458|568644|P1|STARTED|Overall Study||16
237864|NCT00081328|568658|P3|NOT COMPLETED|Overall Study||0
237865|NCT00081328|568659|P2|NOT COMPLETED|Overall Study||0
237866|NCT00081328|568660|P1|NOT COMPLETED|Overall Study||0
237867|NCT00081328|568658|P3|COMPLETED|Overall Study||234
237868|NCT00081328|568659|P2|COMPLETED|Overall Study||233
237869|NCT00081328|568660|P1|COMPLETED|Overall Study||232
237870|NCT00081328|568658|P3|STARTED|Overall Study||234
237871|NCT00081328|568659|P2|STARTED|Overall Study||233
237872|NCT00081328|568660|P1|STARTED|Overall Study||232
237873|NCT00081289|568700|P2|NOT COMPLETED|Overall Study||21
237874|NCT00081289|568701|P1|NOT COMPLETED|Overall Study||21
237875|NCT00081289|568700|P2|COMPLETED|Overall Study||52
237876|NCT00081289|568701|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
237877|NCT00081289|568700|P2|STARTED|Overall Study||73
237878|NCT00081289|568701|P1|STARTED|Overall Study||73
237879|NCT00081159|568709|P2|NOT COMPLETED|Overall Study||5
237880|NCT00081159|568710|P1|NOT COMPLETED|Overall Study||2
237881|NCT00081159|568709|P2|COMPLETED|Overall Study||35
237882|NCT00081159|568710|P1|COMPLETED|Overall Study||37
237883|NCT00081159|568709|P2|STARTED|Overall Study||40
237884|NCT00081159|568710|P1|STARTED|Overall Study||39
237885|NCT00080938|568720|P1|NOT COMPLETED|Overall Study||24
237886|NCT00080938|568720|P1|COMPLETED|Overall Study||2
237887|NCT00080938|568720|P1|Eligible and Treated|Overall Study||21
237888|NCT00080938|568720|P1|Began Protocol Therapy|Overall Study||25
237889|NCT00080938|568720|P1|STARTED|Overall Study||26
237890|NCT00080912|568729|P2|NOT COMPLETED|Overall Study||0
237891|NCT00080912|568730|P1|NOT COMPLETED|Overall Study||0
237892|NCT00080912|568729|P2|COMPLETED|Overall Study||425
237893|NCT00080912|568730|P1|COMPLETED|Overall Study||425
237894|NCT00080912|568729|P2|STARTED|Overall Study||425
237895|NCT00080912|568730|P1|STARTED|Overall Study||425
237896|NCT00080899|568736|P1|NOT COMPLETED|Overall Study||1
237897|NCT00080899|568736|P1|COMPLETED|Overall Study||22
237898|NCT00080899|568736|P1|STARTED|Overall Study||23
237899|NCT00080535|568741|P1|NOT COMPLETED|Overall Study||0
237900|NCT00080535|568741|P1|COMPLETED|Overall Study||10
237901|NCT00080535|568741|P1|STARTED|Overall Study||10
237902|NCT00080483|568748|P2|NOT COMPLETED|Overall Study||2
237903|NCT00080483|568749|P1|NOT COMPLETED|Overall Study||2
237904|NCT00080483|568748|P2|COMPLETED|Overall Study||16
237905|NCT00080483|568749|P1|COMPLETED|Overall Study||15
237906|NCT00080483|568748|P2|STARTED|Overall Study||18
237907|NCT00080483|568749|P1|STARTED|Overall Study||17
237908|NCT00080470|568757|P2|NOT COMPLETED|Overall Study||28
237909|NCT00080470|568758|P1|NOT COMPLETED|Overall Study||34
237910|NCT00080470|568757|P2|COMPLETED|Overall Study||14
237911|NCT00080470|568758|P1|COMPLETED|Overall Study||11
237912|NCT00080470|568757|P2|STARTED|Overall Study||42
237913|NCT00080470|568758|P1|STARTED|Overall Study||45
237914|NCT00080301|568768|P2|NOT COMPLETED|Overall Study||11
237915|NCT00080301|568769|P1|NOT COMPLETED|Overall Study||5
237916|NCT00080301|568768|P2|COMPLETED|Overall Study|Participants who are off treatment|366
237917|NCT00080301|568769|P1|COMPLETED|Overall Study|Participants who are off treatment|370
237918|NCT00080301|568768|P2|Still on Treatment|Overall Study||1
237919|NCT00080301|568769|P1|Still on Treatment|Overall Study||0
237920|NCT00080301|568768|P2|Never Treated|Overall Study||10
237921|NCT00080301|568769|P1|Never Treated|Overall Study||5
237922|NCT00080301|568768|P2|STARTED|Overall Study||377
237923|NCT00080301|568769|P1|STARTED|Overall Study||375
237924|NCT00080288|568789|P2|NOT COMPLETED|Overall Study||38
237925|NCT00080288|568790|P1|NOT COMPLETED|Overall Study||30
237926|NCT00080288|568789|P2|COMPLETED|Overall Study||89
237927|NCT00080288|568790|P1|COMPLETED|Overall Study||97
237928|NCT00080288|568789|P2|STARTED|Overall Study||127
237929|NCT00080288|568790|P1|STARTED|Overall Study||127
237930|NCT00080223|568798|P1|NOT COMPLETED|Overall Study||76
237931|NCT00080223|568798|P1|COMPLETED|Overall Study||7
237932|NCT00080223|568798|P1|STARTED|Overall Study||83
237933|NCT00080119|568810|P4|NOT COMPLETED|Overall Study||163
237934|NCT00080119|568811|P3|NOT COMPLETED|Overall Study||165
237935|NCT00080119|568812|P2|NOT COMPLETED|Overall Study||62
237936|NCT00080119|568813|P1|NOT COMPLETED|Overall Study||56
237937|NCT00080119|568810|P4|COMPLETED|Overall Study||111
237938|NCT00080119|568811|P3|COMPLETED|Overall Study||108
237939|NCT00080119|568812|P2|COMPLETED|Overall Study||339
237940|NCT00080119|568813|P1|COMPLETED|Overall Study||347
237941|NCT00080119|568810|P4|STARTED|Overall Study||274
237942|NCT00080119|568811|P3|STARTED|Overall Study||273
237943|NCT00080119|568812|P2|STARTED|Overall Study||401
237944|NCT00080119|568813|P1|STARTED|Overall Study||403
237945|NCT00079937|568847|P2|NOT COMPLETED|Overall Study||32
237946|NCT00079937|568848|P1|NOT COMPLETED|Overall Study||69
237947|NCT00079937|568847|P2|COMPLETED|Overall Study||175
237948|NCT00079937|568848|P1|COMPLETED|Overall Study||352
237949|NCT00079937|568847|P2|STARTED|Overall Study||207
237950|NCT00079937|568848|P1|STARTED|Overall Study||421
237951|NCT00079781|568867|P3|NOT COMPLETED|Follow-up Period||2
237952|NCT00079781|568868|P2|NOT COMPLETED|Follow-up Period||0
237953|NCT00079781|568869|P1|NOT COMPLETED|Follow-up Period||4
237954|NCT00079781|568867|P3|COMPLETED|Follow-up Period||12
237955|NCT00079781|568868|P2|COMPLETED|Follow-up Period||9
237956|NCT00079781|568869|P1|COMPLETED|Follow-up Period||38
237957|NCT00079781|568867|P3|STARTED|Follow-up Period||14
237958|NCT00079781|568868|P2|STARTED|Follow-up Period||9
237959|NCT00079781|568869|P1|STARTED|Follow-up Period||42
237960|NCT00079781|568867|P3|NOT COMPLETED|Evaluation Period||0
237961|NCT00079781|568868|P2|NOT COMPLETED|Evaluation Period||0
237962|NCT00079781|568869|P1|NOT COMPLETED|Evaluation Period||0
237963|NCT00079781|568867|P3|COMPLETED|Evaluation Period||14
237964|NCT00079781|568868|P2|COMPLETED|Evaluation Period||9
237965|NCT00079781|568869|P1|COMPLETED|Evaluation Period||42
237966|NCT00079781|568867|P3|STARTED|Evaluation Period||14
237967|NCT00079781|568868|P2|STARTED|Evaluation Period||9
237968|NCT00079781|568869|P1|STARTED|Evaluation Period||42
237969|NCT00079781|568867|P3|NOT COMPLETED|Pre-implant Period||1
237970|NCT00079781|568868|P2|NOT COMPLETED|Pre-implant Period||1
237971|NCT00079781|568869|P1|NOT COMPLETED|Pre-implant Period||3
237972|NCT00079781|568867|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
237973|NCT00079781|568868|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
237974|NCT00079781|568869|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
237975|NCT00079781|568867|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
237976|NCT00079781|568868|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
237977|NCT00079781|568869|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
237978|NCT00079677|568878|P2|NOT COMPLETED|Overall Study||14
237979|NCT00079677|568879|P1|NOT COMPLETED|Overall Study||20
237980|NCT00079677|568878|P2|COMPLETED|Overall Study||118
237981|NCT00079677|568879|P1|COMPLETED|Overall Study||111
237982|NCT00079677|568878|P2|STARTED|Overall Study||132
237983|NCT00079677|568879|P1|STARTED|Overall Study||131
237984|NCT00079417|568887|P1|NOT COMPLETED|Overall Study||9
237985|NCT00079417|568887|P1|COMPLETED|Overall Study||19
237986|NCT00079417|568887|P1|STARTED|Overall Study||28
237987|NCT00079391|568891|P1|NOT COMPLETED|Overall Study||1
237988|NCT00079391|568891|P1|COMPLETED|Overall Study||49
237989|NCT00079391|568891|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
237990|NCT00079339|568903|P3|NOT COMPLETED|Overall Study||6
237991|NCT00079339|568904|P2|NOT COMPLETED|Overall Study||39
237992|NCT00079339|568905|P1|NOT COMPLETED|Overall Study||5
237993|NCT00079339|568903|P3|COMPLETED|Overall Study||0
237994|NCT00079339|568904|P2|COMPLETED|Overall Study||1
237995|NCT00079339|568905|P1|COMPLETED|Overall Study||0
237996|NCT00079339|568903|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
237997|NCT00079339|568904|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
237998|NCT00079339|568905|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
237999|NCT00079339|568903|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
238000|NCT00079339|568904|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
238001|NCT00079339|568905|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
238002|NCT00079339|568903|P3|Enrolled in Phase I|Overall Study||6
238003|NCT00079339|568904|P2|Enrolled in Phase I|Overall Study||6
238004|NCT00079339|568905|P1|Enrolled in Phase I|Overall Study||5
238005|NCT00079339|568903|P3|STARTED|Overall Study||6
238006|NCT00079339|568904|P2|STARTED|Overall Study||40
238007|NCT00079339|568905|P1|STARTED|Overall Study||5
238008|NCT00079326|568921|P2|NOT COMPLETED|Overall Study||0
238009|NCT00079326|568922|P1|NOT COMPLETED|Overall Study||0
238010|NCT00079326|568921|P2|COMPLETED|Overall Study||24
238011|NCT00079326|568922|P1|COMPLETED|Overall Study||15
238012|NCT00079326|568921|P2|STARTED|Overall Study||24
238013|NCT00079326|568922|P1|STARTED|Overall Study||15
238014|NCT00079274|568936|P7|NOT COMPLETED|Overall Study||0
238015|NCT00079274|568937|P6|NOT COMPLETED|Overall Study||20
238016|NCT00079274|568938|P5|NOT COMPLETED|Overall Study||15
238017|NCT00079274|568939|P4|NOT COMPLETED|Overall Study||444
238018|NCT00079274|568940|P3|NOT COMPLETED|Overall Study||27
238019|NCT00079274|568941|P2|NOT COMPLETED|Overall Study||27
238020|NCT00079274|568942|P1|NOT COMPLETED|Overall Study||321
238021|NCT00079274|568936|P7|COMPLETED|Overall Study||332
238022|NCT00079274|568937|P6|COMPLETED|Overall Study||26
238023|NCT00079274|568938|P5|COMPLETED|Overall Study||30
238024|NCT00079274|568939|P4|COMPLETED|Overall Study||906
238025|NCT00079274|568940|P3|COMPLETED|Overall Study||84
238026|NCT00079274|568941|P2|COMPLETED|Overall Study||84
238027|NCT00079274|568942|P1|COMPLETED|Overall Study||1081
238028|NCT00079274|568936|P7|STARTED|Overall Study||332
238029|NCT00079274|568937|P6|STARTED|Overall Study||46
238030|NCT00079274|568938|P5|STARTED|Overall Study||45
238031|NCT00079274|568939|P4|STARTED|Overall Study||1350
238032|NCT00079274|568940|P3|STARTED|Overall Study||111
238033|NCT00079274|568941|P2|STARTED|Overall Study||111
238034|NCT00079274|568942|P1|STARTED|Overall Study||1402
238035|NCT00079040|568955|P1|NOT COMPLETED|Overall Study||2
238036|NCT00079040|568955|P1|COMPLETED|Overall Study||63
238037|NCT00079040|568955|P1|STARTED|Overall Study||65
238038|NCT00079001|568963|P2|NOT COMPLETED|Overall Study||0
238039|NCT00079001|568964|P1|NOT COMPLETED|Overall Study||0
238040|NCT00079001|568963|P2|COMPLETED|Overall Study||322
238041|NCT00079001|568964|P1|COMPLETED|Overall Study||323
238042|NCT00079001|568963|P2|STARTED|Overall Study||322
238043|NCT00079001|568964|P1|STARTED|Overall Study||323
238044|NCT00078949|568978|P4|NOT COMPLETED|Maintenance||3
238045|NCT00078949|568979|P3|NOT COMPLETED|Maintenance||3
238046|NCT00078949|568980|P2|NOT COMPLETED|Maintenance||0
238047|NCT00078949|568981|P1|NOT COMPLETED|Maintenance||0
238048|NCT00078949|568978|P4|COMPLETED|Maintenance||112
238049|NCT00078949|568979|P3|COMPLETED|Maintenance||112
238050|NCT00078949|568980|P2|COMPLETED|Maintenance||0
238051|NCT00078949|568981|P1|COMPLETED|Maintenance||0
238052|NCT00078949|568978|P4|STARTED|Maintenance||115
238053|NCT00078949|568979|P3|STARTED|Maintenance||115
238054|NCT00078949|568980|P2|STARTED|Maintenance||0
238055|NCT00078949|568981|P1|STARTED|Maintenance||0
238056|NCT00078949|568978|P4|NOT COMPLETED|Salvage||0
238057|NCT00078949|568979|P3|NOT COMPLETED|Salvage||0
238058|NCT00078949|568980|P2|NOT COMPLETED|Salvage||5
238059|NCT00078949|568981|P1|NOT COMPLETED|Salvage||4
238060|NCT00078949|568978|P4|COMPLETED|Salvage||0
238061|NCT00078949|568979|P3|COMPLETED|Salvage||0
238062|NCT00078949|568980|P2|COMPLETED|Salvage||304
238063|NCT00078949|568981|P1|COMPLETED|Salvage||306
238064|NCT00078949|568978|P4|STARTED|Salvage||0
238065|NCT00078949|568979|P3|STARTED|Salvage||0
238066|NCT00078949|568980|P2|STARTED|Salvage||309
238067|NCT00078949|568981|P1|STARTED|Salvage||310
238068|NCT00078754|568996|P3|NOT COMPLETED|Overall Study||15
238069|NCT00078754|568997|P2|NOT COMPLETED|Overall Study||19
238070|NCT00078754|568998|P1|NOT COMPLETED|Overall Study||15
238071|NCT00078754|568996|P3|COMPLETED|Overall Study||16
238072|NCT00078754|568997|P2|COMPLETED|Overall Study||11
238073|NCT00078754|568998|P1|COMPLETED|Overall Study||14
238074|NCT00078754|568996|P3|STARTED|Overall Study||31
238075|NCT00078754|568997|P2|STARTED|Overall Study||30
238076|NCT00078754|568998|P1|STARTED|Overall Study||29
238077|NCT00078728|569008|P2|NOT COMPLETED|Overall Study||3
238078|NCT00078728|569009|P1|NOT COMPLETED|Overall Study||4
238079|NCT00078728|569008|P2|COMPLETED|Overall Study||17
238080|NCT00078728|569009|P1|COMPLETED|Overall Study||16
238081|NCT00078728|569008|P2|STARTED|Overall Study||20
238082|NCT00078728|569009|P1|STARTED|Overall Study||20
238083|NCT00078715|569015|P2|NOT COMPLETED|Second Intervention||0
238084|NCT00078715|569016|P1|NOT COMPLETED|Second Intervention||0
238085|NCT00078715|569015|P2|COMPLETED|Second Intervention||4
238086|NCT00078715|569016|P1|COMPLETED|Second Intervention||2
238087|NCT00078715|569015|P2|STARTED|Second Intervention||4
238088|NCT00078715|569016|P1|STARTED|Second Intervention||2
238089|NCT00078715|569015|P2|NOT COMPLETED|First Intervention||0
238090|NCT00078715|569016|P1|NOT COMPLETED|First Intervention||0
238091|NCT00078715|569015|P2|COMPLETED|First Intervention||4
238092|NCT00078715|569016|P1|COMPLETED|First Intervention||2
238093|NCT00078715|569015|P2|STARTED|First Intervention||4
238094|NCT00078715|569016|P1|STARTED|First Intervention||2
238095|NCT00078559|569022|P1|NOT COMPLETED|Overall Study||0
238096|NCT00078559|569022|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
238097|NCT00078559|569022|P1|STARTED|Overall Study||10
238098|NCT00078403|569051|P3|NOT COMPLETED|Overall Study||28
238099|NCT00078403|569052|P2|NOT COMPLETED|Overall Study||16
238100|NCT00078403|569053|P1|NOT COMPLETED|Overall Study||18
238101|NCT00078403|569051|P3|COMPLETED|Overall Study||141
238102|NCT00078403|569052|P2|COMPLETED|Overall Study||26
238103|NCT00078403|569053|P1|COMPLETED|Overall Study||26
238104|NCT00078403|569051|P3|STARTED|Overall Study||169
238105|NCT00078403|569052|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
238106|NCT00078403|569053|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
238107|NCT00078377|569113|P3|NOT COMPLETED|Overall Study||9
238108|NCT00078377|569114|P2|NOT COMPLETED|Overall Study||16
238109|NCT00078377|569115|P1|NOT COMPLETED|Overall Study||11
238110|NCT00078377|569113|P3|COMPLETED|Overall Study||55
238111|NCT00078377|569114|P2|COMPLETED|Overall Study||49
238112|NCT00078377|569115|P1|COMPLETED|Overall Study||56
238113|NCT00078377|569113|P3|STARTED|Overall Study||64
238114|NCT00078377|569114|P2|STARTED|Overall Study||65
238115|NCT00078377|569115|P1|STARTED|Overall Study||67
238116|NCT00078325|569131|P3|NOT COMPLETED|Overall Study||11
238117|NCT00078325|569132|P2|NOT COMPLETED|Overall Study||19
238118|NCT00078325|569133|P1|NOT COMPLETED|Overall Study||21
238119|NCT00078325|569131|P3|COMPLETED|Overall Study||120
238120|NCT00078325|569132|P2|COMPLETED|Overall Study||114
238121|NCT00078325|569133|P1|COMPLETED|Overall Study||110
238122|NCT00078325|569131|P3|STARTED|Overall Study||131
238123|NCT00078325|569132|P2|STARTED|Overall Study||133
238124|NCT00078325|569133|P1|STARTED|Overall Study||131
238125|NCT00078312|569144|P1|NOT COMPLETED|Overall Study||177
238126|NCT00078312|569144|P1|COMPLETED|Overall Study||151
238127|NCT00078312|569144|P1|STARTED|Overall Study||328
238128|NCT00078286|569150|P2|NOT COMPLETED|Overall Study||83
238129|NCT00078286|569151|P1|NOT COMPLETED|Overall Study||96
238130|NCT00078286|569150|P2|COMPLETED|Overall Study||152
238131|NCT00078286|569151|P1|COMPLETED|Overall Study||138
238132|NCT00078286|569150|P2|STARTED|Overall Study||235
238133|NCT00078286|569151|P1|STARTED|Overall Study||234
238134|NCT00077974|569159|P1|NOT COMPLETED|Overall Study||104
238135|NCT00077974|569159|P1|COMPLETED|Overall Study||2
238136|NCT00077974|569159|P1|STARTED|Overall Study||106
238137|NCT00077922|569174|P1|NOT COMPLETED|Overall Study||0
238138|NCT00077922|569174|P1|COMPLETED|Overall Study||15
238139|NCT00077922|569174|P1|STARTED|Overall Study||15
238140|NCT00077857|569181|P2|NOT COMPLETED|Overall Study||204
238141|NCT00077857|569182|P1|NOT COMPLETED|Overall Study||201
238142|NCT00077857|569181|P2|COMPLETED|Overall Study||31
238143|NCT00077857|569182|P1|COMPLETED|Overall Study||34
238144|NCT00077857|569181|P2|Safety Population: Actual Dose Received|Overall Study||248
238145|NCT00077857|569182|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
238146|NCT00077857|569181|P2|Received Study Drug|Overall Study||234
238147|NCT00077857|569182|P1|Received Study Drug|Overall Study||231
238148|NCT00077857|569181|P2|STARTED|Overall Study||235
238149|NCT00077857|569182|P1|STARTED|Overall Study||235
238150|NCT00077766|569202|P2|NOT COMPLETED|Overall Study||25
238151|NCT00077766|569203|P1|NOT COMPLETED|Overall Study||39
238152|NCT00077766|569202|P2|COMPLETED|Overall Study||131
238153|NCT00077766|569203|P1|COMPLETED|Overall Study||118
238154|NCT00077766|569202|P2|STARTED|Overall Study||156
238155|NCT00077766|569203|P1|STARTED|Overall Study||157
238156|NCT00077675|569223|P2|NOT COMPLETED|Overall Study||9
238157|NCT00077675|569224|P1|NOT COMPLETED|Overall Study||11
238158|NCT00077675|569223|P2|COMPLETED|Overall Study||89
238159|NCT00077675|569224|P1|COMPLETED|Overall Study||92
238160|NCT00077675|569223|P2|STARTED|Overall Study||98
238161|NCT00077675|569224|P1|STARTED|Overall Study||103
238162|NCT00077649|569234|P4|NOT COMPLETED|Overall Study||17
238163|NCT00077649|569235|P3|NOT COMPLETED|Overall Study||15
238164|NCT00077649|569236|P2|NOT COMPLETED|Overall Study||9
238165|NCT00077649|569237|P1|NOT COMPLETED|Overall Study||14
238166|NCT00077649|569234|P4|COMPLETED|Overall Study||30
238167|NCT00077649|569235|P3|COMPLETED|Overall Study||32
238168|NCT00077649|569236|P2|COMPLETED|Overall Study||38
238169|NCT00077649|569237|P1|COMPLETED|Overall Study||33
238170|NCT00077649|569234|P4|Completed 24 Weeks of Follow-up|Overall Study||31
238171|NCT00077649|569235|P3|Completed 24 Weeks of Follow-up|Overall Study||36
238172|NCT00077649|569236|P2|Completed 24 Weeks of Follow-up|Overall Study||40
238173|NCT00077649|569237|P1|Completed 24 Weeks of Follow-up|Overall Study||36
238174|NCT00077649|569234|P4|STARTED|Overall Study||47
238175|NCT00077649|569235|P3|STARTED|Overall Study||47
238176|NCT00077649|569236|P2|STARTED|Overall Study||47
238177|NCT00077649|569237|P1|STARTED|Overall Study||47
238178|NCT00077636|569285|P2|NOT COMPLETED|Overall Study||92
238179|NCT00077636|569286|P1|NOT COMPLETED|Overall Study||44
238180|NCT00077636|569285|P2|COMPLETED|Overall Study||641
238181|NCT00077636|569286|P1|COMPLETED|Overall Study||692
238182|NCT00077636|569285|P2|STARTED|Overall Study||733
238183|NCT00077636|569286|P1|STARTED|Overall Study||736
238184|NCT00077623|569307|P3|NOT COMPLETED|Overall Study||32
238185|NCT00077623|569308|P2|NOT COMPLETED|Overall Study||43
238186|NCT00077623|569309|P1|NOT COMPLETED|Overall Study||36
238187|NCT00077623|569307|P3|COMPLETED|Overall Study||159
238188|NCT00077623|569308|P2|COMPLETED|Overall Study||148
238189|NCT00077623|569309|P1|COMPLETED|Overall Study||154
238190|NCT00077623|569307|P3|STARTED|Overall Study||191
238191|NCT00077623|569308|P2|STARTED|Overall Study||191
238192|NCT00077623|569309|P1|STARTED|Overall Study||190
238193|NCT00077610|569344|P3|NOT COMPLETED|Overall Study||46
238194|NCT00077610|569345|P2|NOT COMPLETED|Overall Study||56
238195|NCT00077610|569346|P1|NOT COMPLETED|Overall Study||54
238196|NCT00077610|569344|P3|COMPLETED|Overall Study||180
238197|NCT00077610|569345|P2|COMPLETED|Overall Study||168
238198|NCT00077610|569346|P1|COMPLETED|Overall Study||169
238199|NCT00077610|569344|P3|Started Treatment|Overall Study||225
238200|NCT00077610|569345|P2|Started Treatment|Overall Study||220
238201|NCT00077610|569346|P1|Started Treatment|Overall Study||221
238202|NCT00077610|569344|P3|STARTED|Overall Study||226
238203|NCT00077610|569345|P2|STARTED|Overall Study||224
238204|NCT00077610|569346|P1|STARTED|Overall Study||223
238205|NCT00077376|569375|P1|NOT COMPLETED|Overall Study||22
238206|NCT00077376|569375|P1|COMPLETED|Overall Study||39
238207|NCT00077376|569375|P1|HER2+ in Central Testing|Overall Study||39
238208|NCT00077376|569375|P1|Treated|Overall Study||59
238209|NCT00077376|569375|P1|STARTED|Overall Study||61
238210|NCT00077207|569386|P1|NOT COMPLETED|Overall Study||30
238211|NCT00077207|569386|P1|COMPLETED|Overall Study||36
238212|NCT00077207|569386|P1|STARTED|Overall Study||66
238213|NCT00076999|569395|P5|NOT COMPLETED|Overall Study||25
238214|NCT00076999|569396|P4|NOT COMPLETED|Overall Study||1
238215|NCT00076999|569397|P3|NOT COMPLETED|Overall Study||17
238216|NCT00076999|569398|P2|NOT COMPLETED|Overall Study||24
238217|NCT00076999|569399|P1|NOT COMPLETED|Overall Study||12
238218|NCT00076999|569395|P5|COMPLETED|Overall Study||9
238219|NCT00076999|569396|P4|COMPLETED|Overall Study||5
238220|NCT00076999|569397|P3|COMPLETED|Overall Study||2
238221|NCT00076999|569398|P2|COMPLETED|Overall Study||7
238222|NCT00076999|569399|P1|COMPLETED|Overall Study||13
238223|NCT00076999|569395|P5|STARTED|Overall Study||34
238224|NCT00076999|569396|P4|STARTED|Overall Study||6
238225|NCT00076999|569397|P3|STARTED|Overall Study||19
238226|NCT00076999|569398|P2|STARTED|Overall Study||31
238227|NCT00076999|569399|P1|STARTED|Overall Study||25
238228|NCT00076804|569518|P2|NOT COMPLETED|Overall Study||69
238229|NCT00076804|569519|P1|NOT COMPLETED|Overall Study||60
238230|NCT00076804|569518|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
238231|NCT00076804|569519|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
238232|NCT00076804|569518|P2|STARTED|Overall Study||137
238233|NCT00076804|569519|P1|STARTED|Overall Study||137
238234|NCT00076752|569531|P1|NOT COMPLETED|Overall Study||3
238235|NCT00076752|569531|P1|COMPLETED|Overall Study||6
238236|NCT00076752|569531|P1|STARTED|Overall Study||9
238237|NCT00076687|569539|P3|NOT COMPLETED|Overall Study||4
238238|NCT00076687|569540|P2|NOT COMPLETED|Overall Study||5
238239|NCT00076687|569541|P1|NOT COMPLETED|Overall Study||6
238240|NCT00076687|569539|P3|COMPLETED|Overall Study||51
238241|NCT00076687|569540|P2|COMPLETED|Overall Study||47
238242|NCT00076687|569541|P1|COMPLETED|Overall Study||42
238243|NCT00076687|569539|P3|STARTED|Overall Study||55
238244|NCT00076687|569540|P2|STARTED|Overall Study||52
238245|NCT00076687|569541|P1|STARTED|Overall Study||48
238246|NCT00076570|569560|P2|NOT COMPLETED|Overall Study||8
238247|NCT00076570|569561|P1|NOT COMPLETED|Overall Study||8
238248|NCT00076570|569560|P2|COMPLETED|Overall Study||8
238249|NCT00076570|569561|P1|COMPLETED|Overall Study||7
238250|NCT00076570|569560|P2|STARTED|Overall Study||16
238251|NCT00076570|569561|P1|STARTED|Overall Study||15
238252|NCT00075400|569569|P1|NOT COMPLETED|Overall Study||3
238253|NCT00075400|569569|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
238254|NCT00075400|569569|P1|STARTED|Overall Study||26
238255|NCT00075270|569577|P2|NOT COMPLETED|Overall Study||284
238256|NCT00075270|569578|P1|NOT COMPLETED|Overall Study||286
238257|NCT00075270|569577|P2|COMPLETED|Overall Study||4
238258|NCT00075270|569578|P1|COMPLETED|Overall Study||5
238259|NCT00075270|569577|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
238260|NCT00075270|569578|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
238261|NCT00075270|569577|P2|STARTED|Overall Study||288
238262|NCT00075270|569578|P1|STARTED|Overall Study||291
238263|NCT00076336|569624|P2|NOT COMPLETED|Overall Study||56
238264|NCT00076336|569625|P1|NOT COMPLETED|Overall Study||52
238265|NCT00076336|569624|P2|COMPLETED|Overall Study||60
238266|NCT00076336|569625|P1|COMPLETED|Overall Study||64
238267|NCT00076336|569624|P2|Completed Week 104|Overall Study||62
238268|NCT00076336|569625|P1|Completed Week 104|Overall Study||70
238269|NCT00076336|569624|P2|Completed Week 52|Overall Study||94
238270|NCT00076336|569625|P1|Completed Week 52|Overall Study||97
238271|NCT00076336|569624|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
238272|NCT00076336|569625|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
238273|NCT00076336|569624|P2|Safety Population|Overall Study||116
238274|NCT00076336|569625|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
238275|NCT00076336|569624|P2|STARTED|Overall Study||116
238276|NCT00076336|569625|P1|STARTED|Overall Study||116
238277|NCT00076258|569641|P2|NOT COMPLETED|Overall Study||3
238278|NCT00076258|569642|P1|NOT COMPLETED|Overall Study||1
238279|NCT00076258|569641|P2|COMPLETED|Overall Study||61
238280|NCT00076258|569642|P1|COMPLETED|Overall Study||61
238281|NCT00076258|569641|P2|STARTED|Overall Study||64
238282|NCT00076258|569642|P1|STARTED|Overall Study||62
238283|NCT00076245|569652|P4|NOT COMPLETED|Overall Study||1
238284|NCT00076245|569653|P3|NOT COMPLETED|Overall Study||0
238285|NCT00076245|569654|P2|NOT COMPLETED|Overall Study||0
238286|NCT00076245|569655|P1|NOT COMPLETED|Overall Study||0
238287|NCT00076245|569652|P4|COMPLETED|Overall Study||14
238288|NCT00076245|569653|P3|COMPLETED|Overall Study||15
238289|NCT00076245|569654|P2|COMPLETED|Overall Study||15
238290|NCT00076245|569655|P1|COMPLETED|Overall Study||16
238291|NCT00076245|569652|P4|STARTED|Overall Study||15
238292|NCT00076245|569653|P3|STARTED|Overall Study||15
238293|NCT00076245|569654|P2|STARTED|Overall Study||15
238294|NCT00076245|569655|P1|STARTED|Overall Study||16
238295|NCT00076219|569671|P2|NOT COMPLETED|Overall Study||11
238296|NCT00076219|569672|P1|NOT COMPLETED|Overall Study||18
238297|NCT00076219|569671|P2|COMPLETED|Overall Study||550
238298|NCT00076219|569672|P1|COMPLETED|Overall Study||545
238299|NCT00076219|569671|P2|STARTED|Overall Study||561
238300|NCT00076219|569672|P1|STARTED|Overall Study||563
238301|NCT00076102|569678|P1|NOT COMPLETED|Overall Study||0
238302|NCT00076102|569678|P1|COMPLETED|Overall Study||36
238303|NCT00076102|569678|P1|STARTED|Overall Study||36
238304|NCT00076050|569685|P2|NOT COMPLETED|Overall Study||43
238305|NCT00076050|569686|P1|NOT COMPLETED|Overall Study||23
238306|NCT00076050|569685|P2|COMPLETED|Overall Study||83
238307|NCT00076050|569686|P1|COMPLETED|Overall Study||99
238308|NCT00076050|569685|P2|STARTED|Overall Study||126
238309|NCT00076050|569686|P1|STARTED|Overall Study||122
238310|NCT00076024|569699|P4|NOT COMPLETED|Phase 2, Open-label||16
238311|NCT00076024|569700|P3|NOT COMPLETED|Phase 2, Open-label||0
238312|NCT00076024|569701|P2|NOT COMPLETED|Phase 2, Open-label||0
238313|NCT00076024|569702|P1|NOT COMPLETED|Phase 2, Open-label||0
238314|NCT00076024|569699|P4|COMPLETED|Phase 2, Open-label||0
238315|NCT00076024|569700|P3|COMPLETED|Phase 2, Open-label||0
238316|NCT00076024|569701|P2|COMPLETED|Phase 2, Open-label||0
238317|NCT00076024|569702|P1|COMPLETED|Phase 2, Open-label||0
238318|NCT00076024|569699|P4|STARTED|Phase 2, Open-label||16
238319|NCT00076024|569700|P3|STARTED|Phase 2, Open-label||0
238320|NCT00076024|569701|P2|STARTED|Phase 2, Open-label||0
238321|NCT00076024|569702|P1|STARTED|Phase 2, Open-label||0
238322|NCT00076024|569699|P4|NOT COMPLETED|Phase 2, Double-blind||0
238323|NCT00076024|569700|P3|NOT COMPLETED|Phase 2, Double-blind||56
238324|NCT00076024|569701|P2|NOT COMPLETED|Phase 2, Double-blind||112
238325|NCT00076024|569702|P1|NOT COMPLETED|Phase 2, Double-blind||0
238326|NCT00076024|569699|P4|COMPLETED|Phase 2, Double-blind||0
238327|NCT00076024|569700|P3|COMPLETED|Phase 2, Double-blind||0
238328|NCT00076024|569701|P2|COMPLETED|Phase 2, Double-blind||0
238329|NCT00076024|569702|P1|COMPLETED|Phase 2, Double-blind||0
238330|NCT00076024|569699|P4|Treated|Phase 2, Double-blind||0
238331|NCT00076024|569700|P3|Treated|Phase 2, Double-blind||56
238332|NCT00076024|569701|P2|Treated|Phase 2, Double-blind||111
238333|NCT00076024|569702|P1|Treated|Phase 2, Double-blind||0
238334|NCT00076024|569699|P4|STARTED|Phase 2, Double-blind||0
238335|NCT00076024|569700|P3|STARTED|Phase 2, Double-blind||56
238336|NCT00076024|569701|P2|STARTED|Phase 2, Double-blind||112
238337|NCT00076024|569702|P1|STARTED|Phase 2, Double-blind||0
238338|NCT00076024|569699|P4|NOT COMPLETED|Phase 1, Lead-in||0
238339|NCT00076024|569700|P3|NOT COMPLETED|Phase 1, Lead-in||0
238340|NCT00076024|569701|P2|NOT COMPLETED|Phase 1, Lead-in||0
238341|NCT00076024|569702|P1|NOT COMPLETED|Phase 1, Lead-in||6
238342|NCT00076024|569699|P4|COMPLETED|Phase 1, Lead-in||0
238343|NCT00076024|569700|P3|COMPLETED|Phase 1, Lead-in||0
238344|NCT00076024|569701|P2|COMPLETED|Phase 1, Lead-in||0
238345|NCT00076024|569702|P1|COMPLETED|Phase 1, Lead-in||0
238346|NCT00076024|569699|P4|STARTED|Phase 1, Lead-in||0
238347|NCT00076024|569700|P3|STARTED|Phase 1, Lead-in||0
238348|NCT00076024|569701|P2|STARTED|Phase 1, Lead-in||0
238349|NCT00076024|569702|P1|STARTED|Phase 1, Lead-in||6
238350|NCT00076011|569716|P1|NOT COMPLETED|Overall Study||52
238351|NCT00076011|569716|P1|COMPLETED|Overall Study||0
238352|NCT00076011|569716|P1|STARTED|Overall Study||52
238353|NCT00075946|569728|P5|NOT COMPLETED|Overall Study||188
238354|NCT00075946|569729|P4|NOT COMPLETED|Overall Study||30
238355|NCT00075946|569730|P3|NOT COMPLETED|Overall Study||28
238356|NCT00075946|569731|P2|NOT COMPLETED|Overall Study||151
238357|NCT00075946|569732|P1|NOT COMPLETED|Overall Study||148
238358|NCT00075946|569728|P5|COMPLETED|Overall Study||0
238359|NCT00075946|569729|P4|COMPLETED|Overall Study||0
238360|NCT00075946|569730|P3|COMPLETED|Overall Study||0
238361|NCT00075946|569731|P2|COMPLETED|Overall Study||0
238362|NCT00075946|569732|P1|COMPLETED|Overall Study||0
238363|NCT00075946|569728|P5|Included in Primary Analysis|Overall Study||0
238364|NCT00075946|569729|P4|Included in Primary Analysis|Overall Study||29
238365|NCT00075946|569730|P3|Included in Primary Analysis|Overall Study||23
238366|NCT00075946|569731|P2|Included in Primary Analysis|Overall Study||146
238367|NCT00075946|569732|P1|Included in Primary Analysis|Overall Study||143
238368|NCT00075946|569728|P5|Treated and With Toxicity Data Available|Overall Study||154
238369|NCT00075946|569729|P4|Treated and With Toxicity Data Available|Overall Study||29
238370|NCT00075946|569730|P3|Treated and With Toxicity Data Available|Overall Study||27
238371|NCT00075946|569731|P2|Treated and With Toxicity Data Available|Overall Study||148
238372|NCT00075946|569732|P1|Treated and With Toxicity Data Available|Overall Study||142
238373|NCT00075946|569728|P5|STARTED|Overall Study||188
238374|NCT00075946|569729|P4|STARTED|Overall Study||30
238375|NCT00075946|569730|P3|STARTED|Overall Study||28
238376|NCT00075946|569731|P2|STARTED|Overall Study||151
238377|NCT00075946|569732|P1|STARTED|Overall Study||148
238378|NCT00075881|569747|P1|NOT COMPLETED|Overall Study||43
238379|NCT00075881|569747|P1|COMPLETED|Overall Study||1
238380|NCT00075881|569747|P1|Reinduction Treatment|Overall Study||7
238381|NCT00075881|569747|P1|Maintenance Treatment|Overall Study||15
238382|NCT00075881|569747|P1|Induction Treatment|Overall Study||42
238383|NCT00075881|569747|P1|Treated|Overall Study||42
238384|NCT00075881|569747|P1|Eligible|Overall Study||43
238385|NCT00075881|569747|P1|STARTED|Overall Study||44
238386|NCT00075829|569758|P4|NOT COMPLETED|Overall Study||24
238387|NCT00075829|569759|P3|NOT COMPLETED|Overall Study||34
238388|NCT00075829|569760|P2|NOT COMPLETED|Overall Study||118
238389|NCT00075829|569761|P1|NOT COMPLETED|Overall Study||258
238390|NCT00075829|569758|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
238391|NCT00075829|569759|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
238392|NCT00075829|569760|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
238393|NCT00075829|569761|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
238394|NCT00075829|569758|P4|STARTED|Overall Study||37
238395|NCT00075829|569759|P3|STARTED|Overall Study||48
238396|NCT00075829|569760|P2|STARTED|Overall Study||189
238397|NCT00075829|569761|P1|STARTED|Overall Study||436
238398|NCT00075816|569791|P2|NOT COMPLETED|Overall Study||11
238399|NCT00075816|569792|P1|NOT COMPLETED|Overall Study||14
238400|NCT00075816|569791|P2|COMPLETED|Overall Study||262
238401|NCT00075816|569792|P1|COMPLETED|Overall Study||264
238402|NCT00075816|569791|P2|STARTED|Overall Study||273
238403|NCT00075816|569792|P1|STARTED|Overall Study||278
238404|NCT00075803|569832|P2|NOT COMPLETED|Overall Study||0
238405|NCT00075803|569833|P1|NOT COMPLETED|Overall Study||0
238406|NCT00075803|569832|P2|COMPLETED|Overall Study||305
238407|NCT00075803|569833|P1|COMPLETED|Overall Study||295
238408|NCT00075803|569832|P2|STARTED|Overall Study||305
238409|NCT00075803|569833|P1|STARTED|Overall Study||295
238410|NCT00075725|569871|P12|NOT COMPLETED|Overall Study||18
238411|NCT00075725|569872|P11|NOT COMPLETED|Overall Study||9
238412|NCT00075725|569873|P10|NOT COMPLETED|Overall Study||18
238413|NCT00075725|569874|P9|NOT COMPLETED|Overall Study||117
238414|NCT00075725|569875|P8|NOT COMPLETED|Overall Study||295
238415|NCT00075725|569876|P7|NOT COMPLETED|Overall Study||75
238416|NCT00075725|569877|P6|NOT COMPLETED|Overall Study||313
238417|NCT00075725|569878|P5|NOT COMPLETED|Overall Study||66
238418|NCT00075725|569879|P4|NOT COMPLETED|Overall Study||78
238419|NCT00075725|569880|P3|NOT COMPLETED|Overall Study||121
238420|NCT00075725|569881|P2|NOT COMPLETED|Overall Study||49
238421|NCT00075725|569882|P1|NOT COMPLETED|Overall Study||74
238422|NCT00075725|569871|P12|COMPLETED|Overall Study||10
238423|NCT00075725|569872|P11|COMPLETED|Overall Study||3
238424|NCT00075725|569873|P10|COMPLETED|Overall Study||16
238425|NCT00075725|569874|P9|COMPLETED|Overall Study||185
238426|NCT00075725|569875|P8|COMPLETED|Overall Study||401
238427|NCT00075725|569876|P7|COMPLETED|Overall Study||171
238428|NCT00075725|569877|P6|COMPLETED|Overall Study||397
238429|NCT00075725|569878|P5|COMPLETED|Overall Study||166
238430|NCT00075725|569879|P4|COMPLETED|Overall Study||168
238431|NCT00075725|569880|P3|COMPLETED|Overall Study||175
238432|NCT00075725|569881|P2|COMPLETED|Overall Study||57
238433|NCT00075725|569882|P1|COMPLETED|Overall Study||172
238434|NCT00075725|569871|P12|STARTED|Overall Study||28
238435|NCT00075725|569872|P11|STARTED|Overall Study||12
238436|NCT00075725|569873|P10|STARTED|Overall Study||34
238437|NCT00075725|569874|P9|STARTED|Overall Study||302
238438|NCT00075725|569875|P8|STARTED|Overall Study||696
238439|NCT00075725|569876|P7|STARTED|Overall Study||246
238440|NCT00075725|569877|P6|STARTED|Overall Study||710
238441|NCT00075725|569878|P5|STARTED|Overall Study||232
238442|NCT00075725|569879|P4|STARTED|Overall Study||246
238443|NCT00075725|569880|P3|STARTED|Overall Study||296
238444|NCT00075725|569881|P2|STARTED|Overall Study||106
238445|NCT00075725|569882|P1|STARTED|Overall Study||246
238446|NCT00075608|569971|P1|NOT COMPLETED|Overall Study||0
238447|NCT00075608|569971|P1|COMPLETED|Overall Study||12
238448|NCT00075608|569971|P1|STARTED|Overall Study||12
238449|NCT00075582|569979|P2|NOT COMPLETED|Overall Study||35
238450|NCT00075582|569980|P1|NOT COMPLETED|Overall Study||50
238451|NCT00075582|569979|P2|COMPLETED|Overall Study||50
238452|NCT00075582|569980|P1|COMPLETED|Overall Study||255
238453|NCT00075582|569979|P2|STARTED|Overall Study||85
238454|NCT00075582|569980|P1|STARTED|Overall Study||305
238455|NCT00075504|569990|P2|NOT COMPLETED|Overall Study||7
238456|NCT00075504|569991|P1|NOT COMPLETED|Overall Study||9
238457|NCT00075504|569990|P2|COMPLETED|Overall Study||3
238458|NCT00075504|569991|P1|COMPLETED|Overall Study||14
238459|NCT00075504|569990|P2|STARTED|Overall Study||10
238460|NCT00075504|569991|P1|STARTED|Overall Study||23
238461|NCT00075478|570003|P2|NOT COMPLETED|Overall Study||1
238462|NCT00075478|570004|P1|NOT COMPLETED|Overall Study||1
238463|NCT00075478|570003|P2|COMPLETED|Overall Study||44
238464|NCT00075478|570004|P1|COMPLETED|Overall Study||41
238465|NCT00075478|570003|P2|STARTED|Overall Study||45
238466|NCT00075478|570004|P1|STARTED|Overall Study||42
238467|NCT00075218|570026|P3|NOT COMPLETED|Open-Label Treatment||255
238468|NCT00075218|570027|P2|NOT COMPLETED|Open-Label Treatment||0
238469|NCT00075218|570028|P1|NOT COMPLETED|Open-Label Treatment||0
238470|NCT00075218|570026|P3|COMPLETED|Open-Label Treatment||0
238471|NCT00075218|570027|P2|COMPLETED|Open-Label Treatment||0
238472|NCT00075218|570028|P1|COMPLETED|Open-Label Treatment||0
238473|NCT00075218|570026|P3|STARTED|Open-Label Treatment||255
238474|NCT00075218|570027|P2|STARTED|Open-Label Treatment||0
238475|NCT00075218|570028|P1|STARTED|Open-Label Treatment||0
238476|NCT00075218|570026|P3|NOT COMPLETED|Double-Blind Treatment||0
238477|NCT00075218|570027|P2|NOT COMPLETED|Double-Blind Treatment||15
238478|NCT00075218|570028|P1|NOT COMPLETED|Double-Blind Treatment||91
238479|NCT00075218|570026|P3|COMPLETED|Double-Blind Treatment||0
238480|NCT00075218|570027|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
238481|NCT00075218|570028|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
238482|NCT00075218|570026|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
238483|NCT00075218|570027|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
238484|NCT00075218|570028|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
238485|NCT00075218|570026|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
238486|NCT00075218|570027|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
238487|NCT00075218|570028|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
238488|NCT00075218|570026|P3|STARTED|Double-Blind Treatment||0
238489|NCT00075218|570027|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
238490|NCT00075218|570028|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
238491|NCT00075088|570063|P2|NOT COMPLETED|Overall Study||0
238492|NCT00075088|570064|P1|NOT COMPLETED|Overall Study||0
238493|NCT00075088|570063|P2|COMPLETED|Overall Study||391
238494|NCT00075088|570064|P1|COMPLETED|Overall Study||403
238495|NCT00075088|570063|P2|STARTED|Overall Study||391
238496|NCT00075088|570064|P1|STARTED|Overall Study||403
238497|NCT00075023|570077|P2|NOT COMPLETED|Part Two||0
238498|NCT00075023|570078|P1|NOT COMPLETED|Part Two||0
238499|NCT00075023|570077|P2|COMPLETED|Part Two||0
238500|NCT00075023|570078|P1|COMPLETED|Part Two||0
238501|NCT00075023|570077|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
238502|NCT00075023|570078|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
238503|NCT00075023|570077|P2|NOT COMPLETED|Pilot Study||2
238504|NCT00075023|570078|P1|NOT COMPLETED|Pilot Study||2
238505|NCT00075023|570077|P2|COMPLETED|Pilot Study||3
238506|NCT00075023|570078|P1|COMPLETED|Pilot Study||3
238507|NCT00075023|570077|P2|STARTED|Pilot Study||5
238508|NCT00075023|570078|P1|STARTED|Pilot Study||5
238509|NCT00074984|570087|P2|NOT COMPLETED|Overall Study||8
238510|NCT00074984|570088|P1|NOT COMPLETED|Overall Study||3
238511|NCT00074984|570087|P2|COMPLETED|Overall Study||43
238512|NCT00074984|570088|P1|COMPLETED|Overall Study||28
238513|NCT00074984|570087|P2|STARTED|Overall Study||51
238514|NCT00074984|570088|P1|STARTED|Overall Study||31
238515|NCT00074958|570103|P1|NOT COMPLETED|Overall Study||1
238516|NCT00074958|570103|P1|COMPLETED|Overall Study||15
238517|NCT00074958|570103|P1|STARTED|Overall Study||16
238518|NCT00074815|570111|P3|NOT COMPLETED|Overall Study||12
238519|NCT00074815|570112|P2|NOT COMPLETED|Overall Study||6
238520|NCT00074815|570113|P1|NOT COMPLETED|Overall Study||5
238521|NCT00074815|570111|P3|COMPLETED|Overall Study||30
238522|NCT00074815|570112|P2|COMPLETED|Overall Study||34
238523|NCT00074815|570113|P1|COMPLETED|Overall Study||37
238524|NCT00074815|570111|P3|STARTED|Overall Study||42
238525|NCT00074815|570112|P2|STARTED|Overall Study||40
238526|NCT00074815|570113|P1|STARTED|Overall Study||42
238527|NCT00074711|570123|P2|NOT COMPLETED|Overall Study||15
238528|NCT00074711|570124|P1|NOT COMPLETED|Overall Study||15
238529|NCT00074711|570123|P2|COMPLETED|Overall Study||106
238530|NCT00074711|570124|P1|COMPLETED|Overall Study||105
238531|NCT00074711|570123|P2|STARTED|Overall Study||121
238532|NCT00074711|570124|P1|STARTED|Overall Study||120
238533|NCT00074581|570142|P2|NOT COMPLETED|Overall Study||226
238534|NCT00074581|570143|P1|NOT COMPLETED|Overall Study||244
238535|NCT00074581|570142|P2|COMPLETED|Overall Study||1541
238536|NCT00074581|570143|P1|COMPLETED|Overall Study||1545
238537|NCT00074581|570142|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
238538|NCT00074581|570143|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
238539|NCT00074412|570153|P2|NOT COMPLETED|Overall Study||84
238540|NCT00074412|570154|P1|NOT COMPLETED|Overall Study||82
238541|NCT00074412|570153|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
238542|NCT00074412|570154|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
238543|NCT00074412|570153|P2|Month 12 Visit|Overall Study||735
238544|NCT00074412|570154|P1|Month 12 Visit|Overall Study||733
238545|NCT00074412|570153|P2|Month 9 Visit|Overall Study||741
238546|NCT00074412|570154|P1|Month 9 Visit|Overall Study||741
238547|NCT00074412|570153|P2|Month 6 Visit|Overall Study||748
238548|NCT00074412|570154|P1|Month 6 Visit|Overall Study||748
238549|NCT00074412|570153|P2|Month 5 Visit|Overall Study||750
238550|NCT00074412|570154|P1|Month 5 Visit|Overall Study||756
238551|NCT00074412|570153|P2|Month 4 Visit|Overall Study||752
238552|NCT00074412|570154|P1|Month 4 Visit|Overall Study||758
238553|NCT00074412|570153|P2|Month 3 Visit|Overall Study||755
238554|NCT00074412|570154|P1|Month 3 Visit|Overall Study||759
238555|NCT00074412|570153|P2|Week 8 Visit|Overall Study||759
238556|NCT00074412|570154|P1|Week 8 Visit|Overall Study||759
238557|NCT00074412|570153|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
238558|NCT00074412|570154|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
238559|NCT00074269|570168|P1|NOT COMPLETED|Overall Study||0
238560|NCT00074269|570168|P1|COMPLETED|Overall Study||5
238561|NCT00074269|570168|P1|STARTED|Overall Study||5
238562|NCT00074165|570172|P1|NOT COMPLETED|Overall Study||0
238563|NCT00074165|570172|P1|COMPLETED|Overall Study||17
238564|NCT00074165|570172|P1|STARTED|Overall Study||17
238565|NCT00074152|570179|P2|NOT COMPLETED|Overall Study||33
238566|NCT00074152|570180|P1|NOT COMPLETED|Overall Study||55
238567|NCT00074152|570179|P2|COMPLETED|Overall Study||52
238568|NCT00074152|570180|P1|COMPLETED|Overall Study||22
238569|NCT00074152|570179|P2|STARTED|Overall Study||85
238570|NCT00074152|570180|P1|STARTED|Overall Study||77
238571|NCT00073983|570190|P1|NOT COMPLETED|Overall Study||1
238572|NCT00073983|570190|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
238573|NCT00073983|570190|P1|STARTED|Overall Study||54
238574|NCT00073918|570205|P1|NOT COMPLETED|Overall Study||4
238575|NCT00073918|570205|P1|COMPLETED|Overall Study||107
238576|NCT00073918|570205|P1|STARTED|Overall Study||111
238577|NCT00073528|570212|P2|NOT COMPLETED|Overall Study||642
238578|NCT00073528|570213|P1|NOT COMPLETED|Overall Study||644
238579|NCT00073528|570212|P2|COMPLETED|Overall Study||0
238580|NCT00073528|570213|P1|COMPLETED|Overall Study||0
238581|NCT00073528|570212|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
238582|NCT00073528|570213|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
238583|NCT00073528|570212|P2|STARTED|Overall Study||642
238584|NCT00073528|570213|P1|STARTED|Overall Study||644
238585|NCT00073333|570290|P3|NOT COMPLETED|Overall Study||0
238586|NCT00073333|570291|P2|NOT COMPLETED|Overall Study||14
238587|NCT00073333|570292|P1|NOT COMPLETED|Overall Study||14
238588|NCT00073333|570290|P3|COMPLETED|Overall Study||19
238589|NCT00073333|570291|P2|COMPLETED|Overall Study||27
238590|NCT00073333|570292|P1|COMPLETED|Overall Study||32
238591|NCT00073333|570290|P3|STARTED|Overall Study||19
238592|NCT00073333|570291|P2|STARTED|Overall Study||41
238593|NCT00073333|570292|P1|STARTED|Overall Study||46
238594|NCT00073307|570302|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
238595|NCT00073307|570303|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
238596|NCT00073307|570304|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
238597|NCT00073307|570302|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
238598|NCT00073307|570303|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
238599|NCT00073307|570304|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
238600|NCT00073307|570302|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
238601|NCT00073307|570303|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
238602|NCT00073307|570304|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
238603|NCT00073307|570302|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
238604|NCT00073307|570303|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
238605|NCT00073307|570304|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
238606|NCT00073307|570302|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
238607|NCT00073307|570303|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
238608|NCT00073307|570304|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
238609|NCT00073307|570302|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
238610|NCT00073307|570303|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
238611|NCT00073307|570304|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
238612|NCT00073307|570302|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
238613|NCT00073307|570303|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
238614|NCT00073307|570304|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
238615|NCT00073307|570302|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
238616|NCT00073307|570303|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
238617|NCT00073307|570304|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
238618|NCT00073073|570322|P1|NOT COMPLETED|Overall Study||4
238619|NCT00073073|570322|P1|COMPLETED|Overall Study||42
238620|NCT00073073|570322|P1|STARTED|Overall Study||46
238621|NCT00073021|570335|P2|NOT COMPLETED|Overall Study||16
238622|NCT00073021|570336|P1|NOT COMPLETED|Overall Study||26
238623|NCT00073021|570335|P2|COMPLETED|Overall Study||113
238624|NCT00073021|570336|P1|COMPLETED|Overall Study||113
238625|NCT00073021|570335|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
238626|NCT00073021|570336|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
238627|NCT00073008|570366|P2|NOT COMPLETED|Overall Study||63
238628|NCT00073008|570367|P1|NOT COMPLETED|Overall Study||62
238629|NCT00073008|570366|P2|COMPLETED|Overall Study||3
238630|NCT00073008|570367|P1|COMPLETED|Overall Study||3
238631|NCT00073008|570366|P2|STARTED|Overall Study||66
238632|NCT00073008|570367|P1|STARTED|Overall Study||65
238633|NCT00072761|570399|P2|NOT COMPLETED|Overall Study||2
238634|NCT00072761|570400|P1|NOT COMPLETED|Overall Study||9
238635|NCT00072761|570399|P2|COMPLETED|Overall Study||95
238636|NCT00072761|570400|P1|COMPLETED|Overall Study||90
238637|NCT00072761|570399|P2|STARTED|Overall Study||97
238638|NCT00072761|570400|P1|STARTED|Overall Study||99
238639|NCT00072566|570406|P1|NOT COMPLETED|Overall Study||0
238640|NCT00072566|570406|P1|COMPLETED|Overall Study||70
238641|NCT00072566|570406|P1|STARTED|Overall Study||70
238642|NCT00072475|570412|P1|NOT COMPLETED|Overall Study||97
238643|NCT00072475|570412|P1|COMPLETED|Overall Study||45
238644|NCT00072475|570412|P1|STARTED|Overall Study||142
238645|NCT00072449|570420|P1|NOT COMPLETED|Overall Study||0
238646|NCT00072449|570420|P1|COMPLETED|Overall Study||12
238647|NCT00072449|570420|P1|STARTED|Overall Study||12
238648|NCT00072293|570429|P2|NOT COMPLETED|Overall Study||2
238649|NCT00072293|570430|P1|NOT COMPLETED|Overall Study||1
238650|NCT00072293|570429|P2|COMPLETED|Overall Study||467
238651|NCT00072293|570430|P1|COMPLETED|Overall Study||464
238652|NCT00072293|570429|P2|STARTED|Overall Study||469
238653|NCT00072293|570430|P1|STARTED|Overall Study||465
238654|NCT00072280|570442|P2|NOT COMPLETED|Follow-up||2
238655|NCT00072280|570443|P1|NOT COMPLETED|Follow-up||2
238656|NCT00072280|570442|P2|COMPLETED|Follow-up||0
238657|NCT00072280|570443|P1|COMPLETED|Follow-up||0
238658|NCT00072280|570442|P2|STARTED|Follow-up||2
238659|NCT00072280|570443|P1|STARTED|Follow-up||2
238660|NCT00072280|570442|P2|NOT COMPLETED|Treatment||2
238661|NCT00072280|570443|P1|NOT COMPLETED|Treatment||1
238662|NCT00072280|570442|P2|COMPLETED|Treatment||2
238663|NCT00072280|570443|P1|COMPLETED|Treatment||2
238664|NCT00072280|570442|P2|STARTED|Treatment||4
238665|NCT00072280|570443|P1|STARTED|Treatment||3
238666|NCT00072189|570448|P1|NOT COMPLETED|Overall Study||1
238667|NCT00072189|570448|P1|COMPLETED|Overall Study||16
238668|NCT00072189|570448|P1|STARTED|Overall Study||17
238669|NCT00072176|570456|P2|NOT COMPLETED|Overall Study||1
238670|NCT00072176|570457|P1|NOT COMPLETED|Overall Study||1
238671|NCT00072176|570456|P2|COMPLETED|Overall Study||27
238672|NCT00072176|570457|P1|COMPLETED|Overall Study||33
238673|NCT00072176|570456|P2|STARTED|Overall Study||28
238674|NCT00072176|570457|P1|STARTED|Overall Study||34
238675|NCT00071981|570469|P4|NOT COMPLETED|Overall Study||45
238676|NCT00071981|570470|P3|NOT COMPLETED|Overall Study||37
238677|NCT00071981|570471|P2|NOT COMPLETED|Overall Study||41
238678|NCT00071981|570472|P1|NOT COMPLETED|Overall Study||46
238679|NCT00071981|570469|P4|COMPLETED|Overall Study||3
238680|NCT00071981|570470|P3|COMPLETED|Overall Study||0
238681|NCT00071981|570471|P2|COMPLETED|Overall Study||2
238682|NCT00071981|570472|P1|COMPLETED|Overall Study||1
238683|NCT00071981|570469|P4|Have Helper T Cell Response Data|Overall Study||39
238684|NCT00071981|570470|P3|Have Helper T Cell Response Data|Overall Study||25
238685|NCT00071981|570471|P2|Have Helper T Cell Response Data|Overall Study||27
238686|NCT00071981|570472|P1|Have Helper T Cell Response Data|Overall Study||37
238687|NCT00071981|570469|P4|Have CTL Response Data|Overall Study||41
238688|NCT00071981|570470|P3|Have CTL Response Data|Overall Study||29
238689|NCT00071981|570471|P2|Have CTL Response Data|Overall Study||30
238690|NCT00071981|570472|P1|Have CTL Response Data|Overall Study||40
238691|NCT00071981|570469|P4|Eligible and Treated|Overall Study||42
238692|NCT00071981|570470|P3|Eligible and Treated|Overall Study||32
238693|NCT00071981|570471|P2|Eligible and Treated|Overall Study||33
238694|NCT00071981|570472|P1|Eligible and Treated|Overall Study||41
238695|NCT00071981|570469|P4|Treated|Overall Study||48
238696|NCT00071981|570470|P3|Treated|Overall Study||36
238697|NCT00071981|570471|P2|Treated|Overall Study||38
238698|NCT00071981|570472|P1|Treated|Overall Study||45
238699|NCT00071981|570469|P4|Eligible|Overall Study||42
238700|NCT00071981|570470|P3|Eligible|Overall Study||33
238701|NCT00071981|570471|P2|Eligible|Overall Study||36
238702|NCT00071981|570472|P1|Eligible|Overall Study||43
238703|NCT00071981|570469|P4|STARTED|Overall Study||48
238704|NCT00071981|570470|P3|STARTED|Overall Study||37
238705|NCT00071981|570471|P2|STARTED|Overall Study||43
238706|NCT00071981|570472|P1|STARTED|Overall Study||47
238707|NCT00071890|570500|P2|NOT COMPLETED|Overall Study||0
238708|NCT00071890|570501|P1|NOT COMPLETED|Overall Study||0
238709|NCT00071890|570500|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
238710|NCT00071890|570501|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
238711|NCT00071890|570500|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
238712|NCT00071890|570501|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
238713|NCT00071812|570515|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
238714|NCT00071812|570516|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
238715|NCT00071812|570517|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
238716|NCT00071812|570518|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
238717|NCT00071812|570515|P4|COMPLETED|24-Week Open-Label Extension Period||178
238718|NCT00071812|570516|P3|COMPLETED|24-Week Open-Label Extension Period||7
238719|NCT00071812|570517|P2|COMPLETED|24-Week Open-Label Extension Period||11
238720|NCT00071812|570518|P1|COMPLETED|24-Week Open-Label Extension Period||0
238721|NCT00071812|570515|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
238722|NCT00071812|570516|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
238723|NCT00071812|570517|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
238724|NCT00071812|570518|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
238725|NCT00071812|570515|P4|NOT COMPLETED|24-Week Double-Blind Period||11
238726|NCT00071812|570516|P3|NOT COMPLETED|24-Week Double-Blind Period||8
238727|NCT00071812|570517|P2|NOT COMPLETED|24-Week Double-Blind Period||6
238728|NCT00071812|570518|P1|NOT COMPLETED|24-Week Double-Blind Period||10
238729|NCT00071812|570515|P4|COMPLETED|24-Week Double-Blind Period||60
238730|NCT00071812|570516|P3|COMPLETED|24-Week Double-Blind Period||63
238731|NCT00071812|570517|P2|COMPLETED|24-Week Double-Blind Period||66
238732|NCT00071812|570518|P1|COMPLETED|24-Week Double-Blind Period||59
238733|NCT00071812|570515|P4|STARTED|24-Week Double-Blind Period||71
238734|NCT00071812|570516|P3|STARTED|24-Week Double-Blind Period||71
238735|NCT00071812|570517|P2|STARTED|24-Week Double-Blind Period||72
238736|NCT00071812|570518|P1|STARTED|24-Week Double-Blind Period||69
238737|NCT00071799|570560|P2|NOT COMPLETED|Overall Study||98
238738|NCT00071799|570561|P1|NOT COMPLETED|Overall Study||70
238739|NCT00071799|570560|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
238740|NCT00071799|570561|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
238741|NCT00071799|570560|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
238742|NCT00071799|570561|P1|STARTED|Overall Study||179
238743|NCT00071760|570601|P1|NOT COMPLETED|Overall Study||54
238744|NCT00071760|570601|P1|COMPLETED|Overall Study||0
238745|NCT00071760|570601|P1|Ongoing|Overall Study||25
238746|NCT00071760|570601|P1|STARTED|Overall Study||54
238747|NCT00071721|570662|P2|NOT COMPLETED|Overall Study||91
238748|NCT00071721|570663|P1|NOT COMPLETED|Overall Study||72
238749|NCT00071721|570662|P2|COMPLETED|Overall Study||69
238750|NCT00071721|570663|P1|COMPLETED|Overall Study||81
238751|NCT00071721|570662|P2|STARTED|Overall Study||160
238752|NCT00071721|570663|P1|STARTED|Overall Study||153
238753|NCT00071513|570681|P2|NOT COMPLETED|Follow-up Assessment||6
238754|NCT00071513|570682|P1|NOT COMPLETED|Follow-up Assessment||6
238755|NCT00071513|570681|P2|COMPLETED|Follow-up Assessment||247
238756|NCT00071513|570682|P1|COMPLETED|Follow-up Assessment||233
238757|NCT00071513|570681|P2|STARTED|Follow-up Assessment||253
238758|NCT00071513|570682|P1|STARTED|Follow-up Assessment||239
238759|NCT00071513|570681|P2|NOT COMPLETED|Intervention Component||3
238760|NCT00071513|570682|P1|NOT COMPLETED|Intervention Component||2
238761|NCT00071513|570681|P2|COMPLETED|Intervention Component||253
238762|NCT00071513|570682|P1|COMPLETED|Intervention Component||239
238763|NCT00071513|570681|P2|STARTED|Intervention Component||256
238764|NCT00071513|570682|P1|STARTED|Intervention Component||241
238765|NCT00071487|570694|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
238766|NCT00071487|570695|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
238767|NCT00071487|570696|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
238768|NCT00071487|570697|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
238769|NCT00071487|570694|P4|COMPLETED|24-Week Open-Label Extension Period||279
238770|NCT00071487|570695|P3|COMPLETED|24-Week Open-Label Extension Period||23
238771|NCT00071487|570696|P2|COMPLETED|24-Week Open-Label Extension Period||19
238772|NCT00071487|570697|P1|COMPLETED|24-Week Open-Label Extension Period||0
238773|NCT00071487|570694|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
238774|NCT00071487|570695|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
238775|NCT00071487|570696|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
238776|NCT00071487|570697|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
238777|NCT00071487|570694|P4|NOT COMPLETED|52-Week Double-Blind Period||21
238778|NCT00071487|570695|P3|NOT COMPLETED|52-Week Double-Blind Period||17
238779|NCT00071487|570696|P2|NOT COMPLETED|52-Week Double-Blind Period||27
238780|NCT00071487|570697|P1|NOT COMPLETED|52-Week Double-Blind Period||20
238781|NCT00071487|570694|P4|COMPLETED|52-Week Double-Blind Period||90
238782|NCT00071487|570695|P3|COMPLETED|52-Week Double-Blind Period||94
238783|NCT00071487|570696|P2|COMPLETED|52-Week Double-Blind Period||87
238784|NCT00071487|570697|P1|COMPLETED|52-Week Double-Blind Period||93
238785|NCT00071487|570694|P4|STARTED|52-Week Double-Blind Period||111
238786|NCT00071487|570695|P3|STARTED|52-Week Double-Blind Period||111
238787|NCT00071487|570696|P2|STARTED|52-Week Double-Blind Period||114
238788|NCT00071487|570697|P1|STARTED|52-Week Double-Blind Period||113
238789|NCT00071396|570741|P1|NOT COMPLETED|Overall Study||3
238790|NCT00071396|570741|P1|COMPLETED|Overall Study|Evaluable for response.|41
238791|NCT00071396|570741|P1|STARTED|Overall Study||44
238792|NCT00071110|570747|P2|NOT COMPLETED|Overall Study||4
238793|NCT00071110|570748|P1|NOT COMPLETED|Overall Study||0
238794|NCT00071110|570747|P2|COMPLETED|Overall Study||25
238795|NCT00071110|570748|P1|COMPLETED|Overall Study||28
238796|NCT00071110|570747|P2|STARTED|Overall Study||29
238797|NCT00071110|570748|P1|STARTED|Overall Study||28
238798|NCT00071058|570760|P1|NOT COMPLETED|Overall Study||1
238799|NCT00071058|570760|P1|COMPLETED|Overall Study||49
238800|NCT00071058|570760|P1|STARTED|Overall Study||50
238801|NCT00071032|570767|P2|NOT COMPLETED|Overall Study||8
238802|NCT00071032|570768|P1|NOT COMPLETED|Overall Study||9
238803|NCT00071032|570767|P2|COMPLETED|Overall Study||1001
238804|NCT00071032|570768|P1|COMPLETED|Overall Study||998
238805|NCT00071032|570767|P2|STARTED|Overall Study||1009
238806|NCT00071032|570768|P1|STARTED|Overall Study||1007
238807|NCT00071006|570776|P1|NOT COMPLETED|Overall Study||12
238808|NCT00071006|570776|P1|COMPLETED|Overall Study||0
238809|NCT00071006|570776|P1|STARTED|Overall Study||12
238810|NCT00070941|570789|P3|NOT COMPLETED|Overall Study||4
238811|NCT00070941|570790|P2|NOT COMPLETED|Overall Study||8
238812|NCT00070941|570791|P1|NOT COMPLETED|Overall Study||10
238813|NCT00070941|570789|P3|COMPLETED|Overall Study||2
238814|NCT00070941|570790|P2|COMPLETED|Overall Study||3
238815|NCT00070941|570791|P1|COMPLETED|Overall Study||2
238816|NCT00070941|570789|P3|STARTED|Overall Study||6
238817|NCT00070941|570790|P2|STARTED|Overall Study||11
238818|NCT00070941|570791|P1|STARTED|Overall Study||12
238819|NCT00070499|570803|P4|NOT COMPLETED|Overall Study||110
238820|NCT00070499|570804|P3|NOT COMPLETED|Overall Study||120
238821|NCT00070499|570805|P2|NOT COMPLETED|Overall Study||26
238822|NCT00070499|570806|P1|NOT COMPLETED|Overall Study||38
238823|NCT00070499|570803|P4|COMPLETED|Overall Study||17
238824|NCT00070499|570804|P3|COMPLETED|Overall Study||6
238825|NCT00070499|570805|P2|COMPLETED|Overall Study||52
238826|NCT00070499|570806|P1|COMPLETED|Overall Study||37
238827|NCT00070499|570803|P4|Eligible and Treated|Overall Study||123
238828|NCT00070499|570804|P3|Eligible and Treated|Overall Study||123
238829|NCT00070499|570805|P2|Eligible and Treated|Overall Study||73
238830|NCT00070499|570806|P1|Eligible and Treated|Overall Study||72
238831|NCT00070499|570803|P4|Eligible|Overall Study||125
238832|NCT00070499|570804|P3|Eligible|Overall Study||123
238833|NCT00070499|570805|P2|Eligible|Overall Study||73
238834|NCT00070499|570806|P1|Eligible|Overall Study||73
238835|NCT00070499|570803|P4|STARTED|Overall Study||127
238836|NCT00070499|570804|P3|STARTED|Overall Study||126
238837|NCT00070499|570805|P2|STARTED|Overall Study||78
238838|NCT00070499|570806|P1|STARTED|Overall Study||75
238839|NCT00070291|570832|P1|NOT COMPLETED|Step 2||1
238840|NCT00070291|570832|P1|COMPLETED|Step 2||0
238841|NCT00070291|570832|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
238842|NCT00070291|570832|P1|NOT COMPLETED|Step 1||2
238843|NCT00070291|570832|P1|COMPLETED|Step 1||2
238844|NCT00070291|570832|P1|Treated|Step 1||3
238845|NCT00070291|570832|P1|STARTED|Step 1||4
238846|NCT00070109|570842|P5|NOT COMPLETED|Overall Study||8
238847|NCT00070109|570843|P4|NOT COMPLETED|Overall Study||20
238848|NCT00070109|570844|P3|NOT COMPLETED|Overall Study||8
238849|NCT00070109|570845|P2|NOT COMPLETED|Overall Study||6
238850|NCT00070109|570846|P1|NOT COMPLETED|Overall Study||8
238851|NCT00070109|570842|P5|COMPLETED|Overall Study||0
238852|NCT00070109|570843|P4|COMPLETED|Overall Study||0
238853|NCT00070109|570844|P3|COMPLETED|Overall Study||0
238854|NCT00070109|570845|P2|COMPLETED|Overall Study||0
238855|NCT00070109|570846|P1|COMPLETED|Overall Study||0
238856|NCT00070109|570842|P5|STARTED|Overall Study||8
238857|NCT00070109|570843|P4|STARTED|Overall Study||20
238858|NCT00070109|570844|P3|STARTED|Overall Study||8
238859|NCT00070109|570845|P2|STARTED|Overall Study||6
238860|NCT00070109|570846|P1|STARTED|Overall Study||8
238861|NCT00070018|570859|P1|NOT COMPLETED|Overall Study||4
238862|NCT00070018|570859|P1|COMPLETED|Overall Study||42
238863|NCT00070018|570859|P1|Eligible and Began Protocol Therapy|Overall Study||46
238864|NCT00070018|570859|P1|Eligible|Overall Study||46
238865|NCT00070018|570859|P1|STARTED|Overall Study||46
238866|NCT00069953|570863|P1|NOT COMPLETED|Overall Study||2
238867|NCT00069953|570863|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
238868|NCT00069953|570863|P1|STARTED|Overall Study||43
238869|NCT00069823|570869|P2|NOT COMPLETED|Overall Study||3
238870|NCT00069823|570870|P1|NOT COMPLETED|Overall Study||6
238871|NCT00069823|570869|P2|COMPLETED|Overall Study||200
238872|NCT00069823|570870|P1|COMPLETED|Overall Study||193
238873|NCT00069823|570869|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
238956|NCT00069095|571076|P4|COMPLETED|Follow-up Phase||187
238874|NCT00069823|570870|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
238875|NCT00069784|570912|P2|NOT COMPLETED|Overall Study||0
238876|NCT00069784|570913|P1|NOT COMPLETED|Overall Study||1212
238877|NCT00069784|570912|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
238878|NCT00069784|570913|P1|COMPLETED|Overall Study|completed study treatment|5052
238879|NCT00069784|570912|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
238880|NCT00069784|570913|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
238881|NCT00069784|570912|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
238882|NCT00069784|570913|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
238883|NCT00069641|570934|P3|NOT COMPLETED|Overall Study||1
238884|NCT00069641|570935|P2|NOT COMPLETED|Overall Study||0
238885|NCT00069641|570936|P1|NOT COMPLETED|Overall Study||1
238886|NCT00069641|570934|P3|COMPLETED|Overall Study||31
238887|NCT00069641|570935|P2|COMPLETED|Overall Study||32
238888|NCT00069641|570936|P1|COMPLETED|Overall Study||31
238889|NCT00069641|570934|P3|STARTED|Overall Study||32
238890|NCT00069641|570935|P2|STARTED|Overall Study||32
238891|NCT00069641|570936|P1|STARTED|Overall Study||32
238892|NCT00069329|570961|P1|NOT COMPLETED|Overall Study||2
238893|NCT00069329|570961|P1|COMPLETED|Overall Study||41
238894|NCT00069329|570961|P1|STARTED|Overall Study||43
238895|NCT00069277|570985|P1|NOT COMPLETED|Overall Study||21
238896|NCT00069277|570985|P1|COMPLETED|Overall Study||0
238897|NCT00069277|570985|P1|STARTED|Overall Study||21
238898|NCT00069264|570989|P1|NOT COMPLETED|Overall Study||32
238899|NCT00069264|570989|P1|COMPLETED|Overall Study||0
238900|NCT00069264|570989|P1|STARTED|Overall Study||32
238901|NCT00069238|570993|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
238902|NCT00069238|570994|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238903|NCT00069238|570995|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238904|NCT00069238|570993|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
238905|NCT00069238|570994|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238906|NCT00069238|570995|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238907|NCT00069238|570993|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
238908|NCT00069238|570994|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238909|NCT00069238|570995|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
238910|NCT00069238|570993|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238911|NCT00069238|570994|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
238912|NCT00069238|570995|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238913|NCT00069238|570993|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238914|NCT00069238|570994|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
238915|NCT00069238|570995|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238916|NCT00069238|570993|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238917|NCT00069238|570994|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
238918|NCT00069238|570995|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
238919|NCT00069238|570993|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238920|NCT00069238|570994|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238921|NCT00069238|570995|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
238922|NCT00069238|570993|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238923|NCT00069238|570994|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238924|NCT00069238|570995|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
238925|NCT00069238|570993|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238926|NCT00069238|570994|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
238927|NCT00069238|570995|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
238928|NCT00069160|571002|P2|NOT COMPLETED|Overall Study||0
238929|NCT00069160|571003|P1|NOT COMPLETED|Overall Study||0
238930|NCT00069160|571002|P2|COMPLETED|Overall Study||25
238931|NCT00069160|571003|P1|COMPLETED|Overall Study||23
238932|NCT00069160|571002|P2|STARTED|Overall Study||25
238933|NCT00069160|571003|P1|STARTED|Overall Study||23
238934|NCT00069121|571018|P2|NOT COMPLETED|Overall Study||276
238935|NCT00069121|571019|P1|NOT COMPLETED|Overall Study||302
238936|NCT00069121|571018|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
238937|NCT00069121|571019|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
238938|NCT00069121|571018|P2|Received Treatment|Overall Study|Safety Population|938
238939|NCT00069121|571019|P1|Received Treatment|Overall Study|Safety Population|926
238940|NCT00069121|571018|P2|STARTED|Overall Study||944
238941|NCT00069121|571019|P1|STARTED|Overall Study||942
238942|NCT00069108|571041|P2|NOT COMPLETED|Overall Study||219
238943|NCT00069108|571042|P1|NOT COMPLETED|Overall Study||213
238944|NCT00069108|571041|P2|COMPLETED|Overall Study||95
238945|NCT00069108|571042|P1|COMPLETED|Overall Study||100
238946|NCT00069108|571041|P2|STARTED|Overall Study||314
238947|NCT00069108|571042|P1|STARTED|Overall Study||313
238948|NCT00069095|571074|P6|NOT COMPLETED|Follow-up Phase||101
238949|NCT00069095|571075|P5|NOT COMPLETED|Follow-up Phase||92
238950|NCT00069095|571076|P4|NOT COMPLETED|Follow-up Phase||112
238951|NCT00069095|571077|P3|NOT COMPLETED|Follow-up Phase||120
238952|NCT00069095|571078|P2|NOT COMPLETED|Follow-up Phase||206
238953|NCT00069095|571079|P1|NOT COMPLETED|Follow-up Phase||174
238954|NCT00069095|571074|P6|COMPLETED|Follow-up Phase||171
238955|NCT00069095|571075|P5|COMPLETED|Follow-up Phase||186
238957|NCT00069095|571077|P3|COMPLETED|Follow-up Phase||178
238958|NCT00069095|571078|P2|COMPLETED|Follow-up Phase||93
238959|NCT00069095|571079|P1|COMPLETED|Follow-up Phase||110
238960|NCT00069095|571074|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
238961|NCT00069095|571075|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
238962|NCT00069095|571076|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
238963|NCT00069095|571077|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
238964|NCT00069095|571078|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
238965|NCT00069095|571079|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
238966|NCT00069095|571074|P6|NOT COMPLETED|Post-study Treatment Phase||29
238967|NCT00069095|571075|P5|NOT COMPLETED|Post-study Treatment Phase||36
238968|NCT00069095|571076|P4|NOT COMPLETED|Post-study Treatment Phase||17
238969|NCT00069095|571077|P3|NOT COMPLETED|Post-study Treatment Phase||21
238970|NCT00069095|571078|P2|NOT COMPLETED|Post-study Treatment Phase||13
238971|NCT00069095|571079|P1|NOT COMPLETED|Post-study Treatment Phase||8
238972|NCT00069095|571074|P6|COMPLETED|Post-study Treatment Phase||0
238973|NCT00069095|571075|P5|COMPLETED|Post-study Treatment Phase||0
238974|NCT00069095|571076|P4|COMPLETED|Post-study Treatment Phase||0
238975|NCT00069095|571077|P3|COMPLETED|Post-study Treatment Phase||0
238976|NCT00069095|571078|P2|COMPLETED|Post-study Treatment Phase||0
238977|NCT00069095|571079|P1|COMPLETED|Post-study Treatment Phase||0
238978|NCT00069095|571074|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
238979|NCT00069095|571075|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
238980|NCT00069095|571076|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
238981|NCT00069095|571077|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
238982|NCT00069095|571078|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
238983|NCT00069095|571079|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
238984|NCT00069095|571074|P6|NOT COMPLETED|Primary Treatment Phase||301
238985|NCT00069095|571075|P5|NOT COMPLETED|Primary Treatment Phase||302
238986|NCT00069095|571076|P4|NOT COMPLETED|Primary Treatment Phase||320
238987|NCT00069095|571077|P3|NOT COMPLETED|Primary Treatment Phase||314
238988|NCT00069095|571078|P2|NOT COMPLETED|Primary Treatment Phase||302
238989|NCT00069095|571079|P1|NOT COMPLETED|Primary Treatment Phase||295
238990|NCT00069095|571074|P6|COMPLETED|Primary Treatment Phase||48
238991|NCT00069095|571075|P5|COMPLETED|Primary Treatment Phase||48
238992|NCT00069095|571076|P4|COMPLETED|Primary Treatment Phase||31
238993|NCT00069095|571077|P3|COMPLETED|Primary Treatment Phase||36
238994|NCT00069095|571078|P2|COMPLETED|Primary Treatment Phase||15
238995|NCT00069095|571079|P1|COMPLETED|Primary Treatment Phase||22
238996|NCT00069095|571074|P6|STARTED|Primary Treatment Phase||349
238997|NCT00069095|571075|P5|STARTED|Primary Treatment Phase||350
238998|NCT00069095|571076|P4|STARTED|Primary Treatment Phase||351
238999|NCT00069095|571077|P3|STARTED|Primary Treatment Phase||350
239000|NCT00069095|571078|P2|STARTED|Primary Treatment Phase||317
239001|NCT00069095|571079|P1|STARTED|Primary Treatment Phase||317
239002|NCT00068822|571133|P2|NOT COMPLETED|Optional Crossover Intervention||0
239003|NCT00068822|571134|P1|NOT COMPLETED|Optional Crossover Intervention||0
239004|NCT00068822|571133|P2|COMPLETED|Optional Crossover Intervention||29
239005|NCT00068822|571134|P1|COMPLETED|Optional Crossover Intervention||9
239006|NCT00068822|571133|P2|Crossover at Month 3|Optional Crossover Intervention||27
239007|NCT00068822|571134|P1|Crossover at Month 3|Optional Crossover Intervention||8
239008|NCT00068822|571133|P2|Crossover at Month 1|Optional Crossover Intervention||2
239009|NCT00068822|571134|P1|Crossover at Month 1|Optional Crossover Intervention||1
239010|NCT00068822|571133|P2|STARTED|Optional Crossover Intervention||29
239011|NCT00068822|571134|P1|STARTED|Optional Crossover Intervention||9
239012|NCT00068822|571133|P2|NOT COMPLETED|First Randomized Intervention||2
239013|NCT00068822|571134|P1|NOT COMPLETED|First Randomized Intervention||1
239014|NCT00068822|571133|P2|COMPLETED|First Randomized Intervention||61
239015|NCT00068822|571134|P1|COMPLETED|First Randomized Intervention||67
239016|NCT00068822|571133|P2|STARTED|First Randomized Intervention||63
239017|NCT00068822|571134|P1|STARTED|First Randomized Intervention||68
239018|NCT00068770|571146|P2|NOT COMPLETED|Overall Study||0
239019|NCT00068770|571147|P1|NOT COMPLETED|Overall Study||0
239020|NCT00068770|571146|P2|COMPLETED|Overall Study||22
239021|NCT00068770|571147|P1|COMPLETED|Overall Study||13
239022|NCT00068770|571146|P2|STARTED|Overall Study||22
239023|NCT00068770|571147|P1|STARTED|Overall Study||13
239024|NCT00068588|571158|P3|NOT COMPLETED|Overall Study||4
239025|NCT00068588|571159|P2|NOT COMPLETED|Overall Study||0
239026|NCT00068588|571160|P1|NOT COMPLETED|Overall Study||0
239027|NCT00068588|571158|P3|COMPLETED|Overall Study||17
239028|NCT00068588|571159|P2|COMPLETED|Overall Study||3
239029|NCT00068588|571160|P1|COMPLETED|Overall Study||0
239030|NCT00068588|571158|P3|STARTED|Overall Study||21
239031|NCT00068588|571159|P2|STARTED|Overall Study||3
239032|NCT00068588|571160|P1|STARTED|Overall Study||0
239033|NCT00068575|571170|P1|NOT COMPLETED|Overall Study||0
239034|NCT00068575|571170|P1|COMPLETED|Overall Study||28
239035|NCT00068575|571170|P1|STARTED|Overall Study||28
239036|NCT00068419|571174|P1|NOT COMPLETED|Overall Study||60
239037|NCT00068419|571174|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
239038|NCT00068419|571174|P1|STARTED|Overall Study||70
239039|NCT00068393|571178|P1|NOT COMPLETED|Overall Study||10
239040|NCT00068393|571178|P1|COMPLETED|Overall Study||29
239041|NCT00068393|571178|P1|Eligible and Treated|Overall Study||38
239042|NCT00068393|571178|P1|STARTED|Overall Study||39
239043|NCT00068380|571184|P1|NOT COMPLETED|Overall Study||5
239044|NCT00068380|571184|P1|COMPLETED|Overall Study||12
239045|NCT00068380|571184|P1|STARTED|Overall Study||17
239046|NCT00068237|571188|P1|NOT COMPLETED|Overall Study||5
239047|NCT00068237|571188|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
239048|NCT00068237|571188|P1|STARTED|Overall Study||49
239049|NCT00068107|571192|P1|NOT COMPLETED|Overall Study||9
239050|NCT00068107|571192|P1|COMPLETED|Overall Study||3
239051|NCT00068107|571192|P1|STARTED|Overall Study||12
239052|NCT00067808|571206|P3|NOT COMPLETED|Overall Study||0
239053|NCT00067808|571207|P2|NOT COMPLETED|Overall Study||0
239054|NCT00067808|571208|P1|NOT COMPLETED|Overall Study||0
239055|NCT00067808|571206|P3|COMPLETED|Overall Study||14
239056|NCT00067808|571207|P2|COMPLETED|Overall Study||93
239057|NCT00067808|571208|P1|COMPLETED|Overall Study||17
239058|NCT00067808|571206|P3|STARTED|Overall Study||14
239059|NCT00067808|571207|P2|STARTED|Overall Study||93
239060|NCT00067808|571208|P1|STARTED|Overall Study||17
239061|NCT00067470|571218|P2|NOT COMPLETED|Overall Study||1
239062|NCT00067470|571219|P1|NOT COMPLETED|Overall Study||0
239063|NCT00067470|571218|P2|COMPLETED|Overall Study||19
239064|NCT00067470|571219|P1|COMPLETED|Overall Study||19
239065|NCT00067470|571218|P2|STARTED|Overall Study||20
239066|NCT00067470|571219|P1|STARTED|Overall Study||19
239067|NCT00067236|571231|P2|NOT COMPLETED|Overall Study||26
239068|NCT00067236|571232|P1|NOT COMPLETED|Overall Study||20
239069|NCT00067236|571231|P2|COMPLETED|Overall Study||99
239070|NCT00067236|571232|P1|COMPLETED|Overall Study||108
239071|NCT00067236|571231|P2|STARTED|Overall Study||125
239072|NCT00067236|571232|P1|STARTED|Overall Study||128
239073|NCT00066963|571241|P3|NOT COMPLETED|Overall Study||39
239074|NCT00066963|571242|P2|NOT COMPLETED|Overall Study||31
239075|NCT00066963|571243|P1|NOT COMPLETED|Overall Study||26
239076|NCT00066963|571241|P3|COMPLETED|Overall Study||87
239077|NCT00066963|571242|P2|COMPLETED|Overall Study||93
239078|NCT00066963|571243|P1|COMPLETED|Overall Study|any follow-up|100
239079|NCT00066963|571241|P3|STARTED|Overall Study||126
239080|NCT00066963|571242|P2|STARTED|Overall Study||124
239081|NCT00066963|571243|P1|STARTED|Overall Study||126
239082|NCT00066807|571253|P2|NOT COMPLETED|Overall Study||15
239083|NCT00066807|571254|P1|NOT COMPLETED|Overall Study||14
239084|NCT00066807|571253|P2|COMPLETED|Overall Study||0
239085|NCT00066807|571254|P1|COMPLETED|Overall Study||0
239086|NCT00066807|571253|P2|STARTED|Overall Study||15
239087|NCT00066807|571254|P1|STARTED|Overall Study||14
239088|NCT00066742|571266|P1|NOT COMPLETED|Consolidation Chemotherapy||3
239089|NCT00066742|571266|P1|COMPLETED|Consolidation Chemotherapy||39
239090|NCT00066742|571266|P1|Eligible|Consolidation Chemotherapy||40
239091|NCT00066742|571266|P1|STARTED|Consolidation Chemotherapy||42
239092|NCT00066742|571266|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
239093|NCT00066742|571266|P1|COMPLETED|Induction Chemoradiotherapy||43
239094|NCT00066742|571266|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
239095|NCT00066742|571266|P1|Eligible|Induction Chemoradiotherapy||69
239096|NCT00066742|571266|P1|STARTED|Induction Chemoradiotherapy||72
239097|NCT00066703|571275|P2|NOT COMPLETED|Overall Study||582
239098|NCT00066703|571276|P1|NOT COMPLETED|Overall Study||612
239099|NCT00066703|571275|P2|COMPLETED|Overall Study||756
239100|NCT00066703|571276|P1|COMPLETED|Overall Study||722
239101|NCT00066703|571275|P2|STARTED|Overall Study||1338
239102|NCT00066703|571276|P1|STARTED|Overall Study||1334
239103|NCT00066690|571289|P3|NOT COMPLETED|Overall Study||564
239104|NCT00066690|571290|P2|NOT COMPLETED|Overall Study||522
239105|NCT00066690|571291|P1|NOT COMPLETED|Overall Study||598
239106|NCT00066690|571289|P3|COMPLETED|Overall Study||457
239107|NCT00066690|571290|P2|COMPLETED|Overall Study||502
239108|NCT00066690|571291|P1|COMPLETED|Overall Study||423
239109|NCT00066690|571289|P3|STARTED|Overall Study||1021
239110|NCT00066690|571290|P2|STARTED|Overall Study||1024
239111|NCT00066690|571291|P1|STARTED|Overall Study||1021
239112|NCT00066573|571307|P2|NOT COMPLETED|Overall Study||28
239113|NCT00066573|571308|P1|NOT COMPLETED|Overall Study||28
239114|NCT00066573|571307|P2|COMPLETED|Overall Study||3759
239115|NCT00066573|571308|P1|COMPLETED|Overall Study||3761
239116|NCT00066573|571307|P2|STARTED|Overall Study||3787
239117|NCT00066573|571308|P1|STARTED|Overall Study||3789
239118|NCT00066469|571314|P1|NOT COMPLETED|Overall Study||16
239119|NCT00066469|571314|P1|COMPLETED|Overall Study||39
239120|NCT00066469|571314|P1|STARTED|Overall Study||55
239121|NCT00066365|571320|P2|NOT COMPLETED|Overall Study||14
239122|NCT00066365|571321|P1|NOT COMPLETED|Overall Study||23
239123|NCT00066365|571320|P2|COMPLETED|Overall Study||4
239124|NCT00066365|571321|P1|COMPLETED|Overall Study||8
239125|NCT00066365|571320|P2|STARTED|Overall Study||18
239126|NCT00066365|571321|P1|STARTED|Overall Study||31
239127|NCT00066222|571349|P1|NOT COMPLETED|Overall Study||1
239128|NCT00066222|571349|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
239129|NCT00066222|571349|P1|STARTED|Overall Study||72
239130|NCT00066170|571357|P4|NOT COMPLETED|Overall Study||9
239131|NCT00066170|571358|P3|NOT COMPLETED|Overall Study||4
239132|NCT00066170|571359|P2|NOT COMPLETED|Overall Study||10
239133|NCT00066170|571360|P1|NOT COMPLETED|Overall Study||7
239134|NCT00066170|571357|P4|COMPLETED|Overall Study||48
239135|NCT00066170|571358|P3|COMPLETED|Overall Study||59
239136|NCT00066170|571359|P2|COMPLETED|Overall Study||45
239137|NCT00066170|571360|P1|COMPLETED|Overall Study||49
239138|NCT00066170|571357|P4|Intent to Treat|Overall Study||54
239139|NCT00066170|571358|P3|Intent to Treat|Overall Study||63
239140|NCT00066170|571359|P2|Intent to Treat|Overall Study||50
239141|NCT00066170|571360|P1|Intent to Treat|Overall Study||55
239142|NCT00066170|571357|P4|STARTED|Overall Study||57
239143|NCT00066170|571358|P3|STARTED|Overall Study||63
239144|NCT00066170|571359|P2|STARTED|Overall Study||55
239145|NCT00066170|571360|P1|STARTED|Overall Study||56
239146|NCT00066066|571373|P6|NOT COMPLETED|Overall Study||5
239147|NCT00066066|571374|P5|NOT COMPLETED|Overall Study||3
239148|NCT00066066|571375|P4|NOT COMPLETED|Overall Study||4
239149|NCT00066066|571376|P3|NOT COMPLETED|Overall Study||7
239150|NCT00066066|571377|P2|NOT COMPLETED|Overall Study||4
239151|NCT00066066|571378|P1|NOT COMPLETED|Overall Study||6
239152|NCT00066066|571373|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
239153|NCT00066066|571374|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
239154|NCT00066066|571375|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
239155|NCT00066066|571376|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
239156|NCT00066066|571377|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
239157|NCT00066066|571378|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
239158|NCT00066066|571373|P6|12 Month|Overall Study||9
239159|NCT00066066|571374|P5|12 Month|Overall Study||19
239160|NCT00066066|571375|P4|12 Month|Overall Study||11
239161|NCT00066066|571376|P3|12 Month|Overall Study||21
239162|NCT00066066|571377|P2|12 Month|Overall Study||11
239163|NCT00066066|571378|P1|12 Month|Overall Study||18
239164|NCT00066066|571373|P6|6 Month|Overall Study||14
239165|NCT00066066|571374|P5|6 Month|Overall Study||21
239166|NCT00066066|571375|P4|6 Month|Overall Study||13
239167|NCT00066066|571376|P3|6 Month|Overall Study||23
239168|NCT00066066|571377|P2|6 Month|Overall Study||13
239169|NCT00066066|571378|P1|6 Month|Overall Study||19
239170|NCT00066066|571373|P6|3 Month|Overall Study||15
239171|NCT00066066|571374|P5|3 Month|Overall Study||22
239172|NCT00066066|571375|P4|3 Month|Overall Study||16
239173|NCT00066066|571376|P3|3 Month|Overall Study||23
239174|NCT00066066|571377|P2|3 Month|Overall Study||17
239175|NCT00066066|571378|P1|3 Month|Overall Study||21
239176|NCT00066066|571373|P6|Baseline|Overall Study||20
239177|NCT00066066|571374|P5|Baseline|Overall Study||27
239178|NCT00066066|571375|P4|Baseline|Overall Study||20
239179|NCT00066066|571376|P3|Baseline|Overall Study||30
239180|NCT00066066|571377|P2|Baseline|Overall Study||22
239181|NCT00066066|571378|P1|Baseline|Overall Study||27
239182|NCT00066066|571373|P6|STARTED|Overall Study||20
239183|NCT00066066|571374|P5|STARTED|Overall Study||27
239184|NCT00066066|571375|P4|STARTED|Overall Study||20
239185|NCT00066066|571376|P3|STARTED|Overall Study||30
239186|NCT00066066|571377|P2|STARTED|Overall Study||22
239187|NCT00066066|571378|P1|STARTED|Overall Study||27
239188|NCT00065806|571394|P2|NOT COMPLETED|Overall Study||19
239189|NCT00065806|571395|P1|NOT COMPLETED|Overall Study||20
239190|NCT00065806|571394|P2|COMPLETED|Overall Study||89
239191|NCT00065806|571395|P1|COMPLETED|Overall Study||93
239192|NCT00065806|571394|P2|STARTED|Overall Study||108
239193|NCT00065806|571395|P1|STARTED|Overall Study||113
239194|NCT00065611|571439|P2|NOT COMPLETED|Overall Study||1
239195|NCT00065611|571440|P1|NOT COMPLETED|Overall Study||0
239196|NCT00065611|571439|P2|COMPLETED|Overall Study||3
239197|NCT00065611|571440|P1|COMPLETED|Overall Study||4
239198|NCT00065611|571439|P2|STARTED|Overall Study||4
239199|NCT00065611|571440|P1|STARTED|Overall Study||4
239200|NCT00065507|571452|P2|NOT COMPLETED|Overall Study||29
239201|NCT00065507|571453|P1|NOT COMPLETED|Overall Study||29
239202|NCT00065507|571452|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
239203|NCT00065507|571453|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
239204|NCT00065507|571452|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
239205|NCT00065507|571453|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
239206|NCT00065507|571452|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
239281|NCT00065156|571594|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
239207|NCT00065507|571453|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
239208|NCT00065507|571452|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
239209|NCT00065507|571453|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
239210|NCT00065507|571452|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
239211|NCT00065507|571453|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
239212|NCT00065507|571452|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
239213|NCT00065507|571453|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
239214|NCT00065468|571518|P3|NOT COMPLETED|Overall Study||210
239215|NCT00065468|571519|P2|NOT COMPLETED|Overall Study||209
239216|NCT00065468|571520|P1|NOT COMPLETED|Overall Study||207
239217|NCT00065468|571518|P3|COMPLETED|Overall Study||0
239218|NCT00065468|571519|P2|COMPLETED|Overall Study||0
239219|NCT00065468|571520|P1|COMPLETED|Overall Study||0
239220|NCT00065468|571518|P3|Received Treatment|Overall Study||208
239221|NCT00065468|571519|P2|Received Treatment|Overall Study||208
239222|NCT00065468|571520|P1|Received Treatment|Overall Study||200
239223|NCT00065468|571518|P3|STARTED|Overall Study||210
239224|NCT00065468|571519|P2|STARTED|Overall Study||209
239225|NCT00065468|571520|P1|STARTED|Overall Study||207
239226|NCT00065442|571551|P2|NOT COMPLETED|Overall Study||220
239227|NCT00065442|571552|P1|NOT COMPLETED|Overall Study||125
239228|NCT00065442|571551|P2|COMPLETED|Overall Study||121
239229|NCT00065442|571552|P1|COMPLETED|Overall Study||46
239230|NCT00065442|571551|P2|STARTED|Overall Study||341
239231|NCT00065442|571552|P1|STARTED|Overall Study||171
239232|NCT00065429|571567|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239233|NCT00065429|571568|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239234|NCT00065429|571569|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
239235|NCT00065429|571570|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239236|NCT00065429|571571|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239237|NCT00065429|571572|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239238|NCT00065429|571573|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239239|NCT00065429|571567|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239240|NCT00065429|571568|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239241|NCT00065429|571569|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
239242|NCT00065429|571570|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239243|NCT00065429|571571|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239244|NCT00065429|571572|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239245|NCT00065429|571573|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
239246|NCT00065429|571567|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239247|NCT00065429|571568|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239248|NCT00065429|571569|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
239249|NCT00065429|571570|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239250|NCT00065429|571571|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239251|NCT00065429|571572|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239252|NCT00065429|571573|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
239253|NCT00065429|571567|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
239254|NCT00065429|571568|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
239255|NCT00065429|571569|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
239256|NCT00065429|571570|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
239257|NCT00065429|571571|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
239258|NCT00065429|571572|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
239259|NCT00065429|571573|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
239260|NCT00065429|571567|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
239261|NCT00065429|571568|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
239262|NCT00065429|571569|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
239263|NCT00065429|571570|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
239264|NCT00065429|571571|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
239265|NCT00065429|571572|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
239266|NCT00065429|571573|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
239267|NCT00065429|571567|P7|STARTED|Phase I - May 2001 - Oct 2002||4
239268|NCT00065429|571568|P6|STARTED|Phase I - May 2001 - Oct 2002||4
239269|NCT00065429|571569|P5|STARTED|Phase I - May 2001 - Oct 2002||9
239270|NCT00065429|571570|P4|STARTED|Phase I - May 2001 - Oct 2002||4
239271|NCT00065429|571571|P3|STARTED|Phase I - May 2001 - Oct 2002||4
239272|NCT00065429|571572|P2|STARTED|Phase I - May 2001 - Oct 2002||3
239273|NCT00065429|571573|P1|STARTED|Phase I - May 2001 - Oct 2002||4
239274|NCT00065260|571587|P2|NOT COMPLETED|Overall Study||1
239275|NCT00065260|571588|P1|NOT COMPLETED|Overall Study||0
239276|NCT00065260|571587|P2|COMPLETED|Overall Study||26
239277|NCT00065260|571588|P1|COMPLETED|Overall Study||27
239278|NCT00065260|571587|P2|STARTED|Overall Study||27
239279|NCT00065260|571588|P1|STARTED|Overall Study||27
239280|NCT00065156|571594|P1|NOT COMPLETED|Overall Study||124
239282|NCT00065156|571594|P1|Modified Intent to Treat Population|Overall Study||94
239283|NCT00065156|571594|P1|STARTED|Overall Study||148
239284|NCT00065065|571611|P2|NOT COMPLETED|Overall Study||20
239285|NCT00065065|571612|P1|NOT COMPLETED|Overall Study||10
239286|NCT00065065|571611|P2|COMPLETED|Overall Study||33
239287|NCT00065065|571612|P1|COMPLETED|Overall Study||42
239288|NCT00065065|571611|P2|STARTED|Overall Study||53
239289|NCT00065065|571612|P1|STARTED|Overall Study||52
239290|NCT00064844|571622|P2|NOT COMPLETED|Overall Study||19
239291|NCT00064844|571623|P1|NOT COMPLETED|Overall Study||8
239292|NCT00064844|571622|P2|COMPLETED|Overall Study||32
239293|NCT00064844|571623|P1|COMPLETED|Overall Study||37
239294|NCT00064844|571622|P2|12 Month Follow-up|Overall Study||32
239295|NCT00064844|571623|P1|12 Month Follow-up|Overall Study||37
239296|NCT00064844|571622|P2|6 Month Follow-up|Overall Study||40
239297|NCT00064844|571623|P1|6 Month Follow-up|Overall Study||39
239298|NCT00064844|571622|P2|3 Month Follow-up|Overall Study||47
239299|NCT00064844|571623|P1|3 Month Follow-up|Overall Study||40
239300|NCT00064844|571622|P2|2 Week Follow-up|Overall Study||51
239301|NCT00064844|571623|P1|2 Week Follow-up|Overall Study||45
239302|NCT00064844|571622|P2|STARTED|Overall Study||51
239303|NCT00064844|571623|P1|STARTED|Overall Study||45
239304|NCT00064792|571633|P2|NOT COMPLETED|Overall Study||0
239305|NCT00064792|571634|P1|NOT COMPLETED|Overall Study||5
239306|NCT00064792|571633|P2|COMPLETED|Overall Study||10
239307|NCT00064792|571634|P1|COMPLETED|Overall Study||8
239308|NCT00064792|571633|P2|STARTED|Overall Study||10
239309|NCT00064792|571634|P1|STARTED|Overall Study||13
239310|NCT00064753|571644|P2|NOT COMPLETED|Overall Study||648
239311|NCT00064753|571645|P1|NOT COMPLETED|Overall Study||674
239312|NCT00064753|571644|P2|COMPLETED|Overall Study||1406
239313|NCT00064753|571645|P1|COMPLETED|Overall Study||1382
239314|NCT00064753|571644|P2|STARTED|Overall Study||2054
239315|NCT00064753|571645|P1|STARTED|Overall Study||2056
239316|NCT00064701|571676|P3|NOT COMPLETED|Clinical Continuation Phase||140
239317|NCT00064701|571677|P2|NOT COMPLETED|Clinical Continuation Phase||178
239318|NCT00064701|571678|P1|NOT COMPLETED|Clinical Continuation Phase||170
239319|NCT00064701|571676|P3|COMPLETED|Clinical Continuation Phase||11
239320|NCT00064701|571677|P2|COMPLETED|Clinical Continuation Phase||4
239321|NCT00064701|571678|P1|COMPLETED|Clinical Continuation Phase||9
239322|NCT00064701|571676|P3|STARTED|Clinical Continuation Phase||151
239323|NCT00064701|571677|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
239324|NCT00064701|571678|P1|STARTED|Clinical Continuation Phase||179
239325|NCT00064701|571676|P3|NOT COMPLETED|One Year Post-transplant||72
239326|NCT00064701|571677|P2|NOT COMPLETED|One Year Post-transplant||43
239327|NCT00064701|571678|P1|NOT COMPLETED|One Year Post-transplant||40
239328|NCT00064701|571676|P3|COMPLETED|One Year Post-transplant||151
239329|NCT00064701|571677|P2|COMPLETED|One Year Post-transplant||183
239330|NCT00064701|571678|P1|COMPLETED|One Year Post-transplant||179
239331|NCT00064701|571676|P3|Received Study Drug|One Year Post-transplant||212
239332|NCT00064701|571677|P2|Received Study Drug|One Year Post-transplant||214
239333|NCT00064701|571678|P1|Received Study Drug|One Year Post-transplant||212
239334|NCT00064701|571676|P3|STARTED|One Year Post-transplant||223
239335|NCT00064701|571677|P2|STARTED|One Year Post-transplant||226
239336|NCT00064701|571678|P1|STARTED|One Year Post-transplant||219
239337|NCT00064662|571730|P2|NOT COMPLETED|Overall Study||61
239338|NCT00064662|571731|P1|NOT COMPLETED|Overall Study||74
239339|NCT00064662|571730|P2|COMPLETED|Overall Study||265
239340|NCT00064662|571731|P1|COMPLETED|Overall Study||255
239341|NCT00064662|571730|P2|STARTED|Overall Study||326
239342|NCT00064662|571731|P1|STARTED|Overall Study||329
239343|NCT00064350|571742|P3|NOT COMPLETED|Cross-Over||0
239344|NCT00064350|571743|P2|NOT COMPLETED|Cross-Over||14
239345|NCT00064350|571744|P1|NOT COMPLETED|Cross-Over||6
239346|NCT00064350|571742|P3|COMPLETED|Cross-Over||0
239347|NCT00064350|571743|P2|COMPLETED|Cross-Over||13
239348|NCT00064350|571744|P1|COMPLETED|Cross-Over||4
239349|NCT00064350|571742|P3|Eligible and Treated|Cross-Over||0
239350|NCT00064350|571743|P2|Eligible and Treated|Cross-Over||21
239351|NCT00064350|571744|P1|Eligible and Treated|Cross-Over||7
239352|NCT00064350|571742|P3|Treated|Cross-Over||0
239353|NCT00064350|571743|P2|Treated|Cross-Over||26
239354|NCT00064350|571744|P1|Treated|Cross-Over||9
239355|NCT00064350|571742|P3|STARTED|Cross-Over||0
239356|NCT00064350|571743|P2|STARTED|Cross-Over||27
239357|NCT00064350|571744|P1|STARTED|Cross-Over||10
239358|NCT00064350|571742|P3|NOT COMPLETED|Randomization||0
239359|NCT00064350|571743|P2|NOT COMPLETED|Randomization||18
239360|NCT00064350|571744|P1|NOT COMPLETED|Randomization||26
239361|NCT00064350|571742|P3|COMPLETED|Randomization||0
239362|NCT00064350|571743|P2|COMPLETED|Randomization||28
239363|NCT00064350|571744|P1|COMPLETED|Randomization||33
239364|NCT00064350|571742|P3|Eligible and Treated|Randomization||0
239365|NCT00064350|571743|P2|Eligible and Treated|Randomization||31
239366|NCT00064350|571744|P1|Eligible and Treated|Randomization||50
239367|NCT00064350|571742|P3|Treated|Randomization||0
239368|NCT00064350|571743|P2|Treated|Randomization||40
239369|NCT00064350|571744|P1|Treated|Randomization||55
239370|NCT00064350|571742|P3|STARTED|Randomization||0
239371|NCT00064350|571743|P2|STARTED|Randomization||46
239372|NCT00064350|571744|P1|STARTED|Randomization||59
239373|NCT00064350|571742|P3|NOT COMPLETED|Induction Treatment||236
239374|NCT00064350|571743|P2|NOT COMPLETED|Induction Treatment||9
239375|NCT00064350|571744|P1|NOT COMPLETED|Induction Treatment||8
239376|NCT00064350|571742|P3|COMPLETED|Induction Treatment||1
239377|NCT00064350|571743|P2|COMPLETED|Induction Treatment||37
239378|NCT00064350|571744|P1|COMPLETED|Induction Treatment||51
239379|NCT00064350|571742|P3|Eligible and Treated|Induction Treatment||194
239380|NCT00064350|571743|P2|Eligible and Treated|Induction Treatment||46
239381|NCT00064350|571744|P1|Eligible and Treated|Induction Treatment||59
239382|NCT00064350|571742|P3|Treated|Induction Treatment||228
239383|NCT00064350|571743|P2|Treated|Induction Treatment||46
239384|NCT00064350|571744|P1|Treated|Induction Treatment||59
239385|NCT00064350|571742|P3|STARTED|Induction Treatment||237
239386|NCT00064350|571743|P2|STARTED|Induction Treatment||46
239387|NCT00064350|571744|P1|STARTED|Induction Treatment||59
239388|NCT00064259|571759|P4|NOT COMPLETED|Overall Study||1
239389|NCT00064259|571760|P3|NOT COMPLETED|Overall Study||0
239390|NCT00064259|571761|P2|NOT COMPLETED|Overall Study||0
239391|NCT00064259|571762|P1|NOT COMPLETED|Overall Study||1
239392|NCT00064259|571759|P4|COMPLETED|Overall Study||0
239393|NCT00064259|571760|P3|COMPLETED|Overall Study||6
239394|NCT00064259|571761|P2|COMPLETED|Overall Study||4
239395|NCT00064259|571762|P1|COMPLETED|Overall Study||3
239396|NCT00064259|571759|P4|STARTED|Overall Study||1
239397|NCT00064259|571760|P3|STARTED|Overall Study||6
239398|NCT00064259|571761|P2|STARTED|Overall Study||4
239399|NCT00064259|571762|P1|STARTED|Overall Study||4
239400|NCT00064038|571768|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
239401|NCT00064038|571769|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
239402|NCT00064038|571770|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
239403|NCT00064038|571768|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
239404|NCT00064038|571769|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
239405|NCT00064038|571770|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
239406|NCT00064038|571768|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
239407|NCT00064038|571769|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
239408|NCT00064038|571770|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
239409|NCT00064038|571768|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
239410|NCT00064038|571769|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
239411|NCT00064038|571770|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
239412|NCT00064038|571768|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
239413|NCT00064038|571769|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
239414|NCT00064038|571770|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
239415|NCT00064038|571768|P3|NOT COMPLETED|Initial Randomization||0
239416|NCT00064038|571769|P2|NOT COMPLETED|Initial Randomization||98
239417|NCT00064038|571770|P1|NOT COMPLETED|Initial Randomization||100
239418|NCT00064038|571768|P3|COMPLETED|Initial Randomization||0
239419|NCT00064038|571769|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
239420|NCT00064038|571770|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
239421|NCT00064038|571768|P3|Safety Population|Initial Randomization||0
239422|NCT00064038|571769|P2|Safety Population|Initial Randomization||94
239423|NCT00064038|571770|P1|Safety Population|Initial Randomization||96
239424|NCT00064038|571768|P3|Eligible and Analyzable|Initial Randomization||0
239425|NCT00064038|571769|P2|Eligible and Analyzable|Initial Randomization||95
239426|NCT00064038|571770|P1|Eligible and Analyzable|Initial Randomization||97
239427|NCT00064038|571768|P3|STARTED|Initial Randomization||0
239428|NCT00064038|571769|P2|STARTED|Initial Randomization||98
239429|NCT00064038|571770|P1|STARTED|Initial Randomization||100
239430|NCT00064025|571780|P1|NOT COMPLETED|Overall Study||7
239431|NCT00064025|571780|P1|COMPLETED|Overall Study||68
239432|NCT00064025|571780|P1|STARTED|Overall Study||75
239433|NCT00063986|571787|P1|NOT COMPLETED|Overall Study||6
239434|NCT00063986|571787|P1|COMPLETED|Overall Study||104
239435|NCT00063986|571787|P1|Eligible and Treated|Overall Study||104
239436|NCT00063986|571787|P1|Treated|Overall Study||105
239437|NCT00063986|571787|P1|STARTED|Overall Study||110
239438|NCT00063934|571799|P1|NOT COMPLETED|Overall Study||1
239439|NCT00063934|571799|P1|COMPLETED|Overall Study||30
239440|NCT00063934|571799|P1|STARTED|Overall Study||31
239441|NCT00063635|571808|P3|NOT COMPLETED|Overall Study||9
239442|NCT00063635|571809|P2|NOT COMPLETED|Overall Study||8
239443|NCT00063635|571810|P1|NOT COMPLETED|Overall Study||6
239444|NCT00063635|571808|P3|COMPLETED|Overall Study||49
239445|NCT00063635|571809|P2|COMPLETED|Overall Study||50
239446|NCT00063635|571810|P1|COMPLETED|Overall Study||51
239447|NCT00063635|571808|P3|STARTED|Overall Study||58
239448|NCT00063635|571809|P2|STARTED|Overall Study||58
239449|NCT00063635|571810|P1|STARTED|Overall Study||57
239450|NCT00063622|571851|P3|NOT COMPLETED|Overall Study||11
239451|NCT00063622|571852|P2|NOT COMPLETED|Overall Study||4
239452|NCT00063622|571853|P1|NOT COMPLETED|Overall Study||10
239453|NCT00063622|571851|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
239454|NCT00063622|571852|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
239455|NCT00063622|571853|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
239456|NCT00063622|571851|P3|STARTED|Overall Study||83
239457|NCT00063622|571852|P2|STARTED|Overall Study||84
239458|NCT00063622|571853|P1|STARTED|Overall Study||80
239459|NCT00063570|571878|P2|NOT COMPLETED|Overall Study||0
239460|NCT00063570|571879|P1|NOT COMPLETED|Overall Study||0
239461|NCT00063570|571878|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
239462|NCT00063570|571879|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
239463|NCT00063570|571878|P2|STARTED|Overall Study||21
239464|NCT00063570|571879|P1|STARTED|Overall Study||52
239465|NCT00063362|571895|P2|NOT COMPLETED|Overall Study||4
239466|NCT00063362|571896|P1|NOT COMPLETED|Overall Study||4
239467|NCT00063362|571895|P2|COMPLETED|Overall Study||22
239468|NCT00063362|571896|P1|COMPLETED|Overall Study||19
239469|NCT00063362|571895|P2|STARTED|Overall Study||26
239470|NCT00063362|571896|P1|STARTED|Overall Study||23
239471|NCT00063258|571904|P2|NOT COMPLETED|Overall Study||0
239472|NCT00063258|571905|P1|NOT COMPLETED|Overall Study||4
239473|NCT00063258|571904|P2|COMPLETED|Overall Study||0
239474|NCT00063258|571905|P1|COMPLETED|Overall Study||1
239475|NCT00063258|571904|P2|STARTED|Overall Study||0
239476|NCT00063258|571905|P1|STARTED|Overall Study||5
239477|NCT00063232|571911|P1|NOT COMPLETED|Overall Study||0
239478|NCT00063232|571911|P1|COMPLETED|Overall Study||26
239479|NCT00063232|571911|P1|STARTED|Overall Study||26
239480|NCT00063154|571917|P1|NOT COMPLETED|Overall Study||51
239481|NCT00063154|571917|P1|COMPLETED|Overall Study||0
239482|NCT00063154|571917|P1|STARTED|Overall Study||51
239483|NCT00062764|571924|P1|NOT COMPLETED|Overall Study||0
239484|NCT00062764|571924|P1|COMPLETED|Overall Study||18
239485|NCT00062764|571924|P1|STARTED|Overall Study||18
239486|NCT00062751|571937|P5|NOT COMPLETED|Overall Study||6
239487|NCT00062751|571938|P4|NOT COMPLETED|Overall Study||5
239488|NCT00062751|571939|P3|NOT COMPLETED|Overall Study||30
239489|NCT00062751|571940|P2|NOT COMPLETED|Overall Study||30
239490|NCT00062751|571941|P1|NOT COMPLETED|Overall Study||33
239491|NCT00062751|571937|P5|COMPLETED|Overall Study||0
239492|NCT00062751|571938|P4|COMPLETED|Overall Study||1
239493|NCT00062751|571939|P3|COMPLETED|Overall Study||3
239494|NCT00062751|571940|P2|COMPLETED|Overall Study||0
239495|NCT00062751|571941|P1|COMPLETED|Overall Study||0
239496|NCT00062751|571937|P5|STARTED|Overall Study||6
239497|NCT00062751|571938|P4|STARTED|Overall Study||6
239498|NCT00062751|571939|P3|STARTED|Overall Study||33
239499|NCT00062751|571940|P2|STARTED|Overall Study||30
239500|NCT00062751|571941|P1|STARTED|Overall Study||33
239501|NCT00062738|572012|P3|NOT COMPLETED|Overall Study||0
239502|NCT00062738|572013|P2|NOT COMPLETED|Overall Study||0
239503|NCT00062738|572014|P1|NOT COMPLETED|Overall Study||0
239504|NCT00062738|572012|P3|COMPLETED|Overall Study||17
239505|NCT00062738|572013|P2|COMPLETED|Overall Study||18
239506|NCT00062738|572014|P1|COMPLETED|Overall Study||17
239507|NCT00062738|572012|P3|STARTED|Overall Study||17
239508|NCT00062738|572013|P2|STARTED|Overall Study||18
239509|NCT00062738|572014|P1|STARTED|Overall Study||17
239510|NCT00062647|572027|P2|NOT COMPLETED|Overall Study||13
239511|NCT00062647|572028|P1|NOT COMPLETED|Overall Study||16
239512|NCT00062647|572027|P2|COMPLETED|Overall Study||17
239513|NCT00062647|572028|P1|COMPLETED|Overall Study||14
239514|NCT00062647|572027|P2|STARTED|Overall Study||30
239515|NCT00062647|572028|P1|STARTED|Overall Study||30
239516|NCT00062439|572034|P1|NOT COMPLETED|Consolidation Chemotherapy||2
239517|NCT00062439|572034|P1|COMPLETED|Consolidation Chemotherapy||20
239518|NCT00062439|572034|P1|STARTED|Consolidation Chemotherapy||22
239519|NCT00062439|572034|P1|NOT COMPLETED|Surgery||7
239520|NCT00062439|572034|P1|COMPLETED|Surgery||22
239521|NCT00062439|572034|P1|STARTED|Surgery||29
239522|NCT00062439|572034|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
239523|NCT00062439|572034|P1|COMPLETED|Post Chemoradiation Assessment||29
239524|NCT00062439|572034|P1|STARTED|Post Chemoradiation Assessment||38
239525|NCT00062439|572034|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
239526|NCT00062439|572034|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
239527|NCT00062439|572034|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
239528|NCT00062010|572046|P1|NOT COMPLETED|Overall Study||3
239529|NCT00062010|572046|P1|COMPLETED|Overall Study||34
239530|NCT00062010|572046|P1|Eligible and Treated|Overall Study||34
239531|NCT00062010|572046|P1|STARTED|Overall Study||37
239532|NCT00061945|572054|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
239533|NCT00061945|572055|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
239534|NCT00061945|572054|P2|COMPLETED|Course IV: Alemtuzumab||50
239535|NCT00061945|572055|P1|COMPLETED|Course IV: Alemtuzumab||18
239536|NCT00061945|572054|P2|STARTED|Course IV: Alemtuzumab||66
239537|NCT00061945|572055|P1|STARTED|Course IV: Alemtuzumab||25
239538|NCT00061945|572054|P2|NOT COMPLETED|Registration Through Course 3||115
239539|NCT00061945|572055|P1|NOT COMPLETED|Registration Through Course 3||94
239540|NCT00061945|572054|P2|COMPLETED|Registration Through Course 3||66
239541|NCT00061945|572055|P1|COMPLETED|Registration Through Course 3||25
239542|NCT00061945|572054|P2|STARTED|Registration Through Course 3||181
239543|NCT00061945|572055|P1|STARTED|Registration Through Course 3||119
239544|NCT00061932|572065|P2|NOT COMPLETED|Overall Study||4
239545|NCT00061932|572066|P1|NOT COMPLETED|Overall Study||13
239546|NCT00061932|572065|P2|COMPLETED|Overall Study||8
239547|NCT00061932|572066|P1|COMPLETED|Overall Study||16
239548|NCT00061932|572065|P2|STARTED|Overall Study||12
239549|NCT00061932|572066|P1|STARTED|Overall Study||29
239550|NCT00061893|572072|P1|NOT COMPLETED|Overall Study||18
239551|NCT00061893|572072|P1|COMPLETED|Overall Study||20
239552|NCT00061893|572072|P1|STARTED|Overall Study||38
239553|NCT00061633|572079|P2|NOT COMPLETED|Overall Study||11
239554|NCT00061633|572080|P1|NOT COMPLETED|Overall Study||5
239555|NCT00061633|572079|P2|COMPLETED|Overall Study||74
239556|NCT00061633|572080|P1|COMPLETED|Overall Study||79
239557|NCT00061633|572079|P2|STARTED|Overall Study||85
239558|NCT00061633|572080|P1|STARTED|Overall Study||84
239559|NCT00061373|572088|P2|NOT COMPLETED|Overall Study||0
239560|NCT00061373|572089|P1|NOT COMPLETED|Overall Study||0
239561|NCT00061373|572088|P2|COMPLETED|Overall Study||3
239562|NCT00061373|572089|P1|COMPLETED|Overall Study||15
239563|NCT00061373|572088|P2|Aspirin and Tinzaparin|Overall Study||3
239564|NCT00061373|572089|P1|Aspirin and Tinzaparin|Overall Study||15
239565|NCT00061373|572088|P2|STARTED|Overall Study||3
239566|NCT00061373|572089|P1|STARTED|Overall Study||15
239567|NCT00061048|572105|P1|NOT COMPLETED|Overall Study||22
239568|NCT00061048|572105|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
239569|NCT00061048|572105|P1|STARTED|Overall Study||29
239570|NCT00060944|572115|P2|NOT COMPLETED|Overall Study||134
239571|NCT00060944|572116|P1|NOT COMPLETED|Overall Study||136
239572|NCT00060944|572115|P2|COMPLETED|Overall Study||0
239573|NCT00060944|572116|P1|COMPLETED|Overall Study||0
239574|NCT00060944|572115|P2|Treated|Overall Study||130
239575|NCT00060944|572116|P1|Treated|Overall Study||130
239576|NCT00060944|572115|P2|STARTED|Overall Study||134
239577|NCT00060944|572116|P1|STARTED|Overall Study||136
239578|NCT00060840|572132|P2|NOT COMPLETED|Overall Study||9
239579|NCT00060840|572133|P1|NOT COMPLETED|Overall Study||4
239580|NCT00060840|572132|P2|COMPLETED|Overall Study||68
239581|NCT00060840|572133|P1|COMPLETED|Overall Study||69
239582|NCT00060840|572132|P2|STARTED|Overall Study||77
239583|NCT00060840|572133|P1|STARTED|Overall Study||73
239584|NCT00060528|572139|P4|NOT COMPLETED|Overall Study||0
239585|NCT00060528|572140|P3|NOT COMPLETED|Overall Study||0
239586|NCT00060528|572141|P2|NOT COMPLETED|Overall Study||0
239587|NCT00060528|572142|P1|NOT COMPLETED|Overall Study||0
239588|NCT00060528|572139|P4|COMPLETED|Overall Study||8
239589|NCT00060528|572140|P3|COMPLETED|Overall Study||7
239590|NCT00060528|572141|P2|COMPLETED|Overall Study||9
239591|NCT00060528|572142|P1|COMPLETED|Overall Study||8
239592|NCT00060528|572139|P4|STARTED|Overall Study||8
239593|NCT00060528|572140|P3|STARTED|Overall Study||7
239594|NCT00060528|572141|P2|STARTED|Overall Study||9
239595|NCT00060528|572142|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
239596|NCT00060346|572156|P1|NOT COMPLETED|Overall Study||0
239597|NCT00060346|572156|P1|COMPLETED|Overall Study||16
239598|NCT00060346|572156|P1|Eligible and Treated|Overall Study||16
239599|NCT00060346|572156|P1|STARTED|Overall Study||16
239600|NCT00060008|572160|P1|NOT COMPLETED|Overall Study||0
239601|NCT00060008|572160|P1|COMPLETED|Overall Study||18
239602|NCT00060008|572160|P1|STARTED|Overall Study||18
239603|NCT00059839|572167|P2|NOT COMPLETED|Overall Study||17
239604|NCT00059839|572168|P1|NOT COMPLETED|Overall Study||12
239605|NCT00059839|572167|P2|COMPLETED|Overall Study||47
239606|NCT00059839|572168|P1|COMPLETED|Overall Study||53
239607|NCT00059839|572167|P2|STARTED|Overall Study||64
239608|NCT00059839|572168|P1|STARTED|Overall Study||65
239609|NCT00059787|572174|P1|NOT COMPLETED|Overall Study||20
239610|NCT00059787|572174|P1|COMPLETED|Overall Study||36
239611|NCT00059787|572174|P1|STARTED|Overall Study||56
239612|NCT00059475|572190|P8|NOT COMPLETED|Overall Study||0
239613|NCT00059475|572191|P7|NOT COMPLETED|Overall Study||0
239614|NCT00059475|572192|P6|NOT COMPLETED|Overall Study||0
239615|NCT00059475|572193|P5|NOT COMPLETED|Overall Study||0
239616|NCT00059475|572194|P4|NOT COMPLETED|Overall Study||0
239617|NCT00059475|572195|P3|NOT COMPLETED|Overall Study||0
239618|NCT00059475|572196|P2|NOT COMPLETED|Overall Study||0
239619|NCT00059475|572197|P1|NOT COMPLETED|Overall Study||0
239620|NCT00059475|572190|P8|COMPLETED|Overall Study||7
239621|NCT00059475|572191|P7|COMPLETED|Overall Study||34
239622|NCT00059475|572192|P6|COMPLETED|Overall Study||2
239623|NCT00059475|572193|P5|COMPLETED|Overall Study||33
239624|NCT00059475|572194|P4|COMPLETED|Overall Study||3
239625|NCT00059475|572195|P3|COMPLETED|Overall Study||24
239626|NCT00059475|572196|P2|COMPLETED|Overall Study||2
239627|NCT00059475|572197|P1|COMPLETED|Overall Study||33
239628|NCT00059475|572190|P8|STARTED|Overall Study||7
239629|NCT00059475|572191|P7|STARTED|Overall Study||34
239630|NCT00059475|572192|P6|STARTED|Overall Study||2
239631|NCT00059475|572193|P5|STARTED|Overall Study||33
239632|NCT00059475|572194|P4|STARTED|Overall Study||3
239633|NCT00059475|572195|P3|STARTED|Overall Study||24
239634|NCT00059475|572196|P2|STARTED|Overall Study||2
239635|NCT00059475|572197|P1|STARTED|Overall Study||33
239636|NCT00059332|572225|P2|NOT COMPLETED|Overall Study||2
239637|NCT00059332|572226|P1|NOT COMPLETED|Overall Study||3
239638|NCT00059332|572225|P2|COMPLETED|Overall Study||855
239639|NCT00059332|572226|P1|COMPLETED|Overall Study||840
239640|NCT00059332|572225|P2|STARTED|Overall Study||857
239641|NCT00059332|572226|P1|STARTED|Overall Study||843
239642|NCT00059215|572252|P4|NOT COMPLETED|Overall Study||15
239643|NCT00059215|572253|P3|NOT COMPLETED|Overall Study||15
239644|NCT00059215|572254|P2|NOT COMPLETED|Overall Study||14
239645|NCT00059215|572255|P1|NOT COMPLETED|Overall Study||13
239646|NCT00059215|572252|P4|COMPLETED|Overall Study||239
239647|NCT00059215|572253|P3|COMPLETED|Overall Study||236
239648|NCT00059215|572254|P2|COMPLETED|Overall Study||186
239649|NCT00059215|572255|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
239650|NCT00059215|572252|P4|STARTED|Overall Study||254
239651|NCT00059215|572253|P3|STARTED|Overall Study||251
239652|NCT00059215|572254|P2|STARTED|Overall Study||200
239653|NCT00059215|572255|P1|STARTED|Overall Study||200
239654|NCT00058825|572281|P1|NOT COMPLETED|Overall Study||22
239655|NCT00058825|572281|P1|COMPLETED|Overall Study||5
239656|NCT00058825|572281|P1|STARTED|Overall Study||27
239657|NCT00058552|572297|P2|NOT COMPLETED|Overall Study||62
239658|NCT00058552|572298|P1|NOT COMPLETED|Overall Study||65
239659|NCT00058552|572297|P2|COMPLETED|Overall Study||2
239660|NCT00058552|572298|P1|COMPLETED|Overall Study||0
239661|NCT00058552|572297|P2|STARTED|Overall Study||64
239662|NCT00058552|572298|P1|STARTED|Overall Study||65
239663|NCT00058539|572316|P1|NOT COMPLETED|Overall Study||42
239664|NCT00058539|572316|P1|COMPLETED|Overall Study||0
239665|NCT00058539|572316|P1|STARTED|Overall Study||42
239666|NCT00058214|572326|P1|NOT COMPLETED|Overall Study||1
239667|NCT00058214|572326|P1|COMPLETED|Overall Study||24
239668|NCT00058214|572326|P1|STARTED|Overall Study||25
239669|NCT00058019|572333|P2|NOT COMPLETED|Overall Study||0
239670|NCT00058019|572334|P1|NOT COMPLETED|Overall Study||0
239671|NCT00058019|572333|P2|COMPLETED|Overall Study||12
239672|NCT00058019|572334|P1|COMPLETED|Overall Study||39
239673|NCT00058019|572333|P2|STARTED|Overall Study||12
239674|NCT00058019|572334|P1|STARTED|Overall Study||39
239675|NCT00057954|572347|P1|NOT COMPLETED|Overall Study||2
239676|NCT00057954|572347|P1|COMPLETED|Overall Study||4
239677|NCT00057954|572347|P1|STARTED|Overall Study||6
239678|NCT00057941|572355|P2|NOT COMPLETED|Overall Study||74
239679|NCT00057941|572356|P1|NOT COMPLETED|Overall Study||74
239680|NCT00057941|572355|P2|COMPLETED|Overall Study||0
239681|NCT00057941|572356|P1|COMPLETED|Overall Study||0
239682|NCT00057941|572355|P2|Eligible|Overall Study||69
239683|NCT00057941|572356|P1|Eligible|Overall Study||72
239684|NCT00057941|572355|P2|Treated|Overall Study||74
239685|NCT00057941|572356|P1|Treated|Overall Study||74
239686|NCT00057941|572355|P2|STARTED|Overall Study||74
239687|NCT00057941|572356|P1|STARTED|Overall Study||74
239688|NCT00057876|572364|P2|NOT COMPLETED|Overall Study||27
239689|NCT00057876|572365|P1|NOT COMPLETED|Overall Study||29
239690|NCT00057876|572364|P2|COMPLETED|Overall Study||9
239691|NCT00057876|572365|P1|COMPLETED|Overall Study||9
239692|NCT00057876|572364|P2|Eligible and Treated|Overall Study||34
239693|NCT00057876|572365|P1|Eligible and Treated|Overall Study||34
239694|NCT00057876|572364|P2|Began Protocol Therapy|Overall Study||34
239695|NCT00057876|572365|P1|Began Protocol Therapy|Overall Study||35
239696|NCT00057876|572364|P2|Eligible|Overall Study||34
239697|NCT00057876|572365|P1|Eligible|Overall Study||37
239698|NCT00057876|572364|P2|STARTED|Overall Study||36
239699|NCT00057876|572365|P1|STARTED|Overall Study||38
239700|NCT00057863|572375|P1|NOT COMPLETED|Overall Study||3
239701|NCT00057863|572375|P1|COMPLETED|Overall Study||32
239702|NCT00057863|572375|P1|STARTED|Overall Study||35
239703|NCT00057837|572384|P2|NOT COMPLETED|Overall Study||39
239704|NCT00057837|572385|P1|NOT COMPLETED|Overall Study||31
239705|NCT00057837|572384|P2|COMPLETED|Overall Study||31
239706|NCT00057837|572385|P1|COMPLETED|Overall Study||39
239707|NCT00057837|572384|P2|Patients With Response|Overall Study||38
239708|NCT00057837|572385|P1|Patients With Response|Overall Study||46
239709|NCT00057837|572384|P2|Eligible and Treated|Overall Study||66
239710|NCT00057837|572385|P1|Eligible and Treated|Overall Study||66
239711|NCT00057837|572384|P2|Treated|Overall Study||68
239712|NCT00057837|572385|P1|Treated|Overall Study||69
239713|NCT00057837|572384|P2|STARTED|Overall Study||70
239714|NCT00057837|572385|P1|STARTED|Overall Study||70
239715|NCT00057811|572397|P2|NOT COMPLETED|Overall Study||12
239716|NCT00057811|572398|P1|NOT COMPLETED|Overall Study||10
239717|NCT00057811|572397|P2|COMPLETED|Overall Study||34
239718|NCT00057811|572398|P1|COMPLETED|Overall Study||41
239719|NCT00057811|572397|P2|STARTED|Overall Study||46
239720|NCT00057811|572398|P1|STARTED|Overall Study||51
239721|NCT00057785|572410|P1|NOT COMPLETED|Overall Study||0
239722|NCT00057785|572410|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
239723|NCT00057785|572410|P1|STARTED|Overall Study||68
239724|NCT00057746|572417|P3|NOT COMPLETED|Overall Study||1
239725|NCT00057746|572418|P2|NOT COMPLETED|Overall Study||0
239726|NCT00057746|572419|P1|NOT COMPLETED|Overall Study||0
239727|NCT00057746|572417|P3|COMPLETED|Overall Study||66
239728|NCT00057746|572418|P2|COMPLETED|Overall Study||67
239729|NCT00057746|572419|P1|COMPLETED|Overall Study||131
239730|NCT00057746|572417|P3|STARTED|Overall Study||67
239731|NCT00057746|572418|P2|STARTED|Overall Study||67
239732|NCT00057746|572419|P1|STARTED|Overall Study||131
239733|NCT00057681|572430|P3|NOT COMPLETED|Overall Study||34
239734|NCT00057681|572431|P2|NOT COMPLETED|Overall Study||72
239735|NCT00057681|572432|P1|NOT COMPLETED|Overall Study||65
239736|NCT00057681|572430|P3|COMPLETED|Overall Study||69
239737|NCT00057681|572431|P2|COMPLETED|Overall Study||67
239738|NCT00057681|572432|P1|COMPLETED|Overall Study||72
239739|NCT00057681|572430|P3|STARTED|Overall Study||103
239740|NCT00057681|572431|P2|STARTED|Overall Study||139
239741|NCT00057681|572432|P1|STARTED|Overall Study||137
239742|NCT00057577|572448|P2|NOT COMPLETED|Overall Study||0
239743|NCT00057577|572449|P1|NOT COMPLETED|Overall Study||0
239744|NCT00057577|572448|P2|COMPLETED|Overall Study||225
239745|NCT00057577|572449|P1|COMPLETED|Overall Study||227
239746|NCT00057577|572448|P2|STARTED|Overall Study||225
239747|NCT00057577|572449|P1|STARTED|Overall Study||227
239748|NCT00057551|572460|P3|NOT COMPLETED|Overall Study||16
239749|NCT00057551|572461|P2|NOT COMPLETED|Overall Study||27
239750|NCT00057551|572462|P1|NOT COMPLETED|Overall Study||25
239751|NCT00057551|572460|P3|COMPLETED|Overall Study||80
239752|NCT00057551|572461|P2|COMPLETED|Overall Study||168
239753|NCT00057551|572462|P1|COMPLETED|Overall Study||175
239754|NCT00057551|572460|P3|STARTED|Overall Study||96
239755|NCT00057551|572461|P2|STARTED|Overall Study||195
239756|NCT00057551|572462|P1|STARTED|Overall Study||200
239757|NCT00057330|572472|P2|NOT COMPLETED|Overall Study||920
239758|NCT00057330|572473|P1|NOT COMPLETED|Overall Study||1132
239759|NCT00057330|572472|P2|COMPLETED|Overall Study||2826
239760|NCT00057330|572473|P1|COMPLETED|Overall Study||3445
239761|NCT00057330|572472|P2|STARTED|Overall Study||3746
239762|NCT00057330|572473|P1|STARTED|Overall Study||4577
239763|NCT00056862|572503|P2|NOT COMPLETED|Overall Study||0
239764|NCT00056862|572504|P1|NOT COMPLETED|Overall Study||1
239765|NCT00056862|572503|P2|COMPLETED|Overall Study||27
239766|NCT00056862|572504|P1|COMPLETED|Overall Study||30
239767|NCT00056862|572503|P2|STARTED|Overall Study||27
239768|NCT00056862|572504|P1|STARTED|Overall Study||31
239769|NCT00056563|572520|P2|NOT COMPLETED|Overall Study||0
239770|NCT00056563|572521|P1|NOT COMPLETED|Overall Study||0
239771|NCT00056563|572520|P2|COMPLETED|Overall Study||134
239772|NCT00056563|572521|P1|COMPLETED|Overall Study||121
239773|NCT00056563|572520|P2|STARTED|Overall Study||134
239774|NCT00056563|572521|P1|STARTED|Overall Study||121
239775|NCT00056550|572529|P1|NOT COMPLETED|Overall Study||0
239776|NCT00056550|572529|P1|COMPLETED|Overall Study||14
239777|NCT00056550|572529|P1|STARTED|Overall Study||14
239778|NCT00056498|572536|P2|NOT COMPLETED|Overall Study||7
239779|NCT00056498|572537|P1|NOT COMPLETED|Overall Study||5
239780|NCT00056498|572536|P2|COMPLETED|Overall Study||28
239781|NCT00056498|572537|P1|COMPLETED|Overall Study||25
239782|NCT00056498|572536|P2|STARTED|Overall Study||35
239783|NCT00056498|572537|P1|STARTED|Overall Study||30
239784|NCT00056472|572545|P2|NOT COMPLETED|Overall Study||69
239785|NCT00056472|572546|P1|NOT COMPLETED|Overall Study||48
239786|NCT00056472|572545|P2|COMPLETED|Overall Study||61
239787|NCT00056472|572546|P1|COMPLETED|Overall Study||81
239788|NCT00056472|572545|P2|STARTED|Overall Study||130
239789|NCT00056472|572546|P1|STARTED|Overall Study||129
239790|NCT00056407|572558|P2|NOT COMPLETED|Overall Study||1193
239791|NCT00056407|572559|P1|NOT COMPLETED|Overall Study||1211
239792|NCT00056407|572558|P2|COMPLETED|Overall Study||2912
239793|NCT00056407|572559|P1|COMPLETED|Overall Study||2915
239794|NCT00056407|572558|P2|STARTED|Overall Study||4105
239795|NCT00056407|572559|P1|STARTED|Overall Study||4126
239796|NCT00056316|572617|P2|NOT COMPLETED|Overall Study||3
239797|NCT00056316|572618|P1|NOT COMPLETED|Overall Study||3
239798|NCT00056316|572617|P2|COMPLETED|Overall Study||38
239799|NCT00056316|572618|P1|COMPLETED|Overall Study||30
239800|NCT00056316|572617|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
239801|NCT00056316|572618|P1|STARTED|Overall Study||33
239802|NCT00056160|572632|P2|NOT COMPLETED|Final Follow-up||0
239803|NCT00056160|572633|P1|NOT COMPLETED|Final Follow-up||6
239804|NCT00056160|572632|P2|COMPLETED|Final Follow-up||0
239805|NCT00056160|572633|P1|COMPLETED|Final Follow-up||0
239806|NCT00056160|572632|P2|STARTED|Final Follow-up||0
239807|NCT00056160|572633|P1|STARTED|Final Follow-up||6
239808|NCT00056160|572632|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
239809|NCT00056160|572633|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
239810|NCT00056160|572632|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
239811|NCT00056160|572633|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
239812|NCT00056160|572632|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
239813|NCT00056160|572633|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
239814|NCT00056160|572632|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
239815|NCT00056160|572633|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
239816|NCT00056160|572632|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
239817|NCT00056160|572633|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
239818|NCT00056160|572632|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
239819|NCT00056160|572633|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
239820|NCT00055692|572645|P1|NOT COMPLETED|Overall Study||0
239821|NCT00055692|572645|P1|COMPLETED|Overall Study||46
239822|NCT00055692|572645|P1|STARTED|Overall Study||46
239823|NCT00055601|572656|P2|NOT COMPLETED|Overall Study||2
239824|NCT00055601|572657|P1|NOT COMPLETED|Overall Study||2
239825|NCT00055601|572656|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
239826|NCT00055601|572657|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
239827|NCT00055601|572656|P2|STARTED|Overall Study||49
239828|NCT00055601|572657|P1|STARTED|Overall Study||48
239829|NCT00055497|572671|P4|NOT COMPLETED|Overall Study||90
239830|NCT00055497|572672|P3|NOT COMPLETED|Overall Study||2
239831|NCT00055497|572673|P2|NOT COMPLETED|Overall Study||3
239832|NCT00055497|572674|P1|NOT COMPLETED|Overall Study||5
239833|NCT00055497|572671|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
239834|NCT00055497|572672|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
239835|NCT00055497|572673|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
239836|NCT00055497|572674|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
239837|NCT00055497|572671|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
239838|NCT00055497|572672|P3|STARTED|Overall Study||18
239839|NCT00055497|572673|P2|STARTED|Overall Study||19
239840|NCT00055497|572674|P1|STARTED|Overall Study||18
239841|NCT00055471|572719|P3|NOT COMPLETED|Period 2: Extension Period||0
239842|NCT00055471|572720|P2|NOT COMPLETED|Period 2: Extension Period||0
239843|NCT00055471|572721|P1|NOT COMPLETED|Period 2: Extension Period||0
239844|NCT00055471|572719|P3|COMPLETED|Period 2: Extension Period||0
239845|NCT00055471|572720|P2|COMPLETED|Period 2: Extension Period||6
239846|NCT00055471|572721|P1|COMPLETED|Period 2: Extension Period||3
239847|NCT00055471|572719|P3|STARTED|Period 2: Extension Period||0
239848|NCT00055471|572720|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
239849|NCT00055471|572721|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
239850|NCT00055471|572719|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
239851|NCT00055471|572720|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
239852|NCT00055471|572721|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
239853|NCT00055471|572719|P3|COMPLETED|Period 1: Dose Escalation Period||0
239854|NCT00055471|572720|P2|COMPLETED|Period 1: Dose Escalation Period||8
239855|NCT00055471|572721|P1|COMPLETED|Period 1: Dose Escalation Period||3
239856|NCT00055471|572719|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
239857|NCT00055471|572720|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
239858|NCT00055471|572721|P1|STARTED|Period 1: Dose Escalation Period||3
239859|NCT00055237|572749|P2|NOT COMPLETED|Overall Study||0
239860|NCT00055237|572750|P1|NOT COMPLETED|Overall Study||0
239861|NCT00055237|572749|P2|COMPLETED|Overall Study||2
239862|NCT00055237|572750|P1|COMPLETED|Overall Study||17
239863|NCT00055237|572749|P2|STARTED|Overall Study||2
239864|NCT00055237|572750|P1|STARTED|Overall Study||17
239865|NCT00054847|572757|P2|NOT COMPLETED|Overall Study||100
239866|NCT00054847|572758|P1|NOT COMPLETED|Overall Study||98
239867|NCT00054847|572757|P2|COMPLETED|Overall Study||266
239868|NCT00054847|572758|P1|COMPLETED|Overall Study||269
239869|NCT00054847|572757|P2|STARTED|Overall Study||366
239870|NCT00054847|572758|P1|STARTED|Overall Study||367
239871|NCT00054717|572772|P2|NOT COMPLETED|Overall Study||299
239872|NCT00054717|572773|P1|NOT COMPLETED|Overall Study||262
239873|NCT00054717|572772|P2|COMPLETED|Overall Study||18
239874|NCT00054717|572773|P1|COMPLETED|Overall Study||51
239875|NCT00054717|572772|P2|STARTED|Overall Study||317
239876|NCT00054717|572773|P1|STARTED|Overall Study||313
239877|NCT00054704|572961|P2|NOT COMPLETED|Overall Study||5
239878|NCT00054704|572962|P1|NOT COMPLETED|Overall Study||5
239879|NCT00054704|572961|P2|COMPLETED|Overall Study||6
239880|NCT00054704|572962|P1|COMPLETED|Overall Study||4
239881|NCT00054704|572961|P2|STARTED|Overall Study||11
239882|NCT00054704|572962|P1|STARTED|Overall Study||9
239883|NCT00054691|572968|P1|NOT COMPLETED|Overall Study||3
239884|NCT00054691|572968|P1|COMPLETED|Overall Study||37
239885|NCT00054691|572968|P1|STARTED|Overall Study||40
239886|NCT00054665|572973|P2|NOT COMPLETED|Part B||0
239887|NCT00054665|572974|P1|NOT COMPLETED|Part B||0
239888|NCT00054665|572973|P2|COMPLETED|Part B||44
239889|NCT00054665|572974|P1|COMPLETED|Part B||0
239890|NCT00054665|572973|P2|STARTED|Part B|26 participants received only Part B|44
239891|NCT00054665|572974|P1|STARTED|Part B||0
239892|NCT00054665|572973|P2|NOT COMPLETED|Part A||0
239893|NCT00054665|572974|P1|NOT COMPLETED|Part A||0
239894|NCT00054665|572973|P2|COMPLETED|Part A||0
239895|NCT00054665|572974|P1|COMPLETED|Part A||23
239896|NCT00054665|572973|P2|STARTED|Part A||0
239897|NCT00054665|572974|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
239898|NCT00054639|572982|P1|NOT COMPLETED|Overall Study||2
239899|NCT00054639|572982|P1|COMPLETED|Overall Study||46
239900|NCT00054639|572982|P1|STARTED|Overall Study||48
239901|NCT00054327|572992|P6|NOT COMPLETED|Overall Study||0
239902|NCT00054327|572993|P5|NOT COMPLETED|Overall Study||0
239903|NCT00054327|572994|P4|NOT COMPLETED|Overall Study||0
239904|NCT00054327|572995|P3|NOT COMPLETED|Overall Study||0
239905|NCT00054327|572996|P2|NOT COMPLETED|Overall Study||0
239906|NCT00054327|572997|P1|NOT COMPLETED|Overall Study||1
239907|NCT00054327|572992|P6|COMPLETED|Overall Study||2
239908|NCT00054327|572993|P5|COMPLETED|Overall Study||10
239909|NCT00054327|572994|P4|COMPLETED|Overall Study||4
239910|NCT00054327|572995|P3|COMPLETED|Overall Study||3
239911|NCT00054327|572996|P2|COMPLETED|Overall Study||4
239912|NCT00054327|572997|P1|COMPLETED|Overall Study||10
239913|NCT00054327|572992|P6|STARTED|Overall Study||2
239914|NCT00054327|572993|P5|STARTED|Overall Study||10
239915|NCT00054327|572994|P4|STARTED|Overall Study||4
239916|NCT00054327|572995|P3|STARTED|Overall Study||3
239917|NCT00054327|572996|P2|STARTED|Overall Study||4
239918|NCT00054327|572997|P1|STARTED|Overall Study||11
239919|NCT00054275|573035|P1|NOT COMPLETED|Overall Study||11
239920|NCT00054275|573035|P1|COMPLETED|Overall Study||28
239921|NCT00054275|573035|P1|STARTED|Overall Study||39
239922|NCT00054028|573043|P1|NOT COMPLETED|Overall Study||0
239923|NCT00054028|573043|P1|COMPLETED|Overall Study||31
239924|NCT00054028|573043|P1|Phase II|Overall Study||22
239925|NCT00054028|573043|P1|Phase I|Overall Study||9
239926|NCT00054028|573043|P1|STARTED|Overall Study||31
239927|NCT00053846|573051|P2|NOT COMPLETED|Overall Study||27
239928|NCT00053846|573052|P1|NOT COMPLETED|Overall Study||26
239929|NCT00053846|573051|P2|COMPLETED|Overall Study||192
239930|NCT00053846|573052|P1|COMPLETED|Overall Study||187
239931|NCT00053846|573051|P2|STARTED|Overall Study||219
239932|NCT00053846|573052|P1|STARTED|Overall Study||213
239933|NCT00053703|573061|P3|NOT COMPLETED|Overall Study||15
239934|NCT00053703|573062|P2|NOT COMPLETED|Overall Study||13
239935|NCT00053703|573063|P1|NOT COMPLETED|Overall Study||18
239936|NCT00053703|573061|P3|COMPLETED|Overall Study||25
239937|NCT00053703|573062|P2|COMPLETED|Overall Study||28
239938|NCT00053703|573063|P1|COMPLETED|Overall Study||17
239939|NCT00053703|573061|P3|STARTED|Overall Study||40
239940|NCT00053703|573062|P2|STARTED|Overall Study||41
239941|NCT00053703|573063|P1|STARTED|Overall Study||35
239942|NCT00053495|573091|P5|NOT COMPLETED|Overall Study||0
239943|NCT00053495|573092|P4|NOT COMPLETED|Overall Study||0
239944|NCT00053495|573093|P3|NOT COMPLETED|Overall Study||0
239945|NCT00053495|573094|P2|NOT COMPLETED|Overall Study||0
239946|NCT00053495|573095|P1|NOT COMPLETED|Overall Study||0
239947|NCT00053495|573091|P5|COMPLETED|Overall Study||49
239948|NCT00053495|573092|P4|COMPLETED|Overall Study||51
239949|NCT00053495|573093|P3|COMPLETED|Overall Study||101
239950|NCT00053495|573094|P2|COMPLETED|Overall Study||101
239951|NCT00053495|573095|P1|COMPLETED|Overall Study||51
239952|NCT00053495|573091|P5|STARTED|Overall Study||49
239953|NCT00053495|573092|P4|STARTED|Overall Study||51
239954|NCT00053495|573093|P3|STARTED|Overall Study||101
239955|NCT00053495|573094|P2|STARTED|Overall Study||101
239956|NCT00053495|573095|P1|STARTED|Overall Study||51
239957|NCT00053482|573147|P5|NOT COMPLETED|Overall Study||0
239958|NCT00053482|573148|P4|NOT COMPLETED|Overall Study||0
239959|NCT00053482|573149|P3|NOT COMPLETED|Overall Study||0
239960|NCT00053482|573150|P2|NOT COMPLETED|Overall Study||0
239961|NCT00053482|573151|P1|NOT COMPLETED|Overall Study||0
239962|NCT00053482|573147|P5|COMPLETED|Overall Study||52
239963|NCT00053482|573148|P4|COMPLETED|Overall Study||50
239964|NCT00053482|573149|P3|COMPLETED|Overall Study||102
239965|NCT00053482|573150|P2|COMPLETED|Overall Study||102
239966|NCT00053482|573151|P1|COMPLETED|Overall Study||51
239967|NCT00053482|573147|P5|STARTED|Overall Study||52
239968|NCT00053482|573148|P4|STARTED|Overall Study||50
239969|NCT00053482|573149|P3|STARTED|Overall Study||102
239970|NCT00053482|573150|P2|STARTED|Overall Study||102
239971|NCT00053482|573151|P1|STARTED|Overall Study||51
239972|NCT00053417|573202|P4|NOT COMPLETED|Overall Study||6
239973|NCT00053417|573203|P3|NOT COMPLETED|Overall Study||1
239974|NCT00053417|573204|P2|NOT COMPLETED|Overall Study||2
239975|NCT00053417|573205|P1|NOT COMPLETED|Overall Study||2
239976|NCT00053417|573202|P4|COMPLETED|Overall Study||51
239977|NCT00053417|573203|P3|COMPLETED|Overall Study||49
239978|NCT00053417|573204|P2|COMPLETED|Overall Study||50
239979|NCT00053417|573205|P1|COMPLETED|Overall Study||45
239980|NCT00053417|573202|P4|STARTED|Overall Study||57
239981|NCT00053417|573203|P3|STARTED|Overall Study||50
239982|NCT00053417|573204|P2|STARTED|Overall Study||52
239983|NCT00053417|573205|P1|STARTED|Overall Study||47
239984|NCT00053365|573215|P1|NOT COMPLETED|Overall Study||6
239985|NCT00053365|573215|P1|COMPLETED|Overall Study||55
239986|NCT00053365|573215|P1|STARTED|Overall Study||61
239987|NCT00053014|573220|P1|NOT COMPLETED|Overall Study||0
239988|NCT00053014|573220|P1|COMPLETED|Overall Study||5
239989|NCT00053014|573220|P1|STARTED|Overall Study||5
239990|NCT00052962|573227|P2|NOT COMPLETED|Overall Study||2
239991|NCT00052962|573228|P1|NOT COMPLETED|Overall Study||1
239992|NCT00052962|573227|P2|COMPLETED|Overall Study||15
239993|NCT00052962|573228|P1|COMPLETED|Overall Study||12
239994|NCT00052962|573227|P2|STARTED|Overall Study||17
239995|NCT00052962|573228|P1|STARTED|Overall Study||13
239996|NCT00052429|573236|P1|NOT COMPLETED|Overall Study||0
239997|NCT00052429|573236|P1|COMPLETED|Overall Study||25
239998|NCT00052429|573236|P1|STARTED|Overall Study||25
239999|NCT00051636|573243|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
240000|NCT00051636|573244|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
240001|NCT00051636|573243|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
240088|NCT00050011|573475|P2|NOT COMPLETED|Overall Study||126
240002|NCT00051636|573244|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
240003|NCT00051636|573243|P2|STARTED|Period 2- Extended Observation Period||52
240004|NCT00051636|573244|P1|STARTED|Period 2- Extended Observation Period||75
240005|NCT00051636|573243|P2|NOT COMPLETED|Period 1 - Core||6
240006|NCT00051636|573244|P1|NOT COMPLETED|Period 1 - Core||4
240007|NCT00051636|573243|P2|COMPLETED|Period 1 - Core||76
240008|NCT00051636|573244|P1|COMPLETED|Period 1 - Core||86
240009|NCT00051636|573243|P2|STARTED|Period 1 - Core||82
240010|NCT00051636|573244|P1|STARTED|Period 1 - Core||90
240011|NCT00051558|573272|P2|NOT COMPLETED|Overall Study||96
240012|NCT00051558|573273|P1|NOT COMPLETED|Overall Study||91
240013|NCT00051558|573272|P2|COMPLETED|Overall Study||118
240014|NCT00051558|573273|P1|COMPLETED|Overall Study||123
240015|NCT00051558|573272|P2|STARTED|Overall Study||214
240016|NCT00051558|573273|P1|STARTED|Overall Study||214
240017|NCT00051363|573309|P2|NOT COMPLETED|Overall Study||144
240018|NCT00051363|573310|P1|NOT COMPLETED|Overall Study||115
240019|NCT00051363|573309|P2|COMPLETED|Overall Study||403
240020|NCT00051363|573310|P1|COMPLETED|Overall Study||443
240021|NCT00051363|573309|P2|Completed 6M Vist On-Study|Overall Study||403
240022|NCT00051363|573310|P1|Completed 6M Vist On-Study|Overall Study||443
240023|NCT00051363|573309|P2|Completed 6M Visit On-Treatment|Overall Study||372
240024|NCT00051363|573310|P1|Completed 6M Visit On-Treatment|Overall Study||427
240025|NCT00051363|573309|P2|Completed 2M Visit On-Study|Overall Study||432
240026|NCT00051363|573310|P1|Completed 2M Visit On-Study|Overall Study||468
240027|NCT00051363|573309|P2|Completed 2M Visit On-Treatment|Overall Study||417
240028|NCT00051363|573310|P1|Completed 2M Visit On-Treatment|Overall Study||456
240029|NCT00051363|573309|P2|Randomized & Analyzed|Overall Study||542
240030|NCT00051363|573310|P1|Randomized & Analyzed|Overall Study||556
240031|NCT00051363|573309|P2|STARTED|Overall Study||547
240032|NCT00051363|573310|P1|STARTED|Overall Study||558
240033|NCT00051168|573344|P1|NOT COMPLETED|Overall Study||135
240034|NCT00051168|573344|P1|COMPLETED|Overall Study||367
240035|NCT00051168|573344|P1|STARTED|Overall Study||502
240036|NCT00050167|573350|P2|NOT COMPLETED|Overall Study||1
240037|NCT00050167|573351|P1|NOT COMPLETED|Overall Study||1
240038|NCT00050167|573350|P2|COMPLETED|Overall Study||300
240039|NCT00050167|573351|P1|COMPLETED|Overall Study||301
240040|NCT00050167|573350|P2|STARTED|Overall Study||301
240041|NCT00050167|573351|P1|STARTED|Overall Study||302
240042|NCT00051025|573359|P2|NOT COMPLETED|Overall Study||4
240043|NCT00051025|573360|P1|NOT COMPLETED|Overall Study||2
240044|NCT00051025|573359|P2|COMPLETED|Overall Study||0
240045|NCT00051025|573360|P1|COMPLETED|Overall Study||3
240046|NCT00051025|573359|P2|STARTED|Overall Study||4
240047|NCT00051025|573360|P1|STARTED|Overall Study||5
240048|NCT00050986|573368|P1|NOT COMPLETED|Overall Study||2
240049|NCT00050986|573368|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
240050|NCT00050986|573368|P1|STARTED|Overall Study||55
240051|NCT00050960|573374|P2|NOT COMPLETED|Overall Study||304
240052|NCT00050960|573375|P1|NOT COMPLETED|Overall Study||302
240053|NCT00050960|573374|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
240054|NCT00050960|573375|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
240055|NCT00050960|573374|P2|STARTED|Overall Study||306
240056|NCT00050960|573375|P1|STARTED|Overall Study||306
240057|NCT00050778|573384|P3|NOT COMPLETED|Overall Study||18
240058|NCT00050778|573385|P2|NOT COMPLETED|Overall Study||21
240059|NCT00050778|573386|P1|NOT COMPLETED|Overall Study||45
240060|NCT00050778|573384|P3|COMPLETED|Overall Study||92
240061|NCT00050778|573385|P2|COMPLETED|Overall Study||92
240062|NCT00050778|573386|P1|COMPLETED|Overall Study||66
240063|NCT00050778|573384|P3|Treated|Overall Study||108
240064|NCT00050778|573385|P2|Treated|Overall Study||108
240065|NCT00050778|573386|P1|Treated|Overall Study||107
240066|NCT00050778|573384|P3|STARTED|Overall Study||110
240067|NCT00050778|573385|P2|STARTED|Overall Study||113
240068|NCT00050778|573386|P1|STARTED|Overall Study|Randomized.|111
240069|NCT00050622|573412|P1|NOT COMPLETED|Overall Study||1
240070|NCT00050622|573412|P1|COMPLETED|Overall Study||153
240071|NCT00050622|573412|P1|STARTED|Overall Study||154
240072|NCT00050089|573452|P4|NOT COMPLETED|Overall Study||0
240073|NCT00050089|573453|P3|NOT COMPLETED|Overall Study||0
240074|NCT00050089|573454|P2|NOT COMPLETED|Overall Study||0
240075|NCT00050089|573455|P1|NOT COMPLETED|Overall Study||0
240076|NCT00050089|573452|P4|COMPLETED|Overall Study|For primary outcome assessment|78
240077|NCT00050089|573453|P3|COMPLETED|Overall Study|For primary outcome assessment|86
240078|NCT00050089|573454|P2|COMPLETED|Overall Study|For primary outcome assessment|98
240079|NCT00050089|573455|P1|COMPLETED|Overall Study|For primary outcome assessment|106
240080|NCT00050089|573452|P4|Baseline|Overall Study||78
240081|NCT00050089|573453|P3|Baseline|Overall Study||86
240082|NCT00050089|573454|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
240083|NCT00050089|573455|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
240084|NCT00050089|573452|P4|STARTED|Overall Study||78
240085|NCT00050089|573453|P3|STARTED|Overall Study||86
240086|NCT00050089|573454|P2|STARTED|Overall Study||98
240087|NCT00050089|573455|P1|STARTED|Overall Study||106
240089|NCT00050011|573476|P1|NOT COMPLETED|Overall Study||121
240090|NCT00050011|573475|P2|COMPLETED|Overall Study||175
240091|NCT00050011|573476|P1|COMPLETED|Overall Study||180
240092|NCT00050011|573475|P2|Intent-to-treat Population|Overall Study||300
240093|NCT00050011|573476|P1|Intent-to-treat Population|Overall Study||300
240094|NCT00050011|573475|P2|STARTED|Overall Study||301
240095|NCT00050011|573476|P1|STARTED|Overall Study||301
240096|NCT00049842|573498|P2|NOT COMPLETED|Follow-up Phase||5
240097|NCT00049842|573499|P1|NOT COMPLETED|Follow-up Phase||7
240098|NCT00049842|573498|P2|COMPLETED|Follow-up Phase||189
240099|NCT00049842|573499|P1|COMPLETED|Follow-up Phase||211
240100|NCT00049842|573498|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
240101|NCT00049842|573499|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
240102|NCT00049842|573498|P2|NOT COMPLETED|Treatment Phase||78
240103|NCT00049842|573499|P1|NOT COMPLETED|Treatment Phase||93
240104|NCT00049842|573498|P2|COMPLETED|Treatment Phase||192
240105|NCT00049842|573499|P1|COMPLETED|Treatment Phase||177
240106|NCT00049842|573498|P2|STARTED|Treatment Phase||270
240107|NCT00049842|573499|P1|STARTED|Treatment Phase||270
240108|NCT00049543|573517|P2|NOT COMPLETED|Overall Study||9
240109|NCT00049543|573518|P1|NOT COMPLETED|Overall Study||2
240110|NCT00049543|573517|P2|COMPLETED|Overall Study||243
240111|NCT00049543|573518|P1|COMPLETED|Overall Study||249
240112|NCT00049543|573517|P2|STARTED|Overall Study||252
240113|NCT00049543|573518|P1|STARTED|Overall Study||251
240114|NCT00049530|573528|P1|NOT COMPLETED|Overall Study||32
240115|NCT00049530|573528|P1|COMPLETED|Overall Study||0
240116|NCT00049530|573528|P1|Eligible and Treated|Overall Study||29
240117|NCT00049530|573528|P1|STARTED|Overall Study||32
240118|NCT00049517|573537|P6|NOT COMPLETED|Conditioning/Transplant||6
240119|NCT00049517|573538|P5|NOT COMPLETED|Conditioning/Transplant||6
240120|NCT00049517|573539|P4|NOT COMPLETED|Conditioning/Transplant||43
240121|NCT00049517|573540|P3|NOT COMPLETED|Conditioning/Transplant||38
240122|NCT00049517|573541|P2|NOT COMPLETED|Conditioning/Transplant||50
240123|NCT00049517|573542|P1|NOT COMPLETED|Conditioning/Transplant||52
240124|NCT00049517|573537|P6|COMPLETED|Conditioning/Transplant||18
240125|NCT00049517|573538|P5|COMPLETED|Conditioning/Transplant||15
240126|NCT00049517|573539|P4|COMPLETED|Conditioning/Transplant||32
240127|NCT00049517|573540|P3|COMPLETED|Conditioning/Transplant||25
240128|NCT00049517|573541|P2|COMPLETED|Conditioning/Transplant||40
240129|NCT00049517|573542|P1|COMPLETED|Conditioning/Transplant||27
240130|NCT00049517|573537|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
240131|NCT00049517|573538|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
240132|NCT00049517|573539|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
240133|NCT00049517|573540|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
240134|NCT00049517|573541|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
240135|NCT00049517|573542|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
240136|NCT00049517|573537|P6|STARTED|Conditioning/Transplant||24
240137|NCT00049517|573538|P5|STARTED|Conditioning/Transplant||21
240138|NCT00049517|573539|P4|STARTED|Conditioning/Transplant||75
240139|NCT00049517|573540|P3|STARTED|Conditioning/Transplant||63
240140|NCT00049517|573541|P2|STARTED|Conditioning/Transplant||90
240141|NCT00049517|573542|P1|STARTED|Conditioning/Transplant||79
240142|NCT00049517|573537|P6|NOT COMPLETED|Induction||54
240143|NCT00049517|573538|P5|NOT COMPLETED|Induction||60
240144|NCT00049517|573539|P4|NOT COMPLETED|Induction||0
240145|NCT00049517|573540|P3|NOT COMPLETED|Induction||0
240146|NCT00049517|573541|P2|NOT COMPLETED|Induction||0
240147|NCT00049517|573542|P1|NOT COMPLETED|Induction||0
240148|NCT00049517|573537|P6|COMPLETED|Induction||108
240149|NCT00049517|573538|P5|COMPLETED|Induction||128
240150|NCT00049517|573539|P4|COMPLETED|Induction||75
240151|NCT00049517|573540|P3|COMPLETED|Induction||63
240152|NCT00049517|573541|P2|COMPLETED|Induction||90
240153|NCT00049517|573542|P1|COMPLETED|Induction||79
240154|NCT00049517|573537|P6|Treated|Induction||160
240155|NCT00049517|573538|P5|Treated|Induction||186
240156|NCT00049517|573539|P4|Treated|Induction||75
240157|NCT00049517|573540|P3|Treated|Induction||63
240158|NCT00049517|573541|P2|Treated|Induction||90
240159|NCT00049517|573542|P1|Treated|Induction||79
240160|NCT00049517|573537|P6|STARTED|Induction||162
240161|NCT00049517|573538|P5|STARTED|Induction||188
240162|NCT00049517|573539|P4|STARTED|Induction||75
240163|NCT00049517|573540|P3|STARTED|Induction||63
240164|NCT00049517|573541|P2|STARTED|Induction||90
240165|NCT00049517|573542|P1|STARTED|Induction||79
240166|NCT00049322|573554|P2|NOT COMPLETED|Overall Study||6
240167|NCT00049322|573555|P1|NOT COMPLETED|Overall Study||1
240168|NCT00049322|573554|P2|COMPLETED|Overall Study||9
240169|NCT00049322|573555|P1|COMPLETED|Overall Study||14
240170|NCT00049322|573554|P2|STARTED|Overall Study||15
240171|NCT00049322|573555|P1|STARTED|Overall Study||15
240172|NCT00049257|573567|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
240173|NCT00049257|573567|P1|COMPLETED|Follow-up Period for Survival Status||41
240174|NCT00049257|573567|P1|STARTED|Follow-up Period for Survival Status||45
240175|NCT00049257|573567|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
240176|NCT00049257|573567|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
240177|NCT00049257|573567|P1|STARTED|Carboplatin, Paclitaxel||58
240178|NCT00049127|573579|P5|NOT COMPLETED|Overall Study||0
240179|NCT00049127|573580|P4|NOT COMPLETED|Overall Study||0
240180|NCT00049127|573581|P3|NOT COMPLETED|Overall Study||1
240181|NCT00049127|573582|P2|NOT COMPLETED|Overall Study||0
240182|NCT00049127|573583|P1|NOT COMPLETED|Overall Study||0
240183|NCT00049127|573579|P5|COMPLETED|Overall Study||12
240184|NCT00049127|573580|P4|COMPLETED|Overall Study||0
240185|NCT00049127|573581|P3|COMPLETED|Overall Study||39
240186|NCT00049127|573582|P2|COMPLETED|Overall Study||0
240187|NCT00049127|573583|P1|COMPLETED|Overall Study||12
240188|NCT00049127|573579|P5|STARTED|Overall Study||12
240189|NCT00049127|573580|P4|STARTED|Overall Study||0
240190|NCT00049127|573581|P3|STARTED|Overall Study||40
240191|NCT00049127|573582|P2|STARTED|Overall Study||0
240192|NCT00049127|573583|P1|STARTED|Overall Study||12
240193|NCT00049036|573612|P2|NOT COMPLETED|Overall Study||0
240194|NCT00049036|573613|P1|NOT COMPLETED|Overall Study||0
240195|NCT00049036|573612|P2|COMPLETED|Overall Study||55
240196|NCT00049036|573613|P1|COMPLETED|Overall Study||51
240197|NCT00049036|573612|P2|STARTED|Overall Study||55
240198|NCT00049036|573613|P1|STARTED|Overall Study||51
240199|NCT00048997|573621|P2|NOT COMPLETED|Overall Study||3
240200|NCT00048997|573622|P1|NOT COMPLETED|Overall Study||13
240201|NCT00048997|573621|P2|COMPLETED|Overall Study||177
240202|NCT00048997|573622|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
240203|NCT00048997|573621|P2|STARTED|Overall Study||180
240204|NCT00048997|573622|P1|STARTED|Overall Study||176
240205|NCT00048932|573629|P3|NOT COMPLETED|Open Label Period (OL)||441
240206|NCT00048932|573630|P2|NOT COMPLETED|Open Label Period (OL)||0
240207|NCT00048932|573631|P1|NOT COMPLETED|Open Label Period (OL)||0
240208|NCT00048932|573629|P3|COMPLETED|Open Label Period (OL)||743
240209|NCT00048932|573630|P2|COMPLETED|Open Label Period (OL)||0
240210|NCT00048932|573631|P1|COMPLETED|Open Label Period (OL)||0
240211|NCT00048932|573629|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
240212|NCT00048932|573630|P2|STARTED|Open Label Period (OL)||0
240213|NCT00048932|573631|P1|STARTED|Open Label Period (OL)||0
240214|NCT00048932|573629|P3|NOT COMPLETED|Double Blind Period (DB)||0
240215|NCT00048932|573630|P2|NOT COMPLETED|Double Blind Period (DB)||87
240216|NCT00048932|573631|P1|NOT COMPLETED|Double Blind Period (DB)||123
240217|NCT00048932|573629|P3|COMPLETED|Double Blind Period (DB)||0
240218|NCT00048932|573630|P2|COMPLETED|Double Blind Period (DB)||395
240219|NCT00048932|573631|P1|COMPLETED|Double Blind Period (DB)||836
240220|NCT00048932|573629|P3|STARTED|Double Blind Period (DB)||0
240221|NCT00048932|573630|P2|STARTED|Double Blind Period (DB)|Number Treated|482
240222|NCT00048932|573631|P1|STARTED|Double Blind Period (DB)|Number Treated|959
240223|NCT00048893|573655|P1|NOT COMPLETED|Overall Study||0
240224|NCT00048893|573655|P1|COMPLETED|Overall Study||37
240225|NCT00048893|573655|P1|STARTED|Overall Study||37
240226|NCT00048737|573666|P1|NOT COMPLETED|Overall Study||0
240227|NCT00048737|573666|P1|COMPLETED|Overall Study||70
240228|NCT00048737|573666|P1|STARTED|Overall Study||70
240229|NCT00048724|573672|P2|NOT COMPLETED|Overall Study||118
240230|NCT00048724|573673|P1|NOT COMPLETED|Overall Study||116
240231|NCT00048724|573672|P2|COMPLETED|Overall Study||197
240232|NCT00048724|573673|P1|COMPLETED|Overall Study||195
240233|NCT00048724|573672|P2|STARTED|Overall Study||315
240234|NCT00048724|573673|P1|STARTED|Overall Study||311
240235|NCT00048581|573683|P3|NOT COMPLETED|Open-Label Period||167
240236|NCT00048581|573684|P2|NOT COMPLETED|Open-Label Period||0
240237|NCT00048581|573685|P1|NOT COMPLETED|Open-Label Period||0
240238|NCT00048581|573683|P3|COMPLETED|Open-Label Period||150
240239|NCT00048581|573684|P2|COMPLETED|Open-Label Period||0
240240|NCT00048581|573685|P1|COMPLETED|Open-Label Period||0
240241|NCT00048581|573683|P3|STARTED|Open-Label Period||317
240242|NCT00048581|573684|P2|STARTED|Open-Label Period||0
240243|NCT00048581|573685|P1|STARTED|Open-Label Period||0
240244|NCT00048581|573683|P3|NOT COMPLETED|Double-Blind Period||0
240245|NCT00048581|573684|P2|NOT COMPLETED|Double-Blind Period||34
240246|NCT00048581|573685|P1|NOT COMPLETED|Double-Blind Period||35
240247|NCT00048581|573683|P3|COMPLETED|Double-Blind Period||0
240248|NCT00048581|573684|P2|COMPLETED|Double-Blind Period||99
240249|NCT00048581|573685|P1|COMPLETED|Double-Blind Period||223
240250|NCT00048581|573683|P3|STARTED|Double-Blind Period||0
240251|NCT00048581|573684|P2|STARTED|Double-Blind Period||133
240252|NCT00048581|573685|P1|STARTED|Double-Blind Period||258
240253|NCT00048568|573852|P3|NOT COMPLETED|Open-Label Period||160
240254|NCT00048568|573853|P2|NOT COMPLETED|Open-Label Period||0
240255|NCT00048568|573854|P1|NOT COMPLETED|Open-Label Period||0
240256|NCT00048568|573852|P3|COMPLETED|Open-Label Period||379
240257|NCT00048568|573853|P2|COMPLETED|Open-Label Period||0
240258|NCT00048568|573854|P1|COMPLETED|Open-Label Period||0
240259|NCT00048568|573852|P3|STARTED|Open-Label Period||539
240260|NCT00048568|573853|P2|STARTED|Open-Label Period||0
240261|NCT00048568|573854|P1|STARTED|Open-Label Period||0
240262|NCT00048568|573852|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
240263|NCT00048568|573853|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
240264|NCT00048568|573854|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
240265|NCT00048568|573852|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
240266|NCT00048568|573853|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
240267|NCT00048568|573854|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
240268|NCT00048568|573852|P3|STARTED|Double-Blind Period Days 170 to 365||0
240269|NCT00048568|573853|P2|STARTED|Double-Blind Period Days 170 to 365||174
240270|NCT00048568|573854|P1|STARTED|Double-Blind Period Days 170 to 365||401
240271|NCT00048568|573852|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
240272|NCT00048568|573853|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
240273|NCT00048568|573854|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
240274|NCT00048568|573852|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
240275|NCT00048568|573853|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
240276|NCT00048568|573854|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
240277|NCT00048568|573852|P3|STARTED|Double-Blind Period Days 1 to 169||0
240278|NCT00048568|573853|P2|STARTED|Double-Blind Period Days 1 to 169||219
240279|NCT00048568|573854|P1|STARTED|Double-Blind Period Days 1 to 169||433
240280|NCT00048542|574146|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
240281|NCT00048542|574147|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
240282|NCT00048542|574148|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240283|NCT00048542|574149|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240284|NCT00048542|574150|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240285|NCT00048542|574151|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240286|NCT00048542|574152|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240287|NCT00048542|574153|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
240288|NCT00048542|574146|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
240289|NCT00048542|574147|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
240290|NCT00048542|574148|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240291|NCT00048542|574149|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240292|NCT00048542|574150|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240293|NCT00048542|574151|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240294|NCT00048542|574152|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240295|NCT00048542|574153|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
240296|NCT00048542|574146|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
240297|NCT00048542|574147|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
240298|NCT00048542|574148|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
240299|NCT00048542|574149|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
240300|NCT00048542|574150|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
240301|NCT00048542|574151|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
240302|NCT00048542|574152|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
240303|NCT00048542|574153|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
240304|NCT00048542|574146|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
240305|NCT00048542|574147|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
240306|NCT00048542|574148|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
240307|NCT00048542|574149|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
240308|NCT00048542|574150|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
240309|NCT00048542|574151|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
240310|NCT00048542|574152|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
240311|NCT00048542|574153|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
240312|NCT00048542|574146|P8|COMPLETED|Open-Label Extension BSA Phase||0
240313|NCT00048542|574147|P7|COMPLETED|Open-Label Extension BSA Phase||0
240314|NCT00048542|574148|P6|COMPLETED|Open-Label Extension BSA Phase||47
240315|NCT00048542|574149|P5|COMPLETED|Open-Label Extension BSA Phase||59
240316|NCT00048542|574150|P4|COMPLETED|Open-Label Extension BSA Phase||0
240317|NCT00048542|574151|P3|COMPLETED|Open-Label Extension BSA Phase||0
240318|NCT00048542|574152|P2|COMPLETED|Open-Label Extension BSA Phase||0
240319|NCT00048542|574153|P1|COMPLETED|Open-Label Extension BSA Phase||0
240320|NCT00048542|574146|P8|STARTED|Open-Label Extension BSA Phase||0
240321|NCT00048542|574147|P7|STARTED|Open-Label Extension BSA Phase||0
240322|NCT00048542|574148|P6|STARTED|Open-Label Extension BSA Phase||57
240323|NCT00048542|574149|P5|STARTED|Open-Label Extension BSA Phase||71
240324|NCT00048542|574150|P4|STARTED|Open-Label Extension BSA Phase||0
240325|NCT00048542|574151|P3|STARTED|Open-Label Extension BSA Phase||0
240326|NCT00048542|574152|P2|STARTED|Open-Label Extension BSA Phase||0
240327|NCT00048542|574153|P1|STARTED|Open-Label Extension BSA Phase||0
240328|NCT00048542|574146|P8|NOT COMPLETED|Double-Blind Phase||0
240329|NCT00048542|574147|P7|NOT COMPLETED|Double-Blind Phase||0
240330|NCT00048542|574148|P6|NOT COMPLETED|Double-Blind Phase||0
240331|NCT00048542|574149|P5|NOT COMPLETED|Double-Blind Phase||0
240332|NCT00048542|574150|P4|NOT COMPLETED|Double-Blind Phase||0
240333|NCT00048542|574151|P3|NOT COMPLETED|Double-Blind Phase||1
240334|NCT00048542|574152|P2|NOT COMPLETED|Double-Blind Phase||1
240335|NCT00048542|574153|P1|NOT COMPLETED|Double-Blind Phase||3
240336|NCT00048542|574146|P8|COMPLETED|Double-Blind Phase||0
240337|NCT00048542|574147|P7|COMPLETED|Double-Blind Phase||0
240338|NCT00048542|574148|P6|COMPLETED|Double-Blind Phase||0
240339|NCT00048542|574149|P5|COMPLETED|Double-Blind Phase||0
240340|NCT00048542|574150|P4|COMPLETED|Double-Blind Phase||28
240341|NCT00048542|574151|P3|COMPLETED|Double-Blind Phase||29
240342|NCT00048542|574152|P2|COMPLETED|Double-Blind Phase||36
240343|NCT00048542|574153|P1|COMPLETED|Double-Blind Phase||35
240344|NCT00048542|574146|P8|STARTED|Double-Blind Phase||0
240345|NCT00048542|574147|P7|STARTED|Double-Blind Phase||0
240346|NCT00048542|574148|P6|STARTED|Double-Blind Phase||0
240347|NCT00048542|574149|P5|STARTED|Double-Blind Phase||0
240348|NCT00048542|574150|P4|STARTED|Double-Blind Phase||28
240349|NCT00048542|574151|P3|STARTED|Double-Blind Phase||30
240350|NCT00048542|574152|P2|STARTED|Double-Blind Phase||37
240351|NCT00048542|574153|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
240352|NCT00048347|574219|P1|NOT COMPLETED|Overall Study||2
240353|NCT00048347|574219|P1|COMPLETED|Overall Study||16
240354|NCT00048347|574219|P1|STARTED|Overall Study||18
240355|NCT00048165|574225|P2|NOT COMPLETED|Completed 12 Months Study||3
240356|NCT00048165|574226|P1|NOT COMPLETED|Completed 12 Months Study||3
240357|NCT00048165|574225|P2|COMPLETED|Completed 12 Months Study||167
240358|NCT00048165|574226|P1|COMPLETED|Completed 12 Months Study||162
240359|NCT00048165|574225|P2|STARTED|Completed 12 Months Study||170
240360|NCT00048165|574226|P1|STARTED|Completed 12 Months Study||165
240361|NCT00048165|574225|P2|NOT COMPLETED|Completed 6 Months Study||48
240362|NCT00048165|574226|P1|NOT COMPLETED|Completed 6 Months Study||51
240363|NCT00048165|574225|P2|COMPLETED|Completed 6 Months Study||170
240364|NCT00048165|574226|P1|COMPLETED|Completed 6 Months Study||165
240365|NCT00048165|574225|P2|STARTED|Completed 6 Months Study||218
240366|NCT00048165|574226|P1|STARTED|Completed 6 Months Study||216
240367|NCT00048074|574261|P3|NOT COMPLETED|Overall Study||97
240368|NCT00048074|574262|P2|NOT COMPLETED|Overall Study||87
240369|NCT00048074|574263|P1|NOT COMPLETED|Overall Study||81
240370|NCT00048074|574261|P3|COMPLETED|Overall Study||372
240371|NCT00048074|574262|P2|COMPLETED|Overall Study||361
240372|NCT00048074|574263|P1|COMPLETED|Overall Study||384
240373|NCT00048074|574261|P3|STARTED|Overall Study||469
240374|NCT00048074|574262|P2|STARTED|Overall Study||448
240375|NCT00048074|574263|P1|STARTED|Overall Study||465
240376|NCT00048061|574320|P4|NOT COMPLETED|Overall Study||79
240377|NCT00048061|574321|P3|NOT COMPLETED|Overall Study||84
240378|NCT00048061|574322|P2|NOT COMPLETED|Overall Study||73
240379|NCT00048061|574323|P1|NOT COMPLETED|Overall Study||75
240380|NCT00048061|574320|P4|COMPLETED|Overall Study||322
240381|NCT00048061|574321|P3|COMPLETED|Overall Study||316
240382|NCT00048061|574322|P2|COMPLETED|Overall Study||328
240383|NCT00048061|574323|P1|COMPLETED|Overall Study||325
240384|NCT00048061|574320|P4|STARTED|Overall Study||401
240385|NCT00048061|574321|P3|STARTED|Overall Study||400
240386|NCT00048061|574322|P2|STARTED|Overall Study||401
240387|NCT00048061|574323|P1|STARTED|Overall Study||400
240388|NCT00048035|574399|P8|NOT COMPLETED|Extension Year 2||3
240389|NCT00048035|574400|P7|NOT COMPLETED|Extension Year 2||3
240390|NCT00048035|574401|P6|NOT COMPLETED|Extension Year 2||0
240391|NCT00048035|574402|P5|NOT COMPLETED|Extension Year 2||0
240392|NCT00048035|574403|P4|NOT COMPLETED|Extension Year 2||0
240393|NCT00048035|574404|P3|NOT COMPLETED|Extension Year 2||0
240394|NCT00048035|574405|P2|NOT COMPLETED|Extension Year 2||0
240395|NCT00048035|574406|P1|NOT COMPLETED|Extension Year 2||0
240396|NCT00048035|574399|P8|COMPLETED|Extension Year 2||10
240397|NCT00048035|574400|P7|COMPLETED|Extension Year 2||11
240398|NCT00048035|574401|P6|COMPLETED|Extension Year 2||0
240399|NCT00048035|574402|P5|COMPLETED|Extension Year 2||0
240400|NCT00048035|574403|P4|COMPLETED|Extension Year 2||0
240401|NCT00048035|574404|P3|COMPLETED|Extension Year 2||0
240402|NCT00048035|574405|P2|COMPLETED|Extension Year 2||0
240403|NCT00048035|574406|P1|COMPLETED|Extension Year 2||0
240404|NCT00048035|574399|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
240405|NCT00048035|574400|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
240406|NCT00048035|574401|P6|STARTED|Extension Year 2||0
240407|NCT00048035|574402|P5|STARTED|Extension Year 2||0
240408|NCT00048035|574403|P4|STARTED|Extension Year 2||0
240409|NCT00048035|574404|P3|STARTED|Extension Year 2||0
240410|NCT00048035|574405|P2|STARTED|Extension Year 2||0
240411|NCT00048035|574406|P1|STARTED|Extension Year 2||0
240412|NCT00048035|574399|P8|NOT COMPLETED|Extension Year 1||11
240413|NCT00048035|574400|P7|NOT COMPLETED|Extension Year 1||11
240414|NCT00048035|574401|P6|NOT COMPLETED|Extension Year 1||0
240415|NCT00048035|574402|P5|NOT COMPLETED|Extension Year 1||0
240416|NCT00048035|574403|P4|NOT COMPLETED|Extension Year 1||0
240417|NCT00048035|574404|P3|NOT COMPLETED|Extension Year 1||0
240418|NCT00048035|574405|P2|NOT COMPLETED|Extension Year 1||0
240419|NCT00048035|574406|P1|NOT COMPLETED|Extension Year 1||0
240420|NCT00048035|574399|P8|COMPLETED|Extension Year 1||15
240421|NCT00048035|574400|P7|COMPLETED|Extension Year 1||16
240422|NCT00048035|574401|P6|COMPLETED|Extension Year 1||0
240423|NCT00048035|574402|P5|COMPLETED|Extension Year 1||0
240424|NCT00048035|574403|P4|COMPLETED|Extension Year 1||0
240425|NCT00048035|574404|P3|COMPLETED|Extension Year 1||0
240426|NCT00048035|574405|P2|COMPLETED|Extension Year 1||0
240427|NCT00048035|574406|P1|COMPLETED|Extension Year 1||0
240428|NCT00048035|574399|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
240429|NCT00048035|574400|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
240430|NCT00048035|574401|P6|STARTED|Extension Year 1||0
240431|NCT00048035|574402|P5|STARTED|Extension Year 1||0
240432|NCT00048035|574403|P4|STARTED|Extension Year 1||0
240433|NCT00048035|574404|P3|STARTED|Extension Year 1||0
240434|NCT00048035|574405|P2|STARTED|Extension Year 1||0
240435|NCT00048035|574406|P1|STARTED|Extension Year 1||0
240436|NCT00048035|574399|P8|NOT COMPLETED|Core Period||0
240437|NCT00048035|574400|P7|NOT COMPLETED|Core Period||0
240438|NCT00048035|574401|P6|NOT COMPLETED|Core Period||1
240439|NCT00048035|574402|P5|NOT COMPLETED|Core Period||1
240440|NCT00048035|574403|P4|NOT COMPLETED|Core Period||1
240441|NCT00048035|574404|P3|NOT COMPLETED|Core Period||1
240442|NCT00048035|574405|P2|NOT COMPLETED|Core Period||2
240443|NCT00048035|574406|P1|NOT COMPLETED|Core Period||4
240444|NCT00048035|574399|P8|COMPLETED|Core Period||0
240445|NCT00048035|574400|P7|COMPLETED|Core Period||0
240446|NCT00048035|574401|P6|COMPLETED|Core Period||14
240447|NCT00048035|574402|P5|COMPLETED|Core Period||15
240448|NCT00048035|574403|P4|COMPLETED|Core Period||14
240449|NCT00048035|574404|P3|COMPLETED|Core Period||14
240450|NCT00048035|574405|P2|COMPLETED|Core Period||13
240451|NCT00048035|574406|P1|COMPLETED|Core Period||11
240452|NCT00048035|574399|P8|STARTED|Core Period||0
240453|NCT00048035|574400|P7|STARTED|Core Period||0
240454|NCT00048035|574401|P6|STARTED|Core Period||15
240455|NCT00048035|574402|P5|STARTED|Core Period||16
240456|NCT00048035|574403|P4|STARTED|Core Period||15
240457|NCT00048035|574404|P3|STARTED|Core Period||15
240458|NCT00048035|574405|P2|STARTED|Core Period||15
240459|NCT00048035|574406|P1|STARTED|Core Period||15
240460|NCT00047879|574444|P2|NOT COMPLETED|Overall Study||3
240461|NCT00047879|574445|P1|NOT COMPLETED|Overall Study||4
240462|NCT00047879|574444|P2|COMPLETED|Overall Study||0
240463|NCT00047879|574445|P1|COMPLETED|Overall Study||0
240464|NCT00047879|574444|P2|STARTED|Overall Study||3
240465|NCT00047879|574445|P1|STARTED|Overall Study||4
240466|NCT00047619|574457|P2|NOT COMPLETED|Overall Study||0
240467|NCT00047619|574458|P1|NOT COMPLETED|Overall Study||0
240468|NCT00047619|574457|P2|COMPLETED|Overall Study||14
240469|NCT00047619|574458|P1|COMPLETED|Overall Study||14
240470|NCT00047619|574457|P2|STARTED|Overall Study||14
240471|NCT00047619|574458|P1|STARTED|Overall Study||14
240472|NCT00047463|574468|P2|NOT COMPLETED|Overall Study||3
240473|NCT00047463|574469|P1|NOT COMPLETED|Overall Study||0
240474|NCT00047463|574468|P2|COMPLETED|Overall Study||19
240475|NCT00047463|574469|P1|COMPLETED|Overall Study||13
240476|NCT00047463|574468|P2|STARTED|Overall Study||22
240477|NCT00047463|574469|P1|STARTED|Overall Study||13
240478|NCT00047385|574480|P2|NOT COMPLETED|Overall Study||500
240479|NCT00047385|574481|P1|NOT COMPLETED|Overall Study||267
240480|NCT00047385|574480|P2|COMPLETED|Overall Study||26232
240481|NCT00047385|574481|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
240482|NCT00047385|574480|P2|STARTED|Overall Study||26732
240483|NCT00047385|574481|P1|STARTED|Overall Study||26722
240484|NCT00047320|574499|P1|NOT COMPLETED|Overall Study||28
240485|NCT00047320|574499|P1|COMPLETED|Overall Study||76
240486|NCT00047320|574499|P1|STARTED|Overall Study||104
240487|NCT00047008|574505|P2|NOT COMPLETED|Overall Study||11
240488|NCT00047008|574506|P1|NOT COMPLETED|Overall Study||11
240489|NCT00047008|574505|P2|COMPLETED|Overall Study||360
240490|NCT00047008|574506|P1|COMPLETED|Overall Study||361
240491|NCT00047008|574505|P2|STARTED|Overall Study||371
240492|NCT00047008|574506|P1|STARTED|Overall Study||372
240493|NCT00046930|574514|P2|NOT COMPLETED|Overall Study||4
240494|NCT00046930|574515|P1|NOT COMPLETED|Overall Study||12
240495|NCT00046930|574514|P2|COMPLETED|Overall Study||221
240496|NCT00046930|574515|P1|COMPLETED|Overall Study||212
240497|NCT00046930|574514|P2|STARTED|Overall Study||225
240498|NCT00046930|574515|P1|STARTED|Overall Study||224
240499|NCT00046891|574530|P2|NOT COMPLETED|Overall Study||30
240500|NCT00046891|574531|P1|NOT COMPLETED|Overall Study||29
240501|NCT00046891|574530|P2|COMPLETED|Overall Study||83
240502|NCT00046891|574531|P1|COMPLETED|Overall Study||84
240503|NCT00046891|574530|P2|STARTED|Overall Study||113
240504|NCT00046891|574531|P1|STARTED|Overall Study||113
240505|NCT00046839|574551|P2|NOT COMPLETED|Overall Study||2
240506|NCT00046839|574552|P1|NOT COMPLETED|Overall Study||1
240507|NCT00046839|574551|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
240508|NCT00046839|574552|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
240509|NCT00046839|574551|P2|STARTED|Overall Study||13
240510|NCT00046839|574552|P1|STARTED|Overall Study||8
240511|NCT00046475|574561|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
240512|NCT00046475|574562|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
240513|NCT00046475|574563|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
240514|NCT00046475|574561|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
240515|NCT00046475|574562|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
240516|NCT00046475|574563|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
240517|NCT00046475|574561|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
240518|NCT00046475|574562|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
240519|NCT00046475|574563|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
240520|NCT00046475|574561|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
240521|NCT00046475|574562|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
240522|NCT00046475|574563|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
240523|NCT00046475|574561|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
240524|NCT00046475|574562|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
240525|NCT00046475|574563|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
240526|NCT00046475|574561|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
240527|NCT00046475|574562|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
240528|NCT00046475|574563|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
240529|NCT00046475|574561|P3|NOT COMPLETED|Titration (1 Week)||0
240530|NCT00046475|574562|P2|NOT COMPLETED|Titration (1 Week)||0
240531|NCT00046475|574563|P1|NOT COMPLETED|Titration (1 Week)||0
240532|NCT00046475|574561|P3|COMPLETED|Titration (1 Week)||0
240533|NCT00046475|574562|P2|COMPLETED|Titration (1 Week)||0
240534|NCT00046475|574563|P1|COMPLETED|Titration (1 Week)||136
240535|NCT00046475|574561|P3|STARTED|Titration (1 Week)||0
240536|NCT00046475|574562|P2|STARTED|Titration (1 Week)||0
240537|NCT00046475|574563|P1|STARTED|Titration (1 Week)||136
240538|NCT00046475|574561|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
240539|NCT00046475|574562|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
240540|NCT00046475|574563|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
240541|NCT00046475|574561|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
240542|NCT00046475|574562|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
240543|NCT00046475|574563|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
240544|NCT00046475|574561|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
240545|NCT00046475|574562|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
240546|NCT00046475|574563|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
240547|NCT00046228|574602|P3|NOT COMPLETED|1 Year||12
240548|NCT00046228|574603|P2|NOT COMPLETED|1 Year||14
240549|NCT00046228|574604|P1|NOT COMPLETED|1 Year||19
240550|NCT00046228|574602|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
240551|NCT00046228|574603|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
240552|NCT00046228|574604|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
240553|NCT00046228|574602|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
240554|NCT00046228|574603|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
240555|NCT00046228|574604|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
240556|NCT00046228|574602|P3|NOT COMPLETED|90 Days||15
240557|NCT00046228|574603|P2|NOT COMPLETED|90 Days||8
240558|NCT00046228|574604|P1|NOT COMPLETED|90 Days||13
240559|NCT00046228|574602|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
240560|NCT00046228|574603|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
240561|NCT00046228|574604|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
240562|NCT00046228|574602|P3|STARTED|90 Days||828
240563|NCT00046228|574603|P2|STARTED|90 Days||818
240564|NCT00046228|574604|P1|STARTED|90 Days||806
240565|NCT00045630|574639|P1|NOT COMPLETED|Overall Study||6
240566|NCT00045630|574639|P1|COMPLETED|Overall Study||71
240567|NCT00045630|574639|P1|Eligible and Began Protocol Therapy|Overall Study||74
240568|NCT00045630|574639|P1|Eligible|Overall Study||75
240569|NCT00045630|574639|P1|STARTED|Overall Study||77
240570|NCT00045487|574645|P1|NOT COMPLETED|Overall Study||11
240571|NCT00045487|574645|P1|COMPLETED|Overall Study||30
240572|NCT00045487|574645|P1|STARTED|Overall Study||41
240573|NCT00045305|574649|P1|NOT COMPLETED|Overall Study||14
240574|NCT00045305|574649|P1|COMPLETED|Overall Study||3
240575|NCT00045305|574649|P1|Eligible and Treated|Overall Study||17
240576|NCT00045305|574649|P1|STARTED|Overall Study||17
240577|NCT00045162|574660|P2|NOT COMPLETED|Overall Study||118
240578|NCT00045162|574661|P1|NOT COMPLETED|Overall Study||142
240579|NCT00045162|574660|P2|COMPLETED|Overall Study||217
240580|NCT00045162|574661|P1|COMPLETED|Overall Study||194
240581|NCT00045162|574660|P2|STARTED|Overall Study||335
240582|NCT00045162|574661|P1|STARTED|Overall Study||336
240583|NCT00044655|574675|P2|NOT COMPLETED|Overall Study||38
240584|NCT00044655|574676|P1|NOT COMPLETED|Overall Study||20
240585|NCT00044655|574675|P2|COMPLETED|Overall Study||79
240586|NCT00044655|574676|P1|COMPLETED|Overall Study||82
240587|NCT00044655|574675|P2|STARTED|Overall Study||117
240588|NCT00044655|574676|P1|STARTED|Overall Study||102
240589|NCT00044512|574682|P1|NOT COMPLETED|Follow Up||2
240590|NCT00044512|574682|P1|COMPLETED|Follow Up||135
240591|NCT00044512|574682|P1|STARTED|Follow Up||137
240592|NCT00044512|574682|P1|NOT COMPLETED|Treatment||0
240593|NCT00044512|574682|P1|COMPLETED|Treatment||137
240594|NCT00044512|574682|P1|STARTED|Treatment||137
240595|NCT00044213|574697|P4|NOT COMPLETED|Overall Study||136
240596|NCT00044213|574698|P3|NOT COMPLETED|Overall Study||138
240597|NCT00044213|574699|P2|NOT COMPLETED|Overall Study||112
240598|NCT00044213|574700|P1|NOT COMPLETED|Overall Study||100
240599|NCT00044213|574697|P4|COMPLETED|Overall Study||301
240600|NCT00044213|574698|P3|COMPLETED|Overall Study||294
240601|NCT00044213|574699|P2|COMPLETED|Overall Study||306
240602|NCT00044213|574700|P1|COMPLETED|Overall Study||321
240603|NCT00044213|574697|P4|STARTED|Overall Study||437
240604|NCT00044213|574698|P3|STARTED|Overall Study||432
240605|NCT00044213|574699|P2|STARTED|Overall Study||418
240606|NCT00044213|574700|P1|STARTED|Overall Study||421
240607|NCT00044044|574719|P5|NOT COMPLETED|Overall Study||36
240608|NCT00044044|574720|P4|NOT COMPLETED|Overall Study||44
240609|NCT00044044|574721|P3|NOT COMPLETED|Overall Study||40
240610|NCT00044044|574722|P2|NOT COMPLETED|Overall Study||41
240611|NCT00044044|574723|P1|NOT COMPLETED|Overall Study||44
240612|NCT00044044|574719|P5|COMPLETED|Overall Study||36
240613|NCT00044044|574720|P4|COMPLETED|Overall Study||29
240614|NCT00044044|574721|P3|COMPLETED|Overall Study||31
240615|NCT00044044|574722|P2|COMPLETED|Overall Study||28
240616|NCT00044044|574723|P1|COMPLETED|Overall Study||27
240617|NCT00044044|574719|P5|STARTED|Overall Study||72
240618|NCT00044044|574720|P4|STARTED|Overall Study||73
240619|NCT00044044|574721|P3|STARTED|Overall Study||71
240620|NCT00044044|574722|P2|STARTED|Overall Study||69
240621|NCT00044044|574723|P1|STARTED|Overall Study||71
240622|NCT00044005|574753|P3|NOT COMPLETED|Overall Study||22
240623|NCT00044005|574754|P2|NOT COMPLETED|Overall Study||14
240624|NCT00044005|574755|P1|NOT COMPLETED|Overall Study||19
240625|NCT00044005|574753|P3|COMPLETED|Overall Study||11
240626|NCT00044005|574754|P2|COMPLETED|Overall Study||19
240627|NCT00044005|574755|P1|COMPLETED|Overall Study||13
240628|NCT00044005|574753|P3|STARTED|Overall Study||33
240629|NCT00044005|574754|P2|STARTED|Overall Study||33
240630|NCT00044005|574755|P1|STARTED|Overall Study||32
240631|NCT00043979|574765|P3|NOT COMPLETED|Period 2||0
240632|NCT00043979|574766|P2|NOT COMPLETED|Period 2||0
240633|NCT00043979|574767|P1|NOT COMPLETED|Period 2||0
240634|NCT00043979|574765|P3|COMPLETED|Period 2||10
240635|NCT00043979|574766|P2|COMPLETED|Period 2||13
240636|NCT00043979|574767|P1|COMPLETED|Period 2||0
240637|NCT00043979|574765|P3|STARTED|Period 2||10
240638|NCT00043979|574766|P2|STARTED|Period 2||13
240639|NCT00043979|574767|P1|STARTED|Period 2||0
240640|NCT00043979|574765|P3|NOT COMPLETED|Period 1||3
240641|NCT00043979|574766|P2|NOT COMPLETED|Period 1||4
240642|NCT00043979|574767|P1|NOT COMPLETED|Period 1||7
240643|NCT00043979|574765|P3|COMPLETED|Period 1||10
240644|NCT00043979|574766|P2|COMPLETED|Period 1||13
240645|NCT00043979|574767|P1|COMPLETED|Period 1||23
240646|NCT00043979|574765|P3|STARTED|Period 1||13
240647|NCT00043979|574766|P2|STARTED|Period 1||17
240648|NCT00043979|574767|P1|STARTED|Period 1||30
240649|NCT00043186|574783|P9|NOT COMPLETED|Overall Study||17
240650|NCT00043186|574784|P8|NOT COMPLETED|Overall Study||16
240651|NCT00043186|574785|P7|NOT COMPLETED|Overall Study||17
240652|NCT00043186|574786|P6|NOT COMPLETED|Overall Study||8
240653|NCT00043186|574787|P5|NOT COMPLETED|Overall Study||18
240654|NCT00043186|574788|P4|NOT COMPLETED|Overall Study||22
240655|NCT00043186|574789|P3|NOT COMPLETED|Overall Study||20
240656|NCT00043186|574790|P2|NOT COMPLETED|Overall Study||15
240657|NCT00043186|574791|P1|NOT COMPLETED|Overall Study||17
240658|NCT00043186|574783|P9|COMPLETED|Overall Study||30
240659|NCT00043186|574784|P8|COMPLETED|Overall Study||31
240660|NCT00043186|574785|P7|COMPLETED|Overall Study||25
240661|NCT00043186|574786|P6|COMPLETED|Overall Study||39
240662|NCT00043186|574787|P5|COMPLETED|Overall Study||36
240663|NCT00043186|574788|P4|COMPLETED|Overall Study||19
240664|NCT00043186|574789|P3|COMPLETED|Overall Study||24
240665|NCT00043186|574790|P2|COMPLETED|Overall Study||29
240666|NCT00043186|574791|P1|COMPLETED|Overall Study||29
240667|NCT00043186|574783|P9|STARTED|Overall Study||47
240668|NCT00043186|574784|P8|STARTED|Overall Study||47
240669|NCT00043186|574785|P7|STARTED|Overall Study||42
240670|NCT00043186|574786|P6|STARTED|Overall Study||47
240671|NCT00043186|574787|P5|STARTED|Overall Study||54
240672|NCT00043186|574788|P4|STARTED|Overall Study||41
240673|NCT00043186|574789|P3|STARTED|Overall Study||44
240674|NCT00043186|574790|P2|STARTED|Overall Study||44
240675|NCT00043186|574791|P1|STARTED|Overall Study||46
240676|NCT00042991|575124|P7|NOT COMPLETED|Overall Study||2
240677|NCT00042991|575125|P6|NOT COMPLETED|Overall Study||5
240678|NCT00042991|575126|P5|NOT COMPLETED|Overall Study||3
240679|NCT00042991|575127|P4|NOT COMPLETED|Overall Study||2
240680|NCT00042991|575128|P3|NOT COMPLETED|Overall Study||6
240681|NCT00042991|575129|P2|NOT COMPLETED|Overall Study||40
240682|NCT00042991|575130|P1|NOT COMPLETED|Overall Study||6
240683|NCT00042991|575124|P7|COMPLETED|Overall Study||1
240684|NCT00042991|575125|P6|COMPLETED|Overall Study||0
240685|NCT00042991|575126|P5|COMPLETED|Overall Study||0
240686|NCT00042991|575127|P4|COMPLETED|Overall Study||0
240687|NCT00042991|575128|P3|COMPLETED|Overall Study||1
240688|NCT00042991|575129|P2|COMPLETED|Overall Study||3
240689|NCT00042991|575130|P1|COMPLETED|Overall Study||0
240690|NCT00042991|575124|P7|Phase-II Trial|Overall Study||0
240691|NCT00042991|575125|P6|Phase-II Trial|Overall Study||0
240692|NCT00042991|575126|P5|Phase-II Trial|Overall Study||0
240693|NCT00042991|575127|P4|Phase-II Trial|Overall Study||0
240694|NCT00042991|575128|P3|Phase-II Trial|Overall Study||0
240695|NCT00042991|575129|P2|Phase-II Trial|Overall Study||36
240696|NCT00042991|575130|P1|Phase-II Trial|Overall Study||0
240697|NCT00042991|575124|P7|Phase-I Trial|Overall Study||3
240698|NCT00042991|575125|P6|Phase-I Trial|Overall Study||5
240699|NCT00042991|575126|P5|Phase-I Trial|Overall Study||3
240700|NCT00042991|575127|P4|Phase-I Trial|Overall Study||2
240701|NCT00042991|575128|P3|Phase-I Trial|Overall Study||7
240702|NCT00042991|575129|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
240703|NCT00042991|575130|P1|Phase-I Trial|Overall Study||6
240704|NCT00042991|575124|P7|STARTED|Overall Study||3
240705|NCT00042991|575125|P6|STARTED|Overall Study||5
240706|NCT00042991|575126|P5|STARTED|Overall Study||3
240707|NCT00042991|575127|P4|STARTED|Overall Study||2
240708|NCT00042991|575128|P3|STARTED|Overall Study||7
240709|NCT00042991|575129|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
240710|NCT00042991|575130|P1|STARTED|Overall Study||6
240711|NCT00042939|575173|P2|NOT COMPLETED|Overall Study||21
240712|NCT00042939|575174|P1|NOT COMPLETED|Overall Study||24
240713|NCT00042939|575173|P2|COMPLETED|Overall Study||25
240714|NCT00042939|575174|P1|COMPLETED|Overall Study||24
240715|NCT00042939|575173|P2|Patients With EGFR Results Available|Overall Study||31
240716|NCT00042939|575174|P1|Patients With EGFR Results Available|Overall Study||30
240717|NCT00042939|575173|P2|Eligible and Began Protocol Therapy|Overall Study||43
240718|NCT00042939|575174|P1|Eligible and Began Protocol Therapy|Overall Study||44
240719|NCT00042939|575173|P2|Treated|Overall Study||45
240720|NCT00042939|575174|P1|Treated|Overall Study||46
240721|NCT00042939|575173|P2|STARTED|Overall Study||46
240722|NCT00042939|575174|P1|STARTED|Overall Study||48
240723|NCT00041938|575190|P2|NOT COMPLETED|Overall Study||31
240724|NCT00041938|575191|P1|NOT COMPLETED|Overall Study||38
240725|NCT00041938|575190|P2|COMPLETED|Overall Study||1111
240726|NCT00041938|575191|P1|COMPLETED|Overall Study||1125
240727|NCT00041938|575190|P2|Withdrew Consent|Overall Study||14
240728|NCT00041938|575191|P1|Withdrew Consent|Overall Study||20
240729|NCT00041938|575190|P2|Lost to Follow-up|Overall Study||17
240730|NCT00041938|575191|P1|Lost to Follow-up|Overall Study||18
240731|NCT00041938|575190|P2|Only Vital Status Known|Overall Study||46
240732|NCT00041938|575191|P1|Only Vital Status Known|Overall Study||44
240733|NCT00041938|575190|P2|Primary Endpoint|Overall Study||302
240734|NCT00041938|575191|P1|Primary Endpoint|Overall Study||320
240735|NCT00041938|575190|P2|Completed Follow-up|Overall Study||745
240736|NCT00041938|575191|P1|Completed Follow-up|Overall Study||761
240737|NCT00041938|575190|P2|STARTED|Overall Study||1142
240738|NCT00041938|575191|P1|STARTED|Overall Study||1163
240739|NCT00041080|575221|P2|NOT COMPLETED|Overall Study||10
240740|NCT00041080|575222|P1|NOT COMPLETED|Overall Study||30
240741|NCT00041080|575221|P2|COMPLETED|Overall Study||60
240742|NCT00041080|575222|P1|COMPLETED|Overall Study||39
240743|NCT00041080|575221|P2|STARTED|Overall Study|number patients enrolled on study|70
240744|NCT00041080|575222|P1|STARTED|Overall Study|number patients enrolled on study|69
240745|NCT00041067|575228|P1|NOT COMPLETED|Overall Study||76
240746|NCT00041067|575228|P1|COMPLETED|Overall Study||0
240747|NCT00041067|575228|P1|Eligible|Overall Study||74
240748|NCT00041067|575228|P1|STARTED|Overall Study||76
240749|NCT00040937|575235|P1|NOT COMPLETED|Maintenance||0
240750|NCT00040937|575235|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
240751|NCT00040937|575235|P1|STARTED|Maintenance||76
240752|NCT00040937|575235|P1|NOT COMPLETED|Autologous PBSCT||31
240753|NCT00040937|575235|P1|COMPLETED|Autologous PBSCT||77
240754|NCT00040937|575235|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
240755|NCT00040937|575235|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
240756|NCT00040937|575235|P1|COMPLETED|Induction/PBSC Mobilization||110
240757|NCT00040937|575235|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
240758|NCT00042432|575244|P2|NOT COMPLETED|Overall Study||7
240759|NCT00042432|575245|P1|NOT COMPLETED|Overall Study||9
240760|NCT00042432|575244|P2|COMPLETED|Overall Study||20
240761|NCT00042432|575245|P1|COMPLETED|Overall Study||18
240762|NCT00042432|575244|P2|STARTED|Overall Study||27
240763|NCT00042432|575245|P1|STARTED|Overall Study||27
240764|NCT00042224|575255|P2|NOT COMPLETED|Overall Study||3
240765|NCT00042224|575256|P1|NOT COMPLETED|Overall Study||3
240766|NCT00042224|575255|P2|COMPLETED|Overall Study||16
240767|NCT00042224|575256|P1|COMPLETED|Overall Study||17
240768|NCT00042224|575255|P2|STARTED|Overall Study||19
240769|NCT00042224|575256|P1|STARTED|Overall Study||20
240770|NCT00041756|575267|P5|NOT COMPLETED|Overall Study||60
240771|NCT00041756|575268|P4|NOT COMPLETED|Overall Study||16
240772|NCT00041756|575269|P3|NOT COMPLETED|Overall Study||13
240773|NCT00041756|575270|P2|NOT COMPLETED|Overall Study||15
240774|NCT00041756|575271|P1|NOT COMPLETED|Overall Study||8
240775|NCT00041756|575267|P5|COMPLETED|Overall Study||19
240776|NCT00041756|575268|P4|COMPLETED|Overall Study||64
240777|NCT00041756|575269|P3|COMPLETED|Overall Study||66
240778|NCT00041756|575270|P2|COMPLETED|Overall Study||65
240779|NCT00041756|575271|P1|COMPLETED|Overall Study||69
240780|NCT00041756|575267|P5|STARTED|Overall Study||79
240781|NCT00041756|575268|P4|STARTED|Overall Study||80
240782|NCT00041756|575269|P3|STARTED|Overall Study||79
240783|NCT00041756|575270|P2|STARTED|Overall Study||80
240784|NCT00041756|575271|P1|STARTED|Overall Study||77
240785|NCT00041717|575290|P2|NOT COMPLETED|Overall Study||12
240786|NCT00041717|575291|P1|NOT COMPLETED|Overall Study||33
240787|NCT00041717|575290|P2|COMPLETED|Overall Study||86
240788|NCT00041717|575291|P1|COMPLETED|Overall Study||81
240789|NCT00041717|575290|P2|STARTED|Overall Study||98
240790|NCT00041717|575291|P1|STARTED|Overall Study||114
240791|NCT00041392|575301|P2|NOT COMPLETED|Overall Study||0
240792|NCT00041392|575302|P1|NOT COMPLETED|Overall Study||0
240793|NCT00041392|575301|P2|COMPLETED|Overall Study||191
240794|NCT00041392|575302|P1|COMPLETED|Overall Study||198
240795|NCT00041392|575301|P2|STARTED|Overall Study||191
240796|NCT00041392|575302|P1|STARTED|Overall Study||198
240797|NCT00041132|575308|P1|NOT COMPLETED|Overall Study||30
240798|NCT00041132|575308|P1|COMPLETED|Overall Study||26
240799|NCT00041132|575308|P1|Eligible and Began Protocol Therapy|Overall Study||49
240800|NCT00041132|575308|P1|Eligible|Overall Study||49
240801|NCT00041132|575308|P1|STARTED|Overall Study||56
240802|NCT00040742|575318|P4|NOT COMPLETED|Overall Study||34
240803|NCT00040742|575319|P3|NOT COMPLETED|Overall Study||46
240804|NCT00040742|575320|P2|NOT COMPLETED|Overall Study||49
240805|NCT00040742|575321|P1|NOT COMPLETED|Overall Study||39
240806|NCT00040742|575318|P4|COMPLETED|Overall Study||152
240807|NCT00040742|575319|P3|COMPLETED|Overall Study||141
240808|NCT00040742|575320|P2|COMPLETED|Overall Study||134
240809|NCT00040742|575321|P1|COMPLETED|Overall Study||149
240810|NCT00040742|575318|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
240811|NCT00040742|575319|P3|STARTED|Overall Study||187
240812|NCT00040742|575320|P2|STARTED|Overall Study||183
240813|NCT00040742|575321|P1|STARTED|Overall Study||188
240814|NCT00040664|575335|P4|NOT COMPLETED|Overall Study||27
240815|NCT00040664|575336|P3|NOT COMPLETED|Overall Study||13
240816|NCT00040664|575337|P2|NOT COMPLETED|Overall Study||13
240817|NCT00040664|575338|P1|NOT COMPLETED|Overall Study||53
240818|NCT00040664|575335|P4|COMPLETED|Overall Study||8
240819|NCT00040664|575336|P3|COMPLETED|Overall Study||4
240820|NCT00040664|575337|P2|COMPLETED|Overall Study||4
240821|NCT00040664|575338|P1|COMPLETED|Overall Study||16
240822|NCT00040664|575335|P4|STARTED|Overall Study||35
240823|NCT00040664|575336|P3|STARTED|Overall Study||17
240824|NCT00040664|575337|P2|STARTED|Overall Study||17
240825|NCT00040664|575338|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
240826|NCT00040365|575386|P1|NOT COMPLETED|Overall Study||11
240827|NCT00040365|575386|P1|COMPLETED|Overall Study||19
240828|NCT00040365|575386|P1|Completed Follow Up Phase|Overall Study||19
240829|NCT00040365|575386|P1|STARTED|Overall Study||30
240830|NCT00039195|575395|P1|NOT COMPLETED|Overall Study||0
240831|NCT00039195|575395|P1|COMPLETED|Overall Study||98
240832|NCT00039195|575395|P1|STARTED|Overall Study||98
240833|NCT00039130|575399|P1|NOT COMPLETED|Overall Study||30
240834|NCT00039130|575399|P1|COMPLETED|Overall Study||75
240835|NCT00039130|575399|P1|STARTED|Overall Study||105
240836|NCT00039871|575405|P1|NOT COMPLETED|Overall Study||1384
240837|NCT00039871|575405|P1|COMPLETED|Overall Study||928
240838|NCT00039871|575405|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
240839|NCT00039741|575415|P4|NOT COMPLETED|Overall Study||14
240840|NCT00039741|575416|P3|NOT COMPLETED|Overall Study||11
240841|NCT00039741|575417|P2|NOT COMPLETED|Overall Study||12
240842|NCT00039741|575418|P1|NOT COMPLETED|Overall Study||15
240843|NCT00039741|575415|P4|COMPLETED|Overall Study||50
240844|NCT00039741|575416|P3|COMPLETED|Overall Study||54
240845|NCT00039741|575417|P2|COMPLETED|Overall Study||56
240846|NCT00039741|575418|P1|COMPLETED|Overall Study||51
240847|NCT00039741|575415|P4|Death|Overall Study||0
240848|NCT00039741|575416|P3|Death|Overall Study||0
240849|NCT00039741|575417|P2|Death|Overall Study||1
240850|NCT00039741|575418|P1|Death|Overall Study||0
240851|NCT00039741|575415|P4|STARTED|Overall Study||64
240852|NCT00039741|575416|P3|STARTED|Overall Study||65
240853|NCT00039741|575417|P2|STARTED|Overall Study||68
240854|NCT00039741|575418|P1|STARTED|Overall Study||66
240855|NCT00039377|575460|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
240856|NCT00039377|575461|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
240857|NCT00039377|575462|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
240858|NCT00039377|575463|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
240859|NCT00039377|575460|P4|COMPLETED|Course 5 (Transplant Assignments)||1
240860|NCT00039377|575461|P3|COMPLETED|Course 5 (Transplant Assignments)||19
240861|NCT00039377|575462|P2|COMPLETED|Course 5 (Transplant Assignments)||15
240862|NCT00039377|575463|P1|COMPLETED|Course 5 (Transplant Assignments)||0
240863|NCT00039377|575460|P4|STARTED|Course 5 (Transplant Assignments)||1
240864|NCT00039377|575461|P3|STARTED|Course 5 (Transplant Assignments)||19
240865|NCT00039377|575462|P2|STARTED|Course 5 (Transplant Assignments)||15
240866|NCT00039377|575463|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
240867|NCT00039377|575460|P4|NOT COMPLETED|Initial Registration||0
240868|NCT00039377|575461|P3|NOT COMPLETED|Initial Registration||0
240869|NCT00039377|575462|P2|NOT COMPLETED|Initial Registration||0
240870|NCT00039377|575463|P1|NOT COMPLETED|Initial Registration||22
240871|NCT00039377|575460|P4|COMPLETED|Initial Registration||0
240872|NCT00039377|575461|P3|COMPLETED|Initial Registration||0
240873|NCT00039377|575462|P2|COMPLETED|Initial Registration||0
240874|NCT00039377|575463|P1|COMPLETED|Initial Registration||35
240875|NCT00039377|575460|P4|STARTED|Initial Registration||0
240876|NCT00039377|575461|P3|STARTED|Initial Registration||0
240877|NCT00039377|575462|P2|STARTED|Initial Registration||0
240878|NCT00039377|575463|P1|STARTED|Initial Registration||57
240879|NCT00038948|575477|P2|NOT COMPLETED|Overall Study||77
240880|NCT00038948|575478|P1|NOT COMPLETED|Overall Study||169
240881|NCT00038948|575477|P2|COMPLETED|Overall Study||198
240882|NCT00038948|575478|P1|COMPLETED|Overall Study||386
240883|NCT00038948|575477|P2|STARTED|Overall Study||275
240884|NCT00038948|575478|P1|STARTED|Overall Study||555
240885|NCT00038857|575490|P1|NOT COMPLETED|Overall Study||1
240886|NCT00038857|575490|P1|COMPLETED|Overall Study||28
240887|NCT00038857|575490|P1|STARTED|Overall Study||29
240888|NCT00038610|575494|P1|NOT COMPLETED|Overall Study||0
240889|NCT00038610|575494|P1|COMPLETED|Overall Study||54
240890|NCT00038610|575494|P1|STARTED|Overall Study||54
240891|NCT00038467|575502|P2|NOT COMPLETED|Overall Study||542
240892|NCT00038467|575503|P1|NOT COMPLETED|Overall Study||542
240893|NCT00038467|575502|P2|COMPLETED|Overall Study||1830
240894|NCT00038467|575503|P1|COMPLETED|Overall Study||1810
240895|NCT00038467|575502|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
240896|NCT00038467|575503|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
240897|NCT00038467|575502|P2|STARTED|Overall Study||2372
240898|NCT00038467|575503|P1|STARTED|Overall Study||2352
240899|NCT00038103|575565|P2|NOT COMPLETED|Overall Study||56
240900|NCT00038103|575566|P1|NOT COMPLETED|Overall Study||55
240901|NCT00038103|575565|P2|COMPLETED|Overall Study||0
240902|NCT00038103|575566|P1|COMPLETED|Overall Study||0
240903|NCT00038103|575565|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
240904|NCT00038103|575566|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
240905|NCT00038103|575565|P2|STARTED|Overall Study||56
240906|NCT00038103|575566|P1|STARTED|Overall Study||55
240907|NCT00037830|575589|P3|NOT COMPLETED|Overall Study||1
240908|NCT00037830|575590|P2|NOT COMPLETED|Overall Study||7
240909|NCT00037830|575591|P1|NOT COMPLETED|Overall Study||10
240910|NCT00037830|575589|P3|COMPLETED|Overall Study||16
240911|NCT00037830|575590|P2|COMPLETED|Overall Study||31
240912|NCT00037830|575591|P1|COMPLETED|Overall Study||29
240913|NCT00037830|575589|P3|STARTED|Overall Study||17
240914|NCT00037830|575590|P2|STARTED|Overall Study||38
240915|NCT00037830|575591|P1|STARTED|Overall Study||39
240916|NCT00036569|575612|P1|NOT COMPLETED|Overall Study||0
240917|NCT00036569|575612|P1|COMPLETED|Overall Study||32
240918|NCT00036569|575612|P1|STARTED|Overall Study||32
240919|NCT00036270|575623|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
240920|NCT00036270|575624|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
240921|NCT00036270|575623|P2|COMPLETED|Study Treatment to 5 Year Report||1380
240922|NCT00036270|575624|P1|COMPLETED|Study Treatment to 5 Year Report||2333
240923|NCT00036270|575623|P2|Treated|Study Treatment to 5 Year Report||4814
240924|NCT00036270|575624|P1|Treated|Study Treatment to 5 Year Report||4852
240925|NCT00036270|575623|P2|STARTED|Study Treatment to 5 Year Report||4868
240926|NCT00036270|575624|P1|STARTED|Study Treatment to 5 Year Report||4898
240927|NCT00036270|575623|P2|NOT COMPLETED|Randomized to Study Treatment||7
240928|NCT00036270|575624|P1|NOT COMPLETED|Randomized to Study Treatment||6
240929|NCT00036270|575623|P2|COMPLETED|Randomized to Study Treatment||4868
240930|NCT00036270|575624|P1|COMPLETED|Randomized to Study Treatment||4898
240931|NCT00036270|575623|P2|STARTED|Randomized to Study Treatment||4875
240932|NCT00036270|575624|P1|STARTED|Randomized to Study Treatment||4904
240933|NCT00035932|575643|P3|NOT COMPLETED|Overall Study||49
240934|NCT00035932|575644|P2|NOT COMPLETED|Overall Study||60
240935|NCT00035932|575645|P1|NOT COMPLETED|Overall Study||56
240936|NCT00035932|575643|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
240937|NCT00035932|575644|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
240938|NCT00035932|575645|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
240939|NCT00035932|575643|P3|Discontinued on or After Week 96|Overall Study||6
240940|NCT00035932|575644|P2|Discontinued on or After Week 96|Overall Study||4
240941|NCT00035932|575645|P1|Discontinued on or After Week 96|Overall Study||4
240942|NCT00035932|575643|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
240943|NCT00035932|575644|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
240944|NCT00035932|575645|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
240945|NCT00035932|575643|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
240946|NCT00035932|575644|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
240947|NCT00035932|575645|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
240948|NCT00035932|575643|P3|STARTED|Overall Study|123 randomized, 118 treated|118
240949|NCT00035932|575644|P2|STARTED|Overall Study|115 randomized, 110 treated|110
240950|NCT00035932|575645|P1|STARTED|Overall Study|120 randomized, 119 treated|119
240951|NCT00035815|575771|P2|NOT COMPLETED|Overall Study||11
240952|NCT00035815|575772|P1|NOT COMPLETED|Overall Study||17
240953|NCT00035815|575771|P2|COMPLETED|Overall Study||152
240954|NCT00035815|575772|P1|COMPLETED|Overall Study||150
240955|NCT00035815|575771|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
240956|NCT00035815|575772|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
240957|NCT00035555|575785|P3|NOT COMPLETED|Overall Study||22
240958|NCT00035555|575786|P2|NOT COMPLETED|Overall Study||16
240959|NCT00035555|575787|P1|NOT COMPLETED|Overall Study||16
240960|NCT00035555|575785|P3|COMPLETED|Overall Study||51
240961|NCT00035555|575786|P2|COMPLETED|Overall Study||55
240962|NCT00035555|575787|P1|COMPLETED|Overall Study||58
240963|NCT00035555|575785|P3|Number Who Received Study Drug|Overall Study||71
240964|NCT00035555|575786|P2|Number Who Received Study Drug|Overall Study||71
240965|NCT00035555|575787|P1|Number Who Received Study Drug|Overall Study||74
240966|NCT00035555|575785|P3|Number Who Had Undergone Transplantation|Overall Study||73
240967|NCT00035555|575786|P2|Number Who Had Undergone Transplantation|Overall Study||71
240968|NCT00035555|575787|P1|Number Who Had Undergone Transplantation|Overall Study||74
240969|NCT00035555|575785|P3|STARTED|Overall Study|Randomized patients|73
240970|NCT00035555|575786|P2|STARTED|Overall Study|Randomized patients|71
240971|NCT00035555|575787|P1|STARTED|Overall Study|Randomized patients|74
240972|NCT00033917|575830|P2|NOT COMPLETED|Overall Study||0
240973|NCT00033917|575831|P1|NOT COMPLETED|Overall Study||0
240974|NCT00033917|575830|P2|COMPLETED|Overall Study||222
240975|NCT00033917|575831|P1|COMPLETED|Overall Study||209
240976|NCT00033917|575830|P2|STARTED|Overall Study||222
240977|NCT00033917|575831|P1|STARTED|Overall Study||209
240978|NCT00033657|575843|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
240979|NCT00033657|575844|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
240980|NCT00033657|575843|P2|COMPLETED|Adjuvant Chemotherapy||16
240981|NCT00033657|575844|P1|COMPLETED|Adjuvant Chemotherapy||18
240982|NCT00033657|575843|P2|STARTED|Adjuvant Chemotherapy||33
240983|NCT00033657|575844|P1|STARTED|Adjuvant Chemotherapy||36
240984|NCT00033657|575843|P2|NOT COMPLETED|Surgical Resection||3
240985|NCT00033657|575844|P1|NOT COMPLETED|Surgical Resection||0
240986|NCT00033657|575843|P2|COMPLETED|Surgical Resection||33
240987|NCT00033657|575844|P1|COMPLETED|Surgical Resection||36
240988|NCT00033657|575843|P2|STARTED|Surgical Resection||36
240989|NCT00033657|575844|P1|STARTED|Surgical Resection||36
240990|NCT00033657|575843|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
240991|NCT00033657|575844|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
240992|NCT00033657|575843|P2|COMPLETED|Neoadjuvant Chemotherapy||36
240993|NCT00033657|575844|P1|COMPLETED|Neoadjuvant Chemotherapy||36
240994|NCT00033657|575843|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
240995|NCT00033657|575844|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
240996|NCT00033657|575843|P2|Eligible|Neoadjuvant Chemotherapy||43
240997|NCT00033657|575844|P1|Eligible|Neoadjuvant Chemotherapy||42
240998|NCT00033657|575843|P2|STARTED|Neoadjuvant Chemotherapy||47
240999|NCT00033657|575844|P1|STARTED|Neoadjuvant Chemotherapy||50
241000|NCT00033631|575858|P2|NOT COMPLETED|Overall Study||15
241001|NCT00033631|575859|P1|NOT COMPLETED|Overall Study||18
241002|NCT00033631|575858|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
241003|NCT00033631|575859|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
241004|NCT00033631|575858|P2|STARTED|Overall Study||763
241005|NCT00033631|575859|P1|STARTED|Overall Study||769
241006|NCT00033540|575877|P1|NOT COMPLETED|Overall Study||57
241007|NCT00033540|575877|P1|COMPLETED|Overall Study||0
241008|NCT00033540|575877|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
241009|NCT00033540|575877|P1|Eligible|Overall Study||54
241010|NCT00033540|575877|P1|STARTED|Overall Study||57
241011|NCT00033514|575887|P2|NOT COMPLETED|Overall Study||4
241012|NCT00033514|575888|P1|NOT COMPLETED|Overall Study||1
241013|NCT00033514|575887|P2|COMPLETED|Overall Study||7
241014|NCT00033514|575888|P1|COMPLETED|Overall Study||15
241015|NCT00033514|575887|P2|STARTED|Overall Study||11
241016|NCT00033514|575888|P1|STARTED|Overall Study||16
241017|NCT00033371|575898|P2|NOT COMPLETED|Overall Study||10
241018|NCT00033371|575899|P1|NOT COMPLETED|Overall Study||6
241019|NCT00033371|575898|P2|COMPLETED|Overall Study||47
241020|NCT00033371|575899|P1|COMPLETED|Overall Study||49
241021|NCT00033371|575898|P2|STARTED|Overall Study||57
241022|NCT00033371|575899|P1|STARTED|Overall Study||55
241023|NCT00033293|575907|P2|NOT COMPLETED|Overall Study||18
241024|NCT00033293|575908|P1|NOT COMPLETED|Overall Study||10
241025|NCT00033293|575907|P2|COMPLETED|Overall Study||9
241026|NCT00033293|575908|P1|COMPLETED|Overall Study||16
241027|NCT00033293|575907|P2|STARTED|Overall Study||27
241028|NCT00033293|575908|P1|STARTED|Overall Study||26
241029|NCT00032630|575916|P2|NOT COMPLETED|Overall Study||43
241030|NCT00032630|575917|P1|NOT COMPLETED|Overall Study||49
241031|NCT00032630|575916|P2|COMPLETED|Overall Study||1061
241032|NCT00032630|575917|P1|COMPLETED|Overall Study||1050
241033|NCT00032630|575916|P2|STARTED|Overall Study||1104
241034|NCT00032630|575917|P1|STARTED|Overall Study||1099
241035|NCT00032591|575927|P2|NOT COMPLETED|Follow-up||5
241036|NCT00032591|575928|P1|NOT COMPLETED|Follow-up||2
241037|NCT00032591|575927|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
241038|NCT00032591|575928|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
241039|NCT00032591|575927|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
241040|NCT00032591|575928|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
241041|NCT00032591|575927|P2|NOT COMPLETED|Randomization||0
241042|NCT00032591|575928|P1|NOT COMPLETED|Randomization||0
241043|NCT00032591|575927|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
241044|NCT00032591|575928|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
241045|NCT00032591|575927|P2|STARTED|Randomization||1457
241046|NCT00032591|575928|P1|STARTED|Randomization|2922 underwent randomization|1465
241047|NCT00032591|575927|P2|NOT COMPLETED|Screening||415
241048|NCT00032591|575928|P1|NOT COMPLETED|Screening||408
241049|NCT00032591|575927|P2|COMPLETED|Screening||1457
241050|NCT00032591|575928|P1|COMPLETED|Screening|823 were excluded from the study|1465
241051|NCT00032591|575927|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
241052|NCT00032591|575928|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
241053|NCT00032487|575944|P2|NOT COMPLETED|Overall Study||120
241054|NCT00032487|575945|P1|NOT COMPLETED|Overall Study||139
241055|NCT00032487|575944|P2|COMPLETED|Overall Study||772
241056|NCT00032487|575945|P1|COMPLETED|Overall Study||760
241057|NCT00032487|575944|P2|STARTED|Overall Study||892
241058|NCT00032487|575945|P1|STARTED|Overall Study||899
241059|NCT00031694|575953|P1|NOT COMPLETED|Overall Study||19
241060|NCT00031694|575953|P1|COMPLETED|Overall Study||0
241061|NCT00031694|575953|P1|STARTED|Overall Study||19
241062|NCT00031551|575959|P2|NOT COMPLETED|Overall Study||0
241063|NCT00031551|575960|P1|NOT COMPLETED|Overall Study||2
241064|NCT00031551|575959|P2|COMPLETED|Overall Study||25
241065|NCT00031551|575960|P1|COMPLETED|Overall Study||0
241066|NCT00031551|575959|P2|STARTED|Overall Study||25
241067|NCT00031551|575960|P1|STARTED|Overall Study||2
241068|NCT00031486|575972|P2|NOT COMPLETED|Overall Study||12
241069|NCT00031486|575973|P1|NOT COMPLETED|Overall Study||7
241070|NCT00031486|575972|P2|COMPLETED|Overall Study||35
241071|NCT00031486|575973|P1|COMPLETED|Overall Study||33
241072|NCT00031486|575972|P2|STARTED|Overall Study||47
241073|NCT00031486|575973|P1|STARTED|Overall Study||40
241074|NCT00031460|575999|P2|NOT COMPLETED|Overall Study||14
241075|NCT00031460|576000|P1|NOT COMPLETED|Overall Study||9
241076|NCT00031460|575999|P2|COMPLETED|Overall Study||8
241077|NCT00031460|576000|P1|COMPLETED|Overall Study||15
241078|NCT00031460|575999|P2|STARTED|Overall Study||22
241079|NCT00031460|576000|P1|STARTED|Overall Study||24
241080|NCT00031447|576014|P2|NOT COMPLETED|Overall Study||7
241081|NCT00031447|576015|P1|NOT COMPLETED|Overall Study||10
241082|NCT00031447|576014|P2|COMPLETED|Overall Study||8
241083|NCT00031447|576015|P1|COMPLETED|Overall Study||4
241084|NCT00031447|576014|P2|STARTED|Overall Study||15
241085|NCT00031447|576015|P1|STARTED|Overall Study||14
241086|NCT00030992|576027|P1|NOT COMPLETED|Overall Study||0
241087|NCT00030992|576027|P1|COMPLETED|Overall Study||102
241088|NCT00030992|576027|P1|STARTED|Overall Study||102
241089|NCT00030901|576034|P3|NOT COMPLETED|Randomization||88
241090|NCT00030901|576035|P2|NOT COMPLETED|Randomization||101
241091|NCT00030901|576036|P1|NOT COMPLETED|Randomization||0
241092|NCT00030901|576034|P3|COMPLETED|Randomization||137
241093|NCT00030901|576035|P2|COMPLETED|Randomization||126
241094|NCT00030901|576036|P1|COMPLETED|Randomization||0
241095|NCT00030901|576034|P3|Eligible|Randomization||211
241096|NCT00030901|576035|P2|Eligible|Randomization||212
241097|NCT00030901|576036|P1|Eligible|Randomization||0
241098|NCT00030901|576034|P3|STARTED|Randomization||225
241099|NCT00030901|576035|P2|STARTED|Randomization||227
241100|NCT00030901|576036|P1|STARTED|Randomization||0
241101|NCT00030901|576034|P3|NOT COMPLETED|Initial Registration||0
241102|NCT00030901|576035|P2|NOT COMPLETED|Initial Registration||0
241103|NCT00030901|576036|P1|NOT COMPLETED|Initial Registration||167
241104|NCT00030901|576034|P3|COMPLETED|Initial Registration||0
241105|NCT00030901|576035|P2|COMPLETED|Initial Registration||0
241106|NCT00030901|576036|P1|COMPLETED|Initial Registration||452
241107|NCT00030901|576034|P3|STARTED|Initial Registration||0
241108|NCT00030901|576035|P2|STARTED|Initial Registration||0
241109|NCT00030901|576036|P1|STARTED|Initial Registration||619
241110|NCT00030823|576044|P1|NOT COMPLETED|Overall Study||1
241111|NCT00030823|576044|P1|COMPLETED|Overall Study||13
241112|NCT00030823|576044|P1|STARTED|Overall Study||14
241113|NCT00030147|576052|P4|NOT COMPLETED|Overall Study||0
241114|NCT00030147|576053|P3|NOT COMPLETED|Overall Study||0
241115|NCT00030147|576054|P2|NOT COMPLETED|Overall Study||1
241116|NCT00030147|576055|P1|NOT COMPLETED|Overall Study||0
241117|NCT00030147|576052|P4|COMPLETED|Overall Study||11
241118|NCT00030147|576053|P3|COMPLETED|Overall Study||16
241119|NCT00030147|576054|P2|COMPLETED|Overall Study||18
241120|NCT00030147|576055|P1|COMPLETED|Overall Study||17
241121|NCT00030147|576052|P4|STARTED|Overall Study||11
241122|NCT00030147|576053|P3|STARTED|Overall Study||16
241123|NCT00030147|576054|P2|STARTED|Overall Study||19
241124|NCT00030147|576055|P1|STARTED|Overall Study||17
241125|NCT00029172|576069|P1|NOT COMPLETED|Overall Study||6
241126|NCT00029172|576069|P1|COMPLETED|Overall Study||182
241127|NCT00029172|576069|P1|STARTED|Overall Study||188
241128|NCT00029146|576075|P2|NOT COMPLETED|Overall Study||1
241129|NCT00029146|576076|P1|NOT COMPLETED|Overall Study||2
241130|NCT00029146|576075|P2|COMPLETED|Overall Study||97
241131|NCT00029146|576076|P1|COMPLETED|Overall Study||95
241132|NCT00029146|576075|P2|STARTED|Overall Study||98
241133|NCT00029146|576076|P1|STARTED|Overall Study||97
241134|NCT00029107|576105|P2|NOT COMPLETED|Overall Study||0
241135|NCT00029107|576106|P1|NOT COMPLETED|Overall Study||0
241136|NCT00029107|576105|P2|COMPLETED|Overall Study||12
241137|NCT00029107|576106|P1|COMPLETED|Overall Study||12
241138|NCT00029107|576105|P2|STARTED|Overall Study||12
241139|NCT00029107|576106|P1|STARTED|Overall Study||12
241140|NCT00028769|576112|P1|NOT COMPLETED|Overall Study||41
241141|NCT00028769|576112|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
241142|NCT00028769|576112|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
241143|NCT00028769|576112|P1|Eligible|Overall Study||36
241144|NCT00028769|576112|P1|STARTED|Overall Study||41
241145|NCT00028262|576118|P1|NOT COMPLETED|Overall Study||1
241146|NCT00028262|576118|P1|COMPLETED|Overall Study||9
241147|NCT00028262|576118|P1|STARTED|Overall Study||10
241148|NCT00028093|576124|P2|NOT COMPLETED|Overall Study||0
241149|NCT00028093|576125|P1|NOT COMPLETED|Overall Study||0
241150|NCT00028093|576124|P2|COMPLETED|Overall Study||25
241151|NCT00028093|576125|P1|COMPLETED|Overall Study||25
241152|NCT00028093|576124|P2|STARTED|Overall Study||25
241153|NCT00028093|576125|P1|STARTED|Overall Study||25
241154|NCT00028002|576131|P1|NOT COMPLETED|Overall Study||11
241155|NCT00028002|576131|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
241156|NCT00028002|576131|P1|STARTED|Overall Study||63
241157|NCT00027560|576135|P1|NOT COMPLETED|Overall Study||1
241158|NCT00027560|576135|P1|COMPLETED|Overall Study||50
241159|NCT00027560|576135|P1|STARTED|Overall Study||51
241160|NCT00027378|576146|P2|NOT COMPLETED|Overall Study||3
241161|NCT00027378|576147|P1|NOT COMPLETED|Overall Study||0
241162|NCT00027378|576146|P2|COMPLETED|Overall Study||23
241163|NCT00027378|576147|P1|COMPLETED|Overall Study||24
241164|NCT00027378|576146|P2|STARTED|Overall Study||26
241165|NCT00027378|576147|P1|STARTED|Overall Study||24
241166|NCT00027027|576160|P5|NOT COMPLETED|Overall Study||8
241167|NCT00027027|576161|P4|NOT COMPLETED|Overall Study||3
241168|NCT00027027|576162|P3|NOT COMPLETED|Overall Study||4
241169|NCT00027027|576163|P2|NOT COMPLETED|Overall Study||3
241170|NCT00027027|576164|P1|NOT COMPLETED|Overall Study||3
241171|NCT00027027|576160|P5|COMPLETED|Overall Study||0
241172|NCT00027027|576161|P4|COMPLETED|Overall Study||0
241173|NCT00027027|576162|P3|COMPLETED|Overall Study||0
241174|NCT00027027|576163|P2|COMPLETED|Overall Study||0
241175|NCT00027027|576164|P1|COMPLETED|Overall Study||0
241176|NCT00027027|576160|P5|Treated Beyond Cycle 2|Overall Study||4
241177|NCT00027027|576161|P4|Treated Beyond Cycle 2|Overall Study||2
241178|NCT00027027|576162|P3|Treated Beyond Cycle 2|Overall Study||2
241179|NCT00027027|576163|P2|Treated Beyond Cycle 2|Overall Study||1
241180|NCT00027027|576164|P1|Treated Beyond Cycle 2|Overall Study||1
241181|NCT00027027|576160|P5|Discontinued at Cycle 2|Overall Study||3
241182|NCT00027027|576161|P4|Discontinued at Cycle 2|Overall Study||1
241183|NCT00027027|576162|P3|Discontinued at Cycle 2|Overall Study||1
241184|NCT00027027|576163|P2|Discontinued at Cycle 2|Overall Study||2
241185|NCT00027027|576164|P1|Discontinued at Cycle 2|Overall Study||2
241186|NCT00027027|576160|P5|Completed 2 Cycles of Treatment|Overall Study||7
241187|NCT00027027|576161|P4|Completed 2 Cycles of Treatment|Overall Study||3
241188|NCT00027027|576162|P3|Completed 2 Cycles of Treatment|Overall Study||3
241189|NCT00027027|576163|P2|Completed 2 Cycles of Treatment|Overall Study||3
241190|NCT00027027|576164|P1|Completed 2 Cycles of Treatment|Overall Study||3
241191|NCT00027027|576160|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
241192|NCT00027027|576161|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
241193|NCT00027027|576162|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
241194|NCT00027027|576163|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
241195|NCT00027027|576164|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
241196|NCT00027027|576160|P5|STARTED|Overall Study||8
241197|NCT00027027|576161|P4|STARTED|Overall Study||3
241198|NCT00027027|576162|P3|STARTED|Overall Study||4
241199|NCT00027027|576163|P2|STARTED|Overall Study||3
241200|NCT00027027|576164|P1|STARTED|Overall Study||3
241201|NCT00026494|576213|P4|NOT COMPLETED|Overall Study||0
241202|NCT00026494|576214|P3|NOT COMPLETED|Overall Study||6
241203|NCT00026494|576215|P2|NOT COMPLETED|Overall Study||0
241204|NCT00026494|576216|P1|NOT COMPLETED|Overall Study||2
241205|NCT00026494|576213|P4|COMPLETED|Overall Study||16
241206|NCT00026494|576214|P3|COMPLETED|Overall Study||16
241207|NCT00026494|576215|P2|COMPLETED|Overall Study||4
241208|NCT00026494|576216|P1|COMPLETED|Overall Study||5
241209|NCT00026494|576213|P4|STARTED|Overall Study||16
241210|NCT00026494|576214|P3|STARTED|Overall Study||22
241211|NCT00026494|576215|P2|STARTED|Overall Study||4
241212|NCT00026494|576216|P1|STARTED|Overall Study||7
241213|NCT00026221|576229|P3|NOT COMPLETED|Overall Study||0
241214|NCT00026221|576230|P2|NOT COMPLETED|Overall Study||0
241215|NCT00026221|576231|P1|NOT COMPLETED|Overall Study||0
241216|NCT00026221|576229|P3|COMPLETED|Overall Study||25
241217|NCT00026221|576230|P2|COMPLETED|Overall Study||16
241218|NCT00026221|576231|P1|COMPLETED|Overall Study||16
241219|NCT00026221|576229|P3|STARTED|Overall Study||25
241220|NCT00026221|576230|P2|STARTED|Overall Study||16
241221|NCT00026221|576231|P1|STARTED|Overall Study||16
241222|NCT00025883|576250|P1|NOT COMPLETED|Overall Study||17
241223|NCT00025883|576250|P1|COMPLETED|Overall Study||86
241224|NCT00025883|576250|P1|Partial Lipodystrophy|Overall Study||40
241225|NCT00025883|576250|P1|Generalized Lipodystrophy|Overall Study||63
241226|NCT00025883|576250|P1|STARTED|Overall Study||103
241227|NCT00025662|576257|P1|NOT COMPLETED|Overall Study||3
241228|NCT00025662|576257|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
241229|NCT00025662|576257|P1|STARTED|Overall Study||25
241230|NCT00025506|576265|P1|NOT COMPLETED|Overall Study||10
241231|NCT00025506|576265|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
241232|NCT00025506|576265|P1|STARTED|Overall Study||55
241233|NCT00025233|576271|P1|NOT COMPLETED|Overall Study||4
241234|NCT00025233|576271|P1|COMPLETED|Overall Study||46
241235|NCT00025233|576271|P1|STARTED|Overall Study||50
241236|NCT00025155|576277|P1|NOT COMPLETED|Overall Study||2
241237|NCT00025155|576277|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
241238|NCT00025155|576277|P1|STARTED|Overall Study||51
241239|NCT00024258|576283|P1|NOT COMPLETED|Overall Study||9
241240|NCT00024258|576283|P1|COMPLETED|Overall Study||13
241241|NCT00024258|576283|P1|STARTED|Overall Study||22
241242|NCT00024167|576290|P2|NOT COMPLETED|Overall Study||47
241243|NCT00024167|576291|P1|NOT COMPLETED|Overall Study||53
241244|NCT00024167|576290|P2|COMPLETED|Overall Study||15
241245|NCT00024167|576291|P1|COMPLETED|Overall Study||12
241246|NCT00024167|576290|P2|Induction Treatment Option 2 Completed|Overall Study||41
241247|NCT00024167|576291|P1|Induction Treatment Option 2 Completed|Overall Study||43
241248|NCT00024167|576290|P2|Induction Treatment Option 1 Completed|Overall Study||21
241249|NCT00024167|576291|P1|Induction Treatment Option 1 Completed|Overall Study||22
241250|NCT00024167|576290|P2|STARTED|Overall Study||62
241251|NCT00024167|576291|P1|STARTED|Overall Study||65
241252|NCT00024102|576302|P2|NOT COMPLETED|Overall Study||0
241253|NCT00024102|576303|P1|NOT COMPLETED|Overall Study||0
241254|NCT00024102|576302|P2|COMPLETED|Overall Study||307
241255|NCT00024102|576303|P1|COMPLETED|Overall Study||326
241256|NCT00024102|576302|P2|STARTED|Overall Study||307
241257|NCT00024102|576303|P1|STARTED|Overall Study||326
241258|NCT00023764|576315|P1|NOT COMPLETED|Overall Study||14
241259|NCT00023764|576315|P1|COMPLETED|Overall Study||89
241260|NCT00023764|576315|P1|STARTED|Overall Study||103
241261|NCT00023712|576322|P2|NOT COMPLETED|Overall Study||1
241262|NCT00023712|576323|P1|NOT COMPLETED|Overall Study||2
241263|NCT00023712|576322|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
241264|NCT00023712|576323|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
241265|NCT00023712|576322|P2|STARTED|Overall Study|total number of participants enrolled on study|30
241266|NCT00023712|576323|P1|STARTED|Overall Study|total number of participants enrolled on study|28
241267|NCT00023673|576338|P4|NOT COMPLETED|Overall Study||2
241268|NCT00023673|576339|P3|NOT COMPLETED|Overall Study||0
241269|NCT00023673|576340|P2|NOT COMPLETED|Overall Study||0
241270|NCT00023673|576341|P1|NOT COMPLETED|Overall Study||0
241271|NCT00023673|576338|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
241272|NCT00023673|576339|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
241273|NCT00023673|576340|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
241274|NCT00023673|576341|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
241275|NCT00023673|576338|P4|STARTED|Overall Study||46
241276|NCT00023673|576339|P3|STARTED|Overall Study||0
241277|NCT00023673|576340|P2|STARTED|Overall Study||9
241278|NCT00023673|576341|P1|STARTED|Overall Study||8
241279|NCT00023452|576350|P2|NOT COMPLETED|Overall Study||872
241280|NCT00023452|576351|P1|NOT COMPLETED|Overall Study||1323
241281|NCT00023452|576350|P2|COMPLETED|Overall Study||3273
241282|NCT00023452|576351|P1|COMPLETED|Overall Study||2585
241283|NCT00023452|576350|P2|Completed Study|Overall Study||3475
241284|NCT00023452|576351|P1|Completed Study|Overall Study||3174
241285|NCT00023452|576350|P2|Not Treated|Overall Study||105
241286|NCT00023452|576351|P1|Not Treated|Overall Study||149
241287|NCT00023452|576350|P2|Completed Treatment|Overall Study||3273
241288|NCT00023452|576351|P1|Completed Treatment|Overall Study||2585
241289|NCT00023452|576350|P2|Enrolled as Part of a Cluster|Overall Study||971
241290|NCT00023452|576351|P1|Enrolled as Part of a Cluster|Overall Study||718
241291|NCT00023452|576350|P2|Randomized|Overall Study||3174
241292|NCT00023452|576351|P1|Randomized|Overall Study||3190
241293|NCT00023452|576350|P2|STARTED|Overall Study||4145
241294|NCT00023452|576351|P1|STARTED|Overall Study||3908
241295|NCT00023322|576375|P1|NOT COMPLETED|Overall Study||1
241296|NCT00023322|576375|P1|COMPLETED|Overall Study||12
241297|NCT00023322|576375|P1|STARTED|Overall Study||13
241298|NCT00023309|576382|P2|NOT COMPLETED|Overall Study||0
241299|NCT00023309|576383|P1|NOT COMPLETED|Overall Study||0
241300|NCT00023309|576382|P2|COMPLETED|Overall Study||19
241301|NCT00023309|576383|P1|COMPLETED|Overall Study||22
241302|NCT00023309|576382|P2|STARTED|Overall Study||19
241303|NCT00023309|576383|P1|STARTED|Overall Study||22
241304|NCT00022763|576399|P2|NOT COMPLETED|Overall Study||17
241305|NCT00022763|576400|P1|NOT COMPLETED|Overall Study||9
241306|NCT00022763|576399|P2|COMPLETED|Overall Study||11
241307|NCT00022763|576400|P1|COMPLETED|Overall Study||15
241308|NCT00022763|576399|P2|STARTED|Overall Study||28
241309|NCT00022763|576400|P1|STARTED|Overall Study||24
241310|NCT00022698|576425|P2|NOT COMPLETED|Overall Study||35
241311|NCT00022698|576426|P1|NOT COMPLETED|Overall Study||8
241312|NCT00022698|576425|P2|COMPLETED|Overall Study||17
241313|NCT00022698|576426|P1|COMPLETED|Overall Study||7
241314|NCT00022698|576425|P2|STARTED|Overall Study||52
241315|NCT00022698|576426|P1|STARTED|Overall Study||15
241316|NCT00022672|576451|P2|NOT COMPLETED|Extension Phase||51
241317|NCT00022672|576452|P1|NOT COMPLETED|Extension Phase||3
241318|NCT00022672|576451|P2|COMPLETED|Extension Phase||7
241319|NCT00022672|576452|P1|COMPLETED|Extension Phase||11
241320|NCT00022672|576451|P2|Safety Set: Received Study Drug|Extension Phase||58
241321|NCT00022672|576452|P1|Safety Set: Received Study Drug|Extension Phase||14
241322|NCT00022672|576451|P2|STARTED|Extension Phase||58
241323|NCT00022672|576452|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
241324|NCT00022672|576451|P2|NOT COMPLETED|Main Phase: 24 Months||100
241325|NCT00022672|576452|P1|NOT COMPLETED|Main Phase: 24 Months||87
241326|NCT00022672|576451|P2|COMPLETED|Main Phase: 24 Months||4
241327|NCT00022672|576452|P1|COMPLETED|Main Phase: 24 Months||16
241328|NCT00022672|576451|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
241329|NCT00022672|576452|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
241330|NCT00022672|576451|P2|STARTED|Main Phase: 24 Months||104
241331|NCT00022672|576452|P1|STARTED|Main Phase: 24 Months||103
241332|NCT00022659|576485|P1|NOT COMPLETED|Overall Study||2
241333|NCT00022659|576485|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
241334|NCT00022659|576485|P1|STARTED|Overall Study||64
241335|NCT00022633|576493|P2|NOT COMPLETED|Overall Study||5
241336|NCT00022633|576494|P1|NOT COMPLETED|Overall Study||32
241337|NCT00022633|576493|P2|COMPLETED|Overall Study||5
241338|NCT00022633|576494|P1|COMPLETED|Overall Study||23
241339|NCT00022633|576493|P2|Eligible|Overall Study||10
241340|NCT00022633|576494|P1|Eligible|Overall Study||51
241341|NCT00022633|576493|P2|STARTED|Overall Study||10
241342|NCT00022633|576494|P1|STARTED|Overall Study||55
241343|NCT00022516|576507|P2|NOT COMPLETED|Overall Study||230
241344|NCT00022516|576508|P1|NOT COMPLETED|Overall Study||3
241345|NCT00022516|576507|P2|COMPLETED|Overall Study||314
241346|NCT00022516|576508|P1|COMPLETED|Overall Study||539
241347|NCT00022516|576507|P2|STARTED|Overall Study||544
241348|NCT00022516|576508|P1|STARTED|Overall Study||542
241349|NCT00022490|576520|P1|NOT COMPLETED|Overall Study||0
241350|NCT00022490|576520|P1|COMPLETED|Overall Study||24
241351|NCT00022490|576520|P1|STARTED|Overall Study||24
241352|NCT00021541|576526|P2|NOT COMPLETED|Period 2-crossover||11
241353|NCT00021541|576527|P1|NOT COMPLETED|Period 2-crossover||10
241354|NCT00021541|576526|P2|COMPLETED|Period 2-crossover||12
241355|NCT00021541|576527|P1|COMPLETED|Period 2-crossover||10
241356|NCT00021541|576526|P2|STARTED|Period 2-crossover||23
241357|NCT00021541|576527|P1|STARTED|Period 2-crossover||20
241358|NCT00021541|576526|P2|NOT COMPLETED|Period 1-First Treatment||8
241359|NCT00021541|576527|P1|NOT COMPLETED|Period 1-First Treatment||11
241360|NCT00021541|576526|P2|COMPLETED|Period 1-First Treatment||23
241361|NCT00021541|576527|P1|COMPLETED|Period 1-First Treatment||20
241362|NCT00021541|576526|P2|Ineligible Patients|Period 1-First Treatment||2
241363|NCT00021541|576527|P1|Ineligible Patients|Period 1-First Treatment||0
241364|NCT00021541|576526|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
241365|NCT00021541|576527|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
241366|NCT00021541|576526|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
241367|NCT00021541|576527|P1|STARTED|Period 1-First Treatment||31
241368|NCT00021255|576536|P3|NOT COMPLETED|Overall Study||149
241369|NCT00021255|576537|P2|NOT COMPLETED|Overall Study||270
241370|NCT00021255|576538|P1|NOT COMPLETED|Overall Study||121
241371|NCT00021255|576536|P3|COMPLETED|Overall Study||926
241372|NCT00021255|576537|P2|COMPLETED|Overall Study||804
241373|NCT00021255|576538|P1|COMPLETED|Overall Study||952
241374|NCT00021255|576536|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
241375|NCT00021255|576537|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
241376|NCT00021255|576538|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
241377|NCT00021255|576536|P3|Treated|Overall Study||1057
241378|NCT00021255|576537|P2|Treated|Overall Study||1072
241379|NCT00021255|576538|P1|Treated|Overall Study||1045
241380|NCT00021255|576536|P3|STARTED|Overall Study|Randomized|1075
241381|NCT00021255|576537|P2|STARTED|Overall Study|Randomized|1074
241382|NCT00021255|576538|P1|STARTED|Overall Study|Randomized|1073
241383|NCT00021229|576555|P3|NOT COMPLETED|Overall Study||16
241384|NCT00021229|576556|P2|NOT COMPLETED|Overall Study||33
241385|NCT00021229|576557|P1|NOT COMPLETED|Overall Study||35
241386|NCT00021229|576555|P3|COMPLETED|Overall Study||0
241387|NCT00021229|576556|P2|COMPLETED|Overall Study||0
241388|NCT00021229|576557|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
241389|NCT00021229|576555|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
241390|NCT00021229|576556|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
241391|NCT00021229|576557|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
241392|NCT00021229|576555|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
241393|NCT00021229|576556|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
241394|NCT00021229|576557|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
241395|NCT00021229|576555|P3|Enrolled in Phase I|Overall Study||16
241396|NCT00021229|576556|P2|Enrolled in Phase I|Overall Study||33
241397|NCT00021229|576557|P1|Enrolled in Phase I|Overall Study||35
241398|NCT00021229|576555|P3|STARTED|Overall Study||16
241399|NCT00021229|576556|P2|STARTED|Overall Study||33
241400|NCT00021229|576557|P1|STARTED|Overall Study||36
241401|NCT00020722|576583|P1|NOT COMPLETED|Overall Study||0
241402|NCT00020722|576583|P1|COMPLETED|Overall Study||7
241403|NCT00020722|576583|P1|STARTED|Overall Study||7
241404|NCT00019747|576590|P2|NOT COMPLETED|Overall Study||0
241405|NCT00019747|576591|P1|NOT COMPLETED|Overall Study||0
241406|NCT00019747|576590|P2|COMPLETED|Overall Study||16
241407|NCT00019747|576591|P1|COMPLETED|Overall Study||23
241408|NCT00019747|576590|P2|STARTED|Overall Study||16
241409|NCT00019747|576591|P1|STARTED|Overall Study||23
241410|NCT00019604|576597|P1|NOT COMPLETED|Overall Study||39
241411|NCT00019604|576597|P1|COMPLETED|Overall Study||5
241412|NCT00019604|576597|P1|STARTED|Overall Study||44
241413|NCT00016913|576610|P1|NOT COMPLETED|Overall Study||0
241414|NCT00016913|576610|P1|COMPLETED|Overall Study||27
241415|NCT00016913|576610|P1|STARTED|Overall Study||27
241416|NCT00018031|576616|P1|NOT COMPLETED|Overall Study||0
241417|NCT00018031|576616|P1|COMPLETED|Overall Study||36
241418|NCT00018031|576616|P1|STARTED|Overall Study||36
241419|NCT00017563|576620|P1|NOT COMPLETED|Overall Study||1
241420|NCT00017563|576620|P1|COMPLETED|Overall Study||56
241421|NCT00017563|576620|P1|STARTED|Overall Study||57
241422|NCT00016354|576624|P8|NOT COMPLETED|Overall Study||1
241423|NCT00016354|576625|P7|NOT COMPLETED|Overall Study||0
241424|NCT00016354|576626|P6|NOT COMPLETED|Overall Study||0
241425|NCT00016354|576627|P5|NOT COMPLETED|Overall Study||0
241426|NCT00016354|576628|P4|NOT COMPLETED|Overall Study||0
241427|NCT00016354|576629|P3|NOT COMPLETED|Overall Study||0
241428|NCT00016354|576630|P2|NOT COMPLETED|Overall Study||0
241429|NCT00016354|576631|P1|NOT COMPLETED|Overall Study||0
241430|NCT00016354|576624|P8|COMPLETED|Overall Study||6
241431|NCT00016354|576625|P7|COMPLETED|Overall Study||6
241432|NCT00016354|576626|P6|COMPLETED|Overall Study||1
241433|NCT00016354|576627|P5|COMPLETED|Overall Study||1
241434|NCT00016354|576628|P4|COMPLETED|Overall Study||1
241435|NCT00016354|576629|P3|COMPLETED|Overall Study||1
241436|NCT00016354|576630|P2|COMPLETED|Overall Study||1
241437|NCT00016354|576631|P1|COMPLETED|Overall Study||1
241438|NCT00016354|576624|P8|STARTED|Overall Study||7
241439|NCT00016354|576625|P7|STARTED|Overall Study||6
241440|NCT00016354|576626|P6|STARTED|Overall Study||1
241441|NCT00016354|576627|P5|STARTED|Overall Study||1
241442|NCT00016354|576628|P4|STARTED|Overall Study||1
241443|NCT00016354|576629|P3|STARTED|Overall Study||1
241444|NCT00016354|576630|P2|STARTED|Overall Study||1
241445|NCT00016354|576631|P1|STARTED|Overall Study||1
241446|NCT00015847|576635|P1|NOT COMPLETED|Overall Study||0
241447|NCT00015847|576635|P1|COMPLETED|Overall Study||25
241448|NCT00015847|576635|P1|STARTED|Overall Study||25
241449|NCT00014495|576645|P4|NOT COMPLETED|Overall Study||1
241450|NCT00014495|576646|P3|NOT COMPLETED|Overall Study||1
241451|NCT00014495|576647|P2|NOT COMPLETED|Overall Study||0
241452|NCT00014495|576648|P1|NOT COMPLETED|Overall Study||0
241453|NCT00014495|576645|P4|COMPLETED|Overall Study||5
241454|NCT00014495|576646|P3|COMPLETED|Overall Study||19
241455|NCT00014495|576647|P2|COMPLETED|Overall Study||3
241456|NCT00014495|576648|P1|COMPLETED|Overall Study||3
241457|NCT00014495|576645|P4|STARTED|Overall Study||6
241458|NCT00014495|576646|P3|STARTED|Overall Study||20
241459|NCT00014495|576647|P2|STARTED|Overall Study||3
241460|NCT00014495|576648|P1|STARTED|Overall Study||3
241461|NCT00015457|576655|P2|NOT COMPLETED|Second Intervention||0
241462|NCT00015457|576656|P1|NOT COMPLETED|Second Intervention||1
241463|NCT00015457|576655|P2|COMPLETED|Second Intervention||5
241464|NCT00015457|576656|P1|COMPLETED|Second Intervention||7
241465|NCT00015457|576655|P2|STARTED|Second Intervention||5
241466|NCT00015457|576656|P1|STARTED|Second Intervention||8
241467|NCT00015457|576655|P2|NOT COMPLETED|First Intervention||3
241468|NCT00015457|576656|P1|NOT COMPLETED|First Intervention||0
241469|NCT00015457|576655|P2|COMPLETED|First Intervention||5
241470|NCT00015457|576656|P1|COMPLETED|First Intervention||8
241471|NCT00015457|576655|P2|STARTED|First Intervention||8
241472|NCT00015457|576656|P1|STARTED|First Intervention||8
241473|NCT00014911|576664|P1|NOT COMPLETED|Overall Study||11
241474|NCT00014911|576664|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
241475|NCT00014911|576664|P1|STARTED|Overall Study||36
241476|NCT00014560|576673|P1|NOT COMPLETED|Overall Study||3
241477|NCT00014560|576673|P1|COMPLETED|Overall Study||0
241478|NCT00014560|576673|P1|STARTED|Overall Study||3
241479|NCT00013611|576679|P2|NOT COMPLETED|Overall Study||100
241480|NCT00013611|576680|P1|NOT COMPLETED|Overall Study||91
241481|NCT00013611|576679|P2|COMPLETED|Overall Study||746
241482|NCT00013611|576680|P1|COMPLETED|Overall Study||758
241483|NCT00013611|576679|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
241484|NCT00013611|576680|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
241485|NCT00012298|576703|P7|NOT COMPLETED|Overall Study||0
241486|NCT00012298|576704|P6|NOT COMPLETED|Overall Study||0
241487|NCT00012298|576705|P5|NOT COMPLETED|Overall Study||0
241488|NCT00012298|576706|P4|NOT COMPLETED|Overall Study||0
241489|NCT00012298|576707|P3|NOT COMPLETED|Overall Study||0
241490|NCT00012298|576708|P2|NOT COMPLETED|Overall Study||0
241491|NCT00012298|576709|P1|NOT COMPLETED|Overall Study||0
241492|NCT00012298|576703|P7|COMPLETED|Overall Study||39
241493|NCT00012298|576704|P6|COMPLETED|Overall Study||6
241494|NCT00012298|576705|P5|COMPLETED|Overall Study||5
241495|NCT00012298|576706|P4|COMPLETED|Overall Study||4
241496|NCT00012298|576707|P3|COMPLETED|Overall Study||9
241497|NCT00012298|576708|P2|COMPLETED|Overall Study||7
241498|NCT00012298|576709|P1|COMPLETED|Overall Study||11
241499|NCT00012298|576703|P7|STARTED|Overall Study||39
241500|NCT00012298|576704|P6|STARTED|Overall Study||6
241501|NCT00012298|576705|P5|STARTED|Overall Study||5
241502|NCT00012298|576706|P4|STARTED|Overall Study||4
241503|NCT00012298|576707|P3|STARTED|Overall Study||9
241504|NCT00012298|576708|P2|STARTED|Overall Study||7
241505|NCT00012298|576709|P1|STARTED|Overall Study||11
241506|NCT00012012|576733|P2|NOT COMPLETED|Overall Study||3
241507|NCT00012012|576734|P1|NOT COMPLETED|Overall Study||1
241508|NCT00012012|576733|P2|COMPLETED|Overall Study||15
241509|NCT00012012|576734|P1|COMPLETED|Overall Study||26
241510|NCT00012012|576733|P2|STARTED|Overall Study||18
241511|NCT00012012|576734|P1|STARTED|Overall Study||27
241512|NCT00011986|576745|P5|NOT COMPLETED|Overall Study||0
241513|NCT00011986|576746|P4|NOT COMPLETED|Overall Study||0
241514|NCT00011986|576747|P3|NOT COMPLETED|Overall Study||0
241515|NCT00011986|576748|P2|NOT COMPLETED|Overall Study||0
241516|NCT00011986|576749|P1|NOT COMPLETED|Overall Study||0
241517|NCT00011986|576745|P5|COMPLETED|Overall Study||861
241518|NCT00011986|576746|P4|COMPLETED|Overall Study||861
241519|NCT00011986|576747|P3|COMPLETED|Overall Study||862
241520|NCT00011986|576748|P2|COMPLETED|Overall Study||864
241521|NCT00011986|576749|P1|COMPLETED|Overall Study||864
241522|NCT00011986|576745|P5|Initiated Treatment|Overall Study||851
241523|NCT00011986|576746|P4|Initiated Treatment|Overall Study||846
241524|NCT00011986|576747|P3|Initiated Treatment|Overall Study||854
241525|NCT00011986|576748|P2|Initiated Treatment|Overall Study||860
241526|NCT00011986|576749|P1|Initiated Treatment|Overall Study||862
241527|NCT00011986|576745|P5|STARTED|Overall Study||861
241528|NCT00011986|576746|P4|STARTED|Overall Study||861
241529|NCT00011986|576747|P3|STARTED|Overall Study||862
241530|NCT00011986|576748|P2|STARTED|Overall Study||864
241531|NCT00011986|576749|P1|STARTED|Overall Study||864
241532|NCT00010803|576763|P2|NOT COMPLETED|Overall Study||98
241533|NCT00010803|576764|P1|NOT COMPLETED|Overall Study||97
241534|NCT00010803|576763|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
241535|NCT00010803|576764|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
241536|NCT00010803|576763|P2|STARTED|Overall Study|Randomized|1524
241537|NCT00010803|576764|P1|STARTED|Overall Study|Randomized|1545
241538|NCT00010439|576774|P1|NOT COMPLETED|Overall Study||0
241539|NCT00010439|576774|P1|COMPLETED|Overall Study||10
241540|NCT00010439|576774|P1|6 Months|Overall Study||10
241541|NCT00010439|576774|P1|STARTED|Overall Study||10
241542|NCT00010257|576781|P2|NOT COMPLETED|Overall Study||0
241543|NCT00010257|576782|P1|NOT COMPLETED|Overall Study||1
241544|NCT00010257|576781|P2|COMPLETED|Overall Study||21
241545|NCT00010257|576782|P1|COMPLETED|Overall Study||24
241546|NCT00010257|576781|P2|STARTED|Overall Study||21
241547|NCT00010257|576782|P1|STARTED|Overall Study||25
241548|NCT00009737|576792|P2|NOT COMPLETED|Overall Study||123
241549|NCT00009737|576793|P1|NOT COMPLETED|Overall Study||170
241550|NCT00009737|576792|P2|COMPLETED|Overall Study||860
241551|NCT00009737|576793|P1|COMPLETED|Overall Study||834
241552|NCT00009737|576792|P2|STARTED|Overall Study||983
241553|NCT00009737|576793|P1|STARTED|Overall Study||1004
241554|NCT00008385|576811|P2|NOT COMPLETED|Overall Study||802
241555|NCT00008385|576812|P1|NOT COMPLETED|Overall Study||387
241556|NCT00008385|576811|P2|COMPLETED|Overall Study||238
241557|NCT00008385|576812|P1|COMPLETED|Overall Study||134
241558|NCT00008385|576811|P2|Off Treatment Reasons Reported|Overall Study||795
241559|NCT00008385|576812|P1|Off Treatment Reasons Reported|Overall Study||398
241560|NCT00008385|576811|P2|Treated|Overall Study||865
241561|NCT00008385|576812|P1|Treated|Overall Study||477
241562|NCT00008385|576811|P2|STARTED|Overall Study||1040
241563|NCT00008385|576812|P1|STARTED|Overall Study||521
241564|NCT00008138|576822|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
241565|NCT00008138|576822|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
241566|NCT00008138|576822|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
241567|NCT00008138|576822|P1|NOT COMPLETED|Interval Debulking||2
241568|NCT00008138|576822|P1|COMPLETED|Interval Debulking||36
241569|NCT00008138|576822|P1|Received Protocol Surgery|Interval Debulking||36
241570|NCT00008138|576822|P1|STARTED|Interval Debulking||38
241571|NCT00008138|576822|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
241572|NCT00008138|576822|P1|COMPLETED|Neoadjuvant Chemotherapy||38
241573|NCT00008138|576822|P1|Eligible|Neoadjuvant Chemotherapy||58
241574|NCT00008138|576822|P1|STARTED|Neoadjuvant Chemotherapy||58
241575|NCT00007644|576830|P2|NOT COMPLETED|Overall Study||0
241576|NCT00007644|576831|P1|NOT COMPLETED|Overall Study||0
241577|NCT00007644|576830|P2|COMPLETED|Overall Study||367
241578|NCT00007644|576831|P1|COMPLETED|Overall Study||364
241579|NCT00007644|576830|P2|STARTED|Overall Study||367
241580|NCT00007644|576831|P1|STARTED|Overall Study||364
241581|NCT00007475|576840|P4|NOT COMPLETED|Overall Study||0
241582|NCT00007475|576841|P3|NOT COMPLETED|Overall Study||0
241583|NCT00007475|576842|P2|NOT COMPLETED|Overall Study||0
241584|NCT00007475|576843|P1|NOT COMPLETED|Overall Study||4
241585|NCT00007475|576840|P4|COMPLETED|Overall Study||0
241586|NCT00007475|576841|P3|COMPLETED|Overall Study||2
241587|NCT00007475|576842|P2|COMPLETED|Overall Study||1
241588|NCT00007475|576843|P1|COMPLETED|Overall Study||8
241589|NCT00007475|576840|P4|Initiate Cyclophosphamide|Overall Study||0
241590|NCT00007475|576841|P3|Initiate Cyclophosphamide|Overall Study||2
241591|NCT00007475|576842|P2|Initiate Cyclophosphamide|Overall Study||1
241592|NCT00007475|576843|P1|Initiate Cyclophosphamide|Overall Study||12
241593|NCT00007475|576840|P4|Initial Plasma Exchange|Overall Study||0
241594|NCT00007475|576841|P3|Initial Plasma Exchange|Overall Study||2
241595|NCT00007475|576842|P2|Initial Plasma Exchange|Overall Study||1
241596|NCT00007475|576843|P1|Initial Plasma Exchange|Overall Study||12
241597|NCT00007475|576840|P4|Post-initial Transplant Proteinuria|Overall Study||0
241598|NCT00007475|576841|P3|Post-initial Transplant Proteinuria|Overall Study||2
241599|NCT00007475|576842|P2|Post-initial Transplant Proteinuria|Overall Study||1
241600|NCT00007475|576843|P1|Post-initial Transplant Proteinuria|Overall Study||12
241601|NCT00007475|576840|P4|Initial Transplant|Overall Study||0
241602|NCT00007475|576841|P3|Initial Transplant|Overall Study||2
241603|NCT00007475|576842|P2|Initial Transplant|Overall Study||1
241604|NCT00007475|576843|P1|Initial Transplant|Overall Study||12
241605|NCT00007475|576840|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
241606|NCT00007475|576841|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
241607|NCT00007475|576842|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
241608|NCT00007475|576843|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
241609|NCT00007475|576840|P4|STARTED|Overall Study||0
241610|NCT00007475|576841|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
241611|NCT00007475|576842|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
241612|NCT00007475|576843|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
241613|NCT00007345|576865|P2|NOT COMPLETED|Overall Study||11
241614|NCT00007345|576866|P1|NOT COMPLETED|Overall Study||2
241615|NCT00007345|576865|P2|COMPLETED|Overall Study||73
241616|NCT00007345|576866|P1|COMPLETED|Overall Study||45
241617|NCT00007345|576865|P2|STARTED|Overall Study||84
241618|NCT00007345|576866|P1|STARTED|Overall Study||47
241619|NCT00006916|576876|P1|NOT COMPLETED|Overall Study||5
241620|NCT00006916|576876|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
241621|NCT00006916|576876|P1|STARTED|Overall Study||19
241622|NCT00006903|576882|P3|NOT COMPLETED|Overall Study||6
241623|NCT00006903|576883|P2|NOT COMPLETED|Overall Study||4
241624|NCT00006903|576884|P1|NOT COMPLETED|Overall Study||10
241625|NCT00006903|576882|P3|COMPLETED|Overall Study||27
241626|NCT00006903|576883|P2|COMPLETED|Overall Study||20
241627|NCT00006903|576884|P1|COMPLETED|Overall Study||0
241628|NCT00006903|576882|P3|STARTED|Overall Study||33
241629|NCT00006903|576883|P2|STARTED|Overall Study||24
241630|NCT00006903|576884|P1|STARTED|Overall Study||10
241631|NCT00006721|576892|P3|NOT COMPLETED|Overall Study||33
241632|NCT00006721|576893|P2|NOT COMPLETED|Overall Study||25
241633|NCT00006721|576894|P1|NOT COMPLETED|Overall Study||4
241634|NCT00006721|576892|P3|COMPLETED|Overall Study||242
241635|NCT00006721|576893|P2|COMPLETED|Overall Study||254
241636|NCT00006721|576894|P1|COMPLETED|Overall Study||13
241637|NCT00006721|576892|P3|Eligible and Began Protocol Therapy|Overall Study||265
241638|NCT00006721|576893|P2|Eligible and Began Protocol Therapy|Overall Study||267
241639|NCT00006721|576894|P1|Eligible and Began Protocol Therapy|Overall Study||14
241640|NCT00006721|576892|P3|Eligible|Overall Study||265
241641|NCT00006721|576893|P2|Eligible|Overall Study||267
241642|NCT00006721|576894|P1|Eligible|Overall Study||15
241643|NCT00006721|576892|P3|STARTED|Overall Study||275
241644|NCT00006721|576893|P2|STARTED|Overall Study||279
241645|NCT00006721|576894|P1|STARTED|Overall Study||17
241646|NCT00006604|576919|P17|NOT COMPLETED|Overall Study||9
241647|NCT00006604|576920|P16|NOT COMPLETED|Overall Study||5
241648|NCT00006604|576921|P15|NOT COMPLETED|Overall Study||10
241649|NCT00006604|576922|P14|NOT COMPLETED|Overall Study||6
241650|NCT00006604|576923|P13|NOT COMPLETED|Overall Study||4
241651|NCT00006604|576924|P12|NOT COMPLETED|Overall Study||6
241652|NCT00006604|576925|P11|NOT COMPLETED|Overall Study||8
241653|NCT00006604|576926|P10|NOT COMPLETED|Overall Study||19
241654|NCT00006604|576927|P9|NOT COMPLETED|Overall Study||1
241655|NCT00006604|576928|P8|NOT COMPLETED|Overall Study||3
241656|NCT00006604|576929|P7|NOT COMPLETED|Overall Study||9
241657|NCT00006604|576930|P6|NOT COMPLETED|Overall Study||3
241658|NCT00006604|576931|P5|NOT COMPLETED|Overall Study||2
241659|NCT00006604|576932|P4|NOT COMPLETED|Overall Study||5
241660|NCT00006604|576933|P3|NOT COMPLETED|Overall Study||4
241661|NCT00006604|576934|P2|NOT COMPLETED|Overall Study||0
241662|NCT00006604|576935|P1|NOT COMPLETED|Overall Study||2
241663|NCT00006604|576919|P17|COMPLETED|Overall Study||6
241664|NCT00006604|576920|P16|COMPLETED|Overall Study||1
241665|NCT00006604|576921|P15|COMPLETED|Overall Study||14
241666|NCT00006604|576922|P14|COMPLETED|Overall Study||0
241667|NCT00006604|576923|P13|COMPLETED|Overall Study||22
241668|NCT00006604|576924|P12|COMPLETED|Overall Study||6
241669|NCT00006604|576925|P11|COMPLETED|Overall Study||13
241670|NCT00006604|576926|P10|COMPLETED|Overall Study||6
241671|NCT00006604|576927|P9|COMPLETED|Overall Study||4
241672|NCT00006604|576928|P8|COMPLETED|Overall Study||2
241673|NCT00006604|576929|P7|COMPLETED|Overall Study||12
241674|NCT00006604|576930|P6|COMPLETED|Overall Study||2
241675|NCT00006604|576931|P5|COMPLETED|Overall Study||3
241676|NCT00006604|576932|P4|COMPLETED|Overall Study||1
241677|NCT00006604|576933|P3|COMPLETED|Overall Study||1
241678|NCT00006604|576934|P2|COMPLETED|Overall Study||2
241679|NCT00006604|576935|P1|COMPLETED|Overall Study||4
241680|NCT00006604|576919|P17|STARTED|Overall Study||15
241681|NCT00006604|576920|P16|STARTED|Overall Study||6
241682|NCT00006604|576921|P15|STARTED|Overall Study||24
241683|NCT00006604|576922|P14|STARTED|Overall Study||6
241684|NCT00006604|576923|P13|STARTED|Overall Study||26
241685|NCT00006604|576924|P12|STARTED|Overall Study||12
241686|NCT00006604|576925|P11|STARTED|Overall Study||21
241687|NCT00006604|576926|P10|STARTED|Overall Study||25
241688|NCT00006604|576927|P9|STARTED|Overall Study||5
241689|NCT00006604|576928|P8|STARTED|Overall Study||5
241690|NCT00006604|576929|P7|STARTED|Overall Study||21
241691|NCT00006604|576930|P6|STARTED|Overall Study||5
241692|NCT00006604|576931|P5|STARTED|Overall Study||5
241693|NCT00006604|576932|P4|STARTED|Overall Study||6
241694|NCT00006604|576933|P3|STARTED|Overall Study||5
241695|NCT00006604|576934|P2|STARTED|Overall Study||2
241696|NCT00006604|576935|P1|STARTED|Overall Study||6
241697|NCT00006478|577049|P1|NOT COMPLETED|Overall Study||7
241698|NCT00006478|577049|P1|COMPLETED|Overall Study||12
241699|NCT00006478|577049|P1|STARTED|Overall Study||19
241700|NCT00006409|577059|P6|NOT COMPLETED|Post-3 Year Intervention||62
241701|NCT00006409|577060|P5|NOT COMPLETED|Post-3 Year Intervention||62
241702|NCT00006409|577061|P4|NOT COMPLETED|Post-3 Year Intervention||0
241703|NCT00006409|577062|P3|NOT COMPLETED|Post-3 Year Intervention||0
241704|NCT00006409|577063|P2|NOT COMPLETED|Post-3 Year Intervention||0
241705|NCT00006409|577064|P1|NOT COMPLETED|Post-3 Year Intervention||0
241706|NCT00006409|577059|P6|COMPLETED|Post-3 Year Intervention||1714
241707|NCT00006409|577060|P5|COMPLETED|Post-3 Year Intervention||1664
241708|NCT00006409|577061|P4|COMPLETED|Post-3 Year Intervention||0
241709|NCT00006409|577062|P3|COMPLETED|Post-3 Year Intervention||0
241710|NCT00006409|577063|P2|COMPLETED|Post-3 Year Intervention||0
241711|NCT00006409|577064|P1|COMPLETED|Post-3 Year Intervention||0
241712|NCT00006409|577059|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
241713|NCT00006409|577060|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
241714|NCT00006409|577061|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
241715|NCT00006409|577062|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
241716|NCT00006409|577063|P2|STARTED|Post-3 Year Intervention||0
241717|NCT00006409|577064|P1|STARTED|Post-3 Year Intervention||0
241718|NCT00006409|577059|P6|NOT COMPLETED|Post-2 Year Intervention||0
241719|NCT00006409|577060|P5|NOT COMPLETED|Post-2 Year Intervention||0
241720|NCT00006409|577061|P4|NOT COMPLETED|Post-2 Year Intervention||168
241721|NCT00006409|577062|P3|NOT COMPLETED|Post-2 Year Intervention||251
241722|NCT00006409|577063|P2|NOT COMPLETED|Post-2 Year Intervention||0
241723|NCT00006409|577064|P1|NOT COMPLETED|Post-2 Year Intervention||0
241724|NCT00006409|577059|P6|COMPLETED|Post-2 Year Intervention||0
241725|NCT00006409|577060|P5|COMPLETED|Post-2 Year Intervention||0
241726|NCT00006409|577061|P4|COMPLETED|Post-2 Year Intervention||1545
241727|NCT00006409|577062|P3|COMPLETED|Post-2 Year Intervention||1540
241728|NCT00006409|577063|P2|COMPLETED|Post-2 Year Intervention||0
241729|NCT00006409|577064|P1|COMPLETED|Post-2 Year Intervention||0
241730|NCT00006409|577059|P6|STARTED|Post-2 Year Intervention||0
241731|NCT00006409|577060|P5|STARTED|Post-2 Year Intervention||0
241732|NCT00006409|577061|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
241733|NCT00006409|577062|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
241734|NCT00006409|577063|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
241735|NCT00006409|577064|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
241736|NCT00006409|577059|P6|NOT COMPLETED|Baseline||0
241737|NCT00006409|577060|P5|NOT COMPLETED|Baseline||0
241738|NCT00006409|577061|P4|NOT COMPLETED|Baseline||0
241739|NCT00006409|577062|P3|NOT COMPLETED|Baseline||0
241740|NCT00006409|577063|P2|NOT COMPLETED|Baseline||70
241741|NCT00006409|577064|P1|NOT COMPLETED|Baseline||48
241742|NCT00006409|577059|P6|COMPLETED|Baseline||0
241743|NCT00006409|577060|P5|COMPLETED|Baseline||0
241744|NCT00006409|577061|P4|COMPLETED|Baseline||0
241745|NCT00006409|577062|P3|COMPLETED|Baseline||0
241746|NCT00006409|577063|P2|COMPLETED|Baseline||786
241747|NCT00006409|577064|P1|COMPLETED|Baseline||817
241748|NCT00006409|577059|P6|STARTED|Baseline||0
241749|NCT00006409|577060|P5|STARTED|Baseline||0
241750|NCT00006409|577061|P4|STARTED|Baseline||0
241751|NCT00006409|577062|P3|STARTED|Baseline||0
241752|NCT00006409|577063|P2|STARTED|Baseline||856
241753|NCT00006409|577064|P1|STARTED|Baseline||865
241754|NCT00006392|577088|P4|NOT COMPLETED|Overall Study||160
241755|NCT00006392|577089|P3|NOT COMPLETED|Overall Study||160
241756|NCT00006392|577090|P2|NOT COMPLETED|Overall Study||158
241757|NCT00006392|577091|P1|NOT COMPLETED|Overall Study||167
241758|NCT00006392|577088|P4|COMPLETED|Overall Study||8696
241759|NCT00006392|577089|P3|COMPLETED|Overall Study||8703
241760|NCT00006392|577090|P2|COMPLETED|Overall Study||8752
241761|NCT00006392|577091|P1|COMPLETED|Overall Study||8737
241762|NCT00006392|577088|P4|STARTED|Overall Study||8856
241763|NCT00006392|577089|P3|STARTED|Overall Study||8863
241764|NCT00006392|577090|P2|STARTED|Overall Study||8910
241765|NCT00006392|577091|P1|STARTED|Overall Study||8904
241766|NCT00006389|577121|P1|NOT COMPLETED|Overall Study||1
241767|NCT00006389|577121|P1|COMPLETED|Overall Study||11
241768|NCT00006389|577121|P1|STARTED|Overall Study||12
241769|NCT00006305|577131|P4|NOT COMPLETED|Overall Study||14
241770|NCT00006305|577132|P3|NOT COMPLETED|Overall Study||15
241771|NCT00006305|577133|P2|NOT COMPLETED|Overall Study||10
241772|NCT00006305|577134|P1|NOT COMPLETED|Overall Study||17
241773|NCT00006305|577131|P4|COMPLETED|Overall Study||585
241774|NCT00006305|577132|P3|COMPLETED|Overall Study||578
241775|NCT00006305|577133|P2|COMPLETED|Overall Study||574
241776|NCT00006305|577134|P1|COMPLETED|Overall Study||575
241777|NCT00006305|577131|P4|STARTED|Overall Study||599
241778|NCT00006305|577132|P3|STARTED|Overall Study||593
241779|NCT00006305|577133|P2|STARTED|Overall Study||584
241780|NCT00006305|577134|P1|STARTED|Overall Study||592
241781|NCT00006289|577150|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
241782|NCT00006289|577151|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
241783|NCT00006289|577150|P2|COMPLETED|Second Intervention (5 Weeks)||9
241784|NCT00006289|577151|P1|COMPLETED|Second Intervention (5 Weeks)||9
241785|NCT00006289|577150|P2|STARTED|Second Intervention (5 Weeks)||10
241786|NCT00006289|577151|P1|STARTED|Second Intervention (5 Weeks)||10
241787|NCT00006289|577150|P2|NOT COMPLETED|Washout (>= 1 Week)||0
241788|NCT00006289|577151|P1|NOT COMPLETED|Washout (>= 1 Week)||0
241789|NCT00006289|577150|P2|COMPLETED|Washout (>= 1 Week)||10
241790|NCT00006289|577151|P1|COMPLETED|Washout (>= 1 Week)||10
241791|NCT00006289|577150|P2|STARTED|Washout (>= 1 Week)||10
241792|NCT00006289|577151|P1|STARTED|Washout (>= 1 Week)||10
241793|NCT00006289|577150|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
241794|NCT00006289|577151|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
241795|NCT00006289|577150|P2|COMPLETED|First Intervention (5 Weeks)||10
241796|NCT00006289|577151|P1|COMPLETED|First Intervention (5 Weeks)||10
241797|NCT00006289|577150|P2|STARTED|First Intervention (5 Weeks)||10
241798|NCT00006289|577151|P1|STARTED|First Intervention (5 Weeks)||11
241799|NCT00006237|577169|P2|NOT COMPLETED|Overall Study||61
241800|NCT00006237|577170|P1|NOT COMPLETED|Overall Study||125
241801|NCT00006237|577169|P2|COMPLETED|Overall Study||159
241802|NCT00006237|577170|P1|COMPLETED|Overall Study||87
241803|NCT00006237|577169|P2|Eligible and Treated|Overall Study||199
241804|NCT00006237|577170|P1|Eligible and Treated|Overall Study||203
241805|NCT00006237|577169|P2|Eligible|Overall Study||200
241806|NCT00006237|577170|P1|Eligible|Overall Study||203
241807|NCT00006237|577169|P2|STARTED|Overall Study||220
241808|NCT00006237|577170|P1|STARTED|Overall Study||212
241809|NCT00006184|577182|P2|NOT COMPLETED|Overall Study||0
241810|NCT00006184|577183|P1|NOT COMPLETED|Overall Study||1
241811|NCT00006184|577182|P2|COMPLETED|Overall Study||10
241812|NCT00006184|577183|P1|COMPLETED|Overall Study||9
241813|NCT00006184|577182|P2|STARTED|Overall Study||10
241814|NCT00006184|577183|P1|STARTED|Overall Study||10
241815|NCT00006178|577190|P1|NOT COMPLETED|Overall Study||0
241816|NCT00006178|577190|P1|COMPLETED|Overall Study||12
241817|NCT00006178|577190|P1|STARTED|Overall Study||12
241818|NCT00006170|577201|P4|NOT COMPLETED|Overall Study||39
241819|NCT00006170|577202|P3|NOT COMPLETED|Overall Study||43
241820|NCT00006170|577203|P2|NOT COMPLETED|Overall Study||50
241821|NCT00006170|577204|P1|NOT COMPLETED|Overall Study||49
241822|NCT00006170|577201|P4|COMPLETED|Overall Study||28
241823|NCT00006170|577202|P3|COMPLETED|Overall Study||46
241824|NCT00006170|577203|P2|COMPLETED|Overall Study||37
241825|NCT00006170|577204|P1|COMPLETED|Overall Study||57
241826|NCT00006170|577201|P4|STARTED|Overall Study||67
241827|NCT00006170|577202|P3|STARTED|Overall Study||89
241828|NCT00006170|577203|P2|STARTED|Overall Study||87
241829|NCT00006170|577204|P1|STARTED|Overall Study||106
241830|NCT00006164|577224|P2|NOT COMPLETED|Overall Study||81
241831|NCT00006164|577225|P1|NOT COMPLETED|Overall Study||70
241832|NCT00006164|577224|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
241833|NCT00006164|577225|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
241834|NCT00006164|577224|P2|STARTED|Overall Study||533
241835|NCT00006164|577225|P1|STARTED|Overall Study||517
241836|NCT00006156|577251|P2|NOT COMPLETED|Overall Study||0
241837|NCT00006156|577252|P1|NOT COMPLETED|Overall Study||0
241838|NCT00006156|577251|P2|COMPLETED|Overall Study||7
241839|NCT00006156|577252|P1|COMPLETED|Overall Study||42
241840|NCT00006156|577251|P2|STARTED|Overall Study||7
241841|NCT00006156|577252|P1|STARTED|Overall Study||42
241842|NCT00006151|577261|P2|NOT COMPLETED|Overall Study||14
241843|NCT00006151|577262|P1|NOT COMPLETED|Overall Study||13
241844|NCT00006151|577261|P2|COMPLETED|Overall Study||16
241845|NCT00006151|577262|P1|COMPLETED|Overall Study||17
241846|NCT00006151|577261|P2|STARTED|Overall Study||30
241847|NCT00006151|577262|P1|STARTED|Overall Study||30
241848|NCT00006011|577271|P3|NOT COMPLETED|Overall Study||73
241849|NCT00006011|577272|P2|NOT COMPLETED|Overall Study||77
241850|NCT00006011|577273|P1|NOT COMPLETED|Overall Study||65
241851|NCT00006011|577271|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
241852|NCT00006011|577272|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
241853|NCT00006011|577273|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
241854|NCT00006011|577271|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
241855|NCT00006011|577272|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
241856|NCT00006011|577273|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
241857|NCT00005957|577281|P2|NOT COMPLETED|Overall Study||28
241858|NCT00005957|577282|P1|NOT COMPLETED|Overall Study||8
241859|NCT00005957|577281|P2|COMPLETED|Overall Study||888
241860|NCT00005957|577282|P1|COMPLETED|Overall Study||908
241861|NCT00005957|577281|P2|STARTED|Overall Study||916
241862|NCT00005957|577282|P1|STARTED|Overall Study||916
241863|NCT00005947|577292|P2|NOT COMPLETED|Overall Study||41
241864|NCT00005947|577293|P1|NOT COMPLETED|Overall Study||57
241865|NCT00005947|577292|P2|COMPLETED|Overall Study||4
241866|NCT00005947|577293|P1|COMPLETED|Overall Study||25
241867|NCT00005947|577292|P2|STARTED|Overall Study||45
241868|NCT00005947|577293|P1|STARTED|Overall Study||82
241869|NCT00005937|577301|P1|NOT COMPLETED|Overall Study||5
241870|NCT00005937|577301|P1|COMPLETED|Overall Study||37
241871|NCT00005937|577301|P1|STARTED|Overall Study||42
241872|NCT00005908|577305|P2|NOT COMPLETED|Overall Study||0
241873|NCT00005908|577306|P1|NOT COMPLETED|Overall Study||1
241874|NCT00005908|577305|P2|COMPLETED|Overall Study||20
241875|NCT00005908|577306|P1|COMPLETED|Overall Study||9
241876|NCT00005908|577305|P2|STARTED|Overall Study||20
241877|NCT00005908|577306|P1|STARTED|Overall Study||10
241878|NCT00005906|577315|P1|NOT COMPLETED|Overall Study||3
241879|NCT00005906|577315|P1|COMPLETED|Overall Study||1
241880|NCT00005906|577315|P1|STARTED|Overall Study||4
241881|NCT00005901|577323|P2|NOT COMPLETED|Overall Study||0
241882|NCT00005901|577324|P1|NOT COMPLETED|Overall Study||0
241883|NCT00005901|577323|P2|COMPLETED|Overall Study||15
241884|NCT00005901|577324|P1|COMPLETED|Overall Study||19
241885|NCT00005901|577323|P2|STARTED|Overall Study||15
241886|NCT00005901|577324|P1|STARTED|Overall Study||19
241887|NCT00005669|577342|P2|NOT COMPLETED|Overall Study||7
241888|NCT00005669|577343|P1|NOT COMPLETED|Overall Study||8
241889|NCT00005669|577342|P2|COMPLETED|Overall Study||40
241890|NCT00005669|577343|P1|COMPLETED|Overall Study||45
241891|NCT00005669|577342|P2|STARTED|Overall Study||47
241892|NCT00005669|577343|P1|STARTED|Overall Study||53
241893|NCT00004980|577359|P2|NOT COMPLETED|Overall Study||2
241894|NCT00004980|577360|P1|NOT COMPLETED|Overall Study||2
241895|NCT00004980|577359|P2|COMPLETED|Overall Study||21
241896|NCT00004980|577360|P1|COMPLETED|Overall Study||25
241897|NCT00004980|577359|P2|STARTED|Overall Study||23
241898|NCT00004980|577360|P1|STARTED|Overall Study||27
241899|NCT00004978|577374|P2|NOT COMPLETED|Overall Study||270
241900|NCT00004978|577375|P1|NOT COMPLETED|Overall Study||244
241901|NCT00004978|577374|P2|COMPLETED|Overall Study||1790
241902|NCT00004978|577375|P1|COMPLETED|Overall Study||1846
241903|NCT00004978|577374|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
241904|NCT00004978|577375|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
241905|NCT00004888|577401|P2|NOT COMPLETED|Overall Study||24
241906|NCT00004888|577402|P1|NOT COMPLETED|Overall Study||11
241907|NCT00004888|577401|P2|COMPLETED|Overall Study||22
241908|NCT00004888|577402|P1|COMPLETED|Overall Study||27
241909|NCT00004888|577401|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
241910|NCT00004888|577402|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
241911|NCT00004859|577420|P2|NOT COMPLETED|Overall Study||282
241912|NCT00004859|577421|P1|NOT COMPLETED|Overall Study||118
241913|NCT00004859|577420|P2|COMPLETED|Overall Study||12
241914|NCT00004859|577421|P1|COMPLETED|Overall Study||177
241915|NCT00004859|577420|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
241916|NCT00004859|577421|P1|Treated and Having Toxicity Data|Overall Study||289
241917|NCT00004859|577420|P2|Treated|Overall Study||289
241918|NCT00004859|577421|P1|Treated|Overall Study||289
241919|NCT00004859|577420|P2|Eligible|Overall Study||271
241920|NCT00004859|577421|P1|Eligible|Overall Study||275
241921|NCT00004859|577420|P2|STARTED|Overall Study||294
241922|NCT00004859|577421|P1|STARTED|Overall Study||295
241923|NCT00004732|577433|P2|NOT COMPLETED|Overall Study||111
241924|NCT00004732|577434|P1|NOT COMPLETED|Overall Study||69
241925|NCT00004732|577433|P2|COMPLETED|Overall Study||1129
241926|NCT00004732|577434|P1|COMPLETED|Overall Study||1193
241927|NCT00004732|577433|P2|STARTED|Overall Study||1240
241928|NCT00004732|577434|P1|STARTED|Overall Study||1262
241929|NCT00004635|577444|P2|NOT COMPLETED|Period Two||9
241930|NCT00004635|577445|P1|NOT COMPLETED|Period Two||6
241931|NCT00004635|577444|P2|COMPLETED|Period Two||50
241932|NCT00004635|577445|P1|COMPLETED|Period Two||38
241933|NCT00004635|577444|P2|STARTED|Period Two||59
241934|NCT00004635|577445|P1|STARTED|Period Two||44
241935|NCT00004635|577444|P2|NOT COMPLETED|Period One||6
241936|NCT00004635|577445|P1|NOT COMPLETED|Period One||6
241937|NCT00004635|577444|P2|COMPLETED|Period One||74
241938|NCT00004635|577445|P1|COMPLETED|Period One||73
241939|NCT00004635|577444|P2|Received Treatment|Period One||75
241940|NCT00004635|577445|P1|Received Treatment|Period One||73
241941|NCT00004635|577444|P2|STARTED|Period One||80
241942|NCT00004635|577445|P1|STARTED|Period One||79
241943|NCT00004563|577457|P2|NOT COMPLETED|Overall Study||24
241944|NCT00004563|577458|P1|NOT COMPLETED|Overall Study||25
241945|NCT00004563|577457|P2|COMPLETED|Overall Study||55
241946|NCT00004563|577458|P1|COMPLETED|Overall Study||54
241947|NCT00004563|577457|P2|STARTED|Overall Study||79
241948|NCT00004563|577458|P1|STARTED|Overall Study||79
241949|NCT00004562|577470|P2|NOT COMPLETED|Overall Study||91
241950|NCT00004562|577471|P1|NOT COMPLETED|Overall Study||102
241951|NCT00004562|577470|P2|COMPLETED|Overall Study||1009
241952|NCT00004562|577471|P1|COMPLETED|Overall Study||999
241953|NCT00004562|577470|P2|STARTED|Overall Study||1100
241954|NCT00004562|577471|P1|STARTED|Overall Study||1101
241955|NCT00004547|577482|P3|NOT COMPLETED|Overall Study||22
241956|NCT00004547|577483|P2|NOT COMPLETED|Overall Study||9
241957|NCT00004547|577484|P1|NOT COMPLETED|Overall Study||22
241958|NCT00004547|577482|P3|COMPLETED|Overall Study||35
241959|NCT00004547|577483|P2|COMPLETED|Overall Study||39
241960|NCT00004547|577484|P1|COMPLETED|Overall Study||61
241961|NCT00004547|577482|P3|Not Evaluable|Overall Study||23
241962|NCT00004547|577483|P2|Not Evaluable|Overall Study||9
241963|NCT00004547|577484|P1|Not Evaluable|Overall Study||21
241964|NCT00004547|577482|P3|STARTED|Overall Study||57
241965|NCT00004547|577483|P2|STARTED|Overall Study||48
241966|NCT00004547|577484|P1|STARTED|Overall Study||83
241967|NCT00004500|577504|P2|NOT COMPLETED|Overall Study||0
241968|NCT00004500|577505|P1|NOT COMPLETED|Overall Study||0
241969|NCT00004500|577504|P2|COMPLETED|Overall Study||31
241970|NCT00004500|577505|P1|COMPLETED|Overall Study||38
241971|NCT00004500|577504|P2|1 Year Follow-Up|Overall Study||24
241972|NCT00004500|577505|P1|1 Year Follow-Up|Overall Study||24
241973|NCT00004500|577504|P2|STARTED|Overall Study||31
241974|NCT00004500|577505|P1|STARTED|Overall Study||38
241975|NCT00004412|577518|P3|NOT COMPLETED|Crossover Period||0
241976|NCT00004412|577519|P2|NOT COMPLETED|Crossover Period||0
241977|NCT00004412|577520|P1|NOT COMPLETED|Crossover Period||0
241978|NCT00004412|577518|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
241979|NCT00004412|577519|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
241980|NCT00004412|577520|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
241981|NCT00004412|577518|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
241982|NCT00004412|577519|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
241983|NCT00004412|577520|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
241984|NCT00004412|577518|P3|NOT COMPLETED|Randomized Period||0
241985|NCT00004412|577519|P2|NOT COMPLETED|Randomized Period||0
241986|NCT00004412|577520|P1|NOT COMPLETED|Randomized Period||3
241987|NCT00004412|577518|P3|COMPLETED|Randomized Period||0
241988|NCT00004412|577519|P2|COMPLETED|Randomized Period||12
241989|NCT00004412|577520|P1|COMPLETED|Randomized Period||8
241990|NCT00004412|577518|P3|STARTED|Randomized Period||0
241991|NCT00004412|577519|P2|STARTED|Randomized Period||12
241992|NCT00004412|577520|P1|STARTED|Randomized Period||11
241993|NCT00004228|577535|P7|NOT COMPLETED|Overall Study||12
241994|NCT00004228|577536|P6|NOT COMPLETED|Overall Study||14
241995|NCT00004228|577537|P5|NOT COMPLETED|Overall Study||16
241996|NCT00004228|577538|P4|NOT COMPLETED|Overall Study||7
241997|NCT00004228|577539|P3|NOT COMPLETED|Overall Study||19
241998|NCT00004228|577540|P2|NOT COMPLETED|Overall Study||15
241999|NCT00004228|577541|P1|NOT COMPLETED|Overall Study||9
242000|NCT00004228|577535|P7|COMPLETED|Overall Study||45
242001|NCT00004228|577536|P6|COMPLETED|Overall Study||51
242002|NCT00004228|577537|P5|COMPLETED|Overall Study||51
242003|NCT00004228|577538|P4|COMPLETED|Overall Study||6
242004|NCT00004228|577539|P3|COMPLETED|Overall Study||46
242005|NCT00004228|577540|P2|COMPLETED|Overall Study||51
242006|NCT00004228|577541|P1|COMPLETED|Overall Study||51
242007|NCT00004228|577535|P7|STARTED|Overall Study||57
242008|NCT00004228|577536|P6|STARTED|Overall Study||65
242009|NCT00004228|577537|P5|STARTED|Overall Study||67
242010|NCT00004228|577538|P4|STARTED|Overall Study||13
242011|NCT00004228|577539|P3|STARTED|Overall Study||65
242012|NCT00004228|577540|P2|STARTED|Overall Study||66
242013|NCT00004228|577541|P1|STARTED|Overall Study||60
242014|NCT00004146|577564|P1|NOT COMPLETED|Overall Study||0
242015|NCT00004146|577564|P1|COMPLETED|Overall Study||55
242016|NCT00004146|577564|P1|STARTED|Overall Study||55
242017|NCT00004143|577571|P1|NOT COMPLETED|Overall Study||0
242018|NCT00004143|577571|P1|COMPLETED|Overall Study||2
242019|NCT00004143|577571|P1|STARTED|Overall Study||2
242020|NCT00004092|577582|P2|NOT COMPLETED|Overall Study||0
242021|NCT00004092|577583|P1|NOT COMPLETED|Overall Study||0
242022|NCT00004092|577582|P2|COMPLETED|Overall Study||51
242023|NCT00004092|577583|P1|COMPLETED|Overall Study||21
242024|NCT00004092|577582|P2|STARTED|Overall Study||51
242025|NCT00004092|577583|P1|STARTED|Overall Study||21
242026|NCT00004054|577593|P2|NOT COMPLETED|Overall Study||0
242027|NCT00004054|577594|P1|NOT COMPLETED|Overall Study||0
242028|NCT00004054|577593|P2|COMPLETED|Overall Study||200
242029|NCT00004054|577594|P1|COMPLETED|Overall Study||197
242030|NCT00004054|577593|P2|STARTED|Overall Study||200
242031|NCT00004054|577594|P1|STARTED|Overall Study||197
242032|NCT00003910|577600|P2|NOT COMPLETED|Step 2||0
242033|NCT00003910|577601|P1|NOT COMPLETED|Step 2||0
242034|NCT00003910|577600|P2|COMPLETED|Step 2||16
242035|NCT00003910|577601|P1|COMPLETED|Step 2||0
242036|NCT00003910|577600|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
242037|NCT00003910|577601|P1|STARTED|Step 2||0
242038|NCT00003910|577600|P2|NOT COMPLETED|Step 1||0
242039|NCT00003910|577601|P1|NOT COMPLETED|Step 1||0
242040|NCT00003910|577600|P2|COMPLETED|Step 1||0
242041|NCT00003910|577601|P1|COMPLETED|Step 1||55
242042|NCT00003910|577600|P2|STARTED|Step 1||0
242043|NCT00003910|577601|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
242044|NCT00003907|577608|P2|NOT COMPLETED|Overall Study||23
242045|NCT00003907|577609|P1|NOT COMPLETED|Overall Study||13
242046|NCT00003907|577608|P2|COMPLETED|Overall Study||8
242047|NCT00003907|577609|P1|COMPLETED|Overall Study||6
242048|NCT00003907|577608|P2|Eligible and Treated|Overall Study||29
242049|NCT00003907|577609|P1|Eligible and Treated|Overall Study||17
242050|NCT00003907|577608|P2|Received Protocol Therapy (Treated)|Overall Study||31
242051|NCT00003907|577609|P1|Received Protocol Therapy (Treated)|Overall Study||18
242052|NCT00003907|577608|P2|Eligible|Overall Study||29
242053|NCT00003907|577609|P1|Eligible|Overall Study||18
242054|NCT00003907|577608|P2|STARTED|Overall Study||31
242055|NCT00003907|577609|P1|STARTED|Overall Study||19
242056|NCT00003901|577619|P1|NOT COMPLETED|Overall Study||17
242057|NCT00003901|577619|P1|COMPLETED|Overall Study||1030
242058|NCT00003901|577619|P1|STARTED|Overall Study||1047
242059|NCT00003896|577630|P1|NOT COMPLETED|Overall Study||29
242060|NCT00003896|577630|P1|COMPLETED|Overall Study||39
242061|NCT00003896|577630|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
242062|NCT00003896|577630|P1|STARTED|Overall Study||68
242063|NCT00003869|577638|P2|NOT COMPLETED|Overall Study||12
242064|NCT00003869|577639|P1|NOT COMPLETED|Overall Study||41
242065|NCT00003869|577638|P2|COMPLETED|Overall Study||80
242066|NCT00003869|577639|P1|COMPLETED|Overall Study||53
242067|NCT00003869|577638|P2|STARTED|Overall Study||92
242068|NCT00003869|577639|P1|STARTED|Overall Study||94
242069|NCT00003782|577658|P3|NOT COMPLETED|Overall Study||26
242070|NCT00003782|577659|P2|NOT COMPLETED|Overall Study||31
242071|NCT00003782|577660|P1|NOT COMPLETED|Overall Study||30
242072|NCT00003782|577658|P3|COMPLETED|Overall Study||1758
242073|NCT00003782|577659|P2|COMPLETED|Overall Study||1753
242074|NCT00003782|577660|P1|COMPLETED|Overall Study||1753
242075|NCT00003782|577658|P3|STARTED|Overall Study||1784
242076|NCT00003782|577659|P2|STARTED|Overall Study||1784
242077|NCT00003782|577660|P1|STARTED|Overall Study||1783
242078|NCT00003726|577668|P1|NOT COMPLETED|Overall Study||1
242079|NCT00003726|577668|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
242080|NCT00003726|577668|P1|STARTED|Overall Study||1
242081|NCT00003659|577672|P1|NOT COMPLETED|Overall Study||3
242082|NCT00003659|577672|P1|COMPLETED|Overall Study||36
242083|NCT00003659|577672|P1|STARTED|Overall Study||39
242084|NCT00003641|577680|P2|NOT COMPLETED|Overall Study||174
242085|NCT00003641|577681|P1|NOT COMPLETED|Overall Study||569
242086|NCT00003641|577680|P2|COMPLETED|Overall Study||407
242087|NCT00003641|577681|P1|COMPLETED|Overall Study||0
242088|NCT00003641|577680|P2|Toxicity Assessed|Overall Study||568
242089|NCT00003641|577681|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
242090|NCT00003641|577680|P2|Treated|Overall Study||569
242091|NCT00003641|577681|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
242092|NCT00003641|577680|P2|STARTED|Overall Study||581
242093|NCT00003641|577681|P1|STARTED|Overall Study||569
242094|NCT00003631|577692|P3|NOT COMPLETED|Overall Study||9
242095|NCT00003631|577693|P2|NOT COMPLETED|Overall Study||1
242096|NCT00003631|577694|P1|NOT COMPLETED|Overall Study||3
242097|NCT00003631|577692|P3|COMPLETED|Overall Study||15
242098|NCT00003631|577693|P2|COMPLETED|Overall Study||43
242099|NCT00003631|577694|P1|COMPLETED|Overall Study||47
242100|NCT00003631|577692|P3|STARTED|Overall Study||24
242101|NCT00003631|577693|P2|STARTED|Overall Study||44
242102|NCT00003631|577694|P1|STARTED|Overall Study||50
242103|NCT00003590|577702|P1|NOT COMPLETED|Overall Study||22
242104|NCT00003590|577702|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
242105|NCT00003590|577702|P1|Eligible and Began Protocol Therapy|Overall Study||28
242106|NCT00003590|577702|P1|Eligible|Overall Study||28
242107|NCT00003590|577702|P1|STARTED|Overall Study||29
242108|NCT00003483|577707|P1|NOT COMPLETED|Overall Study||1
242109|NCT00003483|577707|P1|COMPLETED|Overall Study||2
242110|NCT00003483|577707|P1|STARTED|Overall Study||3
242111|NCT00003479|577712|P1|NOT COMPLETED|Overall Study||3
242112|NCT00003479|577712|P1|COMPLETED|Overall Study||6
242113|NCT00003479|577712|P1|STARTED|Overall Study||9
242114|NCT00003477|577717|P1|NOT COMPLETED|Overall Study||4
242115|NCT00003477|577717|P1|COMPLETED|Overall Study||8
242116|NCT00003477|577717|P1|STARTED|Overall Study||12
242117|NCT00003475|577722|P1|NOT COMPLETED|Overall Study||13
242118|NCT00003475|577722|P1|COMPLETED|Overall Study||27
242119|NCT00003475|577722|P1|STARTED|Overall Study||40
242120|NCT00003473|577727|P1|NOT COMPLETED|Overall Study||3
242121|NCT00003473|577727|P1|COMPLETED|Overall Study||17
242122|NCT00003473|577727|P1|STARTED|Overall Study||20
242123|NCT00003470|577732|P1|NOT COMPLETED|Overall Study||6
242124|NCT00003470|577732|P1|COMPLETED|Overall Study||21
242125|NCT00003470|577732|P1|STARTED|Overall Study||27
242126|NCT00003468|577737|P1|NOT COMPLETED|Overall Study||2
242127|NCT00003468|577737|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
242128|NCT00003468|577737|P1|STARTED|Overall Study||11
242129|NCT00003460|577742|P1|NOT COMPLETED|Overall Study||1
242130|NCT00003460|577742|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
242131|NCT00003460|577742|P1|STARTED|Overall Study||13
242132|NCT00003459|577747|P1|NOT COMPLETED|Overall Study||9
242133|NCT00003459|577747|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
242134|NCT00003459|577747|P1|STARTED|Overall Study||40
242135|NCT00003458|577752|P1|NOT COMPLETED|Overall Study||4
242136|NCT00003458|577752|P1|COMPLETED|Overall Study||30
242137|NCT00003458|577752|P1|STARTED|Overall Study||34
242138|NCT00003457|577757|P1|NOT COMPLETED|Overall Study||9
242139|NCT00003457|577757|P1|COMPLETED|Overall Study||31
242140|NCT00003457|577757|P1|STARTED|Overall Study||40
242141|NCT00003389|577764|P2|NOT COMPLETED|Overall Study||60
242142|NCT00003389|577765|P1|NOT COMPLETED|Overall Study||98
242143|NCT00003389|577764|P2|COMPLETED|Overall Study||366
242144|NCT00003389|577765|P1|COMPLETED|Overall Study||330
242145|NCT00003389|577764|P2|Eligible Patients|Overall Study||399
242146|NCT00003389|577765|P1|Eligible Patients|Overall Study||395
242147|NCT00003389|577764|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
242148|NCT00003389|577765|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
242149|NCT00003389|577764|P2|STARTED|Overall Study||426
242150|NCT00003389|577765|P1|STARTED|Overall Study||428
242151|NCT00003377|577780|P5|NOT COMPLETED|Period II||1
242152|NCT00003377|577781|P4|NOT COMPLETED|Period II||0
242153|NCT00003377|577782|P3|NOT COMPLETED|Period II||0
242154|NCT00003377|577783|P2|NOT COMPLETED|Period II||0
242155|NCT00003377|577784|P1|NOT COMPLETED|Period II||0
242156|NCT00003377|577780|P5|COMPLETED|Period II||16
242157|NCT00003377|577781|P4|COMPLETED|Period II||0
242158|NCT00003377|577782|P3|COMPLETED|Period II||0
242159|NCT00003377|577783|P2|COMPLETED|Period II||0
242160|NCT00003377|577784|P1|COMPLETED|Period II||0
242161|NCT00003377|577780|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
242162|NCT00003377|577781|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
242163|NCT00003377|577782|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
242164|NCT00003377|577783|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
242165|NCT00003377|577784|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
242166|NCT00003377|577780|P5|NOT COMPLETED|Period I||0
242167|NCT00003377|577781|P4|NOT COMPLETED|Period I||1
242168|NCT00003377|577782|P3|NOT COMPLETED|Period I||1
242169|NCT00003377|577783|P2|NOT COMPLETED|Period I||0
242170|NCT00003377|577784|P1|NOT COMPLETED|Period I||0
242171|NCT00003377|577780|P5|COMPLETED|Period I||0
242172|NCT00003377|577781|P4|COMPLETED|Period I||2
242173|NCT00003377|577782|P3|COMPLETED|Period I||2
242174|NCT00003377|577783|P2|COMPLETED|Period I||3
242175|NCT00003377|577784|P1|COMPLETED|Period I||3
242176|NCT00003377|577780|P5|STARTED|Period I||0
242177|NCT00003377|577781|P4|STARTED|Period I||3
242178|NCT00003377|577782|P3|STARTED|Period I||3
242179|NCT00003377|577783|P2|STARTED|Period I||3
242180|NCT00003377|577784|P1|STARTED|Period I||3
242181|NCT00003298|577798|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
242182|NCT00003298|577798|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
242183|NCT00003298|577798|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
242184|NCT00003298|577798|P1|STARTED|Step 2 (Adjuvant Therapy)||10
242185|NCT00003298|577798|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
242186|NCT00003298|577798|P1|COMPLETED|Re-register to Step 2 After Surgery||10
242187|NCT00003298|577798|P1|STARTED|Re-register to Step 2 After Surgery||28
242188|NCT00003298|577798|P1|NOT COMPLETED|Surgery||7
242189|NCT00003298|577798|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
242190|NCT00003298|577798|P1|STARTED|Surgery||35
242191|NCT00003298|577798|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
242192|NCT00003298|577798|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
242193|NCT00003298|577798|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
242194|NCT00003298|577798|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
242195|NCT00003298|577798|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
242196|NCT00003224|577812|P6|NOT COMPLETED|Overall Study||0
242197|NCT00003224|577813|P5|NOT COMPLETED|Overall Study||0
242198|NCT00003224|577814|P4|NOT COMPLETED|Overall Study||0
242199|NCT00003224|577815|P3|NOT COMPLETED|Overall Study||0
242200|NCT00003224|577816|P2|NOT COMPLETED|Overall Study||0
242201|NCT00003224|577817|P1|NOT COMPLETED|Overall Study||0
242202|NCT00003224|577812|P6|COMPLETED|Overall Study||3
242203|NCT00003224|577813|P5|COMPLETED|Overall Study||4
242204|NCT00003224|577814|P4|COMPLETED|Overall Study||2
242205|NCT00003224|577815|P3|COMPLETED|Overall Study||4
242206|NCT00003224|577816|P2|COMPLETED|Overall Study||5
242207|NCT00003224|577817|P1|COMPLETED|Overall Study||4
242208|NCT00003224|577812|P6|STARTED|Overall Study||3
242209|NCT00003224|577813|P5|STARTED|Overall Study||4
242210|NCT00003224|577814|P4|STARTED|Overall Study||2
242211|NCT00003224|577815|P3|STARTED|Overall Study||4
242212|NCT00003224|577816|P2|STARTED|Overall Study||5
242213|NCT00003224|577817|P1|STARTED|Overall Study||4
242214|NCT00003222|577837|P2|NOT COMPLETED|Overall Study||1
242215|NCT00003222|577838|P1|NOT COMPLETED|Overall Study||0
242216|NCT00003222|577837|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
242217|NCT00003222|577838|P1|COMPLETED|Overall Study||13
242218|NCT00003222|577837|P2|STARTED|Overall Study||28
242219|NCT00003222|577838|P1|STARTED|Overall Study||13
242220|NCT00003138|577850|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
242221|NCT00003138|577851|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
242222|NCT00003138|577850|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
242223|NCT00003138|577851|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
242224|NCT00003138|577850|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
242225|NCT00003138|577851|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
242226|NCT00003138|577850|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
242227|NCT00003138|577851|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
242228|NCT00003138|577850|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
242229|NCT00003138|577851|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
242230|NCT00003138|577850|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
242231|NCT00003138|577851|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
242232|NCT00003138|577850|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
242233|NCT00003138|577851|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
242234|NCT00003138|577850|P2|NOT COMPLETED|Step 2 (Cross Over)||0
242235|NCT00003138|577851|P1|NOT COMPLETED|Step 2 (Cross Over)||26
242236|NCT00003138|577850|P2|COMPLETED|Step 2 (Cross Over)||0
242237|NCT00003138|577851|P1|COMPLETED|Step 2 (Cross Over)||0
242238|NCT00003138|577850|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
242239|NCT00003138|577851|P1|STARTED|Step 2 (Cross Over)||26
242240|NCT00003138|577850|P2|NOT COMPLETED|Step 1||57
242241|NCT00003138|577851|P1|NOT COMPLETED|Step 1||61
242242|NCT00003138|577850|P2|COMPLETED|Step 1||0
242243|NCT00003138|577851|P1|COMPLETED|Step 1||0
242244|NCT00003138|577850|P2|Patients With Transfusion Data|Step 1||42
242245|NCT00003138|577851|P1|Patients With Transfusion Data|Step 1||37
242246|NCT00003138|577850|P2|Patients With QOL Data at 4 Months|Step 1||42
242247|NCT00003138|577851|P1|Patients With QOL Data at 4 Months|Step 1||42
242248|NCT00003138|577850|P2|Eligible and Treated|Step 1||50
242249|NCT00003138|577851|P1|Eligible and Treated|Step 1||52
242250|NCT00003138|577850|P2|Treated|Step 1||53
242251|NCT00003138|577851|P1|Treated|Step 1||56
242252|NCT00003138|577850|P2|Patients With Complete Data|Step 1||53
242253|NCT00003138|577851|P1|Patients With Complete Data|Step 1||57
242254|NCT00003138|577850|P2|STARTED|Step 1||57
242255|NCT00003138|577851|P1|STARTED|Step 1||61
242256|NCT00002975|577864|P1|NOT COMPLETED|Overall Study||5
242257|NCT00002975|577864|P1|COMPLETED|Overall Study||175
242258|NCT00002975|577864|P1|Treated With Study Therapy|Overall Study||175
242259|NCT00002975|577864|P1|STARTED|Overall Study||180
242260|NCT00002931|577868|P1|NOT COMPLETED|Overall Study||2
242261|NCT00002931|577868|P1|COMPLETED|Overall Study||46
242262|NCT00002931|577868|P1|STARTED|Overall Study||48
242263|NCT00002850|577877|P3|NOT COMPLETED|Overall Study||4
242264|NCT00002850|577878|P2|NOT COMPLETED|Overall Study||2
242265|NCT00002850|577879|P1|NOT COMPLETED|Overall Study||5
242266|NCT00002850|577877|P3|COMPLETED|Overall Study||63
242267|NCT00002850|577878|P2|COMPLETED|Overall Study||74
242268|NCT00002850|577879|P1|COMPLETED|Overall Study||64
242269|NCT00002850|577877|P3|STARTED|Overall Study||67
242270|NCT00002850|577878|P2|STARTED|Overall Study||76
242271|NCT00002850|577879|P1|STARTED|Overall Study||69
242272|NCT00002766|577889|P2|NOT COMPLETED|Overall Study||4
242273|NCT00002766|577890|P1|NOT COMPLETED|Overall Study||3
242274|NCT00002766|577889|P2|COMPLETED|Overall Study||85
242275|NCT00002766|577890|P1|COMPLETED|Overall Study||78
242276|NCT00002766|577889|P2|STARTED|Overall Study||89
242277|NCT00002766|577890|P1|STARTED|Overall Study||81
242278|NCT00002601|577896|P1|NOT COMPLETED|Overall Study||0
242279|NCT00002601|577896|P1|COMPLETED|Overall Study||13
242280|NCT00002601|577896|P1|STARTED|Overall Study||13
242281|NCT00002558|577906|P2|NOT COMPLETED|Overall Study||1
242282|NCT00002558|577907|P1|NOT COMPLETED|Overall Study||0
242283|NCT00002558|577906|P2|COMPLETED|Overall Study||15
242284|NCT00002558|577907|P1|COMPLETED|Overall Study||92
242285|NCT00002558|577906|P2|STARTED|Overall Study||16
242286|NCT00002558|577907|P1|STARTED|Overall Study||92
242287|NCT00002540|577915|P2|NOT COMPLETED|Overall Study||2464
242288|NCT00002540|577916|P1|NOT COMPLETED|Overall Study||801
242289|NCT00002540|577915|P2|COMPLETED|Overall Study||35876
242290|NCT00002540|577916|P1|COMPLETED|Overall Study||37544
242291|NCT00002540|577915|P2|STARTED|Overall Study||38340
242292|NCT00002540|577916|P1|STARTED|Overall Study||38345
242293|NCT00002525|577944|P2|NOT COMPLETED|Overall Study||0
242294|NCT00002525|577945|P1|NOT COMPLETED|Overall Study||186
242295|NCT00002525|577944|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
242296|NCT00002525|577945|P1|COMPLETED|Overall Study||241
242297|NCT00002525|577944|P2|Dukes' B2 Stage|Overall Study||139
242298|NCT00002525|577945|P1|Dukes' B2 Stage|Overall Study||150
242299|NCT00002525|577944|P2|Dukes' B3 or C Stage|Overall Study||158
242300|NCT00002525|577945|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
242301|NCT00002525|577944|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
242302|NCT00002525|577945|P1|Treated|Overall Study||419
242303|NCT00002525|577944|P2|STARTED|Overall Study||428
242304|NCT00002525|577945|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
242305|NCT00001984|577959|P1|NOT COMPLETED|Overall Study||0
242306|NCT00001984|577959|P1|COMPLETED|Overall Study||5
242307|NCT00001984|577959|P1|STARTED|Overall Study||5
242308|NCT00001962|577969|P1|NOT COMPLETED|Overall Study||28
242309|NCT00001962|577969|P1|COMPLETED|Overall Study||72
242310|NCT00001962|577969|P1|STARTED|Overall Study||100
242311|NCT00001959|577973|P1|NOT COMPLETED|Overall Study||3
242312|NCT00001959|577973|P1|COMPLETED|Overall Study||18
242313|NCT00001959|577973|P1|STARTED|Overall Study||21
242314|NCT00001941|577979|P5|NOT COMPLETED|Overall Study||1
242315|NCT00001941|577980|P4|NOT COMPLETED|Overall Study||0
242316|NCT00001941|577981|P3|NOT COMPLETED|Overall Study||0
242317|NCT00001941|577982|P2|NOT COMPLETED|Overall Study||0
242318|NCT00001941|577983|P1|NOT COMPLETED|Overall Study||0
242319|NCT00001941|577979|P5|COMPLETED|Overall Study||19
242320|NCT00001941|577980|P4|COMPLETED|Overall Study||3
242321|NCT00001941|577981|P3|COMPLETED|Overall Study||3
242322|NCT00001941|577982|P2|COMPLETED|Overall Study||5
242323|NCT00001941|577983|P1|COMPLETED|Overall Study||3
242324|NCT00001941|577979|P5|STARTED|Overall Study||20
242325|NCT00001941|577980|P4|STARTED|Overall Study||3
242326|NCT00001941|577981|P3|STARTED|Overall Study||3
242327|NCT00001941|577982|P2|STARTED|Overall Study||5
242328|NCT00001941|577983|P1|STARTED|Overall Study||3
242329|NCT00001832|578004|P15|NOT COMPLETED|Treatment Period||0
242330|NCT00001832|578005|P14|NOT COMPLETED|Treatment Period||0
242331|NCT00001832|578006|P13|NOT COMPLETED|Treatment Period||0
242332|NCT00001832|578007|P12|NOT COMPLETED|Treatment Period||0
242333|NCT00001832|578008|P11|NOT COMPLETED|Treatment Period||0
242334|NCT00001832|578009|P10|NOT COMPLETED|Treatment Period||0
242335|NCT00001832|578010|P9|NOT COMPLETED|Treatment Period||0
242336|NCT00001832|578011|P8|NOT COMPLETED|Treatment Period||1
242337|NCT00001832|578012|P7|NOT COMPLETED|Treatment Period||0
242338|NCT00001832|578013|P6|NOT COMPLETED|Treatment Period||1
242339|NCT00001832|578014|P5|NOT COMPLETED|Treatment Period||0
242340|NCT00001832|578015|P4|NOT COMPLETED|Treatment Period||0
242341|NCT00001832|578016|P3|NOT COMPLETED|Treatment Period||0
242342|NCT00001832|578017|P2|NOT COMPLETED|Treatment Period||0
242343|NCT00001832|578018|P1|NOT COMPLETED|Treatment Period||0
242344|NCT00001832|578004|P15|COMPLETED|Treatment Period||2
242345|NCT00001832|578005|P14|COMPLETED|Treatment Period||3
242346|NCT00001832|578006|P13|COMPLETED|Treatment Period||6
242347|NCT00001832|578007|P12|COMPLETED|Treatment Period||7
242348|NCT00001832|578008|P11|COMPLETED|Treatment Period||1
242349|NCT00001832|578009|P10|COMPLETED|Treatment Period||6
242350|NCT00001832|578010|P9|COMPLETED|Treatment Period||8
242351|NCT00001832|578011|P8|COMPLETED|Treatment Period||6
242352|NCT00001832|578012|P7|COMPLETED|Treatment Period||4
242353|NCT00001832|578013|P6|COMPLETED|Treatment Period||50
242354|NCT00001832|578014|P5|COMPLETED|Treatment Period||6
242355|NCT00001832|578015|P4|COMPLETED|Treatment Period||3
242356|NCT00001832|578016|P3|COMPLETED|Treatment Period||3
242357|NCT00001832|578017|P2|COMPLETED|Treatment Period||3
242358|NCT00001832|578018|P1|COMPLETED|Treatment Period||0
242359|NCT00001832|578004|P15|STARTED|Treatment Period||2
242360|NCT00001832|578005|P14|STARTED|Treatment Period||3
242361|NCT00001832|578006|P13|STARTED|Treatment Period||6
242362|NCT00001832|578007|P12|STARTED|Treatment Period||7
242363|NCT00001832|578008|P11|STARTED|Treatment Period||1
242364|NCT00001832|578009|P10|STARTED|Treatment Period||6
242365|NCT00001832|578010|P9|STARTED|Treatment Period||8
242366|NCT00001832|578011|P8|STARTED|Treatment Period||7
242367|NCT00001832|578012|P7|STARTED|Treatment Period||4
242368|NCT00001832|578013|P6|STARTED|Treatment Period||51
242369|NCT00001832|578014|P5|STARTED|Treatment Period||6
242370|NCT00001832|578015|P4|STARTED|Treatment Period||3
242371|NCT00001832|578016|P3|STARTED|Treatment Period||3
242372|NCT00001832|578017|P2|STARTED|Treatment Period||3
242373|NCT00001832|578018|P1|STARTED|Treatment Period||0
242374|NCT00001832|578004|P15|NOT COMPLETED|Apheresis Period||0
242375|NCT00001832|578005|P14|NOT COMPLETED|Apheresis Period||0
242376|NCT00001832|578006|P13|NOT COMPLETED|Apheresis Period||0
242377|NCT00001832|578007|P12|NOT COMPLETED|Apheresis Period||0
242378|NCT00001832|578008|P11|NOT COMPLETED|Apheresis Period||0
242379|NCT00001832|578009|P10|NOT COMPLETED|Apheresis Period||0
242380|NCT00001832|578010|P9|NOT COMPLETED|Apheresis Period||0
242381|NCT00001832|578011|P8|NOT COMPLETED|Apheresis Period||0
242382|NCT00001832|578012|P7|NOT COMPLETED|Apheresis Period||0
242383|NCT00001832|578013|P6|NOT COMPLETED|Apheresis Period||0
242384|NCT00001832|578014|P5|NOT COMPLETED|Apheresis Period||0
242385|NCT00001832|578015|P4|NOT COMPLETED|Apheresis Period||0
242386|NCT00001832|578016|P3|NOT COMPLETED|Apheresis Period||0
242387|NCT00001832|578017|P2|NOT COMPLETED|Apheresis Period||0
242388|NCT00001832|578018|P1|NOT COMPLETED|Apheresis Period||60
242389|NCT00001832|578004|P15|COMPLETED|Apheresis Period||0
242390|NCT00001832|578005|P14|COMPLETED|Apheresis Period||0
242391|NCT00001832|578006|P13|COMPLETED|Apheresis Period||0
242392|NCT00001832|578007|P12|COMPLETED|Apheresis Period||0
242393|NCT00001832|578008|P11|COMPLETED|Apheresis Period||0
242394|NCT00001832|578009|P10|COMPLETED|Apheresis Period||0
242395|NCT00001832|578010|P9|COMPLETED|Apheresis Period||0
242396|NCT00001832|578011|P8|COMPLETED|Apheresis Period||0
242397|NCT00001832|578012|P7|COMPLETED|Apheresis Period||0
242398|NCT00001832|578013|P6|COMPLETED|Apheresis Period||0
242399|NCT00001832|578014|P5|COMPLETED|Apheresis Period||0
242400|NCT00001832|578015|P4|COMPLETED|Apheresis Period||0
242401|NCT00001832|578016|P3|COMPLETED|Apheresis Period||0
242402|NCT00001832|578017|P2|COMPLETED|Apheresis Period||0
242403|NCT00001832|578018|P1|COMPLETED|Apheresis Period||110
242404|NCT00001832|578004|P15|STARTED|Apheresis Period||0
242405|NCT00001832|578005|P14|STARTED|Apheresis Period||0
242406|NCT00001832|578006|P13|STARTED|Apheresis Period||0
242407|NCT00001832|578007|P12|STARTED|Apheresis Period||0
242408|NCT00001832|578008|P11|STARTED|Apheresis Period||0
242409|NCT00001832|578009|P10|STARTED|Apheresis Period||0
242410|NCT00001832|578010|P9|STARTED|Apheresis Period||0
242411|NCT00001832|578011|P8|STARTED|Apheresis Period||0
242412|NCT00001832|578012|P7|STARTED|Apheresis Period||0
242413|NCT00001832|578013|P6|STARTED|Apheresis Period||0
242414|NCT00001832|578014|P5|STARTED|Apheresis Period||0
242415|NCT00001832|578015|P4|STARTED|Apheresis Period||0
242416|NCT00001832|578016|P3|STARTED|Apheresis Period||0
242417|NCT00001832|578017|P2|STARTED|Apheresis Period||0
242418|NCT00001832|578018|P1|STARTED|Apheresis Period||170
242419|NCT00001723|578064|P2|NOT COMPLETED|Overall Study||16
242420|NCT00001723|578065|P1|NOT COMPLETED|Overall Study||13
242421|NCT00001723|578064|P2|COMPLETED|Overall Study||84
242422|NCT00001723|578065|P1|COMPLETED|Overall Study||87
242423|NCT00001723|578064|P2|STARTED|Overall Study||100
242424|NCT00001723|578065|P1|STARTED|Overall Study||100
242425|NCT00001703|578081|P1|NOT COMPLETED|Overall Study||5
242426|NCT00001703|578081|P1|COMPLETED|Overall Study||1
242427|NCT00001703|578081|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
242428|NCT00001703|578081|P1|STARTED|Overall Study||6
242429|NCT00001656|578088|P2|NOT COMPLETED|Overall Study||0
242430|NCT00001656|578089|P1|NOT COMPLETED|Overall Study||1
242431|NCT00001656|578088|P2|COMPLETED|Overall Study||12
242432|NCT00001656|578089|P1|COMPLETED|Overall Study||12
242433|NCT00001656|578088|P2|STARTED|Overall Study||12
242434|NCT00001656|578089|P1|STARTED|Overall Study||13
242435|NCT00001596|578119|P2|NOT COMPLETED|Overall Study||10
242436|NCT00001596|578120|P1|NOT COMPLETED|Overall Study||17
242437|NCT00001596|578119|P2|COMPLETED|Overall Study||2
242438|NCT00001596|578120|P1|COMPLETED|Overall Study||6
242439|NCT00001596|578119|P2|STARTED|Overall Study||12
242440|NCT00001596|578120|P1|STARTED|Overall Study||23
242441|NCT00001586|578142|P2|NOT COMPLETED|Overall Study||0
242442|NCT00001586|578143|P1|NOT COMPLETED|Overall Study||0
242443|NCT00001586|578142|P2|COMPLETED|Overall Study||56
242444|NCT00001586|578143|P1|COMPLETED|Overall Study||49
242445|NCT00001586|578142|P2|STARTED|Overall Study||56
242446|NCT00001586|578143|P1|STARTED|Overall Study||49
242447|NCT00001575|578151|P1|NOT COMPLETED|Overall Study||45
242448|NCT00001575|578151|P1|COMPLETED|Overall Study||42
242449|NCT00001575|578151|P1|Treated|Overall Study||65
242450|NCT00001575|578151|P1|STARTED|Overall Study||87
242451|NCT00001566|578157|P1|NOT COMPLETED|Overall Study||19
242452|NCT00001566|578157|P1|COMPLETED|Overall Study||23
242453|NCT00001566|578157|P1|Completed Immunotherapy|Overall Study||23
242454|NCT00001566|578157|P1|STARTED|Overall Study||42
242455|NCT00001304|578171|P2|NOT COMPLETED|Overall Study||0
242456|NCT00001304|578172|P1|NOT COMPLETED|Overall Study||0
242457|NCT00001304|578171|P2|COMPLETED|Overall Study||14
242458|NCT00001304|578172|P1|COMPLETED|Overall Study||13
242459|NCT00001304|578171|P2|STARTED|Overall Study||14
242460|NCT00001304|578172|P1|STARTED|Overall Study||13
242461|NCT00001262|578193|P3|NOT COMPLETED|Overall Study||0
242462|NCT00001262|578194|P2|NOT COMPLETED|Overall Study||14
242463|NCT00001262|578195|P1|NOT COMPLETED|Overall Study||10
242464|NCT00001262|578193|P3|COMPLETED|Overall Study||3
242465|NCT00001262|578194|P2|COMPLETED|Overall Study||8
242466|NCT00001262|578195|P1|COMPLETED|Overall Study||25
242467|NCT00001262|578193|P3|STARTED|Overall Study||3
242468|NCT00001262|578194|P2|STARTED|Overall Study||22
242469|NCT00001262|578195|P1|STARTED|Overall Study||35
242470|NCT00001213|578221|P1|NOT COMPLETED|Overall Study||18
242471|NCT00001213|578221|P1|COMPLETED|Overall Study||310
242472|NCT00001213|578221|P1|STARTED|Overall Study||328
242473|NCT00001151|578226|P1|NOT COMPLETED|Overall Study||5
242474|NCT00001151|578226|P1|COMPLETED|Overall Study||1
242475|NCT00001151|578226|P1|STARTED|Overall Study||6
242476|NCT00000620|578232|P8|NOT COMPLETED|Overall Study||146
242477|NCT00000620|578233|P7|NOT COMPLETED|Overall Study||149
242478|NCT00000620|578234|P6|NOT COMPLETED|Overall Study||152
242479|NCT00000620|578235|P5|NOT COMPLETED|Overall Study||135
242480|NCT00000620|578236|P4|NOT COMPLETED|Overall Study||178
242481|NCT00000620|578237|P3|NOT COMPLETED|Overall Study||170
242482|NCT00000620|578238|P2|NOT COMPLETED|Overall Study||136
242483|NCT00000620|578239|P1|NOT COMPLETED|Overall Study||162
242484|NCT00000620|578232|P8|COMPLETED|Overall Study||1224
242485|NCT00000620|578233|P7|COMPLETED|Overall Study||1242
242486|NCT00000620|578234|P6|COMPLETED|Overall Study||1026
242487|NCT00000620|578235|P5|COMPLETED|Overall Study||1049
242488|NCT00000620|578236|P4|COMPLETED|Overall Study||1205
242489|NCT00000620|578237|P3|COMPLETED|Overall Study||1204
242490|NCT00000620|578238|P2|COMPLETED|Overall Study||1057
242491|NCT00000620|578239|P1|COMPLETED|Overall Study||1016
242492|NCT00000620|578232|P8|STARTED|Overall Study||1370
242493|NCT00000620|578233|P7|STARTED|Overall Study||1391
242494|NCT00000620|578234|P6|STARTED|Overall Study||1178
242495|NCT00000620|578235|P5|STARTED|Overall Study||1184
242496|NCT00000620|578236|P4|STARTED|Overall Study||1383
242497|NCT00000620|578237|P3|STARTED|Overall Study||1374
242498|NCT00000620|578238|P2|STARTED|Overall Study||1193
242499|NCT00000620|578239|P1|STARTED|Overall Study||1178
242500|NCT00000575|578258|P3|NOT COMPLETED|Overall Study||0
242501|NCT00000575|578259|P2|NOT COMPLETED|Overall Study||0
242502|NCT00000575|578260|P1|NOT COMPLETED|Overall Study||0
242503|NCT00000575|578258|P3|COMPLETED|Overall Study||418
242504|NCT00000575|578259|P2|COMPLETED|Overall Study||312
242505|NCT00000575|578260|P1|COMPLETED|Overall Study||311
242506|NCT00000575|578258|P3|STARTED|Overall Study||418
242507|NCT00000575|578259|P2|STARTED|Overall Study||312
242508|NCT00000575|578260|P1|STARTED|Overall Study||311
242509|NCT00000479|578290|P4|NOT COMPLETED|Overall Study||0
242510|NCT00000479|578291|P3|NOT COMPLETED|Overall Study||0
242511|NCT00000479|578292|P2|NOT COMPLETED|Overall Study||0
242512|NCT00000479|578293|P1|NOT COMPLETED|Overall Study||0
242513|NCT00000479|578290|P4|COMPLETED|Overall Study||9971
242514|NCT00000479|578291|P3|COMPLETED|Overall Study||9966
242515|NCT00000479|578292|P2|COMPLETED|Overall Study||9971
242516|NCT00000479|578293|P1|COMPLETED|Overall Study||9968
242517|NCT00000479|578290|P4|STARTED|Overall Study||9971
242518|NCT00000479|578291|P3|STARTED|Overall Study||9966
242519|NCT00000479|578292|P2|STARTED|Overall Study||9971
242520|NCT00000479|578293|P1|STARTED|Overall Study||9968
242521|NCT00000392|578309|P2|NOT COMPLETED|Overall Study||32
242522|NCT00000392|578310|P1|NOT COMPLETED|Overall Study||40
242523|NCT00000392|578309|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
242524|NCT00000392|578310|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
242525|NCT00000392|578309|P2|STARTED|Overall Study||109
242526|NCT00000392|578310|P1|STARTED|Overall Study||106
242527|NCT00000378|578320|P2|NOT COMPLETED|Overall Study||14
242528|NCT00000378|578321|P1|NOT COMPLETED|Overall Study||16
242529|NCT00000378|578320|P2|COMPLETED|Overall Study||38
242530|NCT00000378|578321|P1|COMPLETED|Overall Study||42
242531|NCT00000378|578320|P2|STARTED|Overall Study||52
242532|NCT00000378|578321|P1|STARTED|Overall Study||58
242533|NCT00000371|578329|P2|NOT COMPLETED|Overall Study||16
242534|NCT00000371|578330|P1|NOT COMPLETED|Overall Study||13
242535|NCT00000371|578329|P2|COMPLETED|Overall Study||12
242536|NCT00000371|578330|P1|COMPLETED|Overall Study||14
242537|NCT00000371|578329|P2|STARTED|Overall Study||28
242538|NCT00000371|578330|P1|STARTED|Overall Study||27
242539|NCT00000143|578338|P2|NOT COMPLETED|Overall Study||0
242540|NCT00000143|578339|P1|NOT COMPLETED|Overall Study||0
242541|NCT00000143|578338|P2|COMPLETED|Overall Study||30
242542|NCT00000143|578339|P1|COMPLETED|Overall Study||31
242543|NCT00000143|578338|P2|STARTED|Overall Study||30
242544|NCT00000143|578339|P1|STARTED|Overall Study||31
242545|NCT00000142|578348|P3|NOT COMPLETED|Overall Study||0
242546|NCT00000142|578349|P2|NOT COMPLETED|Overall Study||0
242547|NCT00000142|578350|P1|NOT COMPLETED|Overall Study||0
242548|NCT00000142|578348|P3|COMPLETED|Overall Study||12
242549|NCT00000142|578349|P2|COMPLETED|Overall Study||26
242550|NCT00000142|578350|P1|COMPLETED|Overall Study||26
242551|NCT00000142|578348|P3|STARTED|Overall Study||12
242552|NCT00000142|578349|P2|STARTED|Overall Study||26
242553|NCT00000142|578350|P1|STARTED|Overall Study||26
242554|NCT00000136|578360|P2|NOT COMPLETED|Overall Study||0
242555|NCT00000136|578361|P1|NOT COMPLETED|Overall Study||0
242556|NCT00000136|578360|P2|COMPLETED|Overall Study||127
242557|NCT00000136|578361|P1|COMPLETED|Overall Study||107
242558|NCT00000136|578360|P2|STARTED|Overall Study||127
242559|NCT00000136|578361|P1|STARTED|Overall Study||107
242560|NCT00000135|578369|P2|NOT COMPLETED|Overall Study||14
242561|NCT00000135|578370|P1|NOT COMPLETED|Overall Study||27
242562|NCT00000135|578369|P2|COMPLETED|Overall Study||91
242563|NCT00000135|578370|P1|COMPLETED|Overall Study||77
242564|NCT00000135|578369|P2|STARTED|Overall Study||105
242565|NCT00000135|578370|P1|STARTED|Overall Study||104
242566|NCT00000134|578379|P3|NOT COMPLETED|Overall Study||0
242567|NCT00000134|578380|P2|NOT COMPLETED|Overall Study||0
242568|NCT00000134|578381|P1|NOT COMPLETED|Overall Study||0
242569|NCT00000134|578379|P3|COMPLETED|Overall Study||96
242570|NCT00000134|578380|P2|COMPLETED|Overall Study||94
242571|NCT00000134|578381|P1|COMPLETED|Overall Study||89
242572|NCT00000134|578379|P3|STARTED|Overall Study||96
242573|NCT00000134|578380|P2|STARTED|Overall Study||94
242574|NCT00000134|578381|P1|STARTED|Overall Study||89
242575|NCT00000125|578391|P2|NOT COMPLETED|Overall Study||238
242576|NCT00000125|578392|P1|NOT COMPLETED|Overall Study||239
242577|NCT00000125|578391|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
242578|NCT00000125|578392|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
242579|NCT00000125|578391|P2|Completed OHTS Phase I, June 2002|Overall Study||702
242580|NCT00000125|578392|P1|Completed OHTS Phase I, June 2002|Overall Study||706
242581|NCT00000125|578391|P2|STARTED|Overall Study||817
242582|NCT00000125|578392|P1|STARTED|Overall Study||819
